id	sid	tid	token	lemma	pos
46745	1	1	THE	the	DT
46745	1	2	ACTION	action	NN
46745	1	3	OF	of	IN
46745	1	4	MEDICINES	medicine	NNS
46745	1	5	IN	in	IN
46745	1	6	THE	the	DT
46745	1	7	SYSTEM	system	NN
46745	1	8	;	;	:
46745	1	9	OR	or	CC
46745	1	10	,	,	,
46745	1	11	"	"	''
46745	1	12	ON	on	IN
46745	1	13	THE	the	DT
46745	1	14	MODE	MODE	NNP
46745	1	15	IN	in	IN
46745	1	16	WHICH	which	WDT
46745	1	17	THERAPEUTIC	therapeutic	VBP
46745	1	18	AGENTS	agents	JJ
46745	1	19	INTRODUCED	INTRODUCED	NNS
46745	1	20	INTO	into	VBP
46745	1	21	THE	the	DT
46745	1	22	STOMACH	STOMACH	NNP
46745	1	23	PRODUCE	PRODUCE	NNP
46745	1	24	THEIR	their	NN
46745	1	25	PECULIAR	peculiar	JJ
46745	1	26	EFFECTS	effect	NNS
46745	1	27	ON	on	IN
46745	1	28	THE	the	DT
46745	1	29	ANIMAL	ANIMAL	NNP
46745	1	30	ECONOMY	ECONOMY	NNS
46745	1	31	.	.	.
46745	1	32	"	"	''
46745	2	1	Being	be	VBG
46745	2	2	the	the	DT
46745	2	3	Prize	Prize	NNP
46745	2	4	Essay	Essay	NNP
46745	2	5	TO	to	IN
46745	2	6	WHICH	which	WDT
46745	2	7	THE	the	DT
46745	2	8	MEDICAL	MEDICAL	NNP
46745	2	9	SOCIETY	SOCIETY	NNP
46745	2	10	OF	of	IN
46745	2	11	LONDON	LONDON	NNP
46745	2	12	AWARDED	AWARDED	NNP
46745	2	13	THE	the	DT
46745	2	14	FOTHERGILLIAN	FOTHERGILLIAN	NNP
46745	2	15	GOLD	gold	NN
46745	2	16	MEDAL	medal	NN
46745	2	17	FOR	for	IN
46745	2	18	MDCCCLII	MDCCCLII	NNP
46745	2	19	.	.	.
46745	3	1	BY	by	IN
46745	3	2	FREDERICK	FREDERICK	NNP
46745	3	3	WILLIAM	WILLIAM	NNPS
46745	3	4	HEADLAND	HEADLAND	NNP
46745	3	5	,	,	,
46745	3	6	B.A.	B.A.	NNP
46745	3	7	,	,	,
46745	3	8	M.	M.	NNP
46745	3	9	R.	R.	NNP
46745	3	10	C.	C.	NNP
46745	3	11	S.	S.	NNP
46745	3	12	,	,	,
46745	3	13	ETC	ETC	NNP
46745	3	14	.	.	.
46745	4	1	[	[	-LRB-
46745	4	2	Illustration	illustration	NN
46745	4	3	]	]	-RRB-
46745	4	4	PHILADELPHIA	PHILADELPHIA	NNP
46745	4	5	:	:	:
46745	4	6	LINDSAY	LINDSAY	NNP
46745	4	7	AND	and	CC
46745	4	8	BLAKISTON	BLAKISTON	NNP
46745	4	9	.	.	.
46745	5	1	1853	1853	CD
46745	5	2	.	.	.
46745	6	1	WM	WM	NNP
46745	6	2	.	.	.
46745	7	1	S.	S.	NNP
46745	7	2	YOUNG	YOUNG	NNP
46745	7	3	PRINTER	printer	NN
46745	7	4	TO	to	IN
46745	7	5	THE	the	DT
46745	7	6	PRESIDENT	PRESIDENT	NNP
46745	7	7	,	,	,
46745	7	8	OFFICERS	OFFICERS	NNP
46745	7	9	,	,	,
46745	7	10	AND	and	CC
46745	7	11	FELLOWS	FELLOWS	NNP
46745	7	12	OF	of	IN
46745	7	13	THE	the	DT
46745	7	14	MEDICAL	MEDICAL	NNP
46745	7	15	SOCIETY	SOCIETY	NNP
46745	7	16	OF	of	IN
46745	7	17	LONDON	LONDON	NNP
46745	7	18	,	,	,
46745	7	19	This	this	DT
46745	7	20	Essay	Essay	NNP
46745	7	21	IS	be	VBZ
46745	7	22	RESPECTFULLY	RESPECTFULLY	NNP
46745	7	23	INSCRIBED	inscribe	VBN
46745	7	24	,	,	,
46745	7	25	BY	by	IN
46745	7	26	THEIR	their	FW
46745	7	27	VERY	very	RB
46745	7	28	OBLIGED	oblige	VBN
46745	7	29	FRIEND	friend	NN
46745	7	30	AND	and	CC
46745	7	31	SERVANT	servant	NN
46745	7	32	,	,	,
46745	7	33	THE	the	DT
46745	7	34	AUTHOR	AUTHOR	NNP
46745	7	35	.	.	.
46745	8	1	CONTENTS	content	NNS
46745	8	2	.	.	.
46745	9	1	CHAPTER	CHAPTER	NNP
46745	9	2	I.	I.	NNP
46745	10	1	PAGE	page	NN
46745	10	2	INTRODUCTORY	INTRODUCTORY	NNP
46745	10	3	REMARKS	remarks	NN
46745	10	4	13	13	CD
46745	10	5	CHAPTER	chapter	NN
46745	10	6	II	ii	CD
46745	10	7	.	.	.
46745	11	1	ON	on	IN
46745	11	2	SOME	SOME	NNP
46745	11	3	OF	of	IN
46745	11	4	THE	the	DT
46745	11	5	MORE	more	RBR
46745	11	6	IMPORTANT	important	JJ
46745	11	7	CLASSIFICATIONS	classification	NNS
46745	11	8	OF	of	IN
46745	11	9	MEDICINES	medicine	NNS
46745	11	10	,	,	,
46745	11	11	AND	and	CC
46745	11	12	OPINIONS	opinions	NN
46745	11	13	OF	of	IN
46745	11	14	AUTHORS	author	NNS
46745	11	15	RESPECTING	respect	VBG
46745	11	16	THEIR	their	NN
46745	11	17	ACTIONS	ACTIONS	NNP
46745	11	18	29	29	CD
46745	11	19	CHAPTER	chapter	NN
46745	11	20	III	iii	CD
46745	11	21	.	.	.
46745	12	1	ON	on	IN
46745	12	2	THE	the	DT
46745	12	3	GENERAL	GENERAL	NNP
46745	12	4	MODES	MODES	NNP
46745	12	5	OF	of	IN
46745	12	6	ACTION	action	NN
46745	12	7	OF	of	IN
46745	12	8	THERAPEUTIC	therapeutic	JJ
46745	12	9	AGENTS	agents	JJ
46745	12	10	INTRODUCED	INTRODUCED	NNS
46745	12	11	INTO	into	VBP
46745	12	12	THE	the	DT
46745	12	13	STOMACH	STOMACH	NNP
46745	12	14	;	;	,
46745	12	15	TREATED	TREATED	NNP
46745	12	16	OF	of	IN
46745	12	17	IN	in	IN
46745	12	18	TEN	TEN	NNP
46745	12	19	PROPOSITIONS	proposition	NNS
46745	12	20	60	60	CD
46745	12	21	PROP	PROP	NNS
46745	12	22	.	.	.
46745	13	1	I.	I.	NNP
46745	14	1	61	61	CD
46745	14	2	That	that	IN
46745	14	3	the	the	DT
46745	14	4	great	great	JJ
46745	14	5	majority	majority	NN
46745	14	6	of	of	IN
46745	14	7	medicines	medicine	NNS
46745	14	8	must	must	MD
46745	14	9	obtain	obtain	VB
46745	14	10	entry	entry	NN
46745	14	11	into	into	IN
46745	14	12	the	the	DT
46745	14	13	blood	blood	NN
46745	14	14	,	,	,
46745	14	15	or	or	CC
46745	14	16	internal	internal	JJ
46745	14	17	fluids	fluid	NNS
46745	14	18	of	of	IN
46745	14	19	the	the	DT
46745	14	20	body	body	NN
46745	14	21	,	,	,
46745	14	22	before	before	IN
46745	14	23	their	-PRON-	PRP$
46745	14	24	action	action	NN
46745	14	25	can	can	MD
46745	14	26	be	be	VB
46745	14	27	manifested	manifest	VBN
46745	14	28	.	.	.
46745	15	1	PROP	PROP	NNP
46745	15	2	.	.	.
46745	16	1	II	ii	CD
46745	16	2	.	.	.
46745	17	1	68	68	CD
46745	17	2	That	that	IN
46745	17	3	the	the	DT
46745	17	4	great	great	JJ
46745	17	5	majority	majority	NN
46745	17	6	of	of	IN
46745	17	7	medicines	medicine	NNS
46745	17	8	are	be	VBP
46745	17	9	capable	capable	JJ
46745	17	10	of	of	IN
46745	17	11	solution	solution	NN
46745	17	12	in	in	IN
46745	17	13	the	the	DT
46745	17	14	gastric	gastric	JJ
46745	17	15	or	or	CC
46745	17	16	intestinal	intestinal	JJ
46745	17	17	secretions	secretion	NNS
46745	17	18	,	,	,
46745	17	19	and	and	CC
46745	17	20	pass	pass	VB
46745	17	21	without	without	IN
46745	17	22	material	material	NN
46745	17	23	change	change	NN
46745	17	24	,	,	,
46745	17	25	by	by	IN
46745	17	26	a	a	DT
46745	17	27	process	process	NN
46745	17	28	of	of	IN
46745	17	29	absorption	absorption	NN
46745	17	30	,	,	,
46745	17	31	through	through	IN
46745	17	32	the	the	DT
46745	17	33	coats	coat	NNS
46745	17	34	of	of	IN
46745	17	35	the	the	DT
46745	17	36	stomach	stomach	NN
46745	17	37	and	and	CC
46745	17	38	intestines	intestine	NNS
46745	17	39	,	,	,
46745	17	40	to	to	TO
46745	17	41	enter	enter	VB
46745	17	42	the	the	DT
46745	17	43	capillaries	capillary	NNS
46745	17	44	of	of	IN
46745	17	45	the	the	DT
46745	17	46	Portal	Portal	NNP
46745	17	47	system	system	NN
46745	17	48	of	of	IN
46745	17	49	veins	vein	NNS
46745	17	50	.	.	.
46745	18	1	PROP	PROP	NNP
46745	18	2	.	.	.
46745	19	1	III	iii	CD
46745	19	2	.	.	.
46745	20	1	87	87	CD
46745	20	2	That	that	IN
46745	20	3	those	those	DT
46745	20	4	medicines	medicine	NNS
46745	20	5	which	which	WDT
46745	20	6	are	be	VBP
46745	20	7	completely	completely	RB
46745	20	8	insoluble	insoluble	JJ
46745	20	9	in	in	IN
46745	20	10	water	water	NN
46745	20	11	,	,	,
46745	20	12	and	and	CC
46745	20	13	in	in	IN
46745	20	14	the	the	DT
46745	20	15	gastric	gastric	JJ
46745	20	16	and	and	CC
46745	20	17	intestinal	intestinal	JJ
46745	20	18	juices	juice	NNS
46745	20	19	,	,	,
46745	20	20	can	can	MD
46745	20	21	not	not	RB
46745	20	22	gain	gain	VB
46745	20	23	entrance	entrance	NN
46745	20	24	into	into	IN
46745	20	25	the	the	DT
46745	20	26	circulation	circulation	NN
46745	20	27	.	.	.
46745	21	1	PROP	PROP	NNP
46745	21	2	.	.	.
46745	22	1	IV	IV	NNP
46745	22	2	.	.	.
46745	23	1	90	90	CD
46745	23	2	That	that	IN
46745	23	3	some	some	DT
46745	23	4	few	few	JJ
46745	23	5	remedial	remedial	JJ
46745	23	6	agents	agent	NNS
46745	23	7	act	act	VBP
46745	23	8	locally	locally	RB
46745	23	9	on	on	IN
46745	23	10	the	the	DT
46745	23	11	mucous	mucous	JJ
46745	23	12	surface	surface	NN
46745	23	13	,	,	,
46745	23	14	either	either	CC
46745	23	15	before	before	IN
46745	23	16	absorption	absorption	NN
46745	23	17	,	,	,
46745	23	18	or	or	CC
46745	23	19	without	without	IN
46745	23	20	being	be	VBG
46745	23	21	absorbed	absorb	VBN
46745	23	22	at	at	RB
46745	23	23	all	all	RB
46745	23	24	.	.	.
46745	24	1	That	that	IN
46745	24	2	they	-PRON-	PRP
46745	24	3	are	be	VBP
46745	24	4	chiefly	chiefly	RB
46745	24	5	as	as	IN
46745	24	6	follow:--	follow:--	NNP
46745	24	7	_	_	NNP
46745	24	8	a.	a.	NN
46745	24	9	_	_	NNP
46745	24	10	Irritant	Irritant	NNP
46745	24	11	Emetics	Emetics	NNP
46745	24	12	.	.	.
46745	25	1	_	_	NNP
46745	25	2	b.	b.	NN
46745	25	3	_	_	NNP
46745	25	4	Stomach	Stomach	NNP
46745	25	5	Anæsthetics	Anæsthetics	NNP
46745	25	6	,	,	,
46745	25	7	_	_	NNP
46745	25	8	c.	c.	NN
46745	25	9	_	_	NNP
46745	25	10	Irritant	Irritant	NNP
46745	25	11	Cathartics	Cathartics	NNP
46745	25	12	.	.	.
46745	26	1	PROP	PROP	NNP
46745	26	2	.	.	.
46745	27	1	V.	V.	NNP
46745	27	2	98	98	CD
46745	27	3	That	that	IN
46745	27	4	the	the	DT
46745	27	5	medicine	medicine	NN
46745	27	6	,	,	,
46745	27	7	when	when	WRB
46745	27	8	in	in	IN
46745	27	9	the	the	DT
46745	27	10	blood	blood	NN
46745	27	11	,	,	,
46745	27	12	must	must	MD
46745	27	13	permeate	permeate	VB
46745	27	14	the	the	DT
46745	27	15	mass	mass	NN
46745	27	16	of	of	IN
46745	27	17	the	the	DT
46745	27	18	circulation	circulation	NN
46745	27	19	,	,	,
46745	27	20	so	so	RB
46745	27	21	far	far	RB
46745	27	22	as	as	IN
46745	27	23	may	may	MD
46745	27	24	be	be	VB
46745	27	25	required	require	VBN
46745	27	26	to	to	TO
46745	27	27	reach	reach	VB
46745	27	28	the	the	DT
46745	27	29	parts	part	NNS
46745	27	30	on	on	IN
46745	27	31	which	which	WDT
46745	27	32	it	-PRON-	PRP
46745	27	33	tends	tend	VBZ
46745	27	34	to	to	TO
46745	27	35	act	act	VB
46745	27	36	.	.	.
46745	28	1	That	that	IN
46745	28	2	there	there	EX
46745	28	3	are	be	VBP
46745	28	4	two	two	CD
46745	28	5	possible	possible	JJ
46745	28	6	exceptions	exception	NNS
46745	28	7	to	to	IN
46745	28	8	this	this	DT
46745	28	9	rule:--	rule:--	NNP
46745	28	10	_	_	NNP
46745	28	11	a.	a.	NN
46745	28	12	_	_	NNP
46745	28	13	The	the	DT
46745	28	14	production	production	NN
46745	28	15	of	of	IN
46745	28	16	sensation	sensation	NN
46745	28	17	or	or	CC
46745	28	18	pain	pain	NN
46745	28	19	at	at	IN
46745	28	20	a	a	DT
46745	28	21	distant	distant	JJ
46745	28	22	point	point	NN
46745	28	23	.	.	.
46745	29	1	_	_	NNP
46745	29	2	b.	b.	NN
46745	29	3	_	_	NNP
46745	29	4	The	the	DT
46745	29	5	production	production	NN
46745	29	6	of	of	IN
46745	29	7	muscular	muscular	JJ
46745	29	8	contraction	contraction	NN
46745	29	9	at	at	IN
46745	29	10	a	a	DT
46745	29	11	distant	distant	JJ
46745	29	12	point	point	NN
46745	29	13	.	.	.
46745	30	1	PROP	PROP	NNP
46745	30	2	.	.	.
46745	31	1	VI	VI	NNP
46745	31	2	.	.	.
46745	32	1	103	103	CD
46745	32	2	That	that	IN
46745	32	3	while	while	IN
46745	32	4	in	in	IN
46745	32	5	the	the	DT
46745	32	6	blood	blood	NN
46745	32	7	the	the	DT
46745	32	8	medicine	medicine	NN
46745	32	9	may	may	MD
46745	32	10	undergo	undergo	VB
46745	32	11	changes	change	NNS
46745	32	12	,	,	,
46745	32	13	which	which	WDT
46745	32	14	in	in	IN
46745	32	15	some	some	DT
46745	32	16	cases	case	NNS
46745	32	17	may	may	MD
46745	32	18	,	,	,
46745	32	19	in	in	IN
46745	32	20	others	other	NNS
46745	32	21	may	may	MD
46745	32	22	not	not	RB
46745	32	23	,	,	,
46745	32	24	affect	affect	VB
46745	32	25	its	-PRON-	PRP$
46745	32	26	influence	influence	NN
46745	32	27	.	.	.
46745	33	1	That	that	IN
46745	33	2	these	these	DT
46745	33	3	changes	change	NNS
46745	33	4	may	may	MD
46745	33	5	be--	be--	NNP
46745	33	6	_	_	NNP
46745	33	7	a.	a.	NN
46745	33	8	_	_	NNP
46745	33	9	Of	of	IN
46745	33	10	Combination	Combination	NNP
46745	33	11	.	.	.
46745	34	1	_	_	NNP
46745	34	2	b.	b.	NNP
46745	34	3	_	_	NNP
46745	34	4	Of	of	IN
46745	34	5	Reconstruction	Reconstruction	NNP
46745	34	6	.	.	.
46745	35	1	_	_	NNP
46745	35	2	c.	c.	NNP
46745	35	3	_	_	NNP
46745	35	4	Of	of	IN
46745	35	5	Decomposition	Decomposition	NNP
46745	35	6	.	.	.
46745	36	1	PROP	PROP	NNP
46745	36	2	.	.	.
46745	37	1	VII	VII	NNP
46745	37	2	.	.	.
46745	38	1	106	106	CD
46745	38	2	That	that	IN
46745	38	3	a	a	DT
46745	38	4	first	first	JJ
46745	38	5	class	class	NN
46745	38	6	of	of	IN
46745	38	7	medicines	medicine	NNS
46745	38	8	,	,	,
46745	38	9	called	call	VBN
46745	38	10	Hæmatics	Hæmatics	NNP
46745	38	11	,	,	,
46745	38	12	act	act	VB
46745	38	13	while	while	IN
46745	38	14	in	in	IN
46745	38	15	the	the	DT
46745	38	16	blood	blood	NN
46745	38	17	,	,	,
46745	38	18	which	which	WDT
46745	38	19	they	-PRON-	PRP
46745	38	20	influence	influence	VBP
46745	38	21	.	.	.
46745	39	1	That	that	IN
46745	39	2	their	-PRON-	PRP$
46745	39	3	action	action	NN
46745	39	4	is	be	VBZ
46745	39	5	permanent	permanent	JJ
46745	39	6	.	.	.
46745	40	1	1	1	LS
46745	40	2	.	.	.
46745	41	1	That	that	DT
46745	41	2	of	of	IN
46745	41	3	these	these	DT
46745	41	4	some	some	DT
46745	41	5	,	,	,
46745	41	6	called	call	VBN
46745	41	7	Restoratives	Restoratives	NNP
46745	41	8	,	,	,
46745	41	9	act	act	VB
46745	41	10	by	by	IN
46745	41	11	supplying	supply	VBG
46745	41	12	,	,	,
46745	41	13	or	or	CC
46745	41	14	causing	cause	VBG
46745	41	15	to	to	TO
46745	41	16	be	be	VB
46745	41	17	supplied	supply	VBN
46745	41	18	,	,	,
46745	41	19	a	a	DT
46745	41	20	material	material	NN
46745	41	21	wanting	want	VBG
46745	41	22	;	;	:
46745	41	23	and	and	CC
46745	41	24	may	may	MD
46745	41	25	remain	remain	VB
46745	41	26	in	in	IN
46745	41	27	the	the	DT
46745	41	28	blood	blood	NN
46745	41	29	.	.	.
46745	42	1	2	2	LS
46745	42	2	.	.	.
46745	43	1	That	that	IN
46745	43	2	others	other	NNS
46745	43	3	,	,	,
46745	43	4	called	call	VBD
46745	43	5	Catalytics	Catalytics	NNP
46745	43	6	,	,	,
46745	43	7	act	act	VBP
46745	43	8	so	so	IN
46745	43	9	as	as	IN
46745	43	10	to	to	TO
46745	43	11	counteract	counteract	VB
46745	43	12	a	a	DT
46745	43	13	morbid	morbid	NN
46745	43	14	material	material	NN
46745	43	15	or	or	CC
46745	43	16	process	process	NN
46745	43	17	;	;	:
46745	43	18	and	and	CC
46745	43	19	must	must	MD
46745	43	20	pass	pass	VB
46745	43	21	out	out	IN
46745	43	22	of	of	IN
46745	43	23	the	the	DT
46745	43	24	body	body	NN
46745	43	25	.	.	.
46745	44	1	PROP	PROP	NNP
46745	44	2	.	.	.
46745	45	1	VIII	VIII	NNP
46745	45	2	.	.	.
46745	46	1	217	217	CD
46745	46	2	That	that	IN
46745	46	3	a	a	DT
46745	46	4	second	second	JJ
46745	46	5	class	class	NN
46745	46	6	of	of	IN
46745	46	7	medicines	medicine	NNS
46745	46	8	,	,	,
46745	46	9	called	call	VBN
46745	46	10	Neurotics	Neurotics	NNP
46745	46	11	,	,	,
46745	46	12	act	act	NN
46745	46	13	by	by	IN
46745	46	14	passing	pass	VBG
46745	46	15	from	from	IN
46745	46	16	the	the	DT
46745	46	17	blood	blood	NN
46745	46	18	to	to	IN
46745	46	19	the	the	DT
46745	46	20	nerves	nerve	NNS
46745	46	21	or	or	CC
46745	46	22	nerve	nerve	NN
46745	46	23	-	-	HYPH
46745	46	24	centres	centre	NNS
46745	46	25	,	,	,
46745	46	26	which	which	WDT
46745	46	27	they	-PRON-	PRP
46745	46	28	influence	influence	VBP
46745	46	29	.	.	.
46745	47	1	That	that	IN
46745	47	2	they	-PRON-	PRP
46745	47	3	are	be	VBP
46745	47	4	transitory	transitory	JJ
46745	47	5	in	in	IN
46745	47	6	action	action	NN
46745	47	7	.	.	.
46745	48	1	1	1	LS
46745	48	2	.	.	.
46745	49	1	That	that	DT
46745	49	2	of	of	IN
46745	49	3	these	these	DT
46745	49	4	some	some	DT
46745	49	5	,	,	,
46745	49	6	called	call	VBN
46745	49	7	stimulants	stimulant	NNS
46745	49	8	,	,	,
46745	49	9	act	act	VB
46745	49	10	so	so	IN
46745	49	11	as	as	IN
46745	49	12	to	to	TO
46745	49	13	exalt	exalt	VB
46745	49	14	nervous	nervous	JJ
46745	49	15	force	force	NN
46745	49	16	,	,	,
46745	49	17	in	in	IN
46745	49	18	general	general	JJ
46745	49	19	or	or	CC
46745	49	20	in	in	IN
46745	49	21	particular	particular	JJ
46745	49	22	.	.	.
46745	50	1	2	2	LS
46745	50	2	.	.	.
46745	51	1	That	that	IN
46745	51	2	others	other	NNS
46745	51	3	called	call	VBD
46745	51	4	Narcotics	Narcotics	NNP
46745	51	5	,	,	,
46745	51	6	act	act	VB
46745	51	7	so	so	RB
46745	51	8	as	as	IN
46745	51	9	first	first	JJ
46745	51	10	to	to	TO
46745	51	11	exalt	exalt	VB
46745	51	12	nervous	nervous	JJ
46745	51	13	force	force	NN
46745	51	14	,	,	,
46745	51	15	and	and	CC
46745	51	16	then	then	RB
46745	51	17	to	to	TO
46745	51	18	depress	depress	VB
46745	51	19	it	-PRON-	PRP
46745	51	20	;	;	:
46745	51	21	and	and	CC
46745	51	22	have	have	VBP
46745	51	23	also	also	RB
46745	51	24	a	a	DT
46745	51	25	special	special	JJ
46745	51	26	influence	influence	NN
46745	51	27	on	on	IN
46745	51	28	the	the	DT
46745	51	29	intellectual	intellectual	JJ
46745	51	30	part	part	NN
46745	51	31	of	of	IN
46745	51	32	the	the	DT
46745	51	33	brain	brain	NN
46745	51	34	.	.	.
46745	52	1	3	3	LS
46745	52	2	.	.	.
46745	53	1	That	that	IN
46745	53	2	others	other	NNS
46745	53	3	again	again	RB
46745	53	4	,	,	,
46745	53	5	called	call	VBN
46745	53	6	Sedatives	Sedatives	NNP
46745	53	7	,	,	,
46745	53	8	act	act	VB
46745	53	9	so	so	IN
46745	53	10	as	as	IN
46745	53	11	to	to	TO
46745	53	12	depress	depress	VB
46745	53	13	nervous	nervous	JJ
46745	53	14	force	force	NN
46745	53	15	,	,	,
46745	53	16	in	in	IN
46745	53	17	general	general	JJ
46745	53	18	or	or	CC
46745	53	19	in	in	IN
46745	53	20	particular	particular	JJ
46745	53	21	.	.	.
46745	54	1	PROP	PROP	NNP
46745	54	2	.	.	.
46745	55	1	IX	ix	NN
46745	55	2	.	.	.
46745	56	1	256	256	LS
46745	56	2	That	that	IN
46745	56	3	a	a	DT
46745	56	4	third	third	JJ
46745	56	5	class	class	NN
46745	56	6	of	of	IN
46745	56	7	medicines	medicine	NNS
46745	56	8	,	,	,
46745	56	9	called	call	VBN
46745	56	10	Astringents	Astringents	NNP
46745	56	11	,	,	,
46745	56	12	act	act	VB
46745	56	13	by	by	IN
46745	56	14	passing	pass	VBG
46745	56	15	from	from	IN
46745	56	16	the	the	DT
46745	56	17	blood	blood	NN
46745	56	18	to	to	IN
46745	56	19	muscular	muscular	JJ
46745	56	20	fibre	fibre	NNP
46745	56	21	,	,	,
46745	56	22	which	which	WDT
46745	56	23	they	-PRON-	PRP
46745	56	24	excite	excite	VBP
46745	56	25	to	to	IN
46745	56	26	contraction	contraction	NN
46745	56	27	.	.	.
46745	57	1	PROP	PROP	NNP
46745	57	2	.	.	.
46745	58	1	X.	X.	NNP
46745	59	1	268	268	CD
46745	59	2	That	that	IN
46745	59	3	a	a	DT
46745	59	4	fourth	fourth	JJ
46745	59	5	class	class	NN
46745	59	6	of	of	IN
46745	59	7	medicines	medicine	NNS
46745	59	8	,	,	,
46745	59	9	called	call	VBN
46745	59	10	Eliminatives	Eliminatives	NNPS
46745	59	11	,	,	,
46745	59	12	act	act	VB
46745	59	13	by	by	IN
46745	59	14	passing	pass	VBG
46745	59	15	out	out	RP
46745	59	16	the	the	DT
46745	59	17	blood	blood	NN
46745	59	18	through	through	IN
46745	59	19	the	the	DT
46745	59	20	glands	gland	NNS
46745	59	21	,	,	,
46745	59	22	which	which	WDT
46745	59	23	they	-PRON-	PRP
46745	59	24	excite	excite	VBP
46745	59	25	to	to	IN
46745	59	26	the	the	DT
46745	59	27	performance	performance	NN
46745	59	28	of	of	IN
46745	59	29	their	-PRON-	PRP$
46745	59	30	functions	function	NNS
46745	59	31	.	.	.
46745	60	1	CHAPTER	CHAPTER	NNP
46745	60	2	IV	IV	NNP
46745	60	3	.	.	.
46745	61	1	309	309	CD
46745	61	2	ON	on	IN
46745	61	3	THE	the	DT
46745	61	4	ACTION	action	NN
46745	61	5	OF	of	IN
46745	61	6	SOME	some	NN
46745	61	7	OF	of	IN
46745	61	8	THE	the	DT
46745	61	9	MORE	more	RBR
46745	61	10	IMPORTANT	important	JJ
46745	61	11	MEDICINES	medicine	NNS
46745	61	12	IN	in	IN
46745	61	13	PARTICULAR	PARTICULAR	NNP
46745	61	14	A	A	NNP
46745	61	15	CLASSIFICATION	classification	NN
46745	61	16	OF	of	IN
46745	61	17	MEDICINES	medicine	NNS
46745	61	18	WHICH	which	WDT
46745	61	19	ACT	act	VBP
46745	61	20	AFTER	after	IN
46745	61	21	ENTERING	enter	VBG
46745	61	22	INTO	into	VBP
46745	61	23	THE	the	DT
46745	61	24	BLOOD	blood	NN
46745	61	25	,	,	,
46745	61	26	ACCORDING	accord	VBG
46745	61	27	TO	to	IN
46745	61	28	THEIR	their	NN
46745	61	29	SUPPOSED	supposed	NN
46745	61	30	MODES	MODES	NNP
46745	61	31	OF	of	IN
46745	61	32	OPERATION	operation	NN
46745	61	33	.	.	.
46745	62	1	PAGE	page	NN
46745	62	2	CLASS	CLASS	NNP
46745	62	3	I.	i.	NN
46745	62	4	HÆMATICA	HÆMATICA	NNP
46745	62	5	106	106	CD
46745	62	6	DIV	DIV	NNP
46745	62	7	.	.	.
46745	63	1	I.	I.	NNP
46745	63	2	RESTAURANTIA	RESTAURANTIA	NNP
46745	63	3	113	113	CD
46745	63	4	Ordo	Ordo	NNP
46745	63	5	1	1	CD
46745	63	6	.	.	.
46745	64	1	Alimenta	Alimenta	NNP
46745	64	2	115	115	CD
46745	64	3	Ordo	Ordo	NNP
46745	64	4	2	2	CD
46745	64	5	.	.	.
46745	65	1	Acida	Acida	NNP
46745	65	2	120	120	CD
46745	65	3	Ordo	Ordo	NNP
46745	65	4	3	3	CD
46745	65	5	.	.	.
46745	66	1	Alkalia	Alkalia	NNP
46745	66	2	126	126	CD
46745	66	3	Ordo	Ordo	NNP
46745	66	4	4	4	CD
46745	66	5	.	.	.
46745	67	1	Tonica	Tonica	NNP
46745	67	2	129	129	CD
46745	67	3	Ordo	Ordo	NNP
46745	67	4	5	5	CD
46745	67	5	.	.	.
46745	68	1	Chalybeata	Chalybeata	NNP
46745	68	2	145	145	CD
46745	68	3	Ordo	Ordo	NNP
46745	68	4	6	6	CD
46745	68	5	.	.	.
46745	69	1	Solventia	Solventia	NNP
46745	69	2	149	149	CD
46745	69	3	DIV	div	NN
46745	69	4	.	.	.
46745	70	1	II	ii	CD
46745	70	2	.	.	.
46745	71	1	CATALYTICA	CATALYTICA	NNP
46745	71	2	157	157	CD
46745	71	3	Ordo	ordo	NN
46745	71	4	1	1	CD
46745	71	5	.	.	.
46745	72	1	Antiphlogistica	Antiphlogistica	NNP
46745	72	2	185	185	CD
46745	72	3	Ordo	Ordo	NNP
46745	72	4	2	2	CD
46745	72	5	.	.	.
46745	73	1	Antisyphilitica	Antisyphilitica	NNP
46745	73	2	188	188	CD
46745	73	3	Ordo	Ordo	NNP
46745	73	4	3	3	CD
46745	73	5	.	.	.
46745	74	1	Antiscrofulosa	Antiscrofulosa	NNP
46745	74	2	191	191	CD
46745	74	3	Ordo	Ordo	NNP
46745	74	4	4	4	CD
46745	74	5	.	.	.
46745	75	1	Antiarthritica	Antiarthritica	NNP
46745	75	2	194	194	CD
46745	75	3	Ordo	Ordo	NNP
46745	75	4	5	5	CD
46745	75	5	.	.	.
46745	76	1	Antiscorbutica	Antiscorbutica	NNP
46745	76	2	205	205	CD
46745	76	3	Ordo	Ordo	NNP
46745	76	4	6	6	CD
46745	76	5	.	.	.
46745	77	1	Antiperiodica	Antiperiodica	NNP
46745	77	2	207	207	CD
46745	77	3	Ordo	Ordo	NNP
46745	77	4	7	7	CD
46745	77	5	.	.	.
46745	78	1	Anticonvulsiva	Anticonvulsiva	NNP
46745	78	2	211	211	CD
46745	78	3	Ordo	Ordo	NNP
46745	78	4	8	8	CD
46745	78	5	.	.	.
46745	79	1	Antisquamosa	Antisquamosa	NNP
46745	79	2	213	213	CD
46745	79	3	CLASS	class	NN
46745	79	4	II	ii	CD
46745	79	5	.	.	.
46745	80	1	NEUROTICA	NEUROTICA	NNP
46745	80	2	217	217	CD
46745	80	3	DIV	DIV	NNP
46745	80	4	.	.	.
46745	81	1	I.	I.	NNP
46745	81	2	STIMULANTIA	STIMULANTIA	NNP
46745	81	3	226	226	CD
46745	81	4	Ordo	Ordo	NNP
46745	81	5	1	1	CD
46745	81	6	.	.	.
46745	82	1	Stimulantia	Stimulantia	NNP
46745	82	2	Generalia	Generalia	NNP
46745	82	3	227	227	CD
46745	82	4	Ordo	ordo	NN
46745	82	5	2	2	CD
46745	82	6	.	.	.
46745	83	1	Stimulantia	Stimulantia	NNP
46745	83	2	Specifica	Specifica	NNP
46745	83	3	232	232	CD
46745	83	4	DIV	DIV	NNP
46745	83	5	.	.	.
46745	84	1	II	ii	CD
46745	84	2	.	.	.
46745	85	1	NARCOTICA	NARCOTICA	NNP
46745	85	2	234	234	CD
46745	85	3	Ordo	Ordo	NNP
46745	85	4	1	1	CD
46745	85	5	.	.	.
46745	86	1	Inebriantia	Inebriantia	NNP
46745	86	2	237	237	CD
46745	86	3	Ordo	ordo	NN
46745	86	4	2	2	CD
46745	86	5	.	.	.
46745	87	1	Somnifera	Somnifera	NNP
46745	87	2	238	238	CD
46745	87	3	Ordo	ordo	NN
46745	87	4	3	3	CD
46745	87	5	.	.	.
46745	88	1	Deliriantia	deliriantia	NN
46745	88	2	240	240	CD
46745	88	3	DIV	div	NN
46745	88	4	.	.	.
46745	89	1	III	iii	CD
46745	89	2	.	.	.
46745	90	1	SEDANTIA	SEDANTIA	NNP
46745	90	2	242	242	CD
46745	90	3	Ordo	Ordo	NNP
46745	90	4	1	1	CD
46745	90	5	.	.	.
46745	91	1	Sedantia	Sedantia	NNP
46745	91	2	Generalia	Generalia	NNP
46745	91	3	244	244	CD
46745	91	4	Ordo	ordo	NN
46745	91	5	2	2	CD
46745	91	6	.	.	.
46745	92	1	Sedantia	Sedantia	NNP
46745	92	2	Specifica	Specifica	NNP
46745	92	3	249	249	CD
46745	92	4	CLASS	class	NN
46745	92	5	III	iii	CD
46745	92	6	.	.	.
46745	93	1	ASTRINGENTIA	ASTRINGENTIA	NNP
46745	93	2	256	256	CD
46745	93	3	Ordo	ordo	NN
46745	93	4	1	1	CD
46745	93	5	.	.	.
46745	94	1	Astringentia	Astringentia	NNP
46745	94	2	Mineralia	Mineralia	NNP
46745	94	3	260	260	CD
46745	94	4	Ordo	Ordo	NNP
46745	94	5	2	2	CD
46745	94	6	.	.	.
46745	95	1	Astringentia	Astringentia	NNP
46745	95	2	Vegetabilia	Vegetabilia	NNP
46745	95	3	265	265	CD
46745	95	4	CLASS	CLASS	NNP
46745	95	5	IV	IV	NNP
46745	95	6	.	.	.
46745	96	1	ELIMINANTIA	ELIMINANTIA	NNP
46745	96	2	268	268	CD
46745	96	3	Ordo	ordo	NN
46745	96	4	1	1	CD
46745	96	5	.	.	.
46745	97	1	Sialagoga	sialagoga	NN
46745	97	2	281	281	CD
46745	97	3	Ordo	Ordo	NNP
46745	97	4	2	2	CD
46745	97	5	.	.	.
46745	98	1	Expectorantia	Expectorantia	NNP
46745	98	2	283	283	CD
46745	98	3	Ordo	Ordo	NNP
46745	98	4	3	3	CD
46745	98	5	.	.	.
46745	99	1	Cathartica	Cathartica	NNP
46745	99	2	286	286	CD
46745	99	3	Ordo	Ordo	NNP
46745	99	4	4	4	CD
46745	99	5	.	.	.
46745	100	1	Cholagoga	cholagoga	NN
46745	100	2	295	295	CD
46745	100	3	Ordo	Ordo	NNP
46745	100	4	5	5	CD
46745	100	5	.	.	.
46745	101	1	Diaphoretica	Diaphoretica	NNP
46745	101	2	298	298	CD
46745	101	3	Ordo	Ordo	NNP
46745	101	4	6	6	CD
46745	101	5	.	.	.
46745	102	1	Diuretica	Diuretica	NNP
46745	102	2	302	302	CD
46745	102	3	ON	on	IN
46745	102	4	THE	the	DT
46745	102	5	ACTION	action	NN
46745	102	6	OF	of	IN
46745	102	7	MEDICINES	medicine	NNS
46745	102	8	IN	in	IN
46745	102	9	THE	the	DT
46745	102	10	SYSTEM	system	NN
46745	102	11	.	.	.
46745	103	1	CHAPTER	CHAPTER	NNP
46745	103	2	I.	I.	NNP
46745	104	1	INTRODUCTORY	INTRODUCTORY	NNP
46745	104	2	REMARKS	REMARKS	NNP
46745	104	3	.	.	.
46745	105	1	In	in	IN
46745	105	2	commencing	commence	VBG
46745	105	3	this	this	DT
46745	105	4	Essay	Essay	NNP
46745	105	5	on	on	IN
46745	105	6	the	the	DT
46745	105	7	Action	Action	NNP
46745	105	8	of	of	IN
46745	105	9	Medicines	Medicines	NNP
46745	105	10	,	,	,
46745	105	11	I	-PRON-	PRP
46745	105	12	must	must	MD
46745	105	13	confess	confess	VB
46745	105	14	that	that	IN
46745	105	15	I	-PRON-	PRP
46745	105	16	feel	feel	VBP
46745	105	17	at	at	IN
46745	105	18	first	first	RB
46745	105	19	a	a	DT
46745	105	20	certain	certain	JJ
46745	105	21	discomfort	discomfort	NN
46745	105	22	when	when	WRB
46745	105	23	I	-PRON-	PRP
46745	105	24	consider	consider	VBP
46745	105	25	the	the	DT
46745	105	26	magnitude	magnitude	NN
46745	105	27	of	of	IN
46745	105	28	the	the	DT
46745	105	29	task	task	NN
46745	105	30	before	before	IN
46745	105	31	me	-PRON-	PRP
46745	105	32	.	.	.
46745	106	1	Many	many	JJ
46745	106	2	a	a	DT
46745	106	3	volume	volume	NN
46745	106	4	has	have	VBZ
46745	106	5	been	be	VBN
46745	106	6	written	write	VBN
46745	106	7	to	to	TO
46745	106	8	elucidate	elucidate	VB
46745	106	9	the	the	DT
46745	106	10	operations	operation	NNS
46745	106	11	of	of	IN
46745	106	12	single	single	JJ
46745	106	13	medicines	medicine	NNS
46745	106	14	,	,	,
46745	106	15	and	and	CC
46745	106	16	when	when	WRB
46745	106	17	the	the	DT
46745	106	18	variety	variety	NN
46745	106	19	and	and	CC
46745	106	20	complexity	complexity	NN
46745	106	21	of	of	IN
46745	106	22	such	such	PDT
46745	106	23	an	an	DT
46745	106	24	operation	operation	NN
46745	106	25	is	be	VBZ
46745	106	26	considered	consider	VBN
46745	106	27	,	,	,
46745	106	28	the	the	DT
46745	106	29	space	space	NN
46745	106	30	devoted	devote	VBN
46745	106	31	to	to	IN
46745	106	32	its	-PRON-	PRP$
46745	106	33	consideration	consideration	NN
46745	106	34	will	will	MD
46745	106	35	hardly	hardly	RB
46745	106	36	seem	seem	VB
46745	106	37	too	too	RB
46745	106	38	great	great	JJ
46745	106	39	.	.	.
46745	107	1	Thus	thus	RB
46745	107	2	it	-PRON-	PRP
46745	107	3	is	be	VBZ
46745	107	4	not	not	RB
46745	107	5	to	to	TO
46745	107	6	be	be	VB
46745	107	7	wondered	wonder	VBN
46745	107	8	at	at	IN
46745	107	9	that	that	DT
46745	107	10	,	,	,
46745	107	11	when	when	WRB
46745	107	12	pausing	pause	VBG
46745	107	13	on	on	IN
46745	107	14	the	the	DT
46745	107	15	threshold	threshold	NN
46745	107	16	of	of	IN
46745	107	17	my	-PRON-	PRP$
46745	107	18	subject	subject	NN
46745	107	19	,	,	,
46745	107	20	I	-PRON-	PRP
46745	107	21	should	should	MD
46745	107	22	be	be	VB
46745	107	23	sensible	sensible	JJ
46745	107	24	of	of	IN
46745	107	25	the	the	DT
46745	107	26	many	many	JJ
46745	107	27	difficulties	difficulty	NNS
46745	107	28	with	with	IN
46745	107	29	which	which	WDT
46745	107	30	such	such	PDT
46745	107	31	an	an	DT
46745	107	32	inquiry	inquiry	NN
46745	107	33	is	be	VBZ
46745	107	34	surrounded	surround	VBN
46745	107	35	.	.	.
46745	108	1	In	in	IN
46745	108	2	this	this	DT
46745	108	3	introductory	introductory	JJ
46745	108	4	chapter	chapter	NN
46745	108	5	it	-PRON-	PRP
46745	108	6	will	will	MD
46745	108	7	be	be	VB
46745	108	8	my	-PRON-	PRP$
46745	108	9	aim	aim	NN
46745	108	10	,	,	,
46745	108	11	in	in	IN
46745	108	12	the	the	DT
46745	108	13	first	first	JJ
46745	108	14	place	place	NN
46745	108	15	,	,	,
46745	108	16	to	to	TO
46745	108	17	set	set	VB
46745	108	18	forth	forth	RP
46745	108	19	briefly	briefly	RB
46745	108	20	the	the	DT
46745	108	21	great	great	JJ
46745	108	22	importance	importance	NN
46745	108	23	and	and	CC
46745	108	24	extent	extent	NN
46745	108	25	of	of	IN
46745	108	26	the	the	DT
46745	108	27	subject	subject	NN
46745	108	28	,	,	,
46745	108	29	showing	show	VBG
46745	108	30	that	that	IN
46745	108	31	it	-PRON-	PRP
46745	108	32	is	be	VBZ
46745	108	33	an	an	DT
46745	108	34	essential	essential	JJ
46745	108	35	requisite	requisite	NN
46745	108	36	in	in	IN
46745	108	37	the	the	DT
46745	108	38	advance	advance	NN
46745	108	39	and	and	CC
46745	108	40	perfection	perfection	NN
46745	108	41	of	of	IN
46745	108	42	medical	medical	JJ
46745	108	43	science	science	NN
46745	108	44	.	.	.
46745	109	1	Next	next	RB
46745	109	2	,	,	,
46745	109	3	I	-PRON-	PRP
46745	109	4	must	must	MD
46745	109	5	insist	insist	VB
46745	109	6	on	on	IN
46745	109	7	the	the	DT
46745	109	8	advantage	advantage	NN
46745	109	9	of	of	IN
46745	109	10	correctness	correctness	NN
46745	109	11	and	and	CC
46745	109	12	clearness	clearness	NN
46745	109	13	of	of	IN
46745	109	14	language	language	NN
46745	109	15	and	and	CC
46745	109	16	argument	argument	NN
46745	109	17	in	in	IN
46745	109	18	the	the	DT
46745	109	19	treatment	treatment	NN
46745	109	20	of	of	IN
46745	109	21	such	such	JJ
46745	109	22	topics	topic	NNS
46745	109	23	as	as	IN
46745	109	24	this	this	DT
46745	109	25	,	,	,
46745	109	26	and	and	CC
46745	109	27	show	show	VBP
46745	109	28	in	in	IN
46745	109	29	what	what	WDT
46745	109	30	manner	manner	NN
46745	109	31	I	-PRON-	PRP
46745	109	32	propose	propose	VBP
46745	109	33	myself	-PRON-	PRP
46745	109	34	to	to	TO
46745	109	35	attain	attain	VB
46745	109	36	to	to	IN
46745	109	37	it	-PRON-	PRP
46745	109	38	.	.	.
46745	110	1	And	and	CC
46745	110	2	in	in	IN
46745	110	3	the	the	DT
46745	110	4	third	third	JJ
46745	110	5	place	place	NN
46745	110	6	,	,	,
46745	110	7	I	-PRON-	PRP
46745	110	8	must	must	MD
46745	110	9	shortly	shortly	RB
46745	110	10	explain	explain	VB
46745	110	11	the	the	DT
46745	110	12	scheme	scheme	NN
46745	110	13	or	or	CC
46745	110	14	arrangement	arrangement	NN
46745	110	15	which	which	WDT
46745	110	16	will	will	MD
46745	110	17	be	be	VB
46745	110	18	followed	follow	VBN
46745	110	19	in	in	IN
46745	110	20	this	this	DT
46745	110	21	Essay	Essay	NNP
46745	110	22	.	.	.
46745	111	1	If	if	IN
46745	111	2	the	the	DT
46745	111	3	preliminary	preliminary	JJ
46745	111	4	remarks	remark	NNS
46745	111	5	contained	contain	VBN
46745	111	6	in	in	IN
46745	111	7	this	this	DT
46745	111	8	chapter	chapter	NN
46745	111	9	are	be	VBP
46745	111	10	not	not	RB
46745	111	11	first	first	RB
46745	111	12	considered	consider	VBN
46745	111	13	and	and	CC
46745	111	14	clearly	clearly	RB
46745	111	15	apprehended	apprehend	VBN
46745	111	16	,	,	,
46745	111	17	I	-PRON-	PRP
46745	111	18	fear	fear	VBP
46745	111	19	that	that	IN
46745	111	20	I	-PRON-	PRP
46745	111	21	may	may	MD
46745	111	22	be	be	VB
46745	111	23	but	but	CC
46745	111	24	imperfectly	imperfectly	RB
46745	111	25	understood	understand	VBN
46745	111	26	in	in	IN
46745	111	27	what	what	WP
46745	111	28	I	-PRON-	PRP
46745	111	29	shall	shall	MD
46745	111	30	have	have	VB
46745	111	31	to	to	TO
46745	111	32	say	say	VB
46745	111	33	hereafter	hereafter	RB
46745	111	34	.	.	.
46745	112	1	There	there	EX
46745	112	2	have	have	VBP
46745	112	3	been	be	VBN
46745	112	4	,	,	,
46745	112	5	more	more	RBR
46745	112	6	or	or	CC
46745	112	7	less	less	RBR
46745	112	8	,	,	,
46745	112	9	in	in	IN
46745	112	10	all	all	DT
46745	112	11	ages	age	NNS
46745	112	12	,	,	,
46745	112	13	two	two	CD
46745	112	14	systems	system	NNS
46745	112	15	or	or	CC
46745	112	16	schools	school	NNS
46745	112	17	of	of	IN
46745	112	18	medical	medical	JJ
46745	112	19	treatment	treatment	NN
46745	112	20	,	,	,
46745	112	21	of	of	IN
46745	112	22	which	which	WDT
46745	112	23	the	the	DT
46745	112	24	one	one	NN
46745	112	25	prevails	prevail	VBZ
46745	112	26	among	among	IN
46745	112	27	ignorant	ignorant	JJ
46745	112	28	men	man	NNS
46745	112	29	,	,	,
46745	112	30	and	and	CC
46745	112	31	in	in	IN
46745	112	32	rude	rude	JJ
46745	112	33	states	state	NNS
46745	112	34	of	of	IN
46745	112	35	society	society	NN
46745	112	36	,	,	,
46745	112	37	but	but	CC
46745	112	38	the	the	DT
46745	112	39	other	other	JJ
46745	112	40	requires	require	VBZ
46745	112	41	a	a	DT
46745	112	42	higher	high	JJR
46745	112	43	degree	degree	NN
46745	112	44	of	of	IN
46745	112	45	enlightenment	enlightenment	NN
46745	112	46	.	.	.
46745	113	1	These	these	DT
46745	113	2	are	be	VBP
46745	113	3	the	the	DT
46745	113	4	Empirical	Empirical	NNP
46745	113	5	and	and	CC
46745	113	6	the	the	DT
46745	113	7	Rational	Rational	NNP
46745	113	8	systems	system	NNS
46745	113	9	.	.	.
46745	114	1	The	the	DT
46745	114	2	first	first	JJ
46745	114	3	is	be	VBZ
46745	114	4	founded	found	VBN
46745	114	5	on	on	IN
46745	114	6	simple	simple	JJ
46745	114	7	induction	induction	NN
46745	114	8	.	.	.
46745	115	1	By	by	IN
46745	115	2	accident	accident	NN
46745	115	3	or	or	CC
46745	115	4	by	by	IN
46745	115	5	experience	experience	NN
46745	115	6	it	-PRON-	PRP
46745	115	7	is	be	VBZ
46745	115	8	found	find	VBN
46745	115	9	that	that	IN
46745	115	10	a	a	DT
46745	115	11	certain	certain	JJ
46745	115	12	medicine	medicine	NN
46745	115	13	is	be	VBZ
46745	115	14	of	of	IN
46745	115	15	use	use	NN
46745	115	16	in	in	IN
46745	115	17	the	the	DT
46745	115	18	treatment	treatment	NN
46745	115	19	of	of	IN
46745	115	20	a	a	DT
46745	115	21	certain	certain	JJ
46745	115	22	disorder	disorder	NN
46745	115	23	:	:	:
46745	115	24	it	-PRON-	PRP
46745	115	25	is	be	VBZ
46745	115	26	henceforth	henceforth	RB
46745	115	27	administered	administer	VBN
46745	115	28	in	in	IN
46745	115	29	that	that	DT
46745	115	30	disorder	disorder	NN
46745	115	31	;	;	:
46745	115	32	and	and	CC
46745	115	33	on	on	IN
46745	115	34	a	a	DT
46745	115	35	number	number	NN
46745	115	36	of	of	IN
46745	115	37	such	such	JJ
46745	115	38	separate	separate	JJ
46745	115	39	data	datum	NNS
46745	115	40	an	an	DT
46745	115	41	empirical	empirical	JJ
46745	115	42	system	system	NN
46745	115	43	is	be	VBZ
46745	115	44	constructed	construct	VBN
46745	115	45	.	.	.
46745	116	1	It	-PRON-	PRP
46745	116	2	naturally	naturally	RB
46745	116	3	requires	require	VBZ
46745	116	4	for	for	IN
46745	116	5	its	-PRON-	PRP$
46745	116	6	elaboration	elaboration	NN
46745	116	7	a	a	DT
46745	116	8	comparatively	comparatively	RB
46745	116	9	small	small	JJ
46745	116	10	degree	degree	NN
46745	116	11	of	of	IN
46745	116	12	knowledge	knowledge	NN
46745	116	13	.	.	.
46745	117	1	Now	now	RB
46745	117	2	this	this	DT
46745	117	3	observation	observation	NN
46745	117	4	of	of	IN
46745	117	5	facts	fact	NNS
46745	117	6	is	be	VBZ
46745	117	7	indispensable	indispensable	JJ
46745	117	8	as	as	IN
46745	117	9	a	a	DT
46745	117	10	beginning	beginning	NN
46745	117	11	,	,	,
46745	117	12	but	but	CC
46745	117	13	something	something	NN
46745	117	14	more	more	RBR
46745	117	15	is	be	VBZ
46745	117	16	required	require	VBN
46745	117	17	.	.	.
46745	118	1	We	-PRON-	PRP
46745	118	2	must	must	MD
46745	118	3	not	not	RB
46745	118	4	be	be	VB
46745	118	5	satisfied	satisfied	JJ
46745	118	6	with	with	IN
46745	118	7	taking	take	VBG
46745	118	8	them	-PRON-	PRP
46745	118	9	separately	separately	RB
46745	118	10	,	,	,
46745	118	11	but	but	CC
46745	118	12	we	-PRON-	PRP
46745	118	13	must	must	MD
46745	118	14	proceed	proceed	VB
46745	118	15	to	to	TO
46745	118	16	compare	compare	VB
46745	118	17	together	together	RB
46745	118	18	a	a	DT
46745	118	19	large	large	JJ
46745	118	20	number	number	NN
46745	118	21	of	of	IN
46745	118	22	facts	fact	NNS
46745	118	23	,	,	,
46745	118	24	and	and	CC
46745	118	25	draw	draw	VB
46745	118	26	inferences	inference	NNS
46745	118	27	from	from	IN
46745	118	28	this	this	DT
46745	118	29	comparison	comparison	NN
46745	118	30	.	.	.
46745	119	1	And	and	CC
46745	119	2	our	-PRON-	PRP$
46745	119	3	plan	plan	NN
46745	119	4	of	of	IN
46745	119	5	treatment	treatment	NN
46745	119	6	will	will	MD
46745	119	7	become	become	VB
46745	119	8	rational	rational	JJ
46745	119	9	,	,	,
46745	119	10	when	when	WRB
46745	119	11	on	on	IN
46745	119	12	the	the	DT
46745	119	13	one	one	CD
46745	119	14	hand	hand	NN
46745	119	15	,	,	,
46745	119	16	from	from	IN
46745	119	17	an	an	DT
46745	119	18	accurate	accurate	JJ
46745	119	19	knowledge	knowledge	NN
46745	119	20	of	of	IN
46745	119	21	the	the	DT
46745	119	22	symptoms	symptom	NNS
46745	119	23	of	of	IN
46745	119	24	diseases	disease	NNS
46745	119	25	,	,	,
46745	119	26	we	-PRON-	PRP
46745	119	27	are	be	VBP
46745	119	28	better	well	RBR
46745	119	29	enabled	enable	VBN
46745	119	30	to	to	TO
46745	119	31	meet	meet	VB
46745	119	32	each	each	DT
46745	119	33	by	by	IN
46745	119	34	its	-PRON-	PRP$
46745	119	35	appropriate	appropriate	JJ
46745	119	36	remedy	remedy	NN
46745	119	37	,	,	,
46745	119	38	and	and	CC
46745	119	39	on	on	IN
46745	119	40	the	the	DT
46745	119	41	other	other	JJ
46745	119	42	hand	hand	NN
46745	119	43	,	,	,
46745	119	44	from	from	IN
46745	119	45	some	some	DT
46745	119	46	acquaintance	acquaintance	NN
46745	119	47	with	with	IN
46745	119	48	the	the	DT
46745	119	49	general	general	JJ
46745	119	50	action	action	NN
46745	119	51	of	of	IN
46745	119	52	a	a	DT
46745	119	53	medicine	medicine	NN
46745	119	54	,	,	,
46745	119	55	we	-PRON-	PRP
46745	119	56	are	be	VBP
46745	119	57	fitted	fit	VBN
46745	119	58	to	to	TO
46745	119	59	wield	wield	VB
46745	119	60	it	-PRON-	PRP
46745	119	61	with	with	IN
46745	119	62	more	more	JJR
46745	119	63	skill	skill	NN
46745	119	64	and	and	CC
46745	119	65	effect	effect	NN
46745	119	66	,	,	,
46745	119	67	and	and	CC
46745	119	68	to	to	TO
46745	119	69	apply	apply	VB
46745	119	70	it	-PRON-	PRP
46745	119	71	even	even	RB
46745	119	72	in	in	IN
46745	119	73	cases	case	NNS
46745	119	74	where	where	WRB
46745	119	75	it	-PRON-	PRP
46745	119	76	has	have	VBZ
46745	119	77	not	not	RB
46745	119	78	yet	yet	RB
46745	119	79	been	be	VBN
46745	119	80	proved	prove	VBN
46745	119	81	beneficial	beneficial	JJ
46745	119	82	.	.	.
46745	120	1	Thus	thus	RB
46745	120	2	,	,	,
46745	120	3	for	for	IN
46745	120	4	the	the	DT
46745	120	5	proper	proper	JJ
46745	120	6	perfection	perfection	NN
46745	120	7	of	of	IN
46745	120	8	medicine	medicine	NN
46745	120	9	as	as	IN
46745	120	10	a	a	DT
46745	120	11	rational	rational	JJ
46745	120	12	science	science	NN
46745	120	13	,	,	,
46745	120	14	two	two	CD
46745	120	15	things	thing	NNS
46745	120	16	are	be	VBP
46745	120	17	in	in	IN
46745	120	18	the	the	DT
46745	120	19	main	main	JJ
46745	120	20	needed	need	VBN
46745	120	21	:	:	:
46745	120	22	the	the	DT
46745	120	23	first	first	JJ
46745	120	24	is	be	VBZ
46745	120	25	a	a	DT
46745	120	26	right	right	JJ
46745	120	27	understanding	understanding	NN
46745	120	28	of	of	IN
46745	120	29	the	the	DT
46745	120	30	causes	cause	NNS
46745	120	31	and	and	CC
46745	120	32	symptoms	symptom	NNS
46745	120	33	of	of	IN
46745	120	34	disease	disease	NN
46745	120	35	;	;	:
46745	120	36	the	the	DT
46745	120	37	second	second	JJ
46745	120	38	,	,	,
46745	120	39	a	a	DT
46745	120	40	correct	correct	JJ
46745	120	41	knowledge	knowledge	NN
46745	120	42	of	of	IN
46745	120	43	the	the	DT
46745	120	44	action	action	NN
46745	120	45	of	of	IN
46745	120	46	medicines	medicine	NNS
46745	120	47	.	.	.
46745	121	1	Should	Should	MD
46745	121	2	our	-PRON-	PRP$
46745	121	3	acquaintance	acquaintance	NN
46745	121	4	with	with	IN
46745	121	5	these	these	DT
46745	121	6	two	two	CD
46745	121	7	subjects	subject	NNS
46745	121	8	be	be	VB
46745	121	9	complete	complete	JJ
46745	121	10	,	,	,
46745	121	11	we	-PRON-	PRP
46745	121	12	should	should	MD
46745	121	13	then	then	RB
46745	121	14	be	be	VB
46745	121	15	able	able	JJ
46745	121	16	to	to	TO
46745	121	17	do	do	VB
46745	121	18	all	all	PDT
46745	121	19	that	that	DT
46745	121	20	man	man	NN
46745	121	21	could	could	MD
46745	121	22	by	by	IN
46745	121	23	any	any	DT
46745	121	24	possibility	possibility	NN
46745	121	25	effect	effect	NN
46745	121	26	in	in	IN
46745	121	27	the	the	DT
46745	121	28	alleviation	alleviation	NN
46745	121	29	of	of	IN
46745	121	30	human	human	JJ
46745	121	31	suffering	suffering	NN
46745	121	32	.	.	.
46745	122	1	This	this	DT
46745	122	2	sublime	sublime	JJ
46745	122	3	problem	problem	NN
46745	122	4	is	be	VBZ
46745	122	5	already	already	RB
46745	122	6	being	be	VBG
46745	122	7	unravelled	unravel	VBN
46745	122	8	at	at	IN
46745	122	9	one	one	CD
46745	122	10	end	end	NN
46745	122	11	.	.	.
46745	123	1	Diagnosis	diagnosis	NN
46745	123	2	and	and	CC
46745	123	3	Nosology	nosology	NN
46745	123	4	are	be	VBP
46745	123	5	making	make	VBG
46745	123	6	rapid	rapid	JJ
46745	123	7	strides	stride	NNS
46745	123	8	;	;	:
46745	123	9	and	and	CC
46745	123	10	perhaps	perhaps	RB
46745	123	11	we	-PRON-	PRP
46745	123	12	shall	shall	MD
46745	123	13	soon	soon	RB
46745	123	14	know	know	VB
46745	123	15	what	what	WP
46745	123	16	we	-PRON-	PRP
46745	123	17	have	have	VBP
46745	123	18	to	to	TO
46745	123	19	cure	cure	VB
46745	123	20	.	.	.
46745	124	1	But	but	CC
46745	124	2	at	at	IN
46745	124	3	the	the	DT
46745	124	4	other	other	JJ
46745	124	5	end	end	NN
46745	124	6	our	-PRON-	PRP$
46745	124	7	medical	medical	JJ
46745	124	8	system	system	NN
46745	124	9	is	be	VBZ
46745	124	10	in	in	IN
46745	124	11	a	a	DT
46745	124	12	less	less	RBR
46745	124	13	satisfactory	satisfactory	JJ
46745	124	14	condition	condition	NN
46745	124	15	;	;	:
46745	124	16	and	and	CC
46745	124	17	though	though	IN
46745	124	18	some	some	DT
46745	124	19	impatient	impatient	JJ
46745	124	20	men	man	NNS
46745	124	21	have	have	VBP
46745	124	22	essayed	essay	VBN
46745	124	23	,	,	,
46745	124	24	as	as	IN
46745	124	25	it	-PRON-	PRP
46745	124	26	were	be	VBD
46745	124	27	,	,	,
46745	124	28	to	to	TO
46745	124	29	cut	cut	VB
46745	124	30	the	the	DT
46745	124	31	Gordian	gordian	JJ
46745	124	32	knot	knot	NN
46745	124	33	,	,	,
46745	124	34	and	and	CC
46745	124	35	have	have	VBP
46745	124	36	declared	declare	VBN
46745	124	37	boldly	boldly	RB
46745	124	38	on	on	IN
46745	124	39	subjects	subject	NNS
46745	124	40	of	of	IN
46745	124	41	which	which	WDT
46745	124	42	they	-PRON-	PRP
46745	124	43	are	be	VBP
46745	124	44	ignorant	ignorant	JJ
46745	124	45	,	,	,
46745	124	46	yet	yet	CC
46745	124	47	it	-PRON-	PRP
46745	124	48	must	must	MD
46745	124	49	be	be	VB
46745	124	50	confessed	confess	VBN
46745	124	51	,	,	,
46745	124	52	that	that	IN
46745	124	53	in	in	IN
46745	124	54	the	the	DT
46745	124	55	understanding	understanding	NN
46745	124	56	of	of	IN
46745	124	57	the	the	DT
46745	124	58	action	action	NN
46745	124	59	of	of	IN
46745	124	60	medicines	medicine	NNS
46745	124	61	,	,	,
46745	124	62	and	and	CC
46745	124	63	of	of	IN
46745	124	64	their	-PRON-	PRP$
46745	124	65	agency	agency	NN
46745	124	66	in	in	IN
46745	124	67	the	the	DT
46745	124	68	cure	cure	NN
46745	124	69	of	of	IN
46745	124	70	diseases	disease	NNS
46745	124	71	,	,	,
46745	124	72	we	-PRON-	PRP
46745	124	73	do	do	VBP
46745	124	74	not	not	RB
46745	124	75	so	so	RB
46745	124	76	much	much	RB
46745	124	77	excel	excel	VB
46745	124	78	our	-PRON-	PRP$
46745	124	79	ancestors	ancestor	NNS
46745	124	80	.	.	.
46745	125	1	While	while	IN
46745	125	2	other	other	JJ
46745	125	3	sciences	science	NNS
46745	125	4	are	be	VBP
46745	125	5	moving	move	VBG
46745	125	6	,	,	,
46745	125	7	and	and	CC
46745	125	8	other	other	JJ
46745	125	9	inquiries	inquiry	NNS
46745	125	10	progressing	progress	VBG
46745	125	11	fast	fast	RB
46745	125	12	,	,	,
46745	125	13	this	this	DT
46745	125	14	subject	subject	NN
46745	125	15	,	,	,
46745	125	16	so	so	RB
46745	125	17	momentous	momentous	JJ
46745	125	18	in	in	IN
46745	125	19	its	-PRON-	PRP$
46745	125	20	applications	application	NNS
46745	125	21	,	,	,
46745	125	22	has	have	VBZ
46745	125	23	,	,	,
46745	125	24	in	in	IN
46745	125	25	spite	spite	NN
46745	125	26	of	of	IN
46745	125	27	the	the	DT
46745	125	28	earnest	earnest	JJ
46745	125	29	labours	labour	NNS
46745	125	30	of	of	IN
46745	125	31	a	a	DT
46745	125	32	few	few	JJ
46745	125	33	talented	talented	JJ
46745	125	34	investigators	investigator	NNS
46745	125	35	,	,	,
46745	125	36	made	make	VBN
46745	125	37	after	after	RB
46745	125	38	all	all	RB
46745	125	39	but	but	CC
46745	125	40	small	small	JJ
46745	125	41	progress	progress	NN
46745	125	42	.	.	.
46745	126	1	Let	let	VB
46745	126	2	but	but	CC
46745	126	3	those	those	DT
46745	126	4	who	who	WP
46745	126	5	feel	feel	VBP
46745	126	6	this	this	DT
46745	126	7	want	want	VBP
46745	126	8	bestir	bestir	VBD
46745	126	9	themselves	-PRON-	PRP
46745	126	10	to	to	TO
46745	126	11	remove	remove	VB
46745	126	12	it	-PRON-	PRP
46745	126	13	,	,	,
46745	126	14	and	and	CC
46745	126	15	it	-PRON-	PRP
46745	126	16	will	will	MD
46745	126	17	soon	soon	RB
46745	126	18	be	be	VB
46745	126	19	done	do	VBN
46745	126	20	.	.	.
46745	127	1	Those	those	DT
46745	127	2	doubts	doubt	NNS
46745	127	3	and	and	CC
46745	127	4	difficulties	difficulty	NNS
46745	127	5	,	,	,
46745	127	6	which	which	WDT
46745	127	7	are	be	VBP
46745	127	8	now	now	RB
46745	127	9	slowly	slowly	RB
46745	127	10	clearing	clear	VBG
46745	127	11	away	away	RP
46745	127	12	before	before	IN
46745	127	13	the	the	DT
46745	127	14	efforts	effort	NNS
46745	127	15	of	of	IN
46745	127	16	a	a	DT
46745	127	17	few	few	JJ
46745	127	18	,	,	,
46745	127	19	will	will	MD
46745	127	20	then	then	RB
46745	127	21	be	be	VB
46745	127	22	finally	finally	RB
46745	127	23	dispelled	dispel	VBN
46745	127	24	by	by	IN
46745	127	25	the	the	DT
46745	127	26	united	united	NNP
46745	127	27	energies	energy	NNS
46745	127	28	of	of	IN
46745	127	29	all	all	DT
46745	127	30	;	;	:
46745	127	31	and	and	CC
46745	127	32	instead	instead	RB
46745	127	33	of	of	IN
46745	127	34	our	-PRON-	PRP$
46745	127	35	present	present	JJ
46745	127	36	indecision	indecision	NN
46745	127	37	and	and	CC
46745	127	38	uncertainty	uncertainty	NN
46745	127	39	on	on	IN
46745	127	40	many	many	JJ
46745	127	41	points	point	NNS
46745	127	42	,	,	,
46745	127	43	we	-PRON-	PRP
46745	127	44	shall	shall	MD
46745	127	45	find	find	VB
46745	127	46	ourselves	-PRON-	PRP
46745	127	47	eminently	eminently	RB
46745	127	48	qualified	qualified	JJ
46745	127	49	to	to	TO
46745	127	50	wage	wage	VB
46745	127	51	the	the	DT
46745	127	52	conflict	conflict	NN
46745	127	53	with	with	IN
46745	127	54	disease	disease	NN
46745	127	55	,	,	,
46745	127	56	being	be	VBG
46745	127	57	skilled	skilled	JJ
46745	127	58	in	in	IN
46745	127	59	that	that	DT
46745	127	60	science	science	NN
46745	127	61	whose	whose	WP$
46745	127	62	name	name	NN
46745	127	63	bespeaks	bespeak	VBZ
46745	127	64	its	-PRON-	PRP$
46745	127	65	peculiar	peculiar	JJ
46745	127	66	importance	importance	NN
46745	127	67	,	,	,
46745	127	68	the	the	DT
46745	127	69	science	science	NN
46745	127	70	of	of	IN
46745	127	71	_	_	NNP
46745	127	72	Therapeutics	Therapeutics	NNP
46745	127	73	_	_	NNP
46745	127	74	.	.	.
46745	128	1	The	the	DT
46745	128	2	subject	subject	NN
46745	128	3	assigned	assign	VBN
46745	128	4	to	to	IN
46745	128	5	me	-PRON-	PRP
46745	128	6	as	as	IN
46745	128	7	the	the	DT
46745	128	8	text	text	NN
46745	128	9	of	of	IN
46745	128	10	this	this	DT
46745	128	11	Essay	Essay	NNP
46745	128	12	concerns	concern	VBZ
46745	128	13	this	this	DT
46745	128	14	problem:--"On	problem:--"On	VBZ
46745	128	15	the	the	DT
46745	128	16	mode	mode	NN
46745	128	17	in	in	IN
46745	128	18	which	which	WDT
46745	128	19	Therapeutic	therapeutic	JJ
46745	128	20	Agents	Agents	NNPS
46745	128	21	introduced	introduce	VBD
46745	128	22	into	into	IN
46745	128	23	the	the	DT
46745	128	24	stomach	stomach	NN
46745	128	25	produce	produce	VBP
46745	128	26	their	-PRON-	PRP$
46745	128	27	peculiar	peculiar	JJ
46745	128	28	effects	effect	NNS
46745	128	29	on	on	IN
46745	128	30	the	the	DT
46745	128	31	Animal	Animal	NNP
46745	128	32	Economy	economy	NN
46745	128	33	.	.	.
46745	128	34	"	"	''
46745	129	1	It	-PRON-	PRP
46745	129	2	is	be	VBZ
46745	129	3	naturally	naturally	RB
46745	129	4	a	a	DT
46745	129	5	subject	subject	NN
46745	129	6	of	of	IN
46745	129	7	very	very	RB
46745	129	8	great	great	JJ
46745	129	9	extent	extent	NN
46745	129	10	;	;	:
46745	129	11	and	and	CC
46745	129	12	one	one	CD
46745	129	13	difficulty	difficulty	NN
46745	129	14	with	with	IN
46745	129	15	which	which	WDT
46745	129	16	I	-PRON-	PRP
46745	129	17	am	be	VBP
46745	129	18	beset	beset	NN
46745	129	19	is	be	VBZ
46745	129	20	that	that	IN
46745	129	21	I	-PRON-	PRP
46745	129	22	scarcely	scarcely	RB
46745	129	23	know	know	VBP
46745	129	24	how	how	WRB
46745	129	25	to	to	TO
46745	129	26	compress	compress	VB
46745	129	27	what	what	WP
46745	129	28	I	-PRON-	PRP
46745	129	29	have	have	VBP
46745	129	30	to	to	TO
46745	129	31	say	say	VB
46745	129	32	on	on	IN
46745	129	33	the	the	DT
46745	129	34	action	action	NN
46745	129	35	of	of	IN
46745	129	36	medicines	medicine	NNS
46745	129	37	into	into	IN
46745	129	38	the	the	DT
46745	129	39	compass	compass	NN
46745	129	40	required	require	VBN
46745	129	41	.	.	.
46745	130	1	It	-PRON-	PRP
46745	130	2	will	will	MD
46745	130	3	be	be	VB
46745	130	4	granted	grant	VBN
46745	130	5	that	that	IN
46745	130	6	it	-PRON-	PRP
46745	130	7	is	be	VBZ
46745	130	8	an	an	DT
46745	130	9	important	important	JJ
46745	130	10	subject	subject	NN
46745	130	11	;	;	:
46745	130	12	it	-PRON-	PRP
46745	130	13	is	be	VBZ
46745	130	14	also	also	RB
46745	130	15	a	a	DT
46745	130	16	difficult	difficult	JJ
46745	130	17	one	one	NN
46745	130	18	.	.	.
46745	131	1	This	this	DT
46745	131	2	difficulty	difficulty	NN
46745	131	3	depends	depend	VBZ
46745	131	4	mainly	mainly	RB
46745	131	5	on	on	IN
46745	131	6	the	the	DT
46745	131	7	variety	variety	NN
46745	131	8	and	and	CC
46745	131	9	complexity	complexity	NN
46745	131	10	of	of	IN
46745	131	11	the	the	DT
46745	131	12	proof	proof	NN
46745	131	13	required	require	VBN
46745	131	14	to	to	TO
46745	131	15	establish	establish	VB
46745	131	16	any	any	DT
46745	131	17	one	one	CD
46745	131	18	point	point	NN
46745	131	19	with	with	IN
46745	131	20	absolute	absolute	JJ
46745	131	21	certainty	certainty	NN
46745	131	22	.	.	.
46745	132	1	[	[	-LRB-
46745	132	2	1	1	LS
46745	132	3	]	]	-RRB-
46745	132	4	A	a	DT
46745	132	5	long	long	JJ
46745	132	6	time	time	NN
46745	132	7	ago	ago	RB
46745	132	8	,	,	,
46745	132	9	when	when	WRB
46745	132	10	men	man	NNS
46745	132	11	knew	know	VBD
46745	132	12	and	and	CC
46745	132	13	understood	understand	VBD
46745	132	14	less	less	JJR
46745	132	15	than	than	IN
46745	132	16	they	-PRON-	PRP
46745	132	17	do	do	VBP
46745	132	18	now	now	RB
46745	132	19	,	,	,
46745	132	20	it	-PRON-	PRP
46745	132	21	was	be	VBD
46745	132	22	fancied	fancy	VBN
46745	132	23	that	that	IN
46745	132	24	the	the	DT
46745	132	25	action	action	NN
46745	132	26	and	and	CC
46745	132	27	choice	choice	NN
46745	132	28	of	of	IN
46745	132	29	medicines	medicine	NNS
46745	132	30	was	be	VBD
46745	132	31	a	a	DT
46745	132	32	thing	thing	NN
46745	132	33	of	of	IN
46745	132	34	the	the	DT
46745	132	35	utmost	utmost	JJ
46745	132	36	simplicity	simplicity	NN
46745	132	37	;	;	:
46745	132	38	that	that	IN
46745	132	39	it	-PRON-	PRP
46745	132	40	was	be	VBD
46745	132	41	comparatively	comparatively	RB
46745	132	42	an	an	DT
46745	132	43	easy	easy	JJ
46745	132	44	matter	matter	NN
46745	132	45	to	to	TO
46745	132	46	fix	fix	VB
46745	132	47	at	at	RP
46745	132	48	once	once	RB
46745	132	49	upon	upon	IN
46745	132	50	that	that	DT
46745	132	51	remedy	remedy	NN
46745	132	52	required	require	VBD
46745	132	53	most	most	RBS
46745	132	54	in	in	IN
46745	132	55	any	any	DT
46745	132	56	particular	particular	JJ
46745	132	57	case	case	NN
46745	132	58	.	.	.
46745	133	1	[	[	-LRB-
46745	133	2	2	2	CD
46745	133	3	]	]	-RRB-
46745	133	4	But	but	CC
46745	133	5	the	the	DT
46745	133	6	light	light	NN
46745	133	7	of	of	IN
46745	133	8	science	science	NN
46745	133	9	,	,	,
46745	133	10	which	which	WDT
46745	133	11	in	in	IN
46745	133	12	this	this	DT
46745	133	13	day	day	NN
46745	133	14	burns	burn	VBZ
46745	133	15	more	more	RBR
46745	133	16	brightly	brightly	RB
46745	133	17	,	,	,
46745	133	18	at	at	IN
46745	133	19	the	the	DT
46745	133	20	same	same	JJ
46745	133	21	time	time	NN
46745	133	22	that	that	WDT
46745	133	23	it	-PRON-	PRP
46745	133	24	displays	display	VBZ
46745	133	25	all	all	DT
46745	133	26	objects	object	NNS
46745	133	27	with	with	IN
46745	133	28	greater	great	JJR
46745	133	29	distinctness	distinctness	NN
46745	133	30	,	,	,
46745	133	31	discloses	disclose	VBZ
46745	133	32	to	to	IN
46745	133	33	us	-PRON-	PRP
46745	133	34	also	also	RB
46745	133	35	many	many	JJ
46745	133	36	dim	dim	VB
46745	133	37	vast	vast	JJ
46745	133	38	tracts	tract	NNS
46745	133	39	in	in	IN
46745	133	40	the	the	DT
46745	133	41	distance	distance	NN
46745	133	42	,	,	,
46745	133	43	of	of	IN
46745	133	44	which	which	WDT
46745	133	45	nothing	nothing	NN
46745	133	46	had	have	VBD
46745	133	47	been	be	VBN
46745	133	48	seen	see	VBN
46745	133	49	or	or	CC
46745	133	50	imagined	imagine	VBN
46745	133	51	before	before	RB
46745	133	52	.	.	.
46745	134	1	In	in	IN
46745	134	2	this	this	DT
46745	134	3	,	,	,
46745	134	4	as	as	IN
46745	134	5	in	in	IN
46745	134	6	other	other	JJ
46745	134	7	things	thing	NNS
46745	134	8	,	,	,
46745	134	9	the	the	DT
46745	134	10	more	more	RBR
46745	134	11	we	-PRON-	PRP
46745	134	12	know	know	VBP
46745	134	13	the	the	DT
46745	134	14	more	more	RBR
46745	134	15	we	-PRON-	PRP
46745	134	16	discover	discover	VBP
46745	134	17	our	-PRON-	PRP$
46745	134	18	real	real	JJ
46745	134	19	ignorance	ignorance	NN
46745	134	20	.	.	.
46745	135	1	It	-PRON-	PRP
46745	135	2	is	be	VBZ
46745	135	3	wrong	wrong	JJ
46745	135	4	,	,	,
46745	135	5	then	then	RB
46745	135	6	,	,	,
46745	135	7	to	to	TO
46745	135	8	treat	treat	VB
46745	135	9	dogmatically	dogmatically	RB
46745	135	10	of	of	IN
46745	135	11	matters	matter	NNS
46745	135	12	that	that	WDT
46745	135	13	we	-PRON-	PRP
46745	135	14	can	can	MD
46745	135	15	not	not	RB
46745	135	16	comprehend	comprehend	VB
46745	135	17	;	;	:
46745	135	18	and	and	CC
46745	135	19	when	when	WRB
46745	135	20	perfectly	perfectly	RB
46745	135	21	in	in	IN
46745	135	22	the	the	DT
46745	135	23	dark	dark	NN
46745	135	24	as	as	IN
46745	135	25	to	to	IN
46745	135	26	the	the	DT
46745	135	27	operation	operation	NN
46745	135	28	of	of	IN
46745	135	29	a	a	DT
46745	135	30	medicine	medicine	NN
46745	135	31	,	,	,
46745	135	32	we	-PRON-	PRP
46745	135	33	should	should	MD
46745	135	34	rest	rest	VB
46745	135	35	content	content	NN
46745	135	36	with	with	IN
46745	135	37	declaring	declare	VBG
46745	135	38	the	the	DT
46745	135	39	result	result	NN
46745	135	40	of	of	IN
46745	135	41	that	that	DT
46745	135	42	operation	operation	NN
46745	135	43	.	.	.
46745	136	1	This	this	DT
46745	136	2	by	by	IN
46745	136	3	itself	-PRON-	PRP
46745	136	4	will	will	MD
46745	136	5	be	be	VB
46745	136	6	of	of	IN
46745	136	7	great	great	JJ
46745	136	8	use	use	NN
46745	136	9	to	to	IN
46745	136	10	us	-PRON-	PRP
46745	136	11	.	.	.
46745	137	1	[	[	-LRB-
46745	137	2	3	3	CD
46745	137	3	]	]	-RRB-
46745	137	4	I	-PRON-	PRP
46745	137	5	am	be	VBP
46745	137	6	induced	induce	VBN
46745	137	7	to	to	TO
46745	137	8	lay	lay	VB
46745	137	9	stress	stress	NN
46745	137	10	on	on	IN
46745	137	11	the	the	DT
46745	137	12	difficulties	difficulty	NNS
46745	137	13	surrounding	surround	VBG
46745	137	14	an	an	DT
46745	137	15	inquiry	inquiry	NN
46745	137	16	into	into	IN
46745	137	17	the	the	DT
46745	137	18	_	_	NNP
46745	137	19	modus	modus	NN
46745	137	20	operandi	operandi	NNP
46745	137	21	_	_	NNP
46745	137	22	of	of	IN
46745	137	23	medicines	medicine	NNS
46745	137	24	,	,	,
46745	137	25	because	because	IN
46745	137	26	it	-PRON-	PRP
46745	137	27	will	will	MD
46745	137	28	be	be	VB
46745	137	29	some	some	DT
46745	137	30	excuse	excuse	NN
46745	137	31	for	for	IN
46745	137	32	the	the	DT
46745	137	33	manifest	manif	JJS
46745	137	34	insufficiency	insufficiency	NN
46745	137	35	of	of	IN
46745	137	36	the	the	DT
46745	137	37	sketch	sketch	NN
46745	137	38	which	which	WDT
46745	137	39	I	-PRON-	PRP
46745	137	40	am	be	VBP
46745	137	41	about	about	JJ
46745	137	42	to	to	TO
46745	137	43	draw	draw	VB
46745	137	44	.	.	.
46745	138	1	For	for	IN
46745	138	2	this	this	DT
46745	138	3	,	,	,
46745	138	4	too	too	RB
46745	138	5	,	,	,
46745	138	6	I	-PRON-	PRP
46745	138	7	may	may	MD
46745	138	8	find	find	VB
46745	138	9	a	a	DT
46745	138	10	further	further	JJ
46745	138	11	apology	apology	NN
46745	138	12	in	in	IN
46745	138	13	the	the	DT
46745	138	14	fallacies	fallacy	NNS
46745	138	15	and	and	CC
46745	138	16	mistakes	mistake	NNS
46745	138	17	,	,	,
46745	138	18	both	both	DT
46745	138	19	of	of	IN
46745	138	20	reasoning	reasoning	NN
46745	138	21	and	and	CC
46745	138	22	statement	statement	NN
46745	138	23	,	,	,
46745	138	24	of	of	IN
46745	138	25	which	which	WDT
46745	138	26	previous	previous	JJ
46745	138	27	writers	writer	NNS
46745	138	28	have	have	VBP
46745	138	29	been	be	VBN
46745	138	30	guilty	guilty	JJ
46745	138	31	.	.	.
46745	139	1	These	these	DT
46745	139	2	are	be	VBP
46745	139	3	best	well	RBS
46745	139	4	shown	show	VBN
46745	139	5	by	by	IN
46745	139	6	their	-PRON-	PRP$
46745	139	7	discrepancies	discrepancy	NNS
46745	139	8	.	.	.
46745	140	1	On	on	IN
46745	140	2	no	no	DT
46745	140	3	question	question	NN
46745	140	4	,	,	,
46745	140	5	perhaps	perhaps	RB
46745	140	6	,	,	,
46745	140	7	have	have	VBP
46745	140	8	scientific	scientific	JJ
46745	140	9	men	man	NNS
46745	140	10	differed	differ	VBD
46745	140	11	more	more	JJR
46745	140	12	than	than	IN
46745	140	13	on	on	IN
46745	140	14	the	the	DT
46745	140	15	theory	theory	NN
46745	140	16	of	of	IN
46745	140	17	the	the	DT
46745	140	18	action	action	NN
46745	140	19	of	of	IN
46745	140	20	medicines	medicine	NNS
46745	140	21	.	.	.
46745	141	1	Either	either	DT
46745	141	2	facts	fact	NNS
46745	141	3	essentially	essentially	RB
46745	141	4	opposed	opposed	JJ
46745	141	5	and	and	CC
46745	141	6	incompatible	incompatible	JJ
46745	141	7	have	have	VBP
46745	141	8	been	be	VBN
46745	141	9	adduced	adduce	VBN
46745	141	10	by	by	IN
46745	141	11	the	the	DT
46745	141	12	disagreeing	disagree	VBG
46745	141	13	parties	party	NNS
46745	141	14	;	;	:
46745	141	15	or	or	CC
46745	141	16	,	,	,
46745	141	17	which	which	WDT
46745	141	18	is	be	VBZ
46745	141	19	nearly	nearly	RB
46745	141	20	as	as	RB
46745	141	21	common	common	JJ
46745	141	22	,	,	,
46745	141	23	the	the	DT
46745	141	24	same	same	JJ
46745	141	25	fact	fact	NN
46745	141	26	has	have	VBZ
46745	141	27	received	receive	VBN
46745	141	28	two	two	CD
46745	141	29	distinct	distinct	JJ
46745	141	30	and	and	CC
46745	141	31	opposite	opposite	JJ
46745	141	32	interpretations	interpretation	NNS
46745	141	33	.	.	.
46745	142	1	Many	many	JJ
46745	142	2	hypotheses	hypothesis	NNS
46745	142	3	,	,	,
46745	142	4	when	when	WRB
46745	142	5	tested	test	VBN
46745	142	6	,	,	,
46745	142	7	are	be	VBP
46745	142	8	seen	see	VBN
46745	142	9	to	to	TO
46745	142	10	be	be	VB
46745	142	11	grounded	ground	VBN
46745	142	12	on	on	IN
46745	142	13	bare	bare	JJ
46745	142	14	assertions	assertion	NNS
46745	142	15	,	,	,
46745	142	16	and	and	CC
46745	142	17	to	to	TO
46745	142	18	be	be	VB
46745	142	19	destitute	destitute	JJ
46745	142	20	of	of	IN
46745	142	21	logical	logical	JJ
46745	142	22	proof	proof	NN
46745	142	23	;	;	:
46745	142	24	many	many	JJ
46745	142	25	others	other	NNS
46745	142	26	are	be	VBP
46745	142	27	attempted	attempt	VBN
46745	142	28	to	to	TO
46745	142	29	be	be	VB
46745	142	30	established	establish	VBN
46745	142	31	on	on	IN
46745	142	32	ill	ill	RB
46745	142	33	-	-	HYPH
46745	142	34	sustained	sustained	JJ
46745	142	35	analogies	analogy	NNS
46745	142	36	.	.	.
46745	143	1	Analogy	analogy	NN
46745	143	2	,	,	,
46745	143	3	in	in	IN
46745	143	4	such	such	PDT
46745	143	5	a	a	DT
46745	143	6	case	case	NN
46745	143	7	as	as	IN
46745	143	8	this	this	DT
46745	143	9	,	,	,
46745	143	10	may	may	MD
46745	143	11	be	be	VB
46745	143	12	used	use	VBN
46745	143	13	to	to	TO
46745	143	14	increase	increase	VB
46745	143	15	a	a	DT
46745	143	16	probability	probability	NN
46745	143	17	already	already	RB
46745	143	18	evidenced	evidence	VBN
46745	143	19	;	;	:
46745	143	20	but	but	CC
46745	143	21	by	by	IN
46745	143	22	itself	-PRON-	PRP
46745	143	23	it	-PRON-	PRP
46745	143	24	is	be	VBZ
46745	143	25	no	no	DT
46745	143	26	proof	proof	NN
46745	143	27	,	,	,
46745	143	28	for	for	IN
46745	143	29	we	-PRON-	PRP
46745	143	30	find	find	VBP
46745	143	31	often	often	RB
46745	143	32	that	that	IN
46745	143	33	medicines	medicine	NNS
46745	143	34	are	be	VBP
46745	143	35	capable	capable	JJ
46745	143	36	of	of	IN
46745	143	37	producing	produce	VBG
46745	143	38	the	the	DT
46745	143	39	same	same	JJ
46745	143	40	result	result	NN
46745	143	41	in	in	IN
46745	143	42	very	very	RB
46745	143	43	dissimilar	dissimilar	JJ
46745	143	44	ways	way	NNS
46745	143	45	.	.	.
46745	144	1	How	how	WRB
46745	144	2	then	then	RB
46745	144	3	are	be	VBP
46745	144	4	we	-PRON-	PRP
46745	144	5	to	to	TO
46745	144	6	arrive	arrive	VB
46745	144	7	at	at	IN
46745	144	8	the	the	DT
46745	144	9	truth	truth	NN
46745	144	10	!	!	.
46745	145	1	The	the	DT
46745	145	2	best	good	JJS
46745	145	3	and	and	CC
46745	145	4	surest	sure	JJS
46745	145	5	way	way	NN
46745	145	6	is	be	VBZ
46745	145	7	to	to	TO
46745	145	8	be	be	VB
46745	145	9	extremely	extremely	RB
46745	145	10	careful	careful	JJ
46745	145	11	in	in	IN
46745	145	12	the	the	DT
46745	145	13	means	mean	NNS
46745	145	14	which	which	WDT
46745	145	15	we	-PRON-	PRP
46745	145	16	employ	employ	VBP
46745	145	17	in	in	IN
46745	145	18	its	-PRON-	PRP$
46745	145	19	discovery	discovery	NN
46745	145	20	.	.	.
46745	146	1	It	-PRON-	PRP
46745	146	2	is	be	VBZ
46745	146	3	,	,	,
46745	146	4	I	-PRON-	PRP
46745	146	5	think	think	VBP
46745	146	6	,	,	,
46745	146	7	impossible	impossible	JJ
46745	146	8	to	to	TO
46745	146	9	overrate	overrate	VB
46745	146	10	the	the	DT
46745	146	11	importance	importance	NN
46745	146	12	of	of	IN
46745	146	13	_	_	NNP
46745	146	14	exact	exact	JJ
46745	146	15	precision	precision	NN
46745	146	16	of	of	IN
46745	146	17	language	language	NN
46745	146	18	and	and	CC
46745	146	19	thought	think	VBD
46745	146	20	_	_	NNP
46745	146	21	in	in	IN
46745	146	22	scientific	scientific	JJ
46745	146	23	details	detail	NNS
46745	146	24	,	,	,
46745	146	25	and	and	CC
46745	146	26	in	in	IN
46745	146	27	the	the	DT
46745	146	28	deduction	deduction	NN
46745	146	29	of	of	IN
46745	146	30	conclusions	conclusion	NNS
46745	146	31	from	from	IN
46745	146	32	them	-PRON-	PRP
46745	146	33	.	.	.
46745	147	1	[	[	-LRB-
46745	147	2	4	4	LS
46745	147	3	]	]	-RRB-
46745	147	4	A	a	DT
46745	147	5	subject	subject	NN
46745	147	6	so	so	RB
46745	147	7	interesting	interesting	JJ
46745	147	8	as	as	IN
46745	147	9	this	this	DT
46745	147	10	requires	require	VBZ
46745	147	11	to	to	TO
46745	147	12	be	be	VB
46745	147	13	treated	treat	VBN
46745	147	14	in	in	IN
46745	147	15	a	a	DT
46745	147	16	logical	logical	JJ
46745	147	17	way	way	NN
46745	147	18	.	.	.
46745	148	1	Facts	fact	NNS
46745	148	2	,	,	,
46745	148	3	when	when	WRB
46745	148	4	ascertained	ascertain	VBN
46745	148	5	,	,	,
46745	148	6	should	should	MD
46745	148	7	be	be	VB
46745	148	8	ranged	range	VBN
46745	148	9	together	together	RB
46745	148	10	and	and	CC
46745	148	11	compared	compare	VBN
46745	148	12	,	,	,
46745	148	13	and	and	CC
46745	148	14	exact	exact	JJ
46745	148	15	inferences	inference	NNS
46745	148	16	made	make	VBN
46745	148	17	,	,	,
46745	148	18	without	without	IN
46745	148	19	ever	ever	RB
46745	148	20	straining	strain	VBG
46745	148	21	a	a	DT
46745	148	22	point	point	NN
46745	148	23	.	.	.
46745	149	1	And	and	CC
46745	149	2	when	when	WRB
46745	149	3	we	-PRON-	PRP
46745	149	4	are	be	VBP
46745	149	5	inclined	inclined	JJ
46745	149	6	to	to	TO
46745	149	7	hazard	hazard	VB
46745	149	8	a	a	DT
46745	149	9	theory	theory	NN
46745	149	10	that	that	WDT
46745	149	11	is	be	VBZ
46745	149	12	barely	barely	RB
46745	149	13	supported	support	VBN
46745	149	14	,	,	,
46745	149	15	we	-PRON-	PRP
46745	149	16	should	should	MD
46745	149	17	take	take	VB
46745	149	18	care	care	NN
46745	149	19	to	to	IN
46745	149	20	state	state	VB
46745	149	21	it	-PRON-	PRP
46745	149	22	as	as	IN
46745	149	23	a	a	DT
46745	149	24	theory	theory	NN
46745	149	25	,	,	,
46745	149	26	and	and	CC
46745	149	27	not	not	RB
46745	149	28	to	to	TO
46745	149	29	bring	bring	VB
46745	149	30	it	-PRON-	PRP
46745	149	31	forward	forward	RB
46745	149	32	as	as	IN
46745	149	33	a	a	DT
46745	149	34	truth	truth	NN
46745	149	35	.	.	.
46745	150	1	It	-PRON-	PRP
46745	150	2	has	have	VBZ
46745	150	3	not	not	RB
46745	150	4	been	be	VBN
46745	150	5	an	an	DT
46745	150	6	uncommon	uncommon	JJ
46745	150	7	habit	habit	NN
46745	150	8	among	among	IN
46745	150	9	scientific	scientific	JJ
46745	150	10	authors	author	NNS
46745	150	11	,	,	,
46745	150	12	who	who	WP
46745	150	13	should	should	MD
46745	150	14	be	be	VB
46745	150	15	of	of	IN
46745	150	16	all	all	DT
46745	150	17	men	man	NNS
46745	150	18	the	the	DT
46745	150	19	most	most	RBS
46745	150	20	careful	careful	JJ
46745	150	21	and	and	CC
46745	150	22	exact	exact	JJ
46745	150	23	,	,	,
46745	150	24	to	to	TO
46745	150	25	confound	confound	VB
46745	150	26	assertion	assertion	NN
46745	150	27	with	with	IN
46745	150	28	fact	fact	NN
46745	150	29	--	--	:
46745	150	30	to	to	TO
46745	150	31	mistake	mistake	VB
46745	150	32	hypothesis	hypothesis	NN
46745	150	33	for	for	IN
46745	150	34	truth	truth	NN
46745	150	35	.	.	.
46745	151	1	In	in	IN
46745	151	2	such	such	JJ
46745	151	3	illogical	illogical	JJ
46745	151	4	and	and	CC
46745	151	5	incorrect	incorrect	JJ
46745	151	6	reasoning	reasoning	NN
46745	151	7	is	be	VBZ
46745	151	8	to	to	TO
46745	151	9	be	be	VB
46745	151	10	found	find	VBN
46745	151	11	the	the	DT
46745	151	12	true	true	JJ
46745	151	13	source	source	NN
46745	151	14	of	of	IN
46745	151	15	a	a	DT
46745	151	16	multitude	multitude	NN
46745	151	17	of	of	IN
46745	151	18	errors	error	NNS
46745	151	19	.	.	.
46745	152	1	Being	be	VBG
46745	152	2	sensible	sensible	JJ
46745	152	3	of	of	IN
46745	152	4	this	this	DT
46745	152	5	danger	danger	NN
46745	152	6	,	,	,
46745	152	7	I	-PRON-	PRP
46745	152	8	have	have	VBP
46745	152	9	endeavoured	endeavour	VBN
46745	152	10	to	to	TO
46745	152	11	keep	keep	VB
46745	152	12	it	-PRON-	PRP
46745	152	13	in	in	IN
46745	152	14	view	view	NN
46745	152	15	in	in	IN
46745	152	16	the	the	DT
46745	152	17	arrangement	arrangement	NN
46745	152	18	of	of	IN
46745	152	19	this	this	DT
46745	152	20	Essay	Essay	NNP
46745	152	21	.	.	.
46745	153	1	In	in	IN
46745	153	2	order	order	NN
46745	153	3	to	to	TO
46745	153	4	obtain	obtain	VB
46745	153	5	,	,	,
46745	153	6	if	if	IN
46745	153	7	possible	possible	JJ
46745	153	8	,	,	,
46745	153	9	this	this	DT
46745	153	10	clearness	clearness	NN
46745	153	11	and	and	CC
46745	153	12	precision	precision	NN
46745	153	13	,	,	,
46745	153	14	or	or	CC
46745	153	15	at	at	IN
46745	153	16	all	all	DT
46745	153	17	events	event	NNS
46745	153	18	,	,	,
46745	153	19	to	to	TO
46745	153	20	be	be	VB
46745	153	21	better	well	RBR
46745	153	22	understood	understand	VBN
46745	153	23	,	,	,
46745	153	24	I	-PRON-	PRP
46745	153	25	have	have	VBP
46745	153	26	arranged	arrange	VBN
46745	153	27	the	the	DT
46745	153	28	heads	head	NNS
46745	153	29	of	of	IN
46745	153	30	my	-PRON-	PRP$
46745	153	31	ideas	idea	NNS
46745	153	32	on	on	IN
46745	153	33	the	the	DT
46745	153	34	action	action	NN
46745	153	35	of	of	IN
46745	153	36	medicines	medicine	NNS
46745	153	37	in	in	IN
46745	153	38	a	a	DT
46745	153	39	number	number	NN
46745	153	40	of	of	IN
46745	153	41	distinct	distinct	JJ
46745	153	42	propositions	proposition	NNS
46745	153	43	,	,	,
46745	153	44	the	the	DT
46745	153	45	scope	scope	NN
46745	153	46	of	of	IN
46745	153	47	which	which	WDT
46745	153	48	will	will	MD
46745	153	49	be	be	VB
46745	153	50	presently	presently	RB
46745	153	51	described	describe	VBN
46745	153	52	.	.	.
46745	154	1	I	-PRON-	PRP
46745	154	2	shall	shall	MD
46745	154	3	attempt	attempt	VB
46745	154	4	to	to	TO
46745	154	5	prove	prove	VB
46745	154	6	each	each	DT
46745	154	7	of	of	IN
46745	154	8	them	-PRON-	PRP
46745	154	9	separately	separately	RB
46745	154	10	,	,	,
46745	154	11	as	as	IN
46745	154	12	if	if	IN
46745	154	13	it	-PRON-	PRP
46745	154	14	were	be	VBD
46745	154	15	a	a	DT
46745	154	16	theorem	theorem	NN
46745	154	17	in	in	IN
46745	154	18	geometry	geometry	NN
46745	154	19	,	,	,
46745	154	20	sometimes	sometimes	RB
46745	154	21	dividing	divide	VBG
46745	154	22	it	-PRON-	PRP
46745	154	23	first	first	RB
46745	154	24	into	into	IN
46745	154	25	a	a	DT
46745	154	26	number	number	NN
46745	154	27	of	of	IN
46745	154	28	minor	minor	JJ
46745	154	29	propositions	proposition	NNS
46745	154	30	,	,	,
46745	154	31	which	which	WDT
46745	154	32	,	,	,
46745	154	33	taken	take	VBN
46745	154	34	together	together	RB
46745	154	35	,	,	,
46745	154	36	imply	imply	VB
46745	154	37	the	the	DT
46745	154	38	original	original	JJ
46745	154	39	one	one	NN
46745	154	40	,	,	,
46745	154	41	and	and	CC
46745	154	42	which	which	WDT
46745	154	43	have	have	VBP
46745	154	44	to	to	TO
46745	154	45	be	be	VB
46745	154	46	severally	severally	RB
46745	154	47	discussed	discuss	VBN
46745	154	48	.	.	.
46745	155	1	The	the	DT
46745	155	2	great	great	JJ
46745	155	3	use	use	NN
46745	155	4	of	of	IN
46745	155	5	such	such	PDT
46745	155	6	an	an	DT
46745	155	7	arrangement	arrangement	NN
46745	155	8	is	be	VBZ
46745	155	9	its	-PRON-	PRP$
46745	155	10	distinctness	distinctness	NN
46745	155	11	:	:	:
46745	155	12	so	so	IN
46745	155	13	that	that	IN
46745	155	14	it	-PRON-	PRP
46745	155	15	may	may	MD
46745	155	16	in	in	IN
46745	155	17	any	any	DT
46745	155	18	case	case	NN
46745	155	19	be	be	VB
46745	155	20	easily	easily	RB
46745	155	21	seen	see	VBN
46745	155	22	whether	whether	IN
46745	155	23	a	a	DT
46745	155	24	proposition	proposition	NN
46745	155	25	has	have	VBZ
46745	155	26	been	be	VBN
46745	155	27	established	establish	VBN
46745	155	28	,	,	,
46745	155	29	or	or	CC
46745	155	30	whether	whether	IN
46745	155	31	I	-PRON-	PRP
46745	155	32	have	have	VBP
46745	155	33	failed	fail	VBN
46745	155	34	to	to	TO
46745	155	35	prove	prove	VB
46745	155	36	it	-PRON-	PRP
46745	155	37	.	.	.
46745	156	1	These	these	DT
46745	156	2	propositions	proposition	NNS
46745	156	3	are	be	VBP
46745	156	4	the	the	DT
46745	156	5	foundation	foundation	NN
46745	156	6	of	of	IN
46745	156	7	the	the	DT
46745	156	8	Essay	Essay	NNP
46745	156	9	;	;	:
46745	156	10	and	and	CC
46745	156	11	upon	upon	IN
46745	156	12	them	-PRON-	PRP
46745	156	13	has	have	VBZ
46745	156	14	been	be	VBN
46745	156	15	erected	erect	VBN
46745	156	16	a	a	DT
46745	156	17	superstructure	superstructure	NN
46745	156	18	of	of	IN
46745	156	19	more	more	JJR
46745	156	20	or	or	CC
46745	156	21	less	less	RBR
46745	156	22	logical	logical	JJ
46745	156	23	consistency	consistency	NN
46745	156	24	.	.	.
46745	157	1	In	in	IN
46745	157	2	them	-PRON-	PRP
46745	157	3	has	have	VBZ
46745	157	4	been	be	VBN
46745	157	5	stated	state	VBN
46745	157	6	about	about	IN
46745	157	7	as	as	RB
46745	157	8	much	much	JJ
46745	157	9	of	of	IN
46745	157	10	the	the	DT
46745	157	11	general	general	JJ
46745	157	12	principles	principle	NNS
46745	157	13	by	by	IN
46745	157	14	which	which	WDT
46745	157	15	medicines	medicine	NNS
46745	157	16	operate	operate	VBP
46745	157	17	as	as	IN
46745	157	18	seems	seem	VBZ
46745	157	19	to	to	IN
46745	157	20	me	-PRON-	PRP
46745	157	21	to	to	TO
46745	157	22	be	be	VB
46745	157	23	capable	capable	JJ
46745	157	24	of	of	IN
46745	157	25	distinct	distinct	JJ
46745	157	26	proof	proof	NN
46745	157	27	:	:	:
46745	157	28	_	_	NNP
46745	157	29	i.e.	i.e.	FW
46745	157	30	_	_	NNP
46745	157	31	which	which	WDT
46745	157	32	may	may	MD
46745	157	33	be	be	VB
46745	157	34	regarded	regard	VBN
46745	157	35	with	with	IN
46745	157	36	that	that	DT
46745	157	37	kind	kind	NN
46745	157	38	of	of	IN
46745	157	39	certainty	certainty	NN
46745	157	40	which	which	WDT
46745	157	41	we	-PRON-	PRP
46745	157	42	generally	generally	RB
46745	157	43	expect	expect	VBP
46745	157	44	to	to	TO
46745	157	45	attain	attain	VB
46745	157	46	to	to	IN
46745	157	47	in	in	IN
46745	157	48	scientific	scientific	JJ
46745	157	49	matters	matter	NNS
46745	157	50	.	.	.
46745	158	1	So	so	RB
46745	158	2	far	far	RB
46745	158	3	,	,	,
46745	158	4	then	then	RB
46745	158	5	,	,	,
46745	158	6	I	-PRON-	PRP
46745	158	7	have	have	VBP
46745	158	8	kept	keep	VBN
46745	158	9	myself	-PRON-	PRP
46745	158	10	in	in	IN
46745	158	11	a	a	DT
46745	158	12	straight	straight	JJ
46745	158	13	road	road	NN
46745	158	14	,	,	,
46745	158	15	between	between	IN
46745	158	16	two	two	CD
46745	158	17	walls	wall	NNS
46745	158	18	,	,	,
46745	158	19	diverging	diverge	VBG
46745	158	20	neither	neither	CC
46745	158	21	to	to	IN
46745	158	22	the	the	DT
46745	158	23	right	right	NN
46745	158	24	nor	nor	CC
46745	158	25	to	to	IN
46745	158	26	the	the	DT
46745	158	27	left	left	NN
46745	158	28	to	to	TO
46745	158	29	gratify	gratify	VB
46745	158	30	my	-PRON-	PRP$
46745	158	31	inclination	inclination	NN
46745	158	32	;	;	:
46745	158	33	it	-PRON-	PRP
46745	158	34	being	be	VBG
46745	158	35	,	,	,
46745	158	36	as	as	IN
46745	158	37	I	-PRON-	PRP
46745	158	38	have	have	VBP
46745	158	39	said	say	VBD
46745	158	40	,	,	,
46745	158	41	a	a	DT
46745	158	42	most	most	RBS
46745	158	43	obvious	obvious	JJ
46745	158	44	duty	duty	NN
46745	158	45	to	to	TO
46745	158	46	guard	guard	VB
46745	158	47	against	against	IN
46745	158	48	stating	state	VBG
46745	158	49	that	that	IN
46745	158	50	for	for	IN
46745	158	51	fact	fact	NN
46745	158	52	which	which	WDT
46745	158	53	is	be	VBZ
46745	158	54	at	at	IN
46745	158	55	the	the	DT
46745	158	56	best	good	JJS
46745	158	57	uncertain	uncertain	JJ
46745	158	58	.	.	.
46745	159	1	But	but	CC
46745	159	2	having	have	VBG
46745	159	3	gone	go	VBN
46745	159	4	so	so	RB
46745	159	5	far	far	RB
46745	159	6	,	,	,
46745	159	7	I	-PRON-	PRP
46745	159	8	have	have	VBP
46745	159	9	in	in	IN
46745	159	10	several	several	JJ
46745	159	11	instances	instance	NNS
46745	159	12	indulged	indulge	VBN
46745	159	13	in	in	IN
46745	159	14	speculations	speculation	NNS
46745	159	15	and	and	CC
46745	159	16	hypotheses	hypothesis	NNS
46745	159	17	on	on	IN
46745	159	18	certain	certain	JJ
46745	159	19	matters	matter	NNS
46745	159	20	,	,	,
46745	159	21	taking	take	VBG
46745	159	22	care	care	NN
46745	159	23	to	to	IN
46745	159	24	state	state	NN
46745	159	25	that	that	IN
46745	159	26	such	such	JJ
46745	159	27	explanations	explanation	NNS
46745	159	28	are	be	VBP
46745	159	29	only	only	RB
46745	159	30	probable	probable	JJ
46745	159	31	,	,	,
46745	159	32	and	and	CC
46745	159	33	very	very	RB
46745	159	34	far	far	RB
46745	159	35	from	from	IN
46745	159	36	determined	determined	JJ
46745	159	37	.	.	.
46745	160	1	But	but	CC
46745	160	2	it	-PRON-	PRP
46745	160	3	is	be	VBZ
46745	160	4	often	often	RB
46745	160	5	our	-PRON-	PRP$
46745	160	6	duty	duty	NN
46745	160	7	to	to	TO
46745	160	8	inquire	inquire	VB
46745	160	9	into	into	IN
46745	160	10	uncertain	uncertain	JJ
46745	160	11	things	thing	NNS
46745	160	12	;	;	:
46745	160	13	and	and	CC
46745	160	14	those	those	DT
46745	160	15	who	who	WP
46745	160	16	do	do	VBP
46745	160	17	so	so	RB
46745	160	18	,	,	,
46745	160	19	who	who	WP
46745	160	20	officiate	officiate	VBP
46745	160	21	,	,	,
46745	160	22	in	in	IN
46745	160	23	however	however	RB
46745	160	24	humble	humble	JJ
46745	160	25	a	a	DT
46745	160	26	capacity	capacity	NN
46745	160	27	,	,	,
46745	160	28	as	as	IN
46745	160	29	the	the	DT
46745	160	30	pioneers	pioneer	NNS
46745	160	31	of	of	IN
46745	160	32	knowledge	knowledge	NN
46745	160	33	,	,	,
46745	160	34	have	have	VBP
46745	160	35	to	to	TO
46745	160	36	hazard	hazard	VB
46745	160	37	many	many	JJ
46745	160	38	conjectures	conjecture	NNS
46745	160	39	before	before	IN
46745	160	40	they	-PRON-	PRP
46745	160	41	arrive	arrive	VBP
46745	160	42	at	at	IN
46745	160	43	the	the	DT
46745	160	44	truth	truth	NN
46745	160	45	.	.	.
46745	161	1	In	in	IN
46745	161	2	striving	strive	VBG
46745	161	3	after	after	IN
46745	161	4	truth	truth	NN
46745	161	5	,	,	,
46745	161	6	we	-PRON-	PRP
46745	161	7	must	must	MD
46745	161	8	investigate	investigate	VB
46745	161	9	many	many	JJ
46745	161	10	an	an	DT
46745	161	11	unknown	unknown	JJ
46745	161	12	path	path	NN
46745	161	13	,	,	,
46745	161	14	and	and	CC
46745	161	15	try	try	VB
46745	161	16	at	at	IN
46745	161	17	many	many	JJ
46745	161	18	a	a	DT
46745	161	19	door	door	NN
46745	161	20	where	where	WRB
46745	161	21	we	-PRON-	PRP
46745	161	22	have	have	VBP
46745	161	23	not	not	RB
46745	161	24	before	before	RB
46745	161	25	entered	enter	VBN
46745	161	26	.	.	.
46745	162	1	Thus	thus	RB
46745	162	2	,	,	,
46745	162	3	when	when	WRB
46745	162	4	in	in	IN
46745	162	5	some	some	DT
46745	162	6	cases	case	NNS
46745	162	7	I	-PRON-	PRP
46745	162	8	have	have	VBP
46745	162	9	perceived	perceive	VBN
46745	162	10	before	before	IN
46745	162	11	me	-PRON-	PRP
46745	162	12	a	a	DT
46745	162	13	line	line	NN
46745	162	14	of	of	IN
46745	162	15	thought	thought	NN
46745	162	16	stretching	stretch	VBG
46745	162	17	onwards	onwards	RB
46745	162	18	,	,	,
46745	162	19	and	and	CC
46745	162	20	seeming	seeming	JJ
46745	162	21	to	to	TO
46745	162	22	lead	lead	VB
46745	162	23	somewhere	somewhere	RB
46745	162	24	in	in	IN
46745	162	25	the	the	DT
46745	162	26	direction	direction	NN
46745	162	27	of	of	IN
46745	162	28	truth	truth	NN
46745	162	29	,	,	,
46745	162	30	I	-PRON-	PRP
46745	162	31	have	have	VBP
46745	162	32	not	not	RB
46745	162	33	,	,	,
46745	162	34	as	as	IN
46745	162	35	it	-PRON-	PRP
46745	162	36	were	be	VBD
46745	162	37	,	,	,
46745	162	38	shunned	shun	VBD
46745	162	39	it	-PRON-	PRP
46745	162	40	,	,	,
46745	162	41	or	or	CC
46745	162	42	turned	turn	VBD
46745	162	43	aside	aside	RB
46745	162	44	to	to	IN
46745	162	45	tread	tread	VB
46745	162	46	only	only	RB
46745	162	47	in	in	IN
46745	162	48	more	more	JJR
46745	162	49	certain	certain	JJ
46745	162	50	paths	path	NNS
46745	162	51	,	,	,
46745	162	52	but	but	CC
46745	162	53	I	-PRON-	PRP
46745	162	54	have	have	VBP
46745	162	55	thought	think	VBN
46745	162	56	it	-PRON-	PRP
46745	162	57	my	-PRON-	PRP$
46745	162	58	duty	duty	NN
46745	162	59	to	to	TO
46745	162	60	follow	follow	VB
46745	162	61	it	-PRON-	PRP
46745	162	62	up	up	RP
46745	162	63	,	,	,
46745	162	64	and	and	CC
46745	162	65	to	to	TO
46745	162	66	investigate	investigate	VB
46745	162	67	it	-PRON-	PRP
46745	162	68	thoroughly	thoroughly	RB
46745	162	69	,	,	,
46745	162	70	to	to	TO
46745	162	71	see	see	VB
46745	162	72	if	if	IN
46745	162	73	by	by	IN
46745	162	74	any	any	DT
46745	162	75	means	mean	NNS
46745	162	76	it	-PRON-	PRP
46745	162	77	might	may	MD
46745	162	78	not	not	RB
46745	162	79	help	help	VB
46745	162	80	me	-PRON-	PRP
46745	162	81	on	on	IN
46745	162	82	my	-PRON-	PRP$
46745	162	83	way	way	NN
46745	162	84	to	to	IN
46745	162	85	that	that	DT
46745	162	86	desired	desire	VBN
46745	162	87	haven	haven	NNP
46745	162	88	.	.	.
46745	163	1	These	these	DT
46745	163	2	theories	theory	NNS
46745	163	3	are	be	VBP
46745	163	4	the	the	DT
46745	163	5	weak	weak	JJ
46745	163	6	points	point	NNS
46745	163	7	of	of	IN
46745	163	8	the	the	DT
46745	163	9	Essay	Essay	NNP
46745	163	10	,	,	,
46745	163	11	but	but	CC
46745	163	12	I	-PRON-	PRP
46745	163	13	must	must	MD
46745	163	14	crave	crave	VB
46745	163	15	indulgence	indulgence	NN
46745	163	16	for	for	IN
46745	163	17	them	-PRON-	PRP
46745	163	18	on	on	IN
46745	163	19	the	the	DT
46745	163	20	grounds	ground	NNS
46745	163	21	alleged	allege	VBN
46745	163	22	above	above	RB
46745	163	23	.	.	.
46745	164	1	It	-PRON-	PRP
46745	164	2	will	will	MD
46745	164	3	be	be	VB
46745	164	4	observed	observe	VBN
46745	164	5	that	that	IN
46745	164	6	the	the	DT
46745	164	7	original	original	JJ
46745	164	8	propositions	proposition	NNS
46745	164	9	are	be	VBP
46745	164	10	so	so	RB
46745	164	11	stated	stated	JJ
46745	164	12	,	,	,
46745	164	13	that	that	IN
46745	164	14	the	the	DT
46745	164	15	overthrow	overthrow	NN
46745	164	16	of	of	IN
46745	164	17	any	any	DT
46745	164	18	one	one	CD
46745	164	19	of	of	IN
46745	164	20	these	these	DT
46745	164	21	extra	extra	JJ
46745	164	22	hypotheses	hypothesis	NNS
46745	164	23	would	would	MD
46745	164	24	not	not	RB
46745	164	25	shake	shake	VB
46745	164	26	them	-PRON-	PRP
46745	164	27	,	,	,
46745	164	28	or	or	CC
46745	164	29	in	in	IN
46745	164	30	any	any	DT
46745	164	31	way	way	NN
46745	164	32	invalidate	invalidate	VB
46745	164	33	their	-PRON-	PRP$
46745	164	34	proof	proof	NN
46745	164	35	.	.	.
46745	165	1	I	-PRON-	PRP
46745	165	2	will	will	MD
46745	165	3	now	now	RB
46745	165	4	sketch	sketch	VB
46745	165	5	out	out	RP
46745	165	6	the	the	DT
46745	165	7	arrangement	arrangement	NN
46745	165	8	which	which	WDT
46745	165	9	I	-PRON-	PRP
46745	165	10	propose	propose	VBP
46745	165	11	to	to	TO
46745	165	12	follow	follow	VB
46745	165	13	in	in	IN
46745	165	14	the	the	DT
46745	165	15	consideration	consideration	NN
46745	165	16	of	of	IN
46745	165	17	the	the	DT
46745	165	18	topics	topic	NNS
46745	165	19	which	which	WDT
46745	165	20	present	present	VBP
46745	165	21	themselves	-PRON-	PRP
46745	165	22	to	to	IN
46745	165	23	me	-PRON-	PRP
46745	165	24	.	.	.
46745	166	1	In	in	IN
46745	166	2	the	the	DT
46745	166	3	next	next	JJ
46745	166	4	chapter	chapter	NN
46745	166	5	I	-PRON-	PRP
46745	166	6	shall	shall	MD
46745	166	7	take	take	VB
46745	166	8	a	a	DT
46745	166	9	brief	brief	JJ
46745	166	10	review	review	NN
46745	166	11	of	of	IN
46745	166	12	the	the	DT
46745	166	13	opinions	opinion	NNS
46745	166	14	of	of	IN
46745	166	15	other	other	JJ
46745	166	16	writers	writer	NNS
46745	166	17	on	on	IN
46745	166	18	the	the	DT
46745	166	19	subject	subject	NN
46745	166	20	of	of	IN
46745	166	21	the	the	DT
46745	166	22	action	action	NN
46745	166	23	of	of	IN
46745	166	24	medicines	medicine	NNS
46745	166	25	;	;	,
46745	166	26	knowing	know	VBG
46745	166	27	,	,	,
46745	166	28	indeed	indeed	RB
46745	166	29	,	,	,
46745	166	30	that	that	IN
46745	166	31	in	in	IN
46745	166	32	so	so	RB
46745	166	33	short	short	JJ
46745	166	34	a	a	DT
46745	166	35	notice	notice	NN
46745	166	36	I	-PRON-	PRP
46745	166	37	shall	shall	MD
46745	166	38	be	be	VB
46745	166	39	perfectly	perfectly	RB
46745	166	40	unable	unable	JJ
46745	166	41	to	to	TO
46745	166	42	do	do	VB
46745	166	43	them	-PRON-	PRP
46745	166	44	justice	justice	NN
46745	166	45	,	,	,
46745	166	46	but	but	CC
46745	166	47	wishing	wish	VBG
46745	166	48	,	,	,
46745	166	49	in	in	IN
46745	166	50	some	some	DT
46745	166	51	broad	broad	JJ
46745	166	52	points	point	NNS
46745	166	53	,	,	,
46745	166	54	to	to	TO
46745	166	55	draw	draw	VB
46745	166	56	the	the	DT
46745	166	57	line	line	NN
46745	166	58	between	between	IN
46745	166	59	what	what	WP
46745	166	60	is	be	VBZ
46745	166	61	known	know	VBN
46745	166	62	and	and	CC
46745	166	63	what	what	WP
46745	166	64	is	be	VBZ
46745	166	65	unknown,--what	unknown,--what	NNP
46745	166	66	is	be	VBZ
46745	166	67	ascertained	ascertain	VBN
46745	166	68	and	and	CC
46745	166	69	what	what	WP
46745	166	70	is	be	VBZ
46745	166	71	debated,--what	debated,--what	,
46745	166	72	is	be	VBZ
46745	166	73	approved	approve	VBN
46745	166	74	and	and	CC
46745	166	75	what	what	WP
46745	166	76	condemned	condemn	VBD
46745	166	77	.	.	.
46745	167	1	In	in	IN
46745	167	2	some	some	DT
46745	167	3	cases	case	NNS
46745	167	4	also	also	RB
46745	167	5	I	-PRON-	PRP
46745	167	6	may	may	MD
46745	167	7	venture	venture	VB
46745	167	8	to	to	IN
46745	167	9	object	object	VB
46745	167	10	to	to	IN
46745	167	11	opinions	opinion	NNS
46745	167	12	hitherto	hitherto	NNP
46745	167	13	unquestioned	unquestioned	JJ
46745	167	14	.	.	.
46745	168	1	Now	now	RB
46745	168	2	,	,	,
46745	168	3	as	as	IN
46745	168	4	the	the	DT
46745	168	5	best	good	JJS
46745	168	6	key	key	NN
46745	168	7	to	to	IN
46745	168	8	the	the	DT
46745	168	9	main	main	JJ
46745	168	10	opinions	opinion	NNS
46745	168	11	of	of	IN
46745	168	12	authors	author	NNS
46745	168	13	on	on	IN
46745	168	14	this	this	DT
46745	168	15	subject	subject	NN
46745	168	16	,	,	,
46745	168	17	we	-PRON-	PRP
46745	168	18	have	have	VBP
46745	168	19	to	to	TO
46745	168	20	consider	consider	VB
46745	168	21	the	the	DT
46745	168	22	various	various	JJ
46745	168	23	classifications	classification	NNS
46745	168	24	of	of	IN
46745	168	25	medicines	medicine	NNS
46745	168	26	which	which	WDT
46745	168	27	they	-PRON-	PRP
46745	168	28	have	have	VBP
46745	168	29	adopted	adopt	VBN
46745	168	30	.	.	.
46745	169	1	A	a	DT
46745	169	2	classification	classification	NN
46745	169	3	of	of	IN
46745	169	4	remedies	remedy	NNS
46745	169	5	presupposes	presuppose	VBZ
46745	169	6	a	a	DT
46745	169	7	set	set	NN
46745	169	8	of	of	IN
46745	169	9	theories	theory	NNS
46745	169	10	concerning	concern	VBG
46745	169	11	either	either	CC
46745	169	12	their	-PRON-	PRP$
46745	169	13	primary	primary	JJ
46745	169	14	action	action	NN
46745	169	15	or	or	CC
46745	169	16	their	-PRON-	PRP$
46745	169	17	general	general	JJ
46745	169	18	results	result	NNS
46745	169	19	,	,	,
46745	169	20	and	and	CC
46745	169	21	is	be	VBZ
46745	169	22	,	,	,
46745	169	23	in	in	IN
46745	169	24	fact	fact	NN
46745	169	25	,	,	,
46745	169	26	identical	identical	JJ
46745	169	27	with	with	IN
46745	169	28	them	-PRON-	PRP
46745	169	29	.	.	.
46745	170	1	The	the	DT
46745	170	2	formation	formation	NN
46745	170	3	of	of	IN
46745	170	4	such	such	PDT
46745	170	5	an	an	DT
46745	170	6	arrangement	arrangement	NN
46745	170	7	depends	depend	VBZ
46745	170	8	on	on	IN
46745	170	9	the	the	DT
46745	170	10	necessity	necessity	NN
46745	170	11	of	of	IN
46745	170	12	considering	consider	VBG
46745	170	13	medicines	medicine	NNS
46745	170	14	in	in	IN
46745	170	15	groups	group	NNS
46745	170	16	,	,	,
46745	170	17	each	each	DT
46745	170	18	possessed	possess	VBN
46745	170	19	of	of	IN
46745	170	20	some	some	DT
46745	170	21	common	common	JJ
46745	170	22	character	character	NN
46745	170	23	,	,	,
46745	170	24	in	in	IN
46745	170	25	order	order	NN
46745	170	26	that	that	IN
46745	170	27	their	-PRON-	PRP$
46745	170	28	various	various	JJ
46745	170	29	properties	property	NNS
46745	170	30	may	may	MD
46745	170	31	be	be	VB
46745	170	32	simplified	simplify	VBN
46745	170	33	,	,	,
46745	170	34	and	and	CC
46745	170	35	admit	admit	VB
46745	170	36	of	of	IN
46745	170	37	being	be	VBG
46745	170	38	compared	compare	VBN
46745	170	39	.	.	.
46745	171	1	In	in	IN
46745	171	2	a	a	DT
46745	171	3	classification	classification	NN
46745	171	4	we	-PRON-	PRP
46745	171	5	do	do	VBP
46745	171	6	not	not	RB
46745	171	7	so	so	RB
46745	171	8	much	much	RB
46745	171	9	consider	consider	VB
46745	171	10	the	the	DT
46745	171	11	peculiarities	peculiarity	NNS
46745	171	12	of	of	IN
46745	171	13	single	single	JJ
46745	171	14	remedies	remedy	NNS
46745	171	15	,	,	,
46745	171	16	as	as	IN
46745	171	17	the	the	DT
46745	171	18	points	point	NNS
46745	171	19	in	in	IN
46745	171	20	which	which	WDT
46745	171	21	large	large	JJ
46745	171	22	numbers	number	NNS
46745	171	23	agree	agree	VBP
46745	171	24	together	together	RB
46745	171	25	.	.	.
46745	172	1	These	these	DT
46745	172	2	points	point	NNS
46745	172	3	of	of	IN
46745	172	4	resemblance	resemblance	NN
46745	172	5	we	-PRON-	PRP
46745	172	6	gene	gene	VBP
46745	172	7	rally	rally	NN
46745	172	8	find	find	VBP
46745	172	9	to	to	TO
46745	172	10	be	be	VB
46745	172	11	of	of	IN
46745	172	12	the	the	DT
46745	172	13	most	most	JJS
46745	172	14	importance	importance	NN
46745	172	15	.	.	.
46745	173	1	I	-PRON-	PRP
46745	173	2	have	have	VBP
46745	173	3	to	to	TO
46745	173	4	consider	consider	VB
46745	173	5	three	three	CD
46745	173	6	sets	set	NNS
46745	173	7	of	of	IN
46745	173	8	authors	author	NNS
46745	173	9	in	in	IN
46745	173	10	the	the	DT
46745	173	11	second	second	JJ
46745	173	12	chapter	chapter	NN
46745	173	13	.	.	.
46745	174	1	The	the	DT
46745	174	2	first	first	JJ
46745	174	3	set	set	VBN
46745	174	4	treat	treat	NN
46745	174	5	of	of	IN
46745	174	6	the	the	DT
46745	174	7	general	general	JJ
46745	174	8	or	or	CC
46745	174	9	ultimate	ultimate	JJ
46745	174	10	effect	effect	NN
46745	174	11	of	of	IN
46745	174	12	a	a	DT
46745	174	13	medicine	medicine	NN
46745	174	14	on	on	IN
46745	174	15	the	the	DT
46745	174	16	system	system	NN
46745	174	17	;	;	:
46745	174	18	and	and	CC
46745	174	19	classify	classify	VB
46745	174	20	medicines	medicine	NNS
46745	174	21	accordingly	accordingly	RB
46745	174	22	.	.	.
46745	175	1	A	a	DT
46745	175	2	second	second	JJ
46745	175	3	set	set	NN
46745	175	4	of	of	IN
46745	175	5	writers	writer	NNS
46745	175	6	have	have	VBP
46745	175	7	arranged	arrange	VBN
46745	175	8	therapeutical	therapeutical	JJ
46745	175	9	agents	agent	NNS
46745	175	10	according	accord	VBG
46745	175	11	to	to	IN
46745	175	12	the	the	DT
46745	175	13	organ	organ	NN
46745	175	14	or	or	CC
46745	175	15	part	part	NN
46745	175	16	of	of	IN
46745	175	17	the	the	DT
46745	175	18	body	body	NN
46745	175	19	to	to	TO
46745	175	20	which	which	WDT
46745	175	21	their	-PRON-	PRP$
46745	175	22	action	action	NN
46745	175	23	is	be	VBZ
46745	175	24	especially	especially	RB
46745	175	25	directed	direct	VBN
46745	175	26	.	.	.
46745	176	1	Neither	neither	DT
46745	176	2	of	of	IN
46745	176	3	these	these	DT
46745	176	4	deal	deal	NN
46745	176	5	with	with	IN
46745	176	6	the	the	DT
46745	176	7	mode	mode	NN
46745	176	8	in	in	IN
46745	176	9	which	which	WDT
46745	176	10	medicines	medicines	NNP
46745	176	11	act	act	VBP
46745	176	12	as	as	IN
46745	176	13	the	the	DT
46745	176	14	basis	basis	NN
46745	176	15	of	of	IN
46745	176	16	classification	classification	NN
46745	176	17	.	.	.
46745	177	1	A	a	DT
46745	177	2	third	third	JJ
46745	177	3	set	set	NN
46745	177	4	of	of	IN
46745	177	5	writers	writer	NNS
46745	177	6	have	have	VBP
46745	177	7	attempted	attempt	VBN
46745	177	8	in	in	IN
46745	177	9	various	various	JJ
46745	177	10	ways	way	NNS
46745	177	11	to	to	TO
46745	177	12	explain	explain	VB
46745	177	13	the	the	DT
46745	177	14	modes	mode	NNS
46745	177	15	of	of	IN
46745	177	16	operation	operation	NN
46745	177	17	of	of	IN
46745	177	18	medicines	medicine	NNS
46745	177	19	.	.	.
46745	178	1	They	-PRON-	PRP
46745	178	2	have	have	VBP
46745	178	3	laid	lay	VBN
46745	178	4	down	down	RP
46745	178	5	general	general	JJ
46745	178	6	rules	rule	NNS
46745	178	7	about	about	IN
46745	178	8	these	these	DT
46745	178	9	operations	operation	NNS
46745	178	10	,	,	,
46745	178	11	and	and	CC
46745	178	12	have	have	VBP
46745	178	13	constructed	construct	VBN
46745	178	14	more	more	RBR
46745	178	15	or	or	CC
46745	178	16	less	less	JJR
46745	178	17	plausible	plausible	JJ
46745	178	18	theories	theory	NNS
46745	178	19	on	on	IN
46745	178	20	the	the	DT
46745	178	21	subject	subject	NN
46745	178	22	.	.	.
46745	179	1	Some	some	DT
46745	179	2	few	few	JJ
46745	179	3	have	have	VBP
46745	179	4	classified	classify	VBN
46745	179	5	remedies	remedy	NNS
46745	179	6	on	on	IN
46745	179	7	this	this	DT
46745	179	8	plan	plan	NN
46745	179	9	.	.	.
46745	180	1	Now	now	RB
46745	180	2	,	,	,
46745	180	3	with	with	IN
46745	180	4	these	these	DT
46745	180	5	theories	theory	NNS
46745	180	6	I	-PRON-	PRP
46745	180	7	am	be	VBP
46745	180	8	more	more	RBR
46745	180	9	particularly	particularly	RB
46745	180	10	concerned	concern	VBN
46745	180	11	,	,	,
46745	180	12	as	as	IN
46745	180	13	they	-PRON-	PRP
46745	180	14	trench	trench	VBP
46745	180	15	immediately	immediately	RB
46745	180	16	on	on	IN
46745	180	17	the	the	DT
46745	180	18	subject	subject	NN
46745	180	19	of	of	IN
46745	180	20	this	this	DT
46745	180	21	Essay	Essay	NNP
46745	180	22	.	.	.
46745	181	1	But	but	CC
46745	181	2	they	-PRON-	PRP
46745	181	3	are	be	VBP
46745	181	4	not	not	RB
46745	181	5	many	many	JJ
46745	181	6	,	,	,
46745	181	7	and	and	CC
46745	181	8	it	-PRON-	PRP
46745	181	9	will	will	MD
46745	181	10	not	not	RB
46745	181	11	take	take	VB
46745	181	12	us	-PRON-	PRP
46745	181	13	long	long	JJ
46745	181	14	to	to	TO
46745	181	15	review	review	VB
46745	181	16	them	-PRON-	PRP
46745	181	17	.	.	.
46745	182	1	It	-PRON-	PRP
46745	182	2	is	be	VBZ
46745	182	3	easier	easy	JJR
46745	182	4	to	to	TO
46745	182	5	find	find	VB
46745	182	6	fault	fault	NN
46745	182	7	than	than	IN
46745	182	8	to	to	TO
46745	182	9	teach	teach	VB
46745	182	10	.	.	.
46745	183	1	After	after	IN
46745	183	2	pointing	point	VBG
46745	183	3	out	out	RP
46745	183	4	the	the	DT
46745	183	5	shortcomings	shortcoming	NNS
46745	183	6	of	of	IN
46745	183	7	some	some	DT
46745	183	8	who	who	WP
46745	183	9	have	have	VBP
46745	183	10	preceded	precede	VBN
46745	183	11	me	-PRON-	PRP
46745	183	12	,	,	,
46745	183	13	I	-PRON-	PRP
46745	183	14	find	find	VBP
46745	183	15	myself	-PRON-	PRP
46745	183	16	necessitated	necessitated	JJ
46745	183	17	in	in	IN
46745	183	18	the	the	DT
46745	183	19	third	third	JJ
46745	183	20	chapter	chapter	NN
46745	183	21	to	to	TO
46745	183	22	state	state	VB
46745	183	23	my	-PRON-	PRP$
46745	183	24	own	own	JJ
46745	183	25	conclusions	conclusion	NNS
46745	183	26	as	as	IN
46745	183	27	to	to	IN
46745	183	28	the	the	DT
46745	183	29	_	_	NNP
46745	183	30	modus	modus	NN
46745	183	31	operandi	operandi	NNP
46745	183	32	_	_	NNP
46745	183	33	of	of	IN
46745	183	34	medicines	medicine	NNS
46745	183	35	.	.	.
46745	184	1	Let	let	VB
46745	184	2	us	-PRON-	PRP
46745	184	3	consider	consider	VB
46745	184	4	,	,	,
46745	184	5	as	as	IN
46745	184	6	it	-PRON-	PRP
46745	184	7	were	be	VBD
46745	184	8	,	,	,
46745	184	9	the	the	DT
46745	184	10	history	history	NN
46745	184	11	of	of	IN
46745	184	12	a	a	DT
46745	184	13	remedy	remedy	NN
46745	184	14	from	from	IN
46745	184	15	the	the	DT
46745	184	16	beginning	beginning	NN
46745	184	17	to	to	IN
46745	184	18	the	the	DT
46745	184	19	end	end	NN
46745	184	20	of	of	IN
46745	184	21	its	-PRON-	PRP$
46745	184	22	course	course	NN
46745	184	23	.	.	.
46745	185	1	It	-PRON-	PRP
46745	185	2	is	be	VBZ
46745	185	3	already	already	RB
46745	185	4	"	"	``
46745	185	5	introduced	introduce	VBN
46745	185	6	into	into	IN
46745	185	7	the	the	DT
46745	185	8	stomach"--we	stomach"--we	NNP
46745	185	9	must	must	MD
46745	185	10	commence	commence	VB
46745	185	11	with	with	IN
46745	185	12	it	-PRON-	PRP
46745	185	13	there	there	RB
46745	185	14	.	.	.
46745	186	1	Now	now	RB
46745	186	2	it	-PRON-	PRP
46745	186	3	does	do	VBZ
46745	186	4	not	not	RB
46745	186	5	remain	remain	VB
46745	186	6	there	there	RB
46745	186	7	.	.	.
46745	187	1	It	-PRON-	PRP
46745	187	2	can	can	MD
46745	187	3	not	not	RB
46745	187	4	act	act	VB
46745	187	5	from	from	IN
46745	187	6	the	the	DT
46745	187	7	surface	surface	NN
46745	187	8	of	of	IN
46745	187	9	the	the	DT
46745	187	10	stomach	stomach	NN
46745	187	11	through	through	IN
46745	187	12	the	the	DT
46745	187	13	medium	medium	NN
46745	187	14	of	of	IN
46745	187	15	the	the	DT
46745	187	16	nervous	nervous	JJ
46745	187	17	system	system	NN
46745	187	18	.	.	.
46745	188	1	In	in	IN
46745	188	2	the	the	DT
46745	188	3	_	_	NNP
46745	188	4	First	First	NNP
46745	188	5	Proposition	Proposition	NNP
46745	188	6	_	_	IN
46745	188	7	it	-PRON-	PRP
46745	188	8	is	be	VBZ
46745	188	9	affirmed	affirm	VBN
46745	188	10	that	that	IN
46745	188	11	it	-PRON-	PRP
46745	188	12	must	must	MD
46745	188	13	obtain	obtain	VB
46745	188	14	entry	entry	NN
46745	188	15	into	into	IN
46745	188	16	the	the	DT
46745	188	17	fluids	fluid	NNS
46745	188	18	of	of	IN
46745	188	19	the	the	DT
46745	188	20	body	body	NN
46745	188	21	--	--	:
46745	188	22	pass	pass	VB
46745	188	23	,	,	,
46745	188	24	that	that	RB
46745	188	25	is	is	RB
46745	188	26	,	,	,
46745	188	27	from	from	IN
46745	188	28	the	the	DT
46745	188	29	intestinal	intestinal	JJ
46745	188	30	canal	canal	NN
46745	188	31	into	into	IN
46745	188	32	the	the	DT
46745	188	33	system	system	NN
46745	188	34	at	at	IN
46745	188	35	large	large	JJ
46745	188	36	--	--	:
46745	188	37	before	before	IN
46745	188	38	its	-PRON-	PRP$
46745	188	39	action	action	NN
46745	188	40	can	can	MD
46745	188	41	begin	begin	VB
46745	188	42	.	.	.
46745	189	1	There	there	EX
46745	189	2	are	be	VBP
46745	189	3	four	four	CD
46745	189	4	proofs	proof	NNS
46745	189	5	of	of	IN
46745	189	6	this	this	DT
46745	189	7	.	.	.
46745	190	1	It	-PRON-	PRP
46745	190	2	is	be	VBZ
46745	190	3	shown	show	VBN
46745	190	4	that	that	IN
46745	190	5	when	when	WRB
46745	190	6	introduced	introduce	VBN
46745	190	7	at	at	IN
46745	190	8	another	another	DT
46745	190	9	part	part	NN
46745	190	10	of	of	IN
46745	190	11	the	the	DT
46745	190	12	body	body	NN
46745	190	13	a	a	DT
46745	190	14	medicine	medicine	NN
46745	190	15	acts	act	VBZ
46745	190	16	in	in	IN
46745	190	17	the	the	DT
46745	190	18	same	same	JJ
46745	190	19	way	way	NN
46745	190	20	as	as	IN
46745	190	21	when	when	WRB
46745	190	22	placed	place	VBN
46745	190	23	in	in	IN
46745	190	24	the	the	DT
46745	190	25	stomach	stomach	NN
46745	190	26	.	.	.
46745	191	1	It	-PRON-	PRP
46745	191	2	is	be	VBZ
46745	191	3	found	find	VBN
46745	191	4	by	by	IN
46745	191	5	direct	direct	JJ
46745	191	6	experiment	experiment	NN
46745	191	7	that	that	IN
46745	191	8	a	a	DT
46745	191	9	poison	poison	NN
46745	191	10	will	will	MD
46745	191	11	not	not	RB
46745	191	12	act	act	VB
46745	191	13	through	through	IN
46745	191	14	the	the	DT
46745	191	15	medium	medium	NN
46745	191	16	of	of	IN
46745	191	17	nerves	nerve	NNS
46745	191	18	only	only	RB
46745	191	19	,	,	,
46745	191	20	but	but	CC
46745	191	21	that	that	IN
46745	191	22	its	-PRON-	PRP$
46745	191	23	passage	passage	NN
46745	191	24	in	in	IN
46745	191	25	the	the	DT
46745	191	26	blood	blood	NN
46745	191	27	is	be	VBZ
46745	191	28	required	require	VBN
46745	191	29	.	.	.
46745	192	1	Thirdly	thirdly	RB
46745	192	2	,	,	,
46745	192	3	the	the	DT
46745	192	4	course	course	NN
46745	192	5	of	of	IN
46745	192	6	the	the	DT
46745	192	7	circulation	circulation	NN
46745	192	8	is	be	VBZ
46745	192	9	quick	quick	JJ
46745	192	10	enough	enough	RB
46745	192	11	for	for	IN
46745	192	12	the	the	DT
46745	192	13	most	most	RBS
46745	192	14	rapid	rapid	JJ
46745	192	15	poison	poison	NN
46745	192	16	or	or	CC
46745	192	17	medicine	medicine	NN
46745	192	18	to	to	TO
46745	192	19	pass	pass	VB
46745	192	20	quite	quite	RB
46745	192	21	round	round	IN
46745	192	22	the	the	DT
46745	192	23	body	body	NN
46745	192	24	from	from	IN
46745	192	25	the	the	DT
46745	192	26	veins	vein	NNS
46745	192	27	of	of	IN
46745	192	28	the	the	DT
46745	192	29	stomach	stomach	NN
46745	192	30	before	before	IN
46745	192	31	it	-PRON-	PRP
46745	192	32	begins	begin	VBZ
46745	192	33	to	to	TO
46745	192	34	operate	operate	VB
46745	192	35	.	.	.
46745	193	1	The	the	DT
46745	193	2	last	last	JJ
46745	193	3	and	and	CC
46745	193	4	most	most	RBS
46745	193	5	conclusive	conclusive	JJ
46745	193	6	argument	argument	NN
46745	193	7	to	to	TO
46745	193	8	show	show	VB
46745	193	9	that	that	IN
46745	193	10	medicines	medicine	NNS
46745	193	11	pass	pass	VB
46745	193	12	out	out	IN
46745	193	13	of	of	IN
46745	193	14	the	the	DT
46745	193	15	stomach	stomach	NN
46745	193	16	into	into	IN
46745	193	17	the	the	DT
46745	193	18	system	system	NN
46745	193	19	,	,	,
46745	193	20	is	be	VBZ
46745	193	21	that	that	IN
46745	193	22	they	-PRON-	PRP
46745	193	23	have	have	VBP
46745	193	24	actually	actually	RB
46745	193	25	been	be	VBN
46745	193	26	detected	detect	VBN
46745	193	27	by	by	IN
46745	193	28	chemists	chemist	NNS
46745	193	29	,	,	,
46745	193	30	not	not	RB
46745	193	31	only	only	RB
46745	193	32	in	in	IN
46745	193	33	the	the	DT
46745	193	34	blood	blood	NN
46745	193	35	,	,	,
46745	193	36	but	but	CC
46745	193	37	in	in	IN
46745	193	38	the	the	DT
46745	193	39	secretions	secretion	NNS
46745	193	40	formed	form	VBN
46745	193	41	from	from	IN
46745	193	42	the	the	DT
46745	193	43	blood	blood	NN
46745	193	44	.	.	.
46745	194	1	Remedies	remedy	NNS
46745	194	2	,	,	,
46745	194	3	then	then	RB
46745	194	4	,	,	,
46745	194	5	pass	pass	VB
46745	194	6	from	from	IN
46745	194	7	the	the	DT
46745	194	8	stomach	stomach	NN
46745	194	9	into	into	IN
46745	194	10	the	the	DT
46745	194	11	blood	blood	NN
46745	194	12	and	and	CC
46745	194	13	fluids	fluid	NNS
46745	194	14	.	.	.
46745	195	1	How	how	WRB
46745	195	2	do	do	VBP
46745	195	3	they	-PRON-	PRP
46745	195	4	do	do	VB
46745	195	5	so	so	RB
46745	195	6	?	?	.
46745	196	1	In	in	IN
46745	196	2	the	the	DT
46745	196	3	_	_	NNP
46745	196	4	Second	Second	NNP
46745	196	5	Proposition	Proposition	NNP
46745	196	6	_	_	IN
46745	196	7	it	-PRON-	PRP
46745	196	8	is	be	VBZ
46745	196	9	laid	lay	VBN
46745	196	10	down	down	RP
46745	196	11	that	that	IN
46745	196	12	all	all	PDT
46745	196	13	those	those	DT
46745	196	14	which	which	WDT
46745	196	15	are	be	VBP
46745	196	16	soluble	soluble	JJ
46745	196	17	in	in	IN
46745	196	18	water	water	NN
46745	196	19	,	,	,
46745	196	20	or	or	CC
46745	196	21	in	in	IN
46745	196	22	the	the	DT
46745	196	23	secretions	secretion	NNS
46745	196	24	of	of	IN
46745	196	25	the	the	DT
46745	196	26	stomach	stomach	NN
46745	196	27	or	or	CC
46745	196	28	intestines	intestine	NNS
46745	196	29	,	,	,
46745	196	30	pass	pass	VB
46745	196	31	through	through	IN
46745	196	32	the	the	DT
46745	196	33	coats	coat	NNS
46745	196	34	of	of	IN
46745	196	35	these	these	DT
46745	196	36	organs	organ	NNS
46745	196	37	into	into	IN
46745	196	38	the	the	DT
46745	196	39	interior	interior	NN
46745	196	40	of	of	IN
46745	196	41	the	the	DT
46745	196	42	capillary	capillary	JJ
46745	196	43	veins	vein	NNS
46745	196	44	which	which	WDT
46745	196	45	surround	surround	VBP
46745	196	46	them	-PRON-	PRP
46745	196	47	.	.	.
46745	197	1	It	-PRON-	PRP
46745	197	2	has	have	VBZ
46745	197	3	already	already	RB
46745	197	4	been	be	VBN
46745	197	5	shown	show	VBN
46745	197	6	that	that	IN
46745	197	7	most	most	JJS
46745	197	8	medicines	medicine	NNS
46745	197	9	pass	pass	VBP
46745	197	10	through	through	RP
46745	197	11	in	in	IN
46745	197	12	some	some	DT
46745	197	13	way	way	NN
46745	197	14	;	;	:
46745	197	15	we	-PRON-	PRP
46745	197	16	shall	shall	MD
46745	197	17	now	now	RB
46745	197	18	have	have	VB
46745	197	19	to	to	TO
46745	197	20	learn	learn	VB
46745	197	21	how	how	WRB
46745	197	22	they	-PRON-	PRP
46745	197	23	pass	pass	VBP
46745	197	24	,	,	,
46745	197	25	and	and	CC
46745	197	26	what	what	WDT
46745	197	27	special	special	JJ
46745	197	28	arrangements	arrangement	NNS
46745	197	29	are	be	VBP
46745	197	30	made	make	VBN
46745	197	31	for	for	IN
46745	197	32	the	the	DT
46745	197	33	passage	passage	NN
46745	197	34	of	of	IN
46745	197	35	substances	substance	NNS
46745	197	36	differing	differ	VBG
46745	197	37	in	in	IN
46745	197	38	nature	nature	NN
46745	197	39	.	.	.
46745	198	1	By	by	IN
46745	198	2	the	the	DT
46745	198	3	physical	physical	JJ
46745	198	4	process	process	NN
46745	198	5	of	of	IN
46745	198	6	absorption	absorption	NN
46745	198	7	a	a	DT
46745	198	8	liquid	liquid	NN
46745	198	9	may	may	MD
46745	198	10	pass	pass	VB
46745	198	11	through	through	IN
46745	198	12	the	the	DT
46745	198	13	animal	animal	NN
46745	198	14	membranes	membrane	NNS
46745	198	15	,	,	,
46745	198	16	from	from	IN
46745	198	17	the	the	DT
46745	198	18	interior	interior	NN
46745	198	19	of	of	IN
46745	198	20	the	the	DT
46745	198	21	stomach	stomach	NN
46745	198	22	or	or	CC
46745	198	23	intestine	intestine	NN
46745	198	24	to	to	IN
46745	198	25	the	the	DT
46745	198	26	interior	interior	NN
46745	198	27	of	of	IN
46745	198	28	the	the	DT
46745	198	29	small	small	JJ
46745	198	30	vein	vein	NN
46745	198	31	which	which	WDT
46745	198	32	lies	lie	VBZ
46745	198	33	close	close	RB
46745	198	34	outside	outside	IN
46745	198	35	it	-PRON-	PRP
46745	198	36	.	.	.
46745	199	1	In	in	IN
46745	199	2	examining	examine	VBG
46745	199	3	the	the	DT
46745	199	4	laws	law	NNS
46745	199	5	by	by	IN
46745	199	6	which	which	WDT
46745	199	7	this	this	DT
46745	199	8	process	process	NN
46745	199	9	is	be	VBZ
46745	199	10	conducted	conduct	VBN
46745	199	11	,	,	,
46745	199	12	we	-PRON-	PRP
46745	199	13	shall	shall	MD
46745	199	14	find	find	VB
46745	199	15	that	that	IN
46745	199	16	all	all	PDT
46745	199	17	the	the	DT
46745	199	18	requirements	requirement	NNS
46745	199	19	are	be	VBP
46745	199	20	present	present	JJ
46745	199	21	in	in	IN
46745	199	22	these	these	DT
46745	199	23	parts	part	NNS
46745	199	24	,	,	,
46745	199	25	provided	provide	VBN
46745	199	26	only	only	RB
46745	199	27	that	that	IN
46745	199	28	the	the	DT
46745	199	29	substance	substance	NN
46745	199	30	to	to	TO
46745	199	31	be	be	VB
46745	199	32	absorbed	absorb	VBN
46745	199	33	shall	shall	MD
46745	199	34	be	be	VB
46745	199	35	first	first	JJ
46745	199	36	in	in	IN
46745	199	37	some	some	DT
46745	199	38	way	way	NN
46745	199	39	dissolved	dissolve	VBN
46745	199	40	,	,	,
46745	199	41	and	and	CC
46745	199	42	reduced	reduce	VBN
46745	199	43	to	to	IN
46745	199	44	the	the	DT
46745	199	45	liquid	liquid	JJ
46745	199	46	state	state	NN
46745	199	47	.	.	.
46745	200	1	In	in	IN
46745	200	2	the	the	DT
46745	200	3	stomach	stomach	NN
46745	200	4	there	there	EX
46745	200	5	is	be	VBZ
46745	200	6	,	,	,
46745	200	7	in	in	IN
46745	200	8	contact	contact	NN
46745	200	9	with	with	IN
46745	200	10	the	the	DT
46745	200	11	substance	substance	NN
46745	200	12	just	just	RB
46745	200	13	introduced	introduce	VBN
46745	200	14	,	,	,
46745	200	15	a	a	DT
46745	200	16	thin	thin	JJ
46745	200	17	watery	watery	JJ
46745	200	18	secretion	secretion	NN
46745	200	19	containing	contain	VBG
46745	200	20	acid	acid	NN
46745	200	21	and	and	CC
46745	200	22	a	a	DT
46745	200	23	matter	matter	NN
46745	200	24	called	call	VBN
46745	200	25	pepsin	pepsin	NN
46745	200	26	:	:	:
46745	200	27	this	this	DT
46745	200	28	is	be	VBZ
46745	200	29	the	the	DT
46745	200	30	gastric	gastric	JJ
46745	200	31	juice	juice	NN
46745	200	32	.	.	.
46745	201	1	A	a	DT
46745	201	2	large	large	JJ
46745	201	3	number	number	NN
46745	201	4	of	of	IN
46745	201	5	medicines	medicine	NNS
46745	201	6	are	be	VBP
46745	201	7	soluble	soluble	JJ
46745	201	8	in	in	IN
46745	201	9	water	water	NN
46745	201	10	.	.	.
46745	202	1	They	-PRON-	PRP
46745	202	2	are	be	VBP
46745	202	3	dissolved	dissolve	VBN
46745	202	4	in	in	IN
46745	202	5	this	this	DT
46745	202	6	fluid	fluid	NN
46745	202	7	.	.	.
46745	203	1	Some	some	DT
46745	203	2	others	other	NNS
46745	203	3	are	be	VBP
46745	203	4	soluble	soluble	JJ
46745	203	5	in	in	IN
46745	203	6	dilute	dilute	NN
46745	203	7	acid	acid	NN
46745	203	8	.	.	.
46745	204	1	These	these	DT
46745	204	2	too	too	RB
46745	204	3	are	be	VBP
46745	204	4	dissolved	dissolve	VBN
46745	204	5	here	here	RB
46745	204	6	.	.	.
46745	205	1	Albumen	Albumen	NNP
46745	205	2	,	,	,
46745	205	3	and	and	CC
46745	205	4	matters	matter	NNS
46745	205	5	like	like	IN
46745	205	6	it	-PRON-	PRP
46745	205	7	,	,	,
46745	205	8	are	be	VBP
46745	205	9	reduced	reduce	VBN
46745	205	10	to	to	IN
46745	205	11	solution	solution	NN
46745	205	12	by	by	IN
46745	205	13	the	the	DT
46745	205	14	aid	aid	NN
46745	205	15	of	of	IN
46745	205	16	the	the	DT
46745	205	17	pepsin	pepsin	NN
46745	205	18	,	,	,
46745	205	19	which	which	WDT
46745	205	20	is	be	VBZ
46745	205	21	the	the	DT
46745	205	22	principle	principle	NN
46745	205	23	of	of	IN
46745	205	24	digestion	digestion	NN
46745	205	25	.	.	.
46745	206	1	But	but	CC
46745	206	2	there	there	EX
46745	206	3	are	be	VBP
46745	206	4	some	some	DT
46745	206	5	few	few	JJ
46745	206	6	mineral	mineral	NN
46745	206	7	bodies	body	NNS
46745	206	8	,	,	,
46745	206	9	and	and	CC
46745	206	10	many	many	JJ
46745	206	11	vegetable	vegetable	JJ
46745	206	12	substances	substance	NNS
46745	206	13	,	,	,
46745	206	14	as	as	IN
46745	206	15	fats	fat	NNS
46745	206	16	and	and	CC
46745	206	17	resins	resin	NNS
46745	206	18	,	,	,
46745	206	19	which	which	WDT
46745	206	20	can	can	MD
46745	206	21	not	not	RB
46745	206	22	be	be	VB
46745	206	23	thus	thus	RB
46745	206	24	dissolved	dissolve	VBN
46745	206	25	by	by	IN
46745	206	26	the	the	DT
46745	206	27	juice	juice	NN
46745	206	28	of	of	IN
46745	206	29	the	the	DT
46745	206	30	stomach	stomach	NN
46745	206	31	.	.	.
46745	207	1	They	-PRON-	PRP
46745	207	2	are	be	VBP
46745	207	3	soluble	soluble	JJ
46745	207	4	,	,	,
46745	207	5	more	more	RBR
46745	207	6	or	or	CC
46745	207	7	less	less	RBR
46745	207	8	,	,	,
46745	207	9	in	in	IN
46745	207	10	a	a	DT
46745	207	11	weak	weak	JJ
46745	207	12	alkaline	alkaline	NN
46745	207	13	fluid	fluid	NN
46745	207	14	;	;	:
46745	207	15	and	and	CC
46745	207	16	such	such	PDT
46745	207	17	a	a	DT
46745	207	18	fluid	fluid	NN
46745	207	19	is	be	VBZ
46745	207	20	the	the	DT
46745	207	21	bile	bile	NN
46745	207	22	,	,	,
46745	207	23	which	which	WDT
46745	207	24	is	be	VBZ
46745	207	25	poured	pour	VBN
46745	207	26	out	out	RP
46745	207	27	into	into	IN
46745	207	28	the	the	DT
46745	207	29	first	first	JJ
46745	207	30	portion	portion	NN
46745	207	31	of	of	IN
46745	207	32	the	the	DT
46745	207	33	intestine	intestine	NN
46745	207	34	.	.	.
46745	208	1	They	-PRON-	PRP
46745	208	2	too	too	RB
46745	208	3	are	be	VBP
46745	208	4	reduced	reduce	VBN
46745	208	5	to	to	IN
46745	208	6	solution	solution	NN
46745	208	7	and	and	CC
46745	208	8	absorbed	absorb	VBN
46745	208	9	.	.	.
46745	209	1	In	in	IN
46745	209	2	this	this	DT
46745	209	3	manner	manner	NN
46745	209	4	it	-PRON-	PRP
46745	209	5	is	be	VBZ
46745	209	6	shown	show	VBN
46745	209	7	that	that	IN
46745	209	8	a	a	DT
46745	209	9	very	very	RB
46745	209	10	great	great	JJ
46745	209	11	majority	majority	NN
46745	209	12	of	of	IN
46745	209	13	remedial	remedial	JJ
46745	209	14	agents	agent	NNS
46745	209	15	are	be	VBP
46745	209	16	capable	capable	JJ
46745	209	17	of	of	IN
46745	209	18	being	be	VBG
46745	209	19	reduced	reduce	VBN
46745	209	20	to	to	IN
46745	209	21	solution	solution	NN
46745	209	22	,	,	,
46745	209	23	of	of	IN
46745	209	24	being	be	VBG
46745	209	25	absorbed	absorb	VBN
46745	209	26	without	without	IN
46745	209	27	material	material	NN
46745	209	28	change	change	NN
46745	209	29	,	,	,
46745	209	30	and	and	CC
46745	209	31	of	of	IN
46745	209	32	passing	pass	VBG
46745	209	33	thus	thus	RB
46745	209	34	into	into	IN
46745	209	35	the	the	DT
46745	209	36	circulation	circulation	NN
46745	209	37	.	.	.
46745	210	1	[	[	-LRB-
46745	210	2	5	5	CD
46745	210	3	]	]	-RRB-
46745	210	4	Very	very	RB
46745	210	5	few	few	JJ
46745	210	6	are	be	VBP
46745	210	7	quite	quite	RB
46745	210	8	insoluble	insoluble	JJ
46745	210	9	;	;	:
46745	210	10	but	but	CC
46745	210	11	some	some	DT
46745	210	12	that	that	WDT
46745	210	13	are	be	VBP
46745	210	14	dissolved	dissolve	VBN
46745	210	15	with	with	IN
46745	210	16	difficulty	difficulty	NN
46745	210	17	may	may	MD
46745	210	18	be	be	VB
46745	210	19	left	leave	VBN
46745	210	20	partly	partly	RB
46745	210	21	undissolved	undissolved	JJ
46745	210	22	in	in	IN
46745	210	23	the	the	DT
46745	210	24	intestinal	intestinal	JJ
46745	210	25	canal	canal	NN
46745	210	26	.	.	.
46745	211	1	What	what	WP
46745	211	2	becomes	become	VBZ
46745	211	3	of	of	IN
46745	211	4	these	these	DT
46745	211	5	?	?	.
46745	212	1	It	-PRON-	PRP
46745	212	2	is	be	VBZ
46745	212	3	asserted	assert	VBN
46745	212	4	in	in	IN
46745	212	5	the	the	DT
46745	212	6	_	_	NNP
46745	212	7	Third	Third	NNP
46745	212	8	Proposition	Proposition	NNP
46745	212	9	_	_	NNP
46745	212	10	that	that	IN
46745	212	11	substances	substance	NNS
46745	212	12	which	which	WDT
46745	212	13	are	be	VBP
46745	212	14	thus	thus	RB
46745	212	15	insoluble	insoluble	JJ
46745	212	16	can	can	MD
46745	212	17	not	not	RB
46745	212	18	pass	pass	VB
46745	212	19	into	into	IN
46745	212	20	the	the	DT
46745	212	21	circulation	circulation	NN
46745	212	22	.	.	.
46745	213	1	Arguing	argue	VBG
46745	213	2	from	from	IN
46745	213	3	a	a	DT
46745	213	4	physical	physical	JJ
46745	213	5	law	law	NN
46745	213	6	,	,	,
46745	213	7	we	-PRON-	PRP
46745	213	8	should	should	MD
46745	213	9	say	say	VB
46745	213	10	at	at	IN
46745	213	11	once	once	RB
46745	213	12	that	that	IN
46745	213	13	it	-PRON-	PRP
46745	213	14	was	be	VBD
46745	213	15	impossible	impossible	JJ
46745	213	16	;	;	:
46745	213	17	but	but	CC
46745	213	18	the	the	DT
46745	213	19	matter	matter	NN
46745	213	20	can	can	MD
46745	213	21	not	not	RB
46745	213	22	be	be	VB
46745	213	23	so	so	RB
46745	213	24	lightly	lightly	RB
46745	213	25	dismissed	dismiss	VBN
46745	213	26	,	,	,
46745	213	27	for	for	IN
46745	213	28	a	a	DT
46745	213	29	foreign	foreign	JJ
46745	213	30	professor	professor	NN
46745	213	31	has	have	VBZ
46745	213	32	lately	lately	RB
46745	213	33	asserted	assert	VBN
46745	213	34	that	that	IN
46745	213	35	insoluble	insoluble	JJ
46745	213	36	matters	matter	NNS
46745	213	37	may	may	MD
46745	213	38	and	and	CC
46745	213	39	do	do	VB
46745	213	40	pass	pass	VB
46745	213	41	into	into	IN
46745	213	42	the	the	DT
46745	213	43	circulation	circulation	NN
46745	213	44	.	.	.
46745	214	1	I	-PRON-	PRP
46745	214	2	have	have	VBP
46745	214	3	made	make	VBN
46745	214	4	experiments	experiment	NNS
46745	214	5	to	to	TO
46745	214	6	satisfy	satisfy	VB
46745	214	7	myself	-PRON-	PRP
46745	214	8	on	on	IN
46745	214	9	the	the	DT
46745	214	10	point	point	NN
46745	214	11	,	,	,
46745	214	12	and	and	CC
46745	214	13	have	have	VBP
46745	214	14	come	come	VBN
46745	214	15	to	to	IN
46745	214	16	the	the	DT
46745	214	17	contrary	contrary	JJ
46745	214	18	conclusion	conclusion	NN
46745	214	19	.	.	.
46745	215	1	In	in	IN
46745	215	2	the	the	DT
46745	215	3	_	_	NNP
46745	215	4	Fourth	Fourth	NNP
46745	215	5	Proposition	Proposition	NNP
46745	215	6	_	_	IN
46745	215	7	it	-PRON-	PRP
46745	215	8	is	be	VBZ
46745	215	9	stated	state	VBN
46745	215	10	that	that	IN
46745	215	11	some	some	DT
46745	215	12	few	few	JJ
46745	215	13	substances	substance	NNS
46745	215	14	may	may	MD
46745	215	15	act	act	VB
46745	215	16	locally	locally	RB
46745	215	17	,	,	,
46745	215	18	by	by	IN
46745	215	19	irritation	irritation	NN
46745	215	20	or	or	CC
46745	215	21	otherwise	otherwise	RB
46745	215	22	,	,	,
46745	215	23	on	on	IN
46745	215	24	the	the	DT
46745	215	25	mucous	mucous	JJ
46745	215	26	surface	surface	NN
46745	215	27	of	of	IN
46745	215	28	the	the	DT
46745	215	29	stomach	stomach	NN
46745	215	30	or	or	CC
46745	215	31	intestines	intestine	NNS
46745	215	32	.	.	.
46745	216	1	These	these	DT
46745	216	2	are	be	VBP
46745	216	3	not	not	RB
46745	216	4	many	many	JJ
46745	216	5	;	;	:
46745	216	6	they	-PRON-	PRP
46745	216	7	act	act	VBP
46745	216	8	without	without	IN
46745	216	9	being	be	VBG
46745	216	10	absorbed	absorb	VBN
46745	216	11	;	;	:
46745	216	12	and	and	CC
46745	216	13	they	-PRON-	PRP
46745	216	14	do	do	VBP
46745	216	15	not	not	RB
46745	216	16	extend	extend	VB
46745	216	17	into	into	IN
46745	216	18	the	the	DT
46745	216	19	system	system	NN
46745	216	20	at	at	IN
46745	216	21	large	large	JJ
46745	216	22	.	.	.
46745	217	1	In	in	IN
46745	217	2	some	some	DT
46745	217	3	few	few	JJ
46745	217	4	cases	case	NNS
46745	217	5	,	,	,
46745	217	6	these	these	DT
46745	217	7	local	local	JJ
46745	217	8	actions	action	NNS
46745	217	9	may	may	MD
46745	217	10	be	be	VB
46745	217	11	succeeded	succeed	VBN
46745	217	12	by	by	IN
46745	217	13	changes	change	NNS
46745	217	14	in	in	IN
46745	217	15	distant	distant	JJ
46745	217	16	parts	part	NNS
46745	217	17	,	,	,
46745	217	18	on	on	IN
46745	217	19	the	the	DT
46745	217	20	principle	principle	NN
46745	217	21	of	of	IN
46745	217	22	_	_	NNP
46745	217	23	Revulsion	Revulsion	NNP
46745	217	24	_	_	NNP
46745	217	25	.	.	.
46745	218	1	Having	have	VBG
46745	218	2	just	just	RB
46745	218	3	shown	show	VBN
46745	218	4	how	how	WRB
46745	218	5	medicinal	medicinal	JJ
46745	218	6	substances	substance	NNS
46745	218	7	are	be	VBP
46745	218	8	absorbed	absorb	VBN
46745	218	9	,	,	,
46745	218	10	we	-PRON-	PRP
46745	218	11	have	have	VBP
46745	218	12	now	now	RB
46745	218	13	to	to	TO
46745	218	14	suppose	suppose	VB
46745	218	15	that	that	IN
46745	218	16	they	-PRON-	PRP
46745	218	17	are	be	VBP
46745	218	18	in	in	IN
46745	218	19	the	the	DT
46745	218	20	blood	blood	NN
46745	218	21	.	.	.
46745	219	1	It	-PRON-	PRP
46745	219	2	is	be	VBZ
46745	219	3	next	next	RB
46745	219	4	maintained	maintain	VBN
46745	219	5	,	,	,
46745	219	6	in	in	IN
46745	219	7	the	the	DT
46745	219	8	_	_	NNP
46745	219	9	Fifth	Fifth	NNP
46745	219	10	Proposition	Proposition	NNP
46745	219	11	_	_	NNP
46745	219	12	,	,	,
46745	219	13	that	that	IN
46745	219	14	the	the	DT
46745	219	15	medicine	medicine	NN
46745	219	16	,	,	,
46745	219	17	being	be	VBG
46745	219	18	in	in	IN
46745	219	19	the	the	DT
46745	219	20	blood	blood	NN
46745	219	21	,	,	,
46745	219	22	must	must	MD
46745	219	23	permeate	permeate	VB
46745	219	24	the	the	DT
46745	219	25	mass	mass	NN
46745	219	26	of	of	IN
46745	219	27	the	the	DT
46745	219	28	circulation	circulation	NN
46745	219	29	as	as	RB
46745	219	30	far	far	RB
46745	219	31	as	as	IN
46745	219	32	to	to	TO
46745	219	33	reach	reach	VB
46745	219	34	the	the	DT
46745	219	35	part	part	NN
46745	219	36	on	on	IN
46745	219	37	which	which	WDT
46745	219	38	it	-PRON-	PRP
46745	219	39	tends	tend	VBZ
46745	219	40	to	to	TO
46745	219	41	act	act	VB
46745	219	42	.	.	.
46745	220	1	This	this	DT
46745	220	2	it	-PRON-	PRP
46745	220	3	can	can	MD
46745	220	4	easily	easily	RB
46745	220	5	do	do	VB
46745	220	6	.	.	.
46745	221	1	The	the	DT
46745	221	2	circulating	circulate	VBG
46745	221	3	blood	blood	NN
46745	221	4	will	will	MD
46745	221	5	conduct	conduct	VB
46745	221	6	it	-PRON-	PRP
46745	221	7	any	any	DT
46745	221	8	where	where	WRB
46745	221	9	,	,	,
46745	221	10	in	in	IN
46745	221	11	a	a	DT
46745	221	12	very	very	RB
46745	221	13	short	short	JJ
46745	221	14	time	time	NN
46745	221	15	.	.	.
46745	222	1	Supposing	suppose	VBG
46745	222	2	a	a	DT
46745	222	3	medicine	medicine	NN
46745	222	4	has	have	VBZ
46745	222	5	to	to	TO
46745	222	6	act	act	VB
46745	222	7	on	on	IN
46745	222	8	the	the	DT
46745	222	9	liver	liver	NN
46745	222	10	,	,	,
46745	222	11	or	or	CC
46745	222	12	on	on	IN
46745	222	13	the	the	DT
46745	222	14	brain	brain	NN
46745	222	15	,	,	,
46745	222	16	or	or	CC
46745	222	17	on	on	IN
46745	222	18	the	the	DT
46745	222	19	kidney	kidney	NN
46745	222	20	,	,	,
46745	222	21	it	-PRON-	PRP
46745	222	22	does	do	VBZ
46745	222	23	not	not	RB
46745	222	24	influence	influence	VB
46745	222	25	these	these	DT
46745	222	26	organs	organ	NNS
46745	222	27	at	at	IN
46745	222	28	a	a	DT
46745	222	29	distance	distance	NN
46745	222	30	,	,	,
46745	222	31	but	but	CC
46745	222	32	it	-PRON-	PRP
46745	222	33	passes	pass	VBZ
46745	222	34	directly	directly	RB
46745	222	35	to	to	IN
46745	222	36	them	-PRON-	PRP
46745	222	37	in	in	IN
46745	222	38	the	the	DT
46745	222	39	blood	blood	NN
46745	222	40	,	,	,
46745	222	41	and	and	CC
46745	222	42	then	then	RB
46745	222	43	its	-PRON-	PRP$
46745	222	44	operation	operation	NN
46745	222	45	is	be	VBZ
46745	222	46	manifested	manifest	VBN
46745	222	47	.	.	.
46745	223	1	This	this	DT
46745	223	2	may	may	MD
46745	223	3	be	be	VB
46745	223	4	called	call	VBN
46745	223	5	the	the	DT
46745	223	6	rule	rule	NN
46745	223	7	of	of	IN
46745	223	8	_	_	NNP
46745	223	9	local	local	JJ
46745	223	10	access	access	NN
46745	223	11	_	_	NNP
46745	223	12	.	.	.
46745	224	1	Its	-PRON-	PRP$
46745	224	2	proof	proof	NN
46745	224	3	depends	depend	VBZ
46745	224	4	on	on	IN
46745	224	5	two	two	CD
46745	224	6	things	thing	NNS
46745	224	7	:	:	:
46745	224	8	on	on	IN
46745	224	9	the	the	DT
46745	224	10	impossibility	impossibility	NN
46745	224	11	of	of	IN
46745	224	12	the	the	DT
46745	224	13	medicinal	medicinal	JJ
46745	224	14	influence	influence	NN
46745	224	15	reaching	reach	VBG
46745	224	16	the	the	DT
46745	224	17	part	part	NN
46745	224	18	in	in	IN
46745	224	19	any	any	DT
46745	224	20	other	other	JJ
46745	224	21	way	way	NN
46745	224	22	,	,	,
46745	224	23	as	as	IN
46745	224	24	shown	show	VBN
46745	224	25	in	in	IN
46745	224	26	the	the	DT
46745	224	27	first	first	JJ
46745	224	28	proposition	proposition	NN
46745	224	29	;	;	:
46745	224	30	and	and	CC
46745	224	31	on	on	IN
46745	224	32	the	the	DT
46745	224	33	fact	fact	NN
46745	224	34	of	of	IN
46745	224	35	medicinal	medicinal	JJ
46745	224	36	agents	agent	NNS
46745	224	37	having	have	VBG
46745	224	38	been	be	VBN
46745	224	39	actually	actually	RB
46745	224	40	detected	detect	VBN
46745	224	41	in	in	IN
46745	224	42	many	many	JJ
46745	224	43	cases	case	NNS
46745	224	44	in	in	IN
46745	224	45	the	the	DT
46745	224	46	very	very	JJ
46745	224	47	organs	organ	NNS
46745	224	48	over	over	IN
46745	224	49	which	which	WDT
46745	224	50	they	-PRON-	PRP
46745	224	51	exert	exert	VBP
46745	224	52	a	a	DT
46745	224	53	special	special	JJ
46745	224	54	influence	influence	NN
46745	224	55	.	.	.
46745	225	1	But	but	CC
46745	225	2	are	be	VBP
46745	225	3	there	there	EX
46745	225	4	any	any	DT
46745	225	5	exceptions	exception	NNS
46745	225	6	to	to	IN
46745	225	7	this	this	DT
46745	225	8	?	?	.
46745	226	1	Can	Can	MD
46745	226	2	a	a	DT
46745	226	3	medicine	medicine	NN
46745	226	4	ever	ever	RB
46745	226	5	produce	produce	VBP
46745	226	6	an	an	DT
46745	226	7	effect	effect	NN
46745	226	8	without	without	IN
46745	226	9	actually	actually	RB
46745	226	10	reaching	reach	VBG
46745	226	11	the	the	DT
46745	226	12	part	part	NN
46745	226	13	?	?	.
46745	227	1	It	-PRON-	PRP
46745	227	2	seems	seem	VBZ
46745	227	3	that	that	IN
46745	227	4	there	there	EX
46745	227	5	may	may	MD
46745	227	6	be	be	VB
46745	227	7	two	two	CD
46745	227	8	exceptions	exception	NNS
46745	227	9	.	.	.
46745	228	1	In	in	IN
46745	228	2	some	some	DT
46745	228	3	cases	case	NNS
46745	228	4	an	an	DT
46745	228	5	impression	impression	NN
46745	228	6	of	of	IN
46745	228	7	_	_	NNP
46745	228	8	pain	pain	NN
46745	228	9	_	_	NNP
46745	228	10	may	may	MD
46745	228	11	be	be	VB
46745	228	12	transmitted	transmit	VBN
46745	228	13	along	along	IN
46745	228	14	a	a	DT
46745	228	15	nerve	nerve	NN
46745	228	16	from	from	IN
46745	228	17	one	one	CD
46745	228	18	part	part	NN
46745	228	19	to	to	IN
46745	228	20	another	another	DT
46745	228	21	;	;	:
46745	228	22	and	and	CC
46745	228	23	in	in	IN
46745	228	24	some	some	DT
46745	228	25	other	other	JJ
46745	228	26	few	few	JJ
46745	228	27	instances	instance	NNS
46745	228	28	a	a	DT
46745	228	29	muscle	muscle	NN
46745	228	30	,	,	,
46745	228	31	when	when	WRB
46745	228	32	caused	cause	VBN
46745	228	33	to	to	TO
46745	228	34	contract	contract	VB
46745	228	35	by	by	IN
46745	228	36	the	the	DT
46745	228	37	influence	influence	NN
46745	228	38	of	of	IN
46745	228	39	a	a	DT
46745	228	40	medicine	medicine	NN
46745	228	41	,	,	,
46745	228	42	may	may	MD
46745	228	43	cause	cause	VB
46745	228	44	other	other	JJ
46745	228	45	muscles	muscle	NNS
46745	228	46	near	near	IN
46745	228	47	it	-PRON-	PRP
46745	228	48	to	to	TO
46745	228	49	contract	contract	VB
46745	228	50	by	by	IN
46745	228	51	sympathy	sympathy	NN
46745	228	52	.	.	.
46745	229	1	Before	before	IN
46745	229	2	we	-PRON-	PRP
46745	229	3	inquire	inquire	VBP
46745	229	4	into	into	IN
46745	229	5	the	the	DT
46745	229	6	remedial	remedial	JJ
46745	229	7	action	action	NN
46745	229	8	of	of	IN
46745	229	9	the	the	DT
46745	229	10	medicine	medicine	NN
46745	229	11	in	in	IN
46745	229	12	the	the	DT
46745	229	13	blood	blood	NN
46745	229	14	,	,	,
46745	229	15	we	-PRON-	PRP
46745	229	16	must	must	MD
46745	229	17	consider	consider	VB
46745	229	18	whether	whether	IN
46745	229	19	that	that	DT
46745	229	20	fluid	fluid	NN
46745	229	21	may	may	MD
46745	229	22	not	not	RB
46745	229	23	first	first	RB
46745	229	24	alter	alter	VB
46745	229	25	it	-PRON-	PRP
46745	229	26	in	in	IN
46745	229	27	some	some	DT
46745	229	28	way	way	NN
46745	229	29	,	,	,
46745	229	30	so	so	IN
46745	229	31	as	as	IN
46745	229	32	to	to	TO
46745	229	33	hinder	hinder	VB
46745	229	34	or	or	CC
46745	229	35	affect	affect	VB
46745	229	36	its	-PRON-	PRP$
46745	229	37	operation	operation	NN
46745	229	38	.	.	.
46745	230	1	To	to	IN
46745	230	2	a	a	DT
46745	230	3	certain	certain	JJ
46745	230	4	extent	extent	NN
46745	230	5	this	this	DT
46745	230	6	is	be	VBZ
46745	230	7	possible	possible	JJ
46745	230	8	.	.	.
46745	231	1	In	in	IN
46745	231	2	the	the	DT
46745	231	3	_	_	NNP
46745	231	4	Sixth	Sixth	NNP
46745	231	5	Proposition	Proposition	NNP
46745	231	6	_	_	IN
46745	231	7	it	-PRON-	PRP
46745	231	8	is	be	VBZ
46745	231	9	asserted	assert	VBN
46745	231	10	that	that	IN
46745	231	11	while	while	IN
46745	231	12	in	in	IN
46745	231	13	the	the	DT
46745	231	14	blood	blood	NN
46745	231	15	the	the	DT
46745	231	16	medicine	medicine	NN
46745	231	17	may	may	MD
46745	231	18	undergo	undergo	VB
46745	231	19	change	change	NN
46745	231	20	,	,	,
46745	231	21	which	which	WDT
46745	231	22	change	change	VBP
46745	231	23	may	may	MD
46745	231	24	or	or	CC
46745	231	25	may	may	MD
46745	231	26	not	not	RB
46745	231	27	affect	affect	VB
46745	231	28	its	-PRON-	PRP$
46745	231	29	influence	influence	NN
46745	231	30	.	.	.
46745	232	1	It	-PRON-	PRP
46745	232	2	will	will	MD
46745	232	3	have	have	VB
46745	232	4	to	to	TO
46745	232	5	be	be	VB
46745	232	6	shown	show	VBN
46745	232	7	that	that	IN
46745	232	8	this	this	DT
46745	232	9	change	change	NN
46745	232	10	may	may	MD
46745	232	11	be	be	VB
46745	232	12	one	one	CD
46745	232	13	of	of	IN
46745	232	14	_	_	NNP
46745	232	15	combination	combination	NN
46745	232	16	_	_	NNP
46745	232	17	,	,	,
46745	232	18	as	as	IN
46745	232	19	of	of	IN
46745	232	20	an	an	DT
46745	232	21	acid	acid	NN
46745	232	22	with	with	IN
46745	232	23	an	an	DT
46745	232	24	alkali	alkali	JJ
46745	232	25	;	;	:
46745	232	26	of	of	IN
46745	232	27	_	_	NNP
46745	232	28	reconstruction	reconstruction	NN
46745	232	29	_	_	NNP
46745	232	30	,	,	,
46745	232	31	when	when	WRB
46745	232	32	the	the	DT
46745	232	33	elements	element	NNS
46745	232	34	of	of	IN
46745	232	35	a	a	DT
46745	232	36	body	body	NN
46745	232	37	are	be	VBP
46745	232	38	arranged	arrange	VBN
46745	232	39	in	in	IN
46745	232	40	a	a	DT
46745	232	41	different	different	JJ
46745	232	42	way	way	NN
46745	232	43	,	,	,
46745	232	44	without	without	IN
46745	232	45	a	a	DT
46745	232	46	material	material	JJ
46745	232	47	change	change	NN
46745	232	48	in	in	IN
46745	232	49	its	-PRON-	PRP$
46745	232	50	medical	medical	JJ
46745	232	51	properties	property	NNS
46745	232	52	,	,	,
46745	232	53	as	as	IN
46745	232	54	when	when	WRB
46745	232	55	benzoic	benzoic	NNP
46745	232	56	is	be	VBZ
46745	232	57	changed	change	VBN
46745	232	58	into	into	IN
46745	232	59	hippuric	hippuric	NN
46745	232	60	acid	acid	NN
46745	232	61	;	;	:
46745	232	62	or	or	CC
46745	232	63	of	of	IN
46745	232	64	_	_	NNP
46745	232	65	decomposition	decomposition	NN
46745	232	66	_	_	NNP
46745	232	67	,	,	,
46745	232	68	when	when	WRB
46745	232	69	a	a	DT
46745	232	70	substance	substance	NN
46745	232	71	is	be	VBZ
46745	232	72	altogether	altogether	RB
46745	232	73	altered	alter	VBN
46745	232	74	or	or	CC
46745	232	75	destroyed	destroy	VBN
46745	232	76	,	,	,
46745	232	77	as	as	IN
46745	232	78	when	when	WRB
46745	232	79	the	the	DT
46745	232	80	vegetable	vegetable	NN
46745	232	81	acids	acid	NNS
46745	232	82	are	be	VBP
46745	232	83	oxidized	oxidize	VBN
46745	232	84	into	into	IN
46745	232	85	carbonic	carbonic	JJ
46745	232	86	acid	acid	NN
46745	232	87	.	.	.
46745	233	1	Having	have	VBG
46745	233	2	considered	consider	VBN
46745	233	3	these	these	DT
46745	233	4	preliminary	preliminary	JJ
46745	233	5	matters	matter	NNS
46745	233	6	,	,	,
46745	233	7	we	-PRON-	PRP
46745	233	8	shall	shall	MD
46745	233	9	arrive	arrive	VB
46745	233	10	at	at	IN
46745	233	11	the	the	DT
46745	233	12	main	main	JJ
46745	233	13	point	point	NN
46745	233	14	.	.	.
46745	234	1	The	the	DT
46745	234	2	medicines	medicine	NNS
46745	234	3	are	be	VBP
46745	234	4	now	now	RB
46745	234	5	in	in	IN
46745	234	6	the	the	DT
46745	234	7	blood	blood	NN
46745	234	8	.	.	.
46745	235	1	We	-PRON-	PRP
46745	235	2	must	must	MD
46745	235	3	consider	consider	VB
46745	235	4	what	what	WP
46745	235	5	becomes	become	VBZ
46745	235	6	of	of	IN
46745	235	7	them	-PRON-	PRP
46745	235	8	;	;	:
46745	235	9	what	what	WP
46745	235	10	they	-PRON-	PRP
46745	235	11	do	do	VBP
46745	235	12	next	next	RB
46745	235	13	;	;	:
46745	235	14	where	where	WRB
46745	235	15	they	-PRON-	PRP
46745	235	16	go	go	VBP
46745	235	17	next	next	RB
46745	235	18	;	;	:
46745	235	19	and	and	CC
46745	235	20	how	how	WRB
46745	235	21	they	-PRON-	PRP
46745	235	22	operate	operate	VBP
46745	235	23	in	in	IN
46745	235	24	the	the	DT
46745	235	25	cure	cure	NN
46745	235	26	of	of	IN
46745	235	27	diseases	disease	NNS
46745	235	28	.	.	.
46745	236	1	I	-PRON-	PRP
46745	236	2	have	have	VBP
46745	236	3	made	make	VBN
46745	236	4	a	a	DT
46745	236	5	classification	classification	NN
46745	236	6	in	in	IN
46745	236	7	which	which	WDT
46745	236	8	medicines	medicine	NNS
46745	236	9	are	be	VBP
46745	236	10	divided	divide	VBN
46745	236	11	according	accord	VBG
46745	236	12	to	to	IN
46745	236	13	my	-PRON-	PRP$
46745	236	14	views	view	NNS
46745	236	15	of	of	IN
46745	236	16	their	-PRON-	PRP$
46745	236	17	mode	mode	NN
46745	236	18	of	of	IN
46745	236	19	operation	operation	NN
46745	236	20	.	.	.
46745	237	1	The	the	DT
46745	237	2	classes	class	NNS
46745	237	3	and	and	CC
46745	237	4	their	-PRON-	PRP$
46745	237	5	subdivisions	subdivision	NNS
46745	237	6	will	will	MD
46745	237	7	serve	serve	VB
46745	237	8	for	for	IN
46745	237	9	references	reference	NNS
46745	237	10	in	in	IN
46745	237	11	illustration	illustration	NN
46745	237	12	of	of	IN
46745	237	13	what	what	WP
46745	237	14	I	-PRON-	PRP
46745	237	15	have	have	VBP
46745	237	16	to	to	TO
46745	237	17	say	say	VB
46745	237	18	.	.	.
46745	238	1	For	for	IN
46745	238	2	it	-PRON-	PRP
46745	238	3	is	be	VBZ
46745	238	4	not	not	RB
46745	238	5	possible	possible	JJ
46745	238	6	to	to	TO
46745	238	7	speak	speak	VB
46745	238	8	of	of	IN
46745	238	9	the	the	DT
46745	238	10	general	general	JJ
46745	238	11	operation	operation	NN
46745	238	12	of	of	IN
46745	238	13	medicines	medicine	NNS
46745	238	14	without	without	IN
46745	238	15	adducing	adduce	VBG
46745	238	16	particular	particular	JJ
46745	238	17	instances	instance	NNS
46745	238	18	;	;	:
46745	238	19	nor	nor	CC
46745	238	20	will	will	MD
46745	238	21	time	time	NN
46745	238	22	and	and	CC
46745	238	23	space	space	NN
46745	238	24	always	always	RB
46745	238	25	allow	allow	VB
46745	238	26	me	-PRON-	PRP
46745	238	27	,	,	,
46745	238	28	in	in	IN
46745	238	29	doing	do	VBG
46745	238	30	so	so	RB
46745	238	31	,	,	,
46745	238	32	to	to	TO
46745	238	33	refer	refer	VB
46745	238	34	to	to	IN
46745	238	35	individual	individual	JJ
46745	238	36	medicines	medicine	NNS
46745	238	37	.	.	.
46745	239	1	There	there	EX
46745	239	2	are	be	VBP
46745	239	3	four	four	CD
46745	239	4	great	great	JJ
46745	239	5	groups	group	NNS
46745	239	6	of	of	IN
46745	239	7	medicines	medicine	NNS
46745	239	8	,	,	,
46745	239	9	the	the	DT
46745	239	10	action	action	NN
46745	239	11	of	of	IN
46745	239	12	each	each	DT
46745	239	13	of	of	IN
46745	239	14	which	which	WDT
46745	239	15	is	be	VBZ
46745	239	16	well	well	RB
46745	239	17	marked	marked	JJ
46745	239	18	and	and	CC
46745	239	19	distinct	distinct	JJ
46745	239	20	.	.	.
46745	240	1	The	the	DT
46745	240	2	first	first	JJ
46745	240	3	class	class	NN
46745	240	4	acts	act	NNS
46745	240	5	in	in	IN
46745	240	6	the	the	DT
46745	240	7	blood	blood	NN
46745	240	8	;	;	:
46745	240	9	and	and	CC
46745	240	10	as	as	IN
46745	240	11	a	a	DT
46745	240	12	large	large	JJ
46745	240	13	number	number	NN
46745	240	14	of	of	IN
46745	240	15	diseases	disease	NNS
46745	240	16	depends	depend	VBZ
46745	240	17	on	on	IN
46745	240	18	a	a	DT
46745	240	19	fault	fault	NN
46745	240	20	in	in	IN
46745	240	21	that	that	DT
46745	240	22	fluid	fluid	NN
46745	240	23	,	,	,
46745	240	24	we	-PRON-	PRP
46745	240	25	may	may	MD
46745	240	26	by	by	IN
46745	240	27	their	-PRON-	PRP$
46745	240	28	means	mean	NNS
46745	240	29	be	be	VB
46745	240	30	enabled	enable	VBN
46745	240	31	to	to	TO
46745	240	32	remedy	remedy	VB
46745	240	33	that	that	DT
46745	240	34	fault	fault	NN
46745	240	35	.	.	.
46745	241	1	They	-PRON-	PRP
46745	241	2	are	be	VBP
46745	241	3	the	the	DT
46745	241	4	most	most	RBS
46745	241	5	important	important	JJ
46745	241	6	of	of	IN
46745	241	7	all	all	DT
46745	241	8	medicines	medicine	NNS
46745	241	9	.	.	.
46745	242	1	They	-PRON-	PRP
46745	242	2	are	be	VBP
46745	242	3	called	call	VBN
46745	242	4	Hæmatics	Hæmatics	NNPS
46745	242	5	,	,	,
46745	242	6	or	or	CC
46745	242	7	blood	blood	NN
46745	242	8	-	-	HYPH
46745	242	9	medicines	medicine	NNS
46745	242	10	.	.	.
46745	243	1	They	-PRON-	PRP
46745	243	2	are	be	VBP
46745	243	3	used	use	VBN
46745	243	4	chiefly	chiefly	RB
46745	243	5	in	in	IN
46745	243	6	chronic	chronic	JJ
46745	243	7	and	and	CC
46745	243	8	constitutional	constitutional	JJ
46745	243	9	disorders	disorder	NNS
46745	243	10	.	.	.
46745	244	1	But	but	CC
46745	244	2	a	a	DT
46745	244	3	second	second	JJ
46745	244	4	class	class	NN
46745	244	5	of	of	IN
46745	244	6	remedies	remedy	NNS
46745	244	7	are	be	VBP
46745	244	8	temporary	temporary	JJ
46745	244	9	in	in	IN
46745	244	10	their	-PRON-	PRP$
46745	244	11	action	action	NN
46745	244	12	.	.	.
46745	245	1	They	-PRON-	PRP
46745	245	2	influence	influence	VBP
46745	245	3	the	the	DT
46745	245	4	nervous	nervous	JJ
46745	245	5	system	system	NN
46745	245	6	,	,	,
46745	245	7	exciting	excite	VBG
46745	245	8	it	-PRON-	PRP
46745	245	9	,	,	,
46745	245	10	depressing	depress	VBG
46745	245	11	it	-PRON-	PRP
46745	245	12	,	,	,
46745	245	13	or	or	CC
46745	245	14	otherwise	otherwise	RB
46745	245	15	altering	alter	VBG
46745	245	16	its	-PRON-	PRP$
46745	245	17	tone	tone	NN
46745	245	18	.	.	.
46745	246	1	They	-PRON-	PRP
46745	246	2	are	be	VBP
46745	246	3	chiefly	chiefly	RB
46745	246	4	useful	useful	JJ
46745	246	5	in	in	IN
46745	246	6	the	the	DT
46745	246	7	temporary	temporary	JJ
46745	246	8	emergencies	emergency	NNS
46745	246	9	of	of	IN
46745	246	10	acute	acute	JJ
46745	246	11	disorders	disorder	NNS
46745	246	12	.	.	.
46745	247	1	They	-PRON-	PRP
46745	247	2	can	can	MD
46745	247	3	seldom	seldom	RB
46745	247	4	effect	effect	VB
46745	247	5	a	a	DT
46745	247	6	permanent	permanent	JJ
46745	247	7	cure	cure	NN
46745	247	8	,	,	,
46745	247	9	unless	unless	IN
46745	247	10	when	when	WRB
46745	247	11	the	the	DT
46745	247	12	contingency	contingency	NN
46745	247	13	in	in	IN
46745	247	14	which	which	WDT
46745	247	15	they	-PRON-	PRP
46745	247	16	are	be	VBP
46745	247	17	administered	administer	VBN
46745	247	18	is	be	VBZ
46745	247	19	also	also	RB
46745	247	20	of	of	IN
46745	247	21	a	a	DT
46745	247	22	temporary	temporary	JJ
46745	247	23	nature	nature	NN
46745	247	24	.	.	.
46745	248	1	They	-PRON-	PRP
46745	248	2	are	be	VBP
46745	248	3	called	call	VBN
46745	248	4	Neurotics	neurotic	NNS
46745	248	5	,	,	,
46745	248	6	or	or	CC
46745	248	7	nerve	nerve	NN
46745	248	8	-	-	HYPH
46745	248	9	medicines	medicine	NNS
46745	248	10	.	.	.
46745	249	1	A	a	DT
46745	249	2	third	third	JJ
46745	249	3	set	set	NN
46745	249	4	of	of	IN
46745	249	5	medicines	medicine	NNS
46745	249	6	,	,	,
46745	249	7	less	less	RBR
46745	249	8	extensive	extensive	JJ
46745	249	9	and	and	CC
46745	249	10	less	less	RBR
46745	249	11	important	important	JJ
46745	249	12	than	than	IN
46745	249	13	the	the	DT
46745	249	14	others	other	NNS
46745	249	15	,	,	,
46745	249	16	acts	act	VBZ
46745	249	17	upon	upon	IN
46745	249	18	muscular	muscular	JJ
46745	249	19	fibre	fibre	NN
46745	249	20	,	,	,
46745	249	21	which	which	WDT
46745	249	22	is	be	VBZ
46745	249	23	caused	cause	VBN
46745	249	24	by	by	IN
46745	249	25	them	-PRON-	PRP
46745	249	26	to	to	TO
46745	249	27	contract	contract	VB
46745	249	28	.	.	.
46745	250	1	Involuntary	involuntary	JJ
46745	250	2	muscular	muscular	JJ
46745	250	3	fibre	fibre	NN
46745	250	4	exists	exist	VBZ
46745	250	5	in	in	IN
46745	250	6	the	the	DT
46745	250	7	coats	coat	NNS
46745	250	8	of	of	IN
46745	250	9	small	small	JJ
46745	250	10	blood	blood	NN
46745	250	11	vessels	vessel	NNS
46745	250	12	,	,	,
46745	250	13	and	and	CC
46745	250	14	in	in	IN
46745	250	15	the	the	DT
46745	250	16	ducts	duct	NNS
46745	250	17	of	of	IN
46745	250	18	glands	gland	NNS
46745	250	19	.	.	.
46745	251	1	Thus	thus	RB
46745	251	2	Astringents	Astringents	NNPS
46745	251	3	,	,	,
46745	251	4	as	as	IN
46745	251	5	these	these	DT
46745	251	6	agents	agent	NNS
46745	251	7	are	be	VBP
46745	251	8	called	call	VBN
46745	251	9	,	,	,
46745	251	10	are	be	VBP
46745	251	11	able	able	JJ
46745	251	12	,	,	,
46745	251	13	by	by	IN
46745	251	14	contracting	contract	VBG
46745	251	15	muscular	muscular	JJ
46745	251	16	fibre	fibre	NN
46745	251	17	,	,	,
46745	251	18	and	and	CC
46745	251	19	thus	thus	RB
46745	251	20	diminishing	diminish	VBG
46745	251	21	the	the	DT
46745	251	22	calibre	calibre	NN
46745	251	23	of	of	IN
46745	251	24	these	these	DT
46745	251	25	canals	canal	NNS
46745	251	26	,	,	,
46745	251	27	to	to	TO
46745	251	28	arrest	arrest	VB
46745	251	29	hemorrhage	hemorrhage	NN
46745	251	30	in	in	IN
46745	251	31	one	one	CD
46745	251	32	case	case	NN
46745	251	33	(	(	-LRB-
46745	251	34	when	when	WRB
46745	251	35	a	a	DT
46745	251	36	small	small	JJ
46745	251	37	vessel	vessel	NN
46745	251	38	is	be	VBZ
46745	251	39	ruptured	rupture	VBN
46745	251	40	,	,	,
46745	251	41	)	)	-RRB-
46745	251	42	and	and	CC
46745	251	43	to	to	TO
46745	251	44	prevent	prevent	VB
46745	251	45	the	the	DT
46745	251	46	outpouring	outpoure	VBG
46745	251	47	of	of	IN
46745	251	48	a	a	DT
46745	251	49	secretion	secretion	NN
46745	251	50	in	in	IN
46745	251	51	another	another	DT
46745	251	52	case	case	NN
46745	251	53	.	.	.
46745	252	1	The	the	DT
46745	252	2	fourth	fourth	JJ
46745	252	3	class	class	NN
46745	252	4	is	be	VBZ
46745	252	5	of	of	IN
46745	252	6	considerable	considerable	JJ
46745	252	7	importance	importance	NN
46745	252	8	.	.	.
46745	253	1	Some	some	DT
46745	253	2	medicines	medicine	NNS
46745	253	3	have	have	VBP
46745	253	4	the	the	DT
46745	253	5	power	power	NN
46745	253	6	of	of	IN
46745	253	7	increasing	increase	VBG
46745	253	8	the	the	DT
46745	253	9	secretions	secretion	NNS
46745	253	10	which	which	WDT
46745	253	11	are	be	VBP
46745	253	12	formed	form	VBN
46745	253	13	from	from	IN
46745	253	14	the	the	DT
46745	253	15	blood	blood	NN
46745	253	16	by	by	IN
46745	253	17	various	various	JJ
46745	253	18	glands	gland	NNS
46745	253	19	at	at	IN
46745	253	20	different	different	JJ
46745	253	21	parts	part	NNS
46745	253	22	of	of	IN
46745	253	23	the	the	DT
46745	253	24	body	body	NN
46745	253	25	.	.	.
46745	254	1	By	by	IN
46745	254	2	their	-PRON-	PRP$
46745	254	3	aid	aid	NN
46745	254	4	we	-PRON-	PRP
46745	254	5	may	may	MD
46745	254	6	be	be	VB
46745	254	7	enabled	enable	VBN
46745	254	8	to	to	TO
46745	254	9	eliminate	eliminate	VB
46745	254	10	from	from	IN
46745	254	11	the	the	DT
46745	254	12	blood	blood	NN
46745	254	13	a	a	DT
46745	254	14	morbid	morbid	NN
46745	254	15	material	material	NN
46745	254	16	through	through	IN
46745	254	17	the	the	DT
46745	254	18	glands	gland	NNS
46745	254	19	;	;	:
46745	254	20	or	or	CC
46745	254	21	we	-PRON-	PRP
46745	254	22	may	may	MD
46745	254	23	do	do	VB
46745	254	24	great	great	JJ
46745	254	25	good	good	NN
46745	254	26	by	by	IN
46745	254	27	restoring	restore	VBG
46745	254	28	a	a	DT
46745	254	29	secretion	secretion	NN
46745	254	30	when	when	WRB
46745	254	31	unnaturally	unnaturally	RB
46745	254	32	suppressed	suppress	VBN
46745	254	33	.	.	.
46745	255	1	They	-PRON-	PRP
46745	255	2	are	be	VBP
46745	255	3	called	call	VBN
46745	255	4	Eliminatives	Eliminatives	NNPS
46745	255	5	.	.	.
46745	256	1	Like	like	IN
46745	256	2	Hæmatics	Hæmatics	NNPS
46745	256	3	,	,	,
46745	256	4	their	-PRON-	PRP$
46745	256	5	influence	influence	NN
46745	256	6	is	be	VBZ
46745	256	7	more	more	RBR
46745	256	8	or	or	CC
46745	256	9	less	less	RBR
46745	256	10	permanent	permanent	JJ
46745	256	11	.	.	.
46745	257	1	That	that	DT
46745	257	2	of	of	IN
46745	257	3	Neurotics	Neurotics	NNP
46745	257	4	and	and	CC
46745	257	5	Astringents	Astringents	NNPS
46745	257	6	,	,	,
46745	257	7	particularly	particularly	RB
46745	257	8	the	the	DT
46745	257	9	former	former	JJ
46745	257	10	,	,	,
46745	257	11	is	be	VBZ
46745	257	12	transient	transient	JJ
46745	257	13	.	.	.
46745	258	1	The	the	DT
46745	258	2	general	general	JJ
46745	258	3	mode	mode	NN
46745	258	4	of	of	IN
46745	258	5	action	action	NN
46745	258	6	of	of	IN
46745	258	7	these	these	DT
46745	258	8	four	four	CD
46745	258	9	classes	class	NNS
46745	258	10	of	of	IN
46745	258	11	therapeutic	therapeutic	JJ
46745	258	12	agents	agent	NNS
46745	258	13	is	be	VBZ
46745	258	14	laid	lay	VBN
46745	258	15	down	down	RP
46745	258	16	in	in	IN
46745	258	17	the	the	DT
46745	258	18	four	four	CD
46745	258	19	remaining	remain	VBG
46745	258	20	propositions	proposition	NNS
46745	258	21	,	,	,
46745	258	22	about	about	RB
46745	258	23	as	as	RB
46745	258	24	far	far	RB
46745	258	25	as	as	IN
46745	258	26	it	-PRON-	PRP
46745	258	27	seems	seem	VBZ
46745	258	28	to	to	IN
46745	258	29	me	-PRON-	PRP
46745	258	30	to	to	TO
46745	258	31	be	be	VB
46745	258	32	capable	capable	JJ
46745	258	33	of	of	IN
46745	258	34	a	a	DT
46745	258	35	positive	positive	JJ
46745	258	36	definition	definition	NN
46745	258	37	.	.	.
46745	259	1	Each	each	DT
46745	259	2	proposition	proposition	NN
46745	259	3	concerns	concern	VBZ
46745	259	4	one	one	CD
46745	259	5	of	of	IN
46745	259	6	these	these	DT
46745	259	7	classes	class	NNS
46745	259	8	of	of	IN
46745	259	9	medicines	medicine	NNS
46745	259	10	.	.	.
46745	260	1	All	all	DT
46745	260	2	I	-PRON-	PRP
46745	260	3	can	can	MD
46745	260	4	do	do	VB
46745	260	5	now	now	RB
46745	260	6	is	be	VBZ
46745	260	7	to	to	TO
46745	260	8	recapitulate	recapitulate	VB
46745	260	9	the	the	DT
46745	260	10	chief	chief	JJ
46745	260	11	affirmations	affirmation	NNS
46745	260	12	made	make	VBN
46745	260	13	;	;	:
46745	260	14	as	as	IN
46745	260	15	to	to	TO
46745	260	16	give	give	VB
46745	260	17	any	any	DT
46745	260	18	idea	idea	NN
46745	260	19	of	of	IN
46745	260	20	their	-PRON-	PRP$
46745	260	21	proof	proof	NN
46745	260	22	would	would	MD
46745	260	23	require	require	VB
46745	260	24	me	-PRON-	PRP
46745	260	25	to	to	TO
46745	260	26	enter	enter	VB
46745	260	27	into	into	IN
46745	260	28	a	a	DT
46745	260	29	number	number	NN
46745	260	30	of	of	IN
46745	260	31	details	detail	NNS
46745	260	32	which	which	WDT
46745	260	33	had	have	VBD
46745	260	34	better	well	JJR
46745	260	35	be	be	VB
46745	260	36	postponed	postpone	VBN
46745	260	37	to	to	IN
46745	260	38	the	the	DT
46745	260	39	third	third	JJ
46745	260	40	chapter	chapter	NN
46745	260	41	.	.	.
46745	261	1	In	in	IN
46745	261	2	the	the	DT
46745	261	3	_	_	NNP
46745	261	4	Seventh	Seventh	NNP
46745	261	5	Proposition	Proposition	NNP
46745	261	6	_	_	IN
46745	261	7	it	-PRON-	PRP
46745	261	8	is	be	VBZ
46745	261	9	stated	state	VBN
46745	261	10	of	of	IN
46745	261	11	Hæmatic	hæmatic	JJ
46745	261	12	medicines	medicine	NNS
46745	261	13	that	that	IN
46745	261	14	they	-PRON-	PRP
46745	261	15	act	act	VBP
46745	261	16	while	while	IN
46745	261	17	in	in	IN
46745	261	18	the	the	DT
46745	261	19	blood	blood	NN
46745	261	20	,	,	,
46745	261	21	over	over	IN
46745	261	22	which	which	WDT
46745	261	23	fluid	fluid	NN
46745	261	24	they	-PRON-	PRP
46745	261	25	exert	exert	VBP
46745	261	26	an	an	DT
46745	261	27	influence	influence	NN
46745	261	28	;	;	,
46745	261	29	and	and	CC
46745	261	30	that	that	IN
46745	261	31	their	-PRON-	PRP$
46745	261	32	effect	effect	NN
46745	261	33	,	,	,
46745	261	34	whatever	whatever	WDT
46745	261	35	it	-PRON-	PRP
46745	261	36	be	be	VB
46745	261	37	,	,	,
46745	261	38	is	be	VBZ
46745	261	39	of	of	IN
46745	261	40	a	a	DT
46745	261	41	more	more	RBR
46745	261	42	or	or	CC
46745	261	43	less	less	RBR
46745	261	44	permanent	permanent	JJ
46745	261	45	character	character	NN
46745	261	46	.	.	.
46745	262	1	A	a	DT
46745	262	2	line	line	NN
46745	262	3	of	of	IN
46745	262	4	distinction	distinction	NN
46745	262	5	is	be	VBZ
46745	262	6	drawn	draw	VBN
46745	262	7	between	between	IN
46745	262	8	two	two	CD
46745	262	9	divisions	division	NNS
46745	262	10	of	of	IN
46745	262	11	this	this	DT
46745	262	12	class	class	NN
46745	262	13	of	of	IN
46745	262	14	blood	blood	NN
46745	262	15	-	-	HYPH
46745	262	16	medicines	medicine	NNS
46745	262	17	.	.	.
46745	263	1	Some	some	DT
46745	263	2	of	of	IN
46745	263	3	them	-PRON-	PRP
46745	263	4	are	be	VBP
46745	263	5	natural	natural	JJ
46745	263	6	to	to	IN
46745	263	7	the	the	DT
46745	263	8	blood	blood	NN
46745	263	9	;	;	:
46745	263	10	they	-PRON-	PRP
46745	263	11	resemble	resemble	VBP
46745	263	12	or	or	CC
46745	263	13	coincide	coincide	VBP
46745	263	14	with	with	IN
46745	263	15	certain	certain	JJ
46745	263	16	substances	substance	NNS
46745	263	17	that	that	WDT
46745	263	18	exist	exist	VBP
46745	263	19	in	in	IN
46745	263	20	that	that	DT
46745	263	21	fluid	fluid	NN
46745	263	22	;	;	:
46745	263	23	so	so	IN
46745	263	24	that	that	IN
46745	263	25	,	,	,
46745	263	26	having	have	VBG
46745	263	27	entered	enter	VBN
46745	263	28	it	-PRON-	PRP
46745	263	29	,	,	,
46745	263	30	they	-PRON-	PRP
46745	263	31	may	may	MD
46745	263	32	remain	remain	VB
46745	263	33	there	there	RB
46745	263	34	,	,	,
46745	263	35	and	and	CC
46745	263	36	are	be	VBP
46745	263	37	not	not	RB
46745	263	38	necessarily	necessarily	RB
46745	263	39	excreted	excrete	VBN
46745	263	40	again	again	RB
46745	263	41	.	.	.
46745	264	1	These	these	DT
46745	264	2	are	be	VBP
46745	264	3	useful	useful	JJ
46745	264	4	when	when	WRB
46745	264	5	the	the	DT
46745	264	6	blood	blood	NN
46745	264	7	is	be	VBZ
46745	264	8	wanting	want	VBG
46745	264	9	in	in	IN
46745	264	10	one	one	CD
46745	264	11	or	or	CC
46745	264	12	more	more	JJR
46745	264	13	of	of	IN
46745	264	14	its	-PRON-	PRP$
46745	264	15	natural	natural	JJ
46745	264	16	constituents	constituent	NNS
46745	264	17	.	.	.
46745	265	1	This	this	DT
46745	265	2	want	want	NN
46745	265	3	causes	cause	VBZ
46745	265	4	a	a	DT
46745	265	5	disease	disease	NN
46745	265	6	,	,	,
46745	265	7	and	and	CC
46745	265	8	may	may	MD
46745	265	9	be	be	VB
46745	265	10	supplied	supply	VBN
46745	265	11	by	by	IN
46745	265	12	the	the	DT
46745	265	13	medicine	medicine	NN
46745	265	14	,	,	,
46745	265	15	which	which	WDT
46745	265	16	in	in	IN
46745	265	17	this	this	DT
46745	265	18	way	way	NN
46745	265	19	tends	tend	VBZ
46745	265	20	to	to	TO
46745	265	21	cure	cure	VB
46745	265	22	the	the	DT
46745	265	23	disease	disease	NN
46745	265	24	.	.	.
46745	266	1	Medicines	medicine	NNS
46745	266	2	of	of	IN
46745	266	3	this	this	DT
46745	266	4	division	division	NN
46745	266	5	are	be	VBP
46745	266	6	called	call	VBN
46745	266	7	Restoratives	restorative	NNS
46745	266	8	;	;	:
46745	266	9	for	for	IN
46745	266	10	they	-PRON-	PRP
46745	266	11	_	_	NNP
46745	266	12	restore	restore	NN
46745	266	13	_	_	NNP
46745	266	14	what	what	WP
46745	266	15	is	be	VBZ
46745	266	16	wanting	want	VBG
46745	266	17	.	.	.
46745	267	1	Some	some	DT
46745	267	2	other	other	JJ
46745	267	3	blood	blood	NN
46745	267	4	-	-	HYPH
46745	267	5	medicines	medicine	NNS
46745	267	6	,	,	,
46745	267	7	although	although	IN
46745	267	8	they	-PRON-	PRP
46745	267	9	enter	enter	VBP
46745	267	10	the	the	DT
46745	267	11	blood	blood	NN
46745	267	12	,	,	,
46745	267	13	are	be	VBP
46745	267	14	not	not	RB
46745	267	15	natural	natural	JJ
46745	267	16	constituents	constituent	NNS
46745	267	17	of	of	IN
46745	267	18	the	the	DT
46745	267	19	vital	vital	JJ
46745	267	20	fluid	fluid	NN
46745	267	21	,	,	,
46745	267	22	and	and	CC
46745	267	23	can	can	MD
46745	267	24	not	not	RB
46745	267	25	remain	remain	VB
46745	267	26	there	there	RB
46745	267	27	,	,	,
46745	267	28	for	for	IN
46745	267	29	they	-PRON-	PRP
46745	267	30	are	be	VBP
46745	267	31	noxious	noxious	JJ
46745	267	32	and	and	CC
46745	267	33	foreign	foreign	JJ
46745	267	34	to	to	IN
46745	267	35	it	-PRON-	PRP
46745	267	36	.	.	.
46745	268	1	They	-PRON-	PRP
46745	268	2	must	must	MD
46745	268	3	sooner	soon	RBR
46745	268	4	or	or	CC
46745	268	5	later	later	RB
46745	268	6	be	be	VB
46745	268	7	excreted	excrete	VBN
46745	268	8	from	from	IN
46745	268	9	it	-PRON-	PRP
46745	268	10	by	by	IN
46745	268	11	the	the	DT
46745	268	12	glands	gland	NNS
46745	268	13	.	.	.
46745	269	1	They	-PRON-	PRP
46745	269	2	are	be	VBP
46745	269	3	of	of	IN
46745	269	4	use	use	NN
46745	269	5	when	when	WRB
46745	269	6	disease	disease	NN
46745	269	7	depends	depend	VBZ
46745	269	8	on	on	IN
46745	269	9	the	the	DT
46745	269	10	presence	presence	NN
46745	269	11	and	and	CC
46745	269	12	working	work	VBG
46745	269	13	in	in	IN
46745	269	14	the	the	DT
46745	269	15	blood	blood	NN
46745	269	16	of	of	IN
46745	269	17	some	some	DT
46745	269	18	morbid	morbid	NN
46745	269	19	material	material	NN
46745	269	20	or	or	CC
46745	269	21	agency	agency	NN
46745	269	22	,	,	,
46745	269	23	which	which	WDT
46745	269	24	material	material	NN
46745	269	25	or	or	CC
46745	269	26	action	action	NN
46745	269	27	they	-PRON-	PRP
46745	269	28	tend	tend	VBP
46745	269	29	to	to	TO
46745	269	30	counteract	counteract	VB
46745	269	31	or	or	CC
46745	269	32	destroy	destroy	VB
46745	269	33	.	.	.
46745	270	1	They	-PRON-	PRP
46745	270	2	may	may	MD
46745	270	3	be	be	VB
46745	270	4	called	call	VBN
46745	270	5	_	_	NNP
46745	270	6	vital	vital	JJ
46745	270	7	antidotes	antidote	NNS
46745	270	8	_	_	NNP
46745	270	9	;	;	:
46745	270	10	not	not	RB
46745	270	11	strictly	strictly	RB
46745	270	12	_	_	NNP
46745	270	13	specifics	specific	NNS
46745	270	14	_	_	NNP
46745	270	15	,	,	,
46745	270	16	for	for	IN
46745	270	17	they	-PRON-	PRP
46745	270	18	are	be	VBP
46745	270	19	not	not	RB
46745	270	20	always	always	RB
46745	270	21	efficacious	efficacious	JJ
46745	270	22	,	,	,
46745	270	23	on	on	IN
46745	270	24	account	account	NN
46745	270	25	of	of	IN
46745	270	26	variations	variation	NNS
46745	270	27	in	in	IN
46745	270	28	the	the	DT
46745	270	29	animal	animal	NN
46745	270	30	poisons	poison	NNS
46745	270	31	,	,	,
46745	270	32	or	or	CC
46745	270	33	from	from	IN
46745	270	34	the	the	DT
46745	270	35	casual	casual	JJ
46745	270	36	operation	operation	NN
46745	270	37	of	of	IN
46745	270	38	disturbing	disturb	VBG
46745	270	39	causes	cause	NNS
46745	270	40	.	.	.
46745	271	1	They	-PRON-	PRP
46745	271	2	are	be	VBP
46745	271	3	applicable	applicable	JJ
46745	271	4	in	in	IN
46745	271	5	those	those	DT
46745	271	6	many	many	JJ
46745	271	7	disorders	disorder	NNS
46745	271	8	which	which	WDT
46745	271	9	depend	depend	VBP
46745	271	10	,	,	,
46745	271	11	not	not	RB
46745	271	12	on	on	IN
46745	271	13	the	the	DT
46745	271	14	absence	absence	NN
46745	271	15	of	of	IN
46745	271	16	a	a	DT
46745	271	17	natural	natural	JJ
46745	271	18	substance	substance	NN
46745	271	19	,	,	,
46745	271	20	but	but	CC
46745	271	21	on	on	IN
46745	271	22	the	the	DT
46745	271	23	presence	presence	NN
46745	271	24	of	of	IN
46745	271	25	an	an	DT
46745	271	26	unnatural	unnatural	JJ
46745	271	27	agent	agent	NN
46745	271	28	in	in	IN
46745	271	29	the	the	DT
46745	271	30	blood	blood	NN
46745	271	31	.	.	.
46745	272	1	These	these	DT
46745	272	2	medicines	medicine	NNS
46745	272	3	are	be	VBP
46745	272	4	called	call	VBN
46745	272	5	Catalytics	Catalytics	NNP
46745	272	6	,	,	,
46745	272	7	from	from	IN
46745	272	8	a	a	DT
46745	272	9	Greek	greek	JJ
46745	272	10	word	word	NN
46745	272	11	which	which	WDT
46745	272	12	signifies	signify	VBZ
46745	272	13	_	_	NNP
46745	272	14	to	to	TO
46745	272	15	break	break	VB
46745	272	16	up	up	RP
46745	272	17	_	_	NNP
46745	272	18	or	or	CC
46745	272	19	_	_	NNP
46745	272	20	to	to	TO
46745	272	21	destroy	destroy	VB
46745	272	22	_	_	NNP
46745	272	23	.	.	.
46745	273	1	Having	have	VBG
46745	273	2	performed	perform	VBN
46745	273	3	this	this	DT
46745	273	4	,	,	,
46745	273	5	their	-PRON-	PRP$
46745	273	6	function	function	NN
46745	273	7	,	,	,
46745	273	8	they	-PRON-	PRP
46745	273	9	then	then	RB
46745	273	10	pass	pass	VBP
46745	273	11	out	out	IN
46745	273	12	of	of	IN
46745	273	13	the	the	DT
46745	273	14	blood	blood	NN
46745	273	15	.	.	.
46745	274	1	All	all	PDT
46745	274	2	this	this	DT
46745	274	3	requires	require	VBZ
46745	274	4	to	to	TO
46745	274	5	be	be	VB
46745	274	6	proved	prove	VBN
46745	274	7	.	.	.
46745	275	1	In	in	IN
46745	275	2	the	the	DT
46745	275	3	_	_	NNP
46745	275	4	Eighth	Eighth	NNP
46745	275	5	Proposition	Proposition	NNP
46745	275	6	_	_	NNP
46745	275	7	it	-PRON-	PRP
46745	275	8	is	be	VBZ
46745	275	9	stated	state	VBN
46745	275	10	of	of	IN
46745	275	11	Neurotics	Neurotics	NNP
46745	275	12	,	,	,
46745	275	13	or	or	CC
46745	275	14	nerve	nerve	NN
46745	275	15	-	-	HYPH
46745	275	16	medicines	medicine	NNS
46745	275	17	,	,	,
46745	275	18	that	that	IN
46745	275	19	they	-PRON-	PRP
46745	275	20	act	act	VBP
46745	275	21	by	by	IN
46745	275	22	passing	pass	VBG
46745	275	23	out	out	IN
46745	275	24	of	of	IN
46745	275	25	the	the	DT
46745	275	26	blood	blood	NN
46745	275	27	to	to	IN
46745	275	28	the	the	DT
46745	275	29	nerves	nerve	NNS
46745	275	30	,	,	,
46745	275	31	which	which	WDT
46745	275	32	they	-PRON-	PRP
46745	275	33	influence	influence	VBP
46745	275	34	.	.	.
46745	276	1	This	this	DT
46745	276	2	is	be	VBZ
46745	276	3	only	only	RB
46745	276	4	to	to	TO
46745	276	5	insist	insist	VB
46745	276	6	on	on	IN
46745	276	7	the	the	DT
46745	276	8	rule	rule	NN
46745	276	9	of	of	IN
46745	276	10	_	_	NNP
46745	276	11	local	local	JJ
46745	276	12	access	access	NN
46745	276	13	_	_	NNP
46745	276	14	,	,	,
46745	276	15	already	already	RB
46745	276	16	laid	lay	VBN
46745	276	17	down	down	RP
46745	276	18	in	in	IN
46745	276	19	Prop	Prop	NNP
46745	276	20	.	.	.
46745	277	1	V.	V.	NNP
46745	277	2	It	-PRON-	PRP
46745	277	3	is	be	VBZ
46745	277	4	further	further	RB
46745	277	5	affirmed	affirm	VBN
46745	277	6	that	that	IN
46745	277	7	they	-PRON-	PRP
46745	277	8	are	be	VBP
46745	277	9	transitory	transitory	JJ
46745	277	10	in	in	IN
46745	277	11	action	action	NN
46745	277	12	.	.	.
46745	278	1	They	-PRON-	PRP
46745	278	2	appear	appear	VBP
46745	278	3	to	to	TO
46745	278	4	effect	effect	VB
46745	278	5	molecular	molecular	JJ
46745	278	6	changes	change	NNS
46745	278	7	in	in	IN
46745	278	8	nerve	nerve	NN
46745	278	9	-	-	HYPH
46745	278	10	fibre	fibre	NN
46745	278	11	,	,	,
46745	278	12	similar	similar	JJ
46745	278	13	to	to	IN
46745	278	14	those	those	DT
46745	278	15	by	by	IN
46745	278	16	which	which	WDT
46745	278	17	the	the	DT
46745	278	18	phenomena	phenomenon	NNS
46745	278	19	of	of	IN
46745	278	20	the	the	DT
46745	278	21	senses	sense	NNS
46745	278	22	are	be	VBP
46745	278	23	produced	produce	VBN
46745	278	24	,	,	,
46745	278	25	and	and	CC
46745	278	26	which	which	WDT
46745	278	27	are	be	VBP
46745	278	28	by	by	IN
46745	278	29	nature	nature	NN
46745	278	30	transitory	transitory	NN
46745	278	31	in	in	IN
46745	278	32	their	-PRON-	PRP$
46745	278	33	results	result	NNS
46745	278	34	.	.	.
46745	279	1	And	and	CC
46745	279	2	yet	yet	RB
46745	279	3	they	-PRON-	PRP
46745	279	4	may	may	MD
46745	279	5	be	be	VB
46745	279	6	very	very	RB
46745	279	7	powerful	powerful	JJ
46745	279	8	,	,	,
46745	279	9	even	even	RB
46745	279	10	so	so	IN
46745	279	11	as	as	IN
46745	279	12	to	to	TO
46745	279	13	extinguish	extinguish	VB
46745	279	14	vital	vital	JJ
46745	279	15	force	force	NN
46745	279	16	.	.	.
46745	280	1	Thus	thus	RB
46745	280	2	,	,	,
46745	280	3	short	short	JJ
46745	280	4	and	and	CC
46745	280	5	unenduring	unenduring	JJ
46745	280	6	as	as	IN
46745	280	7	is	be	VBZ
46745	280	8	the	the	DT
46745	280	9	operation	operation	NN
46745	280	10	of	of	IN
46745	280	11	these	these	DT
46745	280	12	agents	agent	NNS
46745	280	13	,	,	,
46745	280	14	it	-PRON-	PRP
46745	280	15	may	may	MD
46745	280	16	last	last	VB
46745	280	17	long	long	RB
46745	280	18	enough	enough	RB
46745	280	19	to	to	TO
46745	280	20	cause	cause	VB
46745	280	21	death	death	NN
46745	280	22	,	,	,
46745	280	23	and	and	CC
46745	280	24	so	so	RB
46745	280	25	a	a	DT
46745	280	26	temporary	temporary	JJ
46745	280	27	influence	influence	NN
46745	280	28	produce	produce	VBP
46745	280	29	a	a	DT
46745	280	30	permanent	permanent	JJ
46745	280	31	result	result	NN
46745	280	32	.	.	.
46745	281	1	There	there	EX
46745	281	2	are	be	VBP
46745	281	3	three	three	CD
46745	281	4	divisions	division	NNS
46745	281	5	of	of	IN
46745	281	6	Neurotics	Neurotics	NNP
46745	281	7	.	.	.
46745	282	1	The	the	DT
46745	282	2	first	first	JJ
46745	282	3	set	set	NN
46745	282	4	are	be	VBP
46745	282	5	of	of	IN
46745	282	6	use	use	NN
46745	282	7	when	when	WRB
46745	282	8	there	there	EX
46745	282	9	is	be	VBZ
46745	282	10	a	a	DT
46745	282	11	dangerous	dangerous	JJ
46745	282	12	deficiency	deficiency	NN
46745	282	13	of	of	IN
46745	282	14	vital	vital	JJ
46745	282	15	action	action	NN
46745	282	16	.	.	.
46745	283	1	These	these	DT
46745	283	2	are	be	VBP
46745	283	3	Stimulants	stimulant	NNS
46745	283	4	.	.	.
46745	284	1	They	-PRON-	PRP
46745	284	2	exalt	exalt	VBP
46745	284	3	nervous	nervous	JJ
46745	284	4	force	force	NN
46745	284	5	,	,	,
46745	284	6	either	either	DT
46745	284	7	of	of	IN
46745	284	8	the	the	DT
46745	284	9	whole	whole	JJ
46745	284	10	nervous	nervous	JJ
46745	284	11	system	system	NN
46745	284	12	,	,	,
46745	284	13	or	or	CC
46745	284	14	only	only	RB
46745	284	15	of	of	IN
46745	284	16	a	a	DT
46745	284	17	part	part	NN
46745	284	18	of	of	IN
46745	284	19	it	-PRON-	PRP
46745	284	20	.	.	.
46745	285	1	They	-PRON-	PRP
46745	285	2	vary	vary	VBP
46745	285	3	very	very	RB
46745	285	4	much	much	RB
46745	285	5	in	in	IN
46745	285	6	power	power	NN
46745	285	7	.	.	.
46745	286	1	A	a	DT
46745	286	2	second	second	JJ
46745	286	3	set	set	NN
46745	286	4	,	,	,
46745	286	5	called	call	VBN
46745	286	6	Narcotics	Narcotics	NNP
46745	286	7	,	,	,
46745	286	8	first	first	RB
46745	286	9	exalt	exalt	VB
46745	286	10	nervous	nervous	JJ
46745	286	11	force	force	NN
46745	286	12	,	,	,
46745	286	13	and	and	CC
46745	286	14	then	then	RB
46745	286	15	depress	depress	VB
46745	286	16	it	-PRON-	PRP
46745	286	17	.	.	.
46745	287	1	They	-PRON-	PRP
46745	287	2	have	have	VBP
46745	287	3	thus	thus	RB
46745	287	4	a	a	DT
46745	287	5	double	double	JJ
46745	287	6	action	action	NN
46745	287	7	;	;	:
46745	287	8	but	but	CC
46745	287	9	they	-PRON-	PRP
46745	287	10	have	have	VBP
46745	287	11	also	also	RB
46745	287	12	a	a	DT
46745	287	13	peculiar	peculiar	JJ
46745	287	14	influence	influence	NN
46745	287	15	over	over	IN
46745	287	16	the	the	DT
46745	287	17	functions	function	NNS
46745	287	18	of	of	IN
46745	287	19	the	the	DT
46745	287	20	brain	brain	NN
46745	287	21	,	,	,
46745	287	22	which	which	WDT
46745	287	23	is	be	VBZ
46745	287	24	different	different	JJ
46745	287	25	from	from	IN
46745	287	26	any	any	DT
46745	287	27	possessed	possess	VBN
46745	287	28	by	by	IN
46745	287	29	other	other	JJ
46745	287	30	nerve	nerve	NN
46745	287	31	-	-	HYPH
46745	287	32	medicines	medicine	NNS
46745	287	33	.	.	.
46745	288	1	They	-PRON-	PRP
46745	288	2	control	control	VBP
46745	288	3	the	the	DT
46745	288	4	intellectual	intellectual	JJ
46745	288	5	part	part	NN
46745	288	6	of	of	IN
46745	288	7	the	the	DT
46745	288	8	brain	brain	NN
46745	288	9	,	,	,
46745	288	10	as	as	IN
46745	288	11	distinguished	distinguish	VBN
46745	288	12	from	from	IN
46745	288	13	its	-PRON-	PRP$
46745	288	14	organic	organic	JJ
46745	288	15	function	function	NN
46745	288	16	;	;	:
46745	288	17	the	the	DT
46745	288	18	powers	power	NNS
46745	288	19	of	of	IN
46745	288	20	_	_	NNP
46745	288	21	mind	mind	NN
46745	288	22	_	_	NNP
46745	288	23	more	more	JJR
46745	288	24	than	than	IN
46745	288	25	those	those	DT
46745	288	26	of	of	IN
46745	288	27	_	_	NNP
46745	288	28	life	life	NN
46745	288	29	_	_	NNP
46745	288	30	.	.	.
46745	289	1	Some	some	DT
46745	289	2	Narcotics	narcotic	NNS
46745	289	3	tend	tend	VBP
46745	289	4	to	to	TO
46745	289	5	produce	produce	VB
46745	289	6	inebriation	inebriation	NN
46745	289	7	;	;	:
46745	289	8	others	other	NNS
46745	289	9	,	,	,
46745	289	10	sleep	sleep	NN
46745	289	11	;	;	:
46745	289	12	others	other	NNS
46745	289	13	,	,	,
46745	289	14	again	again	RB
46745	289	15	,	,	,
46745	289	16	delirium	delirium	NN
46745	289	17	.	.	.
46745	290	1	In	in	IN
46745	290	2	the	the	DT
46745	290	3	third	third	JJ
46745	290	4	place	place	NN
46745	290	5	some	some	DT
46745	290	6	Neurotics	neurotic	NNS
46745	290	7	tend	tend	VBP
46745	290	8	simply	simply	RB
46745	290	9	and	and	CC
46745	290	10	primarily	primarily	RB
46745	290	11	to	to	TO
46745	290	12	depress	depress	VB
46745	290	13	nervous	nervous	JJ
46745	290	14	force	force	NN
46745	290	15	.	.	.
46745	291	1	They	-PRON-	PRP
46745	291	2	may	may	MD
46745	291	3	act	act	VB
46745	291	4	on	on	IN
46745	291	5	the	the	DT
46745	291	6	whole	whole	JJ
46745	291	7	nervous	nervous	JJ
46745	291	8	system	system	NN
46745	291	9	,	,	,
46745	291	10	or	or	CC
46745	291	11	on	on	IN
46745	291	12	a	a	DT
46745	291	13	part	part	NN
46745	291	14	of	of	IN
46745	291	15	it	-PRON-	PRP
46745	291	16	only	only	RB
46745	291	17	.	.	.
46745	292	1	They	-PRON-	PRP
46745	292	2	are	be	VBP
46745	292	3	often	often	RB
46745	292	4	very	very	RB
46745	292	5	powerful	powerful	JJ
46745	292	6	;	;	:
46745	292	7	and	and	CC
46745	292	8	they	-PRON-	PRP
46745	292	9	are	be	VBP
46745	292	10	of	of	IN
46745	292	11	use	use	NN
46745	292	12	when	when	WRB
46745	292	13	,	,	,
46745	292	14	from	from	IN
46745	292	15	any	any	DT
46745	292	16	cause	cause	NN
46745	292	17	,	,	,
46745	292	18	some	some	DT
46745	292	19	part	part	NN
46745	292	20	of	of	IN
46745	292	21	the	the	DT
46745	292	22	nervous	nervous	JJ
46745	292	23	system	system	NN
46745	292	24	is	be	VBZ
46745	292	25	over	over	RB
46745	292	26	-	-	HYPH
46745	292	27	excited	excited	JJ
46745	292	28	.	.	.
46745	293	1	They	-PRON-	PRP
46745	293	2	are	be	VBP
46745	293	3	called	call	VBN
46745	293	4	Sedatives	sedative	NNS
46745	293	5	.	.	.
46745	294	1	Like	like	IN
46745	294	2	other	other	JJ
46745	294	3	Neurotics	neurotic	NNS
46745	294	4	,	,	,
46745	294	5	they	-PRON-	PRP
46745	294	6	are	be	VBP
46745	294	7	used	use	VBN
46745	294	8	in	in	IN
46745	294	9	medicine	medicine	NN
46745	294	10	as	as	IN
46745	294	11	temporary	temporary	JJ
46745	294	12	agents	agent	NNS
46745	294	13	in	in	IN
46745	294	14	temporary	temporary	JJ
46745	294	15	emergencies	emergency	NNS
46745	294	16	.	.	.
46745	295	1	If	if	IN
46745	295	2	a	a	DT
46745	295	3	permanent	permanent	JJ
46745	295	4	action	action	NN
46745	295	5	be	be	VB
46745	295	6	required	require	VBN
46745	295	7	,	,	,
46745	295	8	the	the	DT
46745	295	9	remedy	remedy	NN
46745	295	10	must	must	MD
46745	295	11	be	be	VB
46745	295	12	constantly	constantly	RB
46745	295	13	administered	administer	VBN
46745	295	14	,	,	,
46745	295	15	that	that	IN
46745	295	16	the	the	DT
46745	295	17	effect	effect	NN
46745	295	18	may	may	MD
46745	295	19	be	be	VB
46745	295	20	kept	keep	VBN
46745	295	21	up	up	RP
46745	295	22	by	by	IN
46745	295	23	continual	continual	JJ
46745	295	24	repetition	repetition	NN
46745	295	25	.	.	.
46745	296	1	In	in	IN
46745	296	2	the	the	DT
46745	296	3	_	_	NNP
46745	296	4	Ninth	Ninth	NNP
46745	296	5	Proposition	Proposition	NNP
46745	296	6	_	_	IN
46745	296	7	it	-PRON-	PRP
46745	296	8	is	be	VBZ
46745	296	9	affirmed	affirm	VBN
46745	296	10	of	of	IN
46745	296	11	Astringent	Astringent	NNP
46745	296	12	medicines	medicine	NNS
46745	296	13	that	that	IN
46745	296	14	they	-PRON-	PRP
46745	296	15	act	act	VBP
46745	296	16	by	by	IN
46745	296	17	passing	pass	VBG
46745	296	18	out	out	IN
46745	296	19	of	of	IN
46745	296	20	the	the	DT
46745	296	21	blood	blood	NN
46745	296	22	to	to	IN
46745	296	23	muscular	muscular	JJ
46745	296	24	fibre	fibre	NNP
46745	296	25	,	,	,
46745	296	26	which	which	WDT
46745	296	27	by	by	IN
46745	296	28	their	-PRON-	PRP$
46745	296	29	contact	contact	NN
46745	296	30	they	-PRON-	PRP
46745	296	31	excite	excite	VBP
46745	296	32	to	to	IN
46745	296	33	contraction	contraction	NN
46745	296	34	.	.	.
46745	297	1	They	-PRON-	PRP
46745	297	2	do	do	VBP
46745	297	3	not	not	RB
46745	297	4	so	so	RB
46745	297	5	much	much	JJ
46745	297	6	influence	influence	NN
46745	297	7	the	the	DT
46745	297	8	voluntary	voluntary	JJ
46745	297	9	fibre	fibre	NN
46745	297	10	of	of	IN
46745	297	11	the	the	DT
46745	297	12	muscles	muscle	NNS
46745	297	13	,	,	,
46745	297	14	which	which	WDT
46745	297	15	is	be	VBZ
46745	297	16	under	under	IN
46745	297	17	the	the	DT
46745	297	18	direct	direct	JJ
46745	297	19	control	control	NN
46745	297	20	of	of	IN
46745	297	21	the	the	DT
46745	297	22	nervous	nervous	JJ
46745	297	23	system	system	NN
46745	297	24	:	:	:
46745	297	25	but	but	CC
46745	297	26	they	-PRON-	PRP
46745	297	27	chiefly	chiefly	RB
46745	297	28	manifest	manifest	VBP
46745	297	29	their	-PRON-	PRP$
46745	297	30	action	action	NN
46745	297	31	on	on	IN
46745	297	32	the	the	DT
46745	297	33	involuntary	involuntary	JJ
46745	297	34	or	or	CC
46745	297	35	unstriped	unstriped	JJ
46745	297	36	muscular	muscular	JJ
46745	297	37	fibre	fibre	NN
46745	297	38	,	,	,
46745	297	39	which	which	WDT
46745	297	40	is	be	VBZ
46745	297	41	not	not	RB
46745	297	42	directly	directly	RB
46745	297	43	controlled	control	VBN
46745	297	44	by	by	IN
46745	297	45	the	the	DT
46745	297	46	brain	brain	NN
46745	297	47	and	and	CC
46745	297	48	nerve	nerve	NN
46745	297	49	-	-	HYPH
46745	297	50	centres	centre	NNS
46745	297	51	,	,	,
46745	297	52	and	and	CC
46745	297	53	for	for	IN
46745	297	54	this	this	DT
46745	297	55	reason	reason	NN
46745	297	56	more	more	JJR
46745	297	57	under	under	IN
46745	297	58	the	the	DT
46745	297	59	operation	operation	NN
46745	297	60	of	of	IN
46745	297	61	external	external	JJ
46745	297	62	or	or	CC
46745	297	63	irritating	irritating	JJ
46745	297	64	agents	agent	NNS
46745	297	65	.	.	.
46745	298	1	Meeting	meet	VBG
46745	298	2	this	this	DT
46745	298	3	in	in	IN
46745	298	4	the	the	DT
46745	298	5	coats	coat	NNS
46745	298	6	of	of	IN
46745	298	7	the	the	DT
46745	298	8	capillary	capillary	JJ
46745	298	9	vessels	vessel	NNS
46745	298	10	and	and	CC
46745	298	11	of	of	IN
46745	298	12	the	the	DT
46745	298	13	ducts	duct	NNS
46745	298	14	of	of	IN
46745	298	15	glands	gland	NNS
46745	298	16	,	,	,
46745	298	17	they	-PRON-	PRP
46745	298	18	are	be	VBP
46745	298	19	enabled	enable	VBN
46745	298	20	to	to	TO
46745	298	21	act	act	VB
46745	298	22	as	as	IN
46745	298	23	styptics	styptic	NNS
46745	298	24	,	,	,
46745	298	25	and	and	CC
46745	298	26	as	as	IN
46745	298	27	checkers	checker	NNS
46745	298	28	of	of	IN
46745	298	29	secretion	secretion	NN
46745	298	30	.	.	.
46745	299	1	The	the	DT
46745	299	2	action	action	NN
46745	299	3	of	of	IN
46745	299	4	Astringents	astringent	NNS
46745	299	5	appears	appear	VBZ
46745	299	6	to	to	TO
46745	299	7	depend	depend	VB
46745	299	8	on	on	IN
46745	299	9	a	a	DT
46745	299	10	chemical	chemical	NN
46745	299	11	cause	cause	NN
46745	299	12	;	;	,
46745	299	13	for	for	IN
46745	299	14	we	-PRON-	PRP
46745	299	15	find	find	VBP
46745	299	16	that	that	IN
46745	299	17	all	all	DT
46745	299	18	of	of	IN
46745	299	19	them	-PRON-	PRP
46745	299	20	possess	possess	VBP
46745	299	21	the	the	DT
46745	299	22	power	power	NN
46745	299	23	of	of	IN
46745	299	24	coagulating	coagulate	VBG
46745	299	25	albumen	albuman	NNS
46745	299	26	.	.	.
46745	300	1	The	the	DT
46745	300	2	_	_	NNP
46745	300	3	Tenth	Tenth	NNP
46745	300	4	Proposition	Proposition	NNP
46745	300	5	_	_	IN
46745	300	6	treats	treat	NNS
46745	300	7	of	of	IN
46745	300	8	Eliminatives	Eliminatives	NNPS
46745	300	9	.	.	.
46745	301	1	It	-PRON-	PRP
46745	301	2	is	be	VBZ
46745	301	3	not	not	RB
46745	301	4	said	say	VBN
46745	301	5	simply	simply	RB
46745	301	6	that	that	IN
46745	301	7	these	these	DT
46745	301	8	increase	increase	VB
46745	301	9	the	the	DT
46745	301	10	secretions	secretion	NNS
46745	301	11	of	of	IN
46745	301	12	a	a	DT
46745	301	13	gland	gland	NN
46745	301	14	;	;	:
46745	301	15	or	or	CC
46745	301	16	that	that	IN
46745	301	17	they	-PRON-	PRP
46745	301	18	stimulate	stimulate	VBP
46745	301	19	the	the	DT
46745	301	20	glands	gland	NNS
46745	301	21	while	while	IN
46745	301	22	passing	pass	VBG
46745	301	23	by	by	IN
46745	301	24	them	-PRON-	PRP
46745	301	25	in	in	IN
46745	301	26	the	the	DT
46745	301	27	blood	blood	NN
46745	301	28	.	.	.
46745	302	1	But	but	CC
46745	302	2	it	-PRON-	PRP
46745	302	3	is	be	VBZ
46745	302	4	laid	lay	VBN
46745	302	5	down	down	RP
46745	302	6	as	as	IN
46745	302	7	a	a	DT
46745	302	8	rule	rule	NN
46745	302	9	that	that	IN
46745	302	10	they	-PRON-	PRP
46745	302	11	act	act	VBP
46745	302	12	by	by	IN
46745	302	13	themselves	-PRON-	PRP
46745	302	14	passing	pass	VBG
46745	302	15	out	out	IN
46745	302	16	of	of	IN
46745	302	17	the	the	DT
46745	302	18	blood	blood	NN
46745	302	19	through	through	IN
46745	302	20	the	the	DT
46745	302	21	glands	gland	NNS
46745	302	22	,	,	,
46745	302	23	and	and	CC
46745	302	24	that	that	IN
46745	302	25	while	while	IN
46745	302	26	so	so	RB
46745	302	27	doing	do	VBG
46745	302	28	they	-PRON-	PRP
46745	302	29	excite	excite	VBP
46745	302	30	them	-PRON-	PRP
46745	302	31	to	to	IN
46745	302	32	the	the	DT
46745	302	33	performance	performance	NN
46745	302	34	of	of	IN
46745	302	35	their	-PRON-	PRP$
46745	302	36	natural	natural	JJ
46745	302	37	function	function	NN
46745	302	38	.	.	.
46745	303	1	They	-PRON-	PRP
46745	303	2	are	be	VBP
46745	303	3	substances	substance	NNS
46745	303	4	which	which	WDT
46745	303	5	are	be	VBP
46745	303	6	unnatural	unnatural	JJ
46745	303	7	to	to	IN
46745	303	8	the	the	DT
46745	303	9	blood	blood	NN
46745	303	10	,	,	,
46745	303	11	and	and	CC
46745	303	12	must	must	MD
46745	303	13	therefore	therefore	RB
46745	303	14	pass	pass	VB
46745	303	15	out	out	IN
46745	303	16	of	of	IN
46745	303	17	it	-PRON-	PRP
46745	303	18	.	.	.
46745	304	1	In	in	IN
46745	304	2	so	so	RB
46745	304	3	doing	do	VBG
46745	304	4	they	-PRON-	PRP
46745	304	5	tend	tend	VBP
46745	304	6	to	to	TO
46745	304	7	pass	pass	VB
46745	304	8	by	by	RP
46745	304	9	some	some	DT
46745	304	10	glands	gland	NNS
46745	304	11	rather	rather	RB
46745	304	12	than	than	IN
46745	304	13	by	by	IN
46745	304	14	others	other	NNS
46745	304	15	:	:	:
46745	304	16	in	in	IN
46745	304	17	these	these	DT
46745	304	18	secretions	secretion	NNS
46745	304	19	they	-PRON-	PRP
46745	304	20	may	may	MD
46745	304	21	be	be	VB
46745	304	22	detected	detect	VBN
46745	304	23	chemically	chemically	RB
46745	304	24	;	;	:
46745	304	25	and	and	CC
46745	304	26	it	-PRON-	PRP
46745	304	27	is	be	VBZ
46745	304	28	on	on	IN
46745	304	29	these	these	DT
46745	304	30	glands	gland	NNS
46745	304	31	that	that	WDT
46745	304	32	they	-PRON-	PRP
46745	304	33	have	have	VBP
46745	304	34	an	an	DT
46745	304	35	especial	especial	JJ
46745	304	36	influence	influence	NN
46745	304	37	.	.	.
46745	305	1	Their	-PRON-	PRP$
46745	305	2	uses	use	NNS
46745	305	3	in	in	IN
46745	305	4	treatment	treatment	NN
46745	305	5	are	be	VBP
46745	305	6	various	various	JJ
46745	305	7	and	and	CC
46745	305	8	manifold	manifold	JJ
46745	305	9	.	.	.
46745	306	1	In	in	IN
46745	306	2	these	these	DT
46745	306	3	classes	class	NNS
46745	306	4	are	be	VBP
46745	306	5	included	include	VBN
46745	306	6	all	all	DT
46745	306	7	medicines	medicine	NNS
46745	306	8	that	that	WDT
46745	306	9	act	act	VBP
46745	306	10	after	after	IN
46745	306	11	entry	entry	NN
46745	306	12	into	into	IN
46745	306	13	the	the	DT
46745	306	14	blood	blood	NN
46745	306	15	.	.	.
46745	307	1	On	on	IN
46745	307	2	referring	refer	VBG
46745	307	3	to	to	IN
46745	307	4	the	the	DT
46745	307	5	classification	classification	NN
46745	307	6	which	which	WDT
46745	307	7	precedes	precede	NNS
46745	307	8	this	this	DT
46745	307	9	chapter	chapter	NN
46745	307	10	,	,	,
46745	307	11	it	-PRON-	PRP
46745	307	12	will	will	MD
46745	307	13	be	be	VB
46745	307	14	seen	see	VBN
46745	307	15	at	at	IN
46745	307	16	a	a	DT
46745	307	17	glance	glance	NN
46745	307	18	what	what	WDT
46745	307	19	groups	group	NNS
46745	307	20	of	of	IN
46745	307	21	medicines	medicine	NNS
46745	307	22	are	be	VBP
46745	307	23	arranged	arrange	VBN
46745	307	24	as	as	IN
46745	307	25	orders	order	NNS
46745	307	26	under	under	IN
46745	307	27	each	each	DT
46745	307	28	class	class	NN
46745	307	29	or	or	CC
46745	307	30	division	division	NN
46745	307	31	.	.	.
46745	308	1	[	[	-LRB-
46745	308	2	6	6	CD
46745	308	3	]	]	-RRB-
46745	308	4	In	in	IN
46745	308	5	the	the	DT
46745	308	6	third	third	JJ
46745	308	7	chapter	chapter	NN
46745	308	8	I	-PRON-	PRP
46745	308	9	shall	shall	MD
46745	308	10	attempt	attempt	VB
46745	308	11	at	at	IN
46745	308	12	some	some	DT
46745	308	13	length	length	NN
46745	308	14	to	to	TO
46745	308	15	prove	prove	VB
46745	308	16	the	the	DT
46745	308	17	propositions	proposition	NNS
46745	308	18	which	which	WDT
46745	308	19	treat	treat	VBP
46745	308	20	of	of	IN
46745	308	21	these	these	DT
46745	308	22	four	four	CD
46745	308	23	classes	class	NNS
46745	308	24	;	;	:
46745	308	25	and	and	CC
46745	308	26	I	-PRON-	PRP
46745	308	27	shall	shall	MD
46745	308	28	also	also	RB
46745	308	29	attempt	attempt	VB
46745	308	30	to	to	TO
46745	308	31	explain	explain	VB
46745	308	32	the	the	DT
46745	308	33	nature	nature	NN
46745	308	34	and	and	CC
46745	308	35	mode	mode	NN
46745	308	36	of	of	IN
46745	308	37	action	action	NN
46745	308	38	of	of	IN
46745	308	39	the	the	DT
46745	308	40	orders	order	NNS
46745	308	41	,	,	,
46745	308	42	or	or	CC
46745	308	43	small	small	JJ
46745	308	44	groups	group	NNS
46745	308	45	of	of	IN
46745	308	46	remedies	remedy	NNS
46745	308	47	.	.	.
46745	309	1	In	in	IN
46745	309	2	the	the	DT
46745	309	3	fourth	fourth	JJ
46745	309	4	chapter	chapter	NN
46745	309	5	some	some	DT
46745	309	6	of	of	IN
46745	309	7	the	the	DT
46745	309	8	more	more	RBR
46745	309	9	important	important	JJ
46745	309	10	medicines	medicine	NNS
46745	309	11	will	will	MD
46745	309	12	be	be	VB
46745	309	13	considered	consider	VBN
46745	309	14	separately	separately	RB
46745	309	15	,	,	,
46745	309	16	either	either	CC
46745	309	17	as	as	IN
46745	309	18	individually	individually	RB
46745	309	19	interesting	interesting	JJ
46745	309	20	,	,	,
46745	309	21	or	or	CC
46745	309	22	as	as	IN
46745	309	23	illustrative	illustrative	JJ
46745	309	24	of	of	IN
46745	309	25	general	general	JJ
46745	309	26	modes	mode	NNS
46745	309	27	of	of	IN
46745	309	28	operation	operation	NN
46745	309	29	previously	previously	RB
46745	309	30	described	describe	VBN
46745	309	31	.	.	.
46745	310	1	I	-PRON-	PRP
46745	310	2	may	may	MD
46745	310	3	point	point	VB
46745	310	4	to	to	IN
46745	310	5	some	some	DT
46745	310	6	parts	part	NNS
46745	310	7	of	of	IN
46745	310	8	the	the	DT
46745	310	9	Essay	Essay	NNP
46745	310	10	as	as	IN
46745	310	11	being	be	VBG
46745	310	12	more	more	RBR
46745	310	13	original	original	JJ
46745	310	14	than	than	IN
46745	310	15	others	other	NNS
46745	310	16	,	,	,
46745	310	17	although	although	IN
46745	310	18	not	not	RB
46745	310	19	perhaps	perhaps	RB
46745	310	20	for	for	IN
46745	310	21	that	that	DT
46745	310	22	reason	reason	NN
46745	310	23	more	more	RBR
46745	310	24	valuable	valuable	JJ
46745	310	25	.	.	.
46745	311	1	For	for	IN
46745	311	2	this	this	DT
46745	311	3	purpose	purpose	NN
46745	311	4	may	may	MD
46745	311	5	be	be	VB
46745	311	6	mentioned	mention	VBN
46745	311	7	the	the	DT
46745	311	8	treatment	treatment	NN
46745	311	9	of	of	IN
46745	311	10	the	the	DT
46745	311	11	second	second	JJ
46745	311	12	proposition	proposition	NN
46745	311	13	:	:	:
46745	311	14	the	the	DT
46745	311	15	distinction	distinction	NN
46745	311	16	attempted	attempt	VBD
46745	311	17	to	to	TO
46745	311	18	be	be	VB
46745	311	19	drawn	draw	VBN
46745	311	20	between	between	IN
46745	311	21	the	the	DT
46745	311	22	two	two	CD
46745	311	23	divisions	division	NNS
46745	311	24	of	of	IN
46745	311	25	blood	blood	NN
46745	311	26	-	-	HYPH
46745	311	27	medicines	medicine	NNS
46745	311	28	;	;	:
46745	311	29	the	the	DT
46745	311	30	account	account	NN
46745	311	31	given	give	VBN
46745	311	32	of	of	IN
46745	311	33	Tonics	Tonics	NNPS
46745	311	34	in	in	IN
46745	311	35	one	one	CD
46745	311	36	of	of	IN
46745	311	37	these	these	DT
46745	311	38	divisions	division	NNS
46745	311	39	,	,	,
46745	311	40	and	and	CC
46745	311	41	of	of	IN
46745	311	42	Anti	Anti	NNP
46745	311	43	-	-	NN
46745	311	44	arthritics	arthritics	NNP
46745	311	45	in	in	IN
46745	311	46	the	the	DT
46745	311	47	other	other	JJ
46745	311	48	;	;	:
46745	311	49	the	the	DT
46745	311	50	theory	theory	NN
46745	311	51	of	of	IN
46745	311	52	the	the	DT
46745	311	53	action	action	NN
46745	311	54	of	of	IN
46745	311	55	Eliminative	eliminative	JJ
46745	311	56	medicines	medicine	NNS
46745	311	57	;	;	:
46745	311	58	and	and	CC
46745	311	59	the	the	DT
46745	311	60	experiments	experiment	NNS
46745	311	61	made	make	VBN
46745	311	62	on	on	IN
46745	311	63	the	the	DT
46745	311	64	action	action	NN
46745	311	65	of	of	IN
46745	311	66	Aconitina	Aconitina	NNP
46745	311	67	.	.	.
46745	312	1	CHAPTER	CHAPTER	NNP
46745	312	2	II	II	NNP
46745	312	3	.	.	.
46745	313	1	ON	on	IN
46745	313	2	SOME	SOME	NNP
46745	313	3	OF	of	IN
46745	313	4	THE	the	DT
46745	313	5	MORE	more	RBR
46745	313	6	IMPORTANT	important	JJ
46745	313	7	CLASSIFICATIONS	classification	NNS
46745	313	8	OF	of	IN
46745	313	9	MEDICINES	medicine	NNS
46745	313	10	,	,	,
46745	313	11	AND	and	CC
46745	313	12	OPINIONS	opinions	NN
46745	313	13	OF	of	IN
46745	313	14	AUTHORS	author	NNS
46745	313	15	RESPECTING	respect	VBG
46745	313	16	THEIR	their	NN
46745	313	17	ACTIONS	actions	NN
46745	313	18	.	.	.
46745	314	1	I	-PRON-	PRP
46745	314	2	have	have	VBP
46745	314	3	thought	think	VBN
46745	314	4	it	-PRON-	PRP
46745	314	5	necessary	necessary	JJ
46745	314	6	,	,	,
46745	314	7	before	before	IN
46745	314	8	stating	state	VBG
46745	314	9	at	at	IN
46745	314	10	length	length	NN
46745	314	11	my	-PRON-	PRP$
46745	314	12	own	own	JJ
46745	314	13	conclusions	conclusion	NNS
46745	314	14	,	,	,
46745	314	15	to	to	TO
46745	314	16	refer	refer	VB
46745	314	17	to	to	IN
46745	314	18	some	some	DT
46745	314	19	of	of	IN
46745	314	20	the	the	DT
46745	314	21	more	more	RBR
46745	314	22	important	important	JJ
46745	314	23	statements	statement	NNS
46745	314	24	of	of	IN
46745	314	25	authors	author	NNS
46745	314	26	concerning	concern	VBG
46745	314	27	the	the	DT
46745	314	28	subject	subject	NN
46745	314	29	of	of	IN
46745	314	30	which	which	WDT
46745	314	31	I	-PRON-	PRP
46745	314	32	have	have	VBP
46745	314	33	to	to	TO
46745	314	34	treat	treat	VB
46745	314	35	;	;	:
46745	314	36	because	because	IN
46745	314	37	by	by	IN
46745	314	38	so	so	RB
46745	314	39	doing	do	VBG
46745	314	40	I	-PRON-	PRP
46745	314	41	may	may	MD
46745	314	42	to	to	IN
46745	314	43	some	some	DT
46745	314	44	extent	extent	NN
46745	314	45	indicate	indicate	VB
46745	314	46	what	what	WP
46745	314	47	points	point	NNS
46745	314	48	are	be	VBP
46745	314	49	to	to	TO
46745	314	50	be	be	VB
46745	314	51	regarded	regard	VBN
46745	314	52	as	as	IN
46745	314	53	determined	determined	JJ
46745	314	54	and	and	CC
46745	314	55	proved	proved	JJ
46745	314	56	,	,	,
46745	314	57	and	and	CC
46745	314	58	what	what	WP
46745	314	59	as	as	IN
46745	314	60	still	still	RB
46745	314	61	unsettled	unsettled	JJ
46745	314	62	,	,	,
46745	314	63	and	and	CC
46745	314	64	point	point	VB
46745	314	65	out	out	RP
46745	314	66	where	where	WRB
46745	314	67	I	-PRON-	PRP
46745	314	68	can	can	MD
46745	314	69	agree	agree	VB
46745	314	70	with	with	IN
46745	314	71	other	other	JJ
46745	314	72	writers	writer	NNS
46745	314	73	,	,	,
46745	314	74	and	and	CC
46745	314	75	where	where	WRB
46745	314	76	I	-PRON-	PRP
46745	314	77	am	be	VBP
46745	314	78	disposed	disposed	JJ
46745	314	79	to	to	TO
46745	314	80	differ	differ	VB
46745	314	81	from	from	IN
46745	314	82	them	-PRON-	PRP
46745	314	83	.	.	.
46745	315	1	The	the	DT
46745	315	2	opinions	opinion	NNS
46745	315	3	of	of	IN
46745	315	4	authors	author	NNS
46745	315	5	on	on	IN
46745	315	6	the	the	DT
46745	315	7	general	general	JJ
46745	315	8	action	action	NN
46745	315	9	of	of	IN
46745	315	10	medicines	medicine	NNS
46745	315	11	are	be	VBP
46745	315	12	in	in	IN
46745	315	13	most	most	JJS
46745	315	14	cases	case	NNS
46745	315	15	best	best	RB
46745	315	16	ascertained	ascertain	VBN
46745	315	17	by	by	IN
46745	315	18	observing	observe	VBG
46745	315	19	the	the	DT
46745	315	20	manner	manner	NN
46745	315	21	in	in	IN
46745	315	22	which	which	WDT
46745	315	23	they	-PRON-	PRP
46745	315	24	have	have	VBP
46745	315	25	arranged	arrange	VBN
46745	315	26	and	and	CC
46745	315	27	classified	classify	VBN
46745	315	28	them	-PRON-	PRP
46745	315	29	,	,	,
46745	315	30	grouping	group	VBG
46745	315	31	together	together	RB
46745	315	32	those	those	DT
46745	315	33	which	which	WDT
46745	315	34	they	-PRON-	PRP
46745	315	35	consider	consider	VBP
46745	315	36	to	to	TO
46745	315	37	be	be	VB
46745	315	38	alike	alike	RB
46745	315	39	in	in	IN
46745	315	40	their	-PRON-	PRP$
46745	315	41	mode	mode	NN
46745	315	42	of	of	IN
46745	315	43	operation	operation	NN
46745	315	44	.	.	.
46745	316	1	Differences	difference	NNS
46745	316	2	of	of	IN
46745	316	3	opinion	opinion	NN
46745	316	4	respecting	respect	VBG
46745	316	5	individual	individual	JJ
46745	316	6	medicines	medicine	NNS
46745	316	7	will	will	MD
46745	316	8	be	be	VB
46745	316	9	best	well	RBS
46745	316	10	considered	consider	VBN
46745	316	11	afterwards	afterwards	RB
46745	316	12	,	,	,
46745	316	13	when	when	WRB
46745	316	14	we	-PRON-	PRP
46745	316	15	come	come	VBP
46745	316	16	to	to	TO
46745	316	17	discuss	discuss	VB
46745	316	18	those	those	DT
46745	316	19	medicines	medicine	NNS
46745	316	20	.	.	.
46745	317	1	We	-PRON-	PRP
46745	317	2	are	be	VBP
46745	317	3	now	now	RB
46745	317	4	to	to	TO
46745	317	5	make	make	VB
46745	317	6	inquiry	inquiry	NN
46745	317	7	as	as	IN
46745	317	8	to	to	IN
46745	317	9	the	the	DT
46745	317	10	action	action	NN
46745	317	11	of	of	IN
46745	317	12	classes	class	NNS
46745	317	13	and	and	CC
46745	317	14	groups	group	NNS
46745	317	15	.	.	.
46745	318	1	So	so	RB
46745	318	2	that	that	IN
46745	318	3	,	,	,
46745	318	4	in	in	IN
46745	318	5	examining	examine	VBG
46745	318	6	classifications	classification	NNS
46745	318	7	as	as	IN
46745	318	8	a	a	DT
46745	318	9	key	key	NN
46745	318	10	to	to	IN
46745	318	11	the	the	DT
46745	318	12	opinions	opinion	NNS
46745	318	13	of	of	IN
46745	318	14	writers	writer	NNS
46745	318	15	on	on	IN
46745	318	16	this	this	DT
46745	318	17	matter	matter	NN
46745	318	18	,	,	,
46745	318	19	we	-PRON-	PRP
46745	318	20	are	be	VBP
46745	318	21	only	only	RB
46745	318	22	concerned	concerned	JJ
46745	318	23	with	with	IN
46745	318	24	those	those	DT
46745	318	25	which	which	WDT
46745	318	26	are	be	VBP
46745	318	27	founded	found	VBN
46745	318	28	in	in	IN
46745	318	29	some	some	DT
46745	318	30	way	way	NN
46745	318	31	on	on	IN
46745	318	32	the	the	DT
46745	318	33	effects	effect	NNS
46745	318	34	and	and	CC
46745	318	35	operations	operation	NNS
46745	318	36	of	of	IN
46745	318	37	medicines	medicine	NNS
46745	318	38	.	.	.
46745	319	1	Now	now	RB
46745	319	2	there	there	EX
46745	319	3	are	be	VBP
46745	319	4	three	three	CD
46745	319	5	different	different	JJ
46745	319	6	points	point	NNS
46745	319	7	of	of	IN
46745	319	8	view	view	NN
46745	319	9	from	from	IN
46745	319	10	which	which	WDT
46745	319	11	the	the	DT
46745	319	12	action	action	NN
46745	319	13	of	of	IN
46745	319	14	a	a	DT
46745	319	15	medicine	medicine	NN
46745	319	16	may	may	MD
46745	319	17	be	be	VB
46745	319	18	regarded	regard	VBN
46745	319	19	.	.	.
46745	320	1	We	-PRON-	PRP
46745	320	2	may	may	MD
46745	320	3	ask,--1	ask,--1	PRP
46745	320	4	.	.	.
46745	321	1	What	what	WP
46745	321	2	is	be	VBZ
46745	321	3	the	the	DT
46745	321	4	ultimate	ultimate	JJ
46745	321	5	effect	effect	NN
46745	321	6	of	of	IN
46745	321	7	its	-PRON-	PRP$
46745	321	8	action	action	NN
46745	321	9	on	on	IN
46745	321	10	the	the	DT
46745	321	11	system	system	NN
46745	321	12	?	?	.
46745	322	1	2	2	LS
46745	322	2	.	.	.
46745	323	1	To	to	IN
46745	323	2	what	what	WP
46745	323	3	organ	organ	NN
46745	323	4	or	or	CC
46745	323	5	tissue	tissue	NN
46745	323	6	is	be	VBZ
46745	323	7	its	-PRON-	PRP$
46745	323	8	action	action	NN
46745	323	9	directed	direct	VBN
46745	323	10	?	?	.
46745	324	1	3	3	LS
46745	324	2	.	.	.
46745	325	1	In	in	IN
46745	325	2	what	what	WDT
46745	325	3	way	way	NN
46745	325	4	does	do	VBZ
46745	325	5	it	-PRON-	PRP
46745	325	6	operate	operate	VB
46745	325	7	?	?	.
46745	326	1	In	in	IN
46745	326	2	other	other	JJ
46745	326	3	words	word	NNS
46745	326	4	,	,	,
46745	326	5	we	-PRON-	PRP
46745	326	6	may	may	MD
46745	326	7	speak	speak	VB
46745	326	8	of	of	IN
46745	326	9	the	the	DT
46745	326	10	_	_	NNP
46745	326	11	result	result	NN
46745	326	12	of	of	IN
46745	326	13	the	the	DT
46745	326	14	action	action	NN
46745	326	15	_	_	NNP
46745	326	16	of	of	IN
46745	326	17	a	a	DT
46745	326	18	medicine	medicine	NN
46745	326	19	,	,	,
46745	326	20	of	of	IN
46745	326	21	the	the	DT
46745	326	22	_	_	NNP
46745	326	23	direction	direction	NN
46745	326	24	of	of	IN
46745	326	25	the	the	DT
46745	326	26	action	action	NN
46745	326	27	_	_	NNP
46745	326	28	of	of	IN
46745	326	29	a	a	DT
46745	326	30	medicine	medicine	NN
46745	326	31	,	,	,
46745	326	32	or	or	CC
46745	326	33	of	of	IN
46745	326	34	the	the	DT
46745	326	35	_	_	NNP
46745	326	36	mode	mode	NN
46745	326	37	of	of	IN
46745	326	38	operation	operation	NN
46745	326	39	_	_	NNP
46745	326	40	of	of	IN
46745	326	41	a	a	DT
46745	326	42	medicine	medicine	NN
46745	326	43	.	.	.
46745	327	1	The	the	DT
46745	327	2	first	first	JJ
46745	327	3	of	of	IN
46745	327	4	these	these	DT
46745	327	5	questions	question	NNS
46745	327	6	is	be	VBZ
46745	327	7	the	the	DT
46745	327	8	simplest	simple	JJS
46745	327	9	,	,	,
46745	327	10	and	and	CC
46745	327	11	may	may	MD
46745	327	12	be	be	VB
46745	327	13	answered	answer	VBN
46745	327	14	from	from	IN
46745	327	15	experience	experience	NN
46745	327	16	.	.	.
46745	328	1	We	-PRON-	PRP
46745	328	2	know	know	VBP
46745	328	3	that	that	IN
46745	328	4	one	one	CD
46745	328	5	medicine	medicine	NN
46745	328	6	is	be	VBZ
46745	328	7	a	a	DT
46745	328	8	purgative	purgative	JJ
46745	328	9	,	,	,
46745	328	10	because	because	IN
46745	328	11	it	-PRON-	PRP
46745	328	12	opens	open	VBZ
46745	328	13	the	the	DT
46745	328	14	bowels	bowel	NNS
46745	328	15	.	.	.
46745	329	1	We	-PRON-	PRP
46745	329	2	call	call	VBP
46745	329	3	another	another	DT
46745	329	4	an	an	DT
46745	329	5	alterative	alterative	NN
46745	329	6	,	,	,
46745	329	7	because	because	IN
46745	329	8	the	the	DT
46745	329	9	manifestations	manifestation	NNS
46745	329	10	of	of	IN
46745	329	11	vital	vital	JJ
46745	329	12	action	action	NN
46745	329	13	are	be	VBP
46745	329	14	somewhat	somewhat	RB
46745	329	15	different	different	JJ
46745	329	16	after	after	IN
46745	329	17	its	-PRON-	PRP$
46745	329	18	use	use	NN
46745	329	19	from	from	IN
46745	329	20	what	what	WP
46745	329	21	they	-PRON-	PRP
46745	329	22	were	be	VBD
46745	329	23	before	before	RB
46745	329	24	.	.	.
46745	330	1	The	the	DT
46745	330	2	last	last	JJ
46745	330	3	question	question	NN
46745	330	4	is	be	VBZ
46745	330	5	the	the	DT
46745	330	6	most	most	RBS
46745	330	7	difficult	difficult	JJ
46745	330	8	to	to	TO
46745	330	9	answer	answer	VB
46745	330	10	,	,	,
46745	330	11	because	because	IN
46745	330	12	it	-PRON-	PRP
46745	330	13	involves	involve	VBZ
46745	330	14	the	the	DT
46745	330	15	exact	exact	JJ
46745	330	16	mode	mode	NN
46745	330	17	in	in	IN
46745	330	18	which	which	WDT
46745	330	19	a	a	DT
46745	330	20	medicine	medicine	NN
46745	330	21	first	first	JJ
46745	330	22	behaves	behave	VBZ
46745	330	23	itself	-PRON-	PRP
46745	330	24	,	,	,
46745	330	25	so	so	IN
46745	330	26	as	as	IN
46745	330	27	to	to	TO
46745	330	28	bring	bring	VB
46745	330	29	about	about	RP
46745	330	30	its	-PRON-	PRP$
46745	330	31	recognised	recognise	VBN
46745	330	32	operation	operation	NN
46745	330	33	.	.	.
46745	331	1	Though	though	IN
46745	331	2	the	the	DT
46745	331	3	arrangements	arrangement	NNS
46745	331	4	and	and	CC
46745	331	5	theories	theory	NNS
46745	331	6	of	of	IN
46745	331	7	authors	author	NNS
46745	331	8	have	have	VBP
46745	331	9	generally	generally	RB
46745	331	10	taken	take	VBN
46745	331	11	into	into	IN
46745	331	12	account	account	NN
46745	331	13	all	all	DT
46745	331	14	three	three	CD
46745	331	15	of	of	IN
46745	331	16	these	these	DT
46745	331	17	questions	question	NNS
46745	331	18	,	,	,
46745	331	19	yet	yet	CC
46745	331	20	they	-PRON-	PRP
46745	331	21	have	have	VBP
46745	331	22	usually	usually	RB
46745	331	23	given	give	VBN
46745	331	24	greater	great	JJR
46745	331	25	prominence	prominence	NN
46745	331	26	to	to	IN
46745	331	27	one	one	CD
46745	331	28	or	or	CC
46745	331	29	other	other	JJ
46745	331	30	of	of	IN
46745	331	31	them	-PRON-	PRP
46745	331	32	.	.	.
46745	332	1	And	and	CC
46745	332	2	according	accord	VBG
46745	332	3	to	to	IN
46745	332	4	this	this	DT
46745	332	5	their	-PRON-	PRP$
46745	332	6	predominant	predominant	JJ
46745	332	7	idea	idea	NN
46745	332	8	,	,	,
46745	332	9	I	-PRON-	PRP
46745	332	10	will	will	MD
46745	332	11	take	take	VB
46745	332	12	the	the	DT
46745	332	13	liberty	liberty	NN
46745	332	14	of	of	IN
46745	332	15	grouping	group	VBG
46745	332	16	them	-PRON-	PRP
46745	332	17	into	into	IN
46745	332	18	three	three	CD
46745	332	19	schools	school	NNS
46745	332	20	for	for	IN
46745	332	21	the	the	DT
46745	332	22	sake	sake	NN
46745	332	23	of	of	IN
46745	332	24	convenience	convenience	NN
46745	332	25	;	;	,
46745	332	26	considering	consider	VBG
46745	332	27	,	,	,
46745	332	28	first	first	RB
46745	332	29	,	,	,
46745	332	30	some	some	DT
46745	332	31	theories	theory	NNS
46745	332	32	and	and	CC
46745	332	33	therapeutical	therapeutical	JJ
46745	332	34	arrangements	arrangement	NNS
46745	332	35	which	which	WDT
46745	332	36	are	be	VBP
46745	332	37	based	base	VBN
46745	332	38	upon	upon	IN
46745	332	39	the	the	DT
46745	332	40	ultimate	ultimate	JJ
46745	332	41	effect	effect	NN
46745	332	42	of	of	IN
46745	332	43	medicines	medicine	NNS
46745	332	44	;	;	:
46745	332	45	secondly	secondly	RB
46745	332	46	,	,	,
46745	332	47	some	some	DT
46745	332	48	that	that	WDT
46745	332	49	depend	depend	VBP
46745	332	50	upon	upon	IN
46745	332	51	their	-PRON-	PRP$
46745	332	52	local	local	JJ
46745	332	53	tendencies	tendency	NNS
46745	332	54	;	;	:
46745	332	55	and	and	CC
46745	332	56	thirdly	thirdly	RB
46745	332	57	,	,	,
46745	332	58	some	some	DT
46745	332	59	others	other	NNS
46745	332	60	that	that	WDT
46745	332	61	concern	concern	VBP
46745	332	62	their	-PRON-	PRP$
46745	332	63	mode	mode	NN
46745	332	64	of	of	IN
46745	332	65	operation	operation	NN
46745	332	66	.	.	.
46745	333	1	Among	among	IN
46745	333	2	those	those	DT
46745	333	3	who	who	WP
46745	333	4	have	have	VBP
46745	333	5	directed	direct	VBN
46745	333	6	attention	attention	NN
46745	333	7	to	to	IN
46745	333	8	their	-PRON-	PRP$
46745	333	9	ultimate	ultimate	JJ
46745	333	10	effect	effect	NN
46745	333	11	,	,	,
46745	333	12	regarding	regard	VBG
46745	333	13	that	that	IN
46745	333	14	as	as	IN
46745	333	15	generally	generally	RB
46745	333	16	sufficient	sufficient	JJ
46745	333	17	for	for	IN
46745	333	18	practical	practical	JJ
46745	333	19	purposes	purpose	NNS
46745	333	20	,	,	,
46745	333	21	are	be	VBP
46745	333	22	included	include	VBN
46745	333	23	the	the	DT
46745	333	24	great	great	JJ
46745	333	25	majority	majority	NN
46745	333	26	of	of	IN
46745	333	27	those	those	DT
46745	333	28	who	who	WP
46745	333	29	have	have	VBP
46745	333	30	classified	classify	VBN
46745	333	31	medicines	medicine	NNS
46745	333	32	.	.	.
46745	334	1	Such	such	JJ
46745	334	2	arrangements	arrangement	NNS
46745	334	3	are	be	VBP
46745	334	4	practically	practically	RB
46745	334	5	useful	useful	JJ
46745	334	6	,	,	,
46745	334	7	as	as	IN
46745	334	8	by	by	IN
46745	334	9	their	-PRON-	PRP$
46745	334	10	means	mean	NNS
46745	334	11	we	-PRON-	PRP
46745	334	12	are	be	VBP
46745	334	13	enabled	enable	VBN
46745	334	14	easily	easily	RB
46745	334	15	to	to	TO
46745	334	16	select	select	VB
46745	334	17	a	a	DT
46745	334	18	medicine	medicine	NN
46745	334	19	which	which	WDT
46745	334	20	shall	shall	MD
46745	334	21	produce	produce	VB
46745	334	22	a	a	DT
46745	334	23	required	require	VBN
46745	334	24	result	result	NN
46745	334	25	.	.	.
46745	335	1	A	a	DT
46745	335	2	classification	classification	NN
46745	335	3	founded	found	VBN
46745	335	4	upon	upon	IN
46745	335	5	local	local	JJ
46745	335	6	tendency	tendency	NN
46745	335	7	is	be	VBZ
46745	335	8	such	such	JJ
46745	335	9	as	as	IN
46745	335	10	hardly	hardly	RB
46745	335	11	to	to	TO
46745	335	12	admit	admit	VB
46745	335	13	of	of	IN
46745	335	14	practical	practical	JJ
46745	335	15	application	application	NN
46745	335	16	,	,	,
46745	335	17	for	for	IN
46745	335	18	it	-PRON-	PRP
46745	335	19	is	be	VBZ
46745	335	20	too	too	RB
46745	335	21	vague	vague	JJ
46745	335	22	.	.	.
46745	336	1	It	-PRON-	PRP
46745	336	2	is	be	VBZ
46745	336	3	said	say	VBN
46745	336	4	that	that	IN
46745	336	5	the	the	DT
46745	336	6	action	action	NN
46745	336	7	of	of	IN
46745	336	8	mercury	mercury	NN
46745	336	9	is	be	VBZ
46745	336	10	directed	direct	VBN
46745	336	11	to	to	IN
46745	336	12	the	the	DT
46745	336	13	blood	blood	NN
46745	336	14	;	;	:
46745	336	15	that	that	DT
46745	336	16	of	of	IN
46745	336	17	a	a	DT
46745	336	18	tonic	tonic	NN
46745	336	19	,	,	,
46745	336	20	to	to	IN
46745	336	21	the	the	DT
46745	336	22	muscular	muscular	JJ
46745	336	23	system	system	NN
46745	336	24	.	.	.
46745	337	1	It	-PRON-	PRP
46745	337	2	is	be	VBZ
46745	337	3	not	not	RB
46745	337	4	said	say	VBN
46745	337	5	how	how	WRB
46745	337	6	they	-PRON-	PRP
46745	337	7	operate	operate	VBP
46745	337	8	,	,	,
46745	337	9	or	or	CC
46745	337	10	how	how	WRB
46745	337	11	these	these	DT
46745	337	12	parts	part	NNS
46745	337	13	are	be	VBP
46745	337	14	affected	affect	VBN
46745	337	15	.	.	.
46745	338	1	The	the	DT
46745	338	2	terms	term	NNS
46745	338	3	employed	employ	VBN
46745	338	4	are	be	VBP
46745	338	5	too	too	RB
46745	338	6	wide	wide	JJ
46745	338	7	and	and	CC
46745	338	8	indefinite	indefinite	JJ
46745	338	9	.	.	.
46745	339	1	Supposing	suppose	VBG
46745	339	2	the	the	DT
46745	339	3	word	word	NN
46745	339	4	_	_	NNP
46745	339	5	Neurotic	Neurotic	NNP
46745	339	6	_	_	NNP
46745	339	7	to	to	TO
46745	339	8	signify	signify	VB
46745	339	9	a	a	DT
46745	339	10	medicine	medicine	NN
46745	339	11	acting	act	VBG
46745	339	12	on	on	IN
46745	339	13	the	the	DT
46745	339	14	nerves	nerve	NNS
46745	339	15	,	,	,
46745	339	16	we	-PRON-	PRP
46745	339	17	can	can	MD
46745	339	18	not	not	RB
46745	339	19	say	say	VB
46745	339	20	that	that	IN
46745	339	21	any	any	DT
46745	339	22	known	know	VBN
46745	339	23	medicine	medicine	NN
46745	339	24	may	may	MD
46745	339	25	not	not	RB
46745	339	26	at	at	RB
46745	339	27	some	some	DT
46745	339	28	time	time	NN
46745	339	29	or	or	CC
46745	339	30	in	in	IN
46745	339	31	some	some	DT
46745	339	32	way	way	NN
46745	339	33	act	act	NN
46745	339	34	on	on	IN
46745	339	35	the	the	DT
46745	339	36	nervous	nervous	JJ
46745	339	37	system	system	NN
46745	339	38	.	.	.
46745	340	1	The	the	DT
46745	340	2	same	same	JJ
46745	340	3	term	term	NN
46745	340	4	means	mean	VBZ
46745	340	5	a	a	DT
46745	340	6	very	very	RB
46745	340	7	different	different	JJ
46745	340	8	thing	thing	NN
46745	340	9	when	when	WRB
46745	340	10	found	find	VBN
46745	340	11	in	in	IN
46745	340	12	a	a	DT
46745	340	13	classification	classification	NN
46745	340	14	based	base	VBN
46745	340	15	on	on	IN
46745	340	16	the	the	DT
46745	340	17	mode	mode	NN
46745	340	18	of	of	IN
46745	340	19	operation	operation	NN
46745	340	20	of	of	IN
46745	340	21	medicines	medicine	NNS
46745	340	22	,	,	,
46745	340	23	for	for	IN
46745	340	24	then	then	RB
46745	340	25	it	-PRON-	PRP
46745	340	26	signifies	signify	VBZ
46745	340	27	a	a	DT
46745	340	28	medicine	medicine	NN
46745	340	29	acting	act	VBG
46745	340	30	on	on	IN
46745	340	31	the	the	DT
46745	340	32	nerves	nerve	NNS
46745	340	33	in	in	IN
46745	340	34	a	a	DT
46745	340	35	certain	certain	JJ
46745	340	36	way	way	NN
46745	340	37	which	which	WDT
46745	340	38	is	be	VBZ
46745	340	39	defined	define	VBN
46745	340	40	,	,	,
46745	340	41	and	and	CC
46745	340	42	it	-PRON-	PRP
46745	340	43	conveys	convey	VBZ
46745	340	44	to	to	IN
46745	340	45	us	-PRON-	PRP
46745	340	46	an	an	DT
46745	340	47	amount	amount	NN
46745	340	48	of	of	IN
46745	340	49	information	information	NN
46745	340	50	respecting	respect	VBG
46745	340	51	that	that	IN
46745	340	52	medicine	medicine	NN
46745	340	53	and	and	CC
46745	340	54	its	-PRON-	PRP$
46745	340	55	applicability	applicability	NN
46745	340	56	which	which	WDT
46745	340	57	we	-PRON-	PRP
46745	340	58	had	have	VBD
46745	340	59	not	not	RB
46745	340	60	otherwise	otherwise	RB
46745	340	61	acquired	acquire	VBN
46745	340	62	.	.	.
46745	341	1	A	a	DT
46745	341	2	classification	classification	NN
46745	341	3	of	of	IN
46745	341	4	this	this	DT
46745	341	5	third	third	JJ
46745	341	6	kind	kind	NN
46745	341	7	,	,	,
46745	341	8	though	though	IN
46745	341	9	difficult	difficult	JJ
46745	341	10	of	of	IN
46745	341	11	construction	construction	NN
46745	341	12	,	,	,
46745	341	13	would	would	MD
46745	341	14	naturally	naturally	RB
46745	341	15	be	be	VB
46745	341	16	of	of	IN
46745	341	17	great	great	JJ
46745	341	18	practical	practical	JJ
46745	341	19	and	and	CC
46745	341	20	scientific	scientific	JJ
46745	341	21	utility	utility	NN
46745	341	22	.	.	.
46745	342	1	The	the	DT
46745	342	2	precise	precise	JJ
46745	342	3	mode	mode	NN
46745	342	4	in	in	IN
46745	342	5	which	which	WDT
46745	342	6	groups	group	NNS
46745	342	7	of	of	IN
46745	342	8	medicines	medicine	NNS
46745	342	9	operate	operate	VBP
46745	342	10	has	have	VBZ
46745	342	11	first	first	RB
46745	342	12	to	to	TO
46745	342	13	be	be	VB
46745	342	14	discovered	discover	VBN
46745	342	15	and	and	CC
46745	342	16	laid	lay	VBN
46745	342	17	down	down	RP
46745	342	18	,	,	,
46745	342	19	together	together	RB
46745	342	20	with	with	IN
46745	342	21	the	the	DT
46745	342	22	results	result	NNS
46745	342	23	of	of	IN
46745	342	24	that	that	DT
46745	342	25	operation	operation	NN
46745	342	26	;	;	:
46745	342	27	and	and	CC
46745	342	28	it	-PRON-	PRP
46745	342	29	has	have	VBZ
46745	342	30	then	then	RB
46745	342	31	to	to	TO
46745	342	32	be	be	VB
46745	342	33	proved	prove	VBN
46745	342	34	that	that	IN
46745	342	35	each	each	DT
46745	342	36	remedy	remedy	NN
46745	342	37	included	include	VBN
46745	342	38	in	in	IN
46745	342	39	a	a	DT
46745	342	40	class	class	NN
46745	342	41	operates	operate	NNS
46745	342	42	in	in	IN
46745	342	43	the	the	DT
46745	342	44	exact	exact	JJ
46745	342	45	way	way	NN
46745	342	46	predicated	predicate	VBN
46745	342	47	of	of	IN
46745	342	48	that	that	DT
46745	342	49	class	class	NN
46745	342	50	.	.	.
46745	343	1	None	none	NN
46745	343	2	which	which	WDT
46745	343	3	do	do	VBP
46745	343	4	not	not	RB
46745	343	5	do	do	VB
46745	343	6	so	so	RB
46745	343	7	can	can	MD
46745	343	8	be	be	VB
46745	343	9	consistently	consistently	RB
46745	343	10	included	include	VBN
46745	343	11	in	in	IN
46745	343	12	it	-PRON-	PRP
46745	343	13	.	.	.
46745	344	1	Such	such	PDT
46745	344	2	an	an	DT
46745	344	3	arrangement	arrangement	NN
46745	344	4	is	be	VBZ
46745	344	5	precise	precise	JJ
46745	344	6	;	;	:
46745	344	7	there	there	EX
46745	344	8	may	may	MD
46745	344	9	be	be	VB
46745	344	10	a	a	DT
46745	344	11	great	great	JJ
46745	344	12	deal	deal	NN
46745	344	13	of	of	IN
46745	344	14	error	error	NN
46745	344	15	,	,	,
46745	344	16	but	but	CC
46745	344	17	there	there	EX
46745	344	18	is	be	VBZ
46745	344	19	very	very	RB
46745	344	20	little	little	JJ
46745	344	21	vagueness	vagueness	NN
46745	344	22	about	about	IN
46745	344	23	it	-PRON-	PRP
46745	344	24	.	.	.
46745	345	1	Each	each	DT
46745	345	2	name	name	NN
46745	345	3	and	and	CC
46745	345	4	term	term	NN
46745	345	5	should	should	MD
46745	345	6	contain	contain	VB
46745	345	7	in	in	IN
46745	345	8	itself	-PRON-	PRP
46745	345	9	and	and	CC
46745	345	10	in	in	IN
46745	345	11	its	-PRON-	PRP$
46745	345	12	position	position	NN
46745	345	13	an	an	DT
46745	345	14	exact	exact	JJ
46745	345	15	description	description	NN
46745	345	16	of	of	IN
46745	345	17	the	the	DT
46745	345	18	general	general	JJ
46745	345	19	action	action	NN
46745	345	20	of	of	IN
46745	345	21	the	the	DT
46745	345	22	substances	substance	NNS
46745	345	23	included	include	VBN
46745	345	24	under	under	IN
46745	345	25	it	-PRON-	PRP
46745	345	26	.	.	.
46745	346	1	Such	such	PDT
46745	346	2	an	an	DT
46745	346	3	arrangement	arrangement	NN
46745	346	4	I	-PRON-	PRP
46745	346	5	have	have	VBP
46745	346	6	attempted	attempt	VBN
46745	346	7	to	to	TO
46745	346	8	construct	construct	VB
46745	346	9	myself	-PRON-	PRP
46745	346	10	,	,	,
46745	346	11	as	as	IN
46745	346	12	it	-PRON-	PRP
46745	346	13	is	be	VBZ
46745	346	14	with	with	IN
46745	346	15	the	the	DT
46745	346	16	mode	mode	NN
46745	346	17	of	of	IN
46745	346	18	operation	operation	NN
46745	346	19	of	of	IN
46745	346	20	medicines	medicine	NNS
46745	346	21	that	that	WDT
46745	346	22	I	-PRON-	PRP
46745	346	23	am	be	VBP
46745	346	24	particularly	particularly	RB
46745	346	25	concerned	concern	VBN
46745	346	26	.	.	.
46745	347	1	The	the	DT
46745	347	2	chief	chief	JJ
46745	347	3	and	and	CC
46745	347	4	obvious	obvious	JJ
46745	347	5	objection	objection	NN
46745	347	6	to	to	IN
46745	347	7	such	such	PDT
46745	347	8	a	a	DT
46745	347	9	classification	classification	NN
46745	347	10	consists	consist	VBZ
46745	347	11	in	in	IN
46745	347	12	the	the	DT
46745	347	13	insufficiency	insufficiency	NN
46745	347	14	or	or	CC
46745	347	15	insecurity	insecurity	NN
46745	347	16	of	of	IN
46745	347	17	the	the	DT
46745	347	18	data	datum	NNS
46745	347	19	which	which	WDT
46745	347	20	we	-PRON-	PRP
46745	347	21	have	have	VBP
46745	347	22	to	to	TO
46745	347	23	guide	guide	VB
46745	347	24	us	-PRON-	PRP
46745	347	25	.	.	.
46745	348	1	Thus	thus	RB
46745	348	2	the	the	DT
46745	348	3	best	good	JJS
46745	348	4	and	and	CC
46745	348	5	safest	safe	JJS
46745	348	6	way	way	NN
46745	348	7	is	be	VBZ
46745	348	8	to	to	TO
46745	348	9	select	select	VB
46745	348	10	as	as	IN
46745	348	11	the	the	DT
46745	348	12	bases	basis	NNS
46745	348	13	of	of	IN
46745	348	14	primary	primary	JJ
46745	348	15	subdivision	subdivision	NN
46745	348	16	those	those	DT
46745	348	17	distinctions	distinction	NNS
46745	348	18	which	which	WDT
46745	348	19	admit	admit	VBP
46745	348	20	of	of	IN
46745	348	21	being	be	VBG
46745	348	22	the	the	DT
46745	348	23	most	most	RBS
46745	348	24	readily	readily	RB
46745	348	25	and	and	CC
46745	348	26	firmly	firmly	RB
46745	348	27	established	establish	VBN
46745	348	28	,	,	,
46745	348	29	and	and	CC
46745	348	30	not	not	RB
46745	348	31	to	to	TO
46745	348	32	rest	rest	VB
46745	348	33	it	-PRON-	PRP
46745	348	34	on	on	IN
46745	348	35	a	a	DT
46745	348	36	number	number	NN
46745	348	37	of	of	IN
46745	348	38	uncertain	uncertain	JJ
46745	348	39	or	or	CC
46745	348	40	questionable	questionable	JJ
46745	348	41	hypotheses	hypothesis	NNS
46745	348	42	.	.	.
46745	349	1	I.	I.	NNP
46745	350	1	OPINIONS	OPINIONS	NNP
46745	350	2	CONCERNING	concern	VBD
46745	350	3	THE	the	DT
46745	350	4	ULTIMATE	ULTIMATE	NNP
46745	350	5	EFFECT	EFFECT	NNP
46745	350	6	OF	of	IN
46745	350	7	MEDICINES	MEDICINES	NNP
46745	350	8	,	,	,
46745	350	9	AND	and	CC
46745	350	10	CLASSIFICATIONS	CLASSIFICATIONS	NNP
46745	350	11	FOUNDED	founded	NN
46745	350	12	ON	on	IN
46745	350	13	THIS	this	DT
46745	350	14	.	.	.
46745	351	1	Most	Most	JJS
46745	351	2	authors	author	NNS
46745	351	3	have	have	VBP
46745	351	4	grouped	group	VBN
46745	351	5	remedies	remedy	NNS
46745	351	6	together	together	RB
46745	351	7	according	accord	VBG
46745	351	8	to	to	IN
46745	351	9	the	the	DT
46745	351	10	broad	broad	JJ
46745	351	11	results	result	NNS
46745	351	12	of	of	IN
46745	351	13	their	-PRON-	PRP$
46745	351	14	action	action	NN
46745	351	15	.	.	.
46745	352	1	They	-PRON-	PRP
46745	352	2	do	do	VBP
46745	352	3	not	not	RB
46745	352	4	make	make	VB
46745	352	5	inquiry	inquiry	NN
46745	352	6	as	as	IN
46745	352	7	to	to	IN
46745	352	8	the	the	DT
46745	352	9	mode	mode	NN
46745	352	10	of	of	IN
46745	352	11	operation	operation	NN
46745	352	12	or	or	CC
46745	352	13	behaviour	behaviour	NN
46745	352	14	of	of	IN
46745	352	15	a	a	DT
46745	352	16	medicine	medicine	NN
46745	352	17	after	after	IN
46745	352	18	passage	passage	NN
46745	352	19	into	into	IN
46745	352	20	the	the	DT
46745	352	21	system	system	NN
46745	352	22	;	;	:
46745	352	23	nor	nor	CC
46745	352	24	do	do	VBP
46745	352	25	they	-PRON-	PRP
46745	352	26	ask	ask	VB
46745	352	27	whether	whether	IN
46745	352	28	this	this	DT
46745	352	29	action	action	NN
46745	352	30	is	be	VBZ
46745	352	31	especially	especially	RB
46745	352	32	directed	direct	VBN
46745	352	33	to	to	IN
46745	352	34	any	any	DT
46745	352	35	organ	organ	NN
46745	352	36	or	or	CC
46745	352	37	tissue	tissue	NN
46745	352	38	;	;	:
46745	352	39	but	but	CC
46745	352	40	they	-PRON-	PRP
46745	352	41	judge	judge	VBP
46745	352	42	by	by	IN
46745	352	43	external	external	JJ
46745	352	44	evidence	evidence	NN
46745	352	45	of	of	IN
46745	352	46	its	-PRON-	PRP$
46745	352	47	ultimate	ultimate	JJ
46745	352	48	effect	effect	NN
46745	352	49	on	on	IN
46745	352	50	the	the	DT
46745	352	51	body	body	NN
46745	352	52	,	,	,
46745	352	53	and	and	CC
46745	352	54	on	on	IN
46745	352	55	the	the	DT
46745	352	56	powers	power	NNS
46745	352	57	of	of	IN
46745	352	58	life	life	NN
46745	352	59	.	.	.
46745	353	1	There	there	EX
46745	353	2	is	be	VBZ
46745	353	3	commonly	commonly	RB
46745	353	4	a	a	DT
46745	353	5	tendency	tendency	NN
46745	353	6	to	to	TO
46745	353	7	describe	describe	VB
46745	353	8	all	all	DT
46745	353	9	medicines	medicine	NNS
46745	353	10	under	under	IN
46745	353	11	two	two	CD
46745	353	12	heads	head	NNS
46745	353	13	,	,	,
46745	353	14	as	as	IN
46745	353	15	either	either	DT
46745	353	16	causing	cause	VBG
46745	353	17	or	or	CC
46745	353	18	diminishing	diminish	VBG
46745	353	19	vital	vital	JJ
46745	353	20	activity	activity	NN
46745	353	21	.	.	.
46745	354	1	Dr.	Dr.	NNP
46745	354	2	Murray	Murray	NNP
46745	354	3	indeed	indeed	RB
46745	354	4	confounds	confound	VBZ
46745	354	5	these	these	DT
46745	354	6	two	two	CD
46745	354	7	effects	effect	NNS
46745	354	8	,	,	,
46745	354	9	and	and	CC
46745	354	10	adopts	adopt	VBZ
46745	354	11	an	an	DT
46745	354	12	idea	idea	NN
46745	354	13	on	on	IN
46745	354	14	this	this	DT
46745	354	15	subject	subject	NN
46745	354	16	which	which	WDT
46745	354	17	was	be	VBD
46745	354	18	originated	originate	VBN
46745	354	19	by	by	IN
46745	354	20	Mr.	Mr.	NNP
46745	354	21	Brown	Brown	NNP
46745	354	22	.	.	.
46745	355	1	I	-PRON-	PRP
46745	355	2	shall	shall	MD
46745	355	3	now	now	RB
46745	355	4	represent	represent	VB
46745	355	5	in	in	IN
46745	355	6	an	an	DT
46745	355	7	abridged	abridge	VBN
46745	355	8	form	form	NN
46745	355	9	the	the	DT
46745	355	10	classifications	classification	NNS
46745	355	11	adopted	adopt	VBN
46745	355	12	severally	severally	RB
46745	355	13	by	by	IN
46745	355	14	Dr.	Dr.	NNP
46745	355	15	Young	Young	NNP
46745	355	16	,	,	,
46745	355	17	Dr.	Dr.	NNP
46745	355	18	Duncan	Duncan	NNP
46745	355	19	,	,	,
46745	355	20	and	and	CC
46745	355	21	Dr.	Dr.	NNP
46745	355	22	Murray	Murray	NNP
46745	355	23	.	.	.
46745	356	1	DR	DR	NNS
46745	356	2	.	.	.
46745	356	3	YOUNG	YOUNG	NNP
46745	356	4	.	.	.
46745	357	1	1	1	LS
46745	357	2	.	.	.
46745	358	1	CHEMICAL	chemical	NN
46745	358	2	AGENTS	agent	NNS
46745	358	3	.	.	.
46745	359	1	Caustics	caustic	NNS
46745	359	2	,	,	,
46745	359	3	etc	etc	FW
46745	359	4	.	.	.
46745	360	1	2	2	LS
46745	360	2	.	.	.
46745	361	1	VITAL	vital	JJ
46745	361	2	AGENTS	agent	NNS
46745	361	3	.	.	.
46745	362	1	A.	A.	NNP
46745	363	1	_	_	NNP
46745	363	2	Supporting	Supporting	NNP
46745	363	3	strength	strength	NN
46745	363	4	.	.	.
46745	363	5	_	_	NNP
46745	363	6	Nutrients	Nutrients	NNP
46745	363	7	.	.	.
46745	364	1	B.	B.	NNP
46745	365	1	_	_	NNP
46745	365	2	Causing	cause	VBG
46745	365	3	action	action	NN
46745	365	4	.	.	.
46745	365	5	_	_	NNP
46745	365	6	(	(	-LRB-
46745	365	7	Partial	partial	JJ
46745	365	8	and	and	CC
46745	365	9	transitory	transitory	JJ
46745	365	10	.	.	.
46745	365	11	)	)	-RRB-
46745	366	1	Stimulants	stimulant	NNS
46745	366	2	,	,	,
46745	366	3	Irritants	Irritants	NNPS
46745	366	4	,	,	,
46745	366	5	Astringents	Astringents	NNPS
46745	366	6	,	,	,
46745	366	7	Alteratives	Alteratives	NNPS
46745	366	8	,	,	,
46745	366	9	Evacuants	Evacuants	NNPS
46745	366	10	.	.	.
46745	367	1	(	(	-LRB-
46745	367	2	Permanent	permanent	JJ
46745	367	3	.	.	.
46745	367	4	)	)	-RRB-
46745	368	1	Tonics	tonic	NNS
46745	368	2	.	.	.
46745	369	1	C.	C.	NNP
46745	369	2	_	_	NNP
46745	369	3	Diminishing	diminish	VBG
46745	369	4	action	action	NN
46745	369	5	or	or	CC
46745	369	6	sensation	sensation	NN
46745	369	7	.	.	.
46745	369	8	_	_	NNP
46745	369	9	(	(	-LRB-
46745	369	10	Primarily	Primarily	NNP
46745	369	11	.	.	.
46745	369	12	)	)	-RRB-
46745	370	1	Narcotics	narcotic	NNS
46745	370	2	,	,	,
46745	370	3	Nauseants	Nauseants	NNPS
46745	370	4	,	,	,
46745	370	5	Sedatives	Sedatives	NNPS
46745	370	6	,	,	,
46745	370	7	Diaphoretics	Diaphoretics	NNP
46745	370	8	.	.	.
46745	371	1	(	(	-LRB-
46745	371	2	Secondarily	Secondarily	NNP
46745	371	3	.	.	.
46745	371	4	)	)	-RRB-
46745	372	1	Exhaurients	exhaurient	NNS
46745	372	2	.	.	.
46745	373	1	3	3	LS
46745	373	2	.	.	.
46745	374	1	INSENSIBLE	insensible	JJ
46745	374	2	AGENTS	agent	NNS
46745	374	3	.	.	.
46745	375	1	Specifics	specific	NNS
46745	375	2	.	.	.
46745	376	1	In	in	IN
46745	376	2	the	the	DT
46745	376	3	names	name	NNS
46745	376	4	of	of	IN
46745	376	5	these	these	DT
46745	376	6	three	three	CD
46745	376	7	classes	class	NNS
46745	376	8	some	some	DT
46745	376	9	reference	reference	NN
46745	376	10	is	be	VBZ
46745	376	11	made	make	VBN
46745	376	12	to	to	IN
46745	376	13	the	the	DT
46745	376	14	_	_	NNP
46745	376	15	modus	modus	NN
46745	376	16	operandi	operandi	NNP
46745	376	17	_	_	NNP
46745	376	18	of	of	IN
46745	376	19	medicines	medicine	NNS
46745	376	20	,	,	,
46745	376	21	but	but	CC
46745	376	22	the	the	DT
46745	376	23	distinctions	distinction	NNS
46745	376	24	thus	thus	RB
46745	376	25	attempted	attempt	VBD
46745	376	26	to	to	TO
46745	376	27	be	be	VB
46745	376	28	drawn	draw	VBN
46745	376	29	are	be	VBP
46745	376	30	of	of	IN
46745	376	31	the	the	DT
46745	376	32	slenderest	slender	JJS
46745	376	33	possible	possible	JJ
46745	376	34	description	description	NN
46745	376	35	.	.	.
46745	377	1	Among	among	IN
46745	377	2	_	_	NNP
46745	377	3	chemical	chemical	NN
46745	377	4	_	_	NNP
46745	377	5	agents	agent	NNS
46745	377	6	are	be	VBP
46745	377	7	included	include	VBN
46745	377	8	some	some	DT
46745	377	9	that	that	WDT
46745	377	10	are	be	VBP
46745	377	11	applied	apply	VBN
46745	377	12	externally	externally	RB
46745	377	13	,	,	,
46745	377	14	and	and	CC
46745	377	15	act	act	VBP
46745	377	16	then	then	RB
46745	377	17	on	on	IN
46745	377	18	the	the	DT
46745	377	19	tissues	tissue	NNS
46745	377	20	in	in	IN
46745	377	21	obedience	obedience	NN
46745	377	22	to	to	TO
46745	377	23	known	known	VB
46745	377	24	chemical	chemical	NN
46745	377	25	laws	law	NNS
46745	377	26	.	.	.
46745	378	1	But	but	CC
46745	378	2	how	how	WRB
46745	378	3	can	can	MD
46745	378	4	we	-PRON-	PRP
46745	378	5	affirm	affirm	VB
46745	378	6	that	that	IN
46745	378	7	some	some	DT
46745	378	8	medicines	medicine	NNS
46745	378	9	passing	pass	VBG
46745	378	10	into	into	IN
46745	378	11	the	the	DT
46745	378	12	stomach	stomach	NN
46745	378	13	may	may	MD
46745	378	14	not	not	RB
46745	378	15	operate	operate	VB
46745	378	16	chemically	chemically	RB
46745	378	17	?	?	.
46745	379	1	The	the	DT
46745	379	2	term	term	NN
46745	379	3	_	_	NNP
46745	379	4	vital	vital	JJ
46745	379	5	_	_	NNP
46745	379	6	signifies	signifie	NNS
46745	379	7	little	little	JJ
46745	379	8	;	;	:
46745	379	9	and	and	CC
46745	379	10	the	the	DT
46745	379	11	word	word	NN
46745	379	12	_	_	NNP
46745	379	13	insensible	insensible	JJ
46745	379	14	_	_	NNP
46745	379	15	,	,	,
46745	379	16	applied	apply	VBD
46745	379	17	to	to	IN
46745	379	18	the	the	DT
46745	379	19	third	third	JJ
46745	379	20	class	class	NN
46745	379	21	,	,	,
46745	379	22	is	be	VBZ
46745	379	23	a	a	DT
46745	379	24	confession	confession	NN
46745	379	25	of	of	IN
46745	379	26	absolute	absolute	JJ
46745	379	27	ignorance	ignorance	NN
46745	379	28	.	.	.
46745	380	1	It	-PRON-	PRP
46745	380	2	does	do	VBZ
46745	380	3	not	not	RB
46745	380	4	attach	attach	VB
46745	380	5	to	to	IN
46745	380	6	a	a	DT
46745	380	7	medicine	medicine	NN
46745	380	8	any	any	DT
46745	380	9	distinctive	distinctive	JJ
46745	380	10	character	character	NN
46745	380	11	to	to	TO
46745	380	12	say	say	VB
46745	380	13	that	that	IN
46745	380	14	we	-PRON-	PRP
46745	380	15	know	know	VBP
46745	380	16	nothing	nothing	NN
46745	380	17	of	of	IN
46745	380	18	its	-PRON-	PRP$
46745	380	19	operation	operation	NN
46745	380	20	.	.	.
46745	381	1	Pursuing	pursue	VBG
46745	381	2	the	the	DT
46745	381	3	subdivision	subdivision	NN
46745	381	4	further	further	RB
46745	381	5	,	,	,
46745	381	6	we	-PRON-	PRP
46745	381	7	find	find	VBP
46745	381	8	that	that	IN
46745	381	9	the	the	DT
46745	381	10	distinctions	distinction	NNS
46745	381	11	are	be	VBP
46745	381	12	not	not	RB
46745	381	13	well	well	RB
46745	381	14	maintained	maintain	VBN
46745	381	15	.	.	.
46745	382	1	Tonics	tonic	NNS
46745	382	2	support	support	VBP
46745	382	3	strength	strength	NN
46745	382	4	as	as	RB
46745	382	5	well	well	RB
46745	382	6	as	as	IN
46745	382	7	cause	cause	NN
46745	382	8	action	action	NN
46745	382	9	;	;	:
46745	382	10	and	and	CC
46745	382	11	it	-PRON-	PRP
46745	382	12	can	can	MD
46745	382	13	hardly	hardly	RB
46745	382	14	be	be	VB
46745	382	15	said	say	VBN
46745	382	16	that	that	IN
46745	382	17	the	the	DT
46745	382	18	action	action	NN
46745	382	19	of	of	IN
46745	382	20	an	an	DT
46745	382	21	Alterative	Alterative	NNP
46745	382	22	,	,	,
46745	382	23	such	such	JJ
46745	382	24	as	as	IN
46745	382	25	mercury	mercury	NN
46745	382	26	,	,	,
46745	382	27	is	be	VBZ
46745	382	28	partial	partial	JJ
46745	382	29	and	and	CC
46745	382	30	transitory	transitory	JJ
46745	382	31	.	.	.
46745	383	1	It	-PRON-	PRP
46745	383	2	seems	seem	VBZ
46745	383	3	unwise	unwise	JJ
46745	383	4	to	to	TO
46745	383	5	have	have	VB
46745	383	6	made	make	VBN
46745	383	7	a	a	DT
46745	383	8	separate	separate	JJ
46745	383	9	class	class	NN
46745	383	10	of	of	IN
46745	383	11	Specifics	Specifics	NNPS
46745	383	12	.	.	.
46745	384	1	They	-PRON-	PRP
46745	384	2	are	be	VBP
46745	384	3	especially	especially	RB
46745	384	4	associated	associate	VBN
46745	384	5	with	with	IN
46745	384	6	Alteratives	alterative	NNS
46745	384	7	.	.	.
46745	385	1	Mercury	Mercury	NNP
46745	385	2	,	,	,
46745	385	3	Iodine	Iodine	NNP
46745	385	4	,	,	,
46745	385	5	and	and	CC
46745	385	6	others	other	NNS
46745	385	7	,	,	,
46745	385	8	would	would	MD
46745	385	9	fall	fall	VB
46745	385	10	under	under	IN
46745	385	11	both	both	DT
46745	385	12	groups	group	NNS
46745	385	13	.	.	.
46745	386	1	Of	of	IN
46745	386	2	Evacuants	evacuant	NNS
46745	386	3	it	-PRON-	PRP
46745	386	4	may	may	MD
46745	386	5	be	be	VB
46745	386	6	observed	observe	VBN
46745	386	7	,	,	,
46745	386	8	that	that	IN
46745	386	9	they	-PRON-	PRP
46745	386	10	are	be	VBP
46745	386	11	also	also	RB
46745	386	12	Exhaurient	Exhaurient	NNP
46745	386	13	,	,	,
46745	386	14	and	and	CC
46745	386	15	thus	thus	RB
46745	386	16	included	include	VBN
46745	386	17	in	in	IN
46745	386	18	two	two	CD
46745	386	19	opposed	oppose	VBN
46745	386	20	classes	class	NNS
46745	386	21	;	;	:
46745	386	22	that	that	IN
46745	386	23	their	-PRON-	PRP$
46745	386	24	action	action	NN
46745	386	25	is	be	VBZ
46745	386	26	not	not	RB
46745	386	27	always	always	RB
46745	386	28	partial	partial	JJ
46745	386	29	and	and	CC
46745	386	30	transitory	transitory	JJ
46745	386	31	,	,	,
46745	386	32	as	as	IN
46745	386	33	,	,	,
46745	386	34	for	for	IN
46745	386	35	example	example	NN
46745	386	36	,	,	,
46745	386	37	Purgatives	purgative	NNS
46745	386	38	may	may	MD
46745	386	39	permanently	permanently	RB
46745	386	40	remedy	remedy	VB
46745	386	41	constipation	constipation	NN
46745	386	42	;	;	:
46745	386	43	and	and	CC
46745	386	44	that	that	IN
46745	386	45	it	-PRON-	PRP
46745	386	46	seems	seem	VBZ
46745	386	47	wrong	wrong	JJ
46745	386	48	to	to	TO
46745	386	49	have	have	VB
46745	386	50	separated	separate	VBN
46745	386	51	Diaphoretics	diaphoretic	NNS
46745	386	52	from	from	IN
46745	386	53	them	-PRON-	PRP
46745	386	54	.	.	.
46745	387	1	Thus	thus	RB
46745	387	2	neither	neither	CC
46745	387	3	the	the	DT
46745	387	4	primary	primary	JJ
46745	387	5	nor	nor	CC
46745	387	6	the	the	DT
46745	387	7	secondary	secondary	JJ
46745	387	8	subdivisions	subdivision	NNS
46745	387	9	of	of	IN
46745	387	10	this	this	DT
46745	387	11	arrangement	arrangement	NN
46745	387	12	can	can	MD
46745	387	13	be	be	VB
46745	387	14	reasonably	reasonably	RB
46745	387	15	maintained	maintain	VBN
46745	387	16	in	in	IN
46745	387	17	theory	theory	NN
46745	387	18	,	,	,
46745	387	19	and	and	CC
46745	387	20	we	-PRON-	PRP
46745	387	21	must	must	MD
46745	387	22	fall	fall	VB
46745	387	23	back	back	RB
46745	387	24	on	on	IN
46745	387	25	the	the	DT
46745	387	26	ultimate	ultimate	JJ
46745	387	27	groups	group	NNS
46745	387	28	which	which	WDT
46745	387	29	are	be	VBP
46745	387	30	based	base	VBN
46745	387	31	upon	upon	IN
46745	387	32	common	common	JJ
46745	387	33	experience	experience	NN
46745	387	34	.	.	.
46745	388	1	From	from	IN
46745	388	2	this	this	DT
46745	388	3	failure	failure	NN
46745	388	4	we	-PRON-	PRP
46745	388	5	may	may	MD
46745	388	6	infer	infer	VB
46745	388	7	that	that	IN
46745	388	8	the	the	DT
46745	388	9	idea	idea	NN
46745	388	10	that	that	WDT
46745	388	11	medicines	medicine	NNS
46745	388	12	differ	differ	VBP
46745	388	13	prominently	prominently	RB
46745	388	14	in	in	IN
46745	388	15	causing	cause	VBG
46745	388	16	or	or	CC
46745	388	17	diminishing	diminish	VBG
46745	388	18	vital	vital	JJ
46745	388	19	activity	activity	NN
46745	388	20	,	,	,
46745	388	21	upon	upon	IN
46745	388	22	which	which	WDT
46745	388	23	idea	idea	NN
46745	388	24	this	this	DT
46745	388	25	and	and	CC
46745	388	26	many	many	JJ
46745	388	27	other	other	JJ
46745	388	28	arrangements	arrangement	NNS
46745	388	29	are	be	VBP
46745	388	30	founded	found	VBN
46745	388	31	,	,	,
46745	388	32	is	be	VBZ
46745	388	33	in	in	IN
46745	388	34	fact	fact	NN
46745	388	35	an	an	DT
46745	388	36	erroneous	erroneous	JJ
46745	388	37	one	one	NN
46745	388	38	.	.	.
46745	389	1	There	there	EX
46745	389	2	is	be	VBZ
46745	389	3	no	no	DT
46745	389	4	such	such	JJ
46745	389	5	universal	universal	JJ
46745	389	6	distinction	distinction	NN
46745	389	7	.	.	.
46745	390	1	A	a	DT
46745	390	2	medicine	medicine	NN
46745	390	3	which	which	WDT
46745	390	4	at	at	IN
46745	390	5	one	one	CD
46745	390	6	time	time	NN
46745	390	7	raises	raise	VBZ
46745	390	8	or	or	CC
46745	390	9	excites	excite	VBZ
46745	390	10	the	the	DT
46745	390	11	vital	vital	JJ
46745	390	12	forces	force	NNS
46745	390	13	,	,	,
46745	390	14	may	may	MD
46745	390	15	at	at	IN
46745	390	16	another	another	DT
46745	390	17	time	time	NN
46745	390	18	depress	depress	VB
46745	390	19	them	-PRON-	PRP
46745	390	20	;	;	:
46745	390	21	it	-PRON-	PRP
46745	390	22	may	may	MD
46745	390	23	do	do	VB
46745	390	24	one	one	CD
46745	390	25	thing	thing	NN
46745	390	26	with	with	IN
46745	390	27	a	a	DT
46745	390	28	sick	sick	JJ
46745	390	29	man	man	NN
46745	390	30	,	,	,
46745	390	31	the	the	DT
46745	390	32	other	other	JJ
46745	390	33	thing	thing	NN
46745	390	34	with	with	IN
46745	390	35	a	a	DT
46745	390	36	healthy	healthy	JJ
46745	390	37	man	man	NN
46745	390	38	;	;	:
46745	390	39	it	-PRON-	PRP
46745	390	40	may	may	MD
46745	390	41	have	have	VB
46745	390	42	the	the	DT
46745	390	43	one	one	CD
46745	390	44	effect	effect	NN
46745	390	45	when	when	WRB
46745	390	46	taken	take	VBN
46745	390	47	for	for	IN
46745	390	48	a	a	DT
46745	390	49	short	short	JJ
46745	390	50	time	time	NN
46745	390	51	in	in	IN
46745	390	52	moderation	moderation	NN
46745	390	53	,	,	,
46745	390	54	the	the	DT
46745	390	55	other	other	JJ
46745	390	56	effect	effect	NN
46745	390	57	when	when	WRB
46745	390	58	taken	take	VBN
46745	390	59	for	for	IN
46745	390	60	a	a	DT
46745	390	61	long	long	JJ
46745	390	62	time	time	NN
46745	390	63	or	or	CC
46745	390	64	in	in	IN
46745	390	65	excess	excess	NN
46745	390	66	.	.	.
46745	391	1	In	in	IN
46745	391	2	fine	fine	JJ
46745	391	3	,	,	,
46745	391	4	the	the	DT
46745	391	5	result	result	NN
46745	391	6	of	of	IN
46745	391	7	the	the	DT
46745	391	8	operation	operation	NN
46745	391	9	of	of	IN
46745	391	10	a	a	DT
46745	391	11	medicine	medicine	NN
46745	391	12	does	do	VBZ
46745	391	13	not	not	RB
46745	391	14	necessarily	necessarily	RB
46745	391	15	depend	depend	VB
46745	391	16	upon	upon	IN
46745	391	17	this	this	DT
46745	391	18	alternative	alternative	NN
46745	391	19	.	.	.
46745	392	1	Although	although	IN
46745	392	2	there	there	EX
46745	392	3	are	be	VBP
46745	392	4	undoubtedly	undoubtedly	RB
46745	392	5	some	some	DT
46745	392	6	medicines	medicine	NNS
46745	392	7	which	which	WDT
46745	392	8	tend	tend	VBP
46745	392	9	to	to	TO
46745	392	10	stimulate	stimulate	VB
46745	392	11	the	the	DT
46745	392	12	nervous	nervous	JJ
46745	392	13	forces	force	NNS
46745	392	14	,	,	,
46745	392	15	and	and	CC
46745	392	16	others	other	NNS
46745	392	17	which	which	WDT
46745	392	18	tend	tend	VBP
46745	392	19	to	to	TO
46745	392	20	depress	depress	VB
46745	392	21	them	-PRON-	PRP
46745	392	22	,	,	,
46745	392	23	yet	yet	CC
46745	392	24	as	as	IN
46745	392	25	there	there	EX
46745	392	26	are	be	VBP
46745	392	27	many	many	JJ
46745	392	28	remedies	remedy	NNS
46745	392	29	which	which	WDT
46745	392	30	may	may	MD
46745	392	31	operate	operate	VB
46745	392	32	well	well	RB
46745	392	33	without	without	IN
46745	392	34	doing	do	VBG
46745	392	35	either	either	CC
46745	392	36	the	the	DT
46745	392	37	one	one	CD
46745	392	38	or	or	CC
46745	392	39	the	the	DT
46745	392	40	other	other	JJ
46745	392	41	,	,	,
46745	392	42	and	and	CC
46745	392	43	whose	whose	WP$
46745	392	44	operation	operation	NN
46745	392	45	does	do	VBZ
46745	392	46	not	not	RB
46745	392	47	depend	depend	VB
46745	392	48	at	at	RB
46745	392	49	all	all	RB
46745	392	50	upon	upon	IN
46745	392	51	this	this	DT
46745	392	52	,	,	,
46745	392	53	the	the	DT
46745	392	54	distinction	distinction	NN
46745	392	55	can	can	MD
46745	392	56	not	not	RB
46745	392	57	be	be	VB
46745	392	58	generally	generally	RB
46745	392	59	applied	apply	VBN
46745	392	60	.	.	.
46745	393	1	The	the	DT
46745	393	2	next	next	JJ
46745	393	3	arrangement	arrangement	NN
46745	393	4	,	,	,
46745	393	5	that	that	DT
46745	393	6	of	of	IN
46745	393	7	Dr.	Dr.	NNP
46745	393	8	Duncan	Duncan	NNP
46745	393	9	,	,	,
46745	393	10	appears	appear	VBZ
46745	393	11	,	,	,
46745	393	12	as	as	RB
46745	393	13	far	far	RB
46745	393	14	as	as	IN
46745	393	15	it	-PRON-	PRP
46745	393	16	extends	extend	VBZ
46745	393	17	,	,	,
46745	393	18	to	to	TO
46745	393	19	be	be	VB
46745	393	20	correct	correct	JJ
46745	393	21	in	in	IN
46745	393	22	theory	theory	NN
46745	393	23	.	.	.
46745	394	1	If	if	IN
46745	394	2	some	some	DT
46745	394	3	additions	addition	NNS
46745	394	4	were	be	VBD
46745	394	5	made	make	VBN
46745	394	6	to	to	IN
46745	394	7	it	-PRON-	PRP
46745	394	8	,	,	,
46745	394	9	it	-PRON-	PRP
46745	394	10	would	would	MD
46745	394	11	be	be	VB
46745	394	12	a	a	DT
46745	394	13	tolerably	tolerably	RB
46745	394	14	perfect	perfect	JJ
46745	394	15	classification	classification	NN
46745	394	16	of	of	IN
46745	394	17	this	this	DT
46745	394	18	kind	kind	NN
46745	394	19	.	.	.
46745	395	1	Assuming	assume	VBG
46745	395	2	as	as	IN
46745	395	3	a	a	DT
46745	395	4	basis	basis	NN
46745	395	5	the	the	DT
46745	395	6	ultimate	ultimate	JJ
46745	395	7	or	or	CC
46745	395	8	practical	practical	JJ
46745	395	9	effect	effect	NN
46745	395	10	of	of	IN
46745	395	11	medicines	medicine	NNS
46745	395	12	,	,	,
46745	395	13	we	-PRON-	PRP
46745	395	14	may	may	MD
46745	395	15	proceed	proceed	VB
46745	395	16	to	to	TO
46745	395	17	divide	divide	VB
46745	395	18	them	-PRON-	PRP
46745	395	19	into	into	IN
46745	395	20	groups	group	NNS
46745	395	21	in	in	IN
46745	395	22	a	a	DT
46745	395	23	natural	natural	JJ
46745	395	24	way	way	NN
46745	395	25	.	.	.
46745	396	1	Food	food	NN
46745	396	2	and	and	CC
46745	396	3	liquids	liquid	NNS
46745	396	4	are	be	VBP
46745	396	5	of	of	IN
46745	396	6	use	use	NN
46745	396	7	in	in	IN
46745	396	8	the	the	DT
46745	396	9	nutrition	nutrition	NN
46745	396	10	of	of	IN
46745	396	11	the	the	DT
46745	396	12	tissues	tissue	NNS
46745	396	13	,	,	,
46745	396	14	and	and	CC
46745	396	15	will	will	MD
46745	396	16	form	form	VB
46745	396	17	the	the	DT
46745	396	18	first	first	JJ
46745	396	19	class	class	NN
46745	396	20	.	.	.
46745	397	1	A	a	DT
46745	397	2	second	second	JJ
46745	397	3	set	set	NN
46745	397	4	of	of	IN
46745	397	5	substances	substance	NNS
46745	397	6	act	act	VBP
46745	397	7	so	so	IN
46745	397	8	as	as	IN
46745	397	9	to	to	TO
46745	397	10	expel	expel	VB
46745	397	11	from	from	IN
46745	397	12	the	the	DT
46745	397	13	body	body	NN
46745	397	14	certain	certain	JJ
46745	397	15	humours	humour	NNS
46745	397	16	and	and	CC
46745	397	17	secretions	secretion	NNS
46745	397	18	.	.	.
46745	398	1	Another	another	DT
46745	398	2	class	class	NN
46745	398	3	exalt	exalt	VBP
46745	398	4	the	the	DT
46745	398	5	tone	tone	NN
46745	398	6	of	of	IN
46745	398	7	the	the	DT
46745	398	8	nervous	nervous	JJ
46745	398	9	system	system	NN
46745	398	10	,	,	,
46745	398	11	and	and	CC
46745	398	12	through	through	IN
46745	398	13	it	-PRON-	PRP
46745	398	14	stimulate	stimulate	VBP
46745	398	15	the	the	DT
46745	398	16	system	system	NN
46745	398	17	at	at	IN
46745	398	18	large	large	JJ
46745	398	19	.	.	.
46745	399	1	A	a	DT
46745	399	2	fourth	fourth	JJ
46745	399	3	set	set	NN
46745	399	4	depress	depress	NN
46745	399	5	the	the	DT
46745	399	6	same	same	JJ
46745	399	7	.	.	.
46745	400	1	And	and	CC
46745	400	2	a	a	DT
46745	400	3	fifth	fifth	JJ
46745	400	4	group	group	NN
46745	400	5	do	do	VBP
46745	400	6	none	none	NN
46745	400	7	of	of	IN
46745	400	8	these	these	DT
46745	400	9	things	thing	NNS
46745	400	10	;	;	:
46745	400	11	but	but	CC
46745	400	12	their	-PRON-	PRP$
46745	400	13	action	action	NN
46745	400	14	results	result	NNS
46745	400	15	in	in	IN
46745	400	16	certain	certain	JJ
46745	400	17	obvious	obvious	JJ
46745	400	18	changes	change	NNS
46745	400	19	in	in	IN
46745	400	20	the	the	DT
46745	400	21	chemical	chemical	NN
46745	400	22	nature	nature	NN
46745	400	23	of	of	IN
46745	400	24	the	the	DT
46745	400	25	secretions	secretion	NNS
46745	400	26	.	.	.
46745	401	1	DR	DR	NNP
46745	401	2	.	.	.
46745	401	3	DUNCAN	DUNCAN	NNP
46745	401	4	.	.	.
46745	402	1	ALIMENTA	ALIMENTA	NNP
46745	402	2	.	.	.
46745	403	1	Diluentia	Diluentia	NNP
46745	403	2	,	,	,
46745	403	3	Demulcentia	Demulcentia	NNP
46745	403	4	.	.	.
46745	404	1	EVACUANTIA	EVACUANTIA	NNS
46745	404	2	.	.	.
46745	405	1	Diaphoretica	Diaphoretica	NNP
46745	405	2	,	,	,
46745	405	3	Errhina	Errhina	NNP
46745	405	4	,	,	,
46745	405	5	Expectorantia	Expectorantia	NNP
46745	405	6	,	,	,
46745	405	7	Cathartica	Cathartica	NNP
46745	405	8	,	,	,
46745	405	9	etc	etc	FW
46745	405	10	.	.	.
46745	406	1	STIMULANTIA	STIMULANTIA	NNP
46745	406	2	.	.	.
46745	407	1	Topica	Topica	NNP
46745	407	2	(	(	-LRB-
46745	407	3	irritants	irritant	NNS
46745	407	4	,	,	,
46745	407	5	etc	etc	FW
46745	407	6	.	.	.
46745	407	7	)	)	-RRB-
46745	408	1	Generalia	generalia	JJ
46745	408	2	permanentia	permanentia	NN
46745	408	3	.	.	.
46745	409	1	Generalia	Generalia	NNP
46745	409	2	transitoria	transitoria	NN
46745	409	3	.	.	.
46745	410	1	DEPRIMENTIA	DEPRIMENTIA	NNP
46745	410	2	.	.	.
46745	411	1	Refrigerantia	Refrigerantia	NNP
46745	411	2	,	,	,
46745	411	3	Narcotica	Narcotica	NNP
46745	411	4	.	.	.
46745	412	1	CHEMICA	CHEMICA	NNP
46745	412	2	.	.	.
46745	413	1	Acida	Acida	NNP
46745	413	2	,	,	,
46745	413	3	Alkalina	Alkalina	NNP
46745	413	4	.	.	.
46745	414	1	As	as	RB
46745	414	2	far	far	RB
46745	414	3	as	as	IN
46745	414	4	it	-PRON-	PRP
46745	414	5	extends	extend	VBZ
46745	414	6	,	,	,
46745	414	7	this	this	DT
46745	414	8	classification	classification	NN
46745	414	9	seems	seem	VBZ
46745	414	10	to	to	TO
46745	414	11	be	be	VB
46745	414	12	founded	found	VBN
46745	414	13	on	on	IN
46745	414	14	correct	correct	JJ
46745	414	15	data	datum	NNS
46745	414	16	.	.	.
46745	415	1	The	the	DT
46745	415	2	smaller	small	JJR
46745	415	3	divisions	division	NNS
46745	415	4	are	be	VBP
46745	415	5	natural	natural	JJ
46745	415	6	.	.	.
46745	416	1	Thus	thus	RB
46745	416	2	Evacuants	evacuant	NNS
46745	416	3	are	be	VBP
46745	416	4	grouped	group	VBN
46745	416	5	according	accord	VBG
46745	416	6	to	to	IN
46745	416	7	the	the	DT
46745	416	8	part	part	NN
46745	416	9	of	of	IN
46745	416	10	the	the	DT
46745	416	11	system	system	NN
46745	416	12	at	at	IN
46745	416	13	which	which	WDT
46745	416	14	the	the	DT
46745	416	15	evacuation	evacuation	NN
46745	416	16	is	be	VBZ
46745	416	17	made	make	VBN
46745	416	18	.	.	.
46745	417	1	General	General	NNP
46745	417	2	Stimulants	Stimulants	NNP
46745	417	3	are	be	VBP
46745	417	4	divided	divide	VBN
46745	417	5	into	into	IN
46745	417	6	those	those	DT
46745	417	7	which	which	WDT
46745	417	8	are	be	VBP
46745	417	9	transitory	transitory	JJ
46745	417	10	in	in	IN
46745	417	11	action	action	NN
46745	417	12	,	,	,
46745	417	13	and	and	CC
46745	417	14	those	those	DT
46745	417	15	whose	whose	WP$
46745	417	16	effect	effect	NN
46745	417	17	is	be	VBZ
46745	417	18	permanent	permanent	JJ
46745	417	19	,	,	,
46745	417	20	as	as	IN
46745	417	21	Tonics	Tonics	NNP
46745	417	22	.	.	.
46745	418	1	Dr.	Dr.	NNP
46745	418	2	Duncan	Duncan	NNP
46745	418	3	is	be	VBZ
46745	418	4	concerned	concern	VBN
46745	418	5	only	only	RB
46745	418	6	with	with	IN
46745	418	7	the	the	DT
46745	418	8	ultimate	ultimate	JJ
46745	418	9	effect	effect	NN
46745	418	10	,	,	,
46745	418	11	and	and	CC
46745	418	12	enters	enter	VBZ
46745	418	13	into	into	IN
46745	418	14	no	no	DT
46745	418	15	theory	theory	NN
46745	418	16	respecting	respect	VBG
46745	418	17	the	the	DT
46745	418	18	action	action	NN
46745	418	19	of	of	IN
46745	418	20	Tonics	Tonics	NNP
46745	418	21	.	.	.
46745	419	1	I	-PRON-	PRP
46745	419	2	regard	regard	VBP
46745	419	3	them	-PRON-	PRP
46745	419	4	as	as	IN
46745	419	5	medicines	medicine	NNS
46745	419	6	acting	act	VBG
46745	419	7	primarily	primarily	RB
46745	419	8	in	in	IN
46745	419	9	the	the	DT
46745	419	10	blood	blood	NN
46745	419	11	,	,	,
46745	419	12	and	and	CC
46745	419	13	,	,	,
46745	419	14	applying	apply	VBG
46745	419	15	my	-PRON-	PRP$
46745	419	16	terms	term	NNS
46745	419	17	with	with	IN
46745	419	18	a	a	DT
46745	419	19	view	view	NN
46745	419	20	to	to	IN
46745	419	21	the	the	DT
46745	419	22	_	_	NNP
46745	419	23	modus	modus	NN
46745	419	24	operandi	operandi	NNP
46745	419	25	_	_	NNP
46745	419	26	,	,	,
46745	419	27	I	-PRON-	PRP
46745	419	28	would	would	MD
46745	419	29	restrict	restrict	VB
46745	419	30	the	the	DT
46745	419	31	term	term	NN
46745	419	32	Stimulant	stimulant	JJ
46745	419	33	to	to	IN
46745	419	34	medicines	medicine	NNS
46745	419	35	acting	act	VBG
46745	419	36	on	on	IN
46745	419	37	the	the	DT
46745	419	38	nerves	nerve	NNS
46745	419	39	,	,	,
46745	419	40	whose	whose	WP$
46745	419	41	effect	effect	NN
46745	419	42	is	be	VBZ
46745	419	43	transitory	transitory	JJ
46745	419	44	.	.	.
46745	420	1	The	the	DT
46745	420	2	great	great	JJ
46745	420	3	fault	fault	NN
46745	420	4	of	of	IN
46745	420	5	this	this	DT
46745	420	6	arrangement	arrangement	NN
46745	420	7	is	be	VBZ
46745	420	8	the	the	DT
46745	420	9	omission	omission	NN
46745	420	10	of	of	IN
46745	420	11	the	the	DT
46745	420	12	very	very	RB
46745	420	13	important	important	JJ
46745	420	14	class	class	NN
46745	420	15	of	of	IN
46745	420	16	Alteratives	Alteratives	NNPS
46745	420	17	.	.	.
46745	421	1	We	-PRON-	PRP
46745	421	2	have	have	VBP
46745	421	3	medicines	medicine	NNS
46745	421	4	which	which	WDT
46745	421	5	increase	increase	VBP
46745	421	6	secretion	secretion	NN
46745	421	7	;	;	:
46745	421	8	medicines	medicine	NNS
46745	421	9	which	which	WDT
46745	421	10	exalt	exalt	VBP
46745	421	11	or	or	CC
46745	421	12	diminish	diminish	VB
46745	421	13	the	the	DT
46745	421	14	vital	vital	JJ
46745	421	15	energy	energy	NN
46745	421	16	;	;	:
46745	421	17	but	but	CC
46745	421	18	where	where	WRB
46745	421	19	are	be	VBP
46745	421	20	the	the	DT
46745	421	21	remedies	remedy	NNS
46745	421	22	which	which	WDT
46745	421	23	act	act	VBP
46745	421	24	in	in	IN
46745	421	25	the	the	DT
46745	421	26	blood	blood	NN
46745	421	27	?	?	.
46745	422	1	Where	where	WRB
46745	422	2	,	,	,
46745	422	3	for	for	IN
46745	422	4	example	example	NN
46745	422	5	,	,	,
46745	422	6	shall	shall	MD
46745	422	7	we	-PRON-	PRP
46745	422	8	place	place	VB
46745	422	9	such	such	JJ
46745	422	10	medicines	medicine	NNS
46745	422	11	as	as	IN
46745	422	12	Mercury	Mercury	NNP
46745	422	13	,	,	,
46745	422	14	Arsenic	Arsenic	NNP
46745	422	15	,	,	,
46745	422	16	and	and	CC
46745	422	17	Iodine	Iodine	NNP
46745	422	18	,	,	,
46745	422	19	which	which	WDT
46745	422	20	neither	neither	DT
46745	422	21	act	act	VBP
46745	422	22	by	by	IN
46745	422	23	eliminating	eliminate	VBG
46745	422	24	,	,	,
46745	422	25	nor	nor	CC
46745	422	26	by	by	IN
46745	422	27	stimulating	stimulate	VBG
46745	422	28	,	,	,
46745	422	29	nor	nor	CC
46745	422	30	by	by	IN
46745	422	31	depressing	depress	VBG
46745	422	32	,	,	,
46745	422	33	but	but	CC
46745	422	34	appear	appear	VB
46745	422	35	to	to	TO
46745	422	36	counteract	counteract	VB
46745	422	37	in	in	IN
46745	422	38	the	the	DT
46745	422	39	blood	blood	NN
46745	422	40	the	the	DT
46745	422	41	agency	agency	NN
46745	422	42	of	of	IN
46745	422	43	certain	certain	JJ
46745	422	44	morbid	morbid	NN
46745	422	45	poisons	poison	NNS
46745	422	46	?	?	.
46745	423	1	In	in	IN
46745	423	2	an	an	DT
46745	423	3	arrangement	arrangement	NN
46745	423	4	founded	found	VBN
46745	423	5	on	on	IN
46745	423	6	ultimate	ultimate	JJ
46745	423	7	effect	effect	NN
46745	423	8	,	,	,
46745	423	9	they	-PRON-	PRP
46745	423	10	should	should	MD
46745	423	11	be	be	VB
46745	423	12	grouped	group	VBN
46745	423	13	in	in	IN
46745	423	14	a	a	DT
46745	423	15	class	class	NN
46745	423	16	as	as	IN
46745	423	17	Alteratives	Alteratives	NNPS
46745	423	18	,	,	,
46745	423	19	as	as	IN
46745	423	20	medicines	medicine	NNS
46745	423	21	which	which	WDT
46745	423	22	result	result	VBP
46745	423	23	in	in	IN
46745	423	24	_	_	NNP
46745	423	25	altering	alter	VBG
46745	423	26	_	_	NNP
46745	423	27	for	for	IN
46745	423	28	the	the	DT
46745	423	29	better	well	JJR
46745	423	30	the	the	DT
46745	423	31	condition	condition	NN
46745	423	32	of	of	IN
46745	423	33	the	the	DT
46745	423	34	system	system	NN
46745	423	35	.	.	.
46745	424	1	Both	both	CC
46745	424	2	Dr.	Dr.	NNP
46745	424	3	Duncan	Duncan	NNP
46745	424	4	and	and	CC
46745	424	5	Dr.	Dr.	NNP
46745	424	6	Murray	Murray	NNP
46745	424	7	seem	seem	VBP
46745	424	8	to	to	TO
46745	424	9	have	have	VB
46745	424	10	thought	think	VBN
46745	424	11	that	that	IN
46745	424	12	no	no	DT
46745	424	13	medicines	medicine	NNS
46745	424	14	could	could	MD
46745	424	15	act	act	VB
46745	424	16	in	in	IN
46745	424	17	the	the	DT
46745	424	18	fluids	fluid	NNS
46745	424	19	but	but	CC
46745	424	20	such	such	JJ
46745	424	21	as	as	IN
46745	424	22	have	have	VBP
46745	424	23	a	a	DT
46745	424	24	well	well	RB
46745	424	25	known	know	VBN
46745	424	26	chemical	chemical	NN
46745	424	27	effect	effect	NN
46745	424	28	upon	upon	IN
46745	424	29	them	-PRON-	PRP
46745	424	30	.	.	.
46745	425	1	It	-PRON-	PRP
46745	425	2	can	can	MD
46745	425	3	not	not	RB
46745	425	4	be	be	VB
46745	425	5	that	that	IN
46745	425	6	medicines	medicine	NNS
46745	425	7	should	should	MD
46745	425	8	be	be	VB
46745	425	9	able	able	JJ
46745	425	10	to	to	TO
46745	425	11	affect	affect	VB
46745	425	12	the	the	DT
46745	425	13	nerves	nerve	NNS
46745	425	14	,	,	,
46745	425	15	and	and	CC
46745	425	16	to	to	TO
46745	425	17	influence	influence	VB
46745	425	18	the	the	DT
46745	425	19	glands	gland	NNS
46745	425	20	,	,	,
46745	425	21	in	in	IN
46745	425	22	divers	diver	NNS
46745	425	23	ways	way	NNS
46745	425	24	,	,	,
46745	425	25	but	but	CC
46745	425	26	that	that	IN
46745	425	27	none	none	NN
46745	425	28	should	should	MD
46745	425	29	exert	exert	VB
46745	425	30	any	any	DT
46745	425	31	action	action	NN
46745	425	32	upon	upon	IN
46745	425	33	the	the	DT
46745	425	34	blood	blood	NN
46745	425	35	,	,	,
46745	425	36	a	a	DT
46745	425	37	most	most	RBS
46745	425	38	susceptible	susceptible	JJ
46745	425	39	and	and	CC
46745	425	40	changeable	changeable	JJ
46745	425	41	fluid	fluid	NN
46745	425	42	,	,	,
46745	425	43	the	the	DT
46745	425	44	medium	medium	NN
46745	425	45	of	of	IN
46745	425	46	nutrition	nutrition	NN
46745	425	47	,	,	,
46745	425	48	the	the	DT
46745	425	49	source	source	NN
46745	425	50	of	of	IN
46745	425	51	all	all	PDT
46745	425	52	the	the	DT
46745	425	53	tissues	tissue	NNS
46745	425	54	,	,	,
46745	425	55	the	the	DT
46745	425	56	"	"	``
46745	425	57	_	_	NNP
46745	425	58	fons	fon	NNS
46745	425	59	et	et	NNP
46745	425	60	origo	origo	NNP
46745	425	61	_	_	NNP
46745	425	62	"	"	``
46745	425	63	of	of	IN
46745	425	64	disease	disease	NN
46745	425	65	.	.	.
46745	426	1	It	-PRON-	PRP
46745	426	2	is	be	VBZ
46745	426	3	only	only	RB
46745	426	4	very	very	RB
46745	426	5	lately	lately	RB
46745	426	6	that	that	IN
46745	426	7	authors	author	NNS
46745	426	8	have	have	VBP
46745	426	9	begun	begin	VBN
46745	426	10	to	to	TO
46745	426	11	recognise	recognise	VB
46745	426	12	and	and	CC
46745	426	13	include	include	VB
46745	426	14	in	in	IN
46745	426	15	their	-PRON-	PRP$
46745	426	16	arrangements	arrangement	NNS
46745	426	17	the	the	DT
46745	426	18	class	class	NN
46745	426	19	of	of	IN
46745	426	20	blood	blood	NN
46745	426	21	-	-	HYPH
46745	426	22	medicines	medicine	NNS
46745	426	23	,	,	,
46745	426	24	which	which	WDT
46745	426	25	seem	seem	VBP
46745	426	26	to	to	IN
46745	426	27	me	-PRON-	PRP
46745	426	28	to	to	TO
46745	426	29	be	be	VB
46745	426	30	considerably	considerably	RB
46745	426	31	more	more	RBR
46745	426	32	important	important	JJ
46745	426	33	than	than	IN
46745	426	34	any	any	DT
46745	426	35	other	other	JJ
46745	426	36	.	.	.
46745	427	1	Having	have	VBG
46745	427	2	shown	show	VBN
46745	427	3	thus	thus	RB
46745	427	4	what	what	WP
46745	427	5	appear	appear	VBP
46745	427	6	to	to	IN
46745	427	7	me	-PRON-	PRP
46745	427	8	to	to	TO
46745	427	9	be	be	VB
46745	427	10	the	the	DT
46745	427	11	correct	correct	JJ
46745	427	12	bases	basis	NNS
46745	427	13	upon	upon	IN
46745	427	14	which	which	WDT
46745	427	15	an	an	DT
46745	427	16	arrangement	arrangement	NN
46745	427	17	of	of	IN
46745	427	18	this	this	DT
46745	427	19	kind	kind	NN
46745	427	20	should	should	MD
46745	427	21	be	be	VB
46745	427	22	constructed	construct	VBN
46745	427	23	,	,	,
46745	427	24	I	-PRON-	PRP
46745	427	25	shall	shall	MD
46745	427	26	quote	quote	VB
46745	427	27	as	as	IN
46745	427	28	another	another	DT
46745	427	29	specimen	specimen	VBZ
46745	427	30	the	the	DT
46745	427	31	classification	classification	NN
46745	427	32	of	of	IN
46745	427	33	Dr.	Dr.	NNP
46745	427	34	John	John	NNP
46745	427	35	Murray	Murray	NNP
46745	427	36	,	,	,
46745	427	37	but	but	CC
46745	427	38	mentioning	mention	VBG
46745	427	39	only	only	RB
46745	427	40	its	-PRON-	PRP$
46745	427	41	most	most	RBS
46745	427	42	prominent	prominent	JJ
46745	427	43	details	detail	NNS
46745	427	44	.	.	.
46745	428	1	DR	DR	NNP
46745	428	2	.	.	.
46745	428	3	MURRAY	MURRAY	NNP
46745	428	4	.	.	.
46745	429	1	GENERAL	GENERAL	NNP
46745	429	2	STIMULANTS	STIMULANTS	NNP
46745	429	3	.	.	.
46745	430	1	_	_	NNP
46745	430	2	Diffusible	Diffusible	NNP
46745	430	3	_	_	NNP
46745	430	4	{	{	-LRB-
46745	430	5	Narcotics	Narcotics	NNP
46745	430	6	.	.	.
46745	431	1	{	{	-LRB-
46745	431	2	Antispasmodics	Antispasmodics	NNP
46745	431	3	.	.	.
46745	432	1	_	_	NNP
46745	432	2	Permanent	Permanent	NNP
46745	432	3	_	_	NNP
46745	432	4	{	{	-LRB-
46745	432	5	Tonics	Tonics	NNP
46745	432	6	.	.	.
46745	433	1	{	{	-LRB-
46745	433	2	Astringents	astringent	NNS
46745	433	3	.	.	.
46745	434	1	LOCAL	LOCAL	NNP
46745	434	2	STIMULANTS	STIMULANTS	NNP
46745	434	3	.	.	.
46745	435	1	Evacuants	evacuant	NNS
46745	435	2	,	,	,
46745	435	3	Irritants	Irritants	NNPS
46745	435	4	.	.	.
46745	436	1	CHEMICAL	chemical	NN
46745	436	2	AGENTS	agent	NNS
46745	436	3	.	.	.
46745	437	1	MECHANICAL	MECHANICAL	NNP
46745	437	2	AGENTS	AGENTS	NNP
46745	437	3	.	.	.
46745	438	1	We	-PRON-	PRP
46745	438	2	find	find	VBP
46745	438	3	in	in	IN
46745	438	4	this	this	DT
46745	438	5	division	division	NN
46745	438	6	some	some	DT
46745	438	7	reference	reference	NN
46745	438	8	made	make	VBN
46745	438	9	to	to	IN
46745	438	10	the	the	DT
46745	438	11	local	local	JJ
46745	438	12	tendencies	tendency	NNS
46745	438	13	of	of	IN
46745	438	14	medicines	medicine	NNS
46745	438	15	.	.	.
46745	439	1	Evacuants	evacuant	NNS
46745	439	2	are	be	VBP
46745	439	3	classed	class	VBN
46745	439	4	as	as	IN
46745	439	5	Stimulants	stimulant	NNS
46745	439	6	which	which	WDT
46745	439	7	tend	tend	VBP
46745	439	8	to	to	TO
46745	439	9	act	act	VB
46745	439	10	locally	locally	RB
46745	439	11	on	on	IN
46745	439	12	the	the	DT
46745	439	13	glands	gland	NNS
46745	439	14	.	.	.
46745	440	1	In	in	IN
46745	440	2	the	the	DT
46745	440	3	arrangement	arrangement	NN
46745	440	4	of	of	IN
46745	440	5	Dr.	Dr.	NNP
46745	440	6	A.	A.	NNP
46745	440	7	T.	T.	NNP
46745	440	8	Thomson	Thomson	NNP
46745	440	9	,	,	,
46745	440	10	founded	found	VBN
46745	440	11	upon	upon	IN
46745	440	12	this	this	DT
46745	440	13	one	one	NN
46745	440	14	,	,	,
46745	440	15	still	still	RB
46745	440	16	further	further	JJ
46745	440	17	reference	reference	NN
46745	440	18	is	be	VBZ
46745	440	19	made	make	VBN
46745	440	20	to	to	IN
46745	440	21	the	the	DT
46745	440	22	local	local	JJ
46745	440	23	tendencies	tendency	NNS
46745	440	24	of	of	IN
46745	440	25	different	different	JJ
46745	440	26	medicines	medicine	NNS
46745	440	27	.	.	.
46745	441	1	Dr.	Dr.	NNP
46745	441	2	Paris	Paris	NNP
46745	441	3	also	also	RB
46745	441	4	has	have	VBZ
46745	441	5	adopted	adopt	VBN
46745	441	6	this	this	DT
46745	441	7	arrangement	arrangement	NN
46745	441	8	,	,	,
46745	441	9	but	but	CC
46745	441	10	in	in	IN
46745	441	11	a	a	DT
46745	441	12	very	very	RB
46745	441	13	much	much	RB
46745	441	14	improved	improve	VBN
46745	441	15	form	form	NN
46745	441	16	.	.	.
46745	442	1	Both	both	CC
46745	442	2	Dr.	Dr.	NNP
46745	442	3	Thomson	Thomson	NNP
46745	442	4	and	and	CC
46745	442	5	Dr.	Dr.	NNP
46745	442	6	Paris	Paris	NNP
46745	442	7	take	take	VB
46745	442	8	exception	exception	NN
46745	442	9	to	to	IN
46745	442	10	the	the	DT
46745	442	11	inclusion	inclusion	NN
46745	442	12	of	of	IN
46745	442	13	Sedatives	Sedatives	NNP
46745	442	14	(	(	-LRB-
46745	442	15	under	under	IN
46745	442	16	the	the	DT
46745	442	17	head	head	NN
46745	442	18	of	of	IN
46745	442	19	Narcotics	Narcotics	NNP
46745	442	20	)	)	-RRB-
46745	442	21	among	among	IN
46745	442	22	general	general	JJ
46745	442	23	Stimulants	Stimulants	NNP
46745	442	24	.	.	.
46745	443	1	This	this	DT
46745	443	2	is	be	VBZ
46745	443	3	the	the	DT
46745	443	4	great	great	JJ
46745	443	5	fault	fault	NN
46745	443	6	of	of	IN
46745	443	7	Dr.	Dr.	NNP
46745	443	8	Murray	Murray	NNP
46745	443	9	's	's	POS
46745	443	10	classification	classification	NN
46745	443	11	.	.	.
46745	444	1	The	the	DT
46745	444	2	idea	idea	NN
46745	444	3	,	,	,
46745	444	4	as	as	IN
46745	444	5	he	-PRON-	PRP
46745	444	6	states	state	VBZ
46745	444	7	,	,	,
46745	444	8	was	be	VBD
46745	444	9	taken	take	VBN
46745	444	10	from	from	IN
46745	444	11	Brown	Brown	NNP
46745	444	12	.	.	.
46745	445	1	It	-PRON-	PRP
46745	445	2	is	be	VBZ
46745	445	3	considered	consider	VBN
46745	445	4	that	that	IN
46745	445	5	both	both	DT
46745	445	6	Stimulants	Stimulants	NNPS
46745	445	7	and	and	CC
46745	445	8	Narcotics	Narcotics	NNP
46745	445	9	act	act	VBP
46745	445	10	alike	alike	RB
46745	445	11	;	;	:
46745	445	12	that	that	RB
46745	445	13	is	is	RB
46745	445	14	,	,	,
46745	445	15	that	that	IN
46745	445	16	they	-PRON-	PRP
46745	445	17	both	both	DT
46745	445	18	produce	produce	VBP
46745	445	19	a	a	DT
46745	445	20	primary	primary	JJ
46745	445	21	stimulation	stimulation	NN
46745	445	22	followed	follow	VBN
46745	445	23	by	by	IN
46745	445	24	a	a	DT
46745	445	25	secondary	secondary	JJ
46745	445	26	depression	depression	NN
46745	445	27	;	;	:
46745	445	28	only	only	RB
46745	445	29	that	that	IN
46745	445	30	,	,	,
46745	445	31	in	in	IN
46745	445	32	the	the	DT
46745	445	33	case	case	NN
46745	445	34	of	of	IN
46745	445	35	Narcotics	Narcotics	NNP
46745	445	36	(	(	-LRB-
46745	445	37	under	under	IN
46745	445	38	which	which	WDT
46745	445	39	head	head	NN
46745	445	40	all	all	DT
46745	445	41	Sedatives	Sedatives	NNPS
46745	445	42	are	be	VBP
46745	445	43	included	include	VBN
46745	445	44	)	)	-RRB-
46745	445	45	the	the	DT
46745	445	46	stimulation	stimulation	NN
46745	445	47	is	be	VBZ
46745	445	48	very	very	RB
46745	445	49	brief	brief	JJ
46745	445	50	,	,	,
46745	445	51	and	and	CC
46745	445	52	rapidly	rapidly	RB
46745	445	53	passes	pass	VBZ
46745	445	54	away	away	RB
46745	445	55	,	,	,
46745	445	56	to	to	TO
46745	445	57	be	be	VB
46745	445	58	followed	follow	VBN
46745	445	59	by	by	IN
46745	445	60	a	a	DT
46745	445	61	great	great	JJ
46745	445	62	depression	depression	NN
46745	445	63	.	.	.
46745	446	1	Now	now	RB
46745	446	2	,	,	,
46745	446	3	even	even	RB
46745	446	4	if	if	IN
46745	446	5	this	this	DT
46745	446	6	were	be	VBD
46745	446	7	true	true	JJ
46745	446	8	,	,	,
46745	446	9	the	the	DT
46745	446	10	most	most	RBS
46745	446	11	prominent	prominent	JJ
46745	446	12	action	action	NN
46745	446	13	would	would	MD
46745	446	14	be	be	VB
46745	446	15	the	the	DT
46745	446	16	depressing	depress	VBG
46745	446	17	effect	effect	NN
46745	446	18	,	,	,
46745	446	19	and	and	CC
46745	446	20	it	-PRON-	PRP
46745	446	21	is	be	VBZ
46745	446	22	on	on	IN
46745	446	23	the	the	DT
46745	446	24	most	most	RBS
46745	446	25	prominent	prominent	JJ
46745	446	26	action	action	NN
46745	446	27	that	that	IN
46745	446	28	denominations	denomination	NNS
46745	446	29	such	such	JJ
46745	446	30	as	as	IN
46745	446	31	these	these	DT
46745	446	32	are	be	VBP
46745	446	33	usually	usually	RB
46745	446	34	based	base	VBN
46745	446	35	.	.	.
46745	447	1	But	but	CC
46745	447	2	it	-PRON-	PRP
46745	447	3	is	be	VBZ
46745	447	4	well	well	RB
46745	447	5	urged	urge	VBN
46745	447	6	by	by	IN
46745	447	7	Dr.	Dr.	NNP
46745	447	8	Thomson	Thomson	NNP
46745	447	9	that	that	IN
46745	447	10	in	in	IN
46745	447	11	the	the	DT
46745	447	12	case	case	NN
46745	447	13	of	of	IN
46745	447	14	true	true	JJ
46745	447	15	sedatives	sedative	NNS
46745	447	16	there	there	EX
46745	447	17	is	be	VBZ
46745	447	18	no	no	DT
46745	447	19	stimulant	stimulant	JJ
46745	447	20	action	action	NN
46745	447	21	whatever	whatever	WDT
46745	447	22	;	;	:
46745	447	23	and	and	CC
46745	447	24	it	-PRON-	PRP
46745	447	25	is	be	VBZ
46745	447	26	manifestly	manifestly	RB
46745	447	27	unreasonable	unreasonable	JJ
46745	447	28	to	to	TO
46745	447	29	suppose	suppose	VB
46745	447	30	that	that	IN
46745	447	31	the	the	DT
46745	447	32	depressing	depress	VBG
46745	447	33	effect	effect	NN
46745	447	34	follows	follow	VBZ
46745	447	35	as	as	IN
46745	447	36	a	a	DT
46745	447	37	consequence	consequence	NN
46745	447	38	on	on	IN
46745	447	39	the	the	DT
46745	447	40	primary	primary	JJ
46745	447	41	stimulation	stimulation	NN
46745	447	42	,	,	,
46745	447	43	when	when	WRB
46745	447	44	the	the	DT
46745	447	45	latter	latter	NN
46745	447	46	is	be	VBZ
46745	447	47	so	so	RB
46745	447	48	inconspicuous	inconspicuous	JJ
46745	447	49	.	.	.
46745	448	1	At	at	IN
46745	448	2	any	any	DT
46745	448	3	rate	rate	NN
46745	448	4	such	such	PDT
46745	448	5	an	an	DT
46745	448	6	arrangement	arrangement	NN
46745	448	7	as	as	IN
46745	448	8	that	that	DT
46745	448	9	of	of	IN
46745	448	10	Dr.	Dr.	NNP
46745	448	11	Murray	Murray	NNP
46745	448	12	can	can	MD
46745	448	13	be	be	VB
46745	448	14	of	of	IN
46745	448	15	little	little	JJ
46745	448	16	practical	practical	JJ
46745	448	17	utility	utility	NN
46745	448	18	in	in	IN
46745	448	19	its	-PRON-	PRP$
46745	448	20	original	original	JJ
46745	448	21	form	form	NN
46745	448	22	.	.	.
46745	449	1	A	a	DT
46745	449	2	man	man	NN
46745	449	3	would	would	MD
46745	449	4	be	be	VB
46745	449	5	considered	consider	VBN
46745	449	6	to	to	TO
46745	449	7	be	be	VB
46745	449	8	indulging	indulge	VBG
46745	449	9	in	in	IN
46745	449	10	the	the	DT
46745	449	11	wildest	wild	JJS
46745	449	12	and	and	CC
46745	449	13	most	most	RBS
46745	449	14	dangerous	dangerous	JJ
46745	449	15	fancies	fancy	NNS
46745	449	16	who	who	WP
46745	449	17	would	would	MD
46745	449	18	run	run	VB
46745	449	19	through	through	IN
46745	449	20	the	the	DT
46745	449	21	catalogue	catalogue	NN
46745	449	22	of	of	IN
46745	449	23	Narcotics	Narcotics	NNP
46745	449	24	when	when	WRB
46745	449	25	he	-PRON-	PRP
46745	449	26	desired	desire	VBD
46745	449	27	to	to	TO
46745	449	28	produce	produce	VB
46745	449	29	a	a	DT
46745	449	30	general	general	JJ
46745	449	31	stimulant	stimulant	NN
46745	449	32	effect	effect	NN
46745	449	33	.	.	.
46745	450	1	To	to	IN
46745	450	2	this	this	DT
46745	450	3	system	system	NN
46745	450	4	it	-PRON-	PRP
46745	450	5	might	may	MD
46745	450	6	further	further	RB
46745	450	7	be	be	VB
46745	450	8	objected	object	VBN
46745	450	9	,	,	,
46745	450	10	that	that	IN
46745	450	11	Alteratives	alterative	NNS
46745	450	12	are	be	VBP
46745	450	13	again	again	RB
46745	450	14	entirely	entirely	RB
46745	450	15	omitted	omit	VBN
46745	450	16	;	;	:
46745	450	17	and	and	CC
46745	450	18	that	that	IN
46745	450	19	the	the	DT
46745	450	20	class	class	NN
46745	450	21	of	of	IN
46745	450	22	Mechanical	mechanical	JJ
46745	450	23	agents	agent	NNS
46745	450	24	would	would	MD
46745	450	25	seem	seem	VB
46745	450	26	to	to	TO
46745	450	27	belong	belong	VB
46745	450	28	to	to	IN
46745	450	29	the	the	DT
46745	450	30	division	division	NN
46745	450	31	of	of	IN
46745	450	32	Irritants	Irritants	NNP
46745	450	33	,	,	,
46745	450	34	included	include	VBN
46745	450	35	among	among	IN
46745	450	36	Local	Local	NNP
46745	450	37	Stimulants	Stimulants	NNPS
46745	450	38	.	.	.
46745	451	1	Dr.	Dr.	NNP
46745	451	2	Murray	Murray	NNP
46745	451	3	classes	class	VBZ
46745	451	4	Refrigerants	Refrigerants	NNP
46745	451	5	among	among	IN
46745	451	6	Chemical	Chemical	NNP
46745	451	7	remedies	remedy	NNS
46745	451	8	,	,	,
46745	451	9	for	for	IN
46745	451	10	which	which	WDT
46745	451	11	,	,	,
46745	451	12	when	when	WRB
46745	451	13	I	-PRON-	PRP
46745	451	14	come	come	VBP
46745	451	15	to	to	TO
46745	451	16	speak	speak	VB
46745	451	17	of	of	IN
46745	451	18	Acids	Acids	NNP
46745	451	19	,	,	,
46745	451	20	I	-PRON-	PRP
46745	451	21	hope	hope	VBP
46745	451	22	to	to	TO
46745	451	23	show	show	VB
46745	451	24	that	that	IN
46745	451	25	there	there	EX
46745	451	26	are	be	VBP
46745	451	27	good	good	JJ
46745	451	28	reasons	reason	NNS
46745	451	29	.	.	.
46745	452	1	II	ii	CD
46745	452	2	.	.	.
46745	453	1	OPINIONS	opinion	NNS
46745	453	2	CONCERNING	concern	VBD
46745	453	3	THE	the	DT
46745	453	4	LOCAL	local	NN
46745	453	5	TENDENCY	tendency	NN
46745	453	6	OF	of	IN
46745	453	7	MEDICINES	medicine	NNS
46745	453	8	,	,	,
46745	453	9	AND	and	CC
46745	453	10	CLASSIFICATIONS	CLASSIFICATIONS	NNP
46745	453	11	FOUNDED	founded	NN
46745	453	12	UPON	upon	IN
46745	453	13	THIS	THIS	NNP
46745	453	14	.	.	.
46745	454	1	Here	here	RB
46745	454	2	another	another	DT
46745	454	3	step	step	NN
46745	454	4	is	be	VBZ
46745	454	5	made	make	VBN
46745	454	6	in	in	IN
46745	454	7	the	the	DT
46745	454	8	explanation	explanation	NN
46745	454	9	of	of	IN
46745	454	10	the	the	DT
46745	454	11	action	action	NN
46745	454	12	of	of	IN
46745	454	13	medicines	medicine	NNS
46745	454	14	.	.	.
46745	455	1	They	-PRON-	PRP
46745	455	2	are	be	VBP
46745	455	3	said	say	VBN
46745	455	4	to	to	TO
46745	455	5	have	have	VB
46745	455	6	particular	particular	JJ
46745	455	7	tendencies	tendency	NNS
46745	455	8	towards	towards	IN
46745	455	9	certain	certain	JJ
46745	455	10	parts	part	NNS
46745	455	11	of	of	IN
46745	455	12	the	the	DT
46745	455	13	body	body	NN
46745	455	14	,	,	,
46745	455	15	over	over	IN
46745	455	16	which	which	WDT
46745	455	17	parts	part	NNS
46745	455	18	they	-PRON-	PRP
46745	455	19	exert	exert	VBP
46745	455	20	a	a	DT
46745	455	21	peculiar	peculiar	JJ
46745	455	22	and	and	CC
46745	455	23	special	special	JJ
46745	455	24	influence	influence	NN
46745	455	25	.	.	.
46745	456	1	It	-PRON-	PRP
46745	456	2	is	be	VBZ
46745	456	3	thought	think	VBN
46745	456	4	that	that	IN
46745	456	5	we	-PRON-	PRP
46745	456	6	shall	shall	MD
46745	456	7	make	make	VB
46745	456	8	an	an	DT
46745	456	9	advance	advance	NN
46745	456	10	in	in	IN
46745	456	11	our	-PRON-	PRP$
46745	456	12	knowledge	knowledge	NN
46745	456	13	of	of	IN
46745	456	14	the	the	DT
46745	456	15	subject	subject	NN
46745	456	16	,	,	,
46745	456	17	if	if	IN
46745	456	18	we	-PRON-	PRP
46745	456	19	can	can	MD
46745	456	20	discover	discover	VB
46745	456	21	what	what	WP
46745	456	22	these	these	DT
46745	456	23	tendencies	tendency	NNS
46745	456	24	are	be	VBP
46745	456	25	.	.	.
46745	457	1	An	an	DT
46745	457	2	arrangement	arrangement	NN
46745	457	3	of	of	IN
46745	457	4	medicines	medicine	NNS
46745	457	5	may	may	MD
46745	457	6	be	be	VB
46745	457	7	made	make	VBN
46745	457	8	accordingly	accordingly	RB
46745	457	9	.	.	.
46745	458	1	It	-PRON-	PRP
46745	458	2	is	be	VBZ
46745	458	3	certainly	certainly	RB
46745	458	4	more	more	RBR
46745	458	5	scientific	scientific	JJ
46745	458	6	than	than	IN
46745	458	7	a	a	DT
46745	458	8	merely	merely	RB
46745	458	9	empirical	empirical	JJ
46745	458	10	arrangement	arrangement	NN
46745	458	11	;	;	:
46745	458	12	and	and	CC
46745	458	13	it	-PRON-	PRP
46745	458	14	will	will	MD
46745	458	15	be	be	VB
46745	458	16	so	so	RB
46745	458	17	far	far	RB
46745	458	18	of	of	IN
46745	458	19	use	use	NN
46745	458	20	that	that	WDT
46745	458	21	it	-PRON-	PRP
46745	458	22	will	will	MD
46745	458	23	enable	enable	VB
46745	458	24	us	-PRON-	PRP
46745	458	25	,	,	,
46745	458	26	when	when	WRB
46745	458	27	we	-PRON-	PRP
46745	458	28	wish	wish	VBP
46745	458	29	to	to	TO
46745	458	30	make	make	VB
46745	458	31	an	an	DT
46745	458	32	impression	impression	NN
46745	458	33	on	on	IN
46745	458	34	a	a	DT
46745	458	35	certain	certain	JJ
46745	458	36	organ	organ	NN
46745	458	37	or	or	CC
46745	458	38	set	set	NN
46745	458	39	of	of	IN
46745	458	40	organs	organ	NNS
46745	458	41	,	,	,
46745	458	42	to	to	TO
46745	458	43	select	select	VB
46745	458	44	those	those	DT
46745	458	45	medicines	medicine	NNS
46745	458	46	which	which	WDT
46745	458	47	especially	especially	RB
46745	458	48	influence	influence	VBP
46745	458	49	it	-PRON-	PRP
46745	458	50	or	or	CC
46745	458	51	them	-PRON-	PRP
46745	458	52	.	.	.
46745	459	1	There	there	EX
46745	459	2	is	be	VBZ
46745	459	3	no	no	DT
46745	459	4	doubt	doubt	RB
46745	459	5	whatever	whatever	WDT
46745	459	6	of	of	IN
46745	459	7	the	the	DT
46745	459	8	existence	existence	NN
46745	459	9	of	of	IN
46745	459	10	these	these	DT
46745	459	11	local	local	JJ
46745	459	12	tendencies	tendency	NNS
46745	459	13	.	.	.
46745	460	1	There	there	EX
46745	460	2	is	be	VBZ
46745	460	3	no	no	DT
46745	460	4	doubt	doubt	NN
46745	460	5	that	that	IN
46745	460	6	some	some	DT
46745	460	7	medicines	medicine	NNS
46745	460	8	,	,	,
46745	460	9	such	such	JJ
46745	460	10	as	as	IN
46745	460	11	Iodine	Iodine	NNP
46745	460	12	,	,	,
46745	460	13	Bromine	Bromine	NNP
46745	460	14	,	,	,
46745	460	15	Mercury	Mercury	NNP
46745	460	16	,	,	,
46745	460	17	and	and	CC
46745	460	18	Iron	Iron	NNP
46745	460	19	,	,	,
46745	460	20	tend	tend	VBP
46745	460	21	especially	especially	RB
46745	460	22	to	to	TO
46745	460	23	affect	affect	VB
46745	460	24	the	the	DT
46745	460	25	blood	blood	NN
46745	460	26	and	and	CC
46745	460	27	the	the	DT
46745	460	28	blood	blood	NN
46745	460	29	-	-	HYPH
46745	460	30	making	make	VBG
46745	460	31	organs	organ	NNS
46745	460	32	,	,	,
46745	460	33	as	as	IN
46745	460	34	the	the	DT
46745	460	35	liver	liver	NN
46745	460	36	and	and	CC
46745	460	37	spleen	spleen	NN
46745	460	38	,	,	,
46745	460	39	rather	rather	RB
46745	460	40	than	than	IN
46745	460	41	to	to	TO
46745	460	42	act	act	VB
46745	460	43	on	on	IN
46745	460	44	the	the	DT
46745	460	45	nervous	nervous	JJ
46745	460	46	or	or	CC
46745	460	47	glandular	glandular	JJ
46745	460	48	systems	system	NNS
46745	460	49	.	.	.
46745	461	1	That	that	IN
46745	461	2	some	some	DT
46745	461	3	tend	tend	VBP
46745	461	4	particularly	particularly	RB
46745	461	5	towards	towards	IN
46745	461	6	the	the	DT
46745	461	7	nerves	nerve	NNS
46745	461	8	,	,	,
46745	461	9	and	and	CC
46745	461	10	prefer	prefer	VB
46745	461	11	individually	individually	RB
46745	461	12	different	different	JJ
46745	461	13	parts	part	NNS
46745	461	14	of	of	IN
46745	461	15	the	the	DT
46745	461	16	nervous	nervous	JJ
46745	461	17	system	system	NN
46745	461	18	,	,	,
46745	461	19	as	as	IN
46745	461	20	Opium	Opium	NNP
46745	461	21	acts	act	VBZ
46745	461	22	on	on	IN
46745	461	23	the	the	DT
46745	461	24	brain	brain	NN
46745	461	25	,	,	,
46745	461	26	Aconite	aconite	JJ
46745	461	27	on	on	IN
46745	461	28	the	the	DT
46745	461	29	superficial	superficial	JJ
46745	461	30	sensory	sensory	JJ
46745	461	31	nerves	nerve	NNS
46745	461	32	,	,	,
46745	461	33	Digitalis	Digitalis	NNP
46745	461	34	on	on	IN
46745	461	35	the	the	DT
46745	461	36	organic	organic	JJ
46745	461	37	nerves	nerve	NNS
46745	461	38	of	of	IN
46745	461	39	the	the	DT
46745	461	40	heart	heart	NN
46745	461	41	,	,	,
46745	461	42	and	and	CC
46745	461	43	Stramonium	Stramonium	NNP
46745	461	44	on	on	IN
46745	461	45	those	those	DT
46745	461	46	of	of	IN
46745	461	47	the	the	DT
46745	461	48	lungs	lung	NNS
46745	461	49	.	.	.
46745	462	1	Again	again	RB
46745	462	2	,	,	,
46745	462	3	it	-PRON-	PRP
46745	462	4	is	be	VBZ
46745	462	5	evident	evident	JJ
46745	462	6	that	that	IN
46745	462	7	some	some	DT
46745	462	8	medicines	medicine	NNS
46745	462	9	tend	tend	VBP
46745	462	10	to	to	TO
46745	462	11	act	act	VB
46745	462	12	on	on	IN
46745	462	13	the	the	DT
46745	462	14	organs	organ	NNS
46745	462	15	of	of	IN
46745	462	16	secretion	secretion	NN
46745	462	17	;	;	:
46745	462	18	and	and	CC
46745	462	19	of	of	IN
46745	462	20	these	these	DT
46745	462	21	,	,	,
46745	462	22	particular	particular	JJ
46745	462	23	sets	set	NNS
46745	462	24	select	select	VBP
46745	462	25	particular	particular	JJ
46745	462	26	glands	gland	NNS
46745	462	27	,	,	,
46745	462	28	as	as	IN
46745	462	29	Diuretics	Diuretics	NNP
46745	462	30	the	the	DT
46745	462	31	kidneys	kidney	NNS
46745	462	32	,	,	,
46745	462	33	Diaphoretics	diaphoretic	NNS
46745	462	34	the	the	DT
46745	462	35	glands	gland	NNS
46745	462	36	of	of	IN
46745	462	37	the	the	DT
46745	462	38	skin	skin	NN
46745	462	39	,	,	,
46745	462	40	and	and	CC
46745	462	41	Purgatives	purgative	VBZ
46745	462	42	those	those	DT
46745	462	43	of	of	IN
46745	462	44	the	the	DT
46745	462	45	bowels	bowel	NNS
46745	462	46	.	.	.
46745	463	1	There	there	EX
46745	463	2	may	may	MD
46745	463	3	be	be	VB
46745	463	4	disagreements	disagreement	NNS
46745	463	5	on	on	IN
46745	463	6	minor	minor	JJ
46745	463	7	points	point	NNS
46745	463	8	,	,	,
46745	463	9	but	but	CC
46745	463	10	there	there	EX
46745	463	11	can	can	MD
46745	463	12	be	be	VB
46745	463	13	no	no	DT
46745	463	14	dispute	dispute	NN
46745	463	15	as	as	IN
46745	463	16	to	to	IN
46745	463	17	the	the	DT
46745	463	18	fact	fact	NN
46745	463	19	of	of	IN
46745	463	20	the	the	DT
46745	463	21	existence	existence	NN
46745	463	22	of	of	IN
46745	463	23	these	these	DT
46745	463	24	local	local	JJ
46745	463	25	partialities	partiality	NNS
46745	463	26	.	.	.
46745	464	1	[	[	-LRB-
46745	464	2	7	7	CD
46745	464	3	]	]	-RRB-
46745	464	4	But	but	CC
46745	464	5	,	,	,
46745	464	6	though	though	IN
46745	464	7	such	such	JJ
46745	464	8	statements	statement	NNS
46745	464	9	are	be	VBP
46745	464	10	admitted	admit	VBN
46745	464	11	to	to	TO
46745	464	12	be	be	VB
46745	464	13	correct	correct	JJ
46745	464	14	in	in	IN
46745	464	15	theory	theory	NN
46745	464	16	,	,	,
46745	464	17	it	-PRON-	PRP
46745	464	18	remains	remain	VBZ
46745	464	19	still	still	RB
46745	464	20	to	to	TO
46745	464	21	be	be	VB
46745	464	22	considered	consider	VBN
46745	464	23	whether	whether	IN
46745	464	24	they	-PRON-	PRP
46745	464	25	form	form	VBP
46745	464	26	a	a	DT
46745	464	27	fitting	fitting	JJ
46745	464	28	basis	basis	NN
46745	464	29	for	for	IN
46745	464	30	a	a	DT
46745	464	31	classification	classification	NN
46745	464	32	of	of	IN
46745	464	33	medicines	medicine	NNS
46745	464	34	.	.	.
46745	465	1	Now	now	RB
46745	465	2	it	-PRON-	PRP
46745	465	3	will	will	MD
46745	465	4	be	be	VB
46745	465	5	observed	observe	VBN
46745	465	6	that	that	IN
46745	465	7	no	no	DT
46745	465	8	theory	theory	NN
46745	465	9	of	of	IN
46745	465	10	action	action	NN
46745	465	11	enters	enter	VBZ
46745	465	12	into	into	IN
46745	465	13	such	such	PDT
46745	465	14	an	an	DT
46745	465	15	arrangement	arrangement	NN
46745	465	16	,	,	,
46745	465	17	but	but	CC
46745	465	18	merely	merely	RB
46745	465	19	the	the	DT
46745	465	20	tendency	tendency	NN
46745	465	21	of	of	IN
46745	465	22	the	the	DT
46745	465	23	action	action	NN
46745	465	24	of	of	IN
46745	465	25	each	each	DT
46745	465	26	medicine	medicine	NN
46745	465	27	is	be	VBZ
46745	465	28	considered	consider	VBN
46745	465	29	;	;	:
46745	465	30	and	and	CC
46745	465	31	as	as	IN
46745	465	32	each	each	DT
46745	465	33	medicine	medicine	NN
46745	465	34	has	have	VBZ
46745	465	35	naturally	naturally	RB
46745	465	36	many	many	JJ
46745	465	37	distinct	distinct	JJ
46745	465	38	tendencies	tendency	NNS
46745	465	39	,	,	,
46745	465	40	it	-PRON-	PRP
46745	465	41	comes	come	VBZ
46745	465	42	therefore	therefore	RB
46745	465	43	under	under	IN
46745	465	44	many	many	JJ
46745	465	45	different	different	JJ
46745	465	46	heads	head	NNS
46745	465	47	.	.	.
46745	466	1	But	but	CC
46745	466	2	the	the	DT
46745	466	3	chief	chief	JJ
46745	466	4	practical	practical	JJ
46745	466	5	use	use	NN
46745	466	6	of	of	IN
46745	466	7	a	a	DT
46745	466	8	classification	classification	NN
46745	466	9	seems	seem	VBZ
46745	466	10	to	to	TO
46745	466	11	be	be	VB
46745	466	12	,	,	,
46745	466	13	that	that	IN
46745	466	14	we	-PRON-	PRP
46745	466	15	may	may	MD
46745	466	16	quickly	quickly	RB
46745	466	17	learn	learn	VB
46745	466	18	from	from	IN
46745	466	19	it	-PRON-	PRP
46745	466	20	the	the	DT
46745	466	21	general	general	JJ
46745	466	22	action	action	NN
46745	466	23	or	or	CC
46745	466	24	effect	effect	NN
46745	466	25	of	of	IN
46745	466	26	a	a	DT
46745	466	27	medicine	medicine	NN
46745	466	28	;	;	:
46745	466	29	so	so	IN
46745	466	30	that	that	IN
46745	466	31	,	,	,
46745	466	32	if	if	IN
46745	466	33	it	-PRON-	PRP
46745	466	34	is	be	VBZ
46745	466	35	stated	state	VBN
46745	466	36	to	to	TO
46745	466	37	have	have	VB
46745	466	38	many	many	JJ
46745	466	39	different	different	JJ
46745	466	40	tendencies	tendency	NNS
46745	466	41	,	,	,
46745	466	42	and	and	CC
46745	466	43	is	be	VBZ
46745	466	44	ranged	range	VBN
46745	466	45	under	under	IN
46745	466	46	no	no	DT
46745	466	47	one	one	CD
46745	466	48	particular	particular	JJ
46745	466	49	head	head	NN
46745	466	50	,	,	,
46745	466	51	we	-PRON-	PRP
46745	466	52	can	can	MD
46745	466	53	gain	gain	VB
46745	466	54	from	from	IN
46745	466	55	this	this	DT
46745	466	56	no	no	DT
46745	466	57	very	very	RB
46745	466	58	distinct	distinct	JJ
46745	466	59	practical	practical	JJ
46745	466	60	information	information	NN
46745	466	61	respecting	respect	VBG
46745	466	62	it	-PRON-	PRP
46745	466	63	.	.	.
46745	467	1	In	in	IN
46745	467	2	an	an	DT
46745	467	3	arrangement	arrangement	NN
46745	467	4	of	of	IN
46745	467	5	the	the	DT
46745	467	6	kind	kind	NN
46745	467	7	that	that	WDT
46745	467	8	we	-PRON-	PRP
46745	467	9	have	have	VBP
46745	467	10	last	last	RB
46745	467	11	examined	examine	VBN
46745	467	12	,	,	,
46745	467	13	the	the	DT
46745	467	14	most	most	RBS
46745	467	15	important	important	JJ
46745	467	16	result	result	NN
46745	467	17	is	be	VBZ
46745	467	18	the	the	DT
46745	467	19	chief	chief	JJ
46745	467	20	point	point	NN
46745	467	21	considered	consider	VBN
46745	467	22	.	.	.
46745	468	1	Thus	thus	RB
46745	468	2	it	-PRON-	PRP
46745	468	3	is	be	VBZ
46745	468	4	rendered	render	VBN
46745	468	5	useful	useful	JJ
46745	468	6	.	.	.
46745	469	1	And	and	CC
46745	469	2	in	in	IN
46745	469	3	one	one	CD
46745	469	4	of	of	IN
46745	469	5	the	the	DT
46745	469	6	third	third	JJ
46745	469	7	kind	kind	NN
46745	469	8	,	,	,
46745	469	9	where	where	WRB
46745	469	10	the	the	DT
46745	469	11	mode	mode	NN
46745	469	12	of	of	IN
46745	469	13	operation	operation	NN
46745	469	14	is	be	VBZ
46745	469	15	the	the	DT
46745	469	16	great	great	JJ
46745	469	17	thing	thing	NN
46745	469	18	taken	take	VBN
46745	469	19	into	into	IN
46745	469	20	account	account	NN
46745	469	21	,	,	,
46745	469	22	as	as	IN
46745	469	23	each	each	DT
46745	469	24	remedy	remedy	NN
46745	469	25	has	have	VBZ
46745	469	26	only	only	RB
46745	469	27	one	one	CD
46745	469	28	primary	primary	JJ
46745	469	29	operation	operation	NN
46745	469	30	,	,	,
46745	469	31	and	and	CC
46745	469	32	according	accord	VBG
46745	469	33	to	to	IN
46745	469	34	this	this	DT
46745	469	35	is	be	VBZ
46745	469	36	classified	classify	VBN
46745	469	37	,	,	,
46745	469	38	we	-PRON-	PRP
46745	469	39	gain	gain	VBP
46745	469	40	from	from	IN
46745	469	41	its	-PRON-	PRP$
46745	469	42	designation	designation	NN
46745	469	43	some	some	DT
46745	469	44	useful	useful	JJ
46745	469	45	information	information	NN
46745	469	46	respecting	respect	VBG
46745	469	47	it	-PRON-	PRP
46745	469	48	.	.	.
46745	470	1	It	-PRON-	PRP
46745	470	2	may	may	MD
46745	470	3	sometimes	sometimes	RB
46745	470	4	come	come	VB
46745	470	5	under	under	IN
46745	470	6	another	another	DT
46745	470	7	head	head	NN
46745	470	8	in	in	IN
46745	470	9	its	-PRON-	PRP$
46745	470	10	secondary	secondary	JJ
46745	470	11	operation	operation	NN
46745	470	12	,	,	,
46745	470	13	but	but	CC
46745	470	14	only	only	RB
46745	470	15	according	accord	VBG
46745	470	16	to	to	IN
46745	470	17	the	the	DT
46745	470	18	primary	primary	NN
46745	470	19	should	should	MD
46745	470	20	it	-PRON-	PRP
46745	470	21	be	be	VB
46745	470	22	classed	class	VBN
46745	470	23	,	,	,
46745	470	24	the	the	DT
46745	470	25	other	other	JJ
46745	470	26	term	term	NN
46745	470	27	being	be	VBG
46745	470	28	supplementary	supplementary	JJ
46745	470	29	.	.	.
46745	471	1	The	the	DT
46745	471	2	designations	designation	NNS
46745	471	3	founded	found	VBN
46745	471	4	on	on	IN
46745	471	5	local	local	JJ
46745	471	6	tendency	tendency	NN
46745	471	7	are	be	VBP
46745	471	8	further	furth	JJR
46745	471	9	of	of	IN
46745	471	10	an	an	DT
46745	471	11	indefinite	indefinite	JJ
46745	471	12	character	character	NN
46745	471	13	,	,	,
46745	471	14	because	because	IN
46745	471	15	they	-PRON-	PRP
46745	471	16	do	do	VBP
46745	471	17	not	not	RB
46745	471	18	denote	denote	VB
46745	471	19	the	the	DT
46745	471	20	kind	kind	NN
46745	471	21	of	of	IN
46745	471	22	action	action	NN
46745	471	23	exerted	exert	VBD
46745	471	24	.	.	.
46745	472	1	Of	of	IN
46745	472	2	such	such	PDT
46745	472	3	a	a	DT
46745	472	4	kind	kind	NN
46745	472	5	is	be	VBZ
46745	472	6	the	the	DT
46745	472	7	classification	classification	NN
46745	472	8	adopted	adopt	VBN
46745	472	9	by	by	IN
46745	472	10	Dr.	Dr.	NNP
46745	472	11	A.	A.	NNP
46745	472	12	T.	T.	NNP
46745	472	13	Thomson	Thomson	NNP
46745	472	14	,	,	,
46745	472	15	founded	found	VBN
46745	472	16	on	on	IN
46745	472	17	that	that	DT
46745	472	18	of	of	IN
46745	472	19	Dr.	Dr.	NNP
46745	472	20	Murray	Murray	NNP
46745	472	21	.	.	.
46745	473	1	He	-PRON-	PRP
46745	473	2	divides	divide	VBZ
46745	473	3	what	what	WP
46745	473	4	he	-PRON-	PRP
46745	473	5	calls	call	VBZ
46745	473	6	_	_	NNP
46745	473	7	Vital	vital	JJ
46745	473	8	remedies	remedy	NNS
46745	473	9	_	_	XX
46745	473	10	into	into	IN
46745	473	11	one	one	CD
46745	473	12	division	division	NN
46745	473	13	that	that	WDT
46745	473	14	acts	act	VBZ
46745	473	15	on	on	IN
46745	473	16	the	the	DT
46745	473	17	nervous	nervous	JJ
46745	473	18	system	system	NN
46745	473	19	,	,	,
46745	473	20	a	a	DT
46745	473	21	second	second	JJ
46745	473	22	that	that	WDT
46745	473	23	affects	affect	VBZ
46745	473	24	the	the	DT
46745	473	25	secerning	secern	VBG
46745	473	26	system	system	NN
46745	473	27	,	,	,
46745	473	28	and	and	CC
46745	473	29	a	a	DT
46745	473	30	third	third	JJ
46745	473	31	that	that	WDT
46745	473	32	influences	influence	VBZ
46745	473	33	the	the	DT
46745	473	34	muscular	muscular	JJ
46745	473	35	and	and	CC
46745	473	36	sanguiferous	sanguiferous	JJ
46745	473	37	systems	system	NNS
46745	473	38	.	.	.
46745	474	1	This	this	DT
46745	474	2	is	be	VBZ
46745	474	3	certainly	certainly	RB
46745	474	4	a	a	DT
46745	474	5	step	step	NN
46745	474	6	in	in	IN
46745	474	7	the	the	DT
46745	474	8	right	right	JJ
46745	474	9	direction	direction	NN
46745	474	10	.	.	.
46745	475	1	Nerve	Nerve	NNP
46745	475	2	-	-	HYPH
46745	475	3	medicines	medicine	NNS
46745	475	4	seem	seem	VBP
46745	475	5	to	to	TO
46745	475	6	have	have	VB
46745	475	7	no	no	DT
46745	475	8	relation	relation	NN
46745	475	9	to	to	IN
46745	475	10	those	those	DT
46745	475	11	that	that	WDT
46745	475	12	act	act	VBP
46745	475	13	on	on	IN
46745	475	14	the	the	DT
46745	475	15	glands	gland	NNS
46745	475	16	,	,	,
46745	475	17	though	though	IN
46745	475	18	connected	connect	VBN
46745	475	19	with	with	IN
46745	475	20	them	-PRON-	PRP
46745	475	21	as	as	IN
46745	475	22	Stimulants	stimulant	NNS
46745	475	23	by	by	IN
46745	475	24	Dr.	Dr.	NNP
46745	475	25	Murray	Murray	NNP
46745	475	26	.	.	.
46745	476	1	They	-PRON-	PRP
46745	476	2	are	be	VBP
46745	476	3	thus	thus	RB
46745	476	4	separated	separate	VBN
46745	476	5	.	.	.
46745	477	1	Tonics	tonic	NNS
46745	477	2	are	be	VBP
46745	477	3	also	also	RB
46745	477	4	separated	separate	VBN
46745	477	5	from	from	IN
46745	477	6	Stimulants	Stimulants	NNP
46745	477	7	,	,	,
46745	477	8	and	and	CC
46745	477	9	included	include	VBD
46745	477	10	with	with	IN
46745	477	11	those	those	DT
46745	477	12	which	which	WDT
46745	477	13	act	act	VBP
46745	477	14	on	on	IN
46745	477	15	the	the	DT
46745	477	16	muscular	muscular	JJ
46745	477	17	and	and	CC
46745	477	18	sanguiferous	sanguiferous	JJ
46745	477	19	systems	system	NNS
46745	477	20	.	.	.
46745	478	1	This	this	DT
46745	478	2	seems	seem	VBZ
46745	478	3	to	to	IN
46745	478	4	me	-PRON-	PRP
46745	478	5	to	to	TO
46745	478	6	be	be	VB
46745	478	7	a	a	DT
46745	478	8	correct	correct	JJ
46745	478	9	view	view	NN
46745	478	10	of	of	IN
46745	478	11	their	-PRON-	PRP$
46745	478	12	action	action	NN
46745	478	13	.	.	.
46745	479	1	I	-PRON-	PRP
46745	479	2	do	do	VBP
46745	479	3	not	not	RB
46745	479	4	consider	consider	VB
46745	479	5	that	that	IN
46745	479	6	they	-PRON-	PRP
46745	479	7	act	act	VBP
46745	479	8	primarily	primarily	RB
46745	479	9	on	on	IN
46745	479	10	the	the	DT
46745	479	11	nerves	nerve	NNS
46745	479	12	,	,	,
46745	479	13	but	but	CC
46745	479	14	on	on	IN
46745	479	15	the	the	DT
46745	479	16	blood	blood	NN
46745	479	17	.	.	.
46745	480	1	Dr.	Dr.	NNP
46745	480	2	Thomson	Thomson	NNP
46745	480	3	places	place	VBZ
46745	480	4	Astringents	astringent	NNS
46745	480	5	beside	beside	IN
46745	480	6	them	-PRON-	PRP
46745	480	7	.	.	.
46745	481	1	Though	though	IN
46745	481	2	alike	alike	RB
46745	481	3	in	in	IN
46745	481	4	some	some	DT
46745	481	5	points	point	NNS
46745	481	6	,	,	,
46745	481	7	as	as	IN
46745	481	8	with	with	IN
46745	481	9	regard	regard	NN
46745	481	10	to	to	IN
46745	481	11	their	-PRON-	PRP$
46745	481	12	tendency	tendency	NN
46745	481	13	to	to	TO
46745	481	14	affect	affect	VB
46745	481	15	the	the	DT
46745	481	16	condition	condition	NN
46745	481	17	of	of	IN
46745	481	18	muscular	muscular	JJ
46745	481	19	fibre	fibre	NNP
46745	481	20	,	,	,
46745	481	21	yet	yet	CC
46745	481	22	there	there	EX
46745	481	23	appears	appear	VBZ
46745	481	24	to	to	TO
46745	481	25	be	be	VB
46745	481	26	very	very	RB
46745	481	27	little	little	JJ
46745	481	28	agreement	agreement	NN
46745	481	29	in	in	IN
46745	481	30	the	the	DT
46745	481	31	mode	mode	NN
46745	481	32	of	of	IN
46745	481	33	operation	operation	NN
46745	481	34	of	of	IN
46745	481	35	Tonics	Tonics	NNP
46745	481	36	and	and	CC
46745	481	37	Astringents	Astringents	NNPS
46745	481	38	.	.	.
46745	482	1	There	there	EX
46745	482	2	is	be	VBZ
46745	482	3	not	not	RB
46745	482	4	altogether	altogether	RB
46745	482	5	much	much	JJ
46745	482	6	similarity	similarity	NN
46745	482	7	between	between	IN
46745	482	8	Quina	Quina	NNP
46745	482	9	and	and	CC
46745	482	10	Sulphuric	Sulphuric	NNP
46745	482	11	acid	acid	NN
46745	482	12	.	.	.
46745	483	1	I	-PRON-	PRP
46745	483	2	will	will	MD
46745	483	3	now	now	RB
46745	483	4	transcribe	transcribe	VB
46745	483	5	the	the	DT
46745	483	6	chief	chief	JJ
46745	483	7	divisions	division	NNS
46745	483	8	adopted	adopt	VBN
46745	483	9	in	in	IN
46745	483	10	the	the	DT
46745	483	11	classification	classification	NN
46745	483	12	of	of	IN
46745	483	13	Eberle	Eberle	NNP
46745	483	14	,	,	,
46745	483	15	which	which	WDT
46745	483	16	seems	seem	VBZ
46745	483	17	to	to	TO
46745	483	18	have	have	VB
46745	483	19	been	be	VBN
46745	483	20	the	the	DT
46745	483	21	prototype	prototype	NN
46745	483	22	of	of	IN
46745	483	23	that	that	DT
46745	483	24	one	one	CD
46745	483	25	since	since	IN
46745	483	26	so	so	RB
46745	483	27	ably	ably	RB
46745	483	28	elaborated	elaborate	VBN
46745	483	29	by	by	IN
46745	483	30	Dr.	Dr.	NNP
46745	483	31	Pereira	Pereira	NNP
46745	483	32	.	.	.
46745	484	1	EBERLE	EBERLE	NNP
46745	484	2	'S	be	VBZ
46745	484	3	CLASSES	class	NNS
46745	484	4	.	.	.
46745	485	1	A.	A.	NNP
46745	486	1	Medicines	medicine	NNS
46745	486	2	acting	act	VBG
46745	486	3	on	on	IN
46745	486	4	the	the	DT
46745	486	5	intestinal	intestinal	JJ
46745	486	6	canal	canal	NN
46745	486	7	,	,	,
46745	486	8	or	or	CC
46745	486	9	its	-PRON-	PRP$
46745	486	10	contents	content	NNS
46745	486	11	.	.	.
46745	487	1	B.	B.	NNP
46745	488	1	Medicines	medicine	NNS
46745	488	2	acting	act	VBG
46745	488	3	on	on	IN
46745	488	4	the	the	DT
46745	488	5	muscular	muscular	JJ
46745	488	6	system	system	NN
46745	488	7	.	.	.
46745	489	1	C.	C.	NNP
46745	489	2	On	on	IN
46745	489	3	the	the	DT
46745	489	4	uterine	uterine	JJ
46745	489	5	system	system	NN
46745	489	6	.	.	.
46745	490	1	D.	D.	NNP
46745	490	2	On	on	IN
46745	490	3	the	the	DT
46745	490	4	nervous	nervous	JJ
46745	490	5	system	system	NN
46745	490	6	.	.	.
46745	491	1	E.	E.	NNP
46745	491	2	On	on	IN
46745	491	3	the	the	DT
46745	491	4	circulating	circulate	VBG
46745	491	5	system	system	NN
46745	491	6	.	.	.
46745	492	1	F.	F.	NNP
46745	492	2	On	on	IN
46745	492	3	the	the	DT
46745	492	4	organs	organ	NNS
46745	492	5	of	of	IN
46745	492	6	secretion	secretion	NN
46745	492	7	.	.	.
46745	493	1	G.	G.	NNP
46745	493	2	On	on	IN
46745	493	3	the	the	DT
46745	493	4	respiratory	respiratory	JJ
46745	493	5	organs	organ	NNS
46745	493	6	.	.	.
46745	494	1	The	the	DT
46745	494	2	subdivisions	subdivision	NNS
46745	494	3	are	be	VBP
46745	494	4	founded	found	VBN
46745	494	5	on	on	IN
46745	494	6	the	the	DT
46745	494	7	kind	kind	NN
46745	494	8	of	of	IN
46745	494	9	effect	effect	NN
46745	494	10	produced	produce	VBN
46745	494	11	.	.	.
46745	495	1	As	as	IN
46745	495	2	in	in	IN
46745	495	3	Dr.	Dr.	NNP
46745	495	4	Thomson	Thomson	NNP
46745	495	5	's	's	POS
46745	495	6	arrangement	arrangement	NN
46745	495	7	,	,	,
46745	495	8	Tonics	Tonics	NNP
46745	495	9	and	and	CC
46745	495	10	Astringents	Astringents	NNPS
46745	495	11	are	be	VBP
46745	495	12	said	say	VBN
46745	495	13	to	to	TO
46745	495	14	act	act	VB
46745	495	15	on	on	IN
46745	495	16	the	the	DT
46745	495	17	muscles	muscle	NNS
46745	495	18	;	;	:
46745	495	19	but	but	CC
46745	495	20	no	no	DT
46745	495	21	mention	mention	NN
46745	495	22	is	be	VBZ
46745	495	23	made	make	VBN
46745	495	24	here	here	RB
46745	495	25	of	of	IN
46745	495	26	either	either	DT
46745	495	27	of	of	IN
46745	495	28	them	-PRON-	PRP
46745	495	29	acting	act	VBG
46745	495	30	on	on	IN
46745	495	31	the	the	DT
46745	495	32	blood	blood	NN
46745	495	33	.	.	.
46745	496	1	While	while	IN
46745	496	2	Narcotics	narcotic	NNS
46745	496	3	are	be	VBP
46745	496	4	placed	place	VBN
46745	496	5	among	among	IN
46745	496	6	nerve	nerve	NN
46745	496	7	-	-	HYPH
46745	496	8	medicines	medicine	NNS
46745	496	9	,	,	,
46745	496	10	Stimulants	Stimulants	NNP
46745	496	11	are	be	VBP
46745	496	12	classed	class	VBN
46745	496	13	as	as	IN
46745	496	14	acting	act	VBG
46745	496	15	on	on	IN
46745	496	16	the	the	DT
46745	496	17	circulating	circulate	VBG
46745	496	18	system	system	NN
46745	496	19	.	.	.
46745	497	1	They	-PRON-	PRP
46745	497	2	no	no	RB
46745	497	3	doubt	doubt	RB
46745	497	4	act	act	VBP
46745	497	5	on	on	IN
46745	497	6	the	the	DT
46745	497	7	nerves	nerve	NNS
46745	497	8	,	,	,
46745	497	9	and	and	CC
46745	497	10	then	then	RB
46745	497	11	through	through	IN
46745	497	12	them	-PRON-	PRP
46745	497	13	on	on	IN
46745	497	14	the	the	DT
46745	497	15	vessels	vessel	NNS
46745	497	16	;	;	:
46745	497	17	but	but	CC
46745	497	18	so	so	RB
46745	497	19	also	also	RB
46745	497	20	do	do	VB
46745	497	21	Narcotics	Narcotics	NNP
46745	497	22	,	,	,
46745	497	23	from	from	IN
46745	497	24	which	which	WDT
46745	497	25	they	-PRON-	PRP
46745	497	26	are	be	VBP
46745	497	27	separated	separate	VBN
46745	497	28	.	.	.
46745	498	1	If	if	IN
46745	498	2	in	in	IN
46745	498	3	class	class	NN
46745	498	4	E	e	NN
46745	498	5	are	be	VBP
46745	498	6	only	only	RB
46745	498	7	included	include	VBN
46745	498	8	medicines	medicine	NNS
46745	498	9	acting	act	VBG
46745	498	10	on	on	IN
46745	498	11	the	the	DT
46745	498	12	organic	organic	JJ
46745	498	13	nerves	nerve	NNS
46745	498	14	of	of	IN
46745	498	15	the	the	DT
46745	498	16	heart	heart	NN
46745	498	17	and	and	CC
46745	498	18	arteries	artery	NNS
46745	498	19	,	,	,
46745	498	20	why	why	WRB
46745	498	21	were	be	VBD
46745	498	22	they	-PRON-	PRP
46745	498	23	not	not	RB
46745	498	24	placed	place	VBN
46745	498	25	in	in	IN
46745	498	26	D	d	NN
46745	498	27	,	,	,
46745	498	28	with	with	IN
46745	498	29	Nerve	Nerve	NNP
46745	498	30	-	-	HYPH
46745	498	31	medicines	medicine	NNS
46745	498	32	?	?	.
46745	499	1	But	but	CC
46745	499	2	if	if	IN
46745	499	3	medicines	medicine	NNS
46745	499	4	acting	act	VBG
46745	499	5	on	on	IN
46745	499	6	the	the	DT
46745	499	7	contents	content	NNS
46745	499	8	of	of	IN
46745	499	9	the	the	DT
46745	499	10	vessels	vessel	NNS
46745	499	11	are	be	VBP
46745	499	12	meant	mean	VBN
46745	499	13	,	,	,
46745	499	14	why	why	WRB
46745	499	15	were	be	VBD
46745	499	16	not	not	RB
46745	499	17	Blood	blood	NN
46745	499	18	-	-	HYPH
46745	499	19	medicines	medicine	NNS
46745	499	20	,	,	,
46745	499	21	or	or	CC
46745	499	22	Alteratives	Alteratives	NNPS
46745	499	23	,	,	,
46745	499	24	placed	place	VBN
46745	499	25	here	here	RB
46745	499	26	?	?	.
46745	500	1	They	-PRON-	PRP
46745	500	2	are	be	VBP
46745	500	3	entirely	entirely	RB
46745	500	4	omitted	omit	VBN
46745	500	5	;	;	:
46745	500	6	which	which	WDT
46745	500	7	seems	seem	VBZ
46745	500	8	to	to	TO
46745	500	9	be	be	VB
46745	500	10	a	a	DT
46745	500	11	fault	fault	NN
46745	500	12	in	in	IN
46745	500	13	this	this	DT
46745	500	14	system	system	NN
46745	500	15	.	.	.
46745	501	1	Dr.	Dr.	NNP
46745	501	2	Pereira	Pereira	NNP
46745	501	3	seems	seem	VBZ
46745	501	4	to	to	TO
46745	501	5	have	have	VB
46745	501	6	adopted	adopt	VBN
46745	501	7	a	a	DT
46745	501	8	more	more	RBR
46745	501	9	correct	correct	JJ
46745	501	10	view	view	NN
46745	501	11	of	of	IN
46745	501	12	both	both	DT
46745	501	13	of	of	IN
46745	501	14	these	these	DT
46745	501	15	cases	case	NNS
46745	501	16	.	.	.
46745	502	1	He	-PRON-	PRP
46745	502	2	includes	include	VBZ
46745	502	3	Stimulants	stimulant	NNS
46745	502	4	with	with	IN
46745	502	5	_	_	NNP
46745	502	6	Neurotics	Neurotics	NNP
46745	502	7	_	_	NNP
46745	502	8	,	,	,
46745	502	9	and	and	CC
46745	502	10	places	place	NNS
46745	502	11	among	among	IN
46745	502	12	_	_	NNP
46745	502	13	"	"	``
46745	502	14	Hæmatics	Hæmatics	NNPS
46745	502	15	"	"	''
46745	502	16	_	_	NNP
46745	502	17	those	those	DT
46745	502	18	medicines	medicine	NNS
46745	502	19	which	which	WDT
46745	502	20	are	be	VBP
46745	502	21	commonly	commonly	RB
46745	502	22	termed	term	VBN
46745	502	23	Alteratives	alterative	NNS
46745	502	24	.	.	.
46745	503	1	It	-PRON-	PRP
46745	503	2	seems	seem	VBZ
46745	503	3	to	to	IN
46745	503	4	me	-PRON-	PRP
46745	503	5	that	that	IN
46745	503	6	when	when	WRB
46745	503	7	a	a	DT
46745	503	8	medicine	medicine	NN
46745	503	9	acts	act	VBZ
46745	503	10	on	on	IN
46745	503	11	the	the	DT
46745	503	12	blood	blood	NN
46745	503	13	,	,	,
46745	503	14	this	this	DT
46745	503	15	action	action	NN
46745	503	16	ought	ought	MD
46745	503	17	not	not	RB
46745	503	18	to	to	TO
46745	503	19	be	be	VB
46745	503	20	thrown	throw	VBN
46745	503	21	into	into	IN
46745	503	22	the	the	DT
46745	503	23	shade	shade	NN
46745	503	24	,	,	,
46745	503	25	but	but	CC
46745	503	26	should	should	MD
46745	503	27	rather	rather	RB
46745	503	28	be	be	VB
46745	503	29	placed	place	VBN
46745	503	30	before	before	IN
46745	503	31	all	all	DT
46745	503	32	its	-PRON-	PRP$
46745	503	33	other	other	JJ
46745	503	34	operations	operation	NNS
46745	503	35	,	,	,
46745	503	36	as	as	IN
46745	503	37	being	be	VBG
46745	503	38	of	of	IN
46745	503	39	more	more	JJR
46745	503	40	importance	importance	NN
46745	503	41	than	than	IN
46745	503	42	any	any	DT
46745	503	43	of	of	IN
46745	503	44	them	-PRON-	PRP
46745	503	45	.	.	.
46745	504	1	Dr.	Dr.	NNP
46745	504	2	Pereira	Pereira	NNP
46745	504	3	arranges	arrange	VBZ
46745	504	4	in	in	IN
46745	504	5	six	six	CD
46745	504	6	classes	class	NNS
46745	504	7	those	those	DT
46745	504	8	medicines	medicine	NNS
46745	504	9	which	which	WDT
46745	504	10	are	be	VBP
46745	504	11	given	give	VBN
46745	504	12	internally	internally	RB
46745	504	13	,	,	,
46745	504	14	having	have	VBG
46745	504	15	previously	previously	RB
46745	504	16	made	make	VBN
46745	504	17	three	three	CD
46745	504	18	classes	class	NNS
46745	504	19	of	of	IN
46745	504	20	external	external	JJ
46745	504	21	or	or	CC
46745	504	22	topical	topical	JJ
46745	504	23	agents	agent	NNS
46745	504	24	,	,	,
46745	504	25	with	with	IN
46745	504	26	which	which	WDT
46745	504	27	we	-PRON-	PRP
46745	504	28	are	be	VBP
46745	504	29	not	not	RB
46745	504	30	now	now	RB
46745	504	31	concerned	concern	VBN
46745	504	32	.	.	.
46745	505	1	Some	some	DT
46745	505	2	of	of	IN
46745	505	3	the	the	DT
46745	505	4	classes	class	NNS
46745	505	5	are	be	VBP
46745	505	6	again	again	RB
46745	505	7	divided	divide	VBN
46745	505	8	into	into	IN
46745	505	9	large	large	JJ
46745	505	10	groups	group	NNS
46745	505	11	,	,	,
46745	505	12	these	these	DT
46745	505	13	and	and	CC
46745	505	14	the	the	DT
46745	505	15	other	other	JJ
46745	505	16	subdivisions	subdivision	NNS
46745	505	17	being	be	VBG
46745	505	18	either	either	RB
46745	505	19	based	base	VBN
46745	505	20	on	on	IN
46745	505	21	more	more	RBR
46745	505	22	particular	particular	JJ
46745	505	23	local	local	JJ
46745	505	24	tendencies	tendency	NNS
46745	505	25	,	,	,
46745	505	26	or	or	CC
46745	505	27	on	on	IN
46745	505	28	the	the	DT
46745	505	29	_	_	NNP
46745	505	30	physiological	physiological	JJ
46745	505	31	action	action	NN
46745	505	32	_	_	NNP
46745	505	33	of	of	IN
46745	505	34	the	the	DT
46745	505	35	medicine	medicine	NN
46745	505	36	on	on	IN
46745	505	37	the	the	DT
46745	505	38	part	part	NN
46745	505	39	to	to	TO
46745	505	40	which	which	WDT
46745	505	41	its	-PRON-	PRP$
46745	505	42	operation	operation	NN
46745	505	43	tends	tend	VBZ
46745	505	44	.	.	.
46745	506	1	DR	DR	NNP
46745	506	2	.	.	.
46745	506	3	PEREIRA	PEREIRA	NNP
46745	506	4	'S	be	VBZ
46745	506	5	CLASSES	class	NNS
46745	506	6	.	.	.
46745	507	1	CLASS	CLASS	NNP
46745	507	2	IV	IV	NNP
46745	507	3	.	.	.
46745	508	1	Hæmatica	Hæmatica	NNP
46745	508	2	.	.	.
46745	509	1	1	1	LS
46745	509	2	.	.	.
46745	510	1	_	_	NNP
46745	510	2	Spanæmica	Spanæmica	NNP
46745	510	3	.	.	.
46745	510	4	_	_	NNP
46745	510	5	2	2	CD
46745	510	6	.	.	.
46745	511	1	_	_	NNP
46745	511	2	Hæmatinica	Hæmatinica	NNP
46745	511	3	.	.	.
46745	511	4	_	_	NNP
46745	511	5	CLASS	CLASS	NNP
46745	511	6	V.	V.	NNP
46745	511	7	Pneumatica	Pneumatica	NNP
46745	511	8	.	.	.
46745	512	1	CLASS	CLASS	NNP
46745	512	2	VI	VI	NNP
46745	512	3	.	.	.
46745	513	1	Neurotica	Neurotica	NNP
46745	513	2	.	.	.
46745	514	1	1	1	LS
46745	514	2	.	.	.
46745	515	1	_	_	NNP
46745	515	2	Cerebro	Cerebro	NNP
46745	515	3	-	-	HYPH
46745	515	4	spinalia	spinalia	NNP
46745	515	5	.	.	.
46745	515	6	_	_	NNP
46745	515	7	2	2	CD
46745	515	8	.	.	.
46745	516	1	_	_	NNP
46745	516	2	Ganglionica	Ganglionica	NNP
46745	516	3	.	.	.
46745	516	4	_	_	NNP
46745	516	5	CLASS	CLASS	NNP
46745	516	6	VII	vii	NN
46745	516	7	.	.	.
46745	517	1	C[oe]liaca	c[oe]liaca	NN
46745	517	2	.	.	.
46745	518	1	CLASS	class	NN
46745	518	2	VIII	viii	NN
46745	518	3	.	.	.
46745	519	1	Eccritica	Eccritica	NNP
46745	519	2	.	.	.
46745	520	1	CLASS	CLASS	NNP
46745	520	2	IX	IX	NNP
46745	520	3	.	.	.
46745	521	1	Genetica	Genetica	NNP
46745	521	2	.	.	.
46745	522	1	These	these	DT
46745	522	2	groups	group	NNS
46745	522	3	,	,	,
46745	522	4	though	though	IN
46745	522	5	differently	differently	RB
46745	522	6	placed	place	VBN
46745	522	7	,	,	,
46745	522	8	correspond	correspond	VB
46745	522	9	to	to	IN
46745	522	10	six	six	CD
46745	522	11	of	of	IN
46745	522	12	Eberle	Eberle	NNP
46745	522	13	's	's	POS
46745	522	14	seven	seven	CD
46745	522	15	classes	class	NNS
46745	522	16	.	.	.
46745	523	1	The	the	DT
46745	523	2	class	class	NN
46745	523	3	acting	act	VBG
46745	523	4	on	on	IN
46745	523	5	the	the	DT
46745	523	6	muscular	muscular	JJ
46745	523	7	system	system	NN
46745	523	8	is	be	VBZ
46745	523	9	omitted	omit	VBN
46745	523	10	.	.	.
46745	524	1	The	the	DT
46745	524	2	subdivision	subdivision	NN
46745	524	3	here	here	RB
46745	524	4	is	be	VBZ
46745	524	5	more	more	RBR
46745	524	6	accurate	accurate	JJ
46745	524	7	and	and	CC
46745	524	8	scientific	scientific	JJ
46745	524	9	.	.	.
46745	525	1	_	_	NNP
46745	525	2	Hæmatics	Hæmatics	NNP
46745	525	3	_	_	NNP
46745	525	4	or	or	CC
46745	525	5	blood	blood	NN
46745	525	6	-	-	HYPH
46745	525	7	medicines	medicine	NNS
46745	525	8	,	,	,
46745	525	9	are	be	VBP
46745	525	10	divided	divide	VBN
46745	525	11	into	into	IN
46745	525	12	two	two	CD
46745	525	13	classes	class	NNS
46745	525	14	.	.	.
46745	526	1	_	_	NNP
46745	526	2	Spanæmics	Spanæmics	NNP
46745	526	3	_	_	NNP
46745	526	4	the	the	DT
46745	526	5	first	first	JJ
46745	526	6	of	of	IN
46745	526	7	these	these	DT
46745	526	8	,	,	,
46745	526	9	are	be	VBP
46745	526	10	named	name	VBN
46745	526	11	from	from	IN
46745	526	12	their	-PRON-	PRP$
46745	526	13	tendency	tendency	NN
46745	526	14	to	to	TO
46745	526	15	impoverish	impoverish	VB
46745	526	16	the	the	DT
46745	526	17	blood	blood	NN
46745	526	18	.	.	.
46745	527	1	_	_	NNP
46745	527	2	Hæmatinics	Hæmatinics	NNP
46745	527	3	_	_	NNP
46745	527	4	including	include	VBG
46745	527	5	the	the	DT
46745	527	6	compounds	compound	NNS
46745	527	7	of	of	IN
46745	527	8	Iron	Iron	NNP
46745	527	9	,	,	,
46745	527	10	tend	tend	VBP
46745	527	11	to	to	TO
46745	527	12	enrich	enrich	VB
46745	527	13	it	-PRON-	PRP
46745	527	14	.	.	.
46745	528	1	In	in	IN
46745	528	2	the	the	DT
46745	528	3	first	first	JJ
46745	528	4	division	division	NN
46745	528	5	are	be	VBP
46745	528	6	included	include	VBN
46745	528	7	the	the	DT
46745	528	8	medicines	medicine	NNS
46745	528	9	commonly	commonly	RB
46745	528	10	termed	term	VBN
46745	528	11	Alteratives	alterative	NNS
46745	528	12	,	,	,
46745	528	13	as	as	RB
46745	528	14	well	well	RB
46745	528	15	as	as	IN
46745	528	16	Acids	Acids	NNP
46745	528	17	,	,	,
46745	528	18	Alkalies	Alkalies	NNPS
46745	528	19	,	,	,
46745	528	20	the	the	DT
46745	528	21	compounds	compound	NNS
46745	528	22	of	of	IN
46745	528	23	Lead	Lead	NNP
46745	528	24	,	,	,
46745	528	25	Silver	Silver	NNP
46745	528	26	,	,	,
46745	528	27	Copper	Copper	NNP
46745	528	28	,	,	,
46745	528	29	etc	etc	FW
46745	528	30	.	.	.
46745	529	1	In	in	IN
46745	529	2	the	the	DT
46745	529	3	selection	selection	NN
46745	529	4	of	of	IN
46745	529	5	the	the	DT
46745	529	6	above	above	JJ
46745	529	7	name	name	NN
46745	529	8	attention	attention	NN
46745	529	9	is	be	VBZ
46745	529	10	paid	pay	VBN
46745	529	11	to	to	IN
46745	529	12	the	the	DT
46745	529	13	abstract	abstract	JJ
46745	529	14	physiological	physiological	JJ
46745	529	15	effect	effect	NN
46745	529	16	of	of	IN
46745	529	17	these	these	DT
46745	529	18	medicines	medicine	NNS
46745	529	19	,	,	,
46745	529	20	rather	rather	RB
46745	529	21	than	than	IN
46745	529	22	to	to	IN
46745	529	23	their	-PRON-	PRP$
46745	529	24	therapeutical	therapeutical	JJ
46745	529	25	applications	application	NNS
46745	529	26	.	.	.
46745	530	1	The	the	DT
46745	530	2	impoverishing	impoverishing	NN
46745	530	3	of	of	IN
46745	530	4	the	the	DT
46745	530	5	blood	blood	NN
46745	530	6	may	may	MD
46745	530	7	be	be	VB
46745	530	8	the	the	DT
46745	530	9	ultimate	ultimate	JJ
46745	530	10	action	action	NN
46745	530	11	of	of	IN
46745	530	12	such	such	PDT
46745	530	13	a	a	DT
46745	530	14	medicine	medicine	NN
46745	530	15	as	as	IN
46745	530	16	Potash	Potash	NNP
46745	530	17	or	or	CC
46745	530	18	Mercury	Mercury	NNP
46745	530	19	,	,	,
46745	530	20	but	but	CC
46745	530	21	not	not	RB
46745	530	22	exactly	exactly	RB
46745	530	23	the	the	DT
46745	530	24	primary	primary	JJ
46745	530	25	operation	operation	NN
46745	530	26	for	for	IN
46745	530	27	which	which	WDT
46745	530	28	it	-PRON-	PRP
46745	530	29	is	be	VBZ
46745	530	30	used	use	VBN
46745	530	31	in	in	IN
46745	530	32	medicine	medicine	NN
46745	530	33	.	.	.
46745	531	1	It	-PRON-	PRP
46745	531	2	is	be	VBZ
46745	531	3	produced	produce	VBN
46745	531	4	by	by	IN
46745	531	5	the	the	DT
46745	531	6	remedy	remedy	NN
46745	531	7	when	when	WRB
46745	531	8	taken	take	VBN
46745	531	9	in	in	IN
46745	531	10	excess	excess	NN
46745	531	11	,	,	,
46745	531	12	and	and	CC
46745	531	13	not	not	RB
46745	531	14	when	when	WRB
46745	531	15	given	give	VBN
46745	531	16	in	in	IN
46745	531	17	small	small	JJ
46745	531	18	doses	dose	NNS
46745	531	19	.	.	.
46745	532	1	_	_	NNP
46745	532	2	Neurotics	Neurotics	NNP
46745	532	3	_	_	NNP
46745	532	4	,	,	,
46745	532	5	or	or	CC
46745	532	6	medicines	medicine	NNS
46745	532	7	which	which	WDT
46745	532	8	act	act	VBP
46745	532	9	on	on	IN
46745	532	10	the	the	DT
46745	532	11	nerves	nerve	NNS
46745	532	12	,	,	,
46745	532	13	are	be	VBP
46745	532	14	divided	divide	VBN
46745	532	15	into	into	IN
46745	532	16	those	those	DT
46745	532	17	which	which	WDT
46745	532	18	affect	affect	VBP
46745	532	19	the	the	DT
46745	532	20	brain	brain	NN
46745	532	21	and	and	CC
46745	532	22	spinal	spinal	JJ
46745	532	23	system	system	NN
46745	532	24	,	,	,
46745	532	25	and	and	CC
46745	532	26	those	those	DT
46745	532	27	which	which	WDT
46745	532	28	are	be	VBP
46745	532	29	supposed	suppose	VBN
46745	532	30	to	to	TO
46745	532	31	influence	influence	VB
46745	532	32	the	the	DT
46745	532	33	ganglionic	ganglionic	NN
46745	532	34	system	system	NN
46745	532	35	,	,	,
46745	532	36	and	and	CC
46745	532	37	through	through	IN
46745	532	38	it	-PRON-	PRP
46745	532	39	the	the	DT
46745	532	40	heart	heart	NN
46745	532	41	and	and	CC
46745	532	42	great	great	JJ
46745	532	43	vessels	vessel	NNS
46745	532	44	.	.	.
46745	533	1	(	(	-LRB-
46745	533	2	When	when	WRB
46745	533	3	we	-PRON-	PRP
46745	533	4	shall	shall	MD
46745	533	5	afterwards	afterwards	RB
46745	533	6	discuss	discuss	VB
46745	533	7	the	the	DT
46745	533	8	action	action	NN
46745	533	9	of	of	IN
46745	533	10	nerve	nerve	NN
46745	533	11	-	-	HYPH
46745	533	12	medicines	medicine	NNS
46745	533	13	,	,	,
46745	533	14	it	-PRON-	PRP
46745	533	15	will	will	MD
46745	533	16	be	be	VB
46745	533	17	seen	see	VBN
46745	533	18	that	that	IN
46745	533	19	it	-PRON-	PRP
46745	533	20	is	be	VBZ
46745	533	21	very	very	RB
46745	533	22	difficult	difficult	JJ
46745	533	23	,	,	,
46745	533	24	if	if	IN
46745	533	25	not	not	RB
46745	533	26	impossible	impossible	JJ
46745	533	27	,	,	,
46745	533	28	to	to	TO
46745	533	29	enforce	enforce	VB
46745	533	30	this	this	DT
46745	533	31	distinction	distinction	NN
46745	533	32	.	.	.
46745	533	33	)	)	-RRB-
46745	534	1	The	the	DT
46745	534	2	different	different	JJ
46745	534	3	kinds	kind	NNS
46745	534	4	of	of	IN
46745	534	5	Narcotics	Narcotics	NNP
46745	534	6	form	form	VBP
46745	534	7	the	the	DT
46745	534	8	first	first	JJ
46745	534	9	division	division	NN
46745	534	10	,	,	,
46745	534	11	while	while	IN
46745	534	12	the	the	DT
46745	534	13	second	second	JJ
46745	534	14	includes	include	VBZ
46745	534	15	Stimulants	Stimulants	NNP
46745	534	16	and	and	CC
46745	534	17	vascular	vascular	JJ
46745	534	18	Sedatives	Sedatives	NNPS
46745	534	19	.	.	.
46745	535	1	The	the	DT
46745	535	2	class	class	NN
46745	535	3	of	of	IN
46745	535	4	_	_	NNP
46745	535	5	Eccritics	Eccritics	NNP
46745	535	6	_	_	NNP
46745	535	7	includes	include	VBZ
46745	535	8	all	all	DT
46745	535	9	medicines	medicine	NNS
46745	535	10	acting	act	VBG
46745	535	11	on	on	IN
46745	535	12	the	the	DT
46745	535	13	glands	gland	NNS
46745	535	14	,	,	,
46745	535	15	commonly	commonly	RB
46745	535	16	called	call	VBN
46745	535	17	Evacuants	evacuant	NNS
46745	535	18	.	.	.
46745	536	1	The	the	DT
46745	536	2	details	detail	NNS
46745	536	3	of	of	IN
46745	536	4	this	this	DT
46745	536	5	arrangement	arrangement	NN
46745	536	6	,	,	,
46745	536	7	to	to	TO
46745	536	8	which	which	WDT
46745	536	9	I	-PRON-	PRP
46745	536	10	shall	shall	MD
46745	536	11	at	at	IN
46745	536	12	present	present	JJ
46745	536	13	venture	venture	NN
46745	536	14	to	to	IN
46745	536	15	object	object	NN
46745	536	16	,	,	,
46745	536	17	are	be	VBP
46745	536	18	,	,	,
46745	536	19	first	first	RB
46745	536	20	,	,	,
46745	536	21	the	the	DT
46745	536	22	multiplicity	multiplicity	NN
46745	536	23	of	of	IN
46745	536	24	classes	class	NNS
46745	536	25	,	,	,
46745	536	26	and	and	CC
46745	536	27	secondly	secondly	RB
46745	536	28	,	,	,
46745	536	29	the	the	DT
46745	536	30	inclusion	inclusion	NN
46745	536	31	of	of	IN
46745	536	32	certain	certain	JJ
46745	536	33	medicines	medicine	NNS
46745	536	34	in	in	IN
46745	536	35	the	the	DT
46745	536	36	division	division	NN
46745	536	37	of	of	IN
46745	536	38	_	_	NNP
46745	536	39	Cerebro	Cerebro	NNP
46745	536	40	-	-	HYPH
46745	536	41	spinals	spinal	NNS
46745	536	42	_	_	NNP
46745	536	43	.	.	.
46745	537	1	Three	three	CD
46745	537	2	of	of	IN
46745	537	3	the	the	DT
46745	537	4	classes	class	NNS
46745	537	5	seem	seem	VBP
46745	537	6	to	to	TO
46745	537	7	be	be	VB
46745	537	8	superfluous	superfluous	JJ
46745	537	9	,	,	,
46745	537	10	and	and	CC
46745	537	11	only	only	RB
46745	537	12	tend	tend	VB
46745	537	13	to	to	TO
46745	537	14	confuse	confuse	VB
46745	537	15	.	.	.
46745	538	1	There	there	EX
46745	538	2	is	be	VBZ
46745	538	3	a	a	DT
46745	538	4	class	class	NN
46745	538	5	of	of	IN
46745	538	6	_	_	NNP
46745	538	7	Pneumatics	Pneumatics	NNPS
46745	538	8	_	_	NNP
46745	538	9	,	,	,
46745	538	10	acting	act	VBG
46745	538	11	on	on	IN
46745	538	12	the	the	DT
46745	538	13	respiratory	respiratory	JJ
46745	538	14	organs	organ	NNS
46745	538	15	.	.	.
46745	539	1	But	but	CC
46745	539	2	Expectorants	expectorant	NNS
46745	539	3	are	be	VBP
46745	539	4	found	find	VBN
46745	539	5	elsewhere	elsewhere	RB
46745	539	6	among	among	IN
46745	539	7	_	_	NNP
46745	539	8	Eccritics	Eccritics	NNP
46745	539	9	_	_	NNP
46745	539	10	;	;	:
46745	539	11	and	and	CC
46745	539	12	those	those	DT
46745	539	13	medicines	medicine	NNS
46745	539	14	which	which	WDT
46745	539	15	influence	influence	VBP
46745	539	16	the	the	DT
46745	539	17	nerves	nerve	NNS
46745	539	18	of	of	IN
46745	539	19	the	the	DT
46745	539	20	lungs	lung	NNS
46745	539	21	,	,	,
46745	539	22	among	among	IN
46745	539	23	_	_	NNP
46745	539	24	Neurotics	Neurotics	NNP
46745	539	25	_	_	NNP
46745	539	26	.	.	.
46745	540	1	The	the	DT
46745	540	2	same	same	JJ
46745	540	3	with	with	IN
46745	540	4	_	_	NNP
46745	540	5	C[oe]liacs	C[oe]liacs	NNP
46745	540	6	_	_	NNP
46745	540	7	;	;	:
46745	540	8	for	for	IN
46745	540	9	Cathartics	Cathartics	NNP
46745	540	10	,	,	,
46745	540	11	found	find	VBN
46745	540	12	among	among	IN
46745	540	13	_	_	NNP
46745	540	14	Eccritics	Eccritics	NNP
46745	540	15	_	_	NNP
46745	540	16	,	,	,
46745	540	17	are	be	VBP
46745	540	18	the	the	DT
46745	540	19	most	most	RBS
46745	540	20	important	important	JJ
46745	540	21	medicines	medicine	NNS
46745	540	22	acting	act	VBG
46745	540	23	on	on	IN
46745	540	24	the	the	DT
46745	540	25	intestines	intestine	NNS
46745	540	26	.	.	.
46745	541	1	_	_	NNP
46745	541	2	Genetics	Genetics	NNP
46745	541	3	_	_	NNP
46745	541	4	contain	contain	NN
46745	541	5	medicines	medicine	NNS
46745	541	6	which	which	WDT
46745	541	7	control	control	VBP
46745	541	8	the	the	DT
46745	541	9	uterine	uterine	JJ
46745	541	10	and	and	CC
46745	541	11	sexual	sexual	JJ
46745	541	12	systems	system	NNS
46745	541	13	,	,	,
46745	541	14	which	which	WDT
46745	541	15	may	may	MD
46745	541	16	all	all	DT
46745	541	17	be	be	VB
46745	541	18	reckoned	reckon	VBN
46745	541	19	among	among	IN
46745	541	20	_	_	NNP
46745	541	21	Neurotics	Neurotics	NNP
46745	541	22	_	_	NNP
46745	541	23	.	.	.
46745	542	1	And	and	CC
46745	542	2	yet	yet	RB
46745	542	3	this	this	DT
46745	542	4	multiplicity	multiplicity	NN
46745	542	5	of	of	IN
46745	542	6	names	name	NNS
46745	542	7	is	be	VBZ
46745	542	8	consistently	consistently	RB
46745	542	9	employed	employ	VBN
46745	542	10	in	in	IN
46745	542	11	carrying	carry	VBG
46745	542	12	out	out	RP
46745	542	13	the	the	DT
46745	542	14	principle	principle	NN
46745	542	15	of	of	IN
46745	542	16	this	this	DT
46745	542	17	classification	classification	NN
46745	542	18	,	,	,
46745	542	19	which	which	WDT
46745	542	20	is	be	VBZ
46745	542	21	,	,	,
46745	542	22	to	to	TO
46745	542	23	arrange	arrange	VB
46745	542	24	according	accord	VBG
46745	542	25	to	to	IN
46745	542	26	the	the	DT
46745	542	27	different	different	JJ
46745	542	28	parts	part	NNS
46745	542	29	of	of	IN
46745	542	30	the	the	DT
46745	542	31	system	system	NN
46745	542	32	all	all	DT
46745	542	33	substances	substance	NNS
46745	542	34	which	which	WDT
46745	542	35	have	have	VBP
46745	542	36	any	any	DT
46745	542	37	tendency	tendency	NN
46745	542	38	to	to	TO
46745	542	39	act	act	VB
46745	542	40	on	on	IN
46745	542	41	those	those	DT
46745	542	42	parts	part	NNS
46745	542	43	.	.	.
46745	543	1	Dr.	Dr.	NNP
46745	543	2	Pereira	Pereira	NNP
46745	543	3	makes	make	VBZ
46745	543	4	four	four	CD
46745	543	5	orders	order	NNS
46745	543	6	of	of	IN
46745	543	7	_	_	NNP
46745	543	8	Cerebro	Cerebro	NNP
46745	543	9	-	-	HYPH
46745	543	10	spinals	spinal	NNS
46745	543	11	_	_	NNP
46745	543	12	;	;	:
46745	543	13	three	three	CD
46745	543	14	include	include	VBP
46745	543	15	different	different	JJ
46745	543	16	kinds	kind	NNS
46745	543	17	of	of	IN
46745	543	18	Narcotics	Narcotics	NNP
46745	543	19	,	,	,
46745	543	20	very	very	RB
46745	543	21	minutely	minutely	RB
46745	543	22	subdivided	subdivide	VBN
46745	543	23	;	;	:
46745	543	24	another	another	DT
46745	543	25	is	be	VBZ
46745	543	26	called	call	VBN
46745	543	27	_	_	NNP
46745	543	28	Cinetics	Cinetics	NNP
46745	543	29	_	_	NNP
46745	543	30	.	.	.
46745	544	1	They	-PRON-	PRP
46745	544	2	affect	affect	VBP
46745	544	3	the	the	DT
46745	544	4	muscular	muscular	JJ
46745	544	5	system	system	NN
46745	544	6	;	;	:
46745	544	7	but	but	CC
46745	544	8	it	-PRON-	PRP
46745	544	9	is	be	VBZ
46745	544	10	altogether	altogether	RB
46745	544	11	an	an	DT
46745	544	12	assumption	assumption	NN
46745	544	13	to	to	TO
46745	544	14	assert	assert	VB
46745	544	15	that	that	IN
46745	544	16	these	these	DT
46745	544	17	medicines	medicine	NNS
46745	544	18	,	,	,
46745	544	19	Astringents	Astringents	NNPS
46745	544	20	and	and	CC
46745	544	21	Tonics	Tonics	NNP
46745	544	22	,	,	,
46745	544	23	do	do	VB
46745	544	24	so	so	RB
46745	544	25	by	by	IN
46745	544	26	influencing	influence	VBG
46745	544	27	the	the	DT
46745	544	28	nerves	nerve	NNS
46745	544	29	.	.	.
46745	545	1	As	as	IN
46745	545	2	to	to	IN
46745	545	3	Astringents	Astringents	NNP
46745	545	4	,	,	,
46745	545	5	it	-PRON-	PRP
46745	545	6	appears	appear	VBZ
46745	545	7	that	that	IN
46745	545	8	they	-PRON-	PRP
46745	545	9	do	do	VBP
46745	545	10	not	not	RB
46745	545	11	affect	affect	VB
46745	545	12	the	the	DT
46745	545	13	nerves	nerve	NNS
46745	545	14	in	in	IN
46745	545	15	any	any	DT
46745	545	16	way	way	NN
46745	545	17	,	,	,
46745	545	18	for	for	IN
46745	545	19	which	which	WDT
46745	545	20	reason	reason	NN
46745	545	21	I	-PRON-	PRP
46745	545	22	shall	shall	MD
46745	545	23	have	have	VB
46745	545	24	to	to	TO
46745	545	25	make	make	VB
46745	545	26	a	a	DT
46745	545	27	separate	separate	JJ
46745	545	28	class	class	NN
46745	545	29	of	of	IN
46745	545	30	them	-PRON-	PRP
46745	545	31	.	.	.
46745	546	1	For	for	IN
46745	546	2	Tonics	tonic	NNS
46745	546	3	,	,	,
46745	546	4	there	there	EX
46745	546	5	is	be	VBZ
46745	546	6	great	great	JJ
46745	546	7	reason	reason	NN
46745	546	8	to	to	TO
46745	546	9	suppose	suppose	VB
46745	546	10	that	that	IN
46745	546	11	in	in	IN
46745	546	12	the	the	DT
46745	546	13	first	first	JJ
46745	546	14	place	place	NN
46745	546	15	they	-PRON-	PRP
46745	546	16	act	act	VBP
46745	546	17	on	on	IN
46745	546	18	the	the	DT
46745	546	19	blood	blood	NN
46745	546	20	;	;	:
46745	546	21	so	so	IN
46745	546	22	that	that	IN
46745	546	23	I	-PRON-	PRP
46745	546	24	can	can	MD
46745	546	25	not	not	RB
46745	546	26	agree	agree	VB
46745	546	27	with	with	IN
46745	546	28	Dr.	Dr.	NNP
46745	546	29	Pereira	Pereira	NNP
46745	546	30	,	,	,
46745	546	31	who	who	WP
46745	546	32	ranks	rank	VBZ
46745	546	33	them	-PRON-	PRP
46745	546	34	among	among	IN
46745	546	35	_	_	NNP
46745	546	36	Neurotics	Neurotics	NNP
46745	546	37	_	_	NNP
46745	546	38	.	.	.
46745	547	1	Emetics	emetic	NNS
46745	547	2	are	be	VBP
46745	547	3	classed	class	VBN
46745	547	4	by	by	IN
46745	547	5	him	-PRON-	PRP
46745	547	6	among	among	IN
46745	547	7	_	_	NNP
46745	547	8	Eccritics	Eccritics	NNP
46745	547	9	_	_	NNP
46745	547	10	;	;	:
46745	547	11	but	but	CC
46745	547	12	it	-PRON-	PRP
46745	547	13	seems	seem	VBZ
46745	547	14	to	to	IN
46745	547	15	me	-PRON-	PRP
46745	547	16	that	that	IN
46745	547	17	their	-PRON-	PRP$
46745	547	18	action	action	NN
46745	547	19	is	be	VBZ
46745	547	20	either	either	CC
46745	547	21	external	external	JJ
46745	547	22	,	,	,
46745	547	23	and	and	CC
46745	547	24	of	of	IN
46745	547	25	an	an	DT
46745	547	26	irritant	irritant	JJ
46745	547	27	nature	nature	NN
46745	547	28	,	,	,
46745	547	29	or	or	CC
46745	547	30	when	when	WRB
46745	547	31	from	from	IN
46745	547	32	the	the	DT
46745	547	33	blood	blood	NN
46745	547	34	,	,	,
46745	547	35	that	that	IN
46745	547	36	it	-PRON-	PRP
46745	547	37	is	be	VBZ
46745	547	38	exerted	exert	VBN
46745	547	39	upon	upon	IN
46745	547	40	the	the	DT
46745	547	41	nerves	nerve	NNS
46745	547	42	of	of	IN
46745	547	43	the	the	DT
46745	547	44	stomach	stomach	NN
46745	547	45	.	.	.
46745	548	1	The	the	DT
46745	548	2	stomach	stomach	NN
46745	548	3	is	be	VBZ
46745	548	4	not	not	RB
46745	548	5	,	,	,
46745	548	6	like	like	IN
46745	548	7	most	most	JJS
46745	548	8	glandular	glandular	JJ
46745	548	9	organs	organ	NNS
46745	548	10	,	,	,
46745	548	11	a	a	DT
46745	548	12	simple	simple	JJ
46745	548	13	emunctory	emunctory	NN
46745	548	14	,	,	,
46745	548	15	and	and	CC
46745	548	16	it	-PRON-	PRP
46745	548	17	is	be	VBZ
46745	548	18	affected	affect	VBN
46745	548	19	by	by	IN
46745	548	20	medicines	medicine	NNS
46745	548	21	in	in	IN
46745	548	22	a	a	DT
46745	548	23	different	different	JJ
46745	548	24	way	way	NN
46745	548	25	.	.	.
46745	549	1	Whereas	whereas	IN
46745	549	2	gland	gland	NN
46745	549	3	-	-	HYPH
46745	549	4	medicines	medicines	NNP
46745	549	5	increase	increase	VBP
46745	549	6	secretion	secretion	NN
46745	549	7	,	,	,
46745	549	8	the	the	DT
46745	549	9	chief	chief	JJ
46745	549	10	action	action	NN
46745	549	11	of	of	IN
46745	549	12	Emetics	Emetics	NNPS
46745	549	13	is	be	VBZ
46745	549	14	to	to	TO
46745	549	15	cause	cause	VB
46745	549	16	an	an	DT
46745	549	17	evacuation	evacuation	NN
46745	549	18	of	of	IN
46745	549	19	the	the	DT
46745	549	20	contents	content	NNS
46745	549	21	of	of	IN
46745	549	22	the	the	DT
46745	549	23	stomach	stomach	NN
46745	549	24	by	by	IN
46745	549	25	contraction	contraction	NN
46745	549	26	of	of	IN
46745	549	27	itself	-PRON-	PRP
46745	549	28	and	and	CC
46745	549	29	of	of	IN
46745	549	30	other	other	JJ
46745	549	31	muscles	muscle	NNS
46745	549	32	.	.	.
46745	550	1	All	all	DT
46745	550	2	substances	substance	NNS
46745	550	3	which	which	WDT
46745	550	4	touch	touch	VBP
46745	550	5	the	the	DT
46745	550	6	stomach	stomach	NN
46745	550	7	cause	cause	VB
46745	550	8	the	the	DT
46745	550	9	copious	copious	JJ
46745	550	10	outpouring	outpouring	NN
46745	550	11	of	of	IN
46745	550	12	a	a	DT
46745	550	13	thin	thin	JJ
46745	550	14	fluid	fluid	NN
46745	550	15	by	by	IN
46745	550	16	mere	mere	JJ
46745	550	17	contact	contact	NN
46745	550	18	;	;	:
46745	550	19	yet	yet	CC
46745	550	20	we	-PRON-	PRP
46745	550	21	can	can	MD
46745	550	22	not	not	RB
46745	550	23	for	for	IN
46745	550	24	this	this	DT
46745	550	25	reason	reason	NN
46745	550	26	call	call	VB
46745	550	27	them	-PRON-	PRP
46745	550	28	medicines	medicine	NNS
46745	550	29	which	which	WDT
46745	550	30	tend	tend	VBP
46745	550	31	to	to	TO
46745	550	32	increase	increase	VB
46745	550	33	secretion	secretion	NN
46745	550	34	.	.	.
46745	551	1	Emetics	emetic	NNS
46745	551	2	acting	act	VBG
46745	551	3	from	from	IN
46745	551	4	the	the	DT
46745	551	5	blood	blood	NN
46745	551	6	after	after	IN
46745	551	7	absorption	absorption	NN
46745	551	8	,	,	,
46745	551	9	as	as	IN
46745	551	10	Tartar	Tartar	NNP
46745	551	11	emetic	emetic	NN
46745	551	12	,	,	,
46745	551	13	which	which	WDT
46745	551	14	generally	generally	RB
46745	551	15	influence	influence	VBP
46745	551	16	at	at	IN
46745	551	17	the	the	DT
46745	551	18	same	same	JJ
46745	551	19	time	time	NN
46745	551	20	either	either	CC
46745	551	21	the	the	DT
46745	551	22	lungs	lung	NNS
46745	551	23	or	or	CC
46745	551	24	the	the	DT
46745	551	25	heart	heart	NN
46745	551	26	,	,	,
46745	551	27	parts	part	NNS
46745	551	28	supplied	supply	VBN
46745	551	29	by	by	IN
46745	551	30	the	the	DT
46745	551	31	other	other	JJ
46745	551	32	branches	branch	NNS
46745	551	33	of	of	IN
46745	551	34	the	the	DT
46745	551	35	Vagus	Vagus	NNP
46745	551	36	nerve	nerve	NN
46745	551	37	,	,	,
46745	551	38	which	which	WDT
46745	551	39	is	be	VBZ
46745	551	40	distributed	distribute	VBN
46745	551	41	to	to	IN
46745	551	42	the	the	DT
46745	551	43	stomach	stomach	NN
46745	551	44	,	,	,
46745	551	45	seem	seem	VBP
46745	551	46	to	to	IN
46745	551	47	me	-PRON-	PRP
46745	551	48	to	to	TO
46745	551	49	be	be	VB
46745	551	50	Specific	Specific	NNP
46745	551	51	Neurotics	neurotic	NNS
46745	551	52	,	,	,
46745	551	53	probably	probably	RB
46745	551	54	acting	act	VBG
46745	551	55	on	on	IN
46745	551	56	that	that	DT
46745	551	57	nerve	nerve	NN
46745	551	58	.	.	.
46745	552	1	So	so	IN
46745	552	2	that	that	IN
46745	552	3	in	in	IN
46745	552	4	these	these	DT
46745	552	5	points	point	NNS
46745	552	6	,	,	,
46745	552	7	as	as	RB
46745	552	8	well	well	RB
46745	552	9	as	as	IN
46745	552	10	in	in	IN
46745	552	11	some	some	DT
46745	552	12	others	other	NNS
46745	552	13	,	,	,
46745	552	14	I	-PRON-	PRP
46745	552	15	am	be	VBP
46745	552	16	disposed	disposed	JJ
46745	552	17	to	to	TO
46745	552	18	differ	differ	VB
46745	552	19	from	from	IN
46745	552	20	Dr.	Dr.	NNP
46745	552	21	Pereira	Pereira	NNP
46745	552	22	.	.	.
46745	553	1	It	-PRON-	PRP
46745	553	2	is	be	VBZ
46745	553	3	apparent	apparent	JJ
46745	553	4	that	that	IN
46745	553	5	in	in	IN
46745	553	6	none	none	NN
46745	553	7	of	of	IN
46745	553	8	the	the	DT
46745	553	9	classifications	classification	NNS
46745	553	10	of	of	IN
46745	553	11	this	this	DT
46745	553	12	second	second	JJ
46745	553	13	kind	kind	NN
46745	553	14	is	be	VBZ
46745	553	15	any	any	DT
46745	553	16	mention	mention	NN
46745	553	17	made	make	VBN
46745	553	18	of	of	IN
46745	553	19	the	the	DT
46745	553	20	primary	primary	JJ
46745	553	21	action	action	NN
46745	553	22	or	or	CC
46745	553	23	_	_	NNP
46745	553	24	modus	modus	NN
46745	553	25	operandi	operandi	NNP
46745	553	26	_	_	NNP
46745	553	27	of	of	IN
46745	553	28	medicines	medicine	NNS
46745	553	29	in	in	IN
46745	553	30	the	the	DT
46745	553	31	cure	cure	NN
46745	553	32	of	of	IN
46745	553	33	disease	disease	NN
46745	553	34	,	,	,
46745	553	35	as	as	IN
46745	553	36	a	a	DT
46745	553	37	necessary	necessary	JJ
46745	553	38	basis	basis	NN
46745	553	39	of	of	IN
46745	553	40	such	such	JJ
46745	553	41	distinctions	distinction	NNS
46745	553	42	.	.	.
46745	554	1	III	iii	CD
46745	554	2	.	.	.
46745	555	1	OPINIONS	OPINIONS	NNP
46745	555	2	CONCERNING	concern	VBD
46745	555	3	THE	the	DT
46745	555	4	MODE	mode	NN
46745	555	5	OF	of	IN
46745	555	6	OPERATION	OPERATION	NNP
46745	555	7	OF	of	IN
46745	555	8	MEDICINES	MEDICINES	NNP
46745	555	9	,	,	,
46745	555	10	AND	and	CC
46745	555	11	CLASSIFICATIONS	CLASSIFICATIONS	NNP
46745	555	12	FOUNDED	founded	NN
46745	555	13	ON	on	IN
46745	555	14	THIS	this	DT
46745	555	15	.	.	.
46745	556	1	In	in	IN
46745	556	2	this	this	DT
46745	556	3	third	third	JJ
46745	556	4	division	division	NN
46745	556	5	are	be	VBP
46745	556	6	included	include	VBN
46745	556	7	those	those	DT
46745	556	8	writers	writer	NNS
46745	556	9	who	who	WP
46745	556	10	have	have	VBP
46745	556	11	attempted	attempt	VBN
46745	556	12	to	to	TO
46745	556	13	account	account	VB
46745	556	14	for	for	IN
46745	556	15	the	the	DT
46745	556	16	mode	mode	NN
46745	556	17	in	in	IN
46745	556	18	which	which	WDT
46745	556	19	medicines	medicine	NNS
46745	556	20	produce	produce	VBP
46745	556	21	each	each	DT
46745	556	22	their	-PRON-	PRP$
46745	556	23	peculiar	peculiar	JJ
46745	556	24	effects	effect	NNS
46745	556	25	after	after	IN
46745	556	26	entering	enter	VBG
46745	556	27	into	into	IN
46745	556	28	the	the	DT
46745	556	29	blood	blood	NN
46745	556	30	,	,	,
46745	556	31	and	and	CC
46745	556	32	some	some	DT
46745	556	33	who	who	WP
46745	556	34	have	have	VBP
46745	556	35	classified	classify	VBN
46745	556	36	them	-PRON-	PRP
46745	556	37	according	accord	VBG
46745	556	38	to	to	IN
46745	556	39	their	-PRON-	PRP$
46745	556	40	ideas	idea	NNS
46745	556	41	on	on	IN
46745	556	42	this	this	DT
46745	556	43	point	point	NN
46745	556	44	.	.	.
46745	557	1	It	-PRON-	PRP
46745	557	2	is	be	VBZ
46745	557	3	with	with	IN
46745	557	4	such	such	JJ
46745	557	5	theories	theory	NNS
46745	557	6	as	as	IN
46745	557	7	these	these	DT
46745	557	8	that	that	WDT
46745	557	9	I	-PRON-	PRP
46745	557	10	am	be	VBP
46745	557	11	more	more	RBR
46745	557	12	immediately	immediately	RB
46745	557	13	concerned	concerned	JJ
46745	557	14	in	in	IN
46745	557	15	this	this	DT
46745	557	16	Essay	Essay	NNP
46745	557	17	.	.	.
46745	558	1	Such	such	JJ
46745	558	2	writers	writer	NNS
46745	558	3	have	have	VBP
46745	558	4	dived	dive	VBN
46745	558	5	into	into	IN
46745	558	6	a	a	DT
46745	558	7	deeper	deep	JJR
46745	558	8	subject	subject	NN
46745	558	9	than	than	IN
46745	558	10	those	those	DT
46745	558	11	who	who	WP
46745	558	12	have	have	VBP
46745	558	13	directed	direct	VBN
46745	558	14	attention	attention	NN
46745	558	15	to	to	IN
46745	558	16	the	the	DT
46745	558	17	general	general	JJ
46745	558	18	effects	effect	NNS
46745	558	19	or	or	CC
46745	558	20	tendencies	tendency	NNS
46745	558	21	of	of	IN
46745	558	22	medicines	medicine	NNS
46745	558	23	rather	rather	RB
46745	558	24	than	than	IN
46745	558	25	to	to	IN
46745	558	26	the	the	DT
46745	558	27	means	mean	NNS
46745	558	28	by	by	IN
46745	558	29	which	which	WDT
46745	558	30	such	such	JJ
46745	558	31	results	result	NNS
46745	558	32	are	be	VBP
46745	558	33	attained	attain	VBN
46745	558	34	.	.	.
46745	559	1	Thus	thus	RB
46745	559	2	it	-PRON-	PRP
46745	559	3	is	be	VBZ
46745	559	4	not	not	RB
46745	559	5	to	to	TO
46745	559	6	be	be	VB
46745	559	7	wondered	wonder	VBN
46745	559	8	at	at	IN
46745	559	9	that	that	IN
46745	559	10	they	-PRON-	PRP
46745	559	11	have	have	VBP
46745	559	12	sometimes	sometimes	RB
46745	559	13	failed	fail	VBN
46745	559	14	.	.	.
46745	560	1	Those	those	DT
46745	560	2	have	have	VBP
46745	560	3	erred	err	VBN
46745	560	4	most	most	RBS
46745	560	5	who	who	WP
46745	560	6	have	have	VBP
46745	560	7	allowed	allow	VBN
46745	560	8	their	-PRON-	PRP$
46745	560	9	imaginations	imagination	NNS
46745	560	10	to	to	TO
46745	560	11	lead	lead	VB
46745	560	12	them	-PRON-	PRP
46745	560	13	astray	astray	RB
46745	560	14	from	from	IN
46745	560	15	facts	fact	NNS
46745	560	16	,	,	,
46745	560	17	or	or	CC
46745	560	18	to	to	TO
46745	560	19	guide	guide	VB
46745	560	20	them	-PRON-	PRP
46745	560	21	in	in	IN
46745	560	22	matters	matter	NNS
46745	560	23	which	which	WDT
46745	560	24	are	be	VBP
46745	560	25	naturally	naturally	RB
46745	560	26	incomprehensible	incomprehensible	JJ
46745	560	27	,	,	,
46745	560	28	to	to	TO
46745	560	29	which	which	WDT
46745	560	30	our	-PRON-	PRP$
46745	560	31	reason	reason	NN
46745	560	32	gives	give	VBZ
46745	560	33	us	-PRON-	PRP
46745	560	34	no	no	DT
46745	560	35	clue	clue	NN
46745	560	36	.	.	.
46745	561	1	Attempts	attempt	NNS
46745	561	2	have	have	VBP
46745	561	3	been	be	VBN
46745	561	4	made	make	VBN
46745	561	5	to	to	TO
46745	561	6	account	account	VB
46745	561	7	for	for	IN
46745	561	8	the	the	DT
46745	561	9	_	_	NNP
46745	561	10	modus	modus	NN
46745	561	11	operandi	operandi	NNP
46745	561	12	_	_	NNP
46745	561	13	of	of	IN
46745	561	14	therapeutic	therapeutic	JJ
46745	561	15	agents	agent	NNS
46745	561	16	generally	generally	RB
46745	561	17	,	,	,
46745	561	18	in	in	IN
46745	561	19	three	three	CD
46745	561	20	different	different	JJ
46745	561	21	ways	way	NNS
46745	561	22	.	.	.
46745	562	1	1	1	LS
46745	562	2	.	.	.
46745	563	1	On	on	IN
46745	563	2	mechanical	mechanical	JJ
46745	563	3	principles	principle	NNS
46745	563	4	.	.	.
46745	564	1	2	2	LS
46745	564	2	.	.	.
46745	565	1	On	on	IN
46745	565	2	chemical	chemical	JJ
46745	565	3	principles	principle	NNS
46745	565	4	.	.	.
46745	566	1	3	3	LS
46745	566	2	.	.	.
46745	567	1	On	on	IN
46745	567	2	general	general	JJ
46745	567	3	or	or	CC
46745	567	4	vital	vital	JJ
46745	567	5	principles	principle	NNS
46745	567	6	.	.	.
46745	568	1	1	1	LS
46745	568	2	.	.	.
46745	569	1	Mechanical	mechanical	JJ
46745	569	2	theories	theory	NNS
46745	569	3	of	of	IN
46745	569	4	the	the	DT
46745	569	5	action	action	NN
46745	569	6	of	of	IN
46745	569	7	medicines	medicine	NNS
46745	569	8	were	be	VBD
46745	569	9	greatly	greatly	RB
46745	569	10	in	in	IN
46745	569	11	vogue	vogue	NN
46745	569	12	during	during	IN
46745	569	13	the	the	DT
46745	569	14	seventeenth	seventeenth	JJ
46745	569	15	and	and	CC
46745	569	16	eighteenth	eighteenth	JJ
46745	569	17	centuries	century	NNS
46745	569	18	.	.	.
46745	570	1	There	there	EX
46745	570	2	is	be	VBZ
46745	570	3	a	a	DT
46745	570	4	tendency	tendency	NN
46745	570	5	in	in	IN
46745	570	6	the	the	DT
46745	570	7	human	human	JJ
46745	570	8	mind	mind	NN
46745	570	9	to	to	TO
46745	570	10	explain	explain	VB
46745	570	11	every	every	DT
46745	570	12	thing	thing	NN
46745	570	13	;	;	:
46745	570	14	and	and	CC
46745	570	15	it	-PRON-	PRP
46745	570	16	was	be	VBD
46745	570	17	only	only	RB
46745	570	18	natural	natural	JJ
46745	570	19	for	for	IN
46745	570	20	men	man	NNS
46745	570	21	who	who	WP
46745	570	22	knew	know	VBD
46745	570	23	little	little	JJ
46745	570	24	of	of	IN
46745	570	25	chemistry	chemistry	NN
46745	570	26	or	or	CC
46745	570	27	of	of	IN
46745	570	28	physiology	physiology	NN
46745	570	29	to	to	TO
46745	570	30	resort	resort	VB
46745	570	31	to	to	IN
46745	570	32	the	the	DT
46745	570	33	science	science	NN
46745	570	34	of	of	IN
46745	570	35	physics	physics	NN
46745	570	36	,	,	,
46745	570	37	which	which	WDT
46745	570	38	they	-PRON-	PRP
46745	570	39	could	could	MD
46745	570	40	comprehend	comprehend	VB
46745	570	41	,	,	,
46745	570	42	in	in	IN
46745	570	43	attempting	attempt	VBG
46745	570	44	the	the	DT
46745	570	45	explanation	explanation	NN
46745	570	46	of	of	IN
46745	570	47	observed	observed	JJ
46745	570	48	phenomena	phenomenon	NNS
46745	570	49	.	.	.
46745	571	1	John	John	NNP
46745	571	2	Locke	Locke	NNP
46745	571	3	,	,	,
46745	571	4	in	in	IN
46745	571	5	his	-PRON-	PRP$
46745	571	6	essay	essay	NN
46745	571	7	concerning	concern	VBG
46745	571	8	the	the	DT
46745	571	9	Human	Human	NNP
46745	571	10	Understanding	Understanding	NNP
46745	571	11	,	,	,
46745	571	12	published	publish	VBN
46745	571	13	in	in	IN
46745	571	14	1689	1689	CD
46745	571	15	,	,	,
46745	571	16	gave	give	VBD
46745	571	17	it	-PRON-	PRP
46745	571	18	as	as	IN
46745	571	19	his	-PRON-	PRP$
46745	571	20	opinion	opinion	NN
46745	571	21	,	,	,
46745	571	22	that	that	IN
46745	571	23	the	the	DT
46745	571	24	shapes	shape	NNS
46745	571	25	of	of	IN
46745	571	26	the	the	DT
46745	571	27	minute	minute	JJ
46745	571	28	particles	particle	NNS
46745	571	29	of	of	IN
46745	571	30	medicines	medicine	NNS
46745	571	31	were	be	VBD
46745	571	32	sufficient	sufficient	JJ
46745	571	33	to	to	TO
46745	571	34	account	account	VB
46745	571	35	for	for	IN
46745	571	36	their	-PRON-	PRP$
46745	571	37	several	several	JJ
46745	571	38	operations	operation	NNS
46745	571	39	.	.	.
46745	572	1	"	"	``
46745	572	2	Did	do	VBD
46745	572	3	we	-PRON-	PRP
46745	572	4	know	know	VB
46745	572	5	,	,	,
46745	572	6	"	"	''
46745	572	7	said	say	VBD
46745	572	8	he	-PRON-	PRP
46745	572	9	,	,	,
46745	572	10	"	"	``
46745	572	11	the	the	DT
46745	572	12	mechanical	mechanical	JJ
46745	572	13	affections	affection	NNS
46745	572	14	of	of	IN
46745	572	15	the	the	DT
46745	572	16	particles	particle	NNS
46745	572	17	of	of	IN
46745	572	18	rhubarb	rhubarb	NNP
46745	572	19	,	,	,
46745	572	20	hemlock	hemlock	NNP
46745	572	21	,	,	,
46745	572	22	opium	opium	NN
46745	572	23	,	,	,
46745	572	24	and	and	CC
46745	572	25	a	a	DT
46745	572	26	man	man	NN
46745	572	27	,	,	,
46745	572	28	as	as	IN
46745	572	29	a	a	DT
46745	572	30	watchmaker	watchmaker	NN
46745	572	31	does	do	VBZ
46745	572	32	those	those	DT
46745	572	33	of	of	IN
46745	572	34	a	a	DT
46745	572	35	watch	watch	NN
46745	572	36	,	,	,
46745	572	37	whereby	whereby	WRB
46745	572	38	it	-PRON-	PRP
46745	572	39	performs	perform	VBZ
46745	572	40	its	-PRON-	PRP$
46745	572	41	operations	operation	NNS
46745	572	42	,	,	,
46745	572	43	and	and	CC
46745	572	44	of	of	IN
46745	572	45	a	a	DT
46745	572	46	file	file	NN
46745	572	47	,	,	,
46745	572	48	which	which	WDT
46745	572	49	,	,	,
46745	572	50	by	by	IN
46745	572	51	rubbing	rub	VBG
46745	572	52	on	on	IN
46745	572	53	them	-PRON-	PRP
46745	572	54	,	,	,
46745	572	55	will	will	MD
46745	572	56	alter	alter	VB
46745	572	57	the	the	DT
46745	572	58	figure	figure	NN
46745	572	59	of	of	IN
46745	572	60	any	any	DT
46745	572	61	of	of	IN
46745	572	62	the	the	DT
46745	572	63	wheels	wheel	NNS
46745	572	64	,	,	,
46745	572	65	we	-PRON-	PRP
46745	572	66	should	should	MD
46745	572	67	be	be	VB
46745	572	68	able	able	JJ
46745	572	69	to	to	TO
46745	572	70	tell	tell	VB
46745	572	71	beforehand	beforehand	RB
46745	572	72	that	that	IN
46745	572	73	rhubarb	rhubarb	NN
46745	572	74	will	will	MD
46745	572	75	purge	purge	VB
46745	572	76	,	,	,
46745	572	77	hemlock	hemlock	NNP
46745	572	78	kill	kill	NNP
46745	572	79	,	,	,
46745	572	80	and	and	CC
46745	572	81	opium	opium	NN
46745	572	82	make	make	VBP
46745	572	83	a	a	DT
46745	572	84	man	man	NN
46745	572	85	sleep	sleep	NN
46745	572	86	.	.	.
46745	572	87	"	"	''
46745	573	1	This	this	DT
46745	573	2	idea	idea	NN
46745	573	3	did	do	VBD
46745	573	4	not	not	RB
46745	573	5	originate	originate	VB
46745	573	6	with	with	IN
46745	573	7	the	the	DT
46745	573	8	great	great	JJ
46745	573	9	metaphysician	metaphysician	NN
46745	573	10	.	.	.
46745	574	1	The	the	DT
46745	574	2	first	first	JJ
46745	574	3	rudiments	rudiment	NNS
46745	574	4	are	be	VBP
46745	574	5	to	to	TO
46745	574	6	be	be	VB
46745	574	7	found	find	VBN
46745	574	8	in	in	IN
46745	574	9	the	the	DT
46745	574	10	doctrines	doctrine	NNS
46745	574	11	of	of	IN
46745	574	12	the	the	DT
46745	574	13	_	_	NNP
46745	574	14	Methodic	Methodic	NNP
46745	574	15	Sect	Sect	NNP
46745	574	16	_	_	NNP
46745	574	17	among	among	IN
46745	574	18	the	the	DT
46745	574	19	Romans	Romans	NNPS
46745	574	20	,	,	,
46745	574	21	a	a	DT
46745	574	22	medical	medical	JJ
46745	574	23	branch	branch	NN
46745	574	24	of	of	IN
46745	574	25	the	the	DT
46745	574	26	Epicurean	epicurean	JJ
46745	574	27	school	school	NN
46745	574	28	.	.	.
46745	575	1	They	-PRON-	PRP
46745	575	2	held	hold	VBD
46745	575	3	that	that	IN
46745	575	4	diseases	disease	NNS
46745	575	5	depended	depend	VBD
46745	575	6	either	either	CC
46745	575	7	on	on	IN
46745	575	8	constriction	constriction	NN
46745	575	9	or	or	CC
46745	575	10	relaxation	relaxation	NN
46745	575	11	of	of	IN
46745	575	12	the	the	DT
46745	575	13	tissues	tissue	NNS
46745	575	14	,	,	,
46745	575	15	and	and	CC
46745	575	16	that	that	IN
46745	575	17	medicines	medicine	NNS
46745	575	18	operated	operate	VBN
46745	575	19	by	by	IN
46745	575	20	mechanically	mechanically	RB
46745	575	21	affecting	affect	VBG
46745	575	22	these	these	DT
46745	575	23	conditions	condition	NNS
46745	575	24	.	.	.
46745	576	1	The	the	DT
46745	576	2	simple	simple	JJ
46745	576	3	and	and	CC
46745	576	4	philosophical	philosophical	JJ
46745	576	5	statement	statement	NN
46745	576	6	of	of	IN
46745	576	7	Locke	Locke	NNP
46745	576	8	was	be	VBD
46745	576	9	not	not	RB
46745	576	10	improved	improve	VBN
46745	576	11	by	by	IN
46745	576	12	the	the	DT
46745	576	13	various	various	JJ
46745	576	14	applications	application	NNS
46745	576	15	which	which	WDT
46745	576	16	were	be	VBD
46745	576	17	subsequently	subsequently	RB
46745	576	18	made	make	VBN
46745	576	19	of	of	IN
46745	576	20	it	-PRON-	PRP
46745	576	21	.	.	.
46745	577	1	At	at	IN
46745	577	2	the	the	DT
46745	577	3	early	early	JJ
46745	577	4	part	part	NN
46745	577	5	of	of	IN
46745	577	6	the	the	DT
46745	577	7	eighteenth	eighteenth	JJ
46745	577	8	century	century	NN
46745	577	9	these	these	DT
46745	577	10	ideas	idea	NNS
46745	577	11	derived	derive	VBD
46745	577	12	great	great	JJ
46745	577	13	support	support	NN
46745	577	14	from	from	IN
46745	577	15	the	the	DT
46745	577	16	principles	principle	NNS
46745	577	17	inculcated	inculcate	VBN
46745	577	18	by	by	IN
46745	577	19	Dr.	Dr.	NNP
46745	577	20	Herman	Herman	NNP
46745	577	21	Boerhaave	Boerhaave	NNP
46745	577	22	,	,	,
46745	577	23	the	the	DT
46745	577	24	learned	learn	VBN
46745	577	25	physician	physician	NN
46745	577	26	of	of	IN
46745	577	27	Leyden	Leyden	NNP
46745	577	28	.	.	.
46745	578	1	He	-PRON-	PRP
46745	578	2	likewise	likewise	RB
46745	578	3	supposed	suppose	VBD
46745	578	4	that	that	IN
46745	578	5	many	many	JJ
46745	578	6	diseases	disease	NNS
46745	578	7	of	of	IN
46745	578	8	the	the	DT
46745	578	9	solid	solid	JJ
46745	578	10	parts	part	NNS
46745	578	11	were	be	VBD
46745	578	12	to	to	TO
46745	578	13	be	be	VB
46745	578	14	attributed	attribute	VBN
46745	578	15	to	to	IN
46745	578	16	a	a	DT
46745	578	17	weakness	weakness	NN
46745	578	18	or	or	CC
46745	578	19	laxity	laxity	NN
46745	578	20	of	of	IN
46745	578	21	the	the	DT
46745	578	22	animal	animal	NN
46745	578	23	fibres	fibre	NNS
46745	578	24	,	,	,
46745	578	25	and	and	CC
46745	578	26	were	be	VBD
46745	578	27	to	to	TO
46745	578	28	be	be	VB
46745	578	29	cured	cure	VBN
46745	578	30	by	by	IN
46745	578	31	external	external	JJ
46745	578	32	or	or	CC
46745	578	33	internal	internal	JJ
46745	578	34	agents	agent	NNS
46745	578	35	,	,	,
46745	578	36	which	which	WDT
46745	578	37	should	should	MD
46745	578	38	act	act	VB
46745	578	39	mechanically	mechanically	RB
46745	578	40	on	on	IN
46745	578	41	those	those	DT
46745	578	42	fibres	fibre	NNS
46745	578	43	so	so	IN
46745	578	44	as	as	IN
46745	578	45	to	to	TO
46745	578	46	increase	increase	VB
46745	578	47	their	-PRON-	PRP$
46745	578	48	tenacity	tenacity	NN
46745	578	49	.	.	.
46745	579	1	Also	also	RB
46745	579	2	,	,	,
46745	579	3	that	that	IN
46745	579	4	disorders	disorder	NNS
46745	579	5	of	of	IN
46745	579	6	the	the	DT
46745	579	7	fluids	fluid	NNS
46745	579	8	often	often	RB
46745	579	9	depended	depend	VBD
46745	579	10	on	on	IN
46745	579	11	their	-PRON-	PRP$
46745	579	12	being	be	VBG
46745	579	13	too	too	RB
46745	579	14	viscid	viscid	JJ
46745	579	15	,	,	,
46745	579	16	and	and	CC
46745	579	17	that	that	IN
46745	579	18	this	this	DT
46745	579	19	condition	condition	NN
46745	579	20	might	may	MD
46745	579	21	be	be	VB
46745	579	22	improved	improve	VBN
46745	579	23	by	by	IN
46745	579	24	agents	agent	NNS
46745	579	25	which	which	WDT
46745	579	26	should	should	MD
46745	579	27	attenuate	attenuate	VB
46745	579	28	this	this	DT
46745	579	29	viscidity	viscidity	NN
46745	579	30	.	.	.
46745	580	1	Dr.	Dr.	NNP
46745	580	2	Archibald	Archibald	NNP
46745	580	3	Pitcairn	Pitcairn	NNP
46745	580	4	,	,	,
46745	580	5	a	a	DT
46745	580	6	Scotchman	Scotchman	NNP
46745	580	7	,	,	,
46745	580	8	the	the	DT
46745	580	9	immediate	immediate	JJ
46745	580	10	predecessor	predecessor	NN
46745	580	11	and	and	CC
46745	580	12	contemporary	contemporary	NN
46745	580	13	of	of	IN
46745	580	14	Boerhaave	Boerhaave	NNP
46745	580	15	,	,	,
46745	580	16	was	be	VBD
46745	580	17	elected	elect	VBN
46745	580	18	to	to	IN
46745	580	19	the	the	DT
46745	580	20	Chair	Chair	NNP
46745	580	21	of	of	IN
46745	580	22	Physic	Physic	NNP
46745	580	23	in	in	IN
46745	580	24	Leyden	Leyden	NNP
46745	580	25	in	in	IN
46745	580	26	1691	1691	CD
46745	580	27	,	,	,
46745	580	28	and	and	CC
46745	580	29	was	be	VBD
46745	580	30	also	also	RB
46745	580	31	an	an	DT
46745	580	32	able	able	JJ
46745	580	33	exponent	exponent	NN
46745	580	34	of	of	IN
46745	580	35	the	the	DT
46745	580	36	mathematical	mathematical	JJ
46745	580	37	theories	theory	NNS
46745	580	38	.	.	.
46745	581	1	But	but	CC
46745	581	2	he	-PRON-	PRP
46745	581	3	applied	apply	VBD
46745	581	4	to	to	TO
46745	581	5	physiology	physiology	VB
46745	581	6	those	those	DT
46745	581	7	ideas	idea	NNS
46745	581	8	which	which	WDT
46745	581	9	were	be	VBD
46745	581	10	employed	employ	VBN
46745	581	11	by	by	IN
46745	581	12	the	the	DT
46745	581	13	other	other	JJ
46745	581	14	to	to	TO
46745	581	15	throw	throw	VB
46745	581	16	light	light	NN
46745	581	17	upon	upon	IN
46745	581	18	physic	physic	NN
46745	581	19	;	;	:
46745	581	20	if	if	IN
46745	581	21	that	that	DT
46745	581	22	may	may	MD
46745	581	23	be	be	VB
46745	581	24	called	call	VBN
46745	581	25	_	_	NNP
46745	581	26	light	light	NN
46745	581	27	_	_	NNP
46745	581	28	which	which	WDT
46745	581	29	was	be	VBD
46745	581	30	at	at	IN
46745	581	31	least	least	JJS
46745	581	32	an	an	DT
46745	581	33	improvement	improvement	NN
46745	581	34	on	on	IN
46745	581	35	the	the	DT
46745	581	36	ignorance	ignorance	NN
46745	581	37	which	which	WDT
46745	581	38	preceded	precede	VBD
46745	581	39	it	-PRON-	PRP
46745	581	40	.	.	.
46745	582	1	[	[	-LRB-
46745	582	2	8	8	CD
46745	582	3	]	]	-RRB-
46745	582	4	He	-PRON-	PRP
46745	582	5	explained	explain	VBD
46745	582	6	the	the	DT
46745	582	7	digestive	digestive	JJ
46745	582	8	process	process	NN
46745	582	9	by	by	IN
46745	582	10	the	the	DT
46745	582	11	mechanical	mechanical	JJ
46745	582	12	trituration	trituration	NN
46745	582	13	to	to	IN
46745	582	14	which	which	WDT
46745	582	15	the	the	DT
46745	582	16	food	food	NN
46745	582	17	was	be	VBD
46745	582	18	subjected	subject	VBN
46745	582	19	in	in	IN
46745	582	20	the	the	DT
46745	582	21	stomach	stomach	NN
46745	582	22	;	;	:
46745	582	23	and	and	CC
46745	582	24	accounted	account	VBD
46745	582	25	for	for	IN
46745	582	26	secretion	secretion	NN
46745	582	27	by	by	IN
46745	582	28	supposing	suppose	VBG
46745	582	29	the	the	DT
46745	582	30	existence	existence	NN
46745	582	31	in	in	IN
46745	582	32	glands	gland	NNS
46745	582	33	of	of	IN
46745	582	34	vascular	vascular	JJ
46745	582	35	pores	pore	NNS
46745	582	36	of	of	IN
46745	582	37	different	different	JJ
46745	582	38	sizes	size	NNS
46745	582	39	,	,	,
46745	582	40	which	which	WDT
46745	582	41	intercepted	intercept	VBD
46745	582	42	certain	certain	JJ
46745	582	43	particles	particle	NNS
46745	582	44	of	of	IN
46745	582	45	the	the	DT
46745	582	46	blood	blood	NN
46745	582	47	;	;	:
46745	582	48	actually	actually	RB
46745	582	49	giving	give	VBG
46745	582	50	for	for	IN
46745	582	51	the	the	DT
46745	582	52	process	process	NN
46745	582	53	a	a	DT
46745	582	54	mathematical	mathematical	JJ
46745	582	55	formula	formula	NN
46745	582	56	.	.	.
46745	583	1	He	-PRON-	PRP
46745	583	2	was	be	VBD
46745	583	3	a	a	DT
46745	583	4	vehement	vehement	JJ
46745	583	5	opponent	opponent	NN
46745	583	6	of	of	IN
46745	583	7	those	those	DT
46745	583	8	who	who	WP
46745	583	9	based	base	VBD
46745	583	10	their	-PRON-	PRP$
46745	583	11	theories	theory	NNS
46745	583	12	on	on	IN
46745	583	13	the	the	DT
46745	583	14	then	then	RB
46745	583	15	youthful	youthful	JJ
46745	583	16	science	science	NN
46745	583	17	of	of	IN
46745	583	18	chemistry	chemistry	NN
46745	583	19	,	,	,
46745	583	20	who	who	WP
46745	583	21	,	,	,
46745	583	22	having	have	VBG
46745	583	23	scarce	scarce	NN
46745	583	24	yet	yet	RB
46745	583	25	shaken	shake	VBN
46745	583	26	off	off	RP
46745	583	27	from	from	IN
46745	583	28	them	-PRON-	PRP
46745	583	29	the	the	DT
46745	583	30	dust	dust	NN
46745	583	31	of	of	IN
46745	583	32	alchemy	alchemy	NNP
46745	583	33	,	,	,
46745	583	34	only	only	RB
46745	583	35	substituting	substitute	VBG
46745	583	36	Acids	Acids	NNPS
46745	583	37	,	,	,
46745	583	38	Alkalies	Alkalies	NNPS
46745	583	39	,	,	,
46745	583	40	and	and	CC
46745	583	41	Fermentations	fermentation	NNS
46745	583	42	,	,	,
46745	583	43	for	for	IN
46745	583	44	_	_	NNP
46745	583	45	Salt	Salt	NNP
46745	583	46	_	_	NNP
46745	583	47	,	,	,
46745	583	48	_	_	NNP
46745	583	49	Sulphur	Sulphur	NNP
46745	583	50	_	_	NNP
46745	583	51	,	,	,
46745	583	52	and	and	CC
46745	583	53	_	_	NNP
46745	583	54	Mercury	Mercury	NNP
46745	583	55	_	_	NNP
46745	583	56	,	,	,
46745	583	57	fell	fall	VBD
46745	583	58	easy	easy	JJ
46745	583	59	victims	victim	NNS
46745	583	60	to	to	IN
46745	583	61	his	-PRON-	PRP$
46745	583	62	satire	satire	NN
46745	583	63	.	.	.
46745	584	1	Dr.	Dr.	NNP
46745	584	2	Charles	Charles	NNP
46745	584	3	Perry	Perry	NNP
46745	584	4	,	,	,
46745	584	5	in	in	IN
46745	584	6	1741	1741	CD
46745	584	7	,	,	,
46745	584	8	propounded	propound	VBD
46745	584	9	a	a	DT
46745	584	10	mechanical	mechanical	JJ
46745	584	11	view	view	NN
46745	584	12	of	of	IN
46745	584	13	the	the	DT
46745	584	14	action	action	NN
46745	584	15	of	of	IN
46745	584	16	Mercury	Mercury	NNP
46745	584	17	and	and	CC
46745	584	18	Arsenic	Arsenic	NNP
46745	584	19	.	.	.
46745	585	1	He	-PRON-	PRP
46745	585	2	thought	think	VBD
46745	585	3	that	that	IN
46745	585	4	the	the	DT
46745	585	5	particles	particle	NNS
46745	585	6	of	of	IN
46745	585	7	the	the	DT
46745	585	8	former	former	JJ
46745	585	9	,	,	,
46745	585	10	being	be	VBG
46745	585	11	round	round	JJ
46745	585	12	and	and	CC
46745	585	13	heavy	heavy	JJ
46745	585	14	,	,	,
46745	585	15	were	be	VBD
46745	585	16	able	able	JJ
46745	585	17	,	,	,
46745	585	18	when	when	WRB
46745	585	19	shaken	shake	VBN
46745	585	20	about	about	IN
46745	585	21	in	in	IN
46745	585	22	the	the	DT
46745	585	23	vessels	vessel	NNS
46745	585	24	,	,	,
46745	585	25	to	to	TO
46745	585	26	break	break	VB
46745	585	27	up	up	RP
46745	585	28	and	and	CC
46745	585	29	to	to	TO
46745	585	30	annihilate	annihilate	VB
46745	585	31	those	those	DT
46745	585	32	crude	crude	JJ
46745	585	33	acrid	acrid	NNP
46745	585	34	humours	humours	NNP
46745	585	35	which	which	WDT
46745	585	36	were	be	VBD
46745	585	37	the	the	DT
46745	585	38	causes	cause	NNS
46745	585	39	of	of	IN
46745	585	40	disease	disease	NN
46745	585	41	;	;	:
46745	585	42	and	and	CC
46745	585	43	that	that	IN
46745	585	44	Arsenic	Arsenic	NNP
46745	585	45	acted	act	VBD
46745	585	46	as	as	IN
46745	585	47	an	an	DT
46745	585	48	irritant	irritant	NN
46745	585	49	by	by	IN
46745	585	50	the	the	DT
46745	585	51	sharp	sharp	JJ
46745	585	52	and	and	CC
46745	585	53	pointed	pointed	JJ
46745	585	54	nature	nature	NN
46745	585	55	of	of	IN
46745	585	56	its	-PRON-	PRP$
46745	585	57	atoms	atom	NNS
46745	585	58	.	.	.
46745	586	1	He	-PRON-	PRP
46745	586	2	attributed	attribute	VBD
46745	586	3	the	the	DT
46745	586	4	occasional	occasional	JJ
46745	586	5	poisonous	poisonous	JJ
46745	586	6	effects	effect	NNS
46745	586	7	of	of	IN
46745	586	8	Mercury	Mercury	NNP
46745	586	9	to	to	IN
46745	586	10	the	the	DT
46745	586	11	presence	presence	NN
46745	586	12	of	of	IN
46745	586	13	Arsenic	Arsenic	NNP
46745	586	14	or	or	CC
46745	586	15	some	some	DT
46745	586	16	such	such	JJ
46745	586	17	substance	substance	NN
46745	586	18	as	as	IN
46745	586	19	an	an	DT
46745	586	20	impurity	impurity	NN
46745	586	21	.	.	.
46745	587	1	[	[	-LRB-
46745	587	2	9	9	CD
46745	587	3	]	]	-RRB-
46745	587	4	Dr.	Dr.	NNP
46745	587	5	Mead	Mead	NNP
46745	587	6	,	,	,
46745	587	7	in	in	IN
46745	587	8	1751	1751	CD
46745	587	9	,	,	,
46745	587	10	states	state	VBZ
46745	587	11	that	that	IN
46745	587	12	the	the	DT
46745	587	13	administration	administration	NN
46745	587	14	of	of	IN
46745	587	15	Mercury	Mercury	NNP
46745	587	16	is	be	VBZ
46745	587	17	dangerous	dangerous	JJ
46745	587	18	in	in	IN
46745	587	19	cases	case	NNS
46745	587	20	where	where	WRB
46745	587	21	there	there	EX
46745	587	22	is	be	VBZ
46745	587	23	carious	carious	JJ
46745	587	24	bone	bone	NN
46745	587	25	,	,	,
46745	587	26	as	as	IN
46745	587	27	there	there	EX
46745	587	28	is	be	VBZ
46745	587	29	a	a	DT
46745	587	30	fear	fear	NN
46745	587	31	that	that	IN
46745	587	32	its	-PRON-	PRP$
46745	587	33	ponderous	ponderous	JJ
46745	587	34	particles	particle	NNS
46745	587	35	may	may	MD
46745	587	36	break	break	VB
46745	587	37	the	the	DT
46745	587	38	weak	weak	JJ
46745	587	39	lamellæ	lamellæ	NN
46745	587	40	.	.	.
46745	588	1	[	[	-LRB-
46745	588	2	10	10	CD
46745	588	3	]	]	-RRB-
46745	588	4	He	-PRON-	PRP
46745	588	5	was	be	VBD
46745	588	6	the	the	DT
46745	588	7	Court	Court	NNP
46745	588	8	Physician	Physician	NNP
46745	588	9	in	in	IN
46745	588	10	the	the	DT
46745	588	11	reign	reign	NN
46745	588	12	of	of	IN
46745	588	13	George	George	NNP
46745	588	14	II	II	NNP
46745	588	15	.	.	.
46745	589	1	He	-PRON-	PRP
46745	589	2	accounted	account	VBD
46745	589	3	for	for	IN
46745	589	4	the	the	DT
46745	589	5	poisonous	poisonous	JJ
46745	589	6	nature	nature	NN
46745	589	7	of	of	IN
46745	589	8	the	the	DT
46745	589	9	venom	venom	NN
46745	589	10	of	of	IN
46745	589	11	serpents	serpent	NNS
46745	589	12	by	by	IN
46745	589	13	asserting	assert	VBG
46745	589	14	that	that	IN
46745	589	15	it	-PRON-	PRP
46745	589	16	consisted	consist	VBD
46745	589	17	of	of	IN
46745	589	18	pointed	point	VBN
46745	589	19	particles	particle	NNS
46745	589	20	,	,	,
46745	589	21	which	which	WDT
46745	589	22	pierced	pierce	VBD
46745	589	23	and	and	CC
46745	589	24	destroyed	destroy	VBD
46745	589	25	the	the	DT
46745	589	26	globules	globule	NNS
46745	589	27	of	of	IN
46745	589	28	the	the	DT
46745	589	29	blood	blood	NN
46745	589	30	.	.	.
46745	590	1	Dr.	Dr.	NNP
46745	590	2	Perry	Perry	NNP
46745	590	3	conceived	conceive	VBD
46745	590	4	that	that	IN
46745	590	5	some	some	DT
46745	590	6	medicines	medicine	NNS
46745	590	7	,	,	,
46745	590	8	such	such	JJ
46745	590	9	as	as	IN
46745	590	10	Steel	Steel	NNP
46745	590	11	and	and	CC
46745	590	12	Antimony	Antimony	NNP
46745	590	13	,	,	,
46745	590	14	did	do	VBD
46745	590	15	not	not	RB
46745	590	16	act	act	VB
46745	590	17	by	by	IN
46745	590	18	their	-PRON-	PRP$
46745	590	19	mere	mere	JJ
46745	590	20	bodily	bodily	JJ
46745	590	21	presence	presence	NN
46745	590	22	,	,	,
46745	590	23	but	but	CC
46745	590	24	by	by	IN
46745	590	25	certain	certain	JJ
46745	590	26	subtle	subtle	JJ
46745	590	27	vapours	vapour	NNS
46745	590	28	which	which	WDT
46745	590	29	emanated	emanate	VBD
46745	590	30	from	from	IN
46745	590	31	them	-PRON-	PRP
46745	590	32	,	,	,
46745	590	33	and	and	CC
46745	590	34	affected	affect	VBD
46745	590	35	the	the	DT
46745	590	36	vital	vital	JJ
46745	590	37	spirits	spirit	NNS
46745	590	38	.	.	.
46745	591	1	This	this	DT
46745	591	2	was	be	VBD
46745	591	3	a	a	DT
46745	591	4	very	very	RB
46745	591	5	misty	misty	JJ
46745	591	6	notion	notion	NN
46745	591	7	.	.	.
46745	592	1	He	-PRON-	PRP
46745	592	2	stated	state	VBD
46745	592	3	that	that	IN
46745	592	4	he	-PRON-	PRP
46745	592	5	borrowed	borrow	VBD
46745	592	6	this	this	DT
46745	592	7	idea	idea	NN
46745	592	8	from	from	IN
46745	592	9	a	a	DT
46745	592	10	great	great	JJ
46745	592	11	philosopher	philosopher	NN
46745	592	12	of	of	IN
46745	592	13	the	the	DT
46745	592	14	German	german	JJ
46745	592	15	nation	nation	NN
46745	592	16	.	.	.
46745	593	1	This	this	DT
46745	593	2	was	be	VBD
46745	593	3	probably	probably	RB
46745	593	4	Boerhaave	Boerhaave	NNP
46745	593	5	,	,	,
46745	593	6	who	who	WP
46745	593	7	lectured	lecture	VBD
46745	593	8	at	at	IN
46745	593	9	Leyden	Leyden	NNP
46745	593	10	in	in	IN
46745	593	11	1707	1707	CD
46745	593	12	.	.	.
46745	594	1	Among	among	IN
46745	594	2	those	those	DT
46745	594	3	who	who	WP
46745	594	4	regarded	regard	VBD
46745	594	5	with	with	IN
46745	594	6	favour	favour	NN
46745	594	7	the	the	DT
46745	594	8	mechanical	mechanical	JJ
46745	594	9	hypothesis	hypothesis	NN
46745	594	10	,	,	,
46745	594	11	were	be	VBD
46745	594	12	Fourcroy	Fourcroy	NNP
46745	594	13	and	and	CC
46745	594	14	Hecquet	Hecquet	NNP
46745	594	15	in	in	IN
46745	594	16	France	France	NNP
46745	594	17	,	,	,
46745	594	18	Van	Van	NNP
46745	594	19	Swieten	Swieten	NNP
46745	594	20	and	and	CC
46745	594	21	Huygens	Huygens	NNPS
46745	594	22	in	in	IN
46745	594	23	Holland	Holland	NNP
46745	594	24	,	,	,
46745	594	25	and	and	CC
46745	594	26	Bellini	Bellini	NNP
46745	594	27	in	in	IN
46745	594	28	Italy	Italy	NNP
46745	594	29	.	.	.
46745	595	1	Excepting	except	VBG
46745	595	2	perhaps	perhaps	RB
46745	595	3	the	the	DT
46745	595	4	case	case	NN
46745	595	5	of	of	IN
46745	595	6	external	external	JJ
46745	595	7	irritants	irritant	NNS
46745	595	8	,	,	,
46745	595	9	these	these	DT
46745	595	10	explanations	explanation	NNS
46745	595	11	of	of	IN
46745	595	12	the	the	DT
46745	595	13	action	action	NN
46745	595	14	of	of	IN
46745	595	15	medicines	medicine	NNS
46745	595	16	have	have	VBP
46745	595	17	been	be	VBN
46745	595	18	universally	universally	RB
46745	595	19	condemned	condemn	VBN
46745	595	20	by	by	IN
46745	595	21	scientific	scientific	JJ
46745	595	22	men	man	NNS
46745	595	23	at	at	IN
46745	595	24	the	the	DT
46745	595	25	present	present	JJ
46745	595	26	day	day	NN
46745	595	27	.	.	.
46745	596	1	Doubtless	doubtless	RB
46745	596	2	these	these	DT
46745	596	3	old	old	JJ
46745	596	4	authors	author	NNS
46745	596	5	were	be	VBD
46745	596	6	in	in	IN
46745	596	7	the	the	DT
46745	596	8	wrong	wrong	NN
46745	596	9	,	,	,
46745	596	10	both	both	CC
46745	596	11	in	in	IN
46745	596	12	applying	apply	VBG
46745	596	13	one	one	CD
46745	596	14	hypothesis	hypothesis	NN
46745	596	15	to	to	IN
46745	596	16	the	the	DT
46745	596	17	action	action	NN
46745	596	18	of	of	IN
46745	596	19	all	all	DT
46745	596	20	remedial	remedial	JJ
46745	596	21	agents	agent	NNS
46745	596	22	alike	alike	RB
46745	596	23	,	,	,
46745	596	24	and	and	CC
46745	596	25	still	still	RB
46745	596	26	more	more	JJR
46745	596	27	,	,	,
46745	596	28	in	in	IN
46745	596	29	carrying	carry	VBG
46745	596	30	their	-PRON-	PRP$
46745	596	31	theories	theory	NNS
46745	596	32	into	into	IN
46745	596	33	such	such	JJ
46745	596	34	minute	minute	NN
46745	596	35	details	detail	NNS
46745	596	36	,	,	,
46745	596	37	where	where	WRB
46745	596	38	it	-PRON-	PRP
46745	596	39	is	be	VBZ
46745	596	40	impossible	impossible	JJ
46745	596	41	that	that	IN
46745	596	42	they	-PRON-	PRP
46745	596	43	should	should	MD
46745	596	44	be	be	VB
46745	596	45	verified	verify	VBN
46745	596	46	.	.	.
46745	597	1	And	and	CC
46745	597	2	yet	yet	RB
46745	597	3	we	-PRON-	PRP
46745	597	4	may	may	MD
46745	597	5	go	go	VB
46745	597	6	too	too	RB
46745	597	7	far	far	RB
46745	597	8	in	in	IN
46745	597	9	our	-PRON-	PRP$
46745	597	10	condemnation	condemnation	NN
46745	597	11	of	of	IN
46745	597	12	all	all	DT
46745	597	13	such	such	JJ
46745	597	14	ideas	idea	NNS
46745	597	15	.	.	.
46745	598	1	It	-PRON-	PRP
46745	598	2	does	do	VBZ
46745	598	3	not	not	RB
46745	598	4	seem	seem	VB
46745	598	5	to	to	IN
46745	598	6	me	-PRON-	PRP
46745	598	7	to	to	TO
46745	598	8	be	be	VB
46745	598	9	so	so	RB
46745	598	10	impossible	impossible	JJ
46745	598	11	,	,	,
46745	598	12	or	or	CC
46745	598	13	even	even	RB
46745	598	14	improbable	improbable	JJ
46745	598	15	,	,	,
46745	598	16	that	that	IN
46745	598	17	the	the	DT
46745	598	18	operation	operation	NN
46745	598	19	of	of	IN
46745	598	20	some	some	DT
46745	598	21	medicinal	medicinal	JJ
46745	598	22	agents	agent	NNS
46745	598	23	,	,	,
46745	598	24	particularly	particularly	RB
46745	598	25	those	those	DT
46745	598	26	which	which	WDT
46745	598	27	act	act	VBP
46745	598	28	on	on	IN
46745	598	29	the	the	DT
46745	598	30	nerves	nerve	NNS
46745	598	31	,	,	,
46745	598	32	may	may	MD
46745	598	33	depend	depend	VB
46745	598	34	in	in	IN
46745	598	35	some	some	DT
46745	598	36	way	way	NN
46745	598	37	on	on	IN
46745	598	38	the	the	DT
46745	598	39	shapes	shape	NNS
46745	598	40	of	of	IN
46745	598	41	the	the	DT
46745	598	42	atoms	atom	NNS
46745	598	43	of	of	IN
46745	598	44	these	these	DT
46745	598	45	substances	substance	NNS
46745	598	46	,	,	,
46745	598	47	as	as	IN
46745	598	48	related	relate	VBN
46745	598	49	to	to	IN
46745	598	50	those	those	DT
46745	598	51	of	of	IN
46745	598	52	the	the	DT
46745	598	53	tissues	tissue	NNS
46745	598	54	which	which	WDT
46745	598	55	they	-PRON-	PRP
46745	598	56	influence	influence	VBP
46745	598	57	.	.	.
46745	599	1	At	at	RB
46745	599	2	least	least	JJS
46745	599	3	,	,	,
46745	599	4	there	there	EX
46745	599	5	is	be	VBZ
46745	599	6	no	no	DT
46745	599	7	other	other	JJ
46745	599	8	possible	possible	JJ
46745	599	9	explanation	explanation	NN
46745	599	10	of	of	IN
46745	599	11	the	the	DT
46745	599	12	power	power	NN
46745	599	13	of	of	IN
46745	599	14	such	such	JJ
46745	599	15	substances	substance	NNS
46745	599	16	.	.	.
46745	600	1	We	-PRON-	PRP
46745	600	2	know	know	VBP
46745	600	3	that	that	IN
46745	600	4	the	the	DT
46745	600	5	nerves	nerve	NNS
46745	600	6	are	be	VBP
46745	600	7	very	very	RB
46745	600	8	much	much	RB
46745	600	9	under	under	IN
46745	600	10	the	the	DT
46745	600	11	influence	influence	NN
46745	600	12	of	of	IN
46745	600	13	mechanical	mechanical	JJ
46745	600	14	impressions	impression	NNS
46745	600	15	,	,	,
46745	600	16	upon	upon	IN
46745	600	17	which	which	WDT
46745	600	18	depend	depend	VBP
46745	600	19	the	the	DT
46745	600	20	phenomena	phenomenon	NNS
46745	600	21	of	of	IN
46745	600	22	two	two	CD
46745	600	23	at	at	IN
46745	600	24	least	least	JJS
46745	600	25	out	out	IN
46745	600	26	of	of	IN
46745	600	27	the	the	DT
46745	600	28	five	five	CD
46745	600	29	senses	sense	NNS
46745	600	30	,	,	,
46745	600	31	those	those	DT
46745	600	32	of	of	IN
46745	600	33	hearing	hearing	NN
46745	600	34	and	and	CC
46745	600	35	touch	touch	NN
46745	600	36	,	,	,
46745	600	37	as	as	IN
46745	600	38	probably	probably	RB
46745	600	39	also	also	RB
46745	600	40	of	of	IN
46745	600	41	the	the	DT
46745	600	42	other	other	JJ
46745	600	43	three	three	CD
46745	600	44	,	,	,
46745	600	45	if	if	IN
46745	600	46	we	-PRON-	PRP
46745	600	47	understood	understand	VBD
46745	600	48	them	-PRON-	PRP
46745	600	49	better	well	RBR
46745	600	50	.	.	.
46745	601	1	We	-PRON-	PRP
46745	601	2	know	know	VBP
46745	601	3	also	also	RB
46745	601	4	that	that	IN
46745	601	5	if	if	IN
46745	601	6	we	-PRON-	PRP
46745	601	7	accept	accept	VBP
46745	601	8	the	the	DT
46745	601	9	Atomic	atomic	JJ
46745	601	10	theory	theory	NN
46745	601	11	,	,	,
46745	601	12	by	by	IN
46745	601	13	which	which	WDT
46745	601	14	so	so	RB
46745	601	15	many	many	JJ
46745	601	16	chemical	chemical	NN
46745	601	17	phenomena	phenomenon	NNS
46745	601	18	are	be	VBP
46745	601	19	cleared	clear	VBN
46745	601	20	up	up	RP
46745	601	21	and	and	CC
46745	601	22	explained	explain	VBD
46745	601	23	,	,	,
46745	601	24	we	-PRON-	PRP
46745	601	25	must	must	MD
46745	601	26	admit	admit	VB
46745	601	27	a	a	DT
46745	601	28	certain	certain	JJ
46745	601	29	definite	definite	JJ
46745	601	30	and	and	CC
46745	601	31	peculiar	peculiar	JJ
46745	601	32	arrangement	arrangement	NN
46745	601	33	and	and	CC
46745	601	34	shape	shape	VB
46745	601	35	to	to	IN
46745	601	36	the	the	DT
46745	601	37	ultimate	ultimate	JJ
46745	601	38	particles	particle	NNS
46745	601	39	of	of	IN
46745	601	40	every	every	DT
46745	601	41	compound	compound	NN
46745	601	42	body	body	NN
46745	601	43	.	.	.
46745	602	1	These	these	DT
46745	602	2	considerations	consideration	NNS
46745	602	3	render	render	VBP
46745	602	4	it	-PRON-	PRP
46745	602	5	possible	possible	JJ
46745	602	6	that	that	IN
46745	602	7	the	the	DT
46745	602	8	ultimate	ultimate	JJ
46745	602	9	particles	particle	NNS
46745	602	10	of	of	IN
46745	602	11	a	a	DT
46745	602	12	stimulant	stimulant	NN
46745	602	13	medicine	medicine	NN
46745	602	14	may	may	MD
46745	602	15	be	be	VB
46745	602	16	of	of	IN
46745	602	17	such	such	PDT
46745	602	18	a	a	DT
46745	602	19	nature	nature	NN
46745	602	20	as	as	IN
46745	602	21	to	to	TO
46745	602	22	irritate	irritate	VB
46745	602	23	,	,	,
46745	602	24	or	or	CC
46745	602	25	to	to	TO
46745	602	26	refuse	refuse	VB
46745	602	27	to	to	TO
46745	602	28	coincide	coincide	VB
46745	602	29	with	with	IN
46745	602	30	,	,	,
46745	602	31	the	the	DT
46745	602	32	ultimate	ultimate	JJ
46745	602	33	molecules	molecule	NNS
46745	602	34	of	of	IN
46745	602	35	the	the	DT
46745	602	36	sensitive	sensitive	JJ
46745	602	37	nerve	nerve	NN
46745	602	38	with	with	IN
46745	602	39	which	which	WDT
46745	602	40	they	-PRON-	PRP
46745	602	41	come	come	VBP
46745	602	42	in	in	IN
46745	602	43	contact	contact	NN
46745	602	44	;	;	:
46745	602	45	and	and	CC
46745	602	46	those	those	DT
46745	602	47	of	of	IN
46745	602	48	a	a	DT
46745	602	49	sedative	sedative	NN
46745	602	50	may	may	NNP
46745	602	51	,	,	,
46745	602	52	on	on	IN
46745	602	53	the	the	DT
46745	602	54	other	other	JJ
46745	602	55	hand	hand	NN
46745	602	56	,	,	,
46745	602	57	be	be	VB
46745	602	58	so	so	RB
46745	602	59	shaped	shaped	JJ
46745	602	60	and	and	CC
46745	602	61	arranged	arrange	VBD
46745	602	62	as	as	IN
46745	602	63	to	to	TO
46745	602	64	dove	dove	VB
46745	602	65	-	-	HYPH
46745	602	66	tail	tail	VB
46745	602	67	with	with	IN
46745	602	68	those	those	DT
46745	602	69	particles	particle	NNS
46745	602	70	,	,	,
46745	602	71	and	and	CC
46745	602	72	by	by	IN
46745	602	73	extinguishing	extinguish	VBG
46745	602	74	,	,	,
46745	602	75	as	as	IN
46745	602	76	it	-PRON-	PRP
46745	602	77	were	be	VBD
46745	602	78	,	,	,
46745	602	79	their	-PRON-	PRP$
46745	602	80	salient	salient	NN
46745	602	81	points	point	NNS
46745	602	82	,	,	,
46745	602	83	to	to	TO
46745	602	84	cloak	cloak	VB
46745	602	85	their	-PRON-	PRP$
46745	602	86	vital	vital	JJ
46745	602	87	sensibility	sensibility	NN
46745	602	88	.	.	.
46745	603	1	This	this	DT
46745	603	2	is	be	VBZ
46745	603	3	obviously	obviously	RB
46745	603	4	a	a	DT
46745	603	5	mere	mere	JJ
46745	603	6	conjecture	conjecture	NN
46745	603	7	,	,	,
46745	603	8	and	and	CC
46745	603	9	the	the	DT
46745	603	10	only	only	JJ
46745	603	11	value	value	NN
46745	603	12	which	which	WDT
46745	603	13	can	can	MD
46745	603	14	attach	attach	VB
46745	603	15	to	to	IN
46745	603	16	it	-PRON-	PRP
46745	603	17	is	be	VBZ
46745	603	18	,	,	,
46745	603	19	that	that	IN
46745	603	20	it	-PRON-	PRP
46745	603	21	appears	appear	VBZ
46745	603	22	in	in	IN
46745	603	23	some	some	DT
46745	603	24	sort	sort	NN
46745	603	25	to	to	TO
46745	603	26	explain	explain	VB
46745	603	27	a	a	DT
46745	603	28	thing	thing	NN
46745	603	29	which	which	WDT
46745	603	30	without	without	IN
46745	603	31	it	-PRON-	PRP
46745	603	32	is	be	VBZ
46745	603	33	inexplicable	inexplicable	JJ
46745	603	34	.	.	.
46745	604	1	Some	some	DT
46745	604	2	modern	modern	JJ
46745	604	3	writers	writer	NNS
46745	604	4	have	have	VBP
46745	604	5	attempted	attempt	VBN
46745	604	6	to	to	TO
46745	604	7	clear	clear	VB
46745	604	8	up	up	RP
46745	604	9	the	the	DT
46745	604	10	actions	action	NNS
46745	604	11	of	of	IN
46745	604	12	certain	certain	JJ
46745	604	13	medicines	medicine	NNS
46745	604	14	by	by	IN
46745	604	15	their	-PRON-	PRP$
46745	604	16	supposed	suppose	VBN
46745	604	17	influence	influence	NN
46745	604	18	on	on	IN
46745	604	19	the	the	DT
46745	604	20	physical	physical	JJ
46745	604	21	process	process	NN
46745	604	22	of	of	IN
46745	604	23	endosmosis	endosmosis	NN
46745	604	24	,	,	,
46745	604	25	as	as	IN
46745	604	26	carried	carry	VBN
46745	604	27	on	on	RP
46745	604	28	through	through	IN
46745	604	29	the	the	DT
46745	604	30	coats	coat	NNS
46745	604	31	of	of	IN
46745	604	32	the	the	DT
46745	604	33	stomach	stomach	NN
46745	604	34	and	and	CC
46745	604	35	intestines	intestine	NNS
46745	604	36	.	.	.
46745	605	1	Poissenille	Poissenille	NNP
46745	605	2	and	and	CC
46745	605	3	Matteucci	Matteucci	NNP
46745	605	4	have	have	VBP
46745	605	5	attempted	attempt	VBN
46745	605	6	to	to	TO
46745	605	7	prove	prove	VB
46745	605	8	that	that	IN
46745	605	9	the	the	DT
46745	605	10	action	action	NN
46745	605	11	of	of	IN
46745	605	12	saline	saline	NN
46745	605	13	liquids	liquid	NNS
46745	605	14	in	in	IN
46745	605	15	causing	cause	VBG
46745	605	16	purging	purging	NN
46745	605	17	,	,	,
46745	605	18	and	and	CC
46745	605	19	that	that	DT
46745	605	20	of	of	IN
46745	605	21	a	a	DT
46745	605	22	solution	solution	NN
46745	605	23	of	of	IN
46745	605	24	morphia	morphia	NN
46745	605	25	in	in	IN
46745	605	26	preventing	prevent	VBG
46745	605	27	the	the	DT
46745	605	28	same	same	JJ
46745	605	29	,	,	,
46745	605	30	may	may	MD
46745	605	31	be	be	VB
46745	605	32	explained	explain	VBN
46745	605	33	by	by	IN
46745	605	34	the	the	DT
46745	605	35	_	_	NNP
46745	605	36	endosmotic	endosmotic	JJ
46745	605	37	_	_	NNP
46745	605	38	properties	property	NNS
46745	605	39	of	of	IN
46745	605	40	these	these	DT
46745	605	41	liquids	liquid	NNS
46745	605	42	,	,	,
46745	605	43	as	as	IN
46745	605	44	ascertained	ascertain	VBN
46745	605	45	by	by	IN
46745	605	46	experiment	experiment	NN
46745	605	47	.	.	.
46745	606	1	It	-PRON-	PRP
46745	606	2	does	do	VBZ
46745	606	3	not	not	RB
46745	606	4	seem	seem	VB
46745	606	5	to	to	IN
46745	606	6	me	-PRON-	PRP
46745	606	7	that	that	IN
46745	606	8	these	these	DT
46745	606	9	ideas	idea	NNS
46745	606	10	can	can	MD
46745	606	11	be	be	VB
46745	606	12	successfully	successfully	RB
46745	606	13	maintained	maintain	VBN
46745	606	14	.	.	.
46745	607	1	(	(	-LRB-
46745	607	2	_	_	NNP
46745	607	3	Vide	Vide	NNP
46745	607	4	_	_	NNP
46745	607	5	Prop	Prop	NNP
46745	607	6	.	.	.
46745	608	1	II	II	NNP
46745	608	2	.	.	.
46745	608	3	)	)	-RRB-
46745	609	1	2	2	LS
46745	609	2	.	.	.
46745	610	1	Several	several	JJ
46745	610	2	attempts	attempt	NNS
46745	610	3	have	have	VBP
46745	610	4	been	be	VBN
46745	610	5	made	make	VBN
46745	610	6	to	to	TO
46745	610	7	explain	explain	VB
46745	610	8	the	the	DT
46745	610	9	general	general	JJ
46745	610	10	action	action	NN
46745	610	11	of	of	IN
46745	610	12	medicines	medicine	NNS
46745	610	13	on	on	IN
46745	610	14	chemical	chemical	JJ
46745	610	15	principles	principle	NNS
46745	610	16	.	.	.
46745	611	1	Perhaps	perhaps	RB
46745	611	2	the	the	DT
46745	611	3	strange	strange	JJ
46745	611	4	doctrine	doctrine	NN
46745	611	5	taught	teach	VBN
46745	611	6	by	by	IN
46745	611	7	Galen	Galen	NNP
46745	611	8	,	,	,
46745	611	9	which	which	WDT
46745	611	10	prevailed	prevail	VBD
46745	611	11	for	for	IN
46745	611	12	so	so	RB
46745	611	13	many	many	JJ
46745	611	14	centuries	century	NNS
46745	611	15	afterwards	afterwards	RB
46745	611	16	,	,	,
46745	611	17	should	should	MD
46745	611	18	be	be	VB
46745	611	19	mentioned	mention	VBN
46745	611	20	under	under	IN
46745	611	21	this	this	DT
46745	611	22	head	head	NN
46745	611	23	as	as	IN
46745	611	24	the	the	DT
46745	611	25	first	first	JJ
46745	611	26	approach	approach	NN
46745	611	27	to	to	IN
46745	611	28	a	a	DT
46745	611	29	chemical	chemical	NN
46745	611	30	theory	theory	NN
46745	611	31	.	.	.
46745	612	1	He	-PRON-	PRP
46745	612	2	considered	consider	VBD
46745	612	3	all	all	DT
46745	612	4	medicines	medicine	NNS
46745	612	5	to	to	TO
46745	612	6	be	be	VB
46745	612	7	_	_	NNP
46745	612	8	hot	hot	JJ
46745	612	9	_	_	NNP
46745	612	10	,	,	,
46745	612	11	_	_	NNP
46745	612	12	cold	cold	JJ
46745	612	13	_	_	NNP
46745	612	14	,	,	,
46745	612	15	_	_	NNP
46745	612	16	moist	moist	NN
46745	612	17	_	_	NNP
46745	612	18	,	,	,
46745	612	19	or	or	CC
46745	612	20	_	_	NNP
46745	612	21	dry	dry	JJ
46745	612	22	_	_	NNP
46745	612	23	.	.	.
46745	613	1	There	there	EX
46745	613	2	were	be	VBD
46745	613	3	four	four	CD
46745	613	4	degrees	degree	NNS
46745	613	5	of	of	IN
46745	613	6	each	each	DT
46745	613	7	of	of	IN
46745	613	8	these	these	DT
46745	613	9	properties	property	NNS
46745	613	10	.	.	.
46745	614	1	In	in	IN
46745	614	2	the	the	DT
46745	614	3	_	_	NNP
46745	614	4	Pharmacopæia	Pharmacopæia	NNP
46745	614	5	Londinensis	Londinensis	NNP
46745	614	6	_	_	NNP
46745	614	7	of	of	IN
46745	614	8	1702	1702	CD
46745	614	9	,	,	,
46745	614	10	translated	translate	VBN
46745	614	11	by	by	IN
46745	614	12	Dr.	Dr.	NNP
46745	614	13	Salmon	Salmon	NNP
46745	614	14	,	,	,
46745	614	15	it	-PRON-	PRP
46745	614	16	is	be	VBZ
46745	614	17	stated	state	VBN
46745	614	18	of	of	IN
46745	614	19	every	every	DT
46745	614	20	herb	herb	NN
46745	614	21	that	that	WDT
46745	614	22	it	-PRON-	PRP
46745	614	23	possesses	possess	VBZ
46745	614	24	in	in	IN
46745	614	25	a	a	DT
46745	614	26	certain	certain	JJ
46745	614	27	degree	degree	NN
46745	614	28	one	one	CD
46745	614	29	or	or	CC
46745	614	30	more	more	JJR
46745	614	31	of	of	IN
46745	614	32	these	these	DT
46745	614	33	qualities	quality	NNS
46745	614	34	.	.	.
46745	615	1	It	-PRON-	PRP
46745	615	2	is	be	VBZ
46745	615	3	amusing	amusing	JJ
46745	615	4	to	to	TO
46745	615	5	find	find	VB
46745	615	6	Dr.	Dr.	NNP
46745	615	7	Salmon	Salmon	NNP
46745	615	8	in	in	IN
46745	615	9	great	great	JJ
46745	615	10	doubt	doubt	NN
46745	615	11	as	as	IN
46745	615	12	to	to	IN
46745	615	13	whether	whether	IN
46745	615	14	Opium	Opium	NNP
46745	615	15	were	be	VBD
46745	615	16	_	_	NNP
46745	615	17	hot	hot	JJ
46745	615	18	_	_	NNP
46745	615	19	or	or	CC
46745	615	20	_	_	NNP
46745	615	21	cold	cold	JJ
46745	615	22	_	_	NNP
46745	615	23	,	,	,
46745	615	24	as	as	IN
46745	615	25	the	the	DT
46745	615	26	Ancients	Ancients	NNPS
46745	615	27	said	say	VBD
46745	615	28	one	one	CD
46745	615	29	thing	thing	NN
46745	615	30	,	,	,
46745	615	31	and	and	CC
46745	615	32	the	the	DT
46745	615	33	Moderns	Moderns	NNPS
46745	615	34	another	another	DT
46745	615	35	.	.	.
46745	616	1	Galen	Galen	NNP
46745	616	2	supposed	suppose	VBD
46745	616	3	that	that	IN
46745	616	4	diseases	disease	NNS
46745	616	5	depended	depend	VBD
46745	616	6	on	on	IN
46745	616	7	similar	similar	JJ
46745	616	8	qualities	quality	NNS
46745	616	9	,	,	,
46745	616	10	and	and	CC
46745	616	11	were	be	VBD
46745	616	12	to	to	TO
46745	616	13	be	be	VB
46745	616	14	counteracted	counteract	VBN
46745	616	15	by	by	IN
46745	616	16	medicines	medicine	NNS
46745	616	17	;	;	:
46745	616	18	that	that	IN
46745	616	19	,	,	,
46745	616	20	for	for	IN
46745	616	21	example	example	NN
46745	616	22	,	,	,
46745	616	23	we	-PRON-	PRP
46745	616	24	were	be	VBD
46745	616	25	to	to	TO
46745	616	26	meet	meet	VB
46745	616	27	a	a	DT
46745	616	28	_	_	NNP
46745	616	29	hot	hot	JJ
46745	616	30	_	_	NNP
46745	616	31	disease	disease	NN
46745	616	32	by	by	IN
46745	616	33	a	a	DT
46745	616	34	_	_	NNP
46745	616	35	cold	cold	JJ
46745	616	36	_	_	NNP
46745	616	37	remedy	remedy	NN
46745	616	38	.	.	.
46745	617	1	The	the	DT
46745	617	2	next	next	JJ
46745	617	3	advance	advance	NN
46745	617	4	,	,	,
46745	617	5	if	if	IN
46745	617	6	such	such	JJ
46745	617	7	it	-PRON-	PRP
46745	617	8	may	may	MD
46745	617	9	be	be	VB
46745	617	10	termed	term	VBN
46745	617	11	,	,	,
46745	617	12	was	be	VBD
46745	617	13	made	make	VBN
46745	617	14	by	by	IN
46745	617	15	the	the	DT
46745	617	16	Alchemists	Alchemists	NNPS
46745	617	17	of	of	IN
46745	617	18	the	the	DT
46745	617	19	middle	middle	JJ
46745	617	20	ages	age	NNS
46745	617	21	,	,	,
46745	617	22	who	who	WP
46745	617	23	frequently	frequently	RB
46745	617	24	turned	turn	VBD
46745	617	25	their	-PRON-	PRP$
46745	617	26	attention	attention	NN
46745	617	27	towards	towards	IN
46745	617	28	the	the	DT
46745	617	29	healing	heal	VBG
46745	617	30	art	art	NN
46745	617	31	,	,	,
46745	617	32	and	and	CC
46745	617	33	almost	almost	RB
46745	617	34	imagined	imagine	VBD
46745	617	35	that	that	IN
46745	617	36	by	by	IN
46745	617	37	their	-PRON-	PRP$
46745	617	38	_	_	NNP
46745	617	39	Philosophers	Philosophers	NNPS
46745	617	40	'	'	POS
46745	617	41	stone	stone	NN
46745	617	42	_	_	NNP
46745	617	43	they	-PRON-	PRP
46745	617	44	could	could	MD
46745	617	45	purify	purify	VB
46745	617	46	and	and	CC
46745	617	47	rekindle	rekindle	VB
46745	617	48	the	the	DT
46745	617	49	perishable	perishable	JJ
46745	617	50	_	_	NNP
46745	617	51	base	base	NN
46745	617	52	metal	metal	NN
46745	617	53	_	_	NNP
46745	617	54	of	of	IN
46745	617	55	the	the	DT
46745	617	56	human	human	JJ
46745	617	57	body	body	NN
46745	617	58	.	.	.
46745	618	1	One	one	CD
46745	618	2	of	of	IN
46745	618	3	their	-PRON-	PRP$
46745	618	4	dreams	dream	NNS
46745	618	5	was	be	VBD
46745	618	6	,	,	,
46745	618	7	that	that	IN
46745	618	8	from	from	IN
46745	618	9	Gold	gold	NN
46745	618	10	,	,	,
46745	618	11	the	the	DT
46745	618	12	most	most	RBS
46745	618	13	durable	durable	JJ
46745	618	14	of	of	IN
46745	618	15	metals	metal	NNS
46745	618	16	,	,	,
46745	618	17	or	or	CC
46745	618	18	from	from	IN
46745	618	19	Mercury	Mercury	NNP
46745	618	20	,	,	,
46745	618	21	the	the	DT
46745	618	22	most	most	RBS
46745	618	23	lively	lively	JJ
46745	618	24	and	and	CC
46745	618	25	volatile	volatile	JJ
46745	618	26	,	,	,
46745	618	27	they	-PRON-	PRP
46745	618	28	might	may	MD
46745	618	29	by	by	IN
46745	618	30	their	-PRON-	PRP$
46745	618	31	magical	magical	JJ
46745	618	32	arts	art	NNS
46745	618	33	be	be	VB
46745	618	34	enabled	enable	VBN
46745	618	35	to	to	TO
46745	618	36	prepare	prepare	VB
46745	618	37	a	a	DT
46745	618	38	medicine	medicine	NN
46745	618	39	that	that	WDT
46745	618	40	should	should	MD
46745	618	41	render	render	VB
46745	618	42	life	life	NN
46745	618	43	perennial	perennial	JJ
46745	618	44	.	.	.
46745	619	1	A	a	DT
46745	619	2	most	most	RBS
46745	619	3	impracticable	impracticable	JJ
46745	619	4	formula	formula	NN
46745	619	5	for	for	IN
46745	619	6	the	the	DT
46745	619	7	preparation	preparation	NN
46745	619	8	of	of	IN
46745	619	9	this	this	DT
46745	619	10	_	_	NNP
46745	619	11	Elixir	Elixir	NNP
46745	619	12	Vitæ	Vitæ	NNP
46745	619	13	_	_	NNP
46745	619	14	was	be	VBD
46745	619	15	given	give	VBN
46745	619	16	,	,	,
46745	619	17	among	among	IN
46745	619	18	others	other	NNS
46745	619	19	,	,	,
46745	619	20	by	by	IN
46745	619	21	Carolus	Carolus	NNP
46745	619	22	Musitanus	Musitanus	NNP
46745	619	23	.	.	.
46745	620	1	Basil	Basil	NNP
46745	620	2	Valentine	Valentine	NNP
46745	620	3	,	,	,
46745	620	4	who	who	WP
46745	620	5	flourished	flourish	VBD
46745	620	6	in	in	IN
46745	620	7	the	the	DT
46745	620	8	fifteenth	fifteenth	JJ
46745	620	9	century	century	NN
46745	620	10	,	,	,
46745	620	11	did	do	VBD
46745	620	12	good	good	JJ
46745	620	13	service	service	NN
46745	620	14	by	by	IN
46745	620	15	adding	add	VBG
46745	620	16	to	to	IN
46745	620	17	the	the	DT
46745	620	18	Materia	Materia	NNP
46745	620	19	Medica	Medica	NNP
46745	620	20	the	the	DT
46745	620	21	preparations	preparation	NNS
46745	620	22	of	of	IN
46745	620	23	Antimony	Antimony	NNP
46745	620	24	,	,	,
46745	620	25	as	as	RB
46745	620	26	well	well	RB
46745	620	27	as	as	IN
46745	620	28	the	the	DT
46745	620	29	Mineral	Mineral	NNP
46745	620	30	Acids	Acids	NNPS
46745	620	31	.	.	.
46745	621	1	In	in	IN
46745	621	2	the	the	DT
46745	621	3	sixteenth	sixteenth	NN
46745	621	4	lived	live	VBD
46745	621	5	Paracelsus	Paracelsus	NNP
46745	621	6	and	and	CC
46745	621	7	Von	Von	NNP
46745	621	8	Helmont	Helmont	NNP
46745	621	9	,	,	,
46745	621	10	the	the	DT
46745	621	11	latest	late	JJS
46745	621	12	and	and	CC
46745	621	13	most	most	RBS
46745	621	14	enthusiastic	enthusiastic	JJ
46745	621	15	of	of	IN
46745	621	16	the	the	DT
46745	621	17	medical	medical	JJ
46745	621	18	Alchemists	Alchemists	NNPS
46745	621	19	.	.	.
46745	622	1	They	-PRON-	PRP
46745	622	2	considered	consider	VBD
46745	622	3	the	the	DT
46745	622	4	chemical	chemical	NN
46745	622	5	principles	principle	NNS
46745	622	6	of	of	IN
46745	622	7	medicines	medicine	NNS
46745	622	8	,	,	,
46745	622	9	by	by	IN
46745	622	10	virtue	virtue	NN
46745	622	11	of	of	IN
46745	622	12	which	which	WDT
46745	622	13	they	-PRON-	PRP
46745	622	14	operated	operate	VBD
46745	622	15	,	,	,
46745	622	16	to	to	TO
46745	622	17	be	be	VB
46745	622	18	three	three	CD
46745	622	19	in	in	IN
46745	622	20	number,--viz	number,--viz	NNP
46745	622	21	.	.	.
46745	622	22	,	,	,
46745	622	23	_	_	NNP
46745	622	24	Salt	Salt	NNP
46745	622	25	_	_	NNP
46745	622	26	,	,	,
46745	622	27	_	_	NNP
46745	622	28	Sulphur	Sulphur	NNP
46745	622	29	_	_	NNP
46745	622	30	,	,	,
46745	622	31	and	and	CC
46745	622	32	_	_	NNP
46745	622	33	Mercury	Mercury	NNP
46745	622	34	_	_	NNP
46745	622	35	.	.	.
46745	623	1	And	and	CC
46745	623	2	though	though	IN
46745	623	3	the	the	DT
46745	623	4	seventeenth	seventeenth	JJ
46745	623	5	century	century	NN
46745	623	6	was	be	VBD
46745	623	7	illumined	illumine	VBN
46745	623	8	by	by	IN
46745	623	9	the	the	DT
46745	623	10	philosophy	philosophy	NN
46745	623	11	of	of	IN
46745	623	12	Bacon	Bacon	NNP
46745	623	13	,	,	,
46745	623	14	and	and	CC
46745	623	15	the	the	DT
46745	623	16	discoveries	discovery	NNS
46745	623	17	of	of	IN
46745	623	18	Newton	Newton	NNP
46745	623	19	and	and	CC
46745	623	20	Boyle	Boyle	NNP
46745	623	21	,	,	,
46745	623	22	we	-PRON-	PRP
46745	623	23	find	find	VBP
46745	623	24	that	that	IN
46745	623	25	this	this	DT
46745	623	26	strange	strange	JJ
46745	623	27	doctrine	doctrine	NN
46745	623	28	survived	survive	VBD
46745	623	29	in	in	IN
46745	623	30	full	full	JJ
46745	623	31	vigour	vigour	NN
46745	623	32	at	at	IN
46745	623	33	the	the	DT
46745	623	34	commencement	commencement	NN
46745	623	35	of	of	IN
46745	623	36	the	the	DT
46745	623	37	eighteenth	eighteenth	NN
46745	623	38	.	.	.
46745	624	1	It	-PRON-	PRP
46745	624	2	is	be	VBZ
46745	624	3	laid	lay	VBN
46745	624	4	down	down	RP
46745	624	5	as	as	IN
46745	624	6	an	an	DT
46745	624	7	axiom	axiom	NN
46745	624	8	in	in	IN
46745	624	9	Dr.	Dr.	NNP
46745	624	10	Salmon	Salmon	NNP
46745	624	11	's	's	POS
46745	624	12	Pharmacopæia	Pharmacopæia	NNP
46745	624	13	in	in	IN
46745	624	14	1702	1702	CD
46745	624	15	.	.	.
46745	625	1	[	[	-LRB-
46745	625	2	11	11	CD
46745	625	3	]	]	-RRB-
46745	625	4	About	about	IN
46745	625	5	the	the	DT
46745	625	6	middle	middle	NN
46745	625	7	of	of	IN
46745	625	8	this	this	DT
46745	625	9	century	century	NN
46745	625	10	there	there	RB
46745	625	11	arose	arise	VBD
46745	625	12	a	a	DT
46745	625	13	new	new	JJ
46745	625	14	sect	sect	NN
46745	625	15	of	of	IN
46745	625	16	chemical	chemical	JJ
46745	625	17	philosophers	philosopher	NNS
46745	625	18	,	,	,
46745	625	19	somewhat	somewhat	RB
46745	625	20	better	well	RBR
46745	625	21	informed	informed	JJ
46745	625	22	than	than	IN
46745	625	23	the	the	DT
46745	625	24	last	last	JJ
46745	625	25	.	.	.
46745	626	1	They	-PRON-	PRP
46745	626	2	imagined	imagine	VBD
46745	626	3	that	that	IN
46745	626	4	most	most	JJS
46745	626	5	diseases	disease	NNS
46745	626	6	depended	depend	VBD
46745	626	7	on	on	IN
46745	626	8	the	the	DT
46745	626	9	predominance	predominance	NN
46745	626	10	in	in	IN
46745	626	11	the	the	DT
46745	626	12	blood	blood	NN
46745	626	13	of	of	IN
46745	626	14	_	_	NNP
46745	626	15	acid	acid	NN
46745	626	16	_	_	NNP
46745	626	17	or	or	CC
46745	626	18	_	_	NNP
46745	626	19	alkalic	alkalic	JJ
46745	626	20	humours	humour	VBZ
46745	626	21	_	_	NNP
46745	626	22	,	,	,
46745	626	23	and	and	CC
46745	626	24	that	that	IN
46745	626	25	each	each	DT
46745	626	26	of	of	IN
46745	626	27	these	these	DT
46745	626	28	conditions	condition	NNS
46745	626	29	should	should	MD
46745	626	30	be	be	VB
46745	626	31	counteracted	counteract	VBN
46745	626	32	by	by	IN
46745	626	33	a	a	DT
46745	626	34	direct	direct	JJ
46745	626	35	chemical	chemical	NN
46745	626	36	antidote	antidote	NN
46745	626	37	.	.	.
46745	627	1	They	-PRON-	PRP
46745	627	2	supposed	suppose	VBD
46745	627	3	also	also	RB
46745	627	4	that	that	IN
46745	627	5	the	the	DT
46745	627	6	various	various	JJ
46745	627	7	secretions	secretion	NNS
46745	627	8	were	be	VBD
46745	627	9	the	the	DT
46745	627	10	products	product	NNS
46745	627	11	of	of	IN
46745	627	12	_	_	NNP
46745	627	13	fermentations	fermentation	NNS
46745	627	14	_	_	NNP
46745	627	15	in	in	IN
46745	627	16	the	the	DT
46745	627	17	blood	blood	NN
46745	627	18	which	which	WDT
46745	627	19	took	take	VBD
46745	627	20	place	place	NN
46745	627	21	in	in	IN
46745	627	22	the	the	DT
46745	627	23	neighbourhood	neighbourhood	NN
46745	627	24	of	of	IN
46745	627	25	the	the	DT
46745	627	26	glandular	glandular	JJ
46745	627	27	organs	organ	NNS
46745	627	28	.	.	.
46745	628	1	(	(	-LRB-
46745	628	2	_	_	NNP
46745	628	3	Vide	Vide	NNP
46745	628	4	_	_	NNP
46745	628	5	Eliminatives	Eliminatives	NNPS
46745	628	6	.	.	.
46745	628	7	)	)	-RRB-
46745	629	1	In	in	IN
46745	629	2	some	some	DT
46745	629	3	of	of	IN
46745	629	4	their	-PRON-	PRP$
46745	629	5	ideas	idea	NNS
46745	629	6	there	there	EX
46745	629	7	was	be	VBD
46745	629	8	much	much	JJ
46745	629	9	that	that	WDT
46745	629	10	was	be	VBD
46745	629	11	reasonable	reasonable	JJ
46745	629	12	;	;	:
46745	629	13	but	but	CC
46745	629	14	it	-PRON-	PRP
46745	629	15	must	must	MD
46745	629	16	be	be	VB
46745	629	17	confessed	confess	VBN
46745	629	18	that	that	IN
46745	629	19	they	-PRON-	PRP
46745	629	20	were	be	VBD
46745	629	21	rather	rather	RB
46745	629	22	imaginative	imaginative	JJ
46745	629	23	than	than	IN
46745	629	24	argumentative	argumentative	JJ
46745	629	25	,	,	,
46745	629	26	and	and	CC
46745	629	27	,	,	,
46745	629	28	knowing	know	VBG
46745	629	29	really	really	RB
46745	629	30	but	but	CC
46745	629	31	little	little	JJ
46745	629	32	of	of	IN
46745	629	33	the	the	DT
46745	629	34	principles	principle	NNS
46745	629	35	of	of	IN
46745	629	36	that	that	DT
46745	629	37	science	science	NN
46745	629	38	on	on	IN
46745	629	39	which	which	WDT
46745	629	40	their	-PRON-	PRP$
46745	629	41	system	system	NN
46745	629	42	was	be	VBD
46745	629	43	ostensibly	ostensibly	RB
46745	629	44	based	base	VBN
46745	629	45	,	,	,
46745	629	46	they	-PRON-	PRP
46745	629	47	were	be	VBD
46745	629	48	ill	ill	RB
46745	629	49	-	-	HYPH
46745	629	50	qualified	qualified	JJ
46745	629	51	to	to	TO
46745	629	52	contend	contend	VB
46745	629	53	with	with	IN
46745	629	54	their	-PRON-	PRP$
46745	629	55	opponents	opponent	NNS
46745	629	56	of	of	IN
46745	629	57	the	the	DT
46745	629	58	mathematical	mathematical	JJ
46745	629	59	school	school	NN
46745	629	60	,	,	,
46745	629	61	who	who	WP
46745	629	62	at	at	IN
46745	629	63	least	least	JJS
46745	629	64	understood	understand	VBD
46745	629	65	their	-PRON-	PRP$
46745	629	66	own	own	JJ
46745	629	67	position	position	NN
46745	629	68	.	.	.
46745	630	1	Foremost	foremost	RB
46745	630	2	among	among	IN
46745	630	3	these	these	DT
46745	630	4	new	new	JJ
46745	630	5	chemical	chemical	NN
46745	630	6	philosophers	philosopher	NNS
46745	630	7	was	be	VBD
46745	630	8	Raymond	Raymond	NNP
46745	630	9	Vieussens	Vieussens	NNP
46745	630	10	,	,	,
46745	630	11	who	who	WP
46745	630	12	was	be	VBD
46745	630	13	severely	severely	RB
46745	630	14	censured	censure	VBN
46745	630	15	by	by	IN
46745	630	16	Dr.	Dr.	NNP
46745	630	17	Pitcairn	Pitcairn	NNP
46745	630	18	for	for	IN
46745	630	19	having	have	VBG
46745	630	20	asserted	assert	VBN
46745	630	21	that	that	IN
46745	630	22	he	-PRON-	PRP
46745	630	23	had	have	VBD
46745	630	24	found	find	VBN
46745	630	25	an	an	DT
46745	630	26	acid	acid	NN
46745	630	27	in	in	IN
46745	630	28	human	human	JJ
46745	630	29	blood	blood	NN
46745	630	30	.	.	.
46745	631	1	[	[	-LRB-
46745	631	2	12	12	CD
46745	631	3	]	]	-RRB-
46745	631	4	Vieussens	Vieussens	NNP
46745	631	5	was	be	VBD
46745	631	6	one	one	CD
46745	631	7	of	of	IN
46745	631	8	the	the	DT
46745	631	9	earliest	early	JJS
46745	631	10	of	of	IN
46745	631	11	the	the	DT
46745	631	12	sect	sect	NN
46745	631	13	,	,	,
46745	631	14	which	which	WDT
46745	631	15	afterwards	afterwards	RB
46745	631	16	numbered	number	VBD
46745	631	17	many	many	JJ
46745	631	18	followers	follower	NNS
46745	631	19	.	.	.
46745	632	1	There	there	EX
46745	632	2	is	be	VBZ
46745	632	3	very	very	RB
46745	632	4	little	little	JJ
46745	632	5	that	that	WDT
46745	632	6	is	be	VBZ
46745	632	7	tangible	tangible	JJ
46745	632	8	to	to	TO
46745	632	9	be	be	VB
46745	632	10	discovered	discover	VBN
46745	632	11	in	in	IN
46745	632	12	these	these	DT
46745	632	13	old	old	JJ
46745	632	14	chemical	chemical	JJ
46745	632	15	theories	theory	NNS
46745	632	16	of	of	IN
46745	632	17	the	the	DT
46745	632	18	action	action	NN
46745	632	19	of	of	IN
46745	632	20	medicines	medicine	NNS
46745	632	21	;	;	:
46745	632	22	and	and	CC
46745	632	23	it	-PRON-	PRP
46745	632	24	is	be	VBZ
46745	632	25	not	not	RB
46745	632	26	to	to	TO
46745	632	27	be	be	VB
46745	632	28	wondered	wonder	VBN
46745	632	29	at	at	IN
46745	632	30	that	that	DT
46745	632	31	most	most	JJS
46745	632	32	of	of	IN
46745	632	33	them	-PRON-	PRP
46745	632	34	have	have	VBP
46745	632	35	faded	fade	VBN
46745	632	36	away	away	RP
46745	632	37	before	before	IN
46745	632	38	the	the	DT
46745	632	39	advance	advance	NN
46745	632	40	of	of	IN
46745	632	41	science	science	NN
46745	632	42	,	,	,
46745	632	43	and	and	CC
46745	632	44	particularly	particularly	RB
46745	632	45	before	before	IN
46745	632	46	that	that	DT
46745	632	47	wonderful	wonderful	JJ
46745	632	48	development	development	NN
46745	632	49	of	of	IN
46745	632	50	the	the	DT
46745	632	51	science	science	NN
46745	632	52	of	of	IN
46745	632	53	chemistry	chemistry	NN
46745	632	54	,	,	,
46745	632	55	which	which	WDT
46745	632	56	has	have	VBZ
46745	632	57	distinguished	distinguish	VBN
46745	632	58	the	the	DT
46745	632	59	end	end	NN
46745	632	60	of	of	IN
46745	632	61	the	the	DT
46745	632	62	last	last	JJ
46745	632	63	,	,	,
46745	632	64	and	and	CC
46745	632	65	the	the	DT
46745	632	66	first	first	JJ
46745	632	67	half	half	NN
46745	632	68	of	of	IN
46745	632	69	the	the	DT
46745	632	70	present	present	JJ
46745	632	71	century	century	NN
46745	632	72	.	.	.
46745	633	1	We	-PRON-	PRP
46745	633	2	have	have	VBP
46745	633	3	seen	see	VBN
46745	633	4	that	that	IN
46745	633	5	some	some	DT
46745	633	6	of	of	IN
46745	633	7	the	the	DT
46745	633	8	early	early	JJ
46745	633	9	writers	writer	NNS
46745	633	10	made	make	VBD
46745	633	11	great	great	JJ
46745	633	12	account	account	NN
46745	633	13	of	of	IN
46745	633	14	the	the	DT
46745	633	15	affinities	affinity	NNS
46745	633	16	of	of	IN
46745	633	17	acids	acid	NNS
46745	633	18	and	and	CC
46745	633	19	alkalies	alkali	NNS
46745	633	20	.	.	.
46745	634	1	So	so	RB
46745	634	2	also	also	RB
46745	634	3	a	a	DT
46745	634	4	chemical	chemical	JJ
46745	634	5	explanation	explanation	NN
46745	634	6	of	of	IN
46745	634	7	the	the	DT
46745	634	8	action	action	NN
46745	634	9	of	of	IN
46745	634	10	these	these	DT
46745	634	11	remedies	remedy	NNS
46745	634	12	is	be	VBZ
46745	634	13	generally	generally	RB
46745	634	14	adopted	adopt	VBN
46745	634	15	by	by	IN
46745	634	16	writers	writer	NNS
46745	634	17	at	at	IN
46745	634	18	the	the	DT
46745	634	19	present	present	JJ
46745	634	20	day	day	NN
46745	634	21	.	.	.
46745	635	1	It	-PRON-	PRP
46745	635	2	is	be	VBZ
46745	635	3	known	know	VBN
46745	635	4	that	that	IN
46745	635	5	they	-PRON-	PRP
46745	635	6	have	have	VBP
46745	635	7	powerful	powerful	JJ
46745	635	8	tendencies	tendency	NNS
46745	635	9	to	to	TO
46745	635	10	combine	combine	VB
46745	635	11	with	with	IN
46745	635	12	each	each	DT
46745	635	13	other	other	JJ
46745	635	14	,	,	,
46745	635	15	and	and	CC
46745	635	16	it	-PRON-	PRP
46745	635	17	is	be	VBZ
46745	635	18	supposed	suppose	VBN
46745	635	19	that	that	IN
46745	635	20	these	these	DT
46745	635	21	affinities	affinity	NNS
46745	635	22	are	be	VBP
46745	635	23	manifested	manifest	VBN
46745	635	24	even	even	RB
46745	635	25	in	in	IN
46745	635	26	the	the	DT
46745	635	27	living	live	VBG
46745	635	28	blood	blood	NN
46745	635	29	.	.	.
46745	636	1	Schultz	Schultz	NNP
46745	636	2	attempts	attempt	VBZ
46745	636	3	a	a	DT
46745	636	4	further	further	JJ
46745	636	5	chemical	chemical	JJ
46745	636	6	explanation	explanation	NN
46745	636	7	of	of	IN
46745	636	8	their	-PRON-	PRP$
46745	636	9	action	action	NN
46745	636	10	in	in	IN
46745	636	11	some	some	DT
46745	636	12	diseases	disease	NNS
46745	636	13	,	,	,
46745	636	14	particularly	particularly	RB
46745	636	15	inflammations	inflammation	NNS
46745	636	16	.	.	.
46745	637	1	He	-PRON-	PRP
46745	637	2	says	say	VBZ
46745	637	3	that	that	IN
46745	637	4	both	both	DT
46745	637	5	affect	affect	VBP
46745	637	6	the	the	DT
46745	637	7	condition	condition	NN
46745	637	8	of	of	IN
46745	637	9	the	the	DT
46745	637	10	blood	blood	NN
46745	637	11	;	;	:
46745	637	12	but	but	CC
46745	637	13	that	that	IN
46745	637	14	acids	acid	NNS
46745	637	15	tend	tend	VBP
46745	637	16	to	to	TO
46745	637	17	dissolve	dissolve	VB
46745	637	18	and	and	CC
46745	637	19	destroy	destroy	VB
46745	637	20	the	the	DT
46745	637	21	corpuscles	corpuscle	NNS
46745	637	22	,	,	,
46745	637	23	wherefore	wherefore	VBD
46745	637	24	he	-PRON-	PRP
46745	637	25	terms	term	VBZ
46745	637	26	them	-PRON-	PRP
46745	637	27	_	_	IN
46745	637	28	Hæmatolytica	Hæmatolytica	NNP
46745	637	29	Physoda	Physoda	NNP
46745	637	30	_	_	NNP
46745	637	31	;	;	:
46745	637	32	and	and	CC
46745	637	33	alkalies	alkali	NNS
46745	637	34	prevent	prevent	VBP
46745	637	35	the	the	DT
46745	637	36	coagulation	coagulation	NN
46745	637	37	of	of	IN
46745	637	38	the	the	DT
46745	637	39	fibrine	fibrine	NN
46745	637	40	of	of	IN
46745	637	41	the	the	DT
46745	637	42	plasma	plasma	NN
46745	637	43	,	,	,
46745	637	44	for	for	IN
46745	637	45	which	which	WDT
46745	637	46	reason	reason	NN
46745	637	47	he	-PRON-	PRP
46745	637	48	calls	call	VBZ
46745	637	49	them	-PRON-	PRP
46745	637	50	_	_	IN
46745	637	51	Hæmatolytica	Hæmatolytica	NNP
46745	637	52	Plasmatoda	Plasmatoda	NNP
46745	637	53	_	_	NNP
46745	637	54	.	.	.
46745	638	1	Some	some	DT
46745	638	2	modern	modern	JJ
46745	638	3	writers	writer	NNS
46745	638	4	have	have	VBP
46745	638	5	tried	try	VBN
46745	638	6	to	to	TO
46745	638	7	extend	extend	VB
46745	638	8	a	a	DT
46745	638	9	chemical	chemical	NN
46745	638	10	theory	theory	NN
46745	638	11	to	to	IN
46745	638	12	the	the	DT
46745	638	13	operation	operation	NN
46745	638	14	of	of	IN
46745	638	15	medicines	medicine	NNS
46745	638	16	in	in	IN
46745	638	17	general	general	JJ
46745	638	18	.	.	.
46745	639	1	This	this	DT
46745	639	2	is	be	VBZ
46745	639	3	an	an	DT
46745	639	4	error	error	NN
46745	639	5	to	to	TO
46745	639	6	which	which	WDT
46745	639	7	those	those	DT
46745	639	8	who	who	WP
46745	639	9	have	have	VBP
46745	639	10	devoted	devote	VBN
46745	639	11	themselves	-PRON-	PRP
46745	639	12	particularly	particularly	RB
46745	639	13	to	to	IN
46745	639	14	the	the	DT
46745	639	15	study	study	NN
46745	639	16	of	of	IN
46745	639	17	chemical	chemical	NN
46745	639	18	phenomena	phenomenon	NNS
46745	639	19	are	be	VBP
46745	639	20	especially	especially	RB
46745	639	21	prone	prone	JJ
46745	639	22	.	.	.
46745	640	1	Müller	Müller	NNP
46745	640	2	thinks	think	VBZ
46745	640	3	that	that	IN
46745	640	4	the	the	DT
46745	640	5	agency	agency	NN
46745	640	6	of	of	IN
46745	640	7	many	many	JJ
46745	640	8	remedies	remedy	NNS
46745	640	9	may	may	MD
46745	640	10	be	be	VB
46745	640	11	explained	explain	VBN
46745	640	12	by	by	IN
46745	640	13	their	-PRON-	PRP$
46745	640	14	chemical	chemical	JJ
46745	640	15	affinities	affinity	NNS
46745	640	16	.	.	.
46745	641	1	He	-PRON-	PRP
46745	641	2	supposes	suppose	VBZ
46745	641	3	that	that	IN
46745	641	4	they	-PRON-	PRP
46745	641	5	may	may	MD
46745	641	6	effect	effect	VB
46745	641	7	a	a	DT
46745	641	8	change	change	NN
46745	641	9	in	in	IN
46745	641	10	the	the	DT
46745	641	11	nutritive	nutritive	JJ
46745	641	12	fluids	fluid	NNS
46745	641	13	,	,	,
46745	641	14	or	or	CC
46745	641	15	that	that	IN
46745	641	16	they	-PRON-	PRP
46745	641	17	may	may	MD
46745	641	18	so	so	RB
46745	641	19	disturb	disturb	VB
46745	641	20	the	the	DT
46745	641	21	state	state	NN
46745	641	22	of	of	IN
46745	641	23	combination	combination	NN
46745	641	24	in	in	IN
46745	641	25	which	which	WDT
46745	641	26	the	the	DT
46745	641	27	elements	element	NNS
46745	641	28	of	of	IN
46745	641	29	an	an	DT
46745	641	30	organ	organ	NN
46745	641	31	may	may	MD
46745	641	32	be	be	VB
46745	641	33	,	,	,
46745	641	34	that	that	IN
46745	641	35	it	-PRON-	PRP
46745	641	36	becomes	become	VBZ
46745	641	37	insensible	insensible	JJ
46745	641	38	to	to	IN
46745	641	39	the	the	DT
46745	641	40	action	action	NN
46745	641	41	of	of	IN
46745	641	42	morbid	morbid	NN
46745	641	43	stimuli	stimulus	NNS
46745	641	44	.	.	.
46745	642	1	Some	some	DT
46745	642	2	chemists	chemist	NNS
46745	642	3	have	have	VBP
46745	642	4	accounted	account	VBN
46745	642	5	for	for	IN
46745	642	6	the	the	DT
46745	642	7	action	action	NN
46745	642	8	of	of	IN
46745	642	9	Alcohol	Alcohol	NNP
46745	642	10	by	by	IN
46745	642	11	its	-PRON-	PRP$
46745	642	12	chemical	chemical	NN
46745	642	13	affinity	affinity	NN
46745	642	14	for	for	IN
46745	642	15	the	the	DT
46745	642	16	brain	brain	NN
46745	642	17	substance	substance	NN
46745	642	18	.	.	.
46745	643	1	Liebig	Liebig	NNP
46745	643	2	considers	consider	VBZ
46745	643	3	that	that	IN
46745	643	4	the	the	DT
46745	643	5	similarity	similarity	NN
46745	643	6	of	of	IN
46745	643	7	their	-PRON-	PRP$
46745	643	8	composition	composition	NN
46745	643	9	to	to	IN
46745	643	10	that	that	DT
46745	643	11	of	of	IN
46745	643	12	the	the	DT
46745	643	13	brain	brain	NN
46745	643	14	may	may	MD
46745	643	15	serve	serve	VB
46745	643	16	to	to	TO
46745	643	17	explain	explain	VB
46745	643	18	the	the	DT
46745	643	19	operation	operation	NN
46745	643	20	of	of	IN
46745	643	21	such	such	JJ
46745	643	22	medicines	medicine	NNS
46745	643	23	as	as	IN
46745	643	24	Quina	Quina	NNP
46745	643	25	and	and	CC
46745	643	26	Morphia	Morphia	NNP
46745	643	27	.	.	.
46745	644	1	Such	such	JJ
46745	644	2	ideas	idea	NNS
46745	644	3	as	as	IN
46745	644	4	these	these	DT
46745	644	5	are	be	VBP
46745	644	6	at	at	IN
46745	644	7	the	the	DT
46745	644	8	best	good	JJS
46745	644	9	purely	purely	RB
46745	644	10	hypothetical	hypothetical	JJ
46745	644	11	,	,	,
46745	644	12	and	and	CC
46745	644	13	even	even	RB
46745	644	14	as	as	IN
46745	644	15	theories	theory	NNS
46745	644	16	they	-PRON-	PRP
46745	644	17	seem	seem	VBP
46745	644	18	to	to	IN
46745	644	19	me	-PRON-	PRP
46745	644	20	to	to	TO
46745	644	21	be	be	VB
46745	644	22	untenable,--for	untenable,--for	IN
46745	644	23	what	what	WP
46745	644	24	reasons	reason	NNS
46745	644	25	I	-PRON-	PRP
46745	644	26	shall	shall	MD
46745	644	27	have	have	VB
46745	644	28	to	to	TO
46745	644	29	show	show	VB
46745	644	30	when	when	WRB
46745	644	31	I	-PRON-	PRP
46745	644	32	consider	consider	VBP
46745	644	33	these	these	DT
46745	644	34	remedies	remedy	NNS
46745	644	35	.	.	.
46745	645	1	Liebig	Liebig	NNP
46745	645	2	has	have	VBZ
46745	645	3	hazarded	hazard	VBN
46745	645	4	several	several	JJ
46745	645	5	other	other	JJ
46745	645	6	explanations	explanation	NNS
46745	645	7	of	of	IN
46745	645	8	a	a	DT
46745	645	9	similar	similar	JJ
46745	645	10	kind	kind	NN
46745	645	11	,	,	,
46745	645	12	of	of	IN
46745	645	13	which	which	WDT
46745	645	14	the	the	DT
46745	645	15	following	follow	VBG
46745	645	16	is	be	VBZ
46745	645	17	an	an	DT
46745	645	18	example:--"The	example:--"The	.
46745	645	19	frightful	frightful	JJ
46745	645	20	effects	effect	NNS
46745	645	21	of	of	IN
46745	645	22	Sulphuretted	sulphuret	VBN
46745	645	23	Hydrogen	Hydrogen	NNP
46745	645	24	and	and	CC
46745	645	25	Hydrocyanic	Hydrocyanic	NNP
46745	645	26	Acid	Acid	NNP
46745	645	27	are	be	VBP
46745	645	28	explained	explain	VBN
46745	645	29	by	by	IN
46745	645	30	the	the	DT
46745	645	31	well	well	RB
46745	645	32	-	-	HYPH
46745	645	33	known	know	VBN
46745	645	34	action	action	NN
46745	645	35	of	of	IN
46745	645	36	these	these	DT
46745	645	37	compounds	compound	NNS
46745	645	38	on	on	IN
46745	645	39	those	those	DT
46745	645	40	of	of	IN
46745	645	41	Iron	Iron	NNP
46745	645	42	,	,	,
46745	645	43	when	when	WRB
46745	645	44	Alkalies	alkali	NNS
46745	645	45	are	be	VBP
46745	645	46	present	present	JJ
46745	645	47	,	,	,
46745	645	48	and	and	CC
46745	645	49	free	free	JJ
46745	645	50	Alkali	Alkali	NNP
46745	645	51	is	be	VBZ
46745	645	52	never	never	RB
46745	645	53	absent	absent	JJ
46745	645	54	in	in	IN
46745	645	55	the	the	DT
46745	645	56	blood	blood	NN
46745	645	57	.	.	.
46745	645	58	"	"	''
46745	646	1	(	(	-LRB-
46745	646	2	_	_	NNP
46745	646	3	Organic	Organic	NNP
46745	646	4	Chemistry	Chemistry	NNP
46745	646	5	_	_	NNP
46745	646	6	,	,	,
46745	646	7	p.	p.	NN
46745	647	1	274	274	CD
46745	647	2	.	.	.
46745	647	3	)	)	-RRB-
46745	648	1	Now	now	RB
46745	648	2	in	in	IN
46745	648	3	the	the	DT
46745	648	4	first	first	JJ
46745	648	5	place	place	NN
46745	648	6	it	-PRON-	PRP
46745	648	7	is	be	VBZ
46745	648	8	not	not	RB
46745	648	9	proved	prove	VBN
46745	648	10	that	that	IN
46745	648	11	the	the	DT
46745	648	12	complete	complete	JJ
46745	648	13	abstraction	abstraction	NN
46745	648	14	of	of	IN
46745	648	15	iron	iron	NN
46745	648	16	from	from	IN
46745	648	17	the	the	DT
46745	648	18	blood	blood	NN
46745	648	19	would	would	MD
46745	648	20	occasion	occasion	VB
46745	648	21	sudden	sudden	JJ
46745	648	22	death	death	NN
46745	648	23	,	,	,
46745	648	24	though	though	IN
46745	648	25	doubtless	doubtless	RB
46745	648	26	it	-PRON-	PRP
46745	648	27	is	be	VBZ
46745	648	28	a	a	DT
46745	648	29	necessary	necessary	JJ
46745	648	30	constituent	constituent	NN
46745	648	31	of	of	IN
46745	648	32	that	that	DT
46745	648	33	fluid	fluid	NN
46745	648	34	.	.	.
46745	649	1	Further	further	RB
46745	649	2	,	,	,
46745	649	3	Prussic	Prussic	NNP
46745	649	4	Acid	Acid	NNP
46745	649	5	acts	act	VBZ
46745	649	6	on	on	IN
46745	649	7	the	the	DT
46745	649	8	superficial	superficial	JJ
46745	649	9	nerves	nerve	NNS
46745	649	10	as	as	IN
46745	649	11	an	an	DT
46745	649	12	Anodyne	Anodyne	NNP
46745	649	13	when	when	WRB
46745	649	14	applied	apply	VBN
46745	649	15	externally	externally	RB
46745	649	16	,	,	,
46745	649	17	which	which	WDT
46745	649	18	it	-PRON-	PRP
46745	649	19	can	can	MD
46745	649	20	hardly	hardly	RB
46745	649	21	do	do	VB
46745	649	22	by	by	IN
46745	649	23	displacing	displace	VBG
46745	649	24	iron	iron	NN
46745	649	25	.	.	.
46745	650	1	Besides	besides	RB
46745	650	2	,	,	,
46745	650	3	by	by	IN
46745	650	4	parity	parity	NN
46745	650	5	of	of	IN
46745	650	6	reasoning	reasoning	NN
46745	650	7	,	,	,
46745	650	8	Ammonia	Ammonia	NNP
46745	650	9	,	,	,
46745	650	10	or	or	CC
46745	650	11	Benzoic	benzoic	JJ
46745	650	12	or	or	CC
46745	650	13	Cinnamic	Cinnamic	NNP
46745	650	14	Acid	Acid	NNP
46745	650	15	,	,	,
46745	650	16	should	should	MD
46745	650	17	precipitate	precipitate	VB
46745	650	18	iron	iron	NN
46745	650	19	,	,	,
46745	650	20	if	if	IN
46745	650	21	present	present	JJ
46745	650	22	in	in	IN
46745	650	23	the	the	DT
46745	650	24	blood	blood	NN
46745	650	25	in	in	IN
46745	650	26	the	the	DT
46745	650	27	soluble	soluble	JJ
46745	650	28	state	state	NN
46745	650	29	,	,	,
46745	650	30	and	and	CC
46745	650	31	Sulphuric	Sulphuric	NNP
46745	650	32	or	or	CC
46745	650	33	Nitric	Nitric	NNP
46745	650	34	Acid	Acid	NNP
46745	650	35	should	should	MD
46745	650	36	dissolve	dissolve	VB
46745	650	37	it	-PRON-	PRP
46745	650	38	,	,	,
46745	650	39	if	if	IN
46745	650	40	in	in	IN
46745	650	41	the	the	DT
46745	650	42	state	state	NN
46745	650	43	of	of	IN
46745	650	44	peroxide	peroxide	NN
46745	650	45	;	;	:
46745	650	46	and	and	CC
46745	650	47	yet	yet	RB
46745	650	48	none	none	NN
46745	650	49	of	of	IN
46745	650	50	these	these	DT
46745	650	51	agents	agent	NNS
46745	650	52	are	be	VBP
46745	650	53	frightful	frightful	JJ
46745	650	54	poisons	poison	NNS
46745	650	55	.	.	.
46745	651	1	It	-PRON-	PRP
46745	651	2	is	be	VBZ
46745	651	3	not	not	RB
46745	651	4	to	to	TO
46745	651	5	be	be	VB
46745	651	6	imagined	imagine	VBN
46745	651	7	that	that	IN
46745	651	8	chemical	chemical	JJ
46745	651	9	solutions	solution	NNS
46745	651	10	and	and	CC
46745	651	11	decompositions	decomposition	NNS
46745	651	12	of	of	IN
46745	651	13	every	every	DT
46745	651	14	kind	kind	NN
46745	651	15	are	be	VBP
46745	651	16	allowed	allow	VBN
46745	651	17	to	to	TO
46745	651	18	take	take	VB
46745	651	19	effect	effect	NN
46745	651	20	in	in	IN
46745	651	21	the	the	DT
46745	651	22	human	human	JJ
46745	651	23	system	system	NN
46745	651	24	in	in	IN
46745	651	25	the	the	DT
46745	651	26	same	same	JJ
46745	651	27	way	way	NN
46745	651	28	as	as	IN
46745	651	29	in	in	IN
46745	651	30	the	the	DT
46745	651	31	laboratory	laboratory	NN
46745	651	32	of	of	IN
46745	651	33	the	the	DT
46745	651	34	chemist	chemist	NN
46745	651	35	,	,	,
46745	651	36	for	for	IN
46745	651	37	there	there	EX
46745	651	38	are	be	VBP
46745	651	39	in	in	IN
46745	651	40	the	the	DT
46745	651	41	former	former	JJ
46745	651	42	many	many	JJ
46745	651	43	disturbing	disturbing	JJ
46745	651	44	and	and	CC
46745	651	45	controlling	controlling	JJ
46745	651	46	causes	cause	NNS
46745	651	47	which	which	WDT
46745	651	48	suffice	suffice	VBP
46745	651	49	to	to	TO
46745	651	50	hold	hold	VB
46745	651	51	them	-PRON-	PRP
46745	651	52	in	in	IN
46745	651	53	check	check	NN
46745	651	54	.	.	.
46745	652	1	We	-PRON-	PRP
46745	652	2	may	may	MD
46745	652	3	altogether	altogether	RB
46745	652	4	conclude	conclude	VB
46745	652	5	,	,	,
46745	652	6	that	that	IN
46745	652	7	though	though	IN
46745	652	8	the	the	DT
46745	652	9	actions	action	NNS
46745	652	10	of	of	IN
46745	652	11	many	many	JJ
46745	652	12	remedies	remedy	NNS
46745	652	13	may	may	MD
46745	652	14	be	be	VB
46745	652	15	partly	partly	RB
46745	652	16	elucidated	elucidate	VBN
46745	652	17	by	by	IN
46745	652	18	chemical	chemical	JJ
46745	652	19	considerations	consideration	NNS
46745	652	20	,	,	,
46745	652	21	it	-PRON-	PRP
46745	652	22	is	be	VBZ
46745	652	23	impossible	impossible	JJ
46745	652	24	to	to	TO
46745	652	25	account	account	VB
46745	652	26	for	for	IN
46745	652	27	the	the	DT
46745	652	28	influence	influence	NN
46745	652	29	of	of	IN
46745	652	30	all	all	DT
46745	652	31	alike	alike	RB
46745	652	32	in	in	IN
46745	652	33	this	this	DT
46745	652	34	way	way	NN
46745	652	35	.	.	.
46745	653	1	For	for	IN
46745	653	2	at	at	IN
46745	653	3	least	least	JJS
46745	653	4	the	the	DT
46745	653	5	actions	action	NNS
46745	653	6	of	of	IN
46745	653	7	nerve	nerve	NN
46745	653	8	-	-	HYPH
46745	653	9	medicines	medicine	NNS
46745	653	10	and	and	CC
46745	653	11	of	of	IN
46745	653	12	gland	gland	NNP
46745	653	13	-	-	HYPH
46745	653	14	medicines	medicines	NNP
46745	653	15	can	can	MD
46745	653	16	not	not	RB
46745	653	17	be	be	VB
46745	653	18	reasonably	reasonably	RB
46745	653	19	explained	explain	VBN
46745	653	20	on	on	IN
46745	653	21	any	any	DT
46745	653	22	such	such	JJ
46745	653	23	hypothesis	hypothesis	NN
46745	653	24	.	.	.
46745	654	1	3	3	LS
46745	654	2	.	.	.
46745	655	1	The	the	DT
46745	655	2	most	most	RBS
46745	655	3	plausible	plausible	JJ
46745	655	4	explanations	explanation	NNS
46745	655	5	of	of	IN
46745	655	6	the	the	DT
46745	655	7	mode	mode	NN
46745	655	8	of	of	IN
46745	655	9	operation	operation	NN
46745	655	10	of	of	IN
46745	655	11	medicines	medicine	NNS
46745	655	12	have	have	VBP
46745	655	13	been	be	VBN
46745	655	14	founded	found	VBN
46745	655	15	on	on	IN
46745	655	16	_	_	NNP
46745	655	17	vital	vital	JJ
46745	655	18	_	_	NNP
46745	655	19	or	or	CC
46745	655	20	_	_	NNP
46745	655	21	general	general	JJ
46745	655	22	_	_	NNP
46745	655	23	principles	principle	NNS
46745	655	24	.	.	.
46745	656	1	By	by	IN
46745	656	2	_	_	NNP
46745	656	3	vital	vital	NN
46745	656	4	_	_	NNP
46745	656	5	I	-PRON-	PRP
46745	656	6	mean	mean	VBP
46745	656	7	that	that	IN
46745	656	8	these	these	DT
46745	656	9	theories	theory	NNS
46745	656	10	concern	concern	NN
46745	656	11	actions	action	NNS
46745	656	12	which	which	WDT
46745	656	13	could	could	MD
46745	656	14	only	only	RB
46745	656	15	take	take	VB
46745	656	16	place	place	NN
46745	656	17	in	in	IN
46745	656	18	the	the	DT
46745	656	19	living	live	VBG
46745	656	20	body	body	NN
46745	656	21	.	.	.
46745	657	1	They	-PRON-	PRP
46745	657	2	may	may	MD
46745	657	3	be	be	VB
46745	657	4	termed	term	VBN
46745	657	5	_	_	NNP
46745	657	6	general	general	JJ
46745	657	7	_	_	NNP
46745	657	8	principles	principle	NNS
46745	657	9	,	,	,
46745	657	10	because	because	IN
46745	657	11	the	the	DT
46745	657	12	grounds	ground	NNS
46745	657	13	on	on	IN
46745	657	14	which	which	WDT
46745	657	15	they	-PRON-	PRP
46745	657	16	are	be	VBP
46745	657	17	based	base	VBN
46745	657	18	are	be	VBP
46745	657	19	neither	neither	CC
46745	657	20	mechanical	mechanical	JJ
46745	657	21	nor	nor	CC
46745	657	22	chemical	chemical	JJ
46745	657	23	,	,	,
46745	657	24	but	but	CC
46745	657	25	something	something	NN
46745	657	26	different	different	JJ
46745	657	27	from	from	IN
46745	657	28	both	both	DT
46745	657	29	.	.	.
46745	658	1	The	the	DT
46745	658	2	term	term	NN
46745	658	3	_	_	NNP
46745	658	4	dynamical	dynamical	JJ
46745	658	5	_	_	NNP
46745	658	6	has	have	VBZ
46745	658	7	sometimes	sometimes	RB
46745	658	8	been	be	VBN
46745	658	9	applied	apply	VBN
46745	658	10	to	to	IN
46745	658	11	an	an	DT
46745	658	12	ill	ill	RB
46745	658	13	-	-	HYPH
46745	658	14	understood	understand	VBN
46745	658	15	vital	vital	JJ
46745	658	16	action	action	NN
46745	658	17	of	of	IN
46745	658	18	this	this	DT
46745	658	19	sort	sort	NN
46745	658	20	.	.	.
46745	659	1	Many	many	JJ
46745	659	2	different	different	JJ
46745	659	3	ideas	idea	NNS
46745	659	4	have	have	VBP
46745	659	5	been	be	VBN
46745	659	6	broached	broach	VBN
46745	659	7	to	to	TO
46745	659	8	account	account	VB
46745	659	9	thus	thus	RB
46745	659	10	for	for	IN
46745	659	11	the	the	DT
46745	659	12	action	action	NN
46745	659	13	of	of	IN
46745	659	14	medicines	medicine	NNS
46745	659	15	.	.	.
46745	660	1	Some	some	DT
46745	660	2	,	,	,
46745	660	3	who	who	WP
46745	660	4	have	have	VBP
46745	660	5	constructed	construct	VBN
46745	660	6	very	very	RB
46745	660	7	ingenious	ingenious	JJ
46745	660	8	and	and	CC
46745	660	9	plausible	plausible	JJ
46745	660	10	systems	system	NNS
46745	660	11	,	,	,
46745	660	12	have	have	VBP
46745	660	13	explained	explain	VBN
46745	660	14	in	in	IN
46745	660	15	different	different	JJ
46745	660	16	ways	way	NNS
46745	660	17	the	the	DT
46745	660	18	operations	operation	NNS
46745	660	19	of	of	IN
46745	660	20	different	different	JJ
46745	660	21	groups	group	NNS
46745	660	22	of	of	IN
46745	660	23	medicines	medicine	NNS
46745	660	24	.	.	.
46745	661	1	But	but	CC
46745	661	2	when	when	WRB
46745	661	3	others	other	NNS
46745	661	4	have	have	VBP
46745	661	5	adopted	adopt	VBN
46745	661	6	a	a	DT
46745	661	7	single	single	JJ
46745	661	8	inflexible	inflexible	JJ
46745	661	9	hypothesis	hypothesis	NN
46745	661	10	to	to	TO
46745	661	11	account	account	VB
46745	661	12	for	for	IN
46745	661	13	the	the	DT
46745	661	14	action	action	NN
46745	661	15	of	of	IN
46745	661	16	all	all	DT
46745	661	17	alike	alike	RB
46745	661	18	,	,	,
46745	661	19	this	this	DT
46745	661	20	is	be	VBZ
46745	661	21	found	find	VBN
46745	661	22	,	,	,
46745	661	23	as	as	IN
46745	661	24	might	may	MD
46745	661	25	be	be	VB
46745	661	26	supposed	suppose	VBN
46745	661	27	,	,	,
46745	661	28	to	to	TO
46745	661	29	be	be	VB
46745	661	30	of	of	IN
46745	661	31	a	a	DT
46745	661	32	very	very	RB
46745	661	33	untenable	untenable	JJ
46745	661	34	character	character	NN
46745	661	35	.	.	.
46745	662	1	I	-PRON-	PRP
46745	662	2	will	will	MD
46745	662	3	now	now	RB
46745	662	4	consider	consider	VB
46745	662	5	very	very	RB
46745	662	6	briefly	briefly	RB
46745	662	7	several	several	JJ
46745	662	8	such	such	JJ
46745	662	9	ideas	idea	NNS
46745	662	10	;	;	:
46745	662	11	first	first	RB
46745	662	12	,	,	,
46745	662	13	for	for	IN
46745	662	14	the	the	DT
46745	662	15	sake	sake	NN
46745	662	16	of	of	IN
46745	662	17	clearness	clearness	NN
46745	662	18	,	,	,
46745	662	19	dividing	divide	VBG
46745	662	20	them	-PRON-	PRP
46745	662	21	into	into	IN
46745	662	22	seven	seven	CD
46745	662	23	sections	section	NNS
46745	662	24	.	.	.
46745	663	1	I	-PRON-	PRP
46745	663	2	shall	shall	MD
46745	663	3	explain	explain	VB
46745	663	4	my	-PRON-	PRP$
46745	663	5	meaning	meaning	NN
46745	663	6	as	as	IN
46745	663	7	I	-PRON-	PRP
46745	663	8	proceed	proceed	VBP
46745	663	9	.	.	.
46745	664	1	Different	different	JJ
46745	664	2	writers	writer	NNS
46745	664	3	have	have	VBP
46745	664	4	supposed	suppose	VBN
46745	664	5	that	that	IN
46745	664	6	the	the	DT
46745	664	7	general	general	JJ
46745	664	8	operation	operation	NN
46745	664	9	of	of	IN
46745	664	10	remedies	remedy	NNS
46745	664	11	in	in	IN
46745	664	12	the	the	DT
46745	664	13	cure	cure	NN
46745	664	14	of	of	IN
46745	664	15	disease	disease	NN
46745	664	16	is	be	VBZ
46745	664	17	conducted	conduct	VBN
46745	664	18	in	in	IN
46745	664	19	these	these	DT
46745	664	20	various	various	JJ
46745	664	21	ways	way	NNS
46745	664	22	.	.	.
46745	665	1	_	_	NNP
46745	665	2	a.	a.	NN
46745	665	3	_	_	NNP
46745	665	4	By	by	IN
46745	665	5	degrees	degree	NNS
46745	665	6	of	of	IN
46745	665	7	stimulation	stimulation	NN
46745	665	8	.	.	.
46745	666	1	_	_	NNP
46745	666	2	b.	b.	NN
46745	666	3	_	_	NNP
46745	666	4	By	by	IN
46745	666	5	counter	counter	NN
46745	666	6	-	-	NN
46745	666	7	stimulation	stimulation	NN
46745	666	8	.	.	.
46745	667	1	_	_	NNP
46745	667	2	c.	c.	NNP
46745	667	3	_	_	NNP
46745	667	4	By	by	IN
46745	667	5	opposition	opposition	NN
46745	667	6	.	.	.
46745	668	1	_	_	NNP
46745	668	2	d.	d.	NNP
46745	668	3	_	_	NNP
46745	668	4	By	by	IN
46745	668	5	similar	similar	JJ
46745	668	6	agencies	agency	NNS
46745	668	7	.	.	.
46745	669	1	_	_	NNP
46745	669	2	e.	e.	NNP
46745	669	3	_	_	NNP
46745	669	4	By	by	IN
46745	669	5	elimination	elimination	NN
46745	669	6	.	.	.
46745	670	1	_	_	NNP
46745	670	2	f.	f.	NNP
46745	670	3	_	_	NNP
46745	670	4	By	by	IN
46745	670	5	alterative	alterative	JJ
46745	670	6	actions	action	NNS
46745	670	7	.	.	.
46745	671	1	_	_	NNP
46745	671	2	g.	g.	NNP
46745	671	3	_	_	NNP
46745	671	4	By	by	IN
46745	671	5	various	various	JJ
46745	671	6	counteractions	counteraction	NNS
46745	671	7	.	.	.
46745	672	1	_	_	NNP
46745	672	2	a.	a.	NN
46745	672	3	_	_	NNP
46745	672	4	This	this	DT
46745	672	5	idea	idea	NN
46745	672	6	has	have	VBZ
46745	672	7	received	receive	VBN
46745	672	8	the	the	DT
46745	672	9	title	title	NN
46745	672	10	of	of	IN
46745	672	11	the	the	DT
46745	672	12	"	"	``
46745	672	13	Brunonian	brunonian	JJ
46745	672	14	Theory	Theory	NNP
46745	672	15	,	,	,
46745	672	16	"	"	''
46745	672	17	from	from	IN
46745	672	18	the	the	DT
46745	672	19	name	name	NN
46745	672	20	of	of	IN
46745	672	21	its	-PRON-	PRP$
46745	672	22	founder	founder	NN
46745	672	23	.	.	.
46745	673	1	It	-PRON-	PRP
46745	673	2	was	be	VBD
46745	673	3	promulgated	promulgate	VBN
46745	673	4	by	by	IN
46745	673	5	the	the	DT
46745	673	6	famous	famous	JJ
46745	673	7	Dr.	Dr.	NNP
46745	673	8	John	John	NNP
46745	673	9	Brown	Brown	NNP
46745	673	10	at	at	IN
46745	673	11	the	the	DT
46745	673	12	close	close	NN
46745	673	13	of	of	IN
46745	673	14	the	the	DT
46745	673	15	last	last	JJ
46745	673	16	century	century	NN
46745	673	17	.	.	.
46745	674	1	He	-PRON-	PRP
46745	674	2	considered	consider	VBD
46745	674	3	all	all	DT
46745	674	4	diseases	disease	NNS
46745	674	5	to	to	TO
46745	674	6	arise	arise	VB
46745	674	7	from	from	IN
46745	674	8	excessive	excessive	JJ
46745	674	9	or	or	CC
46745	674	10	diminished	diminished	JJ
46745	674	11	"	"	``
46745	674	12	excitement	excitement	NN
46745	674	13	.	.	.
46745	674	14	"	"	''
46745	675	1	He	-PRON-	PRP
46745	675	2	was	be	VBD
46745	675	3	of	of	IN
46745	675	4	opinion	opinion	NN
46745	675	5	that	that	IN
46745	675	6	all	all	DT
46745	675	7	medicinal	medicinal	JJ
46745	675	8	agents	agent	NNS
46745	675	9	were	be	VBD
46745	675	10	stimulants	stimulant	NNS
46745	675	11	,	,	,
46745	675	12	only	only	RB
46745	675	13	that	that	IN
46745	675	14	some	some	DT
46745	675	15	acted	act	VBD
46745	675	16	so	so	RB
46745	675	17	powerfully	powerfully	RB
46745	675	18	as	as	IN
46745	675	19	to	to	TO
46745	675	20	produce	produce	VB
46745	675	21	"	"	``
46745	675	22	indirect	indirect	JJ
46745	675	23	debility	debility	NN
46745	675	24	.	.	.
46745	675	25	"	"	''
46745	676	1	These	these	DT
46745	676	2	latter	latter	JJ
46745	676	3	were	be	VBD
46745	676	4	to	to	TO
46745	676	5	be	be	VB
46745	676	6	used	use	VBN
46745	676	7	in	in	IN
46745	676	8	sthenic	sthenic	JJ
46745	676	9	,	,	,
46745	676	10	the	the	DT
46745	676	11	others	other	NNS
46745	676	12	in	in	IN
46745	676	13	asthenic	asthenic	JJ
46745	676	14	disorders	disorder	NNS
46745	676	15	.	.	.
46745	677	1	But	but	CC
46745	677	2	it	-PRON-	PRP
46745	677	3	is	be	VBZ
46745	677	4	to	to	TO
46745	677	5	be	be	VB
46745	677	6	urged	urge	VBN
46745	677	7	against	against	IN
46745	677	8	this	this	DT
46745	677	9	idea	idea	NN
46745	677	10	,	,	,
46745	677	11	that	that	IN
46745	677	12	many	many	JJ
46745	677	13	sedatives	sedative	NNS
46745	677	14	produce	produce	VBP
46745	677	15	no	no	DT
46745	677	16	appreciable	appreciable	JJ
46745	677	17	degree	degree	NN
46745	677	18	of	of	IN
46745	677	19	"	"	``
46745	677	20	primary	primary	JJ
46745	677	21	stimulation	stimulation	NN
46745	677	22	;	;	:
46745	677	23	"	"	``
46745	677	24	that	that	IN
46745	677	25	alterative	alterative	JJ
46745	677	26	medicines	medicine	NNS
46745	677	27	are	be	VBP
46745	677	28	neither	neither	CC
46745	677	29	stimulant	stimulant	NN
46745	677	30	nor	nor	CC
46745	677	31	depressent	depressent	NN
46745	677	32	;	;	:
46745	677	33	and	and	CC
46745	677	34	that	that	IN
46745	677	35	the	the	DT
46745	677	36	actions	action	NNS
46745	677	37	of	of	IN
46745	677	38	different	different	JJ
46745	677	39	therapeutic	therapeutic	NN
46745	677	40	agents,--as	agents,--as	NNP
46745	677	41	,	,	,
46745	677	42	for	for	IN
46745	677	43	example	example	NN
46745	677	44	,	,	,
46745	677	45	of	of	IN
46745	677	46	Opium	Opium	NNP
46745	677	47	,	,	,
46745	677	48	Mercury	Mercury	NNP
46745	677	49	,	,	,
46745	677	50	and	and	CC
46745	677	51	Rhubarb,--differ	rhubarb,--differ	VB
46745	677	52	very	very	RB
46745	677	53	much	much	RB
46745	677	54	in	in	IN
46745	677	55	quality	quality	NN
46745	677	56	,	,	,
46745	677	57	and	and	CC
46745	677	58	not	not	RB
46745	677	59	simply	simply	RB
46745	677	60	in	in	IN
46745	677	61	degree	degree	NN
46745	677	62	,	,	,
46745	677	63	as	as	IN
46745	677	64	Dr.	Dr.	NNP
46745	677	65	Brown	Brown	NNP
46745	677	66	supposed	suppose	VBD
46745	677	67	.	.	.
46745	678	1	The	the	DT
46745	678	2	principle	principle	NN
46745	678	3	,	,	,
46745	678	4	then	then	RB
46745	678	5	,	,	,
46745	678	6	can	can	MD
46745	678	7	not	not	RB
46745	678	8	be	be	VB
46745	678	9	maintained	maintain	VBN
46745	678	10	.	.	.
46745	679	1	_	_	NNP
46745	679	2	b.	b.	NN
46745	679	3	_	_	NNP
46745	679	4	Rasori	Rasori	NNP
46745	679	5	and	and	CC
46745	679	6	other	other	JJ
46745	679	7	Italians	Italians	NNPS
46745	679	8	adopted	adopt	VBD
46745	679	9	a	a	DT
46745	679	10	similar	similar	JJ
46745	679	11	idea	idea	NN
46745	679	12	about	about	IN
46745	679	13	the	the	DT
46745	679	14	commencement	commencement	NN
46745	679	15	of	of	IN
46745	679	16	this	this	DT
46745	679	17	century	century	NN
46745	679	18	,	,	,
46745	679	19	only	only	RB
46745	679	20	that	that	IN
46745	679	21	they	-PRON-	PRP
46745	679	22	supposed	suppose	VBD
46745	679	23	two	two	CD
46745	679	24	contrary	contrary	JJ
46745	679	25	agencies	agency	NNS
46745	679	26	,	,	,
46745	679	27	instead	instead	RB
46745	679	28	of	of	IN
46745	679	29	variations	variation	NNS
46745	679	30	in	in	IN
46745	679	31	the	the	DT
46745	679	32	degree	degree	NN
46745	679	33	of	of	IN
46745	679	34	the	the	DT
46745	679	35	same	same	JJ
46745	679	36	action	action	NN
46745	679	37	,	,	,
46745	679	38	like	like	IN
46745	679	39	the	the	DT
46745	679	40	Brunonians	Brunonians	NNPS
46745	679	41	.	.	.
46745	680	1	Giacomini	Giacomini	NNP
46745	680	2	classified	classify	VBD
46745	680	3	medicines	medicine	NNS
46745	680	4	on	on	IN
46745	680	5	this	this	DT
46745	680	6	plan	plan	NN
46745	680	7	.	.	.
46745	681	1	The	the	DT
46745	681	2	two	two	CD
46745	681	3	classes	class	NNS
46745	681	4	of	of	IN
46745	681	5	medicines	medicine	NNS
46745	681	6	are	be	VBP
46745	681	7	termed	term	VBN
46745	681	8	"	"	``
46745	681	9	Hypersthenics	Hypersthenics	NNPS
46745	681	10	,	,	,
46745	681	11	"	"	''
46745	681	12	and	and	CC
46745	681	13	"	"	``
46745	681	14	Hyposthenics,"--	Hyposthenics,"--	NNP
46745	681	15	_	_	NNP
46745	681	16	i.e.	i.e.	FW
46745	681	17	_	_	NNP
46745	681	18	Stimulants	Stimulants	NNP
46745	681	19	,	,	,
46745	681	20	and	and	CC
46745	681	21	Contra	Contra	NNP
46745	681	22	-	-	HYPH
46745	681	23	stimulants	stimulant	NNS
46745	681	24	,	,	,
46745	681	25	or	or	CC
46745	681	26	Sedatives	Sedatives	NNPS
46745	681	27	.	.	.
46745	682	1	These	these	DT
46745	682	2	were	be	VBD
46745	682	3	to	to	TO
46745	682	4	be	be	VB
46745	682	5	used	use	VBN
46745	682	6	respectively	respectively	RB
46745	682	7	in	in	IN
46745	682	8	asthenic	asthenic	NNP
46745	682	9	and	and	CC
46745	682	10	in	in	IN
46745	682	11	sthenic	sthenic	JJ
46745	682	12	disorders	disorder	NNS
46745	682	13	.	.	.
46745	683	1	But	but	CC
46745	683	2	this	this	DT
46745	683	3	idea	idea	NN
46745	683	4	did	do	VBD
46745	683	5	not	not	RB
46745	683	6	originate	originate	VB
46745	683	7	with	with	IN
46745	683	8	these	these	DT
46745	683	9	physicians	physician	NNS
46745	683	10	.	.	.
46745	684	1	It	-PRON-	PRP
46745	684	2	prevails	prevail	VBZ
46745	684	3	among	among	IN
46745	684	4	the	the	DT
46745	684	5	modern	modern	JJ
46745	684	6	Hindoos	Hindoos	NNP
46745	684	7	,	,	,
46745	684	8	and	and	CC
46745	684	9	seems	seem	VBZ
46745	684	10	to	to	TO
46745	684	11	have	have	VB
46745	684	12	been	be	VBN
46745	684	13	inculcated	inculcate	VBN
46745	684	14	by	by	IN
46745	684	15	certain	certain	JJ
46745	684	16	medical	medical	JJ
46745	684	17	writers	writer	NNS
46745	684	18	of	of	IN
46745	684	19	that	that	DT
46745	684	20	nation	nation	NN
46745	684	21	in	in	IN
46745	684	22	very	very	RB
46745	684	23	remote	remote	JJ
46745	684	24	times	time	NNS
46745	684	25	.	.	.
46745	685	1	(	(	-LRB-
46745	685	2	_	_	NNP
46745	685	3	On	On	NNP
46745	685	4	the	the	DT
46745	685	5	Hindoo	Hindoo	NNP
46745	685	6	System	System	NNP
46745	685	7	of	of	IN
46745	685	8	Medicine	Medicine	NNP
46745	685	9	,	,	,
46745	685	10	by	by	IN
46745	685	11	Dr.	Dr.	NNP
46745	685	12	Wise	Wise	NNP
46745	685	13	_	_	NNP
46745	685	14	,	,	,
46745	685	15	1845	1845	CD
46745	685	16	,	,	,
46745	685	17	p.	p.	NN
46745	686	1	213	213	CD
46745	686	2	.	.	.
46745	686	3	)	)	-RRB-
46745	687	1	_	_	NNP
46745	687	2	c.	c.	NNP
46745	687	3	_	_	NNP
46745	687	4	The	the	DT
46745	687	5	last	last	RB
46745	687	6	-	-	HYPH
46745	687	7	mentioned	mention	VBN
46745	687	8	idea	idea	NN
46745	687	9	supposes	suppose	VBZ
46745	687	10	only	only	RB
46745	687	11	one	one	CD
46745	687	12	kind	kind	NN
46745	687	13	of	of	IN
46745	687	14	opposition	opposition	NN
46745	687	15	,	,	,
46745	687	16	and	and	CC
46745	687	17	therefore	therefore	RB
46745	687	18	only	only	RB
46745	687	19	two	two	CD
46745	687	20	descriptions	description	NNS
46745	687	21	of	of	IN
46745	687	22	diseased	diseased	JJ
46745	687	23	action	action	NN
46745	687	24	.	.	.
46745	688	1	But	but	CC
46745	688	2	a	a	DT
46745	688	3	much	much	RB
46745	688	4	more	more	RBR
46745	688	5	plausible	plausible	JJ
46745	688	6	notion	notion	NN
46745	688	7	than	than	IN
46745	688	8	that	that	DT
46745	688	9	is	is	RB
46745	688	10	,	,	,
46745	688	11	that	that	IN
46745	688	12	each	each	DT
46745	688	13	particular	particular	JJ
46745	688	14	disease	disease	NN
46745	688	15	or	or	CC
46745	688	16	symptom	symptom	NN
46745	688	17	is	be	VBZ
46745	688	18	to	to	TO
46745	688	19	be	be	VB
46745	688	20	cured	cure	VBN
46745	688	21	by	by	IN
46745	688	22	administering	administer	VBG
46745	688	23	a	a	DT
46745	688	24	remedy	remedy	NN
46745	688	25	which	which	WDT
46745	688	26	is	be	VBZ
46745	688	27	capable	capable	JJ
46745	688	28	of	of	IN
46745	688	29	producing	produce	VBG
46745	688	30	a	a	DT
46745	688	31	contrary	contrary	JJ
46745	688	32	state	state	NN
46745	688	33	.	.	.
46745	689	1	By	by	IN
46745	689	2	this	this	DT
46745	689	3	contrary	contrary	JJ
46745	689	4	condition	condition	NN
46745	689	5	the	the	DT
46745	689	6	disorder	disorder	NN
46745	689	7	is	be	VBZ
46745	689	8	to	to	TO
46745	689	9	be	be	VB
46745	689	10	neutralized	neutralize	VBN
46745	689	11	.	.	.
46745	690	1	This	this	DT
46745	690	2	was	be	VBD
46745	690	3	the	the	DT
46745	690	4	maxim	maxim	NN
46745	690	5	of	of	IN
46745	690	6	Hippocrates--[Greek	Hippocrates--[Greek	NNP
46745	690	7	:	:	:
46745	690	8	ta	ta	NNP
46745	690	9	enantia	enantia	NNP
46745	690	10	tôn	tôn	NNP
46745	690	11	enantiôn	enantiôn	NNP
46745	690	12	estin	estin	NNP
46745	690	13	iêmata]--"contraries	iêmata]--"contrarie	NNS
46745	690	14	are	be	VBP
46745	690	15	the	the	DT
46745	690	16	remedies	remedy	NNS
46745	690	17	of	of	IN
46745	690	18	contraries	contrary	NNS
46745	690	19	.	.	.
46745	690	20	"	"	''
46745	691	1	(	(	-LRB-
46745	691	2	De	De	NNP
46745	691	3	Flatibus	Flatibus	NNP
46745	691	4	,	,	,
46745	691	5	par	par	NN
46745	691	6	.	.	.
46745	692	1	iii	iii	NNP
46745	692	2	.	.	.
46745	692	3	)	)	-RRB-
46745	693	1	On	on	IN
46745	693	2	this	this	DT
46745	693	3	principle	principle	NN
46745	693	4	we	-PRON-	PRP
46745	693	5	give	give	VBP
46745	693	6	purgatives	purgative	NNS
46745	693	7	in	in	IN
46745	693	8	constipation	constipation	NN
46745	693	9	,	,	,
46745	693	10	opium	opium	NN
46745	693	11	in	in	IN
46745	693	12	diarrh[oe]a	diarrh[oe]a	NNP
46745	693	13	,	,	,
46745	693	14	sedatives	sedative	NNS
46745	693	15	to	to	TO
46745	693	16	relieve	relieve	VB
46745	693	17	pain	pain	NN
46745	693	18	,	,	,
46745	693	19	sudorifics	sudorific	NNS
46745	693	20	to	to	TO
46745	693	21	combat	combat	VB
46745	693	22	dryness	dryness	NN
46745	693	23	of	of	IN
46745	693	24	skin	skin	NN
46745	693	25	,	,	,
46745	693	26	etc	etc	FW
46745	693	27	.	.	.
46745	694	1	etc	etc	FW
46745	694	2	.	.	.
46745	695	1	But	but	CC
46745	695	2	the	the	DT
46745	695	3	rule	rule	NN
46745	695	4	becomes	become	VBZ
46745	695	5	inapplicable	inapplicable	JJ
46745	695	6	when	when	WRB
46745	695	7	the	the	DT
46745	695	8	cause	cause	NN
46745	695	9	of	of	IN
46745	695	10	disease	disease	NN
46745	695	11	is	be	VBZ
46745	695	12	so	so	RB
46745	695	13	complicated	complicated	JJ
46745	695	14	that	that	IN
46745	695	15	we	-PRON-	PRP
46745	695	16	can	can	MD
46745	695	17	not	not	RB
46745	695	18	tell	tell	VB
46745	695	19	where	where	WRB
46745	695	20	to	to	TO
46745	695	21	find	find	VB
46745	695	22	a	a	DT
46745	695	23	substance	substance	NN
46745	695	24	that	that	WDT
46745	695	25	shall	shall	MD
46745	695	26	directly	directly	RB
46745	695	27	oppose	oppose	VB
46745	695	28	its	-PRON-	PRP$
46745	695	29	agency	agency	NN
46745	695	30	.	.	.
46745	696	1	Besides	besides	RB
46745	696	2	,	,	,
46745	696	3	it	-PRON-	PRP
46745	696	4	can	can	MD
46745	696	5	not	not	RB
46745	696	6	in	in	IN
46745	696	7	theory	theory	NN
46745	696	8	be	be	VB
46745	696	9	universally	universally	RB
46745	696	10	applied	apply	VBN
46745	696	11	,	,	,
46745	696	12	for	for	IN
46745	696	13	it	-PRON-	PRP
46745	696	14	takes	take	VBZ
46745	696	15	no	no	DT
46745	696	16	notice	notice	NN
46745	696	17	of	of	IN
46745	696	18	treatment	treatment	NN
46745	696	19	by	by	IN
46745	696	20	evacuation	evacuation	NN
46745	696	21	or	or	CC
46745	696	22	by	by	IN
46745	696	23	revulsion	revulsion	NN
46745	696	24	.	.	.
46745	697	1	_	_	NNP
46745	697	2	d.	d.	NNP
46745	697	3	_	_	NNP
46745	697	4	I	-PRON-	PRP
46745	697	5	am	be	VBP
46745	697	6	brought	bring	VBN
46745	697	7	now	now	RB
46745	697	8	to	to	IN
46745	697	9	an	an	DT
46745	697	10	idea	idea	NN
46745	697	11	which	which	WDT
46745	697	12	is	be	VBZ
46745	697	13	directly	directly	RB
46745	697	14	opposed	opposed	JJ
46745	697	15	to	to	IN
46745	697	16	the	the	DT
46745	697	17	last	last	JJ
46745	697	18	.	.	.
46745	698	1	The	the	DT
46745	698	2	rule	rule	NN
46745	698	3	of	of	IN
46745	698	4	the	the	DT
46745	698	5	disciples	disciple	NNS
46745	698	6	of	of	IN
46745	698	7	Hahnemann	Hahnemann	NNP
46745	698	8	is	be	VBZ
46745	698	9	,	,	,
46745	698	10	"	"	``
46745	698	11	Similia	Similia	NNP
46745	698	12	similibus	similibus	NNP
46745	698	13	curantur"--or	curantur"--or	NN
46745	698	14	,	,	,
46745	698	15	diseases	disease	NNS
46745	698	16	are	be	VBP
46745	698	17	to	to	TO
46745	698	18	be	be	VB
46745	698	19	cured	cure	VBN
46745	698	20	by	by	IN
46745	698	21	remedies	remedy	NNS
46745	698	22	which	which	WDT
46745	698	23	shall	shall	MD
46745	698	24	produce	produce	VB
46745	698	25	effects	effect	NNS
46745	698	26	similar	similar	JJ
46745	698	27	to	to	IN
46745	698	28	them	-PRON-	PRP
46745	698	29	.	.	.
46745	699	1	Now	now	RB
46745	699	2	if	if	IN
46745	699	3	this	this	DT
46745	699	4	were	be	VBD
46745	699	5	the	the	DT
46745	699	6	case	case	NN
46745	699	7	,	,	,
46745	699	8	the	the	DT
46745	699	9	majority	majority	NN
46745	699	10	of	of	IN
46745	699	11	disorders	disorder	NNS
46745	699	12	would	would	MD
46745	699	13	be	be	VB
46745	699	14	hopelessly	hopelessly	RB
46745	699	15	incurable	incurable	JJ
46745	699	16	.	.	.
46745	700	1	We	-PRON-	PRP
46745	700	2	know	know	VBP
46745	700	3	of	of	IN
46745	700	4	no	no	DT
46745	700	5	medicines	medicine	NNS
46745	700	6	that	that	WDT
46745	700	7	are	be	VBP
46745	700	8	capable	capable	JJ
46745	700	9	of	of	IN
46745	700	10	producing	produce	VBG
46745	700	11	such	such	JJ
46745	700	12	affections	affection	NNS
46745	700	13	as	as	IN
46745	700	14	ague	ague	NN
46745	700	15	,	,	,
46745	700	16	small	small	JJ
46745	700	17	-	-	HYPH
46745	700	18	pox	pox	NN
46745	700	19	,	,	,
46745	700	20	or	or	CC
46745	700	21	phthisis	phthisis	NN
46745	700	22	;	;	:
46745	700	23	and	and	CC
46745	700	24	when	when	WRB
46745	700	25	such	such	JJ
46745	700	26	remedies	remedy	NNS
46745	700	27	are	be	VBP
46745	700	28	known	know	VBN
46745	700	29	,	,	,
46745	700	30	their	-PRON-	PRP$
46745	700	31	employment	employment	NN
46745	700	32	would	would	MD
46745	700	33	certainly	certainly	RB
46745	700	34	be	be	VB
46745	700	35	singularly	singularly	RB
46745	700	36	objectionable	objectionable	JJ
46745	700	37	.	.	.
46745	701	1	Who	who	WP
46745	701	2	would	would	MD
46745	701	3	administer	administer	VB
46745	701	4	Strychnia	Strychnia	NNP
46745	701	5	in	in	IN
46745	701	6	tetanus	tetanus	NN
46745	701	7	,	,	,
46745	701	8	Opium	opium	NN
46745	701	9	in	in	IN
46745	701	10	congestion	congestion	NN
46745	701	11	of	of	IN
46745	701	12	the	the	DT
46745	701	13	brain	brain	NN
46745	701	14	,	,	,
46745	701	15	or	or	CC
46745	701	16	irritants	irritant	NNS
46745	701	17	in	in	IN
46745	701	18	Gastrodynia	Gastrodynia	NNP
46745	701	19	?	?	.
46745	702	1	The	the	DT
46745	702	2	arguments	argument	NNS
46745	702	3	alleged	allege	VBD
46745	702	4	in	in	IN
46745	702	5	support	support	NN
46745	702	6	of	of	IN
46745	702	7	the	the	DT
46745	702	8	theory	theory	NN
46745	702	9	are	be	VBP
46745	702	10	of	of	IN
46745	702	11	the	the	DT
46745	702	12	most	most	RBS
46745	702	13	fallacious	fallacious	JJ
46745	702	14	kind	kind	NN
46745	702	15	.	.	.
46745	703	1	For	for	IN
46745	703	2	example	example	NN
46745	703	3	,	,	,
46745	703	4	it	-PRON-	PRP
46745	703	5	is	be	VBZ
46745	703	6	said	say	VBN
46745	703	7	that	that	IN
46745	703	8	diaphoretics	diaphoretic	NNS
46745	703	9	cured	cure	VBD
46745	703	10	the	the	DT
46745	703	11	sweating	sweating	NN
46745	703	12	-	-	HYPH
46745	703	13	sickness	sickness	NN
46745	703	14	,	,	,
46745	703	15	and	and	CC
46745	703	16	purgatives	purgative	NNS
46745	703	17	are	be	VBP
46745	703	18	given	give	VBN
46745	703	19	with	with	IN
46745	703	20	advantage	advantage	NN
46745	703	21	in	in	IN
46745	703	22	diarrh[oe]a	diarrh[oe]a	NNP
46745	703	23	,	,	,
46745	703	24	on	on	IN
46745	703	25	the	the	DT
46745	703	26	"	"	``
46745	703	27	Hom[oe]opathic	hom[oe]opathic	JJ
46745	703	28	"	"	''
46745	703	29	principle	principle	NN
46745	703	30	.	.	.
46745	704	1	But	but	CC
46745	704	2	it	-PRON-	PRP
46745	704	3	should	should	MD
46745	704	4	be	be	VB
46745	704	5	observed	observe	VBN
46745	704	6	that	that	IN
46745	704	7	the	the	DT
46745	704	8	sweating	sweating	NN
46745	704	9	in	in	IN
46745	704	10	one	one	CD
46745	704	11	case	case	NN
46745	704	12	,	,	,
46745	704	13	and	and	CC
46745	704	14	diarrh[oe]a	diarrh[oe]a	NNP
46745	704	15	in	in	IN
46745	704	16	the	the	DT
46745	704	17	other	other	JJ
46745	704	18	,	,	,
46745	704	19	are	be	VBP
46745	704	20	the	the	DT
46745	704	21	attempts	attempt	NNS
46745	704	22	of	of	IN
46745	704	23	nature	nature	NN
46745	704	24	to	to	TO
46745	704	25	get	get	VB
46745	704	26	rid	rid	VBN
46745	704	27	of	of	IN
46745	704	28	the	the	DT
46745	704	29	disease	disease	NN
46745	704	30	by	by	IN
46745	704	31	eliminating	eliminate	VBG
46745	704	32	a	a	DT
46745	704	33	poison	poison	NN
46745	704	34	;	;	,
46745	704	35	and	and	CC
46745	704	36	that	that	IN
46745	704	37	in	in	IN
46745	704	38	seconding	second	VBG
46745	704	39	these	these	DT
46745	704	40	attempts	attempt	NNS
46745	704	41	we	-PRON-	PRP
46745	704	42	are	be	VBP
46745	704	43	availing	avail	VBG
46745	704	44	ourselves	-PRON-	PRP
46745	704	45	of	of	IN
46745	704	46	an	an	DT
46745	704	47	agency	agency	NN
46745	704	48	which	which	WDT
46745	704	49	does	do	VBZ
46745	704	50	not	not	RB
46745	704	51	resemble	resemble	VB
46745	704	52	the	the	DT
46745	704	53	disease	disease	NN
46745	704	54	,	,	,
46745	704	55	but	but	CC
46745	704	56	is	be	VBZ
46745	704	57	like	like	IN
46745	704	58	to	to	IN
46745	704	59	the	the	DT
46745	704	60	natural	natural	JJ
46745	704	61	mode	mode	NN
46745	704	62	of	of	IN
46745	704	63	cure	cure	NN
46745	704	64	.	.	.
46745	705	1	Such	such	JJ
46745	705	2	treatment	treatment	NN
46745	705	3	depends	depend	VBZ
46745	705	4	,	,	,
46745	705	5	in	in	IN
46745	705	6	fact	fact	NN
46745	705	7	,	,	,
46745	705	8	upon	upon	IN
46745	705	9	the	the	DT
46745	705	10	principle	principle	NN
46745	705	11	which	which	WDT
46745	705	12	will	will	MD
46745	705	13	have	have	VB
46745	705	14	to	to	TO
46745	705	15	be	be	VB
46745	705	16	considered	consider	VBN
46745	705	17	next	next	RB
46745	705	18	in	in	IN
46745	705	19	order	order	NN
46745	705	20	.	.	.
46745	706	1	The	the	DT
46745	706	2	hom[oe]opathists	hom[oe]opathists	NNP
46745	706	3	would	would	MD
46745	706	4	work	work	VB
46745	706	5	a	a	DT
46745	706	6	strange	strange	JJ
46745	706	7	revolution	revolution	NN
46745	706	8	in	in	IN
46745	706	9	the	the	DT
46745	706	10	Materia	Materia	NNP
46745	706	11	Medica	Medica	NNP
46745	706	12	.	.	.
46745	707	1	[	[	-LRB-
46745	707	2	13	13	CD
46745	707	3	]	]	-RRB-
46745	707	4	Charcoal	Charcoal	NNP
46745	707	5	,	,	,
46745	707	6	Silica	Silica	NNP
46745	707	7	,	,	,
46745	707	8	and	and	CC
46745	707	9	other	other	JJ
46745	707	10	substances	substance	NNS
46745	707	11	commonly	commonly	RB
46745	707	12	supposed	suppose	VBN
46745	707	13	to	to	TO
46745	707	14	be	be	VB
46745	707	15	inert	inert	JJ
46745	707	16	,	,	,
46745	707	17	appear	appear	VBP
46745	707	18	as	as	IN
46745	707	19	remedies	remedy	NNS
46745	707	20	of	of	IN
46745	707	21	wonderful	wonderful	JJ
46745	707	22	efficacy	efficacy	NN
46745	707	23	.	.	.
46745	708	1	It	-PRON-	PRP
46745	708	2	is	be	VBZ
46745	708	3	said	say	VBN
46745	708	4	that	that	IN
46745	708	5	Belladonna	Belladonna	NNP
46745	708	6	produces	produce	VBZ
46745	708	7	a	a	DT
46745	708	8	state	state	NN
46745	708	9	like	like	IN
46745	708	10	scarlatina	scarlatina	NN
46745	708	11	,	,	,
46745	708	12	and	and	CC
46745	708	13	also	also	RB
46745	708	14	a	a	DT
46745	708	15	condition	condition	NN
46745	708	16	resembling	resemble	VBG
46745	708	17	hydrophobia	hydrophobia	NN
46745	708	18	,	,	,
46745	708	19	and	and	CC
46745	708	20	thus	thus	RB
46745	708	21	cures	cure	VBZ
46745	708	22	both	both	DT
46745	708	23	of	of	IN
46745	708	24	these	these	DT
46745	708	25	disorders	disorder	NNS
46745	708	26	.	.	.
46745	709	1	Of	of	IN
46745	709	2	these	these	DT
46745	709	3	three	three	CD
46745	709	4	propositions	proposition	NNS
46745	709	5	it	-PRON-	PRP
46745	709	6	is	be	VBZ
46745	709	7	almost	almost	RB
46745	709	8	needless	needless	JJ
46745	709	9	to	to	TO
46745	709	10	say	say	VB
46745	709	11	that	that	IN
46745	709	12	all	all	DT
46745	709	13	are	be	VBP
46745	709	14	equally	equally	RB
46745	709	15	erroneous	erroneous	JJ
46745	709	16	.	.	.
46745	710	1	Further	further	RB
46745	710	2	,	,	,
46745	710	3	an	an	DT
46745	710	4	experimental	experimental	JJ
46745	710	5	trial	trial	NN
46745	710	6	of	of	IN
46745	710	7	this	this	DT
46745	710	8	principle	principle	NN
46745	710	9	was	be	VBD
46745	710	10	made	make	VBN
46745	710	11	by	by	IN
46745	710	12	Andral	Andral	NNP
46745	710	13	on	on	IN
46745	710	14	a	a	DT
46745	710	15	large	large	JJ
46745	710	16	number	number	NN
46745	710	17	of	of	IN
46745	710	18	patients	patient	NNS
46745	710	19	at	at	IN
46745	710	20	the	the	DT
46745	710	21	Académie	Académie	NNP
46745	710	22	in	in	IN
46745	710	23	Paris	Paris	NNP
46745	710	24	,	,	,
46745	710	25	with	with	IN
46745	710	26	the	the	DT
46745	710	27	assistance	assistance	NN
46745	710	28	of	of	IN
46745	710	29	the	the	DT
46745	710	30	hom[oe]opathists	hom[oe]opathists	XX
46745	710	31	themselves	-PRON-	PRP
46745	710	32	.	.	.
46745	711	1	The	the	DT
46745	711	2	medicines	medicine	NNS
46745	711	3	were	be	VBD
46745	711	4	carefully	carefully	RB
46745	711	5	and	and	CC
46745	711	6	fairly	fairly	RB
46745	711	7	administered	administer	VBN
46745	711	8	,	,	,
46745	711	9	but	but	CC
46745	711	10	in	in	IN
46745	711	11	no	no	DT
46745	711	12	one	one	CD
46745	711	13	instance	instance	NN
46745	711	14	were	be	VBD
46745	711	15	they	-PRON-	PRP
46745	711	16	successful	successful	JJ
46745	711	17	.	.	.
46745	712	1	(	(	-LRB-
46745	712	2	_	_	NNP
46745	712	3	Medical	Medical	NNP
46745	712	4	Gazette	Gazette	NNP
46745	712	5	_	_	NNP
46745	712	6	,	,	,
46745	712	7	vol	vol	NNP
46745	712	8	.	.	.
46745	713	1	xv	xv	NNP
46745	713	2	.	.	.
46745	714	1	p.	p.	NN
46745	715	1	922	922	CD
46745	715	2	.	.	.
46745	715	3	)	)	-RRB-
46745	716	1	_	_	NNP
46745	716	2	e.	e.	NNP
46745	716	3	_	_	NNP
46745	716	4	The	the	DT
46745	716	5	idea	idea	NN
46745	716	6	that	that	IN
46745	716	7	diseases	disease	NNS
46745	716	8	are	be	VBP
46745	716	9	to	to	TO
46745	716	10	be	be	VB
46745	716	11	cured	cure	VBN
46745	716	12	by	by	IN
46745	716	13	assisting	assist	VBG
46745	716	14	nature	nature	NN
46745	716	15	to	to	TO
46745	716	16	eliminate	eliminate	VB
46745	716	17	from	from	IN
46745	716	18	the	the	DT
46745	716	19	system	system	NN
46745	716	20	the	the	DT
46745	716	21	morbid	morbid	NN
46745	716	22	material	material	NN
46745	716	23	,	,	,
46745	716	24	is	be	VBZ
46745	716	25	probably	probably	RB
46745	716	26	as	as	RB
46745	716	27	old	old	JJ
46745	716	28	as	as	IN
46745	716	29	medicine	medicine	NN
46745	716	30	.	.	.
46745	717	1	It	-PRON-	PRP
46745	717	2	was	be	VBD
46745	717	3	one	one	CD
46745	717	4	of	of	IN
46745	717	5	the	the	DT
46745	717	6	doctrines	doctrine	NNS
46745	717	7	of	of	IN
46745	717	8	Hippocrates	Hippocrates	NNPS
46745	717	9	;	;	:
46745	717	10	but	but	CC
46745	717	11	long	long	RB
46745	717	12	even	even	RB
46745	717	13	before	before	IN
46745	717	14	his	-PRON-	PRP$
46745	717	15	time	time	NN
46745	717	16	it	-PRON-	PRP
46745	717	17	appears	appear	VBZ
46745	717	18	to	to	TO
46745	717	19	have	have	VB
46745	717	20	been	be	VBN
46745	717	21	inculcated	inculcate	VBN
46745	717	22	by	by	IN
46745	717	23	a	a	DT
46745	717	24	certain	certain	JJ
46745	717	25	sect	sect	NN
46745	717	26	of	of	IN
46745	717	27	old	old	JJ
46745	717	28	medical	medical	JJ
46745	717	29	writers	writer	NNS
46745	717	30	among	among	IN
46745	717	31	the	the	DT
46745	717	32	Hindoos	Hindoos	NNP
46745	717	33	.	.	.
46745	718	1	These	these	DT
46745	718	2	last	last	JJ
46745	718	3	were	be	VBD
46745	718	4	the	the	DT
46745	718	5	very	very	RB
46745	718	6	earliest	early	JJS
46745	718	7	advocates	advocate	NNS
46745	718	8	of	of	IN
46745	718	9	the	the	DT
46745	718	10	humoral	humoral	JJ
46745	718	11	pathology	pathology	NN
46745	718	12	.	.	.
46745	719	1	(	(	-LRB-
46745	719	2	_	_	NNP
46745	719	3	Dr	Dr	NNP
46745	719	4	.	.	.
46745	720	1	Wise	Wise	NNP
46745	720	2	_	_	NNP
46745	720	3	,	,	,
46745	720	4	_	_	NNP
46745	720	5	op	op	NN
46745	720	6	.	.	.
46745	721	1	cit	cit	NNP
46745	721	2	.	.	.
46745	721	3	_	_	NNP
46745	721	4	p.	p.	NN
46745	722	1	212	212	CD
46745	722	2	.	.	.
46745	722	3	)	)	-RRB-
46745	723	1	Dr.	Dr.	NNP
46745	723	2	Thomas	Thomas	NNP
46745	723	3	Sydenham	Sydenham	NNP
46745	723	4	,	,	,
46745	723	5	born	bear	VBN
46745	723	6	in	in	IN
46745	723	7	1624	1624	CD
46745	723	8	,	,	,
46745	723	9	the	the	DT
46745	723	10	contemporary	contemporary	NN
46745	723	11	of	of	IN
46745	723	12	Harvey	Harvey	NNP
46745	723	13	,	,	,
46745	723	14	and	and	CC
46745	723	15	the	the	DT
46745	723	16	most	most	RBS
46745	723	17	illustrious	illustrious	JJ
46745	723	18	of	of	IN
46745	723	19	the	the	DT
46745	723	20	early	early	JJ
46745	723	21	English	english	JJ
46745	723	22	exponents	exponent	NNS
46745	723	23	of	of	IN
46745	723	24	the	the	DT
46745	723	25	humoral	humoral	JJ
46745	723	26	system	system	NN
46745	723	27	,	,	,
46745	723	28	was	be	VBD
46745	723	29	probably	probably	RB
46745	723	30	the	the	DT
46745	723	31	first	first	JJ
46745	723	32	in	in	IN
46745	723	33	this	this	DT
46745	723	34	country	country	NN
46745	723	35	who	who	WP
46745	723	36	clearly	clearly	RB
46745	723	37	elaborated	elaborate	VBD
46745	723	38	this	this	DT
46745	723	39	view	view	NN
46745	723	40	of	of	IN
46745	723	41	the	the	DT
46745	723	42	action	action	NN
46745	723	43	of	of	IN
46745	723	44	medicines	medicine	NNS
46745	723	45	by	by	IN
46745	723	46	elimination	elimination	NN
46745	723	47	;	;	:
46745	723	48	which	which	WDT
46745	723	49	has	have	VBZ
46745	723	50	been	be	VBN
46745	723	51	more	more	RBR
46745	723	52	or	or	CC
46745	723	53	less	less	RBR
46745	723	54	approved	approve	VBN
46745	723	55	,	,	,
46745	723	56	though	though	IN
46745	723	57	not	not	RB
46745	723	58	so	so	RB
46745	723	59	universally	universally	RB
46745	723	60	applied	apply	VBN
46745	723	61	,	,	,
46745	723	62	by	by	IN
46745	723	63	all	all	DT
46745	723	64	who	who	WP
46745	723	65	have	have	VBP
46745	723	66	lived	live	VBN
46745	723	67	since	since	IN
46745	723	68	his	-PRON-	PRP$
46745	723	69	time	time	NN
46745	723	70	.	.	.
46745	724	1	Agreeing	agree	VBG
46745	724	2	with	with	IN
46745	724	3	Stahl	Stahl	NNPS
46745	724	4	in	in	IN
46745	724	5	his	-PRON-	PRP$
46745	724	6	view	view	NN
46745	724	7	of	of	IN
46745	724	8	the	the	DT
46745	724	9	advantages	advantage	NNS
46745	724	10	of	of	IN
46745	724	11	the	the	DT
46745	724	12	"	"	``
46745	724	13	expectant	expectant	JJ
46745	724	14	"	"	''
46745	724	15	treatment	treatment	NN
46745	724	16	of	of	IN
46745	724	17	diseases	disease	NNS
46745	724	18	,	,	,
46745	724	19	he	-PRON-	PRP
46745	724	20	thought	think	VBD
46745	724	21	it	-PRON-	PRP
46745	724	22	better	well	RBR
46745	724	23	to	to	TO
46745	724	24	rely	rely	VB
46745	724	25	on	on	IN
46745	724	26	the	the	DT
46745	724	27	"	"	``
46745	724	28	vis	vis	FW
46745	724	29	medicatrix	medicatrix	NNP
46745	724	30	naturæ	naturæ	NNPS
46745	724	31	,	,	,
46745	724	32	"	"	''
46745	724	33	than	than	IN
46745	724	34	to	to	TO
46745	724	35	make	make	VB
46745	724	36	rash	rash	JJ
46745	724	37	or	or	CC
46745	724	38	violent	violent	JJ
46745	724	39	attempts	attempt	NNS
46745	724	40	at	at	IN
46745	724	41	a	a	DT
46745	724	42	cure	cure	NN
46745	724	43	.	.	.
46745	725	1	He	-PRON-	PRP
46745	725	2	maintained	maintain	VBD
46745	725	3	that	that	IN
46745	725	4	what	what	WP
46745	725	5	we	-PRON-	PRP
46745	725	6	call	call	VBP
46745	725	7	a	a	DT
46745	725	8	_	_	NNP
46745	725	9	disease	disease	NN
46745	725	10	_	_	NNP
46745	725	11	was	be	VBD
46745	725	12	in	in	IN
46745	725	13	fact	fact	NN
46745	725	14	"	"	``
46745	725	15	no	no	DT
46745	725	16	more	more	JJR
46745	725	17	than	than	IN
46745	725	18	a	a	DT
46745	725	19	vigorous	vigorous	JJ
46745	725	20	effort	effort	NN
46745	725	21	of	of	IN
46745	725	22	nature	nature	NN
46745	725	23	to	to	TO
46745	725	24	throw	throw	VB
46745	725	25	off	off	RP
46745	725	26	the	the	DT
46745	725	27	morbific	morbific	JJ
46745	725	28	matter	matter	NN
46745	725	29	,	,	,
46745	725	30	and	and	CC
46745	725	31	thus	thus	RB
46745	725	32	recover	recover	VB
46745	725	33	the	the	DT
46745	725	34	patient	patient	NN
46745	725	35	.	.	.
46745	726	1	"	"	``
46745	726	2	[	[	-LRB-
46745	726	3	14	14	CD
46745	726	4	]	]	-RRB-
46745	726	5	He	-PRON-	PRP
46745	726	6	proposed	propose	VBD
46745	726	7	,	,	,
46745	726	8	therefore	therefore	RB
46745	726	9	,	,	,
46745	726	10	that	that	IN
46745	726	11	our	-PRON-	PRP$
46745	726	12	efforts	effort	NNS
46745	726	13	should	should	MD
46745	726	14	be	be	VB
46745	726	15	directed	direct	VBN
46745	726	16	to	to	TO
46745	726	17	assist	assist	VB
46745	726	18	nature	nature	NN
46745	726	19	to	to	TO
46745	726	20	procure	procure	VB
46745	726	21	the	the	DT
46745	726	22	evacuation	evacuation	NN
46745	726	23	of	of	IN
46745	726	24	a	a	DT
46745	726	25	poison	poison	NN
46745	726	26	,	,	,
46745	726	27	promoting	promote	VBG
46745	726	28	its	-PRON-	PRP$
46745	726	29	elimination	elimination	NN
46745	726	30	by	by	IN
46745	726	31	acting	act	VBG
46745	726	32	on	on	IN
46745	726	33	the	the	DT
46745	726	34	various	various	JJ
46745	726	35	secretions	secretion	NNS
46745	726	36	--	--	:
46745	726	37	as	as	IN
46745	726	38	by	by	IN
46745	726	39	purgatives	purgative	NNS
46745	726	40	,	,	,
46745	726	41	diaphoretics	diaphoretic	NNS
46745	726	42	and	and	CC
46745	726	43	such	such	JJ
46745	726	44	medicines	medicine	NNS
46745	726	45	.	.	.
46745	727	1	For	for	IN
46745	727	2	he	-PRON-	PRP
46745	727	3	had	have	VBD
46745	727	4	noticed	notice	VBN
46745	727	5	that	that	IN
46745	727	6	in	in	IN
46745	727	7	fevers	fever	NNS
46745	727	8	and	and	CC
46745	727	9	febrile	febrile	NN
46745	727	10	disorders	disorder	VBZ
46745	727	11	the	the	DT
46745	727	12	crisis	crisis	NN
46745	727	13	or	or	CC
46745	727	14	turning	turning	NN
46745	727	15	-	-	HYPH
46745	727	16	point	point	NN
46745	727	17	was	be	VBD
46745	727	18	generally	generally	RB
46745	727	19	accompanied	accompany	VBN
46745	727	20	or	or	CC
46745	727	21	preceded	precede	VBN
46745	727	22	by	by	IN
46745	727	23	an	an	DT
46745	727	24	increase	increase	NN
46745	727	25	in	in	IN
46745	727	26	one	one	CD
46745	727	27	or	or	CC
46745	727	28	more	more	JJR
46745	727	29	of	of	IN
46745	727	30	these	these	DT
46745	727	31	secretions	secretion	NNS
46745	727	32	,	,	,
46745	727	33	and	and	CC
46745	727	34	he	-PRON-	PRP
46745	727	35	regarded	regard	VBD
46745	727	36	this	this	DT
46745	727	37	as	as	IN
46745	727	38	an	an	DT
46745	727	39	indication	indication	NN
46745	727	40	of	of	IN
46745	727	41	the	the	DT
46745	727	42	treatment	treatment	NN
46745	727	43	to	to	TO
46745	727	44	be	be	VB
46745	727	45	pursued	pursue	VBN
46745	727	46	in	in	IN
46745	727	47	all	all	DT
46745	727	48	such	such	JJ
46745	727	49	cases	case	NNS
46745	727	50	.	.	.
46745	728	1	"	"	``
46745	728	2	That	that	IN
46745	728	3	,	,	,
46745	728	4	"	"	''
46745	728	5	said	say	VBD
46745	728	6	he	-PRON-	PRP
46745	728	7	,	,	,
46745	728	8	"	"	``
46745	728	9	appears	appear	VBZ
46745	728	10	to	to	TO
46745	728	11	be	be	VB
46745	728	12	the	the	DT
46745	728	13	best	good	JJS
46745	728	14	method	method	NN
46745	728	15	of	of	IN
46745	728	16	curing	cure	VBG
46745	728	17	acute	acute	JJ
46745	728	18	diseases	disease	NNS
46745	728	19	,	,	,
46745	728	20	which	which	WDT
46745	728	21	,	,	,
46745	728	22	after	after	IN
46745	728	23	nature	nature	NN
46745	728	24	has	have	VBZ
46745	728	25	pitched	pitch	VBN
46745	728	26	upon	upon	IN
46745	728	27	a	a	DT
46745	728	28	certain	certain	JJ
46745	728	29	kind	kind	NN
46745	728	30	of	of	IN
46745	728	31	evacuation	evacuation	NN
46745	728	32	,	,	,
46745	728	33	assists	assist	VBZ
46745	728	34	her	-PRON-	PRP
46745	728	35	in	in	IN
46745	728	36	promoting	promote	VBG
46745	728	37	it	-PRON-	PRP
46745	728	38	,	,	,
46745	728	39	and	and	CC
46745	728	40	so	so	RB
46745	728	41	necessarily	necessarily	RB
46745	728	42	contributes	contribute	VBZ
46745	728	43	to	to	TO
46745	728	44	cure	cure	VB
46745	728	45	the	the	DT
46745	728	46	distemper	distemper	NN
46745	728	47	.	.	.
46745	729	1	"	"	``
46745	729	2	[	[	-LRB-
46745	729	3	15	15	CD
46745	729	4	]	]	-RRB-
46745	729	5	He	-PRON-	PRP
46745	729	6	further	further	RB
46745	729	7	proposed	propose	VBD
46745	729	8	,	,	,
46745	729	9	that	that	IN
46745	729	10	in	in	IN
46745	729	11	the	the	DT
46745	729	12	treatment	treatment	NN
46745	729	13	of	of	IN
46745	729	14	chronic	chronic	JJ
46745	729	15	diseases	disease	NNS
46745	729	16	,	,	,
46745	729	17	when	when	WRB
46745	729	18	nature	nature	NN
46745	729	19	herself	-PRON-	PRP
46745	729	20	was	be	VBD
46745	729	21	slow	slow	JJ
46745	729	22	in	in	IN
46745	729	23	procuring	procure	VBG
46745	729	24	this	this	DT
46745	729	25	evacuation	evacuation	NN
46745	729	26	,	,	,
46745	729	27	we	-PRON-	PRP
46745	729	28	should	should	MD
46745	729	29	seek	seek	VB
46745	729	30	for	for	IN
46745	729	31	_	_	NNP
46745	729	32	specific	specific	JJ
46745	729	33	_	_	NNP
46745	729	34	medicines	medicine	NNS
46745	729	35	,	,	,
46745	729	36	by	by	IN
46745	729	37	which	which	WDT
46745	729	38	we	-PRON-	PRP
46745	729	39	might	may	MD
46745	729	40	assist	assist	VB
46745	729	41	her	-PRON-	PRP
46745	729	42	in	in	IN
46745	729	43	doing	do	VBG
46745	729	44	so	so	RB
46745	729	45	,	,	,
46745	729	46	and	and	CC
46745	729	47	thus	thus	RB
46745	729	48	effectually	effectually	RB
46745	729	49	expel	expel	VB
46745	729	50	the	the	DT
46745	729	51	morbific	morbific	JJ
46745	729	52	matter	matter	NN
46745	729	53	.	.	.
46745	730	1	This	this	DT
46745	730	2	theory	theory	NN
46745	730	3	was	be	VBD
46745	730	4	reasonable	reasonable	JJ
46745	730	5	and	and	CC
46745	730	6	natural	natural	JJ
46745	730	7	compared	compare	VBN
46745	730	8	to	to	IN
46745	730	9	those	those	DT
46745	730	10	that	that	WDT
46745	730	11	followed	follow	VBD
46745	730	12	it	-PRON-	PRP
46745	730	13	;	;	:
46745	730	14	but	but	CC
46745	730	15	it	-PRON-	PRP
46745	730	16	was	be	VBD
46745	730	17	nearly	nearly	RB
46745	730	18	extinguished	extinguish	VBN
46745	730	19	and	and	CC
46745	730	20	forgotten	forget	VBN
46745	730	21	amid	amid	IN
46745	730	22	the	the	DT
46745	730	23	war	war	NN
46745	730	24	of	of	IN
46745	730	25	opinions	opinion	NNS
46745	730	26	which	which	WDT
46745	730	27	was	be	VBD
46745	730	28	subsequently	subsequently	RB
46745	730	29	kindled	kindle	VBN
46745	730	30	by	by	IN
46745	730	31	the	the	DT
46745	730	32	_	_	NNP
46745	730	33	aphorisms	aphorisms	NNPS
46745	730	34	_	_	NNP
46745	730	35	of	of	IN
46745	730	36	Boerhaave	Boerhaave	NNP
46745	730	37	.	.	.
46745	731	1	About	about	RB
46745	731	2	this	this	DT
46745	731	3	time	time	NN
46745	731	4	we	-PRON-	PRP
46745	731	5	find	find	VBP
46745	731	6	Dr.	Dr.	NNP
46745	731	7	Pitcairn	Pitcairn	NNP
46745	731	8	mixing	mix	VBG
46745	731	9	up	up	RP
46745	731	10	this	this	DT
46745	731	11	idea	idea	NN
46745	731	12	with	with	IN
46745	731	13	his	-PRON-	PRP$
46745	731	14	mechanical	mechanical	JJ
46745	731	15	notions	notion	NNS
46745	731	16	,	,	,
46745	731	17	in	in	IN
46745	731	18	a	a	DT
46745	731	19	treatise	treatise	NN
46745	731	20	"	"	''
46745	731	21	On	on	IN
46745	731	22	the	the	DT
46745	731	23	Cure	Cure	NNP
46745	731	24	of	of	IN
46745	731	25	Fevers	fever	NNS
46745	731	26	by	by	IN
46745	731	27	Evacuation	evacuation	NN
46745	731	28	.	.	.
46745	731	29	"	"	''
46745	732	1	Huxham	Huxham	NNP
46745	732	2	also	also	RB
46745	732	3	,	,	,
46745	732	4	in	in	IN
46745	732	5	1729	1729	CD
46745	732	6	,	,	,
46745	732	7	maintained	maintain	VBD
46745	732	8	similar	similar	JJ
46745	732	9	principles	principle	NNS
46745	732	10	.	.	.
46745	733	1	At	at	IN
46745	733	2	the	the	DT
46745	733	3	present	present	JJ
46745	733	4	day	day	NN
46745	733	5	a	a	DT
46745	733	6	more	more	RBR
46745	733	7	enlarged	enlarged	JJ
46745	733	8	view	view	NN
46745	733	9	is	be	VBZ
46745	733	10	adopted	adopt	VBN
46745	733	11	.	.	.
46745	734	1	It	-PRON-	PRP
46745	734	2	is	be	VBZ
46745	734	3	admitted	admit	VBN
46745	734	4	that	that	IN
46745	734	5	we	-PRON-	PRP
46745	734	6	may	may	MD
46745	734	7	often	often	RB
46745	734	8	assist	assist	VB
46745	734	9	these	these	DT
46745	734	10	attempts	attempt	NNS
46745	734	11	of	of	IN
46745	734	12	nature	nature	NN
46745	734	13	at	at	IN
46745	734	14	a	a	DT
46745	734	15	cure	cure	NN
46745	734	16	,	,	,
46745	734	17	and	and	CC
46745	734	18	do	do	VB
46745	734	19	good	good	NN
46745	734	20	by	by	IN
46745	734	21	the	the	DT
46745	734	22	use	use	NN
46745	734	23	,	,	,
46745	734	24	when	when	WRB
46745	734	25	thus	thus	RB
46745	734	26	needed	need	VBN
46745	734	27	,	,	,
46745	734	28	of	of	IN
46745	734	29	evacuant	evacuant	JJ
46745	734	30	medicines	medicine	NNS
46745	734	31	;	;	:
46745	734	32	but	but	CC
46745	734	33	at	at	IN
46745	734	34	the	the	DT
46745	734	35	same	same	JJ
46745	734	36	time	time	NN
46745	734	37	we	-PRON-	PRP
46745	734	38	must	must	MD
46745	734	39	allow	allow	VB
46745	734	40	that	that	IN
46745	734	41	there	there	EX
46745	734	42	are	be	VBP
46745	734	43	many	many	JJ
46745	734	44	other	other	JJ
46745	734	45	advantageous	advantageous	JJ
46745	734	46	modes	mode	NNS
46745	734	47	of	of	IN
46745	734	48	treatment,--that	treatment,--that	NNP
46745	734	49	we	-PRON-	PRP
46745	734	50	may	may	MD
46745	734	51	sometimes	sometimes	RB
46745	734	52	cut	cut	VB
46745	734	53	short	short	JJ
46745	734	54	a	a	DT
46745	734	55	disease	disease	NN
46745	734	56	in	in	IN
46745	734	57	the	the	DT
46745	734	58	blood	blood	NN
46745	734	59	,	,	,
46745	734	60	or	or	CC
46745	734	61	relieve	relieve	VB
46745	734	62	a	a	DT
46745	734	63	disorder	disorder	NN
46745	734	64	by	by	IN
46745	734	65	controlling	control	VBG
46745	734	66	vascular	vascular	JJ
46745	734	67	or	or	CC
46745	734	68	nervous	nervous	JJ
46745	734	69	excitement	excitement	NN
46745	734	70	,	,	,
46745	734	71	without	without	IN
46745	734	72	resorting	resort	VBG
46745	734	73	to	to	IN
46745	734	74	elimination	elimination	NN
46745	734	75	at	at	RB
46745	734	76	all	all	RB
46745	734	77	.	.	.
46745	735	1	_	_	NNP
46745	735	2	f.	f.	NNP
46745	735	3	_	_	NNP
46745	735	4	M.	M.	NNP
46745	735	5	Broussais	Broussais	NNP
46745	735	6	was	be	VBD
46745	735	7	one	one	CD
46745	735	8	of	of	IN
46745	735	9	the	the	DT
46745	735	10	first	first	JJ
46745	735	11	who	who	WP
46745	735	12	rightly	rightly	RB
46745	735	13	maintained	maintain	VBD
46745	735	14	that	that	IN
46745	735	15	many	many	JJ
46745	735	16	medicines	medicine	NNS
46745	735	17	were	be	VBD
46745	735	18	of	of	IN
46745	735	19	use	use	NN
46745	735	20	by	by	IN
46745	735	21	means	mean	NNS
46745	735	22	of	of	IN
46745	735	23	an	an	DT
46745	735	24	_	_	NNP
46745	735	25	alterative	alterative	JJ
46745	735	26	_	_	NNP
46745	735	27	or	or	CC
46745	735	28	_	_	NNP
46745	735	29	revulsive	revulsive	JJ
46745	735	30	_	_	NNP
46745	735	31	action	action	NN
46745	735	32	,	,	,
46745	735	33	by	by	IN
46745	735	34	producing	produce	VBG
46745	735	35	a	a	DT
46745	735	36	distinct	distinct	JJ
46745	735	37	effect	effect	NN
46745	735	38	which	which	WDT
46745	735	39	diverted	divert	VBD
46745	735	40	the	the	DT
46745	735	41	attention	attention	NN
46745	735	42	of	of	IN
46745	735	43	the	the	DT
46745	735	44	system	system	NN
46745	735	45	from	from	IN
46745	735	46	the	the	DT
46745	735	47	disease	disease	NN
46745	735	48	.	.	.
46745	736	1	His	-PRON-	PRP$
46745	736	2	followers	follower	NNS
46745	736	3	have	have	VBP
46745	736	4	classed	class	VBN
46745	736	5	remedies	remedy	NNS
46745	736	6	under	under	IN
46745	736	7	three	three	CD
46745	736	8	heads,--as	heads,--as	NN
46745	736	9	_	_	NNP
46745	736	10	Stimulants	Stimulants	NNP
46745	736	11	_	_	NNP
46745	736	12	,	,	,
46745	736	13	_	_	NNP
46745	736	14	Debilitants	Debilitants	NNP
46745	736	15	_	_	NNP
46745	736	16	,	,	,
46745	736	17	and	and	CC
46745	736	18	_	_	NNP
46745	736	19	Revulsives	Revulsives	NNP
46745	736	20	_	_	NNP
46745	736	21	.	.	.
46745	737	1	He	-PRON-	PRP
46745	737	2	maintained	maintain	VBD
46745	737	3	also	also	RB
46745	737	4	some	some	DT
46745	737	5	other	other	JJ
46745	737	6	peculiar	peculiar	JJ
46745	737	7	ideas	idea	NNS
46745	737	8	.	.	.
46745	738	1	Blood	blood	NN
46745	738	2	-	-	HYPH
46745	738	3	medicines	medicine	NNS
46745	738	4	are	be	VBP
46745	738	5	commonly	commonly	RB
46745	738	6	termed	term	VBN
46745	738	7	_	_	NNP
46745	738	8	Alteratives	Alteratives	NNPS
46745	738	9	_	_	NNP
46745	738	10	,	,	,
46745	738	11	from	from	IN
46745	738	12	the	the	DT
46745	738	13	notion	notion	NN
46745	738	14	that	that	IN
46745	738	15	they	-PRON-	PRP
46745	738	16	divert	divert	VBP
46745	738	17	or	or	CC
46745	738	18	alter	alter	VBP
46745	738	19	the	the	DT
46745	738	20	original	original	JJ
46745	738	21	disease	disease	NN
46745	738	22	by	by	IN
46745	738	23	setting	set	VBG
46745	738	24	up	up	RP
46745	738	25	in	in	IN
46745	738	26	the	the	DT
46745	738	27	system	system	NN
46745	738	28	a	a	DT
46745	738	29	peculiar	peculiar	JJ
46745	738	30	process	process	NN
46745	738	31	of	of	IN
46745	738	32	their	-PRON-	PRP$
46745	738	33	own	own	JJ
46745	738	34	.	.	.
46745	739	1	The	the	DT
46745	739	2	term	term	NN
46745	739	3	_	_	NNP
46745	739	4	Revulsive	Revulsive	NNP
46745	739	5	_	_	NNP
46745	739	6	is	be	VBZ
46745	739	7	especially	especially	RB
46745	739	8	applied	apply	VBN
46745	739	9	to	to	IN
46745	739	10	medicines	medicine	NNS
46745	739	11	which	which	WDT
46745	739	12	produce	produce	VBP
46745	739	13	a	a	DT
46745	739	14	powerful	powerful	JJ
46745	739	15	local	local	JJ
46745	739	16	effect	effect	NN
46745	739	17	,	,	,
46745	739	18	and	and	CC
46745	739	19	are	be	VBP
46745	739	20	supposed	suppose	VBN
46745	739	21	so	so	RB
46745	739	22	to	to	TO
46745	739	23	occupy	occupy	VB
46745	739	24	the	the	DT
46745	739	25	attention	attention	NN
46745	739	26	of	of	IN
46745	739	27	the	the	DT
46745	739	28	system	system	NN
46745	739	29	as	as	IN
46745	739	30	to	to	TO
46745	739	31	tend	tend	VB
46745	739	32	to	to	TO
46745	739	33	cure	cure	VB
46745	739	34	the	the	DT
46745	739	35	disease	disease	NN
46745	739	36	which	which	WDT
46745	739	37	formerly	formerly	RB
46745	739	38	engaged	engage	VBD
46745	739	39	it	-PRON-	PRP
46745	739	40	.	.	.
46745	740	1	Counter	counter	NN
46745	740	2	-	-	HYPH
46745	740	3	irritants	irritant	NNS
46745	740	4	externally	externally	RB
46745	740	5	,	,	,
46745	740	6	and	and	CC
46745	740	7	emetics	emetic	NNS
46745	740	8	among	among	IN
46745	740	9	internal	internal	JJ
46745	740	10	medicines	medicine	NNS
46745	740	11	,	,	,
46745	740	12	are	be	VBP
46745	740	13	generally	generally	RB
46745	740	14	admitted	admit	VBN
46745	740	15	as	as	IN
46745	740	16	revulsives	revulsive	NNS
46745	740	17	.	.	.
46745	741	1	The	the	DT
46745	741	2	idea	idea	NN
46745	741	3	of	of	IN
46745	741	4	revulsion	revulsion	NN
46745	741	5	is	be	VBZ
46745	741	6	a	a	DT
46745	741	7	prominent	prominent	JJ
46745	741	8	feature	feature	NN
46745	741	9	in	in	IN
46745	741	10	the	the	DT
46745	741	11	arrangement	arrangement	NN
46745	741	12	of	of	IN
46745	741	13	medicines	medicine	NNS
46745	741	14	adopted	adopt	VBN
46745	741	15	by	by	IN
46745	741	16	Dr.	Dr.	NNP
46745	741	17	Schultz	Schultz	NNP
46745	741	18	,	,	,
46745	741	19	of	of	IN
46745	741	20	Berlin	Berlin	NNP
46745	741	21	,	,	,
46745	741	22	who	who	WP
46745	741	23	adds	add	VBZ
46745	741	24	to	to	IN
46745	741	25	the	the	DT
46745	741	26	above	above	JJ
46745	741	27	,	,	,
46745	741	28	Expectorants	Expectorants	NNPS
46745	741	29	,	,	,
46745	741	30	Purgatives	Purgatives	NNPS
46745	741	31	,	,	,
46745	741	32	Diuretics	Diuretics	NNP
46745	741	33	,	,	,
46745	741	34	and	and	CC
46745	741	35	Sudorifics	Sudorifics	NNP
46745	741	36	.	.	.
46745	742	1	He	-PRON-	PRP
46745	742	2	divides	divide	VBZ
46745	742	3	medicines	medicine	NNS
46745	742	4	into	into	IN
46745	742	5	_	_	NNP
46745	742	6	Biolytics	Biolytics	NNP
46745	742	7	_	_	NNP
46745	742	8	,	,	,
46745	742	9	tending	tend	VBG
46745	742	10	to	to	TO
46745	742	11	dissolve	dissolve	VB
46745	742	12	life	life	NN
46745	742	13	and	and	CC
46745	742	14	structure	structure	NN
46745	742	15	;	;	:
46745	742	16	_	_	NNP
46745	742	17	Anabiotics	Anabiotics	NNP
46745	742	18	_	_	NNP
46745	742	19	,	,	,
46745	742	20	which	which	WDT
46745	742	21	tend	tend	VBP
46745	742	22	to	to	TO
46745	742	23	stimulate	stimulate	VB
46745	742	24	the	the	DT
46745	742	25	same	same	JJ
46745	742	26	;	;	:
46745	742	27	and	and	CC
46745	742	28	_	_	NNP
46745	742	29	Agonistics	Agonistics	NNP
46745	742	30	_	_	NNP
46745	742	31	,	,	,
46745	742	32	tending	tend	VBG
46745	742	33	to	to	TO
46745	742	34	produce	produce	VB
46745	742	35	a	a	DT
46745	742	36	"	"	``
46745	742	37	defensive	defensive	JJ
46745	742	38	"	"	''
46745	742	39	process	process	NN
46745	742	40	,	,	,
46745	742	41	and	and	CC
46745	742	42	acting	act	VBG
46745	742	43	by	by	IN
46745	742	44	revulsion	revulsion	NN
46745	742	45	.	.	.
46745	743	1	Each	each	DT
46745	743	2	class	class	NN
46745	743	3	is	be	VBZ
46745	743	4	again	again	RB
46745	743	5	divided	divide	VBN
46745	743	6	into	into	IN
46745	743	7	those	those	DT
46745	743	8	which	which	WDT
46745	743	9	affect	affect	VBP
46745	743	10	the	the	DT
46745	743	11	organs	organ	NNS
46745	743	12	and	and	CC
46745	743	13	nutrition	nutrition	NN
46745	743	14	in	in	IN
46745	743	15	general	general	JJ
46745	743	16	;	;	:
46745	743	17	those	those	DT
46745	743	18	which	which	WDT
46745	743	19	act	act	VBP
46745	743	20	on	on	IN
46745	743	21	the	the	DT
46745	743	22	blood	blood	NN
46745	743	23	;	;	:
46745	743	24	and	and	CC
46745	743	25	those	those	DT
46745	743	26	which	which	WDT
46745	743	27	particularly	particularly	RB
46745	743	28	influence	influence	VBP
46745	743	29	the	the	DT
46745	743	30	nerves	nerve	NNS
46745	743	31	.	.	.
46745	744	1	I	-PRON-	PRP
46745	744	2	will	will	MD
46745	744	3	give	give	VB
46745	744	4	examples	example	NNS
46745	744	5	of	of	IN
46745	744	6	each	each	DT
46745	744	7	.	.	.
46745	745	1	SCHULTZ	SCHULTZ	NNP
46745	745	2	'S	'S	NNP
46745	745	3	CLASSIFICATION	classification	NN
46745	745	4	.	.	.
46745	746	1	A.	a.	JJ
46745	746	2	BIOLYTICA	BIOLYTICA	NNP
46745	746	3	.	.	.
46745	747	1	(	(	-LRB-
46745	747	2	_	_	NNP
46745	747	3	Depressents	Depressents	NNP
46745	747	4	.	.	.
46745	747	5	_	_	NNP
46745	747	6	)	)	-RRB-
46745	747	7	1	1	CD
46745	747	8	.	.	.
46745	748	1	Plastilytica	Plastilytica	NNP
46745	748	2	.	.	.
46745	749	1	(	(	-LRB-
46745	749	2	Mercury	Mercury	NNP
46745	749	3	,	,	,
46745	749	4	Alteratives	Alteratives	NNP
46745	749	5	.	.	.
46745	749	6	)	)	-RRB-
46745	750	1	2	2	LS
46745	750	2	.	.	.
46745	751	1	Hæmatolytica	Hæmatolytica	NNP
46745	751	2	.	.	.
46745	752	1	(	(	-LRB-
46745	752	2	Acids	Acids	NNP
46745	752	3	,	,	,
46745	752	4	Alkalies	Alkalies	NNPS
46745	752	5	.	.	.
46745	752	6	)	)	-RRB-
46745	753	1	3	3	LS
46745	753	2	.	.	.
46745	754	1	Neurolytica	Neurolytica	NNP
46745	754	2	.	.	.
46745	755	1	(	(	-LRB-
46745	755	2	Sedatives	sedative	NNS
46745	755	3	.	.	.
46745	755	4	)	)	-RRB-
46745	756	1	B.	B.	NNP
46745	756	2	ANABIOTICA	ANABIOTICA	NNP
46745	756	3	.	.	.
46745	757	1	(	(	-LRB-
46745	757	2	_	_	NNP
46745	757	3	Excitants	Excitants	NNP
46745	757	4	.	.	.
46745	757	5	_	_	NNP
46745	757	6	)	)	-RRB-
46745	757	7	1	1	CD
46745	757	8	.	.	.
46745	758	1	Plastibiotica	Plastibiotica	NNP
46745	758	2	.	.	.
46745	759	1	(	(	-LRB-
46745	759	2	Astringents	astringent	NNS
46745	759	3	.	.	.
46745	759	4	)	)	-RRB-
46745	760	1	2	2	LS
46745	760	2	.	.	.
46745	761	1	Hæmatobiotica	Hæmatobiotica	NNP
46745	761	2	.	.	.
46745	762	1	(	(	-LRB-
46745	762	2	Diffusible	diffusible	JJ
46745	762	3	stimulants	stimulant	NNS
46745	762	4	.	.	.
46745	762	5	)	)	-RRB-
46745	763	1	3	3	LS
46745	763	2	.	.	.
46745	764	1	Neurobiotica	Neurobiotica	NNP
46745	764	2	.	.	.
46745	765	1	(	(	-LRB-
46745	765	2	Opium	Opium	NNP
46745	765	3	,	,	,
46745	765	4	Strychnia	Strychnia	NNP
46745	765	5	.	.	.
46745	765	6	)	)	-RRB-
46745	766	1	C.	C.	NNP
46745	766	2	AGONISTICA	AGONISTICA	NNP
46745	766	3	.	.	.
46745	767	1	(	(	-LRB-
46745	767	2	_	_	NNP
46745	767	3	Revulsives	Revulsives	NNP
46745	767	4	.	.	.
46745	767	5	_	_	NNP
46745	767	6	)	)	-RRB-
46745	767	7	1	1	CD
46745	767	8	.	.	.
46745	768	1	Plastagonistica	Plastagonistica	NNP
46745	768	2	.	.	.
46745	769	1	(	(	-LRB-
46745	769	2	Purgatives	purgative	NNS
46745	769	3	,	,	,
46745	769	4	etc	etc	FW
46745	769	5	.	.	.
46745	769	6	)	)	-RRB-
46745	770	1	2	2	LS
46745	770	2	.	.	.
46745	771	1	Hæmatagonistica	Hæmatagonistica	NNP
46745	771	2	.	.	.
46745	772	1	(	(	-LRB-
46745	772	2	Irritants	irritant	NNS
46745	772	3	.	.	.
46745	772	4	)	)	-RRB-
46745	773	1	3	3	LS
46745	773	2	.	.	.
46745	774	1	Neuragonistica	Neuragonistica	NNP
46745	774	2	.	.	.
46745	775	1	(	(	-LRB-
46745	775	2	Emetics	emetic	NNS
46745	775	3	,	,	,
46745	775	4	Expectorants	Expectorants	NNPS
46745	775	5	.	.	.
46745	775	6	)	)	-RRB-
46745	776	1	These	these	DT
46745	776	2	divisions	division	NNS
46745	776	3	are	be	VBP
46745	776	4	again	again	RB
46745	776	5	subdivided	subdivide	VBN
46745	776	6	with	with	IN
46745	776	7	great	great	JJ
46745	776	8	minuteness	minuteness	NN
46745	776	9	,	,	,
46745	776	10	according	accord	VBG
46745	776	11	to	to	IN
46745	776	12	their	-PRON-	PRP$
46745	776	13	supposed	suppose	VBN
46745	776	14	operation	operation	NN
46745	776	15	.	.	.
46745	777	1	And	and	CC
46745	777	2	yet	yet	RB
46745	777	3	it	-PRON-	PRP
46745	777	4	will	will	MD
46745	777	5	be	be	VB
46745	777	6	seen	see	VBN
46745	777	7	that	that	IN
46745	777	8	,	,	,
46745	777	9	in	in	IN
46745	777	10	spite	spite	NN
46745	777	11	of	of	IN
46745	777	12	the	the	DT
46745	777	13	hard	hard	JJ
46745	777	14	names	name	NNS
46745	777	15	,	,	,
46745	777	16	there	there	EX
46745	777	17	is	be	VBZ
46745	777	18	an	an	DT
46745	777	19	admirable	admirable	JJ
46745	777	20	simplicity	simplicity	NN
46745	777	21	in	in	IN
46745	777	22	this	this	DT
46745	777	23	arrangement	arrangement	NN
46745	777	24	.	.	.
46745	778	1	So	so	RB
46745	778	2	many	many	JJ
46745	778	3	and	and	CC
46745	778	4	so	so	RB
46745	778	5	various	various	JJ
46745	778	6	are	be	VBP
46745	778	7	the	the	DT
46745	778	8	statements	statement	NNS
46745	778	9	made	make	VBN
46745	778	10	,	,	,
46745	778	11	and	and	CC
46745	778	12	so	so	RB
46745	778	13	plausible	plausible	JJ
46745	778	14	the	the	DT
46745	778	15	theories	theory	NNS
46745	778	16	involved	involve	VBN
46745	778	17	,	,	,
46745	778	18	that	that	IN
46745	778	19	I	-PRON-	PRP
46745	778	20	can	can	MD
46745	778	21	not	not	RB
46745	778	22	accord	accord	VB
46745	778	23	to	to	IN
46745	778	24	it	-PRON-	PRP
46745	778	25	here	here	RB
46745	778	26	a	a	DT
46745	778	27	fair	fair	JJ
46745	778	28	consideration	consideration	NN
46745	778	29	.	.	.
46745	779	1	I	-PRON-	PRP
46745	779	2	must	must	MD
46745	779	3	object	object	VB
46745	779	4	to	to	IN
46745	779	5	it	-PRON-	PRP
46745	779	6	,	,	,
46745	779	7	however	however	RB
46745	779	8	,	,	,
46745	779	9	that	that	IN
46745	779	10	there	there	EX
46745	779	11	is	be	VBZ
46745	779	12	too	too	RB
46745	779	13	much	much	JJ
46745	779	14	generalization	generalization	NN
46745	779	15	,	,	,
46745	779	16	and	and	CC
46745	779	17	,	,	,
46745	779	18	what	what	WP
46745	779	19	is	be	VBZ
46745	779	20	more	more	RBR
46745	779	21	important	important	JJ
46745	779	22	,	,	,
46745	779	23	that	that	IN
46745	779	24	many	many	JJ
46745	779	25	medicines	medicine	NNS
46745	779	26	may	may	MD
46745	779	27	cure	cure	VB
46745	779	28	diseases	disease	NNS
46745	779	29	without	without	IN
46745	779	30	necessarily	necessarily	RB
46745	779	31	causing	cause	VBG
46745	779	32	either	either	CC
46745	779	33	excitation	excitation	NN
46745	779	34	or	or	CC
46745	779	35	depression	depression	NN
46745	779	36	or	or	CC
46745	779	37	acting	act	VBG
46745	779	38	distinctly	distinctly	RB
46745	779	39	by	by	IN
46745	779	40	revulsion	revulsion	NN
46745	779	41	.	.	.
46745	780	1	The	the	DT
46745	780	2	only	only	JJ
46745	780	3	principles	principle	NNS
46745	780	4	of	of	IN
46745	780	5	action	action	NN
46745	780	6	admitted	admit	VBN
46745	780	7	here	here	RB
46745	780	8	are	be	VBP
46745	780	9	these	these	DT
46745	780	10	three	three	CD
46745	780	11	,	,	,
46745	780	12	the	the	DT
46745	780	13	same	same	JJ
46745	780	14	which	which	WDT
46745	780	15	are	be	VBP
46745	780	16	adopted	adopt	VBN
46745	780	17	by	by	IN
46745	780	18	the	the	DT
46745	780	19	disciples	disciple	NNS
46745	780	20	of	of	IN
46745	780	21	Broussais	Broussais	NNP
46745	780	22	.	.	.
46745	781	1	To	to	TO
46745	781	2	suppose	suppose	VB
46745	781	3	that	that	IN
46745	781	4	medicines	medicine	NNS
46745	781	5	acting	act	VBG
46745	781	6	on	on	IN
46745	781	7	the	the	DT
46745	781	8	glands	gland	NNS
46745	781	9	are	be	VBP
46745	781	10	only	only	RB
46745	781	11	of	of	IN
46745	781	12	use	use	NN
46745	781	13	as	as	IN
46745	781	14	revulsives	revulsive	NNS
46745	781	15	,	,	,
46745	781	16	that	that	IN
46745	781	17	they	-PRON-	PRP
46745	781	18	have	have	VBP
46745	781	19	no	no	DT
46745	781	20	influence	influence	NN
46745	781	21	on	on	IN
46745	781	22	the	the	DT
46745	781	23	blood	blood	NN
46745	781	24	,	,	,
46745	781	25	and	and	CC
46745	781	26	are	be	VBP
46745	781	27	never	never	RB
46745	781	28	engaged	engage	VBN
46745	781	29	in	in	IN
46745	781	30	purging	purge	VBG
46745	781	31	the	the	DT
46745	781	32	system	system	NN
46745	781	33	of	of	IN
46745	781	34	peccant	peccant	NN
46745	781	35	or	or	CC
46745	781	36	morbid	morbid	NN
46745	781	37	matter	matter	NN
46745	781	38	,	,	,
46745	781	39	is	be	VBZ
46745	781	40	surely	surely	RB
46745	781	41	incorrect	incorrect	JJ
46745	781	42	in	in	IN
46745	781	43	theory	theory	NN
46745	781	44	.	.	.
46745	782	1	Medicines	medicine	NNS
46745	782	2	of	of	IN
46745	782	3	the	the	DT
46745	782	4	first	first	JJ
46745	782	5	class	class	NN
46745	782	6	,	,	,
46745	782	7	when	when	WRB
46745	782	8	given	give	VBN
46745	782	9	in	in	IN
46745	782	10	proper	proper	JJ
46745	782	11	dose	dose	NN
46745	782	12	and	and	CC
46745	782	13	in	in	IN
46745	782	14	fit	fit	JJ
46745	782	15	cases	case	NNS
46745	782	16	,	,	,
46745	782	17	are	be	VBP
46745	782	18	not	not	RB
46745	782	19	engaged	engage	VBN
46745	782	20	in	in	IN
46745	782	21	_	_	NNP
46745	782	22	destroying	destroy	VBG
46745	782	23	_	_	NNP
46745	782	24	organization	organization	NN
46745	782	25	,	,	,
46745	782	26	nor	nor	CC
46745	782	27	is	be	VBZ
46745	782	28	it	-PRON-	PRP
46745	782	29	invariably	invariably	RB
46745	782	30	the	the	DT
46745	782	31	case	case	NN
46745	782	32	that	that	IN
46745	782	33	such	such	JJ
46745	782	34	remedies	remedy	NNS
46745	782	35	as	as	IN
46745	782	36	Mercury	Mercury	NNP
46745	782	37	,	,	,
46745	782	38	Acids	Acids	NNP
46745	782	39	,	,	,
46745	782	40	and	and	CC
46745	782	41	Alkalies	Alkalies	NNPS
46745	782	42	act	act	VBP
46745	782	43	even	even	RB
46745	782	44	as	as	IN
46745	782	45	depressents	depressent	NNS
46745	782	46	,	,	,
46745	782	47	when	when	WRB
46745	782	48	given	give	VBN
46745	782	49	in	in	IN
46745	782	50	moderation	moderation	NN
46745	782	51	.	.	.
46745	783	1	Further	further	RB
46745	783	2	,	,	,
46745	783	3	the	the	DT
46745	783	4	lines	line	NNS
46745	783	5	of	of	IN
46745	783	6	distinction	distinction	NN
46745	783	7	are	be	VBP
46745	783	8	too	too	RB
46745	783	9	arbitrary	arbitrary	JJ
46745	783	10	,	,	,
46745	783	11	and	and	CC
46745	783	12	drawn	draw	VBN
46745	783	13	with	with	IN
46745	783	14	too	too	RB
46745	783	15	much	much	JJ
46745	783	16	precision	precision	NN
46745	783	17	.	.	.
46745	784	1	The	the	DT
46745	784	2	variations	variation	NNS
46745	784	3	in	in	IN
46745	784	4	the	the	DT
46745	784	5	actions	action	NNS
46745	784	6	of	of	IN
46745	784	7	different	different	JJ
46745	784	8	medicines	medicine	NNS
46745	784	9	are	be	VBP
46745	784	10	too	too	RB
46745	784	11	many	many	JJ
46745	784	12	and	and	CC
46745	784	13	too	too	RB
46745	784	14	great	great	JJ
46745	784	15	to	to	TO
46745	784	16	be	be	VB
46745	784	17	thus	thus	RB
46745	784	18	easily	easily	RB
46745	784	19	accounted	account	VBN
46745	784	20	for	for	IN
46745	784	21	,	,	,
46745	784	22	and	and	CC
46745	784	23	we	-PRON-	PRP
46745	784	24	do	do	VBP
46745	784	25	not	not	RB
46745	784	26	know	know	VB
46745	784	27	enough	enough	JJ
46745	784	28	about	about	IN
46745	784	29	many	many	JJ
46745	784	30	of	of	IN
46745	784	31	them	-PRON-	PRP
46745	784	32	to	to	TO
46745	784	33	be	be	VB
46745	784	34	able	able	JJ
46745	784	35	to	to	TO
46745	784	36	define	define	VB
46745	784	37	their	-PRON-	PRP$
46745	784	38	operation	operation	NN
46745	784	39	so	so	RB
46745	784	40	exactly	exactly	RB
46745	784	41	.	.	.
46745	785	1	And	and	CC
46745	785	2	there	there	EX
46745	785	3	is	be	VBZ
46745	785	4	no	no	DT
46745	785	5	explanation	explanation	NN
46745	785	6	at	at	RB
46745	785	7	all	all	RB
46745	785	8	given	give	VBN
46745	785	9	here	here	RB
46745	785	10	of	of	IN
46745	785	11	the	the	DT
46745	785	12	special	special	JJ
46745	785	13	tendencies	tendency	NNS
46745	785	14	of	of	IN
46745	785	15	some	some	DT
46745	785	16	remedies	remedy	NNS
46745	785	17	,	,	,
46745	785	18	by	by	IN
46745	785	19	which	which	WDT
46745	785	20	we	-PRON-	PRP
46745	785	21	are	be	VBP
46745	785	22	enabled	enable	VBN
46745	785	23	to	to	TO
46745	785	24	cure	cure	VB
46745	785	25	a	a	DT
46745	785	26	great	great	JJ
46745	785	27	number	number	NN
46745	785	28	of	of	IN
46745	785	29	disorders	disorder	NNS
46745	785	30	.	.	.
46745	786	1	_	_	NNP
46745	786	2	g.	g.	NNP
46745	786	3	_	_	NNP
46745	786	4	The	the	DT
46745	786	5	Hippocratic	Hippocratic	NNP
46745	786	6	maxim	maxim	NN
46745	786	7	was	be	VBD
46745	786	8	a	a	DT
46745	786	9	step	step	NN
46745	786	10	towards	towards	IN
46745	786	11	a	a	DT
46745	786	12	correct	correct	JJ
46745	786	13	solution	solution	NN
46745	786	14	of	of	IN
46745	786	15	the	the	DT
46745	786	16	therapeutical	therapeutical	JJ
46745	786	17	operations	operation	NNS
46745	786	18	of	of	IN
46745	786	19	remedial	remedial	JJ
46745	786	20	agents	agent	NNS
46745	786	21	.	.	.
46745	787	1	The	the	DT
46745	787	2	humoral	humoral	JJ
46745	787	3	theory	theory	NN
46745	787	4	of	of	IN
46745	787	5	Sydenham	Sydenham	NNP
46745	787	6	,	,	,
46745	787	7	and	and	CC
46745	787	8	the	the	DT
46745	787	9	threefold	threefold	JJ
46745	787	10	action	action	NN
46745	787	11	supposed	suppose	VBN
46745	787	12	by	by	IN
46745	787	13	Broussais	Broussais	NNP
46745	787	14	,	,	,
46745	787	15	were	be	VBD
46745	787	16	further	further	JJ
46745	787	17	advances	advance	NNS
46745	787	18	in	in	IN
46745	787	19	the	the	DT
46745	787	20	right	right	JJ
46745	787	21	direction	direction	NN
46745	787	22	.	.	.
46745	788	1	But	but	CC
46745	788	2	these	these	DT
46745	788	3	views	view	NNS
46745	788	4	were	be	VBD
46745	788	5	all	all	RB
46745	788	6	too	too	RB
46745	788	7	confined	confined	JJ
46745	788	8	.	.	.
46745	789	1	Correct	correct	JJ
46745	789	2	as	as	RB
46745	789	3	far	far	RB
46745	789	4	as	as	IN
46745	789	5	they	-PRON-	PRP
46745	789	6	extended	extend	VBD
46745	789	7	,	,	,
46745	789	8	they	-PRON-	PRP
46745	789	9	did	do	VBD
46745	789	10	not	not	RB
46745	789	11	embrace	embrace	VB
46745	789	12	the	the	DT
46745	789	13	whole	whole	JJ
46745	789	14	range	range	NN
46745	789	15	of	of	IN
46745	789	16	the	the	DT
46745	789	17	subject	subject	NN
46745	789	18	;	;	:
46745	789	19	for	for	IN
46745	789	20	it	-PRON-	PRP
46745	789	21	is	be	VBZ
46745	789	22	impossible	impossible	JJ
46745	789	23	to	to	TO
46745	789	24	explain	explain	VB
46745	789	25	by	by	IN
46745	789	26	any	any	DT
46745	789	27	one	one	CD
46745	789	28	of	of	IN
46745	789	29	them	-PRON-	PRP
46745	789	30	the	the	DT
46745	789	31	operations	operation	NNS
46745	789	32	of	of	IN
46745	789	33	all	all	DT
46745	789	34	medicines	medicine	NNS
46745	789	35	.	.	.
46745	790	1	Biassed	bias	VBN
46745	790	2	by	by	IN
46745	790	3	the	the	DT
46745	790	4	satisfactory	satisfactory	JJ
46745	790	5	observation	observation	NN
46745	790	6	which	which	WDT
46745	790	7	he	-PRON-	PRP
46745	790	8	had	have	VBD
46745	790	9	made	make	VBN
46745	790	10	of	of	IN
46745	790	11	the	the	DT
46745	790	12	_	_	NNP
46745	790	13	modus	modus	NN
46745	790	14	operandi	operandi	NNP
46745	790	15	_	_	NNP
46745	790	16	of	of	IN
46745	790	17	particular	particular	JJ
46745	790	18	medicines	medicine	NNS
46745	790	19	,	,	,
46745	790	20	and	and	CC
46745	790	21	misled	mislead	VBN
46745	790	22	by	by	IN
46745	790	23	the	the	DT
46745	790	24	insufficiency	insufficiency	NN
46745	790	25	of	of	IN
46745	790	26	his	-PRON-	PRP$
46745	790	27	knowledge	knowledge	NN
46745	790	28	,	,	,
46745	790	29	each	each	DT
46745	790	30	of	of	IN
46745	790	31	these	these	DT
46745	790	32	writers	writer	NNS
46745	790	33	was	be	VBD
46745	790	34	tempted	tempt	VBN
46745	790	35	to	to	TO
46745	790	36	apply	apply	VB
46745	790	37	the	the	DT
46745	790	38	view	view	NN
46745	790	39	which	which	WDT
46745	790	40	was	be	VBD
46745	790	41	applicable	applicable	JJ
46745	790	42	to	to	IN
46745	790	43	a	a	DT
46745	790	44	certain	certain	JJ
46745	790	45	set	set	NN
46745	790	46	to	to	IN
46745	790	47	all	all	DT
46745	790	48	remedies	remedy	NNS
46745	790	49	alike	alike	RB
46745	790	50	.	.	.
46745	791	1	Once	once	RB
46745	791	2	persuaded	persuade	VBN
46745	791	3	of	of	IN
46745	791	4	its	-PRON-	PRP$
46745	791	5	sufficiency	sufficiency	NN
46745	791	6	,	,	,
46745	791	7	he	-PRON-	PRP
46745	791	8	easily	easily	RB
46745	791	9	found	find	VBD
46745	791	10	arguments	argument	NNS
46745	791	11	by	by	IN
46745	791	12	which	which	WDT
46745	791	13	to	to	TO
46745	791	14	fortify	fortify	VB
46745	791	15	both	both	CC
46745	791	16	himself	-PRON-	PRP
46745	791	17	and	and	CC
46745	791	18	others	other	NNS
46745	791	19	against	against	IN
46745	791	20	any	any	DT
46745	791	21	subsequent	subsequent	JJ
46745	791	22	objections	objection	NNS
46745	791	23	.	.	.
46745	792	1	The	the	DT
46745	792	2	right	right	JJ
46745	792	3	course	course	NN
46745	792	4	lies	lie	VBZ
46745	792	5	in	in	IN
46745	792	6	a	a	DT
46745	792	7	combination	combination	NN
46745	792	8	of	of	IN
46745	792	9	these	these	DT
46745	792	10	various	various	JJ
46745	792	11	theories	theory	NNS
46745	792	12	,	,	,
46745	792	13	embracing	embrace	VBG
46745	792	14	what	what	WP
46745	792	15	is	be	VBZ
46745	792	16	true	true	JJ
46745	792	17	and	and	CC
46745	792	18	discarding	discard	VBG
46745	792	19	what	what	WP
46745	792	20	is	be	VBZ
46745	792	21	erroneous	erroneous	JJ
46745	792	22	in	in	IN
46745	792	23	each	each	DT
46745	792	24	of	of	IN
46745	792	25	them	-PRON-	PRP
46745	792	26	,	,	,
46745	792	27	and	and	CC
46745	792	28	supplying	supply	VBG
46745	792	29	what	what	WP
46745	792	30	may	may	MD
46745	792	31	seem	seem	VB
46745	792	32	to	to	TO
46745	792	33	be	be	VB
46745	792	34	wanting	want	VBG
46745	792	35	in	in	IN
46745	792	36	the	the	DT
46745	792	37	whole	whole	NN
46745	792	38	.	.	.
46745	793	1	None	none	NN
46745	793	2	of	of	IN
46745	793	3	these	these	DT
46745	793	4	ideas	idea	NNS
46745	793	5	being	be	VBG
46745	793	6	by	by	IN
46745	793	7	itself	-PRON-	PRP
46745	793	8	perfect	perfect	JJ
46745	793	9	,	,	,
46745	793	10	the	the	DT
46745	793	11	sounder	sounder	NN
46745	793	12	reasoners	reasoner	NNS
46745	793	13	of	of	IN
46745	793	14	the	the	DT
46745	793	15	present	present	JJ
46745	793	16	day	day	NN
46745	793	17	are	be	VBP
46745	793	18	driven	drive	VBN
46745	793	19	to	to	TO
46745	793	20	suppose	suppose	VB
46745	793	21	that	that	IN
46745	793	22	there	there	EX
46745	793	23	are	be	VBP
46745	793	24	_	_	NNP
46745	793	25	various	various	JJ
46745	793	26	_	_	NNP
46745	793	27	different	different	JJ
46745	793	28	ways	way	NNS
46745	793	29	in	in	IN
46745	793	30	which	which	WDT
46745	793	31	medicines	medicine	NNS
46745	793	32	may	may	MD
46745	793	33	_	_	NNP
46745	793	34	counteract	counteract	NNP
46745	793	35	_	_	NNP
46745	793	36	,	,	,
46745	793	37	and	and	CC
46745	793	38	thus	thus	RB
46745	793	39	cure	cure	JJ
46745	793	40	,	,	,
46745	793	41	different	different	JJ
46745	793	42	diseases	disease	NNS
46745	793	43	.	.	.
46745	794	1	This	this	DT
46745	794	2	_	_	NNP
46745	794	3	counteraction	counteraction	NN
46745	794	4	_	_	NNP
46745	794	5	is	be	VBZ
46745	794	6	distinct	distinct	JJ
46745	794	7	from	from	IN
46745	794	8	_	_	NNP
46745	794	9	contrary	contrary	JJ
46745	794	10	action	action	NN
46745	794	11	_	_	NNP
46745	794	12	;	;	:
46745	794	13	it	-PRON-	PRP
46745	794	14	may	may	MD
46745	794	15	be	be	VB
46745	794	16	direct	direct	JJ
46745	794	17	or	or	CC
46745	794	18	indirect	indirect	JJ
46745	794	19	;	;	:
46745	794	20	and	and	CC
46745	794	21	it	-PRON-	PRP
46745	794	22	allows	allow	VBZ
46745	794	23	of	of	IN
46745	794	24	any	any	DT
46745	794	25	action	action	NN
46745	794	26	in	in	IN
46745	794	27	a	a	DT
46745	794	28	medicine	medicine	NN
46745	794	29	,	,	,
46745	794	30	tending	tend	VBG
46745	794	31	to	to	TO
46745	794	32	restore	restore	VB
46745	794	33	health	health	NN
46745	794	34	,	,	,
46745	794	35	except	except	IN
46745	794	36	an	an	DT
46745	794	37	effect	effect	NN
46745	794	38	similar	similar	JJ
46745	794	39	to	to	IN
46745	794	40	the	the	DT
46745	794	41	disease	disease	NN
46745	794	42	.	.	.
46745	795	1	Such	such	PDT
46745	795	2	a	a	DT
46745	795	3	view	view	NN
46745	795	4	was	be	VBD
46745	795	5	adopted	adopt	VBN
46745	795	6	by	by	IN
46745	795	7	Dr.	Dr.	NNP
46745	795	8	Cullen	Cullen	NNP
46745	795	9	,	,	,
46745	795	10	the	the	DT
46745	795	11	well	well	RB
46745	795	12	known	know	VBN
46745	795	13	Nosologist	Nosologist	NNP
46745	795	14	,	,	,
46745	795	15	who	who	WP
46745	795	16	lectured	lecture	VBD
46745	795	17	at	at	IN
46745	795	18	Edinburgh	Edinburgh	NNP
46745	795	19	towards	towards	IN
46745	795	20	the	the	DT
46745	795	21	close	close	NN
46745	795	22	of	of	IN
46745	795	23	the	the	DT
46745	795	24	last	last	JJ
46745	795	25	century	century	NN
46745	795	26	.	.	.
46745	796	1	He	-PRON-	PRP
46745	796	2	discarded	discard	VBD
46745	796	3	all	all	DT
46745	796	4	special	special	JJ
46745	796	5	and	and	CC
46745	796	6	confined	confined	JJ
46745	796	7	views	view	NNS
46745	796	8	of	of	IN
46745	796	9	the	the	DT
46745	796	10	operation	operation	NN
46745	796	11	of	of	IN
46745	796	12	medicines	medicine	NNS
46745	796	13	,	,	,
46745	796	14	believing	believe	VBG
46745	796	15	that	that	IN
46745	796	16	they	-PRON-	PRP
46745	796	17	acted	act	VBD
46745	796	18	in	in	IN
46745	796	19	many	many	JJ
46745	796	20	and	and	CC
46745	796	21	various	various	JJ
46745	796	22	ways	way	NNS
46745	796	23	,	,	,
46745	796	24	all	all	DT
46745	796	25	of	of	IN
46745	796	26	which	which	WDT
46745	796	27	tended	tend	VBD
46745	796	28	to	to	IN
46745	796	29	the	the	DT
46745	796	30	same	same	JJ
46745	796	31	end	end	NN
46745	796	32	--	--	:
46745	796	33	to	to	TO
46745	796	34	counteract	counteract	VB
46745	796	35	the	the	DT
46745	796	36	influence	influence	NN
46745	796	37	of	of	IN
46745	796	38	the	the	DT
46745	796	39	disorder	disorder	NN
46745	796	40	.	.	.
46745	797	1	This	this	DT
46745	797	2	is	be	VBZ
46745	797	3	well	well	RB
46745	797	4	exemplified	exemplify	VBN
46745	797	5	in	in	IN
46745	797	6	his	-PRON-	PRP$
46745	797	7	admirable	admirable	JJ
46745	797	8	directions	direction	NNS
46745	797	9	for	for	IN
46745	797	10	the	the	DT
46745	797	11	treatment	treatment	NN
46745	797	12	of	of	IN
46745	797	13	fever	fever	NN
46745	797	14	,	,	,
46745	797	15	in	in	IN
46745	797	16	which	which	WDT
46745	797	17	he	-PRON-	PRP
46745	797	18	enjoined	enjoin	VBD
46745	797	19	the	the	DT
46745	797	20	use	use	NN
46745	797	21	of	of	IN
46745	797	22	a	a	DT
46745	797	23	number	number	NN
46745	797	24	of	of	IN
46745	797	25	different	different	JJ
46745	797	26	remedies	remedy	NNS
46745	797	27	,	,	,
46745	797	28	varied	vary	VBD
46745	797	29	according	accord	VBG
46745	797	30	to	to	IN
46745	797	31	the	the	DT
46745	797	32	nature	nature	NN
46745	797	33	of	of	IN
46745	797	34	the	the	DT
46745	797	35	case	case	NN
46745	797	36	,	,	,
46745	797	37	and	and	CC
46745	797	38	progress	progress	NN
46745	797	39	of	of	IN
46745	797	40	the	the	DT
46745	797	41	symptoms	symptom	NNS
46745	797	42	.	.	.
46745	798	1	[	[	-LRB-
46745	798	2	16	16	CD
46745	798	3	]	]	-RRB-
46745	798	4	Dr.	Dr.	NNP
46745	798	5	Pereira	Pereira	NNP
46745	798	6	,	,	,
46745	798	7	the	the	DT
46745	798	8	most	most	RBS
46745	798	9	learned	learned	JJ
46745	798	10	and	and	CC
46745	798	11	acute	acute	JJ
46745	798	12	of	of	IN
46745	798	13	living	live	VBG
46745	798	14	English	english	JJ
46745	798	15	writers	writer	NNS
46745	798	16	on	on	IN
46745	798	17	this	this	DT
46745	798	18	subject	subject	NN
46745	798	19	,	,	,
46745	798	20	appears	appear	VBZ
46745	798	21	,	,	,
46745	798	22	like	like	IN
46745	798	23	many	many	JJ
46745	798	24	others	other	NNS
46745	798	25	,	,	,
46745	798	26	to	to	TO
46745	798	27	prefer	prefer	VB
46745	798	28	a	a	DT
46745	798	29	wide	wide	JJ
46745	798	30	explanation	explanation	NN
46745	798	31	of	of	IN
46745	798	32	this	this	DT
46745	798	33	description	description	NN
46745	798	34	.	.	.
46745	799	1	On	on	IN
46745	799	2	such	such	JJ
46745	799	3	views	view	NNS
46745	799	4	my	-PRON-	PRP$
46745	799	5	own	own	JJ
46745	799	6	statements	statement	NNS
46745	799	7	are	be	VBP
46745	799	8	based	base	VBN
46745	799	9	.	.	.
46745	800	1	I	-PRON-	PRP
46745	800	2	suppose	suppose	VBP
46745	800	3	that	that	IN
46745	800	4	a	a	DT
46745	800	5	disease	disease	NN
46745	800	6	in	in	IN
46745	800	7	the	the	DT
46745	800	8	blood	blood	NN
46745	800	9	is	be	VBZ
46745	800	10	to	to	TO
46745	800	11	be	be	VB
46745	800	12	met	meet	VBN
46745	800	13	by	by	IN
46745	800	14	agents	agent	NNS
46745	800	15	in	in	IN
46745	800	16	the	the	DT
46745	800	17	blood	blood	NN
46745	800	18	,	,	,
46745	800	19	which	which	WDT
46745	800	20	directly	directly	RB
46745	800	21	or	or	CC
46745	800	22	indirectly	indirectly	RB
46745	800	23	counteract	counteract	VB
46745	800	24	it	-PRON-	PRP
46745	800	25	there	there	RB
46745	800	26	;	;	:
46745	800	27	that	that	IN
46745	800	28	disorders	disorder	VBZ
46745	800	29	,	,	,
46745	800	30	generally	generally	RB
46745	800	31	temporary	temporary	JJ
46745	800	32	,	,	,
46745	800	33	which	which	WDT
46745	800	34	depend	depend	VBP
46745	800	35	on	on	IN
46745	800	36	nervous	nervous	JJ
46745	800	37	derangement	derangement	NN
46745	800	38	,	,	,
46745	800	39	are	be	VBP
46745	800	40	to	to	TO
46745	800	41	be	be	VB
46745	800	42	benefited	benefit	VBN
46745	800	43	by	by	IN
46745	800	44	remedies	remedy	NNS
46745	800	45	which	which	WDT
46745	800	46	affect	affect	VBP
46745	800	47	the	the	DT
46745	800	48	nerves	nerve	NNS
46745	800	49	;	;	:
46745	800	50	and	and	CC
46745	800	51	in	in	IN
46745	800	52	the	the	DT
46745	800	53	same	same	JJ
46745	800	54	way	way	NN
46745	800	55	that	that	WDT
46745	800	56	a	a	DT
46745	800	57	laxity	laxity	NN
46745	800	58	of	of	IN
46745	800	59	muscular	muscular	JJ
46745	800	60	fibre	fibre	NN
46745	800	61	,	,	,
46745	800	62	or	or	CC
46745	800	63	a	a	DT
46745	800	64	failure	failure	NN
46745	800	65	in	in	IN
46745	800	66	a	a	DT
46745	800	67	secretion	secretion	NN
46745	800	68	,	,	,
46745	800	69	should	should	MD
46745	800	70	be	be	VB
46745	800	71	treated	treat	VBN
46745	800	72	by	by	IN
46745	800	73	agents	agent	NNS
46745	800	74	which	which	WDT
46745	800	75	especially	especially	RB
46745	800	76	possess	possess	VBP
46745	800	77	the	the	DT
46745	800	78	property	property	NN
46745	800	79	of	of	IN
46745	800	80	restoring	restore	VBG
46745	800	81	to	to	IN
46745	800	82	a	a	DT
46745	800	83	right	right	JJ
46745	800	84	condition	condition	NN
46745	800	85	such	such	JJ
46745	800	86	parts	part	NNS
46745	800	87	or	or	CC
46745	800	88	functions	function	NNS
46745	800	89	.	.	.
46745	801	1	Concluding	concluding	NN
46745	801	2	,	,	,
46745	801	3	then	then	RB
46745	801	4	,	,	,
46745	801	5	that	that	IN
46745	801	6	it	-PRON-	PRP
46745	801	7	is	be	VBZ
46745	801	8	impossible	impossible	JJ
46745	801	9	to	to	TO
46745	801	10	account	account	VB
46745	801	11	clearly	clearly	RB
46745	801	12	for	for	IN
46745	801	13	the	the	DT
46745	801	14	actions	action	NNS
46745	801	15	of	of	IN
46745	801	16	most	most	JJS
46745	801	17	medicines	medicine	NNS
46745	801	18	on	on	IN
46745	801	19	_	_	NNP
46745	801	20	Mechanical	Mechanical	NNP
46745	801	21	_	_	NNP
46745	801	22	or	or	CC
46745	801	23	on	on	IN
46745	801	24	_	_	NNP
46745	801	25	Chemical	Chemical	NNP
46745	801	26	_	_	NNP
46745	801	27	principles	principle	NNS
46745	801	28	,	,	,
46745	801	29	we	-PRON-	PRP
46745	801	30	are	be	VBP
46745	801	31	led	lead	VBN
46745	801	32	to	to	TO
46745	801	33	infer	infer	VB
46745	801	34	that	that	IN
46745	801	35	their	-PRON-	PRP$
46745	801	36	influence	influence	NN
46745	801	37	must	must	MD
46745	801	38	for	for	IN
46745	801	39	the	the	DT
46745	801	40	most	most	JJS
46745	801	41	part	part	NN
46745	801	42	be	be	VB
46745	801	43	_	_	NNP
46745	801	44	vital	vital	JJ
46745	801	45	_	_	NNP
46745	801	46	in	in	IN
46745	801	47	its	-PRON-	PRP$
46745	801	48	nature	nature	NN
46745	801	49	--	--	:
46745	801	50	that	that	IN
46745	801	51	it	-PRON-	PRP
46745	801	52	must	must	MD
46745	801	53	be	be	VB
46745	801	54	such	such	JJ
46745	801	55	as	as	IN
46745	801	56	could	could	MD
46745	801	57	only	only	RB
46745	801	58	be	be	VB
46745	801	59	exerted	exert	VBN
46745	801	60	in	in	IN
46745	801	61	the	the	DT
46745	801	62	living	living	NN
46745	801	63	body	body	NN
46745	801	64	.	.	.
46745	802	1	Even	even	RB
46745	802	2	then	then	RB
46745	802	3	we	-PRON-	PRP
46745	802	4	are	be	VBP
46745	802	5	unable	unable	JJ
46745	802	6	to	to	TO
46745	802	7	fix	fix	VB
46745	802	8	upon	upon	IN
46745	802	9	any	any	DT
46745	802	10	single	single	JJ
46745	802	11	rule	rule	NN
46745	802	12	or	or	CC
46745	802	13	formula	formula	NN
46745	802	14	which	which	WDT
46745	802	15	shall	shall	MD
46745	802	16	be	be	VB
46745	802	17	capable	capable	JJ
46745	802	18	of	of	IN
46745	802	19	accounting	account	VBG
46745	802	20	for	for	IN
46745	802	21	the	the	DT
46745	802	22	actions	action	NNS
46745	802	23	of	of	IN
46745	802	24	all	all	DT
46745	802	25	at	at	IN
46745	802	26	once	once	RB
46745	802	27	.	.	.
46745	803	1	So	so	CC
46745	803	2	it	-PRON-	PRP
46745	803	3	seems	seem	VBZ
46745	803	4	that	that	IN
46745	803	5	the	the	DT
46745	803	6	only	only	JJ
46745	803	7	general	general	JJ
46745	803	8	explanation	explanation	NN
46745	803	9	which	which	WDT
46745	803	10	we	-PRON-	PRP
46745	803	11	can	can	MD
46745	803	12	offer	offer	VB
46745	803	13	of	of	IN
46745	803	14	the	the	DT
46745	803	15	_	_	NNP
46745	803	16	modus	modus	NN
46745	803	17	operandi	operandi	NNP
46745	803	18	_	_	NNP
46745	803	19	of	of	IN
46745	803	20	medicines	medicine	NNS
46745	803	21	in	in	IN
46745	803	22	the	the	DT
46745	803	23	cure	cure	NN
46745	803	24	of	of	IN
46745	803	25	diseases	disease	NNS
46745	803	26	,	,	,
46745	803	27	is	be	VBZ
46745	803	28	to	to	TO
46745	803	29	say	say	VB
46745	803	30	that	that	IN
46745	803	31	they	-PRON-	PRP
46745	803	32	operate	operate	VBP
46745	803	33	by	by	IN
46745	803	34	_	_	NNP
46745	803	35	various	various	JJ
46745	803	36	counteractions	counteraction	NNS
46745	803	37	_	_	NNP
46745	803	38	.	.	.
46745	804	1	This	this	DT
46745	804	2	,	,	,
46745	804	3	then	then	RB
46745	804	4	,	,	,
46745	804	5	introduces	introduce	VBZ
46745	804	6	my	-PRON-	PRP$
46745	804	7	Third	Third	NNP
46745	804	8	Chapter	Chapter	NNP
46745	804	9	.	.	.
46745	805	1	CHAPTER	CHAPTER	NNP
46745	805	2	III	III	NNP
46745	805	3	.	.	.
46745	806	1	ON	on	IN
46745	806	2	THE	the	DT
46745	806	3	GENERAL	GENERAL	NNP
46745	806	4	MODES	MODES	NNP
46745	806	5	OF	of	IN
46745	806	6	ACTION	action	NN
46745	806	7	OF	of	IN
46745	806	8	THERAPEUTIC	therapeutic	JJ
46745	806	9	AGENTS	agents	JJ
46745	806	10	INTRODUCED	INTRODUCED	NNS
46745	806	11	INTO	into	VBP
46745	806	12	THE	the	DT
46745	806	13	STOMACH	STOMACH	NNP
46745	806	14	.	.	.
46745	807	1	The	the	DT
46745	807	2	principal	principal	JJ
46745	807	3	affirmations	affirmation	NNS
46745	807	4	which	which	WDT
46745	807	5	I	-PRON-	PRP
46745	807	6	have	have	VBP
46745	807	7	to	to	TO
46745	807	8	make	make	VB
46745	807	9	on	on	IN
46745	807	10	this	this	DT
46745	807	11	subject	subject	NN
46745	807	12	are	be	VBP
46745	807	13	divisible	divisible	JJ
46745	807	14	into	into	IN
46745	807	15	Ten	Ten	NNP
46745	807	16	Propositions	Propositions	NNPS
46745	807	17	,	,	,
46745	807	18	as	as	IN
46745	807	19	seen	see	VBN
46745	807	20	in	in	IN
46745	807	21	the	the	DT
46745	807	22	Table	table	NN
46745	807	23	of	of	IN
46745	807	24	Contents	Contents	NNPS
46745	807	25	.	.	.
46745	808	1	The	the	DT
46745	808	2	first	first	JJ
46745	808	3	four	four	CD
46745	808	4	of	of	IN
46745	808	5	these	these	DT
46745	808	6	concern	concern	NN
46745	808	7	the	the	DT
46745	808	8	general	general	JJ
46745	808	9	conduct	conduct	NN
46745	808	10	of	of	IN
46745	808	11	medicines	medicine	NNS
46745	808	12	after	after	IN
46745	808	13	their	-PRON-	PRP$
46745	808	14	introduction	introduction	NN
46745	808	15	into	into	IN
46745	808	16	the	the	DT
46745	808	17	stomach	stomach	NN
46745	808	18	,	,	,
46745	808	19	and	and	CC
46745	808	20	before	before	IN
46745	808	21	their	-PRON-	PRP$
46745	808	22	passage	passage	NN
46745	808	23	into	into	IN
46745	808	24	the	the	DT
46745	808	25	blood	blood	NN
46745	808	26	.	.	.
46745	809	1	Some	some	DT
46745	809	2	broad	broad	JJ
46745	809	3	rules	rule	NNS
46745	809	4	are	be	VBP
46745	809	5	laid	lay	VBN
46745	809	6	down	down	RP
46745	809	7	by	by	IN
46745	809	8	which	which	WDT
46745	809	9	the	the	DT
46745	809	10	course	course	NN
46745	809	11	which	which	WDT
46745	809	12	they	-PRON-	PRP
46745	809	13	take	take	VBP
46745	809	14	must	must	MD
46745	809	15	be	be	VB
46745	809	16	determined	determine	VBN
46745	809	17	.	.	.
46745	810	1	The	the	DT
46745	810	2	action	action	NN
46745	810	3	of	of	IN
46745	810	4	some	some	DT
46745	810	5	few	few	JJ
46745	810	6	on	on	IN
46745	810	7	the	the	DT
46745	810	8	mucous	mucous	JJ
46745	810	9	membrane	membrane	NN
46745	810	10	is	be	VBZ
46745	810	11	also	also	RB
46745	810	12	defined	define	VBN
46745	810	13	.	.	.
46745	811	1	The	the	DT
46745	811	2	remaining	remain	VBG
46745	811	3	six	six	CD
46745	811	4	propositions	proposition	NNS
46745	811	5	treat	treat	VBP
46745	811	6	of	of	IN
46745	811	7	the	the	DT
46745	811	8	subsequent	subsequent	JJ
46745	811	9	behaviour	behaviour	NN
46745	811	10	of	of	IN
46745	811	11	those	those	DT
46745	811	12	medicines	medicine	NNS
46745	811	13	which	which	WDT
46745	811	14	pass	pass	VBP
46745	811	15	into	into	IN
46745	811	16	the	the	DT
46745	811	17	blood	blood	NN
46745	811	18	and	and	CC
46745	811	19	fluids	fluid	NNS
46745	811	20	of	of	IN
46745	811	21	the	the	DT
46745	811	22	body	body	NN
46745	811	23	.	.	.
46745	812	1	Of	of	IN
46745	812	2	these	these	DT
46745	812	3	,	,	,
46745	812	4	the	the	DT
46745	812	5	fifth	fifth	JJ
46745	812	6	specifies	specify	VBZ
46745	812	7	their	-PRON-	PRP$
46745	812	8	general	general	JJ
46745	812	9	course	course	NN
46745	812	10	.	.	.
46745	813	1	The	the	DT
46745	813	2	sixth	sixth	JJ
46745	813	3	states	state	NNS
46745	813	4	that	that	IN
46745	813	5	they	-PRON-	PRP
46745	813	6	may	may	MD
46745	813	7	undergo	undergo	VB
46745	813	8	certain	certain	JJ
46745	813	9	changes	change	NNS
46745	813	10	in	in	IN
46745	813	11	the	the	DT
46745	813	12	system	system	NN
46745	813	13	.	.	.
46745	814	1	And	and	CC
46745	814	2	the	the	DT
46745	814	3	concluding	conclude	VBG
46745	814	4	four	four	CD
46745	814	5	treat	treat	NN
46745	814	6	of	of	IN
46745	814	7	the	the	DT
46745	814	8	various	various	JJ
46745	814	9	modes	mode	NNS
46745	814	10	in	in	IN
46745	814	11	which	which	WDT
46745	814	12	these	these	DT
46745	814	13	agents	agent	NNS
46745	814	14	may	may	MD
46745	814	15	operate	operate	VB
46745	814	16	in	in	IN
46745	814	17	the	the	DT
46745	814	18	cure	cure	NN
46745	814	19	of	of	IN
46745	814	20	disease	disease	NN
46745	814	21	.	.	.
46745	815	1	The	the	DT
46745	815	2	first	first	JJ
46745	815	3	proposition	proposition	NN
46745	815	4	lays	lay	VBZ
46745	815	5	down	down	IN
46745	815	6	the	the	DT
46745	815	7	great	great	JJ
46745	815	8	fundamental	fundamental	JJ
46745	815	9	rule	rule	NN
46745	815	10	of	of	IN
46745	815	11	the	the	DT
46745	815	12	action	action	NN
46745	815	13	of	of	IN
46745	815	14	medicines	medicine	NNS
46745	815	15	through	through	IN
46745	815	16	the	the	DT
46745	815	17	medium	medium	NN
46745	815	18	of	of	IN
46745	815	19	the	the	DT
46745	815	20	blood	blood	NN
46745	815	21	and	and	CC
46745	815	22	fluids	fluid	NNS
46745	815	23	.	.	.
46745	816	1	PROP	PROP	NNP
46745	816	2	.	.	.
46745	817	1	I.--_That	i.--_that	IN
46745	817	2	the	the	DT
46745	817	3	great	great	JJ
46745	817	4	majority	majority	NN
46745	817	5	of	of	IN
46745	817	6	medicines	medicine	NNS
46745	817	7	must	must	MD
46745	817	8	obtain	obtain	VB
46745	817	9	entry	entry	NN
46745	817	10	into	into	IN
46745	817	11	the	the	DT
46745	817	12	blood	blood	NN
46745	817	13	,	,	,
46745	817	14	or	or	CC
46745	817	15	internal	internal	JJ
46745	817	16	fluids	fluid	NNS
46745	817	17	of	of	IN
46745	817	18	the	the	DT
46745	817	19	body	body	NN
46745	817	20	,	,	,
46745	817	21	before	before	IN
46745	817	22	their	-PRON-	PRP$
46745	817	23	action	action	NN
46745	817	24	can	can	MD
46745	817	25	be	be	VB
46745	817	26	manifested	manifest	VBN
46745	817	27	.	.	.
46745	817	28	_	_	NNP
46745	817	29	This	this	DT
46745	817	30	is	be	VBZ
46745	817	31	to	to	TO
46745	817	32	say	say	VB
46745	817	33	,	,	,
46745	817	34	that	that	IN
46745	817	35	the	the	DT
46745	817	36	mere	mere	JJ
46745	817	37	contact	contact	NN
46745	817	38	of	of	IN
46745	817	39	a	a	DT
46745	817	40	medicine	medicine	NN
46745	817	41	with	with	IN
46745	817	42	the	the	DT
46745	817	43	stomach	stomach	NN
46745	817	44	is	be	VBZ
46745	817	45	not	not	RB
46745	817	46	in	in	IN
46745	817	47	general	general	JJ
46745	817	48	sufficient	sufficient	NN
46745	817	49	for	for	IN
46745	817	50	the	the	DT
46745	817	51	production	production	NN
46745	817	52	of	of	IN
46745	817	53	its	-PRON-	PRP$
46745	817	54	peculiar	peculiar	JJ
46745	817	55	action	action	NN
46745	817	56	.	.	.
46745	818	1	It	-PRON-	PRP
46745	818	2	will	will	MD
46745	818	3	be	be	VB
46745	818	4	seen	see	VBN
46745	818	5	that	that	IN
46745	818	6	the	the	DT
46745	818	7	only	only	JJ
46745	818	8	apparent	apparent	JJ
46745	818	9	exception	exception	NN
46745	818	10	to	to	IN
46745	818	11	this	this	DT
46745	818	12	rule	rule	NN
46745	818	13	consists	consist	VBZ
46745	818	14	of	of	IN
46745	818	15	agents	agent	NNS
46745	818	16	having	have	VBG
46745	818	17	a	a	DT
46745	818	18	mere	mere	JJ
46745	818	19	local	local	JJ
46745	818	20	action	action	NN
46745	818	21	on	on	IN
46745	818	22	the	the	DT
46745	818	23	mucous	mucous	JJ
46745	818	24	membrane	membrane	NN
46745	818	25	,	,	,
46745	818	26	for	for	IN
46745	818	27	which	which	WDT
46745	818	28	simple	simple	JJ
46745	818	29	contact	contact	NN
46745	818	30	is	be	VBZ
46745	818	31	all	all	DT
46745	818	32	that	that	WDT
46745	818	33	is	be	VBZ
46745	818	34	required	require	VBN
46745	818	35	.	.	.
46745	819	1	Even	even	RB
46745	819	2	when	when	WRB
46745	819	3	acting	act	VBG
46745	819	4	on	on	IN
46745	819	5	any	any	DT
46745	819	6	part	part	NN
46745	819	7	of	of	IN
46745	819	8	the	the	DT
46745	819	9	system	system	NN
46745	819	10	removed	remove	VBN
46745	819	11	from	from	IN
46745	819	12	this	this	DT
46745	819	13	mucous	mucous	JJ
46745	819	14	surface	surface	NN
46745	819	15	,	,	,
46745	819	16	as	as	IN
46745	819	17	when	when	WRB
46745	819	18	applied	apply	VBN
46745	819	19	to	to	IN
46745	819	20	the	the	DT
46745	819	21	skin	skin	NN
46745	819	22	,	,	,
46745	819	23	it	-PRON-	PRP
46745	819	24	is	be	VBZ
46745	819	25	necessary	necessary	JJ
46745	819	26	that	that	IN
46745	819	27	the	the	DT
46745	819	28	medicine	medicine	NN
46745	819	29	pass	pass	VB
46745	819	30	away	away	RB
46745	819	31	from	from	IN
46745	819	32	it	-PRON-	PRP
46745	819	33	to	to	TO
46745	819	34	enter	enter	VB
46745	819	35	the	the	DT
46745	819	36	blood	blood	NN
46745	819	37	or	or	CC
46745	819	38	internal	internal	JJ
46745	819	39	fluids	fluid	NNS
46745	819	40	.	.	.
46745	820	1	In	in	IN
46745	820	2	the	the	DT
46745	820	3	great	great	JJ
46745	820	4	majority	majority	NN
46745	820	5	of	of	IN
46745	820	6	instances	instance	NNS
46745	820	7	it	-PRON-	PRP
46745	820	8	enters	enter	VBZ
46745	820	9	the	the	DT
46745	820	10	blood	blood	NN
46745	820	11	directly	directly	RB
46745	820	12	.	.	.
46745	821	1	But	but	CC
46745	821	2	we	-PRON-	PRP
46745	821	3	know	know	VBP
46745	821	4	that	that	IN
46745	821	5	it	-PRON-	PRP
46745	821	6	would	would	MD
46745	821	7	be	be	VB
46745	821	8	sufficient	sufficient	JJ
46745	821	9	for	for	IN
46745	821	10	its	-PRON-	PRP$
46745	821	11	operation	operation	NN
46745	821	12	if	if	IN
46745	821	13	it	-PRON-	PRP
46745	821	14	were	be	VBD
46745	821	15	to	to	TO
46745	821	16	enter	enter	VB
46745	821	17	through	through	IN
46745	821	18	the	the	DT
46745	821	19	chyle	chyle	NN
46745	821	20	,	,	,
46745	821	21	or	or	CC
46745	821	22	into	into	IN
46745	821	23	the	the	DT
46745	821	24	serous	serous	JJ
46745	821	25	fluid	fluid	NN
46745	821	26	which	which	WDT
46745	821	27	exists	exist	VBZ
46745	821	28	in	in	IN
46745	821	29	the	the	DT
46745	821	30	interstices	interstice	NNS
46745	821	31	of	of	IN
46745	821	32	the	the	DT
46745	821	33	tissues	tissue	NNS
46745	821	34	throughout	throughout	IN
46745	821	35	the	the	DT
46745	821	36	body	body	NN
46745	821	37	.	.	.
46745	822	1	For	for	IN
46745	822	2	by	by	IN
46745	822	3	these	these	DT
46745	822	4	it	-PRON-	PRP
46745	822	5	might	may	MD
46745	822	6	at	at	IN
46745	822	7	length	length	NN
46745	822	8	be	be	VB
46745	822	9	conducted	conduct	VBN
46745	822	10	to	to	TO
46745	822	11	distant	distant	VB
46745	822	12	parts	part	NNS
46745	822	13	.	.	.
46745	823	1	This	this	DT
46745	823	2	is	be	VBZ
46745	823	3	what	what	WP
46745	823	4	is	be	VBZ
46745	823	5	meant	mean	VBN
46745	823	6	by	by	IN
46745	823	7	_	_	NNP
46745	823	8	internal	internal	JJ
46745	823	9	fluids	fluid	NNS
46745	823	10	_	_	NNP
46745	823	11	.	.	.
46745	824	1	We	-PRON-	PRP
46745	824	2	are	be	VBP
46745	824	3	not	not	RB
46745	824	4	just	just	RB
46745	824	5	now	now	RB
46745	824	6	concerned	concerned	JJ
46745	824	7	with	with	IN
46745	824	8	the	the	DT
46745	824	9	way	way	NN
46745	824	10	in	in	IN
46745	824	11	which	which	WDT
46745	824	12	this	this	DT
46745	824	13	passage	passage	NN
46745	824	14	into	into	IN
46745	824	15	the	the	DT
46745	824	16	blood	blood	NN
46745	824	17	and	and	CC
46745	824	18	fluids	fluid	NNS
46745	824	19	is	be	VBZ
46745	824	20	obtained	obtain	VBN
46745	824	21	.	.	.
46745	825	1	It	-PRON-	PRP
46745	825	2	is	be	VBZ
46745	825	3	by	by	IN
46745	825	4	the	the	DT
46745	825	5	process	process	NN
46745	825	6	of	of	IN
46745	825	7	absorption	absorption	NN
46745	825	8	.	.	.
46745	826	1	The	the	DT
46745	826	2	question	question	NN
46745	826	3	of	of	IN
46745	826	4	passage	passage	NN
46745	826	5	by	by	IN
46745	826	6	absorption	absorption	NN
46745	826	7	is	be	VBZ
46745	826	8	treated	treat	VBN
46745	826	9	in	in	IN
46745	826	10	the	the	DT
46745	826	11	second	second	JJ
46745	826	12	and	and	CC
46745	826	13	third	third	JJ
46745	826	14	propositions	proposition	NNS
46745	826	15	.	.	.
46745	827	1	What	what	WP
46745	827	2	we	-PRON-	PRP
46745	827	3	have	have	VBP
46745	827	4	now	now	RB
46745	827	5	to	to	TO
46745	827	6	decide	decide	VB
46745	827	7	is	be	VBZ
46745	827	8	,	,	,
46745	827	9	whether	whether	IN
46745	827	10	a	a	DT
46745	827	11	medicine	medicine	NN
46745	827	12	acts	act	NNS
46745	827	13	by	by	IN
46745	827	14	mere	mere	JJ
46745	827	15	contact	contact	NN
46745	827	16	with	with	IN
46745	827	17	the	the	DT
46745	827	18	stomach	stomach	NN
46745	827	19	,	,	,
46745	827	20	its	-PRON-	PRP$
46745	827	21	influence	influence	NN
46745	827	22	being	be	VBG
46745	827	23	propagated	propagate	VBN
46745	827	24	to	to	TO
46745	827	25	distant	distant	VB
46745	827	26	parts	part	NNS
46745	827	27	by	by	IN
46745	827	28	means	mean	NNS
46745	827	29	of	of	IN
46745	827	30	the	the	DT
46745	827	31	nerves	nerve	NNS
46745	827	32	;	;	:
46745	827	33	or	or	CC
46745	827	34	by	by	IN
46745	827	35	passage	passage	NN
46745	827	36	thence	thence	NN
46745	827	37	into	into	IN
46745	827	38	the	the	DT
46745	827	39	system	system	NN
46745	827	40	,	,	,
46745	827	41	acting	act	VBG
46745	827	42	through	through	IN
46745	827	43	the	the	DT
46745	827	44	medium	medium	NN
46745	827	45	of	of	IN
46745	827	46	the	the	DT
46745	827	47	blood	blood	NN
46745	827	48	and	and	CC
46745	827	49	fluids	fluid	NNS
46745	827	50	.	.	.
46745	828	1	I	-PRON-	PRP
46745	828	2	affirm	affirm	VBP
46745	828	3	that	that	IN
46745	828	4	it	-PRON-	PRP
46745	828	5	operates	operate	VBZ
46745	828	6	in	in	IN
46745	828	7	this	this	DT
46745	828	8	latter	latter	JJ
46745	828	9	way	way	NN
46745	828	10	;	;	:
46745	828	11	and	and	CC
46745	828	12	this	this	DT
46745	828	13	is	be	VBZ
46745	828	14	to	to	TO
46745	828	15	be	be	VB
46745	828	16	proved	prove	VBN
46745	828	17	by	by	IN
46745	828	18	four	four	CD
46745	828	19	considerations	consideration	NNS
46745	828	20	,	,	,
46745	828	21	which	which	WDT
46745	828	22	we	-PRON-	PRP
46745	828	23	will	will	MD
46745	828	24	consider	consider	VB
46745	828	25	in	in	IN
46745	828	26	succession	succession	NN
46745	828	27	.	.	.
46745	829	1	_	_	NNP
46745	829	2	A	a	DT
46745	829	3	medicine	medicine	NN
46745	829	4	introduced	introduce	VBN
46745	829	5	into	into	IN
46745	829	6	the	the	DT
46745	829	7	system	system	NN
46745	829	8	elsewhere	elsewhere	RB
46745	829	9	acts	act	VBZ
46745	829	10	in	in	IN
46745	829	11	the	the	DT
46745	829	12	same	same	JJ
46745	829	13	way	way	NN
46745	829	14	as	as	IN
46745	829	15	when	when	WRB
46745	829	16	introduced	introduce	VBN
46745	829	17	into	into	IN
46745	829	18	the	the	DT
46745	829	19	stomach	stomach	NN
46745	829	20	.	.	.
46745	829	21	_	_	NNP
46745	829	22	This	this	DT
46745	829	23	proves	prove	VBZ
46745	829	24	at	at	IN
46745	829	25	least	least	JJS
46745	829	26	that	that	DT
46745	829	27	contact	contact	NN
46745	829	28	with	with	IN
46745	829	29	the	the	DT
46745	829	30	mucous	mucous	JJ
46745	829	31	surface	surface	NN
46745	829	32	is	be	VBZ
46745	829	33	not	not	RB
46745	829	34	an	an	DT
46745	829	35	essential	essential	JJ
46745	829	36	requisite	requisite	NN
46745	829	37	for	for	IN
46745	829	38	the	the	DT
46745	829	39	operation	operation	NN
46745	829	40	of	of	IN
46745	829	41	a	a	DT
46745	829	42	remedy	remedy	NN
46745	829	43	.	.	.
46745	830	1	We	-PRON-	PRP
46745	830	2	may	may	MD
46745	830	3	cause	cause	VB
46745	830	4	a	a	DT
46745	830	5	medicine	medicine	NN
46745	830	6	to	to	TO
46745	830	7	be	be	VB
46745	830	8	absorbed	absorb	VBN
46745	830	9	by	by	IN
46745	830	10	the	the	DT
46745	830	11	skin	skin	NN
46745	830	12	,	,	,
46745	830	13	or	or	CC
46745	830	14	inject	inject	VB
46745	830	15	it	-PRON-	PRP
46745	830	16	directly	directly	RB
46745	830	17	into	into	IN
46745	830	18	an	an	DT
46745	830	19	opened	open	VBN
46745	830	20	vein	vein	NN
46745	830	21	.	.	.
46745	831	1	The	the	DT
46745	831	2	result	result	NN
46745	831	3	of	of	IN
46745	831	4	this	this	DT
46745	831	5	latter	latter	JJ
46745	831	6	experiment	experiment	NN
46745	831	7	proves	prove	VBZ
46745	831	8	not	not	RB
46745	831	9	only	only	RB
46745	831	10	that	that	IN
46745	831	11	entry	entry	NN
46745	831	12	into	into	IN
46745	831	13	a	a	DT
46745	831	14	distant	distant	JJ
46745	831	15	part	part	NN
46745	831	16	of	of	IN
46745	831	17	the	the	DT
46745	831	18	system	system	NN
46745	831	19	is	be	VBZ
46745	831	20	sufficient	sufficient	JJ
46745	831	21	for	for	IN
46745	831	22	the	the	DT
46745	831	23	action	action	NN
46745	831	24	of	of	IN
46745	831	25	a	a	DT
46745	831	26	medicine	medicine	NN
46745	831	27	,	,	,
46745	831	28	but	but	CC
46745	831	29	that	that	IN
46745	831	30	it	-PRON-	PRP
46745	831	31	will	will	MD
46745	831	32	operate	operate	VB
46745	831	33	when	when	WRB
46745	831	34	introduced	introduce	VBN
46745	831	35	into	into	IN
46745	831	36	the	the	DT
46745	831	37	blood	blood	NN
46745	831	38	.	.	.
46745	832	1	Numberless	numberless	JJ
46745	832	2	proofs	proof	NNS
46745	832	3	of	of	IN
46745	832	4	this	this	DT
46745	832	5	affirmation	affirmation	NN
46745	832	6	may	may	MD
46745	832	7	be	be	VB
46745	832	8	adduced	adduce	VBN
46745	832	9	.	.	.
46745	833	1	Tartar	Tartar	NNP
46745	833	2	Emetic	Emetic	NNP
46745	833	3	injected	inject	VBD
46745	833	4	into	into	IN
46745	833	5	the	the	DT
46745	833	6	veins	vein	NNS
46745	833	7	produces	produce	VBZ
46745	833	8	vomiting	vomit	VBG
46745	833	9	.	.	.
46745	834	1	Croton	Croton	NNP
46745	834	2	Oil	Oil	NNP
46745	834	3	rubbed	rub	VBD
46745	834	4	on	on	IN
46745	834	5	the	the	DT
46745	834	6	surface	surface	NN
46745	834	7	of	of	IN
46745	834	8	the	the	DT
46745	834	9	abdomen	abdomen	NNP
46745	834	10	causes	cause	VBZ
46745	834	11	purging	purging	NN
46745	834	12	.	.	.
46745	835	1	Mercurial	mercurial	JJ
46745	835	2	ointment	ointment	NN
46745	835	3	applied	apply	VBN
46745	835	4	by	by	IN
46745	835	5	friction	friction	NN
46745	835	6	to	to	IN
46745	835	7	the	the	DT
46745	835	8	skin	skin	NN
46745	835	9	will	will	MD
46745	835	10	produce	produce	VB
46745	835	11	salivation	salivation	NN
46745	835	12	.	.	.
46745	836	1	Extract	Extract	NNP
46745	836	2	of	of	IN
46745	836	3	Belladonna	Belladonna	NNP
46745	836	4	applied	apply	VBD
46745	836	5	to	to	IN
46745	836	6	the	the	DT
46745	836	7	temples	temple	NNS
46745	836	8	causes	cause	VBZ
46745	836	9	dilatation	dilatation	NN
46745	836	10	of	of	IN
46745	836	11	the	the	DT
46745	836	12	pupil	pupil	NN
46745	836	13	of	of	IN
46745	836	14	the	the	DT
46745	836	15	eye	eye	NN
46745	836	16	;	;	:
46745	836	17	and	and	CC
46745	836	18	tincture	tincture	NN
46745	836	19	of	of	IN
46745	836	20	Opium	Opium	NNP
46745	836	21	dropped	drop	VBD
46745	836	22	on	on	IN
46745	836	23	the	the	DT
46745	836	24	eyeball	eyeball	NN
46745	836	25	causes	cause	VBZ
46745	836	26	the	the	DT
46745	836	27	pupil	pupil	NN
46745	836	28	to	to	TO
46745	836	29	contract	contract	VB
46745	836	30	.	.	.
46745	837	1	Ammonia	Ammonia	NNP
46745	837	2	inhaled	inhale	VBD
46745	837	3	as	as	IN
46745	837	4	gas	gas	NN
46745	837	5	into	into	IN
46745	837	6	the	the	DT
46745	837	7	lungs	lung	NNS
46745	837	8	will	will	MD
46745	837	9	relieve	relieve	VB
46745	837	10	fainting	faint	VBG
46745	837	11	in	in	IN
46745	837	12	the	the	DT
46745	837	13	same	same	JJ
46745	837	14	way	way	NN
46745	837	15	as	as	IN
46745	837	16	when	when	WRB
46745	837	17	swallowed	swallow	VBN
46745	837	18	.	.	.
46745	838	1	The	the	DT
46745	838	2	breathing	breathing	NN
46745	838	3	of	of	IN
46745	838	4	Prussic	Prussic	NNP
46745	838	5	acid	acid	NN
46745	838	6	,	,	,
46745	838	7	causing	cause	VBG
46745	838	8	its	-PRON-	PRP$
46745	838	9	vapour	vapour	NN
46745	838	10	to	to	TO
46745	838	11	be	be	VB
46745	838	12	applied	apply	VBN
46745	838	13	to	to	IN
46745	838	14	the	the	DT
46745	838	15	pulmonary	pulmonary	JJ
46745	838	16	surface	surface	NN
46745	838	17	,	,	,
46745	838	18	is	be	VBZ
46745	838	19	sufficient	sufficient	JJ
46745	838	20	to	to	TO
46745	838	21	kill	kill	VB
46745	838	22	.	.	.
46745	839	1	Prussic	prussic	JJ
46745	839	2	acid	acid	NN
46745	839	3	,	,	,
46745	839	4	dropped	drop	VBD
46745	839	5	in	in	IN
46745	839	6	a	a	DT
46745	839	7	concentrated	concentrated	JJ
46745	839	8	state	state	NN
46745	839	9	into	into	IN
46745	839	10	the	the	DT
46745	839	11	eye	eye	NN
46745	839	12	of	of	IN
46745	839	13	a	a	DT
46745	839	14	dog	dog	NN
46745	839	15	,	,	,
46745	839	16	causes	cause	VBZ
46745	839	17	speedy	speedy	JJ
46745	839	18	death	death	NN
46745	839	19	.	.	.
46745	840	1	Solution	Solution	NNP
46745	840	2	of	of	IN
46745	840	3	Aconitina	Aconitina	NNP
46745	840	4	,	,	,
46745	840	5	applied	apply	VBD
46745	840	6	to	to	IN
46745	840	7	the	the	DT
46745	840	8	skin	skin	NN
46745	840	9	,	,	,
46745	840	10	will	will	MD
46745	840	11	produce	produce	VB
46745	840	12	numbness	numbness	NN
46745	840	13	,	,	,
46745	840	14	and	and	CC
46745	840	15	tingling	tingle	VBG
46745	840	16	of	of	IN
46745	840	17	distant	distant	JJ
46745	840	18	parts	part	NNS
46745	840	19	.	.	.
46745	841	1	Injection	injection	NN
46745	841	2	of	of	IN
46745	841	3	Nux	Nux	NNP
46745	841	4	Vomica	Vomica	NNP
46745	841	5	,	,	,
46745	841	6	or	or	CC
46745	841	7	any	any	DT
46745	841	8	powerful	powerful	JJ
46745	841	9	poison	poison	NN
46745	841	10	,	,	,
46745	841	11	into	into	IN
46745	841	12	the	the	DT
46745	841	13	veins	vein	NNS
46745	841	14	,	,	,
46745	841	15	is	be	VBZ
46745	841	16	rapidly	rapidly	RB
46745	841	17	followed	follow	VBN
46745	841	18	by	by	IN
46745	841	19	symptoms	symptom	NNS
46745	841	20	of	of	IN
46745	841	21	poisoning	poisoning	NN
46745	841	22	,	,	,
46745	841	23	like	like	IN
46745	841	24	those	those	DT
46745	841	25	which	which	WDT
46745	841	26	would	would	MD
46745	841	27	have	have	VB
46745	841	28	followed	follow	VBN
46745	841	29	its	-PRON-	PRP$
46745	841	30	introduction	introduction	NN
46745	841	31	into	into	IN
46745	841	32	the	the	DT
46745	841	33	stomach	stomach	NN
46745	841	34	.	.	.
46745	842	1	[	[	-LRB-
46745	842	2	17	17	CD
46745	842	3	]	]	-RRB-
46745	842	4	Thus	thus	RB
46745	842	5	contact	contact	NN
46745	842	6	with	with	IN
46745	842	7	the	the	DT
46745	842	8	stomach	stomach	NN
46745	842	9	is	be	VBZ
46745	842	10	not	not	RB
46745	842	11	necessary	necessary	JJ
46745	842	12	,	,	,
46745	842	13	but	but	CC
46745	842	14	introduction	introduction	NN
46745	842	15	into	into	IN
46745	842	16	the	the	DT
46745	842	17	system	system	NN
46745	842	18	any	any	RB
46745	842	19	where	where	WRB
46745	842	20	is	be	VBZ
46745	842	21	sufficient	sufficient	JJ
46745	842	22	.	.	.
46745	843	1	But	but	CC
46745	843	2	still	still	RB
46745	843	3	,	,	,
46745	843	4	may	may	MD
46745	843	5	not	not	RB
46745	843	6	the	the	DT
46745	843	7	poison	poison	NN
46745	843	8	in	in	IN
46745	843	9	either	either	DT
46745	843	10	case	case	NN
46745	843	11	act	act	NNP
46745	843	12	by	by	IN
46745	843	13	influencing	influence	VBG
46745	843	14	the	the	DT
46745	843	15	nerves	nerve	NNS
46745	843	16	?	?	.
46745	844	1	Even	even	RB
46745	844	2	when	when	WRB
46745	844	3	it	-PRON-	PRP
46745	844	4	has	have	VBZ
46745	844	5	entered	enter	VBN
46745	844	6	the	the	DT
46745	844	7	blood	blood	NN
46745	844	8	,	,	,
46745	844	9	it	-PRON-	PRP
46745	844	10	may	may	MD
46745	844	11	not	not	RB
46745	844	12	travel	travel	VB
46745	844	13	along	along	IN
46745	844	14	in	in	IN
46745	844	15	it	-PRON-	PRP
46745	844	16	,	,	,
46745	844	17	but	but	CC
46745	844	18	act	act	VB
46745	844	19	in	in	IN
46745	844	20	a	a	DT
46745	844	21	more	more	RBR
46745	844	22	direct	direct	JJ
46745	844	23	way	way	NN
46745	844	24	.	.	.
46745	845	1	So	so	RB
46745	845	2	in	in	IN
46745	845	3	the	the	DT
46745	845	4	second	second	JJ
46745	845	5	part	part	NN
46745	845	6	of	of	IN
46745	845	7	the	the	DT
46745	845	8	proof	proof	NN
46745	845	9	we	-PRON-	PRP
46745	845	10	must	must	MD
46745	845	11	show	show	VB
46745	845	12	that	that	IN
46745	845	13	a	a	DT
46745	845	14	remedy	remedy	NN
46745	845	15	can	can	MD
46745	845	16	not	not	RB
46745	845	17	act	act	VB
46745	845	18	by	by	IN
46745	845	19	an	an	DT
46745	845	20	impression	impression	NN
46745	845	21	conducted	conduct	VBN
46745	845	22	from	from	IN
46745	845	23	the	the	DT
46745	845	24	surface	surface	NN
46745	845	25	of	of	IN
46745	845	26	the	the	DT
46745	845	27	stomach	stomach	NN
46745	845	28	by	by	IN
46745	845	29	means	mean	NNS
46745	845	30	of	of	IN
46745	845	31	the	the	DT
46745	845	32	nerves	nerve	NNS
46745	845	33	.	.	.
46745	846	1	_	_	NNP
46745	846	2	The	the	DT
46745	846	3	continuity	continuity	NN
46745	846	4	of	of	IN
46745	846	5	nerve	nerve	NN
46745	846	6	is	be	VBZ
46745	846	7	not	not	RB
46745	846	8	necessary	necessary	JJ
46745	846	9	for	for	IN
46745	846	10	the	the	DT
46745	846	11	propagation	propagation	NN
46745	846	12	of	of	IN
46745	846	13	such	such	JJ
46745	846	14	effects	effect	NNS
46745	846	15	;	;	:
46745	846	16	but	but	CC
46745	846	17	vascular	vascular	JJ
46745	846	18	connexion	connexion	NN
46745	846	19	is	be	VBZ
46745	846	20	necessary	necessary	JJ
46745	846	21	.	.	.
46745	846	22	_	_	NNP
46745	846	23	This	this	DT
46745	846	24	alone	alone	RB
46745	846	25	,	,	,
46745	846	26	if	if	IN
46745	846	27	established	establish	VBN
46745	846	28	,	,	,
46745	846	29	would	would	MD
46745	846	30	be	be	VB
46745	846	31	sufficient	sufficient	JJ
46745	846	32	to	to	TO
46745	846	33	prove	prove	VB
46745	846	34	that	that	IN
46745	846	35	a	a	DT
46745	846	36	medicine	medicine	NN
46745	846	37	must	must	MD
46745	846	38	be	be	VB
46745	846	39	introduced	introduce	VBN
46745	846	40	into	into	IN
46745	846	41	the	the	DT
46745	846	42	circulation	circulation	NN
46745	846	43	,	,	,
46745	846	44	in	in	IN
46745	846	45	order	order	NN
46745	846	46	to	to	TO
46745	846	47	act	act	VB
46745	846	48	on	on	IN
46745	846	49	distant	distant	JJ
46745	846	50	parts	part	NNS
46745	846	51	.	.	.
46745	847	1	When	when	WRB
46745	847	2	confined	confine	VBN
46745	847	3	to	to	IN
46745	847	4	a	a	DT
46745	847	5	surface	surface	NN
46745	847	6	,	,	,
46745	847	7	it	-PRON-	PRP
46745	847	8	can	can	MD
46745	847	9	operate	operate	VB
46745	847	10	on	on	IN
46745	847	11	the	the	DT
46745	847	12	remote	remote	JJ
46745	847	13	part	part	NN
46745	847	14	only	only	RB
46745	847	15	by	by	IN
46745	847	16	its	-PRON-	PRP$
46745	847	17	contact	contact	NN
46745	847	18	with	with	IN
46745	847	19	the	the	DT
46745	847	20	superficial	superficial	JJ
46745	847	21	extremities	extremity	NNS
46745	847	22	of	of	IN
46745	847	23	the	the	DT
46745	847	24	nerves	nerve	NNS
46745	847	25	.	.	.
46745	848	1	For	for	IN
46745	848	2	vascular	vascular	JJ
46745	848	3	connexion	connexion	NN
46745	848	4	to	to	TO
46745	848	5	be	be	VB
46745	848	6	established	establish	VBN
46745	848	7	,	,	,
46745	848	8	it	-PRON-	PRP
46745	848	9	must	must	MD
46745	848	10	first	first	RB
46745	848	11	enter	enter	VB
46745	848	12	the	the	DT
46745	848	13	vessels	vessel	NNS
46745	848	14	.	.	.
46745	849	1	Many	many	JJ
46745	849	2	experiments	experiment	NNS
46745	849	3	have	have	VBP
46745	849	4	been	be	VBN
46745	849	5	made	make	VBN
46745	849	6	which	which	WDT
46745	849	7	demonstrate	demonstrate	VB
46745	849	8	that	that	IN
46745	849	9	the	the	DT
46745	849	10	vessels	vessel	NNS
46745	849	11	are	be	VBP
46745	849	12	the	the	DT
46745	849	13	only	only	JJ
46745	849	14	channel	channel	NN
46745	849	15	by	by	IN
46745	849	16	which	which	WDT
46745	849	17	medicinal	medicinal	JJ
46745	849	18	effects	effect	NNS
46745	849	19	can	can	MD
46745	849	20	be	be	VB
46745	849	21	propagated	propagate	VBN
46745	849	22	.	.	.
46745	850	1	M.	M.	NNP
46745	850	2	Magendie	Magendie	NNP
46745	850	3	introduced	introduce	VBD
46745	850	4	some	some	DT
46745	850	5	Woorara	Woorara	NNP
46745	850	6	poison	poison	NN
46745	850	7	into	into	IN
46745	850	8	the	the	DT
46745	850	9	limb	limb	NN
46745	850	10	of	of	IN
46745	850	11	a	a	DT
46745	850	12	dog	dog	NN
46745	850	13	,	,	,
46745	850	14	which	which	WDT
46745	850	15	was	be	VBD
46745	850	16	only	only	RB
46745	850	17	connected	connect	VBN
46745	850	18	with	with	IN
46745	850	19	the	the	DT
46745	850	20	trunk	trunk	NN
46745	850	21	by	by	IN
46745	850	22	means	mean	NNS
46745	850	23	of	of	IN
46745	850	24	quills	quill	NNS
46745	850	25	uniting	unite	VBG
46745	850	26	the	the	DT
46745	850	27	divided	divided	JJ
46745	850	28	ends	end	NNS
46745	850	29	of	of	IN
46745	850	30	the	the	DT
46745	850	31	main	main	JJ
46745	850	32	vessels	vessel	NNS
46745	850	33	.	.	.
46745	851	1	It	-PRON-	PRP
46745	851	2	rapidly	rapidly	RB
46745	851	3	took	take	VBD
46745	851	4	effect	effect	NN
46745	851	5	.	.	.
46745	852	1	Having	have	VBG
46745	852	2	divided	divide	VBN
46745	852	3	all	all	PDT
46745	852	4	the	the	DT
46745	852	5	nerves	nerve	NNS
46745	852	6	and	and	CC
46745	852	7	lymphatics	lymphatic	NNS
46745	852	8	in	in	IN
46745	852	9	the	the	DT
46745	852	10	intestine	intestine	NN
46745	852	11	of	of	IN
46745	852	12	another	another	DT
46745	852	13	dog	dog	NN
46745	852	14	,	,	,
46745	852	15	he	-PRON-	PRP
46745	852	16	introduced	introduce	VBD
46745	852	17	into	into	IN
46745	852	18	it	-PRON-	PRP
46745	852	19	some	some	DT
46745	852	20	Nux	Nux	NNP
46745	852	21	Vomica	Vomica	NNP
46745	852	22	,	,	,
46745	852	23	beyond	beyond	IN
46745	852	24	the	the	DT
46745	852	25	division	division	NN
46745	852	26	.	.	.
46745	853	1	It	-PRON-	PRP
46745	853	2	quickly	quickly	RB
46745	853	3	acted	act	VBD
46745	853	4	,	,	,
46745	853	5	and	and	CC
46745	853	6	must	must	MD
46745	853	7	again	again	RB
46745	853	8	have	have	VB
46745	853	9	done	do	VBN
46745	853	10	so	so	RB
46745	853	11	through	through	IN
46745	853	12	the	the	DT
46745	853	13	vessels	vessel	NNS
46745	853	14	.	.	.
46745	854	1	Sir	Sir	NNP
46745	854	2	B.	B.	NNP
46745	854	3	Brodie	Brodie	NNP
46745	854	4	cut	cut	VBD
46745	854	5	all	all	PDT
46745	854	6	the	the	DT
46745	854	7	nerves	nerve	NNS
46745	854	8	of	of	IN
46745	854	9	the	the	DT
46745	854	10	anterior	anterior	JJ
46745	854	11	extremity	extremity	NN
46745	854	12	of	of	IN
46745	854	13	a	a	DT
46745	854	14	rabbit	rabbit	NN
46745	854	15	,	,	,
46745	854	16	near	near	IN
46745	854	17	the	the	DT
46745	854	18	axilla	axilla	NN
46745	854	19	,	,	,
46745	854	20	and	and	CC
46745	854	21	then	then	RB
46745	854	22	introduced	introduce	VBD
46745	854	23	Woorara	Woorara	NNP
46745	854	24	into	into	IN
46745	854	25	the	the	DT
46745	854	26	foot	foot	NN
46745	854	27	.	.	.
46745	855	1	It	-PRON-	PRP
46745	855	2	rapidly	rapidly	RB
46745	855	3	acted	act	VBD
46745	855	4	.	.	.
46745	856	1	[	[	-LRB-
46745	856	2	18	18	CD
46745	856	3	]	]	-RRB-
46745	856	4	Thus	thus	RB
46745	856	5	we	-PRON-	PRP
46745	856	6	see	see	VBP
46745	856	7	that	that	IN
46745	856	8	vascular	vascular	JJ
46745	856	9	connexion	connexion	NN
46745	856	10	is	be	VBZ
46745	856	11	sufficient	sufficient	JJ
46745	856	12	,	,	,
46745	856	13	and	and	CC
46745	856	14	that	that	IN
46745	856	15	nervous	nervous	JJ
46745	856	16	connexion	connexion	NN
46745	856	17	is	be	VBZ
46745	856	18	not	not	RB
46745	856	19	necessary	necessary	JJ
46745	856	20	.	.	.
46745	857	1	By	by	IN
46745	857	2	other	other	JJ
46745	857	3	similar	similar	JJ
46745	857	4	trials	trial	NNS
46745	857	5	it	-PRON-	PRP
46745	857	6	is	be	VBZ
46745	857	7	found	find	VBN
46745	857	8	that	that	IN
46745	857	9	vascular	vascular	JJ
46745	857	10	connexion	connexion	NN
46745	857	11	is	be	VBZ
46745	857	12	absolutely	absolutely	RB
46745	857	13	necessary	necessary	JJ
46745	857	14	,	,	,
46745	857	15	for	for	IN
46745	857	16	when	when	WRB
46745	857	17	it	-PRON-	PRP
46745	857	18	is	be	VBZ
46745	857	19	interrupted	interrupt	VBN
46745	857	20	,	,	,
46745	857	21	the	the	DT
46745	857	22	action	action	NN
46745	857	23	can	can	MD
46745	857	24	not	not	RB
46745	857	25	be	be	VB
46745	857	26	propagated	propagate	VBN
46745	857	27	along	along	IN
46745	857	28	a	a	DT
46745	857	29	nerve	nerve	NN
46745	857	30	.	.	.
46745	858	1	If	if	IN
46745	858	2	,	,	,
46745	858	3	on	on	IN
46745	858	4	introducing	introduce	VBG
46745	858	5	poison	poison	NN
46745	858	6	into	into	IN
46745	858	7	an	an	DT
46745	858	8	extremity	extremity	NN
46745	858	9	,	,	,
46745	858	10	a	a	DT
46745	858	11	cord	cord	NN
46745	858	12	be	be	VB
46745	858	13	tightened	tighten	VBN
46745	858	14	round	round	IN
46745	858	15	the	the	DT
46745	858	16	limb	limb	NN
46745	858	17	above	above	IN
46745	858	18	it	-PRON-	PRP
46745	858	19	so	so	IN
46745	858	20	as	as	IN
46745	858	21	to	to	TO
46745	858	22	intercept	intercept	VB
46745	858	23	the	the	DT
46745	858	24	flow	flow	NN
46745	858	25	of	of	IN
46745	858	26	blood	blood	NN
46745	858	27	,	,	,
46745	858	28	no	no	DT
46745	858	29	effect	effect	NN
46745	858	30	is	be	VBZ
46745	858	31	produced	produce	VBN
46745	858	32	.	.	.
46745	859	1	It	-PRON-	PRP
46745	859	2	takes	take	VBZ
46745	859	3	effect	effect	NN
46745	859	4	after	after	IN
46745	859	5	the	the	DT
46745	859	6	ligature	ligature	NN
46745	859	7	is	be	VBZ
46745	859	8	relaxed	relaxed	JJ
46745	859	9	.	.	.
46745	860	1	Sir	Sir	NNP
46745	860	2	B.	B.	NNP
46745	860	3	Brodie	Brodie	NNP
46745	860	4	introduced	introduce	VBD
46745	860	5	Woorara	Woorara	NNP
46745	860	6	into	into	IN
46745	860	7	the	the	DT
46745	860	8	leg	leg	NN
46745	860	9	of	of	IN
46745	860	10	a	a	DT
46745	860	11	dog	dog	NN
46745	860	12	,	,	,
46745	860	13	which	which	WDT
46745	860	14	was	be	VBD
46745	860	15	connected	connect	VBN
46745	860	16	with	with	IN
46745	860	17	the	the	DT
46745	860	18	trunk	trunk	NN
46745	860	19	only	only	RB
46745	860	20	by	by	IN
46745	860	21	means	mean	NNS
46745	860	22	of	of	IN
46745	860	23	the	the	DT
46745	860	24	principal	principal	JJ
46745	860	25	nerve	nerve	NN
46745	860	26	,	,	,
46745	860	27	carefully	carefully	RB
46745	860	28	dissected	dissect	VBN
46745	860	29	out	out	RP
46745	860	30	.	.	.
46745	861	1	No	no	DT
46745	861	2	effect	effect	NN
46745	861	3	followed	follow	VBD
46745	861	4	.	.	.
46745	862	1	M.	M.	NNP
46745	862	2	Ehbert	Ehbert	NNP
46745	862	3	found	find	VBD
46745	862	4	that	that	IN
46745	862	5	poison	poison	NN
46745	862	6	would	would	MD
46745	862	7	not	not	RB
46745	862	8	act	act	VB
46745	862	9	when	when	WRB
46745	862	10	applied	apply	VBN
46745	862	11	to	to	IN
46745	862	12	an	an	DT
46745	862	13	amputated	amputate	VBN
46745	862	14	limb	limb	NN
46745	862	15	connected	connect	VBN
46745	862	16	with	with	IN
46745	862	17	the	the	DT
46745	862	18	trunk	trunk	NN
46745	862	19	by	by	IN
46745	862	20	a	a	DT
46745	862	21	nerve	nerve	NN
46745	862	22	only	only	RB
46745	862	23	.	.	.
46745	863	1	Thus	thus	RB
46745	863	2	vascular	vascular	JJ
46745	863	3	connexion	connexion	NN
46745	863	4	is	be	VBZ
46745	863	5	necessary	necessary	JJ
46745	863	6	;	;	:
46745	863	7	whereas	whereas	IN
46745	863	8	continuity	continuity	NN
46745	863	9	of	of	IN
46745	863	10	nerve	nerve	NN
46745	863	11	is	be	VBZ
46745	863	12	not	not	RB
46745	863	13	necessary	necessary	JJ
46745	863	14	,	,	,
46745	863	15	neither	neither	CC
46745	863	16	is	be	VBZ
46745	863	17	it	-PRON-	PRP
46745	863	18	sufficient	sufficient	JJ
46745	863	19	by	by	IN
46745	863	20	itself	-PRON-	PRP
46745	863	21	.	.	.
46745	864	1	[	[	-LRB-
46745	864	2	19	19	CD
46745	864	3	]	]	-RRB-
46745	864	4	Woorara	Woorara	NNP
46745	864	5	poison	poison	NN
46745	864	6	is	be	VBZ
46745	864	7	a	a	DT
46745	864	8	substance	substance	NN
46745	864	9	which	which	WDT
46745	864	10	acts	act	VBZ
46745	864	11	with	with	IN
46745	864	12	great	great	JJ
46745	864	13	rapidity	rapidity	NN
46745	864	14	on	on	IN
46745	864	15	the	the	DT
46745	864	16	nervous	nervous	JJ
46745	864	17	system	system	NN
46745	864	18	;	;	:
46745	864	19	and	and	CC
46745	864	20	if	if	IN
46745	864	21	its	-PRON-	PRP$
46745	864	22	action	action	NN
46745	864	23	can	can	MD
46745	864	24	not	not	RB
46745	864	25	be	be	VB
46745	864	26	propagated	propagate	VBN
46745	864	27	by	by	IN
46745	864	28	means	mean	NNS
46745	864	29	of	of	IN
46745	864	30	the	the	DT
46745	864	31	nerves	nerve	NNS
46745	864	32	,	,	,
46745	864	33	_	_	NNP
46745	864	34	à	à	NNP
46745	864	35	fortiori	fortiori	NN
46745	864	36	_	_	NNP
46745	864	37	would	would	MD
46745	864	38	it	-PRON-	PRP
46745	864	39	seem	seem	VB
46745	864	40	that	that	IN
46745	864	41	slower	slow	JJR
46745	864	42	poisons	poison	NNS
46745	864	43	must	must	MD
46745	864	44	act	act	VB
46745	864	45	through	through	IN
46745	864	46	the	the	DT
46745	864	47	circulation	circulation	NN
46745	864	48	.	.	.
46745	865	1	But	but	CC
46745	865	2	,	,	,
46745	865	3	granting	grant	VBG
46745	865	4	that	that	IN
46745	865	5	it	-PRON-	PRP
46745	865	6	has	have	VBZ
46745	865	7	been	be	VBN
46745	865	8	shown	show	VBN
46745	865	9	that	that	IN
46745	865	10	introduction	introduction	NN
46745	865	11	into	into	IN
46745	865	12	the	the	DT
46745	865	13	stomach	stomach	NN
46745	865	14	is	be	VBZ
46745	865	15	not	not	RB
46745	865	16	necessary	necessary	JJ
46745	865	17	for	for	IN
46745	865	18	the	the	DT
46745	865	19	action	action	NN
46745	865	20	of	of	IN
46745	865	21	a	a	DT
46745	865	22	medicine	medicine	NN
46745	865	23	,	,	,
46745	865	24	and	and	CC
46745	865	25	that	that	IN
46745	865	26	when	when	WRB
46745	865	27	in	in	IN
46745	865	28	the	the	DT
46745	865	29	stomach	stomach	NN
46745	865	30	medicines	medicine	NNS
46745	865	31	do	do	VBP
46745	865	32	not	not	RB
46745	865	33	act	act	VB
46745	865	34	by	by	IN
46745	865	35	influencing	influence	VBG
46745	865	36	the	the	DT
46745	865	37	nerves	nerve	NNS
46745	865	38	,	,	,
46745	865	39	still	still	RB
46745	865	40	it	-PRON-	PRP
46745	865	41	may	may	MD
46745	865	42	be	be	VB
46745	865	43	objected	object	VBN
46745	865	44	that	that	IN
46745	865	45	the	the	DT
46745	865	46	rule	rule	NN
46745	865	47	can	can	MD
46745	865	48	not	not	RB
46745	865	49	possibly	possibly	RB
46745	865	50	be	be	VB
46745	865	51	universal	universal	JJ
46745	865	52	.	.	.
46745	866	1	It	-PRON-	PRP
46745	866	2	may	may	MD
46745	866	3	be	be	VB
46745	866	4	urged	urge	VBN
46745	866	5	that	that	IN
46745	866	6	some	some	DT
46745	866	7	poisons	poison	NNS
46745	866	8	and	and	CC
46745	866	9	medicines	medicine	NNS
46745	866	10	,	,	,
46745	866	11	as	as	IN
46745	866	12	Hydrocyanic	hydrocyanic	JJ
46745	866	13	acid	acid	NN
46745	866	14	and	and	CC
46745	866	15	Ammonia	Ammonia	NNP
46745	866	16	,	,	,
46745	866	17	act	act	VB
46745	866	18	with	with	IN
46745	866	19	such	such	JJ
46745	866	20	great	great	JJ
46745	866	21	rapidity	rapidity	NN
46745	866	22	,	,	,
46745	866	23	that	that	IN
46745	866	24	we	-PRON-	PRP
46745	866	25	can	can	MD
46745	866	26	only	only	RB
46745	866	27	suppose	suppose	VB
46745	866	28	their	-PRON-	PRP$
46745	866	29	influence	influence	NN
46745	866	30	to	to	TO
46745	866	31	be	be	VB
46745	866	32	transmitted	transmit	VBN
46745	866	33	directly	directly	RB
46745	866	34	along	along	IN
46745	866	35	a	a	DT
46745	866	36	nerve	nerve	NN
46745	866	37	-	-	HYPH
46745	866	38	fibre	fibre	NN
46745	866	39	to	to	IN
46745	866	40	the	the	DT
46745	866	41	nervous	nervous	JJ
46745	866	42	centre	centre	NN
46745	866	43	,	,	,
46745	866	44	because	because	IN
46745	866	45	the	the	DT
46745	866	46	process	process	NN
46745	866	47	of	of	IN
46745	866	48	passage	passage	NN
46745	866	49	in	in	IN
46745	866	50	the	the	DT
46745	866	51	blood	blood	NN
46745	866	52	to	to	IN
46745	866	53	this	this	DT
46745	866	54	distant	distant	JJ
46745	866	55	part	part	NN
46745	866	56	would	would	MD
46745	866	57	be	be	VB
46745	866	58	far	far	RB
46745	866	59	too	too	RB
46745	866	60	slow	slow	JJ
46745	866	61	.	.	.
46745	867	1	This	this	DT
46745	867	2	argument	argument	NN
46745	867	3	requires	require	VBZ
46745	867	4	us	-PRON-	PRP
46745	867	5	to	to	TO
46745	867	6	prove	prove	VB
46745	867	7	a	a	DT
46745	867	8	third	third	JJ
46745	867	9	thing	thing	NN
46745	867	10	.	.	.
46745	868	1	_	_	NNP
46745	868	2	The	the	DT
46745	868	3	circulation	circulation	NN
46745	868	4	of	of	IN
46745	868	5	the	the	DT
46745	868	6	blood	blood	NN
46745	868	7	is	be	VBZ
46745	868	8	sufficiently	sufficiently	RB
46745	868	9	quick	quick	JJ
46745	868	10	to	to	TO
46745	868	11	account	account	VB
46745	868	12	even	even	RB
46745	868	13	for	for	IN
46745	868	14	the	the	DT
46745	868	15	operation	operation	NN
46745	868	16	of	of	IN
46745	868	17	those	those	DT
46745	868	18	poisons	poison	NNS
46745	868	19	which	which	WDT
46745	868	20	act	act	VBP
46745	868	21	most	most	RBS
46745	868	22	rapidly	rapidly	RB
46745	868	23	by	by	IN
46745	868	24	influencing	influence	VBG
46745	868	25	the	the	DT
46745	868	26	nerve	nerve	NN
46745	868	27	-	-	HYPH
46745	868	28	centres	centre	NNS
46745	868	29	.	.	.
46745	868	30	_	_	NNP
46745	868	31	There	there	EX
46745	868	32	is	be	VBZ
46745	868	33	no	no	DT
46745	868	34	poison	poison	NN
46745	868	35	whatever	whatever	WDT
46745	868	36	which	which	WDT
46745	868	37	acts	act	VBZ
46745	868	38	so	so	RB
46745	868	39	quickly	quickly	RB
46745	868	40	on	on	IN
46745	868	41	distant	distant	JJ
46745	868	42	parts	part	NNS
46745	868	43	that	that	WDT
46745	868	44	the	the	DT
46745	868	45	circulation	circulation	NN
46745	868	46	can	can	MD
46745	868	47	not	not	RB
46745	868	48	previously	previously	RB
46745	868	49	have	have	VB
46745	868	50	had	have	VBN
46745	868	51	time	time	NN
46745	868	52	to	to	TO
46745	868	53	conduct	conduct	VB
46745	868	54	it	-PRON-	PRP
46745	868	55	to	to	IN
46745	868	56	them	-PRON-	PRP
46745	868	57	.	.	.
46745	869	1	By	by	IN
46745	869	2	means	mean	NNS
46745	869	3	of	of	IN
46745	869	4	an	an	DT
46745	869	5	instrument	instrument	NN
46745	869	6	invented	invent	VBN
46745	869	7	by	by	IN
46745	869	8	M.	M.	NNP
46745	869	9	Poisseuille	Poisseuille	NNP
46745	869	10	,	,	,
46745	869	11	Dr.	Dr.	NNP
46745	869	12	Blake	Blake	NNP
46745	869	13	found	find	VBD
46745	869	14	that	that	IN
46745	869	15	a	a	DT
46745	869	16	chemical	chemical	NN
46745	869	17	substance	substance	NN
46745	869	18	traversed	traverse	VBD
46745	869	19	the	the	DT
46745	869	20	whole	whole	JJ
46745	869	21	circulation	circulation	NN
46745	869	22	of	of	IN
46745	869	23	a	a	DT
46745	869	24	dog	dog	NN
46745	869	25	in	in	IN
46745	869	26	nine	nine	CD
46745	869	27	seconds	second	NNS
46745	869	28	,	,	,
46745	869	29	and	and	CC
46745	869	30	of	of	IN
46745	869	31	a	a	DT
46745	869	32	horse	horse	NN
46745	869	33	in	in	IN
46745	869	34	twenty	twenty	CD
46745	869	35	seconds	second	NNS
46745	869	36	.	.	.
46745	870	1	[	[	-LRB-
46745	870	2	20	20	CD
46745	870	3	]	]	-RRB-
46745	870	4	The	the	DT
46745	870	5	results	result	NNS
46745	870	6	of	of	IN
46745	870	7	Hering	hering	NN
46745	870	8	were	be	VBD
46745	870	9	similar	similar	JJ
46745	870	10	.	.	.
46745	871	1	M.	M.	NNP
46745	871	2	Volkmann	Volkmann	NNP
46745	871	3	,	,	,
46745	871	4	in	in	IN
46745	871	5	the	the	DT
46745	871	6	tenth	tenth	JJ
46745	871	7	chapter	chapter	NN
46745	871	8	of	of	IN
46745	871	9	his	-PRON-	PRP$
46745	871	10	work	work	NN
46745	871	11	on	on	IN
46745	871	12	Hæmadynamics	Hæmadynamics	NNP
46745	871	13	,	,	,
46745	871	14	states	state	NNS
46745	871	15	,	,	,
46745	871	16	as	as	IN
46745	871	17	the	the	DT
46745	871	18	result	result	NN
46745	871	19	of	of	IN
46745	871	20	several	several	JJ
46745	871	21	experiments	experiment	NNS
46745	871	22	,	,	,
46745	871	23	that	that	IN
46745	871	24	the	the	DT
46745	871	25	whole	whole	JJ
46745	871	26	circulation	circulation	NN
46745	871	27	in	in	IN
46745	871	28	an	an	DT
46745	871	29	adult	adult	NN
46745	871	30	man	man	NN
46745	871	31	occupies	occupy	VBZ
46745	871	32	exactly	exactly	RB
46745	871	33	65.76	65.76	CD
46745	871	34	seconds	second	NNS
46745	871	35	.	.	.
46745	872	1	Now	now	RB
46745	872	2	a	a	DT
46745	872	3	poison	poison	NN
46745	872	4	that	that	WDT
46745	872	5	operated	operate	VBN
46745	872	6	by	by	IN
46745	872	7	nervous	nervous	JJ
46745	872	8	connexion	connexion	NN
46745	872	9	would	would	MD
46745	872	10	probably	probably	RB
46745	872	11	operate	operate	VB
46745	872	12	directly	directly	RB
46745	872	13	when	when	WRB
46745	872	14	it	-PRON-	PRP
46745	872	15	touched	touch	VBD
46745	872	16	the	the	DT
46745	872	17	stomach	stomach	NN
46745	872	18	.	.	.
46745	873	1	This	this	DT
46745	873	2	is	be	VBZ
46745	873	3	not	not	RB
46745	873	4	the	the	DT
46745	873	5	case	case	NN
46745	873	6	even	even	RB
46745	873	7	with	with	IN
46745	873	8	Hydrocyanic	hydrocyanic	JJ
46745	873	9	acid	acid	NN
46745	873	10	.	.	.
46745	874	1	This	this	DT
46745	874	2	,	,	,
46745	874	3	the	the	DT
46745	874	4	most	most	RBS
46745	874	5	sudden	sudden	JJ
46745	874	6	of	of	IN
46745	874	7	all	all	DT
46745	874	8	poisons	poison	NNS
46745	874	9	,	,	,
46745	874	10	before	before	IN
46745	874	11	it	-PRON-	PRP
46745	874	12	takes	take	VBZ
46745	874	13	effect	effect	NN
46745	874	14	,	,	,
46745	874	15	allows	allow	VBZ
46745	874	16	sufficient	sufficient	JJ
46745	874	17	time	time	NN
46745	874	18	to	to	TO
46745	874	19	elapse	elapse	VB
46745	874	20	for	for	IN
46745	874	21	the	the	DT
46745	874	22	blood	blood	NN
46745	874	23	to	to	TO
46745	874	24	conduct	conduct	VB
46745	874	25	it	-PRON-	PRP
46745	874	26	to	to	IN
46745	874	27	the	the	DT
46745	874	28	brain	brain	NN
46745	874	29	.	.	.
46745	875	1	Blake	Blake	NNP
46745	875	2	made	make	VBD
46745	875	3	an	an	DT
46745	875	4	interesting	interesting	JJ
46745	875	5	experiment	experiment	NN
46745	875	6	upon	upon	IN
46745	875	7	it	-PRON-	PRP
46745	875	8	.	.	.
46745	876	1	He	-PRON-	PRP
46745	876	2	placed	place	VBD
46745	876	3	some	some	DT
46745	876	4	on	on	IN
46745	876	5	the	the	DT
46745	876	6	tongue	tongue	NN
46745	876	7	of	of	IN
46745	876	8	a	a	DT
46745	876	9	dog	dog	NN
46745	876	10	,	,	,
46745	876	11	having	have	VBG
46745	876	12	first	first	RB
46745	876	13	fitted	fit	VBN
46745	876	14	a	a	DT
46745	876	15	tube	tube	NN
46745	876	16	into	into	IN
46745	876	17	the	the	DT
46745	876	18	larynx	larynx	NN
46745	876	19	,	,	,
46745	876	20	so	so	IN
46745	876	21	as	as	IN
46745	876	22	to	to	TO
46745	876	23	prevent	prevent	VB
46745	876	24	the	the	DT
46745	876	25	vapour	vapour	NN
46745	876	26	from	from	IN
46745	876	27	passing	pass	VBG
46745	876	28	into	into	IN
46745	876	29	the	the	DT
46745	876	30	lungs	lung	NNS
46745	876	31	.	.	.
46745	877	1	The	the	DT
46745	877	2	effect	effect	NN
46745	877	3	did	do	VBD
46745	877	4	not	not	RB
46745	877	5	commence	commence	VB
46745	877	6	until	until	IN
46745	877	7	sixteen	sixteen	CD
46745	877	8	seconds	second	NNS
46745	877	9	had	have	VBD
46745	877	10	elapsed	elapse	VBN
46745	877	11	,	,	,
46745	877	12	and	and	CC
46745	877	13	forty	forty	CD
46745	877	14	-	-	HYPH
46745	877	15	five	five	CD
46745	877	16	were	be	VBD
46745	877	17	required	require	VBN
46745	877	18	for	for	IN
46745	877	19	its	-PRON-	PRP$
46745	877	20	completion	completion	NN
46745	877	21	.	.	.
46745	878	1	This	this	DT
46745	878	2	allowed	allow	VBN
46745	878	3	of	of	IN
46745	878	4	time	time	NN
46745	878	5	for	for	IN
46745	878	6	absorption	absorption	NN
46745	878	7	.	.	.
46745	879	1	Thus	thus	RB
46745	879	2	it	-PRON-	PRP
46745	879	3	is	be	VBZ
46745	879	4	proved	prove	VBN
46745	879	5	that	that	IN
46745	879	6	poisons	poison	NNS
46745	879	7	act	act	VBP
46745	879	8	when	when	WRB
46745	879	9	introduced	introduce	VBN
46745	879	10	into	into	IN
46745	879	11	the	the	DT
46745	879	12	system	system	NN
46745	879	13	at	at	IN
46745	879	14	any	any	DT
46745	879	15	point	point	NN
46745	879	16	;	;	:
46745	879	17	that	that	IN
46745	879	18	vascular	vascular	JJ
46745	879	19	connexion	connexion	NN
46745	879	20	is	be	VBZ
46745	879	21	required	require	VBN
46745	879	22	for	for	IN
46745	879	23	this	this	DT
46745	879	24	action	action	NN
46745	879	25	;	;	:
46745	879	26	and	and	CC
46745	879	27	that	that	IN
46745	879	28	the	the	DT
46745	879	29	rapidity	rapidity	NN
46745	879	30	of	of	IN
46745	879	31	the	the	DT
46745	879	32	circulation	circulation	NN
46745	879	33	is	be	VBZ
46745	879	34	in	in	IN
46745	879	35	all	all	DT
46745	879	36	cases	case	NNS
46745	879	37	quick	quick	JJ
46745	879	38	enough	enough	RB
46745	879	39	to	to	TO
46745	879	40	account	account	VB
46745	879	41	for	for	IN
46745	879	42	it	-PRON-	PRP
46745	879	43	.	.	.
46745	880	1	But	but	CC
46745	880	2	this	this	DT
46745	880	3	last	last	NN
46745	880	4	is	be	VBZ
46745	880	5	only	only	RB
46745	880	6	a	a	DT
46745	880	7	proof	proof	NN
46745	880	8	of	of	IN
46745	880	9	_	_	NNP
46745	880	10	possibility	possibility	NN
46745	880	11	_	_	NNP
46745	880	12	,	,	,
46745	880	13	and	and	CC
46745	880	14	does	do	VBZ
46745	880	15	not	not	RB
46745	880	16	by	by	IN
46745	880	17	itself	-PRON-	PRP
46745	880	18	show	show	VBP
46745	880	19	that	that	IN
46745	880	20	a	a	DT
46745	880	21	substance	substance	NN
46745	880	22	may	may	MD
46745	880	23	not	not	RB
46745	880	24	nevertheless	nevertheless	RB
46745	880	25	act	act	VB
46745	880	26	through	through	IN
46745	880	27	the	the	DT
46745	880	28	nerves	nerve	NNS
46745	880	29	.	.	.
46745	881	1	And	and	CC
46745	881	2	to	to	IN
46745	881	3	the	the	DT
46745	881	4	experiments	experiment	NNS
46745	881	5	on	on	IN
46745	881	6	nervous	nervous	JJ
46745	881	7	connexion	connexion	NN
46745	881	8	some	some	DT
46745	881	9	may	may	MD
46745	881	10	object	object	VB
46745	881	11	that	that	IN
46745	881	12	no	no	DT
46745	881	13	conclusions	conclusion	NNS
46745	881	14	on	on	IN
46745	881	15	this	this	DT
46745	881	16	point	point	NN
46745	881	17	can	can	MD
46745	881	18	be	be	VB
46745	881	19	drawn	draw	VBN
46745	881	20	from	from	IN
46745	881	21	trials	trial	NNS
46745	881	22	made	make	VBN
46745	881	23	on	on	IN
46745	881	24	isolated	isolated	JJ
46745	881	25	and	and	CC
46745	881	26	exposed	expose	VBN
46745	881	27	nerves	nerve	NNS
46745	881	28	.	.	.
46745	882	1	So	so	RB
46745	882	2	we	-PRON-	PRP
46745	882	3	may	may	MD
46745	882	4	imagine	imagine	VB
46745	882	5	a	a	DT
46745	882	6	person	person	NN
46745	882	7	to	to	TO
46745	882	8	be	be	VB
46745	882	9	still	still	RB
46745	882	10	incredulous	incredulous	JJ
46745	882	11	as	as	IN
46745	882	12	to	to	IN
46745	882	13	the	the	DT
46745	882	14	truth	truth	NN
46745	882	15	of	of	IN
46745	882	16	the	the	DT
46745	882	17	Proposition	Proposition	NNP
46745	882	18	,	,	,
46745	882	19	that	that	IN
46745	882	20	medicines	medicine	NNS
46745	882	21	must	must	MD
46745	882	22	pass	pass	VB
46745	882	23	into	into	IN
46745	882	24	the	the	DT
46745	882	25	blood	blood	NN
46745	882	26	before	before	IN
46745	882	27	they	-PRON-	PRP
46745	882	28	can	can	MD
46745	882	29	act	act	VB
46745	882	30	.	.	.
46745	883	1	But	but	CC
46745	883	2	a	a	DT
46745	883	3	fourth	fourth	JJ
46745	883	4	consideration	consideration	NN
46745	883	5	will	will	MD
46745	883	6	suffice	suffice	VB
46745	883	7	to	to	TO
46745	883	8	bring	bring	VB
46745	883	9	this	this	DT
46745	883	10	probability	probability	NN
46745	883	11	as	as	RB
46745	883	12	close	close	RB
46745	883	13	as	as	IN
46745	883	14	possible	possible	JJ
46745	883	15	to	to	IN
46745	883	16	a	a	DT
46745	883	17	certainty	certainty	NN
46745	883	18	.	.	.
46745	884	1	_	_	NNP
46745	884	2	The	the	DT
46745	884	3	great	great	JJ
46745	884	4	majority	majority	NN
46745	884	5	of	of	IN
46745	884	6	medicines	medicine	NNS
46745	884	7	have	have	VBP
46745	884	8	been	be	VBN
46745	884	9	detected	detect	VBN
46745	884	10	in	in	IN
46745	884	11	the	the	DT
46745	884	12	blood	blood	NN
46745	884	13	,	,	,
46745	884	14	and	and	CC
46745	884	15	found	find	VBN
46745	884	16	in	in	IN
46745	884	17	the	the	DT
46745	884	18	secretions	secretion	NNS
46745	884	19	formed	form	VBN
46745	884	20	out	out	IN
46745	884	21	of	of	IN
46745	884	22	it	-PRON-	PRP
46745	884	23	.	.	.
46745	884	24	_	_	NNP
46745	884	25	Having	have	VBG
46745	884	26	tried	try	VBD
46745	884	27	to	to	TO
46745	884	28	prove	prove	VB
46745	884	29	that	that	IN
46745	884	30	they	-PRON-	PRP
46745	884	31	must	must	MD
46745	884	32	pass	pass	VB
46745	884	33	into	into	IN
46745	884	34	the	the	DT
46745	884	35	blood	blood	NN
46745	884	36	,	,	,
46745	884	37	if	if	IN
46745	884	38	we	-PRON-	PRP
46745	884	39	find	find	VBP
46745	884	40	that	that	IN
46745	884	41	they	-PRON-	PRP
46745	884	42	actually	actually	RB
46745	884	43	do	do	VBP
46745	884	44	so	so	RB
46745	884	45	,	,	,
46745	884	46	we	-PRON-	PRP
46745	884	47	shall	shall	MD
46745	884	48	establish	establish	VB
46745	884	49	a	a	DT
46745	884	50	stronger	strong	JJR
46745	884	51	case	case	NN
46745	884	52	.	.	.
46745	885	1	Isolated	isolated	JJ
46745	885	2	observations	observation	NNS
46745	885	3	on	on	IN
46745	885	4	this	this	DT
46745	885	5	subject	subject	NN
46745	885	6	have	have	VBP
46745	885	7	been	be	VBN
46745	885	8	frequently	frequently	RB
46745	885	9	made	make	VBN
46745	885	10	.	.	.
46745	886	1	Thus	thus	RB
46745	886	2	in	in	IN
46745	886	3	1847	1847	CD
46745	886	4	Mr.	Mr.	NNP
46745	886	5	Allen	Allen	NNP
46745	886	6	detected	detect	VBD
46745	886	7	Daturia	Daturia	NNP
46745	886	8	in	in	IN
46745	886	9	the	the	DT
46745	886	10	urine	urine	NN
46745	886	11	of	of	IN
46745	886	12	a	a	DT
46745	886	13	man	man	NN
46745	886	14	poisoned	poison	VBN
46745	886	15	by	by	IN
46745	886	16	Stramonium	Stramonium	NNP
46745	886	17	.	.	.
46745	887	1	In	in	IN
46745	887	2	1824	1824	CD
46745	887	3	M.	M.	NNP
46745	887	4	Runge	Runge	NNP
46745	887	5	had	have	VBD
46745	887	6	discovered	discover	VBN
46745	887	7	in	in	IN
46745	887	8	the	the	DT
46745	887	9	same	same	JJ
46745	887	10	way	way	NN
46745	887	11	the	the	DT
46745	887	12	principles	principle	NNS
46745	887	13	of	of	IN
46745	887	14	Henbane	Henbane	NNP
46745	887	15	and	and	CC
46745	887	16	Belladonna	Belladonna	NNP
46745	887	17	.	.	.
46745	888	1	M.	M.	NNP
46745	888	2	Ragsky	Ragsky	NNP
46745	888	3	has	have	VBZ
46745	888	4	lately	lately	RB
46745	888	5	detected	detect	VBN
46745	888	6	Chloroform	Chloroform	NNP
46745	888	7	in	in	IN
46745	888	8	the	the	DT
46745	888	9	blood	blood	NN
46745	888	10	.	.	.
46745	889	1	(	(	-LRB-
46745	889	2	_	_	NNP
46745	889	3	Journal	Journal	NNP
46745	889	4	für	für	NN
46745	889	5	Prakt	Prakt	NNP
46745	889	6	.	.	.
46745	890	1	Chem	Chem	NNP
46745	890	2	.	.	.
46745	891	1	1849	1849	CD
46745	891	2	.	.	.
46745	891	3	_	_	NNP
46745	891	4	)	)	-RRB-
46745	891	5	Dr.	Dr.	NNP
46745	891	6	Golding	Golding	NNP
46745	891	7	Bird	Bird	NNP
46745	891	8	observes	observe	VBZ
46745	891	9	that	that	IN
46745	891	10	Indigo	Indigo	NNP
46745	891	11	,	,	,
46745	891	12	when	when	WRB
46745	891	13	given	give	VBN
46745	891	14	for	for	IN
46745	891	15	Epilepsy	Epilepsy	NNP
46745	891	16	,	,	,
46745	891	17	has	have	VBZ
46745	891	18	turned	turn	VBN
46745	891	19	the	the	DT
46745	891	20	urine	urine	NN
46745	891	21	blue	blue	NN
46745	891	22	;	;	:
46745	891	23	that	that	IN
46745	891	24	Logwood	Logwood	NNP
46745	891	25	also	also	RB
46745	891	26	passes	pass	VBZ
46745	891	27	into	into	IN
46745	891	28	it	-PRON-	PRP
46745	891	29	,	,	,
46745	891	30	and	and	CC
46745	891	31	causes	cause	VBZ
46745	891	32	it	-PRON-	PRP
46745	891	33	to	to	TO
46745	891	34	give	give	VB
46745	891	35	a	a	DT
46745	891	36	dark	dark	JJ
46745	891	37	precipitate	precipitate	NN
46745	891	38	with	with	IN
46745	891	39	solutions	solution	NNS
46745	891	40	containing	contain	VBG
46745	891	41	iron	iron	NN
46745	891	42	;	;	:
46745	891	43	and	and	CC
46745	891	44	that	that	IN
46745	891	45	during	during	IN
46745	891	46	a	a	DT
46745	891	47	course	course	NN
46745	891	48	of	of	IN
46745	891	49	Copaiba	Copaiba	NNP
46745	891	50	or	or	CC
46745	891	51	Cubebs	Cubebs	NNP
46745	891	52	,	,	,
46745	891	53	a	a	DT
46745	891	54	resin	resin	NN
46745	891	55	may	may	MD
46745	891	56	be	be	VB
46745	891	57	precipitated	precipitate	VBN
46745	891	58	from	from	IN
46745	891	59	it	-PRON-	PRP
46745	891	60	on	on	IN
46745	891	61	the	the	DT
46745	891	62	addition	addition	NN
46745	891	63	of	of	IN
46745	891	64	Nitric	Nitric	NNP
46745	891	65	Acid	Acid	NNP
46745	891	66	.	.	.
46745	892	1	If	if	IN
46745	892	2	a	a	DT
46745	892	3	medicine	medicine	NN
46745	892	4	can	can	MD
46745	892	5	not	not	RB
46745	892	6	be	be	VB
46745	892	7	proved	prove	VBN
46745	892	8	to	to	TO
46745	892	9	pass	pass	VB
46745	892	10	into	into	IN
46745	892	11	the	the	DT
46745	892	12	blood	blood	NN
46745	892	13	or	or	CC
46745	892	14	secretions	secretion	NNS
46745	892	15	,	,	,
46745	892	16	we	-PRON-	PRP
46745	892	17	can	can	MD
46745	892	18	not	not	RB
46745	892	19	so	so	RB
46745	892	20	certainly	certainly	RB
46745	892	21	affirm	affirm	JJ
46745	892	22	that	that	IN
46745	892	23	it	-PRON-	PRP
46745	892	24	does	do	VBZ
46745	892	25	not	not	RB
46745	892	26	act	act	VB
46745	892	27	through	through	IN
46745	892	28	the	the	DT
46745	892	29	nerves	nerve	NNS
46745	892	30	.	.	.
46745	893	1	But	but	CC
46745	893	2	the	the	DT
46745	893	3	experiments	experiment	NNS
46745	893	4	of	of	IN
46745	893	5	Tiedemann	Tiedemann	NNP
46745	893	6	and	and	CC
46745	893	7	Gmelin	Gmelin	NNP
46745	893	8	,	,	,
46745	893	9	and	and	CC
46745	893	10	since	since	IN
46745	893	11	then	then	RB
46745	893	12	of	of	IN
46745	893	13	Wöhler	Wöhler	NNP
46745	893	14	,	,	,
46745	893	15	have	have	VBP
46745	893	16	definitively	definitively	RB
46745	893	17	settled	settle	VBN
46745	893	18	this	this	DT
46745	893	19	point	point	NN
46745	893	20	.	.	.
46745	894	1	The	the	DT
46745	894	2	former	former	JJ
46745	894	3	two	two	CD
46745	894	4	have	have	VBP
46745	894	5	found	find	VBN
46745	894	6	the	the	DT
46745	894	7	great	great	JJ
46745	894	8	majority	majority	NN
46745	894	9	of	of	IN
46745	894	10	mineral	mineral	NN
46745	894	11	,	,	,
46745	894	12	and	and	CC
46745	894	13	many	many	JJ
46745	894	14	vegetable	vegetable	JJ
46745	894	15	substances	substance	NNS
46745	894	16	,	,	,
46745	894	17	in	in	IN
46745	894	18	the	the	DT
46745	894	19	blood	blood	NN
46745	894	20	of	of	IN
46745	894	21	animals	animal	NNS
46745	894	22	to	to	TO
46745	894	23	which	which	WDT
46745	894	24	they	-PRON-	PRP
46745	894	25	had	have	VBD
46745	894	26	been	be	VBN
46745	894	27	administered	administer	VBN
46745	894	28	.	.	.
46745	895	1	Thus	thus	RB
46745	895	2	,	,	,
46745	895	3	from	from	IN
46745	895	4	these	these	DT
46745	895	5	four	four	CD
46745	895	6	considerations	consideration	NNS
46745	895	7	,	,	,
46745	895	8	we	-PRON-	PRP
46745	895	9	are	be	VBP
46745	895	10	strictly	strictly	RB
46745	895	11	justified	justify	VBN
46745	895	12	in	in	IN
46745	895	13	concluding	conclude	VBG
46745	895	14	that	that	IN
46745	895	15	a	a	DT
46745	895	16	medicine	medicine	NN
46745	895	17	must	must	MD
46745	895	18	pass	pass	VB
46745	895	19	from	from	IN
46745	895	20	the	the	DT
46745	895	21	stomach	stomach	NN
46745	895	22	into	into	IN
46745	895	23	the	the	DT
46745	895	24	blood	blood	NN
46745	895	25	before	before	IN
46745	895	26	its	-PRON-	PRP$
46745	895	27	action	action	NN
46745	895	28	can	can	MD
46745	895	29	be	be	VB
46745	895	30	manifested	manifest	VBN
46745	895	31	.	.	.
46745	896	1	This	this	DT
46745	896	2	action	action	NN
46745	896	3	can	can	MD
46745	896	4	not	not	RB
46745	896	5	then	then	RB
46745	896	6	be	be	VB
46745	896	7	conducted	conduct	VBN
46745	896	8	from	from	IN
46745	896	9	the	the	DT
46745	896	10	surface	surface	NN
46745	896	11	of	of	IN
46745	896	12	the	the	DT
46745	896	13	stomach	stomach	NN
46745	896	14	through	through	IN
46745	896	15	the	the	DT
46745	896	16	agency	agency	NN
46745	896	17	of	of	IN
46745	896	18	the	the	DT
46745	896	19	nerves	nerve	NNS
46745	896	20	.	.	.
46745	897	1	Some	some	DT
46745	897	2	experiments	experiment	NNS
46745	897	3	made	make	VBN
46745	897	4	by	by	IN
46745	897	5	Dr.	Dr.	NNP
46745	897	6	Garrod	Garrod	NNP
46745	897	7	and	and	CC
46745	897	8	others	other	NNS
46745	897	9	on	on	IN
46745	897	10	the	the	DT
46745	897	11	action	action	NN
46745	897	12	of	of	IN
46745	897	13	animal	animal	NN
46745	897	14	charcoal	charcoal	NN
46745	897	15	as	as	IN
46745	897	16	an	an	DT
46745	897	17	antidote	antidote	NN
46745	897	18	,	,	,
46745	897	19	furnish	furnish	VB
46745	897	20	again	again	RB
46745	897	21	an	an	DT
46745	897	22	additional	additional	JJ
46745	897	23	confirmation	confirmation	NN
46745	897	24	of	of	IN
46745	897	25	this	this	DT
46745	897	26	fact	fact	NN
46745	897	27	.	.	.
46745	898	1	He	-PRON-	PRP
46745	898	2	finds	find	VBZ
46745	898	3	that	that	IN
46745	898	4	if	if	IN
46745	898	5	a	a	DT
46745	898	6	sufficient	sufficient	JJ
46745	898	7	quantity	quantity	NN
46745	898	8	of	of	IN
46745	898	9	this	this	DT
46745	898	10	absorbing	absorb	VBG
46745	898	11	agent	agent	NN
46745	898	12	be	be	VB
46745	898	13	introduced	introduce	VBN
46745	898	14	into	into	IN
46745	898	15	the	the	DT
46745	898	16	stomach	stomach	NN
46745	898	17	before	before	IN
46745	898	18	time	time	NN
46745	898	19	has	have	VBZ
46745	898	20	been	be	VBN
46745	898	21	allowed	allow	VBN
46745	898	22	for	for	IN
46745	898	23	the	the	DT
46745	898	24	passage	passage	NN
46745	898	25	of	of	IN
46745	898	26	a	a	DT
46745	898	27	medicine	medicine	NN
46745	898	28	through	through	IN
46745	898	29	the	the	DT
46745	898	30	mucous	mucous	JJ
46745	898	31	membrane	membrane	NN
46745	898	32	,	,	,
46745	898	33	then	then	RB
46745	898	34	even	even	RB
46745	898	35	such	such	JJ
46745	898	36	powerful	powerful	JJ
46745	898	37	nerve	nerve	NN
46745	898	38	-	-	HYPH
46745	898	39	medicines	medicine	NNS
46745	898	40	as	as	IN
46745	898	41	Morphia	Morphia	NNP
46745	898	42	and	and	CC
46745	898	43	Strychnia	Strychnia	NNP
46745	898	44	,	,	,
46745	898	45	in	in	IN
46745	898	46	very	very	RB
46745	898	47	large	large	JJ
46745	898	48	doses	dose	NNS
46745	898	49	,	,	,
46745	898	50	are	be	VBP
46745	898	51	prevented	prevent	VBN
46745	898	52	from	from	IN
46745	898	53	taking	take	VBG
46745	898	54	effect	effect	NN
46745	898	55	.	.	.
46745	899	1	Yet	yet	CC
46745	899	2	before	before	IN
46745	899	3	the	the	DT
46745	899	4	contact	contact	NN
46745	899	5	of	of	IN
46745	899	6	the	the	DT
46745	899	7	charcoal	charcoal	NN
46745	899	8	they	-PRON-	PRP
46745	899	9	would	would	MD
46745	899	10	have	have	VB
46745	899	11	had	have	VBN
46745	899	12	time	time	NN
46745	899	13	to	to	TO
46745	899	14	act	act	VB
46745	899	15	through	through	IN
46745	899	16	the	the	DT
46745	899	17	nerves	nerve	NNS
46745	899	18	,	,	,
46745	899	19	had	have	VBD
46745	899	20	they	-PRON-	PRP
46745	899	21	been	be	VBN
46745	899	22	capable	capable	JJ
46745	899	23	of	of	IN
46745	899	24	any	any	DT
46745	899	25	such	such	JJ
46745	899	26	action	action	NN
46745	899	27	.	.	.
46745	900	1	In	in	IN
46745	900	2	the	the	DT
46745	900	3	fifth	fifth	JJ
46745	900	4	Proposition	Proposition	NNP
46745	900	5	the	the	DT
46745	900	6	rule	rule	NN
46745	900	7	here	here	RB
46745	900	8	laid	lay	VBD
46745	900	9	down	down	RP
46745	900	10	will	will	MD
46745	900	11	have	have	VB
46745	900	12	to	to	TO
46745	900	13	be	be	VB
46745	900	14	further	further	RB
46745	900	15	extended	extend	VBN
46745	900	16	.	.	.
46745	901	1	It	-PRON-	PRP
46745	901	2	will	will	MD
46745	901	3	be	be	VB
46745	901	4	shown	show	VBN
46745	901	5	that	that	IN
46745	901	6	medicines	medicine	NNS
46745	901	7	,	,	,
46745	901	8	having	have	VBG
46745	901	9	already	already	RB
46745	901	10	passed	pass	VBN
46745	901	11	into	into	IN
46745	901	12	the	the	DT
46745	901	13	blood	blood	NN
46745	901	14	,	,	,
46745	901	15	must	must	MD
46745	901	16	travel	travel	VB
46745	901	17	along	along	RB
46745	901	18	in	in	IN
46745	901	19	it	-PRON-	PRP
46745	901	20	so	so	RB
46745	901	21	far	far	RB
46745	901	22	as	as	IN
46745	901	23	to	to	TO
46745	901	24	reach	reach	VB
46745	901	25	the	the	DT
46745	901	26	part	part	NN
46745	901	27	of	of	IN
46745	901	28	the	the	DT
46745	901	29	system	system	NN
46745	901	30	on	on	IN
46745	901	31	which	which	WDT
46745	901	32	they	-PRON-	PRP
46745	901	33	act	act	VBP
46745	901	34	.	.	.
46745	902	1	Before	before	IN
46745	902	2	concluding	conclude	VBG
46745	902	3	this	this	DT
46745	902	4	question	question	NN
46745	902	5	,	,	,
46745	902	6	a	a	DT
46745	902	7	few	few	JJ
46745	902	8	remarks	remark	NNS
46745	902	9	must	must	MD
46745	902	10	be	be	VB
46745	902	11	made	make	VBN
46745	902	12	on	on	IN
46745	902	13	a	a	DT
46745	902	14	subject	subject	NN
46745	902	15	which	which	WDT
46745	902	16	will	will	MD
46745	902	17	be	be	VB
46745	902	18	again	again	RB
46745	902	19	referred	refer	VBN
46745	902	20	to	to	IN
46745	902	21	in	in	IN
46745	902	22	the	the	DT
46745	902	23	discussion	discussion	NN
46745	902	24	of	of	IN
46745	902	25	the	the	DT
46745	902	26	Fourth	Fourth	NNP
46745	902	27	Proposition	Proposition	NNP
46745	902	28	.	.	.
46745	903	1	The	the	DT
46745	903	2	proper	proper	JJ
46745	903	3	and	and	CC
46745	903	4	peculiar	peculiar	JJ
46745	903	5	action	action	NN
46745	903	6	of	of	IN
46745	903	7	a	a	DT
46745	903	8	medicine	medicine	NN
46745	903	9	,	,	,
46745	903	10	by	by	IN
46745	903	11	which	which	WDT
46745	903	12	I	-PRON-	PRP
46745	903	13	mean	mean	VBP
46745	903	14	that	that	IN
46745	903	15	action	action	NN
46745	903	16	on	on	IN
46745	903	17	the	the	DT
46745	903	18	system	system	NN
46745	903	19	which	which	WDT
46745	903	20	is	be	VBZ
46745	903	21	immediately	immediately	RB
46745	903	22	recognised	recognise	VBN
46745	903	23	as	as	IN
46745	903	24	distinct	distinct	JJ
46745	903	25	from	from	IN
46745	903	26	that	that	DT
46745	903	27	of	of	IN
46745	903	28	any	any	DT
46745	903	29	other	other	JJ
46745	903	30	agent	agent	NN
46745	903	31	,	,	,
46745	903	32	can	can	MD
46745	903	33	not	not	RB
46745	903	34	be	be	VB
46745	903	35	exerted	exert	VBN
46745	903	36	on	on	IN
46745	903	37	distant	distant	JJ
46745	903	38	parts	part	NNS
46745	903	39	from	from	IN
46745	903	40	the	the	DT
46745	903	41	stomach	stomach	NN
46745	903	42	-	-	HYPH
46745	903	43	surface	surface	NN
46745	903	44	,	,	,
46745	903	45	but	but	CC
46745	903	46	requires	require	VBZ
46745	903	47	the	the	DT
46745	903	48	passage	passage	NN
46745	903	49	of	of	IN
46745	903	50	the	the	DT
46745	903	51	medicine	medicine	NN
46745	903	52	into	into	IN
46745	903	53	the	the	DT
46745	903	54	circulation	circulation	NN
46745	903	55	.	.	.
46745	904	1	But	but	CC
46745	904	2	can	can	MD
46745	904	3	any	any	DT
46745	904	4	other	other	JJ
46745	904	5	action	action	NN
46745	904	6	on	on	IN
46745	904	7	distant	distant	JJ
46745	904	8	parts	part	NNS
46745	904	9	be	be	VB
46745	904	10	produced	produce	VBN
46745	904	11	by	by	IN
46745	904	12	the	the	DT
46745	904	13	remedy	remedy	NN
46745	904	14	while	while	IN
46745	904	15	in	in	IN
46745	904	16	the	the	DT
46745	904	17	stomach	stomach	NN
46745	904	18	?	?	.
46745	905	1	This	this	DT
46745	905	2	is	be	VBZ
46745	905	3	a	a	DT
46745	905	4	different	different	JJ
46745	905	5	question	question	NN
46745	905	6	,	,	,
46745	905	7	and	and	CC
46745	905	8	must	must	MD
46745	905	9	be	be	VB
46745	905	10	answered	answer	VBN
46745	905	11	in	in	IN
46745	905	12	the	the	DT
46745	905	13	affirmative	affirmative	NN
46745	905	14	.	.	.
46745	906	1	Suppose	suppose	VB
46745	906	2	a	a	DT
46745	906	3	Cantharides	Cantharides	NNP
46745	906	4	plaster	plaster	NN
46745	906	5	be	be	VB
46745	906	6	applied	apply	VBN
46745	906	7	to	to	IN
46745	906	8	the	the	DT
46745	906	9	surface	surface	NN
46745	906	10	of	of	IN
46745	906	11	the	the	DT
46745	906	12	chest	chest	NN
46745	906	13	in	in	IN
46745	906	14	a	a	DT
46745	906	15	case	case	NN
46745	906	16	of	of	IN
46745	906	17	Pericarditis	Pericarditis	NNP
46745	906	18	,	,	,
46745	906	19	so	so	IN
46745	906	20	as	as	IN
46745	906	21	to	to	IN
46745	906	22	redden	redden	VB
46745	906	23	or	or	CC
46745	906	24	blister	blister	VB
46745	906	25	the	the	DT
46745	906	26	skin	skin	NN
46745	906	27	,	,	,
46745	906	28	absorption	absorption	NN
46745	906	29	of	of	IN
46745	906	30	the	the	DT
46745	906	31	fluid	fluid	NN
46745	906	32	in	in	IN
46745	906	33	the	the	DT
46745	906	34	pericardium	pericardium	NN
46745	906	35	may	may	MD
46745	906	36	follow	follow	VB
46745	906	37	this	this	DT
46745	906	38	application	application	NN
46745	906	39	.	.	.
46745	907	1	But	but	CC
46745	907	2	any	any	DT
46745	907	3	other	other	JJ
46745	907	4	irritant	irritant	NN
46745	907	5	would	would	MD
46745	907	6	have	have	VB
46745	907	7	done	do	VBN
46745	907	8	this	this	DT
46745	907	9	.	.	.
46745	908	1	It	-PRON-	PRP
46745	908	2	is	be	VBZ
46745	908	3	not	not	RB
46745	908	4	the	the	DT
46745	908	5	proper	proper	JJ
46745	908	6	or	or	CC
46745	908	7	peculiar	peculiar	JJ
46745	908	8	action	action	NN
46745	908	9	of	of	IN
46745	908	10	Cantharides	Cantharides	NNP
46745	908	11	,	,	,
46745	908	12	but	but	CC
46745	908	13	an	an	DT
46745	908	14	operation	operation	NN
46745	908	15	of	of	IN
46745	908	16	the	the	DT
46745	908	17	nervous	nervous	JJ
46745	908	18	system	system	NN
46745	908	19	which	which	WDT
46745	908	20	follows	follow	VBZ
46745	908	21	the	the	DT
46745	908	22	local	local	JJ
46745	908	23	change	change	NN
46745	908	24	.	.	.
46745	909	1	Such	such	JJ
46745	909	2	agents	agent	NNS
46745	909	3	are	be	VBP
46745	909	4	said	say	VBN
46745	909	5	to	to	TO
46745	909	6	act	act	VB
46745	909	7	by	by	IN
46745	909	8	_	_	NNP
46745	909	9	Counter	Counter	NNP
46745	909	10	-	-	HYPH
46745	909	11	irritation	irritation	NN
46745	909	12	_	_	NNP
46745	909	13	or	or	CC
46745	909	14	_	_	NNP
46745	909	15	Revulsion	Revulsion	NNP
46745	909	16	_	_	NNP
46745	909	17	,	,	,
46745	909	18	because	because	IN
46745	909	19	it	-PRON-	PRP
46745	909	20	appears	appear	VBZ
46745	909	21	that	that	DT
46745	909	22	,	,	,
46745	909	23	as	as	IN
46745	909	24	a	a	DT
46745	909	25	consequence	consequence	NN
46745	909	26	of	of	IN
46745	909	27	their	-PRON-	PRP$
46745	909	28	action	action	NN
46745	909	29	,	,	,
46745	909	30	the	the	DT
46745	909	31	attention	attention	NN
46745	909	32	of	of	IN
46745	909	33	the	the	DT
46745	909	34	nervous	nervous	JJ
46745	909	35	system	system	NN
46745	909	36	may	may	MD
46745	909	37	be	be	VB
46745	909	38	drawn	draw	VBN
46745	909	39	off	off	RP
46745	909	40	from	from	IN
46745	909	41	a	a	DT
46745	909	42	morbid	morbid	NN
46745	909	43	process	process	NN
46745	909	44	going	go	VBG
46745	909	45	on	on	RP
46745	909	46	at	at	IN
46745	909	47	some	some	DT
46745	909	48	other	other	JJ
46745	909	49	part	part	NN
46745	909	50	of	of	IN
46745	909	51	the	the	DT
46745	909	52	body	body	NN
46745	909	53	.	.	.
46745	910	1	But	but	CC
46745	910	2	it	-PRON-	PRP
46745	910	3	is	be	VBZ
46745	910	4	only	only	RB
46745	910	5	a	a	DT
46745	910	6	consequence	consequence	NN
46745	910	7	,	,	,
46745	910	8	and	and	CC
46745	910	9	not	not	RB
46745	910	10	a	a	DT
46745	910	11	direct	direct	JJ
46745	910	12	operation	operation	NN
46745	910	13	.	.	.
46745	911	1	Such	such	PDT
46745	911	2	an	an	DT
46745	911	3	effect	effect	NN
46745	911	4	is	be	VBZ
46745	911	5	no	no	RB
46745	911	6	more	more	JJR
46745	911	7	the	the	DT
46745	911	8	action	action	NN
46745	911	9	of	of	IN
46745	911	10	Cantharides	Cantharides	NNPS
46745	911	11	than	than	IN
46745	911	12	the	the	DT
46745	911	13	healthy	healthy	JJ
46745	911	14	functions	function	NNS
46745	911	15	following	follow	VBG
46745	911	16	recovery	recovery	NN
46745	911	17	from	from	IN
46745	911	18	sickness	sickness	NN
46745	911	19	can	can	MD
46745	911	20	be	be	VB
46745	911	21	ascribed	ascribe	VBN
46745	911	22	to	to	IN
46745	911	23	the	the	DT
46745	911	24	remedy	remedy	NN
46745	911	25	which	which	WDT
46745	911	26	has	have	VBZ
46745	911	27	cured	cure	VBN
46745	911	28	the	the	DT
46745	911	29	latter	latter	JJ
46745	911	30	.	.	.
46745	912	1	Now	now	RB
46745	912	2	some	some	DT
46745	912	3	few	few	JJ
46745	912	4	medicines	medicine	NNS
46745	912	5	have	have	VBP
46745	912	6	a	a	DT
46745	912	7	marked	mark	VBN
46745	912	8	local	local	JJ
46745	912	9	action	action	NN
46745	912	10	on	on	IN
46745	912	11	the	the	DT
46745	912	12	mucous	mucous	JJ
46745	912	13	surface	surface	NN
46745	912	14	of	of	IN
46745	912	15	the	the	DT
46745	912	16	stomach	stomach	NN
46745	912	17	and	and	CC
46745	912	18	intestines	intestine	NNS
46745	912	19	.	.	.
46745	913	1	(	(	-LRB-
46745	913	2	_	_	NNP
46745	913	3	Vide	Vide	NNP
46745	913	4	_	_	NNP
46745	913	5	Prop	Prop	NNP
46745	913	6	.	.	.
46745	914	1	IV	IV	NNP
46745	914	2	.	.	.
46745	914	3	)	)	-RRB-
46745	915	1	These	these	DT
46745	915	2	,	,	,
46745	915	3	and	and	CC
46745	915	4	these	these	DT
46745	915	5	only	only	RB
46745	915	6	,	,	,
46745	915	7	may	may	MD
46745	915	8	,	,	,
46745	915	9	without	without	IN
46745	915	10	passing	pass	VBG
46745	915	11	into	into	IN
46745	915	12	the	the	DT
46745	915	13	blood	blood	NN
46745	915	14	,	,	,
46745	915	15	produce	produce	VBP
46745	915	16	on	on	IN
46745	915	17	distant	distant	JJ
46745	915	18	parts	part	NNS
46745	915	19	an	an	DT
46745	915	20	action	action	NN
46745	915	21	of	of	IN
46745	915	22	this	this	DT
46745	915	23	kind	kind	NN
46745	915	24	by	by	IN
46745	915	25	counter	counter	NN
46745	915	26	-	-	NN
46745	915	27	irritation	irritation	NN
46745	915	28	.	.	.
46745	916	1	Thus	thus	RB
46745	916	2	the	the	DT
46745	916	3	operation	operation	NN
46745	916	4	of	of	IN
46745	916	5	an	an	DT
46745	916	6	irritant	irritant	JJ
46745	916	7	emetic	emetic	NN
46745	916	8	may	may	MD
46745	916	9	be	be	VB
46745	916	10	followed	follow	VBN
46745	916	11	by	by	IN
46745	916	12	the	the	DT
46745	916	13	arrest	arrest	NN
46745	916	14	of	of	IN
46745	916	15	some	some	DT
46745	916	16	incipient	incipient	JJ
46745	916	17	inflammation	inflammation	NN
46745	916	18	,	,	,
46745	916	19	_	_	NNP
46745	916	20	e.g.	e.g.	RB
46745	916	21	_	_	NNP
46745	916	22	Ophthalmia	Ophthalmia	NNP
46745	916	23	.	.	.
46745	917	1	This	this	DT
46745	917	2	revulsive	revulsive	JJ
46745	917	3	action	action	NN
46745	917	4	,	,	,
46745	917	5	when	when	WRB
46745	917	6	carried	carry	VBN
46745	917	7	to	to	IN
46745	917	8	an	an	DT
46745	917	9	extreme	extreme	NN
46745	917	10	,	,	,
46745	917	11	so	so	RB
46745	917	12	powerfully	powerfully	RB
46745	917	13	impresses	impress	VBZ
46745	917	14	the	the	DT
46745	917	15	nervous	nervous	JJ
46745	917	16	system	system	NN
46745	917	17	,	,	,
46745	917	18	that	that	IN
46745	917	19	it	-PRON-	PRP
46745	917	20	puts	put	VBZ
46745	917	21	a	a	DT
46745	917	22	stop	stop	NN
46745	917	23	to	to	IN
46745	917	24	all	all	DT
46745	917	25	other	other	JJ
46745	917	26	actions	action	NNS
46745	917	27	,	,	,
46745	917	28	and	and	CC
46745	917	29	produces	produce	VBZ
46745	917	30	Syncope	Syncope	NNP
46745	917	31	or	or	CC
46745	917	32	Death	Death	NNP
46745	917	33	.	.	.
46745	918	1	This	this	DT
46745	918	2	extreme	extreme	JJ
46745	918	3	action	action	NN
46745	918	4	is	be	VBZ
46745	918	5	called	call	VBN
46745	918	6	_	_	NNP
46745	918	7	Shock	Shock	NNP
46745	918	8	_	_	NNP
46745	918	9	.	.	.
46745	919	1	Powerful	powerful	JJ
46745	919	2	corrosive	corrosive	JJ
46745	919	3	poisons	poison	NNS
46745	919	4	may	may	MD
46745	919	5	effect	effect	VB
46745	919	6	this	this	DT
46745	919	7	by	by	IN
46745	919	8	a	a	DT
46745	919	9	sudden	sudden	JJ
46745	919	10	destruction	destruction	NN
46745	919	11	of	of	IN
46745	919	12	the	the	DT
46745	919	13	mucous	mucous	JJ
46745	919	14	surface	surface	NN
46745	919	15	,	,	,
46745	919	16	operating	operate	VBG
46745	919	17	like	like	IN
46745	919	18	a	a	DT
46745	919	19	surgical	surgical	JJ
46745	919	20	injury	injury	NN
46745	919	21	.	.	.
46745	920	1	But	but	CC
46745	920	2	such	such	JJ
46745	920	3	actions	action	NNS
46745	920	4	,	,	,
46745	920	5	not	not	RB
46745	920	6	being	be	VBG
46745	920	7	the	the	DT
46745	920	8	proper	proper	JJ
46745	920	9	and	and	CC
46745	920	10	characteristic	characteristic	JJ
46745	920	11	operations	operation	NNS
46745	920	12	of	of	IN
46745	920	13	medicines	medicine	NNS
46745	920	14	,	,	,
46745	920	15	but	but	CC
46745	920	16	rather	rather	RB
46745	920	17	attributable	attributable	JJ
46745	920	18	to	to	IN
46745	920	19	a	a	DT
46745	920	20	change	change	NN
46745	920	21	in	in	IN
46745	920	22	the	the	DT
46745	920	23	relations	relation	NNS
46745	920	24	of	of	IN
46745	920	25	the	the	DT
46745	920	26	nervous	nervous	JJ
46745	920	27	system	system	NN
46745	920	28	,	,	,
46745	920	29	following	follow	VBG
46745	920	30	a	a	DT
46745	920	31	local	local	JJ
46745	920	32	impression	impression	NN
46745	920	33	,	,	,
46745	920	34	are	be	VBP
46745	920	35	not	not	RB
46745	920	36	to	to	TO
46745	920	37	be	be	VB
46745	920	38	considered	consider	VBN
46745	920	39	as	as	IN
46745	920	40	exceptions	exception	NNS
46745	920	41	to	to	IN
46745	920	42	the	the	DT
46745	920	43	above	above	JJ
46745	920	44	rule	rule	NN
46745	920	45	,	,	,
46745	920	46	that	that	IN
46745	920	47	medicines	medicine	NNS
46745	920	48	can	can	MD
46745	920	49	not	not	RB
46745	920	50	from	from	IN
46745	920	51	the	the	DT
46745	920	52	surface	surface	NN
46745	920	53	of	of	IN
46745	920	54	the	the	DT
46745	920	55	stomach	stomach	NN
46745	920	56	or	or	CC
46745	920	57	intestines	intestine	NNS
46745	920	58	propagate	propagate	VBP
46745	920	59	their	-PRON-	PRP$
46745	920	60	influence	influence	NN
46745	920	61	to	to	TO
46745	920	62	remote	remote	VB
46745	920	63	parts	part	NNS
46745	920	64	.	.	.
46745	921	1	PROP	PROP	NNP
46745	921	2	.	.	.
46745	922	1	II.--_That	ii.--_that	UH
46745	922	2	the	the	DT
46745	922	3	great	great	JJ
46745	922	4	majority	majority	NN
46745	922	5	of	of	IN
46745	922	6	medicines	medicine	NNS
46745	922	7	are	be	VBP
46745	922	8	capable	capable	JJ
46745	922	9	of	of	IN
46745	922	10	solution	solution	NN
46745	922	11	in	in	IN
46745	922	12	the	the	DT
46745	922	13	gastric	gastric	JJ
46745	922	14	or	or	CC
46745	922	15	intestinal	intestinal	JJ
46745	922	16	secretions	secretion	NNS
46745	922	17	,	,	,
46745	922	18	and	and	CC
46745	922	19	pass	pass	VB
46745	922	20	without	without	IN
46745	922	21	material	material	NN
46745	922	22	change	change	NN
46745	922	23	,	,	,
46745	922	24	by	by	IN
46745	922	25	a	a	DT
46745	922	26	process	process	NN
46745	922	27	of	of	IN
46745	922	28	absorption	absorption	NN
46745	922	29	,	,	,
46745	922	30	through	through	IN
46745	922	31	the	the	DT
46745	922	32	coats	coat	NNS
46745	922	33	of	of	IN
46745	922	34	the	the	DT
46745	922	35	stomach	stomach	NN
46745	922	36	and	and	CC
46745	922	37	intestines	intestine	NNS
46745	922	38	,	,	,
46745	922	39	to	to	TO
46745	922	40	enter	enter	VB
46745	922	41	the	the	DT
46745	922	42	capillaries	capillary	NNS
46745	922	43	of	of	IN
46745	922	44	the	the	DT
46745	922	45	Portal	Portal	NNP
46745	922	46	system	system	NN
46745	922	47	of	of	IN
46745	922	48	veins	vein	NNS
46745	922	49	.	.	.
46745	922	50	_	_	NNP
46745	922	51	It	-PRON-	PRP
46745	922	52	has	have	VBZ
46745	922	53	already	already	RB
46745	922	54	been	be	VBN
46745	922	55	shown	show	VBN
46745	922	56	of	of	IN
46745	922	57	medicines	medicine	NNS
46745	922	58	in	in	IN
46745	922	59	general	general	JJ
46745	922	60	,	,	,
46745	922	61	that	that	IN
46745	922	62	it	-PRON-	PRP
46745	922	63	is	be	VBZ
46745	922	64	necessary	necessary	JJ
46745	922	65	for	for	IN
46745	922	66	them	-PRON-	PRP
46745	922	67	to	to	TO
46745	922	68	pass	pass	VB
46745	922	69	away	away	RB
46745	922	70	from	from	IN
46745	922	71	the	the	DT
46745	922	72	mucous	mucous	JJ
46745	922	73	surface	surface	NN
46745	922	74	into	into	IN
46745	922	75	the	the	DT
46745	922	76	circulation	circulation	NN
46745	922	77	.	.	.
46745	923	1	Mention	Mention	NNP
46745	923	2	has	have	VBZ
46745	923	3	been	be	VBN
46745	923	4	made	make	VBN
46745	923	5	of	of	IN
46745	923	6	their	-PRON-	PRP$
46745	923	7	discovery	discovery	NN
46745	923	8	in	in	IN
46745	923	9	the	the	DT
46745	923	10	blood	blood	NN
46745	923	11	by	by	IN
46745	923	12	chemical	chemical	NN
46745	923	13	means	mean	NNS
46745	923	14	;	;	:
46745	923	15	and	and	CC
46745	923	16	as	as	IN
46745	923	17	we	-PRON-	PRP
46745	923	18	proceed	proceed	VBP
46745	923	19	it	-PRON-	PRP
46745	923	20	will	will	MD
46745	923	21	be	be	VB
46745	923	22	shown	show	VBN
46745	923	23	more	more	RBR
46745	923	24	particularly	particularly	RB
46745	923	25	of	of	IN
46745	923	26	different	different	JJ
46745	923	27	sets	set	NNS
46745	923	28	of	of	IN
46745	923	29	medicines	medicine	NNS
46745	923	30	that	that	IN
46745	923	31	each	each	DT
46745	923	32	of	of	IN
46745	923	33	them	-PRON-	PRP
46745	923	34	has	have	VBZ
46745	923	35	been	be	VBN
46745	923	36	found	find	VBN
46745	923	37	in	in	IN
46745	923	38	that	that	DT
46745	923	39	fluid	fluid	NN
46745	923	40	.	.	.
46745	924	1	Now	now	RB
46745	924	2	,	,	,
46745	924	3	to	to	TO
46745	924	4	gain	gain	VB
46745	924	5	entrance	entrance	NN
46745	924	6	there	there	RB
46745	924	7	,	,	,
46745	924	8	the	the	DT
46745	924	9	medicine	medicine	NN
46745	924	10	must	must	MD
46745	924	11	first	first	RB
46745	924	12	pass	pass	VB
46745	924	13	through	through	RP
46745	924	14	the	the	DT
46745	924	15	soft	soft	JJ
46745	924	16	mucous	mucous	JJ
46745	924	17	membrane	membrane	NN
46745	924	18	lining	line	VBG
46745	924	19	the	the	DT
46745	924	20	stomach	stomach	NN
46745	924	21	and	and	CC
46745	924	22	intestine	intestine	NN
46745	924	23	.	.	.
46745	925	1	This	this	DT
46745	925	2	passage	passage	NN
46745	925	3	is	be	VBZ
46745	925	4	performed	perform	VBN
46745	925	5	by	by	IN
46745	925	6	a	a	DT
46745	925	7	process	process	NN
46745	925	8	to	to	TO
46745	925	9	which	which	WDT
46745	925	10	the	the	DT
46745	925	11	names	name	NNS
46745	925	12	of	of	IN
46745	925	13	_	_	NNP
46745	925	14	Absorption	Absorption	NNP
46745	925	15	_	_	NNP
46745	925	16	and	and	CC
46745	925	17	_	_	NNP
46745	925	18	Endosmosis	Endosmosis	NNP
46745	925	19	_	_	NNP
46745	925	20	have	have	VBP
46745	925	21	been	be	VBN
46745	925	22	applied	apply	VBN
46745	925	23	.	.	.
46745	926	1	Immediately	immediately	RB
46745	926	2	outside	outside	IN
46745	926	3	this	this	DT
46745	926	4	membrane	membrane	NN
46745	926	5	,	,	,
46745	926	6	and	and	CC
46745	926	7	between	between	IN
46745	926	8	the	the	DT
46745	926	9	tubes	tube	NNS
46745	926	10	and	and	CC
46745	926	11	cells	cell	NNS
46745	926	12	which	which	WDT
46745	926	13	are	be	VBP
46745	926	14	formed	form	VBN
46745	926	15	by	by	IN
46745	926	16	its	-PRON-	PRP$
46745	926	17	involution	involution	NN
46745	926	18	,	,	,
46745	926	19	is	be	VBZ
46745	926	20	a	a	DT
46745	926	21	close	close	JJ
46745	926	22	net	net	JJ
46745	926	23	-	-	HYPH
46745	926	24	work	work	NN
46745	926	25	of	of	IN
46745	926	26	very	very	RB
46745	926	27	small	small	JJ
46745	926	28	veins	vein	NNS
46745	926	29	,	,	,
46745	926	30	having	have	VBG
46745	926	31	thin	thin	JJ
46745	926	32	and	and	CC
46745	926	33	delicate	delicate	JJ
46745	926	34	walls	wall	NNS
46745	926	35	.	.	.
46745	927	1	Now	now	RB
46745	927	2	the	the	DT
46745	927	3	same	same	JJ
46745	927	4	forces	force	NNS
46745	927	5	,	,	,
46745	927	6	whatever	whatever	WDT
46745	927	7	they	-PRON-	PRP
46745	927	8	be	be	VBP
46745	927	9	,	,	,
46745	927	10	which	which	WDT
46745	927	11	conduct	conduct	VBP
46745	927	12	the	the	DT
46745	927	13	medicinal	medicinal	JJ
46745	927	14	solution	solution	NN
46745	927	15	through	through	IN
46745	927	16	the	the	DT
46745	927	17	mucous	mucous	JJ
46745	927	18	membrane	membrane	NN
46745	927	19	,	,	,
46745	927	20	cause	cause	VB
46745	927	21	it	-PRON-	PRP
46745	927	22	to	to	TO
46745	927	23	pass	pass	VB
46745	927	24	on	on	RP
46745	927	25	through	through	IN
46745	927	26	the	the	DT
46745	927	27	fine	fine	JJ
46745	927	28	walls	wall	NNS
46745	927	29	of	of	IN
46745	927	30	these	these	DT
46745	927	31	vessels	vessel	NNS
46745	927	32	.	.	.
46745	928	1	The	the	DT
46745	928	2	two	two	CD
46745	928	3	membranes	membrane	NNS
46745	928	4	,	,	,
46745	928	5	lying	lie	VBG
46745	928	6	in	in	IN
46745	928	7	such	such	JJ
46745	928	8	juxtaposition	juxtaposition	NN
46745	928	9	,	,	,
46745	928	10	are	be	VBP
46745	928	11	to	to	IN
46745	928	12	all	all	DT
46745	928	13	intents	intent	NNS
46745	928	14	the	the	DT
46745	928	15	same	same	JJ
46745	928	16	as	as	IN
46745	928	17	one	one	CD
46745	928	18	.	.	.
46745	929	1	Thus	thus	RB
46745	929	2	the	the	DT
46745	929	3	medicine	medicine	NN
46745	929	4	passes	pass	VBZ
46745	929	5	into	into	IN
46745	929	6	the	the	DT
46745	929	7	blood	blood	NN
46745	929	8	,	,	,
46745	929	9	and	and	CC
46745	929	10	this	this	DT
46745	929	11	is	be	VBZ
46745	929	12	the	the	DT
46745	929	13	only	only	JJ
46745	929	14	direct	direct	JJ
46745	929	15	way	way	NN
46745	929	16	by	by	IN
46745	929	17	which	which	WDT
46745	929	18	it	-PRON-	PRP
46745	929	19	can	can	MD
46745	929	20	gain	gain	VB
46745	929	21	entrance	entrance	NN
46745	929	22	into	into	IN
46745	929	23	it	-PRON-	PRP
46745	929	24	.	.	.
46745	930	1	These	these	DT
46745	930	2	small	small	JJ
46745	930	3	veins	vein	NNS
46745	930	4	,	,	,
46745	930	5	or	or	CC
46745	930	6	capillaries	capillary	NNS
46745	930	7	,	,	,
46745	930	8	lead	lead	VBP
46745	930	9	at	at	IN
46745	930	10	length	length	NN
46745	930	11	to	to	IN
46745	930	12	the	the	DT
46745	930	13	Mesenteric	mesenteric	JJ
46745	930	14	veins	vein	NNS
46745	930	15	,	,	,
46745	930	16	which	which	WDT
46745	930	17	pour	pour	VBP
46745	930	18	into	into	IN
46745	930	19	the	the	DT
46745	930	20	Portal	Portal	NNP
46745	930	21	vein	vein	NN
46745	930	22	,	,	,
46745	930	23	by	by	IN
46745	930	24	which	which	WDT
46745	930	25	the	the	DT
46745	930	26	blood	blood	NN
46745	930	27	proceeding	proceed	VBG
46745	930	28	from	from	IN
46745	930	29	them	-PRON-	PRP
46745	930	30	is	be	VBZ
46745	930	31	conducted	conduct	VBN
46745	930	32	into	into	IN
46745	930	33	the	the	DT
46745	930	34	Liver	Liver	NNP
46745	930	35	.	.	.
46745	931	1	The	the	DT
46745	931	2	process	process	NN
46745	931	3	of	of	IN
46745	931	4	Absorption	Absorption	NNP
46745	931	5	is	be	VBZ
46745	931	6	the	the	DT
46745	931	7	only	only	JJ
46745	931	8	mode	mode	NN
46745	931	9	by	by	IN
46745	931	10	which	which	WDT
46745	931	11	remedies	remedy	NNS
46745	931	12	can	can	MD
46745	931	13	thus	thus	RB
46745	931	14	enter	enter	VB
46745	931	15	the	the	DT
46745	931	16	blood	blood	NN
46745	931	17	;	;	:
46745	931	18	we	-PRON-	PRP
46745	931	19	have	have	VBP
46745	931	20	now	now	RB
46745	931	21	to	to	TO
46745	931	22	consider	consider	VB
46745	931	23	what	what	WP
46745	931	24	it	-PRON-	PRP
46745	931	25	is	be	VBZ
46745	931	26	,	,	,
46745	931	27	and	and	CC
46745	931	28	to	to	TO
46745	931	29	show	show	VB
46745	931	30	in	in	IN
46745	931	31	what	what	WDT
46745	931	32	manner	manner	NN
46745	931	33	and	and	CC
46745	931	34	by	by	IN
46745	931	35	what	what	WP
46745	931	36	agents	agent	NNS
46745	931	37	different	different	JJ
46745	931	38	medicines	medicine	NNS
46745	931	39	are	be	VBP
46745	931	40	fitted	fit	VBN
46745	931	41	to	to	TO
46745	931	42	undergo	undergo	VB
46745	931	43	it	-PRON-	PRP
46745	931	44	.	.	.
46745	932	1	The	the	DT
46745	932	2	subject	subject	NN
46745	932	3	of	of	IN
46745	932	4	this	this	DT
46745	932	5	Proposition	Proposition	NNP
46745	932	6	divides	divide	VBZ
46745	932	7	itself	-PRON-	PRP
46745	932	8	naturally	naturally	RB
46745	932	9	into	into	IN
46745	932	10	three	three	CD
46745	932	11	parts	part	NNS
46745	932	12	.	.	.
46745	933	1	We	-PRON-	PRP
46745	933	2	shall	shall	MD
46745	933	3	have	have	VB
46745	933	4	to	to	TO
46745	933	5	consider--1	consider--1	VB
46745	933	6	.	.	.
46745	934	1	What	what	WP
46745	934	2	is	be	VBZ
46745	934	3	the	the	DT
46745	934	4	nature	nature	NN
46745	934	5	,	,	,
46745	934	6	and	and	CC
46745	934	7	what	what	WP
46745	934	8	the	the	DT
46745	934	9	function	function	NN
46745	934	10	,	,	,
46745	934	11	of	of	IN
46745	934	12	the	the	DT
46745	934	13	gastric	gastric	JJ
46745	934	14	and	and	CC
46745	934	15	intestinal	intestinal	JJ
46745	934	16	secretions	secretion	NNS
46745	934	17	.	.	.
46745	935	1	2	2	LS
46745	935	2	.	.	.
46745	936	1	The	the	DT
46745	936	2	laws	law	NNS
46745	936	3	of	of	IN
46745	936	4	this	this	DT
46745	936	5	process	process	NN
46745	936	6	of	of	IN
46745	936	7	Endosmotic	endosmotic	JJ
46745	936	8	absorption	absorption	NN
46745	936	9	,	,	,
46745	936	10	and	and	CC
46745	936	11	how	how	WRB
46745	936	12	they	-PRON-	PRP
46745	936	13	are	be	VBP
46745	936	14	fulfilled	fulfil	VBN
46745	936	15	in	in	IN
46745	936	16	this	this	DT
46745	936	17	case	case	NN
46745	936	18	;	;	:
46745	936	19	and	and	CC
46745	936	20	,	,	,
46745	936	21	3	3	CD
46745	936	22	.	.	.
46745	937	1	The	the	DT
46745	937	2	mode	mode	NN
46745	937	3	in	in	IN
46745	937	4	which	which	WDT
46745	937	5	the	the	DT
46745	937	6	great	great	JJ
46745	937	7	majority	majority	NN
46745	937	8	of	of	IN
46745	937	9	medicines	medicine	NNS
46745	937	10	are	be	VBP
46745	937	11	reduced	reduce	VBN
46745	937	12	to	to	IN
46745	937	13	a	a	DT
46745	937	14	state	state	NN
46745	937	15	of	of	IN
46745	937	16	solution	solution	NN
46745	937	17	,	,	,
46745	937	18	which	which	WDT
46745	937	19	is	be	VBZ
46745	937	20	necessary	necessary	JJ
46745	937	21	before	before	IN
46745	937	22	they	-PRON-	PRP
46745	937	23	can	can	MD
46745	937	24	be	be	VB
46745	937	25	absorbed	absorb	VBN
46745	937	26	.	.	.
46745	938	1	The	the	DT
46745	938	2	process	process	NN
46745	938	3	of	of	IN
46745	938	4	stomach	stomach	NN
46745	938	5	-	-	HYPH
46745	938	6	digestion	digestion	NN
46745	938	7	has	have	VBZ
46745	938	8	been	be	VBN
46745	938	9	cleared	clear	VBN
46745	938	10	up	up	RP
46745	938	11	of	of	IN
46745	938	12	late	late	JJ
46745	938	13	years	year	NNS
46745	938	14	by	by	IN
46745	938	15	the	the	DT
46745	938	16	decisive	decisive	JJ
46745	938	17	experiments	experiment	NNS
46745	938	18	of	of	IN
46745	938	19	Spallanzani	Spallanzani	NNP
46745	938	20	and	and	CC
46745	938	21	Réaumur	Réaumur	NNP
46745	938	22	,	,	,
46745	938	23	of	of	IN
46745	938	24	Tiedemann	Tiedemann	NNP
46745	938	25	and	and	CC
46745	938	26	Gmelin	Gmelin	NNP
46745	938	27	,	,	,
46745	938	28	and	and	CC
46745	938	29	of	of	IN
46745	938	30	Dr.	Dr.	NNP
46745	938	31	Beaumont	Beaumont	NNP
46745	938	32	of	of	IN
46745	938	33	Canada	Canada	NNP
46745	938	34	.	.	.
46745	939	1	Immediately	immediately	RB
46745	939	2	that	that	IN
46745	939	3	a	a	DT
46745	939	4	substance	substance	NN
46745	939	5	touches	touch	VBZ
46745	939	6	the	the	DT
46745	939	7	mucous	mucous	JJ
46745	939	8	surface	surface	NN
46745	939	9	of	of	IN
46745	939	10	the	the	DT
46745	939	11	stomach	stomach	NN
46745	939	12	it	-PRON-	PRP
46745	939	13	causes	cause	VBZ
46745	939	14	the	the	DT
46745	939	15	copious	copious	JJ
46745	939	16	outpouring	outpouring	NN
46745	939	17	of	of	IN
46745	939	18	a	a	DT
46745	939	19	thin	thin	JJ
46745	939	20	fluid	fluid	NN
46745	939	21	,	,	,
46745	939	22	which	which	WDT
46745	939	23	is	be	VBZ
46745	939	24	secreted	secrete	VBN
46745	939	25	by	by	IN
46745	939	26	a	a	DT
46745	939	27	glandular	glandular	JJ
46745	939	28	apparatus	apparatus	NN
46745	939	29	.	.	.
46745	940	1	This	this	DT
46745	940	2	gastric	gastric	JJ
46745	940	3	juice	juice	NN
46745	940	4	is	be	VBZ
46745	940	5	highly	highly	RB
46745	940	6	acid	acid	JJ
46745	940	7	,	,	,
46745	940	8	and	and	CC
46745	940	9	contains	contain	VBZ
46745	940	10	besides	besides	IN
46745	940	11	a	a	DT
46745	940	12	peculiar	peculiar	JJ
46745	940	13	nitrogenous	nitrogenous	JJ
46745	940	14	substance	substance	NN
46745	940	15	called	call	VBN
46745	940	16	Pepsin	Pepsin	NNP
46745	940	17	.	.	.
46745	941	1	Dr.	Dr.	NNP
46745	941	2	Prout	Prout	NNP
46745	941	3	thought	think	VBD
46745	941	4	that	that	IN
46745	941	5	the	the	DT
46745	941	6	reaction	reaction	NN
46745	941	7	was	be	VBD
46745	941	8	due	due	JJ
46745	941	9	to	to	IN
46745	941	10	free	free	JJ
46745	941	11	Hydrochloric	Hydrochloric	NNP
46745	941	12	acid	acid	NN
46745	941	13	.	.	.
46745	942	1	But	but	CC
46745	942	2	it	-PRON-	PRP
46745	942	3	seems	seem	VBZ
46745	942	4	more	more	RBR
46745	942	5	likely	likely	JJ
46745	942	6	that	that	IN
46745	942	7	it	-PRON-	PRP
46745	942	8	is	be	VBZ
46745	942	9	due	due	JJ
46745	942	10	to	to	IN
46745	942	11	Lactic	lactic	JJ
46745	942	12	acid	acid	NN
46745	942	13	.	.	.
46745	943	1	Such	such	JJ
46745	943	2	at	at	IN
46745	943	3	least	least	JJS
46745	943	4	is	be	VBZ
46745	943	5	the	the	DT
46745	943	6	opinion	opinion	NN
46745	943	7	entertained	entertain	VBD
46745	943	8	both	both	CC
46745	943	9	by	by	IN
46745	943	10	Liebig	Liebig	NNP
46745	943	11	and	and	CC
46745	943	12	Lehmann	Lehmann	NNP
46745	943	13	.	.	.
46745	944	1	Now	now	RB
46745	944	2	the	the	DT
46745	944	3	result	result	NN
46745	944	4	of	of	IN
46745	944	5	the	the	DT
46745	944	6	action	action	NN
46745	944	7	of	of	IN
46745	944	8	this	this	DT
46745	944	9	fluid	fluid	NN
46745	944	10	is	be	VBZ
46745	944	11	to	to	TO
46745	944	12	dissolve	dissolve	VB
46745	944	13	down	down	RP
46745	944	14	the	the	DT
46745	944	15	solid	solid	JJ
46745	944	16	materials	material	NNS
46745	944	17	of	of	IN
46745	944	18	the	the	DT
46745	944	19	food	food	NN
46745	944	20	,	,	,
46745	944	21	or	or	CC
46745	944	22	other	other	JJ
46745	944	23	substances	substance	NNS
46745	944	24	presented	present	VBN
46745	944	25	to	to	IN
46745	944	26	it	-PRON-	PRP
46745	944	27	,	,	,
46745	944	28	reducing	reduce	VBG
46745	944	29	them	-PRON-	PRP
46745	944	30	to	to	IN
46745	944	31	a	a	DT
46745	944	32	thin	thin	JJ
46745	944	33	watery	watery	JJ
46745	944	34	pulp	pulp	NN
46745	944	35	.	.	.
46745	945	1	This	this	DT
46745	945	2	pulp	pulp	NN
46745	945	3	is	be	VBZ
46745	945	4	then	then	RB
46745	945	5	mainly	mainly	RB
46745	945	6	absorbed	absorb	VBN
46745	945	7	;	;	:
46745	945	8	and	and	CC
46745	945	9	that	that	DT
46745	945	10	which	which	WDT
46745	945	11	is	be	VBZ
46745	945	12	not	not	RB
46745	945	13	taken	take	VBN
46745	945	14	up	up	RP
46745	945	15	through	through	IN
46745	945	16	the	the	DT
46745	945	17	coat	coat	NN
46745	945	18	of	of	IN
46745	945	19	the	the	DT
46745	945	20	stomach	stomach	NN
46745	945	21	is	be	VBZ
46745	945	22	absorbed	absorb	VBN
46745	945	23	in	in	IN
46745	945	24	the	the	DT
46745	945	25	earlier	early	JJR
46745	945	26	portion	portion	NN
46745	945	27	of	of	IN
46745	945	28	the	the	DT
46745	945	29	intestinal	intestinal	JJ
46745	945	30	canal	canal	NN
46745	945	31	.	.	.
46745	946	1	I	-PRON-	PRP
46745	946	2	shall	shall	MD
46745	946	3	have	have	VB
46745	946	4	to	to	TO
46745	946	5	treat	treat	VB
46745	946	6	of	of	IN
46745	946	7	Aliments	aliment	NNS
46745	946	8	as	as	IN
46745	946	9	one	one	CD
46745	946	10	of	of	IN
46745	946	11	the	the	DT
46745	946	12	orders	order	NNS
46745	946	13	of	of	IN
46745	946	14	Restorative	Restorative	NNP
46745	946	15	Hæmatics	Hæmatics	NNPS
46745	946	16	.	.	.
46745	947	1	We	-PRON-	PRP
46745	947	2	are	be	VBP
46745	947	3	now	now	RB
46745	947	4	concerned	concerned	JJ
46745	947	5	with	with	IN
46745	947	6	medicines	medicine	NNS
46745	947	7	in	in	IN
46745	947	8	general	general	JJ
46745	947	9	.	.	.
46745	948	1	The	the	DT
46745	948	2	same	same	JJ
46745	948	3	juice	juice	NN
46745	948	4	is	be	VBZ
46745	948	5	poured	pour	VBN
46745	948	6	out	out	RP
46745	948	7	to	to	TO
46745	948	8	receive	receive	VB
46745	948	9	them	-PRON-	PRP
46745	948	10	.	.	.
46745	949	1	Such	such	JJ
46745	949	2	as	as	IN
46745	949	3	are	be	VBP
46745	949	4	dissolved	dissolve	VBN
46745	949	5	by	by	IN
46745	949	6	it	-PRON-	PRP
46745	949	7	are	be	VBP
46745	949	8	immediately	immediately	RB
46745	949	9	absorbed	absorb	VBN
46745	949	10	.	.	.
46745	950	1	Some	some	DT
46745	950	2	other	other	JJ
46745	950	3	matters	matter	NNS
46745	950	4	may	may	MD
46745	950	5	be	be	VB
46745	950	6	rendered	render	VBN
46745	950	7	soluble	soluble	JJ
46745	950	8	by	by	IN
46745	950	9	the	the	DT
46745	950	10	agency	agency	NN
46745	950	11	of	of	IN
46745	950	12	the	the	DT
46745	950	13	Bile	Bile	NNP
46745	950	14	and	and	CC
46745	950	15	Pancreatic	pancreatic	JJ
46745	950	16	juice	juice	NN
46745	950	17	which	which	WDT
46745	950	18	are	be	VBP
46745	950	19	poured	pour	VBN
46745	950	20	out	out	RP
46745	950	21	into	into	IN
46745	950	22	the	the	DT
46745	950	23	middle	middle	NN
46745	950	24	of	of	IN
46745	950	25	the	the	DT
46745	950	26	Duodenum	Duodenum	NNP
46745	950	27	.	.	.
46745	951	1	The	the	DT
46745	951	2	former	former	JJ
46745	951	3	is	be	VBZ
46745	951	4	an	an	DT
46745	951	5	alkaline	alkaline	NN
46745	951	6	fluid	fluid	NN
46745	951	7	,	,	,
46745	951	8	containing	contain	VBG
46745	951	9	carbonate	carbonate	NN
46745	951	10	of	of	IN
46745	951	11	Soda	Soda	NNP
46745	951	12	.	.	.
46745	952	1	The	the	DT
46745	952	2	Pancreatic	pancreatic	JJ
46745	952	3	juice	juice	NN
46745	952	4	is	be	VBZ
46745	952	5	also	also	RB
46745	952	6	said	say	VBN
46745	952	7	to	to	TO
46745	952	8	be	be	VB
46745	952	9	alkaline	alkaline	NN
46745	952	10	.	.	.
46745	953	1	That	that	IN
46745	953	2	the	the	DT
46745	953	3	stomach	stomach	NN
46745	953	4	is	be	VBZ
46745	953	5	absorbent	absorbent	JJ
46745	953	6	may	may	MD
46745	953	7	be	be	VB
46745	953	8	proved	prove	VBN
46745	953	9	by	by	IN
46745	953	10	the	the	DT
46745	953	11	experiment	experiment	NN
46745	953	12	of	of	IN
46745	953	13	placing	place	VBG
46745	953	14	a	a	DT
46745	953	15	ligature	ligature	NN
46745	953	16	round	round	IN
46745	953	17	the	the	DT
46745	953	18	intestine	intestine	NN
46745	953	19	of	of	IN
46745	953	20	a	a	DT
46745	953	21	dog	dog	NN
46745	953	22	,	,	,
46745	953	23	just	just	RB
46745	953	24	below	below	IN
46745	953	25	the	the	DT
46745	953	26	pylorus	pylorus	NN
46745	953	27	.	.	.
46745	954	1	It	-PRON-	PRP
46745	954	2	is	be	VBZ
46745	954	3	then	then	RB
46745	954	4	found	find	VBN
46745	954	5	that	that	IN
46745	954	6	soluble	soluble	JJ
46745	954	7	substances	substance	NNS
46745	954	8	placed	place	VBN
46745	954	9	in	in	IN
46745	954	10	the	the	DT
46745	954	11	stomach	stomach	NN
46745	954	12	pass	pass	VB
46745	954	13	rapidly	rapidly	RB
46745	954	14	from	from	IN
46745	954	15	it	-PRON-	PRP
46745	954	16	into	into	IN
46745	954	17	the	the	DT
46745	954	18	circulation	circulation	NN
46745	954	19	.	.	.
46745	955	1	It	-PRON-	PRP
46745	955	2	is	be	VBZ
46745	955	3	probable	probable	JJ
46745	955	4	that	that	IN
46745	955	5	all	all	DT
46745	955	6	substances	substance	NNS
46745	955	7	which	which	WDT
46745	955	8	are	be	VBP
46745	955	9	easily	easily	RB
46745	955	10	dissolved	dissolve	VBN
46745	955	11	pass	pass	NN
46745	955	12	through	through	IN
46745	955	13	the	the	DT
46745	955	14	coats	coat	NNS
46745	955	15	of	of	IN
46745	955	16	the	the	DT
46745	955	17	stomach	stomach	NN
46745	955	18	.	.	.
46745	956	1	That	that	IN
46745	956	2	the	the	DT
46745	956	3	surface	surface	NN
46745	956	4	of	of	IN
46745	956	5	the	the	DT
46745	956	6	intestines	intestine	NNS
46745	956	7	is	be	VBZ
46745	956	8	absorbent	absorbent	JJ
46745	956	9	may	may	MD
46745	956	10	be	be	VB
46745	956	11	proved	prove	VBN
46745	956	12	by	by	IN
46745	956	13	the	the	DT
46745	956	14	disappearance	disappearance	NN
46745	956	15	of	of	IN
46745	956	16	enemata	enemata	JJ
46745	956	17	thrown	throw	VBN
46745	956	18	into	into	IN
46745	956	19	them	-PRON-	PRP
46745	956	20	.	.	.
46745	957	1	Liebig	Liebig	NNP
46745	957	2	states	state	VBZ
46745	957	3	that	that	IN
46745	957	4	a	a	DT
46745	957	5	solution	solution	NN
46745	957	6	of	of	IN
46745	957	7	common	common	JJ
46745	957	8	salt	salt	NN
46745	957	9	,	,	,
46745	957	10	in	in	IN
46745	957	11	the	the	DT
46745	957	12	proportion	proportion	NN
46745	957	13	of	of	IN
46745	957	14	one	one	CD
46745	957	15	part	part	NN
46745	957	16	to	to	IN
46745	957	17	eighty	eighty	CD
46745	957	18	of	of	IN
46745	957	19	water	water	NN
46745	957	20	,	,	,
46745	957	21	disappeared	disappear	VBD
46745	957	22	so	so	RB
46745	957	23	completely	completely	RB
46745	957	24	in	in	IN
46745	957	25	the	the	DT
46745	957	26	rectum	rectum	NN
46745	957	27	that	that	IN
46745	957	28	an	an	DT
46745	957	29	evacuation	evacuation	NN
46745	957	30	one	one	CD
46745	957	31	hour	hour	NN
46745	957	32	afterwards	afterwards	RB
46745	957	33	was	be	VBD
46745	957	34	found	find	VBN
46745	957	35	to	to	TO
46745	957	36	contain	contain	VB
46745	957	37	no	no	DT
46745	957	38	more	more	JJR
46745	957	39	than	than	IN
46745	957	40	the	the	DT
46745	957	41	usual	usual	JJ
46745	957	42	proportion	proportion	NN
46745	957	43	of	of	IN
46745	957	44	salt	salt	NN
46745	957	45	.	.	.
46745	958	1	(	(	-LRB-
46745	958	2	_	_	NNP
46745	958	3	Animal	Animal	NNP
46745	958	4	Chemistry	Chemistry	NNP
46745	958	5	_	_	NNP
46745	958	6	,	,	,
46745	958	7	_	_	NNP
46745	958	8	p.	p.	NNP
46745	958	9	_	_	NNP
46745	958	10	77	77	CD
46745	958	11	.	.	.
46745	958	12	)	)	-RRB-
46745	959	1	On	on	IN
46745	959	2	the	the	DT
46745	959	3	mucous	mucous	JJ
46745	959	4	surface	surface	NN
46745	959	5	of	of	IN
46745	959	6	the	the	DT
46745	959	7	small	small	JJ
46745	959	8	intestines	intestine	NNS
46745	959	9	are	be	VBP
46745	959	10	a	a	DT
46745	959	11	number	number	NN
46745	959	12	of	of	IN
46745	959	13	small	small	JJ
46745	959	14	projections	projection	NNS
46745	959	15	,	,	,
46745	959	16	called	call	VBD
46745	959	17	Villi	Villi	NNP
46745	959	18	.	.	.
46745	960	1	Within	within	IN
46745	960	2	these	these	DT
46745	960	3	are	be	VBP
46745	960	4	the	the	DT
46745	960	5	origins	origin	NNS
46745	960	6	of	of	IN
46745	960	7	the	the	DT
46745	960	8	Lacteals	Lacteals	NNPS
46745	960	9	,	,	,
46745	960	10	a	a	DT
46745	960	11	peculiar	peculiar	JJ
46745	960	12	set	set	NN
46745	960	13	of	of	IN
46745	960	14	Lymphatic	lymphatic	JJ
46745	960	15	vessels	vessel	NNS
46745	960	16	,	,	,
46745	960	17	which	which	WDT
46745	960	18	are	be	VBP
46745	960	19	engaged	engage	VBN
46745	960	20	in	in	IN
46745	960	21	the	the	DT
46745	960	22	absorption	absorption	NN
46745	960	23	of	of	IN
46745	960	24	chyle	chyle	NN
46745	960	25	.	.	.
46745	961	1	This	this	DT
46745	961	2	chyle	chyle	NN
46745	961	3	is	be	VBZ
46745	961	4	a	a	DT
46745	961	5	thick	thick	JJ
46745	961	6	fluid	fluid	NN
46745	961	7	which	which	WDT
46745	961	8	is	be	VBZ
46745	961	9	formed	form	VBN
46745	961	10	by	by	IN
46745	961	11	the	the	DT
46745	961	12	meeting	meeting	NN
46745	961	13	of	of	IN
46745	961	14	the	the	DT
46745	961	15	Bile	Bile	NNP
46745	961	16	and	and	CC
46745	961	17	Pancreatic	pancreatic	JJ
46745	961	18	juice	juice	NN
46745	961	19	with	with	IN
46745	961	20	that	that	DT
46745	961	21	part	part	NN
46745	961	22	of	of	IN
46745	961	23	the	the	DT
46745	961	24	digested	digested	JJ
46745	961	25	food	food	NN
46745	961	26	which	which	WDT
46745	961	27	passes	pass	VBZ
46745	961	28	into	into	IN
46745	961	29	the	the	DT
46745	961	30	Duodenum	Duodenum	NNP
46745	961	31	.	.	.
46745	962	1	It	-PRON-	PRP
46745	962	2	is	be	VBZ
46745	962	3	generally	generally	RB
46745	962	4	white	white	JJ
46745	962	5	,	,	,
46745	962	6	from	from	IN
46745	962	7	the	the	DT
46745	962	8	presence	presence	NN
46745	962	9	of	of	IN
46745	962	10	fat	fat	NN
46745	962	11	.	.	.
46745	963	1	Now	now	RB
46745	963	2	these	these	DT
46745	963	3	lacteal	lacteal	NN
46745	963	4	vessels	vessel	NNS
46745	963	5	are	be	VBP
46745	963	6	no	no	RB
46745	963	7	doubt	doubt	RB
46745	963	8	absorbent	absorbent	JJ
46745	963	9	,	,	,
46745	963	10	but	but	CC
46745	963	11	are	be	VBP
46745	963	12	they	-PRON-	PRP
46745	963	13	ever	ever	RB
46745	963	14	engaged	engage	VBN
46745	963	15	in	in	IN
46745	963	16	the	the	DT
46745	963	17	absorption	absorption	NN
46745	963	18	of	of	IN
46745	963	19	medicinal	medicinal	JJ
46745	963	20	solutions	solution	NNS
46745	963	21	?	?	.
46745	964	1	It	-PRON-	PRP
46745	964	2	seems	seem	VBZ
46745	964	3	that	that	IN
46745	964	4	they	-PRON-	PRP
46745	964	5	are	be	VBP
46745	964	6	not	not	RB
46745	964	7	in	in	IN
46745	964	8	ordinary	ordinary	JJ
46745	964	9	cases	case	NNS
46745	964	10	at	at	RB
46745	964	11	all	all	RB
46745	964	12	concerned	concerned	JJ
46745	964	13	in	in	IN
46745	964	14	this	this	DT
46745	964	15	;	;	:
46745	964	16	for	for	IN
46745	964	17	three	three	CD
46745	964	18	chief	chief	JJ
46745	964	19	reasons	reason	NNS
46745	964	20	.	.	.
46745	965	1	In	in	IN
46745	965	2	the	the	DT
46745	965	3	first	first	JJ
46745	965	4	place	place	NN
46745	965	5	it	-PRON-	PRP
46745	965	6	appears	appear	VBZ
46745	965	7	from	from	IN
46745	965	8	the	the	DT
46745	965	9	researches	research	NNS
46745	965	10	of	of	IN
46745	965	11	Bernard	Bernard	NNP
46745	965	12	and	and	CC
46745	965	13	others	other	NNS
46745	965	14	that	that	IN
46745	965	15	the	the	DT
46745	965	16	lacteal	lacteal	NN
46745	965	17	system	system	NN
46745	965	18	is	be	VBZ
46745	965	19	a	a	DT
46745	965	20	special	special	JJ
46745	965	21	arrangement	arrangement	NN
46745	965	22	for	for	IN
46745	965	23	the	the	DT
46745	965	24	absorption	absorption	NN
46745	965	25	of	of	IN
46745	965	26	fatty	fatty	NN
46745	965	27	substances	substance	NNS
46745	965	28	,	,	,
46745	965	29	and	and	CC
46745	965	30	that	that	IN
46745	965	31	other	other	JJ
46745	965	32	matters	matter	NNS
46745	965	33	,	,	,
46745	965	34	such	such	JJ
46745	965	35	as	as	IN
46745	965	36	albuminous	albuminous	JJ
46745	965	37	compounds	compound	NNS
46745	965	38	,	,	,
46745	965	39	pass	pass	VB
46745	965	40	generally	generally	RB
46745	965	41	into	into	IN
46745	965	42	the	the	DT
46745	965	43	veins	vein	NNS
46745	965	44	,	,	,
46745	965	45	and	and	CC
46745	965	46	thence	thence	NN
46745	965	47	to	to	IN
46745	965	48	the	the	DT
46745	965	49	liver	liver	NN
46745	965	50	.	.	.
46745	966	1	Besides	besides	RB
46745	966	2	,	,	,
46745	966	3	it	-PRON-	PRP
46745	966	4	seems	seem	VBZ
46745	966	5	that	that	IN
46745	966	6	these	these	DT
46745	966	7	lacteal	lacteal	NN
46745	966	8	absorbents	absorbent	NNS
46745	966	9	are	be	VBP
46745	966	10	only	only	RB
46745	966	11	in	in	IN
46745	966	12	action	action	NN
46745	966	13	during	during	IN
46745	966	14	the	the	DT
46745	966	15	digestion	digestion	NN
46745	966	16	of	of	IN
46745	966	17	food	food	NN
46745	966	18	,	,	,
46745	966	19	when	when	WRB
46745	966	20	the	the	DT
46745	966	21	epithelium	epithelium	NN
46745	966	22	on	on	IN
46745	966	23	the	the	DT
46745	966	24	surface	surface	NN
46745	966	25	of	of	IN
46745	966	26	each	each	DT
46745	966	27	villus	villus	NN
46745	966	28	becomes	become	VBZ
46745	966	29	loosened	loosen	VBN
46745	966	30	,	,	,
46745	966	31	in	in	IN
46745	966	32	order	order	NN
46745	966	33	to	to	TO
46745	966	34	allow	allow	VB
46745	966	35	to	to	IN
46745	966	36	the	the	DT
46745	966	37	chyle	chyle	NN
46745	966	38	an	an	DT
46745	966	39	easier	easy	JJR
46745	966	40	access	access	NN
46745	966	41	to	to	IN
46745	966	42	the	the	DT
46745	966	43	lacteal	lacteal	NN
46745	966	44	within	within	IN
46745	966	45	it	-PRON-	PRP
46745	966	46	.	.	.
46745	967	1	[	[	-LRB-
46745	967	2	21	21	CD
46745	967	3	]	]	-RRB-
46745	967	4	So	so	IN
46745	967	5	that	that	IN
46745	967	6	it	-PRON-	PRP
46745	967	7	is	be	VBZ
46745	967	8	likely	likely	JJ
46745	967	9	that	that	IN
46745	967	10	a	a	DT
46745	967	11	small	small	JJ
46745	967	12	portion	portion	NN
46745	967	13	of	of	IN
46745	967	14	a	a	DT
46745	967	15	fluid	fluid	JJ
46745	967	16	or	or	CC
46745	967	17	soluble	soluble	JJ
46745	967	18	substance	substance	NN
46745	967	19	would	would	MD
46745	967	20	be	be	VB
46745	967	21	insufficient	insufficient	JJ
46745	967	22	to	to	TO
46745	967	23	rouse	rouse	VB
46745	967	24	them	-PRON-	PRP
46745	967	25	to	to	IN
46745	967	26	action	action	NN
46745	967	27	.	.	.
46745	968	1	And	and	CC
46745	968	2	,	,	,
46745	968	3	inthe	inthe	DT
46745	968	4	third	third	JJ
46745	968	5	place	place	NN
46745	968	6	,	,	,
46745	968	7	direct	direct	JJ
46745	968	8	experiments	experiment	NNS
46745	968	9	of	of	IN
46745	968	10	a	a	DT
46745	968	11	decisive	decisive	JJ
46745	968	12	kind	kind	NN
46745	968	13	have	have	VBP
46745	968	14	been	be	VBN
46745	968	15	made	make	VBN
46745	968	16	on	on	IN
46745	968	17	this	this	DT
46745	968	18	point	point	NN
46745	968	19	.	.	.
46745	969	1	Magendie	Magendie	NNP
46745	969	2	has	have	VBZ
46745	969	3	found	find	VBN
46745	969	4	that	that	IN
46745	969	5	the	the	DT
46745	969	6	ligature	ligature	NN
46745	969	7	of	of	IN
46745	969	8	the	the	DT
46745	969	9	lacteal	lacteal	NN
46745	969	10	trunks	trunk	NNS
46745	969	11	does	do	VBZ
46745	969	12	not	not	RB
46745	969	13	prevent	prevent	VB
46745	969	14	the	the	DT
46745	969	15	occurrence	occurrence	NN
46745	969	16	of	of	IN
46745	969	17	poisoning	poisoning	NN
46745	969	18	from	from	IN
46745	969	19	agents	agent	NNS
46745	969	20	introduced	introduce	VBN
46745	969	21	into	into	IN
46745	969	22	the	the	DT
46745	969	23	bowels	bowel	NNS
46745	969	24	.	.	.
46745	970	1	And	and	CC
46745	970	2	Tiedemann	Tiedemann	NNP
46745	970	3	and	and	CC
46745	970	4	Gmelin	Gmelin	NNP
46745	970	5	have	have	VBP
46745	970	6	carefully	carefully	RB
46745	970	7	sought	seek	VBN
46745	970	8	in	in	IN
46745	970	9	the	the	DT
46745	970	10	chyle	chyle	NN
46745	970	11	for	for	IN
46745	970	12	a	a	DT
46745	970	13	number	number	NN
46745	970	14	of	of	IN
46745	970	15	different	different	JJ
46745	970	16	medicines	medicine	NNS
46745	970	17	administered	administer	VBN
46745	970	18	to	to	IN
46745	970	19	animals	animal	NNS
46745	970	20	in	in	IN
46745	970	21	their	-PRON-	PRP$
46745	970	22	food	food	NN
46745	970	23	,	,	,
46745	970	24	and	and	CC
46745	970	25	have	have	VBP
46745	970	26	been	be	VBN
46745	970	27	unable	unable	JJ
46745	970	28	to	to	TO
46745	970	29	detect	detect	VB
46745	970	30	any	any	DT
46745	970	31	of	of	IN
46745	970	32	them	-PRON-	PRP
46745	970	33	there	there	RB
46745	970	34	.	.	.
46745	971	1	So	so	RB
46745	971	2	that	that	DT
46745	971	3	,	,	,
46745	971	4	with	with	IN
46745	971	5	the	the	DT
46745	971	6	exception	exception	NN
46745	971	7	perhaps	perhaps	RB
46745	971	8	of	of	IN
46745	971	9	fats	fat	NNS
46745	971	10	and	and	CC
46745	971	11	fixed	fix	VBN
46745	971	12	oils	oil	NNS
46745	971	13	,	,	,
46745	971	14	we	-PRON-	PRP
46745	971	15	may	may	MD
46745	971	16	reasonably	reasonably	RB
46745	971	17	conclude	conclude	VB
46745	971	18	that	that	IN
46745	971	19	no	no	DT
46745	971	20	medicinal	medicinal	JJ
46745	971	21	substances	substance	NNS
46745	971	22	pass	pass	VBP
46745	971	23	into	into	IN
46745	971	24	the	the	DT
46745	971	25	system	system	NN
46745	971	26	through	through	IN
46745	971	27	the	the	DT
46745	971	28	lacteals	lacteal	NNS
46745	971	29	,	,	,
46745	971	30	but	but	CC
46745	971	31	that	that	IN
46745	971	32	all	all	DT
46745	971	33	are	be	VBP
46745	971	34	absorbed	absorb	VBN
46745	971	35	by	by	IN
46745	971	36	the	the	DT
46745	971	37	veins	vein	NNS
46745	971	38	or	or	CC
46745	971	39	capillary	capillary	JJ
46745	971	40	vessels	vessel	NNS
46745	971	41	.	.	.
46745	972	1	[	[	-LRB-
46745	972	2	22	22	CD
46745	972	3	]	]	-RRB-
46745	972	4	It	-PRON-	PRP
46745	972	5	seems	seem	VBZ
46745	972	6	probable	probable	JJ
46745	972	7	that	that	IN
46745	972	8	the	the	DT
46745	972	9	Bile	Bile	NNP
46745	972	10	and	and	CC
46745	972	11	Pancreatic	pancreatic	JJ
46745	972	12	juice	juice	NN
46745	972	13	may	may	MD
46745	972	14	be	be	VB
46745	972	15	engaged	engage	VBN
46745	972	16	in	in	IN
46745	972	17	reducing	reduce	VBG
46745	972	18	to	to	IN
46745	972	19	a	a	DT
46745	972	20	soluble	soluble	JJ
46745	972	21	state	state	NN
46745	972	22	certain	certain	JJ
46745	972	23	medicines	medicine	NNS
46745	972	24	that	that	WDT
46745	972	25	are	be	VBP
46745	972	26	insoluble	insoluble	JJ
46745	972	27	in	in	IN
46745	972	28	the	the	DT
46745	972	29	Gastric	Gastric	NNP
46745	972	30	secretion	secretion	NN
46745	972	31	,	,	,
46745	972	32	and	and	CC
46745	972	33	may	may	MD
46745	972	34	thus	thus	RB
46745	972	35	procure	procure	VB
46745	972	36	the	the	DT
46745	972	37	absorption	absorption	NN
46745	972	38	of	of	IN
46745	972	39	these	these	DT
46745	972	40	substances	substance	NNS
46745	972	41	by	by	IN
46745	972	42	the	the	DT
46745	972	43	veins	vein	NNS
46745	972	44	of	of	IN
46745	972	45	the	the	DT
46745	972	46	intestinal	intestinal	JJ
46745	972	47	canal	canal	NN
46745	972	48	.	.	.
46745	973	1	Having	have	VBG
46745	973	2	briefly	briefly	RB
46745	973	3	considered	consider	VBN
46745	973	4	the	the	DT
46745	973	5	secretions	secretion	NNS
46745	973	6	which	which	WDT
46745	973	7	meet	meet	VBP
46745	973	8	the	the	DT
46745	973	9	medicine	medicine	NN
46745	973	10	on	on	IN
46745	973	11	its	-PRON-	PRP$
46745	973	12	first	first	JJ
46745	973	13	entrance	entrance	NN
46745	973	14	into	into	IN
46745	973	15	the	the	DT
46745	973	16	system	system	NN
46745	973	17	,	,	,
46745	973	18	we	-PRON-	PRP
46745	973	19	are	be	VBP
46745	973	20	next	next	JJ
46745	973	21	to	to	TO
46745	973	22	inquire	inquire	VB
46745	973	23	into	into	IN
46745	973	24	the	the	DT
46745	973	25	manner	manner	NN
46745	973	26	in	in	IN
46745	973	27	which	which	WDT
46745	973	28	this	this	DT
46745	973	29	medicine	medicine	NN
46745	973	30	gains	gain	VBZ
46745	973	31	admission	admission	NN
46745	973	32	into	into	IN
46745	973	33	the	the	DT
46745	973	34	blood	blood	NN
46745	973	35	.	.	.
46745	974	1	In	in	IN
46745	974	2	the	the	DT
46745	974	3	first	first	JJ
46745	974	4	place	place	NN
46745	974	5	,	,	,
46745	974	6	it	-PRON-	PRP
46745	974	7	must	must	MD
46745	974	8	be	be	VB
46745	974	9	in	in	IN
46745	974	10	a	a	DT
46745	974	11	fluid	fluid	JJ
46745	974	12	state	state	NN
46745	974	13	,	,	,
46745	974	14	or	or	CC
46745	974	15	it	-PRON-	PRP
46745	974	16	can	can	MD
46745	974	17	not	not	RB
46745	974	18	be	be	VB
46745	974	19	absorbed	absorb	VBN
46745	974	20	at	at	RB
46745	974	21	all	all	RB
46745	974	22	.	.	.
46745	975	1	It	-PRON-	PRP
46745	975	2	will	will	MD
46745	975	3	be	be	VB
46745	975	4	most	most	RBS
46745	975	5	convenient	convenient	JJ
46745	975	6	to	to	TO
46745	975	7	consider	consider	VB
46745	975	8	afterwards	afterwards	RB
46745	975	9	how	how	WRB
46745	975	10	different	different	JJ
46745	975	11	remedies	remedy	NNS
46745	975	12	are	be	VBP
46745	975	13	to	to	TO
46745	975	14	be	be	VB
46745	975	15	reduced	reduce	VBN
46745	975	16	to	to	IN
46745	975	17	this	this	DT
46745	975	18	condition	condition	NN
46745	975	19	.	.	.
46745	976	1	Now	now	RB
46745	976	2	the	the	DT
46745	976	3	force	force	NN
46745	976	4	or	or	CC
46745	976	5	process	process	NN
46745	976	6	by	by	IN
46745	976	7	which	which	WDT
46745	976	8	fluids	fluid	NNS
46745	976	9	are	be	VBP
46745	976	10	enabled	enable	VBN
46745	976	11	to	to	TO
46745	976	12	pass	pass	VB
46745	976	13	and	and	CC
46745	976	14	repass	repass	VB
46745	976	15	through	through	IN
46745	976	16	an	an	DT
46745	976	17	animal	animal	NN
46745	976	18	membrane	membrane	NN
46745	976	19	,	,	,
46745	976	20	has	have	VBZ
46745	976	21	been	be	VBN
46745	976	22	named	name	VBN
46745	976	23	by	by	IN
46745	976	24	Dutrochet	Dutrochet	NNP
46745	976	25	_	_	NNP
46745	976	26	Endosmose	Endosmose	NNP
46745	976	27	_	_	NNP
46745	976	28	and	and	CC
46745	976	29	_	_	NNP
46745	976	30	Exosmose	Exosmose	NNP
46745	976	31	_	_	NNP
46745	976	32	,	,	,
46745	976	33	according	accord	VBG
46745	976	34	as	as	IN
46745	976	35	the	the	DT
46745	976	36	current	current	JJ
46745	976	37	tends	tend	VBZ
46745	976	38	inwards	inward	NNS
46745	976	39	or	or	CC
46745	976	40	outwards	outward	NNS
46745	976	41	.	.	.
46745	977	1	There	there	EX
46745	977	2	are	be	VBP
46745	977	3	fluids	fluid	NNS
46745	977	4	on	on	IN
46745	977	5	both	both	DT
46745	977	6	sides	side	NNS
46745	977	7	of	of	IN
46745	977	8	the	the	DT
46745	977	9	membrane	membrane	NN
46745	977	10	.	.	.
46745	978	1	The	the	DT
46745	978	2	circumstances	circumstance	NNS
46745	978	3	which	which	WDT
46745	978	4	determine	determine	VBP
46745	978	5	their	-PRON-	PRP$
46745	978	6	passage	passage	NN
46745	978	7	are	be	VBP
46745	978	8	mainly	mainly	RB
46745	978	9	five	five	CD
46745	978	10	.	.	.
46745	979	1	1	1	LS
46745	979	2	.	.	.
46745	980	1	_	_	NNP
46745	980	2	The	the	DT
46745	980	3	densities	density	NNS
46745	980	4	of	of	IN
46745	980	5	the	the	DT
46745	980	6	liquids	liquid	NNS
46745	980	7	:	:	:
46745	980	8	_	_	NNP
46745	980	9	other	other	JJ
46745	980	10	things	thing	NNS
46745	980	11	being	be	VBG
46745	980	12	equal	equal	JJ
46745	980	13	,	,	,
46745	980	14	the	the	DT
46745	980	15	lighter	light	JJR
46745	980	16	of	of	IN
46745	980	17	the	the	DT
46745	980	18	two	two	CD
46745	980	19	tends	tend	VBZ
46745	980	20	to	to	TO
46745	980	21	pass	pass	VB
46745	980	22	through	through	RP
46745	980	23	to	to	IN
46745	980	24	the	the	DT
46745	980	25	heavier	heavy	JJR
46745	980	26	,	,	,
46745	980	27	more	more	JJR
46745	980	28	than	than	IN
46745	980	29	the	the	DT
46745	980	30	heavier	heavy	JJR
46745	980	31	to	to	IN
46745	980	32	the	the	DT
46745	980	33	lighter	light	JJR
46745	980	34	.	.	.
46745	981	1	2	2	LS
46745	981	2	.	.	.
46745	982	1	_	_	NNP
46745	982	2	Their	-PRON-	PRP$
46745	982	3	attraction	attraction	NN
46745	982	4	for	for	IN
46745	982	5	the	the	DT
46745	982	6	intervening	intervene	VBG
46745	982	7	membrane._--That	membrane._--that	ADD
46745	982	8	one	one	PRP
46745	982	9	passes	pass	VBZ
46745	982	10	through	through	IN
46745	982	11	most	most	JJS
46745	982	12	which	which	WDT
46745	982	13	has	have	VBZ
46745	982	14	the	the	DT
46745	982	15	greatest	great	JJS
46745	982	16	affinity	affinity	NN
46745	982	17	for	for	IN
46745	982	18	the	the	DT
46745	982	19	membrane	membrane	NN
46745	982	20	.	.	.
46745	983	1	3	3	LS
46745	983	2	.	.	.
46745	984	1	_	_	NNP
46745	984	2	The	the	DT
46745	984	3	affinity	affinity	NN
46745	984	4	of	of	IN
46745	984	5	the	the	DT
46745	984	6	fluids	fluid	NNS
46745	984	7	for	for	IN
46745	984	8	each	each	DT
46745	984	9	other._--A	other._--A	NNP
46745	984	10	fluid	fluid	NN
46745	984	11	passes	pass	VBZ
46745	984	12	through	through	RP
46745	984	13	more	more	RBR
46745	984	14	rapidly	rapidly	RB
46745	984	15	when	when	WRB
46745	984	16	it	-PRON-	PRP
46745	984	17	is	be	VBZ
46745	984	18	readily	readily	RB
46745	984	19	taken	take	VBN
46745	984	20	up	up	RP
46745	984	21	and	and	CC
46745	984	22	dissolved	dissolve	VBN
46745	984	23	by	by	IN
46745	984	24	that	that	DT
46745	984	25	on	on	IN
46745	984	26	the	the	DT
46745	984	27	opposite	opposite	JJ
46745	984	28	side	side	NN
46745	984	29	.	.	.
46745	985	1	By	by	IN
46745	985	2	virtue	virtue	NN
46745	985	3	of	of	IN
46745	985	4	the	the	DT
46745	985	5	last	last	JJ
46745	985	6	two	two	CD
46745	985	7	laws	law	NNS
46745	985	8	,	,	,
46745	985	9	but	but	CC
46745	985	10	contrary	contrary	RB
46745	985	11	to	to	IN
46745	985	12	the	the	DT
46745	985	13	first	first	JJ
46745	985	14	,	,	,
46745	985	15	water	water	NN
46745	985	16	passes	pass	VBZ
46745	985	17	through	through	RP
46745	985	18	to	to	IN
46745	985	19	alcohol	alcohol	NN
46745	985	20	more	more	RBR
46745	985	21	rapidly	rapidly	RB
46745	985	22	than	than	IN
46745	985	23	alcohol	alcohol	NN
46745	985	24	to	to	IN
46745	985	25	water	water	NN
46745	985	26	.	.	.
46745	986	1	4	4	LS
46745	986	2	.	.	.
46745	987	1	_	_	NNP
46745	987	2	The	the	DT
46745	987	3	motion	motion	NN
46745	987	4	of	of	IN
46745	987	5	the	the	DT
46745	987	6	fluid	fluid	NN
46745	987	7	on	on	IN
46745	987	8	one	one	CD
46745	987	9	side	side	NN
46745	987	10	_	_	NNP
46745	987	11	promotes	promote	VBZ
46745	987	12	the	the	DT
46745	987	13	passage	passage	NN
46745	987	14	through	through	IN
46745	987	15	of	of	IN
46745	987	16	that	that	DT
46745	987	17	on	on	IN
46745	987	18	the	the	DT
46745	987	19	other	other	JJ
46745	987	20	,	,	,
46745	987	21	because	because	IN
46745	987	22	it	-PRON-	PRP
46745	987	23	is	be	VBZ
46745	987	24	carried	carry	VBN
46745	987	25	off	off	RP
46745	987	26	as	as	RB
46745	987	27	fast	fast	RB
46745	987	28	as	as	IN
46745	987	29	it	-PRON-	PRP
46745	987	30	permeates	permeate	VBZ
46745	987	31	the	the	DT
46745	987	32	membrane	membrane	NN
46745	987	33	.	.	.
46745	988	1	This	this	DT
46745	988	2	also	also	RB
46745	988	3	will	will	MD
46745	988	4	cause	cause	VB
46745	988	5	endosmosis	endosmosis	NN
46745	988	6	in	in	IN
46745	988	7	defiance	defiance	NN
46745	988	8	of	of	IN
46745	988	9	the	the	DT
46745	988	10	first	first	JJ
46745	988	11	law	law	NN
46745	988	12	.	.	.
46745	989	1	This	this	DT
46745	989	2	may	may	MD
46745	989	3	be	be	VB
46745	989	4	proved	prove	VBN
46745	989	5	by	by	IN
46745	989	6	a	a	DT
46745	989	7	simple	simple	JJ
46745	989	8	experiment	experiment	NN
46745	989	9	.	.	.
46745	990	1	Let	let	VB
46745	990	2	a	a	DT
46745	990	3	large	large	JJ
46745	990	4	vein	vein	NN
46745	990	5	,	,	,
46745	990	6	cleanly	cleanly	RB
46745	990	7	dissected	dissect	VBN
46745	990	8	,	,	,
46745	990	9	be	be	VB
46745	990	10	attached	attach	VBN
46745	990	11	at	at	IN
46745	990	12	one	one	CD
46745	990	13	end	end	NN
46745	990	14	to	to	IN
46745	990	15	the	the	DT
46745	990	16	stopcock	stopcock	NN
46745	990	17	of	of	IN
46745	990	18	a	a	DT
46745	990	19	vessel	vessel	NN
46745	990	20	containing	contain	VBG
46745	990	21	pure	pure	JJ
46745	990	22	water	water	NN
46745	990	23	.	.	.
46745	991	1	Let	let	VB
46745	991	2	it	-PRON-	PRP
46745	991	3	then	then	RB
46745	991	4	pass	pass	VB
46745	991	5	through	through	RP
46745	991	6	a	a	DT
46745	991	7	basin	basin	NN
46745	991	8	containing	contain	VBG
46745	991	9	a	a	DT
46745	991	10	strong	strong	JJ
46745	991	11	solution	solution	NN
46745	991	12	of	of	IN
46745	991	13	Ferrocyanide	Ferrocyanide	NNP
46745	991	14	of	of	IN
46745	991	15	Potassium	Potassium	NNP
46745	991	16	,	,	,
46745	991	17	and	and	CC
46745	991	18	let	let	VB
46745	991	19	the	the	DT
46745	991	20	other	other	JJ
46745	991	21	end	end	NN
46745	991	22	hang	hang	VB
46745	991	23	over	over	IN
46745	991	24	a	a	DT
46745	991	25	jar	jar	NN
46745	991	26	filled	fill	VBN
46745	991	27	with	with	IN
46745	991	28	a	a	DT
46745	991	29	solution	solution	NN
46745	991	30	of	of	IN
46745	991	31	the	the	DT
46745	991	32	Sesquichloride	Sesquichloride	NNP
46745	991	33	of	of	IN
46745	991	34	Iron	Iron	NNP
46745	991	35	.	.	.
46745	992	1	If	if	IN
46745	992	2	the	the	DT
46745	992	3	cock	cock	NN
46745	992	4	be	be	VBP
46745	992	5	now	now	RB
46745	992	6	turned	turn	VBN
46745	992	7	,	,	,
46745	992	8	and	and	CC
46745	992	9	water	water	NN
46745	992	10	be	be	VB
46745	992	11	allowed	allow	VBN
46745	992	12	to	to	TO
46745	992	13	pass	pass	VB
46745	992	14	through	through	IN
46745	992	15	the	the	DT
46745	992	16	vein	vein	NN
46745	992	17	into	into	IN
46745	992	18	the	the	DT
46745	992	19	vessel	vessel	NN
46745	992	20	beyond	beyond	IN
46745	992	21	,	,	,
46745	992	22	the	the	DT
46745	992	23	solution	solution	NN
46745	992	24	of	of	IN
46745	992	25	Iron	Iron	NNP
46745	992	26	will	will	MD
46745	992	27	quickly	quickly	RB
46745	992	28	acquire	acquire	VB
46745	992	29	the	the	DT
46745	992	30	tint	tint	NN
46745	992	31	of	of	IN
46745	992	32	Prussian	prussian	JJ
46745	992	33	blue	blue	NN
46745	992	34	;	;	:
46745	992	35	for	for	IN
46745	992	36	the	the	DT
46745	992	37	heavy	heavy	JJ
46745	992	38	solution	solution	NN
46745	992	39	in	in	IN
46745	992	40	the	the	DT
46745	992	41	central	central	JJ
46745	992	42	vessel	vessel	NN
46745	992	43	has	have	VBZ
46745	992	44	passed	pass	VBN
46745	992	45	through	through	RP
46745	992	46	to	to	IN
46745	992	47	the	the	DT
46745	992	48	simple	simple	JJ
46745	992	49	water	water	NN
46745	992	50	of	of	IN
46745	992	51	the	the	DT
46745	992	52	vein	vein	NN
46745	992	53	,	,	,
46745	992	54	mainly	mainly	RB
46745	992	55	by	by	IN
46745	992	56	virtue	virtue	NN
46745	992	57	of	of	IN
46745	992	58	the	the	DT
46745	992	59	motion	motion	NN
46745	992	60	of	of	IN
46745	992	61	the	the	DT
46745	992	62	latter	latter	JJ
46745	992	63	.	.	.
46745	993	1	It	-PRON-	PRP
46745	993	2	will	will	MD
46745	993	3	be	be	VB
46745	993	4	seen	see	VBN
46745	993	5	directly	directly	RB
46745	993	6	that	that	IN
46745	993	7	this	this	DT
46745	993	8	is	be	VBZ
46745	993	9	a	a	DT
46745	993	10	matter	matter	NN
46745	993	11	of	of	IN
46745	993	12	considerable	considerable	JJ
46745	993	13	importance	importance	NN
46745	993	14	.	.	.
46745	994	1	5	5	CD
46745	994	2	.	.	.
46745	995	1	The	the	DT
46745	995	2	last	last	JJ
46745	995	3	law	law	NN
46745	995	4	is	be	VBZ
46745	995	5	,	,	,
46745	995	6	that	that	WDT
46745	995	7	_	_	NNP
46745	995	8	any	any	DT
46745	995	9	pressure	pressure	NN
46745	995	10	on	on	IN
46745	995	11	the	the	DT
46745	995	12	fluid	fluid	NN
46745	995	13	on	on	IN
46745	995	14	one	one	CD
46745	995	15	side	side	NN
46745	995	16	of	of	IN
46745	995	17	the	the	DT
46745	995	18	membrane	membrane	NN
46745	995	19	_	_	NNP
46745	995	20	has	have	VBZ
46745	995	21	a	a	DT
46745	995	22	powerful	powerful	JJ
46745	995	23	influence	influence	NN
46745	995	24	in	in	IN
46745	995	25	determining	determine	VBG
46745	995	26	the	the	DT
46745	995	27	passage	passage	NN
46745	995	28	of	of	IN
46745	995	29	the	the	DT
46745	995	30	current	current	NN
46745	995	31	from	from	IN
46745	995	32	that	that	DT
46745	995	33	side	side	NN
46745	995	34	.	.	.
46745	996	1	(	(	-LRB-
46745	996	2	_	_	NNP
46745	996	3	Vide	Vide	NNP
46745	996	4	Liebig	Liebig	NNP
46745	996	5	's	's	POS
46745	996	6	Animal	Animal	NNP
46745	996	7	Chemistry	Chemistry	NNP
46745	996	8	_	_	NNP
46745	996	9	,	,	,
46745	996	10	p.	p.	NN
46745	996	11	72	72	CD
46745	996	12	;	;	:
46745	996	13	_	_	NNP
46745	996	14	Liebig	Liebig	NNP
46745	996	15	on	on	IN
46745	996	16	the	the	DT
46745	996	17	Motion	Motion	NNP
46745	996	18	of	of	IN
46745	996	19	the	the	DT
46745	996	20	Juices	Juices	NNPS
46745	996	21	_	_	NNP
46745	996	22	;	;	:
46745	996	23	and	and	CC
46745	996	24	the	the	DT
46745	996	25	_	_	NNP
46745	996	26	Lectures	Lectures	NNP
46745	996	27	of	of	IN
46745	996	28	Professor	Professor	NNP
46745	996	29	Matteucci	Matteucci	NNP
46745	996	30	of	of	IN
46745	996	31	Pisa	Pisa	NNP
46745	996	32	_	_	NNP
46745	996	33	.	.	.
46745	996	34	)	)	-RRB-
46745	997	1	The	the	DT
46745	997	2	mucous	mucous	JJ
46745	997	3	membrane	membrane	NN
46745	997	4	and	and	CC
46745	997	5	the	the	DT
46745	997	6	coat	coat	NN
46745	997	7	of	of	IN
46745	997	8	the	the	DT
46745	997	9	capillary	capillary	JJ
46745	997	10	vessel	vessel	NN
46745	997	11	beyond	beyond	IN
46745	997	12	it	-PRON-	PRP
46745	997	13	are	be	VBP
46745	997	14	probably	probably	RB
46745	997	15	subject	subject	JJ
46745	997	16	to	to	IN
46745	997	17	about	about	IN
46745	997	18	the	the	DT
46745	997	19	same	same	JJ
46745	997	20	physical	physical	JJ
46745	997	21	conditions	condition	NNS
46745	997	22	of	of	IN
46745	997	23	absorption	absorption	NN
46745	997	24	as	as	IN
46745	997	25	those	those	DT
46745	997	26	which	which	WDT
46745	997	27	are	be	VBP
46745	997	28	thus	thus	RB
46745	997	29	found	find	VBN
46745	997	30	by	by	IN
46745	997	31	experiment	experiment	NN
46745	997	32	to	to	TO
46745	997	33	regulate	regulate	VB
46745	997	34	the	the	DT
46745	997	35	passage	passage	NN
46745	997	36	of	of	IN
46745	997	37	fluids	fluid	NNS
46745	997	38	through	through	IN
46745	997	39	dead	dead	JJ
46745	997	40	animal	animal	NN
46745	997	41	membranes	membrane	NNS
46745	997	42	.	.	.
46745	998	1	As	as	IN
46745	998	2	to	to	IN
46745	998	3	the	the	DT
46745	998	4	first	first	JJ
46745	998	5	condition	condition	NN
46745	998	6	,	,	,
46745	998	7	it	-PRON-	PRP
46745	998	8	is	be	VBZ
46745	998	9	probable	probable	JJ
46745	998	10	that	that	IN
46745	998	11	the	the	DT
46745	998	12	aliment	aliment	JJ
46745	998	13	or	or	CC
46745	998	14	medicine	medicine	NN
46745	998	15	which	which	WDT
46745	998	16	is	be	VBZ
46745	998	17	digested	digest	VBN
46745	998	18	,	,	,
46745	998	19	however	however	WRB
46745	998	20	solid	solid	JJ
46745	998	21	and	and	CC
46745	998	22	dense	dense	JJ
46745	998	23	,	,	,
46745	998	24	may	may	MD
46745	998	25	be	be	VB
46745	998	26	diluted	dilute	VBN
46745	998	27	down	down	RP
46745	998	28	by	by	IN
46745	998	29	the	the	DT
46745	998	30	gastric	gastric	JJ
46745	998	31	juice	juice	NN
46745	998	32	until	until	IN
46745	998	33	the	the	DT
46745	998	34	solution	solution	NN
46745	998	35	is	be	VBZ
46745	998	36	of	of	IN
46745	998	37	less	less	RBR
46745	998	38	specific	specific	JJ
46745	998	39	gravity	gravity	NN
46745	998	40	than	than	IN
46745	998	41	the	the	DT
46745	998	42	serum	serum	NN
46745	998	43	of	of	IN
46745	998	44	the	the	DT
46745	998	45	blood	blood	NN
46745	998	46	.	.	.
46745	999	1	With	with	IN
46745	999	2	the	the	DT
46745	999	3	second	second	JJ
46745	999	4	law	law	NN
46745	999	5	we	-PRON-	PRP
46745	999	6	are	be	VBP
46745	999	7	not	not	RB
46745	999	8	so	so	RB
46745	999	9	much	much	RB
46745	999	10	concerned	concern	VBN
46745	999	11	,	,	,
46745	999	12	as	as	IN
46745	999	13	the	the	DT
46745	999	14	medicine	medicine	NN
46745	999	15	after	after	IN
46745	999	16	solution	solution	NN
46745	999	17	has	have	VBZ
46745	999	18	generally	generally	RB
46745	999	19	no	no	DT
46745	999	20	repulsion	repulsion	NN
46745	999	21	for	for	IN
46745	999	22	the	the	DT
46745	999	23	animal	animal	NN
46745	999	24	membrane	membrane	NN
46745	999	25	.	.	.
46745	1000	1	So	so	RB
46745	1000	2	also	also	RB
46745	1000	3	with	with	IN
46745	1000	4	the	the	DT
46745	1000	5	third	third	JJ
46745	1000	6	,	,	,
46745	1000	7	as	as	IN
46745	1000	8	the	the	DT
46745	1000	9	serum	serum	NN
46745	1000	10	of	of	IN
46745	1000	11	the	the	DT
46745	1000	12	blood	blood	NN
46745	1000	13	mixes	mix	VBZ
46745	1000	14	readily	readily	RB
46745	1000	15	with	with	IN
46745	1000	16	all	all	DT
46745	1000	17	watery	watery	JJ
46745	1000	18	fluids	fluid	NNS
46745	1000	19	.	.	.
46745	1001	1	The	the	DT
46745	1001	2	fourth	fourth	JJ
46745	1001	3	,	,	,
46745	1001	4	viz	viz	NN
46745	1001	5	.	.	.
46745	1002	1	the	the	DT
46745	1002	2	condition	condition	NN
46745	1002	3	of	of	IN
46745	1002	4	motion	motion	NN
46745	1002	5	,	,	,
46745	1002	6	is	be	VBZ
46745	1002	7	of	of	IN
46745	1002	8	great	great	JJ
46745	1002	9	importance	importance	NN
46745	1002	10	;	;	:
46745	1002	11	for	for	IN
46745	1002	12	by	by	IN
46745	1002	13	it	-PRON-	PRP
46745	1002	14	the	the	DT
46745	1002	15	motion	motion	NN
46745	1002	16	of	of	IN
46745	1002	17	the	the	DT
46745	1002	18	contents	content	NNS
46745	1002	19	of	of	IN
46745	1002	20	the	the	DT
46745	1002	21	capillary	capillary	JJ
46745	1002	22	vessels	vessel	NNS
46745	1002	23	will	will	MD
46745	1002	24	tend	tend	VB
46745	1002	25	powerfully	powerfully	RB
46745	1002	26	to	to	TO
46745	1002	27	determine	determine	VB
46745	1002	28	the	the	DT
46745	1002	29	passage	passage	NN
46745	1002	30	through	through	IN
46745	1002	31	of	of	IN
46745	1002	32	the	the	DT
46745	1002	33	liquid	liquid	NN
46745	1002	34	on	on	IN
46745	1002	35	the	the	DT
46745	1002	36	other	other	JJ
46745	1002	37	side	side	NN
46745	1002	38	.	.	.
46745	1003	1	Fifthly	fifthly	RB
46745	1003	2	,	,	,
46745	1003	3	the	the	DT
46745	1003	4	influence	influence	NN
46745	1003	5	of	of	IN
46745	1003	6	pressure	pressure	NN
46745	1003	7	on	on	IN
46745	1003	8	endosmosis	endosmosis	NN
46745	1003	9	is	be	VBZ
46745	1003	10	one	one	CD
46745	1003	11	which	which	WDT
46745	1003	12	is	be	VBZ
46745	1003	13	certainly	certainly	RB
46745	1003	14	exerted	exert	VBN
46745	1003	15	in	in	IN
46745	1003	16	the	the	DT
46745	1003	17	case	case	NN
46745	1003	18	of	of	IN
46745	1003	19	the	the	DT
46745	1003	20	stomach	stomach	NN
46745	1003	21	and	and	CC
46745	1003	22	intestines	intestine	NNS
46745	1003	23	,	,	,
46745	1003	24	which	which	WDT
46745	1003	25	are	be	VBP
46745	1003	26	muscular	muscular	JJ
46745	1003	27	,	,	,
46745	1003	28	and	and	CC
46745	1003	29	during	during	IN
46745	1003	30	the	the	DT
46745	1003	31	process	process	NN
46745	1003	32	of	of	IN
46745	1003	33	digestion	digestion	NN
46745	1003	34	contract	contract	NN
46745	1003	35	on	on	IN
46745	1003	36	their	-PRON-	PRP$
46745	1003	37	contents	content	NNS
46745	1003	38	with	with	IN
46745	1003	39	considerable	considerable	JJ
46745	1003	40	force	force	NN
46745	1003	41	.	.	.
46745	1004	1	This	this	DT
46745	1004	2	contraction	contraction	NN
46745	1004	3	,	,	,
46745	1004	4	together	together	RB
46745	1004	5	with	with	IN
46745	1004	6	the	the	DT
46745	1004	7	circulation	circulation	NN
46745	1004	8	of	of	IN
46745	1004	9	the	the	DT
46745	1004	10	blood	blood	NN
46745	1004	11	in	in	IN
46745	1004	12	the	the	DT
46745	1004	13	capillaries	capillary	NNS
46745	1004	14	,	,	,
46745	1004	15	would	would	MD
46745	1004	16	doubtless	doubtless	RB
46745	1004	17	be	be	VB
46745	1004	18	sufficient	sufficient	JJ
46745	1004	19	to	to	TO
46745	1004	20	determine	determine	VB
46745	1004	21	the	the	DT
46745	1004	22	passage	passage	NN
46745	1004	23	of	of	IN
46745	1004	24	the	the	DT
46745	1004	25	digested	digest	VBN
46745	1004	26	matters	matter	NNS
46745	1004	27	inwards	inward	NNS
46745	1004	28	,	,	,
46745	1004	29	even	even	RB
46745	1004	30	in	in	IN
46745	1004	31	opposition	opposition	NN
46745	1004	32	to	to	IN
46745	1004	33	the	the	DT
46745	1004	34	first	first	JJ
46745	1004	35	law	law	NN
46745	1004	36	.	.	.
46745	1005	1	[	[	-LRB-
46745	1005	2	23	23	CD
46745	1005	3	]	]	-RRB-
46745	1005	4	Under	under	IN
46745	1005	5	the	the	DT
46745	1005	6	first	first	JJ
46745	1005	7	proposition	proposition	NN
46745	1005	8	I	-PRON-	PRP
46745	1005	9	have	have	VBP
46745	1005	10	shown	show	VBN
46745	1005	11	that	that	IN
46745	1005	12	the	the	DT
46745	1005	13	majority	majority	NN
46745	1005	14	of	of	IN
46745	1005	15	medicines	medicine	NNS
46745	1005	16	are	be	VBP
46745	1005	17	absorbed	absorb	VBN
46745	1005	18	into	into	IN
46745	1005	19	the	the	DT
46745	1005	20	system	system	NN
46745	1005	21	.	.	.
46745	1006	1	It	-PRON-	PRP
46745	1006	2	is	be	VBZ
46745	1006	3	now	now	RB
46745	1006	4	seen	see	VBN
46745	1006	5	where	where	WRB
46745	1006	6	and	and	CC
46745	1006	7	how	how	WRB
46745	1006	8	they	-PRON-	PRP
46745	1006	9	are	be	VBP
46745	1006	10	absorbed	absorb	VBN
46745	1006	11	.	.	.
46745	1007	1	But	but	CC
46745	1007	2	it	-PRON-	PRP
46745	1007	3	still	still	RB
46745	1007	4	remains	remain	VBZ
46745	1007	5	to	to	TO
46745	1007	6	be	be	VB
46745	1007	7	seen	see	VBN
46745	1007	8	what	what	WDT
46745	1007	9	particular	particular	JJ
46745	1007	10	substances	substance	NNS
46745	1007	11	or	or	CC
46745	1007	12	classes	class	NNS
46745	1007	13	of	of	IN
46745	1007	14	medicaments	medicament	NNS
46745	1007	15	are	be	VBP
46745	1007	16	thus	thus	RB
46745	1007	17	taken	take	VBN
46745	1007	18	into	into	IN
46745	1007	19	the	the	DT
46745	1007	20	blood	blood	NN
46745	1007	21	,	,	,
46745	1007	22	and	and	CC
46745	1007	23	whether	whether	IN
46745	1007	24	while	while	IN
46745	1007	25	so	so	RB
46745	1007	26	passing	pass	VBG
46745	1007	27	they	-PRON-	PRP
46745	1007	28	undergo	undergo	VBP
46745	1007	29	any	any	DT
46745	1007	30	modifications	modification	NNS
46745	1007	31	.	.	.
46745	1008	1	The	the	DT
46745	1008	2	following	follow	VBG
46745	1008	3	,	,	,
46745	1008	4	then	then	RB
46745	1008	5	,	,	,
46745	1008	6	are	be	VBP
46745	1008	7	the	the	DT
46745	1008	8	chief	chief	JJ
46745	1008	9	classes	class	NNS
46745	1008	10	which	which	WDT
46745	1008	11	I	-PRON-	PRP
46745	1008	12	believe	believe	VBP
46745	1008	13	to	to	TO
46745	1008	14	undergo	undergo	VB
46745	1008	15	solution	solution	NN
46745	1008	16	and	and	CC
46745	1008	17	absorption	absorption	NN
46745	1008	18	in	in	IN
46745	1008	19	the	the	DT
46745	1008	20	intestinal	intestinal	JJ
46745	1008	21	canal	canal	NN
46745	1008	22	.	.	.
46745	1009	1	They	-PRON-	PRP
46745	1009	2	comprise	comprise	VBP
46745	1009	3	the	the	DT
46745	1009	4	great	great	JJ
46745	1009	5	majority	majority	NN
46745	1009	6	of	of	IN
46745	1009	7	all	all	DT
46745	1009	8	substances	substance	NNS
46745	1009	9	used	use	VBN
46745	1009	10	either	either	CC
46745	1009	11	as	as	IN
46745	1009	12	food	food	NN
46745	1009	13	or	or	CC
46745	1009	14	medicine:--	medicine:--	NNP
46745	1009	15	1	1	CD
46745	1009	16	.	.	.
46745	1010	1	Mineral	mineral	NN
46745	1010	2	substances	substance	NNS
46745	1010	3	soluble	soluble	JJ
46745	1010	4	in	in	IN
46745	1010	5	water	water	NN
46745	1010	6	.	.	.
46745	1011	1	2	2	LS
46745	1011	2	.	.	.
46745	1012	1	Mineral	mineral	NN
46745	1012	2	substances	substance	NNS
46745	1012	3	soluble	soluble	JJ
46745	1012	4	in	in	IN
46745	1012	5	acids	acid	NNS
46745	1012	6	.	.	.
46745	1013	1	3	3	LS
46745	1013	2	.	.	.
46745	1014	1	Mineral	mineral	NN
46745	1014	2	substances	substance	NNS
46745	1014	3	soluble	soluble	JJ
46745	1014	4	in	in	IN
46745	1014	5	alkalies	alkali	NNS
46745	1014	6	.	.	.
46745	1015	1	4	4	LS
46745	1015	2	.	.	.
46745	1016	1	Vegetable	vegetable	NN
46745	1016	2	products	product	NNS
46745	1016	3	soluble	soluble	JJ
46745	1016	4	in	in	IN
46745	1016	5	water	water	NN
46745	1016	6	.	.	.
46745	1017	1	5	5	CD
46745	1017	2	.	.	.
46745	1018	1	Animal	animal	NN
46745	1018	2	and	and	CC
46745	1018	3	vegetable	vegetable	NN
46745	1018	4	substances	substance	NNS
46745	1018	5	rendered	render	VBN
46745	1018	6	soluble	soluble	JJ
46745	1018	7	by	by	IN
46745	1018	8	the	the	DT
46745	1018	9	gastric	gastric	JJ
46745	1018	10	juice	juice	NN
46745	1018	11	.	.	.
46745	1019	1	6	6	CD
46745	1019	2	.	.	.
46745	1020	1	Fatty	Fatty	NNP
46745	1020	2	and	and	CC
46745	1020	3	resinous	resinous	JJ
46745	1020	4	substances	substance	NNS
46745	1020	5	soluble	soluble	JJ
46745	1020	6	in	in	IN
46745	1020	7	alkali	alkali	JJ
46745	1020	8	.	.	.
46745	1021	1	1	1	LS
46745	1021	2	.	.	.
46745	1022	1	All	all	DT
46745	1022	2	soluble	soluble	JJ
46745	1022	3	mineral	mineral	NN
46745	1022	4	substances	substance	NNS
46745	1022	5	--	--	:
46745	1022	6	acids	acid	NNS
46745	1022	7	,	,	,
46745	1022	8	alkalies	alkali	NNS
46745	1022	9	,	,	,
46745	1022	10	salts	salt	NNS
46745	1022	11	,	,	,
46745	1022	12	and	and	CC
46745	1022	13	soluble	soluble	JJ
46745	1022	14	compounds	compound	NNS
46745	1022	15	of	of	IN
46745	1022	16	the	the	DT
46745	1022	17	earths	earth	NNS
46745	1022	18	and	and	CC
46745	1022	19	metals	metal	NNS
46745	1022	20	--	--	:
46745	1022	21	are	be	VBP
46745	1022	22	absorbed	absorb	VBN
46745	1022	23	in	in	IN
46745	1022	24	the	the	DT
46745	1022	25	stomach	stomach	NN
46745	1022	26	and	and	CC
46745	1022	27	intestines	intestine	NNS
46745	1022	28	.	.	.
46745	1023	1	The	the	DT
46745	1023	2	conditions	condition	NNS
46745	1023	3	and	and	CC
46745	1023	4	the	the	DT
46745	1023	5	process	process	NN
46745	1023	6	of	of	IN
46745	1023	7	absorption	absorption	NN
46745	1023	8	have	have	VBP
46745	1023	9	been	be	VBN
46745	1023	10	already	already	RB
46745	1023	11	stated	state	VBN
46745	1023	12	.	.	.
46745	1024	1	When	when	WRB
46745	1024	2	solid	solid	JJ
46745	1024	3	they	-PRON-	PRP
46745	1024	4	are	be	VBP
46745	1024	5	first	first	RB
46745	1024	6	dissolved	dissolve	VBN
46745	1024	7	,	,	,
46745	1024	8	when	when	WRB
46745	1024	9	in	in	IN
46745	1024	10	a	a	DT
46745	1024	11	dense	dense	JJ
46745	1024	12	solution	solution	NN
46745	1024	13	diluted	dilute	VBN
46745	1024	14	down	down	RP
46745	1024	15	by	by	IN
46745	1024	16	the	the	DT
46745	1024	17	gastric	gastric	JJ
46745	1024	18	fluid	fluid	NN
46745	1024	19	before	before	IN
46745	1024	20	they	-PRON-	PRP
46745	1024	21	are	be	VBP
46745	1024	22	absorbed	absorb	VBN
46745	1024	23	.	.	.
46745	1025	1	Thin	thin	JJ
46745	1025	2	watery	watery	JJ
46745	1025	3	liquids	liquid	NNS
46745	1025	4	are	be	VBP
46745	1025	5	quickly	quickly	RB
46745	1025	6	taken	take	VBN
46745	1025	7	up	up	RP
46745	1025	8	.	.	.
46745	1026	1	Motion	motion	NN
46745	1026	2	on	on	IN
46745	1026	3	one	one	CD
46745	1026	4	side	side	NN
46745	1026	5	,	,	,
46745	1026	6	and	and	CC
46745	1026	7	pressure	pressure	NN
46745	1026	8	on	on	IN
46745	1026	9	the	the	DT
46745	1026	10	other	other	JJ
46745	1026	11	,	,	,
46745	1026	12	hasten	hasten	VB
46745	1026	13	the	the	DT
46745	1026	14	process	process	NN
46745	1026	15	.	.	.
46745	1027	1	I	-PRON-	PRP
46745	1027	2	am	be	VBP
46745	1027	3	not	not	RB
46745	1027	4	inclined	inclined	JJ
46745	1027	5	to	to	TO
46745	1027	6	make	make	VB
46745	1027	7	any	any	DT
46745	1027	8	exception	exception	NN
46745	1027	9	to	to	IN
46745	1027	10	this	this	DT
46745	1027	11	rule	rule	NN
46745	1027	12	.	.	.
46745	1028	1	This	this	DT
46745	1028	2	leads	lead	VBZ
46745	1028	3	me	-PRON-	PRP
46745	1028	4	to	to	TO
46745	1028	5	make	make	VB
46745	1028	6	some	some	DT
46745	1028	7	remarks	remark	NNS
46745	1028	8	on	on	IN
46745	1028	9	_	_	NNP
46745	1028	10	the	the	DT
46745	1028	11	Endosmotic	endosmotic	JJ
46745	1028	12	theory	theory	NN
46745	1028	13	of	of	IN
46745	1028	14	the	the	DT
46745	1028	15	action	action	NN
46745	1028	16	of	of	IN
46745	1028	17	saline	saline	JJ
46745	1028	18	purgatives	purgative	NNS
46745	1028	19	_	_	NNP
46745	1028	20	.	.	.
46745	1029	1	M.	M.	NNP
46745	1029	2	Poisseuille	Poisseuille	NNP
46745	1029	3	found	find	VBD
46745	1029	4	that	that	IN
46745	1029	5	the	the	DT
46745	1029	6	serum	serum	NN
46745	1029	7	of	of	IN
46745	1029	8	the	the	DT
46745	1029	9	blood	blood	NN
46745	1029	10	would	would	MD
46745	1029	11	pass	pass	VB
46745	1029	12	through	through	RP
46745	1029	13	an	an	DT
46745	1029	14	animal	animal	NN
46745	1029	15	membrane	membrane	NN
46745	1029	16	to	to	IN
46745	1029	17	a	a	DT
46745	1029	18	solution	solution	NN
46745	1029	19	of	of	IN
46745	1029	20	Sulphate	Sulphate	NNP
46745	1029	21	of	of	IN
46745	1029	22	Soda	Soda	NNP
46745	1029	23	of	of	IN
46745	1029	24	greater	great	JJR
46745	1029	25	specific	specific	JJ
46745	1029	26	gravity	gravity	NN
46745	1029	27	.	.	.
46745	1030	1	He	-PRON-	PRP
46745	1030	2	thus	thus	RB
46745	1030	3	concluded	conclude	VBD
46745	1030	4	that	that	IN
46745	1030	5	an	an	DT
46745	1030	6	ordinary	ordinary	JJ
46745	1030	7	saline	saline	NN
46745	1030	8	purgative	purgative	JJ
46745	1030	9	of	of	IN
46745	1030	10	greater	great	JJR
46745	1030	11	specific	specific	JJ
46745	1030	12	gravity	gravity	NN
46745	1030	13	than	than	IN
46745	1030	14	serum	serum	NN
46745	1030	15	(	(	-LRB-
46745	1030	16	1.028	1.028	CD
46745	1030	17	)	)	-RRB-
46745	1030	18	acted	act	VBN
46745	1030	19	by	by	IN
46745	1030	20	causing	cause	VBG
46745	1030	21	the	the	DT
46745	1030	22	passage	passage	NN
46745	1030	23	of	of	IN
46745	1030	24	this	this	DT
46745	1030	25	serum	serum	NN
46745	1030	26	outwards	outward	VBZ
46745	1030	27	into	into	IN
46745	1030	28	the	the	DT
46745	1030	29	intestine	intestine	NN
46745	1030	30	,	,	,
46745	1030	31	producing	produce	VBG
46745	1030	32	a	a	DT
46745	1030	33	watery	watery	JJ
46745	1030	34	evacuation	evacuation	NN
46745	1030	35	.	.	.
46745	1031	1	The	the	DT
46745	1031	2	theory	theory	NN
46745	1031	3	was	be	VBD
46745	1031	4	taken	take	VBN
46745	1031	5	up	up	RP
46745	1031	6	by	by	IN
46745	1031	7	Liebig	Liebig	NNP
46745	1031	8	and	and	CC
46745	1031	9	Matteucci	Matteucci	NNP
46745	1031	10	,	,	,
46745	1031	11	and	and	CC
46745	1031	12	by	by	IN
46745	1031	13	Laveran	Laveran	NNP
46745	1031	14	and	and	CC
46745	1031	15	Millon	Millon	NNP
46745	1031	16	.	.	.
46745	1032	1	Dr.	Dr.	NNP
46745	1032	2	Pereira	Pereira	NNP
46745	1032	3	and	and	CC
46745	1032	4	Dr.	Dr.	NNP
46745	1032	5	Golding	Golding	NNP
46745	1032	6	Bird	Bird	NNP
46745	1032	7	have	have	VBP
46745	1032	8	drawn	draw	VBN
46745	1032	9	some	some	DT
46745	1032	10	practical	practical	JJ
46745	1032	11	inferences	inference	NNS
46745	1032	12	from	from	IN
46745	1032	13	it	-PRON-	PRP
46745	1032	14	.	.	.
46745	1033	1	It	-PRON-	PRP
46745	1033	2	is	be	VBZ
46745	1033	3	said	say	VBN
46745	1033	4	that	that	IN
46745	1033	5	when	when	WRB
46745	1033	6	a	a	DT
46745	1033	7	saline	saline	NN
46745	1033	8	is	be	VBZ
46745	1033	9	absorbed	absorb	VBN
46745	1033	10	it	-PRON-	PRP
46745	1033	11	produces	produce	VBZ
46745	1033	12	diuresis	diuresis	NN
46745	1033	13	,	,	,
46745	1033	14	and	and	CC
46745	1033	15	no	no	DT
46745	1033	16	purging	purging	NN
46745	1033	17	;	;	:
46745	1033	18	that	that	IN
46745	1033	19	when	when	WRB
46745	1033	20	it	-PRON-	PRP
46745	1033	21	purges	purge	VBZ
46745	1033	22	it	-PRON-	PRP
46745	1033	23	is	be	VBZ
46745	1033	24	not	not	RB
46745	1033	25	absorbed	absorb	VBN
46745	1033	26	;	;	:
46745	1033	27	that	that	IN
46745	1033	28	when	when	WRB
46745	1033	29	given	give	VBN
46745	1033	30	to	to	TO
46745	1033	31	act	act	VB
46745	1033	32	on	on	IN
46745	1033	33	the	the	DT
46745	1033	34	kidneys	kidney	NNS
46745	1033	35	,	,	,
46745	1033	36	the	the	DT
46745	1033	37	solution	solution	NN
46745	1033	38	should	should	MD
46745	1033	39	be	be	VB
46745	1033	40	so	so	RB
46745	1033	41	diluted	diluted	JJ
46745	1033	42	as	as	IN
46745	1033	43	to	to	TO
46745	1033	44	contain	contain	VB
46745	1033	45	less	less	JJR
46745	1033	46	than	than	IN
46745	1033	47	five	five	CD
46745	1033	48	per	per	NN
46745	1033	49	cent	cent	NN
46745	1033	50	.	.	.
46745	1034	1	of	of	IN
46745	1034	2	the	the	DT
46745	1034	3	solid	solid	JJ
46745	1034	4	;	;	:
46745	1034	5	and	and	CC
46745	1034	6	when	when	WRB
46745	1034	7	administered	administer	VBN
46745	1034	8	as	as	IN
46745	1034	9	a	a	DT
46745	1034	10	purgative	purgative	NN
46745	1034	11	,	,	,
46745	1034	12	the	the	DT
46745	1034	13	specific	specific	JJ
46745	1034	14	gravity	gravity	NN
46745	1034	15	should	should	MD
46745	1034	16	be	be	VB
46745	1034	17	considerably	considerably	RB
46745	1034	18	above	above	IN
46745	1034	19	1.028	1.028	CD
46745	1034	20	.	.	.
46745	1035	1	Now	now	RB
46745	1035	2	I	-PRON-	PRP
46745	1035	3	do	do	VBP
46745	1035	4	not	not	RB
46745	1035	5	deny	deny	VB
46745	1035	6	that	that	IN
46745	1035	7	a	a	DT
46745	1035	8	weak	weak	JJ
46745	1035	9	solution	solution	NN
46745	1035	10	is	be	VBZ
46745	1035	11	more	more	RBR
46745	1035	12	likely	likely	JJ
46745	1035	13	to	to	TO
46745	1035	14	pass	pass	VB
46745	1035	15	off	off	RP
46745	1035	16	by	by	IN
46745	1035	17	the	the	DT
46745	1035	18	kidneys	kidney	NNS
46745	1035	19	,	,	,
46745	1035	20	and	and	CC
46745	1035	21	a	a	DT
46745	1035	22	dense	dense	JJ
46745	1035	23	one	one	NN
46745	1035	24	by	by	IN
46745	1035	25	the	the	DT
46745	1035	26	bowels	bowel	NNS
46745	1035	27	;	;	:
46745	1035	28	but	but	CC
46745	1035	29	I	-PRON-	PRP
46745	1035	30	consider	consider	VBP
46745	1035	31	this	this	DT
46745	1035	32	due	due	IN
46745	1035	33	to	to	IN
46745	1035	34	the	the	DT
46745	1035	35	fact	fact	NN
46745	1035	36	,	,	,
46745	1035	37	that	that	IN
46745	1035	38	the	the	DT
46745	1035	39	kidneys	kidney	NNS
46745	1035	40	are	be	VBP
46745	1035	41	the	the	DT
46745	1035	42	proper	proper	JJ
46745	1035	43	emunctories	emunctorie	NNS
46745	1035	44	of	of	IN
46745	1035	45	water	water	NN
46745	1035	46	,	,	,
46745	1035	47	and	and	CC
46745	1035	48	of	of	IN
46745	1035	49	such	such	JJ
46745	1035	50	matters	matter	NNS
46745	1035	51	as	as	IN
46745	1035	52	are	be	VBP
46745	1035	53	soluble	soluble	JJ
46745	1035	54	in	in	IN
46745	1035	55	it	-PRON-	PRP
46745	1035	56	.	.	.
46745	1036	1	But	but	CC
46745	1036	2	I	-PRON-	PRP
46745	1036	3	believe	believe	VBP
46745	1036	4	that	that	IN
46745	1036	5	these	these	DT
46745	1036	6	solutions	solution	NNS
46745	1036	7	are	be	VBP
46745	1036	8	equally	equally	RB
46745	1036	9	absorbed	absorb	VBN
46745	1036	10	,	,	,
46745	1036	11	both	both	CC
46745	1036	12	heavy	heavy	JJ
46745	1036	13	and	and	CC
46745	1036	14	weak	weak	JJ
46745	1036	15	,	,	,
46745	1036	16	and	and	CC
46745	1036	17	that	that	IN
46745	1036	18	the	the	DT
46745	1036	19	purging	purging	NN
46745	1036	20	or	or	CC
46745	1036	21	diuretic	diuretic	JJ
46745	1036	22	effect	effect	NN
46745	1036	23	depends	depend	VBZ
46745	1036	24	mainly	mainly	RB
46745	1036	25	on	on	IN
46745	1036	26	the	the	DT
46745	1036	27	quantity	quantity	NN
46745	1036	28	of	of	IN
46745	1036	29	the	the	DT
46745	1036	30	salt	salt	NN
46745	1036	31	,	,	,
46745	1036	32	as	as	IN
46745	1036	33	the	the	DT
46745	1036	34	kidneys	kidney	NNS
46745	1036	35	will	will	MD
46745	1036	36	not	not	RB
46745	1036	37	eliminate	eliminate	VB
46745	1036	38	beyond	beyond	IN
46745	1036	39	a	a	DT
46745	1036	40	certain	certain	JJ
46745	1036	41	amount	amount	NN
46745	1036	42	of	of	IN
46745	1036	43	it	-PRON-	PRP
46745	1036	44	.	.	.
46745	1037	1	I	-PRON-	PRP
46745	1037	2	must	must	MD
46745	1037	3	allege	allege	VB
46745	1037	4	,	,	,
46745	1037	5	to	to	TO
46745	1037	6	support	support	VB
46745	1037	7	this	this	DT
46745	1037	8	view	view	NN
46745	1037	9	of	of	IN
46745	1037	10	the	the	DT
46745	1037	11	question	question	NN
46745	1037	12	,	,	,
46745	1037	13	firstly	firstly	RB
46745	1037	14	,	,	,
46745	1037	15	some	some	DT
46745	1037	16	arguments	argument	NNS
46745	1037	17	_	_	NNP
46745	1037	18	à	à	NNP
46745	1037	19	priori	priori	VBP
46745	1037	20	_	_	NNP
46745	1037	21	;	;	:
46745	1037	22	and	and	CC
46745	1037	23	secondly	secondly	RB
46745	1037	24	,	,	,
46745	1037	25	some	some	DT
46745	1037	26	experiments	experiment	NNS
46745	1037	27	which	which	WDT
46745	1037	28	I	-PRON-	PRP
46745	1037	29	have	have	VBP
46745	1037	30	made	make	VBN
46745	1037	31	to	to	TO
46745	1037	32	satisfy	satisfy	VB
46745	1037	33	myself	-PRON-	PRP
46745	1037	34	.	.	.
46745	1038	1	To	to	TO
46745	1038	2	consider	consider	VB
46745	1038	3	first	first	RB
46745	1038	4	the	the	DT
46745	1038	5	former	former	JJ
46745	1038	6	.	.	.
46745	1039	1	Analogy	analogy	NN
46745	1039	2	is	be	VBZ
46745	1039	3	certainly	certainly	RB
46745	1039	4	against	against	IN
46745	1039	5	this	this	DT
46745	1039	6	theory	theory	NN
46745	1039	7	.	.	.
46745	1040	1	Other	other	JJ
46745	1040	2	purgatives	purgative	NNS
46745	1040	3	from	from	IN
46745	1040	4	the	the	DT
46745	1040	5	vegetable	vegetable	JJ
46745	1040	6	kingdom	kingdom	NN
46745	1040	7	produce	produce	VBP
46745	1040	8	their	-PRON-	PRP$
46745	1040	9	effect	effect	NN
46745	1040	10	when	when	WRB
46745	1040	11	injected	inject	VBN
46745	1040	12	into	into	IN
46745	1040	13	the	the	DT
46745	1040	14	blood	blood	NN
46745	1040	15	,	,	,
46745	1040	16	and	and	CC
46745	1040	17	are	be	VBP
46745	1040	18	yet	yet	RB
46745	1040	19	often	often	RB
46745	1040	20	powerfully	powerfully	RB
46745	1040	21	hydragogue	hydragogue	NN
46745	1040	22	.	.	.
46745	1041	1	What	what	WDT
46745	1041	2	effect	effect	NN
46745	1041	3	on	on	IN
46745	1041	4	the	the	DT
46745	1041	5	process	process	NN
46745	1041	6	of	of	IN
46745	1041	7	endosmosis	endosmosis	NN
46745	1041	8	can	can	MD
46745	1041	9	be	be	VB
46745	1041	10	exerted	exert	VBN
46745	1041	11	by	by	IN
46745	1041	12	Castor	Castor	NNP
46745	1041	13	or	or	CC
46745	1041	14	Croton	Croton	NNP
46745	1041	15	oils	oil	NNS
46745	1041	16	,	,	,
46745	1041	17	or	or	CC
46745	1041	18	by	by	IN
46745	1041	19	calcined	calcine	VBN
46745	1041	20	Magnesia	Magnesia	NNP
46745	1041	21	?	?	.
46745	1042	1	On	on	IN
46745	1042	2	turning	turn	VBG
46745	1042	3	to	to	IN
46745	1042	4	what	what	WP
46745	1042	5	we	-PRON-	PRP
46745	1042	6	know	know	VBP
46745	1042	7	of	of	IN
46745	1042	8	the	the	DT
46745	1042	9	theory	theory	NN
46745	1042	10	of	of	IN
46745	1042	11	digestive	digestive	JJ
46745	1042	12	endosmosis	endosmosis	NN
46745	1042	13	,	,	,
46745	1042	14	we	-PRON-	PRP
46745	1042	15	find	find	VBP
46745	1042	16	that	that	IN
46745	1042	17	the	the	DT
46745	1042	18	solid	solid	JJ
46745	1042	19	parts	part	NNS
46745	1042	20	of	of	IN
46745	1042	21	the	the	DT
46745	1042	22	food	food	NN
46745	1042	23	are	be	VBP
46745	1042	24	diluted	dilute	VBN
46745	1042	25	down	down	RP
46745	1042	26	so	so	IN
46745	1042	27	as	as	IN
46745	1042	28	to	to	TO
46745	1042	29	be	be	VB
46745	1042	30	absorbed	absorb	VBN
46745	1042	31	,	,	,
46745	1042	32	and	and	CC
46745	1042	33	that	that	IN
46745	1042	34	the	the	DT
46745	1042	35	influence	influence	NN
46745	1042	36	of	of	IN
46745	1042	37	pressure	pressure	NN
46745	1042	38	is	be	VBZ
46745	1042	39	to	to	TO
46745	1042	40	be	be	VB
46745	1042	41	taken	take	VBN
46745	1042	42	into	into	IN
46745	1042	43	calculation	calculation	NN
46745	1042	44	.	.	.
46745	1043	1	It	-PRON-	PRP
46745	1043	2	was	be	VBD
46745	1043	3	laid	lay	VBN
46745	1043	4	down	down	RP
46745	1043	5	by	by	IN
46745	1043	6	the	the	DT
46745	1043	7	great	great	JJ
46745	1043	8	Boerhaave	Boerhaave	NNP
46745	1043	9	that	that	IN
46745	1043	10	a	a	DT
46745	1043	11	necessary	necessary	JJ
46745	1043	12	requisite	requisite	NN
46745	1043	13	for	for	IN
46745	1043	14	the	the	DT
46745	1043	15	formation	formation	NN
46745	1043	16	and	and	CC
46745	1043	17	absorption	absorption	NN
46745	1043	18	of	of	IN
46745	1043	19	chyle	chyle	NN
46745	1043	20	was	be	VBD
46745	1043	21	the	the	DT
46745	1043	22	contractile	contractile	JJ
46745	1043	23	force	force	NN
46745	1043	24	of	of	IN
46745	1043	25	the	the	DT
46745	1043	26	viscera	viscera	NN
46745	1043	27	.	.	.
46745	1044	1	(	(	-LRB-
46745	1044	2	_	_	NNP
46745	1044	3	Van	Van	NNP
46745	1044	4	Sweiten	Sweiten	NNP
46745	1044	5	's	's	POS
46745	1044	6	Comment	Comment	NNP
46745	1044	7	_	_	NNP
46745	1044	8	,	,	,
46745	1044	9	vol	vol	NNP
46745	1044	10	.	.	.
46745	1045	1	i.	i.	NNP
46745	1045	2	p.	p.	NNP
46745	1046	1	290	290	CD
46745	1046	2	.	.	.
46745	1046	3	)	)	-RRB-
46745	1047	1	This	this	DT
46745	1047	2	,	,	,
46745	1047	3	in	in	IN
46745	1047	4	fact	fact	NN
46745	1047	5	,	,	,
46745	1047	6	would	would	MD
46745	1047	7	press	press	VB
46745	1047	8	the	the	DT
46745	1047	9	fluid	fluid	NN
46745	1047	10	into	into	IN
46745	1047	11	the	the	DT
46745	1047	12	absorbent	absorbent	JJ
46745	1047	13	vessels	vessel	NNS
46745	1047	14	,	,	,
46745	1047	15	even	even	RB
46745	1047	16	if	if	IN
46745	1047	17	against	against	IN
46745	1047	18	the	the	DT
46745	1047	19	other	other	JJ
46745	1047	20	endosmotic	endosmotic	JJ
46745	1047	21	forces	force	NNS
46745	1047	22	.	.	.
46745	1048	1	Further	further	RB
46745	1048	2	,	,	,
46745	1048	3	a	a	DT
46745	1048	4	fundamental	fundamental	JJ
46745	1048	5	principle	principle	NN
46745	1048	6	was	be	VBD
46745	1048	7	insisted	insist	VBN
46745	1048	8	on	on	IN
46745	1048	9	by	by	IN
46745	1048	10	Dutrochet	Dutrochet	NNP
46745	1048	11	--	--	:
46745	1048	12	that	that	IN
46745	1048	13	even	even	RB
46745	1048	14	when	when	WRB
46745	1048	15	the	the	DT
46745	1048	16	liquids	liquid	NNS
46745	1048	17	on	on	IN
46745	1048	18	the	the	DT
46745	1048	19	two	two	CD
46745	1048	20	sides	side	NNS
46745	1048	21	varied	varied	JJ
46745	1048	22	in	in	IN
46745	1048	23	density	density	NN
46745	1048	24	,	,	,
46745	1048	25	they	-PRON-	PRP
46745	1048	26	would	would	MD
46745	1048	27	both	both	DT
46745	1048	28	pass	pass	VB
46745	1048	29	through	through	RP
46745	1048	30	to	to	IN
46745	1048	31	each	each	DT
46745	1048	32	other	other	JJ
46745	1048	33	,	,	,
46745	1048	34	though	though	IN
46745	1048	35	in	in	IN
46745	1048	36	different	different	JJ
46745	1048	37	proportions	proportion	NNS
46745	1048	38	.	.	.
46745	1049	1	The	the	DT
46745	1049	2	ultimate	ultimate	JJ
46745	1049	3	result	result	NN
46745	1049	4	of	of	IN
46745	1049	5	this	this	DT
46745	1049	6	would	would	MD
46745	1049	7	be	be	VB
46745	1049	8	,	,	,
46745	1049	9	that	that	IN
46745	1049	10	a	a	DT
46745	1049	11	heavy	heavy	JJ
46745	1049	12	saline	saline	NN
46745	1049	13	solution	solution	NN
46745	1049	14	would	would	MD
46745	1049	15	be	be	VB
46745	1049	16	diluted	dilute	VBN
46745	1049	17	down	down	RP
46745	1049	18	to	to	IN
46745	1049	19	the	the	DT
46745	1049	20	specific	specific	JJ
46745	1049	21	gravity	gravity	NN
46745	1049	22	of	of	IN
46745	1049	23	the	the	DT
46745	1049	24	serum	serum	NN
46745	1049	25	,	,	,
46745	1049	26	and	and	CC
46745	1049	27	would	would	MD
46745	1049	28	then	then	RB
46745	1049	29	pass	pass	VB
46745	1049	30	through	through	RP
46745	1049	31	.	.	.
46745	1050	1	This	this	DT
46745	1050	2	point	point	NN
46745	1050	3	I	-PRON-	PRP
46745	1050	4	have	have	VBP
46745	1050	5	illustrated	illustrate	VBN
46745	1050	6	in	in	IN
46745	1050	7	my	-PRON-	PRP$
46745	1050	8	first	first	JJ
46745	1050	9	experiment	experiment	NN
46745	1050	10	.	.	.
46745	1051	1	Thus	thus	RB
46745	1051	2	it	-PRON-	PRP
46745	1051	3	seems	seem	VBZ
46745	1051	4	that	that	IN
46745	1051	5	my	-PRON-	PRP$
46745	1051	6	view	view	NN
46745	1051	7	is	be	VBZ
46745	1051	8	favoured	favour	VBN
46745	1051	9	by	by	IN
46745	1051	10	these	these	DT
46745	1051	11	physical	physical	JJ
46745	1051	12	laws	law	NNS
46745	1051	13	.	.	.
46745	1052	1	But	but	CC
46745	1052	2	even	even	RB
46745	1052	3	if	if	IN
46745	1052	4	it	-PRON-	PRP
46745	1052	5	were	be	VBD
46745	1052	6	not	not	RB
46745	1052	7	so	so	RB
46745	1052	8	,	,	,
46745	1052	9	I	-PRON-	PRP
46745	1052	10	should	should	MD
46745	1052	11	not	not	RB
46745	1052	12	be	be	VB
46745	1052	13	inclined	incline	VBN
46745	1052	14	to	to	TO
46745	1052	15	admit	admit	VB
46745	1052	16	that	that	IN
46745	1052	17	all	all	PDT
46745	1052	18	the	the	DT
46745	1052	19	endosmotic	endosmotic	JJ
46745	1052	20	processes	process	NNS
46745	1052	21	in	in	IN
46745	1052	22	the	the	DT
46745	1052	23	living	live	VBG
46745	1052	24	body	body	NN
46745	1052	25	were	be	VBD
46745	1052	26	regulated	regulate	VBN
46745	1052	27	by	by	IN
46745	1052	28	merely	merely	RB
46745	1052	29	physical	physical	JJ
46745	1052	30	tendencies	tendency	NNS
46745	1052	31	.	.	.
46745	1053	1	This	this	DT
46745	1053	2	can	can	MD
46745	1053	3	not	not	RB
46745	1053	4	be	be	VB
46745	1053	5	the	the	DT
46745	1053	6	case	case	NN
46745	1053	7	with	with	IN
46745	1053	8	some	some	DT
46745	1053	9	of	of	IN
46745	1053	10	the	the	DT
46745	1053	11	secretions	secretion	NNS
46745	1053	12	.	.	.
46745	1054	1	The	the	DT
46745	1054	2	bile	bile	NN
46745	1054	3	is	be	VBZ
46745	1054	4	of	of	IN
46745	1054	5	higher	high	JJR
46745	1054	6	specific	specific	JJ
46745	1054	7	gravity	gravity	NN
46745	1054	8	than	than	IN
46745	1054	9	the	the	DT
46745	1054	10	serum	serum	NN
46745	1054	11	of	of	IN
46745	1054	12	blood	blood	NN
46745	1054	13	.	.	.
46745	1055	1	Urine	urine	NN
46745	1055	2	in	in	IN
46745	1055	3	health	health	NN
46745	1055	4	is	be	VBZ
46745	1055	5	lower	low	JJR
46745	1055	6	,	,	,
46745	1055	7	but	but	CC
46745	1055	8	in	in	IN
46745	1055	9	diabetes	diabete	NNS
46745	1055	10	often	often	RB
46745	1055	11	much	much	RB
46745	1055	12	higher	high	JJR
46745	1055	13	.	.	.
46745	1056	1	The	the	DT
46745	1056	2	production	production	NN
46745	1056	3	of	of	IN
46745	1056	4	these	these	DT
46745	1056	5	secretions	secretion	NNS
46745	1056	6	,	,	,
46745	1056	7	differing	differ	VBG
46745	1056	8	in	in	IN
46745	1056	9	density	density	NN
46745	1056	10	from	from	IN
46745	1056	11	the	the	DT
46745	1056	12	serum	serum	NN
46745	1056	13	of	of	IN
46745	1056	14	blood	blood	NN
46745	1056	15	,	,	,
46745	1056	16	would	would	MD
46745	1056	17	be	be	VB
46745	1056	18	inconsistent	inconsistent	JJ
46745	1056	19	with	with	IN
46745	1056	20	the	the	DT
46745	1056	21	first	first	JJ
46745	1056	22	law	law	NN
46745	1056	23	of	of	IN
46745	1056	24	endosmosis	endosmosis	NN
46745	1056	25	.	.	.
46745	1057	1	Lastly	lastly	RB
46745	1057	2	,	,	,
46745	1057	3	we	-PRON-	PRP
46745	1057	4	find	find	VBP
46745	1057	5	that	that	IN
46745	1057	6	in	in	IN
46745	1057	7	many	many	JJ
46745	1057	8	known	know	VBN
46745	1057	9	cases	case	NNS
46745	1057	10	the	the	DT
46745	1057	11	theory	theory	NN
46745	1057	12	which	which	WDT
46745	1057	13	I	-PRON-	PRP
46745	1057	14	am	be	VBP
46745	1057	15	contesting	contest	VBG
46745	1057	16	does	do	VBZ
46745	1057	17	not	not	RB
46745	1057	18	hold	hold	VB
46745	1057	19	good	good	JJ
46745	1057	20	.	.	.
46745	1058	1	Seidlitz	Seidlitz	NNP
46745	1058	2	water	water	NN
46745	1058	3	and	and	CC
46745	1058	4	sea	sea	NN
46745	1058	5	-	-	HYPH
46745	1058	6	water	water	NN
46745	1058	7	are	be	VBP
46745	1058	8	both	both	DT
46745	1058	9	known	know	VBN
46745	1058	10	to	to	TO
46745	1058	11	be	be	VB
46745	1058	12	purgative	purgative	JJ
46745	1058	13	.	.	.
46745	1059	1	In	in	IN
46745	1059	2	both	both	CC
46745	1059	3	the	the	DT
46745	1059	4	specific	specific	JJ
46745	1059	5	gravity	gravity	NN
46745	1059	6	is	be	VBZ
46745	1059	7	_	_	NNP
46745	1059	8	below	below	IN
46745	1059	9	_	_	NNP
46745	1059	10	that	that	DT
46745	1059	11	of	of	IN
46745	1059	12	the	the	DT
46745	1059	13	serum	serum	NN
46745	1059	14	of	of	IN
46745	1059	15	blood	blood	NN
46745	1059	16	.	.	.
46745	1060	1	The	the	DT
46745	1060	2	first	first	JJ
46745	1060	3	,	,	,
46745	1060	4	according	accord	VBG
46745	1060	5	to	to	IN
46745	1060	6	Bergmann	Bergmann	NNP
46745	1060	7	,	,	,
46745	1060	8	has	have	VBZ
46745	1060	9	a	a	DT
46745	1060	10	density	density	NN
46745	1060	11	of	of	IN
46745	1060	12	1.006	1.006	CD
46745	1060	13	.	.	.
46745	1061	1	It	-PRON-	PRP
46745	1061	2	contains	contain	VBZ
46745	1061	3	in	in	IN
46745	1061	4	each	each	DT
46745	1061	5	pint	pint	NN
46745	1061	6	192.8	192.8	CD
46745	1061	7	grains	grain	NNS
46745	1061	8	of	of	IN
46745	1061	9	solid	solid	JJ
46745	1061	10	matter	matter	NN
46745	1061	11	.	.	.
46745	1062	1	Out	out	IN
46745	1062	2	of	of	IN
46745	1062	3	this	this	DT
46745	1062	4	,	,	,
46745	1062	5	180	180	CD
46745	1062	6	grains	grain	NNS
46745	1062	7	consist	consist	VBP
46745	1062	8	of	of	IN
46745	1062	9	Sulphate	Sulphate	NNP
46745	1062	10	of	of	IN
46745	1062	11	Magnesia	Magnesia	NNP
46745	1062	12	.	.	.
46745	1063	1	Sea	sea	NN
46745	1063	2	-	-	HYPH
46745	1063	3	water	water	NN
46745	1063	4	has	have	VBZ
46745	1063	5	a	a	DT
46745	1063	6	specific	specific	JJ
46745	1063	7	gravity	gravity	NN
46745	1063	8	of	of	IN
46745	1063	9	1.026	1.026	CD
46745	1063	10	,	,	,
46745	1063	11	and	and	CC
46745	1063	12	its	-PRON-	PRP$
46745	1063	13	solid	solid	JJ
46745	1063	14	contents	content	NNS
46745	1063	15	are	be	VBP
46745	1063	16	about	about	RB
46745	1063	17	3.5	3.5	CD
46745	1063	18	per	per	NN
46745	1063	19	cent	cent	NN
46745	1063	20	.	.	.
46745	1064	1	But	but	CC
46745	1064	2	Dr.	Dr.	NNP
46745	1064	3	G.	G.	NNP
46745	1064	4	Bird	Bird	NNP
46745	1064	5	says	say	VBZ
46745	1064	6	that	that	IN
46745	1064	7	less	less	JJR
46745	1064	8	than	than	IN
46745	1064	9	five	five	CD
46745	1064	10	per	per	NN
46745	1064	11	cent	cent	NN
46745	1064	12	.	.	.
46745	1065	1	of	of	IN
46745	1065	2	saline	saline	NNP
46745	1065	3	matter	matter	NN
46745	1065	4	constitutes	constitute	VBZ
46745	1065	5	a	a	DT
46745	1065	6	liquid	liquid	JJ
46745	1065	7	diuretic	diuretic	NN
46745	1065	8	.	.	.
46745	1066	1	These	these	DT
46745	1066	2	,	,	,
46745	1066	3	then	then	RB
46745	1066	4	,	,	,
46745	1066	5	are	be	VBP
46745	1066	6	strong	strong	JJ
46745	1066	7	reasons	reason	NNS
46745	1066	8	against	against	IN
46745	1066	9	this	this	DT
46745	1066	10	idea	idea	NN
46745	1066	11	considered	consider	VBN
46745	1066	12	merely	merely	RB
46745	1066	13	as	as	IN
46745	1066	14	a	a	DT
46745	1066	15	theory	theory	NN
46745	1066	16	.	.	.
46745	1067	1	But	but	CC
46745	1067	2	it	-PRON-	PRP
46745	1067	3	can	can	MD
46745	1067	4	readily	readily	RB
46745	1067	5	be	be	VB
46745	1067	6	put	put	VBN
46745	1067	7	to	to	IN
46745	1067	8	the	the	DT
46745	1067	9	proof	proof	NN
46745	1067	10	.	.	.
46745	1068	1	With	with	IN
46745	1068	2	this	this	DT
46745	1068	3	purpose	purpose	NN
46745	1068	4	I	-PRON-	PRP
46745	1068	5	have	have	VBP
46745	1068	6	made	make	VBN
46745	1068	7	the	the	DT
46745	1068	8	following	follow	VBG
46745	1068	9	experiments	experiment	NNS
46745	1068	10	.	.	.
46745	1069	1	As	as	RB
46745	1069	2	far	far	RB
46745	1069	3	as	as	IN
46745	1069	4	they	-PRON-	PRP
46745	1069	5	are	be	VBP
46745	1069	6	concerned	concern	VBN
46745	1069	7	,	,	,
46745	1069	8	they	-PRON-	PRP
46745	1069	9	seem	seem	VBP
46745	1069	10	to	to	TO
46745	1069	11	show	show	VB
46745	1069	12	that	that	IN
46745	1069	13	salines	saline	NNS
46745	1069	14	are	be	VBP
46745	1069	15	in	in	IN
46745	1069	16	all	all	DT
46745	1069	17	cases	case	NNS
46745	1069	18	absorbed	absorb	VBN
46745	1069	19	,	,	,
46745	1069	20	and	and	CC
46745	1069	21	that	that	IN
46745	1069	22	whether	whether	IN
46745	1069	23	they	-PRON-	PRP
46745	1069	24	are	be	VBP
46745	1069	25	subsequently	subsequently	RB
46745	1069	26	excreted	excrete	VBN
46745	1069	27	through	through	IN
46745	1069	28	the	the	DT
46745	1069	29	kidneys	kidney	NNS
46745	1069	30	or	or	CC
46745	1069	31	by	by	IN
46745	1069	32	the	the	DT
46745	1069	33	bowels	bowel	NNS
46745	1069	34	depends	depend	VBZ
46745	1069	35	more	more	JJR
46745	1069	36	on	on	IN
46745	1069	37	the	the	DT
46745	1069	38	quantity	quantity	NN
46745	1069	39	administered	administer	VBN
46745	1069	40	than	than	IN
46745	1069	41	on	on	IN
46745	1069	42	the	the	DT
46745	1069	43	degree	degree	NN
46745	1069	44	of	of	IN
46745	1069	45	dilution	dilution	NN
46745	1069	46	of	of	IN
46745	1069	47	the	the	DT
46745	1069	48	dose	dose	NN
46745	1069	49	.	.	.
46745	1070	1	EXP	EXP	NNP
46745	1070	2	.	.	.
46745	1071	1	1.--A	1.--a	CD
46745	1071	2	sufficient	sufficient	JJ
46745	1071	3	quantity	quantity	NN
46745	1071	4	of	of	IN
46745	1071	5	white	white	JJ
46745	1071	6	sugar	sugar	NN
46745	1071	7	was	be	VBD
46745	1071	8	dissolved	dissolve	VBN
46745	1071	9	in	in	IN
46745	1071	10	four	four	CD
46745	1071	11	ounces	ounce	NNS
46745	1071	12	of	of	IN
46745	1071	13	water	water	NN
46745	1071	14	to	to	TO
46745	1071	15	raise	raise	VB
46745	1071	16	its	-PRON-	PRP$
46745	1071	17	specific	specific	JJ
46745	1071	18	gravity	gravity	NN
46745	1071	19	to	to	IN
46745	1071	20	1.028	1.028	CD
46745	1071	21	,	,	,
46745	1071	22	that	that	DT
46745	1071	23	of	of	IN
46745	1071	24	the	the	DT
46745	1071	25	serum	serum	NN
46745	1071	26	of	of	IN
46745	1071	27	the	the	DT
46745	1071	28	blood	blood	NN
46745	1071	29	.	.	.
46745	1072	1	Two	two	CD
46745	1072	2	drachms	drachm	NNS
46745	1072	3	of	of	IN
46745	1072	4	sulphate	sulphate	NN
46745	1072	5	of	of	IN
46745	1072	6	magnesia	magnesia	NNP
46745	1072	7	were	be	VBD
46745	1072	8	dissolved	dissolve	VBN
46745	1072	9	in	in	IN
46745	1072	10	another	another	DT
46745	1072	11	ounce	ounce	NN
46745	1072	12	of	of	IN
46745	1072	13	water	water	NN
46745	1072	14	,	,	,
46745	1072	15	so	so	IN
46745	1072	16	that	that	IN
46745	1072	17	the	the	DT
46745	1072	18	solution	solution	NN
46745	1072	19	measured	measure	VBD
46745	1072	20	nine	nine	CD
46745	1072	21	fluid	fluid	JJ
46745	1072	22	drachms	drachms	NN
46745	1072	23	,	,	,
46745	1072	24	and	and	CC
46745	1072	25	had	have	VBD
46745	1072	26	a	a	DT
46745	1072	27	density	density	NN
46745	1072	28	of	of	IN
46745	1072	29	1.060	1.060	CD
46745	1072	30	.	.	.
46745	1073	1	This	this	DT
46745	1073	2	heavier	heavy	JJR
46745	1073	3	solution	solution	NN
46745	1073	4	was	be	VBD
46745	1073	5	introduced	introduce	VBN
46745	1073	6	into	into	IN
46745	1073	7	an	an	DT
46745	1073	8	open	open	JJ
46745	1073	9	wide	wide	JJ
46745	1073	10	tube	tube	NN
46745	1073	11	,	,	,
46745	1073	12	closed	close	VBD
46745	1073	13	completely	completely	RB
46745	1073	14	below	below	IN
46745	1073	15	by	by	IN
46745	1073	16	a	a	DT
46745	1073	17	clean	clean	JJ
46745	1073	18	piece	piece	NN
46745	1073	19	of	of	IN
46745	1073	20	bladder	bladder	NN
46745	1073	21	.	.	.
46745	1074	1	It	-PRON-	PRP
46745	1074	2	was	be	VBD
46745	1074	3	introduced	introduce	VBN
46745	1074	4	into	into	IN
46745	1074	5	a	a	DT
46745	1074	6	small	small	JJ
46745	1074	7	vessel	vessel	NN
46745	1074	8	containing	contain	VBG
46745	1074	9	the	the	DT
46745	1074	10	solution	solution	NN
46745	1074	11	of	of	IN
46745	1074	12	sugar	sugar	NN
46745	1074	13	,	,	,
46745	1074	14	and	and	CC
46745	1074	15	arranged	arrange	VBD
46745	1074	16	so	so	IN
46745	1074	17	that	that	IN
46745	1074	18	the	the	DT
46745	1074	19	height	height	NN
46745	1074	20	of	of	IN
46745	1074	21	the	the	DT
46745	1074	22	two	two	CD
46745	1074	23	liquids	liquid	NNS
46745	1074	24	should	should	MD
46745	1074	25	correspond	correspond	VB
46745	1074	26	.	.	.
46745	1075	1	After	after	IN
46745	1075	2	three	three	CD
46745	1075	3	days	day	NNS
46745	1075	4	,	,	,
46745	1075	5	the	the	DT
46745	1075	6	inner	inner	JJ
46745	1075	7	solution	solution	NN
46745	1075	8	measured	measure	VBD
46745	1075	9	two	two	CD
46745	1075	10	drachms	drachm	NNS
46745	1075	11	more	more	JJR
46745	1075	12	,	,	,
46745	1075	13	and	and	CC
46745	1075	14	the	the	DT
46745	1075	15	specific	specific	JJ
46745	1075	16	gravity	gravity	NN
46745	1075	17	had	have	VBD
46745	1075	18	sunk	sink	VBN
46745	1075	19	to	to	IN
46745	1075	20	1.050	1.050	CD
46745	1075	21	.	.	.
46745	1076	1	The	the	DT
46745	1076	2	outer	outer	JJ
46745	1076	3	solution	solution	NN
46745	1076	4	,	,	,
46745	1076	5	after	after	IN
46745	1076	6	making	make	VBG
46745	1076	7	up	up	RP
46745	1076	8	exactly	exactly	RB
46745	1076	9	the	the	DT
46745	1076	10	loss	loss	NN
46745	1076	11	by	by	IN
46745	1076	12	evaporation	evaporation	NN
46745	1076	13	,	,	,
46745	1076	14	was	be	VBD
46745	1076	15	found	find	VBN
46745	1076	16	to	to	TO
46745	1076	17	have	have	VB
46745	1076	18	risen	rise	VBN
46745	1076	19	in	in	IN
46745	1076	20	density	density	NN
46745	1076	21	to	to	IN
46745	1076	22	1.040	1.040	CD
46745	1076	23	.	.	.
46745	1077	1	On	on	IN
46745	1077	2	adding	add	VBG
46745	1077	3	a	a	DT
46745	1077	4	small	small	JJ
46745	1077	5	quantity	quantity	NN
46745	1077	6	each	each	DT
46745	1077	7	of	of	IN
46745	1077	8	the	the	DT
46745	1077	9	solutions	solution	NNS
46745	1077	10	of	of	IN
46745	1077	11	phosphate	phosphate	NN
46745	1077	12	of	of	IN
46745	1077	13	soda	soda	NN
46745	1077	14	and	and	CC
46745	1077	15	carbonate	carbonate	NN
46745	1077	16	of	of	IN
46745	1077	17	ammonia	ammonia	NNP
46745	1077	18	,	,	,
46745	1077	19	a	a	DT
46745	1077	20	copious	copious	JJ
46745	1077	21	precipitate	precipitate	NN
46745	1077	22	took	take	VBD
46745	1077	23	place	place	NN
46745	1077	24	,	,	,
46745	1077	25	indicating	indicate	VBG
46745	1077	26	the	the	DT
46745	1077	27	presence	presence	NN
46745	1077	28	of	of	IN
46745	1077	29	magnesia	magnesia	NNP
46745	1077	30	.	.	.
46745	1078	1	Thus	thus	RB
46745	1078	2	it	-PRON-	PRP
46745	1078	3	appeared	appear	VBD
46745	1078	4	that	that	IN
46745	1078	5	the	the	DT
46745	1078	6	fluids	fluid	NNS
46745	1078	7	passed	pass	VBD
46745	1078	8	both	both	DT
46745	1078	9	ways	way	NNS
46745	1078	10	,	,	,
46745	1078	11	some	some	DT
46745	1078	12	of	of	IN
46745	1078	13	the	the	DT
46745	1078	14	heavy	heavy	JJ
46745	1078	15	solution	solution	NN
46745	1078	16	of	of	IN
46745	1078	17	magnesia	magnesia	NNP
46745	1078	18	finding	find	VBG
46745	1078	19	its	-PRON-	PRP$
46745	1078	20	way	way	NN
46745	1078	21	through	through	IN
46745	1078	22	to	to	IN
46745	1078	23	the	the	DT
46745	1078	24	lighter	light	JJR
46745	1078	25	solution	solution	NN
46745	1078	26	of	of	IN
46745	1078	27	sugar	sugar	NN
46745	1078	28	.	.	.
46745	1079	1	The	the	DT
46745	1079	2	tendency	tendency	NN
46745	1079	3	of	of	IN
46745	1079	4	this	this	DT
46745	1079	5	process	process	NN
46745	1079	6	was	be	VBD
46745	1079	7	evidently	evidently	RB
46745	1079	8	to	to	IN
46745	1079	9	an	an	DT
46745	1079	10	equalization	equalization	NN
46745	1079	11	of	of	IN
46745	1079	12	their	-PRON-	PRP$
46745	1079	13	densities	density	NNS
46745	1079	14	,	,	,
46745	1079	15	both	both	CC
46745	1079	16	by	by	IN
46745	1079	17	endosmose	endosmose	JJ
46745	1079	18	one	one	CD
46745	1079	19	way	way	NN
46745	1079	20	and	and	CC
46745	1079	21	by	by	IN
46745	1079	22	exosmose	exosmose	VB
46745	1079	23	the	the	DT
46745	1079	24	other	other	JJ
46745	1079	25	.	.	.
46745	1080	1	Thus	thus	RB
46745	1080	2	,	,	,
46745	1080	3	apparently	apparently	RB
46745	1080	4	,	,	,
46745	1080	5	would	would	MD
46745	1080	6	it	-PRON-	PRP
46745	1080	7	be	be	VB
46745	1080	8	with	with	IN
46745	1080	9	a	a	DT
46745	1080	10	saline	saline	NN
46745	1080	11	purgative	purgative	JJ
46745	1080	12	,	,	,
46745	1080	13	and	and	CC
46745	1080	14	with	with	IN
46745	1080	15	the	the	DT
46745	1080	16	serum	serum	NN
46745	1080	17	of	of	IN
46745	1080	18	the	the	DT
46745	1080	19	blood	blood	NN
46745	1080	20	.	.	.
46745	1081	1	EXP	EXP	NNP
46745	1081	2	.	.	.
46745	1082	1	2.--Three	2.--three	CD
46745	1082	2	drachms	drachm	NNS
46745	1082	3	of	of	IN
46745	1082	4	Sulphate	Sulphate	NNP
46745	1082	5	of	of	IN
46745	1082	6	Magnesia	Magnesia	NNP
46745	1082	7	(	(	-LRB-
46745	1082	8	a	a	DT
46745	1082	9	very	very	RB
46745	1082	10	mild	mild	JJ
46745	1082	11	purgative	purgative	JJ
46745	1082	12	dose	dose	NN
46745	1082	13	)	)	-RRB-
46745	1082	14	were	be	VBD
46745	1082	15	dissolved	dissolve	VBN
46745	1082	16	in	in	IN
46745	1082	17	ten	ten	CD
46745	1082	18	ounces	ounce	NNS
46745	1082	19	of	of	IN
46745	1082	20	water	water	NN
46745	1082	21	,	,	,
46745	1082	22	and	and	CC
46745	1082	23	thus	thus	RB
46745	1082	24	administered	administer	VBN
46745	1082	25	to	to	IN
46745	1082	26	a	a	DT
46745	1082	27	healthy	healthy	JJ
46745	1082	28	young	young	JJ
46745	1082	29	man	man	NN
46745	1082	30	.	.	.
46745	1083	1	It	-PRON-	PRP
46745	1083	2	produced	produce	VBD
46745	1083	3	,	,	,
46745	1083	4	after	after	IN
46745	1083	5	some	some	DT
46745	1083	6	time	time	NN
46745	1083	7	,	,	,
46745	1083	8	slight	slight	JJ
46745	1083	9	purging	purging	NN
46745	1083	10	,	,	,
46745	1083	11	and	and	CC
46745	1083	12	some	some	DT
46745	1083	13	diuresis	diuresis	NN
46745	1083	14	.	.	.
46745	1084	1	The	the	DT
46745	1084	2	urine	urine	NN
46745	1084	3	,	,	,
46745	1084	4	when	when	WRB
46745	1084	5	tested	test	VBN
46745	1084	6	,	,	,
46745	1084	7	contained	contain	VBD
46745	1084	8	only	only	RB
46745	1084	9	a	a	DT
46745	1084	10	very	very	RB
46745	1084	11	little	little	JJ
46745	1084	12	more	more	JJR
46745	1084	13	than	than	IN
46745	1084	14	the	the	DT
46745	1084	15	usual	usual	JJ
46745	1084	16	quantity	quantity	NN
46745	1084	17	of	of	IN
46745	1084	18	magnesia	magnesia	NNP
46745	1084	19	.	.	.
46745	1085	1	The	the	DT
46745	1085	2	quantity	quantity	NN
46745	1085	3	in	in	IN
46745	1085	4	the	the	DT
46745	1085	5	dose	dose	NN
46745	1085	6	was	be	VBD
46745	1085	7	less	less	JJR
46745	1085	8	than	than	IN
46745	1085	9	five	five	CD
46745	1085	10	per	per	NN
46745	1085	11	cent	cent	NN
46745	1085	12	.	.	.
46745	1086	1	of	of	IN
46745	1086	2	the	the	DT
46745	1086	3	solution	solution	NN
46745	1086	4	,	,	,
46745	1086	5	and	and	CC
46745	1086	6	thus	thus	RB
46745	1086	7	,	,	,
46745	1086	8	according	accord	VBG
46745	1086	9	to	to	IN
46745	1086	10	the	the	DT
46745	1086	11	endosmotic	endosmotic	JJ
46745	1086	12	theory	theory	NN
46745	1086	13	,	,	,
46745	1086	14	should	should	MD
46745	1086	15	have	have	VB
46745	1086	16	produced	produce	VBN
46745	1086	17	no	no	DT
46745	1086	18	purging	purging	NN
46745	1086	19	.	.	.
46745	1087	1	EXP	EXP	NNP
46745	1087	2	.	.	.
46745	1088	1	3.--Six	3.--six	CD
46745	1088	2	drachms	drachms	NN
46745	1088	3	of	of	IN
46745	1088	4	the	the	DT
46745	1088	5	same	same	JJ
46745	1088	6	salt	salt	NN
46745	1088	7	were	be	VBD
46745	1088	8	given	give	VBN
46745	1088	9	in	in	IN
46745	1088	10	eighteen	eighteen	CD
46745	1088	11	ounces	ounce	NNS
46745	1088	12	of	of	IN
46745	1088	13	water	water	NN
46745	1088	14	to	to	IN
46745	1088	15	the	the	DT
46745	1088	16	same	same	JJ
46745	1088	17	patient	patient	NN
46745	1088	18	.	.	.
46745	1089	1	After	after	IN
46745	1089	2	a	a	DT
46745	1089	3	few	few	JJ
46745	1089	4	hours	hour	NNS
46745	1089	5	,	,	,
46745	1089	6	it	-PRON-	PRP
46745	1089	7	caused	cause	VBD
46745	1089	8	very	very	RB
46745	1089	9	copious	copious	JJ
46745	1089	10	and	and	CC
46745	1089	11	long	long	JJ
46745	1089	12	-	-	HYPH
46745	1089	13	continued	continue	VBN
46745	1089	14	watery	watery	JJ
46745	1089	15	purging	purging	NN
46745	1089	16	.	.	.
46745	1090	1	The	the	DT
46745	1090	2	urine	urine	NN
46745	1090	3	did	do	VBD
46745	1090	4	not	not	RB
46745	1090	5	seem	seem	VB
46745	1090	6	to	to	TO
46745	1090	7	be	be	VB
46745	1090	8	increased	increase	VBN
46745	1090	9	,	,	,
46745	1090	10	and	and	CC
46745	1090	11	contained	contain	VBD
46745	1090	12	no	no	DT
46745	1090	13	excess	excess	NN
46745	1090	14	of	of	IN
46745	1090	15	magnesia	magnesia	NNP
46745	1090	16	.	.	.
46745	1091	1	It	-PRON-	PRP
46745	1091	2	seemed	seem	VBD
46745	1091	3	,	,	,
46745	1091	4	that	that	IN
46745	1091	5	in	in	IN
46745	1091	6	spite	spite	NN
46745	1091	7	of	of	IN
46745	1091	8	the	the	DT
46745	1091	9	dilution	dilution	NN
46745	1091	10	,	,	,
46745	1091	11	the	the	DT
46745	1091	12	quantity	quantity	NN
46745	1091	13	of	of	IN
46745	1091	14	the	the	DT
46745	1091	15	salt	salt	NN
46745	1091	16	was	be	VBD
46745	1091	17	so	so	RB
46745	1091	18	large	large	JJ
46745	1091	19	,	,	,
46745	1091	20	that	that	IN
46745	1091	21	it	-PRON-	PRP
46745	1091	22	could	could	MD
46745	1091	23	not	not	RB
46745	1091	24	pass	pass	VB
46745	1091	25	off	off	RP
46745	1091	26	by	by	IN
46745	1091	27	the	the	DT
46745	1091	28	kidneys	kidney	NNS
46745	1091	29	,	,	,
46745	1091	30	and	and	CC
46745	1091	31	so	so	RB
46745	1091	32	was	be	VBD
46745	1091	33	eliminated	eliminate	VBN
46745	1091	34	from	from	IN
46745	1091	35	the	the	DT
46745	1091	36	blood	blood	NN
46745	1091	37	by	by	IN
46745	1091	38	the	the	DT
46745	1091	39	bowels	bowel	NNS
46745	1091	40	,	,	,
46745	1091	41	in	in	IN
46745	1091	42	the	the	DT
46745	1091	43	same	same	JJ
46745	1091	44	way	way	NN
46745	1091	45	as	as	IN
46745	1091	46	other	other	JJ
46745	1091	47	purgative	purgative	JJ
46745	1091	48	medicines	medicine	NNS
46745	1091	49	.	.	.
46745	1092	1	(	(	-LRB-
46745	1092	2	_	_	NNP
46745	1092	3	Vide	Vide	NNP
46745	1092	4	_	_	NNP
46745	1092	5	Chap	Chap	NNP
46745	1092	6	.	.	.
46745	1093	1	IV	IV	NNP
46745	1093	2	.	.	.
46745	1093	3	)	)	-RRB-
46745	1094	1	EXP	EXP	NNP
46745	1094	2	.	.	.
46745	1095	1	4.--This	4.--this	CD
46745	1095	2	trial	trial	NN
46745	1095	3	was	be	VBD
46745	1095	4	the	the	DT
46745	1095	5	reverse	reverse	NN
46745	1095	6	of	of	IN
46745	1095	7	the	the	DT
46745	1095	8	last	last	JJ
46745	1095	9	.	.	.
46745	1096	1	Two	two	CD
46745	1096	2	scruples	scruple	NNS
46745	1096	3	of	of	IN
46745	1096	4	Acetate	Acetate	NNP
46745	1096	5	of	of	IN
46745	1096	6	Potash	Potash	NNP
46745	1096	7	were	be	VBD
46745	1096	8	dissolved	dissolve	VBN
46745	1096	9	in	in	IN
46745	1096	10	three	three	CD
46745	1096	11	drachms	drachm	NNS
46745	1096	12	of	of	IN
46745	1096	13	water	water	NN
46745	1096	14	,	,	,
46745	1096	15	and	and	CC
46745	1096	16	thus	thus	RB
46745	1096	17	administered	administer	VBN
46745	1096	18	.	.	.
46745	1097	1	The	the	DT
46745	1097	2	solution	solution	NN
46745	1097	3	then	then	RB
46745	1097	4	contained	contain	VBD
46745	1097	5	about	about	RB
46745	1097	6	twenty	twenty	CD
46745	1097	7	per	per	IN
46745	1097	8	cent	cent	NN
46745	1097	9	.	.	.
46745	1098	1	of	of	IN
46745	1098	2	the	the	DT
46745	1098	3	salt	salt	NN
46745	1098	4	.	.	.
46745	1099	1	According	accord	VBG
46745	1099	2	to	to	IN
46745	1099	3	the	the	DT
46745	1099	4	endosmotic	endosmotic	JJ
46745	1099	5	theory	theory	NN
46745	1099	6	,	,	,
46745	1099	7	it	-PRON-	PRP
46745	1099	8	should	should	MD
46745	1099	9	have	have	VB
46745	1099	10	caused	cause	VBN
46745	1099	11	only	only	RB
46745	1099	12	slight	slight	JJ
46745	1099	13	purging	purging	NN
46745	1099	14	,	,	,
46745	1099	15	on	on	IN
46745	1099	16	account	account	NN
46745	1099	17	of	of	IN
46745	1099	18	its	-PRON-	PRP$
46745	1099	19	density	density	NN
46745	1099	20	.	.	.
46745	1100	1	It	-PRON-	PRP
46745	1100	2	did	do	VBD
46745	1100	3	not	not	RB
46745	1100	4	do	do	VB
46745	1100	5	so	so	RB
46745	1100	6	,	,	,
46745	1100	7	but	but	CC
46745	1100	8	produced	produce	VBD
46745	1100	9	diuresis	diuresis	NN
46745	1100	10	.	.	.
46745	1101	1	The	the	DT
46745	1101	2	dose	dose	NN
46745	1101	3	was	be	VBD
46745	1101	4	so	so	RB
46745	1101	5	small	small	JJ
46745	1101	6	,	,	,
46745	1101	7	that	that	IN
46745	1101	8	after	after	IN
46745	1101	9	absorption	absorption	NN
46745	1101	10	it	-PRON-	PRP
46745	1101	11	was	be	VBD
46745	1101	12	easily	easily	RB
46745	1101	13	eliminated	eliminate	VBN
46745	1101	14	by	by	IN
46745	1101	15	the	the	DT
46745	1101	16	kidneys	kidney	NNS
46745	1101	17	.	.	.
46745	1102	1	These	these	DT
46745	1102	2	experiments	experiment	NNS
46745	1102	3	are	be	VBP
46745	1102	4	in	in	IN
46745	1102	5	favour	favour	NN
46745	1102	6	of	of	IN
46745	1102	7	my	-PRON-	PRP$
46745	1102	8	views	view	NNS
46745	1102	9	,	,	,
46745	1102	10	and	and	CC
46745	1102	11	seem	seem	VB
46745	1102	12	,	,	,
46745	1102	13	as	as	RB
46745	1102	14	far	far	RB
46745	1102	15	as	as	IN
46745	1102	16	they	-PRON-	PRP
46745	1102	17	go	go	VBP
46745	1102	18	,	,	,
46745	1102	19	to	to	TO
46745	1102	20	cast	cast	VB
46745	1102	21	discredit	discredit	NN
46745	1102	22	on	on	IN
46745	1102	23	the	the	DT
46745	1102	24	theory	theory	NN
46745	1102	25	of	of	IN
46745	1102	26	Poisseuille	Poisseuille	NNP
46745	1102	27	.	.	.
46745	1103	1	It	-PRON-	PRP
46745	1103	2	will	will	MD
46745	1103	3	be	be	VB
46745	1103	4	very	very	RB
46745	1103	5	easy	easy	JJ
46745	1103	6	to	to	TO
46745	1103	7	multiply	multiply	VB
46745	1103	8	them	-PRON-	PRP
46745	1103	9	,	,	,
46745	1103	10	so	so	IN
46745	1103	11	as	as	IN
46745	1103	12	to	to	TO
46745	1103	13	place	place	VB
46745	1103	14	the	the	DT
46745	1103	15	fact	fact	NN
46745	1103	16	beyond	beyond	IN
46745	1103	17	a	a	DT
46745	1103	18	doubt	doubt	NN
46745	1103	19	.	.	.
46745	1104	1	[	[	-LRB-
46745	1104	2	24	24	CD
46745	1104	3	]	]	-RRB-
46745	1104	4	This	this	DT
46745	1104	5	point	point	NN
46745	1104	6	being	be	VBG
46745	1104	7	so	so	RB
46745	1104	8	far	far	RB
46745	1104	9	settled	settle	VBN
46745	1104	10	,	,	,
46745	1104	11	and	and	CC
46745	1104	12	there	there	EX
46745	1104	13	being	be	VBG
46745	1104	14	no	no	DT
46745	1104	15	physical	physical	JJ
46745	1104	16	reason	reason	NN
46745	1104	17	why	why	WRB
46745	1104	18	any	any	DT
46745	1104	19	other	other	JJ
46745	1104	20	soluble	soluble	JJ
46745	1104	21	mineral	mineral	NN
46745	1104	22	substance	substance	NN
46745	1104	23	should	should	MD
46745	1104	24	not	not	RB
46745	1104	25	be	be	VB
46745	1104	26	absorbed	absorb	VBN
46745	1104	27	--	--	:
46745	1104	28	it	-PRON-	PRP
46745	1104	29	being	be	VBG
46745	1104	30	,	,	,
46745	1104	31	moreover	moreover	RB
46745	1104	32	,	,	,
46745	1104	33	proved	prove	VBD
46745	1104	34	,	,	,
46745	1104	35	by	by	IN
46745	1104	36	repeated	repeat	VBN
46745	1104	37	experiments	experiment	NNS
46745	1104	38	,	,	,
46745	1104	39	that	that	IN
46745	1104	40	they	-PRON-	PRP
46745	1104	41	all	all	DT
46745	1104	42	pass	pass	VBP
46745	1104	43	into	into	IN
46745	1104	44	the	the	DT
46745	1104	45	blood	blood	NN
46745	1104	46	,	,	,
46745	1104	47	we	-PRON-	PRP
46745	1104	48	therefore	therefore	RB
46745	1104	49	proceed	proceed	VBP
46745	1104	50	to	to	IN
46745	1104	51	the	the	DT
46745	1104	52	second	second	JJ
46745	1104	53	class	class	NN
46745	1104	54	of	of	IN
46745	1104	55	bodies	body	NNS
46745	1104	56	capable	capable	JJ
46745	1104	57	of	of	IN
46745	1104	58	absorption	absorption	NN
46745	1104	59	.	.	.
46745	1105	1	2	2	LS
46745	1105	2	.	.	.
46745	1106	1	Mineral	mineral	NN
46745	1106	2	substances	substance	NNS
46745	1106	3	soluble	soluble	JJ
46745	1106	4	in	in	IN
46745	1106	5	acids.--It	acids.--it	NN
46745	1106	6	is	be	VBZ
46745	1106	7	apparent	apparent	JJ
46745	1106	8	that	that	IN
46745	1106	9	if	if	IN
46745	1106	10	any	any	DT
46745	1106	11	insoluble	insoluble	JJ
46745	1106	12	substance	substance	NN
46745	1106	13	will	will	MD
46745	1106	14	admit	admit	VB
46745	1106	15	of	of	IN
46745	1106	16	easy	easy	JJ
46745	1106	17	solution	solution	NN
46745	1106	18	in	in	IN
46745	1106	19	the	the	DT
46745	1106	20	fluids	fluid	NNS
46745	1106	21	of	of	IN
46745	1106	22	the	the	DT
46745	1106	23	stomach	stomach	NN
46745	1106	24	and	and	CC
46745	1106	25	intestines	intestine	NNS
46745	1106	26	,	,	,
46745	1106	27	it	-PRON-	PRP
46745	1106	28	may	may	MD
46745	1106	29	be	be	VB
46745	1106	30	brought	bring	VBN
46745	1106	31	to	to	IN
46745	1106	32	the	the	DT
46745	1106	33	condition	condition	NN
46745	1106	34	of	of	IN
46745	1106	35	a	a	DT
46745	1106	36	soluble	soluble	JJ
46745	1106	37	one	one	NN
46745	1106	38	and	and	CC
46745	1106	39	thus	thus	RB
46745	1106	40	absorbed	absorb	VBN
46745	1106	41	.	.	.
46745	1107	1	Now	now	RB
46745	1107	2	the	the	DT
46745	1107	3	gastric	gastric	JJ
46745	1107	4	juice	juice	NN
46745	1107	5	is	be	VBZ
46745	1107	6	acid	acid	JJ
46745	1107	7	.	.	.
46745	1108	1	This	this	DT
46745	1108	2	secretion	secretion	NN
46745	1108	3	has	have	VBZ
46745	1108	4	been	be	VBN
46745	1108	5	variously	variously	RB
46745	1108	6	ascribed	ascribe	VBN
46745	1108	7	to	to	TO
46745	1108	8	free	free	VB
46745	1108	9	hydrochloric	hydrochloric	JJ
46745	1108	10	,	,	,
46745	1108	11	acetic	acetic	JJ
46745	1108	12	,	,	,
46745	1108	13	phosphoric	phosphoric	NN
46745	1108	14	,	,	,
46745	1108	15	and	and	CC
46745	1108	16	lactic	lactic	JJ
46745	1108	17	acids	acid	NNS
46745	1108	18	;	;	:
46745	1108	19	also	also	RB
46745	1108	20	to	to	IN
46745	1108	21	an	an	DT
46745	1108	22	acid	acid	JJ
46745	1108	23	phosphate	phosphate	NN
46745	1108	24	or	or	CC
46745	1108	25	lactate	lactate	NN
46745	1108	26	of	of	IN
46745	1108	27	magnesia	magnesia	NNP
46745	1108	28	.	.	.
46745	1109	1	There	there	EX
46745	1109	2	seems	seem	VBZ
46745	1109	3	to	to	TO
46745	1109	4	be	be	VB
46745	1109	5	most	most	JJS
46745	1109	6	reason	reason	NN
46745	1109	7	to	to	TO
46745	1109	8	conclude	conclude	VB
46745	1109	9	that	that	IN
46745	1109	10	it	-PRON-	PRP
46745	1109	11	is	be	VBZ
46745	1109	12	lactic	lactic	JJ
46745	1109	13	acid	acid	NN
46745	1109	14	,	,	,
46745	1109	15	which	which	WDT
46745	1109	16	would	would	MD
46745	1109	17	be	be	VB
46745	1109	18	easily	easily	RB
46745	1109	19	formed	form	VBN
46745	1109	20	out	out	IN
46745	1109	21	of	of	IN
46745	1109	22	the	the	DT
46745	1109	23	constituents	constituent	NNS
46745	1109	24	of	of	IN
46745	1109	25	the	the	DT
46745	1109	26	food	food	NN
46745	1109	27	.	.	.
46745	1110	1	[	[	-LRB-
46745	1110	2	25	25	CD
46745	1110	3	]	]	-RRB-
46745	1110	4	But	but	CC
46745	1110	5	we	-PRON-	PRP
46745	1110	6	have	have	VBP
46745	1110	7	now	now	RB
46745	1110	8	only	only	RB
46745	1110	9	to	to	TO
46745	1110	10	regard	regard	VB
46745	1110	11	the	the	DT
46745	1110	12	gastric	gastric	JJ
46745	1110	13	juice	juice	NN
46745	1110	14	as	as	IN
46745	1110	15	containing	contain	VBG
46745	1110	16	a	a	DT
46745	1110	17	free	free	JJ
46745	1110	18	acid	acid	NN
46745	1110	19	.	.	.
46745	1111	1	This	this	DT
46745	1111	2	would	would	MD
46745	1111	3	reduce	reduce	VB
46745	1111	4	to	to	TO
46745	1111	5	solution	solution	VB
46745	1111	6	the	the	DT
46745	1111	7	carbonates	carbonate	NNS
46745	1111	8	and	and	CC
46745	1111	9	oxides	oxide	NNS
46745	1111	10	of	of	IN
46745	1111	11	all	all	PDT
46745	1111	12	the	the	DT
46745	1111	13	metals	metal	NNS
46745	1111	14	;	;	:
46745	1111	15	less	less	RBR
46745	1111	16	perfectly	perfectly	RB
46745	1111	17	when	when	WRB
46745	1111	18	anhydrous	anhydrous	JJ
46745	1111	19	,	,	,
46745	1111	20	more	more	RBR
46745	1111	21	easily	easily	RB
46745	1111	22	when	when	WRB
46745	1111	23	in	in	IN
46745	1111	24	the	the	DT
46745	1111	25	hydrated	hydrated	JJ
46745	1111	26	form	form	NN
46745	1111	27	.	.	.
46745	1112	1	In	in	IN
46745	1112	2	this	this	DT
46745	1112	3	manner	manner	NN
46745	1112	4	are	be	VBP
46745	1112	5	absorbed	absorb	VBN
46745	1112	6	the	the	DT
46745	1112	7	oxides	oxide	NNS
46745	1112	8	of	of	IN
46745	1112	9	Iron	Iron	NNP
46745	1112	10	and	and	CC
46745	1112	11	Silver	Silver	NNP
46745	1112	12	,	,	,
46745	1112	13	the	the	DT
46745	1112	14	carbonates	carbonate	NNS
46745	1112	15	of	of	IN
46745	1112	16	Lime	Lime	NNP
46745	1112	17	and	and	CC
46745	1112	18	Magnesia	Magnesia	NNP
46745	1112	19	,	,	,
46745	1112	20	and	and	CC
46745	1112	21	other	other	JJ
46745	1112	22	medicines	medicine	NNS
46745	1112	23	of	of	IN
46745	1112	24	the	the	DT
46745	1112	25	same	same	JJ
46745	1112	26	kind	kind	NN
46745	1112	27	.	.	.
46745	1113	1	They	-PRON-	PRP
46745	1113	2	would	would	MD
46745	1113	3	be	be	VB
46745	1113	4	slightly	slightly	RB
46745	1113	5	modified	modify	VBN
46745	1113	6	,	,	,
46745	1113	7	being	be	VBG
46745	1113	8	absorbed	absorb	VBN
46745	1113	9	in	in	IN
46745	1113	10	combination	combination	NN
46745	1113	11	with	with	IN
46745	1113	12	the	the	DT
46745	1113	13	(	(	-LRB-
46745	1113	14	lactic	lactic	JJ
46745	1113	15	)	)	-RRB-
46745	1113	16	acid	acid	NN
46745	1113	17	of	of	IN
46745	1113	18	the	the	DT
46745	1113	19	stomach	stomach	NN
46745	1113	20	.	.	.
46745	1114	1	In	in	IN
46745	1114	2	this	this	DT
46745	1114	3	they	-PRON-	PRP
46745	1114	4	would	would	MD
46745	1114	5	differ	differ	VB
46745	1114	6	somewhat	somewhat	RB
46745	1114	7	from	from	IN
46745	1114	8	the	the	DT
46745	1114	9	substances	substance	NNS
46745	1114	10	already	already	RB
46745	1114	11	soluble	soluble	JJ
46745	1114	12	,	,	,
46745	1114	13	which	which	WDT
46745	1114	14	would	would	MD
46745	1114	15	probably	probably	RB
46745	1114	16	be	be	VB
46745	1114	17	absorbed	absorb	VBN
46745	1114	18	unchanged	unchanged	JJ
46745	1114	19	,	,	,
46745	1114	20	unless	unless	IN
46745	1114	21	we	-PRON-	PRP
46745	1114	22	except	except	IN
46745	1114	23	the	the	DT
46745	1114	24	alkalies	alkali	NNS
46745	1114	25	and	and	CC
46745	1114	26	their	-PRON-	PRP$
46745	1114	27	carbonates	carbonate	NNS
46745	1114	28	,	,	,
46745	1114	29	which	which	WDT
46745	1114	30	might	may	MD
46745	1114	31	be	be	VB
46745	1114	32	similarly	similarly	RB
46745	1114	33	decomposed	decompose	VBN
46745	1114	34	.	.	.
46745	1115	1	Even	even	RB
46745	1115	2	these	these	DT
46745	1115	3	,	,	,
46745	1115	4	if	if	IN
46745	1115	5	given	give	VBN
46745	1115	6	in	in	IN
46745	1115	7	solution	solution	NN
46745	1115	8	,	,	,
46745	1115	9	would	would	MD
46745	1115	10	probably	probably	RB
46745	1115	11	be	be	VB
46745	1115	12	absorbed	absorb	VBN
46745	1115	13	faster	fast	RBR
46745	1115	14	than	than	IN
46745	1115	15	the	the	DT
46745	1115	16	gastric	gastric	JJ
46745	1115	17	acid	acid	NN
46745	1115	18	could	could	MD
46745	1115	19	be	be	VB
46745	1115	20	secreted	secrete	VBN
46745	1115	21	to	to	TO
46745	1115	22	neutralize	neutralize	VB
46745	1115	23	them	-PRON-	PRP
46745	1115	24	.	.	.
46745	1116	1	Other	other	JJ
46745	1116	2	insoluble	insoluble	JJ
46745	1116	3	substances	substance	NNS
46745	1116	4	,	,	,
46745	1116	5	such	such	JJ
46745	1116	6	as	as	IN
46745	1116	7	calomel	calomel	NN
46745	1116	8	and	and	CC
46745	1116	9	metallic	metallic	JJ
46745	1116	10	sulphurets	sulphuret	NNS
46745	1116	11	,	,	,
46745	1116	12	would	would	MD
46745	1116	13	be	be	VB
46745	1116	14	more	more	RBR
46745	1116	15	or	or	CC
46745	1116	16	less	less	RBR
46745	1116	17	dissolved	dissolve	VBN
46745	1116	18	by	by	IN
46745	1116	19	the	the	DT
46745	1116	20	action	action	NN
46745	1116	21	of	of	IN
46745	1116	22	this	this	DT
46745	1116	23	acid	acid	NN
46745	1116	24	.	.	.
46745	1117	1	But	but	CC
46745	1117	2	as	as	IN
46745	1117	3	a	a	DT
46745	1117	4	great	great	JJ
46745	1117	5	part	part	NN
46745	1117	6	would	would	MD
46745	1117	7	necessarily	necessarily	RB
46745	1117	8	escape	escape	VB
46745	1117	9	its	-PRON-	PRP$
46745	1117	10	influence	influence	NN
46745	1117	11	,	,	,
46745	1117	12	being	be	VBG
46745	1117	13	propelled	propel	VBN
46745	1117	14	onwards	onwards	RB
46745	1117	15	by	by	IN
46745	1117	16	the	the	DT
46745	1117	17	muscular	muscular	JJ
46745	1117	18	contraction	contraction	NN
46745	1117	19	of	of	IN
46745	1117	20	the	the	DT
46745	1117	21	stomach	stomach	NN
46745	1117	22	,	,	,
46745	1117	23	it	-PRON-	PRP
46745	1117	24	follows	follow	VBZ
46745	1117	25	that	that	IN
46745	1117	26	insoluble	insoluble	JJ
46745	1117	27	substances	substance	NNS
46745	1117	28	of	of	IN
46745	1117	29	this	this	DT
46745	1117	30	kind	kind	NN
46745	1117	31	are	be	VBP
46745	1117	32	much	much	RB
46745	1117	33	less	less	RBR
46745	1117	34	active	active	JJ
46745	1117	35	as	as	IN
46745	1117	36	medicines	medicine	NNS
46745	1117	37	than	than	IN
46745	1117	38	similar	similar	JJ
46745	1117	39	compounds	compound	NNS
46745	1117	40	introduced	introduce	VBN
46745	1117	41	in	in	IN
46745	1117	42	a	a	DT
46745	1117	43	soluble	soluble	JJ
46745	1117	44	state	state	NN
46745	1117	45	.	.	.
46745	1118	1	It	-PRON-	PRP
46745	1118	2	is	be	VBZ
46745	1118	3	also	also	RB
46745	1118	4	likely	likely	JJ
46745	1118	5	that	that	IN
46745	1118	6	a	a	DT
46745	1118	7	certain	certain	JJ
46745	1118	8	quantity	quantity	NN
46745	1118	9	would	would	MD
46745	1118	10	be	be	VB
46745	1118	11	sufficient	sufficient	JJ
46745	1118	12	to	to	TO
46745	1118	13	exhaust	exhaust	VB
46745	1118	14	for	for	IN
46745	1118	15	a	a	DT
46745	1118	16	time	time	NN
46745	1118	17	the	the	DT
46745	1118	18	acid	acid	NNP
46745	1118	19	gastric	gastric	JJ
46745	1118	20	secretion	secretion	NN
46745	1118	21	.	.	.
46745	1119	1	We	-PRON-	PRP
46745	1119	2	now	now	RB
46745	1119	3	pass	pass	VBP
46745	1119	4	on	on	RP
46745	1119	5	to	to	IN
46745	1119	6	a	a	DT
46745	1119	7	third	third	JJ
46745	1119	8	class	class	NN
46745	1119	9	of	of	IN
46745	1119	10	mineral	mineral	NN
46745	1119	11	products	product	NNS
46745	1119	12	,	,	,
46745	1119	13	which	which	WDT
46745	1119	14	,	,	,
46745	1119	15	though	though	IN
46745	1119	16	insoluble	insoluble	JJ
46745	1119	17	both	both	DT
46745	1119	18	in	in	IN
46745	1119	19	water	water	NN
46745	1119	20	and	and	CC
46745	1119	21	in	in	IN
46745	1119	22	acid	acid	NN
46745	1119	23	,	,	,
46745	1119	24	yet	yet	RB
46745	1119	25	,	,	,
46745	1119	26	being	be	VBG
46745	1119	27	soluble	soluble	JJ
46745	1119	28	in	in	IN
46745	1119	29	alkalies	alkali	NNS
46745	1119	30	,	,	,
46745	1119	31	appear	appear	VB
46745	1119	32	to	to	TO
46745	1119	33	be	be	VB
46745	1119	34	in	in	IN
46745	1119	35	this	this	DT
46745	1119	36	way	way	NN
46745	1119	37	prepared	prepare	VBN
46745	1119	38	by	by	IN
46745	1119	39	absorption	absorption	NN
46745	1119	40	.	.	.
46745	1120	1	3	3	LS
46745	1120	2	.	.	.
46745	1121	1	Mineral	mineral	NN
46745	1121	2	bodies	body	NNS
46745	1121	3	insoluble	insoluble	JJ
46745	1121	4	in	in	IN
46745	1121	5	water	water	NN
46745	1121	6	and	and	CC
46745	1121	7	in	in	IN
46745	1121	8	acid	acid	NN
46745	1121	9	,	,	,
46745	1121	10	but	but	CC
46745	1121	11	soluble	soluble	JJ
46745	1121	12	in	in	IN
46745	1121	13	alkalies.--These	alkalies.--these	CD
46745	1121	14	remain	remain	VBP
46745	1121	15	unaffected	unaffected	JJ
46745	1121	16	by	by	IN
46745	1121	17	the	the	DT
46745	1121	18	action	action	NN
46745	1121	19	of	of	IN
46745	1121	20	the	the	DT
46745	1121	21	gastric	gastric	JJ
46745	1121	22	juice	juice	NN
46745	1121	23	,	,	,
46745	1121	24	but	but	CC
46745	1121	25	on	on	IN
46745	1121	26	passing	pass	VBG
46745	1121	27	on	on	RP
46745	1121	28	as	as	RB
46745	1121	29	far	far	RB
46745	1121	30	as	as	IN
46745	1121	31	the	the	DT
46745	1121	32	centre	centre	NN
46745	1121	33	of	of	IN
46745	1121	34	the	the	DT
46745	1121	35	duodenum	duodenum	NN
46745	1121	36	,	,	,
46745	1121	37	they	-PRON-	PRP
46745	1121	38	meet	meet	VBP
46745	1121	39	with	with	IN
46745	1121	40	two	two	CD
46745	1121	41	alkaline	alkaline	NN
46745	1121	42	fluids	fluid	NNS
46745	1121	43	.	.	.
46745	1122	1	These	these	DT
46745	1122	2	are	be	VBP
46745	1122	3	the	the	DT
46745	1122	4	bile	bile	NN
46745	1122	5	and	and	CC
46745	1122	6	the	the	DT
46745	1122	7	pancreatic	pancreatic	JJ
46745	1122	8	juice	juice	NN
46745	1122	9	.	.	.
46745	1123	1	We	-PRON-	PRP
46745	1123	2	know	know	VBP
46745	1123	3	that	that	IN
46745	1123	4	some	some	DT
46745	1123	5	such	such	JJ
46745	1123	6	insoluble	insoluble	JJ
46745	1123	7	bodies	body	NNS
46745	1123	8	pass	pass	VBP
46745	1123	9	into	into	IN
46745	1123	10	the	the	DT
46745	1123	11	blood	blood	NN
46745	1123	12	.	.	.
46745	1124	1	It	-PRON-	PRP
46745	1124	2	will	will	MD
46745	1124	3	be	be	VB
46745	1124	4	shown	show	VBN
46745	1124	5	in	in	IN
46745	1124	6	the	the	DT
46745	1124	7	proof	proof	NN
46745	1124	8	of	of	IN
46745	1124	9	the	the	DT
46745	1124	10	next	next	JJ
46745	1124	11	Proposition	Proposition	NNP
46745	1124	12	,	,	,
46745	1124	13	that	that	IN
46745	1124	14	they	-PRON-	PRP
46745	1124	15	can	can	MD
46745	1124	16	not	not	RB
46745	1124	17	do	do	VB
46745	1124	18	so	so	RB
46745	1124	19	without	without	IN
46745	1124	20	being	be	VBG
46745	1124	21	first	first	RB
46745	1124	22	dissolved	dissolve	VBN
46745	1124	23	.	.	.
46745	1125	1	Therefore	therefore	RB
46745	1125	2	,	,	,
46745	1125	3	there	there	EX
46745	1125	4	must	must	MD
46745	1125	5	be	be	VB
46745	1125	6	in	in	IN
46745	1125	7	the	the	DT
46745	1125	8	intestinal	intestinal	JJ
46745	1125	9	canal	canal	NN
46745	1125	10	something	something	NN
46745	1125	11	capable	capable	JJ
46745	1125	12	of	of	IN
46745	1125	13	thus	thus	RB
46745	1125	14	dissolving	dissolve	VBG
46745	1125	15	them	-PRON-	PRP
46745	1125	16	.	.	.
46745	1126	1	For	for	IN
46745	1126	2	this	this	DT
46745	1126	3	purpose	purpose	NN
46745	1126	4	these	these	DT
46745	1126	5	two	two	CD
46745	1126	6	alkaline	alkaline	NN
46745	1126	7	secretions	secretion	NNS
46745	1126	8	are	be	VBP
46745	1126	9	well	well	RB
46745	1126	10	adapted	adapt	VBN
46745	1126	11	.	.	.
46745	1127	1	As	as	IN
46745	1127	2	an	an	DT
46745	1127	3	example	example	NN
46745	1127	4	of	of	IN
46745	1127	5	such	such	JJ
46745	1127	6	mineral	mineral	NN
46745	1127	7	bodies	body	NNS
46745	1127	8	,	,	,
46745	1127	9	of	of	IN
46745	1127	10	which	which	WDT
46745	1127	11	there	there	EX
46745	1127	12	are	be	VBP
46745	1127	13	not	not	RB
46745	1127	14	many	many	JJ
46745	1127	15	,	,	,
46745	1127	16	I	-PRON-	PRP
46745	1127	17	may	may	MD
46745	1127	18	adduce	adduce	VB
46745	1127	19	sulphur	sulphur	NNP
46745	1127	20	.	.	.
46745	1128	1	It	-PRON-	PRP
46745	1128	2	unquestionably	unquestionably	RB
46745	1128	3	passes	pass	VBZ
46745	1128	4	into	into	IN
46745	1128	5	the	the	DT
46745	1128	6	blood	blood	NN
46745	1128	7	,	,	,
46745	1128	8	and	and	CC
46745	1128	9	is	be	VBZ
46745	1128	10	found	find	VBN
46745	1128	11	there	there	RB
46745	1128	12	in	in	IN
46745	1128	13	combination	combination	NN
46745	1128	14	with	with	IN
46745	1128	15	alkalies	alkali	NNS
46745	1128	16	,	,	,
46745	1128	17	as	as	IN
46745	1128	18	a	a	DT
46745	1128	19	sulphuret	sulphuret	NN
46745	1128	20	or	or	CC
46745	1128	21	sulphate	sulphate	NN
46745	1128	22	.	.	.
46745	1129	1	It	-PRON-	PRP
46745	1129	2	has	have	VBZ
46745	1129	3	been	be	VBN
46745	1129	4	detected	detect	VBN
46745	1129	5	in	in	IN
46745	1129	6	the	the	DT
46745	1129	7	urine	urine	NN
46745	1129	8	of	of	IN
46745	1129	9	those	those	DT
46745	1129	10	who	who	WP
46745	1129	11	were	be	VBD
46745	1129	12	taking	take	VBG
46745	1129	13	it	-PRON-	PRP
46745	1129	14	,	,	,
46745	1129	15	by	by	IN
46745	1129	16	Dr.	Dr.	NNP
46745	1129	17	Ronalds	Ronalds	NNP
46745	1129	18	and	and	CC
46745	1129	19	others	other	NNS
46745	1129	20	.	.	.
46745	1130	1	It	-PRON-	PRP
46745	1130	2	is	be	VBZ
46745	1130	3	possible	possible	JJ
46745	1130	4	that	that	IN
46745	1130	5	iodine	iodine	NN
46745	1130	6	,	,	,
46745	1130	7	bromine	bromine	NNP
46745	1130	8	,	,	,
46745	1130	9	and	and	CC
46745	1130	10	some	some	DT
46745	1130	11	of	of	IN
46745	1130	12	the	the	DT
46745	1130	13	hydrated	hydrated	JJ
46745	1130	14	metallic	metallic	JJ
46745	1130	15	oxides	oxide	NNS
46745	1130	16	;	;	:
46745	1130	17	may	may	MD
46745	1130	18	enter	enter	VB
46745	1130	19	the	the	DT
46745	1130	20	blood	blood	NN
46745	1130	21	in	in	IN
46745	1130	22	the	the	DT
46745	1130	23	same	same	JJ
46745	1130	24	way	way	NN
46745	1130	25	.	.	.
46745	1131	1	4	4	LS
46745	1131	2	.	.	.
46745	1132	1	Vegetable	vegetable	NN
46745	1132	2	substances	substance	NNS
46745	1132	3	soluble	soluble	JJ
46745	1132	4	in	in	IN
46745	1132	5	water.--These	water.--These	NNP
46745	1132	6	would	would	MD
46745	1132	7	be	be	VB
46745	1132	8	absorbed	absorb	VBN
46745	1132	9	with	with	IN
46745	1132	10	more	more	JJR
46745	1132	11	or	or	CC
46745	1132	12	less	less	RBR
46745	1132	13	readiness	readiness	NN
46745	1132	14	according	accord	VBG
46745	1132	15	to	to	IN
46745	1132	16	their	-PRON-	PRP$
46745	1132	17	degree	degree	NN
46745	1132	18	of	of	IN
46745	1132	19	solubility	solubility	NN
46745	1132	20	.	.	.
46745	1133	1	They	-PRON-	PRP
46745	1133	2	would	would	MD
46745	1133	3	probably	probably	RB
46745	1133	4	be	be	VB
46745	1133	5	taken	take	VBN
46745	1133	6	up	up	RP
46745	1133	7	in	in	IN
46745	1133	8	great	great	JJ
46745	1133	9	part	part	NN
46745	1133	10	by	by	IN
46745	1133	11	the	the	DT
46745	1133	12	stomach	stomach	NN
46745	1133	13	.	.	.
46745	1134	1	Some	some	DT
46745	1134	2	vegetable	vegetable	NN
46745	1134	3	matters	matter	NNS
46745	1134	4	--	--	:
46745	1134	5	as	as	IN
46745	1134	6	Lignine	Lignine	NNP
46745	1134	7	,	,	,
46745	1134	8	or	or	CC
46745	1134	9	woody	woody	NN
46745	1134	10	fibre	fibre	NN
46745	1134	11	,	,	,
46745	1134	12	and	and	CC
46745	1134	13	Resins	Resins	NNPS
46745	1134	14	--	--	:
46745	1134	15	are	be	VBP
46745	1134	16	insoluble	insoluble	JJ
46745	1134	17	in	in	IN
46745	1134	18	water	water	NN
46745	1134	19	.	.	.
46745	1135	1	Starch	starch	NN
46745	1135	2	even	even	RB
46745	1135	3	is	be	VBZ
46745	1135	4	comparatively	comparatively	RB
46745	1135	5	insoluble	insoluble	JJ
46745	1135	6	,	,	,
46745	1135	7	and	and	CC
46745	1135	8	thus	thus	RB
46745	1135	9	comes	come	VBZ
46745	1135	10	under	under	IN
46745	1135	11	another	another	DT
46745	1135	12	division	division	NN
46745	1135	13	,	,	,
46745	1135	14	being	be	VBG
46745	1135	15	probably	probably	RB
46745	1135	16	one	one	CD
46745	1135	17	of	of	IN
46745	1135	18	those	those	DT
46745	1135	19	vegetable	vegetable	JJ
46745	1135	20	substances	substance	NNS
46745	1135	21	which	which	WDT
46745	1135	22	are	be	VBP
46745	1135	23	rendered	render	VBN
46745	1135	24	soluble	soluble	JJ
46745	1135	25	by	by	IN
46745	1135	26	the	the	DT
46745	1135	27	aid	aid	NN
46745	1135	28	of	of	IN
46745	1135	29	the	the	DT
46745	1135	30	pepsin	pepsin	NN
46745	1135	31	of	of	IN
46745	1135	32	the	the	DT
46745	1135	33	gastric	gastric	JJ
46745	1135	34	juice	juice	NN
46745	1135	35	.	.	.
46745	1136	1	These	these	DT
46745	1136	2	soluble	soluble	JJ
46745	1136	3	vegetable	vegetable	NN
46745	1136	4	matters	matter	NNS
46745	1136	5	are	be	VBP
46745	1136	6	of	of	IN
46745	1136	7	several	several	JJ
46745	1136	8	kinds	kind	NNS
46745	1136	9	.	.	.
46745	1137	1	Cane	cane	NN
46745	1137	2	-	-	HYPH
46745	1137	3	sugar	sugar	NN
46745	1137	4	and	and	CC
46745	1137	5	grape	grape	NN
46745	1137	6	-	-	HYPH
46745	1137	7	sugar	sugar	NN
46745	1137	8	are	be	VBP
46745	1137	9	readily	readily	RB
46745	1137	10	soluble	soluble	JJ
46745	1137	11	.	.	.
46745	1138	1	So	so	RB
46745	1138	2	also	also	RB
46745	1138	3	are	be	VBP
46745	1138	4	the	the	DT
46745	1138	5	various	various	JJ
46745	1138	6	vegetable	vegetable	NN
46745	1138	7	acids	acid	NNS
46745	1138	8	.	.	.
46745	1139	1	There	there	EX
46745	1139	2	is	be	VBZ
46745	1139	3	another	another	DT
46745	1139	4	class	class	NN
46745	1139	5	of	of	IN
46745	1139	6	bodies	body	NNS
46745	1139	7	which	which	WDT
46745	1139	8	is	be	VBZ
46745	1139	9	highly	highly	RB
46745	1139	10	important	important	JJ
46745	1139	11	in	in	IN
46745	1139	12	a	a	DT
46745	1139	13	medical	medical	JJ
46745	1139	14	point	point	NN
46745	1139	15	of	of	IN
46745	1139	16	view	view	NN
46745	1139	17	.	.	.
46745	1140	1	These	these	DT
46745	1140	2	are	be	VBP
46745	1140	3	the	the	DT
46745	1140	4	natural	natural	JJ
46745	1140	5	salts	salt	NNS
46745	1140	6	of	of	IN
46745	1140	7	the	the	DT
46745	1140	8	vegetable	vegetable	NN
46745	1140	9	alkaloids	alkaloid	NNS
46745	1140	10	,	,	,
46745	1140	11	of	of	IN
46745	1140	12	which	which	WDT
46745	1140	13	are	be	VBP
46745	1140	14	constituted	constitute	VBN
46745	1140	15	so	so	RB
46745	1140	16	many	many	JJ
46745	1140	17	of	of	IN
46745	1140	18	the	the	DT
46745	1140	19	active	active	JJ
46745	1140	20	principles	principle	NNS
46745	1140	21	of	of	IN
46745	1140	22	plants	plant	NNS
46745	1140	23	.	.	.
46745	1141	1	In	in	IN
46745	1141	2	pharmaceutical	pharmaceutical	JJ
46745	1141	3	operations	operation	NNS
46745	1141	4	we	-PRON-	PRP
46745	1141	5	are	be	VBP
46745	1141	6	enabled	enable	VBN
46745	1141	7	,	,	,
46745	1141	8	by	by	IN
46745	1141	9	the	the	DT
46745	1141	10	judicious	judicious	JJ
46745	1141	11	employment	employment	NN
46745	1141	12	of	of	IN
46745	1141	13	different	different	JJ
46745	1141	14	menstrua	menstrua	NN
46745	1141	15	,	,	,
46745	1141	16	to	to	TO
46745	1141	17	extract	extract	VB
46745	1141	18	from	from	IN
46745	1141	19	the	the	DT
46745	1141	20	crude	crude	NN
46745	1141	21	and	and	CC
46745	1141	22	inert	inert	JJ
46745	1141	23	mass	mass	FW
46745	1141	24	these	these	DT
46745	1141	25	vegetable	vegetable	JJ
46745	1141	26	active	active	JJ
46745	1141	27	principles	principle	NNS
46745	1141	28	,	,	,
46745	1141	29	and	and	CC
46745	1141	30	thus	thus	RB
46745	1141	31	to	to	TO
46745	1141	32	obtain	obtain	VB
46745	1141	33	in	in	IN
46745	1141	34	a	a	DT
46745	1141	35	concentrated	concentrated	JJ
46745	1141	36	form	form	NN
46745	1141	37	the	the	DT
46745	1141	38	medicinal	medicinal	JJ
46745	1141	39	power	power	NN
46745	1141	40	for	for	IN
46745	1141	41	which	which	WDT
46745	1141	42	each	each	DT
46745	1141	43	plant	plant	NN
46745	1141	44	is	be	VBZ
46745	1141	45	esteemed	esteemed	JJ
46745	1141	46	.	.	.
46745	1142	1	This	this	DT
46745	1142	2	process	process	NN
46745	1142	3	is	be	VBZ
46745	1142	4	also	also	RB
46745	1142	5	performed	perform	VBN
46745	1142	6	in	in	IN
46745	1142	7	the	the	DT
46745	1142	8	stomach	stomach	NN
46745	1142	9	.	.	.
46745	1143	1	By	by	IN
46745	1143	2	digestion	digestion	NN
46745	1143	3	and	and	CC
46745	1143	4	concoction	concoction	NN
46745	1143	5	,	,	,
46745	1143	6	with	with	IN
46745	1143	7	or	or	CC
46745	1143	8	without	without	IN
46745	1143	9	the	the	DT
46745	1143	10	aid	aid	NN
46745	1143	11	of	of	IN
46745	1143	12	acid	acid	NN
46745	1143	13	,	,	,
46745	1143	14	it	-PRON-	PRP
46745	1143	15	is	be	VBZ
46745	1143	16	enabled	enable	VBN
46745	1143	17	to	to	TO
46745	1143	18	dissolve	dissolve	VB
46745	1143	19	out	out	RP
46745	1143	20	these	these	DT
46745	1143	21	soluble	soluble	JJ
46745	1143	22	and	and	CC
46745	1143	23	potent	potent	JJ
46745	1143	24	matters	matter	NNS
46745	1143	25	from	from	IN
46745	1143	26	the	the	DT
46745	1143	27	ligneous	ligneous	JJ
46745	1143	28	and	and	CC
46745	1143	29	bulky	bulky	JJ
46745	1143	30	tissues	tissue	NNS
46745	1143	31	which	which	WDT
46745	1143	32	surround	surround	VBP
46745	1143	33	them	-PRON-	PRP
46745	1143	34	.	.	.
46745	1144	1	For	for	IN
46745	1144	2	though	though	IN
46745	1144	3	the	the	DT
46745	1144	4	alkaloids	alkaloid	NNS
46745	1144	5	themselves	-PRON-	PRP
46745	1144	6	are	be	VBP
46745	1144	7	in	in	IN
46745	1144	8	general	general	JJ
46745	1144	9	almost	almost	RB
46745	1144	10	insoluble	insoluble	JJ
46745	1144	11	in	in	IN
46745	1144	12	water	water	NN
46745	1144	13	,	,	,
46745	1144	14	yet	yet	CC
46745	1144	15	their	-PRON-	PRP$
46745	1144	16	natural	natural	JJ
46745	1144	17	salts	salt	NNS
46745	1144	18	which	which	WDT
46745	1144	19	occur	occur	VBP
46745	1144	20	in	in	IN
46745	1144	21	the	the	DT
46745	1144	22	vegetable	vegetable	NN
46745	1144	23	kingdom	kingdom	NN
46745	1144	24	are	be	VBP
46745	1144	25	mostly	mostly	RB
46745	1144	26	very	very	RB
46745	1144	27	soluble	soluble	JJ
46745	1144	28	.	.	.
46745	1145	1	The	the	DT
46745	1145	2	most	most	RBS
46745	1145	3	important	important	JJ
46745	1145	4	of	of	IN
46745	1145	5	these	these	DT
46745	1145	6	salts	salt	NNS
46745	1145	7	are	be	VBP
46745	1145	8	as	as	IN
46745	1145	9	follow	follow	NN
46745	1145	10	.	.	.
46745	1146	1	In	in	IN
46745	1146	2	Cinchona	Cinchona	NNP
46745	1146	3	bark	bark	NN
46745	1146	4	,	,	,
46745	1146	5	the	the	DT
46745	1146	6	Kinates	Kinates	NNPS
46745	1146	7	of	of	IN
46745	1146	8	Quina	Quina	NNP
46745	1146	9	and	and	CC
46745	1146	10	Cinchonia	Cinchonia	NNP
46745	1146	11	.	.	.
46745	1147	1	In	in	IN
46745	1147	2	Opium	Opium	NNP
46745	1147	3	,	,	,
46745	1147	4	the	the	DT
46745	1147	5	Bimeconates	Bimeconates	NNP
46745	1147	6	of	of	IN
46745	1147	7	Morphia	Morphia	NNP
46745	1147	8	and	and	CC
46745	1147	9	Codeia	Codeia	NNP
46745	1147	10	.	.	.
46745	1148	1	In	in	IN
46745	1148	2	Nux	Nux	NNP
46745	1148	3	Vomica	Vomica	NNP
46745	1148	4	,	,	,
46745	1148	5	the	the	DT
46745	1148	6	Igasaurate	Igasaurate	NNP
46745	1148	7	of	of	IN
46745	1148	8	Strychnia	Strychnia	NNP
46745	1148	9	.	.	.
46745	1149	1	In	in	IN
46745	1149	2	Aconite	Aconite	NNP
46745	1149	3	,	,	,
46745	1149	4	the	the	DT
46745	1149	5	Aconitate	Aconitate	NNP
46745	1149	6	of	of	IN
46745	1149	7	Aconitina	Aconitina	NNP
46745	1149	8	.	.	.
46745	1150	1	In	in	IN
46745	1150	2	Colchicum	Colchicum	NNP
46745	1150	3	and	and	CC
46745	1150	4	Sabadilla	Sabadilla	NNP
46745	1150	5	,	,	,
46745	1150	6	the	the	DT
46745	1150	7	Supergallates	Supergallates	NNPS
46745	1150	8	of	of	IN
46745	1150	9	Colchicia	Colchicia	NNP
46745	1150	10	and	and	CC
46745	1150	11	Veratria	Veratria	NNP
46745	1150	12	.	.	.
46745	1151	1	There	there	EX
46745	1151	2	are	be	VBP
46745	1151	3	some	some	DT
46745	1151	4	neutral	neutral	JJ
46745	1151	5	soluble	soluble	JJ
46745	1151	6	substances	substance	NNS
46745	1151	7	,	,	,
46745	1151	8	not	not	RB
46745	1151	9	partaking	partake	VBG
46745	1151	10	of	of	IN
46745	1151	11	the	the	DT
46745	1151	12	nature	nature	NN
46745	1151	13	of	of	IN
46745	1151	14	Alkalies	Alkalies	NNPS
46745	1151	15	.	.	.
46745	1152	1	Thus	thus	RB
46745	1152	2	we	-PRON-	PRP
46745	1152	3	find	find	VBP
46745	1152	4	in	in	IN
46745	1152	5	Ipecacuanha	Ipecacuanha	NNP
46745	1152	6	and	and	CC
46745	1152	7	Ionidium	Ionidium	NNP
46745	1152	8	,	,	,
46745	1152	9	Emetine	Emetine	NNP
46745	1152	10	;	;	:
46745	1152	11	in	in	IN
46745	1152	12	Tea	Tea	NNP
46745	1152	13	and	and	CC
46745	1152	14	Coffee	Coffee	NNP
46745	1152	15	,	,	,
46745	1152	16	Caffeine	Caffeine	NNP
46745	1152	17	;	;	:
46745	1152	18	in	in	IN
46745	1152	19	Willow	willow	NN
46745	1152	20	-	-	HYPH
46745	1152	21	bark	bark	NN
46745	1152	22	,	,	,
46745	1152	23	Salicine	Salicine	NNP
46745	1152	24	;	;	:
46745	1152	25	and	and	CC
46745	1152	26	the	the	DT
46745	1152	27	soluble	soluble	JJ
46745	1152	28	active	active	JJ
46745	1152	29	principles	principle	NNS
46745	1152	30	of	of	IN
46745	1152	31	Senna	Senna	NNP
46745	1152	32	,	,	,
46745	1152	33	Aloes	Aloes	NNP
46745	1152	34	,	,	,
46745	1152	35	and	and	CC
46745	1152	36	Gentian	Gentian	NNP
46745	1152	37	,	,	,
46745	1152	38	are	be	VBP
46745	1152	39	probably	probably	RB
46745	1152	40	of	of	IN
46745	1152	41	the	the	DT
46745	1152	42	same	same	JJ
46745	1152	43	nature	nature	NN
46745	1152	44	.	.	.
46745	1153	1	Many	many	JJ
46745	1153	2	other	other	JJ
46745	1153	3	alkaloids	alkaloid	NNS
46745	1153	4	are	be	VBP
46745	1153	5	known	know	VBN
46745	1153	6	.	.	.
46745	1154	1	Atropia	Atropia	NNP
46745	1154	2	in	in	IN
46745	1154	3	Belladonna	Belladonna	NNP
46745	1154	4	,	,	,
46745	1154	5	Daturia	Daturia	NNP
46745	1154	6	in	in	IN
46745	1154	7	Stramonium	Stramonium	NNP
46745	1154	8	,	,	,
46745	1154	9	and	and	CC
46745	1154	10	Hyoscyamia	Hyoscyamia	NNP
46745	1154	11	in	in	IN
46745	1154	12	Hyoscyamus	Hyoscyamus	NNP
46745	1154	13	,	,	,
46745	1154	14	occur	occur	VBP
46745	1154	15	in	in	IN
46745	1154	16	combination	combination	NN
46745	1154	17	with	with	IN
46745	1154	18	Malic	malic	JJ
46745	1154	19	acid	acid	NN
46745	1154	20	.	.	.
46745	1155	1	Conia	Conia	NNP
46745	1155	2	in	in	IN
46745	1155	3	Hemlock	Hemlock	NNP
46745	1155	4	,	,	,
46745	1155	5	and	and	CC
46745	1155	6	Nicotia	Nicotia	NNP
46745	1155	7	in	in	IN
46745	1155	8	Tobacco	Tobacco	NNP
46745	1155	9	,	,	,
46745	1155	10	are	be	VBP
46745	1155	11	peculiar	peculiar	JJ
46745	1155	12	volatile	volatile	JJ
46745	1155	13	alkalies	alkali	NNS
46745	1155	14	containing	contain	VBG
46745	1155	15	no	no	DT
46745	1155	16	Oxygen	oxygen	NN
46745	1155	17	:	:	:
46745	1155	18	thus	thus	RB
46745	1155	19	in	in	IN
46745	1155	20	two	two	CD
46745	1155	21	respects	respect	NNS
46745	1155	22	they	-PRON-	PRP
46745	1155	23	resemble	resemble	VBP
46745	1155	24	Ammonia	Ammonia	NNP
46745	1155	25	.	.	.
46745	1156	1	They	-PRON-	PRP
46745	1156	2	too	too	RB
46745	1156	3	are	be	VBP
46745	1156	4	soluble	soluble	JJ
46745	1156	5	in	in	IN
46745	1156	6	water	water	NN
46745	1156	7	.	.	.
46745	1157	1	Alcoholic	alcoholic	JJ
46745	1157	2	and	and	CC
46745	1157	3	Ethereal	Ethereal	NNP
46745	1157	4	fluids	fluid	NNS
46745	1157	5	may	may	MD
46745	1157	6	be	be	VB
46745	1157	7	enumerated	enumerate	VBN
46745	1157	8	here	here	RB
46745	1157	9	as	as	IN
46745	1157	10	soluble	soluble	JJ
46745	1157	11	products	product	NNS
46745	1157	12	of	of	IN
46745	1157	13	the	the	DT
46745	1157	14	vegetable	vegetable	JJ
46745	1157	15	kingdom	kingdom	NN
46745	1157	16	.	.	.
46745	1158	1	Alcohol	alcohol	NN
46745	1158	2	mixes	mix	VBZ
46745	1158	3	with	with	IN
46745	1158	4	water	water	NN
46745	1158	5	to	to	IN
46745	1158	6	any	any	DT
46745	1158	7	extent	extent	NN
46745	1158	8	;	;	:
46745	1158	9	and	and	CC
46745	1158	10	one	one	CD
46745	1158	11	part	part	NN
46745	1158	12	of	of	IN
46745	1158	13	Ether	Ether	NNP
46745	1158	14	is	be	VBZ
46745	1158	15	soluble	soluble	JJ
46745	1158	16	in	in	IN
46745	1158	17	ten	ten	CD
46745	1158	18	parts	part	NNS
46745	1158	19	of	of	IN
46745	1158	20	water	water	NN
46745	1158	21	.	.	.
46745	1159	1	Nitric	Nitric	NNP
46745	1159	2	Ether	Ether	NNP
46745	1159	3	and	and	CC
46745	1159	4	Chloroform	Chloroform	NNP
46745	1159	5	are	be	VBP
46745	1159	6	also	also	RB
46745	1159	7	sufficiently	sufficiently	RB
46745	1159	8	soluble	soluble	JJ
46745	1159	9	.	.	.
46745	1160	1	So	so	RB
46745	1160	2	is	be	VBZ
46745	1160	3	Creosote	Creosote	NNP
46745	1160	4	,	,	,
46745	1160	5	1.25	1.25	CD
46745	1160	6	parts	part	NNS
46745	1160	7	of	of	IN
46745	1160	8	which	which	WDT
46745	1160	9	dissolve	dissolve	VBP
46745	1160	10	in	in	IN
46745	1160	11	100	100	CD
46745	1160	12	of	of	IN
46745	1160	13	water	water	NN
46745	1160	14	.	.	.
46745	1161	1	But	but	CC
46745	1161	2	this	this	DT
46745	1161	3	may	may	MD
46745	1161	4	be	be	VB
46745	1161	5	absorbed	absorb	VBN
46745	1161	6	in	in	IN
46745	1161	7	another	another	DT
46745	1161	8	way	way	NN
46745	1161	9	,	,	,
46745	1161	10	as	as	IN
46745	1161	11	will	will	MD
46745	1161	12	be	be	VB
46745	1161	13	seen	see	VBN
46745	1161	14	presently	presently	RB
46745	1161	15	.	.	.
46745	1162	1	Volatile	Volatile	NNP
46745	1162	2	Oils	Oils	NNP
46745	1162	3	and	and	CC
46745	1162	4	Turpentine	Turpentine	NNP
46745	1162	5	come	come	VBP
46745	1162	6	also	also	RB
46745	1162	7	under	under	IN
46745	1162	8	this	this	DT
46745	1162	9	head	head	NN
46745	1162	10	.	.	.
46745	1163	1	They	-PRON-	PRP
46745	1163	2	are	be	VBP
46745	1163	3	all	all	RB
46745	1163	4	slightly	slightly	RB
46745	1163	5	soluble	soluble	JJ
46745	1163	6	in	in	IN
46745	1163	7	water	water	NN
46745	1163	8	.	.	.
46745	1164	1	The	the	DT
46745	1164	2	former	former	JJ
46745	1164	3	,	,	,
46745	1164	4	when	when	WRB
46745	1164	5	given	give	VBN
46745	1164	6	in	in	IN
46745	1164	7	small	small	JJ
46745	1164	8	doses	dose	NNS
46745	1164	9	,	,	,
46745	1164	10	are	be	VBP
46745	1164	11	probably	probably	RB
46745	1164	12	absorbed	absorb	VBN
46745	1164	13	in	in	IN
46745	1164	14	this	this	DT
46745	1164	15	way	way	NN
46745	1164	16	.	.	.
46745	1165	1	Turpentine	turpentine	NN
46745	1165	2	,	,	,
46745	1165	3	when	when	WRB
46745	1165	4	given	give	VBN
46745	1165	5	in	in	IN
46745	1165	6	large	large	JJ
46745	1165	7	doses	dose	NNS
46745	1165	8	,	,	,
46745	1165	9	may	may	MD
46745	1165	10	perhaps	perhaps	RB
46745	1165	11	,	,	,
46745	1165	12	by	by	IN
46745	1165	13	undergoing	undergo	VBG
46745	1165	14	a	a	DT
46745	1165	15	change	change	NN
46745	1165	16	,	,	,
46745	1165	17	come	come	VB
46745	1165	18	under	under	IN
46745	1165	19	the	the	DT
46745	1165	20	head	head	NN
46745	1165	21	of	of	IN
46745	1165	22	vegetable	vegetable	JJ
46745	1165	23	substances	substance	NNS
46745	1165	24	dissolved	dissolve	VBN
46745	1165	25	by	by	IN
46745	1165	26	alkalies	alkali	NNS
46745	1165	27	.	.	.
46745	1166	1	Camphor	Camphor	NNP
46745	1166	2	may	may	MD
46745	1166	3	be	be	VB
46745	1166	4	included	include	VBN
46745	1166	5	here	here	RB
46745	1166	6	:	:	:
46745	1166	7	one	one	CD
46745	1166	8	part	part	NN
46745	1166	9	is	be	VBZ
46745	1166	10	soluble	soluble	JJ
46745	1166	11	in	in	IN
46745	1166	12	1000	1000	CD
46745	1166	13	parts	part	NNS
46745	1166	14	of	of	IN
46745	1166	15	water	water	NN
46745	1166	16	.	.	.
46745	1167	1	The	the	DT
46745	1167	2	soluble	soluble	JJ
46745	1167	3	gummy	gummy	JJ
46745	1167	4	matters	matter	NNS
46745	1167	5	of	of	IN
46745	1167	6	plants	plant	NNS
46745	1167	7	,	,	,
46745	1167	8	when	when	WRB
46745	1167	9	added	add	VBN
46745	1167	10	to	to	IN
46745	1167	11	the	the	DT
46745	1167	12	substances	substance	NNS
46745	1167	13	enumerated	enumerate	VBN
46745	1167	14	above	above	RB
46745	1167	15	,	,	,
46745	1167	16	constitute	constitute	VBP
46745	1167	17	an	an	DT
46745	1167	18	aggregate	aggregate	NN
46745	1167	19	which	which	WDT
46745	1167	20	is	be	VBZ
46745	1167	21	called	call	VBN
46745	1167	22	the	the	DT
46745	1167	23	_	_	NNP
46745	1167	24	watery	watery	RB
46745	1167	25	extractive	extractive	JJ
46745	1167	26	_	_	NNP
46745	1167	27	of	of	IN
46745	1167	28	a	a	DT
46745	1167	29	vegetable	vegetable	JJ
46745	1167	30	product	product	NN
46745	1167	31	:	:	:
46745	1167	32	_	_	NNP
46745	1167	33	i.e.	i.e.	FW
46745	1167	34	_	_	NNP
46745	1167	35	that	that	DT
46745	1167	36	part	part	NN
46745	1167	37	which	which	WDT
46745	1167	38	is	be	VBZ
46745	1167	39	capable	capable	JJ
46745	1167	40	of	of	IN
46745	1167	41	being	be	VBG
46745	1167	42	dissolved	dissolve	VBN
46745	1167	43	out	out	IN
46745	1167	44	of	of	IN
46745	1167	45	it	-PRON-	PRP
46745	1167	46	by	by	IN
46745	1167	47	pure	pure	JJ
46745	1167	48	water	water	NN
46745	1167	49	.	.	.
46745	1168	1	But	but	CC
46745	1168	2	there	there	EX
46745	1168	3	are	be	VBP
46745	1168	4	other	other	JJ
46745	1168	5	active	active	JJ
46745	1168	6	parts	part	NNS
46745	1168	7	of	of	IN
46745	1168	8	vegetables	vegetable	NNS
46745	1168	9	,	,	,
46745	1168	10	such	such	JJ
46745	1168	11	as	as	IN
46745	1168	12	oily	oily	JJ
46745	1168	13	and	and	CC
46745	1168	14	resinous	resinous	JJ
46745	1168	15	matters	matter	NNS
46745	1168	16	,	,	,
46745	1168	17	and	and	CC
46745	1168	18	some	some	DT
46745	1168	19	neutral	neutral	JJ
46745	1168	20	acrid	acrid	JJ
46745	1168	21	principles	principle	NNS
46745	1168	22	,	,	,
46745	1168	23	which	which	WDT
46745	1168	24	,	,	,
46745	1168	25	before	before	IN
46745	1168	26	they	-PRON-	PRP
46745	1168	27	can	can	MD
46745	1168	28	be	be	VB
46745	1168	29	dissolved	dissolve	VBN
46745	1168	30	by	by	IN
46745	1168	31	water	water	NN
46745	1168	32	,	,	,
46745	1168	33	require	require	VB
46745	1168	34	the	the	DT
46745	1168	35	aid	aid	NN
46745	1168	36	of	of	IN
46745	1168	37	an	an	DT
46745	1168	38	alkali	alkali	NN
46745	1168	39	.	.	.
46745	1169	1	These	these	DT
46745	1169	2	will	will	MD
46745	1169	3	be	be	VB
46745	1169	4	considered	consider	VBN
46745	1169	5	separately	separately	RB
46745	1169	6	.	.	.
46745	1170	1	We	-PRON-	PRP
46745	1170	2	now	now	RB
46745	1170	3	arrive	arrive	VBP
46745	1170	4	at	at	IN
46745	1170	5	a	a	DT
46745	1170	6	fifth	fifth	JJ
46745	1170	7	class	class	NN
46745	1170	8	of	of	IN
46745	1170	9	matters	matter	NNS
46745	1170	10	which	which	WDT
46745	1170	11	are	be	VBP
46745	1170	12	taken	take	VBN
46745	1170	13	up	up	RP
46745	1170	14	by	by	IN
46745	1170	15	absorption	absorption	NN
46745	1170	16	.	.	.
46745	1171	1	5	5	CD
46745	1171	2	.	.	.
46745	1172	1	Animal	animal	NN
46745	1172	2	and	and	CC
46745	1172	3	vegetable	vegetable	NN
46745	1172	4	products	product	NNS
46745	1172	5	dissolved	dissolve	VBN
46745	1172	6	by	by	IN
46745	1172	7	the	the	DT
46745	1172	8	gastric	gastric	JJ
46745	1172	9	juice.--The	juice.--the	CC
46745	1172	10	most	most	RBS
46745	1172	11	important	important	JJ
46745	1172	12	of	of	IN
46745	1172	13	these	these	DT
46745	1172	14	are	be	VBP
46745	1172	15	the	the	DT
46745	1172	16	nitrogenous	nitrogenous	JJ
46745	1172	17	and	and	CC
46745	1172	18	nutritive	nutritive	JJ
46745	1172	19	constituents	constituent	NNS
46745	1172	20	of	of	IN
46745	1172	21	the	the	DT
46745	1172	22	flesh	flesh	NN
46745	1172	23	of	of	IN
46745	1172	24	animals	animal	NNS
46745	1172	25	and	and	CC
46745	1172	26	of	of	IN
46745	1172	27	the	the	DT
46745	1172	28	parts	part	NNS
46745	1172	29	of	of	IN
46745	1172	30	vegetables	vegetable	NNS
46745	1172	31	.	.	.
46745	1173	1	Albumen	Albumen	NNP
46745	1173	2	,	,	,
46745	1173	3	Glutine	Glutine	NNP
46745	1173	4	,	,	,
46745	1173	5	Fibrine	Fibrine	NNP
46745	1173	6	,	,	,
46745	1173	7	and	and	CC
46745	1173	8	Caseine	Caseine	NNP
46745	1173	9	,	,	,
46745	1173	10	are	be	VBP
46745	1173	11	connected	connect	VBN
46745	1173	12	together	together	RB
46745	1173	13	as	as	IN
46745	1173	14	compounds	compound	NNS
46745	1173	15	of	of	IN
46745	1173	16	Proteine	Proteine	NNP
46745	1173	17	.	.	.
46745	1174	1	Animal	Animal	NNP
46745	1174	2	Fibrine	Fibrine	NNP
46745	1174	3	,	,	,
46745	1174	4	and	and	CC
46745	1174	5	the	the	DT
46745	1174	6	analogous	analogous	JJ
46745	1174	7	Glutine	Glutine	NNP
46745	1174	8	of	of	IN
46745	1174	9	vegetables	vegetable	NNS
46745	1174	10	,	,	,
46745	1174	11	are	be	VBP
46745	1174	12	quite	quite	RB
46745	1174	13	insoluble	insoluble	JJ
46745	1174	14	in	in	IN
46745	1174	15	water	water	NN
46745	1174	16	.	.	.
46745	1175	1	Albumen	Albumen	NNP
46745	1175	2	and	and	CC
46745	1175	3	Caseine	Caseine	NNP
46745	1175	4	,	,	,
46745	1175	5	though	though	IN
46745	1175	6	soluble	soluble	JJ
46745	1175	7	,	,	,
46745	1175	8	are	be	VBP
46745	1175	9	immediately	immediately	RB
46745	1175	10	precipitated	precipitate	VBN
46745	1175	11	by	by	IN
46745	1175	12	acids	acid	NNS
46745	1175	13	.	.	.
46745	1176	1	This	this	DT
46745	1176	2	is	be	VBZ
46745	1176	3	known	know	VBN
46745	1176	4	to	to	TO
46745	1176	5	be	be	VB
46745	1176	6	at	at	IN
46745	1176	7	first	first	RB
46745	1176	8	effected	effect	VBN
46745	1176	9	by	by	IN
46745	1176	10	the	the	DT
46745	1176	11	gastric	gastric	JJ
46745	1176	12	juice	juice	NN
46745	1176	13	on	on	IN
46745	1176	14	their	-PRON-	PRP$
46745	1176	15	entry	entry	NN
46745	1176	16	into	into	IN
46745	1176	17	the	the	DT
46745	1176	18	stomach	stomach	NN
46745	1176	19	.	.	.
46745	1177	1	But	but	CC
46745	1177	2	the	the	DT
46745	1177	3	action	action	NN
46745	1177	4	of	of	IN
46745	1177	5	the	the	DT
46745	1177	6	gastric	gastric	JJ
46745	1177	7	juice	juice	NN
46745	1177	8	which	which	WDT
46745	1177	9	contains	contain	VBZ
46745	1177	10	an	an	DT
46745	1177	11	acid	acid	NN
46745	1177	12	,	,	,
46745	1177	13	and	and	CC
46745	1177	14	a	a	DT
46745	1177	15	peculiar	peculiar	JJ
46745	1177	16	nitrogenous	nitrogenous	JJ
46745	1177	17	material	material	NN
46745	1177	18	called	call	VBN
46745	1177	19	Pepsin,--together	Pepsin,--together	NNP
46745	1177	20	with	with	IN
46745	1177	21	the	the	DT
46745	1177	22	temperature	temperature	NN
46745	1177	23	of	of	IN
46745	1177	24	the	the	DT
46745	1177	25	body	body	NN
46745	1177	26	,	,	,
46745	1177	27	which	which	WDT
46745	1177	28	is	be	VBZ
46745	1177	29	about	about	RB
46745	1177	30	100	100	CD
46745	1177	31	°	°	NNS
46745	1177	32	,--causes	,--causes	,
46745	1177	33	at	at	IN
46745	1177	34	length	length	NN
46745	1177	35	the	the	DT
46745	1177	36	gradual	gradual	JJ
46745	1177	37	solution	solution	NN
46745	1177	38	of	of	IN
46745	1177	39	these	these	DT
46745	1177	40	previously	previously	RB
46745	1177	41	insoluble	insoluble	JJ
46745	1177	42	matters	matter	NNS
46745	1177	43	.	.	.
46745	1178	1	This	this	DT
46745	1178	2	is	be	VBZ
46745	1178	3	found	find	VBN
46745	1178	4	to	to	TO
46745	1178	5	take	take	VB
46745	1178	6	place	place	NN
46745	1178	7	out	out	IN
46745	1178	8	of	of	IN
46745	1178	9	the	the	DT
46745	1178	10	body	body	NN
46745	1178	11	when	when	WRB
46745	1178	12	the	the	DT
46745	1178	13	above	above	JJ
46745	1178	14	conditions	condition	NNS
46745	1178	15	are	be	VBP
46745	1178	16	imitated	imitate	VBN
46745	1178	17	with	with	IN
46745	1178	18	an	an	DT
46745	1178	19	artificial	artificial	JJ
46745	1178	20	gastric	gastric	JJ
46745	1178	21	fluid	fluid	NN
46745	1178	22	.	.	.
46745	1179	1	The	the	DT
46745	1179	2	result	result	NN
46745	1179	3	of	of	IN
46745	1179	4	the	the	DT
46745	1179	5	process	process	NN
46745	1179	6	is	be	VBZ
46745	1179	7	a	a	DT
46745	1179	8	viscid	viscid	JJ
46745	1179	9	fluid	fluid	NN
46745	1179	10	,	,	,
46745	1179	11	which	which	WDT
46745	1179	12	is	be	VBZ
46745	1179	13	then	then	RB
46745	1179	14	absorbed	absorb	VBN
46745	1179	15	.	.	.
46745	1180	1	The	the	DT
46745	1180	2	hard	hard	JJ
46745	1180	3	Gelatine	Gelatine	NNP
46745	1180	4	of	of	IN
46745	1180	5	gristle	gristle	NN
46745	1180	6	and	and	CC
46745	1180	7	bone	bone	NN
46745	1180	8	is	be	VBZ
46745	1180	9	not	not	RB
46745	1180	10	soluble	soluble	JJ
46745	1180	11	in	in	IN
46745	1180	12	water	water	NN
46745	1180	13	at	at	IN
46745	1180	14	this	this	DT
46745	1180	15	temperature	temperature	NN
46745	1180	16	,	,	,
46745	1180	17	but	but	CC
46745	1180	18	is	be	VBZ
46745	1180	19	readily	readily	RB
46745	1180	20	soluble	soluble	JJ
46745	1180	21	in	in	IN
46745	1180	22	the	the	DT
46745	1180	23	acid	acid	JJ
46745	1180	24	gastric	gastric	JJ
46745	1180	25	juice	juice	NN
46745	1180	26	.	.	.
46745	1181	1	The	the	DT
46745	1181	2	Pepsine	Pepsine	NNP
46745	1181	3	seems	seem	VBZ
46745	1181	4	to	to	TO
46745	1181	5	be	be	VB
46745	1181	6	an	an	DT
46745	1181	7	important	important	JJ
46745	1181	8	agent	agent	NN
46745	1181	9	in	in	IN
46745	1181	10	this	this	DT
46745	1181	11	process	process	NN
46745	1181	12	,	,	,
46745	1181	13	for	for	IN
46745	1181	14	an	an	DT
46745	1181	15	acid	acid	NN
46745	1181	16	by	by	IN
46745	1181	17	itself	-PRON-	PRP
46745	1181	18	is	be	VBZ
46745	1181	19	found	find	VBN
46745	1181	20	to	to	TO
46745	1181	21	produce	produce	VB
46745	1181	22	an	an	DT
46745	1181	23	imperfect	imperfect	JJ
46745	1181	24	solution	solution	NN
46745	1181	25	.	.	.
46745	1182	1	The	the	DT
46745	1182	2	nitrogenous	nitrogenous	JJ
46745	1182	3	matters	matter	NNS
46745	1182	4	thus	thus	RB
46745	1182	5	digested	digest	VBD
46745	1182	6	and	and	CC
46745	1182	7	absorbed	absorb	VBD
46745	1182	8	constitute	constitute	NN
46745	1182	9	that	that	DT
46745	1182	10	portion	portion	NN
46745	1182	11	of	of	IN
46745	1182	12	the	the	DT
46745	1182	13	food	food	NN
46745	1182	14	which	which	WDT
46745	1182	15	is	be	VBZ
46745	1182	16	of	of	IN
46745	1182	17	most	most	JJS
46745	1182	18	use	use	NN
46745	1182	19	in	in	IN
46745	1182	20	the	the	DT
46745	1182	21	nutriment	nutriment	NN
46745	1182	22	of	of	IN
46745	1182	23	the	the	DT
46745	1182	24	system	system	NN
46745	1182	25	;	;	:
46745	1182	26	for	for	IN
46745	1182	27	the	the	DT
46745	1182	28	starchy	starchy	JJ
46745	1182	29	compounds	compound	NNS
46745	1182	30	can	can	MD
46745	1182	31	not	not	RB
46745	1182	32	be	be	VB
46745	1182	33	appropriated	appropriate	VBN
46745	1182	34	to	to	IN
46745	1182	35	the	the	DT
46745	1182	36	more	more	RBR
46745	1182	37	solid	solid	JJ
46745	1182	38	tissues	tissue	NNS
46745	1182	39	,	,	,
46745	1182	40	although	although	IN
46745	1182	41	in	in	IN
46745	1182	42	some	some	DT
46745	1182	43	cases	case	NNS
46745	1182	44	they	-PRON-	PRP
46745	1182	45	may	may	MD
46745	1182	46	be	be	VB
46745	1182	47	converted	convert	VBN
46745	1182	48	into	into	IN
46745	1182	49	fat	fat	NN
46745	1182	50	,	,	,
46745	1182	51	as	as	IN
46745	1182	52	in	in	IN
46745	1182	53	herbivorous	herbivorous	JJ
46745	1182	54	animals	animal	NNS
46745	1182	55	.	.	.
46745	1183	1	(	(	-LRB-
46745	1183	2	Liebig	Liebig	NNP
46745	1183	3	's	's	POS
46745	1183	4	_	_	NNP
46745	1183	5	Animal	Animal	NNP
46745	1183	6	Chemistry	Chemistry	NNP
46745	1183	7	_	_	NNP
46745	1183	8	,	,	,
46745	1183	9	p.	p.	NN
46745	1184	1	113	113	CD
46745	1184	2	.	.	.
46745	1184	3	)	)	-RRB-
46745	1185	1	Starch	starch	NN
46745	1185	2	itself	-PRON-	PRP
46745	1185	3	is	be	VBZ
46745	1185	4	one	one	CD
46745	1185	5	of	of	IN
46745	1185	6	this	this	DT
46745	1185	7	class	class	NN
46745	1185	8	.	.	.
46745	1186	1	Tiedemann	Tiedemann	NNP
46745	1186	2	and	and	CC
46745	1186	3	Gmelin	Gmelin	NNP
46745	1186	4	found	find	VBD
46745	1186	5	that	that	IN
46745	1186	6	by	by	IN
46745	1186	7	the	the	DT
46745	1186	8	action	action	NN
46745	1186	9	of	of	IN
46745	1186	10	the	the	DT
46745	1186	11	gastric	gastric	JJ
46745	1186	12	juice	juice	NN
46745	1186	13	it	-PRON-	PRP
46745	1186	14	was	be	VBD
46745	1186	15	slowly	slowly	RB
46745	1186	16	converted	convert	VBN
46745	1186	17	into	into	IN
46745	1186	18	Dextrine	Dextrine	NNP
46745	1186	19	,	,	,
46745	1186	20	which	which	WDT
46745	1186	21	afterwards	afterwards	RB
46745	1186	22	changed	change	VBD
46745	1186	23	into	into	IN
46745	1186	24	grape	grape	NN
46745	1186	25	sugar	sugar	NN
46745	1186	26	.	.	.
46745	1187	1	Both	both	DT
46745	1187	2	of	of	IN
46745	1187	3	these	these	DT
46745	1187	4	are	be	VBP
46745	1187	5	very	very	RB
46745	1187	6	soluble	soluble	JJ
46745	1187	7	.	.	.
46745	1188	1	From	from	IN
46745	1188	2	the	the	DT
46745	1188	3	researches	research	NNS
46745	1188	4	of	of	IN
46745	1188	5	Bouchardat	Bouchardat	NNP
46745	1188	6	and	and	CC
46745	1188	7	others	other	NNS
46745	1188	8	,	,	,
46745	1188	9	it	-PRON-	PRP
46745	1188	10	appears	appear	VBZ
46745	1188	11	that	that	IN
46745	1188	12	other	other	JJ
46745	1188	13	fluids	fluid	NNS
46745	1188	14	,	,	,
46745	1188	15	as	as	IN
46745	1188	16	the	the	DT
46745	1188	17	Saliva	Saliva	NNP
46745	1188	18	,	,	,
46745	1188	19	the	the	DT
46745	1188	20	secretion	secretion	NN
46745	1188	21	of	of	IN
46745	1188	22	Brunner	Brunner	NNP
46745	1188	23	's	's	POS
46745	1188	24	glands	gland	NNS
46745	1188	25	,	,	,
46745	1188	26	and	and	CC
46745	1188	27	the	the	DT
46745	1188	28	Pancreatic	pancreatic	JJ
46745	1188	29	juice	juice	NN
46745	1188	30	,	,	,
46745	1188	31	possess	possess	VB
46745	1188	32	also	also	RB
46745	1188	33	this	this	DT
46745	1188	34	power	power	NN
46745	1188	35	of	of	IN
46745	1188	36	converting	convert	VBG
46745	1188	37	starch	starch	NN
46745	1188	38	into	into	IN
46745	1188	39	a	a	DT
46745	1188	40	more	more	RBR
46745	1188	41	soluble	soluble	JJ
46745	1188	42	compound	compound	NN
46745	1188	43	.	.	.
46745	1189	1	So	so	RB
46745	1189	2	that	that	IN
46745	1189	3	if	if	IN
46745	1189	4	any	any	DT
46745	1189	5	of	of	IN
46745	1189	6	it	-PRON-	PRP
46745	1189	7	escape	escape	VB
46745	1189	8	the	the	DT
46745	1189	9	action	action	NN
46745	1189	10	of	of	IN
46745	1189	11	the	the	DT
46745	1189	12	stomach	stomach	NN
46745	1189	13	-	-	HYPH
46745	1189	14	secretion	secretion	NN
46745	1189	15	,	,	,
46745	1189	16	it	-PRON-	PRP
46745	1189	17	is	be	VBZ
46745	1189	18	probably	probably	RB
46745	1189	19	reduced	reduce	VBN
46745	1189	20	to	to	IN
46745	1189	21	solution	solution	NN
46745	1189	22	and	and	CC
46745	1189	23	absorbed	absorb	VBN
46745	1189	24	in	in	IN
46745	1189	25	the	the	DT
46745	1189	26	small	small	JJ
46745	1189	27	intestine	intestine	NN
46745	1189	28	.	.	.
46745	1190	1	This	this	DT
46745	1190	2	change	change	NN
46745	1190	3	of	of	IN
46745	1190	4	starch	starch	NN
46745	1190	5	is	be	VBZ
46745	1190	6	the	the	DT
46745	1190	7	first	first	JJ
46745	1190	8	of	of	IN
46745	1190	9	a	a	DT
46745	1190	10	series	series	NN
46745	1190	11	of	of	IN
46745	1190	12	transformations	transformation	NNS
46745	1190	13	,	,	,
46745	1190	14	now	now	RB
46745	1190	15	ascertained	ascertain	VBN
46745	1190	16	,	,	,
46745	1190	17	the	the	DT
46745	1190	18	ultimate	ultimate	JJ
46745	1190	19	result	result	NN
46745	1190	20	of	of	IN
46745	1190	21	which	which	WDT
46745	1190	22	is	be	VBZ
46745	1190	23	its	-PRON-	PRP$
46745	1190	24	combustion	combustion	NN
46745	1190	25	and	and	CC
46745	1190	26	resolution	resolution	NN
46745	1190	27	into	into	IN
46745	1190	28	carbonic	carbonic	JJ
46745	1190	29	acid	acid	NN
46745	1190	30	.	.	.
46745	1191	1	Thus	thus	RB
46745	1191	2	the	the	DT
46745	1191	3	nitrogenous	nitrogenous	JJ
46745	1191	4	compounds	compound	NNS
46745	1191	5	are	be	VBP
46745	1191	6	called	call	VBN
46745	1191	7	the	the	DT
46745	1191	8	_	_	NNP
46745	1191	9	nutritive	nutritive	JJ
46745	1191	10	_	_	NNP
46745	1191	11	,	,	,
46745	1191	12	and	and	CC
46745	1191	13	the	the	DT
46745	1191	14	starchy	starchy	JJ
46745	1191	15	materials	material	NNS
46745	1191	16	the	the	DT
46745	1191	17	_	_	NNP
46745	1191	18	calorifacient	calorifacient	NN
46745	1191	19	_	_	NNP
46745	1191	20	elements	element	NNS
46745	1191	21	of	of	IN
46745	1191	22	the	the	DT
46745	1191	23	food	food	NN
46745	1191	24	.	.	.
46745	1192	1	Considered	consider	VBN
46745	1192	2	as	as	IN
46745	1192	3	medicines	medicine	NNS
46745	1192	4	,	,	,
46745	1192	5	these	these	DT
46745	1192	6	substances	substance	NNS
46745	1192	7	belong	belong	VBP
46745	1192	8	to	to	IN
46745	1192	9	the	the	DT
46745	1192	10	division	division	NN
46745	1192	11	of	of	IN
46745	1192	12	Aliments	aliment	NNS
46745	1192	13	.	.	.
46745	1193	1	6	6	CD
46745	1193	2	.	.	.
46745	1194	1	We	-PRON-	PRP
46745	1194	2	have	have	VBP
46745	1194	3	already	already	RB
46745	1194	4	considered	consider	VBN
46745	1194	5	some	some	DT
46745	1194	6	few	few	JJ
46745	1194	7	mineral	mineral	NN
46745	1194	8	substances	substance	NNS
46745	1194	9	which	which	WDT
46745	1194	10	are	be	VBP
46745	1194	11	absorbed	absorb	VBN
46745	1194	12	by	by	IN
46745	1194	13	the	the	DT
46745	1194	14	aid	aid	NN
46745	1194	15	of	of	IN
46745	1194	16	the	the	DT
46745	1194	17	free	free	JJ
46745	1194	18	alkali	alkali	NNP
46745	1194	19	contained	contain	VBN
46745	1194	20	in	in	IN
46745	1194	21	the	the	DT
46745	1194	22	Biliary	Biliary	NNP
46745	1194	23	and	and	CC
46745	1194	24	Pancreatic	pancreatic	JJ
46745	1194	25	secretions	secretion	NNS
46745	1194	26	.	.	.
46745	1195	1	[	[	-LRB-
46745	1195	2	26	26	CD
46745	1195	3	]	]	-RRB-
46745	1195	4	The	the	DT
46745	1195	5	sixth	sixth	JJ
46745	1195	6	kind	kind	NN
46745	1195	7	of	of	IN
46745	1195	8	absorbed	absorbed	JJ
46745	1195	9	matters	matter	NNS
46745	1195	10	consists	consist	VBZ
46745	1195	11	of	of	IN
46745	1195	12	some	some	DT
46745	1195	13	vegetable	vegetable	NN
46745	1195	14	and	and	CC
46745	1195	15	animal	animal	NN
46745	1195	16	products	product	NNS
46745	1195	17	which	which	WDT
46745	1195	18	can	can	MD
46745	1195	19	only	only	RB
46745	1195	20	be	be	VB
46745	1195	21	rendered	render	VBN
46745	1195	22	soluble	soluble	JJ
46745	1195	23	by	by	IN
46745	1195	24	a	a	DT
46745	1195	25	similar	similar	JJ
46745	1195	26	agency	agency	NN
46745	1195	27	.	.	.
46745	1196	1	Fats	fat	NNS
46745	1196	2	and	and	CC
46745	1196	3	oils	oil	NNS
46745	1196	4	,	,	,
46745	1196	5	resinous	resinous	JJ
46745	1196	6	matters	matter	NNS
46745	1196	7	,	,	,
46745	1196	8	and	and	CC
46745	1196	9	some	some	DT
46745	1196	10	principles	principle	NNS
46745	1196	11	resembling	resemble	VBG
46745	1196	12	resins	resin	NNS
46745	1196	13	,	,	,
46745	1196	14	come	come	VB
46745	1196	15	under	under	IN
46745	1196	16	this	this	DT
46745	1196	17	head	head	NN
46745	1196	18	.	.	.
46745	1197	1	Fats	fat	NNS
46745	1197	2	and	and	CC
46745	1197	3	fixed	fix	VBN
46745	1197	4	oils	oil	NNS
46745	1197	5	consist	consist	VBP
46745	1197	6	of	of	IN
46745	1197	7	acids	acid	NNS
46745	1197	8	,	,	,
46745	1197	9	as	as	IN
46745	1197	10	Stearic	Stearic	NNP
46745	1197	11	,	,	,
46745	1197	12	Margaric	Margaric	NNP
46745	1197	13	,	,	,
46745	1197	14	and	and	CC
46745	1197	15	Oleic	Oleic	NNP
46745	1197	16	,	,	,
46745	1197	17	insoluble	insoluble	JJ
46745	1197	18	in	in	IN
46745	1197	19	water	water	NN
46745	1197	20	,	,	,
46745	1197	21	in	in	IN
46745	1197	22	combination	combination	NN
46745	1197	23	with	with	IN
46745	1197	24	a	a	DT
46745	1197	25	base	base	NN
46745	1197	26	,	,	,
46745	1197	27	Glycerine	Glycerine	NNP
46745	1197	28	,	,	,
46745	1197	29	which	which	WDT
46745	1197	30	,	,	,
46745	1197	31	when	when	WRB
46745	1197	32	isolated	isolate	VBN
46745	1197	33	,	,	,
46745	1197	34	is	be	VBZ
46745	1197	35	soluble	soluble	JJ
46745	1197	36	.	.	.
46745	1198	1	With	with	IN
46745	1198	2	a	a	DT
46745	1198	3	free	free	JJ
46745	1198	4	alkali	alkali	NN
46745	1198	5	such	such	PDT
46745	1198	6	a	a	DT
46745	1198	7	fat	fat	JJ
46745	1198	8	forms	form	NNS
46745	1198	9	a	a	DT
46745	1198	10	soluble	soluble	JJ
46745	1198	11	salt	salt	NN
46745	1198	12	,	,	,
46745	1198	13	called	call	VBD
46745	1198	14	a	a	DT
46745	1198	15	soap	soap	NN
46745	1198	16	,	,	,
46745	1198	17	and	and	CC
46745	1198	18	the	the	DT
46745	1198	19	base	base	NN
46745	1198	20	Glycerine	Glycerine	NNP
46745	1198	21	is	be	VBZ
46745	1198	22	set	set	VBN
46745	1198	23	free	free	JJ
46745	1198	24	.	.	.
46745	1199	1	In	in	IN
46745	1199	2	Man	Man	NNP
46745	1199	3	the	the	DT
46745	1199	4	Bile	Bile	NNP
46745	1199	5	and	and	CC
46745	1199	6	Pancreatic	pancreatic	JJ
46745	1199	7	juice	juice	NN
46745	1199	8	are	be	VBP
46745	1199	9	discharged	discharge	VBN
46745	1199	10	together	together	RB
46745	1199	11	into	into	IN
46745	1199	12	the	the	DT
46745	1199	13	middle	middle	NN
46745	1199	14	of	of	IN
46745	1199	15	the	the	DT
46745	1199	16	Duodenum	Duodenum	NNP
46745	1199	17	.	.	.
46745	1200	1	The	the	DT
46745	1200	2	fatty	fatty	NN
46745	1200	3	matters	matter	NNS
46745	1200	4	of	of	IN
46745	1200	5	the	the	DT
46745	1200	6	food	food	NN
46745	1200	7	are	be	VBP
46745	1200	8	not	not	RB
46745	1200	9	absorbed	absorb	VBN
46745	1200	10	before	before	IN
46745	1200	11	they	-PRON-	PRP
46745	1200	12	meet	meet	VBP
46745	1200	13	with	with	IN
46745	1200	14	these	these	DT
46745	1200	15	secretions	secretion	NNS
46745	1200	16	.	.	.
46745	1201	1	But	but	CC
46745	1201	2	,	,	,
46745	1201	3	after	after	IN
46745	1201	4	they	-PRON-	PRP
46745	1201	5	have	have	VBP
46745	1201	6	mixed	mix	VBN
46745	1201	7	with	with	IN
46745	1201	8	them	-PRON-	PRP
46745	1201	9	,	,	,
46745	1201	10	a	a	DT
46745	1201	11	milky	milky	NN
46745	1201	12	fluid	fluid	NN
46745	1201	13	,	,	,
46745	1201	14	called	call	VBN
46745	1201	15	chyle	chyle	NN
46745	1201	16	,	,	,
46745	1201	17	is	be	VBZ
46745	1201	18	formed	form	VBN
46745	1201	19	,	,	,
46745	1201	20	which	which	WDT
46745	1201	21	is	be	VBZ
46745	1201	22	then	then	RB
46745	1201	23	taken	take	VBN
46745	1201	24	up	up	RP
46745	1201	25	by	by	IN
46745	1201	26	the	the	DT
46745	1201	27	lacteal	lacteal	NN
46745	1201	28	absorbents	absorbent	NNS
46745	1201	29	.	.	.
46745	1202	1	It	-PRON-	PRP
46745	1202	2	passes	pass	VBZ
46745	1202	3	thence	thence	NN
46745	1202	4	into	into	IN
46745	1202	5	the	the	DT
46745	1202	6	Thoracic	Thoracic	NNP
46745	1202	7	duct	duct	NN
46745	1202	8	,	,	,
46745	1202	9	meeting	meet	VBG
46745	1202	10	there	there	RB
46745	1202	11	with	with	IN
46745	1202	12	an	an	DT
46745	1202	13	albuminous	albuminous	JJ
46745	1202	14	lymph	lymph	NN
46745	1202	15	,	,	,
46745	1202	16	and	and	CC
46745	1202	17	is	be	VBZ
46745	1202	18	discharged	discharge	VBN
46745	1202	19	at	at	IN
46745	1202	20	length	length	NN
46745	1202	21	into	into	IN
46745	1202	22	the	the	DT
46745	1202	23	general	general	JJ
46745	1202	24	circulation	circulation	NN
46745	1202	25	at	at	IN
46745	1202	26	the	the	DT
46745	1202	27	junction	junction	NN
46745	1202	28	of	of	IN
46745	1202	29	the	the	DT
46745	1202	30	left	left	JJ
46745	1202	31	jugular	jugular	JJ
46745	1202	32	and	and	CC
46745	1202	33	subclavian	subclavian	JJ
46745	1202	34	veins	vein	NNS
46745	1202	35	.	.	.
46745	1203	1	M.	M.	NNP
46745	1203	2	Bernard	Bernard	NNP
46745	1203	3	,	,	,
46745	1203	4	in	in	IN
46745	1203	5	some	some	DT
46745	1203	6	papers	paper	NNS
46745	1203	7	laid	lay	VBN
46745	1203	8	lately	lately	RB
46745	1203	9	before	before	IN
46745	1203	10	the	the	DT
46745	1203	11	French	French	NNP
46745	1203	12	Academy	Academy	NNP
46745	1203	13	,	,	,
46745	1203	14	states	state	NNS
46745	1203	15	,	,	,
46745	1203	16	as	as	IN
46745	1203	17	the	the	DT
46745	1203	18	result	result	NN
46745	1203	19	of	of	IN
46745	1203	20	his	-PRON-	PRP$
46745	1203	21	experiments	experiment	NNS
46745	1203	22	,	,	,
46745	1203	23	that	that	IN
46745	1203	24	the	the	DT
46745	1203	25	function	function	NN
46745	1203	26	of	of	IN
46745	1203	27	the	the	DT
46745	1203	28	Pancreatic	pancreatic	JJ
46745	1203	29	juice	juice	NN
46745	1203	30	is	be	VBZ
46745	1203	31	to	to	TO
46745	1203	32	reduce	reduce	VB
46745	1203	33	the	the	DT
46745	1203	34	fat	fat	NN
46745	1203	35	to	to	IN
46745	1203	36	the	the	DT
46745	1203	37	condition	condition	NN
46745	1203	38	of	of	IN
46745	1203	39	a	a	DT
46745	1203	40	white	white	JJ
46745	1203	41	emulsion	emulsion	NN
46745	1203	42	.	.	.
46745	1204	1	He	-PRON-	PRP
46745	1204	2	states	state	VBZ
46745	1204	3	that	that	IN
46745	1204	4	no	no	DT
46745	1204	5	milky	milky	JJ
46745	1204	6	chyle	chyle	NN
46745	1204	7	is	be	VBZ
46745	1204	8	formed	form	VBN
46745	1204	9	when	when	WRB
46745	1204	10	the	the	DT
46745	1204	11	Pancreatic	pancreatic	JJ
46745	1204	12	ducts	duct	NNS
46745	1204	13	are	be	VBP
46745	1204	14	tied	tie	VBN
46745	1204	15	in	in	IN
46745	1204	16	dogs	dog	NNS
46745	1204	17	.	.	.
46745	1205	1	He	-PRON-	PRP
46745	1205	2	considers	consider	VBZ
46745	1205	3	it	-PRON-	PRP
46745	1205	4	absolutely	absolutely	RB
46745	1205	5	necessary	necessary	JJ
46745	1205	6	that	that	IN
46745	1205	7	saccharine	saccharine	JJ
46745	1205	8	and	and	CC
46745	1205	9	albuminous	albuminous	JJ
46745	1205	10	matters	matter	NNS
46745	1205	11	should	should	MD
46745	1205	12	be	be	VB
46745	1205	13	absorbed	absorb	VBN
46745	1205	14	by	by	IN
46745	1205	15	the	the	DT
46745	1205	16	capillaries	capillary	NNS
46745	1205	17	of	of	IN
46745	1205	18	the	the	DT
46745	1205	19	Portal	portal	JJ
46745	1205	20	veins	vein	NNS
46745	1205	21	,	,	,
46745	1205	22	and	and	CC
46745	1205	23	then	then	RB
46745	1205	24	pass	pass	VB
46745	1205	25	through	through	RP
46745	1205	26	the	the	DT
46745	1205	27	liver	liver	NN
46745	1205	28	;	;	:
46745	1205	29	and	and	CC
46745	1205	30	believes	believe	VBZ
46745	1205	31	that	that	IN
46745	1205	32	the	the	DT
46745	1205	33	sole	sole	JJ
46745	1205	34	function	function	NN
46745	1205	35	of	of	IN
46745	1205	36	the	the	DT
46745	1205	37	lacteals	lacteal	NNS
46745	1205	38	is	be	VBZ
46745	1205	39	to	to	TO
46745	1205	40	take	take	VB
46745	1205	41	up	up	RP
46745	1205	42	fat	fat	NN
46745	1205	43	thus	thus	RB
46745	1205	44	emulsified	emulsify	VBN
46745	1205	45	.	.	.
46745	1206	1	His	-PRON-	PRP$
46745	1206	2	experiments	experiment	NNS
46745	1206	3	and	and	CC
46745	1206	4	inferences	inference	NNS
46745	1206	5	have	have	VBP
46745	1206	6	received	receive	VBN
46745	1206	7	the	the	DT
46745	1206	8	high	high	JJ
46745	1206	9	sanction	sanction	NN
46745	1206	10	of	of	IN
46745	1206	11	M.	M.	NNP
46745	1206	12	Magendie	Magendie	NNP
46745	1206	13	.	.	.
46745	1207	1	M.	M.	NNP
46745	1207	2	Frerichs	Frerichs	NNP
46745	1207	3	has	have	VBZ
46745	1207	4	since	since	IN
46745	1207	5	affirmed	affirm	VBN
46745	1207	6	that	that	IN
46745	1207	7	,	,	,
46745	1207	8	whatever	whatever	WDT
46745	1207	9	be	be	VB
46745	1207	10	the	the	DT
46745	1207	11	function	function	NN
46745	1207	12	of	of	IN
46745	1207	13	the	the	DT
46745	1207	14	Pancreatic	pancreatic	JJ
46745	1207	15	juice	juice	NN
46745	1207	16	,	,	,
46745	1207	17	the	the	DT
46745	1207	18	Bile	Bile	NNP
46745	1207	19	,	,	,
46745	1207	20	by	by	IN
46745	1207	21	virtue	virtue	NN
46745	1207	22	of	of	IN
46745	1207	23	the	the	DT
46745	1207	24	alkali	alkali	JJ
46745	1207	25	which	which	WDT
46745	1207	26	it	-PRON-	PRP
46745	1207	27	contains	contain	VBZ
46745	1207	28	,	,	,
46745	1207	29	is	be	VBZ
46745	1207	30	an	an	DT
46745	1207	31	indispensable	indispensable	JJ
46745	1207	32	agent	agent	NN
46745	1207	33	in	in	IN
46745	1207	34	the	the	DT
46745	1207	35	absorption	absorption	NN
46745	1207	36	of	of	IN
46745	1207	37	fats	fat	NNS
46745	1207	38	.	.	.
46745	1208	1	But	but	CC
46745	1208	2	M.	M.	NNP
46745	1208	3	Bernard	Bernard	NNP
46745	1208	4	has	have	VBZ
46745	1208	5	also	also	RB
46745	1208	6	found	find	VBN
46745	1208	7	that	that	IN
46745	1208	8	the	the	DT
46745	1208	9	Pancreatic	pancreatic	JJ
46745	1208	10	juice	juice	NN
46745	1208	11	is	be	VBZ
46745	1208	12	always	always	RB
46745	1208	13	alkaline	alkaline	VB
46745	1208	14	in	in	IN
46745	1208	15	health	health	NN
46745	1208	16	.	.	.
46745	1209	1	Whatever	whatever	WDT
46745	1209	2	be	be	VB
46745	1209	3	the	the	DT
46745	1209	4	particular	particular	JJ
46745	1209	5	function	function	NN
46745	1209	6	of	of	IN
46745	1209	7	the	the	DT
46745	1209	8	Bile	Bile	NNP
46745	1209	9	,	,	,
46745	1209	10	it	-PRON-	PRP
46745	1209	11	may	may	MD
46745	1209	12	reasonably	reasonably	RB
46745	1209	13	be	be	VB
46745	1209	14	concluded	conclude	VBN
46745	1209	15	that	that	IN
46745	1209	16	the	the	DT
46745	1209	17	alkali	alkali	JJ
46745	1209	18	contained	contain	VBN
46745	1209	19	in	in	IN
46745	1209	20	one	one	CD
46745	1209	21	or	or	CC
46745	1209	22	both	both	DT
46745	1209	23	of	of	IN
46745	1209	24	these	these	DT
46745	1209	25	fluids	fluid	NNS
46745	1209	26	is	be	VBZ
46745	1209	27	engaged	engage	VBN
46745	1209	28	in	in	IN
46745	1209	29	the	the	DT
46745	1209	30	saponification	saponification	NN
46745	1209	31	and	and	CC
46745	1209	32	solution	solution	NN
46745	1209	33	of	of	IN
46745	1209	34	the	the	DT
46745	1209	35	emulsified	emulsified	JJ
46745	1209	36	fats	fat	NNS
46745	1209	37	.	.	.
46745	1210	1	If	if	IN
46745	1210	2	it	-PRON-	PRP
46745	1210	3	were	be	VBD
46745	1210	4	not	not	RB
46745	1210	5	for	for	IN
46745	1210	6	this	this	DT
46745	1210	7	,	,	,
46745	1210	8	this	this	DT
46745	1210	9	alkali	alkali	NN
46745	1210	10	would	would	MD
46745	1210	11	seem	seem	VB
46745	1210	12	without	without	IN
46745	1210	13	an	an	DT
46745	1210	14	object	object	NN
46745	1210	15	;	;	:
46745	1210	16	and	and	CC
46745	1210	17	further	far	RBR
46745	1210	18	,	,	,
46745	1210	19	it	-PRON-	PRP
46745	1210	20	is	be	VBZ
46745	1210	21	contrary	contrary	JJ
46745	1210	22	to	to	IN
46745	1210	23	all	all	DT
46745	1210	24	we	-PRON-	PRP
46745	1210	25	know	know	VBP
46745	1210	26	of	of	IN
46745	1210	27	the	the	DT
46745	1210	28	process	process	NN
46745	1210	29	of	of	IN
46745	1210	30	absorption	absorption	NN
46745	1210	31	to	to	TO
46745	1210	32	suppose	suppose	VB
46745	1210	33	that	that	IN
46745	1210	34	oil	oil	NN
46745	1210	35	could	could	MD
46745	1210	36	pass	pass	VB
46745	1210	37	through	through	RP
46745	1210	38	to	to	IN
46745	1210	39	a	a	DT
46745	1210	40	watery	watery	JJ
46745	1210	41	fluid	fluid	NN
46745	1210	42	without	without	IN
46745	1210	43	the	the	DT
46745	1210	44	intervention	intervention	NN
46745	1210	45	of	of	IN
46745	1210	46	an	an	DT
46745	1210	47	alkali	alkali	NN
46745	1210	48	to	to	TO
46745	1210	49	reduce	reduce	VB
46745	1210	50	it	-PRON-	PRP
46745	1210	51	to	to	IN
46745	1210	52	the	the	DT
46745	1210	53	soluble	soluble	JJ
46745	1210	54	state	state	NN
46745	1210	55	.	.	.
46745	1211	1	Thus	thus	RB
46745	1211	2	it	-PRON-	PRP
46745	1211	3	would	would	MD
46745	1211	4	seem	seem	VB
46745	1211	5	likely	likely	JJ
46745	1211	6	that	that	IN
46745	1211	7	by	by	IN
46745	1211	8	means	mean	NNS
46745	1211	9	of	of	IN
46745	1211	10	the	the	DT
46745	1211	11	Pancreatic	pancreatic	JJ
46745	1211	12	juice	juice	NN
46745	1211	13	,	,	,
46745	1211	14	with	with	IN
46745	1211	15	or	or	CC
46745	1211	16	without	without	IN
46745	1211	17	the	the	DT
46745	1211	18	aid	aid	NN
46745	1211	19	of	of	IN
46745	1211	20	the	the	DT
46745	1211	21	Bile	Bile	NNP
46745	1211	22	,	,	,
46745	1211	23	fatty	fatty	NN
46745	1211	24	matters	matter	NNS
46745	1211	25	are	be	VBP
46745	1211	26	first	first	RB
46745	1211	27	emulsified	emulsify	VBN
46745	1211	28	,	,	,
46745	1211	29	in	in	IN
46745	1211	30	order	order	NN
46745	1211	31	to	to	TO
46745	1211	32	undergo	undergo	VB
46745	1211	33	an	an	DT
46745	1211	34	increase	increase	NN
46745	1211	35	of	of	IN
46745	1211	36	surface	surface	NN
46745	1211	37	,	,	,
46745	1211	38	and	and	CC
46745	1211	39	then	then	RB
46745	1211	40	again	again	RB
46745	1211	41	saponified	saponify	VBD
46745	1211	42	before	before	IN
46745	1211	43	they	-PRON-	PRP
46745	1211	44	can	can	MD
46745	1211	45	be	be	VB
46745	1211	46	absorbed	absorb	VBN
46745	1211	47	by	by	IN
46745	1211	48	the	the	DT
46745	1211	49	lacteal	lacteal	NN
46745	1211	50	villi	villi	NN
46745	1211	51	.	.	.
46745	1212	1	The	the	DT
46745	1212	2	principal	principal	JJ
46745	1212	3	fixed	fix	VBN
46745	1212	4	oils	oil	NNS
46745	1212	5	which	which	WDT
46745	1212	6	are	be	VBP
46745	1212	7	used	use	VBN
46745	1212	8	in	in	IN
46745	1212	9	medicine	medicine	NN
46745	1212	10	are	be	VBP
46745	1212	11	Castor	Castor	NNP
46745	1212	12	,	,	,
46745	1212	13	Olive	Olive	NNP
46745	1212	14	,	,	,
46745	1212	15	Almond	Almond	NNP
46745	1212	16	,	,	,
46745	1212	17	Croton	Croton	NNP
46745	1212	18	,	,	,
46745	1212	19	and	and	CC
46745	1212	20	Cod	Cod	NNP
46745	1212	21	oils	oil	NNS
46745	1212	22	.	.	.
46745	1213	1	It	-PRON-	PRP
46745	1213	2	is	be	VBZ
46745	1213	3	certainly	certainly	RB
46745	1213	4	to	to	TO
46745	1213	5	be	be	VB
46745	1213	6	regarded	regard	VBN
46745	1213	7	as	as	IN
46745	1213	8	a	a	DT
46745	1213	9	very	very	RB
46745	1213	10	beautiful	beautiful	JJ
46745	1213	11	arrangement	arrangement	NN
46745	1213	12	in	in	IN
46745	1213	13	the	the	DT
46745	1213	14	animal	animal	NN
46745	1213	15	economy	economy	NN
46745	1213	16	,	,	,
46745	1213	17	that	that	IN
46745	1213	18	those	those	DT
46745	1213	19	substances	substance	NNS
46745	1213	20	which	which	WDT
46745	1213	21	are	be	VBP
46745	1213	22	not	not	RB
46745	1213	23	acted	act	VBN
46745	1213	24	upon	upon	IN
46745	1213	25	by	by	IN
46745	1213	26	an	an	DT
46745	1213	27	acid	acid	JJ
46745	1213	28	fluid	fluid	NN
46745	1213	29	should	should	MD
46745	1213	30	be	be	VB
46745	1213	31	subsequently	subsequently	RB
46745	1213	32	subjected	subject	VBN
46745	1213	33	to	to	IN
46745	1213	34	the	the	DT
46745	1213	35	action	action	NN
46745	1213	36	of	of	IN
46745	1213	37	a	a	DT
46745	1213	38	free	free	JJ
46745	1213	39	alkali	alkali	NN
46745	1213	40	,	,	,
46745	1213	41	so	so	IN
46745	1213	42	that	that	IN
46745	1213	43	by	by	IN
46745	1213	44	the	the	DT
46745	1213	45	successive	successive	JJ
46745	1213	46	action	action	NN
46745	1213	47	of	of	IN
46745	1213	48	these	these	DT
46745	1213	49	solvents	solvent	NNS
46745	1213	50	,	,	,
46745	1213	51	together	together	RB
46745	1213	52	with	with	IN
46745	1213	53	the	the	DT
46745	1213	54	peculiar	peculiar	JJ
46745	1213	55	process	process	NN
46745	1213	56	of	of	IN
46745	1213	57	stomach	stomach	NN
46745	1213	58	digestion	digestion	NN
46745	1213	59	,	,	,
46745	1213	60	the	the	DT
46745	1213	61	great	great	JJ
46745	1213	62	majority	majority	NN
46745	1213	63	of	of	IN
46745	1213	64	substances	substance	NNS
46745	1213	65	taken	take	VBN
46745	1213	66	into	into	IN
46745	1213	67	the	the	DT
46745	1213	68	system	system	NN
46745	1213	69	are	be	VBP
46745	1213	70	dissolved	dissolve	VBN
46745	1213	71	and	and	CC
46745	1213	72	rendered	render	VBN
46745	1213	73	fit	fit	JJ
46745	1213	74	for	for	IN
46745	1213	75	absorption	absorption	NN
46745	1213	76	.	.	.
46745	1214	1	There	there	EX
46745	1214	2	seem	seem	VBP
46745	1214	3	to	to	TO
46745	1214	4	be	be	VB
46745	1214	5	other	other	JJ
46745	1214	6	vegetable	vegetable	JJ
46745	1214	7	substances	substance	NNS
46745	1214	8	which	which	WDT
46745	1214	9	are	be	VBP
46745	1214	10	rendered	render	VBN
46745	1214	11	soluble	soluble	JJ
46745	1214	12	by	by	IN
46745	1214	13	means	mean	NNS
46745	1214	14	of	of	IN
46745	1214	15	alkali	alkali	JJ
46745	1214	16	in	in	IN
46745	1214	17	the	the	DT
46745	1214	18	way	way	NN
46745	1214	19	already	already	RB
46745	1214	20	described	describe	VBN
46745	1214	21	.	.	.
46745	1215	1	Resins	resin	NNS
46745	1215	2	form	form	VBP
46745	1215	3	an	an	DT
46745	1215	4	important	important	JJ
46745	1215	5	class	class	NN
46745	1215	6	of	of	IN
46745	1215	7	remedial	remedial	JJ
46745	1215	8	agents	agent	NNS
46745	1215	9	,	,	,
46745	1215	10	in	in	IN
46745	1215	11	which	which	WDT
46745	1215	12	are	be	VBP
46745	1215	13	comprised	comprise	VBN
46745	1215	14	many	many	JJ
46745	1215	15	Diuretics	Diuretics	NNPS
46745	1215	16	,	,	,
46745	1215	17	Diaphoretics	Diaphoretics	NNP
46745	1215	18	,	,	,
46745	1215	19	and	and	CC
46745	1215	20	Purgatives	purgative	NNS
46745	1215	21	.	.	.
46745	1216	1	They	-PRON-	PRP
46745	1216	2	consist	consist	VBP
46745	1216	3	chemically	chemically	RB
46745	1216	4	of	of	IN
46745	1216	5	peculiar	peculiar	JJ
46745	1216	6	acids	acid	NNS
46745	1216	7	,	,	,
46745	1216	8	which	which	WDT
46745	1216	9	,	,	,
46745	1216	10	though	though	IN
46745	1216	11	themselves	-PRON-	PRP
46745	1216	12	insoluble	insoluble	JJ
46745	1216	13	in	in	IN
46745	1216	14	water	water	NN
46745	1216	15	,	,	,
46745	1216	16	combine	combine	VB
46745	1216	17	with	with	IN
46745	1216	18	alkalies	alkali	NNS
46745	1216	19	to	to	TO
46745	1216	20	form	form	VB
46745	1216	21	salts	salt	NNS
46745	1216	22	which	which	WDT
46745	1216	23	are	be	VBP
46745	1216	24	soluble	soluble	JJ
46745	1216	25	.	.	.
46745	1217	1	They	-PRON-	PRP
46745	1217	2	are	be	VBP
46745	1217	3	certainly	certainly	RB
46745	1217	4	in	in	IN
46745	1217	5	most	most	JJS
46745	1217	6	cases	case	NNS
46745	1217	7	absorbed	absorb	VBN
46745	1217	8	.	.	.
46745	1218	1	They	-PRON-	PRP
46745	1218	2	have	have	VBP
46745	1218	3	been	be	VBN
46745	1218	4	found	find	VBN
46745	1218	5	in	in	IN
46745	1218	6	the	the	DT
46745	1218	7	blood	blood	NN
46745	1218	8	,	,	,
46745	1218	9	and	and	CC
46745	1218	10	detected	detect	VBD
46745	1218	11	when	when	WRB
46745	1218	12	passing	pass	VBG
46745	1218	13	out	out	RP
46745	1218	14	in	in	IN
46745	1218	15	the	the	DT
46745	1218	16	urine	urine	NN
46745	1218	17	.	.	.
46745	1219	1	From	from	IN
46745	1219	2	this	this	DT
46745	1219	3	last	last	JJ
46745	1219	4	they	-PRON-	PRP
46745	1219	5	may	may	MD
46745	1219	6	be	be	VB
46745	1219	7	precipitated	precipitate	VBN
46745	1219	8	by	by	IN
46745	1219	9	an	an	DT
46745	1219	10	acid	acid	NN
46745	1219	11	,	,	,
46745	1219	12	indicating	indicate	VBG
46745	1219	13	that	that	IN
46745	1219	14	they	-PRON-	PRP
46745	1219	15	are	be	VBP
46745	1219	16	held	hold	VBN
46745	1219	17	in	in	IN
46745	1219	18	solution	solution	NN
46745	1219	19	by	by	IN
46745	1219	20	an	an	DT
46745	1219	21	alkali	alkali	NN
46745	1219	22	.	.	.
46745	1220	1	In	in	IN
46745	1220	2	large	large	JJ
46745	1220	3	doses	dose	NNS
46745	1220	4	they	-PRON-	PRP
46745	1220	5	may	may	MD
46745	1220	6	not	not	RB
46745	1220	7	be	be	VB
46745	1220	8	absorbed	absorb	VBN
46745	1220	9	,	,	,
46745	1220	10	but	but	CC
46745	1220	11	by	by	IN
46745	1220	12	irritating	irritate	VBG
46745	1220	13	the	the	DT
46745	1220	14	surface	surface	NN
46745	1220	15	of	of	IN
46745	1220	16	the	the	DT
46745	1220	17	intestinal	intestinal	JJ
46745	1220	18	canal	canal	NN
46745	1220	19	,	,	,
46745	1220	20	may	may	MD
46745	1220	21	act	act	VB
46745	1220	22	externally	externally	RB
46745	1220	23	as	as	IN
46745	1220	24	Cathartics	Cathartics	NNP
46745	1220	25	,	,	,
46745	1220	26	and	and	CC
46745	1220	27	be	be	VB
46745	1220	28	expelled	expel	VBN
46745	1220	29	by	by	IN
46745	1220	30	the	the	DT
46745	1220	31	peristaltic	peristaltic	JJ
46745	1220	32	action	action	NN
46745	1220	33	which	which	WDT
46745	1220	34	they	-PRON-	PRP
46745	1220	35	excite	excite	VBP
46745	1220	36	.	.	.
46745	1221	1	But	but	CC
46745	1221	2	in	in	IN
46745	1221	3	small	small	JJ
46745	1221	4	doses	dose	NNS
46745	1221	5	they	-PRON-	PRP
46745	1221	6	enter	enter	VBP
46745	1221	7	the	the	DT
46745	1221	8	circulation	circulation	NN
46745	1221	9	in	in	IN
46745	1221	10	solution	solution	NN
46745	1221	11	,	,	,
46745	1221	12	and	and	CC
46745	1221	13	affect	affect	VB
46745	1221	14	remote	remote	JJ
46745	1221	15	organs	organ	NNS
46745	1221	16	.	.	.
46745	1222	1	The	the	DT
46745	1222	2	only	only	JJ
46745	1222	3	way	way	NN
46745	1222	4	in	in	IN
46745	1222	5	which	which	WDT
46745	1222	6	they	-PRON-	PRP
46745	1222	7	can	can	MD
46745	1222	8	be	be	VB
46745	1222	9	dissolved	dissolve	VBN
46745	1222	10	is	be	VBZ
46745	1222	11	by	by	IN
46745	1222	12	means	mean	NNS
46745	1222	13	of	of	IN
46745	1222	14	the	the	DT
46745	1222	15	alkali	alkali	NN
46745	1222	16	of	of	IN
46745	1222	17	the	the	DT
46745	1222	18	two	two	CD
46745	1222	19	intestinal	intestinal	JJ
46745	1222	20	fluids	fluid	NNS
46745	1222	21	.	.	.
46745	1223	1	Among	among	IN
46745	1223	2	resinous	resinous	JJ
46745	1223	3	medicines	medicine	NNS
46745	1223	4	I	-PRON-	PRP
46745	1223	5	may	may	MD
46745	1223	6	mention	mention	VB
46745	1223	7	Catechu	Catechu	NNP
46745	1223	8	,	,	,
46745	1223	9	Kino	Kino	NNP
46745	1223	10	,	,	,
46745	1223	11	Benzoin	Benzoin	NNP
46745	1223	12	,	,	,
46745	1223	13	Storax	Storax	NNP
46745	1223	14	,	,	,
46745	1223	15	Peru	Peru	NNP
46745	1223	16	and	and	CC
46745	1223	17	Tolu	Tolu	NNP
46745	1223	18	,	,	,
46745	1223	19	Copaiba	Copaiba	NNP
46745	1223	20	,	,	,
46745	1223	21	Guaiacum	Guaiacum	NNP
46745	1223	22	,	,	,
46745	1223	23	the	the	DT
46745	1223	24	fetid	fetid	JJ
46745	1223	25	resins	resin	NNS
46745	1223	26	,	,	,
46745	1223	27	etc	etc	FW
46745	1223	28	.	.	.
46745	1224	1	Many	many	JJ
46745	1224	2	purgative	purgative	JJ
46745	1224	3	drugs	drug	NNS
46745	1224	4	,	,	,
46745	1224	5	as	as	IN
46745	1224	6	Jalap	Jalap	NNP
46745	1224	7	,	,	,
46745	1224	8	Scammony	Scammony	NNP
46745	1224	9	,	,	,
46745	1224	10	and	and	CC
46745	1224	11	Gamboge	Gamboge	NNP
46745	1224	12	,	,	,
46745	1224	13	owe	owe	VBP
46745	1224	14	their	-PRON-	PRP$
46745	1224	15	efficacy	efficacy	NN
46745	1224	16	to	to	TO
46745	1224	17	resin	resin	VB
46745	1224	18	.	.	.
46745	1225	1	There	there	EX
46745	1225	2	are	be	VBP
46745	1225	3	moreover	moreover	RB
46745	1225	4	certain	certain	JJ
46745	1225	5	neutral	neutral	JJ
46745	1225	6	acrid	acrid	NNP
46745	1225	7	principles	principle	NNS
46745	1225	8	,	,	,
46745	1225	9	similar	similar	JJ
46745	1225	10	in	in	IN
46745	1225	11	their	-PRON-	PRP$
46745	1225	12	nature	nature	NN
46745	1225	13	to	to	IN
46745	1225	14	resins	resin	NNS
46745	1225	15	,	,	,
46745	1225	16	which	which	WDT
46745	1225	17	are	be	VBP
46745	1225	18	soluble	soluble	JJ
46745	1225	19	only	only	RB
46745	1225	20	in	in	IN
46745	1225	21	alkalies	alkali	NNS
46745	1225	22	,	,	,
46745	1225	23	and	and	CC
46745	1225	24	thus	thus	RB
46745	1225	25	come	come	VB
46745	1225	26	under	under	IN
46745	1225	27	this	this	DT
46745	1225	28	head	head	NN
46745	1225	29	.	.	.
46745	1226	1	Such	such	JJ
46745	1226	2	are	be	VBP
46745	1226	3	Cantharidin	Cantharidin	NNP
46745	1226	4	,	,	,
46745	1226	5	Piperin	Piperin	NNP
46745	1226	6	,	,	,
46745	1226	7	Pyrethrin	Pyrethrin	NNP
46745	1226	8	,	,	,
46745	1226	9	Colocynthin	Colocynthin	NNP
46745	1226	10	,	,	,
46745	1226	11	Elaterin	Elaterin	NNP
46745	1226	12	,	,	,
46745	1226	13	and	and	CC
46745	1226	14	Capsicin	Capsicin	NNPS
46745	1226	15	,	,	,
46745	1226	16	obtained	obtain	VBN
46745	1226	17	from	from	IN
46745	1226	18	Cantharides	Cantharides	NNP
46745	1226	19	,	,	,
46745	1226	20	Pepper	Pepper	NNP
46745	1226	21	,	,	,
46745	1226	22	Pyrethrum	Pyrethrum	NNP
46745	1226	23	,	,	,
46745	1226	24	Colocynth	Colocynth	NNP
46745	1226	25	,	,	,
46745	1226	26	Elaterium	Elaterium	NNP
46745	1226	27	,	,	,
46745	1226	28	and	and	CC
46745	1226	29	Capsicum	Capsicum	NNP
46745	1226	30	.	.	.
46745	1227	1	But	but	CC
46745	1227	2	it	-PRON-	PRP
46745	1227	3	should	should	MD
46745	1227	4	be	be	VB
46745	1227	5	observed	observe	VBN
46745	1227	6	that	that	IN
46745	1227	7	some	some	DT
46745	1227	8	of	of	IN
46745	1227	9	these	these	DT
46745	1227	10	are	be	VBP
46745	1227	11	soluble	soluble	JJ
46745	1227	12	in	in	IN
46745	1227	13	Acetic	acetic	JJ
46745	1227	14	acid	acid	NN
46745	1227	15	;	;	:
46745	1227	16	and	and	CC
46745	1227	17	if	if	IN
46745	1227	18	,	,	,
46745	1227	19	as	as	IN
46745	1227	20	some	some	DT
46745	1227	21	have	have	VBP
46745	1227	22	supposed	suppose	VBN
46745	1227	23	,	,	,
46745	1227	24	this	this	DT
46745	1227	25	acid	acid	NN
46745	1227	26	exist	exist	VBP
46745	1227	27	in	in	IN
46745	1227	28	the	the	DT
46745	1227	29	gastric	gastric	JJ
46745	1227	30	juice	juice	NN
46745	1227	31	,	,	,
46745	1227	32	then	then	RB
46745	1227	33	they	-PRON-	PRP
46745	1227	34	might	may	MD
46745	1227	35	be	be	VB
46745	1227	36	dissolved	dissolve	VBN
46745	1227	37	in	in	IN
46745	1227	38	the	the	DT
46745	1227	39	stomach	stomach	NN
46745	1227	40	.	.	.
46745	1228	1	We	-PRON-	PRP
46745	1228	2	may	may	MD
46745	1228	3	add	add	VB
46745	1228	4	here	here	RB
46745	1228	5	some	some	DT
46745	1228	6	medicines	medicine	NNS
46745	1228	7	which	which	WDT
46745	1228	8	were	be	VBD
46745	1228	9	enumerated	enumerate	VBN
46745	1228	10	also	also	RB
46745	1228	11	in	in	IN
46745	1228	12	a	a	DT
46745	1228	13	former	former	JJ
46745	1228	14	division	division	NN
46745	1228	15	.	.	.
46745	1229	1	Creosote	creosote	NN
46745	1229	2	,	,	,
46745	1229	3	not	not	RB
46745	1229	4	very	very	RB
46745	1229	5	soluble	soluble	JJ
46745	1229	6	in	in	IN
46745	1229	7	water	water	NN
46745	1229	8	,	,	,
46745	1229	9	is	be	VBZ
46745	1229	10	easily	easily	RB
46745	1229	11	dissolved	dissolve	VBN
46745	1229	12	in	in	IN
46745	1229	13	a	a	DT
46745	1229	14	free	free	JJ
46745	1229	15	alkali	alkali	NN
46745	1229	16	.	.	.
46745	1230	1	This	this	DT
46745	1230	2	substance	substance	NN
46745	1230	3	also	also	RB
46745	1230	4	,	,	,
46745	1230	5	like	like	IN
46745	1230	6	the	the	DT
46745	1230	7	last	last	JJ
46745	1230	8	,	,	,
46745	1230	9	is	be	VBZ
46745	1230	10	soluble	soluble	JJ
46745	1230	11	in	in	IN
46745	1230	12	Acetic	acetic	JJ
46745	1230	13	acid	acid	NN
46745	1230	14	.	.	.
46745	1231	1	Some	some	DT
46745	1231	2	volatile	volatile	JJ
46745	1231	3	oils	oil	NNS
46745	1231	4	,	,	,
46745	1231	5	especially	especially	RB
46745	1231	6	Turpentine	Turpentine	NNP
46745	1231	7	,	,	,
46745	1231	8	display	display	VBP
46745	1231	9	a	a	DT
46745	1231	10	marked	marked	JJ
46745	1231	11	tendency	tendency	NN
46745	1231	12	to	to	TO
46745	1231	13	oxidize	oxidize	VB
46745	1231	14	into	into	IN
46745	1231	15	resins	resin	NNS
46745	1231	16	;	;	:
46745	1231	17	and	and	CC
46745	1231	18	being	be	VBG
46745	1231	19	themselves	-PRON-	PRP
46745	1231	20	very	very	RB
46745	1231	21	sparingly	sparingly	RB
46745	1231	22	soluble	soluble	JJ
46745	1231	23	in	in	IN
46745	1231	24	water	water	NN
46745	1231	25	,	,	,
46745	1231	26	may	may	MD
46745	1231	27	perhaps	perhaps	RB
46745	1231	28	be	be	VB
46745	1231	29	dissolved	dissolve	VBN
46745	1231	30	after	after	IN
46745	1231	31	having	have	VBG
46745	1231	32	undergone	undergo	VBN
46745	1231	33	this	this	DT
46745	1231	34	change	change	NN
46745	1231	35	.	.	.
46745	1232	1	Thus	thus	RB
46745	1232	2	Turpentine	turpentine	NN
46745	1232	3	changes	change	VBZ
46745	1232	4	into	into	IN
46745	1232	5	common	common	JJ
46745	1232	6	Resin	Resin	NNP
46745	1232	7	,	,	,
46745	1232	8	which	which	WDT
46745	1232	9	consists	consist	VBZ
46745	1232	10	of	of	IN
46745	1232	11	two	two	CD
46745	1232	12	isomeric	isomeric	JJ
46745	1232	13	acids	acid	NNS
46745	1232	14	,	,	,
46745	1232	15	Pinic	Pinic	NNP
46745	1232	16	and	and	CC
46745	1232	17	Sylvic	Sylvic	NNP
46745	1232	18	.	.	.
46745	1233	1	Turpentine	turpentine	NN
46745	1233	2	=	=	NFP
46745	1233	3	C_{20}H_{16	c_{20}h_{16	UH
46745	1233	4	}	}	-RRB-
46745	1233	5	Pinic	Pinic	NNP
46745	1233	6	Acid	Acid	NNP
46745	1233	7	=	=	SYM
46745	1233	8	C_{20}H_{15}O_{2	c_{20}h_{15}o_{2	NN
46745	1233	9	}	}	-RRB-
46745	1233	10	and	and	CC
46745	1233	11	,	,	,
46745	1233	12	C_{20}H_{16	C_{20}H_{16	NNP
46745	1233	13	}	}	-RRB-
46745	1233	14	+	+	SYM
46745	1233	15	3O	3O	NNP
46745	1233	16	=	=	SYM
46745	1233	17	C_{20}H_{15}O_{2	C_{20}H_{15}O_{2	NNP
46745	1233	18	}	}	-RRB-
46745	1233	19	+	+	CC
46745	1233	20	HO	HO	NNP
46745	1233	21	.	.	.
46745	1234	1	or	or	CC
46745	1234	2	,	,	,
46745	1234	3	Oil	Oil	NNP
46745	1234	4	of	of	IN
46745	1234	5	Turpentine	Turpentine	NNP
46745	1234	6	,	,	,
46745	1234	7	with	with	IN
46745	1234	8	the	the	DT
46745	1234	9	addition	addition	NN
46745	1234	10	of	of	IN
46745	1234	11	three	three	CD
46745	1234	12	atoms	atom	NNS
46745	1234	13	of	of	IN
46745	1234	14	Oxygen	oxygen	NN
46745	1234	15	,	,	,
46745	1234	16	produces	produce	VBZ
46745	1234	17	Pinic	pinic	JJ
46745	1234	18	acid	acid	NN
46745	1234	19	,	,	,
46745	1234	20	_	_	NNP
46745	1234	21	i.e.	i.e.	FW
46745	1234	22	_	_	NNP
46745	1234	23	Resin	Resin	NNP
46745	1234	24	,	,	,
46745	1234	25	and	and	CC
46745	1234	26	an	an	DT
46745	1234	27	atom	atom	NN
46745	1234	28	of	of	IN
46745	1234	29	water	water	NN
46745	1234	30	.	.	.
46745	1235	1	Now	now	RB
46745	1235	2	Turpentine	Turpentine	NNP
46745	1235	3	,	,	,
46745	1235	4	when	when	WRB
46745	1235	5	given	give	VBN
46745	1235	6	in	in	IN
46745	1235	7	large	large	JJ
46745	1235	8	quantities	quantity	NNS
46745	1235	9	,	,	,
46745	1235	10	irritates	irritate	VBZ
46745	1235	11	the	the	DT
46745	1235	12	surface	surface	NN
46745	1235	13	of	of	IN
46745	1235	14	the	the	DT
46745	1235	15	intestinal	intestinal	JJ
46745	1235	16	canal	canal	NN
46745	1235	17	in	in	IN
46745	1235	18	man	man	NN
46745	1235	19	,	,	,
46745	1235	20	and	and	CC
46745	1235	21	is	be	VBZ
46745	1235	22	not	not	RB
46745	1235	23	absorbed	absorb	VBN
46745	1235	24	.	.	.
46745	1236	1	But	but	CC
46745	1236	2	in	in	IN
46745	1236	3	the	the	DT
46745	1236	4	horse	horse	NN
46745	1236	5	very	very	RB
46745	1236	6	large	large	JJ
46745	1236	7	doses	dose	NNS
46745	1236	8	are	be	VBP
46745	1236	9	found	find	VBN
46745	1236	10	to	to	TO
46745	1236	11	pass	pass	VB
46745	1236	12	through	through	IN
46745	1236	13	the	the	DT
46745	1236	14	system	system	NN
46745	1236	15	into	into	IN
46745	1236	16	the	the	DT
46745	1236	17	urine	urine	NN
46745	1236	18	.	.	.
46745	1237	1	It	-PRON-	PRP
46745	1237	2	is	be	VBZ
46745	1237	3	not	not	RB
46745	1237	4	likely	likely	JJ
46745	1237	5	that	that	IN
46745	1237	6	a	a	DT
46745	1237	7	large	large	JJ
46745	1237	8	quantity	quantity	NN
46745	1237	9	should	should	MD
46745	1237	10	enter	enter	VB
46745	1237	11	in	in	IN
46745	1237	12	solution	solution	NN
46745	1237	13	in	in	IN
46745	1237	14	water	water	NN
46745	1237	15	.	.	.
46745	1238	1	It	-PRON-	PRP
46745	1238	2	seems	seem	VBZ
46745	1238	3	more	more	RBR
46745	1238	4	probable	probable	JJ
46745	1238	5	that	that	IN
46745	1238	6	it	-PRON-	PRP
46745	1238	7	may	may	MD
46745	1238	8	first	first	RB
46745	1238	9	in	in	IN
46745	1238	10	some	some	DT
46745	1238	11	way	way	NN
46745	1238	12	become	become	VBN
46745	1238	13	oxidized	oxidized	JJ
46745	1238	14	,	,	,
46745	1238	15	and	and	CC
46745	1238	16	then	then	RB
46745	1238	17	dissolved	dissolve	VBN
46745	1238	18	as	as	IN
46745	1238	19	a	a	DT
46745	1238	20	resin	resin	NN
46745	1238	21	.	.	.
46745	1239	1	The	the	DT
46745	1239	2	action	action	NN
46745	1239	3	of	of	IN
46745	1239	4	turpentine	turpentine	NN
46745	1239	5	resembles	resemble	NNS
46745	1239	6	that	that	DT
46745	1239	7	of	of	IN
46745	1239	8	some	some	DT
46745	1239	9	other	other	JJ
46745	1239	10	substances	substance	NNS
46745	1239	11	which	which	WDT
46745	1239	12	contain	contain	VBP
46745	1239	13	resin	resin	NN
46745	1239	14	,	,	,
46745	1239	15	as	as	IN
46745	1239	16	Copaiba	Copaiba	NNP
46745	1239	17	and	and	CC
46745	1239	18	Balsam	Balsam	NNP
46745	1239	19	of	of	IN
46745	1239	20	Peru	Peru	NNP
46745	1239	21	.	.	.
46745	1240	1	The	the	DT
46745	1240	2	resins	resin	NNS
46745	1240	3	thus	thus	RB
46745	1240	4	dissolved	dissolve	VBN
46745	1240	5	would	would	MD
46745	1240	6	pass	pass	VB
46745	1240	7	,	,	,
46745	1240	8	like	like	IN
46745	1240	9	other	other	JJ
46745	1240	10	solutions	solution	NNS
46745	1240	11	,	,	,
46745	1240	12	through	through	IN
46745	1240	13	the	the	DT
46745	1240	14	mucous	mucous	JJ
46745	1240	15	membrane	membrane	NN
46745	1240	16	of	of	IN
46745	1240	17	the	the	DT
46745	1240	18	intestines	intestine	NNS
46745	1240	19	into	into	IN
46745	1240	20	the	the	DT
46745	1240	21	Portal	Portal	NNP
46745	1240	22	capillaries	capillary	NNS
46745	1240	23	.	.	.
46745	1241	1	But	but	CC
46745	1241	2	of	of	IN
46745	1241	3	the	the	DT
46745	1241	4	fats	fat	NNS
46745	1241	5	and	and	CC
46745	1241	6	fixed	fix	VBN
46745	1241	7	oils	oil	NNS
46745	1241	8	it	-PRON-	PRP
46745	1241	9	can	can	MD
46745	1241	10	not	not	RB
46745	1241	11	be	be	VB
46745	1241	12	said	say	VBN
46745	1241	13	to	to	TO
46745	1241	14	be	be	VB
46745	1241	15	_	_	NNP
46745	1241	16	proved	prove	VBD
46745	1241	17	_	_	NNP
46745	1241	18	that	that	IN
46745	1241	19	they	-PRON-	PRP
46745	1241	20	are	be	VBP
46745	1241	21	absorbed	absorb	VBN
46745	1241	22	in	in	IN
46745	1241	23	a	a	DT
46745	1241	24	state	state	NN
46745	1241	25	of	of	IN
46745	1241	26	solution	solution	NN
46745	1241	27	,	,	,
46745	1241	28	although	although	IN
46745	1241	29	such	such	PDT
46745	1241	30	a	a	DT
46745	1241	31	conclusion	conclusion	NN
46745	1241	32	is	be	VBZ
46745	1241	33	almost	almost	RB
46745	1241	34	forced	force	VBN
46745	1241	35	upon	upon	IN
46745	1241	36	us	-PRON-	PRP
46745	1241	37	by	by	IN
46745	1241	38	a	a	DT
46745	1241	39	consideration	consideration	NN
46745	1241	40	of	of	IN
46745	1241	41	the	the	DT
46745	1241	42	laws	law	NNS
46745	1241	43	of	of	IN
46745	1241	44	endosmosis	endosmosis	NN
46745	1241	45	.	.	.
46745	1242	1	They	-PRON-	PRP
46745	1242	2	do	do	VBP
46745	1242	3	not	not	RB
46745	1242	4	pass	pass	VB
46745	1242	5	into	into	IN
46745	1242	6	the	the	DT
46745	1242	7	veins	vein	NNS
46745	1242	8	,	,	,
46745	1242	9	but	but	CC
46745	1242	10	are	be	VBP
46745	1242	11	taken	take	VBN
46745	1242	12	up	up	RP
46745	1242	13	by	by	IN
46745	1242	14	the	the	DT
46745	1242	15	lacteal	lacteal	NN
46745	1242	16	absorbents	absorbent	NNS
46745	1242	17	.	.	.
46745	1243	1	They	-PRON-	PRP
46745	1243	2	are	be	VBP
46745	1243	3	_	_	NNP
46745	1243	4	capable	capable	JJ
46745	1243	5	of	of	IN
46745	1243	6	solution	solution	NN
46745	1243	7	_	_	NNP
46745	1243	8	,	,	,
46745	1243	9	and	and	CC
46745	1243	10	are	be	VBP
46745	1243	11	thus	thus	RB
46745	1243	12	not	not	RB
46745	1243	13	in	in	IN
46745	1243	14	that	that	DT
46745	1243	15	sense	sense	NN
46745	1243	16	an	an	DT
46745	1243	17	exception	exception	NN
46745	1243	18	to	to	IN
46745	1243	19	the	the	DT
46745	1243	20	rule	rule	NN
46745	1243	21	of	of	IN
46745	1243	22	Prop	Prop	NNP
46745	1243	23	.	.	.
46745	1244	1	II	ii	CD
46745	1244	2	.	.	.
46745	1245	1	But	but	CC
46745	1245	2	in	in	IN
46745	1245	3	another	another	DT
46745	1245	4	sense	sense	NN
46745	1245	5	they	-PRON-	PRP
46745	1245	6	are	be	VBP
46745	1245	7	an	an	DT
46745	1245	8	exception	exception	NN
46745	1245	9	to	to	IN
46745	1245	10	it	-PRON-	PRP
46745	1245	11	;	;	:
46745	1245	12	for	for	IN
46745	1245	13	they	-PRON-	PRP
46745	1245	14	do	do	VBP
46745	1245	15	not	not	RB
46745	1245	16	pass	pass	VB
46745	1245	17	directly	directly	RB
46745	1245	18	into	into	IN
46745	1245	19	the	the	DT
46745	1245	20	veins	vein	NNS
46745	1245	21	,	,	,
46745	1245	22	but	but	CC
46745	1245	23	through	through	IN
46745	1245	24	the	the	DT
46745	1245	25	lacteal	lacteal	NN
46745	1245	26	system	system	NN
46745	1245	27	.	.	.
46745	1246	1	It	-PRON-	PRP
46745	1246	2	seems	seem	VBZ
46745	1246	3	that	that	IN
46745	1246	4	the	the	DT
46745	1246	5	sole	sole	JJ
46745	1246	6	purpose	purpose	NN
46745	1246	7	of	of	IN
46745	1246	8	these	these	DT
46745	1246	9	lacteal	lacteal	NN
46745	1246	10	vessels	vessel	NNS
46745	1246	11	is	be	VBZ
46745	1246	12	to	to	TO
46745	1246	13	absorb	absorb	VB
46745	1246	14	fats	fat	NNS
46745	1246	15	.	.	.
46745	1247	1	Thus	thus	RB
46745	1247	2	it	-PRON-	PRP
46745	1247	3	appears	appear	VBZ
46745	1247	4	that	that	IN
46745	1247	5	all	all	DT
46745	1247	6	soluble	soluble	JJ
46745	1247	7	substances	substance	NNS
46745	1247	8	,	,	,
46745	1247	9	whether	whether	IN
46745	1247	10	in	in	IN
46745	1247	11	the	the	DT
46745	1247	12	food	food	NN
46745	1247	13	or	or	CC
46745	1247	14	given	give	VBN
46745	1247	15	as	as	IN
46745	1247	16	medicine	medicine	NN
46745	1247	17	,	,	,
46745	1247	18	and	and	CC
46745	1247	19	in	in	IN
46745	1247	20	whatever	whatever	WDT
46745	1247	21	manner	manner	NN
46745	1247	22	rendered	render	VBN
46745	1247	23	soluble	soluble	JJ
46745	1247	24	,	,	,
46745	1247	25	whether	whether	IN
46745	1247	26	by	by	IN
46745	1247	27	acid	acid	NN
46745	1247	28	,	,	,
46745	1247	29	by	by	IN
46745	1247	30	alkali	alkali	JJ
46745	1247	31	,	,	,
46745	1247	32	or	or	CC
46745	1247	33	by	by	IN
46745	1247	34	stomach	stomach	NN
46745	1247	35	digestion	digestion	NN
46745	1247	36	,	,	,
46745	1247	37	are	be	VBP
46745	1247	38	absorbed	absorb	VBN
46745	1247	39	in	in	IN
46745	1247	40	the	the	DT
46745	1247	41	stomach	stomach	NN
46745	1247	42	and	and	CC
46745	1247	43	intestines	intestine	NNS
46745	1247	44	.	.	.
46745	1248	1	All	all	DT
46745	1248	2	of	of	IN
46745	1248	3	them	-PRON-	PRP
46745	1248	4	,	,	,
46745	1248	5	with	with	IN
46745	1248	6	the	the	DT
46745	1248	7	exception	exception	NN
46745	1248	8	of	of	IN
46745	1248	9	fatty	fatty	NN
46745	1248	10	matters	matter	NNS
46745	1248	11	,	,	,
46745	1248	12	pass	pass	VBP
46745	1248	13	directly	directly	RB
46745	1248	14	into	into	IN
46745	1248	15	the	the	DT
46745	1248	16	blood	blood	NN
46745	1248	17	,	,	,
46745	1248	18	traversing	traverse	VBG
46745	1248	19	the	the	DT
46745	1248	20	mesenteric	mesenteric	JJ
46745	1248	21	and	and	CC
46745	1248	22	Portal	portal	JJ
46745	1248	23	veins	vein	NNS
46745	1248	24	,	,	,
46745	1248	25	to	to	TO
46745	1248	26	reach	reach	VB
46745	1248	27	the	the	DT
46745	1248	28	liver	liver	NN
46745	1248	29	.	.	.
46745	1249	1	From	from	IN
46745	1249	2	this	this	DT
46745	1249	3	organ	organ	NN
46745	1249	4	they	-PRON-	PRP
46745	1249	5	pass	pass	VBP
46745	1249	6	on	on	RP
46745	1249	7	into	into	IN
46745	1249	8	the	the	DT
46745	1249	9	heart	heart	NN
46745	1249	10	through	through	IN
46745	1249	11	the	the	DT
46745	1249	12	Vena	Vena	NNP
46745	1249	13	cava	cava	NN
46745	1249	14	inferior	inferior	JJ
46745	1249	15	.	.	.
46745	1250	1	I	-PRON-	PRP
46745	1250	2	have	have	VBP
46745	1250	3	shown	show	VBN
46745	1250	4	also	also	RB
46745	1250	5	that	that	IN
46745	1250	6	they	-PRON-	PRP
46745	1250	7	are	be	VBP
46745	1250	8	mostly	mostly	RB
46745	1250	9	absorbed	absorb	VBN
46745	1250	10	without	without	IN
46745	1250	11	material	material	NN
46745	1250	12	change	change	NN
46745	1250	13	.	.	.
46745	1251	1	Supposing	suppose	VBG
46745	1251	2	the	the	DT
46745	1251	3	stomach	stomach	NN
46745	1251	4	acid	acid	NN
46745	1251	5	to	to	TO
46745	1251	6	be	be	VB
46745	1251	7	lactic	lactic	JJ
46745	1251	8	,	,	,
46745	1251	9	it	-PRON-	PRP
46745	1251	10	would	would	MD
46745	1251	11	be	be	VB
46745	1251	12	too	too	RB
46745	1251	13	weak	weak	JJ
46745	1251	14	to	to	TO
46745	1251	15	displace	displace	VB
46745	1251	16	mineral	mineral	NN
46745	1251	17	acids	acid	NNS
46745	1251	18	.	.	.
46745	1252	1	It	-PRON-	PRP
46745	1252	2	would	would	MD
46745	1252	3	,	,	,
46745	1252	4	however	however	RB
46745	1252	5	,	,	,
46745	1252	6	decompose	decompose	VB
46745	1252	7	a	a	DT
46745	1252	8	few	few	JJ
46745	1252	9	insoluble	insoluble	JJ
46745	1252	10	matters	matter	NNS
46745	1252	11	,	,	,
46745	1252	12	and	and	CC
46745	1252	13	combine	combine	VB
46745	1252	14	with	with	IN
46745	1252	15	alkalies	alkali	NNS
46745	1252	16	and	and	CC
46745	1252	17	their	-PRON-	PRP$
46745	1252	18	carbonates	carbonate	NNS
46745	1252	19	,	,	,
46745	1252	20	forming	form	VBG
46745	1252	21	salts	salt	NNS
46745	1252	22	which	which	WDT
46745	1252	23	in	in	IN
46745	1252	24	the	the	DT
46745	1252	25	blood	blood	NN
46745	1252	26	would	would	MD
46745	1252	27	again	again	RB
46745	1252	28	change	change	VB
46745	1252	29	into	into	IN
46745	1252	30	carbonates	carbonate	NNS
46745	1252	31	.	.	.
46745	1253	1	(	(	-LRB-
46745	1253	2	_	_	NNP
46745	1253	3	Vide	Vide	NNP
46745	1253	4	_	_	NNP
46745	1253	5	Prop	Prop	NNP
46745	1253	6	.	.	.
46745	1254	1	VI	VI	NNP
46745	1254	2	.	.	.
46745	1254	3	)	)	-RRB-
46745	1255	1	PROP	PROP	NNP
46745	1255	2	.	.	.
46745	1256	1	III.--_That	III.--_That	NFP
46745	1256	2	those	those	DT
46745	1256	3	medicines	medicine	NNS
46745	1256	4	which	which	WDT
46745	1256	5	are	be	VBP
46745	1256	6	completely	completely	RB
46745	1256	7	insoluble	insoluble	JJ
46745	1256	8	in	in	IN
46745	1256	9	water	water	NN
46745	1256	10	,	,	,
46745	1256	11	and	and	CC
46745	1256	12	in	in	IN
46745	1256	13	the	the	DT
46745	1256	14	gastric	gastric	JJ
46745	1256	15	and	and	CC
46745	1256	16	intestinal	intestinal	JJ
46745	1256	17	juices	juice	NNS
46745	1256	18	,	,	,
46745	1256	19	can	can	MD
46745	1256	20	not	not	RB
46745	1256	21	gain	gain	VB
46745	1256	22	entrance	entrance	NN
46745	1256	23	into	into	IN
46745	1256	24	the	the	DT
46745	1256	25	circulation	circulation	NN
46745	1256	26	.	.	.
46745	1256	27	_	_	NNP
46745	1256	28	It	-PRON-	PRP
46745	1256	29	may	may	MD
46745	1256	30	at	at	IN
46745	1256	31	first	first	JJ
46745	1256	32	sight	sight	NN
46745	1256	33	be	be	VB
46745	1256	34	objected	object	VBN
46745	1256	35	to	to	IN
46745	1256	36	this	this	DT
46745	1256	37	proposition	proposition	NN
46745	1256	38	,	,	,
46745	1256	39	that	that	IN
46745	1256	40	fatty	fatty	NN
46745	1256	41	matters	matter	NNS
46745	1256	42	may	may	MD
46745	1256	43	probably	probably	RB
46745	1256	44	enter	enter	VB
46745	1256	45	the	the	DT
46745	1256	46	lacteals	lacteal	NNS
46745	1256	47	in	in	IN
46745	1256	48	an	an	DT
46745	1256	49	undissolved	undissolved	JJ
46745	1256	50	state	state	NN
46745	1256	51	.	.	.
46745	1257	1	But	but	CC
46745	1257	2	this	this	DT
46745	1257	3	is	be	VBZ
46745	1257	4	not	not	RB
46745	1257	5	proved	prove	VBN
46745	1257	6	;	;	:
46745	1257	7	and	and	CC
46745	1257	8	besides	besides	RB
46745	1257	9	,	,	,
46745	1257	10	whether	whether	IN
46745	1257	11	dissolved	dissolve	VBN
46745	1257	12	or	or	CC
46745	1257	13	not	not	RB
46745	1257	14	,	,	,
46745	1257	15	we	-PRON-	PRP
46745	1257	16	know	know	VBP
46745	1257	17	that	that	IN
46745	1257	18	they	-PRON-	PRP
46745	1257	19	are	be	VBP
46745	1257	20	soluble	soluble	JJ
46745	1257	21	in	in	IN
46745	1257	22	one	one	CD
46745	1257	23	at	at	IN
46745	1257	24	least	least	JJS
46745	1257	25	of	of	IN
46745	1257	26	the	the	DT
46745	1257	27	intestinal	intestinal	JJ
46745	1257	28	juices	juice	NNS
46745	1257	29	--	--	:
46745	1257	30	viz	viz	NN
46745	1257	31	.	.	.
46745	1258	1	the	the	DT
46745	1258	2	Bile	Bile	NNP
46745	1258	3	.	.	.
46745	1259	1	So	so	IN
46745	1259	2	that	that	IN
46745	1259	3	they	-PRON-	PRP
46745	1259	4	do	do	VBP
46745	1259	5	not	not	RB
46745	1259	6	come	come	VB
46745	1259	7	under	under	IN
46745	1259	8	the	the	DT
46745	1259	9	above	above	JJ
46745	1259	10	definition	definition	NN
46745	1259	11	.	.	.
46745	1260	1	We	-PRON-	PRP
46745	1260	2	have	have	VBP
46745	1260	3	just	just	RB
46745	1260	4	seen	see	VBN
46745	1260	5	that	that	IN
46745	1260	6	many	many	JJ
46745	1260	7	medicines	medicine	NNS
46745	1260	8	which	which	WDT
46745	1260	9	are	be	VBP
46745	1260	10	given	give	VBN
46745	1260	11	in	in	IN
46745	1260	12	the	the	DT
46745	1260	13	insoluble	insoluble	JJ
46745	1260	14	form	form	NN
46745	1260	15	are	be	VBP
46745	1260	16	capable	capable	JJ
46745	1260	17	of	of	IN
46745	1260	18	being	be	VBG
46745	1260	19	dissolved	dissolve	VBN
46745	1260	20	in	in	IN
46745	1260	21	the	the	DT
46745	1260	22	fluids	fluid	NNS
46745	1260	23	of	of	IN
46745	1260	24	the	the	DT
46745	1260	25	intestinal	intestinal	JJ
46745	1260	26	canal	canal	NN
46745	1260	27	.	.	.
46745	1261	1	This	this	DT
46745	1261	2	so	so	RB
46745	1261	3	much	much	JJ
46745	1261	4	reduces	reduce	VBZ
46745	1261	5	the	the	DT
46745	1261	6	list	list	NN
46745	1261	7	of	of	IN
46745	1261	8	perfectly	perfectly	RB
46745	1261	9	insoluble	insoluble	JJ
46745	1261	10	medicines	medicine	NNS
46745	1261	11	,	,	,
46745	1261	12	that	that	IN
46745	1261	13	it	-PRON-	PRP
46745	1261	14	is	be	VBZ
46745	1261	15	difficult	difficult	JJ
46745	1261	16	to	to	TO
46745	1261	17	find	find	VB
46745	1261	18	any	any	DT
46745	1261	19	that	that	WDT
46745	1261	20	come	come	VB
46745	1261	21	under	under	IN
46745	1261	22	such	such	PDT
46745	1261	23	a	a	DT
46745	1261	24	definition	definition	NN
46745	1261	25	.	.	.
46745	1262	1	But	but	CC
46745	1262	2	Charcoal	Charcoal	NNP
46745	1262	3	,	,	,
46745	1262	4	the	the	DT
46745	1262	5	simple	simple	JJ
46745	1262	6	metals	metal	NNS
46745	1262	7	,	,	,
46745	1262	8	woody	woody	NN
46745	1262	9	fibre	fibre	NN
46745	1262	10	,	,	,
46745	1262	11	and	and	CC
46745	1262	12	Nitrate	Nitrate	NNP
46745	1262	13	of	of	IN
46745	1262	14	Bismuth	Bismuth	NNP
46745	1262	15	,	,	,
46745	1262	16	will	will	MD
46745	1262	17	serve	serve	VB
46745	1262	18	as	as	IN
46745	1262	19	examples	example	NNS
46745	1262	20	.	.	.
46745	1263	1	Sulphate	sulphate	NN
46745	1263	2	of	of	IN
46745	1263	3	Lead	lead	NN
46745	1263	4	is	be	VBZ
46745	1263	5	often	often	RB
46745	1263	6	quoted	quote	VBN
46745	1263	7	as	as	IN
46745	1263	8	perfectly	perfectly	RB
46745	1263	9	insoluble	insoluble	JJ
46745	1263	10	;	;	:
46745	1263	11	but	but	CC
46745	1263	12	this	this	DT
46745	1263	13	is	be	VBZ
46745	1263	14	not	not	RB
46745	1263	15	the	the	DT
46745	1263	16	case	case	NN
46745	1263	17	.	.	.
46745	1264	1	It	-PRON-	PRP
46745	1264	2	is	be	VBZ
46745	1264	3	soluble	soluble	JJ
46745	1264	4	in	in	IN
46745	1264	5	a	a	DT
46745	1264	6	solution	solution	NN
46745	1264	7	of	of	IN
46745	1264	8	acetate	acetate	NN
46745	1264	9	of	of	IN
46745	1264	10	ammonia	ammonia	NN
46745	1264	11	.	.	.
46745	1265	1	This	this	DT
46745	1265	2	salt	salt	NN
46745	1265	3	is	be	VBZ
46745	1265	4	contained	contain	VBN
46745	1265	5	in	in	IN
46745	1265	6	the	the	DT
46745	1265	7	perspiration	perspiration	NN
46745	1265	8	.	.	.
46745	1266	1	Thus	thus	RB
46745	1266	2	the	the	DT
46745	1266	3	sulphate	sulphate	NN
46745	1266	4	,	,	,
46745	1266	5	when	when	WRB
46745	1266	6	substituted	substitute	VBN
46745	1266	7	for	for	IN
46745	1266	8	the	the	DT
46745	1266	9	carbonate	carbonate	NN
46745	1266	10	in	in	IN
46745	1266	11	some	some	DT
46745	1266	12	lead	lead	NN
46745	1266	13	works	work	VBZ
46745	1266	14	at	at	IN
46745	1266	15	Paris	Paris	NNP
46745	1266	16	,	,	,
46745	1266	17	proved	prove	VBD
46745	1266	18	fatal	fatal	JJ
46745	1266	19	to	to	IN
46745	1266	20	the	the	DT
46745	1266	21	foreman	foreman	NN
46745	1266	22	,	,	,
46745	1266	23	who	who	WP
46745	1266	24	died	die	VBD
46745	1266	25	of	of	IN
46745	1266	26	colic	colic	NNP
46745	1266	27	.	.	.
46745	1267	1	M.	M.	NNP
46745	1267	2	Flandin	Flandin	NNP
46745	1267	3	found	find	VBD
46745	1267	4	that	that	IN
46745	1267	5	it	-PRON-	PRP
46745	1267	6	poisoned	poison	VBD
46745	1267	7	a	a	DT
46745	1267	8	dog	dog	NN
46745	1267	9	when	when	WRB
46745	1267	10	rubbed	rub	VBN
46745	1267	11	into	into	IN
46745	1267	12	the	the	DT
46745	1267	13	skin	skin	NN
46745	1267	14	as	as	IN
46745	1267	15	ointment	ointment	NN
46745	1267	16	.	.	.
46745	1268	1	Even	even	RB
46745	1268	2	some	some	DT
46745	1268	3	metals	metal	NNS
46745	1268	4	may	may	MD
46745	1268	5	possibly	possibly	RB
46745	1268	6	be	be	VB
46745	1268	7	brought	bring	VBN
46745	1268	8	within	within	IN
46745	1268	9	the	the	DT
46745	1268	10	influence	influence	NN
46745	1268	11	of	of	IN
46745	1268	12	weak	weak	JJ
46745	1268	13	acids	acid	NNS
46745	1268	14	when	when	WRB
46745	1268	15	in	in	IN
46745	1268	16	a	a	DT
46745	1268	17	fine	fine	JJ
46745	1268	18	state	state	NN
46745	1268	19	of	of	IN
46745	1268	20	subdivision	subdivision	NN
46745	1268	21	,	,	,
46745	1268	22	as	as	IN
46745	1268	23	Mercury	Mercury	NNP
46745	1268	24	in	in	IN
46745	1268	25	blue	blue	JJ
46745	1268	26	-	-	HYPH
46745	1268	27	pill	pill	NN
46745	1268	28	.	.	.
46745	1269	1	Gold	gold	NN
46745	1269	2	in	in	IN
46745	1269	3	a	a	DT
46745	1269	4	very	very	RB
46745	1269	5	fine	fine	JJ
46745	1269	6	powder	powder	NN
46745	1269	7	has	have	VBZ
46745	1269	8	been	be	VBN
46745	1269	9	used	use	VBN
46745	1269	10	successfully	successfully	RB
46745	1269	11	in	in	IN
46745	1269	12	syphilis	syphilis	NNP
46745	1269	13	.	.	.
46745	1270	1	Thus	thus	RB
46745	1270	2	the	the	DT
46745	1270	3	list	list	NN
46745	1270	4	of	of	IN
46745	1270	5	insoluble	insoluble	JJ
46745	1270	6	substances	substance	NNS
46745	1270	7	is	be	VBZ
46745	1270	8	still	still	RB
46745	1270	9	further	far	RBR
46745	1270	10	reduced	reduce	VBN
46745	1270	11	.	.	.
46745	1271	1	But	but	CC
46745	1271	2	there	there	EX
46745	1271	3	is	be	VBZ
46745	1271	4	no	no	DT
46745	1271	5	doubt	doubt	NN
46745	1271	6	that	that	IN
46745	1271	7	many	many	JJ
46745	1271	8	substances	substance	NNS
46745	1271	9	which	which	WDT
46745	1271	10	are	be	VBP
46745	1271	11	slightly	slightly	RB
46745	1271	12	soluble	soluble	JJ
46745	1271	13	in	in	IN
46745	1271	14	the	the	DT
46745	1271	15	intestinal	intestinal	JJ
46745	1271	16	fluids	fluid	NNS
46745	1271	17	may	may	MD
46745	1271	18	in	in	IN
46745	1271	19	great	great	JJ
46745	1271	20	part	part	NN
46745	1271	21	escape	escape	VB
46745	1271	22	this	this	DT
46745	1271	23	solution	solution	NN
46745	1271	24	,	,	,
46745	1271	25	and	and	CC
46745	1271	26	pass	pass	VB
46745	1271	27	out	out	RP
46745	1271	28	with	with	IN
46745	1271	29	the	the	DT
46745	1271	30	fæces	fæce	NNS
46745	1271	31	just	just	RB
46745	1271	32	as	as	IN
46745	1271	33	they	-PRON-	PRP
46745	1271	34	went	go	VBD
46745	1271	35	in	in	RB
46745	1271	36	.	.	.
46745	1272	1	To	to	TO
46745	1272	2	assert	assert	VB
46745	1272	3	that	that	IN
46745	1272	4	the	the	DT
46745	1272	5	particles	particle	NNS
46745	1272	6	of	of	IN
46745	1272	7	an	an	DT
46745	1272	8	insoluble	insoluble	JJ
46745	1272	9	substance	substance	NN
46745	1272	10	can	can	MD
46745	1272	11	not	not	RB
46745	1272	12	pass	pass	VB
46745	1272	13	through	through	IN
46745	1272	14	the	the	DT
46745	1272	15	homogeneous	homogeneous	JJ
46745	1272	16	wall	wall	NN
46745	1272	17	of	of	IN
46745	1272	18	the	the	DT
46745	1272	19	capillary	capillary	JJ
46745	1272	20	or	or	CC
46745	1272	21	absorbent	absorbent	JJ
46745	1272	22	vessels	vessel	NNS
46745	1272	23	,	,	,
46745	1272	24	is	be	VBZ
46745	1272	25	merely	merely	RB
46745	1272	26	to	to	TO
46745	1272	27	state	state	VB
46745	1272	28	what	what	WP
46745	1272	29	follows	follow	VBZ
46745	1272	30	from	from	IN
46745	1272	31	an	an	DT
46745	1272	32	absolute	absolute	JJ
46745	1272	33	physical	physical	JJ
46745	1272	34	law	law	NN
46745	1272	35	,	,	,
46745	1272	36	and	and	CC
46745	1272	37	is	be	VBZ
46745	1272	38	generally	generally	RB
46745	1272	39	admitted	admit	VBN
46745	1272	40	by	by	IN
46745	1272	41	physiologists	physiologist	NNS
46745	1272	42	.	.	.
46745	1273	1	But	but	CC
46745	1273	2	even	even	RB
46745	1273	3	this	this	DT
46745	1273	4	fundamental	fundamental	JJ
46745	1273	5	datum	datum	NN
46745	1273	6	has	have	VBZ
46745	1273	7	been	be	VBN
46745	1273	8	lately	lately	RB
46745	1273	9	attacked	attack	VBN
46745	1273	10	.	.	.
46745	1274	1	Professor	Professor	NNP
46745	1274	2	[	[	-LRB-
46745	1274	3	OE]sterlen	OE]sterlen	NNP
46745	1274	4	of	of	IN
46745	1274	5	Dorpat	Dorpat	NNP
46745	1274	6	has	have	VBZ
46745	1274	7	been	be	VBN
46745	1274	8	induced	induce	VBN
46745	1274	9	to	to	TO
46745	1274	10	affirm	affirm	VB
46745	1274	11	the	the	DT
46745	1274	12	possibility	possibility	NN
46745	1274	13	of	of	IN
46745	1274	14	the	the	DT
46745	1274	15	absorption	absorption	NN
46745	1274	16	of	of	IN
46745	1274	17	insoluble	insoluble	JJ
46745	1274	18	substances	substance	NNS
46745	1274	19	,	,	,
46745	1274	20	from	from	IN
46745	1274	21	some	some	DT
46745	1274	22	experiments	experiment	NNS
46745	1274	23	which	which	WDT
46745	1274	24	he	-PRON-	PRP
46745	1274	25	has	have	VBZ
46745	1274	26	made	make	VBN
46745	1274	27	.	.	.
46745	1275	1	Finely	finely	RB
46745	1275	2	-	-	HYPH
46745	1275	3	powdered	powder	VBN
46745	1275	4	charcoal	charcoal	NN
46745	1275	5	was	be	VBD
46745	1275	6	administered	administer	VBN
46745	1275	7	to	to	IN
46745	1275	8	rabbits	rabbit	NNS
46745	1275	9	for	for	IN
46745	1275	10	some	some	DT
46745	1275	11	days	day	NNS
46745	1275	12	.	.	.
46745	1276	1	They	-PRON-	PRP
46745	1276	2	were	be	VBD
46745	1276	3	then	then	RB
46745	1276	4	killed	kill	VBN
46745	1276	5	,	,	,
46745	1276	6	and	and	CC
46745	1276	7	globules	globule	NNS
46745	1276	8	of	of	IN
46745	1276	9	charcoal	charcoal	NN
46745	1276	10	,	,	,
46745	1276	11	measuring	measure	VBG
46745	1276	12	from	from	IN
46745	1276	13	1/6000	1/6000	CD
46745	1276	14	to	to	IN
46745	1276	15	1/3000	1/3000	CD
46745	1276	16	of	of	IN
46745	1276	17	an	an	DT
46745	1276	18	inch	inch	NN
46745	1276	19	,	,	,
46745	1276	20	were	be	VBD
46745	1276	21	found	find	VBN
46745	1276	22	in	in	IN
46745	1276	23	the	the	DT
46745	1276	24	blood	blood	NN
46745	1276	25	of	of	IN
46745	1276	26	the	the	DT
46745	1276	27	Portal	Portal	NNP
46745	1276	28	circulation	circulation	NN
46745	1276	29	.	.	.
46745	1277	1	(	(	-LRB-
46745	1277	2	_	_	NNP
46745	1277	3	Zeitschrift	Zeitschrift	NNP
46745	1277	4	für	für	NN
46745	1277	5	Rationelle	Rationelle	NNP
46745	1277	6	Medizin	Medizin	NNP
46745	1277	7	_	_	NNP
46745	1277	8	,	,	,
46745	1277	9	1847	1847	CD
46745	1277	10	.	.	.
46745	1277	11	)	)	-RRB-
46745	1278	1	To	to	TO
46745	1278	2	obtain	obtain	VB
46745	1278	3	these	these	DT
46745	1278	4	results	result	NNS
46745	1278	5	the	the	DT
46745	1278	6	microscope	microscope	NN
46745	1278	7	was	be	VBD
46745	1278	8	used	use	VBN
46745	1278	9	,	,	,
46745	1278	10	a	a	DT
46745	1278	11	far	far	RB
46745	1278	12	less	less	RBR
46745	1278	13	certain	certain	JJ
46745	1278	14	test	test	NN
46745	1278	15	in	in	IN
46745	1278	16	such	such	JJ
46745	1278	17	matters	matter	NNS
46745	1278	18	than	than	IN
46745	1278	19	chemical	chemical	JJ
46745	1278	20	analysis	analysis	NN
46745	1278	21	.	.	.
46745	1279	1	[	[	-LRB-
46745	1279	2	OE]sterlen	OE]sterlen	NNP
46745	1279	3	reasonably	reasonably	RB
46745	1279	4	concludes	conclude	VBZ
46745	1279	5	that	that	IN
46745	1279	6	,	,	,
46745	1279	7	if	if	IN
46745	1279	8	charcoal	charcoal	NN
46745	1279	9	can	can	MD
46745	1279	10	so	so	RB
46745	1279	11	pass	pass	VB
46745	1279	12	,	,	,
46745	1279	13	so	so	RB
46745	1279	14	also	also	RB
46745	1279	15	can	can	MD
46745	1279	16	any	any	DT
46745	1279	17	other	other	JJ
46745	1279	18	insoluble	insoluble	JJ
46745	1279	19	substance	substance	NN
46745	1279	20	.	.	.
46745	1280	1	The	the	DT
46745	1280	2	necessity	necessity	NN
46745	1280	3	of	of	IN
46745	1280	4	solution	solution	NN
46745	1280	5	could	could	MD
46745	1280	6	then	then	RB
46745	1280	7	at	at	IN
46745	1280	8	once	once	RB
46745	1280	9	be	be	VB
46745	1280	10	done	do	VBN
46745	1280	11	away	away	RB
46745	1280	12	with	with	IN
46745	1280	13	,	,	,
46745	1280	14	and	and	CC
46745	1280	15	the	the	DT
46745	1280	16	blood	blood	NN
46745	1280	17	continually	continually	RB
46745	1280	18	liable	liable	JJ
46745	1280	19	to	to	TO
46745	1280	20	admixture	admixture	VB
46745	1280	21	with	with	IN
46745	1280	22	all	all	DT
46745	1280	23	kinds	kind	NNS
46745	1280	24	of	of	IN
46745	1280	25	heterogeneous	heterogeneous	JJ
46745	1280	26	and	and	CC
46745	1280	27	crude	crude	JJ
46745	1280	28	materials	material	NNS
46745	1280	29	.	.	.
46745	1281	1	[	[	-LRB-
46745	1281	2	OE]sterlen	OE]sterlen	NNP
46745	1281	3	asserts	assert	VBZ
46745	1281	4	further	further	RB
46745	1281	5	that	that	IN
46745	1281	6	he	-PRON-	PRP
46745	1281	7	has	have	VBZ
46745	1281	8	found	find	VBN
46745	1281	9	minute	minute	JJ
46745	1281	10	globules	globule	NNS
46745	1281	11	of	of	IN
46745	1281	12	mercury	mercury	NN
46745	1281	13	under	under	IN
46745	1281	14	the	the	DT
46745	1281	15	skin	skin	NN
46745	1281	16	after	after	IN
46745	1281	17	rubbing	rub	VBG
46745	1281	18	in	in	IN
46745	1281	19	mercurial	mercurial	JJ
46745	1281	20	ointment	ointment	NN
46745	1281	21	.	.	.
46745	1282	1	(	(	-LRB-
46745	1282	2	_	_	NNP
46745	1282	3	Journal	Journal	NNP
46745	1282	4	für	für	NN
46745	1282	5	Praktische	Praktische	NNP
46745	1282	6	Chem	Chem	NNP
46745	1282	7	.	.	.
46745	1282	8	_	_	NNP
46745	1282	9	,	,	,
46745	1282	10	No	no	UH
46745	1282	11	.	.	.
46745	1283	1	IX	ix	NN
46745	1283	2	.	.	.
46745	1284	1	1850	1850	CD
46745	1284	2	.	.	.
46745	1284	3	)	)	-RRB-
46745	1285	1	Now	now	RB
46745	1285	2	,	,	,
46745	1285	3	if	if	IN
46745	1285	4	these	these	DT
46745	1285	5	things	thing	NNS
46745	1285	6	were	be	VBD
46745	1285	7	true	true	JJ
46745	1285	8	,	,	,
46745	1285	9	there	there	EX
46745	1285	10	could	could	MD
46745	1285	11	be	be	VB
46745	1285	12	no	no	DT
46745	1285	13	need	need	NN
46745	1285	14	to	to	TO
46745	1285	15	suppose	suppose	VB
46745	1285	16	the	the	DT
46745	1285	17	solution	solution	NN
46745	1285	18	of	of	IN
46745	1285	19	insoluble	insoluble	JJ
46745	1285	20	active	active	JJ
46745	1285	21	medicines	medicine	NNS
46745	1285	22	,	,	,
46745	1285	23	for	for	IN
46745	1285	24	they	-PRON-	PRP
46745	1285	25	would	would	MD
46745	1285	26	be	be	VB
46745	1285	27	enabled	enable	VBN
46745	1285	28	without	without	IN
46745	1285	29	difficulty	difficulty	NN
46745	1285	30	to	to	TO
46745	1285	31	pass	pass	VB
46745	1285	32	through	through	RP
46745	1285	33	in	in	IN
46745	1285	34	an	an	DT
46745	1285	35	undissolved	undissolved	JJ
46745	1285	36	state	state	NN
46745	1285	37	.	.	.
46745	1286	1	To	to	TO
46745	1286	2	test	test	VB
46745	1286	3	for	for	IN
46745	1286	4	myself	-PRON-	PRP
46745	1286	5	the	the	DT
46745	1286	6	accuracy	accuracy	NN
46745	1286	7	of	of	IN
46745	1286	8	such	such	JJ
46745	1286	9	statements	statement	NNS
46745	1286	10	,	,	,
46745	1286	11	I	-PRON-	PRP
46745	1286	12	have	have	VBP
46745	1286	13	made	make	VBN
46745	1286	14	some	some	DT
46745	1286	15	experiments	experiment	NNS
46745	1286	16	,	,	,
46745	1286	17	the	the	DT
46745	1286	18	object	object	NN
46745	1286	19	of	of	IN
46745	1286	20	which	which	WDT
46745	1286	21	is	be	VBZ
46745	1286	22	to	to	TO
46745	1286	23	discover	discover	VB
46745	1286	24	if	if	IN
46745	1286	25	some	some	DT
46745	1286	26	of	of	IN
46745	1286	27	the	the	DT
46745	1286	28	most	most	RBS
46745	1286	29	insoluble	insoluble	JJ
46745	1286	30	of	of	IN
46745	1286	31	our	-PRON-	PRP$
46745	1286	32	known	known	JJ
46745	1286	33	remedies	remedy	NNS
46745	1286	34	,	,	,
46745	1286	35	which	which	WDT
46745	1286	36	are	be	VBP
46745	1286	37	yet	yet	RB
46745	1286	38	known	know	VBN
46745	1286	39	to	to	TO
46745	1286	40	obtain	obtain	VB
46745	1286	41	entry	entry	NN
46745	1286	42	somehow	somehow	RB
46745	1286	43	into	into	IN
46745	1286	44	the	the	DT
46745	1286	45	blood	blood	NN
46745	1286	46	,	,	,
46745	1286	47	could	could	MD
46745	1286	48	do	do	VB
46745	1286	49	so	so	RB
46745	1286	50	while	while	IN
46745	1286	51	yet	yet	RB
46745	1286	52	in	in	IN
46745	1286	53	the	the	DT
46745	1286	54	insoluble	insoluble	JJ
46745	1286	55	state	state	NN
46745	1286	56	.	.	.
46745	1287	1	They	-PRON-	PRP
46745	1287	2	are	be	VBP
46745	1287	3	as	as	IN
46745	1287	4	follow:--	follow:--	NNP
46745	1287	5	EXP	EXP	NNP
46745	1287	6	.	.	.
46745	1288	1	1.--Ten	1.--ten	CD
46745	1288	2	grains	grain	NNS
46745	1288	3	of	of	IN
46745	1288	4	calomel	calomel	NN
46745	1288	5	were	be	VBD
46745	1288	6	given	give	VBN
46745	1288	7	to	to	IN
46745	1288	8	a	a	DT
46745	1288	9	large	large	JJ
46745	1288	10	dog	dog	NN
46745	1288	11	.	.	.
46745	1289	1	It	-PRON-	PRP
46745	1289	2	was	be	VBD
46745	1289	3	killed	kill	VBN
46745	1289	4	after	after	IN
46745	1289	5	three	three	CD
46745	1289	6	hours	hour	NNS
46745	1289	7	,	,	,
46745	1289	8	allowing	allow	VBG
46745	1289	9	this	this	DT
46745	1289	10	time	time	NN
46745	1289	11	for	for	IN
46745	1289	12	digestion	digestion	NN
46745	1289	13	.	.	.
46745	1290	1	A	a	DT
46745	1290	2	considerable	considerable	JJ
46745	1290	3	quantity	quantity	NN
46745	1290	4	of	of	IN
46745	1290	5	blood	blood	NN
46745	1290	6	was	be	VBD
46745	1290	7	collected	collect	VBN
46745	1290	8	from	from	IN
46745	1290	9	the	the	DT
46745	1290	10	Portal	Portal	NNP
46745	1290	11	vein	vein	NN
46745	1290	12	,	,	,
46745	1290	13	and	and	CC
46745	1290	14	submitted	submit	VBN
46745	1290	15	to	to	IN
46745	1290	16	analysis	analysis	NN
46745	1290	17	to	to	TO
46745	1290	18	determine	determine	VB
46745	1290	19	whether	whether	IN
46745	1290	20	it	-PRON-	PRP
46745	1290	21	contained	contain	VBD
46745	1290	22	any	any	DT
46745	1290	23	compound	compound	NN
46745	1290	24	of	of	IN
46745	1290	25	Mercury	Mercury	NNP
46745	1290	26	in	in	IN
46745	1290	27	an	an	DT
46745	1290	28	insoluble	insoluble	JJ
46745	1290	29	form	form	NN
46745	1290	30	.	.	.
46745	1291	1	The	the	DT
46745	1291	2	blood	blood	NN
46745	1291	3	was	be	VBD
46745	1291	4	dried	dry	VBN
46745	1291	5	and	and	CC
46745	1291	6	pulverized	pulverize	VBN
46745	1291	7	.	.	.
46745	1292	1	The	the	DT
46745	1292	2	result	result	NN
46745	1292	3	was	be	VBD
46745	1292	4	boiled	boil	VBN
46745	1292	5	for	for	IN
46745	1292	6	some	some	DT
46745	1292	7	time	time	NN
46745	1292	8	in	in	IN
46745	1292	9	water	water	NN
46745	1292	10	,	,	,
46745	1292	11	and	and	CC
46745	1292	12	the	the	DT
46745	1292	13	insoluble	insoluble	JJ
46745	1292	14	part	part	NN
46745	1292	15	collected	collect	VBN
46745	1292	16	.	.	.
46745	1293	1	It	-PRON-	PRP
46745	1293	2	was	be	VBD
46745	1293	3	dissolved	dissolve	VBN
46745	1293	4	in	in	IN
46745	1293	5	a	a	DT
46745	1293	6	small	small	JJ
46745	1293	7	quantity	quantity	NN
46745	1293	8	of	of	IN
46745	1293	9	aqua	aqua	NNP
46745	1293	10	regia	regia	NNP
46745	1293	11	,	,	,
46745	1293	12	and	and	CC
46745	1293	13	the	the	DT
46745	1293	14	clear	clear	JJ
46745	1293	15	acid	acid	NN
46745	1293	16	solution	solution	NN
46745	1293	17	placed	place	VBN
46745	1293	18	in	in	IN
46745	1293	19	a	a	DT
46745	1293	20	test	test	NN
46745	1293	21	tube	tube	NN
46745	1293	22	.	.	.
46745	1294	1	A	a	DT
46745	1294	2	slip	slip	NN
46745	1294	3	of	of	IN
46745	1294	4	zinc	zinc	NN
46745	1294	5	foil	foil	NN
46745	1294	6	was	be	VBD
46745	1294	7	folded	fold	VBN
46745	1294	8	round	round	IN
46745	1294	9	a	a	DT
46745	1294	10	narrow	narrow	JJ
46745	1294	11	plate	plate	NN
46745	1294	12	made	make	VBN
46745	1294	13	of	of	IN
46745	1294	14	gold	gold	NN
46745	1294	15	foil	foil	NN
46745	1294	16	,	,	,
46745	1294	17	and	and	CC
46745	1294	18	introduced	introduce	VBN
46745	1294	19	into	into	IN
46745	1294	20	the	the	DT
46745	1294	21	solution	solution	NN
46745	1294	22	.	.	.
46745	1295	1	A	a	DT
46745	1295	2	galvanic	galvanic	JJ
46745	1295	3	current	current	NN
46745	1295	4	being	be	VBG
46745	1295	5	thus	thus	RB
46745	1295	6	set	set	VBN
46745	1295	7	up	up	RP
46745	1295	8	,	,	,
46745	1295	9	the	the	DT
46745	1295	10	minutest	minute	JJS
46745	1295	11	quantity	quantity	NN
46745	1295	12	of	of	IN
46745	1295	13	mercury	mercury	NN
46745	1295	14	,	,	,
46745	1295	15	if	if	IN
46745	1295	16	present	present	NN
46745	1295	17	,	,	,
46745	1295	18	would	would	MD
46745	1295	19	have	have	VB
46745	1295	20	been	be	VBN
46745	1295	21	deposited	deposit	VBN
46745	1295	22	on	on	IN
46745	1295	23	the	the	DT
46745	1295	24	gold	gold	NN
46745	1295	25	,	,	,
46745	1295	26	so	so	IN
46745	1295	27	as	as	IN
46745	1295	28	to	to	TO
46745	1295	29	tarnish	tarnish	VB
46745	1295	30	it	-PRON-	PRP
46745	1295	31	.	.	.
46745	1296	1	But	but	CC
46745	1296	2	this	this	DT
46745	1296	3	did	do	VBD
46745	1296	4	not	not	RB
46745	1296	5	take	take	VB
46745	1296	6	place	place	NN
46745	1296	7	,	,	,
46745	1296	8	and	and	CC
46745	1296	9	when	when	WRB
46745	1296	10	at	at	IN
46745	1296	11	last	last	JJ
46745	1296	12	the	the	DT
46745	1296	13	zinc	zinc	NN
46745	1296	14	was	be	VBD
46745	1296	15	completely	completely	RB
46745	1296	16	dissolved	dissolve	VBN
46745	1296	17	,	,	,
46745	1296	18	the	the	DT
46745	1296	19	gold	gold	NN
46745	1296	20	remained	remain	VBD
46745	1296	21	as	as	RB
46745	1296	22	bright	bright	JJ
46745	1296	23	as	as	IN
46745	1296	24	before	before	RB
46745	1296	25	.	.	.
46745	1297	1	Thus	thus	RB
46745	1297	2	there	there	EX
46745	1297	3	was	be	VBD
46745	1297	4	_	_	NNP
46745	1297	5	no	no	DT
46745	1297	6	_	_	NNP
46745	1297	7	Calomel	Calomel	NNP
46745	1297	8	,	,	,
46745	1297	9	or	or	CC
46745	1297	10	compound	compound	NN
46745	1297	11	of	of	IN
46745	1297	12	mercury	mercury	NN
46745	1297	13	,	,	,
46745	1297	14	present	present	JJ
46745	1297	15	in	in	IN
46745	1297	16	the	the	DT
46745	1297	17	insoluble	insoluble	JJ
46745	1297	18	form	form	NN
46745	1297	19	.	.	.
46745	1298	1	EXP	EXP	NNP
46745	1298	2	.	.	.
46745	1299	1	2.--Ten	2.--ten	CD
46745	1299	2	grains	grain	NNS
46745	1299	3	of	of	IN
46745	1299	4	strong	strong	JJ
46745	1299	5	mercurial	mercurial	JJ
46745	1299	6	ointment	ointment	NN
46745	1299	7	(	(	-LRB-
46745	1299	8	containing	contain	VBG
46745	1299	9	half	half	PDT
46745	1299	10	its	-PRON-	PRP$
46745	1299	11	weight	weight	NN
46745	1299	12	of	of	IN
46745	1299	13	metallic	metallic	JJ
46745	1299	14	mercury	mercury	NN
46745	1299	15	,	,	,
46745	1299	16	with	with	IN
46745	1299	17	some	some	DT
46745	1299	18	oxide	oxide	NN
46745	1299	19	)	)	-RRB-
46745	1299	20	were	be	VBD
46745	1299	21	given	give	VBN
46745	1299	22	to	to	IN
46745	1299	23	another	another	DT
46745	1299	24	dog	dog	NN
46745	1299	25	.	.	.
46745	1300	1	He	-PRON-	PRP
46745	1300	2	was	be	VBD
46745	1300	3	killed	kill	VBN
46745	1300	4	after	after	IN
46745	1300	5	the	the	DT
46745	1300	6	same	same	JJ
46745	1300	7	time	time	NN
46745	1300	8	,	,	,
46745	1300	9	and	and	CC
46745	1300	10	the	the	DT
46745	1300	11	Portal	Portal	NNP
46745	1300	12	blood	blood	NN
46745	1300	13	analyzed	analyze	VBD
46745	1300	14	carefully	carefully	RB
46745	1300	15	in	in	IN
46745	1300	16	the	the	DT
46745	1300	17	same	same	JJ
46745	1300	18	way	way	NN
46745	1300	19	,	,	,
46745	1300	20	but	but	CC
46745	1300	21	here	here	RB
46745	1300	22	also	also	RB
46745	1300	23	_	_	NNP
46745	1300	24	no	no	DT
46745	1300	25	_	_	NNP
46745	1300	26	mercurial	mercurial	JJ
46745	1300	27	compound	compound	NN
46745	1300	28	was	be	VBD
46745	1300	29	present	present	JJ
46745	1300	30	in	in	IN
46745	1300	31	the	the	DT
46745	1300	32	insoluble	insoluble	JJ
46745	1300	33	form	form	NN
46745	1300	34	.	.	.
46745	1301	1	EXP	EXP	NNP
46745	1301	2	.	.	.
46745	1302	1	3.--To	3.--to	CD
46745	1302	2	a	a	DT
46745	1302	3	third	third	JJ
46745	1302	4	dog	dog	NN
46745	1302	5	five	five	CD
46745	1302	6	grains	grain	NNS
46745	1302	7	of	of	IN
46745	1302	8	Oxide	oxide	NN
46745	1302	9	of	of	IN
46745	1302	10	Silver	Silver	NNP
46745	1302	11	were	be	VBD
46745	1302	12	administered	administer	VBN
46745	1302	13	.	.	.
46745	1303	1	After	after	IN
46745	1303	2	three	three	CD
46745	1303	3	hours	hour	NNS
46745	1303	4	he	-PRON-	PRP
46745	1303	5	was	be	VBD
46745	1303	6	killed	kill	VBN
46745	1303	7	.	.	.
46745	1304	1	The	the	DT
46745	1304	2	Portal	Portal	NNP
46745	1304	3	blood	blood	NN
46745	1304	4	was	be	VBD
46745	1304	5	dried	dry	VBN
46745	1304	6	in	in	IN
46745	1304	7	a	a	DT
46745	1304	8	water	water	NN
46745	1304	9	-	-	HYPH
46745	1304	10	bath	bath	NN
46745	1304	11	,	,	,
46745	1304	12	and	and	CC
46745	1304	13	reduced	reduce	VBN
46745	1304	14	to	to	IN
46745	1304	15	powder	powder	NN
46745	1304	16	.	.	.
46745	1305	1	This	this	DT
46745	1305	2	was	be	VBD
46745	1305	3	boiled	boil	VBN
46745	1305	4	for	for	IN
46745	1305	5	some	some	DT
46745	1305	6	time	time	NN
46745	1305	7	in	in	IN
46745	1305	8	water	water	NN
46745	1305	9	,	,	,
46745	1305	10	which	which	WDT
46745	1305	11	was	be	VBD
46745	1305	12	separated	separate	VBN
46745	1305	13	by	by	IN
46745	1305	14	filtration	filtration	NN
46745	1305	15	.	.	.
46745	1306	1	Aqua	Aqua	NNP
46745	1306	2	regia	regia	NNP
46745	1306	3	was	be	VBD
46745	1306	4	then	then	RB
46745	1306	5	boiled	boil	VBN
46745	1306	6	on	on	IN
46745	1306	7	the	the	DT
46745	1306	8	insoluble	insoluble	JJ
46745	1306	9	part	part	NN
46745	1306	10	.	.	.
46745	1307	1	This	this	DT
46745	1307	2	would	would	MD
46745	1307	3	convert	convert	VB
46745	1307	4	any	any	DT
46745	1307	5	silver	silver	NN
46745	1307	6	into	into	IN
46745	1307	7	chloride	chloride	NN
46745	1307	8	.	.	.
46745	1308	1	The	the	DT
46745	1308	2	acid	acid	NN
46745	1308	3	was	be	VBD
46745	1308	4	evaporated	evaporate	VBN
46745	1308	5	off	off	RP
46745	1308	6	as	as	RB
46745	1308	7	much	much	RB
46745	1308	8	as	as	IN
46745	1308	9	possible	possible	JJ
46745	1308	10	,	,	,
46745	1308	11	and	and	CC
46745	1308	12	the	the	DT
46745	1308	13	solid	solid	JJ
46745	1308	14	remainder	remainder	NN
46745	1308	15	heated	heat	VBN
46745	1308	16	in	in	IN
46745	1308	17	a	a	DT
46745	1308	18	small	small	JJ
46745	1308	19	porcelain	porcelain	NN
46745	1308	20	crucible	crucible	JJ
46745	1308	21	to	to	IN
46745	1308	22	dull	dull	JJ
46745	1308	23	redness	redness	NN
46745	1308	24	.	.	.
46745	1309	1	The	the	DT
46745	1309	2	result	result	NN
46745	1309	3	was	be	VBD
46745	1309	4	powdered	powder	VBN
46745	1309	5	,	,	,
46745	1309	6	and	and	CC
46745	1309	7	digested	digest	VBN
46745	1309	8	in	in	IN
46745	1309	9	liquor	liquor	NN
46745	1309	10	ammoniæ	ammoniæ	NN
46745	1309	11	.	.	.
46745	1310	1	It	-PRON-	PRP
46745	1310	2	was	be	VBD
46745	1310	3	filtered	filter	VBN
46745	1310	4	,	,	,
46745	1310	5	and	and	CC
46745	1310	6	excess	excess	NN
46745	1310	7	of	of	IN
46745	1310	8	nitric	nitric	JJ
46745	1310	9	acid	acid	NN
46745	1310	10	was	be	VBD
46745	1310	11	added	add	VBN
46745	1310	12	.	.	.
46745	1311	1	There	there	EX
46745	1311	2	was	be	VBD
46745	1311	3	not	not	RB
46745	1311	4	any	any	DT
46745	1311	5	precipitate	precipitate	NN
46745	1311	6	.	.	.
46745	1312	1	Had	have	VBD
46745	1312	2	chloride	chloride	NN
46745	1312	3	of	of	IN
46745	1312	4	silver	silver	NN
46745	1312	5	been	be	VBN
46745	1312	6	present	present	JJ
46745	1312	7	,	,	,
46745	1312	8	it	-PRON-	PRP
46745	1312	9	would	would	MD
46745	1312	10	have	have	VB
46745	1312	11	been	be	VBN
46745	1312	12	dissolved	dissolve	VBN
46745	1312	13	by	by	IN
46745	1312	14	the	the	DT
46745	1312	15	ammonia	ammonia	NN
46745	1312	16	,	,	,
46745	1312	17	and	and	CC
46745	1312	18	precipitated	precipitate	VBN
46745	1312	19	by	by	IN
46745	1312	20	the	the	DT
46745	1312	21	acid	acid	NN
46745	1312	22	.	.	.
46745	1313	1	Thus	thus	RB
46745	1313	2	no	no	DT
46745	1313	3	insoluble	insoluble	JJ
46745	1313	4	silver	silver	NN
46745	1313	5	compound	compound	NN
46745	1313	6	was	be	VBD
46745	1313	7	contained	contain	VBN
46745	1313	8	in	in	IN
46745	1313	9	the	the	DT
46745	1313	10	blood	blood	NN
46745	1313	11	analyzed	analyze	VBD
46745	1313	12	.	.	.
46745	1314	1	EXP	EXP	NNP
46745	1314	2	.	.	.
46745	1315	1	4.--Ten	4.--Ten	NNP
46745	1315	2	grains	grain	NNS
46745	1315	3	of	of	IN
46745	1315	4	sulphur	sulphur	NNP
46745	1315	5	were	be	VBD
46745	1315	6	administered	administer	VBN
46745	1315	7	in	in	IN
46745	1315	8	the	the	DT
46745	1315	9	same	same	JJ
46745	1315	10	way	way	NN
46745	1315	11	to	to	IN
46745	1315	12	a	a	DT
46745	1315	13	fourth	fourth	JJ
46745	1315	14	dog	dog	NN
46745	1315	15	.	.	.
46745	1316	1	On	on	IN
46745	1316	2	killing	kill	VBG
46745	1316	3	it	-PRON-	PRP
46745	1316	4	and	and	CC
46745	1316	5	opening	open	VBG
46745	1316	6	the	the	DT
46745	1316	7	body	body	NN
46745	1316	8	,	,	,
46745	1316	9	the	the	DT
46745	1316	10	thoracic	thoracic	NNP
46745	1316	11	duct	duct	NN
46745	1316	12	was	be	VBD
46745	1316	13	found	find	VBN
46745	1316	14	to	to	TO
46745	1316	15	be	be	VB
46745	1316	16	full	full	JJ
46745	1316	17	.	.	.
46745	1317	1	A	a	DT
46745	1317	2	considerable	considerable	JJ
46745	1317	3	quantity	quantity	NN
46745	1317	4	of	of	IN
46745	1317	5	chyle	chyle	NN
46745	1317	6	was	be	VBD
46745	1317	7	collected	collect	VBN
46745	1317	8	from	from	IN
46745	1317	9	it	-PRON-	PRP
46745	1317	10	.	.	.
46745	1318	1	Now	now	RB
46745	1318	2	,	,	,
46745	1318	3	as	as	IN
46745	1318	4	it	-PRON-	PRP
46745	1318	5	is	be	VBZ
46745	1318	6	asserted	assert	VBN
46745	1318	7	by	by	IN
46745	1318	8	some	some	DT
46745	1318	9	,	,	,
46745	1318	10	that	that	IN
46745	1318	11	fat	fat	NN
46745	1318	12	passes	pass	VBZ
46745	1318	13	undissolved	undissolve	VBN
46745	1318	14	into	into	IN
46745	1318	15	the	the	DT
46745	1318	16	chyle	chyle	NN
46745	1318	17	,	,	,
46745	1318	18	and	and	CC
46745	1318	19	as	as	IN
46745	1318	20	I	-PRON-	PRP
46745	1318	21	believe	believe	VBP
46745	1318	22	that	that	IN
46745	1318	23	sulphur	sulphur	NNP
46745	1318	24	is	be	VBZ
46745	1318	25	digested	digest	VBN
46745	1318	26	in	in	IN
46745	1318	27	the	the	DT
46745	1318	28	neighbourhood	neighbourhood	NN
46745	1318	29	of	of	IN
46745	1318	30	the	the	DT
46745	1318	31	bile	bile	NN
46745	1318	32	duct	duct	NN
46745	1318	33	,	,	,
46745	1318	34	this	this	DT
46745	1318	35	chyle	chyle	NN
46745	1318	36	was	be	VBD
46745	1318	37	chosen	choose	VBN
46745	1318	38	for	for	IN
46745	1318	39	analysis	analysis	NN
46745	1318	40	in	in	IN
46745	1318	41	preference	preference	NN
46745	1318	42	to	to	IN
46745	1318	43	blood	blood	NN
46745	1318	44	,	,	,
46745	1318	45	as	as	IN
46745	1318	46	more	more	RBR
46745	1318	47	likely	likely	JJ
46745	1318	48	to	to	TO
46745	1318	49	contain	contain	VB
46745	1318	50	any	any	DT
46745	1318	51	insoluble	insoluble	JJ
46745	1318	52	sulphur	sulphur	NN
46745	1318	53	.	.	.
46745	1319	1	Besides	besides	RB
46745	1319	2	,	,	,
46745	1319	3	the	the	DT
46745	1319	4	blood	blood	NN
46745	1319	5	would	would	MD
46745	1319	6	be	be	VB
46745	1319	7	less	less	RBR
46745	1319	8	satisfactory	satisfactory	JJ
46745	1319	9	,	,	,
46745	1319	10	on	on	IN
46745	1319	11	account	account	NN
46745	1319	12	of	of	IN
46745	1319	13	the	the	DT
46745	1319	14	large	large	JJ
46745	1319	15	quantity	quantity	NN
46745	1319	16	of	of	IN
46745	1319	17	albumen	albuman	NNS
46745	1319	18	and	and	CC
46745	1319	19	fibrine	fibrine	NN
46745	1319	20	contained	contain	VBN
46745	1319	21	in	in	IN
46745	1319	22	it	-PRON-	PRP
46745	1319	23	,	,	,
46745	1319	24	both	both	DT
46745	1319	25	of	of	IN
46745	1319	26	them	-PRON-	PRP
46745	1319	27	also	also	RB
46745	1319	28	containing	contain	VBG
46745	1319	29	sulphur	sulphur	NN
46745	1319	30	.	.	.
46745	1320	1	The	the	DT
46745	1320	2	insoluble	insoluble	JJ
46745	1320	3	part	part	NN
46745	1320	4	of	of	IN
46745	1320	5	the	the	DT
46745	1320	6	chyle	chyle	NN
46745	1320	7	was	be	VBD
46745	1320	8	obtained	obtain	VBN
46745	1320	9	in	in	IN
46745	1320	10	the	the	DT
46745	1320	11	same	same	JJ
46745	1320	12	manner	manner	NN
46745	1320	13	as	as	IN
46745	1320	14	with	with	IN
46745	1320	15	the	the	DT
46745	1320	16	blood	blood	NN
46745	1320	17	.	.	.
46745	1321	1	It	-PRON-	PRP
46745	1321	2	was	be	VBD
46745	1321	3	then	then	RB
46745	1321	4	boiled	boil	VBN
46745	1321	5	in	in	IN
46745	1321	6	a	a	DT
46745	1321	7	small	small	JJ
46745	1321	8	quantity	quantity	NN
46745	1321	9	of	of	IN
46745	1321	10	a	a	DT
46745	1321	11	weak	weak	JJ
46745	1321	12	solution	solution	NN
46745	1321	13	of	of	IN
46745	1321	14	caustic	caustic	JJ
46745	1321	15	potash	potash	NN
46745	1321	16	.	.	.
46745	1322	1	By	by	IN
46745	1322	2	this	this	DT
46745	1322	3	any	any	DT
46745	1322	4	free	free	JJ
46745	1322	5	sulphur	sulphur	NN
46745	1322	6	would	would	MD
46745	1322	7	be	be	VB
46745	1322	8	converted	convert	VBN
46745	1322	9	into	into	IN
46745	1322	10	a	a	DT
46745	1322	11	soluble	soluble	JJ
46745	1322	12	sulphate	sulphate	NN
46745	1322	13	of	of	IN
46745	1322	14	Potassium	Potassium	NNP
46745	1322	15	.	.	.
46745	1323	1	The	the	DT
46745	1323	2	solution	solution	NN
46745	1323	3	was	be	VBD
46745	1323	4	filtered	filter	VBN
46745	1323	5	,	,	,
46745	1323	6	and	and	CC
46745	1323	7	a	a	DT
46745	1323	8	few	few	JJ
46745	1323	9	drops	drop	NNS
46745	1323	10	of	of	IN
46745	1323	11	a	a	DT
46745	1323	12	solution	solution	NN
46745	1323	13	of	of	IN
46745	1323	14	the	the	DT
46745	1323	15	Nitro	Nitro	NNP
46745	1323	16	-	-	HYPH
46745	1323	17	prusside	prusside	NN
46745	1323	18	of	of	IN
46745	1323	19	Potassium	Potassium	NNP
46745	1323	20	added	add	VBD
46745	1323	21	.	.	.
46745	1324	1	(	(	-LRB-
46745	1324	2	This	this	DT
46745	1324	3	is	be	VBZ
46745	1324	4	a	a	DT
46745	1324	5	salt	salt	NN
46745	1324	6	lately	lately	RB
46745	1324	7	discovered	discover	VBN
46745	1324	8	by	by	IN
46745	1324	9	Dr.	Dr.	NNP
46745	1324	10	Playfair	Playfair	NNP
46745	1324	11	.	.	.
46745	1325	1	It	-PRON-	PRP
46745	1325	2	is	be	VBZ
46745	1325	3	a	a	DT
46745	1325	4	delicate	delicate	JJ
46745	1325	5	test	test	NN
46745	1325	6	for	for	IN
46745	1325	7	soluble	soluble	JJ
46745	1325	8	sulphurets	sulphuret	NNS
46745	1325	9	,	,	,
46745	1325	10	with	with	IN
46745	1325	11	which	which	WDT
46745	1325	12	it	-PRON-	PRP
46745	1325	13	strikes	strike	VBZ
46745	1325	14	a	a	DT
46745	1325	15	deep	deep	JJ
46745	1325	16	purple	purple	JJ
46745	1325	17	colour	colour	NN
46745	1325	18	.	.	.
46745	1325	19	)	)	-RRB-
46745	1326	1	No	no	DT
46745	1326	2	change	change	NN
46745	1326	3	was	be	VBD
46745	1326	4	produced	produce	VBN
46745	1326	5	.	.	.
46745	1327	1	Therefore	therefore	RB
46745	1327	2	no	no	DT
46745	1327	3	insoluble	insoluble	JJ
46745	1327	4	sulphur	sulphur	NN
46745	1327	5	was	be	VBD
46745	1327	6	present	present	JJ
46745	1327	7	in	in	IN
46745	1327	8	the	the	DT
46745	1327	9	chyle	chyle	NN
46745	1327	10	.	.	.
46745	1328	1	The	the	DT
46745	1328	2	results	result	NNS
46745	1328	3	of	of	IN
46745	1328	4	these	these	DT
46745	1328	5	experiments	experiment	NNS
46745	1328	6	are	be	VBP
46745	1328	7	thus	thus	RB
46745	1328	8	in	in	IN
46745	1328	9	direct	direct	JJ
46745	1328	10	opposition	opposition	NN
46745	1328	11	to	to	IN
46745	1328	12	those	those	DT
46745	1328	13	of	of	IN
46745	1328	14	M.	M.	NNP
46745	1328	15	[	[	-LRB-
46745	1328	16	OE]sterlen	OE]sterlen	NNP
46745	1328	17	,	,	,
46745	1328	18	and	and	CC
46745	1328	19	support	support	VB
46745	1328	20	a	a	DT
46745	1328	21	view	view	NN
46745	1328	22	of	of	IN
46745	1328	23	the	the	DT
46745	1328	24	question	question	NN
46745	1328	25	which	which	WDT
46745	1328	26	seems	seem	VBZ
46745	1328	27	even	even	RB
46745	1328	28	_	_	NNP
46745	1328	29	à	à	NNP
46745	1328	30	priori	priori	VBP
46745	1328	31	_	_	NNP
46745	1328	32	more	more	RBR
46745	1328	33	philosophical	philosophical	JJ
46745	1328	34	and	and	CC
46745	1328	35	reasonable	reasonable	JJ
46745	1328	36	than	than	IN
46745	1328	37	that	that	DT
46745	1328	38	which	which	WDT
46745	1328	39	he	-PRON-	PRP
46745	1328	40	has	have	VBZ
46745	1328	41	adopted	adopt	VBN
46745	1328	42	.	.	.
46745	1329	1	I	-PRON-	PRP
46745	1329	2	believe	believe	VBP
46745	1329	3	that	that	IN
46745	1329	4	no	no	DT
46745	1329	5	insoluble	insoluble	JJ
46745	1329	6	medicine	medicine	NN
46745	1329	7	can	can	MD
46745	1329	8	in	in	IN
46745	1329	9	any	any	DT
46745	1329	10	way	way	NN
46745	1329	11	gain	gain	VB
46745	1329	12	entry	entry	NN
46745	1329	13	into	into	IN
46745	1329	14	the	the	DT
46745	1329	15	blood	blood	NN
46745	1329	16	without	without	IN
46745	1329	17	first	first	JJ
46745	1329	18	undergoing	undergoing	JJ
46745	1329	19	solution	solution	NN
46745	1329	20	in	in	IN
46745	1329	21	some	some	DT
46745	1329	22	way	way	NN
46745	1329	23	or	or	CC
46745	1329	24	another	another	DT
46745	1329	25	.	.	.
46745	1330	1	PROP	PROP	NNP
46745	1330	2	.	.	.
46745	1331	1	IV.--_That	iv.--_that	LS
46745	1331	2	some	some	DT
46745	1331	3	few	few	JJ
46745	1331	4	remedial	remedial	JJ
46745	1331	5	agents	agent	NNS
46745	1331	6	act	act	VBP
46745	1331	7	locally	locally	RB
46745	1331	8	on	on	IN
46745	1331	9	the	the	DT
46745	1331	10	mucous	mucous	JJ
46745	1331	11	surface	surface	NN
46745	1331	12	,	,	,
46745	1331	13	either	either	CC
46745	1331	14	before	before	IN
46745	1331	15	absorption	absorption	NN
46745	1331	16	,	,	,
46745	1331	17	or	or	CC
46745	1331	18	without	without	IN
46745	1331	19	being	be	VBG
46745	1331	20	absorbed	absorb	VBN
46745	1331	21	at	at	RB
46745	1331	22	all	all	RB
46745	1331	23	.	.	.
46745	1332	1	That	that	IN
46745	1332	2	they	-PRON-	PRP
46745	1332	3	are	be	VBP
46745	1332	4	chiefly	chiefly	RB
46745	1332	5	as	as	IN
46745	1332	6	follow:_--	follow:_--	NNP
46745	1332	7	_	_	NNP
46745	1332	8	A.	a.	NN
46745	1333	1	Irritant	Irritant	NNP
46745	1333	2	Emetics	Emetics	NNP
46745	1333	3	.	.	.
46745	1333	4	_	_	NNP
46745	1333	5	_	_	NNP
46745	1333	6	B.	B.	NNP
46745	1334	1	Stomach	Stomach	NNP
46745	1334	2	Anæsthetics	Anæsthetics	NNP
46745	1334	3	.	.	.
46745	1334	4	_	_	NNP
46745	1334	5	_	_	NNP
46745	1334	6	C.	C.	NNP
46745	1335	1	Irritant	Irritant	NNP
46745	1335	2	Cathartics	Cathartics	NNP
46745	1335	3	.	.	.
46745	1335	4	_	_	NNP
46745	1335	5	It	-PRON-	PRP
46745	1335	6	has	have	VBZ
46745	1335	7	already	already	RB
46745	1335	8	been	be	VBN
46745	1335	9	shown	show	VBN
46745	1335	10	,	,	,
46745	1335	11	during	during	IN
46745	1335	12	the	the	DT
46745	1335	13	consideration	consideration	NN
46745	1335	14	of	of	IN
46745	1335	15	the	the	DT
46745	1335	16	first	first	JJ
46745	1335	17	proposition	proposition	NN
46745	1335	18	,	,	,
46745	1335	19	that	that	IN
46745	1335	20	medicines	medicine	NNS
46745	1335	21	which	which	WDT
46745	1335	22	act	act	VBP
46745	1335	23	on	on	IN
46745	1335	24	distant	distant	JJ
46745	1335	25	parts	part	NNS
46745	1335	26	of	of	IN
46745	1335	27	the	the	DT
46745	1335	28	body	body	NN
46745	1335	29	must	must	MD
46745	1335	30	be	be	VB
46745	1335	31	,	,	,
46745	1335	32	and	and	CC
46745	1335	33	are	be	VBP
46745	1335	34	,	,	,
46745	1335	35	absorbed	absorb	VBN
46745	1335	36	before	before	IN
46745	1335	37	they	-PRON-	PRP
46745	1335	38	can	can	MD
46745	1335	39	so	so	RB
46745	1335	40	act	act	VB
46745	1335	41	.	.	.
46745	1336	1	This	this	DT
46745	1336	2	necessity	necessity	NN
46745	1336	3	for	for	IN
46745	1336	4	absorption	absorption	NN
46745	1336	5	has	have	VBZ
46745	1336	6	been	be	VBN
46745	1336	7	shown	show	VBN
46745	1336	8	to	to	TO
46745	1336	9	extend	extend	VB
46745	1336	10	even	even	RB
46745	1336	11	to	to	IN
46745	1336	12	medicines	medicine	NNS
46745	1336	13	which	which	WDT
46745	1336	14	act	act	VBP
46745	1336	15	most	most	RBS
46745	1336	16	rapidly	rapidly	RB
46745	1336	17	on	on	IN
46745	1336	18	the	the	DT
46745	1336	19	nervous	nervous	JJ
46745	1336	20	system	system	NN
46745	1336	21	.	.	.
46745	1337	1	If	if	IN
46745	1337	2	any	any	DT
46745	1337	3	medicines	medicine	NNS
46745	1337	4	could	could	MD
46745	1337	5	produce	produce	VB
46745	1337	6	a	a	DT
46745	1337	7	distant	distant	JJ
46745	1337	8	effect	effect	NN
46745	1337	9	by	by	IN
46745	1337	10	a	a	DT
46745	1337	11	mere	mere	JJ
46745	1337	12	contact	contact	NN
46745	1337	13	with	with	IN
46745	1337	14	the	the	DT
46745	1337	15	coats	coat	NNS
46745	1337	16	of	of	IN
46745	1337	17	the	the	DT
46745	1337	18	stomach	stomach	NN
46745	1337	19	,	,	,
46745	1337	20	such	such	PDT
46745	1337	21	a	a	DT
46745	1337	22	power	power	NN
46745	1337	23	would	would	MD
46745	1337	24	be	be	VB
46745	1337	25	ascribed	ascribe	VBN
46745	1337	26	to	to	IN
46745	1337	27	those	those	DT
46745	1337	28	stimulants	stimulant	NNS
46745	1337	29	and	and	CC
46745	1337	30	sedatives	sedative	NNS
46745	1337	31	which	which	WDT
46745	1337	32	,	,	,
46745	1337	33	from	from	IN
46745	1337	34	the	the	DT
46745	1337	35	suddenness	suddenness	NN
46745	1337	36	of	of	IN
46745	1337	37	their	-PRON-	PRP$
46745	1337	38	action	action	NN
46745	1337	39	,	,	,
46745	1337	40	are	be	VBP
46745	1337	41	called	call	VBN
46745	1337	42	diffusible	diffusible	JJ
46745	1337	43	.	.	.
46745	1338	1	Such	such	JJ
46745	1338	2	are	be	VBP
46745	1338	3	Hydrocyanic	Hydrocyanic	NNP
46745	1338	4	Acid	Acid	NNP
46745	1338	5	and	and	CC
46745	1338	6	Ammonia	Ammonia	NNP
46745	1338	7	.	.	.
46745	1339	1	Their	-PRON-	PRP$
46745	1339	2	rapidity	rapidity	NN
46745	1339	3	of	of	IN
46745	1339	4	action	action	NN
46745	1339	5	is	be	VBZ
46745	1339	6	to	to	TO
46745	1339	7	be	be	VB
46745	1339	8	ascribed	ascribe	VBN
46745	1339	9	to	to	IN
46745	1339	10	their	-PRON-	PRP$
46745	1339	11	volatility	volatility	NN
46745	1339	12	,	,	,
46745	1339	13	whereby	whereby	WRB
46745	1339	14	they	-PRON-	PRP
46745	1339	15	spread	spread	VBD
46745	1339	16	over	over	IN
46745	1339	17	a	a	DT
46745	1339	18	large	large	JJ
46745	1339	19	surface	surface	NN
46745	1339	20	,	,	,
46745	1339	21	and	and	CC
46745	1339	22	are	be	VBP
46745	1339	23	almost	almost	RB
46745	1339	24	_	_	NNP
46745	1339	25	suddenly	suddenly	RB
46745	1339	26	_	_	NNP
46745	1339	27	absorbed	absorb	VBD
46745	1339	28	and	and	CC
46745	1339	29	transmitted	transmit	VBD
46745	1339	30	through	through	IN
46745	1339	31	the	the	DT
46745	1339	32	blood	blood	NN
46745	1339	33	.	.	.
46745	1340	1	But	but	CC
46745	1340	2	Hydrocyanic	hydrocyanic	JJ
46745	1340	3	Acid	Acid	NNP
46745	1340	4	may	may	MD
46745	1340	5	be	be	VB
46745	1340	6	absorbed	absorb	VBN
46745	1340	7	from	from	IN
46745	1340	8	any	any	DT
46745	1340	9	surface	surface	NN
46745	1340	10	.	.	.
46745	1341	1	It	-PRON-	PRP
46745	1341	2	is	be	VBZ
46745	1341	3	poisonous	poisonous	JJ
46745	1341	4	when	when	WRB
46745	1341	5	inhaled	inhale	VBN
46745	1341	6	into	into	IN
46745	1341	7	the	the	DT
46745	1341	8	lungs	lung	NNS
46745	1341	9	.	.	.
46745	1342	1	It	-PRON-	PRP
46745	1342	2	rapidly	rapidly	RB
46745	1342	3	causes	cause	VBZ
46745	1342	4	death	death	NN
46745	1342	5	when	when	WRB
46745	1342	6	dropped	drop	VBD
46745	1342	7	into	into	IN
46745	1342	8	the	the	DT
46745	1342	9	eye	eye	NN
46745	1342	10	of	of	IN
46745	1342	11	an	an	DT
46745	1342	12	animal	animal	NN
46745	1342	13	.	.	.
46745	1343	1	So	so	RB
46745	1343	2	also	also	RB
46745	1343	3	the	the	DT
46745	1343	4	results	result	NNS
46745	1343	5	of	of	IN
46745	1343	6	the	the	DT
46745	1343	7	inhalation	inhalation	NN
46745	1343	8	of	of	IN
46745	1343	9	ammoniacal	ammoniacal	JJ
46745	1343	10	gas	gas	NN
46745	1343	11	are	be	VBP
46745	1343	12	the	the	DT
46745	1343	13	same	same	JJ
46745	1343	14	as	as	IN
46745	1343	15	of	of	IN
46745	1343	16	the	the	DT
46745	1343	17	ingestion	ingestion	NN
46745	1343	18	of	of	IN
46745	1343	19	its	-PRON-	PRP$
46745	1343	20	solution	solution	NN
46745	1343	21	.	.	.
46745	1344	1	I	-PRON-	PRP
46745	1344	2	believe	believe	VBP
46745	1344	3	that	that	IN
46745	1344	4	the	the	DT
46745	1344	5	latter	latter	JJ
46745	1344	6	,	,	,
46745	1344	7	on	on	IN
46745	1344	8	account	account	NN
46745	1344	9	of	of	IN
46745	1344	10	its	-PRON-	PRP$
46745	1344	11	diffusibility	diffusibility	NN
46745	1344	12	and	and	CC
46745	1344	13	rapid	rapid	JJ
46745	1344	14	absorption	absorption	NN
46745	1344	15	,	,	,
46745	1344	16	escapes	escape	VBZ
46745	1344	17	neutralization	neutralization	NN
46745	1344	18	by	by	IN
46745	1344	19	the	the	DT
46745	1344	20	stomach	stomach	NN
46745	1344	21	acid	acid	NN
46745	1344	22	,	,	,
46745	1344	23	and	and	CC
46745	1344	24	passes	pass	VBZ
46745	1344	25	into	into	IN
46745	1344	26	the	the	DT
46745	1344	27	blood	blood	NN
46745	1344	28	as	as	IN
46745	1344	29	free	free	JJ
46745	1344	30	Ammonia	Ammonia	NNP
46745	1344	31	.	.	.
46745	1345	1	In	in	IN
46745	1345	2	the	the	DT
46745	1345	3	consideration	consideration	NN
46745	1345	4	of	of	IN
46745	1345	5	the	the	DT
46745	1345	6	first	first	JJ
46745	1345	7	Proposition	Proposition	NNP
46745	1345	8	,	,	,
46745	1345	9	I	-PRON-	PRP
46745	1345	10	endeavoured	endeavour	VBD
46745	1345	11	to	to	TO
46745	1345	12	point	point	VB
46745	1345	13	out	out	RP
46745	1345	14	that	that	IN
46745	1345	15	though	though	IN
46745	1345	16	the	the	DT
46745	1345	17	proper	proper	JJ
46745	1345	18	action	action	NN
46745	1345	19	of	of	IN
46745	1345	20	a	a	DT
46745	1345	21	medicine	medicine	NN
46745	1345	22	could	could	MD
46745	1345	23	in	in	IN
46745	1345	24	no	no	DT
46745	1345	25	case	case	NN
46745	1345	26	be	be	VB
46745	1345	27	conducted	conduct	VBN
46745	1345	28	,	,	,
46745	1345	29	without	without	IN
46745	1345	30	absorption	absorption	NN
46745	1345	31	,	,	,
46745	1345	32	from	from	IN
46745	1345	33	the	the	DT
46745	1345	34	mucous	mucous	JJ
46745	1345	35	surface	surface	NN
46745	1345	36	to	to	IN
46745	1345	37	a	a	DT
46745	1345	38	distant	distant	JJ
46745	1345	39	part	part	NN
46745	1345	40	of	of	IN
46745	1345	41	the	the	DT
46745	1345	42	system	system	NN
46745	1345	43	,	,	,
46745	1345	44	yet	yet	CC
46745	1345	45	that	that	IN
46745	1345	46	a	a	DT
46745	1345	47	remote	remote	JJ
46745	1345	48	action	action	NN
46745	1345	49	of	of	IN
46745	1345	50	another	another	DT
46745	1345	51	kind	kind	NN
46745	1345	52	might	may	MD
46745	1345	53	occur	occur	VB
46745	1345	54	as	as	IN
46745	1345	55	the	the	DT
46745	1345	56	result	result	NN
46745	1345	57	of	of	IN
46745	1345	58	a	a	DT
46745	1345	59	change	change	NN
46745	1345	60	in	in	IN
46745	1345	61	the	the	DT
46745	1345	62	nervous	nervous	JJ
46745	1345	63	system	system	NN
46745	1345	64	produced	produce	VBN
46745	1345	65	by	by	IN
46745	1345	66	a	a	DT
46745	1345	67	powerful	powerful	JJ
46745	1345	68	local	local	JJ
46745	1345	69	impression	impression	NN
46745	1345	70	.	.	.
46745	1346	1	I	-PRON-	PRP
46745	1346	2	stated	state	VBD
46745	1346	3	that	that	IN
46745	1346	4	the	the	DT
46745	1346	5	term	term	NN
46745	1346	6	_	_	NNP
46745	1346	7	Counter	Counter	NNP
46745	1346	8	-	-	HYPH
46745	1346	9	irritation	irritation	NN
46745	1346	10	_	_	NNP
46745	1346	11	was	be	VBD
46745	1346	12	employed	employ	VBN
46745	1346	13	to	to	TO
46745	1346	14	express	express	VB
46745	1346	15	this	this	DT
46745	1346	16	action	action	NN
46745	1346	17	,	,	,
46745	1346	18	the	the	DT
46745	1346	19	nature	nature	NN
46745	1346	20	of	of	IN
46745	1346	21	it	-PRON-	PRP
46745	1346	22	being	be	VBG
46745	1346	23	but	but	CC
46745	1346	24	ill	ill	JJ
46745	1346	25	understood	understood	NN
46745	1346	26	.	.	.
46745	1347	1	A	a	DT
46745	1347	2	powerful	powerful	JJ
46745	1347	3	impression	impression	NN
46745	1347	4	on	on	IN
46745	1347	5	any	any	DT
46745	1347	6	surface	surface	NN
46745	1347	7	of	of	IN
46745	1347	8	the	the	DT
46745	1347	9	body	body	NN
46745	1347	10	,	,	,
46745	1347	11	external	external	JJ
46745	1347	12	or	or	CC
46745	1347	13	internal	internal	JJ
46745	1347	14	,	,	,
46745	1347	15	seems	seem	VBZ
46745	1347	16	to	to	TO
46745	1347	17	be	be	VB
46745	1347	18	capable	capable	JJ
46745	1347	19	of	of	IN
46745	1347	20	arresting	arrest	VBG
46745	1347	21	and	and	CC
46745	1347	22	diverting	diverting	NN
46745	1347	23	,	,	,
46745	1347	24	as	as	IN
46745	1347	25	it	-PRON-	PRP
46745	1347	26	were	be	VBD
46745	1347	27	,	,	,
46745	1347	28	the	the	DT
46745	1347	29	attention	attention	NN
46745	1347	30	of	of	IN
46745	1347	31	the	the	DT
46745	1347	32	system	system	NN
46745	1347	33	,	,	,
46745	1347	34	and	and	CC
46745	1347	35	thus	thus	RB
46745	1347	36	,	,	,
46745	1347	37	for	for	IN
46745	1347	38	a	a	DT
46745	1347	39	time	time	NN
46745	1347	40	,	,	,
46745	1347	41	of	of	IN
46745	1347	42	checking	check	VBG
46745	1347	43	a	a	DT
46745	1347	44	morbid	morbid	NN
46745	1347	45	process	process	NN
46745	1347	46	.	.	.
46745	1348	1	Frictions	Frictions	NNP
46745	1348	2	and	and	CC
46745	1348	3	Sinapisms	Sinapisms	NNP
46745	1348	4	act	act	VBP
46745	1348	5	on	on	IN
46745	1348	6	the	the	DT
46745	1348	7	skin	skin	NN
46745	1348	8	externally	externally	RB
46745	1348	9	on	on	IN
46745	1348	10	this	this	DT
46745	1348	11	principle	principle	NN
46745	1348	12	.	.	.
46745	1349	1	So	so	RB
46745	1349	2	do	do	VB
46745	1349	3	Blisters	blister	NNS
46745	1349	4	and	and	CC
46745	1349	5	Issues	Issues	NNPS
46745	1349	6	;	;	:
46745	1349	7	but	but	CC
46745	1349	8	they	-PRON-	PRP
46745	1349	9	are	be	VBP
46745	1349	10	not	not	RB
46745	1349	11	simply	simply	RB
46745	1349	12	counter	counter	NN
46745	1349	13	-	-	NNS
46745	1349	14	irritants	irritant	NNS
46745	1349	15	,	,	,
46745	1349	16	for	for	IN
46745	1349	17	they	-PRON-	PRP
46745	1349	18	also	also	RB
46745	1349	19	drain	drain	VBP
46745	1349	20	away	away	RB
46745	1349	21	the	the	DT
46745	1349	22	serum	serum	NN
46745	1349	23	of	of	IN
46745	1349	24	the	the	DT
46745	1349	25	blood	blood	NN
46745	1349	26	.	.	.
46745	1350	1	It	-PRON-	PRP
46745	1350	2	is	be	VBZ
46745	1350	3	not	not	RB
46745	1350	4	now	now	RB
46745	1350	5	within	within	IN
46745	1350	6	my	-PRON-	PRP$
46745	1350	7	province	province	NN
46745	1350	8	to	to	TO
46745	1350	9	consider	consider	VB
46745	1350	10	such	such	PDT
46745	1350	11	an	an	DT
46745	1350	12	action	action	NN
46745	1350	13	on	on	IN
46745	1350	14	the	the	DT
46745	1350	15	skin	skin	NN
46745	1350	16	,	,	,
46745	1350	17	any	any	DT
46745	1350	18	further	further	RB
46745	1350	19	than	than	IN
46745	1350	20	for	for	IN
46745	1350	21	the	the	DT
46745	1350	22	purpose	purpose	NN
46745	1350	23	of	of	IN
46745	1350	24	stating	state	VBG
46745	1350	25	that	that	IN
46745	1350	26	similar	similar	JJ
46745	1350	27	local	local	JJ
46745	1350	28	impressions	impression	NNS
46745	1350	29	on	on	IN
46745	1350	30	the	the	DT
46745	1350	31	mucous	mucous	JJ
46745	1350	32	surface	surface	NN
46745	1350	33	of	of	IN
46745	1350	34	the	the	DT
46745	1350	35	stomach	stomach	NN
46745	1350	36	and	and	CC
46745	1350	37	intestines	intestine	NNS
46745	1350	38	are	be	VBP
46745	1350	39	capable	capable	JJ
46745	1350	40	of	of	IN
46745	1350	41	operating	operate	VBG
46745	1350	42	on	on	IN
46745	1350	43	the	the	DT
46745	1350	44	same	same	JJ
46745	1350	45	principle	principle	NN
46745	1350	46	.	.	.
46745	1351	1	We	-PRON-	PRP
46745	1351	2	have	have	VBP
46745	1351	3	then	then	RB
46745	1351	4	to	to	TO
46745	1351	5	consider	consider	VB
46745	1351	6	what	what	WP
46745	1351	7	are	be	VBP
46745	1351	8	the	the	DT
46745	1351	9	local	local	JJ
46745	1351	10	actions	action	NNS
46745	1351	11	that	that	WDT
46745	1351	12	medicines	medicine	NNS
46745	1351	13	are	be	VBP
46745	1351	14	capable	capable	JJ
46745	1351	15	of	of	IN
46745	1351	16	producing	produce	VBG
46745	1351	17	on	on	IN
46745	1351	18	these	these	DT
46745	1351	19	surfaces	surface	NNS
46745	1351	20	.	.	.
46745	1352	1	And	and	CC
46745	1352	2	first	first	RB
46745	1352	3	,	,	,
46745	1352	4	it	-PRON-	PRP
46745	1352	5	must	must	MD
46745	1352	6	be	be	VB
46745	1352	7	laid	lay	VBN
46745	1352	8	down	down	RP
46745	1352	9	as	as	IN
46745	1352	10	a	a	DT
46745	1352	11	rule	rule	NN
46745	1352	12	,	,	,
46745	1352	13	that	that	IN
46745	1352	14	all	all	DT
46745	1352	15	medicines	medicine	NNS
46745	1352	16	,	,	,
46745	1352	17	when	when	WRB
46745	1352	18	given	give	VBN
46745	1352	19	in	in	IN
46745	1352	20	excess	excess	NN
46745	1352	21	,	,	,
46745	1352	22	act	act	VBP
46745	1352	23	as	as	IN
46745	1352	24	irritants	irritant	NNS
46745	1352	25	on	on	IN
46745	1352	26	the	the	DT
46745	1352	27	stomach	stomach	NN
46745	1352	28	and	and	CC
46745	1352	29	intestines	intestine	NNS
46745	1352	30	.	.	.
46745	1353	1	This	this	DT
46745	1353	2	is	be	VBZ
46745	1353	3	more	more	RBR
46745	1353	4	especially	especially	RB
46745	1353	5	the	the	DT
46745	1353	6	case	case	NN
46745	1353	7	with	with	IN
46745	1353	8	mineral	mineral	NN
46745	1353	9	salts	salt	NNS
46745	1353	10	,	,	,
46745	1353	11	with	with	IN
46745	1353	12	the	the	DT
46745	1353	13	bitter	bitter	JJ
46745	1353	14	and	and	CC
46745	1353	15	astringent	astringent	JJ
46745	1353	16	principles	principle	NNS
46745	1353	17	of	of	IN
46745	1353	18	vegetables	vegetable	NNS
46745	1353	19	,	,	,
46745	1353	20	and	and	CC
46745	1353	21	with	with	IN
46745	1353	22	acrid	acrid	JJ
46745	1353	23	and	and	CC
46745	1353	24	resinous	resinous	JJ
46745	1353	25	matters	matter	NNS
46745	1353	26	.	.	.
46745	1354	1	By	by	IN
46745	1354	2	irritating	irritate	VBG
46745	1354	3	the	the	DT
46745	1354	4	stomach	stomach	NN
46745	1354	5	locally	locally	RB
46745	1354	6	,	,	,
46745	1354	7	they	-PRON-	PRP
46745	1354	8	cause	cause	VBP
46745	1354	9	vomiting	vomit	VBG
46745	1354	10	;	;	:
46745	1354	11	by	by	IN
46745	1354	12	causing	cause	VBG
46745	1354	13	peristaltic	peristaltic	JJ
46745	1354	14	action	action	NN
46745	1354	15	of	of	IN
46745	1354	16	the	the	DT
46745	1354	17	bowels	bowel	NNS
46745	1354	18	,	,	,
46745	1354	19	purging	purge	VBG
46745	1354	20	.	.	.
46745	1355	1	Some	some	DT
46745	1355	2	of	of	IN
46745	1355	3	them	-PRON-	PRP
46745	1355	4	are	be	VBP
46745	1355	5	actually	actually	RB
46745	1355	6	employed	employ	VBN
46745	1355	7	to	to	TO
46745	1355	8	produce	produce	VB
46745	1355	9	these	these	DT
46745	1355	10	effects	effect	NNS
46745	1355	11	,	,	,
46745	1355	12	and	and	CC
46745	1355	13	will	will	MD
46745	1355	14	be	be	VB
46745	1355	15	presently	presently	RB
46745	1355	16	specified	specify	VBN
46745	1355	17	.	.	.
46745	1356	1	The	the	DT
46745	1356	2	corrosive	corrosive	JJ
46745	1356	3	and	and	CC
46745	1356	4	narcotico	narcotico	JJ
46745	1356	5	-	-	HYPH
46745	1356	6	acrid	acrid	JJ
46745	1356	7	poisons	poison	NNS
46745	1356	8	may	may	MD
46745	1356	9	produce	produce	VB
46745	1356	10	by	by	IN
46745	1356	11	this	this	DT
46745	1356	12	local	local	JJ
46745	1356	13	action	action	NN
46745	1356	14	a	a	DT
46745	1356	15	degree	degree	NN
46745	1356	16	of	of	IN
46745	1356	17	irritation	irritation	NN
46745	1356	18	sufficient	sufficient	JJ
46745	1356	19	to	to	TO
46745	1356	20	cause	cause	VB
46745	1356	21	death	death	NN
46745	1356	22	.	.	.
46745	1357	1	In	in	IN
46745	1357	2	the	the	DT
46745	1357	3	case	case	NN
46745	1357	4	of	of	IN
46745	1357	5	the	the	DT
46745	1357	6	first	first	JJ
46745	1357	7	,	,	,
46745	1357	8	some	some	DT
46745	1357	9	erosion	erosion	NN
46745	1357	10	of	of	IN
46745	1357	11	the	the	DT
46745	1357	12	mucous	mucous	JJ
46745	1357	13	surface	surface	NN
46745	1357	14	may	may	MD
46745	1357	15	occur	occur	VB
46745	1357	16	.	.	.
46745	1358	1	By	by	IN
46745	1358	2	both	both	DT
46745	1358	3	kinds	kind	NNS
46745	1358	4	violent	violent	JJ
46745	1358	5	vomiting	vomiting	NN
46745	1358	6	and	and	CC
46745	1358	7	purging	purging	NN
46745	1358	8	is	be	VBZ
46745	1358	9	apt	apt	JJ
46745	1358	10	to	to	TO
46745	1358	11	be	be	VB
46745	1358	12	produced	produce	VBN
46745	1358	13	,	,	,
46745	1358	14	and	and	CC
46745	1358	15	succeeded	succeed	VBN
46745	1358	16	by	by	IN
46745	1358	17	symptoms	symptom	NNS
46745	1358	18	of	of	IN
46745	1358	19	collapse	collapse	NN
46745	1358	20	.	.	.
46745	1359	1	These	these	DT
46745	1359	2	last	last	JJ
46745	1359	3	,	,	,
46745	1359	4	however	however	RB
46745	1359	5	,	,	,
46745	1359	6	are	be	VBP
46745	1359	7	not	not	RB
46745	1359	8	_	_	NNP
46745	1359	9	therapeutic	therapeutic	JJ
46745	1359	10	_	_	NNP
46745	1359	11	agents	agent	NNS
46745	1359	12	,	,	,
46745	1359	13	when	when	WRB
46745	1359	14	in	in	IN
46745	1359	15	such	such	JJ
46745	1359	16	doses	dose	NNS
46745	1359	17	.	.	.
46745	1360	1	Antidotes	antidote	NNS
46745	1360	2	,	,	,
46745	1360	3	employed	employ	VBN
46745	1360	4	to	to	TO
46745	1360	5	counteract	counteract	VB
46745	1360	6	these	these	DT
46745	1360	7	poisons	poison	NNS
46745	1360	8	,	,	,
46745	1360	9	are	be	VBP
46745	1360	10	remedies	remedy	NNS
46745	1360	11	which	which	WDT
46745	1360	12	are	be	VBP
46745	1360	13	given	give	VBN
46745	1360	14	to	to	TO
46745	1360	15	act	act	VB
46745	1360	16	locally	locally	RB
46745	1360	17	in	in	IN
46745	1360	18	extraordinary	extraordinary	JJ
46745	1360	19	cases	case	NNS
46745	1360	20	.	.	.
46745	1361	1	There	there	EX
46745	1361	2	are	be	VBP
46745	1361	3	three	three	CD
46745	1361	4	chief	chief	JJ
46745	1361	5	kinds	kind	NNS
46745	1361	6	of	of	IN
46745	1361	7	them	-PRON-	PRP
46745	1361	8	;	;	:
46745	1361	9	Demulcents	demulcent	NNS
46745	1361	10	,	,	,
46745	1361	11	to	to	TO
46745	1361	12	sheath	sheath	VB
46745	1361	13	the	the	DT
46745	1361	14	irritated	irritated	JJ
46745	1361	15	surface	surface	NN
46745	1361	16	,	,	,
46745	1361	17	and	and	CC
46745	1361	18	protect	protect	VB
46745	1361	19	it	-PRON-	PRP
46745	1361	20	from	from	IN
46745	1361	21	further	further	JJ
46745	1361	22	injury	injury	NN
46745	1361	23	;	;	:
46745	1361	24	Emetics	Emetics	NNPS
46745	1361	25	and	and	CC
46745	1361	26	Purgatives	Purgatives	NNPS
46745	1361	27	,	,	,
46745	1361	28	to	to	TO
46745	1361	29	get	get	VB
46745	1361	30	rid	rid	VBN
46745	1361	31	of	of	IN
46745	1361	32	the	the	DT
46745	1361	33	poison	poison	NN
46745	1361	34	;	;	,
46745	1361	35	and	and	CC
46745	1361	36	chemical	chemical	NN
46745	1361	37	antidotes	antidote	NNS
46745	1361	38	,	,	,
46745	1361	39	to	to	TO
46745	1361	40	neutralize	neutralize	VB
46745	1361	41	it	-PRON-	PRP
46745	1361	42	or	or	CC
46745	1361	43	render	render	VB
46745	1361	44	it	-PRON-	PRP
46745	1361	45	insoluble	insoluble	JJ
46745	1361	46	while	while	IN
46745	1361	47	in	in	IN
46745	1361	48	the	the	DT
46745	1361	49	stomach	stomach	NN
46745	1361	50	.	.	.
46745	1362	1	With	with	IN
46745	1362	2	this	this	DT
46745	1362	3	last	last	JJ
46745	1362	4	object	object	NN
46745	1362	5	,	,	,
46745	1362	6	acids	acid	NNS
46745	1362	7	are	be	VBP
46745	1362	8	given	give	VBN
46745	1362	9	in	in	IN
46745	1362	10	alkaline	alkaline	NN
46745	1362	11	,	,	,
46745	1362	12	and	and	CC
46745	1362	13	alkalies	alkali	NNS
46745	1362	14	in	in	IN
46745	1362	15	acid	acid	JJ
46745	1362	16	poisoning	poisoning	NN
46745	1362	17	.	.	.
46745	1363	1	The	the	DT
46745	1363	2	soluble	soluble	JJ
46745	1363	3	salts	salt	NNS
46745	1363	4	of	of	IN
46745	1363	5	Lead	lead	NN
46745	1363	6	may	may	MD
46745	1363	7	be	be	VB
46745	1363	8	precipitated	precipitate	VBN
46745	1363	9	and	and	CC
46745	1363	10	rendered	render	VBN
46745	1363	11	insoluble	insoluble	JJ
46745	1363	12	by	by	IN
46745	1363	13	sulphuric	sulphuric	JJ
46745	1363	14	acid	acid	NN
46745	1363	15	or	or	CC
46745	1363	16	sulphates	sulphate	NNS
46745	1363	17	.	.	.
46745	1364	1	Those	those	DT
46745	1364	2	of	of	IN
46745	1364	3	Mercury	Mercury	NNP
46745	1364	4	,	,	,
46745	1364	5	Copper	Copper	NNP
46745	1364	6	,	,	,
46745	1364	7	and	and	CC
46745	1364	8	Zinc	Zinc	NNP
46745	1364	9	,	,	,
46745	1364	10	by	by	IN
46745	1364	11	albumen	albuman	NNS
46745	1364	12	.	.	.
46745	1365	1	Tannic	tannic	JJ
46745	1365	2	acid	acid	NN
46745	1365	3	precipitates	precipitate	VBZ
46745	1365	4	the	the	DT
46745	1365	5	vegetable	vegetable	NN
46745	1365	6	alkaloids	alkaloid	NNS
46745	1365	7	.	.	.
46745	1366	1	There	there	EX
46745	1366	2	are	be	VBP
46745	1366	3	some	some	DT
46745	1366	4	other	other	JJ
46745	1366	5	special	special	JJ
46745	1366	6	antidotes	antidote	NNS
46745	1366	7	of	of	IN
46745	1366	8	the	the	DT
46745	1366	9	same	same	JJ
46745	1366	10	kind	kind	NN
46745	1366	11	.	.	.
46745	1367	1	Let	let	VB
46745	1367	2	us	-PRON-	PRP
46745	1367	3	now	now	RB
46745	1367	4	consider	consider	VB
46745	1367	5	the	the	DT
46745	1367	6	three	three	CD
46745	1367	7	kinds	kind	NNS
46745	1367	8	of	of	IN
46745	1367	9	remedial	remedial	JJ
46745	1367	10	agents	agent	NNS
46745	1367	11	in	in	IN
46745	1367	12	ordinary	ordinary	JJ
46745	1367	13	use	use	NN
46745	1367	14	,	,	,
46745	1367	15	which	which	WDT
46745	1367	16	are	be	VBP
46745	1367	17	employed	employ	VBN
46745	1367	18	for	for	IN
46745	1367	19	the	the	DT
46745	1367	20	purpose	purpose	NN
46745	1367	21	of	of	IN
46745	1367	22	producing	produce	VBG
46745	1367	23	a	a	DT
46745	1367	24	local	local	JJ
46745	1367	25	effect	effect	NN
46745	1367	26	on	on	IN
46745	1367	27	the	the	DT
46745	1367	28	mucous	mucous	JJ
46745	1367	29	surfaces	surface	NNS
46745	1367	30	,	,	,
46745	1367	31	before	before	IN
46745	1367	32	absorption	absorption	NN
46745	1367	33	,	,	,
46745	1367	34	or	or	CC
46745	1367	35	without	without	IN
46745	1367	36	absorption	absorption	NN
46745	1367	37	.	.	.
46745	1368	1	_	_	NNP
46745	1368	2	a.	a.	NN
46745	1369	1	Irritant	irritant	JJ
46745	1369	2	emetics._--Two	emetics._--Two	NNS
46745	1369	3	kinds	kind	NNS
46745	1369	4	of	of	IN
46745	1369	5	medicines	medicine	NNS
46745	1369	6	are	be	VBP
46745	1369	7	employed	employ	VBN
46745	1369	8	to	to	TO
46745	1369	9	produce	produce	VB
46745	1369	10	Vomiting,--specific	Vomiting,--specific	NNP
46745	1369	11	emetics	emetic	NNS
46745	1369	12	,	,	,
46745	1369	13	and	and	CC
46745	1369	14	irritant	irritant	JJ
46745	1369	15	emetics	emetic	NNS
46745	1369	16	.	.	.
46745	1370	1	The	the	DT
46745	1370	2	former	former	JJ
46745	1370	3	act	act	NN
46745	1370	4	from	from	IN
46745	1370	5	the	the	DT
46745	1370	6	blood	blood	NN
46745	1370	7	;	;	:
46745	1370	8	the	the	DT
46745	1370	9	latter	latter	JJ
46745	1370	10	,	,	,
46745	1370	11	by	by	IN
46745	1370	12	local	local	JJ
46745	1370	13	irritation	irritation	NN
46745	1370	14	.	.	.
46745	1371	1	In	in	IN
46745	1371	2	the	the	DT
46745	1371	3	same	same	JJ
46745	1371	4	way	way	NN
46745	1371	5	that	that	IN
46745	1371	6	irritation	irritation	NN
46745	1371	7	of	of	IN
46745	1371	8	the	the	DT
46745	1371	9	external	external	JJ
46745	1371	10	surface	surface	NN
46745	1371	11	of	of	IN
46745	1371	12	the	the	DT
46745	1371	13	body	body	NN
46745	1371	14	will	will	MD
46745	1371	15	sometimes	sometimes	RB
46745	1371	16	cause	cause	VB
46745	1371	17	at	at	IN
46745	1371	18	the	the	DT
46745	1371	19	same	same	JJ
46745	1371	20	time	time	NN
46745	1371	21	the	the	DT
46745	1371	22	_	_	NNP
46745	1371	23	direct	direct	JJ
46745	1371	24	_	_	NNP
46745	1371	25	contraction	contraction	NN
46745	1371	26	of	of	IN
46745	1371	27	a	a	DT
46745	1371	28	neighbouring	neighbouring	NN
46745	1371	29	muscle	muscle	NN
46745	1371	30	,	,	,
46745	1371	31	and	and	CC
46745	1371	32	the	the	DT
46745	1371	33	_	_	NNP
46745	1371	34	reflex	reflex	NN
46745	1371	35	_	_	NNP
46745	1371	36	contraction	contraction	NN
46745	1371	37	of	of	IN
46745	1371	38	others	other	NNS
46745	1371	39	at	at	IN
46745	1371	40	a	a	DT
46745	1371	41	distance	distance	NN
46745	1371	42	,	,	,
46745	1371	43	so	so	RB
46745	1371	44	does	do	VBZ
46745	1371	45	local	local	JJ
46745	1371	46	irritation	irritation	NN
46745	1371	47	operate	operate	VB
46745	1371	48	on	on	IN
46745	1371	49	the	the	DT
46745	1371	50	surface	surface	NN
46745	1371	51	of	of	IN
46745	1371	52	the	the	DT
46745	1371	53	stomach	stomach	NN
46745	1371	54	.	.	.
46745	1372	1	On	on	IN
46745	1372	2	the	the	DT
46745	1372	3	one	one	CD
46745	1372	4	hand	hand	NN
46745	1372	5	the	the	DT
46745	1372	6	muscle	muscle	NN
46745	1372	7	of	of	IN
46745	1372	8	the	the	DT
46745	1372	9	stomach	stomach	NN
46745	1372	10	itself	-PRON-	PRP
46745	1372	11	is	be	VBZ
46745	1372	12	caused	cause	VBN
46745	1372	13	to	to	TO
46745	1372	14	contract	contract	VB
46745	1372	15	,	,	,
46745	1372	16	so	so	IN
46745	1372	17	that	that	IN
46745	1372	18	,	,	,
46745	1372	19	the	the	DT
46745	1372	20	pylorus	pylorus	NN
46745	1372	21	being	be	VBG
46745	1372	22	at	at	IN
46745	1372	23	the	the	DT
46745	1372	24	same	same	JJ
46745	1372	25	time	time	NN
46745	1372	26	forcibly	forcibly	RB
46745	1372	27	closed	closed	JJ
46745	1372	28	,	,	,
46745	1372	29	it	-PRON-	PRP
46745	1372	30	tends	tend	VBZ
46745	1372	31	to	to	TO
46745	1372	32	expel	expel	VB
46745	1372	33	its	-PRON-	PRP$
46745	1372	34	contents	content	NNS
46745	1372	35	in	in	IN
46745	1372	36	the	the	DT
46745	1372	37	wrong	wrong	JJ
46745	1372	38	direction	direction	NN
46745	1372	39	.	.	.
46745	1373	1	On	on	IN
46745	1373	2	the	the	DT
46745	1373	3	other	other	JJ
46745	1373	4	hand	hand	NN
46745	1373	5	,	,	,
46745	1373	6	a	a	DT
46745	1373	7	large	large	JJ
46745	1373	8	set	set	NN
46745	1373	9	of	of	IN
46745	1373	10	distant	distant	JJ
46745	1373	11	muscles	muscle	NNS
46745	1373	12	is	be	VBZ
46745	1373	13	thrown	throw	VBN
46745	1373	14	into	into	IN
46745	1373	15	sudden	sudden	JJ
46745	1373	16	action	action	NN
46745	1373	17	.	.	.
46745	1374	1	First	first	RB
46745	1374	2	,	,	,
46745	1374	3	a	a	DT
46745	1374	4	quick	quick	JJ
46745	1374	5	deep	deep	JJ
46745	1374	6	breath	breath	NN
46745	1374	7	is	be	VBZ
46745	1374	8	taken	take	VBN
46745	1374	9	by	by	IN
46745	1374	10	means	mean	NNS
46745	1374	11	of	of	IN
46745	1374	12	the	the	DT
46745	1374	13	inspiratory	inspiratory	NN
46745	1374	14	muscles	muscle	NNS
46745	1374	15	.	.	.
46745	1375	1	Then	then	RB
46745	1375	2	the	the	DT
46745	1375	3	aperture	aperture	NN
46745	1375	4	of	of	IN
46745	1375	5	the	the	DT
46745	1375	6	glottis	glottis	NN
46745	1375	7	is	be	VBZ
46745	1375	8	spasmodically	spasmodically	RB
46745	1375	9	closed	close	VBN
46745	1375	10	,	,	,
46745	1375	11	so	so	IN
46745	1375	12	that	that	IN
46745	1375	13	,	,	,
46745	1375	14	the	the	DT
46745	1375	15	lungs	lung	NNS
46745	1375	16	being	be	VBG
46745	1375	17	full	full	JJ
46745	1375	18	,	,	,
46745	1375	19	the	the	DT
46745	1375	20	diaphragm	diaphragm	NN
46745	1375	21	can	can	MD
46745	1375	22	not	not	RB
46745	1375	23	be	be	VB
46745	1375	24	pushed	push	VBN
46745	1375	25	upwards	upwards	RB
46745	1375	26	.	.	.
46745	1376	1	Then	then	RB
46745	1376	2	immediately	immediately	RB
46745	1376	3	the	the	DT
46745	1376	4	abdominal	abdominal	JJ
46745	1376	5	muscles	muscle	NNS
46745	1376	6	contract	contract	NN
46745	1376	7	,	,	,
46745	1376	8	and	and	CC
46745	1376	9	being	be	VBG
46745	1376	10	unable	unable	JJ
46745	1376	11	to	to	TO
46745	1376	12	act	act	VB
46745	1376	13	on	on	IN
46745	1376	14	the	the	DT
46745	1376	15	diaphragm	diaphragm	NN
46745	1376	16	,	,	,
46745	1376	17	they	-PRON-	PRP
46745	1376	18	press	press	VBP
46745	1376	19	on	on	IN
46745	1376	20	the	the	DT
46745	1376	21	stomach	stomach	NN
46745	1376	22	,	,	,
46745	1376	23	emptying	empty	VBG
46745	1376	24	it	-PRON-	PRP
46745	1376	25	forcibly	forcibly	RB
46745	1376	26	of	of	IN
46745	1376	27	its	-PRON-	PRP$
46745	1376	28	contents	content	NNS
46745	1376	29	.	.	.
46745	1377	1	All	all	DT
46745	1377	2	this	this	DT
46745	1377	3	is	be	VBZ
46745	1377	4	by	by	IN
46745	1377	5	reflex	reflex	JJ
46745	1377	6	action	action	NN
46745	1377	7	,	,	,
46745	1377	8	and	and	CC
46745	1377	9	follows	follow	VBZ
46745	1377	10	sympathetically	sympathetically	RB
46745	1377	11	the	the	DT
46745	1377	12	contractions	contraction	NNS
46745	1377	13	of	of	IN
46745	1377	14	the	the	DT
46745	1377	15	stomach	stomach	NN
46745	1377	16	,	,	,
46745	1377	17	co	co	NN
46745	1377	18	-	-	NN
46745	1377	19	operating	operate	VBG
46745	1377	20	with	with	IN
46745	1377	21	it	-PRON-	PRP
46745	1377	22	,	,	,
46745	1377	23	and	and	CC
46745	1377	24	resulting	result	VBG
46745	1377	25	,	,	,
46745	1377	26	like	like	IN
46745	1377	27	it	-PRON-	PRP
46745	1377	28	,	,	,
46745	1377	29	from	from	IN
46745	1377	30	irritation	irritation	NN
46745	1377	31	of	of	IN
46745	1377	32	the	the	DT
46745	1377	33	sensitive	sensitive	JJ
46745	1377	34	mucous	mucous	JJ
46745	1377	35	surface	surface	NN
46745	1377	36	.	.	.
46745	1378	1	[	[	-LRB-
46745	1378	2	27	27	CD
46745	1378	3	]	]	-RRB-
46745	1378	4	Such	such	JJ
46745	1378	5	is	be	VBZ
46745	1378	6	the	the	DT
46745	1378	7	action	action	NN
46745	1378	8	of	of	IN
46745	1378	9	an	an	DT
46745	1378	10	irritant	irritant	JJ
46745	1378	11	emetic	emetic	NN
46745	1378	12	.	.	.
46745	1379	1	Now	now	RB
46745	1379	2	,	,	,
46745	1379	3	Tartar	Tartar	NNP
46745	1379	4	Emetic	Emetic	NNP
46745	1379	5	and	and	CC
46745	1379	6	Ipecacuanha	Ipecacuanha	NNP
46745	1379	7	do	do	VBP
46745	1379	8	not	not	RB
46745	1379	9	act	act	VB
46745	1379	10	in	in	IN
46745	1379	11	this	this	DT
46745	1379	12	way	way	NN
46745	1379	13	.	.	.
46745	1380	1	When	when	WRB
46745	1380	2	injected	inject	VBN
46745	1380	3	into	into	IN
46745	1380	4	the	the	DT
46745	1380	5	blood	blood	NN
46745	1380	6	elsewhere	elsewhere	RB
46745	1380	7	,	,	,
46745	1380	8	in	in	IN
46745	1380	9	sufficient	sufficient	JJ
46745	1380	10	quantity	quantity	NN
46745	1380	11	,	,	,
46745	1380	12	they	-PRON-	PRP
46745	1380	13	are	be	VBP
46745	1380	14	found	find	VBN
46745	1380	15	to	to	TO
46745	1380	16	produce	produce	VB
46745	1380	17	vomiting	vomit	VBG
46745	1380	18	.	.	.
46745	1381	1	They	-PRON-	PRP
46745	1381	2	have	have	VBP
46745	1381	3	also	also	RB
46745	1381	4	special	special	JJ
46745	1381	5	actions	action	NNS
46745	1381	6	on	on	IN
46745	1381	7	the	the	DT
46745	1381	8	heart	heart	NN
46745	1381	9	and	and	CC
46745	1381	10	lungs	lung	NNS
46745	1381	11	,	,	,
46745	1381	12	which	which	WDT
46745	1381	13	are	be	VBP
46745	1381	14	not	not	RB
46745	1381	15	possessed	possess	VBN
46745	1381	16	by	by	IN
46745	1381	17	merely	merely	RB
46745	1381	18	irritant	irritant	JJ
46745	1381	19	emetics	emetic	NNS
46745	1381	20	.	.	.
46745	1382	1	They	-PRON-	PRP
46745	1382	2	seem	seem	VBP
46745	1382	3	to	to	IN
46745	1382	4	me	-PRON-	PRP
46745	1382	5	to	to	TO
46745	1382	6	act	act	VB
46745	1382	7	specifically	specifically	RB
46745	1382	8	on	on	IN
46745	1382	9	the	the	DT
46745	1382	10	Vagus	Vagus	NNP
46745	1382	11	Nerve	Nerve	NNP
46745	1382	12	,	,	,
46745	1382	13	which	which	WDT
46745	1382	14	is	be	VBZ
46745	1382	15	supplied	supply	VBN
46745	1382	16	to	to	IN
46745	1382	17	these	these	DT
46745	1382	18	organs	organ	NNS
46745	1382	19	as	as	RB
46745	1382	20	well	well	RB
46745	1382	21	as	as	IN
46745	1382	22	to	to	IN
46745	1382	23	the	the	DT
46745	1382	24	stomach	stomach	NN
46745	1382	25	,	,	,
46745	1382	26	and	and	CC
46745	1382	27	to	to	TO
46745	1382	28	cause	cause	VB
46745	1382	29	vomiting	vomit	VBG
46745	1382	30	by	by	IN
46745	1382	31	deranging	derange	VBG
46745	1382	32	its	-PRON-	PRP$
46745	1382	33	functions	function	NNS
46745	1382	34	.	.	.
46745	1383	1	By	by	IN
46745	1383	2	this	this	DT
46745	1383	3	action	action	NN
46745	1383	4	on	on	IN
46745	1383	5	the	the	DT
46745	1383	6	Vagus	Vagus	NNP
46745	1383	7	while	while	IN
46745	1383	8	in	in	IN
46745	1383	9	the	the	DT
46745	1383	10	blood	blood	NN
46745	1383	11	,	,	,
46745	1383	12	they	-PRON-	PRP
46745	1383	13	excite	excite	VBP
46745	1383	14	,	,	,
46745	1383	15	in	in	IN
46745	1383	16	a	a	DT
46745	1383	17	special	special	JJ
46745	1383	18	way	way	NN
46745	1383	19	,	,	,
46745	1383	20	the	the	DT
46745	1383	21	same	same	JJ
46745	1383	22	reflex	reflex	JJ
46745	1383	23	contractions	contraction	NNS
46745	1383	24	which	which	WDT
46745	1383	25	are	be	VBP
46745	1383	26	produced	produce	VBN
46745	1383	27	,	,	,
46745	1383	28	in	in	IN
46745	1383	29	the	the	DT
46745	1383	30	case	case	NN
46745	1383	31	of	of	IN
46745	1383	32	an	an	DT
46745	1383	33	irritant	irritant	JJ
46745	1383	34	emetic	emetic	NN
46745	1383	35	,	,	,
46745	1383	36	by	by	IN
46745	1383	37	irritation	irritation	NN
46745	1383	38	of	of	IN
46745	1383	39	the	the	DT
46745	1383	40	extremity	extremity	NN
46745	1383	41	of	of	IN
46745	1383	42	that	that	DT
46745	1383	43	nerve	nerve	NN
46745	1383	44	in	in	IN
46745	1383	45	the	the	DT
46745	1383	46	mucous	mucous	JJ
46745	1383	47	membrane	membrane	NN
46745	1383	48	.	.	.
46745	1384	1	They	-PRON-	PRP
46745	1384	2	are	be	VBP
46745	1384	3	thus	thus	RB
46745	1384	4	Neurotics	neurotic	NNS
46745	1384	5	,	,	,
46745	1384	6	or	or	CC
46745	1384	7	nerve	nerve	NN
46745	1384	8	-	-	HYPH
46745	1384	9	medicines	medicine	NNS
46745	1384	10	.	.	.
46745	1385	1	They	-PRON-	PRP
46745	1385	2	are	be	VBP
46745	1385	3	not	not	RB
46745	1385	4	gland	gland	NN
46745	1385	5	-	-	HYPH
46745	1385	6	medicines	medicine	NNS
46745	1385	7	;	;	:
46745	1385	8	or	or	CC
46745	1385	9	,	,	,
46745	1385	10	at	at	IN
46745	1385	11	least	least	JJS
46745	1385	12	,	,	,
46745	1385	13	there	there	EX
46745	1385	14	is	be	VBZ
46745	1385	15	no	no	DT
46745	1385	16	proof	proof	NN
46745	1385	17	that	that	IN
46745	1385	18	they	-PRON-	PRP
46745	1385	19	are	be	VBP
46745	1385	20	excreted	excrete	VBN
46745	1385	21	by	by	IN
46745	1385	22	the	the	DT
46745	1385	23	stomach	stomach	NN
46745	1385	24	,	,	,
46745	1385	25	and	and	CC
46745	1385	26	thus	thus	RB
46745	1385	27	they	-PRON-	PRP
46745	1385	28	do	do	VBP
46745	1385	29	not	not	RB
46745	1385	30	come	come	VB
46745	1385	31	under	under	IN
46745	1385	32	my	-PRON-	PRP$
46745	1385	33	definition	definition	NN
46745	1385	34	of	of	IN
46745	1385	35	Eliminatives	Eliminatives	NNPS
46745	1385	36	.	.	.
46745	1386	1	All	all	DT
46745	1386	2	substances	substance	NNS
46745	1386	3	which	which	WDT
46745	1386	4	touch	touch	VBP
46745	1386	5	the	the	DT
46745	1386	6	surface	surface	NN
46745	1386	7	of	of	IN
46745	1386	8	the	the	DT
46745	1386	9	stomach	stomach	NN
46745	1386	10	cause	cause	IN
46745	1386	11	it	-PRON-	PRP
46745	1386	12	to	to	TO
46745	1386	13	pour	pour	VB
46745	1386	14	out	out	RP
46745	1386	15	its	-PRON-	PRP$
46745	1386	16	secretion	secretion	NN
46745	1386	17	.	.	.
46745	1387	1	Specific	specific	JJ
46745	1387	2	emetics	emetic	NNS
46745	1387	3	cause	cause	VBP
46745	1387	4	nausea	nausea	NN
46745	1387	5	,	,	,
46745	1387	6	even	even	RB
46745	1387	7	without	without	IN
46745	1387	8	vomiting	vomit	VBG
46745	1387	9	,	,	,
46745	1387	10	depressing	depress	VBG
46745	1387	11	the	the	DT
46745	1387	12	action	action	NN
46745	1387	13	of	of	IN
46745	1387	14	the	the	DT
46745	1387	15	heart	heart	NN
46745	1387	16	by	by	IN
46745	1387	17	their	-PRON-	PRP$
46745	1387	18	influence	influence	NN
46745	1387	19	over	over	IN
46745	1387	20	the	the	DT
46745	1387	21	Vagus	Vagus	NNP
46745	1387	22	nerve	nerve	NN
46745	1387	23	.	.	.
46745	1388	1	Irritant	irritant	JJ
46745	1388	2	emetics	emetic	NNS
46745	1388	3	scarcely	scarcely	RB
46745	1388	4	cause	cause	VBP
46745	1388	5	nausea	nausea	NN
46745	1388	6	,	,	,
46745	1388	7	producing	produce	VBG
46745	1388	8	only	only	RB
46745	1388	9	a	a	DT
46745	1388	10	feeling	feeling	NN
46745	1388	11	of	of	IN
46745	1388	12	discomfort	discomfort	NN
46745	1388	13	,	,	,
46745	1388	14	arising	arise	VBG
46745	1388	15	from	from	IN
46745	1388	16	the	the	DT
46745	1388	17	inverted	inverted	JJ
46745	1388	18	action	action	NN
46745	1388	19	of	of	IN
46745	1388	20	the	the	DT
46745	1388	21	stomach	stomach	NN
46745	1388	22	.	.	.
46745	1389	1	The	the	DT
46745	1389	2	Sulphates	Sulphates	NNP
46745	1389	3	of	of	IN
46745	1389	4	Zinc	Zinc	NNP
46745	1389	5	and	and	CC
46745	1389	6	of	of	IN
46745	1389	7	Copper	copper	NN
46745	1389	8	;	;	:
46745	1389	9	common	common	JJ
46745	1389	10	Salt	Salt	NNP
46745	1389	11	,	,	,
46745	1389	12	and	and	CC
46745	1389	13	among	among	IN
46745	1389	14	vegetables	vegetable	NNS
46745	1389	15	,	,	,
46745	1389	16	Mustard	Mustard	NNP
46745	1389	17	and	and	CC
46745	1389	18	Horse	Horse	NNP
46745	1389	19	-	-	HYPH
46745	1389	20	radish	radish	NNP
46745	1389	21	,	,	,
46745	1389	22	are	be	VBP
46745	1389	23	used	use	VBN
46745	1389	24	as	as	IN
46745	1389	25	irritant	irritant	JJ
46745	1389	26	emetics	emetic	NNS
46745	1389	27	.	.	.
46745	1390	1	They	-PRON-	PRP
46745	1390	2	cause	cause	VBP
46745	1390	3	,	,	,
46745	1390	4	by	by	IN
46745	1390	5	contact	contact	NN
46745	1390	6	and	and	CC
46745	1390	7	irritation	irritation	NN
46745	1390	8	,	,	,
46745	1390	9	a	a	DT
46745	1390	10	large	large	JJ
46745	1390	11	quantity	quantity	NN
46745	1390	12	of	of	IN
46745	1390	13	the	the	DT
46745	1390	14	gastric	gastric	JJ
46745	1390	15	juice	juice	NN
46745	1390	16	to	to	TO
46745	1390	17	be	be	VB
46745	1390	18	poured	pour	VBN
46745	1390	19	out	out	RP
46745	1390	20	.	.	.
46745	1391	1	This	this	DT
46745	1391	2	,	,	,
46745	1391	3	together	together	RB
46745	1391	4	with	with	IN
46745	1391	5	the	the	DT
46745	1391	6	emetic	emetic	JJ
46745	1391	7	,	,	,
46745	1391	8	and	and	CC
46745	1391	9	any	any	DT
46745	1391	10	contents	content	NNS
46745	1391	11	of	of	IN
46745	1391	12	the	the	DT
46745	1391	13	stomach	stomach	NN
46745	1391	14	,	,	,
46745	1391	15	is	be	VBZ
46745	1391	16	rejected	reject	VBN
46745	1391	17	.	.	.
46745	1392	1	The	the	DT
46745	1392	2	process	process	NN
46745	1392	3	is	be	VBZ
46745	1392	4	not	not	RB
46745	1392	5	followed	follow	VBN
46745	1392	6	by	by	IN
46745	1392	7	much	much	JJ
46745	1392	8	inconvenience	inconvenience	NN
46745	1392	9	.	.	.
46745	1393	1	Such	such	JJ
46745	1393	2	emetics	emetic	NNS
46745	1393	3	are	be	VBP
46745	1393	4	chiefly	chiefly	RB
46745	1393	5	used	use	VBN
46745	1393	6	when	when	WRB
46745	1393	7	we	-PRON-	PRP
46745	1393	8	wish	wish	VBP
46745	1393	9	to	to	TO
46745	1393	10	unload	unload	VB
46745	1393	11	the	the	DT
46745	1393	12	stomach	stomach	NN
46745	1393	13	of	of	IN
46745	1393	14	any	any	DT
46745	1393	15	irritating	irritating	JJ
46745	1393	16	or	or	CC
46745	1393	17	poisonous	poisonous	JJ
46745	1393	18	matters	matter	NNS
46745	1393	19	;	;	:
46745	1393	20	but	but	CC
46745	1393	21	not	not	RB
46745	1393	22	when	when	WRB
46745	1393	23	our	-PRON-	PRP$
46745	1393	24	object	object	NN
46745	1393	25	is	be	VBZ
46745	1393	26	to	to	TO
46745	1393	27	cause	cause	VB
46745	1393	28	nausea	nausea	NN
46745	1393	29	,	,	,
46745	1393	30	depression	depression	NN
46745	1393	31	of	of	IN
46745	1393	32	the	the	DT
46745	1393	33	heart	heart	NN
46745	1393	34	's	's	POS
46745	1393	35	action	action	NN
46745	1393	36	,	,	,
46745	1393	37	or	or	CC
46745	1393	38	relaxation	relaxation	NN
46745	1393	39	of	of	IN
46745	1393	40	the	the	DT
46745	1393	41	muscles	muscle	NNS
46745	1393	42	.	.	.
46745	1394	1	The	the	DT
46745	1394	2	violent	violent	JJ
46745	1394	3	action	action	NN
46745	1394	4	which	which	WDT
46745	1394	5	they	-PRON-	PRP
46745	1394	6	produce	produce	VBP
46745	1394	7	may	may	MD
46745	1394	8	possibly	possibly	RB
46745	1394	9	act	act	VB
46745	1394	10	on	on	IN
46745	1394	11	remote	remote	JJ
46745	1394	12	parts	part	NNS
46745	1394	13	on	on	IN
46745	1394	14	the	the	DT
46745	1394	15	principle	principle	NN
46745	1394	16	of	of	IN
46745	1394	17	counter	counter	NN
46745	1394	18	-	-	NN
46745	1394	19	irritation	irritation	NN
46745	1394	20	.	.	.
46745	1395	1	Thus	thus	RB
46745	1395	2	emetics	emetic	NNS
46745	1395	3	of	of	IN
46745	1395	4	various	various	JJ
46745	1395	5	kinds	kind	NNS
46745	1395	6	are	be	VBP
46745	1395	7	often	often	RB
46745	1395	8	administered	administer	VBN
46745	1395	9	in	in	IN
46745	1395	10	the	the	DT
46745	1395	11	early	early	JJ
46745	1395	12	stages	stage	NNS
46745	1395	13	of	of	IN
46745	1395	14	inflammatory	inflammatory	JJ
46745	1395	15	disorders	disorder	NNS
46745	1395	16	,	,	,
46745	1395	17	and	and	CC
46745	1395	18	have	have	VBP
46745	1395	19	been	be	VBN
46745	1395	20	known	know	VBN
46745	1395	21	sometimes	sometimes	RB
46745	1395	22	to	to	TO
46745	1395	23	cut	cut	VB
46745	1395	24	them	-PRON-	PRP
46745	1395	25	short	short	JJ
46745	1395	26	.	.	.
46745	1396	1	But	but	CC
46745	1396	2	such	such	PDT
46745	1396	3	an	an	DT
46745	1396	4	effect	effect	NN
46745	1396	5	is	be	VBZ
46745	1396	6	much	much	RB
46745	1396	7	more	more	RBR
46745	1396	8	likely	likely	JJ
46745	1396	9	to	to	TO
46745	1396	10	be	be	VB
46745	1396	11	produced	produce	VBN
46745	1396	12	by	by	IN
46745	1396	13	a	a	DT
46745	1396	14	specific	specific	JJ
46745	1396	15	emetic	emetic	NN
46745	1396	16	,	,	,
46745	1396	17	which	which	WDT
46745	1396	18	adds	add	VBZ
46745	1396	19	to	to	IN
46745	1396	20	this	this	DT
46745	1396	21	counter	counter	JJ
46745	1396	22	-	-	JJ
46745	1396	23	irritant	irritant	JJ
46745	1396	24	action	action	NN
46745	1396	25	the	the	DT
46745	1396	26	production	production	NN
46745	1396	27	of	of	IN
46745	1396	28	nausea	nausea	NN
46745	1396	29	,	,	,
46745	1396	30	by	by	IN
46745	1396	31	which	which	WDT
46745	1396	32	the	the	DT
46745	1396	33	force	force	NN
46745	1396	34	of	of	IN
46745	1396	35	the	the	DT
46745	1396	36	heart	heart	NN
46745	1396	37	is	be	VBZ
46745	1396	38	powerfully	powerfully	RB
46745	1396	39	depressed	depressed	JJ
46745	1396	40	,	,	,
46745	1396	41	and	and	CC
46745	1396	42	the	the	DT
46745	1396	43	pulse	pulse	NN
46745	1396	44	reduced	reduce	VBD
46745	1396	45	.	.	.
46745	1397	1	Tartar	Tartar	NNP
46745	1397	2	Emetic	Emetic	NNP
46745	1397	3	,	,	,
46745	1397	4	the	the	DT
46745	1397	5	most	most	RBS
46745	1397	6	powerful	powerful	JJ
46745	1397	7	of	of	IN
46745	1397	8	these	these	DT
46745	1397	9	specific	specific	JJ
46745	1397	10	agents	agent	NNS
46745	1397	11	,	,	,
46745	1397	12	must	must	MD
46745	1397	13	doubtless	doubtless	RB
46745	1397	14	be	be	VB
46745	1397	15	absorbed	absorb	VBN
46745	1397	16	to	to	IN
46745	1397	17	a	a	DT
46745	1397	18	certain	certain	JJ
46745	1397	19	extent	extent	NN
46745	1397	20	before	before	IN
46745	1397	21	it	-PRON-	PRP
46745	1397	22	can	can	MD
46745	1397	23	produce	produce	VB
46745	1397	24	its	-PRON-	PRP$
46745	1397	25	effect	effect	NN
46745	1397	26	.	.	.
46745	1398	1	Thus	thus	RB
46745	1398	2	the	the	DT
46745	1398	3	important	important	JJ
46745	1398	4	difference	difference	NN
46745	1398	5	between	between	IN
46745	1398	6	the	the	DT
46745	1398	7	modes	mode	NNS
46745	1398	8	of	of	IN
46745	1398	9	operation	operation	NN
46745	1398	10	of	of	IN
46745	1398	11	irritant	irritant	JJ
46745	1398	12	and	and	CC
46745	1398	13	specific	specific	JJ
46745	1398	14	emetics	emetic	NNS
46745	1398	15	is	be	VBZ
46745	1398	16	,	,	,
46745	1398	17	that	that	IN
46745	1398	18	the	the	DT
46745	1398	19	former	former	JJ
46745	1398	20	do	do	VBP
46745	1398	21	not	not	RB
46745	1398	22	produce	produce	VB
46745	1398	23	vomiting	vomiting	NN
46745	1398	24	when	when	WRB
46745	1398	25	injected	inject	VBN
46745	1398	26	into	into	IN
46745	1398	27	the	the	DT
46745	1398	28	blood	blood	NN
46745	1398	29	,	,	,
46745	1398	30	but	but	CC
46745	1398	31	act	act	VB
46745	1398	32	locally	locally	RB
46745	1398	33	;	;	:
46745	1398	34	whereas	whereas	IN
46745	1398	35	the	the	DT
46745	1398	36	latter	latter	JJ
46745	1398	37	act	act	NN
46745	1398	38	from	from	IN
46745	1398	39	the	the	DT
46745	1398	40	blood	blood	NN
46745	1398	41	on	on	IN
46745	1398	42	the	the	DT
46745	1398	43	nerves	nerve	NNS
46745	1398	44	.	.	.
46745	1399	1	(	(	-LRB-
46745	1399	2	_	_	NNP
46745	1399	3	Vide	Vide	NNP
46745	1399	4	Prop	Prop	NNP
46745	1399	5	.	.	.
46745	1400	1	VIII	VIII	NNP
46745	1400	2	.	.	.
46745	1400	3	,	,	,
46745	1400	4	Specific	Specific	NNP
46745	1400	5	Sedatives	Sedatives	NNPS
46745	1400	6	.	.	.
46745	1400	7	_	_	NNP
46745	1400	8	)	)	-RRB-
46745	1400	9	_	_	NNP
46745	1400	10	b.	b.	NN
46745	1401	1	Stomach	stomach	NN
46745	1401	2	-	-	HYPH
46745	1401	3	Anæsthetics._--There	Anæsthetics._--There	NNP
46745	1401	4	is	be	VBZ
46745	1401	5	a	a	DT
46745	1401	6	class	class	NN
46745	1401	7	of	of	IN
46745	1401	8	medicines	medicine	NNS
46745	1401	9	used	use	VBN
46745	1401	10	in	in	IN
46745	1401	11	Gastrodynia	Gastrodynia	NNP
46745	1401	12	which	which	WDT
46745	1401	13	seem	seem	VBP
46745	1401	14	to	to	TO
46745	1401	15	act	act	VB
46745	1401	16	locally	locally	RB
46745	1401	17	on	on	IN
46745	1401	18	the	the	DT
46745	1401	19	sentient	sentient	NN
46745	1401	20	nerves	nerve	NNS
46745	1401	21	of	of	IN
46745	1401	22	the	the	DT
46745	1401	23	stomach	stomach	NN
46745	1401	24	,	,	,
46745	1401	25	in	in	IN
46745	1401	26	the	the	DT
46745	1401	27	same	same	JJ
46745	1401	28	way	way	NN
46745	1401	29	that	that	WDT
46745	1401	30	Aconite	aconite	JJ
46745	1401	31	acts	act	NNS
46745	1401	32	on	on	IN
46745	1401	33	the	the	DT
46745	1401	34	superficial	superficial	JJ
46745	1401	35	nerves	nerve	NNS
46745	1401	36	of	of	IN
46745	1401	37	the	the	DT
46745	1401	38	skin	skin	NN
46745	1401	39	.	.	.
46745	1402	1	Although	although	IN
46745	1402	2	the	the	DT
46745	1402	3	majority	majority	NN
46745	1402	4	of	of	IN
46745	1402	5	them	-PRON-	PRP
46745	1402	6	are	be	VBP
46745	1402	7	subsequently	subsequently	RB
46745	1402	8	absorbed	absorb	VBN
46745	1402	9	,	,	,
46745	1402	10	yet	yet	CC
46745	1402	11	,	,	,
46745	1402	12	in	in	IN
46745	1402	13	order	order	NN
46745	1402	14	to	to	TO
46745	1402	15	exert	exert	VB
46745	1402	16	this	this	DT
46745	1402	17	particular	particular	JJ
46745	1402	18	action	action	NN
46745	1402	19	,	,	,
46745	1402	20	it	-PRON-	PRP
46745	1402	21	is	be	VBZ
46745	1402	22	not	not	RB
46745	1402	23	necessary	necessary	JJ
46745	1402	24	that	that	IN
46745	1402	25	they	-PRON-	PRP
46745	1402	26	should	should	MD
46745	1402	27	pass	pass	VB
46745	1402	28	beyond	beyond	IN
46745	1402	29	the	the	DT
46745	1402	30	substance	substance	NN
46745	1402	31	of	of	IN
46745	1402	32	the	the	DT
46745	1402	33	stomach	stomach	NN
46745	1402	34	itself	-PRON-	PRP
46745	1402	35	.	.	.
46745	1403	1	They	-PRON-	PRP
46745	1403	2	do	do	VBP
46745	1403	3	not	not	RB
46745	1403	4	seem	seem	VB
46745	1403	5	to	to	TO
46745	1403	6	have	have	VB
46745	1403	7	any	any	DT
46745	1403	8	special	special	JJ
46745	1403	9	or	or	CC
46745	1403	10	peculiar	peculiar	JJ
46745	1403	11	tendencies	tendency	NNS
46745	1403	12	towards	towards	IN
46745	1403	13	the	the	DT
46745	1403	14	stomach	stomach	NN
46745	1403	15	nerves	nerve	NNS
46745	1403	16	.	.	.
46745	1404	1	But	but	CC
46745	1404	2	if	if	IN
46745	1404	3	introduced	introduce	VBN
46745	1404	4	into	into	IN
46745	1404	5	the	the	DT
46745	1404	6	blood	blood	NN
46745	1404	7	elsewhere	elsewhere	RB
46745	1404	8	,	,	,
46745	1404	9	they	-PRON-	PRP
46745	1404	10	would	would	MD
46745	1404	11	not	not	RB
46745	1404	12	pass	pass	VB
46745	1404	13	the	the	DT
46745	1404	14	nerves	nerve	NNS
46745	1404	15	of	of	IN
46745	1404	16	the	the	DT
46745	1404	17	stomach	stomach	NN
46745	1404	18	in	in	IN
46745	1404	19	so	so	RB
46745	1404	20	concentrated	concentrate	VBD
46745	1404	21	a	a	DT
46745	1404	22	form	form	NN
46745	1404	23	as	as	IN
46745	1404	24	when	when	WRB
46745	1404	25	coming	come	VBG
46745	1404	26	directly	directly	RB
46745	1404	27	from	from	IN
46745	1404	28	the	the	DT
46745	1404	29	mouth	mouth	NN
46745	1404	30	,	,	,
46745	1404	31	and	and	CC
46745	1404	32	thus	thus	RB
46745	1404	33	would	would	MD
46745	1404	34	not	not	RB
46745	1404	35	be	be	VB
46745	1404	36	so	so	RB
46745	1404	37	useful	useful	JJ
46745	1404	38	as	as	IN
46745	1404	39	stomach	stomach	NN
46745	1404	40	-	-	HYPH
46745	1404	41	anæsthetics	anæsthetic	NNS
46745	1404	42	.	.	.
46745	1405	1	Thus	thus	RB
46745	1405	2	this	this	DT
46745	1405	3	action	action	NN
46745	1405	4	depends	depend	VBZ
46745	1405	5	upon	upon	IN
46745	1405	6	local	local	JJ
46745	1405	7	contact	contact	NN
46745	1405	8	,	,	,
46745	1405	9	and	and	CC
46745	1405	10	is	be	VBZ
46745	1405	11	so	so	RB
46745	1405	12	far	far	RB
46745	1405	13	a	a	DT
46745	1405	14	local	local	JJ
46745	1405	15	action	action	NN
46745	1405	16	.	.	.
46745	1406	1	Hydrocyanic	hydrocyanic	JJ
46745	1406	2	acid	acid	NN
46745	1406	3	,	,	,
46745	1406	4	Creosote	Creosote	NNP
46745	1406	5	,	,	,
46745	1406	6	and	and	CC
46745	1406	7	Nitrate	Nitrate	NNP
46745	1406	8	(	(	-LRB-
46745	1406	9	also	also	RB
46745	1406	10	called	call	VBN
46745	1406	11	Tris	Tris	NNP
46745	1406	12	-	-	HYPH
46745	1406	13	Nitrate	Nitrate	NNP
46745	1406	14	)	)	-RRB-
46745	1406	15	of	of	IN
46745	1406	16	Bismuth	Bismuth	NNP
46745	1406	17	,	,	,
46745	1406	18	are	be	VBP
46745	1406	19	the	the	DT
46745	1406	20	most	most	RBS
46745	1406	21	useful	useful	JJ
46745	1406	22	of	of	IN
46745	1406	23	these	these	DT
46745	1406	24	medicines	medicine	NNS
46745	1406	25	.	.	.
46745	1407	1	The	the	DT
46745	1407	2	first	first	JJ
46745	1407	3	two	two	CD
46745	1407	4	are	be	VBP
46745	1407	5	subsequently	subsequently	RB
46745	1407	6	absorbed	absorb	VBN
46745	1407	7	,	,	,
46745	1407	8	and	and	CC
46745	1407	9	pass	pass	VB
46745	1407	10	into	into	IN
46745	1407	11	the	the	DT
46745	1407	12	blood	blood	NN
46745	1407	13	.	.	.
46745	1408	1	The	the	DT
46745	1408	2	third	third	JJ
46745	1408	3	is	be	VBZ
46745	1408	4	a	a	DT
46745	1408	5	very	very	RB
46745	1408	6	insoluble	insoluble	JJ
46745	1408	7	salt	salt	NN
46745	1408	8	.	.	.
46745	1409	1	It	-PRON-	PRP
46745	1409	2	acts	act	VBZ
46745	1409	3	also	also	RB
46745	1409	4	as	as	IN
46745	1409	5	an	an	DT
46745	1409	6	astringent	astringent	NN
46745	1409	7	on	on	IN
46745	1409	8	the	the	DT
46745	1409	9	mucous	mucous	JJ
46745	1409	10	surface	surface	NN
46745	1409	11	of	of	IN
46745	1409	12	the	the	DT
46745	1409	13	intestine	intestine	NN
46745	1409	14	,	,	,
46745	1409	15	and	and	CC
46745	1409	16	is	be	VBZ
46745	1409	17	probably	probably	RB
46745	1409	18	the	the	DT
46745	1409	19	only	only	JJ
46745	1409	20	astringent	astringent	NN
46745	1409	21	which	which	WDT
46745	1409	22	is	be	VBZ
46745	1409	23	not	not	RB
46745	1409	24	absorbed	absorb	VBN
46745	1409	25	.	.	.
46745	1410	1	Being	be	VBG
46745	1410	2	insoluble	insoluble	JJ
46745	1410	3	,	,	,
46745	1410	4	its	-PRON-	PRP$
46745	1410	5	action	action	NN
46745	1410	6	is	be	VBZ
46745	1410	7	quite	quite	RB
46745	1410	8	confined	confine	VBN
46745	1410	9	to	to	IN
46745	1410	10	the	the	DT
46745	1410	11	mucous	mucous	JJ
46745	1410	12	surface	surface	NN
46745	1410	13	.	.	.
46745	1411	1	It	-PRON-	PRP
46745	1411	2	may	may	MD
46745	1411	3	be	be	VB
46745	1411	4	given	give	VBN
46745	1411	5	safely	safely	RB
46745	1411	6	in	in	IN
46745	1411	7	very	very	RB
46745	1411	8	large	large	JJ
46745	1411	9	doses	dose	NNS
46745	1411	10	,	,	,
46745	1411	11	(	(	-LRB-
46745	1411	12	as	as	IN
46745	1411	13	[	[	-LRB-
46745	1411	14	dram]ss	dram]s	NNS
46745	1411	15	,	,	,
46745	1411	16	or	or	CC
46745	1411	17	even	even	RB
46745	1411	18	[	[	-LRB-
46745	1411	19	dram]j	dram]j	NNP
46745	1411	20	.	.	.
46745	1411	21	)	)	-RRB-
46745	1412	1	and	and	CC
46745	1412	2	it	-PRON-	PRP
46745	1412	3	is	be	VBZ
46745	1412	4	likely	likely	JJ
46745	1412	5	that	that	IN
46745	1412	6	its	-PRON-	PRP$
46745	1412	7	anæsthetic	anæsthetic	JJ
46745	1412	8	action	action	NN
46745	1412	9	may	may	MD
46745	1412	10	be	be	VB
46745	1412	11	in	in	IN
46745	1412	12	some	some	DT
46745	1412	13	part	part	NN
46745	1412	14	mechanical	mechanical	JJ
46745	1412	15	in	in	IN
46745	1412	16	nature	nature	NN
46745	1412	17	,	,	,
46745	1412	18	and	and	CC
46745	1412	19	depend	depend	VB
46745	1412	20	upon	upon	IN
46745	1412	21	its	-PRON-	PRP$
46745	1412	22	affording	afford	VBG
46745	1412	23	a	a	DT
46745	1412	24	mechanical	mechanical	JJ
46745	1412	25	sheath	sheath	NN
46745	1412	26	to	to	IN
46745	1412	27	the	the	DT
46745	1412	28	irritable	irritable	JJ
46745	1412	29	and	and	CC
46745	1412	30	painful	painful	JJ
46745	1412	31	surface	surface	NN
46745	1412	32	of	of	IN
46745	1412	33	the	the	DT
46745	1412	34	stomach	stomach	NN
46745	1412	35	.	.	.
46745	1413	1	Hydrocyanic	hydrocyanic	JJ
46745	1413	2	acid	acid	NN
46745	1413	3	and	and	CC
46745	1413	4	Creosote,--general	creosote,--general	JJ
46745	1413	5	sedatives,--act	sedatives,--act	NN
46745	1413	6	locally	locally	RB
46745	1413	7	as	as	IN
46745	1413	8	anodynes	anodyne	NNS
46745	1413	9	to	to	IN
46745	1413	10	the	the	DT
46745	1413	11	nerves	nerve	NNS
46745	1413	12	of	of	IN
46745	1413	13	the	the	DT
46745	1413	14	stomach	stomach	NN
46745	1413	15	.	.	.
46745	1414	1	_	_	NNP
46745	1414	2	c.	c.	NNP
46745	1415	1	Irritant	irritant	JJ
46745	1415	2	Cathartics._--As	cathartics._--as	NN
46745	1415	3	there	there	EX
46745	1415	4	are	be	VBP
46745	1415	5	two	two	CD
46745	1415	6	kinds	kind	NNS
46745	1415	7	of	of	IN
46745	1415	8	emetics	emetic	NNS
46745	1415	9	,	,	,
46745	1415	10	differing	differ	VBG
46745	1415	11	in	in	IN
46745	1415	12	their	-PRON-	PRP$
46745	1415	13	mode	mode	NN
46745	1415	14	of	of	IN
46745	1415	15	operation	operation	NN
46745	1415	16	,	,	,
46745	1415	17	so	so	RB
46745	1415	18	also	also	RB
46745	1415	19	do	do	VBP
46745	1415	20	there	there	EX
46745	1415	21	seem	seem	VB
46745	1415	22	to	to	TO
46745	1415	23	be	be	VB
46745	1415	24	two	two	CD
46745	1415	25	kinds	kind	NNS
46745	1415	26	of	of	IN
46745	1415	27	Cathartics	Cathartics	NNPS
46745	1415	28	.	.	.
46745	1416	1	But	but	CC
46745	1416	2	the	the	DT
46745	1416	3	distinction	distinction	NN
46745	1416	4	between	between	IN
46745	1416	5	them	-PRON-	PRP
46745	1416	6	is	be	VBZ
46745	1416	7	not	not	RB
46745	1416	8	exactly	exactly	RB
46745	1416	9	the	the	DT
46745	1416	10	same	same	JJ
46745	1416	11	.	.	.
46745	1417	1	As	as	IN
46745	1417	2	with	with	IN
46745	1417	3	the	the	DT
46745	1417	4	Emetics	Emetics	NNPS
46745	1417	5	,	,	,
46745	1417	6	one	one	CD
46745	1417	7	kind	kind	NN
46745	1417	8	seem	seem	VBP
46745	1417	9	to	to	TO
46745	1417	10	act	act	VB
46745	1417	11	by	by	IN
46745	1417	12	topical	topical	JJ
46745	1417	13	irritation	irritation	NN
46745	1417	14	,	,	,
46745	1417	15	exciting	excite	VBG
46745	1417	16	an	an	DT
46745	1417	17	outpouring	outpouring	NN
46745	1417	18	of	of	IN
46745	1417	19	the	the	DT
46745	1417	20	intestinal	intestinal	JJ
46745	1417	21	secretions	secretion	NNS
46745	1417	22	,	,	,
46745	1417	23	and	and	CC
46745	1417	24	causing	cause	VBG
46745	1417	25	an	an	DT
46745	1417	26	expulsion	expulsion	NN
46745	1417	27	of	of	IN
46745	1417	28	the	the	DT
46745	1417	29	contents	content	NNS
46745	1417	30	by	by	IN
46745	1417	31	exciting	exciting	JJ
46745	1417	32	peristaltic	peristaltic	JJ
46745	1417	33	contraction	contraction	NN
46745	1417	34	.	.	.
46745	1418	1	But	but	CC
46745	1418	2	Specific	Specific	NNP
46745	1418	3	Emetics	Emetics	NNPS
46745	1418	4	,	,	,
46745	1418	5	which	which	WDT
46745	1418	6	act	act	VBP
46745	1418	7	from	from	IN
46745	1418	8	the	the	DT
46745	1418	9	blood	blood	NN
46745	1418	10	,	,	,
46745	1418	11	seem	seem	VBP
46745	1418	12	to	to	TO
46745	1418	13	produce	produce	VB
46745	1418	14	their	-PRON-	PRP$
46745	1418	15	effect	effect	NN
46745	1418	16	by	by	IN
46745	1418	17	influencing	influence	VBG
46745	1418	18	the	the	DT
46745	1418	19	nerve	nerve	NN
46745	1418	20	of	of	IN
46745	1418	21	the	the	DT
46745	1418	22	stomach	stomach	NN
46745	1418	23	;	;	:
46745	1418	24	so	so	IN
46745	1418	25	that	that	IN
46745	1418	26	they	-PRON-	PRP
46745	1418	27	are	be	VBP
46745	1418	28	Neurotic	neurotic	JJ
46745	1418	29	medicines	medicine	NNS
46745	1418	30	.	.	.
46745	1419	1	Specific	specific	JJ
46745	1419	2	Cathartics	Cathartics	NNPS
46745	1419	3	act	act	VBP
46745	1419	4	differently	differently	RB
46745	1419	5	.	.	.
46745	1420	1	They	-PRON-	PRP
46745	1420	2	are	be	VBP
46745	1420	3	truly	truly	RB
46745	1420	4	Eliminatives	Eliminatives	NNPS
46745	1420	5	.	.	.
46745	1421	1	They	-PRON-	PRP
46745	1421	2	exert	exert	VBP
46745	1421	3	no	no	DT
46745	1421	4	influence	influence	NN
46745	1421	5	over	over	IN
46745	1421	6	nerves	nerve	NNS
46745	1421	7	,	,	,
46745	1421	8	but	but	CC
46745	1421	9	they	-PRON-	PRP
46745	1421	10	operate	operate	VBP
46745	1421	11	by	by	IN
46745	1421	12	passing	pass	VBG
46745	1421	13	out	out	IN
46745	1421	14	of	of	IN
46745	1421	15	the	the	DT
46745	1421	16	blood	blood	NN
46745	1421	17	through	through	IN
46745	1421	18	the	the	DT
46745	1421	19	intestinal	intestinal	JJ
46745	1421	20	glands	gland	NNS
46745	1421	21	.	.	.
46745	1422	1	Like	like	IN
46745	1422	2	Specific	Specific	NNP
46745	1422	3	Emetics	Emetics	NNPS
46745	1422	4	,	,	,
46745	1422	5	they	-PRON-	PRP
46745	1422	6	must	must	MD
46745	1422	7	be	be	VB
46745	1422	8	first	first	RB
46745	1422	9	absorbed	absorb	VBN
46745	1422	10	.	.	.
46745	1423	1	I	-PRON-	PRP
46745	1423	2	will	will	MD
46745	1423	3	not	not	RB
46745	1423	4	now	now	RB
46745	1423	5	enter	enter	VB
46745	1423	6	into	into	IN
46745	1423	7	the	the	DT
46745	1423	8	theory	theory	NN
46745	1423	9	of	of	IN
46745	1423	10	Elimination	elimination	NN
46745	1423	11	,	,	,
46745	1423	12	which	which	WDT
46745	1423	13	I	-PRON-	PRP
46745	1423	14	shall	shall	MD
46745	1423	15	have	have	VB
46745	1423	16	to	to	TO
46745	1423	17	consider	consider	VB
46745	1423	18	afterwards	afterwards	RB
46745	1423	19	,	,	,
46745	1423	20	but	but	CC
46745	1423	21	I	-PRON-	PRP
46745	1423	22	wish	wish	VBP
46745	1423	23	merely	merely	RB
46745	1423	24	to	to	TO
46745	1423	25	distinguish	distinguish	VB
46745	1423	26	between	between	IN
46745	1423	27	local	local	JJ
46745	1423	28	action	action	NN
46745	1423	29	on	on	IN
46745	1423	30	a	a	DT
46745	1423	31	surface	surface	NN
46745	1423	32	,	,	,
46745	1423	33	and	and	CC
46745	1423	34	specific	specific	JJ
46745	1423	35	action	action	NN
46745	1423	36	on	on	IN
46745	1423	37	a	a	DT
46745	1423	38	gland	gland	NN
46745	1423	39	,	,	,
46745	1423	40	exerted	exert	VBN
46745	1423	41	from	from	IN
46745	1423	42	the	the	DT
46745	1423	43	blood	blood	NN
46745	1423	44	.	.	.
46745	1424	1	Many	many	JJ
46745	1424	2	substances	substance	NNS
46745	1424	3	used	use	VBN
46745	1424	4	as	as	IN
46745	1424	5	purgatives	purgative	NNS
46745	1424	6	are	be	VBP
46745	1424	7	capable	capable	JJ
46745	1424	8	of	of	IN
46745	1424	9	absorption	absorption	NN
46745	1424	10	,	,	,
46745	1424	11	and	and	CC
46745	1424	12	are	be	VBP
46745	1424	13	absorbed	absorb	VBN
46745	1424	14	.	.	.
46745	1425	1	But	but	CC
46745	1425	2	it	-PRON-	PRP
46745	1425	3	seems	seem	VBZ
46745	1425	4	that	that	IN
46745	1425	5	they	-PRON-	PRP
46745	1425	6	are	be	VBP
46745	1425	7	not	not	RB
46745	1425	8	fit	fit	JJ
46745	1425	9	to	to	TO
46745	1425	10	remain	remain	VB
46745	1425	11	in	in	IN
46745	1425	12	the	the	DT
46745	1425	13	blood	blood	NN
46745	1425	14	;	;	:
46745	1425	15	and	and	CC
46745	1425	16	after	after	IN
46745	1425	17	passing	pass	VBG
46745	1425	18	round	round	NN
46745	1425	19	in	in	IN
46745	1425	20	the	the	DT
46745	1425	21	circulation	circulation	NN
46745	1425	22	,	,	,
46745	1425	23	they	-PRON-	PRP
46745	1425	24	are	be	VBP
46745	1425	25	expelled	expel	VBN
46745	1425	26	by	by	IN
46745	1425	27	the	the	DT
46745	1425	28	depurative	depurative	JJ
46745	1425	29	force	force	NN
46745	1425	30	at	at	IN
46745	1425	31	a	a	DT
46745	1425	32	point	point	NN
46745	1425	33	near	near	IN
46745	1425	34	to	to	IN
46745	1425	35	that	that	DT
46745	1425	36	at	at	IN
46745	1425	37	which	which	WDT
46745	1425	38	they	-PRON-	PRP
46745	1425	39	previously	previously	RB
46745	1425	40	entered	enter	VBD
46745	1425	41	by	by	IN
46745	1425	42	the	the	DT
46745	1425	43	laws	law	NNS
46745	1425	44	of	of	IN
46745	1425	45	absorption	absorption	NN
46745	1425	46	,	,	,
46745	1425	47	namely	namely	RB
46745	1425	48	,	,	,
46745	1425	49	the	the	DT
46745	1425	50	mucous	mucous	JJ
46745	1425	51	surface	surface	NN
46745	1425	52	of	of	IN
46745	1425	53	the	the	DT
46745	1425	54	bowels	bowel	NNS
46745	1425	55	.	.	.
46745	1426	1	They	-PRON-	PRP
46745	1426	2	are	be	VBP
46745	1426	3	most	most	RBS
46745	1426	4	commonly	commonly	RB
46745	1426	5	expelled	expel	VBN
46745	1426	6	by	by	IN
46745	1426	7	the	the	DT
46745	1426	8	glands	gland	NNS
46745	1426	9	of	of	IN
46745	1426	10	this	this	DT
46745	1426	11	surface	surface	NN
46745	1426	12	somewhere	somewhere	RB
46745	1426	13	in	in	IN
46745	1426	14	the	the	DT
46745	1426	15	lower	low	JJR
46745	1426	16	or	or	CC
46745	1426	17	fæcal	fæcal	JJ
46745	1426	18	portion	portion	NN
46745	1426	19	of	of	IN
46745	1426	20	the	the	DT
46745	1426	21	intestinal	intestinal	JJ
46745	1426	22	canal	canal	NN
46745	1426	23	,	,	,
46745	1426	24	which	which	WDT
46745	1426	25	is	be	VBZ
46745	1426	26	more	more	RBR
46745	1426	27	engaged	engaged	JJ
46745	1426	28	in	in	IN
46745	1426	29	secretion	secretion	NN
46745	1426	30	,	,	,
46745	1426	31	but	but	CC
46745	1426	32	less	less	RBR
46745	1426	33	active	active	JJ
46745	1426	34	in	in	IN
46745	1426	35	absorption	absorption	NN
46745	1426	36	,	,	,
46745	1426	37	than	than	IN
46745	1426	38	the	the	DT
46745	1426	39	upper	upper	JJ
46745	1426	40	part	part	NN
46745	1426	41	.	.	.
46745	1427	1	The	the	DT
46745	1427	2	increased	increase	VBN
46745	1427	3	secretion	secretion	NN
46745	1427	4	which	which	WDT
46745	1427	5	they	-PRON-	PRP
46745	1427	6	excite	excite	VBP
46745	1427	7	causes	cause	VBZ
46745	1427	8	peristaltic	peristaltic	JJ
46745	1427	9	action	action	NN
46745	1427	10	,	,	,
46745	1427	11	which	which	WDT
46745	1427	12	expels	expel	VBZ
46745	1427	13	both	both	CC
46745	1427	14	it	-PRON-	PRP
46745	1427	15	and	and	CC
46745	1427	16	them	-PRON-	PRP
46745	1427	17	,	,	,
46745	1427	18	so	so	IN
46745	1427	19	that	that	IN
46745	1427	20	they	-PRON-	PRP
46745	1427	21	can	can	MD
46745	1427	22	not	not	RB
46745	1427	23	again	again	RB
46745	1427	24	be	be	VB
46745	1427	25	absorbed	absorb	VBN
46745	1427	26	.	.	.
46745	1428	1	Such	such	PDT
46745	1428	2	a	a	DT
46745	1428	3	specific	specific	JJ
46745	1428	4	Cathartic	cathartic	NN
46745	1428	5	would	would	MD
46745	1428	6	be	be	VB
46745	1428	7	capable	capable	JJ
46745	1428	8	of	of	IN
46745	1428	9	acting	act	VBG
46745	1428	10	thus	thus	RB
46745	1428	11	if	if	IN
46745	1428	12	introduced	introduce	VBN
46745	1428	13	into	into	IN
46745	1428	14	the	the	DT
46745	1428	15	system	system	NN
46745	1428	16	at	at	IN
46745	1428	17	any	any	DT
46745	1428	18	point	point	NN
46745	1428	19	.	.	.
46745	1429	1	Castor	Castor	NNP
46745	1429	2	Oil	Oil	NNP
46745	1429	3	and	and	CC
46745	1429	4	Croton	Croton	NNP
46745	1429	5	Oil	Oil	NNP
46745	1429	6	,	,	,
46745	1429	7	whether	whether	IN
46745	1429	8	received	receive	VBD
46745	1429	9	into	into	IN
46745	1429	10	the	the	DT
46745	1429	11	stomach	stomach	NN
46745	1429	12	,	,	,
46745	1429	13	or	or	CC
46745	1429	14	injected	inject	VBN
46745	1429	15	into	into	IN
46745	1429	16	the	the	DT
46745	1429	17	veins	vein	NNS
46745	1429	18	,	,	,
46745	1429	19	or	or	CC
46745	1429	20	introduced	introduce	VBN
46745	1429	21	into	into	IN
46745	1429	22	the	the	DT
46745	1429	23	system	system	NN
46745	1429	24	at	at	IN
46745	1429	25	any	any	DT
46745	1429	26	part	part	NN
46745	1429	27	,	,	,
46745	1429	28	equally	equally	RB
46745	1429	29	produce	produce	VBP
46745	1429	30	purging	purge	VBG
46745	1429	31	.	.	.
46745	1430	1	So	so	RB
46745	1430	2	also	also	RB
46745	1430	3	do	do	VB
46745	1430	4	Rhubarb	Rhubarb	NNP
46745	1430	5	,	,	,
46745	1430	6	Aloes	Aloes	NNPS
46745	1430	7	,	,	,
46745	1430	8	and	and	CC
46745	1430	9	Senna	Senna	NNP
46745	1430	10	.	.	.
46745	1431	1	The	the	DT
46745	1431	2	principles	principle	NNS
46745	1431	3	of	of	IN
46745	1431	4	these	these	DT
46745	1431	5	medicines	medicine	NNS
46745	1431	6	have	have	VBP
46745	1431	7	been	be	VBN
46745	1431	8	detected	detect	VBN
46745	1431	9	in	in	IN
46745	1431	10	the	the	DT
46745	1431	11	blood	blood	NN
46745	1431	12	by	by	IN
46745	1431	13	Tiedemann	Tiedemann	NNP
46745	1431	14	,	,	,
46745	1431	15	Gmelin	Gmelin	NNP
46745	1431	16	,	,	,
46745	1431	17	and	and	CC
46745	1431	18	others	other	NNS
46745	1431	19	.	.	.
46745	1432	1	Colocynth	Colocynth	NNP
46745	1432	2	and	and	CC
46745	1432	3	Elaterium	Elaterium	NNP
46745	1432	4	have	have	VBP
46745	1432	5	also	also	RB
46745	1432	6	been	be	VBN
46745	1432	7	proved	prove	VBN
46745	1432	8	to	to	TO
46745	1432	9	act	act	VB
46745	1432	10	specifically	specifically	RB
46745	1432	11	.	.	.
46745	1433	1	[	[	-LRB-
46745	1433	2	28	28	CD
46745	1433	3	]	]	-RRB-
46745	1433	4	It	-PRON-	PRP
46745	1433	5	is	be	VBZ
46745	1433	6	to	to	TO
46745	1433	7	be	be	VB
46745	1433	8	inferred	infer	VBN
46745	1433	9	from	from	IN
46745	1433	10	analogy	analogy	NN
46745	1433	11	that	that	IN
46745	1433	12	other	other	JJ
46745	1433	13	resinous	resinous	JJ
46745	1433	14	Cathartics	cathartic	NNS
46745	1433	15	,	,	,
46745	1433	16	as	as	IN
46745	1433	17	Jalap	Jalap	NNP
46745	1433	18	,	,	,
46745	1433	19	Scammony	Scammony	NNP
46745	1433	20	,	,	,
46745	1433	21	and	and	CC
46745	1433	22	Gamboge	Gamboge	NNP
46745	1433	23	,	,	,
46745	1433	24	must	must	MD
46745	1433	25	also	also	RB
46745	1433	26	act	act	VB
46745	1433	27	from	from	IN
46745	1433	28	the	the	DT
46745	1433	29	blood	blood	NN
46745	1433	30	.	.	.
46745	1434	1	It	-PRON-	PRP
46745	1434	2	has	have	VBZ
46745	1434	3	also	also	RB
46745	1434	4	been	be	VBN
46745	1434	5	shown	show	VBN
46745	1434	6	that	that	IN
46745	1434	7	both	both	DT
46745	1434	8	from	from	IN
46745	1434	9	actual	actual	JJ
46745	1434	10	experiment	experiment	NN
46745	1434	11	,	,	,
46745	1434	12	and	and	CC
46745	1434	13	from	from	IN
46745	1434	14	a	a	DT
46745	1434	15	consideration	consideration	NN
46745	1434	16	of	of	IN
46745	1434	17	the	the	DT
46745	1434	18	laws	law	NNS
46745	1434	19	of	of	IN
46745	1434	20	the	the	DT
46745	1434	21	process	process	NN
46745	1434	22	of	of	IN
46745	1434	23	absorption	absorption	NN
46745	1434	24	,	,	,
46745	1434	25	we	-PRON-	PRP
46745	1434	26	must	must	MD
46745	1434	27	conclude	conclude	VB
46745	1434	28	that	that	IN
46745	1434	29	saline	saline	JJ
46745	1434	30	Cathartics	Cathartics	NNPS
46745	1434	31	are	be	VBP
46745	1434	32	absorbed	absorb	VBN
46745	1434	33	into	into	IN
46745	1434	34	the	the	DT
46745	1434	35	blood	blood	NN
46745	1434	36	before	before	IN
46745	1434	37	they	-PRON-	PRP
46745	1434	38	cause	cause	VBP
46745	1434	39	purging	purge	VBG
46745	1434	40	.	.	.
46745	1435	1	But	but	CC
46745	1435	2	we	-PRON-	PRP
46745	1435	3	have	have	VBP
46745	1435	4	now	now	RB
46745	1435	5	to	to	TO
46745	1435	6	do	do	VB
46745	1435	7	with	with	IN
46745	1435	8	Cathartics	Cathartics	NNPS
46745	1435	9	that	that	WDT
46745	1435	10	act	act	VBP
46745	1435	11	by	by	IN
46745	1435	12	topical	topical	JJ
46745	1435	13	irritation	irritation	NN
46745	1435	14	.	.	.
46745	1436	1	Which	which	WDT
46745	1436	2	are	be	VBP
46745	1436	3	they	-PRON-	PRP
46745	1436	4	?	?	.
46745	1437	1	I	-PRON-	PRP
46745	1437	2	believe	believe	VBP
46745	1437	3	that	that	IN
46745	1437	4	the	the	DT
46745	1437	5	same	same	JJ
46745	1437	6	resinous	resinous	JJ
46745	1437	7	Cathartics	cathartic	NNS
46745	1437	8	which	which	WDT
46745	1437	9	have	have	VBP
46745	1437	10	the	the	DT
46745	1437	11	power	power	NN
46745	1437	12	of	of	IN
46745	1437	13	acting	acting	NN
46745	1437	14	specifically	specifically	RB
46745	1437	15	,	,	,
46745	1437	16	may	may	MD
46745	1437	17	have	have	VB
46745	1437	18	,	,	,
46745	1437	19	especially	especially	RB
46745	1437	20	when	when	WRB
46745	1437	21	in	in	IN
46745	1437	22	large	large	JJ
46745	1437	23	doses	dose	NNS
46745	1437	24	,	,	,
46745	1437	25	a	a	DT
46745	1437	26	double	double	JJ
46745	1437	27	action	action	NN
46745	1437	28	.	.	.
46745	1438	1	It	-PRON-	PRP
46745	1438	2	has	have	VBZ
46745	1438	3	been	be	VBN
46745	1438	4	shown	show	VBN
46745	1438	5	that	that	IN
46745	1438	6	resins	resin	NNS
46745	1438	7	are	be	VBP
46745	1438	8	difficult	difficult	JJ
46745	1438	9	of	of	IN
46745	1438	10	absorption	absorption	NN
46745	1438	11	;	;	:
46745	1438	12	and	and	CC
46745	1438	13	whether	whether	IN
46745	1438	14	they	-PRON-	PRP
46745	1438	15	be	be	VBP
46745	1438	16	absorbed	absorb	VBN
46745	1438	17	or	or	CC
46745	1438	18	not	not	RB
46745	1438	19	,	,	,
46745	1438	20	we	-PRON-	PRP
46745	1438	21	know	know	VBP
46745	1438	22	that	that	IN
46745	1438	23	they	-PRON-	PRP
46745	1438	24	must	must	MD
46745	1438	25	irritate	irritate	VB
46745	1438	26	the	the	DT
46745	1438	27	intestinal	intestinal	JJ
46745	1438	28	surface	surface	NN
46745	1438	29	,	,	,
46745	1438	30	from	from	IN
46745	1438	31	the	the	DT
46745	1438	32	violent	violent	JJ
46745	1438	33	griping	griping	NN
46745	1438	34	which	which	WDT
46745	1438	35	often	often	RB
46745	1438	36	attends	attend	VBZ
46745	1438	37	their	-PRON-	PRP$
46745	1438	38	operation	operation	NN
46745	1438	39	.	.	.
46745	1439	1	Thus	thus	RB
46745	1439	2	Scammony	Scammony	NNP
46745	1439	3	does	do	VBZ
46745	1439	4	not	not	RB
46745	1439	5	act	act	VB
46745	1439	6	so	so	RB
46745	1439	7	well	well	RB
46745	1439	8	,	,	,
46745	1439	9	and	and	CC
46745	1439	10	does	do	VBZ
46745	1439	11	not	not	RB
46745	1439	12	gripe	gripe	VB
46745	1439	13	,	,	,
46745	1439	14	when	when	WRB
46745	1439	15	the	the	DT
46745	1439	16	bowels	bowel	NNS
46745	1439	17	are	be	VBP
46745	1439	18	lined	line	VBN
46745	1439	19	with	with	IN
46745	1439	20	mucus	mucus	NN
46745	1439	21	.	.	.
46745	1440	1	Gamboge	Gamboge	NNP
46745	1440	2	and	and	CC
46745	1440	3	Euphorbium	Euphorbium	NNP
46745	1440	4	are	be	VBP
46745	1440	5	irritant	irritant	JJ
46745	1440	6	in	in	IN
46745	1440	7	an	an	DT
46745	1440	8	extreme	extreme	JJ
46745	1440	9	degree	degree	NN
46745	1440	10	,	,	,
46745	1440	11	and	and	CC
46745	1440	12	are	be	VBP
46745	1440	13	therefore	therefore	RB
46745	1440	14	too	too	RB
46745	1440	15	dangerous	dangerous	JJ
46745	1440	16	for	for	IN
46745	1440	17	general	general	JJ
46745	1440	18	use	use	NN
46745	1440	19	.	.	.
46745	1441	1	The	the	DT
46745	1441	2	powder	powder	NN
46745	1441	3	of	of	IN
46745	1441	4	Euphorbium	Euphorbium	NNP
46745	1441	5	resin	resin	NN
46745	1441	6	has	have	VBZ
46745	1441	7	been	be	VBN
46745	1441	8	used	use	VBN
46745	1441	9	as	as	IN
46745	1441	10	an	an	DT
46745	1441	11	Errhine	Errhine	NNP
46745	1441	12	,	,	,
46745	1441	13	for	for	IN
46745	1441	14	,	,	,
46745	1441	15	by	by	IN
46745	1441	16	irritating	irritate	VBG
46745	1441	17	the	the	DT
46745	1441	18	mucous	mucous	JJ
46745	1441	19	membrane	membrane	NN
46745	1441	20	of	of	IN
46745	1441	21	the	the	DT
46745	1441	22	nose	nose	NN
46745	1441	23	,	,	,
46745	1441	24	it	-PRON-	PRP
46745	1441	25	increases	increase	VBZ
46745	1441	26	its	-PRON-	PRP$
46745	1441	27	secretion	secretion	NN
46745	1441	28	.	.	.
46745	1442	1	This	this	DT
46745	1442	2	illustrates	illustrate	VBZ
46745	1442	3	the	the	DT
46745	1442	4	operation	operation	NN
46745	1442	5	of	of	IN
46745	1442	6	irritant	irritant	JJ
46745	1442	7	Cathartics	Cathartics	NNPS
46745	1442	8	.	.	.
46745	1443	1	A	a	DT
46745	1443	2	great	great	JJ
46745	1443	3	part	part	NN
46745	1443	4	of	of	IN
46745	1443	5	the	the	DT
46745	1443	6	fæces	fæce	NNS
46745	1443	7	is	be	VBZ
46745	1443	8	secreted	secrete	VBN
46745	1443	9	by	by	IN
46745	1443	10	the	the	DT
46745	1443	11	mucous	mucous	JJ
46745	1443	12	membrane	membrane	NN
46745	1443	13	of	of	IN
46745	1443	14	the	the	DT
46745	1443	15	bowel	bowel	NN
46745	1443	16	.	.	.
46745	1444	1	This	this	DT
46745	1444	2	secretion	secretion	NN
46745	1444	3	a	a	DT
46745	1444	4	Cathartic	Cathartic	NNP
46745	1444	5	may	may	MD
46745	1444	6	increase	increase	VB
46745	1444	7	by	by	IN
46745	1444	8	mere	mere	JJ
46745	1444	9	contact	contact	NN
46745	1444	10	and	and	CC
46745	1444	11	irritation	irritation	NN
46745	1444	12	;	;	:
46745	1444	13	or	or	CC
46745	1444	14	,	,	,
46745	1444	15	being	be	VBG
46745	1444	16	also	also	RB
46745	1444	17	a	a	DT
46745	1444	18	specific	specific	JJ
46745	1444	19	agent	agent	NN
46745	1444	20	,	,	,
46745	1444	21	by	by	IN
46745	1444	22	absorption	absorption	NN
46745	1444	23	and	and	CC
46745	1444	24	elimination	elimination	NN
46745	1444	25	likewise	likewise	RB
46745	1444	26	.	.	.
46745	1445	1	[	[	-LRB-
46745	1445	2	29	29	CD
46745	1445	3	]	]	-RRB-
46745	1445	4	Some	some	DT
46745	1445	5	Cathartics	Cathartics	NNPS
46745	1445	6	employed	employ	VBD
46745	1445	7	as	as	IN
46745	1445	8	Vermifuges	vermifuge	NNS
46745	1445	9	,	,	,
46745	1445	10	as	as	IN
46745	1445	11	the	the	DT
46745	1445	12	hairs	hair	NNS
46745	1445	13	of	of	IN
46745	1445	14	_	_	NNP
46745	1445	15	Mucuna	Mucuna	NNP
46745	1445	16	pruriens	prurien	VBZ
46745	1445	17	_	_	NNP
46745	1445	18	,	,	,
46745	1445	19	metallic	metallic	JJ
46745	1445	20	Mercury	Mercury	NNP
46745	1445	21	,	,	,
46745	1445	22	and	and	CC
46745	1445	23	Tin	Tin	NNP
46745	1445	24	powder	powder	NN
46745	1445	25	,	,	,
46745	1445	26	can	can	MD
46745	1445	27	not	not	RB
46745	1445	28	be	be	VB
46745	1445	29	absorbed	absorb	VBN
46745	1445	30	at	at	RB
46745	1445	31	all	all	RB
46745	1445	32	,	,	,
46745	1445	33	and	and	CC
46745	1445	34	must	must	MD
46745	1445	35	act	act	VB
46745	1445	36	solely	solely	RB
46745	1445	37	and	and	CC
46745	1445	38	altogether	altogether	RB
46745	1445	39	by	by	IN
46745	1445	40	irritation	irritation	NN
46745	1445	41	.	.	.
46745	1446	1	These	these	DT
46745	1446	2	Vermifuges	vermifuge	NNS
46745	1446	3	,	,	,
46745	1446	4	or	or	CC
46745	1446	5	Anthelmintics	Anthelmintics	NNPS
46745	1446	6	,	,	,
46745	1446	7	are	be	VBP
46745	1446	8	employed	employ	VBN
46745	1446	9	for	for	IN
46745	1446	10	a	a	DT
46745	1446	11	strictly	strictly	RB
46745	1446	12	local	local	JJ
46745	1446	13	purpose	purpose	NN
46745	1446	14	--	--	:
46745	1446	15	that	that	IN
46745	1446	16	of	of	IN
46745	1446	17	killing	kill	VBG
46745	1446	18	and	and	CC
46745	1446	19	expelling	expel	VBG
46745	1446	20	intestinal	intestinal	JJ
46745	1446	21	worms	worm	NNS
46745	1446	22	.	.	.
46745	1447	1	Any	any	DT
46745	1447	2	powerful	powerful	JJ
46745	1447	3	Cathartic	Cathartic	NNP
46745	1447	4	may	may	MD
46745	1447	5	be	be	VB
46745	1447	6	used	use	VBN
46745	1447	7	to	to	TO
46745	1447	8	expel	expel	VB
46745	1447	9	them	-PRON-	PRP
46745	1447	10	.	.	.
46745	1448	1	But	but	CC
46745	1448	2	such	such	PDT
46745	1448	3	an	an	DT
46745	1448	4	agent	agent	NN
46745	1448	5	should	should	MD
46745	1448	6	generally	generally	RB
46745	1448	7	be	be	VB
46745	1448	8	conjoined	conjoin	VBN
46745	1448	9	with	with	IN
46745	1448	10	a	a	DT
46745	1448	11	medicine	medicine	NN
46745	1448	12	that	that	WDT
46745	1448	13	tends	tend	VBZ
46745	1448	14	directly	directly	RB
46745	1448	15	to	to	TO
46745	1448	16	kill	kill	VB
46745	1448	17	the	the	DT
46745	1448	18	parasite	parasite	NN
46745	1448	19	;	;	:
46745	1448	20	for	for	IN
46745	1448	21	after	after	IN
46745	1448	22	that	that	IN
46745	1448	23	it	-PRON-	PRP
46745	1448	24	will	will	MD
46745	1448	25	be	be	VB
46745	1448	26	more	more	RBR
46745	1448	27	easily	easily	RB
46745	1448	28	dislodged	dislodge	VBN
46745	1448	29	.	.	.
46745	1449	1	For	for	IN
46745	1449	2	this	this	DT
46745	1449	3	purpose	purpose	NN
46745	1449	4	the	the	DT
46745	1449	5	root	root	NN
46745	1449	6	of	of	IN
46745	1449	7	Male	Male	NNP
46745	1449	8	Fern	Fern	NNP
46745	1449	9	,	,	,
46745	1449	10	Kousso	Kousso	NNP
46745	1449	11	,	,	,
46745	1449	12	and	and	CC
46745	1449	13	the	the	DT
46745	1449	14	bark	bark	NN
46745	1449	15	of	of	IN
46745	1449	16	the	the	DT
46745	1449	17	root	root	NN
46745	1449	18	of	of	IN
46745	1449	19	Pomegranate	Pomegranate	NNP
46745	1449	20	,	,	,
46745	1449	21	have	have	VBP
46745	1449	22	been	be	VBN
46745	1449	23	used	use	VBN
46745	1449	24	with	with	IN
46745	1449	25	advantage	advantage	NN
46745	1449	26	in	in	IN
46745	1449	27	the	the	DT
46745	1449	28	case	case	NN
46745	1449	29	of	of	IN
46745	1449	30	tape	tape	NN
46745	1449	31	-	-	HYPH
46745	1449	32	worm	worm	NN
46745	1449	33	.	.	.
46745	1450	1	Ascarides	ascaride	NNS
46745	1450	2	are	be	VBP
46745	1450	3	situated	situate	VBN
46745	1450	4	low	low	RB
46745	1450	5	down	down	RB
46745	1450	6	in	in	IN
46745	1450	7	the	the	DT
46745	1450	8	intestine	intestine	NN
46745	1450	9	,	,	,
46745	1450	10	and	and	CC
46745	1450	11	may	may	MD
46745	1450	12	be	be	VB
46745	1450	13	dislodged	dislodge	VBN
46745	1450	14	by	by	IN
46745	1450	15	the	the	DT
46745	1450	16	use	use	NN
46745	1450	17	of	of	IN
46745	1450	18	an	an	DT
46745	1450	19	enema	enema	NN
46745	1450	20	,	,	,
46745	1450	21	as	as	IN
46745	1450	22	of	of	IN
46745	1450	23	Salt	Salt	NNP
46745	1450	24	.	.	.
46745	1451	1	Turpentine	turpentine	NN
46745	1451	2	is	be	VBZ
46745	1451	3	often	often	RB
46745	1451	4	very	very	RB
46745	1451	5	efficacious	efficacious	JJ
46745	1451	6	in	in	IN
46745	1451	7	cases	case	NNS
46745	1451	8	of	of	IN
46745	1451	9	this	this	DT
46745	1451	10	kind	kind	NN
46745	1451	11	,	,	,
46745	1451	12	being	be	VBG
46745	1451	13	at	at	IN
46745	1451	14	once	once	RB
46745	1451	15	a	a	DT
46745	1451	16	poison	poison	NN
46745	1451	17	to	to	IN
46745	1451	18	the	the	DT
46745	1451	19	worms	worm	NNS
46745	1451	20	and	and	CC
46745	1451	21	a	a	DT
46745	1451	22	powerful	powerful	JJ
46745	1451	23	irritant	irritant	JJ
46745	1451	24	cathartic	cathartic	NN
46745	1451	25	.	.	.
46745	1452	1	I	-PRON-	PRP
46745	1452	2	have	have	VBP
46745	1452	3	already	already	RB
46745	1452	4	alluded	allude	VBN
46745	1452	5	to	to	IN
46745	1452	6	Nitrate	Nitrate	NNP
46745	1452	7	of	of	IN
46745	1452	8	Bismuth	Bismuth	NNP
46745	1452	9	,	,	,
46745	1452	10	as	as	IN
46745	1452	11	seeming	seeming	JJ
46745	1452	12	to	to	TO
46745	1452	13	be	be	VB
46745	1452	14	an	an	DT
46745	1452	15	astringent	astringent	NN
46745	1452	16	to	to	IN
46745	1452	17	the	the	DT
46745	1452	18	mucous	mucous	JJ
46745	1452	19	surface	surface	NN
46745	1452	20	of	of	IN
46745	1452	21	the	the	DT
46745	1452	22	intestine	intestine	NN
46745	1452	23	,	,	,
46745	1452	24	although	although	IN
46745	1452	25	apparently	apparently	RB
46745	1452	26	incapable	incapable	JJ
46745	1452	27	of	of	IN
46745	1452	28	absorption	absorption	NN
46745	1452	29	.	.	.
46745	1453	1	It	-PRON-	PRP
46745	1453	2	has	have	VBZ
46745	1453	3	been	be	VBN
46745	1453	4	used	use	VBN
46745	1453	5	with	with	IN
46745	1453	6	advantage	advantage	NN
46745	1453	7	in	in	IN
46745	1453	8	diarrh[oe]a	diarrh[oe]a	NNP
46745	1453	9	,	,	,
46745	1453	10	and	and	CC
46745	1453	11	is	be	VBZ
46745	1453	12	highly	highly	RB
46745	1453	13	recommended	recommend	VBN
46745	1453	14	by	by	IN
46745	1453	15	Dr.	Dr.	NNP
46745	1453	16	Theophilus	Theophilus	NNP
46745	1453	17	Thompson	Thompson	NNP
46745	1453	18	in	in	IN
46745	1453	19	the	the	DT
46745	1453	20	diarrh[oe]a	diarrh[oe]a	NNP
46745	1453	21	of	of	IN
46745	1453	22	Phthisis	Phthisis	NNP
46745	1453	23	.	.	.
46745	1454	1	But	but	CC
46745	1454	2	all	all	DT
46745	1454	3	other	other	JJ
46745	1454	4	astringents	astringent	NNS
46745	1454	5	are	be	VBP
46745	1454	6	absorbed	absorb	VBN
46745	1454	7	;	;	:
46745	1454	8	and	and	CC
46745	1454	9	when	when	WRB
46745	1454	10	they	-PRON-	PRP
46745	1454	11	act	act	VBP
46745	1454	12	on	on	IN
46745	1454	13	the	the	DT
46745	1454	14	mucous	mucous	JJ
46745	1454	15	glands	gland	NNS
46745	1454	16	of	of	IN
46745	1454	17	the	the	DT
46745	1454	18	intestines	intestine	NNS
46745	1454	19	,	,	,
46745	1454	20	it	-PRON-	PRP
46745	1454	21	is	be	VBZ
46745	1454	22	probably	probably	RB
46745	1454	23	from	from	IN
46745	1454	24	the	the	DT
46745	1454	25	blood	blood	NN
46745	1454	26	.	.	.
46745	1455	1	It	-PRON-	PRP
46745	1455	2	has	have	VBZ
46745	1455	3	been	be	VBN
46745	1455	4	supposed	suppose	VBN
46745	1455	5	by	by	IN
46745	1455	6	M.	M.	NNP
46745	1455	7	Poisseuille	Poisseuille	NNP
46745	1455	8	and	and	CC
46745	1455	9	others	other	NNS
46745	1455	10	that	that	IN
46745	1455	11	the	the	DT
46745	1455	12	action	action	NN
46745	1455	13	of	of	IN
46745	1455	14	Opium	Opium	NNP
46745	1455	15	in	in	IN
46745	1455	16	confining	confine	VBG
46745	1455	17	the	the	DT
46745	1455	18	bowels	bowel	NNS
46745	1455	19	is	be	VBZ
46745	1455	20	to	to	TO
46745	1455	21	be	be	VB
46745	1455	22	attributed	attribute	VBN
46745	1455	23	to	to	IN
46745	1455	24	a	a	DT
46745	1455	25	power	power	NN
46745	1455	26	of	of	IN
46745	1455	27	checking	check	VBG
46745	1455	28	the	the	DT
46745	1455	29	process	process	NN
46745	1455	30	of	of	IN
46745	1455	31	endosmosis	endosmosis	NN
46745	1455	32	,	,	,
46745	1455	33	said	say	VBD
46745	1455	34	to	to	TO
46745	1455	35	be	be	VB
46745	1455	36	possessed	possess	VBN
46745	1455	37	by	by	IN
46745	1455	38	a	a	DT
46745	1455	39	solution	solution	NN
46745	1455	40	of	of	IN
46745	1455	41	Morphia	Morphia	NNP
46745	1455	42	.	.	.
46745	1456	1	I	-PRON-	PRP
46745	1456	2	shall	shall	MD
46745	1456	3	afterwards	afterwards	RB
46745	1456	4	state	state	VB
46745	1456	5	my	-PRON-	PRP$
46745	1456	6	reasons	reason	NNS
46745	1456	7	for	for	IN
46745	1456	8	discrediting	discredit	VBG
46745	1456	9	this	this	DT
46745	1456	10	explanation	explanation	NN
46745	1456	11	.	.	.
46745	1457	1	(	(	-LRB-
46745	1457	2	_	_	NNP
46745	1457	3	Vide	Vide	NNP
46745	1457	4	Chap	Chap	NNP
46745	1457	5	.	.	.
46745	1458	1	IV	IV	NNP
46745	1458	2	.	.	NNP
46745	1458	3	,	,	,
46745	1458	4	Art	art	NN
46745	1458	5	.	.	.
46745	1459	1	Opium	opium	NN
46745	1459	2	.	.	.
46745	1459	3	_	_	NNP
46745	1459	4	)	)	-RRB-
46745	1459	5	Thus	thus	RB
46745	1459	6	we	-PRON-	PRP
46745	1459	7	have	have	VBP
46745	1459	8	concluded	conclude	VBN
46745	1459	9	the	the	DT
46745	1459	10	list	list	NN
46745	1459	11	of	of	IN
46745	1459	12	substances	substance	NNS
46745	1459	13	which	which	WDT
46745	1459	14	seem	seem	VBP
46745	1459	15	to	to	TO
46745	1459	16	act	act	VB
46745	1459	17	locally	locally	RB
46745	1459	18	on	on	IN
46745	1459	19	the	the	DT
46745	1459	20	mucous	mucous	JJ
46745	1459	21	surface	surface	NN
46745	1459	22	,	,	,
46745	1459	23	without	without	IN
46745	1459	24	passing	pass	VBG
46745	1459	25	into	into	IN
46745	1459	26	the	the	DT
46745	1459	27	blood	blood	NN
46745	1459	28	.	.	.
46745	1460	1	Having	have	VBG
46745	1460	2	previously	previously	RB
46745	1460	3	endeavoured	endeavour	VBN
46745	1460	4	to	to	TO
46745	1460	5	explain	explain	VB
46745	1460	6	the	the	DT
46745	1460	7	various	various	JJ
46745	1460	8	modes	mode	NNS
46745	1460	9	in	in	IN
46745	1460	10	which	which	WDT
46745	1460	11	medicines	medicine	NNS
46745	1460	12	are	be	VBP
46745	1460	13	absorbed	absorb	VBN
46745	1460	14	and	and	CC
46745	1460	15	pass	pass	VB
46745	1460	16	into	into	IN
46745	1460	17	the	the	DT
46745	1460	18	blood	blood	NN
46745	1460	19	,	,	,
46745	1460	20	and	and	CC
46745	1460	21	having	have	VBG
46745	1460	22	now	now	RB
46745	1460	23	defined	define	VBN
46745	1460	24	the	the	DT
46745	1460	25	action	action	NN
46745	1460	26	of	of	IN
46745	1460	27	some	some	DT
46745	1460	28	few	few	JJ
46745	1460	29	before	before	IN
46745	1460	30	absorption	absorption	NN
46745	1460	31	,	,	,
46745	1460	32	the	the	DT
46745	1460	33	greater	great	JJR
46745	1460	34	part	part	NN
46745	1460	35	of	of	IN
46745	1460	36	our	-PRON-	PRP$
46745	1460	37	investigation	investigation	NN
46745	1460	38	remains	remain	VBZ
46745	1460	39	still	still	RB
46745	1460	40	to	to	TO
46745	1460	41	be	be	VB
46745	1460	42	accomplished	accomplish	VBN
46745	1460	43	.	.	.
46745	1461	1	The	the	DT
46745	1461	2	actions	action	NNS
46745	1461	3	of	of	IN
46745	1461	4	medicines	medicine	NNS
46745	1461	5	in	in	IN
46745	1461	6	the	the	DT
46745	1461	7	blood	blood	NN
46745	1461	8	,	,	,
46745	1461	9	and	and	CC
46745	1461	10	their	-PRON-	PRP$
46745	1461	11	various	various	JJ
46745	1461	12	and	and	CC
46745	1461	13	complicated	complicated	JJ
46745	1461	14	operations	operation	NNS
46745	1461	15	in	in	IN
46745	1461	16	the	the	DT
46745	1461	17	cure	cure	NN
46745	1461	18	of	of	IN
46745	1461	19	diseases	disease	NNS
46745	1461	20	,	,	,
46745	1461	21	have	have	VBP
46745	1461	22	to	to	TO
46745	1461	23	be	be	VB
46745	1461	24	traced	trace	VBN
46745	1461	25	out	out	RP
46745	1461	26	,	,	,
46745	1461	27	and	and	CC
46745	1461	28	,	,	,
46745	1461	29	if	if	IN
46745	1461	30	possible	possible	JJ
46745	1461	31	,	,	,
46745	1461	32	accounted	account	VBD
46745	1461	33	for	for	IN
46745	1461	34	.	.	.
46745	1462	1	The	the	DT
46745	1462	2	remaining	remain	VBG
46745	1462	3	six	six	CD
46745	1462	4	Propositions	proposition	NNS
46745	1462	5	concern	concern	VBP
46745	1462	6	the	the	DT
46745	1462	7	behaviour	behaviour	NN
46745	1462	8	of	of	IN
46745	1462	9	medicines	medicine	NNS
46745	1462	10	after	after	IN
46745	1462	11	their	-PRON-	PRP$
46745	1462	12	passage	passage	NN
46745	1462	13	into	into	IN
46745	1462	14	the	the	DT
46745	1462	15	blood	blood	NN
46745	1462	16	.	.	.
46745	1463	1	The	the	DT
46745	1463	2	first	first	JJ
46745	1463	3	two	two	CD
46745	1463	4	of	of	IN
46745	1463	5	them	-PRON-	PRP
46745	1463	6	are	be	VBP
46745	1463	7	comparatively	comparatively	RB
46745	1463	8	unimportant	unimportant	JJ
46745	1463	9	.	.	.
46745	1464	1	The	the	DT
46745	1464	2	Fifth	Fifth	NNP
46745	1464	3	is	be	VBZ
46745	1464	4	merely	merely	RB
46745	1464	5	an	an	DT
46745	1464	6	extension	extension	NN
46745	1464	7	of	of	IN
46745	1464	8	the	the	DT
46745	1464	9	First	First	NNP
46745	1464	10	Proposition,--in	Proposition,--in	NNP
46745	1464	11	which	which	WDT
46745	1464	12	the	the	DT
46745	1464	13	same	same	JJ
46745	1464	14	rule	rule	NN
46745	1464	15	is	be	VBZ
46745	1464	16	applied	apply	VBN
46745	1464	17	to	to	IN
46745	1464	18	the	the	DT
46745	1464	19	blood	blood	NN
46745	1464	20	which	which	WDT
46745	1464	21	was	be	VBD
46745	1464	22	there	there	RB
46745	1464	23	proved	prove	VBN
46745	1464	24	of	of	IN
46745	1464	25	a	a	DT
46745	1464	26	surface,--and	surface,--and	NN
46745	1464	27	indeed	indeed	RB
46745	1464	28	follows	follow	VBZ
46745	1464	29	in	in	IN
46745	1464	30	part	part	NN
46745	1464	31	from	from	IN
46745	1464	32	the	the	DT
46745	1464	33	latter	latter	JJ
46745	1464	34	.	.	.
46745	1465	1	The	the	DT
46745	1465	2	Sixth	Sixth	NNP
46745	1465	3	Proposition	Proposition	NNP
46745	1465	4	defines	define	VBZ
46745	1465	5	three	three	CD
46745	1465	6	kinds	kind	NNS
46745	1465	7	of	of	IN
46745	1465	8	changes	change	NNS
46745	1465	9	which	which	WDT
46745	1465	10	certain	certain	JJ
46745	1465	11	medicines	medicine	NNS
46745	1465	12	are	be	VBP
46745	1465	13	liable	liable	JJ
46745	1465	14	to	to	TO
46745	1465	15	undergo	undergo	VB
46745	1465	16	during	during	IN
46745	1465	17	their	-PRON-	PRP$
46745	1465	18	stay	stay	NN
46745	1465	19	in	in	IN
46745	1465	20	the	the	DT
46745	1465	21	system	system	NN
46745	1465	22	.	.	.
46745	1466	1	PROP	PROP	NNP
46745	1466	2	.	.	.
46745	1467	1	V.--_That	v.--_that	IN
46745	1467	2	the	the	DT
46745	1467	3	medicine	medicine	NN
46745	1467	4	,	,	,
46745	1467	5	when	when	WRB
46745	1467	6	in	in	IN
46745	1467	7	the	the	DT
46745	1467	8	blood	blood	NN
46745	1467	9	,	,	,
46745	1467	10	must	must	MD
46745	1467	11	permeate	permeate	VB
46745	1467	12	the	the	DT
46745	1467	13	mass	mass	NN
46745	1467	14	of	of	IN
46745	1467	15	the	the	DT
46745	1467	16	circulation	circulation	NN
46745	1467	17	,	,	,
46745	1467	18	so	so	RB
46745	1467	19	far	far	RB
46745	1467	20	as	as	IN
46745	1467	21	may	may	MD
46745	1467	22	be	be	VB
46745	1467	23	required	require	VBN
46745	1467	24	to	to	TO
46745	1467	25	reach	reach	VB
46745	1467	26	the	the	DT
46745	1467	27	parts	part	NNS
46745	1467	28	on	on	IN
46745	1467	29	which	which	WDT
46745	1467	30	it	-PRON-	PRP
46745	1467	31	tends	tend	VBZ
46745	1467	32	to	to	TO
46745	1467	33	act	act	VB
46745	1467	34	.	.	.
46745	1467	35	_	_	NNP
46745	1467	36	_	_	NNP
46745	1467	37	That	that	IN
46745	1467	38	there	there	EX
46745	1467	39	are	be	VBP
46745	1467	40	two	two	CD
46745	1467	41	possible	possible	JJ
46745	1467	42	exceptions	exception	NNS
46745	1467	43	to	to	IN
46745	1467	44	this	this	DT
46745	1467	45	rule	rule	NN
46745	1467	46	:	:	:
46745	1467	47	_	_	NNP
46745	1467	48	_	_	NNP
46745	1467	49	a.	a.	NN
46745	1468	1	The	the	DT
46745	1468	2	production	production	NN
46745	1468	3	of	of	IN
46745	1468	4	sensation	sensation	NN
46745	1468	5	or	or	CC
46745	1468	6	pain	pain	NN
46745	1468	7	at	at	IN
46745	1468	8	a	a	DT
46745	1468	9	distant	distant	JJ
46745	1468	10	point	point	NN
46745	1468	11	.	.	.
46745	1468	12	_	_	NNP
46745	1468	13	_	_	NNP
46745	1468	14	b.	b.	NN
46745	1469	1	The	the	DT
46745	1469	2	production	production	NN
46745	1469	3	of	of	IN
46745	1469	4	muscular	muscular	JJ
46745	1469	5	contraction	contraction	NN
46745	1469	6	at	at	IN
46745	1469	7	a	a	DT
46745	1469	8	distant	distant	JJ
46745	1469	9	point	point	NN
46745	1469	10	.	.	.
46745	1469	11	_	_	NNP
46745	1469	12	We	-PRON-	PRP
46745	1469	13	might	may	MD
46745	1469	14	already	already	RB
46745	1469	15	have	have	VB
46745	1469	16	concluded	conclude	VBN
46745	1469	17	that	that	IN
46745	1469	18	,	,	,
46745	1469	19	as	as	IN
46745	1469	20	a	a	DT
46745	1469	21	general	general	JJ
46745	1469	22	rule	rule	NN
46745	1469	23	,	,	,
46745	1469	24	it	-PRON-	PRP
46745	1469	25	is	be	VBZ
46745	1469	26	impossible	impossible	JJ
46745	1469	27	for	for	IN
46745	1469	28	medicines	medicine	NNS
46745	1469	29	to	to	TO
46745	1469	30	exert	exert	VB
46745	1469	31	their	-PRON-	PRP$
46745	1469	32	primary	primary	JJ
46745	1469	33	action	action	NN
46745	1469	34	on	on	IN
46745	1469	35	a	a	DT
46745	1469	36	remote	remote	JJ
46745	1469	37	part	part	NN
46745	1469	38	by	by	IN
46745	1469	39	nervous	nervous	JJ
46745	1469	40	or	or	CC
46745	1469	41	any	any	DT
46745	1469	42	other	other	JJ
46745	1469	43	agency	agency	NN
46745	1469	44	,	,	,
46745	1469	45	but	but	CC
46745	1469	46	that	that	IN
46745	1469	47	they	-PRON-	PRP
46745	1469	48	must	must	MD
46745	1469	49	actually	actually	RB
46745	1469	50	reach	reach	VB
46745	1469	51	the	the	DT
46745	1469	52	part	part	NN
46745	1469	53	which	which	WDT
46745	1469	54	they	-PRON-	PRP
46745	1469	55	affect	affect	VBP
46745	1469	56	by	by	IN
46745	1469	57	means	mean	NNS
46745	1469	58	of	of	IN
46745	1469	59	the	the	DT
46745	1469	60	circulation	circulation	NN
46745	1469	61	.	.	.
46745	1470	1	The	the	DT
46745	1470	2	experiments	experiment	NNS
46745	1470	3	,	,	,
46745	1470	4	already	already	RB
46745	1470	5	quoted	quote	VBN
46745	1470	6	,	,	,
46745	1470	7	of	of	IN
46745	1470	8	Magendie	Magendie	NNP
46745	1470	9	,	,	,
46745	1470	10	Blake	Blake	NNP
46745	1470	11	,	,	,
46745	1470	12	Ehbert	Ehbert	NNP
46745	1470	13	,	,	,
46745	1470	14	and	and	CC
46745	1470	15	others	other	NNS
46745	1470	16	,	,	,
46745	1470	17	show	show	VBP
46745	1470	18	that	that	IN
46745	1470	19	even	even	RB
46745	1470	20	those	those	DT
46745	1470	21	medicines	medicine	NNS
46745	1470	22	and	and	CC
46745	1470	23	poisons	poison	NNS
46745	1470	24	which	which	WDT
46745	1470	25	tend	tend	VBP
46745	1470	26	most	most	RBS
46745	1470	27	powerfully	powerfully	RB
46745	1470	28	to	to	TO
46745	1470	29	influence	influence	VB
46745	1470	30	the	the	DT
46745	1470	31	nervous	nervous	JJ
46745	1470	32	centres	centre	NNS
46745	1470	33	,	,	,
46745	1470	34	can	can	MD
46745	1470	35	not	not	RB
46745	1470	36	act	act	VB
46745	1470	37	by	by	IN
46745	1470	38	nervous	nervous	JJ
46745	1470	39	connexion	connexion	NN
46745	1470	40	,	,	,
46745	1470	41	or	or	CC
46745	1470	42	without	without	IN
46745	1470	43	being	be	VBG
46745	1470	44	allowed	allow	VBN
46745	1470	45	to	to	TO
46745	1470	46	pass	pass	VB
46745	1470	47	on	on	RP
46745	1470	48	in	in	IN
46745	1470	49	the	the	DT
46745	1470	50	blood	blood	NN
46745	1470	51	.	.	.
46745	1471	1	They	-PRON-	PRP
46745	1471	2	must	must	MD
46745	1471	3	actually	actually	RB
46745	1471	4	reach	reach	VB
46745	1471	5	the	the	DT
46745	1471	6	brain	brain	NN
46745	1471	7	,	,	,
46745	1471	8	before	before	IN
46745	1471	9	they	-PRON-	PRP
46745	1471	10	can	can	MD
46745	1471	11	act	act	VB
46745	1471	12	upon	upon	IN
46745	1471	13	it	-PRON-	PRP
46745	1471	14	.	.	.
46745	1472	1	The	the	DT
46745	1472	2	circulation	circulation	NN
46745	1472	3	of	of	IN
46745	1472	4	the	the	DT
46745	1472	5	blood	blood	NN
46745	1472	6	is	be	VBZ
46745	1472	7	sufficiently	sufficiently	RB
46745	1472	8	quick	quick	JJ
46745	1472	9	to	to	TO
46745	1472	10	allow	allow	VB
46745	1472	11	of	of	IN
46745	1472	12	this	this	DT
46745	1472	13	.	.	.
46745	1473	1	The	the	DT
46745	1473	2	action	action	NN
46745	1473	3	of	of	IN
46745	1473	4	nerve	nerve	NN
46745	1473	5	-	-	HYPH
46745	1473	6	medicines	medicine	NNS
46745	1473	7	when	when	WRB
46745	1473	8	applied	apply	VBD
46745	1473	9	to	to	IN
46745	1473	10	a	a	DT
46745	1473	11	part	part	NN
46745	1473	12	,	,	,
46745	1473	13	being	be	VBG
46745	1473	14	similar	similar	JJ
46745	1473	15	to	to	IN
46745	1473	16	that	that	DT
46745	1473	17	which	which	WDT
46745	1473	18	follows	follow	VBZ
46745	1473	19	their	-PRON-	PRP$
46745	1473	20	absorption	absorption	NN
46745	1473	21	,	,	,
46745	1473	22	would	would	MD
46745	1473	23	alone	alone	RB
46745	1473	24	render	render	VB
46745	1473	25	it	-PRON-	PRP
46745	1473	26	highly	highly	RB
46745	1473	27	probable	probable	JJ
46745	1473	28	that	that	IN
46745	1473	29	in	in	IN
46745	1473	30	the	the	DT
46745	1473	31	latter	latter	JJ
46745	1473	32	case	case	NN
46745	1473	33	they	-PRON-	PRP
46745	1473	34	reached	reach	VBD
46745	1473	35	the	the	DT
46745	1473	36	part	part	NN
46745	1473	37	in	in	IN
46745	1473	38	the	the	DT
46745	1473	39	blood	blood	NN
46745	1473	40	.	.	.
46745	1474	1	Thus	thus	RB
46745	1474	2	Morphia	Morphia	NNP
46745	1474	3	,	,	,
46745	1474	4	Hydrocyanic	Hydrocyanic	NNP
46745	1474	5	Acid	Acid	NNP
46745	1474	6	,	,	,
46745	1474	7	Chloroform	Chloroform	NNP
46745	1474	8	,	,	,
46745	1474	9	and	and	CC
46745	1474	10	Aconite	Aconite	NNP
46745	1474	11	,	,	,
46745	1474	12	benumb	benumb	VBN
46745	1474	13	the	the	DT
46745	1474	14	superficial	superficial	JJ
46745	1474	15	nerves	nerve	NNS
46745	1474	16	:	:	:
46745	1474	17	Belladonna	Belladonna	NNP
46745	1474	18	dilates	dilate	VBZ
46745	1474	19	the	the	DT
46745	1474	20	pupil	pupil	NN
46745	1474	21	;	;	:
46745	1474	22	and	and	CC
46745	1474	23	Strychnia	Strychnia	NNP
46745	1474	24	augments	augment	VBZ
46745	1474	25	muscular	muscular	JJ
46745	1474	26	irritability	irritability	NN
46745	1474	27	;	;	:
46745	1474	28	whether	whether	CC
46745	1474	29	locally	locally	RB
46745	1474	30	applied	apply	VBN
46745	1474	31	,	,	,
46745	1474	32	or	or	CC
46745	1474	33	administered	administer	VBN
46745	1474	34	through	through	IN
46745	1474	35	the	the	DT
46745	1474	36	stomach	stomach	NN
46745	1474	37	.	.	.
46745	1475	1	Neurotic	neurotic	JJ
46745	1475	2	medicines	medicine	NNS
46745	1475	3	have	have	VBP
46745	1475	4	even	even	RB
46745	1475	5	been	be	VBN
46745	1475	6	detected	detect	VBN
46745	1475	7	after	after	IN
46745	1475	8	death	death	NN
46745	1475	9	in	in	IN
46745	1475	10	the	the	DT
46745	1475	11	parts	part	NNS
46745	1475	12	and	and	CC
46745	1475	13	organs	organ	NNS
46745	1475	14	which	which	WDT
46745	1475	15	they	-PRON-	PRP
46745	1475	16	influence	influence	VBP
46745	1475	17	.	.	.
46745	1476	1	Thus	thus	RB
46745	1476	2	Alcohol	Alcohol	NNP
46745	1476	3	has	have	VBZ
46745	1476	4	been	be	VBN
46745	1476	5	found	find	VBN
46745	1476	6	in	in	IN
46745	1476	7	the	the	DT
46745	1476	8	brain	brain	NN
46745	1476	9	,	,	,
46745	1476	10	and	and	CC
46745	1476	11	Lead	lead	NN
46745	1476	12	in	in	IN
46745	1476	13	the	the	DT
46745	1476	14	spinal	spinal	JJ
46745	1476	15	cord	cord	NN
46745	1476	16	and	and	CC
46745	1476	17	muscles	muscle	NNS
46745	1476	18	.	.	.
46745	1477	1	From	from	IN
46745	1477	2	these	these	DT
46745	1477	3	various	various	JJ
46745	1477	4	facts	fact	NNS
46745	1477	5	we	-PRON-	PRP
46745	1477	6	may	may	MD
46745	1477	7	conclude	conclude	VB
46745	1477	8	that	that	IN
46745	1477	9	however	however	RB
46745	1477	10	near	near	IN
46745	1477	11	these	these	DT
46745	1477	12	remedies	remedy	NNS
46745	1477	13	may	may	MD
46745	1477	14	be	be	VB
46745	1477	15	brought	bring	VBN
46745	1477	16	to	to	IN
46745	1477	17	that	that	DT
46745	1477	18	part	part	NN
46745	1477	19	of	of	IN
46745	1477	20	the	the	DT
46745	1477	21	nervous	nervous	JJ
46745	1477	22	system	system	NN
46745	1477	23	over	over	IN
46745	1477	24	which	which	WDT
46745	1477	25	their	-PRON-	PRP$
46745	1477	26	power	power	NN
46745	1477	27	extends	extend	VBZ
46745	1477	28	,	,	,
46745	1477	29	whether	whether	IN
46745	1477	30	it	-PRON-	PRP
46745	1477	31	be	be	VB
46745	1477	32	centre	centre	NN
46745	1477	33	or	or	CC
46745	1477	34	periphery	periphery	NN
46745	1477	35	,	,	,
46745	1477	36	they	-PRON-	PRP
46745	1477	37	do	do	VBP
46745	1477	38	not	not	RB
46745	1477	39	in	in	IN
46745	1477	40	general	general	JJ
46745	1477	41	affect	affect	VB
46745	1477	42	it	-PRON-	PRP
46745	1477	43	,	,	,
46745	1477	44	unless	unless	IN
46745	1477	45	they	-PRON-	PRP
46745	1477	46	are	be	VBP
46745	1477	47	allowed	allow	VBN
46745	1477	48	to	to	TO
46745	1477	49	reach	reach	VB
46745	1477	50	it	-PRON-	PRP
46745	1477	51	.	.	.
46745	1478	1	And	and	CC
46745	1478	2	what	what	WP
46745	1478	3	is	be	VBZ
46745	1478	4	proved	prove	VBN
46745	1478	5	of	of	IN
46745	1478	6	nerve	nerve	NN
46745	1478	7	-	-	HYPH
46745	1478	8	medicines	medicines	NNP
46745	1478	9	holds	hold	VBZ
46745	1478	10	good	good	JJ
46745	1478	11	still	still	RB
46745	1478	12	more	more	RBR
46745	1478	13	obviously	obviously	RB
46745	1478	14	with	with	IN
46745	1478	15	medicines	medicine	NNS
46745	1478	16	that	that	WDT
46745	1478	17	act	act	VBP
46745	1478	18	on	on	IN
46745	1478	19	the	the	DT
46745	1478	20	blood	blood	NN
46745	1478	21	,	,	,
46745	1478	22	and	and	CC
46745	1478	23	on	on	IN
46745	1478	24	blood	blood	NN
46745	1478	25	disorders	disorder	NNS
46745	1478	26	.	.	.
46745	1479	1	Nearly	nearly	RB
46745	1479	2	all	all	DT
46745	1479	3	of	of	IN
46745	1479	4	these	these	DT
46745	1479	5	have	have	VBP
46745	1479	6	been	be	VBN
46745	1479	7	found	find	VBN
46745	1479	8	to	to	TO
46745	1479	9	exist	exist	VB
46745	1479	10	in	in	IN
46745	1479	11	the	the	DT
46745	1479	12	blood	blood	NN
46745	1479	13	,	,	,
46745	1479	14	and	and	CC
46745	1479	15	to	to	TO
46745	1479	16	pervade	pervade	VB
46745	1479	17	the	the	DT
46745	1479	18	whole	whole	JJ
46745	1479	19	mass	mass	NN
46745	1479	20	of	of	IN
46745	1479	21	the	the	DT
46745	1479	22	circulation	circulation	NN
46745	1479	23	,	,	,
46745	1479	24	wherever	wherever	WRB
46745	1479	25	at	at	IN
46745	1479	26	first	first	RB
46745	1479	27	introduced	introduce	VBN
46745	1479	28	.	.	.
46745	1480	1	The	the	DT
46745	1480	2	glands	gland	NNS
46745	1480	3	of	of	IN
46745	1480	4	the	the	DT
46745	1480	5	body	body	NN
46745	1480	6	form	form	NN
46745	1480	7	a	a	DT
46745	1480	8	third	third	JJ
46745	1480	9	case	case	NN
46745	1480	10	in	in	IN
46745	1480	11	which	which	WDT
46745	1480	12	we	-PRON-	PRP
46745	1480	13	require	require	VBP
46745	1480	14	proof	proof	NN
46745	1480	15	of	of	IN
46745	1480	16	actual	actual	JJ
46745	1480	17	local	local	JJ
46745	1480	18	access	access	NN
46745	1480	19	.	.	.
46745	1481	1	This	this	DT
46745	1481	2	matter	matter	NN
46745	1481	3	will	will	MD
46745	1481	4	be	be	VB
46745	1481	5	discussed	discuss	VBN
46745	1481	6	when	when	WRB
46745	1481	7	we	-PRON-	PRP
46745	1481	8	have	have	VBP
46745	1481	9	to	to	TO
46745	1481	10	consider	consider	VB
46745	1481	11	the	the	DT
46745	1481	12	subject	subject	NN
46745	1481	13	of	of	IN
46745	1481	14	Eliminative	eliminative	JJ
46745	1481	15	medicines	medicine	NNS
46745	1481	16	,	,	,
46745	1481	17	when	when	WRB
46745	1481	18	I	-PRON-	PRP
46745	1481	19	shall	shall	MD
46745	1481	20	attempt	attempt	VB
46745	1481	21	to	to	TO
46745	1481	22	show	show	VB
46745	1481	23	that	that	IN
46745	1481	24	the	the	DT
46745	1481	25	majority	majority	NN
46745	1481	26	of	of	IN
46745	1481	27	those	those	DT
46745	1481	28	medicines	medicine	NNS
46745	1481	29	actually	actually	RB
46745	1481	30	pass	pass	VBP
46745	1481	31	through	through	RB
46745	1481	32	and	and	CC
46745	1481	33	are	be	VBP
46745	1481	34	excreted	excrete	VBN
46745	1481	35	by	by	IN
46745	1481	36	the	the	DT
46745	1481	37	glands	gland	NNS
46745	1481	38	which	which	WDT
46745	1481	39	they	-PRON-	PRP
46745	1481	40	affect	affect	VBP
46745	1481	41	.	.	.
46745	1482	1	When	when	WRB
46745	1482	2	Mercury	Mercury	NNP
46745	1482	3	is	be	VBZ
46745	1482	4	chemically	chemically	RB
46745	1482	5	detected	detect	VBN
46745	1482	6	in	in	IN
46745	1482	7	the	the	DT
46745	1482	8	secretions	secretion	NNS
46745	1482	9	of	of	IN
46745	1482	10	the	the	DT
46745	1482	11	liver	liver	NN
46745	1482	12	and	and	CC
46745	1482	13	bowels	bowel	NNS
46745	1482	14	;	;	:
46745	1482	15	Sulphur	Sulphur	NNP
46745	1482	16	in	in	IN
46745	1482	17	that	that	DT
46745	1482	18	of	of	IN
46745	1482	19	the	the	DT
46745	1482	20	skin	skin	NN
46745	1482	21	;	;	:
46745	1482	22	Turpentine	Turpentine	NNP
46745	1482	23	and	and	CC
46745	1482	24	Copaiba	Copaiba	NNP
46745	1482	25	in	in	IN
46745	1482	26	that	that	DT
46745	1482	27	of	of	IN
46745	1482	28	the	the	DT
46745	1482	29	kidneys	kidney	NNS
46745	1482	30	;	;	:
46745	1482	31	it	-PRON-	PRP
46745	1482	32	is	be	VBZ
46745	1482	33	evident	evident	JJ
46745	1482	34	that	that	IN
46745	1482	35	these	these	DT
46745	1482	36	substances	substance	NNS
46745	1482	37	must	must	MD
46745	1482	38	have	have	VB
46745	1482	39	reached	reach	VBN
46745	1482	40	bodily	bodily	RB
46745	1482	41	the	the	DT
46745	1482	42	glandular	glandular	JJ
46745	1482	43	organs	organ	NNS
46745	1482	44	to	to	TO
46745	1482	45	which	which	WDT
46745	1482	46	their	-PRON-	PRP$
46745	1482	47	action	action	NN
46745	1482	48	is	be	VBZ
46745	1482	49	directed	direct	VBN
46745	1482	50	.	.	.
46745	1483	1	Astringents	astringent	NNS
46745	1483	2	are	be	VBP
46745	1483	3	medicines	medicine	NNS
46745	1483	4	which	which	WDT
46745	1483	5	from	from	IN
46745	1483	6	the	the	DT
46745	1483	7	very	very	JJ
46745	1483	8	nature	nature	NN
46745	1483	9	of	of	IN
46745	1483	10	their	-PRON-	PRP$
46745	1483	11	action	action	NN
46745	1483	12	--	--	:
46745	1483	13	apparently	apparently	RB
46745	1483	14	a	a	DT
46745	1483	15	chemical	chemical	NN
46745	1483	16	one	one	CD
46745	1483	17	--	--	:
46745	1483	18	cannot	cannot	NN
46745	1483	19	operate	operate	VBP
46745	1483	20	at	at	RB
46745	1483	21	all	all	RB
46745	1483	22	without	without	IN
46745	1483	23	touching	touch	VBG
46745	1483	24	the	the	DT
46745	1483	25	muscular	muscular	JJ
46745	1483	26	fibre	fibre	NN
46745	1483	27	,	,	,
46745	1483	28	which	which	WDT
46745	1483	29	they	-PRON-	PRP
46745	1483	30	cause	cause	VBP
46745	1483	31	to	to	TO
46745	1483	32	become	become	VB
46745	1483	33	contracted	contract	VBN
46745	1483	34	.	.	.
46745	1484	1	But	but	CC
46745	1484	2	in	in	IN
46745	1484	3	laying	lay	VBG
46745	1484	4	down	down	RP
46745	1484	5	this	this	DT
46745	1484	6	rule	rule	NN
46745	1484	7	of	of	IN
46745	1484	8	the	the	DT
46745	1484	9	necessity	necessity	NN
46745	1484	10	of	of	IN
46745	1484	11	local	local	JJ
46745	1484	12	access	access	NN
46745	1484	13	for	for	IN
46745	1484	14	the	the	DT
46745	1484	15	production	production	NN
46745	1484	16	of	of	IN
46745	1484	17	the	the	DT
46745	1484	18	primary[30	primary[30	NN
46745	1484	19	]	]	-RRB-
46745	1484	20	effect	effect	NN
46745	1484	21	of	of	IN
46745	1484	22	a	a	DT
46745	1484	23	medicine	medicine	NN
46745	1484	24	,	,	,
46745	1484	25	we	-PRON-	PRP
46745	1484	26	must	must	MD
46745	1484	27	be	be	VB
46745	1484	28	careful	careful	JJ
46745	1484	29	that	that	IN
46745	1484	30	we	-PRON-	PRP
46745	1484	31	do	do	VBP
46745	1484	32	not	not	RB
46745	1484	33	make	make	VB
46745	1484	34	it	-PRON-	PRP
46745	1484	35	too	too	RB
46745	1484	36	absolute	absolute	JJ
46745	1484	37	.	.	.
46745	1485	1	In	in	IN
46745	1485	2	saying	say	VBG
46745	1485	3	that	that	IN
46745	1485	4	no	no	DT
46745	1485	5	action	action	NN
46745	1485	6	at	at	RB
46745	1485	7	all	all	RB
46745	1485	8	can	can	MD
46745	1485	9	be	be	VB
46745	1485	10	propagated	propagate	VBN
46745	1485	11	by	by	IN
46745	1485	12	the	the	DT
46745	1485	13	agency	agency	NN
46745	1485	14	of	of	IN
46745	1485	15	the	the	DT
46745	1485	16	nervous	nervous	JJ
46745	1485	17	system	system	NN
46745	1485	18	,	,	,
46745	1485	19	we	-PRON-	PRP
46745	1485	20	do	do	VBP
46745	1485	21	not	not	RB
46745	1485	22	make	make	VB
46745	1485	23	proper	proper	JJ
46745	1485	24	allowance	allowance	NN
46745	1485	25	for	for	IN
46745	1485	26	the	the	DT
46745	1485	27	vital	vital	JJ
46745	1485	28	properties	property	NNS
46745	1485	29	of	of	IN
46745	1485	30	nerve	nerve	NN
46745	1485	31	-	-	HYPH
46745	1485	32	fibre	fibre	NN
46745	1485	33	.	.	.
46745	1486	1	The	the	DT
46745	1486	2	vital	vital	JJ
46745	1486	3	nature	nature	NN
46745	1486	4	of	of	IN
46745	1486	5	common	common	JJ
46745	1486	6	nerve	nerve	NN
46745	1486	7	-	-	HYPH
46745	1486	8	fibre	fibre	NN
46745	1486	9	is	be	VBZ
46745	1486	10	such	such	JJ
46745	1486	11	that	that	IN
46745	1486	12	two	two	CD
46745	1486	13	actions	action	NNS
46745	1486	14	can	can	MD
46745	1486	15	be	be	VB
46745	1486	16	conducted	conduct	VBN
46745	1486	17	along	along	IN
46745	1486	18	it;--an	it;--an	NNP
46745	1486	19	impulse	impulse	NN
46745	1486	20	producing	produce	VBG
46745	1486	21	sensation	sensation	NN
46745	1486	22	,	,	,
46745	1486	23	or	or	CC
46745	1486	24	an	an	DT
46745	1486	25	impulse	impulse	NN
46745	1486	26	producing	produce	VBG
46745	1486	27	muscular	muscular	JJ
46745	1486	28	action	action	NN
46745	1486	29	,	,	,
46745	1486	30	at	at	IN
46745	1486	31	a	a	DT
46745	1486	32	distant	distant	JJ
46745	1486	33	point	point	NN
46745	1486	34	.	.	.
46745	1487	1	It	-PRON-	PRP
46745	1487	2	is	be	VBZ
46745	1487	3	known	know	VBN
46745	1487	4	that	that	IN
46745	1487	5	an	an	DT
46745	1487	6	impression	impression	NN
46745	1487	7	on	on	IN
46745	1487	8	the	the	DT
46745	1487	9	terminal	terminal	JJ
46745	1487	10	extremity	extremity	NN
46745	1487	11	of	of	IN
46745	1487	12	a	a	DT
46745	1487	13	sensory	sensory	JJ
46745	1487	14	nerve	nerve	NN
46745	1487	15	is	be	VBZ
46745	1487	16	capable	capable	JJ
46745	1487	17	of	of	IN
46745	1487	18	producing	produce	VBG
46745	1487	19	either	either	DT
46745	1487	20	sensation	sensation	NN
46745	1487	21	or	or	CC
46745	1487	22	motion	motion	NN
46745	1487	23	at	at	IN
46745	1487	24	a	a	DT
46745	1487	25	distance	distance	NN
46745	1487	26	,	,	,
46745	1487	27	by	by	IN
46745	1487	28	what	what	WP
46745	1487	29	is	be	VBZ
46745	1487	30	called	call	VBN
46745	1487	31	_	_	NNP
46745	1487	32	reflex	reflex	NN
46745	1487	33	nervous	nervous	JJ
46745	1487	34	action	action	NN
46745	1487	35	_	_	NNP
46745	1487	36	.	.	.
46745	1488	1	Though	though	IN
46745	1488	2	this	this	DT
46745	1488	3	impression	impression	NN
46745	1488	4	must	must	MD
46745	1488	5	pass	pass	VB
46745	1488	6	through	through	IN
46745	1488	7	the	the	DT
46745	1488	8	brain	brain	NN
46745	1488	9	or	or	CC
46745	1488	10	spinal	spinal	JJ
46745	1488	11	cord	cord	NN
46745	1488	12	,	,	,
46745	1488	13	yet	yet	CC
46745	1488	14	these	these	DT
46745	1488	15	centres	centre	NNS
46745	1488	16	are	be	VBP
46745	1488	17	not	not	RB
46745	1488	18	appreciably	appreciably	RB
46745	1488	19	affected	affect	VBN
46745	1488	20	by	by	IN
46745	1488	21	it	-PRON-	PRP
46745	1488	22	.	.	.
46745	1489	1	Now	now	RB
46745	1489	2	it	-PRON-	PRP
46745	1489	3	is	be	VBZ
46745	1489	4	possible	possible	JJ
46745	1489	5	,	,	,
46745	1489	6	though	though	IN
46745	1489	7	it	-PRON-	PRP
46745	1489	8	does	do	VBZ
46745	1489	9	not	not	RB
46745	1489	10	often	often	RB
46745	1489	11	happen	happen	VB
46745	1489	12	,	,	,
46745	1489	13	that	that	IN
46745	1489	14	the	the	DT
46745	1489	15	action	action	NN
46745	1489	16	of	of	IN
46745	1489	17	a	a	DT
46745	1489	18	medicine	medicine	NN
46745	1489	19	on	on	IN
46745	1489	20	the	the	DT
46745	1489	21	extremity	extremity	NN
46745	1489	22	of	of	IN
46745	1489	23	a	a	DT
46745	1489	24	nerve	nerve	NN
46745	1489	25	may	may	MD
46745	1489	26	cause	cause	VB
46745	1489	27	this	this	DT
46745	1489	28	distant	distant	JJ
46745	1489	29	action	action	NN
46745	1489	30	,	,	,
46745	1489	31	without	without	IN
46745	1489	32	reaching	reach	VBG
46745	1489	33	the	the	DT
46745	1489	34	part	part	NN
46745	1489	35	at	at	IN
46745	1489	36	which	which	WDT
46745	1489	37	it	-PRON-	PRP
46745	1489	38	is	be	VBZ
46745	1489	39	manifested	manifest	VBN
46745	1489	40	.	.	.
46745	1490	1	It	-PRON-	PRP
46745	1490	2	may	may	MD
46745	1490	3	be	be	VB
46745	1490	4	positively	positively	RB
46745	1490	5	affirmed	affirm	VBN
46745	1490	6	that	that	IN
46745	1490	7	in	in	IN
46745	1490	8	no	no	DT
46745	1490	9	other	other	JJ
46745	1490	10	case	case	NN
46745	1490	11	can	can	MD
46745	1490	12	the	the	DT
46745	1490	13	direct	direct	JJ
46745	1490	14	action	action	NN
46745	1490	15	of	of	IN
46745	1490	16	a	a	DT
46745	1490	17	medicine	medicine	NN
46745	1490	18	be	be	VB
46745	1490	19	conducted	conduct	VBN
46745	1490	20	along	along	IN
46745	1490	21	a	a	DT
46745	1490	22	nerve	nerve	NN
46745	1490	23	.	.	.
46745	1491	1	Having	have	VBG
46745	1491	2	made	make	VBN
46745	1491	3	allowance	allowance	NN
46745	1491	4	for	for	IN
46745	1491	5	the	the	DT
46745	1491	6	physiological	physiological	JJ
46745	1491	7	characters	character	NNS
46745	1491	8	of	of	IN
46745	1491	9	nerve	nerve	NN
46745	1491	10	,	,	,
46745	1491	11	we	-PRON-	PRP
46745	1491	12	must	must	MD
46745	1491	13	also	also	RB
46745	1491	14	take	take	VB
46745	1491	15	notice	notice	NN
46745	1491	16	of	of	IN
46745	1491	17	the	the	DT
46745	1491	18	vital	vital	JJ
46745	1491	19	properties	property	NNS
46745	1491	20	of	of	IN
46745	1491	21	muscular	muscular	JJ
46745	1491	22	fibre	fibre	NN
46745	1491	23	.	.	.
46745	1492	1	We	-PRON-	PRP
46745	1492	2	sometimes	sometimes	RB
46745	1492	3	find	find	VBP
46745	1492	4	,	,	,
46745	1492	5	especially	especially	RB
46745	1492	6	in	in	IN
46745	1492	7	the	the	DT
46745	1492	8	case	case	NN
46745	1492	9	of	of	IN
46745	1492	10	unstriped	unstriped	JJ
46745	1492	11	muscle	muscle	NN
46745	1492	12	,	,	,
46745	1492	13	that	that	IN
46745	1492	14	when	when	WRB
46745	1492	15	one	one	CD
46745	1492	16	part	part	NN
46745	1492	17	of	of	IN
46745	1492	18	a	a	DT
46745	1492	19	muscular	muscular	JJ
46745	1492	20	organ	organ	NN
46745	1492	21	is	be	VBZ
46745	1492	22	caused	cause	VBN
46745	1492	23	to	to	TO
46745	1492	24	contract	contract	VB
46745	1492	25	,	,	,
46745	1492	26	a	a	DT
46745	1492	27	wave	wave	NN
46745	1492	28	of	of	IN
46745	1492	29	contraction	contraction	NN
46745	1492	30	is	be	VBZ
46745	1492	31	propagated	propagate	VBN
46745	1492	32	along	along	IN
46745	1492	33	the	the	DT
46745	1492	34	fibres	fibre	NNS
46745	1492	35	;	;	:
46745	1492	36	and	and	CC
46745	1492	37	this	this	DT
46745	1492	38	action	action	NN
46745	1492	39	may	may	MD
46745	1492	40	even	even	RB
46745	1492	41	be	be	VB
46745	1492	42	extended	extend	VBN
46745	1492	43	to	to	IN
46745	1492	44	a	a	DT
46745	1492	45	neighbouring	neighbour	VBG
46745	1492	46	muscle	muscle	NN
46745	1492	47	,	,	,
46745	1492	48	either	either	CC
46745	1492	49	by	by	IN
46745	1492	50	contact	contact	NN
46745	1492	51	or	or	CC
46745	1492	52	sympathy	sympathy	NN
46745	1492	53	.	.	.
46745	1493	1	In	in	IN
46745	1493	2	one	one	CD
46745	1493	3	or	or	CC
46745	1493	4	two	two	CD
46745	1493	5	cases	case	NNS
46745	1493	6	it	-PRON-	PRP
46745	1493	7	seems	seem	VBZ
46745	1493	8	that	that	IN
46745	1493	9	muscular	muscular	JJ
46745	1493	10	contraction	contraction	NN
46745	1493	11	may	may	MD
46745	1493	12	occur	occur	VB
46745	1493	13	in	in	IN
46745	1493	14	this	this	DT
46745	1493	15	way	way	NN
46745	1493	16	as	as	IN
46745	1493	17	the	the	DT
46745	1493	18	result	result	NN
46745	1493	19	of	of	IN
46745	1493	20	the	the	DT
46745	1493	21	action	action	NN
46745	1493	22	of	of	IN
46745	1493	23	a	a	DT
46745	1493	24	medicine	medicine	NN
46745	1493	25	.	.	.
46745	1494	1	We	-PRON-	PRP
46745	1494	2	will	will	MD
46745	1494	3	now	now	RB
46745	1494	4	consider	consider	VB
46745	1494	5	separately	separately	RB
46745	1494	6	the	the	DT
46745	1494	7	two	two	CD
46745	1494	8	exceptional	exceptional	JJ
46745	1494	9	cases	case	NNS
46745	1494	10	.	.	.
46745	1495	1	_	_	NNP
46745	1495	2	a.	a.	NN
46745	1495	3	_	_	NNP
46745	1495	4	_	_	NNP
46745	1495	5	A	a	DT
46745	1495	6	medicine	medicine	NN
46745	1495	7	may	may	MD
46745	1495	8	occasionally	occasionally	RB
46745	1495	9	produce	produce	VB
46745	1495	10	pain	pain	NN
46745	1495	11	or	or	CC
46745	1495	12	sensation	sensation	NN
46745	1495	13	at	at	IN
46745	1495	14	a	a	DT
46745	1495	15	distant	distant	JJ
46745	1495	16	part	part	NN
46745	1495	17	,	,	,
46745	1495	18	without	without	IN
46745	1495	19	reaching	reach	VBG
46745	1495	20	that	that	DT
46745	1495	21	part	part	NN
46745	1495	22	.	.	.
46745	1495	23	_	_	NNP
46745	1495	24	We	-PRON-	PRP
46745	1495	25	often	often	RB
46745	1495	26	find	find	VBP
46745	1495	27	that	that	IN
46745	1495	28	a	a	DT
46745	1495	29	morbid	morbid	NN
46745	1495	30	action	action	NN
46745	1495	31	at	at	IN
46745	1495	32	one	one	CD
46745	1495	33	part	part	NN
46745	1495	34	of	of	IN
46745	1495	35	the	the	DT
46745	1495	36	body	body	NN
46745	1495	37	is	be	VBZ
46745	1495	38	capable	capable	JJ
46745	1495	39	of	of	IN
46745	1495	40	producing	produce	VBG
46745	1495	41	pain	pain	NN
46745	1495	42	or	or	CC
46745	1495	43	uneasiness	uneasiness	NN
46745	1495	44	at	at	IN
46745	1495	45	another	another	DT
46745	1495	46	distant	distant	JJ
46745	1495	47	part	part	NN
46745	1495	48	by	by	IN
46745	1495	49	a	a	DT
46745	1495	50	reflex	reflex	JJ
46745	1495	51	nervous	nervous	JJ
46745	1495	52	action	action	NN
46745	1495	53	.	.	.
46745	1496	1	We	-PRON-	PRP
46745	1496	2	are	be	VBP
46745	1496	3	familiar	familiar	JJ
46745	1496	4	with	with	IN
46745	1496	5	instances	instance	NNS
46745	1496	6	of	of	IN
46745	1496	7	this	this	DT
46745	1496	8	among	among	IN
46745	1496	9	the	the	DT
46745	1496	10	symptoms	symptom	NNS
46745	1496	11	of	of	IN
46745	1496	12	disease	disease	NN
46745	1496	13	.	.	.
46745	1497	1	The	the	DT
46745	1497	2	pain	pain	NN
46745	1497	3	in	in	IN
46745	1497	4	the	the	DT
46745	1497	5	knee	knee	NN
46745	1497	6	which	which	WDT
46745	1497	7	occurs	occur	VBZ
46745	1497	8	in	in	IN
46745	1497	9	disease	disease	NN
46745	1497	10	of	of	IN
46745	1497	11	the	the	DT
46745	1497	12	hip	hip	NN
46745	1497	13	-	-	HYPH
46745	1497	14	joint	joint	NN
46745	1497	15	;	;	:
46745	1497	16	in	in	IN
46745	1497	17	the	the	DT
46745	1497	18	left	left	JJ
46745	1497	19	arm	arm	NN
46745	1497	20	,	,	,
46745	1497	21	in	in	IN
46745	1497	22	some	some	DT
46745	1497	23	cases	case	NNS
46745	1497	24	of	of	IN
46745	1497	25	heart	heart	NN
46745	1497	26	disease	disease	NN
46745	1497	27	;	;	:
46745	1497	28	and	and	CC
46745	1497	29	in	in	IN
46745	1497	30	the	the	DT
46745	1497	31	right	right	JJ
46745	1497	32	shoulder	shoulder	NN
46745	1497	33	,	,	,
46745	1497	34	in	in	IN
46745	1497	35	disorders	disorder	NNS
46745	1497	36	of	of	IN
46745	1497	37	the	the	DT
46745	1497	38	liver	liver	NN
46745	1497	39	;	;	:
46745	1497	40	are	be	VBP
46745	1497	41	examples	example	NNS
46745	1497	42	.	.	.
46745	1498	1	Certain	certain	JJ
46745	1498	2	impressions	impression	NNS
46745	1498	3	on	on	IN
46745	1498	4	the	the	DT
46745	1498	5	surface	surface	NN
46745	1498	6	of	of	IN
46745	1498	7	the	the	DT
46745	1498	8	stomach	stomach	NN
46745	1498	9	may	may	MD
46745	1498	10	cause	cause	VB
46745	1498	11	such	such	PDT
46745	1498	12	a	a	DT
46745	1498	13	reflex	reflex	JJ
46745	1498	14	pain	pain	NN
46745	1498	15	.	.	.
46745	1499	1	Swallowing	swallow	VBG
46745	1499	2	a	a	DT
46745	1499	3	piece	piece	NN
46745	1499	4	of	of	IN
46745	1499	5	ice	ice	NN
46745	1499	6	will	will	MD
46745	1499	7	sometimes	sometimes	RB
46745	1499	8	produce	produce	VB
46745	1499	9	pain	pain	NN
46745	1499	10	over	over	IN
46745	1499	11	the	the	DT
46745	1499	12	brow	brow	NN
46745	1499	13	;	;	:
46745	1499	14	and	and	CC
46745	1499	15	it	-PRON-	PRP
46745	1499	16	is	be	VBZ
46745	1499	17	likely	likely	JJ
46745	1499	18	that	that	IN
46745	1499	19	the	the	DT
46745	1499	20	headache	headache	NN
46745	1499	21	which	which	WDT
46745	1499	22	follows	follow	VBZ
46745	1499	23	over	over	RB
46745	1499	24	-	-	HYPH
46745	1499	25	eating	eat	VBG
46745	1499	26	,	,	,
46745	1499	27	or	or	CC
46745	1499	28	a	a	DT
46745	1499	29	large	large	JJ
46745	1499	30	dose	dose	NN
46745	1499	31	of	of	IN
46745	1499	32	a	a	DT
46745	1499	33	tonic	tonic	NN
46745	1499	34	medicine	medicine	NN
46745	1499	35	,	,	,
46745	1499	36	may	may	MD
46745	1499	37	result	result	VB
46745	1499	38	in	in	IN
46745	1499	39	a	a	DT
46745	1499	40	similar	similar	JJ
46745	1499	41	way	way	NN
46745	1499	42	from	from	IN
46745	1499	43	mere	mere	JJ
46745	1499	44	irritation	irritation	NN
46745	1499	45	of	of	IN
46745	1499	46	the	the	DT
46745	1499	47	stomach	stomach	NN
46745	1499	48	.	.	.
46745	1500	1	Any	any	DT
46745	1500	2	irritant	irritant	NN
46745	1500	3	,	,	,
46745	1500	4	as	as	IN
46745	1500	5	a	a	DT
46745	1500	6	solution	solution	NN
46745	1500	7	of	of	IN
46745	1500	8	Iron	Iron	NNP
46745	1500	9	,	,	,
46745	1500	10	Arsenic	Arsenic	NNP
46745	1500	11	,	,	,
46745	1500	12	or	or	CC
46745	1500	13	Zinc	Zinc	NNP
46745	1500	14	,	,	,
46745	1500	15	will	will	MD
46745	1500	16	do	do	VB
46745	1500	17	the	the	DT
46745	1500	18	same	same	JJ
46745	1500	19	.	.	.
46745	1501	1	The	the	DT
46745	1501	2	action	action	NN
46745	1501	3	of	of	IN
46745	1501	4	a	a	DT
46745	1501	5	violent	violent	JJ
46745	1501	6	purgative	purgative	NN
46745	1501	7	will	will	MD
46745	1501	8	cause	cause	VB
46745	1501	9	headache	headache	NN
46745	1501	10	while	while	IN
46745	1501	11	it	-PRON-	PRP
46745	1501	12	lasts	last	VBZ
46745	1501	13	.	.	.
46745	1502	1	Although	although	IN
46745	1502	2	we	-PRON-	PRP
46745	1502	3	can	can	MD
46745	1502	4	not	not	RB
46745	1502	5	deny	deny	VB
46745	1502	6	the	the	DT
46745	1502	7	possibility	possibility	NN
46745	1502	8	of	of	IN
46745	1502	9	other	other	JJ
46745	1502	10	actions	action	NNS
46745	1502	11	of	of	IN
46745	1502	12	the	the	DT
46745	1502	13	same	same	JJ
46745	1502	14	kind	kind	NN
46745	1502	15	,	,	,
46745	1502	16	yet	yet	CC
46745	1502	17	there	there	EX
46745	1502	18	are	be	VBP
46745	1502	19	so	so	RB
46745	1502	20	few	few	JJ
46745	1502	21	medicines	medicine	NNS
46745	1502	22	which	which	WDT
46745	1502	23	,	,	,
46745	1502	24	in	in	IN
46745	1502	25	ordinary	ordinary	JJ
46745	1502	26	and	and	CC
46745	1502	27	safe	safe	JJ
46745	1502	28	doses	dose	NNS
46745	1502	29	,	,	,
46745	1502	30	are	be	VBP
46745	1502	31	capable	capable	JJ
46745	1502	32	of	of	IN
46745	1502	33	producing	produce	VBG
46745	1502	34	pain	pain	NN
46745	1502	35	in	in	IN
46745	1502	36	any	any	DT
46745	1502	37	way	way	NN
46745	1502	38	,	,	,
46745	1502	39	that	that	IN
46745	1502	40	it	-PRON-	PRP
46745	1502	41	becomes	become	VBZ
46745	1502	42	difficult	difficult	JJ
46745	1502	43	or	or	CC
46745	1502	44	impossible	impossible	JJ
46745	1502	45	to	to	TO
46745	1502	46	adduce	adduce	VB
46745	1502	47	a	a	DT
46745	1502	48	satisfactory	satisfactory	JJ
46745	1502	49	example	example	NN
46745	1502	50	of	of	IN
46745	1502	51	an	an	DT
46745	1502	52	agent	agent	NN
46745	1502	53	which	which	WDT
46745	1502	54	operates	operate	VBZ
46745	1502	55	on	on	IN
46745	1502	56	distant	distant	JJ
46745	1502	57	parts	part	NNS
46745	1502	58	in	in	IN
46745	1502	59	this	this	DT
46745	1502	60	manner	manner	NN
46745	1502	61	when	when	WRB
46745	1502	62	in	in	IN
46745	1502	63	the	the	DT
46745	1502	64	blood	blood	NN
46745	1502	65	.	.	.
46745	1503	1	_	_	NNP
46745	1503	2	b.	b.	NNP
46745	1503	3	_	_	NNP
46745	1503	4	_	_	NNP
46745	1503	5	A	a	DT
46745	1503	6	medicine	medicine	NN
46745	1503	7	may	may	MD
46745	1503	8	occasionally	occasionally	RB
46745	1503	9	produce	produce	VB
46745	1503	10	muscular	muscular	JJ
46745	1503	11	contraction	contraction	NN
46745	1503	12	at	at	IN
46745	1503	13	a	a	DT
46745	1503	14	distant	distant	JJ
46745	1503	15	part	part	NN
46745	1503	16	,	,	,
46745	1503	17	without	without	IN
46745	1503	18	reaching	reach	VBG
46745	1503	19	that	that	DT
46745	1503	20	part	part	NN
46745	1503	21	.	.	.
46745	1503	22	_	_	NNP
46745	1503	23	This	this	DT
46745	1503	24	may	may	MD
46745	1503	25	be	be	VB
46745	1503	26	done	do	VBN
46745	1503	27	in	in	IN
46745	1503	28	two	two	CD
46745	1503	29	ways	way	NNS
46745	1503	30	;	;	:
46745	1503	31	either	either	CC
46745	1503	32	by	by	IN
46745	1503	33	a	a	DT
46745	1503	34	reflex	reflex	JJ
46745	1503	35	nervous	nervous	JJ
46745	1503	36	action	action	NN
46745	1503	37	,	,	,
46745	1503	38	or	or	CC
46745	1503	39	by	by	IN
46745	1503	40	a	a	DT
46745	1503	41	propagation	propagation	NN
46745	1503	42	of	of	IN
46745	1503	43	the	the	DT
46745	1503	44	contraction	contraction	NN
46745	1503	45	from	from	IN
46745	1503	46	one	one	CD
46745	1503	47	muscle	muscle	NN
46745	1503	48	to	to	IN
46745	1503	49	another	another	DT
46745	1503	50	in	in	IN
46745	1503	51	its	-PRON-	PRP$
46745	1503	52	neighbourhood	neighbourhood	NN
46745	1503	53	.	.	.
46745	1504	1	The	the	DT
46745	1504	2	first	first	JJ
46745	1504	3	of	of	IN
46745	1504	4	these	these	DT
46745	1504	5	never	never	RB
46745	1504	6	results	result	VBZ
46745	1504	7	from	from	IN
46745	1504	8	the	the	DT
46745	1504	9	action	action	NN
46745	1504	10	of	of	IN
46745	1504	11	a	a	DT
46745	1504	12	medicine	medicine	NN
46745	1504	13	while	while	IN
46745	1504	14	in	in	IN
46745	1504	15	the	the	DT
46745	1504	16	blood	blood	NN
46745	1504	17	;	;	:
46745	1504	18	but	but	CC
46745	1504	19	it	-PRON-	PRP
46745	1504	20	may	may	MD
46745	1504	21	follow	follow	VB
46745	1504	22	an	an	DT
46745	1504	23	impression	impression	NN
46745	1504	24	on	on	IN
46745	1504	25	a	a	DT
46745	1504	26	surface	surface	NN
46745	1504	27	.	.	.
46745	1505	1	Thus	thus	RB
46745	1505	2	we	-PRON-	PRP
46745	1505	3	have	have	VBP
46745	1505	4	already	already	RB
46745	1505	5	seen	see	VBN
46745	1505	6	that	that	IN
46745	1505	7	the	the	DT
46745	1505	8	irritation	irritation	NN
46745	1505	9	of	of	IN
46745	1505	10	the	the	DT
46745	1505	11	mucous	mucous	JJ
46745	1505	12	membrane	membrane	NN
46745	1505	13	of	of	IN
46745	1505	14	the	the	DT
46745	1505	15	stomach	stomach	NN
46745	1505	16	,	,	,
46745	1505	17	and	and	CC
46745	1505	18	probably	probably	RB
46745	1505	19	of	of	IN
46745	1505	20	the	the	DT
46745	1505	21	filaments	filament	NNS
46745	1505	22	of	of	IN
46745	1505	23	the	the	DT
46745	1505	24	Vagus	Vagus	NNP
46745	1505	25	nerve	nerve	NN
46745	1505	26	distributed	distribute	VBN
46745	1505	27	in	in	IN
46745	1505	28	it	-PRON-	PRP
46745	1505	29	,	,	,
46745	1505	30	which	which	WDT
46745	1505	31	precedes	precede	VBZ
46745	1505	32	the	the	DT
46745	1505	33	act	act	NN
46745	1505	34	of	of	IN
46745	1505	35	vomiting	vomiting	NN
46745	1505	36	,	,	,
46745	1505	37	may	may	MD
46745	1505	38	cause	cause	VB
46745	1505	39	the	the	DT
46745	1505	40	contraction	contraction	NN
46745	1505	41	of	of	IN
46745	1505	42	the	the	DT
46745	1505	43	muscles	muscle	NNS
46745	1505	44	of	of	IN
46745	1505	45	the	the	DT
46745	1505	46	abdomen	abdomen	NNP
46745	1505	47	.	.	.
46745	1506	1	The	the	DT
46745	1506	2	propagation	propagation	NN
46745	1506	3	of	of	IN
46745	1506	4	contraction	contraction	NN
46745	1506	5	from	from	IN
46745	1506	6	one	one	CD
46745	1506	7	muscular	muscular	JJ
46745	1506	8	organ	organ	NN
46745	1506	9	to	to	IN
46745	1506	10	another	another	DT
46745	1506	11	appears	appear	VBZ
46745	1506	12	to	to	TO
46745	1506	13	take	take	VB
46745	1506	14	place	place	NN
46745	1506	15	in	in	IN
46745	1506	16	the	the	DT
46745	1506	17	case	case	NN
46745	1506	18	of	of	IN
46745	1506	19	violent	violent	JJ
46745	1506	20	purgatives	purgative	NNS
46745	1506	21	,	,	,
46745	1506	22	particularly	particularly	RB
46745	1506	23	some	some	DT
46745	1506	24	,	,	,
46745	1506	25	as	as	IN
46745	1506	26	Aloes	Aloes	NNP
46745	1506	27	and	and	CC
46745	1506	28	Savine	Savine	NNP
46745	1506	29	,	,	,
46745	1506	30	which	which	WDT
46745	1506	31	act	act	VBP
46745	1506	32	on	on	IN
46745	1506	33	the	the	DT
46745	1506	34	lowest	low	JJS
46745	1506	35	portion	portion	NN
46745	1506	36	of	of	IN
46745	1506	37	the	the	DT
46745	1506	38	large	large	JJ
46745	1506	39	intestine	intestine	NN
46745	1506	40	,	,	,
46745	1506	41	exciting	excite	VBG
46745	1506	42	it	-PRON-	PRP
46745	1506	43	to	to	IN
46745	1506	44	a	a	DT
46745	1506	45	peristaltic	peristaltic	JJ
46745	1506	46	contraction,--whose	contraction,--whose	NNP
46745	1506	47	action	action	NN
46745	1506	48	may	may	MD
46745	1506	49	thus	thus	RB
46745	1506	50	be	be	VB
46745	1506	51	extended	extend	VBN
46745	1506	52	to	to	IN
46745	1506	53	the	the	DT
46745	1506	54	contiguous	contiguous	JJ
46745	1506	55	Uterus	Uterus	NNP
46745	1506	56	in	in	IN
46745	1506	57	the	the	DT
46745	1506	58	female	female	NN
46745	1506	59	,	,	,
46745	1506	60	causing	cause	VBG
46745	1506	61	it	-PRON-	PRP
46745	1506	62	also	also	RB
46745	1506	63	to	to	TO
46745	1506	64	contract	contract	VB
46745	1506	65	.	.	.
46745	1507	1	This	this	DT
46745	1507	2	renders	render	VBZ
46745	1507	3	the	the	DT
46745	1507	4	employment	employment	NN
46745	1507	5	of	of	IN
46745	1507	6	such	such	JJ
46745	1507	7	medicines	medicine	NNS
46745	1507	8	dangerous	dangerous	JJ
46745	1507	9	in	in	IN
46745	1507	10	cases	case	NNS
46745	1507	11	of	of	IN
46745	1507	12	pregnancy	pregnancy	NN
46745	1507	13	,	,	,
46745	1507	14	as	as	IN
46745	1507	15	tending	tend	VBG
46745	1507	16	to	to	TO
46745	1507	17	produce	produce	VB
46745	1507	18	abortion	abortion	NN
46745	1507	19	.	.	.
46745	1508	1	In	in	IN
46745	1508	2	other	other	JJ
46745	1508	3	cases	case	NNS
46745	1508	4	these	these	DT
46745	1508	5	agents	agent	NNS
46745	1508	6	may	may	MD
46745	1508	7	be	be	VB
46745	1508	8	useful	useful	JJ
46745	1508	9	;	;	:
46745	1508	10	for	for	CC
46745	1508	11	by	by	IN
46745	1508	12	the	the	DT
46745	1508	13	irritation	irritation	NN
46745	1508	14	and	and	CC
46745	1508	15	congestion	congestion	NN
46745	1508	16	which	which	WDT
46745	1508	17	follows	follow	VBZ
46745	1508	18	this	this	DT
46745	1508	19	action	action	NN
46745	1508	20	on	on	IN
46745	1508	21	the	the	DT
46745	1508	22	Uterus	Uterus	NNP
46745	1508	23	,	,	,
46745	1508	24	they	-PRON-	PRP
46745	1508	25	may	may	MD
46745	1508	26	cause	cause	VB
46745	1508	27	the	the	DT
46745	1508	28	appearance	appearance	NN
46745	1508	29	of	of	IN
46745	1508	30	the	the	DT
46745	1508	31	menstrual	menstrual	JJ
46745	1508	32	secretion	secretion	NN
46745	1508	33	when	when	WRB
46745	1508	34	deficient	deficient	JJ
46745	1508	35	or	or	CC
46745	1508	36	retained	retained	JJ
46745	1508	37	.	.	.
46745	1509	1	This	this	DT
46745	1509	2	also	also	RB
46745	1509	3	is	be	VBZ
46745	1509	4	the	the	DT
46745	1509	5	result	result	NN
46745	1509	6	of	of	IN
46745	1509	7	an	an	DT
46745	1509	8	action	action	NN
46745	1509	9	on	on	IN
46745	1509	10	a	a	DT
46745	1509	11	surface	surface	NN
46745	1509	12	.	.	.
46745	1510	1	Now	now	RB
46745	1510	2	,	,	,
46745	1510	3	though	though	IN
46745	1510	4	in	in	IN
46745	1510	5	such	such	JJ
46745	1510	6	cases	case	NNS
46745	1510	7	the	the	DT
46745	1510	8	action	action	NN
46745	1510	9	of	of	IN
46745	1510	10	a	a	DT
46745	1510	11	medicine	medicine	NN
46745	1510	12	seems	seem	VBZ
46745	1510	13	to	to	TO
46745	1510	14	be	be	VB
46745	1510	15	continued	continue	VBN
46745	1510	16	from	from	IN
46745	1510	17	the	the	DT
46745	1510	18	part	part	NN
46745	1510	19	where	where	WRB
46745	1510	20	it	-PRON-	PRP
46745	1510	21	is	be	VBZ
46745	1510	22	situated	situate	VBN
46745	1510	23	to	to	IN
46745	1510	24	a	a	DT
46745	1510	25	distant	distant	JJ
46745	1510	26	point	point	NN
46745	1510	27	,	,	,
46745	1510	28	there	there	EX
46745	1510	29	are	be	VBP
46745	1510	30	certainly	certainly	RB
46745	1510	31	no	no	DT
46745	1510	32	authenticated	authenticate	VBN
46745	1510	33	examples	example	NNS
46745	1510	34	of	of	IN
46745	1510	35	such	such	PDT
46745	1510	36	an	an	DT
46745	1510	37	action	action	NN
46745	1510	38	by	by	IN
46745	1510	39	a	a	DT
46745	1510	40	remedy	remedy	NN
46745	1510	41	in	in	IN
46745	1510	42	the	the	DT
46745	1510	43	blood	blood	NN
46745	1510	44	.	.	.
46745	1511	1	Yet	yet	CC
46745	1511	2	it	-PRON-	PRP
46745	1511	3	would	would	MD
46745	1511	4	not	not	RB
46745	1511	5	be	be	VB
46745	1511	6	reasonable	reasonable	JJ
46745	1511	7	to	to	TO
46745	1511	8	deny	deny	VB
46745	1511	9	the	the	DT
46745	1511	10	bare	bare	JJ
46745	1511	11	possibility	possibility	NN
46745	1511	12	of	of	IN
46745	1511	13	such	such	PDT
46745	1511	14	a	a	DT
46745	1511	15	thing	thing	NN
46745	1511	16	.	.	.
46745	1512	1	But	but	CC
46745	1512	2	such	such	JJ
46745	1512	3	instances	instance	NNS
46745	1512	4	are	be	VBP
46745	1512	5	at	at	IN
46745	1512	6	all	all	DT
46745	1512	7	events	event	NNS
46745	1512	8	rare	rare	JJ
46745	1512	9	,	,	,
46745	1512	10	and	and	CC
46745	1512	11	,	,	,
46745	1512	12	being	be	VBG
46745	1512	13	cases	case	NNS
46745	1512	14	of	of	IN
46745	1512	15	the	the	DT
46745	1512	16	manifestation	manifestation	NN
46745	1512	17	of	of	IN
46745	1512	18	their	-PRON-	PRP$
46745	1512	19	vital	vital	JJ
46745	1512	20	properties	property	NNS
46745	1512	21	by	by	IN
46745	1512	22	nerve	nerve	NN
46745	1512	23	and	and	CC
46745	1512	24	muscle	muscle	NN
46745	1512	25	,	,	,
46745	1512	26	rather	rather	RB
46745	1512	27	than	than	IN
46745	1512	28	of	of	IN
46745	1512	29	the	the	DT
46745	1512	30	proper	proper	JJ
46745	1512	31	action	action	NN
46745	1512	32	of	of	IN
46745	1512	33	a	a	DT
46745	1512	34	medicine	medicine	NN
46745	1512	35	,	,	,
46745	1512	36	must	must	MD
46745	1512	37	not	not	RB
46745	1512	38	be	be	VB
46745	1512	39	considered	consider	VBN
46745	1512	40	to	to	TO
46745	1512	41	invalidate	invalidate	VB
46745	1512	42	the	the	DT
46745	1512	43	above	above	JJ
46745	1512	44	proposition	proposition	NN
46745	1512	45	,	,	,
46745	1512	46	which	which	WDT
46745	1512	47	,	,	,
46745	1512	48	as	as	IN
46745	1512	49	a	a	DT
46745	1512	50	general	general	JJ
46745	1512	51	rule	rule	NN
46745	1512	52	,	,	,
46745	1512	53	is	be	VBZ
46745	1512	54	of	of	IN
46745	1512	55	considerable	considerable	JJ
46745	1512	56	importance	importance	NN
46745	1512	57	.	.	.
46745	1513	1	PROP	PROP	NNP
46745	1513	2	.	.	.
46745	1514	1	VI.--_That	vi.--_that	FW
46745	1514	2	while	while	IN
46745	1514	3	in	in	IN
46745	1514	4	the	the	DT
46745	1514	5	blood	blood	NN
46745	1514	6	,	,	,
46745	1514	7	the	the	DT
46745	1514	8	medicine	medicine	NN
46745	1514	9	may	may	MD
46745	1514	10	undergo	undergo	VB
46745	1514	11	change	change	NN
46745	1514	12	,	,	,
46745	1514	13	which	which	WDT
46745	1514	14	in	in	IN
46745	1514	15	some	some	DT
46745	1514	16	cases	case	NNS
46745	1514	17	may	may	MD
46745	1514	18	,	,	,
46745	1514	19	in	in	IN
46745	1514	20	others	other	NNS
46745	1514	21	may	may	MD
46745	1514	22	not	not	RB
46745	1514	23	,	,	,
46745	1514	24	affect	affect	VB
46745	1514	25	its	-PRON-	PRP$
46745	1514	26	influence	influence	NN
46745	1514	27	.	.	.
46745	1515	1	That	that	IN
46745	1515	2	these	these	DT
46745	1515	3	changes	change	NNS
46745	1515	4	may	may	MD
46745	1515	5	be--	be--	NNP
46745	1515	6	_	_	NNP
46745	1515	7	_	_	NNP
46745	1515	8	a.	a.	NN
46745	1515	9	_	_	NNP
46745	1515	10	_	_	NNP
46745	1515	11	Of	of	IN
46745	1515	12	Combination	Combination	NNP
46745	1515	13	.	.	.
46745	1515	14	_	_	NNP
46745	1515	15	_	_	NNP
46745	1515	16	b.	b.	NN
46745	1515	17	_	_	NNP
46745	1515	18	_	_	NNP
46745	1515	19	Of	of	IN
46745	1515	20	Reconstruction	Reconstruction	NNP
46745	1515	21	.	.	.
46745	1515	22	_	_	NNP
46745	1515	23	_	_	NNP
46745	1515	24	c.	c.	NNP
46745	1515	25	_	_	NNP
46745	1515	26	_	_	NNP
46745	1515	27	Of	of	IN
46745	1515	28	Decomposition	Decomposition	NNP
46745	1515	29	.	.	.
46745	1515	30	_	_	NNP
46745	1515	31	Before	before	IN
46745	1515	32	advancing	advance	VBG
46745	1515	33	to	to	IN
46745	1515	34	the	the	DT
46745	1515	35	consideration	consideration	NN
46745	1515	36	of	of	IN
46745	1515	37	the	the	DT
46745	1515	38	modes	mode	NNS
46745	1515	39	in	in	IN
46745	1515	40	which	which	WDT
46745	1515	41	medicines	medicine	NNS
46745	1515	42	operate	operate	VBP
46745	1515	43	in	in	IN
46745	1515	44	the	the	DT
46745	1515	45	cure	cure	NN
46745	1515	46	of	of	IN
46745	1515	47	disease	disease	NN
46745	1515	48	,	,	,
46745	1515	49	it	-PRON-	PRP
46745	1515	50	is	be	VBZ
46745	1515	51	of	of	IN
46745	1515	52	importance	importance	NN
46745	1515	53	to	to	TO
46745	1515	54	mention	mention	VB
46745	1515	55	that	that	IN
46745	1515	56	some	some	DT
46745	1515	57	of	of	IN
46745	1515	58	them	-PRON-	PRP
46745	1515	59	are	be	VBP
46745	1515	60	liable	liable	JJ
46745	1515	61	to	to	TO
46745	1515	62	undergo	undergo	VB
46745	1515	63	changes	change	NNS
46745	1515	64	in	in	IN
46745	1515	65	the	the	DT
46745	1515	66	animal	animal	NN
46745	1515	67	organism	organism	NN
46745	1515	68	,	,	,
46745	1515	69	because	because	IN
46745	1515	70	in	in	IN
46745	1515	71	particular	particular	JJ
46745	1515	72	cases	case	NNS
46745	1515	73	these	these	DT
46745	1515	74	changes	change	NNS
46745	1515	75	may	may	MD
46745	1515	76	materially	materially	RB
46745	1515	77	affect	affect	VB
46745	1515	78	their	-PRON-	PRP$
46745	1515	79	action	action	NN
46745	1515	80	,	,	,
46745	1515	81	and	and	CC
46745	1515	82	in	in	IN
46745	1515	83	all	all	DT
46745	1515	84	cases	case	NNS
46745	1515	85	they	-PRON-	PRP
46745	1515	86	have	have	VBP
46745	1515	87	some	some	DT
46745	1515	88	bearing	bearing	NN
46745	1515	89	upon	upon	IN
46745	1515	90	it	-PRON-	PRP
46745	1515	91	.	.	.
46745	1516	1	With	with	IN
46745	1516	2	a	a	DT
46745	1516	3	view	view	NN
46745	1516	4	to	to	IN
46745	1516	5	this	this	DT
46745	1516	6	point	point	NN
46745	1516	7	I	-PRON-	PRP
46745	1516	8	have	have	VBP
46745	1516	9	divided	divide	VBN
46745	1516	10	these	these	DT
46745	1516	11	changes	change	NNS
46745	1516	12	,	,	,
46745	1516	13	somewhat	somewhat	RB
46745	1516	14	arbitrarily	arbitrarily	RB
46745	1516	15	,	,	,
46745	1516	16	into	into	IN
46745	1516	17	three	three	CD
46745	1516	18	kinds,--of	kinds,--of	NNP
46745	1516	19	which	which	WDT
46745	1516	20	the	the	DT
46745	1516	21	first	first	JJ
46745	1516	22	does	do	VBZ
46745	1516	23	not	not	RB
46745	1516	24	hinder	hinder	VB
46745	1516	25	the	the	DT
46745	1516	26	effect	effect	NN
46745	1516	27	of	of	IN
46745	1516	28	a	a	DT
46745	1516	29	medicine	medicine	NN
46745	1516	30	--	--	:
46745	1516	31	the	the	DT
46745	1516	32	second	second	JJ
46745	1516	33	may	may	MD
46745	1516	34	alter	alter	VB
46745	1516	35	it	-PRON-	PRP
46745	1516	36	slightly	slightly	RB
46745	1516	37	--	--	:
46745	1516	38	and	and	CC
46745	1516	39	the	the	DT
46745	1516	40	third	third	JJ
46745	1516	41	entirely	entirely	RB
46745	1516	42	changes	change	VBZ
46745	1516	43	or	or	CC
46745	1516	44	neutralizes	neutralize	VBZ
46745	1516	45	it	-PRON-	PRP
46745	1516	46	.	.	.
46745	1517	1	Some	some	DT
46745	1517	2	of	of	IN
46745	1517	3	these	these	DT
46745	1517	4	change	change	NN
46745	1517	5	have	have	VBP
46745	1517	6	to	to	TO
46745	1517	7	be	be	VB
46745	1517	8	considered	consider	VBN
46745	1517	9	more	more	JJR
46745	1517	10	at	at	IN
46745	1517	11	length	length	NN
46745	1517	12	in	in	IN
46745	1517	13	the	the	DT
46745	1517	14	progress	progress	NN
46745	1517	15	of	of	IN
46745	1517	16	the	the	DT
46745	1517	17	Essay	Essay	NNP
46745	1517	18	,	,	,
46745	1517	19	so	so	IN
46745	1517	20	that	that	IN
46745	1517	21	here	here	RB
46745	1517	22	I	-PRON-	PRP
46745	1517	23	will	will	MD
46745	1517	24	only	only	RB
46745	1517	25	give	give	VB
46745	1517	26	an	an	DT
46745	1517	27	outline	outline	NN
46745	1517	28	of	of	IN
46745	1517	29	them	-PRON-	PRP
46745	1517	30	.	.	.
46745	1518	1	_	_	NNP
46745	1518	2	Changes	Changes	NNPS
46745	1518	3	of	of	IN
46745	1518	4	Combination._--The	combination._--the	CD
46745	1518	5	chief	chief	NN
46745	1518	6	,	,	,
46745	1518	7	and	and	CC
46745	1518	8	indeed	indeed	RB
46745	1518	9	almost	almost	RB
46745	1518	10	the	the	DT
46745	1518	11	only	only	JJ
46745	1518	12	way	way	NN
46745	1518	13	of	of	IN
46745	1518	14	detecting	detect	VBG
46745	1518	15	changes	change	NNS
46745	1518	16	in	in	IN
46745	1518	17	medicines	medicine	NNS
46745	1518	18	,	,	,
46745	1518	19	is	be	VBZ
46745	1518	20	by	by	IN
46745	1518	21	taking	take	VBG
46745	1518	22	notice	notice	NN
46745	1518	23	of	of	IN
46745	1518	24	their	-PRON-	PRP$
46745	1518	25	effect	effect	NN
46745	1518	26	upon	upon	IN
46745	1518	27	the	the	DT
46745	1518	28	composition	composition	NN
46745	1518	29	of	of	IN
46745	1518	30	the	the	DT
46745	1518	31	secretions	secretion	NNS
46745	1518	32	.	.	.
46745	1519	1	Now	now	RB
46745	1519	2	in	in	IN
46745	1519	3	the	the	DT
46745	1519	4	blood	blood	NN
46745	1519	5	we	-PRON-	PRP
46745	1519	6	have	have	VBP
46745	1519	7	a	a	DT
46745	1519	8	slight	slight	JJ
46745	1519	9	excess	excess	NN
46745	1519	10	of	of	IN
46745	1519	11	alkali	alkali	JJ
46745	1519	12	;	;	:
46745	1519	13	in	in	IN
46745	1519	14	the	the	DT
46745	1519	15	urine	urine	NN
46745	1519	16	,	,	,
46745	1519	17	an	an	DT
46745	1519	18	excess	excess	NN
46745	1519	19	of	of	IN
46745	1519	20	acid	acid	NN
46745	1519	21	.	.	.
46745	1520	1	Acids	acid	NNS
46745	1520	2	and	and	CC
46745	1520	3	alkalies	alkali	NNS
46745	1520	4	are	be	VBP
46745	1520	5	often	often	RB
46745	1520	6	given	give	VBN
46745	1520	7	as	as	IN
46745	1520	8	medicines	medicine	NNS
46745	1520	9	;	;	:
46745	1520	10	and	and	CC
46745	1520	11	as	as	IN
46745	1520	12	it	-PRON-	PRP
46745	1520	13	is	be	VBZ
46745	1520	14	not	not	RB
46745	1520	15	right	right	JJ
46745	1520	16	that	that	IN
46745	1520	17	there	there	EX
46745	1520	18	should	should	MD
46745	1520	19	be	be	VB
46745	1520	20	much	much	RB
46745	1520	21	excess	excess	NN
46745	1520	22	of	of	IN
46745	1520	23	either	either	CC
46745	1520	24	in	in	IN
46745	1520	25	the	the	DT
46745	1520	26	blood	blood	NN
46745	1520	27	,	,	,
46745	1520	28	both	both	DT
46745	1520	29	are	be	VBP
46745	1520	30	generally	generally	RB
46745	1520	31	soon	soon	RB
46745	1520	32	neutralized	neutralize	VBN
46745	1520	33	in	in	IN
46745	1520	34	the	the	DT
46745	1520	35	system	system	NN
46745	1520	36	,	,	,
46745	1520	37	and	and	CC
46745	1520	38	reduced	reduce	VBN
46745	1520	39	to	to	IN
46745	1520	40	salts	salt	NNS
46745	1520	41	.	.	.
46745	1521	1	This	this	DT
46745	1521	2	may	may	MD
46745	1521	3	sometimes	sometimes	RB
46745	1521	4	occur	occur	VB
46745	1521	5	before	before	IN
46745	1521	6	absorption	absorption	NN
46745	1521	7	,	,	,
46745	1521	8	but	but	CC
46745	1521	9	perhaps	perhaps	RB
46745	1521	10	more	more	RBR
46745	1521	11	often	often	RB
46745	1521	12	after	after	IN
46745	1521	13	it	-PRON-	PRP
46745	1521	14	.	.	.
46745	1522	1	Now	now	RB
46745	1522	2	,	,	,
46745	1522	3	it	-PRON-	PRP
46745	1522	4	may	may	MD
46745	1522	5	seem	seem	VB
46745	1522	6	strange	strange	JJ
46745	1522	7	for	for	IN
46745	1522	8	me	-PRON-	PRP
46745	1522	9	to	to	TO
46745	1522	10	say	say	VB
46745	1522	11	that	that	IN
46745	1522	12	this	this	DT
46745	1522	13	neutralization	neutralization	NN
46745	1522	14	does	do	VBZ
46745	1522	15	not	not	RB
46745	1522	16	destroy	destroy	VB
46745	1522	17	their	-PRON-	PRP$
46745	1522	18	influence	influence	NN
46745	1522	19	.	.	.
46745	1523	1	But	but	CC
46745	1523	2	it	-PRON-	PRP
46745	1523	3	evidently	evidently	RB
46745	1523	4	does	do	VBZ
46745	1523	5	not	not	RB
46745	1523	6	;	;	:
46745	1523	7	for	for	IN
46745	1523	8	in	in	IN
46745	1523	9	being	be	VBG
46745	1523	10	neutralized	neutralize	VBN
46745	1523	11	they	-PRON-	PRP
46745	1523	12	diminish	diminish	VBP
46745	1523	13	in	in	IN
46745	1523	14	the	the	DT
46745	1523	15	blood	blood	NN
46745	1523	16	,	,	,
46745	1523	17	and	and	CC
46745	1523	18	in	in	IN
46745	1523	19	the	the	DT
46745	1523	20	system	system	NN
46745	1523	21	generally	generally	RB
46745	1523	22	,	,	,
46745	1523	23	the	the	DT
46745	1523	24	quantity	quantity	NN
46745	1523	25	of	of	IN
46745	1523	26	basic	basic	JJ
46745	1523	27	or	or	CC
46745	1523	28	of	of	IN
46745	1523	29	acid	acid	JJ
46745	1523	30	matter	matter	NN
46745	1523	31	,	,	,
46745	1523	32	and	and	CC
46745	1523	33	thus	thus	RB
46745	1523	34	tend	tend	VBP
46745	1523	35	to	to	TO
46745	1523	36	alter	alter	VB
46745	1523	37	the	the	DT
46745	1523	38	reaction	reaction	NN
46745	1523	39	of	of	IN
46745	1523	40	the	the	DT
46745	1523	41	secretions	secretion	NNS
46745	1523	42	.	.	.
46745	1524	1	Though	though	IN
46745	1524	2	an	an	DT
46745	1524	3	acid	acid	NN
46745	1524	4	may	may	MD
46745	1524	5	combine	combine	VB
46745	1524	6	in	in	IN
46745	1524	7	the	the	DT
46745	1524	8	blood	blood	NN
46745	1524	9	with	with	IN
46745	1524	10	Soda	Soda	NNP
46745	1524	11	,	,	,
46745	1524	12	or	or	CC
46745	1524	13	with	with	IN
46745	1524	14	salts	salt	NNS
46745	1524	15	of	of	IN
46745	1524	16	Soda	Soda	NNP
46745	1524	17	,	,	,
46745	1524	18	yet	yet	CC
46745	1524	19	by	by	IN
46745	1524	20	so	so	RB
46745	1524	21	doing	do	VBG
46745	1524	22	it	-PRON-	PRP
46745	1524	23	causes	cause	VBZ
46745	1524	24	an	an	DT
46745	1524	25	excess	excess	NN
46745	1524	26	of	of	IN
46745	1524	27	some	some	DT
46745	1524	28	other	other	JJ
46745	1524	29	acid	acid	NN
46745	1524	30	,	,	,
46745	1524	31	probably	probably	RB
46745	1524	32	an	an	DT
46745	1524	33	animal	animal	NN
46745	1524	34	acid	acid	NN
46745	1524	35	,	,	,
46745	1524	36	which	which	WDT
46745	1524	37	,	,	,
46745	1524	38	being	be	VBG
46745	1524	39	set	set	VBN
46745	1524	40	free	free	JJ
46745	1524	41	,	,	,
46745	1524	42	acts	act	NNS
46745	1524	43	on	on	IN
46745	1524	44	the	the	DT
46745	1524	45	secretion	secretion	NN
46745	1524	46	of	of	IN
46745	1524	47	urine	urine	NN
46745	1524	48	much	much	JJ
46745	1524	49	in	in	IN
46745	1524	50	the	the	DT
46745	1524	51	same	same	JJ
46745	1524	52	way	way	NN
46745	1524	53	that	that	WDT
46745	1524	54	the	the	DT
46745	1524	55	first	first	JJ
46745	1524	56	acid	acid	NN
46745	1524	57	would	would	MD
46745	1524	58	have	have	VB
46745	1524	59	done	do	VBN
46745	1524	60	.	.	.
46745	1525	1	It	-PRON-	PRP
46745	1525	2	is	be	VBZ
46745	1525	3	easier	easy	JJR
46745	1525	4	to	to	TO
46745	1525	5	render	render	VB
46745	1525	6	the	the	DT
46745	1525	7	urine	urine	NN
46745	1525	8	alkaline	alkaline	NN
46745	1525	9	than	than	IN
46745	1525	10	to	to	TO
46745	1525	11	make	make	VB
46745	1525	12	it	-PRON-	PRP
46745	1525	13	acid	acid	VB
46745	1525	14	,	,	,
46745	1525	15	for	for	IN
46745	1525	16	two	two	CD
46745	1525	17	reasons	reason	NNS
46745	1525	18	;	;	:
46745	1525	19	first	first	RB
46745	1525	20	,	,	,
46745	1525	21	as	as	IN
46745	1525	22	I	-PRON-	PRP
46745	1525	23	shall	shall	MD
46745	1525	24	show	show	VB
46745	1525	25	hereafter	hereafter	NN
46745	1525	26	,	,	,
46745	1525	27	an	an	DT
46745	1525	28	acid	acid	NN
46745	1525	29	may	may	MD
46745	1525	30	pass	pass	VB
46745	1525	31	out	out	RP
46745	1525	32	through	through	IN
46745	1525	33	other	other	JJ
46745	1525	34	glands	gland	NNS
46745	1525	35	besides	besides	IN
46745	1525	36	the	the	DT
46745	1525	37	kidneys	kidney	NNS
46745	1525	38	;	;	:
46745	1525	39	and	and	CC
46745	1525	40	secondly	secondly	RB
46745	1525	41	,	,	,
46745	1525	42	an	an	DT
46745	1525	43	alkali	alkali	NN
46745	1525	44	is	be	VBZ
46745	1525	45	not	not	RB
46745	1525	46	so	so	RB
46745	1525	47	easily	easily	RB
46745	1525	48	neutralized	neutralize	VBN
46745	1525	49	,	,	,
46745	1525	50	either	either	CC
46745	1525	51	before	before	IN
46745	1525	52	or	or	CC
46745	1525	53	after	after	IN
46745	1525	54	absorption	absorption	NN
46745	1525	55	,	,	,
46745	1525	56	the	the	DT
46745	1525	57	blood	blood	NN
46745	1525	58	being	be	VBG
46745	1525	59	already	already	RB
46745	1525	60	more	more	RBR
46745	1525	61	or	or	CC
46745	1525	62	less	less	RBR
46745	1525	63	alkaline	alkaline	NN
46745	1525	64	.	.	.
46745	1526	1	A	a	DT
46745	1526	2	large	large	JJ
46745	1526	3	quantity	quantity	NN
46745	1526	4	of	of	IN
46745	1526	5	acid	acid	NN
46745	1526	6	would	would	MD
46745	1526	7	easily	easily	RB
46745	1526	8	overcome	overcome	VB
46745	1526	9	the	the	DT
46745	1526	10	feeble	feeble	JJ
46745	1526	11	reaction	reaction	NN
46745	1526	12	of	of	IN
46745	1526	13	the	the	DT
46745	1526	14	blood	blood	NN
46745	1526	15	,	,	,
46745	1526	16	and	and	CC
46745	1526	17	thus	thus	RB
46745	1526	18	,	,	,
46745	1526	19	by	by	IN
46745	1526	20	remaining	remain	VBG
46745	1526	21	free	free	JJ
46745	1526	22	,	,	,
46745	1526	23	Sulphuric	Sulphuric	NNP
46745	1526	24	and	and	CC
46745	1526	25	other	other	JJ
46745	1526	26	acids	acid	NNS
46745	1526	27	are	be	VBP
46745	1526	28	enabled	enable	VBN
46745	1526	29	to	to	TO
46745	1526	30	act	act	VB
46745	1526	31	as	as	IN
46745	1526	32	astringents	astringent	NNS
46745	1526	33	on	on	IN
46745	1526	34	certain	certain	JJ
46745	1526	35	of	of	IN
46745	1526	36	the	the	DT
46745	1526	37	glands	gland	NNS
46745	1526	38	.	.	.
46745	1527	1	Other	other	JJ
46745	1527	2	changes	change	NNS
46745	1527	3	of	of	IN
46745	1527	4	combination	combination	NN
46745	1527	5	have	have	VBP
46745	1527	6	already	already	RB
46745	1527	7	been	be	VBN
46745	1527	8	shown	show	VBN
46745	1527	9	to	to	TO
46745	1527	10	take	take	VB
46745	1527	11	place	place	NN
46745	1527	12	during	during	IN
46745	1527	13	the	the	DT
46745	1527	14	process	process	NN
46745	1527	15	of	of	IN
46745	1527	16	absorption	absorption	NN
46745	1527	17	.	.	.
46745	1528	1	Alkalies	alkali	NNS
46745	1528	2	and	and	CC
46745	1528	3	their	-PRON-	PRP$
46745	1528	4	carbonates	carbonate	NNS
46745	1528	5	are	be	VBP
46745	1528	6	more	more	RBR
46745	1528	7	or	or	CC
46745	1528	8	less	less	RBR
46745	1528	9	neutralized	neutralize	VBN
46745	1528	10	by	by	IN
46745	1528	11	the	the	DT
46745	1528	12	stomach	stomach	NN
46745	1528	13	acid	acid	NN
46745	1528	14	.	.	.
46745	1529	1	Substances	substance	NNS
46745	1529	2	soluble	soluble	JJ
46745	1529	3	in	in	IN
46745	1529	4	alkalies	alkali	NNS
46745	1529	5	are	be	VBP
46745	1529	6	probably	probably	RB
46745	1529	7	absorbed	absorb	VBN
46745	1529	8	in	in	IN
46745	1529	9	such	such	JJ
46745	1529	10	solution	solution	NN
46745	1529	11	.	.	.
46745	1530	1	Calomel	Calomel	NNP
46745	1530	2	,	,	,
46745	1530	3	Chalk	Chalk	NNP
46745	1530	4	,	,	,
46745	1530	5	Magnesia	Magnesia	NNP
46745	1530	6	,	,	,
46745	1530	7	and	and	CC
46745	1530	8	metallic	metallic	JJ
46745	1530	9	oxides	oxide	NNS
46745	1530	10	,	,	,
46745	1530	11	as	as	RB
46745	1530	12	well	well	RB
46745	1530	13	as	as	IN
46745	1530	14	other	other	JJ
46745	1530	15	insoluble	insoluble	JJ
46745	1530	16	medicines	medicine	NNS
46745	1530	17	,	,	,
46745	1530	18	are	be	VBP
46745	1530	19	taken	take	VBN
46745	1530	20	up	up	RP
46745	1530	21	in	in	IN
46745	1530	22	the	the	DT
46745	1530	23	soluble	soluble	JJ
46745	1530	24	form	form	NN
46745	1530	25	,	,	,
46745	1530	26	in	in	IN
46745	1530	27	which	which	WDT
46745	1530	28	only	only	RB
46745	1530	29	they	-PRON-	PRP
46745	1530	30	are	be	VBP
46745	1530	31	capable	capable	JJ
46745	1530	32	of	of	IN
46745	1530	33	acting	act	VBG
46745	1530	34	.	.	.
46745	1531	1	But	but	CC
46745	1531	2	we	-PRON-	PRP
46745	1531	3	are	be	VBP
46745	1531	4	now	now	RB
46745	1531	5	concerned	concerned	JJ
46745	1531	6	with	with	IN
46745	1531	7	medicines	medicine	NNS
46745	1531	8	in	in	IN
46745	1531	9	the	the	DT
46745	1531	10	blood	blood	NN
46745	1531	11	.	.	.
46745	1532	1	And	and	CC
46745	1532	2	here	here	RB
46745	1532	3	I	-PRON-	PRP
46745	1532	4	must	must	MD
46745	1532	5	protest	protest	VB
46745	1532	6	against	against	IN
46745	1532	7	the	the	DT
46745	1532	8	idea	idea	NN
46745	1532	9	that	that	IN
46745	1532	10	all	all	DT
46745	1532	11	chemical	chemical	JJ
46745	1532	12	affinities	affinity	NNS
46745	1532	13	have	have	VBP
46745	1532	14	free	free	JJ
46745	1532	15	play	play	NN
46745	1532	16	in	in	IN
46745	1532	17	that	that	DT
46745	1532	18	liquid	liquid	NN
46745	1532	19	.	.	.
46745	1533	1	If	if	IN
46745	1533	2	it	-PRON-	PRP
46745	1533	3	were	be	VBD
46745	1533	4	so	so	RB
46745	1533	5	,	,	,
46745	1533	6	many	many	JJ
46745	1533	7	of	of	IN
46745	1533	8	our	-PRON-	PRP$
46745	1533	9	most	most	RBS
46745	1533	10	valuable	valuable	JJ
46745	1533	11	medicines	medicine	NNS
46745	1533	12	would	would	MD
46745	1533	13	be	be	VB
46745	1533	14	decomposed	decompose	VBN
46745	1533	15	and	and	CC
46745	1533	16	rendered	render	VBN
46745	1533	17	insoluble	insoluble	JJ
46745	1533	18	there	there	RB
46745	1533	19	.	.	.
46745	1534	1	All	all	PDT
46745	1534	2	the	the	DT
46745	1534	3	mineral	mineral	NN
46745	1534	4	salts	salt	NNS
46745	1534	5	would	would	MD
46745	1534	6	be	be	VB
46745	1534	7	precipitated	precipitate	VBN
46745	1534	8	by	by	IN
46745	1534	9	the	the	DT
46745	1534	10	free	free	JJ
46745	1534	11	Soda	Soda	NNP
46745	1534	12	in	in	IN
46745	1534	13	that	that	DT
46745	1534	14	fluid	fluid	NN
46745	1534	15	.	.	.
46745	1535	1	Acetate	Acetate	NNP
46745	1535	2	of	of	IN
46745	1535	3	lead	lead	NN
46745	1535	4	would	would	MD
46745	1535	5	be	be	VB
46745	1535	6	immediately	immediately	RB
46745	1535	7	decomposed	decompose	VBN
46745	1535	8	by	by	IN
46745	1535	9	sulphates	sulphate	NNS
46745	1535	10	,	,	,
46745	1535	11	and	and	CC
46745	1535	12	Nitrate	Nitrate	NNP
46745	1535	13	of	of	IN
46745	1535	14	Silver	Silver	NNP
46745	1535	15	precipitated	precipitate	VBN
46745	1535	16	by	by	IN
46745	1535	17	chlorides	chloride	NNS
46745	1535	18	.	.	.
46745	1536	1	It	-PRON-	PRP
46745	1536	2	is	be	VBZ
46745	1536	3	probable	probable	JJ
46745	1536	4	that	that	IN
46745	1536	5	the	the	DT
46745	1536	6	vital	vital	JJ
46745	1536	7	forces	force	NNS
46745	1536	8	,	,	,
46745	1536	9	as	as	RB
46745	1536	10	well	well	RB
46745	1536	11	as	as	IN
46745	1536	12	the	the	DT
46745	1536	13	viscidity	viscidity	NN
46745	1536	14	of	of	IN
46745	1536	15	the	the	DT
46745	1536	16	plasma	plasma	NN
46745	1536	17	,	,	,
46745	1536	18	exert	exert	VB
46745	1536	19	a	a	DT
46745	1536	20	retarding	retarding	NN
46745	1536	21	or	or	CC
46745	1536	22	controlling	control	VBG
46745	1536	23	power	power	NN
46745	1536	24	over	over	IN
46745	1536	25	such	such	JJ
46745	1536	26	chemical	chemical	NN
46745	1536	27	tendencies	tendency	NNS
46745	1536	28	.	.	.
46745	1537	1	Some	some	DT
46745	1537	2	substances	substance	NNS
46745	1537	3	are	be	VBP
46745	1537	4	decomposed	decompose	VBN
46745	1537	5	while	while	IN
46745	1537	6	passing	pass	VBG
46745	1537	7	out	out	IN
46745	1537	8	of	of	IN
46745	1537	9	the	the	DT
46745	1537	10	body	body	NN
46745	1537	11	.	.	.
46745	1538	1	Decomposing	decompose	VBG
46745	1538	2	matters	matter	NNS
46745	1538	3	in	in	IN
46745	1538	4	the	the	DT
46745	1538	5	intestines	intestine	NNS
46745	1538	6	and	and	CC
46745	1538	7	in	in	IN
46745	1538	8	the	the	DT
46745	1538	9	saliva	saliva	NN
46745	1538	10	,	,	,
46745	1538	11	cause	cause	VB
46745	1538	12	the	the	DT
46745	1538	13	formation	formation	NN
46745	1538	14	of	of	IN
46745	1538	15	Sulphuret	Sulphuret	NNP
46745	1538	16	of	of	IN
46745	1538	17	Iron	Iron	NNP
46745	1538	18	,	,	,
46745	1538	19	while	while	IN
46745	1538	20	chaly	chaly	NNS
46745	1538	21	-	-	HYPH
46745	1538	22	beates	beate	NNS
46745	1538	23	are	be	VBP
46745	1538	24	taken	take	VBN
46745	1538	25	,	,	,
46745	1538	26	which	which	WDT
46745	1538	27	blackens	blacken	VBZ
46745	1538	28	the	the	DT
46745	1538	29	fæces	fæce	NNS
46745	1538	30	;	;	:
46745	1538	31	and	and	CC
46745	1538	32	of	of	IN
46745	1538	33	Sulphuret	Sulphuret	NNP
46745	1538	34	of	of	IN
46745	1538	35	Lead	Lead	NNP
46745	1538	36	,	,	,
46745	1538	37	when	when	WRB
46745	1538	38	lead	lead	NN
46745	1538	39	is	be	VBZ
46745	1538	40	taken	take	VBN
46745	1538	41	for	for	IN
46745	1538	42	some	some	DT
46745	1538	43	time	time	NN
46745	1538	44	,	,	,
46745	1538	45	producing	produce	VBG
46745	1538	46	the	the	DT
46745	1538	47	well	well	RB
46745	1538	48	known	know	VBN
46745	1538	49	blue	blue	JJ
46745	1538	50	line	line	NN
46745	1538	51	on	on	IN
46745	1538	52	the	the	DT
46745	1538	53	gums	gum	NNS
46745	1538	54	.	.	.
46745	1539	1	_	_	NNP
46745	1539	2	Changes	Changes	NNPS
46745	1539	3	of	of	IN
46745	1539	4	Reconstruction._--The	reconstruction._--the	CD
46745	1539	5	elements	element	NNS
46745	1539	6	of	of	IN
46745	1539	7	a	a	DT
46745	1539	8	body	body	NN
46745	1539	9	may	may	MD
46745	1539	10	be	be	VB
46745	1539	11	disturbed	disturb	VBN
46745	1539	12	in	in	IN
46745	1539	13	the	the	DT
46745	1539	14	system	system	NN
46745	1539	15	,	,	,
46745	1539	16	and	and	CC
46745	1539	17	combined	combine	VBN
46745	1539	18	together	together	RB
46745	1539	19	anew	anew	RB
46745	1539	20	,	,	,
46745	1539	21	without	without	IN
46745	1539	22	any	any	DT
46745	1539	23	material	material	NN
46745	1539	24	or	or	CC
46745	1539	25	apparent	apparent	JJ
46745	1539	26	alteration	alteration	NN
46745	1539	27	of	of	IN
46745	1539	28	its	-PRON-	PRP$
46745	1539	29	properties	property	NNS
46745	1539	30	.	.	.
46745	1540	1	Probably	probably	RB
46745	1540	2	many	many	JJ
46745	1540	3	changes	change	NNS
46745	1540	4	of	of	IN
46745	1540	5	this	this	DT
46745	1540	6	kind	kind	NN
46745	1540	7	occur	occur	VBP
46745	1540	8	,	,	,
46745	1540	9	but	but	CC
46745	1540	10	only	only	RB
46745	1540	11	some	some	DT
46745	1540	12	isolated	isolated	JJ
46745	1540	13	instances	instance	NNS
46745	1540	14	have	have	VBP
46745	1540	15	been	be	VBN
46745	1540	16	verified	verify	VBN
46745	1540	17	.	.	.
46745	1541	1	Thus	thus	RB
46745	1541	2	Tannic	tannic	JJ
46745	1541	3	acid	acid	NN
46745	1541	4	,	,	,
46745	1541	5	acquiring	acquire	VBG
46745	1541	6	Oxygen	oxygen	NN
46745	1541	7	,	,	,
46745	1541	8	changes	change	VBZ
46745	1541	9	into	into	IN
46745	1541	10	Gallic	Gallic	NNP
46745	1541	11	.	.	.
46745	1542	1	Benzoic	benzoic	JJ
46745	1542	2	and	and	CC
46745	1542	3	Cinnamic	cinnamic	JJ
46745	1542	4	acids	acid	NNS
46745	1542	5	are	be	VBP
46745	1542	6	converted	convert	VBN
46745	1542	7	into	into	IN
46745	1542	8	Hippuric	Hippuric	NNP
46745	1542	9	acid	acid	NN
46745	1542	10	,	,	,
46745	1542	11	which	which	WDT
46745	1542	12	passes	pass	VBZ
46745	1542	13	out	out	RP
46745	1542	14	in	in	IN
46745	1542	15	the	the	DT
46745	1542	16	urine	urine	NN
46745	1542	17	.	.	.
46745	1543	1	Turpentine	turpentine	NN
46745	1543	2	changes	change	VBZ
46745	1543	3	into	into	IN
46745	1543	4	a	a	DT
46745	1543	5	volatile	volatile	JJ
46745	1543	6	oil	oil	NN
46745	1543	7	,	,	,
46745	1543	8	which	which	WDT
46745	1543	9	communicates	communicate	VBZ
46745	1543	10	to	to	IN
46745	1543	11	the	the	DT
46745	1543	12	urine	urine	NN
46745	1543	13	an	an	DT
46745	1543	14	odour	odour	NN
46745	1543	15	of	of	IN
46745	1543	16	violets	violet	NNS
46745	1543	17	.	.	.
46745	1544	1	Ferridcyanide	ferridcyanide	NN
46745	1544	2	of	of	IN
46745	1544	3	Potassium	Potassium	NNP
46745	1544	4	changes	change	NNS
46745	1544	5	in	in	IN
46745	1544	6	the	the	DT
46745	1544	7	system	system	NN
46745	1544	8	into	into	IN
46745	1544	9	Ferrocyanide	Ferrocyanide	NNP
46745	1544	10	.	.	.
46745	1545	1	Some	some	DT
46745	1545	2	of	of	IN
46745	1545	3	these	these	DT
46745	1545	4	changes	change	NNS
46745	1545	5	will	will	MD
46745	1545	6	be	be	VB
46745	1545	7	afterwards	afterwards	RB
46745	1545	8	considered	consider	VBN
46745	1545	9	more	more	JJR
46745	1545	10	at	at	IN
46745	1545	11	length	length	NN
46745	1545	12	.	.	.
46745	1546	1	_	_	NNP
46745	1546	2	Changes	Changes	NNPS
46745	1546	3	of	of	IN
46745	1546	4	decomposition._--By	decomposition._--by	NN
46745	1546	5	this	this	DT
46745	1546	6	I	-PRON-	PRP
46745	1546	7	mean	mean	VBP
46745	1546	8	such	such	PDT
46745	1546	9	a	a	DT
46745	1546	10	disarrangement	disarrangement	NN
46745	1546	11	of	of	IN
46745	1546	12	elements	element	NNS
46745	1546	13	as	as	IN
46745	1546	14	shall	shall	MD
46745	1546	15	neutralize	neutralize	VB
46745	1546	16	or	or	CC
46745	1546	17	reverse	reverse	VB
46745	1546	18	the	the	DT
46745	1546	19	action	action	NN
46745	1546	20	of	of	IN
46745	1546	21	a	a	DT
46745	1546	22	medicine	medicine	NN
46745	1546	23	.	.	.
46745	1547	1	There	there	EX
46745	1547	2	is	be	VBZ
46745	1547	3	free	free	JJ
46745	1547	4	Oxygen	oxygen	NN
46745	1547	5	in	in	IN
46745	1547	6	the	the	DT
46745	1547	7	blood	blood	NN
46745	1547	8	,	,	,
46745	1547	9	and	and	CC
46745	1547	10	the	the	DT
46745	1547	11	most	most	RBS
46745	1547	12	important	important	JJ
46745	1547	13	change	change	NN
46745	1547	14	to	to	TO
46745	1547	15	which	which	WDT
46745	1547	16	all	all	DT
46745	1547	17	organic	organic	JJ
46745	1547	18	substances	substance	NNS
46745	1547	19	are	be	VBP
46745	1547	20	liable	liable	JJ
46745	1547	21	there	there	EX
46745	1547	22	is	be	VBZ
46745	1547	23	_	_	NNP
46745	1547	24	oxidation	oxidation	NN
46745	1547	25	_	_	NNP
46745	1547	26	.	.	.
46745	1548	1	This	this	DT
46745	1548	2	probably	probably	RB
46745	1548	3	occurs	occur	VBZ
46745	1548	4	in	in	IN
46745	1548	5	many	many	JJ
46745	1548	6	cases	case	NNS
46745	1548	7	.	.	.
46745	1549	1	It	-PRON-	PRP
46745	1549	2	always	always	RB
46745	1549	3	takes	take	VBZ
46745	1549	4	place	place	NN
46745	1549	5	with	with	IN
46745	1549	6	the	the	DT
46745	1549	7	starchy	starchy	JJ
46745	1549	8	elements	element	NNS
46745	1549	9	of	of	IN
46745	1549	10	the	the	DT
46745	1549	11	food	food	NN
46745	1549	12	,	,	,
46745	1549	13	and	and	CC
46745	1549	14	with	with	IN
46745	1549	15	those	those	DT
46745	1549	16	parts	part	NNS
46745	1549	17	of	of	IN
46745	1549	18	the	the	DT
46745	1549	19	nitrogenous	nitrogenous	JJ
46745	1549	20	tissues	tissue	NNS
46745	1549	21	that	that	WDT
46745	1549	22	have	have	VBP
46745	1549	23	done	do	VBN
46745	1549	24	their	-PRON-	PRP$
46745	1549	25	work	work	NN
46745	1549	26	,	,	,
46745	1549	27	and	and	CC
46745	1549	28	are	be	VBP
46745	1549	29	preparing	prepare	VBG
46745	1549	30	to	to	TO
46745	1549	31	be	be	VB
46745	1549	32	excreted	excrete	VBN
46745	1549	33	from	from	IN
46745	1549	34	the	the	DT
46745	1549	35	body	body	NN
46745	1549	36	.	.	.
46745	1550	1	By	by	IN
46745	1550	2	this	this	DT
46745	1550	3	oxidation	oxidation	NN
46745	1550	4	Wöhler	Wöhler	NNP
46745	1550	5	has	have	VBZ
46745	1550	6	proved	prove	VBN
46745	1550	7	that	that	IN
46745	1550	8	the	the	DT
46745	1550	9	alkaline	alkaline	NN
46745	1550	10	salts	salt	VBZ
46745	1550	11	with	with	IN
46745	1550	12	vegetable	vegetable	NN
46745	1550	13	acids	acid	NNS
46745	1550	14	are	be	VBP
46745	1550	15	changed	change	VBN
46745	1550	16	in	in	IN
46745	1550	17	the	the	DT
46745	1550	18	blood	blood	NN
46745	1550	19	into	into	IN
46745	1550	20	alkaline	alkaline	NN
46745	1550	21	carbonates	carbonate	NNS
46745	1550	22	.	.	.
46745	1551	1	From	from	IN
46745	1551	2	being	be	VBG
46745	1551	3	first	first	RB
46745	1551	4	neutral	neutral	JJ
46745	1551	5	,	,	,
46745	1551	6	they	-PRON-	PRP
46745	1551	7	become	become	VBP
46745	1551	8	now	now	RB
46745	1551	9	alkaline	alkaline	VBP
46745	1551	10	in	in	IN
46745	1551	11	their	-PRON-	PRP$
46745	1551	12	reaction	reaction	NN
46745	1551	13	,	,	,
46745	1551	14	and	and	CC
46745	1551	15	affect	affect	VB
46745	1551	16	the	the	DT
46745	1551	17	urine	urine	NN
46745	1551	18	in	in	IN
46745	1551	19	the	the	DT
46745	1551	20	same	same	JJ
46745	1551	21	way	way	NN
46745	1551	22	as	as	IN
46745	1551	23	free	free	JJ
46745	1551	24	alkalies	alkali	NNS
46745	1551	25	.	.	.
46745	1552	1	(	(	-LRB-
46745	1552	2	_	_	NNP
46745	1552	3	Vide	Vide	NNP
46745	1552	4	Hæmatics	Hæmatics	NNP
46745	1552	5	,	,	,
46745	1552	6	ord	ord	NN
46745	1552	7	.	.	.
46745	1553	1	Acida	Acida	NNP
46745	1553	2	,	,	,
46745	1553	3	Alkalia	Alkalia	NNP
46745	1553	4	,	,	,
46745	1553	5	Tonica	Tonica	NNP
46745	1553	6	,	,	,
46745	1553	7	Solventia	Solventia	NNP
46745	1553	8	.	.	.
46745	1553	9	_	_	NNP
46745	1553	10	)	)	-RRB-
46745	1553	11	We	-PRON-	PRP
46745	1553	12	have	have	VBP
46745	1553	13	now	now	RB
46745	1553	14	to	to	TO
46745	1553	15	treat	treat	VB
46745	1553	16	of	of	IN
46745	1553	17	the	the	DT
46745	1553	18	actions	action	NNS
46745	1553	19	of	of	IN
46745	1553	20	medicines	medicine	NNS
46745	1553	21	in	in	IN
46745	1553	22	the	the	DT
46745	1553	23	blood	blood	NN
46745	1553	24	.	.	.
46745	1554	1	These	these	DT
46745	1554	2	are	be	VBP
46745	1554	3	recited	recite	VBN
46745	1554	4	in	in	IN
46745	1554	5	the	the	DT
46745	1554	6	four	four	CD
46745	1554	7	remaining	remain	VBG
46745	1554	8	Propositions	Propositions	NNPS
46745	1554	9	.	.	.
46745	1555	1	The	the	DT
46745	1555	2	seventh	seventh	JJ
46745	1555	3	treats	treat	NNS
46745	1555	4	of	of	IN
46745	1555	5	Hæmatics	Hæmatics	NNPS
46745	1555	6	,	,	,
46745	1555	7	acting	act	VBG
46745	1555	8	primarily	primarily	RB
46745	1555	9	in	in	IN
46745	1555	10	the	the	DT
46745	1555	11	blood	blood	NN
46745	1555	12	.	.	.
46745	1556	1	The	the	DT
46745	1556	2	eighth	eighth	JJ
46745	1556	3	treats	treat	NNS
46745	1556	4	of	of	IN
46745	1556	5	Neurotics	Neurotics	NNP
46745	1556	6	,	,	,
46745	1556	7	passing	pass	VBG
46745	1556	8	from	from	IN
46745	1556	9	the	the	DT
46745	1556	10	blood	blood	NN
46745	1556	11	to	to	IN
46745	1556	12	the	the	DT
46745	1556	13	nerves	nerve	NNS
46745	1556	14	.	.	.
46745	1557	1	The	the	DT
46745	1557	2	ninth	ninth	JJ
46745	1557	3	of	of	IN
46745	1557	4	Astringents	astringent	NNS
46745	1557	5	,	,	,
46745	1557	6	passing	pass	VBG
46745	1557	7	to	to	IN
46745	1557	8	muscular	muscular	JJ
46745	1557	9	fibre	fibre	NN
46745	1557	10	.	.	.
46745	1558	1	The	the	DT
46745	1558	2	tenth	tenth	JJ
46745	1558	3	and	and	CC
46745	1558	4	last	last	JJ
46745	1558	5	treats	treat	NNS
46745	1558	6	of	of	IN
46745	1558	7	Eliminatives	Eliminatives	NNPS
46745	1558	8	,	,	,
46745	1558	9	which	which	WDT
46745	1558	10	pass	pass	VBP
46745	1558	11	out	out	IN
46745	1558	12	of	of	IN
46745	1558	13	the	the	DT
46745	1558	14	body	body	NN
46745	1558	15	through	through	IN
46745	1558	16	the	the	DT
46745	1558	17	glands	gland	NNS
46745	1558	18	.	.	.
46745	1559	1	PROP	PROP	NNP
46745	1559	2	.	.	.
46745	1560	1	VII.--_That	vii.--_that	IN
46745	1560	2	a	a	DT
46745	1560	3	first	first	JJ
46745	1560	4	class	class	NN
46745	1560	5	of	of	IN
46745	1560	6	medicines	medicine	NNS
46745	1560	7	,	,	,
46745	1560	8	called	call	VBD
46745	1560	9	_	_	NNP
46745	1560	10	HÆMATICS	HÆMATICS	NNP
46745	1560	11	,	,	,
46745	1560	12	_	_	NNP
46745	1560	13	act	act	NN
46745	1560	14	while	while	IN
46745	1560	15	in	in	IN
46745	1560	16	the	the	DT
46745	1560	17	blood	blood	NN
46745	1560	18	,	,	,
46745	1560	19	which	which	WDT
46745	1560	20	they	-PRON-	PRP
46745	1560	21	influence	influence	VBP
46745	1560	22	.	.	.
46745	1561	1	That	that	IN
46745	1561	2	their	-PRON-	PRP$
46745	1561	3	action	action	NN
46745	1561	4	is	be	VBZ
46745	1561	5	permanent	permanent	JJ
46745	1561	6	.	.	.
46745	1561	7	_	_	NNP
46745	1561	8	1	1	CD
46745	1561	9	.	.	.
46745	1562	1	_	_	NNP
46745	1562	2	That	that	DT
46745	1562	3	of	of	IN
46745	1562	4	these	these	DT
46745	1562	5	,	,	,
46745	1562	6	some	some	DT
46745	1562	7	,	,	,
46745	1562	8	called	call	VBN
46745	1562	9	_	_	NNP
46745	1562	10	RESTORATIVES	RESTORATIVES	NNP
46745	1562	11	,	,	,
46745	1562	12	_	_	NNP
46745	1562	13	act	act	NN
46745	1562	14	by	by	IN
46745	1562	15	supplying	supply	VBG
46745	1562	16	,	,	,
46745	1562	17	or	or	CC
46745	1562	18	causing	cause	VBG
46745	1562	19	to	to	TO
46745	1562	20	be	be	VB
46745	1562	21	supplied	supply	VBN
46745	1562	22	,	,	,
46745	1562	23	a	a	DT
46745	1562	24	material	material	NN
46745	1562	25	wanting	wanting	NN
46745	1562	26	,	,	,
46745	1562	27	and	and	CC
46745	1562	28	may	may	MD
46745	1562	29	remain	remain	VB
46745	1562	30	in	in	IN
46745	1562	31	the	the	DT
46745	1562	32	blood	blood	NN
46745	1562	33	.	.	.
46745	1562	34	_	_	NNP
46745	1562	35	2	2	CD
46745	1562	36	.	.	.
46745	1563	1	_	_	NNP
46745	1563	2	That	that	IN
46745	1563	3	others	other	NNS
46745	1563	4	,	,	,
46745	1563	5	called	call	VBD
46745	1563	6	_	_	NNP
46745	1563	7	CATALYTICS	CATALYTICS	NNP
46745	1563	8	,	,	,
46745	1563	9	_	_	NNP
46745	1563	10	act	act	NN
46745	1563	11	so	so	IN
46745	1563	12	as	as	IN
46745	1563	13	to	to	TO
46745	1563	14	counteract	counteract	VB
46745	1563	15	a	a	DT
46745	1563	16	morbid	morbid	NN
46745	1563	17	material	material	NN
46745	1563	18	or	or	CC
46745	1563	19	process	process	NN
46745	1563	20	,	,	,
46745	1563	21	and	and	CC
46745	1563	22	must	must	MD
46745	1563	23	pass	pass	VB
46745	1563	24	out	out	IN
46745	1563	25	of	of	IN
46745	1563	26	the	the	DT
46745	1563	27	body	body	NN
46745	1563	28	.	.	.
46745	1563	29	_	_	NNP
46745	1563	30	Supposing	Supposing	NNP
46745	1563	31	that	that	IN
46745	1563	32	a	a	DT
46745	1563	33	medicine	medicine	NN
46745	1563	34	has	have	VBZ
46745	1563	35	fairly	fairly	RB
46745	1563	36	passed	pass	VBN
46745	1563	37	into	into	IN
46745	1563	38	the	the	DT
46745	1563	39	blood	blood	NN
46745	1563	40	,	,	,
46745	1563	41	and	and	CC
46745	1563	42	circulates	circulate	VBZ
46745	1563	43	round	round	RB
46745	1563	44	with	with	IN
46745	1563	45	it	-PRON-	PRP
46745	1563	46	,	,	,
46745	1563	47	there	there	EX
46745	1563	48	are	be	VBP
46745	1563	49	now	now	RB
46745	1563	50	two	two	CD
46745	1563	51	ways	way	NNS
46745	1563	52	in	in	IN
46745	1563	53	which	which	WDT
46745	1563	54	it	-PRON-	PRP
46745	1563	55	may	may	MD
46745	1563	56	behave	behave	VB
46745	1563	57	itself	-PRON-	PRP
46745	1563	58	.	.	.
46745	1564	1	In	in	IN
46745	1564	2	the	the	DT
46745	1564	3	first	first	JJ
46745	1564	4	place	place	NN
46745	1564	5	,	,	,
46745	1564	6	it	-PRON-	PRP
46745	1564	7	may	may	MD
46745	1564	8	have	have	VB
46745	1564	9	a	a	DT
46745	1564	10	tendency	tendency	NN
46745	1564	11	towards	towards	IN
46745	1564	12	some	some	DT
46745	1564	13	tissues	tissue	NNS
46745	1564	14	or	or	CC
46745	1564	15	parts	part	NNS
46745	1564	16	of	of	IN
46745	1564	17	the	the	DT
46745	1564	18	body	body	NN
46745	1564	19	,	,	,
46745	1564	20	on	on	IN
46745	1564	21	which	which	WDT
46745	1564	22	to	to	TO
46745	1564	23	exert	exert	VB
46745	1564	24	its	-PRON-	PRP$
46745	1564	25	powers	power	NNS
46745	1564	26	,	,	,
46745	1564	27	as	as	IN
46745	1564	28	the	the	DT
46745	1564	29	nerves	nerve	NNS
46745	1564	30	,	,	,
46745	1564	31	or	or	CC
46745	1564	32	the	the	DT
46745	1564	33	glands	gland	NNS
46745	1564	34	,	,	,
46745	1564	35	or	or	CC
46745	1564	36	muscular	muscular	JJ
46745	1564	37	fibre	fibre	NN
46745	1564	38	,	,	,
46745	1564	39	and	and	CC
46745	1564	40	may	may	MD
46745	1564	41	use	use	VB
46745	1564	42	the	the	DT
46745	1564	43	blood	blood	NN
46745	1564	44	only	only	RB
46745	1564	45	as	as	IN
46745	1564	46	a	a	DT
46745	1564	47	vehicle	vehicle	NN
46745	1564	48	by	by	IN
46745	1564	49	which	which	WDT
46745	1564	50	most	most	RBS
46745	1564	51	readily	readily	RB
46745	1564	52	and	and	CC
46745	1564	53	easily	easily	RB
46745	1564	54	to	to	TO
46745	1564	55	attain	attain	VB
46745	1564	56	to	to	IN
46745	1564	57	these	these	DT
46745	1564	58	.	.	.
46745	1565	1	Such	such	JJ
46745	1565	2	are	be	VBP
46745	1565	3	Neurotics	neurotic	NNS
46745	1565	4	,	,	,
46745	1565	5	Astringents	Astringents	NNPS
46745	1565	6	,	,	,
46745	1565	7	and	and	CC
46745	1565	8	Eliminatives	Eliminatives	NNPS
46745	1565	9	.	.	.
46745	1566	1	They	-PRON-	PRP
46745	1566	2	may	may	MD
46745	1566	3	not	not	RB
46745	1566	4	affect	affect	VB
46745	1566	5	the	the	DT
46745	1566	6	blood	blood	NN
46745	1566	7	,	,	,
46745	1566	8	but	but	CC
46745	1566	9	they	-PRON-	PRP
46745	1566	10	must	must	MD
46745	1566	11	pass	pass	VB
46745	1566	12	through	through	IN
46745	1566	13	it	-PRON-	PRP
46745	1566	14	.	.	.
46745	1567	1	But	but	CC
46745	1567	2	there	there	EX
46745	1567	3	is	be	VBZ
46745	1567	4	another	another	DT
46745	1567	5	and	and	CC
46745	1567	6	still	still	RB
46745	1567	7	more	more	RBR
46745	1567	8	important	important	JJ
46745	1567	9	class	class	NN
46745	1567	10	of	of	IN
46745	1567	11	medicines	medicine	NNS
46745	1567	12	,	,	,
46745	1567	13	whose	whose	WP$
46745	1567	14	action	action	NN
46745	1567	15	is	be	VBZ
46745	1567	16	particularly	particularly	RB
46745	1567	17	directed	direct	VBN
46745	1567	18	towards	towards	IN
46745	1567	19	the	the	DT
46745	1567	20	blood	blood	NN
46745	1567	21	itself	-PRON-	PRP
46745	1567	22	.	.	.
46745	1568	1	The	the	DT
46745	1568	2	blood	blood	NN
46745	1568	3	,	,	,
46745	1568	4	after	after	IN
46745	1568	5	their	-PRON-	PRP$
46745	1568	6	action	action	NN
46745	1568	7	,	,	,
46745	1568	8	is	be	VBZ
46745	1568	9	different	different	JJ
46745	1568	10	from	from	IN
46745	1568	11	what	what	WP
46745	1568	12	it	-PRON-	PRP
46745	1568	13	was	be	VBD
46745	1568	14	before	before	RB
46745	1568	15	.	.	.
46745	1569	1	It	-PRON-	PRP
46745	1569	2	may	may	MD
46745	1569	3	be	be	VB
46745	1569	4	a	a	DT
46745	1569	5	change	change	NN
46745	1569	6	for	for	IN
46745	1569	7	the	the	DT
46745	1569	8	better	well	JJR
46745	1569	9	or	or	CC
46745	1569	10	for	for	IN
46745	1569	11	the	the	DT
46745	1569	12	worse	bad	JJR
46745	1569	13	;	;	:
46745	1569	14	but	but	CC
46745	1569	15	there	there	EX
46745	1569	16	certainly	certainly	RB
46745	1569	17	is	be	VBZ
46745	1569	18	a	a	DT
46745	1569	19	change	change	NN
46745	1569	20	.	.	.
46745	1570	1	Medical	medical	JJ
46745	1570	2	authors	author	NNS
46745	1570	3	,	,	,
46745	1570	4	with	with	IN
46745	1570	5	few	few	JJ
46745	1570	6	exceptions	exception	NNS
46745	1570	7	,	,	,
46745	1570	8	have	have	VBP
46745	1570	9	been	be	VBN
46745	1570	10	very	very	RB
46745	1570	11	backward	backward	JJ
46745	1570	12	to	to	TO
46745	1570	13	acknowledge	acknowledge	VB
46745	1570	14	the	the	DT
46745	1570	15	existence	existence	NN
46745	1570	16	of	of	IN
46745	1570	17	medicines	medicine	NNS
46745	1570	18	of	of	IN
46745	1570	19	this	this	DT
46745	1570	20	description	description	NN
46745	1570	21	.	.	.
46745	1571	1	But	but	CC
46745	1571	2	even	even	RB
46745	1571	3	those	those	DT
46745	1571	4	who	who	WP
46745	1571	5	would	would	MD
46745	1571	6	fain	fain	VB
46745	1571	7	have	have	VB
46745	1571	8	classed	class	VBN
46745	1571	9	all	all	DT
46745	1571	10	medicines	medicine	NNS
46745	1571	11	as	as	IN
46745	1571	12	stimulants	stimulant	NNS
46745	1571	13	or	or	CC
46745	1571	14	sedatives	sedative	NNS
46745	1571	15	,	,	,
46745	1571	16	differing	differ	VBG
46745	1571	17	only	only	RB
46745	1571	18	in	in	IN
46745	1571	19	the	the	DT
46745	1571	20	kind	kind	NN
46745	1571	21	or	or	CC
46745	1571	22	degree	degree	NN
46745	1571	23	of	of	IN
46745	1571	24	their	-PRON-	PRP$
46745	1571	25	action	action	NN
46745	1571	26	on	on	IN
46745	1571	27	the	the	DT
46745	1571	28	nervous	nervous	JJ
46745	1571	29	system	system	NN
46745	1571	30	,	,	,
46745	1571	31	have	have	VBP
46745	1571	32	in	in	IN
46745	1571	33	many	many	JJ
46745	1571	34	cases	case	NNS
46745	1571	35	been	be	VBN
46745	1571	36	obliged	oblige	VBN
46745	1571	37	to	to	TO
46745	1571	38	confess	confess	VB
46745	1571	39	that	that	IN
46745	1571	40	there	there	EX
46745	1571	41	is	be	VBZ
46745	1571	42	a	a	DT
46745	1571	43	set	set	NN
46745	1571	44	of	of	IN
46745	1571	45	remedies	remedy	NNS
46745	1571	46	which	which	WDT
46745	1571	47	they	-PRON-	PRP
46745	1571	48	call	call	VBP
46745	1571	49	"	"	``
46745	1571	50	Alteratives	alterative	NNS
46745	1571	51	,	,	,
46745	1571	52	"	"	''
46745	1571	53	whose	whose	WP$
46745	1571	54	action	action	NN
46745	1571	55	,	,	,
46745	1571	56	though	though	IN
46745	1571	57	slower	slow	JJR
46745	1571	58	,	,	,
46745	1571	59	is	be	VBZ
46745	1571	60	more	more	RBR
46745	1571	61	certain	certain	JJ
46745	1571	62	and	and	CC
46745	1571	63	more	more	RBR
46745	1571	64	durable	durable	JJ
46745	1571	65	than	than	IN
46745	1571	66	that	that	DT
46745	1571	67	of	of	IN
46745	1571	68	the	the	DT
46745	1571	69	former	former	JJ
46745	1571	70	.	.	.
46745	1572	1	It	-PRON-	PRP
46745	1572	2	is	be	VBZ
46745	1572	3	allowed	allow	VBN
46745	1572	4	that	that	IN
46745	1572	5	they	-PRON-	PRP
46745	1572	6	alter	alter	VBP
46745	1572	7	the	the	DT
46745	1572	8	condition	condition	NN
46745	1572	9	of	of	IN
46745	1572	10	the	the	DT
46745	1572	11	blood	blood	NN
46745	1572	12	.	.	.
46745	1573	1	To	to	TO
46745	1573	2	suppose	suppose	VB
46745	1573	3	that	that	IN
46745	1573	4	they	-PRON-	PRP
46745	1573	5	do	do	VBP
46745	1573	6	so	so	RB
46745	1573	7	by	by	IN
46745	1573	8	first	first	RB
46745	1573	9	influencing	influence	VBG
46745	1573	10	the	the	DT
46745	1573	11	nerves	nerve	NNS
46745	1573	12	,	,	,
46745	1573	13	is	be	VBZ
46745	1573	14	to	to	TO
46745	1573	15	adopt	adopt	VB
46745	1573	16	a	a	DT
46745	1573	17	circuitous	circuitous	JJ
46745	1573	18	and	and	CC
46745	1573	19	uncalled	uncalled	JJ
46745	1573	20	-	-	HYPH
46745	1573	21	for	for	IN
46745	1573	22	explanation	explanation	NN
46745	1573	23	.	.	.
46745	1574	1	It	-PRON-	PRP
46745	1574	2	is	be	VBZ
46745	1574	3	proved	prove	VBN
46745	1574	4	that	that	IN
46745	1574	5	they	-PRON-	PRP
46745	1574	6	pass	pass	VBP
46745	1574	7	into	into	IN
46745	1574	8	the	the	DT
46745	1574	9	blood	blood	NN
46745	1574	10	.	.	.
46745	1575	1	It	-PRON-	PRP
46745	1575	2	is	be	VBZ
46745	1575	3	known	know	VBN
46745	1575	4	that	that	IN
46745	1575	5	when	when	WRB
46745	1575	6	actually	actually	RB
46745	1575	7	applied	apply	VBN
46745	1575	8	to	to	IN
46745	1575	9	nerves	nerve	NNS
46745	1575	10	,	,	,
46745	1575	11	they	-PRON-	PRP
46745	1575	12	do	do	VBP
46745	1575	13	not	not	RB
46745	1575	14	affect	affect	VB
46745	1575	15	them	-PRON-	PRP
46745	1575	16	.	.	.
46745	1576	1	From	from	IN
46745	1576	2	these	these	DT
46745	1576	3	considerations	consideration	NNS
46745	1576	4	merely	merely	RB
46745	1576	5	,	,	,
46745	1576	6	without	without	IN
46745	1576	7	further	further	JJ
46745	1576	8	evidence	evidence	NN
46745	1576	9	,	,	,
46745	1576	10	it	-PRON-	PRP
46745	1576	11	would	would	MD
46745	1576	12	seem	seem	VB
46745	1576	13	tolerably	tolerably	RB
46745	1576	14	clear	clear	JJ
46745	1576	15	that	that	IN
46745	1576	16	they	-PRON-	PRP
46745	1576	17	act	act	VBP
46745	1576	18	by	by	IN
46745	1576	19	influencing	influence	VBG
46745	1576	20	the	the	DT
46745	1576	21	blood	blood	NN
46745	1576	22	itself	-PRON-	PRP
46745	1576	23	,	,	,
46745	1576	24	simply	simply	RB
46745	1576	25	and	and	CC
46745	1576	26	solely	solely	RB
46745	1576	27	.	.	.
46745	1577	1	But	but	CC
46745	1577	2	this	this	DT
46745	1577	3	it	-PRON-	PRP
46745	1577	4	will	will	MD
46745	1577	5	be	be	VB
46745	1577	6	my	-PRON-	PRP$
46745	1577	7	business	business	NN
46745	1577	8	to	to	TO
46745	1577	9	prove	prove	VB
46745	1577	10	more	more	JJR
46745	1577	11	at	at	IN
46745	1577	12	length	length	NN
46745	1577	13	directly	directly	RB
46745	1577	14	.	.	.
46745	1578	1	Such	such	JJ
46745	1578	2	medicines	medicine	NNS
46745	1578	3	,	,	,
46745	1578	4	then	then	RB
46745	1578	5	,	,	,
46745	1578	6	I	-PRON-	PRP
46745	1578	7	have	have	VBP
46745	1578	8	designated	designate	VBN
46745	1578	9	Hæmatics	Hæmatics	NNPS
46745	1578	10	,	,	,
46745	1578	11	a	a	DT
46745	1578	12	simple	simple	JJ
46745	1578	13	and	and	CC
46745	1578	14	expressive	expressive	JJ
46745	1578	15	term	term	NN
46745	1578	16	which	which	WDT
46745	1578	17	has	have	VBZ
46745	1578	18	been	be	VBN
46745	1578	19	used	use	VBN
46745	1578	20	by	by	IN
46745	1578	21	others	other	NNS
46745	1578	22	before	before	IN
46745	1578	23	me	-PRON-	PRP
46745	1578	24	.	.	.
46745	1579	1	It	-PRON-	PRP
46745	1579	2	is	be	VBZ
46745	1579	3	obviously	obviously	RB
46745	1579	4	necessary	necessary	JJ
46745	1579	5	that	that	IN
46745	1579	6	a	a	DT
46745	1579	7	medicine	medicine	NN
46745	1579	8	of	of	IN
46745	1579	9	this	this	DT
46745	1579	10	class	class	NN
46745	1579	11	should	should	MD
46745	1579	12	be	be	VB
46745	1579	13	absorbed	absorb	VBN
46745	1579	14	.	.	.
46745	1580	1	Now	now	RB
46745	1580	2	some	some	DT
46745	1580	3	of	of	IN
46745	1580	4	them	-PRON-	PRP
46745	1580	5	tend	tend	VBP
46745	1580	6	in	in	IN
46745	1580	7	the	the	DT
46745	1580	8	end	end	NN
46745	1580	9	to	to	TO
46745	1580	10	act	act	VB
46745	1580	11	on	on	IN
46745	1580	12	the	the	DT
46745	1580	13	nerves	nerve	NNS
46745	1580	14	or	or	CC
46745	1580	15	on	on	IN
46745	1580	16	the	the	DT
46745	1580	17	glands	gland	NNS
46745	1580	18	,	,	,
46745	1580	19	not	not	RB
46745	1580	20	merely	merely	RB
46745	1580	21	indirectly	indirectly	RB
46745	1580	22	,	,	,
46745	1580	23	but	but	CC
46745	1580	24	by	by	IN
46745	1580	25	bodily	bodily	JJ
46745	1580	26	contact	contact	NN
46745	1580	27	.	.	.
46745	1581	1	But	but	CC
46745	1581	2	,	,	,
46745	1581	3	whatever	whatever	WDT
46745	1581	4	their	-PRON-	PRP$
46745	1581	5	subsequent	subsequent	JJ
46745	1581	6	action	action	NN
46745	1581	7	,	,	,
46745	1581	8	they	-PRON-	PRP
46745	1581	9	exert	exert	VBP
46745	1581	10	a	a	DT
46745	1581	11	primary	primary	JJ
46745	1581	12	and	and	CC
46745	1581	13	apparent	apparent	JJ
46745	1581	14	influence	influence	NN
46745	1581	15	on	on	IN
46745	1581	16	the	the	DT
46745	1581	17	blood	blood	NN
46745	1581	18	itself	-PRON-	PRP
46745	1581	19	.	.	.
46745	1582	1	A	a	DT
46745	1582	2	little	little	JJ
46745	1582	3	reflection	reflection	NN
46745	1582	4	will	will	MD
46745	1582	5	convince	convince	VB
46745	1582	6	us	-PRON-	PRP
46745	1582	7	that	that	IN
46745	1582	8	these	these	DT
46745	1582	9	remedies	remedy	NNS
46745	1582	10	are	be	VBP
46745	1582	11	more	more	RBR
46745	1582	12	efficient	efficient	JJ
46745	1582	13	than	than	IN
46745	1582	14	any	any	DT
46745	1582	15	others	other	NNS
46745	1582	16	that	that	WDT
46745	1582	17	can	can	MD
46745	1582	18	be	be	VB
46745	1582	19	selected	select	VBN
46745	1582	20	out	out	IN
46745	1582	21	of	of	IN
46745	1582	22	the	the	DT
46745	1582	23	armory	armory	NN
46745	1582	24	of	of	IN
46745	1582	25	physic	physic	NN
46745	1582	26	.	.	.
46745	1583	1	It	-PRON-	PRP
46745	1583	2	is	be	VBZ
46745	1583	3	easy	easy	JJ
46745	1583	4	,	,	,
46745	1583	5	and	and	CC
46745	1583	6	satisfactory	satisfactory	JJ
46745	1583	7	for	for	IN
46745	1583	8	the	the	DT
46745	1583	9	time	time	NN
46745	1583	10	,	,	,
46745	1583	11	to	to	TO
46745	1583	12	allay	allay	VB
46745	1583	13	nervous	nervous	JJ
46745	1583	14	excitement	excitement	NN
46745	1583	15	by	by	IN
46745	1583	16	employing	employ	VBG
46745	1583	17	a	a	DT
46745	1583	18	sedative	sedative	NN
46745	1583	19	,	,	,
46745	1583	20	or	or	CC
46745	1583	21	by	by	IN
46745	1583	22	using	use	VBG
46745	1583	23	a	a	DT
46745	1583	24	stimulant	stimulant	NN
46745	1583	25	to	to	TO
46745	1583	26	communicate	communicate	VB
46745	1583	27	to	to	IN
46745	1583	28	the	the	DT
46745	1583	29	system	system	NN
46745	1583	30	a	a	DT
46745	1583	31	temporary	temporary	JJ
46745	1583	32	strength	strength	NN
46745	1583	33	.	.	.
46745	1584	1	It	-PRON-	PRP
46745	1584	2	is	be	VBZ
46745	1584	3	easy	easy	JJ
46745	1584	4	to	to	TO
46745	1584	5	knock	knock	VB
46745	1584	6	down	down	RP
46745	1584	7	an	an	DT
46745	1584	8	inflammation	inflammation	NN
46745	1584	9	,	,	,
46745	1584	10	or	or	CC
46745	1584	11	to	to	TO
46745	1584	12	evacuate	evacuate	VB
46745	1584	13	morbid	morbid	NN
46745	1584	14	humours	humours	NN
46745	1584	15	,	,	,
46745	1584	16	by	by	IN
46745	1584	17	stirring	stir	VBG
46745	1584	18	up	up	RP
46745	1584	19	the	the	DT
46745	1584	20	glands	gland	NNS
46745	1584	21	with	with	IN
46745	1584	22	a	a	DT
46745	1584	23	powerful	powerful	JJ
46745	1584	24	eliminative	eliminative	NN
46745	1584	25	.	.	.
46745	1585	1	But	but	CC
46745	1585	2	these	these	DT
46745	1585	3	are	be	VBP
46745	1585	4	all	all	RB
46745	1585	5	at	at	IN
46745	1585	6	the	the	DT
46745	1585	7	best	good	JJS
46745	1585	8	but	but	CC
46745	1585	9	temporary	temporary	JJ
46745	1585	10	measures	measure	NNS
46745	1585	11	.	.	.
46745	1586	1	Unless	unless	IN
46745	1586	2	the	the	DT
46745	1586	3	exigency	exigency	NN
46745	1586	4	be	be	VB
46745	1586	5	also	also	RB
46745	1586	6	of	of	IN
46745	1586	7	a	a	DT
46745	1586	8	temporary	temporary	JJ
46745	1586	9	character	character	NN
46745	1586	10	,	,	,
46745	1586	11	the	the	DT
46745	1586	12	disorder	disorder	NN
46745	1586	13	may	may	MD
46745	1586	14	soon	soon	RB
46745	1586	15	return	return	VB
46745	1586	16	with	with	IN
46745	1586	17	unabated	unabated	JJ
46745	1586	18	violence	violence	NN
46745	1586	19	;	;	:
46745	1586	20	again	again	RB
46745	1586	21	is	be	VBZ
46745	1586	22	the	the	DT
46745	1586	23	patient	patient	NN
46745	1586	24	bowed	bow	VBD
46745	1586	25	down	down	RP
46745	1586	26	by	by	IN
46745	1586	27	its	-PRON-	PRP$
46745	1586	28	strong	strong	JJ
46745	1586	29	hand	hand	NN
46745	1586	30	;	;	:
46745	1586	31	again	again	RB
46745	1586	32	is	be	VBZ
46745	1586	33	the	the	DT
46745	1586	34	fatal	fatal	JJ
46745	1586	35	termination	termination	NN
46745	1586	36	seen	see	VBN
46745	1586	37	looming	loom	VBG
46745	1586	38	in	in	IN
46745	1586	39	the	the	DT
46745	1586	40	distance	distance	NN
46745	1586	41	but	but	CC
46745	1586	42	too	too	RB
46745	1586	43	distinctly	distinctly	RB
46745	1586	44	.	.	.
46745	1587	1	Then	then	RB
46745	1587	2	has	have	VBZ
46745	1587	3	the	the	DT
46745	1587	4	physician	physician	NN
46745	1587	5	to	to	TO
46745	1587	6	call	call	VB
46745	1587	7	to	to	IN
46745	1587	8	his	-PRON-	PRP$
46745	1587	9	aid	aid	NN
46745	1587	10	more	more	RBR
46745	1587	11	potent	potent	JJ
46745	1587	12	means	mean	NNS
46745	1587	13	,	,	,
46745	1587	14	remedies	remedy	NNS
46745	1587	15	of	of	IN
46745	1587	16	more	more	RBR
46745	1587	17	permanent	permanent	JJ
46745	1587	18	and	and	CC
46745	1587	19	certain	certain	JJ
46745	1587	20	efficacy	efficacy	NN
46745	1587	21	.	.	.
46745	1588	1	The	the	DT
46745	1588	2	disease	disease	NN
46745	1588	3	is	be	VBZ
46745	1588	4	in	in	IN
46745	1588	5	the	the	DT
46745	1588	6	blood	blood	NN
46745	1588	7	--	--	:
46745	1588	8	ever	ever	RB
46745	1588	9	circulating	circulate	VBG
46745	1588	10	,	,	,
46745	1588	11	breeding	breed	VBG
46745	1588	12	,	,	,
46745	1588	13	and	and	CC
46745	1588	14	destroying	destroy	VBG
46745	1588	15	.	.	.
46745	1589	1	It	-PRON-	PRP
46745	1589	2	is	be	VBZ
46745	1589	3	there	there	RB
46745	1589	4	that	that	IN
46745	1589	5	it	-PRON-	PRP
46745	1589	6	must	must	MD
46745	1589	7	be	be	VB
46745	1589	8	met	meet	VBN
46745	1589	9	;	;	:
46745	1589	10	let	let	VB
46745	1589	11	the	the	DT
46745	1589	12	physician	physician	NN
46745	1589	13	strike	strike	VB
46745	1589	14	boldly	boldly	RB
46745	1589	15	and	and	CC
46745	1589	16	warily	warily	RB
46745	1589	17	there	there	RB
46745	1589	18	,	,	,
46745	1589	19	if	if	IN
46745	1589	20	he	-PRON-	PRP
46745	1589	21	would	would	MD
46745	1589	22	effect	effect	VB
46745	1589	23	a	a	DT
46745	1589	24	cure	cure	NN
46745	1589	25	.	.	.
46745	1590	1	These	these	DT
46745	1590	2	medicines	medicine	NNS
46745	1590	3	,	,	,
46745	1590	4	then	then	RB
46745	1590	5	,	,	,
46745	1590	6	act	act	VB
46745	1590	7	in	in	IN
46745	1590	8	the	the	DT
46745	1590	9	blood	blood	NN
46745	1590	10	.	.	.
46745	1591	1	How	how	WRB
46745	1591	2	they	-PRON-	PRP
46745	1591	3	do	do	VBP
46745	1591	4	so	so	RB
46745	1591	5	,	,	,
46745	1591	6	and	and	CC
46745	1591	7	in	in	IN
46745	1591	8	what	what	WDT
46745	1591	9	way	way	NN
46745	1591	10	they	-PRON-	PRP
46745	1591	11	prove	prove	VBP
46745	1591	12	of	of	IN
46745	1591	13	use	use	NN
46745	1591	14	in	in	IN
46745	1591	15	the	the	DT
46745	1591	16	cure	cure	NN
46745	1591	17	of	of	IN
46745	1591	18	disease	disease	NN
46745	1591	19	,	,	,
46745	1591	20	I	-PRON-	PRP
46745	1591	21	shall	shall	MD
46745	1591	22	next	next	RB
46745	1591	23	have	have	VB
46745	1591	24	to	to	TO
46745	1591	25	show	show	VB
46745	1591	26	,	,	,
46745	1591	27	while	while	IN
46745	1591	28	attempting	attempt	VBG
46745	1591	29	to	to	TO
46745	1591	30	prove	prove	VB
46745	1591	31	the	the	DT
46745	1591	32	proposition	proposition	NN
46745	1591	33	in	in	IN
46745	1591	34	which	which	WDT
46745	1591	35	I	-PRON-	PRP
46745	1591	36	have	have	VBP
46745	1591	37	briefly	briefly	RB
46745	1591	38	stated	state	VBN
46745	1591	39	this	this	DT
46745	1591	40	mode	mode	NN
46745	1591	41	of	of	IN
46745	1591	42	operation	operation	NN
46745	1591	43	.	.	.
46745	1592	1	Hæmatics	hæmatic	NNS
46745	1592	2	are	be	VBP
46745	1592	3	very	very	RB
46745	1592	4	numerous	numerous	JJ
46745	1592	5	,	,	,
46745	1592	6	and	and	CC
46745	1592	7	very	very	RB
46745	1592	8	important	important	JJ
46745	1592	9	:	:	:
46745	1592	10	I	-PRON-	PRP
46745	1592	11	shall	shall	MD
46745	1592	12	thus	thus	RB
46745	1592	13	devote	devote	VB
46745	1592	14	some	some	DT
46745	1592	15	space	space	NN
46745	1592	16	to	to	IN
46745	1592	17	their	-PRON-	PRP$
46745	1592	18	consideration	consideration	NN
46745	1592	19	.	.	.
46745	1593	1	But	but	CC
46745	1593	2	I	-PRON-	PRP
46745	1593	3	must	must	MD
46745	1593	4	first	first	RB
46745	1593	5	lay	lay	VB
46745	1593	6	down	down	RP
46745	1593	7	a	a	DT
46745	1593	8	broad	broad	JJ
46745	1593	9	distinction	distinction	NN
46745	1593	10	between	between	IN
46745	1593	11	the	the	DT
46745	1593	12	two	two	CD
46745	1593	13	divisions	division	NNS
46745	1593	14	of	of	IN
46745	1593	15	Hæmatic	hæmatic	JJ
46745	1593	16	medicines	medicine	NNS
46745	1593	17	.	.	.
46745	1594	1	The	the	DT
46745	1594	2	diseases	disease	NNS
46745	1594	3	in	in	IN
46745	1594	4	which	which	WDT
46745	1594	5	they	-PRON-	PRP
46745	1594	6	are	be	VBP
46745	1594	7	used	use	VBN
46745	1594	8	appear	appear	VBP
46745	1594	9	all	all	RB
46745	1594	10	to	to	TO
46745	1594	11	originate	originate	VB
46745	1594	12	in	in	IN
46745	1594	13	the	the	DT
46745	1594	14	blood	blood	NN
46745	1594	15	,	,	,
46745	1594	16	however	however	RB
46745	1594	17	they	-PRON-	PRP
46745	1594	18	may	may	MD
46745	1594	19	manifest	manifest	VB
46745	1594	20	themselves	-PRON-	PRP
46745	1594	21	.	.	.
46745	1595	1	Now	now	RB
46745	1595	2	some	some	DT
46745	1595	3	of	of	IN
46745	1595	4	these	these	DT
46745	1595	5	diseases	disease	NNS
46745	1595	6	originate	originate	VBP
46745	1595	7	in	in	IN
46745	1595	8	a	a	DT
46745	1595	9	want	want	NN
46745	1595	10	of	of	IN
46745	1595	11	some	some	DT
46745	1595	12	principle	principle	JJ
46745	1595	13	or	or	CC
46745	1595	14	constituent	constituent	NN
46745	1595	15	of	of	IN
46745	1595	16	the	the	DT
46745	1595	17	blood	blood	NN
46745	1595	18	,	,	,
46745	1595	19	which	which	WDT
46745	1595	20	want	want	VBP
46745	1595	21	causes	cause	VBZ
46745	1595	22	an	an	DT
46745	1595	23	aberration	aberration	NN
46745	1595	24	of	of	IN
46745	1595	25	the	the	DT
46745	1595	26	vital	vital	JJ
46745	1595	27	functions	function	NNS
46745	1595	28	.	.	.
46745	1596	1	Thus	thus	RB
46745	1596	2	,	,	,
46745	1596	3	in	in	IN
46745	1596	4	anæmia	anæmia	NN
46745	1596	5	,	,	,
46745	1596	6	there	there	EX
46745	1596	7	is	be	VBZ
46745	1596	8	a	a	DT
46745	1596	9	deficiency	deficiency	NN
46745	1596	10	of	of	IN
46745	1596	11	the	the	DT
46745	1596	12	Hæmatosin	Hæmatosin	NNP
46745	1596	13	of	of	IN
46745	1596	14	the	the	DT
46745	1596	15	blood	blood	NN
46745	1596	16	corpuscles	corpuscle	NNS
46745	1596	17	.	.	.
46745	1597	1	In	in	IN
46745	1597	2	simple	simple	JJ
46745	1597	3	debility	debility	NN
46745	1597	4	a	a	DT
46745	1597	5	want	want	NN
46745	1597	6	of	of	IN
46745	1597	7	a	a	DT
46745	1597	8	similar	similar	JJ
46745	1597	9	nature	nature	NN
46745	1597	10	probably	probably	RB
46745	1597	11	exists	exist	VBZ
46745	1597	12	.	.	.
46745	1598	1	In	in	IN
46745	1598	2	rheumatic	rheumatic	JJ
46745	1598	3	fever	fever	NN
46745	1598	4	and	and	CC
46745	1598	5	other	other	JJ
46745	1598	6	disorders	disorder	VBZ
46745	1598	7	an	an	DT
46745	1598	8	excess	excess	NN
46745	1598	9	of	of	IN
46745	1598	10	acid	acid	NN
46745	1598	11	is	be	VBZ
46745	1598	12	formed	form	VBN
46745	1598	13	and	and	CC
46745	1598	14	eliminated	eliminate	VBN
46745	1598	15	,	,	,
46745	1598	16	possibly	possibly	RB
46745	1598	17	from	from	IN
46745	1598	18	a	a	DT
46745	1598	19	want	want	NN
46745	1598	20	of	of	IN
46745	1598	21	the	the	DT
46745	1598	22	alkali	alkali	JJ
46745	1598	23	by	by	IN
46745	1598	24	which	which	WDT
46745	1598	25	it	-PRON-	PRP
46745	1598	26	should	should	MD
46745	1598	27	be	be	VB
46745	1598	28	neutralized	neutralize	VBN
46745	1598	29	.	.	.
46745	1599	1	In	in	IN
46745	1599	2	common	common	JJ
46745	1599	3	inflammatory	inflammatory	JJ
46745	1599	4	fever	fever	NN
46745	1599	5	there	there	EX
46745	1599	6	is	be	VBZ
46745	1599	7	an	an	DT
46745	1599	8	abnormal	abnormal	JJ
46745	1599	9	oxidation	oxidation	NN
46745	1599	10	of	of	IN
46745	1599	11	the	the	DT
46745	1599	12	Proteinaceous	proteinaceous	JJ
46745	1599	13	compounds	compound	NNS
46745	1599	14	,	,	,
46745	1599	15	possibly	possibly	RB
46745	1599	16	arising	arise	VBG
46745	1599	17	,	,	,
46745	1599	18	as	as	IN
46745	1599	19	we	-PRON-	PRP
46745	1599	20	shall	shall	MD
46745	1599	21	see	see	VB
46745	1599	22	hereafter	hereafter	RB
46745	1599	23	,	,	,
46745	1599	24	from	from	IN
46745	1599	25	a	a	DT
46745	1599	26	failure	failure	NN
46745	1599	27	of	of	IN
46745	1599	28	some	some	DT
46745	1599	29	principles	principle	NNS
46745	1599	30	which	which	WDT
46745	1599	31	are	be	VBP
46745	1599	32	the	the	DT
46745	1599	33	proper	proper	JJ
46745	1599	34	food	food	NN
46745	1599	35	of	of	IN
46745	1599	36	the	the	DT
46745	1599	37	oxygen	oxygen	NN
46745	1599	38	.	.	.
46745	1600	1	In	in	IN
46745	1600	2	diseases	disease	NNS
46745	1600	3	causing	cause	VBG
46745	1600	4	urinary	urinary	JJ
46745	1600	5	deposits	deposit	NNS
46745	1600	6	there	there	EX
46745	1600	7	is	be	VBZ
46745	1600	8	a	a	DT
46745	1600	9	want	want	NN
46745	1600	10	of	of	IN
46745	1600	11	those	those	DT
46745	1600	12	principles	principle	NNS
46745	1600	13	which	which	WDT
46745	1600	14	should	should	MD
46745	1600	15	naturally	naturally	RB
46745	1600	16	retain	retain	VB
46745	1600	17	them	-PRON-	PRP
46745	1600	18	in	in	IN
46745	1600	19	solution	solution	NN
46745	1600	20	.	.	.
46745	1601	1	In	in	IN
46745	1601	2	typhoid	typhoid	NN
46745	1601	3	fever	fever	NN
46745	1601	4	there	there	EX
46745	1601	5	is	be	VBZ
46745	1601	6	said	say	VBN
46745	1601	7	to	to	TO
46745	1601	8	be	be	VB
46745	1601	9	an	an	DT
46745	1601	10	excess	excess	NN
46745	1601	11	of	of	IN
46745	1601	12	basic	basic	JJ
46745	1601	13	matter	matter	NN
46745	1601	14	,	,	,
46745	1601	15	and	and	CC
46745	1601	16	a	a	DT
46745	1601	17	deficiency	deficiency	NN
46745	1601	18	of	of	IN
46745	1601	19	acid	acid	NN
46745	1601	20	,	,	,
46745	1601	21	in	in	IN
46745	1601	22	the	the	DT
46745	1601	23	blood	blood	NN
46745	1601	24	.	.	.
46745	1602	1	In	in	IN
46745	1602	2	pulmonary	pulmonary	JJ
46745	1602	3	phthisis	phthisis	NN
46745	1602	4	there	there	EX
46745	1602	5	is	be	VBZ
46745	1602	6	a	a	DT
46745	1602	7	deficiency	deficiency	NN
46745	1602	8	of	of	IN
46745	1602	9	fat	fat	NN
46745	1602	10	in	in	IN
46745	1602	11	the	the	DT
46745	1602	12	system	system	NN
46745	1602	13	.	.	.
46745	1603	1	In	in	IN
46745	1603	2	the	the	DT
46745	1603	3	latter	latter	JJ
46745	1603	4	stage	stage	NN
46745	1603	5	of	of	IN
46745	1603	6	malignant	malignant	JJ
46745	1603	7	cholera	cholera	NNS
46745	1603	8	there	there	EX
46745	1603	9	is	be	VBZ
46745	1603	10	an	an	DT
46745	1603	11	absence	absence	NN
46745	1603	12	of	of	IN
46745	1603	13	watery	watery	JJ
46745	1603	14	particles	particle	NNS
46745	1603	15	in	in	IN
46745	1603	16	the	the	DT
46745	1603	17	blood	blood	NN
46745	1603	18	.	.	.
46745	1604	1	Some	some	DT
46745	1604	2	suppose	suppose	VBP
46745	1604	3	that	that	IN
46745	1604	4	in	in	IN
46745	1604	5	scurvy	scurvy	NN
46745	1604	6	there	there	EX
46745	1604	7	is	be	VBZ
46745	1604	8	a	a	DT
46745	1604	9	want	want	NN
46745	1604	10	of	of	IN
46745	1604	11	the	the	DT
46745	1604	12	salts	salt	NNS
46745	1604	13	of	of	IN
46745	1604	14	Potash	Potash	NNP
46745	1604	15	in	in	IN
46745	1604	16	the	the	DT
46745	1604	17	blood	blood	NN
46745	1604	18	.	.	.
46745	1605	1	These	these	DT
46745	1605	2	diseases	disease	NNS
46745	1605	3	,	,	,
46745	1605	4	then	then	RB
46745	1605	5	,	,	,
46745	1605	6	in	in	IN
46745	1605	7	some	some	DT
46745	1605	8	of	of	IN
46745	1605	9	which	which	WDT
46745	1605	10	the	the	DT
46745	1605	11	want	want	NN
46745	1605	12	is	be	VBZ
46745	1605	13	proved	prove	VBN
46745	1605	14	,	,	,
46745	1605	15	in	in	IN
46745	1605	16	others	other	NNS
46745	1605	17	partly	partly	RB
46745	1605	18	hypothetical	hypothetical	JJ
46745	1605	19	,	,	,
46745	1605	20	may	may	MD
46745	1605	21	be	be	VB
46745	1605	22	treated	treat	VBN
46745	1605	23	by	by	IN
46745	1605	24	medicines	medicine	NNS
46745	1605	25	which	which	WDT
46745	1605	26	supply	supply	VBP
46745	1605	27	the	the	DT
46745	1605	28	deficient	deficient	JJ
46745	1605	29	matter	matter	NN
46745	1605	30	,	,	,
46745	1605	31	and	and	CC
46745	1605	32	thus	thus	RB
46745	1605	33	restore	restore	VB
46745	1605	34	a	a	DT
46745	1605	35	right	right	JJ
46745	1605	36	state	state	NN
46745	1605	37	of	of	IN
46745	1605	38	things	thing	NNS
46745	1605	39	.	.	.
46745	1606	1	They	-PRON-	PRP
46745	1606	2	may	may	MD
46745	1606	3	supply	supply	VB
46745	1606	4	it	-PRON-	PRP
46745	1606	5	to	to	IN
46745	1606	6	the	the	DT
46745	1606	7	blood	blood	NN
46745	1606	8	directly	directly	RB
46745	1606	9	,	,	,
46745	1606	10	or	or	CC
46745	1606	11	else	else	RB
46745	1606	12	cause	cause	VB
46745	1606	13	it	-PRON-	PRP
46745	1606	14	to	to	TO
46745	1606	15	be	be	VB
46745	1606	16	generated	generate	VBN
46745	1606	17	there	there	RB
46745	1606	18	.	.	.
46745	1607	1	The	the	DT
46745	1607	2	former	former	JJ
46745	1607	3	of	of	IN
46745	1607	4	these	these	DT
46745	1607	5	modes	mode	NNS
46745	1607	6	of	of	IN
46745	1607	7	restoration	restoration	NN
46745	1607	8	seems	seem	VBZ
46745	1607	9	to	to	TO
46745	1607	10	be	be	VB
46745	1607	11	the	the	DT
46745	1607	12	most	most	RBS
46745	1607	13	frequent	frequent	JJ
46745	1607	14	,	,	,
46745	1607	15	and	and	CC
46745	1607	16	may	may	MD
46745	1607	17	possibly	possibly	RB
46745	1607	18	,	,	,
46745	1607	19	when	when	WRB
46745	1607	20	we	-PRON-	PRP
46745	1607	21	shall	shall	MD
46745	1607	22	know	know	VB
46745	1607	23	more	more	JJR
46745	1607	24	of	of	IN
46745	1607	25	such	such	JJ
46745	1607	26	matters	matter	NNS
46745	1607	27	,	,	,
46745	1607	28	be	be	VB
46745	1607	29	found	find	VBN
46745	1607	30	to	to	TO
46745	1607	31	occur	occur	VB
46745	1607	32	in	in	IN
46745	1607	33	all	all	DT
46745	1607	34	cases	case	NNS
46745	1607	35	.	.	.
46745	1608	1	This	this	DT
46745	1608	2	division	division	NN
46745	1608	3	of	of	IN
46745	1608	4	Hæmatics	Hæmatics	NNPS
46745	1608	5	I	-PRON-	PRP
46745	1608	6	have	have	VBP
46745	1608	7	named	name	VBN
46745	1608	8	Restoratives	Restoratives	NNP
46745	1608	9	(	(	-LRB-
46745	1608	10	Restaurantia	Restaurantia	NNP
46745	1608	11	.	.	.
46745	1608	12	)	)	-RRB-
46745	1609	1	Their	-PRON-	PRP$
46745	1609	2	action	action	NN
46745	1609	3	,	,	,
46745	1609	4	as	as	IN
46745	1609	5	we	-PRON-	PRP
46745	1609	6	shall	shall	MD
46745	1609	7	see	see	VB
46745	1609	8	,	,	,
46745	1609	9	is	be	VBZ
46745	1609	10	in	in	IN
46745	1609	11	some	some	DT
46745	1609	12	cases	case	NNS
46745	1609	13	apparent	apparent	JJ
46745	1609	14	,	,	,
46745	1609	15	in	in	IN
46745	1609	16	others	other	NNS
46745	1609	17	more	more	RBR
46745	1609	18	obscure	obscure	JJ
46745	1609	19	.	.	.
46745	1610	1	They	-PRON-	PRP
46745	1610	2	restore	restore	VBP
46745	1610	3	the	the	DT
46745	1610	4	blood	blood	NN
46745	1610	5	directly	directly	RB
46745	1610	6	to	to	IN
46745	1610	7	its	-PRON-	PRP$
46745	1610	8	proper	proper	JJ
46745	1610	9	condition	condition	NN
46745	1610	10	,	,	,
46745	1610	11	if	if	IN
46745	1610	12	there	there	EX
46745	1610	13	is	be	VBZ
46745	1610	14	only	only	RB
46745	1610	15	a	a	DT
46745	1610	16	deficiency	deficiency	NN
46745	1610	17	,	,	,
46745	1610	18	but	but	CC
46745	1610	19	they	-PRON-	PRP
46745	1610	20	do	do	VBP
46745	1610	21	not	not	RB
46745	1610	22	in	in	IN
46745	1610	23	general	general	JJ
46745	1610	24	seem	seem	VBP
46745	1610	25	to	to	TO
46745	1610	26	have	have	VB
46745	1610	27	the	the	DT
46745	1610	28	power	power	NN
46745	1610	29	of	of	IN
46745	1610	30	counteracting	counteract	VBG
46745	1610	31	any	any	DT
46745	1610	32	morbid	morbid	NN
46745	1610	33	or	or	CC
46745	1610	34	active	active	JJ
46745	1610	35	material	material	NN
46745	1610	36	that	that	WDT
46745	1610	37	may	may	MD
46745	1610	38	exist	exist	VB
46745	1610	39	in	in	IN
46745	1610	40	the	the	DT
46745	1610	41	blood	blood	NN
46745	1610	42	.	.	.
46745	1611	1	Nor	nor	CC
46745	1611	2	do	do	VBP
46745	1611	3	they	-PRON-	PRP
46745	1611	4	,	,	,
46745	1611	5	except	except	IN
46745	1611	6	in	in	IN
46745	1611	7	large	large	JJ
46745	1611	8	doses	dose	NNS
46745	1611	9	,	,	,
46745	1611	10	exert	exert	VB
46745	1611	11	themselves	-PRON-	PRP
46745	1611	12	any	any	DT
46745	1611	13	peculiar	peculiar	JJ
46745	1611	14	action	action	NN
46745	1611	15	on	on	IN
46745	1611	16	that	that	DT
46745	1611	17	fluid	fluid	NN
46745	1611	18	.	.	.
46745	1612	1	In	in	IN
46745	1612	2	these	these	DT
46745	1612	3	respects	respect	NNS
46745	1612	4	they	-PRON-	PRP
46745	1612	5	differ	differ	VBP
46745	1612	6	from	from	IN
46745	1612	7	the	the	DT
46745	1612	8	other	other	JJ
46745	1612	9	division	division	NN
46745	1612	10	of	of	IN
46745	1612	11	Hæmatics	Hæmatics	NNP
46745	1612	12	.	.	.
46745	1613	1	They	-PRON-	PRP
46745	1613	2	also	also	RB
46745	1613	3	differ	differ	VBP
46745	1613	4	in	in	IN
46745	1613	5	another	another	DT
46745	1613	6	important	important	JJ
46745	1613	7	character	character	NN
46745	1613	8	.	.	.
46745	1614	1	Each	each	DT
46745	1614	2	Restorative	Restorative	NNP
46745	1614	3	has	have	VBZ
46745	1614	4	in	in	IN
46745	1614	5	healthy	healthy	JJ
46745	1614	6	blood	blood	NN
46745	1614	7	a	a	DT
46745	1614	8	substance	substance	NN
46745	1614	9	analogous	analogous	JJ
46745	1614	10	to	to	TO
46745	1614	11	,	,	,
46745	1614	12	or	or	CC
46745	1614	13	identical	identical	JJ
46745	1614	14	with	with	IN
46745	1614	15	itself	-PRON-	PRP
46745	1614	16	:	:	:
46745	1614	17	it	-PRON-	PRP
46745	1614	18	replaces	replace	VBZ
46745	1614	19	this	this	DT
46745	1614	20	when	when	WRB
46745	1614	21	deficient	deficient	JJ
46745	1614	22	.	.	.
46745	1615	1	Not	not	RB
46745	1615	2	so	so	RB
46745	1615	3	with	with	IN
46745	1615	4	other	other	JJ
46745	1615	5	Hæmatics	Hæmatics	NNPS
46745	1615	6	.	.	.
46745	1616	1	There	there	EX
46745	1616	2	is	be	VBZ
46745	1616	3	in	in	IN
46745	1616	4	general	general	JJ
46745	1616	5	nothing	nothing	NN
46745	1616	6	in	in	IN
46745	1616	7	the	the	DT
46745	1616	8	blood	blood	NN
46745	1616	9	corresponding	correspond	VBG
46745	1616	10	to	to	IN
46745	1616	11	them	-PRON-	PRP
46745	1616	12	--	--	:
46745	1616	13	or	or	CC
46745	1616	14	if	if	IN
46745	1616	15	there	there	EX
46745	1616	16	be	be	VBP
46745	1616	17	in	in	IN
46745	1616	18	some	some	DT
46745	1616	19	cases	case	NNS
46745	1616	20	,	,	,
46745	1616	21	they	-PRON-	PRP
46745	1616	22	are	be	VBP
46745	1616	23	not	not	RB
46745	1616	24	introduced	introduce	VBN
46745	1616	25	with	with	IN
46745	1616	26	the	the	DT
46745	1616	27	intention	intention	NN
46745	1616	28	of	of	IN
46745	1616	29	supplying	supply	VBG
46745	1616	30	its	-PRON-	PRP$
46745	1616	31	wants	want	NNS
46745	1616	32	.	.	.
46745	1617	1	Thus	thus	RB
46745	1617	2	Restoratives	restorative	NNS
46745	1617	3	may	may	MD
46745	1617	4	remain	remain	VB
46745	1617	5	in	in	IN
46745	1617	6	the	the	DT
46745	1617	7	system	system	NN
46745	1617	8	,	,	,
46745	1617	9	and	and	CC
46745	1617	10	are	be	VBP
46745	1617	11	intended	intend	VBN
46745	1617	12	so	so	RB
46745	1617	13	to	to	TO
46745	1617	14	do	do	VB
46745	1617	15	;	;	:
46745	1617	16	but	but	CC
46745	1617	17	these	these	DT
46745	1617	18	may	may	MD
46745	1617	19	not	not	RB
46745	1617	20	remain	remain	VB
46745	1617	21	.	.	.
46745	1618	1	They	-PRON-	PRP
46745	1618	2	must	must	MD
46745	1618	3	pass	pass	VB
46745	1618	4	out	out	RP
46745	1618	5	.	.	.
46745	1619	1	In	in	IN
46745	1619	2	so	so	RB
46745	1619	3	doing	do	VBG
46745	1619	4	they	-PRON-	PRP
46745	1619	5	come	come	VBP
46745	1619	6	under	under	IN
46745	1619	7	the	the	DT
46745	1619	8	head	head	NN
46745	1619	9	of	of	IN
46745	1619	10	Eliminatives	Eliminatives	NNPS
46745	1619	11	,	,	,
46745	1619	12	or	or	CC
46745	1619	13	that	that	DT
46745	1619	14	of	of	IN
46745	1619	15	Astringents	astringent	NNS
46745	1619	16	.	.	.
46745	1620	1	This	this	DT
46745	1620	2	is	be	VBZ
46745	1620	3	their	-PRON-	PRP$
46745	1620	4	secondary	secondary	JJ
46745	1620	5	action	action	NN
46745	1620	6	,	,	,
46745	1620	7	distinct	distinct	JJ
46745	1620	8	from	from	IN
46745	1620	9	their	-PRON-	PRP$
46745	1620	10	primary	primary	JJ
46745	1620	11	and	and	CC
46745	1620	12	most	most	RBS
46745	1620	13	important	important	JJ
46745	1620	14	operation	operation	NN
46745	1620	15	.	.	.
46745	1621	1	What	what	WP
46745	1621	2	then	then	RB
46745	1621	3	is	be	VBZ
46745	1621	4	the	the	DT
46745	1621	5	curative	curative	JJ
46745	1621	6	action	action	NN
46745	1621	7	of	of	IN
46745	1621	8	these	these	DT
46745	1621	9	remedies	remedy	NNS
46745	1621	10	?	?	.
46745	1622	1	A	a	DT
46745	1622	2	large	large	JJ
46745	1622	3	class	class	NN
46745	1622	4	of	of	IN
46745	1622	5	diseases	disease	NNS
46745	1622	6	depends	depend	VBZ
46745	1622	7	on	on	IN
46745	1622	8	the	the	DT
46745	1622	9	presence	presence	NN
46745	1622	10	in	in	IN
46745	1622	11	the	the	DT
46745	1622	12	blood	blood	NN
46745	1622	13	of	of	IN
46745	1622	14	a	a	DT
46745	1622	15	morbid	morbid	NN
46745	1622	16	material	material	NN
46745	1622	17	,	,	,
46745	1622	18	or	or	CC
46745	1622	19	,	,	,
46745	1622	20	what	what	WP
46745	1622	21	amounts	amount	VBZ
46745	1622	22	to	to	IN
46745	1622	23	the	the	DT
46745	1622	24	same	same	JJ
46745	1622	25	thing	thing	NN
46745	1622	26	,	,	,
46745	1622	27	on	on	IN
46745	1622	28	the	the	DT
46745	1622	29	constant	constant	JJ
46745	1622	30	working	working	NN
46745	1622	31	of	of	IN
46745	1622	32	a	a	DT
46745	1622	33	morbid	morbid	NN
46745	1622	34	process	process	NN
46745	1622	35	in	in	IN
46745	1622	36	that	that	DT
46745	1622	37	fluid	fluid	NN
46745	1622	38	.	.	.
46745	1623	1	Some	some	DT
46745	1623	2	of	of	IN
46745	1623	3	these	these	DT
46745	1623	4	,	,	,
46745	1623	5	as	as	IN
46745	1623	6	the	the	DT
46745	1623	7	eruptive	eruptive	JJ
46745	1623	8	fevers	fever	NNS
46745	1623	9	,	,	,
46745	1623	10	will	will	MD
46745	1623	11	run	run	VB
46745	1623	12	a	a	DT
46745	1623	13	certain	certain	JJ
46745	1623	14	course	course	NN
46745	1623	15	,	,	,
46745	1623	16	and	and	CC
46745	1623	17	then	then	RB
46745	1623	18	come	come	VB
46745	1623	19	to	to	IN
46745	1623	20	an	an	DT
46745	1623	21	end	end	NN
46745	1623	22	.	.	.
46745	1624	1	These	these	DT
46745	1624	2	we	-PRON-	PRP
46745	1624	3	can	can	MD
46745	1624	4	not	not	RB
46745	1624	5	generally	generally	RB
46745	1624	6	stop	stop	VB
46745	1624	7	,	,	,
46745	1624	8	but	but	CC
46745	1624	9	can	can	MD
46745	1624	10	only	only	RB
46745	1624	11	alleviate	alleviate	VB
46745	1624	12	.	.	.
46745	1625	1	But	but	CC
46745	1625	2	others	other	NNS
46745	1625	3	,	,	,
46745	1625	4	more	more	RBR
46745	1625	5	in	in	IN
46745	1625	6	number	number	NN
46745	1625	7	,	,	,
46745	1625	8	and	and	CC
46745	1625	9	more	more	RBR
46745	1625	10	commonly	commonly	RB
46745	1625	11	met	meet	VBN
46745	1625	12	with	with	IN
46745	1625	13	,	,	,
46745	1625	14	tend	tend	VB
46745	1625	15	naturally	naturally	RB
46745	1625	16	to	to	TO
46745	1625	17	run	run	VB
46745	1625	18	on	on	RP
46745	1625	19	for	for	IN
46745	1625	20	an	an	DT
46745	1625	21	indefinite	indefinite	JJ
46745	1625	22	period	period	NN
46745	1625	23	,	,	,
46745	1625	24	unless	unless	IN
46745	1625	25	by	by	IN
46745	1625	26	any	any	DT
46745	1625	27	means	mean	NNS
46745	1625	28	we	-PRON-	PRP
46745	1625	29	can	can	MD
46745	1625	30	arrest	arrest	VB
46745	1625	31	their	-PRON-	PRP$
46745	1625	32	progress	progress	NN
46745	1625	33	.	.	.
46745	1626	1	Some	some	DT
46745	1626	2	depend	depend	VBP
46745	1626	3	on	on	IN
46745	1626	4	a	a	DT
46745	1626	5	contagious	contagious	JJ
46745	1626	6	virus	virus	NN
46745	1626	7	,	,	,
46745	1626	8	communicable	communicable	JJ
46745	1626	9	from	from	IN
46745	1626	10	one	one	CD
46745	1626	11	person	person	NN
46745	1626	12	to	to	IN
46745	1626	13	another	another	DT
46745	1626	14	,	,	,
46745	1626	15	as	as	IN
46745	1626	16	Syphilis	Syphilis	NNP
46745	1626	17	.	.	.
46745	1627	1	Some	some	DT
46745	1627	2	,	,	,
46745	1627	3	as	as	IN
46745	1627	4	Ague	Ague	NNP
46745	1627	5	,	,	,
46745	1627	6	are	be	VBP
46745	1627	7	dependent	dependent	JJ
46745	1627	8	on	on	IN
46745	1627	9	atmospheric	atmospheric	JJ
46745	1627	10	or	or	CC
46745	1627	11	terrestrial	terrestrial	JJ
46745	1627	12	influences	influence	NNS
46745	1627	13	.	.	.
46745	1628	1	Others	other	NNS
46745	1628	2	are	be	VBP
46745	1628	3	due	due	JJ
46745	1628	4	to	to	IN
46745	1628	5	some	some	DT
46745	1628	6	derangement	derangement	NN
46745	1628	7	of	of	IN
46745	1628	8	the	the	DT
46745	1628	9	secondary	secondary	JJ
46745	1628	10	assimilative	assimilative	NN
46745	1628	11	processes	process	NNS
46745	1628	12	,	,	,
46745	1628	13	as	as	IN
46745	1628	14	Scrofula	Scrofula	NNP
46745	1628	15	,	,	,
46745	1628	16	Scurvy	Scurvy	NNP
46745	1628	17	,	,	,
46745	1628	18	Gout	gout	UH
46745	1628	19	,	,	,
46745	1628	20	and	and	CC
46745	1628	21	Rheumatism	rheumatism	NN
46745	1628	22	.	.	.
46745	1629	1	Others	other	NNS
46745	1629	2	again	again	RB
46745	1629	3	,	,	,
46745	1629	4	to	to	IN
46745	1629	5	causes	cause	NNS
46745	1629	6	that	that	WDT
46745	1629	7	are	be	VBP
46745	1629	8	ill	ill	JJ
46745	1629	9	understood	understand	VBN
46745	1629	10	,	,	,
46745	1629	11	as	as	IN
46745	1629	12	convulsive	convulsive	NN
46745	1629	13	disorders	disorder	NNS
46745	1629	14	and	and	CC
46745	1629	15	skin	skin	NN
46745	1629	16	diseases	disease	NNS
46745	1629	17	.	.	.
46745	1630	1	Lastly	lastly	RB
46745	1630	2	,	,	,
46745	1630	3	some	some	DT
46745	1630	4	may	may	MD
46745	1630	5	be	be	VB
46745	1630	6	caused	cause	VBN
46745	1630	7	in	in	IN
46745	1630	8	many	many	JJ
46745	1630	9	different	different	JJ
46745	1630	10	ways	way	NNS
46745	1630	11	,	,	,
46745	1630	12	as	as	IN
46745	1630	13	common	common	JJ
46745	1630	14	inflammatory	inflammatory	JJ
46745	1630	15	fever	fever	NN
46745	1630	16	.	.	.
46745	1631	1	Now	now	RB
46745	1631	2	the	the	DT
46745	1631	3	object	object	NN
46745	1631	4	in	in	IN
46745	1631	5	the	the	DT
46745	1631	6	treatment	treatment	NN
46745	1631	7	of	of	IN
46745	1631	8	such	such	JJ
46745	1631	9	diseases	disease	NNS
46745	1631	10	is	be	VBZ
46745	1631	11	to	to	TO
46745	1631	12	obtain	obtain	VB
46745	1631	13	in	in	IN
46745	1631	14	each	each	DT
46745	1631	15	case	case	NN
46745	1631	16	some	some	DT
46745	1631	17	remedy	remedy	NN
46745	1631	18	,	,	,
46745	1631	19	that	that	WDT
46745	1631	20	shall	shall	MD
46745	1631	21	be	be	VB
46745	1631	22	able	able	JJ
46745	1631	23	to	to	TO
46745	1631	24	counteract	counteract	VB
46745	1631	25	this	this	DT
46745	1631	26	process	process	NN
46745	1631	27	,	,	,
46745	1631	28	something	something	NN
46745	1631	29	that	that	WDT
46745	1631	30	shall	shall	MD
46745	1631	31	destroy	destroy	VB
46745	1631	32	the	the	DT
46745	1631	33	morbid	morbid	NN
46745	1631	34	influence	influence	NN
46745	1631	35	at	at	IN
46745	1631	36	work	work	NN
46745	1631	37	,	,	,
46745	1631	38	and	and	CC
46745	1631	39	thus	thus	RB
46745	1631	40	restore	restore	VB
46745	1631	41	health	health	NN
46745	1631	42	.	.	.
46745	1632	1	Medicines	medicine	NNS
46745	1632	2	that	that	WDT
46745	1632	3	are	be	VBP
46745	1632	4	used	use	VBN
46745	1632	5	with	with	IN
46745	1632	6	this	this	DT
46745	1632	7	intention	intention	NN
46745	1632	8	form	form	NN
46745	1632	9	the	the	DT
46745	1632	10	second	second	JJ
46745	1632	11	division	division	NN
46745	1632	12	of	of	IN
46745	1632	13	Hæmatics	Hæmatics	NNP
46745	1632	14	,	,	,
46745	1632	15	which	which	WDT
46745	1632	16	I	-PRON-	PRP
46745	1632	17	have	have	VBP
46745	1632	18	named	name	VBN
46745	1632	19	Catalytics	Catalytics	NNP
46745	1632	20	(	(	-LRB-
46745	1632	21	Catalytica	Catalytica	NNP
46745	1632	22	,	,	,
46745	1632	23	)	)	-RRB-
46745	1632	24	from	from	IN
46745	1632	25	a	a	DT
46745	1632	26	Greek	greek	JJ
46745	1632	27	verb	verb	NN
46745	1632	28	signifying	signifying	NN
46745	1632	29	to	to	TO
46745	1632	30	destroy	destroy	VB
46745	1632	31	or	or	CC
46745	1632	32	to	to	TO
46745	1632	33	unbind	unbind	VB
46745	1632	34	.	.	.
46745	1633	1	Now	now	RB
46745	1633	2	though	though	IN
46745	1633	3	I	-PRON-	PRP
46745	1633	4	have	have	VBP
46745	1633	5	a	a	DT
46745	1633	6	probable	probable	JJ
46745	1633	7	hypothesis	hypothesis	NN
46745	1633	8	to	to	TO
46745	1633	9	advance	advance	VB
46745	1633	10	as	as	IN
46745	1633	11	to	to	IN
46745	1633	12	the	the	DT
46745	1633	13	action	action	NN
46745	1633	14	of	of	IN
46745	1633	15	some	some	DT
46745	1633	16	of	of	IN
46745	1633	17	these	these	DT
46745	1633	18	,	,	,
46745	1633	19	I	-PRON-	PRP
46745	1633	20	would	would	MD
46745	1633	21	not	not	RB
46745	1633	22	have	have	VB
46745	1633	23	this	this	DT
46745	1633	24	considered	consider	VBN
46745	1633	25	as	as	IN
46745	1633	26	more	more	RBR
46745	1633	27	than	than	IN
46745	1633	28	hypothetical	hypothetical	JJ
46745	1633	29	.	.	.
46745	1634	1	I	-PRON-	PRP
46745	1634	2	would	would	MD
46745	1634	3	not	not	RB
46745	1634	4	speak	speak	VB
46745	1634	5	positively	positively	RB
46745	1634	6	of	of	IN
46745	1634	7	the	the	DT
46745	1634	8	action	action	NN
46745	1634	9	of	of	IN
46745	1634	10	any	any	DT
46745	1634	11	one	one	CD
46745	1634	12	of	of	IN
46745	1634	13	them	-PRON-	PRP
46745	1634	14	,	,	,
46745	1634	15	any	any	DT
46745	1634	16	more	more	RBR
46745	1634	17	than	than	IN
46745	1634	18	to	to	TO
46745	1634	19	say	say	VB
46745	1634	20	that	that	IN
46745	1634	21	each	each	DT
46745	1634	22	of	of	IN
46745	1634	23	them	-PRON-	PRP
46745	1634	24	tends	tend	VBZ
46745	1634	25	to	to	TO
46745	1634	26	neutralize	neutralize	VB
46745	1634	27	one	one	CD
46745	1634	28	or	or	CC
46745	1634	29	more	more	RBR
46745	1634	30	particular	particular	JJ
46745	1634	31	morbid	morbid	NN
46745	1634	32	poisons	poison	NNS
46745	1634	33	.	.	.
46745	1635	1	Some	some	DT
46745	1635	2	have	have	VBP
46745	1635	3	tried	try	VBN
46745	1635	4	to	to	TO
46745	1635	5	give	give	VB
46745	1635	6	a	a	DT
46745	1635	7	general	general	JJ
46745	1635	8	explanation	explanation	NN
46745	1635	9	of	of	IN
46745	1635	10	their	-PRON-	PRP$
46745	1635	11	action	action	NN
46745	1635	12	,	,	,
46745	1635	13	and	and	CC
46745	1635	14	have	have	VBP
46745	1635	15	talked	talk	VBN
46745	1635	16	of	of	IN
46745	1635	17	it	-PRON-	PRP
46745	1635	18	as	as	IN
46745	1635	19	if	if	IN
46745	1635	20	it	-PRON-	PRP
46745	1635	21	were	be	VBD
46745	1635	22	easily	easily	RB
46745	1635	23	understood	understand	VBN
46745	1635	24	by	by	IN
46745	1635	25	their	-PRON-	PRP$
46745	1635	26	known	know	VBN
46745	1635	27	properties	property	NNS
46745	1635	28	.	.	.
46745	1636	1	I	-PRON-	PRP
46745	1636	2	am	be	VBP
46745	1636	3	not	not	RB
46745	1636	4	of	of	IN
46745	1636	5	their	-PRON-	PRP$
46745	1636	6	opinion	opinion	NN
46745	1636	7	;	;	:
46745	1636	8	and	and	CC
46745	1636	9	when	when	WRB
46745	1636	10	I	-PRON-	PRP
46745	1636	11	speak	speak	VBP
46745	1636	12	of	of	IN
46745	1636	13	Catalytics	Catalytics	NNP
46745	1636	14	,	,	,
46745	1636	15	I	-PRON-	PRP
46745	1636	16	shall	shall	MD
46745	1636	17	give	give	VB
46745	1636	18	my	-PRON-	PRP$
46745	1636	19	reasons	reason	NNS
46745	1636	20	for	for	IN
46745	1636	21	disagreeing	disagree	VBG
46745	1636	22	with	with	IN
46745	1636	23	them	-PRON-	PRP
46745	1636	24	.	.	.
46745	1637	1	Now	now	RB
46745	1637	2	each	each	DT
46745	1637	3	Catalytic	catalytic	JJ
46745	1637	4	has	have	VBZ
46745	1637	5	peculiarities	peculiarity	NNS
46745	1637	6	and	and	CC
46745	1637	7	affinities	affinity	NNS
46745	1637	8	that	that	WDT
46745	1637	9	distinguish	distinguish	VBP
46745	1637	10	it	-PRON-	PRP
46745	1637	11	from	from	IN
46745	1637	12	all	all	DT
46745	1637	13	others	other	NNS
46745	1637	14	.	.	.
46745	1638	1	I	-PRON-	PRP
46745	1638	2	have	have	VBP
46745	1638	3	not	not	RB
46745	1638	4	thought	think	VBN
46745	1638	5	that	that	IN
46745	1638	6	I	-PRON-	PRP
46745	1638	7	could	could	MD
46745	1638	8	arrange	arrange	VB
46745	1638	9	them	-PRON-	PRP
46745	1638	10	more	more	RBR
46745	1638	11	truthfully	truthfully	RB
46745	1638	12	than	than	IN
46745	1638	13	by	by	IN
46745	1638	14	subdividing	subdivide	VBG
46745	1638	15	them	-PRON-	PRP
46745	1638	16	according	accord	VBG
46745	1638	17	to	to	IN
46745	1638	18	diseases	disease	NNS
46745	1638	19	which	which	WDT
46745	1638	20	they	-PRON-	PRP
46745	1638	21	tend	tend	VBP
46745	1638	22	to	to	TO
46745	1638	23	counteract	counteract	VB
46745	1638	24	.	.	.
46745	1639	1	How	how	WRB
46745	1639	2	inadequately	inadequately	RB
46745	1639	3	is	be	VBZ
46745	1639	4	the	the	DT
46745	1639	5	action	action	NN
46745	1639	6	of	of	IN
46745	1639	7	Mercury	Mercury	NNP
46745	1639	8	and	and	CC
46745	1639	9	of	of	IN
46745	1639	10	Iodine	Iodine	NNP
46745	1639	11	expressed	express	VBN
46745	1639	12	by	by	IN
46745	1639	13	calling	call	VBG
46745	1639	14	them	-PRON-	PRP
46745	1639	15	special	special	JJ
46745	1639	16	stimulants	stimulant	NNS
46745	1639	17	,	,	,
46745	1639	18	alteratives	alterative	NNS
46745	1639	19	,	,	,
46745	1639	20	or	or	CC
46745	1639	21	absorbents	absorbent	NNS
46745	1639	22	!	!	.
46745	1640	1	Is	be	VBZ
46745	1640	2	it	-PRON-	PRP
46745	1640	3	not	not	RB
46745	1640	4	better	well	JJR
46745	1640	5	and	and	CC
46745	1640	6	more	more	RBR
46745	1640	7	correct	correct	JJ
46745	1640	8	to	to	TO
46745	1640	9	say	say	VB
46745	1640	10	at	at	IN
46745	1640	11	once	once	RB
46745	1640	12	that	that	DT
46745	1640	13	Mercury	Mercury	NNP
46745	1640	14	is	be	VBZ
46745	1640	15	useful	useful	JJ
46745	1640	16	in	in	IN
46745	1640	17	checking	check	VBG
46745	1640	18	inflammation	inflammation	NN
46745	1640	19	in	in	IN
46745	1640	20	general	general	JJ
46745	1640	21	,	,	,
46745	1640	22	and	and	CC
46745	1640	23	in	in	IN
46745	1640	24	counteracting	counteract	VBG
46745	1640	25	the	the	DT
46745	1640	26	poison	poison	NN
46745	1640	27	of	of	IN
46745	1640	28	Syphilis	Syphilis	NNP
46745	1640	29	in	in	IN
46745	1640	30	particular	particular	JJ
46745	1640	31	?	?	.
46745	1641	1	and	and	CC
46745	1641	2	that	that	IN
46745	1641	3	Iodine	Iodine	NNP
46745	1641	4	is	be	VBZ
46745	1641	5	effective	effective	JJ
46745	1641	6	in	in	IN
46745	1641	7	secondary	secondary	JJ
46745	1641	8	forms	form	NNS
46745	1641	9	of	of	IN
46745	1641	10	the	the	DT
46745	1641	11	latter	latter	JJ
46745	1641	12	disorder	disorder	NN
46745	1641	13	,	,	,
46745	1641	14	as	as	RB
46745	1641	15	well	well	RB
46745	1641	16	as	as	IN
46745	1641	17	in	in	IN
46745	1641	18	Scrofula	Scrofula	NNP
46745	1641	19	?	?	.
46745	1642	1	These	these	DT
46745	1642	2	medicines	medicine	NNS
46745	1642	3	,	,	,
46745	1642	4	then	then	RB
46745	1642	5	,	,	,
46745	1642	6	are	be	VBP
46745	1642	7	specifics	specific	NNS
46745	1642	8	,	,	,
46745	1642	9	in	in	IN
46745	1642	10	so	so	RB
46745	1642	11	far	far	RB
46745	1642	12	as	as	IN
46745	1642	13	they	-PRON-	PRP
46745	1642	14	are	be	VBP
46745	1642	15	particularly	particularly	RB
46745	1642	16	useful	useful	JJ
46745	1642	17	in	in	IN
46745	1642	18	certain	certain	JJ
46745	1642	19	disorders	disorder	NNS
46745	1642	20	,	,	,
46745	1642	21	and	and	CC
46745	1642	22	in	in	IN
46745	1642	23	those	those	DT
46745	1642	24	excel	excel	VBP
46745	1642	25	other	other	JJ
46745	1642	26	remedies	remedy	NNS
46745	1642	27	;	;	:
46745	1642	28	but	but	CC
46745	1642	29	they	-PRON-	PRP
46745	1642	30	are	be	VBP
46745	1642	31	not	not	RB
46745	1642	32	,	,	,
46745	1642	33	in	in	IN
46745	1642	34	the	the	DT
46745	1642	35	vulgar	vulgar	JJ
46745	1642	36	acceptation	acceptation	NN
46745	1642	37	of	of	IN
46745	1642	38	that	that	DT
46745	1642	39	term	term	NN
46745	1642	40	,	,	,
46745	1642	41	the	the	DT
46745	1642	42	only	only	JJ
46745	1642	43	medicines	medicine	NNS
46745	1642	44	which	which	WDT
46745	1642	45	can	can	MD
46745	1642	46	be	be	VB
46745	1642	47	employed	employ	VBN
46745	1642	48	in	in	IN
46745	1642	49	such	such	PDT
46745	1642	50	a	a	DT
46745	1642	51	disease	disease	NN
46745	1642	52	,	,	,
46745	1642	53	nor	nor	CC
46745	1642	54	is	be	VBZ
46745	1642	55	their	-PRON-	PRP$
46745	1642	56	use	use	NN
46745	1642	57	to	to	TO
46745	1642	58	be	be	VB
46745	1642	59	restricted	restrict	VBN
46745	1642	60	to	to	IN
46745	1642	61	it	-PRON-	PRP
46745	1642	62	alone	alone	JJ
46745	1642	63	.	.	.
46745	1643	1	I	-PRON-	PRP
46745	1643	2	have	have	VBP
46745	1643	3	already	already	RB
46745	1643	4	said	say	VBN
46745	1643	5	that	that	IN
46745	1643	6	a	a	DT
46745	1643	7	Catalytic	catalytic	JJ
46745	1643	8	tends	tend	NNS
46745	1643	9	of	of	IN
46745	1643	10	itself	-PRON-	PRP
46745	1643	11	to	to	TO
46745	1643	12	work	work	VB
46745	1643	13	out	out	RP
46745	1643	14	a	a	DT
46745	1643	15	peculiar	peculiar	JJ
46745	1643	16	process	process	NN
46745	1643	17	in	in	IN
46745	1643	18	the	the	DT
46745	1643	19	blood	blood	NN
46745	1643	20	.	.	.
46745	1644	1	For	for	IN
46745	1644	2	this	this	DT
46745	1644	3	reason	reason	NN
46745	1644	4	their	-PRON-	PRP$
46745	1644	5	administration	administration	NN
46745	1644	6	in	in	IN
46745	1644	7	health	health	NN
46745	1644	8	generally	generally	RB
46745	1644	9	does	do	VBZ
46745	1644	10	harm	harm	NN
46745	1644	11	.	.	.
46745	1645	1	They	-PRON-	PRP
46745	1645	2	have	have	VBP
46745	1645	3	nothing	nothing	NN
46745	1645	4	in	in	IN
46745	1645	5	the	the	DT
46745	1645	6	blood	blood	NN
46745	1645	7	corresponding	correspond	VBG
46745	1645	8	to	to	IN
46745	1645	9	them	-PRON-	PRP
46745	1645	10	;	;	:
46745	1645	11	or	or	CC
46745	1645	12	if	if	IN
46745	1645	13	so	so	RB
46745	1645	14	,	,	,
46745	1645	15	they	-PRON-	PRP
46745	1645	16	are	be	VBP
46745	1645	17	not	not	RB
46745	1645	18	introduced	introduce	VBN
46745	1645	19	to	to	TO
46745	1645	20	supply	supply	VB
46745	1645	21	its	-PRON-	PRP$
46745	1645	22	want	want	NN
46745	1645	23	.	.	.
46745	1646	1	Thus	thus	RB
46745	1646	2	they	-PRON-	PRP
46745	1646	3	must	must	MD
46745	1646	4	eventually	eventually	RB
46745	1646	5	pass	pass	VB
46745	1646	6	out	out	IN
46745	1646	7	of	of	IN
46745	1646	8	the	the	DT
46745	1646	9	body	body	NN
46745	1646	10	.	.	.
46745	1647	1	Before	before	IN
46745	1647	2	doing	do	VBG
46745	1647	3	so	so	RB
46745	1647	4	,	,	,
46745	1647	5	some	some	DT
46745	1647	6	may	may	MD
46745	1647	7	act	act	VB
46745	1647	8	on	on	IN
46745	1647	9	the	the	DT
46745	1647	10	nerves	nerve	NNS
46745	1647	11	.	.	.
46745	1648	1	While	while	IN
46745	1648	2	so	so	RB
46745	1648	3	passing	pass	VBG
46745	1648	4	out	out	RP
46745	1648	5	,	,	,
46745	1648	6	they	-PRON-	PRP
46745	1648	7	may	may	MD
46745	1648	8	,	,	,
46745	1648	9	as	as	IN
46745	1648	10	I	-PRON-	PRP
46745	1648	11	have	have	VBP
46745	1648	12	said	say	VBD
46745	1648	13	,	,	,
46745	1648	14	act	act	VB
46745	1648	15	either	either	CC
46745	1648	16	as	as	IN
46745	1648	17	Astringents	Astringents	NNPS
46745	1648	18	or	or	CC
46745	1648	19	Eliminatives	Eliminatives	NNPS
46745	1648	20	on	on	IN
46745	1648	21	the	the	DT
46745	1648	22	glands	gland	NNS
46745	1648	23	.	.	.
46745	1649	1	Under	under	IN
46745	1649	2	these	these	DT
46745	1649	3	heads	head	NNS
46745	1649	4	their	-PRON-	PRP$
46745	1649	5	secondary	secondary	JJ
46745	1649	6	action	action	NN
46745	1649	7	will	will	MD
46745	1649	8	be	be	VB
46745	1649	9	subsequently	subsequently	RB
46745	1649	10	considered	consider	VBN
46745	1649	11	.	.	.
46745	1650	1	Being	be	VBG
46745	1650	2	thus	thus	RB
46745	1650	3	foreign	foreign	JJ
46745	1650	4	to	to	IN
46745	1650	5	the	the	DT
46745	1650	6	blood	blood	NN
46745	1650	7	,	,	,
46745	1650	8	Catalytics	Catalytics	NNP
46745	1650	9	do	do	VBP
46745	1650	10	not	not	RB
46745	1650	11	remain	remain	VB
46745	1650	12	there	there	RB
46745	1650	13	to	to	TO
46745	1650	14	supply	supply	VB
46745	1650	15	a	a	DT
46745	1650	16	want	want	NN
46745	1650	17	;	;	:
46745	1650	18	but	but	CC
46745	1650	19	just	just	RB
46745	1650	20	long	long	RB
46745	1650	21	enough	enough	RB
46745	1650	22	to	to	TO
46745	1650	23	counteract	counteract	VB
46745	1650	24	a	a	DT
46745	1650	25	morbid	morbid	NN
46745	1650	26	action	action	NN
46745	1650	27	,	,	,
46745	1650	28	and	and	CC
46745	1650	29	are	be	VBP
46745	1650	30	then	then	RB
46745	1650	31	excreted	excrete	VBN
46745	1650	32	.	.	.
46745	1651	1	Such	such	JJ
46745	1651	2	is	be	VBZ
46745	1651	3	the	the	DT
46745	1651	4	difference	difference	NN
46745	1651	5	between	between	IN
46745	1651	6	Restorative	Restorative	NNP
46745	1651	7	and	and	CC
46745	1651	8	Catalytic	catalytic	JJ
46745	1651	9	medicines	medicine	NNS
46745	1651	10	.	.	.
46745	1652	1	Although	although	IN
46745	1652	2	so	so	RB
46745	1652	3	far	far	RB
46745	1652	4	as	as	IN
46745	1652	5	this	this	DT
46745	1652	6	their	-PRON-	PRP$
46745	1652	7	action	action	NN
46745	1652	8	is	be	VBZ
46745	1652	9	sufficiently	sufficiently	RB
46745	1652	10	distinct	distinct	JJ
46745	1652	11	,	,	,
46745	1652	12	yet	yet	CC
46745	1652	13	some	some	DT
46745	1652	14	care	care	NN
46745	1652	15	is	be	VBZ
46745	1652	16	required	require	VBN
46745	1652	17	in	in	IN
46745	1652	18	separating	separate	VBG
46745	1652	19	the	the	DT
46745	1652	20	remedies	remedy	NNS
46745	1652	21	in	in	IN
46745	1652	22	one	one	CD
46745	1652	23	division	division	NN
46745	1652	24	from	from	IN
46745	1652	25	those	those	DT
46745	1652	26	in	in	IN
46745	1652	27	the	the	DT
46745	1652	28	other	other	JJ
46745	1652	29	.	.	.
46745	1653	1	Sometimes	sometimes	RB
46745	1653	2	both	both	DT
46745	1653	3	kinds	kind	NNS
46745	1653	4	are	be	VBP
46745	1653	5	used	use	VBN
46745	1653	6	in	in	IN
46745	1653	7	the	the	DT
46745	1653	8	same	same	JJ
46745	1653	9	disorder	disorder	NN
46745	1653	10	.	.	.
46745	1654	1	For	for	IN
46745	1654	2	whenever	whenever	WRB
46745	1654	3	the	the	DT
46745	1654	4	action	action	NN
46745	1654	5	of	of	IN
46745	1654	6	a	a	DT
46745	1654	7	morbid	morbid	NN
46745	1654	8	poison	poison	NN
46745	1654	9	causes	cause	VBZ
46745	1654	10	any	any	DT
46745	1654	11	derangement	derangement	NN
46745	1654	12	in	in	IN
46745	1654	13	the	the	DT
46745	1654	14	proportion	proportion	NN
46745	1654	15	of	of	IN
46745	1654	16	the	the	DT
46745	1654	17	normal	normal	JJ
46745	1654	18	constituents	constituent	NNS
46745	1654	19	of	of	IN
46745	1654	20	the	the	DT
46745	1654	21	blood	blood	NN
46745	1654	22	,	,	,
46745	1654	23	a	a	DT
46745	1654	24	Restorative	Restorative	NNP
46745	1654	25	may	may	MD
46745	1654	26	become	become	VB
46745	1654	27	of	of	IN
46745	1654	28	use	use	NN
46745	1654	29	to	to	TO
46745	1654	30	supply	supply	VB
46745	1654	31	this	this	DT
46745	1654	32	defect	defect	NN
46745	1654	33	.	.	.
46745	1655	1	Thus	thus	RB
46745	1655	2	a	a	DT
46745	1655	3	cancerous	cancerous	JJ
46745	1655	4	or	or	CC
46745	1655	5	scrofulous	scrofulous	JJ
46745	1655	6	condition	condition	NN
46745	1655	7	may	may	MD
46745	1655	8	cause	cause	VB
46745	1655	9	a	a	DT
46745	1655	10	deficiency	deficiency	NN
46745	1655	11	in	in	IN
46745	1655	12	the	the	DT
46745	1655	13	red	red	JJ
46745	1655	14	colouring	colouring	NN
46745	1655	15	matter	matter	NN
46745	1655	16	of	of	IN
46745	1655	17	the	the	DT
46745	1655	18	blood	blood	NN
46745	1655	19	,	,	,
46745	1655	20	which	which	WDT
46745	1655	21	may	may	MD
46745	1655	22	be	be	VB
46745	1655	23	supplied	supply	VBN
46745	1655	24	by	by	IN
46745	1655	25	Iron	Iron	NNP
46745	1655	26	.	.	.
46745	1656	1	When	when	WRB
46745	1656	2	,	,	,
46745	1656	3	as	as	IN
46745	1656	4	in	in	IN
46745	1656	5	Gout	Gout	NNP
46745	1656	6	and	and	CC
46745	1656	7	Rheumatism	Rheumatism	NNP
46745	1656	8	,	,	,
46745	1656	9	there	there	EX
46745	1656	10	is	be	VBZ
46745	1656	11	an	an	DT
46745	1656	12	excess	excess	NN
46745	1656	13	of	of	IN
46745	1656	14	acid	acid	NN
46745	1656	15	in	in	IN
46745	1656	16	the	the	DT
46745	1656	17	system	system	NN
46745	1656	18	,	,	,
46745	1656	19	partly	partly	RB
46745	1656	20	due	due	JJ
46745	1656	21	to	to	IN
46745	1656	22	an	an	DT
46745	1656	23	absence	absence	NN
46745	1656	24	of	of	IN
46745	1656	25	that	that	DT
46745	1656	26	basic	basic	JJ
46745	1656	27	matter	matter	NN
46745	1656	28	which	which	WDT
46745	1656	29	should	should	MD
46745	1656	30	be	be	VB
46745	1656	31	present	present	JJ
46745	1656	32	to	to	TO
46745	1656	33	neutralize	neutralize	VB
46745	1656	34	it	-PRON-	PRP
46745	1656	35	,	,	,
46745	1656	36	this	this	DT
46745	1656	37	may	may	MD
46745	1656	38	be	be	VB
46745	1656	39	restored	restore	VBN
46745	1656	40	by	by	IN
46745	1656	41	an	an	DT
46745	1656	42	alkaline	alkaline	JJ
46745	1656	43	remedy	remedy	NN
46745	1656	44	.	.	.
46745	1657	1	In	in	IN
46745	1657	2	both	both	DT
46745	1657	3	of	of	IN
46745	1657	4	these	these	DT
46745	1657	5	cases	case	NNS
46745	1657	6	a	a	DT
46745	1657	7	Restorative	Restorative	NNP
46745	1657	8	may	may	MD
46745	1657	9	be	be	VB
46745	1657	10	used	use	VBN
46745	1657	11	in	in	IN
46745	1657	12	a	a	DT
46745	1657	13	disease	disease	NN
46745	1657	14	which	which	WDT
46745	1657	15	depends	depend	VBZ
46745	1657	16	on	on	IN
46745	1657	17	a	a	DT
46745	1657	18	morbid	morbid	NN
46745	1657	19	agency	agency	NN
46745	1657	20	.	.	.
46745	1658	1	But	but	CC
46745	1658	2	other	other	JJ
46745	1658	3	remedies	remedy	NNS
46745	1658	4	,	,	,
46745	1658	5	Catalytic	catalytic	JJ
46745	1658	6	in	in	IN
46745	1658	7	their	-PRON-	PRP$
46745	1658	8	action	action	NN
46745	1658	9	,	,	,
46745	1658	10	are	be	VBP
46745	1658	11	of	of	IN
46745	1658	12	more	more	RBR
46745	1658	13	direct	direct	JJ
46745	1658	14	use	use	NN
46745	1658	15	in	in	IN
46745	1658	16	such	such	JJ
46745	1658	17	disorders	disorder	NNS
46745	1658	18	.	.	.
46745	1659	1	They	-PRON-	PRP
46745	1659	2	counteract	counteract	VBD
46745	1659	3	the	the	DT
46745	1659	4	original	original	JJ
46745	1659	5	poison	poison	NN
46745	1659	6	,	,	,
46745	1659	7	and	and	CC
46745	1659	8	striking	strike	VBG
46745	1659	9	at	at	IN
46745	1659	10	the	the	DT
46745	1659	11	root	root	NN
46745	1659	12	of	of	IN
46745	1659	13	the	the	DT
46745	1659	14	evil	evil	NN
46745	1659	15	,	,	,
46745	1659	16	instead	instead	RB
46745	1659	17	of	of	IN
46745	1659	18	correcting	correct	VBG
46745	1659	19	the	the	DT
46745	1659	20	consequences	consequence	NNS
46745	1659	21	,	,	,
46745	1659	22	they	-PRON-	PRP
46745	1659	23	are	be	VBP
46745	1659	24	more	more	RBR
46745	1659	25	likely	likely	JJ
46745	1659	26	to	to	TO
46745	1659	27	eradicate	eradicate	VB
46745	1659	28	the	the	DT
46745	1659	29	disease	disease	NN
46745	1659	30	.	.	.
46745	1660	1	Some	some	DT
46745	1660	2	medicines	medicine	NNS
46745	1660	3	come	come	VBP
46745	1660	4	under	under	IN
46745	1660	5	both	both	DT
46745	1660	6	heads	head	NNS
46745	1660	7	,	,	,
46745	1660	8	acting	act	VBG
46745	1660	9	in	in	IN
46745	1660	10	different	different	JJ
46745	1660	11	ways	way	NNS
46745	1660	12	in	in	IN
46745	1660	13	different	different	JJ
46745	1660	14	cases	case	NNS
46745	1660	15	.	.	.
46745	1661	1	Thus	thus	RB
46745	1661	2	Potash	Potash	NNP
46745	1661	3	may	may	MD
46745	1661	4	be	be	VB
46745	1661	5	a	a	DT
46745	1661	6	Restorative	Restorative	NNP
46745	1661	7	in	in	IN
46745	1661	8	Rheumatism	Rheumatism	NNP
46745	1661	9	,	,	,
46745	1661	10	but	but	CC
46745	1661	11	a	a	DT
46745	1661	12	Catalytic	catalytic	JJ
46745	1661	13	in	in	IN
46745	1661	14	Scrofula	Scrofula	NNP
46745	1661	15	.	.	.
46745	1662	1	The	the	DT
46745	1662	2	operation	operation	NN
46745	1662	3	of	of	IN
46745	1662	4	some	some	DT
46745	1662	5	particular	particular	JJ
46745	1662	6	agents	agent	NNS
46745	1662	7	is	be	VBZ
46745	1662	8	rather	rather	RB
46745	1662	9	obscure	obscure	JJ
46745	1662	10	.	.	.
46745	1663	1	I	-PRON-	PRP
46745	1663	2	shall	shall	MD
46745	1663	3	have	have	VB
46745	1663	4	to	to	TO
46745	1663	5	show	show	VB
46745	1663	6	how	how	WRB
46745	1663	7	it	-PRON-	PRP
46745	1663	8	seems	seem	VBZ
46745	1663	9	to	to	IN
46745	1663	10	me	-PRON-	PRP
46745	1663	11	that	that	IN
46745	1663	12	the	the	DT
46745	1663	13	vegetable	vegetable	NN
46745	1663	14	acids	acid	NNS
46745	1663	15	may	may	MD
46745	1663	16	act	act	VB
46745	1663	17	as	as	IN
46745	1663	18	Restoratives	Restoratives	NNPS
46745	1663	19	in	in	IN
46745	1663	20	fevers	fever	NNS
46745	1663	21	;	;	:
46745	1663	22	and	and	CC
46745	1663	23	also	also	RB
46745	1663	24	to	to	TO
46745	1663	25	explain	explain	VB
46745	1663	26	why	why	WRB
46745	1663	27	,	,	,
46745	1663	28	of	of	IN
46745	1663	29	those	those	DT
46745	1663	30	medicines	medicine	NNS
46745	1663	31	which	which	WDT
46745	1663	32	are	be	VBP
46745	1663	33	used	use	VBN
46745	1663	34	in	in	IN
46745	1663	35	Intermittents	intermittent	NNS
46745	1663	36	,	,	,
46745	1663	37	I	-PRON-	PRP
46745	1663	38	have	have	VBP
46745	1663	39	placed	place	VBN
46745	1663	40	Quina	Quina	NNP
46745	1663	41	among	among	IN
46745	1663	42	Restoratives	restorative	NNS
46745	1663	43	,	,	,
46745	1663	44	and	and	CC
46745	1663	45	Arsenic	arsenic	JJ
46745	1663	46	with	with	IN
46745	1663	47	Catalytics	Catalytics	NNP
46745	1663	48	.	.	.
46745	1664	1	It	-PRON-	PRP
46745	1664	2	may	may	MD
46745	1664	3	be	be	VB
46745	1664	4	remarked	remark	VBN
46745	1664	5	that	that	IN
46745	1664	6	the	the	DT
46745	1664	7	fact	fact	NN
46745	1664	8	that	that	IN
46745	1664	9	Catalytic	catalytic	JJ
46745	1664	10	medicines	medicine	NNS
46745	1664	11	produce	produce	VBP
46745	1664	12	of	of	IN
46745	1664	13	themselves	-PRON-	PRP
46745	1664	14	distinct	distinct	JJ
46745	1664	15	actions	action	NNS
46745	1664	16	in	in	IN
46745	1664	17	the	the	DT
46745	1664	18	blood	blood	NN
46745	1664	19	has	have	VBZ
46745	1664	20	proved	prove	VBN
46745	1664	21	a	a	DT
46745	1664	22	stumbling	stumbling	JJ
46745	1664	23	-	-	HYPH
46745	1664	24	block	block	NN
46745	1664	25	to	to	IN
46745	1664	26	the	the	DT
46745	1664	27	disciples	disciple	NNS
46745	1664	28	of	of	IN
46745	1664	29	M.	M.	NNP
46745	1664	30	Hahnemann	Hahnemann	NNP
46745	1664	31	.	.	.
46745	1665	1	For	for	IN
46745	1665	2	in	in	IN
46745	1665	3	some	some	DT
46745	1665	4	few	few	JJ
46745	1665	5	cases	case	NNS
46745	1665	6	their	-PRON-	PRP$
46745	1665	7	action	action	NN
46745	1665	8	may	may	MD
46745	1665	9	,	,	,
46745	1665	10	to	to	IN
46745	1665	11	a	a	DT
46745	1665	12	certain	certain	JJ
46745	1665	13	extent	extent	NN
46745	1665	14	,	,	,
46745	1665	15	simulate	simulate	VB
46745	1665	16	the	the	DT
46745	1665	17	disease	disease	NN
46745	1665	18	which	which	WDT
46745	1665	19	they	-PRON-	PRP
46745	1665	20	tend	tend	VBP
46745	1665	21	to	to	TO
46745	1665	22	cure	cure	VB
46745	1665	23	,	,	,
46745	1665	24	and	and	CC
46745	1665	25	has	have	VBZ
46745	1665	26	thus	thus	RB
46745	1665	27	been	be	VBN
46745	1665	28	confounded	confound	VBN
46745	1665	29	with	with	IN
46745	1665	30	it	-PRON-	PRP
46745	1665	31	by	by	IN
46745	1665	32	this	this	DT
46745	1665	33	imaginative	imaginative	JJ
46745	1665	34	observer	observer	NN
46745	1665	35	.	.	.
46745	1666	1	This	this	DT
46745	1666	2	partial	partial	JJ
46745	1666	3	resemblance	resemblance	NN
46745	1666	4	is	be	VBZ
46745	1666	5	probably	probably	RB
46745	1666	6	due	due	IN
46745	1666	7	to	to	IN
46745	1666	8	the	the	DT
46745	1666	9	fact	fact	NN
46745	1666	10	that	that	IN
46745	1666	11	both	both	DT
46745	1666	12	disease	disease	NN
46745	1666	13	and	and	CC
46745	1666	14	remedy	remedy	NN
46745	1666	15	produce	produce	VBP
46745	1666	16	a	a	DT
46745	1666	17	series	series	NN
46745	1666	18	of	of	IN
46745	1666	19	changes	change	NNS
46745	1666	20	in	in	IN
46745	1666	21	the	the	DT
46745	1666	22	same	same	JJ
46745	1666	23	set	set	NN
46745	1666	24	of	of	IN
46745	1666	25	particles	particle	NNS
46745	1666	26	in	in	IN
46745	1666	27	the	the	DT
46745	1666	28	blood	blood	NN
46745	1666	29	.	.	.
46745	1667	1	If	if	IN
46745	1667	2	it	-PRON-	PRP
46745	1667	3	were	be	VBD
46745	1667	4	not	not	RB
46745	1667	5	so	so	RB
46745	1667	6	,	,	,
46745	1667	7	the	the	DT
46745	1667	8	remedy	remedy	NN
46745	1667	9	could	could	MD
46745	1667	10	not	not	RB
46745	1667	11	meet	meet	VB
46745	1667	12	the	the	DT
46745	1667	13	disease	disease	NN
46745	1667	14	.	.	.
46745	1668	1	It	-PRON-	PRP
46745	1668	2	would	would	MD
46745	1668	3	be	be	VB
46745	1668	4	out	out	IN
46745	1668	5	of	of	IN
46745	1668	6	its	-PRON-	PRP$
46745	1668	7	province	province	NN
46745	1668	8	,	,	,
46745	1668	9	as	as	IN
46745	1668	10	not	not	RB
46745	1668	11	acting	act	VBG
46745	1668	12	at	at	RB
46745	1668	13	all	all	RB
46745	1668	14	in	in	IN
46745	1668	15	the	the	DT
46745	1668	16	same	same	JJ
46745	1668	17	sphere	sphere	NN
46745	1668	18	.	.	.
46745	1669	1	But	but	CC
46745	1669	2	that	that	IN
46745	1669	3	the	the	DT
46745	1669	4	actions	action	NNS
46745	1669	5	are	be	VBP
46745	1669	6	essentially	essentially	RB
46745	1669	7	different	different	JJ
46745	1669	8	is	be	VBZ
46745	1669	9	sufficiently	sufficiently	RB
46745	1669	10	proved	prove	VBN
46745	1669	11	by	by	IN
46745	1669	12	the	the	DT
46745	1669	13	fact	fact	NN
46745	1669	14	that	that	IN
46745	1669	15	they	-PRON-	PRP
46745	1669	16	counteract	counteract	VBP
46745	1669	17	each	each	DT
46745	1669	18	other	other	JJ
46745	1669	19	.	.	.
46745	1670	1	The	the	DT
46745	1670	2	remedy	remedy	NN
46745	1670	3	,	,	,
46745	1670	4	moreover	moreover	RB
46745	1670	5	,	,	,
46745	1670	6	is	be	VBZ
46745	1670	7	often	often	RB
46745	1670	8	of	of	IN
46745	1670	9	equal	equal	JJ
46745	1670	10	efficacy	efficacy	NN
46745	1670	11	in	in	IN
46745	1670	12	other	other	JJ
46745	1670	13	different	different	JJ
46745	1670	14	disorders	disorder	NNS
46745	1670	15	.	.	.
46745	1671	1	It	-PRON-	PRP
46745	1671	2	has	have	VBZ
46745	1671	3	been	be	VBN
46745	1671	4	shown	show	VBN
46745	1671	5	in	in	IN
46745	1671	6	Chapter	Chapter	NNP
46745	1671	7	II	II	NNP
46745	1671	8	.	.	NNP
46745	1671	9	,	,	,
46745	1671	10	that	that	IN
46745	1671	11	with	with	IN
46745	1671	12	regard	regard	NN
46745	1671	13	to	to	IN
46745	1671	14	Eliminative	eliminative	JJ
46745	1671	15	medicines	medicine	NNS
46745	1671	16	,	,	,
46745	1671	17	the	the	DT
46745	1671	18	Hom[oe]opathic	hom[oe]opathic	JJ
46745	1671	19	theory	theory	NN
46745	1671	20	is	be	VBZ
46745	1671	21	founded	found	VBN
46745	1671	22	on	on	IN
46745	1671	23	a	a	DT
46745	1671	24	misapprehension	misapprehension	NN
46745	1671	25	of	of	IN
46745	1671	26	facts	fact	NNS
46745	1671	27	.	.	.
46745	1672	1	It	-PRON-	PRP
46745	1672	2	must	must	MD
46745	1672	3	not	not	RB
46745	1672	4	be	be	VB
46745	1672	5	inferred	infer	VBN
46745	1672	6	,	,	,
46745	1672	7	from	from	IN
46745	1672	8	what	what	WP
46745	1672	9	has	have	VBZ
46745	1672	10	been	be	VBN
46745	1672	11	said	say	VBN
46745	1672	12	on	on	IN
46745	1672	13	the	the	DT
46745	1672	14	importance	importance	NN
46745	1672	15	of	of	IN
46745	1672	16	blood	blood	NN
46745	1672	17	-	-	HYPH
46745	1672	18	medicines	medicine	NNS
46745	1672	19	,	,	,
46745	1672	20	that	that	IN
46745	1672	21	I	-PRON-	PRP
46745	1672	22	am	be	VBP
46745	1672	23	disposed	disposed	JJ
46745	1672	24	to	to	TO
46745	1672	25	agree	agree	VB
46745	1672	26	with	with	IN
46745	1672	27	those	those	DT
46745	1672	28	who	who	WP
46745	1672	29	would	would	MD
46745	1672	30	account	account	VB
46745	1672	31	for	for	IN
46745	1672	32	all	all	DT
46745	1672	33	diseases	disease	NNS
46745	1672	34	by	by	IN
46745	1672	35	some	some	DT
46745	1672	36	fault	fault	NN
46745	1672	37	in	in	IN
46745	1672	38	the	the	DT
46745	1672	39	humours	humours	NN
46745	1672	40	of	of	IN
46745	1672	41	the	the	DT
46745	1672	42	body	body	NN
46745	1672	43	.	.	.
46745	1673	1	For	for	IN
46745	1673	2	though	though	IN
46745	1673	3	we	-PRON-	PRP
46745	1673	4	know	know	VBP
46745	1673	5	that	that	IN
46745	1673	6	many	many	JJ
46745	1673	7	cases	case	NNS
46745	1673	8	of	of	IN
46745	1673	9	convulsive	convulsive	NN
46745	1673	10	disorder	disorder	NN
46745	1673	11	,	,	,
46745	1673	12	as	as	IN
46745	1673	13	of	of	IN
46745	1673	14	Hysteria	Hysteria	NNP
46745	1673	15	,	,	,
46745	1673	16	Chorea	Chorea	NNP
46745	1673	17	,	,	,
46745	1673	18	and	and	CC
46745	1673	19	Epilepsy	Epilepsy	NNP
46745	1673	20	,	,	,
46745	1673	21	may	may	MD
46745	1673	22	be	be	VB
46745	1673	23	reasonably	reasonably	RB
46745	1673	24	accounted	account	VBN
46745	1673	25	for	for	IN
46745	1673	26	by	by	IN
46745	1673	27	supposing	suppose	VBG
46745	1673	28	the	the	DT
46745	1673	29	existence	existence	NN
46745	1673	30	of	of	IN
46745	1673	31	a	a	DT
46745	1673	32	wrong	wrong	NN
46745	1673	33	in	in	IN
46745	1673	34	the	the	DT
46745	1673	35	blood	blood	NN
46745	1673	36	,	,	,
46745	1673	37	which	which	WDT
46745	1673	38	has	have	VBZ
46745	1673	39	affected	affect	VBN
46745	1673	40	the	the	DT
46745	1673	41	nervous	nervous	JJ
46745	1673	42	system,--yet	system,--yet	NN
46745	1673	43	there	there	EX
46745	1673	44	are	be	VBP
46745	1673	45	doubtless	doubtless	RB
46745	1673	46	many	many	JJ
46745	1673	47	nervous	nervous	JJ
46745	1673	48	affections	affection	NNS
46745	1673	49	which	which	WDT
46745	1673	50	are	be	VBP
46745	1673	51	primarily	primarily	RB
46745	1673	52	independent	independent	JJ
46745	1673	53	of	of	IN
46745	1673	54	the	the	DT
46745	1673	55	blood	blood	NN
46745	1673	56	,	,	,
46745	1673	57	which	which	WDT
46745	1673	58	can	can	MD
46745	1673	59	only	only	RB
46745	1673	60	be	be	VB
46745	1673	61	treated	treat	VBN
46745	1673	62	by	by	IN
46745	1673	63	Neurotic	neurotic	JJ
46745	1673	64	medicines	medicine	NNS
46745	1673	65	,	,	,
46745	1673	66	and	and	CC
46745	1673	67	even	even	RB
46745	1673	68	then	then	RB
46745	1673	69	often	often	RB
46745	1673	70	without	without	IN
46745	1673	71	benefit	benefit	NN
46745	1673	72	.	.	.
46745	1674	1	Thus	thus	RB
46745	1674	2	far	far	RB
46745	1674	3	I	-PRON-	PRP
46745	1674	4	have	have	VBP
46745	1674	5	chiefly	chiefly	RB
46745	1674	6	dealt	deal	VBN
46745	1674	7	in	in	IN
46745	1674	8	assertions	assertion	NNS
46745	1674	9	on	on	IN
46745	1674	10	the	the	DT
46745	1674	11	subject	subject	NN
46745	1674	12	of	of	IN
46745	1674	13	Hæmatic	hæmatic	JJ
46745	1674	14	medicines	medicine	NNS
46745	1674	15	,	,	,
46745	1674	16	but	but	CC
46745	1674	17	I	-PRON-	PRP
46745	1674	18	am	be	VBP
46745	1674	19	now	now	RB
46745	1674	20	about	about	JJ
46745	1674	21	to	to	TO
46745	1674	22	attempt	attempt	VB
46745	1674	23	a	a	DT
46745	1674	24	thing	thing	NN
46745	1674	25	which	which	WDT
46745	1674	26	is	be	VBZ
46745	1674	27	more	more	RBR
46745	1674	28	difficult	difficult	JJ
46745	1674	29	,	,	,
46745	1674	30	that	that	RB
46745	1674	31	is	is	RB
46745	1674	32	,	,	,
46745	1674	33	positive	positive	JJ
46745	1674	34	proof	proof	NN
46745	1674	35	.	.	.
46745	1675	1	I	-PRON-	PRP
46745	1675	2	shall	shall	MD
46745	1675	3	treat	treat	VB
46745	1675	4	separately	separately	RB
46745	1675	5	of	of	IN
46745	1675	6	Restoratives	Restoratives	NNPS
46745	1675	7	and	and	CC
46745	1675	8	Catalytics	Catalytics	NNPS
46745	1675	9	;	;	:
46745	1675	10	each	each	DT
46745	1675	11	division	division	NN
46745	1675	12	will	will	MD
46745	1675	13	be	be	VB
46745	1675	14	divided	divide	VBN
46745	1675	15	into	into	IN
46745	1675	16	certain	certain	JJ
46745	1675	17	distinct	distinct	JJ
46745	1675	18	orders	order	NNS
46745	1675	19	of	of	IN
46745	1675	20	medicines	medicine	NNS
46745	1675	21	;	;	:
46745	1675	22	and	and	CC
46745	1675	23	of	of	IN
46745	1675	24	each	each	DT
46745	1675	25	of	of	IN
46745	1675	26	these	these	DT
46745	1675	27	orders	order	NNS
46745	1675	28	in	in	IN
46745	1675	29	turn	turn	NN
46745	1675	30	I	-PRON-	PRP
46745	1675	31	shall	shall	MD
46745	1675	32	attempt	attempt	VB
46745	1675	33	to	to	TO
46745	1675	34	prove	prove	VB
46745	1675	35	what	what	WP
46745	1675	36	is	be	VBZ
46745	1675	37	laid	lay	VBN
46745	1675	38	down	down	RP
46745	1675	39	concisely	concisely	RB
46745	1675	40	in	in	IN
46745	1675	41	Proposition	Proposition	NNP
46745	1675	42	VII	VII	NNP
46745	1675	43	.	.	.
46745	1676	1	To	to	TO
46745	1676	2	simplify	simplify	VB
46745	1676	3	this	this	DT
46745	1676	4	proof	proof	NN
46745	1676	5	,	,	,
46745	1676	6	that	that	DT
46745	1676	7	part	part	NN
46745	1676	8	of	of	IN
46745	1676	9	the	the	DT
46745	1676	10	Proposition	Proposition	NNP
46745	1676	11	which	which	WDT
46745	1676	12	relates	relate	VBZ
46745	1676	13	to	to	IN
46745	1676	14	Restoratives	restorative	NNS
46745	1676	15	will	will	MD
46745	1676	16	be	be	VB
46745	1676	17	divided	divide	VBN
46745	1676	18	first	first	RB
46745	1676	19	into	into	IN
46745	1676	20	a	a	DT
46745	1676	21	number	number	NN
46745	1676	22	of	of	IN
46745	1676	23	minor	minor	JJ
46745	1676	24	propositions	proposition	NNS
46745	1676	25	,	,	,
46745	1676	26	which	which	WDT
46745	1676	27	,	,	,
46745	1676	28	taken	take	VBN
46745	1676	29	together	together	RB
46745	1676	30	,	,	,
46745	1676	31	imply	imply	VB
46745	1676	32	the	the	DT
46745	1676	33	original	original	JJ
46745	1676	34	one	one	NN
46745	1676	35	.	.	.
46745	1677	1	Each	each	DT
46745	1677	2	must	must	MD
46745	1677	3	be	be	VB
46745	1677	4	shortly	shortly	RB
46745	1677	5	proved	prove	VBN
46745	1677	6	applicable	applicable	JJ
46745	1677	7	to	to	IN
46745	1677	8	each	each	DT
46745	1677	9	order	order	NN
46745	1677	10	of	of	IN
46745	1677	11	Restoratives	restorative	NNS
46745	1677	12	.	.	.
46745	1678	1	The	the	DT
46745	1678	2	same	same	JJ
46745	1678	3	will	will	MD
46745	1678	4	be	be	VB
46745	1678	5	subsequently	subsequently	RB
46745	1678	6	done	do	VBN
46745	1678	7	with	with	IN
46745	1678	8	Catalytics	Catalytics	NNP
46745	1678	9	.	.	.
46745	1679	1	Having	have	VBG
46745	1679	2	sustained	sustain	VBN
46745	1679	3	the	the	DT
46745	1679	4	original	original	JJ
46745	1679	5	proposition	proposition	NN
46745	1679	6	to	to	IN
46745	1679	7	my	-PRON-	PRP$
46745	1679	8	own	own	JJ
46745	1679	9	satisfaction	satisfaction	NN
46745	1679	10	,	,	,
46745	1679	11	I	-PRON-	PRP
46745	1679	12	shall	shall	MD
46745	1679	13	,	,	,
46745	1679	14	in	in	IN
46745	1679	15	some	some	DT
46745	1679	16	cases	case	NNS
46745	1679	17	,	,	,
46745	1679	18	venture	venture	NN
46745	1679	19	to	to	TO
46745	1679	20	offer	offer	VB
46745	1679	21	an	an	DT
46745	1679	22	additional	additional	JJ
46745	1679	23	hypothesis	hypothesis	NN
46745	1679	24	--	--	:
46745	1679	25	only	only	RB
46745	1679	26	as	as	IN
46745	1679	27	hypothetical	hypothetical	JJ
46745	1679	28	--	--	:
46745	1679	29	on	on	IN
46745	1679	30	the	the	DT
46745	1679	31	action	action	NN
46745	1679	32	of	of	IN
46745	1679	33	particular	particular	JJ
46745	1679	34	medicines	medicine	NNS
46745	1679	35	.	.	.
46745	1680	1	Let	let	VB
46745	1680	2	us	-PRON-	PRP
46745	1680	3	now	now	RB
46745	1680	4	proceed	proceed	VB
46745	1680	5	to	to	IN
46745	1680	6	the	the	DT
46745	1680	7	consideration	consideration	NN
46745	1680	8	of	of	IN
46745	1680	9	the	the	DT
46745	1680	10	first	first	JJ
46745	1680	11	division	division	NN
46745	1680	12	of	of	IN
46745	1680	13	Hæmatic	hæmatic	JJ
46745	1680	14	medicines	medicine	NNS
46745	1680	15	.	.	.
46745	1681	1	RESTORATIVES	RESTORATIVES	NNP
46745	1681	2	.	.	.
46745	1682	1	The	the	DT
46745	1682	2	general	general	JJ
46745	1682	3	name	name	NN
46745	1682	4	given	give	VBN
46745	1682	5	to	to	IN
46745	1682	6	the	the	DT
46745	1682	7	medicines	medicine	NNS
46745	1682	8	in	in	IN
46745	1682	9	this	this	DT
46745	1682	10	division	division	NN
46745	1682	11	is	be	VBZ
46745	1682	12	founded	found	VBN
46745	1682	13	upon	upon	IN
46745	1682	14	a	a	DT
46745	1682	15	fact	fact	NN
46745	1682	16	relative	relative	JJ
46745	1682	17	to	to	IN
46745	1682	18	their	-PRON-	PRP$
46745	1682	19	action	action	NN
46745	1682	20	,	,	,
46745	1682	21	which	which	WDT
46745	1682	22	will	will	MD
46745	1682	23	be	be	VB
46745	1682	24	acknowledged	acknowledge	VBN
46745	1682	25	of	of	IN
46745	1682	26	most	most	JJS
46745	1682	27	that	that	WDT
46745	1682	28	I	-PRON-	PRP
46745	1682	29	have	have	VBP
46745	1682	30	here	here	RB
46745	1682	31	included	include	VBN
46745	1682	32	--	--	:
46745	1682	33	namely	namely	RB
46745	1682	34	,	,	,
46745	1682	35	that	that	IN
46745	1682	36	they	-PRON-	PRP
46745	1682	37	restore	restore	VBP
46745	1682	38	to	to	IN
46745	1682	39	the	the	DT
46745	1682	40	blood	blood	NN
46745	1682	41	certain	certain	JJ
46745	1682	42	materials	material	NNS
46745	1682	43	in	in	IN
46745	1682	44	which	which	WDT
46745	1682	45	it	-PRON-	PRP
46745	1682	46	is	be	VBZ
46745	1682	47	deficient	deficient	JJ
46745	1682	48	.	.	.
46745	1683	1	[	[	-LRB-
46745	1683	2	31	31	CD
46745	1683	3	]	]	-RRB-
46745	1683	4	I	-PRON-	PRP
46745	1683	5	will	will	MD
46745	1683	6	divide	divide	VB
46745	1683	7	them	-PRON-	PRP
46745	1683	8	into	into	IN
46745	1683	9	six	six	CD
46745	1683	10	orders	order	NNS
46745	1683	11	,	,	,
46745	1683	12	which	which	WDT
46745	1683	13	are	be	VBP
46745	1683	14	all	all	DT
46745	1683	15	distinct	distinct	JJ
46745	1683	16	and	and	CC
46745	1683	17	characteristic	characteristic	JJ
46745	1683	18	in	in	IN
46745	1683	19	their	-PRON-	PRP$
46745	1683	20	mode	mode	NN
46745	1683	21	of	of	IN
46745	1683	22	action	action	NN
46745	1683	23	.	.	.
46745	1684	1	RESTAURANTIA	RESTAURANTIA	NNP
46745	1684	2	.	.	.
46745	1685	1	Ord	Ord	NNP
46745	1685	2	.	.	.
46745	1686	1	1	1	LS
46745	1686	2	.	.	.
46745	1687	1	Alimenta	Alimenta	NNP
46745	1687	2	.	.	.
46745	1688	1	Ord	Ord	NNP
46745	1688	2	.	.	.
46745	1689	1	2	2	LS
46745	1689	2	.	.	.
46745	1690	1	Acida	Acida	NNP
46745	1690	2	.	.	.
46745	1691	1	Ord	Ord	NNP
46745	1691	2	.	.	.
46745	1692	1	3	3	LS
46745	1692	2	.	.	.
46745	1693	1	Alkalia	Alkalia	NNP
46745	1693	2	.	.	.
46745	1694	1	Ord	Ord	NNP
46745	1694	2	.	.	.
46745	1695	1	4	4	LS
46745	1695	2	.	.	.
46745	1696	1	Tonica	Tonica	NNP
46745	1696	2	.	.	.
46745	1697	1	Ord	Ord	NNP
46745	1697	2	.	.	.
46745	1698	1	5	5	CD
46745	1698	2	.	.	.
46745	1699	1	Chalybeata	Chalybeata	NNS
46745	1699	2	.	.	.
46745	1700	1	Ord	Ord	NNP
46745	1700	2	.	.	.
46745	1701	1	6	6	CD
46745	1701	2	.	.	.
46745	1702	1	Solventia	Solventia	NNP
46745	1702	2	.	.	.
46745	1703	1	On	on	IN
46745	1703	2	reverting	revert	VBG
46745	1703	3	to	to	IN
46745	1703	4	Proposition	Proposition	NNP
46745	1703	5	VII	VII	NNP
46745	1703	6	.	.	NNP
46745	1703	7	,	,	,
46745	1703	8	which	which	WDT
46745	1703	9	treats	treat	VBZ
46745	1703	10	of	of	IN
46745	1703	11	the	the	DT
46745	1703	12	action	action	NN
46745	1703	13	of	of	IN
46745	1703	14	the	the	DT
46745	1703	15	first	first	JJ
46745	1703	16	class	class	NN
46745	1703	17	of	of	IN
46745	1703	18	medicines	medicine	NNS
46745	1703	19	,	,	,
46745	1703	20	it	-PRON-	PRP
46745	1703	21	will	will	MD
46745	1703	22	be	be	VB
46745	1703	23	seen	see	VBN
46745	1703	24	that	that	IN
46745	1703	25	what	what	WP
46745	1703	26	has	have	VBZ
46745	1703	27	been	be	VBN
46745	1703	28	there	there	RB
46745	1703	29	stated	state	VBN
46745	1703	30	with	with	IN
46745	1703	31	respect	respect	NN
46745	1703	32	to	to	IN
46745	1703	33	the	the	DT
46745	1703	34	action	action	NN
46745	1703	35	of	of	IN
46745	1703	36	Restoratives	restorative	NNS
46745	1703	37	resolves	resolve	VBZ
46745	1703	38	itself	-PRON-	PRP
46745	1703	39	into	into	IN
46745	1703	40	the	the	DT
46745	1703	41	following	follow	VBG
46745	1703	42	simple	simple	JJ
46745	1703	43	affirmations	affirmation	NNS
46745	1703	44	or	or	CC
46745	1703	45	minor	minor	JJ
46745	1703	46	propositions	proposition	NNS
46745	1703	47	.	.	.
46745	1704	1	_	_	NNP
46745	1704	2	m.	m.	NN
46745	1705	1	p.	p.	NN
46745	1705	2	_	_	NNP
46745	1705	3	1.--That	1.--That	NNP
46745	1705	4	they	-PRON-	PRP
46745	1705	5	act	act	VBP
46745	1705	6	in	in	IN
46745	1705	7	the	the	DT
46745	1705	8	blood	blood	NN
46745	1705	9	,	,	,
46745	1705	10	and	and	CC
46745	1705	11	that	that	IN
46745	1705	12	their	-PRON-	PRP$
46745	1705	13	effect	effect	NN
46745	1705	14	is	be	VBZ
46745	1705	15	permanent	permanent	JJ
46745	1705	16	.	.	.
46745	1706	1	_	_	NNP
46745	1706	2	m.	m.	NN
46745	1707	1	p.	p.	NN
46745	1707	2	_	_	NNP
46745	1707	3	2.--That	2.--that	CD
46745	1707	4	there	there	EX
46745	1707	5	are	be	VBP
46745	1707	6	naturally	naturally	RB
46745	1707	7	in	in	IN
46745	1707	8	the	the	DT
46745	1707	9	blood	blood	NN
46745	1707	10	substances	substance	NNS
46745	1707	11	which	which	WDT
46745	1707	12	resemble	resemble	VBP
46745	1707	13	or	or	CC
46745	1707	14	coincide	coincide	VBP
46745	1707	15	with	with	IN
46745	1707	16	them	-PRON-	PRP
46745	1707	17	.	.	.
46745	1708	1	_	_	NNP
46745	1708	2	m.	m.	NN
46745	1709	1	p.	p.	NN
46745	1709	2	_	_	NNP
46745	1709	3	3.--That	3.--That	NNP
46745	1709	4	they	-PRON-	PRP
46745	1709	5	are	be	VBP
46745	1709	6	not	not	RB
46745	1709	7	of	of	IN
46745	1709	8	necessity	necessity	NN
46745	1709	9	excreted	excrete	VBN
46745	1709	10	,	,	,
46745	1709	11	but	but	CC
46745	1709	12	may	may	MD
46745	1709	13	remain	remain	VB
46745	1709	14	in	in	IN
46745	1709	15	the	the	DT
46745	1709	16	blood	blood	NN
46745	1709	17	.	.	.
46745	1710	1	_	_	NNP
46745	1710	2	m.	m.	NN
46745	1711	1	p.	p.	NN
46745	1711	2	_	_	NNP
46745	1711	3	4.--That	4.--That	NNP
46745	1711	4	they	-PRON-	PRP
46745	1711	5	are	be	VBP
46745	1711	6	of	of	IN
46745	1711	7	use	use	NN
46745	1711	8	when	when	WRB
46745	1711	9	a	a	DT
46745	1711	10	disease	disease	NN
46745	1711	11	depends	depend	VBZ
46745	1711	12	on	on	IN
46745	1711	13	the	the	DT
46745	1711	14	want	want	NN
46745	1711	15	of	of	IN
46745	1711	16	one	one	CD
46745	1711	17	or	or	CC
46745	1711	18	more	more	JJR
46745	1711	19	materials	material	NNS
46745	1711	20	in	in	IN
46745	1711	21	the	the	DT
46745	1711	22	blood	blood	NN
46745	1711	23	.	.	.
46745	1712	1	It	-PRON-	PRP
46745	1712	2	will	will	MD
46745	1712	3	be	be	VB
46745	1712	4	seen	see	VBN
46745	1712	5	that	that	IN
46745	1712	6	the	the	DT
46745	1712	7	first	first	JJ
46745	1712	8	minor	minor	JJ
46745	1712	9	proposition	proposition	NN
46745	1712	10	affirms	affirm	VBZ
46745	1712	11	them	-PRON-	PRP
46745	1712	12	to	to	TO
46745	1712	13	be	be	VB
46745	1712	14	Hæmatic	hæmatic	JJ
46745	1712	15	medicines	medicine	NNS
46745	1712	16	,	,	,
46745	1712	17	according	accord	VBG
46745	1712	18	to	to	IN
46745	1712	19	the	the	DT
46745	1712	20	definition	definition	NN
46745	1712	21	given	give	VBN
46745	1712	22	before	before	RB
46745	1712	23	.	.	.
46745	1713	1	The	the	DT
46745	1713	2	second	second	JJ
46745	1713	3	is	be	VBZ
46745	1713	4	required	require	VBN
46745	1713	5	;	;	:
46745	1713	6	for	for	IN
46745	1713	7	if	if	IN
46745	1713	8	there	there	EX
46745	1713	9	were	be	VBD
46745	1713	10	not	not	RB
46745	1713	11	a	a	DT
46745	1713	12	necessity	necessity	NN
46745	1713	13	in	in	IN
46745	1713	14	the	the	DT
46745	1713	15	blood	blood	NN
46745	1713	16	for	for	IN
46745	1713	17	substances	substance	NNS
46745	1713	18	like	like	IN
46745	1713	19	them	-PRON-	PRP
46745	1713	20	,	,	,
46745	1713	21	they	-PRON-	PRP
46745	1713	22	could	could	MD
46745	1713	23	supply	supply	VB
46745	1713	24	nothing	nothing	NN
46745	1713	25	.	.	.
46745	1714	1	The	the	DT
46745	1714	2	third	third	NN
46745	1714	3	also	also	RB
46745	1714	4	is	be	VBZ
46745	1714	5	necessary	necessary	JJ
46745	1714	6	,	,	,
46745	1714	7	for	for	IN
46745	1714	8	if	if	IN
46745	1714	9	they	-PRON-	PRP
46745	1714	10	were	be	VBD
46745	1714	11	excreted	excrete	VBN
46745	1714	12	in	in	IN
46745	1714	13	all	all	DT
46745	1714	14	cases	case	NNS
46745	1714	15	,	,	,
46745	1714	16	it	-PRON-	PRP
46745	1714	17	is	be	VBZ
46745	1714	18	evident	evident	JJ
46745	1714	19	that	that	IN
46745	1714	20	their	-PRON-	PRP$
46745	1714	21	Restorative	restorative	JJ
46745	1714	22	action	action	NN
46745	1714	23	could	could	MD
46745	1714	24	not	not	RB
46745	1714	25	be	be	VB
46745	1714	26	lasting	last	VBG
46745	1714	27	.	.	.
46745	1715	1	An	an	DT
46745	1715	2	exception	exception	NN
46745	1715	3	must	must	MD
46745	1715	4	be	be	VB
46745	1715	5	made	make	VBN
46745	1715	6	in	in	IN
46745	1715	7	the	the	DT
46745	1715	8	case	case	NN
46745	1715	9	of	of	IN
46745	1715	10	those	those	DT
46745	1715	11	that	that	WDT
46745	1715	12	are	be	VBP
46745	1715	13	used	use	VBN
46745	1715	14	to	to	TO
46745	1715	15	supply	supply	VB
46745	1715	16	something	something	NN
46745	1715	17	which	which	WDT
46745	1715	18	is	be	VBZ
46745	1715	19	necessary	necessary	JJ
46745	1715	20	in	in	IN
46745	1715	21	order	order	NN
46745	1715	22	that	that	IN
46745	1715	23	a	a	DT
46745	1715	24	secretion	secretion	NN
46745	1715	25	may	may	MD
46745	1715	26	be	be	VB
46745	1715	27	properly	properly	RB
46745	1715	28	elaborated	elaborate	VBN
46745	1715	29	.	.	.
46745	1716	1	Medicines	medicine	NNS
46745	1716	2	of	of	IN
46745	1716	3	the	the	DT
46745	1716	4	Sixth	Sixth	NNP
46745	1716	5	Order	Order	NNP
46745	1716	6	are	be	VBP
46745	1716	7	particularly	particularly	RB
46745	1716	8	used	use	VBN
46745	1716	9	with	with	IN
46745	1716	10	this	this	DT
46745	1716	11	intent	intent	NN
46745	1716	12	;	;	:
46745	1716	13	as	as	IN
46745	1716	14	also	also	RB
46745	1716	15	some	some	DT
46745	1716	16	acids	acid	NNS
46745	1716	17	and	and	CC
46745	1716	18	alkalies	alkali	NNS
46745	1716	19	.	.	.
46745	1717	1	But	but	CC
46745	1717	2	these	these	DT
46745	1717	3	are	be	VBP
46745	1717	4	not	not	RB
46745	1717	5	repugnant	repugnant	JJ
46745	1717	6	to	to	IN
46745	1717	7	the	the	DT
46745	1717	8	blood	blood	NN
46745	1717	9	,	,	,
46745	1717	10	like	like	IN
46745	1717	11	Catalytics	Catalytics	NNP
46745	1717	12	.	.	.
46745	1718	1	In	in	IN
46745	1718	2	the	the	DT
46745	1718	3	fourth	fourth	JJ
46745	1718	4	place	place	NN
46745	1718	5	it	-PRON-	PRP
46745	1718	6	is	be	VBZ
46745	1718	7	affirmed	affirm	VBN
46745	1718	8	that	that	IN
46745	1718	9	being	be	VBG
46745	1718	10	thus	thus	RB
46745	1718	11	fitted	fit	VBN
46745	1718	12	for	for	IN
46745	1718	13	the	the	DT
46745	1718	14	blood	blood	NN
46745	1718	15	,	,	,
46745	1718	16	and	and	CC
46745	1718	17	allowed	allow	VBN
46745	1718	18	to	to	TO
46745	1718	19	remain	remain	VB
46745	1718	20	in	in	IN
46745	1718	21	it	-PRON-	PRP
46745	1718	22	,	,	,
46745	1718	23	they	-PRON-	PRP
46745	1718	24	tend	tend	VBP
46745	1718	25	to	to	TO
46745	1718	26	cure	cure	VB
46745	1718	27	a	a	DT
46745	1718	28	disease	disease	NN
46745	1718	29	which	which	WDT
46745	1718	30	depends	depend	VBZ
46745	1718	31	on	on	IN
46745	1718	32	the	the	DT
46745	1718	33	want	want	NN
46745	1718	34	of	of	IN
46745	1718	35	a	a	DT
46745	1718	36	substance	substance	NN
46745	1718	37	similar	similar	JJ
46745	1718	38	in	in	IN
46745	1718	39	nature	nature	NN
46745	1718	40	to	to	IN
46745	1718	41	themselves	-PRON-	PRP
46745	1718	42	.	.	.
46745	1719	1	After	after	IN
46745	1719	2	giving	give	VBG
46745	1719	3	a	a	DT
46745	1719	4	brief	brief	JJ
46745	1719	5	account	account	NN
46745	1719	6	of	of	IN
46745	1719	7	each	each	DT
46745	1719	8	of	of	IN
46745	1719	9	the	the	DT
46745	1719	10	orders	order	NNS
46745	1719	11	of	of	IN
46745	1719	12	Restoratives	restorative	NNS
46745	1719	13	,	,	,
46745	1719	14	it	-PRON-	PRP
46745	1719	15	will	will	MD
46745	1719	16	be	be	VB
46745	1719	17	my	-PRON-	PRP$
46745	1719	18	object	object	NN
46745	1719	19	to	to	TO
46745	1719	20	prove	prove	VB
46745	1719	21	that	that	IN
46745	1719	22	these	these	DT
46745	1719	23	affirmations	affirmation	NNS
46745	1719	24	are	be	VBP
46745	1719	25	severally	severally	RB
46745	1719	26	applicable	applicable	JJ
46745	1719	27	to	to	IN
46745	1719	28	each	each	DT
46745	1719	29	of	of	IN
46745	1719	30	them	-PRON-	PRP
46745	1719	31	.	.	.
46745	1720	1	ORD	ORD	NNP
46745	1720	2	.	.	.
46745	1721	1	I.	I.	NNP
46745	1721	2	ALIMENTS	aliment	NNS
46745	1721	3	.	.	.
46745	1722	1	An	an	DT
46745	1722	2	article	article	NN
46745	1722	3	of	of	IN
46745	1722	4	food	food	NN
46745	1722	5	is	be	VBZ
46745	1722	6	the	the	DT
46745	1722	7	simplest	simple	JJS
46745	1722	8	form	form	NN
46745	1722	9	,	,	,
46745	1722	10	and	and	CC
46745	1722	11	in	in	IN
46745	1722	12	fact	fact	NN
46745	1722	13	the	the	DT
46745	1722	14	type	type	NN
46745	1722	15	,	,	,
46745	1722	16	of	of	IN
46745	1722	17	all	all	DT
46745	1722	18	medicines	medicine	NNS
46745	1722	19	of	of	IN
46745	1722	20	this	this	DT
46745	1722	21	division	division	NN
46745	1722	22	.	.	.
46745	1723	1	Out	out	IN
46745	1723	2	of	of	IN
46745	1723	3	the	the	DT
46745	1723	4	materials	material	NNS
46745	1723	5	of	of	IN
46745	1723	6	the	the	DT
46745	1723	7	food	food	NN
46745	1723	8	the	the	DT
46745	1723	9	whole	whole	JJ
46745	1723	10	blood	blood	NN
46745	1723	11	is	be	VBZ
46745	1723	12	constantly	constantly	RB
46745	1723	13	elaborated	elaborate	VBN
46745	1723	14	,	,	,
46745	1723	15	and	and	CC
46745	1723	16	all	all	PDT
46745	1723	17	the	the	DT
46745	1723	18	tissues	tissue	NNS
46745	1723	19	are	be	VBP
46745	1723	20	constructed	construct	VBN
46745	1723	21	.	.	.
46745	1724	1	Aliments	aliment	NNS
46745	1724	2	were	be	VBD
46745	1724	3	divided	divide	VBN
46745	1724	4	by	by	IN
46745	1724	5	Dr.	Dr.	NNP
46745	1724	6	Prout	Prout	NNP
46745	1724	7	into	into	IN
46745	1724	8	four	four	CD
46745	1724	9	kinds:--(1	kinds:--(1	NN
46745	1724	10	)	)	-RRB-
46745	1724	11	Aqueous	aqueous	JJ
46745	1724	12	;	;	:
46745	1724	13	(	(	-LRB-
46745	1724	14	2	2	LS
46745	1724	15	)	)	-RRB-
46745	1724	16	Albuminous	albuminous	JJ
46745	1724	17	;	;	:
46745	1724	18	(	(	-LRB-
46745	1724	19	3	3	LS
46745	1724	20	)	)	-RRB-
46745	1724	21	Saccharine	Saccharine	NNP
46745	1724	22	;	;	:
46745	1724	23	(	(	-LRB-
46745	1724	24	4	4	LS
46745	1724	25	)	)	-RRB-
46745	1724	26	Oleaginous	oleaginous	JJ
46745	1724	27	.	.	.
46745	1725	1	These	these	DT
46745	1725	2	kinds	kind	NNS
46745	1725	3	differ	differ	VBP
46745	1725	4	much	much	RB
46745	1725	5	in	in	IN
46745	1725	6	chemical	chemical	NN
46745	1725	7	conformation	conformation	NN
46745	1725	8	.	.	.
46745	1726	1	The	the	DT
46745	1726	2	second	second	JJ
46745	1726	3	kind	kind	NN
46745	1726	4	alone	alone	RB
46745	1726	5	contain	contain	VBP
46745	1726	6	Nitrogen	Nitrogen	NNP
46745	1726	7	.	.	.
46745	1727	1	The	the	DT
46745	1727	2	last	last	JJ
46745	1727	3	two	two	CD
46745	1727	4	are	be	VBP
46745	1727	5	both	both	DT
46745	1727	6	called	call	VBN
46745	1727	7	_	_	NNP
46745	1727	8	carbonaceous	carbonaceous	JJ
46745	1727	9	_	_	NNP
46745	1727	10	;	;	:
46745	1727	11	but	but	CC
46745	1727	12	those	those	DT
46745	1727	13	of	of	IN
46745	1727	14	the	the	DT
46745	1727	15	fourth	fourth	JJ
46745	1727	16	kind	kind	NN
46745	1727	17	contain	contain	VBP
46745	1727	18	more	more	JJR
46745	1727	19	Carbon	carbon	NN
46745	1727	20	than	than	IN
46745	1727	21	those	those	DT
46745	1727	22	of	of	IN
46745	1727	23	the	the	DT
46745	1727	24	third	third	JJ
46745	1727	25	.	.	.
46745	1728	1	The	the	DT
46745	1728	2	following	follow	VBG
46745	1728	3	will	will	MD
46745	1728	4	serve	serve	VB
46745	1728	5	to	to	TO
46745	1728	6	illustrate	illustrate	VB
46745	1728	7	the	the	DT
46745	1728	8	differences	difference	NNS
46745	1728	9	in	in	IN
46745	1728	10	the	the	DT
46745	1728	11	chemical	chemical	JJ
46745	1728	12	composition	composition	NN
46745	1728	13	of	of	IN
46745	1728	14	these	these	DT
46745	1728	15	groups	group	NNS
46745	1728	16	.	.	.
46745	1729	1	1	1	LS
46745	1729	2	.	.	.
46745	1730	1	Water	water	NN
46745	1730	2	=	=	SYM
46745	1730	3	H	h	NN
46745	1730	4	O	o	NN
46745	1730	5	2	2	CD
46745	1730	6	.	.	.
46745	1731	1	Proteine	proteine	NN
46745	1731	2	=	=	SYM
46745	1731	3	C_{40}H_{31}N_{5}O_{12	c_{40}h_{31}n_{5}o_{12	NN
46745	1731	4	}	}	-RRB-
46745	1731	5	3	3	CD
46745	1731	6	.	.	.
46745	1732	1	Starch	Starch	NNP
46745	1732	2	=	=	SYM
46745	1732	3	C_{10}H_{10	C_{10}H_{10	NNP
46745	1732	4	}	}	-RRB-
46745	1732	5	O_{10	O_{10	NNP
46745	1732	6	}	}	-RRB-
46745	1732	7	4	4	CD
46745	1732	8	.	.	.
46745	1733	1	Stearic	stearic	NN
46745	1733	2	Acid	acid	NN
46745	1733	3	=	=	SYM
46745	1733	4	C_{68}H_{68}O_{7	c_{68}h_{68}o_{7	NN
46745	1733	5	}	}	-RRB-
46745	1733	6	Water	Water	NNP
46745	1733	7	is	be	VBZ
46745	1733	8	useful	useful	JJ
46745	1733	9	in	in	IN
46745	1733	10	dissolving	dissolve	VBG
46745	1733	11	the	the	DT
46745	1733	12	other	other	JJ
46745	1733	13	elements	element	NNS
46745	1733	14	,	,	,
46745	1733	15	and	and	CC
46745	1733	16	reducing	reduce	VBG
46745	1733	17	them	-PRON-	PRP
46745	1733	18	to	to	IN
46745	1733	19	a	a	DT
46745	1733	20	state	state	NN
46745	1733	21	of	of	IN
46745	1733	22	solution	solution	NN
46745	1733	23	which	which	WDT
46745	1733	24	is	be	VBZ
46745	1733	25	fitted	fit	VBN
46745	1733	26	for	for	IN
46745	1733	27	the	the	DT
46745	1733	28	formation	formation	NN
46745	1733	29	of	of	IN
46745	1733	30	blood	blood	NN
46745	1733	31	,	,	,
46745	1733	32	and	and	CC
46745	1733	33	of	of	IN
46745	1733	34	the	the	DT
46745	1733	35	other	other	JJ
46745	1733	36	fluids	fluid	NNS
46745	1733	37	of	of	IN
46745	1733	38	the	the	DT
46745	1733	39	body	body	NN
46745	1733	40	.	.	.
46745	1734	1	We	-PRON-	PRP
46745	1734	2	have	have	VBP
46745	1734	3	already	already	RB
46745	1734	4	seen	see	VBN
46745	1734	5	in	in	IN
46745	1734	6	what	what	WDT
46745	1734	7	way	way	NN
46745	1734	8	these	these	DT
46745	1734	9	various	various	JJ
46745	1734	10	matters	matter	NNS
46745	1734	11	are	be	VBP
46745	1734	12	dissolved	dissolve	VBN
46745	1734	13	and	and	CC
46745	1734	14	absorbed	absorb	VBN
46745	1734	15	in	in	IN
46745	1734	16	the	the	DT
46745	1734	17	_	_	NNP
46745	1734	18	primæ	primæ	NN
46745	1734	19	viæ	viæ	NNP
46745	1734	20	_	_	NNP
46745	1734	21	,	,	,
46745	1734	22	and	and	CC
46745	1734	23	how	how	WRB
46745	1734	24	they	-PRON-	PRP
46745	1734	25	pass	pass	VBP
46745	1734	26	into	into	IN
46745	1734	27	the	the	DT
46745	1734	28	circulation	circulation	NN
46745	1734	29	;	;	:
46745	1734	30	that	that	DT
46745	1734	31	Proteinaceous	proteinaceous	JJ
46745	1734	32	and	and	CC
46745	1734	33	Saccharine	Saccharine	NNP
46745	1734	34	matters	matter	NNS
46745	1734	35	pass	pass	VBP
46745	1734	36	into	into	IN
46745	1734	37	the	the	DT
46745	1734	38	capillaries	capillary	NNS
46745	1734	39	of	of	IN
46745	1734	40	the	the	DT
46745	1734	41	Portal	Portal	NNP
46745	1734	42	vein	vein	NN
46745	1734	43	,	,	,
46745	1734	44	and	and	CC
46745	1734	45	thence	thence	NN
46745	1734	46	onwards	onwards	RB
46745	1734	47	through	through	IN
46745	1734	48	the	the	DT
46745	1734	49	liver	liver	NN
46745	1734	50	;	;	:
46745	1734	51	and	and	CC
46745	1734	52	that	that	IN
46745	1734	53	fatty	fatty	NN
46745	1734	54	matters	matter	NNS
46745	1734	55	are	be	VBP
46745	1734	56	reduced	reduce	VBN
46745	1734	57	to	to	IN
46745	1734	58	a	a	DT
46745	1734	59	kind	kind	NN
46745	1734	60	of	of	IN
46745	1734	61	emulsion	emulsion	NN
46745	1734	62	by	by	IN
46745	1734	63	the	the	DT
46745	1734	64	intestinal	intestinal	JJ
46745	1734	65	juices	juice	NNS
46745	1734	66	,	,	,
46745	1734	67	and	and	CC
46745	1734	68	pass	pass	VB
46745	1734	69	through	through	IN
46745	1734	70	the	the	DT
46745	1734	71	lacteals	lacteal	NNS
46745	1734	72	into	into	IN
46745	1734	73	the	the	DT
46745	1734	74	thoracic	thoracic	NNP
46745	1734	75	duct	duct	NN
46745	1734	76	,	,	,
46745	1734	77	by	by	IN
46745	1734	78	which	which	WDT
46745	1734	79	they	-PRON-	PRP
46745	1734	80	are	be	VBP
46745	1734	81	conducted	conduct	VBN
46745	1734	82	into	into	IN
46745	1734	83	the	the	DT
46745	1734	84	circulation	circulation	NN
46745	1734	85	at	at	IN
46745	1734	86	large	large	JJ
46745	1734	87	.	.	.
46745	1735	1	What	what	WP
46745	1735	2	then	then	RB
46745	1735	3	are	be	VBP
46745	1735	4	the	the	DT
46745	1735	5	chief	chief	NN
46745	1735	6	uses	use	NNS
46745	1735	7	for	for	IN
46745	1735	8	which	which	WDT
46745	1735	9	these	these	DT
46745	1735	10	matters	matter	NNS
46745	1735	11	are	be	VBP
46745	1735	12	required	require	VBN
46745	1735	13	in	in	IN
46745	1735	14	the	the	DT
46745	1735	15	system	system	NN
46745	1735	16	,	,	,
46745	1735	17	and	and	CC
46745	1735	18	what	what	WP
46745	1735	19	great	great	JJ
46745	1735	20	functions	function	NNS
46745	1735	21	do	do	VBP
46745	1735	22	they	-PRON-	PRP
46745	1735	23	fulfil	fulfil	VB
46745	1735	24	?	?	.
46745	1736	1	The	the	DT
46745	1736	2	nitrogenous	nitrogenous	JJ
46745	1736	3	Aliments	aliment	NNS
46745	1736	4	are	be	VBP
46745	1736	5	needed	need	VBN
46745	1736	6	particularly	particularly	RB
46745	1736	7	to	to	TO
46745	1736	8	supply	supply	VB
46745	1736	9	the	the	DT
46745	1736	10	growth	growth	NN
46745	1736	11	and	and	CC
46745	1736	12	waste	waste	NN
46745	1736	13	of	of	IN
46745	1736	14	the	the	DT
46745	1736	15	muscular	muscular	JJ
46745	1736	16	and	and	CC
46745	1736	17	nervous	nervous	JJ
46745	1736	18	tissues	tissue	NNS
46745	1736	19	,	,	,
46745	1736	20	which	which	WDT
46745	1736	21	both	both	DT
46745	1736	22	contain	contain	VBP
46745	1736	23	Nitrogen	Nitrogen	NNP
46745	1736	24	;	;	:
46745	1736	25	as	as	IN
46745	1736	26	also	also	RB
46745	1736	27	do	do	VBP
46745	1736	28	all	all	PDT
46745	1736	29	the	the	DT
46745	1736	30	parts	part	NNS
46745	1736	31	of	of	IN
46745	1736	32	the	the	DT
46745	1736	33	body	body	NN
46745	1736	34	,	,	,
46745	1736	35	excepting	except	VBG
46745	1736	36	Fat	fat	NN
46745	1736	37	.	.	.
46745	1737	1	This	this	DT
46745	1737	2	waste	waste	NN
46745	1737	3	is	be	VBZ
46745	1737	4	continually	continually	RB
46745	1737	5	going	go	VBG
46745	1737	6	on	on	RP
46745	1737	7	.	.	.
46745	1738	1	It	-PRON-	PRP
46745	1738	2	depends	depend	VBZ
46745	1738	3	upon	upon	IN
46745	1738	4	the	the	DT
46745	1738	5	fact	fact	NN
46745	1738	6	that	that	IN
46745	1738	7	,	,	,
46745	1738	8	after	after	IN
46745	1738	9	having	have	VBG
46745	1738	10	lasted	last	VBN
46745	1738	11	a	a	DT
46745	1738	12	certain	certain	JJ
46745	1738	13	time	time	NN
46745	1738	14	,	,	,
46745	1738	15	the	the	DT
46745	1738	16	particles	particle	NNS
46745	1738	17	of	of	IN
46745	1738	18	all	all	PDT
46745	1738	19	these	these	DT
46745	1738	20	tissues	tissue	NNS
46745	1738	21	are	be	VBP
46745	1738	22	gradually	gradually	RB
46745	1738	23	displaced	displace	VBN
46745	1738	24	,	,	,
46745	1738	25	oxidized	oxidize	VBN
46745	1738	26	,	,	,
46745	1738	27	and	and	CC
46745	1738	28	conveyed	convey	VBN
46745	1738	29	away	away	RB
46745	1738	30	out	out	IN
46745	1738	31	of	of	IN
46745	1738	32	the	the	DT
46745	1738	33	blood	blood	NN
46745	1738	34	into	into	IN
46745	1738	35	the	the	DT
46745	1738	36	urine	urine	NN
46745	1738	37	and	and	CC
46745	1738	38	other	other	JJ
46745	1738	39	secretions	secretion	NNS
46745	1738	40	.	.	.
46745	1739	1	In	in	IN
46745	1739	2	the	the	DT
46745	1739	3	urine	urine	NN
46745	1739	4	these	these	DT
46745	1739	5	waste	waste	NN
46745	1739	6	matters	matter	NNS
46745	1739	7	are	be	VBP
46745	1739	8	found	find	VBN
46745	1739	9	as	as	IN
46745	1739	10	Urea	Urea	NNP
46745	1739	11	,	,	,
46745	1739	12	Uric	Uric	NNP
46745	1739	13	acid	acid	NN
46745	1739	14	,	,	,
46745	1739	15	and	and	CC
46745	1739	16	Kreatine	Kreatine	NNP
46745	1739	17	.	.	.
46745	1740	1	The	the	DT
46745	1740	2	starchy	starchy	JJ
46745	1740	3	and	and	CC
46745	1740	4	saccharine	saccharine	JJ
46745	1740	5	parts	part	NNS
46745	1740	6	of	of	IN
46745	1740	7	the	the	DT
46745	1740	8	food	food	NN
46745	1740	9	are	be	VBP
46745	1740	10	destined	destine	VBN
46745	1740	11	to	to	TO
46745	1740	12	pass	pass	VB
46745	1740	13	through	through	RP
46745	1740	14	a	a	DT
46745	1740	15	series	series	NN
46745	1740	16	of	of	IN
46745	1740	17	changes	change	NNS
46745	1740	18	,	,	,
46745	1740	19	which	which	WDT
46745	1740	20	ends	end	VBZ
46745	1740	21	also	also	RB
46745	1740	22	in	in	IN
46745	1740	23	their	-PRON-	PRP$
46745	1740	24	being	be	VBG
46745	1740	25	burnt	burn	VBN
46745	1740	26	and	and	CC
46745	1740	27	oxidized	oxidize	VBN
46745	1740	28	,	,	,
46745	1740	29	maintaining	maintain	VBG
46745	1740	30	the	the	DT
46745	1740	31	animal	animal	NN
46745	1740	32	heat	heat	NN
46745	1740	33	,	,	,
46745	1740	34	and	and	CC
46745	1740	35	forming	form	VBG
46745	1740	36	Carbonic	carbonic	JJ
46745	1740	37	acid	acid	NN
46745	1740	38	.	.	.
46745	1741	1	Starch	starch	NN
46745	1741	2	passes	pass	VBZ
46745	1741	3	first	first	RB
46745	1741	4	into	into	IN
46745	1741	5	grape	grape	NN
46745	1741	6	-	-	HYPH
46745	1741	7	sugar	sugar	NN
46745	1741	8	,	,	,
46745	1741	9	by	by	IN
46745	1741	10	taking	take	VBG
46745	1741	11	into	into	IN
46745	1741	12	itself	-PRON-	PRP
46745	1741	13	two	two	CD
46745	1741	14	atoms	atom	NNS
46745	1741	15	of	of	IN
46745	1741	16	water	water	NN
46745	1741	17	,	,	,
46745	1741	18	becoming	become	VBG
46745	1741	19	C_{12}H_{12}O_{12	C_{12}H_{12}O_{12	NNP
46745	1741	20	}	}	-RRB-
46745	1741	21	.	.	.
46745	1742	1	The	the	DT
46745	1742	2	Ptyaline	Ptyaline	NNP
46745	1742	3	of	of	IN
46745	1742	4	Saliva	Saliva	NNP
46745	1742	5	,	,	,
46745	1742	6	Pepsin	Pepsin	NNP
46745	1742	7	of	of	IN
46745	1742	8	the	the	DT
46745	1742	9	gastric	gastric	JJ
46745	1742	10	juice	juice	NN
46745	1742	11	,	,	,
46745	1742	12	and	and	CC
46745	1742	13	some	some	DT
46745	1742	14	similar	similar	JJ
46745	1742	15	principle	principle	NN
46745	1742	16	in	in	IN
46745	1742	17	the	the	DT
46745	1742	18	Pancreatic	pancreatic	JJ
46745	1742	19	fluid	fluid	NN
46745	1742	20	,	,	,
46745	1742	21	are	be	VBP
46745	1742	22	all	all	RB
46745	1742	23	capable	capable	JJ
46745	1742	24	of	of	IN
46745	1742	25	causing	cause	VBG
46745	1742	26	this	this	DT
46745	1742	27	first	first	JJ
46745	1742	28	transformation	transformation	NN
46745	1742	29	.	.	.
46745	1743	1	This	this	DT
46745	1743	2	sugar	sugar	NN
46745	1743	3	is	be	VBZ
46745	1743	4	more	more	RBR
46745	1743	5	soluble	soluble	JJ
46745	1743	6	than	than	IN
46745	1743	7	Starch	Starch	NNP
46745	1743	8	.	.	.
46745	1744	1	When	when	WRB
46745	1744	2	in	in	IN
46745	1744	3	the	the	DT
46745	1744	4	blood	blood	NN
46745	1744	5	,	,	,
46745	1744	6	it	-PRON-	PRP
46745	1744	7	undergoes	undergo	VBZ
46745	1744	8	a	a	DT
46745	1744	9	further	further	JJ
46745	1744	10	change	change	NN
46745	1744	11	,	,	,
46745	1744	12	the	the	DT
46745	1744	13	nature	nature	NN
46745	1744	14	of	of	IN
46745	1744	15	which	which	WDT
46745	1744	16	is	be	VBZ
46745	1744	17	not	not	RB
46745	1744	18	so	so	RB
46745	1744	19	clear	clear	JJ
46745	1744	20	.	.	.
46745	1745	1	It	-PRON-	PRP
46745	1745	2	is	be	VBZ
46745	1745	3	supposed	suppose	VBN
46745	1745	4	to	to	TO
46745	1745	5	be	be	VB
46745	1745	6	into	into	IN
46745	1745	7	Lactic	lactic	JJ
46745	1745	8	acid	acid	NN
46745	1745	9	(	(	-LRB-
46745	1745	10	C_{6}H_{5}O_{5	c_{6}h_{5}o_{5	NN
46745	1745	11	}	}	-RRB-
46745	1745	12	,	,	,
46745	1745	13	HO_{7	ho_{7	VB
46745	1745	14	}	}	-RRB-
46745	1745	15	)	)	-RRB-
46745	1745	16	whose	whose	WP$
46745	1745	17	equivalent	equivalent	JJ
46745	1745	18	number	number	NN
46745	1745	19	is	be	VBZ
46745	1745	20	just	just	RB
46745	1745	21	half	half	PDT
46745	1745	22	that	that	DT
46745	1745	23	of	of	IN
46745	1745	24	anhydrous	anhydrous	JJ
46745	1745	25	grape	grape	NN
46745	1745	26	-	-	HYPH
46745	1745	27	sugar	sugar	NN
46745	1745	28	,	,	,
46745	1745	29	so	so	IN
46745	1745	30	that	that	IN
46745	1745	31	one	one	CD
46745	1745	32	atom	atom	NN
46745	1745	33	of	of	IN
46745	1745	34	the	the	DT
46745	1745	35	latter	latter	JJ
46745	1745	36	may	may	MD
46745	1745	37	become	become	VB
46745	1745	38	two	two	CD
46745	1745	39	of	of	IN
46745	1745	40	the	the	DT
46745	1745	41	former	former	JJ
46745	1745	42	.	.	.
46745	1746	1	This	this	DT
46745	1746	2	important	important	JJ
46745	1746	3	compound	compound	NN
46745	1746	4	was	be	VBD
46745	1746	5	found	find	VBN
46745	1746	6	by	by	IN
46745	1746	7	Berzelius	Berzelius	NNP
46745	1746	8	,	,	,
46745	1746	9	in	in	IN
46745	1746	10	1807	1807	CD
46745	1746	11	,	,	,
46745	1746	12	to	to	TO
46745	1746	13	exist	exist	VB
46745	1746	14	constantly	constantly	RB
46745	1746	15	in	in	IN
46745	1746	16	the	the	DT
46745	1746	17	juice	juice	NN
46745	1746	18	of	of	IN
46745	1746	19	muscle	muscle	NN
46745	1746	20	,	,	,
46745	1746	21	as	as	RB
46745	1746	22	well	well	RB
46745	1746	23	as	as	IN
46745	1746	24	in	in	IN
46745	1746	25	the	the	DT
46745	1746	26	urine	urine	NN
46745	1746	27	and	and	CC
46745	1746	28	sweat	sweat	NN
46745	1746	29	.	.	.
46745	1747	1	(	(	-LRB-
46745	1747	2	_	_	NNP
46745	1747	3	Annuaire	Annuaire	NNP
46745	1747	4	_	_	NNP
46745	1747	5	,	,	,
46745	1747	6	1848	1848	CD
46745	1747	7	,	,	,
46745	1747	8	p.	p.	NN
46745	1748	1	347	347	CD
46745	1748	2	.	.	.
46745	1748	3	)	)	-RRB-
46745	1749	1	Liebig	Liebig	NNP
46745	1749	2	at	at	IN
46745	1749	3	first	first	RB
46745	1749	4	controverted	controvert	VBD
46745	1749	5	this	this	DT
46745	1749	6	,	,	,
46745	1749	7	but	but	CC
46745	1749	8	in	in	IN
46745	1749	9	1847	1847	CD
46745	1749	10	he	-PRON-	PRP
46745	1749	11	assented	assent	VBD
46745	1749	12	to	to	IN
46745	1749	13	the	the	DT
46745	1749	14	statement	statement	NN
46745	1749	15	of	of	IN
46745	1749	16	Berzelius	Berzelius	NNP
46745	1749	17	,	,	,
46745	1749	18	which	which	WDT
46745	1749	19	had	have	VBD
46745	1749	20	already	already	RB
46745	1749	21	been	be	VBN
46745	1749	22	further	further	RB
46745	1749	23	confirmed	confirm	VBN
46745	1749	24	by	by	IN
46745	1749	25	the	the	DT
46745	1749	26	experiments	experiment	NNS
46745	1749	27	of	of	IN
46745	1749	28	M.	M.	NNP
46745	1749	29	Pelouze	Pelouze	NNP
46745	1749	30	.	.	.
46745	1750	1	Many	many	JJ
46745	1750	2	modern	modern	JJ
46745	1750	3	chemists	chemist	NNS
46745	1750	4	,	,	,
46745	1750	5	among	among	IN
46745	1750	6	whom	whom	WP
46745	1750	7	may	may	MD
46745	1750	8	be	be	VB
46745	1750	9	mentioned	mention	VBN
46745	1750	10	Dr.	Dr.	NNP
46745	1750	11	Bence	Bence	NNP
46745	1750	12	Jones,[32	Jones,[32	NNP
46745	1750	13	]	]	-RRB-
46745	1750	14	consider	consider	VBP
46745	1750	15	that	that	IN
46745	1750	16	Lactic	lactic	JJ
46745	1750	17	acid	acid	NN
46745	1750	18	,	,	,
46745	1750	19	or	or	CC
46745	1750	20	some	some	DT
46745	1750	21	compound	compound	NN
46745	1750	22	nearly	nearly	RB
46745	1750	23	resembling	resemble	VBG
46745	1750	24	it	-PRON-	PRP
46745	1750	25	,	,	,
46745	1750	26	is	be	VBZ
46745	1750	27	formed	form	VBN
46745	1750	28	at	at	IN
46745	1750	29	this	this	DT
46745	1750	30	step	step	NN
46745	1750	31	of	of	IN
46745	1750	32	the	the	DT
46745	1750	33	process	process	NN
46745	1750	34	of	of	IN
46745	1750	35	changes	change	NNS
46745	1750	36	connected	connect	VBN
46745	1750	37	with	with	IN
46745	1750	38	the	the	DT
46745	1750	39	function	function	NN
46745	1750	40	of	of	IN
46745	1750	41	respiration	respiration	NN
46745	1750	42	.	.	.
46745	1751	1	The	the	DT
46745	1751	2	acid	acid	NN
46745	1751	3	next	next	JJ
46745	1751	4	combines	combine	NNS
46745	1751	5	with	with	IN
46745	1751	6	free	free	JJ
46745	1751	7	Soda	Soda	NNP
46745	1751	8	,	,	,
46745	1751	9	existing	exist	VBG
46745	1751	10	in	in	IN
46745	1751	11	the	the	DT
46745	1751	12	blood	blood	NN
46745	1751	13	;	;	:
46745	1751	14	and	and	CC
46745	1751	15	this	this	DT
46745	1751	16	salt	salt	NN
46745	1751	17	is	be	VBZ
46745	1751	18	oxidized	oxidize	VBN
46745	1751	19	into	into	IN
46745	1751	20	Carbonate	Carbonate	NNP
46745	1751	21	of	of	IN
46745	1751	22	Soda	Soda	NNP
46745	1751	23	and	and	CC
46745	1751	24	water	water	NN
46745	1751	25	,	,	,
46745	1751	26	just	just	RB
46745	1751	27	as	as	IN
46745	1751	28	a	a	DT
46745	1751	29	Tartrate	Tartrate	NNP
46745	1751	30	or	or	CC
46745	1751	31	a	a	DT
46745	1751	32	Citrate	citrate	NN
46745	1751	33	might	may	MD
46745	1751	34	be	be	VB
46745	1751	35	.	.	.
46745	1752	1	(	(	-LRB-
46745	1752	2	_	_	NNP
46745	1752	3	Vide	Vide	NNP
46745	1752	4	_	_	NNP
46745	1752	5	page	page	NN
46745	1752	6	127	127	CD
46745	1752	7	.	.	.
46745	1752	8	)	)	-RRB-
46745	1753	1	This	this	DT
46745	1753	2	has	have	VBZ
46745	1753	3	been	be	VBN
46745	1753	4	ascertained	ascertain	VBN
46745	1753	5	by	by	IN
46745	1753	6	Magnus	Magnus	NNP
46745	1753	7	and	and	CC
46745	1753	8	Dumas	Dumas	NNP
46745	1753	9	.	.	.
46745	1754	1	Fatty	fatty	NN
46745	1754	2	matters	matter	NNS
46745	1754	3	are	be	VBP
46745	1754	4	used	use	VBN
46745	1754	5	in	in	IN
46745	1754	6	the	the	DT
46745	1754	7	production	production	NN
46745	1754	8	and	and	CC
46745	1754	9	renovation	renovation	NN
46745	1754	10	of	of	IN
46745	1754	11	the	the	DT
46745	1754	12	adipose	adipose	NN
46745	1754	13	tissues	tissue	NNS
46745	1754	14	;	;	:
46745	1754	15	and	and	CC
46745	1754	16	may	may	MD
46745	1754	17	also	also	RB
46745	1754	18	,	,	,
46745	1754	19	like	like	IN
46745	1754	20	the	the	DT
46745	1754	21	last	last	JJ
46745	1754	22	,	,	,
46745	1754	23	be	be	VB
46745	1754	24	burnt	burn	VBN
46745	1754	25	and	and	CC
46745	1754	26	oxidized	oxidize	VBN
46745	1754	27	to	to	TO
46745	1754	28	support	support	VB
46745	1754	29	the	the	DT
46745	1754	30	animal	animal	NN
46745	1754	31	heat	heat	NN
46745	1754	32	.	.	.
46745	1755	1	As	as	IN
46745	1755	2	a	a	DT
46745	1755	3	general	general	JJ
46745	1755	4	rule	rule	NN
46745	1755	5	,	,	,
46745	1755	6	the	the	DT
46745	1755	7	diet	diet	NN
46745	1755	8	of	of	IN
46745	1755	9	a	a	DT
46745	1755	10	man	man	NN
46745	1755	11	in	in	IN
46745	1755	12	health	health	NN
46745	1755	13	should	should	MD
46745	1755	14	contain	contain	VB
46745	1755	15	a	a	DT
46745	1755	16	due	due	JJ
46745	1755	17	proportion	proportion	NN
46745	1755	18	of	of	IN
46745	1755	19	all	all	DT
46745	1755	20	four	four	CD
46745	1755	21	kinds	kind	NNS
46745	1755	22	of	of	IN
46745	1755	23	food	food	NN
46745	1755	24	;	;	:
46745	1755	25	for	for	IN
46745	1755	26	each	each	DT
46745	1755	27	one	one	CD
46745	1755	28	of	of	IN
46745	1755	29	them	-PRON-	PRP
46745	1755	30	is	be	VBZ
46745	1755	31	essential	essential	JJ
46745	1755	32	,	,	,
46745	1755	33	and	and	CC
46745	1755	34	has	have	VBZ
46745	1755	35	its	-PRON-	PRP$
46745	1755	36	proper	proper	JJ
46745	1755	37	function	function	NN
46745	1755	38	in	in	IN
46745	1755	39	the	the	DT
46745	1755	40	system	system	NN
46745	1755	41	.	.	.
46745	1756	1	The	the	DT
46745	1756	2	albuminous	albuminous	JJ
46745	1756	3	material	material	NN
46745	1756	4	can	can	MD
46745	1756	5	not	not	RB
46745	1756	6	be	be	VB
46745	1756	7	dispensed	dispense	VBN
46745	1756	8	with	with	IN
46745	1756	9	;	;	:
46745	1756	10	and	and	CC
46745	1756	11	is	be	VBZ
46745	1756	12	also	also	RB
46745	1756	13	the	the	DT
46745	1756	14	only	only	JJ
46745	1756	15	food	food	NN
46745	1756	16	which	which	WDT
46745	1756	17	will	will	MD
46745	1756	18	suffice	suffice	VB
46745	1756	19	by	by	IN
46745	1756	20	itself	-PRON-	PRP
46745	1756	21	to	to	TO
46745	1756	22	sustain	sustain	VB
46745	1756	23	life	life	NN
46745	1756	24	.	.	.
46745	1757	1	The	the	DT
46745	1757	2	mode	mode	NN
46745	1757	3	in	in	IN
46745	1757	4	which	which	WDT
46745	1757	5	it	-PRON-	PRP
46745	1757	6	can	can	MD
46745	1757	7	adapt	adapt	VB
46745	1757	8	itself	-PRON-	PRP
46745	1757	9	to	to	TO
46745	1757	10	perform	perform	VB
46745	1757	11	the	the	DT
46745	1757	12	office	office	NN
46745	1757	13	of	of	IN
46745	1757	14	the	the	DT
46745	1757	15	other	other	JJ
46745	1757	16	varieties	variety	NNS
46745	1757	17	of	of	IN
46745	1757	18	food	food	NN
46745	1757	19	was	be	VBD
46745	1757	20	ill	ill	RB
46745	1757	21	understood	understand	VBN
46745	1757	22	,	,	,
46745	1757	23	until	until	IN
46745	1757	24	explained	explain	VBN
46745	1757	25	by	by	IN
46745	1757	26	the	the	DT
46745	1757	27	researches	research	NNS
46745	1757	28	of	of	IN
46745	1757	29	M.	M.	NNP
46745	1757	30	Bernard	Bernard	NNP
46745	1757	31	.	.	.
46745	1758	1	From	from	IN
46745	1758	2	some	some	DT
46745	1758	3	experiments	experiment	NNS
46745	1758	4	detailed	detail	VBN
46745	1758	5	in	in	IN
46745	1758	6	a	a	DT
46745	1758	7	paper	paper	NN
46745	1758	8	read	read	NN
46745	1758	9	before	before	IN
46745	1758	10	the	the	DT
46745	1758	11	Académie	Académie	NNP
46745	1758	12	Française	Française	NNP
46745	1758	13	in	in	IN
46745	1758	14	1848	1848	CD
46745	1758	15	,	,	,
46745	1758	16	he	-PRON-	PRP
46745	1758	17	concluded	conclude	VBD
46745	1758	18	that	that	IN
46745	1758	19	the	the	DT
46745	1758	20	liver	liver	NN
46745	1758	21	was	be	VBD
46745	1758	22	capable	capable	JJ
46745	1758	23	of	of	IN
46745	1758	24	actually	actually	RB
46745	1758	25	producing	produce	VBG
46745	1758	26	sugar	sugar	NN
46745	1758	27	and	and	CC
46745	1758	28	fat	fat	NN
46745	1758	29	out	out	IN
46745	1758	30	of	of	IN
46745	1758	31	Proteine	Proteine	NNP
46745	1758	32	compounds	compound	NNS
46745	1758	33	.	.	.
46745	1759	1	For	for	IN
46745	1759	2	he	-PRON-	PRP
46745	1759	3	found	find	VBD
46745	1759	4	sugar	sugar	NN
46745	1759	5	to	to	TO
46745	1759	6	exist	exist	VB
46745	1759	7	in	in	IN
46745	1759	8	the	the	DT
46745	1759	9	substance	substance	NN
46745	1759	10	of	of	IN
46745	1759	11	the	the	DT
46745	1759	12	liver	liver	NN
46745	1759	13	when	when	WRB
46745	1759	14	none	none	NN
46745	1759	15	was	be	VBD
46745	1759	16	to	to	TO
46745	1759	17	be	be	VB
46745	1759	18	detected	detect	VBN
46745	1759	19	in	in	IN
46745	1759	20	the	the	DT
46745	1759	21	blood	blood	NN
46745	1759	22	of	of	IN
46745	1759	23	the	the	DT
46745	1759	24	Portal	Portal	NNP
46745	1759	25	vein	vein	NN
46745	1759	26	which	which	WDT
46745	1759	27	proceeds	proceed	VBZ
46745	1759	28	to	to	IN
46745	1759	29	it	-PRON-	PRP
46745	1759	30	.	.	.
46745	1760	1	His	-PRON-	PRP$
46745	1760	2	results	result	NNS
46745	1760	3	have	have	VBP
46745	1760	4	been	be	VBN
46745	1760	5	mainly	mainly	RB
46745	1760	6	confirmed	confirm	VBN
46745	1760	7	by	by	IN
46745	1760	8	M.	M.	NNP
46745	1760	9	Lehmann	Lehmann	NNP
46745	1760	10	.	.	.
46745	1761	1	M.	M.	NNP
46745	1761	2	Bernard	Bernard	NNP
46745	1761	3	states	state	VBZ
46745	1761	4	further	far	RBR
46745	1761	5	,	,	,
46745	1761	6	that	that	IN
46745	1761	7	the	the	DT
46745	1761	8	action	action	NN
46745	1761	9	of	of	IN
46745	1761	10	the	the	DT
46745	1761	11	liver	liver	NN
46745	1761	12	is	be	VBZ
46745	1761	13	in	in	IN
46745	1761	14	some	some	DT
46745	1761	15	way	way	NN
46745	1761	16	essential	essential	JJ
46745	1761	17	to	to	IN
46745	1761	18	the	the	DT
46745	1761	19	assimilation	assimilation	NN
46745	1761	20	of	of	IN
46745	1761	21	saccharine	saccharine	NNP
46745	1761	22	matters	matter	NNS
46745	1761	23	;	;	:
46745	1761	24	for	for	IN
46745	1761	25	he	-PRON-	PRP
46745	1761	26	has	have	VBZ
46745	1761	27	found	find	VBN
46745	1761	28	that	that	IN
46745	1761	29	when	when	WRB
46745	1761	30	sugar	sugar	NN
46745	1761	31	is	be	VBZ
46745	1761	32	injected	inject	VBN
46745	1761	33	into	into	IN
46745	1761	34	the	the	DT
46745	1761	35	veins	vein	NNS
46745	1761	36	beyond	beyond	IN
46745	1761	37	the	the	DT
46745	1761	38	liver	liver	NN
46745	1761	39	,	,	,
46745	1761	40	it	-PRON-	PRP
46745	1761	41	passes	pass	VBZ
46745	1761	42	out	out	RP
46745	1761	43	unaltered	unaltered	JJ
46745	1761	44	in	in	IN
46745	1761	45	the	the	DT
46745	1761	46	urine	urine	NN
46745	1761	47	.	.	.
46745	1762	1	Thus	thus	RB
46745	1762	2	the	the	DT
46745	1762	3	process	process	NN
46745	1762	4	of	of	IN
46745	1762	5	assimilation	assimilation	NN
46745	1762	6	,	,	,
46745	1762	7	whether	whether	IN
46745	1762	8	of	of	IN
46745	1762	9	albuminous	albuminous	JJ
46745	1762	10	or	or	CC
46745	1762	11	of	of	IN
46745	1762	12	saccharine	saccharine	NNP
46745	1762	13	matters	matter	NNS
46745	1762	14	,	,	,
46745	1762	15	is	be	VBZ
46745	1762	16	not	not	RB
46745	1762	17	so	so	RB
46745	1762	18	easy	easy	JJ
46745	1762	19	and	and	CC
46745	1762	20	so	so	RB
46745	1762	21	simple	simple	JJ
46745	1762	22	a	a	DT
46745	1762	23	thing	thing	NN
46745	1762	24	as	as	IN
46745	1762	25	might	may	MD
46745	1762	26	at	at	IN
46745	1762	27	first	first	RB
46745	1762	28	be	be	VB
46745	1762	29	imagined	imagine	VBN
46745	1762	30	.	.	.
46745	1763	1	The	the	DT
46745	1763	2	study	study	NN
46745	1763	3	of	of	IN
46745	1763	4	this	this	DT
46745	1763	5	process	process	NN
46745	1763	6	is	be	VBZ
46745	1763	7	of	of	IN
46745	1763	8	great	great	JJ
46745	1763	9	importance	importance	NN
46745	1763	10	;	;	:
46745	1763	11	and	and	CC
46745	1763	12	it	-PRON-	PRP
46745	1763	13	appears	appear	VBZ
46745	1763	14	to	to	TO
46745	1763	15	afford	afford	VB
46745	1763	16	us	-PRON-	PRP
46745	1763	17	a	a	DT
46745	1763	18	clue	clue	NN
46745	1763	19	to	to	IN
46745	1763	20	the	the	DT
46745	1763	21	causation	causation	NN
46745	1763	22	of	of	IN
46745	1763	23	certain	certain	JJ
46745	1763	24	disorders	disorder	NNS
46745	1763	25	of	of	IN
46745	1763	26	the	the	DT
46745	1763	27	blood	blood	NN
46745	1763	28	,	,	,
46745	1763	29	of	of	IN
46745	1763	30	which	which	WDT
46745	1763	31	I	-PRON-	PRP
46745	1763	32	shall	shall	MD
46745	1763	33	have	have	VB
46745	1763	34	to	to	TO
46745	1763	35	speak	speak	VB
46745	1763	36	hereafter	hereafter	RB
46745	1763	37	.	.	.
46745	1764	1	Upon	upon	IN
46745	1764	2	the	the	DT
46745	1764	3	regulation	regulation	NN
46745	1764	4	of	of	IN
46745	1764	5	diet	diet	NN
46745	1764	6	,	,	,
46745	1764	7	one	one	CD
46745	1764	8	of	of	IN
46745	1764	9	the	the	DT
46745	1764	10	most	most	RBS
46745	1764	11	important	important	JJ
46745	1764	12	of	of	IN
46745	1764	13	the	the	DT
46745	1764	14	duties	duty	NNS
46745	1764	15	that	that	WDT
46745	1764	16	devolve	devolve	VBP
46745	1764	17	upon	upon	IN
46745	1764	18	the	the	DT
46745	1764	19	medical	medical	JJ
46745	1764	20	man	man	NN
46745	1764	21	,	,	,
46745	1764	22	it	-PRON-	PRP
46745	1764	23	is	be	VBZ
46745	1764	24	not	not	RB
46745	1764	25	my	-PRON-	PRP$
46745	1764	26	purpose	purpose	NN
46745	1764	27	to	to	TO
46745	1764	28	make	make	VB
46745	1764	29	more	more	JJR
46745	1764	30	than	than	IN
46745	1764	31	a	a	DT
46745	1764	32	few	few	JJ
46745	1764	33	observations	observation	NNS
46745	1764	34	.	.	.
46745	1765	1	All	all	DT
46745	1765	2	kinds	kind	NNS
46745	1765	3	of	of	IN
46745	1765	4	food	food	NN
46745	1765	5	are	be	VBP
46745	1765	6	less	less	RBR
46745	1765	7	required	require	VBN
46745	1765	8	by	by	IN
46745	1765	9	the	the	DT
46745	1765	10	system	system	NN
46745	1765	11	in	in	IN
46745	1765	12	inflammatory	inflammatory	NN
46745	1765	13	and	and	CC
46745	1765	14	febrile	febrile	NN
46745	1765	15	disorders	disorder	NNS
46745	1765	16	;	;	:
46745	1765	17	and	and	CC
46745	1765	18	should	should	MD
46745	1765	19	then	then	RB
46745	1765	20	be	be	VB
46745	1765	21	administered	administer	VBN
46745	1765	22	sparingly	sparingly	RB
46745	1765	23	,	,	,
46745	1765	24	or	or	CC
46745	1765	25	wholly	wholly	RB
46745	1765	26	denied	deny	VBN
46745	1765	27	,	,	,
46745	1765	28	according	accord	VBG
46745	1765	29	to	to	IN
46745	1765	30	the	the	DT
46745	1765	31	severity	severity	NN
46745	1765	32	of	of	IN
46745	1765	33	the	the	DT
46745	1765	34	case	case	NN
46745	1765	35	.	.	.
46745	1766	1	But	but	CC
46745	1766	2	in	in	IN
46745	1766	3	Typhus	Typhus	NNP
46745	1766	4	fever	fever	VBP
46745	1766	5	long	long	JJ
46745	1766	6	abstinence	abstinence	NN
46745	1766	7	would	would	MD
46745	1766	8	be	be	VB
46745	1766	9	dangerous	dangerous	JJ
46745	1766	10	;	;	:
46745	1766	11	the	the	DT
46745	1766	12	patient	patient	NN
46745	1766	13	is	be	VBZ
46745	1766	14	in	in	IN
46745	1766	15	peril	peril	NN
46745	1766	16	from	from	IN
46745	1766	17	extreme	extreme	JJ
46745	1766	18	weakness	weakness	NN
46745	1766	19	and	and	CC
46745	1766	20	inanition	inanition	NN
46745	1766	21	,	,	,
46745	1766	22	and	and	CC
46745	1766	23	,	,	,
46745	1766	24	being	be	VBG
46745	1766	25	often	often	RB
46745	1766	26	totally	totally	RB
46745	1766	27	unconscious	unconscious	JJ
46745	1766	28	of	of	IN
46745	1766	29	his	-PRON-	PRP$
46745	1766	30	natural	natural	JJ
46745	1766	31	wants	want	VBZ
46745	1766	32	,	,	,
46745	1766	33	requires	require	VBZ
46745	1766	34	to	to	TO
46745	1766	35	be	be	VB
46745	1766	36	carefully	carefully	RB
46745	1766	37	sustained	sustain	VBN
46745	1766	38	by	by	IN
46745	1766	39	constant	constant	JJ
46745	1766	40	and	and	CC
46745	1766	41	small	small	JJ
46745	1766	42	increments	increment	NNS
46745	1766	43	of	of	IN
46745	1766	44	animal	animal	NN
46745	1766	45	and	and	CC
46745	1766	46	farinaceous	farinaceous	JJ
46745	1766	47	food	food	NN
46745	1766	48	.	.	.
46745	1767	1	Water	water	NN
46745	1767	2	may	may	MD
46745	1767	3	be	be	VB
46745	1767	4	given	give	VBN
46745	1767	5	largely	largely	RB
46745	1767	6	whenever	whenever	WRB
46745	1767	7	we	-PRON-	PRP
46745	1767	8	wish	wish	VBP
46745	1767	9	to	to	TO
46745	1767	10	increase	increase	VB
46745	1767	11	the	the	DT
46745	1767	12	amount	amount	NN
46745	1767	13	of	of	IN
46745	1767	14	any	any	DT
46745	1767	15	of	of	IN
46745	1767	16	the	the	DT
46745	1767	17	fluid	fluid	JJ
46745	1767	18	secretions	secretion	NNS
46745	1767	19	;	;	:
46745	1767	20	as	as	IN
46745	1767	21	the	the	DT
46745	1767	22	urine	urine	NN
46745	1767	23	,	,	,
46745	1767	24	to	to	TO
46745	1767	25	render	render	VB
46745	1767	26	less	less	RBR
46745	1767	27	likely	likely	JJ
46745	1767	28	the	the	DT
46745	1767	29	deposition	deposition	NN
46745	1767	30	of	of	IN
46745	1767	31	gravel	gravel	NN
46745	1767	32	;	;	:
46745	1767	33	or	or	CC
46745	1767	34	the	the	DT
46745	1767	35	perspiration	perspiration	NN
46745	1767	36	,	,	,
46745	1767	37	when	when	WRB
46745	1767	38	it	-PRON-	PRP
46745	1767	39	is	be	VBZ
46745	1767	40	desirable	desirable	JJ
46745	1767	41	to	to	TO
46745	1767	42	promote	promote	VB
46745	1767	43	it	-PRON-	PRP
46745	1767	44	in	in	IN
46745	1767	45	fevers	fever	NNS
46745	1767	46	or	or	CC
46745	1767	47	other	other	JJ
46745	1767	48	disorders	disorder	NNS
46745	1767	49	.	.	.
46745	1768	1	Albuminous	albuminous	JJ
46745	1768	2	food	food	NN
46745	1768	3	is	be	VBZ
46745	1768	4	always	always	RB
46745	1768	5	necessary	necessary	JJ
46745	1768	6	in	in	IN
46745	1768	7	health	health	NN
46745	1768	8	,	,	,
46745	1768	9	and	and	CC
46745	1768	10	is	be	VBZ
46745	1768	11	contained	contain	VBN
46745	1768	12	not	not	RB
46745	1768	13	only	only	RB
46745	1768	14	in	in	IN
46745	1768	15	the	the	DT
46745	1768	16	flesh	flesh	NN
46745	1768	17	of	of	IN
46745	1768	18	animals	animal	NNS
46745	1768	19	,	,	,
46745	1768	20	but	but	CC
46745	1768	21	in	in	IN
46745	1768	22	vegetable	vegetable	JJ
46745	1768	23	substances	substance	NNS
46745	1768	24	in	in	IN
46745	1768	25	their	-PRON-	PRP$
46745	1768	26	natural	natural	JJ
46745	1768	27	condition	condition	NN
46745	1768	28	.	.	.
46745	1769	1	It	-PRON-	PRP
46745	1769	2	is	be	VBZ
46745	1769	3	recommended	recommend	VBN
46745	1769	4	to	to	TO
46745	1769	5	restrict	restrict	VB
46745	1769	6	it	-PRON-	PRP
46745	1769	7	in	in	IN
46745	1769	8	the	the	DT
46745	1769	9	management	management	NN
46745	1769	10	of	of	IN
46745	1769	11	gouty	gouty	NN
46745	1769	12	or	or	CC
46745	1769	13	plethoric	plethoric	NN
46745	1769	14	patients	patient	NNS
46745	1769	15	.	.	.
46745	1770	1	On	on	IN
46745	1770	2	the	the	DT
46745	1770	3	other	other	JJ
46745	1770	4	hand	hand	NN
46745	1770	5	,	,	,
46745	1770	6	animal	animal	NN
46745	1770	7	is	be	VBZ
46745	1770	8	more	more	RBR
46745	1770	9	easily	easily	RB
46745	1770	10	digested	digested	JJ
46745	1770	11	than	than	IN
46745	1770	12	vegetable	vegetable	JJ
46745	1770	13	food	food	NN
46745	1770	14	in	in	IN
46745	1770	15	many	many	JJ
46745	1770	16	cases	case	NNS
46745	1770	17	of	of	IN
46745	1770	18	dyspepsia	dyspepsia	NNP
46745	1770	19	.	.	.
46745	1771	1	In	in	IN
46745	1771	2	Diabetes	diabetes	NN
46745	1771	3	mellitus	mellitus	NN
46745	1771	4	,	,	,
46745	1771	5	when	when	WRB
46745	1771	6	a	a	DT
46745	1771	7	large	large	JJ
46745	1771	8	quantity	quantity	NN
46745	1771	9	of	of	IN
46745	1771	10	sugar	sugar	NN
46745	1771	11	is	be	VBZ
46745	1771	12	excreted	excrete	VBN
46745	1771	13	in	in	IN
46745	1771	14	the	the	DT
46745	1771	15	urine	urine	NN
46745	1771	16	,	,	,
46745	1771	17	it	-PRON-	PRP
46745	1771	18	is	be	VBZ
46745	1771	19	a	a	DT
46745	1771	20	common	common	JJ
46745	1771	21	practice	practice	NN
46745	1771	22	to	to	TO
46745	1771	23	confine	confine	VB
46745	1771	24	the	the	DT
46745	1771	25	patient	patient	NN
46745	1771	26	to	to	IN
46745	1771	27	a	a	DT
46745	1771	28	diet	diet	NN
46745	1771	29	of	of	IN
46745	1771	30	meat	meat	NN
46745	1771	31	and	and	CC
46745	1771	32	gluten	gluten	VBN
46745	1771	33	bread	bread	NN
46745	1771	34	.	.	.
46745	1772	1	This	this	DT
46745	1772	2	latter	latter	NN
46745	1772	3	is	be	VBZ
46745	1772	4	a	a	DT
46745	1772	5	tough	tough	JJ
46745	1772	6	horny	horny	JJ
46745	1772	7	material	material	NN
46745	1772	8	,	,	,
46745	1772	9	prepared	prepare	VBN
46745	1772	10	from	from	IN
46745	1772	11	flour	flour	NN
46745	1772	12	from	from	IN
46745	1772	13	which	which	WDT
46745	1772	14	the	the	DT
46745	1772	15	starch	starch	NN
46745	1772	16	has	have	VBZ
46745	1772	17	been	be	VBN
46745	1772	18	separated	separate	VBN
46745	1772	19	by	by	IN
46745	1772	20	washing	wash	VBG
46745	1772	21	.	.	.
46745	1773	1	It	-PRON-	PRP
46745	1773	2	is	be	VBZ
46745	1773	3	thought	think	VBN
46745	1773	4	that	that	IN
46745	1773	5	if	if	IN
46745	1773	6	no	no	DT
46745	1773	7	starch	starch	NN
46745	1773	8	be	be	VB
46745	1773	9	given	give	VBN
46745	1773	10	,	,	,
46745	1773	11	no	no	DT
46745	1773	12	sugar	sugar	NN
46745	1773	13	can	can	MD
46745	1773	14	be	be	VB
46745	1773	15	formed	form	VBN
46745	1773	16	;	;	:
46745	1773	17	but	but	CC
46745	1773	18	it	-PRON-	PRP
46745	1773	19	is	be	VBZ
46745	1773	20	found	find	VBN
46745	1773	21	that	that	IN
46745	1773	22	,	,	,
46745	1773	23	though	though	IN
46745	1773	24	both	both	CC
46745	1773	25	the	the	DT
46745	1773	26	amount	amount	NN
46745	1773	27	of	of	IN
46745	1773	28	urine	urine	NN
46745	1773	29	and	and	CC
46745	1773	30	the	the	DT
46745	1773	31	quantity	quantity	NN
46745	1773	32	of	of	IN
46745	1773	33	sugar	sugar	NN
46745	1773	34	in	in	IN
46745	1773	35	it	-PRON-	PRP
46745	1773	36	are	be	VBP
46745	1773	37	diminished	diminish	VBN
46745	1773	38	by	by	IN
46745	1773	39	this	this	DT
46745	1773	40	plan	plan	NN
46745	1773	41	,	,	,
46745	1773	42	yet	yet	CC
46745	1773	43	the	the	DT
46745	1773	44	latter	latter	JJ
46745	1773	45	does	do	VBZ
46745	1773	46	not	not	RB
46745	1773	47	wholly	wholly	RB
46745	1773	48	disappear	disappear	VB
46745	1773	49	.	.	.
46745	1774	1	This	this	DT
46745	1774	2	may	may	MD
46745	1774	3	be	be	VB
46745	1774	4	easily	easily	RB
46745	1774	5	accounted	account	VBN
46745	1774	6	for	for	IN
46745	1774	7	,	,	,
46745	1774	8	if	if	IN
46745	1774	9	we	-PRON-	PRP
46745	1774	10	admit	admit	VBP
46745	1774	11	that	that	IN
46745	1774	12	sugar	sugar	NN
46745	1774	13	may	may	MD
46745	1774	14	be	be	VB
46745	1774	15	formed	form	VBN
46745	1774	16	from	from	IN
46745	1774	17	albumen	albuman	NNS
46745	1774	18	.	.	.
46745	1775	1	Water	water	NN
46745	1775	2	should	should	MD
46745	1775	3	be	be	VB
46745	1775	4	given	give	VBN
46745	1775	5	sparingly	sparingly	RB
46745	1775	6	in	in	IN
46745	1775	7	this	this	DT
46745	1775	8	disease	disease	NN
46745	1775	9	;	;	:
46745	1775	10	for	for	IN
46745	1775	11	the	the	DT
46745	1775	12	more	more	RBR
46745	1775	13	a	a	DT
46745	1775	14	patient	patient	JJ
46745	1775	15	drinks	drink	NNS
46745	1775	16	,	,	,
46745	1775	17	the	the	DT
46745	1775	18	more	more	JJR
46745	1775	19	urine	urine	NN
46745	1775	20	he	-PRON-	PRP
46745	1775	21	passes	pass	VBZ
46745	1775	22	,	,	,
46745	1775	23	and	and	CC
46745	1775	24	all	all	DT
46745	1775	25	of	of	IN
46745	1775	26	the	the	DT
46745	1775	27	same	same	JJ
46745	1775	28	high	high	JJ
46745	1775	29	specific	specific	JJ
46745	1775	30	gravity	gravity	NN
46745	1775	31	.	.	.
46745	1776	1	Fat	fat	NN
46745	1776	2	may	may	MD
46745	1776	3	be	be	VB
46745	1776	4	given	give	VBN
46745	1776	5	in	in	IN
46745	1776	6	Diabetes	diabetes	NN
46745	1776	7	,	,	,
46745	1776	8	for	for	IN
46745	1776	9	it	-PRON-	PRP
46745	1776	10	is	be	VBZ
46745	1776	11	not	not	RB
46745	1776	12	proved	prove	VBN
46745	1776	13	that	that	IN
46745	1776	14	it	-PRON-	PRP
46745	1776	15	can	can	MD
46745	1776	16	be	be	VB
46745	1776	17	converted	convert	VBN
46745	1776	18	into	into	IN
46745	1776	19	sugar	sugar	NN
46745	1776	20	;	;	:
46745	1776	21	but	but	CC
46745	1776	22	as	as	IN
46745	1776	23	the	the	DT
46745	1776	24	contrary	contrary	NN
46745	1776	25	seems	seem	VBZ
46745	1776	26	to	to	TO
46745	1776	27	be	be	VB
46745	1776	28	the	the	DT
46745	1776	29	case	case	NN
46745	1776	30	with	with	IN
46745	1776	31	albumen	albuman	NNS
46745	1776	32	,	,	,
46745	1776	33	and	and	CC
46745	1776	34	it	-PRON-	PRP
46745	1776	35	being	be	VBG
46745	1776	36	impossible	impossible	JJ
46745	1776	37	to	to	TO
46745	1776	38	withhold	withhold	VB
46745	1776	39	this	this	DT
46745	1776	40	,	,	,
46745	1776	41	the	the	DT
46745	1776	42	cure	cure	NN
46745	1776	43	of	of	IN
46745	1776	44	the	the	DT
46745	1776	45	patient	patient	NN
46745	1776	46	by	by	IN
46745	1776	47	mere	mere	JJ
46745	1776	48	dieting	dieting	NN
46745	1776	49	may	may	MD
46745	1776	50	be	be	VB
46745	1776	51	considered	consider	VBN
46745	1776	52	almost	almost	RB
46745	1776	53	hopeless	hopeless	JJ
46745	1776	54	.	.	.
46745	1777	1	We	-PRON-	PRP
46745	1777	2	have	have	VBP
46745	1777	3	seen	see	VBN
46745	1777	4	that	that	IN
46745	1777	5	Starchy	Starchy	NNP
46745	1777	6	and	and	CC
46745	1777	7	saccharine	saccharine	NN
46745	1777	8	matters	matter	NNS
46745	1777	9	form	form	VBP
46745	1777	10	an	an	DT
46745	1777	11	important	important	JJ
46745	1777	12	element	element	NN
46745	1777	13	of	of	IN
46745	1777	14	the	the	DT
46745	1777	15	food	food	NN
46745	1777	16	;	;	:
46745	1777	17	and	and	CC
46745	1777	18	that	that	IN
46745	1777	19	,	,	,
46745	1777	20	by	by	IN
46745	1777	21	combining	combine	VBG
46745	1777	22	in	in	RP
46745	1777	23	the	the	DT
46745	1777	24	blood	blood	NN
46745	1777	25	with	with	IN
46745	1777	26	the	the	DT
46745	1777	27	Oxygen	Oxygen	NNP
46745	1777	28	absorbed	absorb	VBN
46745	1777	29	in	in	IN
46745	1777	30	the	the	DT
46745	1777	31	respiratory	respiratory	JJ
46745	1777	32	process	process	NN
46745	1777	33	,	,	,
46745	1777	34	they	-PRON-	PRP
46745	1777	35	are	be	VBP
46745	1777	36	of	of	IN
46745	1777	37	use	use	NN
46745	1777	38	in	in	IN
46745	1777	39	maintaining	maintain	VBG
46745	1777	40	the	the	DT
46745	1777	41	heat	heat	NN
46745	1777	42	of	of	IN
46745	1777	43	the	the	DT
46745	1777	44	body	body	NN
46745	1777	45	.	.	.
46745	1778	1	In	in	IN
46745	1778	2	some	some	DT
46745	1778	3	constitutions	constitution	NNS
46745	1778	4	there	there	EX
46745	1778	5	is	be	VBZ
46745	1778	6	a	a	DT
46745	1778	7	peculiar	peculiar	JJ
46745	1778	8	tendency	tendency	NN
46745	1778	9	to	to	IN
46745	1778	10	an	an	DT
46745	1778	11	abnormal	abnormal	JJ
46745	1778	12	oxidation	oxidation	NN
46745	1778	13	of	of	IN
46745	1778	14	these	these	DT
46745	1778	15	materials	material	NNS
46745	1778	16	into	into	IN
46745	1778	17	Oxalic	oxalic	JJ
46745	1778	18	acid	acid	NN
46745	1778	19	.	.	.
46745	1779	1	It	-PRON-	PRP
46745	1779	2	appears	appear	VBZ
46745	1779	3	likely	likely	JJ
46745	1779	4	that	that	IN
46745	1779	5	Cane	Cane	NNP
46745	1779	6	-	-	HYPH
46745	1779	7	sugar	sugar	NN
46745	1779	8	is	be	VBZ
46745	1779	9	more	more	RBR
46745	1779	10	liable	liable	JJ
46745	1779	11	to	to	IN
46745	1779	12	this	this	DT
46745	1779	13	change	change	NN
46745	1779	14	than	than	IN
46745	1779	15	Grape	Grape	NNP
46745	1779	16	-	-	HYPH
46745	1779	17	sugar	sugar	NNP
46745	1779	18	,	,	,
46745	1779	19	although	although	IN
46745	1779	20	it	-PRON-	PRP
46745	1779	21	may	may	MD
46745	1779	22	occur	occur	VB
46745	1779	23	with	with	IN
46745	1779	24	the	the	DT
46745	1779	25	latter	latter	JJ
46745	1779	26	.	.	.
46745	1780	1	Thus	thus	RB
46745	1780	2	the	the	DT
46745	1780	3	patient	patient	NN
46745	1780	4	is	be	VBZ
46745	1780	5	sometimes	sometimes	RB
46745	1780	6	benefited	benefit	VBN
46745	1780	7	by	by	IN
46745	1780	8	an	an	DT
46745	1780	9	injunction	injunction	NN
46745	1780	10	to	to	TO
46745	1780	11	abstain	abstain	VB
46745	1780	12	entirely	entirely	RB
46745	1780	13	from	from	IN
46745	1780	14	this	this	DT
46745	1780	15	article	article	NN
46745	1780	16	of	of	IN
46745	1780	17	food	food	NN
46745	1780	18	.	.	.
46745	1781	1	Fatty	fatty	NN
46745	1781	2	matters	matter	NNS
46745	1781	3	need	need	VBP
46745	1781	4	not	not	RB
46745	1781	5	be	be	VB
46745	1781	6	given	give	VBN
46745	1781	7	where	where	WRB
46745	1781	8	there	there	EX
46745	1781	9	is	be	VBZ
46745	1781	10	organic	organic	JJ
46745	1781	11	disease	disease	NN
46745	1781	12	of	of	IN
46745	1781	13	the	the	DT
46745	1781	14	Pancreas	Pancreas	NNP
46745	1781	15	;	;	:
46745	1781	16	as	as	IN
46745	1781	17	in	in	IN
46745	1781	18	that	that	DT
46745	1781	19	case	case	NN
46745	1781	20	they	-PRON-	PRP
46745	1781	21	are	be	VBP
46745	1781	22	not	not	RB
46745	1781	23	rightly	rightly	RB
46745	1781	24	digested	digest	VBN
46745	1781	25	.	.	.
46745	1782	1	This	this	DT
46745	1782	2	is	be	VBZ
46745	1782	3	a	a	DT
46745	1782	4	rare	rare	JJ
46745	1782	5	case	case	NN
46745	1782	6	.	.	.
46745	1783	1	They	-PRON-	PRP
46745	1783	2	are	be	VBP
46745	1783	3	sometimes	sometimes	RB
46745	1783	4	repugnant	repugnant	JJ
46745	1783	5	to	to	IN
46745	1783	6	the	the	DT
46745	1783	7	stomach	stomach	NN
46745	1783	8	,	,	,
46745	1783	9	from	from	IN
46745	1783	10	other	other	JJ
46745	1783	11	causes	cause	NNS
46745	1783	12	.	.	.
46745	1784	1	The	the	DT
46745	1784	2	application	application	NN
46745	1784	3	of	of	IN
46745	1784	4	oily	oily	JJ
46745	1784	5	substances	substance	NNS
46745	1784	6	to	to	IN
46745	1784	7	the	the	DT
46745	1784	8	cure	cure	NN
46745	1784	9	of	of	IN
46745	1784	10	Phthisis	phthisis	NN
46745	1784	11	is	be	VBZ
46745	1784	12	a	a	DT
46745	1784	13	matter	matter	NN
46745	1784	14	of	of	IN
46745	1784	15	considerable	considerable	JJ
46745	1784	16	importance	importance	NN
46745	1784	17	.	.	.
46745	1785	1	Of	of	IN
46745	1785	2	late	late	JJ
46745	1785	3	years	year	NNS
46745	1785	4	Cod	cod	NN
46745	1785	5	-	-	HYPH
46745	1785	6	liver	liver	NN
46745	1785	7	oil	oil	NN
46745	1785	8	has	have	VBZ
46745	1785	9	been	be	VBN
46745	1785	10	used	use	VBN
46745	1785	11	with	with	IN
46745	1785	12	more	more	JJR
46745	1785	13	success	success	NN
46745	1785	14	than	than	IN
46745	1785	15	any	any	DT
46745	1785	16	other	other	JJ
46745	1785	17	medicine	medicine	NN
46745	1785	18	,	,	,
46745	1785	19	both	both	CC
46745	1785	20	as	as	IN
46745	1785	21	a	a	DT
46745	1785	22	prophylactic	prophylactic	NN
46745	1785	23	,	,	,
46745	1785	24	and	and	CC
46745	1785	25	as	as	IN
46745	1785	26	a	a	DT
46745	1785	27	curative	curative	JJ
46745	1785	28	agent	agent	NN
46745	1785	29	in	in	IN
46745	1785	30	this	this	DT
46745	1785	31	disease	disease	NN
46745	1785	32	.	.	.
46745	1786	1	When	when	WRB
46745	1786	2	this	this	DT
46745	1786	3	remedy	remedy	NN
46745	1786	4	is	be	VBZ
46745	1786	5	considered	consider	VBN
46745	1786	6	separately	separately	RB
46745	1786	7	in	in	IN
46745	1786	8	Chap	Chap	NNP
46745	1786	9	.	.	.
46745	1787	1	IV	IV	NNP
46745	1787	2	.	.	NNP
46745	1787	3	,	,	,
46745	1787	4	mention	mention	NN
46745	1787	5	will	will	MD
46745	1787	6	be	be	VB
46745	1787	7	made	make	VBN
46745	1787	8	of	of	IN
46745	1787	9	several	several	JJ
46745	1787	10	theories	theory	NNS
46745	1787	11	which	which	WDT
46745	1787	12	have	have	VBP
46745	1787	13	been	be	VBN
46745	1787	14	propounded	propound	VBN
46745	1787	15	to	to	TO
46745	1787	16	account	account	VB
46745	1787	17	for	for	IN
46745	1787	18	its	-PRON-	PRP$
46745	1787	19	mode	mode	NN
46745	1787	20	of	of	IN
46745	1787	21	operation	operation	NN
46745	1787	22	.	.	.
46745	1788	1	Liebig	Liebig	NNP
46745	1788	2	's	's	POS
46745	1788	3	idea	idea	NN
46745	1788	4	that	that	IN
46745	1788	5	there	there	EX
46745	1788	6	is	be	VBZ
46745	1788	7	in	in	IN
46745	1788	8	Phthisis	phthisis	NN
46745	1788	9	an	an	DT
46745	1788	10	excess	excess	NN
46745	1788	11	of	of	IN
46745	1788	12	Oxygen	oxygen	NN
46745	1788	13	in	in	IN
46745	1788	14	the	the	DT
46745	1788	15	system	system	NN
46745	1788	16	,	,	,
46745	1788	17	would	would	MD
46745	1788	18	,	,	,
46745	1788	19	if	if	IN
46745	1788	20	sufficiently	sufficiently	RB
46745	1788	21	supported	support	VBN
46745	1788	22	,	,	,
46745	1788	23	serve	serve	VBP
46745	1788	24	to	to	TO
46745	1788	25	explain	explain	VB
46745	1788	26	its	-PRON-	PRP$
46745	1788	27	action	action	NN
46745	1788	28	when	when	WRB
46745	1788	29	considered	consider	VBN
46745	1788	30	simply	simply	RB
46745	1788	31	as	as	IN
46745	1788	32	oil	oil	NN
46745	1788	33	.	.	.
46745	1789	1	This	this	DT
46745	1789	2	Oxygen	oxygen	NN
46745	1789	3	would	would	MD
46745	1789	4	consume	consume	VB
46745	1789	5	the	the	DT
46745	1789	6	Carbon	Carbon	NNP
46745	1789	7	and	and	CC
46745	1789	8	Hydrogen	Hydrogen	NNP
46745	1789	9	in	in	IN
46745	1789	10	the	the	DT
46745	1789	11	food	food	NN
46745	1789	12	,	,	,
46745	1789	13	and	and	CC
46745	1789	14	prevent	prevent	VB
46745	1789	15	the	the	DT
46745	1789	16	accumulation	accumulation	NN
46745	1789	17	of	of	IN
46745	1789	18	fat	fat	NN
46745	1789	19	.	.	.
46745	1790	1	(	(	-LRB-
46745	1790	2	_	_	NNP
46745	1790	3	Liebig	Liebig	NNP
46745	1790	4	's	's	POS
46745	1790	5	Animal	Animal	NNP
46745	1790	6	Chemistry	Chemistry	NNP
46745	1790	7	_	_	NNP
46745	1790	8	,	,	,
46745	1790	9	part	part	NN
46745	1790	10	i.	i.	NNP
46745	1790	11	p.	p.	NN
46745	1791	1	126	126	CD
46745	1791	2	.	.	.
46745	1791	3	)	)	-RRB-
46745	1792	1	A	a	DT
46745	1792	2	supply	supply	NN
46745	1792	3	of	of	IN
46745	1792	4	oil	oil	NN
46745	1792	5	might	may	MD
46745	1792	6	then	then	RB
46745	1792	7	serve	serve	VB
46745	1792	8	to	to	TO
46745	1792	9	restore	restore	VB
46745	1792	10	this	this	DT
46745	1792	11	fat	fat	NN
46745	1792	12	,	,	,
46745	1792	13	and	and	CC
46745	1792	14	afford	afford	VB
46745	1792	15	a	a	DT
46745	1792	16	sufficient	sufficient	JJ
46745	1792	17	pabulum	pabulum	NN
46745	1792	18	to	to	IN
46745	1792	19	the	the	DT
46745	1792	20	devouring	devour	VBG
46745	1792	21	element	element	NN
46745	1792	22	.	.	.
46745	1793	1	Thus	thus	RB
46745	1793	2	an	an	DT
46745	1793	3	attention	attention	NN
46745	1793	4	to	to	IN
46745	1793	5	diet	diet	NN
46745	1793	6	is	be	VBZ
46745	1793	7	of	of	IN
46745	1793	8	great	great	JJ
46745	1793	9	importance	importance	NN
46745	1793	10	in	in	IN
46745	1793	11	the	the	DT
46745	1793	12	cure	cure	NN
46745	1793	13	and	and	CC
46745	1793	14	alleviation	alleviation	NN
46745	1793	15	of	of	IN
46745	1793	16	different	different	JJ
46745	1793	17	diseases	disease	NNS
46745	1793	18	;	;	:
46745	1793	19	for	for	CC
46745	1793	20	by	by	IN
46745	1793	21	this	this	DT
46745	1793	22	means	mean	VBZ
46745	1793	23	we	-PRON-	PRP
46745	1793	24	are	be	VBP
46745	1793	25	enabled	enable	VBN
46745	1793	26	,	,	,
46745	1793	27	within	within	IN
46745	1793	28	a	a	DT
46745	1793	29	certain	certain	JJ
46745	1793	30	limit	limit	NN
46745	1793	31	,	,	,
46745	1793	32	to	to	TO
46745	1793	33	regulate	regulate	VB
46745	1793	34	and	and	CC
46745	1793	35	control	control	VB
46745	1793	36	the	the	DT
46745	1793	37	composition	composition	NN
46745	1793	38	of	of	IN
46745	1793	39	the	the	DT
46745	1793	40	blood	blood	NN
46745	1793	41	,	,	,
46745	1793	42	and	and	CC
46745	1793	43	through	through	IN
46745	1793	44	it	-PRON-	PRP
46745	1793	45	the	the	DT
46745	1793	46	nutrition	nutrition	NN
46745	1793	47	of	of	IN
46745	1793	48	the	the	DT
46745	1793	49	body	body	NN
46745	1793	50	.	.	.
46745	1794	1	Thus	thus	RB
46745	1794	2	are	be	VBP
46745	1794	3	Aliments	aliment	NNS
46745	1794	4	essentially	essentially	RB
46745	1794	5	Restorative	restorative	JJ
46745	1794	6	,	,	,
46745	1794	7	forming	form	VBG
46745	1794	8	and	and	CC
46745	1794	9	supplying	supply	VBG
46745	1794	10	the	the	DT
46745	1794	11	blood	blood	NN
46745	1794	12	,	,	,
46745	1794	13	and	and	CC
46745	1794	14	from	from	IN
46745	1794	15	it	-PRON-	PRP
46745	1794	16	the	the	DT
46745	1794	17	several	several	JJ
46745	1794	18	tissues	tissue	NNS
46745	1794	19	,	,	,
46745	1794	20	which	which	WDT
46745	1794	21	are	be	VBP
46745	1794	22	destined	destine	VBN
46745	1794	23	to	to	TO
46745	1794	24	work	work	VB
46745	1794	25	and	and	CC
46745	1794	26	to	to	TO
46745	1794	27	endure	endure	VB
46745	1794	28	,	,	,
46745	1794	29	until	until	IN
46745	1794	30	,	,	,
46745	1794	31	like	like	IN
46745	1794	32	all	all	DT
46745	1794	33	organic	organic	JJ
46745	1794	34	creations	creation	NNS
46745	1794	35	,	,	,
46745	1794	36	their	-PRON-	PRP$
46745	1794	37	turn	turn	NN
46745	1794	38	is	be	VBZ
46745	1794	39	come	come	VBN
46745	1794	40	to	to	TO
46745	1794	41	die	die	VB
46745	1794	42	.	.	.
46745	1795	1	Then	then	RB
46745	1795	2	only	only	RB
46745	1795	3	are	be	VBP
46745	1795	4	they	-PRON-	PRP
46745	1795	5	excreted	excrete	VBN
46745	1795	6	,	,	,
46745	1795	7	and	and	CC
46745	1795	8	in	in	IN
46745	1795	9	a	a	DT
46745	1795	10	different	different	JJ
46745	1795	11	form	form	NN
46745	1795	12	from	from	IN
46745	1795	13	that	that	DT
46745	1795	14	in	in	IN
46745	1795	15	which	which	WDT
46745	1795	16	they	-PRON-	PRP
46745	1795	17	entered	enter	VBD
46745	1795	18	;	;	:
46745	1795	19	at	at	IN
46745	1795	20	that	that	DT
46745	1795	21	time	time	NN
46745	1795	22	,	,	,
46745	1795	23	developing	develop	VBG
46745	1795	24	into	into	IN
46745	1795	25	tissues	tissue	NNS
46745	1795	26	of	of	IN
46745	1795	27	high	high	JJ
46745	1795	28	organization	organization	NN
46745	1795	29	,	,	,
46745	1795	30	they	-PRON-	PRP
46745	1795	31	now	now	RB
46745	1795	32	decompose	decompose	VBP
46745	1795	33	and	and	CC
46745	1795	34	retrograde	retrograde	VB
46745	1795	35	into	into	IN
46745	1795	36	simpler	simple	JJR
46745	1795	37	bodies	body	NNS
46745	1795	38	;	;	:
46745	1795	39	at	at	IN
46745	1795	40	first	first	RB
46745	1795	41	fitted	fit	VBN
46745	1795	42	for	for	IN
46745	1795	43	life	life	NN
46745	1795	44	,	,	,
46745	1795	45	they	-PRON-	PRP
46745	1795	46	are	be	VBP
46745	1795	47	now	now	RB
46745	1795	48	shaping	shape	VBG
46745	1795	49	for	for	IN
46745	1795	50	destruction	destruction	NN
46745	1795	51	.	.	.
46745	1796	1	The	the	DT
46745	1796	2	disease	disease	NN
46745	1796	3	which	which	WDT
46745	1796	4	collectively	collectively	RB
46745	1796	5	they	-PRON-	PRP
46745	1796	6	are	be	VBP
46745	1796	7	intended	intend	VBN
46745	1796	8	to	to	TO
46745	1796	9	cure	cure	VB
46745	1796	10	is	be	VBZ
46745	1796	11	Hunger	hunger	NN
46745	1796	12	;	;	:
46745	1796	13	which	which	WDT
46745	1796	14	is	be	VBZ
46745	1796	15	in	in	IN
46745	1796	16	fact	fact	NN
46745	1796	17	a	a	DT
46745	1796	18	call	call	NN
46745	1796	19	from	from	IN
46745	1796	20	the	the	DT
46745	1796	21	blood	blood	NN
46745	1796	22	for	for	IN
46745	1796	23	the	the	DT
46745	1796	24	renovation	renovation	NN
46745	1796	25	of	of	IN
46745	1796	26	its	-PRON-	PRP$
46745	1796	27	failing	fail	VBG
46745	1796	28	constituents	constituent	NNS
46745	1796	29	,	,	,
46745	1796	30	a	a	DT
46745	1796	31	demand	demand	NN
46745	1796	32	for	for	IN
46745	1796	33	fresh	fresh	JJ
46745	1796	34	supply	supply	NN
46745	1796	35	from	from	IN
46745	1796	36	the	the	DT
46745	1796	37	body	body	NN
46745	1796	38	,	,	,
46745	1796	39	which	which	WDT
46745	1796	40	,	,	,
46745	1796	41	because	because	IN
46745	1796	42	always	always	RB
46745	1796	43	changing	change	VBG
46745	1796	44	,	,	,
46745	1796	45	is	be	VBZ
46745	1796	46	always	always	RB
46745	1796	47	requiring	require	VBG
46745	1796	48	nutriment	nutriment	NN
46745	1796	49	.	.	.
46745	1797	1	ORD	ORD	NNP
46745	1797	2	.	.	.
46745	1798	1	II	ii	CD
46745	1798	2	.	.	.
46745	1799	1	ACIDS	ACIDS	NNP
46745	1799	2	.	.	.
46745	1800	1	(	(	-LRB-
46745	1800	2	_	_	NNP
46745	1800	3	Mineral:_--Sulphuric	Mineral:_--Sulphuric	NNP
46745	1800	4	,	,	,
46745	1800	5	Hydrochloric	Hydrochloric	NNP
46745	1800	6	,	,	,
46745	1800	7	Nitric	Nitric	NNP
46745	1800	8	,	,	,
46745	1800	9	and	and	CC
46745	1800	10	Phosphoric	Phosphoric	NNP
46745	1800	11	Acids	Acids	NNPS
46745	1800	12	.	.	.
46745	1801	1	_	_	NNP
46745	1801	2	Vegetable:_--Acetic	Vegetable:_--Acetic	NNP
46745	1801	3	,	,	,
46745	1801	4	Citric	Citric	NNP
46745	1801	5	,	,	,
46745	1801	6	Tartaric	tartaric	UH
46745	1801	7	,	,	,
46745	1801	8	and	and	CC
46745	1801	9	Malic	Malic	NNP
46745	1801	10	Acids	Acids	NNPS
46745	1801	11	.	.	.
46745	1801	12	)	)	-RRB-
46745	1802	1	To	to	IN
46745	1802	2	this	this	DT
46745	1802	3	list	list	NN
46745	1802	4	may	may	MD
46745	1802	5	be	be	VB
46745	1802	6	added	add	VBN
46745	1802	7	the	the	DT
46745	1802	8	super	super	JJ
46745	1802	9	-	-	NNS
46745	1802	10	salts	salt	NNS
46745	1802	11	of	of	IN
46745	1802	12	the	the	DT
46745	1802	13	alkalies	alkali	NNS
46745	1802	14	,	,	,
46745	1802	15	which	which	WDT
46745	1802	16	have	have	VBP
46745	1802	17	an	an	DT
46745	1802	18	acid	acid	JJ
46745	1802	19	reaction	reaction	NN
46745	1802	20	.	.	.
46745	1803	1	Although	although	IN
46745	1803	2	the	the	DT
46745	1803	3	mineral	mineral	NN
46745	1803	4	differ	differ	VBP
46745	1803	5	from	from	IN
46745	1803	6	the	the	DT
46745	1803	7	vegetable	vegetable	JJ
46745	1803	8	acids	acid	NNS
46745	1803	9	in	in	IN
46745	1803	10	their	-PRON-	PRP$
46745	1803	11	ultimate	ultimate	JJ
46745	1803	12	action	action	NN
46745	1803	13	,	,	,
46745	1803	14	and	and	CC
46745	1803	15	are	be	VBP
46745	1803	16	altogether	altogether	RB
46745	1803	17	more	more	RBR
46745	1803	18	powerful	powerful	JJ
46745	1803	19	than	than	IN
46745	1803	20	them	-PRON-	PRP
46745	1803	21	,	,	,
46745	1803	22	yet	yet	RB
46745	1803	23	in	in	IN
46745	1803	24	their	-PRON-	PRP$
46745	1803	25	proximate	proximate	NN
46745	1803	26	effects	effect	NNS
46745	1803	27	they	-PRON-	PRP
46745	1803	28	are	be	VBP
46745	1803	29	similar	similar	JJ
46745	1803	30	.	.	.
46745	1804	1	They	-PRON-	PRP
46745	1804	2	are	be	VBP
46745	1804	3	all	all	RB
46745	1804	4	soluble	soluble	JJ
46745	1804	5	in	in	IN
46745	1804	6	water	water	NN
46745	1804	7	,	,	,
46745	1804	8	and	and	CC
46745	1804	9	,	,	,
46745	1804	10	when	when	WRB
46745	1804	11	given	give	VBN
46745	1804	12	as	as	IN
46745	1804	13	medicines	medicine	NNS
46745	1804	14	,	,	,
46745	1804	15	should	should	MD
46745	1804	16	be	be	VB
46745	1804	17	so	so	RB
46745	1804	18	diluted	diluted	JJ
46745	1804	19	that	that	IN
46745	1804	20	they	-PRON-	PRP
46745	1804	21	can	can	MD
46745	1804	22	exert	exert	VB
46745	1804	23	no	no	DT
46745	1804	24	corrosive	corrosive	JJ
46745	1804	25	action	action	NN
46745	1804	26	on	on	IN
46745	1804	27	the	the	DT
46745	1804	28	mucous	mucous	JJ
46745	1804	29	coat	coat	NN
46745	1804	30	of	of	IN
46745	1804	31	the	the	DT
46745	1804	32	stomach	stomach	NN
46745	1804	33	and	and	CC
46745	1804	34	intestines	intestine	NNS
46745	1804	35	.	.	.
46745	1805	1	Dr.	Dr.	NNP
46745	1805	2	Pereira	Pereira	NNP
46745	1805	3	lays	lay	VBZ
46745	1805	4	it	-PRON-	PRP
46745	1805	5	down	down	RP
46745	1805	6	as	as	IN
46745	1805	7	an	an	DT
46745	1805	8	axiom	axiom	NN
46745	1805	9	that	that	IN
46745	1805	10	though	though	IN
46745	1805	11	they	-PRON-	PRP
46745	1805	12	all	all	DT
46745	1805	13	act	act	VBP
46745	1805	14	as	as	IN
46745	1805	15	acids	acid	NNS
46745	1805	16	in	in	IN
46745	1805	17	the	the	DT
46745	1805	18	alimentary	alimentary	JJ
46745	1805	19	canal	canal	NN
46745	1805	20	,	,	,
46745	1805	21	yet	yet	CC
46745	1805	22	that	that	IN
46745	1805	23	they	-PRON-	PRP
46745	1805	24	enter	enter	VBP
46745	1805	25	the	the	DT
46745	1805	26	blood	blood	NN
46745	1805	27	as	as	IN
46745	1805	28	salts	salt	NNS
46745	1805	29	.	.	.
46745	1806	1	He	-PRON-	PRP
46745	1806	2	considers	consider	VBZ
46745	1806	3	that	that	IN
46745	1806	4	they	-PRON-	PRP
46745	1806	5	combine	combine	VBP
46745	1806	6	with	with	IN
46745	1806	7	free	free	JJ
46745	1806	8	alkaline	alkaline	NN
46745	1806	9	matters	matter	NNS
46745	1806	10	in	in	IN
46745	1806	11	the	the	DT
46745	1806	12	saliva	saliva	NN
46745	1806	13	,	,	,
46745	1806	14	bile	bile	NN
46745	1806	15	,	,	,
46745	1806	16	and	and	CC
46745	1806	17	Pancreatic	pancreatic	JJ
46745	1806	18	juice	juice	NN
46745	1806	19	.	.	.
46745	1807	1	(	(	-LRB-
46745	1807	2	_	_	NNP
46745	1807	3	Materia	Materia	NNP
46745	1807	4	Medica	Medica	NNP
46745	1807	5	_	_	NNP
46745	1807	6	,	,	,
46745	1807	7	vol	vol	NNP
46745	1807	8	.	.	.
46745	1808	1	i.	i.	NNP
46745	1808	2	p.	p.	NNP
46745	1809	1	171	171	CD
46745	1809	2	.	.	.
46745	1809	3	)	)	-RRB-
46745	1810	1	But	but	CC
46745	1810	2	this	this	DT
46745	1810	3	explanation	explanation	NN
46745	1810	4	seems	seem	VBZ
46745	1810	5	to	to	IN
46745	1810	6	me	-PRON-	PRP
46745	1810	7	to	to	TO
46745	1810	8	be	be	VB
46745	1810	9	calculated	calculate	VBN
46745	1810	10	to	to	TO
46745	1810	11	communicate	communicate	VB
46745	1810	12	an	an	DT
46745	1810	13	erroneous	erroneous	JJ
46745	1810	14	idea	idea	NN
46745	1810	15	of	of	IN
46745	1810	16	their	-PRON-	PRP$
46745	1810	17	action	action	NN
46745	1810	18	.	.	.
46745	1811	1	For	for	IN
46745	1811	2	supposing	suppose	VBG
46745	1811	3	first	first	RB
46745	1811	4	that	that	IN
46745	1811	5	they	-PRON-	PRP
46745	1811	6	did	do	VBD
46745	1811	7	thus	thus	RB
46745	1811	8	combine	combine	VB
46745	1811	9	with	with	IN
46745	1811	10	alkalies	alkali	NNS
46745	1811	11	before	before	IN
46745	1811	12	entering	enter	VBG
46745	1811	13	the	the	DT
46745	1811	14	blood	blood	NN
46745	1811	15	,	,	,
46745	1811	16	yet	yet	CC
46745	1811	17	as	as	IN
46745	1811	18	more	more	JJR
46745	1811	19	alkaline	alkaline	JJ
46745	1811	20	matter	matter	NN
46745	1811	21	would	would	MD
46745	1811	22	then	then	RB
46745	1811	23	have	have	VB
46745	1811	24	to	to	TO
46745	1811	25	be	be	VB
46745	1811	26	secreted	secrete	VBN
46745	1811	27	to	to	TO
46745	1811	28	supply	supply	VB
46745	1811	29	that	that	IN
46745	1811	30	which	which	WDT
46745	1811	31	they	-PRON-	PRP
46745	1811	32	had	have	VBD
46745	1811	33	neutralized	neutralize	VBN
46745	1811	34	,	,	,
46745	1811	35	they	-PRON-	PRP
46745	1811	36	would	would	MD
46745	1811	37	thus	thus	RB
46745	1811	38	immediately	immediately	RB
46745	1811	39	increase	increase	VB
46745	1811	40	the	the	DT
46745	1811	41	amount	amount	NN
46745	1811	42	of	of	IN
46745	1811	43	acid	acid	NN
46745	1811	44	in	in	IN
46745	1811	45	that	that	DT
46745	1811	46	fluid	fluid	NN
46745	1811	47	.	.	.
46745	1812	1	The	the	DT
46745	1812	2	action	action	NN
46745	1812	3	of	of	IN
46745	1812	4	acids	acid	NNS
46745	1812	5	in	in	IN
46745	1812	6	the	the	DT
46745	1812	7	blood	blood	NN
46745	1812	8	is	be	VBZ
46745	1812	9	very	very	RB
46745	1812	10	different	different	JJ
46745	1812	11	from	from	IN
46745	1812	12	that	that	DT
46745	1812	13	of	of	IN
46745	1812	14	their	-PRON-	PRP$
46745	1812	15	salts	salt	NNS
46745	1812	16	.	.	.
46745	1813	1	Sulphuric	sulphuric	JJ
46745	1813	2	acid	acid	NN
46745	1813	3	does	do	VBZ
46745	1813	4	not	not	RB
46745	1813	5	act	act	VB
46745	1813	6	like	like	IN
46745	1813	7	the	the	DT
46745	1813	8	sulphates	sulphate	NNS
46745	1813	9	of	of	IN
46745	1813	10	Soda	Soda	NNP
46745	1813	11	and	and	CC
46745	1813	12	Magnesia	Magnesia	NNP
46745	1813	13	,	,	,
46745	1813	14	nor	nor	CC
46745	1813	15	is	be	VBZ
46745	1813	16	the	the	DT
46745	1813	17	action	action	NN
46745	1813	18	of	of	IN
46745	1813	19	Hydrochloric	Hydrochloric	NNP
46745	1813	20	acid	acid	VB
46745	1813	21	the	the	DT
46745	1813	22	same	same	JJ
46745	1813	23	as	as	IN
46745	1813	24	that	that	DT
46745	1813	25	of	of	IN
46745	1813	26	common	common	JJ
46745	1813	27	salt	salt	NN
46745	1813	28	.	.	.
46745	1814	1	Again	again	RB
46745	1814	2	,	,	,
46745	1814	3	we	-PRON-	PRP
46745	1814	4	must	must	MD
46745	1814	5	remember	remember	VB
46745	1814	6	that	that	IN
46745	1814	7	the	the	DT
46745	1814	8	secretions	secretion	NNS
46745	1814	9	mentioned	mention	VBN
46745	1814	10	are	be	VBP
46745	1814	11	either	either	CC
46745	1814	12	neutral	neutral	JJ
46745	1814	13	or	or	CC
46745	1814	14	barely	barely	RB
46745	1814	15	alkaline	alkaline	VB
46745	1814	16	in	in	IN
46745	1814	17	their	-PRON-	PRP$
46745	1814	18	reaction	reaction	NN
46745	1814	19	,	,	,
46745	1814	20	and	and	CC
46745	1814	21	that	that	IN
46745	1814	22	the	the	DT
46745	1814	23	acid	acid	JJ
46745	1814	24	medicine	medicine	NN
46745	1814	25	,	,	,
46745	1814	26	on	on	IN
46745	1814	27	passing	pass	VBG
46745	1814	28	into	into	IN
46745	1814	29	the	the	DT
46745	1814	30	stomach	stomach	NN
46745	1814	31	,	,	,
46745	1814	32	would	would	MD
46745	1814	33	meet	meet	VB
46745	1814	34	there	there	RB
46745	1814	35	with	with	IN
46745	1814	36	an	an	DT
46745	1814	37	active	active	JJ
46745	1814	38	absorbent	absorbent	JJ
46745	1814	39	surface	surface	NN
46745	1814	40	,	,	,
46745	1814	41	secreting	secrete	VBG
46745	1814	42	an	an	DT
46745	1814	43	acid	acid	NN
46745	1814	44	,	,	,
46745	1814	45	and	and	CC
46745	1814	46	not	not	RB
46745	1814	47	an	an	DT
46745	1814	48	alkaline	alkaline	NN
46745	1814	49	fluid	fluid	NN
46745	1814	50	.	.	.
46745	1815	1	So	so	RB
46745	1815	2	that	that	IN
46745	1815	3	it	-PRON-	PRP
46745	1815	4	seems	seem	VBZ
46745	1815	5	probable	probable	JJ
46745	1815	6	that	that	IN
46745	1815	7	the	the	DT
46745	1815	8	acid	acid	NN
46745	1815	9	would	would	MD
46745	1815	10	enter	enter	VB
46745	1815	11	the	the	DT
46745	1815	12	blood	blood	NN
46745	1815	13	as	as	IN
46745	1815	14	such	such	JJ
46745	1815	15	.	.	.
46745	1816	1	Now	now	RB
46745	1816	2	the	the	DT
46745	1816	3	presence	presence	NN
46745	1816	4	of	of	IN
46745	1816	5	the	the	DT
46745	1816	6	acid	acid	NN
46745	1816	7	is	be	VBZ
46745	1816	8	not	not	RB
46745	1816	9	unnatural	unnatural	JJ
46745	1816	10	to	to	IN
46745	1816	11	the	the	DT
46745	1816	12	blood	blood	NN
46745	1816	13	.	.	.
46745	1817	1	The	the	DT
46745	1817	2	mineral	mineral	NN
46745	1817	3	acids	acid	NNS
46745	1817	4	exist	exist	VBP
46745	1817	5	there	there	RB
46745	1817	6	in	in	IN
46745	1817	7	combination	combination	NN
46745	1817	8	,	,	,
46745	1817	9	and	and	CC
46745	1817	10	the	the	DT
46745	1817	11	vegetable	vegetable	NN
46745	1817	12	acids	acid	NNS
46745	1817	13	have	have	VBP
46745	1817	14	an	an	DT
46745	1817	15	analogue	analogue	NN
46745	1817	16	in	in	IN
46745	1817	17	lactic	lactic	JJ
46745	1817	18	acid	acid	NN
46745	1817	19	.	.	.
46745	1818	1	The	the	DT
46745	1818	2	blood	blood	NN
46745	1818	3	is	be	VBZ
46745	1818	4	alkaline	alkaline	NN
46745	1818	5	;	;	:
46745	1818	6	which	which	WDT
46745	1818	7	is	be	VBZ
46745	1818	8	due	due	JJ
46745	1818	9	either	either	CC
46745	1818	10	to	to	IN
46745	1818	11	the	the	DT
46745	1818	12	presence	presence	NN
46745	1818	13	of	of	IN
46745	1818	14	carbonate	carbonate	NN
46745	1818	15	of	of	IN
46745	1818	16	Soda	Soda	NNP
46745	1818	17	,	,	,
46745	1818	18	or	or	CC
46745	1818	19	(	(	-LRB-
46745	1818	20	according	accord	VBG
46745	1818	21	to	to	IN
46745	1818	22	Liebig	Liebig	NNP
46745	1818	23	)	)	-RRB-
46745	1818	24	of	of	IN
46745	1818	25	an	an	DT
46745	1818	26	alkaline	alkaline	JJ
46745	1818	27	phosphate	phosphate	NN
46745	1818	28	of	of	IN
46745	1818	29	that	that	DT
46745	1818	30	base	base	NN
46745	1818	31	.	.	.
46745	1819	1	So	so	RB
46745	1819	2	that	that	IN
46745	1819	3	the	the	DT
46745	1819	4	acid	acid	NN
46745	1819	5	,	,	,
46745	1819	6	on	on	IN
46745	1819	7	entering	enter	VBG
46745	1819	8	into	into	IN
46745	1819	9	the	the	DT
46745	1819	10	blood	blood	NN
46745	1819	11	,	,	,
46745	1819	12	passes	pass	VBZ
46745	1819	13	at	at	IN
46745	1819	14	once	once	RB
46745	1819	15	into	into	IN
46745	1819	16	combination	combination	NN
46745	1819	17	with	with	IN
46745	1819	18	this	this	DT
46745	1819	19	alkali	alkali	JJ
46745	1819	20	,	,	,
46745	1819	21	and	and	CC
46745	1819	22	the	the	DT
46745	1819	23	result	result	NN
46745	1819	24	of	of	IN
46745	1819	25	this	this	DT
46745	1819	26	is	be	VBZ
46745	1819	27	a	a	DT
46745	1819	28	general	general	JJ
46745	1819	29	diminution	diminution	NN
46745	1819	30	of	of	IN
46745	1819	31	the	the	DT
46745	1819	32	amount	amount	NN
46745	1819	33	of	of	IN
46745	1819	34	basic	basic	JJ
46745	1819	35	matter	matter	NN
46745	1819	36	in	in	IN
46745	1819	37	the	the	DT
46745	1819	38	system	system	NN
46745	1819	39	,	,	,
46745	1819	40	and	and	CC
46745	1819	41	an	an	DT
46745	1819	42	increase	increase	NN
46745	1819	43	in	in	IN
46745	1819	44	that	that	DT
46745	1819	45	of	of	IN
46745	1819	46	acid	acid	NN
46745	1819	47	.	.	.
46745	1820	1	Thus	thus	RB
46745	1820	2	a	a	DT
46745	1820	3	free	free	JJ
46745	1820	4	acid	acid	NN
46745	1820	5	may	may	MD
46745	1820	6	act	act	VB
46745	1820	7	as	as	IN
46745	1820	8	a	a	DT
46745	1820	9	Restorative	Restorative	NNP
46745	1820	10	in	in	IN
46745	1820	11	cases	case	NNS
46745	1820	12	where	where	WRB
46745	1820	13	there	there	EX
46745	1820	14	is	be	VBZ
46745	1820	15	an	an	DT
46745	1820	16	excess	excess	NN
46745	1820	17	of	of	IN
46745	1820	18	alkali	alkali	JJ
46745	1820	19	in	in	IN
46745	1820	20	the	the	DT
46745	1820	21	blood	blood	NN
46745	1820	22	.	.	.
46745	1821	1	It	-PRON-	PRP
46745	1821	2	may	may	MD
46745	1821	3	either	either	CC
46745	1821	4	remain	remain	VB
46745	1821	5	in	in	IN
46745	1821	6	the	the	DT
46745	1821	7	blood	blood	NN
46745	1821	8	after	after	IN
46745	1821	9	entering	enter	VBG
46745	1821	10	into	into	IN
46745	1821	11	combination	combination	NN
46745	1821	12	,	,	,
46745	1821	13	or	or	CC
46745	1821	14	it	-PRON-	PRP
46745	1821	15	may	may	MD
46745	1821	16	pass	pass	VB
46745	1821	17	off	off	RP
46745	1821	18	by	by	IN
46745	1821	19	the	the	DT
46745	1821	20	urine	urine	NN
46745	1821	21	,	,	,
46745	1821	22	supplying	supply	VBG
46745	1821	23	there	there	RB
46745	1821	24	the	the	DT
46745	1821	25	place	place	NN
46745	1821	26	of	of	IN
46745	1821	27	a	a	DT
46745	1821	28	natural	natural	JJ
46745	1821	29	acid	acid	NN
46745	1821	30	,	,	,
46745	1821	31	which	which	WDT
46745	1821	32	it	-PRON-	PRP
46745	1821	33	leaves	leave	VBZ
46745	1821	34	behind	behind	IN
46745	1821	35	it	-PRON-	PRP
46745	1821	36	in	in	IN
46745	1821	37	the	the	DT
46745	1821	38	system	system	NN
46745	1821	39	.	.	.
46745	1822	1	It	-PRON-	PRP
46745	1822	2	is	be	VBZ
46745	1822	3	on	on	IN
46745	1822	4	such	such	PDT
46745	1822	5	a	a	DT
46745	1822	6	theory	theory	NN
46745	1822	7	as	as	IN
46745	1822	8	this	this	DT
46745	1822	9	that	that	IN
46745	1822	10	the	the	DT
46745	1822	11	action	action	NN
46745	1822	12	of	of	IN
46745	1822	13	mineral	mineral	NN
46745	1822	14	acids	acid	NNS
46745	1822	15	in	in	IN
46745	1822	16	typhoid	typhoid	NN
46745	1822	17	and	and	CC
46745	1822	18	putrid	putrid	JJ
46745	1822	19	fevers	fever	NNS
46745	1822	20	has	have	VBZ
46745	1822	21	been	be	VBN
46745	1822	22	explained	explain	VBN
46745	1822	23	.	.	.
46745	1823	1	I	-PRON-	PRP
46745	1823	2	do	do	VBP
46745	1823	3	not	not	RB
46745	1823	4	mean	mean	VB
46745	1823	5	to	to	TO
46745	1823	6	affirm	affirm	VB
46745	1823	7	positively	positively	RB
46745	1823	8	that	that	IN
46745	1823	9	there	there	EX
46745	1823	10	is	be	VBZ
46745	1823	11	in	in	IN
46745	1823	12	these	these	DT
46745	1823	13	cases	case	NNS
46745	1823	14	an	an	DT
46745	1823	15	excess	excess	NN
46745	1823	16	of	of	IN
46745	1823	17	alkali	alkali	JJ
46745	1823	18	in	in	IN
46745	1823	19	the	the	DT
46745	1823	20	blood	blood	NN
46745	1823	21	.	.	.
46745	1824	1	Although	although	IN
46745	1824	2	likely	likely	RB
46745	1824	3	,	,	,
46745	1824	4	it	-PRON-	PRP
46745	1824	5	is	be	VBZ
46745	1824	6	not	not	RB
46745	1824	7	proved	prove	VBN
46745	1824	8	.	.	.
46745	1825	1	The	the	DT
46745	1825	2	explanation	explanation	NN
46745	1825	3	is	be	VBZ
46745	1825	4	plausible	plausible	JJ
46745	1825	5	.	.	.
46745	1826	1	Acids	acid	NNS
46745	1826	2	are	be	VBP
46745	1826	3	used	use	VBN
46745	1826	4	to	to	TO
46745	1826	5	correct	correct	VB
46745	1826	6	a	a	DT
46745	1826	7	phosphatic	phosphatic	JJ
46745	1826	8	deposit	deposit	NN
46745	1826	9	in	in	IN
46745	1826	10	the	the	DT
46745	1826	11	urine	urine	NN
46745	1826	12	,	,	,
46745	1826	13	caused	cause	VBN
46745	1826	14	by	by	IN
46745	1826	15	an	an	DT
46745	1826	16	alkalinity	alkalinity	NN
46745	1826	17	of	of	IN
46745	1826	18	that	that	DT
46745	1826	19	secretion	secretion	NN
46745	1826	20	.	.	.
46745	1827	1	The	the	DT
46745	1827	2	alkaline	alkaline	NN
46745	1827	3	urine	urine	NN
46745	1827	4	may	may	MD
46745	1827	5	be	be	VB
46745	1827	6	secreted	secrete	VBN
46745	1827	7	so	so	RB
46745	1827	8	,	,	,
46745	1827	9	as	as	IN
46745	1827	10	has	have	VBZ
46745	1827	11	been	be	VBN
46745	1827	12	observed	observe	VBN
46745	1827	13	in	in	IN
46745	1827	14	petechial	petechial	JJ
46745	1827	15	fever	fever	NN
46745	1827	16	by	by	IN
46745	1827	17	Dr.	Dr.	NNP
46745	1827	18	Graves	Graves	NNP
46745	1827	19	and	and	CC
46745	1827	20	Dr.	Dr.	NNP
46745	1827	21	Golding	Golding	NNP
46745	1827	22	Bird	Bird	NNP
46745	1827	23	,	,	,
46745	1827	24	and	and	CC
46745	1827	25	in	in	IN
46745	1827	26	insanity	insanity	NN
46745	1827	27	by	by	IN
46745	1827	28	Dr.	Dr.	NNP
46745	1827	29	Sutherland	Sutherland	NNP
46745	1827	30	,	,	,
46745	1827	31	and	and	CC
46745	1827	32	may	may	MD
46745	1827	33	also	also	RB
46745	1827	34	occur	occur	VB
46745	1827	35	in	in	IN
46745	1827	36	diseases	disease	NNS
46745	1827	37	of	of	IN
46745	1827	38	the	the	DT
46745	1827	39	nervous	nervous	JJ
46745	1827	40	centres	centre	NNS
46745	1827	41	;	;	:
46745	1827	42	or	or	CC
46745	1827	43	it	-PRON-	PRP
46745	1827	44	may	may	MD
46745	1827	45	be	be	VB
46745	1827	46	caused	cause	VBN
46745	1827	47	by	by	IN
46745	1827	48	a	a	DT
46745	1827	49	decomposition	decomposition	NN
46745	1827	50	taking	take	VBG
46745	1827	51	place	place	NN
46745	1827	52	in	in	IN
46745	1827	53	the	the	DT
46745	1827	54	bladder	bladder	NN
46745	1827	55	,	,	,
46745	1827	56	as	as	IN
46745	1827	57	in	in	IN
46745	1827	58	chronic	chronic	JJ
46745	1827	59	inflammation	inflammation	NN
46745	1827	60	,	,	,
46745	1827	61	or	or	CC
46745	1827	62	in	in	IN
46745	1827	63	the	the	DT
46745	1827	64	case	case	NN
46745	1827	65	of	of	IN
46745	1827	66	retention	retention	NN
46745	1827	67	of	of	IN
46745	1827	68	urine	urine	NN
46745	1827	69	from	from	IN
46745	1827	70	any	any	DT
46745	1827	71	cause	cause	NN
46745	1827	72	.	.	.
46745	1828	1	In	in	IN
46745	1828	2	the	the	DT
46745	1828	3	former	former	JJ
46745	1828	4	case	case	NN
46745	1828	5	the	the	DT
46745	1828	6	acid	acid	NN
46745	1828	7	may	may	MD
46745	1828	8	act	act	VB
46745	1828	9	as	as	IN
46745	1828	10	a	a	DT
46745	1828	11	corrective	corrective	NN
46745	1828	12	to	to	IN
46745	1828	13	the	the	DT
46745	1828	14	fluids	fluid	NNS
46745	1828	15	before	before	IN
46745	1828	16	secretion	secretion	NN
46745	1828	17	;	;	:
46745	1828	18	in	in	IN
46745	1828	19	the	the	DT
46745	1828	20	latter	latter	JJ
46745	1828	21	case	case	NN
46745	1828	22	,	,	,
46745	1828	23	after	after	IN
46745	1828	24	it	-PRON-	PRP
46745	1828	25	.	.	.
46745	1829	1	But	but	CC
46745	1829	2	it	-PRON-	PRP
46745	1829	3	is	be	VBZ
46745	1829	4	not	not	RB
46745	1829	5	always	always	RB
46745	1829	6	easy	easy	JJ
46745	1829	7	to	to	TO
46745	1829	8	cause	cause	VB
46745	1829	9	acidity	acidity	NN
46745	1829	10	of	of	IN
46745	1829	11	the	the	DT
46745	1829	12	urine	urine	NN
46745	1829	13	by	by	IN
46745	1829	14	any	any	DT
46745	1829	15	medicines	medicine	NNS
46745	1829	16	.	.	.
46745	1830	1	Mineral	mineral	NN
46745	1830	2	acids	acid	NNS
46745	1830	3	may	may	MD
46745	1830	4	be	be	VB
46745	1830	5	excreted	excrete	VBN
46745	1830	6	in	in	IN
46745	1830	7	other	other	JJ
46745	1830	8	ways	way	NNS
46745	1830	9	,	,	,
46745	1830	10	and	and	CC
46745	1830	11	vegetable	vegetable	NN
46745	1830	12	acids	acid	NNS
46745	1830	13	are	be	VBP
46745	1830	14	liable	liable	JJ
46745	1830	15	to	to	IN
46745	1830	16	decomposition	decomposition	NN
46745	1830	17	in	in	IN
46745	1830	18	the	the	DT
46745	1830	19	system	system	NN
46745	1830	20	.	.	.
46745	1831	1	(	(	-LRB-
46745	1831	2	_	_	NNP
46745	1831	3	Vide	Vide	NNP
46745	1831	4	_	_	NNP
46745	1831	5	page	page	NN
46745	1831	6	125	125	CD
46745	1831	7	.	.	.
46745	1831	8	)	)	-RRB-
46745	1832	1	The	the	DT
46745	1832	2	use	use	NN
46745	1832	3	of	of	IN
46745	1832	4	mineral	mineral	JJ
46745	1832	5	acids	acid	NNS
46745	1832	6	in	in	IN
46745	1832	7	assisting	assist	VBG
46745	1832	8	a	a	DT
46745	1832	9	weak	weak	JJ
46745	1832	10	digestion	digestion	NN
46745	1832	11	admits	admit	NNS
46745	1832	12	of	of	IN
46745	1832	13	a	a	DT
46745	1832	14	simple	simple	JJ
46745	1832	15	explanation	explanation	NN
46745	1832	16	.	.	.
46745	1833	1	For	for	IN
46745	1833	2	whatever	whatever	WDT
46745	1833	3	notion	notion	NN
46745	1833	4	we	-PRON-	PRP
46745	1833	5	adopt	adopt	VBP
46745	1833	6	as	as	IN
46745	1833	7	to	to	IN
46745	1833	8	the	the	DT
46745	1833	9	composition	composition	NN
46745	1833	10	of	of	IN
46745	1833	11	the	the	DT
46745	1833	12	gastric	gastric	JJ
46745	1833	13	juice	juice	NN
46745	1833	14	,	,	,
46745	1833	15	it	-PRON-	PRP
46745	1833	16	is	be	VBZ
46745	1833	17	certain	certain	JJ
46745	1833	18	that	that	IN
46745	1833	19	it	-PRON-	PRP
46745	1833	20	contains	contain	VBZ
46745	1833	21	an	an	DT
46745	1833	22	acid	acid	NN
46745	1833	23	in	in	IN
46745	1833	24	excess	excess	NN
46745	1833	25	.	.	.
46745	1834	1	Now	now	RB
46745	1834	2	an	an	DT
46745	1834	3	acid	acid	JJ
46745	1834	4	medicine	medicine	NN
46745	1834	5	would	would	MD
46745	1834	6	set	set	VB
46745	1834	7	free	free	JJ
46745	1834	8	in	in	IN
46745	1834	9	the	the	DT
46745	1834	10	blood	blood	NN
46745	1834	11	more	more	JJR
46745	1834	12	of	of	IN
46745	1834	13	this	this	DT
46745	1834	14	acid	acid	NN
46745	1834	15	which	which	WDT
46745	1834	16	it	-PRON-	PRP
46745	1834	17	is	be	VBZ
46745	1834	18	the	the	DT
46745	1834	19	business	business	NN
46745	1834	20	of	of	IN
46745	1834	21	the	the	DT
46745	1834	22	stomach	stomach	NN
46745	1834	23	to	to	TO
46745	1834	24	furnish	furnish	VB
46745	1834	25	,	,	,
46745	1834	26	and	and	CC
46745	1834	27	thus	thus	RB
46745	1834	28	prove	prove	VBP
46745	1834	29	useful	useful	JJ
46745	1834	30	in	in	IN
46745	1834	31	that	that	DT
46745	1834	32	kind	kind	NN
46745	1834	33	of	of	IN
46745	1834	34	dyspepsia	dyspepsia	NN
46745	1834	35	which	which	WDT
46745	1834	36	depends	depend	VBZ
46745	1834	37	on	on	IN
46745	1834	38	a	a	DT
46745	1834	39	failure	failure	NN
46745	1834	40	of	of	IN
46745	1834	41	the	the	DT
46745	1834	42	gastric	gastric	JJ
46745	1834	43	secretion	secretion	NN
46745	1834	44	.	.	.
46745	1835	1	Hydrochloric	hydrochloric	JJ
46745	1835	2	acid	acid	NN
46745	1835	3	has	have	VBZ
46745	1835	4	been	be	VBN
46745	1835	5	particularly	particularly	RB
46745	1835	6	recommended	recommend	VBN
46745	1835	7	by	by	IN
46745	1835	8	those	those	DT
46745	1835	9	who	who	WP
46745	1835	10	consider	consider	VBP
46745	1835	11	it	-PRON-	PRP
46745	1835	12	to	to	TO
46745	1835	13	be	be	VB
46745	1835	14	the	the	DT
46745	1835	15	acid	acid	NN
46745	1835	16	normally	normally	RB
46745	1835	17	secreted	secrete	VBN
46745	1835	18	by	by	IN
46745	1835	19	the	the	DT
46745	1835	20	stomach	stomach	NN
46745	1835	21	.	.	.
46745	1836	1	When	when	WRB
46745	1836	2	not	not	RB
46745	1836	3	wanted	want	VBN
46745	1836	4	in	in	IN
46745	1836	5	the	the	DT
46745	1836	6	system	system	NN
46745	1836	7	,	,	,
46745	1836	8	it	-PRON-	PRP
46745	1836	9	seems	seem	VBZ
46745	1836	10	probable	probable	JJ
46745	1836	11	that	that	IN
46745	1836	12	acids	acid	NNS
46745	1836	13	pass	pass	VBP
46745	1836	14	in	in	RP
46745	1836	15	all	all	DT
46745	1836	16	cases	case	NNS
46745	1836	17	out	out	IN
46745	1836	18	of	of	IN
46745	1836	19	the	the	DT
46745	1836	20	blood	blood	NN
46745	1836	21	in	in	IN
46745	1836	22	the	the	DT
46745	1836	23	same	same	JJ
46745	1836	24	condition	condition	NN
46745	1836	25	as	as	IN
46745	1836	26	they	-PRON-	PRP
46745	1836	27	entered	enter	VBD
46745	1836	28	it	-PRON-	PRP
46745	1836	29	.	.	.
46745	1837	1	Thus	thus	RB
46745	1837	2	vegetable	vegetable	JJ
46745	1837	3	acids	acid	NNS
46745	1837	4	act	act	VBP
46745	1837	5	as	as	IN
46745	1837	6	diuretics	diuretic	NNS
46745	1837	7	;	;	:
46745	1837	8	and	and	CC
46745	1837	9	mineral	mineral	NN
46745	1837	10	,	,	,
46745	1837	11	as	as	IN
46745	1837	12	astringents	astringent	NNS
46745	1837	13	to	to	IN
46745	1837	14	the	the	DT
46745	1837	15	glands	gland	NNS
46745	1837	16	generally	generally	RB
46745	1837	17	.	.	.
46745	1838	1	The	the	DT
46745	1838	2	latter	latter	JJ
46745	1838	3	,	,	,
46745	1838	4	when	when	WRB
46745	1838	5	given	give	VBN
46745	1838	6	in	in	IN
46745	1838	7	excess	excess	NN
46745	1838	8	,	,	,
46745	1838	9	may	may	MD
46745	1838	10	prove	prove	VB
46745	1838	11	hurtful	hurtful	JJ
46745	1838	12	by	by	IN
46745	1838	13	causing	cause	VBG
46745	1838	14	a	a	DT
46745	1838	15	lithic	lithic	JJ
46745	1838	16	deposit	deposit	NN
46745	1838	17	in	in	IN
46745	1838	18	the	the	DT
46745	1838	19	urine	urine	NN
46745	1838	20	.	.	.
46745	1839	1	The	the	DT
46745	1839	2	addition	addition	NN
46745	1839	3	of	of	IN
46745	1839	4	a	a	DT
46745	1839	5	mineral	mineral	NN
46745	1839	6	acid	acid	NN
46745	1839	7	to	to	TO
46745	1839	8	healthy	healthy	JJ
46745	1839	9	urine	urine	NN
46745	1839	10	causes	cause	NNS
46745	1839	11	after	after	IN
46745	1839	12	some	some	DT
46745	1839	13	time	time	NN
46745	1839	14	a	a	DT
46745	1839	15	deposit	deposit	NN
46745	1839	16	of	of	IN
46745	1839	17	uric	uric	JJ
46745	1839	18	acid	acid	NN
46745	1839	19	.	.	.
46745	1840	1	The	the	DT
46745	1840	2	action	action	NN
46745	1840	3	of	of	IN
46745	1840	4	acids	acid	NNS
46745	1840	5	on	on	IN
46745	1840	6	the	the	DT
46745	1840	7	urine	urine	NN
46745	1840	8	is	be	VBZ
46745	1840	9	neither	neither	RB
46745	1840	10	so	so	RB
46745	1840	11	constant	constant	JJ
46745	1840	12	nor	nor	CC
46745	1840	13	so	so	RB
46745	1840	14	certain	certain	JJ
46745	1840	15	as	as	IN
46745	1840	16	that	that	DT
46745	1840	17	of	of	IN
46745	1840	18	alkalies	alkali	NNS
46745	1840	19	.	.	.
46745	1841	1	In	in	IN
46745	1841	2	attempting	attempt	VBG
46745	1841	3	to	to	TO
46745	1841	4	correct	correct	VB
46745	1841	5	abnormal	abnormal	JJ
46745	1841	6	conditions	condition	NNS
46745	1841	7	of	of	IN
46745	1841	8	that	that	DT
46745	1841	9	secretion	secretion	NN
46745	1841	10	,	,	,
46745	1841	11	it	-PRON-	PRP
46745	1841	12	must	must	MD
46745	1841	13	be	be	VB
46745	1841	14	remembered	remember	VBN
46745	1841	15	that	that	IN
46745	1841	16	its	-PRON-	PRP$
46745	1841	17	reaction	reaction	NN
46745	1841	18	is	be	VBZ
46745	1841	19	liable	liable	JJ
46745	1841	20	to	to	IN
46745	1841	21	great	great	JJ
46745	1841	22	variations	variation	NNS
46745	1841	23	in	in	IN
46745	1841	24	health	health	NN
46745	1841	25	.	.	.
46745	1842	1	The	the	DT
46745	1842	2	whole	whole	JJ
46745	1842	3	amount	amount	NN
46745	1842	4	passed	pass	VBD
46745	1842	5	during	during	IN
46745	1842	6	a	a	DT
46745	1842	7	day	day	NN
46745	1842	8	should	should	MD
46745	1842	9	be	be	VB
46745	1842	10	examined	examine	VBN
46745	1842	11	together	together	RB
46745	1842	12	.	.	.
46745	1843	1	Dr.	Dr.	NNP
46745	1843	2	Bence	Bence	NNP
46745	1843	3	Jones	Jones	NNP
46745	1843	4	states	state	VBZ
46745	1843	5	that	that	IN
46745	1843	6	the	the	DT
46745	1843	7	urine	urine	NN
46745	1843	8	is	be	VBZ
46745	1843	9	most	most	RBS
46745	1843	10	alkaline	alkaline	NN
46745	1843	11	just	just	RB
46745	1843	12	after	after	IN
46745	1843	13	meals	meal	NNS
46745	1843	14	,	,	,
46745	1843	15	and	and	CC
46745	1843	16	most	most	JJS
46745	1843	17	acid	acid	JJ
46745	1843	18	when	when	WRB
46745	1843	19	a	a	DT
46745	1843	20	sufficient	sufficient	JJ
46745	1843	21	time	time	NN
46745	1843	22	has	have	VBZ
46745	1843	23	elapsed	elapse	VBN
46745	1843	24	for	for	IN
46745	1843	25	the	the	DT
46745	1843	26	completion	completion	NN
46745	1843	27	of	of	IN
46745	1843	28	the	the	DT
46745	1843	29	digestive	digestive	JJ
46745	1843	30	process	process	NN
46745	1843	31	.	.	.
46745	1844	1	(	(	-LRB-
46745	1844	2	_	_	NNP
46745	1844	3	Animal	Animal	NNP
46745	1844	4	Chemistry	Chemistry	NNP
46745	1844	5	_	_	NNP
46745	1844	6	,	,	,
46745	1844	7	p.	p.	NN
46745	1845	1	51	51	CD
46745	1845	2	.	.	.
46745	1845	3	)	)	-RRB-
46745	1846	1	I	-PRON-	PRP
46745	1846	2	shall	shall	MD
46745	1846	3	have	have	VB
46745	1846	4	afterwards	afterwards	RB
46745	1846	5	to	to	TO
46745	1846	6	consider	consider	VB
46745	1846	7	the	the	DT
46745	1846	8	action	action	NN
46745	1846	9	of	of	IN
46745	1846	10	the	the	DT
46745	1846	11	mineral	mineral	NN
46745	1846	12	acids	acid	NNS
46745	1846	13	as	as	IN
46745	1846	14	Astringents	astringent	NNS
46745	1846	15	;	;	:
46745	1846	16	and	and	CC
46745	1846	17	I	-PRON-	PRP
46745	1846	18	must	must	MD
46745	1846	19	now	now	RB
46745	1846	20	add	add	VB
46745	1846	21	a	a	DT
46745	1846	22	few	few	JJ
46745	1846	23	words	word	NNS
46745	1846	24	on	on	IN
46745	1846	25	that	that	DT
46745	1846	26	use	use	NN
46745	1846	27	of	of	IN
46745	1846	28	the	the	DT
46745	1846	29	vegetable	vegetable	NN
46745	1846	30	acids	acid	NNS
46745	1846	31	which	which	WDT
46745	1846	32	has	have	VBZ
46745	1846	33	gained	gain	VBN
46745	1846	34	for	for	IN
46745	1846	35	them	-PRON-	PRP
46745	1846	36	the	the	DT
46745	1846	37	title	title	NN
46745	1846	38	of	of	IN
46745	1846	39	Refrigerants	refrigerant	NNS
46745	1846	40	.	.	.
46745	1847	1	In	in	IN
46745	1847	2	febrile	febrile	NN
46745	1847	3	cases	case	NNS
46745	1847	4	of	of	IN
46745	1847	5	all	all	DT
46745	1847	6	kinds	kind	NNS
46745	1847	7	it	-PRON-	PRP
46745	1847	8	is	be	VBZ
46745	1847	9	often	often	RB
46745	1847	10	found	find	VBN
46745	1847	11	that	that	IN
46745	1847	12	diluent	diluent	JJ
46745	1847	13	drinks	drink	NNS
46745	1847	14	containing	contain	VBG
46745	1847	15	the	the	DT
46745	1847	16	free	free	JJ
46745	1847	17	vegetable	vegetable	NN
46745	1847	18	acids	acid	NNS
46745	1847	19	,	,	,
46745	1847	20	or	or	CC
46745	1847	21	solutions	solution	NNS
46745	1847	22	of	of	IN
46745	1847	23	their	-PRON-	PRP$
46745	1847	24	salts	salt	NNS
46745	1847	25	with	with	IN
46745	1847	26	alkalies	alkali	NNS
46745	1847	27	,	,	,
46745	1847	28	act	act	VB
46745	1847	29	beneficially	beneficially	RB
46745	1847	30	in	in	IN
46745	1847	31	lowering	lower	VBG
46745	1847	32	the	the	DT
46745	1847	33	pulse	pulse	NN
46745	1847	34	,	,	,
46745	1847	35	and	and	CC
46745	1847	36	in	in	IN
46745	1847	37	moderating	moderate	VBG
46745	1847	38	the	the	DT
46745	1847	39	progress	progress	NN
46745	1847	40	of	of	IN
46745	1847	41	the	the	DT
46745	1847	42	disorder	disorder	NN
46745	1847	43	.	.	.
46745	1848	1	These	these	DT
46745	1848	2	should	should	MD
46745	1848	3	both	both	DT
46745	1848	4	be	be	VB
46745	1848	5	distinguished	distinguish	VBN
46745	1848	6	from	from	IN
46745	1848	7	mineral	mineral	JJ
46745	1848	8	saline	saline	JJ
46745	1848	9	drinks	drink	NNS
46745	1848	10	;	;	:
46745	1848	11	for	for	IN
46745	1848	12	mineral	mineral	NN
46745	1848	13	salts	salt	NNS
46745	1848	14	,	,	,
46745	1848	15	from	from	IN
46745	1848	16	their	-PRON-	PRP$
46745	1848	17	known	know	VBN
46745	1848	18	effects	effect	NNS
46745	1848	19	on	on	IN
46745	1848	20	the	the	DT
46745	1848	21	blood	blood	NN
46745	1848	22	,	,	,
46745	1848	23	would	would	MD
46745	1848	24	seem	seem	VB
46745	1848	25	to	to	TO
46745	1848	26	belong	belong	VB
46745	1848	27	simply	simply	RB
46745	1848	28	to	to	IN
46745	1848	29	my	-PRON-	PRP$
46745	1848	30	division	division	NN
46745	1848	31	of	of	IN
46745	1848	32	Catalytics	Catalytics	NNP
46745	1848	33	.	.	.
46745	1849	1	But	but	CC
46745	1849	2	the	the	DT
46745	1849	3	effect	effect	NN
46745	1849	4	of	of	IN
46745	1849	5	these	these	DT
46745	1849	6	vegetable	vegetable	JJ
46745	1849	7	acids	acid	NNS
46745	1849	8	seems	seem	VBZ
46745	1849	9	to	to	TO
46745	1849	10	be	be	VB
46745	1849	11	to	to	TO
46745	1849	12	restore	restore	VB
46745	1849	13	the	the	DT
46745	1849	14	blood	blood	NN
46745	1849	15	to	to	IN
46745	1849	16	a	a	DT
46745	1849	17	more	more	RBR
46745	1849	18	natural	natural	JJ
46745	1849	19	condition	condition	NN
46745	1849	20	,	,	,
46745	1849	21	and	and	CC
46745	1849	22	this	this	DT
46745	1849	23	independently	independently	RB
46745	1849	24	of	of	IN
46745	1849	25	the	the	DT
46745	1849	26	action	action	NN
46745	1849	27	of	of	IN
46745	1849	28	the	the	DT
46745	1849	29	diluent	diluent	NN
46745	1849	30	with	with	IN
46745	1849	31	which	which	WDT
46745	1849	32	they	-PRON-	PRP
46745	1849	33	are	be	VBP
46745	1849	34	administered	administer	VBN
46745	1849	35	.	.	.
46745	1850	1	Now	now	RB
46745	1850	2	of	of	IN
46745	1850	3	this	this	DT
46745	1850	4	effect	effect	NN
46745	1850	5	there	there	EX
46745	1850	6	is	be	VBZ
46745	1850	7	no	no	DT
46745	1850	8	certain	certain	JJ
46745	1850	9	explanation	explanation	NN
46745	1850	10	,	,	,
46745	1850	11	but	but	CC
46745	1850	12	a	a	DT
46745	1850	13	theory	theory	NN
46745	1850	14	,	,	,
46745	1850	15	which	which	WDT
46745	1850	16	may	may	MD
46745	1850	17	or	or	CC
46745	1850	18	may	may	MD
46745	1850	19	not	not	RB
46745	1850	20	be	be	VB
46745	1850	21	true	true	JJ
46745	1850	22	,	,	,
46745	1850	23	may	may	MD
46745	1850	24	be	be	VB
46745	1850	25	ventured	venture	VBN
46745	1850	26	to	to	TO
46745	1850	27	account	account	VB
46745	1850	28	for	for	IN
46745	1850	29	it	-PRON-	PRP
46745	1850	30	.	.	.
46745	1851	1	Should	Should	MD
46745	1851	2	it	-PRON-	PRP
46745	1851	3	prove	prove	VB
46745	1851	4	correct	correct	JJ
46745	1851	5	,	,	,
46745	1851	6	it	-PRON-	PRP
46745	1851	7	would	would	MD
46745	1851	8	seem	seem	VB
46745	1851	9	that	that	IN
46745	1851	10	in	in	IN
46745	1851	11	such	such	JJ
46745	1851	12	cases	case	NNS
46745	1851	13	the	the	DT
46745	1851	14	free	free	JJ
46745	1851	15	vegetable	vegetable	NN
46745	1851	16	acid	acid	NN
46745	1851	17	acts	act	VBZ
46745	1851	18	as	as	IN
46745	1851	19	a	a	DT
46745	1851	20	Restorative	Restorative	NNP
46745	1851	21	;	;	:
46745	1851	22	and	and	CC
46745	1851	23	that	that	IN
46745	1851	24	the	the	DT
46745	1851	25	alkaline	alkaline	JJ
46745	1851	26	salt	salt	NN
46745	1851	27	of	of	IN
46745	1851	28	this	this	DT
46745	1851	29	acid	acid	NN
46745	1851	30	has	have	VBZ
46745	1851	31	at	at	IN
46745	1851	32	first	first	RB
46745	1851	33	the	the	DT
46745	1851	34	same	same	JJ
46745	1851	35	action	action	NN
46745	1851	36	,	,	,
46745	1851	37	but	but	CC
46745	1851	38	adds	add	VBZ
46745	1851	39	to	to	IN
46745	1851	40	it	-PRON-	PRP
46745	1851	41	afterwards	afterwards	RB
46745	1851	42	a	a	DT
46745	1851	43	Catalytic	catalytic	JJ
46745	1851	44	operation	operation	NN
46745	1851	45	.	.	.
46745	1852	1	Let	let	VB
46745	1852	2	us	-PRON-	PRP
46745	1852	3	then	then	RB
46745	1852	4	attempt	attempt	VB
46745	1852	5	to	to	TO
46745	1852	6	clear	clear	VB
46745	1852	7	up	up	RP
46745	1852	8	this	this	DT
46745	1852	9	matter	matter	NN
46745	1852	10	.	.	.
46745	1853	1	It	-PRON-	PRP
46745	1853	2	has	have	VBZ
46745	1853	3	long	long	RB
46745	1853	4	been	be	VBN
46745	1853	5	considered	consider	VBN
46745	1853	6	probable	probable	JJ
46745	1853	7	,	,	,
46745	1853	8	but	but	CC
46745	1853	9	may	may	MD
46745	1853	10	now	now	RB
46745	1853	11	be	be	VB
46745	1853	12	said	say	VBN
46745	1853	13	to	to	TO
46745	1853	14	have	have	VB
46745	1853	15	been	be	VBN
46745	1853	16	proved	prove	VBN
46745	1853	17	by	by	IN
46745	1853	18	the	the	DT
46745	1853	19	researches	research	NNS
46745	1853	20	of	of	IN
46745	1853	21	M.	M.	NNP
46745	1853	22	Becquerel	Becquerel	NNP
46745	1853	23	,	,	,
46745	1853	24	that	that	IN
46745	1853	25	in	in	IN
46745	1853	26	febrile	febrile	NN
46745	1853	27	disorders	disorder	NNS
46745	1853	28	and	and	CC
46745	1853	29	inflammations	inflammation	NNS
46745	1853	30	there	there	EX
46745	1853	31	is	be	VBZ
46745	1853	32	excreted	excrete	VBN
46745	1853	33	in	in	IN
46745	1853	34	the	the	DT
46745	1853	35	urine	urine	NN
46745	1853	36	an	an	DT
46745	1853	37	excess	excess	NN
46745	1853	38	of	of	IN
46745	1853	39	Urea	Urea	NNP
46745	1853	40	and	and	CC
46745	1853	41	of	of	IN
46745	1853	42	Urate	Urate	NNP
46745	1853	43	of	of	IN
46745	1853	44	Ammonia	Ammonia	NNP
46745	1853	45	,	,	,
46745	1853	46	substances	substance	NNS
46745	1853	47	which	which	WDT
46745	1853	48	are	be	VBP
46745	1853	49	formed	form	VBN
46745	1853	50	by	by	IN
46745	1853	51	the	the	DT
46745	1853	52	oxidation	oxidation	NN
46745	1853	53	of	of	IN
46745	1853	54	the	the	DT
46745	1853	55	Nitrogenous	nitrogenous	JJ
46745	1853	56	tissues	tissue	NNS
46745	1853	57	.	.	.
46745	1854	1	This	this	DT
46745	1854	2	extra	extra	JJ
46745	1854	3	-	-	HYPH
46745	1854	4	oxidation	oxidation	NN
46745	1854	5	probably	probably	RB
46745	1854	6	arises	arise	VBZ
46745	1854	7	from	from	IN
46745	1854	8	a	a	DT
46745	1854	9	deficiency	deficiency	NN
46745	1854	10	of	of	IN
46745	1854	11	that	that	DT
46745	1854	12	matter	matter	NN
46745	1854	13	which	which	WDT
46745	1854	14	is	be	VBZ
46745	1854	15	the	the	DT
46745	1854	16	proper	proper	JJ
46745	1854	17	food	food	NN
46745	1854	18	of	of	IN
46745	1854	19	oxygen	oxygen	NN
46745	1854	20	in	in	IN
46745	1854	21	the	the	DT
46745	1854	22	system	system	NN
46745	1854	23	.	.	.
46745	1855	1	This	this	DT
46745	1855	2	,	,	,
46745	1855	3	as	as	IN
46745	1855	4	we	-PRON-	PRP
46745	1855	5	have	have	VBP
46745	1855	6	seen	see	VBN
46745	1855	7	,	,	,
46745	1855	8	being	be	VBG
46745	1855	9	the	the	DT
46745	1855	10	step	step	NN
46745	1855	11	between	between	IN
46745	1855	12	grape	grape	NN
46745	1855	13	-	-	HYPH
46745	1855	14	sugar	sugar	NN
46745	1855	15	and	and	CC
46745	1855	16	Carbonic	carbonic	JJ
46745	1855	17	acid	acid	NN
46745	1855	18	,	,	,
46745	1855	19	must	must	MD
46745	1855	20	either	either	CC
46745	1855	21	be	be	VB
46745	1855	22	Lactic	lactic	JJ
46745	1855	23	acid	acid	NN
46745	1855	24	,	,	,
46745	1855	25	or	or	CC
46745	1855	26	something	something	NN
46745	1855	27	similar	similar	JJ
46745	1855	28	to	to	IN
46745	1855	29	it	-PRON-	PRP
46745	1855	30	.	.	.
46745	1856	1	It	-PRON-	PRP
46745	1856	2	must	must	MD
46745	1856	3	be	be	VB
46745	1856	4	remembered	remember	VBN
46745	1856	5	that	that	IN
46745	1856	6	no	no	DT
46745	1856	7	food	food	NN
46745	1856	8	is	be	VBZ
46745	1856	9	usually	usually	RB
46745	1856	10	taken	take	VBN
46745	1856	11	in	in	IN
46745	1856	12	fever	fever	NN
46745	1856	13	;	;	:
46745	1856	14	this	this	DT
46745	1856	15	would	would	MD
46745	1856	16	at	at	IN
46745	1856	17	length	length	NN
46745	1856	18	quite	quite	RB
46745	1856	19	cut	cut	VBN
46745	1856	20	off	off	RP
46745	1856	21	the	the	DT
46745	1856	22	usual	usual	JJ
46745	1856	23	source	source	NN
46745	1856	24	of	of	IN
46745	1856	25	this	this	DT
46745	1856	26	lactic	lactic	JJ
46745	1856	27	acid	acid	NN
46745	1856	28	,	,	,
46745	1856	29	which	which	WDT
46745	1856	30	is	be	VBZ
46745	1856	31	the	the	DT
46745	1856	32	starch	starch	NN
46745	1856	33	and	and	CC
46745	1856	34	sugar	sugar	NN
46745	1856	35	of	of	IN
46745	1856	36	the	the	DT
46745	1856	37	food	food	NN
46745	1856	38	,	,	,
46745	1856	39	and	and	CC
46745	1856	40	render	render	VB
46745	1856	41	it	-PRON-	PRP
46745	1856	42	necessary	necessary	JJ
46745	1856	43	that	that	IN
46745	1856	44	the	the	DT
46745	1856	45	animal	animal	NN
46745	1856	46	tissues	tissue	NNS
46745	1856	47	should	should	MD
46745	1856	48	continue	continue	VB
46745	1856	49	to	to	TO
46745	1856	50	undergo	undergo	VB
46745	1856	51	oxidation	oxidation	NN
46745	1856	52	,	,	,
46745	1856	53	to	to	TO
46745	1856	54	maintain	maintain	VB
46745	1856	55	the	the	DT
46745	1856	56	animal	animal	NN
46745	1856	57	heat	heat	NN
46745	1856	58	.	.	.
46745	1857	1	Now	now	RB
46745	1857	2	if	if	IN
46745	1857	3	we	-PRON-	PRP
46745	1857	4	compare	compare	VBP
46745	1857	5	the	the	DT
46745	1857	6	commonly	commonly	RB
46745	1857	7	received	receive	VBN
46745	1857	8	formula	formula	NN
46745	1857	9	of	of	IN
46745	1857	10	Proteine	Proteine	NNP
46745	1857	11	with	with	IN
46745	1857	12	those	those	DT
46745	1857	13	of	of	IN
46745	1857	14	Lactic	lactic	JJ
46745	1857	15	acid	acid	NN
46745	1857	16	and	and	CC
46745	1857	17	Tartaric	tartaric	JJ
46745	1857	18	acid	acid	NN
46745	1857	19	,	,	,
46745	1857	20	it	-PRON-	PRP
46745	1857	21	will	will	MD
46745	1857	22	at	at	IN
46745	1857	23	once	once	RB
46745	1857	24	be	be	VB
46745	1857	25	seen	see	VBN
46745	1857	26	,	,	,
46745	1857	27	as	as	IN
46745	1857	28	was	be	VBD
46745	1857	29	pointed	point	VBN
46745	1857	30	out	out	RP
46745	1857	31	some	some	DT
46745	1857	32	time	time	NN
46745	1857	33	ago	ago	RB
46745	1857	34	by	by	IN
46745	1857	35	Dr.	Dr.	NNP
46745	1857	36	Murray	Murray	NNP
46745	1857	37	,	,	,
46745	1857	38	that	that	IN
46745	1857	39	the	the	DT
46745	1857	40	latter	latter	JJ
46745	1857	41	contain	contain	NN
46745	1857	42	more	more	JJR
46745	1857	43	Oxygen	oxygen	NN
46745	1857	44	,	,	,
46745	1857	45	in	in	IN
46745	1857	46	proportion	proportion	NN
46745	1857	47	to	to	IN
46745	1857	48	their	-PRON-	PRP$
46745	1857	49	Carbon	Carbon	NNP
46745	1857	50	and	and	CC
46745	1857	51	Hydrogen	Hydrogen	NNP
46745	1857	52	,	,	,
46745	1857	53	than	than	IN
46745	1857	54	is	be	VBZ
46745	1857	55	found	find	VBN
46745	1857	56	in	in	IN
46745	1857	57	Proteine	Proteine	NNP
46745	1857	58	,	,	,
46745	1857	59	or	or	CC
46745	1857	60	Albumen	Albumen	NNP
46745	1857	61	.	.	.
46745	1858	1	Proteine	proteine	NN
46745	1858	2	=	=	SYM
46745	1858	3	C_{40}H_{31}N_{5}O_{12	c_{40}h_{31}n_{5}o_{12	NN
46745	1858	4	}	}	-RRB-
46745	1858	5	.	.	.
46745	1859	1	Lactic	lactic	JJ
46745	1859	2	acid	acid	NN
46745	1859	3	=	=	SYM
46745	1859	4	C_{6}H_{6}O_{6	c_{6}h_{6}o_{6	NN
46745	1859	5	}	}	-RRB-
46745	1859	6	.	.	.
46745	1860	1	Tartaric	tartaric	JJ
46745	1860	2	acid	acid	NN
46745	1860	3	=	=	SYM
46745	1860	4	C_{8}H_{4}O_{10	C_{8}H_{4}O_{10	NNP
46745	1860	5	}	}	-RRB-
46745	1860	6	+	+	CC
46745	1860	7	2	2	CD
46745	1860	8	HO	HO	NNP
46745	1860	9	.	.	.
46745	1861	1	Thus	thus	RB
46745	1861	2	,	,	,
46745	1861	3	while	while	IN
46745	1861	4	for	for	IN
46745	1861	5	40	40	CD
46745	1861	6	equivalents	equivalent	NNS
46745	1861	7	of	of	IN
46745	1861	8	Carbon	carbon	NN
46745	1861	9	,	,	,
46745	1861	10	Proteine	Proteine	NNP
46745	1861	11	contains	contain	VBZ
46745	1861	12	only	only	RB
46745	1861	13	12	12	CD
46745	1861	14	of	of	IN
46745	1861	15	Oxygen	oxygen	NN
46745	1861	16	;	;	:
46745	1861	17	Lactic	lactic	JJ
46745	1861	18	acid	acid	NN
46745	1861	19	contains	contain	VBZ
46745	1861	20	40	40	CD
46745	1861	21	,	,	,
46745	1861	22	and	and	CC
46745	1861	23	Tartaric	Tartaric	NNP
46745	1861	24	50	50	CD
46745	1861	25	,	,	,
46745	1861	26	of	of	IN
46745	1861	27	that	that	DT
46745	1861	28	element	element	NN
46745	1861	29	.	.	.
46745	1862	1	So	so	CC
46745	1862	2	it	-PRON-	PRP
46745	1862	3	seems	seem	VBZ
46745	1862	4	that	that	IN
46745	1862	5	Albuminous	albuminous	JJ
46745	1862	6	matters	matter	NNS
46745	1862	7	,	,	,
46745	1862	8	containing	contain	VBG
46745	1862	9	less	less	JJR
46745	1862	10	Oxygen	Oxygen	NNP
46745	1862	11	,	,	,
46745	1862	12	would	would	MD
46745	1862	13	require	require	VB
46745	1862	14	much	much	RB
46745	1862	15	more	more	JJR
46745	1862	16	Oxygen	oxygen	NN
46745	1862	17	for	for	IN
46745	1862	18	their	-PRON-	PRP$
46745	1862	19	combustion	combustion	NN
46745	1862	20	;	;	:
46745	1862	21	this	this	DT
46745	1862	22	would	would	MD
46745	1862	23	produce	produce	VB
46745	1862	24	more	more	JJR
46745	1862	25	heat	heat	NN
46745	1862	26	,	,	,
46745	1862	27	augment	augment	VBD
46745	1862	28	the	the	DT
46745	1862	29	number	number	NN
46745	1862	30	of	of	IN
46745	1862	31	respirations	respiration	NNS
46745	1862	32	,	,	,
46745	1862	33	and	and	CC
46745	1862	34	keep	keep	VB
46745	1862	35	up	up	RP
46745	1862	36	the	the	DT
46745	1862	37	fever	fever	NN
46745	1862	38	.	.	.
46745	1863	1	And	and	CC
46745	1863	2	though	though	IN
46745	1863	3	it	-PRON-	PRP
46745	1863	4	has	have	VBZ
46745	1863	5	been	be	VBN
46745	1863	6	proved	prove	VBN
46745	1863	7	by	by	IN
46745	1863	8	Wöhler	Wöhler	NNP
46745	1863	9	that	that	DT
46745	1863	10	free	free	JJ
46745	1863	11	vegetable	vegetable	NN
46745	1863	12	acids	acid	NNS
46745	1863	13	pass	pass	VBP
46745	1863	14	out	out	RP
46745	1863	15	in	in	IN
46745	1863	16	the	the	DT
46745	1863	17	urine	urine	NN
46745	1863	18	without	without	IN
46745	1863	19	having	have	VBG
46745	1863	20	undergone	undergo	VBN
46745	1863	21	oxidation	oxidation	NN
46745	1863	22	,	,	,
46745	1863	23	yet	yet	CC
46745	1863	24	the	the	DT
46745	1863	25	condition	condition	NN
46745	1863	26	of	of	IN
46745	1863	27	fever	fever	NN
46745	1863	28	would	would	MD
46745	1863	29	probably	probably	RB
46745	1863	30	be	be	VB
46745	1863	31	an	an	DT
46745	1863	32	exceptional	exceptional	JJ
46745	1863	33	case	case	NN
46745	1863	34	.	.	.
46745	1864	1	Lactic	lactic	JJ
46745	1864	2	acid	acid	NN
46745	1864	3	,	,	,
46745	1864	4	the	the	DT
46745	1864	5	natural	natural	JJ
46745	1864	6	fuel	fuel	NN
46745	1864	7	,	,	,
46745	1864	8	being	be	VBG
46745	1864	9	deficient	deficient	JJ
46745	1864	10	,	,	,
46745	1864	11	the	the	DT
46745	1864	12	alkali	alkali	JJ
46745	1864	13	with	with	IN
46745	1864	14	which	which	WDT
46745	1864	15	it	-PRON-	PRP
46745	1864	16	should	should	MD
46745	1864	17	combine	combine	VB
46745	1864	18	must	must	MD
46745	1864	19	be	be	VB
46745	1864	20	present	present	JJ
46745	1864	21	in	in	IN
46745	1864	22	some	some	DT
46745	1864	23	excess	excess	NN
46745	1864	24	;	;	:
46745	1864	25	so	so	CC
46745	1864	26	it	-PRON-	PRP
46745	1864	27	seems	seem	VBZ
46745	1864	28	likely	likely	JJ
46745	1864	29	that	that	IN
46745	1864	30	a	a	DT
46745	1864	31	free	free	JJ
46745	1864	32	vegetable	vegetable	NN
46745	1864	33	acid	acid	NN
46745	1864	34	would	would	MD
46745	1864	35	combine	combine	VB
46745	1864	36	at	at	IN
46745	1864	37	once	once	RB
46745	1864	38	with	with	IN
46745	1864	39	this	this	DT
46745	1864	40	alkali	alkali	JJ
46745	1864	41	as	as	IN
46745	1864	42	the	the	DT
46745	1864	43	Lactic	lactic	JJ
46745	1864	44	acid	acid	NN
46745	1864	45	would	would	MD
46745	1864	46	have	have	VB
46745	1864	47	done	do	VBN
46745	1864	48	,	,	,
46745	1864	49	and	and	CC
46745	1864	50	thus	thus	RB
46745	1864	51	be	be	VB
46745	1864	52	burnt	burn	VBN
46745	1864	53	or	or	CC
46745	1864	54	oxidized	oxidize	VBN
46745	1864	55	instead	instead	RB
46745	1864	56	of	of	IN
46745	1864	57	the	the	DT
46745	1864	58	latter	latter	JJ
46745	1864	59	.	.	.
46745	1865	1	Its	-PRON-	PRP$
46745	1865	2	action	action	NN
46745	1865	3	would	would	MD
46745	1865	4	then	then	RB
46745	1865	5	be	be	VB
46745	1865	6	simply	simply	RB
46745	1865	7	Restorative	restorative	JJ
46745	1865	8	.	.	.
46745	1866	1	Requiring	require	VBG
46745	1866	2	less	less	JJR
46745	1866	3	Oxygen	oxygen	NN
46745	1866	4	than	than	IN
46745	1866	5	the	the	DT
46745	1866	6	Proteine	Proteine	NNP
46745	1866	7	would	would	MD
46745	1866	8	need	need	VB
46745	1866	9	to	to	TO
46745	1866	10	transform	transform	VB
46745	1866	11	it	-PRON-	PRP
46745	1866	12	into	into	IN
46745	1866	13	Carbonic	carbonic	JJ
46745	1866	14	acid	acid	NN
46745	1866	15	,	,	,
46745	1866	16	it	-PRON-	PRP
46745	1866	17	would	would	MD
46745	1866	18	thus	thus	RB
46745	1866	19	diminish	diminish	VB
46745	1866	20	the	the	DT
46745	1866	21	number	number	NN
46745	1866	22	of	of	IN
46745	1866	23	the	the	DT
46745	1866	24	respirations	respiration	NNS
46745	1866	25	,	,	,
46745	1866	26	the	the	DT
46745	1866	27	frequency	frequency	NN
46745	1866	28	of	of	IN
46745	1866	29	the	the	DT
46745	1866	30	pulse	pulse	NN
46745	1866	31	,	,	,
46745	1866	32	the	the	DT
46745	1866	33	temperature	temperature	NN
46745	1866	34	of	of	IN
46745	1866	35	the	the	DT
46745	1866	36	body,--and	body,--and	XX
46745	1866	37	in	in	IN
46745	1866	38	this	this	DT
46745	1866	39	way	way	NN
46745	1866	40	allay	allay	VB
46745	1866	41	the	the	DT
46745	1866	42	fever	fever	NN
46745	1866	43	.	.	.
46745	1867	1	It	-PRON-	PRP
46745	1867	2	would	would	MD
46745	1867	3	be	be	VB
46745	1867	4	strongly	strongly	RB
46745	1867	5	confirmatory	confirmatory	RB
46745	1867	6	of	of	IN
46745	1867	7	this	this	DT
46745	1867	8	idea	idea	NN
46745	1867	9	if	if	IN
46745	1867	10	it	-PRON-	PRP
46745	1867	11	were	be	VBD
46745	1867	12	proved	prove	VBN
46745	1867	13	that	that	IN
46745	1867	14	the	the	DT
46745	1867	15	amount	amount	NN
46745	1867	16	of	of	IN
46745	1867	17	Urea	Urea	NNP
46745	1867	18	and	and	CC
46745	1867	19	Urates	Urates	NNPS
46745	1867	20	in	in	IN
46745	1867	21	the	the	DT
46745	1867	22	urine	urine	NN
46745	1867	23	is	be	VBZ
46745	1867	24	actually	actually	RB
46745	1867	25	diminished	diminish	VBN
46745	1867	26	by	by	IN
46745	1867	27	the	the	DT
46745	1867	28	use	use	NN
46745	1867	29	of	of	IN
46745	1867	30	acid	acid	JJ
46745	1867	31	drinks	drink	NNS
46745	1867	32	and	and	CC
46745	1867	33	fruits	fruit	NNS
46745	1867	34	in	in	IN
46745	1867	35	febrile	febrile	NN
46745	1867	36	cases	case	NNS
46745	1867	37	.	.	.
46745	1868	1	This	this	DT
46745	1868	2	hypothesis	hypothesis	NN
46745	1868	3	can	can	MD
46745	1868	4	only	only	RB
46745	1868	5	be	be	VB
46745	1868	6	admitted	admit	VBN
46745	1868	7	on	on	IN
46745	1868	8	the	the	DT
46745	1868	9	supposition	supposition	NN
46745	1868	10	that	that	WDT
46745	1868	11	fever	fever	NN
46745	1868	12	constitutes	constitute	VBZ
46745	1868	13	an	an	DT
46745	1868	14	exception	exception	NN
46745	1868	15	to	to	IN
46745	1868	16	the	the	DT
46745	1868	17	general	general	JJ
46745	1868	18	rule	rule	NN
46745	1868	19	that	that	IN
46745	1868	20	the	the	DT
46745	1868	21	vegetable	vegetable	NN
46745	1868	22	acids	acid	NNS
46745	1868	23	pass	pass	VBP
46745	1868	24	through	through	IN
46745	1868	25	the	the	DT
46745	1868	26	blood	blood	NN
46745	1868	27	without	without	IN
46745	1868	28	undergoing	undergoing	JJ
46745	1868	29	change	change	NN
46745	1868	30	.	.	.
46745	1869	1	Now	now	RB
46745	1869	2	,	,	,
46745	1869	3	the	the	DT
46745	1869	4	salts	salt	NNS
46745	1869	5	of	of	IN
46745	1869	6	these	these	DT
46745	1869	7	acids	acid	NNS
46745	1869	8	,	,	,
46745	1869	9	with	with	IN
46745	1869	10	alkalies	alkali	NNS
46745	1869	11	,	,	,
46745	1869	12	which	which	WDT
46745	1869	13	are	be	VBP
46745	1869	14	often	often	RB
46745	1869	15	administered	administer	VBN
46745	1869	16	in	in	IN
46745	1869	17	the	the	DT
46745	1869	18	form	form	NN
46745	1869	19	of	of	IN
46745	1869	20	effervescing	effervesce	VBG
46745	1869	21	draughts	draught	NNS
46745	1869	22	,	,	,
46745	1869	23	might	may	MD
46745	1869	24	exert	exert	VB
46745	1869	25	the	the	DT
46745	1869	26	same	same	JJ
46745	1869	27	refrigerant	refrigerant	JJ
46745	1869	28	action	action	NN
46745	1869	29	.	.	.
46745	1870	1	But	but	CC
46745	1870	2	there	there	EX
46745	1870	3	would	would	MD
46745	1870	4	be	be	VB
46745	1870	5	this	this	DT
46745	1870	6	difference	difference	NN
46745	1870	7	:	:	:
46745	1870	8	the	the	DT
46745	1870	9	alkali	alkali	NN
46745	1870	10	of	of	IN
46745	1870	11	the	the	DT
46745	1870	12	blood	blood	NN
46745	1870	13	would	would	MD
46745	1870	14	not	not	RB
46745	1870	15	be	be	VB
46745	1870	16	required	require	VBN
46745	1870	17	,	,	,
46745	1870	18	the	the	DT
46745	1870	19	acid	acid	NN
46745	1870	20	being	be	VBG
46745	1870	21	already	already	RB
46745	1870	22	combined	combine	VBN
46745	1870	23	with	with	IN
46745	1870	24	an	an	DT
46745	1870	25	alkali	alkali	NN
46745	1870	26	.	.	.
46745	1871	1	M.	M.	NNP
46745	1871	2	Wöhler	Wöhler	NNP
46745	1871	3	has	have	VBZ
46745	1871	4	found	find	VBN
46745	1871	5	that	that	IN
46745	1871	6	these	these	DT
46745	1871	7	vegetable	vegetable	JJ
46745	1871	8	-	-	HYPH
46745	1871	9	acid	acid	NN
46745	1871	10	salts	salt	NNS
46745	1871	11	always	always	RB
46745	1871	12	undergo	undergo	VBP
46745	1871	13	oxidation	oxidation	NN
46745	1871	14	in	in	IN
46745	1871	15	the	the	DT
46745	1871	16	system	system	NN
46745	1871	17	,	,	,
46745	1871	18	being	be	VBG
46745	1871	19	converted	convert	VBN
46745	1871	20	into	into	IN
46745	1871	21	carbonates	carbonate	NNS
46745	1871	22	or	or	CC
46745	1871	23	bicarbonates	bicarbonate	NNS
46745	1871	24	,	,	,
46745	1871	25	and	and	CC
46745	1871	26	thus	thus	RB
46745	1871	27	reacting	react	VBG
46745	1871	28	on	on	IN
46745	1871	29	the	the	DT
46745	1871	30	secretions	secretion	NNS
46745	1871	31	as	as	IN
46745	1871	32	alkalies	alkali	NNS
46745	1871	33	.	.	.
46745	1872	1	And	and	CC
46745	1872	2	so	so	RB
46745	1872	3	in	in	IN
46745	1872	4	the	the	DT
46745	1872	5	same	same	JJ
46745	1872	6	way	way	NN
46745	1872	7	it	-PRON-	PRP
46745	1872	8	seems	seem	VBZ
46745	1872	9	that	that	IN
46745	1872	10	the	the	DT
46745	1872	11	natural	natural	JJ
46745	1872	12	lactate	lactate	NN
46745	1872	13	of	of	IN
46745	1872	14	soda	soda	NN
46745	1872	15	is	be	VBZ
46745	1872	16	formed	form	VBN
46745	1872	17	into	into	IN
46745	1872	18	a	a	DT
46745	1872	19	carbonate	carbonate	NN
46745	1872	20	,	,	,
46745	1872	21	the	the	DT
46745	1872	22	carbonic	carbonic	JJ
46745	1872	23	acid	acid	NN
46745	1872	24	being	be	VBG
46745	1872	25	afterwards	afterwards	RB
46745	1872	26	freed	free	VBN
46745	1872	27	from	from	IN
46745	1872	28	the	the	DT
46745	1872	29	base	base	NN
46745	1872	30	,	,	,
46745	1872	31	to	to	TO
46745	1872	32	be	be	VB
46745	1872	33	excreted	excrete	VBN
46745	1872	34	by	by	IN
46745	1872	35	the	the	DT
46745	1872	36	lungs	lung	NNS
46745	1872	37	.	.	.
46745	1873	1	But	but	CC
46745	1873	2	by	by	IN
46745	1873	3	this	this	DT
46745	1873	4	natural	natural	JJ
46745	1873	5	process	process	NN
46745	1873	6	the	the	DT
46745	1873	7	quantity	quantity	NN
46745	1873	8	of	of	IN
46745	1873	9	alkali	alkali	JJ
46745	1873	10	in	in	IN
46745	1873	11	the	the	DT
46745	1873	12	blood	blood	NN
46745	1873	13	would	would	MD
46745	1873	14	not	not	RB
46745	1873	15	be	be	VB
46745	1873	16	increased	increase	VBN
46745	1873	17	,	,	,
46745	1873	18	nor	nor	CC
46745	1873	19	would	would	MD
46745	1873	20	it	-PRON-	PRP
46745	1873	21	be	be	VB
46745	1873	22	augmented	augment	VBN
46745	1873	23	by	by	IN
46745	1873	24	the	the	DT
46745	1873	25	action	action	NN
46745	1873	26	of	of	IN
46745	1873	27	a	a	DT
46745	1873	28	free	free	JJ
46745	1873	29	vegetable	vegetable	NN
46745	1873	30	acid	acid	NN
46745	1873	31	.	.	.
46745	1874	1	But	but	CC
46745	1874	2	the	the	DT
46745	1874	3	change	change	NN
46745	1874	4	undergone	undergo	VBN
46745	1874	5	by	by	IN
46745	1874	6	a	a	DT
46745	1874	7	salt	salt	NN
46745	1874	8	of	of	IN
46745	1874	9	this	this	DT
46745	1874	10	acid	acid	NN
46745	1874	11	would	would	MD
46745	1874	12	continually	continually	RB
46745	1874	13	add	add	VB
46745	1874	14	to	to	IN
46745	1874	15	the	the	DT
46745	1874	16	alkaline	alkaline	NN
46745	1874	17	matter	matter	NN
46745	1874	18	already	already	RB
46745	1874	19	in	in	IN
46745	1874	20	the	the	DT
46745	1874	21	system	system	NN
46745	1874	22	.	.	.
46745	1875	1	Now	now	RB
46745	1875	2	,	,	,
46745	1875	3	alkalies	alkali	NNS
46745	1875	4	have	have	VBP
46745	1875	5	a	a	DT
46745	1875	6	Catalytic	catalytic	JJ
46745	1875	7	action	action	NN
46745	1875	8	on	on	IN
46745	1875	9	the	the	DT
46745	1875	10	blood	blood	NN
46745	1875	11	,	,	,
46745	1875	12	which	which	WDT
46745	1875	13	may	may	MD
46745	1875	14	prove	prove	VB
46745	1875	15	useful	useful	JJ
46745	1875	16	in	in	IN
46745	1875	17	some	some	DT
46745	1875	18	sthenic	sthenic	JJ
46745	1875	19	fevers	fever	NNS
46745	1875	20	;	;	:
46745	1875	21	and	and	CC
46745	1875	22	therefore	therefore	RB
46745	1875	23	these	these	DT
46745	1875	24	salts	salt	NNS
46745	1875	25	have	have	VBP
46745	1875	26	a	a	DT
46745	1875	27	double	double	JJ
46745	1875	28	action	action	NN
46745	1875	29	,	,	,
46745	1875	30	and	and	CC
46745	1875	31	are	be	VBP
46745	1875	32	not	not	RB
46745	1875	33	simply	simply	RB
46745	1875	34	Restorative	restorative	JJ
46745	1875	35	.	.	.
46745	1876	1	(	(	-LRB-
46745	1876	2	_	_	NNP
46745	1876	3	Vide	Vide	NNP
46745	1876	4	Alkalies	Alkalies	NNP
46745	1876	5	_	_	NNP
46745	1876	6	;	;	:
46745	1876	7	_	_	NNP
46745	1876	8	Antiphlogistics	Antiphlogistics	NNP
46745	1876	9	_	_	NNP
46745	1876	10	;	;	:
46745	1876	11	_	_	NNP
46745	1876	12	Antiscorbutics	Antiscorbutics	NNP
46745	1876	13	_	_	NNP
46745	1876	14	.	.	.
46745	1876	15	)	)	-RRB-
46745	1877	1	Rheumatism	rheumatism	NN
46745	1877	2	and	and	CC
46745	1877	3	Gout	Gout	NNP
46745	1877	4	differ	differ	VBP
46745	1877	5	considerably	considerably	RB
46745	1877	6	from	from	IN
46745	1877	7	other	other	JJ
46745	1877	8	fevers	fever	NNS
46745	1877	9	,	,	,
46745	1877	10	both	both	CC
46745	1877	11	in	in	IN
46745	1877	12	their	-PRON-	PRP$
46745	1877	13	nature	nature	NN
46745	1877	14	,	,	,
46745	1877	15	and	and	CC
46745	1877	16	in	in	IN
46745	1877	17	the	the	DT
46745	1877	18	remedies	remedy	NNS
46745	1877	19	which	which	WDT
46745	1877	20	they	-PRON-	PRP
46745	1877	21	require	require	VBP
46745	1877	22	.	.	.
46745	1878	1	They	-PRON-	PRP
46745	1878	2	are	be	VBP
46745	1878	3	produced	produce	VBN
46745	1878	4	by	by	IN
46745	1878	5	special	special	JJ
46745	1878	6	morbid	morbid	NN
46745	1878	7	poisons	poison	NNS
46745	1878	8	or	or	CC
46745	1878	9	agencies	agency	NNS
46745	1878	10	,	,	,
46745	1878	11	which	which	WDT
46745	1878	12	we	-PRON-	PRP
46745	1878	13	are	be	VBP
46745	1878	14	enabled	enable	VBN
46745	1878	15	to	to	TO
46745	1878	16	counteract	counteract	VB
46745	1878	17	by	by	IN
46745	1878	18	certain	certain	JJ
46745	1878	19	Catalytic	catalytic	JJ
46745	1878	20	medicines	medicine	NNS
46745	1878	21	.	.	.
46745	1879	1	There	there	EX
46745	1879	2	is	be	VBZ
46745	1879	3	in	in	IN
46745	1879	4	both	both	DT
46745	1879	5	of	of	IN
46745	1879	6	them	-PRON-	PRP
46745	1879	7	an	an	DT
46745	1879	8	excess	excess	NN
46745	1879	9	of	of	IN
46745	1879	10	free	free	JJ
46745	1879	11	acid	acid	NN
46745	1879	12	formed	form	VBN
46745	1879	13	in	in	IN
46745	1879	14	the	the	DT
46745	1879	15	system	system	NN
46745	1879	16	.	.	.
46745	1880	1	Remedies	remedy	NNS
46745	1880	2	which	which	WDT
46745	1880	3	are	be	VBP
46745	1880	4	apparently	apparently	RB
46745	1880	5	opposed	oppose	VBN
46745	1880	6	in	in	IN
46745	1880	7	nature	nature	NN
46745	1880	8	have	have	VBP
46745	1880	9	proved	prove	VBN
46745	1880	10	useful	useful	JJ
46745	1880	11	in	in	IN
46745	1880	12	these	these	DT
46745	1880	13	complaints	complaint	NNS
46745	1880	14	.	.	.
46745	1881	1	On	on	IN
46745	1881	2	the	the	DT
46745	1881	3	Restorative	Restorative	NNP
46745	1881	4	plan	plan	NN
46745	1881	5	,	,	,
46745	1881	6	alkalies	alkali	NNS
46745	1881	7	are	be	VBP
46745	1881	8	the	the	DT
46745	1881	9	remedies	remedy	NNS
46745	1881	10	required	require	VBN
46745	1881	11	;	;	:
46745	1881	12	for	for	IN
46745	1881	13	they	-PRON-	PRP
46745	1881	14	neutralize	neutralize	VBP
46745	1881	15	the	the	DT
46745	1881	16	acid	acid	NN
46745	1881	17	.	.	.
46745	1882	1	But	but	CC
46745	1882	2	in	in	IN
46745	1882	3	spite	spite	NN
46745	1882	4	of	of	IN
46745	1882	5	this	this	DT
46745	1882	6	excess	excess	NN
46745	1882	7	of	of	IN
46745	1882	8	acid	acid	NN
46745	1882	9	,	,	,
46745	1882	10	some	some	DT
46745	1882	11	of	of	IN
46745	1882	12	the	the	DT
46745	1882	13	free	free	JJ
46745	1882	14	vegetable	vegetable	NN
46745	1882	15	acids	acid	NNS
46745	1882	16	have	have	VBP
46745	1882	17	been	be	VBN
46745	1882	18	used	use	VBN
46745	1882	19	with	with	IN
46745	1882	20	advantage	advantage	NN
46745	1882	21	,	,	,
46745	1882	22	particularly	particularly	RB
46745	1882	23	in	in	IN
46745	1882	24	rheumatic	rheumatic	JJ
46745	1882	25	cases	case	NNS
46745	1882	26	.	.	.
46745	1883	1	We	-PRON-	PRP
46745	1883	2	shall	shall	MD
46745	1883	3	have	have	VB
46745	1883	4	hereafter	hereafter	NN
46745	1883	5	to	to	TO
46745	1883	6	consider	consider	VB
46745	1883	7	how	how	WRB
46745	1883	8	far	far	RB
46745	1883	9	this	this	DT
46745	1883	10	operation	operation	NN
46745	1883	11	resembles	resemble	VBZ
46745	1883	12	the	the	DT
46745	1883	13	common	common	JJ
46745	1883	14	refrigerant	refrigerant	JJ
46745	1883	15	action	action	NN
46745	1883	16	of	of	IN
46745	1883	17	these	these	DT
46745	1883	18	remedies	remedy	NNS
46745	1883	19	just	just	RB
46745	1883	20	now	now	RB
46745	1883	21	considered	consider	VBN
46745	1883	22	.	.	.
46745	1884	1	(	(	-LRB-
46745	1884	2	_	_	NNP
46745	1884	3	Vide	Vide	NNP
46745	1884	4	Antiarthritics	Antiarthritics	NNP
46745	1884	5	.	.	.
46745	1884	6	_	_	NNP
46745	1884	7	)	)	-RRB-
46745	1884	8	Some	some	DT
46745	1884	9	obscurity	obscurity	NN
46745	1884	10	rests	rest	VBZ
46745	1884	11	upon	upon	IN
46745	1884	12	the	the	DT
46745	1884	13	subject	subject	NN
46745	1884	14	of	of	IN
46745	1884	15	the	the	DT
46745	1884	16	use	use	NN
46745	1884	17	of	of	IN
46745	1884	18	Citric	Citric	NNP
46745	1884	19	acid	acid	NN
46745	1884	20	in	in	IN
46745	1884	21	scurvy	scurvy	NN
46745	1884	22	;	;	:
46745	1884	23	but	but	CC
46745	1884	24	as	as	IN
46745	1884	25	it	-PRON-	PRP
46745	1884	26	seems	seem	VBZ
46745	1884	27	to	to	TO
46745	1884	28	partake	partake	VB
46745	1884	29	rather	rather	RB
46745	1884	30	of	of	IN
46745	1884	31	the	the	DT
46745	1884	32	nature	nature	NN
46745	1884	33	of	of	IN
46745	1884	34	a	a	DT
46745	1884	35	Catalytic	catalytic	JJ
46745	1884	36	than	than	IN
46745	1884	37	of	of	IN
46745	1884	38	a	a	DT
46745	1884	39	Restorative	restorative	JJ
46745	1884	40	action	action	NN
46745	1884	41	,	,	,
46745	1884	42	I	-PRON-	PRP
46745	1884	43	have	have	VBP
46745	1884	44	placed	place	VBN
46745	1884	45	Antiscorbutics	antiscorbutic	NNS
46745	1884	46	in	in	IN
46745	1884	47	the	the	DT
46745	1884	48	second	second	JJ
46745	1884	49	division	division	NN
46745	1884	50	.	.	.
46745	1885	1	Now	now	RB
46745	1885	2	,	,	,
46745	1885	3	though	though	IN
46745	1885	4	there	there	EX
46745	1885	5	are	be	VBP
46745	1885	6	possibly	possibly	RB
46745	1885	7	some	some	DT
46745	1885	8	exceptions	exception	NNS
46745	1885	9	,	,	,
46745	1885	10	yet	yet	CC
46745	1885	11	in	in	IN
46745	1885	12	most	most	JJS
46745	1885	13	cases	case	NNS
46745	1885	14	Acids	Acids	NNPS
46745	1885	15	act	act	VBP
46745	1885	16	as	as	IN
46745	1885	17	simple	simple	JJ
46745	1885	18	Restoratives	restorative	NNS
46745	1885	19	;	;	:
46745	1885	20	but	but	CC
46745	1885	21	Alkalies	alkali	NNS
46745	1885	22	certainly	certainly	RB
46745	1885	23	operate	operate	VBP
46745	1885	24	as	as	IN
46745	1885	25	Catalytics	Catalytics	NNP
46745	1885	26	in	in	IN
46745	1885	27	some	some	DT
46745	1885	28	disorders	disorder	NNS
46745	1885	29	,	,	,
46745	1885	30	and	and	CC
46745	1885	31	have	have	VBP
46745	1885	32	thus	thus	RB
46745	1885	33	to	to	TO
46745	1885	34	be	be	VB
46745	1885	35	included	include	VBN
46745	1885	36	in	in	IN
46745	1885	37	both	both	DT
46745	1885	38	divisions	division	NNS
46745	1885	39	of	of	IN
46745	1885	40	Hæmatic	hæmatic	JJ
46745	1885	41	medicines	medicine	NNS
46745	1885	42	.	.	.
46745	1886	1	ORD	ORD	NNP
46745	1886	2	.	.	.
46745	1887	1	III	iii	CD
46745	1887	2	.	.	.
46745	1888	1	ALKALIES	ALKALIES	NNP
46745	1888	2	.	.	.
46745	1889	1	(	(	-LRB-
46745	1889	2	Potash	Potash	NNP
46745	1889	3	,	,	,
46745	1889	4	Soda	Soda	NNP
46745	1889	5	,	,	,
46745	1889	6	Ammonia	Ammonia	NNP
46745	1889	7	,	,	,
46745	1889	8	Lime	Lime	NNP
46745	1889	9	,	,	,
46745	1889	10	Magnesia;--their	Magnesia;--their	NNP
46745	1889	11	Carbonates	Carbonates	NNPS
46745	1889	12	,	,	,
46745	1889	13	and	and	CC
46745	1889	14	neutral	neutral	JJ
46745	1889	15	Acetates	Acetates	NNPS
46745	1889	16	,	,	,
46745	1889	17	Citrates	Citrates	NNPS
46745	1889	18	,	,	,
46745	1889	19	and	and	CC
46745	1889	20	Tartrates	Tartrates	NNPS
46745	1889	21	.	.	.
46745	1889	22	)	)	-RRB-
46745	1890	1	We	-PRON-	PRP
46745	1890	2	have	have	VBP
46745	1890	3	to	to	TO
46745	1890	4	consider	consider	VB
46745	1890	5	the	the	DT
46745	1890	6	alkalies	alkali	NNS
46745	1890	7	now	now	RB
46745	1890	8	as	as	IN
46745	1890	9	Restoratives	restorative	NNS
46745	1890	10	--	--	:
46745	1890	11	treating	treat	VBG
46745	1890	12	of	of	IN
46745	1890	13	those	those	DT
46745	1890	14	cases	case	NNS
46745	1890	15	only	only	RB
46745	1890	16	in	in	IN
46745	1890	17	which	which	WDT
46745	1890	18	they	-PRON-	PRP
46745	1890	19	are	be	VBP
46745	1890	20	used	use	VBN
46745	1890	21	to	to	TO
46745	1890	22	restore	restore	VB
46745	1890	23	a	a	DT
46745	1890	24	wanting	want	VBG
46745	1890	25	material	material	NN
46745	1890	26	to	to	IN
46745	1890	27	the	the	DT
46745	1890	28	blood	blood	NN
46745	1890	29	or	or	CC
46745	1890	30	fluids	fluid	NNS
46745	1890	31	of	of	IN
46745	1890	32	the	the	DT
46745	1890	33	body	body	NN
46745	1890	34	.	.	.
46745	1891	1	That	that	IN
46745	1891	2	they	-PRON-	PRP
46745	1891	3	pass	pass	VBP
46745	1891	4	into	into	IN
46745	1891	5	the	the	DT
46745	1891	6	blood	blood	NN
46745	1891	7	,	,	,
46745	1891	8	is	be	VBZ
46745	1891	9	proved	prove	VBN
46745	1891	10	by	by	IN
46745	1891	11	their	-PRON-	PRP$
46745	1891	12	solubility	solubility	NN
46745	1891	13	,	,	,
46745	1891	14	and	and	CC
46745	1891	15	their	-PRON-	PRP$
46745	1891	16	appearance	appearance	NN
46745	1891	17	in	in	IN
46745	1891	18	the	the	DT
46745	1891	19	secretions	secretion	NNS
46745	1891	20	;	;	:
46745	1891	21	and	and	CC
46745	1891	22	that	that	IN
46745	1891	23	they	-PRON-	PRP
46745	1891	24	are	be	VBP
46745	1891	25	natural	natural	JJ
46745	1891	26	to	to	IN
46745	1891	27	it	-PRON-	PRP
46745	1891	28	we	-PRON-	PRP
46745	1891	29	know	know	VBP
46745	1891	30	,	,	,
46745	1891	31	because	because	IN
46745	1891	32	they	-PRON-	PRP
46745	1891	33	are	be	VBP
46745	1891	34	all	all	DT
46745	1891	35	found	find	VBN
46745	1891	36	in	in	IN
46745	1891	37	it	-PRON-	PRP
46745	1891	38	.	.	.
46745	1892	1	Wöhler	Wöhler	NNP
46745	1892	2	has	have	VBZ
46745	1892	3	demonstrated	demonstrate	VBN
46745	1892	4	the	the	DT
46745	1892	5	curious	curious	JJ
46745	1892	6	fact	fact	NN
46745	1892	7	that	that	IN
46745	1892	8	the	the	DT
46745	1892	9	neutral	neutral	JJ
46745	1892	10	salts	salt	NNS
46745	1892	11	of	of	IN
46745	1892	12	the	the	DT
46745	1892	13	alkalies	alkali	NNS
46745	1892	14	with	with	IN
46745	1892	15	vegetable	vegetable	JJ
46745	1892	16	acids	acid	NNS
46745	1892	17	undergo	undergo	VBP
46745	1892	18	oxidation	oxidation	NN
46745	1892	19	in	in	IN
46745	1892	20	the	the	DT
46745	1892	21	blood	blood	NN
46745	1892	22	,	,	,
46745	1892	23	being	be	VBG
46745	1892	24	transformed	transform	VBN
46745	1892	25	into	into	IN
46745	1892	26	carbonates	carbonate	NNS
46745	1892	27	.	.	.
46745	1893	1	(	(	-LRB-
46745	1893	2	I	-PRON-	PRP
46745	1893	3	have	have	VBP
46745	1893	4	just	just	RB
46745	1893	5	said	say	VBN
46745	1893	6	that	that	IN
46745	1893	7	it	-PRON-	PRP
46745	1893	8	seems	seem	VBZ
46745	1893	9	likely	likely	JJ
46745	1893	10	that	that	IN
46745	1893	11	certain	certain	JJ
46745	1893	12	conditions	condition	NNS
46745	1893	13	of	of	IN
46745	1893	14	the	the	DT
46745	1893	15	system	system	NN
46745	1893	16	may	may	MD
46745	1893	17	determine	determine	VB
46745	1893	18	this	this	DT
46745	1893	19	oxidation	oxidation	NN
46745	1893	20	,	,	,
46745	1893	21	even	even	RB
46745	1893	22	in	in	IN
46745	1893	23	the	the	DT
46745	1893	24	case	case	NN
46745	1893	25	of	of	IN
46745	1893	26	the	the	DT
46745	1893	27	free	free	JJ
46745	1893	28	acids	acid	NNS
46745	1893	29	.	.	.
46745	1893	30	)	)	-RRB-
46745	1894	1	Thus	thus	RB
46745	1894	2	it	-PRON-	PRP
46745	1894	3	may	may	MD
46745	1894	4	be	be	VB
46745	1894	5	easily	easily	RB
46745	1894	6	shown	show	VBN
46745	1894	7	how	how	WRB
46745	1894	8	the	the	DT
46745	1894	9	neutral	neutral	JJ
46745	1894	10	(	(	-LRB-
46745	1894	11	bibasic	bibasic	JJ
46745	1894	12	)	)	-RRB-
46745	1894	13	tartrate	tartrate	NN
46745	1894	14	of	of	IN
46745	1894	15	potash	potash	NNP
46745	1894	16	may	may	MD
46745	1894	17	,	,	,
46745	1894	18	with	with	IN
46745	1894	19	the	the	DT
46745	1894	20	addition	addition	NN
46745	1894	21	of	of	IN
46745	1894	22	ten	ten	CD
46745	1894	23	atoms	atom	NNS
46745	1894	24	of	of	IN
46745	1894	25	oxygen	oxygen	NN
46745	1894	26	,	,	,
46745	1894	27	produce	produce	VB
46745	1894	28	two	two	CD
46745	1894	29	equivalents	equivalent	NNS
46745	1894	30	of	of	IN
46745	1894	31	bicarbonate	bicarbonate	NN
46745	1894	32	of	of	IN
46745	1894	33	potash	potash	NN
46745	1894	34	,	,	,
46745	1894	35	together	together	RB
46745	1894	36	with	with	IN
46745	1894	37	four	four	CD
46745	1894	38	of	of	IN
46745	1894	39	carbonic	carbonic	JJ
46745	1894	40	acid	acid	NN
46745	1894	41	and	and	CC
46745	1894	42	four	four	CD
46745	1894	43	of	of	IN
46745	1894	44	water	water	NN
46745	1894	45	.	.	.
46745	1895	1	2	2	CD
46745	1895	2	KO	KO	NNP
46745	1895	3	,	,	,
46745	1895	4	C_{8}H_{4}O_{10	C_{8}H_{4}O_{10	NNP
46745	1895	5	}	}	-RRB-
46745	1895	6	+	+	CC
46745	1895	7	10	10	CD
46745	1895	8	O=2	O=2	NNP
46745	1895	9	KO	KO	NNP
46745	1895	10	+	+	SYM
46745	1895	11	8	8	CD
46745	1895	12	CO_{2	CO_{2	NNP
46745	1895	13	}	}	-RRB-
46745	1895	14	+	+	CC
46745	1895	15	4	4	CD
46745	1895	16	HO	HO	NNP
46745	1895	17	.	.	.
46745	1896	1	_	_	NNP
46745	1896	2	_	_	NNP
46745	1896	3	_	_	NNP
46745	1896	4	_	_	NNP
46745	1896	5	_	_	NNP
46745	1896	6	_	_	NNP
46745	1896	7	_	_	NNP
46745	1896	8	_	_	NNP
46745	1896	9	_	_	NNP
46745	1896	10	_	_	NNP
46745	1896	11	_	_	NNP
46745	1896	12	_	_	NNP
46745	1896	13	=	=	SYM
46745	1896	14	2(KO	2(KO	NNP
46745	1896	15	,	,	,
46745	1896	16	2	2	CD
46745	1896	17	CO_{2	CO_{2	NNP
46745	1896	18	}	}	-RRB-
46745	1896	19	)	)	-RRB-
46745	1896	20	+	+	NFP
46745	1896	21	(	(	-LRB-
46745	1896	22	4	4	CD
46745	1896	23	CO_{2	CO_{2	NNP
46745	1896	24	}	}	-RRB-
46745	1896	25	+	+	CC
46745	1896	26	4	4	CD
46745	1896	27	HO	HO	NNP
46745	1896	28	.	.	.
46745	1896	29	)	)	-RRB-
46745	1897	1	Again	again	RB
46745	1897	2	,	,	,
46745	1897	3	one	one	CD
46745	1897	4	equivalent	equivalent	NN
46745	1897	5	of	of	IN
46745	1897	6	the	the	DT
46745	1897	7	neutral	neutral	JJ
46745	1897	8	acetate	acetate	NN
46745	1897	9	of	of	IN
46745	1897	10	potash	potash	NN
46745	1897	11	,	,	,
46745	1897	12	with	with	IN
46745	1897	13	eight	eight	CD
46745	1897	14	of	of	IN
46745	1897	15	Oxygen	Oxygen	NNP
46745	1897	16	,	,	,
46745	1897	17	will	will	MD
46745	1897	18	make	make	VB
46745	1897	19	one	one	CD
46745	1897	20	equivalent	equivalent	NN
46745	1897	21	of	of	IN
46745	1897	22	the	the	DT
46745	1897	23	bicarbonate	bicarbonate	NN
46745	1897	24	,	,	,
46745	1897	25	two	two	CD
46745	1897	26	of	of	IN
46745	1897	27	free	free	JJ
46745	1897	28	carbonic	carbonic	JJ
46745	1897	29	acid	acid	NN
46745	1897	30	,	,	,
46745	1897	31	and	and	CC
46745	1897	32	three	three	CD
46745	1897	33	of	of	IN
46745	1897	34	water	water	NN
46745	1897	35	.	.	.
46745	1898	1	KO	KO	NNP
46745	1898	2	,	,	,
46745	1898	3	C_{4}H_{3}O_{3	C_{4}H_{3}O_{3	NNP
46745	1898	4	}	}	-RRB-
46745	1898	5	+	+	CC
46745	1898	6	8	8	CD
46745	1898	7	O	o	NN
46745	1898	8	=	=	SYM
46745	1898	9	KO	KO	NNP
46745	1898	10	+	+	SYM
46745	1898	11	4	4	CD
46745	1898	12	CO_{2	CO_{2	NNP
46745	1898	13	}	}	-RRB-
46745	1898	14	+	+	CC
46745	1898	15	3	3	CD
46745	1898	16	HO	HO	NNP
46745	1898	17	.	.	.
46745	1899	1	_	_	NNP
46745	1899	2	_	_	NNP
46745	1899	3	_	_	NNP
46745	1899	4	_	_	NNP
46745	1899	5	_	_	NNP
46745	1899	6	_	_	NNP
46745	1899	7	_	_	NNP
46745	1899	8	_	_	NNP
46745	1899	9	_	_	NNP
46745	1899	10	_	_	NNP
46745	1899	11	_	_	NNP
46745	1899	12	_	_	NNP
46745	1899	13	=	=	SYM
46745	1899	14	KO	KO	NNP
46745	1899	15	,	,	,
46745	1899	16	2	2	CD
46745	1899	17	CO_{2	CO_{2	NNP
46745	1899	18	}	}	-RRB-
46745	1899	19	+	+	CC
46745	1899	20	(	(	-LRB-
46745	1899	21	2	2	CD
46745	1899	22	CO_{2	CO_{2	NNP
46745	1899	23	}	}	-RRB-
46745	1899	24	+	+	CC
46745	1899	25	3	3	CD
46745	1899	26	HO	HO	NNP
46745	1899	27	.	.	.
46745	1899	28	)	)	-RRB-
46745	1900	1	This	this	DT
46745	1900	2	carbonate	carbonate	NN
46745	1900	3	,	,	,
46745	1900	4	easily	easily	RB
46745	1900	5	decomposed	decompose	VBN
46745	1900	6	by	by	IN
46745	1900	7	any	any	DT
46745	1900	8	acid	acid	NN
46745	1900	9	,	,	,
46745	1900	10	is	be	VBZ
46745	1900	11	equivalent	equivalent	JJ
46745	1900	12	to	to	IN
46745	1900	13	a	a	DT
46745	1900	14	free	free	JJ
46745	1900	15	alkali	alkali	NN
46745	1900	16	.	.	.
46745	1901	1	Thus	thus	RB
46745	1901	2	these	these	DT
46745	1901	3	salts	salt	NNS
46745	1901	4	fulfil	fulfil	VBP
46745	1901	5	a	a	DT
46745	1901	6	double	double	JJ
46745	1901	7	function	function	NN
46745	1901	8	.	.	.
46745	1902	1	They	-PRON-	PRP
46745	1902	2	may	may	MD
46745	1902	3	supply	supply	VB
46745	1902	4	the	the	DT
46745	1902	5	respiratory	respiratory	JJ
46745	1902	6	process	process	NN
46745	1902	7	,	,	,
46745	1902	8	as	as	IN
46745	1902	9	has	have	VBZ
46745	1902	10	already	already	RB
46745	1902	11	been	be	VBN
46745	1902	12	explained	explain	VBN
46745	1902	13	.	.	.
46745	1903	1	They	-PRON-	PRP
46745	1903	2	also	also	RB
46745	1903	3	act	act	VBP
46745	1903	4	on	on	IN
46745	1903	5	the	the	DT
46745	1903	6	blood	blood	NN
46745	1903	7	,	,	,
46745	1903	8	and	and	CC
46745	1903	9	on	on	IN
46745	1903	10	the	the	DT
46745	1903	11	secretions	secretion	NNS
46745	1903	12	,	,	,
46745	1903	13	as	as	IN
46745	1903	14	alkalies	alkali	NNS
46745	1903	15	.	.	.
46745	1904	1	Alkalies	alkali	NNS
46745	1904	2	are	be	VBP
46745	1904	3	used	use	VBN
46745	1904	4	wherever	wherever	WRB
46745	1904	5	there	there	EX
46745	1904	6	is	be	VBZ
46745	1904	7	an	an	DT
46745	1904	8	excess	excess	NN
46745	1904	9	of	of	IN
46745	1904	10	acid	acid	NN
46745	1904	11	in	in	IN
46745	1904	12	the	the	DT
46745	1904	13	system	system	NN
46745	1904	14	,	,	,
46745	1904	15	whatever	whatever	WDT
46745	1904	16	that	that	DT
46745	1904	17	acid	acid	NN
46745	1904	18	may	may	MD
46745	1904	19	be	be	VB
46745	1904	20	.	.	.
46745	1905	1	Alkali	Alkali	NNP
46745	1905	2	should	should	MD
46745	1905	3	naturally	naturally	RB
46745	1905	4	be	be	VB
46745	1905	5	present	present	JJ
46745	1905	6	to	to	TO
46745	1905	7	neutralize	neutralize	VB
46745	1905	8	it	-PRON-	PRP
46745	1905	9	,	,	,
46745	1905	10	for	for	IN
46745	1905	11	it	-PRON-	PRP
46745	1905	12	is	be	VBZ
46745	1905	13	unnatural	unnatural	JJ
46745	1905	14	to	to	TO
46745	1905	15	have	have	VB
46745	1905	16	a	a	DT
46745	1905	17	large	large	JJ
46745	1905	18	excess	excess	NN
46745	1905	19	of	of	IN
46745	1905	20	acid	acid	NN
46745	1905	21	in	in	IN
46745	1905	22	the	the	DT
46745	1905	23	secretions	secretion	NNS
46745	1905	24	,	,	,
46745	1905	25	or	or	CC
46745	1905	26	any	any	DT
46745	1905	27	excess	excess	NN
46745	1905	28	in	in	IN
46745	1905	29	the	the	DT
46745	1905	30	blood	blood	NN
46745	1905	31	.	.	.
46745	1906	1	We	-PRON-	PRP
46745	1906	2	thus	thus	RB
46745	1906	3	administer	administer	VBP
46745	1906	4	alkalies	alkali	NNS
46745	1906	5	on	on	IN
46745	1906	6	the	the	DT
46745	1906	7	restorative	restorative	JJ
46745	1906	8	principle	principle	NN
46745	1906	9	.	.	.
46745	1907	1	They	-PRON-	PRP
46745	1907	2	are	be	VBP
46745	1907	3	not	not	RB
46745	1907	4	always	always	RB
46745	1907	5	excreted	excrete	VBN
46745	1907	6	;	;	:
46745	1907	7	but	but	CC
46745	1907	8	whether	whether	IN
46745	1907	9	excreted	excreted	JJ
46745	1907	10	or	or	CC
46745	1907	11	not	not	RB
46745	1907	12	,	,	,
46745	1907	13	they	-PRON-	PRP
46745	1907	14	tend	tend	VBP
46745	1907	15	to	to	TO
46745	1907	16	render	render	VB
46745	1907	17	the	the	DT
46745	1907	18	secretions	secretion	NNS
46745	1907	19	neutral	neutral	JJ
46745	1907	20	and	and	CC
46745	1907	21	alkaline	alkaline	VB
46745	1907	22	by	by	IN
46745	1907	23	increasing	increase	VBG
46745	1907	24	the	the	DT
46745	1907	25	quantity	quantity	NN
46745	1907	26	of	of	IN
46745	1907	27	basic	basic	JJ
46745	1907	28	matter	matter	NN
46745	1907	29	in	in	IN
46745	1907	30	the	the	DT
46745	1907	31	system	system	NN
46745	1907	32	.	.	.
46745	1908	1	Alkalies	alkali	NNS
46745	1908	2	being	be	VBG
46745	1908	3	more	more	RBR
46745	1908	4	stable	stable	JJ
46745	1908	5	than	than	IN
46745	1908	6	acids	acid	NNS
46745	1908	7	,	,	,
46745	1908	8	and	and	CC
46745	1908	9	being	be	VBG
46745	1908	10	more	more	RBR
46745	1908	11	invariably	invariably	RB
46745	1908	12	secreted	secrete	VBN
46745	1908	13	by	by	IN
46745	1908	14	the	the	DT
46745	1908	15	kidneys	kidney	NNS
46745	1908	16	,	,	,
46745	1908	17	it	-PRON-	PRP
46745	1908	18	is	be	VBZ
46745	1908	19	more	more	RBR
46745	1908	20	easy	easy	JJ
46745	1908	21	to	to	TO
46745	1908	22	render	render	VB
46745	1908	23	the	the	DT
46745	1908	24	urine	urine	NN
46745	1908	25	alkaline	alkaline	NN
46745	1908	26	than	than	IN
46745	1908	27	to	to	TO
46745	1908	28	make	make	VB
46745	1908	29	it	-PRON-	PRP
46745	1908	30	acid	acid	VB
46745	1908	31	.	.	.
46745	1909	1	Alkalies	alkali	NNS
46745	1909	2	are	be	VBP
46745	1909	3	thus	thus	RB
46745	1909	4	of	of	IN
46745	1909	5	use	use	NN
46745	1909	6	in	in	IN
46745	1909	7	a	a	DT
46745	1909	8	tendency	tendency	NN
46745	1909	9	to	to	IN
46745	1909	10	lithic	lithic	JJ
46745	1909	11	acid	acid	NN
46745	1909	12	deposit	deposit	NN
46745	1909	13	.	.	.
46745	1910	1	The	the	DT
46745	1910	2	bicarbonates	bicarbonate	NNS
46745	1910	3	are	be	VBP
46745	1910	4	probably	probably	RB
46745	1910	5	the	the	DT
46745	1910	6	best	good	JJS
46745	1910	7	for	for	IN
46745	1910	8	this	this	DT
46745	1910	9	purpose	purpose	NN
46745	1910	10	,	,	,
46745	1910	11	for	for	IN
46745	1910	12	they	-PRON-	PRP
46745	1910	13	may	may	MD
46745	1910	14	be	be	VB
46745	1910	15	given	give	VBN
46745	1910	16	in	in	IN
46745	1910	17	large	large	JJ
46745	1910	18	doses	dose	NNS
46745	1910	19	,	,	,
46745	1910	20	being	be	VBG
46745	1910	21	less	less	RBR
46745	1910	22	irritating	irritating	JJ
46745	1910	23	.	.	.
46745	1911	1	The	the	DT
46745	1911	2	celebrated	celebrated	JJ
46745	1911	3	Vichy	Vichy	NNP
46745	1911	4	water	water	NN
46745	1911	5	contains	contain	VBZ
46745	1911	6	bicarbonate	bicarbonate	NN
46745	1911	7	of	of	IN
46745	1911	8	soda	soda	NN
46745	1911	9	.	.	.
46745	1912	1	Lime	lime	NN
46745	1912	2	-	-	HYPH
46745	1912	3	water	water	NN
46745	1912	4	has	have	VBZ
46745	1912	5	been	be	VBN
46745	1912	6	used	use	VBN
46745	1912	7	as	as	IN
46745	1912	8	a	a	DT
46745	1912	9	solvent	solvent	NN
46745	1912	10	for	for	IN
46745	1912	11	stone	stone	NN
46745	1912	12	.	.	.
46745	1913	1	These	these	DT
46745	1913	2	all	all	DT
46745	1913	3	act	act	VBP
46745	1913	4	by	by	IN
46745	1913	5	first	first	RB
46745	1913	6	diminishing	diminish	VBG
46745	1913	7	the	the	DT
46745	1913	8	acid	acid	NN
46745	1913	9	of	of	IN
46745	1913	10	the	the	DT
46745	1913	11	blood	blood	NN
46745	1913	12	,	,	,
46745	1913	13	and	and	CC
46745	1913	14	subsequently	subsequently	RB
46745	1913	15	influencing	influence	VBG
46745	1913	16	the	the	DT
46745	1913	17	secretion	secretion	NN
46745	1913	18	of	of	IN
46745	1913	19	the	the	DT
46745	1913	20	urine	urine	NN
46745	1913	21	,	,	,
46745	1913	22	which	which	WDT
46745	1913	23	secretion	secretion	NN
46745	1913	24	,	,	,
46745	1913	25	acting	act	VBG
46745	1913	26	as	as	IN
46745	1913	27	a	a	DT
46745	1913	28	counterpoise	counterpoise	NN
46745	1913	29	to	to	IN
46745	1913	30	the	the	DT
46745	1913	31	condition	condition	NN
46745	1913	32	of	of	IN
46745	1913	33	the	the	DT
46745	1913	34	blood	blood	NN
46745	1913	35	,	,	,
46745	1913	36	may	may	MD
46745	1913	37	be	be	VB
46745	1913	38	generally	generally	RB
46745	1913	39	taken	take	VBN
46745	1913	40	as	as	IN
46745	1913	41	an	an	DT
46745	1913	42	index	index	NN
46745	1913	43	to	to	IN
46745	1913	44	it	-PRON-	PRP
46745	1913	45	.	.	.
46745	1914	1	Dr.	Dr.	NNP
46745	1914	2	Pereira	Pereira	NNP
46745	1914	3	recommends	recommend	VBZ
46745	1914	4	alkalies	alkali	NNS
46745	1914	5	in	in	IN
46745	1914	6	cases	case	NNS
46745	1914	7	of	of	IN
46745	1914	8	dyspepsia	dyspepsia	NN
46745	1914	9	and	and	CC
46745	1914	10	pyrosis	pyrosis	NN
46745	1914	11	,	,	,
46745	1914	12	when	when	WRB
46745	1914	13	there	there	EX
46745	1914	14	is	be	VBZ
46745	1914	15	an	an	DT
46745	1914	16	excess	excess	NN
46745	1914	17	of	of	IN
46745	1914	18	acid	acid	NN
46745	1914	19	secreted	secrete	VBN
46745	1914	20	by	by	IN
46745	1914	21	the	the	DT
46745	1914	22	stomach	stomach	NN
46745	1914	23	.	.	.
46745	1915	1	He	-PRON-	PRP
46745	1915	2	further	further	RB
46745	1915	3	thinks	think	VBZ
46745	1915	4	it	-PRON-	PRP
46745	1915	5	likely	likely	JJ
46745	1915	6	that	that	IN
46745	1915	7	they	-PRON-	PRP
46745	1915	8	may	may	MD
46745	1915	9	aid	aid	VB
46745	1915	10	in	in	IN
46745	1915	11	the	the	DT
46745	1915	12	digestion	digestion	NN
46745	1915	13	of	of	IN
46745	1915	14	fatty	fatty	NN
46745	1915	15	substances	substance	NNS
46745	1915	16	when	when	WRB
46745	1915	17	there	there	EX
46745	1915	18	is	be	VBZ
46745	1915	19	a	a	DT
46745	1915	20	deficiency	deficiency	NN
46745	1915	21	of	of	IN
46745	1915	22	bile	bile	NN
46745	1915	23	.	.	.
46745	1916	1	This	this	DT
46745	1916	2	is	be	VBZ
46745	1916	3	quite	quite	RB
46745	1916	4	hypothetical	hypothetical	JJ
46745	1916	5	,	,	,
46745	1916	6	and	and	CC
46745	1916	7	depends	depend	VBZ
46745	1916	8	upon	upon	IN
46745	1916	9	a	a	DT
46745	1916	10	theory	theory	NN
46745	1916	11	which	which	WDT
46745	1916	12	has	have	VBZ
46745	1916	13	been	be	VBN
46745	1916	14	shaken	shake	VBN
46745	1916	15	by	by	IN
46745	1916	16	M.	M.	NNP
46745	1916	17	Bernard	Bernard	NNP
46745	1916	18	.	.	.
46745	1917	1	The	the	DT
46745	1917	2	same	same	JJ
46745	1917	3	eminent	eminent	JJ
46745	1917	4	authority	authority	NN
46745	1917	5	states	state	VBZ
46745	1917	6	that	that	IN
46745	1917	7	Ammonia	Ammonia	NNP
46745	1917	8	invariably	invariably	RB
46745	1917	9	enters	enter	VBZ
46745	1917	10	the	the	DT
46745	1917	11	blood	blood	NN
46745	1917	12	as	as	IN
46745	1917	13	a	a	DT
46745	1917	14	salt	salt	NN
46745	1917	15	,	,	,
46745	1917	16	and	and	CC
46745	1917	17	thus	thus	RB
46745	1917	18	can	can	MD
46745	1917	19	exert	exert	VB
46745	1917	20	no	no	DT
46745	1917	21	peculiar	peculiar	JJ
46745	1917	22	action	action	NN
46745	1917	23	beyond	beyond	IN
46745	1917	24	the	the	DT
46745	1917	25	coats	coat	NNS
46745	1917	26	of	of	IN
46745	1917	27	the	the	DT
46745	1917	28	stomach	stomach	NN
46745	1917	29	.	.	.
46745	1918	1	I	-PRON-	PRP
46745	1918	2	shall	shall	MD
46745	1918	3	state	state	VB
46745	1918	4	my	-PRON-	PRP$
46745	1918	5	reasons	reason	NNS
46745	1918	6	for	for	IN
46745	1918	7	doubting	doubt	VBG
46745	1918	8	this	this	DT
46745	1918	9	when	when	WRB
46745	1918	10	I	-PRON-	PRP
46745	1918	11	consider	consider	VBP
46745	1918	12	Ammonia	Ammonia	NNP
46745	1918	13	separately	separately	RB
46745	1918	14	in	in	IN
46745	1918	15	Chapter	Chapter	NNP
46745	1918	16	IV	IV	NNP
46745	1918	17	.	.	.
46745	1919	1	Ammonia	Ammonia	NNP
46745	1919	2	will	will	MD
46745	1919	3	be	be	VB
46745	1919	4	again	again	RB
46745	1919	5	enumerated	enumerate	VBN
46745	1919	6	as	as	IN
46745	1919	7	a	a	DT
46745	1919	8	stimulant	stimulant	NN
46745	1919	9	--	--	:
46745	1919	10	Potash	Potash	NNP
46745	1919	11	as	as	IN
46745	1919	12	a	a	DT
46745	1919	13	catalytic	catalytic	JJ
46745	1919	14	--	--	:
46745	1919	15	and	and	CC
46745	1919	16	lastly	lastly	RB
46745	1919	17	,	,	,
46745	1919	18	all	all	PDT
46745	1919	19	the	the	DT
46745	1919	20	alkalies	alkali	NNS
46745	1919	21	as	as	IN
46745	1919	22	diuretics	diuretic	NNS
46745	1919	23	.	.	.
46745	1920	1	The	the	DT
46745	1920	2	alkalies	alkali	NNS
46745	1920	3	are	be	VBP
46745	1920	4	useful	useful	JJ
46745	1920	5	in	in	IN
46745	1920	6	gout	gout	NN
46745	1920	7	and	and	CC
46745	1920	8	rheumatism	rheumatism	NN
46745	1920	9	in	in	IN
46745	1920	10	diminishing	diminish	VBG
46745	1920	11	the	the	DT
46745	1920	12	acidity	acidity	NN
46745	1920	13	both	both	DT
46745	1920	14	of	of	IN
46745	1920	15	the	the	DT
46745	1920	16	blood	blood	NN
46745	1920	17	and	and	CC
46745	1920	18	of	of	IN
46745	1920	19	the	the	DT
46745	1920	20	secretions	secretion	NNS
46745	1920	21	.	.	.
46745	1921	1	It	-PRON-	PRP
46745	1921	2	is	be	VBZ
46745	1921	3	often	often	RB
46745	1921	4	advantageous	advantageous	JJ
46745	1921	5	to	to	TO
46745	1921	6	apply	apply	VB
46745	1921	7	an	an	DT
46745	1921	8	alkaline	alkaline	NN
46745	1921	9	wash	wash	NN
46745	1921	10	locally	locally	RB
46745	1921	11	around	around	IN
46745	1921	12	an	an	DT
46745	1921	13	affected	affect	VBN
46745	1921	14	joint	joint	NN
46745	1921	15	,	,	,
46745	1921	16	in	in	IN
46745	1921	17	the	the	DT
46745	1921	18	fluids	fluid	NNS
46745	1921	19	about	about	IN
46745	1921	20	which	which	WDT
46745	1921	21	the	the	DT
46745	1921	22	morbid	morbid	NN
46745	1921	23	process	process	NN
46745	1921	24	seems	seem	VBZ
46745	1921	25	especially	especially	RB
46745	1921	26	to	to	TO
46745	1921	27	have	have	VB
46745	1921	28	fixed	fix	VBN
46745	1921	29	itself	-PRON-	PRP
46745	1921	30	.	.	.
46745	1922	1	If	if	IN
46745	1922	2	we	-PRON-	PRP
46745	1922	3	may	may	MD
46745	1922	4	receive	receive	VB
46745	1922	5	a	a	DT
46745	1922	6	certain	certain	JJ
46745	1922	7	theoretical	theoretical	JJ
46745	1922	8	explanation	explanation	NN
46745	1922	9	of	of	IN
46745	1922	10	these	these	DT
46745	1922	11	two	two	CD
46745	1922	12	kindred	kindred	JJ
46745	1922	13	diseases	disease	NNS
46745	1922	14	,	,	,
46745	1922	15	still	still	RB
46745	1922	16	more	more	JJR
46745	1922	17	light	light	NN
46745	1922	18	will	will	MD
46745	1922	19	be	be	VB
46745	1922	20	thrown	throw	VBN
46745	1922	21	on	on	IN
46745	1922	22	the	the	DT
46745	1922	23	advantage	advantage	NN
46745	1922	24	attending	attend	VBG
46745	1922	25	the	the	DT
46745	1922	26	employment	employment	NN
46745	1922	27	of	of	IN
46745	1922	28	alkaline	alkaline	NN
46745	1922	29	restoratives	restorative	NNS
46745	1922	30	.	.	.
46745	1923	1	To	to	IN
46745	1923	2	this	this	DT
46745	1923	3	I	-PRON-	PRP
46745	1923	4	shall	shall	MD
46745	1923	5	recur	recur	VB
46745	1923	6	when	when	WRB
46745	1923	7	I	-PRON-	PRP
46745	1923	8	consider	consider	VBP
46745	1923	9	the	the	DT
46745	1923	10	Catalytics	Catalytics	NNP
46745	1923	11	which	which	WDT
46745	1923	12	are	be	VBP
46745	1923	13	used	use	VBN
46745	1923	14	to	to	TO
46745	1923	15	counteract	counteract	VB
46745	1923	16	these	these	DT
46745	1923	17	same	same	JJ
46745	1923	18	disorders	disorder	NNS
46745	1923	19	,	,	,
46745	1923	20	not	not	RB
46745	1923	21	,	,	,
46745	1923	22	as	as	RB
46745	1923	23	here	here	RB
46745	1923	24	,	,	,
46745	1923	25	by	by	IN
46745	1923	26	restoring	restore	VBG
46745	1923	27	a	a	DT
46745	1923	28	wanting	want	VBG
46745	1923	29	material	material	NN
46745	1923	30	,	,	,
46745	1923	31	but	but	CC
46745	1923	32	apparently	apparently	RB
46745	1923	33	by	by	IN
46745	1923	34	determining	determine	VBG
46745	1923	35	the	the	DT
46745	1923	36	process	process	NN
46745	1923	37	in	in	IN
46745	1923	38	a	a	DT
46745	1923	39	different	different	JJ
46745	1923	40	direction	direction	NN
46745	1923	41	,	,	,
46745	1923	42	and	and	CC
46745	1923	43	thus	thus	RB
46745	1923	44	checking	check	VBG
46745	1923	45	it	-PRON-	PRP
46745	1923	46	altogether	altogether	RB
46745	1923	47	.	.	.
46745	1924	1	The	the	DT
46745	1924	2	action	action	NN
46745	1924	3	of	of	IN
46745	1924	4	Catalytics	Catalytics	NNP
46745	1924	5	is	be	VBZ
46745	1924	6	more	more	RBR
46745	1924	7	obscure	obscure	JJ
46745	1924	8	than	than	IN
46745	1924	9	that	that	DT
46745	1924	10	of	of	IN
46745	1924	11	Restoratives	restorative	NNS
46745	1924	12	,	,	,
46745	1924	13	but	but	CC
46745	1924	14	there	there	EX
46745	1924	15	is	be	VBZ
46745	1924	16	generally	generally	RB
46745	1924	17	a	a	DT
46745	1924	18	broad	broad	JJ
46745	1924	19	line	line	NN
46745	1924	20	between	between	IN
46745	1924	21	them	-PRON-	PRP
46745	1924	22	.	.	.
46745	1925	1	The	the	DT
46745	1925	2	most	most	RBS
46745	1925	3	difficult	difficult	JJ
46745	1925	4	case	case	NN
46745	1925	5	is	be	VBZ
46745	1925	6	that	that	DT
46745	1925	7	of	of	IN
46745	1925	8	the	the	DT
46745	1925	9	medicines	medicine	NNS
46745	1925	10	used	use	VBN
46745	1925	11	in	in	IN
46745	1925	12	ague	ague	NN
46745	1925	13	and	and	CC
46745	1925	14	other	other	JJ
46745	1925	15	periodic	periodic	JJ
46745	1925	16	diseases	disease	NNS
46745	1925	17	;	;	:
46745	1925	18	of	of	IN
46745	1925	19	these	these	DT
46745	1925	20	,	,	,
46745	1925	21	for	for	IN
46745	1925	22	certain	certain	JJ
46745	1925	23	reasons	reason	NNS
46745	1925	24	that	that	WDT
46745	1925	25	I	-PRON-	PRP
46745	1925	26	shall	shall	MD
46745	1925	27	state	state	NN
46745	1925	28	,	,	,
46745	1925	29	I	-PRON-	PRP
46745	1925	30	have	have	VBP
46745	1925	31	grouped	group	VBN
46745	1925	32	Quina	Quina	NNP
46745	1925	33	and	and	CC
46745	1925	34	tonics	tonic	NNS
46745	1925	35	among	among	IN
46745	1925	36	Restoratives	restorative	NNS
46745	1925	37	,	,	,
46745	1925	38	placing	place	VBG
46745	1925	39	Arsenic	Arsenic	NNP
46745	1925	40	among	among	IN
46745	1925	41	Catalytic	catalytic	JJ
46745	1925	42	medicines	medicine	NNS
46745	1925	43	.	.	.
46745	1926	1	It	-PRON-	PRP
46745	1926	2	seems	seem	VBZ
46745	1926	3	to	to	IN
46745	1926	4	me	-PRON-	PRP
46745	1926	5	that	that	IN
46745	1926	6	Cinchona	Cinchona	NNP
46745	1926	7	bears	bear	VBZ
46745	1926	8	the	the	DT
46745	1926	9	same	same	JJ
46745	1926	10	relation	relation	NN
46745	1926	11	to	to	IN
46745	1926	12	Arsenic	Arsenic	NNP
46745	1926	13	in	in	IN
46745	1926	14	the	the	DT
46745	1926	15	treatment	treatment	NN
46745	1926	16	of	of	IN
46745	1926	17	ague	ague	NN
46745	1926	18	,	,	,
46745	1926	19	as	as	IN
46745	1926	20	Alkalies	alkali	NNS
46745	1926	21	to	to	IN
46745	1926	22	Colchicum	Colchicum	NNP
46745	1926	23	in	in	IN
46745	1926	24	gout	gout	NN
46745	1926	25	;	;	:
46745	1926	26	the	the	DT
46745	1926	27	former	former	JJ
46745	1926	28	,	,	,
46745	1926	29	in	in	IN
46745	1926	30	each	each	DT
46745	1926	31	case	case	NN
46745	1926	32	,	,	,
46745	1926	33	supplying	supply	VBG
46745	1926	34	a	a	DT
46745	1926	35	needful	needful	JJ
46745	1926	36	material	material	NN
46745	1926	37	,	,	,
46745	1926	38	the	the	DT
46745	1926	39	latter	latter	JJ
46745	1926	40	neutralizing	neutralize	VBG
46745	1926	41	a	a	DT
46745	1926	42	morbid	morbid	NN
46745	1926	43	process	process	NN
46745	1926	44	.	.	.
46745	1927	1	Thus	thus	RB
46745	1927	2	,	,	,
46745	1927	3	when	when	WRB
46745	1927	4	air	air	NN
46745	1927	5	has	have	VBZ
46745	1927	6	been	be	VBN
46745	1927	7	rendered	render	VBN
46745	1927	8	impure	impure	NN
46745	1927	9	by	by	IN
46745	1927	10	breathing	breathe	VBG
46745	1927	11	,	,	,
46745	1927	12	we	-PRON-	PRP
46745	1927	13	may	may	MD
46745	1927	14	render	render	VB
46745	1927	15	it	-PRON-	PRP
46745	1927	16	again	again	RB
46745	1927	17	respirable	respirable	VB
46745	1927	18	by	by	IN
46745	1927	19	adding	add	VBG
46745	1927	20	fresh	fresh	JJ
46745	1927	21	oxygen	oxygen	NN
46745	1927	22	;	;	:
46745	1927	23	but	but	CC
46745	1927	24	still	still	RB
46745	1927	25	more	more	RBR
46745	1927	26	certainly	certainly	RB
46745	1927	27	,	,	,
46745	1927	28	by	by	IN
46745	1927	29	neutralizing	neutralize	VBG
46745	1927	30	the	the	DT
46745	1927	31	carbonic	carbonic	JJ
46745	1927	32	acid	acid	NN
46745	1927	33	.	.	.
46745	1928	1	ORD	ORD	NNP
46745	1928	2	.	.	.
46745	1929	1	IV	IV	NNP
46745	1929	2	.	.	.
46745	1930	1	TONICS	tonic	NNS
46745	1930	2	.	.	.
46745	1931	1	Under	under	IN
46745	1931	2	this	this	DT
46745	1931	3	term	term	NN
46745	1931	4	I	-PRON-	PRP
46745	1931	5	intend	intend	VBP
46745	1931	6	to	to	TO
46745	1931	7	include	include	VB
46745	1931	8	only	only	RB
46745	1931	9	the	the	DT
46745	1931	10	bitter	bitter	JJ
46745	1931	11	principles	principle	NNS
46745	1931	12	of	of	IN
46745	1931	13	vegetables	vegetable	NNS
46745	1931	14	.	.	.
46745	1932	1	The	the	DT
46745	1932	2	chief	chief	JJ
46745	1932	3	medicines	medicine	NNS
46745	1932	4	of	of	IN
46745	1932	5	this	this	DT
46745	1932	6	order	order	NN
46745	1932	7	are	be	VBP
46745	1932	8	as	as	IN
46745	1932	9	follow	follow	NN
46745	1932	10	:	:	:
46745	1932	11	_	_	NNP
46745	1932	12	Alkaloids	Alkaloids	NNP
46745	1932	13	and	and	CC
46745	1932	14	neutral	neutral	JJ
46745	1932	15	principles._--Quina	principles._--quina	NN
46745	1932	16	,	,	,
46745	1932	17	Cinchonia	Cinchonia	NNP
46745	1932	18	,	,	,
46745	1932	19	Bebeerine	Bebeerine	NNP
46745	1932	20	,	,	,
46745	1932	21	Narcotine	Narcotine	NNP
46745	1932	22	,	,	,
46745	1932	23	Salicine	Salicine	NNP
46745	1932	24	,	,	,
46745	1932	25	etc	etc	FW
46745	1932	26	.	.	.
46745	1933	1	_	_	NNP
46745	1933	2	Bitter	Bitter	NNP
46745	1933	3	drugs._--Cinchona	drugs._--cinchona	NN
46745	1933	4	,	,	,
46745	1933	5	Quassia	Quassia	NNP
46745	1933	6	,	,	,
46745	1933	7	Cusparia	Cusparia	NNP
46745	1933	8	,	,	,
46745	1933	9	Gentian	Gentian	NNP
46745	1933	10	,	,	,
46745	1933	11	Calumba	Calumba	NNP
46745	1933	12	,	,	,
46745	1933	13	Chiretta	Chiretta	NNP
46745	1933	14	,	,	,
46745	1933	15	Centaurium	Centaurium	NNP
46745	1933	16	,	,	,
46745	1933	17	Menyanthes	Menyanthes	NNP
46745	1933	18	,	,	,
46745	1933	19	Rhubarb	Rhubarb	NNP
46745	1933	20	,	,	,
46745	1933	21	Hops	Hops	NNP
46745	1933	22	,	,	,
46745	1933	23	Elm	Elm	NNP
46745	1933	24	and	and	CC
46745	1933	25	Willow	Willow	NNP
46745	1933	26	barks	bark	NNS
46745	1933	27	,	,	,
46745	1933	28	Tansy	Tansy	NNP
46745	1933	29	,	,	,
46745	1933	30	Wormwood	Wormwood	NNP
46745	1933	31	,	,	,
46745	1933	32	Chamomile	Chamomile	NNP
46745	1933	33	,	,	,
46745	1933	34	Cascarilla	Cascarilla	NNP
46745	1933	35	.	.	.
46745	1934	1	The	the	DT
46745	1934	2	power	power	NN
46745	1934	3	by	by	IN
46745	1934	4	virtue	virtue	NN
46745	1934	5	of	of	IN
46745	1934	6	which	which	WDT
46745	1934	7	these	these	DT
46745	1934	8	medicines	medicine	NNS
46745	1934	9	are	be	VBP
46745	1934	10	enabled	enable	VBN
46745	1934	11	to	to	TO
46745	1934	12	act	act	VB
46745	1934	13	as	as	IN
46745	1934	14	Tonics	Tonics	NNP
46745	1934	15	,	,	,
46745	1934	16	is	be	VBZ
46745	1934	17	due	due	JJ
46745	1934	18	,	,	,
46745	1934	19	in	in	IN
46745	1934	20	each	each	DT
46745	1934	21	case	case	NN
46745	1934	22	,	,	,
46745	1934	23	to	to	IN
46745	1934	24	a	a	DT
46745	1934	25	vegetable	vegetable	NN
46745	1934	26	alkaloid	alkaloid	NN
46745	1934	27	or	or	CC
46745	1934	28	neutral	neutral	JJ
46745	1934	29	principle	principle	NN
46745	1934	30	,	,	,
46745	1934	31	having	have	VBG
46745	1934	32	a	a	DT
46745	1934	33	bitter	bitter	JJ
46745	1934	34	taste	taste	NN
46745	1934	35	.	.	.
46745	1935	1	All	all	DT
46745	1935	2	of	of	IN
46745	1935	3	those	those	DT
46745	1935	4	mentioned	mention	VBN
46745	1935	5	above	above	RB
46745	1935	6	,	,	,
46745	1935	7	with	with	IN
46745	1935	8	the	the	DT
46745	1935	9	exception	exception	NN
46745	1935	10	of	of	IN
46745	1935	11	Salicine	Salicine	NNP
46745	1935	12	,	,	,
46745	1935	13	contain	contain	VB
46745	1935	14	Nitrogen	Nitrogen	NNP
46745	1935	15	.	.	.
46745	1936	1	The	the	DT
46745	1936	2	uses	use	NNS
46745	1936	3	of	of	IN
46745	1936	4	Tonics	tonic	NNS
46745	1936	5	are	be	VBP
46745	1936	6	of	of	IN
46745	1936	7	a	a	DT
46745	1936	8	twofold	twofold	JJ
46745	1936	9	nature	nature	NN
46745	1936	10	.	.	.
46745	1937	1	Firstly	firstly	RB
46745	1937	2	,	,	,
46745	1937	3	they	-PRON-	PRP
46745	1937	4	are	be	VBP
46745	1937	5	of	of	IN
46745	1937	6	use	use	NN
46745	1937	7	in	in	IN
46745	1937	8	simple	simple	JJ
46745	1937	9	debility	debility	NN
46745	1937	10	and	and	CC
46745	1937	11	in	in	IN
46745	1937	12	atonic	atonic	JJ
46745	1937	13	dyspepsia	dyspepsia	NNP
46745	1937	14	.	.	.
46745	1938	1	Here	here	RB
46745	1938	2	they	-PRON-	PRP
46745	1938	3	give	give	VBP
46745	1938	4	an	an	DT
46745	1938	5	appetite	appetite	NN
46745	1938	6	,	,	,
46745	1938	7	increase	increase	VB
46745	1938	8	the	the	DT
46745	1938	9	muscular	muscular	JJ
46745	1938	10	strength	strength	NN
46745	1938	11	and	and	CC
46745	1938	12	powers	power	NNS
46745	1938	13	of	of	IN
46745	1938	14	digestion	digestion	NN
46745	1938	15	,	,	,
46745	1938	16	and	and	CC
46745	1938	17	improve	improve	VB
46745	1938	18	the	the	DT
46745	1938	19	general	general	JJ
46745	1938	20	health	health	NN
46745	1938	21	.	.	.
46745	1939	1	In	in	IN
46745	1939	2	the	the	DT
46745	1939	3	second	second	JJ
46745	1939	4	place	place	NN
46745	1939	5	,	,	,
46745	1939	6	they	-PRON-	PRP
46745	1939	7	have	have	VBP
46745	1939	8	all	all	DT
46745	1939	9	,	,	,
46745	1939	10	more	more	RBR
46745	1939	11	or	or	CC
46745	1939	12	less	less	RBR
46745	1939	13	,	,	,
46745	1939	14	a	a	DT
46745	1939	15	curative	curative	JJ
46745	1939	16	power	power	NN
46745	1939	17	in	in	IN
46745	1939	18	Ague	Ague	NNP
46745	1939	19	and	and	CC
46745	1939	20	other	other	JJ
46745	1939	21	periodic	periodic	JJ
46745	1939	22	disorders	disorder	NNS
46745	1939	23	,	,	,
46745	1939	24	caused	cause	VBN
46745	1939	25	by	by	IN
46745	1939	26	Marsh	Marsh	NNP
46745	1939	27	miasm	miasm	NN
46745	1939	28	.	.	.
46745	1940	1	Many	many	JJ
46745	1940	2	explanations	explanation	NNS
46745	1940	3	have	have	VBP
46745	1940	4	been	be	VBN
46745	1940	5	given	give	VBN
46745	1940	6	of	of	IN
46745	1940	7	this	this	DT
46745	1940	8	curious	curious	JJ
46745	1940	9	and	and	CC
46745	1940	10	double	double	JJ
46745	1940	11	action	action	NN
46745	1940	12	of	of	IN
46745	1940	13	vegetable	vegetable	NN
46745	1940	14	bitters	bitter	NNS
46745	1940	15	;	;	:
46745	1940	16	and	and	CC
46745	1940	17	some	some	DT
46745	1940	18	erroneous	erroneous	JJ
46745	1940	19	theories	theory	NNS
46745	1940	20	have	have	VBP
46745	1940	21	been	be	VBN
46745	1940	22	assumed	assume	VBN
46745	1940	23	,	,	,
46745	1940	24	and	and	CC
46745	1940	25	false	false	JJ
46745	1940	26	analogies	analogy	NNS
46745	1940	27	attempted	attempt	VBD
46745	1940	28	,	,	,
46745	1940	29	in	in	IN
46745	1940	30	the	the	DT
46745	1940	31	classification	classification	NN
46745	1940	32	of	of	IN
46745	1940	33	these	these	DT
46745	1940	34	remedies	remedy	NNS
46745	1940	35	.	.	.
46745	1941	1	The	the	DT
46745	1941	2	subject	subject	NN
46745	1941	3	is	be	VBZ
46745	1941	4	certainly	certainly	RB
46745	1941	5	a	a	DT
46745	1941	6	difficult	difficult	JJ
46745	1941	7	one	one	NN
46745	1941	8	,	,	,
46745	1941	9	and	and	CC
46745	1941	10	there	there	EX
46745	1941	11	are	be	VBP
46745	1941	12	,	,	,
46745	1941	13	at	at	IN
46745	1941	14	starting	start	VBG
46745	1941	15	,	,	,
46745	1941	16	several	several	JJ
46745	1941	17	questions	question	NNS
46745	1941	18	which	which	WDT
46745	1941	19	require	require	VBP
46745	1941	20	a	a	DT
46745	1941	21	distinct	distinct	JJ
46745	1941	22	consideration	consideration	NN
46745	1941	23	and	and	CC
46745	1941	24	reply	reply	NN
46745	1941	25	.	.	.
46745	1942	1	Upon	upon	IN
46745	1942	2	the	the	DT
46745	1942	3	answers	answer	NNS
46745	1942	4	given	give	VBN
46745	1942	5	to	to	IN
46745	1942	6	them	-PRON-	PRP
46745	1942	7	it	-PRON-	PRP
46745	1942	8	must	must	MD
46745	1942	9	depend	depend	VB
46745	1942	10	whether	whether	IN
46745	1942	11	they	-PRON-	PRP
46745	1942	12	should	should	MD
46745	1942	13	rightly	rightly	RB
46745	1942	14	be	be	VB
46745	1942	15	grouped	group	VBN
46745	1942	16	with	with	IN
46745	1942	17	blood	blood	NN
46745	1942	18	-	-	HYPH
46745	1942	19	medicines	medicine	NNS
46745	1942	20	or	or	CC
46745	1942	21	with	with	IN
46745	1942	22	nerve	nerve	NN
46745	1942	23	-	-	HYPH
46745	1942	24	medicines	medicine	NNS
46745	1942	25	;	;	:
46745	1942	26	and	and	CC
46745	1942	27	,	,	,
46745	1942	28	if	if	IN
46745	1942	29	the	the	DT
46745	1942	30	former	former	JJ
46745	1942	31	,	,	,
46745	1942	32	with	with	IN
46745	1942	33	Restoratives	restorative	NNS
46745	1942	34	or	or	CC
46745	1942	35	with	with	IN
46745	1942	36	Catalytics	Catalytics	NNP
46745	1942	37	.	.	.
46745	1943	1	Do	do	VBP
46745	1943	2	these	these	DT
46745	1943	3	medicines	medicine	NNS
46745	1943	4	act	act	VB
46745	1943	5	primarily	primarily	RB
46745	1943	6	in	in	IN
46745	1943	7	the	the	DT
46745	1943	8	blood	blood	NN
46745	1943	9	,	,	,
46745	1943	10	or	or	CC
46745	1943	11	on	on	IN
46745	1943	12	the	the	DT
46745	1943	13	nerves	nerve	NNS
46745	1943	14	?	?	.
46745	1944	1	Is	be	VBZ
46745	1944	2	their	-PRON-	PRP$
46745	1944	3	action	action	NN
46745	1944	4	of	of	IN
46745	1944	5	a	a	DT
46745	1944	6	permanent	permanent	JJ
46745	1944	7	character	character	NN
46745	1944	8	?	?	.
46745	1945	1	Are	be	VBP
46745	1945	2	there	there	EX
46745	1945	3	any	any	DT
46745	1945	4	substances	substance	NNS
46745	1945	5	in	in	IN
46745	1945	6	the	the	DT
46745	1945	7	blood	blood	NN
46745	1945	8	which	which	WDT
46745	1945	9	resemble	resemble	VBP
46745	1945	10	them	-PRON-	PRP
46745	1945	11	?	?	.
46745	1946	1	May	May	MD
46745	1946	2	they	-PRON-	PRP
46745	1946	3	remain	remain	VB
46745	1946	4	in	in	IN
46745	1946	5	the	the	DT
46745	1946	6	blood	blood	NN
46745	1946	7	,	,	,
46745	1946	8	or	or	CC
46745	1946	9	are	be	VBP
46745	1946	10	they	-PRON-	PRP
46745	1946	11	always	always	RB
46745	1946	12	excreted	excrete	VBN
46745	1946	13	?	?	.
46745	1947	1	If	if	IN
46745	1947	2	acting	act	VBG
46745	1947	3	in	in	IN
46745	1947	4	the	the	DT
46745	1947	5	blood	blood	NN
46745	1947	6	,	,	,
46745	1947	7	are	be	VBP
46745	1947	8	they	-PRON-	PRP
46745	1947	9	wo	will	MD
46745	1947	10	nt	not	RB
46745	1947	11	to	to	TO
46745	1947	12	effect	effect	VB
46745	1947	13	a	a	DT
46745	1947	14	cure	cure	NN
46745	1947	15	by	by	IN
46745	1947	16	supplying	supply	VBG
46745	1947	17	to	to	IN
46745	1947	18	it	-PRON-	PRP
46745	1947	19	a	a	DT
46745	1947	20	material	material	NN
46745	1947	21	wanting	want	VBG
46745	1947	22	,	,	,
46745	1947	23	or	or	CC
46745	1947	24	by	by	IN
46745	1947	25	counteracting	counteract	VBG
46745	1947	26	in	in	IN
46745	1947	27	it	-PRON-	PRP
46745	1947	28	a	a	DT
46745	1947	29	morbid	morbid	NN
46745	1947	30	process	process	NN
46745	1947	31	?	?	.
46745	1948	1	These	these	DT
46745	1948	2	questions	question	NNS
46745	1948	3	require	require	VBP
46745	1948	4	each	each	DT
46745	1948	5	a	a	DT
46745	1948	6	satisfactory	satisfactory	JJ
46745	1948	7	reply	reply	NN
46745	1948	8	,	,	,
46745	1948	9	before	before	IN
46745	1948	10	it	-PRON-	PRP
46745	1948	11	can	can	MD
46745	1948	12	be	be	VB
46745	1948	13	proved	prove	VBN
46745	1948	14	that	that	IN
46745	1948	15	I	-PRON-	PRP
46745	1948	16	have	have	VBP
46745	1948	17	done	do	VBN
46745	1948	18	rightly	rightly	RB
46745	1948	19	in	in	IN
46745	1948	20	classing	class	VBG
46745	1948	21	Tonics	Tonics	NNP
46745	1948	22	among	among	IN
46745	1948	23	Restorative	Restorative	NNP
46745	1948	24	medicines	medicine	NNS
46745	1948	25	;	;	:
46745	1948	26	for	for	IN
46745	1948	27	they	-PRON-	PRP
46745	1948	28	coincide	coincide	VBP
46745	1948	29	with	with	IN
46745	1948	30	the	the	DT
46745	1948	31	minor	minor	JJ
46745	1948	32	propositions	proposition	NNS
46745	1948	33	in	in	IN
46745	1948	34	which	which	WDT
46745	1948	35	I	-PRON-	PRP
46745	1948	36	have	have	VBP
46745	1948	37	defined	define	VBN
46745	1948	38	the	the	DT
46745	1948	39	action	action	NN
46745	1948	40	of	of	IN
46745	1948	41	such	such	JJ
46745	1948	42	remedial	remedial	JJ
46745	1948	43	agents	agent	NNS
46745	1948	44	.	.	.
46745	1949	1	Quina	Quina	NNP
46745	1949	2	may	may	MD
46745	1949	3	be	be	VB
46745	1949	4	taken	take	VBN
46745	1949	5	as	as	IN
46745	1949	6	the	the	DT
46745	1949	7	type	type	NN
46745	1949	8	of	of	IN
46745	1949	9	the	the	DT
46745	1949	10	whole	whole	JJ
46745	1949	11	order	order	NN
46745	1949	12	.	.	.
46745	1950	1	It	-PRON-	PRP
46745	1950	2	is	be	VBZ
46745	1950	3	the	the	DT
46745	1950	4	most	most	RBS
46745	1950	5	powerful	powerful	JJ
46745	1950	6	;	;	:
46745	1950	7	and	and	CC
46745	1950	8	the	the	DT
46745	1950	9	others	other	NNS
46745	1950	10	all	all	RB
46745	1950	11	more	more	RBR
46745	1950	12	or	or	CC
46745	1950	13	less	less	RBR
46745	1950	14	resemble	resemble	VB
46745	1950	15	it	-PRON-	PRP
46745	1950	16	.	.	.
46745	1951	1	Perhaps	perhaps	RB
46745	1951	2	Cusparia	Cusparia	NNP
46745	1951	3	bark	bark	NN
46745	1951	4	comes	come	VBZ
46745	1951	5	nearest	near	JJS
46745	1951	6	to	to	IN
46745	1951	7	the	the	DT
46745	1951	8	Cinchona	Cinchona	NNP
46745	1951	9	alkaloids	alkaloid	VBZ
46745	1951	10	in	in	IN
46745	1951	11	its	-PRON-	PRP$
46745	1951	12	anti	anti	JJ
46745	1951	13	-	-	JJ
46745	1951	14	periodic	periodic	JJ
46745	1951	15	action	action	NN
46745	1951	16	.	.	.
46745	1952	1	It	-PRON-	PRP
46745	1952	2	is	be	VBZ
46745	1952	3	worthy	worthy	JJ
46745	1952	4	of	of	IN
46745	1952	5	remark	remark	NN
46745	1952	6	,	,	,
46745	1952	7	that	that	IN
46745	1952	8	some	some	DT
46745	1952	9	common	common	JJ
46745	1952	10	bitters	bitter	NNS
46745	1952	11	which	which	WDT
46745	1952	12	owe	owe	VBP
46745	1952	13	their	-PRON-	PRP$
46745	1952	14	efficacy	efficacy	NN
46745	1952	15	,	,	,
46745	1952	16	not	not	RB
46745	1952	17	to	to	IN
46745	1952	18	alkaloids	alkaloid	NNS
46745	1952	19	,	,	,
46745	1952	20	but	but	CC
46745	1952	21	to	to	IN
46745	1952	22	neutral	neutral	JJ
46745	1952	23	principles	principle	NNS
46745	1952	24	,	,	,
46745	1952	25	as	as	IN
46745	1952	26	Quassia	Quassia	NNP
46745	1952	27	,	,	,
46745	1952	28	Calumba	Calumba	NNP
46745	1952	29	,	,	,
46745	1952	30	and	and	CC
46745	1952	31	Gentian	Gentian	NNP
46745	1952	32	,	,	,
46745	1952	33	possess	possess	VBP
46745	1952	34	the	the	DT
46745	1952	35	least	least	JJS
46745	1952	36	control	control	NN
46745	1952	37	over	over	IN
46745	1952	38	periodic	periodic	JJ
46745	1952	39	affections	affection	NNS
46745	1952	40	.	.	.
46745	1953	1	There	there	EX
46745	1953	2	can	can	MD
46745	1953	3	be	be	VB
46745	1953	4	no	no	DT
46745	1953	5	doubt	doubt	NN
46745	1953	6	that	that	IN
46745	1953	7	these	these	DT
46745	1953	8	active	active	JJ
46745	1953	9	principles	principle	NNS
46745	1953	10	are	be	VBP
46745	1953	11	all	all	DT
46745	1953	12	absorbed	absorb	VBN
46745	1953	13	,	,	,
46745	1953	14	and	and	CC
46745	1953	15	pass	pass	VB
46745	1953	16	into	into	IN
46745	1953	17	the	the	DT
46745	1953	18	blood	blood	NN
46745	1953	19	.	.	.
46745	1954	1	They	-PRON-	PRP
46745	1954	2	may	may	MD
46745	1954	3	easily	easily	RB
46745	1954	4	be	be	VB
46745	1954	5	dissolved	dissolve	VBN
46745	1954	6	out	out	IN
46745	1954	7	of	of	IN
46745	1954	8	the	the	DT
46745	1954	9	vegetable	vegetable	NN
46745	1954	10	which	which	WDT
46745	1954	11	contains	contain	VBZ
46745	1954	12	them	-PRON-	PRP
46745	1954	13	,	,	,
46745	1954	14	if	if	IN
46745	1954	15	not	not	RB
46745	1954	16	by	by	IN
46745	1954	17	simple	simple	JJ
46745	1954	18	water	water	NN
46745	1954	19	,	,	,
46745	1954	20	at	at	IN
46745	1954	21	all	all	DT
46745	1954	22	events	event	NNS
46745	1954	23	by	by	IN
46745	1954	24	such	such	PDT
46745	1954	25	an	an	DT
46745	1954	26	acid	acid	JJ
46745	1954	27	liquid	liquid	NN
46745	1954	28	as	as	IN
46745	1954	29	we	-PRON-	PRP
46745	1954	30	find	find	VBP
46745	1954	31	in	in	IN
46745	1954	32	the	the	DT
46745	1954	33	stomach	stomach	NN
46745	1954	34	.	.	.
46745	1955	1	We	-PRON-	PRP
46745	1955	2	possess	possess	VBP
46745	1955	3	positive	positive	JJ
46745	1955	4	proof	proof	NN
46745	1955	5	of	of	IN
46745	1955	6	absorption	absorption	NN
46745	1955	7	in	in	IN
46745	1955	8	the	the	DT
46745	1955	9	case	case	NN
46745	1955	10	of	of	IN
46745	1955	11	Quina	Quina	NNP
46745	1955	12	,	,	,
46745	1955	13	which	which	WDT
46745	1955	14	has	have	VBZ
46745	1955	15	been	be	VBN
46745	1955	16	detected	detect	VBN
46745	1955	17	by	by	IN
46745	1955	18	Tiedemann	Tiedemann	NNP
46745	1955	19	and	and	CC
46745	1955	20	Gmelin	Gmelin	NNP
46745	1955	21	in	in	IN
46745	1955	22	the	the	DT
46745	1955	23	blood	blood	NN
46745	1955	24	of	of	IN
46745	1955	25	a	a	DT
46745	1955	26	patient	patient	NN
46745	1955	27	to	to	IN
46745	1955	28	whom	whom	WP
46745	1955	29	it	-PRON-	PRP
46745	1955	30	was	be	VBD
46745	1955	31	administered	administer	VBN
46745	1955	32	.	.	.
46745	1956	1	Having	have	VBG
46745	1956	2	them	-PRON-	PRP
46745	1956	3	now	now	RB
46745	1956	4	in	in	IN
46745	1956	5	the	the	DT
46745	1956	6	blood	blood	NN
46745	1956	7	,	,	,
46745	1956	8	we	-PRON-	PRP
46745	1956	9	arrive	arrive	VBP
46745	1956	10	at	at	IN
46745	1956	11	the	the	DT
46745	1956	12	first	first	JJ
46745	1956	13	question	question	NN
46745	1956	14	.	.	.
46745	1957	1	Do	do	VBP
46745	1957	2	Quina	Quina	NNP
46745	1957	3	and	and	CC
46745	1957	4	other	other	JJ
46745	1957	5	vegetable	vegetable	JJ
46745	1957	6	Tonics	Tonics	NNPS
46745	1957	7	act	act	VBP
46745	1957	8	on	on	IN
46745	1957	9	the	the	DT
46745	1957	10	blood	blood	NN
46745	1957	11	or	or	CC
46745	1957	12	on	on	IN
46745	1957	13	the	the	DT
46745	1957	14	nerves	nerve	NNS
46745	1957	15	?	?	.
46745	1958	1	This	this	DT
46745	1958	2	has	have	VBZ
46745	1958	3	been	be	VBN
46745	1958	4	answered	answer	VBN
46745	1958	5	at	at	IN
46745	1958	6	once	once	RB
46745	1958	7	by	by	IN
46745	1958	8	many	many	JJ
46745	1958	9	writers	writer	NNS
46745	1958	10	,	,	,
46745	1958	11	as	as	IN
46745	1958	12	if	if	IN
46745	1958	13	it	-PRON-	PRP
46745	1958	14	were	be	VBD
46745	1958	15	a	a	DT
46745	1958	16	thing	thing	NN
46745	1958	17	of	of	IN
46745	1958	18	great	great	JJ
46745	1958	19	simplicity	simplicity	NN
46745	1958	20	.	.	.
46745	1959	1	But	but	CC
46745	1959	2	it	-PRON-	PRP
46745	1959	3	does	do	VBZ
46745	1959	4	not	not	RB
46745	1959	5	seem	seem	VB
46745	1959	6	to	to	TO
46745	1959	7	be	be	VB
46745	1959	8	so	so	RB
46745	1959	9	.	.	.
46745	1960	1	Tonics	tonic	NNS
46745	1960	2	,	,	,
46745	1960	3	as	as	IN
46745	1960	4	we	-PRON-	PRP
46745	1960	5	know	know	VBP
46745	1960	6	,	,	,
46745	1960	7	have	have	VBP
46745	1960	8	the	the	DT
46745	1960	9	power	power	NN
46745	1960	10	of	of	IN
46745	1960	11	communicating	communicate	VBG
46745	1960	12	health	health	NN
46745	1960	13	and	and	CC
46745	1960	14	strength	strength	NN
46745	1960	15	in	in	IN
46745	1960	16	debility	debility	NN
46745	1960	17	produced	produce	VBN
46745	1960	18	by	by	IN
46745	1960	19	various	various	JJ
46745	1960	20	causes	cause	NNS
46745	1960	21	,	,	,
46745	1960	22	and	and	CC
46745	1960	23	also	also	RB
46745	1960	24	of	of	IN
46745	1960	25	arresting	arrest	VBG
46745	1960	26	the	the	DT
46745	1960	27	progress	progress	NN
46745	1960	28	of	of	IN
46745	1960	29	intermittent	intermittent	JJ
46745	1960	30	fever	fever	NN
46745	1960	31	.	.	.
46745	1961	1	Do	do	VBP
46745	1961	2	they	-PRON-	PRP
46745	1961	3	effect	effect	VB
46745	1961	4	these	these	DT
46745	1961	5	things	thing	NNS
46745	1961	6	by	by	IN
46745	1961	7	bettering	better	VBG
46745	1961	8	the	the	DT
46745	1961	9	condition	condition	NN
46745	1961	10	of	of	IN
46745	1961	11	the	the	DT
46745	1961	12	blood	blood	NN
46745	1961	13	,	,	,
46745	1961	14	and	and	CC
46745	1961	15	,	,	,
46745	1961	16	from	from	IN
46745	1961	17	it	-PRON-	PRP
46745	1961	18	,	,	,
46745	1961	19	that	that	DT
46745	1961	20	of	of	IN
46745	1961	21	the	the	DT
46745	1961	22	system	system	NN
46745	1961	23	at	at	IN
46745	1961	24	large	large	JJ
46745	1961	25	,	,	,
46745	1961	26	or	or	CC
46745	1961	27	do	do	VBP
46745	1961	28	they	-PRON-	PRP
46745	1961	29	at	at	RB
46745	1961	30	once	once	RB
46745	1961	31	,	,	,
46745	1961	32	and	and	CC
46745	1961	33	in	in	IN
46745	1961	34	the	the	DT
46745	1961	35	first	first	JJ
46745	1961	36	place	place	NN
46745	1961	37	,	,	,
46745	1961	38	influence	influence	VB
46745	1961	39	the	the	DT
46745	1961	40	nervous	nervous	JJ
46745	1961	41	system	system	NN
46745	1961	42	?	?	.
46745	1962	1	This	this	DT
46745	1962	2	is	be	VBZ
46745	1962	3	an	an	DT
46745	1962	4	important	important	JJ
46745	1962	5	question	question	NN
46745	1962	6	,	,	,
46745	1962	7	and	and	CC
46745	1962	8	it	-PRON-	PRP
46745	1962	9	has	have	VBZ
46745	1962	10	been	be	VBN
46745	1962	11	variously	variously	RB
46745	1962	12	answered	answer	VBN
46745	1962	13	.	.	.
46745	1963	1	Dr.	Dr.	NNP
46745	1963	2	Pereira	Pereira	NNP
46745	1963	3	,	,	,
46745	1963	4	in	in	IN
46745	1963	5	his	-PRON-	PRP$
46745	1963	6	classification	classification	NN
46745	1963	7	of	of	IN
46745	1963	8	medicines	medicine	NNS
46745	1963	9	,	,	,
46745	1963	10	ranks	rank	VBZ
46745	1963	11	them	-PRON-	PRP
46745	1963	12	among	among	IN
46745	1963	13	_	_	NNP
46745	1963	14	Cinetics	Cinetics	NNP
46745	1963	15	_	_	NNP
46745	1963	16	(	(	-LRB-
46745	1963	17	[	[	-LRB-
46745	1963	18	Greek	Greek	NNP
46745	1963	19	:	:	:
46745	1963	20	kineô	kineô	NNP
46745	1963	21	]	]	-RRB-
46745	1963	22	,	,	,
46745	1963	23	to	to	TO
46745	1963	24	move	move	VB
46745	1963	25	,	,	,
46745	1963	26	)	)	-RRB-
46745	1963	27	which	which	WDT
46745	1963	28	are	be	VBP
46745	1963	29	defined	define	VBN
46745	1963	30	to	to	TO
46745	1963	31	be	be	VB
46745	1963	32	medicines	medicine	NNS
46745	1963	33	exerting	exert	VBG
46745	1963	34	a	a	DT
46745	1963	35	power	power	NN
46745	1963	36	over	over	IN
46745	1963	37	the	the	DT
46745	1963	38	motor	motor	NN
46745	1963	39	system	system	NN
46745	1963	40	of	of	IN
46745	1963	41	nerves	nerve	NNS
46745	1963	42	,	,	,
46745	1963	43	and	and	CC
46745	1963	44	through	through	IN
46745	1963	45	them	-PRON-	PRP
46745	1963	46	on	on	IN
46745	1963	47	the	the	DT
46745	1963	48	muscles	muscle	NNS
46745	1963	49	.	.	.
46745	1964	1	But	but	CC
46745	1964	2	in	in	IN
46745	1964	3	a	a	DT
46745	1964	4	subsequent	subsequent	JJ
46745	1964	5	account	account	NN
46745	1964	6	of	of	IN
46745	1964	7	Quina	Quina	NNP
46745	1964	8	,	,	,
46745	1964	9	he	-PRON-	PRP
46745	1964	10	states	state	VBZ
46745	1964	11	that	that	IN
46745	1964	12	its	-PRON-	PRP$
46745	1964	13	action	action	NN
46745	1964	14	is	be	VBZ
46745	1964	15	quite	quite	RB
46745	1964	16	inexplicable	inexplicable	JJ
46745	1964	17	,	,	,
46745	1964	18	and	and	CC
46745	1964	19	that	that	IN
46745	1964	20	its	-PRON-	PRP$
46745	1964	21	use	use	NN
46745	1964	22	in	in	IN
46745	1964	23	Ague	Ague	NNP
46745	1964	24	must	must	MD
46745	1964	25	be	be	VB
46745	1964	26	ranked	rank	VBN
46745	1964	27	with	with	IN
46745	1964	28	some	some	DT
46745	1964	29	other	other	JJ
46745	1964	30	special	special	JJ
46745	1964	31	and	and	CC
46745	1964	32	ill	ill	RB
46745	1964	33	-	-	HYPH
46745	1964	34	understood	understand	VBN
46745	1964	35	actions	action	NNS
46745	1964	36	,	,	,
46745	1964	37	as	as	IN
46745	1964	38	that	that	DT
46745	1964	39	of	of	IN
46745	1964	40	Mercury	Mercury	NNP
46745	1964	41	in	in	IN
46745	1964	42	Syphilis	Syphilis	NNP
46745	1964	43	,	,	,
46745	1964	44	or	or	CC
46745	1964	45	of	of	IN
46745	1964	46	Arsenic	Arsenic	NNP
46745	1964	47	in	in	IN
46745	1964	48	Lepra	Lepra	NNP
46745	1964	49	.	.	.
46745	1965	1	Dr.	Dr.	NNP
46745	1965	2	Neligan	Neligan	NNP
46745	1965	3	,	,	,
46745	1965	4	(	(	-LRB-
46745	1965	5	in	in	IN
46745	1965	6	his	-PRON-	PRP$
46745	1965	7	work	work	NN
46745	1965	8	_	_	NNP
46745	1965	9	On	on	IN
46745	1965	10	Medicines	Medicines	NNP
46745	1965	11	,	,	,
46745	1965	12	_	_	NNP
46745	1965	13	)	)	-RRB-
46745	1965	14	lays	lay	VBZ
46745	1965	15	it	-PRON-	PRP
46745	1965	16	down	down	RP
46745	1965	17	that	that	IN
46745	1965	18	Tonics	Tonics	NNP
46745	1965	19	act	act	VBP
46745	1965	20	as	as	IN
46745	1965	21	stimulants	stimulant	NNS
46745	1965	22	when	when	WRB
46745	1965	23	given	give	VBN
46745	1965	24	to	to	IN
46745	1965	25	a	a	DT
46745	1965	26	healthy	healthy	JJ
46745	1965	27	man	man	NN
46745	1965	28	.	.	.
46745	1966	1	Dr.	Dr.	NNP
46745	1966	2	Pereira	Pereira	NNP
46745	1966	3	,	,	,
46745	1966	4	on	on	IN
46745	1966	5	the	the	DT
46745	1966	6	contrary	contrary	NN
46745	1966	7	,	,	,
46745	1966	8	states	state	VBZ
46745	1966	9	what	what	WP
46745	1966	10	is	be	VBZ
46745	1966	11	more	more	RBR
46745	1966	12	consonant	consonant	JJ
46745	1966	13	with	with	IN
46745	1966	14	general	general	JJ
46745	1966	15	experience	experience	NN
46745	1966	16	,	,	,
46745	1966	17	_	_	NNP
46745	1966	18	i.e.	i.e.	FW
46745	1966	19	_	_	NNP
46745	1966	20	that	that	IN
46745	1966	21	a	a	DT
46745	1966	22	moderate	moderate	JJ
46745	1966	23	dose	dose	NN
46745	1966	24	of	of	IN
46745	1966	25	a	a	DT
46745	1966	26	tonic	tonic	NN
46745	1966	27	has	have	VBZ
46745	1966	28	little	little	JJ
46745	1966	29	or	or	CC
46745	1966	30	no	no	DT
46745	1966	31	effect	effect	NN
46745	1966	32	on	on	IN
46745	1966	33	a	a	DT
46745	1966	34	man	man	NN
46745	1966	35	in	in	IN
46745	1966	36	perfect	perfect	JJ
46745	1966	37	health	health	NN
46745	1966	38	.	.	.
46745	1967	1	Dr.	Dr.	NNP
46745	1967	2	Neligan	Neligan	NNP
46745	1967	3	admits	admit	VBZ
46745	1967	4	that	that	IN
46745	1967	5	their	-PRON-	PRP$
46745	1967	6	action	action	NN
46745	1967	7	is	be	VBZ
46745	1967	8	permanent	permanent	JJ
46745	1967	9	,	,	,
46745	1967	10	and	and	CC
46745	1967	11	produced	produce	VBN
46745	1967	12	slowly	slowly	RB
46745	1967	13	;	;	:
46745	1967	14	he	-PRON-	PRP
46745	1967	15	also	also	RB
46745	1967	16	declines	decline	VBZ
46745	1967	17	any	any	DT
46745	1967	18	explanation	explanation	NN
46745	1967	19	of	of	IN
46745	1967	20	the	the	DT
46745	1967	21	action	action	NN
46745	1967	22	of	of	IN
46745	1967	23	Quina	Quina	NNP
46745	1967	24	and	and	CC
46745	1967	25	others	other	NNS
46745	1967	26	in	in	IN
46745	1967	27	Ague	Ague	NNP
46745	1967	28	,	,	,
46745	1967	29	calling	call	VBG
46745	1967	30	them	-PRON-	PRP
46745	1967	31	specifics	specific	NNS
46745	1967	32	.	.	.
46745	1968	1	Some	some	DT
46745	1968	2	other	other	JJ
46745	1968	3	authors	author	NNS
46745	1968	4	have	have	VBP
46745	1968	5	been	be	VBN
46745	1968	6	still	still	RB
46745	1968	7	more	more	RBR
46745	1968	8	decided	decide	VBN
46745	1968	9	in	in	IN
46745	1968	10	classing	class	VBG
46745	1968	11	Tonics	Tonics	NNP
46745	1968	12	with	with	IN
46745	1968	13	nerve	nerve	NN
46745	1968	14	-	-	HYPH
46745	1968	15	medicines	medicine	NNS
46745	1968	16	.	.	.
46745	1969	1	Dr.	Dr.	NNP
46745	1970	1	Guy	Guy	NNP
46745	1970	2	,	,	,
46745	1970	3	(	(	-LRB-
46745	1970	4	in	in	IN
46745	1970	5	his	-PRON-	PRP$
46745	1970	6	edition	edition	NN
46745	1970	7	of	of	IN
46745	1970	8	_	_	NNP
46745	1970	9	Dr.	Dr.	NNP
46745	1971	1	Hooper	Hooper	NNP
46745	1971	2	's	's	POS
46745	1971	3	Physician	physician	NN
46745	1971	4	's	's	POS
46745	1971	5	Vade	Vade	NNP
46745	1971	6	Mecum	Mecum	NNP
46745	1971	7	_	_	NNP
46745	1971	8	,	,	,
46745	1971	9	)	)	-RRB-
46745	1971	10	considers	consider	VBZ
46745	1971	11	that	that	IN
46745	1971	12	Stimulants	Stimulants	NNP
46745	1971	13	and	and	CC
46745	1971	14	Tonics	Tonics	NNP
46745	1971	15	should	should	MD
46745	1971	16	rightly	rightly	RB
46745	1971	17	be	be	VB
46745	1971	18	classed	class	VBN
46745	1971	19	together	together	RB
46745	1971	20	,	,	,
46745	1971	21	for	for	IN
46745	1971	22	that	that	DT
46745	1971	23	Stimulants	Stimulants	NNP
46745	1971	24	act	act	VBP
46745	1971	25	as	as	IN
46745	1971	26	Tonics	Tonics	NNPS
46745	1971	27	to	to	IN
46745	1971	28	the	the	DT
46745	1971	29	weak	weak	JJ
46745	1971	30	,	,	,
46745	1971	31	and	and	CC
46745	1971	32	Tonics	Tonics	NNP
46745	1971	33	as	as	IN
46745	1971	34	Stimulants	stimulant	NNS
46745	1971	35	to	to	IN
46745	1971	36	the	the	DT
46745	1971	37	strong	strong	JJ
46745	1971	38	.	.	.
46745	1972	1	It	-PRON-	PRP
46745	1972	2	should	should	MD
46745	1972	3	be	be	VB
46745	1972	4	observed	observe	VBN
46745	1972	5	,	,	,
46745	1972	6	that	that	IN
46745	1972	7	the	the	DT
46745	1972	8	irritant	irritant	JJ
46745	1972	9	action	action	NN
46745	1972	10	on	on	IN
46745	1972	11	the	the	DT
46745	1972	12	stomach	stomach	NN
46745	1972	13	of	of	IN
46745	1972	14	a	a	DT
46745	1972	15	large	large	JJ
46745	1972	16	dose	dose	NN
46745	1972	17	of	of	IN
46745	1972	18	a	a	DT
46745	1972	19	bitter	bitter	JJ
46745	1972	20	medicine	medicine	NN
46745	1972	21	appears	appear	VBZ
46745	1972	22	to	to	TO
46745	1972	23	have	have	VB
46745	1972	24	been	be	VBN
46745	1972	25	the	the	DT
46745	1972	26	chief	chief	JJ
46745	1972	27	foundation	foundation	NN
46745	1972	28	of	of	IN
46745	1972	29	this	this	DT
46745	1972	30	frequent	frequent	JJ
46745	1972	31	opinion	opinion	NN
46745	1972	32	of	of	IN
46745	1972	33	the	the	DT
46745	1972	34	stimulant	stimulant	JJ
46745	1972	35	action	action	NN
46745	1972	36	of	of	IN
46745	1972	37	tonics	tonic	NNS
46745	1972	38	.	.	.
46745	1973	1	The	the	DT
46745	1973	2	irritable	irritable	JJ
46745	1973	3	stomachs	stomach	NNS
46745	1973	4	of	of	IN
46745	1973	5	nervous	nervous	JJ
46745	1973	6	persons	person	NNS
46745	1973	7	are	be	VBP
46745	1973	8	more	more	RBR
46745	1973	9	easily	easily	RB
46745	1973	10	affected	affect	VBN
46745	1973	11	in	in	IN
46745	1973	12	this	this	DT
46745	1973	13	way	way	NN
46745	1973	14	.	.	.
46745	1974	1	Some	some	DT
46745	1974	2	too	too	RB
46745	1974	3	are	be	VBP
46745	1974	4	met	meet	VBN
46745	1974	5	with	with	IN
46745	1974	6	who	who	WP
46745	1974	7	bear	bear	VBP
46745	1974	8	Tonics	tonic	NNS
46745	1974	9	worse	bad	JJR
46745	1974	10	than	than	IN
46745	1974	11	others	other	NNS
46745	1974	12	,	,	,
46745	1974	13	on	on	IN
46745	1974	14	account	account	NN
46745	1974	15	of	of	IN
46745	1974	16	an	an	DT
46745	1974	17	idiosyncrasy	idiosyncrasy	JJ
46745	1974	18	or	or	CC
46745	1974	19	peculiarity	peculiarity	NN
46745	1974	20	of	of	IN
46745	1974	21	constitution	constitution	NN
46745	1974	22	.	.	.
46745	1975	1	But	but	CC
46745	1975	2	this	this	DT
46745	1975	3	irritation	irritation	NN
46745	1975	4	,	,	,
46745	1975	5	and	and	CC
46745	1975	6	the	the	DT
46745	1975	7	headache	headache	NN
46745	1975	8	and	and	CC
46745	1975	9	febrile	febrile	NN
46745	1975	10	symptoms	symptom	NNS
46745	1975	11	which	which	WDT
46745	1975	12	succeed	succeed	VBP
46745	1975	13	to	to	IN
46745	1975	14	it	-PRON-	PRP
46745	1975	15	,	,	,
46745	1975	16	do	do	VBP
46745	1975	17	not	not	RB
46745	1975	18	surely	surely	RB
46745	1975	19	constitute	constitute	VB
46745	1975	20	the	the	DT
46745	1975	21	proper	proper	JJ
46745	1975	22	action	action	NN
46745	1975	23	of	of	IN
46745	1975	24	a	a	DT
46745	1975	25	tonic	tonic	NN
46745	1975	26	medicine	medicine	NN
46745	1975	27	,	,	,
46745	1975	28	which	which	WDT
46745	1975	29	is	be	VBZ
46745	1975	30	found	find	VBN
46745	1975	31	to	to	TO
46745	1975	32	operate	operate	VB
46745	1975	33	most	most	RBS
46745	1975	34	favourably	favourably	RB
46745	1975	35	when	when	WRB
46745	1975	36	given	give	VBN
46745	1975	37	in	in	RB
46745	1975	38	too	too	RB
46745	1975	39	small	small	JJ
46745	1975	40	a	a	DT
46745	1975	41	dose	dose	NN
46745	1975	42	to	to	TO
46745	1975	43	produce	produce	VB
46745	1975	44	any	any	DT
46745	1975	45	thing	thing	NN
46745	1975	46	like	like	IN
46745	1975	47	a	a	DT
46745	1975	48	stimulant	stimulant	JJ
46745	1975	49	effect	effect	NN
46745	1975	50	.	.	.
46745	1976	1	Nor	nor	CC
46745	1976	2	do	do	VBP
46745	1976	3	I	-PRON-	PRP
46745	1976	4	think	think	VB
46745	1976	5	it	-PRON-	PRP
46745	1976	6	proved	prove	VBD
46745	1976	7	that	that	IN
46745	1976	8	any	any	DT
46745	1976	9	true	true	JJ
46745	1976	10	stimulants	stimulant	NNS
46745	1976	11	are	be	VBP
46745	1976	12	capable	capable	JJ
46745	1976	13	of	of	IN
46745	1976	14	communicating	communicate	VBG
46745	1976	15	a	a	DT
46745	1976	16	permanent	permanent	JJ
46745	1976	17	tone	tone	NN
46745	1976	18	to	to	IN
46745	1976	19	the	the	DT
46745	1976	20	system	system	NN
46745	1976	21	,	,	,
46745	1976	22	or	or	CC
46745	1976	23	to	to	IN
46745	1976	24	any	any	DT
46745	1976	25	part	part	NN
46745	1976	26	of	of	IN
46745	1976	27	it	-PRON-	PRP
46745	1976	28	.	.	.
46745	1977	1	Dr.	Dr.	NNP
46745	1977	2	Ballard	Ballard	NNP
46745	1977	3	also	also	RB
46745	1977	4	,	,	,
46745	1977	5	(	(	-LRB-
46745	1977	6	in	in	IN
46745	1977	7	_	_	NNP
46745	1977	8	Ballard	Ballard	NNP
46745	1977	9	and	and	CC
46745	1977	10	Garrod	Garrod	NNP
46745	1977	11	's	's	POS
46745	1977	12	Materia	Materia	NNP
46745	1977	13	Medica	Medica	NNP
46745	1977	14	_	_	NNP
46745	1977	15	,	,	,
46745	1977	16	)	)	-RRB-
46745	1977	17	states	state	VBZ
46745	1977	18	that	that	IN
46745	1977	19	Tonics	Tonics	NNP
46745	1977	20	acts	act	VBZ
46745	1977	21	first	first	RB
46745	1977	22	upon	upon	IN
46745	1977	23	the	the	DT
46745	1977	24	nerves	nerve	NNS
46745	1977	25	,	,	,
46745	1977	26	and	and	CC
46745	1977	27	through	through	IN
46745	1977	28	them	-PRON-	PRP
46745	1977	29	on	on	IN
46745	1977	30	the	the	DT
46745	1977	31	muscular	muscular	JJ
46745	1977	32	system	system	NN
46745	1977	33	.	.	.
46745	1978	1	He	-PRON-	PRP
46745	1978	2	opposes	oppose	VBZ
46745	1978	3	them	-PRON-	PRP
46745	1978	4	to	to	IN
46745	1978	5	Sedatives	Sedatives	NNP
46745	1978	6	,	,	,
46745	1978	7	and	and	CC
46745	1978	8	ranks	rank	VBZ
46745	1978	9	them	-PRON-	PRP
46745	1978	10	with	with	IN
46745	1978	11	stimulants	stimulant	NNS
46745	1978	12	;	;	:
46745	1978	13	quoting	quote	VBG
46745	1978	14	Strychnia	Strychnia	NNP
46745	1978	15	as	as	IN
46745	1978	16	an	an	DT
46745	1978	17	example	example	NN
46745	1978	18	of	of	IN
46745	1978	19	a	a	DT
46745	1978	20	stimulant	stimulant	NN
46745	1978	21	which	which	WDT
46745	1978	22	gives	give	VBZ
46745	1978	23	tone	tone	NN
46745	1978	24	to	to	IN
46745	1978	25	the	the	DT
46745	1978	26	muscular	muscular	JJ
46745	1978	27	system	system	NN
46745	1978	28	.	.	.
46745	1979	1	But	but	CC
46745	1979	2	,	,	,
46745	1979	3	in	in	IN
46745	1979	4	the	the	DT
46745	1979	5	first	first	JJ
46745	1979	6	place	place	NN
46745	1979	7	,	,	,
46745	1979	8	this	this	DT
46745	1979	9	alkaloid	alkaloid	NN
46745	1979	10	is	be	VBZ
46745	1979	11	quite	quite	RB
46745	1979	12	exceptional	exceptional	JJ
46745	1979	13	among	among	IN
46745	1979	14	stimulants	stimulant	NNS
46745	1979	15	;	;	:
46745	1979	16	and	and	CC
46745	1979	17	further	far	RBR
46745	1979	18	,	,	,
46745	1979	19	the	the	DT
46745	1979	20	comparison	comparison	NN
46745	1979	21	with	with	IN
46745	1979	22	Tonics	Tonics	NNP
46745	1979	23	seems	seem	VBZ
46745	1979	24	unnatural	unnatural	JJ
46745	1979	25	,	,	,
46745	1979	26	inasmuch	inasmuch	JJ
46745	1979	27	as	as	IN
46745	1979	28	the	the	DT
46745	1979	29	action	action	NN
46745	1979	30	of	of	IN
46745	1979	31	Strychnia	Strychnia	NNP
46745	1979	32	is	be	VBZ
46745	1979	33	more	more	RBR
46745	1979	34	or	or	CC
46745	1979	35	less	less	RBR
46745	1979	36	immediate	immediate	JJ
46745	1979	37	,	,	,
46745	1979	38	not	not	RB
46745	1979	39	slow	slow	JJ
46745	1979	40	and	and	CC
46745	1979	41	permanent	permanent	JJ
46745	1979	42	,	,	,
46745	1979	43	and	and	CC
46745	1979	44	it	-PRON-	PRP
46745	1979	45	evidently	evidently	RB
46745	1979	46	influences	influence	VBZ
46745	1979	47	the	the	DT
46745	1979	48	spinal	spinal	JJ
46745	1979	49	system	system	NN
46745	1979	50	of	of	IN
46745	1979	51	nerves	nerve	NNS
46745	1979	52	in	in	IN
46745	1979	53	the	the	DT
46745	1979	54	first	first	JJ
46745	1979	55	place	place	NN
46745	1979	56	.	.	.
46745	1980	1	The	the	DT
46745	1980	2	results	result	NNS
46745	1980	3	of	of	IN
46745	1980	4	large	large	JJ
46745	1980	5	doses	dose	NNS
46745	1980	6	of	of	IN
46745	1980	7	Quina	Quina	NNP
46745	1980	8	,	,	,
46745	1980	9	in	in	IN
46745	1980	10	producing	produce	VBG
46745	1980	11	determination	determination	NN
46745	1980	12	of	of	IN
46745	1980	13	blood	blood	NN
46745	1980	14	to	to	IN
46745	1980	15	the	the	DT
46745	1980	16	head	head	NN
46745	1980	17	,	,	,
46745	1980	18	ringing	ring	VBG
46745	1980	19	in	in	IN
46745	1980	20	the	the	DT
46745	1980	21	ears	ear	NNS
46745	1980	22	,	,	,
46745	1980	23	and	and	CC
46745	1980	24	vomiting	vomiting	NN
46745	1980	25	,	,	,
46745	1980	26	seem	seem	VBP
46745	1980	27	to	to	IN
46745	1980	28	me	-PRON-	PRP
46745	1980	29	to	to	TO
46745	1980	30	mark	mark	VB
46745	1980	31	its	-PRON-	PRP$
46745	1980	32	action	action	NN
46745	1980	33	as	as	IN
46745	1980	34	an	an	DT
46745	1980	35	irritant	irritant	JJ
46745	1980	36	poison	poison	NN
46745	1980	37	,	,	,
46745	1980	38	and	and	CC
46745	1980	39	not	not	RB
46745	1980	40	to	to	TO
46745	1980	41	be	be	VB
46745	1980	42	characteristic	characteristic	JJ
46745	1980	43	of	of	IN
46745	1980	44	Tonic	Tonic	NNP
46745	1980	45	medicines	medicine	NNS
46745	1980	46	.	.	.
46745	1981	1	(	(	-LRB-
46745	1981	2	_	_	NNP
46745	1981	3	Vide	Vide	NNP
46745	1981	4	_	_	NNP
46745	1981	5	p.	p.	NN
46745	1982	1	91	91	CD
46745	1982	2	.	.	.
46745	1982	3	)	)	-RRB-
46745	1983	1	The	the	DT
46745	1983	2	action	action	NN
46745	1983	3	of	of	IN
46745	1983	4	Tonics	tonic	NNS
46745	1983	5	has	have	VBZ
46745	1983	6	been	be	VBN
46745	1983	7	more	more	RBR
46745	1983	8	correctly	correctly	RB
46745	1983	9	defined	define	VBN
46745	1983	10	by	by	IN
46745	1983	11	another	another	DT
46745	1983	12	able	able	JJ
46745	1983	13	authority	authority	NN
46745	1983	14	.	.	.
46745	1984	1	"	"	``
46745	1984	2	Tonics	tonic	NNS
46745	1984	3	,	,	,
46745	1984	4	"	"	''
46745	1984	5	says	say	VBZ
46745	1984	6	Dr.	Dr.	NNP
46745	1984	7	A.	A.	NNP
46745	1985	1	Billing	billing	NN
46745	1985	2	,	,	,
46745	1985	3	"	"	``
46745	1985	4	are	be	VBP
46745	1985	5	substances	substance	NNS
46745	1985	6	which	which	WDT
46745	1985	7	neither	neither	CC
46745	1985	8	immediately	immediately	RB
46745	1985	9	nor	nor	CC
46745	1985	10	sensibly	sensibly	RB
46745	1985	11	call	call	VB
46745	1985	12	forth	forth	JJ
46745	1985	13	actions	action	NNS
46745	1985	14	,	,	,
46745	1985	15	like	like	IN
46745	1985	16	stimulants	stimulant	NNS
46745	1985	17	,	,	,
46745	1985	18	nor	nor	CC
46745	1985	19	repress	repress	VB
46745	1985	20	them	-PRON-	PRP
46745	1985	21	,	,	,
46745	1985	22	like	like	IN
46745	1985	23	sedatives	sedative	NNS
46745	1985	24	,	,	,
46745	1985	25	but	but	CC
46745	1985	26	give	give	VB
46745	1985	27	power	power	NN
46745	1985	28	to	to	IN
46745	1985	29	the	the	DT
46745	1985	30	nervous	nervous	JJ
46745	1985	31	system	system	NN
46745	1985	32	to	to	TO
46745	1985	33	generate	generate	VB
46745	1985	34	or	or	CC
46745	1985	35	secrete	secrete	VB
46745	1985	36	the	the	DT
46745	1985	37	nervous	nervous	JJ
46745	1985	38	influence	influence	NN
46745	1985	39	by	by	IN
46745	1985	40	which	which	WDT
46745	1985	41	the	the	DT
46745	1985	42	whole	whole	JJ
46745	1985	43	frame	frame	NN
46745	1985	44	is	be	VBZ
46745	1985	45	strengthened	strengthen	VBN
46745	1985	46	.	.	.
46745	1985	47	"	"	''
46745	1986	1	This	this	DT
46745	1986	2	definition	definition	NN
46745	1986	3	I	-PRON-	PRP
46745	1986	4	would	would	MD
46745	1986	5	accept	accept	VB
46745	1986	6	in	in	IN
46745	1986	7	a	a	DT
46745	1986	8	modified	modify	VBN
46745	1986	9	sense	sense	NN
46745	1986	10	,	,	,
46745	1986	11	considering	consider	VBG
46745	1986	12	that	that	IN
46745	1986	13	no	no	DT
46745	1986	14	permanent	permanent	JJ
46745	1986	15	alteration	alteration	NN
46745	1986	16	in	in	IN
46745	1986	17	the	the	DT
46745	1986	18	nervous	nervous	JJ
46745	1986	19	system	system	NN
46745	1986	20	can	can	MD
46745	1986	21	be	be	VB
46745	1986	22	produced	produce	VBN
46745	1986	23	without	without	IN
46745	1986	24	a	a	DT
46745	1986	25	primary	primary	JJ
46745	1986	26	impression	impression	NN
46745	1986	27	on	on	IN
46745	1986	28	the	the	DT
46745	1986	29	blood	blood	NN
46745	1986	30	.	.	.
46745	1987	1	Dr.	Dr.	NNP
46745	1988	1	Billing	bill	VBG
46745	1988	2	further	further	JJ
46745	1988	3	considers	consider	NNS
46745	1988	4	,	,	,
46745	1988	5	that	that	IN
46745	1988	6	the	the	DT
46745	1988	7	supposed	suppose	VBN
46745	1988	8	stimulant	stimulant	JJ
46745	1988	9	action	action	NN
46745	1988	10	of	of	IN
46745	1988	11	Tonics	Tonics	NNPS
46745	1988	12	in	in	IN
46745	1988	13	some	some	DT
46745	1988	14	cases	case	NNS
46745	1988	15	should	should	MD
46745	1988	16	either	either	RB
46745	1988	17	be	be	VB
46745	1988	18	attributed	attribute	VBN
46745	1988	19	to	to	IN
46745	1988	20	the	the	DT
46745	1988	21	operation	operation	NN
46745	1988	22	of	of	IN
46745	1988	23	the	the	DT
46745	1988	24	disease	disease	NN
46745	1988	25	,	,	,
46745	1988	26	or	or	CC
46745	1988	27	of	of	IN
46745	1988	28	some	some	DT
46745	1988	29	other	other	JJ
46745	1988	30	medicine	medicine	NN
46745	1988	31	administered	administer	VBN
46745	1988	32	along	along	RB
46745	1988	33	with	with	IN
46745	1988	34	them	-PRON-	PRP
46745	1988	35	;	;	:
46745	1988	36	and	and	CC
46745	1988	37	that	that	IN
46745	1988	38	though	though	IN
46745	1988	39	in	in	IN
46745	1988	40	large	large	JJ
46745	1988	41	doses	dose	NNS
46745	1988	42	they	-PRON-	PRP
46745	1988	43	may	may	MD
46745	1988	44	sometimes	sometimes	RB
46745	1988	45	produce	produce	VB
46745	1988	46	a	a	DT
46745	1988	47	quick	quick	JJ
46745	1988	48	pulse	pulse	NN
46745	1988	49	with	with	IN
46745	1988	50	headache	headache	NNP
46745	1988	51	,	,	,
46745	1988	52	and	and	CC
46745	1988	53	in	in	IN
46745	1988	54	other	other	JJ
46745	1988	55	instances	instance	NNS
46745	1988	56	depression	depression	NN
46745	1988	57	with	with	IN
46745	1988	58	nausea	nausea	NN
46745	1988	59	,	,	,
46745	1988	60	yet	yet	CC
46745	1988	61	that	that	IN
46745	1988	62	these	these	DT
46745	1988	63	effects	effect	NNS
46745	1988	64	should	should	MD
46745	1988	65	be	be	VB
46745	1988	66	ascribed	ascribe	VBN
46745	1988	67	merely	merely	RB
46745	1988	68	to	to	IN
46745	1988	69	their	-PRON-	PRP$
46745	1988	70	irritating	irritate	VBG
46745	1988	71	action	action	NN
46745	1988	72	on	on	IN
46745	1988	73	the	the	DT
46745	1988	74	stomach	stomach	NN
46745	1988	75	.	.	.
46745	1989	1	On	on	IN
46745	1989	2	the	the	DT
46745	1989	3	whole	whole	NN
46745	1989	4	,	,	,
46745	1989	5	it	-PRON-	PRP
46745	1989	6	seems	seem	VBZ
46745	1989	7	to	to	IN
46745	1989	8	me	-PRON-	PRP
46745	1989	9	that	that	IN
46745	1989	10	those	those	DT
46745	1989	11	authors	author	NNS
46745	1989	12	who	who	WP
46745	1989	13	,	,	,
46745	1989	14	in	in	IN
46745	1989	15	defining	define	VBG
46745	1989	16	the	the	DT
46745	1989	17	action	action	NN
46745	1989	18	of	of	IN
46745	1989	19	Tonics	Tonics	NNP
46745	1989	20	,	,	,
46745	1989	21	have	have	VBP
46745	1989	22	commenced	commence	VBN
46745	1989	23	by	by	IN
46745	1989	24	saying	say	VBG
46745	1989	25	that	that	IN
46745	1989	26	they	-PRON-	PRP
46745	1989	27	act	act	VBP
46745	1989	28	on	on	IN
46745	1989	29	the	the	DT
46745	1989	30	nervous	nervous	JJ
46745	1989	31	system	system	NN
46745	1989	32	,	,	,
46745	1989	33	have	have	VBP
46745	1989	34	started	start	VBN
46745	1989	35	with	with	IN
46745	1989	36	a	a	DT
46745	1989	37	mistaken	mistaken	JJ
46745	1989	38	notion	notion	NN
46745	1989	39	;	;	:
46745	1989	40	and	and	CC
46745	1989	41	I	-PRON-	PRP
46745	1989	42	am	be	VBP
46745	1989	43	more	more	JJR
46745	1989	44	of	of	IN
46745	1989	45	the	the	DT
46745	1989	46	opinion	opinion	NN
46745	1989	47	of	of	IN
46745	1989	48	Dr.	Dr.	NNP
46745	1989	49	A.	A.	NNP
46745	1989	50	T.	T.	NNP
46745	1989	51	Thomson	Thomson	NNP
46745	1989	52	,	,	,
46745	1989	53	who	who	WP
46745	1989	54	classes	class	VBZ
46745	1989	55	them	-PRON-	PRP
46745	1989	56	as	as	IN
46745	1989	57	medicines	medicine	NNS
46745	1989	58	which	which	WDT
46745	1989	59	act	act	VBP
46745	1989	60	on	on	IN
46745	1989	61	the	the	DT
46745	1989	62	muscular	muscular	JJ
46745	1989	63	and	and	CC
46745	1989	64	sanguiferous	sanguiferous	JJ
46745	1989	65	systems	system	NNS
46745	1989	66	.	.	.
46745	1990	1	I	-PRON-	PRP
46745	1990	2	consider	consider	VBP
46745	1990	3	,	,	,
46745	1990	4	then	then	RB
46745	1990	5	,	,	,
46745	1990	6	that	that	IN
46745	1990	7	Quina	Quina	NNP
46745	1990	8	is	be	VBZ
46745	1990	9	not	not	RB
46745	1990	10	in	in	IN
46745	1990	11	the	the	DT
46745	1990	12	first	first	JJ
46745	1990	13	instance	instance	NN
46745	1990	14	a	a	DT
46745	1990	15	Neurotic	neurotic	JJ
46745	1990	16	medicine	medicine	NN
46745	1990	17	;	;	:
46745	1990	18	and	and	CC
46745	1990	19	for	for	IN
46745	1990	20	the	the	DT
46745	1990	21	following	follow	VBG
46745	1990	22	reasons	reason	NNS
46745	1990	23	.	.	.
46745	1991	1	The	the	DT
46745	1991	2	action	action	NN
46745	1991	3	of	of	IN
46745	1991	4	other	other	JJ
46745	1991	5	nerve	nerve	NN
46745	1991	6	-	-	HYPH
46745	1991	7	medicines	medicine	NNS
46745	1991	8	is	be	VBZ
46745	1991	9	distinguished	distinguish	VBN
46745	1991	10	by	by	IN
46745	1991	11	the	the	DT
46745	1991	12	following	follow	VBG
46745	1991	13	signs	sign	NNS
46745	1991	14	.	.	.
46745	1992	1	It	-PRON-	PRP
46745	1992	2	is	be	VBZ
46745	1992	3	quick	quick	JJ
46745	1992	4	,	,	,
46745	1992	5	and	and	CC
46745	1992	6	very	very	RB
46745	1992	7	rapidly	rapidly	RB
46745	1992	8	follows	follow	VBZ
46745	1992	9	the	the	DT
46745	1992	10	administration	administration	NN
46745	1992	11	of	of	IN
46745	1992	12	a	a	DT
46745	1992	13	substance	substance	NN
46745	1992	14	.	.	.
46745	1993	1	It	-PRON-	PRP
46745	1993	2	is	be	VBZ
46745	1993	3	transient	transient	JJ
46745	1993	4	,	,	,
46745	1993	5	and	and	CC
46745	1993	6	does	do	VBZ
46745	1993	7	not	not	RB
46745	1993	8	endure	endure	VB
46745	1993	9	.	.	.
46745	1994	1	It	-PRON-	PRP
46745	1994	2	requires	require	VBZ
46745	1994	3	no	no	DT
46745	1994	4	particular	particular	JJ
46745	1994	5	state	state	NN
46745	1994	6	,	,	,
46745	1994	7	but	but	CC
46745	1994	8	takes	take	VBZ
46745	1994	9	place	place	NN
46745	1994	10	in	in	IN
46745	1994	11	health	health	NN
46745	1994	12	:	:	:
46745	1994	13	thus	thus	RB
46745	1994	14	Alcohol	Alcohol	NNP
46745	1994	15	stimulates	stimulate	VBZ
46745	1994	16	and	and	CC
46745	1994	17	intoxicates	intoxicate	VBZ
46745	1994	18	both	both	CC
46745	1994	19	healthy	healthy	JJ
46745	1994	20	and	and	CC
46745	1994	21	sickly	sickly	JJ
46745	1994	22	,	,	,
46745	1994	23	and	and	CC
46745	1994	24	Digitalis	Digitalis	NNP
46745	1994	25	would	would	MD
46745	1994	26	subdue	subdue	VB
46745	1994	27	a	a	DT
46745	1994	28	Hercules	Hercules	NNP
46745	1994	29	.	.	.
46745	1995	1	Most	Most	JJS
46745	1995	2	Neurotics	neurotic	NNS
46745	1995	3	are	be	VBP
46745	1995	4	capable	capable	JJ
46745	1995	5	of	of	IN
46745	1995	6	acting	act	VBG
46745	1995	7	without	without	IN
46745	1995	8	entry	entry	NN
46745	1995	9	into	into	IN
46745	1995	10	the	the	DT
46745	1995	11	blood	blood	NN
46745	1995	12	at	at	IN
46745	1995	13	large	large	JJ
46745	1995	14	;	;	:
46745	1995	15	mere	mere	JJ
46745	1995	16	contact	contact	NN
46745	1995	17	with	with	IN
46745	1995	18	the	the	DT
46745	1995	19	nerves	nerve	NNS
46745	1995	20	,	,	,
46745	1995	21	as	as	IN
46745	1995	22	when	when	WRB
46745	1995	23	they	-PRON-	PRP
46745	1995	24	are	be	VBP
46745	1995	25	applied	apply	VBN
46745	1995	26	externally	externally	RB
46745	1995	27	,	,	,
46745	1995	28	being	be	VBG
46745	1995	29	sufficient	sufficient	JJ
46745	1995	30	for	for	IN
46745	1995	31	their	-PRON-	PRP$
46745	1995	32	action	action	NN
46745	1995	33	on	on	IN
46745	1995	34	those	those	DT
46745	1995	35	nerves	nerve	NNS
46745	1995	36	.	.	.
46745	1996	1	Again	again	RB
46745	1996	2	,	,	,
46745	1996	3	Neurotics	neurotic	NNS
46745	1996	4	are	be	VBP
46745	1996	5	chiefly	chiefly	RB
46745	1996	6	used	use	VBN
46745	1996	7	in	in	IN
46745	1996	8	cases	case	NNS
46745	1996	9	in	in	IN
46745	1996	10	which	which	WDT
46745	1996	11	the	the	DT
46745	1996	12	nervous	nervous	JJ
46745	1996	13	system	system	NN
46745	1996	14	is	be	VBZ
46745	1996	15	unusually	unusually	RB
46745	1996	16	excited	excited	JJ
46745	1996	17	or	or	CC
46745	1996	18	depressed	depressed	JJ
46745	1996	19	,	,	,
46745	1996	20	and	and	CC
46745	1996	21	are	be	VBP
46745	1996	22	of	of	IN
46745	1996	23	no	no	DT
46745	1996	24	permanent	permanent	JJ
46745	1996	25	efficacy	efficacy	NN
46745	1996	26	in	in	IN
46745	1996	27	diseases	disease	NNS
46745	1996	28	depending	depend	VBG
46745	1996	29	on	on	IN
46745	1996	30	blood	blood	NN
46745	1996	31	-	-	HYPH
46745	1996	32	disorder	disorder	NN
46745	1996	33	.	.	.
46745	1997	1	The	the	DT
46745	1997	2	action	action	NN
46745	1997	3	of	of	IN
46745	1997	4	Hæmatics	Hæmatics	NNPS
46745	1997	5	is	be	VBZ
46745	1997	6	of	of	IN
46745	1997	7	an	an	DT
46745	1997	8	opposite	opposite	JJ
46745	1997	9	kind	kind	NN
46745	1997	10	.	.	.
46745	1998	1	Now	now	RB
46745	1998	2	is	be	VBZ
46745	1998	3	the	the	DT
46745	1998	4	primary	primary	JJ
46745	1998	5	action	action	NN
46745	1998	6	of	of	IN
46745	1998	7	Tonics	Tonics	NNPS
46745	1998	8	distinguished	distinguish	VBN
46745	1998	9	by	by	IN
46745	1998	10	the	the	DT
46745	1998	11	above	above	JJ
46745	1998	12	signs	sign	NNS
46745	1998	13	?	?	.
46745	1999	1	Are	be	VBP
46745	1999	2	they	-PRON-	PRP
46745	1999	3	quick	quick	JJ
46745	1999	4	and	and	CC
46745	1999	5	sudden	sudden	JJ
46745	1999	6	in	in	IN
46745	1999	7	action	action	NN
46745	1999	8	?	?	.
46745	2000	1	Is	be	VBZ
46745	2000	2	their	-PRON-	PRP$
46745	2000	3	effect	effect	NN
46745	2000	4	transitory	transitory	NN
46745	2000	5	?	?	.
46745	2001	1	Is	be	VBZ
46745	2001	2	it	-PRON-	PRP
46745	2001	3	evidenced	evidence	VBN
46745	2001	4	in	in	IN
46745	2001	5	health	health	NN
46745	2001	6	as	as	RB
46745	2001	7	well	well	RB
46745	2001	8	as	as	IN
46745	2001	9	in	in	IN
46745	2001	10	disease	disease	NN
46745	2001	11	?	?	.
46745	2002	1	Do	do	VBP
46745	2002	2	they	-PRON-	PRP
46745	2002	3	act	act	VB
46745	2002	4	on	on	IN
46745	2002	5	the	the	DT
46745	2002	6	superficial	superficial	JJ
46745	2002	7	nerves	nerve	NNS
46745	2002	8	,	,	,
46745	2002	9	when	when	WRB
46745	2002	10	applied	apply	VBN
46745	2002	11	to	to	IN
46745	2002	12	them	-PRON-	PRP
46745	2002	13	?	?	.
46745	2003	1	In	in	IN
46745	2003	2	each	each	DT
46745	2003	3	case	case	NN
46745	2003	4	the	the	DT
46745	2003	5	answer	answer	NN
46745	2003	6	must	must	MD
46745	2003	7	be	be	VB
46745	2003	8	a	a	DT
46745	2003	9	negative	negative	NN
46745	2003	10	.	.	.
46745	2004	1	In	in	IN
46745	2004	2	all	all	DT
46745	2004	3	of	of	IN
46745	2004	4	these	these	DT
46745	2004	5	particulars	particular	NNS
46745	2004	6	the	the	DT
46745	2004	7	operation	operation	NN
46745	2004	8	of	of	IN
46745	2004	9	vegetable	vegetable	NN
46745	2004	10	bitters	bitter	NNS
46745	2004	11	differs	differ	VBZ
46745	2004	12	from	from	IN
46745	2004	13	that	that	DT
46745	2004	14	of	of	IN
46745	2004	15	Neurotics	Neurotics	NNP
46745	2004	16	,	,	,
46745	2004	17	and	and	CC
46745	2004	18	coincides	coincide	VBZ
46745	2004	19	with	with	IN
46745	2004	20	that	that	DT
46745	2004	21	of	of	IN
46745	2004	22	Hæmatic	hæmatic	JJ
46745	2004	23	medicines	medicine	NNS
46745	2004	24	.	.	.
46745	2005	1	It	-PRON-	PRP
46745	2005	2	appears	appear	VBZ
46745	2005	3	that	that	IN
46745	2005	4	their	-PRON-	PRP$
46745	2005	5	action	action	NN
46745	2005	6	on	on	IN
46745	2005	7	the	the	DT
46745	2005	8	nervous	nervous	JJ
46745	2005	9	and	and	CC
46745	2005	10	muscular	muscular	JJ
46745	2005	11	systems	system	NNS
46745	2005	12	is	be	VBZ
46745	2005	13	secondary	secondary	JJ
46745	2005	14	.	.	.
46745	2006	1	They	-PRON-	PRP
46745	2006	2	could	could	MD
46745	2006	3	hardly	hardly	RB
46745	2006	4	in	in	IN
46745	2006	5	either	either	DT
46745	2006	6	case	case	NN
46745	2006	7	effect	effect	VB
46745	2006	8	any	any	DT
46745	2006	9	permanent	permanent	JJ
46745	2006	10	improvement	improvement	NN
46745	2006	11	without	without	IN
46745	2006	12	first	first	JJ
46745	2006	13	acting	act	VBG
46745	2006	14	on	on	IN
46745	2006	15	the	the	DT
46745	2006	16	blood	blood	NN
46745	2006	17	,	,	,
46745	2006	18	if	if	IN
46745	2006	19	we	-PRON-	PRP
46745	2006	20	may	may	MD
46745	2006	21	argue	argue	VB
46745	2006	22	from	from	IN
46745	2006	23	known	know	VBN
46745	2006	24	analogies	analogy	NNS
46745	2006	25	.	.	.
46745	2007	1	For	for	IN
46745	2007	2	Neurotics	Neurotics	NNP
46745	2007	3	and	and	CC
46745	2007	4	Astringents	Astringents	NNPS
46745	2007	5	,	,	,
46745	2007	6	which	which	WDT
46745	2007	7	operate	operate	VBP
46745	2007	8	directly	directly	RB
46745	2007	9	on	on	IN
46745	2007	10	these	these	DT
46745	2007	11	two	two	CD
46745	2007	12	systems	system	NNS
46745	2007	13	,	,	,
46745	2007	14	are	be	VBP
46745	2007	15	alike	alike	RB
46745	2007	16	transitory	transitory	NN
46745	2007	17	in	in	IN
46745	2007	18	the	the	DT
46745	2007	19	results	result	NNS
46745	2007	20	of	of	IN
46745	2007	21	their	-PRON-	PRP$
46745	2007	22	action	action	NN
46745	2007	23	.	.	.
46745	2008	1	Another	another	DT
46745	2008	2	demonstration	demonstration	NN
46745	2008	3	is	be	VBZ
46745	2008	4	required	require	VBN
46745	2008	5	,	,	,
46745	2008	6	before	before	IN
46745	2008	7	the	the	DT
46745	2008	8	presumption	presumption	NN
46745	2008	9	thus	thus	RB
46745	2008	10	established	establish	VBN
46745	2008	11	can	can	MD
46745	2008	12	approach	approach	VB
46745	2008	13	to	to	IN
46745	2008	14	a	a	DT
46745	2008	15	certainty	certainty	NN
46745	2008	16	.	.	.
46745	2009	1	We	-PRON-	PRP
46745	2009	2	require	require	VBP
46745	2009	3	proof	proof	NN
46745	2009	4	to	to	TO
46745	2009	5	show	show	VB
46745	2009	6	that	that	IN
46745	2009	7	the	the	DT
46745	2009	8	disorders	disorder	NNS
46745	2009	9	in	in	IN
46745	2009	10	which	which	WDT
46745	2009	11	Tonics	tonic	NNS
46745	2009	12	are	be	VBP
46745	2009	13	used	use	VBN
46745	2009	14	are	be	VBP
46745	2009	15	blood	blood	NN
46745	2009	16	-	-	HYPH
46745	2009	17	diseases	disease	NNS
46745	2009	18	.	.	.
46745	2010	1	This	this	DT
46745	2010	2	does	do	VBZ
46745	2010	3	not	not	RB
46745	2010	4	seem	seem	VB
46745	2010	5	to	to	TO
46745	2010	6	be	be	VB
46745	2010	7	difficult	difficult	JJ
46745	2010	8	.	.	.
46745	2011	1	The	the	DT
46745	2011	2	condition	condition	NN
46745	2011	3	of	of	IN
46745	2011	4	Debility	Debility	NNP
46745	2011	5	,	,	,
46745	2011	6	whatever	whatever	WDT
46745	2011	7	its	-PRON-	PRP$
46745	2011	8	proximate	proximate	NN
46745	2011	9	cause	cause	NN
46745	2011	10	,	,	,
46745	2011	11	seems	seem	VBZ
46745	2011	12	always	always	RB
46745	2011	13	to	to	TO
46745	2011	14	be	be	VB
46745	2011	15	traceable	traceable	JJ
46745	2011	16	in	in	IN
46745	2011	17	the	the	DT
46745	2011	18	first	first	JJ
46745	2011	19	place	place	NN
46745	2011	20	to	to	IN
46745	2011	21	a	a	DT
46745	2011	22	want	want	NN
46745	2011	23	in	in	IN
46745	2011	24	the	the	DT
46745	2011	25	blood	blood	NN
46745	2011	26	,	,	,
46745	2011	27	which	which	WDT
46745	2011	28	interferes	interfere	VBZ
46745	2011	29	with	with	IN
46745	2011	30	the	the	DT
46745	2011	31	due	due	JJ
46745	2011	32	exercise	exercise	NN
46745	2011	33	of	of	IN
46745	2011	34	their	-PRON-	PRP$
46745	2011	35	functions	function	NNS
46745	2011	36	by	by	IN
46745	2011	37	the	the	DT
46745	2011	38	nerves	nerve	NNS
46745	2011	39	and	and	CC
46745	2011	40	other	other	JJ
46745	2011	41	organs	organ	NNS
46745	2011	42	,	,	,
46745	2011	43	by	by	IN
46745	2011	44	impairing	impair	VBG
46745	2011	45	their	-PRON-	PRP$
46745	2011	46	nutrition	nutrition	NN
46745	2011	47	.	.	.
46745	2012	1	It	-PRON-	PRP
46745	2012	2	follows	follow	VBZ
46745	2012	3	fevers	fever	NNS
46745	2012	4	,	,	,
46745	2012	5	and	and	CC
46745	2012	6	accompanies	accompany	VBZ
46745	2012	7	chronic	chronic	JJ
46745	2012	8	diseases	disease	NNS
46745	2012	9	,	,	,
46745	2012	10	in	in	IN
46745	2012	11	both	both	DT
46745	2012	12	of	of	IN
46745	2012	13	which	which	WDT
46745	2012	14	cases	case	VBZ
46745	2012	15	the	the	DT
46745	2012	16	blood	blood	NN
46745	2012	17	has	have	VBZ
46745	2012	18	been	be	VBN
46745	2012	19	exhausted	exhaust	VBN
46745	2012	20	by	by	IN
46745	2012	21	continual	continual	JJ
46745	2012	22	waste	waste	NN
46745	2012	23	and	and	CC
46745	2012	24	excretion	excretion	NN
46745	2012	25	,	,	,
46745	2012	26	without	without	IN
46745	2012	27	the	the	DT
46745	2012	28	maintenance	maintenance	NN
46745	2012	29	of	of	IN
46745	2012	30	a	a	DT
46745	2012	31	proper	proper	JJ
46745	2012	32	supply	supply	NN
46745	2012	33	.	.	.
46745	2013	1	In	in	IN
46745	2013	2	cancerous	cancerous	JJ
46745	2013	3	,	,	,
46745	2013	4	scrofulous	scrofulous	JJ
46745	2013	5	,	,	,
46745	2013	6	scorbutic	scorbutic	JJ
46745	2013	7	,	,	,
46745	2013	8	and	and	CC
46745	2013	9	dyspeptic	dyspeptic	JJ
46745	2013	10	habits	habit	NNS
46745	2013	11	,	,	,
46745	2013	12	the	the	DT
46745	2013	13	blood	blood	NN
46745	2013	14	may	may	MD
46745	2013	15	be	be	VB
46745	2013	16	deteriorated	deteriorate	VBN
46745	2013	17	by	by	IN
46745	2013	18	a	a	DT
46745	2013	19	fault	fault	NN
46745	2013	20	in	in	IN
46745	2013	21	the	the	DT
46745	2013	22	assimilative	assimilative	NN
46745	2013	23	processes	process	NNS
46745	2013	24	.	.	.
46745	2014	1	When	when	WRB
46745	2014	2	in	in	IN
46745	2014	3	these	these	DT
46745	2014	4	instances	instance	NNS
46745	2014	5	there	there	EX
46745	2014	6	is	be	VBZ
46745	2014	7	marked	mark	VBN
46745	2014	8	Anæmia	Anæmia	NNP
46745	2014	9	,	,	,
46745	2014	10	iron	iron	NN
46745	2014	11	may	may	MD
46745	2014	12	be	be	VB
46745	2014	13	of	of	IN
46745	2014	14	most	most	JJS
46745	2014	15	service	service	NN
46745	2014	16	;	;	:
46745	2014	17	but	but	CC
46745	2014	18	when	when	WRB
46745	2014	19	the	the	DT
46745	2014	20	blood	blood	NN
46745	2014	21	is	be	VBZ
46745	2014	22	poor	poor	JJ
46745	2014	23	without	without	IN
46745	2014	24	any	any	DT
46745	2014	25	apparent	apparent	JJ
46745	2014	26	deficiency	deficiency	NN
46745	2014	27	of	of	IN
46745	2014	28	red	red	JJ
46745	2014	29	colouring	colouring	NN
46745	2014	30	matter	matter	NN
46745	2014	31	,	,	,
46745	2014	32	then	then	RB
46745	2014	33	are	be	VBP
46745	2014	34	bitter	bitter	JJ
46745	2014	35	Tonics	Tonics	NNPS
46745	2014	36	needed	need	VBN
46745	2014	37	to	to	TO
46745	2014	38	improve	improve	VB
46745	2014	39	its	-PRON-	PRP$
46745	2014	40	condition	condition	NN
46745	2014	41	,	,	,
46745	2014	42	and	and	CC
46745	2014	43	form	form	VB
46745	2014	44	a	a	DT
46745	2014	45	valuable	valuable	JJ
46745	2014	46	adjunct	adjunct	NN
46745	2014	47	to	to	IN
46745	2014	48	the	the	DT
46745	2014	49	special	special	JJ
46745	2014	50	remedies	remedy	NNS
46745	2014	51	that	that	IN
46745	2014	52	the	the	DT
46745	2014	53	case	case	NN
46745	2014	54	may	may	MD
46745	2014	55	require	require	VB
46745	2014	56	.	.	.
46745	2015	1	They	-PRON-	PRP
46745	2015	2	ought	ought	MD
46745	2015	3	not	not	RB
46745	2015	4	,	,	,
46745	2015	5	as	as	IN
46745	2015	6	a	a	DT
46745	2015	7	general	general	JJ
46745	2015	8	rule	rule	NN
46745	2015	9	,	,	,
46745	2015	10	to	to	TO
46745	2015	11	be	be	VB
46745	2015	12	administered	administer	VBN
46745	2015	13	in	in	IN
46745	2015	14	high	high	JJ
46745	2015	15	fever	fever	NN
46745	2015	16	,	,	,
46745	2015	17	or	or	CC
46745	2015	18	when	when	WRB
46745	2015	19	the	the	DT
46745	2015	20	pulse	pulse	NN
46745	2015	21	is	be	VBZ
46745	2015	22	hard	hard	JJ
46745	2015	23	,	,	,
46745	2015	24	the	the	DT
46745	2015	25	tongue	tongue	NN
46745	2015	26	coated	coat	VBD
46745	2015	27	,	,	,
46745	2015	28	or	or	CC
46745	2015	29	the	the	DT
46745	2015	30	stomach	stomach	NN
46745	2015	31	irritable	irritable	JJ
46745	2015	32	.	.	.
46745	2016	1	A	a	DT
46745	2016	2	loss	loss	NN
46745	2016	3	of	of	IN
46745	2016	4	appetite	appetite	NN
46745	2016	5	,	,	,
46745	2016	6	a	a	DT
46745	2016	7	nervous	nervous	JJ
46745	2016	8	headache	headache	NN
46745	2016	9	,	,	,
46745	2016	10	a	a	DT
46745	2016	11	soft	soft	JJ
46745	2016	12	compressible	compressible	JJ
46745	2016	13	pulse	pulse	NN
46745	2016	14	,	,	,
46745	2016	15	a	a	DT
46745	2016	16	quivering	quiver	VBG
46745	2016	17	tongue	tongue	NN
46745	2016	18	,	,	,
46745	2016	19	a	a	DT
46745	2016	20	flabby	flabby	NN
46745	2016	21	condition	condition	NN
46745	2016	22	of	of	IN
46745	2016	23	the	the	DT
46745	2016	24	muscles	muscle	NNS
46745	2016	25	,	,	,
46745	2016	26	with	with	IN
46745	2016	27	general	general	JJ
46745	2016	28	inertia	inertia	NN
46745	2016	29	and	and	CC
46745	2016	30	indisposition	indisposition	NN
46745	2016	31	to	to	IN
46745	2016	32	exertion	exertion	NN
46745	2016	33	,	,	,
46745	2016	34	are	be	VBP
46745	2016	35	indications	indication	NNS
46745	2016	36	for	for	IN
46745	2016	37	their	-PRON-	PRP$
46745	2016	38	employment	employment	NN
46745	2016	39	.	.	.
46745	2017	1	In	in	IN
46745	2017	2	some	some	DT
46745	2017	3	cases	case	NNS
46745	2017	4	emetics	emetic	NNS
46745	2017	5	and	and	CC
46745	2017	6	antimonials	antimonial	NNS
46745	2017	7	,	,	,
46745	2017	8	in	in	IN
46745	2017	9	others	other	NNS
46745	2017	10	mild	mild	JJ
46745	2017	11	purgatives	purgative	NNS
46745	2017	12	,	,	,
46745	2017	13	are	be	VBP
46745	2017	14	of	of	IN
46745	2017	15	use	use	NN
46745	2017	16	in	in	IN
46745	2017	17	preparing	prepare	VBG
46745	2017	18	the	the	DT
46745	2017	19	system	system	NN
46745	2017	20	for	for	IN
46745	2017	21	their	-PRON-	PRP$
46745	2017	22	reception	reception	NN
46745	2017	23	.	.	.
46745	2018	1	It	-PRON-	PRP
46745	2018	2	seems	seem	VBZ
46745	2018	3	then	then	RB
46745	2018	4	that	that	IN
46745	2018	5	Debility	Debility	NNP
46745	2018	6	is	be	VBZ
46745	2018	7	to	to	TO
46745	2018	8	be	be	VB
46745	2018	9	attributed	attribute	VBN
46745	2018	10	generally	generally	RB
46745	2018	11	to	to	IN
46745	2018	12	the	the	DT
46745	2018	13	state	state	NN
46745	2018	14	of	of	IN
46745	2018	15	the	the	DT
46745	2018	16	blood	blood	NN
46745	2018	17	;	;	:
46745	2018	18	and	and	CC
46745	2018	19	is	be	VBZ
46745	2018	20	to	to	TO
46745	2018	21	be	be	VB
46745	2018	22	cured	cure	VBN
46745	2018	23	by	by	IN
46745	2018	24	improving	improve	VBG
46745	2018	25	it	-PRON-	PRP
46745	2018	26	.	.	.
46745	2019	1	By	by	IN
46745	2019	2	so	so	RB
46745	2019	3	doing	do	VBG
46745	2019	4	we	-PRON-	PRP
46745	2019	5	may	may	MD
46745	2019	6	communicate	communicate	VB
46745	2019	7	tone	tone	NN
46745	2019	8	to	to	IN
46745	2019	9	the	the	DT
46745	2019	10	muscular	muscular	JJ
46745	2019	11	system	system	NN
46745	2019	12	,	,	,
46745	2019	13	improve	improve	VB
46745	2019	14	the	the	DT
46745	2019	15	appetite	appetite	NN
46745	2019	16	,	,	,
46745	2019	17	and	and	CC
46745	2019	18	increase	increase	VB
46745	2019	19	the	the	DT
46745	2019	20	nervous	nervous	JJ
46745	2019	21	force	force	NN
46745	2019	22	.	.	.
46745	2020	1	Ague	Ague	NNP
46745	2020	2	,	,	,
46745	2020	3	or	or	CC
46745	2020	4	Intermittent	intermittent	JJ
46745	2020	5	fever	fever	NN
46745	2020	6	,	,	,
46745	2020	7	is	be	VBZ
46745	2020	8	also	also	RB
46745	2020	9	a	a	DT
46745	2020	10	blood	blood	NN
46745	2020	11	-	-	HYPH
46745	2020	12	disease	disease	NN
46745	2020	13	.	.	.
46745	2021	1	If	if	IN
46745	2021	2	it	-PRON-	PRP
46745	2021	3	were	be	VBD
46745	2021	4	only	only	RB
46745	2021	5	from	from	IN
46745	2021	6	the	the	DT
46745	2021	7	analogy	analogy	NN
46745	2021	8	of	of	IN
46745	2021	9	other	other	JJ
46745	2021	10	fevers	fever	NNS
46745	2021	11	,	,	,
46745	2021	12	we	-PRON-	PRP
46745	2021	13	might	may	MD
46745	2021	14	infer	infer	VB
46745	2021	15	this	this	DT
46745	2021	16	.	.	.
46745	2022	1	But	but	CC
46745	2022	2	there	there	EX
46745	2022	3	are	be	VBP
46745	2022	4	more	more	RBR
46745	2022	5	particular	particular	JJ
46745	2022	6	proofs	proof	NNS
46745	2022	7	.	.	.
46745	2023	1	This	this	DT
46745	2023	2	disorder	disorder	NN
46745	2023	3	is	be	VBZ
46745	2023	4	caused	cause	VBN
46745	2023	5	by	by	IN
46745	2023	6	the	the	DT
46745	2023	7	exposure	exposure	NN
46745	2023	8	of	of	IN
46745	2023	9	the	the	DT
46745	2023	10	system	system	NN
46745	2023	11	to	to	IN
46745	2023	12	a	a	DT
46745	2023	13	certain	certain	JJ
46745	2023	14	peculiar	peculiar	JJ
46745	2023	15	poison	poison	NN
46745	2023	16	or	or	CC
46745	2023	17	miasm	miasm	NN
46745	2023	18	,	,	,
46745	2023	19	which	which	WDT
46745	2023	20	is	be	VBZ
46745	2023	21	generated	generate	VBN
46745	2023	22	in	in	IN
46745	2023	23	the	the	DT
46745	2023	24	ground	ground	NN
46745	2023	25	in	in	IN
46745	2023	26	certain	certain	JJ
46745	2023	27	places	place	NNS
46745	2023	28	,	,	,
46745	2023	29	and	and	CC
46745	2023	30	subject	subject	JJ
46745	2023	31	to	to	IN
46745	2023	32	known	know	VBN
46745	2023	33	laws	law	NNS
46745	2023	34	.	.	.
46745	2024	1	The	the	DT
46745	2024	2	result	result	NN
46745	2024	3	of	of	IN
46745	2024	4	the	the	DT
46745	2024	5	influence	influence	NN
46745	2024	6	of	of	IN
46745	2024	7	this	this	DT
46745	2024	8	miasm	miasm	NN
46745	2024	9	is	be	VBZ
46745	2024	10	a	a	DT
46745	2024	11	process	process	NN
46745	2024	12	in	in	IN
46745	2024	13	the	the	DT
46745	2024	14	blood	blood	NN
46745	2024	15	which	which	WDT
46745	2024	16	has	have	VBZ
46745	2024	17	been	be	VBN
46745	2024	18	compared	compare	VBN
46745	2024	19	to	to	IN
46745	2024	20	fermentation	fermentation	NN
46745	2024	21	,	,	,
46745	2024	22	and	and	CC
46745	2024	23	which	which	WDT
46745	2024	24	produces	produce	VBZ
46745	2024	25	regularly	regularly	RB
46745	2024	26	recurring	recur	VBG
46745	2024	27	paroxysms	paroxysm	NNS
46745	2024	28	of	of	IN
46745	2024	29	a	a	DT
46745	2024	30	peculiar	peculiar	JJ
46745	2024	31	kind	kind	NN
46745	2024	32	.	.	.
46745	2025	1	There	there	EX
46745	2025	2	is	be	VBZ
46745	2025	3	apparently	apparently	RB
46745	2025	4	some	some	DT
46745	2025	5	disturbance	disturbance	NN
46745	2025	6	in	in	IN
46745	2025	7	the	the	DT
46745	2025	8	great	great	JJ
46745	2025	9	calorifacient	calorifacient	NN
46745	2025	10	process	process	NN
46745	2025	11	,	,	,
46745	2025	12	in	in	IN
46745	2025	13	which	which	WDT
46745	2025	14	the	the	DT
46745	2025	15	blood	blood	NN
46745	2025	16	is	be	VBZ
46745	2025	17	concerned	concern	VBN
46745	2025	18	,	,	,
46745	2025	19	and	and	CC
46745	2025	20	not	not	RB
46745	2025	21	the	the	DT
46745	2025	22	nerves	nerve	NNS
46745	2025	23	.	.	.
46745	2026	1	Each	each	DT
46745	2026	2	fit	fit	JJ
46745	2026	3	commences	commence	VBZ
46745	2026	4	with	with	IN
46745	2026	5	shivering	shivering	NN
46745	2026	6	;	;	:
46745	2026	7	there	there	EX
46745	2026	8	is	be	VBZ
46745	2026	9	then	then	RB
46745	2026	10	a	a	DT
46745	2026	11	hot	hot	JJ
46745	2026	12	stage	stage	NN
46745	2026	13	;	;	,
46745	2026	14	and	and	CC
46745	2026	15	finally	finally	RB
46745	2026	16	sweating	sweat	VBG
46745	2026	17	.	.	.
46745	2027	1	The	the	DT
46745	2027	2	attack	attack	NN
46745	2027	3	then	then	RB
46745	2027	4	goes	go	VBZ
46745	2027	5	off	off	RP
46745	2027	6	,	,	,
46745	2027	7	seemingly	seemingly	RB
46745	2027	8	as	as	IN
46745	2027	9	if	if	IN
46745	2027	10	the	the	DT
46745	2027	11	poison	poison	NN
46745	2027	12	that	that	WDT
46745	2027	13	caused	cause	VBD
46745	2027	14	it	-PRON-	PRP
46745	2027	15	were	be	VBD
46745	2027	16	eliminated	eliminate	VBN
46745	2027	17	in	in	IN
46745	2027	18	the	the	DT
46745	2027	19	perspiration	perspiration	NN
46745	2027	20	.	.	.
46745	2028	1	But	but	CC
46745	2028	2	it	-PRON-	PRP
46745	2028	3	is	be	VBZ
46745	2028	4	not	not	RB
46745	2028	5	all	all	RB
46745	2028	6	gone	go	VBN
46745	2028	7	.	.	.
46745	2029	1	After	after	IN
46745	2029	2	working	work	VBG
46745	2029	3	in	in	IN
46745	2029	4	the	the	DT
46745	2029	5	blood	blood	NN
46745	2029	6	for	for	IN
46745	2029	7	a	a	DT
46745	2029	8	definite	definite	JJ
46745	2029	9	period	period	NN
46745	2029	10	,	,	,
46745	2029	11	most	most	JJS
46745	2029	12	commonly	commonly	RB
46745	2029	13	two	two	CD
46745	2029	14	days	day	NNS
46745	2029	15	,	,	,
46745	2029	16	it	-PRON-	PRP
46745	2029	17	again	again	RB
46745	2029	18	breaks	break	VBZ
46745	2029	19	out	out	RP
46745	2029	20	,	,	,
46745	2029	21	and	and	CC
46745	2029	22	the	the	DT
46745	2029	23	same	same	JJ
46745	2029	24	train	train	NN
46745	2029	25	of	of	IN
46745	2029	26	symptoms	symptom	NNS
46745	2029	27	recurs	recur	VBZ
46745	2029	28	.	.	.
46745	2030	1	Thus	thus	RB
46745	2030	2	this	this	DT
46745	2030	3	strange	strange	JJ
46745	2030	4	disorder	disorder	NN
46745	2030	5	,	,	,
46745	2030	6	both	both	CC
46745	2030	7	in	in	IN
46745	2030	8	its	-PRON-	PRP$
46745	2030	9	origin	origin	NN
46745	2030	10	and	and	CC
46745	2030	11	in	in	IN
46745	2030	12	its	-PRON-	PRP$
46745	2030	13	progress	progress	NN
46745	2030	14	,	,	,
46745	2030	15	appears	appear	VBZ
46745	2030	16	to	to	TO
46745	2030	17	be	be	VB
46745	2030	18	seated	seat	VBN
46745	2030	19	in	in	IN
46745	2030	20	the	the	DT
46745	2030	21	blood	blood	NN
46745	2030	22	.	.	.
46745	2031	1	So	so	RB
46745	2031	2	also	also	RB
46745	2031	3	are	be	VBP
46745	2031	4	its	-PRON-	PRP$
46745	2031	5	results	result	NNS
46745	2031	6	evidenced	evidence	VBN
46745	2031	7	there	there	RB
46745	2031	8	.	.	.
46745	2032	1	Continual	Continual	NNP
46745	2032	2	Ague	Ague	NNP
46745	2032	3	deteriorates	deteriorate	VBZ
46745	2032	4	that	that	DT
46745	2032	5	fluid	fluid	NN
46745	2032	6	,	,	,
46745	2032	7	causing	cause	VBG
46745	2032	8	general	general	JJ
46745	2032	9	anæmia	anæmia	NN
46745	2032	10	,	,	,
46745	2032	11	and	and	CC
46745	2032	12	producing	produce	VBG
46745	2032	13	more	more	JJR
46745	2032	14	or	or	CC
46745	2032	15	less	less	JJR
46745	2032	16	enlargement	enlargement	NN
46745	2032	17	of	of	IN
46745	2032	18	the	the	DT
46745	2032	19	spleen	spleen	NN
46745	2032	20	,	,	,
46745	2032	21	which	which	WDT
46745	2032	22	could	could	MD
46745	2032	23	only	only	RB
46745	2032	24	be	be	VB
46745	2032	25	brought	bring	VBN
46745	2032	26	about	about	RP
46745	2032	27	by	by	IN
46745	2032	28	some	some	DT
46745	2032	29	faulty	faulty	JJ
46745	2032	30	condition	condition	NN
46745	2032	31	of	of	IN
46745	2032	32	the	the	DT
46745	2032	33	circulation	circulation	NN
46745	2032	34	.	.	.
46745	2033	1	Against	against	IN
46745	2033	2	these	these	DT
46745	2033	3	proofs	proof	NNS
46745	2033	4	it	-PRON-	PRP
46745	2033	5	has	have	VBZ
46745	2033	6	been	be	VBN
46745	2033	7	urged	urge	VBN
46745	2033	8	that	that	IN
46745	2033	9	the	the	DT
46745	2033	10	nervous	nervous	JJ
46745	2033	11	system	system	NN
46745	2033	12	has	have	VBZ
46745	2033	13	certainly	certainly	RB
46745	2033	14	an	an	DT
46745	2033	15	influence	influence	NN
46745	2033	16	over	over	IN
46745	2033	17	this	this	DT
46745	2033	18	disorder	disorder	NN
46745	2033	19	,	,	,
46745	2033	20	for	for	IN
46745	2033	21	that	that	DT
46745	2033	22	a	a	DT
46745	2033	23	sudden	sudden	JJ
46745	2033	24	alarm	alarm	NN
46745	2033	25	has	have	VBZ
46745	2033	26	been	be	VBN
46745	2033	27	known	know	VBN
46745	2033	28	to	to	TO
46745	2033	29	arrest	arrest	VB
46745	2033	30	it	-PRON-	PRP
46745	2033	31	.	.	.
46745	2034	1	But	but	CC
46745	2034	2	this	this	DT
46745	2034	3	may	may	MD
46745	2034	4	occur	occur	VB
46745	2034	5	also	also	RB
46745	2034	6	with	with	IN
46745	2034	7	other	other	JJ
46745	2034	8	blood	blood	NN
46745	2034	9	-	-	HYPH
46745	2034	10	diseases	disease	NNS
46745	2034	11	,	,	,
46745	2034	12	and	and	CC
46745	2034	13	it	-PRON-	PRP
46745	2034	14	does	do	VBZ
46745	2034	15	not	not	RB
46745	2034	16	prove	prove	VB
46745	2034	17	that	that	IN
46745	2034	18	the	the	DT
46745	2034	19	nervous	nervous	JJ
46745	2034	20	system	system	NN
46745	2034	21	is	be	VBZ
46745	2034	22	at	at	RB
46745	2034	23	all	all	RB
46745	2034	24	connected	connected	JJ
46745	2034	25	with	with	IN
46745	2034	26	their	-PRON-	PRP$
46745	2034	27	origin	origin	NN
46745	2034	28	.	.	.
46745	2035	1	It	-PRON-	PRP
46745	2035	2	can	can	MD
46745	2035	3	hardly	hardly	RB
46745	2035	4	be	be	VB
46745	2035	5	supposed	suppose	VBN
46745	2035	6	that	that	IN
46745	2035	7	Goitre	Goitre	NNP
46745	2035	8	or	or	CC
46745	2035	9	Scrofula	Scrofula	NNP
46745	2035	10	is	be	VBZ
46745	2035	11	ever	ever	RB
46745	2035	12	caused	cause	VBN
46745	2035	13	by	by	IN
46745	2035	14	a	a	DT
46745	2035	15	derangement	derangement	NN
46745	2035	16	of	of	IN
46745	2035	17	the	the	DT
46745	2035	18	nerves	nerve	NNS
46745	2035	19	.	.	.
46745	2036	1	And	and	CC
46745	2036	2	yet	yet	RB
46745	2036	3	Baron	Baron	NNP
46745	2036	4	Alibert	Alibert	NNP
46745	2036	5	relates	relate	VBZ
46745	2036	6	an	an	DT
46745	2036	7	authentic	authentic	JJ
46745	2036	8	case	case	NN
46745	2036	9	of	of	IN
46745	2036	10	a	a	DT
46745	2036	11	French	french	JJ
46745	2036	12	lady	lady	NN
46745	2036	13	who	who	WP
46745	2036	14	had	have	VBD
46745	2036	15	a	a	DT
46745	2036	16	large	large	JJ
46745	2036	17	goitre	goitre	NN
46745	2036	18	,	,	,
46745	2036	19	which	which	WDT
46745	2036	20	for	for	IN
46745	2036	21	a	a	DT
46745	2036	22	long	long	JJ
46745	2036	23	time	time	NN
46745	2036	24	resisted	resist	VBD
46745	2036	25	all	all	DT
46745	2036	26	treatment	treatment	NN
46745	2036	27	,	,	,
46745	2036	28	but	but	CC
46745	2036	29	which	which	WDT
46745	2036	30	nevertheless	nevertheless	RB
46745	2036	31	disappeared	disappear	VBD
46745	2036	32	entirely	entirely	RB
46745	2036	33	during	during	IN
46745	2036	34	the	the	DT
46745	2036	35	brief	brief	JJ
46745	2036	36	Reign	Reign	NNP
46745	2036	37	of	of	IN
46745	2036	38	Terror	Terror	NNP
46745	2036	39	in	in	IN
46745	2036	40	the	the	DT
46745	2036	41	French	French	NNP
46745	2036	42	Revolution	Revolution	NNP
46745	2036	43	.	.	.
46745	2037	1	In	in	IN
46745	2037	2	addition	addition	NN
46745	2037	3	to	to	IN
46745	2037	4	these	these	DT
46745	2037	5	arguments	argument	NNS
46745	2037	6	it	-PRON-	PRP
46745	2037	7	may	may	MD
46745	2037	8	be	be	VB
46745	2037	9	urged	urge	VBN
46745	2037	10	that	that	IN
46745	2037	11	Ague	Ague	NNP
46745	2037	12	is	be	VBZ
46745	2037	13	often	often	RB
46745	2037	14	,	,	,
46745	2037	15	if	if	IN
46745	2037	16	not	not	RB
46745	2037	17	always	always	RB
46745	2037	18	,	,	,
46745	2037	19	connected	connect	VBN
46745	2037	20	with	with	IN
46745	2037	21	deranged	deranged	JJ
46745	2037	22	hepatic	hepatic	JJ
46745	2037	23	functions	function	NNS
46745	2037	24	,	,	,
46745	2037	25	a	a	DT
46745	2037	26	fact	fact	NN
46745	2037	27	that	that	IN
46745	2037	28	again	again	RB
46745	2037	29	points	point	VBZ
46745	2037	30	out	out	RP
46745	2037	31	that	that	DT
46745	2037	32	disease	disease	NN
46745	2037	33	as	as	IN
46745	2037	34	a	a	DT
46745	2037	35	blood	blood	NN
46745	2037	36	-	-	HYPH
46745	2037	37	disorder	disorder	NN
46745	2037	38	.	.	.
46745	2038	1	Seeing	see	VBG
46745	2038	2	then	then	RB
46745	2038	3	that	that	IN
46745	2038	4	the	the	DT
46745	2038	5	medicines	medicine	NNS
46745	2038	6	of	of	IN
46745	2038	7	this	this	DT
46745	2038	8	order	order	NN
46745	2038	9	of	of	IN
46745	2038	10	Tonics	Tonics	NNPS
46745	2038	11	differ	differ	VBP
46745	2038	12	in	in	IN
46745	2038	13	each	each	DT
46745	2038	14	particular	particular	JJ
46745	2038	15	of	of	IN
46745	2038	16	their	-PRON-	PRP$
46745	2038	17	action	action	NN
46745	2038	18	from	from	IN
46745	2038	19	those	those	DT
46745	2038	20	remedies	remedy	NNS
46745	2038	21	which	which	WDT
46745	2038	22	influence	influence	VBP
46745	2038	23	the	the	DT
46745	2038	24	nerves	nerve	NNS
46745	2038	25	directly	directly	RB
46745	2038	26	,	,	,
46745	2038	27	and	and	CC
46745	2038	28	that	that	IN
46745	2038	29	the	the	DT
46745	2038	30	diseases	disease	NNS
46745	2038	31	in	in	IN
46745	2038	32	which	which	WDT
46745	2038	33	they	-PRON-	PRP
46745	2038	34	act	act	VBP
46745	2038	35	beneficially	beneficially	RB
46745	2038	36	are	be	VBP
46745	2038	37	essentially	essentially	RB
46745	2038	38	blood	blood	NN
46745	2038	39	-	-	HYPH
46745	2038	40	diseases	disease	NNS
46745	2038	41	,	,	,
46745	2038	42	there	there	EX
46745	2038	43	are	be	VBP
46745	2038	44	sufficient	sufficient	JJ
46745	2038	45	grounds	ground	NNS
46745	2038	46	for	for	IN
46745	2038	47	concluding	conclude	VBG
46745	2038	48	them	-PRON-	PRP
46745	2038	49	to	to	TO
46745	2038	50	be	be	VB
46745	2038	51	Hæmatics	Hæmatics	NNPS
46745	2038	52	,	,	,
46745	2038	53	or	or	CC
46745	2038	54	blood	blood	NN
46745	2038	55	-	-	HYPH
46745	2038	56	medicines	medicine	NNS
46745	2038	57	.	.	.
46745	2039	1	We	-PRON-	PRP
46745	2039	2	have	have	VBP
46745	2039	3	now	now	RB
46745	2039	4	to	to	TO
46745	2039	5	consider	consider	VB
46745	2039	6	the	the	DT
46745	2039	7	remaining	remain	VBG
46745	2039	8	minor	minor	JJ
46745	2039	9	propositions	proposition	NNS
46745	2039	10	,	,	,
46745	2039	11	which	which	WDT
46745	2039	12	treat	treat	VBP
46745	2039	13	of	of	IN
46745	2039	14	their	-PRON-	PRP$
46745	2039	15	action	action	NN
46745	2039	16	as	as	IN
46745	2039	17	Restoratives	restorative	NNS
46745	2039	18	;	;	:
46745	2039	19	to	to	TO
46745	2039	20	ascertain	ascertain	VB
46745	2039	21	whether	whether	IN
46745	2039	22	they	-PRON-	PRP
46745	2039	23	have	have	VBP
46745	2039	24	been	be	VBN
46745	2039	25	rightly	rightly	RB
46745	2039	26	allotted	allot	VBN
46745	2039	27	to	to	IN
46745	2039	28	this	this	DT
46745	2039	29	division	division	NN
46745	2039	30	.	.	.
46745	2040	1	Are	be	VBP
46745	2040	2	there	there	EX
46745	2040	3	in	in	IN
46745	2040	4	healthy	healthy	JJ
46745	2040	5	blood	blood	NN
46745	2040	6	any	any	DT
46745	2040	7	substances	substance	NNS
46745	2040	8	which	which	WDT
46745	2040	9	resemble	resemble	VBP
46745	2040	10	them	-PRON-	PRP
46745	2040	11	?	?	.
46745	2041	1	This	this	DT
46745	2041	2	will	will	MD
46745	2041	3	appear	appear	VB
46745	2041	4	to	to	TO
46745	2041	5	be	be	VB
46745	2041	6	a	a	DT
46745	2041	7	question	question	NN
46745	2041	8	of	of	IN
46745	2041	9	no	no	DT
46745	2041	10	small	small	JJ
46745	2041	11	difficulty	difficulty	NN
46745	2041	12	,	,	,
46745	2041	13	when	when	WRB
46745	2041	14	it	-PRON-	PRP
46745	2041	15	is	be	VBZ
46745	2041	16	considered	consider	VBN
46745	2041	17	how	how	WRB
46745	2041	18	little	little	JJ
46745	2041	19	information	information	NN
46745	2041	20	we	-PRON-	PRP
46745	2041	21	have	have	VBP
46745	2041	22	actually	actually	RB
46745	2041	23	obtained	obtain	VBN
46745	2041	24	respecting	respect	VBG
46745	2041	25	the	the	DT
46745	2041	26	chemical	chemical	JJ
46745	2041	27	composition	composition	NN
46745	2041	28	of	of	IN
46745	2041	29	the	the	DT
46745	2041	30	vital	vital	JJ
46745	2041	31	fluid	fluid	NN
46745	2041	32	.	.	.
46745	2042	1	It	-PRON-	PRP
46745	2042	2	is	be	VBZ
46745	2042	3	nevertheless	nevertheless	RB
46745	2042	4	desirable	desirable	JJ
46745	2042	5	that	that	IN
46745	2042	6	we	-PRON-	PRP
46745	2042	7	should	should	MD
46745	2042	8	inquire	inquire	VB
46745	2042	9	into	into	IN
46745	2042	10	it	-PRON-	PRP
46745	2042	11	to	to	IN
46745	2042	12	the	the	DT
46745	2042	13	best	good	JJS
46745	2042	14	of	of	IN
46745	2042	15	our	-PRON-	PRP$
46745	2042	16	ability	ability	NN
46745	2042	17	.	.	.
46745	2043	1	During	during	IN
46745	2043	2	the	the	DT
46745	2043	3	last	last	JJ
46745	2043	4	few	few	JJ
46745	2043	5	years	year	NNS
46745	2043	6	,	,	,
46745	2043	7	many	many	JJ
46745	2043	8	propositions	proposition	NNS
46745	2043	9	,	,	,
46745	2043	10	intended	intend	VBN
46745	2043	11	to	to	TO
46745	2043	12	throw	throw	VB
46745	2043	13	a	a	DT
46745	2043	14	light	light	NN
46745	2043	15	upon	upon	IN
46745	2043	16	physiological	physiological	JJ
46745	2043	17	science	science	NN
46745	2043	18	,	,	,
46745	2043	19	have	have	VBP
46745	2043	20	emanated	emanate	VBN
46745	2043	21	from	from	IN
46745	2043	22	the	the	DT
46745	2043	23	fertile	fertile	JJ
46745	2043	24	pen	pen	NN
46745	2043	25	of	of	IN
46745	2043	26	M.	M.	NNP
46745	2043	27	Liebig	Liebig	NNP
46745	2043	28	of	of	IN
46745	2043	29	Giessen	Giessen	NNP
46745	2043	30	,	,	,
46745	2043	31	who	who	WP
46745	2043	32	is	be	VBZ
46745	2043	33	rightly	rightly	RB
46745	2043	34	and	and	CC
46745	2043	35	universally	universally	RB
46745	2043	36	ranked	rank	VBN
46745	2043	37	among	among	IN
46745	2043	38	the	the	DT
46745	2043	39	most	most	RBS
46745	2043	40	illustrious	illustrious	JJ
46745	2043	41	of	of	IN
46745	2043	42	modern	modern	JJ
46745	2043	43	chemists	chemist	NNS
46745	2043	44	.	.	.
46745	2044	1	There	there	EX
46745	2044	2	are	be	VBP
46745	2044	3	two	two	CD
46745	2044	4	which	which	WDT
46745	2044	5	especially	especially	RB
46745	2044	6	bear	bear	VBP
46745	2044	7	upon	upon	IN
46745	2044	8	the	the	DT
46745	2044	9	present	present	JJ
46745	2044	10	subject	subject	NN
46745	2044	11	.	.	.
46745	2045	1	In	in	IN
46745	2045	2	his	-PRON-	PRP$
46745	2045	3	first	first	JJ
46745	2045	4	work	work	NN
46745	2045	5	on	on	IN
46745	2045	6	Organic	Organic	NNP
46745	2045	7	Chemistry	Chemistry	NNP
46745	2045	8	(	(	-LRB-
46745	2045	9	p.	p.	NN
46745	2045	10	182	182	CD
46745	2045	11	,	,	,
46745	2045	12	)	)	-RRB-
46745	2045	13	he	-PRON-	PRP
46745	2045	14	argued	argue	VBD
46745	2045	15	,	,	,
46745	2045	16	that	that	IN
46745	2045	17	whereas	whereas	IN
46745	2045	18	the	the	DT
46745	2045	19	alkaloids	alkaloid	NNS
46745	2045	20	Quina	Quina	NNP
46745	2045	21	and	and	CC
46745	2045	22	Morphia	Morphia	NNP
46745	2045	23	resembled	resemble	VBD
46745	2045	24	the	the	DT
46745	2045	25	brain	brain	NN
46745	2045	26	substance	substance	NN
46745	2045	27	in	in	IN
46745	2045	28	their	-PRON-	PRP$
46745	2045	29	chemical	chemical	NN
46745	2045	30	constitution	constitution	NN
46745	2045	31	,	,	,
46745	2045	32	they	-PRON-	PRP
46745	2045	33	were	be	VBD
46745	2045	34	therefore	therefore	RB
46745	2045	35	enabled	enable	VBN
46745	2045	36	to	to	TO
46745	2045	37	exert	exert	VB
46745	2045	38	a	a	DT
46745	2045	39	direct	direct	JJ
46745	2045	40	control	control	NN
46745	2045	41	over	over	IN
46745	2045	42	that	that	DT
46745	2045	43	organ	organ	NN
46745	2045	44	by	by	IN
46745	2045	45	influencing	influence	VBG
46745	2045	46	its	-PRON-	PRP$
46745	2045	47	nutrition	nutrition	NN
46745	2045	48	.	.	.
46745	2046	1	But	but	CC
46745	2046	2	it	-PRON-	PRP
46745	2046	3	is	be	VBZ
46745	2046	4	impossible	impossible	JJ
46745	2046	5	to	to	TO
46745	2046	6	accept	accept	VB
46745	2046	7	this	this	DT
46745	2046	8	explanation	explanation	NN
46745	2046	9	.	.	.
46745	2047	1	The	the	DT
46745	2047	2	composition	composition	NN
46745	2047	3	of	of	IN
46745	2047	4	the	the	DT
46745	2047	5	brain	brain	NN
46745	2047	6	has	have	VBZ
46745	2047	7	been	be	VBN
46745	2047	8	since	since	IN
46745	2047	9	more	more	RBR
46745	2047	10	accurately	accurately	RB
46745	2047	11	investigated	investigate	VBN
46745	2047	12	,	,	,
46745	2047	13	and	and	CC
46745	2047	14	it	-PRON-	PRP
46745	2047	15	has	have	VBZ
46745	2047	16	been	be	VBN
46745	2047	17	shown	show	VBN
46745	2047	18	to	to	TO
46745	2047	19	consist	consist	VB
46745	2047	20	mainly	mainly	RB
46745	2047	21	of	of	IN
46745	2047	22	a	a	DT
46745	2047	23	mixture	mixture	NN
46745	2047	24	of	of	IN
46745	2047	25	albumen	albuman	NNS
46745	2047	26	and	and	CC
46745	2047	27	fat	fat	NN
46745	2047	28	.	.	.
46745	2048	1	Now	now	RB
46745	2048	2	there	there	EX
46745	2048	3	is	be	VBZ
46745	2048	4	no	no	DT
46745	2048	5	reason	reason	NN
46745	2048	6	why	why	WRB
46745	2048	7	these	these	DT
46745	2048	8	substances	substance	NNS
46745	2048	9	should	should	MD
46745	2048	10	have	have	VB
46745	2048	11	a	a	DT
46745	2048	12	special	special	JJ
46745	2048	13	affinity	affinity	NN
46745	2048	14	for	for	IN
46745	2048	15	albumen	albuman	NNS
46745	2048	16	and	and	CC
46745	2048	17	fat	fat	NN
46745	2048	18	in	in	IN
46745	2048	19	the	the	DT
46745	2048	20	brain	brain	NN
46745	2048	21	,	,	,
46745	2048	22	any	any	DT
46745	2048	23	more	more	RBR
46745	2048	24	than	than	IN
46745	2048	25	for	for	IN
46745	2048	26	the	the	DT
46745	2048	27	same	same	JJ
46745	2048	28	elements	element	NNS
46745	2048	29	in	in	IN
46745	2048	30	other	other	JJ
46745	2048	31	parts	part	NNS
46745	2048	32	of	of	IN
46745	2048	33	the	the	DT
46745	2048	34	body	body	NN
46745	2048	35	.	.	.
46745	2049	1	There	there	EX
46745	2049	2	is	be	VBZ
46745	2049	3	also	also	RB
46745	2049	4	no	no	DT
46745	2049	5	analogy	analogy	NN
46745	2049	6	at	at	RB
46745	2049	7	all	all	RB
46745	2049	8	between	between	IN
46745	2049	9	Quina	Quina	NNP
46745	2049	10	and	and	CC
46745	2049	11	Morphia	Morphia	NNP
46745	2049	12	as	as	IN
46745	2049	13	medicines	medicine	NNS
46745	2049	14	beyond	beyond	IN
46745	2049	15	their	-PRON-	PRP$
46745	2049	16	resemblance	resemblance	NN
46745	2049	17	in	in	IN
46745	2049	18	chemical	chemical	NN
46745	2049	19	constitution	constitution	NN
46745	2049	20	.	.	.
46745	2050	1	The	the	DT
46745	2050	2	theory	theory	NN
46745	2050	3	seems	seem	VBZ
46745	2050	4	to	to	TO
46745	2050	5	be	be	VB
46745	2050	6	altogether	altogether	RB
46745	2050	7	groundless	groundless	JJ
46745	2050	8	.	.	.
46745	2051	1	Another	another	DT
46745	2051	2	,	,	,
46745	2051	3	and	and	CC
46745	2051	4	a	a	DT
46745	2051	5	more	more	RBR
46745	2051	6	important	important	JJ
46745	2051	7	suggestion	suggestion	NN
46745	2051	8	has	have	VBZ
46745	2051	9	been	be	VBN
46745	2051	10	made	make	VBN
46745	2051	11	by	by	IN
46745	2051	12	the	the	DT
46745	2051	13	same	same	JJ
46745	2051	14	chemist	chemist	NN
46745	2051	15	.	.	.
46745	2052	1	He	-PRON-	PRP
46745	2052	2	has	have	VBZ
46745	2052	3	pointed	point	VBN
46745	2052	4	out	out	RP
46745	2052	5	a	a	DT
46745	2052	6	chemical	chemical	NN
46745	2052	7	analogy	analogy	NN
46745	2052	8	between	between	IN
46745	2052	9	certain	certain	JJ
46745	2052	10	vegetable	vegetable	NN
46745	2052	11	compounds	compound	NNS
46745	2052	12	and	and	CC
46745	2052	13	a	a	DT
46745	2052	14	substance	substance	NN
46745	2052	15	which	which	WDT
46745	2052	16	exists	exist	VBZ
46745	2052	17	in	in	IN
46745	2052	18	the	the	DT
46745	2052	19	bile	bile	NN
46745	2052	20	.	.	.
46745	2053	1	He	-PRON-	PRP
46745	2053	2	has	have	VBZ
46745	2053	3	shown	show	VBN
46745	2053	4	that	that	IN
46745	2053	5	for	for	IN
46745	2053	6	the	the	DT
46745	2053	7	most	most	JJS
46745	2053	8	part	part	NN
46745	2053	9	the	the	DT
46745	2053	10	elements	element	NNS
46745	2053	11	of	of	IN
46745	2053	12	the	the	DT
46745	2053	13	bile	bile	NN
46745	2053	14	re	re	VB
46745	2053	15	-	-	VB
46745	2053	16	enter	enter	VB
46745	2053	17	the	the	DT
46745	2053	18	blood	blood	NN
46745	2053	19	after	after	IN
46745	2053	20	passing	pass	VBG
46745	2053	21	into	into	IN
46745	2053	22	the	the	DT
46745	2053	23	intestine	intestine	NN
46745	2053	24	,	,	,
46745	2053	25	scarcely	scarcely	RB
46745	2053	26	more	more	JJR
46745	2053	27	than	than	IN
46745	2053	28	the	the	DT
46745	2053	29	colouring	colour	VBG
46745	2053	30	matter	matter	NN
46745	2053	31	being	be	VBG
46745	2053	32	finally	finally	RB
46745	2053	33	excreted	excrete	VBN
46745	2053	34	with	with	IN
46745	2053	35	the	the	DT
46745	2053	36	fæces	fæce	NNS
46745	2053	37	.	.	.
46745	2054	1	He	-PRON-	PRP
46745	2054	2	has	have	VBZ
46745	2054	3	found	find	VBN
46745	2054	4	that	that	IN
46745	2054	5	if	if	IN
46745	2054	6	an	an	DT
46745	2054	7	enema	enema	NN
46745	2054	8	of	of	IN
46745	2054	9	bile	bile	NN
46745	2054	10	be	be	VB
46745	2054	11	injected	inject	VBN
46745	2054	12	into	into	IN
46745	2054	13	the	the	DT
46745	2054	14	rectum	rectum	NN
46745	2054	15	,	,	,
46745	2054	16	it	-PRON-	PRP
46745	2054	17	becomes	become	VBZ
46745	2054	18	absorbed	absorb	VBN
46745	2054	19	there	there	RB
46745	2054	20	,	,	,
46745	2054	21	and	and	CC
46745	2054	22	does	do	VBZ
46745	2054	23	not	not	RB
46745	2054	24	afterwards	afterwards	RB
46745	2054	25	pass	pass	VB
46745	2054	26	out	out	RP
46745	2054	27	into	into	IN
46745	2054	28	the	the	DT
46745	2054	29	urine	urine	NN
46745	2054	30	.	.	.
46745	2055	1	[	[	-LRB-
46745	2055	2	33	33	CD
46745	2055	3	]	]	-RRB-
46745	2055	4	(	(	-LRB-
46745	2055	5	_	_	NNP
46745	2055	6	Animal	Animal	NNP
46745	2055	7	Chemistry	Chemistry	NNP
46745	2055	8	_	_	NNP
46745	2055	9	,	,	,
46745	2055	10	p.	p.	NN
46745	2056	1	77	77	CD
46745	2056	2	.	.	.
46745	2056	3	)	)	-RRB-
46745	2057	1	What	what	WP
46745	2057	2	the	the	DT
46745	2057	3	exact	exact	JJ
46745	2057	4	function	function	NN
46745	2057	5	of	of	IN
46745	2057	6	the	the	DT
46745	2057	7	bile	bile	NN
46745	2057	8	may	may	MD
46745	2057	9	be	be	VB
46745	2057	10	,	,	,
46745	2057	11	is	be	VBZ
46745	2057	12	as	as	RB
46745	2057	13	yet	yet	RB
46745	2057	14	undecided	undecided	JJ
46745	2057	15	.	.	.
46745	2058	1	Its	-PRON-	PRP$
46745	2058	2	most	most	RBS
46745	2058	3	important	important	JJ
46745	2058	4	constituents	constituent	NNS
46745	2058	5	are	be	VBP
46745	2058	6	,	,	,
46745	2058	7	a	a	DT
46745	2058	8	non	non	JJ
46745	2058	9	-	-	JJ
46745	2058	10	saponifiable	saponifiable	JJ
46745	2058	11	fat	fat	NN
46745	2058	12	,	,	,
46745	2058	13	Cholesterine	Cholesterine	NNP
46745	2058	14	;	;	:
46745	2058	15	a	a	DT
46745	2058	16	neutral	neutral	JJ
46745	2058	17	substance	substance	NN
46745	2058	18	,	,	,
46745	2058	19	Taurine	Taurine	NNP
46745	2058	20	;	;	:
46745	2058	21	and	and	CC
46745	2058	22	an	an	DT
46745	2058	23	acid	acid	NN
46745	2058	24	called	call	VBN
46745	2058	25	Choleic	Choleic	NNP
46745	2058	26	,	,	,
46745	2058	27	in	in	IN
46745	2058	28	combination	combination	NN
46745	2058	29	with	with	IN
46745	2058	30	Soda,--which	Soda,--which	NNP
46745	2058	31	latter	latter	NNP
46745	2058	32	is	be	VBZ
46745	2058	33	present	present	JJ
46745	2058	34	in	in	IN
46745	2058	35	excess	excess	NN
46745	2058	36	.	.	.
46745	2059	1	Bile	bile	NN
46745	2059	2	is	be	VBZ
46745	2059	3	bitter	bitter	JJ
46745	2059	4	to	to	IN
46745	2059	5	the	the	DT
46745	2059	6	taste	taste	NN
46745	2059	7	;	;	:
46745	2059	8	and	and	CC
46745	2059	9	ox	ox	JJ
46745	2059	10	-	-	HYPH
46745	2059	11	gall	gall	NN
46745	2059	12	,	,	,
46745	2059	13	or	or	CC
46745	2059	14	the	the	DT
46745	2059	15	bile	bile	NN
46745	2059	16	of	of	IN
46745	2059	17	an	an	DT
46745	2059	18	ox	ox	NN
46745	2059	19	,	,	,
46745	2059	20	has	have	VBZ
46745	2059	21	been	be	VBN
46745	2059	22	found	find	VBN
46745	2059	23	,	,	,
46745	2059	24	when	when	WRB
46745	2059	25	administered	administer	VBN
46745	2059	26	as	as	IN
46745	2059	27	a	a	DT
46745	2059	28	medicine	medicine	NN
46745	2059	29	,	,	,
46745	2059	30	to	to	TO
46745	2059	31	have	have	VB
46745	2059	32	an	an	DT
46745	2059	33	action	action	NN
46745	2059	34	which	which	WDT
46745	2059	35	resembles	resemble	VBZ
46745	2059	36	that	that	IN
46745	2059	37	of	of	IN
46745	2059	38	Tonics	tonic	NNS
46745	2059	39	.	.	.
46745	2060	1	It	-PRON-	PRP
46745	2060	2	appears	appear	VBZ
46745	2060	3	that	that	IN
46745	2060	4	both	both	CC
46745	2060	5	the	the	DT
46745	2060	6	bitterness	bitterness	NN
46745	2060	7	and	and	CC
46745	2060	8	the	the	DT
46745	2060	9	tonic	tonic	NN
46745	2060	10	action	action	NN
46745	2060	11	reside	reside	NN
46745	2060	12	in	in	IN
46745	2060	13	the	the	DT
46745	2060	14	Taurine	Taurine	NNP
46745	2060	15	.	.	.
46745	2061	1	M.	M.	NNP
46745	2061	2	Liebig	Liebig	NNP
46745	2061	3	has	have	VBZ
46745	2061	4	pointed	point	VBN
46745	2061	5	out	out	RP
46745	2061	6	an	an	DT
46745	2061	7	important	important	JJ
46745	2061	8	chemical	chemical	NN
46745	2061	9	resemblance	resemblance	NN
46745	2061	10	between	between	IN
46745	2061	11	this	this	DT
46745	2061	12	Taurine	Taurine	NNP
46745	2061	13	and	and	CC
46745	2061	14	the	the	DT
46745	2061	15	vegetable	vegetable	NN
46745	2061	16	alkaloids	alkaloid	NNS
46745	2061	17	.	.	.
46745	2062	1	Of	of	IN
46745	2062	2	these	these	DT
46745	2062	3	he	-PRON-	PRP
46745	2062	4	has	have	VBZ
46745	2062	5	singled	single	VBN
46745	2062	6	out	out	RP
46745	2062	7	Caffeine	Caffeine	NNP
46745	2062	8	,	,	,
46745	2062	9	the	the	DT
46745	2062	10	peculiar	peculiar	JJ
46745	2062	11	principle	principle	NN
46745	2062	12	of	of	IN
46745	2062	13	Tea	Tea	NNP
46745	2062	14	and	and	CC
46745	2062	15	Coffee	Coffee	NNP
46745	2062	16	,	,	,
46745	2062	17	as	as	IN
46745	2062	18	most	most	RBS
46745	2062	19	analogous	analogous	JJ
46745	2062	20	to	to	IN
46745	2062	21	the	the	DT
46745	2062	22	biliary	biliary	JJ
46745	2062	23	product	product	NN
46745	2062	24	.	.	.
46745	2063	1	From	from	IN
46745	2063	2	the	the	DT
46745	2063	3	analysis	analysis	NN
46745	2063	4	of	of	IN
46745	2063	5	these	these	DT
46745	2063	6	two	two	CD
46745	2063	7	substances	substance	NNS
46745	2063	8	he	-PRON-	PRP
46745	2063	9	has	have	VBZ
46745	2063	10	deduced	deduce	VBN
46745	2063	11	the	the	DT
46745	2063	12	following	follow	VBG
46745	2063	13	formulæ	formulæ	NN
46745	2063	14	.	.	.
46745	2064	1	Taurine	taurine	NN
46745	2064	2	=	=	SYM
46745	2064	3	C_{4}H_{7}NO_{10	C_{4}H_{7}NO_{10	NNP
46745	2064	4	}	}	-RRB-
46745	2064	5	.	.	.
46745	2065	1	Caffeine	Caffeine	NNP
46745	2065	2	=	=	SYM
46745	2065	3	C_{8}HN_{2}O_{2	C_{8}HN_{2}O_{2	-LRB-
46745	2065	4	}	}	-RRB-
46745	2065	5	.	.	.
46745	2066	1	Then	then	RB
46745	2066	2	he	-PRON-	PRP
46745	2066	3	shows	show	VBZ
46745	2066	4	that	that	IN
46745	2066	5	an	an	DT
46745	2066	6	atom	atom	NN
46745	2066	7	of	of	IN
46745	2066	8	Caffeine	Caffeine	NNP
46745	2066	9	,	,	,
46745	2066	10	if	if	IN
46745	2066	11	added	add	VBN
46745	2066	12	to	to	IN
46745	2066	13	9	9	CD
46745	2066	14	of	of	IN
46745	2066	15	water	water	NN
46745	2066	16	and	and	CC
46745	2066	17	9	9	CD
46745	2066	18	of	of	IN
46745	2066	19	oxygen	oxygen	NN
46745	2066	20	,	,	,
46745	2066	21	will	will	MD
46745	2066	22	form	form	VB
46745	2066	23	two	two	CD
46745	2066	24	atoms	atom	NNS
46745	2066	25	of	of	IN
46745	2066	26	Taurine	taurine	NN
46745	2066	27	.	.	.
46745	2067	1	(	(	-LRB-
46745	2067	2	_	_	NNP
46745	2067	3	Organic	Organic	NNP
46745	2067	4	Chemistry	Chemistry	NNP
46745	2067	5	_	_	NNP
46745	2067	6	,	,	,
46745	2067	7	1842	1842	CD
46745	2067	8	,	,	,
46745	2067	9	p.	p.	NN
46745	2068	1	180	180	CD
46745	2068	2	.	.	.
46745	2068	3	)	)	-RRB-
46745	2069	1	It	-PRON-	PRP
46745	2069	2	should	should	MD
46745	2069	3	be	be	VB
46745	2069	4	remarked	remark	VBN
46745	2069	5	that	that	IN
46745	2069	6	a	a	DT
46745	2069	7	different	different	JJ
46745	2069	8	formula	formula	NN
46745	2069	9	for	for	IN
46745	2069	10	Taurine	Taurine	NNP
46745	2069	11	has	have	VBZ
46745	2069	12	been	be	VBN
46745	2069	13	arrived	arrive	VBN
46745	2069	14	at	at	IN
46745	2069	15	by	by	IN
46745	2069	16	M.	M.	NNP
46745	2069	17	Lehmann	Lehmann	NNP
46745	2069	18	and	and	CC
46745	2069	19	others	other	NNS
46745	2069	20	,	,	,
46745	2069	21	who	who	WP
46745	2069	22	assert	assert	VBP
46745	2069	23	that	that	IN
46745	2069	24	it	-PRON-	PRP
46745	2069	25	contains	contain	VBZ
46745	2069	26	Sulphur	Sulphur	NNP
46745	2069	27	.	.	.
46745	2070	1	Choleic	Choleic	NNP
46745	2070	2	acid	acid	NN
46745	2070	3	,	,	,
46745	2070	4	and	and	CC
46745	2070	5	other	other	JJ
46745	2070	6	constituents	constituent	NNS
46745	2070	7	of	of	IN
46745	2070	8	this	this	DT
46745	2070	9	complicated	complicate	VBN
46745	2070	10	fluid	fluid	NN
46745	2070	11	,	,	,
46745	2070	12	certainly	certainly	RB
46745	2070	13	contain	contain	VBP
46745	2070	14	sulphur	sulphur	NN
46745	2070	15	.	.	.
46745	2071	1	But	but	CC
46745	2071	2	even	even	RB
46745	2071	3	if	if	IN
46745	2071	4	Sulphur	Sulphur	NNP
46745	2071	5	be	be	VB
46745	2071	6	combined	combine	VBN
46745	2071	7	with	with	IN
46745	2071	8	Taurine	Taurine	NNP
46745	2071	9	,	,	,
46745	2071	10	it	-PRON-	PRP
46745	2071	11	is	be	VBZ
46745	2071	12	not	not	RB
46745	2071	13	clear	clear	JJ
46745	2071	14	that	that	IN
46745	2071	15	it	-PRON-	PRP
46745	2071	16	enters	enter	VBZ
46745	2071	17	with	with	IN
46745	2071	18	it	-PRON-	PRP
46745	2071	19	into	into	IN
46745	2071	20	the	the	DT
46745	2071	21	blood	blood	NN
46745	2071	22	.	.	.
46745	2072	1	And	and	CC
46745	2072	2	the	the	DT
46745	2072	3	above	above	JJ
46745	2072	4	formula	formula	NN
46745	2072	5	for	for	IN
46745	2072	6	Taurine	Taurine	NNP
46745	2072	7	has	have	VBZ
46745	2072	8	been	be	VBN
46745	2072	9	confirmed	confirm	VBN
46745	2072	10	by	by	IN
46745	2072	11	the	the	DT
46745	2072	12	analysis	analysis	NN
46745	2072	13	of	of	IN
46745	2072	14	M.	M.	NNP
46745	2073	1	Löwig	Löwig	NNP
46745	2073	2	.	.	.
46745	2074	1	[	[	-LRB-
46745	2074	2	34	34	CD
46745	2074	3	]	]	-RRB-
46745	2074	4	It	-PRON-	PRP
46745	2074	5	seems	seem	VBZ
46745	2074	6	to	to	TO
46745	2074	7	be	be	VB
46745	2074	8	sufficiently	sufficiently	RB
46745	2074	9	correct	correct	JJ
46745	2074	10	for	for	IN
46745	2074	11	our	-PRON-	PRP$
46745	2074	12	purpose	purpose	NN
46745	2074	13	.	.	.
46745	2075	1	With	with	IN
46745	2075	2	the	the	DT
46745	2075	3	supposed	suppose	VBN
46745	2075	4	function	function	NN
46745	2075	5	of	of	IN
46745	2075	6	Caffeine	Caffeine	NNP
46745	2075	7	as	as	IN
46745	2075	8	a	a	DT
46745	2075	9	creator	creator	NN
46745	2075	10	of	of	IN
46745	2075	11	bile	bile	NN
46745	2075	12	,	,	,
46745	2075	13	however	however	RB
46745	2075	14	probable	probable	JJ
46745	2075	15	or	or	CC
46745	2075	16	interesting	interesting	JJ
46745	2075	17	,	,	,
46745	2075	18	we	-PRON-	PRP
46745	2075	19	are	be	VBP
46745	2075	20	not	not	RB
46745	2075	21	now	now	RB
46745	2075	22	immediately	immediately	RB
46745	2075	23	concerned	concerned	JJ
46745	2075	24	.	.	.
46745	2076	1	We	-PRON-	PRP
46745	2076	2	are	be	VBP
46745	2076	3	engaged	engage	VBN
46745	2076	4	in	in	IN
46745	2076	5	inquiring	inquire	VBG
46745	2076	6	whether	whether	IN
46745	2076	7	there	there	EX
46745	2076	8	is	be	VBZ
46745	2076	9	naturally	naturally	RB
46745	2076	10	in	in	IN
46745	2076	11	the	the	DT
46745	2076	12	blood	blood	NN
46745	2076	13	any	any	DT
46745	2076	14	substance	substance	NN
46745	2076	15	which	which	WDT
46745	2076	16	resembles	resemble	VBZ
46745	2076	17	the	the	DT
46745	2076	18	tonic	tonic	NN
46745	2076	19	alkaloids	alkaloid	VBZ
46745	2076	20	.	.	.
46745	2077	1	Liebig	Liebig	NNP
46745	2077	2	has	have	VBZ
46745	2077	3	shown	show	VBN
46745	2077	4	that	that	IN
46745	2077	5	this	this	DT
46745	2077	6	element	element	NN
46745	2077	7	of	of	IN
46745	2077	8	the	the	DT
46745	2077	9	bile	bile	NN
46745	2077	10	is	be	VBZ
46745	2077	11	intended	intend	VBN
46745	2077	12	for	for	IN
46745	2077	13	re	re	NN
46745	2077	14	-	-	NN
46745	2077	15	absorption	absorption	NN
46745	2077	16	into	into	IN
46745	2077	17	the	the	DT
46745	2077	18	circulation	circulation	NN
46745	2077	19	.	.	.
46745	2078	1	And	and	CC
46745	2078	2	without	without	IN
46745	2078	3	theorizing	theorize	VBG
46745	2078	4	at	at	RB
46745	2078	5	all	all	RB
46745	2078	6	on	on	IN
46745	2078	7	the	the	DT
46745	2078	8	subject	subject	NN
46745	2078	9	,	,	,
46745	2078	10	it	-PRON-	PRP
46745	2078	11	may	may	MD
46745	2078	12	readily	readily	RB
46745	2078	13	be	be	VB
46745	2078	14	demonstrated	demonstrate	VBN
46745	2078	15	that	that	IN
46745	2078	16	,	,	,
46745	2078	17	with	with	IN
46745	2078	18	the	the	DT
46745	2078	19	existence	existence	NN
46745	2078	20	in	in	IN
46745	2078	21	the	the	DT
46745	2078	22	blood	blood	NN
46745	2078	23	of	of	IN
46745	2078	24	such	such	PDT
46745	2078	25	a	a	DT
46745	2078	26	material	material	NN
46745	2078	27	as	as	IN
46745	2078	28	Taurine	Taurine	NNP
46745	2078	29	,	,	,
46745	2078	30	we	-PRON-	PRP
46745	2078	31	can	can	MD
46745	2078	32	not	not	RB
46745	2078	33	say	say	VB
46745	2078	34	that	that	IN
46745	2078	35	we	-PRON-	PRP
46745	2078	36	have	have	VBP
46745	2078	37	not	not	RB
46745	2078	38	in	in	IN
46745	2078	39	that	that	DT
46745	2078	40	fluid	fluid	NN
46745	2078	41	an	an	DT
46745	2078	42	analogue	analogue	NN
46745	2078	43	to	to	IN
46745	2078	44	substances	substance	NNS
46745	2078	45	like	like	IN
46745	2078	46	Quina	Quina	NNP
46745	2078	47	.	.	.
46745	2079	1	Taurine	taurine	NN
46745	2079	2	is	be	VBZ
46745	2079	3	soluble	soluble	JJ
46745	2079	4	in	in	IN
46745	2079	5	water	water	NN
46745	2079	6	,	,	,
46745	2079	7	and	and	CC
46745	2079	8	crystallizable	crystallizable	JJ
46745	2079	9	;	;	:
46745	2079	10	is	be	VBZ
46745	2079	11	chemically	chemically	RB
46745	2079	12	analogous	analogous	JJ
46745	2079	13	to	to	IN
46745	2079	14	the	the	DT
46745	2079	15	tonic	tonic	JJ
46745	2079	16	bitter	bitter	JJ
46745	2079	17	principles	principle	NNS
46745	2079	18	;	;	:
46745	2079	19	and	and	CC
46745	2079	20	contains	contain	VBZ
46745	2079	21	the	the	DT
46745	2079	22	same	same	JJ
46745	2079	23	four	four	CD
46745	2079	24	elements	element	NNS
46745	2079	25	as	as	IN
46745	2079	26	Quina	Quina	NNP
46745	2079	27	.	.	.
46745	2080	1	If	if	IN
46745	2080	2	necessary	necessary	JJ
46745	2080	3	,	,	,
46745	2080	4	this	this	DT
46745	2080	5	similarity	similarity	NN
46745	2080	6	could	could	MD
46745	2080	7	be	be	VB
46745	2080	8	exchanged	exchange	VBN
46745	2080	9	for	for	IN
46745	2080	10	identity	identity	NN
46745	2080	11	,	,	,
46745	2080	12	and	and	CC
46745	2080	13	Quina	Quina	NNP
46745	2080	14	could	could	MD
46745	2080	15	be	be	VB
46745	2080	16	formed	form	VBN
46745	2080	17	into	into	IN
46745	2080	18	Taurine	Taurine	NNP
46745	2080	19	in	in	IN
46745	2080	20	the	the	DT
46745	2080	21	blood	blood	NN
46745	2080	22	.	.	.
46745	2081	1	If	if	IN
46745	2081	2	there	there	EX
46745	2081	3	be	be	VB
46745	2081	4	one	one	CD
46745	2081	5	change	change	NN
46745	2081	6	in	in	IN
46745	2081	7	the	the	DT
46745	2081	8	blood	blood	NN
46745	2081	9	to	to	IN
46745	2081	10	which	which	WDT
46745	2081	11	,	,	,
46745	2081	12	more	more	JJR
46745	2081	13	than	than	IN
46745	2081	14	to	to	IN
46745	2081	15	any	any	DT
46745	2081	16	other	other	JJ
46745	2081	17	,	,	,
46745	2081	18	the	the	DT
46745	2081	19	substances	substance	NNS
46745	2081	20	which	which	WDT
46745	2081	21	enter	enter	VBP
46745	2081	22	it	-PRON-	PRP
46745	2081	23	are	be	VBP
46745	2081	24	liable	liable	JJ
46745	2081	25	,	,	,
46745	2081	26	it	-PRON-	PRP
46745	2081	27	is	be	VBZ
46745	2081	28	certainly	certainly	RB
46745	2081	29	the	the	DT
46745	2081	30	process	process	NN
46745	2081	31	of	of	IN
46745	2081	32	oxidation	oxidation	NN
46745	2081	33	.	.	.
46745	2082	1	Free	free	JJ
46745	2082	2	oxygen	oxygen	NN
46745	2082	3	is	be	VBZ
46745	2082	4	continually	continually	RB
46745	2082	5	entering	enter	VBG
46745	2082	6	the	the	DT
46745	2082	7	blood	blood	NN
46745	2082	8	through	through	IN
46745	2082	9	the	the	DT
46745	2082	10	air	air	NN
46745	2082	11	-	-	HYPH
46745	2082	12	cells	cell	NNS
46745	2082	13	of	of	IN
46745	2082	14	the	the	DT
46745	2082	15	lungs	lung	NNS
46745	2082	16	.	.	.
46745	2083	1	The	the	DT
46745	2083	2	formula	formula	NN
46745	2083	3	for	for	IN
46745	2083	4	Quina	Quina	NNP
46745	2083	5	is	be	VBZ
46745	2083	6	C_{20}H_{12}NO_{2	c_{20}h_{12}no_{2	NN
46745	2083	7	}	}	-RRB-
46745	2083	8	.	.	.
46745	2084	1	Adding	add	VBG
46745	2084	2	to	to	IN
46745	2084	3	this	this	DT
46745	2084	4	45	45	CD
46745	2084	5	atoms	atom	NNS
46745	2084	6	of	of	IN
46745	2084	7	oxygen	oxygen	NN
46745	2084	8	,	,	,
46745	2084	9	we	-PRON-	PRP
46745	2084	10	could	could	MD
46745	2084	11	make	make	VB
46745	2084	12	out	out	IN
46745	2084	13	of	of	IN
46745	2084	14	it	-PRON-	PRP
46745	2084	15	one	one	CD
46745	2084	16	atom	atom	NN
46745	2084	17	of	of	IN
46745	2084	18	Taurine	Taurine	NNP
46745	2084	19	,	,	,
46745	2084	20	together	together	RB
46745	2084	21	with	with	IN
46745	2084	22	16	16	CD
46745	2084	23	of	of	IN
46745	2084	24	Carbonic	Carbonic	NNP
46745	2084	25	acid	acid	NN
46745	2084	26	,	,	,
46745	2084	27	and	and	CC
46745	2084	28	3	3	CD
46745	2084	29	of	of	IN
46745	2084	30	water	water	NN
46745	2084	31	.	.	.
46745	2085	1	C_{20}H_{12}NO_{2	C_{20}H_{12}NO_{2	NNP
46745	2085	2	}	}	-RRB-
46745	2085	3	+	+	CC
46745	2085	4	45	45	CD
46745	2085	5	O	o	NN
46745	2085	6	=	=	SYM
46745	2085	7	C_{4}H_{7}NO_{10	C_{4}H_{7}NO_{10	NNP
46745	2085	8	}	}	-RRB-
46745	2085	9	+	+	CC
46745	2085	10	16	16	CD
46745	2085	11	CO_{2	CO_{2	NNP
46745	2085	12	}	}	-RRB-
46745	2085	13	+	+	CC
46745	2085	14	5	5	CD
46745	2085	15	HO	HO	NNP
46745	2085	16	.	.	.
46745	2086	1	Thus	thus	RB
46745	2086	2	it	-PRON-	PRP
46745	2086	3	is	be	VBZ
46745	2086	4	conceivable	conceivable	JJ
46745	2086	5	that	that	IN
46745	2086	6	this	this	DT
46745	2086	7	and	and	CC
46745	2086	8	similar	similar	JJ
46745	2086	9	alkaloids	alkaloid	NNS
46745	2086	10	may	may	MD
46745	2086	11	at	at	IN
46745	2086	12	the	the	DT
46745	2086	13	same	same	JJ
46745	2086	14	time	time	NN
46745	2086	15	supply	supply	NN
46745	2086	16	an	an	DT
46745	2086	17	important	important	JJ
46745	2086	18	material	material	NN
46745	2086	19	to	to	IN
46745	2086	20	the	the	DT
46745	2086	21	blood	blood	NN
46745	2086	22	,	,	,
46745	2086	23	and	and	CC
46745	2086	24	serve	serve	VB
46745	2086	25	as	as	IN
46745	2086	26	fuel	fuel	NN
46745	2086	27	to	to	TO
46745	2086	28	support	support	VB
46745	2086	29	the	the	DT
46745	2086	30	animal	animal	NN
46745	2086	31	heat	heat	NN
46745	2086	32	,	,	,
46745	2086	33	by	by	IN
46745	2086	34	combining	combine	VBG
46745	2086	35	with	with	IN
46745	2086	36	oxygen	oxygen	NN
46745	2086	37	and	and	CC
46745	2086	38	giving	give	VBG
46745	2086	39	off	off	RP
46745	2086	40	Carbonic	carbonic	JJ
46745	2086	41	acid	acid	NN
46745	2086	42	.	.	.
46745	2087	1	I	-PRON-	PRP
46745	2087	2	would	would	MD
46745	2087	3	not	not	RB
46745	2087	4	,	,	,
46745	2087	5	of	of	IN
46745	2087	6	course	course	NN
46745	2087	7	,	,	,
46745	2087	8	affirm	affirm	VBP
46745	2087	9	that	that	IN
46745	2087	10	this	this	DT
46745	2087	11	actually	actually	RB
46745	2087	12	does	do	VBZ
46745	2087	13	occur	occur	VB
46745	2087	14	;	;	:
46745	2087	15	but	but	CC
46745	2087	16	if	if	IN
46745	2087	17	it	-PRON-	PRP
46745	2087	18	were	be	VBD
46745	2087	19	to	to	TO
46745	2087	20	take	take	VB
46745	2087	21	place	place	NN
46745	2087	22	,	,	,
46745	2087	23	we	-PRON-	PRP
46745	2087	24	might	may	MD
46745	2087	25	gain	gain	VB
46745	2087	26	,	,	,
46745	2087	27	in	in	IN
46745	2087	28	this	this	DT
46745	2087	29	oxidation	oxidation	NN
46745	2087	30	of	of	IN
46745	2087	31	Quina	Quina	NNP
46745	2087	32	,	,	,
46745	2087	33	some	some	DT
46745	2087	34	clue	clue	NN
46745	2087	35	to	to	IN
46745	2087	36	the	the	DT
46745	2087	37	production	production	NN
46745	2087	38	of	of	IN
46745	2087	39	that	that	DT
46745	2087	40	quickening	quickening	NN
46745	2087	41	of	of	IN
46745	2087	42	the	the	DT
46745	2087	43	pulse	pulse	NN
46745	2087	44	and	and	CC
46745	2087	45	increase	increase	NN
46745	2087	46	of	of	IN
46745	2087	47	the	the	DT
46745	2087	48	general	general	JJ
46745	2087	49	temperature	temperature	NN
46745	2087	50	,	,	,
46745	2087	51	which	which	WDT
46745	2087	52	are	be	VBP
46745	2087	53	affirmed	affirm	VBN
46745	2087	54	by	by	IN
46745	2087	55	some	some	DT
46745	2087	56	to	to	TO
46745	2087	57	follow	follow	VB
46745	2087	58	the	the	DT
46745	2087	59	ingestion	ingestion	NN
46745	2087	60	of	of	IN
46745	2087	61	the	the	DT
46745	2087	62	alkaloid	alkaloid	NN
46745	2087	63	,	,	,
46745	2087	64	even	even	RB
46745	2087	65	in	in	IN
46745	2087	66	small	small	JJ
46745	2087	67	doses	dose	NNS
46745	2087	68	.	.	.
46745	2088	1	But	but	CC
46745	2088	2	it	-PRON-	PRP
46745	2088	3	is	be	VBZ
46745	2088	4	now	now	RB
46745	2088	5	sufficient	sufficient	JJ
46745	2088	6	for	for	IN
46745	2088	7	us	-PRON-	PRP
46745	2088	8	if	if	IN
46745	2088	9	we	-PRON-	PRP
46745	2088	10	have	have	VBP
46745	2088	11	ascertained	ascertain	VBN
46745	2088	12	that	that	IN
46745	2088	13	there	there	EX
46745	2088	14	is	be	VBZ
46745	2088	15	naturally	naturally	RB
46745	2088	16	in	in	IN
46745	2088	17	the	the	DT
46745	2088	18	system	system	NN
46745	2088	19	,	,	,
46745	2088	20	and	and	CC
46745	2088	21	in	in	IN
46745	2088	22	the	the	DT
46745	2088	23	blood	blood	NN
46745	2088	24	,	,	,
46745	2088	25	a	a	DT
46745	2088	26	substance	substance	NN
46745	2088	27	which	which	WDT
46745	2088	28	resembles	resemble	VBZ
46745	2088	29	Quina	Quina	NNP
46745	2088	30	.	.	.
46745	2089	1	We	-PRON-	PRP
46745	2089	2	may	may	MD
46745	2089	3	be	be	VB
46745	2089	4	allowed	allow	VBN
46745	2089	5	to	to	TO
46745	2089	6	infer	infer	VB
46745	2089	7	that	that	IN
46745	2089	8	the	the	DT
46745	2089	9	presence	presence	NN
46745	2089	10	of	of	IN
46745	2089	11	the	the	DT
46745	2089	12	latter	latter	JJ
46745	2089	13	substance	substance	NN
46745	2089	14	in	in	IN
46745	2089	15	that	that	DT
46745	2089	16	fluid	fluid	NN
46745	2089	17	would	would	MD
46745	2089	18	not	not	RB
46745	2089	19	be	be	VB
46745	2089	20	unnatural	unnatural	JJ
46745	2089	21	to	to	IN
46745	2089	22	it	-PRON-	PRP
46745	2089	23	.	.	.
46745	2090	1	Having	have	VBG
46745	2090	2	dismissed	dismiss	VBN
46745	2090	3	the	the	DT
46745	2090	4	second	second	JJ
46745	2090	5	of	of	IN
46745	2090	6	the	the	DT
46745	2090	7	minor	minor	JJ
46745	2090	8	propositions	proposition	NNS
46745	2090	9	which	which	WDT
46745	2090	10	relate	relate	VBP
46745	2090	11	to	to	IN
46745	2090	12	Tonics	Tonics	NNP
46745	2090	13	as	as	IN
46745	2090	14	Restorative	Restorative	NNP
46745	2090	15	medicines	medicine	NNS
46745	2090	16	,	,	,
46745	2090	17	we	-PRON-	PRP
46745	2090	18	pass	pass	VBP
46745	2090	19	on	on	RP
46745	2090	20	to	to	IN
46745	2090	21	the	the	DT
46745	2090	22	third	third	JJ
46745	2090	23	.	.	.
46745	2091	1	Are	be	VBP
46745	2091	2	Quina	Quina	NNP
46745	2091	3	and	and	CC
46745	2091	4	the	the	DT
46745	2091	5	vegetable	vegetable	NN
46745	2091	6	bitters	bitter	NNS
46745	2091	7	necessarily	necessarily	RB
46745	2091	8	excreted	excrete	VBN
46745	2091	9	from	from	IN
46745	2091	10	the	the	DT
46745	2091	11	blood	blood	NN
46745	2091	12	?	?	.
46745	2092	1	It	-PRON-	PRP
46745	2092	2	is	be	VBZ
46745	2092	3	not	not	RB
46745	2092	4	easy	easy	JJ
46745	2092	5	to	to	TO
46745	2092	6	answer	answer	VB
46745	2092	7	this	this	DT
46745	2092	8	question	question	NN
46745	2092	9	with	with	IN
46745	2092	10	certainty	certainty	NN
46745	2092	11	,	,	,
46745	2092	12	because	because	IN
46745	2092	13	it	-PRON-	PRP
46745	2092	14	would	would	MD
46745	2092	15	be	be	VB
46745	2092	16	difficult	difficult	JJ
46745	2092	17	to	to	TO
46745	2092	18	detect	detect	VB
46745	2092	19	small	small	JJ
46745	2092	20	quantities	quantity	NNS
46745	2092	21	of	of	IN
46745	2092	22	this	this	DT
46745	2092	23	alkaloid	alkaloid	NN
46745	2092	24	in	in	IN
46745	2092	25	any	any	DT
46745	2092	26	of	of	IN
46745	2092	27	the	the	DT
46745	2092	28	secretions	secretion	NNS
46745	2092	29	.	.	.
46745	2093	1	But	but	CC
46745	2093	2	all	all	DT
46745	2093	3	that	that	WDT
46745	2093	4	is	be	VBZ
46745	2093	5	known	know	VBN
46745	2093	6	on	on	IN
46745	2093	7	the	the	DT
46745	2093	8	subject	subject	NN
46745	2093	9	is	be	VBZ
46745	2093	10	in	in	IN
46745	2093	11	favour	favour	NN
46745	2093	12	of	of	IN
46745	2093	13	a	a	DT
46745	2093	14	negative	negative	JJ
46745	2093	15	answer	answer	NN
46745	2093	16	.	.	.
46745	2094	1	A	a	DT
46745	2094	2	number	number	NN
46745	2094	3	of	of	IN
46745	2094	4	careful	careful	JJ
46745	2094	5	and	and	CC
46745	2094	6	elaborate	elaborate	JJ
46745	2094	7	experiments	experiment	NNS
46745	2094	8	on	on	IN
46745	2094	9	the	the	DT
46745	2094	10	passage	passage	NN
46745	2094	11	of	of	IN
46745	2094	12	medicines	medicine	NNS
46745	2094	13	into	into	IN
46745	2094	14	the	the	DT
46745	2094	15	urine	urine	NN
46745	2094	16	have	have	VBP
46745	2094	17	been	be	VBN
46745	2094	18	made	make	VBN
46745	2094	19	by	by	IN
46745	2094	20	M.	M.	NNP
46745	2094	21	Wöhler	Wöhler	NNP
46745	2094	22	,	,	,
46745	2094	23	and	and	CC
46745	2094	24	in	in	IN
46745	2094	25	the	the	DT
46745	2094	26	long	long	JJ
46745	2094	27	list	list	NN
46745	2094	28	of	of	IN
46745	2094	29	substances	substance	NNS
46745	2094	30	detected	detect	VBN
46745	2094	31	by	by	IN
46745	2094	32	him	-PRON-	PRP
46745	2094	33	in	in	IN
46745	2094	34	that	that	DT
46745	2094	35	secretion	secretion	NN
46745	2094	36	,	,	,
46745	2094	37	Quina	Quina	NNP
46745	2094	38	is	be	VBZ
46745	2094	39	not	not	RB
46745	2094	40	mentioned	mention	VBN
46745	2094	41	.	.	.
46745	2095	1	Neither	neither	DT
46745	2095	2	has	have	VBZ
46745	2095	3	it	-PRON-	PRP
46745	2095	4	been	be	VBN
46745	2095	5	found	find	VBN
46745	2095	6	in	in	IN
46745	2095	7	any	any	DT
46745	2095	8	other	other	JJ
46745	2095	9	of	of	IN
46745	2095	10	the	the	DT
46745	2095	11	secretions	secretion	NNS
46745	2095	12	.	.	.
46745	2096	1	The	the	DT
46745	2096	2	same	same	JJ
46745	2096	3	may	may	MD
46745	2096	4	be	be	VB
46745	2096	5	said	say	VBN
46745	2096	6	of	of	IN
46745	2096	7	all	all	PDT
46745	2096	8	the	the	DT
46745	2096	9	Tonic	Tonic	NNP
46745	2096	10	principles	principle	NNS
46745	2096	11	.	.	.
46745	2097	1	There	there	EX
46745	2097	2	is	be	VBZ
46745	2097	3	no	no	DT
46745	2097	4	proof	proof	NN
46745	2097	5	that	that	IN
46745	2097	6	they	-PRON-	PRP
46745	2097	7	are	be	VBP
46745	2097	8	necessarily	necessarily	RB
46745	2097	9	excreted	excrete	VBN
46745	2097	10	,	,	,
46745	2097	11	but	but	CC
46745	2097	12	there	there	EX
46745	2097	13	is	be	VBZ
46745	2097	14	every	every	DT
46745	2097	15	reason	reason	NN
46745	2097	16	to	to	TO
46745	2097	17	suppose	suppose	VB
46745	2097	18	that	that	IN
46745	2097	19	they	-PRON-	PRP
46745	2097	20	may	may	MD
46745	2097	21	remain	remain	VB
46745	2097	22	for	for	IN
46745	2097	23	a	a	DT
46745	2097	24	while	while	NN
46745	2097	25	in	in	IN
46745	2097	26	the	the	DT
46745	2097	27	blood	blood	NN
46745	2097	28	.	.	.
46745	2098	1	Let	let	VB
46745	2098	2	us	-PRON-	PRP
46745	2098	3	then	then	RB
46745	2098	4	consider	consider	VB
46745	2098	5	the	the	DT
46745	2098	6	last	last	JJ
46745	2098	7	question	question	NN
46745	2098	8	.	.	.
46745	2099	1	Can	Can	MD
46745	2099	2	Quina	Quina	NNP
46745	2099	3	,	,	,
46745	2099	4	or	or	CC
46745	2099	5	substances	substance	NNS
46745	2099	6	like	like	IN
46745	2099	7	it	-PRON-	PRP
46745	2099	8	,	,	,
46745	2099	9	improve	improve	VB
46745	2099	10	the	the	DT
46745	2099	11	condition	condition	NN
46745	2099	12	of	of	IN
46745	2099	13	the	the	DT
46745	2099	14	blood	blood	NN
46745	2099	15	when	when	WRB
46745	2099	16	deficient	deficient	JJ
46745	2099	17	in	in	IN
46745	2099	18	any	any	DT
46745	2099	19	of	of	IN
46745	2099	20	its	-PRON-	PRP$
46745	2099	21	natural	natural	JJ
46745	2099	22	materials	material	NNS
46745	2099	23	.	.	.
46745	2100	1	We	-PRON-	PRP
46745	2100	2	know	know	VBP
46745	2100	3	that	that	IN
46745	2100	4	it	-PRON-	PRP
46745	2100	5	is	be	VBZ
46745	2100	6	capable	capable	JJ
46745	2100	7	of	of	IN
46745	2100	8	curing	cure	VBG
46745	2100	9	simple	simple	JJ
46745	2100	10	debility	debility	NN
46745	2100	11	,	,	,
46745	2100	12	ague	ague	NN
46745	2100	13	,	,	,
46745	2100	14	and	and	CC
46745	2100	15	remittent	remittent	NN
46745	2100	16	fevers	fever	NNS
46745	2100	17	.	.	.
46745	2101	1	It	-PRON-	PRP
46745	2101	2	appears	appear	VBZ
46745	2101	3	that	that	IN
46745	2101	4	it	-PRON-	PRP
46745	2101	5	has	have	VBZ
46745	2101	6	also	also	RB
46745	2101	7	been	be	VBN
46745	2101	8	successfully	successfully	RB
46745	2101	9	used	use	VBN
46745	2101	10	of	of	IN
46745	2101	11	late	late	RB
46745	2101	12	by	by	IN
46745	2101	13	Dr.	Dr.	NNP
46745	2101	14	R.	R.	NNP
46745	2101	15	Dundas	Dundas	NNP
46745	2101	16	,	,	,
46745	2101	17	in	in	IN
46745	2101	18	large	large	JJ
46745	2101	19	doses	dose	NNS
46745	2101	20	,	,	,
46745	2101	21	in	in	IN
46745	2101	22	the	the	DT
46745	2101	23	treatment	treatment	NN
46745	2101	24	of	of	IN
46745	2101	25	typhoid	typhoid	NN
46745	2101	26	or	or	CC
46745	2101	27	continued	continue	VBN
46745	2101	28	fever	fever	NN
46745	2101	29	.	.	.
46745	2102	1	Supposing	suppose	VBG
46745	2102	2	it	-PRON-	PRP
46745	2102	3	to	to	TO
46745	2102	4	be	be	VB
46745	2102	5	proved	prove	VBN
46745	2102	6	that	that	IN
46745	2102	7	this	this	DT
46745	2102	8	agent	agent	NN
46745	2102	9	operates	operate	VBZ
46745	2102	10	in	in	IN
46745	2102	11	the	the	DT
46745	2102	12	blood	blood	NN
46745	2102	13	,	,	,
46745	2102	14	does	do	VBZ
46745	2102	15	it	-PRON-	PRP
46745	2102	16	remedy	remedy	VB
46745	2102	17	a	a	DT
46745	2102	18	disease	disease	NN
46745	2102	19	by	by	IN
46745	2102	20	supplying	supply	VBG
46745	2102	21	something	something	NN
46745	2102	22	wanting	want	VBG
46745	2102	23	,	,	,
46745	2102	24	or	or	CC
46745	2102	25	by	by	IN
46745	2102	26	counteracting	counteract	VBG
46745	2102	27	something	something	NN
46745	2102	28	present	present	JJ
46745	2102	29	in	in	IN
46745	2102	30	that	that	DT
46745	2102	31	fluid	fluid	NN
46745	2102	32	?	?	.
46745	2103	1	In	in	IN
46745	2103	2	fine	fine	JJ
46745	2103	3	,	,	,
46745	2103	4	is	be	VBZ
46745	2103	5	it	-PRON-	PRP
46745	2103	6	a	a	DT
46745	2103	7	Restorative	Restorative	NNP
46745	2103	8	or	or	CC
46745	2103	9	a	a	DT
46745	2103	10	Catalytic	catalytic	JJ
46745	2103	11	medicine	medicine	NN
46745	2103	12	?	?	.
46745	2104	1	The	the	DT
46745	2104	2	probabilities	probability	NNS
46745	2104	3	which	which	WDT
46745	2104	4	have	have	VBP
46745	2104	5	been	be	VBN
46745	2104	6	established	establish	VBN
46745	2104	7	,	,	,
46745	2104	8	that	that	IN
46745	2104	9	it	-PRON-	PRP
46745	2104	10	is	be	VBZ
46745	2104	11	not	not	RB
46745	2104	12	unnatural	unnatural	JJ
46745	2104	13	to	to	IN
46745	2104	14	the	the	DT
46745	2104	15	blood	blood	NN
46745	2104	16	,	,	,
46745	2104	17	and	and	CC
46745	2104	18	is	be	VBZ
46745	2104	19	not	not	RB
46745	2104	20	always	always	RB
46745	2104	21	excreted	excrete	VBN
46745	2104	22	from	from	IN
46745	2104	23	it	-PRON-	PRP
46745	2104	24	,	,	,
46745	2104	25	are	be	VBP
46745	2104	26	in	in	IN
46745	2104	27	favour	favour	NN
46745	2104	28	_	_	NNP
46745	2104	29	à	à	NNP
46745	2104	30	priori	priori	VBP
46745	2104	31	_	_	NNP
46745	2104	32	of	of	IN
46745	2104	33	its	-PRON-	PRP$
46745	2104	34	being	be	VBG
46745	2104	35	Restorative	Restorative	NNP
46745	2104	36	.	.	.
46745	2105	1	Catalytics	catalytic	NNS
46745	2105	2	are	be	VBP
46745	2105	3	generally	generally	RB
46745	2105	4	unnatural	unnatural	JJ
46745	2105	5	to	to	IN
46745	2105	6	the	the	DT
46745	2105	7	blood	blood	NN
46745	2105	8	,	,	,
46745	2105	9	and	and	CC
46745	2105	10	are	be	VBP
46745	2105	11	excreted	excrete	VBN
46745	2105	12	because	because	IN
46745	2105	13	they	-PRON-	PRP
46745	2105	14	can	can	MD
46745	2105	15	not	not	RB
46745	2105	16	remain	remain	VB
46745	2105	17	in	in	IN
46745	2105	18	it	-PRON-	PRP
46745	2105	19	.	.	.
46745	2106	1	Besides	besides	RB
46745	2106	2	,	,	,
46745	2106	3	a	a	DT
46745	2106	4	Catalytic	catalytic	JJ
46745	2106	5	has	have	VBZ
46745	2106	6	generally	generally	RB
46745	2106	7	some	some	DT
46745	2106	8	peculiar	peculiar	JJ
46745	2106	9	action	action	NN
46745	2106	10	on	on	IN
46745	2106	11	the	the	DT
46745	2106	12	blood	blood	NN
46745	2106	13	in	in	IN
46745	2106	14	health	health	NN
46745	2106	15	;	;	:
46745	2106	16	but	but	CC
46745	2106	17	a	a	DT
46745	2106	18	Restorative	Restorative	NNP
46745	2106	19	,	,	,
46745	2106	20	in	in	IN
46745	2106	21	moderate	moderate	JJ
46745	2106	22	doses	dose	NNS
46745	2106	23	,	,	,
46745	2106	24	none,--only	none,--only	RB
46745	2106	25	evidencing	evidence	VBG
46745	2106	26	its	-PRON-	PRP$
46745	2106	27	operation	operation	NN
46745	2106	28	when	when	WRB
46745	2106	29	supplying	supply	VBG
46745	2106	30	a	a	DT
46745	2106	31	previous	previous	JJ
46745	2106	32	want	want	NN
46745	2106	33	.	.	.
46745	2107	1	In	in	IN
46745	2107	2	this	this	DT
46745	2107	3	also	also	RB
46745	2107	4	Quina	Quina	NNP
46745	2107	5	and	and	CC
46745	2107	6	its	-PRON-	PRP$
46745	2107	7	congeners	congener	NNS
46745	2107	8	agree	agree	VBP
46745	2107	9	with	with	IN
46745	2107	10	Restoratives	restorative	NNS
46745	2107	11	and	and	CC
46745	2107	12	differ	differ	VBP
46745	2107	13	from	from	IN
46745	2107	14	Catalytic	catalytic	JJ
46745	2107	15	medicines	medicine	NNS
46745	2107	16	.	.	.
46745	2108	1	Arsenic	Arsenic	NNP
46745	2108	2	is	be	VBZ
46745	2108	3	of	of	IN
46745	2108	4	use	use	NN
46745	2108	5	in	in	IN
46745	2108	6	Ague	Ague	NNP
46745	2108	7	;	;	:
46745	2108	8	and	and	CC
46745	2108	9	Arsenic	Arsenic	NNP
46745	2108	10	is	be	VBZ
46745	2108	11	decidedly	decidedly	RB
46745	2108	12	a	a	DT
46745	2108	13	Catalytic	catalytic	JJ
46745	2108	14	in	in	IN
46745	2108	15	all	all	PDT
46745	2108	16	these	these	DT
46745	2108	17	particulars	particular	NNS
46745	2108	18	.	.	.
46745	2109	1	In	in	IN
46745	2109	2	other	other	JJ
46745	2109	3	respects	respect	NNS
46745	2109	4	,	,	,
46745	2109	5	too	too	RB
46745	2109	6	,	,	,
46745	2109	7	it	-PRON-	PRP
46745	2109	8	differs	differ	VBZ
46745	2109	9	widely	widely	RB
46745	2109	10	from	from	IN
46745	2109	11	Quina	Quina	NNP
46745	2109	12	.	.	.
46745	2110	1	The	the	DT
46745	2110	2	latter	latter	NN
46745	2110	3	is	be	VBZ
46745	2110	4	employed	employ	VBN
46745	2110	5	in	in	IN
46745	2110	6	debility	debility	NN
46745	2110	7	,	,	,
46745	2110	8	which	which	WDT
46745	2110	9	depends	depend	VBZ
46745	2110	10	evidently	evidently	RB
46745	2110	11	on	on	IN
46745	2110	12	some	some	DT
46745	2110	13	want	want	NN
46745	2110	14	in	in	IN
46745	2110	15	the	the	DT
46745	2110	16	system	system	NN
46745	2110	17	,	,	,
46745	2110	18	and	and	CC
46745	2110	19	not	not	RB
46745	2110	20	on	on	IN
46745	2110	21	any	any	DT
46745	2110	22	morbid	morbid	JJ
46745	2110	23	agent	agent	NN
46745	2110	24	.	.	.
46745	2111	1	Arsenic	arsenic	JJ
46745	2111	2	,	,	,
46745	2111	3	on	on	IN
46745	2111	4	the	the	DT
46745	2111	5	contrary	contrary	NN
46745	2111	6	,	,	,
46745	2111	7	is	be	VBZ
46745	2111	8	of	of	IN
46745	2111	9	use	use	NN
46745	2111	10	in	in	IN
46745	2111	11	Lepra	Lepra	NNP
46745	2111	12	,	,	,
46745	2111	13	which	which	WDT
46745	2111	14	,	,	,
46745	2111	15	like	like	IN
46745	2111	16	other	other	JJ
46745	2111	17	skin	skin	NN
46745	2111	18	diseases	disease	NNS
46745	2111	19	,	,	,
46745	2111	20	must	must	MD
46745	2111	21	be	be	VB
46745	2111	22	caused	cause	VBN
46745	2111	23	by	by	IN
46745	2111	24	some	some	DT
46745	2111	25	morbid	morbid	NN
46745	2111	26	agency	agency	NN
46745	2111	27	,	,	,
46745	2111	28	though	though	IN
46745	2111	29	we	-PRON-	PRP
46745	2111	30	know	know	VBP
46745	2111	31	not	not	RB
46745	2111	32	what	what	WP
46745	2111	33	precisely	precisely	RB
46745	2111	34	.	.	.
46745	2112	1	But	but	CC
46745	2112	2	some	some	DT
46745	2112	3	diseases	disease	NNS
46745	2112	4	may	may	MD
46745	2112	5	be	be	VB
46745	2112	6	cured	cure	VBN
46745	2112	7	in	in	IN
46745	2112	8	two	two	CD
46745	2112	9	ways	way	NNS
46745	2112	10	;	;	:
46745	2112	11	either	either	CC
46745	2112	12	by	by	IN
46745	2112	13	the	the	DT
46745	2112	14	supply	supply	NN
46745	2112	15	of	of	IN
46745	2112	16	something	something	NN
46745	2112	17	,	,	,
46745	2112	18	or	or	CC
46745	2112	19	by	by	IN
46745	2112	20	the	the	DT
46745	2112	21	neutralization	neutralization	NN
46745	2112	22	of	of	IN
46745	2112	23	something	something	NN
46745	2112	24	else	else	RB
46745	2112	25	.	.	.
46745	2113	1	Perhaps	perhaps	RB
46745	2113	2	Ague	Ague	NNP
46745	2113	3	is	be	VBZ
46745	2113	4	one	one	CD
46745	2113	5	of	of	IN
46745	2113	6	these	these	DT
46745	2113	7	.	.	.
46745	2114	1	And	and	CC
46745	2114	2	it	-PRON-	PRP
46745	2114	3	is	be	VBZ
46745	2114	4	not	not	RB
46745	2114	5	repugnant	repugnant	JJ
46745	2114	6	to	to	IN
46745	2114	7	what	what	WP
46745	2114	8	we	-PRON-	PRP
46745	2114	9	know	know	VBP
46745	2114	10	of	of	IN
46745	2114	11	Ague	Ague	NNP
46745	2114	12	to	to	TO
46745	2114	13	suppose	suppose	VB
46745	2114	14	that	that	IN
46745	2114	15	there	there	EX
46745	2114	16	is	be	VBZ
46745	2114	17	in	in	IN
46745	2114	18	it	-PRON-	PRP
46745	2114	19	a	a	DT
46745	2114	20	want	want	NN
46745	2114	21	of	of	IN
46745	2114	22	some	some	DT
46745	2114	23	natural	natural	JJ
46745	2114	24	material	material	NN
46745	2114	25	,	,	,
46745	2114	26	which	which	WDT
46745	2114	27	would	would	MD
46745	2114	28	have	have	VB
46745	2114	29	,	,	,
46745	2114	30	when	when	WRB
46745	2114	31	present	present	JJ
46745	2114	32	,	,	,
46745	2114	33	the	the	DT
46745	2114	34	effect	effect	NN
46745	2114	35	of	of	IN
46745	2114	36	checking	check	VBG
46745	2114	37	the	the	DT
46745	2114	38	operation	operation	NN
46745	2114	39	of	of	IN
46745	2114	40	the	the	DT
46745	2114	41	morbid	morbid	NN
46745	2114	42	agent	agent	NN
46745	2114	43	.	.	.
46745	2115	1	The	the	DT
46745	2115	2	fact	fact	NN
46745	2115	3	of	of	IN
46745	2115	4	having	have	VBG
46745	2115	5	had	have	VBD
46745	2115	6	Ague	Ague	NNP
46745	2115	7	once	once	RB
46745	2115	8	does	do	VBZ
46745	2115	9	not	not	RB
46745	2115	10	,	,	,
46745	2115	11	as	as	IN
46745	2115	12	in	in	IN
46745	2115	13	the	the	DT
46745	2115	14	case	case	NN
46745	2115	15	of	of	IN
46745	2115	16	the	the	DT
46745	2115	17	Eruptive	eruptive	JJ
46745	2115	18	fevers	fever	NNS
46745	2115	19	,	,	,
46745	2115	20	protect	protect	VB
46745	2115	21	a	a	DT
46745	2115	22	man	man	NN
46745	2115	23	from	from	IN
46745	2115	24	the	the	DT
46745	2115	25	disorder	disorder	NN
46745	2115	26	thenceforward	thenceforward	NN
46745	2115	27	.	.	.
46745	2116	1	So	so	RB
46745	2116	2	in	in	IN
46745	2116	3	this	this	DT
46745	2116	4	sense	sense	NN
46745	2116	5	all	all	DT
46745	2116	6	persons	person	NNS
46745	2116	7	may	may	MD
46745	2116	8	be	be	VB
46745	2116	9	said	say	VBN
46745	2116	10	to	to	TO
46745	2116	11	be	be	VB
46745	2116	12	liable	liable	JJ
46745	2116	13	to	to	IN
46745	2116	14	Ague	Ague	NNP
46745	2116	15	,	,	,
46745	2116	16	and	and	CC
46745	2116	17	none	none	NN
46745	2116	18	protected	protect	VBD
46745	2116	19	from	from	IN
46745	2116	20	its	-PRON-	PRP$
46745	2116	21	assault	assault	NN
46745	2116	22	.	.	.
46745	2117	1	But	but	CC
46745	2117	2	it	-PRON-	PRP
46745	2117	3	is	be	VBZ
46745	2117	4	not	not	RB
46745	2117	5	the	the	DT
46745	2117	6	case	case	NN
46745	2117	7	with	with	IN
46745	2117	8	Ague	Ague	NNP
46745	2117	9	as	as	IN
46745	2117	10	it	-PRON-	PRP
46745	2117	11	is	be	VBZ
46745	2117	12	with	with	IN
46745	2117	13	Syphilis	Syphilis	NNP
46745	2117	14	and	and	CC
46745	2117	15	Small	Small	NNP
46745	2117	16	Pox	Pox	NNP
46745	2117	17	,	,	,
46745	2117	18	which	which	WDT
46745	2117	19	diseases	disease	VBZ
46745	2117	20	most	most	JJS
46745	2117	21	persons	person	NNS
46745	2117	22	inevitably	inevitably	RB
46745	2117	23	catch	catch	VBP
46745	2117	24	who	who	WP
46745	2117	25	are	be	VBP
46745	2117	26	exposed	expose	VBN
46745	2117	27	to	to	IN
46745	2117	28	the	the	DT
46745	2117	29	virus	virus	NN
46745	2117	30	for	for	IN
46745	2117	31	the	the	DT
46745	2117	32	first	first	JJ
46745	2117	33	time	time	NN
46745	2117	34	in	in	IN
46745	2117	35	their	-PRON-	PRP$
46745	2117	36	lives	life	NNS
46745	2117	37	.	.	.
46745	2118	1	For	for	IN
46745	2118	2	,	,	,
46745	2118	3	of	of	IN
46745	2118	4	a	a	DT
46745	2118	5	number	number	NN
46745	2118	6	of	of	IN
46745	2118	7	persons	person	NNS
46745	2118	8	exposed	expose	VBN
46745	2118	9	to	to	IN
46745	2118	10	the	the	DT
46745	2118	11	same	same	JJ
46745	2118	12	malarious	malarious	JJ
46745	2118	13	influence	influence	NN
46745	2118	14	,	,	,
46745	2118	15	only	only	RB
46745	2118	16	a	a	DT
46745	2118	17	part	part	NN
46745	2118	18	take	take	VB
46745	2118	19	the	the	DT
46745	2118	20	disorder	disorder	NN
46745	2118	21	;	;	:
46745	2118	22	some	some	DT
46745	2118	23	escape	escape	NN
46745	2118	24	.	.	.
46745	2119	1	It	-PRON-	PRP
46745	2119	2	is	be	VBZ
46745	2119	3	generally	generally	RB
46745	2119	4	found	find	VBN
46745	2119	5	that	that	IN
46745	2119	6	those	those	DT
46745	2119	7	are	be	VBP
46745	2119	8	most	most	RBS
46745	2119	9	likely	likely	JJ
46745	2119	10	to	to	TO
46745	2119	11	take	take	VB
46745	2119	12	it	-PRON-	PRP
46745	2119	13	who	who	WP
46745	2119	14	have	have	VBP
46745	2119	15	been	be	VBN
46745	2119	16	previously	previously	RB
46745	2119	17	debilitated	debilitate	VBN
46745	2119	18	by	by	IN
46745	2119	19	any	any	DT
46745	2119	20	cause	cause	NN
46745	2119	21	;	;	:
46745	2119	22	so	so	CC
46745	2119	23	that	that	IN
46745	2119	24	we	-PRON-	PRP
46745	2119	25	must	must	MD
46745	2119	26	suppose	suppose	VB
46745	2119	27	that	that	IN
46745	2119	28	the	the	DT
46745	2119	29	rest	rest	NN
46745	2119	30	have	have	VBP
46745	2119	31	in	in	IN
46745	2119	32	their	-PRON-	PRP$
46745	2119	33	blood	blood	NN
46745	2119	34	some	some	DT
46745	2119	35	material	material	NN
46745	2119	36	which	which	WDT
46745	2119	37	serves	serve	VBZ
46745	2119	38	to	to	TO
46745	2119	39	prevent	prevent	VB
46745	2119	40	the	the	DT
46745	2119	41	working	working	NN
46745	2119	42	in	in	IN
46745	2119	43	it	-PRON-	PRP
46745	2119	44	of	of	IN
46745	2119	45	the	the	DT
46745	2119	46	Ague	Ague	NNP
46745	2119	47	-	-	HYPH
46745	2119	48	poison	poison	NN
46745	2119	49	,	,	,
46745	2119	50	which	which	WDT
46745	2119	51	apparently	apparently	RB
46745	2119	52	must	must	MD
46745	2119	53	enter	enter	VB
46745	2119	54	it	-PRON-	PRP
46745	2119	55	.	.	.
46745	2120	1	It	-PRON-	PRP
46745	2120	2	is	be	VBZ
46745	2120	3	not	not	RB
46745	2120	4	unlikely	unlikely	JJ
46745	2120	5	then	then	RB
46745	2120	6	that	that	IN
46745	2120	7	Ague	Ague	NNP
46745	2120	8	may	may	MD
46745	2120	9	be	be	VB
46745	2120	10	cured	cure	VBN
46745	2120	11	by	by	IN
46745	2120	12	supplying	supply	VBG
46745	2120	13	the	the	DT
46745	2120	14	want	want	NN
46745	2120	15	of	of	IN
46745	2120	16	this	this	DT
46745	2120	17	material	material	NN
46745	2120	18	.	.	.
46745	2121	1	Coupling	couple	VBG
46745	2121	2	with	with	IN
46745	2121	3	this	this	DT
46745	2121	4	consideration	consideration	NN
46745	2121	5	those	those	DT
46745	2121	6	facts	fact	NNS
46745	2121	7	which	which	WDT
46745	2121	8	have	have	VBP
46745	2121	9	been	be	VBN
46745	2121	10	previously	previously	RB
46745	2121	11	stated	state	VBN
46745	2121	12	,	,	,
46745	2121	13	we	-PRON-	PRP
46745	2121	14	may	may	MD
46745	2121	15	reasonably	reasonably	RB
46745	2121	16	conclude	conclude	VB
46745	2121	17	that	that	IN
46745	2121	18	Tonics	Tonics	NNPS
46745	2121	19	are	be	VBP
46745	2121	20	Restorative	restorative	JJ
46745	2121	21	,	,	,
46745	2121	22	and	and	CC
46745	2121	23	not	not	RB
46745	2121	24	Catalytic	catalytic	JJ
46745	2121	25	in	in	IN
46745	2121	26	their	-PRON-	PRP$
46745	2121	27	action	action	NN
46745	2121	28	;	;	:
46745	2121	29	that	that	IN
46745	2121	30	they	-PRON-	PRP
46745	2121	31	supply	supply	VBP
46745	2121	32	,	,	,
46745	2121	33	or	or	CC
46745	2121	34	cause	cause	VB
46745	2121	35	to	to	TO
46745	2121	36	be	be	VB
46745	2121	37	supplied	supply	VBN
46745	2121	38	,	,	,
46745	2121	39	a	a	DT
46745	2121	40	material	material	NN
46745	2121	41	wanting	want	VBG
46745	2121	42	in	in	IN
46745	2121	43	the	the	DT
46745	2121	44	blood	blood	NN
46745	2121	45	.	.	.
46745	2122	1	How	how	WRB
46745	2122	2	this	this	DT
46745	2122	3	material	material	NN
46745	2122	4	is	be	VBZ
46745	2122	5	enabled	enable	VBN
46745	2122	6	to	to	TO
46745	2122	7	resist	resist	VB
46745	2122	8	the	the	DT
46745	2122	9	morbid	morbid	NN
46745	2122	10	influence	influence	NN
46745	2122	11	of	of	IN
46745	2122	12	the	the	DT
46745	2122	13	miasm	miasm	NN
46745	2122	14	--	--	:
46745	2122	15	whether	whether	IN
46745	2122	16	it	-PRON-	PRP
46745	2122	17	is	be	VBZ
46745	2122	18	by	by	IN
46745	2122	19	an	an	DT
46745	2122	20	antiseptic	antiseptic	JJ
46745	2122	21	property	property	NN
46745	2122	22	,	,	,
46745	2122	23	such	such	JJ
46745	2122	24	as	as	IN
46745	2122	25	has	have	VBZ
46745	2122	26	been	be	VBN
46745	2122	27	attributed	attribute	VBN
46745	2122	28	to	to	IN
46745	2122	29	Quina	Quina	NNP
46745	2122	30	--	--	:
46745	2122	31	I	-PRON-	PRP
46745	2122	32	can	can	MD
46745	2122	33	not	not	RB
46745	2122	34	determine	determine	VB
46745	2122	35	.	.	.
46745	2123	1	Having	have	VBG
46745	2123	2	now	now	RB
46745	2123	3	done	do	VBN
46745	2123	4	my	-PRON-	PRP$
46745	2123	5	best	good	JJS
46745	2123	6	to	to	TO
46745	2123	7	establish	establish	VB
46745	2123	8	the	the	DT
46745	2123	9	Proposition	Proposition	NNP
46745	2123	10	,	,	,
46745	2123	11	as	as	IN
46745	2123	12	applicable	applicable	JJ
46745	2123	13	to	to	IN
46745	2123	14	Tonic	Tonic	NNP
46745	2123	15	medicines	medicine	NNS
46745	2123	16	,	,	,
46745	2123	17	I	-PRON-	PRP
46745	2123	18	may	may	MD
46745	2123	19	venture	venture	VB
46745	2123	20	to	to	TO
46745	2123	21	bring	bring	VB
46745	2123	22	forward	forward	RB
46745	2123	23	a	a	DT
46745	2123	24	speculation	speculation	NN
46745	2123	25	concerning	concern	VBG
46745	2123	26	their	-PRON-	PRP$
46745	2123	27	action	action	NN
46745	2123	28	,	,	,
46745	2123	29	which	which	WDT
46745	2123	30	I	-PRON-	PRP
46745	2123	31	would	would	MD
46745	2123	32	not	not	RB
46745	2123	33	wish	wish	VB
46745	2123	34	to	to	TO
46745	2123	35	rate	rate	VB
46745	2123	36	higher	high	JJR
46745	2123	37	than	than	IN
46745	2123	38	it	-PRON-	PRP
46745	2123	39	is	be	VBZ
46745	2123	40	worth	worth	JJ
46745	2123	41	,	,	,
46745	2123	42	and	and	CC
46745	2123	43	still	still	RB
46745	2123	44	less	less	JJR
46745	2123	45	endeavour	endeavour	NN
46745	2123	46	to	to	TO
46745	2123	47	demonstrate	demonstrate	VB
46745	2123	48	as	as	IN
46745	2123	49	a	a	DT
46745	2123	50	fact	fact	NN
46745	2123	51	.	.	.
46745	2124	1	I	-PRON-	PRP
46745	2124	2	have	have	VBP
46745	2124	3	already	already	RB
46745	2124	4	made	make	VBN
46745	2124	5	use	use	NN
46745	2124	6	of	of	IN
46745	2124	7	Taurine	Taurine	NNP
46745	2124	8	,	,	,
46745	2124	9	one	one	CD
46745	2124	10	of	of	IN
46745	2124	11	the	the	DT
46745	2124	12	principles	principle	NNS
46745	2124	13	of	of	IN
46745	2124	14	the	the	DT
46745	2124	15	Bile	Bile	NNP
46745	2124	16	,	,	,
46745	2124	17	for	for	IN
46745	2124	18	the	the	DT
46745	2124	19	purpose	purpose	NN
46745	2124	20	of	of	IN
46745	2124	21	showing	show	VBG
46745	2124	22	that	that	DT
46745	2124	23	among	among	IN
46745	2124	24	the	the	DT
46745	2124	25	natural	natural	JJ
46745	2124	26	constituents	constituent	NNS
46745	2124	27	of	of	IN
46745	2124	28	the	the	DT
46745	2124	29	blood	blood	NN
46745	2124	30	there	there	EX
46745	2124	31	is	be	VBZ
46745	2124	32	a	a	DT
46745	2124	33	substance	substance	NN
46745	2124	34	which	which	WDT
46745	2124	35	chemically	chemically	RB
46745	2124	36	resembles	resemble	VBZ
46745	2124	37	a	a	DT
46745	2124	38	tonic	tonic	NN
46745	2124	39	alkaloid	alkaloid	NN
46745	2124	40	,	,	,
46745	2124	41	like	like	IN
46745	2124	42	Quina	Quina	NNP
46745	2124	43	.	.	.
46745	2125	1	This	this	DT
46745	2125	2	similarity	similarity	NN
46745	2125	3	admits	admit	VBZ
46745	2125	4	of	of	IN
46745	2125	5	a	a	DT
46745	2125	6	further	further	JJ
46745	2125	7	and	and	CC
46745	2125	8	more	more	RBR
46745	2125	9	direct	direct	JJ
46745	2125	10	application	application	NN
46745	2125	11	.	.	.
46745	2126	1	It	-PRON-	PRP
46745	2126	2	is	be	VBZ
46745	2126	3	ascertained	ascertain	VBN
46745	2126	4	that	that	IN
46745	2126	5	many	many	JJ
46745	2126	6	,	,	,
46745	2126	7	if	if	IN
46745	2126	8	not	not	RB
46745	2126	9	all	all	DT
46745	2126	10	,	,	,
46745	2126	11	of	of	IN
46745	2126	12	the	the	DT
46745	2126	13	diseases	disease	NNS
46745	2126	14	in	in	IN
46745	2126	15	which	which	WDT
46745	2126	16	Quina	Quina	NNP
46745	2126	17	and	and	CC
46745	2126	18	its	-PRON-	PRP$
46745	2126	19	kindred	kindred	JJ
46745	2126	20	medicines	medicine	NNS
46745	2126	21	are	be	VBP
46745	2126	22	found	find	VBN
46745	2126	23	to	to	TO
46745	2126	24	be	be	VB
46745	2126	25	of	of	IN
46745	2126	26	use	use	NN
46745	2126	27	,	,	,
46745	2126	28	are	be	VBP
46745	2126	29	connected	connect	VBN
46745	2126	30	with	with	IN
46745	2126	31	a	a	DT
46745	2126	32	derangement	derangement	NN
46745	2126	33	of	of	IN
46745	2126	34	the	the	DT
46745	2126	35	secretory	secretory	JJ
46745	2126	36	functions	function	NNS
46745	2126	37	of	of	IN
46745	2126	38	the	the	DT
46745	2126	39	liver	liver	NN
46745	2126	40	.	.	.
46745	2127	1	One	one	CD
46745	2127	2	of	of	IN
46745	2127	3	these	these	DT
46745	2127	4	diseases	disease	NNS
46745	2127	5	is	be	VBZ
46745	2127	6	the	the	DT
46745	2127	7	debility	debility	NN
46745	2127	8	which	which	WDT
46745	2127	9	is	be	VBZ
46745	2127	10	consequent	consequent	JJ
46745	2127	11	upon	upon	IN
46745	2127	12	Typhoid	Typhoid	NNP
46745	2127	13	and	and	CC
46745	2127	14	other	other	JJ
46745	2127	15	fevers	fever	NNS
46745	2127	16	.	.	.
46745	2128	1	In	in	IN
46745	2128	2	these	these	DT
46745	2128	3	fevers	fever	NNS
46745	2128	4	the	the	DT
46745	2128	5	function	function	NN
46745	2128	6	of	of	IN
46745	2128	7	the	the	DT
46745	2128	8	liver	liver	NN
46745	2128	9	is	be	VBZ
46745	2128	10	always	always	RB
46745	2128	11	more	more	RBR
46745	2128	12	or	or	CC
46745	2128	13	less	less	RBR
46745	2128	14	interfered	interfered	JJ
46745	2128	15	with	with	IN
46745	2128	16	,	,	,
46745	2128	17	though	though	IN
46745	2128	18	more	more	RBR
46745	2128	19	obviously	obviously	RB
46745	2128	20	in	in	IN
46745	2128	21	some	some	DT
46745	2128	22	cases	case	NNS
46745	2128	23	than	than	IN
46745	2128	24	in	in	IN
46745	2128	25	others	other	NNS
46745	2128	26	.	.	.
46745	2129	1	In	in	IN
46745	2129	2	strumous	strumous	JJ
46745	2129	3	habits	habit	NNS
46745	2129	4	,	,	,
46745	2129	5	in	in	IN
46745	2129	6	which	which	WDT
46745	2129	7	generally	generally	RB
46745	2129	8	bark	bark	VBP
46745	2129	9	is	be	VBZ
46745	2129	10	of	of	IN
46745	2129	11	signal	signal	NN
46745	2129	12	service,--and	service,--and	NNP
46745	2129	13	was	be	VBD
46745	2129	14	very	very	RB
46745	2129	15	strongly	strongly	RB
46745	2129	16	recommended	recommend	VBN
46745	2129	17	by	by	IN
46745	2129	18	Cullen	Cullen	NNP
46745	2129	19	,	,	,
46745	2129	20	Fordyce	Fordyce	NNP
46745	2129	21	,	,	,
46745	2129	22	and	and	CC
46745	2129	23	others,--there	others,--there	EX
46745	2129	24	is	be	VBZ
46745	2129	25	very	very	RB
46745	2129	26	commonly	commonly	RB
46745	2129	27	a	a	DT
46745	2129	28	peculiar	peculiar	JJ
46745	2129	29	degeneration	degeneration	NN
46745	2129	30	of	of	IN
46745	2129	31	the	the	DT
46745	2129	32	liver	liver	NN
46745	2129	33	,	,	,
46745	2129	34	which	which	WDT
46745	2129	35	has	have	VBZ
46745	2129	36	been	be	VBN
46745	2129	37	ably	ably	RB
46745	2129	38	described	describe	VBN
46745	2129	39	by	by	IN
46745	2129	40	Dr.	Dr.	NNP
46745	2129	41	G.	G.	NNP
46745	2129	42	Budd	Budd	NNP
46745	2129	43	.	.	.
46745	2130	1	This	this	DT
46745	2130	2	state	state	NN
46745	2130	3	is	be	VBZ
46745	2130	4	distinct	distinct	JJ
46745	2130	5	from	from	IN
46745	2130	6	the	the	DT
46745	2130	7	fatty	fatty	NN
46745	2130	8	enlargement	enlargement	NN
46745	2130	9	common	common	JJ
46745	2130	10	in	in	IN
46745	2130	11	Phthisis	Phthisis	NNP
46745	2130	12	,	,	,
46745	2130	13	in	in	IN
46745	2130	14	the	the	DT
46745	2130	15	early	early	JJ
46745	2130	16	stage	stage	NN
46745	2130	17	of	of	IN
46745	2130	18	which	which	WDT
46745	2130	19	disease	disease	NN
46745	2130	20	Quinine	Quinine	NNP
46745	2130	21	is	be	VBZ
46745	2130	22	also	also	RB
46745	2130	23	very	very	RB
46745	2130	24	serviceable	serviceable	JJ
46745	2130	25	.	.	.
46745	2131	1	Quinine	Quinine	NNP
46745	2131	2	is	be	VBZ
46745	2131	3	often	often	RB
46745	2131	4	beneficial	beneficial	JJ
46745	2131	5	in	in	IN
46745	2131	6	Gout	Gout	NNP
46745	2131	7	,	,	,
46745	2131	8	in	in	IN
46745	2131	9	which	which	WDT
46745	2131	10	the	the	DT
46745	2131	11	liver	liver	NN
46745	2131	12	is	be	VBZ
46745	2131	13	always	always	RB
46745	2131	14	more	more	RBR
46745	2131	15	or	or	CC
46745	2131	16	less	less	RBR
46745	2131	17	deranged	deranged	JJ
46745	2131	18	.	.	.
46745	2132	1	Turning	turn	VBG
46745	2132	2	to	to	IN
46745	2132	3	periodic	periodic	JJ
46745	2132	4	diseases	disease	NNS
46745	2132	5	,	,	,
46745	2132	6	we	-PRON-	PRP
46745	2132	7	find	find	VBP
46745	2132	8	that	that	IN
46745	2132	9	impaired	impaired	JJ
46745	2132	10	hepatic	hepatic	JJ
46745	2132	11	functions	function	NNS
46745	2132	12	are	be	VBP
46745	2132	13	the	the	DT
46745	2132	14	rule	rule	NN
46745	2132	15	,	,	,
46745	2132	16	and	and	CC
46745	2132	17	the	the	DT
46745	2132	18	absence	absence	NN
46745	2132	19	of	of	IN
46745	2132	20	such	such	JJ
46745	2132	21	disorder	disorder	NN
46745	2132	22	the	the	DT
46745	2132	23	exception	exception	NN
46745	2132	24	.	.	.
46745	2133	1	This	this	DT
46745	2133	2	will	will	MD
46745	2133	3	be	be	VB
46745	2133	4	at	at	IN
46745	2133	5	once	once	RB
46745	2133	6	admitted	admit	VBN
46745	2133	7	in	in	IN
46745	2133	8	the	the	DT
46745	2133	9	case	case	NN
46745	2133	10	of	of	IN
46745	2133	11	Dysentery	Dysentery	NNP
46745	2133	12	,	,	,
46745	2133	13	and	and	CC
46745	2133	14	of	of	IN
46745	2133	15	the	the	DT
46745	2133	16	Remittent	Remittent	NNP
46745	2133	17	and	and	CC
46745	2133	18	Yellow	Yellow	NNP
46745	2133	19	fevers	fever	NNS
46745	2133	20	of	of	IN
46745	2133	21	the	the	DT
46745	2133	22	tropics	tropic	NNS
46745	2133	23	.	.	.
46745	2134	1	It	-PRON-	PRP
46745	2134	2	is	be	VBZ
46745	2134	3	also	also	RB
46745	2134	4	true	true	JJ
46745	2134	5	of	of	IN
46745	2134	6	Ague	Ague	NNP
46745	2134	7	.	.	.
46745	2135	1	It	-PRON-	PRP
46745	2135	2	seems	seem	VBZ
46745	2135	3	even	even	RB
46745	2135	4	likely	likely	JJ
46745	2135	5	that	that	IN
46745	2135	6	the	the	DT
46745	2135	7	enlarged	enlarged	JJ
46745	2135	8	spleen	spleen	NN
46745	2135	9	may	may	MD
46745	2135	10	be	be	VB
46745	2135	11	partly	partly	RB
46745	2135	12	caused	cause	VBN
46745	2135	13	by	by	IN
46745	2135	14	an	an	DT
46745	2135	15	obstruction	obstruction	NN
46745	2135	16	to	to	IN
46745	2135	17	the	the	DT
46745	2135	18	circulation	circulation	NN
46745	2135	19	in	in	IN
46745	2135	20	the	the	DT
46745	2135	21	liver	liver	NN
46745	2135	22	.	.	.
46745	2136	1	This	this	DT
46745	2136	2	affection	affection	NN
46745	2136	3	of	of	IN
46745	2136	4	the	the	DT
46745	2136	5	spleen	spleen	NN
46745	2136	6	is	be	VBZ
46745	2136	7	not	not	RB
46745	2136	8	uncommon	uncommon	JJ
46745	2136	9	in	in	IN
46745	2136	10	other	other	JJ
46745	2136	11	liver	liver	NN
46745	2136	12	diseases	disease	NNS
46745	2136	13	.	.	.
46745	2137	1	In	in	IN
46745	2137	2	Typhus	Typhus	NNP
46745	2137	3	fever	fever	VBP
46745	2137	4	both	both	DT
46745	2137	5	the	the	DT
46745	2137	6	spleen	spleen	NN
46745	2137	7	is	be	VBZ
46745	2137	8	disorganized	disorganized	JJ
46745	2137	9	and	and	CC
46745	2137	10	the	the	DT
46745	2137	11	liver	liver	NN
46745	2137	12	deranged	derange	VBD
46745	2137	13	.	.	.
46745	2138	1	It	-PRON-	PRP
46745	2138	2	is	be	VBZ
46745	2138	3	observed	observe	VBN
46745	2138	4	in	in	IN
46745	2138	5	tropical	tropical	JJ
46745	2138	6	countries	country	NNS
46745	2138	7	that	that	WDT
46745	2138	8	severe	severe	JJ
46745	2138	9	forms	form	NNS
46745	2138	10	of	of	IN
46745	2138	11	remittent	remittent	NN
46745	2138	12	not	not	RB
46745	2138	13	unfrequently	unfrequently	RB
46745	2138	14	pass	pass	VBP
46745	2138	15	into	into	IN
46745	2138	16	continued	continue	VBN
46745	2138	17	fever	fever	NN
46745	2138	18	,	,	,
46745	2138	19	which	which	WDT
46745	2138	20	seems	seem	VBZ
46745	2138	21	to	to	TO
46745	2138	22	point	point	VB
46745	2138	23	to	to	IN
46745	2138	24	some	some	DT
46745	2138	25	analogy	analogy	NN
46745	2138	26	between	between	IN
46745	2138	27	the	the	DT
46745	2138	28	two	two	CD
46745	2138	29	.	.	.
46745	2139	1	Ague	Ague	NNP
46745	2139	2	even	even	RB
46745	2139	3	may	may	MD
46745	2139	4	pass	pass	VB
46745	2139	5	into	into	IN
46745	2139	6	Typhoid	Typhoid	NNP
46745	2139	7	fever	fever	NN
46745	2139	8	.	.	.
46745	2140	1	And	and	CC
46745	2140	2	I	-PRON-	PRP
46745	2140	3	have	have	VBP
46745	2140	4	already	already	RB
46745	2140	5	referred	refer	VBN
46745	2140	6	to	to	IN
46745	2140	7	the	the	DT
46745	2140	8	fact	fact	NN
46745	2140	9	that	that	IN
46745	2140	10	Quina	Quina	NNP
46745	2140	11	has	have	VBZ
46745	2140	12	of	of	IN
46745	2140	13	late	late	RB
46745	2140	14	been	be	VBN
46745	2140	15	strongly	strongly	RB
46745	2140	16	recommended	recommend	VBN
46745	2140	17	in	in	IN
46745	2140	18	the	the	DT
46745	2140	19	treatment	treatment	NN
46745	2140	20	of	of	IN
46745	2140	21	continued	continued	JJ
46745	2140	22	fevers	fever	NNS
46745	2140	23	in	in	IN
46745	2140	24	general	general	NN
46745	2140	25	.	.	.
46745	2141	1	Dr.	Dr.	NNP
46745	2141	2	Watson	Watson	NNP
46745	2141	3	states	state	VBZ
46745	2141	4	that	that	IN
46745	2141	5	in	in	IN
46745	2141	6	New	New	NNP
46745	2141	7	Zealand	Zealand	NNP
46745	2141	8	the	the	DT
46745	2141	9	biliary	biliary	JJ
46745	2141	10	functions	function	NNS
46745	2141	11	suffer	suffer	VBP
46745	2141	12	so	so	RB
46745	2141	13	much	much	RB
46745	2141	14	in	in	IN
46745	2141	15	the	the	DT
46745	2141	16	intermittent	intermittent	NN
46745	2141	17	which	which	WDT
46745	2141	18	occurs	occur	VBZ
46745	2141	19	there	there	RB
46745	2141	20	,	,	,
46745	2141	21	that	that	IN
46745	2141	22	it	-PRON-	PRP
46745	2141	23	is	be	VBZ
46745	2141	24	known	know	VBN
46745	2141	25	among	among	IN
46745	2141	26	the	the	DT
46745	2141	27	inhabitants	inhabitant	NNS
46745	2141	28	by	by	IN
46745	2141	29	the	the	DT
46745	2141	30	name	name	NN
46745	2141	31	of	of	IN
46745	2141	32	the	the	DT
46745	2141	33	"	"	``
46745	2141	34	Gall	gall	NN
46745	2141	35	-	-	HYPH
46745	2141	36	fever	fever	NN
46745	2141	37	.	.	.
46745	2141	38	"	"	''
46745	2142	1	(	(	-LRB-
46745	2142	2	_	_	NNP
46745	2142	3	Lectures	Lectures	NNP
46745	2142	4	on	on	IN
46745	2142	5	the	the	DT
46745	2142	6	Practice	Practice	NNP
46745	2142	7	of	of	IN
46745	2142	8	Medicine	Medicine	NNP
46745	2142	9	_	_	NNP
46745	2142	10	,	,	,
46745	2142	11	vol	vol	NNP
46745	2142	12	.	.	.
46745	2143	1	i.	i.	NNP
46745	2143	2	p.	p.	NNP
46745	2144	1	793	793	CD
46745	2144	2	.	.	.
46745	2144	3	)	)	-RRB-
46745	2145	1	Let	let	VB
46745	2145	2	us	-PRON-	PRP
46745	2145	3	now	now	RB
46745	2145	4	place	place	VB
46745	2145	5	in	in	IN
46745	2145	6	conjunction	conjunction	NN
46745	2145	7	with	with	IN
46745	2145	8	these	these	DT
46745	2145	9	facts	fact	NNS
46745	2145	10	the	the	DT
46745	2145	11	similarity	similarity	NN
46745	2145	12	which	which	WDT
46745	2145	13	has	have	VBZ
46745	2145	14	been	be	VBN
46745	2145	15	pointed	point	VBN
46745	2145	16	out	out	RP
46745	2145	17	between	between	IN
46745	2145	18	the	the	DT
46745	2145	19	bitter	bitter	JJ
46745	2145	20	vegetable	vegetable	NN
46745	2145	21	principles	principle	NNS
46745	2145	22	,	,	,
46745	2145	23	and	and	CC
46745	2145	24	one	one	CD
46745	2145	25	of	of	IN
46745	2145	26	the	the	DT
46745	2145	27	chief	chief	JJ
46745	2145	28	constituents	constituent	NNS
46745	2145	29	of	of	IN
46745	2145	30	the	the	DT
46745	2145	31	re	re	NN
46745	2145	32	-	-	JJ
46745	2145	33	absorbed	absorbed	JJ
46745	2145	34	bile	bile	NN
46745	2145	35	.	.	.
46745	2146	1	Quina	Quina	NNP
46745	2146	2	and	and	CC
46745	2146	3	others	other	NNS
46745	2146	4	resemble	resemble	VBP
46745	2146	5	Taurine	taurine	NN
46745	2146	6	;	;	:
46745	2146	7	they	-PRON-	PRP
46745	2146	8	tend	tend	VBP
46745	2146	9	to	to	TO
46745	2146	10	cure	cure	VB
46745	2146	11	certain	certain	JJ
46745	2146	12	diseases	disease	NNS
46745	2146	13	;	;	:
46745	2146	14	and	and	CC
46745	2146	15	these	these	DT
46745	2146	16	diseases	disease	NNS
46745	2146	17	depend	depend	VBP
46745	2146	18	on	on	IN
46745	2146	19	deranged	deranged	JJ
46745	2146	20	hepatic	hepatic	JJ
46745	2146	21	functions	function	NNS
46745	2146	22	.	.	.
46745	2147	1	Does	do	VBZ
46745	2147	2	not	not	RB
46745	2147	3	this	this	DT
46745	2147	4	suggest	suggest	VB
46745	2147	5	the	the	DT
46745	2147	6	possibility	possibility	NN
46745	2147	7	that	that	IN
46745	2147	8	they	-PRON-	PRP
46745	2147	9	may	may	MD
46745	2147	10	be	be	VB
46745	2147	11	of	of	IN
46745	2147	12	service	service	NN
46745	2147	13	by	by	IN
46745	2147	14	actually	actually	RB
46745	2147	15	forming	form	VBG
46745	2147	16	the	the	DT
46745	2147	17	Taurine	Taurine	NNP
46745	2147	18	,	,	,
46745	2147	19	or	or	CC
46745	2147	20	by	by	IN
46745	2147	21	supplying	supply	VBG
46745	2147	22	its	-PRON-	PRP$
46745	2147	23	place	place	NN
46745	2147	24	in	in	IN
46745	2147	25	the	the	DT
46745	2147	26	blood	blood	NN
46745	2147	27	?	?	.
46745	2148	1	It	-PRON-	PRP
46745	2148	2	is	be	VBZ
46745	2148	3	possible	possible	JJ
46745	2148	4	that	that	IN
46745	2148	5	such	such	JJ
46745	2148	6	bodies	body	NNS
46745	2148	7	as	as	IN
46745	2148	8	Quina	Quina	NNP
46745	2148	9	and	and	CC
46745	2148	10	Cinchonia	Cinchonia	NNP
46745	2148	11	may	may	MD
46745	2148	12	be	be	VB
46745	2148	13	able	able	JJ
46745	2148	14	to	to	TO
46745	2148	15	fulfil	fulfil	VB
46745	2148	16	the	the	DT
46745	2148	17	functions	function	NNS
46745	2148	18	of	of	IN
46745	2148	19	Taurine	Taurine	NNP
46745	2148	20	in	in	IN
46745	2148	21	the	the	DT
46745	2148	22	blood	blood	NN
46745	2148	23	by	by	IN
46745	2148	24	remaining	remain	VBG
46745	2148	25	as	as	IN
46745	2148	26	they	-PRON-	PRP
46745	2148	27	are	be	VBP
46745	2148	28	,	,	,
46745	2148	29	without	without	IN
46745	2148	30	even	even	RB
46745	2148	31	changing	change	VBG
46745	2148	32	into	into	IN
46745	2148	33	it	-PRON-	PRP
46745	2148	34	.	.	.
46745	2149	1	It	-PRON-	PRP
46745	2149	2	is	be	VBZ
46745	2149	3	just	just	RB
46745	2149	4	possible	possible	JJ
46745	2149	5	that	that	IN
46745	2149	6	the	the	DT
46745	2149	7	presence	presence	NN
46745	2149	8	in	in	IN
46745	2149	9	the	the	DT
46745	2149	10	blood	blood	NN
46745	2149	11	of	of	IN
46745	2149	12	this	this	DT
46745	2149	13	bile	bile	NN
46745	2149	14	-	-	HYPH
46745	2149	15	product	product	NN
46745	2149	16	,	,	,
46745	2149	17	the	the	DT
46745	2149	18	supply	supply	NN
46745	2149	19	of	of	IN
46745	2149	20	which	which	WDT
46745	2149	21	has	have	VBZ
46745	2149	22	been	be	VBN
46745	2149	23	cut	cut	VBN
46745	2149	24	off	off	RP
46745	2149	25	by	by	IN
46745	2149	26	the	the	DT
46745	2149	27	hepatic	hepatic	JJ
46745	2149	28	disease	disease	NN
46745	2149	29	,	,	,
46745	2149	30	might	may	MD
46745	2149	31	have	have	VB
46745	2149	32	prevented	prevent	VBN
46745	2149	33	the	the	DT
46745	2149	34	continual	continual	JJ
46745	2149	35	action	action	NN
46745	2149	36	of	of	IN
46745	2149	37	the	the	DT
46745	2149	38	Ague	Ague	NNP
46745	2149	39	-	-	HYPH
46745	2149	40	poison	poison	NN
46745	2149	41	.	.	.
46745	2150	1	There	there	EX
46745	2150	2	is	be	VBZ
46745	2150	3	another	another	DT
46745	2150	4	fact	fact	NN
46745	2150	5	which	which	WDT
46745	2150	6	gives	give	VBZ
46745	2150	7	additional	additional	JJ
46745	2150	8	probability	probability	NN
46745	2150	9	to	to	IN
46745	2150	10	such	such	PDT
46745	2150	11	an	an	DT
46745	2150	12	idea	idea	NN
46745	2150	13	.	.	.
46745	2151	1	Another	another	DT
46745	2151	2	remedy	remedy	NN
46745	2151	3	of	of	IN
46745	2151	4	a	a	DT
46745	2151	5	different	different	JJ
46745	2151	6	kind	kind	NN
46745	2151	7	has	have	VBZ
46745	2151	8	been	be	VBN
46745	2151	9	used	use	VBN
46745	2151	10	in	in	IN
46745	2151	11	all	all	PDT
46745	2151	12	the	the	DT
46745	2151	13	diseases	disease	NNS
46745	2151	14	in	in	IN
46745	2151	15	which	which	WDT
46745	2151	16	Quina	Quina	NNP
46745	2151	17	is	be	VBZ
46745	2151	18	admissible	admissible	JJ
46745	2151	19	,	,	,
46745	2151	20	proving	prove	VBG
46745	2151	21	in	in	IN
46745	2151	22	some	some	DT
46745	2151	23	cases	case	NNS
46745	2151	24	superior	superior	JJ
46745	2151	25	,	,	,
46745	2151	26	and	and	CC
46745	2151	27	in	in	IN
46745	2151	28	other	other	JJ
46745	2151	29	instances	instance	NNS
46745	2151	30	second	second	JJ
46745	2151	31	only	only	RB
46745	2151	32	to	to	IN
46745	2151	33	it	-PRON-	PRP
46745	2151	34	in	in	IN
46745	2151	35	its	-PRON-	PRP$
46745	2151	36	beneficial	beneficial	JJ
46745	2151	37	action	action	NN
46745	2151	38	.	.	.
46745	2152	1	This	this	DT
46745	2152	2	is	be	VBZ
46745	2152	3	Mercury	Mercury	NNP
46745	2152	4	;	;	,
46745	2152	5	used	use	VBN
46745	2152	6	in	in	IN
46745	2152	7	remittent	remittent	NN
46745	2152	8	and	and	CC
46745	2152	9	yellow	yellow	JJ
46745	2152	10	fevers	fever	NNS
46745	2152	11	;	;	:
46745	2152	12	of	of	IN
46745	2152	13	the	the	DT
46745	2152	14	first	first	JJ
46745	2152	15	importance	importance	NN
46745	2152	16	in	in	IN
46745	2152	17	dysentery	dysentery	NN
46745	2152	18	;	;	:
46745	2152	19	employed	employ	VBN
46745	2152	20	by	by	IN
46745	2152	21	Dr.	Dr.	NNP
46745	2152	22	Baillie	Baillie	NNP
46745	2152	23	in	in	IN
46745	2152	24	Ague	Ague	NNP
46745	2152	25	,	,	,
46745	2152	26	and	and	CC
46745	2152	27	pronounced	pronounce	VBN
46745	2152	28	by	by	IN
46745	2152	29	him	-PRON-	PRP
46745	2152	30	to	to	TO
46745	2152	31	be	be	VB
46745	2152	32	in	in	IN
46745	2152	33	some	some	DT
46745	2152	34	cases	case	NNS
46745	2152	35	superior	superior	JJ
46745	2152	36	even	even	RB
46745	2152	37	to	to	IN
46745	2152	38	Quina	Quina	NNP
46745	2152	39	.	.	.
46745	2153	1	In	in	IN
46745	2153	2	small	small	JJ
46745	2153	3	doses	dose	NNS
46745	2153	4	it	-PRON-	PRP
46745	2153	5	is	be	VBZ
46745	2153	6	frequently	frequently	RB
46745	2153	7	of	of	IN
46745	2153	8	use	use	NN
46745	2153	9	in	in	IN
46745	2153	10	cases	case	NNS
46745	2153	11	of	of	IN
46745	2153	12	debility	debility	NN
46745	2153	13	and	and	CC
46745	2153	14	scrofula	scrofula	NN
46745	2153	15	.	.	.
46745	2154	1	And	and	CC
46745	2154	2	Mercury	Mercury	NNP
46745	2154	3	is	be	VBZ
46745	2154	4	a	a	DT
46745	2154	5	Cholagogue	Cholagogue	NNP
46745	2154	6	;	;	:
46745	2154	7	_	_	NNP
46745	2154	8	i.e.	i.e.	FW
46745	2154	9	_	_	NNP
46745	2154	10	an	an	DT
46745	2154	11	agent	agent	NN
46745	2154	12	which	which	WDT
46745	2154	13	is	be	VBZ
46745	2154	14	known	know	VBN
46745	2154	15	to	to	TO
46745	2154	16	have	have	VB
46745	2154	17	the	the	DT
46745	2154	18	effect	effect	NN
46745	2154	19	of	of	IN
46745	2154	20	promoting	promote	VBG
46745	2154	21	the	the	DT
46745	2154	22	secretory	secretory	JJ
46745	2154	23	function	function	NN
46745	2154	24	of	of	IN
46745	2154	25	the	the	DT
46745	2154	26	liver	liver	NN
46745	2154	27	.	.	.
46745	2155	1	Thus	thus	RB
46745	2155	2	we	-PRON-	PRP
46745	2155	3	may	may	MD
46745	2155	4	conceive	conceive	VB
46745	2155	5	that	that	IN
46745	2155	6	Mercury	Mercury	NNP
46745	2155	7	,	,	,
46745	2155	8	not	not	RB
46745	2155	9	given	give	VBN
46745	2155	10	in	in	IN
46745	2155	11	excess	excess	NN
46745	2155	12	,	,	,
46745	2155	13	or	or	CC
46745	2155	14	to	to	IN
46745	2155	15	salivation	salivation	NN
46745	2155	16	,	,	,
46745	2155	17	may	may	MD
46745	2155	18	operate	operate	VB
46745	2155	19	in	in	IN
46745	2155	20	a	a	DT
46745	2155	21	different	different	JJ
46745	2155	22	way	way	NN
46745	2155	23	to	to	TO
46745	2155	24	produce	produce	VB
46745	2155	25	the	the	DT
46745	2155	26	same	same	JJ
46745	2155	27	end	end	NN
46745	2155	28	as	as	IN
46745	2155	29	Quina	Quina	NNP
46745	2155	30	.	.	.
46745	2156	1	One	one	CD
46745	2156	2	explanation	explanation	NN
46745	2156	3	would	would	MD
46745	2156	4	suffice	suffice	VB
46745	2156	5	for	for	IN
46745	2156	6	both	both	DT
46745	2156	7	.	.	.
46745	2157	1	If	if	IN
46745	2157	2	this	this	DT
46745	2157	3	connexion	connexion	NN
46745	2157	4	between	between	IN
46745	2157	5	Tonics	Tonics	NNP
46745	2157	6	and	and	CC
46745	2157	7	the	the	DT
46745	2157	8	Bile	Bile	NNP
46745	2157	9	were	be	VBD
46745	2157	10	actually	actually	RB
46745	2157	11	established	establish	VBN
46745	2157	12	,	,	,
46745	2157	13	then	then	RB
46745	2157	14	we	-PRON-	PRP
46745	2157	15	should	should	MD
46745	2157	16	be	be	VB
46745	2157	17	enabled	enable	VBN
46745	2157	18	to	to	TO
46745	2157	19	explain	explain	VB
46745	2157	20	a	a	DT
46745	2157	21	matter	matter	NN
46745	2157	22	which	which	WDT
46745	2157	23	would	would	MD
46745	2157	24	otherwise	otherwise	RB
46745	2157	25	seem	seem	VB
46745	2157	26	difficult	difficult	JJ
46745	2157	27	to	to	TO
46745	2157	28	understand,--how	understand,--how	VB
46745	2157	29	it	-PRON-	PRP
46745	2157	30	is	be	VBZ
46745	2157	31	that	that	IN
46745	2157	32	small	small	JJ
46745	2157	33	doses	dose	NNS
46745	2157	34	of	of	IN
46745	2157	35	Mercury	Mercury	NNP
46745	2157	36	may	may	MD
46745	2157	37	sometimes	sometimes	RB
46745	2157	38	act	act	VB
46745	2157	39	as	as	IN
46745	2157	40	Tonics	Tonics	NNP
46745	2157	41	,	,	,
46745	2157	42	though	though	IN
46745	2157	43	we	-PRON-	PRP
46745	2157	44	know	know	VBP
46745	2157	45	that	that	IN
46745	2157	46	the	the	DT
46745	2157	47	ultimate	ultimate	JJ
46745	2157	48	action	action	NN
46745	2157	49	of	of	IN
46745	2157	50	this	this	DT
46745	2157	51	medicine	medicine	NN
46745	2157	52	,	,	,
46745	2157	53	like	like	IN
46745	2157	54	that	that	DT
46745	2157	55	of	of	IN
46745	2157	56	other	other	JJ
46745	2157	57	Catalytics	Catalytics	NNP
46745	2157	58	,	,	,
46745	2157	59	is	be	VBZ
46745	2157	60	to	to	TO
46745	2157	61	deteriorate	deteriorate	VB
46745	2157	62	the	the	DT
46745	2157	63	blood	blood	NN
46745	2157	64	.	.	.
46745	2158	1	Even	even	RB
46745	2158	2	in	in	IN
46745	2158	3	scrofulous	scrofulous	JJ
46745	2158	4	and	and	CC
46745	2158	5	enfeebled	enfeebled	JJ
46745	2158	6	cases	case	NNS
46745	2158	7	,	,	,
46745	2158	8	small	small	JJ
46745	2158	9	doses	dose	NNS
46745	2158	10	of	of	IN
46745	2158	11	blue	blue	JJ
46745	2158	12	pill	pill	NN
46745	2158	13	or	or	CC
46745	2158	14	of	of	IN
46745	2158	15	Calomel	Calomel	NNP
46745	2158	16	are	be	VBP
46745	2158	17	often	often	RB
46745	2158	18	signally	signally	RB
46745	2158	19	useful	useful	JJ
46745	2158	20	;	;	:
46745	2158	21	and	and	CC
46745	2158	22	not	not	RB
46745	2158	23	prejudicial	prejudicial	JJ
46745	2158	24	,	,	,
46745	2158	25	as	as	IN
46745	2158	26	is	be	VBZ
46745	2158	27	sometimes	sometimes	RB
46745	2158	28	stated	state	VBN
46745	2158	29	by	by	IN
46745	2158	30	those	those	DT
46745	2158	31	who	who	WP
46745	2158	32	confound	confound	VBP
46745	2158	33	their	-PRON-	PRP$
46745	2158	34	application	application	NN
46745	2158	35	with	with	IN
46745	2158	36	that	that	DT
46745	2158	37	of	of	IN
46745	2158	38	Mercury	Mercury	NNP
46745	2158	39	given	give	VBN
46745	2158	40	in	in	IN
46745	2158	41	salivating	salivate	VBG
46745	2158	42	doses	dose	NNS
46745	2158	43	.	.	.
46745	2159	1	Under	under	IN
46745	2159	2	such	such	PDT
46745	2159	3	a	a	DT
46745	2159	4	course	course	NN
46745	2159	5	,	,	,
46745	2159	6	when	when	WRB
46745	2159	7	judiciously	judiciously	RB
46745	2159	8	enforced	enforce	VBN
46745	2159	9	,	,	,
46745	2159	10	we	-PRON-	PRP
46745	2159	11	may	may	MD
46745	2159	12	see	see	VB
46745	2159	13	the	the	DT
46745	2159	14	dilated	dilate	VBN
46745	2159	15	pupil	pupil	NN
46745	2159	16	contract	contract	NN
46745	2159	17	to	to	IN
46745	2159	18	its	-PRON-	PRP$
46745	2159	19	normal	normal	JJ
46745	2159	20	size	size	NN
46745	2159	21	,	,	,
46745	2159	22	and	and	CC
46745	2159	23	the	the	DT
46745	2159	24	pale	pale	JJ
46745	2159	25	enervated	enervate	VBN
46745	2159	26	countenance	countenance	NN
46745	2159	27	become	become	VBP
46745	2159	28	rosy	rosy	JJ
46745	2159	29	and	and	CC
46745	2159	30	lively	lively	JJ
46745	2159	31	;	;	:
46745	2159	32	and	and	CC
46745	2159	33	feel	feel	VB
46745	2159	34	the	the	DT
46745	2159	35	weak	weak	JJ
46745	2159	36	compressible	compressible	JJ
46745	2159	37	pulse	pulse	NN
46745	2159	38	to	to	TO
46745	2159	39	become	become	VB
46745	2159	40	hard	hard	JJ
46745	2159	41	and	and	CC
46745	2159	42	firm	firm	JJ
46745	2159	43	.	.	.
46745	2160	1	Perhaps	perhaps	RB
46745	2160	2	Mercury	Mercury	NNP
46745	2160	3	in	in	IN
46745	2160	4	such	such	PDT
46745	2160	5	a	a	DT
46745	2160	6	case	case	NN
46745	2160	7	may	may	MD
46745	2160	8	be	be	VB
46745	2160	9	indirectly	indirectly	RB
46745	2160	10	tonic	tonic	JJ
46745	2160	11	,	,	,
46745	2160	12	by	by	IN
46745	2160	13	restoring	restore	VBG
46745	2160	14	to	to	IN
46745	2160	15	the	the	DT
46745	2160	16	blood	blood	NN
46745	2160	17	the	the	DT
46745	2160	18	natural	natural	JJ
46745	2160	19	tonic	tonic	NN
46745	2160	20	principle	principle	NN
46745	2160	21	of	of	IN
46745	2160	22	the	the	DT
46745	2160	23	bile	bile	NN
46745	2160	24	.	.	.
46745	2161	1	It	-PRON-	PRP
46745	2161	2	will	will	MD
46745	2161	3	be	be	VB
46745	2161	4	conceded	concede	VBN
46745	2161	5	that	that	IN
46745	2161	6	it	-PRON-	PRP
46745	2161	7	is	be	VBZ
46745	2161	8	a	a	DT
46745	2161	9	great	great	JJ
46745	2161	10	merit	merit	NN
46745	2161	11	in	in	IN
46745	2161	12	a	a	DT
46745	2161	13	theory	theory	NN
46745	2161	14	,	,	,
46745	2161	15	when	when	WRB
46745	2161	16	it	-PRON-	PRP
46745	2161	17	succeeds	succeed	VBZ
46745	2161	18	in	in	IN
46745	2161	19	explaining	explain	VBG
46745	2161	20	at	at	IN
46745	2161	21	the	the	DT
46745	2161	22	same	same	JJ
46745	2161	23	time	time	NN
46745	2161	24	a	a	DT
46745	2161	25	number	number	NN
46745	2161	26	of	of	IN
46745	2161	27	different	different	JJ
46745	2161	28	things	thing	NNS
46745	2161	29	in	in	IN
46745	2161	30	a	a	DT
46745	2161	31	plausible	plausible	JJ
46745	2161	32	way	way	NN
46745	2161	33	.	.	.
46745	2162	1	It	-PRON-	PRP
46745	2162	2	seems	seem	VBZ
46745	2162	3	that	that	IN
46745	2162	4	this	this	DT
46745	2162	5	hypothesis	hypothesis	NN
46745	2162	6	of	of	IN
46745	2162	7	the	the	DT
46745	2162	8	connexion	connexion	NN
46745	2162	9	of	of	IN
46745	2162	10	Tonics	Tonics	NNP
46745	2162	11	with	with	IN
46745	2162	12	Taurine	Taurine	NNP
46745	2162	13	,	,	,
46745	2162	14	or	or	CC
46745	2162	15	some	some	DT
46745	2162	16	such	such	JJ
46745	2162	17	element	element	NN
46745	2162	18	of	of	IN
46745	2162	19	the	the	DT
46745	2162	20	Bile	Bile	NNP
46745	2162	21	,	,	,
46745	2162	22	is	be	VBZ
46745	2162	23	capable	capable	JJ
46745	2162	24	of	of	IN
46745	2162	25	so	so	RB
46745	2162	26	doing	do	VBG
46745	2162	27	.	.	.
46745	2163	1	I	-PRON-	PRP
46745	2163	2	am	be	VBP
46745	2163	3	very	very	RB
46745	2163	4	far	far	RB
46745	2163	5	from	from	IN
46745	2163	6	asserting	assert	VBG
46745	2163	7	that	that	IN
46745	2163	8	it	-PRON-	PRP
46745	2163	9	is	be	VBZ
46745	2163	10	proved	prove	VBN
46745	2163	11	,	,	,
46745	2163	12	or	or	CC
46745	2163	13	from	from	IN
46745	2163	14	supposing	suppose	VBG
46745	2163	15	that	that	IN
46745	2163	16	it	-PRON-	PRP
46745	2163	17	is	be	VBZ
46745	2163	18	at	at	RB
46745	2163	19	all	all	RB
46745	2163	20	likely	likely	JJ
46745	2163	21	to	to	TO
46745	2163	22	be	be	VB
46745	2163	23	so	so	RB
46745	2163	24	in	in	IN
46745	2163	25	the	the	DT
46745	2163	26	present	present	JJ
46745	2163	27	state	state	NN
46745	2163	28	of	of	IN
46745	2163	29	our	-PRON-	PRP$
46745	2163	30	knowledge	knowledge	NN
46745	2163	31	of	of	IN
46745	2163	32	the	the	DT
46745	2163	33	subject	subject	NN
46745	2163	34	;	;	:
46745	2163	35	but	but	CC
46745	2163	36	I	-PRON-	PRP
46745	2163	37	think	think	VBP
46745	2163	38	that	that	IN
46745	2163	39	if	if	IN
46745	2163	40	not	not	RB
46745	2163	41	evidently	evidently	RB
46745	2163	42	true	true	JJ
46745	2163	43	,	,	,
46745	2163	44	it	-PRON-	PRP
46745	2163	45	appears	appear	VBZ
46745	2163	46	at	at	IN
46745	2163	47	least	least	JJS
46745	2163	48	reasonable	reasonable	JJ
46745	2163	49	.	.	.
46745	2164	1	And	and	CC
46745	2164	2	it	-PRON-	PRP
46745	2164	3	may	may	MD
46745	2164	4	be	be	VB
46745	2164	5	observed	observe	VBN
46745	2164	6	,	,	,
46745	2164	7	that	that	IN
46745	2164	8	even	even	RB
46745	2164	9	should	should	MD
46745	2164	10	this	this	DT
46745	2164	11	idea	idea	NN
46745	2164	12	be	be	VB
46745	2164	13	completely	completely	RB
46745	2164	14	overthrown	overthrow	VBN
46745	2164	15	,	,	,
46745	2164	16	which	which	WDT
46745	2164	17	is	be	VBZ
46745	2164	18	neither	neither	CC
46745	2164	19	impossible	impossible	JJ
46745	2164	20	nor	nor	CC
46745	2164	21	unlikely	unlikely	JJ
46745	2164	22	,	,	,
46745	2164	23	there	there	EX
46745	2164	24	would	would	MD
46745	2164	25	still	still	RB
46745	2164	26	seem	seem	VB
46745	2164	27	to	to	TO
46745	2164	28	be	be	VB
46745	2164	29	left	leave	VBN
46745	2164	30	ample	ample	JJ
46745	2164	31	evidence	evidence	NN
46745	2164	32	to	to	TO
46745	2164	33	prove	prove	VB
46745	2164	34	that	that	DT
46745	2164	35	Quina	Quina	NNP
46745	2164	36	and	and	CC
46745	2164	37	other	other	JJ
46745	2164	38	vegetable	vegetable	NN
46745	2164	39	bitters	bitter	NNS
46745	2164	40	act	act	VBP
46745	2164	41	on	on	IN
46745	2164	42	the	the	DT
46745	2164	43	blood	blood	NN
46745	2164	44	on	on	IN
46745	2164	45	the	the	DT
46745	2164	46	restorative	restorative	JJ
46745	2164	47	principle,--though	principle,--though	NNP
46745	2164	48	in	in	IN
46745	2164	49	what	what	WP
46745	2164	50	exact	exact	JJ
46745	2164	51	way	way	NN
46745	2164	52	is	be	VBZ
46745	2164	53	uncertain	uncertain	JJ
46745	2164	54	.	.	.
46745	2165	1	ORD	ORD	NNP
46745	2165	2	.	.	.
46745	2166	1	V.	V.	NNP
46745	2166	2	CHALYBEATES	chalybeate	NNS
46745	2166	3	.	.	.
46745	2167	1	(	(	-LRB-
46745	2167	2	Protoxide	Protoxide	NNP
46745	2167	3	,	,	,
46745	2167	4	Sesquioxide	Sesquioxide	NNP
46745	2167	5	,	,	,
46745	2167	6	and	and	CC
46745	2167	7	Sesquichloride	Sesquichloride	NNP
46745	2167	8	of	of	IN
46745	2167	9	Iron	Iron	NNP
46745	2167	10	.	.	.
46745	2168	1	Salts	Salts	NNP
46745	2168	2	of	of	IN
46745	2168	3	Iron:--viz	Iron:--viz	NNP
46745	2168	4	.	.	.
46745	2168	5	,	,	,
46745	2168	6	the	the	DT
46745	2168	7	Carbonate	carbonate	JJ
46745	2168	8	;	;	:
46745	2168	9	Protosulphate	protosulphate	JJ
46745	2168	10	;	;	:
46745	2168	11	Persulphate	persulphate	NN
46745	2168	12	;	;	:
46745	2168	13	Phosphate	Phosphate	NNP
46745	2168	14	;	;	:
46745	2168	15	Pernitrate	pernitrate	NN
46745	2168	16	;	;	:
46745	2168	17	Peracetate	peracetate	JJ
46745	2168	18	;	;	:
46745	2168	19	Ammonio	ammonio	NN
46745	2168	20	-	-	HYPH
46745	2168	21	citrate	citrate	NN
46745	2168	22	;	;	:
46745	2168	23	Potassio	Potassio	NNP
46745	2168	24	-	-	HYPH
46745	2168	25	tartrate	tartrate	NNP
46745	2168	26	.	.	.
46745	2169	1	Vinum	Vinum	NNP
46745	2169	2	Ferri	Ferri	NNP
46745	2169	3	.	.	.
46745	2170	1	Chalybeate	Chalybeate	NNP
46745	2170	2	Waters	Waters	NNPS
46745	2170	3	.	.	.
46745	2170	4	)	)	-RRB-
46745	2171	1	Most	Most	JJS
46745	2171	2	of	of	IN
46745	2171	3	these	these	DT
46745	2171	4	substances	substance	NNS
46745	2171	5	are	be	VBP
46745	2171	6	readily	readily	RB
46745	2171	7	soluble	soluble	JJ
46745	2171	8	in	in	IN
46745	2171	9	water	water	NN
46745	2171	10	.	.	.
46745	2172	1	Steel	steel	NN
46745	2172	2	wine	wine	NN
46745	2172	3	contains	contain	VBZ
46745	2172	4	a	a	DT
46745	2172	5	Tartrate	Tartrate	NNP
46745	2172	6	.	.	.
46745	2173	1	The	the	DT
46745	2173	2	insoluble	insoluble	JJ
46745	2173	3	oxides	oxide	NNS
46745	2173	4	are	be	VBP
46745	2173	5	doubtless	doubtless	RB
46745	2173	6	dissolved	dissolve	VBN
46745	2173	7	by	by	IN
46745	2173	8	the	the	DT
46745	2173	9	aid	aid	NN
46745	2173	10	of	of	IN
46745	2173	11	the	the	DT
46745	2173	12	acid	acid	NN
46745	2173	13	of	of	IN
46745	2173	14	the	the	DT
46745	2173	15	stomach	stomach	NN
46745	2173	16	;	;	:
46745	2173	17	and	and	CC
46745	2173	18	we	-PRON-	PRP
46745	2173	19	find	find	VBP
46745	2173	20	that	that	IN
46745	2173	21	both	both	DT
46745	2173	22	are	be	VBP
46745	2173	23	most	most	RBS
46745	2173	24	active	active	JJ
46745	2173	25	when	when	WRB
46745	2173	26	given	give	VBN
46745	2173	27	in	in	IN
46745	2173	28	the	the	DT
46745	2173	29	form	form	NN
46745	2173	30	of	of	IN
46745	2173	31	hydrate	hydrate	NN
46745	2173	32	,	,	,
46745	2173	33	which	which	WDT
46745	2173	34	is	be	VBZ
46745	2173	35	most	most	RBS
46745	2173	36	easily	easily	RB
46745	2173	37	soluble	soluble	JJ
46745	2173	38	in	in	IN
46745	2173	39	such	such	PDT
46745	2173	40	a	a	DT
46745	2173	41	menstruum	menstruum	NN
46745	2173	42	.	.	.
46745	2174	1	Thus	thus	RB
46745	2174	2	Chalybeates	Chalybeates	NNPS
46745	2174	3	are	be	VBP
46745	2174	4	capable	capable	JJ
46745	2174	5	of	of	IN
46745	2174	6	being	be	VBG
46745	2174	7	absorbed	absorb	VBN
46745	2174	8	;	;	:
46745	2174	9	and	and	CC
46745	2174	10	they	-PRON-	PRP
46745	2174	11	no	no	RB
46745	2174	12	doubt	doubt	RB
46745	2174	13	are	be	VBP
46745	2174	14	absorbed	absorb	VBN
46745	2174	15	.	.	.
46745	2175	1	They	-PRON-	PRP
46745	2175	2	have	have	VBP
46745	2175	3	been	be	VBN
46745	2175	4	detected	detect	VBN
46745	2175	5	in	in	IN
46745	2175	6	the	the	DT
46745	2175	7	blood	blood	NN
46745	2175	8	,	,	,
46745	2175	9	and	and	CC
46745	2175	10	discovered	discover	VBN
46745	2175	11	in	in	IN
46745	2175	12	the	the	DT
46745	2175	13	secretions	secretion	NNS
46745	2175	14	of	of	IN
46745	2175	15	urine	urine	NN
46745	2175	16	and	and	CC
46745	2175	17	milk	milk	NN
46745	2175	18	.	.	.
46745	2176	1	Being	be	VBG
46745	2176	2	in	in	IN
46745	2176	3	the	the	DT
46745	2176	4	blood	blood	NN
46745	2176	5	,	,	,
46745	2176	6	they	-PRON-	PRP
46745	2176	7	act	act	VBP
46745	2176	8	by	by	IN
46745	2176	9	an	an	DT
46745	2176	10	influence	influence	NN
46745	2176	11	which	which	WDT
46745	2176	12	they	-PRON-	PRP
46745	2176	13	exert	exert	VBP
46745	2176	14	upon	upon	IN
46745	2176	15	it	-PRON-	PRP
46745	2176	16	;	;	:
46745	2176	17	for	for	IN
46745	2176	18	they	-PRON-	PRP
46745	2176	19	are	be	VBP
46745	2176	20	wanting	want	VBG
46745	2176	21	in	in	IN
46745	2176	22	all	all	PDT
46745	2176	23	the	the	DT
46745	2176	24	characters	character	NNS
46745	2176	25	which	which	WDT
46745	2176	26	distinguish	distinguish	VBP
46745	2176	27	nerve	nerve	NN
46745	2176	28	-	-	HYPH
46745	2176	29	medicines	medicine	NNS
46745	2176	30	.	.	.
46745	2177	1	They	-PRON-	PRP
46745	2177	2	are	be	VBP
46745	2177	3	never	never	RB
46745	2177	4	sudden	sudden	JJ
46745	2177	5	in	in	IN
46745	2177	6	their	-PRON-	PRP$
46745	2177	7	action	action	NN
46745	2177	8	,	,	,
46745	2177	9	and	and	CC
46745	2177	10	the	the	DT
46745	2177	11	effect	effect	NN
46745	2177	12	which	which	WDT
46745	2177	13	they	-PRON-	PRP
46745	2177	14	produce	produce	VBP
46745	2177	15	is	be	VBZ
46745	2177	16	lasting	last	VBG
46745	2177	17	.	.	.
46745	2178	1	Iron	iron	NN
46745	2178	2	is	be	VBZ
46745	2178	3	found	find	VBN
46745	2178	4	naturally	naturally	RB
46745	2178	5	in	in	IN
46745	2178	6	the	the	DT
46745	2178	7	blood	blood	NN
46745	2178	8	;	;	:
46745	2178	9	and	and	CC
46745	2178	10	the	the	DT
46745	2178	11	substance	substance	NN
46745	2178	12	in	in	IN
46745	2178	13	which	which	WDT
46745	2178	14	it	-PRON-	PRP
46745	2178	15	is	be	VBZ
46745	2178	16	found	find	VBN
46745	2178	17	is	be	VBZ
46745	2178	18	that	that	IN
46745	2178	19	which	which	WDT
46745	2178	20	constitutes	constitute	VBZ
46745	2178	21	the	the	DT
46745	2178	22	colouring	colour	VBG
46745	2178	23	material	material	NN
46745	2178	24	of	of	IN
46745	2178	25	the	the	DT
46745	2178	26	red	red	JJ
46745	2178	27	corpuscles	corpuscle	NNS
46745	2178	28	.	.	.
46745	2179	1	This	this	DT
46745	2179	2	is	be	VBZ
46745	2179	3	called	call	VBN
46745	2179	4	Hæmatosin	Hæmatosin	NNP
46745	2179	5	.	.	.
46745	2180	1	It	-PRON-	PRP
46745	2180	2	has	have	VBZ
46745	2180	3	been	be	VBN
46745	2180	4	asserted	assert	VBN
46745	2180	5	by	by	IN
46745	2180	6	some	some	DT
46745	2180	7	that	that	WDT
46745	2180	8	the	the	DT
46745	2180	9	red	red	JJ
46745	2180	10	colour	colour	NN
46745	2180	11	of	of	IN
46745	2180	12	Hæmatosin	Hæmatosin	NNP
46745	2180	13	does	do	VBZ
46745	2180	14	not	not	RB
46745	2180	15	depend	depend	VB
46745	2180	16	upon	upon	IN
46745	2180	17	the	the	DT
46745	2180	18	iron	iron	NN
46745	2180	19	which	which	WDT
46745	2180	20	it	-PRON-	PRP
46745	2180	21	contains	contain	VBZ
46745	2180	22	.	.	.
46745	2181	1	But	but	CC
46745	2181	2	however	however	RB
46745	2181	3	improbable	improbable	JJ
46745	2181	4	this	this	DT
46745	2181	5	may	may	MD
46745	2181	6	be	be	VB
46745	2181	7	,	,	,
46745	2181	8	it	-PRON-	PRP
46745	2181	9	matters	matter	VBZ
46745	2181	10	not	not	RB
46745	2181	11	here	here	RB
46745	2181	12	whether	whether	IN
46745	2181	13	it	-PRON-	PRP
46745	2181	14	be	be	VB
46745	2181	15	proved	prove	VBN
46745	2181	16	so	so	RB
46745	2181	17	or	or	CC
46745	2181	18	not	not	RB
46745	2181	19	;	;	:
46745	2181	20	for	for	IN
46745	2181	21	it	-PRON-	PRP
46745	2181	22	is	be	VBZ
46745	2181	23	sufficient	sufficient	JJ
46745	2181	24	that	that	IN
46745	2181	25	it	-PRON-	PRP
46745	2181	26	is	be	VBZ
46745	2181	27	ascertained	ascertain	VBN
46745	2181	28	that	that	IN
46745	2181	29	Iron	Iron	NNP
46745	2181	30	is	be	VBZ
46745	2181	31	essential	essential	JJ
46745	2181	32	to	to	IN
46745	2181	33	the	the	DT
46745	2181	34	chemical	chemical	NN
46745	2181	35	constitution	constitution	NN
46745	2181	36	of	of	IN
46745	2181	37	this	this	DT
46745	2181	38	red	red	JJ
46745	2181	39	matter	matter	NN
46745	2181	40	.	.	.
46745	2182	1	Without	without	IN
46745	2182	2	Iron	Iron	NNP
46745	2182	3	,	,	,
46745	2182	4	Hæmatosin	Hæmatosin	NNP
46745	2182	5	could	could	MD
46745	2182	6	not	not	RB
46745	2182	7	exist	exist	VB
46745	2182	8	,	,	,
46745	2182	9	any	any	DT
46745	2182	10	more	more	JJR
46745	2182	11	than	than	IN
46745	2182	12	Albumen	Albumen	NNP
46745	2182	13	could	could	MD
46745	2182	14	continue	continue	VB
46745	2182	15	to	to	TO
46745	2182	16	be	be	VB
46745	2182	17	Albumen	Albumen	NNP
46745	2182	18	,	,	,
46745	2182	19	when	when	WRB
46745	2182	20	deprived	deprive	VBN
46745	2182	21	of	of	IN
46745	2182	22	nitrogen	nitrogen	NN
46745	2182	23	.	.	.
46745	2183	1	According	accord	VBG
46745	2183	2	to	to	IN
46745	2183	3	the	the	DT
46745	2183	4	analysis	analysis	NN
46745	2183	5	of	of	IN
46745	2183	6	Mulder	Mulder	NNP
46745	2183	7	,	,	,
46745	2183	8	Hæmatosin	Hæmatosin	NNP
46745	2183	9	=	=	SYM
46745	2183	10	C_{44}H_{22}O_{5}N_{3}Fe	C_{44}H_{22}O_{5}N_{3}Fe	NNP
46745	2183	11	.	.	.
46745	2184	1	It	-PRON-	PRP
46745	2184	2	is	be	VBZ
46745	2184	3	a	a	DT
46745	2184	4	very	very	RB
46745	2184	5	peculiar	peculiar	JJ
46745	2184	6	body	body	NN
46745	2184	7	,	,	,
46745	2184	8	and	and	CC
46745	2184	9	apparently	apparently	RB
46745	2184	10	an	an	DT
46745	2184	11	essential	essential	JJ
46745	2184	12	and	and	CC
46745	2184	13	most	most	RBS
46745	2184	14	important	important	JJ
46745	2184	15	constituent	constituent	NN
46745	2184	16	of	of	IN
46745	2184	17	the	the	DT
46745	2184	18	blood	blood	NN
46745	2184	19	;	;	:
46745	2184	20	for	for	IN
46745	2184	21	when	when	WRB
46745	2184	22	it	-PRON-	PRP
46745	2184	23	is	be	VBZ
46745	2184	24	deficient	deficient	JJ
46745	2184	25	,	,	,
46745	2184	26	as	as	IN
46745	2184	27	evidenced	evidence	VBN
46745	2184	28	by	by	IN
46745	2184	29	the	the	DT
46745	2184	30	paleness	paleness	NN
46745	2184	31	of	of	IN
46745	2184	32	the	the	DT
46745	2184	33	tissues	tissue	NNS
46745	2184	34	in	in	IN
46745	2184	35	Anæmia	Anæmia	NNP
46745	2184	36	,	,	,
46745	2184	37	the	the	DT
46745	2184	38	whole	whole	JJ
46745	2184	39	system	system	NN
46745	2184	40	suffers	suffer	VBZ
46745	2184	41	materially	materially	RB
46745	2184	42	,	,	,
46745	2184	43	and	and	CC
46745	2184	44	great	great	JJ
46745	2184	45	and	and	CC
46745	2184	46	general	general	JJ
46745	2184	47	debility	debility	NN
46745	2184	48	is	be	VBZ
46745	2184	49	produced	produce	VBN
46745	2184	50	.	.	.
46745	2185	1	The	the	DT
46745	2185	2	result	result	NN
46745	2185	3	of	of	IN
46745	2185	4	the	the	DT
46745	2185	5	administration	administration	NN
46745	2185	6	of	of	IN
46745	2185	7	an	an	DT
46745	2185	8	Iron	Iron	NNP
46745	2185	9	medicine	medicine	NN
46745	2185	10	is	be	VBZ
46745	2185	11	the	the	DT
46745	2185	12	restoration	restoration	NN
46745	2185	13	of	of	IN
46745	2185	14	this	this	DT
46745	2185	15	wanting	want	VBG
46745	2185	16	colouring	colouring	NN
46745	2185	17	matter	matter	NN
46745	2185	18	.	.	.
46745	2186	1	For	for	IN
46745	2186	2	if	if	IN
46745	2186	3	the	the	DT
46745	2186	4	blood	blood	NN
46745	2186	5	be	be	VB
46745	2186	6	analyzed	analyze	VBN
46745	2186	7	before	before	RB
46745	2186	8	and	and	CC
46745	2186	9	after	after	IN
46745	2186	10	its	-PRON-	PRP$
46745	2186	11	employment	employment	NN
46745	2186	12	,	,	,
46745	2186	13	it	-PRON-	PRP
46745	2186	14	is	be	VBZ
46745	2186	15	found	find	VBN
46745	2186	16	to	to	TO
46745	2186	17	have	have	VB
46745	2186	18	undergone	undergo	VBN
46745	2186	19	a	a	DT
46745	2186	20	remarkable	remarkable	JJ
46745	2186	21	change	change	NN
46745	2186	22	,	,	,
46745	2186	23	most	most	RBS
46745	2186	24	particularly	particularly	RB
46745	2186	25	in	in	IN
46745	2186	26	the	the	DT
46745	2186	27	quantity	quantity	NN
46745	2186	28	of	of	IN
46745	2186	29	Hæmatosin	Hæmatosin	NNP
46745	2186	30	which	which	WDT
46745	2186	31	it	-PRON-	PRP
46745	2186	32	contains	contain	VBZ
46745	2186	33	.	.	.
46745	2187	1	A	a	DT
46745	2187	2	case	case	NN
46745	2187	3	in	in	IN
46745	2187	4	illustration	illustration	NN
46745	2187	5	of	of	IN
46745	2187	6	this	this	DT
46745	2187	7	is	be	VBZ
46745	2187	8	given	give	VBN
46745	2187	9	by	by	IN
46745	2187	10	M.	M.	NNP
46745	2187	11	Simon	Simon	NNP
46745	2187	12	,	,	,
46745	2187	13	of	of	IN
46745	2187	14	Berlin	Berlin	NNP
46745	2187	15	.	.	.
46745	2188	1	(	(	-LRB-
46745	2188	2	_	_	NNP
46745	2188	3	Anim	Anim	NNP
46745	2188	4	.	.	.
46745	2189	1	Chem	Chem	NNP
46745	2189	2	.	.	.
46745	2189	3	_	_	NNP
46745	2189	4	,	,	,
46745	2189	5	vol	vol	NNP
46745	2189	6	.	.	.
46745	2190	1	i.	i.	NNP
46745	2190	2	pp	pp	NNP
46745	2190	3	.	.	.
46745	2191	1	310	310	CD
46745	2191	2	,	,	,
46745	2191	3	313	313	CD
46745	2191	4	.	.	.
46745	2192	1	_	_	NNP
46745	2192	2	Syd	Syd	NNP
46745	2192	3	.	.	.
46745	2193	1	Society	society	NN
46745	2193	2	.	.	.
46745	2193	3	_	_	NNP
46745	2193	4	)	)	-RRB-
46745	2193	5	The	the	DT
46745	2193	6	solid	solid	JJ
46745	2193	7	constituents	constituent	NNS
46745	2193	8	of	of	IN
46745	2193	9	the	the	DT
46745	2193	10	blood	blood	NN
46745	2193	11	,	,	,
46745	2193	12	in	in	IN
46745	2193	13	a	a	DT
46745	2193	14	case	case	NN
46745	2193	15	of	of	IN
46745	2193	16	Chlorosis	Chlorosis	NNP
46745	2193	17	,	,	,
46745	2193	18	had	have	VBD
46745	2193	19	increased	increase	VBN
46745	2193	20	,	,	,
46745	2193	21	under	under	IN
46745	2193	22	the	the	DT
46745	2193	23	use	use	NN
46745	2193	24	of	of	IN
46745	2193	25	iron	iron	NN
46745	2193	26	,	,	,
46745	2193	27	from	from	IN
46745	2193	28	128.5	128.5	CD
46745	2193	29	to	to	IN
46745	2193	30	193.5	193.5	CD
46745	2193	31	in	in	IN
46745	2193	32	1000	1000	CD
46745	2193	33	parts	part	NNS
46745	2193	34	;	;	:
46745	2193	35	the	the	DT
46745	2193	36	Globuline	Globuline	NNP
46745	2193	37	from	from	IN
46745	2193	38	30	30	CD
46745	2193	39	to	to	TO
46745	2193	40	90	90	CD
46745	2193	41	;	;	:
46745	2193	42	and	and	CC
46745	2193	43	the	the	DT
46745	2193	44	Hæmatosin	Hæmatosin	NNP
46745	2193	45	from	from	IN
46745	2193	46	1.48	1.48	CD
46745	2193	47	to	to	IN
46745	2193	48	4.59	4.59	CD
46745	2193	49	,	,	,
46745	2193	50	in	in	IN
46745	2193	51	the	the	DT
46745	2193	52	same	same	JJ
46745	2193	53	amount	amount	NN
46745	2193	54	.	.	.
46745	2194	1	It	-PRON-	PRP
46745	2194	2	is	be	VBZ
46745	2194	3	probable	probable	JJ
46745	2194	4	that	that	IN
46745	2194	5	the	the	DT
46745	2194	6	increase	increase	NN
46745	2194	7	in	in	IN
46745	2194	8	the	the	DT
46745	2194	9	Hæmatosin	Hæmatosin	NNP
46745	2194	10	is	be	VBZ
46745	2194	11	the	the	DT
46745	2194	12	first	first	JJ
46745	2194	13	change	change	NN
46745	2194	14	;	;	:
46745	2194	15	that	that	IN
46745	2194	16	this	this	DT
46745	2194	17	then	then	RB
46745	2194	18	improves	improve	VBZ
46745	2194	19	the	the	DT
46745	2194	20	condition	condition	NN
46745	2194	21	of	of	IN
46745	2194	22	the	the	DT
46745	2194	23	blood	blood	NN
46745	2194	24	corpuscles	corpuscle	NNS
46745	2194	25	,	,	,
46745	2194	26	increases	increase	VBZ
46745	2194	27	their	-PRON-	PRP$
46745	2194	28	number	number	NN
46745	2194	29	,	,	,
46745	2194	30	and	and	CC
46745	2194	31	through	through	IN
46745	2194	32	them	-PRON-	PRP
46745	2194	33	betters	better	NNS
46745	2194	34	the	the	DT
46745	2194	35	condition	condition	NN
46745	2194	36	of	of	IN
46745	2194	37	the	the	DT
46745	2194	38	blood	blood	NN
46745	2194	39	,	,	,
46745	2194	40	and	and	CC
46745	2194	41	of	of	IN
46745	2194	42	the	the	DT
46745	2194	43	system	system	NN
46745	2194	44	generally	generally	RB
46745	2194	45	.	.	.
46745	2195	1	In	in	IN
46745	2195	2	a	a	DT
46745	2195	3	case	case	NN
46745	2195	4	which	which	WDT
46745	2195	5	came	come	VBD
46745	2195	6	under	under	IN
46745	2195	7	my	-PRON-	PRP$
46745	2195	8	own	own	JJ
46745	2195	9	observation	observation	NN
46745	2195	10	,	,	,
46745	2195	11	the	the	DT
46745	2195	12	blood	blood	NN
46745	2195	13	of	of	IN
46745	2195	14	an	an	DT
46745	2195	15	anæmic	anæmic	JJ
46745	2195	16	girl	girl	NN
46745	2195	17	was	be	VBD
46745	2195	18	found	find	VBN
46745	2195	19	,	,	,
46745	2195	20	before	before	IN
46745	2195	21	the	the	DT
46745	2195	22	use	use	NN
46745	2195	23	of	of	IN
46745	2195	24	Iron	Iron	NNP
46745	2195	25	,	,	,
46745	2195	26	to	to	TO
46745	2195	27	contain	contain	VB
46745	2195	28	only	only	RB
46745	2195	29	50	50	CD
46745	2195	30	parts	part	NNS
46745	2195	31	of	of	IN
46745	2195	32	globules	globule	NNS
46745	2195	33	in	in	IN
46745	2195	34	1000	1000	CD
46745	2195	35	,	,	,
46745	2195	36	instead	instead	RB
46745	2195	37	of	of	IN
46745	2195	38	120	120	CD
46745	2195	39	,	,	,
46745	2195	40	the	the	DT
46745	2195	41	normal	normal	JJ
46745	2195	42	average	average	NN
46745	2195	43	.	.	.
46745	2196	1	The	the	DT
46745	2196	2	Ammonio	Ammonio	NNP
46745	2196	3	-	-	HYPH
46745	2196	4	citrate	citrate	NN
46745	2196	5	of	of	IN
46745	2196	6	Iron	Iron	NNP
46745	2196	7	was	be	VBD
46745	2196	8	prescribed	prescribe	VBN
46745	2196	9	,	,	,
46745	2196	10	in	in	IN
46745	2196	11	five	five	CD
46745	2196	12	-	-	HYPH
46745	2196	13	grain	grain	NN
46745	2196	14	doses	dose	NNS
46745	2196	15	,	,	,
46745	2196	16	three	three	CD
46745	2196	17	times	time	NNS
46745	2196	18	a	a	DT
46745	2196	19	day	day	NN
46745	2196	20	.	.	.
46745	2197	1	After	after	IN
46745	2197	2	it	-PRON-	PRP
46745	2197	3	had	have	VBD
46745	2197	4	been	be	VBN
46745	2197	5	continued	continue	VBN
46745	2197	6	for	for	IN
46745	2197	7	a	a	DT
46745	2197	8	month	month	NN
46745	2197	9	,	,	,
46745	2197	10	the	the	DT
46745	2197	11	blood	blood	NN
46745	2197	12	was	be	VBD
46745	2197	13	again	again	RB
46745	2197	14	analyzed	analyze	VBN
46745	2197	15	,	,	,
46745	2197	16	and	and	CC
46745	2197	17	the	the	DT
46745	2197	18	amount	amount	NN
46745	2197	19	of	of	IN
46745	2197	20	corpuscles	corpuscle	NNS
46745	2197	21	found	find	VBN
46745	2197	22	to	to	TO
46745	2197	23	have	have	VB
46745	2197	24	increased	increase	VBN
46745	2197	25	to	to	IN
46745	2197	26	76	76	CD
46745	2197	27	parts	part	NNS
46745	2197	28	.	.	.
46745	2198	1	After	after	IN
46745	2198	2	another	another	DT
46745	2198	3	month	month	NN
46745	2198	4	,	,	,
46745	2198	5	they	-PRON-	PRP
46745	2198	6	had	have	VBD
46745	2198	7	reached	reach	VBN
46745	2198	8	to	to	IN
46745	2198	9	upwards	upward	NNS
46745	2198	10	of	of	IN
46745	2198	11	100	100	CD
46745	2198	12	in	in	IN
46745	2198	13	1000	1000	CD
46745	2198	14	parts	part	NNS
46745	2198	15	of	of	IN
46745	2198	16	blood	blood	NN
46745	2198	17	.	.	.
46745	2199	1	In	in	IN
46745	2199	2	the	the	DT
46745	2199	3	mean	mean	JJ
46745	2199	4	time	time	NN
46745	2199	5	the	the	DT
46745	2199	6	appearance	appearance	NN
46745	2199	7	of	of	IN
46745	2199	8	the	the	DT
46745	2199	9	patient	patient	NN
46745	2199	10	had	have	VBD
46745	2199	11	improved	improve	VBN
46745	2199	12	immensely	immensely	RB
46745	2199	13	.	.	.
46745	2200	1	Chalybeates	chalybeate	NNS
46745	2200	2	have	have	VBP
46745	2200	3	thus	thus	RB
46745	2200	4	a	a	DT
46745	2200	5	most	most	RBS
46745	2200	6	immediate	immediate	JJ
46745	2200	7	and	and	CC
46745	2200	8	obvious	obvious	JJ
46745	2200	9	effect	effect	NN
46745	2200	10	in	in	IN
46745	2200	11	restoring	restore	VBG
46745	2200	12	to	to	IN
46745	2200	13	the	the	DT
46745	2200	14	blood	blood	NN
46745	2200	15	this	this	DT
46745	2200	16	wanting	want	VBG
46745	2200	17	Hæmatosin	Hæmatosin	NNP
46745	2200	18	.	.	.
46745	2201	1	As	as	IN
46745	2201	2	the	the	DT
46745	2201	3	exact	exact	JJ
46745	2201	4	chemical	chemical	JJ
46745	2201	5	condition	condition	NN
46745	2201	6	of	of	IN
46745	2201	7	the	the	DT
46745	2201	8	Iron	Iron	NNP
46745	2201	9	in	in	IN
46745	2201	10	Hæmatosin	Hæmatosin	NNP
46745	2201	11	has	have	VBZ
46745	2201	12	not	not	RB
46745	2201	13	been	be	VBN
46745	2201	14	discovered	discover	VBN
46745	2201	15	,	,	,
46745	2201	16	so	so	RB
46745	2201	17	also	also	RB
46745	2201	18	the	the	DT
46745	2201	19	precise	precise	JJ
46745	2201	20	changes	change	NNS
46745	2201	21	which	which	WDT
46745	2201	22	Chalybeate	Chalybeate	NNP
46745	2201	23	medicines	medicine	NNS
46745	2201	24	have	have	VBP
46745	2201	25	to	to	TO
46745	2201	26	undergo	undergo	VB
46745	2201	27	before	before	IN
46745	2201	28	they	-PRON-	PRP
46745	2201	29	can	can	MD
46745	2201	30	supply	supply	VB
46745	2201	31	this	this	DT
46745	2201	32	deficient	deficient	JJ
46745	2201	33	material	material	NN
46745	2201	34	in	in	IN
46745	2201	35	a	a	DT
46745	2201	36	fit	fit	JJ
46745	2201	37	and	and	CC
46745	2201	38	proper	proper	JJ
46745	2201	39	form	form	NN
46745	2201	40	,	,	,
46745	2201	41	are	be	VBP
46745	2201	42	not	not	RB
46745	2201	43	known	know	VBN
46745	2201	44	.	.	.
46745	2202	1	All	all	PDT
46745	2202	2	the	the	DT
46745	2202	3	known	know	VBN
46745	2202	4	soluble	soluble	JJ
46745	2202	5	compounds	compound	NNS
46745	2202	6	of	of	IN
46745	2202	7	Iron	Iron	NNP
46745	2202	8	,	,	,
46745	2202	9	except	except	IN
46745	2202	10	the	the	DT
46745	2202	11	Ferrocyanide	Ferrocyanide	NNP
46745	2202	12	and	and	CC
46745	2202	13	Ferridcyanide	Ferridcyanide	NNP
46745	2202	14	of	of	IN
46745	2202	15	Potassium	Potassium	NNP
46745	2202	16	,	,	,
46745	2202	17	possess	possess	VB
46745	2202	18	this	this	DT
46745	2202	19	Restorative	restorative	JJ
46745	2202	20	power	power	NN
46745	2202	21	.	.	.
46745	2203	1	In	in	IN
46745	2203	2	most	most	JJS
46745	2203	3	Chalybeates	chalybeate	VBZ
46745	2203	4	the	the	DT
46745	2203	5	Iron	Iron	NNP
46745	2203	6	acts	act	VBZ
46745	2203	7	the	the	DT
46745	2203	8	part	part	NN
46745	2203	9	of	of	IN
46745	2203	10	a	a	DT
46745	2203	11	base	base	NN
46745	2203	12	;	;	:
46745	2203	13	but	but	CC
46745	2203	14	in	in	IN
46745	2203	15	some	some	DT
46745	2203	16	,	,	,
46745	2203	17	as	as	IN
46745	2203	18	the	the	DT
46745	2203	19	Ammonio	Ammonio	NNP
46745	2203	20	-	-	HYPH
46745	2203	21	citrate	citrate	NNP
46745	2203	22	and	and	CC
46745	2203	23	Potassio	Potassio	NNP
46745	2203	24	-	-	HYPH
46745	2203	25	tartrate	tartrate	NNP
46745	2203	26	,	,	,
46745	2203	27	it	-PRON-	PRP
46745	2203	28	exists	exist	VBZ
46745	2203	29	in	in	IN
46745	2203	30	a	a	DT
46745	2203	31	peculiar	peculiar	JJ
46745	2203	32	condition	condition	NN
46745	2203	33	,	,	,
46745	2203	34	and	and	CC
46745	2203	35	can	can	MD
46745	2203	36	not	not	RB
46745	2203	37	be	be	VB
46745	2203	38	precipitated	precipitate	VBN
46745	2203	39	from	from	IN
46745	2203	40	their	-PRON-	PRP$
46745	2203	41	solutions	solution	NNS
46745	2203	42	by	by	IN
46745	2203	43	Ammonia	Ammonia	NNP
46745	2203	44	.	.	.
46745	2204	1	The	the	DT
46745	2204	2	water	water	NN
46745	2204	3	of	of	IN
46745	2204	4	Chalybeate	Chalybeate	NNP
46745	2204	5	springs	spring	NNS
46745	2204	6	generally	generally	RB
46745	2204	7	contains	contain	VBZ
46745	2204	8	a	a	DT
46745	2204	9	Carbonate	carbonate	NN
46745	2204	10	of	of	IN
46745	2204	11	Iron	Iron	NNP
46745	2204	12	,	,	,
46745	2204	13	held	hold	VBN
46745	2204	14	in	in	IN
46745	2204	15	solution	solution	NN
46745	2204	16	by	by	IN
46745	2204	17	an	an	DT
46745	2204	18	excess	excess	NN
46745	2204	19	of	of	IN
46745	2204	20	Carbonic	carbonic	JJ
46745	2204	21	acid	acid	NN
46745	2204	22	.	.	.
46745	2205	1	The	the	DT
46745	2205	2	same	same	JJ
46745	2205	3	salt	salt	NN
46745	2205	4	is	be	VBZ
46745	2205	5	contained	contain	VBN
46745	2205	6	in	in	IN
46745	2205	7	the	the	DT
46745	2205	8	compound	compound	NN
46745	2205	9	Iron	Iron	NNP
46745	2205	10	mixture	mixture	NN
46745	2205	11	and	and	CC
46745	2205	12	pill	pill	NN
46745	2205	13	of	of	IN
46745	2205	14	the	the	DT
46745	2205	15	Pharmacop[oe]ia	pharmacop[oe]ia	NN
46745	2205	16	,	,	,
46745	2205	17	when	when	WRB
46745	2205	18	these	these	DT
46745	2205	19	are	be	VBP
46745	2205	20	rightly	rightly	RB
46745	2205	21	prepared	prepared	JJ
46745	2205	22	.	.	.
46745	2206	1	When	when	WRB
46745	2206	2	the	the	DT
46745	2206	3	Iron	Iron	NNP
46745	2206	4	has	have	VBZ
46745	2206	5	entered	enter	VBN
46745	2206	6	the	the	DT
46745	2206	7	system	system	NN
46745	2206	8	,	,	,
46745	2206	9	it	-PRON-	PRP
46745	2206	10	is	be	VBZ
46745	2206	11	not	not	RB
46745	2206	12	necessarily	necessarily	RB
46745	2206	13	excreted	excrete	VBN
46745	2206	14	again	again	RB
46745	2206	15	from	from	IN
46745	2206	16	it	-PRON-	PRP
46745	2206	17	,	,	,
46745	2206	18	because	because	IN
46745	2206	19	it	-PRON-	PRP
46745	2206	20	is	be	VBZ
46745	2206	21	not	not	RB
46745	2206	22	unnatural	unnatural	JJ
46745	2206	23	to	to	IN
46745	2206	24	the	the	DT
46745	2206	25	blood	blood	NN
46745	2206	26	.	.	.
46745	2207	1	To	to	TO
46745	2207	2	ascertain	ascertain	VB
46745	2207	3	whether	whether	IN
46745	2207	4	Iron	Iron	NNP
46745	2207	5	given	give	VBN
46745	2207	6	in	in	IN
46745	2207	7	small	small	JJ
46745	2207	8	quantities	quantity	NNS
46745	2207	9	is	be	VBZ
46745	2207	10	excreted	excrete	VBN
46745	2207	11	by	by	IN
46745	2207	12	the	the	DT
46745	2207	13	kidneys	kidney	NNS
46745	2207	14	,	,	,
46745	2207	15	I	-PRON-	PRP
46745	2207	16	have	have	VBP
46745	2207	17	tested	test	VBN
46745	2207	18	the	the	DT
46745	2207	19	urine	urine	NN
46745	2207	20	of	of	IN
46745	2207	21	a	a	DT
46745	2207	22	patient	patient	NN
46745	2207	23	who	who	WP
46745	2207	24	had	have	VBD
46745	2207	25	been	be	VBN
46745	2207	26	for	for	IN
46745	2207	27	some	some	DT
46745	2207	28	time	time	NN
46745	2207	29	taking	take	VBG
46745	2207	30	thirty	thirty	CD
46745	2207	31	drops	drop	NNS
46745	2207	32	of	of	IN
46745	2207	33	the	the	DT
46745	2207	34	Tincture	Tincture	NNP
46745	2207	35	of	of	IN
46745	2207	36	the	the	DT
46745	2207	37	Sesquichloride	sesquichloride	JJ
46745	2207	38	twice	twice	PDT
46745	2207	39	a	a	DT
46745	2207	40	day	day	NN
46745	2207	41	:	:	:
46745	2207	42	but	but	CC
46745	2207	43	I	-PRON-	PRP
46745	2207	44	was	be	VBD
46745	2207	45	unable	unable	JJ
46745	2207	46	to	to	TO
46745	2207	47	detect	detect	VB
46745	2207	48	in	in	IN
46745	2207	49	it	-PRON-	PRP
46745	2207	50	any	any	DT
46745	2207	51	trace	trace	NN
46745	2207	52	of	of	IN
46745	2207	53	the	the	DT
46745	2207	54	metal	metal	NN
46745	2207	55	.	.	.
46745	2208	1	But	but	CC
46745	2208	2	when	when	WRB
46745	2208	3	given	give	VBN
46745	2208	4	in	in	IN
46745	2208	5	large	large	JJ
46745	2208	6	doses	dose	NNS
46745	2208	7	,	,	,
46745	2208	8	Iron	Iron	NNP
46745	2208	9	passes	pass	VBZ
46745	2208	10	off	off	RP
46745	2208	11	by	by	IN
46745	2208	12	the	the	DT
46745	2208	13	urine	urine	NN
46745	2208	14	and	and	CC
46745	2208	15	by	by	IN
46745	2208	16	other	other	JJ
46745	2208	17	secretions	secretion	NNS
46745	2208	18	.	.	.
46745	2209	1	Some	some	DT
46745	2209	2	portion	portion	NN
46745	2209	3	may	may	MD
46745	2209	4	be	be	VB
46745	2209	5	excreted	excrete	VBN
46745	2209	6	by	by	IN
46745	2209	7	the	the	DT
46745	2209	8	mucous	mucous	JJ
46745	2209	9	membrane	membrane	NN
46745	2209	10	of	of	IN
46745	2209	11	the	the	DT
46745	2209	12	intestines	intestine	NNS
46745	2209	13	,	,	,
46745	2209	14	and	and	CC
46745	2209	15	combine	combine	VB
46745	2209	16	in	in	IN
46745	2209	17	the	the	DT
46745	2209	18	cavity	cavity	NN
46745	2209	19	of	of	IN
46745	2209	20	the	the	DT
46745	2209	21	bowel	bowel	NN
46745	2209	22	with	with	IN
46745	2209	23	Sulphuretted	sulphuret	VBN
46745	2209	24	Hydrogen	Hydrogen	NNP
46745	2209	25	.	.	.
46745	2210	1	The	the	DT
46745	2210	2	resulting	result	VBG
46745	2210	3	Sulphuret	sulphuret	JJ
46745	2210	4	communicates	communicate	NNS
46745	2210	5	to	to	IN
46745	2210	6	the	the	DT
46745	2210	7	fæces	fæce	NNS
46745	2210	8	a	a	DT
46745	2210	9	characteristic	characteristic	JJ
46745	2210	10	black	black	JJ
46745	2210	11	colour	colour	NN
46745	2210	12	.	.	.
46745	2211	1	The	the	DT
46745	2211	2	cause	cause	NN
46745	2211	3	of	of	IN
46745	2211	4	this	this	DT
46745	2211	5	colour	colour	NN
46745	2211	6	was	be	VBD
46745	2211	7	ill	ill	JJ
46745	2211	8	understood	understand	VBN
46745	2211	9	;	;	:
46745	2211	10	until	until	IN
46745	2211	11	pointed	point	VBN
46745	2211	12	out	out	RP
46745	2211	13	by	by	IN
46745	2211	14	Berzelius	Berzelius	NNP
46745	2211	15	.	.	.
46745	2212	1	When	when	WRB
46745	2212	2	the	the	DT
46745	2212	3	salts	salt	NNS
46745	2212	4	of	of	IN
46745	2212	5	Iron	Iron	NNP
46745	2212	6	pass	pass	VB
46745	2212	7	through	through	IN
46745	2212	8	the	the	DT
46745	2212	9	glands	gland	NNS
46745	2212	10	,	,	,
46745	2212	11	they	-PRON-	PRP
46745	2212	12	generally	generally	RB
46745	2212	13	prove	prove	VBP
46745	2212	14	to	to	TO
46745	2212	15	be	be	VB
46745	2212	16	more	more	RBR
46745	2212	17	or	or	CC
46745	2212	18	less	less	RBR
46745	2212	19	astringent	astringent	JJ
46745	2212	20	.	.	.
46745	2213	1	The	the	DT
46745	2213	2	Chloride	Chloride	NNP
46745	2213	3	and	and	CC
46745	2213	4	Sulphate	Sulphate	NNP
46745	2213	5	are	be	VBP
46745	2213	6	most	most	RBS
46745	2213	7	so	so	RB
46745	2213	8	;	;	:
46745	2213	9	and	and	CC
46745	2213	10	they	-PRON-	PRP
46745	2213	11	will	will	MD
46745	2213	12	thus	thus	RB
46745	2213	13	be	be	VB
46745	2213	14	mentioned	mention	VBN
46745	2213	15	again	again	RB
46745	2213	16	under	under	IN
46745	2213	17	the	the	DT
46745	2213	18	head	head	NN
46745	2213	19	of	of	IN
46745	2213	20	Astringent	astringent	JJ
46745	2213	21	medicines	medicine	NNS
46745	2213	22	.	.	.
46745	2214	1	The	the	DT
46745	2214	2	tincture	tincture	NN
46745	2214	3	of	of	IN
46745	2214	4	the	the	DT
46745	2214	5	Sesquichloride	Sesquichloride	NNP
46745	2214	6	has	have	VBZ
46745	2214	7	obtained	obtain	VBN
46745	2214	8	the	the	DT
46745	2214	9	reputation	reputation	NN
46745	2214	10	of	of	IN
46745	2214	11	being	be	VBG
46745	2214	12	diuretic	diuretic	JJ
46745	2214	13	.	.	.
46745	2215	1	But	but	CC
46745	2215	2	this	this	DT
46745	2215	3	constitutes	constitute	VBZ
46745	2215	4	no	no	DT
46745	2215	5	exception	exception	NN
46745	2215	6	to	to	IN
46745	2215	7	the	the	DT
46745	2215	8	rule	rule	NN
46745	2215	9	of	of	IN
46745	2215	10	its	-PRON-	PRP$
46745	2215	11	being	be	VBG
46745	2215	12	astringent	astringent	NN
46745	2215	13	;	;	:
46745	2215	14	for	for	IN
46745	2215	15	this	this	DT
46745	2215	16	diuretic	diuretic	JJ
46745	2215	17	power	power	NN
46745	2215	18	is	be	VBZ
46745	2215	19	owing	owe	VBG
46745	2215	20	to	to	IN
46745	2215	21	a	a	DT
46745	2215	22	peculiar	peculiar	JJ
46745	2215	23	ether	ether	NN
46745	2215	24	,	,	,
46745	2215	25	formed	form	VBN
46745	2215	26	with	with	IN
46745	2215	27	the	the	DT
46745	2215	28	spirit	spirit	NN
46745	2215	29	by	by	IN
46745	2215	30	an	an	DT
46745	2215	31	excess	excess	NN
46745	2215	32	of	of	IN
46745	2215	33	hydrochloric	hydrochloric	JJ
46745	2215	34	acid	acid	NN
46745	2215	35	used	use	VBN
46745	2215	36	in	in	IN
46745	2215	37	the	the	DT
46745	2215	38	preparation	preparation	NN
46745	2215	39	of	of	IN
46745	2215	40	the	the	DT
46745	2215	41	tincture	tincture	NN
46745	2215	42	.	.	.
46745	2216	1	I	-PRON-	PRP
46745	2216	2	believe	believe	VBP
46745	2216	3	Iron	Iron	NNP
46745	2216	4	to	to	TO
46745	2216	5	be	be	VB
46745	2216	6	simply	simply	RB
46745	2216	7	and	and	CC
46745	2216	8	solely	solely	RB
46745	2216	9	a	a	DT
46745	2216	10	Restorative	restorative	JJ
46745	2216	11	remedy	remedy	NN
46745	2216	12	.	.	.
46745	2217	1	By	by	IN
46745	2217	2	improving	improve	VBG
46745	2217	3	the	the	DT
46745	2217	4	condition	condition	NN
46745	2217	5	of	of	IN
46745	2217	6	the	the	DT
46745	2217	7	blood	blood	NN
46745	2217	8	,	,	,
46745	2217	9	it	-PRON-	PRP
46745	2217	10	appears	appear	VBZ
46745	2217	11	similar	similar	JJ
46745	2217	12	in	in	IN
46745	2217	13	action	action	NN
46745	2217	14	to	to	IN
46745	2217	15	Tonics	tonic	NNS
46745	2217	16	;	;	:
46745	2217	17	but	but	CC
46745	2217	18	it	-PRON-	PRP
46745	2217	19	is	be	VBZ
46745	2217	20	not	not	RB
46745	2217	21	a	a	DT
46745	2217	22	true	true	JJ
46745	2217	23	Tonic	Tonic	NNP
46745	2217	24	,	,	,
46745	2217	25	for	for	IN
46745	2217	26	neither	neither	DT
46745	2217	27	in	in	IN
46745	2217	28	debility	debility	NN
46745	2217	29	nor	nor	CC
46745	2217	30	in	in	IN
46745	2217	31	Ague	Ague	NNP
46745	2217	32	is	be	VBZ
46745	2217	33	it	-PRON-	PRP
46745	2217	34	of	of	IN
46745	2217	35	any	any	DT
46745	2217	36	service	service	NN
46745	2217	37	,	,	,
46745	2217	38	unless	unless	IN
46745	2217	39	there	there	EX
46745	2217	40	is	be	VBZ
46745	2217	41	at	at	IN
46745	2217	42	the	the	DT
46745	2217	43	same	same	JJ
46745	2217	44	time	time	NN
46745	2217	45	Anæmia	Anæmia	NNP
46745	2217	46	.	.	.
46745	2218	1	In	in	IN
46745	2218	2	some	some	DT
46745	2218	3	cases	case	NNS
46745	2218	4	,	,	,
46745	2218	5	even	even	RB
46745	2218	6	of	of	IN
46745	2218	7	Anæmia	Anæmia	NNP
46745	2218	8	,	,	,
46745	2218	9	Iron	Iron	NNP
46745	2218	10	will	will	MD
46745	2218	11	not	not	RB
46745	2218	12	effect	effect	VB
46745	2218	13	a	a	DT
46745	2218	14	cure	cure	NN
46745	2218	15	.	.	.
46745	2219	1	This	this	DT
46745	2219	2	must	must	MD
46745	2219	3	be	be	VB
46745	2219	4	because	because	IN
46745	2219	5	the	the	DT
46745	2219	6	appropriative	appropriative	JJ
46745	2219	7	power	power	NN
46745	2219	8	of	of	IN
46745	2219	9	the	the	DT
46745	2219	10	system	system	NN
46745	2219	11	is	be	VBZ
46745	2219	12	so	so	RB
46745	2219	13	weakened	weaken	VBN
46745	2219	14	and	and	CC
46745	2219	15	degenerated	degenerate	VBN
46745	2219	16	,	,	,
46745	2219	17	that	that	IN
46745	2219	18	it	-PRON-	PRP
46745	2219	19	is	be	VBZ
46745	2219	20	incapable	incapable	JJ
46745	2219	21	of	of	IN
46745	2219	22	consigning	consign	VBG
46745	2219	23	even	even	RB
46745	2219	24	this	this	DT
46745	2219	25	needful	needful	JJ
46745	2219	26	substance	substance	NN
46745	2219	27	to	to	IN
46745	2219	28	its	-PRON-	PRP$
46745	2219	29	proper	proper	JJ
46745	2219	30	destination	destination	NN
46745	2219	31	.	.	.
46745	2220	1	Anæmia	anæmia	NN
46745	2220	2	is	be	VBZ
46745	2220	3	the	the	DT
46745	2220	4	one	one	CD
46745	2220	5	disease	disease	NN
46745	2220	6	in	in	IN
46745	2220	7	which	which	WDT
46745	2220	8	Iron	Iron	NNP
46745	2220	9	is	be	VBZ
46745	2220	10	of	of	IN
46745	2220	11	use	use	NN
46745	2220	12	.	.	.
46745	2221	1	Purgative	purgative	JJ
46745	2221	2	medicines	medicine	NNS
46745	2221	3	form	form	VBP
46745	2221	4	a	a	DT
46745	2221	5	valuable	valuable	JJ
46745	2221	6	adjunct	adjunct	NN
46745	2221	7	to	to	IN
46745	2221	8	the	the	DT
46745	2221	9	treatment	treatment	NN
46745	2221	10	in	in	IN
46745	2221	11	most	most	JJS
46745	2221	12	cases	case	NNS
46745	2221	13	.	.	.
46745	2222	1	Dr.	Dr.	NNP
46745	2222	2	G.	G.	NNP
46745	2222	3	Owen	Owen	NNP
46745	2222	4	Rees	Rees	NNPS
46745	2222	5	has	have	VBZ
46745	2222	6	suggested	suggest	VBN
46745	2222	7	that	that	IN
46745	2222	8	they	-PRON-	PRP
46745	2222	9	may	may	MD
46745	2222	10	be	be	VB
46745	2222	11	of	of	IN
46745	2222	12	use	use	NN
46745	2222	13	by	by	IN
46745	2222	14	removing	remove	VBG
46745	2222	15	some	some	DT
46745	2222	16	of	of	IN
46745	2222	17	the	the	DT
46745	2222	18	water	water	NN
46745	2222	19	of	of	IN
46745	2222	20	the	the	DT
46745	2222	21	blood	blood	NN
46745	2222	22	,	,	,
46745	2222	23	so	so	IN
46745	2222	24	that	that	IN
46745	2222	25	the	the	DT
46745	2222	26	corpuscles	corpuscle	NNS
46745	2222	27	,	,	,
46745	2222	28	being	be	VBG
46745	2222	29	then	then	RB
46745	2222	30	shrivelled	shrivel	VBN
46745	2222	31	by	by	IN
46745	2222	32	exosmosis	exosmosis	NN
46745	2222	33	of	of	IN
46745	2222	34	their	-PRON-	PRP$
46745	2222	35	contents	content	NNS
46745	2222	36	,	,	,
46745	2222	37	may	may	MD
46745	2222	38	be	be	VB
46745	2222	39	in	in	IN
46745	2222	40	a	a	DT
46745	2222	41	fitter	fitter	NN
46745	2222	42	condition	condition	NN
46745	2222	43	to	to	TO
46745	2222	44	absorb	absorb	VB
46745	2222	45	the	the	DT
46745	2222	46	"	"	``
46745	2222	47	ferriferous	ferriferous	JJ
46745	2222	48	chyle	chyle	NN
46745	2222	49	.	.	.
46745	2222	50	"	"	''
46745	2223	1	And	and	CC
46745	2223	2	yet	yet	RB
46745	2223	3	,	,	,
46745	2223	4	if	if	IN
46745	2223	5	so	so	RB
46745	2223	6	,	,	,
46745	2223	7	the	the	DT
46745	2223	8	drinking	drinking	NN
46745	2223	9	of	of	IN
46745	2223	10	a	a	DT
46745	2223	11	single	single	JJ
46745	2223	12	glass	glass	NN
46745	2223	13	of	of	IN
46745	2223	14	water	water	NN
46745	2223	15	would	would	MD
46745	2223	16	probably	probably	RB
46745	2223	17	be	be	VB
46745	2223	18	sufficient	sufficient	JJ
46745	2223	19	to	to	TO
46745	2223	20	swell	swell	VB
46745	2223	21	out	out	RP
46745	2223	22	the	the	DT
46745	2223	23	corpuscles	corpuscle	NNS
46745	2223	24	again	again	RB
46745	2223	25	,	,	,
46745	2223	26	and	and	CC
46745	2223	27	thus	thus	RB
46745	2223	28	put	put	VB
46745	2223	29	a	a	DT
46745	2223	30	stop	stop	NN
46745	2223	31	to	to	IN
46745	2223	32	the	the	DT
46745	2223	33	process	process	NN
46745	2223	34	.	.	.
46745	2224	1	It	-PRON-	PRP
46745	2224	2	is	be	VBZ
46745	2224	3	just	just	RB
46745	2224	4	possible	possible	JJ
46745	2224	5	that	that	IN
46745	2224	6	a	a	DT
46745	2224	7	Cathartic	cathartic	JJ
46745	2224	8	may	may	MD
46745	2224	9	be	be	VB
46745	2224	10	serviceable	serviceable	JJ
46745	2224	11	by	by	IN
46745	2224	12	purging	purge	VBG
46745	2224	13	away	away	RB
46745	2224	14	from	from	IN
46745	2224	15	the	the	DT
46745	2224	16	blood	blood	NN
46745	2224	17	some	some	DT
46745	2224	18	effete	effete	JJ
46745	2224	19	matters	matter	NNS
46745	2224	20	,	,	,
46745	2224	21	as	as	IN
46745	2224	22	Sulphuretted	Sulphuretted	NNP
46745	2224	23	Hydrogen	Hydrogen	NNP
46745	2224	24	,	,	,
46745	2224	25	formed	form	VBN
46745	2224	26	by	by	IN
46745	2224	27	the	the	DT
46745	2224	28	continual	continual	JJ
46745	2224	29	decomposition	decomposition	NN
46745	2224	30	of	of	IN
46745	2224	31	the	the	DT
46745	2224	32	tissues	tissue	NNS
46745	2224	33	,	,	,
46745	2224	34	which	which	WDT
46745	2224	35	would	would	MD
46745	2224	36	have	have	VB
46745	2224	37	hindered	hinder	VBN
46745	2224	38	the	the	DT
46745	2224	39	operation	operation	NN
46745	2224	40	of	of	IN
46745	2224	41	the	the	DT
46745	2224	42	Chalybeate	Chalybeate	NNP
46745	2224	43	in	in	IN
46745	2224	44	the	the	DT
46745	2224	45	blood	blood	NN
46745	2224	46	,	,	,
46745	2224	47	by	by	IN
46745	2224	48	decomposing	decompose	VBG
46745	2224	49	it	-PRON-	PRP
46745	2224	50	.	.	.
46745	2225	1	The	the	DT
46745	2225	2	use	use	NN
46745	2225	3	of	of	IN
46745	2225	4	Iron	Iron	NNP
46745	2225	5	may	may	MD
46745	2225	6	,	,	,
46745	2225	7	I	-PRON-	PRP
46745	2225	8	think	think	VBP
46745	2225	9	,	,	,
46745	2225	10	be	be	VB
46745	2225	11	summed	sum	VBN
46745	2225	12	up	up	RP
46745	2225	13	by	by	IN
46745	2225	14	saying	say	VBG
46745	2225	15	that	that	IN
46745	2225	16	it	-PRON-	PRP
46745	2225	17	cures	cure	VBZ
46745	2225	18	Anæmia	Anæmia	NNP
46745	2225	19	.	.	.
46745	2226	1	In	in	IN
46745	2226	2	this	this	DT
46745	2226	3	way	way	NN
46745	2226	4	it	-PRON-	PRP
46745	2226	5	may	may	MD
46745	2226	6	benefit	benefit	VB
46745	2226	7	,	,	,
46745	2226	8	and	and	CC
46745	2226	9	sometimes	sometimes	RB
46745	2226	10	cure	cure	VB
46745	2226	11	,	,	,
46745	2226	12	other	other	JJ
46745	2226	13	disorders	disorder	NNS
46745	2226	14	,	,	,
46745	2226	15	in	in	IN
46745	2226	16	which	which	WDT
46745	2226	17	Anæmia	Anæmia	NNP
46745	2226	18	is	be	VBZ
46745	2226	19	apt	apt	JJ
46745	2226	20	to	to	TO
46745	2226	21	be	be	VB
46745	2226	22	a	a	DT
46745	2226	23	prominent	prominent	JJ
46745	2226	24	symptom	symptom	NN
46745	2226	25	.	.	.
46745	2227	1	Such	such	JJ
46745	2227	2	are	be	VBP
46745	2227	3	Amenorrh[oe]a	amenorrh[oe]a	JJ
46745	2227	4	,	,	,
46745	2227	5	Scrofula	Scrofula	NNP
46745	2227	6	,	,	,
46745	2227	7	Cancer	Cancer	NNP
46745	2227	8	,	,	,
46745	2227	9	chronic	chronic	JJ
46745	2227	10	Ague	Ague	NNP
46745	2227	11	,	,	,
46745	2227	12	Hysteria	Hysteria	NNP
46745	2227	13	,	,	,
46745	2227	14	Chorea	Chorea	NNP
46745	2227	15	,	,	,
46745	2227	16	and	and	CC
46745	2227	17	Bright	Bright	NNP
46745	2227	18	's	's	POS
46745	2227	19	disease	disease	NN
46745	2227	20	of	of	IN
46745	2227	21	the	the	DT
46745	2227	22	kidney	kidney	NN
46745	2227	23	.	.	.
46745	2228	1	But	but	CC
46745	2228	2	it	-PRON-	PRP
46745	2228	3	seems	seem	VBZ
46745	2228	4	that	that	IN
46745	2228	5	it	-PRON-	PRP
46745	2228	6	can	can	MD
46745	2228	7	never	never	RB
46745	2228	8	be	be	VB
46745	2228	9	used	use	VBN
46745	2228	10	advantageously	advantageously	RB
46745	2228	11	in	in	IN
46745	2228	12	these	these	DT
46745	2228	13	disorders	disorder	NNS
46745	2228	14	,	,	,
46745	2228	15	when	when	WRB
46745	2228	16	they	-PRON-	PRP
46745	2228	17	are	be	VBP
46745	2228	18	unattended	unattende	VBN
46745	2228	19	with	with	IN
46745	2228	20	Anæmia	Anæmia	NNP
46745	2228	21	;	;	:
46745	2228	22	nor	nor	CC
46745	2228	23	even	even	RB
46745	2228	24	then	then	RB
46745	2228	25	is	be	VBZ
46745	2228	26	it	-PRON-	PRP
46745	2228	27	to	to	TO
46745	2228	28	be	be	VB
46745	2228	29	preferred	prefer	VBN
46745	2228	30	to	to	IN
46745	2228	31	the	the	DT
46745	2228	32	other	other	JJ
46745	2228	33	remedies	remedy	NNS
46745	2228	34	specially	specially	RB
46745	2228	35	appropriate	appropriate	JJ
46745	2228	36	in	in	IN
46745	2228	37	each	each	DT
46745	2228	38	case	case	NN
46745	2228	39	,	,	,
46745	2228	40	but	but	CC
46745	2228	41	ought	ought	MD
46745	2228	42	rather	rather	RB
46745	2228	43	to	to	TO
46745	2228	44	be	be	VB
46745	2228	45	conjoined	conjoin	VBN
46745	2228	46	with	with	IN
46745	2228	47	them	-PRON-	PRP
46745	2228	48	.	.	.
46745	2229	1	Cancer	cancer	NN
46745	2229	2	,	,	,
46745	2229	3	and	and	CC
46745	2229	4	granular	granular	JJ
46745	2229	5	kidney	kidney	NN
46745	2229	6	disease	disease	NN
46745	2229	7	,	,	,
46745	2229	8	may	may	MD
46745	2229	9	perhaps	perhaps	RB
46745	2229	10	be	be	VB
46745	2229	11	alleviated	alleviate	VBN
46745	2229	12	,	,	,
46745	2229	13	but	but	CC
46745	2229	14	are	be	VBP
46745	2229	15	seldom	seldom	RB
46745	2229	16	cured	cure	VBN
46745	2229	17	.	.	.
46745	2230	1	In	in	IN
46745	2230	2	Chorea	Chorea	NNP
46745	2230	3	,	,	,
46745	2230	4	Arsenic	Arsenic	NNP
46745	2230	5	or	or	CC
46745	2230	6	Quinine	Quinine	NNP
46745	2230	7	may	may	MD
46745	2230	8	be	be	VB
46745	2230	9	used	use	VBN
46745	2230	10	,	,	,
46745	2230	11	with	with	IN
46745	2230	12	or	or	CC
46745	2230	13	without	without	IN
46745	2230	14	Iron	Iron	NNP
46745	2230	15	.	.	.
46745	2231	1	Aloetic	aloetic	JJ
46745	2231	2	purgatives	purgative	NNS
46745	2231	3	may	may	MD
46745	2231	4	be	be	VB
46745	2231	5	advantageously	advantageously	RB
46745	2231	6	conjoined	conjoin	VBN
46745	2231	7	with	with	IN
46745	2231	8	Chalybeates	Chalybeates	NNPS
46745	2231	9	in	in	IN
46745	2231	10	Amenorrh[oe]a	Amenorrh[oe]a	NNP
46745	2231	11	and	and	CC
46745	2231	12	Hysteria	Hysteria	NNP
46745	2231	13	.	.	.
46745	2232	1	Their	-PRON-	PRP$
46745	2232	2	use	use	NN
46745	2232	3	may	may	MD
46745	2232	4	be	be	VB
46745	2232	5	accompanied	accompany	VBN
46745	2232	6	by	by	IN
46745	2232	7	cold	cold	JJ
46745	2232	8	affusions	affusion	NNS
46745	2232	9	,	,	,
46745	2232	10	or	or	CC
46745	2232	11	by	by	IN
46745	2232	12	some	some	DT
46745	2232	13	antispasmodic	antispasmodic	JJ
46745	2232	14	stimulant	stimulant	NN
46745	2232	15	.	.	.
46745	2233	1	In	in	IN
46745	2233	2	Scrofula	Scrofula	NNP
46745	2233	3	the	the	DT
46745	2233	4	Iodide	Iodide	NNP
46745	2233	5	of	of	IN
46745	2233	6	Iron	Iron	NNP
46745	2233	7	affords	afford	VBZ
46745	2233	8	us	-PRON-	PRP
46745	2233	9	a	a	DT
46745	2233	10	valuable	valuable	JJ
46745	2233	11	double	double	JJ
46745	2233	12	remedy	remedy	NN
46745	2233	13	.	.	.
46745	2234	1	In	in	IN
46745	2234	2	chronic	chronic	JJ
46745	2234	3	cases	case	NNS
46745	2234	4	of	of	IN
46745	2234	5	Ague	Ague	NNP
46745	2234	6	,	,	,
46745	2234	7	when	when	WRB
46745	2234	8	accompanied	accompany	VBN
46745	2234	9	with	with	IN
46745	2234	10	Anæmia	Anæmia	NNP
46745	2234	11	,	,	,
46745	2234	12	as	as	IN
46745	2234	13	is	be	VBZ
46745	2234	14	often	often	RB
46745	2234	15	the	the	DT
46745	2234	16	case	case	NN
46745	2234	17	,	,	,
46745	2234	18	Iron	Iron	NNP
46745	2234	19	may	may	MD
46745	2234	20	be	be	VB
46745	2234	21	prescribed	prescribe	VBN
46745	2234	22	with	with	IN
46745	2234	23	advantage	advantage	NN
46745	2234	24	.	.	.
46745	2235	1	In	in	IN
46745	2235	2	general	general	JJ
46745	2235	3	Anæmia	Anæmia	NNP
46745	2235	4	,	,	,
46745	2235	5	an	an	DT
46745	2235	6	occasional	occasional	JJ
46745	2235	7	purge	purge	NN
46745	2235	8	,	,	,
46745	2235	9	a	a	DT
46745	2235	10	generous	generous	JJ
46745	2235	11	diet	diet	NN
46745	2235	12	,	,	,
46745	2235	13	with	with	IN
46745	2235	14	good	good	JJ
46745	2235	15	air	air	NN
46745	2235	16	and	and	CC
46745	2235	17	exercise	exercise	NN
46745	2235	18	should	should	MD
46745	2235	19	be	be	VB
46745	2235	20	combined	combine	VBN
46745	2235	21	,	,	,
46745	2235	22	if	if	IN
46745	2235	23	possible	possible	JJ
46745	2235	24	,	,	,
46745	2235	25	with	with	IN
46745	2235	26	the	the	DT
46745	2235	27	Chalybeate	Chalybeate	NNP
46745	2235	28	treatment	treatment	NN
46745	2235	29	.	.	.
46745	2236	1	ORD	ORD	NNP
46745	2236	2	.	.	.
46745	2237	1	VI	VI	NNP
46745	2237	2	.	.	.
46745	2238	1	SOLVENTS	solvent	NNS
46745	2238	2	.	.	.
46745	2239	1	(	(	-LRB-
46745	2239	2	_	_	NNP
46745	2239	3	Antilithics	Antilithics	NNPS
46745	2239	4	.	.	.
46745	2239	5	_	_	NNP
46745	2239	6	The	the	DT
46745	2239	7	mineral	mineral	NN
46745	2239	8	Alkalies	Alkalies	NNPS
46745	2239	9	,	,	,
46745	2239	10	their	-PRON-	PRP$
46745	2239	11	Carbonates	Carbonates	NNPS
46745	2239	12	,	,	,
46745	2239	13	and	and	CC
46745	2239	14	neutral	neutral	JJ
46745	2239	15	salts	salt	NNS
46745	2239	16	with	with	IN
46745	2239	17	vegetable	vegetable	NN
46745	2239	18	acids	acid	NNS
46745	2239	19	.	.	.
46745	2240	1	Biborate	Biborate	NNP
46745	2240	2	and	and	CC
46745	2240	3	Phosphate	Phosphate	NNP
46745	2240	4	of	of	IN
46745	2240	5	Soda	Soda	NNP
46745	2240	6	.	.	.
46745	2241	1	Benzoic	benzoic	JJ
46745	2241	2	and	and	CC
46745	2241	3	Cinnamic	cinnamic	JJ
46745	2241	4	acids	acid	NNS
46745	2241	5	.	.	.
46745	2242	1	_	_	NNP
46745	2242	2	Antiphosphatics	Antiphosphatics	NNP
46745	2242	3	.	.	.
46745	2242	4	_	_	NNP
46745	2242	5	Mineral	Mineral	NNP
46745	2242	6	and	and	CC
46745	2242	7	vegetable	vegetable	NN
46745	2242	8	acids	acid	NNS
46745	2242	9	.	.	.
46745	2243	1	Sour	sour	JJ
46745	2243	2	fruits	fruit	NNS
46745	2243	3	.	.	.
46745	2243	4	)	)	-RRB-
46745	2244	1	Of	of	IN
46745	2244	2	all	all	PDT
46745	2244	3	the	the	DT
46745	2244	4	fluid	fluid	JJ
46745	2244	5	secretions	secretion	NNS
46745	2244	6	,	,	,
46745	2244	7	the	the	DT
46745	2244	8	secretion	secretion	NN
46745	2244	9	of	of	IN
46745	2244	10	Urine	Urine	NNP
46745	2244	11	is	be	VBZ
46745	2244	12	perhaps	perhaps	RB
46745	2244	13	the	the	DT
46745	2244	14	only	only	JJ
46745	2244	15	important	important	JJ
46745	2244	16	one	one	NN
46745	2244	17	which	which	WDT
46745	2244	18	can	can	MD
46745	2244	19	not	not	RB
46745	2244	20	cease	cease	VB
46745	2244	21	to	to	TO
46745	2244	22	be	be	VB
46745	2244	23	fluid	fluid	JJ
46745	2244	24	without	without	IN
46745	2244	25	immediate	immediate	JJ
46745	2244	26	damage	damage	NN
46745	2244	27	to	to	IN
46745	2244	28	the	the	DT
46745	2244	29	system	system	NN
46745	2244	30	.	.	.
46745	2245	1	The	the	DT
46745	2245	2	deposit	deposit	NN
46745	2245	3	of	of	IN
46745	2245	4	solid	solid	JJ
46745	2245	5	matter	matter	NN
46745	2245	6	from	from	IN
46745	2245	7	this	this	DT
46745	2245	8	secretion	secretion	NN
46745	2245	9	is	be	VBZ
46745	2245	10	dangerous	dangerous	JJ
46745	2245	11	,	,	,
46745	2245	12	because	because	IN
46745	2245	13	tending	tend	VBG
46745	2245	14	to	to	IN
46745	2245	15	the	the	DT
46745	2245	16	formation	formation	NN
46745	2245	17	of	of	IN
46745	2245	18	a	a	DT
46745	2245	19	solid	solid	JJ
46745	2245	20	calculus	calculus	NN
46745	2245	21	in	in	IN
46745	2245	22	the	the	DT
46745	2245	23	kidney	kidney	NN
46745	2245	24	or	or	CC
46745	2245	25	the	the	DT
46745	2245	26	bladder	bladder	NN
46745	2245	27	,	,	,
46745	2245	28	in	in	IN
46745	2245	29	neither	neither	DT
46745	2245	30	case	case	NN
46745	2245	31	easily	easily	RB
46745	2245	32	extracted	extract	VBD
46745	2245	33	,	,	,
46745	2245	34	and	and	CC
46745	2245	35	acting	act	VBG
46745	2245	36	like	like	IN
46745	2245	37	a	a	DT
46745	2245	38	foreign	foreign	JJ
46745	2245	39	body	body	NN
46745	2245	40	in	in	IN
46745	2245	41	these	these	DT
46745	2245	42	sensitive	sensitive	JJ
46745	2245	43	organs	organ	NNS
46745	2245	44	.	.	.
46745	2246	1	This	this	DT
46745	2246	2	urine	urine	NN
46745	2246	3	,	,	,
46745	2246	4	naturally	naturally	RB
46745	2246	5	clear	clear	JJ
46745	2246	6	and	and	CC
46745	2246	7	limpid	limpid	JJ
46745	2246	8	,	,	,
46745	2246	9	contains	contain	VBZ
46745	2246	10	in	in	IN
46745	2246	11	it	-PRON-	PRP
46745	2246	12	several	several	JJ
46745	2246	13	substances	substance	NNS
46745	2246	14	which	which	WDT
46745	2246	15	are	be	VBP
46745	2246	16	by	by	IN
46745	2246	17	their	-PRON-	PRP$
46745	2246	18	nature	nature	NN
46745	2246	19	insoluble	insoluble	JJ
46745	2246	20	,	,	,
46745	2246	21	but	but	CC
46745	2246	22	are	be	VBP
46745	2246	23	held	hold	VBN
46745	2246	24	in	in	IN
46745	2246	25	solution	solution	NN
46745	2246	26	by	by	IN
46745	2246	27	certain	certain	JJ
46745	2246	28	other	other	JJ
46745	2246	29	materials	material	NNS
46745	2246	30	.	.	.
46745	2247	1	But	but	CC
46745	2247	2	in	in	IN
46745	2247	3	some	some	DT
46745	2247	4	morbid	morbid	NN
46745	2247	5	states	state	VBZ
46745	2247	6	these	these	DT
46745	2247	7	latter	latter	JJ
46745	2247	8	materials	material	NNS
46745	2247	9	may	may	MD
46745	2247	10	be	be	VB
46745	2247	11	wanting	want	VBG
46745	2247	12	,	,	,
46745	2247	13	or	or	CC
46745	2247	14	else	else	RB
46745	2247	15	the	the	DT
46745	2247	16	insoluble	insoluble	JJ
46745	2247	17	bodies	body	NNS
46745	2247	18	may	may	MD
46745	2247	19	be	be	VB
46745	2247	20	secreted	secrete	VBN
46745	2247	21	in	in	IN
46745	2247	22	such	such	JJ
46745	2247	23	quantity	quantity	NN
46745	2247	24	that	that	WDT
46745	2247	25	the	the	DT
46745	2247	26	solvent	solvent	NN
46745	2247	27	material	material	NN
46745	2247	28	is	be	VBZ
46745	2247	29	unable	unable	JJ
46745	2247	30	to	to	TO
46745	2247	31	hold	hold	VB
46745	2247	32	them	-PRON-	PRP
46745	2247	33	in	in	IN
46745	2247	34	solution	solution	NN
46745	2247	35	.	.	.
46745	2248	1	In	in	IN
46745	2248	2	such	such	JJ
46745	2248	3	instances	instance	NNS
46745	2248	4	,	,	,
46745	2248	5	these	these	DT
46745	2248	6	parts	part	NNS
46745	2248	7	of	of	IN
46745	2248	8	the	the	DT
46745	2248	9	urine	urine	NN
46745	2248	10	may	may	MD
46745	2248	11	either	either	CC
46745	2248	12	be	be	VB
46745	2248	13	separated	separate	VBN
46745	2248	14	by	by	IN
46745	2248	15	the	the	DT
46745	2248	16	kidneys	kidney	NNS
46745	2248	17	from	from	IN
46745	2248	18	the	the	DT
46745	2248	19	blood	blood	NN
46745	2248	20	in	in	IN
46745	2248	21	a	a	DT
46745	2248	22	solid	solid	JJ
46745	2248	23	state	state	NN
46745	2248	24	,	,	,
46745	2248	25	or	or	CC
46745	2248	26	may	may	MD
46745	2248	27	be	be	VB
46745	2248	28	deposited	deposit	VBN
46745	2248	29	from	from	IN
46745	2248	30	the	the	DT
46745	2248	31	urine	urine	NN
46745	2248	32	after	after	IN
46745	2248	33	excretion	excretion	NN
46745	2248	34	or	or	CC
46745	2248	35	on	on	IN
46745	2248	36	cooling	cool	VBG
46745	2248	37	.	.	.
46745	2249	1	They	-PRON-	PRP
46745	2249	2	then	then	RB
46745	2249	3	fall	fall	VBP
46745	2249	4	down	down	RP
46745	2249	5	in	in	IN
46745	2249	6	a	a	DT
46745	2249	7	crystalline	crystalline	NN
46745	2249	8	or	or	CC
46745	2249	9	finely	finely	RB
46745	2249	10	divided	divide	VBN
46745	2249	11	state	state	NN
46745	2249	12	,	,	,
46745	2249	13	and	and	CC
46745	2249	14	constitute	constitute	VB
46745	2249	15	Urinary	Urinary	NNP
46745	2249	16	Deposits	Deposits	NNP
46745	2249	17	.	.	.
46745	2250	1	Solvents	solvent	NNS
46745	2250	2	are	be	VBP
46745	2250	3	medicines	medicine	NNS
46745	2250	4	which	which	WDT
46745	2250	5	are	be	VBP
46745	2250	6	employed	employ	VBN
46745	2250	7	to	to	TO
46745	2250	8	hold	hold	VB
46745	2250	9	these	these	DT
46745	2250	10	insoluble	insoluble	JJ
46745	2250	11	substances	substance	NNS
46745	2250	12	in	in	IN
46745	2250	13	solution	solution	NN
46745	2250	14	,	,	,
46745	2250	15	where	where	WRB
46745	2250	16	there	there	EX
46745	2250	17	is	be	VBZ
46745	2250	18	not	not	RB
46745	2250	19	enough	enough	JJ
46745	2250	20	of	of	IN
46745	2250	21	the	the	DT
46745	2250	22	natural	natural	JJ
46745	2250	23	solvent	solvent	NN
46745	2250	24	material	material	NN
46745	2250	25	in	in	IN
46745	2250	26	the	the	DT
46745	2250	27	system	system	NN
46745	2250	28	.	.	.
46745	2251	1	They	-PRON-	PRP
46745	2251	2	are	be	VBP
46745	2251	3	medicines	medicine	NNS
46745	2251	4	which	which	WDT
46745	2251	5	tend	tend	VBP
46745	2251	6	,	,	,
46745	2251	7	after	after	IN
46745	2251	8	being	be	VBG
46745	2251	9	absorbed	absorb	VBN
46745	2251	10	,	,	,
46745	2251	11	to	to	TO
46745	2251	12	pass	pass	VB
46745	2251	13	out	out	IN
46745	2251	14	of	of	IN
46745	2251	15	the	the	DT
46745	2251	16	blood	blood	NN
46745	2251	17	into	into	IN
46745	2251	18	the	the	DT
46745	2251	19	urine	urine	NN
46745	2251	20	.	.	.
46745	2252	1	Although	although	IN
46745	2252	2	we	-PRON-	PRP
46745	2252	3	are	be	VBP
46745	2252	4	ill	ill	RB
46745	2252	5	-	-	HYPH
46745	2252	6	informed	inform	VBN
46745	2252	7	as	as	IN
46745	2252	8	to	to	IN
46745	2252	9	the	the	DT
46745	2252	10	nature	nature	NN
46745	2252	11	of	of	IN
46745	2252	12	the	the	DT
46745	2252	13	ordinary	ordinary	JJ
46745	2252	14	urinary	urinary	JJ
46745	2252	15	solvents	solvent	NNS
46745	2252	16	,	,	,
46745	2252	17	yet	yet	CC
46745	2252	18	it	-PRON-	PRP
46745	2252	19	is	be	VBZ
46745	2252	20	evident	evident	JJ
46745	2252	21	that	that	IN
46745	2252	22	they	-PRON-	PRP
46745	2252	23	must	must	MD
46745	2252	24	be	be	VB
46745	2252	25	present	present	JJ
46745	2252	26	,	,	,
46745	2252	27	because	because	IN
46745	2252	28	substances	substance	NNS
46745	2252	29	which	which	WDT
46745	2252	30	are	be	VBP
46745	2252	31	by	by	IN
46745	2252	32	their	-PRON-	PRP$
46745	2252	33	nature	nature	NN
46745	2252	34	insoluble	insoluble	JJ
46745	2252	35	occur	occur	VBP
46745	2252	36	in	in	IN
46745	2252	37	healthy	healthy	JJ
46745	2252	38	urine	urine	NN
46745	2252	39	.	.	.
46745	2253	1	And	and	CC
46745	2253	2	it	-PRON-	PRP
46745	2253	3	is	be	VBZ
46745	2253	4	also	also	RB
46745	2253	5	evident	evident	JJ
46745	2253	6	that	that	IN
46745	2253	7	these	these	DT
46745	2253	8	medicines	medicine	NNS
46745	2253	9	are	be	VBP
46745	2253	10	able	able	JJ
46745	2253	11	to	to	TO
46745	2253	12	supply	supply	VB
46745	2253	13	their	-PRON-	PRP$
46745	2253	14	place	place	NN
46745	2253	15	;	;	:
46745	2253	16	for	for	IN
46745	2253	17	,	,	,
46745	2253	18	after	after	IN
46745	2253	19	one	one	CD
46745	2253	20	is	be	VBZ
46745	2253	21	given	give	VBN
46745	2253	22	in	in	IN
46745	2253	23	a	a	DT
46745	2253	24	case	case	NN
46745	2253	25	of	of	IN
46745	2253	26	urinary	urinary	NNP
46745	2253	27	deposit	deposit	NN
46745	2253	28	,	,	,
46745	2253	29	this	this	DT
46745	2253	30	latter	latter	JJ
46745	2253	31	disappears	disappear	VBZ
46745	2253	32	,	,	,
46745	2253	33	at	at	IN
46745	2253	34	the	the	DT
46745	2253	35	same	same	JJ
46745	2253	36	time	time	NN
46745	2253	37	that	that	WDT
46745	2253	38	the	the	DT
46745	2253	39	solvent	solvent	NN
46745	2253	40	remedy	remedy	NN
46745	2253	41	may	may	MD
46745	2253	42	be	be	VB
46745	2253	43	detected	detect	VBN
46745	2253	44	chemically	chemically	RB
46745	2253	45	in	in	IN
46745	2253	46	the	the	DT
46745	2253	47	urine	urine	NN
46745	2253	48	.	.	.
46745	2254	1	In	in	IN
46745	2254	2	this	this	DT
46745	2254	3	,	,	,
46745	2254	4	the	the	DT
46745	2254	5	last	last	JJ
46745	2254	6	order	order	NN
46745	2254	7	of	of	IN
46745	2254	8	Restorative	Restorative	NNP
46745	2254	9	Hæmatics	Hæmatics	NNPS
46745	2254	10	,	,	,
46745	2254	11	a	a	DT
46745	2254	12	number	number	NN
46745	2254	13	of	of	IN
46745	2254	14	apparently	apparently	RB
46745	2254	15	dissimilar	dissimilar	JJ
46745	2254	16	medicines	medicine	NNS
46745	2254	17	are	be	VBP
46745	2254	18	grouped	group	VBN
46745	2254	19	together	together	RB
46745	2254	20	,	,	,
46745	2254	21	all	all	DT
46745	2254	22	of	of	IN
46745	2254	23	which	which	WDT
46745	2254	24	agree	agree	VBP
46745	2254	25	in	in	IN
46745	2254	26	this	this	DT
46745	2254	27	point	point	NN
46745	2254	28	of	of	IN
46745	2254	29	their	-PRON-	PRP$
46745	2254	30	action	action	NN
46745	2254	31	.	.	.
46745	2255	1	The	the	DT
46745	2255	2	deposits	deposit	NNS
46745	2255	3	in	in	IN
46745	2255	4	which	which	WDT
46745	2255	5	solvents	solvent	NNS
46745	2255	6	are	be	VBP
46745	2255	7	appropriate	appropriate	JJ
46745	2255	8	are	be	VBP
46745	2255	9	termed	term	VBN
46745	2255	10	respectively	respectively	RB
46745	2255	11	Lithic	Lithic	NNP
46745	2255	12	and	and	CC
46745	2255	13	Phosphatic	phosphatic	JJ
46745	2255	14	.	.	.
46745	2256	1	Among	among	IN
46745	2256	2	the	the	DT
46745	2256	3	first	first	JJ
46745	2256	4	are	be	VBP
46745	2256	5	comprehended	comprehend	VBN
46745	2256	6	Uric	Uric	NNP
46745	2256	7	acid	acid	NN
46745	2256	8	(	(	-LRB-
46745	2256	9	also	also	RB
46745	2256	10	called	call	VBN
46745	2256	11	Lithic	Lithic	NNP
46745	2256	12	,	,	,
46745	2256	13	)	)	-RRB-
46745	2256	14	Urate	Urate	NNP
46745	2256	15	of	of	IN
46745	2256	16	Ammonia	Ammonia	NNP
46745	2256	17	,	,	,
46745	2256	18	and	and	CC
46745	2256	19	the	the	DT
46745	2256	20	more	more	RBR
46745	2256	21	rarely	rarely	RB
46745	2256	22	occurring	occur	VBG
46745	2256	23	Urate	Urate	NNP
46745	2256	24	of	of	IN
46745	2256	25	Soda	Soda	NNP
46745	2256	26	.	.	.
46745	2257	1	In	in	IN
46745	2257	2	the	the	DT
46745	2257	3	second	second	JJ
46745	2257	4	set	set	NN
46745	2257	5	are	be	VBP
46745	2257	6	comprised	comprise	VBN
46745	2257	7	the	the	DT
46745	2257	8	Triple	Triple	NNP
46745	2257	9	Phosphate	Phosphate	NNP
46745	2257	10	of	of	IN
46745	2257	11	Ammonia	Ammonia	NNP
46745	2257	12	and	and	CC
46745	2257	13	Magnesia	Magnesia	NNP
46745	2257	14	,	,	,
46745	2257	15	and	and	CC
46745	2257	16	the	the	DT
46745	2257	17	Phosphate	Phosphate	NNP
46745	2257	18	of	of	IN
46745	2257	19	Lime	Lime	NNP
46745	2257	20	.	.	.
46745	2258	1	These	these	DT
46745	2258	2	deposits	deposit	NNS
46745	2258	3	are	be	VBP
46745	2258	4	each	each	DT
46745	2258	5	known	know	VBN
46745	2258	6	by	by	IN
46745	2258	7	their	-PRON-	PRP$
46745	2258	8	peculiar	peculiar	JJ
46745	2258	9	form	form	NN
46745	2258	10	under	under	IN
46745	2258	11	the	the	DT
46745	2258	12	microscope	microscope	NN
46745	2258	13	.	.	.
46745	2259	1	[	[	-LRB-
46745	2259	2	35	35	CD
46745	2259	3	]	]	-RRB-
46745	2259	4	They	-PRON-	PRP
46745	2259	5	may	may	MD
46745	2259	6	easily	easily	RB
46745	2259	7	be	be	VB
46745	2259	8	separated	separate	VBN
46745	2259	9	from	from	IN
46745	2259	10	the	the	DT
46745	2259	11	urine	urine	NN
46745	2259	12	,	,	,
46745	2259	13	when	when	WRB
46745	2259	14	in	in	IN
46745	2259	15	any	any	DT
46745	2259	16	amount	amount	NN
46745	2259	17	,	,	,
46745	2259	18	and	and	CC
46745	2259	19	tested	test	VBN
46745	2259	20	chemically	chemically	RB
46745	2259	21	.	.	.
46745	2260	1	The	the	DT
46745	2260	2	Lithic	lithic	JJ
46745	2260	3	deposits	deposit	NNS
46745	2260	4	,	,	,
46745	2260	5	(	(	-LRB-
46745	2260	6	_	_	NNP
46745	2260	7	i.e.	i.e.	FW
46745	2260	8	_	_	NNP
46745	2260	9	Uric	Uric	NNP
46745	2260	10	acid	acid	NN
46745	2260	11	and	and	CC
46745	2260	12	Urate	Urate	NNP
46745	2260	13	of	of	IN
46745	2260	14	Ammonia	Ammonia	NNP
46745	2260	15	,	,	,
46745	2260	16	)	)	-RRB-
46745	2260	17	are	be	VBP
46745	2260	18	entirely	entirely	RB
46745	2260	19	dispelled	dispel	VBN
46745	2260	20	by	by	IN
46745	2260	21	a	a	DT
46745	2260	22	red	red	JJ
46745	2260	23	heat	heat	NN
46745	2260	24	,	,	,
46745	2260	25	and	and	CC
46745	2260	26	are	be	VBP
46745	2260	27	soluble	soluble	JJ
46745	2260	28	in	in	IN
46745	2260	29	alkalies	alkali	NNS
46745	2260	30	.	.	.
46745	2261	1	The	the	DT
46745	2261	2	Phosphatic	phosphatic	JJ
46745	2261	3	deposits	deposit	NNS
46745	2261	4	leave	leave	VBP
46745	2261	5	an	an	DT
46745	2261	6	earthy	earthy	JJ
46745	2261	7	residue	residue	NN
46745	2261	8	when	when	WRB
46745	2261	9	heated	heat	VBN
46745	2261	10	,	,	,
46745	2261	11	and	and	CC
46745	2261	12	are	be	VBP
46745	2261	13	soluble	soluble	JJ
46745	2261	14	in	in	IN
46745	2261	15	acids	acid	NNS
46745	2261	16	.	.	.
46745	2262	1	When	when	WRB
46745	2262	2	thus	thus	RB
46745	2262	3	held	hold	VBN
46745	2262	4	in	in	IN
46745	2262	5	solution	solution	NN
46745	2262	6	,	,	,
46745	2262	7	the	the	DT
46745	2262	8	former	former	JJ
46745	2262	9	are	be	VBP
46745	2262	10	precipitated	precipitate	VBN
46745	2262	11	by	by	IN
46745	2262	12	an	an	DT
46745	2262	13	acid	acid	NN
46745	2262	14	,	,	,
46745	2262	15	the	the	DT
46745	2262	16	latter	latter	JJ
46745	2262	17	by	by	IN
46745	2262	18	an	an	DT
46745	2262	19	alkali	alkali	JJ
46745	2262	20	,	,	,
46745	2262	21	because	because	IN
46745	2262	22	by	by	IN
46745	2262	23	such	such	PDT
46745	2262	24	a	a	DT
46745	2262	25	reagent	reagent	NN
46745	2262	26	that	that	DT
46745	2262	27	solvent	solvent	NN
46745	2262	28	is	be	VBZ
46745	2262	29	neutralized	neutralize	VBN
46745	2262	30	in	in	IN
46745	2262	31	each	each	DT
46745	2262	32	case	case	NN
46745	2262	33	.	.	.
46745	2263	1	Now	now	RB
46745	2263	2	the	the	DT
46745	2263	3	circumstances	circumstance	NNS
46745	2263	4	which	which	WDT
46745	2263	5	may	may	MD
46745	2263	6	cause	cause	VB
46745	2263	7	these	these	DT
46745	2263	8	deposits	deposit	NNS
46745	2263	9	are	be	VBP
46745	2263	10	mainly	mainly	RB
46745	2263	11	of	of	IN
46745	2263	12	four	four	CD
46745	2263	13	kinds	kind	NNS
46745	2263	14	.	.	.
46745	2264	1	(	(	-LRB-
46745	2264	2	1	1	CD
46745	2264	3	.	.	.
46745	2264	4	)	)	-RRB-
46745	2265	1	A	a	DT
46745	2265	2	wrong	wrong	NN
46745	2265	3	in	in	IN
46745	2265	4	the	the	DT
46745	2265	5	diet	diet	NN
46745	2265	6	.	.	.
46745	2266	1	(	(	-LRB-
46745	2266	2	2	2	CD
46745	2266	3	.	.	.
46745	2266	4	)	)	-RRB-
46745	2267	1	An	an	DT
46745	2267	2	error	error	NN
46745	2267	3	in	in	IN
46745	2267	4	the	the	DT
46745	2267	5	normal	normal	JJ
46745	2267	6	reaction	reaction	NN
46745	2267	7	of	of	IN
46745	2267	8	the	the	DT
46745	2267	9	blood	blood	NN
46745	2267	10	,	,	,
46745	2267	11	causing	cause	VBG
46745	2267	12	these	these	DT
46745	2267	13	matters	matter	NNS
46745	2267	14	to	to	TO
46745	2267	15	be	be	VB
46745	2267	16	deposited	deposit	VBN
46745	2267	17	,	,	,
46745	2267	18	_	_	NNP
46745	2267	19	without	without	IN
46745	2267	20	being	be	VBG
46745	2267	21	themselves	-PRON-	PRP
46745	2267	22	in	in	IN
46745	2267	23	excess	excess	JJ
46745	2267	24	_	_	NNP
46745	2267	25	.	.	.
46745	2268	1	(	(	-LRB-
46745	2268	2	3	3	CD
46745	2268	3	.	.	.
46745	2268	4	)	)	-RRB-
46745	2269	1	The	the	DT
46745	2269	2	suppression	suppression	NN
46745	2269	3	of	of	IN
46745	2269	4	another	another	DT
46745	2269	5	secretion	secretion	NN
46745	2269	6	.	.	.
46745	2270	1	(	(	-LRB-
46745	2270	2	4	4	CD
46745	2270	3	.	.	.
46745	2270	4	)	)	-RRB-
46745	2271	1	A	a	DT
46745	2271	2	fault	fault	NN
46745	2271	3	of	of	IN
46745	2271	4	some	some	DT
46745	2271	5	process	process	NN
46745	2271	6	of	of	IN
46745	2271	7	assimilation	assimilation	NN
46745	2271	8	or	or	CC
46745	2271	9	secretion	secretion	NN
46745	2271	10	,	,	,
46745	2271	11	causing	cause	VBG
46745	2271	12	_	_	NNP
46745	2271	13	an	an	DT
46745	2271	14	absolute	absolute	JJ
46745	2271	15	excess	excess	JJ
46745	2271	16	_	_	NN
46745	2271	17	of	of	IN
46745	2271	18	these	these	DT
46745	2271	19	constituents	constituent	NNS
46745	2271	20	of	of	IN
46745	2271	21	the	the	DT
46745	2271	22	urine	urine	NN
46745	2271	23	.	.	.
46745	2272	1	Urinary	urinary	JJ
46745	2272	2	sediments	sediment	NNS
46745	2272	3	may	may	MD
46745	2272	4	be	be	VB
46745	2272	5	caused	cause	VBN
46745	2272	6	by	by	IN
46745	2272	7	slight	slight	JJ
46745	2272	8	variations	variation	NNS
46745	2272	9	in	in	IN
46745	2272	10	diet	diet	NNP
46745	2272	11	.	.	.
46745	2273	1	Excessive	excessive	JJ
46745	2273	2	indulgence	indulgence	NN
46745	2273	3	in	in	IN
46745	2273	4	animal	animal	NN
46745	2273	5	food	food	NN
46745	2273	6	or	or	CC
46745	2273	7	in	in	IN
46745	2273	8	wine	wine	NN
46745	2273	9	may	may	MD
46745	2273	10	cause	cause	VB
46745	2273	11	an	an	DT
46745	2273	12	over	over	NN
46745	2273	13	-	-	HYPH
46745	2273	14	secretion	secretion	NN
46745	2273	15	of	of	IN
46745	2273	16	Lithic	Lithic	NNP
46745	2273	17	acid	acid	NN
46745	2273	18	.	.	.
46745	2274	1	Sour	sour	JJ
46745	2274	2	drinks	drink	NNS
46745	2274	3	may	may	MD
46745	2274	4	cause	cause	VB
46745	2274	5	a	a	DT
46745	2274	6	similar	similar	JJ
46745	2274	7	deposit	deposit	NN
46745	2274	8	,	,	,
46745	2274	9	by	by	IN
46745	2274	10	rendering	render	VBG
46745	2274	11	the	the	DT
46745	2274	12	urine	urine	NN
46745	2274	13	acid	acid	NN
46745	2274	14	;	;	:
46745	2274	15	and	and	CC
46745	2274	16	sweet	sweet	JJ
46745	2274	17	fruits	fruit	NNS
46745	2274	18	,	,	,
46745	2274	19	containing	contain	VBG
46745	2274	20	vegetable	vegetable	NN
46745	2274	21	salts	salt	NNS
46745	2274	22	of	of	IN
46745	2274	23	the	the	DT
46745	2274	24	alkalies	alkali	NNS
46745	2274	25	,	,	,
46745	2274	26	may	may	MD
46745	2274	27	produce	produce	VB
46745	2274	28	a	a	DT
46745	2274	29	phosphatic	phosphatic	JJ
46745	2274	30	sediment	sediment	NN
46745	2274	31	,	,	,
46745	2274	32	by	by	IN
46745	2274	33	rendering	render	VBG
46745	2274	34	it	-PRON-	PRP
46745	2274	35	alkaline	alkaline	VBP
46745	2274	36	.	.	.
46745	2275	1	Such	such	JJ
46745	2275	2	cases	case	NNS
46745	2275	3	may	may	MD
46745	2275	4	be	be	VB
46745	2275	5	remedied	remedie	VBN
46745	2275	6	by	by	IN
46745	2275	7	an	an	DT
46745	2275	8	attention	attention	NN
46745	2275	9	to	to	IN
46745	2275	10	diet	diet	NNP
46745	2275	11	.	.	.
46745	2276	1	Again	again	RB
46745	2276	2	,	,	,
46745	2276	3	deposits	deposit	NNS
46745	2276	4	may	may	MD
46745	2276	5	be	be	VB
46745	2276	6	caused	cause	VBN
46745	2276	7	by	by	IN
46745	2276	8	an	an	DT
46745	2276	9	excess	excess	NN
46745	2276	10	of	of	IN
46745	2276	11	acid	acid	NN
46745	2276	12	or	or	CC
46745	2276	13	of	of	IN
46745	2276	14	alkali	alkali	JJ
46745	2276	15	in	in	IN
46745	2276	16	the	the	DT
46745	2276	17	blood	blood	NN
46745	2276	18	,	,	,
46745	2276	19	which	which	WDT
46745	2276	20	excess	excess	NN
46745	2276	21	is	be	VBZ
46745	2276	22	excreted	excrete	VBN
46745	2276	23	by	by	IN
46745	2276	24	the	the	DT
46745	2276	25	kidneys	kidney	NNS
46745	2276	26	,	,	,
46745	2276	27	and	and	CC
46745	2276	28	causes	cause	VBZ
46745	2276	29	a	a	DT
46745	2276	30	lithic	lithic	JJ
46745	2276	31	or	or	CC
46745	2276	32	phosphatic	phosphatic	JJ
46745	2276	33	gravel	gravel	NN
46745	2276	34	,	,	,
46745	2276	35	without	without	IN
46745	2276	36	an	an	DT
46745	2276	37	excess	excess	NN
46745	2276	38	of	of	IN
46745	2276	39	Lithates	Lithates	NNPS
46745	2276	40	or	or	CC
46745	2276	41	of	of	IN
46745	2276	42	Phosphates	Phosphates	NNPS
46745	2276	43	in	in	IN
46745	2276	44	the	the	DT
46745	2276	45	urine	urine	NN
46745	2276	46	.	.	.
46745	2277	1	Whatever	whatever	WDT
46745	2277	2	be	be	VB
46745	2277	3	the	the	DT
46745	2277	4	condition	condition	NN
46745	2277	5	of	of	IN
46745	2277	6	Uric	Uric	NNP
46745	2277	7	acid	acid	NN
46745	2277	8	in	in	IN
46745	2277	9	urine	urine	NN
46745	2277	10	,	,	,
46745	2277	11	it	-PRON-	PRP
46745	2277	12	is	be	VBZ
46745	2277	13	certain	certain	JJ
46745	2277	14	that	that	IN
46745	2277	15	it	-PRON-	PRP
46745	2277	16	is	be	VBZ
46745	2277	17	held	hold	VBN
46745	2277	18	in	in	IN
46745	2277	19	solution	solution	NN
46745	2277	20	by	by	IN
46745	2277	21	some	some	DT
46745	2277	22	matter	matter	NN
46745	2277	23	of	of	IN
46745	2277	24	an	an	DT
46745	2277	25	alkaline	alkaline	JJ
46745	2277	26	nature	nature	NN
46745	2277	27	.	.	.
46745	2278	1	[	[	-LRB-
46745	2278	2	36	36	CD
46745	2278	3	]	]	-RRB-
46745	2278	4	When	when	WRB
46745	2278	5	this	this	DT
46745	2278	6	alkaline	alkaline	NN
46745	2278	7	matter	matter	NN
46745	2278	8	is	be	VBZ
46745	2278	9	neutralized	neutralize	VBN
46745	2278	10	by	by	IN
46745	2278	11	an	an	DT
46745	2278	12	acid	acid	NN
46745	2278	13	,	,	,
46745	2278	14	the	the	DT
46745	2278	15	Uric	Uric	NNP
46745	2278	16	acid	acid	NN
46745	2278	17	precipitates	precipitate	NNS
46745	2278	18	.	.	.
46745	2279	1	This	this	DT
46745	2279	2	may	may	MD
46745	2279	3	perhaps	perhaps	RB
46745	2279	4	be	be	VB
46745	2279	5	caused	cause	VBN
46745	2279	6	in	in	IN
46745	2279	7	Rheumatic	rheumatic	JJ
46745	2279	8	fever	fever	NN
46745	2279	9	by	by	IN
46745	2279	10	an	an	DT
46745	2279	11	excess	excess	NN
46745	2279	12	of	of	IN
46745	2279	13	Lactic	lactic	JJ
46745	2279	14	acid	acid	NN
46745	2279	15	.	.	.
46745	2280	1	The	the	DT
46745	2280	2	Phosphates	Phosphates	NNPS
46745	2280	3	are	be	VBP
46745	2280	4	held	hold	VBN
46745	2280	5	in	in	IN
46745	2280	6	solution	solution	NN
46745	2280	7	by	by	IN
46745	2280	8	Phosphoric	Phosphoric	NNP
46745	2280	9	acid	acid	NN
46745	2280	10	,	,	,
46745	2280	11	or	or	CC
46745	2280	12	by	by	IN
46745	2280	13	that	that	DT
46745	2280	14	matter	matter	NN
46745	2280	15	which	which	WDT
46745	2280	16	gives	give	VBZ
46745	2280	17	to	to	IN
46745	2280	18	healthy	healthy	JJ
46745	2280	19	urine	urine	NN
46745	2280	20	its	-PRON-	PRP$
46745	2280	21	slight	slight	JJ
46745	2280	22	acid	acid	NN
46745	2280	23	reaction	reaction	NN
46745	2280	24	.	.	.
46745	2281	1	[	[	-LRB-
46745	2281	2	37	37	CD
46745	2281	3	]	]	-RRB-
46745	2281	4	An	an	DT
46745	2281	5	excess	excess	NN
46745	2281	6	of	of	IN
46745	2281	7	alkali	alkali	JJ
46745	2281	8	in	in	IN
46745	2281	9	the	the	DT
46745	2281	10	blood	blood	NN
46745	2281	11	,	,	,
46745	2281	12	which	which	WDT
46745	2281	13	may	may	MD
46745	2281	14	probably	probably	RB
46745	2281	15	occur	occur	VB
46745	2281	16	in	in	IN
46745	2281	17	Typhoid	Typhoid	NNP
46745	2281	18	and	and	CC
46745	2281	19	low	low	JJ
46745	2281	20	fevers	fever	NNS
46745	2281	21	,	,	,
46745	2281	22	will	will	MD
46745	2281	23	cause	cause	VB
46745	2281	24	their	-PRON-	PRP$
46745	2281	25	precipitation	precipitation	NN
46745	2281	26	.	.	.
46745	2282	1	Or	or	CC
46745	2282	2	the	the	DT
46745	2282	3	alkali	alkali	JJ
46745	2282	4	may	may	MD
46745	2282	5	be	be	VB
46745	2282	6	formed	form	VBN
46745	2282	7	in	in	IN
46745	2282	8	the	the	DT
46745	2282	9	bladder	bladder	NN
46745	2282	10	by	by	IN
46745	2282	11	the	the	DT
46745	2282	12	decomposition	decomposition	NN
46745	2282	13	of	of	IN
46745	2282	14	the	the	DT
46745	2282	15	urine	urine	NN
46745	2282	16	.	.	.
46745	2283	1	This	this	DT
46745	2283	2	may	may	MD
46745	2283	3	occur	occur	VB
46745	2283	4	in	in	IN
46745	2283	5	inflammation	inflammation	NN
46745	2283	6	of	of	IN
46745	2283	7	the	the	DT
46745	2283	8	bladder	bladder	NN
46745	2283	9	;	;	:
46745	2283	10	or	or	CC
46745	2283	11	in	in	IN
46745	2283	12	retention	retention	NN
46745	2283	13	of	of	IN
46745	2283	14	urine	urine	NN
46745	2283	15	caused	cause	VBN
46745	2283	16	by	by	IN
46745	2283	17	paraplegic	paraplegic	JJ
46745	2283	18	paralysis	paralysis	NN
46745	2283	19	.	.	.
46745	2284	1	In	in	IN
46745	2284	2	such	such	JJ
46745	2284	3	cases	case	NNS
46745	2284	4	there	there	EX
46745	2284	5	is	be	VBZ
46745	2284	6	no	no	DT
46745	2284	7	absolute	absolute	JJ
46745	2284	8	excess	excess	NN
46745	2284	9	of	of	IN
46745	2284	10	the	the	DT
46745	2284	11	deposited	deposited	JJ
46745	2284	12	matter	matter	NN
46745	2284	13	;	;	:
46745	2284	14	but	but	CC
46745	2284	15	it	-PRON-	PRP
46745	2284	16	is	be	VBZ
46745	2284	17	in	in	IN
46745	2284	18	relative	relative	JJ
46745	2284	19	excess	excess	NN
46745	2284	20	,	,	,
46745	2284	21	for	for	IN
46745	2284	22	the	the	DT
46745	2284	23	substance	substance	NN
46745	2284	24	which	which	WDT
46745	2284	25	should	should	MD
46745	2284	26	properly	properly	RB
46745	2284	27	dissolve	dissolve	VB
46745	2284	28	it	-PRON-	PRP
46745	2284	29	is	be	VBZ
46745	2284	30	neutralized	neutralize	VBN
46745	2284	31	by	by	IN
46745	2284	32	a	a	DT
46745	2284	33	reagent	reagent	NN
46745	2284	34	of	of	IN
46745	2284	35	an	an	DT
46745	2284	36	opposite	opposite	JJ
46745	2284	37	nature	nature	NN
46745	2284	38	.	.	.
46745	2285	1	Acids	acid	NNS
46745	2285	2	and	and	CC
46745	2285	3	alkalies	alkali	NNS
46745	2285	4	have	have	VBP
46745	2285	5	already	already	RB
46745	2285	6	been	be	VBN
46745	2285	7	mentioned	mention	VBN
46745	2285	8	as	as	IN
46745	2285	9	efficacious	efficacious	JJ
46745	2285	10	in	in	IN
46745	2285	11	these	these	DT
46745	2285	12	instances	instance	NNS
46745	2285	13	;	;	:
46745	2285	14	the	the	DT
46745	2285	15	former	former	JJ
46745	2285	16	in	in	IN
46745	2285	17	phosphatic	phosphatic	JJ
46745	2285	18	,	,	,
46745	2285	19	the	the	DT
46745	2285	20	latter	latter	JJ
46745	2285	21	in	in	IN
46745	2285	22	lithic	lithic	JJ
46745	2285	23	deposits	deposit	NNS
46745	2285	24	.	.	.
46745	2286	1	They	-PRON-	PRP
46745	2286	2	directly	directly	RB
46745	2286	3	neutralize	neutralize	VBP
46745	2286	4	the	the	DT
46745	2286	5	disturbing	disturbing	JJ
46745	2286	6	cause	cause	NN
46745	2286	7	;	;	:
46745	2286	8	the	the	DT
46745	2286	9	alkali	alkali	JJ
46745	2286	10	,	,	,
46745	2286	11	or	or	CC
46745	2286	12	the	the	DT
46745	2286	13	acid	acid	NN
46745	2286	14	.	.	.
46745	2287	1	They	-PRON-	PRP
46745	2287	2	are	be	VBP
46745	2287	3	not	not	RB
46745	2287	4	in	in	IN
46745	2287	5	such	such	JJ
46745	2287	6	cases	case	NNS
46745	2287	7	truly	truly	RB
46745	2287	8	solvents	solvent	VBZ
46745	2287	9	;	;	:
46745	2287	10	they	-PRON-	PRP
46745	2287	11	do	do	VBP
46745	2287	12	not	not	RB
46745	2287	13	themselves	-PRON-	PRP
46745	2287	14	hold	hold	VB
46745	2287	15	in	in	IN
46745	2287	16	solution	solution	NN
46745	2287	17	the	the	DT
46745	2287	18	insoluble	insoluble	JJ
46745	2287	19	material	material	NN
46745	2287	20	,	,	,
46745	2287	21	but	but	CC
46745	2287	22	they	-PRON-	PRP
46745	2287	23	set	set	VBD
46745	2287	24	free	free	JJ
46745	2287	25	something	something	NN
46745	2287	26	else	else	RB
46745	2287	27	that	that	WDT
46745	2287	28	shall	shall	MD
46745	2287	29	be	be	VB
46745	2287	30	capable	capable	JJ
46745	2287	31	of	of	IN
46745	2287	32	doing	do	VBG
46745	2287	33	so	so	RB
46745	2287	34	.	.	.
46745	2288	1	(	(	-LRB-
46745	2288	2	_	_	NNP
46745	2288	3	Vide	Vide	NNP
46745	2288	4	Acids	Acids	NNPS
46745	2288	5	;	;	:
46745	2288	6	Alkalies	Alkalies	NNP
46745	2288	7	.	.	.
46745	2288	8	_	_	NNP
46745	2288	9	)	)	-RRB-
46745	2288	10	A	a	DT
46745	2288	11	suppression	suppression	NN
46745	2288	12	of	of	IN
46745	2288	13	the	the	DT
46745	2288	14	secretion	secretion	NN
46745	2288	15	of	of	IN
46745	2288	16	the	the	DT
46745	2288	17	skin	skin	NN
46745	2288	18	causes	cause	VBZ
46745	2288	19	a	a	DT
46745	2288	20	lithic	lithic	JJ
46745	2288	21	deposit	deposit	NN
46745	2288	22	in	in	IN
46745	2288	23	some	some	DT
46745	2288	24	cases	case	NNS
46745	2288	25	,	,	,
46745	2288	26	as	as	IN
46745	2288	27	in	in	IN
46745	2288	28	a	a	DT
46745	2288	29	common	common	JJ
46745	2288	30	"	"	``
46745	2288	31	cold	cold	JJ
46745	2288	32	.	.	.
46745	2288	33	"	"	''
46745	2289	1	For	for	IN
46745	2289	2	the	the	DT
46745	2289	3	perspiration	perspiration	NN
46745	2289	4	contains	contain	VBZ
46745	2289	5	a	a	DT
46745	2289	6	free	free	JJ
46745	2289	7	acid	acid	NN
46745	2289	8	,	,	,
46745	2289	9	probably	probably	RB
46745	2289	10	lactic	lactic	JJ
46745	2289	11	or	or	CC
46745	2289	12	butyric	butyric	JJ
46745	2289	13	;	;	:
46745	2289	14	and	and	CC
46745	2289	15	when	when	WRB
46745	2289	16	it	-PRON-	PRP
46745	2289	17	is	be	VBZ
46745	2289	18	suppressed	suppress	VBN
46745	2289	19	,	,	,
46745	2289	20	the	the	DT
46745	2289	21	secretion	secretion	NN
46745	2289	22	of	of	IN
46745	2289	23	this	this	DT
46745	2289	24	acid	acid	NN
46745	2289	25	is	be	VBZ
46745	2289	26	thrown	throw	VBN
46745	2289	27	upon	upon	IN
46745	2289	28	the	the	DT
46745	2289	29	kidneys	kidney	NNS
46745	2289	30	,	,	,
46745	2289	31	and	and	CC
46745	2289	32	the	the	DT
46745	2289	33	urine	urine	NN
46745	2289	34	is	be	VBZ
46745	2289	35	rendered	render	VBN
46745	2289	36	more	more	JJR
46745	2289	37	acid	acid	NN
46745	2289	38	than	than	IN
46745	2289	39	naturally	naturally	RB
46745	2289	40	.	.	.
46745	2290	1	The	the	DT
46745	2290	2	obvious	obvious	JJ
46745	2290	3	indication	indication	NN
46745	2290	4	in	in	IN
46745	2290	5	the	the	DT
46745	2290	6	treatment	treatment	NN
46745	2290	7	is	be	VBZ
46745	2290	8	to	to	TO
46745	2290	9	restore	restore	VB
46745	2290	10	the	the	DT
46745	2290	11	function	function	NN
46745	2290	12	of	of	IN
46745	2290	13	the	the	DT
46745	2290	14	skin	skin	NN
46745	2290	15	,	,	,
46745	2290	16	as	as	IN
46745	2290	17	by	by	IN
46745	2290	18	warm	warm	JJ
46745	2290	19	baths	bath	NNS
46745	2290	20	,	,	,
46745	2290	21	diaphoretics	diaphoretic	NNS
46745	2290	22	,	,	,
46745	2290	23	etc	etc	FW
46745	2290	24	.	.	.
46745	2291	1	It	-PRON-	PRP
46745	2291	2	is	be	VBZ
46745	2291	3	in	in	IN
46745	2291	4	the	the	DT
46745	2291	5	case	case	NN
46745	2291	6	of	of	IN
46745	2291	7	urinary	urinary	JJ
46745	2291	8	deposits	deposit	NNS
46745	2291	9	produced	produce	VBN
46745	2291	10	in	in	IN
46745	2291	11	the	the	DT
46745	2291	12	fourth	fourth	JJ
46745	2291	13	way	way	NN
46745	2291	14	that	that	IN
46745	2291	15	true	true	JJ
46745	2291	16	solvents	solvent	NNS
46745	2291	17	are	be	VBP
46745	2291	18	appropriate	appropriate	JJ
46745	2291	19	.	.	.
46745	2292	1	From	from	IN
46745	2292	2	some	some	DT
46745	2292	3	morbid	morbid	NN
46745	2292	4	condition	condition	NN
46745	2292	5	of	of	IN
46745	2292	6	the	the	DT
46745	2292	7	system	system	NN
46745	2292	8	,	,	,
46745	2292	9	it	-PRON-	PRP
46745	2292	10	happens	happen	VBZ
46745	2292	11	that	that	IN
46745	2292	12	these	these	DT
46745	2292	13	insoluble	insoluble	JJ
46745	2292	14	constituents	constituent	NNS
46745	2292	15	of	of	IN
46745	2292	16	the	the	DT
46745	2292	17	urine	urine	NN
46745	2292	18	are	be	VBP
46745	2292	19	secreted	secrete	VBN
46745	2292	20	in	in	IN
46745	2292	21	absolute	absolute	JJ
46745	2292	22	excess,--in	excess,--in	NNP
46745	2292	23	a	a	DT
46745	2292	24	larger	large	JJR
46745	2292	25	quantity	quantity	NN
46745	2292	26	than	than	IN
46745	2292	27	in	in	IN
46745	2292	28	health	health	NN
46745	2292	29	.	.	.
46745	2293	1	Now	now	RB
46745	2293	2	the	the	DT
46745	2293	3	system	system	NN
46745	2293	4	labours	labour	VBZ
46745	2293	5	to	to	TO
46745	2293	6	excrete	excrete	VB
46745	2293	7	them	-PRON-	PRP
46745	2293	8	in	in	IN
46745	2293	9	solution	solution	NN
46745	2293	10	,	,	,
46745	2293	11	even	even	RB
46745	2293	12	when	when	WRB
46745	2293	13	in	in	IN
46745	2293	14	excess	excess	NN
46745	2293	15	;	;	,
46745	2293	16	and	and	CC
46745	2293	17	often	often	RB
46745	2293	18	succeeds	succeed	VBZ
46745	2293	19	in	in	IN
46745	2293	20	doing	do	VBG
46745	2293	21	so	so	RB
46745	2293	22	.	.	.
46745	2294	1	But	but	CC
46745	2294	2	frequently	frequently	RB
46745	2294	3	this	this	DT
46745	2294	4	can	can	MD
46745	2294	5	not	not	RB
46745	2294	6	be	be	VB
46745	2294	7	done	do	VBN
46745	2294	8	,	,	,
46745	2294	9	it	-PRON-	PRP
46745	2294	10	being	be	VBG
46745	2294	11	impossible	impossible	JJ
46745	2294	12	for	for	IN
46745	2294	13	a	a	DT
46745	2294	14	sufficient	sufficient	JJ
46745	2294	15	quantity	quantity	NN
46745	2294	16	of	of	IN
46745	2294	17	the	the	DT
46745	2294	18	solvent	solvent	NN
46745	2294	19	material	material	NN
46745	2294	20	to	to	TO
46745	2294	21	be	be	VB
46745	2294	22	formed	form	VBN
46745	2294	23	out	out	IN
46745	2294	24	of	of	IN
46745	2294	25	the	the	DT
46745	2294	26	blood	blood	NN
46745	2294	27	.	.	.
46745	2295	1	There	there	EX
46745	2295	2	is	be	VBZ
46745	2295	3	then	then	RB
46745	2295	4	a	a	DT
46745	2295	5	deposit	deposit	NN
46745	2295	6	in	in	IN
46745	2295	7	the	the	DT
46745	2295	8	urine	urine	NN
46745	2295	9	.	.	.
46745	2296	1	We	-PRON-	PRP
46745	2296	2	have	have	VBP
46745	2296	3	seen	see	VBN
46745	2296	4	that	that	IN
46745	2296	5	when	when	WRB
46745	2296	6	such	such	JJ
46745	2296	7	matters	matter	NNS
46745	2296	8	are	be	VBP
46745	2296	9	deposited	deposit	VBN
46745	2296	10	because	because	IN
46745	2296	11	in	in	IN
46745	2296	12	relative	relative	JJ
46745	2296	13	excess	excess	NN
46745	2296	14	,	,	,
46745	2296	15	the	the	DT
46745	2296	16	only	only	JJ
46745	2296	17	fit	fit	JJ
46745	2296	18	mode	mode	NN
46745	2296	19	of	of	IN
46745	2296	20	treatment	treatment	NN
46745	2296	21	consists	consist	VBZ
46745	2296	22	in	in	IN
46745	2296	23	the	the	DT
46745	2296	24	administration	administration	NN
46745	2296	25	of	of	IN
46745	2296	26	an	an	DT
46745	2296	27	acid	acid	NN
46745	2296	28	or	or	CC
46745	2296	29	an	an	DT
46745	2296	30	alkali	alkali	JJ
46745	2296	31	,	,	,
46745	2296	32	which	which	WDT
46745	2296	33	shall	shall	MD
46745	2296	34	neutralize	neutralize	VB
46745	2296	35	the	the	DT
46745	2296	36	morbid	morbid	NN
46745	2296	37	reaction	reaction	NN
46745	2296	38	of	of	IN
46745	2296	39	the	the	DT
46745	2296	40	blood	blood	NN
46745	2296	41	.	.	.
46745	2297	1	Such	such	PDT
46745	2297	2	a	a	DT
46745	2297	3	case	case	NN
46745	2297	4	is	be	VBZ
46745	2297	5	rare	rare	JJ
46745	2297	6	;	;	:
46745	2297	7	but	but	CC
46745	2297	8	these	these	DT
46745	2297	9	cases	case	NNS
46745	2297	10	of	of	IN
46745	2297	11	absolute	absolute	JJ
46745	2297	12	excess	excess	NN
46745	2297	13	are	be	VBP
46745	2297	14	much	much	RB
46745	2297	15	more	more	RBR
46745	2297	16	common	common	JJ
46745	2297	17	.	.	.
46745	2298	1	There	there	EX
46745	2298	2	are	be	VBP
46745	2298	3	two	two	CD
46745	2298	4	ways	way	NNS
46745	2298	5	in	in	IN
46745	2298	6	which	which	WDT
46745	2298	7	we	-PRON-	PRP
46745	2298	8	may	may	MD
46745	2298	9	treat	treat	VB
46745	2298	10	them	-PRON-	PRP
46745	2298	11	;	;	:
46745	2298	12	we	-PRON-	PRP
46745	2298	13	may	may	MD
46745	2298	14	adopt	adopt	VB
46745	2298	15	either	either	CC
46745	2298	16	curative	curative	JJ
46745	2298	17	or	or	CC
46745	2298	18	palliative	palliative	JJ
46745	2298	19	remedies	remedy	NNS
46745	2298	20	.	.	.
46745	2299	1	We	-PRON-	PRP
46745	2299	2	may	may	MD
46745	2299	3	aim	aim	VB
46745	2299	4	at	at	IN
46745	2299	5	the	the	DT
46745	2299	6	cause	cause	NN
46745	2299	7	of	of	IN
46745	2299	8	the	the	DT
46745	2299	9	disease	disease	NN
46745	2299	10	,	,	,
46745	2299	11	which	which	WDT
46745	2299	12	is	be	VBZ
46745	2299	13	generally	generally	RB
46745	2299	14	in	in	IN
46745	2299	15	the	the	DT
46745	2299	16	blood	blood	NN
46745	2299	17	.	.	.
46745	2300	1	An	an	DT
46745	2300	2	absolute	absolute	JJ
46745	2300	3	excess	excess	NN
46745	2300	4	of	of	IN
46745	2300	5	Lithates	Lithates	NNPS
46745	2300	6	may	may	MD
46745	2300	7	be	be	VB
46745	2300	8	caused	cause	VBN
46745	2300	9	by	by	IN
46745	2300	10	dyspepsia	dyspepsia	NNP
46745	2300	11	,	,	,
46745	2300	12	or	or	CC
46745	2300	13	by	by	IN
46745	2300	14	a	a	DT
46745	2300	15	gouty	gouty	JJ
46745	2300	16	disorder	disorder	NN
46745	2300	17	.	.	.
46745	2301	1	This	this	DT
46745	2301	2	is	be	VBZ
46745	2301	3	most	most	RBS
46745	2301	4	surely	surely	RB
46745	2301	5	controlled	control	VBN
46745	2301	6	by	by	IN
46745	2301	7	a	a	DT
46745	2301	8	Catalytic	catalytic	JJ
46745	2301	9	medicine	medicine	NN
46745	2301	10	.	.	.
46745	2302	1	(	(	-LRB-
46745	2302	2	_	_	NNP
46745	2302	3	Vide	Vide	NNP
46745	2302	4	Antiarthritics	Antiarthritics	NNP
46745	2302	5	.	.	.
46745	2302	6	_	_	NNP
46745	2302	7	)	)	-RRB-
46745	2302	8	An	an	DT
46745	2302	9	absolute	absolute	JJ
46745	2302	10	excess	excess	NN
46745	2302	11	of	of	IN
46745	2302	12	Phosphates	Phosphates	NNPS
46745	2302	13	may	may	MD
46745	2302	14	be	be	VB
46745	2302	15	caused	cause	VBN
46745	2302	16	by	by	IN
46745	2302	17	an	an	DT
46745	2302	18	organic	organic	JJ
46745	2302	19	derangement	derangement	NN
46745	2302	20	of	of	IN
46745	2302	21	the	the	DT
46745	2302	22	nervous	nervous	JJ
46745	2302	23	centres	centre	NNS
46745	2302	24	,	,	,
46745	2302	25	when	when	WRB
46745	2302	26	it	-PRON-	PRP
46745	2302	27	is	be	VBZ
46745	2302	28	very	very	RB
46745	2302	29	difficult	difficult	JJ
46745	2302	30	to	to	TO
46745	2302	31	cure	cure	VB
46745	2302	32	;	;	:
46745	2302	33	or	or	CC
46745	2302	34	it	-PRON-	PRP
46745	2302	35	may	may	MD
46745	2302	36	simply	simply	RB
46745	2302	37	be	be	VB
46745	2302	38	due	due	JJ
46745	2302	39	to	to	IN
46745	2302	40	great	great	JJ
46745	2302	41	nervous	nervous	JJ
46745	2302	42	excitement	excitement	NN
46745	2302	43	,	,	,
46745	2302	44	hard	hard	JJ
46745	2302	45	study	study	NN
46745	2302	46	,	,	,
46745	2302	47	or	or	CC
46745	2302	48	melancholia	melancholia	NN
46745	2302	49	.	.	.
46745	2303	1	Such	such	JJ
46745	2303	2	cases	case	NNS
46745	2303	3	should	should	MD
46745	2303	4	be	be	VB
46745	2303	5	distinguished	distinguish	VBN
46745	2303	6	from	from	IN
46745	2303	7	a	a	DT
46745	2303	8	mere	mere	JJ
46745	2303	9	alkaline	alkaline	JJ
46745	2303	10	condition	condition	NN
46745	2303	11	of	of	IN
46745	2303	12	the	the	DT
46745	2303	13	urine	urine	NN
46745	2303	14	,	,	,
46745	2303	15	without	without	IN
46745	2303	16	absolute	absolute	JJ
46745	2303	17	excess	excess	NN
46745	2303	18	of	of	IN
46745	2303	19	Phosphates	Phosphates	NNPS
46745	2303	20	,	,	,
46745	2303	21	and	and	CC
46745	2303	22	may	may	MD
46745	2303	23	often	often	RB
46745	2303	24	be	be	VB
46745	2303	25	cured	cure	VBN
46745	2303	26	by	by	IN
46745	2303	27	attention	attention	NN
46745	2303	28	to	to	IN
46745	2303	29	the	the	DT
46745	2303	30	disturbed	disturbed	JJ
46745	2303	31	nervous	nervous	JJ
46745	2303	32	functions	function	NNS
46745	2303	33	.	.	.
46745	2304	1	Such	such	PDT
46745	2304	2	a	a	DT
46745	2304	3	curative	curative	JJ
46745	2304	4	course	course	NN
46745	2304	5	of	of	IN
46745	2304	6	treatment	treatment	NN
46745	2304	7	aims	aim	VBZ
46745	2304	8	at	at	IN
46745	2304	9	the	the	DT
46745	2304	10	primary	primary	JJ
46745	2304	11	cause	cause	NN
46745	2304	12	of	of	IN
46745	2304	13	the	the	DT
46745	2304	14	deposit	deposit	NN
46745	2304	15	;	;	:
46745	2304	16	but	but	CC
46745	2304	17	when	when	WRB
46745	2304	18	we	-PRON-	PRP
46745	2304	19	are	be	VBP
46745	2304	20	unsuccessful	unsuccessful	JJ
46745	2304	21	in	in	IN
46745	2304	22	our	-PRON-	PRP$
46745	2304	23	attempt	attempt	NN
46745	2304	24	to	to	TO
46745	2304	25	control	control	VB
46745	2304	26	this	this	DT
46745	2304	27	,	,	,
46745	2304	28	or	or	CC
46745	2304	29	when	when	WRB
46745	2304	30	the	the	DT
46745	2304	31	excess	excess	NN
46745	2304	32	of	of	IN
46745	2304	33	solid	solid	JJ
46745	2304	34	matter	matter	NN
46745	2304	35	is	be	VBZ
46745	2304	36	so	so	RB
46745	2304	37	great	great	JJ
46745	2304	38	as	as	IN
46745	2304	39	to	to	TO
46745	2304	40	be	be	VB
46745	2304	41	positively	positively	RB
46745	2304	42	dangerous	dangerous	JJ
46745	2304	43	,	,	,
46745	2304	44	we	-PRON-	PRP
46745	2304	45	are	be	VBP
46745	2304	46	then	then	RB
46745	2304	47	driven	drive	VBN
46745	2304	48	to	to	TO
46745	2304	49	have	have	VB
46745	2304	50	recourse	recourse	VBN
46745	2304	51	to	to	TO
46745	2304	52	palliative	palliative	JJ
46745	2304	53	remedies	remedy	NNS
46745	2304	54	.	.	.
46745	2305	1	These	these	DT
46745	2305	2	are	be	VBP
46745	2305	3	Solvents	solvent	NNS
46745	2305	4	;	;	:
46745	2305	5	medicines	medicine	NNS
46745	2305	6	which	which	WDT
46745	2305	7	pass	pass	VBP
46745	2305	8	into	into	IN
46745	2305	9	the	the	DT
46745	2305	10	blood	blood	NN
46745	2305	11	,	,	,
46745	2305	12	combine	combine	VB
46745	2305	13	there	there	RB
46745	2305	14	with	with	IN
46745	2305	15	the	the	DT
46745	2305	16	peccant	peccant	JJ
46745	2305	17	matters	matter	NNS
46745	2305	18	,	,	,
46745	2305	19	pass	pass	VB
46745	2305	20	out	out	RP
46745	2305	21	with	with	IN
46745	2305	22	them	-PRON-	PRP
46745	2305	23	into	into	IN
46745	2305	24	the	the	DT
46745	2305	25	urinary	urinary	JJ
46745	2305	26	secretion	secretion	NN
46745	2305	27	,	,	,
46745	2305	28	and	and	CC
46745	2305	29	hold	hold	VB
46745	2305	30	them	-PRON-	PRP
46745	2305	31	there	there	RB
46745	2305	32	securely	securely	RB
46745	2305	33	in	in	IN
46745	2305	34	solution	solution	NN
46745	2305	35	.	.	.
46745	2306	1	Such	such	PDT
46745	2306	2	an	an	DT
46745	2306	3	agent	agent	NN
46745	2306	4	may	may	MD
46745	2306	5	often	often	RB
46745	2306	6	be	be	VB
46745	2306	7	advantageously	advantageously	RB
46745	2306	8	combined	combine	VBN
46745	2306	9	with	with	IN
46745	2306	10	the	the	DT
46745	2306	11	Catalytic	catalytic	JJ
46745	2306	12	remedy	remedy	NN
46745	2306	13	,	,	,
46745	2306	14	which	which	WDT
46745	2306	15	tends	tend	VBZ
46745	2306	16	to	to	TO
46745	2306	17	cure	cure	VB
46745	2306	18	the	the	DT
46745	2306	19	systemic	systemic	JJ
46745	2306	20	disorder	disorder	NN
46745	2306	21	.	.	.
46745	2307	1	It	-PRON-	PRP
46745	2307	2	is	be	VBZ
46745	2307	3	a	a	DT
46745	2307	4	blood	blood	NN
46745	2307	5	-	-	HYPH
46745	2307	6	medicine	medicine	NN
46745	2307	7	.	.	.
46745	2308	1	Its	-PRON-	PRP$
46745	2308	2	action	action	NN
46745	2308	3	is	be	VBZ
46745	2308	4	so	so	RB
46745	2308	5	far	far	RB
46745	2308	6	permanent	permanent	JJ
46745	2308	7	,	,	,
46745	2308	8	that	that	IN
46745	2308	9	it	-PRON-	PRP
46745	2308	10	effects	effect	VBZ
46745	2308	11	its	-PRON-	PRP$
46745	2308	12	object	object	NN
46745	2308	13	definitely	definitely	RB
46745	2308	14	,	,	,
46745	2308	15	dissolving	dissolve	VBG
46745	2308	16	and	and	CC
46745	2308	17	carrying	carry	VBG
46745	2308	18	away	away	RP
46745	2308	19	a	a	DT
46745	2308	20	certain	certain	JJ
46745	2308	21	portion	portion	NN
46745	2308	22	of	of	IN
46745	2308	23	insoluble	insoluble	JJ
46745	2308	24	matter	matter	NN
46745	2308	25	.	.	.
46745	2309	1	But	but	CC
46745	2309	2	as	as	IN
46745	2309	3	it	-PRON-	PRP
46745	2309	4	also	also	RB
46745	2309	5	passes	pass	VBZ
46745	2309	6	out	out	RP
46745	2309	7	itself	-PRON-	PRP
46745	2309	8	,	,	,
46745	2309	9	it	-PRON-	PRP
46745	2309	10	requires	require	VBZ
46745	2309	11	to	to	TO
46745	2309	12	be	be	VB
46745	2309	13	frequently	frequently	RB
46745	2309	14	repeated	repeat	VBN
46745	2309	15	,	,	,
46745	2309	16	because	because	IN
46745	2309	17	the	the	DT
46745	2309	18	deposit	deposit	NN
46745	2309	19	continues	continue	VBZ
46745	2309	20	to	to	TO
46745	2309	21	be	be	VB
46745	2309	22	formed	form	VBN
46745	2309	23	,	,	,
46745	2309	24	and	and	CC
46745	2309	25	requires	require	VBZ
46745	2309	26	each	each	DT
46745	2309	27	time	time	NN
46745	2309	28	a	a	DT
46745	2309	29	fresh	fresh	JJ
46745	2309	30	portion	portion	NN
46745	2309	31	of	of	IN
46745	2309	32	solvent	solvent	NN
46745	2309	33	.	.	.
46745	2310	1	It	-PRON-	PRP
46745	2310	2	obviously	obviously	RB
46745	2310	3	acts	act	VBZ
46745	2310	4	on	on	IN
46745	2310	5	the	the	DT
46745	2310	6	Restorative	Restorative	NNP
46745	2310	7	principle	principle	NN
46745	2310	8	.	.	.
46745	2311	1	The	the	DT
46745	2311	2	deposit	deposit	NN
46745	2311	3	should	should	MD
46745	2311	4	be	be	VB
46745	2311	5	excreted	excrete	VBN
46745	2311	6	in	in	IN
46745	2311	7	a	a	DT
46745	2311	8	dissolved	dissolved	JJ
46745	2311	9	state	state	NN
46745	2311	10	,	,	,
46745	2311	11	but	but	CC
46745	2311	12	is	be	VBZ
46745	2311	13	not	not	RB
46745	2311	14	.	.	.
46745	2312	1	The	the	DT
46745	2312	2	remedy	remedy	NN
46745	2312	3	therefore	therefore	RB
46745	2312	4	supplies	supply	VBZ
46745	2312	5	a	a	DT
46745	2312	6	want	want	NN
46745	2312	7	.	.	.
46745	2313	1	Water	water	NN
46745	2313	2	is	be	VBZ
46745	2313	3	the	the	DT
46745	2313	4	simplest	simple	JJS
46745	2313	5	and	and	CC
46745	2313	6	most	most	RBS
46745	2313	7	efficacious	efficacious	JJ
46745	2313	8	of	of	IN
46745	2313	9	all	all	DT
46745	2313	10	solvents	solvent	NNS
46745	2313	11	,	,	,
46745	2313	12	and	and	CC
46745	2313	13	should	should	MD
46745	2313	14	in	in	IN
46745	2313	15	all	all	DT
46745	2313	16	cases	case	NNS
46745	2313	17	of	of	IN
46745	2313	18	gravel	gravel	NN
46745	2313	19	be	be	VB
46745	2313	20	very	very	RB
46745	2313	21	freely	freely	RB
46745	2313	22	administered	administer	VBN
46745	2313	23	.	.	.
46745	2314	1	Bouchardat	Bouchardat	NNP
46745	2314	2	has	have	VBZ
46745	2314	3	remarked	remark	VBN
46745	2314	4	that	that	DT
46745	2314	5	great	great	JJ
46745	2314	6	water	water	NN
46745	2314	7	-	-	HYPH
46745	2314	8	drinkers	drinker	NNS
46745	2314	9	are	be	VBP
46745	2314	10	never	never	RB
46745	2314	11	afflicted	afflict	VBN
46745	2314	12	with	with	IN
46745	2314	13	stone	stone	NN
46745	2314	14	.	.	.
46745	2315	1	All	all	PDT
46745	2315	2	the	the	DT
46745	2315	3	urinary	urinary	JJ
46745	2315	4	deposits	deposit	NNS
46745	2315	5	are	be	VBP
46745	2315	6	,	,	,
46745	2315	7	to	to	IN
46745	2315	8	some	some	DT
46745	2315	9	extent	extent	NN
46745	2315	10	,	,	,
46745	2315	11	soluble	soluble	JJ
46745	2315	12	in	in	IN
46745	2315	13	water	water	NN
46745	2315	14	,	,	,
46745	2315	15	although	although	IN
46745	2315	16	_	_	NNP
46745	2315	17	comparatively	comparatively	RB
46745	2315	18	_	_	NNP
46745	2315	19	insoluble	insoluble	NN
46745	2315	20	.	.	.
46745	2316	1	Whenever	whenever	WRB
46745	2316	2	the	the	DT
46745	2316	3	urine	urine	NN
46745	2316	4	is	be	VBZ
46745	2316	5	of	of	IN
46745	2316	6	higher	high	JJR
46745	2316	7	specific	specific	JJ
46745	2316	8	gravity	gravity	NN
46745	2316	9	than	than	IN
46745	2316	10	it	-PRON-	PRP
46745	2316	11	should	should	MD
46745	2316	12	be	be	VB
46745	2316	13	in	in	IN
46745	2316	14	health	health	NN
46745	2316	15	,	,	,
46745	2316	16	more	more	JJR
46745	2316	17	water	water	NN
46745	2316	18	should	should	MD
46745	2316	19	be	be	VB
46745	2316	20	drunk	drunk	JJ
46745	2316	21	.	.	.
46745	2317	1	The	the	DT
46745	2317	2	average	average	JJ
46745	2317	3	specific	specific	JJ
46745	2317	4	gravity	gravity	NN
46745	2317	5	of	of	IN
46745	2317	6	healthy	healthy	JJ
46745	2317	7	urine	urine	NN
46745	2317	8	is	be	VBZ
46745	2317	9	about	about	RB
46745	2317	10	1.018	1.018	CD
46745	2317	11	.	.	.
46745	2318	1	[	[	-LRB-
46745	2318	2	38	38	CD
46745	2318	3	]	]	-RRB-
46745	2318	4	Acids	Acids	NNPS
46745	2318	5	and	and	CC
46745	2318	6	Alkalies	Alkalies	NNPS
46745	2318	7	are	be	VBP
46745	2318	8	most	most	RBS
46745	2318	9	important	important	JJ
46745	2318	10	as	as	IN
46745	2318	11	solvents	solvent	NNS
46745	2318	12	.	.	.
46745	2319	1	They	-PRON-	PRP
46745	2319	2	do	do	VBP
46745	2319	3	not	not	RB
46745	2319	4	now	now	RB
46745	2319	5	act	act	VB
46745	2319	6	indirectly	indirectly	RB
46745	2319	7	,	,	,
46745	2319	8	as	as	IN
46745	2319	9	in	in	IN
46745	2319	10	the	the	DT
46745	2319	11	case	case	NN
46745	2319	12	before	before	IN
46745	2319	13	mentioned	mention	VBN
46745	2319	14	,	,	,
46745	2319	15	but	but	CC
46745	2319	16	directly	directly	RB
46745	2319	17	dissolve	dissolve	VB
46745	2319	18	the	the	DT
46745	2319	19	insoluble	insoluble	JJ
46745	2319	20	matter	matter	NN
46745	2319	21	.	.	.
46745	2320	1	Acids	acid	NNS
46745	2320	2	dissolve	dissolve	VBP
46745	2320	3	a	a	DT
46745	2320	4	phosphatic	phosphatic	NN
46745	2320	5	,	,	,
46745	2320	6	and	and	CC
46745	2320	7	Alkalies	Alkalies	NNPS
46745	2320	8	or	or	CC
46745	2320	9	their	-PRON-	PRP$
46745	2320	10	carbonates	carbonate	NNS
46745	2320	11	a	a	DT
46745	2320	12	lithic	lithic	JJ
46745	2320	13	deposit	deposit	NN
46745	2320	14	,	,	,
46745	2320	15	in	in	IN
46745	2320	16	the	the	DT
46745	2320	17	body	body	NN
46745	2320	18	,	,	,
46745	2320	19	as	as	RB
46745	2320	20	well	well	RB
46745	2320	21	as	as	IN
46745	2320	22	out	out	IN
46745	2320	23	of	of	IN
46745	2320	24	it	-PRON-	PRP
46745	2320	25	.	.	.
46745	2321	1	Although	although	IN
46745	2321	2	the	the	DT
46745	2321	3	natural	natural	JJ
46745	2321	4	solvent	solvent	NN
46745	2321	5	may	may	MD
46745	2321	6	be	be	VB
46745	2321	7	neither	neither	CC
46745	2321	8	an	an	DT
46745	2321	9	acid	acid	NN
46745	2321	10	nor	nor	CC
46745	2321	11	an	an	DT
46745	2321	12	alkali	alkali	JJ
46745	2321	13	,	,	,
46745	2321	14	but	but	CC
46745	2321	15	something	something	NN
46745	2321	16	else	else	RB
46745	2321	17	different	different	JJ
46745	2321	18	in	in	IN
46745	2321	19	nature	nature	NN
46745	2321	20	from	from	IN
46745	2321	21	these	these	DT
46745	2321	22	,	,	,
46745	2321	23	yet	yet	CC
46745	2321	24	any	any	DT
46745	2321	25	thing	thing	NN
46745	2321	26	that	that	WDT
46745	2321	27	will	will	MD
46745	2321	28	rightly	rightly	RB
46745	2321	29	dissolve	dissolve	VB
46745	2321	30	the	the	DT
46745	2321	31	deposit	deposit	NN
46745	2321	32	will	will	MD
46745	2321	33	be	be	VB
46745	2321	34	fit	fit	JJ
46745	2321	35	to	to	TO
46745	2321	36	supply	supply	VB
46745	2321	37	its	-PRON-	PRP$
46745	2321	38	place	place	NN
46745	2321	39	.	.	.
46745	2322	1	Any	any	DT
46745	2322	2	of	of	IN
46745	2322	3	the	the	DT
46745	2322	4	free	free	JJ
46745	2322	5	Acids	Acids	NNPS
46745	2322	6	may	may	MD
46745	2322	7	serve	serve	VB
46745	2322	8	to	to	TO
46745	2322	9	dissolve	dissolve	VB
46745	2322	10	a	a	DT
46745	2322	11	precipitated	precipitate	VBN
46745	2322	12	phosphate	phosphate	NN
46745	2322	13	.	.	.
46745	2323	1	Hydrochloric	Hydrochloric	NNP
46745	2323	2	is	be	VBZ
46745	2323	3	perhaps	perhaps	RB
46745	2323	4	the	the	DT
46745	2323	5	best	good	JJS
46745	2323	6	of	of	IN
46745	2323	7	the	the	DT
46745	2323	8	mineral	mineral	NN
46745	2323	9	acids	acid	NNS
46745	2323	10	,	,	,
46745	2323	11	although	although	IN
46745	2323	12	Phosphoric	Phosphoric	NNP
46745	2323	13	has	have	VBZ
46745	2323	14	been	be	VBN
46745	2323	15	recommended	recommend	VBN
46745	2323	16	on	on	IN
46745	2323	17	theoretical	theoretical	JJ
46745	2323	18	grounds	ground	NNS
46745	2323	19	.	.	.
46745	2324	1	Sulphuric	Sulphuric	NNP
46745	2324	2	is	be	VBZ
46745	2324	3	the	the	DT
46745	2324	4	least	least	JJS
46745	2324	5	efficacious	efficacious	JJ
46745	2324	6	because	because	IN
46745	2324	7	it	-PRON-	PRP
46745	2324	8	does	do	VBZ
46745	2324	9	not	not	RB
46745	2324	10	always	always	RB
46745	2324	11	pass	pass	VB
46745	2324	12	out	out	RP
46745	2324	13	in	in	IN
46745	2324	14	the	the	DT
46745	2324	15	urine	urine	NN
46745	2324	16	.	.	.
46745	2325	1	(	(	-LRB-
46745	2325	2	_	_	NNP
46745	2325	3	Vide	Vide	NNP
46745	2325	4	Chap	Chap	NNP
46745	2325	5	.	.	.
46745	2326	1	IV	IV	NNP
46745	2326	2	.	.	.
46745	2326	3	_	_	NNP
46745	2326	4	)	)	-RRB-
46745	2326	5	Sour	sour	JJ
46745	2326	6	fruits	fruit	NNS
46745	2326	7	,	,	,
46745	2326	8	as	as	IN
46745	2326	9	Currants	currant	NNS
46745	2326	10	or	or	CC
46745	2326	11	green	green	JJ
46745	2326	12	Gooseberries	gooseberry	NNS
46745	2326	13	,	,	,
46745	2326	14	may	may	MD
46745	2326	15	be	be	VB
46745	2326	16	useful	useful	JJ
46745	2326	17	in	in	IN
46745	2326	18	phosphatic	phosphatic	JJ
46745	2326	19	cases	case	NNS
46745	2326	20	;	;	:
46745	2326	21	but	but	CC
46745	2326	22	ripe	ripe	JJ
46745	2326	23	fruits	fruit	NNS
46745	2326	24	have	have	VBP
46745	2326	25	an	an	DT
46745	2326	26	opposite	opposite	JJ
46745	2326	27	tendency	tendency	NN
46745	2326	28	.	.	.
46745	2327	1	Acidulous	acidulous	JJ
46745	2327	2	drinks	drink	NNS
46745	2327	3	may	may	MD
46745	2327	4	be	be	VB
46745	2327	5	recommended	recommend	VBN
46745	2327	6	,	,	,
46745	2327	7	as	as	IN
46745	2327	8	Cider	Cider	NNP
46745	2327	9	,	,	,
46745	2327	10	Perry	Perry	NNP
46745	2327	11	,	,	,
46745	2327	12	and	and	CC
46745	2327	13	Rhenish	rhenish	JJ
46745	2327	14	wines	wine	NNS
46745	2327	15	.	.	.
46745	2328	1	Of	of	IN
46745	2328	2	the	the	DT
46745	2328	3	free	free	JJ
46745	2328	4	alkalies	alkali	NNS
46745	2328	5	used	use	VBN
46745	2328	6	to	to	TO
46745	2328	7	dissolve	dissolve	VB
46745	2328	8	a	a	DT
46745	2328	9	lithic	lithic	JJ
46745	2328	10	sediment	sediment	NN
46745	2328	11	,	,	,
46745	2328	12	Potash	Potash	NNP
46745	2328	13	is	be	VBZ
46745	2328	14	preferable	preferable	JJ
46745	2328	15	to	to	IN
46745	2328	16	Soda	Soda	NNP
46745	2328	17	,	,	,
46745	2328	18	because	because	IN
46745	2328	19	it	-PRON-	PRP
46745	2328	20	forms	form	VBZ
46745	2328	21	a	a	DT
46745	2328	22	more	more	RBR
46745	2328	23	soluble	soluble	JJ
46745	2328	24	compound	compound	NN
46745	2328	25	with	with	IN
46745	2328	26	Uric	Uric	NNP
46745	2328	27	acid	acid	NN
46745	2328	28	.	.	.
46745	2329	1	The	the	DT
46745	2329	2	Bicarbonates	Bicarbonates	NNPS
46745	2329	3	of	of	IN
46745	2329	4	the	the	DT
46745	2329	5	fixed	fix	VBN
46745	2329	6	alkalies	alkali	NNS
46745	2329	7	are	be	VBP
46745	2329	8	best	good	JJS
46745	2329	9	,	,	,
46745	2329	10	because	because	IN
46745	2329	11	least	least	JJS
46745	2329	12	irritant	irritant	JJ
46745	2329	13	.	.	.
46745	2330	1	Bicarbonate	Bicarbonate	NNP
46745	2330	2	of	of	IN
46745	2330	3	Soda	Soda	NNP
46745	2330	4	is	be	VBZ
46745	2330	5	contained	contain	VBN
46745	2330	6	in	in	IN
46745	2330	7	Vichy	Vichy	NNP
46745	2330	8	water	water	NN
46745	2330	9	.	.	.
46745	2331	1	The	the	DT
46745	2331	2	soluble	soluble	JJ
46745	2331	3	Bicarbonate	Bicarbonate	NNP
46745	2331	4	of	of	IN
46745	2331	5	Magnesia	Magnesia	NNP
46745	2331	6	may	may	MD
46745	2331	7	be	be	VB
46745	2331	8	given	give	VBN
46745	2331	9	with	with	IN
46745	2331	10	advantage	advantage	NN
46745	2331	11	.	.	.
46745	2332	1	The	the	DT
46745	2332	2	Carbonate	carbonate	NN
46745	2332	3	of	of	IN
46745	2332	4	Lithia	Lithia	NNP
46745	2332	5	has	have	VBZ
46745	2332	6	been	be	VBN
46745	2332	7	recommended	recommend	VBN
46745	2332	8	by	by	IN
46745	2332	9	Mr.	Mr.	NNP
46745	2332	10	A.	A.	NNP
46745	2332	11	Ure	Ure	NNP
46745	2332	12	;	;	:
46745	2332	13	but	but	CC
46745	2332	14	it	-PRON-	PRP
46745	2332	15	is	be	VBZ
46745	2332	16	comparatively	comparatively	RB
46745	2332	17	insoluble	insoluble	JJ
46745	2332	18	.	.	.
46745	2333	1	The	the	DT
46745	2333	2	neutral	neutral	JJ
46745	2333	3	vegetable	vegetable	NN
46745	2333	4	salts	salt	NNS
46745	2333	5	of	of	IN
46745	2333	6	the	the	DT
46745	2333	7	alkalies	alkali	NNS
46745	2333	8	,	,	,
46745	2333	9	and	and	CC
46745	2333	10	sweet	sweet	JJ
46745	2333	11	fruits	fruit	NNS
46745	2333	12	which	which	WDT
46745	2333	13	contain	contain	VBP
46745	2333	14	them	-PRON-	PRP
46745	2333	15	,	,	,
46745	2333	16	are	be	VBP
46745	2333	17	equivalent	equivalent	JJ
46745	2333	18	to	to	IN
46745	2333	19	the	the	DT
46745	2333	20	Carbonates	Carbonates	NNPS
46745	2333	21	,	,	,
46745	2333	22	because	because	IN
46745	2333	23	converted	convert	VBN
46745	2333	24	into	into	IN
46745	2333	25	them	-PRON-	PRP
46745	2333	26	in	in	IN
46745	2333	27	the	the	DT
46745	2333	28	system	system	NN
46745	2333	29	,	,	,
46745	2333	30	as	as	IN
46745	2333	31	has	have	VBZ
46745	2333	32	already	already	RB
46745	2333	33	been	be	VBN
46745	2333	34	shown	show	VBN
46745	2333	35	.	.	.
46745	2334	1	They	-PRON-	PRP
46745	2334	2	may	may	MD
46745	2334	3	be	be	VB
46745	2334	4	pleasantly	pleasantly	RB
46745	2334	5	administered	administer	VBN
46745	2334	6	in	in	IN
46745	2334	7	the	the	DT
46745	2334	8	form	form	NN
46745	2334	9	of	of	IN
46745	2334	10	effervescing	effervesce	VBG
46745	2334	11	draughts	draught	NNS
46745	2334	12	,	,	,
46745	2334	13	in	in	IN
46745	2334	14	the	the	DT
46745	2334	15	formation	formation	NN
46745	2334	16	of	of	IN
46745	2334	17	which	which	WDT
46745	2334	18	the	the	DT
46745	2334	19	Carbonic	carbonic	JJ
46745	2334	20	acid	acid	NN
46745	2334	21	of	of	IN
46745	2334	22	an	an	DT
46745	2334	23	alkaline	alkaline	NN
46745	2334	24	carbonate	carbonate	NN
46745	2334	25	is	be	VBZ
46745	2334	26	displaced	displace	VBN
46745	2334	27	by	by	IN
46745	2334	28	Citric	Citric	NNP
46745	2334	29	or	or	CC
46745	2334	30	Tartaric	Tartaric	NNP
46745	2334	31	acid	acid	NN
46745	2334	32	.	.	.
46745	2335	1	The	the	DT
46745	2335	2	danger	danger	NN
46745	2335	3	which	which	WDT
46745	2335	4	attends	attend	VBZ
46745	2335	5	the	the	DT
46745	2335	6	continual	continual	JJ
46745	2335	7	use	use	NN
46745	2335	8	of	of	IN
46745	2335	9	acids	acid	NNS
46745	2335	10	,	,	,
46745	2335	11	or	or	CC
46745	2335	12	of	of	IN
46745	2335	13	alkalies	alkali	NNS
46745	2335	14	,	,	,
46745	2335	15	particularly	particularly	RB
46745	2335	16	of	of	IN
46745	2335	17	the	the	DT
46745	2335	18	latter	latter	JJ
46745	2335	19	,	,	,
46745	2335	20	is	be	VBZ
46745	2335	21	that	that	IN
46745	2335	22	their	-PRON-	PRP$
46745	2335	23	long	long	JJ
46745	2335	24	employment	employment	NN
46745	2335	25	may	may	MD
46745	2335	26	engender	engender	VB
46745	2335	27	a	a	DT
46745	2335	28	condition	condition	NN
46745	2335	29	of	of	IN
46745	2335	30	an	an	DT
46745	2335	31	opposite	opposite	JJ
46745	2335	32	nature	nature	NN
46745	2335	33	to	to	IN
46745	2335	34	that	that	DT
46745	2335	35	which	which	WDT
46745	2335	36	they	-PRON-	PRP
46745	2335	37	were	be	VBD
46745	2335	38	intended	intend	VBN
46745	2335	39	to	to	TO
46745	2335	40	alleviate	alleviate	VB
46745	2335	41	.	.	.
46745	2336	1	An	an	DT
46745	2336	2	acid	acid	NN
46745	2336	3	may	may	MD
46745	2336	4	at	at	IN
46745	2336	5	length	length	NN
46745	2336	6	cause	cause	VB
46745	2336	7	a	a	DT
46745	2336	8	lithic	lithic	JJ
46745	2336	9	deposit	deposit	NN
46745	2336	10	in	in	IN
46745	2336	11	the	the	DT
46745	2336	12	urine	urine	NN
46745	2336	13	;	;	:
46745	2336	14	or	or	CC
46745	2336	15	,	,	,
46745	2336	16	still	still	RB
46745	2336	17	more	more	RBR
46745	2336	18	frequently	frequently	RB
46745	2336	19	,	,	,
46745	2336	20	an	an	DT
46745	2336	21	alkali	alkali	NN
46745	2336	22	may	may	MD
46745	2336	23	produce	produce	VB
46745	2336	24	a	a	DT
46745	2336	25	phosphatic	phosphatic	JJ
46745	2336	26	sediment	sediment	NN
46745	2336	27	.	.	.
46745	2337	1	Their	-PRON-	PRP$
46745	2337	2	administration	administration	NN
46745	2337	3	should	should	MD
46745	2337	4	therefore	therefore	RB
46745	2337	5	be	be	VB
46745	2337	6	conducted	conduct	VBN
46745	2337	7	with	with	IN
46745	2337	8	caution	caution	NN
46745	2337	9	.	.	.
46745	2338	1	There	there	EX
46745	2338	2	are	be	VBP
46745	2338	3	some	some	DT
46745	2338	4	other	other	JJ
46745	2338	5	remedies	remedy	NNS
46745	2338	6	which	which	WDT
46745	2338	7	may	may	MD
46745	2338	8	be	be	VB
46745	2338	9	advantageously	advantageously	RB
46745	2338	10	employed	employ	VBN
46745	2338	11	as	as	IN
46745	2338	12	solvents	solvent	NNS
46745	2338	13	for	for	IN
46745	2338	14	Uric	uric	JJ
46745	2338	15	acid	acid	NN
46745	2338	16	and	and	CC
46745	2338	17	Urates	urate	NNS
46745	2338	18	,	,	,
46745	2338	19	whose	whose	WP$
46745	2338	20	use	use	NN
46745	2338	21	is	be	VBZ
46745	2338	22	not	not	RB
46745	2338	23	attended	attend	VBN
46745	2338	24	with	with	IN
46745	2338	25	this	this	DT
46745	2338	26	danger	danger	NN
46745	2338	27	,	,	,
46745	2338	28	and	and	CC
46745	2338	29	whose	whose	WP$
46745	2338	30	efficacy	efficacy	NN
46745	2338	31	is	be	VBZ
46745	2338	32	a	a	DT
46745	2338	33	proof	proof	NN
46745	2338	34	that	that	IN
46745	2338	35	the	the	DT
46745	2338	36	occurrence	occurrence	NN
46745	2338	37	of	of	IN
46745	2338	38	a	a	DT
46745	2338	39	deposit	deposit	NN
46745	2338	40	in	in	IN
46745	2338	41	the	the	DT
46745	2338	42	urine	urine	NN
46745	2338	43	is	be	VBZ
46745	2338	44	not	not	RB
46745	2338	45	a	a	DT
46745	2338	46	mere	mere	JJ
46745	2338	47	question	question	NN
46745	2338	48	of	of	IN
46745	2338	49	the	the	DT
46745	2338	50	preponderance	preponderance	NN
46745	2338	51	of	of	IN
46745	2338	52	acid	acid	NN
46745	2338	53	or	or	CC
46745	2338	54	of	of	IN
46745	2338	55	alkali	alkali	JJ
46745	2338	56	in	in	IN
46745	2338	57	that	that	DT
46745	2338	58	secretion	secretion	NN
46745	2338	59	.	.	.
46745	2339	1	The	the	DT
46745	2339	2	most	most	RBS
46745	2339	3	important	important	JJ
46745	2339	4	of	of	IN
46745	2339	5	these	these	DT
46745	2339	6	is	be	VBZ
46745	2339	7	the	the	DT
46745	2339	8	common	common	JJ
46745	2339	9	Phosphate	Phosphate	NNP
46745	2339	10	of	of	IN
46745	2339	11	Soda	Soda	NNP
46745	2339	12	,	,	,
46745	2339	13	first	first	RB
46745	2339	14	recommended	recommend	VBN
46745	2339	15	by	by	IN
46745	2339	16	Liebig	Liebig	NNP
46745	2339	17	,	,	,
46745	2339	18	who	who	WP
46745	2339	19	discovered	discover	VBD
46745	2339	20	that	that	IN
46745	2339	21	Uric	Uric	NNP
46745	2339	22	acid	acid	NN
46745	2339	23	was	be	VBD
46745	2339	24	soluble	soluble	JJ
46745	2339	25	in	in	IN
46745	2339	26	a	a	DT
46745	2339	27	solution	solution	NN
46745	2339	28	of	of	IN
46745	2339	29	that	that	DT
46745	2339	30	salt	salt	NN
46745	2339	31	.	.	.
46745	2340	1	If	if	IN
46745	2340	2	forty	forty	CD
46745	2340	3	grains	grain	NNS
46745	2340	4	of	of	IN
46745	2340	5	dry	dry	JJ
46745	2340	6	Phosphate	Phosphate	NNP
46745	2340	7	of	of	IN
46745	2340	8	Soda	Soda	NNP
46745	2340	9	,	,	,
46745	2340	10	seven	seven	CD
46745	2340	11	grains	grain	NNS
46745	2340	12	of	of	IN
46745	2340	13	Uric	Uric	NNP
46745	2340	14	acid	acid	NN
46745	2340	15	,	,	,
46745	2340	16	and	and	CC
46745	2340	17	fifteen	fifteen	CD
46745	2340	18	of	of	IN
46745	2340	19	Hippuric	Hippuric	NNP
46745	2340	20	acid	acid	NN
46745	2340	21	,	,	,
46745	2340	22	be	be	VB
46745	2340	23	dissolved	dissolve	VBN
46745	2340	24	in	in	IN
46745	2340	25	a	a	DT
46745	2340	26	pint	pint	NN
46745	2340	27	of	of	IN
46745	2340	28	hot	hot	JJ
46745	2340	29	water	water	NN
46745	2340	30	,	,	,
46745	2340	31	and	and	CC
46745	2340	32	to	to	IN
46745	2340	33	this	this	DT
46745	2340	34	solution	solution	NN
46745	2340	35	two	two	CD
46745	2340	36	per	per	NN
46745	2340	37	cent	cent	NN
46745	2340	38	.	.	.
46745	2341	1	of	of	IN
46745	2341	2	Urea	Urea	NNP
46745	2341	3	be	be	VB
46745	2341	4	added	add	VBN
46745	2341	5	,	,	,
46745	2341	6	a	a	DT
46745	2341	7	kind	kind	NN
46745	2341	8	of	of	IN
46745	2341	9	artificial	artificial	JJ
46745	2341	10	urine	urine	NN
46745	2341	11	will	will	MD
46745	2341	12	be	be	VB
46745	2341	13	formed	form	VBN
46745	2341	14	.	.	.
46745	2342	1	Biborate	biborate	NN
46745	2342	2	of	of	IN
46745	2342	3	Soda	Soda	NNP
46745	2342	4	,	,	,
46745	2342	5	or	or	CC
46745	2342	6	Borax	Borax	NNP
46745	2342	7	,	,	,
46745	2342	8	has	have	VBZ
46745	2342	9	also	also	RB
46745	2342	10	the	the	DT
46745	2342	11	power	power	NN
46745	2342	12	of	of	IN
46745	2342	13	dissolving	dissolve	VBG
46745	2342	14	Uric	Uric	NNP
46745	2342	15	acid	acid	NN
46745	2342	16	,	,	,
46745	2342	17	and	and	CC
46745	2342	18	has	have	VBZ
46745	2342	19	been	be	VBN
46745	2342	20	recommended	recommend	VBN
46745	2342	21	in	in	IN
46745	2342	22	the	the	DT
46745	2342	23	treatment	treatment	NN
46745	2342	24	of	of	IN
46745	2342	25	lithic	lithic	JJ
46745	2342	26	deposits	deposit	NNS
46745	2342	27	by	by	IN
46745	2342	28	Bouchardat	Bouchardat	NNP
46745	2342	29	and	and	CC
46745	2342	30	Binswanger	Binswanger	NNP
46745	2342	31	.	.	.
46745	2343	1	Mr.	Mr.	NNP
46745	2343	2	A.	A.	NNP
46745	2343	3	Ure	Ure	NNP
46745	2343	4	has	have	VBZ
46745	2343	5	strongly	strongly	RB
46745	2343	6	recommended	recommend	VBN
46745	2343	7	Benzoic	Benzoic	NNP
46745	2343	8	acid	acid	NN
46745	2343	9	in	in	IN
46745	2343	10	these	these	DT
46745	2343	11	cases	case	NNS
46745	2343	12	.	.	.
46745	2344	1	It	-PRON-	PRP
46745	2344	2	passes	pass	VBZ
46745	2344	3	out	out	RP
46745	2344	4	in	in	IN
46745	2344	5	the	the	DT
46745	2344	6	urine	urine	NN
46745	2344	7	as	as	IN
46745	2344	8	Hippuric	Hippuric	NNP
46745	2344	9	acid	acid	NN
46745	2344	10	.	.	.
46745	2345	1	(	(	-LRB-
46745	2345	2	_	_	NNP
46745	2345	3	Vide	Vide	NNP
46745	2345	4	Prop	Prop	NNP
46745	2345	5	.	.	.
46745	2346	1	VI	VI	NNP
46745	2346	2	.	.	.
46745	2346	3	_	_	NNP
46745	2346	4	)	)	-RRB-
46745	2346	5	The	the	DT
46745	2346	6	amount	amount	NN
46745	2346	7	of	of	IN
46745	2346	8	the	the	DT
46745	2346	9	deposit	deposit	NN
46745	2346	10	appears	appear	VBZ
46745	2346	11	to	to	TO
46745	2346	12	decrease	decrease	VB
46745	2346	13	under	under	IN
46745	2346	14	the	the	DT
46745	2346	15	use	use	NN
46745	2346	16	of	of	IN
46745	2346	17	this	this	DT
46745	2346	18	remedy	remedy	NN
46745	2346	19	,	,	,
46745	2346	20	but	but	CC
46745	2346	21	whether	whether	IN
46745	2346	22	the	the	DT
46745	2346	23	formation	formation	NN
46745	2346	24	of	of	IN
46745	2346	25	the	the	DT
46745	2346	26	Uric	Uric	NNP
46745	2346	27	acid	acid	NN
46745	2346	28	in	in	IN
46745	2346	29	the	the	DT
46745	2346	30	blood	blood	NN
46745	2346	31	is	be	VBZ
46745	2346	32	prevented	prevent	VBN
46745	2346	33	,	,	,
46745	2346	34	as	as	IN
46745	2346	35	supposed	suppose	VBN
46745	2346	36	by	by	IN
46745	2346	37	Mr.	Mr.	NNP
46745	2346	38	Ure	Ure	NNP
46745	2346	39	,	,	,
46745	2346	40	or	or	CC
46745	2346	41	whether	whether	IN
46745	2346	42	it	-PRON-	PRP
46745	2346	43	is	be	VBZ
46745	2346	44	not	not	RB
46745	2346	45	simply	simply	RB
46745	2346	46	held	hold	VBN
46745	2346	47	in	in	IN
46745	2346	48	solution	solution	NN
46745	2346	49	by	by	IN
46745	2346	50	means	mean	NNS
46745	2346	51	of	of	IN
46745	2346	52	the	the	DT
46745	2346	53	Hippuric	Hippuric	NNP
46745	2346	54	acid	acid	NN
46745	2346	55	,	,	,
46745	2346	56	is	be	VBZ
46745	2346	57	not	not	RB
46745	2346	58	clear	clear	JJ
46745	2346	59	.	.	.
46745	2347	1	Dr.	Dr.	NNP
46745	2347	2	Golding	Golding	NNP
46745	2347	3	Bird	Bird	NNP
46745	2347	4	recommends	recommend	VBZ
46745	2347	5	also	also	RB
46745	2347	6	Cinnamic	Cinnamic	NNP
46745	2347	7	acid	acid	NN
46745	2347	8	,	,	,
46745	2347	9	which	which	WDT
46745	2347	10	is	be	VBZ
46745	2347	11	contained	contain	VBN
46745	2347	12	in	in	IN
46745	2347	13	Cinnamon	Cinnamon	NNP
46745	2347	14	water	water	NN
46745	2347	15	,	,	,
46745	2347	16	and	and	CC
46745	2347	17	in	in	IN
46745	2347	18	the	the	DT
46745	2347	19	balsams	balsam	NNS
46745	2347	20	of	of	IN
46745	2347	21	Peru	Peru	NNP
46745	2347	22	and	and	CC
46745	2347	23	Tolu	Tolu	NNP
46745	2347	24	.	.	.
46745	2348	1	It	-PRON-	PRP
46745	2348	2	resembles	resemble	VBZ
46745	2348	3	Benzoic	Benzoic	NNP
46745	2348	4	,	,	,
46745	2348	5	and	and	CC
46745	2348	6	undergoes	undergo	VBZ
46745	2348	7	the	the	DT
46745	2348	8	same	same	JJ
46745	2348	9	change	change	NN
46745	2348	10	into	into	IN
46745	2348	11	Hippuric	Hippuric	NNP
46745	2348	12	acid	acid	NN
46745	2348	13	.	.	.
46745	2349	1	The	the	DT
46745	2349	2	salts	salt	NNS
46745	2349	3	of	of	IN
46745	2349	4	these	these	DT
46745	2349	5	acids	acid	NNS
46745	2349	6	possess	possess	VBP
46745	2349	7	a	a	DT
46745	2349	8	similar	similar	JJ
46745	2349	9	power	power	NN
46745	2349	10	.	.	.
46745	2350	1	Diuretics	diuretic	NNS
46745	2350	2	in	in	IN
46745	2350	3	general	general	JJ
46745	2350	4	are	be	VBP
46745	2350	5	useful	useful	JJ
46745	2350	6	in	in	IN
46745	2350	7	all	all	DT
46745	2350	8	cases	case	NNS
46745	2350	9	of	of	IN
46745	2350	10	urinary	urinary	JJ
46745	2350	11	deposit	deposit	NN
46745	2350	12	,	,	,
46745	2350	13	for	for	IN
46745	2350	14	they	-PRON-	PRP
46745	2350	15	increase	increase	VBP
46745	2350	16	the	the	DT
46745	2350	17	quantity	quantity	NN
46745	2350	18	of	of	IN
46745	2350	19	the	the	DT
46745	2350	20	fluid	fluid	JJ
46745	2350	21	part	part	NN
46745	2350	22	of	of	IN
46745	2350	23	the	the	DT
46745	2350	24	urine	urine	NN
46745	2350	25	.	.	.
46745	2351	1	It	-PRON-	PRP
46745	2351	2	is	be	VBZ
46745	2351	3	observed	observe	VBN
46745	2351	4	by	by	IN
46745	2351	5	Dr.	Dr.	NNP
46745	2351	6	Prout	Prout	NNP
46745	2351	7	that	that	DT
46745	2351	8	healthy	healthy	JJ
46745	2351	9	urine	urine	NN
46745	2351	10	is	be	VBZ
46745	2351	11	the	the	DT
46745	2351	12	best	good	JJS
46745	2351	13	solvent	solvent	NN
46745	2351	14	that	that	IN
46745	2351	15	we	-PRON-	PRP
46745	2351	16	are	be	VBP
46745	2351	17	able	able	JJ
46745	2351	18	to	to	TO
46745	2351	19	supply	supply	VB
46745	2351	20	.	.	.
46745	2352	1	When	when	WRB
46745	2352	2	solvent	solvent	NN
46745	2352	3	remedies	remedy	NNS
46745	2352	4	are	be	VBP
46745	2352	5	employed	employ	VBN
46745	2352	6	for	for	IN
46745	2352	7	the	the	DT
46745	2352	8	purposes	purpose	NNS
46745	2352	9	above	above	IN
46745	2352	10	mentioned	mention	VBD
46745	2352	11	,	,	,
46745	2352	12	they	-PRON-	PRP
46745	2352	13	not	not	RB
46745	2352	14	unfrequently	unfrequently	RB
46745	2352	15	fail	fail	VBP
46745	2352	16	altogether	altogether	RB
46745	2352	17	;	;	:
46745	2352	18	and	and	CC
46745	2352	19	,	,	,
46745	2352	20	as	as	IN
46745	2352	21	has	have	VBZ
46745	2352	22	been	be	VBN
46745	2352	23	already	already	RB
46745	2352	24	observed	observe	VBN
46745	2352	25	,	,	,
46745	2352	26	they	-PRON-	PRP
46745	2352	27	require	require	VBP
46745	2352	28	,	,	,
46745	2352	29	even	even	RB
46745	2352	30	when	when	WRB
46745	2352	31	successful	successful	JJ
46745	2352	32	,	,	,
46745	2352	33	to	to	TO
46745	2352	34	be	be	VB
46745	2352	35	perpetually	perpetually	RB
46745	2352	36	administered	administer	VBN
46745	2352	37	,	,	,
46745	2352	38	or	or	CC
46745	2352	39	else	else	RB
46745	2352	40	the	the	DT
46745	2352	41	deposit	deposit	NN
46745	2352	42	will	will	MD
46745	2352	43	recur	recur	VB
46745	2352	44	.	.	.
46745	2353	1	For	for	IN
46745	2353	2	the	the	DT
46745	2353	3	solvent	solvent	NN
46745	2353	4	passes	pass	VBZ
46745	2353	5	out	out	RP
46745	2353	6	along	along	IN
46745	2353	7	with	with	IN
46745	2353	8	each	each	DT
46745	2353	9	successive	successive	JJ
46745	2353	10	quantity	quantity	NN
46745	2353	11	of	of	IN
46745	2353	12	the	the	DT
46745	2353	13	Lithic	lithic	JJ
46745	2353	14	or	or	CC
46745	2353	15	Phosphatic	phosphatic	JJ
46745	2353	16	matter	matter	NN
46745	2353	17	that	that	WDT
46745	2353	18	is	be	VBZ
46745	2353	19	formed	form	VBN
46745	2353	20	and	and	CC
46745	2353	21	excreted	excrete	VBN
46745	2353	22	.	.	.
46745	2354	1	A	a	DT
46745	2354	2	radical	radical	JJ
46745	2354	3	cure	cure	NN
46745	2354	4	of	of	IN
46745	2354	5	such	such	JJ
46745	2354	6	deposits	deposit	NNS
46745	2354	7	can	can	MD
46745	2354	8	only	only	RB
46745	2354	9	be	be	VB
46745	2354	10	effected	effect	VBN
46745	2354	11	by	by	IN
46745	2354	12	a	a	DT
46745	2354	13	medicine	medicine	NN
46745	2354	14	that	that	WDT
46745	2354	15	shall	shall	MD
46745	2354	16	counteract	counteract	VB
46745	2354	17	the	the	DT
46745	2354	18	morbid	morbid	NN
46745	2354	19	process	process	NN
46745	2354	20	by	by	IN
46745	2354	21	which	which	WDT
46745	2354	22	they	-PRON-	PRP
46745	2354	23	are	be	VBP
46745	2354	24	continually	continually	RB
46745	2354	25	produced	produce	VBN
46745	2354	26	.	.	.
46745	2355	1	This	this	DT
46745	2355	2	can	can	MD
46745	2355	3	not	not	RB
46745	2355	4	be	be	VB
46745	2355	5	done	do	VBN
46745	2355	6	by	by	IN
46745	2355	7	a	a	DT
46745	2355	8	Restorative	Restorative	NNP
46745	2355	9	,	,	,
46745	2355	10	but	but	CC
46745	2355	11	requires	require	VBZ
46745	2355	12	a	a	DT
46745	2355	13	Catalytic	catalytic	JJ
46745	2355	14	medicine	medicine	NN
46745	2355	15	.	.	.
46745	2356	1	Such	such	JJ
46745	2356	2	remedies	remedy	NNS
46745	2356	3	we	-PRON-	PRP
46745	2356	4	must	must	MD
46745	2356	5	presently	presently	RB
46745	2356	6	consider	consider	VB
46745	2356	7	.	.	.
46745	2357	1	(	(	-LRB-
46745	2357	2	_	_	NNP
46745	2357	3	Vide	Vide	NNP
46745	2357	4	Antiarthritics	Antiarthritics	NNP
46745	2357	5	.	.	.
46745	2357	6	_	_	NNP
46745	2357	7	)	)	-RRB-
46745	2357	8	Thus	thus	RB
46745	2357	9	are	be	VBP
46745	2357	10	concluded	conclude	VBN
46745	2357	11	the	the	DT
46745	2357	12	six	six	CD
46745	2357	13	orders	order	NNS
46745	2357	14	of	of	IN
46745	2357	15	restorative	restorative	JJ
46745	2357	16	medicines	medicine	NNS
46745	2357	17	;	;	:
46745	2357	18	all	all	DT
46745	2357	19	of	of	IN
46745	2357	20	which	which	WDT
46745	2357	21	are	be	VBP
46745	2357	22	seen	see	VBN
46745	2357	23	to	to	TO
46745	2357	24	agree	agree	VB
46745	2357	25	together	together	RB
46745	2357	26	in	in	IN
46745	2357	27	some	some	DT
46745	2357	28	common	common	JJ
46745	2357	29	characters	character	NNS
46745	2357	30	.	.	.
46745	2358	1	When	when	WRB
46745	2358	2	a	a	DT
46745	2358	3	disease	disease	NN
46745	2358	4	depends	depend	VBZ
46745	2358	5	on	on	IN
46745	2358	6	a	a	DT
46745	2358	7	want	want	NN
46745	2358	8	of	of	IN
46745	2358	9	some	some	DT
46745	2358	10	material	material	NN
46745	2358	11	in	in	IN
46745	2358	12	the	the	DT
46745	2358	13	system	system	NN
46745	2358	14	,	,	,
46745	2358	15	then	then	RB
46745	2358	16	it	-PRON-	PRP
46745	2358	17	admits	admit	VBZ
46745	2358	18	of	of	IN
46745	2358	19	being	be	VBG
46745	2358	20	cured	cure	VBN
46745	2358	21	by	by	IN
46745	2358	22	a	a	DT
46745	2358	23	restorative	restorative	NN
46745	2358	24	,	,	,
46745	2358	25	which	which	WDT
46745	2358	26	,	,	,
46745	2358	27	in	in	IN
46745	2358	28	the	the	DT
46745	2358	29	theory	theory	NN
46745	2358	30	of	of	IN
46745	2358	31	its	-PRON-	PRP$
46745	2358	32	action	action	NN
46745	2358	33	,	,	,
46745	2358	34	is	be	VBZ
46745	2358	35	the	the	DT
46745	2358	36	simplest	simple	JJS
46745	2358	37	of	of	IN
46745	2358	38	all	all	DT
46745	2358	39	known	know	VBN
46745	2358	40	medicines	medicine	NNS
46745	2358	41	.	.	.
46745	2359	1	And	and	CC
46745	2359	2	when	when	WRB
46745	2359	3	a	a	DT
46745	2359	4	morbid	morbid	NN
46745	2359	5	process	process	NN
46745	2359	6	results	result	VBZ
46745	2359	7	in	in	IN
46745	2359	8	a	a	DT
46745	2359	9	diminution	diminution	NN
46745	2359	10	of	of	IN
46745	2359	11	the	the	DT
46745	2359	12	amount	amount	NN
46745	2359	13	in	in	IN
46745	2359	14	the	the	DT
46745	2359	15	blood	blood	NN
46745	2359	16	of	of	IN
46745	2359	17	some	some	DT
46745	2359	18	necessary	necessary	JJ
46745	2359	19	constituent	constituent	NN
46745	2359	20	,	,	,
46745	2359	21	then	then	RB
46745	2359	22	also	also	RB
46745	2359	23	may	may	MD
46745	2359	24	a	a	DT
46745	2359	25	Restorative	Restorative	NNP
46745	2359	26	be	be	VB
46745	2359	27	of	of	IN
46745	2359	28	use	use	NN
46745	2359	29	in	in	IN
46745	2359	30	alleviating	alleviate	VBG
46745	2359	31	the	the	DT
46745	2359	32	consequences	consequence	NNS
46745	2359	33	of	of	IN
46745	2359	34	such	such	PDT
46745	2359	35	a	a	DT
46745	2359	36	disorder	disorder	NN
46745	2359	37	;	;	:
46745	2359	38	or	or	CC
46745	2359	39	may	may	MD
46745	2359	40	even	even	RB
46745	2359	41	effect	effect	VB
46745	2359	42	a	a	DT
46745	2359	43	cure	cure	NN
46745	2359	44	,	,	,
46745	2359	45	when	when	WRB
46745	2359	46	the	the	DT
46745	2359	47	morbid	morbid	NN
46745	2359	48	process	process	NN
46745	2359	49	has	have	VBZ
46745	2359	50	ceased	cease	VBN
46745	2359	51	,	,	,
46745	2359	52	and	and	CC
46745	2359	53	left	leave	VBD
46745	2359	54	only	only	RB
46745	2359	55	its	-PRON-	PRP$
46745	2359	56	results	result	NNS
46745	2359	57	behind	behind	IN
46745	2359	58	it	-PRON-	PRP
46745	2359	59	.	.	.
46745	2360	1	But	but	CC
46745	2360	2	when	when	WRB
46745	2360	3	the	the	DT
46745	2360	4	_	_	NNP
46745	2360	5	materies	materie	NNS
46745	2360	6	morbi	morbi	VBP
46745	2360	7	_	_	NNP
46745	2360	8	is	be	VBZ
46745	2360	9	still	still	RB
46745	2360	10	working	work	VBG
46745	2360	11	in	in	IN
46745	2360	12	the	the	DT
46745	2360	13	blood	blood	NN
46745	2360	14	,	,	,
46745	2360	15	a	a	DT
46745	2360	16	radical	radical	JJ
46745	2360	17	cure	cure	NN
46745	2360	18	can	can	MD
46745	2360	19	only	only	RB
46745	2360	20	be	be	VB
46745	2360	21	effected	effect	VBN
46745	2360	22	by	by	IN
46745	2360	23	a	a	DT
46745	2360	24	Catalytic	catalytic	JJ
46745	2360	25	medicine	medicine	NN
46745	2360	26	,	,	,
46745	2360	27	which	which	WDT
46745	2360	28	shall	shall	MD
46745	2360	29	be	be	VB
46745	2360	30	capable	capable	JJ
46745	2360	31	of	of	IN
46745	2360	32	meeting	meet	VBG
46745	2360	33	it	-PRON-	PRP
46745	2360	34	there	there	RB
46745	2360	35	,	,	,
46745	2360	36	and	and	CC
46745	2360	37	of	of	IN
46745	2360	38	counteracting	counteract	VBG
46745	2360	39	its	-PRON-	PRP$
46745	2360	40	noxious	noxious	JJ
46745	2360	41	influence	influence	NN
46745	2360	42	.	.	.
46745	2361	1	Some	some	DT
46745	2361	2	Restoratives	restorative	NNS
46745	2361	3	are	be	VBP
46745	2361	4	also	also	RB
46745	2361	5	included	include	VBN
46745	2361	6	among	among	IN
46745	2361	7	Catalytics	Catalytics	NNP
46745	2361	8	,	,	,
46745	2361	9	from	from	IN
46745	2361	10	a	a	DT
46745	2361	11	regard	regard	NN
46745	2361	12	to	to	IN
46745	2361	13	a	a	DT
46745	2361	14	different	different	JJ
46745	2361	15	phase	phase	NN
46745	2361	16	of	of	IN
46745	2361	17	their	-PRON-	PRP$
46745	2361	18	action	action	NN
46745	2361	19	.	.	.
46745	2362	1	The	the	DT
46745	2362	2	most	most	RBS
46745	2362	3	important	important	JJ
46745	2362	4	of	of	IN
46745	2362	5	these	these	DT
46745	2362	6	are	be	VBP
46745	2362	7	Alkalies	Alkalies	NNPS
46745	2362	8	,	,	,
46745	2362	9	which	which	WDT
46745	2362	10	are	be	VBP
46745	2362	11	of	of	IN
46745	2362	12	use	use	NN
46745	2362	13	in	in	IN
46745	2362	14	general	general	JJ
46745	2362	15	inflammation	inflammation	NN
46745	2362	16	,	,	,
46745	2362	17	and	and	CC
46745	2362	18	also	also	RB
46745	2362	19	in	in	IN
46745	2362	20	Scrofulous	scrofulous	JJ
46745	2362	21	and	and	CC
46745	2362	22	Scorbutic	scorbutic	JJ
46745	2362	23	diseases	disease	NNS
46745	2362	24	,	,	,
46745	2362	25	acting	act	VBG
46745	2362	26	in	in	IN
46745	2362	27	a	a	DT
46745	2362	28	way	way	NN
46745	2362	29	that	that	WDT
46745	2362	30	is	be	VBZ
46745	2362	31	at	at	IN
46745	2362	32	present	present	JJ
46745	2362	33	but	but	CC
46745	2362	34	obscurely	obscurely	RB
46745	2362	35	explained	explain	VBD
46745	2362	36	.	.	.
46745	2363	1	When	when	WRB
46745	2363	2	the	the	DT
46745	2363	3	_	_	NNP
46745	2363	4	modus	modus	NN
46745	2363	5	operandi	operandi	NNP
46745	2363	6	_	_	NNP
46745	2363	7	of	of	IN
46745	2363	8	a	a	DT
46745	2363	9	medicine	medicine	NN
46745	2363	10	is	be	VBZ
46745	2363	11	obscure	obscure	JJ
46745	2363	12	,	,	,
46745	2363	13	but	but	CC
46745	2363	14	when	when	WRB
46745	2363	15	it	-PRON-	PRP
46745	2363	16	is	be	VBZ
46745	2363	17	apparent	apparent	JJ
46745	2363	18	that	that	IN
46745	2363	19	it	-PRON-	PRP
46745	2363	20	has	have	VBZ
46745	2363	21	the	the	DT
46745	2363	22	power	power	NN
46745	2363	23	of	of	IN
46745	2363	24	counteracting	counteract	VBG
46745	2363	25	a	a	DT
46745	2363	26	disease	disease	NN
46745	2363	27	,	,	,
46745	2363	28	I	-PRON-	PRP
46745	2363	29	have	have	VBP
46745	2363	30	preferred	prefer	VBN
46745	2363	31	to	to	TO
46745	2363	32	place	place	VB
46745	2363	33	it	-PRON-	PRP
46745	2363	34	among	among	IN
46745	2363	35	Catalytics	Catalytics	NNP
46745	2363	36	,	,	,
46745	2363	37	rather	rather	RB
46745	2363	38	than	than	IN
46745	2363	39	to	to	TO
46745	2363	40	include	include	VB
46745	2363	41	it	-PRON-	PRP
46745	2363	42	with	with	IN
46745	2363	43	Restorative	restorative	JJ
46745	2363	44	medicines	medicine	NNS
46745	2363	45	.	.	.
46745	2364	1	But	but	CC
46745	2364	2	there	there	EX
46745	2364	3	are	be	VBP
46745	2364	4	not	not	RB
46745	2364	5	many	many	JJ
46745	2364	6	cases	case	NNS
46745	2364	7	in	in	IN
46745	2364	8	which	which	WDT
46745	2364	9	we	-PRON-	PRP
46745	2364	10	are	be	VBP
46745	2364	11	thus	thus	RB
46745	2364	12	left	leave	VBN
46745	2364	13	in	in	IN
46745	2364	14	doubt	doubt	NN
46745	2364	15	.	.	.
46745	2365	1	The	the	DT
46745	2365	2	diseases	disease	NNS
46745	2365	3	curable	curable	JJ
46745	2365	4	by	by	IN
46745	2365	5	Catalytics	catalytic	NNS
46745	2365	6	are	be	VBP
46745	2365	7	all	all	DT
46745	2365	8	evidently	evidently	RB
46745	2365	9	produced	produce	VBN
46745	2365	10	by	by	IN
46745	2365	11	an	an	DT
46745	2365	12	active	active	JJ
46745	2365	13	morbid	morbid	NN
46745	2365	14	agency	agency	NN
46745	2365	15	.	.	.
46745	2366	1	Those	those	DT
46745	2366	2	which	which	WDT
46745	2366	3	are	be	VBP
46745	2366	4	treated	treat	VBN
46745	2366	5	by	by	IN
46745	2366	6	Restoratives	restorative	NNS
46745	2366	7	are	be	VBP
46745	2366	8	just	just	RB
46745	2366	9	as	as	RB
46745	2366	10	evidently	evidently	RB
46745	2366	11	remediable	remediable	JJ
46745	2366	12	by	by	IN
46745	2366	13	the	the	DT
46745	2366	14	artificial	artificial	JJ
46745	2366	15	supply	supply	NN
46745	2366	16	or	or	CC
46745	2366	17	substitution	substitution	NN
46745	2366	18	of	of	IN
46745	2366	19	some	some	DT
46745	2366	20	one	one	CD
46745	2366	21	or	or	CC
46745	2366	22	more	more	JJR
46745	2366	23	of	of	IN
46745	2366	24	the	the	DT
46745	2366	25	elements	element	NNS
46745	2366	26	of	of	IN
46745	2366	27	the	the	DT
46745	2366	28	blood	blood	NN
46745	2366	29	.	.	.
46745	2367	1	CATALYTICS	CATALYTICS	NNP
46745	2367	2	.	.	.
46745	2368	1	These	these	DT
46745	2368	2	constitute	constitute	VBP
46745	2368	3	the	the	DT
46745	2368	4	second	second	JJ
46745	2368	5	division	division	NN
46745	2368	6	of	of	IN
46745	2368	7	Hæmatic	hæmatic	JJ
46745	2368	8	medicines	medicine	NNS
46745	2368	9	.	.	.
46745	2369	1	The	the	DT
46745	2369	2	above	above	JJ
46745	2369	3	name	name	NN
46745	2369	4	is	be	VBZ
46745	2369	5	applied	apply	VBN
46745	2369	6	to	to	IN
46745	2369	7	them	-PRON-	PRP
46745	2369	8	on	on	IN
46745	2369	9	the	the	DT
46745	2369	10	assumption	assumption	NN
46745	2369	11	that	that	IN
46745	2369	12	their	-PRON-	PRP$
46745	2369	13	operation	operation	NN
46745	2369	14	in	in	IN
46745	2369	15	the	the	DT
46745	2369	16	blood	blood	NN
46745	2369	17	results	result	NNS
46745	2369	18	in	in	IN
46745	2369	19	the	the	DT
46745	2369	20	destruction	destruction	NN
46745	2369	21	or	or	CC
46745	2369	22	counteraction	counteraction	NN
46745	2369	23	of	of	IN
46745	2369	24	certain	certain	JJ
46745	2369	25	morbid	morbid	NN
46745	2369	26	agencies	agency	NNS
46745	2369	27	.	.	.
46745	2370	1	(	(	-LRB-
46745	2370	2	[	[	-LRB-
46745	2370	3	Greek	Greek	NNP
46745	2370	4	:	:	:
46745	2370	5	kataluô	kataluô	NNP
46745	2370	6	]	]	-RRB-
46745	2370	7	.	.	.
46745	2370	8	)	)	-RRB-
46745	2371	1	The	the	DT
46745	2371	2	differences	difference	NNS
46745	2371	3	in	in	IN
46745	2371	4	action	action	NN
46745	2371	5	between	between	IN
46745	2371	6	this	this	DT
46745	2371	7	and	and	CC
46745	2371	8	the	the	DT
46745	2371	9	preceding	precede	VBG
46745	2371	10	division	division	NN
46745	2371	11	of	of	IN
46745	2371	12	blood	blood	NN
46745	2371	13	-	-	HYPH
46745	2371	14	medicines	medicine	NNS
46745	2371	15	have	have	VBP
46745	2371	16	been	be	VBN
46745	2371	17	stated	state	VBN
46745	2371	18	at	at	IN
46745	2371	19	length	length	NN
46745	2371	20	in	in	IN
46745	2371	21	the	the	DT
46745	2371	22	remarks	remark	NNS
46745	2371	23	on	on	IN
46745	2371	24	Hæmatics	Hæmatics	NNPS
46745	2371	25	in	in	IN
46745	2371	26	general	general	JJ
46745	2371	27	.	.	.
46745	2372	1	On	on	IN
46745	2372	2	recurring	recur	VBG
46745	2372	3	to	to	IN
46745	2372	4	Prop	Prop	NNP
46745	2372	5	.	.	.
46745	2373	1	VII	VII	NNP
46745	2373	2	.	.	NNP
46745	2373	3	,	,	,
46745	2373	4	it	-PRON-	PRP
46745	2373	5	will	will	MD
46745	2373	6	be	be	VB
46745	2373	7	seen	see	VBN
46745	2373	8	that	that	IN
46745	2373	9	it	-PRON-	PRP
46745	2373	10	is	be	VBZ
46745	2373	11	there	there	EX
46745	2373	12	stated--	stated--	NN
46745	2373	13	"	"	''
46745	2373	14	That	that	IN
46745	2373	15	others	other	NNS
46745	2373	16	,	,	,
46745	2373	17	(	(	-LRB-
46745	2373	18	medicines	medicine	NNS
46745	2373	19	of	of	IN
46745	2373	20	the	the	DT
46745	2373	21	first	first	JJ
46745	2373	22	class	class	NN
46745	2373	23	,	,	,
46745	2373	24	)	)	-RRB-
46745	2373	25	called	call	VBD
46745	2373	26	Catalytics	Catalytics	NNP
46745	2373	27	,	,	,
46745	2373	28	act	act	VBP
46745	2373	29	so	so	IN
46745	2373	30	as	as	IN
46745	2373	31	to	to	TO
46745	2373	32	counteract	counteract	VB
46745	2373	33	a	a	DT
46745	2373	34	morbid	morbid	NN
46745	2373	35	material	material	NN
46745	2373	36	or	or	CC
46745	2373	37	process	process	NN
46745	2373	38	,	,	,
46745	2373	39	and	and	CC
46745	2373	40	must	must	MD
46745	2373	41	pass	pass	VB
46745	2373	42	out	out	IN
46745	2373	43	of	of	IN
46745	2373	44	the	the	DT
46745	2373	45	body	body	NN
46745	2373	46	.	.	.
46745	2373	47	"	"	''
46745	2374	1	The	the	DT
46745	2374	2	action	action	NN
46745	2374	3	of	of	IN
46745	2374	4	the	the	DT
46745	2374	5	remedies	remedy	NNS
46745	2374	6	in	in	IN
46745	2374	7	this	this	DT
46745	2374	8	division	division	NN
46745	2374	9	,	,	,
46745	2374	10	which	which	WDT
46745	2374	11	are	be	VBP
46745	2374	12	the	the	DT
46745	2374	13	surest	sure	JJS
46745	2374	14	and	and	CC
46745	2374	15	most	most	RBS
46745	2374	16	potent	potent	JJ
46745	2374	17	of	of	IN
46745	2374	18	all	all	PDT
46745	2374	19	those	those	DT
46745	2374	20	that	that	WDT
46745	2374	21	are	be	VBP
46745	2374	22	employed	employ	VBN
46745	2374	23	in	in	IN
46745	2374	24	the	the	DT
46745	2374	25	treatment	treatment	NN
46745	2374	26	of	of	IN
46745	2374	27	disease	disease	NN
46745	2374	28	,	,	,
46745	2374	29	is	be	VBZ
46745	2374	30	involved	involve	VBN
46745	2374	31	in	in	IN
46745	2374	32	a	a	DT
46745	2374	33	greater	great	JJR
46745	2374	34	degree	degree	NN
46745	2374	35	of	of	IN
46745	2374	36	doubt	doubt	NN
46745	2374	37	and	and	CC
46745	2374	38	obscurity	obscurity	NN
46745	2374	39	than	than	IN
46745	2374	40	that	that	DT
46745	2374	41	of	of	IN
46745	2374	42	any	any	DT
46745	2374	43	other	other	JJ
46745	2374	44	class	class	NN
46745	2374	45	.	.	.
46745	2375	1	Though	though	IN
46745	2375	2	there	there	EX
46745	2375	3	may	may	MD
46745	2375	4	be	be	VB
46745	2375	5	in	in	IN
46745	2375	6	some	some	DT
46745	2375	7	cases	case	NNS
46745	2375	8	a	a	DT
46745	2375	9	certain	certain	JJ
46745	2375	10	dim	dim	JJ
46745	2375	11	explanation	explanation	NN
46745	2375	12	which	which	WDT
46745	2375	13	we	-PRON-	PRP
46745	2375	14	may	may	MD
46745	2375	15	catch	catch	VB
46745	2375	16	hold	hold	NN
46745	2375	17	of	of	IN
46745	2375	18	,	,	,
46745	2375	19	and	and	CC
46745	2375	20	strive	strive	VB
46745	2375	21	to	to	TO
46745	2375	22	fix	fix	VB
46745	2375	23	or	or	CC
46745	2375	24	to	to	TO
46745	2375	25	render	render	VB
46745	2375	26	definite	definite	JJ
46745	2375	27	,	,	,
46745	2375	28	yet	yet	CC
46745	2375	29	in	in	IN
46745	2375	30	many	many	JJ
46745	2375	31	instances	instance	NNS
46745	2375	32	there	there	EX
46745	2375	33	is	be	VBZ
46745	2375	34	not	not	RB
46745	2375	35	even	even	RB
46745	2375	36	so	so	RB
46745	2375	37	much	much	RB
46745	2375	38	as	as	IN
46745	2375	39	this	this	DT
46745	2375	40	.	.	.
46745	2376	1	How	how	WRB
46745	2376	2	can	can	MD
46745	2376	3	we	-PRON-	PRP
46745	2376	4	,	,	,
46745	2376	5	for	for	IN
46745	2376	6	example	example	NN
46745	2376	7	,	,	,
46745	2376	8	by	by	IN
46745	2376	9	any	any	DT
46745	2376	10	of	of	IN
46745	2376	11	the	the	DT
46745	2376	12	common	common	JJ
46745	2376	13	terms	term	NNS
46745	2376	14	which	which	WDT
46745	2376	15	are	be	VBP
46745	2376	16	made	make	VBN
46745	2376	17	use	use	NN
46745	2376	18	of	of	IN
46745	2376	19	to	to	TO
46745	2376	20	designate	designate	VB
46745	2376	21	the	the	DT
46745	2376	22	actions	action	NNS
46745	2376	23	of	of	IN
46745	2376	24	Mercury	Mercury	NNP
46745	2376	25	,	,	,
46745	2376	26	of	of	IN
46745	2376	27	Arsenic	Arsenic	NNP
46745	2376	28	,	,	,
46745	2376	29	and	and	CC
46745	2376	30	of	of	IN
46745	2376	31	Iodine	Iodine	NNP
46745	2376	32	,	,	,
46745	2376	33	express	express	VB
46745	2376	34	the	the	DT
46745	2376	35	peculiarity	peculiarity	NN
46745	2376	36	of	of	IN
46745	2376	37	their	-PRON-	PRP$
46745	2376	38	influence	influence	NN
46745	2376	39	over	over	IN
46745	2376	40	Syphilis	Syphilis	NNP
46745	2376	41	,	,	,
46745	2376	42	Lepra	Lepra	NNP
46745	2376	43	,	,	,
46745	2376	44	and	and	CC
46745	2376	45	Scrofula	Scrofula	NNP
46745	2376	46	,	,	,
46745	2376	47	respectively	respectively	RB
46745	2376	48	?	?	.
46745	2377	1	Does	do	VBZ
46745	2377	2	it	-PRON-	PRP
46745	2377	3	not	not	RB
46745	2377	4	seem	seem	VB
46745	2377	5	better	well	JJR
46745	2377	6	to	to	TO
46745	2377	7	confess	confess	VB
46745	2377	8	our	-PRON-	PRP$
46745	2377	9	ignorance	ignorance	NN
46745	2377	10	,	,	,
46745	2377	11	and	and	CC
46745	2377	12	to	to	TO
46745	2377	13	say	say	VB
46745	2377	14	that	that	IN
46745	2377	15	all	all	DT
46745	2377	16	we	-PRON-	PRP
46745	2377	17	know	know	VBP
46745	2377	18	for	for	IN
46745	2377	19	certain	certain	JJ
46745	2377	20	is	be	VBZ
46745	2377	21	that	that	IN
46745	2377	22	these	these	DT
46745	2377	23	remedies	remedy	NNS
46745	2377	24	have	have	VBP
46745	2377	25	the	the	DT
46745	2377	26	power	power	NN
46745	2377	27	of	of	IN
46745	2377	28	antagonizing	antagonize	VBG
46745	2377	29	certain	certain	JJ
46745	2377	30	diseases	disease	NNS
46745	2377	31	?	?	.
46745	2378	1	Having	have	VBG
46745	2378	2	done	do	VBN
46745	2378	3	this	this	DT
46745	2378	4	,	,	,
46745	2378	5	we	-PRON-	PRP
46745	2378	6	may	may	MD
46745	2378	7	afterwards	afterwards	RB
46745	2378	8	try	try	VB
46745	2378	9	,	,	,
46745	2378	10	if	if	IN
46745	2378	11	we	-PRON-	PRP
46745	2378	12	can	can	MD
46745	2378	13	,	,	,
46745	2378	14	to	to	TO
46745	2378	15	invent	invent	VB
46745	2378	16	for	for	IN
46745	2378	17	this	this	DT
46745	2378	18	action	action	NN
46745	2378	19	a	a	DT
46745	2378	20	theoretical	theoretical	JJ
46745	2378	21	explanation	explanation	NN
46745	2378	22	.	.	.
46745	2379	1	Our	-PRON-	PRP$
46745	2379	2	arguments	argument	NNS
46745	2379	3	and	and	CC
46745	2379	4	theories	theory	NNS
46745	2379	5	will	will	MD
46745	2379	6	not	not	RB
46745	2379	7	affect	affect	VB
46745	2379	8	the	the	DT
46745	2379	9	fact	fact	NN
46745	2379	10	,	,	,
46745	2379	11	nor	nor	CC
46745	2379	12	will	will	MD
46745	2379	13	they	-PRON-	PRP
46745	2379	14	lead	lead	VB
46745	2379	15	us	-PRON-	PRP
46745	2379	16	into	into	IN
46745	2379	17	danger	danger	NN
46745	2379	18	,	,	,
46745	2379	19	if	if	IN
46745	2379	20	we	-PRON-	PRP
46745	2379	21	have	have	VBP
46745	2379	22	first	first	RB
46745	2379	23	laid	lay	VBN
46745	2379	24	down	down	RP
46745	2379	25	the	the	DT
46745	2379	26	truth	truth	NN
46745	2379	27	,	,	,
46745	2379	28	however	however	RB
46745	2379	29	incomprehensible	incomprehensible	JJ
46745	2379	30	,	,	,
46745	2379	31	as	as	IN
46745	2379	32	the	the	DT
46745	2379	33	only	only	JJ
46745	2379	34	secure	secure	JJ
46745	2379	35	foundation	foundation	NN
46745	2379	36	,	,	,
46745	2379	37	in	in	IN
46745	2379	38	such	such	PDT
46745	2379	39	a	a	DT
46745	2379	40	manner	manner	NN
46745	2379	41	that	that	IN
46745	2379	42	it	-PRON-	PRP
46745	2379	43	shall	shall	MD
46745	2379	44	be	be	VB
46745	2379	45	incapable	incapable	JJ
46745	2379	46	of	of	IN
46745	2379	47	being	be	VBG
46745	2379	48	disturbed	disturb	VBN
46745	2379	49	by	by	IN
46745	2379	50	the	the	DT
46745	2379	51	flimsy	flimsy	JJ
46745	2379	52	superstructure	superstructure	NN
46745	2379	53	.	.	.
46745	2380	1	Some	some	DT
46745	2380	2	philosophers	philosopher	NNS
46745	2380	3	have	have	VBP
46745	2380	4	erred	err	VBN
46745	2380	5	in	in	IN
46745	2380	6	this	this	DT
46745	2380	7	;	;	:
46745	2380	8	that	that	IN
46745	2380	9	they	-PRON-	PRP
46745	2380	10	have	have	VBP
46745	2380	11	first	first	RB
46745	2380	12	,	,	,
46745	2380	13	with	with	IN
46745	2380	14	much	much	JJ
46745	2380	15	pains	pain	NNS
46745	2380	16	and	and	CC
46745	2380	17	labour	labour	NN
46745	2380	18	,	,	,
46745	2380	19	erected	erect	VBD
46745	2380	20	an	an	DT
46745	2380	21	airy	airy	JJ
46745	2380	22	fabric	fabric	NN
46745	2380	23	on	on	IN
46745	2380	24	a	a	DT
46745	2380	25	basis	basis	NN
46745	2380	26	of	of	IN
46745	2380	27	incontestable	incontestable	JJ
46745	2380	28	truth,--but	truth,--but	CD
46745	2380	29	subsequently	subsequently	RB
46745	2380	30	,	,	,
46745	2380	31	relying	rely	VBG
46745	2380	32	too	too	RB
46745	2380	33	much	much	JJ
46745	2380	34	on	on	IN
46745	2380	35	that	that	DT
46745	2380	36	which	which	WDT
46745	2380	37	they	-PRON-	PRP
46745	2380	38	have	have	VBP
46745	2380	39	themselves	-PRON-	PRP
46745	2380	40	raised	raise	VBN
46745	2380	41	,	,	,
46745	2380	42	they	-PRON-	PRP
46745	2380	43	have	have	VBP
46745	2380	44	commenced	commence	VBN
46745	2380	45	to	to	TO
46745	2380	46	pull	pull	VB
46745	2380	47	up	up	RP
46745	2380	48	the	the	DT
46745	2380	49	blocks	block	NNS
46745	2380	50	on	on	IN
46745	2380	51	which	which	WDT
46745	2380	52	it	-PRON-	PRP
46745	2380	53	was	be	VBD
46745	2380	54	founded	found	VBN
46745	2380	55	,	,	,
46745	2380	56	and	and	CC
46745	2380	57	have	have	VBP
46745	2380	58	thus	thus	RB
46745	2380	59	brought	bring	VBN
46745	2380	60	the	the	DT
46745	2380	61	whole	whole	JJ
46745	2380	62	speculation	speculation	NN
46745	2380	63	tumbling	tumble	VBG
46745	2380	64	to	to	IN
46745	2380	65	the	the	DT
46745	2380	66	ground	ground	NN
46745	2380	67	in	in	IN
46745	2380	68	ruins	ruin	NNS
46745	2380	69	.	.	.
46745	2381	1	Considering	consider	VBG
46745	2381	2	then	then	RB
46745	2381	3	that	that	IN
46745	2381	4	the	the	DT
46745	2381	5	action	action	NN
46745	2381	6	of	of	IN
46745	2381	7	Catalytic	catalytic	JJ
46745	2381	8	medicines	medicine	NNS
46745	2381	9	in	in	IN
46745	2381	10	each	each	DT
46745	2381	11	disorder	disorder	NN
46745	2381	12	is	be	VBZ
46745	2381	13	of	of	IN
46745	2381	14	a	a	DT
46745	2381	15	special	special	JJ
46745	2381	16	and	and	CC
46745	2381	17	peculiar	peculiar	JJ
46745	2381	18	kind	kind	NN
46745	2381	19	,	,	,
46745	2381	20	which	which	WDT
46745	2381	21	I	-PRON-	PRP
46745	2381	22	think	think	VBP
46745	2381	23	will	will	MD
46745	2381	24	not	not	RB
46745	2381	25	be	be	VB
46745	2381	26	denied	deny	VBN
46745	2381	27	,	,	,
46745	2381	28	I	-PRON-	PRP
46745	2381	29	have	have	VBP
46745	2381	30	grouped	group	VBN
46745	2381	31	them	-PRON-	PRP
46745	2381	32	in	in	IN
46745	2381	33	orders	order	NNS
46745	2381	34	which	which	WDT
46745	2381	35	are	be	VBP
46745	2381	36	named	name	VBN
46745	2381	37	according	accord	VBG
46745	2381	38	to	to	IN
46745	2381	39	the	the	DT
46745	2381	40	several	several	JJ
46745	2381	41	morbid	morbid	NN
46745	2381	42	states	state	NNS
46745	2381	43	in	in	IN
46745	2381	44	which	which	WDT
46745	2381	45	they	-PRON-	PRP
46745	2381	46	are	be	VBP
46745	2381	47	employed	employ	VBN
46745	2381	48	.	.	.
46745	2382	1	CATALYTICA	CATALYTICA	NNP
46745	2382	2	.	.	.
46745	2383	1	Ord	Ord	NNP
46745	2383	2	.	.	.
46745	2384	1	1	1	LS
46745	2384	2	.	.	.
46745	2385	1	Antiphlogistica	Antiphlogistica	NNP
46745	2385	2	.	.	.
46745	2386	1	Ord	Ord	NNP
46745	2386	2	.	.	.
46745	2387	1	2	2	LS
46745	2387	2	.	.	.
46745	2388	1	Antisyphilitica	Antisyphilitica	NNP
46745	2388	2	.	.	.
46745	2389	1	Ord	Ord	NNP
46745	2389	2	.	.	.
46745	2390	1	3	3	LS
46745	2390	2	.	.	.
46745	2391	1	Antiscrofulosa	Antiscrofulosa	NNP
46745	2391	2	.	.	.
46745	2392	1	Ord	Ord	NNP
46745	2392	2	.	.	.
46745	2393	1	4	4	LS
46745	2393	2	.	.	.
46745	2394	1	Antiarthritica	Antiarthritica	NNP
46745	2394	2	.	.	.
46745	2395	1	Ord	Ord	NNP
46745	2395	2	.	.	.
46745	2396	1	5	5	CD
46745	2396	2	.	.	.
46745	2397	1	Antiscorbutica	Antiscorbutica	NNP
46745	2397	2	.	.	.
46745	2398	1	Ord	Ord	NNP
46745	2398	2	.	.	.
46745	2399	1	6	6	CD
46745	2399	2	.	.	.
46745	2400	1	Antiperiodica	Antiperiodica	NNP
46745	2400	2	.	.	.
46745	2401	1	Ord	Ord	NNP
46745	2401	2	.	.	.
46745	2402	1	7	7	LS
46745	2402	2	.	.	.
46745	2403	1	Anticonvulsiva	Anticonvulsiva	NNP
46745	2403	2	.	.	.
46745	2404	1	Ord	Ord	NNP
46745	2404	2	.	.	.
46745	2405	1	8	8	LS
46745	2405	2	.	.	.
46745	2406	1	Antisquamosa	Antisquamosa	NNP
46745	2406	2	.	.	.
46745	2407	1	The	the	DT
46745	2407	2	medicines	medicine	NNS
46745	2407	3	of	of	IN
46745	2407	4	the	the	DT
46745	2407	5	first	first	JJ
46745	2407	6	order	order	NN
46745	2407	7	are	be	VBP
46745	2407	8	employed	employ	VBN
46745	2407	9	in	in	IN
46745	2407	10	inflammatory	inflammatory	JJ
46745	2407	11	disorders	disorder	NNS
46745	2407	12	generally	generally	RB
46745	2407	13	,	,	,
46745	2407	14	and	and	CC
46745	2407	15	possess	possess	VB
46745	2407	16	an	an	DT
46745	2407	17	influence	influence	NN
46745	2407	18	over	over	IN
46745	2407	19	the	the	DT
46745	2407	20	process	process	NN
46745	2407	21	of	of	IN
46745	2407	22	sthenic	sthenic	JJ
46745	2407	23	inflammation	inflammation	NN
46745	2407	24	,	,	,
46745	2407	25	however	however	RB
46745	2407	26	first	first	RB
46745	2407	27	produced	produce	VBN
46745	2407	28	.	.	.
46745	2408	1	The	the	DT
46745	2408	2	second	second	JJ
46745	2408	3	order	order	NN
46745	2408	4	contains	contain	VBZ
46745	2408	5	those	those	DT
46745	2408	6	that	that	WDT
46745	2408	7	are	be	VBP
46745	2408	8	used	use	VBN
46745	2408	9	in	in	IN
46745	2408	10	the	the	DT
46745	2408	11	several	several	JJ
46745	2408	12	forms	form	NNS
46745	2408	13	of	of	IN
46745	2408	14	Syphilis	Syphilis	NNP
46745	2408	15	.	.	.
46745	2409	1	The	the	DT
46745	2409	2	third	third	JJ
46745	2409	3	,	,	,
46745	2409	4	those	those	DT
46745	2409	5	that	that	WDT
46745	2409	6	are	be	VBP
46745	2409	7	employed	employ	VBN
46745	2409	8	in	in	IN
46745	2409	9	Scrofula	Scrofula	NNP
46745	2409	10	.	.	.
46745	2410	1	The	the	DT
46745	2410	2	fourth	fourth	JJ
46745	2410	3	,	,	,
46745	2410	4	those	those	DT
46745	2410	5	that	that	WDT
46745	2410	6	are	be	VBP
46745	2410	7	found	find	VBN
46745	2410	8	to	to	TO
46745	2410	9	be	be	VB
46745	2410	10	useful	useful	JJ
46745	2410	11	in	in	IN
46745	2410	12	the	the	DT
46745	2410	13	cure	cure	NN
46745	2410	14	of	of	IN
46745	2410	15	painful	painful	JJ
46745	2410	16	affections	affection	NNS
46745	2410	17	of	of	IN
46745	2410	18	the	the	DT
46745	2410	19	joints	joint	NNS
46745	2410	20	,	,	,
46745	2410	21	as	as	IN
46745	2410	22	Gout	Gout	NNP
46745	2410	23	and	and	CC
46745	2410	24	Rheumatism	Rheumatism	NNP
46745	2410	25	;	;	:
46745	2410	26	and	and	CC
46745	2410	27	also	also	RB
46745	2410	28	of	of	IN
46745	2410	29	Oxaluria	Oxaluria	NNP
46745	2410	30	,	,	,
46745	2410	31	Lithiasis	Lithiasis	NNP
46745	2410	32	,	,	,
46745	2410	33	Diabetes	diabetes	NN
46745	2410	34	,	,	,
46745	2410	35	and	and	CC
46745	2410	36	other	other	JJ
46745	2410	37	disorders	disorder	NNS
46745	2410	38	of	of	IN
46745	2410	39	secondary	secondary	JJ
46745	2410	40	assimilation	assimilation	NN
46745	2410	41	.	.	.
46745	2411	1	The	the	DT
46745	2411	2	fifth	fifth	JJ
46745	2411	3	order	order	NN
46745	2411	4	contains	contain	VBZ
46745	2411	5	those	those	DT
46745	2411	6	that	that	WDT
46745	2411	7	are	be	VBP
46745	2411	8	useful	useful	JJ
46745	2411	9	in	in	IN
46745	2411	10	Scurvy	Scurvy	NNP
46745	2411	11	.	.	.
46745	2412	1	The	the	DT
46745	2412	2	sixth	sixth	JJ
46745	2412	3	,	,	,
46745	2412	4	those	those	DT
46745	2412	5	that	that	WDT
46745	2412	6	are	be	VBP
46745	2412	7	employed	employ	VBN
46745	2412	8	in	in	IN
46745	2412	9	Ague	Ague	NNP
46745	2412	10	,	,	,
46745	2412	11	Remittents	Remittents	NNP
46745	2412	12	,	,	,
46745	2412	13	and	and	CC
46745	2412	14	other	other	JJ
46745	2412	15	periodic	periodic	JJ
46745	2412	16	disorders	disorder	NNS
46745	2412	17	,	,	,
46745	2412	18	on	on	IN
46745	2412	19	the	the	DT
46745	2412	20	Catalytic	catalytic	JJ
46745	2412	21	principle	principle	NN
46745	2412	22	.	.	.
46745	2413	1	The	the	DT
46745	2413	2	seventh	seventh	JJ
46745	2413	3	,	,	,
46745	2413	4	those	those	DT
46745	2413	5	used	use	VBN
46745	2413	6	in	in	IN
46745	2413	7	convulsive	convulsive	NN
46745	2413	8	disorders	disorder	NNS
46745	2413	9	.	.	.
46745	2414	1	Lastly	lastly	RB
46745	2414	2	,	,	,
46745	2414	3	the	the	DT
46745	2414	4	eighth	eighth	JJ
46745	2414	5	,	,	,
46745	2414	6	those	those	DT
46745	2414	7	that	that	WDT
46745	2414	8	are	be	VBP
46745	2414	9	capable	capable	JJ
46745	2414	10	of	of	IN
46745	2414	11	curing	cure	VBG
46745	2414	12	Lepra	Lepra	NNP
46745	2414	13	,	,	,
46745	2414	14	Psoriasis	Psoriasis	NNP
46745	2414	15	vulgaris	vulgaris	NN
46745	2414	16	,	,	,
46745	2414	17	and	and	CC
46745	2414	18	some	some	DT
46745	2414	19	other	other	JJ
46745	2414	20	skin	skin	NN
46745	2414	21	diseases	disease	NNS
46745	2414	22	.	.	.
46745	2415	1	The	the	DT
46745	2415	2	action	action	NN
46745	2415	3	of	of	IN
46745	2415	4	these	these	DT
46745	2415	5	medicines	medicine	NNS
46745	2415	6	being	be	VBG
46745	2415	7	much	much	RB
46745	2415	8	more	more	RBR
46745	2415	9	obscure	obscure	JJ
46745	2415	10	than	than	IN
46745	2415	11	that	that	DT
46745	2415	12	of	of	IN
46745	2415	13	Restoratives	restorative	NNS
46745	2415	14	,	,	,
46745	2415	15	I	-PRON-	PRP
46745	2415	16	shall	shall	MD
46745	2415	17	therefore	therefore	RB
46745	2415	18	have	have	VB
46745	2415	19	less	less	JJR
46745	2415	20	to	to	TO
46745	2415	21	say	say	VB
46745	2415	22	about	about	IN
46745	2415	23	them	-PRON-	PRP
46745	2415	24	individually	individually	RB
46745	2415	25	,	,	,
46745	2415	26	and	and	CC
46745	2415	27	shall	shall	MD
46745	2415	28	not	not	RB
46745	2415	29	go	go	VB
46745	2415	30	so	so	RB
46745	2415	31	much	much	RB
46745	2415	32	into	into	IN
46745	2415	33	particulars	particular	NNS
46745	2415	34	.	.	.
46745	2416	1	That	that	DT
46745	2416	2	part	part	NN
46745	2416	3	of	of	IN
46745	2416	4	Prop	Prop	NNP
46745	2416	5	.	.	.
46745	2417	1	VII	VII	NNP
46745	2417	2	.	.	.
46745	2418	1	which	which	WDT
46745	2418	2	refers	refer	VBZ
46745	2418	3	to	to	IN
46745	2418	4	Catalytics	Catalytics	NNP
46745	2418	5	,	,	,
46745	2418	6	may	may	MD
46745	2418	7	be	be	VB
46745	2418	8	divided	divide	VBN
46745	2418	9	into	into	IN
46745	2418	10	the	the	DT
46745	2418	11	following	follow	VBG
46745	2418	12	minor	minor	JJ
46745	2418	13	propositions:--	propositions:--	NN
46745	2418	14	_	_	NNP
46745	2418	15	m.	m.	NN
46745	2419	1	p.	p.	NN
46745	2419	2	_	_	NNP
46745	2419	3	1.--That	1.--That	NNP
46745	2419	4	they	-PRON-	PRP
46745	2419	5	act	act	VBP
46745	2419	6	in	in	IN
46745	2419	7	the	the	DT
46745	2419	8	blood	blood	NN
46745	2419	9	,	,	,
46745	2419	10	and	and	CC
46745	2419	11	that	that	IN
46745	2419	12	their	-PRON-	PRP$
46745	2419	13	effect	effect	NN
46745	2419	14	is	be	VBZ
46745	2419	15	permanent	permanent	JJ
46745	2419	16	.	.	.
46745	2420	1	_	_	NNP
46745	2420	2	m.	m.	NN
46745	2421	1	p.	p.	NN
46745	2421	2	_	_	NNP
46745	2421	3	2.--That	2.--that	CD
46745	2421	4	each	each	DT
46745	2421	5	of	of	IN
46745	2421	6	itself	-PRON-	PRP
46745	2421	7	tends	tend	VBZ
46745	2421	8	to	to	TO
46745	2421	9	work	work	VB
46745	2421	10	out	out	RP
46745	2421	11	a	a	DT
46745	2421	12	peculiar	peculiar	JJ
46745	2421	13	operation	operation	NN
46745	2421	14	in	in	IN
46745	2421	15	the	the	DT
46745	2421	16	blood	blood	NN
46745	2421	17	.	.	.
46745	2422	1	_	_	NNP
46745	2422	2	m.	m.	NN
46745	2423	1	p.	p.	NN
46745	2423	2	_	_	NNP
46745	2423	3	3.--That	3.--that	CD
46745	2423	4	the	the	DT
46745	2423	5	diseases	disease	NNS
46745	2423	6	in	in	IN
46745	2423	7	which	which	WDT
46745	2423	8	they	-PRON-	PRP
46745	2423	9	are	be	VBP
46745	2423	10	used	use	VBN
46745	2423	11	depend	depend	VBP
46745	2423	12	on	on	IN
46745	2423	13	certain	certain	JJ
46745	2423	14	morbid	morbid	NN
46745	2423	15	materials	material	NNS
46745	2423	16	or	or	CC
46745	2423	17	actions	action	NNS
46745	2423	18	in	in	IN
46745	2423	19	the	the	DT
46745	2423	20	blood	blood	NN
46745	2423	21	.	.	.
46745	2424	1	_	_	NNP
46745	2424	2	m.	m.	NN
46745	2425	1	p.	p.	NNP
46745	2425	2	_	_	NNP
46745	2425	3	4.--That	4.--that	CD
46745	2425	4	the	the	DT
46745	2425	5	result	result	NN
46745	2425	6	of	of	IN
46745	2425	7	the	the	DT
46745	2425	8	action	action	NN
46745	2425	9	of	of	IN
46745	2425	10	a	a	DT
46745	2425	11	Catalytic	catalytic	JJ
46745	2425	12	medicine	medicine	NN
46745	2425	13	is	be	VBZ
46745	2425	14	in	in	IN
46745	2425	15	some	some	DT
46745	2425	16	way	way	NN
46745	2425	17	to	to	TO
46745	2425	18	neutralize	neutralize	VB
46745	2425	19	or	or	CC
46745	2425	20	counteract	counteract	VB
46745	2425	21	some	some	DT
46745	2425	22	one	one	CD
46745	2425	23	or	or	CC
46745	2425	24	more	more	JJR
46745	2425	25	of	of	IN
46745	2425	26	these	these	DT
46745	2425	27	morbid	morbid	NN
46745	2425	28	processes	process	NNS
46745	2425	29	.	.	.
46745	2426	1	_	_	NNP
46745	2426	2	m.	m.	NN
46745	2427	1	p.	p.	NN
46745	2427	2	_	_	NNP
46745	2427	3	5.--That	5.--That	NNP
46745	2427	4	these	these	DT
46745	2427	5	medicines	medicine	NNS
46745	2427	6	are	be	VBP
46745	2427	7	all	all	DT
46745	2427	8	unnatural	unnatural	JJ
46745	2427	9	to	to	IN
46745	2427	10	the	the	DT
46745	2427	11	blood	blood	NN
46745	2427	12	,	,	,
46745	2427	13	and	and	CC
46745	2427	14	must	must	MD
46745	2427	15	at	at	IN
46745	2427	16	length	length	NN
46745	2427	17	pass	pass	NN
46745	2427	18	out	out	IN
46745	2427	19	of	of	IN
46745	2427	20	the	the	DT
46745	2427	21	system	system	NN
46745	2427	22	.	.	.
46745	2428	1	It	-PRON-	PRP
46745	2428	2	might	may	MD
46745	2428	3	seem	seem	VB
46745	2428	4	at	at	RB
46745	2428	5	first	first	RB
46745	2428	6	as	as	IN
46745	2428	7	if	if	IN
46745	2428	8	the	the	DT
46745	2428	9	first	first	JJ
46745	2428	10	,	,	,
46745	2428	11	fourth	fourth	JJ
46745	2428	12	and	and	CC
46745	2428	13	fifth	fifth	JJ
46745	2428	14	of	of	IN
46745	2428	15	these	these	DT
46745	2428	16	minor	minor	JJ
46745	2428	17	propositions	proposition	NNS
46745	2428	18	would	would	MD
46745	2428	19	alone	alone	RB
46745	2428	20	suffice	suffice	VB
46745	2428	21	to	to	TO
46745	2428	22	include	include	VB
46745	2428	23	the	the	DT
46745	2428	24	original	original	JJ
46745	2428	25	affirmation	affirmation	NN
46745	2428	26	.	.	.
46745	2429	1	But	but	CC
46745	2429	2	a	a	DT
46745	2429	3	medicine	medicine	NN
46745	2429	4	may	may	MD
46745	2429	5	act	act	VB
46745	2429	6	in	in	IN
46745	2429	7	the	the	DT
46745	2429	8	blood	blood	NN
46745	2429	9	,	,	,
46745	2429	10	and	and	CC
46745	2429	11	may	may	MD
46745	2429	12	counteract	counteract	VB
46745	2429	13	a	a	DT
46745	2429	14	disorder	disorder	NN
46745	2429	15	;	;	:
46745	2429	16	and	and	CC
46745	2429	17	yet	yet	RB
46745	2429	18	it	-PRON-	PRP
46745	2429	19	may	may	MD
46745	2429	20	counteract	counteract	VB
46745	2429	21	the	the	DT
46745	2429	22	disorder	disorder	NN
46745	2429	23	in	in	IN
46745	2429	24	some	some	DT
46745	2429	25	other	other	JJ
46745	2429	26	way	way	NN
46745	2429	27	than	than	IN
46745	2429	28	by	by	IN
46745	2429	29	acting	act	VBG
46745	2429	30	in	in	IN
46745	2429	31	the	the	DT
46745	2429	32	blood	blood	NN
46745	2429	33	.	.	.
46745	2430	1	It	-PRON-	PRP
46745	2430	2	is	be	VBZ
46745	2430	3	necessary	necessary	JJ
46745	2430	4	further	further	RB
46745	2430	5	to	to	TO
46745	2430	6	prove	prove	VB
46745	2430	7	the	the	DT
46745	2430	8	disease	disease	NN
46745	2430	9	to	to	TO
46745	2430	10	be	be	VB
46745	2430	11	a	a	DT
46745	2430	12	blood	blood	NN
46745	2430	13	disease	disease	NN
46745	2430	14	.	.	.
46745	2431	1	And	and	CC
46745	2431	2	the	the	DT
46745	2431	3	evidence	evidence	NN
46745	2431	4	of	of	IN
46745	2431	5	counteraction	counteraction	NN
46745	2431	6	will	will	MD
46745	2431	7	be	be	VB
46745	2431	8	rendered	render	VBN
46745	2431	9	stronger	strong	JJR
46745	2431	10	if	if	IN
46745	2431	11	we	-PRON-	PRP
46745	2431	12	can	can	MD
46745	2431	13	prove	prove	VB
46745	2431	14	that	that	IN
46745	2431	15	the	the	DT
46745	2431	16	medicine	medicine	NN
46745	2431	17	employed	employ	VBN
46745	2431	18	is	be	VBZ
46745	2431	19	itself	-PRON-	PRP
46745	2431	20	capable	capable	JJ
46745	2431	21	of	of	IN
46745	2431	22	setting	set	VBG
46745	2431	23	up	up	RP
46745	2431	24	in	in	IN
46745	2431	25	the	the	DT
46745	2431	26	blood	blood	NN
46745	2431	27	some	some	DT
46745	2431	28	peculiar	peculiar	JJ
46745	2431	29	process	process	NN
46745	2431	30	--	--	:
46745	2431	31	of	of	IN
46745	2431	32	causing	cause	VBG
46745	2431	33	in	in	IN
46745	2431	34	it	-PRON-	PRP
46745	2431	35	a	a	DT
46745	2431	36	change	change	NN
46745	2431	37	of	of	IN
46745	2431	38	some	some	DT
46745	2431	39	special	special	JJ
46745	2431	40	kind	kind	NN
46745	2431	41	.	.	.
46745	2432	1	For	for	IN
46745	2432	2	,	,	,
46745	2432	3	were	be	VBD
46745	2432	4	it	-PRON-	PRP
46745	2432	5	not	not	RB
46745	2432	6	to	to	TO
46745	2432	7	do	do	VB
46745	2432	8	so	so	RB
46745	2432	9	,	,	,
46745	2432	10	we	-PRON-	PRP
46745	2432	11	could	could	MD
46745	2432	12	hardly	hardly	RB
46745	2432	13	understand	understand	VB
46745	2432	14	how	how	WRB
46745	2432	15	it	-PRON-	PRP
46745	2432	16	could	could	MD
46745	2432	17	meet	meet	VB
46745	2432	18	the	the	DT
46745	2432	19	requirements	requirement	NNS
46745	2432	20	of	of	IN
46745	2432	21	one	one	CD
46745	2432	22	case	case	NN
46745	2432	23	more	more	RBR
46745	2432	24	than	than	IN
46745	2432	25	of	of	IN
46745	2432	26	another	another	DT
46745	2432	27	,	,	,
46745	2432	28	or	or	CC
46745	2432	29	how	how	WRB
46745	2432	30	it	-PRON-	PRP
46745	2432	31	could	could	MD
46745	2432	32	at	at	RB
46745	2432	33	all	all	RB
46745	2432	34	arrest	arrest	VB
46745	2432	35	an	an	DT
46745	2432	36	active	active	JJ
46745	2432	37	process	process	NN
46745	2432	38	in	in	IN
46745	2432	39	that	that	DT
46745	2432	40	fluid	fluid	NN
46745	2432	41	over	over	IN
46745	2432	42	which	which	WDT
46745	2432	43	it	-PRON-	PRP
46745	2432	44	exerted	exert	VBD
46745	2432	45	itself	-PRON-	PRP
46745	2432	46	no	no	DT
46745	2432	47	particular	particular	JJ
46745	2432	48	influence	influence	NN
46745	2432	49	.	.	.
46745	2433	1	And	and	CC
46745	2433	2	this	this	DT
46745	2433	3	thing	thing	NN
46745	2433	4	,	,	,
46745	2433	5	which	which	WDT
46745	2433	6	is	be	VBZ
46745	2433	7	laid	lay	VBN
46745	2433	8	down	down	RP
46745	2433	9	in	in	IN
46745	2433	10	the	the	DT
46745	2433	11	second	second	JJ
46745	2433	12	minor	minor	JJ
46745	2433	13	proposition	proposition	NN
46745	2433	14	,	,	,
46745	2433	15	can	can	MD
46745	2433	16	,	,	,
46745	2433	17	I	-PRON-	PRP
46745	2433	18	think	think	VBP
46745	2433	19	,	,	,
46745	2433	20	be	be	VB
46745	2433	21	proved	prove	VBN
46745	2433	22	in	in	IN
46745	2433	23	the	the	DT
46745	2433	24	great	great	JJ
46745	2433	25	majority	majority	NN
46745	2433	26	of	of	IN
46745	2433	27	instances	instance	NNS
46745	2433	28	.	.	.
46745	2434	1	The	the	DT
46745	2434	2	following	follow	VBG
46745	2434	3	is	be	VBZ
46745	2434	4	the	the	DT
46745	2434	5	arrangement	arrangement	NN
46745	2434	6	of	of	IN
46745	2434	7	the	the	DT
46745	2434	8	subject	subject	NN
46745	2434	9	which	which	WDT
46745	2434	10	I	-PRON-	PRP
46745	2434	11	have	have	VBP
46745	2434	12	thought	think	VBN
46745	2434	13	it	-PRON-	PRP
46745	2434	14	best	well	RBS
46745	2434	15	to	to	TO
46745	2434	16	adopt	adopt	VB
46745	2434	17	.	.	.
46745	2435	1	We	-PRON-	PRP
46745	2435	2	will	will	MD
46745	2435	3	,	,	,
46745	2435	4	in	in	IN
46745	2435	5	the	the	DT
46745	2435	6	first	first	JJ
46745	2435	7	place	place	NN
46745	2435	8	,	,	,
46745	2435	9	consider	consider	VB
46745	2435	10	some	some	DT
46745	2435	11	of	of	IN
46745	2435	12	the	the	DT
46745	2435	13	statements	statement	NNS
46745	2435	14	ventured	venture	VBN
46745	2435	15	by	by	IN
46745	2435	16	authors	author	NNS
46745	2435	17	respecting	respect	VBG
46745	2435	18	this	this	DT
46745	2435	19	kind	kind	NN
46745	2435	20	of	of	IN
46745	2435	21	medicines	medicine	NNS
46745	2435	22	:	:	:
46745	2435	23	as	as	IN
46745	2435	24	a	a	DT
46745	2435	25	comparison	comparison	NN
46745	2435	26	of	of	IN
46745	2435	27	these	these	DT
46745	2435	28	should	should	MD
46745	2435	29	aid	aid	VB
46745	2435	30	us	-PRON-	PRP
46745	2435	31	in	in	IN
46745	2435	32	the	the	DT
46745	2435	33	discovery	discovery	NN
46745	2435	34	of	of	IN
46745	2435	35	the	the	DT
46745	2435	36	truth	truth	NN
46745	2435	37	.	.	.
46745	2436	1	In	in	IN
46745	2436	2	the	the	DT
46745	2436	3	second	second	JJ
46745	2436	4	place	place	NN
46745	2436	5	,	,	,
46745	2436	6	it	-PRON-	PRP
46745	2436	7	will	will	MD
46745	2436	8	be	be	VB
46745	2436	9	convenient	convenient	JJ
46745	2436	10	to	to	TO
46745	2436	11	enumerate	enumerate	VB
46745	2436	12	the	the	DT
46745	2436	13	medicines	medicine	NNS
46745	2436	14	contained	contain	VBN
46745	2436	15	in	in	IN
46745	2436	16	the	the	DT
46745	2436	17	orders	order	NNS
46745	2436	18	named	name	VBN
46745	2436	19	above	above	RB
46745	2436	20	,	,	,
46745	2436	21	and	and	CC
46745	2436	22	to	to	TO
46745	2436	23	proceed	proceed	VB
46745	2436	24	to	to	TO
46745	2436	25	prove	prove	VB
46745	2436	26	the	the	DT
46745	2436	27	minor	minor	JJ
46745	2436	28	propositions	proposition	NNS
46745	2436	29	of	of	IN
46745	2436	30	Catalytics	catalytic	NNS
46745	2436	31	taken	take	VBN
46745	2436	32	altogether	altogether	RB
46745	2436	33	.	.	.
46745	2437	1	A	a	DT
46745	2437	2	considerable	considerable	JJ
46745	2437	3	amount	amount	NN
46745	2437	4	of	of	IN
46745	2437	5	difficulty	difficulty	NN
46745	2437	6	attaches	attach	VBZ
46745	2437	7	to	to	IN
46745	2437	8	this	this	DT
46745	2437	9	consideration	consideration	NN
46745	2437	10	;	;	:
46745	2437	11	and	and	CC
46745	2437	12	,	,	,
46745	2437	13	as	as	IN
46745	2437	14	the	the	DT
46745	2437	15	argument	argument	NN
46745	2437	16	which	which	WDT
46745	2437	17	applies	apply	VBZ
46745	2437	18	to	to	IN
46745	2437	19	one	one	CD
46745	2437	20	order	order	NN
46745	2437	21	will	will	MD
46745	2437	22	apply	apply	VB
46745	2437	23	to	to	IN
46745	2437	24	all	all	DT
46745	2437	25	,	,	,
46745	2437	26	much	much	JJ
46745	2437	27	unnecessary	unnecessary	JJ
46745	2437	28	repetition	repetition	NN
46745	2437	29	will	will	MD
46745	2437	30	be	be	VB
46745	2437	31	avoided	avoid	VBN
46745	2437	32	by	by	IN
46745	2437	33	this	this	DT
46745	2437	34	plan	plan	NN
46745	2437	35	.	.	.
46745	2438	1	In	in	IN
46745	2438	2	the	the	DT
46745	2438	3	third	third	JJ
46745	2438	4	place	place	NN
46745	2438	5	I	-PRON-	PRP
46745	2438	6	must	must	MD
46745	2438	7	conclude	conclude	VB
46745	2438	8	by	by	IN
46745	2438	9	making	make	VBG
46745	2438	10	some	some	DT
46745	2438	11	remarks	remark	NNS
46745	2438	12	on	on	IN
46745	2438	13	each	each	DT
46745	2438	14	of	of	IN
46745	2438	15	the	the	DT
46745	2438	16	orders	order	NNS
46745	2438	17	in	in	IN
46745	2438	18	succession	succession	NN
46745	2438	19	.	.	.
46745	2439	1	To	to	TO
46745	2439	2	proceed	proceed	VB
46745	2439	3	now	now	RB
46745	2439	4	to	to	IN
46745	2439	5	the	the	DT
46745	2439	6	first	first	JJ
46745	2439	7	of	of	IN
46745	2439	8	these	these	DT
46745	2439	9	topics	topic	NNS
46745	2439	10	.	.	.
46745	2440	1	In	in	IN
46745	2440	2	referring	refer	VBG
46745	2440	3	to	to	IN
46745	2440	4	the	the	DT
46745	2440	5	opinions	opinion	NNS
46745	2440	6	that	that	WDT
46745	2440	7	have	have	VBP
46745	2440	8	been	be	VBN
46745	2440	9	advanced	advance	VBN
46745	2440	10	on	on	IN
46745	2440	11	the	the	DT
46745	2440	12	action	action	NN
46745	2440	13	of	of	IN
46745	2440	14	this	this	DT
46745	2440	15	group	group	NN
46745	2440	16	of	of	IN
46745	2440	17	medicines	medicine	NNS
46745	2440	18	,	,	,
46745	2440	19	our	-PRON-	PRP$
46745	2440	20	task	task	NN
46745	2440	21	is	be	VBZ
46745	2440	22	rendered	render	VBN
46745	2440	23	comparatively	comparatively	RB
46745	2440	24	easy	easy	JJ
46745	2440	25	by	by	IN
46745	2440	26	the	the	DT
46745	2440	27	fact	fact	NN
46745	2440	28	that	that	IN
46745	2440	29	a	a	DT
46745	2440	30	great	great	JJ
46745	2440	31	number	number	NN
46745	2440	32	of	of	IN
46745	2440	33	writers	writer	NNS
46745	2440	34	on	on	IN
46745	2440	35	Materia	Materia	NNP
46745	2440	36	Medica	Medica	NNP
46745	2440	37	have	have	VBP
46745	2440	38	failed	fail	VBN
46745	2440	39	to	to	TO
46745	2440	40	recognise	recognise	VB
46745	2440	41	them	-PRON-	PRP
46745	2440	42	collectively	collectively	RB
46745	2440	43	.	.	.
46745	2441	1	It	-PRON-	PRP
46745	2441	2	may	may	MD
46745	2441	3	seem	seem	VB
46745	2441	4	strange	strange	JJ
46745	2441	5	to	to	IN
46745	2441	6	one	one	CD
46745	2441	7	who	who	WP
46745	2441	8	has	have	VBZ
46745	2441	9	reflected	reflect	VBN
46745	2441	10	on	on	IN
46745	2441	11	the	the	DT
46745	2441	12	subject	subject	NN
46745	2441	13	,	,	,
46745	2441	14	but	but	CC
46745	2441	15	it	-PRON-	PRP
46745	2441	16	is	be	VBZ
46745	2441	17	nevertheless	nevertheless	RB
46745	2441	18	true	true	JJ
46745	2441	19	,	,	,
46745	2441	20	that	that	IN
46745	2441	21	the	the	DT
46745	2441	22	majority	majority	NN
46745	2441	23	of	of	IN
46745	2441	24	authors	author	NNS
46745	2441	25	have	have	VBP
46745	2441	26	taken	take	VBN
46745	2441	27	no	no	DT
46745	2441	28	notice	notice	NN
46745	2441	29	whatever	whatever	WDT
46745	2441	30	of	of	IN
46745	2441	31	medicines	medicine	NNS
46745	2441	32	acting	act	VBG
46745	2441	33	in	in	IN
46745	2441	34	the	the	DT
46745	2441	35	blood	blood	NN
46745	2441	36	,	,	,
46745	2441	37	with	with	IN
46745	2441	38	the	the	DT
46745	2441	39	exception	exception	NN
46745	2441	40	of	of	IN
46745	2441	41	Acids	Acids	NNPS
46745	2441	42	and	and	CC
46745	2441	43	Alkalies	Alkalies	NNPS
46745	2441	44	,	,	,
46745	2441	45	which	which	WDT
46745	2441	46	are	be	VBP
46745	2441	47	grouped	group	VBN
46745	2441	48	by	by	IN
46745	2441	49	some	some	DT
46745	2441	50	as	as	IN
46745	2441	51	chemical	chemical	JJ
46745	2441	52	remedies	remedy	NNS
46745	2441	53	.	.	.
46745	2442	1	All	all	DT
46745	2442	2	other	other	JJ
46745	2442	3	medicines	medicine	NNS
46745	2442	4	have	have	VBP
46745	2442	5	been	be	VBN
46745	2442	6	generally	generally	RB
46745	2442	7	arranged	arrange	VBN
46745	2442	8	under	under	IN
46745	2442	9	the	the	DT
46745	2442	10	two	two	CD
46745	2442	11	great	great	JJ
46745	2442	12	and	and	CC
46745	2442	13	ill	ill	RB
46745	2442	14	-	-	HYPH
46745	2442	15	defined	define	VBN
46745	2442	16	heads	head	NNS
46745	2442	17	of	of	IN
46745	2442	18	Nerve	Nerve	NNP
46745	2442	19	-	-	HYPH
46745	2442	20	medicines	medicine	NNS
46745	2442	21	and	and	CC
46745	2442	22	Eliminatives	Eliminatives	NNPS
46745	2442	23	.	.	.
46745	2443	1	I	-PRON-	PRP
46745	2443	2	can	can	MD
46745	2443	3	not	not	RB
46745	2443	4	find	find	VB
46745	2443	5	it	-PRON-	PRP
46745	2443	6	possible	possible	JJ
46745	2443	7	,	,	,
46745	2443	8	by	by	IN
46745	2443	9	either	either	DT
46745	2443	10	of	of	IN
46745	2443	11	these	these	DT
46745	2443	12	terms	term	NNS
46745	2443	13	,	,	,
46745	2443	14	to	to	TO
46745	2443	15	give	give	VB
46745	2443	16	any	any	DT
46745	2443	17	idea	idea	NN
46745	2443	18	of	of	IN
46745	2443	19	the	the	DT
46745	2443	20	real	real	JJ
46745	2443	21	action	action	NN
46745	2443	22	of	of	IN
46745	2443	23	the	the	DT
46745	2443	24	many	many	JJ
46745	2443	25	important	important	JJ
46745	2443	26	agents	agent	NNS
46745	2443	27	which	which	WDT
46745	2443	28	I	-PRON-	PRP
46745	2443	29	have	have	VBP
46745	2443	30	included	include	VBN
46745	2443	31	in	in	IN
46745	2443	32	this	this	DT
46745	2443	33	division	division	NN
46745	2443	34	.	.	.
46745	2444	1	It	-PRON-	PRP
46745	2444	2	would	would	MD
46745	2444	3	seem	seem	VB
46745	2444	4	that	that	IN
46745	2444	5	it	-PRON-	PRP
46745	2444	6	has	have	VBZ
46745	2444	7	been	be	VBN
46745	2444	8	generally	generally	RB
46745	2444	9	supposed	suppose	VBN
46745	2444	10	that	that	IN
46745	2444	11	medicines,--bodies	medicines,--bodie	NNS
46745	2444	12	of	of	IN
46745	2444	13	active	active	JJ
46745	2444	14	properties	property	NNS
46745	2444	15	,	,	,
46745	2444	16	and	and	CC
46745	2444	17	more	more	RBR
46745	2444	18	or	or	CC
46745	2444	19	less	less	RBR
46745	2444	20	peculiar	peculiar	JJ
46745	2444	21	construction,--are	construction,--are	NN
46745	2444	22	able	able	JJ
46745	2444	23	to	to	TO
46745	2444	24	enter	enter	VB
46745	2444	25	and	and	CC
46745	2444	26	to	to	TO
46745	2444	27	pass	pass	VB
46745	2444	28	through	through	RP
46745	2444	29	a	a	DT
46745	2444	30	fluid	fluid	NN
46745	2444	31	which	which	WDT
46745	2444	32	is	be	VBZ
46745	2444	33	still	still	RB
46745	2444	34	more	more	RBR
46745	2444	35	complicated	complicated	JJ
46745	2444	36	and	and	CC
46745	2444	37	changeable	changeable	JJ
46745	2444	38	in	in	IN
46745	2444	39	nature	nature	NN
46745	2444	40	than	than	IN
46745	2444	41	themselves	-PRON-	PRP
46745	2444	42	,	,	,
46745	2444	43	yet	yet	CC
46745	2444	44	that	that	IN
46745	2444	45	while	while	IN
46745	2444	46	so	so	RB
46745	2444	47	doing	do	VBG
46745	2444	48	they	-PRON-	PRP
46745	2444	49	produce	produce	VBP
46745	2444	50	no	no	DT
46745	2444	51	impression	impression	NN
46745	2444	52	upon	upon	IN
46745	2444	53	it	-PRON-	PRP
46745	2444	54	,	,	,
46745	2444	55	but	but	CC
46745	2444	56	proceed	proceed	VB
46745	2444	57	passively	passively	RB
46745	2444	58	to	to	IN
46745	2444	59	the	the	DT
46745	2444	60	solid	solid	JJ
46745	2444	61	tissues	tissue	NNS
46745	2444	62	,	,	,
46745	2444	63	or	or	CC
46745	2444	64	quietly	quietly	RB
46745	2444	65	pass	pass	VB
46745	2444	66	out	out	IN
46745	2444	67	of	of	IN
46745	2444	68	the	the	DT
46745	2444	69	body	body	NN
46745	2444	70	,	,	,
46745	2444	71	without	without	IN
46745	2444	72	ever	ever	RB
46745	2444	73	leaving	leave	VBG
46745	2444	74	behind	behind	IN
46745	2444	75	them	-PRON-	PRP
46745	2444	76	any	any	DT
46745	2444	77	trace	trace	NN
46745	2444	78	of	of	IN
46745	2444	79	their	-PRON-	PRP$
46745	2444	80	action	action	NN
46745	2444	81	.	.	.
46745	2445	1	Certain	certain	JJ
46745	2445	2	writers	writer	NNS
46745	2445	3	have	have	VBP
46745	2445	4	made	make	VBN
46745	2445	5	some	some	DT
46745	2445	6	amends	amend	NNS
46745	2445	7	by	by	IN
46745	2445	8	including	include	VBG
46745	2445	9	in	in	IN
46745	2445	10	their	-PRON-	PRP$
46745	2445	11	arrangements	arrangement	NNS
46745	2445	12	a	a	DT
46745	2445	13	class	class	NN
46745	2445	14	termed	term	VBN
46745	2445	15	Alteratives	alterative	NNS
46745	2445	16	.	.	.
46745	2446	1	But	but	CC
46745	2446	2	even	even	RB
46745	2446	3	then	then	RB
46745	2446	4	they	-PRON-	PRP
46745	2446	5	have	have	VBP
46745	2446	6	not	not	RB
46745	2446	7	unfrequently	unfrequently	RB
46745	2446	8	laid	lay	VBN
46745	2446	9	it	-PRON-	PRP
46745	2446	10	down	down	RP
46745	2446	11	as	as	IN
46745	2446	12	a	a	DT
46745	2446	13	rule	rule	NN
46745	2446	14	that	that	IN
46745	2446	15	they	-PRON-	PRP
46745	2446	16	produce	produce	VBP
46745	2446	17	,	,	,
46745	2446	18	in	in	IN
46745	2446	19	the	the	DT
46745	2446	20	first	first	JJ
46745	2446	21	place	place	NN
46745	2446	22	,	,	,
46745	2446	23	an	an	DT
46745	2446	24	impression	impression	NN
46745	2446	25	on	on	IN
46745	2446	26	the	the	DT
46745	2446	27	nervous	nervous	JJ
46745	2446	28	system	system	NN
46745	2446	29	,	,	,
46745	2446	30	and	and	CC
46745	2446	31	that	that	IN
46745	2446	32	this	this	DT
46745	2446	33	has	have	VBZ
46745	2446	34	subsequently	subsequently	RB
46745	2446	35	the	the	DT
46745	2446	36	effect	effect	NN
46745	2446	37	of	of	IN
46745	2446	38	altering	alter	VBG
46745	2446	39	the	the	DT
46745	2446	40	manifestations	manifestation	NNS
46745	2446	41	of	of	IN
46745	2446	42	vital	vital	JJ
46745	2446	43	force	force	NN
46745	2446	44	.	.	.
46745	2447	1	How	how	WRB
46745	2447	2	varied	varied	JJ
46745	2447	3	and	and	CC
46745	2447	4	peculiar	peculiar	JJ
46745	2447	5	in	in	IN
46745	2447	6	nature	nature	NN
46745	2447	7	must	must	MD
46745	2447	8	these	these	DT
46745	2447	9	nervous	nervous	JJ
46745	2447	10	impressions	impression	NNS
46745	2447	11	be	be	VB
46745	2447	12	,	,	,
46745	2447	13	to	to	TO
46745	2447	14	account	account	VB
46745	2447	15	for	for	IN
46745	2447	16	actions	action	NNS
46745	2447	17	which	which	WDT
46745	2447	18	are	be	VBP
46745	2447	19	often	often	RB
46745	2447	20	so	so	RB
46745	2447	21	widely	widely	RB
46745	2447	22	different	different	JJ
46745	2447	23	!	!	.
46745	2448	1	The	the	DT
46745	2448	2	medicines	medicine	NNS
46745	2448	3	thus	thus	RB
46745	2448	4	grouped	group	VBN
46745	2448	5	as	as	IN
46745	2448	6	Alteratives	alterative	NNS
46745	2448	7	correspond	correspond	VBP
46745	2448	8	very	very	RB
46745	2448	9	nearly	nearly	RB
46745	2448	10	with	with	IN
46745	2448	11	my	-PRON-	PRP$
46745	2448	12	division	division	NN
46745	2448	13	of	of	IN
46745	2448	14	Catalytics	Catalytics	NNP
46745	2448	15	.	.	.
46745	2449	1	The	the	DT
46745	2449	2	permanency	permanency	NN
46745	2449	3	of	of	IN
46745	2449	4	their	-PRON-	PRP$
46745	2449	5	effects	effect	NNS
46745	2449	6	,	,	,
46745	2449	7	and	and	CC
46745	2449	8	the	the	DT
46745	2449	9	fact	fact	NN
46745	2449	10	that	that	IN
46745	2449	11	the	the	DT
46745	2449	12	disorders	disorder	NNS
46745	2449	13	which	which	WDT
46745	2449	14	they	-PRON-	PRP
46745	2449	15	cure	cure	VBP
46745	2449	16	are	be	VBP
46745	2449	17	blood	blood	NN
46745	2449	18	-	-	HYPH
46745	2449	19	disorders	disorder	NNS
46745	2449	20	,	,	,
46745	2449	21	will	will	MD
46745	2449	22	sufficiently	sufficiently	RB
46745	2449	23	stamp	stamp	VB
46745	2449	24	the	the	DT
46745	2449	25	character	character	NN
46745	2449	26	of	of	IN
46745	2449	27	the	the	DT
46745	2449	28	operation	operation	NN
46745	2449	29	of	of	IN
46745	2449	30	these	these	DT
46745	2449	31	remedies	remedy	NNS
46745	2449	32	.	.	.
46745	2450	1	In	in	IN
46745	2450	2	many	many	JJ
46745	2450	3	works	work	NNS
46745	2450	4	,	,	,
46745	2450	5	as	as	IN
46745	2450	6	in	in	IN
46745	2450	7	those	those	DT
46745	2450	8	of	of	IN
46745	2450	9	Dr.	Dr.	NNP
46745	2450	10	Duncan	Duncan	NNP
46745	2450	11	,	,	,
46745	2450	12	of	of	IN
46745	2450	13	Dr.	Dr.	NNP
46745	2450	14	A.	A.	NNP
46745	2450	15	T.	T.	NNP
46745	2450	16	Thomson	Thomson	NNP
46745	2450	17	,	,	,
46745	2450	18	and	and	CC
46745	2450	19	more	more	RBR
46745	2450	20	lately	lately	RB
46745	2450	21	,	,	,
46745	2450	22	of	of	IN
46745	2450	23	Drs	Drs	NNP
46745	2450	24	.	.	.
46745	2451	1	Ballard	Ballard	NNP
46745	2451	2	and	and	CC
46745	2451	3	Garrod	Garrod	NNP
46745	2451	4	,	,	,
46745	2451	5	the	the	DT
46745	2451	6	existence	existence	NN
46745	2451	7	of	of	IN
46745	2451	8	a	a	DT
46745	2451	9	class	class	NN
46745	2451	10	of	of	IN
46745	2451	11	Alteratives	Alteratives	NNPS
46745	2451	12	or	or	CC
46745	2451	13	blood	blood	NN
46745	2451	14	-	-	HYPH
46745	2451	15	medicines	medicine	NNS
46745	2451	16	is	be	VBZ
46745	2451	17	not	not	RB
46745	2451	18	even	even	RB
46745	2451	19	recognised	recognise	VBN
46745	2451	20	or	or	CC
46745	2451	21	alluded	allude	VBN
46745	2451	22	to	to	IN
46745	2451	23	.	.	.
46745	2452	1	But	but	CC
46745	2452	2	in	in	IN
46745	2452	3	the	the	DT
46745	2452	4	learned	learned	JJ
46745	2452	5	classification	classification	NN
46745	2452	6	of	of	IN
46745	2452	7	Dr.	Dr.	NNP
46745	2452	8	Pereira	Pereira	NNP
46745	2452	9	blood	blood	NN
46745	2452	10	-	-	HYPH
46745	2452	11	medicines	medicine	NNS
46745	2452	12	hold	hold	VBP
46745	2452	13	an	an	DT
46745	2452	14	important	important	JJ
46745	2452	15	place	place	NN
46745	2452	16	.	.	.
46745	2453	1	All	all	DT
46745	2453	2	except	except	IN
46745	2453	3	Chalybeates	Chalybeates	NNPS
46745	2453	4	are	be	VBP
46745	2453	5	grouped	group	VBN
46745	2453	6	together	together	RB
46745	2453	7	in	in	IN
46745	2453	8	a	a	DT
46745	2453	9	sub	sub	JJ
46745	2453	10	-	-	NN
46745	2453	11	class	class	NN
46745	2453	12	,	,	,
46745	2453	13	called	call	VBN
46745	2453	14	Spanæmics	Spanæmics	NNPS
46745	2453	15	,	,	,
46745	2453	16	because	because	IN
46745	2453	17	they	-PRON-	PRP
46745	2453	18	tend	tend	VBP
46745	2453	19	to	to	TO
46745	2453	20	impoverish	impoverish	VB
46745	2453	21	the	the	DT
46745	2453	22	blood	blood	NN
46745	2453	23	.	.	.
46745	2454	1	In	in	IN
46745	2454	2	addition	addition	NN
46745	2454	3	to	to	IN
46745	2454	4	those	those	DT
46745	2454	5	which	which	WDT
46745	2454	6	I	-PRON-	PRP
46745	2454	7	have	have	VBP
46745	2454	8	named	name	VBN
46745	2454	9	Catalytics	Catalytics	NNP
46745	2454	10	,	,	,
46745	2454	11	there	there	EX
46745	2454	12	are	be	VBP
46745	2454	13	here	here	RB
46745	2454	14	the	the	DT
46745	2454	15	acids	acid	NNS
46745	2454	16	and	and	CC
46745	2454	17	alkalies	alkali	NNS
46745	2454	18	.	.	.
46745	2455	1	It	-PRON-	PRP
46745	2455	2	is	be	VBZ
46745	2455	3	true	true	JJ
46745	2455	4	that	that	IN
46745	2455	5	all	all	PDT
46745	2455	6	these	these	DT
46745	2455	7	medicines	medicine	NNS
46745	2455	8	,	,	,
46745	2455	9	after	after	IN
46745	2455	10	long	long	JJ
46745	2455	11	use	use	NN
46745	2455	12	,	,	,
46745	2455	13	impoverish	impoverish	VBP
46745	2455	14	the	the	DT
46745	2455	15	blood	blood	NN
46745	2455	16	,	,	,
46745	2455	17	which	which	WDT
46745	2455	18	,	,	,
46745	2455	19	indeed	indeed	RB
46745	2455	20	,	,	,
46745	2455	21	suffices	suffice	VBZ
46745	2455	22	to	to	TO
46745	2455	23	prove	prove	VB
46745	2455	24	my	-PRON-	PRP$
46745	2455	25	first	first	JJ
46745	2455	26	point	point	NN
46745	2455	27	,	,	,
46745	2455	28	viz	viz	NN
46745	2455	29	,	,	,
46745	2455	30	:	:	:
46745	2455	31	that	that	IN
46745	2455	32	they	-PRON-	PRP
46745	2455	33	act	act	VBP
46745	2455	34	in	in	IN
46745	2455	35	the	the	DT
46745	2455	36	blood	blood	NN
46745	2455	37	,	,	,
46745	2455	38	and	and	CC
46745	2455	39	that	that	IN
46745	2455	40	their	-PRON-	PRP$
46745	2455	41	effect	effect	NN
46745	2455	42	is	be	VBZ
46745	2455	43	permanent	permanent	JJ
46745	2455	44	.	.	.
46745	2456	1	But	but	CC
46745	2456	2	Dr.	Dr.	NNP
46745	2456	3	Pereira	Pereira	NNP
46745	2456	4	has	have	VBZ
46745	2456	5	founded	found	VBN
46745	2456	6	his	-PRON-	PRP$
46745	2456	7	classification	classification	NN
46745	2456	8	on	on	IN
46745	2456	9	the	the	DT
46745	2456	10	physiological	physiological	JJ
46745	2456	11	action	action	NN
46745	2456	12	of	of	IN
46745	2456	13	medicines	medicine	NNS
46745	2456	14	,	,	,
46745	2456	15	and	and	CC
46745	2456	16	not	not	RB
46745	2456	17	on	on	IN
46745	2456	18	their	-PRON-	PRP$
46745	2456	19	therapeutical	therapeutical	JJ
46745	2456	20	uses	use	NNS
46745	2456	21	,	,	,
46745	2456	22	which	which	WDT
46745	2456	23	form	form	VBP
46745	2456	24	the	the	DT
46745	2456	25	basis	basis	NN
46745	2456	26	of	of	IN
46745	2456	27	mine	-PRON-	PRP
46745	2456	28	.	.	.
46745	2457	1	Thus	thus	RB
46745	2457	2	he	-PRON-	PRP
46745	2457	3	takes	take	VBZ
46745	2457	4	no	no	DT
46745	2457	5	notice	notice	NN
46745	2457	6	of	of	IN
46745	2457	7	the	the	DT
46745	2457	8	questions	question	NNS
46745	2457	9	of	of	IN
46745	2457	10	what	what	WP
46745	2457	11	their	-PRON-	PRP$
46745	2457	12	ultimate	ultimate	JJ
46745	2457	13	destination	destination	NN
46745	2457	14	may	may	MD
46745	2457	15	be	be	VB
46745	2457	16	,	,	,
46745	2457	17	or	or	CC
46745	2457	18	what	what	WP
46745	2457	19	their	-PRON-	PRP$
46745	2457	20	primary	primary	JJ
46745	2457	21	_	_	NNP
46745	2457	22	modus	modus	NN
46745	2457	23	operandi	operandi	NNP
46745	2457	24	_	_	NNP
46745	2457	25	,	,	,
46745	2457	26	whether	whether	IN
46745	2457	27	they	-PRON-	PRP
46745	2457	28	have	have	VBP
46745	2457	29	to	to	TO
46745	2457	30	remain	remain	VB
46745	2457	31	in	in	IN
46745	2457	32	the	the	DT
46745	2457	33	blood	blood	NN
46745	2457	34	,	,	,
46745	2457	35	or	or	CC
46745	2457	36	to	to	TO
46745	2457	37	pass	pass	VB
46745	2457	38	out	out	IN
46745	2457	39	of	of	IN
46745	2457	40	it	-PRON-	PRP
46745	2457	41	,	,	,
46745	2457	42	and	and	CC
46745	2457	43	whether	whether	IN
46745	2457	44	they	-PRON-	PRP
46745	2457	45	can	can	MD
46745	2457	46	act	act	VB
46745	2457	47	by	by	IN
46745	2457	48	supplying	supply	VBG
46745	2457	49	a	a	DT
46745	2457	50	material	material	NN
46745	2457	51	to	to	IN
46745	2457	52	it	-PRON-	PRP
46745	2457	53	,	,	,
46745	2457	54	or	or	CC
46745	2457	55	by	by	IN
46745	2457	56	neutralizing	neutralize	VBG
46745	2457	57	a	a	DT
46745	2457	58	material	material	NN
46745	2457	59	in	in	IN
46745	2457	60	it	-PRON-	PRP
46745	2457	61	.	.	.
46745	2458	1	The	the	DT
46745	2458	2	subsequent	subsequent	JJ
46745	2458	3	statements	statement	NNS
46745	2458	4	which	which	WDT
46745	2458	5	Dr.	Dr.	NNP
46745	2458	6	Pereira	Pereira	NNP
46745	2458	7	has	have	VBZ
46745	2458	8	chosen	choose	VBN
46745	2458	9	as	as	IN
46745	2458	10	the	the	DT
46745	2458	11	basis	basis	NN
46745	2458	12	of	of	IN
46745	2458	13	his	-PRON-	PRP$
46745	2458	14	subdivisions	subdivision	NNS
46745	2458	15	,	,	,
46745	2458	16	founded	found	VBN
46745	2458	17	often	often	RB
46745	2458	18	on	on	IN
46745	2458	19	therapeutical	therapeutical	JJ
46745	2458	20	action	action	NN
46745	2458	21	,	,	,
46745	2458	22	seem	seem	VBP
46745	2458	23	in	in	IN
46745	2458	24	certain	certain	JJ
46745	2458	25	cases	case	NNS
46745	2458	26	to	to	TO
46745	2458	27	be	be	VB
46745	2458	28	somewhat	somewhat	RB
46745	2458	29	problematical	problematical	JJ
46745	2458	30	.	.	.
46745	2459	1	Thus	thus	RB
46745	2459	2	he	-PRON-	PRP
46745	2459	3	calls	call	VBZ
46745	2459	4	Acids	Acids	NNP
46745	2459	5	"	"	``
46745	2459	6	adipsa	adipsa	NN
46745	2459	7	,	,	,
46745	2459	8	"	"	''
46745	2459	9	or	or	CC
46745	2459	10	thirst	thirst	NN
46745	2459	11	-	-	HYPH
46745	2459	12	quenching	quenching	NN
46745	2459	13	,	,	,
46745	2459	14	which	which	WDT
46745	2459	15	very	very	RB
46745	2459	16	imperfectly	imperfectly	RB
46745	2459	17	expresses	express	VBZ
46745	2459	18	their	-PRON-	PRP$
46745	2459	19	action	action	NN
46745	2459	20	.	.	.
46745	2460	1	Alkalies	alkali	NNS
46745	2460	2	are	be	VBP
46745	2460	3	grouped	group	VBN
46745	2460	4	with	with	IN
46745	2460	5	Salts	Salts	NNP
46745	2460	6	,	,	,
46745	2460	7	Iodine	Iodine	NNP
46745	2460	8	,	,	,
46745	2460	9	and	and	CC
46745	2460	10	Sulphur	Sulphur	NNP
46745	2460	11	,	,	,
46745	2460	12	under	under	IN
46745	2460	13	the	the	DT
46745	2460	14	general	general	JJ
46745	2460	15	title	title	NN
46745	2460	16	of	of	IN
46745	2460	17	"	"	``
46745	2460	18	resolventia	resolventia	NNP
46745	2460	19	seu	seu	NNP
46745	2460	20	liquefacientia	liquefacientia	NNP
46745	2460	21	,	,	,
46745	2460	22	"	"	''
46745	2460	23	_	_	NNP
46745	2460	24	i.e.	i.e.	FW
46745	2460	25	_	_	NNP
46745	2460	26	resolvents	resolvent	NNS
46745	2460	27	,	,	,
46745	2460	28	or	or	CC
46745	2460	29	liquefacients	liquefacient	NNS
46745	2460	30	,	,	,
46745	2460	31	which	which	WDT
46745	2460	32	involves	involve	VBZ
46745	2460	33	an	an	DT
46745	2460	34	assumption	assumption	NN
46745	2460	35	that	that	IN
46745	2460	36	some	some	DT
46745	2460	37	might	may	MD
46745	2460	38	be	be	VB
46745	2460	39	inclined	incline	VBN
46745	2460	40	to	to	TO
46745	2460	41	dispute	dispute	VB
46745	2460	42	.	.	.
46745	2461	1	The	the	DT
46745	2461	2	title	title	NN
46745	2461	3	of	of	IN
46745	2461	4	Spanæmics	Spanæmics	NNP
46745	2461	5	,	,	,
46745	2461	6	applied	apply	VBD
46745	2461	7	to	to	IN
46745	2461	8	the	the	DT
46745	2461	9	whole	whole	NN
46745	2461	10	,	,	,
46745	2461	11	though	though	IN
46745	2461	12	unobjectionable	unobjectionable	JJ
46745	2461	13	in	in	IN
46745	2461	14	a	a	DT
46745	2461	15	classification	classification	NN
46745	2461	16	which	which	WDT
46745	2461	17	is	be	VBZ
46745	2461	18	founded	found	VBN
46745	2461	19	upon	upon	IN
46745	2461	20	their	-PRON-	PRP$
46745	2461	21	ultimate	ultimate	JJ
46745	2461	22	action	action	NN
46745	2461	23	in	in	IN
46745	2461	24	health	health	NN
46745	2461	25	,	,	,
46745	2461	26	would	would	MD
46745	2461	27	be	be	VB
46745	2461	28	quite	quite	RB
46745	2461	29	inappropriate	inappropriate	JJ
46745	2461	30	in	in	IN
46745	2461	31	an	an	DT
46745	2461	32	arrangement	arrangement	NN
46745	2461	33	like	like	IN
46745	2461	34	mine	-PRON-	PRP
46745	2461	35	,	,	,
46745	2461	36	which	which	WDT
46745	2461	37	has	have	VBZ
46745	2461	38	to	to	TO
46745	2461	39	do	do	VB
46745	2461	40	with	with	IN
46745	2461	41	their	-PRON-	PRP$
46745	2461	42	influence	influence	NN
46745	2461	43	in	in	IN
46745	2461	44	the	the	DT
46745	2461	45	cure	cure	NN
46745	2461	46	of	of	IN
46745	2461	47	diseases	disease	NNS
46745	2461	48	.	.	.
46745	2462	1	For	for	IN
46745	2462	2	our	-PRON-	PRP$
46745	2462	3	object	object	NN
46745	2462	4	in	in	IN
46745	2462	5	making	make	VBG
46745	2462	6	use	use	NN
46745	2462	7	of	of	IN
46745	2462	8	such	such	JJ
46745	2462	9	agents	agent	NNS
46745	2462	10	is	be	VBZ
46745	2462	11	not	not	RB
46745	2462	12	to	to	TO
46745	2462	13	impoverish	impoverish	VB
46745	2462	14	the	the	DT
46745	2462	15	blood	blood	NN
46745	2462	16	,	,	,
46745	2462	17	but	but	CC
46745	2462	18	to	to	TO
46745	2462	19	obtain	obtain	VB
46745	2462	20	such	such	PDT
46745	2462	21	a	a	DT
46745	2462	22	manifestation	manifestation	NN
46745	2462	23	of	of	IN
46745	2462	24	their	-PRON-	PRP$
46745	2462	25	power	power	NN
46745	2462	26	as	as	IN
46745	2462	27	shall	shall	MD
46745	2462	28	suffice	suffice	VB
46745	2462	29	to	to	TO
46745	2462	30	neutralize	neutralize	VB
46745	2462	31	the	the	DT
46745	2462	32	noxious	noxious	JJ
46745	2462	33	agent	agent	NN
46745	2462	34	,	,	,
46745	2462	35	and	and	CC
46745	2462	36	no	no	RB
46745	2462	37	more	more	JJR
46745	2462	38	.	.	.
46745	2463	1	Dr.	Dr.	NNP
46745	2463	2	A.	A.	NNP
46745	2464	1	Billing	Billing	NNP
46745	2464	2	(	(	-LRB-
46745	2464	3	_	_	NNP
46745	2464	4	Principles	Principles	NNPS
46745	2464	5	of	of	IN
46745	2464	6	Medicine	Medicine	NNP
46745	2464	7	,	,	,
46745	2464	8	5th	5th	JJ
46745	2464	9	edit	edit	NN
46745	2464	10	.	.	.
46745	2464	11	_	_	NNP
46745	2464	12	pp	pp	NNP
46745	2464	13	.	.	.
46745	2465	1	70	70	CD
46745	2465	2	-	-	SYM
46745	2465	3	75	75	CD
46745	2465	4	)	)	-RRB-
46745	2465	5	considers	consider	VBZ
46745	2465	6	that	that	IN
46745	2465	7	Mercury	Mercury	NNP
46745	2465	8	,	,	,
46745	2465	9	Arsenic	Arsenic	NNP
46745	2465	10	,	,	,
46745	2465	11	Colchicum	Colchicum	NNP
46745	2465	12	,	,	,
46745	2465	13	and	and	CC
46745	2465	14	all	all	PDT
46745	2465	15	the	the	DT
46745	2465	16	medicines	medicine	NNS
46745	2465	17	which	which	WDT
46745	2465	18	have	have	VBP
46745	2465	19	been	be	VBN
46745	2465	20	called	call	VBN
46745	2465	21	Specifics	Specifics	NNPS
46745	2465	22	,	,	,
46745	2465	23	are	be	VBP
46745	2465	24	not	not	RB
46745	2465	25	in	in	IN
46745	2465	26	fact	fact	NN
46745	2465	27	so	so	RB
46745	2465	28	,	,	,
46745	2465	29	but	but	CC
46745	2465	30	that	that	IN
46745	2465	31	they	-PRON-	PRP
46745	2465	32	are	be	VBP
46745	2465	33	capable	capable	JJ
46745	2465	34	of	of	IN
46745	2465	35	subduing	subdue	VBG
46745	2465	36	different	different	JJ
46745	2465	37	kinds	kind	NNS
46745	2465	38	of	of	IN
46745	2465	39	inflammation	inflammation	NN
46745	2465	40	by	by	IN
46745	2465	41	causing	cause	VBG
46745	2465	42	contraction	contraction	NN
46745	2465	43	of	of	IN
46745	2465	44	the	the	DT
46745	2465	45	dilated	dilate	VBN
46745	2465	46	capillary	capillary	JJ
46745	2465	47	vessels	vessel	NNS
46745	2465	48	.	.	.
46745	2466	1	This	this	DT
46745	2466	2	explanation	explanation	NN
46745	2466	3	has	have	VBZ
46745	2466	4	certainly	certainly	RB
46745	2466	5	the	the	DT
46745	2466	6	charm	charm	NN
46745	2466	7	of	of	IN
46745	2466	8	simplicity	simplicity	NN
46745	2466	9	,	,	,
46745	2466	10	but	but	CC
46745	2466	11	not	not	RB
46745	2466	12	,	,	,
46745	2466	13	in	in	IN
46745	2466	14	my	-PRON-	PRP$
46745	2466	15	opinion	opinion	NN
46745	2466	16	,	,	,
46745	2466	17	the	the	DT
46745	2466	18	merit	merit	NN
46745	2466	19	of	of	IN
46745	2466	20	truth	truth	NN
46745	2466	21	.	.	.
46745	2467	1	Dr.	Dr.	NNP
46745	2468	1	Billing	billing	NN
46745	2468	2	supports	support	VBZ
46745	2468	3	his	-PRON-	PRP$
46745	2468	4	argument	argument	NN
46745	2468	5	by	by	IN
46745	2468	6	instancing	instance	VBG
46745	2468	7	the	the	DT
46745	2468	8	number	number	NN
46745	2468	9	of	of	IN
46745	2468	10	remedies	remedy	NNS
46745	2468	11	that	that	WDT
46745	2468	12	have	have	VBP
46745	2468	13	been	be	VBN
46745	2468	14	used	use	VBN
46745	2468	15	in	in	IN
46745	2468	16	Syphilis	Syphilis	NNP
46745	2468	17	,	,	,
46745	2468	18	and	and	CC
46745	2468	19	considers	consider	VBZ
46745	2468	20	that	that	IN
46745	2468	21	they	-PRON-	PRP
46745	2468	22	must	must	MD
46745	2468	23	all	all	RB
46745	2468	24	operate	operate	VB
46745	2468	25	in	in	IN
46745	2468	26	a	a	DT
46745	2468	27	similar	similar	JJ
46745	2468	28	way	way	NN
46745	2468	29	,	,	,
46745	2468	30	both	both	CC
46745	2468	31	in	in	IN
46745	2468	32	this	this	DT
46745	2468	33	and	and	CC
46745	2468	34	in	in	IN
46745	2468	35	other	other	JJ
46745	2468	36	disorders	disorder	NNS
46745	2468	37	.	.	.
46745	2469	1	Yet	yet	CC
46745	2469	2	are	be	VBP
46745	2469	3	all	all	PDT
46745	2469	4	these	these	DT
46745	2469	5	medicines	medicine	NNS
46745	2469	6	of	of	IN
46745	2469	7	use	use	NN
46745	2469	8	or	or	CC
46745	2469	9	advantage	advantage	NN
46745	2469	10	in	in	IN
46745	2469	11	Ague	Ague	NNP
46745	2469	12	,	,	,
46745	2469	13	in	in	IN
46745	2469	14	Lepra	Lepra	NNP
46745	2469	15	,	,	,
46745	2469	16	in	in	IN
46745	2469	17	Chorea	Chorea	NNP
46745	2469	18	,	,	,
46745	2469	19	and	and	CC
46745	2469	20	in	in	IN
46745	2469	21	Scrofula	Scrofula	NNP
46745	2469	22	?	?	.
46745	2470	1	But	but	CC
46745	2470	2	why	why	WRB
46745	2470	3	is	be	VBZ
46745	2470	4	it	-PRON-	PRP
46745	2470	5	not	not	RB
46745	2470	6	so	so	RB
46745	2470	7	,	,	,
46745	2470	8	if	if	IN
46745	2470	9	all	all	DT
46745	2470	10	act	act	VBP
46745	2470	11	in	in	IN
46745	2470	12	the	the	DT
46745	2470	13	same	same	JJ
46745	2470	14	way	way	NN
46745	2470	15	?	?	.
46745	2471	1	Their	-PRON-	PRP$
46745	2471	2	several	several	JJ
46745	2471	3	actions	action	NNS
46745	2471	4	should	should	MD
46745	2471	5	exhibit	exhibit	VB
46745	2471	6	no	no	DT
46745	2471	7	difference	difference	NN
46745	2471	8	in	in	IN
46745	2471	9	kind	kind	NN
46745	2471	10	,	,	,
46745	2471	11	but	but	CC
46745	2471	12	only	only	RB
46745	2471	13	in	in	IN
46745	2471	14	degree	degree	NN
46745	2471	15	.	.	.
46745	2472	1	It	-PRON-	PRP
46745	2472	2	is	be	VBZ
46745	2472	3	the	the	DT
46745	2472	4	opinion	opinion	NN
46745	2472	5	of	of	IN
46745	2472	6	the	the	DT
46745	2472	7	same	same	JJ
46745	2472	8	able	able	JJ
46745	2472	9	authority	authority	NN
46745	2472	10	that	that	IN
46745	2472	11	Mercury	Mercury	NNP
46745	2472	12	and	and	CC
46745	2472	13	Iodine	Iodine	NNP
46745	2472	14	diminish	diminish	JJ
46745	2472	15	morbid	morbid	NN
46745	2472	16	growths	growth	NNS
46745	2472	17	by	by	IN
46745	2472	18	starving	starve	VBG
46745	2472	19	them	-PRON-	PRP
46745	2472	20	;	;	:
46745	2472	21	that	that	IN
46745	2472	22	they	-PRON-	PRP
46745	2472	23	cut	cut	VBD
46745	2472	24	off	off	RP
46745	2472	25	the	the	DT
46745	2472	26	supply	supply	NN
46745	2472	27	of	of	IN
46745	2472	28	blood	blood	NN
46745	2472	29	by	by	IN
46745	2472	30	contracting	contract	VBG
46745	2472	31	the	the	DT
46745	2472	32	capillaries	capillary	NNS
46745	2472	33	in	in	IN
46745	2472	34	the	the	DT
46745	2472	35	same	same	JJ
46745	2472	36	way	way	NN
46745	2472	37	as	as	IN
46745	2472	38	in	in	IN
46745	2472	39	other	other	JJ
46745	2472	40	cases	case	NNS
46745	2472	41	.	.	.
46745	2473	1	But	but	CC
46745	2473	2	why	why	WRB
46745	2473	3	then	then	RB
46745	2473	4	can	can	MD
46745	2473	5	we	-PRON-	PRP
46745	2473	6	not	not	RB
46745	2473	7	thus	thus	RB
46745	2473	8	remove	remove	VB
46745	2473	9	a	a	DT
46745	2473	10	fatty	fatty	NN
46745	2473	11	tumour	tumour	NN
46745	2473	12	,	,	,
46745	2473	13	a	a	DT
46745	2473	14	true	true	JJ
46745	2473	15	exostosis	exostosis	NN
46745	2473	16	,	,	,
46745	2473	17	or	or	CC
46745	2473	18	a	a	DT
46745	2473	19	malignant	malignant	JJ
46745	2473	20	growth	growth	NN
46745	2473	21	?	?	.
46745	2474	1	We	-PRON-	PRP
46745	2474	2	are	be	VBP
46745	2474	3	seldom	seldom	RB
46745	2474	4	able	able	JJ
46745	2474	5	by	by	IN
46745	2474	6	such	such	JJ
46745	2474	7	means	mean	NNS
46745	2474	8	to	to	TO
46745	2474	9	reduce	reduce	VB
46745	2474	10	the	the	DT
46745	2474	11	size	size	NN
46745	2474	12	of	of	IN
46745	2474	13	a	a	DT
46745	2474	14	tumour	tumour	NN
46745	2474	15	,	,	,
46745	2474	16	unless	unless	IN
46745	2474	17	it	-PRON-	PRP
46745	2474	18	depends	depend	VBZ
46745	2474	19	on	on	IN
46745	2474	20	a	a	DT
46745	2474	21	blood	blood	NN
46745	2474	22	-	-	HYPH
46745	2474	23	disorder	disorder	NN
46745	2474	24	,	,	,
46745	2474	25	as	as	IN
46745	2474	26	Syphilis	Syphilis	NNP
46745	2474	27	or	or	CC
46745	2474	28	Scrofula	Scrofula	NNP
46745	2474	29	.	.	.
46745	2475	1	The	the	DT
46745	2475	2	wide	wide	JJ
46745	2475	3	distinctions	distinction	NNS
46745	2475	4	and	and	CC
46745	2475	5	the	the	DT
46745	2475	6	shades	shade	NNS
46745	2475	7	of	of	IN
46745	2475	8	difference	difference	NN
46745	2475	9	which	which	WDT
46745	2475	10	exist	exist	VBP
46745	2475	11	between	between	IN
46745	2475	12	the	the	DT
46745	2475	13	operations	operation	NNS
46745	2475	14	of	of	IN
46745	2475	15	these	these	DT
46745	2475	16	several	several	JJ
46745	2475	17	medicines	medicine	NNS
46745	2475	18	are	be	VBP
46745	2475	19	surely	surely	RB
46745	2475	20	too	too	RB
46745	2475	21	many	many	JJ
46745	2475	22	and	and	CC
46745	2475	23	too	too	RB
46745	2475	24	serious	serious	JJ
46745	2475	25	to	to	TO
46745	2475	26	allow	allow	VB
46745	2475	27	us	-PRON-	PRP
46745	2475	28	to	to	TO
46745	2475	29	account	account	VB
46745	2475	30	for	for	IN
46745	2475	31	them	-PRON-	PRP
46745	2475	32	all	all	DT
46745	2475	33	by	by	IN
46745	2475	34	one	one	CD
46745	2475	35	explanation	explanation	NN
46745	2475	36	.	.	.
46745	2476	1	But	but	CC
46745	2476	2	we	-PRON-	PRP
46745	2476	3	may	may	MD
46745	2476	4	put	put	VB
46745	2476	5	aside	aside	RB
46745	2476	6	general	general	JJ
46745	2476	7	arguments	argument	NNS
46745	2476	8	,	,	,
46745	2476	9	and	and	CC
46745	2476	10	appeal	appeal	VBP
46745	2476	11	to	to	IN
46745	2476	12	facts	fact	NNS
46745	2476	13	.	.	.
46745	2477	1	In	in	IN
46745	2477	2	the	the	DT
46745	2477	3	first	first	JJ
46745	2477	4	place	place	NN
46745	2477	5	,	,	,
46745	2477	6	it	-PRON-	PRP
46745	2477	7	is	be	VBZ
46745	2477	8	very	very	RB
46745	2477	9	far	far	RB
46745	2477	10	from	from	IN
46745	2477	11	being	be	VBG
46745	2477	12	proved	prove	VBN
46745	2477	13	that	that	IN
46745	2477	14	in	in	IN
46745	2477	15	all	all	PDT
46745	2477	16	these	these	DT
46745	2477	17	disorders	disorder	NNS
46745	2477	18	the	the	DT
46745	2477	19	capillary	capillary	JJ
46745	2477	20	vessels	vessel	NNS
46745	2477	21	are	be	VBP
46745	2477	22	dilated	dilate	VBN
46745	2477	23	.	.	.
46745	2478	1	But	but	CC
46745	2478	2	let	let	VB
46745	2478	3	us	-PRON-	PRP
46745	2478	4	even	even	RB
46745	2478	5	admit	admit	VB
46745	2478	6	that	that	IN
46745	2478	7	it	-PRON-	PRP
46745	2478	8	is	be	VBZ
46745	2478	9	so	so	RB
46745	2478	10	proved	proved	JJ
46745	2478	11	,	,	,
46745	2478	12	and	and	CC
46745	2478	13	we	-PRON-	PRP
46745	2478	14	are	be	VBP
46745	2478	15	not	not	RB
46745	2478	16	then	then	RB
46745	2478	17	nearer	nearer	JJ
46745	2478	18	to	to	IN
46745	2478	19	the	the	DT
46745	2478	20	establishment	establishment	NN
46745	2478	21	of	of	IN
46745	2478	22	the	the	DT
46745	2478	23	above	above	JJ
46745	2478	24	hypothesis	hypothesis	NN
46745	2478	25	.	.	.
46745	2479	1	For	for	IN
46745	2479	2	is	be	VBZ
46745	2479	3	the	the	DT
46745	2479	4	action	action	NN
46745	2479	5	of	of	IN
46745	2479	6	any	any	DT
46745	2479	7	medicinal	medicinal	JJ
46745	2479	8	agent	agent	NN
46745	2479	9	on	on	IN
46745	2479	10	the	the	DT
46745	2479	11	capillaries	capillary	NNS
46745	2479	12	constant	constant	JJ
46745	2479	13	in	in	IN
46745	2479	14	character	character	NN
46745	2479	15	?	?	.
46745	2480	1	Mr.	Mr.	NNP
46745	2480	2	Wharton	Wharton	NNP
46745	2480	3	Jones	Jones	NNP
46745	2480	4	,	,	,
46745	2480	5	in	in	IN
46745	2480	6	his	-PRON-	PRP$
46745	2480	7	Astley	Astley	NNP
46745	2480	8	Cooper	Cooper	NNP
46745	2480	9	Prize	Prize	NNP
46745	2480	10	Essay	Essay	NNP
46745	2480	11	,	,	,
46745	2480	12	states	state	VBZ
46745	2480	13	that	that	IN
46745	2480	14	he	-PRON-	PRP
46745	2480	15	has	have	VBZ
46745	2480	16	found	find	VBN
46745	2480	17	the	the	DT
46745	2480	18	effects	effect	NNS
46745	2480	19	of	of	IN
46745	2480	20	medicinal	medicinal	JJ
46745	2480	21	solutions	solution	NNS
46745	2480	22	on	on	IN
46745	2480	23	the	the	DT
46745	2480	24	capillaries	capillary	NNS
46745	2480	25	in	in	IN
46745	2480	26	the	the	DT
46745	2480	27	web	web	NN
46745	2480	28	of	of	IN
46745	2480	29	a	a	DT
46745	2480	30	frog	frog	NN
46745	2480	31	's	's	POS
46745	2480	32	foot	foot	NN
46745	2480	33	to	to	TO
46745	2480	34	be	be	VB
46745	2480	35	very	very	RB
46745	2480	36	various	various	JJ
46745	2480	37	.	.	.
46745	2481	1	For	for	IN
46745	2481	2	even	even	RB
46745	2481	3	a	a	DT
46745	2481	4	solution	solution	NN
46745	2481	5	of	of	IN
46745	2481	6	Sulphate	Sulphate	NNP
46745	2481	7	of	of	IN
46745	2481	8	Copper	Copper	NNP
46745	2481	9	has	have	VBZ
46745	2481	10	been	be	VBN
46745	2481	11	known	know	VBN
46745	2481	12	to	to	TO
46745	2481	13	cause	cause	VB
46745	2481	14	dilatation	dilatation	NN
46745	2481	15	,	,	,
46745	2481	16	and	and	CC
46745	2481	17	one	one	CD
46745	2481	18	of	of	IN
46745	2481	19	Atropia	Atropia	NNP
46745	2481	20	to	to	TO
46745	2481	21	produce	produce	VB
46745	2481	22	constriction	constriction	NN
46745	2481	23	;	;	,
46745	2481	24	though	though	IN
46745	2481	25	the	the	DT
46745	2481	26	former	former	JJ
46745	2481	27	is	be	VBZ
46745	2481	28	an	an	DT
46745	2481	29	astringent	astringent	NN
46745	2481	30	;	;	:
46745	2481	31	and	and	CC
46745	2481	32	the	the	DT
46745	2481	33	latter	latter	JJ
46745	2481	34	a	a	DT
46745	2481	35	paralyzer	paralyzer	NN
46745	2481	36	.	.	.
46745	2482	1	So	so	RB
46745	2482	2	that	that	IN
46745	2482	3	the	the	DT
46745	2482	4	vessels	vessel	NNS
46745	2482	5	are	be	VBP
46745	2482	6	not	not	RB
46745	2482	7	nearly	nearly	RB
46745	2482	8	so	so	RB
46745	2482	9	much	much	JJ
46745	2482	10	under	under	IN
46745	2482	11	the	the	DT
46745	2482	12	influence	influence	NN
46745	2482	13	of	of	IN
46745	2482	14	such	such	JJ
46745	2482	15	agencies	agency	NNS
46745	2482	16	as	as	IN
46745	2482	17	Dr.	Dr.	NNP
46745	2483	1	Billing	billing	NN
46745	2483	2	would	would	MD
46745	2483	3	seem	seem	VB
46745	2483	4	to	to	TO
46745	2483	5	imagine	imagine	VB
46745	2483	6	.	.	.
46745	2484	1	In	in	IN
46745	2484	2	these	these	DT
46745	2484	3	experiments	experiment	NNS
46745	2484	4	the	the	DT
46745	2484	5	solutions	solution	NNS
46745	2484	6	were	be	VBD
46745	2484	7	concentrated	concentrate	VBN
46745	2484	8	,	,	,
46745	2484	9	and	and	CC
46745	2484	10	applied	apply	VBD
46745	2484	11	directly	directly	RB
46745	2484	12	.	.	.
46745	2485	1	But	but	CC
46745	2485	2	in	in	IN
46745	2485	3	the	the	DT
46745	2485	4	cases	case	NNS
46745	2485	5	in	in	IN
46745	2485	6	point	point	NN
46745	2485	7	we	-PRON-	PRP
46745	2485	8	might	may	MD
46745	2485	9	have	have	VB
46745	2485	10	two	two	CD
46745	2485	11	or	or	CC
46745	2485	12	three	three	CD
46745	2485	13	grains	grain	NNS
46745	2485	14	of	of	IN
46745	2485	15	Iodide	Iodide	NNP
46745	2485	16	of	of	IN
46745	2485	17	Potassium	Potassium	NNP
46745	2485	18	,	,	,
46745	2485	19	one	one	CD
46745	2485	20	-	-	HYPH
46745	2485	21	tenth	tenth	NN
46745	2485	22	of	of	IN
46745	2485	23	a	a	DT
46745	2485	24	grain	grain	NN
46745	2485	25	of	of	IN
46745	2485	26	Arsenite	Arsenite	NNP
46745	2485	27	of	of	IN
46745	2485	28	Potash	Potash	NNP
46745	2485	29	,	,	,
46745	2485	30	or	or	CC
46745	2485	31	one	one	CD
46745	2485	32	-	-	HYPH
46745	2485	33	twentieth	twentieth	NN
46745	2485	34	of	of	IN
46745	2485	35	a	a	DT
46745	2485	36	grain	grain	NN
46745	2485	37	of	of	IN
46745	2485	38	Bichloride	Bichloride	NNP
46745	2485	39	of	of	IN
46745	2485	40	Mercury	Mercury	NNP
46745	2485	41	,	,	,
46745	2485	42	diluted	dilute	VBN
46745	2485	43	down	down	RP
46745	2485	44	by	by	IN
46745	2485	45	about	about	RB
46745	2485	46	twenty	twenty	CD
46745	2485	47	pounds	pound	NNS
46745	2485	48	of	of	IN
46745	2485	49	blood	blood	NN
46745	2485	50	,	,	,
46745	2485	51	and	and	CC
46745	2485	52	extended	extend	VBD
46745	2485	53	through	through	IN
46745	2485	54	many	many	JJ
46745	2485	55	miles	mile	NNS
46745	2485	56	of	of	IN
46745	2485	57	capillary	capillary	JJ
46745	2485	58	tubes	tube	NNS
46745	2485	59	!	!	.
46745	2486	1	And	and	CC
46745	2486	2	if	if	IN
46745	2486	3	simple	simple	JJ
46745	2486	4	contraction	contraction	NN
46745	2486	5	of	of	IN
46745	2486	6	the	the	DT
46745	2486	7	capillaries	capillary	NNS
46745	2486	8	were	be	VBD
46745	2486	9	required	require	VBN
46745	2486	10	,	,	,
46745	2486	11	surely	surely	RB
46745	2486	12	Astringents	astringent	NNS
46745	2486	13	,	,	,
46745	2486	14	which	which	WDT
46745	2486	15	are	be	VBP
46745	2486	16	known	know	VBN
46745	2486	17	to	to	TO
46745	2486	18	effect	effect	VB
46745	2486	19	this	this	DT
46745	2486	20	,	,	,
46745	2486	21	should	should	MD
46745	2486	22	be	be	VB
46745	2486	23	the	the	DT
46745	2486	24	most	most	RBS
46745	2486	25	useful	useful	JJ
46745	2486	26	of	of	IN
46745	2486	27	all	all	PDT
46745	2486	28	these	these	DT
46745	2486	29	medicines	medicine	NNS
46745	2486	30	.	.	.
46745	2487	1	But	but	CC
46745	2487	2	we	-PRON-	PRP
46745	2487	3	do	do	VBP
46745	2487	4	not	not	RB
46745	2487	5	find	find	VB
46745	2487	6	it	-PRON-	PRP
46745	2487	7	to	to	TO
46745	2487	8	be	be	VB
46745	2487	9	so	so	RB
46745	2487	10	.	.	.
46745	2488	1	Further	further	RB
46745	2488	2	,	,	,
46745	2488	3	this	this	DT
46745	2488	4	idea	idea	NN
46745	2488	5	must	must	MD
46745	2488	6	include	include	VB
46745	2488	7	a	a	DT
46745	2488	8	virtual	virtual	JJ
46745	2488	9	denial	denial	NN
46745	2488	10	of	of	IN
46745	2488	11	the	the	DT
46745	2488	12	causation	causation	NN
46745	2488	13	of	of	IN
46745	2488	14	blood	blood	NN
46745	2488	15	disorders	disorder	NNS
46745	2488	16	by	by	IN
46745	2488	17	special	special	JJ
46745	2488	18	morbid	morbid	NN
46745	2488	19	agencies	agency	NNS
46745	2488	20	.	.	.
46745	2489	1	Such	such	JJ
46745	2489	2	are	be	VBP
46745	2489	3	the	the	DT
46745	2489	4	grounds	ground	NNS
46745	2489	5	upon	upon	IN
46745	2489	6	which	which	WDT
46745	2489	7	is	be	VBZ
46745	2489	8	founded	found	VBN
46745	2489	9	a	a	DT
46745	2489	10	denial	denial	NN
46745	2489	11	of	of	IN
46745	2489	12	the	the	DT
46745	2489	13	existence	existence	NN
46745	2489	14	of	of	IN
46745	2489	15	specific	specific	JJ
46745	2489	16	medicines--_i.e	medicines--_i.e	NNP
46745	2489	17	.	.	.
46745	2489	18	_	_	NNP
46745	2489	19	of	of	IN
46745	2489	20	remedies	remedy	NNS
46745	2489	21	which	which	WDT
46745	2489	22	are	be	VBP
46745	2489	23	of	of	IN
46745	2489	24	particular	particular	JJ
46745	2489	25	or	or	CC
46745	2489	26	special	special	JJ
46745	2489	27	use	use	NN
46745	2489	28	in	in	IN
46745	2489	29	one	one	CD
46745	2489	30	or	or	CC
46745	2489	31	more	more	JJR
46745	2489	32	disorders	disorder	NNS
46745	2489	33	.	.	.
46745	2490	1	Is	be	VBZ
46745	2490	2	it	-PRON-	PRP
46745	2490	3	reasonable	reasonable	JJ
46745	2490	4	to	to	TO
46745	2490	5	deny	deny	VB
46745	2490	6	that	that	IN
46745	2490	7	Mercury	Mercury	NNP
46745	2490	8	is	be	VBZ
46745	2490	9	of	of	IN
46745	2490	10	particular	particular	JJ
46745	2490	11	use	use	NN
46745	2490	12	in	in	IN
46745	2490	13	Syphilis	Syphilis	NNP
46745	2490	14	?	?	.
46745	2491	1	that	that	IN
46745	2491	2	Iodide	Iodide	NNP
46745	2491	3	of	of	IN
46745	2491	4	Potassium	Potassium	NNP
46745	2491	5	exerts	exert	VBZ
46745	2491	6	a	a	DT
46745	2491	7	special	special	JJ
46745	2491	8	influence	influence	NN
46745	2491	9	over	over	IN
46745	2491	10	secondary	secondary	JJ
46745	2491	11	forms	form	NNS
46745	2491	12	of	of	IN
46745	2491	13	the	the	DT
46745	2491	14	same	same	JJ
46745	2491	15	malady	malady	NN
46745	2491	16	?	?	.
46745	2492	1	that	that	IN
46745	2492	2	Iodine	Iodine	NNP
46745	2492	3	and	and	CC
46745	2492	4	Potash	Potash	NNP
46745	2492	5	are	be	VBP
46745	2492	6	each	each	DT
46745	2492	7	peculiarly	peculiarly	RB
46745	2492	8	adapted	adapt	VBN
46745	2492	9	to	to	IN
46745	2492	10	scrofulous	scrofulous	JJ
46745	2492	11	cases	case	NNS
46745	2492	12	?	?	.
46745	2493	1	or	or	CC
46745	2493	2	that	that	IN
46745	2493	3	Colchicum	Colchicum	NNP
46745	2493	4	will	will	MD
46745	2493	5	often	often	RB
46745	2493	6	stop	stop	VB
46745	2493	7	a	a	DT
46745	2493	8	fit	fit	NN
46745	2493	9	of	of	IN
46745	2493	10	the	the	DT
46745	2493	11	Gout	Gout	NNP
46745	2493	12	when	when	WRB
46745	2493	13	other	other	JJ
46745	2493	14	medicines	medicine	NNS
46745	2493	15	have	have	VBP
46745	2493	16	failed	fail	VBN
46745	2493	17	to	to	TO
46745	2493	18	relieve	relieve	VB
46745	2493	19	it	-PRON-	PRP
46745	2493	20	?	?	.
46745	2494	1	If	if	IN
46745	2494	2	we	-PRON-	PRP
46745	2494	3	can	can	MD
46745	2494	4	not	not	RB
46745	2494	5	deny	deny	VB
46745	2494	6	it	-PRON-	PRP
46745	2494	7	,	,	,
46745	2494	8	we	-PRON-	PRP
46745	2494	9	must	must	MD
46745	2494	10	admit	admit	VB
46745	2494	11	such	such	JJ
46745	2494	12	actions	action	NNS
46745	2494	13	to	to	TO
46745	2494	14	be	be	VB
46745	2494	15	in	in	IN
46745	2494	16	some	some	DT
46745	2494	17	degree	degree	NN
46745	2494	18	specific	specific	JJ
46745	2494	19	.	.	.
46745	2495	1	To	to	TO
46745	2495	2	adopt	adopt	VB
46745	2495	3	this	this	DT
46745	2495	4	term	term	NN
46745	2495	5	is	be	VBZ
46745	2495	6	to	to	IN
46745	2495	7	a	a	DT
46745	2495	8	certain	certain	JJ
46745	2495	9	extent	extent	NN
46745	2495	10	to	to	TO
46745	2495	11	confess	confess	VB
46745	2495	12	our	-PRON-	PRP$
46745	2495	13	ignorance	ignorance	NN
46745	2495	14	,	,	,
46745	2495	15	and	and	CC
46745	2495	16	for	for	IN
46745	2495	17	this	this	DT
46745	2495	18	reason	reason	NN
46745	2495	19	many	many	JJ
46745	2495	20	have	have	VBP
46745	2495	21	objected	object	VBN
46745	2495	22	to	to	IN
46745	2495	23	it	-PRON-	PRP
46745	2495	24	;	;	:
46745	2495	25	but	but	CC
46745	2495	26	this	this	DT
46745	2495	27	we	-PRON-	PRP
46745	2495	28	can	can	MD
46745	2495	29	not	not	RB
46745	2495	30	avoid	avoid	VB
46745	2495	31	.	.	.
46745	2496	1	The	the	DT
46745	2496	2	word	word	NN
46745	2496	3	is	be	VBZ
46745	2496	4	,	,	,
46745	2496	5	however	however	RB
46745	2496	6	,	,	,
46745	2496	7	decidedly	decidedly	RB
46745	2496	8	objectionable	objectionable	JJ
46745	2496	9	,	,	,
46745	2496	10	when	when	WRB
46745	2496	11	it	-PRON-	PRP
46745	2496	12	is	be	VBZ
46745	2496	13	misapplied	misapply	VBN
46745	2496	14	to	to	TO
46745	2496	15	express	express	VB
46745	2496	16	the	the	DT
46745	2496	17	idea	idea	NN
46745	2496	18	of	of	IN
46745	2496	19	some	some	DT
46745	2496	20	particular	particular	JJ
46745	2496	21	medicine	medicine	NN
46745	2496	22	being	be	VBG
46745	2496	23	the	the	DT
46745	2496	24	only	only	JJ
46745	2496	25	one	one	NN
46745	2496	26	that	that	WDT
46745	2496	27	can	can	MD
46745	2496	28	be	be	VB
46745	2496	29	used	use	VBN
46745	2496	30	in	in	IN
46745	2496	31	a	a	DT
46745	2496	32	certain	certain	JJ
46745	2496	33	disorder	disorder	NN
46745	2496	34	.	.	.
46745	2497	1	For	for	IN
46745	2497	2	this	this	DT
46745	2497	3	is	be	VBZ
46745	2497	4	an	an	DT
46745	2497	5	exaggeration	exaggeration	NN
46745	2497	6	of	of	IN
46745	2497	7	the	the	DT
46745	2497	8	truth	truth	NN
46745	2497	9	that	that	WDT
46745	2497	10	may	may	MD
46745	2497	11	lead	lead	VB
46745	2497	12	to	to	IN
46745	2497	13	very	very	RB
46745	2497	14	serious	serious	JJ
46745	2497	15	error	error	NN
46745	2497	16	.	.	.
46745	2498	1	Before	before	IN
46745	2498	2	now	now	RB
46745	2498	3	proceeding	proceed	VBG
46745	2498	4	to	to	IN
46745	2498	5	the	the	DT
46745	2498	6	proof	proof	NN
46745	2498	7	of	of	IN
46745	2498	8	the	the	DT
46745	2498	9	minor	minor	JJ
46745	2498	10	propositions	proposition	NNS
46745	2498	11	of	of	IN
46745	2498	12	Catalytics	catalytic	NNS
46745	2498	13	taken	take	VBN
46745	2498	14	collectively	collectively	RB
46745	2498	15	,	,	,
46745	2498	16	I	-PRON-	PRP
46745	2498	17	must	must	MD
46745	2498	18	enumerate	enumerate	VB
46745	2498	19	the	the	DT
46745	2498	20	chief	chief	JJ
46745	2498	21	remedies	remedy	NNS
46745	2498	22	which	which	WDT
46745	2498	23	I	-PRON-	PRP
46745	2498	24	intend	intend	VBP
46745	2498	25	to	to	TO
46745	2498	26	include	include	VB
46745	2498	27	in	in	IN
46745	2498	28	the	the	DT
46745	2498	29	eight	eight	CD
46745	2498	30	separate	separate	JJ
46745	2498	31	orders	order	NNS
46745	2498	32	into	into	IN
46745	2498	33	which	which	WDT
46745	2498	34	this	this	DT
46745	2498	35	division	division	NN
46745	2498	36	of	of	IN
46745	2498	37	blood	blood	NN
46745	2498	38	-	-	HYPH
46745	2498	39	medicines	medicine	NNS
46745	2498	40	has	have	VBZ
46745	2498	41	been	be	VBN
46745	2498	42	divided	divide	VBN
46745	2498	43	.	.	.
46745	2499	1	_	_	NNP
46745	2499	2	Ord	Ord	NNP
46745	2499	3	.	.	.
46745	2500	1	1	1	LS
46745	2500	2	.	.	.
46745	2501	1	Antiphlogistics	antiphlogistic	NNS
46745	2501	2	.	.	.
46745	2501	3	_	_	NNP
46745	2501	4	Antimonials	Antimonials	NNPS
46745	2501	5	;	;	:
46745	2501	6	Mercurials	Mercurials	NNPS
46745	2501	7	;	;	:
46745	2501	8	Alkalies	alkali	NNS
46745	2501	9	;	;	:
46745	2501	10	Salines	Salines	NNP
46745	2501	11	.	.	.
46745	2502	1	_	_	NNP
46745	2502	2	Ord	Ord	NNP
46745	2502	3	.	.	.
46745	2503	1	2	2	LS
46745	2503	2	.	.	.
46745	2504	1	Antisyphilitics	antisyphilitic	NNS
46745	2504	2	.	.	.
46745	2504	3	_	_	NNP
46745	2504	4	Mercurials	Mercurials	NNPS
46745	2504	5	;	;	:
46745	2504	6	Preparations	preparation	NNS
46745	2504	7	of	of	IN
46745	2504	8	Gold	gold	NN
46745	2504	9	;	;	:
46745	2504	10	Iodide	Iodide	NNP
46745	2504	11	of	of	IN
46745	2504	12	Potassium	Potassium	NNP
46745	2504	13	;	;	,
46745	2504	14	Sarsaparilla	Sarsaparilla	NNP
46745	2504	15	(	(	-LRB-
46745	2504	16	?	?	.
46745	2504	17	)	)	-RRB-
46745	2504	18	.	.	.
46745	2505	1	_	_	NNP
46745	2505	2	Ord	Ord	NNP
46745	2505	3	.	.	.
46745	2506	1	3	3	LS
46745	2506	2	.	.	.
46745	2507	1	Antiscrofulitics	antiscrofulitic	NNS
46745	2507	2	.	.	.
46745	2507	3	_	_	NNP
46745	2507	4	Iodine	Iodine	NNP
46745	2507	5	;	;	:
46745	2507	6	Bromine	Bromine	NNP
46745	2507	7	;	;	:
46745	2507	8	Chlorine	Chlorine	NNP
46745	2507	9	;	;	:
46745	2507	10	Iodides	Iodides	NNPS
46745	2507	11	and	and	CC
46745	2507	12	Bromides	Bromides	NNPS
46745	2507	13	;	;	:
46745	2507	14	Potash	Potash	NNP
46745	2507	15	.	.	.
46745	2508	1	_	_	NNP
46745	2508	2	Ord	Ord	NNP
46745	2508	3	.	.	.
46745	2509	1	4	4	LS
46745	2509	2	.	.	.
46745	2510	1	Antiarthritics	antiarthritic	NNS
46745	2510	2	.	.	.
46745	2510	3	_	_	NNP
46745	2510	4	Colchicum	Colchicum	NNP
46745	2510	5	;	;	:
46745	2510	6	Nitro	Nitro	NNP
46745	2510	7	-	-	HYPH
46745	2510	8	hydrochloric	hydrochloric	JJ
46745	2510	9	Acid	acid	NN
46745	2510	10	;	;	:
46745	2510	11	Lemon	lemon	NN
46745	2510	12	-	-	HYPH
46745	2510	13	juice	juice	NN
46745	2510	14	.	.	.
46745	2511	1	_	_	NNP
46745	2511	2	Ord	Ord	NNP
46745	2511	3	.	.	.
46745	2512	1	5	5	CD
46745	2512	2	.	.	.
46745	2513	1	Antiscorbutics	antiscorbutic	NNS
46745	2513	2	.	.	.
46745	2513	3	_	_	NNP
46745	2513	4	Citric	Citric	NNP
46745	2513	5	Acid	Acid	NNP
46745	2513	6	;	;	:
46745	2513	7	Lemon	lemon	NN
46745	2513	8	-	-	HYPH
46745	2513	9	juice	juice	NN
46745	2513	10	;	;	:
46745	2513	11	Fresh	fresh	JJ
46745	2513	12	Vegetables	vegetable	NNS
46745	2513	13	;	;	:
46745	2513	14	Salts	salt	NNS
46745	2513	15	of	of	IN
46745	2513	16	Potash	Potash	NNP
46745	2513	17	(	(	-LRB-
46745	2513	18	?	?	.
46745	2513	19	)	)	-RRB-
46745	2513	20	.	.	.
46745	2514	1	_	_	NNP
46745	2514	2	Ord	Ord	NNP
46745	2514	3	.	.	.
46745	2515	1	6	6	CD
46745	2515	2	.	.	.
46745	2516	1	Antiperiodics	Antiperiodics	NNP
46745	2516	2	.	.	.
46745	2516	3	_	_	NNP
46745	2516	4	Arsenious	Arsenious	NNP
46745	2516	5	Acid	Acid	NNP
46745	2516	6	;	;	:
46745	2516	7	Arsenite	Arsenite	NNP
46745	2516	8	of	of	IN
46745	2516	9	Potash	Potash	NNP
46745	2516	10	;	;	:
46745	2516	11	Alum	Alum	NNP
46745	2516	12	;	;	:
46745	2516	13	Chloride	Chloride	NNP
46745	2516	14	of	of	IN
46745	2516	15	Sodium	Sodium	NNP
46745	2516	16	.	.	.
46745	2517	1	_	_	NNP
46745	2517	2	Ord	Ord	NNP
46745	2517	3	.	.	.
46745	2518	1	7	7	LS
46745	2518	2	.	.	.
46745	2519	1	Anticonvulsives	anticonvulsive	NNS
46745	2519	2	.	.	.
46745	2519	3	_	_	NNP
46745	2519	4	Preparations	Preparations	NNPS
46745	2519	5	of	of	IN
46745	2519	6	Arsenic	Arsenic	NNP
46745	2519	7	,	,	,
46745	2519	8	Silver	Silver	NNP
46745	2519	9	,	,	,
46745	2519	10	Zinc	Zinc	NNP
46745	2519	11	,	,	,
46745	2519	12	Lead	Lead	NNP
46745	2519	13	,	,	,
46745	2519	14	and	and	CC
46745	2519	15	Copper	copper	NN
46745	2519	16	.	.	.
46745	2520	1	_	_	NNP
46745	2520	2	Ord	Ord	NNP
46745	2520	3	.	.	.
46745	2521	1	8	8	LS
46745	2521	2	.	.	.
46745	2522	1	Antisquamics	antisquamic	NNS
46745	2522	2	.	.	.
46745	2522	3	_	_	NNP
46745	2522	4	Preparations	Preparations	NNPS
46745	2522	5	of	of	IN
46745	2522	6	Arsenic	Arsenic	NNP
46745	2522	7	;	;	:
46745	2522	8	Sulphur	Sulphur	NNP
46745	2522	9	;	;	:
46745	2522	10	Pitch	Pitch	NNP
46745	2522	11	.	.	.
46745	2523	1	Under	under	IN
46745	2523	2	each	each	DT
46745	2523	3	head	head	NN
46745	2523	4	I	-PRON-	PRP
46745	2523	5	have	have	VBP
46745	2523	6	given	give	VBN
46745	2523	7	the	the	DT
46745	2523	8	most	most	RBS
46745	2523	9	important	important	JJ
46745	2523	10	of	of	IN
46745	2523	11	those	those	DT
46745	2523	12	medicines	medicine	NNS
46745	2523	13	which	which	WDT
46745	2523	14	I	-PRON-	PRP
46745	2523	15	conceive	conceive	VBP
46745	2523	16	to	to	TO
46745	2523	17	act	act	VB
46745	2523	18	on	on	IN
46745	2523	19	the	the	DT
46745	2523	20	Catalytic	catalytic	JJ
46745	2523	21	principle	principle	NN
46745	2523	22	.	.	.
46745	2524	1	Other	other	JJ
46745	2524	2	medicines	medicine	NNS
46745	2524	3	may	may	MD
46745	2524	4	cure	cure	VB
46745	2524	5	some	some	DT
46745	2524	6	of	of	IN
46745	2524	7	these	these	DT
46745	2524	8	disorders	disorder	NNS
46745	2524	9	,	,	,
46745	2524	10	or	or	CC
46745	2524	11	at	at	IN
46745	2524	12	least	least	JJS
46745	2524	13	alleviate	alleviate	VB
46745	2524	14	them	-PRON-	PRP
46745	2524	15	;	;	:
46745	2524	16	either	either	CC
46745	2524	17	by	by	IN
46745	2524	18	acting	act	VBG
46745	2524	19	as	as	IN
46745	2524	20	Restoratives	Restoratives	NNP
46745	2524	21	,	,	,
46745	2524	22	as	as	IN
46745	2524	23	in	in	IN
46745	2524	24	the	the	DT
46745	2524	25	case	case	NN
46745	2524	26	of	of	IN
46745	2524	27	arthritic	arthritic	JJ
46745	2524	28	and	and	CC
46745	2524	29	of	of	IN
46745	2524	30	periodic	periodic	JJ
46745	2524	31	disorders	disorder	NNS
46745	2524	32	;	;	:
46745	2524	33	or	or	CC
46745	2524	34	by	by	IN
46745	2524	35	influencing	influence	VBG
46745	2524	36	the	the	DT
46745	2524	37	nervous	nervous	JJ
46745	2524	38	system	system	NN
46745	2524	39	,	,	,
46745	2524	40	which	which	WDT
46745	2524	41	plan	plan	NN
46745	2524	42	may	may	MD
46745	2524	43	be	be	VB
46745	2524	44	effectual	effectual	JJ
46745	2524	45	in	in	IN
46745	2524	46	some	some	DT
46745	2524	47	convulsive	convulsive	JJ
46745	2524	48	affections	affection	NNS
46745	2524	49	.	.	.
46745	2525	1	The	the	DT
46745	2525	2	prefix	prefix	NN
46745	2525	3	_	_	NNP
46745	2525	4	Anti-	Anti-	NNP
46745	2525	5	_	_	NNP
46745	2525	6	involves	involve	VBZ
46745	2525	7	a	a	DT
46745	2525	8	principle	principle	NN
46745	2525	9	.	.	.
46745	2526	1	These	these	DT
46745	2526	2	medicines	medicine	NNS
46745	2526	3	produce	produce	VBP
46745	2526	4	certain	certain	JJ
46745	2526	5	actions	action	NNS
46745	2526	6	which	which	WDT
46745	2526	7	are	be	VBP
46745	2526	8	_	_	NNP
46745	2526	9	contrary	contrary	JJ
46745	2526	10	_	_	NNP
46745	2526	11	to	to	IN
46745	2526	12	diseased	disease	VBN
46745	2526	13	actions	action	NNS
46745	2526	14	,	,	,
46745	2526	15	inasmuch	inasmuch	JJ
46745	2526	16	as	as	IN
46745	2526	17	they	-PRON-	PRP
46745	2526	18	neutralize	neutralize	VBP
46745	2526	19	them	-PRON-	PRP
46745	2526	20	,	,	,
46745	2526	21	and	and	CC
46745	2526	22	can	can	MD
46745	2526	23	not	not	RB
46745	2526	24	subsist	subsist	VB
46745	2526	25	with	with	IN
46745	2526	26	them	-PRON-	PRP
46745	2526	27	.	.	.
46745	2527	1	It	-PRON-	PRP
46745	2527	2	is	be	VBZ
46745	2527	3	granted	grant	VBN
46745	2527	4	that	that	IN
46745	2527	5	in	in	IN
46745	2527	6	some	some	DT
46745	2527	7	cases	case	NNS
46745	2527	8	the	the	DT
46745	2527	9	actions	action	NNS
46745	2527	10	may	may	MD
46745	2527	11	appear	appear	VB
46745	2527	12	similar	similar	JJ
46745	2527	13	in	in	IN
46745	2527	14	some	some	DT
46745	2527	15	respects	respect	NNS
46745	2527	16	.	.	.
46745	2528	1	But	but	CC
46745	2528	2	this	this	DT
46745	2528	3	merely	merely	RB
46745	2528	4	shows	show	VBZ
46745	2528	5	that	that	IN
46745	2528	6	they	-PRON-	PRP
46745	2528	7	move	move	VBP
46745	2528	8	,	,	,
46745	2528	9	as	as	IN
46745	2528	10	it	-PRON-	PRP
46745	2528	11	were	be	VBD
46745	2528	12	,	,	,
46745	2528	13	in	in	IN
46745	2528	14	the	the	DT
46745	2528	15	same	same	JJ
46745	2528	16	sphere	sphere	NN
46745	2528	17	,	,	,
46745	2528	18	for	for	IN
46745	2528	19	else	else	RB
46745	2528	20	one	one	CD
46745	2528	21	of	of	IN
46745	2528	22	them	-PRON-	PRP
46745	2528	23	could	could	MD
46745	2528	24	not	not	RB
46745	2528	25	meet	meet	VB
46745	2528	26	the	the	DT
46745	2528	27	other	other	JJ
46745	2528	28	.	.	.
46745	2529	1	However	however	RB
46745	2529	2	the	the	DT
46745	2529	3	operation	operation	NN
46745	2529	4	of	of	IN
46745	2529	5	a	a	DT
46745	2529	6	medicine	medicine	NN
46745	2529	7	may	may	MD
46745	2529	8	sometimes	sometimes	RB
46745	2529	9	seem	seem	VB
46745	2529	10	to	to	TO
46745	2529	11	resemble	resemble	VB
46745	2529	12	that	that	DT
46745	2529	13	of	of	IN
46745	2529	14	a	a	DT
46745	2529	15	disease	disease	NN
46745	2529	16	,	,	,
46745	2529	17	it	-PRON-	PRP
46745	2529	18	is	be	VBZ
46745	2529	19	always	always	RB
46745	2529	20	in	in	IN
46745	2529	21	effect	effect	NN
46745	2529	22	contrary	contrary	JJ
46745	2529	23	to	to	IN
46745	2529	24	it	-PRON-	PRP
46745	2529	25	.	.	.
46745	2530	1	The	the	DT
46745	2530	2	similarity	similarity	NN
46745	2530	3	is	be	VBZ
46745	2530	4	of	of	IN
46745	2530	5	a	a	DT
46745	2530	6	kind	kind	NN
46745	2530	7	which	which	WDT
46745	2530	8	does	do	VBZ
46745	2530	9	not	not	RB
46745	2530	10	concern	concern	VB
46745	2530	11	us	-PRON-	PRP
46745	2530	12	.	.	.
46745	2531	1	An	an	DT
46745	2531	2	acid	acid	NN
46745	2531	3	and	and	CC
46745	2531	4	an	an	DT
46745	2531	5	alkali	alkali	JJ
46745	2531	6	are	be	VBP
46745	2531	7	so	so	RB
46745	2531	8	far	far	RB
46745	2531	9	similar	similar	JJ
46745	2531	10	,	,	,
46745	2531	11	that	that	IN
46745	2531	12	they	-PRON-	PRP
46745	2531	13	may	may	MD
46745	2531	14	both	both	DT
46745	2531	15	produce	produce	VB
46745	2531	16	heat	heat	NN
46745	2531	17	when	when	WRB
46745	2531	18	mixed	mix	VBN
46745	2531	19	with	with	IN
46745	2531	20	water	water	NN
46745	2531	21	,	,	,
46745	2531	22	and	and	CC
46745	2531	23	both	both	DT
46745	2531	24	prove	prove	VBP
46745	2531	25	corrosive	corrosive	JJ
46745	2531	26	and	and	CC
46745	2531	27	destructive	destructive	JJ
46745	2531	28	to	to	IN
46745	2531	29	organized	organize	VBN
46745	2531	30	tissues	tissue	NNS
46745	2531	31	;	;	:
46745	2531	32	but	but	CC
46745	2531	33	they	-PRON-	PRP
46745	2531	34	are	be	VBP
46745	2531	35	practically	practically	RB
46745	2531	36	contrary	contrary	JJ
46745	2531	37	,	,	,
46745	2531	38	and	and	CC
46745	2531	39	when	when	WRB
46745	2531	40	brought	bring	VBN
46745	2531	41	together	together	RB
46745	2531	42	they	-PRON-	PRP
46745	2531	43	neutralize	neutralize	VBP
46745	2531	44	each	each	DT
46745	2531	45	other	other	JJ
46745	2531	46	.	.	.
46745	2532	1	Let	let	VB
46745	2532	2	us	-PRON-	PRP
46745	2532	3	now	now	RB
46745	2532	4	proceed	proceed	VB
46745	2532	5	to	to	IN
46745	2532	6	the	the	DT
46745	2532	7	minor	minor	JJ
46745	2532	8	propositions	proposition	NNS
46745	2532	9	.	.	.
46745	2533	1	_	_	NNP
46745	2533	2	Catalytic	catalytic	JJ
46745	2533	3	medicines	medicine	NNS
46745	2533	4	act	act	VBP
46745	2533	5	in	in	IN
46745	2533	6	the	the	DT
46745	2533	7	blood	blood	NN
46745	2533	8	,	,	,
46745	2533	9	and	and	CC
46745	2533	10	their	-PRON-	PRP$
46745	2533	11	effect	effect	NN
46745	2533	12	is	be	VBZ
46745	2533	13	permanent	permanent	JJ
46745	2533	14	.	.	.
46745	2533	15	_	_	NNP
46745	2533	16	This	this	DT
46745	2533	17	is	be	VBZ
46745	2533	18	simply	simply	RB
46745	2533	19	to	to	TO
46745	2533	20	affirm	affirm	VB
46745	2533	21	that	that	IN
46745	2533	22	they	-PRON-	PRP
46745	2533	23	belong	belong	VBP
46745	2533	24	to	to	IN
46745	2533	25	the	the	DT
46745	2533	26	class	class	NN
46745	2533	27	of	of	IN
46745	2533	28	Hæmatics	Hæmatics	NNPS
46745	2533	29	,	,	,
46745	2533	30	to	to	IN
46745	2533	31	which	which	WDT
46745	2533	32	Restoratives	restorative	NNS
46745	2533	33	also	also	RB
46745	2533	34	belong	belong	VBP
46745	2533	35	.	.	.
46745	2534	1	Of	of	IN
46745	2534	2	all	all	DT
46745	2534	3	that	that	WDT
46745	2534	4	I	-PRON-	PRP
46745	2534	5	have	have	VBP
46745	2534	6	named	name	VBN
46745	2534	7	,	,	,
46745	2534	8	there	there	EX
46745	2534	9	are	be	VBP
46745	2534	10	not	not	RB
46745	2534	11	any	any	DT
46745	2534	12	,	,	,
46745	2534	13	except	except	IN
46745	2534	14	Colchicum	Colchicum	NNP
46745	2534	15	and	and	CC
46745	2534	16	Antimony	Antimony	NNP
46745	2534	17	,	,	,
46745	2534	18	that	that	WDT
46745	2534	19	possess	possess	VBP
46745	2534	20	in	in	IN
46745	2534	21	any	any	DT
46745	2534	22	degree	degree	NN
46745	2534	23	the	the	DT
46745	2534	24	action	action	NN
46745	2534	25	of	of	IN
46745	2534	26	nerve	nerve	NN
46745	2534	27	-	-	HYPH
46745	2534	28	medicines--_i.e	medicines--_i.e	NNP
46745	2534	29	.	.	.
46745	2534	30	_	_	NNP
46745	2534	31	that	that	DT
46745	2534	32	exert	exert	NN
46745	2534	33	a	a	DT
46745	2534	34	sudden	sudden	JJ
46745	2534	35	and	and	CC
46745	2534	36	transient	transient	JJ
46745	2534	37	influence	influence	NN
46745	2534	38	over	over	IN
46745	2534	39	the	the	DT
46745	2534	40	nervous	nervous	JJ
46745	2534	41	system	system	NN
46745	2534	42	.	.	.
46745	2535	1	I	-PRON-	PRP
46745	2535	2	believe	believe	VBP
46745	2535	3	the	the	DT
46745	2535	4	sedative	sedative	JJ
46745	2535	5	powers	power	NNS
46745	2535	6	of	of	IN
46745	2535	7	these	these	DT
46745	2535	8	medicines	medicine	NNS
46745	2535	9	to	to	TO
46745	2535	10	be	be	VB
46745	2535	11	quite	quite	RB
46745	2535	12	distinct	distinct	JJ
46745	2535	13	from	from	IN
46745	2535	14	their	-PRON-	PRP$
46745	2535	15	Catalytic	catalytic	JJ
46745	2535	16	influence	influence	NN
46745	2535	17	.	.	.
46745	2536	1	In	in	IN
46745	2536	2	the	the	DT
46745	2536	3	proof	proof	NN
46745	2536	4	of	of	IN
46745	2536	5	the	the	DT
46745	2536	6	second	second	JJ
46745	2536	7	minor	minor	JJ
46745	2536	8	proposition	proposition	NN
46745	2536	9	,	,	,
46745	2536	10	I	-PRON-	PRP
46745	2536	11	shall	shall	MD
46745	2536	12	attempt	attempt	VB
46745	2536	13	to	to	TO
46745	2536	14	show	show	VB
46745	2536	15	that	that	IN
46745	2536	16	each	each	DT
46745	2536	17	of	of	IN
46745	2536	18	these	these	DT
46745	2536	19	remedies	remedy	NNS
46745	2536	20	has	have	VBZ
46745	2536	21	a	a	DT
46745	2536	22	peculiar	peculiar	JJ
46745	2536	23	action	action	NN
46745	2536	24	of	of	IN
46745	2536	25	its	-PRON-	PRP$
46745	2536	26	own	own	JJ
46745	2536	27	on	on	IN
46745	2536	28	the	the	DT
46745	2536	29	blood	blood	NN
46745	2536	30	,	,	,
46745	2536	31	even	even	RB
46745	2536	32	in	in	IN
46745	2536	33	health	health	NN
46745	2536	34	;	;	:
46745	2536	35	which	which	WDT
46745	2536	36	can	can	MD
46745	2536	37	not	not	RB
46745	2536	38	be	be	VB
46745	2536	39	said	say	VBN
46745	2536	40	of	of	IN
46745	2536	41	Restorative	restorative	JJ
46745	2536	42	medicines	medicine	NNS
46745	2536	43	.	.	.
46745	2537	1	Of	of	IN
46745	2537	2	all	all	PDT
46745	2537	3	these	these	DT
46745	2537	4	Catalytics	catalytic	NNS
46745	2537	5	two	two	CD
46745	2537	6	things	thing	NNS
46745	2537	7	are	be	VBP
46745	2537	8	known	know	VBN
46745	2537	9	.	.	.
46745	2538	1	When	when	WRB
46745	2538	2	they	-PRON-	PRP
46745	2538	3	cure	cure	VBP
46745	2538	4	a	a	DT
46745	2538	5	disease	disease	NN
46745	2538	6	,	,	,
46745	2538	7	they	-PRON-	PRP
46745	2538	8	do	do	VBP
46745	2538	9	so	so	RB
46745	2538	10	definitely	definitely	RB
46745	2538	11	,	,	,
46745	2538	12	so	so	IN
46745	2538	13	that	that	IN
46745	2538	14	it	-PRON-	PRP
46745	2538	15	does	do	VBZ
46745	2538	16	not	not	RB
46745	2538	17	in	in	IN
46745	2538	18	general	general	JJ
46745	2538	19	tend	tend	VB
46745	2538	20	to	to	TO
46745	2538	21	return	return	VB
46745	2538	22	;	;	:
46745	2538	23	and	and	CC
46745	2538	24	when	when	WRB
46745	2538	25	they	-PRON-	PRP
46745	2538	26	only	only	RB
46745	2538	27	alleviate	alleviate	VBP
46745	2538	28	it	-PRON-	PRP
46745	2538	29	,	,	,
46745	2538	30	the	the	DT
46745	2538	31	improvement	improvement	NN
46745	2538	32	effected	effect	VBN
46745	2538	33	is	be	VBZ
46745	2538	34	more	more	RBR
46745	2538	35	or	or	CC
46745	2538	36	less	less	RBR
46745	2538	37	permanent	permanent	JJ
46745	2538	38	.	.	.
46745	2539	1	In	in	IN
46745	2539	2	the	the	DT
46745	2539	3	second	second	JJ
46745	2539	4	place	place	NN
46745	2539	5	,	,	,
46745	2539	6	they	-PRON-	PRP
46745	2539	7	are	be	VBP
46745	2539	8	found	find	VBN
46745	2539	9	to	to	TO
46745	2539	10	produce	produce	VB
46745	2539	11	,	,	,
46745	2539	12	after	after	IN
46745	2539	13	being	be	VBG
46745	2539	14	long	long	RB
46745	2539	15	administered	administer	VBN
46745	2539	16	,	,	,
46745	2539	17	a	a	DT
46745	2539	18	change	change	NN
46745	2539	19	for	for	IN
46745	2539	20	the	the	DT
46745	2539	21	worse	bad	JJR
46745	2539	22	in	in	IN
46745	2539	23	the	the	DT
46745	2539	24	blood	blood	NN
46745	2539	25	,	,	,
46745	2539	26	a	a	DT
46745	2539	27	diminution	diminution	NN
46745	2539	28	in	in	IN
46745	2539	29	the	the	DT
46745	2539	30	amount	amount	NN
46745	2539	31	of	of	IN
46745	2539	32	Fibrine	Fibrine	NNP
46745	2539	33	and	and	CC
46745	2539	34	of	of	IN
46745	2539	35	the	the	DT
46745	2539	36	red	red	JJ
46745	2539	37	corpuscles	corpuscle	NNS
46745	2539	38	.	.	.
46745	2540	1	Thus	thus	RB
46745	2540	2	they	-PRON-	PRP
46745	2540	3	are	be	VBP
46745	2540	4	blood	blood	NN
46745	2540	5	-	-	HYPH
46745	2540	6	impoverishers	impoverisher	NNS
46745	2540	7	,	,	,
46745	2540	8	when	when	WRB
46745	2540	9	given	give	VBN
46745	2540	10	in	in	IN
46745	2540	11	excess	excess	NN
46745	2540	12	.	.	.
46745	2541	1	These	these	DT
46745	2541	2	considerations	consideration	NNS
46745	2541	3	alone	alone	RB
46745	2541	4	,	,	,
46745	2541	5	when	when	WRB
46745	2541	6	combined	combine	VBN
46745	2541	7	with	with	IN
46745	2541	8	the	the	DT
46745	2541	9	proof	proof	NN
46745	2541	10	of	of	IN
46745	2541	11	absorption--_i.e	absorption--_i.e	NNP
46745	2541	12	.	.	.
46745	2541	13	_	_	IN
46745	2541	14	that	that	IN
46745	2541	15	they	-PRON-	PRP
46745	2541	16	all	all	DT
46745	2541	17	pass	pass	VBP
46745	2541	18	into	into	IN
46745	2541	19	the	the	DT
46745	2541	20	secretions	secretion	NNS
46745	2541	21	,	,	,
46745	2541	22	and	and	CC
46745	2541	23	may	may	MD
46745	2541	24	be	be	VB
46745	2541	25	detected	detect	VBN
46745	2541	26	there	there	RB
46745	2541	27	--	--	:
46745	2541	28	are	be	VBP
46745	2541	29	conclusive	conclusive	JJ
46745	2541	30	as	as	IN
46745	2541	31	to	to	IN
46745	2541	32	the	the	DT
46745	2541	33	fact	fact	NN
46745	2541	34	of	of	IN
46745	2541	35	their	-PRON-	PRP$
46745	2541	36	being	be	VBG
46745	2541	37	Hæmatic	hæmatic	JJ
46745	2541	38	medicines	medicine	NNS
46745	2541	39	.	.	.
46745	2542	1	We	-PRON-	PRP
46745	2542	2	pass	pass	VBP
46745	2542	3	on	on	RP
46745	2542	4	now	now	RB
46745	2542	5	to	to	IN
46745	2542	6	the	the	DT
46745	2542	7	third	third	JJ
46745	2542	8	proposition	proposition	NN
46745	2542	9	,	,	,
46745	2542	10	which	which	WDT
46745	2542	11	consists	consist	VBZ
46745	2542	12	in	in	IN
46745	2542	13	the	the	DT
46745	2542	14	statement	statement	NN
46745	2542	15	of	of	IN
46745	2542	16	a	a	DT
46745	2542	17	property	property	NN
46745	2542	18	that	that	WDT
46745	2542	19	is	be	VBZ
46745	2542	20	peculiar	peculiar	JJ
46745	2542	21	to	to	IN
46745	2542	22	Catalytic	catalytic	JJ
46745	2542	23	Hæmatics	Hæmatics	NNPS
46745	2542	24	.	.	.
46745	2543	1	_	_	NNP
46745	2543	2	Each	each	DT
46745	2543	3	Catalytic	catalytic	JJ
46745	2543	4	tends	tend	VBZ
46745	2543	5	of	of	IN
46745	2543	6	itself	-PRON-	PRP
46745	2543	7	to	to	TO
46745	2543	8	work	work	VB
46745	2543	9	out	out	RP
46745	2543	10	a	a	DT
46745	2543	11	peculiar	peculiar	JJ
46745	2543	12	operation	operation	NN
46745	2543	13	in	in	IN
46745	2543	14	the	the	DT
46745	2543	15	blood	blood	NN
46745	2543	16	.	.	.
46745	2543	17	_	_	NNP
46745	2543	18	This	this	DT
46745	2543	19	peculiar	peculiar	JJ
46745	2543	20	process	process	NN
46745	2543	21	,	,	,
46745	2543	22	established	establish	VBN
46745	2543	23	by	by	IN
46745	2543	24	their	-PRON-	PRP$
46745	2543	25	presence	presence	NN
46745	2543	26	in	in	IN
46745	2543	27	the	the	DT
46745	2543	28	blood	blood	NN
46745	2543	29	,	,	,
46745	2543	30	forms	form	VBZ
46745	2543	31	part	part	NN
46745	2543	32	of	of	IN
46745	2543	33	the	the	DT
46745	2543	34	known	know	VBN
46745	2543	35	history	history	NN
46745	2543	36	of	of	IN
46745	2543	37	each	each	DT
46745	2543	38	Catalytic	catalytic	JJ
46745	2543	39	medicine	medicine	NN
46745	2543	40	.	.	.
46745	2544	1	It	-PRON-	PRP
46745	2544	2	will	will	MD
46745	2544	3	suffice	suffice	VB
46745	2544	4	to	to	TO
46745	2544	5	demonstrate	demonstrate	VB
46745	2544	6	this	this	DT
46745	2544	7	if	if	IN
46745	2544	8	I	-PRON-	PRP
46745	2544	9	condense	condense	VBP
46745	2544	10	into	into	IN
46745	2544	11	as	as	RB
46745	2544	12	few	few	JJ
46745	2544	13	words	word	NNS
46745	2544	14	as	as	IN
46745	2544	15	possible	possible	JJ
46745	2544	16	the	the	DT
46745	2544	17	facts	fact	NNS
46745	2544	18	that	that	WDT
46745	2544	19	are	be	VBP
46745	2544	20	known	know	VBN
46745	2544	21	on	on	IN
46745	2544	22	this	this	DT
46745	2544	23	subject	subject	NN
46745	2544	24	,	,	,
46745	2544	25	with	with	IN
46745	2544	26	respect	respect	NN
46745	2544	27	to	to	IN
46745	2544	28	each	each	DT
46745	2544	29	of	of	IN
46745	2544	30	the	the	DT
46745	2544	31	orders	order	NNS
46745	2544	32	of	of	IN
46745	2544	33	this	this	DT
46745	2544	34	division	division	NN
46745	2544	35	of	of	IN
46745	2544	36	remedies	remedy	NNS
46745	2544	37	.	.	.
46745	2545	1	Of	of	IN
46745	2545	2	_	_	NNP
46745	2545	3	Antiphlogistic	Antiphlogistic	NNP
46745	2545	4	_	_	NNP
46745	2545	5	medicines	medicine	NNS
46745	2545	6	,	,	,
46745	2545	7	some	some	DT
46745	2545	8	possess	possess	VBP
46745	2545	9	a	a	DT
46745	2545	10	power	power	NN
46745	2545	11	which	which	WDT
46745	2545	12	stamps	stamp	VBZ
46745	2545	13	them	-PRON-	PRP
46745	2545	14	at	at	RB
46745	2545	15	once	once	RB
46745	2545	16	as	as	RB
46745	2545	17	likely	likely	JJ
46745	2545	18	to	to	TO
46745	2545	19	be	be	VB
46745	2545	20	useful	useful	JJ
46745	2545	21	in	in	IN
46745	2545	22	the	the	DT
46745	2545	23	treatment	treatment	NN
46745	2545	24	of	of	IN
46745	2545	25	inflammatory	inflammatory	JJ
46745	2545	26	disorders	disorder	NNS
46745	2545	27	.	.	.
46745	2546	1	Alkalies	alkali	NNS
46745	2546	2	are	be	VBP
46745	2546	3	known	know	VBN
46745	2546	4	to	to	TO
46745	2546	5	have	have	VB
46745	2546	6	the	the	DT
46745	2546	7	chemical	chemical	NN
46745	2546	8	property	property	NN
46745	2546	9	of	of	IN
46745	2546	10	holding	hold	VBG
46745	2546	11	Fibrine	Fibrine	NNP
46745	2546	12	in	in	IN
46745	2546	13	solution	solution	NN
46745	2546	14	.	.	.
46745	2547	1	By	by	IN
46745	2547	2	exerting	exert	VBG
46745	2547	3	this	this	DT
46745	2547	4	power	power	NN
46745	2547	5	in	in	IN
46745	2547	6	the	the	DT
46745	2547	7	blood	blood	NN
46745	2547	8	,	,	,
46745	2547	9	it	-PRON-	PRP
46745	2547	10	seems	seem	VBZ
46745	2547	11	that	that	IN
46745	2547	12	they	-PRON-	PRP
46745	2547	13	may	may	MD
46745	2547	14	prevent	prevent	VB
46745	2547	15	its	-PRON-	PRP$
46745	2547	16	abnormal	abnormal	JJ
46745	2547	17	deposition	deposition	NN
46745	2547	18	or	or	CC
46745	2547	19	coagulation	coagulation	NN
46745	2547	20	in	in	IN
46745	2547	21	inflammatory	inflammatory	JJ
46745	2547	22	cases	case	NNS
46745	2547	23	,	,	,
46745	2547	24	and	and	CC
46745	2547	25	at	at	IN
46745	2547	26	length	length	NN
46745	2547	27	diminish	diminish	JJ
46745	2547	28	it	-PRON-	PRP
46745	2547	29	in	in	IN
46745	2547	30	quantity	quantity	NN
46745	2547	31	.	.	.
46745	2548	1	On	on	IN
46745	2548	2	this	this	DT
46745	2548	3	principle	principle	NN
46745	2548	4	they	-PRON-	PRP
46745	2548	5	were	be	VBD
46745	2548	6	proposed	propose	VBN
46745	2548	7	and	and	CC
46745	2548	8	used	use	VBN
46745	2548	9	successfully	successfully	RB
46745	2548	10	by	by	IN
46745	2548	11	Mascagni	Mascagni	NNP
46745	2548	12	in	in	IN
46745	2548	13	acute	acute	JJ
46745	2548	14	inflammations	inflammation	NNS
46745	2548	15	.	.	.
46745	2549	1	Their	-PRON-	PRP$
46745	2549	2	efficacy	efficacy	NN
46745	2549	3	in	in	IN
46745	2549	4	retarding	retard	VBG
46745	2549	5	the	the	DT
46745	2549	6	formation	formation	NN
46745	2549	7	of	of	IN
46745	2549	8	crude	crude	JJ
46745	2549	9	deposits	deposit	NNS
46745	2549	10	in	in	IN
46745	2549	11	scrofulous	scrofulous	JJ
46745	2549	12	and	and	CC
46745	2549	13	tubercular	tubercular	JJ
46745	2549	14	diseases	disease	NNS
46745	2549	15	may	may	MD
46745	2549	16	possibly	possibly	RB
46745	2549	17	be	be	VB
46745	2549	18	assigned	assign	VBN
46745	2549	19	to	to	IN
46745	2549	20	the	the	DT
46745	2549	21	same	same	JJ
46745	2549	22	operation	operation	NN
46745	2549	23	.	.	.
46745	2550	1	Potash	Potash	NNP
46745	2550	2	has	have	VBZ
46745	2550	3	been	be	VBN
46745	2550	4	extolled	extoll	VBN
46745	2550	5	by	by	IN
46745	2550	6	Dr.	Dr.	NNP
46745	2550	7	Theophilus	Theophilus	NNP
46745	2550	8	Thompson	Thompson	NNP
46745	2550	9	as	as	IN
46745	2550	10	a	a	DT
46745	2550	11	powerful	powerful	JJ
46745	2550	12	preservative	preservative	NN
46745	2550	13	for	for	IN
46745	2550	14	those	those	DT
46745	2550	15	who	who	WP
46745	2550	16	are	be	VBP
46745	2550	17	predisposed	predispose	VBN
46745	2550	18	to	to	IN
46745	2550	19	phthisical	phthisical	JJ
46745	2550	20	disease	disease	NN
46745	2550	21	.	.	.
46745	2551	1	Alkalies	alkali	NNS
46745	2551	2	in	in	IN
46745	2551	3	small	small	JJ
46745	2551	4	doses	dose	NNS
46745	2551	5	,	,	,
46745	2551	6	and	and	CC
46745	2551	7	in	in	IN
46745	2551	8	cases	case	NNS
46745	2551	9	requiring	require	VBG
46745	2551	10	them	-PRON-	PRP
46745	2551	11	,	,	,
46745	2551	12	may	may	MD
46745	2551	13	be	be	VB
46745	2551	14	Restoratives	restorative	NNS
46745	2551	15	.	.	.
46745	2552	1	Salines	saline	NNS
46745	2552	2	have	have	VBP
46745	2552	3	been	be	VBN
46745	2552	4	shown	show	VBN
46745	2552	5	by	by	IN
46745	2552	6	Mr.	Mr.	NNP
46745	2552	7	Gulliver	Gulliver	NNP
46745	2552	8	to	to	TO
46745	2552	9	have	have	VB
46745	2552	10	the	the	DT
46745	2552	11	effect	effect	NN
46745	2552	12	of	of	IN
46745	2552	13	keeping	keep	VBG
46745	2552	14	the	the	DT
46745	2552	15	blood	blood	NN
46745	2552	16	-	-	HYPH
46745	2552	17	corpuscles	corpuscle	NNS
46745	2552	18	apart	apart	RB
46745	2552	19	from	from	IN
46745	2552	20	one	one	CD
46745	2552	21	another	another	DT
46745	2552	22	.	.	.
46745	2553	1	This	this	DT
46745	2553	2	may	may	MD
46745	2553	3	partly	partly	RB
46745	2553	4	explain	explain	VB
46745	2553	5	their	-PRON-	PRP$
46745	2553	6	action	action	NN
46745	2553	7	;	;	:
46745	2553	8	for	for	IN
46745	2553	9	in	in	IN
46745	2553	10	inflammatory	inflammatory	JJ
46745	2553	11	blood	blood	NN
46745	2553	12	the	the	DT
46745	2553	13	corpuscles	corpuscle	NNS
46745	2553	14	display	display	VBP
46745	2553	15	a	a	DT
46745	2553	16	peculiar	peculiar	JJ
46745	2553	17	and	and	CC
46745	2553	18	abnormal	abnormal	JJ
46745	2553	19	tendency	tendency	NN
46745	2553	20	to	to	TO
46745	2553	21	aggregate	aggregate	VB
46745	2553	22	together	together	RB
46745	2553	23	in	in	IN
46745	2553	24	rows	row	NNS
46745	2553	25	.	.	.
46745	2554	1	Salines	saline	NNS
46745	2554	2	also	also	RB
46745	2554	3	are	be	VBP
46745	2554	4	solvents	solvent	NNS
46745	2554	5	of	of	IN
46745	2554	6	Fibrine	Fibrine	NNP
46745	2554	7	.	.	.
46745	2555	1	The	the	DT
46745	2555	2	immediate	immediate	JJ
46745	2555	3	action	action	NN
46745	2555	4	of	of	IN
46745	2555	5	Mercury	Mercury	NNP
46745	2555	6	in	in	IN
46745	2555	7	checking	check	VBG
46745	2555	8	inflammation	inflammation	NN
46745	2555	9	is	be	VBZ
46745	2555	10	often	often	RB
46745	2555	11	very	very	RB
46745	2555	12	apparent	apparent	JJ
46745	2555	13	in	in	IN
46745	2555	14	the	the	DT
46745	2555	15	case	case	NN
46745	2555	16	of	of	IN
46745	2555	17	Iritis	Iritis	NNP
46745	2555	18	.	.	.
46745	2556	1	This	this	DT
46745	2556	2	medicine	medicine	NN
46745	2556	3	in	in	IN
46745	2556	4	some	some	DT
46745	2556	5	way	way	NN
46745	2556	6	diminishes	diminish	VBZ
46745	2556	7	the	the	DT
46745	2556	8	plasticity	plasticity	NN
46745	2556	9	of	of	IN
46745	2556	10	the	the	DT
46745	2556	11	Fibrine	Fibrine	NNP
46745	2556	12	of	of	IN
46745	2556	13	the	the	DT
46745	2556	14	blood	blood	NN
46745	2556	15	;	;	:
46745	2556	16	and	and	CC
46745	2556	17	probably	probably	RB
46745	2556	18	promotes	promote	VBZ
46745	2556	19	absorption	absorption	NN
46745	2556	20	by	by	IN
46745	2556	21	preventing	prevent	VBG
46745	2556	22	in	in	IN
46745	2556	23	this	this	DT
46745	2556	24	way	way	NN
46745	2556	25	a	a	DT
46745	2556	26	further	further	JJ
46745	2556	27	deposit	deposit	NN
46745	2556	28	of	of	IN
46745	2556	29	lymph	lymph	NN
46745	2556	30	.	.	.
46745	2557	1	If	if	IN
46745	2557	2	the	the	DT
46745	2557	3	blood	blood	NN
46745	2557	4	be	be	VBP
46745	2557	5	analyzed	analyze	VBN
46745	2557	6	after	after	IN
46745	2557	7	the	the	DT
46745	2557	8	continued	continue	VBN
46745	2557	9	use	use	NN
46745	2557	10	of	of	IN
46745	2557	11	Mercury	Mercury	NNP
46745	2557	12	,	,	,
46745	2557	13	it	-PRON-	PRP
46745	2557	14	is	be	VBZ
46745	2557	15	found	find	VBN
46745	2557	16	to	to	TO
46745	2557	17	contain	contain	VB
46745	2557	18	less	less	JJR
46745	2557	19	Fibrine	fibrine	JJ
46745	2557	20	than	than	IN
46745	2557	21	in	in	IN
46745	2557	22	health	health	NN
46745	2557	23	.	.	.
46745	2558	1	It	-PRON-	PRP
46745	2558	2	has	have	VBZ
46745	2558	3	also	also	RB
46745	2558	4	a	a	DT
46745	2558	5	peculiar	peculiar	JJ
46745	2558	6	action	action	NN
46745	2558	7	of	of	IN
46745	2558	8	its	-PRON-	PRP$
46745	2558	9	own	own	JJ
46745	2558	10	in	in	IN
46745	2558	11	the	the	DT
46745	2558	12	blood	blood	NN
46745	2558	13	,	,	,
46745	2558	14	for	for	IN
46745	2558	15	it	-PRON-	PRP
46745	2558	16	sometimes	sometimes	RB
46745	2558	17	produces	produce	VBZ
46745	2558	18	various	various	JJ
46745	2558	19	eruptions	eruption	NNS
46745	2558	20	,	,	,
46745	2558	21	particularly	particularly	RB
46745	2558	22	Eczema	Eczema	NNP
46745	2558	23	,	,	,
46745	2558	24	as	as	RB
46745	2558	25	well	well	RB
46745	2558	26	as	as	IN
46745	2558	27	a	a	DT
46745	2558	28	state	state	NN
46745	2558	29	called	call	VBN
46745	2558	30	Mercurial	mercurial	JJ
46745	2558	31	fever	fever	NN
46745	2558	32	.	.	.
46745	2559	1	Antimony	Antimony	NNP
46745	2559	2	has	have	VBZ
46745	2559	3	various	various	JJ
46745	2559	4	and	and	CC
46745	2559	5	marked	marked	JJ
46745	2559	6	medicinal	medicinal	JJ
46745	2559	7	properties	property	NNS
46745	2559	8	:	:	:
46745	2559	9	in	in	IN
46745	2559	10	large	large	JJ
46745	2559	11	doses	dose	NNS
46745	2559	12	Neurotic	neurotic	JJ
46745	2559	13	;	;	:
46745	2559	14	in	in	IN
46745	2559	15	all	all	DT
46745	2559	16	cases	case	NNS
46745	2559	17	Eliminative	eliminative	JJ
46745	2559	18	.	.	.
46745	2560	1	But	but	CC
46745	2560	2	we	-PRON-	PRP
46745	2560	3	are	be	VBP
46745	2560	4	now	now	RB
46745	2560	5	concerned	concern	VBN
46745	2560	6	merely	merely	RB
46745	2560	7	with	with	IN
46745	2560	8	an	an	DT
46745	2560	9	agency	agency	NN
46745	2560	10	in	in	IN
46745	2560	11	the	the	DT
46745	2560	12	blood	blood	NN
46745	2560	13	.	.	.
46745	2561	1	It	-PRON-	PRP
46745	2561	2	has	have	VBZ
46745	2561	3	certainly	certainly	RB
46745	2561	4	some	some	DT
46745	2561	5	action	action	NN
46745	2561	6	of	of	IN
46745	2561	7	this	this	DT
46745	2561	8	kind	kind	NN
46745	2561	9	.	.	.
46745	2562	1	When	when	WRB
46745	2562	2	rubbed	rub	VBN
46745	2562	3	on	on	IN
46745	2562	4	the	the	DT
46745	2562	5	skin	skin	NN
46745	2562	6	it	-PRON-	PRP
46745	2562	7	produces	produce	VBZ
46745	2562	8	a	a	DT
46745	2562	9	pustular	pustular	JJ
46745	2562	10	eruption	eruption	NN
46745	2562	11	;	;	:
46745	2562	12	and	and	CC
46745	2562	13	M.	M.	NNP
46745	2562	14	Lepelletier	Lepelletier	NNP
46745	2562	15	gives	give	VBZ
46745	2562	16	a	a	DT
46745	2562	17	case	case	NN
46745	2562	18	in	in	IN
46745	2562	19	which	which	WDT
46745	2562	20	it	-PRON-	PRP
46745	2562	21	did	do	VBD
46745	2562	22	this	this	DT
46745	2562	23	when	when	WRB
46745	2562	24	administered	administer	VBN
46745	2562	25	only	only	RB
46745	2562	26	internally	internally	RB
46745	2562	27	.	.	.
46745	2563	1	Magendie	Magendie	NNP
46745	2563	2	found	find	VBD
46745	2563	3	that	that	IN
46745	2563	4	when	when	WRB
46745	2563	5	given	give	VBN
46745	2563	6	to	to	IN
46745	2563	7	dogs	dog	NNS
46745	2563	8	it	-PRON-	PRP
46745	2563	9	produced	produce	VBD
46745	2563	10	engorgement	engorgement	NN
46745	2563	11	,	,	,
46745	2563	12	and	and	CC
46745	2563	13	often	often	RB
46745	2563	14	inflammation	inflammation	NN
46745	2563	15	of	of	IN
46745	2563	16	the	the	DT
46745	2563	17	lungs	lung	NNS
46745	2563	18	.	.	.
46745	2564	1	Antimony	Antimony	NNP
46745	2564	2	seems	seem	VBZ
46745	2564	3	to	to	TO
46745	2564	4	exert	exert	VB
46745	2564	5	a	a	DT
46745	2564	6	blood	blood	NN
46745	2564	7	-	-	HYPH
46745	2564	8	influence	influence	NN
46745	2564	9	over	over	IN
46745	2564	10	inflammation	inflammation	NN
46745	2564	11	somewhat	somewhat	RB
46745	2564	12	similar	similar	JJ
46745	2564	13	to	to	IN
46745	2564	14	that	that	DT
46745	2564	15	of	of	IN
46745	2564	16	Mercury	Mercury	NNP
46745	2564	17	;	;	:
46745	2564	18	but	but	CC
46745	2564	19	it	-PRON-	PRP
46745	2564	20	further	further	RB
46745	2564	21	adds	add	VBZ
46745	2564	22	to	to	IN
46745	2564	23	this	this	DT
46745	2564	24	a	a	DT
46745	2564	25	powerful	powerful	JJ
46745	2564	26	sedative	sedative	JJ
46745	2564	27	effect	effect	NN
46745	2564	28	.	.	.
46745	2565	1	Antimony	Antimony	NNP
46745	2565	2	generally	generally	RB
46745	2565	3	arrests	arrest	VBZ
46745	2565	4	inflammation	inflammation	NN
46745	2565	5	by	by	IN
46745	2565	6	reducing	reduce	VBG
46745	2565	7	the	the	DT
46745	2565	8	pulse	pulse	NN
46745	2565	9	;	;	:
46745	2565	10	but	but	CC
46745	2565	11	Mercury	Mercury	NNP
46745	2565	12	reduces	reduce	VBZ
46745	2565	13	the	the	DT
46745	2565	14	pulse	pulse	NN
46745	2565	15	by	by	IN
46745	2565	16	arresting	arrest	VBG
46745	2565	17	inflammation	inflammation	NN
46745	2565	18	.	.	.
46745	2566	1	Thus	thus	RB
46745	2566	2	do	do	VB
46745	2566	3	Antiphlogistics	antiphlogistic	NNS
46745	2566	4	exert	exert	VB
46745	2566	5	that	that	DT
46745	2566	6	operation	operation	NN
46745	2566	7	in	in	IN
46745	2566	8	the	the	DT
46745	2566	9	blood	blood	NN
46745	2566	10	which	which	WDT
46745	2566	11	is	be	VBZ
46745	2566	12	essential	essential	JJ
46745	2566	13	to	to	IN
46745	2566	14	Catalytic	catalytic	JJ
46745	2566	15	medicines	medicine	NNS
46745	2566	16	.	.	.
46745	2567	1	The	the	DT
46745	2567	2	divisions	division	NNS
46745	2567	3	of	of	IN
46745	2567	4	Hæmatics	Hæmatics	NNPS
46745	2567	5	differ	differ	VBP
46745	2567	6	in	in	IN
46745	2567	7	this	this	DT
46745	2567	8	:	:	:
46745	2567	9	Restoratives	restorative	NNS
46745	2567	10	act	act	VBP
46745	2567	11	by	by	IN
46745	2567	12	being	be	VBG
46745	2567	13	in	in	IN
46745	2567	14	the	the	DT
46745	2567	15	blood	blood	NN
46745	2567	16	;	;	:
46745	2567	17	Catalytics	Catalytics	NNP
46745	2567	18	by	by	IN
46745	2567	19	working	work	VBG
46745	2567	20	in	in	IN
46745	2567	21	the	the	DT
46745	2567	22	blood	blood	NN
46745	2567	23	.	.	.
46745	2568	1	All	all	DT
46745	2568	2	we	-PRON-	PRP
46745	2568	3	have	have	VBP
46745	2568	4	to	to	TO
46745	2568	5	prove	prove	VB
46745	2568	6	of	of	IN
46745	2568	7	the	the	DT
46745	2568	8	latter	latter	JJ
46745	2568	9	just	just	RB
46745	2568	10	now	now	RB
46745	2568	11	is	be	VBZ
46745	2568	12	to	to	TO
46745	2568	13	establish	establish	VB
46745	2568	14	this	this	DT
46745	2568	15	part	part	NN
46745	2568	16	of	of	IN
46745	2568	17	their	-PRON-	PRP$
46745	2568	18	action	action	NN
46745	2568	19	.	.	.
46745	2569	1	_	_	NNP
46745	2569	2	Antisyphilitics	Antisyphilitics	NNPS
46745	2569	3	_	_	NNP
46745	2569	4	have	have	VBP
46745	2569	5	also	also	RB
46745	2569	6	this	this	DT
46745	2569	7	action	action	NN
46745	2569	8	.	.	.
46745	2570	1	Mention	Mention	NNP
46745	2570	2	has	have	VBZ
46745	2570	3	already	already	RB
46745	2570	4	been	be	VBN
46745	2570	5	made	make	VBN
46745	2570	6	of	of	IN
46745	2570	7	the	the	DT
46745	2570	8	hæmatic	hæmatic	JJ
46745	2570	9	effects	effect	NNS
46745	2570	10	of	of	IN
46745	2570	11	Mercurials	mercurial	NNS
46745	2570	12	.	.	.
46745	2571	1	The	the	DT
46745	2571	2	action	action	NN
46745	2571	3	of	of	IN
46745	2571	4	the	the	DT
46745	2571	5	compounds	compound	NNS
46745	2571	6	of	of	IN
46745	2571	7	Gold	Gold	NNP
46745	2571	8	is	be	VBZ
46745	2571	9	similar	similar	JJ
46745	2571	10	,	,	,
46745	2571	11	though	though	IN
46745	2571	12	these	these	DT
46745	2571	13	are	be	VBP
46745	2571	14	not	not	RB
46745	2571	15	now	now	RB
46745	2571	16	often	often	RB
46745	2571	17	employed	employ	VBN
46745	2571	18	.	.	.
46745	2572	1	But	but	CC
46745	2572	2	as	as	IN
46745	2572	3	far	far	RB
46745	2572	4	back	back	RB
46745	2572	5	as	as	IN
46745	2572	6	the	the	DT
46745	2572	7	commencement	commencement	NN
46745	2572	8	of	of	IN
46745	2572	9	the	the	DT
46745	2572	10	eighteenth	eighteenth	JJ
46745	2572	11	century	century	NN
46745	2572	12	the	the	DT
46745	2572	13	administration	administration	NN
46745	2572	14	of	of	IN
46745	2572	15	Gold	Gold	NNP
46745	2572	16	in	in	IN
46745	2572	17	syphilis	syphilis	NNP
46745	2572	18	was	be	VBD
46745	2572	19	strongly	strongly	RB
46745	2572	20	recommended	recommend	VBN
46745	2572	21	by	by	IN
46745	2572	22	Dr.	Dr.	NNP
46745	2572	23	A.	A.	NNP
46745	2572	24	Pitcairn	Pitcairn	NNP
46745	2572	25	.	.	.
46745	2573	1	He	-PRON-	PRP
46745	2573	2	employed	employ	VBD
46745	2573	3	the	the	DT
46745	2573	4	pure	pure	JJ
46745	2573	5	metal	metal	NN
46745	2573	6	in	in	IN
46745	2573	7	a	a	DT
46745	2573	8	fine	fine	JJ
46745	2573	9	state	state	NN
46745	2573	10	of	of	IN
46745	2573	11	division	division	NN
46745	2573	12	.	.	.
46745	2574	1	He	-PRON-	PRP
46745	2574	2	also	also	RB
46745	2574	3	made	make	VBD
46745	2574	4	use	use	NN
46745	2574	5	of	of	IN
46745	2574	6	a	a	DT
46745	2574	7	mercurial	mercurial	NN
46745	2574	8	which	which	WDT
46745	2574	9	resembled	resemble	VBD
46745	2574	10	our	-PRON-	PRP$
46745	2574	11	modern	modern	JJ
46745	2574	12	blue	blue	JJ
46745	2574	13	-	-	HYPH
46745	2574	14	pill	pill	NN
46745	2574	15	,	,	,
46745	2574	16	but	but	CC
46745	2574	17	must	must	MD
46745	2574	18	have	have	VB
46745	2574	19	been	be	VBN
46745	2574	20	considerably	considerably	RB
46745	2574	21	less	less	RBR
46745	2574	22	potent	potent	JJ
46745	2574	23	,	,	,
46745	2574	24	for	for	IN
46745	2574	25	it	-PRON-	PRP
46745	2574	26	was	be	VBD
46745	2574	27	given	give	VBN
46745	2574	28	in	in	IN
46745	2574	29	drachm	drachm	JJ
46745	2574	30	doses	dose	NNS
46745	2574	31	.	.	.
46745	2575	1	Iodide	iodide	NN
46745	2575	2	of	of	IN
46745	2575	3	Potassium	Potassium	NNP
46745	2575	4	may	may	MD
46745	2575	5	be	be	VB
46745	2575	6	said	say	VBN
46745	2575	7	to	to	TO
46745	2575	8	combine	combine	VB
46745	2575	9	the	the	DT
46745	2575	10	actions	action	NNS
46745	2575	11	of	of	IN
46745	2575	12	Iodine	Iodine	NNP
46745	2575	13	and	and	CC
46745	2575	14	of	of	IN
46745	2575	15	Potash	Potash	NNP
46745	2575	16	.	.	.
46745	2576	1	This	this	DT
46745	2576	2	medicine	medicine	NN
46745	2576	3	is	be	VBZ
46745	2576	4	very	very	RB
46745	2576	5	active	active	JJ
46745	2576	6	in	in	IN
46745	2576	7	causing	cause	VBG
46745	2576	8	the	the	DT
46745	2576	9	absorption	absorption	NN
46745	2576	10	of	of	IN
46745	2576	11	syphilitic	syphilitic	NN
46745	2576	12	nodes	node	NNS
46745	2576	13	.	.	.
46745	2577	1	Its	-PRON-	PRP$
46745	2577	2	use	use	NN
46745	2577	3	is	be	VBZ
46745	2577	4	sometimes	sometimes	RB
46745	2577	5	followed	follow	VBN
46745	2577	6	by	by	IN
46745	2577	7	a	a	DT
46745	2577	8	slight	slight	JJ
46745	2577	9	cutaneous	cutaneous	JJ
46745	2577	10	eruption	eruption	NN
46745	2577	11	.	.	.
46745	2578	1	Sarsaparilla	Sarsaparilla	NNP
46745	2578	2	is	be	VBZ
46745	2578	3	supposed	suppose	VBN
46745	2578	4	by	by	IN
46745	2578	5	many	many	JJ
46745	2578	6	to	to	TO
46745	2578	7	exert	exert	VB
46745	2578	8	an	an	DT
46745	2578	9	alterative	alterative	JJ
46745	2578	10	action	action	NN
46745	2578	11	in	in	IN
46745	2578	12	the	the	DT
46745	2578	13	blood	blood	NN
46745	2578	14	;	;	:
46745	2578	15	but	but	CC
46745	2578	16	this	this	DT
46745	2578	17	is	be	VBZ
46745	2578	18	not	not	RB
46745	2578	19	very	very	RB
46745	2578	20	clear	clear	JJ
46745	2578	21	,	,	,
46745	2578	22	nor	nor	CC
46745	2578	23	is	be	VBZ
46745	2578	24	its	-PRON-	PRP$
46745	2578	25	utility	utility	NN
46745	2578	26	often	often	RB
46745	2578	27	very	very	RB
46745	2578	28	decided	decide	VBN
46745	2578	29	.	.	.
46745	2579	1	_	_	NNP
46745	2579	2	Antiscrofulitics	Antiscrofulitics	NNP
46745	2579	3	_	_	NNP
46745	2579	4	form	form	NN
46745	2579	5	the	the	DT
46745	2579	6	third	third	JJ
46745	2579	7	order	order	NN
46745	2579	8	.	.	.
46745	2580	1	Iodine	Iodine	NNP
46745	2580	2	and	and	CC
46745	2580	3	its	-PRON-	PRP$
46745	2580	4	compounds	compound	NNS
46745	2580	5	have	have	VBP
46745	2580	6	certainly	certainly	RB
46745	2580	7	an	an	DT
46745	2580	8	action	action	NN
46745	2580	9	on	on	IN
46745	2580	10	the	the	DT
46745	2580	11	blood	blood	NN
46745	2580	12	.	.	.
46745	2581	1	When	when	WRB
46745	2581	2	given	give	VBN
46745	2581	3	in	in	IN
46745	2581	4	excess	excess	NN
46745	2581	5	,	,	,
46745	2581	6	or	or	CC
46745	2581	7	for	for	IN
46745	2581	8	a	a	DT
46745	2581	9	long	long	JJ
46745	2581	10	time	time	NN
46745	2581	11	,	,	,
46745	2581	12	they	-PRON-	PRP
46745	2581	13	may	may	MD
46745	2581	14	cause	cause	VB
46745	2581	15	a	a	DT
46745	2581	16	train	train	NN
46745	2581	17	of	of	IN
46745	2581	18	symptoms	symptom	NNS
46745	2581	19	to	to	TO
46745	2581	20	which	which	WDT
46745	2581	21	the	the	DT
46745	2581	22	collective	collective	JJ
46745	2581	23	name	name	NN
46745	2581	24	of	of	IN
46745	2581	25	_	_	NNP
46745	2581	26	Iodism	Iodism	NNP
46745	2581	27	_	_	NNP
46745	2581	28	has	have	VBZ
46745	2581	29	been	be	VBN
46745	2581	30	applied	apply	VBN
46745	2581	31	.	.	.
46745	2582	1	The	the	DT
46745	2582	2	most	most	RBS
46745	2582	3	prominent	prominent	JJ
46745	2582	4	are	be	VBP
46745	2582	5	--	--	:
46745	2582	6	coryza	coryza	NNS
46745	2582	7	,	,	,
46745	2582	8	itching	itching	NN
46745	2582	9	,	,	,
46745	2582	10	watering	water	VBG
46745	2582	11	of	of	IN
46745	2582	12	the	the	DT
46745	2582	13	eyes	eye	NNS
46745	2582	14	,	,	,
46745	2582	15	fever	fever	NN
46745	2582	16	,	,	,
46745	2582	17	and	and	CC
46745	2582	18	great	great	JJ
46745	2582	19	constitutional	constitutional	JJ
46745	2582	20	depression	depression	NN
46745	2582	21	.	.	.
46745	2583	1	It	-PRON-	PRP
46745	2583	2	powerfully	powerfully	RB
46745	2583	3	promotes	promote	VBZ
46745	2583	4	absorption	absorption	NN
46745	2583	5	in	in	IN
46745	2583	6	certain	certain	JJ
46745	2583	7	cases	case	NNS
46745	2583	8	.	.	.
46745	2584	1	Its	-PRON-	PRP$
46745	2584	2	special	special	JJ
46745	2584	3	actions	action	NNS
46745	2584	4	will	will	MD
46745	2584	5	be	be	VB
46745	2584	6	subsequently	subsequently	RB
46745	2584	7	described	describe	VBN
46745	2584	8	in	in	IN
46745	2584	9	the	the	DT
46745	2584	10	remarks	remark	NNS
46745	2584	11	made	make	VBN
46745	2584	12	on	on	IN
46745	2584	13	the	the	DT
46745	2584	14	second	second	JJ
46745	2584	15	and	and	CC
46745	2584	16	third	third	JJ
46745	2584	17	orders	order	NNS
46745	2584	18	of	of	IN
46745	2584	19	Catalytic	catalytic	JJ
46745	2584	20	medicines	medicine	NNS
46745	2584	21	.	.	.
46745	2585	1	Potash	Potash	NNP
46745	2585	2	has	have	VBZ
46745	2585	3	been	be	VBN
46745	2585	4	already	already	RB
46745	2585	5	considered	consider	VBN
46745	2585	6	.	.	.
46745	2586	1	Bromine	Bromine	NNP
46745	2586	2	and	and	CC
46745	2586	3	free	free	JJ
46745	2586	4	Chlorine	Chlorine	NNP
46745	2586	5	are	be	VBP
46745	2586	6	very	very	RB
46745	2586	7	analogous	analogous	JJ
46745	2586	8	to	to	IN
46745	2586	9	Iodine	Iodine	NNP
46745	2586	10	in	in	IN
46745	2586	11	their	-PRON-	PRP$
46745	2586	12	operation	operation	NN
46745	2586	13	.	.	.
46745	2587	1	_	_	NNP
46745	2587	2	Antiarthritics	Antiarthritics	NNP
46745	2587	3	_	_	NNP
46745	2587	4	exert	exert	VB
46745	2587	5	an	an	DT
46745	2587	6	influence	influence	NN
46745	2587	7	on	on	IN
46745	2587	8	the	the	DT
46745	2587	9	blood	blood	NN
46745	2587	10	.	.	.
46745	2588	1	This	this	DT
46745	2588	2	is	be	VBZ
46745	2588	3	least	least	RBS
46745	2588	4	apparent	apparent	JJ
46745	2588	5	in	in	IN
46745	2588	6	the	the	DT
46745	2588	7	case	case	NN
46745	2588	8	of	of	IN
46745	2588	9	Colchicum	Colchicum	NNP
46745	2588	10	,	,	,
46745	2588	11	which	which	WDT
46745	2588	12	is	be	VBZ
46745	2588	13	a	a	DT
46745	2588	14	somewhat	somewhat	RB
46745	2588	15	mysterious	mysterious	JJ
46745	2588	16	remedy	remedy	NN
46745	2588	17	.	.	.
46745	2589	1	But	but	CC
46745	2589	2	it	-PRON-	PRP
46745	2589	3	has	have	VBZ
46745	2589	4	been	be	VBN
46745	2589	5	said	say	VBN
46745	2589	6	by	by	IN
46745	2589	7	some	some	DT
46745	2589	8	to	to	TO
46745	2589	9	increase	increase	VB
46745	2589	10	the	the	DT
46745	2589	11	amount	amount	NN
46745	2589	12	of	of	IN
46745	2589	13	Urea	Urea	NNP
46745	2589	14	in	in	IN
46745	2589	15	the	the	DT
46745	2589	16	urine	urine	NN
46745	2589	17	;	;	:
46745	2589	18	by	by	IN
46745	2589	19	others	other	NNS
46745	2589	20	,	,	,
46745	2589	21	to	to	TO
46745	2589	22	promote	promote	VB
46745	2589	23	the	the	DT
46745	2589	24	excretion	excretion	NN
46745	2589	25	of	of	IN
46745	2589	26	Uric	Uric	NNP
46745	2589	27	acid	acid	NN
46745	2589	28	.	.	.
46745	2590	1	(	(	-LRB-
46745	2590	2	_	_	NNP
46745	2590	3	Vide	Vide	NNP
46745	2590	4	Antiarthritics	Antiarthritics	NNP
46745	2590	5	,	,	,
46745	2590	6	and	and	CC
46745	2590	7	Chap	Chap	NNP
46745	2590	8	.	.	.
46745	2591	1	IV	IV	NNP
46745	2591	2	.	.	.
46745	2591	3	_	_	NNP
46745	2591	4	)	)	-RRB-
46745	2591	5	Nitro	Nitro	NNP
46745	2591	6	-	-	HYPH
46745	2591	7	hydrochloric	hydrochloric	JJ
46745	2591	8	acid	acid	NN
46745	2591	9	contains	contain	VBZ
46745	2591	10	Chlorine	Chlorine	NNP
46745	2591	11	,	,	,
46745	2591	12	which	which	WDT
46745	2591	13	is	be	VBZ
46745	2591	14	an	an	DT
46745	2591	15	oxidizing	oxidizing	JJ
46745	2591	16	agent	agent	NN
46745	2591	17	,	,	,
46745	2591	18	and	and	CC
46745	2591	19	probably	probably	RB
46745	2591	20	exerts	exert	NNS
46745	2591	21	in	in	IN
46745	2591	22	the	the	DT
46745	2591	23	blood	blood	NN
46745	2591	24	an	an	DT
46745	2591	25	action	action	NN
46745	2591	26	of	of	IN
46745	2591	27	this	this	DT
46745	2591	28	kind	kind	NN
46745	2591	29	.	.	.
46745	2592	1	It	-PRON-	PRP
46745	2592	2	is	be	VBZ
46745	2592	3	clear	clear	JJ
46745	2592	4	that	that	IN
46745	2592	5	it	-PRON-	PRP
46745	2592	6	is	be	VBZ
46745	2592	7	capable	capable	JJ
46745	2592	8	of	of	IN
46745	2592	9	retarding	retard	VBG
46745	2592	10	the	the	DT
46745	2592	11	formation	formation	NN
46745	2592	12	in	in	IN
46745	2592	13	the	the	DT
46745	2592	14	system	system	NN
46745	2592	15	,	,	,
46745	2592	16	and	and	CC
46745	2592	17	deposit	deposit	VB
46745	2592	18	in	in	IN
46745	2592	19	the	the	DT
46745	2592	20	urine	urine	NN
46745	2592	21	,	,	,
46745	2592	22	of	of	IN
46745	2592	23	lithic	lithic	JJ
46745	2592	24	acid	acid	NN
46745	2592	25	and	and	CC
46745	2592	26	oxalate	oxalate	NN
46745	2592	27	of	of	IN
46745	2592	28	lime	lime	NN
46745	2592	29	;	;	:
46745	2592	30	though	though	IN
46745	2592	31	its	-PRON-	PRP$
46745	2592	32	_	_	NNP
46745	2592	33	modus	modus	NN
46745	2592	34	operandi	operandi	NNP
46745	2592	35	_	_	NNP
46745	2592	36	is	be	VBZ
46745	2592	37	not	not	RB
46745	2592	38	determined	determine	VBN
46745	2592	39	with	with	IN
46745	2592	40	certainty	certainty	NN
46745	2592	41	.	.	.
46745	2593	1	This	this	DT
46745	2593	2	question	question	NN
46745	2593	3	is	be	VBZ
46745	2593	4	of	of	IN
46745	2593	5	some	some	DT
46745	2593	6	theoretical	theoretical	JJ
46745	2593	7	importance	importance	NN
46745	2593	8	,	,	,
46745	2593	9	and	and	CC
46745	2593	10	will	will	MD
46745	2593	11	soon	soon	RB
46745	2593	12	be	be	VB
46745	2593	13	considered	consider	VBN
46745	2593	14	at	at	IN
46745	2593	15	some	some	DT
46745	2593	16	length	length	NN
46745	2593	17	.	.	.
46745	2594	1	Among	among	IN
46745	2594	2	_	_	NNP
46745	2594	3	Antiscorbutics	Antiscorbutics	NNP
46745	2594	4	_	_	NNP
46745	2594	5	,	,	,
46745	2594	6	Potash	Potash	NNP
46745	2594	7	and	and	CC
46745	2594	8	its	-PRON-	PRP$
46745	2594	9	salts	salt	NNS
46745	2594	10	have	have	VBP
46745	2594	11	been	be	VBN
46745	2594	12	already	already	RB
46745	2594	13	shown	show	VBN
46745	2594	14	to	to	TO
46745	2594	15	affect	affect	VB
46745	2594	16	the	the	DT
46745	2594	17	blood	blood	NN
46745	2594	18	.	.	.
46745	2595	1	Their	-PRON-	PRP$
46745	2595	2	efficacy	efficacy	NN
46745	2595	3	in	in	IN
46745	2595	4	scurvy	scurvy	NN
46745	2595	5	is	be	VBZ
46745	2595	6	,	,	,
46745	2595	7	however	however	RB
46745	2595	8	,	,	,
46745	2595	9	a	a	DT
46745	2595	10	disputed	dispute	VBN
46745	2595	11	point	point	NN
46745	2595	12	.	.	.
46745	2596	1	That	that	DT
46745	2596	2	of	of	IN
46745	2596	3	Lemon	Lemon	NNP
46745	2596	4	-	-	HYPH
46745	2596	5	juice	juice	NN
46745	2596	6	is	be	VBZ
46745	2596	7	established	establish	VBN
46745	2596	8	.	.	.
46745	2597	1	It	-PRON-	PRP
46745	2597	2	contains	contain	VBZ
46745	2597	3	Citric	citric	JJ
46745	2597	4	acid	acid	NN
46745	2597	5	and	and	CC
46745	2597	6	Potash	Potash	NNP
46745	2597	7	;	;	:
46745	2597	8	the	the	DT
46745	2597	9	former	former	JJ
46745	2597	10	in	in	IN
46745	2597	11	great	great	JJ
46745	2597	12	excess	excess	NN
46745	2597	13	.	.	.
46745	2598	1	Now	now	RB
46745	2598	2	either	either	DT
46745	2598	3	of	of	IN
46745	2598	4	these	these	DT
46745	2598	5	by	by	IN
46745	2598	6	itself	-PRON-	PRP
46745	2598	7	would	would	MD
46745	2598	8	,	,	,
46745	2598	9	in	in	IN
46745	2598	10	cases	case	NNS
46745	2598	11	requiring	require	VBG
46745	2598	12	it	-PRON-	PRP
46745	2598	13	,	,	,
46745	2598	14	and	and	CC
46745	2598	15	given	give	VBN
46745	2598	16	in	in	IN
46745	2598	17	small	small	JJ
46745	2598	18	doses	dose	NNS
46745	2598	19	,	,	,
46745	2598	20	act	act	VB
46745	2598	21	as	as	IN
46745	2598	22	a	a	DT
46745	2598	23	Restorative	Restorative	NNP
46745	2598	24	.	.	.
46745	2599	1	In	in	IN
46745	2599	2	large	large	JJ
46745	2599	3	doses	dose	NNS
46745	2599	4	,	,	,
46745	2599	5	Citric	citric	JJ
46745	2599	6	acid	acid	NN
46745	2599	7	would	would	MD
46745	2599	8	disturb	disturb	VB
46745	2599	9	the	the	DT
46745	2599	10	reaction	reaction	NN
46745	2599	11	of	of	IN
46745	2599	12	the	the	DT
46745	2599	13	secretions	secretion	NNS
46745	2599	14	,	,	,
46745	2599	15	and	and	CC
46745	2599	16	Potash	Potash	NNP
46745	2599	17	would	would	MD
46745	2599	18	impoverish	impoverish	VB
46745	2599	19	the	the	DT
46745	2599	20	blood	blood	NN
46745	2599	21	.	.	.
46745	2600	1	When	when	WRB
46745	2600	2	both	both	DT
46745	2600	3	together	together	RB
46745	2600	4	,	,	,
46745	2600	5	the	the	DT
46745	2600	6	Citrate	Citrate	NNP
46745	2600	7	of	of	IN
46745	2600	8	Potash	Potash	NNP
46745	2600	9	would	would	MD
46745	2600	10	undergo	undergo	VB
46745	2600	11	oxidation	oxidation	NN
46745	2600	12	,	,	,
46745	2600	13	and	and	CC
46745	2600	14	thus	thus	RB
46745	2600	15	exert	exert	VB
46745	2600	16	an	an	DT
46745	2600	17	operation	operation	NN
46745	2600	18	in	in	IN
46745	2600	19	the	the	DT
46745	2600	20	blood	blood	NN
46745	2600	21	of	of	IN
46745	2600	22	a	a	DT
46745	2600	23	refrigerant	refrigerant	JJ
46745	2600	24	kind	kind	NN
46745	2600	25	.	.	.
46745	2601	1	Similar	similar	JJ
46745	2601	2	materials	material	NNS
46745	2601	3	occur	occur	VBP
46745	2601	4	in	in	IN
46745	2601	5	most	most	JJS
46745	2601	6	fresh	fresh	JJ
46745	2601	7	vegetables	vegetable	NNS
46745	2601	8	.	.	.
46745	2602	1	_	_	NNP
46745	2602	2	Antiperiodics	Antiperiodics	NNP
46745	2602	3	_	_	NNP
46745	2602	4	are	be	VBP
46745	2602	5	medicines	medicine	NNS
46745	2602	6	which	which	WDT
46745	2602	7	are	be	VBP
46745	2602	8	used	use	VBN
46745	2602	9	in	in	IN
46745	2602	10	the	the	DT
46745	2602	11	cure	cure	NN
46745	2602	12	of	of	IN
46745	2602	13	Ague	Ague	NNP
46745	2602	14	,	,	,
46745	2602	15	and	and	CC
46745	2602	16	of	of	IN
46745	2602	17	other	other	JJ
46745	2602	18	periodic	periodic	JJ
46745	2602	19	diseases	disease	NNS
46745	2602	20	,	,	,
46745	2602	21	on	on	IN
46745	2602	22	the	the	DT
46745	2602	23	Catalytic	catalytic	JJ
46745	2602	24	principle	principle	NN
46745	2602	25	.	.	.
46745	2603	1	Tonics	tonic	NNS
46745	2603	2	are	be	VBP
46745	2603	3	used	use	VBN
46745	2603	4	in	in	IN
46745	2603	5	the	the	DT
46745	2603	6	same	same	JJ
46745	2603	7	diseases	disease	NNS
46745	2603	8	on	on	IN
46745	2603	9	the	the	DT
46745	2603	10	Restorative	Restorative	NNP
46745	2603	11	plan	plan	NN
46745	2603	12	;	;	:
46745	2603	13	but	but	CC
46745	2603	14	their	-PRON-	PRP$
46745	2603	15	utility	utility	NN
46745	2603	16	extends	extend	VBZ
46745	2603	17	also	also	RB
46745	2603	18	to	to	IN
46745	2603	19	other	other	JJ
46745	2603	20	cases	case	NNS
46745	2603	21	on	on	IN
46745	2603	22	the	the	DT
46745	2603	23	same	same	JJ
46745	2603	24	grounds	ground	NNS
46745	2603	25	.	.	.
46745	2604	1	Arsenic	Arsenic	NNP
46745	2604	2	is	be	VBZ
46745	2604	3	the	the	DT
46745	2604	4	most	most	RBS
46745	2604	5	potent	potent	JJ
46745	2604	6	of	of	IN
46745	2604	7	Antiperiodics	Antiperiodics	NNP
46745	2604	8	.	.	.
46745	2605	1	The	the	DT
46745	2605	2	Terchloride	Terchloride	NNP
46745	2605	3	,	,	,
46745	2605	4	and	and	CC
46745	2605	5	the	the	DT
46745	2605	6	Arsenite	Arsenite	NNP
46745	2605	7	of	of	IN
46745	2605	8	Potash	Potash	NNP
46745	2605	9	,	,	,
46745	2605	10	are	be	VBP
46745	2605	11	the	the	DT
46745	2605	12	preparations	preparation	NNS
46745	2605	13	most	most	RBS
46745	2605	14	frequently	frequently	RB
46745	2605	15	employed	employ	VBN
46745	2605	16	.	.	.
46745	2606	1	Arsenic	Arsenic	NNP
46745	2606	2	produces	produce	VBZ
46745	2606	3	an	an	DT
46745	2606	4	evident	evident	JJ
46745	2606	5	action	action	NN
46745	2606	6	in	in	IN
46745	2606	7	the	the	DT
46745	2606	8	blood	blood	NN
46745	2606	9	.	.	.
46745	2607	1	When	when	WRB
46745	2607	2	given	give	VBN
46745	2607	3	in	in	IN
46745	2607	4	slight	slight	JJ
46745	2607	5	excess	excess	NN
46745	2607	6	,	,	,
46745	2607	7	it	-PRON-	PRP
46745	2607	8	is	be	VBZ
46745	2607	9	apt	apt	JJ
46745	2607	10	to	to	TO
46745	2607	11	bring	bring	VB
46745	2607	12	on	on	RP
46745	2607	13	[	[	-LRB-
46745	2607	14	oe]dema	oe]dema	''
46745	2607	15	of	of	IN
46745	2607	16	the	the	DT
46745	2607	17	face	face	NN
46745	2607	18	,	,	,
46745	2607	19	and	and	CC
46745	2607	20	redness	redness	NN
46745	2607	21	of	of	IN
46745	2607	22	the	the	DT
46745	2607	23	conjunctivæ	conjunctivæ	NN
46745	2607	24	.	.	.
46745	2608	1	Besides	besides	IN
46745	2608	2	causing	cause	VBG
46745	2608	3	various	various	JJ
46745	2608	4	nervous	nervous	JJ
46745	2608	5	disorders	disorder	NNS
46745	2608	6	when	when	WRB
46745	2608	7	in	in	IN
46745	2608	8	large	large	JJ
46745	2608	9	doses	dose	NNS
46745	2608	10	,	,	,
46745	2608	11	its	-PRON-	PRP$
46745	2608	12	continued	continue	VBN
46745	2608	13	use	use	NN
46745	2608	14	may	may	MD
46745	2608	15	bring	bring	VB
46745	2608	16	on	on	RP
46745	2608	17	a	a	DT
46745	2608	18	cutaneous	cutaneous	JJ
46745	2608	19	eruption	eruption	NN
46745	2608	20	,	,	,
46745	2608	21	described	describe	VBN
46745	2608	22	by	by	IN
46745	2608	23	Mr.	Mr.	NNP
46745	2608	24	Hunt	Hunt	NNP
46745	2608	25	as	as	IN
46745	2608	26	a	a	DT
46745	2608	27	kind	kind	NN
46745	2608	28	of	of	IN
46745	2608	29	pityriasis	pityriasis	NN
46745	2608	30	,	,	,
46745	2608	31	together	together	RB
46745	2608	32	with	with	IN
46745	2608	33	a	a	DT
46745	2608	34	failure	failure	NN
46745	2608	35	of	of	IN
46745	2608	36	appetite	appetite	NN
46745	2608	37	,	,	,
46745	2608	38	general	general	JJ
46745	2608	39	depression	depression	NN
46745	2608	40	,	,	,
46745	2608	41	a	a	DT
46745	2608	42	quick	quick	JJ
46745	2608	43	small	small	JJ
46745	2608	44	pulse	pulse	NN
46745	2608	45	,	,	,
46745	2608	46	hurried	hurried	JJ
46745	2608	47	respiration	respiration	NN
46745	2608	48	,	,	,
46745	2608	49	and	and	CC
46745	2608	50	sometimes	sometimes	RB
46745	2608	51	swelling	swell	VBG
46745	2608	52	of	of	IN
46745	2608	53	the	the	DT
46745	2608	54	feet	foot	NNS
46745	2608	55	.	.	.
46745	2609	1	Any	any	DT
46745	2609	2	kind	kind	NN
46745	2609	3	of	of	IN
46745	2609	4	eruption	eruption	NN
46745	2609	5	would	would	MD
46745	2609	6	alone	alone	RB
46745	2609	7	constitute	constitute	VB
46745	2609	8	sufficient	sufficient	JJ
46745	2609	9	proof	proof	NN
46745	2609	10	of	of	IN
46745	2609	11	an	an	DT
46745	2609	12	operation	operation	NN
46745	2609	13	in	in	IN
46745	2609	14	the	the	DT
46745	2609	15	blood	blood	NN
46745	2609	16	.	.	.
46745	2610	1	The	the	DT
46745	2610	2	metallic	metallic	JJ
46745	2610	3	salts	salt	NNS
46745	2610	4	used	use	VBN
46745	2610	5	as	as	IN
46745	2610	6	_	_	NNP
46745	2610	7	Anticonvulsives	Anticonvulsives	NNP
46745	2610	8	_	_	NNP
46745	2610	9	are	be	VBP
46745	2610	10	all	all	RB
46745	2610	11	capable	capable	JJ
46745	2610	12	,	,	,
46745	2610	13	when	when	WRB
46745	2610	14	taken	take	VBN
46745	2610	15	for	for	IN
46745	2610	16	some	some	DT
46745	2610	17	time	time	NN
46745	2610	18	,	,	,
46745	2610	19	of	of	IN
46745	2610	20	causing	cause	VBG
46745	2610	21	a	a	DT
46745	2610	22	deterioration	deterioration	NN
46745	2610	23	of	of	IN
46745	2610	24	the	the	DT
46745	2610	25	blood	blood	NN
46745	2610	26	.	.	.
46745	2611	1	This	this	DT
46745	2611	2	is	be	VBZ
46745	2611	3	most	most	RBS
46745	2611	4	apparent	apparent	JJ
46745	2611	5	in	in	IN
46745	2611	6	the	the	DT
46745	2611	7	case	case	NN
46745	2611	8	of	of	IN
46745	2611	9	Lead	Lead	NNP
46745	2611	10	,	,	,
46745	2611	11	which	which	WDT
46745	2611	12	,	,	,
46745	2611	13	besides	besides	IN
46745	2611	14	a	a	DT
46745	2611	15	number	number	NN
46745	2611	16	of	of	IN
46745	2611	17	nervous	nervous	JJ
46745	2611	18	symptoms	symptom	NNS
46745	2611	19	,	,	,
46745	2611	20	tends	tend	VBZ
46745	2611	21	to	to	TO
46745	2611	22	bring	bring	VB
46745	2611	23	on	on	RP
46745	2611	24	a	a	DT
46745	2611	25	kind	kind	NN
46745	2611	26	of	of	IN
46745	2611	27	jaundice	jaundice	NN
46745	2611	28	,	,	,
46745	2611	29	with	with	IN
46745	2611	30	general	general	JJ
46745	2611	31	wasting	wasting	NN
46745	2611	32	of	of	IN
46745	2611	33	the	the	DT
46745	2611	34	body	body	NN
46745	2611	35	.	.	.
46745	2612	1	Chronic	chronic	JJ
46745	2612	2	poisoning	poisoning	NN
46745	2612	3	by	by	IN
46745	2612	4	Zinc	Zinc	NNP
46745	2612	5	and	and	CC
46745	2612	6	Copper	Copper	NNP
46745	2612	7	resembles	resemble	VBZ
46745	2612	8	that	that	IN
46745	2612	9	by	by	IN
46745	2612	10	Lead	Lead	NNP
46745	2612	11	.	.	.
46745	2613	1	The	the	DT
46745	2613	2	symptoms	symptom	NNS
46745	2613	3	of	of	IN
46745	2613	4	what	what	WP
46745	2613	5	is	be	VBZ
46745	2613	6	called	call	VBN
46745	2613	7	"	"	``
46745	2613	8	Zincal	zincal	JJ
46745	2613	9	intoxication	intoxication	NN
46745	2613	10	"	"	''
46745	2613	11	were	be	VBD
46745	2613	12	recently	recently	RB
46745	2613	13	described	describe	VBN
46745	2613	14	to	to	IN
46745	2613	15	the	the	DT
46745	2613	16	French	French	NNP
46745	2613	17	Academy	Academy	NNP
46745	2613	18	by	by	IN
46745	2613	19	M.	M.	NNP
46745	2613	20	Landouzy	Landouzy	NNP
46745	2613	21	of	of	IN
46745	2613	22	Rheims	Rheims	NNP
46745	2613	23	,	,	,
46745	2613	24	as	as	IN
46745	2613	25	occurring	occur	VBG
46745	2613	26	constantly	constantly	RB
46745	2613	27	among	among	IN
46745	2613	28	the	the	DT
46745	2613	29	zinc	zinc	NN
46745	2613	30	-	-	HYPH
46745	2613	31	workers	worker	NNS
46745	2613	32	.	.	.
46745	2614	1	There	there	EX
46745	2614	2	was	be	VBD
46745	2614	3	sometimes	sometimes	RB
46745	2614	4	an	an	DT
46745	2614	5	[	[	-LRB-
46745	2614	6	oe]dema	oe]dema	``
46745	2614	7	like	like	IN
46745	2614	8	that	that	DT
46745	2614	9	produced	produce	VBN
46745	2614	10	by	by	IN
46745	2614	11	Arsenic	Arsenic	NNP
46745	2614	12	.	.	.
46745	2615	1	The	the	DT
46745	2615	2	production	production	NN
46745	2615	3	of	of	IN
46745	2615	4	all	all	PDT
46745	2615	5	the	the	DT
46745	2615	6	known	know	VBN
46745	2615	7	nervous	nervous	JJ
46745	2615	8	disorders	disorder	NNS
46745	2615	9	by	by	IN
46745	2615	10	the	the	DT
46745	2615	11	presence	presence	NN
46745	2615	12	in	in	IN
46745	2615	13	the	the	DT
46745	2615	14	blood	blood	NN
46745	2615	15	of	of	IN
46745	2615	16	different	different	JJ
46745	2615	17	metallic	metallic	JJ
46745	2615	18	medicines	medicine	NNS
46745	2615	19	,	,	,
46745	2615	20	gives	give	VBZ
46745	2615	21	a	a	DT
46745	2615	22	strong	strong	JJ
46745	2615	23	additional	additional	JJ
46745	2615	24	probability	probability	NN
46745	2615	25	to	to	IN
46745	2615	26	the	the	DT
46745	2615	27	belief	belief	NN
46745	2615	28	that	that	IN
46745	2615	29	these	these	DT
46745	2615	30	disorders	disorder	NNS
46745	2615	31	,	,	,
46745	2615	32	when	when	WRB
46745	2615	33	occurring	occur	VBG
46745	2615	34	spontaneously	spontaneously	RB
46745	2615	35	,	,	,
46745	2615	36	are	be	VBP
46745	2615	37	in	in	IN
46745	2615	38	many	many	JJ
46745	2615	39	cases	case	NNS
46745	2615	40	due	due	IN
46745	2615	41	to	to	IN
46745	2615	42	the	the	DT
46745	2615	43	presence	presence	NN
46745	2615	44	in	in	IN
46745	2615	45	the	the	DT
46745	2615	46	blood	blood	NN
46745	2615	47	of	of	IN
46745	2615	48	some	some	DT
46745	2615	49	unknown	unknown	JJ
46745	2615	50	poison	poison	NN
46745	2615	51	.	.	.
46745	2616	1	Among	among	IN
46745	2616	2	_	_	NNP
46745	2616	3	Antisquamics	Antisquamics	NNPS
46745	2616	4	_	_	NNP
46745	2616	5	,	,	,
46745	2616	6	the	the	DT
46745	2616	7	last	last	JJ
46745	2616	8	Catalytic	catalytic	JJ
46745	2616	9	order	order	NN
46745	2616	10	,	,	,
46745	2616	11	we	-PRON-	PRP
46745	2616	12	meet	meet	VBP
46745	2616	13	with	with	IN
46745	2616	14	Arsenic	Arsenic	NNP
46745	2616	15	again	again	RB
46745	2616	16	.	.	.
46745	2617	1	Common	Common	NNP
46745	2617	2	Pitch	Pitch	NNP
46745	2617	3	is	be	VBZ
46745	2617	4	of	of	IN
46745	2617	5	almost	almost	RB
46745	2617	6	equal	equal	JJ
46745	2617	7	utility	utility	NN
46745	2617	8	in	in	IN
46745	2617	9	Lepra	Lepra	NNP
46745	2617	10	.	.	.
46745	2618	1	It	-PRON-	PRP
46745	2618	2	has	have	VBZ
46745	2618	3	some	some	DT
46745	2618	4	action	action	NN
46745	2618	5	in	in	IN
46745	2618	6	the	the	DT
46745	2618	7	blood	blood	NN
46745	2618	8	,	,	,
46745	2618	9	due	due	IN
46745	2618	10	to	to	IN
46745	2618	11	some	some	DT
46745	2618	12	one	one	CD
46745	2618	13	of	of	IN
46745	2618	14	its	-PRON-	PRP$
46745	2618	15	bituminous	bituminous	JJ
46745	2618	16	principles	principle	NNS
46745	2618	17	;	;	:
46745	2618	18	but	but	CC
46745	2618	19	this	this	DT
46745	2618	20	action	action	NN
46745	2618	21	is	be	VBZ
46745	2618	22	not	not	RB
46745	2618	23	well	well	RB
46745	2618	24	made	make	VBN
46745	2618	25	out	out	RP
46745	2618	26	,	,	,
46745	2618	27	or	or	CC
46745	2618	28	understood	understand	VBD
46745	2618	29	.	.	.
46745	2619	1	Sulphur	Sulphur	NNP
46745	2619	2	,	,	,
46745	2619	3	besides	besides	IN
46745	2619	4	its	-PRON-	PRP$
46745	2619	5	use	use	NN
46745	2619	6	externally	externally	RB
46745	2619	7	in	in	IN
46745	2619	8	Scabies	Scabies	NNP
46745	2619	9	,	,	,
46745	2619	10	is	be	VBZ
46745	2619	11	administered	administer	VBN
46745	2619	12	internally	internally	RB
46745	2619	13	with	with	IN
46745	2619	14	advantage	advantage	NN
46745	2619	15	both	both	CC
46745	2619	16	in	in	IN
46745	2619	17	this	this	DT
46745	2619	18	and	and	CC
46745	2619	19	some	some	DT
46745	2619	20	other	other	JJ
46745	2619	21	skin	skin	NN
46745	2619	22	diseases	disease	NNS
46745	2619	23	.	.	.
46745	2620	1	It	-PRON-	PRP
46745	2620	2	effects	effect	VBZ
46745	2620	3	changes	change	NNS
46745	2620	4	in	in	IN
46745	2620	5	the	the	DT
46745	2620	6	blood	blood	NN
46745	2620	7	,	,	,
46745	2620	8	inasmuch	inasmuch	JJ
46745	2620	9	as	as	IN
46745	2620	10	it	-PRON-	PRP
46745	2620	11	is	be	VBZ
46745	2620	12	found	find	VBN
46745	2620	13	to	to	TO
46745	2620	14	combine	combine	VB
46745	2620	15	there	there	RB
46745	2620	16	both	both	CC
46745	2620	17	with	with	IN
46745	2620	18	hydrogen	hydrogen	NN
46745	2620	19	and	and	CC
46745	2620	20	oxygen	oxygen	NN
46745	2620	21	,	,	,
46745	2620	22	and	and	CC
46745	2620	23	to	to	TO
46745	2620	24	carry	carry	VB
46745	2620	25	them	-PRON-	PRP
46745	2620	26	out	out	IN
46745	2620	27	of	of	IN
46745	2620	28	the	the	DT
46745	2620	29	system	system	NN
46745	2620	30	as	as	IN
46745	2620	31	sulphuretted	sulphuret	VBD
46745	2620	32	hydrogen	hydrogen	NN
46745	2620	33	and	and	CC
46745	2620	34	sulphuric	sulphuric	JJ
46745	2620	35	acid	acid	NN
46745	2620	36	.	.	.
46745	2621	1	Dr.	Dr.	NNP
46745	2621	2	Pereira	Pereira	NNP
46745	2621	3	and	and	CC
46745	2621	4	others	other	NNS
46745	2621	5	ascribe	ascribe	VBP
46745	2621	6	to	to	IN
46745	2621	7	Sulphur	Sulphur	NNP
46745	2621	8	a	a	DT
46745	2621	9	resolvent	resolvent	NN
46745	2621	10	and	and	CC
46745	2621	11	liquefacient	liquefacient	JJ
46745	2621	12	action	action	NN
46745	2621	13	.	.	.
46745	2622	1	Thus	thus	RB
46745	2622	2	it	-PRON-	PRP
46745	2622	3	is	be	VBZ
46745	2622	4	sufficiently	sufficiently	RB
46745	2622	5	shown	show	VBN
46745	2622	6	that	that	IN
46745	2622	7	all	all	DT
46745	2622	8	of	of	IN
46745	2622	9	these	these	DT
46745	2622	10	medicines	medicine	NNS
46745	2622	11	work	work	VBP
46745	2622	12	out	out	RP
46745	2622	13	a	a	DT
46745	2622	14	certain	certain	JJ
46745	2622	15	process	process	NN
46745	2622	16	or	or	CC
46745	2622	17	operation	operation	NN
46745	2622	18	in	in	IN
46745	2622	19	the	the	DT
46745	2622	20	blood	blood	NN
46745	2622	21	,	,	,
46745	2622	22	and	and	CC
46745	2622	23	affect	affect	VB
46745	2622	24	the	the	DT
46745	2622	25	condition	condition	NN
46745	2622	26	of	of	IN
46745	2622	27	that	that	DT
46745	2622	28	fluid	fluid	NN
46745	2622	29	.	.	.
46745	2623	1	But	but	CC
46745	2623	2	I	-PRON-	PRP
46745	2623	3	am	be	VBP
46745	2623	4	very	very	RB
46745	2623	5	far	far	RB
46745	2623	6	from	from	IN
46745	2623	7	believing	believe	VBG
46745	2623	8	that	that	IN
46745	2623	9	this	this	DT
46745	2623	10	known	know	VBN
46745	2623	11	operation	operation	NN
46745	2623	12	is	be	VBZ
46745	2623	13	in	in	IN
46745	2623	14	all	all	DT
46745	2623	15	cases	case	NNS
46745	2623	16	the	the	DT
46745	2623	17	one	one	CD
46745	2623	18	by	by	IN
46745	2623	19	which	which	WDT
46745	2623	20	they	-PRON-	PRP
46745	2623	21	neutralize	neutralize	VBP
46745	2623	22	morbid	morbid	NN
46745	2623	23	poisons	poison	NNS
46745	2623	24	.	.	.
46745	2624	1	This	this	DT
46745	2624	2	action	action	NN
46745	2624	3	is	be	VBZ
46745	2624	4	probably	probably	RB
46745	2624	5	of	of	IN
46745	2624	6	a	a	DT
46745	2624	7	much	much	RB
46745	2624	8	more	more	RBR
46745	2624	9	inscrutable	inscrutable	JJ
46745	2624	10	character	character	NN
46745	2624	11	.	.	.
46745	2625	1	Before	before	IN
46745	2625	2	proceeding	proceed	VBG
46745	2625	3	further	further	RB
46745	2625	4	,	,	,
46745	2625	5	I	-PRON-	PRP
46745	2625	6	may	may	MD
46745	2625	7	here	here	RB
46745	2625	8	take	take	VB
46745	2625	9	the	the	DT
46745	2625	10	opportunity	opportunity	NN
46745	2625	11	of	of	IN
46745	2625	12	insisting	insist	VBG
46745	2625	13	again	again	RB
46745	2625	14	on	on	IN
46745	2625	15	the	the	DT
46745	2625	16	differences	difference	NNS
46745	2625	17	between	between	IN
46745	2625	18	Catalytic	catalytic	JJ
46745	2625	19	and	and	CC
46745	2625	20	Restorative	Restorative	NNP
46745	2625	21	medicines	medicine	NNS
46745	2625	22	.	.	.
46745	2626	1	Catalytics	catalytic	NNS
46745	2626	2	will	will	MD
46745	2626	3	even	even	RB
46745	2626	4	in	in	IN
46745	2626	5	health	health	NN
46745	2626	6	work	work	NN
46745	2626	7	out	out	RP
46745	2626	8	their	-PRON-	PRP$
46745	2626	9	peculiar	peculiar	JJ
46745	2626	10	process	process	NN
46745	2626	11	in	in	IN
46745	2626	12	the	the	DT
46745	2626	13	blood	blood	NN
46745	2626	14	.	.	.
46745	2627	1	Restoratives	restorative	NNS
46745	2627	2	exercise	exercise	VBP
46745	2627	3	in	in	IN
46745	2627	4	that	that	DT
46745	2627	5	case	case	NN
46745	2627	6	no	no	DT
46745	2627	7	particular	particular	JJ
46745	2627	8	influence	influence	NN
46745	2627	9	.	.	.
46745	2628	1	The	the	DT
46745	2628	2	latter	latter	JJ
46745	2628	3	may	may	MD
46745	2628	4	remain	remain	VB
46745	2628	5	in	in	IN
46745	2628	6	the	the	DT
46745	2628	7	blood	blood	NN
46745	2628	8	;	;	:
46745	2628	9	their	-PRON-	PRP$
46745	2628	10	office	office	NN
46745	2628	11	is	be	VBZ
46745	2628	12	supply	supply	NN
46745	2628	13	or	or	CC
46745	2628	14	substitution	substitution	NN
46745	2628	15	.	.	.
46745	2629	1	Catalytics	catalytic	NNS
46745	2629	2	may	may	MD
46745	2629	3	not	not	RB
46745	2629	4	remain	remain	VB
46745	2629	5	beyond	beyond	IN
46745	2629	6	a	a	DT
46745	2629	7	certain	certain	JJ
46745	2629	8	time	time	NN
46745	2629	9	;	;	:
46745	2629	10	their	-PRON-	PRP$
46745	2629	11	office	office	NN
46745	2629	12	is	be	VBZ
46745	2629	13	counteraction	counteraction	NN
46745	2629	14	.	.	.
46745	2630	1	The	the	DT
46745	2630	2	system	system	NN
46745	2630	3	then	then	RB
46745	2630	4	labours	labour	VBZ
46745	2630	5	to	to	TO
46745	2630	6	excrete	excrete	VB
46745	2630	7	them	-PRON-	PRP
46745	2630	8	.	.	.
46745	2631	1	Before	before	IN
46745	2631	2	passing	pass	VBG
46745	2631	3	out	out	IN
46745	2631	4	of	of	IN
46745	2631	5	the	the	DT
46745	2631	6	body	body	NN
46745	2631	7	,	,	,
46745	2631	8	one	one	CD
46745	2631	9	or	or	CC
46745	2631	10	two	two	CD
46745	2631	11	,	,	,
46745	2631	12	as	as	IN
46745	2631	13	Colchicum	Colchicum	NNP
46745	2631	14	,	,	,
46745	2631	15	may	may	MD
46745	2631	16	act	act	VB
46745	2631	17	on	on	IN
46745	2631	18	the	the	DT
46745	2631	19	nerves	nerve	NNS
46745	2631	20	.	.	.
46745	2632	1	In	in	IN
46745	2632	2	the	the	DT
46745	2632	3	moment	moment	NN
46745	2632	4	of	of	IN
46745	2632	5	excretion	excretion	NN
46745	2632	6	,	,	,
46745	2632	7	the	the	DT
46745	2632	8	majority	majority	NN
46745	2632	9	act	act	NN
46745	2632	10	as	as	IN
46745	2632	11	Eliminatives	Eliminatives	NNPS
46745	2632	12	.	.	.
46745	2633	1	But	but	CC
46745	2633	2	some	some	DT
46745	2633	3	,	,	,
46745	2633	4	as	as	IN
46745	2633	5	the	the	DT
46745	2633	6	metals	metal	NNS
46745	2633	7	used	use	VBN
46745	2633	8	as	as	IN
46745	2633	9	Anticonvulsives	Anticonvulsives	NNP
46745	2633	10	,	,	,
46745	2633	11	are	be	VBP
46745	2633	12	astringent	astringent	JJ
46745	2633	13	,	,	,
46745	2633	14	and	and	CC
46745	2633	15	diminish	diminish	JJ
46745	2633	16	secretion	secretion	NN
46745	2633	17	generally	generally	RB
46745	2633	18	.	.	.
46745	2634	1	Mercury	Mercury	NNP
46745	2634	2	,	,	,
46745	2634	3	Antimony	Antimony	NNP
46745	2634	4	,	,	,
46745	2634	5	and	and	CC
46745	2634	6	Iodine	Iodine	NNP
46745	2634	7	,	,	,
46745	2634	8	are	be	VBP
46745	2634	9	among	among	IN
46745	2634	10	the	the	DT
46745	2634	11	most	most	RBS
46745	2634	12	important	important	JJ
46745	2634	13	Eliminatives	Eliminatives	NNPS
46745	2634	14	known	know	VBN
46745	2634	15	.	.	.
46745	2635	1	They	-PRON-	PRP
46745	2635	2	act	act	VBP
46745	2635	3	on	on	IN
46745	2635	4	all	all	DT
46745	2635	5	glands	gland	NNS
46745	2635	6	,	,	,
46745	2635	7	but	but	CC
46745	2635	8	on	on	IN
46745	2635	9	some	some	DT
46745	2635	10	more	more	JJR
46745	2635	11	than	than	IN
46745	2635	12	on	on	IN
46745	2635	13	others	other	NNS
46745	2635	14	.	.	.
46745	2636	1	Antimony	Antimony	NNP
46745	2636	2	is	be	VBZ
46745	2636	3	also	also	RB
46745	2636	4	a	a	DT
46745	2636	5	special	special	JJ
46745	2636	6	sedative	sedative	NN
46745	2636	7	to	to	IN
46745	2636	8	the	the	DT
46745	2636	9	Vagus	Vagus	NNP
46745	2636	10	nerve	nerve	NN
46745	2636	11	,	,	,
46745	2636	12	and	and	CC
46745	2636	13	as	as	IN
46745	2636	14	such	such	JJ
46745	2636	15	exerts	exert	NNS
46745	2636	16	an	an	DT
46745	2636	17	important	important	JJ
46745	2636	18	influence	influence	NN
46745	2636	19	,	,	,
46745	2636	20	which	which	WDT
46745	2636	21	enables	enable	VBZ
46745	2636	22	it	-PRON-	PRP
46745	2636	23	sometimes	sometimes	RB
46745	2636	24	to	to	TO
46745	2636	25	cut	cut	VB
46745	2636	26	short	short	JJ
46745	2636	27	the	the	DT
46745	2636	28	process	process	NN
46745	2636	29	of	of	IN
46745	2636	30	inflammation	inflammation	NN
46745	2636	31	by	by	IN
46745	2636	32	depressing	depress	VBG
46745	2636	33	the	the	DT
46745	2636	34	action	action	NN
46745	2636	35	of	of	IN
46745	2636	36	the	the	DT
46745	2636	37	heart	heart	NN
46745	2636	38	.	.	.
46745	2637	1	We	-PRON-	PRP
46745	2637	2	now	now	RB
46745	2637	3	arrive	arrive	VBP
46745	2637	4	at	at	IN
46745	2637	5	the	the	DT
46745	2637	6	third	third	JJ
46745	2637	7	minor	minor	JJ
46745	2637	8	proposition	proposition	NN
46745	2637	9	.	.	.
46745	2638	1	_	_	NNP
46745	2638	2	The	the	DT
46745	2638	3	diseases	disease	NNS
46745	2638	4	in	in	IN
46745	2638	5	which	which	WDT
46745	2638	6	these	these	DT
46745	2638	7	medicines	medicine	NNS
46745	2638	8	are	be	VBP
46745	2638	9	employed	employ	VBN
46745	2638	10	are	be	VBP
46745	2638	11	active	active	JJ
46745	2638	12	blood	blood	NN
46745	2638	13	-	-	HYPH
46745	2638	14	diseases	disease	NNS
46745	2638	15	.	.	.
46745	2638	16	_	_	NNP
46745	2638	17	This	this	DT
46745	2638	18	consideration	consideration	NN
46745	2638	19	need	nee	MD
46745	2638	20	not	not	RB
46745	2638	21	detain	detain	VB
46745	2638	22	us	-PRON-	PRP
46745	2638	23	long	long	RB
46745	2638	24	,	,	,
46745	2638	25	for	for	IN
46745	2638	26	in	in	IN
46745	2638	27	most	most	JJS
46745	2638	28	cases	case	NNS
46745	2638	29	the	the	DT
46745	2638	30	correctness	correctness	NN
46745	2638	31	of	of	IN
46745	2638	32	the	the	DT
46745	2638	33	statement	statement	NN
46745	2638	34	is	be	VBZ
46745	2638	35	universally	universally	RB
46745	2638	36	admitted	admit	VBN
46745	2638	37	.	.	.
46745	2639	1	_	_	NNP
46745	2639	2	Inflammation	Inflammation	NNP
46745	2639	3	_	_	NNP
46745	2639	4	may	may	MD
46745	2639	5	be	be	VB
46745	2639	6	produced	produce	VBN
46745	2639	7	by	by	IN
46745	2639	8	a	a	DT
46745	2639	9	variety	variety	NN
46745	2639	10	of	of	IN
46745	2639	11	blood	blood	NN
46745	2639	12	-	-	HYPH
46745	2639	13	poisons	poison	NNS
46745	2639	14	,	,	,
46745	2639	15	in	in	IN
46745	2639	16	each	each	DT
46745	2639	17	of	of	IN
46745	2639	18	which	which	WDT
46745	2639	19	instances	instance	VBZ
46745	2639	20	it	-PRON-	PRP
46745	2639	21	partakes	partake	VBZ
46745	2639	22	of	of	IN
46745	2639	23	a	a	DT
46745	2639	24	special	special	JJ
46745	2639	25	character	character	NN
46745	2639	26	.	.	.
46745	2640	1	Thus	thus	RB
46745	2640	2	there	there	EX
46745	2640	3	are	be	VBP
46745	2640	4	the	the	DT
46745	2640	5	syphilitic	syphilitic	JJ
46745	2640	6	,	,	,
46745	2640	7	scrofulous	scrofulous	JJ
46745	2640	8	,	,	,
46745	2640	9	and	and	CC
46745	2640	10	rheumatic	rheumatic	JJ
46745	2640	11	inflammations	inflammation	NNS
46745	2640	12	.	.	.
46745	2641	1	Simple	simple	JJ
46745	2641	2	inflammation	inflammation	NN
46745	2641	3	may	may	MD
46745	2641	4	be	be	VB
46745	2641	5	caused	cause	VBN
46745	2641	6	by	by	IN
46745	2641	7	the	the	DT
46745	2641	8	injury	injury	NN
46745	2641	9	of	of	IN
46745	2641	10	any	any	DT
46745	2641	11	part	part	NN
46745	2641	12	or	or	CC
46745	2641	13	organ	organ	NN
46745	2641	14	,	,	,
46745	2641	15	external	external	JJ
46745	2641	16	or	or	CC
46745	2641	17	internal	internal	JJ
46745	2641	18	.	.	.
46745	2642	1	It	-PRON-	PRP
46745	2642	2	commences	commence	VBZ
46745	2642	3	in	in	IN
46745	2642	4	the	the	DT
46745	2642	5	capillary	capillary	JJ
46745	2642	6	vessels	vessel	NNS
46745	2642	7	,	,	,
46745	2642	8	and	and	CC
46745	2642	9	,	,	,
46745	2642	10	if	if	IN
46745	2642	11	extensive	extensive	JJ
46745	2642	12	,	,	,
46745	2642	13	affects	affect	VBZ
46745	2642	14	the	the	DT
46745	2642	15	blood	blood	NN
46745	2642	16	generally	generally	RB
46745	2642	17	,	,	,
46745	2642	18	and	and	CC
46745	2642	19	produces	produce	VBZ
46745	2642	20	fever	fever	NN
46745	2642	21	.	.	.
46745	2643	1	The	the	DT
46745	2643	2	blood	blood	NN
46745	2643	3	then	then	RB
46745	2643	4	contains	contain	VBZ
46745	2643	5	an	an	DT
46745	2643	6	excess	excess	NN
46745	2643	7	of	of	IN
46745	2643	8	Fibrine	Fibrine	NNP
46745	2643	9	,	,	,
46745	2643	10	causing	cause	VBG
46745	2643	11	it	-PRON-	PRP
46745	2643	12	,	,	,
46745	2643	13	on	on	IN
46745	2643	14	coagulation	coagulation	NN
46745	2643	15	,	,	,
46745	2643	16	to	to	TO
46745	2643	17	exhibit	exhibit	VB
46745	2643	18	the	the	DT
46745	2643	19	"	"	``
46745	2643	20	buffy	buffy	JJ
46745	2643	21	coat	coat	NN
46745	2643	22	.	.	.
46745	2643	23	"	"	''
46745	2644	1	There	there	EX
46745	2644	2	are	be	VBP
46745	2644	3	also	also	RB
46745	2644	4	found	find	VBN
46745	2644	5	in	in	IN
46745	2644	6	this	this	DT
46745	2644	7	,	,	,
46745	2644	8	according	accord	VBG
46745	2644	9	to	to	IN
46745	2644	10	Mulder	Mulder	NNP
46745	2644	11	,	,	,
46745	2644	12	some	some	DT
46745	2644	13	peculiar	peculiar	JJ
46745	2644	14	hyperoxides	hyperoxide	NNS
46745	2644	15	of	of	IN
46745	2644	16	Proteine	Proteine	NNP
46745	2644	17	.	.	.
46745	2645	1	The	the	DT
46745	2645	2	colourless	colourless	JJ
46745	2645	3	corpuscles	corpuscle	NNS
46745	2645	4	are	be	VBP
46745	2645	5	in	in	IN
46745	2645	6	excess	excess	NN
46745	2645	7	;	;	:
46745	2645	8	and	and	CC
46745	2645	9	among	among	IN
46745	2645	10	the	the	DT
46745	2645	11	red	red	JJ
46745	2645	12	corpuscles	corpuscle	NNS
46745	2645	13	is	be	VBZ
46745	2645	14	observed	observe	VBN
46745	2645	15	a	a	DT
46745	2645	16	peculiar	peculiar	JJ
46745	2645	17	tendency	tendency	NN
46745	2645	18	to	to	TO
46745	2645	19	arrange	arrange	VB
46745	2645	20	themselves	-PRON-	PRP
46745	2645	21	together	together	RB
46745	2645	22	in	in	IN
46745	2645	23	rows	row	NNS
46745	2645	24	.	.	.
46745	2646	1	This	this	DT
46745	2646	2	is	be	VBZ
46745	2646	3	doubtless	doubtless	JJ
46745	2646	4	in	in	IN
46745	2646	5	some	some	DT
46745	2646	6	way	way	NN
46745	2646	7	connected	connect	VBN
46745	2646	8	with	with	IN
46745	2646	9	the	the	DT
46745	2646	10	morbid	morbid	NN
46745	2646	11	process	process	NN
46745	2646	12	going	go	VBG
46745	2646	13	on	on	RP
46745	2646	14	in	in	IN
46745	2646	15	the	the	DT
46745	2646	16	blood	blood	NN
46745	2646	17	.	.	.
46745	2647	1	_	_	NNP
46745	2647	2	Syphilis	Syphilis	NNP
46745	2647	3	_	_	NNP
46745	2647	4	is	be	VBZ
46745	2647	5	evidently	evidently	RB
46745	2647	6	traceable	traceable	JJ
46745	2647	7	to	to	IN
46745	2647	8	a	a	DT
46745	2647	9	special	special	JJ
46745	2647	10	poison	poison	NN
46745	2647	11	.	.	.
46745	2648	1	This	this	DT
46745	2648	2	is	be	VBZ
46745	2648	3	recognised	recognise	VBN
46745	2648	4	by	by	IN
46745	2648	5	the	the	DT
46745	2648	6	fact	fact	NN
46745	2648	7	of	of	IN
46745	2648	8	its	-PRON-	PRP$
46745	2648	9	communication	communication	NN
46745	2648	10	from	from	IN
46745	2648	11	one	one	CD
46745	2648	12	person	person	NN
46745	2648	13	to	to	IN
46745	2648	14	another	another	DT
46745	2648	15	.	.	.
46745	2649	1	In	in	IN
46745	2649	2	the	the	DT
46745	2649	3	system	system	NN
46745	2649	4	of	of	IN
46745	2649	5	the	the	DT
46745	2649	6	infected	infected	JJ
46745	2649	7	person	person	NN
46745	2649	8	,	,	,
46745	2649	9	if	if	IN
46745	2649	10	left	leave	VBD
46745	2649	11	alone	alone	RB
46745	2649	12	and	and	CC
46745	2649	13	uncontrolled	uncontrolled	JJ
46745	2649	14	,	,	,
46745	2649	15	it	-PRON-	PRP
46745	2649	16	breeds	breed	VBZ
46745	2649	17	and	and	CC
46745	2649	18	increases	increase	NNS
46745	2649	19	in	in	IN
46745	2649	20	quantity	quantity	NN
46745	2649	21	,	,	,
46745	2649	22	works	work	VBZ
46745	2649	23	out	out	RP
46745	2649	24	all	all	PDT
46745	2649	25	the	the	DT
46745	2649	26	mischief	mischief	NN
46745	2649	27	that	that	IN
46745	2649	28	it	-PRON-	PRP
46745	2649	29	is	be	VBZ
46745	2649	30	capable	capable	JJ
46745	2649	31	of	of	IN
46745	2649	32	effecting	effect	VBG
46745	2649	33	,	,	,
46745	2649	34	and	and	CC
46745	2649	35	may	may	MD
46745	2649	36	again	again	RB
46745	2649	37	be	be	VB
46745	2649	38	propagated	propagate	VBN
46745	2649	39	to	to	IN
46745	2649	40	others	other	NNS
46745	2649	41	,	,	,
46745	2649	42	either	either	CC
46745	2649	43	by	by	IN
46745	2649	44	inoculation	inoculation	NN
46745	2649	45	into	into	IN
46745	2649	46	the	the	DT
46745	2649	47	blood	blood	NN
46745	2649	48	,	,	,
46745	2649	49	or	or	CC
46745	2649	50	by	by	IN
46745	2649	51	an	an	DT
46745	2649	52	equally	equally	RB
46745	2649	53	direct	direct	JJ
46745	2649	54	transmission	transmission	NN
46745	2649	55	to	to	IN
46745	2649	56	a	a	DT
46745	2649	57	tainted	tainted	JJ
46745	2649	58	offspring	offspring	NN
46745	2649	59	.	.	.
46745	2650	1	_	_	NNP
46745	2650	2	Scrofula	Scrofula	NNP
46745	2650	3	_	_	NNP
46745	2650	4	is	be	VBZ
46745	2650	5	also	also	RB
46745	2650	6	a	a	DT
46745	2650	7	blood	blood	NN
46745	2650	8	-	-	HYPH
46745	2650	9	disease	disease	NN
46745	2650	10	.	.	.
46745	2651	1	All	all	DT
46745	2651	2	its	-PRON-	PRP$
46745	2651	3	manifestations	manifestation	NNS
46745	2651	4	are	be	VBP
46745	2651	5	explainable	explainable	JJ
46745	2651	6	on	on	IN
46745	2651	7	such	such	PDT
46745	2651	8	a	a	DT
46745	2651	9	supposition	supposition	NN
46745	2651	10	.	.	.
46745	2652	1	It	-PRON-	PRP
46745	2652	2	is	be	VBZ
46745	2652	3	transmissible	transmissible	JJ
46745	2652	4	from	from	IN
46745	2652	5	parent	parent	NN
46745	2652	6	to	to	IN
46745	2652	7	child	child	NN
46745	2652	8	;	;	:
46745	2652	9	and	and	CC
46745	2652	10	it	-PRON-	PRP
46745	2652	11	holds	hold	VBZ
46745	2652	12	good	good	JJ
46745	2652	13	as	as	IN
46745	2652	14	a	a	DT
46745	2652	15	general	general	JJ
46745	2652	16	rule	rule	NN
46745	2652	17	that	that	IN
46745	2652	18	hereditary	hereditary	JJ
46745	2652	19	diseases	disease	NNS
46745	2652	20	are	be	VBP
46745	2652	21	seated	seat	VBN
46745	2652	22	in	in	IN
46745	2652	23	the	the	DT
46745	2652	24	blood	blood	NN
46745	2652	25	.	.	.
46745	2653	1	It	-PRON-	PRP
46745	2653	2	is	be	VBZ
46745	2653	3	unaffected	unaffected	JJ
46745	2653	4	by	by	IN
46745	2653	5	any	any	DT
46745	2653	6	of	of	IN
46745	2653	7	those	those	DT
46745	2653	8	medicines	medicine	NNS
46745	2653	9	that	that	WDT
46745	2653	10	act	act	VBP
46745	2653	11	only	only	RB
46745	2653	12	on	on	IN
46745	2653	13	the	the	DT
46745	2653	14	nerves	nerve	NNS
46745	2653	15	.	.	.
46745	2654	1	It	-PRON-	PRP
46745	2654	2	produces	produce	VBZ
46745	2654	3	a	a	DT
46745	2654	4	deterioration	deterioration	NN
46745	2654	5	of	of	IN
46745	2654	6	the	the	DT
46745	2654	7	blood	blood	NN
46745	2654	8	.	.	.
46745	2655	1	_	_	NNP
46745	2655	2	Arthritic	Arthritic	NNP
46745	2655	3	_	_	NNP
46745	2655	4	disorders	disorder	NNS
46745	2655	5	are	be	VBP
46745	2655	6	always	always	RB
46745	2655	7	accompanied	accompany	VBN
46745	2655	8	by	by	IN
46745	2655	9	a	a	DT
46745	2655	10	change	change	NN
46745	2655	11	in	in	IN
46745	2655	12	the	the	DT
46745	2655	13	blood	blood	NN
46745	2655	14	.	.	.
46745	2656	1	In	in	IN
46745	2656	2	Diabetes	diabetes	NN
46745	2656	3	grape	grape	NN
46745	2656	4	-	-	HYPH
46745	2656	5	sugar	sugar	NN
46745	2656	6	is	be	VBZ
46745	2656	7	present	present	JJ
46745	2656	8	there	there	RB
46745	2656	9	in	in	IN
46745	2656	10	large	large	JJ
46745	2656	11	quantities	quantity	NNS
46745	2656	12	,	,	,
46745	2656	13	and	and	CC
46745	2656	14	has	have	VBZ
46745	2656	15	to	to	TO
46745	2656	16	be	be	VB
46745	2656	17	excreted	excrete	VBN
46745	2656	18	by	by	IN
46745	2656	19	the	the	DT
46745	2656	20	kidneys	kidney	NNS
46745	2656	21	.	.	.
46745	2657	1	Similarly	similarly	RB
46745	2657	2	,	,	,
46745	2657	3	in	in	IN
46745	2657	4	Oxaluria	Oxaluria	NNP
46745	2657	5	,	,	,
46745	2657	6	oxalic	oxalic	JJ
46745	2657	7	acid	acid	NN
46745	2657	8	is	be	VBZ
46745	2657	9	found	find	VBN
46745	2657	10	there	there	RB
46745	2657	11	;	;	:
46745	2657	12	in	in	IN
46745	2657	13	Lithiasis	Lithiasis	NNP
46745	2657	14	,	,	,
46745	2657	15	lithic	lithic	JJ
46745	2657	16	acid	acid	NN
46745	2657	17	in	in	IN
46745	2657	18	excess	excess	NN
46745	2657	19	.	.	.
46745	2658	1	In	in	IN
46745	2658	2	Rheumatic	rheumatic	JJ
46745	2658	3	fever	fever	NN
46745	2658	4	there	there	EX
46745	2658	5	are	be	VBP
46745	2658	6	profuse	profuse	NN
46745	2658	7	sweats	sweat	NNS
46745	2658	8	,	,	,
46745	2658	9	in	in	IN
46745	2658	10	which	which	WDT
46745	2658	11	the	the	DT
46745	2658	12	natural	natural	JJ
46745	2658	13	acid	acid	NN
46745	2658	14	of	of	IN
46745	2658	15	the	the	DT
46745	2658	16	perspiration	perspiration	NN
46745	2658	17	is	be	VBZ
46745	2658	18	enormously	enormously	RB
46745	2658	19	increased	increase	VBN
46745	2658	20	in	in	IN
46745	2658	21	quantity	quantity	NN
46745	2658	22	.	.	.
46745	2659	1	It	-PRON-	PRP
46745	2659	2	is	be	VBZ
46745	2659	3	stated	state	VBN
46745	2659	4	by	by	IN
46745	2659	5	Berzelius	Berzelius	NNP
46745	2659	6	to	to	TO
46745	2659	7	be	be	VB
46745	2659	8	lactic	lactic	JJ
46745	2659	9	acid	acid	NN
46745	2659	10	.	.	.
46745	2660	1	Either	either	CC
46745	2660	2	this	this	DT
46745	2660	3	,	,	,
46745	2660	4	or	or	CC
46745	2660	5	some	some	DT
46745	2660	6	other	other	JJ
46745	2660	7	acid	acid	NN
46745	2660	8	like	like	IN
46745	2660	9	it	-PRON-	PRP
46745	2660	10	,	,	,
46745	2660	11	must	must	MD
46745	2660	12	be	be	VB
46745	2660	13	formed	form	VBN
46745	2660	14	in	in	IN
46745	2660	15	excess	excess	NN
46745	2660	16	in	in	IN
46745	2660	17	the	the	DT
46745	2660	18	blood	blood	NN
46745	2660	19	.	.	.
46745	2661	1	In	in	IN
46745	2661	2	Gout	Gout	NNP
46745	2661	3	we	-PRON-	PRP
46745	2661	4	have	have	VBP
46745	2661	5	sometimes	sometimes	RB
46745	2661	6	a	a	DT
46745	2661	7	deposit	deposit	NN
46745	2661	8	of	of	IN
46745	2661	9	urate	urate	NN
46745	2661	10	of	of	IN
46745	2661	11	soda	soda	NNP
46745	2661	12	in	in	IN
46745	2661	13	the	the	DT
46745	2661	14	cellular	cellular	JJ
46745	2661	15	tissue	tissue	NN
46745	2661	16	opposite	opposite	IN
46745	2661	17	the	the	DT
46745	2661	18	small	small	JJ
46745	2661	19	joints	joint	NNS
46745	2661	20	.	.	.
46745	2662	1	The	the	DT
46745	2662	2	same	same	JJ
46745	2662	3	salt	salt	NN
46745	2662	4	has	have	VBZ
46745	2662	5	been	be	VBN
46745	2662	6	occasionally	occasionally	RB
46745	2662	7	found	find	VBN
46745	2662	8	in	in	IN
46745	2662	9	the	the	DT
46745	2662	10	urine	urine	NN
46745	2662	11	in	in	IN
46745	2662	12	Gout	Gout	NNP
46745	2662	13	.	.	.
46745	2663	1	Lastly	lastly	RB
46745	2663	2	it	-PRON-	PRP
46745	2663	3	has	have	VBZ
46745	2663	4	been	be	VBN
46745	2663	5	detected	detect	VBN
46745	2663	6	in	in	IN
46745	2663	7	the	the	DT
46745	2663	8	blood	blood	NN
46745	2663	9	in	in	IN
46745	2663	10	that	that	DT
46745	2663	11	disorder	disorder	NN
46745	2663	12	by	by	IN
46745	2663	13	Dr.	Dr.	NNP
46745	2663	14	Garrod	Garrod	NNP
46745	2663	15	,	,	,
46745	2663	16	and	and	CC
46745	2663	17	since	since	IN
46745	2663	18	him	-PRON-	PRP
46745	2663	19	,	,	,
46745	2663	20	by	by	IN
46745	2663	21	Dr.	Dr.	NNP
46745	2663	22	Bence	Bence	NNP
46745	2663	23	Jones	Jones	NNP
46745	2663	24	.	.	.
46745	2664	1	(	(	-LRB-
46745	2664	2	_	_	NNP
46745	2664	3	Animal	Animal	NNP
46745	2664	4	Chemistry	Chemistry	NNP
46745	2664	5	,	,	,
46745	2664	6	p.	p.	NN
46745	2664	7	_	_	NNP
46745	2664	8	29	29	CD
46745	2664	9	.	.	.
46745	2664	10	)	)	-RRB-
46745	2665	1	Thus	thus	RB
46745	2665	2	,	,	,
46745	2665	3	in	in	IN
46745	2665	4	all	all	PDT
46745	2665	5	these	these	DT
46745	2665	6	disorders	disorder	NNS
46745	2665	7	there	there	EX
46745	2665	8	is	be	VBZ
46745	2665	9	a	a	DT
46745	2665	10	wrong	wrong	NN
46745	2665	11	in	in	IN
46745	2665	12	the	the	DT
46745	2665	13	blood	blood	NN
46745	2665	14	.	.	.
46745	2666	1	_	_	NNP
46745	2666	2	Scorbutic	Scorbutic	NNP
46745	2666	3	_	_	NNP
46745	2666	4	diseases	disease	NNS
46745	2666	5	,	,	,
46745	2666	6	_	_	NNP
46745	2666	7	i.e.	i.e.	FW
46745	2666	8	_	_	NNP
46745	2666	9	,	,	,
46745	2666	10	Scurvy	Scurvy	NNP
46745	2666	11	and	and	CC
46745	2666	12	Purpura	Purpura	NNP
46745	2666	13	,	,	,
46745	2666	14	are	be	VBP
46745	2666	15	characterized	characterize	VBN
46745	2666	16	by	by	IN
46745	2666	17	a	a	DT
46745	2666	18	general	general	JJ
46745	2666	19	poorness	poorness	NN
46745	2666	20	of	of	IN
46745	2666	21	the	the	DT
46745	2666	22	blood	blood	NN
46745	2666	23	,	,	,
46745	2666	24	with	with	IN
46745	2666	25	a	a	DT
46745	2666	26	special	special	JJ
46745	2666	27	deficiency	deficiency	NN
46745	2666	28	in	in	IN
46745	2666	29	the	the	DT
46745	2666	30	amount	amount	NN
46745	2666	31	of	of	IN
46745	2666	32	Fibrine	Fibrine	NNP
46745	2666	33	and	and	CC
46745	2666	34	of	of	IN
46745	2666	35	salts	salt	NNS
46745	2666	36	.	.	.
46745	2667	1	There	there	EX
46745	2667	2	is	be	VBZ
46745	2667	3	a	a	DT
46745	2667	4	general	general	JJ
46745	2667	5	tendency	tendency	NN
46745	2667	6	to	to	TO
46745	2667	7	hæmorrhage	hæmorrhage	VB
46745	2667	8	and	and	CC
46745	2667	9	ulceration	ulceration	NN
46745	2667	10	all	all	RB
46745	2667	11	over	over	IN
46745	2667	12	the	the	DT
46745	2667	13	body	body	NN
46745	2667	14	.	.	.
46745	2668	1	It	-PRON-	PRP
46745	2668	2	has	have	VBZ
46745	2668	3	been	be	VBN
46745	2668	4	observed	observe	VBN
46745	2668	5	that	that	IN
46745	2668	6	these	these	DT
46745	2668	7	diseases	disease	NNS
46745	2668	8	seldom	seldom	RB
46745	2668	9	occur	occur	VBP
46745	2668	10	in	in	IN
46745	2668	11	persons	person	NNS
46745	2668	12	who	who	WP
46745	2668	13	are	be	VBP
46745	2668	14	accustomed	accustomed	JJ
46745	2668	15	to	to	IN
46745	2668	16	a	a	DT
46745	2668	17	natural	natural	JJ
46745	2668	18	and	and	CC
46745	2668	19	mixed	mixed	JJ
46745	2668	20	diet	diet	NN
46745	2668	21	.	.	.
46745	2669	1	_	_	NNP
46745	2669	2	Periodic	Periodic	NNP
46745	2669	3	_	_	NNP
46745	2669	4	disorders	disorder	NNS
46745	2669	5	are	be	VBP
46745	2669	6	known	know	VBN
46745	2669	7	to	to	TO
46745	2669	8	be	be	VB
46745	2669	9	attributable	attributable	JJ
46745	2669	10	to	to	IN
46745	2669	11	the	the	DT
46745	2669	12	entrance	entrance	NN
46745	2669	13	into	into	IN
46745	2669	14	the	the	DT
46745	2669	15	blood	blood	NN
46745	2669	16	of	of	IN
46745	2669	17	a	a	DT
46745	2669	18	peculiar	peculiar	JJ
46745	2669	19	aerial	aerial	JJ
46745	2669	20	poison	poison	NN
46745	2669	21	.	.	.
46745	2670	1	The	the	DT
46745	2670	2	mild	mild	JJ
46745	2670	3	malaria	malaria	NN
46745	2670	4	of	of	IN
46745	2670	5	England	England	NNP
46745	2670	6	excites	excite	VBZ
46745	2670	7	a	a	DT
46745	2670	8	comparatively	comparatively	RB
46745	2670	9	tractable	tractable	JJ
46745	2670	10	ague	ague	NN
46745	2670	11	;	;	:
46745	2670	12	that	that	DT
46745	2670	13	of	of	IN
46745	2670	14	the	the	DT
46745	2670	15	Maremma	Maremma	NNP
46745	2670	16	and	and	CC
46745	2670	17	of	of	IN
46745	2670	18	the	the	DT
46745	2670	19	Pontine	Pontine	NNP
46745	2670	20	Marshes	Marshes	NNP
46745	2670	21	,	,	,
46745	2670	22	in	in	IN
46745	2670	23	Italy	Italy	NNP
46745	2670	24	,	,	,
46745	2670	25	brings	bring	VBZ
46745	2670	26	on	on	IN
46745	2670	27	very	very	RB
46745	2670	28	fatal	fatal	JJ
46745	2670	29	fevers	fever	NNS
46745	2670	30	;	;	:
46745	2670	31	while	while	IN
46745	2670	32	the	the	DT
46745	2670	33	remittents	remittent	NNS
46745	2670	34	that	that	WDT
46745	2670	35	are	be	VBP
46745	2670	36	due	due	JJ
46745	2670	37	to	to	IN
46745	2670	38	the	the	DT
46745	2670	39	exhalations	exhalation	NNS
46745	2670	40	from	from	IN
46745	2670	41	the	the	DT
46745	2670	42	ground	ground	NN
46745	2670	43	on	on	IN
46745	2670	44	the	the	DT
46745	2670	45	West	West	NNP
46745	2670	46	coast	coast	NN
46745	2670	47	of	of	IN
46745	2670	48	Africa	Africa	NNP
46745	2670	49	,	,	,
46745	2670	50	and	and	CC
46745	2670	51	in	in	IN
46745	2670	52	the	the	DT
46745	2670	53	West	West	NNP
46745	2670	54	Indian	Indian	NNP
46745	2670	55	Islands	Islands	NNP
46745	2670	56	,	,	,
46745	2670	57	are	be	VBP
46745	2670	58	of	of	IN
46745	2670	59	a	a	DT
46745	2670	60	still	still	RB
46745	2670	61	more	more	RBR
46745	2670	62	virulent	virulent	JJ
46745	2670	63	nature	nature	NN
46745	2670	64	.	.	.
46745	2671	1	Accurate	accurate	JJ
46745	2671	2	observations	observation	NNS
46745	2671	3	have	have	VBP
46745	2671	4	shown	show	VBN
46745	2671	5	that	that	IN
46745	2671	6	they	-PRON-	PRP
46745	2671	7	are	be	VBP
46745	2671	8	all	all	RB
46745	2671	9	caused	cause	VBN
46745	2671	10	by	by	IN
46745	2671	11	the	the	DT
46745	2671	12	exposure	exposure	NN
46745	2671	13	of	of	IN
46745	2671	14	the	the	DT
46745	2671	15	system	system	NN
46745	2671	16	to	to	IN
46745	2671	17	this	this	DT
46745	2671	18	poison	poison	NN
46745	2671	19	,	,	,
46745	2671	20	and	and	CC
46745	2671	21	by	by	IN
46745	2671	22	its	-PRON-	PRP$
46745	2671	23	working	working	NN
46745	2671	24	in	in	IN
46745	2671	25	the	the	DT
46745	2671	26	blood	blood	NN
46745	2671	27	.	.	.
46745	2672	1	With	with	IN
46745	2672	2	_	_	NNP
46745	2672	3	Convulsive	Convulsive	NNP
46745	2672	4	_	_	NNP
46745	2672	5	disorders	disorder	VBZ
46745	2672	6	there	there	EX
46745	2672	7	is	be	VBZ
46745	2672	8	more	more	JJR
46745	2672	9	difficulty	difficulty	NN
46745	2672	10	.	.	.
46745	2673	1	Although	although	IN
46745	2673	2	these	these	DT
46745	2673	3	diseases	disease	NNS
46745	2673	4	are	be	VBP
46745	2673	5	manifested	manifest	VBN
46745	2673	6	either	either	CC
46745	2673	7	by	by	IN
46745	2673	8	a	a	DT
46745	2673	9	derangement	derangement	NN
46745	2673	10	of	of	IN
46745	2673	11	the	the	DT
46745	2673	12	nervous	nervous	JJ
46745	2673	13	system	system	NN
46745	2673	14	in	in	IN
46745	2673	15	general	general	JJ
46745	2673	16	,	,	,
46745	2673	17	or	or	CC
46745	2673	18	by	by	IN
46745	2673	19	a	a	DT
46745	2673	20	disturbance	disturbance	NN
46745	2673	21	of	of	IN
46745	2673	22	the	the	DT
46745	2673	23	functions	function	NNS
46745	2673	24	of	of	IN
46745	2673	25	the	the	DT
46745	2673	26	brain	brain	NN
46745	2673	27	or	or	CC
46745	2673	28	spinal	spinal	JJ
46745	2673	29	cord	cord	NN
46745	2673	30	in	in	IN
46745	2673	31	particular	particular	JJ
46745	2673	32	,	,	,
46745	2673	33	yet	yet	CC
46745	2673	34	they	-PRON-	PRP
46745	2673	35	are	be	VBP
46745	2673	36	very	very	RB
46745	2673	37	rarely	rarely	RB
46745	2673	38	accompanied	accompany	VBN
46745	2673	39	with	with	IN
46745	2673	40	an	an	DT
46745	2673	41	appreciable	appreciable	JJ
46745	2673	42	nervous	nervous	JJ
46745	2673	43	lesion	lesion	NN
46745	2673	44	.	.	.
46745	2674	1	When	when	WRB
46745	2674	2	this	this	DT
46745	2674	3	is	be	VBZ
46745	2674	4	the	the	DT
46745	2674	5	case	case	NN
46745	2674	6	,	,	,
46745	2674	7	as	as	IN
46745	2674	8	in	in	IN
46745	2674	9	the	the	DT
46745	2674	10	instance	instance	NN
46745	2674	11	of	of	IN
46745	2674	12	Tetanus	Tetanus	NNP
46745	2674	13	,	,	,
46745	2674	14	which	which	WDT
46745	2674	15	may	may	MD
46745	2674	16	arise	arise	VB
46745	2674	17	from	from	IN
46745	2674	18	a	a	DT
46745	2674	19	mere	mere	JJ
46745	2674	20	irritation	irritation	NN
46745	2674	21	of	of	IN
46745	2674	22	the	the	DT
46745	2674	23	end	end	NN
46745	2674	24	of	of	IN
46745	2674	25	a	a	DT
46745	2674	26	nerve	nerve	NN
46745	2674	27	,	,	,
46745	2674	28	they	-PRON-	PRP
46745	2674	29	are	be	VBP
46745	2674	30	extremely	extremely	RB
46745	2674	31	intractable	intractable	JJ
46745	2674	32	,	,	,
46745	2674	33	and	and	CC
46745	2674	34	are	be	VBP
46745	2674	35	not	not	RB
46745	2674	36	at	at	RB
46745	2674	37	all	all	RB
46745	2674	38	under	under	IN
46745	2674	39	the	the	DT
46745	2674	40	influence	influence	NN
46745	2674	41	of	of	IN
46745	2674	42	those	those	DT
46745	2674	43	blood	blood	NN
46745	2674	44	-	-	HYPH
46745	2674	45	medicines	medicine	NNS
46745	2674	46	which	which	WDT
46745	2674	47	are	be	VBP
46745	2674	48	useful	useful	JJ
46745	2674	49	in	in	IN
46745	2674	50	other	other	JJ
46745	2674	51	cases	case	NNS
46745	2674	52	.	.	.
46745	2675	1	Epilepsy	Epilepsy	NNP
46745	2675	2	,	,	,
46745	2675	3	too	too	RB
46745	2675	4	,	,	,
46745	2675	5	may	may	MD
46745	2675	6	sometimes	sometimes	RB
46745	2675	7	be	be	VB
46745	2675	8	due	due	JJ
46745	2675	9	to	to	IN
46745	2675	10	a	a	DT
46745	2675	11	bony	bony	NN
46745	2675	12	spicula	spicula	NN
46745	2675	13	or	or	CC
46745	2675	14	tumour	tumour	NN
46745	2675	15	in	in	IN
46745	2675	16	the	the	DT
46745	2675	17	brain	brain	NN
46745	2675	18	,	,	,
46745	2675	19	or	or	CC
46745	2675	20	to	to	IN
46745	2675	21	the	the	DT
46745	2675	22	irritation	irritation	NN
46745	2675	23	produced	produce	VBN
46745	2675	24	by	by	IN
46745	2675	25	intestinal	intestinal	JJ
46745	2675	26	worms	worm	NNS
46745	2675	27	in	in	IN
46745	2675	28	children	child	NNS
46745	2675	29	;	;	:
46745	2675	30	but	but	CC
46745	2675	31	these	these	DT
46745	2675	32	direct	direct	JJ
46745	2675	33	nervous	nervous	JJ
46745	2675	34	causes	cause	NNS
46745	2675	35	of	of	IN
46745	2675	36	such	such	JJ
46745	2675	37	convulsive	convulsive	NN
46745	2675	38	disorders	disorder	NNS
46745	2675	39	are	be	VBP
46745	2675	40	to	to	TO
46745	2675	41	be	be	VB
46745	2675	42	considered	consider	VBN
46745	2675	43	as	as	IN
46745	2675	44	the	the	DT
46745	2675	45	exception	exception	NN
46745	2675	46	,	,	,
46745	2675	47	and	and	CC
46745	2675	48	not	not	RB
46745	2675	49	the	the	DT
46745	2675	50	rule	rule	NN
46745	2675	51	.	.	.
46745	2676	1	For	for	IN
46745	2676	2	they	-PRON-	PRP
46745	2676	3	are	be	VBP
46745	2676	4	more	more	RBR
46745	2676	5	often	often	RB
46745	2676	6	connected	connect	VBN
46745	2676	7	with	with	IN
46745	2676	8	a	a	DT
46745	2676	9	diseased	diseased	JJ
46745	2676	10	condition	condition	NN
46745	2676	11	of	of	IN
46745	2676	12	the	the	DT
46745	2676	13	blood	blood	NN
46745	2676	14	.	.	.
46745	2677	1	Epilepsy	Epilepsy	NNP
46745	2677	2	and	and	CC
46745	2677	3	Hysteria	Hysteria	NNP
46745	2677	4	are	be	VBP
46745	2677	5	frequently	frequently	RB
46745	2677	6	inherited	inherit	VBN
46745	2677	7	.	.	.
46745	2678	1	This	this	DT
46745	2678	2	supplies	supply	VBZ
46745	2678	3	us	-PRON-	PRP
46745	2678	4	with	with	IN
46745	2678	5	one	one	CD
46745	2678	6	argument	argument	NN
46745	2678	7	.	.	.
46745	2679	1	They	-PRON-	PRP
46745	2679	2	are	be	VBP
46745	2679	3	also	also	RB
46745	2679	4	apt	apt	JJ
46745	2679	5	to	to	TO
46745	2679	6	be	be	VB
46745	2679	7	brought	bring	VBN
46745	2679	8	on	on	RP
46745	2679	9	by	by	IN
46745	2679	10	various	various	JJ
46745	2679	11	depressing	depressing	JJ
46745	2679	12	causes	cause	NNS
46745	2679	13	which	which	WDT
46745	2679	14	affect	affect	VBP
46745	2679	15	the	the	DT
46745	2679	16	system	system	NN
46745	2679	17	in	in	IN
46745	2679	18	general	general	NN
46745	2679	19	.	.	.
46745	2680	1	The	the	DT
46745	2680	2	strumous	strumous	JJ
46745	2680	3	diathesis	diathesis	NN
46745	2680	4	,	,	,
46745	2680	5	which	which	WDT
46745	2680	6	originates	originate	VBZ
46745	2680	7	in	in	IN
46745	2680	8	the	the	DT
46745	2680	9	fluids	fluid	NNS
46745	2680	10	,	,	,
46745	2680	11	and	and	CC
46745	2680	12	not	not	RB
46745	2680	13	in	in	IN
46745	2680	14	the	the	DT
46745	2680	15	nervous	nervous	JJ
46745	2680	16	system	system	NN
46745	2680	17	,	,	,
46745	2680	18	is	be	VBZ
46745	2680	19	affirmed	affirm	VBN
46745	2680	20	by	by	IN
46745	2680	21	Dr.	Dr.	NNP
46745	2680	22	Cheyne	Cheyne	NNP
46745	2680	23	and	and	CC
46745	2680	24	Dr.	Dr.	NNP
46745	2680	25	Watson	Watson	NNP
46745	2680	26	to	to	TO
46745	2680	27	be	be	VB
46745	2680	28	a	a	DT
46745	2680	29	powerful	powerful	JJ
46745	2680	30	predisposing	predisposing	NN
46745	2680	31	cause	cause	NN
46745	2680	32	of	of	IN
46745	2680	33	Epilepsy	Epilepsy	NNP
46745	2680	34	.	.	.
46745	2681	1	Hysteria	Hysteria	NNP
46745	2681	2	,	,	,
46745	2681	3	too	too	RB
46745	2681	4	,	,	,
46745	2681	5	is	be	VBZ
46745	2681	6	very	very	RB
46745	2681	7	often	often	RB
46745	2681	8	associated	associate	VBN
46745	2681	9	with	with	IN
46745	2681	10	Anæmia	Anæmia	NNP
46745	2681	11	.	.	.
46745	2682	1	Tetanus	tetanus	NN
46745	2682	2	even	even	RB
46745	2682	3	depends	depend	VBZ
46745	2682	4	very	very	RB
46745	2682	5	much	much	RB
46745	2682	6	on	on	IN
46745	2682	7	certain	certain	JJ
46745	2682	8	atmospheric	atmospheric	JJ
46745	2682	9	conditions	condition	NNS
46745	2682	10	.	.	.
46745	2683	1	There	there	EX
46745	2683	2	are	be	VBP
46745	2683	3	sometimes	sometimes	RB
46745	2683	4	,	,	,
46745	2683	5	as	as	IN
46745	2683	6	it	-PRON-	PRP
46745	2683	7	were	be	VBD
46745	2683	8	,	,	,
46745	2683	9	epidemics	epidemic	NNS
46745	2683	10	of	of	IN
46745	2683	11	Tetanus	Tetanus	NNP
46745	2683	12	,	,	,
46745	2683	13	in	in	IN
46745	2683	14	which	which	WDT
46745	2683	15	the	the	DT
46745	2683	16	slightest	slight	JJS
46745	2683	17	abrasion	abrasion	NN
46745	2683	18	will	will	MD
46745	2683	19	suffice	suffice	VB
46745	2683	20	to	to	TO
46745	2683	21	bring	bring	VB
46745	2683	22	it	-PRON-	PRP
46745	2683	23	on	on	RP
46745	2683	24	among	among	IN
46745	2683	25	the	the	DT
46745	2683	26	people	people	NNS
46745	2683	27	residing	reside	VBG
46745	2683	28	in	in	IN
46745	2683	29	a	a	DT
46745	2683	30	particular	particular	JJ
46745	2683	31	neighbourhood	neighbourhood	NN
46745	2683	32	.	.	.
46745	2684	1	It	-PRON-	PRP
46745	2684	2	is	be	VBZ
46745	2684	3	often	often	RB
46745	2684	4	rife	rife	JJ
46745	2684	5	in	in	IN
46745	2684	6	one	one	CD
46745	2684	7	district	district	NN
46745	2684	8	a	a	DT
46745	2684	9	long	long	JJ
46745	2684	10	consecutive	consecutive	JJ
46745	2684	11	time	time	NN
46745	2684	12	.	.	.
46745	2685	1	Facts	fact	NNS
46745	2685	2	like	like	IN
46745	2685	3	this	this	DT
46745	2685	4	must	must	MD
46745	2685	5	certainly	certainly	RB
46745	2685	6	be	be	VB
46745	2685	7	regarded	regard	VBN
46745	2685	8	as	as	IN
46745	2685	9	pointing	point	VBG
46745	2685	10	to	to	IN
46745	2685	11	a	a	DT
46745	2685	12	condition	condition	NN
46745	2685	13	of	of	IN
46745	2685	14	the	the	DT
46745	2685	15	blood	blood	NN
46745	2685	16	as	as	IN
46745	2685	17	one	one	CD
46745	2685	18	,	,	,
46745	2685	19	at	at	IN
46745	2685	20	least	least	JJS
46745	2685	21	,	,	,
46745	2685	22	of	of	IN
46745	2685	23	the	the	DT
46745	2685	24	causes	cause	NNS
46745	2685	25	of	of	IN
46745	2685	26	this	this	DT
46745	2685	27	terrible	terrible	JJ
46745	2685	28	disorder	disorder	NN
46745	2685	29	.	.	.
46745	2686	1	This	this	DT
46745	2686	2	condition	condition	NN
46745	2686	3	of	of	IN
46745	2686	4	the	the	DT
46745	2686	5	blood	blood	NN
46745	2686	6	may	may	MD
46745	2686	7	react	react	VB
46745	2686	8	upon	upon	IN
46745	2686	9	the	the	DT
46745	2686	10	nerves	nerve	NNS
46745	2686	11	,	,	,
46745	2686	12	and	and	CC
46745	2686	13	maintain	maintain	VB
46745	2686	14	in	in	IN
46745	2686	15	them	-PRON-	PRP
46745	2686	16	a	a	DT
46745	2686	17	particular	particular	JJ
46745	2686	18	morbid	morbid	NN
46745	2686	19	state	state	NN
46745	2686	20	.	.	.
46745	2687	1	Chorea	Chorea	NNP
46745	2687	2	seems	seem	VBZ
46745	2687	3	also	also	RB
46745	2687	4	to	to	TO
46745	2687	5	depend	depend	VB
46745	2687	6	primarily	primarily	RB
46745	2687	7	on	on	IN
46745	2687	8	the	the	DT
46745	2687	9	state	state	NN
46745	2687	10	of	of	IN
46745	2687	11	the	the	DT
46745	2687	12	blood	blood	NN
46745	2687	13	,	,	,
46745	2687	14	and	and	CC
46745	2687	15	is	be	VBZ
46745	2687	16	indirectly	indirectly	RB
46745	2687	17	curable	curable	JJ
46745	2687	18	by	by	IN
46745	2687	19	medicines	medicine	NNS
46745	2687	20	which	which	WDT
46745	2687	21	,	,	,
46745	2687	22	like	like	IN
46745	2687	23	Iron	Iron	NNP
46745	2687	24	and	and	CC
46745	2687	25	Quinine	Quinine	NNP
46745	2687	26	,	,	,
46745	2687	27	improve	improve	VB
46745	2687	28	its	-PRON-	PRP$
46745	2687	29	condition	condition	NN
46745	2687	30	.	.	.
46745	2688	1	In	in	IN
46745	2688	2	a	a	DT
46745	2688	3	weakly	weakly	JJ
46745	2688	4	and	and	CC
46745	2688	5	strumous	strumous	JJ
46745	2688	6	child	child	NN
46745	2688	7	it	-PRON-	PRP
46745	2688	8	may	may	MD
46745	2688	9	be	be	VB
46745	2688	10	brought	bring	VBN
46745	2688	11	on	on	RP
46745	2688	12	by	by	IN
46745	2688	13	a	a	DT
46745	2688	14	sudden	sudden	JJ
46745	2688	15	fright	fright	NN
46745	2688	16	which	which	WDT
46745	2688	17	would	would	MD
46745	2688	18	not	not	RB
46745	2688	19	affect	affect	VB
46745	2688	20	one	one	CD
46745	2688	21	of	of	IN
46745	2688	22	a	a	DT
46745	2688	23	good	good	JJ
46745	2688	24	constitution	constitution	NN
46745	2688	25	.	.	.
46745	2689	1	We	-PRON-	PRP
46745	2689	2	might	may	MD
46745	2689	3	conclude	conclude	VB
46745	2689	4	from	from	IN
46745	2689	5	these	these	DT
46745	2689	6	facts	fact	NNS
46745	2689	7	alone	alone	RB
46745	2689	8	that	that	IN
46745	2689	9	the	the	DT
46745	2689	10	blood	blood	NN
46745	2689	11	is	be	VBZ
46745	2689	12	often	often	RB
46745	2689	13	the	the	DT
46745	2689	14	seat	seat	NN
46745	2689	15	and	and	CC
46745	2689	16	origin	origin	NN
46745	2689	17	of	of	IN
46745	2689	18	these	these	DT
46745	2689	19	diseases	disease	NNS
46745	2689	20	.	.	.
46745	2690	1	But	but	CC
46745	2690	2	there	there	EX
46745	2690	3	is	be	VBZ
46745	2690	4	yet	yet	RB
46745	2690	5	a	a	DT
46745	2690	6	stronger	strong	JJR
46745	2690	7	reason	reason	NN
46745	2690	8	to	to	TO
46745	2690	9	induce	induce	VB
46745	2690	10	us	-PRON-	PRP
46745	2690	11	to	to	TO
46745	2690	12	suppose	suppose	VB
46745	2690	13	that	that	IN
46745	2690	14	they	-PRON-	PRP
46745	2690	15	are	be	VBP
46745	2690	16	frequently	frequently	RB
46745	2690	17	produced	produce	VBN
46745	2690	18	by	by	IN
46745	2690	19	some	some	DT
46745	2690	20	poison	poison	NN
46745	2690	21	in	in	IN
46745	2690	22	the	the	DT
46745	2690	23	blood	blood	NN
46745	2690	24	,	,	,
46745	2690	25	which	which	WDT
46745	2690	26	acts	act	VBZ
46745	2690	27	on	on	IN
46745	2690	28	and	and	CC
46745	2690	29	disturbs	disturb	VBZ
46745	2690	30	the	the	DT
46745	2690	31	nervous	nervous	JJ
46745	2690	32	organs	organ	NNS
46745	2690	33	without	without	IN
46745	2690	34	perceptibly	perceptibly	RB
46745	2690	35	altering	alter	VBG
46745	2690	36	their	-PRON-	PRP$
46745	2690	37	physical	physical	JJ
46745	2690	38	construction	construction	NN
46745	2690	39	.	.	.
46745	2691	1	Many	many	JJ
46745	2691	2	medicinal	medicinal	JJ
46745	2691	3	substances	substance	NNS
46745	2691	4	present	present	VBP
46745	2691	5	us	-PRON-	PRP
46745	2691	6	with	with	IN
46745	2691	7	an	an	DT
46745	2691	8	artificial	artificial	JJ
46745	2691	9	illustration	illustration	NN
46745	2691	10	of	of	IN
46745	2691	11	this	this	DT
46745	2691	12	action	action	NN
46745	2691	13	.	.	.
46745	2692	1	Lead	Lead	NNP
46745	2692	2	,	,	,
46745	2692	3	Copper	Copper	NNP
46745	2692	4	,	,	,
46745	2692	5	Mercury	Mercury	NNP
46745	2692	6	,	,	,
46745	2692	7	and	and	CC
46745	2692	8	Arsenic	Arsenic	NNP
46745	2692	9	,	,	,
46745	2692	10	by	by	IN
46745	2692	11	their	-PRON-	PRP$
46745	2692	12	presence	presence	NN
46745	2692	13	and	and	CC
46745	2692	14	operation	operation	NN
46745	2692	15	in	in	IN
46745	2692	16	the	the	DT
46745	2692	17	blood	blood	NN
46745	2692	18	,	,	,
46745	2692	19	are	be	VBP
46745	2692	20	capable	capable	JJ
46745	2692	21	of	of	IN
46745	2692	22	causing	cause	VBG
46745	2692	23	severe	severe	JJ
46745	2692	24	and	and	CC
46745	2692	25	chronic	chronic	JJ
46745	2692	26	nervous	nervous	JJ
46745	2692	27	disorders	disorder	NNS
46745	2692	28	,	,	,
46745	2692	29	particularly	particularly	RB
46745	2692	30	Paralysis	Paralysis	NNP
46745	2692	31	and	and	CC
46745	2692	32	Epilepsy	Epilepsy	NNP
46745	2692	33	.	.	.
46745	2693	1	Many	many	JJ
46745	2693	2	of	of	IN
46745	2693	3	the	the	DT
46745	2693	4	vegetable	vegetable	NN
46745	2693	5	Neurotics	neurotic	NNS
46745	2693	6	,	,	,
46745	2693	7	after	after	IN
46745	2693	8	their	-PRON-	PRP$
46745	2693	9	passage	passage	NN
46745	2693	10	into	into	IN
46745	2693	11	the	the	DT
46745	2693	12	blood	blood	NN
46745	2693	13	,	,	,
46745	2693	14	bring	bring	VB
46745	2693	15	about	about	RP
46745	2693	16	transient	transient	JJ
46745	2693	17	nervous	nervous	JJ
46745	2693	18	symptoms	symptom	NNS
46745	2693	19	which	which	WDT
46745	2693	20	are	be	VBP
46745	2693	21	identical	identical	JJ
46745	2693	22	with	with	IN
46745	2693	23	those	those	DT
46745	2693	24	of	of	IN
46745	2693	25	disease	disease	NN
46745	2693	26	.	.	.
46745	2694	1	Thus	thus	RB
46745	2694	2	Opium	Opium	NNP
46745	2694	3	produces	produce	VBZ
46745	2694	4	coma	coma	NN
46745	2694	5	;	;	:
46745	2694	6	Belladonna	Belladonna	NNP
46745	2694	7	,	,	,
46745	2694	8	delirium	delirium	NN
46745	2694	9	;	;	:
46745	2694	10	Aconite	Aconite	NNP
46745	2694	11	and	and	CC
46745	2694	12	Hemlock	Hemlock	NNP
46745	2694	13	,	,	,
46745	2694	14	paralysis	paralysis	NN
46745	2694	15	;	;	:
46745	2694	16	Hydrocyanic	hydrocyanic	JJ
46745	2694	17	acid	acid	NN
46745	2694	18	,	,	,
46745	2694	19	convulsions	convulsion	NNS
46745	2694	20	;	;	:
46745	2694	21	Indian	indian	JJ
46745	2694	22	hemp	hemp	NN
46745	2694	23	,	,	,
46745	2694	24	catalepsy	catalepsy	NNP
46745	2694	25	.	.	.
46745	2695	1	When	when	WRB
46745	2695	2	the	the	DT
46745	2695	3	cause	cause	NN
46745	2695	4	of	of	IN
46745	2695	5	these	these	DT
46745	2695	6	affections	affection	NNS
46745	2695	7	is	be	VBZ
46745	2695	8	removed	remove	VBN
46745	2695	9	,	,	,
46745	2695	10	the	the	DT
46745	2695	11	symptoms	symptom	NNS
46745	2695	12	disappear	disappear	VBP
46745	2695	13	;	;	:
46745	2695	14	when	when	WRB
46745	2695	15	the	the	DT
46745	2695	16	cause	cause	NN
46745	2695	17	returns	return	VBZ
46745	2695	18	,	,	,
46745	2695	19	the	the	DT
46745	2695	20	symptoms	symptom	NNS
46745	2695	21	return	return	VBP
46745	2695	22	.	.	.
46745	2696	1	The	the	DT
46745	2696	2	same	same	JJ
46745	2696	3	is	be	VBZ
46745	2696	4	apparently	apparently	RB
46745	2696	5	the	the	DT
46745	2696	6	case	case	NN
46745	2696	7	with	with	IN
46745	2696	8	those	those	DT
46745	2696	9	unknown	unknown	JJ
46745	2696	10	animal	animal	NN
46745	2696	11	poisons	poison	NNS
46745	2696	12	that	that	WDT
46745	2696	13	operate	operate	VBP
46745	2696	14	so	so	IN
46745	2696	15	as	as	IN
46745	2696	16	to	to	TO
46745	2696	17	produce	produce	VB
46745	2696	18	nervous	nervous	JJ
46745	2696	19	symptoms	symptom	NNS
46745	2696	20	,	,	,
46745	2696	21	without	without	IN
46745	2696	22	a	a	DT
46745	2696	23	nervous	nervous	JJ
46745	2696	24	lesion	lesion	NN
46745	2696	25	.	.	.
46745	2697	1	These	these	DT
46745	2697	2	convulsive	convulsive	NN
46745	2697	3	disorders	disorder	NNS
46745	2697	4	may	may	MD
46745	2697	5	be	be	VB
46745	2697	6	treated	treat	VBN
46745	2697	7	in	in	IN
46745	2697	8	either	either	DT
46745	2697	9	or	or	CC
46745	2697	10	both	both	DT
46745	2697	11	of	of	IN
46745	2697	12	two	two	CD
46745	2697	13	ways	way	NNS
46745	2697	14	.	.	.
46745	2698	1	We	-PRON-	PRP
46745	2698	2	may	may	MD
46745	2698	3	attack	attack	VB
46745	2698	4	the	the	DT
46745	2698	5	supposed	supposed	JJ
46745	2698	6	cause	cause	NN
46745	2698	7	in	in	IN
46745	2698	8	the	the	DT
46745	2698	9	blood	blood	NN
46745	2698	10	by	by	IN
46745	2698	11	employing	employ	VBG
46745	2698	12	one	one	CD
46745	2698	13	of	of	IN
46745	2698	14	these	these	DT
46745	2698	15	mineral	mineral	NN
46745	2698	16	Anticonvulsives	Anticonvulsives	NNPS
46745	2698	17	;	;	:
46745	2698	18	or	or	CC
46745	2698	19	we	-PRON-	PRP
46745	2698	20	may	may	MD
46745	2698	21	simply	simply	RB
46745	2698	22	apply	apply	VB
46745	2698	23	our	-PRON-	PRP$
46745	2698	24	remedies	remedy	NNS
46745	2698	25	to	to	IN
46745	2698	26	the	the	DT
46745	2698	27	nervous	nervous	JJ
46745	2698	28	system	system	NN
46745	2698	29	,	,	,
46745	2698	30	the	the	DT
46745	2698	31	more	more	RBR
46745	2698	32	immediate	immediate	JJ
46745	2698	33	seat	seat	NN
46745	2698	34	of	of	IN
46745	2698	35	the	the	DT
46745	2698	36	morbid	morbid	NN
46745	2698	37	manifestations	manifestation	NNS
46745	2698	38	,	,	,
46745	2698	39	and	and	CC
46745	2698	40	adopt	adopt	VB
46745	2698	41	a	a	DT
46745	2698	42	palliative	palliative	JJ
46745	2698	43	or	or	CC
46745	2698	44	defensive	defensive	JJ
46745	2698	45	course	course	NN
46745	2698	46	.	.	.
46745	2699	1	_	_	NNP
46745	2699	2	Skin	Skin	NNP
46745	2699	3	diseases	disease	NNS
46745	2699	4	_	_	NNP
46745	2699	5	are	be	VBP
46745	2699	6	no	no	RB
46745	2699	7	doubt	doubt	RB
46745	2699	8	connected	connected	JJ
46745	2699	9	with	with	IN
46745	2699	10	some	some	DT
46745	2699	11	disorder	disorder	NN
46745	2699	12	in	in	IN
46745	2699	13	the	the	DT
46745	2699	14	blood	blood	NN
46745	2699	15	.	.	.
46745	2700	1	We	-PRON-	PRP
46745	2700	2	might	may	MD
46745	2700	3	almost	almost	RB
46745	2700	4	presume	presume	VB
46745	2700	5	this	this	DT
46745	2700	6	from	from	IN
46745	2700	7	the	the	DT
46745	2700	8	analogy	analogy	NN
46745	2700	9	of	of	IN
46745	2700	10	the	the	DT
46745	2700	11	known	know	VBN
46745	2700	12	blood	blood	NN
46745	2700	13	-	-	HYPH
46745	2700	14	poisons	poison	NNS
46745	2700	15	,	,	,
46745	2700	16	by	by	IN
46745	2700	17	nearly	nearly	RB
46745	2700	18	all	all	DT
46745	2700	19	of	of	IN
46745	2700	20	which	which	WDT
46745	2700	21	an	an	DT
46745	2700	22	eruption	eruption	NN
46745	2700	23	may	may	MD
46745	2700	24	be	be	VB
46745	2700	25	produced	produce	VBN
46745	2700	26	.	.	.
46745	2701	1	The	the	DT
46745	2701	2	eruptive	eruptive	JJ
46745	2701	3	fevers	fever	NNS
46745	2701	4	,	,	,
46745	2701	5	which	which	WDT
46745	2701	6	run	run	VBP
46745	2701	7	a	a	DT
46745	2701	8	certain	certain	JJ
46745	2701	9	course	course	NN
46745	2701	10	,	,	,
46745	2701	11	depend	depend	VBP
46745	2701	12	upon	upon	IN
46745	2701	13	contagious	contagious	JJ
46745	2701	14	poisons	poison	NNS
46745	2701	15	;	;	:
46745	2701	16	but	but	CC
46745	2701	17	they	-PRON-	PRP
46745	2701	18	are	be	VBP
46745	2701	19	not	not	RB
46745	2701	20	under	under	IN
46745	2701	21	the	the	DT
46745	2701	22	influence	influence	NN
46745	2701	23	of	of	IN
46745	2701	24	Antisquamic	antisquamic	JJ
46745	2701	25	remedies	remedy	NNS
46745	2701	26	.	.	.
46745	2702	1	These	these	DT
46745	2702	2	are	be	VBP
46745	2702	3	serviceable	serviceable	JJ
46745	2702	4	in	in	IN
46745	2702	5	a	a	DT
46745	2702	6	class	class	NN
46745	2702	7	of	of	IN
46745	2702	8	disorders	disorder	NNS
46745	2702	9	,	,	,
46745	2702	10	of	of	IN
46745	2702	11	each	each	DT
46745	2702	12	of	of	IN
46745	2702	13	which	which	WDT
46745	2702	14	a	a	DT
46745	2702	15	cutaneous	cutaneous	JJ
46745	2702	16	eruption	eruption	NN
46745	2702	17	is	be	VBZ
46745	2702	18	the	the	DT
46745	2702	19	most	most	RBS
46745	2702	20	apparent	apparent	JJ
46745	2702	21	,	,	,
46745	2702	22	or	or	CC
46745	2702	23	the	the	DT
46745	2702	24	only	only	JJ
46745	2702	25	obvious	obvious	JJ
46745	2702	26	symptom	symptom	NN
46745	2702	27	.	.	.
46745	2703	1	The	the	DT
46745	2703	2	true	true	JJ
46745	2703	3	squamous	squamous	JJ
46745	2703	4	disorders	disorder	NNS
46745	2703	5	are	be	VBP
46745	2703	6	Lepra	Lepra	NNP
46745	2703	7	vulgaris	vulgaris	NN
46745	2703	8	and	and	CC
46745	2703	9	Psoriasis	Psoriasis	NNP
46745	2703	10	vulgaris	vulgaris	NN
46745	2703	11	.	.	.
46745	2704	1	The	the	DT
46745	2704	2	causes	cause	NNS
46745	2704	3	of	of	IN
46745	2704	4	Impetigo	Impetigo	NNP
46745	2704	5	,	,	,
46745	2704	6	Porrigo	Porrigo	NNP
46745	2704	7	,	,	,
46745	2704	8	and	and	CC
46745	2704	9	Scabies	Scabies	NNP
46745	2704	10	,	,	,
46745	2704	11	are	be	VBP
46745	2704	12	probably	probably	RB
46745	2704	13	similar	similar	JJ
46745	2704	14	to	to	IN
46745	2704	15	those	those	DT
46745	2704	16	of	of	IN
46745	2704	17	the	the	DT
46745	2704	18	true	true	JJ
46745	2704	19	squamæ	squamæ	NN
46745	2704	20	,	,	,
46745	2704	21	for	for	IN
46745	2704	22	they	-PRON-	PRP
46745	2704	23	are	be	VBP
46745	2704	24	often	often	RB
46745	2704	25	curable	curable	JJ
46745	2704	26	by	by	IN
46745	2704	27	similar	similar	JJ
46745	2704	28	remedies	remedy	NNS
46745	2704	29	.	.	.
46745	2705	1	The	the	DT
46745	2705	2	actual	actual	JJ
46745	2705	3	eruption	eruption	NN
46745	2705	4	of	of	IN
46745	2705	5	Porrigo	Porrigo	NNP
46745	2705	6	is	be	VBZ
46745	2705	7	accompanied	accompany	VBN
46745	2705	8	by	by	IN
46745	2705	9	a	a	DT
46745	2705	10	parasitic	parasitic	JJ
46745	2705	11	fungus	fungus	NN
46745	2705	12	,	,	,
46745	2705	13	which	which	WDT
46745	2705	14	may	may	MD
46745	2705	15	sometimes	sometimes	RB
46745	2705	16	be	be	VB
46745	2705	17	transmitted	transmit	VBN
46745	2705	18	from	from	IN
46745	2705	19	one	one	CD
46745	2705	20	person	person	NN
46745	2705	21	to	to	IN
46745	2705	22	another	another	DT
46745	2705	23	;	;	:
46745	2705	24	and	and	CC
46745	2705	25	a	a	DT
46745	2705	26	small	small	JJ
46745	2705	27	insect	insect	NN
46745	2705	28	or	or	CC
46745	2705	29	Acarus	Acarus	NNP
46745	2705	30	which	which	WDT
46745	2705	31	haunts	haunt	VBZ
46745	2705	32	the	the	DT
46745	2705	33	vesicles	vesicle	NNS
46745	2705	34	has	have	VBZ
46745	2705	35	been	be	VBN
46745	2705	36	alleged	allege	VBN
46745	2705	37	as	as	IN
46745	2705	38	the	the	DT
46745	2705	39	cause	cause	NN
46745	2705	40	of	of	IN
46745	2705	41	Scabies	scabie	NNS
46745	2705	42	;	;	:
46745	2705	43	but	but	CC
46745	2705	44	it	-PRON-	PRP
46745	2705	45	is	be	VBZ
46745	2705	46	not	not	RB
46745	2705	47	,	,	,
46745	2705	48	after	after	RB
46745	2705	49	all	all	RB
46745	2705	50	,	,	,
46745	2705	51	quite	quite	RB
46745	2705	52	clear	clear	JJ
46745	2705	53	whether	whether	IN
46745	2705	54	these	these	DT
46745	2705	55	attendants	attendant	NNS
46745	2705	56	may	may	MD
46745	2705	57	not	not	RB
46745	2705	58	be	be	VB
46745	2705	59	merely	merely	RB
46745	2705	60	the	the	DT
46745	2705	61	concomitants	concomitant	NNS
46745	2705	62	or	or	CC
46745	2705	63	the	the	DT
46745	2705	64	results	result	NNS
46745	2705	65	of	of	IN
46745	2705	66	these	these	DT
46745	2705	67	two	two	CD
46745	2705	68	disorders	disorder	NNS
46745	2705	69	.	.	.
46745	2706	1	At	at	IN
46745	2706	2	all	all	DT
46745	2706	3	events	event	NNS
46745	2706	4	,	,	,
46745	2706	5	Lepra	Lepra	NNP
46745	2706	6	and	and	CC
46745	2706	7	Psoriasis	Psoriasis	NNP
46745	2706	8	are	be	VBP
46745	2706	9	true	true	JJ
46745	2706	10	blood	blood	NN
46745	2706	11	diseases	disease	NNS
46745	2706	12	,	,	,
46745	2706	13	and	and	CC
46745	2706	14	are	be	VBP
46745	2706	15	often	often	RB
46745	2706	16	inherited	inherit	VBN
46745	2706	17	.	.	.
46745	2707	1	They	-PRON-	PRP
46745	2707	2	are	be	VBP
46745	2707	3	more	more	RBR
46745	2707	4	obviously	obviously	RB
46745	2707	5	under	under	IN
46745	2707	6	the	the	DT
46745	2707	7	influence	influence	NN
46745	2707	8	of	of	IN
46745	2707	9	Antisquamics	Antisquamics	NNPS
46745	2707	10	than	than	IN
46745	2707	11	the	the	DT
46745	2707	12	other	other	JJ
46745	2707	13	skin	skin	NN
46745	2707	14	diseases	disease	NNS
46745	2707	15	.	.	.
46745	2708	1	It	-PRON-	PRP
46745	2708	2	has	have	VBZ
46745	2708	3	thus	thus	RB
46745	2708	4	been	be	VBN
46745	2708	5	shown	show	VBN
46745	2708	6	that	that	IN
46745	2708	7	the	the	DT
46745	2708	8	diseases	disease	NNS
46745	2708	9	in	in	IN
46745	2708	10	which	which	WDT
46745	2708	11	Catalytics	Catalytics	NNP
46745	2708	12	are	be	VBP
46745	2708	13	used	use	VBN
46745	2708	14	are	be	VBP
46745	2708	15	each	each	DT
46745	2708	16	to	to	TO
46745	2708	17	be	be	VB
46745	2708	18	accounted	account	VBN
46745	2708	19	for	for	IN
46745	2708	20	by	by	IN
46745	2708	21	a	a	DT
46745	2708	22	process	process	NN
46745	2708	23	in	in	IN
46745	2708	24	the	the	DT
46745	2708	25	blood	blood	NN
46745	2708	26	.	.	.
46745	2709	1	The	the	DT
46745	2709	2	fourth	fourth	JJ
46745	2709	3	minor	minor	JJ
46745	2709	4	proposition	proposition	NN
46745	2709	5	will	will	MD
46745	2709	6	not	not	RB
46745	2709	7	be	be	VB
46745	2709	8	so	so	RB
46745	2709	9	difficult	difficult	JJ
46745	2709	10	to	to	TO
46745	2709	11	establish	establish	VB
46745	2709	12	as	as	IN
46745	2709	13	the	the	DT
46745	2709	14	last	last	JJ
46745	2709	15	,	,	,
46745	2709	16	although	although	IN
46745	2709	17	it	-PRON-	PRP
46745	2709	18	is	be	VBZ
46745	2709	19	in	in	IN
46745	2709	20	fact	fact	NN
46745	2709	21	the	the	DT
46745	2709	22	most	most	RBS
46745	2709	23	important	important	JJ
46745	2709	24	of	of	IN
46745	2709	25	all	all	DT
46745	2709	26	.	.	.
46745	2710	1	_	_	NNP
46745	2710	2	The	the	DT
46745	2710	3	action	action	NN
46745	2710	4	of	of	IN
46745	2710	5	a	a	DT
46745	2710	6	Catalytic	catalytic	JJ
46745	2710	7	results	result	NNS
46745	2710	8	in	in	IN
46745	2710	9	the	the	DT
46745	2710	10	neutralization	neutralization	NN
46745	2710	11	or	or	CC
46745	2710	12	counteraction	counteraction	NN
46745	2710	13	of	of	IN
46745	2710	14	one	one	CD
46745	2710	15	or	or	CC
46745	2710	16	more	more	JJR
46745	2710	17	of	of	IN
46745	2710	18	these	these	DT
46745	2710	19	morbid	morbid	NN
46745	2710	20	agencies	agency	NNS
46745	2710	21	.	.	.
46745	2710	22	_	_	NNP
46745	2710	23	This	this	DT
46745	2710	24	has	have	VBZ
46745	2710	25	already	already	RB
46745	2710	26	been	be	VBN
46745	2710	27	sufficiently	sufficiently	RB
46745	2710	28	proved	prove	VBN
46745	2710	29	.	.	.
46745	2711	1	It	-PRON-	PRP
46745	2711	2	is	be	VBZ
46745	2711	3	established	establish	VBN
46745	2711	4	by	by	IN
46745	2711	5	experience	experience	NN
46745	2711	6	that	that	IN
46745	2711	7	these	these	DT
46745	2711	8	remedies	remedy	NNS
46745	2711	9	severally	severally	RB
46745	2711	10	counteract	counteract	VBD
46745	2711	11	the	the	DT
46745	2711	12	diseases	disease	NNS
46745	2711	13	named	name	VBN
46745	2711	14	.	.	.
46745	2712	1	They	-PRON-	PRP
46745	2712	2	have	have	VBP
46745	2712	3	been	be	VBN
46745	2712	4	shown	show	VBN
46745	2712	5	to	to	TO
46745	2712	6	have	have	VB
46745	2712	7	an	an	DT
46745	2712	8	action	action	NN
46745	2712	9	in	in	IN
46745	2712	10	the	the	DT
46745	2712	11	blood	blood	NN
46745	2712	12	;	;	:
46745	2712	13	and	and	CC
46745	2712	14	the	the	DT
46745	2712	15	diseases	disease	NNS
46745	2712	16	have	have	VBP
46745	2712	17	been	be	VBN
46745	2712	18	proved	prove	VBN
46745	2712	19	to	to	TO
46745	2712	20	be	be	VB
46745	2712	21	blood	blood	NN
46745	2712	22	-	-	HYPH
46745	2712	23	diseases	disease	NNS
46745	2712	24	.	.	.
46745	2713	1	Thus	thus	RB
46745	2713	2	it	-PRON-	PRP
46745	2713	3	is	be	VBZ
46745	2713	4	clear	clear	JJ
46745	2713	5	,	,	,
46745	2713	6	that	that	IN
46745	2713	7	if	if	IN
46745	2713	8	the	the	DT
46745	2713	9	former	former	JJ
46745	2713	10	counteract	counteract	NN
46745	2713	11	the	the	DT
46745	2713	12	latter	latter	JJ
46745	2713	13	,	,	,
46745	2713	14	and	and	CC
46745	2713	15	have	have	VBP
46745	2713	16	no	no	DT
46745	2713	17	action	action	NN
46745	2713	18	on	on	IN
46745	2713	19	the	the	DT
46745	2713	20	nerves	nerve	NNS
46745	2713	21	,	,	,
46745	2713	22	they	-PRON-	PRP
46745	2713	23	must	must	MD
46745	2713	24	do	do	VB
46745	2713	25	it	-PRON-	PRP
46745	2713	26	by	by	IN
46745	2713	27	some	some	DT
46745	2713	28	agency	agency	NN
46745	2713	29	in	in	IN
46745	2713	30	that	that	DT
46745	2713	31	fluid	fluid	NN
46745	2713	32	,	,	,
46745	2713	33	over	over	IN
46745	2713	34	the	the	DT
46745	2713	35	particles	particle	NNS
46745	2713	36	of	of	IN
46745	2713	37	which	which	WDT
46745	2713	38	both	both	DT
46745	2713	39	exert	exert	VBP
46745	2713	40	an	an	DT
46745	2713	41	influence	influence	NN
46745	2713	42	.	.	.
46745	2714	1	They	-PRON-	PRP
46745	2714	2	are	be	VBP
46745	2714	3	Catalytic	catalytic	JJ
46745	2714	4	Hæmatics	Hæmatics	NNPS
46745	2714	5	;	;	:
46745	2714	6	_	_	NNP
46745	2714	7	i.e.	i.e.	FW
46745	2714	8	_	_	NNP
46745	2714	9	,	,	,
46745	2714	10	medicines	medicine	NNS
46745	2714	11	which	which	WDT
46745	2714	12	,	,	,
46745	2714	13	by	by	IN
46745	2714	14	an	an	DT
46745	2714	15	operation	operation	NN
46745	2714	16	in	in	IN
46745	2714	17	the	the	DT
46745	2714	18	blood	blood	NN
46745	2714	19	,	,	,
46745	2714	20	are	be	VBP
46745	2714	21	enabled	enable	VBN
46745	2714	22	to	to	TO
46745	2714	23	counteract	counteract	VB
46745	2714	24	disorders	disorder	NNS
46745	2714	25	which	which	WDT
46745	2714	26	depend	depend	VBP
46745	2714	27	upon	upon	IN
46745	2714	28	active	active	JJ
46745	2714	29	morbid	morbid	NN
46745	2714	30	agencies	agency	NNS
46745	2714	31	.	.	.
46745	2715	1	This	this	DT
46745	2715	2	is	be	VBZ
46745	2715	3	all	all	DT
46745	2715	4	that	that	WDT
46745	2715	5	can	can	MD
46745	2715	6	be	be	VB
46745	2715	7	positively	positively	RB
46745	2715	8	affirmed	affirm	VBN
46745	2715	9	of	of	IN
46745	2715	10	their	-PRON-	PRP$
46745	2715	11	mode	mode	NN
46745	2715	12	of	of	IN
46745	2715	13	operation	operation	NN
46745	2715	14	.	.	.
46745	2716	1	The	the	DT
46745	2716	2	fifth	fifth	JJ
46745	2716	3	and	and	CC
46745	2716	4	last	last	JJ
46745	2716	5	minor	minor	JJ
46745	2716	6	proposition	proposition	NN
46745	2716	7	relates	relate	VBZ
46745	2716	8	to	to	IN
46745	2716	9	an	an	DT
46745	2716	10	important	important	JJ
46745	2716	11	difference	difference	NN
46745	2716	12	between	between	IN
46745	2716	13	these	these	DT
46745	2716	14	and	and	CC
46745	2716	15	Restorative	Restorative	NNP
46745	2716	16	medicines.--The	medicines.--The	NNP
46745	2716	17	latter	latter	NN
46745	2716	18	may	may	MD
46745	2716	19	remain	remain	VB
46745	2716	20	in	in	IN
46745	2716	21	the	the	DT
46745	2716	22	system	system	NN
46745	2716	23	,	,	,
46745	2716	24	for	for	CC
46745	2716	25	if	if	IN
46745	2716	26	they	-PRON-	PRP
46745	2716	27	did	do	VBD
46745	2716	28	not	not	RB
46745	2716	29	do	do	VB
46745	2716	30	so	so	RB
46745	2716	31	,	,	,
46745	2716	32	they	-PRON-	PRP
46745	2716	33	could	could	MD
46745	2716	34	restore	restore	VB
46745	2716	35	nothing	nothing	NN
46745	2716	36	to	to	IN
46745	2716	37	the	the	DT
46745	2716	38	blood	blood	NN
46745	2716	39	.	.	.
46745	2717	1	But	but	CC
46745	2717	2	Catalytics	Catalytics	NNP
46745	2717	3	can	can	MD
46745	2717	4	not	not	RB
46745	2717	5	restore	restore	VB
46745	2717	6	any	any	DT
46745	2717	7	thing	thing	NN
46745	2717	8	,	,	,
46745	2717	9	for	for	IN
46745	2717	10	they	-PRON-	PRP
46745	2717	11	are	be	VBP
46745	2717	12	generally	generally	RB
46745	2717	13	unnatural	unnatural	JJ
46745	2717	14	to	to	IN
46745	2717	15	the	the	DT
46745	2717	16	blood	blood	NN
46745	2717	17	.	.	.
46745	2718	1	They	-PRON-	PRP
46745	2718	2	must	must	MD
46745	2718	3	sooner	soon	RBR
46745	2718	4	or	or	CC
46745	2718	5	later	later	RB
46745	2718	6	be	be	VB
46745	2718	7	excreted	excrete	VBN
46745	2718	8	.	.	.
46745	2719	1	_	_	NNP
46745	2719	2	Catalytics	Catalytics	NNP
46745	2719	3	are	be	VBP
46745	2719	4	unnatural	unnatural	JJ
46745	2719	5	to	to	IN
46745	2719	6	the	the	DT
46745	2719	7	blood	blood	NN
46745	2719	8	,	,	,
46745	2719	9	and	and	CC
46745	2719	10	must	must	MD
46745	2719	11	at	at	IN
46745	2719	12	length	length	NN
46745	2719	13	pass	pass	NN
46745	2719	14	out	out	IN
46745	2719	15	of	of	IN
46745	2719	16	the	the	DT
46745	2719	17	system	system	NN
46745	2719	18	.	.	.
46745	2719	19	_	_	NNP
46745	2719	20	Of	of	IN
46745	2719	21	the	the	DT
46745	2719	22	list	list	NN
46745	2719	23	of	of	IN
46745	2719	24	Catalytics	Catalytics	NNP
46745	2719	25	,	,	,
46745	2719	26	the	the	DT
46745	2719	27	only	only	JJ
46745	2719	28	medicines	medicine	NNS
46745	2719	29	that	that	WDT
46745	2719	30	occur	occur	VBP
46745	2719	31	as	as	IN
46745	2719	32	constituents	constituent	NNS
46745	2719	33	of	of	IN
46745	2719	34	healthy	healthy	JJ
46745	2719	35	blood	blood	NN
46745	2719	36	,	,	,
46745	2719	37	are	be	VBP
46745	2719	38	Alkalies	Alkalies	NNP
46745	2719	39	,	,	,
46745	2719	40	Salts	Salts	NNPS
46745	2719	41	of	of	IN
46745	2719	42	the	the	DT
46745	2719	43	alkalies	alkali	NNS
46745	2719	44	and	and	CC
46745	2719	45	earths	earth	NNS
46745	2719	46	,	,	,
46745	2719	47	Chlorine	Chlorine	NNP
46745	2719	48	,	,	,
46745	2719	49	and	and	CC
46745	2719	50	Sulphur	Sulphur	NNP
46745	2719	51	.	.	.
46745	2720	1	Of	of	IN
46745	2720	2	these	these	DT
46745	2720	3	,	,	,
46745	2720	4	the	the	DT
46745	2720	5	Alkalies	Alkalies	NNPS
46745	2720	6	,	,	,
46745	2720	7	and	and	CC
46745	2720	8	possibly	possibly	RB
46745	2720	9	also	also	RB
46745	2720	10	the	the	DT
46745	2720	11	others	other	NNS
46745	2720	12	,	,	,
46745	2720	13	are	be	VBP
46745	2720	14	not	not	RB
46745	2720	15	unnatural	unnatural	JJ
46745	2720	16	to	to	IN
46745	2720	17	the	the	DT
46745	2720	18	blood	blood	NN
46745	2720	19	when	when	WRB
46745	2720	20	administered	administer	VBN
46745	2720	21	in	in	IN
46745	2720	22	small	small	JJ
46745	2720	23	quantities	quantity	NNS
46745	2720	24	,	,	,
46745	2720	25	and	and	CC
46745	2720	26	may	may	MD
46745	2720	27	remain	remain	VB
46745	2720	28	in	in	IN
46745	2720	29	the	the	DT
46745	2720	30	system	system	NN
46745	2720	31	and	and	CC
46745	2720	32	act	act	VB
46745	2720	33	as	as	IN
46745	2720	34	Restoratives	Restoratives	NNP
46745	2720	35	,	,	,
46745	2720	36	when	when	WRB
46745	2720	37	there	there	EX
46745	2720	38	is	be	VBZ
46745	2720	39	a	a	DT
46745	2720	40	deficiency	deficiency	NN
46745	2720	41	in	in	IN
46745	2720	42	the	the	DT
46745	2720	43	blood	blood	NN
46745	2720	44	of	of	IN
46745	2720	45	similar	similar	JJ
46745	2720	46	materials	material	NNS
46745	2720	47	.	.	.
46745	2721	1	But	but	CC
46745	2721	2	even	even	RB
46745	2721	3	these	these	DT
46745	2721	4	substances	substance	NNS
46745	2721	5	,	,	,
46745	2721	6	when	when	WRB
46745	2721	7	given	give	VBN
46745	2721	8	in	in	IN
46745	2721	9	large	large	JJ
46745	2721	10	quantity	quantity	NN
46745	2721	11	,	,	,
46745	2721	12	as	as	IN
46745	2721	13	is	be	VBZ
46745	2721	14	the	the	DT
46745	2721	15	case	case	NN
46745	2721	16	when	when	WRB
46745	2721	17	they	-PRON-	PRP
46745	2721	18	are	be	VBP
46745	2721	19	used	use	VBN
46745	2721	20	for	for	IN
46745	2721	21	Catalytic	catalytic	JJ
46745	2721	22	purposes	purpose	NNS
46745	2721	23	,	,	,
46745	2721	24	are	be	VBP
46745	2721	25	unnatural	unnatural	JJ
46745	2721	26	to	to	IN
46745	2721	27	the	the	DT
46745	2721	28	blood	blood	NN
46745	2721	29	,	,	,
46745	2721	30	and	and	CC
46745	2721	31	must	must	MD
46745	2721	32	be	be	VB
46745	2721	33	excreted	excrete	VBN
46745	2721	34	from	from	IN
46745	2721	35	it	-PRON-	PRP
46745	2721	36	.	.	.
46745	2722	1	With	with	IN
46745	2722	2	respect	respect	NN
46745	2722	3	to	to	IN
46745	2722	4	the	the	DT
46745	2722	5	other	other	JJ
46745	2722	6	Catalytics	Catalytics	NNP
46745	2722	7	,	,	,
46745	2722	8	they	-PRON-	PRP
46745	2722	9	can	can	MD
46745	2722	10	not	not	RB
46745	2722	11	any	any	DT
46745	2722	12	of	of	IN
46745	2722	13	them	-PRON-	PRP
46745	2722	14	remain	remain	VBP
46745	2722	15	naturally	naturally	RB
46745	2722	16	in	in	IN
46745	2722	17	the	the	DT
46745	2722	18	blood	blood	NN
46745	2722	19	,	,	,
46745	2722	20	under	under	IN
46745	2722	21	any	any	DT
46745	2722	22	circumstances	circumstance	NNS
46745	2722	23	.	.	.
46745	2723	1	Their	-PRON-	PRP$
46745	2723	2	very	very	JJ
46745	2723	3	presence	presence	NN
46745	2723	4	for	for	IN
46745	2723	5	awhile	awhile	JJ
46745	2723	6	constitutes	constitute	VBZ
46745	2723	7	an	an	DT
46745	2723	8	artificial	artificial	JJ
46745	2723	9	disease	disease	NN
46745	2723	10	,	,	,
46745	2723	11	and	and	CC
46745	2723	12	is	be	VBZ
46745	2723	13	only	only	RB
46745	2723	14	to	to	TO
46745	2723	15	be	be	VB
46745	2723	16	tolerated	tolerate	VBN
46745	2723	17	or	or	CC
46745	2723	18	recommended	recommend	VBN
46745	2723	19	because	because	IN
46745	2723	20	it	-PRON-	PRP
46745	2723	21	may	may	MD
46745	2723	22	serve	serve	VB
46745	2723	23	to	to	TO
46745	2723	24	counteract	counteract	VB
46745	2723	25	a	a	DT
46745	2723	26	morbid	morbid	NN
46745	2723	27	action	action	NN
46745	2723	28	of	of	IN
46745	2723	29	a	a	DT
46745	2723	30	more	more	RBR
46745	2723	31	serious	serious	JJ
46745	2723	32	and	and	CC
46745	2723	33	uncontrollable	uncontrollable	JJ
46745	2723	34	character	character	NN
46745	2723	35	.	.	.
46745	2724	1	The	the	DT
46745	2724	2	kidneys	kidney	NNS
46745	2724	3	generally	generally	RB
46745	2724	4	constitute	constitute	VBP
46745	2724	5	the	the	DT
46745	2724	6	channel	channel	NN
46745	2724	7	by	by	IN
46745	2724	8	which	which	WDT
46745	2724	9	these	these	DT
46745	2724	10	Catalytics	catalytic	NNS
46745	2724	11	are	be	VBP
46745	2724	12	removed	remove	VBN
46745	2724	13	from	from	IN
46745	2724	14	the	the	DT
46745	2724	15	blood	blood	NN
46745	2724	16	.	.	.
46745	2725	1	Most	Most	JJS
46745	2725	2	of	of	IN
46745	2725	3	them	-PRON-	PRP
46745	2725	4	,	,	,
46745	2725	5	in	in	IN
46745	2725	6	passing	pass	VBG
46745	2725	7	out	out	RP
46745	2725	8	,	,	,
46745	2725	9	act	act	VB
46745	2725	10	as	as	IN
46745	2725	11	diuretics	diuretic	NNS
46745	2725	12	.	.	.
46745	2726	1	To	to	IN
46745	2726	2	this	this	DT
46745	2726	3	we	-PRON-	PRP
46745	2726	4	must	must	MD
46745	2726	5	,	,	,
46745	2726	6	perhaps	perhaps	RB
46745	2726	7	,	,	,
46745	2726	8	except	except	IN
46745	2726	9	the	the	DT
46745	2726	10	salts	salt	NNS
46745	2726	11	of	of	IN
46745	2726	12	lead	lead	NN
46745	2726	13	,	,	,
46745	2726	14	zinc	zinc	NN
46745	2726	15	,	,	,
46745	2726	16	and	and	CC
46745	2726	17	copper	copper	NN
46745	2726	18	.	.	.
46745	2727	1	Doubtless	doubtless	RB
46745	2727	2	some	some	DT
46745	2727	3	are	be	VBP
46745	2727	4	excreted	excrete	VBN
46745	2727	5	partially	partially	RB
46745	2727	6	or	or	CC
46745	2727	7	entirely	entirely	RB
46745	2727	8	by	by	IN
46745	2727	9	the	the	DT
46745	2727	10	mucous	mucous	JJ
46745	2727	11	membrane	membrane	NN
46745	2727	12	of	of	IN
46745	2727	13	the	the	DT
46745	2727	14	bowels	bowel	NNS
46745	2727	15	,	,	,
46745	2727	16	but	but	CC
46745	2727	17	this	this	DT
46745	2727	18	we	-PRON-	PRP
46745	2727	19	can	can	MD
46745	2727	20	not	not	RB
46745	2727	21	so	so	RB
46745	2727	22	readily	readily	RB
46745	2727	23	appreciate	appreciate	JJ
46745	2727	24	.	.	.
46745	2728	1	The	the	DT
46745	2728	2	circumstance	circumstance	NN
46745	2728	3	that	that	WDT
46745	2728	4	the	the	DT
46745	2728	5	astringents	astringent	NNS
46745	2728	6	just	just	RB
46745	2728	7	mentioned	mention	VBN
46745	2728	8	are	be	VBP
46745	2728	9	efficacious	efficacious	JJ
46745	2728	10	in	in	IN
46745	2728	11	diarrh[oe]a	diarrh[oe]a	NNP
46745	2728	12	seems	seem	VBZ
46745	2728	13	to	to	TO
46745	2728	14	point	point	VB
46745	2728	15	to	to	IN
46745	2728	16	their	-PRON-	PRP$
46745	2728	17	access	access	NN
46745	2728	18	to	to	IN
46745	2728	19	the	the	DT
46745	2728	20	intestinal	intestinal	JJ
46745	2728	21	surface	surface	NN
46745	2728	22	from	from	IN
46745	2728	23	the	the	DT
46745	2728	24	blood	blood	NN
46745	2728	25	.	.	.
46745	2729	1	It	-PRON-	PRP
46745	2729	2	has	have	VBZ
46745	2729	3	already	already	RB
46745	2729	4	been	be	VBN
46745	2729	5	shown	show	VBN
46745	2729	6	that	that	IN
46745	2729	7	these	these	DT
46745	2729	8	Catalytics	catalytic	NNS
46745	2729	9	are	be	VBP
46745	2729	10	all	all	DT
46745	2729	11	soluble	soluble	JJ
46745	2729	12	in	in	IN
46745	2729	13	some	some	DT
46745	2729	14	way	way	NN
46745	2729	15	in	in	IN
46745	2729	16	the	the	DT
46745	2729	17	intestinal	intestinal	JJ
46745	2729	18	canal	canal	NN
46745	2729	19	,	,	,
46745	2729	20	and	and	CC
46745	2729	21	that	that	IN
46745	2729	22	they	-PRON-	PRP
46745	2729	23	are	be	VBP
46745	2729	24	absorbed	absorb	VBN
46745	2729	25	.	.	.
46745	2730	1	(	(	-LRB-
46745	2730	2	_	_	NNP
46745	2730	3	Vide	Vide	NNP
46745	2730	4	Prop	Prop	NNP
46745	2730	5	.	.	.
46745	2731	1	I.	I.	NNP
46745	2731	2	;	;	:
46745	2731	3	Prop	Prop	NNP
46745	2731	4	.	.	.
46745	2732	1	II	II	NNP
46745	2732	2	.	.	.
46745	2732	3	_	_	NNP
46745	2732	4	)	)	-RRB-
46745	2732	5	All	all	DT
46745	2732	6	of	of	IN
46745	2732	7	them	-PRON-	PRP
46745	2732	8	that	that	WDT
46745	2732	9	can	can	MD
46745	2732	10	be	be	VB
46745	2732	11	detected	detect	VBN
46745	2732	12	by	by	IN
46745	2732	13	chemical	chemical	NN
46745	2732	14	means	mean	NNS
46745	2732	15	,	,	,
46745	2732	16	have	have	VBP
46745	2732	17	actually	actually	RB
46745	2732	18	been	be	VBN
46745	2732	19	discovered	discover	VBN
46745	2732	20	in	in	IN
46745	2732	21	the	the	DT
46745	2732	22	blood	blood	NN
46745	2732	23	.	.	.
46745	2733	1	But	but	CC
46745	2733	2	the	the	DT
46745	2733	3	system	system	NN
46745	2733	4	will	will	MD
46745	2733	5	not	not	RB
46745	2733	6	,	,	,
46745	2733	7	if	if	IN
46745	2733	8	it	-PRON-	PRP
46745	2733	9	can	can	MD
46745	2733	10	be	be	VB
46745	2733	11	avoided	avoid	VBN
46745	2733	12	,	,	,
46745	2733	13	suffer	suffer	VB
46745	2733	14	them	-PRON-	PRP
46745	2733	15	to	to	TO
46745	2733	16	remain	remain	VB
46745	2733	17	there	there	RB
46745	2733	18	long	long	JJ
46745	2733	19	.	.	.
46745	2734	1	The	the	DT
46745	2734	2	glands	gland	NNS
46745	2734	3	are	be	VBP
46745	2734	4	charged	charge	VBN
46745	2734	5	with	with	IN
46745	2734	6	the	the	DT
46745	2734	7	office	office	NN
46745	2734	8	of	of	IN
46745	2734	9	purging	purge	VBG
46745	2734	10	the	the	DT
46745	2734	11	blood	blood	NN
46745	2734	12	of	of	IN
46745	2734	13	all	all	DT
46745	2734	14	morbid	morbid	NN
46745	2734	15	materials	material	NNS
46745	2734	16	;	;	,
46745	2734	17	and	and	CC
46745	2734	18	thus	thus	RB
46745	2734	19	these	these	DT
46745	2734	20	substances	substance	NNS
46745	2734	21	pass	pass	VBP
46745	2734	22	out	out	RP
46745	2734	23	in	in	IN
46745	2734	24	the	the	DT
46745	2734	25	secretions	secretion	NNS
46745	2734	26	;	;	:
46745	2734	27	most	most	RBS
46745	2734	28	particularly	particularly	RB
46745	2734	29	,	,	,
46745	2734	30	as	as	IN
46745	2734	31	I	-PRON-	PRP
46745	2734	32	have	have	VBP
46745	2734	33	just	just	RB
46745	2734	34	said	say	VBN
46745	2734	35	,	,	,
46745	2734	36	in	in	IN
46745	2734	37	the	the	DT
46745	2734	38	secretion	secretion	NN
46745	2734	39	of	of	IN
46745	2734	40	urine	urine	NN
46745	2734	41	.	.	.
46745	2735	1	Every	every	DT
46745	2735	2	one	one	CD
46745	2735	3	of	of	IN
46745	2735	4	the	the	DT
46745	2735	5	medicines	medicine	NNS
46745	2735	6	of	of	IN
46745	2735	7	this	this	DT
46745	2735	8	division	division	NN
46745	2735	9	,	,	,
46745	2735	10	enumerated	enumerate	VBD
46745	2735	11	above,--excepting	above,--excepte	VBG
46745	2735	12	Colchicum	Colchicum	NNP
46745	2735	13	and	and	CC
46745	2735	14	Pitch	Pitch	NNP
46745	2735	15	,	,	,
46745	2735	16	which	which	WDT
46745	2735	17	are	be	VBP
46745	2735	18	difficult	difficult	JJ
46745	2735	19	to	to	TO
46745	2735	20	recognise	recognise	VB
46745	2735	21	chemically,--have	chemically,--have	,
46745	2735	22	been	be	VBN
46745	2735	23	detected	detect	VBN
46745	2735	24	in	in	IN
46745	2735	25	the	the	DT
46745	2735	26	urine	urine	NN
46745	2735	27	by	by	IN
46745	2735	28	M.	M.	NNP
46745	2735	29	Wöhler	Wöhler	NNP
46745	2735	30	,	,	,
46745	2735	31	M.	M.	NNP
46745	2735	32	Orfila	Orfila	NNP
46745	2735	33	,	,	,
46745	2735	34	and	and	CC
46745	2735	35	others	other	NNS
46745	2735	36	.	.	.
46745	2736	1	The	the	DT
46745	2736	2	Alkalies	Alkalies	NNPS
46745	2736	3	and	and	CC
46745	2736	4	Acids	Acids	NNPS
46745	2736	5	are	be	VBP
46745	2736	6	combined	combine	VBN
46745	2736	7	,	,	,
46745	2736	8	so	so	IN
46745	2736	9	as	as	IN
46745	2736	10	to	to	TO
46745	2736	11	form	form	VB
46745	2736	12	salts	salt	NNS
46745	2736	13	;	;	,
46745	2736	14	the	the	DT
46745	2736	15	vegetable	vegetable	NN
46745	2736	16	salts	salt	NNS
46745	2736	17	are	be	VBP
46745	2736	18	decomposed	decompose	VBN
46745	2736	19	;	;	:
46745	2736	20	Sulphur	Sulphur	NNP
46745	2736	21	has	have	VBZ
46745	2736	22	changed	change	VBN
46745	2736	23	into	into	IN
46745	2736	24	Sulphuric	Sulphuric	NNP
46745	2736	25	acid	acid	NN
46745	2736	26	;	;	:
46745	2736	27	and	and	CC
46745	2736	28	the	the	DT
46745	2736	29	metallic	metallic	JJ
46745	2736	30	bases	basis	NNS
46745	2736	31	are	be	VBP
46745	2736	32	found	find	VBN
46745	2736	33	to	to	TO
46745	2736	34	be	be	VB
46745	2736	35	variously	variously	RB
46745	2736	36	combined	combine	VBN
46745	2736	37	;	;	:
46745	2736	38	but	but	CC
46745	2736	39	all	all	PDT
46745	2736	40	the	the	DT
46745	2736	41	fixed	fix	VBN
46745	2736	42	inorganic	inorganic	JJ
46745	2736	43	materials	material	NNS
46745	2736	44	remain	remain	VBP
46745	2736	45	essentially	essentially	RB
46745	2736	46	the	the	DT
46745	2736	47	same	same	JJ
46745	2736	48	,	,	,
46745	2736	49	however	however	RB
46745	2736	50	altered	alter	VBN
46745	2736	51	in	in	IN
46745	2736	52	arrangement	arrangement	NN
46745	2736	53	.	.	.
46745	2737	1	Many	many	JJ
46745	2737	2	of	of	IN
46745	2737	3	these	these	DT
46745	2737	4	medicines	medicine	NNS
46745	2737	5	have	have	VBP
46745	2737	6	been	be	VBN
46745	2737	7	likewise	likewise	RB
46745	2737	8	detected	detect	VBN
46745	2737	9	in	in	IN
46745	2737	10	the	the	DT
46745	2737	11	secretions	secretion	NNS
46745	2737	12	of	of	IN
46745	2737	13	other	other	JJ
46745	2737	14	glands	gland	NNS
46745	2737	15	.	.	.
46745	2738	1	This	this	DT
46745	2738	2	subject	subject	NN
46745	2738	3	will	will	MD
46745	2738	4	be	be	VB
46745	2738	5	further	further	RB
46745	2738	6	discussed	discuss	VBN
46745	2738	7	in	in	IN
46745	2738	8	the	the	DT
46745	2738	9	consideration	consideration	NN
46745	2738	10	of	of	IN
46745	2738	11	Prop	Prop	NNP
46745	2738	12	.	.	.
46745	2739	1	X.	X.	NNP
46745	2739	2	,	,	,
46745	2739	3	and	and	CC
46745	2739	4	does	do	VBZ
46745	2739	5	not	not	RB
46745	2739	6	immediately	immediately	RB
46745	2739	7	concern	concern	VB
46745	2739	8	us	-PRON-	PRP
46745	2739	9	now	now	RB
46745	2739	10	.	.	.
46745	2740	1	Thus	thus	RB
46745	2740	2	the	the	DT
46745	2740	3	minor	minor	JJ
46745	2740	4	propositions	proposition	NNS
46745	2740	5	may	may	MD
46745	2740	6	be	be	VB
46745	2740	7	considered	consider	VBN
46745	2740	8	as	as	IN
46745	2740	9	proved	prove	VBN
46745	2740	10	;	;	:
46745	2740	11	and	and	CC
46745	2740	12	all	all	DT
46745	2740	13	that	that	WDT
46745	2740	14	I	-PRON-	PRP
46745	2740	15	have	have	VBP
46745	2740	16	ventured	venture	VBN
46745	2740	17	to	to	TO
46745	2740	18	affirm	affirm	VB
46745	2740	19	of	of	IN
46745	2740	20	this	this	DT
46745	2740	21	group	group	NN
46745	2740	22	of	of	IN
46745	2740	23	medicines	medicines	NNP
46745	2740	24	is	be	VBZ
46745	2740	25	,	,	,
46745	2740	26	that	that	IN
46745	2740	27	they	-PRON-	PRP
46745	2740	28	counteract	counteract	VBP
46745	2740	29	morbid	morbid	NN
46745	2740	30	agencies	agency	NNS
46745	2740	31	by	by	IN
46745	2740	32	an	an	DT
46745	2740	33	operation	operation	NN
46745	2740	34	in	in	IN
46745	2740	35	the	the	DT
46745	2740	36	blood	blood	NN
46745	2740	37	.	.	.
46745	2741	1	Now	now	RB
46745	2741	2	the	the	DT
46745	2741	3	mode	mode	NN
46745	2741	4	of	of	IN
46745	2741	5	counteraction	counteraction	NN
46745	2741	6	is	be	VBZ
46745	2741	7	not	not	RB
46745	2741	8	defined	define	VBN
46745	2741	9	,	,	,
46745	2741	10	because	because	IN
46745	2741	11	it	-PRON-	PRP
46745	2741	12	is	be	VBZ
46745	2741	13	only	only	RB
46745	2741	14	in	in	IN
46745	2741	15	a	a	DT
46745	2741	16	few	few	JJ
46745	2741	17	cases	case	NNS
46745	2741	18	that	that	WDT
46745	2741	19	we	-PRON-	PRP
46745	2741	20	can	can	MD
46745	2741	21	even	even	RB
46745	2741	22	guess	guess	VB
46745	2741	23	at	at	IN
46745	2741	24	it	-PRON-	PRP
46745	2741	25	.	.	.
46745	2742	1	In	in	IN
46745	2742	2	the	the	DT
46745	2742	3	majority	majority	NN
46745	2742	4	of	of	IN
46745	2742	5	instances	instance	NNS
46745	2742	6	it	-PRON-	PRP
46745	2742	7	seems	seem	VBZ
46745	2742	8	inexplicable	inexplicable	JJ
46745	2742	9	.	.	.
46745	2743	1	We	-PRON-	PRP
46745	2743	2	know	know	VBP
46745	2743	3	that	that	IN
46745	2743	4	Syphilis	Syphilis	NNP
46745	2743	5	is	be	VBZ
46745	2743	6	a	a	DT
46745	2743	7	poison	poison	NN
46745	2743	8	in	in	IN
46745	2743	9	the	the	DT
46745	2743	10	blood	blood	NN
46745	2743	11	.	.	.
46745	2744	1	Mercury	Mercury	NNP
46745	2744	2	also	also	RB
46745	2744	3	is	be	VBZ
46745	2744	4	a	a	DT
46745	2744	5	poison	poison	NN
46745	2744	6	in	in	IN
46745	2744	7	the	the	DT
46745	2744	8	blood	blood	NN
46745	2744	9	.	.	.
46745	2745	1	But	but	CC
46745	2745	2	why	why	WRB
46745	2745	3	does	do	VBZ
46745	2745	4	Mercury	Mercury	NNP
46745	2745	5	antagonize	antagonize	VB
46745	2745	6	and	and	CC
46745	2745	7	annihilate	annihilate	JJ
46745	2745	8	Syphilis	Syphilis	NNP
46745	2745	9	?	?	.
46745	2746	1	The	the	DT
46745	2746	2	case	case	NN
46745	2746	3	is	be	VBZ
46745	2746	4	the	the	DT
46745	2746	5	same	same	JJ
46745	2746	6	with	with	IN
46745	2746	7	Scrofula	Scrofula	NNP
46745	2746	8	and	and	CC
46745	2746	9	Iodine	Iodine	NNP
46745	2746	10	;	;	:
46745	2746	11	with	with	IN
46745	2746	12	Lepra	Lepra	NNP
46745	2746	13	and	and	CC
46745	2746	14	Arsenic	Arsenic	NNP
46745	2746	15	.	.	.
46745	2747	1	It	-PRON-	PRP
46745	2747	2	is	be	VBZ
46745	2747	3	very	very	RB
46745	2747	4	humiliating	humiliating	JJ
46745	2747	5	to	to	TO
46745	2747	6	be	be	VB
46745	2747	7	baffled	baffle	VBN
46745	2747	8	when	when	WRB
46745	2747	9	we	-PRON-	PRP
46745	2747	10	have	have	VBP
46745	2747	11	got	get	VBN
46745	2747	12	thus	thus	RB
46745	2747	13	far	far	RB
46745	2747	14	;	;	:
46745	2747	15	when	when	WRB
46745	2747	16	,	,	,
46745	2747	17	led	lead	VBN
46745	2747	18	by	by	IN
46745	2747	19	the	the	DT
46745	2747	20	hand	hand	NN
46745	2747	21	of	of	IN
46745	2747	22	Science	Science	NNP
46745	2747	23	,	,	,
46745	2747	24	we	-PRON-	PRP
46745	2747	25	have	have	VBP
46745	2747	26	been	be	VBN
46745	2747	27	conducted	conduct	VBN
46745	2747	28	almost	almost	RB
46745	2747	29	to	to	IN
46745	2747	30	the	the	DT
46745	2747	31	end	end	NN
46745	2747	32	of	of	IN
46745	2747	33	this	this	DT
46745	2747	34	interesting	interesting	JJ
46745	2747	35	inquiry	inquiry	NN
46745	2747	36	,	,	,
46745	2747	37	to	to	TO
46745	2747	38	find	find	VB
46745	2747	39	that	that	IN
46745	2747	40	we	-PRON-	PRP
46745	2747	41	are	be	VBP
46745	2747	42	perfectly	perfectly	RB
46745	2747	43	unable	unable	JJ
46745	2747	44	to	to	TO
46745	2747	45	take	take	VB
46745	2747	46	the	the	DT
46745	2747	47	last	last	JJ
46745	2747	48	step	step	NN
46745	2747	49	,	,	,
46745	2747	50	and	and	CC
46745	2747	51	thus	thus	RB
46745	2747	52	to	to	TO
46745	2747	53	conclude	conclude	VB
46745	2747	54	our	-PRON-	PRP$
46745	2747	55	adventure	adventure	NN
46745	2747	56	.	.	.
46745	2748	1	When	when	WRB
46745	2748	2	there	there	EX
46745	2748	3	is	be	VBZ
46745	2748	4	no	no	DT
46745	2748	5	disease	disease	NN
46745	2748	6	,	,	,
46745	2748	7	a	a	DT
46745	2748	8	Catalytic	catalytic	JJ
46745	2748	9	medicine	medicine	NN
46745	2748	10	may	may	MD
46745	2748	11	work	work	VB
46745	2748	12	out	out	RP
46745	2748	13	its	-PRON-	PRP$
46745	2748	14	own	own	JJ
46745	2748	15	action	action	NN
46745	2748	16	in	in	IN
46745	2748	17	the	the	DT
46745	2748	18	blood	blood	NN
46745	2748	19	,	,	,
46745	2748	20	and	and	CC
46745	2748	21	produce	produce	VB
46745	2748	22	a	a	DT
46745	2748	23	disease	disease	NN
46745	2748	24	.	.	.
46745	2749	1	But	but	CC
46745	2749	2	when	when	WRB
46745	2749	3	there	there	EX
46745	2749	4	is	be	VBZ
46745	2749	5	some	some	DT
46745	2749	6	previous	previous	JJ
46745	2749	7	disorder	disorder	NN
46745	2749	8	,	,	,
46745	2749	9	the	the	DT
46745	2749	10	working	working	NN
46745	2749	11	of	of	IN
46745	2749	12	the	the	DT
46745	2749	13	Catalytic	Catalytic	NNP
46745	2749	14	may	may	MD
46745	2749	15	operate	operate	VB
46745	2749	16	so	so	IN
46745	2749	17	as	as	IN
46745	2749	18	to	to	TO
46745	2749	19	counteract	counteract	VB
46745	2749	20	this	this	DT
46745	2749	21	already	already	RB
46745	2749	22	existing	exist	VBG
46745	2749	23	action	action	NN
46745	2749	24	,	,	,
46745	2749	25	being	be	VBG
46745	2749	26	so	so	RB
46745	2749	27	far	far	RB
46745	2749	28	similar	similar	JJ
46745	2749	29	to	to	IN
46745	2749	30	it	-PRON-	PRP
46745	2749	31	,	,	,
46745	2749	32	that	that	IN
46745	2749	33	it	-PRON-	PRP
46745	2749	34	acts	act	VBZ
46745	2749	35	in	in	IN
46745	2749	36	the	the	DT
46745	2749	37	same	same	JJ
46745	2749	38	department	department	NN
46745	2749	39	,	,	,
46745	2749	40	and	and	CC
46745	2749	41	may	may	MD
46745	2749	42	thus	thus	RB
46745	2749	43	occasionally	occasionally	RB
46745	2749	44	produce	produce	VB
46745	2749	45	by	by	IN
46745	2749	46	an	an	DT
46745	2749	47	accident	accident	NN
46745	2749	48	like	like	IN
46745	2749	49	results	result	NNS
46745	2749	50	;	;	:
46745	2749	51	but	but	CC
46745	2749	52	being	be	VBG
46745	2749	53	,	,	,
46745	2749	54	nevertheless	nevertheless	RB
46745	2749	55	,	,	,
46745	2749	56	as	as	IN
46745	2749	57	we	-PRON-	PRP
46745	2749	58	have	have	VBP
46745	2749	59	seen	see	VBN
46745	2749	60	,	,	,
46745	2749	61	essentially	essentially	RB
46745	2749	62	contrary	contrary	JJ
46745	2749	63	to	to	IN
46745	2749	64	it	-PRON-	PRP
46745	2749	65	,	,	,
46745	2749	66	because	because	IN
46745	2749	67	it	-PRON-	PRP
46745	2749	68	neutralizes	neutralize	VBZ
46745	2749	69	it	-PRON-	PRP
46745	2749	70	.	.	.
46745	2750	1	Such	such	JJ
46745	2750	2	opposite	opposite	JJ
46745	2750	3	relations	relation	NNS
46745	2750	4	are	be	VBP
46745	2750	5	met	meet	VBN
46745	2750	6	with	with	IN
46745	2750	7	even	even	RB
46745	2750	8	among	among	IN
46745	2750	9	natural	natural	JJ
46745	2750	10	diseases	disease	NNS
46745	2750	11	.	.	.
46745	2751	1	Vaccination	Vaccination	NNP
46745	2751	2	and	and	CC
46745	2751	3	Small	Small	NNP
46745	2751	4	Pox	Pox	NNP
46745	2751	5	afford	afford	VB
46745	2751	6	us	-PRON-	PRP
46745	2751	7	an	an	DT
46745	2751	8	instance	instance	NN
46745	2751	9	of	of	IN
46745	2751	10	the	the	DT
46745	2751	11	mutual	mutual	JJ
46745	2751	12	counteraction	counteraction	NN
46745	2751	13	of	of	IN
46745	2751	14	morbid	morbid	NN
46745	2751	15	processes	process	NNS
46745	2751	16	.	.	.
46745	2752	1	These	these	DT
46745	2752	2	poisons	poison	NNS
46745	2752	3	are	be	VBP
46745	2752	4	alike	alike	RB
46745	2752	5	in	in	IN
46745	2752	6	their	-PRON-	PRP$
46745	2752	7	operation	operation	NN
46745	2752	8	.	.	.
46745	2753	1	Dr.	Dr.	NNP
46745	2753	2	Fouquet	Fouquet	NNP
46745	2753	3	,	,	,
46745	2753	4	of	of	IN
46745	2753	5	Freiburg	Freiburg	NNP
46745	2753	6	,	,	,
46745	2753	7	has	have	VBZ
46745	2753	8	tried	try	VBN
46745	2753	9	the	the	DT
46745	2753	10	effects	effect	NNS
46745	2753	11	of	of	IN
46745	2753	12	re	re	NN
46745	2753	13	-	-	NN
46745	2753	14	vaccination	vaccination	NN
46745	2753	15	in	in	IN
46745	2753	16	Syphilis	Syphilis	NNP
46745	2753	17	,	,	,
46745	2753	18	on	on	IN
46745	2753	19	the	the	DT
46745	2753	20	inmates	inmate	NNS
46745	2753	21	of	of	IN
46745	2753	22	a	a	DT
46745	2753	23	large	large	JJ
46745	2753	24	military	military	JJ
46745	2753	25	hospital	hospital	NN
46745	2753	26	,	,	,
46745	2753	27	with	with	IN
46745	2753	28	great	great	JJ
46745	2753	29	apparent	apparent	JJ
46745	2753	30	benefit	benefit	NN
46745	2753	31	,	,	,
46745	2753	32	as	as	IN
46745	2753	33	it	-PRON-	PRP
46745	2753	34	is	be	VBZ
46745	2753	35	said	say	VBN
46745	2753	36	.	.	.
46745	2754	1	These	these	DT
46745	2754	2	poisons	poison	NNS
46745	2754	3	are	be	VBP
46745	2754	4	unlike	unlike	IN
46745	2754	5	in	in	IN
46745	2754	6	their	-PRON-	PRP$
46745	2754	7	results	result	NNS
46745	2754	8	.	.	.
46745	2755	1	So	so	CC
46745	2755	2	are	be	VBP
46745	2755	3	Ague	Ague	NNP
46745	2755	4	and	and	CC
46745	2755	5	Phthisis	Phthisis	NNP
46745	2755	6	;	;	:
46745	2755	7	and	and	CC
46745	2755	8	persons	person	NNS
46745	2755	9	who	who	WP
46745	2755	10	have	have	VBP
46745	2755	11	had	have	VBN
46745	2755	12	Ague	Ague	NNP
46745	2755	13	are	be	VBP
46745	2755	14	said	say	VBN
46745	2755	15	to	to	TO
46745	2755	16	be	be	VB
46745	2755	17	less	less	RBR
46745	2755	18	liable	liable	JJ
46745	2755	19	to	to	IN
46745	2755	20	Phthisis	phthisis	NN
46745	2755	21	than	than	IN
46745	2755	22	others	other	NNS
46745	2755	23	.	.	.
46745	2756	1	Again	again	RB
46745	2756	2	,	,	,
46745	2756	3	we	-PRON-	PRP
46745	2756	4	find	find	VBP
46745	2756	5	that	that	IN
46745	2756	6	one	one	CD
46745	2756	7	attack	attack	NN
46745	2756	8	of	of	IN
46745	2756	9	an	an	DT
46745	2756	10	eruptive	eruptive	JJ
46745	2756	11	fever	fever	NN
46745	2756	12	preserves	preserve	VBZ
46745	2756	13	the	the	DT
46745	2756	14	system	system	NN
46745	2756	15	in	in	IN
46745	2756	16	some	some	DT
46745	2756	17	way	way	NN
46745	2756	18	from	from	IN
46745	2756	19	the	the	DT
46745	2756	20	renewed	renew	VBN
46745	2756	21	operation	operation	NN
46745	2756	22	of	of	IN
46745	2756	23	the	the	DT
46745	2756	24	same	same	JJ
46745	2756	25	poison	poison	NN
46745	2756	26	.	.	.
46745	2757	1	In	in	IN
46745	2757	2	these	these	DT
46745	2757	3	morbid	morbid	NN
46745	2757	4	phenomena	phenomena	NN
46745	2757	5	we	-PRON-	PRP
46745	2757	6	find	find	VBP
46745	2757	7	something	something	NN
46745	2757	8	of	of	IN
46745	2757	9	a	a	DT
46745	2757	10	parallel	parallel	NN
46745	2757	11	to	to	IN
46745	2757	12	the	the	DT
46745	2757	13	curious	curious	JJ
46745	2757	14	operation	operation	NN
46745	2757	15	of	of	IN
46745	2757	16	Catalytic	catalytic	JJ
46745	2757	17	medicines	medicine	NNS
46745	2757	18	in	in	IN
46745	2757	19	controlling	control	VBG
46745	2757	20	blood	blood	NN
46745	2757	21	-	-	HYPH
46745	2757	22	diseases	disease	NNS
46745	2757	23	;	;	:
46745	2757	24	for	for	IN
46745	2757	25	I	-PRON-	PRP
46745	2757	26	have	have	VBP
46745	2757	27	shown	show	VBN
46745	2757	28	that	that	IN
46745	2757	29	these	these	DT
46745	2757	30	remedies	remedy	NNS
46745	2757	31	themselves	-PRON-	PRP
46745	2757	32	are	be	VBP
46745	2757	33	artificial	artificial	JJ
46745	2757	34	blood	blood	NN
46745	2757	35	-	-	HYPH
46745	2757	36	diseases	disease	NNS
46745	2757	37	.	.	.
46745	2758	1	Such	such	JJ
46745	2758	2	ideas	idea	NNS
46745	2758	3	lead	lead	VBP
46745	2758	4	us	-PRON-	PRP
46745	2758	5	on	on	RP
46745	2758	6	into	into	IN
46745	2758	7	the	the	DT
46745	2758	8	uncertain	uncertain	JJ
46745	2758	9	regions	region	NNS
46745	2758	10	of	of	IN
46745	2758	11	speculation	speculation	NN
46745	2758	12	.	.	.
46745	2759	1	The	the	DT
46745	2759	2	idea	idea	NN
46745	2759	3	that	that	WDT
46745	2759	4	diseased	disease	VBD
46745	2759	5	actions	action	NNS
46745	2759	6	may	may	MD
46745	2759	7	possibly	possibly	RB
46745	2759	8	be	be	VB
46745	2759	9	accounted	account	VBN
46745	2759	10	for	for	IN
46745	2759	11	by	by	IN
46745	2759	12	supposing	suppose	VBG
46745	2759	13	the	the	DT
46745	2759	14	existence	existence	NN
46745	2759	15	of	of	IN
46745	2759	16	special	special	JJ
46745	2759	17	_	_	NNP
46745	2759	18	fermentations	fermentation	NNS
46745	2759	19	_	_	NNP
46745	2759	20	in	in	IN
46745	2759	21	the	the	DT
46745	2759	22	blood	blood	NN
46745	2759	23	,	,	,
46745	2759	24	is	be	VBZ
46745	2759	25	by	by	IN
46745	2759	26	no	no	DT
46745	2759	27	means	means	NN
46745	2759	28	a	a	DT
46745	2759	29	new	new	JJ
46745	2759	30	one	one	NN
46745	2759	31	.	.	.
46745	2760	1	Inscrutable	inscrutable	JJ
46745	2760	2	as	as	IN
46745	2760	3	these	these	DT
46745	2760	4	diseased	disease	VBN
46745	2760	5	actions	action	NNS
46745	2760	6	themselves	-PRON-	PRP
46745	2760	7	may	may	MD
46745	2760	8	be	be	VB
46745	2760	9	,	,	,
46745	2760	10	yet	yet	RB
46745	2760	11	,	,	,
46745	2760	12	we	-PRON-	PRP
46745	2760	13	are	be	VBP
46745	2760	14	enabled	enable	VBN
46745	2760	15	to	to	TO
46745	2760	16	recognise	recognise	VB
46745	2760	17	processes	process	NNS
46745	2760	18	of	of	IN
46745	2760	19	a	a	DT
46745	2760	20	nature	nature	NN
46745	2760	21	analogous	analogous	JJ
46745	2760	22	to	to	TO
46745	2760	23	fermentation	fermentation	VB
46745	2760	24	as	as	IN
46745	2760	25	going	go	VBG
46745	2760	26	on	on	RP
46745	2760	27	in	in	IN
46745	2760	28	that	that	DT
46745	2760	29	fluid	fluid	NN
46745	2760	30	in	in	IN
46745	2760	31	health	health	NN
46745	2760	32	.	.	.
46745	2761	1	Of	of	IN
46745	2761	2	such	such	PDT
46745	2761	3	a	a	DT
46745	2761	4	kind	kind	NN
46745	2761	5	probably	probably	RB
46745	2761	6	are	be	VBP
46745	2761	7	,	,	,
46745	2761	8	the	the	DT
46745	2761	9	change	change	NN
46745	2761	10	of	of	IN
46745	2761	11	albumen	albuman	NNS
46745	2761	12	into	into	IN
46745	2761	13	fibrine	fibrine	NN
46745	2761	14	;	;	:
46745	2761	15	the	the	DT
46745	2761	16	changes	change	NNS
46745	2761	17	which	which	WDT
46745	2761	18	take	take	VBP
46745	2761	19	place	place	NN
46745	2761	20	in	in	IN
46745	2761	21	the	the	DT
46745	2761	22	starchy	starchy	JJ
46745	2761	23	matters	matter	NNS
46745	2761	24	of	of	IN
46745	2761	25	the	the	DT
46745	2761	26	food	food	NN
46745	2761	27	before	before	IN
46745	2761	28	they	-PRON-	PRP
46745	2761	29	can	can	MD
46745	2761	30	be	be	VB
46745	2761	31	oxidized	oxidize	VBN
46745	2761	32	into	into	IN
46745	2761	33	carbonic	carbonic	JJ
46745	2761	34	acid	acid	NN
46745	2761	35	;	;	:
46745	2761	36	and	and	CC
46745	2761	37	the	the	DT
46745	2761	38	changes	change	NNS
46745	2761	39	that	that	WDT
46745	2761	40	must	must	MD
46745	2761	41	occur	occur	VB
46745	2761	42	in	in	IN
46745	2761	43	nitrogenous	nitrogenous	JJ
46745	2761	44	substances	substance	NNS
46745	2761	45	before	before	IN
46745	2761	46	absorption	absorption	NN
46745	2761	47	,	,	,
46745	2761	48	as	as	RB
46745	2761	49	well	well	RB
46745	2761	50	as	as	IN
46745	2761	51	those	those	DT
46745	2761	52	that	that	WDT
46745	2761	53	accompany	accompany	VBP
46745	2761	54	afterwards	afterwards	RB
46745	2761	55	the	the	DT
46745	2761	56	downward	downward	JJ
46745	2761	57	progress	progress	NN
46745	2761	58	of	of	IN
46745	2761	59	the	the	DT
46745	2761	60	same	same	JJ
46745	2761	61	materials	material	NNS
46745	2761	62	,	,	,
46745	2761	63	from	from	IN
46745	2761	64	living	live	VBG
46745	2761	65	tissue	tissue	NN
46745	2761	66	into	into	IN
46745	2761	67	Urea	Urea	NNP
46745	2761	68	and	and	CC
46745	2761	69	Uric	Uric	NNP
46745	2761	70	acid	acid	NN
46745	2761	71	,	,	,
46745	2761	72	to	to	TO
46745	2761	73	be	be	VB
46745	2761	74	finally	finally	RB
46745	2761	75	excreted	excrete	VBN
46745	2761	76	from	from	IN
46745	2761	77	the	the	DT
46745	2761	78	system	system	NN
46745	2761	79	.	.	.
46745	2762	1	It	-PRON-	PRP
46745	2762	2	is	be	VBZ
46745	2762	3	a	a	DT
46745	2762	4	curious	curious	JJ
46745	2762	5	fact	fact	NN
46745	2762	6	that	that	IN
46745	2762	7	nearly	nearly	RB
46745	2762	8	every	every	DT
46745	2762	9	known	know	VBN
46745	2762	10	product	product	NN
46745	2762	11	of	of	IN
46745	2762	12	organic	organic	JJ
46745	2762	13	fermentation	fermentation	NN
46745	2762	14	has	have	VBZ
46745	2762	15	been	be	VBN
46745	2762	16	discovered	discover	VBN
46745	2762	17	in	in	IN
46745	2762	18	the	the	DT
46745	2762	19	human	human	JJ
46745	2762	20	body	body	NN
46745	2762	21	in	in	IN
46745	2762	22	health	health	NN
46745	2762	23	or	or	CC
46745	2762	24	in	in	IN
46745	2762	25	disease	disease	NN
46745	2762	26	.	.	.
46745	2763	1	Lactic	lactic	JJ
46745	2763	2	,	,	,
46745	2763	3	butyric	butyric	JJ
46745	2763	4	,	,	,
46745	2763	5	and	and	CC
46745	2763	6	acetic	acetic	JJ
46745	2763	7	acids	acid	NNS
46745	2763	8	,	,	,
46745	2763	9	have	have	VBP
46745	2763	10	been	be	VBN
46745	2763	11	frequently	frequently	RB
46745	2763	12	found	find	VBN
46745	2763	13	there	there	RB
46745	2763	14	.	.	.
46745	2764	1	Dr.	Dr.	NNP
46745	2764	2	Heintz	Heintz	NNP
46745	2764	3	has	have	VBZ
46745	2764	4	lately	lately	RB
46745	2764	5	added	add	VBN
46745	2764	6	to	to	IN
46745	2764	7	these	these	DT
46745	2764	8	succinic	succinic	JJ
46745	2764	9	acid	acid	NN
46745	2764	10	,	,	,
46745	2764	11	discovered	discover	VBN
46745	2764	12	in	in	IN
46745	2764	13	a	a	DT
46745	2764	14	hydatid	hydatid	JJ
46745	2764	15	cyst	cyst	NN
46745	2764	16	of	of	IN
46745	2764	17	the	the	DT
46745	2764	18	liver	liver	NN
46745	2764	19	.	.	.
46745	2765	1	The	the	DT
46745	2765	2	production	production	NN
46745	2765	3	of	of	IN
46745	2765	4	many	many	JJ
46745	2765	5	disorders	disorder	NNS
46745	2765	6	by	by	IN
46745	2765	7	the	the	DT
46745	2765	8	access	access	NN
46745	2765	9	of	of	IN
46745	2765	10	a	a	DT
46745	2765	11	known	know	VBN
46745	2765	12	morbid	morbid	NN
46745	2765	13	material	material	NN
46745	2765	14	,	,	,
46745	2765	15	the	the	DT
46745	2765	16	working	working	NN
46745	2765	17	of	of	IN
46745	2765	18	that	that	DT
46745	2765	19	material	material	NN
46745	2765	20	on	on	IN
46745	2765	21	the	the	DT
46745	2765	22	particles	particle	NNS
46745	2765	23	of	of	IN
46745	2765	24	the	the	DT
46745	2765	25	blood	blood	NN
46745	2765	26	after	after	IN
46745	2765	27	a	a	DT
46745	2765	28	special	special	JJ
46745	2765	29	fashion	fashion	NN
46745	2765	30	peculiar	peculiar	JJ
46745	2765	31	to	to	IN
46745	2765	32	itself	-PRON-	PRP
46745	2765	33	alone	alone	JJ
46745	2765	34	,	,	,
46745	2765	35	and	and	CC
46745	2765	36	the	the	DT
46745	2765	37	gradual	gradual	JJ
46745	2765	38	elimination	elimination	NN
46745	2765	39	of	of	IN
46745	2765	40	certain	certain	JJ
46745	2765	41	products	product	NNS
46745	2765	42	,	,	,
46745	2765	43	also	also	RB
46745	2765	44	peculiar	peculiar	JJ
46745	2765	45	to	to	IN
46745	2765	46	this	this	DT
46745	2765	47	one	one	CD
46745	2765	48	operation	operation	NN
46745	2765	49	,	,	,
46745	2765	50	are	be	VBP
46745	2765	51	circumstances	circumstance	NNS
46745	2765	52	in	in	IN
46745	2765	53	which	which	WDT
46745	2765	54	diseases	disease	NNS
46745	2765	55	bear	bear	VBP
46745	2765	56	an	an	DT
46745	2765	57	obvious	obvious	JJ
46745	2765	58	analogy	analogy	NN
46745	2765	59	to	to	IN
46745	2765	60	processes	process	NNS
46745	2765	61	of	of	IN
46745	2765	62	fermentation	fermentation	NN
46745	2765	63	.	.	.
46745	2766	1	The	the	DT
46745	2766	2	same	same	JJ
46745	2766	3	remark	remark	NN
46745	2766	4	applies	apply	VBZ
46745	2766	5	to	to	IN
46745	2766	6	the	the	DT
46745	2766	7	working	working	NN
46745	2766	8	of	of	IN
46745	2766	9	Catalytic	catalytic	JJ
46745	2766	10	medicines	medicine	NNS
46745	2766	11	.	.	.
46745	2767	1	It	-PRON-	PRP
46745	2767	2	is	be	VBZ
46745	2767	3	then	then	RB
46745	2767	4	just	just	RB
46745	2767	5	possible	possible	JJ
46745	2767	6	that	that	IN
46745	2767	7	one	one	CD
46745	2767	8	of	of	IN
46745	2767	9	these	these	DT
46745	2767	10	medicines	medicine	NNS
46745	2767	11	might	may	MD
46745	2767	12	produce	produce	VB
46745	2767	13	in	in	IN
46745	2767	14	the	the	DT
46745	2767	15	blood	blood	NN
46745	2767	16	a	a	DT
46745	2767	17	fermentation	fermentation	NN
46745	2767	18	which	which	WDT
46745	2767	19	should	should	MD
46745	2767	20	meet	meet	VB
46745	2767	21	and	and	CC
46745	2767	22	neutralize	neutralize	VB
46745	2767	23	the	the	DT
46745	2767	24	morbid	morbid	NN
46745	2767	25	fermentation	fermentation	NN
46745	2767	26	;	;	:
46745	2767	27	or	or	CC
46745	2767	28	that	that	IN
46745	2767	29	it	-PRON-	PRP
46745	2767	30	might	may	MD
46745	2767	31	simply	simply	RB
46745	2767	32	determine	determine	VB
46745	2767	33	the	the	DT
46745	2767	34	latter	latter	JJ
46745	2767	35	in	in	IN
46745	2767	36	a	a	DT
46745	2767	37	different	different	JJ
46745	2767	38	direction	direction	NN
46745	2767	39	,	,	,
46745	2767	40	and	and	CC
46745	2767	41	thus	thus	RB
46745	2767	42	bring	bring	VB
46745	2767	43	it	-PRON-	PRP
46745	2767	44	to	to	IN
46745	2767	45	a	a	DT
46745	2767	46	desirable	desirable	JJ
46745	2767	47	end	end	NN
46745	2767	48	.	.	.
46745	2768	1	Acting	act	VBG
46745	2768	2	in	in	IN
46745	2768	3	health	health	NN
46745	2768	4	so	so	IN
46745	2768	5	as	as	IN
46745	2768	6	to	to	TO
46745	2768	7	produce	produce	VB
46745	2768	8	a	a	DT
46745	2768	9	morbid	morbid	NN
46745	2768	10	change	change	NN
46745	2768	11	,	,	,
46745	2768	12	it	-PRON-	PRP
46745	2768	13	might	may	MD
46745	2768	14	operate	operate	VB
46745	2768	15	in	in	IN
46745	2768	16	disease	disease	NN
46745	2768	17	by	by	IN
46745	2768	18	means	mean	NNS
46745	2768	19	of	of	IN
46745	2768	20	diverting	divert	VBG
46745	2768	21	into	into	IN
46745	2768	22	a	a	DT
46745	2768	23	right	right	JJ
46745	2768	24	direction	direction	NN
46745	2768	25	a	a	DT
46745	2768	26	change	change	NN
46745	2768	27	that	that	WDT
46745	2768	28	is	be	VBZ
46745	2768	29	already	already	RB
46745	2768	30	going	go	VBG
46745	2768	31	on	on	RP
46745	2768	32	in	in	IN
46745	2768	33	a	a	DT
46745	2768	34	wrong	wrong	JJ
46745	2768	35	one	one	NN
46745	2768	36	.	.	.
46745	2769	1	But	but	CC
46745	2769	2	let	let	VB
46745	2769	3	us	-PRON-	PRP
46745	2769	4	leave	leave	VB
46745	2769	5	generalities	generality	NNS
46745	2769	6	,	,	,
46745	2769	7	and	and	CC
46745	2769	8	descend	descend	VB
46745	2769	9	more	more	JJR
46745	2769	10	into	into	IN
46745	2769	11	particulars	particular	NNS
46745	2769	12	.	.	.
46745	2770	1	Are	be	VBP
46745	2770	2	we	-PRON-	PRP
46745	2770	3	in	in	IN
46745	2770	4	a	a	DT
46745	2770	5	position	position	NN
46745	2770	6	to	to	TO
46745	2770	7	be	be	VB
46745	2770	8	able	able	JJ
46745	2770	9	to	to	TO
46745	2770	10	indicate	indicate	VB
46745	2770	11	the	the	DT
46745	2770	12	actual	actual	JJ
46745	2770	13	nature	nature	NN
46745	2770	14	of	of	IN
46745	2770	15	the	the	DT
46745	2770	16	changes	change	NNS
46745	2770	17	which	which	WDT
46745	2770	18	we	-PRON-	PRP
46745	2770	19	thus	thus	RB
46745	2770	20	assume	assume	VBP
46745	2770	21	to	to	TO
46745	2770	22	be	be	VB
46745	2770	23	probable	probable	JJ
46745	2770	24	?	?	.
46745	2771	1	The	the	DT
46745	2771	2	term	term	NN
46745	2771	3	Fermentation	Fermentation	NNP
46745	2771	4	is	be	VBZ
46745	2771	5	used	use	VBN
46745	2771	6	to	to	TO
46745	2771	7	express	express	VB
46745	2771	8	a	a	DT
46745	2771	9	change	change	NN
46745	2771	10	or	or	CC
46745	2771	11	series	series	NN
46745	2771	12	of	of	IN
46745	2771	13	changes	change	NNS
46745	2771	14	of	of	IN
46745	2771	15	a	a	DT
46745	2771	16	special	special	JJ
46745	2771	17	character	character	NN
46745	2771	18	,	,	,
46745	2771	19	caused	cause	VBN
46745	2771	20	among	among	IN
46745	2771	21	the	the	DT
46745	2771	22	particles	particle	NNS
46745	2771	23	of	of	IN
46745	2771	24	a	a	DT
46745	2771	25	compound	compound	NN
46745	2771	26	body	body	NN
46745	2771	27	,	,	,
46745	2771	28	by	by	IN
46745	2771	29	the	the	DT
46745	2771	30	presence	presence	NN
46745	2771	31	of	of	IN
46745	2771	32	a	a	DT
46745	2771	33	certain	certain	JJ
46745	2771	34	other	other	JJ
46745	2771	35	body	body	NN
46745	2771	36	called	call	VBN
46745	2771	37	a	a	DT
46745	2771	38	Ferment	Ferment	NNP
46745	2771	39	.	.	.
46745	2772	1	There	there	EX
46745	2772	2	are	be	VBP
46745	2772	3	two	two	CD
46745	2772	4	kinds	kind	NNS
46745	2772	5	of	of	IN
46745	2772	6	fermentation	fermentation	NN
46745	2772	7	.	.	.
46745	2773	1	In	in	IN
46745	2773	2	one	one	CD
46745	2773	3	the	the	DT
46745	2773	4	ferment	ferment	NN
46745	2773	5	itself	-PRON-	PRP
46745	2773	6	is	be	VBZ
46745	2773	7	undergoing	undergo	VBG
46745	2773	8	change	change	NN
46745	2773	9	,	,	,
46745	2773	10	and	and	CC
46745	2773	11	impresses	impress	VBZ
46745	2773	12	a	a	DT
46745	2773	13	similar	similar	JJ
46745	2773	14	change	change	NN
46745	2773	15	upon	upon	IN
46745	2773	16	a	a	DT
46745	2773	17	substance	substance	NN
46745	2773	18	which	which	WDT
46745	2773	19	is	be	VBZ
46745	2773	20	analogous	analogous	JJ
46745	2773	21	in	in	IN
46745	2773	22	nature	nature	NN
46745	2773	23	to	to	IN
46745	2773	24	itself	-PRON-	PRP
46745	2773	25	.	.	.
46745	2774	1	[	[	-LRB-
46745	2774	2	39	39	CD
46745	2774	3	]	]	-RRB-
46745	2774	4	The	the	DT
46745	2774	5	process	process	NN
46745	2774	6	caused	cause	VBN
46745	2774	7	by	by	IN
46745	2774	8	a	a	DT
46745	2774	9	contagious	contagious	JJ
46745	2774	10	disorder	disorder	NN
46745	2774	11	would	would	MD
46745	2774	12	probably	probably	RB
46745	2774	13	be	be	VB
46745	2774	14	of	of	IN
46745	2774	15	this	this	DT
46745	2774	16	kind	kind	NN
46745	2774	17	.	.	.
46745	2775	1	Just	just	RB
46745	2775	2	as	as	IN
46745	2775	3	the	the	DT
46745	2775	4	changing	change	VBG
46745	2775	5	yeast	yeast	NN
46745	2775	6	forms	form	NNS
46745	2775	7	and	and	CC
46745	2775	8	increases	increase	VBZ
46745	2775	9	itself	-PRON-	PRP
46745	2775	10	out	out	IN
46745	2775	11	of	of	IN
46745	2775	12	the	the	DT
46745	2775	13	fermenting	ferment	VBG
46745	2775	14	dough	dough	NN
46745	2775	15	,	,	,
46745	2775	16	so	so	RB
46745	2775	17	does	do	VBZ
46745	2775	18	the	the	DT
46745	2775	19	virus	virus	NN
46745	2775	20	of	of	IN
46745	2775	21	such	such	PDT
46745	2775	22	a	a	DT
46745	2775	23	disease	disease	NN
46745	2775	24	renew	renew	NN
46745	2775	25	and	and	CC
46745	2775	26	propagate	propagate	VB
46745	2775	27	itself	-PRON-	PRP
46745	2775	28	out	out	IN
46745	2775	29	of	of	IN
46745	2775	30	the	the	DT
46745	2775	31	particles	particle	NNS
46745	2775	32	of	of	IN
46745	2775	33	the	the	DT
46745	2775	34	blood	blood	NN
46745	2775	35	.	.	.
46745	2776	1	The	the	DT
46745	2776	2	other	other	JJ
46745	2776	3	kind	kind	NN
46745	2776	4	of	of	IN
46745	2776	5	fermentation	fermentation	NN
46745	2776	6	is	be	VBZ
46745	2776	7	simpler	simple	JJR
46745	2776	8	in	in	IN
46745	2776	9	action	action	NN
46745	2776	10	,	,	,
46745	2776	11	but	but	CC
46745	2776	12	more	more	RBR
46745	2776	13	incomprehensible	incomprehensible	JJ
46745	2776	14	in	in	IN
46745	2776	15	character	character	NN
46745	2776	16	.	.	.
46745	2777	1	It	-PRON-	PRP
46745	2777	2	is	be	VBZ
46745	2777	3	produced	produce	VBN
46745	2777	4	by	by	IN
46745	2777	5	mere	mere	JJ
46745	2777	6	contact	contact	NN
46745	2777	7	,	,	,
46745	2777	8	without	without	IN
46745	2777	9	any	any	DT
46745	2777	10	change	change	NN
46745	2777	11	in	in	IN
46745	2777	12	the	the	DT
46745	2777	13	ferment	ferment	NN
46745	2777	14	itself	-PRON-	PRP
46745	2777	15	.	.	.
46745	2778	1	Thus	thus	RB
46745	2778	2	it	-PRON-	PRP
46745	2778	3	is	be	VBZ
46745	2778	4	known	know	VBN
46745	2778	5	to	to	IN
46745	2778	6	chemists	chemist	NNS
46745	2778	7	that	that	WDT
46745	2778	8	spongy	spongy	VBP
46745	2778	9	platinum	platinum	NN
46745	2778	10	causes	cause	VBZ
46745	2778	11	the	the	DT
46745	2778	12	combination	combination	NN
46745	2778	13	of	of	IN
46745	2778	14	oxygen	oxygen	NN
46745	2778	15	and	and	CC
46745	2778	16	hydrogen	hydrogen	NN
46745	2778	17	,	,	,
46745	2778	18	and	and	CC
46745	2778	19	exerts	exert	NNS
46745	2778	20	generally	generally	RB
46745	2778	21	a	a	DT
46745	2778	22	powerful	powerful	JJ
46745	2778	23	influence	influence	NN
46745	2778	24	over	over	IN
46745	2778	25	the	the	DT
46745	2778	26	affinities	affinity	NNS
46745	2778	27	of	of	IN
46745	2778	28	gases	gas	NNS
46745	2778	29	and	and	CC
46745	2778	30	liquids	liquid	NNS
46745	2778	31	,	,	,
46745	2778	32	without	without	IN
46745	2778	33	ever	ever	RB
46745	2778	34	itself	-PRON-	PRP
46745	2778	35	undergoing	undergo	VBG
46745	2778	36	any	any	DT
46745	2778	37	change	change	NN
46745	2778	38	.	.	.
46745	2779	1	The	the	DT
46745	2779	2	influence	influence	NN
46745	2779	3	of	of	IN
46745	2779	4	Emulsine	Emulsine	NNP
46745	2779	5	,	,	,
46745	2779	6	in	in	IN
46745	2779	7	causing	cause	VBG
46745	2779	8	,	,	,
46745	2779	9	by	by	IN
46745	2779	10	mere	mere	JJ
46745	2779	11	contact	contact	NN
46745	2779	12	,	,	,
46745	2779	13	the	the	DT
46745	2779	14	Amygdaline	Amygdaline	NNP
46745	2779	15	in	in	IN
46745	2779	16	the	the	DT
46745	2779	17	bitter	bitter	JJ
46745	2779	18	almond	almond	NN
46745	2779	19	to	to	TO
46745	2779	20	resolve	resolve	VB
46745	2779	21	into	into	IN
46745	2779	22	Prussic	prussic	JJ
46745	2779	23	acid	acid	NN
46745	2779	24	and	and	CC
46745	2779	25	other	other	JJ
46745	2779	26	compounds	compound	NNS
46745	2779	27	;	;	,
46745	2779	28	and	and	CC
46745	2779	29	that	that	DT
46745	2779	30	of	of	IN
46745	2779	31	Pepsin	Pepsin	NNP
46745	2779	32	or	or	CC
46745	2779	33	of	of	IN
46745	2779	34	Ptyaline	Ptyaline	NNP
46745	2779	35	,	,	,
46745	2779	36	in	in	IN
46745	2779	37	promoting	promote	VBG
46745	2779	38	the	the	DT
46745	2779	39	change	change	NN
46745	2779	40	of	of	IN
46745	2779	41	Starch	Starch	NNP
46745	2779	42	into	into	IN
46745	2779	43	Sugar	Sugar	NNP
46745	2779	44	,	,	,
46745	2779	45	is	be	VBZ
46745	2779	46	of	of	IN
46745	2779	47	this	this	DT
46745	2779	48	kind	kind	NN
46745	2779	49	.	.	.
46745	2780	1	Considering	consider	VBG
46745	2780	2	that	that	IN
46745	2780	3	Catalytic	catalytic	JJ
46745	2780	4	medicines	medicine	NNS
46745	2780	5	are	be	VBP
46745	2780	6	not	not	RB
46745	2780	7	by	by	IN
46745	2780	8	their	-PRON-	PRP$
46745	2780	9	nature	nature	NN
46745	2780	10	changing	change	VBG
46745	2780	11	bodies	body	NNS
46745	2780	12	,	,	,
46745	2780	13	being	be	VBG
46745	2780	14	mostly	mostly	RB
46745	2780	15	minerals	mineral	NNS
46745	2780	16	,	,	,
46745	2780	17	it	-PRON-	PRP
46745	2780	18	is	be	VBZ
46745	2780	19	not	not	RB
46745	2780	20	likely	likely	JJ
46745	2780	21	that	that	IN
46745	2780	22	they	-PRON-	PRP
46745	2780	23	could	could	MD
46745	2780	24	cause	cause	VB
46745	2780	25	that	that	DT
46745	2780	26	kind	kind	NN
46745	2780	27	of	of	IN
46745	2780	28	fermentation	fermentation	NN
46745	2780	29	which	which	WDT
46745	2780	30	requires	require	VBZ
46745	2780	31	that	that	IN
46745	2780	32	the	the	DT
46745	2780	33	ferment	ferment	NN
46745	2780	34	itself	-PRON-	PRP
46745	2780	35	should	should	MD
46745	2780	36	be	be	VB
46745	2780	37	in	in	IN
46745	2780	38	a	a	DT
46745	2780	39	state	state	NN
46745	2780	40	of	of	IN
46745	2780	41	change	change	NN
46745	2780	42	.	.	.
46745	2781	1	The	the	DT
46745	2781	2	influence	influence	NN
46745	2781	3	of	of	IN
46745	2781	4	contact	contact	NN
46745	2781	5	is	be	VBZ
46745	2781	6	the	the	DT
46745	2781	7	one	one	CD
46745	2781	8	which	which	WDT
46745	2781	9	they	-PRON-	PRP
46745	2781	10	would	would	MD
46745	2781	11	be	be	VB
46745	2781	12	most	most	RBS
46745	2781	13	calculated	calculated	JJ
46745	2781	14	to	to	TO
46745	2781	15	exert	exert	VB
46745	2781	16	.	.	.
46745	2782	1	I	-PRON-	PRP
46745	2782	2	may	may	MD
46745	2782	3	remark	remark	VB
46745	2782	4	that	that	IN
46745	2782	5	I	-PRON-	PRP
46745	2782	6	have	have	VBP
46745	2782	7	used	use	VBN
46745	2782	8	the	the	DT
46745	2782	9	term	term	NN
46745	2782	10	Catalytic	catalytic	JJ
46745	2782	11	without	without	IN
46745	2782	12	any	any	DT
46745	2782	13	reference	reference	NN
46745	2782	14	or	or	CC
46745	2782	15	allusion	allusion	NN
46745	2782	16	to	to	IN
46745	2782	17	this	this	DT
46745	2782	18	sense	sense	NN
46745	2782	19	,	,	,
46745	2782	20	in	in	IN
46745	2782	21	which	which	WDT
46745	2782	22	it	-PRON-	PRP
46745	2782	23	has	have	VBZ
46745	2782	24	been	be	VBN
46745	2782	25	frequently	frequently	RB
46745	2782	26	employed	employ	VBN
46745	2782	27	,	,	,
46745	2782	28	but	but	CC
46745	2782	29	merely	merely	RB
46745	2782	30	as	as	IN
46745	2782	31	conveniently	conveniently	RB
46745	2782	32	expressive	expressive	JJ
46745	2782	33	of	of	IN
46745	2782	34	undoing	undo	VBG
46745	2782	35	or	or	CC
46745	2782	36	destroying	destroying	NN
46745	2782	37	.	.	.
46745	2783	1	I	-PRON-	PRP
46745	2783	2	would	would	MD
46745	2783	3	not	not	RB
46745	2783	4	wish	wish	VB
46745	2783	5	,	,	,
46745	2783	6	either	either	CC
46745	2783	7	in	in	IN
46745	2783	8	the	the	DT
46745	2783	9	terms	term	NNS
46745	2783	10	or	or	CC
46745	2783	11	in	in	IN
46745	2783	12	the	the	DT
46745	2783	13	propositions	proposition	NNS
46745	2783	14	which	which	WDT
46745	2783	15	I	-PRON-	PRP
46745	2783	16	have	have	VBP
46745	2783	17	adopted	adopt	VBN
46745	2783	18	,	,	,
46745	2783	19	to	to	TO
46745	2783	20	assume	assume	VB
46745	2783	21	for	for	IN
46745	2783	22	granted	grant	VBN
46745	2783	23	any	any	DT
46745	2783	24	thing	thing	NN
46745	2783	25	which	which	WDT
46745	2783	26	is	be	VBZ
46745	2783	27	not	not	RB
46745	2783	28	proved	prove	VBN
46745	2783	29	,	,	,
46745	2783	30	still	still	RB
46745	2783	31	less	less	JJR
46745	2783	32	an	an	DT
46745	2783	33	idea	idea	NN
46745	2783	34	which	which	WDT
46745	2783	35	is	be	VBZ
46745	2783	36	purely	purely	RB
46745	2783	37	hypothetical	hypothetical	JJ
46745	2783	38	.	.	.
46745	2784	1	But	but	CC
46745	2784	2	it	-PRON-	PRP
46745	2784	3	is	be	VBZ
46745	2784	4	not	not	RB
46745	2784	5	very	very	RB
46745	2784	6	unlikely	unlikely	JJ
46745	2784	7	that	that	IN
46745	2784	8	some	some	DT
46745	2784	9	of	of	IN
46745	2784	10	these	these	DT
46745	2784	11	medicines	medicine	NNS
46745	2784	12	may	may	MD
46745	2784	13	act	act	VB
46745	2784	14	in	in	IN
46745	2784	15	a	a	DT
46745	2784	16	mode	mode	NN
46745	2784	17	which	which	WDT
46745	2784	18	is	be	VBZ
46745	2784	19	more	more	RBR
46745	2784	20	or	or	CC
46745	2784	21	less	less	RBR
46745	2784	22	analogous	analogous	JJ
46745	2784	23	to	to	IN
46745	2784	24	an	an	DT
46745	2784	25	action	action	NN
46745	2784	26	of	of	IN
46745	2784	27	fermentation	fermentation	NN
46745	2784	28	of	of	IN
46745	2784	29	the	the	DT
46745	2784	30	kind	kind	NN
46745	2784	31	just	just	RB
46745	2784	32	described	describe	VBN
46745	2784	33	.	.	.
46745	2785	1	They	-PRON-	PRP
46745	2785	2	might	may	MD
46745	2785	3	then	then	RB
46745	2785	4	either	either	RB
46745	2785	5	cause	cause	VB
46745	2785	6	change	change	VB
46745	2785	7	themselves	-PRON-	PRP
46745	2785	8	,	,	,
46745	2785	9	and	and	CC
46745	2785	10	by	by	IN
46745	2785	11	this	this	DT
46745	2785	12	means	mean	VBZ
46745	2785	13	alter	alter	VB
46745	2785	14	and	and	CC
46745	2785	15	destroy	destroy	VB
46745	2785	16	a	a	DT
46745	2785	17	morbid	morbid	NN
46745	2785	18	process	process	NN
46745	2785	19	somewhat	somewhat	RB
46745	2785	20	similar	similar	JJ
46745	2785	21	to	to	IN
46745	2785	22	that	that	DT
46745	2785	23	which	which	WDT
46745	2785	24	they	-PRON-	PRP
46745	2785	25	themselves	-PRON-	PRP
46745	2785	26	excite	excite	VBP
46745	2785	27	;	;	:
46745	2785	28	or	or	CC
46745	2785	29	they	-PRON-	PRP
46745	2785	30	might	may	MD
46745	2785	31	,	,	,
46745	2785	32	by	by	IN
46745	2785	33	simple	simple	JJ
46745	2785	34	contact	contact	NN
46745	2785	35	,	,	,
46745	2785	36	be	be	VB
46745	2785	37	able	able	JJ
46745	2785	38	to	to	TO
46745	2785	39	resolve	resolve	VB
46745	2785	40	this	this	DT
46745	2785	41	process	process	NN
46745	2785	42	into	into	IN
46745	2785	43	a	a	DT
46745	2785	44	natural	natural	JJ
46745	2785	45	direction	direction	NN
46745	2785	46	.	.	.
46745	2786	1	We	-PRON-	PRP
46745	2786	2	have	have	VBP
46745	2786	3	seen	see	VBN
46745	2786	4	that	that	IN
46745	2786	5	when	when	WRB
46745	2786	6	introduced	introduce	VBN
46745	2786	7	into	into	IN
46745	2786	8	healthy	healthy	JJ
46745	2786	9	blood	blood	NN
46745	2786	10	,	,	,
46745	2786	11	they	-PRON-	PRP
46745	2786	12	invariably	invariably	RB
46745	2786	13	tend	tend	VBP
46745	2786	14	to	to	TO
46745	2786	15	produce	produce	VB
46745	2786	16	a	a	DT
46745	2786	17	change	change	NN
46745	2786	18	in	in	IN
46745	2786	19	it	-PRON-	PRP
46745	2786	20	which	which	WDT
46745	2786	21	is	be	VBZ
46745	2786	22	productive	productive	JJ
46745	2786	23	of	of	IN
46745	2786	24	harm	harm	NN
46745	2786	25	;	;	:
46745	2786	26	but	but	CC
46745	2786	27	that	that	IN
46745	2786	28	when	when	WRB
46745	2786	29	there	there	EX
46745	2786	30	is	be	VBZ
46745	2786	31	already	already	RB
46745	2786	32	an	an	DT
46745	2786	33	abnormal	abnormal	JJ
46745	2786	34	process	process	NN
46745	2786	35	going	go	VBG
46745	2786	36	on	on	RB
46745	2786	37	there	there	RB
46745	2786	38	,	,	,
46745	2786	39	their	-PRON-	PRP$
46745	2786	40	influence	influence	NN
46745	2786	41	will	will	MD
46745	2786	42	effect	effect	VB
46745	2786	43	the	the	DT
46745	2786	44	subversion	subversion	NN
46745	2786	45	or	or	CC
46745	2786	46	annihilation	annihilation	NN
46745	2786	47	of	of	IN
46745	2786	48	this	this	DT
46745	2786	49	other	other	JJ
46745	2786	50	process	process	NN
46745	2786	51	.	.	.
46745	2787	1	And	and	CC
46745	2787	2	there	there	EX
46745	2787	3	are	be	VBP
46745	2787	4	certain	certain	JJ
46745	2787	5	physiological	physiological	JJ
46745	2787	6	considerations	consideration	NNS
46745	2787	7	that	that	WDT
46745	2787	8	render	render	VBP
46745	2787	9	such	such	PDT
46745	2787	10	an	an	DT
46745	2787	11	idea	idea	NN
46745	2787	12	still	still	RB
46745	2787	13	more	more	RBR
46745	2787	14	intelligible	intelligible	JJ
46745	2787	15	and	and	CC
46745	2787	16	plausible	plausible	JJ
46745	2787	17	.	.	.
46745	2788	1	It	-PRON-	PRP
46745	2788	2	is	be	VBZ
46745	2788	3	to	to	TO
46745	2788	4	be	be	VB
46745	2788	5	remembered	remember	VBN
46745	2788	6	that	that	IN
46745	2788	7	the	the	DT
46745	2788	8	blood	blood	NN
46745	2788	9	,	,	,
46745	2788	10	in	in	IN
46745	2788	11	which	which	WDT
46745	2788	12	we	-PRON-	PRP
46745	2788	13	suppose	suppose	VBP
46745	2788	14	such	such	JJ
46745	2788	15	actions	action	NNS
46745	2788	16	to	to	TO
46745	2788	17	go	go	VB
46745	2788	18	on	on	RB
46745	2788	19	,	,	,
46745	2788	20	is	be	VBZ
46745	2788	21	not	not	RB
46745	2788	22	an	an	DT
46745	2788	23	ordinary	ordinary	JJ
46745	2788	24	chemical	chemical	NN
46745	2788	25	fluid	fluid	NN
46745	2788	26	,	,	,
46745	2788	27	subject	subject	JJ
46745	2788	28	to	to	IN
46745	2788	29	common	common	JJ
46745	2788	30	laws	law	NNS
46745	2788	31	,	,	,
46745	2788	32	and	and	CC
46745	2788	33	influences	influence	NNS
46745	2788	34	,	,	,
46745	2788	35	such	such	JJ
46745	2788	36	as	as	IN
46745	2788	37	we	-PRON-	PRP
46745	2788	38	may	may	MD
46745	2788	39	meet	meet	VB
46745	2788	40	with	with	IN
46745	2788	41	out	out	IN
46745	2788	42	of	of	IN
46745	2788	43	the	the	DT
46745	2788	44	body	body	NN
46745	2788	45	;	;	:
46745	2788	46	but	but	CC
46745	2788	47	a	a	DT
46745	2788	48	very	very	RB
46745	2788	49	complicated	complicated	JJ
46745	2788	50	mixture	mixture	NN
46745	2788	51	,	,	,
46745	2788	52	which	which	WDT
46745	2788	53	is	be	VBZ
46745	2788	54	ever	ever	RB
46745	2788	55	circulating	circulate	VBG
46745	2788	56	and	and	CC
46745	2788	57	being	be	VBG
46745	2788	58	maintained	maintain	VBN
46745	2788	59	at	at	IN
46745	2788	60	a	a	DT
46745	2788	61	high	high	JJ
46745	2788	62	temperature	temperature	NN
46745	2788	63	,	,	,
46745	2788	64	and	and	CC
46745	2788	65	contains	contain	VBZ
46745	2788	66	a	a	DT
46745	2788	67	number	number	NN
46745	2788	68	of	of	IN
46745	2788	69	compound	compound	JJ
46745	2788	70	organic	organic	JJ
46745	2788	71	bodies	body	NNS
46745	2788	72	,	,	,
46745	2788	73	each	each	DT
46745	2788	74	of	of	IN
46745	2788	75	which	which	WDT
46745	2788	76	is	be	VBZ
46745	2788	77	liable	liable	JJ
46745	2788	78	to	to	IN
46745	2788	79	a	a	DT
46745	2788	80	series	series	NN
46745	2788	81	of	of	IN
46745	2788	82	varied	varied	JJ
46745	2788	83	metamorphoses	metamorphosis	NNS
46745	2788	84	.	.	.
46745	2789	1	It	-PRON-	PRP
46745	2789	2	is	be	VBZ
46745	2789	3	not	not	RB
46745	2789	4	a	a	DT
46745	2789	5	very	very	RB
46745	2789	6	potent	potent	JJ
46745	2789	7	agency	agency	NN
46745	2789	8	which	which	WDT
46745	2789	9	is	be	VBZ
46745	2789	10	needed	need	VBN
46745	2789	11	to	to	TO
46745	2789	12	disturb	disturb	VB
46745	2789	13	the	the	DT
46745	2789	14	chain	chain	NN
46745	2789	15	of	of	IN
46745	2789	16	conditions	condition	NNS
46745	2789	17	of	of	IN
46745	2789	18	one	one	CD
46745	2789	19	of	of	IN
46745	2789	20	those	those	DT
46745	2789	21	inconstant	inconstant	JJ
46745	2789	22	bodies	body	NNS
46745	2789	23	which	which	WDT
46745	2789	24	is	be	VBZ
46745	2789	25	thus	thus	RB
46745	2789	26	continually	continually	RB
46745	2789	27	performing	perform	VBG
46745	2789	28	the	the	DT
46745	2789	29	circuit	circuit	NN
46745	2789	30	of	of	IN
46745	2789	31	the	the	DT
46745	2789	32	system	system	NN
46745	2789	33	.	.	.
46745	2790	1	I	-PRON-	PRP
46745	2790	2	may	may	MD
46745	2790	3	briefly	briefly	RB
46745	2790	4	exemplify	exemplify	VB
46745	2790	5	the	the	DT
46745	2790	6	series	series	NN
46745	2790	7	of	of	IN
46745	2790	8	changes	change	NNS
46745	2790	9	,	,	,
46745	2790	10	simple	simple	JJ
46745	2790	11	but	but	CC
46745	2790	12	momentous	momentous	JJ
46745	2790	13	,	,	,
46745	2790	14	which	which	WDT
46745	2790	15	an	an	DT
46745	2790	16	organic	organic	JJ
46745	2790	17	body	body	NN
46745	2790	18	is	be	VBZ
46745	2790	19	capable	capable	JJ
46745	2790	20	of	of	IN
46745	2790	21	undergoing	undergo	VBG
46745	2790	22	,	,	,
46745	2790	23	if	if	IN
46745	2790	24	I	-PRON-	PRP
46745	2790	25	instance	instance	VBP
46745	2790	26	the	the	DT
46745	2790	27	combination	combination	NN
46745	2790	28	of	of	IN
46745	2790	29	elements	element	NNS
46745	2790	30	which	which	WDT
46745	2790	31	constitutes	constitute	VBZ
46745	2790	32	Urea	Urea	NNP
46745	2790	33	.	.	.
46745	2791	1	By	by	IN
46745	2791	2	bringing	bring	VBG
46745	2791	3	Ammoniacal	ammoniacal	JJ
46745	2791	4	gas	gas	NN
46745	2791	5	in	in	IN
46745	2791	6	contact	contact	NN
46745	2791	7	with	with	IN
46745	2791	8	the	the	DT
46745	2791	9	vapour	vapour	NN
46745	2791	10	of	of	IN
46745	2791	11	Cyanic	cyanic	JJ
46745	2791	12	acid	acid	NN
46745	2791	13	,	,	,
46745	2791	14	we	-PRON-	PRP
46745	2791	15	produce	produce	VBP
46745	2791	16	Cyanate	Cyanate	NNP
46745	2791	17	of	of	IN
46745	2791	18	Ammonia	Ammonia	NNP
46745	2791	19	,	,	,
46745	2791	20	a	a	DT
46745	2791	21	poisonous	poisonous	JJ
46745	2791	22	salt	salt	NN
46745	2791	23	.	.	.
46745	2792	1	This	this	DT
46745	2792	2	,	,	,
46745	2792	3	when	when	WRB
46745	2792	4	exposed	expose	VBN
46745	2792	5	for	for	IN
46745	2792	6	some	some	DT
46745	2792	7	time	time	NN
46745	2792	8	to	to	IN
46745	2792	9	the	the	DT
46745	2792	10	air	air	NN
46745	2792	11	,	,	,
46745	2792	12	changes	change	VBZ
46745	2792	13	into	into	IN
46745	2792	14	Urea	Urea	NNP
46745	2792	15	,	,	,
46745	2792	16	which	which	WDT
46745	2792	17	is	be	VBZ
46745	2792	18	isomeric	isomeric	JJ
46745	2792	19	with	with	IN
46745	2792	20	it	-PRON-	PRP
46745	2792	21	,	,	,
46745	2792	22	but	but	CC
46745	2792	23	comparatively	comparatively	RB
46745	2792	24	innocuous	innocuous	JJ
46745	2792	25	.	.	.
46745	2793	1	Urea	Urea	NNP
46745	2793	2	,	,	,
46745	2793	3	when	when	WRB
46745	2793	4	heated	heat	VBN
46745	2793	5	,	,	,
46745	2793	6	gives	give	VBZ
46745	2793	7	off	off	RP
46745	2793	8	Ammonia	Ammonia	NNP
46745	2793	9	,	,	,
46745	2793	10	and	and	CC
46745	2793	11	becomes	become	VBZ
46745	2793	12	Cyanuric	Cyanuric	NNP
46745	2793	13	acid	acid	NN
46745	2793	14	.	.	.
46745	2794	1	On	on	IN
46745	2794	2	again	again	RB
46745	2794	3	heating	heat	VBG
46745	2794	4	this	this	DT
46745	2794	5	,	,	,
46745	2794	6	hydrated	hydrated	JJ
46745	2794	7	Cyanic	cyanic	JJ
46745	2794	8	acid	acid	NN
46745	2794	9	sublimes	sublime	NNS
46745	2794	10	.	.	.
46745	2795	1	This	this	DT
46745	2795	2	,	,	,
46745	2795	3	when	when	WRB
46745	2795	4	brought	bring	VBN
46745	2795	5	in	in	RP
46745	2795	6	contact	contact	NN
46745	2795	7	with	with	IN
46745	2795	8	water	water	NN
46745	2795	9	,	,	,
46745	2795	10	becomes	become	VBZ
46745	2795	11	Bicarbonate	Bicarbonate	NNP
46745	2795	12	of	of	IN
46745	2795	13	Ammonia	Ammonia	NNP
46745	2795	14	.	.	.
46745	2796	1	Two	two	CD
46745	2796	2	equivalents	equivalent	NNS
46745	2796	3	of	of	IN
46745	2796	4	Cyanic	cyanic	JJ
46745	2796	5	acid	acid	NN
46745	2796	6	,	,	,
46745	2796	7	uniting	unite	VBG
46745	2796	8	in	in	IN
46745	2796	9	one	one	CD
46745	2796	10	compound	compound	NN
46745	2796	11	,	,	,
46745	2796	12	produce	produce	VBP
46745	2796	13	Fulminic	Fulminic	NNP
46745	2796	14	acid	acid	NN
46745	2796	15	.	.	.
46745	2797	1	This	this	DT
46745	2797	2	,	,	,
46745	2797	3	if	if	IN
46745	2797	4	combined	combine	VBN
46745	2797	5	with	with	IN
46745	2797	6	the	the	DT
46745	2797	7	oxide	oxide	NN
46745	2797	8	of	of	IN
46745	2797	9	Silver	silver	NN
46745	2797	10	or	or	CC
46745	2797	11	of	of	IN
46745	2797	12	Mercury	Mercury	NNP
46745	2797	13	,	,	,
46745	2797	14	forms	form	VBZ
46745	2797	15	a	a	DT
46745	2797	16	compound	compound	NN
46745	2797	17	which	which	WDT
46745	2797	18	is	be	VBZ
46745	2797	19	caused	cause	VBN
46745	2797	20	by	by	IN
46745	2797	21	the	the	DT
46745	2797	22	slightest	slight	JJS
46745	2797	23	friction	friction	NN
46745	2797	24	to	to	TO
46745	2797	25	explode	explode	VB
46745	2797	26	with	with	IN
46745	2797	27	terrific	terrific	JJ
46745	2797	28	violence	violence	NN
46745	2797	29	.	.	.
46745	2798	1	If	if	IN
46745	2798	2	to	to	IN
46745	2798	3	the	the	DT
46745	2798	4	elements	element	NNS
46745	2798	5	of	of	IN
46745	2798	6	this	this	DT
46745	2798	7	dangerous	dangerous	JJ
46745	2798	8	acid	acid	NN
46745	2798	9	be	be	VB
46745	2798	10	added	add	VBN
46745	2798	11	those	those	DT
46745	2798	12	of	of	IN
46745	2798	13	two	two	CD
46745	2798	14	equivalents	equivalent	NNS
46745	2798	15	of	of	IN
46745	2798	16	Ammonia	Ammonia	NNP
46745	2798	17	,	,	,
46745	2798	18	we	-PRON-	PRP
46745	2798	19	again	again	RB
46745	2798	20	have	have	VBP
46745	2798	21	Urea	Urea	NNP
46745	2798	22	,	,	,
46745	2798	23	a	a	DT
46745	2798	24	substance	substance	NN
46745	2798	25	which	which	WDT
46745	2798	26	is	be	VBZ
46745	2798	27	continually	continually	RB
46745	2798	28	forming	form	VBG
46745	2798	29	in	in	IN
46745	2798	30	the	the	DT
46745	2798	31	body	body	NN
46745	2798	32	by	by	IN
46745	2798	33	the	the	DT
46745	2798	34	oxidation	oxidation	NN
46745	2798	35	of	of	IN
46745	2798	36	some	some	DT
46745	2798	37	of	of	IN
46745	2798	38	the	the	DT
46745	2798	39	nitrogenous	nitrogenous	JJ
46745	2798	40	tissues.--Urea	tissues.--urea	CD
46745	2798	41	with	with	IN
46745	2798	42	water	water	NN
46745	2798	43	changes	change	NNS
46745	2798	44	lastly	lastly	RB
46745	2798	45	into	into	IN
46745	2798	46	Carbonate	Carbonate	NNP
46745	2798	47	of	of	IN
46745	2798	48	Ammonia	Ammonia	NNP
46745	2798	49	.	.	.
46745	2799	1	These	these	DT
46745	2799	2	several	several	JJ
46745	2799	3	compounds	compound	NNS
46745	2799	4	,	,	,
46745	2799	5	alike	alike	RB
46745	2799	6	or	or	CC
46745	2799	7	identical	identical	JJ
46745	2799	8	in	in	IN
46745	2799	9	their	-PRON-	PRP$
46745	2799	10	ultimate	ultimate	JJ
46745	2799	11	composition	composition	NN
46745	2799	12	,	,	,
46745	2799	13	are	be	VBP
46745	2799	14	possessed	possess	VBN
46745	2799	15	of	of	IN
46745	2799	16	very	very	RB
46745	2799	17	different	different	JJ
46745	2799	18	properties	property	NNS
46745	2799	19	,	,	,
46745	2799	20	whether	whether	IN
46745	2799	21	regarded	regard	VBN
46745	2799	22	as	as	IN
46745	2799	23	medicinal	medicinal	JJ
46745	2799	24	or	or	CC
46745	2799	25	as	as	IN
46745	2799	26	chemical	chemical	JJ
46745	2799	27	agents	agent	NNS
46745	2799	28	.	.	.
46745	2800	1	A	a	DT
46745	2800	2	similar	similar	JJ
46745	2800	3	set	set	NN
46745	2800	4	of	of	IN
46745	2800	5	changes	change	NNS
46745	2800	6	may	may	MD
46745	2800	7	be	be	VB
46745	2800	8	produced	produce	VBN
46745	2800	9	among	among	IN
46745	2800	10	the	the	DT
46745	2800	11	elements	element	NNS
46745	2800	12	of	of	IN
46745	2800	13	Uric	Uric	NNP
46745	2800	14	acid	acid	NN
46745	2800	15	,	,	,
46745	2800	16	also	also	RB
46745	2800	17	an	an	DT
46745	2800	18	animal	animal	NN
46745	2800	19	product	product	NN
46745	2800	20	.	.	.
46745	2801	1	Changes	change	NNS
46745	2801	2	in	in	IN
46745	2801	3	some	some	DT
46745	2801	4	respect	respect	NN
46745	2801	5	similar	similar	JJ
46745	2801	6	to	to	IN
46745	2801	7	these	these	DT
46745	2801	8	which	which	WDT
46745	2801	9	are	be	VBP
46745	2801	10	produced	produce	VBN
46745	2801	11	by	by	IN
46745	2801	12	the	the	DT
46745	2801	13	Chemist	Chemist	NNP
46745	2801	14	are	be	VBP
46745	2801	15	no	no	RB
46745	2801	16	doubt	doubt	RB
46745	2801	17	continually	continually	RB
46745	2801	18	going	go	VBG
46745	2801	19	on	on	RP
46745	2801	20	,	,	,
46745	2801	21	or	or	CC
46745	2801	22	capable	capable	JJ
46745	2801	23	of	of	IN
46745	2801	24	being	be	VBG
46745	2801	25	set	set	VBN
46745	2801	26	up	up	RP
46745	2801	27	by	by	IN
46745	2801	28	various	various	JJ
46745	2801	29	influences	influence	NNS
46745	2801	30	,	,	,
46745	2801	31	in	in	IN
46745	2801	32	the	the	DT
46745	2801	33	circulating	circulate	VBG
46745	2801	34	blood	blood	NN
46745	2801	35	,	,	,
46745	2801	36	which	which	WDT
46745	2801	37	is	be	VBZ
46745	2801	38	at	at	IN
46745	2801	39	a	a	DT
46745	2801	40	heat	heat	NN
46745	2801	41	fit	fit	JJ
46745	2801	42	for	for	IN
46745	2801	43	such	such	JJ
46745	2801	44	processes	process	NNS
46745	2801	45	;	;	:
46745	2801	46	in	in	IN
46745	2801	47	which	which	WDT
46745	2801	48	also	also	RB
46745	2801	49	is	be	VBZ
46745	2801	50	a	a	DT
46745	2801	51	considerable	considerable	JJ
46745	2801	52	quantity	quantity	NN
46745	2801	53	of	of	IN
46745	2801	54	free	free	JJ
46745	2801	55	oxygen	oxygen	NN
46745	2801	56	,	,	,
46745	2801	57	as	as	RB
46745	2801	58	well	well	RB
46745	2801	59	as	as	IN
46745	2801	60	soda	soda	NN
46745	2801	61	,	,	,
46745	2801	62	ammonia	ammonia	NNP
46745	2801	63	,	,	,
46745	2801	64	and	and	CC
46745	2801	65	other	other	JJ
46745	2801	66	elements	element	NNS
46745	2801	67	,	,	,
46745	2801	68	in	in	IN
46745	2801	69	a	a	DT
46745	2801	70	state	state	NN
46745	2801	71	fit	fit	NN
46745	2801	72	for	for	IN
46745	2801	73	combination	combination	NN
46745	2801	74	;	;	:
46745	2801	75	and	and	CC
46745	2801	76	to	to	IN
46745	2801	77	all	all	PDT
46745	2801	78	these	these	DT
46745	2801	79	is	be	VBZ
46745	2801	80	superadded	superadde	VBN
46745	2801	81	the	the	DT
46745	2801	82	agency	agency	NN
46745	2801	83	of	of	IN
46745	2801	84	the	the	DT
46745	2801	85	vital	vital	JJ
46745	2801	86	principle	principle	NN
46745	2801	87	,	,	,
46745	2801	88	the	the	DT
46745	2801	89	object	object	NN
46745	2801	90	and	and	CC
46745	2801	91	effect	effect	NN
46745	2801	92	of	of	IN
46745	2801	93	which	which	WDT
46745	2801	94	is	be	VBZ
46745	2801	95	continual	continual	JJ
46745	2801	96	alteration	alteration	NN
46745	2801	97	,	,	,
46745	2801	98	destruction	destruction	NN
46745	2801	99	and	and	CC
46745	2801	100	reproduction	reproduction	NN
46745	2801	101	.	.	.
46745	2802	1	By	by	IN
46745	2802	2	supposing	suppose	VBG
46745	2802	3	the	the	DT
46745	2802	4	establishment	establishment	NN
46745	2802	5	of	of	IN
46745	2802	6	a	a	DT
46745	2802	7	set	set	NN
46745	2802	8	of	of	IN
46745	2802	9	changes	change	NNS
46745	2802	10	in	in	IN
46745	2802	11	the	the	DT
46745	2802	12	blood	blood	NN
46745	2802	13	,	,	,
46745	2802	14	we	-PRON-	PRP
46745	2802	15	may	may	MD
46745	2802	16	possibly	possibly	RB
46745	2802	17	gain	gain	VB
46745	2802	18	some	some	DT
46745	2802	19	insight	insight	NN
46745	2802	20	into	into	IN
46745	2802	21	the	the	DT
46745	2802	22	cause	cause	NN
46745	2802	23	of	of	IN
46745	2802	24	the	the	DT
46745	2802	25	powerful	powerful	JJ
46745	2802	26	effects	effect	NNS
46745	2802	27	of	of	IN
46745	2802	28	some	some	DT
46745	2802	29	apparently	apparently	RB
46745	2802	30	insignificant	insignificant	JJ
46745	2802	31	medicines	medicine	NNS
46745	2802	32	belonging	belong	VBG
46745	2802	33	to	to	IN
46745	2802	34	this	this	DT
46745	2802	35	division	division	NN
46745	2802	36	of	of	IN
46745	2802	37	Hæmatics	Hæmatics	NNP
46745	2802	38	.	.	.
46745	2803	1	Neurotic	neurotic	JJ
46745	2803	2	medicines	medicine	NNS
46745	2803	3	appear	appear	VBP
46745	2803	4	to	to	TO
46745	2803	5	act	act	VB
46745	2803	6	by	by	IN
46745	2803	7	their	-PRON-	PRP$
46745	2803	8	mere	mere	JJ
46745	2803	9	presence	presence	NN
46745	2803	10	,	,	,
46745	2803	11	contact	contact	NN
46745	2803	12	and	and	CC
46745	2803	13	excitation	excitation	NN
46745	2803	14	.	.	.
46745	2804	1	This	this	DT
46745	2804	2	may	may	MD
46745	2804	3	not	not	RB
46745	2804	4	always	always	RB
46745	2804	5	be	be	VB
46745	2804	6	the	the	DT
46745	2804	7	case	case	NN
46745	2804	8	with	with	IN
46745	2804	9	Catalytics	Catalytics	NNP
46745	2804	10	.	.	.
46745	2805	1	Their	-PRON-	PRP$
46745	2805	2	power	power	NN
46745	2805	3	can	can	MD
46745	2805	4	not	not	RB
46745	2805	5	in	in	IN
46745	2805	6	all	all	DT
46745	2805	7	cases	case	NNS
46745	2805	8	be	be	VB
46745	2805	9	clearly	clearly	RB
46745	2805	10	accounted	account	VBN
46745	2805	11	for	for	IN
46745	2805	12	by	by	IN
46745	2805	13	a	a	DT
46745	2805	14	simple	simple	JJ
46745	2805	15	and	and	CC
46745	2805	16	direct	direct	JJ
46745	2805	17	influence	influence	NN
46745	2805	18	on	on	IN
46745	2805	19	the	the	DT
46745	2805	20	blood	blood	NN
46745	2805	21	,	,	,
46745	2805	22	the	the	DT
46745	2805	23	muscles	muscle	NNS
46745	2805	24	,	,	,
46745	2805	25	the	the	DT
46745	2805	26	nerves	nerve	NNS
46745	2805	27	,	,	,
46745	2805	28	or	or	CC
46745	2805	29	any	any	DT
46745	2805	30	of	of	IN
46745	2805	31	the	the	DT
46745	2805	32	tissues	tissue	NNS
46745	2805	33	.	.	.
46745	2806	1	It	-PRON-	PRP
46745	2806	2	seems	seem	VBZ
46745	2806	3	sometimes	sometimes	RB
46745	2806	4	as	as	IN
46745	2806	5	if	if	IN
46745	2806	6	it	-PRON-	PRP
46745	2806	7	were	be	VBD
46745	2806	8	on	on	IN
46745	2806	9	the	the	DT
46745	2806	10	processes	process	NNS
46745	2806	11	that	that	WDT
46745	2806	12	their	-PRON-	PRP$
46745	2806	13	presence	presence	NN
46745	2806	14	sets	set	NNS
46745	2806	15	going	go	VBG
46745	2806	16	,	,	,
46745	2806	17	and	and	CC
46745	2806	18	on	on	IN
46745	2806	19	the	the	DT
46745	2806	20	products	product	NNS
46745	2806	21	thus	thus	RB
46745	2806	22	generated	generate	VBN
46745	2806	23	,	,	,
46745	2806	24	that	that	IN
46745	2806	25	their	-PRON-	PRP$
46745	2806	26	influence	influence	NN
46745	2806	27	and	and	CC
46745	2806	28	power	power	NN
46745	2806	29	depend	depend	VBP
46745	2806	30	.	.	.
46745	2807	1	It	-PRON-	PRP
46745	2807	2	may	may	MD
46745	2807	3	be	be	VB
46745	2807	4	observed	observe	VBN
46745	2807	5	that	that	IN
46745	2807	6	this	this	DT
46745	2807	7	idea	idea	NN
46745	2807	8	of	of	IN
46745	2807	9	action	action	NN
46745	2807	10	by	by	IN
46745	2807	11	contact	contact	NN
46745	2807	12	can	can	MD
46745	2807	13	not	not	RB
46745	2807	14	by	by	IN
46745	2807	15	any	any	DT
46745	2807	16	means	mean	NNS
46745	2807	17	be	be	VB
46745	2807	18	supposed	suppose	VBN
46745	2807	19	to	to	TO
46745	2807	20	favour	favour	VB
46745	2807	21	the	the	DT
46745	2807	22	very	very	RB
46745	2807	23	unreasonable	unreasonable	JJ
46745	2807	24	theory	theory	NN
46745	2807	25	of	of	IN
46745	2807	26	the	the	DT
46745	2807	27	efficacy	efficacy	NN
46745	2807	28	of	of	IN
46745	2807	29	infinitesimal	infinitesimal	JJ
46745	2807	30	doses	dose	NNS
46745	2807	31	of	of	IN
46745	2807	32	drugs	drug	NNS
46745	2807	33	.	.	.
46745	2808	1	For	for	IN
46745	2808	2	such	such	JJ
46745	2808	3	medicines	medicine	NNS
46745	2808	4	must	must	MD
46745	2808	5	of	of	IN
46745	2808	6	necessity	necessity	NN
46745	2808	7	be	be	VB
46745	2808	8	present	present	JJ
46745	2808	9	in	in	IN
46745	2808	10	some	some	DT
46745	2808	11	amount	amount	NN
46745	2808	12	,	,	,
46745	2808	13	or	or	CC
46745	2808	14	they	-PRON-	PRP
46745	2808	15	can	can	MD
46745	2808	16	not	not	RB
46745	2808	17	act	act	VB
46745	2808	18	at	at	RB
46745	2808	19	all	all	RB
46745	2808	20	.	.	.
46745	2809	1	Their	-PRON-	PRP$
46745	2809	2	operation	operation	NN
46745	2809	3	can	can	MD
46745	2809	4	not	not	RB
46745	2809	5	be	be	VB
46745	2809	6	like	like	IN
46745	2809	7	that	that	DT
46745	2809	8	of	of	IN
46745	2809	9	the	the	DT
46745	2809	10	putrefying	putrefying	NN
46745	2809	11	yeast	yeast	NN
46745	2809	12	,	,	,
46745	2809	13	or	or	CC
46745	2809	14	of	of	IN
46745	2809	15	the	the	DT
46745	2809	16	poisons	poison	NNS
46745	2809	17	of	of	IN
46745	2809	18	contagious	contagious	JJ
46745	2809	19	fevers	fever	NNS
46745	2809	20	,	,	,
46745	2809	21	each	each	DT
46745	2809	22	of	of	IN
46745	2809	23	which	which	WDT
46745	2809	24	can	can	MD
46745	2809	25	reproduce	reproduce	VB
46745	2809	26	itself	-PRON-	PRP
46745	2809	27	out	out	IN
46745	2809	28	of	of	IN
46745	2809	29	the	the	DT
46745	2809	30	elements	element	NNS
46745	2809	31	of	of	IN
46745	2809	32	the	the	DT
46745	2809	33	changing	change	VBG
46745	2809	34	or	or	CC
46745	2809	35	fermenting	ferment	VBG
46745	2809	36	body	body	NN
46745	2809	37	.	.	.
46745	2810	1	For	for	IN
46745	2810	2	Antimony	Antimony	NNP
46745	2810	3	,	,	,
46745	2810	4	Mercury	Mercury	NNP
46745	2810	5	,	,	,
46745	2810	6	and	and	CC
46745	2810	7	Iodine	Iodine	NNP
46745	2810	8	could	could	MD
46745	2810	9	never	never	RB
46745	2810	10	make	make	VB
46745	2810	11	themselves	-PRON-	PRP
46745	2810	12	out	out	IN
46745	2810	13	of	of	IN
46745	2810	14	blood	blood	NN
46745	2810	15	,	,	,
46745	2810	16	which	which	WDT
46745	2810	17	does	do	VBZ
46745	2810	18	not	not	RB
46745	2810	19	contain	contain	VB
46745	2810	20	them	-PRON-	PRP
46745	2810	21	.	.	.
46745	2811	1	Like	like	IN
46745	2811	2	the	the	DT
46745	2811	3	Emulsine	Emulsine	NNP
46745	2811	4	in	in	IN
46745	2811	5	the	the	DT
46745	2811	6	production	production	NN
46745	2811	7	of	of	IN
46745	2811	8	Hydrocyanic	hydrocyanic	JJ
46745	2811	9	acid	acid	NN
46745	2811	10	out	out	IN
46745	2811	11	of	of	IN
46745	2811	12	the	the	DT
46745	2811	13	material	material	NN
46745	2811	14	of	of	IN
46745	2811	15	the	the	DT
46745	2811	16	bitter	bitter	JJ
46745	2811	17	almond	almond	NN
46745	2811	18	,	,	,
46745	2811	19	they	-PRON-	PRP
46745	2811	20	must	must	MD
46745	2811	21	be	be	VB
46745	2811	22	present	present	JJ
46745	2811	23	in	in	IN
46745	2811	24	certain	certain	JJ
46745	2811	25	quantity	quantity	NN
46745	2811	26	,	,	,
46745	2811	27	or	or	CC
46745	2811	28	they	-PRON-	PRP
46745	2811	29	are	be	VBP
46745	2811	30	quite	quite	RB
46745	2811	31	inoperative	inoperative	JJ
46745	2811	32	.	.	.
46745	2812	1	Even	even	RB
46745	2812	2	a	a	DT
46745	2812	3	tenth	tenth	NN
46745	2812	4	of	of	IN
46745	2812	5	a	a	DT
46745	2812	6	grain	grain	NN
46745	2812	7	would	would	MD
46745	2812	8	generally	generally	RB
46745	2812	9	be	be	VB
46745	2812	10	powerless	powerless	JJ
46745	2812	11	,	,	,
46745	2812	12	not	not	RB
46745	2812	13	to	to	TO
46745	2812	14	mention	mention	VB
46745	2812	15	such	such	JJ
46745	2812	16	irrational	irrational	JJ
46745	2812	17	quantities	quantity	NNS
46745	2812	18	as	as	IN
46745	2812	19	the	the	DT
46745	2812	20	thousandth	thousandth	NN
46745	2812	21	,	,	,
46745	2812	22	millionth	millionth	JJ
46745	2812	23	,	,	,
46745	2812	24	or	or	CC
46745	2812	25	even	even	RB
46745	2812	26	decillionth	decillionth	NN
46745	2812	27	of	of	IN
46745	2812	28	a	a	DT
46745	2812	29	grain	grain	NN
46745	2812	30	.	.	.
46745	2813	1	(	(	-LRB-
46745	2813	2	_	_	NNP
46745	2813	3	Vide	Vide	NNP
46745	2813	4	_	_	NNP
46745	2813	5	page	page	NN
46745	2813	6	54	54	CD
46745	2813	7	.	.	.
46745	2813	8	)	)	-RRB-
46745	2814	1	Experience	experience	NN
46745	2814	2	--	--	:
46745	2814	3	better	well	RBR
46745	2814	4	even	even	RB
46745	2814	5	than	than	IN
46745	2814	6	theories	theory	NNS
46745	2814	7	and	and	CC
46745	2814	8	mathematics	mathematic	NNS
46745	2814	9	--	--	:
46745	2814	10	is	be	VBZ
46745	2814	11	entirely	entirely	RB
46745	2814	12	opposed	oppose	VBN
46745	2814	13	to	to	IN
46745	2814	14	such	such	JJ
46745	2814	15	chimerical	chimerical	JJ
46745	2814	16	fancies	fancy	NNS
46745	2814	17	.	.	.
46745	2815	1	Having	have	VBG
46745	2815	2	thus	thus	RB
46745	2815	3	entered	enter	VBN
46745	2815	4	into	into	IN
46745	2815	5	a	a	DT
46745	2815	6	speculation	speculation	NN
46745	2815	7	concerning	concern	VBG
46745	2815	8	the	the	DT
46745	2815	9	probable	probable	JJ
46745	2815	10	action	action	NN
46745	2815	11	in	in	IN
46745	2815	12	the	the	DT
46745	2815	13	blood	blood	NN
46745	2815	14	of	of	IN
46745	2815	15	Catalytic	catalytic	JJ
46745	2815	16	remedies	remedy	NNS
46745	2815	17	,	,	,
46745	2815	18	I	-PRON-	PRP
46745	2815	19	must	must	MD
46745	2815	20	once	once	RB
46745	2815	21	more	more	JJR
46745	2815	22	remark	remark	NN
46745	2815	23	that	that	IN
46745	2815	24	this	this	DT
46745	2815	25	idea	idea	NN
46745	2815	26	forms	form	VBZ
46745	2815	27	no	no	DT
46745	2815	28	part	part	NN
46745	2815	29	of	of	IN
46745	2815	30	the	the	DT
46745	2815	31	Proposition	Proposition	NNP
46745	2815	32	in	in	IN
46745	2815	33	which	which	WDT
46745	2815	34	I	-PRON-	PRP
46745	2815	35	have	have	VBP
46745	2815	36	defined	define	VBN
46745	2815	37	their	-PRON-	PRP$
46745	2815	38	mode	mode	NN
46745	2815	39	of	of	IN
46745	2815	40	operation	operation	NN
46745	2815	41	.	.	.
46745	2816	1	In	in	IN
46745	2816	2	the	the	DT
46745	2816	3	present	present	JJ
46745	2816	4	state	state	NN
46745	2816	5	of	of	IN
46745	2816	6	our	-PRON-	PRP$
46745	2816	7	information	information	NN
46745	2816	8	on	on	IN
46745	2816	9	the	the	DT
46745	2816	10	subject	subject	NN
46745	2816	11	,	,	,
46745	2816	12	we	-PRON-	PRP
46745	2816	13	can	can	MD
46745	2816	14	not	not	RB
46745	2816	15	certainly	certainly	RB
46745	2816	16	say	say	VB
46745	2816	17	more	more	JJR
46745	2816	18	than	than	IN
46745	2816	19	that	that	IN
46745	2816	20	these	these	DT
46745	2816	21	remedies	remedy	NNS
46745	2816	22	,	,	,
46745	2816	23	by	by	IN
46745	2816	24	some	some	DT
46745	2816	25	blood	blood	NN
46745	2816	26	-	-	HYPH
46745	2816	27	action	action	NN
46745	2816	28	,	,	,
46745	2816	29	are	be	VBP
46745	2816	30	able	able	JJ
46745	2816	31	to	to	TO
46745	2816	32	antagonize	antagonize	VB
46745	2816	33	and	and	CC
46745	2816	34	to	to	TO
46745	2816	35	annihilate	annihilate	VB
46745	2816	36	certain	certain	JJ
46745	2816	37	disorders	disorder	NNS
46745	2816	38	in	in	IN
46745	2816	39	the	the	DT
46745	2816	40	blood	blood	NN
46745	2816	41	.	.	.
46745	2817	1	The	the	DT
46745	2817	2	resolution	resolution	NN
46745	2817	3	of	of	IN
46745	2817	4	a	a	DT
46745	2817	5	disease	disease	NN
46745	2817	6	thus	thus	RB
46745	2817	7	effected	effect	VBN
46745	2817	8	may	may	NNP
46745	2817	9	,	,	,
46745	2817	10	in	in	IN
46745	2817	11	some	some	DT
46745	2817	12	few	few	JJ
46745	2817	13	instances	instance	NNS
46745	2817	14	,	,	,
46745	2817	15	be	be	VB
46745	2817	16	partly	partly	RB
46745	2817	17	explained	explain	VBN
46745	2817	18	by	by	IN
46745	2817	19	certain	certain	JJ
46745	2817	20	chemical	chemical	NN
46745	2817	21	considerations	consideration	NNS
46745	2817	22	,	,	,
46745	2817	23	as	as	IN
46745	2817	24	will	will	MD
46745	2817	25	be	be	VB
46745	2817	26	particularly	particularly	RB
46745	2817	27	shown	show	VBN
46745	2817	28	in	in	IN
46745	2817	29	the	the	DT
46745	2817	30	case	case	NN
46745	2817	31	of	of	IN
46745	2817	32	Antiarthritics	Antiarthritics	NNP
46745	2817	33	.	.	.
46745	2818	1	It	-PRON-	PRP
46745	2818	2	remains	remain	VBZ
46745	2818	3	for	for	IN
46745	2818	4	me	-PRON-	PRP
46745	2818	5	now	now	RB
46745	2818	6	to	to	TO
46745	2818	7	add	add	VB
46745	2818	8	some	some	DT
46745	2818	9	brief	brief	JJ
46745	2818	10	remarks	remark	NNS
46745	2818	11	on	on	IN
46745	2818	12	the	the	DT
46745	2818	13	individual	individual	NN
46745	2818	14	_	_	NNP
46745	2818	15	modus	modus	NN
46745	2818	16	operandi	operandi	NNP
46745	2818	17	_	_	NNP
46745	2818	18	of	of	IN
46745	2818	19	the	the	DT
46745	2818	20	substances	substance	NNS
46745	2818	21	included	include	VBN
46745	2818	22	in	in	IN
46745	2818	23	each	each	DT
46745	2818	24	of	of	IN
46745	2818	25	the	the	DT
46745	2818	26	eight	eight	CD
46745	2818	27	orders	order	NNS
46745	2818	28	of	of	IN
46745	2818	29	Catalytic	catalytic	JJ
46745	2818	30	medicines	medicine	NNS
46745	2818	31	.	.	.
46745	2819	1	Some	some	DT
46745	2819	2	of	of	IN
46745	2819	3	these	these	DT
46745	2819	4	having	have	VBG
46745	2819	5	been	be	VBN
46745	2819	6	partly	partly	RB
46745	2819	7	discussed	discuss	VBN
46745	2819	8	above	above	RB
46745	2819	9	,	,	,
46745	2819	10	in	in	IN
46745	2819	11	arguing	argue	VBG
46745	2819	12	the	the	DT
46745	2819	13	Proposition	Proposition	NNP
46745	2819	14	,	,	,
46745	2819	15	it	-PRON-	PRP
46745	2819	16	will	will	MD
46745	2819	17	not	not	RB
46745	2819	18	be	be	VB
46745	2819	19	found	find	VBN
46745	2819	20	necessary	necessary	JJ
46745	2819	21	to	to	TO
46745	2819	22	travel	travel	VB
46745	2819	23	over	over	RB
46745	2819	24	again	again	RB
46745	2819	25	that	that	DT
46745	2819	26	portion	portion	NN
46745	2819	27	of	of	IN
46745	2819	28	the	the	DT
46745	2819	29	ground	ground	NN
46745	2819	30	which	which	WDT
46745	2819	31	has	have	VBZ
46745	2819	32	already	already	RB
46745	2819	33	been	be	VBN
46745	2819	34	thus	thus	RB
46745	2819	35	traversed	traverse	VBN
46745	2819	36	.	.	.
46745	2820	1	ORD	ORD	NNP
46745	2820	2	.	.	.
46745	2821	1	I.	I.	NNP
46745	2821	2	ANTIPHLOGISTICS	ANTIPHLOGISTICS	NNP
46745	2821	3	.	.	.
46745	2822	1	The	the	DT
46745	2822	2	inflammatory	inflammatory	JJ
46745	2822	3	process	process	NN
46745	2822	4	--	--	:
46745	2822	5	the	the	DT
46745	2822	6	chief	chief	JJ
46745	2822	7	seat	seat	NN
46745	2822	8	of	of	IN
46745	2822	9	which	which	WDT
46745	2822	10	,	,	,
46745	2822	11	however	however	RB
46745	2822	12	it	-PRON-	PRP
46745	2822	13	may	may	MD
46745	2822	14	first	first	RB
46745	2822	15	originate	originate	VB
46745	2822	16	,	,	,
46745	2822	17	is	be	VBZ
46745	2822	18	in	in	IN
46745	2822	19	the	the	DT
46745	2822	20	circulating	circulate	VBG
46745	2822	21	blood	blood	NN
46745	2822	22	--	--	:
46745	2822	23	exerts	exert	VBZ
46745	2822	24	a	a	DT
46745	2822	25	powerful	powerful	JJ
46745	2822	26	influence	influence	NN
46745	2822	27	over	over	IN
46745	2822	28	the	the	DT
46745	2822	29	nervous	nervous	JJ
46745	2822	30	system	system	NN
46745	2822	31	,	,	,
46745	2822	32	and	and	CC
46745	2822	33	may	may	MD
46745	2822	34	,	,	,
46745	2822	35	by	by	IN
46745	2822	36	this	this	DT
46745	2822	37	influence	influence	NN
46745	2822	38	,	,	,
46745	2822	39	cause	cause	VB
46745	2822	40	death	death	NN
46745	2822	41	.	.	.
46745	2823	1	When	when	WRB
46745	2823	2	fever	fever	NN
46745	2823	3	is	be	VBZ
46745	2823	4	produced	produce	VBN
46745	2823	5	to	to	IN
46745	2823	6	any	any	DT
46745	2823	7	extent	extent	NN
46745	2823	8	,	,	,
46745	2823	9	there	there	EX
46745	2823	10	must	must	MD
46745	2823	11	be	be	VB
46745	2823	12	danger	danger	NN
46745	2823	13	.	.	.
46745	2824	1	We	-PRON-	PRP
46745	2824	2	are	be	VBP
46745	2824	3	enabled	enable	VBN
46745	2824	4	in	in	IN
46745	2824	5	two	two	CD
46745	2824	6	ways	way	NNS
46745	2824	7	to	to	TO
46745	2824	8	control	control	VB
46745	2824	9	or	or	CC
46745	2824	10	to	to	TO
46745	2824	11	mitigate	mitigate	VB
46745	2824	12	this	this	DT
46745	2824	13	state	state	NN
46745	2824	14	of	of	IN
46745	2824	15	things	thing	NNS
46745	2824	16	.	.	.
46745	2825	1	We	-PRON-	PRP
46745	2825	2	may	may	MD
46745	2825	3	produce	produce	VB
46745	2825	4	an	an	DT
46745	2825	5	action	action	NN
46745	2825	6	on	on	IN
46745	2825	7	the	the	DT
46745	2825	8	nervous	nervous	JJ
46745	2825	9	system	system	NN
46745	2825	10	,	,	,
46745	2825	11	or	or	CC
46745	2825	12	we	-PRON-	PRP
46745	2825	13	may	may	MD
46745	2825	14	direct	direct	VB
46745	2825	15	our	-PRON-	PRP$
46745	2825	16	attention	attention	NN
46745	2825	17	to	to	IN
46745	2825	18	the	the	DT
46745	2825	19	process	process	NN
46745	2825	20	in	in	IN
46745	2825	21	the	the	DT
46745	2825	22	blood	blood	NN
46745	2825	23	.	.	.
46745	2826	1	Of	of	IN
46745	2826	2	Neurotic	neurotic	JJ
46745	2826	3	medicines	medicine	NNS
46745	2826	4	,	,	,
46745	2826	5	which	which	WDT
46745	2826	6	we	-PRON-	PRP
46745	2826	7	shall	shall	MD
46745	2826	8	have	have	VB
46745	2826	9	to	to	TO
46745	2826	10	consider	consider	VB
46745	2826	11	hereafter	hereafter	RB
46745	2826	12	,	,	,
46745	2826	13	there	there	EX
46745	2826	14	are	be	VBP
46745	2826	15	some	some	DT
46745	2826	16	which	which	WDT
46745	2826	17	may	may	MD
46745	2826	18	be	be	VB
46745	2826	19	made	make	VBN
46745	2826	20	use	use	NN
46745	2826	21	of	of	IN
46745	2826	22	at	at	IN
46745	2826	23	the	the	DT
46745	2826	24	commencement	commencement	NN
46745	2826	25	of	of	IN
46745	2826	26	the	the	DT
46745	2826	27	attack	attack	NN
46745	2826	28	,	,	,
46745	2826	29	and	and	CC
46745	2826	30	others	other	NNS
46745	2826	31	which	which	WDT
46745	2826	32	are	be	VBP
46745	2826	33	appropriate	appropriate	JJ
46745	2826	34	when	when	WRB
46745	2826	35	the	the	DT
46745	2826	36	process	process	NN
46745	2826	37	is	be	VBZ
46745	2826	38	more	more	RBR
46745	2826	39	advanced	advanced	JJ
46745	2826	40	.	.	.
46745	2827	1	Of	of	IN
46745	2827	2	the	the	DT
46745	2827	3	first	first	JJ
46745	2827	4	kind	kind	NN
46745	2827	5	is	be	VBZ
46745	2827	6	Antimony	Antimony	NNP
46745	2827	7	,	,	,
46745	2827	8	considered	consider	VBN
46745	2827	9	in	in	IN
46745	2827	10	its	-PRON-	PRP$
46745	2827	11	Neurotic	neurotic	JJ
46745	2827	12	action	action	NN
46745	2827	13	.	.	.
46745	2828	1	Employing	employ	VBG
46745	2828	2	it	-PRON-	PRP
46745	2828	3	in	in	IN
46745	2828	4	large	large	JJ
46745	2828	5	doses	dose	NNS
46745	2828	6	,	,	,
46745	2828	7	we	-PRON-	PRP
46745	2828	8	may	may	MD
46745	2828	9	produce	produce	VB
46745	2828	10	a	a	DT
46745	2828	11	powerful	powerful	JJ
46745	2828	12	effect	effect	NN
46745	2828	13	upon	upon	IN
46745	2828	14	the	the	DT
46745	2828	15	nerves	nerve	NNS
46745	2828	16	which	which	WDT
46745	2828	17	supply	supply	VBP
46745	2828	18	the	the	DT
46745	2828	19	heart	heart	NN
46745	2828	20	,	,	,
46745	2828	21	and	and	CC
46745	2828	22	thus	thus	RB
46745	2828	23	,	,	,
46745	2828	24	by	by	IN
46745	2828	25	diminishing	diminish	VBG
46745	2828	26	the	the	DT
46745	2828	27	impulse	impulse	NN
46745	2828	28	upon	upon	IN
46745	2828	29	the	the	DT
46745	2828	30	inflamed	inflame	VBN
46745	2828	31	parts	part	NNS
46745	2828	32	,	,	,
46745	2828	33	or	or	CC
46745	2828	34	on	on	IN
46745	2828	35	the	the	DT
46745	2828	36	vascular	vascular	JJ
46745	2828	37	system	system	NN
46745	2828	38	generally	generally	RB
46745	2828	39	,	,	,
46745	2828	40	promote	promote	VB
46745	2828	41	absorption	absorption	NN
46745	2828	42	and	and	CC
46745	2828	43	resolution	resolution	NN
46745	2828	44	.	.	.
46745	2829	1	Blood	blood	NN
46745	2829	2	-	-	HYPH
46745	2829	3	letting	letting	NN
46745	2829	4	produces	produce	VBZ
46745	2829	5	the	the	DT
46745	2829	6	same	same	JJ
46745	2829	7	action	action	NN
46745	2829	8	,	,	,
46745	2829	9	but	but	CC
46745	2829	10	in	in	IN
46745	2829	11	an	an	DT
46745	2829	12	inverse	inverse	NN
46745	2829	13	mode	mode	NN
46745	2829	14	.	.	.
46745	2830	1	Antimony	Antimony	NNP
46745	2830	2	diminishes	diminish	VBZ
46745	2830	3	the	the	DT
46745	2830	4	pressure	pressure	NN
46745	2830	5	on	on	IN
46745	2830	6	the	the	DT
46745	2830	7	vessels	vessel	NNS
46745	2830	8	by	by	IN
46745	2830	9	weakening	weaken	VBG
46745	2830	10	the	the	DT
46745	2830	11	force	force	NN
46745	2830	12	of	of	IN
46745	2830	13	the	the	DT
46745	2830	14	heart	heart	NN
46745	2830	15	;	;	:
46745	2830	16	Blood	blood	NN
46745	2830	17	-	-	HYPH
46745	2830	18	letting	letting	NN
46745	2830	19	weakens	weaken	VBZ
46745	2830	20	the	the	DT
46745	2830	21	force	force	NN
46745	2830	22	of	of	IN
46745	2830	23	the	the	DT
46745	2830	24	heart	heart	NN
46745	2830	25	by	by	IN
46745	2830	26	diminishing	diminish	VBG
46745	2830	27	the	the	DT
46745	2830	28	pressure	pressure	NN
46745	2830	29	on	on	IN
46745	2830	30	the	the	DT
46745	2830	31	vessels	vessel	NNS
46745	2830	32	.	.	.
46745	2831	1	Such	such	JJ
46745	2831	2	Neurotics	Neurotics	NNP
46745	2831	3	as	as	IN
46745	2831	4	Opium	opium	NN
46745	2831	5	are	be	VBP
46745	2831	6	employed	employ	VBN
46745	2831	7	at	at	IN
46745	2831	8	a	a	DT
46745	2831	9	more	more	RBR
46745	2831	10	advanced	advanced	JJ
46745	2831	11	stage	stage	NN
46745	2831	12	,	,	,
46745	2831	13	when	when	WRB
46745	2831	14	the	the	DT
46745	2831	15	inflammation	inflammation	NN
46745	2831	16	can	can	MD
46745	2831	17	not	not	RB
46745	2831	18	be	be	VB
46745	2831	19	suddenly	suddenly	RB
46745	2831	20	put	put	VBN
46745	2831	21	a	a	DT
46745	2831	22	stop	stop	NN
46745	2831	23	to	to	IN
46745	2831	24	,	,	,
46745	2831	25	and	and	CC
46745	2831	26	our	-PRON-	PRP$
46745	2831	27	object	object	NN
46745	2831	28	is	be	VBZ
46745	2831	29	to	to	TO
46745	2831	30	counteract	counteract	VB
46745	2831	31	the	the	DT
46745	2831	32	effects	effect	NNS
46745	2831	33	it	-PRON-	PRP
46745	2831	34	has	have	VBZ
46745	2831	35	produced	produce	VBN
46745	2831	36	.	.	.
46745	2832	1	Besides	besides	IN
46745	2832	2	relieving	relieve	VBG
46745	2832	3	the	the	DT
46745	2832	4	pain	pain	NN
46745	2832	5	and	and	CC
46745	2832	6	nervous	nervous	JJ
46745	2832	7	irritation	irritation	NN
46745	2832	8	which	which	WDT
46745	2832	9	are	be	VBP
46745	2832	10	so	so	RB
46745	2832	11	much	much	JJ
46745	2832	12	to	to	TO
46745	2832	13	be	be	VB
46745	2832	14	dreaded	dread	VBN
46745	2832	15	,	,	,
46745	2832	16	Opium	Opium	NNP
46745	2832	17	may	may	MD
46745	2832	18	be	be	VB
46745	2832	19	employed	employ	VBN
46745	2832	20	to	to	TO
46745	2832	21	prevent	prevent	VB
46745	2832	22	a	a	DT
46745	2832	23	blood	blood	NN
46745	2832	24	-	-	HYPH
46745	2832	25	medicine	medicine	NN
46745	2832	26	from	from	IN
46745	2832	27	passing	pass	VBG
46745	2832	28	out	out	RP
46745	2832	29	through	through	IN
46745	2832	30	the	the	DT
46745	2832	31	bowels	bowel	NNS
46745	2832	32	.	.	.
46745	2833	1	Antimony	Antimony	NNP
46745	2833	2	and	and	CC
46745	2833	3	bleeding	bleeding	NN
46745	2833	4	are	be	VBP
46745	2833	5	appropriate	appropriate	JJ
46745	2833	6	in	in	IN
46745	2833	7	sthenic	sthenic	JJ
46745	2833	8	cases	case	NNS
46745	2833	9	.	.	.
46745	2834	1	Opium	opium	NN
46745	2834	2	should	should	MD
46745	2834	3	not	not	RB
46745	2834	4	generally	generally	RB
46745	2834	5	be	be	VB
46745	2834	6	employed	employ	VBN
46745	2834	7	in	in	IN
46745	2834	8	these	these	DT
46745	2834	9	instances	instance	NNS
46745	2834	10	,	,	,
46745	2834	11	nor	nor	CC
46745	2834	12	should	should	MD
46745	2834	13	it	-PRON-	PRP
46745	2834	14	be	be	VB
46745	2834	15	given	give	VBN
46745	2834	16	in	in	IN
46745	2834	17	brain	brain	NN
46745	2834	18	disorders	disorder	NNS
46745	2834	19	,	,	,
46745	2834	20	or	or	CC
46745	2834	21	in	in	IN
46745	2834	22	any	any	DT
46745	2834	23	case	case	NN
46745	2834	24	where	where	WRB
46745	2834	25	there	there	EX
46745	2834	26	appears	appear	VBZ
46745	2834	27	to	to	TO
46745	2834	28	be	be	VB
46745	2834	29	a	a	DT
46745	2834	30	determination	determination	NN
46745	2834	31	of	of	IN
46745	2834	32	blood	blood	NN
46745	2834	33	to	to	IN
46745	2834	34	the	the	DT
46745	2834	35	head	head	NN
46745	2834	36	.	.	.
46745	2835	1	Certain	certain	JJ
46745	2835	2	medicines	medicine	NNS
46745	2835	3	of	of	IN
46745	2835	4	the	the	DT
46745	2835	5	class	class	NN
46745	2835	6	of	of	IN
46745	2835	7	Eliminatives	Eliminatives	NNPS
46745	2835	8	,	,	,
46745	2835	9	and	and	CC
46745	2835	10	certain	certain	JJ
46745	2835	11	Catalytic	catalytic	JJ
46745	2835	12	remedies	remedy	NNS
46745	2835	13	belonging	belong	VBG
46745	2835	14	to	to	IN
46745	2835	15	the	the	DT
46745	2835	16	present	present	JJ
46745	2835	17	order	order	NN
46745	2835	18	,	,	,
46745	2835	19	are	be	VBP
46745	2835	20	employed	employ	VBN
46745	2835	21	to	to	TO
46745	2835	22	counteract	counteract	VB
46745	2835	23	the	the	DT
46745	2835	24	inflammatory	inflammatory	JJ
46745	2835	25	process	process	NN
46745	2835	26	in	in	IN
46745	2835	27	the	the	DT
46745	2835	28	blood	blood	NN
46745	2835	29	.	.	.
46745	2836	1	Of	of	IN
46745	2836	2	the	the	DT
46745	2836	3	former	former	JJ
46745	2836	4	,	,	,
46745	2836	5	the	the	DT
46745	2836	6	most	most	RBS
46745	2836	7	important	important	JJ
46745	2836	8	are	be	VBP
46745	2836	9	Purgatives	Purgatives	NNPS
46745	2836	10	and	and	CC
46745	2836	11	Diaphoretics	diaphoretic	NNS
46745	2836	12	.	.	.
46745	2837	1	By	by	IN
46745	2837	2	diminishing	diminish	VBG
46745	2837	3	the	the	DT
46745	2837	4	amount	amount	NN
46745	2837	5	of	of	IN
46745	2837	6	the	the	DT
46745	2837	7	serum	serum	NN
46745	2837	8	of	of	IN
46745	2837	9	the	the	DT
46745	2837	10	blood	blood	NN
46745	2837	11	,	,	,
46745	2837	12	they	-PRON-	PRP
46745	2837	13	not	not	RB
46745	2837	14	only	only	RB
46745	2837	15	tend	tend	VBP
46745	2837	16	to	to	TO
46745	2837	17	check	check	VB
46745	2837	18	effusions	effusion	NNS
46745	2837	19	,	,	,
46745	2837	20	but	but	CC
46745	2837	21	act	act	VB
46745	2837	22	indirectly	indirectly	RB
46745	2837	23	on	on	IN
46745	2837	24	the	the	DT
46745	2837	25	heart	heart	NN
46745	2837	26	,	,	,
46745	2837	27	in	in	IN
46745	2837	28	the	the	DT
46745	2837	29	same	same	JJ
46745	2837	30	way	way	NN
46745	2837	31	as	as	IN
46745	2837	32	the	the	DT
46745	2837	33	medicines	medicine	NNS
46745	2837	34	last	last	JJ
46745	2837	35	spoken	spoken	NN
46745	2837	36	of	of	IN
46745	2837	37	;	;	:
46745	2837	38	and	and	CC
46745	2837	39	they	-PRON-	PRP
46745	2837	40	probably	probably	RB
46745	2837	41	also	also	RB
46745	2837	42	promote	promote	VBP
46745	2837	43	the	the	DT
46745	2837	44	passage	passage	NN
46745	2837	45	of	of	IN
46745	2837	46	morbid	morbid	NN
46745	2837	47	or	or	CC
46745	2837	48	of	of	IN
46745	2837	49	peccant	peccant	JJ
46745	2837	50	materials	material	NNS
46745	2837	51	out	out	IN
46745	2837	52	of	of	IN
46745	2837	53	the	the	DT
46745	2837	54	system	system	NN
46745	2837	55	through	through	IN
46745	2837	56	the	the	DT
46745	2837	57	glands	gland	NNS
46745	2837	58	.	.	.
46745	2838	1	Acid	acid	JJ
46745	2838	2	and	and	CC
46745	2838	3	saline	saline	NN
46745	2838	4	drinks	drink	NNS
46745	2838	5	may	may	MD
46745	2838	6	act	act	VB
46745	2838	7	as	as	IN
46745	2838	8	Diaphoretics	Diaphoretics	NNP
46745	2838	9	,	,	,
46745	2838	10	besides	besides	IN
46745	2838	11	exerting	exert	VBG
46745	2838	12	each	each	DT
46745	2838	13	a	a	DT
46745	2838	14	peculiar	peculiar	JJ
46745	2838	15	influence	influence	NN
46745	2838	16	in	in	IN
46745	2838	17	the	the	DT
46745	2838	18	fluids	fluid	NNS
46745	2838	19	.	.	.
46745	2839	1	Of	of	IN
46745	2839	2	this	this	DT
46745	2839	3	Catalytic	catalytic	JJ
46745	2839	4	order	order	NN
46745	2839	5	,	,	,
46745	2839	6	Antimony	Antimony	NNP
46745	2839	7	and	and	CC
46745	2839	8	Mercury	Mercury	NNP
46745	2839	9	are	be	VBP
46745	2839	10	those	those	DT
46745	2839	11	which	which	WDT
46745	2839	12	tend	tend	VBP
46745	2839	13	most	most	RBS
46745	2839	14	powerfully	powerfully	RB
46745	2839	15	to	to	TO
46745	2839	16	check	check	VB
46745	2839	17	the	the	DT
46745	2839	18	general	general	JJ
46745	2839	19	blood	blood	NN
46745	2839	20	-	-	HYPH
46745	2839	21	process	process	NN
46745	2839	22	of	of	IN
46745	2839	23	inflammation	inflammation	NN
46745	2839	24	.	.	.
46745	2840	1	The	the	DT
46745	2840	2	former	former	JJ
46745	2840	3	is	be	VBZ
46745	2840	4	used	use	VBN
46745	2840	5	in	in	IN
46745	2840	6	urgent	urgent	JJ
46745	2840	7	and	and	CC
46745	2840	8	acute	acute	JJ
46745	2840	9	cases	case	NNS
46745	2840	10	to	to	TO
46745	2840	11	make	make	VB
46745	2840	12	a	a	DT
46745	2840	13	sudden	sudden	JJ
46745	2840	14	and	and	CC
46745	2840	15	powerful	powerful	JJ
46745	2840	16	impression	impression	NN
46745	2840	17	,	,	,
46745	2840	18	adding	add	VBG
46745	2840	19	to	to	IN
46745	2840	20	its	-PRON-	PRP$
46745	2840	21	Hæmatic	hæmatic	JJ
46745	2840	22	action	action	NN
46745	2840	23	a	a	DT
46745	2840	24	sedative	sedative	JJ
46745	2840	25	effect	effect	NN
46745	2840	26	on	on	IN
46745	2840	27	the	the	DT
46745	2840	28	heart	heart	NN
46745	2840	29	and	and	CC
46745	2840	30	circulation	circulation	NN
46745	2840	31	.	.	.
46745	2841	1	Mercury	Mercury	NNP
46745	2841	2	exerts	exert	VBZ
46745	2841	3	no	no	DT
46745	2841	4	such	such	JJ
46745	2841	5	immediate	immediate	JJ
46745	2841	6	influence	influence	NN
46745	2841	7	.	.	.
46745	2842	1	Diminishing	diminish	VBG
46745	2842	2	the	the	DT
46745	2842	3	Fibrine	Fibrine	NNP
46745	2842	4	of	of	IN
46745	2842	5	the	the	DT
46745	2842	6	blood	blood	NN
46745	2842	7	,	,	,
46745	2842	8	and	and	CC
46745	2842	9	having	have	VBG
46745	2842	10	other	other	JJ
46745	2842	11	operations	operation	NNS
46745	2842	12	of	of	IN
46745	2842	13	a	a	DT
46745	2842	14	peculiar	peculiar	JJ
46745	2842	15	kind	kind	NN
46745	2842	16	in	in	IN
46745	2842	17	this	this	DT
46745	2842	18	fluid	fluid	NN
46745	2842	19	,	,	,
46745	2842	20	it	-PRON-	PRP
46745	2842	21	powerfully	powerfully	RB
46745	2842	22	promotes	promote	VBZ
46745	2842	23	absorption	absorption	NN
46745	2842	24	and	and	CC
46745	2842	25	counteracts	counteract	NNS
46745	2842	26	effusion	effusion	NN
46745	2842	27	,	,	,
46745	2842	28	in	in	IN
46745	2842	29	all	all	DT
46745	2842	30	inflammations	inflammation	NNS
46745	2842	31	.	.	.
46745	2843	1	The	the	DT
46745	2843	2	blood	blood	NN
46745	2843	3	-	-	HYPH
46745	2843	4	action	action	NN
46745	2843	5	of	of	IN
46745	2843	6	these	these	DT
46745	2843	7	remedies	remedy	NNS
46745	2843	8	,	,	,
46745	2843	9	though	though	IN
46745	2843	10	not	not	RB
46745	2843	11	positively	positively	RB
46745	2843	12	slow	slow	JJ
46745	2843	13	,	,	,
46745	2843	14	is	be	VBZ
46745	2843	15	slow	slow	JJ
46745	2843	16	when	when	WRB
46745	2843	17	compared	compare	VBN
46745	2843	18	to	to	IN
46745	2843	19	an	an	DT
46745	2843	20	action	action	NN
46745	2843	21	on	on	IN
46745	2843	22	nerve	nerve	NN
46745	2843	23	.	.	.
46745	2844	1	Thus	thus	RB
46745	2844	2	when	when	WRB
46745	2844	3	Antimony	Antimony	NNP
46745	2844	4	is	be	VBZ
46745	2844	5	given	give	VBN
46745	2844	6	in	in	IN
46745	2844	7	large	large	JJ
46745	2844	8	doses	dose	NNS
46745	2844	9	,	,	,
46745	2844	10	as	as	IN
46745	2844	11	is	be	VBZ
46745	2844	12	desirable	desirable	JJ
46745	2844	13	in	in	IN
46745	2844	14	some	some	DT
46745	2844	15	highly	highly	RB
46745	2844	16	sthenic	sthenic	JJ
46745	2844	17	and	and	CC
46745	2844	18	dangerous	dangerous	JJ
46745	2844	19	attacks	attack	NNS
46745	2844	20	,	,	,
46745	2844	21	its	-PRON-	PRP$
46745	2844	22	blood	blood	NN
46745	2844	23	-	-	HYPH
46745	2844	24	action	action	NN
46745	2844	25	is	be	VBZ
46745	2844	26	lost	lose	VBN
46745	2844	27	in	in	IN
46745	2844	28	its	-PRON-	PRP$
46745	2844	29	immediate	immediate	JJ
46745	2844	30	Neurotic	neurotic	JJ
46745	2844	31	operation	operation	NN
46745	2844	32	.	.	.
46745	2845	1	So	so	IN
46745	2845	2	that	that	IN
46745	2845	3	in	in	IN
46745	2845	4	Croup	Croup	NNP
46745	2845	5	and	and	CC
46745	2845	6	Pneumonia	Pneumonia	NNP
46745	2845	7	,	,	,
46745	2845	8	both	both	CC
46745	2845	9	rapid	rapid	JJ
46745	2845	10	and	and	CC
46745	2845	11	fatal	fatal	JJ
46745	2845	12	inflammations	inflammation	NNS
46745	2845	13	,	,	,
46745	2845	14	Antimony	Antimony	NNP
46745	2845	15	is	be	VBZ
46745	2845	16	far	far	RB
46745	2845	17	preferable	preferable	JJ
46745	2845	18	to	to	IN
46745	2845	19	Mercury	Mercury	NNP
46745	2845	20	.	.	.
46745	2846	1	But	but	CC
46745	2846	2	in	in	IN
46745	2846	3	Pleurisy	Pleurisy	NNP
46745	2846	4	--	--	:
46745	2846	5	where	where	WRB
46745	2846	6	there	there	EX
46745	2846	7	is	be	VBZ
46745	2846	8	generally	generally	RB
46745	2846	9	no	no	DT
46745	2846	10	immediate	immediate	JJ
46745	2846	11	danger	danger	NN
46745	2846	12	to	to	TO
46745	2846	13	be	be	VB
46745	2846	14	dreaded	dread	VBN
46745	2846	15	,	,	,
46745	2846	16	but	but	CC
46745	2846	17	a	a	DT
46745	2846	18	subsequent	subsequent	JJ
46745	2846	19	effusion	effusion	NN
46745	2846	20	,	,	,
46745	2846	21	Mercury	Mercury	NNP
46745	2846	22	is	be	VBZ
46745	2846	23	best	good	JJS
46745	2846	24	,	,	,
46745	2846	25	being	be	VBG
46745	2846	26	in	in	IN
46745	2846	27	time	time	NN
46745	2846	28	to	to	TO
46745	2846	29	lessen	lessen	VB
46745	2846	30	or	or	CC
46745	2846	31	to	to	TO
46745	2846	32	prevent	prevent	VB
46745	2846	33	this	this	DT
46745	2846	34	result	result	NN
46745	2846	35	.	.	.
46745	2847	1	From	from	IN
46745	2847	2	the	the	DT
46745	2847	3	action	action	NN
46745	2847	4	of	of	IN
46745	2847	5	both	both	DT
46745	2847	6	on	on	IN
46745	2847	7	the	the	DT
46745	2847	8	blood	blood	NN
46745	2847	9	,	,	,
46745	2847	10	and	and	CC
46745	2847	11	one	one	CD
46745	2847	12	on	on	IN
46745	2847	13	the	the	DT
46745	2847	14	nerves	nerve	NNS
46745	2847	15	,	,	,
46745	2847	16	these	these	DT
46745	2847	17	are	be	VBP
46745	2847	18	very	very	RB
46745	2847	19	lowering	lowering	JJ
46745	2847	20	remedies	remedy	NNS
46745	2847	21	.	.	.
46745	2848	1	In	in	IN
46745	2848	2	the	the	DT
46745	2848	3	employment	employment	NN
46745	2848	4	of	of	IN
46745	2848	5	Antimony	Antimony	NNP
46745	2848	6	in	in	IN
46745	2848	7	fevers	fever	NNS
46745	2848	8	and	and	CC
46745	2848	9	inflammations	inflammation	NNS
46745	2848	10	,	,	,
46745	2848	11	the	the	DT
46745	2848	12	production	production	NN
46745	2848	13	of	of	IN
46745	2848	14	nausea	nausea	NN
46745	2848	15	generally	generally	RB
46745	2848	16	indicates	indicate	VBZ
46745	2848	17	that	that	IN
46745	2848	18	it	-PRON-	PRP
46745	2848	19	has	have	VBZ
46745	2848	20	taken	take	VBN
46745	2848	21	sufficient	sufficient	JJ
46745	2848	22	effect	effect	NN
46745	2848	23	;	;	:
46745	2848	24	but	but	CC
46745	2848	25	it	-PRON-	PRP
46745	2848	26	may	may	MD
46745	2848	27	sometimes	sometimes	RB
46745	2848	28	be	be	VB
46745	2848	29	better	well	JJR
46745	2848	30	to	to	TO
46745	2848	31	give	give	VB
46745	2848	32	such	such	PDT
46745	2848	33	a	a	DT
46745	2848	34	dose	dose	NN
46745	2848	35	as	as	IN
46745	2848	36	shall	shall	MD
46745	2848	37	cause	cause	VB
46745	2848	38	vomiting	vomiting	NN
46745	2848	39	,	,	,
46745	2848	40	especially	especially	RB
46745	2848	41	when	when	WRB
46745	2848	42	a	a	DT
46745	2848	43	violent	violent	JJ
46745	2848	44	counter	counter	JJ
46745	2848	45	-	-	JJ
46745	2848	46	irritant	irritant	JJ
46745	2848	47	action	action	NN
46745	2848	48	is	be	VBZ
46745	2848	49	to	to	TO
46745	2848	50	be	be	VB
46745	2848	51	desired	desire	VBN
46745	2848	52	.	.	.
46745	2849	1	The	the	DT
46745	2849	2	increase	increase	NN
46745	2849	3	in	in	IN
46745	2849	4	the	the	DT
46745	2849	5	quantity	quantity	NN
46745	2849	6	of	of	IN
46745	2849	7	saliva	saliva	NN
46745	2849	8	,	,	,
46745	2849	9	and	and	CC
46745	2849	10	slight	slight	JJ
46745	2849	11	soreness	soreness	NN
46745	2849	12	of	of	IN
46745	2849	13	the	the	DT
46745	2849	14	mouth	mouth	NN
46745	2849	15	,	,	,
46745	2849	16	which	which	WDT
46745	2849	17	result	result	VBP
46745	2849	18	from	from	IN
46745	2849	19	its	-PRON-	PRP$
46745	2849	20	action	action	NN
46745	2849	21	,	,	,
46745	2849	22	will	will	MD
46745	2849	23	show	show	VB
46745	2849	24	when	when	WRB
46745	2849	25	the	the	DT
46745	2849	26	administration	administration	NN
46745	2849	27	of	of	IN
46745	2849	28	a	a	DT
46745	2849	29	Mercurial	mercurial	NN
46745	2849	30	has	have	VBZ
46745	2849	31	gone	go	VBN
46745	2849	32	far	far	RB
46745	2849	33	enough	enough	RB
46745	2849	34	.	.	.
46745	2850	1	It	-PRON-	PRP
46745	2850	2	is	be	VBZ
46745	2850	3	seldom	seldom	RB
46745	2850	4	advisable	advisable	JJ
46745	2850	5	to	to	TO
46745	2850	6	cause	cause	VB
46745	2850	7	copious	copious	JJ
46745	2850	8	salivation	salivation	NN
46745	2850	9	.	.	.
46745	2851	1	Alkalies	alkali	NNS
46745	2851	2	dissolve	dissolve	VBP
46745	2851	3	the	the	DT
46745	2851	4	Fibrine	Fibrine	NNP
46745	2851	5	of	of	IN
46745	2851	6	the	the	DT
46745	2851	7	blood	blood	NN
46745	2851	8	,	,	,
46745	2851	9	and	and	CC
46745	2851	10	appear	appear	VB
46745	2851	11	by	by	IN
46745	2851	12	this	this	DT
46745	2851	13	to	to	TO
46745	2851	14	lessen	lessen	VB
46745	2851	15	its	-PRON-	PRP$
46745	2851	16	deposition	deposition	NN
46745	2851	17	,	,	,
46745	2851	18	and	and	CC
46745	2851	19	retard	retard	VB
46745	2851	20	its	-PRON-	PRP$
46745	2851	21	formation	formation	NN
46745	2851	22	.	.	.
46745	2852	1	Thus	thus	RB
46745	2852	2	,	,	,
46745	2852	3	when	when	WRB
46745	2852	4	given	give	VBN
46745	2852	5	in	in	IN
46745	2852	6	large	large	JJ
46745	2852	7	doses	dose	NNS
46745	2852	8	,	,	,
46745	2852	9	they	-PRON-	PRP
46745	2852	10	operate	operate	VBP
46745	2852	11	as	as	IN
46745	2852	12	Antiphlogistics	Antiphlogistics	NNP
46745	2852	13	.	.	.
46745	2853	1	They	-PRON-	PRP
46745	2853	2	have	have	VBP
46745	2853	3	sometimes	sometimes	RB
46745	2853	4	been	be	VBN
46745	2853	5	employed	employ	VBN
46745	2853	6	with	with	IN
46745	2853	7	advantage	advantage	NN
46745	2853	8	in	in	IN
46745	2853	9	fevers	fever	NNS
46745	2853	10	of	of	IN
46745	2853	11	the	the	DT
46745	2853	12	acute	acute	JJ
46745	2853	13	or	or	CC
46745	2853	14	sthenic	sthenic	JJ
46745	2853	15	kind	kind	NN
46745	2853	16	.	.	.
46745	2854	1	Exerting	exert	VBG
46745	2854	2	an	an	DT
46745	2854	3	influence	influence	NN
46745	2854	4	over	over	IN
46745	2854	5	the	the	DT
46745	2854	6	inflammatory	inflammatory	JJ
46745	2854	7	process	process	NN
46745	2854	8	considered	consider	VBN
46745	2854	9	_	_	NNP
46745	2854	10	per	per	FW
46745	2854	11	se	se	FW
46745	2854	12	_	_	NNP
46745	2854	13	,	,	,
46745	2854	14	Alkalies	Alkalies	NNPS
46745	2854	15	and	and	CC
46745	2854	16	Mercurials	Mercurials	NNPS
46745	2854	17	are	be	VBP
46745	2854	18	more	more	RBR
46745	2854	19	particularly	particularly	RB
46745	2854	20	efficacious	efficacious	JJ
46745	2854	21	in	in	IN
46745	2854	22	some	some	DT
46745	2854	23	special	special	JJ
46745	2854	24	varieties	variety	NNS
46745	2854	25	of	of	IN
46745	2854	26	inflammation	inflammation	NN
46745	2854	27	,	,	,
46745	2854	28	because	because	IN
46745	2854	29	in	in	IN
46745	2854	30	such	such	JJ
46745	2854	31	cases	case	NNS
46745	2854	32	they	-PRON-	PRP
46745	2854	33	further	further	RB
46745	2854	34	counteract	counteract	VBD
46745	2854	35	the	the	DT
46745	2854	36	morbid	morbid	NN
46745	2854	37	agency	agency	NN
46745	2854	38	by	by	IN
46745	2854	39	which	which	WDT
46745	2854	40	the	the	DT
46745	2854	41	process	process	NN
46745	2854	42	is	be	VBZ
46745	2854	43	excited	excited	JJ
46745	2854	44	and	and	CC
46745	2854	45	kept	keep	VBD
46745	2854	46	up	up	RP
46745	2854	47	.	.	.
46745	2855	1	In	in	IN
46745	2855	2	the	the	DT
46745	2855	3	Typhoid	Typhoid	NNP
46745	2855	4	and	and	CC
46745	2855	5	Eruptive	Eruptive	NNP
46745	2855	6	Fevers	Fevers	NNPS
46745	2855	7	,	,	,
46745	2855	8	when	when	WRB
46745	2855	9	the	the	DT
46745	2855	10	blood	blood	NN
46745	2855	11	is	be	VBZ
46745	2855	12	already	already	RB
46745	2855	13	sufficiently	sufficiently	RB
46745	2855	14	deteriorated	deteriorate	VBN
46745	2855	15	,	,	,
46745	2855	16	and	and	CC
46745	2855	17	it	-PRON-	PRP
46745	2855	18	is	be	VBZ
46745	2855	19	not	not	RB
46745	2855	20	desirable	desirable	JJ
46745	2855	21	that	that	IN
46745	2855	22	we	-PRON-	PRP
46745	2855	23	should	should	MD
46745	2855	24	reduce	reduce	VB
46745	2855	25	the	the	DT
46745	2855	26	vital	vital	JJ
46745	2855	27	powers	power	NNS
46745	2855	28	beyond	beyond	IN
46745	2855	29	a	a	DT
46745	2855	30	certain	certain	JJ
46745	2855	31	point	point	NN
46745	2855	32	,	,	,
46745	2855	33	Salines	saline	NNS
46745	2855	34	,	,	,
46745	2855	35	as	as	IN
46745	2855	36	Nitrate	nitrate	JJ
46745	2855	37	and	and	CC
46745	2855	38	Chlorate	Chlorate	NNP
46745	2855	39	of	of	IN
46745	2855	40	Potash	Potash	NNP
46745	2855	41	,	,	,
46745	2855	42	supply	supply	VB
46745	2855	43	us	-PRON-	PRP
46745	2855	44	with	with	IN
46745	2855	45	a	a	DT
46745	2855	46	set	set	NN
46745	2855	47	of	of	IN
46745	2855	48	valuable	valuable	JJ
46745	2855	49	and	and	CC
46745	2855	50	sufficiently	sufficiently	RB
46745	2855	51	mild	mild	JJ
46745	2855	52	Antiphlogistic	antiphlogistic	JJ
46745	2855	53	agents	agent	NNS
46745	2855	54	.	.	.
46745	2856	1	It	-PRON-	PRP
46745	2856	2	seems	seem	VBZ
46745	2856	3	that	that	IN
46745	2856	4	they	-PRON-	PRP
46745	2856	5	both	both	DT
46745	2856	6	exercise	exercise	VBP
46745	2856	7	a	a	DT
46745	2856	8	solvent	solvent	NN
46745	2856	9	power	power	NN
46745	2856	10	over	over	IN
46745	2856	11	Fibrine	Fibrine	NNP
46745	2856	12	,	,	,
46745	2856	13	and	and	CC
46745	2856	14	keep	keep	VB
46745	2856	15	asunder	asunder	RB
46745	2856	16	the	the	DT
46745	2856	17	corpuscles	corpuscle	NNS
46745	2856	18	which	which	WDT
46745	2856	19	tend	tend	VBP
46745	2856	20	to	to	TO
46745	2856	21	adhere	adhere	VB
46745	2856	22	together	together	RB
46745	2856	23	in	in	IN
46745	2856	24	inflammatory	inflammatory	JJ
46745	2856	25	blood	blood	NN
46745	2856	26	.	.	.
46745	2857	1	This	this	DT
46745	2857	2	latter	latter	JJ
46745	2857	3	action	action	NN
46745	2857	4	has	have	VBZ
46745	2857	5	been	be	VBN
46745	2857	6	observed	observe	VBN
46745	2857	7	by	by	IN
46745	2857	8	Mr.	Mr.	NNP
46745	2857	9	Gulliver	Gulliver	NNP
46745	2857	10	.	.	.
46745	2858	1	Salts	Salts	NNP
46745	2858	2	are	be	VBP
46745	2858	3	excreted	excrete	VBN
46745	2858	4	,	,	,
46745	2858	5	and	and	CC
46745	2858	6	act	act	VB
46745	2858	7	on	on	IN
46745	2858	8	the	the	DT
46745	2858	9	skin	skin	NN
46745	2858	10	,	,	,
46745	2858	11	or	or	CC
46745	2858	12	the	the	DT
46745	2858	13	kidneys	kidney	NNS
46745	2858	14	,	,	,
46745	2858	15	or	or	CC
46745	2858	16	the	the	DT
46745	2858	17	bowels	bowel	NNS
46745	2858	18	.	.	.
46745	2859	1	They	-PRON-	PRP
46745	2859	2	are	be	VBP
46745	2859	3	not	not	RB
46745	2859	4	so	so	RB
46745	2859	5	potent	potent	JJ
46745	2859	6	as	as	IN
46745	2859	7	Alkalies	alkali	NNS
46745	2859	8	;	;	:
46745	2859	9	for	for	IN
46745	2859	10	salts	salt	NNS
46745	2859	11	pass	pass	VBP
46745	2859	12	out	out	IN
46745	2859	13	of	of	IN
46745	2859	14	the	the	DT
46745	2859	15	body	body	NN
46745	2859	16	as	as	IN
46745	2859	17	they	-PRON-	PRP
46745	2859	18	went	go	VBD
46745	2859	19	in	in	RP
46745	2859	20	;	;	:
46745	2859	21	but	but	CC
46745	2859	22	Alkalies	alkali	NNS
46745	2859	23	pass	pass	VBP
46745	2859	24	out	out	RP
46745	2859	25	into	into	IN
46745	2859	26	the	the	DT
46745	2859	27	secretions	secretion	NNS
46745	2859	28	as	as	IN
46745	2859	29	salts	salt	NNS
46745	2859	30	,	,	,
46745	2859	31	having	have	VBG
46745	2859	32	first	first	RB
46745	2859	33	combined	combine	VBN
46745	2859	34	with	with	IN
46745	2859	35	acid	acid	NN
46745	2859	36	in	in	IN
46745	2859	37	the	the	DT
46745	2859	38	system	system	NN
46745	2859	39	,	,	,
46745	2859	40	so	so	IN
46745	2859	41	that	that	IN
46745	2859	42	they	-PRON-	PRP
46745	2859	43	must	must	MD
46745	2859	44	leave	leave	VB
46745	2859	45	behind	behind	IN
46745	2859	46	them	-PRON-	PRP
46745	2859	47	a	a	DT
46745	2859	48	certain	certain	JJ
46745	2859	49	excess	excess	NN
46745	2859	50	of	of	IN
46745	2859	51	alkali	alkali	JJ
46745	2859	52	in	in	IN
46745	2859	53	the	the	DT
46745	2859	54	blood	blood	NN
46745	2859	55	,	,	,
46745	2859	56	by	by	IN
46745	2859	57	which	which	WDT
46745	2859	58	their	-PRON-	PRP$
46745	2859	59	action	action	NN
46745	2859	60	is	be	VBZ
46745	2859	61	continued	continue	VBN
46745	2859	62	for	for	IN
46745	2859	63	some	some	DT
46745	2859	64	time	time	NN
46745	2859	65	.	.	.
46745	2860	1	(	(	-LRB-
46745	2860	2	_	_	NNP
46745	2860	3	Vide	Vide	NNP
46745	2860	4	Alkalies	Alkalies	NNP
46745	2860	5	;	;	:
46745	2860	6	Prop	Prop	NNP
46745	2860	7	.	.	.
46745	2861	1	VIII	VIII	NNP
46745	2861	2	.	.	.
46745	2862	1	;	;	:
46745	2862	2	Antimony	Antimony	NNP
46745	2862	3	and	and	CC
46745	2862	4	Mercury	Mercury	NNP
46745	2862	5	in	in	IN
46745	2862	6	Chap	Chap	NNP
46745	2862	7	.	.	.
46745	2863	1	IV	IV	NNP
46745	2863	2	.	.	.
46745	2863	3	_	_	NNP
46745	2863	4	)	)	-RRB-
46745	2863	5	ORD	ORD	NNP
46745	2863	6	.	.	.
46745	2864	1	II	ii	CD
46745	2864	2	.	.	.
46745	2865	1	ANTISYPHILITICS	antisyphilitics	RB
46745	2865	2	.	.	.
46745	2866	1	These	these	DT
46745	2866	2	are	be	VBP
46745	2866	3	medicines	medicine	NNS
46745	2866	4	whose	whose	WP$
46745	2866	5	operation	operation	NN
46745	2866	6	in	in	IN
46745	2866	7	the	the	DT
46745	2866	8	blood	blood	NN
46745	2866	9	results	result	NNS
46745	2866	10	in	in	IN
46745	2866	11	the	the	DT
46745	2866	12	counteraction	counteraction	NN
46745	2866	13	or	or	CC
46745	2866	14	neutralization	neutralization	NN
46745	2866	15	of	of	IN
46745	2866	16	the	the	DT
46745	2866	17	syphilitic	syphilitic	JJ
46745	2866	18	poison	poison	NN
46745	2866	19	.	.	.
46745	2867	1	In	in	IN
46745	2867	2	primary	primary	JJ
46745	2867	3	forms	form	NNS
46745	2867	4	of	of	IN
46745	2867	5	Syphilis	Syphilis	NNP
46745	2867	6	,	,	,
46745	2867	7	as	as	IN
46745	2867	8	the	the	DT
46745	2867	9	chancre	chancre	NN
46745	2867	10	,	,	,
46745	2867	11	and	and	CC
46745	2867	12	early	early	JJ
46745	2867	13	eruptions,--as	eruptions,--as	NNP
46745	2867	14	syphilitic	syphilitic	NN
46745	2867	15	Lichen	Lichen	NNP
46745	2867	16	,	,	,
46745	2867	17	Roseola	Roseola	NNP
46745	2867	18	and	and	CC
46745	2867	19	Lepra,--also	Lepra,--also	NNP
46745	2867	20	in	in	IN
46745	2867	21	syphilitic	syphilitic	JJ
46745	2867	22	Iritis	Iritis	NNP
46745	2867	23	,	,	,
46745	2867	24	Mercury	Mercury	NNP
46745	2867	25	is	be	VBZ
46745	2867	26	the	the	DT
46745	2867	27	single	single	JJ
46745	2867	28	and	and	CC
46745	2867	29	best	good	JJS
46745	2867	30	remedy	remedy	NN
46745	2867	31	.	.	.
46745	2868	1	Its	-PRON-	PRP$
46745	2868	2	power	power	NN
46745	2868	3	is	be	VBZ
46745	2868	4	universally	universally	RB
46745	2868	5	admitted	admit	VBN
46745	2868	6	,	,	,
46745	2868	7	both	both	CC
46745	2868	8	by	by	IN
46745	2868	9	English	English	NNP
46745	2868	10	and	and	CC
46745	2868	11	Continental	Continental	NNP
46745	2868	12	surgeons	surgeon	NNS
46745	2868	13	.	.	.
46745	2869	1	It	-PRON-	PRP
46745	2869	2	is	be	VBZ
46745	2869	3	often	often	RB
46745	2869	4	esteemed	esteem	VBN
46745	2869	5	a	a	DT
46745	2869	6	specific	specific	NN
46745	2869	7	.	.	.
46745	2870	1	Among	among	IN
46745	2870	2	others	other	NNS
46745	2870	3	,	,	,
46745	2870	4	Mr.	Mr.	NNP
46745	2870	5	Hunt	Hunt	NNP
46745	2870	6	,	,	,
46745	2870	7	in	in	IN
46745	2870	8	a	a	DT
46745	2870	9	treatise	treatise	NN
46745	2870	10	on	on	IN
46745	2870	11	Syphilitic	syphilitic	JJ
46745	2870	12	eruptions	eruption	NNS
46745	2870	13	,	,	,
46745	2870	14	maintains	maintain	VBZ
46745	2870	15	that	that	IN
46745	2870	16	Syphilis	Syphilis	NNP
46745	2870	17	has	have	VBZ
46745	2870	18	a	a	DT
46745	2870	19	tendency	tendency	NN
46745	2870	20	to	to	TO
46745	2870	21	go	go	VB
46745	2870	22	on	on	RP
46745	2870	23	without	without	IN
46745	2870	24	limit	limit	NN
46745	2870	25	if	if	IN
46745	2870	26	left	leave	VBD
46745	2870	27	alone	alone	RB
46745	2870	28	,	,	,
46745	2870	29	but	but	CC
46745	2870	30	that	that	IN
46745	2870	31	Mercury	Mercury	NNP
46745	2870	32	in	in	IN
46745	2870	33	sufficient	sufficient	JJ
46745	2870	34	doses	dose	NNS
46745	2870	35	possesses	possess	VBZ
46745	2870	36	the	the	DT
46745	2870	37	power	power	NN
46745	2870	38	of	of	IN
46745	2870	39	totally	totally	RB
46745	2870	40	destroying	destroy	VBG
46745	2870	41	the	the	DT
46745	2870	42	poison	poison	NN
46745	2870	43	,	,	,
46745	2870	44	and	and	CC
46745	2870	45	preventing	prevent	VBG
46745	2870	46	its	-PRON-	PRP$
46745	2870	47	transmission	transmission	NN
46745	2870	48	.	.	.
46745	2871	1	Mr.	Mr.	NNP
46745	2871	2	Carmichael	Carmichael	NNP
46745	2871	3	was	be	VBD
46745	2871	4	of	of	IN
46745	2871	5	opinion	opinion	NN
46745	2871	6	that	that	IN
46745	2871	7	Mercury	Mercury	NNP
46745	2871	8	was	be	VBD
46745	2871	9	only	only	RB
46745	2871	10	applicable	applicable	JJ
46745	2871	11	in	in	IN
46745	2871	12	those	those	DT
46745	2871	13	cases	case	NNS
46745	2871	14	which	which	WDT
46745	2871	15	exhibited	exhibit	VBD
46745	2871	16	the	the	DT
46745	2871	17	true	true	JJ
46745	2871	18	Hunterian	hunterian	JJ
46745	2871	19	chancre	chancre	NN
46745	2871	20	,	,	,
46745	2871	21	round	round	JJ
46745	2871	22	,	,	,
46745	2871	23	cup	cup	NN
46745	2871	24	-	-	HYPH
46745	2871	25	like	like	JJ
46745	2871	26	,	,	,
46745	2871	27	and	and	CC
46745	2871	28	hard	hard	RB
46745	2871	29	,	,	,
46745	2871	30	followed	follow	VBN
46745	2871	31	by	by	IN
46745	2871	32	a	a	DT
46745	2871	33	leprous	leprous	JJ
46745	2871	34	eruption	eruption	NN
46745	2871	35	.	.	.
46745	2872	1	But	but	CC
46745	2872	2	it	-PRON-	PRP
46745	2872	3	is	be	VBZ
46745	2872	4	more	more	JJR
46745	2872	5	in	in	IN
46745	2872	6	accordance	accordance	NN
46745	2872	7	with	with	IN
46745	2872	8	common	common	JJ
46745	2872	9	experience	experience	NN
46745	2872	10	to	to	TO
46745	2872	11	say	say	VB
46745	2872	12	that	that	IN
46745	2872	13	the	the	DT
46745	2872	14	only	only	JJ
46745	2872	15	contra	contra	NNP
46745	2872	16	-	-	,
46745	2872	17	indications	indication	NNS
46745	2872	18	to	to	IN
46745	2872	19	the	the	DT
46745	2872	20	use	use	NN
46745	2872	21	of	of	IN
46745	2872	22	Mercury	Mercury	NNP
46745	2872	23	in	in	IN
46745	2872	24	primary	primary	JJ
46745	2872	25	Syphilis	Syphilis	NNP
46745	2872	26	are	be	VBP
46745	2872	27	these	these	DT
46745	2872	28	--	--	:
46745	2872	29	a	a	DT
46745	2872	30	scrofulous	scrofulous	JJ
46745	2872	31	or	or	CC
46745	2872	32	very	very	RB
46745	2872	33	debilitated	debilitated	JJ
46745	2872	34	state	state	NN
46745	2872	35	of	of	IN
46745	2872	36	the	the	DT
46745	2872	37	system	system	NN
46745	2872	38	;	;	:
46745	2872	39	and	and	CC
46745	2872	40	a	a	DT
46745	2872	41	sloughing	sloughing	JJ
46745	2872	42	or	or	CC
46745	2872	43	irregular	irregular	JJ
46745	2872	44	appearance	appearance	NN
46745	2872	45	of	of	IN
46745	2872	46	the	the	DT
46745	2872	47	primary	primary	JJ
46745	2872	48	sore	sore	NN
46745	2872	49	.	.	.
46745	2873	1	We	-PRON-	PRP
46745	2873	2	may	may	MD
46745	2873	3	administer	administer	VB
46745	2873	4	Mercury	Mercury	NNP
46745	2873	5	in	in	IN
46745	2873	6	two	two	CD
46745	2873	7	forms	form	NNS
46745	2873	8	.	.	.
46745	2874	1	It	-PRON-	PRP
46745	2874	2	may	may	MD
46745	2874	3	be	be	VB
46745	2874	4	given	give	VBN
46745	2874	5	as	as	IN
46745	2874	6	Calomel	Calomel	NNP
46745	2874	7	or	or	CC
46745	2874	8	Blue	blue	JJ
46745	2874	9	pill	pill	NN
46745	2874	10	,	,	,
46745	2874	11	with	with	IN
46745	2874	12	or	or	CC
46745	2874	13	without	without	IN
46745	2874	14	Opium	Opium	NNP
46745	2874	15	,	,	,
46745	2874	16	and	and	CC
46745	2874	17	continued	continue	VBD
46745	2874	18	until	until	IN
46745	2874	19	it	-PRON-	PRP
46745	2874	20	affects	affect	VBZ
46745	2874	21	the	the	DT
46745	2874	22	mouth	mouth	NN
46745	2874	23	.	.	.
46745	2875	1	Or	or	CC
46745	2875	2	the	the	DT
46745	2875	3	Bichloride	Bichloride	NNP
46745	2875	4	may	may	MD
46745	2875	5	be	be	VB
46745	2875	6	administered	administer	VBN
46745	2875	7	in	in	IN
46745	2875	8	minute	minute	NN
46745	2875	9	doses	dose	NNS
46745	2875	10	,	,	,
46745	2875	11	and	and	CC
46745	2875	12	may	may	MD
46745	2875	13	prove	prove	VB
46745	2875	14	efficacious	efficacious	JJ
46745	2875	15	without	without	IN
46745	2875	16	producing	produce	VBG
46745	2875	17	salivation	salivation	NN
46745	2875	18	.	.	.
46745	2876	1	It	-PRON-	PRP
46745	2876	2	should	should	MD
46745	2876	3	be	be	VB
46745	2876	4	commenced	commence	VBN
46745	2876	5	as	as	RB
46745	2876	6	early	early	RB
46745	2876	7	as	as	IN
46745	2876	8	possible	possible	JJ
46745	2876	9	;	;	:
46745	2876	10	and	and	CC
46745	2876	11	in	in	IN
46745	2876	12	most	most	JJS
46745	2876	13	cases	case	NNS
46745	2876	14	the	the	DT
46745	2876	15	action	action	NN
46745	2876	16	of	of	IN
46745	2876	17	Mercury	Mercury	NNP
46745	2876	18	in	in	IN
46745	2876	19	the	the	DT
46745	2876	20	blood	blood	NN
46745	2876	21	,	,	,
46745	2876	22	of	of	IN
46745	2876	23	whatever	whatever	WDT
46745	2876	24	nature	nature	NN
46745	2876	25	that	that	IN
46745	2876	26	action	action	NN
46745	2876	27	may	may	MD
46745	2876	28	be	be	VB
46745	2876	29	,	,	,
46745	2876	30	will	will	MD
46745	2876	31	meet	meet	VB
46745	2876	32	and	and	CC
46745	2876	33	neutralize	neutralize	VB
46745	2876	34	the	the	DT
46745	2876	35	advance	advance	NN
46745	2876	36	of	of	IN
46745	2876	37	the	the	DT
46745	2876	38	syphilitic	syphilitic	JJ
46745	2876	39	virus	virus	NN
46745	2876	40	,	,	,
46745	2876	41	preventing	prevent	VBG
46745	2876	42	its	-PRON-	PRP$
46745	2876	43	further	further	JJ
46745	2876	44	manifestation	manifestation	NN
46745	2876	45	in	in	IN
46745	2876	46	a	a	DT
46745	2876	47	secondary	secondary	JJ
46745	2876	48	form	form	NN
46745	2876	49	.	.	.
46745	2877	1	It	-PRON-	PRP
46745	2877	2	is	be	VBZ
46745	2877	3	rarely	rarely	RB
46745	2877	4	necessary	necessary	JJ
46745	2877	5	to	to	TO
46745	2877	6	push	push	VB
46745	2877	7	its	-PRON-	PRP$
46745	2877	8	action	action	NN
46745	2877	9	beyond	beyond	IN
46745	2877	10	the	the	DT
46745	2877	11	first	first	JJ
46745	2877	12	symptom	symptom	NN
46745	2877	13	of	of	IN
46745	2877	14	salivation	salivation	NN
46745	2877	15	;	;	:
46745	2877	16	for	for	IN
46745	2877	17	that	that	DT
46745	2877	18	will	will	MD
46745	2877	19	be	be	VB
46745	2877	20	evidence	evidence	NN
46745	2877	21	that	that	IN
46745	2877	22	the	the	DT
46745	2877	23	system	system	NN
46745	2877	24	is	be	VBZ
46745	2877	25	sufficiently	sufficiently	RB
46745	2877	26	saturated	saturate	VBN
46745	2877	27	with	with	IN
46745	2877	28	it	-PRON-	PRP
46745	2877	29	.	.	.
46745	2878	1	Beneficial	beneficial	JJ
46745	2878	2	as	as	IN
46745	2878	3	it	-PRON-	PRP
46745	2878	4	often	often	RB
46745	2878	5	proves	prove	VBZ
46745	2878	6	when	when	WRB
46745	2878	7	administered	administer	VBN
46745	2878	8	thus	thus	RB
46745	2878	9	cautiously	cautiously	RB
46745	2878	10	,	,	,
46745	2878	11	yet	yet	RB
46745	2878	12	,	,	,
46745	2878	13	if	if	IN
46745	2878	14	given	give	VBN
46745	2878	15	in	in	IN
46745	2878	16	excess	excess	NN
46745	2878	17	,	,	,
46745	2878	18	or	or	CC
46745	2878	19	to	to	IN
46745	2878	20	individuals	individual	NNS
46745	2878	21	that	that	WDT
46745	2878	22	are	be	VBP
46745	2878	23	over	over	RB
46745	2878	24	-	-	HYPH
46745	2878	25	susceptible	susceptible	JJ
46745	2878	26	of	of	IN
46745	2878	27	its	-PRON-	PRP$
46745	2878	28	action	action	NN
46745	2878	29	,	,	,
46745	2878	30	it	-PRON-	PRP
46745	2878	31	is	be	VBZ
46745	2878	32	capable	capable	JJ
46745	2878	33	of	of	IN
46745	2878	34	proving	prove	VBG
46745	2878	35	a	a	DT
46745	2878	36	poison	poison	NN
46745	2878	37	every	every	DT
46745	2878	38	whit	whit	NN
46745	2878	39	as	as	RB
46745	2878	40	noxious	noxious	JJ
46745	2878	41	as	as	IN
46745	2878	42	the	the	DT
46745	2878	43	Syphilis	Syphilis	NNP
46745	2878	44	which	which	WDT
46745	2878	45	it	-PRON-	PRP
46745	2878	46	was	be	VBD
46745	2878	47	intended	intend	VBN
46745	2878	48	to	to	TO
46745	2878	49	neutralize	neutralize	VB
46745	2878	50	.	.	.
46745	2879	1	The	the	DT
46745	2879	2	mercurial	mercurial	JJ
46745	2879	3	cachexy	cachexy	NN
46745	2879	4	is	be	VBZ
46745	2879	5	quite	quite	RB
46745	2879	6	as	as	RB
46745	2879	7	deplorable	deplorable	JJ
46745	2879	8	,	,	,
46745	2879	9	and	and	CC
46745	2879	10	quite	quite	RB
46745	2879	11	as	as	RB
46745	2879	12	incurable	incurable	JJ
46745	2879	13	as	as	IN
46745	2879	14	the	the	DT
46745	2879	15	Syphilitic	syphilitic	JJ
46745	2879	16	cachexy	cachexy	NN
46745	2879	17	.	.	.
46745	2880	1	The	the	DT
46745	2880	2	Terchloride	terchloride	NN
46745	2880	3	of	of	IN
46745	2880	4	Gold	gold	NN
46745	2880	5	may	may	MD
46745	2880	6	be	be	VB
46745	2880	7	used	use	VBN
46745	2880	8	in	in	IN
46745	2880	9	Syphilis	Syphilis	NNP
46745	2880	10	in	in	IN
46745	2880	11	the	the	DT
46745	2880	12	same	same	JJ
46745	2880	13	way	way	NN
46745	2880	14	as	as	IN
46745	2880	15	the	the	DT
46745	2880	16	Bichloride	Bichloride	NNP
46745	2880	17	of	of	IN
46745	2880	18	Mercury	Mercury	NNP
46745	2880	19	;	;	:
46745	2880	20	but	but	CC
46745	2880	21	it	-PRON-	PRP
46745	2880	22	is	be	VBZ
46745	2880	23	much	much	RB
46745	2880	24	more	more	RBR
46745	2880	25	seldom	seldom	RB
46745	2880	26	employed	employ	VBN
46745	2880	27	.	.	.
46745	2881	1	There	there	EX
46745	2881	2	seems	seem	VBZ
46745	2881	3	to	to	TO
46745	2881	4	be	be	VB
46745	2881	5	a	a	DT
46745	2881	6	strong	strong	JJ
46745	2881	7	medicinal	medicinal	JJ
46745	2881	8	as	as	RB
46745	2881	9	well	well	RB
46745	2881	10	as	as	IN
46745	2881	11	chemical	chemical	NN
46745	2881	12	similarity	similarity	NN
46745	2881	13	between	between	IN
46745	2881	14	these	these	DT
46745	2881	15	two	two	CD
46745	2881	16	metals	metal	NNS
46745	2881	17	and	and	CC
46745	2881	18	their	-PRON-	PRP$
46745	2881	19	compounds	compound	NNS
46745	2881	20	.	.	.
46745	2882	1	Even	even	RB
46745	2882	2	the	the	DT
46745	2882	3	insoluble	insoluble	JJ
46745	2882	4	metal	metal	NN
46745	2882	5	itself	-PRON-	PRP
46745	2882	6	was	be	VBD
46745	2882	7	used	use	VBN
46745	2882	8	some	some	DT
46745	2882	9	time	time	NN
46745	2882	10	ago	ago	RB
46745	2882	11	as	as	IN
46745	2882	12	an	an	DT
46745	2882	13	Antisyphilitic	Antisyphilitic	NNP
46745	2882	14	,	,	,
46745	2882	15	apparently	apparently	RB
46745	2882	16	with	with	IN
46745	2882	17	success	success	NN
46745	2882	18	.	.	.
46745	2883	1	In	in	IN
46745	2883	2	1715	1715	CD
46745	2883	3	,	,	,
46745	2883	4	Dr.	Dr.	NNP
46745	2883	5	A.	A.	NNP
46745	2883	6	Pitcairn	Pitcairn	NNP
46745	2883	7	recommended	recommend	VBD
46745	2883	8	finely	finely	RB
46745	2883	9	-	-	HYPH
46745	2883	10	powered	power	VBN
46745	2883	11	Gold	gold	NN
46745	2883	12	as	as	IN
46745	2883	13	even	even	RB
46745	2883	14	more	more	RBR
46745	2883	15	efficacious	efficacious	JJ
46745	2883	16	than	than	IN
46745	2883	17	Mercury	Mercury	NNP
46745	2883	18	in	in	IN
46745	2883	19	the	the	DT
46745	2883	20	treatment	treatment	NN
46745	2883	21	of	of	IN
46745	2883	22	Syphilis	Syphilis	NNP
46745	2883	23	.	.	.
46745	2884	1	In	in	IN
46745	2884	2	secondary	secondary	JJ
46745	2884	3	forms	form	NNS
46745	2884	4	of	of	IN
46745	2884	5	this	this	DT
46745	2884	6	disorder	disorder	NN
46745	2884	7	,	,	,
46745	2884	8	as	as	IN
46745	2884	9	in	in	IN
46745	2884	10	Periostitis	Periostitis	NNP
46745	2884	11	,	,	,
46745	2884	12	ulceration	ulceration	NN
46745	2884	13	of	of	IN
46745	2884	14	the	the	DT
46745	2884	15	mouth	mouth	NN
46745	2884	16	and	and	CC
46745	2884	17	throat,--or	throat,--or	NNP
46745	2884	18	in	in	IN
46745	2884	19	any	any	DT
46745	2884	20	of	of	IN
46745	2884	21	the	the	DT
46745	2884	22	late	late	JJ
46745	2884	23	rashes	rash	NNS
46745	2884	24	,	,	,
46745	2884	25	as	as	IN
46745	2884	26	Rupia,--Iodide	rupia,--iodide	NN
46745	2884	27	of	of	IN
46745	2884	28	Potassium	Potassium	NNP
46745	2884	29	is	be	VBZ
46745	2884	30	the	the	DT
46745	2884	31	best	good	JJS
46745	2884	32	remedy	remedy	NN
46745	2884	33	.	.	.
46745	2885	1	Its	-PRON-	PRP$
46745	2885	2	efficacy	efficacy	NN
46745	2885	3	in	in	IN
46745	2885	4	such	such	JJ
46745	2885	5	cases	case	NNS
46745	2885	6	was	be	VBD
46745	2885	7	discovered	discover	VBN
46745	2885	8	by	by	IN
46745	2885	9	the	the	DT
46745	2885	10	late	late	JJ
46745	2885	11	Dr.	Dr.	NNP
46745	2885	12	Williams	Williams	NNP
46745	2885	13	.	.	.
46745	2886	1	It	-PRON-	PRP
46745	2886	2	may	may	MD
46745	2886	3	sometimes	sometimes	RB
46745	2886	4	fail	fail	VB
46745	2886	5	to	to	TO
46745	2886	6	effect	effect	VB
46745	2886	7	a	a	DT
46745	2886	8	cure	cure	NN
46745	2886	9	;	;	:
46745	2886	10	but	but	CC
46745	2886	11	this	this	DT
46745	2886	12	failure	failure	NN
46745	2886	13	is	be	VBZ
46745	2886	14	often	often	RB
46745	2886	15	due	due	JJ
46745	2886	16	to	to	IN
46745	2886	17	the	the	DT
46745	2886	18	omission	omission	NN
46745	2886	19	of	of	IN
46745	2886	20	Mercury	Mercury	NNP
46745	2886	21	in	in	IN
46745	2886	22	the	the	DT
46745	2886	23	treatment	treatment	NN
46745	2886	24	of	of	IN
46745	2886	25	the	the	DT
46745	2886	26	primary	primary	JJ
46745	2886	27	disease	disease	NN
46745	2886	28	.	.	.
46745	2887	1	It	-PRON-	PRP
46745	2887	2	would	would	MD
46745	2887	3	seem	seem	VB
46745	2887	4	as	as	IN
46745	2887	5	if	if	IN
46745	2887	6	it	-PRON-	PRP
46745	2887	7	were	be	VBD
46745	2887	8	not	not	RB
46745	2887	9	so	so	RB
46745	2887	10	much	much	RB
46745	2887	11	the	the	DT
46745	2887	12	real	real	JJ
46745	2887	13	secondary	secondary	JJ
46745	2887	14	syphilis	syphili	NNS
46745	2887	15	,	,	,
46745	2887	16	but	but	CC
46745	2887	17	a	a	DT
46745	2887	18	certain	certain	JJ
46745	2887	19	smouldering	smoulder	VBG
46745	2887	20	action	action	NN
46745	2887	21	of	of	IN
46745	2887	22	a	a	DT
46745	2887	23	part	part	NN
46745	2887	24	of	of	IN
46745	2887	25	the	the	DT
46745	2887	26	poison	poison	NN
46745	2887	27	which	which	WDT
46745	2887	28	has	have	VBZ
46745	2887	29	escaped	escape	VBN
46745	2887	30	the	the	DT
46745	2887	31	operation	operation	NN
46745	2887	32	of	of	IN
46745	2887	33	Mercury	Mercury	NNP
46745	2887	34	,	,	,
46745	2887	35	but	but	CC
46745	2887	36	has	have	VBZ
46745	2887	37	been	be	VBN
46745	2887	38	modified	modify	VBN
46745	2887	39	by	by	IN
46745	2887	40	it	-PRON-	PRP
46745	2887	41	,	,	,
46745	2887	42	which	which	WDT
46745	2887	43	is	be	VBZ
46745	2887	44	capable	capable	JJ
46745	2887	45	of	of	IN
46745	2887	46	being	be	VBG
46745	2887	47	met	meet	VBN
46745	2887	48	and	and	CC
46745	2887	49	controlled	control	VBN
46745	2887	50	by	by	IN
46745	2887	51	Iodide	Iodide	NNP
46745	2887	52	of	of	IN
46745	2887	53	Potassium	Potassium	NNP
46745	2887	54	.	.	.
46745	2888	1	In	in	IN
46745	2888	2	cases	case	NNS
46745	2888	3	where	where	WRB
46745	2888	4	this	this	DT
46745	2888	5	remedy	remedy	NN
46745	2888	6	fails	fail	VBZ
46745	2888	7	,	,	,
46745	2888	8	I	-PRON-	PRP
46745	2888	9	have	have	VBP
46745	2888	10	found	find	VBN
46745	2888	11	that	that	IN
46745	2888	12	a	a	DT
46745	2888	13	course	course	NN
46745	2888	14	of	of	IN
46745	2888	15	the	the	DT
46745	2888	16	Bichloride	Bichloride	NNP
46745	2888	17	of	of	IN
46745	2888	18	Mercury	Mercury	NNP
46745	2888	19	,	,	,
46745	2888	20	combined	combine	VBN
46745	2888	21	with	with	IN
46745	2888	22	Sarsaparilla	Sarsaparilla	NNP
46745	2888	23	or	or	CC
46745	2888	24	some	some	DT
46745	2888	25	bitter	bitter	JJ
46745	2888	26	tonic	tonic	NN
46745	2888	27	,	,	,
46745	2888	28	proves	prove	VBZ
46745	2888	29	very	very	RB
46745	2888	30	beneficial	beneficial	JJ
46745	2888	31	.	.	.
46745	2889	1	But	but	CC
46745	2889	2	the	the	DT
46745	2889	3	action	action	NN
46745	2889	4	of	of	IN
46745	2889	5	the	the	DT
46745	2889	6	Iodide	Iodide	NNP
46745	2889	7	on	on	IN
46745	2889	8	a	a	DT
46745	2889	9	case	case	NN
46745	2889	10	of	of	IN
46745	2889	11	Periostitis	Periostitis	NNP
46745	2889	12	,	,	,
46745	2889	13	and	and	CC
46745	2889	14	the	the	DT
46745	2889	15	rapid	rapid	JJ
46745	2889	16	absorption	absorption	NN
46745	2889	17	that	that	WDT
46745	2889	18	follows	follow	VBZ
46745	2889	19	its	-PRON-	PRP$
46745	2889	20	exhibition	exhibition	NN
46745	2889	21	,	,	,
46745	2889	22	are	be	VBP
46745	2889	23	sometimes	sometimes	RB
46745	2889	24	fully	fully	RB
46745	2889	25	as	as	RB
46745	2889	26	remarkable	remarkable	JJ
46745	2889	27	as	as	IN
46745	2889	28	the	the	DT
46745	2889	29	influence	influence	NN
46745	2889	30	of	of	IN
46745	2889	31	Mercury	Mercury	NNP
46745	2889	32	over	over	IN
46745	2889	33	the	the	DT
46745	2889	34	primary	primary	JJ
46745	2889	35	disorder	disorder	NN
46745	2889	36	.	.	.
46745	2890	1	Sarsaparilla	Sarsaparilla	NNP
46745	2890	2	is	be	VBZ
46745	2890	3	a	a	DT
46745	2890	4	very	very	RB
46745	2890	5	doubtful	doubtful	JJ
46745	2890	6	member	member	NN
46745	2890	7	of	of	IN
46745	2890	8	this	this	DT
46745	2890	9	order	order	NN
46745	2890	10	.	.	.
46745	2891	1	It	-PRON-	PRP
46745	2891	2	contains	contain	VBZ
46745	2891	3	a	a	DT
46745	2891	4	soluble	soluble	JJ
46745	2891	5	principle	principle	NN
46745	2891	6	called	call	VBN
46745	2891	7	Smilacine	Smilacine	NNP
46745	2891	8	.	.	.
46745	2892	1	It	-PRON-	PRP
46745	2892	2	is	be	VBZ
46745	2892	3	thought	think	VBN
46745	2892	4	by	by	IN
46745	2892	5	some	some	DT
46745	2892	6	to	to	TO
46745	2892	7	purify	purify	VB
46745	2892	8	the	the	DT
46745	2892	9	blood	blood	NN
46745	2892	10	,	,	,
46745	2892	11	and	and	CC
46745	2892	12	also	also	RB
46745	2892	13	to	to	TO
46745	2892	14	have	have	VB
46745	2892	15	a	a	DT
46745	2892	16	kind	kind	NN
46745	2892	17	of	of	IN
46745	2892	18	specific	specific	JJ
46745	2892	19	influence	influence	NN
46745	2892	20	over	over	IN
46745	2892	21	it	-PRON-	PRP
46745	2892	22	in	in	IN
46745	2892	23	old	old	JJ
46745	2892	24	syphilitic	syphilitic	JJ
46745	2892	25	cases	case	NNS
46745	2892	26	.	.	.
46745	2893	1	If	if	IN
46745	2893	2	it	-PRON-	PRP
46745	2893	3	were	be	VBD
46745	2893	4	so	so	RB
46745	2893	5	,	,	,
46745	2893	6	we	-PRON-	PRP
46745	2893	7	should	should	MD
46745	2893	8	have	have	VB
46745	2893	9	from	from	IN
46745	2893	10	the	the	DT
46745	2893	11	vegetable	vegetable	NN
46745	2893	12	kingdom	kingdom	NN
46745	2893	13	a	a	DT
46745	2893	14	distinct	distinct	JJ
46745	2893	15	analogue	analogue	NN
46745	2893	16	to	to	IN
46745	2893	17	one	one	CD
46745	2893	18	of	of	IN
46745	2893	19	these	these	DT
46745	2893	20	mysterious	mysterious	JJ
46745	2893	21	mineral	mineral	NN
46745	2893	22	Catalytics	Catalytics	NNP
46745	2893	23	.	.	.
46745	2894	1	But	but	CC
46745	2894	2	it	-PRON-	PRP
46745	2894	3	is	be	VBZ
46745	2894	4	so	so	RB
46745	2894	5	rarely	rarely	RB
46745	2894	6	given	give	VBN
46745	2894	7	without	without	IN
46745	2894	8	being	be	VBG
46745	2894	9	combined	combine	VBN
46745	2894	10	with	with	IN
46745	2894	11	some	some	DT
46745	2894	12	more	more	RBR
46745	2894	13	powerful	powerful	JJ
46745	2894	14	agent	agent	NN
46745	2894	15	,	,	,
46745	2894	16	that	that	IN
46745	2894	17	it	-PRON-	PRP
46745	2894	18	is	be	VBZ
46745	2894	19	difficult	difficult	JJ
46745	2894	20	to	to	TO
46745	2894	21	judge	judge	VB
46745	2894	22	whether	whether	IN
46745	2894	23	or	or	CC
46745	2894	24	not	not	RB
46745	2894	25	it	-PRON-	PRP
46745	2894	26	may	may	MD
46745	2894	27	have	have	VB
46745	2894	28	any	any	DT
46745	2894	29	striking	striking	JJ
46745	2894	30	virtues	virtue	NNS
46745	2894	31	of	of	IN
46745	2894	32	its	-PRON-	PRP$
46745	2894	33	own	own	JJ
46745	2894	34	.	.	.
46745	2895	1	The	the	DT
46745	2895	2	Antisyphilitics	Antisyphilitics	NNPS
46745	2895	3	,	,	,
46745	2895	4	particularly	particularly	RB
46745	2895	5	the	the	DT
46745	2895	6	insoluble	insoluble	JJ
46745	2895	7	compounds	compound	NNS
46745	2895	8	of	of	IN
46745	2895	9	Mercury	Mercury	NNP
46745	2895	10	,	,	,
46745	2895	11	are	be	VBP
46745	2895	12	frequently	frequently	RB
46745	2895	13	employed	employ	VBN
46745	2895	14	as	as	IN
46745	2895	15	local	local	JJ
46745	2895	16	applications	application	NNS
46745	2895	17	to	to	IN
46745	2895	18	sores	sore	NNS
46745	2895	19	and	and	CC
46745	2895	20	eruptions	eruption	NNS
46745	2895	21	.	.	.
46745	2896	1	When	when	WRB
46745	2896	2	these	these	DT
46745	2896	3	have	have	VBP
46745	2896	4	a	a	DT
46745	2896	5	syphilitic	syphilitic	JJ
46745	2896	6	origin	origin	NN
46745	2896	7	,	,	,
46745	2896	8	the	the	DT
46745	2896	9	mercurial	mercurial	JJ
46745	2896	10	doubtless	doubtless	RB
46745	2896	11	combats	combat	VBZ
46745	2896	12	the	the	DT
46745	2896	13	local	local	JJ
46745	2896	14	manifestation	manifestation	NN
46745	2896	15	in	in	IN
46745	2896	16	the	the	DT
46745	2896	17	same	same	JJ
46745	2896	18	way	way	NN
46745	2896	19	that	that	WDT
46745	2896	20	it	-PRON-	PRP
46745	2896	21	can	can	MD
46745	2896	22	counteract	counteract	VB
46745	2896	23	the	the	DT
46745	2896	24	general	general	JJ
46745	2896	25	action	action	NN
46745	2896	26	in	in	IN
46745	2896	27	the	the	DT
46745	2896	28	blood	blood	NN
46745	2896	29	.	.	.
46745	2897	1	In	in	IN
46745	2897	2	other	other	JJ
46745	2897	3	cases	case	NNS
46745	2897	4	the	the	DT
46745	2897	5	Mercury	Mercury	NNP
46745	2897	6	may	may	MD
46745	2897	7	pass	pass	VB
46745	2897	8	into	into	IN
46745	2897	9	the	the	DT
46745	2897	10	blood	blood	NN
46745	2897	11	of	of	IN
46745	2897	12	the	the	DT
46745	2897	13	part	part	NN
46745	2897	14	,	,	,
46745	2897	15	and	and	CC
46745	2897	16	,	,	,
46745	2897	17	by	by	IN
46745	2897	18	exerting	exert	VBG
46745	2897	19	in	in	IN
46745	2897	20	its	-PRON-	PRP$
46745	2897	21	antiphlogistic	antiphlogistic	JJ
46745	2897	22	operation	operation	NN
46745	2897	23	,	,	,
46745	2897	24	the	the	DT
46745	2897	25	result	result	NN
46745	2897	26	of	of	IN
46745	2897	27	which	which	WDT
46745	2897	28	is	be	VBZ
46745	2897	29	to	to	TO
46745	2897	30	diminish	diminish	VB
46745	2897	31	its	-PRON-	PRP$
46745	2897	32	plasticity	plasticity	NN
46745	2897	33	,	,	,
46745	2897	34	may	may	MD
46745	2897	35	thus	thus	RB
46745	2897	36	promote	promote	VB
46745	2897	37	absorption	absorption	NN
46745	2897	38	.	.	.
46745	2898	1	Mercurial	mercurial	JJ
46745	2898	2	ointment	ointment	NN
46745	2898	3	,	,	,
46745	2898	4	if	if	IN
46745	2898	5	rubbed	rub	VBN
46745	2898	6	into	into	IN
46745	2898	7	the	the	DT
46745	2898	8	skin	skin	NN
46745	2898	9	,	,	,
46745	2898	10	becomes	become	VBZ
46745	2898	11	in	in	IN
46745	2898	12	part	part	NN
46745	2898	13	absorbed	absorb	VBN
46745	2898	14	,	,	,
46745	2898	15	and	and	CC
46745	2898	16	may	may	MD
46745	2898	17	thus	thus	RB
46745	2898	18	produce	produce	VB
46745	2898	19	salivation	salivation	NN
46745	2898	20	.	.	.
46745	2899	1	ORD	ORD	NNP
46745	2899	2	.	.	.
46745	2900	1	III	iii	CD
46745	2900	2	.	.	.
46745	2901	1	ANTISCROFULICS	ANTISCROFULICS	NNP
46745	2901	2	.	.	.
46745	2902	1	These	these	DT
46745	2902	2	are	be	VBP
46745	2902	3	medicines	medicine	NNS
46745	2902	4	which	which	WDT
46745	2902	5	have	have	VBP
46745	2902	6	the	the	DT
46745	2902	7	power	power	NN
46745	2902	8	of	of	IN
46745	2902	9	counteracting	counteract	VBG
46745	2902	10	the	the	DT
46745	2902	11	poison	poison	NN
46745	2902	12	of	of	IN
46745	2902	13	Scrofula	Scrofula	NNP
46745	2902	14	in	in	IN
46745	2902	15	the	the	DT
46745	2902	16	blood	blood	NN
46745	2902	17	.	.	.
46745	2903	1	Common	common	JJ
46745	2903	2	and	and	CC
46745	2903	3	pernicious	pernicious	JJ
46745	2903	4	as	as	IN
46745	2903	5	is	be	VBZ
46745	2903	6	this	this	DT
46745	2903	7	disease	disease	NN
46745	2903	8	,	,	,
46745	2903	9	there	there	EX
46745	2903	10	are	be	VBP
46745	2903	11	not	not	RB
46745	2903	12	many	many	JJ
46745	2903	13	Catalytic	catalytic	JJ
46745	2903	14	remedies	remedy	NNS
46745	2903	15	which	which	WDT
46745	2903	16	exert	exert	VBP
46745	2903	17	any	any	DT
46745	2903	18	marked	marked	JJ
46745	2903	19	control	control	NN
46745	2903	20	over	over	IN
46745	2903	21	it	-PRON-	PRP
46745	2903	22	.	.	.
46745	2904	1	When	when	WRB
46745	2904	2	a	a	DT
46745	2904	3	strumous	strumous	JJ
46745	2904	4	condition	condition	NN
46745	2904	5	is	be	VBZ
46745	2904	6	chronic	chronic	JJ
46745	2904	7	,	,	,
46745	2904	8	and	and	CC
46745	2904	9	has	have	VBZ
46745	2904	10	firmly	firmly	RB
46745	2904	11	established	establish	VBN
46745	2904	12	itself	-PRON-	PRP
46745	2904	13	--	--	:
46745	2904	14	when	when	WRB
46745	2904	15	it	-PRON-	PRP
46745	2904	16	has	have	VBZ
46745	2904	17	descended	descend	VBN
46745	2904	18	through	through	IN
46745	2904	19	many	many	JJ
46745	2904	20	generations	generation	NNS
46745	2904	21	of	of	IN
46745	2904	22	the	the	DT
46745	2904	23	same	same	JJ
46745	2904	24	family,--it	family,--it	NNP
46745	2904	25	is	be	VBZ
46745	2904	26	very	very	RB
46745	2904	27	intractable	intractable	JJ
46745	2904	28	and	and	CC
46745	2904	29	difficult	difficult	JJ
46745	2904	30	to	to	TO
46745	2904	31	cure	cure	VB
46745	2904	32	.	.	.
46745	2905	1	Palliative	palliative	JJ
46745	2905	2	and	and	CC
46745	2905	3	indirect	indirect	JJ
46745	2905	4	remedies	remedy	NNS
46745	2905	5	,	,	,
46745	2905	6	aimed	aim	VBN
46745	2905	7	rather	rather	RB
46745	2905	8	at	at	IN
46745	2905	9	the	the	DT
46745	2905	10	consequences	consequence	NNS
46745	2905	11	than	than	IN
46745	2905	12	at	at	IN
46745	2905	13	the	the	DT
46745	2905	14	source	source	NN
46745	2905	15	of	of	IN
46745	2905	16	the	the	DT
46745	2905	17	disorder	disorder	NN
46745	2905	18	,	,	,
46745	2905	19	are	be	VBP
46745	2905	20	often	often	RB
46745	2905	21	adopted	adopt	VBN
46745	2905	22	with	with	IN
46745	2905	23	benefit	benefit	NN
46745	2905	24	.	.	.
46745	2906	1	Tonics	tonic	NNS
46745	2906	2	,	,	,
46745	2906	3	Chalybeates	Chalybeates	NNPS
46745	2906	4	,	,	,
46745	2906	5	Cod	cod	NN
46745	2906	6	-	-	HYPH
46745	2906	7	liver	liver	NN
46745	2906	8	oil	oil	NN
46745	2906	9	,	,	,
46745	2906	10	and	and	CC
46745	2906	11	cold	cold	JJ
46745	2906	12	bathing	bathing	NN
46745	2906	13	,	,	,
46745	2906	14	are	be	VBP
46745	2906	15	frequently	frequently	RB
46745	2906	16	of	of	IN
46745	2906	17	use	use	NN
46745	2906	18	in	in	IN
46745	2906	19	improving	improve	VBG
46745	2906	20	the	the	DT
46745	2906	21	condition	condition	NN
46745	2906	22	of	of	IN
46745	2906	23	the	the	DT
46745	2906	24	system	system	NN
46745	2906	25	,	,	,
46745	2906	26	when	when	WRB
46745	2906	27	debilitated	debilitate	VBN
46745	2906	28	by	by	IN
46745	2906	29	the	the	DT
46745	2906	30	long	long	JJ
46745	2906	31	continuance	continuance	NN
46745	2906	32	of	of	IN
46745	2906	33	strumous	strumous	JJ
46745	2906	34	disorders	disorder	NNS
46745	2906	35	.	.	.
46745	2907	1	But	but	CC
46745	2907	2	the	the	DT
46745	2907	3	most	most	RBS
46745	2907	4	important	important	JJ
46745	2907	5	and	and	CC
46745	2907	6	direct	direct	JJ
46745	2907	7	remedies	remedy	NNS
46745	2907	8	for	for	IN
46745	2907	9	Scrofula	Scrofula	NNP
46745	2907	10	are	be	VBP
46745	2907	11	to	to	TO
46745	2907	12	be	be	VB
46745	2907	13	found	find	VBN
46745	2907	14	in	in	IN
46745	2907	15	Iodine	Iodine	NNP
46745	2907	16	and	and	CC
46745	2907	17	its	-PRON-	PRP$
46745	2907	18	compounds	compound	NNS
46745	2907	19	.	.	.
46745	2908	1	It	-PRON-	PRP
46745	2908	2	is	be	VBZ
46745	2908	3	not	not	RB
46745	2908	4	to	to	TO
46745	2908	5	be	be	VB
46745	2908	6	wondered	wonder	VBN
46745	2908	7	at	at	IN
46745	2908	8	that	that	DT
46745	2908	9	in	in	IN
46745	2908	10	many	many	JJ
46745	2908	11	cases	case	NNS
46745	2908	12	of	of	IN
46745	2908	13	deeply	deeply	RB
46745	2908	14	-	-	HYPH
46745	2908	15	rooted	root	VBN
46745	2908	16	blood	blood	NN
46745	2908	17	-	-	HYPH
46745	2908	18	disease	disease	NN
46745	2908	19	,	,	,
46745	2908	20	complicated	complicate	VBD
46745	2908	21	perhaps	perhaps	RB
46745	2908	22	with	with	IN
46745	2908	23	anæmia	anæmia	NN
46745	2908	24	,	,	,
46745	2908	25	structural	structural	JJ
46745	2908	26	change	change	NN
46745	2908	27	of	of	IN
46745	2908	28	organs	organ	NNS
46745	2908	29	,	,	,
46745	2908	30	disordered	disorder	VBN
46745	2908	31	assimilation	assimilation	NN
46745	2908	32	,	,	,
46745	2908	33	and	and	CC
46745	2908	34	various	various	JJ
46745	2908	35	nervous	nervous	JJ
46745	2908	36	symptoms	symptom	NNS
46745	2908	37	,	,	,
46745	2908	38	all	all	DT
46745	2908	39	remedies	remedy	NNS
46745	2908	40	alike	alike	RB
46745	2908	41	should	should	MD
46745	2908	42	prove	prove	VB
46745	2908	43	useless	useless	JJ
46745	2908	44	.	.	.
46745	2909	1	So	so	RB
46745	2909	2	that	that	IN
46745	2909	3	the	the	DT
46745	2909	4	experience	experience	NN
46745	2909	5	of	of	IN
46745	2909	6	many	many	JJ
46745	2909	7	practitioners	practitioner	NNS
46745	2909	8	,	,	,
46745	2909	9	thus	thus	RB
46745	2909	10	frequently	frequently	RB
46745	2909	11	disappointed	disappointed	JJ
46745	2909	12	in	in	IN
46745	2909	13	their	-PRON-	PRP$
46745	2909	14	hopes	hope	NNS
46745	2909	15	of	of	IN
46745	2909	16	a	a	DT
46745	2909	17	cure	cure	NN
46745	2909	18	,	,	,
46745	2909	19	has	have	VBZ
46745	2909	20	led	lead	VBN
46745	2909	21	them	-PRON-	PRP
46745	2909	22	to	to	TO
46745	2909	23	question	question	VB
46745	2909	24	altogether	altogether	RB
46745	2909	25	the	the	DT
46745	2909	26	efficacy	efficacy	NN
46745	2909	27	of	of	IN
46745	2909	28	Iodine	Iodine	NNP
46745	2909	29	in	in	IN
46745	2909	30	Scrofulous	scrofulous	JJ
46745	2909	31	disorders	disorder	NNS
46745	2909	32	.	.	.
46745	2910	1	But	but	CC
46745	2910	2	it	-PRON-	PRP
46745	2910	3	is	be	VBZ
46745	2910	4	generally	generally	RB
46745	2910	5	allowed	allow	VBN
46745	2910	6	that	that	IN
46745	2910	7	it	-PRON-	PRP
46745	2910	8	is	be	VBZ
46745	2910	9	more	more	RBR
46745	2910	10	beneficial	beneficial	JJ
46745	2910	11	in	in	IN
46745	2910	12	such	such	JJ
46745	2910	13	cases	case	NNS
46745	2910	14	than	than	IN
46745	2910	15	any	any	DT
46745	2910	16	other	other	JJ
46745	2910	17	medicine	medicine	NN
46745	2910	18	,	,	,
46745	2910	19	and	and	CC
46745	2910	20	is	be	VBZ
46745	2910	21	the	the	DT
46745	2910	22	only	only	JJ
46745	2910	23	remedy	remedy	NN
46745	2910	24	which	which	WDT
46745	2910	25	is	be	VBZ
46745	2910	26	universally	universally	RB
46745	2910	27	applicable	applicable	JJ
46745	2910	28	in	in	IN
46745	2910	29	Scrofula	Scrofula	NNP
46745	2910	30	.	.	.
46745	2911	1	If	if	IN
46745	2911	2	this	this	DT
46745	2911	3	be	be	VB
46745	2911	4	true	true	JJ
46745	2911	5	,	,	,
46745	2911	6	it	-PRON-	PRP
46745	2911	7	follows	follow	VBZ
46745	2911	8	that	that	IN
46745	2911	9	it	-PRON-	PRP
46745	2911	10	must	must	MD
46745	2911	11	have	have	VB
46745	2911	12	a	a	DT
46745	2911	13	special	special	JJ
46745	2911	14	power	power	NN
46745	2911	15	over	over	IN
46745	2911	16	this	this	DT
46745	2911	17	blood	blood	NN
46745	2911	18	-	-	HYPH
46745	2911	19	disease	disease	NN
46745	2911	20	.	.	.
46745	2912	1	Burnt	burn	VBN
46745	2912	2	sponge	sponge	NN
46745	2912	3	,	,	,
46745	2912	4	and	and	CC
46745	2912	5	the	the	DT
46745	2912	6	ashes	ashe	NNS
46745	2912	7	of	of	IN
46745	2912	8	a	a	DT
46745	2912	9	seaweed	seaweed	NN
46745	2912	10	,	,	,
46745	2912	11	the	the	DT
46745	2912	12	Fucus	Fucus	NNP
46745	2912	13	vesiculosus	vesiculosus	NN
46745	2912	14	,	,	,
46745	2912	15	both	both	DT
46745	2912	16	of	of	IN
46745	2912	17	which	which	WDT
46745	2912	18	contain	contain	VBP
46745	2912	19	Iodine	Iodine	NNP
46745	2912	20	,	,	,
46745	2912	21	have	have	VBP
46745	2912	22	been	be	VBN
46745	2912	23	used	use	VBN
46745	2912	24	in	in	IN
46745	2912	25	Scrofula	Scrofula	NNP
46745	2912	26	from	from	IN
46745	2912	27	very	very	RB
46745	2912	28	early	early	JJ
46745	2912	29	times	time	NNS
46745	2912	30	.	.	.
46745	2913	1	But	but	CC
46745	2913	2	it	-PRON-	PRP
46745	2913	3	was	be	VBD
46745	2913	4	not	not	RB
46745	2913	5	until	until	IN
46745	2913	6	the	the	DT
46745	2913	7	present	present	JJ
46745	2913	8	century	century	NN
46745	2913	9	that	that	WDT
46745	2913	10	Iodine	Iodine	NNP
46745	2913	11	was	be	VBD
46745	2913	12	discovered	discover	VBN
46745	2913	13	,	,	,
46745	2913	14	and	and	CC
46745	2913	15	its	-PRON-	PRP$
46745	2913	16	efficacy	efficacy	NN
46745	2913	17	in	in	IN
46745	2913	18	Scrofula	Scrofula	NNP
46745	2913	19	,	,	,
46745	2913	20	particularly	particularly	RB
46745	2913	21	in	in	IN
46745	2913	22	the	the	DT
46745	2913	23	cure	cure	NN
46745	2913	24	of	of	IN
46745	2913	25	Goitre	Goitre	NNP
46745	2913	26	,	,	,
46745	2913	27	pointed	point	VBD
46745	2913	28	out	out	RP
46745	2913	29	by	by	IN
46745	2913	30	Dr.	Dr.	NNP
46745	2913	31	Coindet	Coindet	NNP
46745	2913	32	of	of	IN
46745	2913	33	Geneva	Geneva	NNP
46745	2913	34	.	.	.
46745	2914	1	After	after	IN
46745	2914	2	this	this	DT
46745	2914	3	it	-PRON-	PRP
46745	2914	4	came	come	VBD
46745	2914	5	to	to	TO
46745	2914	6	be	be	VB
46745	2914	7	generally	generally	RB
46745	2914	8	applied	apply	VBN
46745	2914	9	in	in	IN
46745	2914	10	all	all	DT
46745	2914	11	Scrofulous	scrofulous	JJ
46745	2914	12	cases	case	NNS
46745	2914	13	,	,	,
46745	2914	14	and	and	CC
46745	2914	15	was	be	VBD
46745	2914	16	especially	especially	RB
46745	2914	17	recommended	recommend	VBN
46745	2914	18	by	by	IN
46745	2914	19	M.	M.	NNP
46745	2914	20	Lugol	Lugol	NNP
46745	2914	21	in	in	IN
46745	2914	22	France	France	NNP
46745	2914	23	,	,	,
46745	2914	24	as	as	IN
46745	2914	25	a	a	DT
46745	2914	26	specific	specific	NN
46745	2914	27	for	for	IN
46745	2914	28	such	such	JJ
46745	2914	29	maladies	malady	NNS
46745	2914	30	.	.	.
46745	2915	1	When	when	WRB
46745	2915	2	given	give	VBN
46745	2915	3	for	for	IN
46745	2915	4	some	some	DT
46745	2915	5	time	time	NN
46745	2915	6	,	,	,
46745	2915	7	Iodine	Iodine	NNP
46745	2915	8	has	have	VBZ
46745	2915	9	the	the	DT
46745	2915	10	effect	effect	NN
46745	2915	11	of	of	IN
46745	2915	12	impoverishing	impoverish	VBG
46745	2915	13	the	the	DT
46745	2915	14	blood	blood	NN
46745	2915	15	,	,	,
46745	2915	16	like	like	IN
46745	2915	17	Mercury	Mercury	NNP
46745	2915	18	and	and	CC
46745	2915	19	many	many	JJ
46745	2915	20	other	other	JJ
46745	2915	21	Catalytics	Catalytics	NNP
46745	2915	22	,	,	,
46745	2915	23	diminishing	diminish	VBG
46745	2915	24	in	in	IN
46745	2915	25	it	-PRON-	PRP
46745	2915	26	the	the	DT
46745	2915	27	amount	amount	NN
46745	2915	28	of	of	IN
46745	2915	29	Fibrine	Fibrine	NNP
46745	2915	30	.	.	.
46745	2916	1	All	all	DT
46745	2916	2	remedies	remedy	NNS
46745	2916	3	which	which	WDT
46745	2916	4	do	do	VBP
46745	2916	5	this	this	DT
46745	2916	6	favour	favour	NN
46745	2916	7	absorption	absorption	NN
46745	2916	8	.	.	.
46745	2917	1	This	this	DT
46745	2917	2	effect	effect	NN
46745	2917	3	is	be	VBZ
46745	2917	4	obviously	obviously	RB
46745	2917	5	connected	connect	VBN
46745	2917	6	with	with	IN
46745	2917	7	the	the	DT
46745	2917	8	alteration	alteration	NN
46745	2917	9	in	in	IN
46745	2917	10	the	the	DT
46745	2917	11	blood	blood	NN
46745	2917	12	,	,	,
46745	2917	13	and	and	CC
46745	2917	14	there	there	EX
46745	2917	15	is	be	VBZ
46745	2917	16	no	no	DT
46745	2917	17	reason	reason	NN
46745	2917	18	to	to	TO
46745	2917	19	suppose	suppose	VB
46745	2917	20	that	that	IN
46745	2917	21	any	any	DT
46745	2917	22	special	special	JJ
46745	2917	23	stimulant	stimulant	NN
46745	2917	24	action	action	NN
46745	2917	25	is	be	VBZ
46745	2917	26	exerted	exert	VBN
46745	2917	27	on	on	IN
46745	2917	28	the	the	DT
46745	2917	29	absorbent	absorbent	JJ
46745	2917	30	vessels	vessel	NNS
46745	2917	31	.	.	.
46745	2918	1	Those	those	DT
46745	2918	2	Catalytics	catalytic	NNS
46745	2918	3	which	which	WDT
46745	2918	4	favour	favour	VBP
46745	2918	5	absorption	absorption	NN
46745	2918	6	are	be	VBP
46745	2918	7	not	not	RB
46745	2918	8	all	all	RB
46745	2918	9	useful	useful	JJ
46745	2918	10	in	in	IN
46745	2918	11	the	the	DT
46745	2918	12	same	same	JJ
46745	2918	13	cases	case	NNS
46745	2918	14	,	,	,
46745	2918	15	but	but	CC
46745	2918	16	some	some	DT
46745	2918	17	are	be	VBP
46745	2918	18	most	most	RBS
46745	2918	19	useful	useful	JJ
46745	2918	20	in	in	IN
46745	2918	21	one	one	CD
46745	2918	22	disorder	disorder	NN
46745	2918	23	,	,	,
46745	2918	24	some	some	DT
46745	2918	25	in	in	IN
46745	2918	26	another	another	DT
46745	2918	27	.	.	.
46745	2919	1	Thus	thus	RB
46745	2919	2	they	-PRON-	PRP
46745	2919	3	must	must	MD
46745	2919	4	exert	exert	VB
46745	2919	5	a	a	DT
46745	2919	6	special	special	JJ
46745	2919	7	action	action	NN
46745	2919	8	over	over	IN
46745	2919	9	morbid	morbid	NN
46745	2919	10	poisons	poison	NNS
46745	2919	11	;	;	:
46745	2919	12	an	an	DT
46745	2919	13	action	action	NN
46745	2919	14	which	which	WDT
46745	2919	15	is	be	VBZ
46745	2919	16	altogether	altogether	RB
46745	2919	17	distinct	distinct	JJ
46745	2919	18	from	from	IN
46745	2919	19	the	the	DT
46745	2919	20	influence	influence	NN
46745	2919	21	over	over	IN
46745	2919	22	absorption	absorption	NN
46745	2919	23	,	,	,
46745	2919	24	although	although	IN
46745	2919	25	by	by	IN
46745	2919	26	this	this	DT
46745	2919	27	latter	latter	NN
46745	2919	28	they	-PRON-	PRP
46745	2919	29	may	may	MD
46745	2919	30	be	be	VB
46745	2919	31	able	able	JJ
46745	2919	32	to	to	TO
46745	2919	33	cause	cause	VB
46745	2919	34	the	the	DT
46745	2919	35	disappearance	disappearance	NN
46745	2919	36	of	of	IN
46745	2919	37	effused	effuse	VBN
46745	2919	38	products	product	NNS
46745	2919	39	,	,	,
46745	2919	40	and	and	CC
46745	2919	41	of	of	IN
46745	2919	42	tumours	tumour	NNS
46745	2919	43	produced	produce	VBN
46745	2919	44	in	in	IN
46745	2919	45	various	various	JJ
46745	2919	46	ways	way	NNS
46745	2919	47	.	.	.
46745	2920	1	In	in	IN
46745	2920	2	some	some	DT
46745	2920	3	rare	rare	JJ
46745	2920	4	cases	case	NNS
46745	2920	5	Iodine	Iodine	NNP
46745	2920	6	has	have	VBZ
46745	2920	7	even	even	RB
46745	2920	8	been	be	VBN
46745	2920	9	known	know	VBN
46745	2920	10	to	to	TO
46745	2920	11	cause	cause	VB
46745	2920	12	the	the	DT
46745	2920	13	absorption	absorption	NN
46745	2920	14	of	of	IN
46745	2920	15	healthy	healthy	JJ
46745	2920	16	glands	gland	NNS
46745	2920	17	,	,	,
46745	2920	18	as	as	IN
46745	2920	19	the	the	DT
46745	2920	20	mammæ	mammæ	NN
46745	2920	21	and	and	CC
46745	2920	22	testicles	testicle	NNS
46745	2920	23	.	.	.
46745	2921	1	Iodine	Iodine	NNP
46745	2921	2	and	and	CC
46745	2921	3	Iodide	Iodide	NNP
46745	2921	4	of	of	IN
46745	2921	5	Potassium	Potassium	NNP
46745	2921	6	,	,	,
46745	2921	7	when	when	WRB
46745	2921	8	successful	successful	JJ
46745	2921	9	,	,	,
46745	2921	10	do	do	VBP
46745	2921	11	not	not	RB
46745	2921	12	merely	merely	RB
46745	2921	13	cause	cause	VB
46745	2921	14	the	the	DT
46745	2921	15	disappearance	disappearance	NN
46745	2921	16	of	of	IN
46745	2921	17	scrofulous	scrofulous	JJ
46745	2921	18	tumours	tumour	NNS
46745	2921	19	,	,	,
46745	2921	20	but	but	CC
46745	2921	21	further	further	RB
46745	2921	22	meet	meet	VB
46745	2921	23	and	and	CC
46745	2921	24	neutralize	neutralize	VB
46745	2921	25	the	the	DT
46745	2921	26	poison	poison	NN
46745	2921	27	which	which	WDT
46745	2921	28	is	be	VBZ
46745	2921	29	working	work	VBG
46745	2921	30	in	in	IN
46745	2921	31	the	the	DT
46745	2921	32	system	system	NN
46745	2921	33	,	,	,
46745	2921	34	and	and	CC
46745	2921	35	effect	effect	VB
46745	2921	36	a	a	DT
46745	2921	37	more	more	RBR
46745	2921	38	or	or	CC
46745	2921	39	less	less	RBR
46745	2921	40	permanent	permanent	JJ
46745	2921	41	cure	cure	NN
46745	2921	42	.	.	.
46745	2922	1	This	this	DT
46745	2922	2	could	could	MD
46745	2922	3	hardly	hardly	RB
46745	2922	4	be	be	VB
46745	2922	5	done	do	VBN
46745	2922	6	by	by	IN
46745	2922	7	a	a	DT
46745	2922	8	remedy	remedy	NN
46745	2922	9	which	which	WDT
46745	2922	10	had	have	VBD
46745	2922	11	only	only	RB
46745	2922	12	the	the	DT
46745	2922	13	power	power	NN
46745	2922	14	of	of	IN
46745	2922	15	promoting	promote	VBG
46745	2922	16	absorption	absorption	NN
46745	2922	17	.	.	.
46745	2923	1	It	-PRON-	PRP
46745	2923	2	seems	seem	VBZ
46745	2923	3	that	that	IN
46745	2923	4	some	some	DT
46745	2923	5	systems	system	NNS
46745	2923	6	are	be	VBP
46745	2923	7	able	able	JJ
46745	2923	8	to	to	TO
46745	2923	9	bear	bear	VB
46745	2923	10	with	with	IN
46745	2923	11	impunity	impunity	NN
46745	2923	12	very	very	RB
46745	2923	13	large	large	JJ
46745	2923	14	doses	dose	NNS
46745	2923	15	of	of	IN
46745	2923	16	Iodide	Iodide	NNP
46745	2923	17	of	of	IN
46745	2923	18	Potassium	Potassium	NNP
46745	2923	19	.	.	.
46745	2924	1	I	-PRON-	PRP
46745	2924	2	once	once	RB
46745	2924	3	met	meet	VBD
46745	2924	4	with	with	IN
46745	2924	5	a	a	DT
46745	2924	6	medical	medical	JJ
46745	2924	7	man	man	NN
46745	2924	8	who	who	WP
46745	2924	9	denied	deny	VBD
46745	2924	10	its	-PRON-	PRP$
46745	2924	11	power	power	NN
46745	2924	12	altogether	altogether	RB
46745	2924	13	,	,	,
46745	2924	14	because	because	IN
46745	2924	15	he	-PRON-	PRP
46745	2924	16	himself	-PRON-	PRP
46745	2924	17	had	have	VBD
46745	2924	18	frequently	frequently	RB
46745	2924	19	taken	take	VBN
46745	2924	20	a	a	DT
46745	2924	21	scruple	scruple	NN
46745	2924	22	,	,	,
46745	2924	23	and	and	CC
46745	2924	24	sometimes	sometimes	RB
46745	2924	25	a	a	DT
46745	2924	26	drachm	drachm	NN
46745	2924	27	at	at	IN
46745	2924	28	a	a	DT
46745	2924	29	time	time	NN
46745	2924	30	,	,	,
46745	2924	31	without	without	IN
46745	2924	32	any	any	DT
46745	2924	33	effect	effect	NN
46745	2924	34	.	.	.
46745	2925	1	Other	other	JJ
46745	2925	2	men	man	NNS
46745	2925	3	are	be	VBP
46745	2925	4	readily	readily	RB
46745	2925	5	affected	affect	VBN
46745	2925	6	by	by	IN
46745	2925	7	very	very	RB
46745	2925	8	small	small	JJ
46745	2925	9	quantities	quantity	NNS
46745	2925	10	,	,	,
46745	2925	11	and	and	CC
46745	2925	12	quickly	quickly	RB
46745	2925	13	experience	experience	VB
46745	2925	14	the	the	DT
46745	2925	15	symptoms	symptom	NNS
46745	2925	16	of	of	IN
46745	2925	17	Iodism	Iodism	NNP
46745	2925	18	.	.	.
46745	2926	1	It	-PRON-	PRP
46745	2926	2	is	be	VBZ
46745	2926	3	probable	probable	JJ
46745	2926	4	that	that	IN
46745	2926	5	in	in	IN
46745	2926	6	the	the	DT
46745	2926	7	former	former	JJ
46745	2926	8	case	case	NN
46745	2926	9	the	the	DT
46745	2926	10	medicine	medicine	NN
46745	2926	11	is	be	VBZ
46745	2926	12	very	very	RB
46745	2926	13	quickly	quickly	RB
46745	2926	14	eliminated	eliminate	VBN
46745	2926	15	by	by	IN
46745	2926	16	the	the	DT
46745	2926	17	kidneys	kidney	NNS
46745	2926	18	;	;	:
46745	2926	19	but	but	CC
46745	2926	20	that	that	IN
46745	2926	21	in	in	IN
46745	2926	22	the	the	DT
46745	2926	23	latter	latter	JJ
46745	2926	24	it	-PRON-	PRP
46745	2926	25	remains	remain	VBZ
46745	2926	26	in	in	IN
46745	2926	27	the	the	DT
46745	2926	28	system	system	NN
46745	2926	29	for	for	IN
46745	2926	30	some	some	DT
46745	2926	31	time	time	NN
46745	2926	32	.	.	.
46745	2927	1	The	the	DT
46745	2927	2	Iodide	Iodide	NNP
46745	2927	3	of	of	IN
46745	2927	4	Iron	Iron	NNP
46745	2927	5	is	be	VBZ
46745	2927	6	a	a	DT
46745	2927	7	most	most	RBS
46745	2927	8	useful	useful	JJ
46745	2927	9	medicine	medicine	NN
46745	2927	10	for	for	IN
46745	2927	11	scrofulous	scrofulous	JJ
46745	2927	12	children	child	NNS
46745	2927	13	,	,	,
46745	2927	14	who	who	WP
46745	2927	15	commonly	commonly	RB
46745	2927	16	suffer	suffer	VBP
46745	2927	17	under	under	IN
46745	2927	18	Anæmia	Anæmia	NNP
46745	2927	19	,	,	,
46745	2927	20	as	as	IN
46745	2927	21	it	-PRON-	PRP
46745	2927	22	combines	combine	VBZ
46745	2927	23	a	a	DT
46745	2927	24	Chalybeate	Chalybeate	NNP
46745	2927	25	with	with	IN
46745	2927	26	an	an	DT
46745	2927	27	Antiscrofulic	Antiscrofulic	NNP
46745	2927	28	action	action	NN
46745	2927	29	.	.	.
46745	2928	1	Bromine	Bromine	NNP
46745	2928	2	and	and	CC
46745	2928	3	Chlorine	Chlorine	NNP
46745	2928	4	resemble	resemble	JJ
46745	2928	5	Iodine	Iodine	NNP
46745	2928	6	in	in	IN
46745	2928	7	their	-PRON-	PRP$
46745	2928	8	Antiscrofulic	Antiscrofulic	NNP
46745	2928	9	effects	effect	NNS
46745	2928	10	.	.	.
46745	2929	1	It	-PRON-	PRP
46745	2929	2	is	be	VBZ
46745	2929	3	said	say	VBN
46745	2929	4	that	that	IN
46745	2929	5	Scrofula	Scrofula	NNP
46745	2929	6	and	and	CC
46745	2929	7	Consumption	Consumption	NNP
46745	2929	8	are	be	VBP
46745	2929	9	unknown	unknown	JJ
46745	2929	10	among	among	IN
46745	2929	11	the	the	DT
46745	2929	12	workmen	workman	NNS
46745	2929	13	in	in	IN
46745	2929	14	bleaching	bleach	VBG
46745	2929	15	factories	factory	NNS
46745	2929	16	,	,	,
46745	2929	17	where	where	WRB
46745	2929	18	Chlorine	Chlorine	NNP
46745	2929	19	is	be	VBZ
46745	2929	20	being	be	VBG
46745	2929	21	constantly	constantly	RB
46745	2929	22	inhaled	inhale	VBN
46745	2929	23	.	.	.
46745	2930	1	Thus	thus	RB
46745	2930	2	it	-PRON-	PRP
46745	2930	3	has	have	VBZ
46745	2930	4	been	be	VBN
46745	2930	5	strongly	strongly	RB
46745	2930	6	recommended	recommend	VBN
46745	2930	7	that	that	IN
46745	2930	8	diluted	diluted	JJ
46745	2930	9	Chlorine	Chlorine	NNP
46745	2930	10	should	should	MD
46745	2930	11	be	be	VB
46745	2930	12	constantly	constantly	RB
46745	2930	13	inhaled	inhale	VBN
46745	2930	14	by	by	IN
46745	2930	15	consumptive	consumptive	JJ
46745	2930	16	patients	patient	NNS
46745	2930	17	.	.	.
46745	2931	1	It	-PRON-	PRP
46745	2931	2	is	be	VBZ
46745	2931	3	probable	probable	JJ
46745	2931	4	that	that	IN
46745	2931	5	part	part	NN
46745	2931	6	of	of	IN
46745	2931	7	the	the	DT
46745	2931	8	efficacy	efficacy	NN
46745	2931	9	of	of	IN
46745	2931	10	sea	sea	NN
46745	2931	11	-	-	HYPH
46745	2931	12	side	side	NN
46745	2931	13	air	air	NN
46745	2931	14	and	and	CC
46745	2931	15	sea	sea	NN
46745	2931	16	-	-	HYPH
46745	2931	17	voyages	voyage	NNS
46745	2931	18	in	in	IN
46745	2931	19	scrofulous	scrofulous	JJ
46745	2931	20	cases	case	NNS
46745	2931	21	may	may	MD
46745	2931	22	be	be	VB
46745	2931	23	due	due	IN
46745	2931	24	to	to	IN
46745	2931	25	the	the	DT
46745	2931	26	free	free	JJ
46745	2931	27	Chlorine	Chlorine	NNP
46745	2931	28	which	which	WDT
46745	2931	29	is	be	VBZ
46745	2931	30	given	give	VBN
46745	2931	31	off	off	RP
46745	2931	32	in	in	IN
46745	2931	33	small	small	JJ
46745	2931	34	quantities	quantity	NNS
46745	2931	35	from	from	IN
46745	2931	36	the	the	DT
46745	2931	37	salt	salt	NN
46745	2931	38	water	water	NN
46745	2931	39	of	of	IN
46745	2931	40	the	the	DT
46745	2931	41	ocean	ocean	NN
46745	2931	42	.	.	.
46745	2932	1	The	the	DT
46745	2932	2	powers	power	NNS
46745	2932	3	of	of	IN
46745	2932	4	Iodine	Iodine	NNP
46745	2932	5	and	and	CC
46745	2932	6	Bromine	Bromine	NNP
46745	2932	7	are	be	VBP
46745	2932	8	shared	share	VBN
46745	2932	9	by	by	IN
46745	2932	10	their	-PRON-	PRP$
46745	2932	11	compounds	compound	NNS
46745	2932	12	;	;	:
46745	2932	13	and	and	CC
46745	2932	14	probably	probably	RB
46745	2932	15	Chlorine	Chlorine	NNP
46745	2932	16	is	be	VBZ
46745	2932	17	no	no	DT
46745	2932	18	exception	exception	NN
46745	2932	19	to	to	IN
46745	2932	20	this	this	DT
46745	2932	21	rule	rule	NN
46745	2932	22	.	.	.
46745	2933	1	The	the	DT
46745	2933	2	bad	bad	JJ
46745	2933	3	consequences	consequence	NNS
46745	2933	4	which	which	WDT
46745	2933	5	follow	follow	VBP
46745	2933	6	the	the	DT
46745	2933	7	omission	omission	NN
46745	2933	8	of	of	IN
46745	2933	9	common	common	JJ
46745	2933	10	salt	salt	NN
46745	2933	11	from	from	IN
46745	2933	12	the	the	DT
46745	2933	13	food	food	NN
46745	2933	14	,	,	,
46745	2933	15	are	be	VBP
46745	2933	16	sufficient	sufficient	JJ
46745	2933	17	to	to	TO
46745	2933	18	show	show	VB
46745	2933	19	that	that	IN
46745	2933	20	this	this	DT
46745	2933	21	substance	substance	NN
46745	2933	22	has	have	VBZ
46745	2933	23	a	a	DT
46745	2933	24	beneficial	beneficial	JJ
46745	2933	25	action	action	NN
46745	2933	26	on	on	IN
46745	2933	27	the	the	DT
46745	2933	28	blood	blood	NN
46745	2933	29	.	.	.
46745	2934	1	Probably	probably	RB
46745	2934	2	large	large	JJ
46745	2934	3	doses	dose	NNS
46745	2934	4	of	of	IN
46745	2934	5	this	this	DT
46745	2934	6	article	article	NN
46745	2934	7	of	of	IN
46745	2934	8	diet	diet	NN
46745	2934	9	would	would	MD
46745	2934	10	be	be	VB
46745	2934	11	found	find	VBN
46745	2934	12	advantageous	advantageous	JJ
46745	2934	13	in	in	IN
46745	2934	14	Scrofulous	scrofulous	JJ
46745	2934	15	disorders	disorder	NNS
46745	2934	16	.	.	.
46745	2935	1	It	-PRON-	PRP
46745	2935	2	is	be	VBZ
46745	2935	3	easy	easy	JJ
46745	2935	4	to	to	TO
46745	2935	5	recognise	recognise	VB
46745	2935	6	such	such	PDT
46745	2935	7	an	an	DT
46745	2935	8	action	action	NN
46745	2935	9	as	as	IN
46745	2935	10	that	that	DT
46745	2935	11	of	of	IN
46745	2935	12	Iodine	Iodine	NNP
46745	2935	13	in	in	IN
46745	2935	14	Scrofula	Scrofula	NNP
46745	2935	15	,	,	,
46745	2935	16	but	but	CC
46745	2935	17	it	-PRON-	PRP
46745	2935	18	is	be	VBZ
46745	2935	19	almost	almost	RB
46745	2935	20	impossible	impossible	JJ
46745	2935	21	to	to	TO
46745	2935	22	invent	invent	VB
46745	2935	23	a	a	DT
46745	2935	24	satisfactory	satisfactory	JJ
46745	2935	25	explanation	explanation	NN
46745	2935	26	for	for	IN
46745	2935	27	it	-PRON-	PRP
46745	2935	28	.	.	.
46745	2936	1	Potash	Potash	NNP
46745	2936	2	,	,	,
46745	2936	3	free	free	JJ
46745	2936	4	or	or	CC
46745	2936	5	carbonated	carbonate	VBN
46745	2936	6	,	,	,
46745	2936	7	is	be	VBZ
46745	2936	8	another	another	DT
46745	2936	9	remedy	remedy	NN
46745	2936	10	of	of	IN
46745	2936	11	considerable	considerable	JJ
46745	2936	12	importance	importance	NN
46745	2936	13	in	in	IN
46745	2936	14	Scrofulous	scrofulous	JJ
46745	2936	15	diseases	disease	NNS
46745	2936	16	.	.	.
46745	2937	1	It	-PRON-	PRP
46745	2937	2	is	be	VBZ
46745	2937	3	possibly	possibly	RB
46745	2937	4	one	one	CD
46745	2937	5	of	of	IN
46745	2937	6	those	those	DT
46745	2937	7	Catalytics	catalytic	NNS
46745	2937	8	which	which	WDT
46745	2937	9	exert	exert	VBP
46745	2937	10	a	a	DT
46745	2937	11	simple	simple	JJ
46745	2937	12	chemical	chemical	JJ
46745	2937	13	influence	influence	NN
46745	2937	14	.	.	.
46745	2938	1	It	-PRON-	PRP
46745	2938	2	may	may	MD
46745	2938	3	act	act	VB
46745	2938	4	by	by	IN
46745	2938	5	holding	hold	VBG
46745	2938	6	in	in	RP
46745	2938	7	solution	solution	NN
46745	2938	8	fibrinous	fibrinous	JJ
46745	2938	9	and	and	CC
46745	2938	10	fatty	fatty	NN
46745	2938	11	matters	matter	NNS
46745	2938	12	,	,	,
46745	2938	13	and	and	CC
46745	2938	14	preventing	prevent	VBG
46745	2938	15	their	-PRON-	PRP$
46745	2938	16	abnormal	abnormal	JJ
46745	2938	17	deposit	deposit	NN
46745	2938	18	in	in	IN
46745	2938	19	a	a	DT
46745	2938	20	crude	crude	JJ
46745	2938	21	form	form	NN
46745	2938	22	in	in	IN
46745	2938	23	the	the	DT
46745	2938	24	shape	shape	NN
46745	2938	25	of	of	IN
46745	2938	26	tubercular	tubercular	JJ
46745	2938	27	matter	matter	NN
46745	2938	28	.	.	.
46745	2939	1	It	-PRON-	PRP
46745	2939	2	may	may	MD
46745	2939	3	also	also	RB
46745	2939	4	be	be	VB
46745	2939	5	found	find	VBN
46745	2939	6	useful	useful	JJ
46745	2939	7	in	in	IN
46745	2939	8	cases	case	NNS
46745	2939	9	of	of	IN
46745	2939	10	Syphilis	Syphilis	NNP
46745	2939	11	,	,	,
46745	2939	12	when	when	WRB
46745	2939	13	aggravated	aggravate	VBN
46745	2939	14	by	by	IN
46745	2939	15	a	a	DT
46745	2939	16	previously	previously	RB
46745	2939	17	existing	exist	VBG
46745	2939	18	strumous	strumous	JJ
46745	2939	19	tendency	tendency	NN
46745	2939	20	,	,	,
46745	2939	21	and	and	CC
46745	2939	22	where	where	WRB
46745	2939	23	a	a	DT
46745	2939	24	course	course	NN
46745	2939	25	of	of	IN
46745	2939	26	Mercury	Mercury	NNP
46745	2939	27	can	can	MD
46745	2939	28	not	not	RB
46745	2939	29	be	be	VB
46745	2939	30	safely	safely	RB
46745	2939	31	prescribed	prescribe	VBN
46745	2939	32	.	.	.
46745	2940	1	Small	small	JJ
46745	2940	2	doses	dose	NNS
46745	2940	3	of	of	IN
46745	2940	4	Mercury	Mercury	NNP
46745	2940	5	,	,	,
46745	2940	6	as	as	IN
46745	2940	7	an	an	DT
46745	2940	8	alterative	alterative	NN
46745	2940	9	,	,	,
46745	2940	10	are	be	VBP
46745	2940	11	often	often	RB
46745	2940	12	efficacious	efficacious	JJ
46745	2940	13	in	in	IN
46745	2940	14	scrofulous	scrofulous	JJ
46745	2940	15	constitutions	constitution	NNS
46745	2940	16	.	.	.
46745	2941	1	They	-PRON-	PRP
46745	2941	2	appear	appear	VBP
46745	2941	3	to	to	TO
46745	2941	4	act	act	VB
46745	2941	5	simply	simply	RB
46745	2941	6	by	by	IN
46745	2941	7	stimulating	stimulate	VBG
46745	2941	8	the	the	DT
46745	2941	9	torpid	torpid	JJ
46745	2941	10	liver	liver	NN
46745	2941	11	to	to	IN
46745	2941	12	a	a	DT
46745	2941	13	performance	performance	NN
46745	2941	14	of	of	IN
46745	2941	15	its	-PRON-	PRP$
46745	2941	16	proper	proper	JJ
46745	2941	17	function	function	NN
46745	2941	18	.	.	.
46745	2942	1	[	[	-LRB-
46745	2942	2	40	40	CD
46745	2942	3	]	]	-RRB-
46745	2942	4	(	(	-LRB-
46745	2942	5	_	_	NNP
46745	2942	6	Vide	Vide	NNP
46745	2942	7	_	_	NNP
46745	2942	8	page	page	NN
46745	2942	9	144	144	CD
46745	2942	10	.	.	.
46745	2942	11	)	)	-RRB-
46745	2943	1	Potash	Potash	NNP
46745	2943	2	has	have	VBZ
46745	2943	3	been	be	VBN
46745	2943	4	used	use	VBN
46745	2943	5	as	as	IN
46745	2943	6	a	a	DT
46745	2943	7	prophylactic	prophylactic	NN
46745	2943	8	against	against	IN
46745	2943	9	Consumption	consumption	NN
46745	2943	10	.	.	.
46745	2944	1	The	the	DT
46745	2944	2	efficacy	efficacy	NN
46745	2944	3	of	of	IN
46745	2944	4	Cod	Cod	NNP
46745	2944	5	Oil	Oil	NNP
46745	2944	6	in	in	IN
46745	2944	7	this	this	DT
46745	2944	8	disease	disease	NN
46745	2944	9	has	have	VBZ
46745	2944	10	been	be	VBN
46745	2944	11	explained	explain	VBN
46745	2944	12	by	by	IN
46745	2944	13	some	some	DT
46745	2944	14	as	as	IN
46745	2944	15	depending	depend	VBG
46745	2944	16	on	on	IN
46745	2944	17	the	the	DT
46745	2944	18	Iodine	Iodine	NNP
46745	2944	19	which	which	WDT
46745	2944	20	it	-PRON-	PRP
46745	2944	21	contains	contain	VBZ
46745	2944	22	in	in	IN
46745	2944	23	small	small	JJ
46745	2944	24	quantities	quantity	NNS
46745	2944	25	.	.	.
46745	2945	1	I	-PRON-	PRP
46745	2945	2	do	do	VBP
46745	2945	3	not	not	RB
46745	2945	4	consider	consider	VB
46745	2945	5	this	this	DT
46745	2945	6	explanation	explanation	NN
46745	2945	7	to	to	TO
46745	2945	8	be	be	VB
46745	2945	9	the	the	DT
46745	2945	10	correct	correct	JJ
46745	2945	11	one	one	NN
46745	2945	12	.	.	.
46745	2946	1	(	(	-LRB-
46745	2946	2	_	_	NNP
46745	2946	3	Vide	Vide	NNP
46745	2946	4	Cod	Cod	NNP
46745	2946	5	Oil	Oil	NNP
46745	2946	6	,	,	,
46745	2946	7	in	in	IN
46745	2946	8	Chap	Chap	NNP
46745	2946	9	.	.	.
46745	2947	1	IV	IV	NNP
46745	2947	2	.	.	.
46745	2947	3	_	_	NNP
46745	2947	4	)	)	-RRB-
46745	2947	5	ORD	ORD	NNP
46745	2947	6	.	.	.
46745	2948	1	IV	IV	NNP
46745	2948	2	.	.	.
46745	2949	1	ANTIARTHRITICS	antiarthritics	UH
46745	2949	2	.	.	.
46745	2950	1	In	in	IN
46745	2950	2	this	this	DT
46745	2950	3	order	order	NN
46745	2950	4	are	be	VBP
46745	2950	5	included	include	VBN
46745	2950	6	some	some	DT
46745	2950	7	blood	blood	NN
46745	2950	8	-	-	HYPH
46745	2950	9	medicines	medicine	NNS
46745	2950	10	which	which	WDT
46745	2950	11	exert	exert	VBP
46745	2950	12	a	a	DT
46745	2950	13	direct	direct	JJ
46745	2950	14	influence	influence	NN
46745	2950	15	over	over	IN
46745	2950	16	certain	certain	JJ
46745	2950	17	disorders	disorder	NNS
46745	2950	18	which	which	WDT
46745	2950	19	depend	depend	VBP
46745	2950	20	on	on	IN
46745	2950	21	some	some	DT
46745	2950	22	fault	fault	NN
46745	2950	23	in	in	IN
46745	2950	24	the	the	DT
46745	2950	25	complicated	complicated	JJ
46745	2950	26	processes	process	NNS
46745	2950	27	of	of	IN
46745	2950	28	assimilation	assimilation	NN
46745	2950	29	and	and	CC
46745	2950	30	nutrition	nutrition	NN
46745	2950	31	.	.	.
46745	2951	1	The	the	DT
46745	2951	2	chief	chief	NN
46745	2951	3	of	of	IN
46745	2951	4	these	these	DT
46745	2951	5	diseases	disease	NNS
46745	2951	6	are	be	VBP
46745	2951	7	,	,	,
46745	2951	8	Diabetes	diabetes	NN
46745	2951	9	;	;	:
46745	2951	10	Oxaluria	Oxaluria	NNP
46745	2951	11	;	;	:
46745	2951	12	Lithic	lithic	JJ
46745	2951	13	deposit	deposit	NN
46745	2951	14	in	in	IN
46745	2951	15	the	the	DT
46745	2951	16	urine	urine	NN
46745	2951	17	;	;	:
46745	2951	18	and	and	CC
46745	2951	19	the	the	DT
46745	2951	20	true	true	JJ
46745	2951	21	Arthritic	arthritic	JJ
46745	2951	22	disorders	disorder	NNS
46745	2951	23	,	,	,
46745	2951	24	_	_	NNP
46745	2951	25	i.e.	i.e.	FW
46745	2951	26	_	_	NNP
46745	2951	27	,	,	,
46745	2951	28	Gout	Gout	NNP
46745	2951	29	and	and	CC
46745	2951	30	Rheumatism	Rheumatism	NNP
46745	2951	31	.	.	.
46745	2952	1	Most	Most	JJS
46745	2952	2	of	of	IN
46745	2952	3	those	those	DT
46745	2952	4	blood	blood	NN
46745	2952	5	diseases	disease	NNS
46745	2952	6	which	which	WDT
46745	2952	7	can	can	MD
46745	2952	8	not	not	RB
46745	2952	9	be	be	VB
46745	2952	10	clearly	clearly	RB
46745	2952	11	traced	trace	VBN
46745	2952	12	to	to	IN
46745	2952	13	the	the	DT
46745	2952	14	introduction	introduction	NN
46745	2952	15	of	of	IN
46745	2952	16	a	a	DT
46745	2952	17	poison	poison	NN
46745	2952	18	from	from	IN
46745	2952	19	without	without	IN
46745	2952	20	may	may	MD
46745	2952	21	be	be	VB
46745	2952	22	arranged	arrange	VBN
46745	2952	23	under	under	IN
46745	2952	24	this	this	DT
46745	2952	25	head	head	NN
46745	2952	26	,	,	,
46745	2952	27	and	and	CC
46745	2952	28	appear	appear	VB
46745	2952	29	to	to	TO
46745	2952	30	be	be	VB
46745	2952	31	curable	curable	JJ
46745	2952	32	by	by	IN
46745	2952	33	the	the	DT
46745	2952	34	same	same	JJ
46745	2952	35	set	set	NN
46745	2952	36	of	of	IN
46745	2952	37	remedial	remedial	JJ
46745	2952	38	agents	agent	NNS
46745	2952	39	.	.	.
46745	2953	1	There	there	EX
46745	2953	2	are	be	VBP
46745	2953	3	certain	certain	JJ
46745	2953	4	processes	process	NNS
46745	2953	5	always	always	RB
46745	2953	6	going	go	VBG
46745	2953	7	on	on	RP
46745	2953	8	in	in	IN
46745	2953	9	the	the	DT
46745	2953	10	blood	blood	NN
46745	2953	11	,	,	,
46745	2953	12	whose	whose	WP$
46745	2953	13	continuance	continuance	NN
46745	2953	14	in	in	IN
46745	2953	15	the	the	DT
46745	2953	16	right	right	JJ
46745	2953	17	direction	direction	NN
46745	2953	18	is	be	VBZ
46745	2953	19	essential	essential	JJ
46745	2953	20	to	to	TO
46745	2953	21	health	health	VB
46745	2953	22	.	.	.
46745	2954	1	When	when	WRB
46745	2954	2	one	one	CD
46745	2954	3	of	of	IN
46745	2954	4	these	these	DT
46745	2954	5	processes	process	NNS
46745	2954	6	is	be	VBZ
46745	2954	7	disturbed	disturb	VBN
46745	2954	8	,	,	,
46745	2954	9	it	-PRON-	PRP
46745	2954	10	does	do	VBZ
46745	2954	11	not	not	RB
46745	2954	12	generally	generally	RB
46745	2954	13	cease	cease	VB
46745	2954	14	,	,	,
46745	2954	15	but	but	CC
46745	2954	16	it	-PRON-	PRP
46745	2954	17	goes	go	VBZ
46745	2954	18	on	on	RP
46745	2954	19	then	then	RB
46745	2954	20	in	in	IN
46745	2954	21	a	a	DT
46745	2954	22	wrong	wrong	JJ
46745	2954	23	direction	direction	NN
46745	2954	24	.	.	.
46745	2955	1	The	the	DT
46745	2955	2	natural	natural	JJ
46745	2955	3	processes	process	NNS
46745	2955	4	result	result	VBP
46745	2955	5	,	,	,
46745	2955	6	on	on	IN
46745	2955	7	the	the	DT
46745	2955	8	one	one	CD
46745	2955	9	hand	hand	NN
46745	2955	10	,	,	,
46745	2955	11	in	in	IN
46745	2955	12	the	the	DT
46745	2955	13	preparation	preparation	NN
46745	2955	14	of	of	IN
46745	2955	15	fit	fit	JJ
46745	2955	16	and	and	CC
46745	2955	17	proper	proper	JJ
46745	2955	18	nutriment	nutriment	NN
46745	2955	19	out	out	IN
46745	2955	20	of	of	IN
46745	2955	21	the	the	DT
46745	2955	22	materials	material	NNS
46745	2955	23	of	of	IN
46745	2955	24	the	the	DT
46745	2955	25	digested	digested	JJ
46745	2955	26	food	food	NN
46745	2955	27	,	,	,
46745	2955	28	for	for	IN
46745	2955	29	the	the	DT
46745	2955	30	growth	growth	NN
46745	2955	31	and	and	CC
46745	2955	32	support	support	NN
46745	2955	33	of	of	IN
46745	2955	34	the	the	DT
46745	2955	35	several	several	JJ
46745	2955	36	tissues	tissue	NNS
46745	2955	37	and	and	CC
46745	2955	38	functions	function	NNS
46745	2955	39	;	;	,
46745	2955	40	and	and	CC
46745	2955	41	,	,	,
46745	2955	42	on	on	IN
46745	2955	43	the	the	DT
46745	2955	44	other	other	JJ
46745	2955	45	hand	hand	NN
46745	2955	46	,	,	,
46745	2955	47	in	in	IN
46745	2955	48	the	the	DT
46745	2955	49	gradual	gradual	JJ
46745	2955	50	change	change	NN
46745	2955	51	and	and	CC
46745	2955	52	conduction	conduction	NN
46745	2955	53	out	out	IN
46745	2955	54	of	of	IN
46745	2955	55	the	the	DT
46745	2955	56	body	body	NN
46745	2955	57	of	of	IN
46745	2955	58	the	the	DT
46745	2955	59	products	product	NNS
46745	2955	60	of	of	IN
46745	2955	61	the	the	DT
46745	2955	62	waste	waste	NN
46745	2955	63	of	of	IN
46745	2955	64	those	those	DT
46745	2955	65	tissues	tissue	NNS
46745	2955	66	.	.	.
46745	2956	1	But	but	CC
46745	2956	2	when	when	WRB
46745	2956	3	any	any	DT
46745	2956	4	process	process	NN
46745	2956	5	goes	go	VBZ
46745	2956	6	on	on	RP
46745	2956	7	in	in	IN
46745	2956	8	a	a	DT
46745	2956	9	wrong	wrong	JJ
46745	2956	10	direction	direction	NN
46745	2956	11	,	,	,
46745	2956	12	it	-PRON-	PRP
46745	2956	13	results	result	VBZ
46745	2956	14	in	in	IN
46745	2956	15	the	the	DT
46745	2956	16	formation	formation	NN
46745	2956	17	of	of	IN
46745	2956	18	various	various	JJ
46745	2956	19	products	product	NNS
46745	2956	20	different	different	JJ
46745	2956	21	from	from	IN
46745	2956	22	those	those	DT
46745	2956	23	which	which	WDT
46745	2956	24	are	be	VBP
46745	2956	25	required	require	VBN
46745	2956	26	,	,	,
46745	2956	27	and	and	CC
46745	2956	28	which	which	WDT
46745	2956	29	the	the	DT
46745	2956	30	kidneys	kidney	NNS
46745	2956	31	and	and	CC
46745	2956	32	other	other	JJ
46745	2956	33	glands	gland	NNS
46745	2956	34	are	be	VBP
46745	2956	35	at	at	IN
46745	2956	36	length	length	NN
46745	2956	37	called	call	VBN
46745	2956	38	upon	upon	IN
46745	2956	39	to	to	TO
46745	2956	40	excrete	excrete	VB
46745	2956	41	from	from	IN
46745	2956	42	the	the	DT
46745	2956	43	system	system	NN
46745	2956	44	.	.	.
46745	2957	1	The	the	DT
46745	2957	2	result	result	NN
46745	2957	3	is	be	VBZ
46745	2957	4	that	that	IN
46745	2957	5	the	the	DT
46745	2957	6	general	general	JJ
46745	2957	7	health	health	NN
46745	2957	8	is	be	VBZ
46745	2957	9	more	more	RBR
46745	2957	10	or	or	CC
46745	2957	11	less	less	RBR
46745	2957	12	seriously	seriously	RB
46745	2957	13	impaired	impaired	JJ
46745	2957	14	.	.	.
46745	2958	1	There	there	EX
46745	2958	2	is	be	VBZ
46745	2958	3	also	also	RB
46745	2958	4	another	another	DT
46745	2958	5	way	way	NN
46745	2958	6	in	in	IN
46745	2958	7	which	which	WDT
46745	2958	8	these	these	DT
46745	2958	9	diseases	disease	NNS
46745	2958	10	are	be	VBP
46745	2958	11	not	not	RB
46745	2958	12	unfrequently	unfrequently	RB
46745	2958	13	caused	cause	VBN
46745	2958	14	.	.	.
46745	2959	1	A	a	DT
46745	2959	2	natural	natural	JJ
46745	2959	3	process	process	NN
46745	2959	4	may	may	MD
46745	2959	5	stop	stop	VB
46745	2959	6	at	at	IN
46745	2959	7	a	a	DT
46745	2959	8	certain	certain	JJ
46745	2959	9	point	point	NN
46745	2959	10	,	,	,
46745	2959	11	and	and	CC
46745	2959	12	go	go	VB
46745	2959	13	no	no	RB
46745	2959	14	further	further	RB
46745	2959	15	.	.	.
46745	2960	1	The	the	DT
46745	2960	2	material	material	NN
46745	2960	3	formed	form	VBN
46745	2960	4	at	at	IN
46745	2960	5	that	that	DT
46745	2960	6	stage	stage	NN
46745	2960	7	remains	remain	VBZ
46745	2960	8	as	as	IN
46745	2960	9	it	-PRON-	PRP
46745	2960	10	is	be	VBZ
46745	2960	11	.	.	.
46745	2961	1	It	-PRON-	PRP
46745	2961	2	is	be	VBZ
46745	2961	3	not	not	RB
46745	2961	4	wanted	want	VBN
46745	2961	5	;	;	:
46745	2961	6	it	-PRON-	PRP
46745	2961	7	is	be	VBZ
46745	2961	8	morbid	morbid	NN
46745	2961	9	;	;	:
46745	2961	10	and	and	CC
46745	2961	11	it	-PRON-	PRP
46745	2961	12	also	also	RB
46745	2961	13	is	be	VBZ
46745	2961	14	excreted	excrete	VBN
46745	2961	15	from	from	IN
46745	2961	16	the	the	DT
46745	2961	17	body	body	NN
46745	2961	18	.	.	.
46745	2962	1	It	-PRON-	PRP
46745	2962	2	is	be	VBZ
46745	2962	3	possible	possible	JJ
46745	2962	4	that	that	IN
46745	2962	5	these	these	DT
46745	2962	6	errors	error	NNS
46745	2962	7	in	in	IN
46745	2962	8	the	the	DT
46745	2962	9	assimilative	assimilative	JJ
46745	2962	10	processes	process	NNS
46745	2962	11	may	may	MD
46745	2962	12	sometimes	sometimes	RB
46745	2962	13	arise	arise	VB
46745	2962	14	in	in	IN
46745	2962	15	the	the	DT
46745	2962	16	first	first	JJ
46745	2962	17	instance	instance	NN
46745	2962	18	from	from	IN
46745	2962	19	a	a	DT
46745	2962	20	deficiency	deficiency	NN
46745	2962	21	in	in	IN
46745	2962	22	the	the	DT
46745	2962	23	blood	blood	NN
46745	2962	24	of	of	IN
46745	2962	25	some	some	DT
46745	2962	26	substance	substance	NN
46745	2962	27	whose	whose	WP$
46745	2962	28	influence	influence	NN
46745	2962	29	was	be	VBD
46745	2962	30	necessary	necessary	JJ
46745	2962	31	to	to	IN
46745	2962	32	the	the	DT
46745	2962	33	proper	proper	JJ
46745	2962	34	conduct	conduct	NN
46745	2962	35	or	or	CC
46745	2962	36	control	control	NN
46745	2962	37	of	of	IN
46745	2962	38	the	the	DT
46745	2962	39	natural	natural	JJ
46745	2962	40	series	series	NN
46745	2962	41	of	of	IN
46745	2962	42	changes	change	NNS
46745	2962	43	.	.	.
46745	2963	1	Some	some	DT
46745	2963	2	of	of	IN
46745	2963	3	these	these	DT
46745	2963	4	conducting	conduct	VBG
46745	2963	5	materials	material	NNS
46745	2963	6	may	may	MD
46745	2963	7	be	be	VB
46745	2963	8	formed	form	VBN
46745	2963	9	by	by	IN
46745	2963	10	the	the	DT
46745	2963	11	liver	liver	NN
46745	2963	12	;	;	:
46745	2963	13	for	for	IN
46745	2963	14	it	-PRON-	PRP
46745	2963	15	is	be	VBZ
46745	2963	16	found	find	VBN
46745	2963	17	that	that	IN
46745	2963	18	these	these	DT
46745	2963	19	disorders	disorder	NNS
46745	2963	20	are	be	VBP
46745	2963	21	very	very	RB
46745	2963	22	commonly	commonly	RB
46745	2963	23	connected	connect	VBN
46745	2963	24	with	with	IN
46745	2963	25	an	an	DT
46745	2963	26	impairment	impairment	NN
46745	2963	27	of	of	IN
46745	2963	28	the	the	DT
46745	2963	29	function	function	NN
46745	2963	30	of	of	IN
46745	2963	31	that	that	DT
46745	2963	32	organ	organ	NN
46745	2963	33	.	.	.
46745	2964	1	Thus	thus	RB
46745	2964	2	Mercury	Mercury	NNP
46745	2964	3	,	,	,
46745	2964	4	which	which	WDT
46745	2964	5	restores	restore	VBZ
46745	2964	6	the	the	DT
46745	2964	7	secretion	secretion	NN
46745	2964	8	of	of	IN
46745	2964	9	the	the	DT
46745	2964	10	liver	liver	NN
46745	2964	11	,	,	,
46745	2964	12	is	be	VBZ
46745	2964	13	often	often	RB
46745	2964	14	useful	useful	JJ
46745	2964	15	in	in	IN
46745	2964	16	Arthritic	arthritic	JJ
46745	2964	17	disorders	disorder	NNS
46745	2964	18	;	;	:
46745	2964	19	as	as	IN
46745	2964	20	also	also	RB
46745	2964	21	is	be	VBZ
46745	2964	22	Quinine	Quinine	NNP
46745	2964	23	,	,	,
46745	2964	24	which	which	WDT
46745	2964	25	has	have	VBZ
46745	2964	26	already	already	RB
46745	2964	27	been	be	VBN
46745	2964	28	shown	show	VBN
46745	2964	29	to	to	TO
46745	2964	30	have	have	VB
46745	2964	31	a	a	DT
46745	2964	32	peculiar	peculiar	JJ
46745	2964	33	relation	relation	NN
46745	2964	34	to	to	IN
46745	2964	35	liver	liver	NN
46745	2964	36	diseases	disease	NNS
46745	2964	37	.	.	.
46745	2965	1	But	but	CC
46745	2965	2	these	these	DT
46745	2965	3	disorders	disorder	NNS
46745	2965	4	,	,	,
46745	2965	5	however	however	RB
46745	2965	6	they	-PRON-	PRP
46745	2965	7	may	may	MD
46745	2965	8	first	first	RB
46745	2965	9	originate	originate	VB
46745	2965	10	,	,	,
46745	2965	11	consist	consist	VB
46745	2965	12	in	in	IN
46745	2965	13	an	an	DT
46745	2965	14	active	active	JJ
46745	2965	15	morbid	morbid	NN
46745	2965	16	process	process	NN
46745	2965	17	of	of	IN
46745	2965	18	one	one	CD
46745	2965	19	kind	kind	NN
46745	2965	20	or	or	CC
46745	2965	21	another	another	DT
46745	2965	22	;	;	:
46745	2965	23	and	and	CC
46745	2965	24	the	the	DT
46745	2965	25	surest	sure	JJS
46745	2965	26	way	way	NN
46745	2965	27	of	of	IN
46745	2965	28	counteracting	counteract	VBG
46745	2965	29	this	this	DT
46745	2965	30	process	process	NN
46745	2965	31	,	,	,
46745	2965	32	or	or	CC
46745	2965	33	of	of	IN
46745	2965	34	diverting	divert	VBG
46745	2965	35	it	-PRON-	PRP
46745	2965	36	into	into	IN
46745	2965	37	a	a	DT
46745	2965	38	right	right	JJ
46745	2965	39	direction	direction	NN
46745	2965	40	,	,	,
46745	2965	41	is	be	VBZ
46745	2965	42	by	by	IN
46745	2965	43	the	the	DT
46745	2965	44	employment	employment	NN
46745	2965	45	of	of	IN
46745	2965	46	one	one	CD
46745	2965	47	of	of	IN
46745	2965	48	the	the	DT
46745	2965	49	Catalytic	catalytic	JJ
46745	2965	50	medicines	medicine	NNS
46745	2965	51	contained	contain	VBN
46745	2965	52	in	in	IN
46745	2965	53	this	this	DT
46745	2965	54	order	order	NN
46745	2965	55	.	.	.
46745	2966	1	Some	some	DT
46745	2966	2	stages	stage	NNS
46745	2966	3	of	of	IN
46745	2966	4	these	these	DT
46745	2966	5	diseases	disease	NNS
46745	2966	6	are	be	VBP
46745	2966	7	attended	attend	VBN
46745	2966	8	with	with	IN
46745	2966	9	a	a	DT
46745	2966	10	want	want	NN
46745	2966	11	in	in	IN
46745	2966	12	the	the	DT
46745	2966	13	blood	blood	NN
46745	2966	14	of	of	IN
46745	2966	15	some	some	DT
46745	2966	16	of	of	IN
46745	2966	17	its	-PRON-	PRP$
46745	2966	18	ordinary	ordinary	JJ
46745	2966	19	constituents	constituent	NNS
46745	2966	20	;	;	:
46745	2966	21	which	which	WDT
46745	2966	22	condition	condition	NN
46745	2966	23	may	may	MD
46745	2966	24	be	be	VB
46745	2966	25	relieved	relieve	VBN
46745	2966	26	by	by	IN
46745	2966	27	the	the	DT
46745	2966	28	supply	supply	NN
46745	2966	29	of	of	IN
46745	2966	30	a	a	DT
46745	2966	31	Restorative	restorative	JJ
46745	2966	32	remedy	remedy	NN
46745	2966	33	.	.	.
46745	2967	1	Thus	thus	RB
46745	2967	2	in	in	IN
46745	2967	3	this	this	DT
46745	2967	4	group	group	NN
46745	2967	5	of	of	IN
46745	2967	6	disorders	disorder	NNS
46745	2967	7	three	three	CD
46745	2967	8	kinds	kind	NNS
46745	2967	9	of	of	IN
46745	2967	10	medicines	medicine	NNS
46745	2967	11	may	may	MD
46745	2967	12	be	be	VB
46745	2967	13	employed	employ	VBN
46745	2967	14	,	,	,
46745	2967	15	which	which	WDT
46745	2967	16	tend	tend	VBP
46745	2967	17	in	in	IN
46745	2967	18	various	various	JJ
46745	2967	19	ways	way	NNS
46745	2967	20	to	to	TO
46745	2967	21	improve	improve	VB
46745	2967	22	the	the	DT
46745	2967	23	condition	condition	NN
46745	2967	24	of	of	IN
46745	2967	25	the	the	DT
46745	2967	26	blood	blood	NN
46745	2967	27	.	.	.
46745	2968	1	Acids	Acids	NNPS
46745	2968	2	and	and	CC
46745	2968	3	Alkalies	Alkalies	NNPS
46745	2968	4	are	be	VBP
46745	2968	5	sometimes	sometimes	RB
46745	2968	6	needed	need	VBN
46745	2968	7	,	,	,
46745	2968	8	and	and	CC
46745	2968	9	act	act	VB
46745	2968	10	on	on	IN
46745	2968	11	the	the	DT
46745	2968	12	Restorative	Restorative	NNP
46745	2968	13	principle	principle	NN
46745	2968	14	.	.	.
46745	2969	1	The	the	DT
46745	2969	2	true	true	JJ
46745	2969	3	Antiarthritics	Antiarthritics	NNPS
46745	2969	4	are	be	VBP
46745	2969	5	those	those	DT
46745	2969	6	medicines	medicine	NNS
46745	2969	7	which	which	WDT
46745	2969	8	are	be	VBP
46745	2969	9	employed	employ	VBN
46745	2969	10	on	on	IN
46745	2969	11	the	the	DT
46745	2969	12	Catalytic	catalytic	JJ
46745	2969	13	plan	plan	NN
46745	2969	14	,	,	,
46745	2969	15	to	to	TO
46745	2969	16	meet	meet	VB
46745	2969	17	and	and	CC
46745	2969	18	neutralize	neutralize	VB
46745	2969	19	the	the	DT
46745	2969	20	morbid	morbid	NN
46745	2969	21	material	material	NN
46745	2969	22	or	or	CC
46745	2969	23	process	process	NN
46745	2969	24	in	in	IN
46745	2969	25	the	the	DT
46745	2969	26	blood	blood	NN
46745	2969	27	.	.	.
46745	2970	1	And	and	CC
46745	2970	2	sometimes	sometimes	RB
46745	2970	3	Eliminatives	Eliminatives	NNPS
46745	2970	4	are	be	VBP
46745	2970	5	made	make	VBN
46745	2970	6	use	use	NN
46745	2970	7	of	of	IN
46745	2970	8	,	,	,
46745	2970	9	which	which	WDT
46745	2970	10	seem	seem	VBP
46745	2970	11	,	,	,
46745	2970	12	by	by	IN
46745	2970	13	acting	act	VBG
46745	2970	14	on	on	IN
46745	2970	15	the	the	DT
46745	2970	16	secretions	secretion	NNS
46745	2970	17	of	of	IN
46745	2970	18	the	the	DT
46745	2970	19	skin	skin	NN
46745	2970	20	,	,	,
46745	2970	21	kidneys	kidney	NNS
46745	2970	22	,	,	,
46745	2970	23	or	or	CC
46745	2970	24	bowels	bowel	NNS
46745	2970	25	,	,	,
46745	2970	26	to	to	TO
46745	2970	27	be	be	VB
46745	2970	28	able	able	JJ
46745	2970	29	to	to	TO
46745	2970	30	rid	rid	VB
46745	2970	31	the	the	DT
46745	2970	32	blood	blood	NN
46745	2970	33	of	of	IN
46745	2970	34	an	an	DT
46745	2970	35	unnatural	unnatural	JJ
46745	2970	36	product	product	NN
46745	2970	37	.	.	.
46745	2971	1	Thus	thus	RB
46745	2971	2	Guaiacum	Guaiacum	NNP
46745	2971	3	and	and	CC
46745	2971	4	Salines	Salines	NNP
46745	2971	5	are	be	VBP
46745	2971	6	employed	employ	VBN
46745	2971	7	in	in	IN
46745	2971	8	Rheumatism	Rheumatism	NNP
46745	2971	9	,	,	,
46745	2971	10	and	and	CC
46745	2971	11	Purgatives	purgative	NNS
46745	2971	12	in	in	IN
46745	2971	13	Gout	Gout	NNP
46745	2971	14	.	.	.
46745	2972	1	These	these	DT
46745	2972	2	two	two	CD
46745	2972	3	joint	joint	JJ
46745	2972	4	affections	affection	NNS
46745	2972	5	are	be	VBP
46745	2972	6	most	most	RBS
46745	2972	7	characteristically	characteristically	RB
46745	2972	8	under	under	IN
46745	2972	9	the	the	DT
46745	2972	10	influence	influence	NN
46745	2972	11	of	of	IN
46745	2972	12	Catalytic	catalytic	JJ
46745	2972	13	remedies	remedy	NNS
46745	2972	14	.	.	.
46745	2973	1	Diabetes	diabetes	NN
46745	2973	2	and	and	CC
46745	2973	3	Lithiasis	Lithiasis	NNP
46745	2973	4	are	be	VBP
46745	2973	5	more	more	JJR
46745	2973	6	under	under	IN
46745	2973	7	the	the	DT
46745	2973	8	control	control	NN
46745	2973	9	of	of	IN
46745	2973	10	Restoratives	Restoratives	NNPS
46745	2973	11	than	than	IN
46745	2973	12	the	the	DT
46745	2973	13	others	other	NNS
46745	2973	14	.	.	.
46745	2974	1	The	the	DT
46745	2974	2	medicines	medicine	NNS
46745	2974	3	composing	compose	VBG
46745	2974	4	this	this	DT
46745	2974	5	fourth	fourth	JJ
46745	2974	6	order	order	NN
46745	2974	7	of	of	IN
46745	2974	8	Catalytics	catalytic	NNS
46745	2974	9	have	have	VBP
46745	2974	10	been	be	VBN
46745	2974	11	already	already	RB
46745	2974	12	enumerated	enumerate	VBN
46745	2974	13	.	.	.
46745	2975	1	That	that	DT
46745	2975	2	Colchicum	Colchicum	NNP
46745	2975	3	tends	tend	VBZ
46745	2975	4	in	in	IN
46745	2975	5	some	some	DT
46745	2975	6	way	way	NN
46745	2975	7	to	to	TO
46745	2975	8	neutralize	neutralize	VB
46745	2975	9	in	in	IN
46745	2975	10	the	the	DT
46745	2975	11	blood	blood	NN
46745	2975	12	the	the	DT
46745	2975	13	poison	poison	NN
46745	2975	14	of	of	IN
46745	2975	15	Gout	Gout	NNP
46745	2975	16	,	,	,
46745	2975	17	and	and	CC
46745	2975	18	to	to	IN
46745	2975	19	a	a	DT
46745	2975	20	less	less	JJR
46745	2975	21	degree	degree	NN
46745	2975	22	that	that	DT
46745	2975	23	of	of	IN
46745	2975	24	Rheumatism	rheumatism	NN
46745	2975	25	also	also	RB
46745	2975	26	,	,	,
46745	2975	27	is	be	VBZ
46745	2975	28	generally	generally	RB
46745	2975	29	admitted	admit	VBN
46745	2975	30	,	,	,
46745	2975	31	although	although	IN
46745	2975	32	various	various	JJ
46745	2975	33	theories	theory	NNS
46745	2975	34	have	have	VBP
46745	2975	35	been	be	VBN
46745	2975	36	adopted	adopt	VBN
46745	2975	37	to	to	TO
46745	2975	38	explain	explain	VB
46745	2975	39	this	this	DT
46745	2975	40	action	action	NN
46745	2975	41	.	.	.
46745	2976	1	(	(	-LRB-
46745	2976	2	_	_	NNP
46745	2976	3	Vide	Vide	NNP
46745	2976	4	Chap	Chap	NNP
46745	2976	5	.	.	.
46745	2977	1	IV	IV	NNP
46745	2977	2	.	.	.
46745	2978	1	Art	art	NN
46745	2978	2	.	.	.
46745	2979	1	Colchicum	Colchicum	NNP
46745	2979	2	.	.	.
46745	2979	3	_	_	NNP
46745	2979	4	)	)	-RRB-
46745	2979	5	In	in	IN
46745	2979	6	Oxaluria	Oxaluria	NNP
46745	2979	7	,	,	,
46745	2979	8	the	the	DT
46745	2979	9	employment	employment	NN
46745	2979	10	of	of	IN
46745	2979	11	Nitric	nitric	JJ
46745	2979	12	acid	acid	NN
46745	2979	13	as	as	IN
46745	2979	14	a	a	DT
46745	2979	15	remedy	remedy	NN
46745	2979	16	was	be	VBD
46745	2979	17	first	first	RB
46745	2979	18	recommended	recommend	VBN
46745	2979	19	by	by	IN
46745	2979	20	Dr.	Dr.	NNP
46745	2979	21	Prout	Prout	NNP
46745	2979	22	.	.	.
46745	2980	1	Dr.	Dr.	NNP
46745	2980	2	Golding	Golding	NNP
46745	2980	3	Bird	Bird	NNP
46745	2980	4	advised	advise	VBD
46745	2980	5	the	the	DT
46745	2980	6	substitution	substitution	NN
46745	2980	7	of	of	IN
46745	2980	8	Nitro	Nitro	NNP
46745	2980	9	-	-	HYPH
46745	2980	10	hydrochloric	hydrochloric	JJ
46745	2980	11	acid	acid	NN
46745	2980	12	,	,	,
46745	2980	13	which	which	WDT
46745	2980	14	has	have	VBZ
46745	2980	15	proved	prove	VBN
46745	2980	16	to	to	TO
46745	2980	17	be	be	VB
46745	2980	18	a	a	DT
46745	2980	19	most	most	RBS
46745	2980	20	valuable	valuable	JJ
46745	2980	21	remedy	remedy	NN
46745	2980	22	,	,	,
46745	2980	23	not	not	RB
46745	2980	24	only	only	RB
46745	2980	25	in	in	IN
46745	2980	26	this	this	DT
46745	2980	27	disorder	disorder	NN
46745	2980	28	,	,	,
46745	2980	29	but	but	CC
46745	2980	30	also	also	RB
46745	2980	31	in	in	IN
46745	2980	32	some	some	DT
46745	2980	33	cases	case	NNS
46745	2980	34	of	of	IN
46745	2980	35	lithic	lithic	JJ
46745	2980	36	deposit	deposit	NN
46745	2980	37	.	.	.
46745	2981	1	The	the	DT
46745	2981	2	Oxalate	Oxalate	NNP
46745	2981	3	of	of	IN
46745	2981	4	Lime	Lime	NNP
46745	2981	5	rarely	rarely	RB
46745	2981	6	occurs	occur	VBZ
46745	2981	7	alone	alone	RB
46745	2981	8	in	in	IN
46745	2981	9	the	the	DT
46745	2981	10	urine	urine	NN
46745	2981	11	;	;	:
46745	2981	12	there	there	EX
46745	2981	13	is	be	VBZ
46745	2981	14	generally	generally	RB
46745	2981	15	along	along	IN
46745	2981	16	with	with	IN
46745	2981	17	it	-PRON-	PRP
46745	2981	18	some	some	DT
46745	2981	19	Urate	Urate	NNP
46745	2981	20	of	of	IN
46745	2981	21	Ammonia	Ammonia	NNP
46745	2981	22	.	.	.
46745	2982	1	The	the	DT
46745	2982	2	causes	cause	NNS
46745	2982	3	of	of	IN
46745	2982	4	the	the	DT
46745	2982	5	two	two	CD
46745	2982	6	deposits	deposit	NNS
46745	2982	7	appear	appear	VBP
46745	2982	8	to	to	TO
46745	2982	9	be	be	VB
46745	2982	10	in	in	IN
46745	2982	11	some	some	DT
46745	2982	12	way	way	NN
46745	2982	13	connected	connect	VBN
46745	2982	14	.	.	.
46745	2983	1	So	so	RB
46745	2983	2	also	also	RB
46745	2983	3	are	be	VBP
46745	2983	4	the	the	DT
46745	2983	5	remedies	remedy	NNS
46745	2983	6	similar	similar	JJ
46745	2983	7	.	.	.
46745	2984	1	Dr.	Dr.	NNP
46745	2984	2	G.	G.	NNP
46745	2984	3	Bird	Bird	NNP
46745	2984	4	has	have	VBZ
46745	2984	5	found	find	VBN
46745	2984	6	Colchicum	Colchicum	NNP
46745	2984	7	to	to	TO
46745	2984	8	be	be	VB
46745	2984	9	of	of	IN
46745	2984	10	signal	signal	JJ
46745	2984	11	service	service	NN
46745	2984	12	in	in	IN
46745	2984	13	cases	case	NNS
46745	2984	14	of	of	IN
46745	2984	15	lithic	lithic	JJ
46745	2984	16	deposit	deposit	NN
46745	2984	17	in	in	IN
46745	2984	18	the	the	DT
46745	2984	19	urine	urine	NN
46745	2984	20	;	;	,
46745	2984	21	and	and	CC
46745	2984	22	has	have	VBZ
46745	2984	23	proved	prove	VBN
46745	2984	24	the	the	DT
46745	2984	25	same	same	JJ
46745	2984	26	medicine	medicine	NN
46745	2984	27	to	to	TO
46745	2984	28	be	be	VB
46745	2984	29	efficacious	efficacious	JJ
46745	2984	30	in	in	IN
46745	2984	31	Oxaluria	Oxaluria	NNP
46745	2984	32	.	.	.
46745	2985	1	I	-PRON-	PRP
46745	2985	2	will	will	MD
46745	2985	3	now	now	RB
46745	2985	4	attempt	attempt	VB
46745	2985	5	to	to	TO
46745	2985	6	show	show	VB
46745	2985	7	how	how	WRB
46745	2985	8	the	the	DT
46745	2985	9	action	action	NN
46745	2985	10	of	of	IN
46745	2985	11	these	these	DT
46745	2985	12	medicines	medicine	NNS
46745	2985	13	may	may	MD
46745	2985	14	admit	admit	VB
46745	2985	15	,	,	,
46745	2985	16	on	on	IN
46745	2985	17	certain	certain	JJ
46745	2985	18	grounds	ground	NNS
46745	2985	19	,	,	,
46745	2985	20	of	of	IN
46745	2985	21	a	a	DT
46745	2985	22	chemical	chemical	JJ
46745	2985	23	explanation	explanation	NN
46745	2985	24	.	.	.
46745	2986	1	There	there	EX
46745	2986	2	are	be	VBP
46745	2986	3	very	very	RB
46745	2986	4	few	few	JJ
46745	2986	5	Catalytic	catalytic	JJ
46745	2986	6	actions	action	NNS
46745	2986	7	in	in	IN
46745	2986	8	which	which	WDT
46745	2986	9	such	such	PDT
46745	2986	10	an	an	DT
46745	2986	11	explanation	explanation	NN
46745	2986	12	can	can	MD
46745	2986	13	be	be	VB
46745	2986	14	attempted	attempt	VBN
46745	2986	15	,	,	,
46745	2986	16	but	but	CC
46745	2986	17	a	a	DT
46745	2986	18	degree	degree	NN
46745	2986	19	of	of	IN
46745	2986	20	plausibility	plausibility	NN
46745	2986	21	appears	appear	VBZ
46745	2986	22	to	to	TO
46745	2986	23	attach	attach	VB
46745	2986	24	to	to	IN
46745	2986	25	the	the	DT
46745	2986	26	idea	idea	NN
46745	2986	27	in	in	IN
46745	2986	28	this	this	DT
46745	2986	29	case	case	NN
46745	2986	30	,	,	,
46745	2986	31	though	though	IN
46745	2986	32	it	-PRON-	PRP
46745	2986	33	can	can	MD
46745	2986	34	not	not	RB
46745	2986	35	of	of	RB
46745	2986	36	course	course	NN
46745	2986	37	be	be	VB
46745	2986	38	considered	consider	VBN
46745	2986	39	to	to	TO
46745	2986	40	be	be	VB
46745	2986	41	susceptible	susceptible	JJ
46745	2986	42	of	of	IN
46745	2986	43	more	more	JJR
46745	2986	44	than	than	IN
46745	2986	45	a	a	DT
46745	2986	46	demonstration	demonstration	NN
46745	2986	47	of	of	IN
46745	2986	48	probability	probability	NN
46745	2986	49	.	.	.
46745	2987	1	I	-PRON-	PRP
46745	2987	2	have	have	VBP
46745	2987	3	already	already	RB
46745	2987	4	said	say	VBN
46745	2987	5	that	that	IN
46745	2987	6	in	in	IN
46745	2987	7	all	all	PDT
46745	2987	8	the	the	DT
46745	2987	9	disorders	disorder	NNS
46745	2987	10	now	now	RB
46745	2987	11	under	under	IN
46745	2987	12	consideration	consideration	NN
46745	2987	13	there	there	EX
46745	2987	14	are	be	VBP
46745	2987	15	certain	certain	JJ
46745	2987	16	morbid	morbid	NN
46745	2987	17	constituents	constituent	NNS
46745	2987	18	in	in	IN
46745	2987	19	the	the	DT
46745	2987	20	blood	blood	NN
46745	2987	21	which	which	WDT
46745	2987	22	have	have	VBP
46745	2987	23	been	be	VBN
46745	2987	24	recognised	recognise	VBN
46745	2987	25	by	by	IN
46745	2987	26	chemical	chemical	NN
46745	2987	27	tests	test	NNS
46745	2987	28	.	.	.
46745	2988	1	In	in	IN
46745	2988	2	Diabetes	diabete	NNS
46745	2988	3	there	there	EX
46745	2988	4	is	be	VBZ
46745	2988	5	an	an	DT
46745	2988	6	excess	excess	NN
46745	2988	7	of	of	IN
46745	2988	8	grape	grape	NN
46745	2988	9	-	-	HYPH
46745	2988	10	sugar	sugar	NN
46745	2988	11	formed	form	VBN
46745	2988	12	in	in	IN
46745	2988	13	the	the	DT
46745	2988	14	blood	blood	NN
46745	2988	15	,	,	,
46745	2988	16	and	and	CC
46745	2988	17	excreted	excrete	VBD
46745	2988	18	from	from	IN
46745	2988	19	it	-PRON-	PRP
46745	2988	20	in	in	IN
46745	2988	21	the	the	DT
46745	2988	22	urine	urine	NN
46745	2988	23	.	.	.
46745	2989	1	In	in	IN
46745	2989	2	Rheumatism	Rheumatism	NNP
46745	2989	3	we	-PRON-	PRP
46745	2989	4	have	have	VBP
46745	2989	5	a	a	DT
46745	2989	6	painful	painful	JJ
46745	2989	7	joint	joint	NN
46745	2989	8	affection	affection	NN
46745	2989	9	,	,	,
46745	2989	10	attended	attend	VBD
46745	2989	11	with	with	IN
46745	2989	12	a	a	DT
46745	2989	13	great	great	JJ
46745	2989	14	development	development	NN
46745	2989	15	of	of	IN
46745	2989	16	acid	acid	NN
46745	2989	17	in	in	IN
46745	2989	18	the	the	DT
46745	2989	19	system	system	NN
46745	2989	20	;	;	:
46745	2989	21	and	and	CC
46745	2989	22	this	this	DT
46745	2989	23	acid	acid	NN
46745	2989	24	,	,	,
46745	2989	25	which	which	WDT
46745	2989	26	we	-PRON-	PRP
46745	2989	27	have	have	VBP
46745	2989	28	many	many	JJ
46745	2989	29	reasons	reason	NNS
46745	2989	30	for	for	IN
46745	2989	31	supposing	suppose	VBG
46745	2989	32	to	to	TO
46745	2989	33	be	be	VB
46745	2989	34	lactic	lactic	JJ
46745	2989	35	acid	acid	NN
46745	2989	36	,	,	,
46745	2989	37	is	be	VBZ
46745	2989	38	occasionally	occasionally	RB
46745	2989	39	excreted	excrete	VBN
46745	2989	40	by	by	IN
46745	2989	41	the	the	DT
46745	2989	42	skin	skin	NN
46745	2989	43	.	.	.
46745	2990	1	In	in	IN
46745	2990	2	Gout	Gout	NNP
46745	2990	3	we	-PRON-	PRP
46745	2990	4	meet	meet	VBP
46745	2990	5	with	with	IN
46745	2990	6	another	another	DT
46745	2990	7	Arthritic	arthritic	JJ
46745	2990	8	affection	affection	NN
46745	2990	9	,	,	,
46745	2990	10	in	in	IN
46745	2990	11	which	which	WDT
46745	2990	12	there	there	EX
46745	2990	13	is	be	VBZ
46745	2990	14	urate	urate	NN
46745	2990	15	of	of	IN
46745	2990	16	soda	soda	NN
46745	2990	17	in	in	IN
46745	2990	18	the	the	DT
46745	2990	19	blood	blood	NN
46745	2990	20	,	,	,
46745	2990	21	and	and	CC
46745	2990	22	an	an	DT
46745	2990	23	excess	excess	NN
46745	2990	24	of	of	IN
46745	2990	25	uric	uric	JJ
46745	2990	26	acid	acid	NN
46745	2990	27	and	and	CC
46745	2990	28	urea	urea	NNP
46745	2990	29	in	in	IN
46745	2990	30	the	the	DT
46745	2990	31	urine	urine	NN
46745	2990	32	.	.	.
46745	2991	1	A	a	DT
46745	2991	2	simple	simple	JJ
46745	2991	3	excess	excess	NN
46745	2991	4	of	of	IN
46745	2991	5	uric	uric	JJ
46745	2991	6	acid	acid	NN
46745	2991	7	in	in	IN
46745	2991	8	this	this	DT
46745	2991	9	secretion	secretion	NN
46745	2991	10	constitutes	constitute	VBZ
46745	2991	11	Lithiasis	Lithiasis	NNP
46745	2991	12	.	.	.
46745	2992	1	There	there	EX
46745	2992	2	is	be	VBZ
46745	2992	3	an	an	DT
46745	2992	4	obvious	obvious	JJ
46745	2992	5	but	but	CC
46745	2992	6	ill	ill	RB
46745	2992	7	-	-	HYPH
46745	2992	8	understood	understand	VBN
46745	2992	9	connexion	connexion	NN
46745	2992	10	between	between	IN
46745	2992	11	the	the	DT
46745	2992	12	last	last	JJ
46745	2992	13	two	two	CD
46745	2992	14	disorders	disorder	NNS
46745	2992	15	,	,	,
46745	2992	16	and	and	CC
46745	2992	17	,	,	,
46745	2992	18	indeed	indeed	RB
46745	2992	19	,	,	,
46745	2992	20	between	between	IN
46745	2992	21	all	all	PDT
46745	2992	22	those	those	DT
46745	2992	23	of	of	IN
46745	2992	24	which	which	WDT
46745	2992	25	we	-PRON-	PRP
46745	2992	26	are	be	VBP
46745	2992	27	treating	treat	VBG
46745	2992	28	.	.	.
46745	2993	1	In	in	IN
46745	2993	2	Oxaluria	Oxaluria	NNP
46745	2993	3	we	-PRON-	PRP
46745	2993	4	have	have	VBP
46745	2993	5	an	an	DT
46745	2993	6	abnormal	abnormal	JJ
46745	2993	7	formation	formation	NN
46745	2993	8	of	of	IN
46745	2993	9	oxalic	oxalic	JJ
46745	2993	10	acid	acid	NN
46745	2993	11	in	in	IN
46745	2993	12	the	the	DT
46745	2993	13	blood	blood	NN
46745	2993	14	,	,	,
46745	2993	15	which	which	WDT
46745	2993	16	is	be	VBZ
46745	2993	17	excreted	excrete	VBN
46745	2993	18	in	in	IN
46745	2993	19	combination	combination	NN
46745	2993	20	with	with	IN
46745	2993	21	lime	lime	NN
46745	2993	22	,	,	,
46745	2993	23	for	for	IN
46745	2993	24	which	which	WDT
46745	2993	25	base	base	NN
46745	2993	26	it	-PRON-	PRP
46745	2993	27	has	have	VBZ
46745	2993	28	a	a	DT
46745	2993	29	great	great	JJ
46745	2993	30	affinity	affinity	NN
46745	2993	31	.	.	.
46745	2994	1	In	in	IN
46745	2994	2	oxalic	oxalic	JJ
46745	2994	3	urine	urine	NN
46745	2994	4	there	there	EX
46745	2994	5	is	be	VBZ
46745	2994	6	generally	generally	RB
46745	2994	7	an	an	DT
46745	2994	8	excess	excess	NN
46745	2994	9	of	of	IN
46745	2994	10	urea	urea	NNP
46745	2994	11	,	,	,
46745	2994	12	as	as	IN
46745	2994	13	I	-PRON-	PRP
46745	2994	14	have	have	VBP
46745	2994	15	found	find	VBN
46745	2994	16	in	in	IN
46745	2994	17	many	many	JJ
46745	2994	18	cases	case	NNS
46745	2994	19	.	.	.
46745	2995	1	Now	now	RB
46745	2995	2	it	-PRON-	PRP
46745	2995	3	seems	seem	VBZ
46745	2995	4	to	to	IN
46745	2995	5	me	-PRON-	PRP
46745	2995	6	that	that	IN
46745	2995	7	all	all	PDT
46745	2995	8	these	these	DT
46745	2995	9	disorders	disorder	NNS
46745	2995	10	are	be	VBP
46745	2995	11	capable	capable	JJ
46745	2995	12	of	of	IN
46745	2995	13	being	be	VBG
46745	2995	14	explained	explain	VBN
46745	2995	15	by	by	IN
46745	2995	16	reference	reference	NN
46745	2995	17	to	to	IN
46745	2995	18	the	the	DT
46745	2995	19	series	series	NN
46745	2995	20	of	of	IN
46745	2995	21	changes	change	NNS
46745	2995	22	in	in	IN
46745	2995	23	the	the	DT
46745	2995	24	blood	blood	NN
46745	2995	25	which	which	WDT
46745	2995	26	are	be	VBP
46745	2995	27	associated	associate	VBN
46745	2995	28	with	with	IN
46745	2995	29	the	the	DT
46745	2995	30	respiratory	respiratory	JJ
46745	2995	31	process	process	NN
46745	2995	32	.	.	.
46745	2996	1	(	(	-LRB-
46745	2996	2	_	_	NNP
46745	2996	3	Vide	Vide	NNP
46745	2996	4	Liebig	Liebig	NNP
46745	2996	5	's	's	POS
46745	2996	6	Anim	Anim	NNP
46745	2996	7	.	.	.
46745	2997	1	Chem	Chem	NNP
46745	2997	2	.	.	.
46745	2997	3	_	_	NNP
46745	2997	4	,	,	,
46745	2997	5	part	part	NN
46745	2997	6	i.	i.	NNP
46745	2997	7	p.	p.	NN
46745	2997	8	133	133	CD
46745	2997	9	;	;	:
46745	2997	10	_	_	NNP
46745	2997	11	Dr.	Dr.	NNP
46745	2998	1	B.	B.	NNP
46745	2998	2	Jones	Jones	NNP
46745	2998	3	'	'	POS
46745	2998	4	Anim	Anim	NNP
46745	2998	5	.	.	.
46745	2999	1	Chem	Chem	NNP
46745	2999	2	.	.	.
46745	2999	3	_	_	NNP
46745	2999	4	,	,	,
46745	2999	5	pp	pp	NNP
46745	2999	6	.	.	.
46745	3000	1	20	20	CD
46745	3000	2	,	,	,
46745	3000	3	118	118	CD
46745	3000	4	.	.	.
46745	3000	5	)	)	-RRB-
46745	3001	1	It	-PRON-	PRP
46745	3001	2	is	be	VBZ
46745	3001	3	the	the	DT
46745	3001	4	general	general	JJ
46745	3001	5	opinion	opinion	NN
46745	3001	6	of	of	IN
46745	3001	7	modern	modern	JJ
46745	3001	8	chemists	chemist	NNS
46745	3001	9	,	,	,
46745	3001	10	that	that	IN
46745	3001	11	before	before	IN
46745	3001	12	the	the	DT
46745	3001	13	starch	starch	NN
46745	3001	14	of	of	IN
46745	3001	15	the	the	DT
46745	3001	16	food	food	NN
46745	3001	17	can	can	MD
46745	3001	18	be	be	VB
46745	3001	19	applied	apply	VBN
46745	3001	20	to	to	IN
46745	3001	21	the	the	DT
46745	3001	22	maintenance	maintenance	NN
46745	3001	23	of	of	IN
46745	3001	24	the	the	DT
46745	3001	25	animal	animal	NN
46745	3001	26	heat	heat	NN
46745	3001	27	,	,	,
46745	3001	28	for	for	IN
46745	3001	29	which	which	WDT
46745	3001	30	office	office	NN
46745	3001	31	it	-PRON-	PRP
46745	3001	32	is	be	VBZ
46745	3001	33	chiefly	chiefly	RB
46745	3001	34	intended	intend	VBN
46745	3001	35	,	,	,
46745	3001	36	it	-PRON-	PRP
46745	3001	37	passes	pass	VBZ
46745	3001	38	through	through	IN
46745	3001	39	a	a	DT
46745	3001	40	series	series	NN
46745	3001	41	of	of	IN
46745	3001	42	chemical	chemical	NN
46745	3001	43	changes	change	NNS
46745	3001	44	.	.	.
46745	3002	1	First	first	RB
46745	3002	2	,	,	,
46745	3002	3	assuming	assume	VBG
46745	3002	4	two	two	CD
46745	3002	5	equivalents	equivalent	NNS
46745	3002	6	of	of	IN
46745	3002	7	water	water	NN
46745	3002	8	,	,	,
46745	3002	9	it	-PRON-	PRP
46745	3002	10	becomes	become	VBZ
46745	3002	11	grape	grape	NN
46745	3002	12	-	-	HYPH
46745	3002	13	sugar	sugar	NN
46745	3002	14	;	;	:
46745	3002	15	next	next	RB
46745	3002	16	,	,	,
46745	3002	17	this	this	DT
46745	3002	18	changes	change	VBZ
46745	3002	19	into	into	IN
46745	3002	20	lactic	lactic	JJ
46745	3002	21	acid	acid	NN
46745	3002	22	,	,	,
46745	3002	23	which	which	WDT
46745	3002	24	is	be	VBZ
46745	3002	25	isomeric	isomeric	JJ
46745	3002	26	with	with	IN
46745	3002	27	it	-PRON-	PRP
46745	3002	28	;	;	:
46745	3002	29	and	and	CC
46745	3002	30	this	this	DT
46745	3002	31	again	again	RB
46745	3002	32	combines	combine	VBZ
46745	3002	33	with	with	IN
46745	3002	34	twelve	twelve	CD
46745	3002	35	atoms	atom	NNS
46745	3002	36	of	of	IN
46745	3002	37	oxygen	oxygen	NN
46745	3002	38	,	,	,
46745	3002	39	to	to	TO
46745	3002	40	form	form	VB
46745	3002	41	carbonic	carbonic	JJ
46745	3002	42	acid	acid	NN
46745	3002	43	and	and	CC
46745	3002	44	water	water	NN
46745	3002	45	.	.	.
46745	3003	1	This	this	DT
46745	3003	2	last	last	JJ
46745	3003	3	change	change	NN
46745	3003	4	is	be	VBZ
46745	3003	5	a	a	DT
46745	3003	6	process	process	NN
46745	3003	7	of	of	IN
46745	3003	8	combustion	combustion	NN
46745	3003	9	,	,	,
46745	3003	10	and	and	CC
46745	3003	11	thus	thus	RB
46745	3003	12	produces	produce	VBZ
46745	3003	13	heat	heat	NN
46745	3003	14	.	.	.
46745	3004	1	The	the	DT
46745	3004	2	oxygen	oxygen	NN
46745	3004	3	needed	need	VBN
46745	3004	4	for	for	IN
46745	3004	5	it	-PRON-	PRP
46745	3004	6	is	be	VBZ
46745	3004	7	absorbed	absorb	VBN
46745	3004	8	from	from	IN
46745	3004	9	the	the	DT
46745	3004	10	air	air	NN
46745	3004	11	by	by	IN
46745	3004	12	the	the	DT
46745	3004	13	pulmonary	pulmonary	JJ
46745	3004	14	mucous	mucous	JJ
46745	3004	15	membrane	membrane	NN
46745	3004	16	,	,	,
46745	3004	17	and	and	CC
46745	3004	18	the	the	DT
46745	3004	19	carbonic	carbonic	JJ
46745	3004	20	acid	acid	NN
46745	3004	21	formed	form	VBD
46745	3004	22	passes	pass	VBZ
46745	3004	23	out	out	IN
46745	3004	24	of	of	IN
46745	3004	25	the	the	DT
46745	3004	26	blood	blood	NN
46745	3004	27	at	at	IN
46745	3004	28	the	the	DT
46745	3004	29	same	same	JJ
46745	3004	30	surface	surface	NN
46745	3004	31	.	.	.
46745	3005	1	Liebig	Liebig	NNP
46745	3005	2	was	be	VBD
46745	3005	3	the	the	DT
46745	3005	4	first	first	JJ
46745	3005	5	to	to	TO
46745	3005	6	point	point	VB
46745	3005	7	out	out	RP
46745	3005	8	the	the	DT
46745	3005	9	connexion	connexion	NN
46745	3005	10	between	between	IN
46745	3005	11	these	these	DT
46745	3005	12	changes	change	NNS
46745	3005	13	and	and	CC
46745	3005	14	the	the	DT
46745	3005	15	phenomena	phenomenon	NNS
46745	3005	16	of	of	IN
46745	3005	17	Diabetes	diabetes	NN
46745	3005	18	.	.	.
46745	3006	1	It	-PRON-	PRP
46745	3006	2	is	be	VBZ
46745	3006	3	clear	clear	JJ
46745	3006	4	that	that	IN
46745	3006	5	if	if	IN
46745	3006	6	the	the	DT
46745	3006	7	process	process	NN
46745	3006	8	were	be	VBD
46745	3006	9	to	to	TO
46745	3006	10	stop	stop	VB
46745	3006	11	at	at	IN
46745	3006	12	the	the	DT
46745	3006	13	formation	formation	NN
46745	3006	14	of	of	IN
46745	3006	15	grape	grape	NN
46745	3006	16	-	-	HYPH
46745	3006	17	sugar	sugar	NN
46745	3006	18	,	,	,
46745	3006	19	the	the	DT
46745	3006	20	condition	condition	NN
46745	3006	21	of	of	IN
46745	3006	22	blood	blood	NN
46745	3006	23	that	that	WDT
46745	3006	24	exists	exist	VBZ
46745	3006	25	in	in	IN
46745	3006	26	Diabetes	diabetes	NN
46745	3006	27	would	would	MD
46745	3006	28	result	result	VB
46745	3006	29	.	.	.
46745	3007	1	This	this	DT
46745	3007	2	sugar	sugar	NN
46745	3007	3	can	can	MD
46745	3007	4	not	not	RB
46745	3007	5	be	be	VB
46745	3007	6	put	put	VBN
46745	3007	7	to	to	IN
46745	3007	8	any	any	DT
46745	3007	9	use	use	NN
46745	3007	10	,	,	,
46745	3007	11	and	and	CC
46745	3007	12	is	be	VBZ
46745	3007	13	excreted	excrete	VBN
46745	3007	14	as	as	RB
46745	3007	15	fast	fast	RB
46745	3007	16	as	as	IN
46745	3007	17	formed	form	VBN
46745	3007	18	.	.	.
46745	3008	1	There	there	EX
46745	3008	2	is	be	VBZ
46745	3008	3	an	an	DT
46745	3008	4	excess	excess	NN
46745	3008	5	of	of	IN
46745	3008	6	urea	urea	NNP
46745	3008	7	in	in	IN
46745	3008	8	the	the	DT
46745	3008	9	whole	whole	JJ
46745	3008	10	quantity	quantity	NN
46745	3008	11	of	of	IN
46745	3008	12	urine	urine	NN
46745	3008	13	passed	pass	VBN
46745	3008	14	in	in	IN
46745	3008	15	the	the	DT
46745	3008	16	day	day	NN
46745	3008	17	;	;	:
46745	3008	18	probably	probably	RB
46745	3008	19	because	because	IN
46745	3008	20	the	the	DT
46745	3008	21	nitrogenous	nitrogenous	JJ
46745	3008	22	food	food	NN
46745	3008	23	and	and	CC
46745	3008	24	tissues	tissue	NNS
46745	3008	25	are	be	VBP
46745	3008	26	undergoing	undergo	VBG
46745	3008	27	combustion	combustion	NN
46745	3008	28	instead	instead	RB
46745	3008	29	of	of	IN
46745	3008	30	the	the	DT
46745	3008	31	starch	starch	NN
46745	3008	32	.	.	.
46745	3009	1	Before	before	IN
46745	3009	2	becoming	become	VBG
46745	3009	3	grape	grape	NN
46745	3009	4	-	-	HYPH
46745	3009	5	sugar	sugar	NN
46745	3009	6	,	,	,
46745	3009	7	starch	starch	NN
46745	3009	8	undergoes	undergo	VBZ
46745	3009	9	a	a	DT
46745	3009	10	transitional	transitional	JJ
46745	3009	11	change	change	NN
46745	3009	12	into	into	IN
46745	3009	13	Dextrine	Dextrine	NNP
46745	3009	14	,	,	,
46745	3009	15	a	a	DT
46745	3009	16	gummy	gummy	JJ
46745	3009	17	insipid	insipid	JJ
46745	3009	18	substance	substance	NN
46745	3009	19	which	which	WDT
46745	3009	20	has	have	VBZ
46745	3009	21	the	the	DT
46745	3009	22	same	same	JJ
46745	3009	23	composition	composition	NN
46745	3009	24	as	as	IN
46745	3009	25	itself	-PRON-	PRP
46745	3009	26	.	.	.
46745	3010	1	It	-PRON-	PRP
46745	3010	2	seems	seem	VBZ
46745	3010	3	that	that	IN
46745	3010	4	the	the	DT
46745	3010	5	process	process	NN
46745	3010	6	may	may	MD
46745	3010	7	even	even	RB
46745	3010	8	stop	stop	VB
46745	3010	9	as	as	RB
46745	3010	10	early	early	RB
46745	3010	11	as	as	IN
46745	3010	12	this	this	DT
46745	3010	13	,	,	,
46745	3010	14	and	and	CC
46745	3010	15	that	that	IN
46745	3010	16	by	by	IN
46745	3010	17	this	this	DT
46745	3010	18	stoppage	stoppage	NN
46745	3010	19	another	another	DT
46745	3010	20	analogous	analogous	JJ
46745	3010	21	disease	disease	NN
46745	3010	22	may	may	MD
46745	3010	23	be	be	VB
46745	3010	24	produced	produce	VBN
46745	3010	25	,	,	,
46745	3010	26	_	_	NNP
46745	3010	27	i.e.	i.e.	FW
46745	3010	28	_	_	NNP
46745	3010	29	Diabetes	Diabetes	NNP
46745	3010	30	insipidus	insipidus	NN
46745	3010	31	.	.	.
46745	3011	1	The	the	DT
46745	3011	2	common	common	JJ
46745	3011	3	Diabetes	diabetes	NN
46745	3011	4	is	be	VBZ
46745	3011	5	called	call	VBN
46745	3011	6	D.	D.	NNP
46745	3011	7	mellitus	mellitus	NN
46745	3011	8	.	.	.
46745	3012	1	(	(	-LRB-
46745	3012	2	_	_	NNP
46745	3012	3	Vide	Vide	NNP
46745	3012	4	Jones	Jones	NNP
46745	3012	5	'	'	POS
46745	3012	6	Anim	Anim	NNP
46745	3012	7	.	.	.
46745	3013	1	Chem	Chem	NNP
46745	3013	2	.	.	.
46745	3013	3	_	_	NNP
46745	3013	4	p.	p.	NN
46745	3014	1	120	120	CD
46745	3014	2	.	.	.
46745	3014	3	)	)	-RRB-
46745	3015	1	If	if	IN
46745	3015	2	it	-PRON-	PRP
46745	3015	3	were	be	VBD
46745	3015	4	clearly	clearly	RB
46745	3015	5	proved	prove	VBN
46745	3015	6	that	that	IN
46745	3015	7	the	the	DT
46745	3015	8	acid	acid	NN
46745	3015	9	of	of	IN
46745	3015	10	Rheumatic	rheumatic	JJ
46745	3015	11	fever	fever	NN
46745	3015	12	is	be	VBZ
46745	3015	13	lactic	lactic	JJ
46745	3015	14	acid	acid	NN
46745	3015	15	,	,	,
46745	3015	16	then	then	RB
46745	3015	17	this	this	DT
46745	3015	18	affection	affection	NN
46745	3015	19	might	may	MD
46745	3015	20	evidently	evidently	RB
46745	3015	21	be	be	VB
46745	3015	22	produced	produce	VBN
46745	3015	23	by	by	IN
46745	3015	24	a	a	DT
46745	3015	25	stoppage	stoppage	NN
46745	3015	26	of	of	IN
46745	3015	27	the	the	DT
46745	3015	28	process	process	NN
46745	3015	29	at	at	IN
46745	3015	30	the	the	DT
46745	3015	31	next	next	JJ
46745	3015	32	stage	stage	NN
46745	3015	33	.	.	.
46745	3016	1	Lactic	lactic	JJ
46745	3016	2	acid	acid	NN
46745	3016	3	has	have	VBZ
46745	3016	4	been	be	VBN
46745	3016	5	formed	form	VBN
46745	3016	6	;	;	:
46745	3016	7	but	but	CC
46745	3016	8	,	,	,
46745	3016	9	for	for	IN
46745	3016	10	some	some	DT
46745	3016	11	reason	reason	NN
46745	3016	12	unknown	unknown	JJ
46745	3016	13	,	,	,
46745	3016	14	it	-PRON-	PRP
46745	3016	15	is	be	VBZ
46745	3016	16	not	not	RB
46745	3016	17	oxidized	oxidize	VBN
46745	3016	18	into	into	IN
46745	3016	19	carbonic	carbonic	JJ
46745	3016	20	acid	acid	NN
46745	3016	21	.	.	.
46745	3017	1	Urea	Urea	NNP
46745	3017	2	and	and	CC
46745	3017	3	uric	uric	JJ
46745	3017	4	acid	acid	NN
46745	3017	5	are	be	VBP
46745	3017	6	in	in	IN
46745	3017	7	excess	excess	NN
46745	3017	8	in	in	IN
46745	3017	9	the	the	DT
46745	3017	10	urine	urine	NN
46745	3017	11	,	,	,
46745	3017	12	from	from	IN
46745	3017	13	the	the	DT
46745	3017	14	cause	cause	NN
46745	3017	15	alleged	allege	VBN
46745	3017	16	above	above	RB
46745	3017	17	.	.	.
46745	3018	1	But	but	CC
46745	3018	2	suppose	suppose	VB
46745	3018	3	some	some	DT
46745	3018	4	of	of	IN
46745	3018	5	the	the	DT
46745	3018	6	sugar	sugar	NN
46745	3018	7	to	to	TO
46745	3018	8	be	be	VB
46745	3018	9	oxidized	oxidize	VBN
46745	3018	10	prematurely	prematurely	RB
46745	3018	11	,	,	,
46745	3018	12	without	without	IN
46745	3018	13	passing	pass	VBG
46745	3018	14	first	first	RB
46745	3018	15	into	into	IN
46745	3018	16	lactic	lactic	JJ
46745	3018	17	acid	acid	NN
46745	3018	18	.	.	.
46745	3019	1	By	by	IN
46745	3019	2	this	this	DT
46745	3019	3	oxalic	oxalic	JJ
46745	3019	4	acid	acid	NN
46745	3019	5	would	would	MD
46745	3019	6	be	be	VB
46745	3019	7	produced	produce	VBN
46745	3019	8	,	,	,
46745	3019	9	and	and	CC
46745	3019	10	the	the	DT
46745	3019	11	phenomena	phenomenon	NNS
46745	3019	12	of	of	IN
46745	3019	13	Oxaluria	Oxaluria	NNP
46745	3019	14	accounted	account	VBD
46745	3019	15	for	for	IN
46745	3019	16	.	.	.
46745	3020	1	These	these	DT
46745	3020	2	things	thing	NNS
46745	3020	3	are	be	VBP
46745	3020	4	only	only	RB
46745	3020	5	alleged	allege	VBN
46745	3020	6	as	as	IN
46745	3020	7	possible	possible	JJ
46745	3020	8	,	,	,
46745	3020	9	and	and	CC
46745	3020	10	for	for	IN
46745	3020	11	the	the	DT
46745	3020	12	purpose	purpose	NN
46745	3020	13	of	of	IN
46745	3020	14	showing	show	VBG
46745	3020	15	that	that	IN
46745	3020	16	,	,	,
46745	3020	17	should	should	MD
46745	3020	18	they	-PRON-	PRP
46745	3020	19	be	be	VB
46745	3020	20	true	true	JJ
46745	3020	21	,	,	,
46745	3020	22	the	the	DT
46745	3020	23	action	action	NN
46745	3020	24	of	of	IN
46745	3020	25	some	some	DT
46745	3020	26	useful	useful	JJ
46745	3020	27	remedies	remedy	NNS
46745	3020	28	might	may	MD
46745	3020	29	be	be	VB
46745	3020	30	elucidated	elucidate	VBN
46745	3020	31	.	.	.
46745	3021	1	It	-PRON-	PRP
46745	3021	2	is	be	VBZ
46745	3021	3	not	not	RB
46745	3021	4	at	at	RB
46745	3021	5	all	all	RB
46745	3021	6	unlikely	unlikely	JJ
46745	3021	7	that	that	IN
46745	3021	8	the	the	DT
46745	3021	9	accuracy	accuracy	NN
46745	3021	10	of	of	IN
46745	3021	11	such	such	JJ
46745	3021	12	ideas	idea	NNS
46745	3021	13	may	may	MD
46745	3021	14	be	be	VB
46745	3021	15	completely	completely	RB
46745	3021	16	established	establish	VBN
46745	3021	17	by	by	IN
46745	3021	18	fresh	fresh	JJ
46745	3021	19	discoveries	discovery	NNS
46745	3021	20	at	at	IN
46745	3021	21	no	no	DT
46745	3021	22	distant	distant	JJ
46745	3021	23	time	time	NN
46745	3021	24	.	.	.
46745	3022	1	But	but	CC
46745	3022	2	let	let	VB
46745	3022	3	us	-PRON-	PRP
46745	3022	4	continue	continue	VB
46745	3022	5	.	.	.
46745	3023	1	In	in	IN
46745	3023	2	Gout	Gout	NNP
46745	3023	3	and	and	CC
46745	3023	4	Lithiasis	Lithiasis	NNP
46745	3023	5	there	there	EX
46745	3023	6	is	be	VBZ
46745	3023	7	an	an	DT
46745	3023	8	excess	excess	NN
46745	3023	9	in	in	IN
46745	3023	10	the	the	DT
46745	3023	11	system	system	NN
46745	3023	12	of	of	IN
46745	3023	13	nitrogenous	nitrogenous	JJ
46745	3023	14	matter	matter	NN
46745	3023	15	,	,	,
46745	3023	16	and	and	CC
46745	3023	17	thus	thus	RB
46745	3023	18	a	a	DT
46745	3023	19	tendency	tendency	NN
46745	3023	20	to	to	IN
46745	3023	21	an	an	DT
46745	3023	22	extra	extra	JJ
46745	3023	23	formation	formation	NN
46745	3023	24	of	of	IN
46745	3023	25	urea	urea	NNP
46745	3023	26	.	.	.
46745	3024	1	These	these	DT
46745	3024	2	conditions	condition	NNS
46745	3024	3	are	be	VBP
46745	3024	4	often	often	RB
46745	3024	5	brought	bring	VBN
46745	3024	6	on	on	RP
46745	3024	7	,	,	,
46745	3024	8	and	and	CC
46745	3024	9	always	always	RB
46745	3024	10	aggravated	aggravate	VBN
46745	3024	11	,	,	,
46745	3024	12	by	by	IN
46745	3024	13	over	over	IN
46745	3024	14	-	-	HYPH
46745	3024	15	indulgence	indulgence	NN
46745	3024	16	in	in	IN
46745	3024	17	animal	animal	NN
46745	3024	18	food	food	NN
46745	3024	19	.	.	.
46745	3025	1	Now	now	RB
46745	3025	2	if	if	IN
46745	3025	3	we	-PRON-	PRP
46745	3025	4	may	may	MD
46745	3025	5	suppose	suppose	VB
46745	3025	6	that	that	IN
46745	3025	7	some	some	DT
46745	3025	8	of	of	IN
46745	3025	9	the	the	DT
46745	3025	10	lactic	lactic	JJ
46745	3025	11	acid	acid	NN
46745	3025	12	,	,	,
46745	3025	13	instead	instead	RB
46745	3025	14	of	of	IN
46745	3025	15	oxidizing	oxidize	VBG
46745	3025	16	directly	directly	RB
46745	3025	17	into	into	IN
46745	3025	18	carbonic	carbonic	JJ
46745	3025	19	acid	acid	NN
46745	3025	20	,	,	,
46745	3025	21	oxidizes	oxidize	VBZ
46745	3025	22	in	in	IN
46745	3025	23	combination	combination	NN
46745	3025	24	with	with	IN
46745	3025	25	this	this	DT
46745	3025	26	urea	urea	NN
46745	3025	27	which	which	WDT
46745	3025	28	is	be	VBZ
46745	3025	29	in	in	IN
46745	3025	30	excess	excess	NN
46745	3025	31	,	,	,
46745	3025	32	then	then	RB
46745	3025	33	uric	uric	JJ
46745	3025	34	acid	acid	NN
46745	3025	35	and	and	CC
46745	3025	36	water	water	NN
46745	3025	37	might	may	MD
46745	3025	38	result	result	VB
46745	3025	39	,	,	,
46745	3025	40	as	as	IN
46745	3025	41	is	be	VBZ
46745	3025	42	shown	show	VBN
46745	3025	43	below	below	RB
46745	3025	44	.	.	.
46745	3026	1	The	the	DT
46745	3026	2	uric	uric	JJ
46745	3026	3	acid	acid	NN
46745	3026	4	passes	pass	VBZ
46745	3026	5	out	out	RP
46745	3026	6	into	into	IN
46745	3026	7	the	the	DT
46745	3026	8	urine	urine	NN
46745	3026	9	in	in	IN
46745	3026	10	excessive	excessive	JJ
46745	3026	11	quantity	quantity	NN
46745	3026	12	.	.	.
46745	3027	1	Should	Should	MD
46745	3027	2	this	this	DT
46745	3027	3	be	be	VB
46745	3027	4	the	the	DT
46745	3027	5	case	case	NN
46745	3027	6	,	,	,
46745	3027	7	the	the	DT
46745	3027	8	great	great	JJ
46745	3027	9	affinity	affinity	NN
46745	3027	10	existing	exist	VBG
46745	3027	11	between	between	IN
46745	3027	12	the	the	DT
46745	3027	13	course	course	NN
46745	3027	14	and	and	CC
46745	3027	15	symptoms	symptom	NNS
46745	3027	16	of	of	IN
46745	3027	17	Gout	Gout	NNP
46745	3027	18	and	and	CC
46745	3027	19	Rheumatism	Rheumatism	NNP
46745	3027	20	would	would	MD
46745	3027	21	be	be	VB
46745	3027	22	easily	easily	RB
46745	3027	23	explained	explain	VBN
46745	3027	24	,	,	,
46745	3027	25	there	there	EX
46745	3027	26	being	be	VBG
46745	3027	27	in	in	IN
46745	3027	28	both	both	DT
46745	3027	29	disorders	disorder	VBZ
46745	3027	30	an	an	DT
46745	3027	31	impediment	impediment	NN
46745	3027	32	to	to	IN
46745	3027	33	the	the	DT
46745	3027	34	proper	proper	JJ
46745	3027	35	oxidation	oxidation	NN
46745	3027	36	of	of	IN
46745	3027	37	lactic	lactic	JJ
46745	3027	38	into	into	IN
46745	3027	39	carbonic	carbonic	JJ
46745	3027	40	acid	acid	NN
46745	3027	41	.	.	.
46745	3028	1	These	these	DT
46745	3028	2	things	thing	NNS
46745	3028	3	may	may	MD
46745	3028	4	be	be	VB
46745	3028	5	illustrated	illustrate	VBN
46745	3028	6	by	by	IN
46745	3028	7	a	a	DT
46745	3028	8	diagram	diagram	NN
46745	3028	9	,	,	,
46745	3028	10	showing	show	VBG
46745	3028	11	the	the	DT
46745	3028	12	results	result	NNS
46745	3028	13	which	which	WDT
46745	3028	14	are	be	VBP
46745	3028	15	supposed	suppose	VBN
46745	3028	16	to	to	TO
46745	3028	17	take	take	VB
46745	3028	18	place	place	NN
46745	3028	19	when	when	WRB
46745	3028	20	the	the	DT
46745	3028	21	natural	natural	JJ
46745	3028	22	process	process	NN
46745	3028	23	is	be	VBZ
46745	3028	24	arrested	arrest	VBN
46745	3028	25	at	at	IN
46745	3028	26	,	,	,
46745	3028	27	or	or	CC
46745	3028	28	diverted	divert	VBN
46745	3028	29	from	from	IN
46745	3028	30	,	,	,
46745	3028	31	any	any	DT
46745	3028	32	of	of	IN
46745	3028	33	its	-PRON-	PRP$
46745	3028	34	stages:--	stages:--	NN
46745	3028	35	Starch	Starch	NNP
46745	3028	36	.	.	.
46745	3029	1	|+	|+	NN
46745	3029	2	|2	|2	``
46745	3029	3	|a	|a	NN
46745	3029	4	|q	|q	NNP
46745	3029	5	|=	|=	NNP
46745	3029	6	Grape	Grape	NNP
46745	3029	7	Sugar	Sugar	NNP
46745	3029	8	(	(	-LRB-
46745	3029	9	Diabetes	diabetes	NN
46745	3029	10	.	.	.
46745	3029	11	)	)	-RRB-
46745	3030	1	|	|	NNP
46745	3030	2	|\	|\	NNP
46745	3030	3	|	|	NNP
46745	3030	4	\	\	NNP
46745	3030	5	|	|	CD
46745	3030	6	\+	\+	NN
46745	3030	7	O	o	NN
46745	3030	8	=	=	SYM
46745	3030	9	|	|	NNP
46745	3030	10	\	\	NNP
46745	3030	11	|	|	CD
46745	3030	12	\	\	NN
46745	3030	13	|	|	CD
46745	3030	14	\	\	NN
46745	3030	15	Oxalic	oxalic	JJ
46745	3030	16	acid	acid	NN
46745	3030	17	.	.	.
46745	3031	1	(	(	-LRB-
46745	3031	2	_	_	NNP
46745	3031	3	Oxaluria	Oxaluria	NNP
46745	3031	4	.	.	.
46745	3031	5	_	_	NNP
46745	3031	6	)	)	-RRB-
46745	3031	7	|	|	NNP
46745	3031	8	|=	|=	NN
46745	3031	9	Lactic	lactic	JJ
46745	3031	10	acid	acid	NN
46745	3031	11	(	(	-LRB-
46745	3031	12	Rheumatism	rheumatism	NN
46745	3031	13	.	.	.
46745	3031	14	)	)	-RRB-
46745	3032	1	|	|	NNP
46745	3032	2	|\	|\	NNP
46745	3032	3	|	|	NNP
46745	3032	4	\	\	NNP
46745	3032	5	|	|	CD
46745	3032	6	\+	\+	NN
46745	3032	7	2	2	CD
46745	3032	8	Urea	Urea	NNP
46745	3032	9	+	+	CC
46745	3032	10	O	o	NN
46745	3032	11	6	6	CD
46745	3032	12	=	=	SYM
46745	3032	13	|	|	CD
46745	3032	14	\	\	NN
46745	3032	15	Uric	uric	JJ
46745	3032	16	acid	acid	NN
46745	3032	17	+	+	CC
46745	3032	18	10	10	CD
46745	3032	19	aq	aq	NN
46745	3032	20	.	.	.
46745	3033	1	(	(	-LRB-
46745	3033	2	_	_	NNP
46745	3033	3	Gout	Gout	NNP
46745	3033	4	,	,	,
46745	3033	5	and	and	CC
46745	3033	6	Lithiasis	Lithiasis	NNP
46745	3033	7	.	.	.
46745	3033	8	_	_	NNP
46745	3033	9	)	)	-RRB-
46745	3033	10	|+	|+	NN
46745	3033	11	|O	|o	CD
46745	3033	12	|=	|=	NNP
46745	3033	13	Carbonic	carbonic	JJ
46745	3033	14	acid	acid	NN
46745	3033	15	.	.	.
46745	3034	1	Thus	thus	RB
46745	3034	2	,	,	,
46745	3034	3	at	at	IN
46745	3034	4	each	each	DT
46745	3034	5	of	of	IN
46745	3034	6	the	the	DT
46745	3034	7	two	two	CD
46745	3034	8	transitional	transitional	JJ
46745	3034	9	stages	stage	NNS
46745	3034	10	,	,	,
46745	3034	11	we	-PRON-	PRP
46745	3034	12	might	may	MD
46745	3034	13	have	have	VB
46745	3034	14	one	one	CD
46745	3034	15	diseased	disease	VBN
46745	3034	16	condition	condition	NN
46745	3034	17	produced	produce	VBN
46745	3034	18	by	by	IN
46745	3034	19	an	an	DT
46745	3034	20	arrest	arrest	NN
46745	3034	21	of	of	IN
46745	3034	22	the	the	DT
46745	3034	23	process	process	NN
46745	3034	24	,	,	,
46745	3034	25	and	and	CC
46745	3034	26	another	another	DT
46745	3034	27	by	by	IN
46745	3034	28	its	-PRON-	PRP$
46745	3034	29	deviation	deviation	NN
46745	3034	30	.	.	.
46745	3035	1	These	these	DT
46745	3035	2	deviations	deviation	NNS
46745	3035	3	and	and	CC
46745	3035	4	stoppages	stoppage	NNS
46745	3035	5	may	may	MD
46745	3035	6	result	result	VB
46745	3035	7	from	from	IN
46745	3035	8	a	a	DT
46745	3035	9	failure	failure	NN
46745	3035	10	of	of	IN
46745	3035	11	some	some	DT
46745	3035	12	natural	natural	JJ
46745	3035	13	principle	principle	NN
46745	3035	14	which	which	WDT
46745	3035	15	is	be	VBZ
46745	3035	16	gifted	gift	VBN
46745	3035	17	with	with	IN
46745	3035	18	the	the	DT
46745	3035	19	control	control	NN
46745	3035	20	and	and	CC
46745	3035	21	direction	direction	NN
46745	3035	22	of	of	IN
46745	3035	23	the	the	DT
46745	3035	24	series	series	NN
46745	3035	25	of	of	IN
46745	3035	26	transformations	transformation	NNS
46745	3035	27	;	;	:
46745	3035	28	or	or	CC
46745	3035	29	they	-PRON-	PRP
46745	3035	30	may	may	MD
46745	3035	31	simply	simply	RB
46745	3035	32	be	be	VB
46745	3035	33	traceable	traceable	JJ
46745	3035	34	to	to	IN
46745	3035	35	a	a	DT
46745	3035	36	want	want	NN
46745	3035	37	of	of	IN
46745	3035	38	vital	vital	JJ
46745	3035	39	energy	energy	NN
46745	3035	40	,	,	,
46745	3035	41	or	or	CC
46745	3035	42	nervous	nervous	JJ
46745	3035	43	force	force	NN
46745	3035	44	.	.	.
46745	3036	1	The	the	DT
46745	3036	2	same	same	JJ
46745	3036	3	ideas	idea	NNS
46745	3036	4	may	may	MD
46745	3036	5	be	be	VB
46745	3036	6	more	more	RBR
46745	3036	7	distinctly	distinctly	RB
46745	3036	8	expressed	express	VBN
46745	3036	9	by	by	IN
46745	3036	10	a	a	DT
46745	3036	11	few	few	JJ
46745	3036	12	chemical	chemical	NN
46745	3036	13	equations	equation	NNS
46745	3036	14	.	.	.
46745	3037	1	_	_	NNP
46745	3037	2	Natural	natural	JJ
46745	3037	3	process	process	NN
46745	3037	4	.	.	.
46745	3037	5	_	_	NNP
46745	3037	6	C_{12}H_{10}O_{10	C_{12}H_{10}O_{10	NNP
46745	3037	7	}	}	-RRB-
46745	3037	8	+	+	CC
46745	3037	9	2	2	CD
46745	3037	10	HO	HO	NNP
46745	3037	11	=	=	SYM
46745	3037	12	C_{12}H_{12}O_{12	C_{12}H_{12}O_{12	NNP
46745	3037	13	}	}	-RRB-
46745	3037	14	.	.	.
46745	3038	1	=	=	SYM
46745	3038	2	2	2	CD
46745	3038	3	(	(	-LRB-
46745	3038	4	C_{6}H_{5}O_{5	c_{6}h_{5}o_{5	NN
46745	3038	5	}	}	-RRB-
46745	3038	6	,	,	,
46745	3038	7	HO	HO	NNP
46745	3038	8	.	.	.
46745	3038	9	)	)	-RRB-
46745	3039	1	C_{6}H_{6}O_{6	C_{6}H_{6}O_{6	NNP
46745	3039	2	}	}	-RRB-
46745	3039	3	+	+	CC
46745	3039	4	O_{12	o_{12	NN
46745	3039	5	}	}	-RRB-
46745	3039	6	=	=	SYM
46745	3039	7	6	6	CD
46745	3039	8	CO_{2	CO_{2	NNP
46745	3039	9	}	}	-RRB-
46745	3039	10	+	+	CC
46745	3039	11	6	6	CD
46745	3039	12	HO	HO	NNP
46745	3039	13	.	.	.
46745	3040	1	_	_	NNP
46745	3040	2	Oxaluria	Oxaluria	NNP
46745	3040	3	.	.	.
46745	3040	4	_	_	NNP
46745	3040	5	C_{12}H_{12}O_{12	C_{12}H_{12}O_{12	NNP
46745	3040	6	}	}	-RRB-
46745	3040	7	+	+	NNP
46745	3040	8	O_{18	o_{18	NN
46745	3040	9	}	}	-RRB-
46745	3040	10	=	=	SYM
46745	3040	11	6	6	CD
46745	3040	12	C_{2}O_{3	C_{2}O_{3	NNP
46745	3040	13	}	}	-RRB-
46745	3040	14	+	+	CC
46745	3040	15	12	12	CD
46745	3040	16	HO	ho	NN
46745	3040	17	.	.	.
46745	3041	1	_	_	NNP
46745	3041	2	Gout	Gout	NNP
46745	3041	3	and	and	CC
46745	3041	4	Lithiasis	Lithiasis	NNP
46745	3041	5	.	.	.
46745	3041	6	_	_	NNP
46745	3041	7	Lactic	lactic	JJ
46745	3041	8	acid	acid	NN
46745	3041	9	+	+	CC
46745	3041	10	2	2	CD
46745	3041	11	Urea	Urea	NNP
46745	3041	12	+	+	CC
46745	3041	13	O_{5	O_{5	NNP
46745	3041	14	}	}	-RRB-
46745	3041	15	=	=	NFP
46745	3041	16	Uric	uric	NN
46745	3041	17	acid	acid	NN
46745	3041	18	+	+	CC
46745	3041	19	10	10	CD
46745	3041	20	HO	HO	NNP
46745	3041	21	.	.	.
46745	3042	1	The	the	DT
46745	3042	2	last	last	JJ
46745	3042	3	equation	equation	NN
46745	3042	4	may	may	MD
46745	3042	5	be	be	VB
46745	3042	6	thus	thus	RB
46745	3042	7	proved	prove	VBN
46745	3042	8	at	at	IN
46745	3042	9	length:--	length:--	NNP
46745	3042	10	C_{6	C_{6	NNP
46745	3042	11	}	}	-RRB-
46745	3042	12	H_{6	H_{6	NNP
46745	3042	13	}	}	-RRB-
46745	3042	14	O_{6	O_{6	NNP
46745	3042	15	}	}	-RRB-
46745	3042	16	.	.	.
46745	3043	1	C_{10}H_{4	C_{10}H_{4	NNP
46745	3043	2	}	}	-RRB-
46745	3043	3	O_{6	O_{6	NNP
46745	3043	4	}	}	-RRB-
46745	3043	5	N_{4	N_{4	NNP
46745	3043	6	}	}	-RRB-
46745	3043	7	.	.	.
46745	3044	1	C_{4	C_{4	NNP
46745	3044	2	}	}	-RRB-
46745	3044	3	H_{8	H_{8	NNP
46745	3044	4	}	}	-RRB-
46745	3044	5	O_{4	O_{4	NNP
46745	3044	6	}	}	-RRB-
46745	3044	7	N_{4	N_{4	NNP
46745	3044	8	}	}	-RRB-
46745	3044	9	.	.	.
46745	3045	1	O_{6	O_{6	NNP
46745	3045	2	}	}	-RRB-
46745	3045	3	.	.	.
46745	3046	1	H_{10}O_{10	H_{10}O_{10	NNP
46745	3046	2	}	}	-RRB-
46745	3046	3	.	.	.
46745	3047	1	------------------------	------------------------	NFP
46745	3047	2	------------------------	------------------------	NFP
46745	3047	3	C_{10}H_{14}O_{16}N_{4	C_{10}H_{14}O_{16}N_{4	NNP
46745	3047	4	}	}	-RRB-
46745	3047	5	.	.	.
46745	3048	1	=	=	NFP
46745	3048	2	C_{10}H_{14}O_{16}N_{4	c_{10}h_{14}o_{16}n_{4	NN
46745	3048	3	}	}	-RRB-
46745	3048	4	.	.	.
46745	3049	1	It	-PRON-	PRP
46745	3049	2	is	be	VBZ
46745	3049	3	next	next	JJ
46745	3049	4	to	to	TO
46745	3049	5	be	be	VB
46745	3049	6	inquired	inquire	VBN
46745	3049	7	how	how	WRB
46745	3049	8	far	far	RB
46745	3049	9	the	the	DT
46745	3049	10	theoretical	theoretical	JJ
46745	3049	11	explanation	explanation	NN
46745	3049	12	of	of	IN
46745	3049	13	these	these	DT
46745	3049	14	diseases	disease	NNS
46745	3049	15	which	which	WDT
46745	3049	16	has	have	VBZ
46745	3049	17	thus	thus	RB
46745	3049	18	been	be	VBN
46745	3049	19	sketched	sketch	VBN
46745	3049	20	out	out	RP
46745	3049	21	can	can	MD
46745	3049	22	be	be	VB
46745	3049	23	applicable	applicable	JJ
46745	3049	24	to	to	IN
46745	3049	25	the	the	DT
46745	3049	26	matter	matter	NN
46745	3049	27	in	in	IN
46745	3049	28	which	which	WDT
46745	3049	29	we	-PRON-	PRP
46745	3049	30	are	be	VBP
46745	3049	31	more	more	RBR
46745	3049	32	immediately	immediately	RB
46745	3049	33	interested	interested	JJ
46745	3049	34	,	,	,
46745	3049	35	viz	viz	NNP
46745	3049	36	.	.	NNP
46745	3049	37	,	,	,
46745	3049	38	the	the	DT
46745	3049	39	action	action	NN
46745	3049	40	of	of	IN
46745	3049	41	the	the	DT
46745	3049	42	Catalytic	catalytic	JJ
46745	3049	43	remedies	remedy	NNS
46745	3049	44	used	use	VBN
46745	3049	45	to	to	TO
46745	3049	46	cure	cure	VB
46745	3049	47	them	-PRON-	PRP
46745	3049	48	.	.	.
46745	3050	1	For	for	IN
46745	3050	2	the	the	DT
46745	3050	3	radical	radical	JJ
46745	3050	4	cure	cure	NN
46745	3050	5	of	of	IN
46745	3050	6	Diabetes	diabetes	NN
46745	3050	7	there	there	EX
46745	3050	8	is	be	VBZ
46745	3050	9	no	no	DT
46745	3050	10	known	known	JJ
46745	3050	11	remedy	remedy	NN
46745	3050	12	;	;	:
46745	3050	13	though	though	IN
46745	3050	14	some	some	DT
46745	3050	15	relief	relief	NN
46745	3050	16	may	may	MD
46745	3050	17	be	be	VB
46745	3050	18	afforded	afford	VBN
46745	3050	19	by	by	IN
46745	3050	20	a	a	DT
46745	3050	21	system	system	NN
46745	3050	22	of	of	IN
46745	3050	23	dieting	dieting	NN
46745	3050	24	.	.	.
46745	3051	1	(	(	-LRB-
46745	3051	2	_	_	NNP
46745	3051	3	Vide	Vide	NNP
46745	3051	4	Aliments	Aliments	NNP
46745	3051	5	.	.	.
46745	3051	6	_	_	NNP
46745	3051	7	)	)	-RRB-
46745	3051	8	It	-PRON-	PRP
46745	3051	9	is	be	VBZ
46745	3051	10	supposed	suppose	VBN
46745	3051	11	that	that	IN
46745	3051	12	what	what	WP
46745	3051	13	we	-PRON-	PRP
46745	3051	14	have	have	VBP
46745	3051	15	to	to	TO
46745	3051	16	do	do	VB
46745	3051	17	is	be	VBZ
46745	3051	18	to	to	TO
46745	3051	19	convert	convert	VB
46745	3051	20	diabetic	diabetic	JJ
46745	3051	21	sugar	sugar	NN
46745	3051	22	,	,	,
46745	3051	23	_	_	NNP
46745	3051	24	i.e.	i.e.	FW
46745	3051	25	_	_	NNP
46745	3051	26	grape	grape	NN
46745	3051	27	-	-	HYPH
46745	3051	28	sugar	sugar	NN
46745	3051	29	,	,	,
46745	3051	30	into	into	IN
46745	3051	31	lactic	lactic	JJ
46745	3051	32	acid	acid	NN
46745	3051	33	.	.	.
46745	3052	1	This	this	DT
46745	3052	2	acid	acid	NN
46745	3052	3	probably	probably	RB
46745	3052	4	exists	exist	VBZ
46745	3052	5	in	in	IN
46745	3052	6	the	the	DT
46745	3052	7	gastric	gastric	JJ
46745	3052	8	juice	juice	NN
46745	3052	9	.	.	.
46745	3053	1	And	and	CC
46745	3053	2	some	some	DT
46745	3053	3	such	such	JJ
46745	3053	4	substance	substance	NN
46745	3053	5	as	as	IN
46745	3053	6	Pepsin	Pepsin	NNP
46745	3053	7	,	,	,
46745	3053	8	or	or	CC
46745	3053	9	the	the	DT
46745	3053	10	decomposing	decompose	VBG
46745	3053	11	Caseine	Caseine	NNP
46745	3053	12	in	in	IN
46745	3053	13	sour	sour	JJ
46745	3053	14	milk	milk	NN
46745	3053	15	,	,	,
46745	3053	16	which	which	WDT
46745	3053	17	is	be	VBZ
46745	3053	18	capable	capable	JJ
46745	3053	19	of	of	IN
46745	3053	20	effecting	effect	VBG
46745	3053	21	this	this	DT
46745	3053	22	change	change	NN
46745	3053	23	out	out	IN
46745	3053	24	of	of	IN
46745	3053	25	the	the	DT
46745	3053	26	body	body	NN
46745	3053	27	,	,	,
46745	3053	28	might	may	MD
46745	3053	29	perhaps	perhaps	RB
46745	3053	30	avail	avail	VB
46745	3053	31	us	-PRON-	PRP
46745	3053	32	,	,	,
46745	3053	33	if	if	IN
46745	3053	34	we	-PRON-	PRP
46745	3053	35	could	could	MD
46745	3053	36	contrive	contrive	VB
46745	3053	37	to	to	TO
46745	3053	38	introduce	introduce	VB
46745	3053	39	it	-PRON-	PRP
46745	3053	40	into	into	IN
46745	3053	41	the	the	DT
46745	3053	42	blood	blood	NN
46745	3053	43	.	.	.
46745	3054	1	In	in	IN
46745	3054	2	Oxaluria	Oxaluria	NNP
46745	3054	3	,	,	,
46745	3054	4	the	the	DT
46745	3054	5	best	good	JJS
46745	3054	6	treatment	treatment	NN
46745	3054	7	consists	consist	VBZ
46745	3054	8	in	in	IN
46745	3054	9	a	a	DT
46745	3054	10	course	course	NN
46745	3054	11	of	of	IN
46745	3054	12	Nitro	Nitro	NNP
46745	3054	13	-	-	HYPH
46745	3054	14	hydrochloric	hydrochloric	JJ
46745	3054	15	acid	acid	NN
46745	3054	16	.	.	.
46745	3055	1	This	this	DT
46745	3055	2	remedy	remedy	NN
46745	3055	3	is	be	VBZ
46745	3055	4	prepared	prepare	VBN
46745	3055	5	by	by	IN
46745	3055	6	adding	add	VBG
46745	3055	7	one	one	CD
46745	3055	8	part	part	NN
46745	3055	9	of	of	IN
46745	3055	10	Nitric	Nitric	NNP
46745	3055	11	to	to	IN
46745	3055	12	two	two	CD
46745	3055	13	of	of	IN
46745	3055	14	Hydrochloric	Hydrochloric	NNP
46745	3055	15	acid	acid	NN
46745	3055	16	;	;	:
46745	3055	17	and	and	CC
46745	3055	18	is	be	VBZ
46745	3055	19	diluted	dilute	VBN
46745	3055	20	considerably	considerably	RB
46745	3055	21	with	with	IN
46745	3055	22	water	water	NN
46745	3055	23	when	when	WRB
46745	3055	24	prescribed	prescribe	VBN
46745	3055	25	.	.	.
46745	3056	1	The	the	DT
46745	3056	2	Nitric	nitric	JJ
46745	3056	3	acid	acid	NN
46745	3056	4	causes	cause	VBZ
46745	3056	5	the	the	DT
46745	3056	6	oxidation	oxidation	NN
46745	3056	7	of	of	IN
46745	3056	8	some	some	DT
46745	3056	9	of	of	IN
46745	3056	10	the	the	DT
46745	3056	11	Hydrogen	Hydrogen	NNP
46745	3056	12	of	of	IN
46745	3056	13	the	the	DT
46745	3056	14	other	other	JJ
46745	3056	15	acid	acid	NN
46745	3056	16	,	,	,
46745	3056	17	and	and	CC
46745	3056	18	thus	thus	RB
46745	3056	19	sets	set	VBZ
46745	3056	20	free	free	JJ
46745	3056	21	Chlorine	Chlorine	NNP
46745	3056	22	gas	gas	NN
46745	3056	23	.	.	.
46745	3057	1	This	this	DT
46745	3057	2	is	be	VBZ
46745	3057	3	stated	state	VBN
46745	3057	4	by	by	IN
46745	3057	5	Mr.	Mr.	NNP
46745	3057	6	Brande	Brande	NNP
46745	3057	7	to	to	TO
46745	3057	8	go	go	VB
46745	3057	9	on	on	RP
46745	3057	10	until	until	IN
46745	3057	11	the	the	DT
46745	3057	12	liquid	liquid	NN
46745	3057	13	is	be	VBZ
46745	3057	14	saturated	saturate	VBN
46745	3057	15	with	with	IN
46745	3057	16	this	this	DT
46745	3057	17	gas	gas	NN
46745	3057	18	.	.	.
46745	3058	1	The	the	DT
46745	3058	2	result	result	NN
46745	3058	3	of	of	IN
46745	3058	4	the	the	DT
46745	3058	5	presence	presence	NN
46745	3058	6	of	of	IN
46745	3058	7	Chlorine	Chlorine	NNP
46745	3058	8	is	be	VBZ
46745	3058	9	,	,	,
46745	3058	10	that	that	IN
46745	3058	11	from	from	IN
46745	3058	12	the	the	DT
46745	3058	13	affinity	affinity	NN
46745	3058	14	of	of	IN
46745	3058	15	this	this	DT
46745	3058	16	gas	gas	NN
46745	3058	17	for	for	IN
46745	3058	18	Hydrogen	Hydrogen	NNP
46745	3058	19	,	,	,
46745	3058	20	by	by	IN
46745	3058	21	which	which	WDT
46745	3058	22	,	,	,
46745	3058	23	under	under	IN
46745	3058	24	certain	certain	JJ
46745	3058	25	circumstances	circumstance	NNS
46745	3058	26	,	,	,
46745	3058	27	it	-PRON-	PRP
46745	3058	28	is	be	VBZ
46745	3058	29	enabled	enable	VBN
46745	3058	30	to	to	TO
46745	3058	31	set	set	VB
46745	3058	32	free	free	JJ
46745	3058	33	the	the	DT
46745	3058	34	Oxygen	oxygen	NN
46745	3058	35	of	of	IN
46745	3058	36	water	water	NN
46745	3058	37	,	,	,
46745	3058	38	this	this	DT
46745	3058	39	compound	compound	NN
46745	3058	40	acid	acid	NN
46745	3058	41	becomes	become	VBZ
46745	3058	42	the	the	DT
46745	3058	43	most	most	RBS
46745	3058	44	powerful	powerful	JJ
46745	3058	45	oxidizing	oxidizing	JJ
46745	3058	46	agent	agent	NN
46745	3058	47	known	know	VBN
46745	3058	48	.	.	.
46745	3059	1	This	this	DT
46745	3059	2	acid	acid	NN
46745	3059	3	has	have	VBZ
46745	3059	4	been	be	VBN
46745	3059	5	lately	lately	RB
46745	3059	6	used	use	VBN
46745	3059	7	as	as	IN
46745	3059	8	a	a	DT
46745	3059	9	remedy	remedy	NN
46745	3059	10	for	for	IN
46745	3059	11	Gout	Gout	NNP
46745	3059	12	and	and	CC
46745	3059	13	Rheumatism	Rheumatism	NNP
46745	3059	14	,	,	,
46745	3059	15	in	in	IN
46745	3059	16	spite	spite	NN
46745	3059	17	of	of	IN
46745	3059	18	the	the	DT
46745	3059	19	acid	acid	JJ
46745	3059	20	state	state	NN
46745	3059	21	of	of	IN
46745	3059	22	the	the	DT
46745	3059	23	fluids	fluid	NNS
46745	3059	24	in	in	IN
46745	3059	25	those	those	DT
46745	3059	26	cases	case	NNS
46745	3059	27	;	;	:
46745	3059	28	and	and	CC
46745	3059	29	I	-PRON-	PRP
46745	3059	30	believe	believe	VBP
46745	3059	31	it	-PRON-	PRP
46745	3059	32	to	to	TO
46745	3059	33	be	be	VB
46745	3059	34	a	a	DT
46745	3059	35	very	very	RB
46745	3059	36	valuable	valuable	JJ
46745	3059	37	medicine	medicine	NN
46745	3059	38	in	in	IN
46745	3059	39	both	both	DT
46745	3059	40	of	of	IN
46745	3059	41	these	these	DT
46745	3059	42	disorders	disorder	NNS
46745	3059	43	.	.	.
46745	3060	1	A	a	DT
46745	3060	2	simple	simple	JJ
46745	3060	3	mineral	mineral	NN
46745	3060	4	acid	acid	NN
46745	3060	5	would	would	MD
46745	3060	6	do	do	VB
46745	3060	7	no	no	DT
46745	3060	8	harm	harm	NN
46745	3060	9	in	in	IN
46745	3060	10	both	both	DT
46745	3060	11	instances	instance	NNS
46745	3060	12	.	.	.
46745	3061	1	The	the	DT
46745	3061	2	Nitro	Nitro	NNP
46745	3061	3	-	-	HYPH
46745	3061	4	hydrochloric	hydrochloric	JJ
46745	3061	5	acid	acid	NN
46745	3061	6	must	must	MD
46745	3061	7	operate	operate	VB
46745	3061	8	in	in	IN
46745	3061	9	some	some	DT
46745	3061	10	special	special	JJ
46745	3061	11	way	way	NN
46745	3061	12	.	.	.
46745	3062	1	It	-PRON-	PRP
46745	3062	2	is	be	VBZ
46745	3062	3	probable	probable	JJ
46745	3062	4	that	that	IN
46745	3062	5	its	-PRON-	PRP$
46745	3062	6	action	action	NN
46745	3062	7	may	may	MD
46745	3062	8	depend	depend	VB
46745	3062	9	upon	upon	IN
46745	3062	10	its	-PRON-	PRP$
46745	3062	11	oxidizing	oxidizing	JJ
46745	3062	12	power	power	NN
46745	3062	13	.	.	.
46745	3063	1	In	in	IN
46745	3063	2	Oxaluria	Oxaluria	NNP
46745	3063	3	it	-PRON-	PRP
46745	3063	4	might	may	MD
46745	3063	5	cause	cause	VB
46745	3063	6	the	the	DT
46745	3063	7	oxalic	oxalic	JJ
46745	3063	8	acid	acid	NN
46745	3063	9	to	to	TO
46745	3063	10	be	be	VB
46745	3063	11	oxidized	oxidize	VBN
46745	3063	12	into	into	IN
46745	3063	13	carbonic	carbonic	JJ
46745	3063	14	acid	acid	NN
46745	3063	15	,	,	,
46745	3063	16	and	and	CC
46745	3063	17	thus	thus	RB
46745	3063	18	restore	restore	VB
46745	3063	19	health	health	NN
46745	3063	20	.	.	.
46745	3064	1	Thus	thus	RB
46745	3064	2	:	:	:
46745	3064	3	C_{2}O_{3}+O	C_{2}O_{3}+O	NNP
46745	3064	4	=	=	SYM
46745	3064	5	2	2	CD
46745	3064	6	CO_{2	CO_{2	NNP
46745	3064	7	}	}	-RRB-
46745	3064	8	.	.	.
46745	3065	1	In	in	IN
46745	3065	2	Rheumatic	rheumatic	JJ
46745	3065	3	fever	fever	NN
46745	3065	4	,	,	,
46745	3065	5	where	where	WRB
46745	3065	6	we	-PRON-	PRP
46745	3065	7	have	have	VBP
46745	3065	8	supposed	suppose	VBN
46745	3065	9	that	that	IN
46745	3065	10	lactic	lactic	JJ
46745	3065	11	acid	acid	NN
46745	3065	12	is	be	VBZ
46745	3065	13	formed	form	VBN
46745	3065	14	as	as	IN
46745	3065	15	it	-PRON-	PRP
46745	3065	16	should	should	MD
46745	3065	17	be	be	VB
46745	3065	18	,	,	,
46745	3065	19	but	but	CC
46745	3065	20	then	then	RB
46745	3065	21	stops	stop	VBZ
46745	3065	22	short	short	JJ
46745	3065	23	,	,	,
46745	3065	24	and	and	CC
46745	3065	25	proceeds	proceed	VBZ
46745	3065	26	no	no	RB
46745	3065	27	further	further	RB
46745	3065	28	,	,	,
46745	3065	29	the	the	DT
46745	3065	30	oxidizing	oxidizing	JJ
46745	3065	31	agent	agent	NN
46745	3065	32	may	may	MD
46745	3065	33	convert	convert	VB
46745	3065	34	this	this	DT
46745	3065	35	into	into	IN
46745	3065	36	carbonic	carbonic	JJ
46745	3065	37	acid	acid	NN
46745	3065	38	.	.	.
46745	3066	1	In	in	IN
46745	3066	2	Gout	Gout	NNP
46745	3066	3	and	and	CC
46745	3066	4	Lithiasis	Lithiasis	NNP
46745	3066	5	,	,	,
46745	3066	6	where	where	WRB
46745	3066	7	there	there	EX
46745	3066	8	seems	seem	VBZ
46745	3066	9	to	to	TO
46745	3066	10	be	be	VB
46745	3066	11	an	an	DT
46745	3066	12	excess	excess	NN
46745	3066	13	of	of	IN
46745	3066	14	nitrogen	nitrogen	NN
46745	3066	15	in	in	IN
46745	3066	16	the	the	DT
46745	3066	17	system	system	NN
46745	3066	18	,	,	,
46745	3066	19	and	and	CC
46745	3066	20	thus	thus	RB
46745	3066	21	more	more	JJR
46745	3066	22	oxygen	oxygen	NN
46745	3066	23	is	be	VBZ
46745	3066	24	needed	need	VBN
46745	3066	25	to	to	TO
46745	3066	26	restore	restore	VB
46745	3066	27	the	the	DT
46745	3066	28	equilibrium	equilibrium	NN
46745	3066	29	,	,	,
46745	3066	30	I	-PRON-	PRP
46745	3066	31	have	have	VBP
46745	3066	32	supposed	suppose	VBN
46745	3066	33	that	that	IN
46745	3066	34	lactic	lactic	JJ
46745	3066	35	acid	acid	NN
46745	3066	36	and	and	CC
46745	3066	37	urea	urea	NNP
46745	3066	38	are	be	VBP
46745	3066	39	changed	change	VBN
46745	3066	40	together	together	RB
46745	3066	41	into	into	IN
46745	3066	42	uric	uric	JJ
46745	3066	43	acid	acid	NN
46745	3066	44	.	.	.
46745	3067	1	If	if	IN
46745	3067	2	we	-PRON-	PRP
46745	3067	3	adopt	adopt	VBP
46745	3067	4	this	this	DT
46745	3067	5	hypothesis	hypothesis	NN
46745	3067	6	,	,	,
46745	3067	7	it	-PRON-	PRP
46745	3067	8	will	will	MD
46745	3067	9	be	be	VB
46745	3067	10	evident	evident	JJ
46745	3067	11	that	that	IN
46745	3067	12	under	under	IN
46745	3067	13	the	the	DT
46745	3067	14	above	above	JJ
46745	3067	15	treatment	treatment	NN
46745	3067	16	this	this	DT
46745	3067	17	uric	uric	JJ
46745	3067	18	acid	acid	NN
46745	3067	19	may	may	MD
46745	3067	20	be	be	VB
46745	3067	21	oxidized	oxidize	VBN
46745	3067	22	back	back	RB
46745	3067	23	into	into	IN
46745	3067	24	urea	urea	NNP
46745	3067	25	and	and	CC
46745	3067	26	carbonic	carbonic	JJ
46745	3067	27	acid	acid	NN
46745	3067	28	,	,	,
46745	3067	29	and	and	CC
46745	3067	30	the	the	DT
46745	3067	31	balance	balance	NN
46745	3067	32	of	of	IN
46745	3067	33	health	health	NN
46745	3067	34	restored	restore	VBN
46745	3067	35	.	.	.
46745	3068	1	Thus	thus	RB
46745	3068	2	:	:	:
46745	3068	3	Uric	uric	NN
46745	3068	4	acid	acid	NN
46745	3068	5	+	+	CC
46745	3068	6	6	6	CD
46745	3068	7	O	o	NN
46745	3068	8	+	+	CC
46745	3068	9	4	4	CD
46745	3068	10	HO	ho	NN
46745	3068	11	=	=	SYM
46745	3068	12	2	2	CD
46745	3068	13	Urea	Urea	NNP
46745	3068	14	+	+	SYM
46745	3068	15	6	6	CD
46745	3068	16	CO_{2	CO_{2	NNP
46745	3068	17	}	}	-RRB-
46745	3068	18	,	,	,
46745	3068	19	which	which	WDT
46745	3068	20	may	may	MD
46745	3068	21	thus	thus	RB
46745	3068	22	be	be	VB
46745	3068	23	proved	prove	VBN
46745	3068	24	:	:	:
46745	3068	25	C_{10}H_{4}N_{4	c_{10}h_{4}n_{4	JJ
46745	3068	26	}	}	-RRB-
46745	3068	27	O_{6	O_{6	NNP
46745	3068	28	}	}	-RRB-
46745	3068	29	O_{6	O_{6	NNP
46745	3068	30	}	}	-RRB-
46745	3068	31	C_{4	C_{4	NNP
46745	3068	32	}	}	-RRB-
46745	3068	33	H_{8}N_{4	H_{8}N_{4	NNP
46745	3068	34	}	}	-RRB-
46745	3068	35	O_{4	O_{4	NNP
46745	3068	36	}	}	-RRB-
46745	3068	37	.	.	.
46745	3069	1	H_{4	H_{4	NNP
46745	3069	2	}	}	-RRB-
46745	3069	3	O_{4	O_{4	NNP
46745	3069	4	}	}	-RRB-
46745	3069	5	C_{6	C_{6	NNP
46745	3069	6	}	}	-RRB-
46745	3069	7	O_{12	o_{12	RB
46745	3069	8	}	}	-RRB-
46745	3069	9	.	.	.
46745	3070	1	----------------------	----------------------	NFP
46745	3070	2	-----------------------	-----------------------	NFP
46745	3070	3	C_{10}H_{8}N_{4}O_{16	C_{10}H_{8}N_{4}O_{16	NNS
46745	3070	4	}	}	-RRB-
46745	3070	5	=	=	SYM
46745	3070	6	C_{10}H_{8}N_{4}O_{16	c_{10}h_{8}n_{4}o_{16	NN
46745	3070	7	}	}	-RRB-
46745	3070	8	.	.	.
46745	3071	1	Such	such	JJ
46745	3071	2	may	may	MD
46745	3071	3	be	be	VB
46745	3071	4	the	the	DT
46745	3071	5	action	action	NN
46745	3071	6	of	of	IN
46745	3071	7	Nitro	Nitro	NNP
46745	3071	8	-	-	HYPH
46745	3071	9	hydrochloric	hydrochloric	JJ
46745	3071	10	acid	acid	NN
46745	3071	11	.	.	.
46745	3072	1	It	-PRON-	PRP
46745	3072	2	exerts	exert	VBZ
46745	3072	3	a	a	DT
46745	3072	4	true	true	JJ
46745	3072	5	Catalytic	catalytic	JJ
46745	3072	6	or	or	CC
46745	3072	7	counteractive	counteractive	JJ
46745	3072	8	influence	influence	NN
46745	3072	9	.	.	.
46745	3073	1	But	but	CC
46745	3073	2	we	-PRON-	PRP
46745	3073	3	have	have	VBP
46745	3073	4	to	to	TO
46745	3073	5	explain	explain	VB
46745	3073	6	the	the	DT
46745	3073	7	agency	agency	NN
46745	3073	8	of	of	IN
46745	3073	9	another	another	DT
46745	3073	10	class	class	NN
46745	3073	11	of	of	IN
46745	3073	12	very	very	RB
46745	3073	13	different	different	JJ
46745	3073	14	,	,	,
46745	3073	15	and	and	CC
46745	3073	16	apparently	apparently	RB
46745	3073	17	opposite	opposite	JJ
46745	3073	18	remedies	remedy	NNS
46745	3073	19	.	.	.
46745	3074	1	Alkalies	alkali	NNS
46745	3074	2	are	be	VBP
46745	3074	3	employed	employ	VBN
46745	3074	4	with	with	IN
46745	3074	5	benefit	benefit	NN
46745	3074	6	both	both	CC
46745	3074	7	in	in	IN
46745	3074	8	Rheumatism	Rheumatism	NNP
46745	3074	9	and	and	CC
46745	3074	10	in	in	IN
46745	3074	11	Gout	Gout	NNP
46745	3074	12	;	;	:
46745	3074	13	particularly	particularly	RB
46745	3074	14	in	in	IN
46745	3074	15	the	the	DT
46745	3074	16	former	former	JJ
46745	3074	17	disease	disease	NN
46745	3074	18	.	.	.
46745	3075	1	Now	now	RB
46745	3075	2	I	-PRON-	PRP
46745	3075	3	conceive	conceive	VBP
46745	3075	4	these	these	DT
46745	3075	5	to	to	TO
46745	3075	6	act	act	VB
46745	3075	7	,	,	,
46745	3075	8	in	in	IN
46745	3075	9	Rheumatism	rheumatism	NN
46745	3075	10	at	at	IN
46745	3075	11	least	least	JJS
46745	3075	12	,	,	,
46745	3075	13	simply	simply	RB
46745	3075	14	on	on	IN
46745	3075	15	the	the	DT
46745	3075	16	Restorative	Restorative	NNP
46745	3075	17	principle	principle	NN
46745	3075	18	;	;	:
46745	3075	19	supposing	suppose	VBG
46745	3075	20	lactic	lactic	JJ
46745	3075	21	acid	acid	NN
46745	3075	22	to	to	TO
46745	3075	23	exist	exist	VB
46745	3075	24	in	in	IN
46745	3075	25	excess	excess	NN
46745	3075	26	in	in	IN
46745	3075	27	Rheumatic	rheumatic	JJ
46745	3075	28	blood	blood	NN
46745	3075	29	.	.	.
46745	3076	1	This	this	DT
46745	3076	2	by	by	IN
46745	3076	3	itself	-PRON-	PRP
46745	3076	4	may	may	MD
46745	3076	5	have	have	VB
46745	3076	6	no	no	DT
46745	3076	7	more	more	JJR
46745	3076	8	tendency	tendency	NN
46745	3076	9	to	to	TO
46745	3076	10	oxidize	oxidize	VB
46745	3076	11	into	into	IN
46745	3076	12	carbonic	carbonic	JJ
46745	3076	13	acid	acid	NN
46745	3076	14	,	,	,
46745	3076	15	than	than	IN
46745	3076	16	so	so	RB
46745	3076	17	much	much	JJ
46745	3076	18	vegetable	vegetable	NN
46745	3076	19	acid	acid	NN
46745	3076	20	would	would	MD
46745	3076	21	have	have	VB
46745	3076	22	.	.	.
46745	3077	1	In	in	IN
46745	3077	2	ordinary	ordinary	JJ
46745	3077	3	cases	case	NNS
46745	3077	4	a	a	DT
46745	3077	5	free	free	JJ
46745	3077	6	vegetable	vegetable	NN
46745	3077	7	acid	acid	NN
46745	3077	8	passes	pass	VBZ
46745	3077	9	out	out	RP
46745	3077	10	into	into	IN
46745	3077	11	the	the	DT
46745	3077	12	urine	urine	NN
46745	3077	13	without	without	IN
46745	3077	14	undergoing	undergo	VBG
46745	3077	15	any	any	DT
46745	3077	16	change	change	NN
46745	3077	17	in	in	IN
46745	3077	18	the	the	DT
46745	3077	19	system	system	NN
46745	3077	20	.	.	.
46745	3078	1	But	but	CC
46745	3078	2	it	-PRON-	PRP
46745	3078	3	has	have	VBZ
46745	3078	4	been	be	VBN
46745	3078	5	proved	prove	VBN
46745	3078	6	by	by	IN
46745	3078	7	Wöhler	Wöhler	NNP
46745	3078	8	that	that	IN
46745	3078	9	the	the	DT
46745	3078	10	same	same	JJ
46745	3078	11	vegetable	vegetable	NN
46745	3078	12	acid	acid	NN
46745	3078	13	becomes	become	VBZ
46745	3078	14	oxidized	oxidize	VBN
46745	3078	15	when	when	WRB
46745	3078	16	given	give	VBN
46745	3078	17	in	in	IN
46745	3078	18	combination	combination	NN
46745	3078	19	with	with	IN
46745	3078	20	an	an	DT
46745	3078	21	alkali	alkali	NN
46745	3078	22	.	.	.
46745	3079	1	So	so	RB
46745	3079	2	that	that	IN
46745	3079	3	if	if	IN
46745	3079	4	we	-PRON-	PRP
46745	3079	5	introduce	introduce	VBP
46745	3079	6	into	into	IN
46745	3079	7	Rheumatic	rheumatic	JJ
46745	3079	8	blood	blood	NN
46745	3079	9	a	a	DT
46745	3079	10	free	free	JJ
46745	3079	11	alkali	alkali	NN
46745	3079	12	,	,	,
46745	3079	13	a	a	DT
46745	3079	14	lactate	lactate	NN
46745	3079	15	of	of	IN
46745	3079	16	potash	potash	NN
46745	3079	17	or	or	CC
46745	3079	18	of	of	IN
46745	3079	19	soda	soda	NN
46745	3079	20	will	will	MD
46745	3079	21	be	be	VB
46745	3079	22	formed	form	VBN
46745	3079	23	;	;	:
46745	3079	24	this	this	DT
46745	3079	25	may	may	MD
46745	3079	26	then	then	RB
46745	3079	27	be	be	VB
46745	3079	28	enabled	enable	VBN
46745	3079	29	to	to	TO
46745	3079	30	oxidize	oxidize	VB
46745	3079	31	into	into	IN
46745	3079	32	a	a	DT
46745	3079	33	carbonate	carbonate	NN
46745	3079	34	,	,	,
46745	3079	35	and	and	CC
46745	3079	36	the	the	DT
46745	3079	37	natural	natural	JJ
46745	3079	38	process	process	NN
46745	3079	39	be	be	VB
46745	3079	40	completed	complete	VBN
46745	3079	41	.	.	.
46745	3080	1	Such	such	JJ
46745	3080	2	appears	appear	VBZ
46745	3080	3	to	to	TO
46745	3080	4	be	be	VB
46745	3080	5	the	the	DT
46745	3080	6	rationale	rationale	NN
46745	3080	7	of	of	IN
46745	3080	8	the	the	DT
46745	3080	9	action	action	NN
46745	3080	10	of	of	IN
46745	3080	11	alkalies	alkali	NNS
46745	3080	12	.	.	.
46745	3081	1	They	-PRON-	PRP
46745	3081	2	would	would	MD
46745	3081	3	be	be	VB
46745	3081	4	inefficacious	inefficacious	JJ
46745	3081	5	in	in	IN
46745	3081	6	Oxaluria	Oxaluria	NNP
46745	3081	7	,	,	,
46745	3081	8	because	because	IN
46745	3081	9	the	the	DT
46745	3081	10	oxalic	oxalic	JJ
46745	3081	11	acid	acid	NN
46745	3081	12	has	have	VBZ
46745	3081	13	so	so	RB
46745	3081	14	great	great	JJ
46745	3081	15	an	an	DT
46745	3081	16	affinity	affinity	NN
46745	3081	17	for	for	IN
46745	3081	18	lime	lime	NN
46745	3081	19	,	,	,
46745	3081	20	that	that	IN
46745	3081	21	it	-PRON-	PRP
46745	3081	22	could	could	MD
46745	3081	23	not	not	RB
46745	3081	24	be	be	VB
46745	3081	25	separated	separate	VBN
46745	3081	26	from	from	IN
46745	3081	27	this	this	DT
46745	3081	28	combination	combination	NN
46745	3081	29	by	by	IN
46745	3081	30	an	an	DT
46745	3081	31	alkali	alkali	NN
46745	3081	32	.	.	.
46745	3082	1	Dr.	Dr.	NNP
46745	3082	2	Rees	Rees	NNPS
46745	3082	3	and	and	CC
46745	3082	4	others	other	NNS
46745	3082	5	have	have	VBP
46745	3082	6	found	find	VBN
46745	3082	7	Lemon	Lemon	NNP
46745	3082	8	juice	juice	NN
46745	3082	9	of	of	IN
46745	3082	10	great	great	JJ
46745	3082	11	use	use	NN
46745	3082	12	in	in	IN
46745	3082	13	the	the	DT
46745	3082	14	treatment	treatment	NN
46745	3082	15	of	of	IN
46745	3082	16	acute	acute	JJ
46745	3082	17	Rheumatism	rheumatism	NN
46745	3082	18	.	.	.
46745	3083	1	It	-PRON-	PRP
46745	3083	2	contains	contain	VBZ
46745	3083	3	Citric	Citric	NNP
46745	3083	4	acid	acid	NN
46745	3083	5	,	,	,
46745	3083	6	and	and	CC
46745	3083	7	some	some	DT
46745	3083	8	Citrate	Citrate	NNP
46745	3083	9	of	of	IN
46745	3083	10	Potash	Potash	NNP
46745	3083	11	;	;	:
46745	3083	12	the	the	DT
46745	3083	13	latter	latter	JJ
46745	3083	14	being	be	VBG
46745	3083	15	in	in	RB
46745	3083	16	too	too	RB
46745	3083	17	small	small	JJ
46745	3083	18	amount	amount	NN
46745	3083	19	to	to	TO
46745	3083	20	explain	explain	VB
46745	3083	21	the	the	DT
46745	3083	22	action	action	NN
46745	3083	23	of	of	IN
46745	3083	24	the	the	DT
46745	3083	25	remedy	remedy	NN
46745	3083	26	.	.	.
46745	3084	1	I	-PRON-	PRP
46745	3084	2	have	have	VBP
46745	3084	3	already	already	RB
46745	3084	4	shown	show	VBN
46745	3084	5	how	how	WRB
46745	3084	6	it	-PRON-	PRP
46745	3084	7	seems	seem	VBZ
46745	3084	8	possible	possible	JJ
46745	3084	9	that	that	IN
46745	3084	10	the	the	DT
46745	3084	11	vegetable	vegetable	NN
46745	3084	12	acids	acid	NNS
46745	3084	13	may	may	MD
46745	3084	14	act	act	VB
46745	3084	15	as	as	IN
46745	3084	16	refrigerants	refrigerant	NNS
46745	3084	17	in	in	IN
46745	3084	18	simple	simple	JJ
46745	3084	19	fever	fever	NN
46745	3084	20	;	;	:
46745	3084	21	how	how	WRB
46745	3084	22	they	-PRON-	PRP
46745	3084	23	may	may	MD
46745	3084	24	then	then	RB
46745	3084	25	supply	supply	VB
46745	3084	26	the	the	DT
46745	3084	27	place	place	NN
46745	3084	28	of	of	IN
46745	3084	29	the	the	DT
46745	3084	30	natural	natural	JJ
46745	3084	31	lactic	lactic	JJ
46745	3084	32	acid	acid	NN
46745	3084	33	in	in	IN
46745	3084	34	the	the	DT
46745	3084	35	blood	blood	NN
46745	3084	36	,	,	,
46745	3084	37	and	and	CC
46745	3084	38	become	become	VB
46745	3084	39	oxidized	oxidize	VBN
46745	3084	40	instead	instead	RB
46745	3084	41	of	of	IN
46745	3084	42	the	the	DT
46745	3084	43	Proteinaceous	proteinaceous	JJ
46745	3084	44	compounds	compound	NNS
46745	3084	45	.	.	.
46745	3085	1	(	(	-LRB-
46745	3085	2	_	_	NNP
46745	3085	3	Vide	Vide	NNP
46745	3085	4	Acids	Acids	NNP
46745	3085	5	.	.	.
46745	3085	6	_	_	NNP
46745	3085	7	)	)	-RRB-
46745	3085	8	But	but	CC
46745	3085	9	Rheumatic	rheumatic	JJ
46745	3085	10	fever	fever	NN
46745	3085	11	is	be	VBZ
46745	3085	12	a	a	DT
46745	3085	13	very	very	RB
46745	3085	14	different	different	JJ
46745	3085	15	case	case	NN
46745	3085	16	,	,	,
46745	3085	17	for	for	IN
46745	3085	18	there	there	EX
46745	3085	19	is	be	VBZ
46745	3085	20	here	here	RB
46745	3085	21	apparently	apparently	RB
46745	3085	22	an	an	DT
46745	3085	23	excess	excess	NN
46745	3085	24	of	of	IN
46745	3085	25	lactic	lactic	JJ
46745	3085	26	acid	acid	NN
46745	3085	27	,	,	,
46745	3085	28	and	and	CC
46745	3085	29	an	an	DT
46745	3085	30	arrest	arrest	NN
46745	3085	31	of	of	IN
46745	3085	32	its	-PRON-	PRP$
46745	3085	33	oxidation	oxidation	NN
46745	3085	34	.	.	.
46745	3086	1	In	in	IN
46745	3086	2	considering	considering	NN
46745	3086	3	,	,	,
46745	3086	4	however	however	RB
46745	3086	5	,	,	,
46745	3086	6	the	the	DT
46745	3086	7	formula	formula	NN
46745	3086	8	for	for	IN
46745	3086	9	Citric	Citric	NNP
46745	3086	10	acid	acid	NN
46745	3086	11	,	,	,
46745	3086	12	we	-PRON-	PRP
46745	3086	13	perceive	perceive	VBP
46745	3086	14	that	that	IN
46745	3086	15	not	not	RB
46745	3086	16	only	only	RB
46745	3086	17	does	do	VBZ
46745	3086	18	it	-PRON-	PRP
46745	3086	19	contain	contain	VB
46745	3086	20	proportionally	proportionally	RB
46745	3086	21	more	more	JJR
46745	3086	22	Oxygen	oxygen	NN
46745	3086	23	than	than	IN
46745	3086	24	Proteins	Proteins	NNP
46745	3086	25	,	,	,
46745	3086	26	as	as	IN
46745	3086	27	was	be	VBD
46745	3086	28	proved	prove	VBN
46745	3086	29	in	in	IN
46745	3086	30	the	the	DT
46745	3086	31	former	former	JJ
46745	3086	32	instance	instance	NN
46745	3086	33	,	,	,
46745	3086	34	but	but	CC
46745	3086	35	more	more	JJR
46745	3086	36	than	than	IN
46745	3086	37	lactic	lactic	JJ
46745	3086	38	acid	acid	NN
46745	3086	39	contains	contain	NNS
46745	3086	40	.	.	.
46745	3087	1	It	-PRON-	PRP
46745	3087	2	is	be	VBZ
46745	3087	3	C_{12}H_{5}O_{11	c_{12}h_{5}o_{11	NN
46745	3087	4	}	}	-RRB-
46745	3087	5	+	+	CC
46745	3087	6	3	3	CD
46745	3087	7	HO	HO	NNP
46745	3087	8	.	.	.
46745	3088	1	Thus	thus	RB
46745	3088	2	it	-PRON-	PRP
46745	3088	3	is	be	VBZ
46745	3088	4	possible	possible	JJ
46745	3088	5	that	that	IN
46745	3088	6	it	-PRON-	PRP
46745	3088	7	may	may	MD
46745	3088	8	act	act	VB
46745	3088	9	as	as	IN
46745	3088	10	a	a	DT
46745	3088	11	carrier	carrier	NN
46745	3088	12	of	of	IN
46745	3088	13	oxygen	oxygen	NN
46745	3088	14	to	to	IN
46745	3088	15	the	the	DT
46745	3088	16	lactic	lactic	JJ
46745	3088	17	acid	acid	NN
46745	3088	18	,	,	,
46745	3088	19	and	and	CC
46745	3088	20	so	so	RB
46745	3088	21	help	help	VB
46745	3088	22	it	-PRON-	PRP
46745	3088	23	on	on	RP
46745	3088	24	towards	towards	IN
46745	3088	25	its	-PRON-	PRP$
46745	3088	26	transformation	transformation	NN
46745	3088	27	into	into	IN
46745	3088	28	carbonic	carbonic	JJ
46745	3088	29	acid	acid	NN
46745	3088	30	.	.	.
46745	3089	1	It	-PRON-	PRP
46745	3089	2	appears	appear	VBZ
46745	3089	3	to	to	TO
46745	3089	4	be	be	VB
46745	3089	5	decomposed	decompose	VBN
46745	3089	6	in	in	IN
46745	3089	7	the	the	DT
46745	3089	8	system	system	NN
46745	3089	9	,	,	,
46745	3089	10	for	for	IN
46745	3089	11	Dr.	Dr.	NNP
46745	3089	12	Rees	Rees	NNPS
46745	3089	13	has	have	VBZ
46745	3089	14	never	never	RB
46745	3089	15	known	know	VBN
46745	3089	16	it	-PRON-	PRP
46745	3089	17	in	in	IN
46745	3089	18	these	these	DT
46745	3089	19	cases	case	NNS
46745	3089	20	to	to	TO
46745	3089	21	increase	increase	VB
46745	3089	22	the	the	DT
46745	3089	23	acidity	acidity	NN
46745	3089	24	of	of	IN
46745	3089	25	the	the	DT
46745	3089	26	urine	urine	NN
46745	3089	27	.	.	.
46745	3090	1	The	the	DT
46745	3090	2	matter	matter	NN
46745	3090	3	is	be	VBZ
46745	3090	4	obscure	obscure	JJ
46745	3090	5	;	;	:
46745	3090	6	but	but	CC
46745	3090	7	we	-PRON-	PRP
46745	3090	8	can	can	MD
46745	3090	9	discern	discern	VB
46745	3090	10	enough	enough	RB
46745	3090	11	of	of	IN
46745	3090	12	it	-PRON-	PRP
46745	3090	13	to	to	TO
46745	3090	14	convince	convince	VB
46745	3090	15	us	-PRON-	PRP
46745	3090	16	of	of	IN
46745	3090	17	the	the	DT
46745	3090	18	possibility	possibility	NN
46745	3090	19	of	of	IN
46745	3090	20	different	different	JJ
46745	3090	21	medicines	medicine	NNS
46745	3090	22	acting	act	VBG
46745	3090	23	in	in	IN
46745	3090	24	diverse	diverse	JJ
46745	3090	25	ways	way	NNS
46745	3090	26	so	so	IN
46745	3090	27	as	as	IN
46745	3090	28	to	to	TO
46745	3090	29	produce	produce	VB
46745	3090	30	very	very	RB
46745	3090	31	similar	similar	JJ
46745	3090	32	results	result	NNS
46745	3090	33	.	.	.
46745	3091	1	Colchicum	Colchicum	NNP
46745	3091	2	has	have	VBZ
46745	3091	3	apparently	apparently	RB
46745	3091	4	some	some	DT
46745	3091	5	power	power	NN
46745	3091	6	in	in	IN
46745	3091	7	the	the	DT
46745	3091	8	diversion	diversion	NN
46745	3091	9	or	or	CC
46745	3091	10	control	control	NN
46745	3091	11	of	of	IN
46745	3091	12	these	these	DT
46745	3091	13	morbid	morbid	NN
46745	3091	14	processes	process	NNS
46745	3091	15	,	,	,
46745	3091	16	which	which	WDT
46745	3091	17	we	-PRON-	PRP
46745	3091	18	can	can	MD
46745	3091	19	only	only	RB
46745	3091	20	indicate	indicate	VB
46745	3091	21	,	,	,
46745	3091	22	but	but	CC
46745	3091	23	can	can	MD
46745	3091	24	not	not	RB
46745	3091	25	further	further	RB
46745	3091	26	comprehend	comprehend	VB
46745	3091	27	.	.	.
46745	3092	1	It	-PRON-	PRP
46745	3092	2	is	be	VBZ
46745	3092	3	generally	generally	RB
46745	3092	4	best	good	JJS
46745	3092	5	to	to	TO
46745	3092	6	give	give	VB
46745	3092	7	it	-PRON-	PRP
46745	3092	8	so	so	IN
46745	3092	9	that	that	IN
46745	3092	10	it	-PRON-	PRP
46745	3092	11	shall	shall	MD
46745	3092	12	neither	neither	DT
46745	3092	13	produce	produce	VB
46745	3092	14	purging	purging	NN
46745	3092	15	,	,	,
46745	3092	16	nor	nor	CC
46745	3092	17	any	any	DT
46745	3092	18	great	great	JJ
46745	3092	19	degree	degree	NN
46745	3092	20	of	of	IN
46745	3092	21	general	general	JJ
46745	3092	22	depression	depression	NN
46745	3092	23	.	.	.
46745	3093	1	Mercury	Mercury	NNP
46745	3093	2	and	and	CC
46745	3093	3	other	other	JJ
46745	3093	4	medicines	medicine	NNS
46745	3093	5	which	which	WDT
46745	3093	6	promote	promote	VBP
46745	3093	7	the	the	DT
46745	3093	8	secretion	secretion	NN
46745	3093	9	of	of	IN
46745	3093	10	the	the	DT
46745	3093	11	liver	liver	NN
46745	3093	12	,	,	,
46745	3093	13	are	be	VBP
46745	3093	14	found	find	VBN
46745	3093	15	to	to	TO
46745	3093	16	be	be	VB
46745	3093	17	of	of	IN
46745	3093	18	considerable	considerable	JJ
46745	3093	19	use	use	NN
46745	3093	20	in	in	IN
46745	3093	21	the	the	DT
46745	3093	22	treatment	treatment	NN
46745	3093	23	of	of	IN
46745	3093	24	all	all	DT
46745	3093	25	of	of	IN
46745	3093	26	these	these	DT
46745	3093	27	diseases	disease	NNS
46745	3093	28	,	,	,
46745	3093	29	but	but	CC
46745	3093	30	more	more	RBR
46745	3093	31	especially	especially	RB
46745	3093	32	in	in	IN
46745	3093	33	Gout	Gout	NNP
46745	3093	34	.	.	.
46745	3094	1	They	-PRON-	PRP
46745	3094	2	seem	seem	VBP
46745	3094	3	to	to	TO
46745	3094	4	act	act	VB
46745	3094	5	by	by	IN
46745	3094	6	virtue	virtue	NN
46745	3094	7	of	of	IN
46745	3094	8	their	-PRON-	PRP$
46745	3094	9	power	power	NN
46745	3094	10	in	in	IN
46745	3094	11	eliminating	eliminate	VBG
46745	3094	12	and	and	CC
46745	3094	13	producing	produce	VBG
46745	3094	14	Bile	Bile	NNP
46745	3094	15	.	.	.
46745	3095	1	And	and	CC
46745	3095	2	it	-PRON-	PRP
46745	3095	3	is	be	VBZ
46745	3095	4	likely	likely	JJ
46745	3095	5	that	that	IN
46745	3095	6	some	some	DT
46745	3095	7	constituent	constituent	NN
46745	3095	8	of	of	IN
46745	3095	9	Bile	Bile	NNP
46745	3095	10	,	,	,
46745	3095	11	reabsorbed	reabsorb	VBN
46745	3095	12	into	into	IN
46745	3095	13	the	the	DT
46745	3095	14	blood	blood	NN
46745	3095	15	,	,	,
46745	3095	16	is	be	VBZ
46745	3095	17	able	able	JJ
46745	3095	18	to	to	TO
46745	3095	19	exert	exert	VB
46745	3095	20	a	a	DT
46745	3095	21	beneficial	beneficial	JJ
46745	3095	22	influence	influence	NN
46745	3095	23	on	on	IN
46745	3095	24	the	the	DT
46745	3095	25	conduct	conduct	NN
46745	3095	26	of	of	IN
46745	3095	27	such	such	JJ
46745	3095	28	processes	process	NNS
46745	3095	29	as	as	IN
46745	3095	30	those	those	DT
46745	3095	31	which	which	WDT
46745	3095	32	we	-PRON-	PRP
46745	3095	33	have	have	VBP
46745	3095	34	just	just	RB
46745	3095	35	now	now	RB
46745	3095	36	considered	consider	VBN
46745	3095	37	.	.	.
46745	3096	1	Quinine	quinine	JJ
46745	3096	2	and	and	CC
46745	3096	3	Tonics	Tonics	NNP
46745	3096	4	have	have	VBP
46745	3096	5	been	be	VBN
46745	3096	6	strongly	strongly	RB
46745	3096	7	recommended	recommend	VBN
46745	3096	8	by	by	IN
46745	3096	9	Dr.	Dr.	NNP
46745	3096	10	Todd	Todd	NNP
46745	3096	11	in	in	IN
46745	3096	12	Gout	Gout	NNP
46745	3096	13	;	;	:
46745	3096	14	and	and	CC
46745	3096	15	they	-PRON-	PRP
46745	3096	16	seem	seem	VBP
46745	3096	17	to	to	TO
46745	3096	18	be	be	VB
46745	3096	19	signally	signally	RB
46745	3096	20	efficacious	efficacious	JJ
46745	3096	21	,	,	,
46745	3096	22	both	both	DT
46745	3096	23	in	in	IN
46745	3096	24	this	this	DT
46745	3096	25	and	and	CC
46745	3096	26	in	in	IN
46745	3096	27	the	the	DT
46745	3096	28	other	other	JJ
46745	3096	29	Arthritic	arthritic	JJ
46745	3096	30	disorders	disorder	NNS
46745	3096	31	.	.	.
46745	3097	1	This	this	DT
46745	3097	2	is	be	VBZ
46745	3097	3	a	a	DT
46745	3097	4	very	very	RB
46745	3097	5	interesting	interesting	JJ
46745	3097	6	fact	fact	NN
46745	3097	7	.	.	.
46745	3098	1	If	if	IN
46745	3098	2	there	there	EX
46745	3098	3	should	should	MD
46745	3098	4	be	be	VB
46745	3098	5	any	any	DT
46745	3098	6	truth	truth	NN
46745	3098	7	in	in	IN
46745	3098	8	an	an	DT
46745	3098	9	idea	idea	NN
46745	3098	10	which	which	WDT
46745	3098	11	I	-PRON-	PRP
46745	3098	12	have	have	VBP
46745	3098	13	explained	explain	VBN
46745	3098	14	at	at	IN
46745	3098	15	length	length	NN
46745	3098	16	in	in	IN
46745	3098	17	the	the	DT
46745	3098	18	article	article	NN
46745	3098	19	on	on	IN
46745	3098	20	Tonics	Tonics	NNP
46745	3098	21	(	(	-LRB-
46745	3098	22	_	_	NNP
46745	3098	23	vide	vide	NN
46745	3098	24	_	_	NNP
46745	3098	25	p.	p.	NN
46745	3098	26	142	142	CD
46745	3098	27	,	,	,
46745	3098	28	)	)	-RRB-
46745	3098	29	it	-PRON-	PRP
46745	3098	30	would	would	MD
46745	3098	31	seem	seem	VB
46745	3098	32	that	that	IN
46745	3098	33	these	these	DT
46745	3098	34	Tonics	tonic	NNS
46745	3098	35	may	may	MD
46745	3098	36	be	be	VB
46745	3098	37	of	of	IN
46745	3098	38	use	use	NN
46745	3098	39	by	by	IN
46745	3098	40	supplying	supply	VBG
46745	3098	41	in	in	IN
46745	3098	42	the	the	DT
46745	3098	43	blood	blood	NN
46745	3098	44	the	the	DT
46745	3098	45	place	place	NN
46745	3098	46	of	of	IN
46745	3098	47	one	one	CD
46745	3098	48	of	of	IN
46745	3098	49	the	the	DT
46745	3098	50	wanting	want	VBG
46745	3098	51	elements	element	NNS
46745	3098	52	of	of	IN
46745	3098	53	Bile	Bile	NNP
46745	3098	54	.	.	.
46745	3099	1	For	for	IN
46745	3099	2	in	in	IN
46745	3099	3	all	all	DT
46745	3099	4	Arthritic	arthritic	JJ
46745	3099	5	disorders	disorder	NNS
46745	3099	6	there	there	EX
46745	3099	7	is	be	VBZ
46745	3099	8	more	more	RBR
46745	3099	9	or	or	CC
46745	3099	10	less	less	JJR
46745	3099	11	of	of	IN
46745	3099	12	hepatic	hepatic	JJ
46745	3099	13	derangement	derangement	NN
46745	3099	14	.	.	.
46745	3100	1	There	there	EX
46745	3100	2	seem	seem	VBP
46745	3100	3	then	then	RB
46745	3100	4	to	to	TO
46745	3100	5	be	be	VB
46745	3100	6	six	six	CD
46745	3100	7	separate	separate	JJ
46745	3100	8	and	and	CC
46745	3100	9	distinct	distinct	JJ
46745	3100	10	explanations	explanation	NNS
46745	3100	11	of	of	IN
46745	3100	12	the	the	DT
46745	3100	13	cure	cure	NN
46745	3100	14	of	of	IN
46745	3100	15	these	these	DT
46745	3100	16	Arthritic	arthritic	JJ
46745	3100	17	diseases	disease	NNS
46745	3100	18	.	.	.
46745	3101	1	There	there	EX
46745	3101	2	are	be	VBP
46745	3101	3	six	six	CD
46745	3101	4	different	different	JJ
46745	3101	5	modes	mode	NNS
46745	3101	6	of	of	IN
46745	3101	7	operation	operation	NN
46745	3101	8	by	by	IN
46745	3101	9	which	which	WDT
46745	3101	10	the	the	DT
46745	3101	11	same	same	JJ
46745	3101	12	beneficial	beneficial	JJ
46745	3101	13	result	result	NN
46745	3101	14	may	may	MD
46745	3101	15	follow	follow	VB
46745	3101	16	the	the	DT
46745	3101	17	employment	employment	NN
46745	3101	18	of	of	IN
46745	3101	19	Nitro	Nitro	NNP
46745	3101	20	-	-	HYPH
46745	3101	21	hydrochloric	hydrochloric	JJ
46745	3101	22	acid	acid	NN
46745	3101	23	,	,	,
46745	3101	24	free	free	JJ
46745	3101	25	Alkalies	Alkalies	NNPS
46745	3101	26	,	,	,
46745	3101	27	Lemon	Lemon	NNP
46745	3101	28	juice	juice	NN
46745	3101	29	,	,	,
46745	3101	30	Colchicum	Colchicum	NNP
46745	3101	31	,	,	,
46745	3101	32	Mercury	Mercury	NNP
46745	3101	33	and	and	CC
46745	3101	34	Quinine	Quinine	NNP
46745	3101	35	.	.	.
46745	3102	1	So	so	RB
46745	3102	2	that	that	IN
46745	3102	3	if	if	IN
46745	3102	4	it	-PRON-	PRP
46745	3102	5	should	should	MD
46745	3102	6	be	be	VB
46745	3102	7	proved	prove	VBN
46745	3102	8	,	,	,
46745	3102	9	which	which	WDT
46745	3102	10	is	be	VBZ
46745	3102	11	not	not	RB
46745	3102	12	unlikely	unlikely	JJ
46745	3102	13	,	,	,
46745	3102	14	that	that	IN
46745	3102	15	the	the	DT
46745	3102	16	chemical	chemical	NN
46745	3102	17	theory	theory	NN
46745	3102	18	propounded	propound	VBN
46745	3102	19	above	above	RB
46745	3102	20	for	for	IN
46745	3102	21	the	the	DT
46745	3102	22	purpose	purpose	NN
46745	3102	23	of	of	IN
46745	3102	24	accounting	account	VBG
46745	3102	25	for	for	IN
46745	3102	26	the	the	DT
46745	3102	27	production	production	NN
46745	3102	28	of	of	IN
46745	3102	29	these	these	DT
46745	3102	30	disorders	disorder	NNS
46745	3102	31	in	in	IN
46745	3102	32	the	the	DT
46745	3102	33	blood	blood	NN
46745	3102	34	is	be	VBZ
46745	3102	35	a	a	DT
46745	3102	36	correct	correct	JJ
46745	3102	37	view	view	NN
46745	3102	38	of	of	IN
46745	3102	39	the	the	DT
46745	3102	40	case	case	NN
46745	3102	41	,	,	,
46745	3102	42	then	then	RB
46745	3102	43	this	this	DT
46745	3102	44	explanation	explanation	NN
46745	3102	45	of	of	IN
46745	3102	46	the	the	DT
46745	3102	47	action	action	NN
46745	3102	48	of	of	IN
46745	3102	49	the	the	DT
46745	3102	50	various	various	JJ
46745	3102	51	remedies	remedy	NNS
46745	3102	52	used	use	VBN
46745	3102	53	in	in	IN
46745	3102	54	such	such	JJ
46745	3102	55	diseases	disease	NNS
46745	3102	56	would	would	MD
46745	3102	57	acquire	acquire	VB
46745	3102	58	an	an	DT
46745	3102	59	additional	additional	JJ
46745	3102	60	probability	probability	NN
46745	3102	61	.	.	.
46745	3103	1	But	but	CC
46745	3103	2	at	at	IN
46745	3103	3	present	present	JJ
46745	3103	4	the	the	DT
46745	3103	5	idea	idea	NN
46745	3103	6	is	be	VBZ
46745	3103	7	purely	purely	RB
46745	3103	8	hypothetical	hypothetical	JJ
46745	3103	9	,	,	,
46745	3103	10	because	because	IN
46745	3103	11	depending	depend	VBG
46745	3103	12	upon	upon	IN
46745	3103	13	a	a	DT
46745	3103	14	number	number	NN
46745	3103	15	of	of	IN
46745	3103	16	things	thing	NNS
46745	3103	17	which	which	WDT
46745	3103	18	,	,	,
46745	3103	19	although	although	IN
46745	3103	20	they	-PRON-	PRP
46745	3103	21	seem	seem	VBP
46745	3103	22	likely	likely	RB
46745	3103	23	,	,	,
46745	3103	24	are	be	VBP
46745	3103	25	far	far	RB
46745	3103	26	from	from	IN
46745	3103	27	being	be	VBG
46745	3103	28	proved	prove	VBN
46745	3103	29	as	as	RB
46745	3103	30	yet	yet	RB
46745	3103	31	.	.	.
46745	3104	1	All	all	DT
46745	3104	2	that	that	WDT
46745	3104	3	we	-PRON-	PRP
46745	3104	4	can	can	MD
46745	3104	5	affirm	affirm	VB
46745	3104	6	with	with	IN
46745	3104	7	any	any	DT
46745	3104	8	degree	degree	NN
46745	3104	9	of	of	IN
46745	3104	10	certainty	certainty	NN
46745	3104	11	is	be	VBZ
46745	3104	12	that	that	IN
46745	3104	13	a	a	DT
46745	3104	14	number	number	NN
46745	3104	15	of	of	IN
46745	3104	16	blood	blood	NN
46745	3104	17	-	-	HYPH
46745	3104	18	medicines	medicine	NNS
46745	3104	19	are	be	VBP
46745	3104	20	applied	apply	VBN
46745	3104	21	with	with	IN
46745	3104	22	advantage	advantage	NN
46745	3104	23	to	to	IN
46745	3104	24	the	the	DT
46745	3104	25	treatment	treatment	NN
46745	3104	26	of	of	IN
46745	3104	27	these	these	DT
46745	3104	28	kindred	kindred	JJ
46745	3104	29	disorders	disorder	NNS
46745	3104	30	,	,	,
46745	3104	31	tending	tend	VBG
46745	3104	32	to	to	TO
46745	3104	33	counteract	counteract	VB
46745	3104	34	the	the	DT
46745	3104	35	morbid	morbid	NN
46745	3104	36	conditions	condition	NNS
46745	3104	37	by	by	IN
46745	3104	38	which	which	WDT
46745	3104	39	they	-PRON-	PRP
46745	3104	40	are	be	VBP
46745	3104	41	severally	severally	RB
46745	3104	42	produced	produce	VBN
46745	3104	43	.	.	.
46745	3105	1	These	these	DT
46745	3105	2	Antiarthritics	Antiarthritics	NNPS
46745	3105	3	must	must	MD
46745	3105	4	operate	operate	VB
46745	3105	5	,	,	,
46745	3105	6	then	then	RB
46745	3105	7	,	,	,
46745	3105	8	on	on	IN
46745	3105	9	the	the	DT
46745	3105	10	Catalytic	catalytic	JJ
46745	3105	11	principle	principle	NN
46745	3105	12	.	.	.
46745	3106	1	A	a	DT
46745	3106	2	number	number	NN
46745	3106	3	of	of	IN
46745	3106	4	varieties	variety	NNS
46745	3106	5	and	and	CC
46745	3106	6	masked	mask	VBD
46745	3106	7	forms	form	NNS
46745	3106	8	of	of	IN
46745	3106	9	these	these	DT
46745	3106	10	disorders	disorder	NNS
46745	3106	11	are	be	VBP
46745	3106	12	grouped	group	VBN
46745	3106	13	together	together	RB
46745	3106	14	under	under	IN
46745	3106	15	the	the	DT
46745	3106	16	general	general	JJ
46745	3106	17	title	title	NN
46745	3106	18	of	of	IN
46745	3106	19	Dyspepsia	Dyspepsia	NNP
46745	3106	20	.	.	.
46745	3107	1	The	the	DT
46745	3107	2	depraved	depraved	JJ
46745	3107	3	condition	condition	NN
46745	3107	4	of	of	IN
46745	3107	5	the	the	DT
46745	3107	6	blood	blood	NN
46745	3107	7	which	which	WDT
46745	3107	8	tends	tend	VBZ
46745	3107	9	to	to	IN
46745	3107	10	the	the	DT
46745	3107	11	production	production	NN
46745	3107	12	of	of	IN
46745	3107	13	arthritic	arthritic	JJ
46745	3107	14	symptoms	symptom	NNS
46745	3107	15	may	may	MD
46745	3107	16	,	,	,
46745	3107	17	when	when	WRB
46745	3107	18	controlled	control	VBN
46745	3107	19	and	and	CC
46745	3107	20	disturbed	disturb	VBN
46745	3107	21	by	by	IN
46745	3107	22	various	various	JJ
46745	3107	23	causes	cause	NNS
46745	3107	24	,	,	,
46745	3107	25	simply	simply	RB
46745	3107	26	manifest	manifest	VB
46745	3107	27	itself	-PRON-	PRP
46745	3107	28	by	by	IN
46745	3107	29	causing	cause	VBG
46745	3107	30	acidity	acidity	NN
46745	3107	31	of	of	IN
46745	3107	32	the	the	DT
46745	3107	33	stomach	stomach	NN
46745	3107	34	,	,	,
46745	3107	35	flatulence	flatulence	NN
46745	3107	36	,	,	,
46745	3107	37	impairment	impairment	NN
46745	3107	38	of	of	IN
46745	3107	39	digestive	digestive	JJ
46745	3107	40	power	power	NN
46745	3107	41	,	,	,
46745	3107	42	and	and	CC
46745	3107	43	general	general	JJ
46745	3107	44	lassitude	lassitude	NN
46745	3107	45	.	.	.
46745	3108	1	Different	different	JJ
46745	3108	2	Antiarthritic	antiarthritic	JJ
46745	3108	3	remedies	remedy	NNS
46745	3108	4	are	be	VBP
46745	3108	5	applicable	applicable	JJ
46745	3108	6	in	in	IN
46745	3108	7	different	different	JJ
46745	3108	8	cases	case	NNS
46745	3108	9	.	.	.
46745	3109	1	Colchicum	colchicum	JJ
46745	3109	2	or	or	CC
46745	3109	3	Nitro	nitro	JJ
46745	3109	4	-	-	HYPH
46745	3109	5	hydrochloric	hydrochloric	JJ
46745	3109	6	acid	acid	NN
46745	3109	7	are	be	VBP
46745	3109	8	serviceable	serviceable	JJ
46745	3109	9	when	when	WRB
46745	3109	10	this	this	DT
46745	3109	11	condition	condition	NN
46745	3109	12	of	of	IN
46745	3109	13	the	the	DT
46745	3109	14	system	system	NN
46745	3109	15	is	be	VBZ
46745	3109	16	of	of	IN
46745	3109	17	long	long	JJ
46745	3109	18	standing	standing	NN
46745	3109	19	.	.	.
46745	3110	1	Small	small	JJ
46745	3110	2	doses	dose	NNS
46745	3110	3	of	of	IN
46745	3110	4	Mercury	Mercury	NNP
46745	3110	5	are	be	VBP
46745	3110	6	often	often	RB
46745	3110	7	efficacious	efficacious	JJ
46745	3110	8	.	.	.
46745	3111	1	Tonics	tonic	NNS
46745	3111	2	,	,	,
46745	3111	3	and	and	CC
46745	3111	4	a	a	DT
46745	3111	5	Purgative	Purgative	NNP
46745	3111	6	occasionally	occasionally	RB
46745	3111	7	,	,	,
46745	3111	8	may	may	MD
46745	3111	9	be	be	VB
46745	3111	10	recommended	recommend	VBN
46745	3111	11	in	in	IN
46745	3111	12	milder	milder	NN
46745	3111	13	forms	form	NNS
46745	3111	14	of	of	IN
46745	3111	15	the	the	DT
46745	3111	16	disorder	disorder	NN
46745	3111	17	.	.	.
46745	3112	1	ORD	ORD	NNP
46745	3112	2	.	.	.
46745	3113	1	V.	V.	NNP
46745	3113	2	ANTISCORBUTICS	ANTISCORBUTICS	NNP
46745	3113	3	.	.	.
46745	3114	1	These	these	DT
46745	3114	2	are	be	VBP
46745	3114	3	remedies	remedy	NNS
46745	3114	4	which	which	WDT
46745	3114	5	are	be	VBP
46745	3114	6	useful	useful	JJ
46745	3114	7	in	in	IN
46745	3114	8	the	the	DT
46745	3114	9	counteraction	counteraction	NN
46745	3114	10	of	of	IN
46745	3114	11	Scurvy	Scurvy	NNP
46745	3114	12	and	and	CC
46745	3114	13	Purpura	Purpura	NNP
46745	3114	14	.	.	.
46745	3115	1	In	in	IN
46745	3115	2	these	these	DT
46745	3115	3	disorders	disorder	NNS
46745	3115	4	there	there	EX
46745	3115	5	is	be	VBZ
46745	3115	6	a	a	DT
46745	3115	7	thin	thin	JJ
46745	3115	8	and	and	CC
46745	3115	9	poor	poor	JJ
46745	3115	10	condition	condition	NN
46745	3115	11	of	of	IN
46745	3115	12	the	the	DT
46745	3115	13	blood	blood	NN
46745	3115	14	,	,	,
46745	3115	15	together	together	RB
46745	3115	16	with	with	IN
46745	3115	17	a	a	DT
46745	3115	18	deficiency	deficiency	NN
46745	3115	19	in	in	IN
46745	3115	20	the	the	DT
46745	3115	21	amount	amount	NN
46745	3115	22	of	of	IN
46745	3115	23	albumen	albuman	NNS
46745	3115	24	,	,	,
46745	3115	25	fibrine	fibrine	NN
46745	3115	26	,	,	,
46745	3115	27	and	and	CC
46745	3115	28	the	the	DT
46745	3115	29	solids	solid	NNS
46745	3115	30	generally	generally	RB
46745	3115	31	;	;	:
46745	3115	32	a	a	DT
46745	3115	33	tendency	tendency	NN
46745	3115	34	to	to	IN
46745	3115	35	hæmorrhages	hæmorrhage	NNS
46745	3115	36	and	and	CC
46745	3115	37	ulcerations	ulceration	NNS
46745	3115	38	,	,	,
46745	3115	39	consequent	consequent	NN
46745	3115	40	on	on	IN
46745	3115	41	this	this	DT
46745	3115	42	condition	condition	NN
46745	3115	43	of	of	IN
46745	3115	44	the	the	DT
46745	3115	45	blood	blood	NN
46745	3115	46	;	;	:
46745	3115	47	and	and	CC
46745	3115	48	great	great	JJ
46745	3115	49	general	general	JJ
46745	3115	50	depression	depression	NN
46745	3115	51	and	and	CC
46745	3115	52	debility	debility	NN
46745	3115	53	.	.	.
46745	3116	1	There	there	EX
46745	3116	2	is	be	VBZ
46745	3116	3	no	no	DT
46745	3116	4	doubt	doubt	NN
46745	3116	5	that	that	IN
46745	3116	6	these	these	DT
46745	3116	7	changes	change	NNS
46745	3116	8	in	in	IN
46745	3116	9	the	the	DT
46745	3116	10	blood	blood	NN
46745	3116	11	are	be	VBP
46745	3116	12	due	due	JJ
46745	3116	13	to	to	IN
46745	3116	14	a	a	DT
46745	3116	15	certain	certain	JJ
46745	3116	16	morbid	morbid	NN
46745	3116	17	action	action	NN
46745	3116	18	.	.	.
46745	3117	1	It	-PRON-	PRP
46745	3117	2	seems	seem	VBZ
46745	3117	3	that	that	IN
46745	3117	4	there	there	EX
46745	3117	5	are	be	VBP
46745	3117	6	some	some	DT
46745	3117	7	kinds	kind	NNS
46745	3117	8	of	of	IN
46745	3117	9	food	food	NN
46745	3117	10	which	which	WDT
46745	3117	11	are	be	VBP
46745	3117	12	able	able	JJ
46745	3117	13	to	to	TO
46745	3117	14	prevent	prevent	VB
46745	3117	15	the	the	DT
46745	3117	16	occurrence	occurrence	NN
46745	3117	17	of	of	IN
46745	3117	18	this	this	DT
46745	3117	19	morbid	morbid	NN
46745	3117	20	action	action	NN
46745	3117	21	,	,	,
46745	3117	22	or	or	CC
46745	3117	23	to	to	TO
46745	3117	24	control	control	VB
46745	3117	25	it	-PRON-	PRP
46745	3117	26	when	when	WRB
46745	3117	27	it	-PRON-	PRP
46745	3117	28	has	have	VBZ
46745	3117	29	been	be	VBN
46745	3117	30	set	set	VBN
46745	3117	31	up	up	RP
46745	3117	32	.	.	.
46745	3118	1	The	the	DT
46745	3118	2	worst	bad	JJS
46745	3118	3	forms	form	NNS
46745	3118	4	of	of	IN
46745	3118	5	Scurvy	Scurvy	NNP
46745	3118	6	occur	occur	VBP
46745	3118	7	among	among	IN
46745	3118	8	sailors	sailor	NNS
46745	3118	9	in	in	IN
46745	3118	10	long	long	JJ
46745	3118	11	voyages	voyage	NNS
46745	3118	12	,	,	,
46745	3118	13	who	who	WP
46745	3118	14	have	have	VBP
46745	3118	15	been	be	VBN
46745	3118	16	deprived	deprive	VBN
46745	3118	17	for	for	IN
46745	3118	18	some	some	DT
46745	3118	19	time	time	NN
46745	3118	20	of	of	IN
46745	3118	21	fresh	fresh	JJ
46745	3118	22	vegetable	vegetable	NN
46745	3118	23	food	food	NN
46745	3118	24	;	;	:
46745	3118	25	and	and	CC
46745	3118	26	it	-PRON-	PRP
46745	3118	27	is	be	VBZ
46745	3118	28	often	often	RB
46745	3118	29	observed	observe	VBN
46745	3118	30	that	that	IN
46745	3118	31	those	those	DT
46745	3118	32	who	who	WP
46745	3118	33	have	have	VBP
46745	3118	34	been	be	VBN
46745	3118	35	thus	thus	RB
46745	3118	36	afflicted	afflict	VBN
46745	3118	37	on	on	IN
46745	3118	38	land	land	NN
46745	3118	39	have	have	VBP
46745	3118	40	been	be	VBN
46745	3118	41	subjected	subject	VBN
46745	3118	42	to	to	IN
46745	3118	43	the	the	DT
46745	3118	44	same	same	JJ
46745	3118	45	deprivation	deprivation	NN
46745	3118	46	.	.	.
46745	3119	1	But	but	CC
46745	3119	2	it	-PRON-	PRP
46745	3119	3	does	do	VBZ
46745	3119	4	not	not	RB
46745	3119	5	follow	follow	VB
46745	3119	6	as	as	IN
46745	3119	7	a	a	DT
46745	3119	8	matter	matter	NN
46745	3119	9	of	of	IN
46745	3119	10	course	course	NN
46745	3119	11	that	that	IN
46745	3119	12	those	those	DT
46745	3119	13	who	who	WP
46745	3119	14	are	be	VBP
46745	3119	15	thus	thus	RB
46745	3119	16	deprived	deprive	VBN
46745	3119	17	become	become	VBP
46745	3119	18	invariably	invariably	RB
46745	3119	19	the	the	DT
46745	3119	20	victims	victim	NNS
46745	3119	21	of	of	IN
46745	3119	22	Scurvy	Scurvy	NNP
46745	3119	23	.	.	.
46745	3120	1	It	-PRON-	PRP
46745	3120	2	seems	seem	VBZ
46745	3120	3	that	that	IN
46745	3120	4	there	there	EX
46745	3120	5	are	be	VBP
46745	3120	6	certain	certain	JJ
46745	3120	7	constitutions	constitution	NNS
46745	3120	8	which	which	WDT
46745	3120	9	are	be	VBP
46745	3120	10	more	more	RBR
46745	3120	11	disposed	disposed	JJ
46745	3120	12	to	to	IN
46745	3120	13	it	-PRON-	PRP
46745	3120	14	than	than	IN
46745	3120	15	others	other	NNS
46745	3120	16	;	;	:
46745	3120	17	and	and	CC
46745	3120	18	that	that	IN
46745	3120	19	when	when	WRB
46745	3120	20	these	these	DT
46745	3120	21	systems	system	NNS
46745	3120	22	are	be	VBP
46745	3120	23	deprived	deprive	VBN
46745	3120	24	of	of	IN
46745	3120	25	some	some	DT
46745	3120	26	articles	article	NNS
46745	3120	27	of	of	IN
46745	3120	28	diet	diet	NN
46745	3120	29	which	which	WDT
46745	3120	30	are	be	VBP
46745	3120	31	able	able	JJ
46745	3120	32	to	to	TO
46745	3120	33	prevent	prevent	VB
46745	3120	34	or	or	CC
46745	3120	35	to	to	TO
46745	3120	36	neutralize	neutralize	VB
46745	3120	37	the	the	DT
46745	3120	38	working	working	NN
46745	3120	39	of	of	IN
46745	3120	40	the	the	DT
46745	3120	41	poison	poison	NN
46745	3120	42	in	in	IN
46745	3120	43	them	-PRON-	PRP
46745	3120	44	,	,	,
46745	3120	45	the	the	DT
46745	3120	46	latent	latent	NN
46745	3120	47	morbid	morbid	NN
46745	3120	48	action	action	NN
46745	3120	49	is	be	VBZ
46745	3120	50	allowed	allow	VBN
46745	3120	51	to	to	TO
46745	3120	52	commence	commence	VB
46745	3120	53	.	.	.
46745	3121	1	Of	of	IN
46745	3121	2	all	all	PDT
46745	3121	3	the	the	DT
46745	3121	4	substances	substance	NNS
46745	3121	5	of	of	IN
46745	3121	6	which	which	WDT
46745	3121	7	trial	trial	NN
46745	3121	8	has	have	VBZ
46745	3121	9	been	be	VBN
46745	3121	10	made	make	VBN
46745	3121	11	,	,	,
46745	3121	12	Lemon	Lemon	NNP
46745	3121	13	or	or	CC
46745	3121	14	Lime	Lime	NNP
46745	3121	15	juice	juice	NN
46745	3121	16	,	,	,
46745	3121	17	and	and	CC
46745	3121	18	Potatoes	Potatoes	NNP
46745	3121	19	,	,	,
46745	3121	20	are	be	VBP
46745	3121	21	said	say	VBN
46745	3121	22	to	to	TO
46745	3121	23	be	be	VB
46745	3121	24	of	of	IN
46745	3121	25	the	the	DT
46745	3121	26	greatest	great	JJS
46745	3121	27	use	use	NN
46745	3121	28	in	in	IN
46745	3121	29	the	the	DT
46745	3121	30	treatment	treatment	NN
46745	3121	31	of	of	IN
46745	3121	32	scurvy	scurvy	NNP
46745	3121	33	.	.	.
46745	3122	1	The	the	DT
46745	3122	2	former	former	JJ
46745	3122	3	is	be	VBZ
46745	3122	4	generally	generally	RB
46745	3122	5	employed	employ	VBN
46745	3122	6	on	on	IN
46745	3122	7	board	board	NN
46745	3122	8	ships	ship	NNS
46745	3122	9	.	.	.
46745	3123	1	These	these	DT
46745	3123	2	both	both	DT
46745	3123	3	contain	contain	VBP
46745	3123	4	Citric	citric	NN
46745	3123	5	acid	acid	NN
46745	3123	6	and	and	CC
46745	3123	7	salts	salt	NNS
46745	3123	8	of	of	IN
46745	3123	9	potash	potash	NN
46745	3123	10	.	.	.
46745	3124	1	But	but	CC
46745	3124	2	the	the	DT
46745	3124	3	chief	chief	JJ
46745	3124	4	agent	agent	NN
46745	3124	5	in	in	IN
46745	3124	6	the	the	DT
46745	3124	7	cure	cure	NN
46745	3124	8	should	should	MD
46745	3124	9	be	be	VB
46745	3124	10	something	something	NN
46745	3124	11	which	which	WDT
46745	3124	12	is	be	VBZ
46745	3124	13	not	not	RB
46745	3124	14	contained	contain	VBN
46745	3124	15	in	in	IN
46745	3124	16	the	the	DT
46745	3124	17	food	food	NN
46745	3124	18	eaten	eat	VBN
46745	3124	19	by	by	IN
46745	3124	20	those	those	DT
46745	3124	21	who	who	WP
46745	3124	22	are	be	VBP
46745	3124	23	commonly	commonly	RB
46745	3124	24	attacked	attack	VBN
46745	3124	25	with	with	IN
46745	3124	26	Scurvy	Scurvy	NNP
46745	3124	27	.	.	.
46745	3125	1	The	the	DT
46745	3125	2	food	food	NN
46745	3125	3	of	of	IN
46745	3125	4	the	the	DT
46745	3125	5	sailors	sailor	NNS
46745	3125	6	who	who	WP
46745	3125	7	are	be	VBP
46745	3125	8	thus	thus	RB
46745	3125	9	afflicted	afflict	VBN
46745	3125	10	consists	consist	VBZ
46745	3125	11	mainly	mainly	RB
46745	3125	12	of	of	IN
46745	3125	13	salted	salted	JJ
46745	3125	14	beef	beef	NN
46745	3125	15	and	and	CC
46745	3125	16	sea	sea	NN
46745	3125	17	-	-	HYPH
46745	3125	18	biscuit	biscuit	NN
46745	3125	19	.	.	.
46745	3126	1	Both	both	DT
46745	3126	2	contain	contain	VBP
46745	3126	3	salts	salt	NNS
46745	3126	4	of	of	IN
46745	3126	5	Potash	Potash	NNP
46745	3126	6	;	;	:
46745	3126	7	neither	neither	DT
46745	3126	8	contain	contain	VBP
46745	3126	9	Citric	citric	NN
46745	3126	10	acid	acid	NN
46745	3126	11	.	.	.
46745	3127	1	So	so	IN
46745	3127	2	that	that	IN
46745	3127	3	from	from	IN
46745	3127	4	this	this	DT
46745	3127	5	consideration	consideration	NN
46745	3127	6	it	-PRON-	PRP
46745	3127	7	would	would	MD
46745	3127	8	seem	seem	VB
46745	3127	9	as	as	IN
46745	3127	10	if	if	IN
46745	3127	11	the	the	DT
46745	3127	12	free	free	JJ
46745	3127	13	acid	acid	NN
46745	3127	14	must	must	MD
46745	3127	15	be	be	VB
46745	3127	16	the	the	DT
46745	3127	17	remedial	remedial	JJ
46745	3127	18	agent	agent	NN
46745	3127	19	.	.	.
46745	3128	1	Vegetables	vegetable	NNS
46745	3128	2	in	in	IN
46745	3128	3	their	-PRON-	PRP$
46745	3128	4	fresh	fresh	JJ
46745	3128	5	state	state	NN
46745	3128	6	generally	generally	RB
46745	3128	7	contain	contain	VBP
46745	3128	8	a	a	DT
46745	3128	9	small	small	JJ
46745	3128	10	quantity	quantity	NN
46745	3128	11	of	of	IN
46745	3128	12	this	this	DT
46745	3128	13	or	or	CC
46745	3128	14	some	some	DT
46745	3128	15	other	other	JJ
46745	3128	16	acid	acid	NN
46745	3128	17	;	;	:
46745	3128	18	and	and	CC
46745	3128	19	fresh	fresh	JJ
46745	3128	20	vegetable	vegetable	NN
46745	3128	21	food	food	NN
46745	3128	22	is	be	VBZ
46745	3128	23	always	always	RB
46745	3128	24	the	the	DT
46745	3128	25	best	good	JJS
46745	3128	26	prophylactic	prophylactic	NN
46745	3128	27	against	against	IN
46745	3128	28	Scurvy	Scurvy	NNP
46745	3128	29	and	and	CC
46745	3128	30	Purpuric	Purpuric	NNP
46745	3128	31	diseases	disease	NNS
46745	3128	32	.	.	.
46745	3129	1	Various	various	JJ
46745	3129	2	wild	wild	JJ
46745	3129	3	herbs	herb	NNS
46745	3129	4	,	,	,
46745	3129	5	some	some	DT
46745	3129	6	of	of	IN
46745	3129	7	which	which	WDT
46745	3129	8	contain	contain	VBP
46745	3129	9	Oxalic	oxalic	JJ
46745	3129	10	instead	instead	RB
46745	3129	11	of	of	IN
46745	3129	12	Citric	Citric	NNP
46745	3129	13	acid	acid	NN
46745	3129	14	,	,	,
46745	3129	15	are	be	VBP
46745	3129	16	used	use	VBN
46745	3129	17	among	among	IN
46745	3129	18	the	the	DT
46745	3129	19	poor	poor	JJ
46745	3129	20	for	for	IN
46745	3129	21	this	this	DT
46745	3129	22	purpose	purpose	NN
46745	3129	23	.	.	.
46745	3130	1	[	[	-LRB-
46745	3130	2	41	41	CD
46745	3130	3	]	]	-RRB-
46745	3130	4	Dr.	Dr.	NNP
46745	3130	5	A.	A.	NNP
46745	3131	1	B.	B.	NNP
46745	3131	2	Garrod	Garrod	NNP
46745	3131	3	is	be	VBZ
46745	3131	4	of	of	IN
46745	3131	5	opinion	opinion	NN
46745	3131	6	that	that	IN
46745	3131	7	Scurvy	Scurvy	NNP
46745	3131	8	is	be	VBZ
46745	3131	9	attributable	attributable	JJ
46745	3131	10	to	to	IN
46745	3131	11	a	a	DT
46745	3131	12	deficiency	deficiency	NN
46745	3131	13	in	in	IN
46745	3131	14	the	the	DT
46745	3131	15	system	system	NN
46745	3131	16	of	of	IN
46745	3131	17	the	the	DT
46745	3131	18	natural	natural	JJ
46745	3131	19	amount	amount	NN
46745	3131	20	of	of	IN
46745	3131	21	the	the	DT
46745	3131	22	salts	salt	NNS
46745	3131	23	of	of	IN
46745	3131	24	Potash	Potash	NNP
46745	3131	25	;	;	:
46745	3131	26	he	-PRON-	PRP
46745	3131	27	therefore	therefore	RB
46745	3131	28	treats	treat	VBZ
46745	3131	29	it	-PRON-	PRP
46745	3131	30	with	with	IN
46745	3131	31	salts	salt	NNS
46745	3131	32	of	of	IN
46745	3131	33	Potash	Potash	NNP
46745	3131	34	,	,	,
46745	3131	35	and	and	CC
46745	3131	36	apparently	apparently	RB
46745	3131	37	with	with	IN
46745	3131	38	success	success	NN
46745	3131	39	.	.	.
46745	3132	1	(	(	-LRB-
46745	3132	2	_	_	NNP
46745	3132	3	Monthly	Monthly	NNP
46745	3132	4	Journal	Journal	NNP
46745	3132	5	of	of	IN
46745	3132	6	Medicine	Medicine	NNP
46745	3132	7	_	_	NNP
46745	3132	8	,	,	,
46745	3132	9	January	January	NNP
46745	3132	10	,	,	,
46745	3132	11	1848	1848	CD
46745	3132	12	.	.	.
46745	3132	13	)	)	-RRB-
46745	3133	1	The	the	DT
46745	3133	2	salts	salt	NNS
46745	3133	3	of	of	IN
46745	3133	4	Potash	Potash	NNP
46745	3133	5	,	,	,
46745	3133	6	if	if	IN
46745	3133	7	used	use	VBN
46745	3133	8	on	on	IN
46745	3133	9	such	such	JJ
46745	3133	10	grounds	ground	NNS
46745	3133	11	,	,	,
46745	3133	12	would	would	MD
46745	3133	13	obviously	obviously	RB
46745	3133	14	act	act	VB
46745	3133	15	as	as	IN
46745	3133	16	Restorative	Restorative	NNP
46745	3133	17	agents	agent	NNS
46745	3133	18	,	,	,
46745	3133	19	and	and	CC
46745	3133	20	supply	supply	NN
46745	3133	21	to	to	IN
46745	3133	22	the	the	DT
46745	3133	23	blood	blood	NN
46745	3133	24	a	a	DT
46745	3133	25	material	material	NN
46745	3133	26	in	in	IN
46745	3133	27	which	which	WDT
46745	3133	28	it	-PRON-	PRP
46745	3133	29	is	be	VBZ
46745	3133	30	deficient	deficient	JJ
46745	3133	31	.	.	.
46745	3134	1	But	but	CC
46745	3134	2	Citric	Citric	NNP
46745	3134	3	acid	acid	NN
46745	3134	4	could	could	MD
46745	3134	5	not	not	RB
46745	3134	6	remain	remain	VB
46745	3134	7	in	in	IN
46745	3134	8	the	the	DT
46745	3134	9	blood	blood	NN
46745	3134	10	;	;	:
46745	3134	11	and	and	CC
46745	3134	12	if	if	IN
46745	3134	13	it	-PRON-	PRP
46745	3134	14	cures	cure	VBZ
46745	3134	15	Scurvy	Scurvy	NNP
46745	3134	16	,	,	,
46745	3134	17	it	-PRON-	PRP
46745	3134	18	must	must	MD
46745	3134	19	act	act	VB
46745	3134	20	on	on	IN
46745	3134	21	the	the	DT
46745	3134	22	Catalytic	catalytic	JJ
46745	3134	23	principle	principle	NN
46745	3134	24	.	.	.
46745	3135	1	It	-PRON-	PRP
46745	3135	2	could	could	MD
46745	3135	3	not	not	RB
46745	3135	4	supply	supply	VB
46745	3135	5	to	to	IN
46745	3135	6	the	the	DT
46745	3135	7	system	system	NN
46745	3135	8	any	any	DT
46745	3135	9	permanent	permanent	JJ
46745	3135	10	material	material	NN
46745	3135	11	.	.	.
46745	3136	1	Dr.	Dr.	NNP
46745	3136	2	Garrod	Garrod	NNP
46745	3136	3	concludes	conclude	VBZ
46745	3136	4	from	from	IN
46745	3136	5	analysis	analysis	NN
46745	3136	6	that	that	IN
46745	3136	7	the	the	DT
46745	3136	8	antiscorbutic	antiscorbutic	JJ
46745	3136	9	articles	article	NNS
46745	3136	10	of	of	IN
46745	3136	11	diet	diet	NN
46745	3136	12	are	be	VBP
46745	3136	13	distinguished	distinguish	VBN
46745	3136	14	by	by	IN
46745	3136	15	containing	contain	VBG
46745	3136	16	an	an	DT
46745	3136	17	abundance	abundance	NN
46745	3136	18	of	of	IN
46745	3136	19	the	the	DT
46745	3136	20	salts	salt	NNS
46745	3136	21	of	of	IN
46745	3136	22	Potash	Potash	NNP
46745	3136	23	,	,	,
46745	3136	24	but	but	CC
46745	3136	25	that	that	IN
46745	3136	26	the	the	DT
46745	3136	27	reverse	reverse	NN
46745	3136	28	is	be	VBZ
46745	3136	29	the	the	DT
46745	3136	30	case	case	NN
46745	3136	31	with	with	IN
46745	3136	32	the	the	DT
46745	3136	33	materials	material	NNS
46745	3136	34	which	which	WDT
46745	3136	35	form	form	VBP
46745	3136	36	the	the	DT
46745	3136	37	staple	staple	JJ
46745	3136	38	food	food	NN
46745	3136	39	of	of	IN
46745	3136	40	those	those	DT
46745	3136	41	who	who	WP
46745	3136	42	are	be	VBP
46745	3136	43	most	most	RBS
46745	3136	44	liable	liable	JJ
46745	3136	45	to	to	IN
46745	3136	46	Scurvy	Scurvy	NNP
46745	3136	47	.	.	.
46745	3137	1	He	-PRON-	PRP
46745	3137	2	gives	give	VBZ
46745	3137	3	the	the	DT
46745	3137	4	following	following	NN
46745	3137	5	as	as	IN
46745	3137	6	the	the	DT
46745	3137	7	amounts	amount	NNS
46745	3137	8	of	of	IN
46745	3137	9	potash	potash	NN
46745	3137	10	obtained	obtain	VBN
46745	3137	11	from	from	IN
46745	3137	12	one	one	CD
46745	3137	13	ounce	ounce	NN
46745	3137	14	of	of	IN
46745	3137	15	each	each	DT
46745	3137	16	of	of	IN
46745	3137	17	the	the	DT
46745	3137	18	articles	article	NNS
46745	3137	19	of	of	IN
46745	3137	20	diet	diet	NN
46745	3137	21	named:--	named:--	``
46745	3137	22	Wheaten	wheaten	JJ
46745	3137	23	bread	bread	NN
46745	3137	24	.259	.259	CD
46745	3137	25	grains	grain	NNS
46745	3137	26	.	.	.
46745	3138	1	Oatmeal	oatmeal	VB
46745	3138	2	.054	.054	CD
46745	3138	3	"	"	``
46745	3138	4	Salted	salted	JJ
46745	3138	5	beef	beef	NN
46745	3138	6	.572	.572	CD
46745	3138	7	"	"	``
46745	3138	8	Boiled	boil	VBN
46745	3138	9	potatoes	potato	NNS
46745	3138	10	.529	.529	CD
46745	3138	11	"	"	``
46745	3138	12	Lemon	Lemon	NNP
46745	3138	13	-	-	HYPH
46745	3138	14	juice	juice	NN
46745	3138	15	.846	.846	CD
46745	3138	16	"	"	``
46745	3138	17	Thus	thus	RB
46745	3138	18	it	-PRON-	PRP
46745	3138	19	appears	appear	VBZ
46745	3138	20	that	that	IN
46745	3138	21	lemon	lemon	NN
46745	3138	22	-	-	HYPH
46745	3138	23	juice	juice	NN
46745	3138	24	and	and	CC
46745	3138	25	potatoes	potato	NNS
46745	3138	26	contain	contain	VBP
46745	3138	27	more	more	JJR
46745	3138	28	Potash	Potash	NNP
46745	3138	29	than	than	IN
46745	3138	30	wheaten	wheaten	JJ
46745	3138	31	bread	bread	NN
46745	3138	32	,	,	,
46745	3138	33	and	and	CC
46745	3138	34	much	much	RB
46745	3138	35	more	more	JJR
46745	3138	36	than	than	IN
46745	3138	37	oatmeal	oatmeal	NN
46745	3138	38	.	.	.
46745	3139	1	But	but	CC
46745	3139	2	they	-PRON-	PRP
46745	3139	3	do	do	VBP
46745	3139	4	not	not	RB
46745	3139	5	so	so	RB
46745	3139	6	much	much	JJ
46745	3139	7	excel	excel	VB
46745	3139	8	salt	salt	NN
46745	3139	9	beef	beef	NN
46745	3139	10	in	in	IN
46745	3139	11	this	this	DT
46745	3139	12	particular	particular	JJ
46745	3139	13	,	,	,
46745	3139	14	and	and	CC
46745	3139	15	that	that	DT
46745	3139	16	is	be	VBZ
46745	3139	17	one	one	CD
46745	3139	18	of	of	IN
46745	3139	19	the	the	DT
46745	3139	20	chief	chief	JJ
46745	3139	21	articles	article	NNS
46745	3139	22	of	of	IN
46745	3139	23	diet	diet	NN
46745	3139	24	among	among	IN
46745	3139	25	sailors	sailor	NNS
46745	3139	26	.	.	.
46745	3140	1	And	and	CC
46745	3140	2	if	if	IN
46745	3140	3	this	this	DT
46745	3140	4	deficiency	deficiency	NN
46745	3140	5	of	of	IN
46745	3140	6	Potash	Potash	NNP
46745	3140	7	were	be	VBD
46745	3140	8	the	the	DT
46745	3140	9	sole	sole	JJ
46745	3140	10	cause	cause	NN
46745	3140	11	of	of	IN
46745	3140	12	Scurvy	Scurvy	NNP
46745	3140	13	,	,	,
46745	3140	14	then	then	RB
46745	3140	15	it	-PRON-	PRP
46745	3140	16	should	should	MD
46745	3140	17	be	be	VB
46745	3140	18	unknown	unknown	JJ
46745	3140	19	in	in	IN
46745	3140	20	Ireland	Ireland	NNP
46745	3140	21	,	,	,
46745	3140	22	where	where	WRB
46745	3140	23	quantities	quantity	NNS
46745	3140	24	of	of	IN
46745	3140	25	Potatoes	potato	NNS
46745	3140	26	are	be	VBP
46745	3140	27	eaten	eat	VBN
46745	3140	28	,	,	,
46745	3140	29	and	and	CC
46745	3140	30	very	very	RB
46745	3140	31	common	common	JJ
46745	3140	32	in	in	IN
46745	3140	33	Scotland	Scotland	NNP
46745	3140	34	,	,	,
46745	3140	35	where	where	WRB
46745	3140	36	Oatmeal	Oatmeal	NNP
46745	3140	37	forms	form	NNS
46745	3140	38	so	so	RB
46745	3140	39	important	important	JJ
46745	3140	40	an	an	DT
46745	3140	41	article	article	NN
46745	3140	42	of	of	IN
46745	3140	43	diet	diet	NN
46745	3140	44	among	among	IN
46745	3140	45	the	the	DT
46745	3140	46	peasantry	peasantry	NN
46745	3140	47	.	.	.
46745	3141	1	I	-PRON-	PRP
46745	3141	2	am	be	VBP
46745	3141	3	certainly	certainly	RB
46745	3141	4	not	not	RB
46745	3141	5	aware	aware	JJ
46745	3141	6	that	that	IN
46745	3141	7	such	such	JJ
46745	3141	8	is	be	VBZ
46745	3141	9	the	the	DT
46745	3141	10	case	case	NN
46745	3141	11	,	,	,
46745	3141	12	but	but	CC
46745	3141	13	believe	believe	VBP
46745	3141	14	it	-PRON-	PRP
46745	3141	15	is	be	VBZ
46745	3141	16	rather	rather	RB
46745	3141	17	the	the	DT
46745	3141	18	reverse	reverse	NN
46745	3141	19	.	.	.
46745	3142	1	In	in	IN
46745	3142	2	spite	spite	NN
46745	3142	3	of	of	IN
46745	3142	4	the	the	DT
46745	3142	5	very	very	RB
46745	3142	6	able	able	JJ
46745	3142	7	arguments	argument	NNS
46745	3142	8	and	and	CC
46745	3142	9	the	the	DT
46745	3142	10	instances	instance	NNS
46745	3142	11	adduced	adduce	VBN
46745	3142	12	on	on	IN
46745	3142	13	the	the	DT
46745	3142	14	other	other	JJ
46745	3142	15	side	side	NN
46745	3142	16	,	,	,
46745	3142	17	it	-PRON-	PRP
46745	3142	18	seems	seem	VBZ
46745	3142	19	to	to	IN
46745	3142	20	me	-PRON-	PRP
46745	3142	21	that	that	IN
46745	3142	22	the	the	DT
46745	3142	23	probability	probability	NN
46745	3142	24	is	be	VBZ
46745	3142	25	still	still	RB
46745	3142	26	in	in	IN
46745	3142	27	favour	favour	NN
46745	3142	28	of	of	IN
46745	3142	29	the	the	DT
46745	3142	30	vegetable	vegetable	NN
46745	3142	31	acid	acid	NN
46745	3142	32	being	be	VBG
46745	3142	33	the	the	DT
46745	3142	34	active	active	JJ
46745	3142	35	or	or	CC
46745	3142	36	curative	curative	JJ
46745	3142	37	agent	agent	NN
46745	3142	38	in	in	IN
46745	3142	39	these	these	DT
46745	3142	40	antiscorbutic	antiscorbutic	JJ
46745	3142	41	vegetables	vegetable	NNS
46745	3142	42	.	.	.
46745	3143	1	It	-PRON-	PRP
46745	3143	2	seems	seem	VBZ
46745	3143	3	to	to	TO
46745	3143	4	exert	exert	VB
46745	3143	5	a	a	DT
46745	3143	6	purifying	purifying	NN
46745	3143	7	power	power	NN
46745	3143	8	over	over	IN
46745	3143	9	the	the	DT
46745	3143	10	blood	blood	NN
46745	3143	11	in	in	IN
46745	3143	12	this	this	DT
46745	3143	13	disorder	disorder	NN
46745	3143	14	,	,	,
46745	3143	15	of	of	IN
46745	3143	16	the	the	DT
46745	3143	17	exact	exact	JJ
46745	3143	18	nature	nature	NN
46745	3143	19	of	of	IN
46745	3143	20	which	which	WDT
46745	3143	21	we	-PRON-	PRP
46745	3143	22	are	be	VBP
46745	3143	23	not	not	RB
46745	3143	24	aware	aware	JJ
46745	3143	25	.	.	.
46745	3144	1	It	-PRON-	PRP
46745	3144	2	is	be	VBZ
46745	3144	3	probably	probably	RB
46745	3144	4	not	not	RB
46745	3144	5	only	only	RB
46745	3144	6	Citric	citric	JJ
46745	3144	7	acid	acid	NN
46745	3144	8	that	that	WDT
46745	3144	9	is	be	VBZ
46745	3144	10	efficacious	efficacious	JJ
46745	3144	11	,	,	,
46745	3144	12	for	for	IN
46745	3144	13	it	-PRON-	PRP
46745	3144	14	appears	appear	VBZ
46745	3144	15	that	that	IN
46745	3144	16	some	some	DT
46745	3144	17	other	other	JJ
46745	3144	18	vegetable	vegetable	NN
46745	3144	19	acids	acid	NNS
46745	3144	20	,	,	,
46745	3144	21	and	and	CC
46745	3144	22	vegetables	vegetable	NNS
46745	3144	23	which	which	WDT
46745	3144	24	do	do	VBP
46745	3144	25	not	not	RB
46745	3144	26	contain	contain	VB
46745	3144	27	Citric	Citric	NNP
46745	3144	28	acid	acid	NN
46745	3144	29	at	at	RB
46745	3144	30	all	all	RB
46745	3144	31	,	,	,
46745	3144	32	may	may	MD
46745	3144	33	be	be	VB
46745	3144	34	used	use	VBN
46745	3144	35	with	with	IN
46745	3144	36	advantage	advantage	NN
46745	3144	37	in	in	IN
46745	3144	38	Scorbutic	scorbutic	JJ
46745	3144	39	diseases	disease	NNS
46745	3144	40	.	.	.
46745	3145	1	ORD	ORD	NNP
46745	3145	2	.	.	.
46745	3146	1	VI	VI	NNP
46745	3146	2	.	.	.
46745	3147	1	ANTIPERIODICS	ANTIPERIODICS	NNP
46745	3147	2	.	.	.
46745	3148	1	Certain	certain	JJ
46745	3148	2	mineral	mineral	NN
46745	3148	3	medicines	medicine	NNS
46745	3148	4	of	of	IN
46745	3148	5	the	the	DT
46745	3148	6	Catalytic	catalytic	JJ
46745	3148	7	division	division	NN
46745	3148	8	are	be	VBP
46745	3148	9	employed	employ	VBN
46745	3148	10	in	in	IN
46745	3148	11	the	the	DT
46745	3148	12	treatment	treatment	NN
46745	3148	13	of	of	IN
46745	3148	14	periodic	periodic	JJ
46745	3148	15	disorders	disorder	NNS
46745	3148	16	.	.	.
46745	3149	1	Arsenic	Arsenic	NNP
46745	3149	2	is	be	VBZ
46745	3149	3	a	a	DT
46745	3149	4	medicine	medicine	NN
46745	3149	5	of	of	IN
46745	3149	6	considerable	considerable	JJ
46745	3149	7	power	power	NN
46745	3149	8	,	,	,
46745	3149	9	which	which	WDT
46745	3149	10	,	,	,
46745	3149	11	when	when	WRB
46745	3149	12	given	give	VBN
46745	3149	13	in	in	RP
46745	3149	14	too	too	RB
46745	3149	15	large	large	JJ
46745	3149	16	a	a	DT
46745	3149	17	dose	dose	NN
46745	3149	18	,	,	,
46745	3149	19	or	or	CC
46745	3149	20	indeed	indeed	RB
46745	3149	21	when	when	WRB
46745	3149	22	given	give	VBN
46745	3149	23	at	at	RB
46745	3149	24	all	all	RB
46745	3149	25	in	in	IN
46745	3149	26	most	most	JJS
46745	3149	27	cases	case	NNS
46745	3149	28	,	,	,
46745	3149	29	becomes	become	VBZ
46745	3149	30	a	a	DT
46745	3149	31	poison	poison	NN
46745	3149	32	.	.	.
46745	3150	1	It	-PRON-	PRP
46745	3150	2	has	have	VBZ
46745	3150	3	already	already	RB
46745	3150	4	been	be	VBN
46745	3150	5	shown	show	VBN
46745	3150	6	to	to	TO
46745	3150	7	act	act	VB
46745	3150	8	in	in	IN
46745	3150	9	the	the	DT
46745	3150	10	blood	blood	NN
46745	3150	11	,	,	,
46745	3150	12	and	and	CC
46745	3150	13	to	to	TO
46745	3150	14	produce	produce	VB
46745	3150	15	in	in	IN
46745	3150	16	it	-PRON-	PRP
46745	3150	17	a	a	DT
46745	3150	18	number	number	NN
46745	3150	19	of	of	IN
46745	3150	20	effects	effect	NNS
46745	3150	21	of	of	IN
46745	3150	22	a	a	DT
46745	3150	23	particular	particular	JJ
46745	3150	24	kind	kind	NN
46745	3150	25	.	.	.
46745	3151	1	One	one	CD
46745	3151	2	part	part	NN
46745	3151	3	of	of	IN
46745	3151	4	this	this	DT
46745	3151	5	operation	operation	NN
46745	3151	6	is	be	VBZ
46745	3151	7	that	that	IN
46745	3151	8	it	-PRON-	PRP
46745	3151	9	is	be	VBZ
46745	3151	10	capable	capable	JJ
46745	3151	11	of	of	IN
46745	3151	12	antagonizing	antagonize	VBG
46745	3151	13	the	the	DT
46745	3151	14	poisons	poison	NNS
46745	3151	15	of	of	IN
46745	3151	16	intermittent	intermittent	JJ
46745	3151	17	disorders	disorder	NNS
46745	3151	18	,	,	,
46745	3151	19	as	as	IN
46745	3151	20	also	also	RB
46745	3151	21	of	of	IN
46745	3151	22	certain	certain	JJ
46745	3151	23	convulsive	convulsive	JJ
46745	3151	24	affections	affection	NNS
46745	3151	25	and	and	CC
46745	3151	26	skin	skin	NN
46745	3151	27	-	-	HYPH
46745	3151	28	diseases	disease	NNS
46745	3151	29	.	.	.
46745	3152	1	In	in	IN
46745	3152	2	health	health	NN
46745	3152	3	a	a	DT
46745	3152	4	poison	poison	NN
46745	3152	5	,	,	,
46745	3152	6	in	in	IN
46745	3152	7	disease	disease	NN
46745	3152	8	it	-PRON-	PRP
46745	3152	9	proves	prove	VBZ
46745	3152	10	a	a	DT
46745	3152	11	remedy	remedy	NN
46745	3152	12	.	.	.
46745	3153	1	But	but	CC
46745	3153	2	the	the	DT
46745	3153	3	dangerous	dangerous	JJ
46745	3153	4	nature	nature	NN
46745	3153	5	of	of	IN
46745	3153	6	its	-PRON-	PRP$
46745	3153	7	action	action	NN
46745	3153	8	is	be	VBZ
46745	3153	9	such	such	JJ
46745	3153	10	as	as	IN
46745	3153	11	to	to	TO
46745	3153	12	demand	demand	VB
46745	3153	13	considerable	considerable	JJ
46745	3153	14	care	care	NN
46745	3153	15	in	in	IN
46745	3153	16	the	the	DT
46745	3153	17	administration	administration	NN
46745	3153	18	of	of	IN
46745	3153	19	the	the	DT
46745	3153	20	preparations	preparation	NNS
46745	3153	21	of	of	IN
46745	3153	22	Arsenious	arsenious	JJ
46745	3153	23	acid	acid	NN
46745	3153	24	.	.	.
46745	3154	1	Dr.	Dr.	NNP
46745	3154	2	A.	a.	NN
46745	3154	3	T.	T.	NNP
46745	3154	4	Thomson	Thomson	NNP
46745	3154	5	states	state	VBZ
46745	3154	6	that	that	IN
46745	3154	7	the	the	DT
46745	3154	8	action	action	NN
46745	3154	9	of	of	IN
46745	3154	10	Arsenic	Arsenic	NNP
46745	3154	11	is	be	VBZ
46745	3154	12	liable	liable	JJ
46745	3154	13	to	to	IN
46745	3154	14	exacerbations	exacerbation	NNS
46745	3154	15	and	and	CC
46745	3154	16	remissions	remission	NNS
46745	3154	17	,	,	,
46745	3154	18	and	and	CC
46745	3154	19	sometimes	sometimes	RB
46745	3154	20	even	even	RB
46745	3154	21	intermissions	intermission	NNS
46745	3154	22	.	.	.
46745	3155	1	Thus	thus	RB
46745	3155	2	we	-PRON-	PRP
46745	3155	3	may	may	MD
46745	3155	4	suppose	suppose	VB
46745	3155	5	that	that	IN
46745	3155	6	there	there	EX
46745	3155	7	is	be	VBZ
46745	3155	8	a	a	DT
46745	3155	9	certain	certain	JJ
46745	3155	10	degree	degree	NN
46745	3155	11	of	of	IN
46745	3155	12	analogy	analogy	NN
46745	3155	13	between	between	IN
46745	3155	14	its	-PRON-	PRP$
46745	3155	15	operation	operation	NN
46745	3155	16	and	and	CC
46745	3155	17	that	that	DT
46745	3155	18	of	of	IN
46745	3155	19	the	the	DT
46745	3155	20	malarious	malarious	JJ
46745	3155	21	poison	poison	NN
46745	3155	22	,	,	,
46745	3155	23	by	by	IN
46745	3155	24	virtue	virtue	NN
46745	3155	25	of	of	IN
46745	3155	26	which	which	WDT
46745	3155	27	it	-PRON-	PRP
46745	3155	28	may	may	MD
46745	3155	29	perhaps	perhaps	RB
46745	3155	30	exert	exert	VB
46745	3155	31	a	a	DT
46745	3155	32	corrective	corrective	JJ
46745	3155	33	power	power	NN
46745	3155	34	over	over	IN
46745	3155	35	the	the	DT
46745	3155	36	working	working	NN
46745	3155	37	of	of	IN
46745	3155	38	the	the	DT
46745	3155	39	latter	latter	JJ
46745	3155	40	in	in	IN
46745	3155	41	the	the	DT
46745	3155	42	blood	blood	NN
46745	3155	43	.	.	.
46745	3156	1	(	(	-LRB-
46745	3156	2	_	_	NNP
46745	3156	3	Vide	Vide	NNP
46745	3156	4	_	_	NNP
46745	3156	5	page	page	NN
46745	3156	6	166	166	CD
46745	3156	7	.	.	.
46745	3156	8	)	)	-RRB-
46745	3157	1	Such	such	PDT
46745	3157	2	an	an	DT
46745	3157	3	analogy	analogy	NN
46745	3157	4	could	could	MD
46745	3157	5	only	only	RB
46745	3157	6	exist	exist	VB
46745	3157	7	in	in	IN
46745	3157	8	the	the	DT
46745	3157	9	case	case	NN
46745	3157	10	of	of	IN
46745	3157	11	a	a	DT
46745	3157	12	Catalytic	catalytic	JJ
46745	3157	13	medicine	medicine	NN
46745	3157	14	.	.	.
46745	3158	1	It	-PRON-	PRP
46745	3158	2	is	be	VBZ
46745	3158	3	not	not	RB
46745	3158	4	observed	observe	VBN
46745	3158	5	of	of	IN
46745	3158	6	Quina	Quina	NNP
46745	3158	7	,	,	,
46745	3158	8	which	which	WDT
46745	3158	9	is	be	VBZ
46745	3158	10	employed	employ	VBN
46745	3158	11	in	in	IN
46745	3158	12	intermittents	intermittent	NNS
46745	3158	13	on	on	IN
46745	3158	14	the	the	DT
46745	3158	15	Restorative	Restorative	NNP
46745	3158	16	plan	plan	NN
46745	3158	17	.	.	.
46745	3159	1	Arsenic	Arsenic	NNP
46745	3159	2	is	be	VBZ
46745	3159	3	foreign	foreign	JJ
46745	3159	4	to	to	IN
46745	3159	5	the	the	DT
46745	3159	6	blood	blood	NN
46745	3159	7	,	,	,
46745	3159	8	and	and	CC
46745	3159	9	is	be	VBZ
46745	3159	10	in	in	IN
46745	3159	11	every	every	DT
46745	3159	12	way	way	NN
46745	3159	13	a	a	DT
46745	3159	14	Catalytic	catalytic	JJ
46745	3159	15	medicine	medicine	NN
46745	3159	16	.	.	.
46745	3160	1	In	in	IN
46745	3160	2	large	large	JJ
46745	3160	3	doses	dose	NNS
46745	3160	4	Arsenical	arsenical	JJ
46745	3160	5	preparations	preparation	NNS
46745	3160	6	act	act	VB
46745	3160	7	on	on	IN
46745	3160	8	the	the	DT
46745	3160	9	stomach	stomach	NN
46745	3160	10	as	as	IN
46745	3160	11	irritant	irritant	JJ
46745	3160	12	poisons	poison	NNS
46745	3160	13	.	.	.
46745	3161	1	Some	some	DT
46745	3161	2	of	of	IN
46745	3161	3	them	-PRON-	PRP
46745	3161	4	have	have	VBP
46745	3161	5	been	be	VBN
46745	3161	6	used	use	VBN
46745	3161	7	externally	externally	RB
46745	3161	8	as	as	IN
46745	3161	9	Caustics	caustic	NNS
46745	3161	10	,	,	,
46745	3161	11	especially	especially	RB
46745	3161	12	in	in	IN
46745	3161	13	Lupus	Lupus	NNP
46745	3161	14	.	.	.
46745	3162	1	But	but	CC
46745	3162	2	this	this	DT
46745	3162	3	is	be	VBZ
46745	3162	4	a	a	DT
46745	3162	5	kind	kind	NN
46745	3162	6	of	of	IN
46745	3162	7	action	action	NN
46745	3162	8	that	that	WDT
46745	3162	9	does	do	VBZ
46745	3162	10	not	not	RB
46745	3162	11	concern	concern	VB
46745	3162	12	us	-PRON-	PRP
46745	3162	13	now	now	RB
46745	3162	14	.	.	.
46745	3163	1	The	the	DT
46745	3163	2	officinal	officinal	JJ
46745	3163	3	solution	solution	NN
46745	3163	4	of	of	IN
46745	3163	5	Arsenite	Arsenite	NNP
46745	3163	6	of	of	IN
46745	3163	7	Potash	Potash	NNP
46745	3163	8	was	be	VBD
46745	3163	9	introduced	introduce	VBN
46745	3163	10	into	into	IN
46745	3163	11	notice	notice	NN
46745	3163	12	by	by	IN
46745	3163	13	Dr.	Dr.	NNP
46745	3163	14	Fowler	Fowler	NNP
46745	3163	15	,	,	,
46745	3163	16	and	and	CC
46745	3163	17	is	be	VBZ
46745	3163	18	the	the	DT
46745	3163	19	chief	chief	JJ
46745	3163	20	preparation	preparation	NN
46745	3163	21	of	of	IN
46745	3163	22	Arsenic	Arsenic	NNP
46745	3163	23	employed	employ	VBN
46745	3163	24	.	.	.
46745	3164	1	De	De	NNP
46745	3164	2	Valangin	Valangin	NNP
46745	3164	3	's	's	POS
46745	3164	4	solution	solution	NN
46745	3164	5	contains	contain	VBZ
46745	3164	6	a	a	DT
46745	3164	7	Terchloride	terchloride	NN
46745	3164	8	of	of	IN
46745	3164	9	Arsenic	Arsenic	NNP
46745	3164	10	,	,	,
46745	3164	11	and	and	CC
46745	3164	12	is	be	VBZ
46745	3164	13	of	of	IN
46745	3164	14	less	less	JJR
46745	3164	15	than	than	IN
46745	3164	16	half	half	PDT
46745	3164	17	the	the	DT
46745	3164	18	strength	strength	NN
46745	3164	19	of	of	IN
46745	3164	20	the	the	DT
46745	3164	21	others	other	NNS
46745	3164	22	.	.	.
46745	3165	1	Both	both	DT
46745	3165	2	of	of	IN
46745	3165	3	them	-PRON-	PRP
46745	3165	4	are	be	VBP
46745	3165	5	used	use	VBN
46745	3165	6	in	in	IN
46745	3165	7	Ague	Ague	NNP
46745	3165	8	.	.	.
46745	3166	1	Some	some	DT
46745	3166	2	recommend	recommend	VBP
46745	3166	3	,	,	,
46745	3166	4	in	in	IN
46745	3166	5	all	all	DT
46745	3166	6	cases	case	NNS
46745	3166	7	where	where	WRB
46745	3166	8	Arsenic	Arsenic	NNP
46745	3166	9	is	be	VBZ
46745	3166	10	used	use	VBN
46745	3166	11	,	,	,
46745	3166	12	to	to	TO
46745	3166	13	begin	begin	VB
46745	3166	14	with	with	IN
46745	3166	15	small	small	JJ
46745	3166	16	doses	dose	NNS
46745	3166	17	,	,	,
46745	3166	18	as	as	IN
46745	3166	19	two	two	CD
46745	3166	20	drops	drop	NNS
46745	3166	21	of	of	IN
46745	3166	22	Fowler	Fowler	NNP
46745	3166	23	's	's	POS
46745	3166	24	solution	solution	NN
46745	3166	25	three	three	CD
46745	3166	26	times	time	NNS
46745	3166	27	a	a	DT
46745	3166	28	day	day	NN
46745	3166	29	,	,	,
46745	3166	30	and	and	CC
46745	3166	31	gradually	gradually	RB
46745	3166	32	to	to	TO
46745	3166	33	increase	increase	VB
46745	3166	34	the	the	DT
46745	3166	35	quantity	quantity	NN
46745	3166	36	;	;	:
46745	3166	37	from	from	IN
46745	3166	38	the	the	DT
46745	3166	39	idea	idea	NN
46745	3166	40	that	that	IN
46745	3166	41	the	the	DT
46745	3166	42	system	system	NN
46745	3166	43	will	will	MD
46745	3166	44	thus	thus	RB
46745	3166	45	be	be	VB
46745	3166	46	enabled	enable	VBN
46745	3166	47	to	to	TO
46745	3166	48	tolerate	tolerate	VB
46745	3166	49	the	the	DT
46745	3166	50	remedy	remedy	NN
46745	3166	51	better	well	RBR
46745	3166	52	,	,	,
46745	3166	53	and	and	CC
46745	3166	54	that	that	DT
46745	3166	55	irritation	irritation	NN
46745	3166	56	of	of	IN
46745	3166	57	the	the	DT
46745	3166	58	stomach	stomach	NN
46745	3166	59	will	will	MD
46745	3166	60	be	be	VB
46745	3166	61	avoided	avoid	VBN
46745	3166	62	.	.	.
46745	3167	1	Mr.	Mr.	NNP
46745	3167	2	Hunt	Hunt	NNP
46745	3167	3	deprecates	deprecate	VBZ
46745	3167	4	this	this	DT
46745	3167	5	practice	practice	NN
46745	3167	6	,	,	,
46745	3167	7	and	and	CC
46745	3167	8	recommends	recommend	VBZ
46745	3167	9	regular	regular	JJ
46745	3167	10	doses	dose	NNS
46745	3167	11	of	of	IN
46745	3167	12	three	three	CD
46745	3167	13	to	to	TO
46745	3167	14	five	five	CD
46745	3167	15	drops	drop	NNS
46745	3167	16	or	or	CC
46745	3167	17	more	more	JJR
46745	3167	18	.	.	.
46745	3168	1	It	-PRON-	PRP
46745	3168	2	may	may	MD
46745	3168	3	be	be	VB
46745	3168	4	safely	safely	RB
46745	3168	5	continued	continue	VBN
46745	3168	6	during	during	IN
46745	3168	7	the	the	DT
46745	3168	8	paroxysm	paroxysm	NNS
46745	3168	9	of	of	IN
46745	3168	10	Ague	Ague	NNP
46745	3168	11	,	,	,
46745	3168	12	which	which	WDT
46745	3168	13	is	be	VBZ
46745	3168	14	a	a	DT
46745	3168	15	plan	plan	NN
46745	3168	16	that	that	WDT
46745	3168	17	is	be	VBZ
46745	3168	18	generally	generally	RB
46745	3168	19	considered	consider	VBN
46745	3168	20	to	to	TO
46745	3168	21	be	be	VB
46745	3168	22	unadvisable	unadvisable	JJ
46745	3168	23	in	in	IN
46745	3168	24	the	the	DT
46745	3168	25	case	case	NN
46745	3168	26	of	of	IN
46745	3168	27	Quina	Quina	NNP
46745	3168	28	.	.	.
46745	3169	1	The	the	DT
46745	3169	2	latter	latter	JJ
46745	3169	3	may	may	MD
46745	3169	4	be	be	VB
46745	3169	5	given	give	VBN
46745	3169	6	in	in	IN
46745	3169	7	a	a	DT
46745	3169	8	very	very	RB
46745	3169	9	full	full	JJ
46745	3169	10	dose	dose	NN
46745	3169	11	between	between	IN
46745	3169	12	the	the	DT
46745	3169	13	paroxysms	paroxysm	NNS
46745	3169	14	;	;	:
46745	3169	15	but	but	CC
46745	3169	16	this	this	DT
46745	3169	17	can	can	MD
46745	3169	18	not	not	RB
46745	3169	19	be	be	VB
46745	3169	20	done	do	VBN
46745	3169	21	with	with	IN
46745	3169	22	Arsenic	Arsenic	NNP
46745	3169	23	,	,	,
46745	3169	24	for	for	IN
46745	3169	25	the	the	DT
46745	3169	26	consequences	consequence	NNS
46745	3169	27	would	would	MD
46745	3169	28	be	be	VB
46745	3169	29	dangerous	dangerous	JJ
46745	3169	30	.	.	.
46745	3170	1	It	-PRON-	PRP
46745	3170	2	is	be	VBZ
46745	3170	3	best	good	JJS
46745	3170	4	in	in	IN
46745	3170	5	all	all	DT
46745	3170	6	cases	case	NNS
46745	3170	7	to	to	TO
46745	3170	8	give	give	VB
46745	3170	9	the	the	DT
46745	3170	10	Arsenic	Arsenic	NNP
46745	3170	11	after	after	IN
46745	3170	12	a	a	DT
46745	3170	13	meal	meal	NN
46745	3170	14	,	,	,
46745	3170	15	on	on	IN
46745	3170	16	a	a	DT
46745	3170	17	full	full	JJ
46745	3170	18	stomach	stomach	NN
46745	3170	19	,	,	,
46745	3170	20	as	as	IN
46745	3170	21	then	then	RB
46745	3170	22	it	-PRON-	PRP
46745	3170	23	is	be	VBZ
46745	3170	24	less	less	RBR
46745	3170	25	likely	likely	JJ
46745	3170	26	to	to	TO
46745	3170	27	irritate	irritate	VB
46745	3170	28	,	,	,
46745	3170	29	not	not	RB
46745	3170	30	coming	come	VBG
46745	3170	31	directly	directly	RB
46745	3170	32	in	in	IN
46745	3170	33	contact	contact	NN
46745	3170	34	with	with	IN
46745	3170	35	the	the	DT
46745	3170	36	coats	coat	NNS
46745	3170	37	of	of	IN
46745	3170	38	the	the	DT
46745	3170	39	stomach	stomach	NN
46745	3170	40	,	,	,
46745	3170	41	and	and	CC
46745	3170	42	being	be	VBG
46745	3170	43	diluted	dilute	VBN
46745	3170	44	by	by	IN
46745	3170	45	the	the	DT
46745	3170	46	food	food	NN
46745	3170	47	during	during	IN
46745	3170	48	its	-PRON-	PRP$
46745	3170	49	absorption	absorption	NN
46745	3170	50	.	.	.
46745	3171	1	Arsenic	Arsenic	NNP
46745	3171	2	is	be	VBZ
46745	3171	3	useful	useful	JJ
46745	3171	4	in	in	IN
46745	3171	5	other	other	JJ
46745	3171	6	intermittent	intermittent	JJ
46745	3171	7	disorders	disorder	NNS
46745	3171	8	besides	besides	IN
46745	3171	9	Ague	Ague	NNP
46745	3171	10	,	,	,
46745	3171	11	as	as	IN
46745	3171	12	in	in	IN
46745	3171	13	the	the	DT
46745	3171	14	various	various	JJ
46745	3171	15	kinds	kind	NNS
46745	3171	16	of	of	IN
46745	3171	17	intermittent	intermittent	JJ
46745	3171	18	neuralgia	neuralgia	NN
46745	3171	19	.	.	.
46745	3172	1	It	-PRON-	PRP
46745	3172	2	has	have	VBZ
46745	3172	3	been	be	VBN
46745	3172	4	given	give	VBN
46745	3172	5	in	in	IN
46745	3172	6	some	some	DT
46745	3172	7	varieties	variety	NNS
46745	3172	8	of	of	IN
46745	3172	9	intermittent	intermittent	JJ
46745	3172	10	pulse	pulse	NN
46745	3172	11	,	,	,
46745	3172	12	which	which	WDT
46745	3172	13	are	be	VBP
46745	3172	14	not	not	RB
46745	3172	15	due	due	JJ
46745	3172	16	to	to	IN
46745	3172	17	organic	organic	JJ
46745	3172	18	disease	disease	NN
46745	3172	19	of	of	IN
46745	3172	20	the	the	DT
46745	3172	21	heart	heart	NN
46745	3172	22	.	.	.
46745	3173	1	Dr.	Dr.	NNP
46745	3173	2	Darwin	Darwin	NNP
46745	3173	3	cured	cure	VBD
46745	3173	4	a	a	DT
46745	3173	5	case	case	NN
46745	3173	6	in	in	IN
46745	3173	7	which	which	WDT
46745	3173	8	the	the	DT
46745	3173	9	beats	beat	NNS
46745	3173	10	of	of	IN
46745	3173	11	the	the	DT
46745	3173	12	heart	heart	NN
46745	3173	13	intermitted	intermit	VBD
46745	3173	14	regularly	regularly	RB
46745	3173	15	once	once	RB
46745	3173	16	in	in	IN
46745	3173	17	every	every	DT
46745	3173	18	three	three	CD
46745	3173	19	or	or	CC
46745	3173	20	four	four	CD
46745	3173	21	times	time	NNS
46745	3173	22	,	,	,
46745	3173	23	by	by	IN
46745	3173	24	the	the	DT
46745	3173	25	administration	administration	NN
46745	3173	26	of	of	IN
46745	3173	27	four	four	CD
46745	3173	28	drops	drop	NNS
46745	3173	29	of	of	IN
46745	3173	30	a	a	DT
46745	3173	31	saturated	saturate	VBN
46745	3173	32	solution	solution	NN
46745	3173	33	of	of	IN
46745	3173	34	Arsenious	arsenious	JJ
46745	3173	35	acid	acid	NN
46745	3173	36	three	three	CD
46745	3173	37	times	time	NNS
46745	3173	38	a	a	DT
46745	3173	39	day	day	NN
46745	3173	40	.	.	.
46745	3174	1	The	the	DT
46745	3174	2	preparations	preparation	NNS
46745	3174	3	of	of	IN
46745	3174	4	Arsenic	Arsenic	NNP
46745	3174	5	have	have	VBP
46745	3174	6	even	even	RB
46745	3174	7	been	be	VBN
46745	3174	8	used	use	VBN
46745	3174	9	in	in	IN
46745	3174	10	some	some	DT
46745	3174	11	cases	case	NNS
46745	3174	12	of	of	IN
46745	3174	13	Gastrodynia	Gastrodynia	NNP
46745	3174	14	with	with	IN
46745	3174	15	considerable	considerable	JJ
46745	3174	16	advantage	advantage	NN
46745	3174	17	.	.	.
46745	3175	1	In	in	IN
46745	3175	2	these	these	DT
46745	3175	3	instances	instance	NNS
46745	3175	4	the	the	DT
46745	3175	5	disorder	disorder	NN
46745	3175	6	of	of	IN
46745	3175	7	the	the	DT
46745	3175	8	stomach	stomach	NN
46745	3175	9	generally	generally	RB
46745	3175	10	assumes	assume	VBZ
46745	3175	11	an	an	DT
46745	3175	12	intermittent	intermittent	JJ
46745	3175	13	form	form	NN
46745	3175	14	.	.	.
46745	3176	1	It	-PRON-	PRP
46745	3176	2	has	have	VBZ
46745	3176	3	been	be	VBN
46745	3176	4	supposed	suppose	VBN
46745	3176	5	by	by	IN
46745	3176	6	some	some	DT
46745	3176	7	that	that	IN
46745	3176	8	Arsenic	Arsenic	NNP
46745	3176	9	in	in	IN
46745	3176	10	such	such	JJ
46745	3176	11	disorders	disorder	NNS
46745	3176	12	acts	act	VBZ
46745	3176	13	directly	directly	RB
46745	3176	14	upon	upon	IN
46745	3176	15	the	the	DT
46745	3176	16	nerves	nerve	NNS
46745	3176	17	;	;	:
46745	3176	18	but	but	CC
46745	3176	19	it	-PRON-	PRP
46745	3176	20	appears	appear	VBZ
46745	3176	21	to	to	TO
46745	3176	22	counteract	counteract	VB
46745	3176	23	all	all	PDT
46745	3176	24	the	the	DT
46745	3176	25	manifestations	manifestation	NNS
46745	3176	26	of	of	IN
46745	3176	27	this	this	DT
46745	3176	28	intermittent	intermittent	JJ
46745	3176	29	poison	poison	NN
46745	3176	30	,	,	,
46745	3176	31	whether	whether	IN
46745	3176	32	local	local	JJ
46745	3176	33	or	or	CC
46745	3176	34	general	general	JJ
46745	3176	35	,	,	,
46745	3176	36	by	by	IN
46745	3176	37	the	the	DT
46745	3176	38	same	same	JJ
46745	3176	39	action	action	NN
46745	3176	40	in	in	IN
46745	3176	41	the	the	DT
46745	3176	42	blood	blood	NN
46745	3176	43	.	.	.
46745	3177	1	(	(	-LRB-
46745	3177	2	_	_	NNP
46745	3177	3	Vide	Vide	NNP
46745	3177	4	_	_	NNP
46745	3177	5	page	page	NN
46745	3177	6	212	212	CD
46745	3177	7	.	.	.
46745	3177	8	)	)	-RRB-
46745	3178	1	Several	several	JJ
46745	3178	2	attempts	attempt	NNS
46745	3178	3	have	have	VBP
46745	3178	4	been	be	VBN
46745	3178	5	made	make	VBN
46745	3178	6	at	at	IN
46745	3178	7	different	different	JJ
46745	3178	8	times	time	NNS
46745	3178	9	to	to	TO
46745	3178	10	discover	discover	VB
46745	3178	11	a	a	DT
46745	3178	12	substitute	substitute	NN
46745	3178	13	for	for	IN
46745	3178	14	Arsenic	Arsenic	NNP
46745	3178	15	,	,	,
46745	3178	16	and	and	CC
46745	3178	17	a	a	DT
46745	3178	18	cheaper	cheap	JJR
46745	3178	19	remedy	remedy	NN
46745	3178	20	than	than	IN
46745	3178	21	Quinine	Quinine	NNP
46745	3178	22	,	,	,
46745	3178	23	for	for	IN
46745	3178	24	the	the	DT
46745	3178	25	treatment	treatment	NN
46745	3178	26	of	of	IN
46745	3178	27	Ague	Ague	NNP
46745	3178	28	.	.	.
46745	3179	1	Iron	iron	NN
46745	3179	2	is	be	VBZ
46745	3179	3	employed	employ	VBN
46745	3179	4	with	with	IN
46745	3179	5	advantage	advantage	NN
46745	3179	6	in	in	IN
46745	3179	7	old	old	JJ
46745	3179	8	chronic	chronic	JJ
46745	3179	9	cases	case	NNS
46745	3179	10	attended	attend	VBN
46745	3179	11	with	with	IN
46745	3179	12	Anæmia	Anæmia	NNP
46745	3179	13	;	;	:
46745	3179	14	but	but	CC
46745	3179	15	it	-PRON-	PRP
46745	3179	16	is	be	VBZ
46745	3179	17	not	not	RB
46745	3179	18	of	of	IN
46745	3179	19	service	service	NN
46745	3179	20	by	by	IN
46745	3179	21	counteracting	counteract	VBG
46745	3179	22	the	the	DT
46745	3179	23	intermittent	intermittent	NN
46745	3179	24	,	,	,
46745	3179	25	but	but	CC
46745	3179	26	by	by	IN
46745	3179	27	remedying	remedy	VBG
46745	3179	28	the	the	DT
46745	3179	29	anæmic	anæmic	JJ
46745	3179	30	condition	condition	NN
46745	3179	31	which	which	WDT
46745	3179	32	co	co	VBZ
46745	3179	33	-	-	NN
46745	3179	34	exists	exist	VBZ
46745	3179	35	with	with	IN
46745	3179	36	it	-PRON-	PRP
46745	3179	37	.	.	.
46745	3180	1	M.	M.	NNP
46745	3180	2	Piorry	Piorry	NNP
46745	3180	3	,	,	,
46745	3180	4	in	in	IN
46745	3180	5	the	the	DT
46745	3180	6	course	course	NN
46745	3180	7	of	of	IN
46745	3180	8	some	some	DT
46745	3180	9	experiments	experiment	NNS
46745	3180	10	made	make	VBN
46745	3180	11	at	at	IN
46745	3180	12	the	the	DT
46745	3180	13	Hôpital	Hôpital	NNP
46745	3180	14	de	de	NNP
46745	3180	15	la	la	NNP
46745	3180	16	Pitié	Pitié	NNP
46745	3180	17	at	at	IN
46745	3180	18	Paris	Paris	NNP
46745	3180	19	,	,	,
46745	3180	20	has	have	VBZ
46745	3180	21	found	find	VBN
46745	3180	22	common	common	JJ
46745	3180	23	salt	salt	NN
46745	3180	24	in	in	IN
46745	3180	25	half	half	JJ
46745	3180	26	-	-	HYPH
46745	3180	27	ounce	ounce	NN
46745	3180	28	doses	dose	NNS
46745	3180	29	to	to	TO
46745	3180	30	be	be	VB
46745	3180	31	very	very	RB
46745	3180	32	efficient	efficient	JJ
46745	3180	33	.	.	.
46745	3181	1	In	in	IN
46745	3181	2	his	-PRON-	PRP$
46745	3181	3	opinion	opinion	NN
46745	3181	4	it	-PRON-	PRP
46745	3181	5	is	be	VBZ
46745	3181	6	more	more	RBR
46745	3181	7	efficacious	efficacious	JJ
46745	3181	8	than	than	IN
46745	3181	9	Arsenic	Arsenic	NNP
46745	3181	10	,	,	,
46745	3181	11	and	and	CC
46745	3181	12	second	second	RB
46745	3181	13	only	only	RB
46745	3181	14	to	to	IN
46745	3181	15	Quinine	Quinine	NNP
46745	3181	16	,	,	,
46745	3181	17	in	in	IN
46745	3181	18	the	the	DT
46745	3181	19	cure	cure	NN
46745	3181	20	of	of	IN
46745	3181	21	this	this	DT
46745	3181	22	disorder	disorder	NN
46745	3181	23	.	.	.
46745	3182	1	The	the	DT
46745	3182	2	suggestion	suggestion	NN
46745	3182	3	is	be	VBZ
46745	3182	4	a	a	DT
46745	3182	5	valuable	valuable	JJ
46745	3182	6	one	one	NN
46745	3182	7	;	;	:
46745	3182	8	but	but	CC
46745	3182	9	the	the	DT
46745	3182	10	dose	dose	NN
46745	3182	11	is	be	VBZ
46745	3182	12	very	very	RB
46745	3182	13	bulky	bulky	JJ
46745	3182	14	,	,	,
46745	3182	15	and	and	CC
46745	3182	16	it	-PRON-	PRP
46745	3182	17	would	would	MD
46745	3182	18	be	be	VB
46745	3182	19	difficult	difficult	JJ
46745	3182	20	to	to	TO
46745	3182	21	prevent	prevent	VB
46745	3182	22	it	-PRON-	PRP
46745	3182	23	from	from	IN
46745	3182	24	causing	cause	VBG
46745	3182	25	vomiting	vomiting	NN
46745	3182	26	in	in	IN
46745	3182	27	many	many	JJ
46745	3182	28	cases	case	NNS
46745	3182	29	.	.	.
46745	3183	1	Alum	Alum	NNP
46745	3183	2	is	be	VBZ
46745	3183	3	another	another	DT
46745	3183	4	medicine	medicine	NN
46745	3183	5	which	which	WDT
46745	3183	6	has	have	VBZ
46745	3183	7	been	be	VBN
46745	3183	8	recommended	recommend	VBN
46745	3183	9	in	in	IN
46745	3183	10	Ague	Ague	NNP
46745	3183	11	.	.	.
46745	3184	1	It	-PRON-	PRP
46745	3184	2	also	also	RB
46745	3184	3	appears	appear	VBZ
46745	3184	4	to	to	TO
46745	3184	5	act	act	VB
46745	3184	6	on	on	IN
46745	3184	7	the	the	DT
46745	3184	8	Catalytic	catalytic	JJ
46745	3184	9	plan	plan	NN
46745	3184	10	;	;	:
46745	3184	11	but	but	CC
46745	3184	12	it	-PRON-	PRP
46745	3184	13	has	have	VBZ
46745	3184	14	not	not	RB
46745	3184	15	been	be	VBN
46745	3184	16	often	often	RB
46745	3184	17	employed	employ	VBN
46745	3184	18	.	.	.
46745	3185	1	The	the	DT
46745	3185	2	compounds	compound	NNS
46745	3185	3	of	of	IN
46745	3185	4	Arsenic	Arsenic	NNP
46745	3185	5	are	be	VBP
46745	3185	6	found	find	VBN
46745	3185	7	to	to	TO
46745	3185	8	exert	exert	VB
46745	3185	9	a	a	DT
46745	3185	10	curious	curious	JJ
46745	3185	11	antiseptic	antiseptic	JJ
46745	3185	12	influence	influence	NN
46745	3185	13	on	on	IN
46745	3185	14	dead	dead	JJ
46745	3185	15	animal	animal	NN
46745	3185	16	tissues	tissue	NNS
46745	3185	17	.	.	.
46745	3186	1	They	-PRON-	PRP
46745	3186	2	particularly	particularly	RB
46745	3186	3	prevent	prevent	VBP
46745	3186	4	decomposition	decomposition	NN
46745	3186	5	in	in	IN
46745	3186	6	animal	animal	NN
46745	3186	7	membranes	membrane	NNS
46745	3186	8	,	,	,
46745	3186	9	by	by	IN
46745	3186	10	virtue	virtue	NN
46745	3186	11	of	of	IN
46745	3186	12	a	a	DT
46745	3186	13	combination	combination	NN
46745	3186	14	which	which	WDT
46745	3186	15	Arsenic	arsenic	JJ
46745	3186	16	forms	form	NNS
46745	3186	17	with	with	IN
46745	3186	18	Gelatine	Gelatine	NNP
46745	3186	19	.	.	.
46745	3187	1	Liebig	Liebig	NNP
46745	3187	2	has	have	VBZ
46745	3187	3	founded	found	VBN
46745	3187	4	on	on	IN
46745	3187	5	these	these	DT
46745	3187	6	facts	fact	NNS
46745	3187	7	a	a	DT
46745	3187	8	theory	theory	NN
46745	3187	9	of	of	IN
46745	3187	10	the	the	DT
46745	3187	11	medicinal	medicinal	JJ
46745	3187	12	action	action	NN
46745	3187	13	of	of	IN
46745	3187	14	Arsenic	Arsenic	NNP
46745	3187	15	.	.	.
46745	3188	1	(	(	-LRB-
46745	3188	2	_	_	NNP
46745	3188	3	Anim	Anim	NNP
46745	3188	4	.	.	.
46745	3189	1	Chem	Chem	NNP
46745	3189	2	.	.	.
46745	3189	3	_	_	NNP
46745	3189	4	,	,	,
46745	3189	5	part	part	NN
46745	3189	6	i.	i.	NNP
46745	3189	7	p.	p.	NN
46745	3190	1	206	206	CD
46745	3190	2	.	.	.
46745	3190	3	)	)	-RRB-
46745	3191	1	He	-PRON-	PRP
46745	3191	2	supposes	suppose	VBZ
46745	3191	3	that	that	IN
46745	3191	4	substances	substance	NNS
46745	3191	5	as	as	IN
46745	3191	6	Arsenic	Arsenic	NNP
46745	3191	7	and	and	CC
46745	3191	8	Mercury	Mercury	NNP
46745	3191	9	may	may	MD
46745	3191	10	be	be	VB
46745	3191	11	able	able	JJ
46745	3191	12	to	to	TO
46745	3191	13	arrest	arrest	VB
46745	3191	14	contagious	contagious	JJ
46745	3191	15	and	and	CC
46745	3191	16	other	other	JJ
46745	3191	17	disorders	disorder	NNS
46745	3191	18	in	in	IN
46745	3191	19	the	the	DT
46745	3191	20	system	system	NN
46745	3191	21	in	in	IN
46745	3191	22	the	the	DT
46745	3191	23	same	same	JJ
46745	3191	24	way	way	NN
46745	3191	25	that	that	WDT
46745	3191	26	they	-PRON-	PRP
46745	3191	27	control	control	VBP
46745	3191	28	putrefaction	putrefaction	NN
46745	3191	29	out	out	IN
46745	3191	30	of	of	IN
46745	3191	31	the	the	DT
46745	3191	32	body	body	NN
46745	3191	33	.	.	.
46745	3192	1	The	the	DT
46745	3192	2	use	use	NN
46745	3192	3	of	of	IN
46745	3192	4	Salt	Salt	NNP
46745	3192	5	and	and	CC
46745	3192	6	Alum	Alum	NNP
46745	3192	7	in	in	IN
46745	3192	8	Ague	Ague	NNP
46745	3192	9	might	may	MD
46745	3192	10	seem	seem	VB
46745	3192	11	at	at	IN
46745	3192	12	first	first	JJ
46745	3192	13	sight	sight	NN
46745	3192	14	to	to	TO
46745	3192	15	countenance	countenance	VB
46745	3192	16	such	such	PDT
46745	3192	17	a	a	DT
46745	3192	18	hypothesis	hypothesis	NN
46745	3192	19	as	as	RB
46745	3192	20	applicable	applicable	JJ
46745	3192	21	to	to	IN
46745	3192	22	the	the	DT
46745	3192	23	treatment	treatment	NN
46745	3192	24	of	of	IN
46745	3192	25	this	this	DT
46745	3192	26	disease	disease	NN
46745	3192	27	.	.	.
46745	3193	1	But	but	CC
46745	3193	2	we	-PRON-	PRP
46745	3193	3	know	know	VBP
46745	3193	4	that	that	IN
46745	3193	5	Arsenic	Arsenic	NNP
46745	3193	6	does	do	VBZ
46745	3193	7	not	not	RB
46745	3193	8	stop	stop	VB
46745	3193	9	all	all	DT
46745	3193	10	fermentations	fermentation	NNS
46745	3193	11	.	.	.
46745	3194	1	The	the	DT
46745	3194	2	grain	grain	NN
46745	3194	3	of	of	IN
46745	3194	4	wheat	wheat	NN
46745	3194	5	will	will	MD
46745	3194	6	germinate	germinate	VB
46745	3194	7	,	,	,
46745	3194	8	and	and	CC
46745	3194	9	its	-PRON-	PRP$
46745	3194	10	starch	starch	NN
46745	3194	11	be	be	VB
46745	3194	12	converted	convert	VBN
46745	3194	13	into	into	IN
46745	3194	14	sugar	sugar	NN
46745	3194	15	,	,	,
46745	3194	16	after	after	IN
46745	3194	17	it	-PRON-	PRP
46745	3194	18	has	have	VBZ
46745	3194	19	been	be	VBN
46745	3194	20	steeped	steep	VBN
46745	3194	21	in	in	IN
46745	3194	22	a	a	DT
46745	3194	23	solution	solution	NN
46745	3194	24	of	of	IN
46745	3194	25	Arsenic	Arsenic	NNP
46745	3194	26	to	to	TO
46745	3194	27	protect	protect	VB
46745	3194	28	it	-PRON-	PRP
46745	3194	29	from	from	IN
46745	3194	30	vermin	vermin	NNP
46745	3194	31	.	.	.
46745	3195	1	And	and	CC
46745	3195	2	Gelatine	Gelatine	NNP
46745	3195	3	,	,	,
46745	3195	4	for	for	IN
46745	3195	5	which	which	WDT
46745	3195	6	Arsenic	Arsenic	NNP
46745	3195	7	has	have	VBZ
46745	3195	8	an	an	DT
46745	3195	9	affinity	affinity	NN
46745	3195	10	,	,	,
46745	3195	11	has	have	VBZ
46745	3195	12	not	not	RB
46745	3195	13	been	be	VBN
46745	3195	14	proved	prove	VBN
46745	3195	15	to	to	TO
46745	3195	16	exist	exist	VB
46745	3195	17	in	in	IN
46745	3195	18	healthy	healthy	JJ
46745	3195	19	blood	blood	NN
46745	3195	20	.	.	.
46745	3196	1	The	the	DT
46745	3196	2	compounds	compound	NNS
46745	3196	3	of	of	IN
46745	3196	4	Mercury	Mercury	NNP
46745	3196	5	,	,	,
46745	3196	6	the	the	DT
46745	3196	7	operation	operation	NN
46745	3196	8	of	of	IN
46745	3196	9	which	which	WDT
46745	3196	10	in	in	IN
46745	3196	11	Syphilis	Syphilis	NNP
46745	3196	12	is	be	VBZ
46745	3196	13	sought	seek	VBN
46745	3196	14	to	to	TO
46745	3196	15	be	be	VB
46745	3196	16	explained	explain	VBN
46745	3196	17	on	on	IN
46745	3196	18	these	these	DT
46745	3196	19	grounds	ground	NNS
46745	3196	20	,	,	,
46745	3196	21	are	be	VBP
46745	3196	22	not	not	RB
46745	3196	23	nearly	nearly	RB
46745	3196	24	so	so	RB
46745	3196	25	antiseptic	antiseptic	JJ
46745	3196	26	as	as	IN
46745	3196	27	many	many	JJ
46745	3196	28	other	other	JJ
46745	3196	29	minerals	mineral	NNS
46745	3196	30	.	.	.
46745	3197	1	If	if	IN
46745	3197	2	this	this	DT
46745	3197	3	theory	theory	NN
46745	3197	4	were	be	VBD
46745	3197	5	correct	correct	JJ
46745	3197	6	,	,	,
46745	3197	7	then	then	RB
46745	3197	8	all	all	DT
46745	3197	9	Catalytic	catalytic	JJ
46745	3197	10	medicines	medicine	NNS
46745	3197	11	,	,	,
46745	3197	12	and	and	CC
46745	3197	13	all	all	DT
46745	3197	14	antiseptic	antiseptic	JJ
46745	3197	15	substances	substance	NNS
46745	3197	16	,	,	,
46745	3197	17	should	should	MD
46745	3197	18	be	be	VB
46745	3197	19	of	of	IN
46745	3197	20	equal	equal	JJ
46745	3197	21	efficacy	efficacy	NN
46745	3197	22	in	in	IN
46745	3197	23	all	all	DT
46745	3197	24	morbid	morbid	NN
46745	3197	25	processes	process	NNS
46745	3197	26	.	.	.
46745	3198	1	But	but	CC
46745	3198	2	this	this	DT
46745	3198	3	is	be	VBZ
46745	3198	4	far	far	RB
46745	3198	5	from	from	IN
46745	3198	6	being	be	VBG
46745	3198	7	the	the	DT
46745	3198	8	case	case	NN
46745	3198	9	.	.	.
46745	3199	1	Many	many	JJ
46745	3199	2	substances	substance	NNS
46745	3199	3	which	which	WDT
46745	3199	4	are	be	VBP
46745	3199	5	distinguished	distinguish	VBN
46745	3199	6	for	for	IN
46745	3199	7	their	-PRON-	PRP$
46745	3199	8	antiseptic	antiseptic	JJ
46745	3199	9	powers	power	NNS
46745	3199	10	are	be	VBP
46745	3199	11	found	find	VBN
46745	3199	12	to	to	TO
46745	3199	13	have	have	VB
46745	3199	14	no	no	DT
46745	3199	15	influence	influence	NN
46745	3199	16	whatever	whatever	WDT
46745	3199	17	on	on	IN
46745	3199	18	the	the	DT
46745	3199	19	progress	progress	NN
46745	3199	20	of	of	IN
46745	3199	21	these	these	DT
46745	3199	22	disorders	disorder	NNS
46745	3199	23	.	.	.
46745	3200	1	Are	be	VBP
46745	3200	2	Acetic	acetic	JJ
46745	3200	3	acid	acid	NN
46745	3200	4	and	and	CC
46745	3200	5	Creosote	creosote	NN
46745	3200	6	of	of	IN
46745	3200	7	any	any	DT
46745	3200	8	use	use	NN
46745	3200	9	in	in	IN
46745	3200	10	Ague	Ague	NNP
46745	3200	11	?	?	.
46745	3201	1	Does	do	VBZ
46745	3201	2	Alcohol	Alcohol	NNP
46745	3201	3	prevent	prevent	VB
46745	3201	4	the	the	DT
46745	3201	5	drunkard	drunkard	NN
46745	3201	6	from	from	IN
46745	3201	7	contracting	contract	VBG
46745	3201	8	Syphilis	Syphilis	NNP
46745	3201	9	?	?	.
46745	3202	1	And	and	CC
46745	3202	2	if	if	IN
46745	3202	3	Arsenic	Arsenic	NNP
46745	3202	4	,	,	,
46745	3202	5	Alum	Alum	NNP
46745	3202	6	,	,	,
46745	3202	7	and	and	CC
46745	3202	8	common	common	JJ
46745	3202	9	salt	salt	NN
46745	3202	10	,	,	,
46745	3202	11	acted	act	VBD
46745	3202	12	solely	solely	RB
46745	3202	13	by	by	IN
46745	3202	14	arresting	arrest	VBG
46745	3202	15	fermentation	fermentation	NN
46745	3202	16	,	,	,
46745	3202	17	how	how	WRB
46745	3202	18	is	be	VBZ
46745	3202	19	it	-PRON-	PRP
46745	3202	20	that	that	IN
46745	3202	21	they	-PRON-	PRP
46745	3202	22	have	have	VBP
46745	3202	23	no	no	DT
46745	3202	24	control	control	NN
46745	3202	25	over	over	IN
46745	3202	26	the	the	DT
46745	3202	27	supposed	suppose	VBN
46745	3202	28	fermentations	fermentation	NNS
46745	3202	29	of	of	IN
46745	3202	30	Syphilis	Syphilis	NNP
46745	3202	31	and	and	CC
46745	3202	32	other	other	JJ
46745	3202	33	diseases	disease	NNS
46745	3202	34	?	?	.
46745	3203	1	The	the	DT
46745	3203	2	explanation	explanation	NN
46745	3203	3	required	require	VBN
46745	3203	4	must	must	MD
46745	3203	5	needs	needs	VB
46745	3203	6	be	be	VB
46745	3203	7	more	more	RBR
46745	3203	8	specific	specific	JJ
46745	3203	9	and	and	CC
46745	3203	10	particular	particular	JJ
46745	3203	11	.	.	.
46745	3204	1	ORD	ORD	NNP
46745	3204	2	.	.	.
46745	3205	1	VII	VII	NNP
46745	3205	2	.	.	.
46745	3206	1	ANTICONVULSIVES	ANTICONVULSIVES	NNP
46745	3206	2	.	.	.
46745	3207	1	I	-PRON-	PRP
46745	3207	2	have	have	VBP
46745	3207	3	already	already	RB
46745	3207	4	sought	seek	VBN
46745	3207	5	to	to	TO
46745	3207	6	show	show	VB
46745	3207	7	that	that	IN
46745	3207	8	the	the	DT
46745	3207	9	metallic	metallic	JJ
46745	3207	10	substances	substance	NNS
46745	3207	11	which	which	WDT
46745	3207	12	are	be	VBP
46745	3207	13	used	use	VBN
46745	3207	14	in	in	IN
46745	3207	15	the	the	DT
46745	3207	16	treatment	treatment	NN
46745	3207	17	of	of	IN
46745	3207	18	spasmodic	spasmodic	JJ
46745	3207	19	disorders	disorder	NNS
46745	3207	20	act	act	VBP
46745	3207	21	in	in	IN
46745	3207	22	the	the	DT
46745	3207	23	blood	blood	NN
46745	3207	24	,	,	,
46745	3207	25	and	and	CC
46745	3207	26	tend	tend	VB
46745	3207	27	to	to	TO
46745	3207	28	establish	establish	VB
46745	3207	29	in	in	IN
46745	3207	30	it	-PRON-	PRP
46745	3207	31	a	a	DT
46745	3207	32	set	set	NN
46745	3207	33	of	of	IN
46745	3207	34	actions	action	NNS
46745	3207	35	of	of	IN
46745	3207	36	a	a	DT
46745	3207	37	peculiar	peculiar	JJ
46745	3207	38	kind	kind	NN
46745	3207	39	.	.	.
46745	3208	1	I	-PRON-	PRP
46745	3208	2	am	be	VBP
46745	3208	3	able	able	JJ
46745	3208	4	to	to	TO
46745	3208	5	add	add	VB
46745	3208	6	little	little	JJ
46745	3208	7	respecting	respect	VBG
46745	3208	8	the	the	DT
46745	3208	9	rationale	rationale	NN
46745	3208	10	of	of	IN
46745	3208	11	their	-PRON-	PRP$
46745	3208	12	action	action	NN
46745	3208	13	to	to	IN
46745	3208	14	that	that	DT
46745	3208	15	which	which	WDT
46745	3208	16	I	-PRON-	PRP
46745	3208	17	have	have	VBP
46745	3208	18	said	say	VBD
46745	3208	19	of	of	IN
46745	3208	20	the	the	DT
46745	3208	21	operation	operation	NN
46745	3208	22	of	of	IN
46745	3208	23	Catalytic	catalytic	JJ
46745	3208	24	medicines	medicine	NNS
46745	3208	25	in	in	IN
46745	3208	26	general	general	JJ
46745	3208	27	.	.	.
46745	3209	1	It	-PRON-	PRP
46745	3209	2	is	be	VBZ
46745	3209	3	certainly	certainly	RB
46745	3209	4	very	very	RB
46745	3209	5	mysterious	mysterious	JJ
46745	3209	6	;	;	:
46745	3209	7	and	and	CC
46745	3209	8	it	-PRON-	PRP
46745	3209	9	is	be	VBZ
46745	3209	10	perhaps	perhaps	RB
46745	3209	11	mainly	mainly	RB
46745	3209	12	on	on	IN
46745	3209	13	this	this	DT
46745	3209	14	account	account	NN
46745	3209	15	that	that	IN
46745	3209	16	some	some	DT
46745	3209	17	have	have	VBP
46745	3209	18	been	be	VBN
46745	3209	19	induced	induce	VBN
46745	3209	20	altogether	altogether	RB
46745	3209	21	to	to	TO
46745	3209	22	deny	deny	VB
46745	3209	23	it	-PRON-	PRP
46745	3209	24	.	.	.
46745	3210	1	But	but	CC
46745	3210	2	a	a	DT
46745	3210	3	denial	denial	NN
46745	3210	4	so	so	RB
46745	3210	5	grounded	ground	VBN
46745	3210	6	is	be	VBZ
46745	3210	7	disingenuous	disingenuous	JJ
46745	3210	8	and	and	CC
46745	3210	9	wrong	wrong	JJ
46745	3210	10	,	,	,
46745	3210	11	for	for	IN
46745	3210	12	we	-PRON-	PRP
46745	3210	13	must	must	MD
46745	3210	14	often	often	RB
46745	3210	15	be	be	VB
46745	3210	16	content	content	JJ
46745	3210	17	to	to	TO
46745	3210	18	know	know	VB
46745	3210	19	and	and	CC
46745	3210	20	to	to	TO
46745	3210	21	receive	receive	VB
46745	3210	22	many	many	JJ
46745	3210	23	things	thing	NNS
46745	3210	24	that	that	WDT
46745	3210	25	we	-PRON-	PRP
46745	3210	26	do	do	VBP
46745	3210	27	not	not	RB
46745	3210	28	understand	understand	VB
46745	3210	29	.	.	.
46745	3211	1	Perhaps	perhaps	RB
46745	3211	2	the	the	DT
46745	3211	3	most	most	RBS
46745	3211	4	evident	evident	JJ
46745	3211	5	and	and	CC
46745	3211	6	characteristic	characteristic	JJ
46745	3211	7	of	of	IN
46745	3211	8	these	these	DT
46745	3211	9	agencies	agency	NNS
46745	3211	10	is	be	VBZ
46745	3211	11	that	that	DT
46745	3211	12	of	of	IN
46745	3211	13	Nitrate	Nitrate	NNP
46745	3211	14	of	of	IN
46745	3211	15	Silver	silver	NN
46745	3211	16	in	in	IN
46745	3211	17	the	the	DT
46745	3211	18	cure	cure	NN
46745	3211	19	of	of	IN
46745	3211	20	Epilepsy	Epilepsy	NNP
46745	3211	21	.	.	.
46745	3212	1	The	the	DT
46745	3212	2	Acetate	Acetate	NNP
46745	3212	3	of	of	IN
46745	3212	4	Lead	lead	NN
46745	3212	5	,	,	,
46745	3212	6	and	and	CC
46745	3212	7	the	the	DT
46745	3212	8	Ammonio	Ammonio	NNP
46745	3212	9	-	-	HYPH
46745	3212	10	sulphate	sulphate	NN
46745	3212	11	of	of	IN
46745	3212	12	Copper	Copper	NNP
46745	3212	13	,	,	,
46745	3212	14	have	have	VBP
46745	3212	15	been	be	VBN
46745	3212	16	used	use	VBN
46745	3212	17	with	with	IN
46745	3212	18	advantage	advantage	NN
46745	3212	19	in	in	IN
46745	3212	20	the	the	DT
46745	3212	21	same	same	JJ
46745	3212	22	disorder	disorder	NN
46745	3212	23	.	.	.
46745	3213	1	Dr.	Dr.	NNP
46745	3213	2	Babington	Babington	NNP
46745	3213	3	strongly	strongly	RB
46745	3213	4	recommends	recommend	VBZ
46745	3213	5	the	the	DT
46745	3213	6	Sulphate	Sulphate	NNP
46745	3213	7	of	of	IN
46745	3213	8	Zinc	Zinc	NNP
46745	3213	9	,	,	,
46745	3213	10	given	give	VBN
46745	3213	11	at	at	IN
46745	3213	12	first	first	RB
46745	3213	13	in	in	IN
46745	3213	14	small	small	JJ
46745	3213	15	doses	dose	NNS
46745	3213	16	,	,	,
46745	3213	17	and	and	CC
46745	3213	18	then	then	RB
46745	3213	19	gradually	gradually	RB
46745	3213	20	increased	increase	VBD
46745	3213	21	,	,	,
46745	3213	22	so	so	IN
46745	3213	23	that	that	IN
46745	3213	24	it	-PRON-	PRP
46745	3213	25	may	may	MD
46745	3213	26	not	not	RB
46745	3213	27	produce	produce	VB
46745	3213	28	vomiting	vomit	VBG
46745	3213	29	.	.	.
46745	3214	1	In	in	IN
46745	3214	2	the	the	DT
46745	3214	3	treatment	treatment	NN
46745	3214	4	of	of	IN
46745	3214	5	Chorea	Chorea	NNP
46745	3214	6	,	,	,
46745	3214	7	Arsenic	Arsenic	NNP
46745	3214	8	is	be	VBZ
46745	3214	9	highly	highly	RB
46745	3214	10	esteemed	esteemed	JJ
46745	3214	11	and	and	CC
46745	3214	12	recommended	recommend	VBN
46745	3214	13	by	by	IN
46745	3214	14	Dr.	Dr.	NNP
46745	3214	15	Pereira	Pereira	NNP
46745	3214	16	.	.	.
46745	3215	1	In	in	IN
46745	3215	2	Hysteria	Hysteria	NNP
46745	3215	3	these	these	DT
46745	3215	4	medicines	medicine	NNS
46745	3215	5	are	be	VBP
46745	3215	6	all	all	DT
46745	3215	7	probably	probably	RB
46745	3215	8	more	more	RBR
46745	3215	9	or	or	CC
46745	3215	10	less	less	RBR
46745	3215	11	applicable	applicable	JJ
46745	3215	12	;	;	:
46745	3215	13	but	but	CC
46745	3215	14	on	on	IN
46745	3215	15	account	account	NN
46745	3215	16	of	of	IN
46745	3215	17	the	the	DT
46745	3215	18	obstinate	obstinate	NN
46745	3215	19	and	and	CC
46745	3215	20	multiform	multiform	NN
46745	3215	21	nature	nature	NN
46745	3215	22	of	of	IN
46745	3215	23	this	this	DT
46745	3215	24	disease	disease	NN
46745	3215	25	,	,	,
46745	3215	26	their	-PRON-	PRP$
46745	3215	27	use	use	NN
46745	3215	28	in	in	IN
46745	3215	29	it	-PRON-	PRP
46745	3215	30	is	be	VBZ
46745	3215	31	less	less	RBR
46745	3215	32	obvious	obvious	JJ
46745	3215	33	than	than	IN
46745	3215	34	in	in	IN
46745	3215	35	Epilepsy	Epilepsy	NNP
46745	3215	36	and	and	CC
46745	3215	37	Chorea	Chorea	NNP
46745	3215	38	.	.	.
46745	3216	1	Hysteria	Hysteria	NNP
46745	3216	2	,	,	,
46745	3216	3	too	too	RB
46745	3216	4	,	,	,
46745	3216	5	is	be	VBZ
46745	3216	6	more	more	JJR
46745	3216	7	under	under	IN
46745	3216	8	the	the	DT
46745	3216	9	influence	influence	NN
46745	3216	10	of	of	IN
46745	3216	11	Nerve	nerve	NN
46745	3216	12	-	-	HYPH
46745	3216	13	medicines	medicine	NNS
46745	3216	14	than	than	IN
46745	3216	15	are	be	VBP
46745	3216	16	the	the	DT
46745	3216	17	other	other	JJ
46745	3216	18	two	two	CD
46745	3216	19	diseases	disease	NNS
46745	3216	20	.	.	.
46745	3217	1	The	the	DT
46745	3217	2	great	great	JJ
46745	3217	3	objection	objection	NN
46745	3217	4	to	to	IN
46745	3217	5	Silver	Silver	NNP
46745	3217	6	,	,	,
46745	3217	7	in	in	IN
46745	3217	8	whatever	whatever	WDT
46745	3217	9	form	form	NN
46745	3217	10	given	give	VBN
46745	3217	11	,	,	,
46745	3217	12	is	be	VBZ
46745	3217	13	that	that	IN
46745	3217	14	its	-PRON-	PRP$
46745	3217	15	salts	salt	NNS
46745	3217	16	are	be	VBP
46745	3217	17	liable	liable	JJ
46745	3217	18	to	to	TO
46745	3217	19	be	be	VB
46745	3217	20	reduced	reduce	VBN
46745	3217	21	in	in	IN
46745	3217	22	the	the	DT
46745	3217	23	system	system	NN
46745	3217	24	,	,	,
46745	3217	25	and	and	CC
46745	3217	26	it	-PRON-	PRP
46745	3217	27	thus	thus	RB
46745	3217	28	tends	tend	VBZ
46745	3217	29	to	to	TO
46745	3217	30	produce	produce	VB
46745	3217	31	a	a	DT
46745	3217	32	permanent	permanent	JJ
46745	3217	33	discoloration	discoloration	NN
46745	3217	34	of	of	IN
46745	3217	35	the	the	DT
46745	3217	36	skin	skin	NN
46745	3217	37	,	,	,
46745	3217	38	either	either	CC
46745	3217	39	browning	brown	VBG
46745	3217	40	it	-PRON-	PRP
46745	3217	41	or	or	CC
46745	3217	42	communicating	communicate	VBG
46745	3217	43	to	to	IN
46745	3217	44	it	-PRON-	PRP
46745	3217	45	a	a	DT
46745	3217	46	dull	dull	JJ
46745	3217	47	leaden	leaden	NN
46745	3217	48	hue	hue	NN
46745	3217	49	.	.	.
46745	3218	1	This	this	DT
46745	3218	2	naturally	naturally	RB
46745	3218	3	constitutes	constitute	VBZ
46745	3218	4	a	a	DT
46745	3218	5	strong	strong	JJ
46745	3218	6	ground	ground	NN
46745	3218	7	of	of	IN
46745	3218	8	objection	objection	NN
46745	3218	9	with	with	IN
46745	3218	10	the	the	DT
46745	3218	11	unfortunate	unfortunate	JJ
46745	3218	12	patient	patient	NN
46745	3218	13	,	,	,
46745	3218	14	who	who	WP
46745	3218	15	would	would	MD
46745	3218	16	often	often	RB
46745	3218	17	prefer	prefer	VB
46745	3218	18	to	to	TO
46745	3218	19	be	be	VB
46745	3218	20	left	leave	VBN
46745	3218	21	alone	alone	JJ
46745	3218	22	with	with	IN
46745	3218	23	his	-PRON-	PRP$
46745	3218	24	fits	fit	NNS
46745	3218	25	than	than	IN
46745	3218	26	to	to	TO
46745	3218	27	be	be	VB
46745	3218	28	turned	turn	VBN
46745	3218	29	blue	blue	JJ
46745	3218	30	for	for	IN
46745	3218	31	life	life	NN
46745	3218	32	.	.	.
46745	3219	1	M.	M.	NNP
46745	3219	2	Georget	Georget	NNP
46745	3219	3	supposes	suppose	VBZ
46745	3219	4	that	that	IN
46745	3219	5	the	the	DT
46745	3219	6	advocates	advocate	NNS
46745	3219	7	for	for	IN
46745	3219	8	the	the	DT
46745	3219	9	use	use	NN
46745	3219	10	of	of	IN
46745	3219	11	Nitrate	Nitrate	NNP
46745	3219	12	of	of	IN
46745	3219	13	Silver	Silver	NNP
46745	3219	14	in	in	IN
46745	3219	15	Epilepsy	Epilepsy	NNP
46745	3219	16	employ	employ	VB
46745	3219	17	it	-PRON-	PRP
46745	3219	18	on	on	IN
46745	3219	19	the	the	DT
46745	3219	20	principle	principle	NN
46745	3219	21	of	of	IN
46745	3219	22	counter	counter	NN
46745	3219	23	-	-	NN
46745	3219	24	irritation	irritation	NN
46745	3219	25	,	,	,
46745	3219	26	saying	say	VBG
46745	3219	27	that	that	IN
46745	3219	28	they	-PRON-	PRP
46745	3219	29	attempt	attempt	VBP
46745	3219	30	to	to	TO
46745	3219	31	cure	cure	VB
46745	3219	32	a	a	DT
46745	3219	33	diseased	disease	VBN
46745	3219	34	brain	brain	NN
46745	3219	35	by	by	IN
46745	3219	36	cauterizing	cauterize	VBG
46745	3219	37	the	the	DT
46745	3219	38	stomach	stomach	NN
46745	3219	39	.	.	.
46745	3220	1	(	(	-LRB-
46745	3220	2	_	_	NNP
46745	3220	3	Physiology	Physiology	NNP
46745	3220	4	of	of	IN
46745	3220	5	the	the	DT
46745	3220	6	Nerv	Nerv	NNP
46745	3220	7	.	.	.
46745	3221	1	System	System	NNP
46745	3221	2	_	_	NNP
46745	3221	3	,	,	,
46745	3221	4	vol	vol	NNP
46745	3221	5	.	.	.
46745	3222	1	ii	ii	LS
46745	3222	2	.	.	.
46745	3223	1	p.	p.	NN
46745	3224	1	401	401	CD
46745	3224	2	.	.	.
46745	3224	3	)	)	-RRB-
46745	3225	1	But	but	CC
46745	3225	2	I	-PRON-	PRP
46745	3225	3	am	be	VBP
46745	3225	4	not	not	RB
46745	3225	5	aware	aware	JJ
46745	3225	6	that	that	IN
46745	3225	7	any	any	DT
46745	3225	8	English	English	NNP
46745	3225	9	therapeutists	therapeutist	NNS
46745	3225	10	have	have	VBP
46745	3225	11	adopted	adopt	VBN
46745	3225	12	this	this	DT
46745	3225	13	view	view	NN
46745	3225	14	of	of	IN
46745	3225	15	its	-PRON-	PRP$
46745	3225	16	mode	mode	NN
46745	3225	17	of	of	IN
46745	3225	18	operation	operation	NN
46745	3225	19	.	.	.
46745	3226	1	The	the	DT
46745	3226	2	dose	dose	NN
46745	3226	3	of	of	IN
46745	3226	4	the	the	DT
46745	3226	5	Nitrate	Nitrate	NNP
46745	3226	6	of	of	IN
46745	3226	7	Silver	Silver	NNP
46745	3226	8	,	,	,
46745	3226	9	and	and	CC
46745	3226	10	the	the	DT
46745	3226	11	state	state	NN
46745	3226	12	of	of	IN
46745	3226	13	dilution	dilution	NN
46745	3226	14	in	in	IN
46745	3226	15	which	which	WDT
46745	3226	16	it	-PRON-	PRP
46745	3226	17	is	be	VBZ
46745	3226	18	given	give	VBN
46745	3226	19	,	,	,
46745	3226	20	would	would	MD
46745	3226	21	certainly	certainly	RB
46745	3226	22	prevent	prevent	VB
46745	3226	23	it	-PRON-	PRP
46745	3226	24	from	from	IN
46745	3226	25	manifesting	manifest	VBG
46745	3226	26	any	any	DT
46745	3226	27	such	such	JJ
46745	3226	28	action	action	NN
46745	3226	29	.	.	.
46745	3227	1	And	and	CC
46745	3227	2	we	-PRON-	PRP
46745	3227	3	should	should	MD
46745	3227	4	not	not	RB
46745	3227	5	be	be	VB
46745	3227	6	warranted	warrant	VBN
46745	3227	7	in	in	IN
46745	3227	8	supposing	suppose	VBG
46745	3227	9	that	that	IN
46745	3227	10	any	any	DT
46745	3227	11	of	of	IN
46745	3227	12	the	the	DT
46745	3227	13	medicines	medicine	NNS
46745	3227	14	of	of	IN
46745	3227	15	this	this	DT
46745	3227	16	or	or	CC
46745	3227	17	any	any	DT
46745	3227	18	other	other	JJ
46745	3227	19	order	order	NN
46745	3227	20	of	of	IN
46745	3227	21	Catalytic	catalytic	JJ
46745	3227	22	remedies	remedy	NNS
46745	3227	23	could	could	MD
46745	3227	24	act	act	VB
46745	3227	25	in	in	RP
46745	3227	26	so	so	RB
46745	3227	27	direct	direct	JJ
46745	3227	28	and	and	CC
46745	3227	29	so	so	RB
46745	3227	30	easy	easy	JJ
46745	3227	31	a	a	DT
46745	3227	32	way	way	NN
46745	3227	33	as	as	IN
46745	3227	34	that	that	DT
46745	3227	35	,	,	,
46745	3227	36	even	even	RB
46745	3227	37	if	if	IN
46745	3227	38	it	-PRON-	PRP
46745	3227	39	were	be	VBD
46745	3227	40	thus	thus	RB
46745	3227	41	possible	possible	JJ
46745	3227	42	.	.	.
46745	3228	1	Some	some	DT
46745	3228	2	have	have	VBP
46745	3228	3	supposed	suppose	VBN
46745	3228	4	that	that	IN
46745	3228	5	Nitrate	Nitrate	NNP
46745	3228	6	of	of	IN
46745	3228	7	Silver	Silver	NNP
46745	3228	8	cures	cure	VBZ
46745	3228	9	Epilepsy	Epilepsy	NNP
46745	3228	10	by	by	IN
46745	3228	11	diminishing	diminish	VBG
46745	3228	12	an	an	DT
46745	3228	13	irritable	irritable	JJ
46745	3228	14	condition	condition	NN
46745	3228	15	of	of	IN
46745	3228	16	the	the	DT
46745	3228	17	stomach	stomach	NN
46745	3228	18	.	.	.
46745	3229	1	But	but	CC
46745	3229	2	it	-PRON-	PRP
46745	3229	3	is	be	VBZ
46745	3229	4	observed	observe	VBN
46745	3229	5	by	by	IN
46745	3229	6	Dr.	Dr.	NNP
46745	3229	7	Pereira	Pereira	NNP
46745	3229	8	that	that	IN
46745	3229	9	the	the	DT
46745	3229	10	existence	existence	NN
46745	3229	11	of	of	IN
46745	3229	12	this	this	DT
46745	3229	13	irritability	irritability	NN
46745	3229	14	in	in	IN
46745	3229	15	all	all	DT
46745	3229	16	cases	case	NNS
46745	3229	17	of	of	IN
46745	3229	18	Epilepsy	Epilepsy	NNP
46745	3229	19	is	be	VBZ
46745	3229	20	a	a	DT
46745	3229	21	mere	mere	JJ
46745	3229	22	assumption	assumption	NN
46745	3229	23	.	.	.
46745	3230	1	The	the	DT
46745	3230	2	solution	solution	NN
46745	3230	3	of	of	IN
46745	3230	4	this	this	DT
46745	3230	5	salt	salt	NN
46745	3230	6	exerts	exert	NNS
46745	3230	7	,	,	,
46745	3230	8	according	accord	VBG
46745	3230	9	to	to	IN
46745	3230	10	its	-PRON-	PRP$
46745	3230	11	strength	strength	NN
46745	3230	12	,	,	,
46745	3230	13	an	an	DT
46745	3230	14	astringent	astringent	JJ
46745	3230	15	or	or	CC
46745	3230	16	caustic	caustic	JJ
46745	3230	17	action	action	NN
46745	3230	18	on	on	IN
46745	3230	19	all	all	DT
46745	3230	20	mucous	mucous	JJ
46745	3230	21	surfaces	surface	NNS
46745	3230	22	,	,	,
46745	3230	23	and	and	CC
46745	3230	24	thus	thus	RB
46745	3230	25	improves	improve	VBZ
46745	3230	26	their	-PRON-	PRP$
46745	3230	27	condition	condition	NN
46745	3230	28	when	when	WRB
46745	3230	29	they	-PRON-	PRP
46745	3230	30	are	be	VBP
46745	3230	31	relaxed	relaxed	JJ
46745	3230	32	,	,	,
46745	3230	33	inflamed	inflamed	JJ
46745	3230	34	,	,	,
46745	3230	35	irritable	irritable	JJ
46745	3230	36	,	,	,
46745	3230	37	or	or	CC
46745	3230	38	ulcerated	ulcerated	JJ
46745	3230	39	.	.	.
46745	3231	1	The	the	DT
46745	3231	2	occasional	occasional	JJ
46745	3231	3	benefit	benefit	NN
46745	3231	4	which	which	WDT
46745	3231	5	follows	follow	VBZ
46745	3231	6	the	the	DT
46745	3231	7	administration	administration	NN
46745	3231	8	of	of	IN
46745	3231	9	the	the	DT
46745	3231	10	preparations	preparation	NNS
46745	3231	11	of	of	IN
46745	3231	12	Silver	Silver	NNP
46745	3231	13	in	in	IN
46745	3231	14	Gastrodynia	Gastrodynia	NNP
46745	3231	15	may	may	MD
46745	3231	16	be	be	VB
46745	3231	17	referred	refer	VBN
46745	3231	18	to	to	IN
46745	3231	19	an	an	DT
46745	3231	20	action	action	NN
46745	3231	21	of	of	IN
46745	3231	22	this	this	DT
46745	3231	23	kind	kind	NN
46745	3231	24	.	.	.
46745	3232	1	The	the	DT
46745	3232	2	action	action	NN
46745	3232	3	of	of	IN
46745	3232	4	Arsenic	Arsenic	NNP
46745	3232	5	in	in	IN
46745	3232	6	some	some	DT
46745	3232	7	intermittent	intermittent	JJ
46745	3232	8	varieties	variety	NNS
46745	3232	9	of	of	IN
46745	3232	10	this	this	DT
46745	3232	11	painful	painful	JJ
46745	3232	12	affection	affection	NN
46745	3232	13	has	have	VBZ
46745	3232	14	already	already	RB
46745	3232	15	been	be	VBN
46745	3232	16	mentioned	mention	VBN
46745	3232	17	,	,	,
46745	3232	18	and	and	CC
46745	3232	19	is	be	VBZ
46745	3232	20	explained	explain	VBN
46745	3232	21	in	in	IN
46745	3232	22	another	another	DT
46745	3232	23	way	way	NN
46745	3232	24	.	.	.
46745	3233	1	Caustic	caustic	JJ
46745	3233	2	substances	substance	NNS
46745	3233	3	probably	probably	RB
46745	3233	4	act	act	VBP
46745	3233	5	locally	locally	RB
46745	3233	6	in	in	IN
46745	3233	7	these	these	DT
46745	3233	8	cases	case	NNS
46745	3233	9	;	;	:
46745	3233	10	but	but	CC
46745	3233	11	Arsenious	arsenious	JJ
46745	3233	12	preparations	preparation	NNS
46745	3233	13	exert	exert	VBP
46745	3233	14	an	an	DT
46745	3233	15	Antiperiodic	antiperiodic	JJ
46745	3233	16	influence	influence	NN
46745	3233	17	in	in	IN
46745	3233	18	the	the	DT
46745	3233	19	blood	blood	NN
46745	3233	20	generally	generally	RB
46745	3233	21	.	.	.
46745	3234	1	Tetanus	tetanus	NN
46745	3234	2	is	be	VBZ
46745	3234	3	by	by	IN
46745	3234	4	far	far	RB
46745	3234	5	the	the	DT
46745	3234	6	most	most	RBS
46745	3234	7	incurable	incurable	JJ
46745	3234	8	of	of	IN
46745	3234	9	these	these	DT
46745	3234	10	convulsive	convulsive	NN
46745	3234	11	disorders	disorder	NNS
46745	3234	12	.	.	.
46745	3235	1	Arsenic	arsenic	JJ
46745	3235	2	and	and	CC
46745	3235	3	other	other	JJ
46745	3235	4	medicines	medicine	NNS
46745	3235	5	of	of	IN
46745	3235	6	this	this	DT
46745	3235	7	order	order	NN
46745	3235	8	have	have	VBP
46745	3235	9	been	be	VBN
46745	3235	10	recommended	recommend	VBN
46745	3235	11	in	in	IN
46745	3235	12	the	the	DT
46745	3235	13	treatment	treatment	NN
46745	3235	14	;	;	:
46745	3235	15	but	but	CC
46745	3235	16	although	although	IN
46745	3235	17	some	some	DT
46745	3235	18	cases	case	NNS
46745	3235	19	appear	appear	VBP
46745	3235	20	to	to	TO
46745	3235	21	be	be	VB
46745	3235	22	partly	partly	RB
46745	3235	23	connected	connect	VBN
46745	3235	24	in	in	IN
46745	3235	25	their	-PRON-	PRP$
46745	3235	26	first	first	JJ
46745	3235	27	origin	origin	NN
46745	3235	28	with	with	IN
46745	3235	29	a	a	DT
46745	3235	30	certain	certain	JJ
46745	3235	31	condition	condition	NN
46745	3235	32	of	of	IN
46745	3235	33	the	the	DT
46745	3235	34	blood	blood	NN
46745	3235	35	,	,	,
46745	3235	36	this	this	DT
46745	3235	37	disease	disease	NN
46745	3235	38	is	be	VBZ
46745	3235	39	very	very	RB
46745	3235	40	little	little	JJ
46745	3235	41	under	under	IN
46745	3235	42	the	the	DT
46745	3235	43	influence	influence	NN
46745	3235	44	of	of	IN
46745	3235	45	blood	blood	NN
46745	3235	46	medicines	medicine	NNS
46745	3235	47	,	,	,
46745	3235	48	or	or	CC
46745	3235	49	indeed	indeed	RB
46745	3235	50	of	of	IN
46745	3235	51	any	any	DT
46745	3235	52	medicines	medicine	NNS
46745	3235	53	at	at	RB
46745	3235	54	all	all	RB
46745	3235	55	.	.	.
46745	3236	1	ORD	ORD	NNP
46745	3236	2	.	.	.
46745	3237	1	VIII	VIII	NNP
46745	3237	2	.	.	.
46745	3238	1	ANTISQUAMICS	ANTISQUAMICS	NNP
46745	3238	2	.	.	.
46745	3239	1	Skin	skin	NN
46745	3239	2	diseases	disease	NNS
46745	3239	3	are	be	VBP
46745	3239	4	both	both	DT
46745	3239	5	caused	cause	VBN
46745	3239	6	and	and	CC
46745	3239	7	cured	cure	VBN
46745	3239	8	in	in	IN
46745	3239	9	a	a	DT
46745	3239	10	variety	variety	NN
46745	3239	11	of	of	IN
46745	3239	12	ways	way	NNS
46745	3239	13	.	.	.
46745	3240	1	Some	some	DT
46745	3240	2	are	be	VBP
46745	3240	3	produced	produce	VBN
46745	3240	4	by	by	IN
46745	3240	5	external	external	JJ
46745	3240	6	influences	influence	NNS
46745	3240	7	.	.	.
46745	3241	1	They	-PRON-	PRP
46745	3241	2	may	may	MD
46745	3241	3	be	be	VB
46745	3241	4	brought	bring	VBN
46745	3241	5	on	on	RP
46745	3241	6	by	by	IN
46745	3241	7	mere	mere	JJ
46745	3241	8	irritation	irritation	NN
46745	3241	9	,	,	,
46745	3241	10	as	as	IN
46745	3241	11	certain	certain	JJ
46745	3241	12	kinds	kind	NNS
46745	3241	13	of	of	IN
46745	3241	14	Eczema	Eczema	NNP
46745	3241	15	and	and	CC
46745	3241	16	Herpes	Herpes	NNP
46745	3241	17	,	,	,
46745	3241	18	and	and	CC
46745	3241	19	are	be	VBP
46745	3241	20	then	then	RB
46745	3241	21	to	to	TO
46745	3241	22	be	be	VB
46745	3241	23	treated	treat	VBN
46745	3241	24	with	with	IN
46745	3241	25	soothing	soothe	VBG
46745	3241	26	unguents	unguent	NNS
46745	3241	27	or	or	CC
46745	3241	28	cool	cool	JJ
46745	3241	29	lotions	lotion	NNS
46745	3241	30	.	.	.
46745	3242	1	Or	or	CC
46745	3242	2	they	-PRON-	PRP
46745	3242	3	may	may	MD
46745	3242	4	even	even	RB
46745	3242	5	be	be	VB
46745	3242	6	connected	connect	VBN
46745	3242	7	with	with	IN
46745	3242	8	some	some	DT
46745	3242	9	external	external	JJ
46745	3242	10	organization	organization	NN
46745	3242	11	,	,	,
46745	3242	12	of	of	IN
46745	3242	13	a	a	DT
46745	3242	14	vegetable	vegetable	NN
46745	3242	15	or	or	CC
46745	3242	16	animal	animal	NN
46745	3242	17	kind	kind	NN
46745	3242	18	,	,	,
46745	3242	19	as	as	IN
46745	3242	20	Porrigo	Porrigo	NNP
46745	3242	21	and	and	CC
46745	3242	22	Favus	Favus	NNP
46745	3242	23	are	be	VBP
46745	3242	24	traceable	traceable	JJ
46745	3242	25	to	to	IN
46745	3242	26	a	a	DT
46745	3242	27	parasitic	parasitic	JJ
46745	3242	28	fungus	fungus	NN
46745	3242	29	,	,	,
46745	3242	30	and	and	CC
46745	3242	31	Scabies	Scabies	NNP
46745	3242	32	is	be	VBZ
46745	3242	33	accompanied	accompany	VBN
46745	3242	34	by	by	IN
46745	3242	35	the	the	DT
46745	3242	36	development	development	NN
46745	3242	37	of	of	IN
46745	3242	38	a	a	DT
46745	3242	39	species	species	NN
46745	3242	40	of	of	IN
46745	3242	41	Acarus	Acarus	NNP
46745	3242	42	.	.	.
46745	3243	1	Others	other	NNS
46745	3243	2	are	be	VBP
46745	3243	3	due	due	JJ
46745	3243	4	to	to	IN
46745	3243	5	some	some	DT
46745	3243	6	wrong	wrong	NN
46745	3243	7	in	in	IN
46745	3243	8	the	the	DT
46745	3243	9	digestive	digestive	JJ
46745	3243	10	process	process	NN
46745	3243	11	,	,	,
46745	3243	12	or	or	CC
46745	3243	13	to	to	IN
46745	3243	14	a	a	DT
46745	3243	15	plethoric	plethoric	JJ
46745	3243	16	condition	condition	NN
46745	3243	17	of	of	IN
46745	3243	18	the	the	DT
46745	3243	19	system	system	NN
46745	3243	20	.	.	.
46745	3244	1	Urticaria	Urticaria	NNP
46745	3244	2	is	be	VBZ
46745	3244	3	an	an	DT
46745	3244	4	example	example	NN
46745	3244	5	of	of	IN
46745	3244	6	the	the	DT
46745	3244	7	former	former	JJ
46745	3244	8	,	,	,
46745	3244	9	Acne	Acne	NNP
46745	3244	10	of	of	IN
46745	3244	11	the	the	DT
46745	3244	12	latter	latter	JJ
46745	3244	13	.	.	.
46745	3245	1	They	-PRON-	PRP
46745	3245	2	may	may	MD
46745	3245	3	generally	generally	RB
46745	3245	4	be	be	VB
46745	3245	5	treated	treat	VBN
46745	3245	6	most	most	RBS
46745	3245	7	effectually	effectually	RB
46745	3245	8	by	by	IN
46745	3245	9	the	the	DT
46745	3245	10	exhibition	exhibition	NN
46745	3245	11	of	of	IN
46745	3245	12	salines	saline	NNS
46745	3245	13	and	and	CC
46745	3245	14	rhubarb	rhubarb	NN
46745	3245	15	.	.	.
46745	3246	1	A	a	DT
46745	3246	2	third	third	JJ
46745	3246	3	class	class	NN
46745	3246	4	of	of	IN
46745	3246	5	skin	skin	NN
46745	3246	6	diseases	disease	NNS
46745	3246	7	are	be	VBP
46745	3246	8	due	due	JJ
46745	3246	9	to	to	IN
46745	3246	10	the	the	DT
46745	3246	11	existence	existence	NN
46745	3246	12	in	in	IN
46745	3246	13	the	the	DT
46745	3246	14	blood	blood	NN
46745	3246	15	of	of	IN
46745	3246	16	certain	certain	JJ
46745	3246	17	poisons	poison	NNS
46745	3246	18	or	or	CC
46745	3246	19	peculiar	peculiar	JJ
46745	3246	20	morbid	morbid	NN
46745	3246	21	conditions	condition	NNS
46745	3246	22	.	.	.
46745	3247	1	The	the	DT
46745	3247	2	eruption	eruption	NN
46745	3247	3	may	may	MD
46745	3247	4	constitute	constitute	VB
46745	3247	5	one	one	CD
46745	3247	6	only	only	RB
46745	3247	7	among	among	IN
46745	3247	8	many	many	JJ
46745	3247	9	symptoms	symptom	NNS
46745	3247	10	of	of	IN
46745	3247	11	the	the	DT
46745	3247	12	action	action	NN
46745	3247	13	of	of	IN
46745	3247	14	this	this	DT
46745	3247	15	poison	poison	NN
46745	3247	16	,	,	,
46745	3247	17	or	or	CC
46745	3247	18	it	-PRON-	PRP
46745	3247	19	may	may	MD
46745	3247	20	be	be	VB
46745	3247	21	the	the	DT
46745	3247	22	chief	chief	JJ
46745	3247	23	or	or	CC
46745	3247	24	only	only	JJ
46745	3247	25	symptom	symptom	NN
46745	3247	26	.	.	.
46745	3248	1	The	the	DT
46745	3248	2	former	former	JJ
46745	3248	3	is	be	VBZ
46745	3248	4	the	the	DT
46745	3248	5	case	case	NN
46745	3248	6	in	in	IN
46745	3248	7	Syphilis	Syphilis	NNP
46745	3248	8	and	and	CC
46745	3248	9	the	the	DT
46745	3248	10	Eruptive	eruptive	JJ
46745	3248	11	fevers	fever	NNS
46745	3248	12	.	.	.
46745	3249	1	It	-PRON-	PRP
46745	3249	2	is	be	VBZ
46745	3249	3	with	with	IN
46745	3249	4	the	the	DT
46745	3249	5	latter	latter	JJ
46745	3249	6	kind	kind	NN
46745	3249	7	that	that	IN
46745	3249	8	we	-PRON-	PRP
46745	3249	9	are	be	VBP
46745	3249	10	now	now	RB
46745	3249	11	concerned	concern	VBN
46745	3249	12	.	.	.
46745	3250	1	There	there	EX
46745	3250	2	are	be	VBP
46745	3250	3	two	two	CD
46745	3250	4	modes	mode	NNS
46745	3250	5	by	by	IN
46745	3250	6	which	which	WDT
46745	3250	7	we	-PRON-	PRP
46745	3250	8	may	may	MD
46745	3250	9	get	get	VB
46745	3250	10	rid	rid	VBN
46745	3250	11	of	of	IN
46745	3250	12	the	the	DT
46745	3250	13	poison	poison	NN
46745	3250	14	that	that	WDT
46745	3250	15	causes	cause	VBZ
46745	3250	16	the	the	DT
46745	3250	17	eruption	eruption	NN
46745	3250	18	--	--	:
46745	3250	19	Elimination	Elimination	NNP
46745	3250	20	and	and	CC
46745	3250	21	Counteraction	Counteraction	NNP
46745	3250	22	.	.	.
46745	3251	1	The	the	DT
46745	3251	2	first	first	JJ
46745	3251	3	may	may	MD
46745	3251	4	sometimes	sometimes	RB
46745	3251	5	be	be	VB
46745	3251	6	effected	effect	VBN
46745	3251	7	by	by	IN
46745	3251	8	the	the	DT
46745	3251	9	use	use	NN
46745	3251	10	of	of	IN
46745	3251	11	Purgatives	Purgatives	NNP
46745	3251	12	,	,	,
46745	3251	13	Sudorifics	Sudorifics	NNP
46745	3251	14	,	,	,
46745	3251	15	or	or	CC
46745	3251	16	Diuretics	diuretic	NNS
46745	3251	17	.	.	.
46745	3252	1	But	but	CC
46745	3252	2	I	-PRON-	PRP
46745	3252	3	have	have	VBP
46745	3252	4	classed	class	VBN
46745	3252	5	in	in	IN
46745	3252	6	this	this	DT
46745	3252	7	last	last	JJ
46745	3252	8	order	order	NN
46745	3252	9	of	of	IN
46745	3252	10	Catalytic	catalytic	JJ
46745	3252	11	blood	blood	NN
46745	3252	12	-	-	HYPH
46745	3252	13	medicines	medicine	NNS
46745	3252	14	some	some	DT
46745	3252	15	remedies	remedy	NNS
46745	3252	16	that	that	WDT
46745	3252	17	have	have	VBP
46745	3252	18	proved	prove	VBN
46745	3252	19	useful	useful	JJ
46745	3252	20	in	in	IN
46745	3252	21	counteracting	counteract	VBG
46745	3252	22	the	the	DT
46745	3252	23	causes	cause	NNS
46745	3252	24	of	of	IN
46745	3252	25	these	these	DT
46745	3252	26	diseases	disease	NNS
46745	3252	27	.	.	.
46745	3253	1	The	the	DT
46745	3253	2	eruptive	eruptive	JJ
46745	3253	3	disorders	disorder	NNS
46745	3253	4	alluded	allude	VBD
46745	3253	5	to	to	TO
46745	3253	6	are	be	VBP
46745	3253	7	all	all	DT
46745	3253	8	connected	connect	VBN
46745	3253	9	together	together	RB
46745	3253	10	both	both	DT
46745	3253	11	in	in	IN
46745	3253	12	their	-PRON-	PRP$
46745	3253	13	symptoms	symptom	NNS
46745	3253	14	and	and	CC
46745	3253	15	treatment	treatment	NN
46745	3253	16	;	;	:
46745	3253	17	but	but	CC
46745	3253	18	because	because	IN
46745	3253	19	the	the	DT
46745	3253	20	squamous	squamous	JJ
46745	3253	21	diseases	disease	NNS
46745	3253	22	,	,	,
46745	3253	23	Lepra	Lepra	NNP
46745	3253	24	and	and	CC
46745	3253	25	Psoriasis	Psoriasis	NNP
46745	3253	26	,	,	,
46745	3253	27	are	be	VBP
46745	3253	28	the	the	DT
46745	3253	29	most	most	RBS
46745	3253	30	characteristically	characteristically	RB
46745	3253	31	under	under	IN
46745	3253	32	the	the	DT
46745	3253	33	influence	influence	NN
46745	3253	34	of	of	IN
46745	3253	35	these	these	DT
46745	3253	36	remedies	remedy	NNS
46745	3253	37	,	,	,
46745	3253	38	the	the	DT
46745	3253	39	latter	latter	JJ
46745	3253	40	have	have	VBP
46745	3253	41	been	be	VBN
46745	3253	42	named	name	VBN
46745	3253	43	Antisquamics	antisquamic	NNS
46745	3253	44	.	.	.
46745	3254	1	Arsenious	arsenious	JJ
46745	3254	2	acid	acid	NN
46745	3254	3	,	,	,
46745	3254	4	as	as	IN
46745	3254	5	contained	contain	VBN
46745	3254	6	in	in	IN
46745	3254	7	Fowler	Fowler	NNP
46745	3254	8	's	's	POS
46745	3254	9	solution	solution	NN
46745	3254	10	,	,	,
46745	3254	11	a	a	DT
46745	3254	12	remedy	remedy	NN
46745	3254	13	already	already	RB
46745	3254	14	twice	twice	RB
46745	3254	15	named	name	VBN
46745	3254	16	among	among	IN
46745	3254	17	Catalytics	Catalytics	NNP
46745	3254	18	,	,	,
46745	3254	19	is	be	VBZ
46745	3254	20	also	also	RB
46745	3254	21	the	the	DT
46745	3254	22	most	most	RBS
46745	3254	23	powerful	powerful	JJ
46745	3254	24	of	of	IN
46745	3254	25	these	these	DT
46745	3254	26	Antisquamic	antisquamic	JJ
46745	3254	27	agents	agent	NNS
46745	3254	28	.	.	.
46745	3255	1	Mr.	Mr.	NNP
46745	3255	2	Hunt	Hunt	NNP
46745	3255	3	considers	consider	VBZ
46745	3255	4	it	-PRON-	PRP
46745	3255	5	to	to	TO
46745	3255	6	be	be	VB
46745	3255	7	a	a	DT
46745	3255	8	specific	specific	NN
46745	3255	9	for	for	IN
46745	3255	10	all	all	DT
46745	3255	11	skin	skin	NN
46745	3255	12	diseases	disease	NNS
46745	3255	13	that	that	WDT
46745	3255	14	are	be	VBP
46745	3255	15	not	not	RB
46745	3255	16	syphilitic	syphilitic	JJ
46745	3255	17	in	in	IN
46745	3255	18	their	-PRON-	PRP$
46745	3255	19	origin	origin	NN
46745	3255	20	.	.	.
46745	3256	1	Besides	besides	IN
46745	3256	2	Lepra	Lepra	NNP
46745	3256	3	and	and	CC
46745	3256	4	Psoriasis	Psoriasis	NNP
46745	3256	5	,	,	,
46745	3256	6	it	-PRON-	PRP
46745	3256	7	is	be	VBZ
46745	3256	8	found	find	VBN
46745	3256	9	useful	useful	JJ
46745	3256	10	in	in	IN
46745	3256	11	Eczema	Eczema	NNP
46745	3256	12	,	,	,
46745	3256	13	Impetigo	Impetigo	NNP
46745	3256	14	,	,	,
46745	3256	15	and	and	CC
46745	3256	16	Lupus	Lupus	NNP
46745	3256	17	.	.	.
46745	3257	1	In	in	IN
46745	3257	2	the	the	DT
46745	3257	3	last	last	JJ
46745	3257	4	disorder	disorder	NN
46745	3257	5	it	-PRON-	PRP
46745	3257	6	has	have	VBZ
46745	3257	7	been	be	VBN
46745	3257	8	used	use	VBN
46745	3257	9	both	both	DT
46745	3257	10	externally	externally	RB
46745	3257	11	and	and	CC
46745	3257	12	internally	internally	RB
46745	3257	13	,	,	,
46745	3257	14	seeming	seeming	JJ
46745	3257	15	to	to	TO
46745	3257	16	be	be	VB
46745	3257	17	in	in	IN
46745	3257	18	both	both	DT
46745	3257	19	cases	case	NNS
46745	3257	20	specific	specific	JJ
46745	3257	21	in	in	IN
46745	3257	22	its	-PRON-	PRP$
46745	3257	23	action	action	NN
46745	3257	24	.	.	.
46745	3258	1	Thus	thus	RB
46745	3258	2	we	-PRON-	PRP
46745	3258	3	find	find	VBP
46745	3258	4	in	in	IN
46745	3258	5	these	these	DT
46745	3258	6	skin	skin	NN
46745	3258	7	diseases	disease	NNS
46745	3258	8	another	another	DT
46745	3258	9	special	special	JJ
46745	3258	10	antagonism	antagonism	NN
46745	3258	11	for	for	IN
46745	3258	12	this	this	DT
46745	3258	13	extraordinary	extraordinary	JJ
46745	3258	14	medicine	medicine	NN
46745	3258	15	,	,	,
46745	3258	16	which	which	WDT
46745	3258	17	has	have	VBZ
46745	3258	18	already	already	RB
46745	3258	19	been	be	VBN
46745	3258	20	shown	show	VBN
46745	3258	21	to	to	TO
46745	3258	22	be	be	VB
46745	3258	23	of	of	IN
46745	3258	24	considerable	considerable	JJ
46745	3258	25	efficacy	efficacy	NN
46745	3258	26	both	both	CC
46745	3258	27	in	in	IN
46745	3258	28	periodic	periodic	JJ
46745	3258	29	and	and	CC
46745	3258	30	convulsive	convulsive	JJ
46745	3258	31	disorders	disorder	NNS
46745	3258	32	.	.	.
46745	3259	1	Pitch	Pitch	NNP
46745	3259	2	or	or	CC
46745	3259	3	Tar	Tar	NNP
46745	3259	4	is	be	VBZ
46745	3259	5	another	another	DT
46745	3259	6	remedy	remedy	NN
46745	3259	7	which	which	WDT
46745	3259	8	seems	seem	VBZ
46745	3259	9	to	to	TO
46745	3259	10	be	be	VB
46745	3259	11	capable	capable	JJ
46745	3259	12	of	of	IN
46745	3259	13	counteracting	counteract	VBG
46745	3259	14	the	the	DT
46745	3259	15	scaly	scaly	NNP
46745	3259	16	disorders	disorder	NNS
46745	3259	17	.	.	.
46745	3260	1	It	-PRON-	PRP
46745	3260	2	may	may	MD
46745	3260	3	be	be	VB
46745	3260	4	either	either	CC
46745	3260	5	applied	apply	VBN
46745	3260	6	externally	externally	RB
46745	3260	7	,	,	,
46745	3260	8	or	or	CC
46745	3260	9	given	give	VBN
46745	3260	10	internally	internally	RB
46745	3260	11	in	in	IN
46745	3260	12	doses	dose	NNS
46745	3260	13	of	of	IN
46745	3260	14	10	10	CD
46745	3260	15	to	to	TO
46745	3260	16	20	20	CD
46745	3260	17	grains	grain	NNS
46745	3260	18	.	.	.
46745	3261	1	It	-PRON-	PRP
46745	3261	2	has	have	VBZ
46745	3261	3	been	be	VBN
46745	3261	4	recommended	recommend	VBN
46745	3261	5	for	for	IN
46745	3261	6	employment	employment	NN
46745	3261	7	in	in	IN
46745	3261	8	some	some	DT
46745	3261	9	of	of	IN
46745	3261	10	the	the	DT
46745	3261	11	other	other	JJ
46745	3261	12	skin	skin	NN
46745	3261	13	diseases	disease	NNS
46745	3261	14	,	,	,
46745	3261	15	but	but	CC
46745	3261	16	its	-PRON-	PRP$
46745	3261	17	advantage	advantage	NN
46745	3261	18	in	in	IN
46745	3261	19	them	-PRON-	PRP
46745	3261	20	is	be	VBZ
46745	3261	21	not	not	RB
46745	3261	22	so	so	RB
46745	3261	23	obvious	obvious	JJ
46745	3261	24	.	.	.
46745	3262	1	When	when	WRB
46745	3262	2	it	-PRON-	PRP
46745	3262	3	is	be	VBZ
46745	3262	4	applied	apply	VBN
46745	3262	5	to	to	IN
46745	3262	6	the	the	DT
46745	3262	7	skin	skin	NN
46745	3262	8	,	,	,
46745	3262	9	some	some	DT
46745	3262	10	one	one	CD
46745	3262	11	of	of	IN
46745	3262	12	its	-PRON-	PRP$
46745	3262	13	principles	principle	NNS
46745	3262	14	is	be	VBZ
46745	3262	15	probably	probably	RB
46745	3262	16	absorbed	absorb	VBN
46745	3262	17	.	.	.
46745	3263	1	Pitch	Pitch	NNP
46745	3263	2	,	,	,
46745	3263	3	as	as	IN
46745	3263	4	a	a	DT
46745	3263	5	remedy	remedy	NN
46745	3263	6	for	for	IN
46745	3263	7	Lepra	Lepra	NNP
46745	3263	8	,	,	,
46745	3263	9	is	be	VBZ
46745	3263	10	comparatively	comparatively	RB
46745	3263	11	of	of	IN
46745	3263	12	recent	recent	JJ
46745	3263	13	introduction	introduction	NN
46745	3263	14	,	,	,
46745	3263	15	but	but	CC
46745	3263	16	its	-PRON-	PRP$
46745	3263	17	efficacy	efficacy	NN
46745	3263	18	has	have	VBZ
46745	3263	19	already	already	RB
46745	3263	20	been	be	VBN
46745	3263	21	very	very	RB
46745	3263	22	widely	widely	RB
46745	3263	23	acknowledged	acknowledge	VBN
46745	3263	24	.	.	.
46745	3264	1	Tincture	tincture	NN
46745	3264	2	of	of	IN
46745	3264	3	Cantharides	Cantharides	NNPS
46745	3264	4	and	and	CC
46745	3264	5	Acetate	Acetate	NNP
46745	3264	6	of	of	IN
46745	3264	7	Potash	Potash	NNP
46745	3264	8	,	,	,
46745	3264	9	both	both	DT
46745	3264	10	diuretics	diuretic	NNS
46745	3264	11	,	,	,
46745	3264	12	have	have	VBP
46745	3264	13	been	be	VBN
46745	3264	14	employed	employ	VBN
46745	3264	15	in	in	IN
46745	3264	16	Lepra	Lepra	NNP
46745	3264	17	to	to	TO
46745	3264	18	eliminate	eliminate	VB
46745	3264	19	the	the	DT
46745	3264	20	_	_	NNP
46745	3264	21	materies	materie	NNS
46745	3264	22	morbi	morbi	VB
46745	3264	23	_	_	NNP
46745	3264	24	from	from	IN
46745	3264	25	the	the	DT
46745	3264	26	blood	blood	NN
46745	3264	27	into	into	IN
46745	3264	28	the	the	DT
46745	3264	29	urine	urine	NN
46745	3264	30	,	,	,
46745	3264	31	and	and	CC
46745	3264	32	have	have	VBP
46745	3264	33	sometimes	sometimes	RB
46745	3264	34	appeared	appear	VBN
46745	3264	35	to	to	TO
46745	3264	36	succeed	succeed	VB
46745	3264	37	in	in	IN
46745	3264	38	so	so	RB
46745	3264	39	doing	do	VBG
46745	3264	40	.	.	.
46745	3265	1	But	but	CC
46745	3265	2	in	in	IN
46745	3265	3	this	this	DT
46745	3265	4	,	,	,
46745	3265	5	as	as	IN
46745	3265	6	in	in	IN
46745	3265	7	many	many	JJ
46745	3265	8	other	other	JJ
46745	3265	9	cases	case	NNS
46745	3265	10	,	,	,
46745	3265	11	counteraction	counteraction	NN
46745	3265	12	is	be	VBZ
46745	3265	13	both	both	CC
46745	3265	14	easier	easy	JJR
46745	3265	15	and	and	CC
46745	3265	16	more	more	RBR
46745	3265	17	certain	certain	JJ
46745	3265	18	than	than	IN
46745	3265	19	elimination	elimination	NN
46745	3265	20	.	.	.
46745	3266	1	The	the	DT
46745	3266	2	system	system	NN
46745	3266	3	itself	-PRON-	PRP
46745	3266	4	naturally	naturally	RB
46745	3266	5	attempts	attempt	VBZ
46745	3266	6	this	this	DT
46745	3266	7	elimination	elimination	NN
46745	3266	8	,	,	,
46745	3266	9	and	and	CC
46745	3266	10	when	when	WRB
46745	3266	11	it	-PRON-	PRP
46745	3266	12	finds	find	VBZ
46745	3266	13	it	-PRON-	PRP
46745	3266	14	impossible	impossible	JJ
46745	3266	15	,	,	,
46745	3266	16	we	-PRON-	PRP
46745	3266	17	often	often	RB
46745	3266	18	gain	gain	VBP
46745	3266	19	nothing	nothing	NN
46745	3266	20	by	by	IN
46745	3266	21	urging	urge	VBG
46745	3266	22	it	-PRON-	PRP
46745	3266	23	.	.	.
46745	3267	1	I	-PRON-	PRP
46745	3267	2	need	need	VBP
46745	3267	3	scarcely	scarcely	RB
46745	3267	4	say	say	VB
46745	3267	5	that	that	IN
46745	3267	6	these	these	DT
46745	3267	7	remedies	remedy	NNS
46745	3267	8	are	be	VBP
46745	3267	9	applicable	applicable	JJ
46745	3267	10	only	only	RB
46745	3267	11	in	in	IN
46745	3267	12	simple	simple	JJ
46745	3267	13	Lepra	Lepra	NNP
46745	3267	14	and	and	CC
46745	3267	15	Psoriasis	Psoriasis	NNP
46745	3267	16	,	,	,
46745	3267	17	and	and	CC
46745	3267	18	not	not	RB
46745	3267	19	in	in	IN
46745	3267	20	the	the	DT
46745	3267	21	syphilitic	syphilitic	JJ
46745	3267	22	forms	form	NNS
46745	3267	23	of	of	IN
46745	3267	24	those	those	DT
46745	3267	25	eruptions	eruption	NNS
46745	3267	26	,	,	,
46745	3267	27	which	which	WDT
46745	3267	28	are	be	VBP
46745	3267	29	treated	treat	VBN
46745	3267	30	best	well	RBS
46745	3267	31	by	by	IN
46745	3267	32	Mercury	Mercury	NNP
46745	3267	33	,	,	,
46745	3267	34	or	or	CC
46745	3267	35	by	by	IN
46745	3267	36	other	other	JJ
46745	3267	37	medicines	medicine	NNS
46745	3267	38	of	of	IN
46745	3267	39	the	the	DT
46745	3267	40	second	second	JJ
46745	3267	41	order	order	NN
46745	3267	42	of	of	IN
46745	3267	43	Catalytics	Catalytics	NNP
46745	3267	44	.	.	.
46745	3268	1	These	these	DT
46745	3268	2	Syphilitic	syphilitic	JJ
46745	3268	3	eruptions	eruption	NNS
46745	3268	4	are	be	VBP
46745	3268	5	distinguished	distinguish	VBN
46745	3268	6	by	by	IN
46745	3268	7	a	a	DT
46745	3268	8	coppery	coppery	NN
46745	3268	9	or	or	CC
46745	3268	10	a	a	DT
46745	3268	11	livid	livid	JJ
46745	3268	12	-	-	HYPH
46745	3268	13	grayish	grayish	NN
46745	3268	14	colour	colour	NN
46745	3268	15	,	,	,
46745	3268	16	and	and	CC
46745	3268	17	by	by	IN
46745	3268	18	the	the	DT
46745	3268	19	absence	absence	NN
46745	3268	20	of	of	IN
46745	3268	21	itching	itching	NN
46745	3268	22	.	.	.
46745	3269	1	Sulphur	Sulphur	NNP
46745	3269	2	has	have	VBZ
46745	3269	3	been	be	VBN
46745	3269	4	used	use	VBN
46745	3269	5	with	with	IN
46745	3269	6	benefit	benefit	NN
46745	3269	7	in	in	IN
46745	3269	8	Eczema	Eczema	NNP
46745	3269	9	,	,	,
46745	3269	10	Impetigo	Impetigo	NNP
46745	3269	11	,	,	,
46745	3269	12	and	and	CC
46745	3269	13	Lepra	Lepra	NNP
46745	3269	14	.	.	.
46745	3270	1	It	-PRON-	PRP
46745	3270	2	may	may	MD
46745	3270	3	be	be	VB
46745	3270	4	administered	administer	VBN
46745	3270	5	externally	externally	RB
46745	3270	6	in	in	IN
46745	3270	7	the	the	DT
46745	3270	8	form	form	NN
46745	3270	9	of	of	IN
46745	3270	10	fumigation	fumigation	NN
46745	3270	11	or	or	CC
46745	3270	12	ointment	ointment	NN
46745	3270	13	,	,	,
46745	3270	14	or	or	CC
46745	3270	15	internally	internally	RB
46745	3270	16	in	in	IN
46745	3270	17	combination	combination	NN
46745	3270	18	with	with	IN
46745	3270	19	an	an	DT
46745	3270	20	alkali	alkali	JJ
46745	3270	21	or	or	CC
46745	3270	22	with	with	IN
46745	3270	23	Iodine	Iodine	NNP
46745	3270	24	.	.	.
46745	3271	1	In	in	IN
46745	3271	2	the	the	DT
46745	3271	3	case	case	NN
46745	3271	4	of	of	IN
46745	3271	5	Eczema	Eczema	NNP
46745	3271	6	and	and	CC
46745	3271	7	Impetigo	Impetigo	NNP
46745	3271	8	,	,	,
46745	3271	9	the	the	DT
46745	3271	10	fumigation	fumigation	NN
46745	3271	11	and	and	CC
46745	3271	12	internal	internal	JJ
46745	3271	13	administration	administration	NN
46745	3271	14	are	be	VBP
46745	3271	15	preferable	preferable	JJ
46745	3271	16	,	,	,
46745	3271	17	as	as	IN
46745	3271	18	the	the	DT
46745	3271	19	ointment	ointment	NN
46745	3271	20	is	be	VBZ
46745	3271	21	apt	apt	JJ
46745	3271	22	to	to	TO
46745	3271	23	increase	increase	VB
46745	3271	24	the	the	DT
46745	3271	25	existing	exist	VBG
46745	3271	26	irritation	irritation	NN
46745	3271	27	.	.	.
46745	3272	1	In	in	IN
46745	3272	2	the	the	DT
46745	3272	3	cure	cure	NN
46745	3272	4	of	of	IN
46745	3272	5	Lepra	Lepra	NNP
46745	3272	6	the	the	DT
46745	3272	7	mineral	mineral	NN
46745	3272	8	waters	water	NNS
46745	3272	9	of	of	IN
46745	3272	10	Harrowgate	Harrowgate	NNP
46745	3272	11	and	and	CC
46745	3272	12	other	other	JJ
46745	3272	13	places	place	NNS
46745	3272	14	,	,	,
46745	3272	15	containing	contain	VBG
46745	3272	16	Sulphuretted	sulphuret	VBN
46745	3272	17	Hydrogen	Hydrogen	NNP
46745	3272	18	gas	gas	NN
46745	3272	19	,	,	,
46745	3272	20	have	have	VBP
46745	3272	21	been	be	VBN
46745	3272	22	much	much	RB
46745	3272	23	recommended	recommend	VBN
46745	3272	24	.	.	.
46745	3273	1	Thus	thus	RB
46745	3273	2	we	-PRON-	PRP
46745	3273	3	have	have	VBP
46745	3273	4	in	in	IN
46745	3273	5	Sulphur	Sulphur	NNP
46745	3273	6	a	a	DT
46745	3273	7	third	third	JJ
46745	3273	8	Antisquamic	antisquamic	JJ
46745	3273	9	medicine	medicine	NN
46745	3273	10	.	.	.
46745	3274	1	It	-PRON-	PRP
46745	3274	2	is	be	VBZ
46745	3274	3	more	more	RBR
46745	3274	4	or	or	CC
46745	3274	5	less	less	RBR
46745	3274	6	useful	useful	JJ
46745	3274	7	in	in	IN
46745	3274	8	all	all	DT
46745	3274	9	non	non	JJ
46745	3274	10	-	-	JJ
46745	3274	11	syphilitic	syphilitic	JJ
46745	3274	12	cutaneous	cutaneous	JJ
46745	3274	13	disorders	disorder	NNS
46745	3274	14	.	.	.
46745	3275	1	Dr.	Dr.	NNP
46745	3275	2	Burgess	Burgess	NNP
46745	3275	3	has	have	VBZ
46745	3275	4	found	find	VBN
46745	3275	5	sulphur	sulphur	NN
46745	3275	6	ointment	ointment	NN
46745	3275	7	and	and	CC
46745	3275	8	fumigations	fumigation	NNS
46745	3275	9	to	to	TO
46745	3275	10	be	be	VB
46745	3275	11	very	very	RB
46745	3275	12	useful	useful	JJ
46745	3275	13	in	in	IN
46745	3275	14	Psoriasis	Psoriasis	NNP
46745	3275	15	palmaris	palmaris	NNP
46745	3275	16	.	.	.
46745	3276	1	(	(	-LRB-
46745	3276	2	_	_	NNP
46745	3276	3	On	on	IN
46745	3276	4	Eruptions	Eruptions	NNPS
46745	3276	5	of	of	IN
46745	3276	6	the	the	DT
46745	3276	7	Face	face	NN
46745	3276	8	,	,	,
46745	3276	9	etc	etc	FW
46745	3276	10	.	.	NN
46745	3276	11	,	,	,
46745	3276	12	p.	p.	NN
46745	3276	13	_	_	NNP
46745	3276	14	229	229	CD
46745	3276	15	.	.	.
46745	3276	16	)	)	-RRB-
46745	3277	1	Though	though	IN
46745	3277	2	Sulphur	Sulphur	NNP
46745	3277	3	seems	seem	VBZ
46745	3277	4	to	to	TO
46745	3277	5	act	act	VB
46745	3277	6	specifically	specifically	RB
46745	3277	7	in	in	IN
46745	3277	8	the	the	DT
46745	3277	9	treatment	treatment	NN
46745	3277	10	of	of	IN
46745	3277	11	these	these	DT
46745	3277	12	disorders	disorder	NNS
46745	3277	13	,	,	,
46745	3277	14	there	there	EX
46745	3277	15	is	be	VBZ
46745	3277	16	another	another	DT
46745	3277	17	disease	disease	NN
46745	3277	18	of	of	IN
46745	3277	19	a	a	DT
46745	3277	20	similar	similar	JJ
46745	3277	21	kind	kind	NN
46745	3277	22	which	which	WDT
46745	3277	23	it	-PRON-	PRP
46745	3277	24	has	have	VBZ
46745	3277	25	been	be	VBN
46745	3277	26	supposed	suppose	VBN
46745	3277	27	to	to	TO
46745	3277	28	cure	cure	VB
46745	3277	29	by	by	IN
46745	3277	30	a	a	DT
46745	3277	31	mere	mere	JJ
46745	3277	32	external	external	JJ
46745	3277	33	agency	agency	NN
46745	3277	34	.	.	.
46745	3278	1	This	this	DT
46745	3278	2	is	be	VBZ
46745	3278	3	Scabies	scabie	NNS
46745	3278	4	.	.	.
46745	3279	1	Some	some	DT
46745	3279	2	have	have	VBP
46745	3279	3	fancied	fancy	VBN
46745	3279	4	that	that	IN
46745	3279	5	even	even	RB
46745	3279	6	here	here	RB
46745	3279	7	it	-PRON-	PRP
46745	3279	8	acted	act	VBD
46745	3279	9	specifically	specifically	RB
46745	3279	10	,	,	,
46745	3279	11	and	and	CC
46745	3279	12	that	that	IN
46745	3279	13	this	this	DT
46745	3279	14	also	also	RB
46745	3279	15	was	be	VBD
46745	3279	16	a	a	DT
46745	3279	17	blood	blood	NN
46745	3279	18	-	-	HYPH
46745	3279	19	disease	disease	NN
46745	3279	20	.	.	.
46745	3280	1	But	but	CC
46745	3280	2	Scabies	Scabies	NNP
46745	3280	3	has	have	VBZ
46745	3280	4	long	long	RB
46745	3280	5	been	be	VBN
46745	3280	6	attributed	attribute	VBN
46745	3280	7	to	to	IN
46745	3280	8	an	an	DT
46745	3280	9	external	external	JJ
46745	3280	10	cause	cause	NN
46745	3280	11	,	,	,
46745	3280	12	an	an	DT
46745	3280	13	insect	insect	NN
46745	3280	14	,	,	,
46745	3280	15	or	or	CC
46745	3280	16	,	,	,
46745	3280	17	more	more	RBR
46745	3280	18	correctly	correctly	RB
46745	3280	19	,	,	,
46745	3280	20	an	an	DT
46745	3280	21	arachnid	arachnid	NN
46745	3280	22	,	,	,
46745	3280	23	which	which	WDT
46745	3280	24	,	,	,
46745	3280	25	by	by	IN
46745	3280	26	burrowing	burrow	VBG
46745	3280	27	in	in	IN
46745	3280	28	the	the	DT
46745	3280	29	skin	skin	NN
46745	3280	30	,	,	,
46745	3280	31	is	be	VBZ
46745	3280	32	thought	think	VBN
46745	3280	33	to	to	TO
46745	3280	34	produce	produce	VB
46745	3280	35	the	the	DT
46745	3280	36	vesicular	vesicular	JJ
46745	3280	37	eruption	eruption	NN
46745	3280	38	.	.	.
46745	3281	1	The	the	DT
46745	3281	2	Acarus	Acarus	NNP
46745	3281	3	Scabiei	Scabiei	NNP
46745	3281	4	,	,	,
46745	3281	5	or	or	CC
46745	3281	6	Itch	Itch	NNP
46745	3281	7	insect	insect	NN
46745	3281	8	,	,	,
46745	3281	9	was	be	VBD
46745	3281	10	discovered	discover	VBN
46745	3281	11	in	in	IN
46745	3281	12	1179	1179	CD
46745	3281	13	by	by	IN
46745	3281	14	Abenzoar	Abenzoar	NNP
46745	3281	15	,	,	,
46745	3281	16	the	the	DT
46745	3281	17	Arabian	Arabian	NNP
46745	3281	18	.	.	.
46745	3282	1	In	in	IN
46745	3282	2	1687	1687	CD
46745	3282	3	Dr.	Dr.	NNP
46745	3282	4	Giovanni	Giovanni	NNP
46745	3282	5	Bonomo	Bonomo	NNP
46745	3282	6	wrote	write	VBD
46745	3282	7	a	a	DT
46745	3282	8	full	full	JJ
46745	3282	9	account	account	NN
46745	3282	10	of	of	IN
46745	3282	11	it	-PRON-	PRP
46745	3282	12	in	in	IN
46745	3282	13	a	a	DT
46745	3282	14	letter	letter	NN
46745	3282	15	to	to	IN
46745	3282	16	Redi	Redi	NNP
46745	3282	17	of	of	IN
46745	3282	18	Florence	Florence	NNP
46745	3282	19	.	.	.
46745	3283	1	It	-PRON-	PRP
46745	3283	2	is	be	VBZ
46745	3283	3	supposed	suppose	VBN
46745	3283	4	that	that	IN
46745	3283	5	Sulphur	Sulphur	NNP
46745	3283	6	ointments	ointment	NNS
46745	3283	7	and	and	CC
46745	3283	8	Sulphur	Sulphur	NNP
46745	3283	9	fumigations	fumigation	NNS
46745	3283	10	have	have	VBP
46745	3283	11	a	a	DT
46745	3283	12	direct	direct	JJ
46745	3283	13	external	external	JJ
46745	3283	14	action	action	NN
46745	3283	15	in	in	IN
46745	3283	16	causing	cause	VBG
46745	3283	17	the	the	DT
46745	3283	18	death	death	NN
46745	3283	19	of	of	IN
46745	3283	20	this	this	DT
46745	3283	21	Acarus	Acarus	NNP
46745	3283	22	,	,	,
46745	3283	23	by	by	IN
46745	3283	24	the	the	DT
46745	3283	25	bodily	bodily	JJ
46745	3283	26	transmission	transmission	NN
46745	3283	27	of	of	IN
46745	3283	28	which	which	WDT
46745	3283	29	from	from	IN
46745	3283	30	one	one	CD
46745	3283	31	person	person	NN
46745	3283	32	to	to	IN
46745	3283	33	another	another	DT
46745	3283	34	the	the	DT
46745	3283	35	contagious	contagious	JJ
46745	3283	36	nature	nature	NN
46745	3283	37	of	of	IN
46745	3283	38	the	the	DT
46745	3283	39	disease	disease	NN
46745	3283	40	is	be	VBZ
46745	3283	41	accounted	account	VBN
46745	3283	42	for	for	IN
46745	3283	43	.	.	.
46745	3284	1	Dr.	Dr.	NNP
46745	3285	1	Billing	billing	NN
46745	3285	2	considers	consider	VBZ
46745	3285	3	that	that	IN
46745	3285	4	the	the	DT
46745	3285	5	confirmation	confirmation	NN
46745	3285	6	of	of	IN
46745	3285	7	this	this	DT
46745	3285	8	discovery	discovery	NN
46745	3285	9	has	have	VBZ
46745	3285	10	given	give	VBN
46745	3285	11	the	the	DT
46745	3285	12	death	death	NN
46745	3285	13	-	-	HYPH
46745	3285	14	blow	blow	NN
46745	3285	15	to	to	IN
46745	3285	16	an	an	DT
46745	3285	17	idea	idea	NN
46745	3285	18	which	which	WDT
46745	3285	19	will	will	MD
46745	3285	20	probably	probably	RB
46745	3285	21	last	last	VB
46745	3285	22	as	as	RB
46745	3285	23	long	long	RB
46745	3285	24	as	as	IN
46745	3285	25	medicine	medicine	NN
46745	3285	26	;	;	:
46745	3285	27	viz	viz	NNP
46745	3285	28	.	.	NNP
46745	3285	29	,	,	,
46745	3285	30	that	that	IN
46745	3285	31	certain	certain	JJ
46745	3285	32	remedies	remedy	NNS
46745	3285	33	exert	exert	VBP
46745	3285	34	a	a	DT
46745	3285	35	special	special	JJ
46745	3285	36	influence	influence	NN
46745	3285	37	in	in	IN
46745	3285	38	the	the	DT
46745	3285	39	cure	cure	NN
46745	3285	40	of	of	IN
46745	3285	41	particular	particular	JJ
46745	3285	42	diseases	disease	NNS
46745	3285	43	.	.	.
46745	3286	1	(	(	-LRB-
46745	3286	2	_	_	NNP
46745	3286	3	Principles	Principles	NNPS
46745	3286	4	of	of	IN
46745	3286	5	Medicine	Medicine	NNP
46745	3286	6	_	_	NNP
46745	3286	7	,	,	,
46745	3286	8	p.	p.	NN
46745	3287	1	75	75	CD
46745	3287	2	.	.	.
46745	3287	3	)	)	-RRB-
46745	3288	1	But	but	CC
46745	3288	2	we	-PRON-	PRP
46745	3288	3	must	must	MD
46745	3288	4	not	not	RB
46745	3288	5	deny	deny	VB
46745	3288	6	the	the	DT
46745	3288	7	existence	existence	NN
46745	3288	8	of	of	IN
46745	3288	9	special	special	JJ
46745	3288	10	agents	agent	NNS
46745	3288	11	,	,	,
46745	3288	12	simply	simply	RB
46745	3288	13	because	because	IN
46745	3288	14	we	-PRON-	PRP
46745	3288	15	can	can	MD
46745	3288	16	not	not	RB
46745	3288	17	understand	understand	VB
46745	3288	18	their	-PRON-	PRP$
46745	3288	19	operation	operation	NN
46745	3288	20	;	;	:
46745	3288	21	for	for	IN
46745	3288	22	it	-PRON-	PRP
46745	3288	23	is	be	VBZ
46745	3288	24	apparent	apparent	JJ
46745	3288	25	in	in	IN
46745	3288	26	too	too	RB
46745	3288	27	many	many	JJ
46745	3288	28	instances	instance	NNS
46745	3288	29	.	.	.
46745	3289	1	And	and	CC
46745	3289	2	from	from	IN
46745	3289	3	the	the	DT
46745	3289	4	circumstance	circumstance	NN
46745	3289	5	that	that	WDT
46745	3289	6	Sulphur	Sulphur	NNP
46745	3289	7	has	have	VBZ
46745	3289	8	proved	prove	VBN
46745	3289	9	beneficial	beneficial	JJ
46745	3289	10	when	when	WRB
46745	3289	11	given	give	VBN
46745	3289	12	internally	internally	RB
46745	3289	13	in	in	IN
46745	3289	14	Scabies	Scabies	NNP
46745	3289	15	,	,	,
46745	3289	16	as	as	RB
46745	3289	17	well	well	RB
46745	3289	18	as	as	IN
46745	3289	19	the	the	DT
46745	3289	20	fact	fact	NN
46745	3289	21	that	that	IN
46745	3289	22	this	this	DT
46745	3289	23	disease	disease	NN
46745	3289	24	has	have	VBZ
46745	3289	25	often	often	RB
46745	3289	26	an	an	DT
46745	3289	27	idiopathic	idiopathic	JJ
46745	3289	28	origin	origin	NN
46745	3289	29	,	,	,
46745	3289	30	I	-PRON-	PRP
46745	3289	31	am	be	VBP
46745	3289	32	still	still	RB
46745	3289	33	disposed	disposed	JJ
46745	3289	34	to	to	TO
46745	3289	35	doubt	doubt	VB
46745	3289	36	the	the	DT
46745	3289	37	value	value	NN
46745	3289	38	of	of	IN
46745	3289	39	the	the	DT
46745	3289	40	inference	inference	NN
46745	3289	41	which	which	WDT
46745	3289	42	is	be	VBZ
46745	3289	43	drawn	draw	VBN
46745	3289	44	from	from	IN
46745	3289	45	the	the	DT
46745	3289	46	discovery	discovery	NN
46745	3289	47	of	of	IN
46745	3289	48	the	the	DT
46745	3289	49	Acarus	Acarus	NNP
46745	3289	50	,	,	,
46745	3289	51	and	and	CC
46745	3289	52	inclined	incline	VBN
46745	3289	53	to	to	TO
46745	3289	54	believe	believe	VB
46745	3289	55	that	that	IN
46745	3289	56	Sulphur	Sulphur	NNP
46745	3289	57	may	may	MD
46745	3289	58	exert	exert	VB
46745	3289	59	an	an	DT
46745	3289	60	action	action	NN
46745	3289	61	of	of	IN
46745	3289	62	a	a	DT
46745	3289	63	specific	specific	JJ
46745	3289	64	kind	kind	NN
46745	3289	65	in	in	IN
46745	3289	66	this	this	DT
46745	3289	67	disease	disease	NN
46745	3289	68	as	as	RB
46745	3289	69	well	well	RB
46745	3289	70	as	as	IN
46745	3289	71	in	in	IN
46745	3289	72	the	the	DT
46745	3289	73	others	other	NNS
46745	3289	74	.	.	.
46745	3290	1	Some	some	DT
46745	3290	2	other	other	JJ
46745	3290	3	internal	internal	JJ
46745	3290	4	remedies	remedy	NNS
46745	3290	5	,	,	,
46745	3290	6	and	and	CC
46745	3290	7	many	many	JJ
46745	3290	8	other	other	JJ
46745	3290	9	external	external	JJ
46745	3290	10	applications	application	NNS
46745	3290	11	,	,	,
46745	3290	12	have	have	VBP
46745	3290	13	been	be	VBN
46745	3290	14	used	use	VBN
46745	3290	15	in	in	IN
46745	3290	16	Skin	skin	NN
46745	3290	17	diseases	disease	NNS
46745	3290	18	;	;	:
46745	3290	19	but	but	CC
46745	3290	20	these	these	DT
46745	3290	21	that	that	WDT
46745	3290	22	I	-PRON-	PRP
46745	3290	23	have	have	VBP
46745	3290	24	mentioned	mention	VBN
46745	3290	25	are	be	VBP
46745	3290	26	the	the	DT
46745	3290	27	only	only	JJ
46745	3290	28	ones	one	NNS
46745	3290	29	that	that	WDT
46745	3290	30	appear	appear	VBP
46745	3290	31	to	to	TO
46745	3290	32	exert	exert	VB
46745	3290	33	something	something	NN
46745	3290	34	of	of	IN
46745	3290	35	a	a	DT
46745	3290	36	special	special	JJ
46745	3290	37	action	action	NN
46745	3290	38	in	in	IN
46745	3290	39	all	all	DT
46745	3290	40	cases	case	NNS
46745	3290	41	.	.	.
46745	3291	1	Arsenic	Arsenic	NNP
46745	3291	2	is	be	VBZ
46745	3291	3	perhaps	perhaps	RB
46745	3291	4	the	the	DT
46745	3291	5	most	most	RBS
46745	3291	6	universal	universal	JJ
46745	3291	7	in	in	IN
46745	3291	8	its	-PRON-	PRP$
46745	3291	9	application	application	NN
46745	3291	10	.	.	.
46745	3292	1	It	-PRON-	PRP
46745	3292	2	often	often	RB
46745	3292	3	happens	happen	VBZ
46745	3292	4	that	that	IN
46745	3292	5	when	when	WRB
46745	3292	6	this	this	DT
46745	3292	7	remedy	remedy	NN
46745	3292	8	entirely	entirely	RB
46745	3292	9	fails	fail	VBZ
46745	3292	10	,	,	,
46745	3292	11	the	the	DT
46745	3292	12	eruption	eruption	NN
46745	3292	13	is	be	VBZ
46745	3292	14	connected	connect	VBN
46745	3292	15	with	with	IN
46745	3292	16	a	a	DT
46745	3292	17	constitutional	constitutional	JJ
46745	3292	18	taint	taint	NN
46745	3292	19	of	of	IN
46745	3292	20	Syphilis	Syphilis	NNP
46745	3292	21	.	.	.
46745	3293	1	When	when	WRB
46745	3293	2	there	there	EX
46745	3293	3	is	be	VBZ
46745	3293	4	a	a	DT
46745	3293	5	suspicion	suspicion	NN
46745	3293	6	of	of	IN
46745	3293	7	this	this	DT
46745	3293	8	,	,	,
46745	3293	9	such	such	PDT
46745	3293	10	a	a	DT
46745	3293	11	remedy	remedy	NN
46745	3293	12	as	as	IN
46745	3293	13	Donovan	Donovan	NNP
46745	3293	14	's	's	POS
46745	3293	15	solution	solution	NN
46745	3293	16	,	,	,
46745	3293	17	containing	contain	VBG
46745	3293	18	both	both	CC
46745	3293	19	Arsenic	Arsenic	NNP
46745	3293	20	and	and	CC
46745	3293	21	Mercury	Mercury	NNP
46745	3293	22	,	,	,
46745	3293	23	is	be	VBZ
46745	3293	24	peculiarly	peculiarly	RB
46745	3293	25	applicable	applicable	JJ
46745	3293	26	,	,	,
46745	3293	27	because	because	IN
46745	3293	28	capable	capable	JJ
46745	3293	29	of	of	IN
46745	3293	30	acting	act	VBG
46745	3293	31	in	in	IN
46745	3293	32	a	a	DT
46745	3293	33	double	double	JJ
46745	3293	34	way	way	NN
46745	3293	35	.	.	.
46745	3294	1	This	this	DT
46745	3294	2	medicine	medicine	NN
46745	3294	3	also	also	RB
46745	3294	4	contains	contain	VBZ
46745	3294	5	Iodine	Iodine	NNP
46745	3294	6	;	;	:
46745	3294	7	and	and	CC
46745	3294	8	either	either	CC
46745	3294	9	this	this	DT
46745	3294	10	preparation	preparation	NN
46745	3294	11	,	,	,
46745	3294	12	or	or	CC
46745	3294	13	the	the	DT
46745	3294	14	Iodide	Iodide	NNP
46745	3294	15	of	of	IN
46745	3294	16	Potassium	Potassium	NNP
46745	3294	17	,	,	,
46745	3294	18	should	should	MD
46745	3294	19	be	be	VB
46745	3294	20	prescribed	prescribe	VBN
46745	3294	21	when	when	WRB
46745	3294	22	the	the	DT
46745	3294	23	skin	skin	NN
46745	3294	24	disease	disease	NN
46745	3294	25	appears	appear	VBZ
46745	3294	26	to	to	TO
46745	3294	27	be	be	VB
46745	3294	28	connected	connect	VBN
46745	3294	29	with	with	IN
46745	3294	30	a	a	DT
46745	3294	31	strumous	strumous	JJ
46745	3294	32	diathesis	diathesis	NN
46745	3294	33	.	.	.
46745	3295	1	As	as	RB
46745	3295	2	soon	soon	RB
46745	3295	3	as	as	IN
46745	3295	4	the	the	DT
46745	3295	5	course	course	NN
46745	3295	6	of	of	IN
46745	3295	7	Arsenic	Arsenic	NNP
46745	3295	8	is	be	VBZ
46745	3295	9	found	find	VBN
46745	3295	10	to	to	TO
46745	3295	11	produce	produce	VB
46745	3295	12	swelling	swell	VBG
46745	3295	13	of	of	IN
46745	3295	14	the	the	DT
46745	3295	15	face	face	NN
46745	3295	16	,	,	,
46745	3295	17	or	or	CC
46745	3295	18	irritation	irritation	NN
46745	3295	19	of	of	IN
46745	3295	20	the	the	DT
46745	3295	21	conjunctivæ	conjunctivæ	NN
46745	3295	22	,	,	,
46745	3295	23	symptoms	symptom	NNS
46745	3295	24	which	which	WDT
46745	3295	25	denote	denote	VBP
46745	3295	26	the	the	DT
46745	3295	27	saturation	saturation	NN
46745	3295	28	of	of	IN
46745	3295	29	the	the	DT
46745	3295	30	system	system	NN
46745	3295	31	with	with	IN
46745	3295	32	the	the	DT
46745	3295	33	remedy	remedy	NN
46745	3295	34	,	,	,
46745	3295	35	its	-PRON-	PRP$
46745	3295	36	administration	administration	NN
46745	3295	37	should	should	MD
46745	3295	38	be	be	VB
46745	3295	39	suspended	suspend	VBN
46745	3295	40	for	for	IN
46745	3295	41	a	a	DT
46745	3295	42	while	while	NN
46745	3295	43	.	.	.
46745	3296	1	We	-PRON-	PRP
46745	3296	2	have	have	VBP
46745	3296	3	now	now	RB
46745	3296	4	concluded	conclude	VBN
46745	3296	5	the	the	DT
46745	3296	6	subject	subject	NN
46745	3296	7	of	of	IN
46745	3296	8	Hæmatic	hæmatic	JJ
46745	3296	9	medicines	medicine	NNS
46745	3296	10	.	.	.
46745	3297	1	I	-PRON-	PRP
46745	3297	2	have	have	VBP
46745	3297	3	said	say	VBN
46745	3297	4	that	that	IN
46745	3297	5	this	this	DT
46745	3297	6	class	class	NN
46745	3297	7	has	have	VBZ
46745	3297	8	been	be	VBN
46745	3297	9	very	very	RB
46745	3297	10	generally	generally	RB
46745	3297	11	neglected	neglect	VBN
46745	3297	12	and	and	CC
46745	3297	13	overlooked	overlook	VBN
46745	3297	14	by	by	IN
46745	3297	15	writers	writer	NNS
46745	3297	16	on	on	IN
46745	3297	17	the	the	DT
46745	3297	18	subject	subject	NN
46745	3297	19	.	.	.
46745	3298	1	For	for	IN
46745	3298	2	this	this	DT
46745	3298	3	reason	reason	NN
46745	3298	4	,	,	,
46745	3298	5	and	and	CC
46745	3298	6	because	because	IN
46745	3298	7	there	there	EX
46745	3298	8	are	be	VBP
46745	3298	9	some	some	DT
46745	3298	10	ideas	idea	NNS
46745	3298	11	respecting	respect	VBG
46745	3298	12	their	-PRON-	PRP$
46745	3298	13	action	action	NN
46745	3298	14	which	which	WDT
46745	3298	15	I	-PRON-	PRP
46745	3298	16	have	have	VBP
46745	3298	17	thought	think	VBN
46745	3298	18	it	-PRON-	PRP
46745	3298	19	worth	worth	JJ
46745	3298	20	while	while	IN
46745	3298	21	to	to	TO
46745	3298	22	work	work	VB
46745	3298	23	out	out	RP
46745	3298	24	and	and	CC
46745	3298	25	to	to	TO
46745	3298	26	investigate	investigate	VB
46745	3298	27	at	at	IN
46745	3298	28	some	some	DT
46745	3298	29	length	length	NN
46745	3298	30	,	,	,
46745	3298	31	I	-PRON-	PRP
46745	3298	32	have	have	VBP
46745	3298	33	devoted	devote	VBN
46745	3298	34	more	more	JJR
46745	3298	35	space	space	NN
46745	3298	36	to	to	IN
46745	3298	37	its	-PRON-	PRP$
46745	3298	38	elaboration	elaboration	NN
46745	3298	39	than	than	IN
46745	3298	40	I	-PRON-	PRP
46745	3298	41	shall	shall	MD
46745	3298	42	be	be	VB
46745	3298	43	able	able	JJ
46745	3298	44	to	to	TO
46745	3298	45	spare	spare	VB
46745	3298	46	for	for	IN
46745	3298	47	either	either	DT
46745	3298	48	of	of	IN
46745	3298	49	the	the	DT
46745	3298	50	remaining	remain	VBG
46745	3298	51	classes	class	NNS
46745	3298	52	,	,	,
46745	3298	53	in	in	IN
46745	3298	54	the	the	DT
46745	3298	55	consideration	consideration	NN
46745	3298	56	of	of	IN
46745	3298	57	which	which	WDT
46745	3298	58	we	-PRON-	PRP
46745	3298	59	are	be	VBP
46745	3298	60	not	not	RB
46745	3298	61	likely	likely	JJ
46745	3298	62	to	to	TO
46745	3298	63	encounter	encounter	VB
46745	3298	64	so	so	RB
46745	3298	65	many	many	JJ
46745	3298	66	interesting	interesting	JJ
46745	3298	67	and	and	CC
46745	3298	68	debateable	debateable	JJ
46745	3298	69	points	point	NNS
46745	3298	70	.	.	.
46745	3299	1	PROP	PROP	NNP
46745	3299	2	.	.	.
46745	3300	1	VIII.--_That	VIII.--_That	NNP
46745	3300	2	a	a	DT
46745	3300	3	second	second	JJ
46745	3300	4	class	class	NN
46745	3300	5	of	of	IN
46745	3300	6	medicines	medicine	NNS
46745	3300	7	,	,	,
46745	3300	8	called	call	VBD
46745	3300	9	_	_	NNP
46745	3300	10	NEUROTICS	NEUROTICS	NNP
46745	3300	11	,	,	,
46745	3300	12	_	_	NNP
46745	3300	13	act	act	NN
46745	3300	14	by	by	IN
46745	3300	15	passing	pass	VBG
46745	3300	16	from	from	IN
46745	3300	17	the	the	DT
46745	3300	18	blood	blood	NN
46745	3300	19	to	to	IN
46745	3300	20	the	the	DT
46745	3300	21	nerves	nerve	NNS
46745	3300	22	or	or	CC
46745	3300	23	nerve	nerve	NN
46745	3300	24	-	-	HYPH
46745	3300	25	centres	centre	NNS
46745	3300	26	,	,	,
46745	3300	27	which	which	WDT
46745	3300	28	they	-PRON-	PRP
46745	3300	29	influence	influence	VBP
46745	3300	30	.	.	.
46745	3300	31	_	_	NNP
46745	3300	32	1	1	CD
46745	3300	33	.	.	.
46745	3301	1	_	_	NNP
46745	3301	2	That	that	DT
46745	3301	3	of	of	IN
46745	3301	4	these	these	DT
46745	3301	5	,	,	,
46745	3301	6	some	some	DT
46745	3301	7	,	,	,
46745	3301	8	called	call	VBN
46745	3301	9	_	_	NNP
46745	3301	10	STIMULANTS	STIMULANTS	NNP
46745	3301	11	,	,	,
46745	3301	12	_	_	NNP
46745	3301	13	act	act	NN
46745	3301	14	so	so	IN
46745	3301	15	as	as	IN
46745	3301	16	to	to	TO
46745	3301	17	exalt	exalt	VB
46745	3301	18	nervous	nervous	JJ
46745	3301	19	force	force	NN
46745	3301	20	in	in	IN
46745	3301	21	general	general	JJ
46745	3301	22	or	or	CC
46745	3301	23	in	in	IN
46745	3301	24	particular	particular	JJ
46745	3301	25	.	.	.
46745	3301	26	_	_	NNP
46745	3301	27	2	2	CD
46745	3301	28	.	.	.
46745	3302	1	_	_	NNP
46745	3302	2	That	that	IN
46745	3302	3	others	other	NNS
46745	3302	4	,	,	,
46745	3302	5	called	call	VBD
46745	3302	6	_	_	NNP
46745	3302	7	NARCOTICS	NARCOTICS	NNP
46745	3302	8	,	,	,
46745	3302	9	_	_	NNP
46745	3302	10	act	act	NN
46745	3302	11	so	so	RB
46745	3302	12	as	as	RB
46745	3302	13	first	first	JJ
46745	3302	14	to	to	TO
46745	3302	15	exalt	exalt	VB
46745	3302	16	nervous	nervous	JJ
46745	3302	17	force	force	NN
46745	3302	18	,	,	,
46745	3302	19	and	and	CC
46745	3302	20	then	then	RB
46745	3302	21	to	to	TO
46745	3302	22	depress	depress	VB
46745	3302	23	it	-PRON-	PRP
46745	3302	24	;	;	:
46745	3302	25	and	and	CC
46745	3302	26	have	have	VBP
46745	3302	27	also	also	RB
46745	3302	28	a	a	DT
46745	3302	29	special	special	JJ
46745	3302	30	influence	influence	NN
46745	3302	31	on	on	IN
46745	3302	32	the	the	DT
46745	3302	33	intellectual	intellectual	JJ
46745	3302	34	part	part	NN
46745	3302	35	of	of	IN
46745	3302	36	the	the	DT
46745	3302	37	brain	brain	NN
46745	3302	38	.	.	.
46745	3302	39	_	_	NNP
46745	3302	40	3	3	CD
46745	3302	41	.	.	.
46745	3303	1	_	_	NNP
46745	3303	2	That	that	IN
46745	3303	3	others	other	NNS
46745	3303	4	again	again	RB
46745	3303	5	,	,	,
46745	3303	6	called	call	VBN
46745	3303	7	_	_	NNP
46745	3303	8	SEDATIVES	SEDATIVES	NNP
46745	3303	9	,	,	,
46745	3303	10	_	_	NNP
46745	3303	11	act	act	NN
46745	3303	12	so	so	IN
46745	3303	13	as	as	IN
46745	3303	14	to	to	TO
46745	3303	15	depress	depress	VB
46745	3303	16	nervous	nervous	JJ
46745	3303	17	force	force	NN
46745	3303	18	,	,	,
46745	3303	19	in	in	IN
46745	3303	20	general	general	JJ
46745	3303	21	or	or	CC
46745	3303	22	in	in	IN
46745	3303	23	particular	particular	JJ
46745	3303	24	.	.	.
46745	3303	25	_	_	NNP
46745	3303	26	Having	have	VBG
46745	3303	27	investigated	investigate	VBN
46745	3303	28	at	at	IN
46745	3303	29	some	some	DT
46745	3303	30	length	length	NN
46745	3303	31	the	the	DT
46745	3303	32	action	action	NN
46745	3303	33	of	of	IN
46745	3303	34	Blood	blood	NN
46745	3303	35	-	-	HYPH
46745	3303	36	medicines	medicine	NNS
46745	3303	37	,	,	,
46745	3303	38	we	-PRON-	PRP
46745	3303	39	now	now	RB
46745	3303	40	commence	commence	VBP
46745	3303	41	the	the	DT
46745	3303	42	consideration	consideration	NN
46745	3303	43	of	of	IN
46745	3303	44	another	another	DT
46745	3303	45	class	class	NN
46745	3303	46	of	of	IN
46745	3303	47	remedies	remedy	NNS
46745	3303	48	,	,	,
46745	3303	49	which	which	WDT
46745	3303	50	differ	differ	VBP
46745	3303	51	very	very	RB
46745	3303	52	widely	widely	RB
46745	3303	53	from	from	IN
46745	3303	54	the	the	DT
46745	3303	55	last	last	JJ
46745	3303	56	in	in	IN
46745	3303	57	their	-PRON-	PRP$
46745	3303	58	mode	mode	NN
46745	3303	59	of	of	IN
46745	3303	60	operation	operation	NN
46745	3303	61	.	.	.
46745	3304	1	The	the	DT
46745	3304	2	action	action	NN
46745	3304	3	of	of	IN
46745	3304	4	Hæmatics	Hæmatics	NNPS
46745	3304	5	is	be	VBZ
46745	3304	6	slow	slow	JJ
46745	3304	7	,	,	,
46745	3304	8	but	but	CC
46745	3304	9	more	more	RBR
46745	3304	10	or	or	CC
46745	3304	11	less	less	RBR
46745	3304	12	durable	durable	JJ
46745	3304	13	,	,	,
46745	3304	14	because	because	IN
46745	3304	15	it	-PRON-	PRP
46745	3304	16	is	be	VBZ
46745	3304	17	evidenced	evidence	VBN
46745	3304	18	in	in	IN
46745	3304	19	the	the	DT
46745	3304	20	blood	blood	NN
46745	3304	21	;	;	:
46745	3304	22	and	and	CC
46745	3304	23	a	a	DT
46745	3304	24	change	change	NN
46745	3304	25	in	in	IN
46745	3304	26	the	the	DT
46745	3304	27	blood	blood	NN
46745	3304	28	produced	produce	VBN
46745	3304	29	by	by	IN
46745	3304	30	this	this	DT
46745	3304	31	action	action	NN
46745	3304	32	continues	continue	VBZ
46745	3304	33	for	for	IN
46745	3304	34	a	a	DT
46745	3304	35	longer	long	JJR
46745	3304	36	or	or	CC
46745	3304	37	a	a	DT
46745	3304	38	shorter	short	JJR
46745	3304	39	time	time	NN
46745	3304	40	.	.	.
46745	3305	1	The	the	DT
46745	3305	2	action	action	NN
46745	3305	3	of	of	IN
46745	3305	4	Neurotics	Neurotics	NNP
46745	3305	5	,	,	,
46745	3305	6	or	or	CC
46745	3305	7	Nerve	Nerve	NNP
46745	3305	8	-	-	HYPH
46745	3305	9	medicines	medicines	NNP
46745	3305	10	,	,	,
46745	3305	11	is	be	VBZ
46745	3305	12	rapid	rapid	JJ
46745	3305	13	;	;	:
46745	3305	14	but	but	CC
46745	3305	15	it	-PRON-	PRP
46745	3305	16	is	be	VBZ
46745	3305	17	transient	transient	JJ
46745	3305	18	,	,	,
46745	3305	19	and	and	CC
46745	3305	20	is	be	VBZ
46745	3305	21	soon	soon	RB
46745	3305	22	over	over	RB
46745	3305	23	.	.	.
46745	3306	1	A	a	DT
46745	3306	2	Neurotic	neurotic	JJ
46745	3306	3	medicine	medicine	NN
46745	3306	4	does	do	VBZ
46745	3306	5	not	not	RB
46745	3306	6	cause	cause	VB
46745	3306	7	any	any	DT
46745	3306	8	change	change	NN
46745	3306	9	in	in	IN
46745	3306	10	the	the	DT
46745	3306	11	blood	blood	NN
46745	3306	12	;	;	:
46745	3306	13	and	and	CC
46745	3306	14	it	-PRON-	PRP
46745	3306	15	can	can	MD
46745	3306	16	not	not	RB
46745	3306	17	remain	remain	VB
46745	3306	18	in	in	IN
46745	3306	19	it	-PRON-	PRP
46745	3306	20	,	,	,
46745	3306	21	but	but	CC
46745	3306	22	soon	soon	RB
46745	3306	23	passes	pass	VBZ
46745	3306	24	out	out	RP
46745	3306	25	.	.	.
46745	3307	1	It	-PRON-	PRP
46745	3307	2	acts	act	VBZ
46745	3307	3	by	by	IN
46745	3307	4	contact	contact	NN
46745	3307	5	with	with	IN
46745	3307	6	nerve	nerve	NN
46745	3307	7	,	,	,
46745	3307	8	apparently	apparently	RB
46745	3307	9	producing	produce	VBG
46745	3307	10	no	no	DT
46745	3307	11	lasting	lasting	JJ
46745	3307	12	change	change	NN
46745	3307	13	even	even	RB
46745	3307	14	in	in	IN
46745	3307	15	nerve	nerve	NN
46745	3307	16	-	-	HYPH
46745	3307	17	fibre	fibre	NN
46745	3307	18	;	;	,
46745	3307	19	and	and	CC
46745	3307	20	as	as	IN
46745	3307	21	the	the	DT
46745	3307	22	cause	cause	NN
46745	3307	23	of	of	IN
46745	3307	24	the	the	DT
46745	3307	25	action	action	NN
46745	3307	26	can	can	MD
46745	3307	27	not	not	RB
46745	3307	28	remain	remain	VB
46745	3307	29	,	,	,
46745	3307	30	the	the	DT
46745	3307	31	effect	effect	NN
46745	3307	32	also	also	RB
46745	3307	33	soon	soon	RB
46745	3307	34	passes	pass	VBZ
46745	3307	35	away	away	RB
46745	3307	36	.	.	.
46745	3308	1	Whereas	whereas	IN
46745	3308	2	Hæmatics	Hæmatics	NNPS
46745	3308	3	,	,	,
46745	3308	4	durable	durable	JJ
46745	3308	5	agents	agent	NNS
46745	3308	6	in	in	IN
46745	3308	7	the	the	DT
46745	3308	8	blood	blood	NN
46745	3308	9	,	,	,
46745	3308	10	are	be	VBP
46745	3308	11	used	use	VBN
46745	3308	12	to	to	TO
46745	3308	13	counteract	counteract	VB
46745	3308	14	the	the	DT
46745	3308	15	causes	cause	NNS
46745	3308	16	of	of	IN
46745	3308	17	inveterate	inveterate	NN
46745	3308	18	and	and	CC
46745	3308	19	chronic	chronic	JJ
46745	3308	20	disorders	disorder	NNS
46745	3308	21	;	;	:
46745	3308	22	these	these	DT
46745	3308	23	Neurotics	neurotic	NNS
46745	3308	24	,	,	,
46745	3308	25	which	which	WDT
46745	3308	26	produce	produce	VBP
46745	3308	27	a	a	DT
46745	3308	28	transitory	transitory	NN
46745	3308	29	,	,	,
46745	3308	30	but	but	CC
46745	3308	31	more	more	RBR
46745	3308	32	or	or	CC
46745	3308	33	less	less	RBR
46745	3308	34	forcible	forcible	JJ
46745	3308	35	impression	impression	NN
46745	3308	36	on	on	IN
46745	3308	37	the	the	DT
46745	3308	38	nervous	nervous	JJ
46745	3308	39	system	system	NN
46745	3308	40	,	,	,
46745	3308	41	are	be	VBP
46745	3308	42	employed	employ	VBN
46745	3308	43	to	to	TO
46745	3308	44	rouse	rouse	VB
46745	3308	45	it	-PRON-	PRP
46745	3308	46	when	when	WRB
46745	3308	47	torpid	torpid	NNP
46745	3308	48	,	,	,
46745	3308	49	or	or	CC
46745	3308	50	to	to	TO
46745	3308	51	depress	depress	VB
46745	3308	52	it	-PRON-	PRP
46745	3308	53	when	when	WRB
46745	3308	54	over	over	RB
46745	3308	55	-	-	HYPH
46745	3308	56	excited	excited	JJ
46745	3308	57	.	.	.
46745	3309	1	Rarely	rarely	RB
46745	3309	2	of	of	IN
46745	3309	3	use	use	NN
46745	3309	4	in	in	IN
46745	3309	5	chronic	chronic	JJ
46745	3309	6	blood	blood	NN
46745	3309	7	-	-	HYPH
46745	3309	8	disorders	disorder	NNS
46745	3309	9	,	,	,
46745	3309	10	they	-PRON-	PRP
46745	3309	11	are	be	VBP
46745	3309	12	given	give	VBN
46745	3309	13	mostly	mostly	RB
46745	3309	14	in	in	IN
46745	3309	15	the	the	DT
46745	3309	16	temporary	temporary	JJ
46745	3309	17	emergencies	emergency	NNS
46745	3309	18	of	of	IN
46745	3309	19	acute	acute	JJ
46745	3309	20	diseases	disease	NNS
46745	3309	21	.	.	.
46745	3310	1	But	but	CC
46745	3310	2	it	-PRON-	PRP
46745	3310	3	is	be	VBZ
46745	3310	4	obvious	obvious	JJ
46745	3310	5	that	that	IN
46745	3310	6	even	even	RB
46745	3310	7	a	a	DT
46745	3310	8	temporary	temporary	JJ
46745	3310	9	agent	agent	NN
46745	3310	10	may	may	MD
46745	3310	11	prove	prove	VB
46745	3310	12	of	of	IN
46745	3310	13	permanent	permanent	JJ
46745	3310	14	efficacy	efficacy	NN
46745	3310	15	by	by	IN
46745	3310	16	remedying	remedy	VBG
46745	3310	17	a	a	DT
46745	3310	18	temporary	temporary	JJ
46745	3310	19	emergency	emergency	NN
46745	3310	20	.	.	.
46745	3311	1	It	-PRON-	PRP
46745	3311	2	was	be	VBD
46745	3311	3	feasible	feasible	JJ
46745	3311	4	to	to	TO
46745	3311	5	attempt	attempt	VB
46745	3311	6	some	some	DT
46745	3311	7	explanation	explanation	NN
46745	3311	8	of	of	IN
46745	3311	9	the	the	DT
46745	3311	10	actions	action	NNS
46745	3311	11	of	of	IN
46745	3311	12	medicines	medicine	NNS
46745	3311	13	in	in	IN
46745	3311	14	the	the	DT
46745	3311	15	blood	blood	NN
46745	3311	16	,	,	,
46745	3311	17	occasionally	occasionally	RB
46745	3311	18	more	more	RBR
46745	3311	19	or	or	CC
46745	3311	20	less	less	RBR
46745	3311	21	analogous	analogous	JJ
46745	3311	22	to	to	TO
46745	3311	23	known	know	VBN
46745	3311	24	chemical	chemical	NN
46745	3311	25	influences	influence	NNS
46745	3311	26	.	.	.
46745	3312	1	But	but	CC
46745	3312	2	the	the	DT
46745	3312	3	agency	agency	NN
46745	3312	4	of	of	IN
46745	3312	5	nerve	nerve	NN
46745	3312	6	-	-	HYPH
46745	3312	7	medicines	medicine	NNS
46745	3312	8	is	be	VBZ
46745	3312	9	of	of	IN
46745	3312	10	a	a	DT
46745	3312	11	far	far	RB
46745	3312	12	more	more	RBR
46745	3312	13	incomprehensible	incomprehensible	JJ
46745	3312	14	kind	kind	NN
46745	3312	15	.	.	.
46745	3313	1	When	when	WRB
46745	3313	2	we	-PRON-	PRP
46745	3313	3	consider	consider	VBP
46745	3313	4	that	that	DT
46745	3313	5	little	little	JJ
46745	3313	6	or	or	CC
46745	3313	7	nothing	nothing	NN
46745	3313	8	is	be	VBZ
46745	3313	9	known	know	VBN
46745	3313	10	,	,	,
46745	3313	11	or	or	CC
46745	3313	12	can	can	MD
46745	3313	13	be	be	VB
46745	3313	14	known	know	VBN
46745	3313	15	,	,	,
46745	3313	16	about	about	IN
46745	3313	17	the	the	DT
46745	3313	18	ultimate	ultimate	JJ
46745	3313	19	causes	cause	NNS
46745	3313	20	of	of	IN
46745	3313	21	sensation	sensation	NN
46745	3313	22	,	,	,
46745	3313	23	or	or	CC
46745	3313	24	motion	motion	NN
46745	3313	25	,	,	,
46745	3313	26	or	or	CC
46745	3313	27	nervous	nervous	JJ
46745	3313	28	excitement	excitement	NN
46745	3313	29	,	,	,
46745	3313	30	there	there	EX
46745	3313	31	is	be	VBZ
46745	3313	32	no	no	DT
46745	3313	33	need	need	NN
46745	3313	34	for	for	IN
46745	3313	35	wonder	wonder	NN
46745	3313	36	that	that	IN
46745	3313	37	we	-PRON-	PRP
46745	3313	38	find	find	VBP
46745	3313	39	ourselves	-PRON-	PRP
46745	3313	40	at	at	IN
46745	3313	41	a	a	DT
46745	3313	42	loss	loss	NN
46745	3313	43	to	to	TO
46745	3313	44	explain	explain	VB
46745	3313	45	the	the	DT
46745	3313	46	operation	operation	NN
46745	3313	47	of	of	IN
46745	3313	48	medicines	medicine	NNS
46745	3313	49	that	that	WDT
46745	3313	50	influence	influence	VBP
46745	3313	51	these	these	DT
46745	3313	52	conditions	condition	NNS
46745	3313	53	.	.	.
46745	3314	1	Thus	thus	RB
46745	3314	2	I	-PRON-	PRP
46745	3314	3	must	must	MD
46745	3314	4	chiefly	chiefly	RB
46745	3314	5	limit	limit	VB
46745	3314	6	my	-PRON-	PRP$
46745	3314	7	remarks	remark	NNS
46745	3314	8	on	on	IN
46745	3314	9	Neurotics	neurotic	NNS
46745	3314	10	to	to	IN
46745	3314	11	defining	define	VBG
46745	3314	12	_	_	NNP
46745	3314	13	what	what	WP
46745	3314	14	_	_	IN
46745	3314	15	their	-PRON-	PRP$
46745	3314	16	action	action	NN
46745	3314	17	is	be	VBZ
46745	3314	18	,	,	,
46745	3314	19	finding	find	VBG
46745	3314	20	it	-PRON-	PRP
46745	3314	21	impossible	impossible	JJ
46745	3314	22	to	to	TO
46745	3314	23	state	state	VB
46745	3314	24	with	with	IN
46745	3314	25	certainty	certainty	NN
46745	3314	26	_	_	NNP
46745	3314	27	how	how	WRB
46745	3314	28	_	_	NNP
46745	3314	29	they	-PRON-	PRP
46745	3314	30	act	act	VBP
46745	3314	31	.	.	.
46745	3315	1	And	and	CC
46745	3315	2	the	the	DT
46745	3315	3	field	field	NN
46745	3315	4	of	of	IN
46745	3315	5	inquiry	inquiry	NN
46745	3315	6	being	be	VBG
46745	3315	7	so	so	RB
46745	3315	8	limited	limited	JJ
46745	3315	9	,	,	,
46745	3315	10	it	-PRON-	PRP
46745	3315	11	follows	follow	VBZ
46745	3315	12	that	that	IN
46745	3315	13	there	there	EX
46745	3315	14	is	be	VBZ
46745	3315	15	much	much	RB
46745	3315	16	less	less	JJR
46745	3315	17	to	to	TO
46745	3315	18	be	be	VB
46745	3315	19	said	say	VBN
46745	3315	20	about	about	IN
46745	3315	21	them	-PRON-	PRP
46745	3315	22	than	than	IN
46745	3315	23	had	have	VBD
46745	3315	24	to	to	TO
46745	3315	25	be	be	VB
46745	3315	26	said	say	VBN
46745	3315	27	of	of	IN
46745	3315	28	Hæmatics	Hæmatics	NNPS
46745	3315	29	.	.	.
46745	3316	1	Nearly	nearly	RB
46745	3316	2	all	all	PDT
46745	3316	3	the	the	DT
46745	3316	4	powerful	powerful	JJ
46745	3316	5	poisons	poison	NNS
46745	3316	6	that	that	WDT
46745	3316	7	act	act	VBP
46745	3316	8	after	after	IN
46745	3316	9	passage	passage	NN
46745	3316	10	into	into	IN
46745	3316	11	the	the	DT
46745	3316	12	blood	blood	NN
46745	3316	13	,	,	,
46745	3316	14	belong	belong	VB
46745	3316	15	to	to	IN
46745	3316	16	this	this	DT
46745	3316	17	class	class	NN
46745	3316	18	.	.	.
46745	3317	1	Their	-PRON-	PRP$
46745	3317	2	action	action	NN
46745	3317	3	in	in	IN
46745	3317	4	most	most	JJS
46745	3317	5	points	point	NNS
46745	3317	6	of	of	IN
46745	3317	7	view	view	NN
46745	3317	8	is	be	VBZ
46745	3317	9	such	such	JJ
46745	3317	10	as	as	IN
46745	3317	11	completely	completely	RB
46745	3317	12	to	to	TO
46745	3317	13	exceed	exceed	VB
46745	3317	14	our	-PRON-	PRP$
46745	3317	15	means	mean	NNS
46745	3317	16	of	of	IN
46745	3317	17	comprehension	comprehension	NN
46745	3317	18	.	.	.
46745	3318	1	Sudden	sudden	JJ
46745	3318	2	death	death	NN
46745	3318	3	may	may	MD
46745	3318	4	be	be	VB
46745	3318	5	produced	produce	VBN
46745	3318	6	by	by	IN
46745	3318	7	it	-PRON-	PRP
46745	3318	8	.	.	.
46745	3319	1	But	but	CC
46745	3319	2	there	there	EX
46745	3319	3	is	be	VBZ
46745	3319	4	no	no	DT
46745	3319	5	apparent	apparent	JJ
46745	3319	6	cause	cause	NN
46745	3319	7	for	for	IN
46745	3319	8	this	this	DT
46745	3319	9	.	.	.
46745	3320	1	We	-PRON-	PRP
46745	3320	2	find	find	VBP
46745	3320	3	no	no	DT
46745	3320	4	erosion	erosion	NN
46745	3320	5	or	or	CC
46745	3320	6	perforation	perforation	NN
46745	3320	7	of	of	IN
46745	3320	8	the	the	DT
46745	3320	9	coats	coat	NNS
46745	3320	10	of	of	IN
46745	3320	11	the	the	DT
46745	3320	12	stomach	stomach	NN
46745	3320	13	or	or	CC
46745	3320	14	intestines	intestine	NNS
46745	3320	15	;	;	:
46745	3320	16	no	no	DT
46745	3320	17	mechanical	mechanical	JJ
46745	3320	18	disorganization	disorganization	NN
46745	3320	19	of	of	IN
46745	3320	20	the	the	DT
46745	3320	21	tissues	tissue	NNS
46745	3320	22	,	,	,
46745	3320	23	or	or	CC
46745	3320	24	chemical	chemical	NN
46745	3320	25	change	change	NN
46745	3320	26	in	in	IN
46745	3320	27	them	-PRON-	PRP
46745	3320	28	;	;	:
46745	3320	29	no	no	DT
46745	3320	30	hæmorrhage	hæmorrhage	NN
46745	3320	31	,	,	,
46745	3320	32	or	or	CC
46745	3320	33	vascular	vascular	JJ
46745	3320	34	disease	disease	NN
46745	3320	35	;	;	:
46745	3320	36	no	no	DT
46745	3320	37	rupture	rupture	NN
46745	3320	38	of	of	IN
46745	3320	39	nerve	nerve	NN
46745	3320	40	-	-	HYPH
46745	3320	41	fibres	fibre	NNS
46745	3320	42	.	.	.
46745	3321	1	Whence	whence	UH
46745	3321	2	,	,	,
46745	3321	3	then	then	RB
46745	3321	4	,	,	,
46745	3321	5	could	could	MD
46745	3321	6	death	death	NN
46745	3321	7	have	have	VB
46745	3321	8	arisen	arise	VBN
46745	3321	9	?	?	.
46745	3322	1	How	how	WRB
46745	3322	2	could	could	MD
46745	3322	3	the	the	DT
46745	3322	4	mere	mere	JJ
46745	3322	5	presence	presence	NN
46745	3322	6	of	of	IN
46745	3322	7	a	a	DT
46745	3322	8	few	few	JJ
46745	3322	9	atoms	atom	NNS
46745	3322	10	in	in	IN
46745	3322	11	the	the	DT
46745	3322	12	blood,--half	blood,--half	NNP
46745	3322	13	a	a	DT
46745	3322	14	grain	grain	NN
46745	3322	15	,	,	,
46745	3322	16	one	one	CD
46745	3322	17	-	-	HYPH
46745	3322	18	twentieth	twentieth	NN
46745	3322	19	,	,	,
46745	3322	20	or	or	CC
46745	3322	21	even	even	RB
46745	3322	22	one	one	CD
46745	3322	23	-	-	HYPH
46745	3322	24	fiftieth	fiftieth	NN
46745	3322	25	of	of	IN
46745	3322	26	a	a	DT
46745	3322	27	grain	grain	NN
46745	3322	28	--	--	:
46745	3322	29	how	how	WRB
46745	3322	30	could	could	MD
46745	3322	31	this	this	DT
46745	3322	32	apparently	apparently	RB
46745	3322	33	contemptible	contemptible	JJ
46745	3322	34	influence	influence	NN
46745	3322	35	have	have	VBP
46745	3322	36	produced	produce	VBN
46745	3322	37	so	so	RB
46745	3322	38	essential	essential	JJ
46745	3322	39	a	a	DT
46745	3322	40	derangement	derangement	NN
46745	3322	41	of	of	IN
46745	3322	42	the	the	DT
46745	3322	43	vital	vital	JJ
46745	3322	44	functions	function	NNS
46745	3322	45	as	as	IN
46745	3322	46	to	to	TO
46745	3322	47	stop	stop	VB
46745	3322	48	them	-PRON-	PRP
46745	3322	49	altogether	altogether	RB
46745	3322	50	?	?	.
46745	3323	1	It	-PRON-	PRP
46745	3323	2	is	be	VBZ
46745	3323	3	impossible	impossible	JJ
46745	3323	4	to	to	TO
46745	3323	5	answer	answer	VB
46745	3323	6	.	.	.
46745	3324	1	The	the	DT
46745	3324	2	action	action	NN
46745	3324	3	of	of	IN
46745	3324	4	such	such	JJ
46745	3324	5	remedies	remedy	NNS
46745	3324	6	in	in	IN
46745	3324	7	the	the	DT
46745	3324	8	sudden	sudden	JJ
46745	3324	9	causation	causation	NN
46745	3324	10	or	or	CC
46745	3324	11	alleviation	alleviation	NN
46745	3324	12	of	of	IN
46745	3324	13	nervous	nervous	JJ
46745	3324	14	symptoms	symptom	NNS
46745	3324	15	,	,	,
46745	3324	16	when	when	WRB
46745	3324	17	applied	apply	VBN
46745	3324	18	in	in	IN
46745	3324	19	the	the	DT
46745	3324	20	cure	cure	NN
46745	3324	21	of	of	IN
46745	3324	22	disease	disease	NN
46745	3324	23	,	,	,
46745	3324	24	is	be	VBZ
46745	3324	25	equally	equally	RB
46745	3324	26	wonderful	wonderful	JJ
46745	3324	27	.	.	.
46745	3325	1	How	how	WRB
46745	3325	2	are	be	VBP
46745	3325	3	we	-PRON-	PRP
46745	3325	4	to	to	TO
46745	3325	5	account	account	VB
46745	3325	6	for	for	IN
46745	3325	7	their	-PRON-	PRP$
46745	3325	8	different	different	JJ
46745	3325	9	actions	action	NNS
46745	3325	10	on	on	IN
46745	3325	11	different	different	JJ
46745	3325	12	nerves	nerve	NNS
46745	3325	13	?	?	.
46745	3326	1	How	how	WRB
46745	3326	2	is	be	VBZ
46745	3326	3	it	-PRON-	PRP
46745	3326	4	that	that	WDT
46745	3326	5	Opium	Opium	NNP
46745	3326	6	contracts	contract	VBZ
46745	3326	7	the	the	DT
46745	3326	8	pupil	pupil	NN
46745	3326	9	,	,	,
46745	3326	10	and	and	CC
46745	3326	11	Belladonna	Belladonna	NNP
46745	3326	12	dilates	dilate	VBZ
46745	3326	13	it?--that	it?--that	WP
46745	3326	14	Digitalis	Digitalis	NNP
46745	3326	15	affects	affect	VBZ
46745	3326	16	the	the	DT
46745	3326	17	heart	heart	NN
46745	3326	18	,	,	,
46745	3326	19	and	and	CC
46745	3326	20	Stramonium	stramonium	VB
46745	3326	21	the	the	DT
46745	3326	22	respiration?--that	respiration?--that	NNP
46745	3326	23	Prussic	Prussic	NNP
46745	3326	24	acid	acid	NN
46745	3326	25	will	will	MD
46745	3326	26	cause	cause	VB
46745	3326	27	convulsions	convulsion	NNS
46745	3326	28	,	,	,
46745	3326	29	and	and	CC
46745	3326	30	Hyoscyamus	Hyoscyamus	NNP
46745	3326	31	delirium	delirium	NN
46745	3326	32	?	?	.
46745	3327	1	In	in	IN
46745	3327	2	what	what	WDT
46745	3327	3	way	way	NN
46745	3327	4	are	be	VBP
46745	3327	5	these	these	DT
46745	3327	6	various	various	JJ
46745	3327	7	operations	operation	NNS
46745	3327	8	brought	bring	VBN
46745	3327	9	to	to	TO
46745	3327	10	pass	pass	VB
46745	3327	11	?	?	.
46745	3328	1	It	-PRON-	PRP
46745	3328	2	is	be	VBZ
46745	3328	3	impossible	impossible	JJ
46745	3328	4	to	to	TO
46745	3328	5	answer	answer	VB
46745	3328	6	.	.	.
46745	3329	1	Though	though	IN
46745	3329	2	it	-PRON-	PRP
46745	3329	3	is	be	VBZ
46745	3329	4	,	,	,
46745	3329	5	I	-PRON-	PRP
46745	3329	6	say	say	VBP
46745	3329	7	,	,	,
46745	3329	8	quite	quite	RB
46745	3329	9	impossible	impossible	JJ
46745	3329	10	to	to	TO
46745	3329	11	frame	frame	VB
46745	3329	12	for	for	IN
46745	3329	13	any	any	DT
46745	3329	14	one	one	CD
46745	3329	15	of	of	IN
46745	3329	16	these	these	DT
46745	3329	17	questions	question	NNS
46745	3329	18	a	a	DT
46745	3329	19	certain	certain	JJ
46745	3329	20	or	or	CC
46745	3329	21	satisfactory	satisfactory	JJ
46745	3329	22	reply	reply	NN
46745	3329	23	,	,	,
46745	3329	24	on	on	IN
46745	3329	25	account	account	NN
46745	3329	26	of	of	IN
46745	3329	27	the	the	DT
46745	3329	28	manifest	manif	JJS
46745	3329	29	insufficiency	insufficiency	NN
46745	3329	30	of	of	IN
46745	3329	31	our	-PRON-	PRP$
46745	3329	32	acquaintance	acquaintance	NN
46745	3329	33	with	with	IN
46745	3329	34	the	the	DT
46745	3329	35	details	detail	NNS
46745	3329	36	of	of	IN
46745	3329	37	such	such	JJ
46745	3329	38	actions	action	NNS
46745	3329	39	as	as	IN
46745	3329	40	these	these	DT
46745	3329	41	,	,	,
46745	3329	42	yet	yet	CC
46745	3329	43	I	-PRON-	PRP
46745	3329	44	must	must	MD
46745	3329	45	now	now	RB
46745	3329	46	venture	venture	VB
46745	3329	47	to	to	TO
46745	3329	48	repeat	repeat	VB
46745	3329	49	an	an	DT
46745	3329	50	idea	idea	NN
46745	3329	51	which	which	WDT
46745	3329	52	I	-PRON-	PRP
46745	3329	53	have	have	VBP
46745	3329	54	already	already	RB
46745	3329	55	referred	refer	VBN
46745	3329	56	to	to	IN
46745	3329	57	at	at	IN
46745	3329	58	the	the	DT
46745	3329	59	commencement	commencement	NN
46745	3329	60	of	of	IN
46745	3329	61	this	this	DT
46745	3329	62	Essay	Essay	NNP
46745	3329	63	(	(	-LRB-
46745	3329	64	p.	p.	NN
46745	3329	65	46	46	CD
46745	3329	66	,	,	,
46745	3329	67	)	)	-RRB-
46745	3329	68	and	and	CC
46745	3329	69	state	state	VB
46745	3329	70	my	-PRON-	PRP$
46745	3329	71	belief	belief	NN
46745	3329	72	in	in	IN
46745	3329	73	the	the	DT
46745	3329	74	bare	bare	JJ
46745	3329	75	possibility	possibility	NN
46745	3329	76	of	of	IN
46745	3329	77	the	the	DT
46745	3329	78	operations	operation	NNS
46745	3329	79	of	of	IN
46745	3329	80	Neurotic	neurotic	JJ
46745	3329	81	agents	agent	NNS
46745	3329	82	being	be	VBG
46745	3329	83	explicable	explicable	JJ
46745	3329	84	upon	upon	IN
46745	3329	85	mechanical	mechanical	JJ
46745	3329	86	grounds	ground	NNS
46745	3329	87	.	.	.
46745	3330	1	It	-PRON-	PRP
46745	3330	2	is	be	VBZ
46745	3330	3	generally	generally	RB
46745	3330	4	believed	believe	VBN
46745	3330	5	among	among	IN
46745	3330	6	scientific	scientific	JJ
46745	3330	7	men	man	NNS
46745	3330	8	that	that	IN
46745	3330	9	each	each	DT
46745	3330	10	particle	particle	NN
46745	3330	11	of	of	IN
46745	3330	12	a	a	DT
46745	3330	13	compound	compound	NN
46745	3330	14	body	body	NN
46745	3330	15	is	be	VBZ
46745	3330	16	made	make	VBN
46745	3330	17	up	up	RP
46745	3330	18	of	of	IN
46745	3330	19	a	a	DT
46745	3330	20	number	number	NN
46745	3330	21	of	of	IN
46745	3330	22	indivisible	indivisible	JJ
46745	3330	23	atoms	atom	NNS
46745	3330	24	,	,	,
46745	3330	25	each	each	DT
46745	3330	26	of	of	IN
46745	3330	27	which	which	WDT
46745	3330	28	is	be	VBZ
46745	3330	29	inconceivably	inconceivably	RB
46745	3330	30	minute	minute	JJ
46745	3330	31	in	in	IN
46745	3330	32	size	size	NN
46745	3330	33	.	.	.
46745	3331	1	And	and	CC
46745	3331	2	as	as	IN
46745	3331	3	these	these	DT
46745	3331	4	compound	compound	NN
46745	3331	5	bodies	body	NNS
46745	3331	6	have	have	VBP
46745	3331	7	each	each	DT
46745	3331	8	a	a	DT
46745	3331	9	peculiar	peculiar	JJ
46745	3331	10	chemical	chemical	NN
46745	3331	11	constitution	constitution	NN
46745	3331	12	,	,	,
46745	3331	13	so	so	CC
46745	3331	14	must	must	MD
46745	3331	15	each	each	DT
46745	3331	16	of	of	IN
46745	3331	17	their	-PRON-	PRP$
46745	3331	18	ultimate	ultimate	JJ
46745	3331	19	parts	part	NNS
46745	3331	20	be	be	VB
46745	3331	21	composed	compose	VBN
46745	3331	22	of	of	IN
46745	3331	23	a	a	DT
46745	3331	24	peculiar	peculiar	JJ
46745	3331	25	arrangement	arrangement	NN
46745	3331	26	of	of	IN
46745	3331	27	simpler	simple	JJR
46745	3331	28	atoms	atom	NNS
46745	3331	29	,	,	,
46745	3331	30	and	and	CC
46745	3331	31	thus	thus	RB
46745	3331	32	have	have	VB
46745	3331	33	a	a	DT
46745	3331	34	certain	certain	JJ
46745	3331	35	shape	shape	NN
46745	3331	36	of	of	IN
46745	3331	37	its	-PRON-	PRP$
46745	3331	38	own	own	JJ
46745	3331	39	more	more	RBR
46745	3331	40	or	or	CC
46745	3331	41	less	less	RBR
46745	3331	42	different	different	JJ
46745	3331	43	from	from	IN
46745	3331	44	the	the	DT
46745	3331	45	shape	shape	NN
46745	3331	46	of	of	IN
46745	3331	47	every	every	DT
46745	3331	48	other	other	JJ
46745	3331	49	compound	compound	NN
46745	3331	50	atom	atom	NN
46745	3331	51	.	.	.
46745	3332	1	Both	both	DT
46745	3332	2	the	the	DT
46745	3332	3	substance	substance	NN
46745	3332	4	of	of	IN
46745	3332	5	a	a	DT
46745	3332	6	nerve	nerve	NN
46745	3332	7	,	,	,
46745	3332	8	and	and	CC
46745	3332	9	the	the	DT
46745	3332	10	active	active	JJ
46745	3332	11	part	part	NN
46745	3332	12	of	of	IN
46745	3332	13	a	a	DT
46745	3332	14	nerve	nerve	NN
46745	3332	15	-	-	HYPH
46745	3332	16	medicine	medicine	NN
46745	3332	17	,	,	,
46745	3332	18	consist	consist	VB
46745	3332	19	of	of	IN
46745	3332	20	a	a	DT
46745	3332	21	number	number	NN
46745	3332	22	of	of	IN
46745	3332	23	definite	definite	JJ
46745	3332	24	compound	compound	NN
46745	3332	25	atoms	atom	NNS
46745	3332	26	.	.	.
46745	3333	1	And	and	CC
46745	3333	2	it	-PRON-	PRP
46745	3333	3	is	be	VBZ
46745	3333	4	possible	possible	JJ
46745	3333	5	that	that	IN
46745	3333	6	the	the	DT
46745	3333	7	atom	atom	NN
46745	3333	8	of	of	IN
46745	3333	9	a	a	DT
46745	3333	10	stimulant	stimulant	NN
46745	3333	11	medicine	medicine	NN
46745	3333	12	may	may	MD
46745	3333	13	be	be	VB
46745	3333	14	of	of	IN
46745	3333	15	such	such	PDT
46745	3333	16	a	a	DT
46745	3333	17	shape	shape	NN
46745	3333	18	as	as	IN
46745	3333	19	that	that	IN
46745	3333	20	it	-PRON-	PRP
46745	3333	21	shall	shall	MD
46745	3333	22	be	be	VB
46745	3333	23	unable	unable	JJ
46745	3333	24	to	to	TO
46745	3333	25	coincide	coincide	VB
46745	3333	26	with	with	IN
46745	3333	27	,	,	,
46745	3333	28	or	or	CC
46745	3333	29	to	to	TO
46745	3333	30	fit	fit	VB
46745	3333	31	into	into	IN
46745	3333	32	,	,	,
46745	3333	33	the	the	DT
46745	3333	34	series	series	NN
46745	3333	35	of	of	IN
46745	3333	36	atoms	atom	NNS
46745	3333	37	forming	form	VBG
46745	3333	38	the	the	DT
46745	3333	39	sensitive	sensitive	JJ
46745	3333	40	surface	surface	NN
46745	3333	41	of	of	IN
46745	3333	42	the	the	DT
46745	3333	43	nerve	nerve	NN
46745	3333	44	,	,	,
46745	3333	45	and	and	CC
46745	3333	46	thus	thus	RB
46745	3333	47	irritate	irritate	VB
46745	3333	48	this	this	DT
46745	3333	49	when	when	WRB
46745	3333	50	brought	bring	VBN
46745	3333	51	into	into	IN
46745	3333	52	contact	contact	NN
46745	3333	53	with	with	IN
46745	3333	54	it	-PRON-	PRP
46745	3333	55	;	;	:
46745	3333	56	and	and	CC
46745	3333	57	that	that	IN
46745	3333	58	the	the	DT
46745	3333	59	compound	compound	NN
46745	3333	60	atoms	atom	NNS
46745	3333	61	of	of	IN
46745	3333	62	a	a	DT
46745	3333	63	sedative	sedative	JJ
46745	3333	64	may	may	MD
46745	3333	65	so	so	RB
46745	3333	66	arrange	arrange	VB
46745	3333	67	with	with	IN
46745	3333	68	these	these	DT
46745	3333	69	nerve	nerve	NN
46745	3333	70	particles	particle	NNS
46745	3333	71	as	as	IN
46745	3333	72	to	to	TO
46745	3333	73	fit	fit	VB
46745	3333	74	among	among	RP
46745	3333	75	and	and	CC
46745	3333	76	extinguish	extinguish	VB
46745	3333	77	their	-PRON-	PRP$
46745	3333	78	salient	salient	NN
46745	3333	79	points	point	NNS
46745	3333	80	,	,	,
46745	3333	81	and	and	CC
46745	3333	82	annihilate	annihilate	VB
46745	3333	83	their	-PRON-	PRP$
46745	3333	84	natural	natural	JJ
46745	3333	85	sensibility	sensibility	NN
46745	3333	86	.	.	.
46745	3334	1	We	-PRON-	PRP
46745	3334	2	learn	learn	VBP
46745	3334	3	from	from	IN
46745	3334	4	the	the	DT
46745	3334	5	phenomena	phenomenon	NNS
46745	3334	6	of	of	IN
46745	3334	7	the	the	DT
46745	3334	8	senses	sense	NNS
46745	3334	9	that	that	WDT
46745	3334	10	the	the	DT
46745	3334	11	nerves	nerve	NNS
46745	3334	12	are	be	VBP
46745	3334	13	very	very	RB
46745	3334	14	much	much	RB
46745	3334	15	under	under	IN
46745	3334	16	the	the	DT
46745	3334	17	influence	influence	NN
46745	3334	18	of	of	IN
46745	3334	19	mechanical	mechanical	JJ
46745	3334	20	impulses	impulse	NNS
46745	3334	21	of	of	IN
46745	3334	22	all	all	DT
46745	3334	23	kinds	kind	NNS
46745	3334	24	,	,	,
46745	3334	25	and	and	CC
46745	3334	26	particularly	particularly	RB
46745	3334	27	minute	minute	JJ
46745	3334	28	and	and	CC
46745	3334	29	inappreciable	inappreciable	JJ
46745	3334	30	impulses	impulse	NNS
46745	3334	31	of	of	IN
46745	3334	32	this	this	DT
46745	3334	33	description	description	NN
46745	3334	34	.	.	.
46745	3335	1	Another	another	DT
46745	3335	2	fact	fact	NN
46745	3335	3	which	which	WDT
46745	3335	4	gives	give	VBZ
46745	3335	5	additional	additional	JJ
46745	3335	6	credibility	credibility	NN
46745	3335	7	to	to	IN
46745	3335	8	such	such	PDT
46745	3335	9	an	an	DT
46745	3335	10	idea	idea	NN
46745	3335	11	is	be	VBZ
46745	3335	12	,	,	,
46745	3335	13	that	that	IN
46745	3335	14	those	those	DT
46745	3335	15	Neurotic	neurotic	JJ
46745	3335	16	substances	substance	NNS
46745	3335	17	which	which	WDT
46745	3335	18	are	be	VBP
46745	3335	19	chemically	chemically	RB
46745	3335	20	alike	alike	RB
46745	3335	21	are	be	VBP
46745	3335	22	in	in	IN
46745	3335	23	general	general	JJ
46745	3335	24	alike	alike	RB
46745	3335	25	also	also	RB
46745	3335	26	in	in	IN
46745	3335	27	their	-PRON-	PRP$
46745	3335	28	influence	influence	NN
46745	3335	29	on	on	IN
46745	3335	30	nerve	nerve	NN
46745	3335	31	.	.	.
46745	3336	1	The	the	DT
46745	3336	2	particular	particular	JJ
46745	3336	3	way	way	NN
46745	3336	4	in	in	IN
46745	3336	5	which	which	WDT
46745	3336	6	nerve	nerve	NN
46745	3336	7	-	-	HYPH
46745	3336	8	medicines	medicine	NNS
46745	3336	9	affect	affect	VBP
46745	3336	10	different	different	JJ
46745	3336	11	parts	part	NNS
46745	3336	12	of	of	IN
46745	3336	13	the	the	DT
46745	3336	14	nervous	nervous	JJ
46745	3336	15	system	system	NN
46745	3336	16	might	may	MD
46745	3336	17	perhaps	perhaps	RB
46745	3336	18	be	be	VB
46745	3336	19	explained	explain	VBN
46745	3336	20	by	by	IN
46745	3336	21	supposing	suppose	VBG
46745	3336	22	minute	minute	JJ
46745	3336	23	chemical	chemical	NN
46745	3336	24	differences	difference	NNS
46745	3336	25	in	in	IN
46745	3336	26	the	the	DT
46745	3336	27	composition	composition	NN
46745	3336	28	of	of	IN
46745	3336	29	the	the	DT
46745	3336	30	atoms	atom	NNS
46745	3336	31	of	of	IN
46745	3336	32	which	which	WDT
46745	3336	33	those	those	DT
46745	3336	34	parts	part	NNS
46745	3336	35	are	be	VBP
46745	3336	36	constructed	construct	VBN
46745	3336	37	,	,	,
46745	3336	38	sufficient	sufficient	JJ
46745	3336	39	to	to	TO
46745	3336	40	alter	alter	VB
46745	3336	41	their	-PRON-	PRP$
46745	3336	42	relations	relation	NNS
46745	3336	43	to	to	IN
46745	3336	44	the	the	DT
46745	3336	45	atoms	atom	NNS
46745	3336	46	of	of	IN
46745	3336	47	certain	certain	JJ
46745	3336	48	remedies	remedy	NNS
46745	3336	49	.	.	.
46745	3337	1	If	if	IN
46745	3337	2	we	-PRON-	PRP
46745	3337	3	adopt	adopt	VBP
46745	3337	4	the	the	DT
46745	3337	5	Atomic	atomic	JJ
46745	3337	6	theory	theory	NN
46745	3337	7	,	,	,
46745	3337	8	we	-PRON-	PRP
46745	3337	9	must	must	MD
46745	3337	10	perceive	perceive	VB
46745	3337	11	that	that	IN
46745	3337	12	no	no	DT
46745	3337	13	two	two	CD
46745	3337	14	chemical	chemical	JJ
46745	3337	15	bodies	body	NNS
46745	3337	16	can	can	MD
46745	3337	17	be	be	VB
46745	3337	18	precisely	precisely	RB
46745	3337	19	alike	alike	RB
46745	3337	20	in	in	IN
46745	3337	21	the	the	DT
46745	3337	22	shapes	shape	NNS
46745	3337	23	of	of	IN
46745	3337	24	their	-PRON-	PRP$
46745	3337	25	particles	particle	NNS
46745	3337	26	.	.	.
46745	3338	1	This	this	DT
46745	3338	2	various	various	JJ
46745	3338	3	dissimilarity	dissimilarity	NN
46745	3338	4	might	may	MD
46745	3338	5	throw	throw	VB
46745	3338	6	some	some	DT
46745	3338	7	light	light	NN
46745	3338	8	upon	upon	IN
46745	3338	9	the	the	DT
46745	3338	10	many	many	JJ
46745	3338	11	shades	shade	NNS
46745	3338	12	of	of	IN
46745	3338	13	distinction	distinction	NN
46745	3338	14	between	between	IN
46745	3338	15	the	the	DT
46745	3338	16	operations	operation	NNS
46745	3338	17	of	of	IN
46745	3338	18	Neurotic	neurotic	JJ
46745	3338	19	medicines	medicine	NNS
46745	3338	20	on	on	IN
46745	3338	21	different	different	JJ
46745	3338	22	parts	part	NNS
46745	3338	23	.	.	.
46745	3339	1	Thus	thus	RB
46745	3339	2	,	,	,
46745	3339	3	as	as	IN
46745	3339	4	a	a	DT
46745	3339	5	general	general	JJ
46745	3339	6	rule	rule	NN
46745	3339	7	,	,	,
46745	3339	8	both	both	CC
46745	3339	9	Morphia	Morphia	NNP
46745	3339	10	and	and	CC
46745	3339	11	Atropia	Atropia	NNP
46745	3339	12	are	be	VBP
46745	3339	13	paralyzers	paralyzer	NNS
46745	3339	14	of	of	IN
46745	3339	15	motor	motor	NN
46745	3339	16	nerves	nerve	NNS
46745	3339	17	.	.	.
46745	3340	1	But	but	CC
46745	3340	2	they	-PRON-	PRP
46745	3340	3	do	do	VBP
46745	3340	4	not	not	RB
46745	3340	5	act	act	VB
46745	3340	6	alike	alike	RB
46745	3340	7	on	on	IN
46745	3340	8	the	the	DT
46745	3340	9	Ciliary	ciliary	JJ
46745	3340	10	nerves	nerve	NNS
46745	3340	11	by	by	IN
46745	3340	12	which	which	WDT
46745	3340	13	the	the	DT
46745	3340	14	motions	motion	NNS
46745	3340	15	of	of	IN
46745	3340	16	the	the	DT
46745	3340	17	Iris	Iris	NNPS
46745	3340	18	are	be	VBP
46745	3340	19	controlled	control	VBN
46745	3340	20	.	.	.
46745	3341	1	We	-PRON-	PRP
46745	3341	2	may	may	MD
46745	3341	3	suppose	suppose	VB
46745	3341	4	that	that	IN
46745	3341	5	there	there	EX
46745	3341	6	is	be	VBZ
46745	3341	7	a	a	DT
46745	3341	8	certain	certain	JJ
46745	3341	9	chemical	chemical	NN
46745	3341	10	peculiarity	peculiarity	NN
46745	3341	11	in	in	IN
46745	3341	12	the	the	DT
46745	3341	13	particles	particle	NNS
46745	3341	14	of	of	IN
46745	3341	15	these	these	DT
46745	3341	16	nerves	nerve	NNS
46745	3341	17	,	,	,
46745	3341	18	by	by	IN
46745	3341	19	which	which	WDT
46745	3341	20	they	-PRON-	PRP
46745	3341	21	are	be	VBP
46745	3341	22	enabled	enable	VBN
46745	3341	23	to	to	TO
46745	3341	24	coincide	coincide	VB
46745	3341	25	with	with	IN
46745	3341	26	the	the	DT
46745	3341	27	atoms	atom	NNS
46745	3341	28	of	of	IN
46745	3341	29	Atropia	Atropia	NNP
46745	3341	30	,	,	,
46745	3341	31	and	and	CC
46745	3341	32	are	be	VBP
46745	3341	33	thus	thus	RB
46745	3341	34	blunted	blunt	VBN
46745	3341	35	and	and	CC
46745	3341	36	paralyzed	paralyze	VBN
46745	3341	37	by	by	IN
46745	3341	38	them	-PRON-	PRP
46745	3341	39	;	;	:
46745	3341	40	but	but	CC
46745	3341	41	are	be	VBP
46745	3341	42	,	,	,
46745	3341	43	on	on	IN
46745	3341	44	the	the	DT
46745	3341	45	contrary	contrary	NN
46745	3341	46	,	,	,
46745	3341	47	stimulated	stimulate	VBN
46745	3341	48	and	and	CC
46745	3341	49	excited	excite	VBN
46745	3341	50	by	by	IN
46745	3341	51	the	the	DT
46745	3341	52	atoms	atom	NNS
46745	3341	53	of	of	IN
46745	3341	54	Morphia	Morphia	NNP
46745	3341	55	,	,	,
46745	3341	56	which	which	WDT
46745	3341	57	have	have	VBP
46745	3341	58	the	the	DT
46745	3341	59	contrary	contrary	JJ
46745	3341	60	action	action	NN
46745	3341	61	,	,	,
46745	3341	62	because	because	IN
46745	3341	63	unable	unable	JJ
46745	3341	64	,	,	,
46745	3341	65	on	on	IN
46745	3341	66	account	account	NN
46745	3341	67	of	of	IN
46745	3341	68	their	-PRON-	PRP$
46745	3341	69	relative	relative	JJ
46745	3341	70	shape	shape	NN
46745	3341	71	,	,	,
46745	3341	72	to	to	TO
46745	3341	73	dove	dove	VB
46745	3341	74	-	-	HYPH
46745	3341	75	tail	tail	VB
46745	3341	76	with	with	IN
46745	3341	77	these	these	DT
46745	3341	78	atoms	atom	NNS
46745	3341	79	.	.	.
46745	3342	1	This	this	DT
46745	3342	2	idea	idea	NN
46745	3342	3	is	be	VBZ
46745	3342	4	,	,	,
46745	3342	5	as	as	IN
46745	3342	6	I	-PRON-	PRP
46745	3342	7	have	have	VBP
46745	3342	8	said	say	VBD
46745	3342	9	,	,	,
46745	3342	10	purely	purely	RB
46745	3342	11	conjectural	conjectural	JJ
46745	3342	12	and	and	CC
46745	3342	13	fictitious	fictitious	JJ
46745	3342	14	,	,	,
46745	3342	15	and	and	CC
46745	3342	16	is	be	VBZ
46745	3342	17	indeed	indeed	RB
46745	3342	18	likely	likely	JJ
46745	3342	19	to	to	TO
46745	3342	20	remain	remain	VB
46745	3342	21	so	so	RB
46745	3342	22	;	;	:
46745	3342	23	for	for	IN
46745	3342	24	the	the	DT
46745	3342	25	thing	thing	NN
46745	3342	26	is	be	VBZ
46745	3342	27	not	not	RB
46745	3342	28	by	by	IN
46745	3342	29	its	-PRON-	PRP$
46745	3342	30	nature	nature	NN
46745	3342	31	susceptible	susceptible	JJ
46745	3342	32	of	of	IN
46745	3342	33	proof	proof	NN
46745	3342	34	,	,	,
46745	3342	35	nor	nor	CC
46745	3342	36	is	be	VBZ
46745	3342	37	it	-PRON-	PRP
46745	3342	38	even	even	RB
46745	3342	39	possible	possible	JJ
46745	3342	40	to	to	TO
46745	3342	41	inquire	inquire	VB
46745	3342	42	into	into	IN
46745	3342	43	it	-PRON-	PRP
46745	3342	44	.	.	.
46745	3343	1	And	and	CC
46745	3343	2	I	-PRON-	PRP
46745	3343	3	have	have	VBP
46745	3343	4	only	only	RB
46745	3343	5	thought	think	VBN
46745	3343	6	it	-PRON-	PRP
46745	3343	7	worth	worth	JJ
46745	3343	8	while	while	IN
46745	3343	9	to	to	TO
46745	3343	10	explain	explain	VB
46745	3343	11	it	-PRON-	PRP
46745	3343	12	at	at	IN
46745	3343	13	length	length	NN
46745	3343	14	because	because	IN
46745	3343	15	it	-PRON-	PRP
46745	3343	16	is	be	VBZ
46745	3343	17	desirable	desirable	JJ
46745	3343	18	that	that	IN
46745	3343	19	every	every	DT
46745	3343	20	statement	statement	NN
46745	3343	21	which	which	WDT
46745	3343	22	is	be	VBZ
46745	3343	23	made	make	VBN
46745	3343	24	,	,	,
46745	3343	25	however	however	RB
46745	3343	26	improbable	improbable	JJ
46745	3343	27	and	and	CC
46745	3343	28	unworthy	unworthy	JJ
46745	3343	29	of	of	IN
46745	3343	30	credence	credence	NN
46745	3343	31	it	-PRON-	PRP
46745	3343	32	may	may	MD
46745	3343	33	seem	seem	VB
46745	3343	34	,	,	,
46745	3343	35	should	should	MD
46745	3343	36	at	at	IN
46745	3343	37	least	least	JJS
46745	3343	38	be	be	VB
46745	3343	39	placed	place	VBN
46745	3343	40	in	in	IN
46745	3343	41	as	as	RB
46745	3343	42	clear	clear	JJ
46745	3343	43	a	a	DT
46745	3343	44	light	light	NN
46745	3343	45	as	as	IN
46745	3343	46	possible	possible	JJ
46745	3343	47	.	.	.
46745	3344	1	The	the	DT
46745	3344	2	action	action	NN
46745	3344	3	of	of	IN
46745	3344	4	a	a	DT
46745	3344	5	Neurotic	neurotic	JJ
46745	3344	6	is	be	VBZ
46745	3344	7	readily	readily	RB
46745	3344	8	distinguished	distinguish	VBN
46745	3344	9	from	from	IN
46745	3344	10	that	that	DT
46745	3344	11	of	of	IN
46745	3344	12	Hæmatic	hæmatic	JJ
46745	3344	13	medicines	medicine	NNS
46745	3344	14	by	by	IN
46745	3344	15	the	the	DT
46745	3344	16	fact	fact	NN
46745	3344	17	of	of	IN
46745	3344	18	its	-PRON-	PRP$
46745	3344	19	exerting	exert	VBG
46745	3344	20	a	a	DT
46745	3344	21	rapid	rapid	JJ
46745	3344	22	and	and	CC
46745	3344	23	well	well	RB
46745	3344	24	marked	marked	JJ
46745	3344	25	influence	influence	NN
46745	3344	26	of	of	IN
46745	3344	27	some	some	DT
46745	3344	28	kind	kind	NN
46745	3344	29	on	on	IN
46745	3344	30	the	the	DT
46745	3344	31	nervous	nervous	JJ
46745	3344	32	system	system	NN
46745	3344	33	.	.	.
46745	3345	1	As	as	IN
46745	3345	2	it	-PRON-	PRP
46745	3345	3	is	be	VBZ
46745	3345	4	impossible	impossible	JJ
46745	3345	5	that	that	IN
46745	3345	6	the	the	DT
46745	3345	7	medicines	medicine	NNS
46745	3345	8	contained	contain	VBN
46745	3345	9	in	in	IN
46745	3345	10	this	this	DT
46745	3345	11	class	class	NN
46745	3345	12	should	should	MD
46745	3345	13	remain	remain	VB
46745	3345	14	in	in	IN
46745	3345	15	the	the	DT
46745	3345	16	blood	blood	NN
46745	3345	17	,	,	,
46745	3345	18	they	-PRON-	PRP
46745	3345	19	therefore	therefore	RB
46745	3345	20	pass	pass	VBP
46745	3345	21	out	out	IN
46745	3345	22	of	of	IN
46745	3345	23	the	the	DT
46745	3345	24	blood	blood	NN
46745	3345	25	through	through	IN
46745	3345	26	the	the	DT
46745	3345	27	glands	gland	NNS
46745	3345	28	,	,	,
46745	3345	29	and	and	CC
46745	3345	30	in	in	IN
46745	3345	31	so	so	RB
46745	3345	32	doing	do	VBG
46745	3345	33	generally	generally	RB
46745	3345	34	act	act	VB
46745	3345	35	as	as	IN
46745	3345	36	Eliminatives	Eliminatives	NNPS
46745	3345	37	.	.	.
46745	3346	1	This	this	DT
46745	3346	2	,	,	,
46745	3346	3	their	-PRON-	PRP$
46745	3346	4	secondary	secondary	JJ
46745	3346	5	action	action	NN
46745	3346	6	,	,	,
46745	3346	7	will	will	MD
46745	3346	8	be	be	VB
46745	3346	9	subsequently	subsequently	RB
46745	3346	10	considered	consider	VBN
46745	3346	11	.	.	.
46745	3347	1	It	-PRON-	PRP
46745	3347	2	is	be	VBZ
46745	3347	3	generally	generally	RB
46745	3347	4	of	of	IN
46745	3347	5	less	less	JJR
46745	3347	6	importance	importance	NN
46745	3347	7	than	than	IN
46745	3347	8	their	-PRON-	PRP$
46745	3347	9	action	action	NN
46745	3347	10	on	on	IN
46745	3347	11	nerve	nerve	NN
46745	3347	12	;	;	:
46745	3347	13	with	with	IN
46745	3347	14	the	the	DT
46745	3347	15	exception	exception	NN
46745	3347	16	of	of	IN
46745	3347	17	some	some	DT
46745	3347	18	which	which	WDT
46745	3347	19	,	,	,
46745	3347	20	as	as	IN
46745	3347	21	volatile	volatile	JJ
46745	3347	22	oils	oil	NNS
46745	3347	23	and	and	CC
46745	3347	24	resins	resin	NNS
46745	3347	25	,	,	,
46745	3347	26	exert	exert	VB
46745	3347	27	a	a	DT
46745	3347	28	very	very	RB
46745	3347	29	feeble	feeble	JJ
46745	3347	30	Neurotic	neurotic	JJ
46745	3347	31	action	action	NN
46745	3347	32	,	,	,
46745	3347	33	but	but	CC
46745	3347	34	are	be	VBP
46745	3347	35	comparatively	comparatively	RB
46745	3347	36	powerful	powerful	JJ
46745	3347	37	as	as	IN
46745	3347	38	Eliminatives	Eliminatives	NNPS
46745	3347	39	.	.	.
46745	3348	1	In	in	IN
46745	3348	2	this	this	DT
46745	3348	3	case	case	NN
46745	3348	4	the	the	DT
46745	3348	5	secondary	secondary	JJ
46745	3348	6	action	action	NN
46745	3348	7	becomes	become	VBZ
46745	3348	8	the	the	DT
46745	3348	9	more	more	RBR
46745	3348	10	important	important	JJ
46745	3348	11	of	of	IN
46745	3348	12	the	the	DT
46745	3348	13	two	two	CD
46745	3348	14	.	.	.
46745	3349	1	The	the	DT
46745	3349	2	most	most	RBS
46745	3349	3	dangerous	dangerous	JJ
46745	3349	4	symptoms	symptom	NNS
46745	3349	5	of	of	IN
46745	3349	6	disease	disease	NN
46745	3349	7	are	be	VBP
46745	3349	8	evidenced	evidence	VBN
46745	3349	9	in	in	IN
46745	3349	10	the	the	DT
46745	3349	11	nervous	nervous	JJ
46745	3349	12	system	system	NN
46745	3349	13	.	.	.
46745	3350	1	Neurotics	neurotic	NNS
46745	3350	2	are	be	VBP
46745	3350	3	employed	employ	VBN
46745	3350	4	to	to	TO
46745	3350	5	control	control	VB
46745	3350	6	these	these	DT
46745	3350	7	symptoms	symptom	NNS
46745	3350	8	as	as	IN
46745	3350	9	they	-PRON-	PRP
46745	3350	10	arise	arise	VBP
46745	3350	11	,	,	,
46745	3350	12	but	but	CC
46745	3350	13	Hæmatics	Hæmatics	NNPS
46745	3350	14	are	be	VBP
46745	3350	15	used	use	VBN
46745	3350	16	to	to	TO
46745	3350	17	combat	combat	VB
46745	3350	18	the	the	DT
46745	3350	19	cause	cause	NN
46745	3350	20	of	of	IN
46745	3350	21	the	the	DT
46745	3350	22	disorder	disorder	NN
46745	3350	23	.	.	.
46745	3351	1	As	as	IN
46745	3351	2	to	to	IN
46745	3351	3	their	-PRON-	PRP$
46745	3351	4	relative	relative	JJ
46745	3351	5	efficacy	efficacy	NN
46745	3351	6	,	,	,
46745	3351	7	there	there	EX
46745	3351	8	is	be	VBZ
46745	3351	9	an	an	DT
46745	3351	10	advantage	advantage	NN
46745	3351	11	and	and	CC
46745	3351	12	a	a	DT
46745	3351	13	disadvantage	disadvantage	NN
46745	3351	14	on	on	IN
46745	3351	15	each	each	DT
46745	3351	16	side	side	NN
46745	3351	17	.	.	.
46745	3352	1	On	on	IN
46745	3352	2	the	the	DT
46745	3352	3	one	one	CD
46745	3352	4	hand	hand	NN
46745	3352	5	,	,	,
46745	3352	6	nerve	nerve	NN
46745	3352	7	-	-	HYPH
46745	3352	8	medicines	medicine	NNS
46745	3352	9	are	be	VBP
46745	3352	10	more	more	RBR
46745	3352	11	numerous	numerous	JJ
46745	3352	12	and	and	CC
46745	3352	13	more	more	RBR
46745	3352	14	powerful	powerful	JJ
46745	3352	15	than	than	IN
46745	3352	16	blood	blood	NN
46745	3352	17	-	-	HYPH
46745	3352	18	medicines	medicine	NNS
46745	3352	19	,	,	,
46745	3352	20	and	and	CC
46745	3352	21	thus	thus	RB
46745	3352	22	in	in	IN
46745	3352	23	the	the	DT
46745	3352	24	control	control	NN
46745	3352	25	of	of	IN
46745	3352	26	symptoms	symptom	NNS
46745	3352	27	they	-PRON-	PRP
46745	3352	28	are	be	VBP
46745	3352	29	wielded	wield	VBN
46745	3352	30	with	with	IN
46745	3352	31	more	more	JJR
46745	3352	32	immediate	immediate	JJ
46745	3352	33	certainty	certainty	NN
46745	3352	34	than	than	IN
46745	3352	35	the	the	DT
46745	3352	36	others	other	NNS
46745	3352	37	in	in	IN
46745	3352	38	the	the	DT
46745	3352	39	counteraction	counteraction	NN
46745	3352	40	of	of	IN
46745	3352	41	diseases	disease	NNS
46745	3352	42	.	.	.
46745	3353	1	On	on	IN
46745	3353	2	the	the	DT
46745	3353	3	other	other	JJ
46745	3353	4	hand	hand	NN
46745	3353	5	,	,	,
46745	3353	6	the	the	DT
46745	3353	7	symptom	symptom	NN
46745	3353	8	that	that	WDT
46745	3353	9	is	be	VBZ
46745	3353	10	dreaded	dread	VBN
46745	3353	11	is	be	VBZ
46745	3353	12	only	only	RB
46745	3353	13	relieved	relieve	VBN
46745	3353	14	for	for	IN
46745	3353	15	a	a	DT
46745	3353	16	time	time	NN
46745	3353	17	by	by	IN
46745	3353	18	the	the	DT
46745	3353	19	Neurotic	neurotic	JJ
46745	3353	20	remedy	remedy	NN
46745	3353	21	,	,	,
46745	3353	22	while	while	IN
46745	3353	23	the	the	DT
46745	3353	24	morbid	morbid	NN
46745	3353	25	condition	condition	NN
46745	3353	26	that	that	WDT
46745	3353	27	caused	cause	VBD
46745	3353	28	it	-PRON-	PRP
46745	3353	29	continues	continue	VBZ
46745	3353	30	,	,	,
46745	3353	31	and	and	CC
46745	3353	32	will	will	MD
46745	3353	33	perhaps	perhaps	RB
46745	3353	34	cause	cause	VB
46745	3353	35	it	-PRON-	PRP
46745	3353	36	again	again	RB
46745	3353	37	;	;	:
46745	3353	38	but	but	CC
46745	3353	39	when	when	WRB
46745	3353	40	a	a	DT
46745	3353	41	disorder	disorder	NN
46745	3353	42	is	be	VBZ
46745	3353	43	remedied	remedie	VBN
46745	3353	44	by	by	IN
46745	3353	45	the	the	DT
46745	3353	46	employment	employment	NN
46745	3353	47	of	of	IN
46745	3353	48	Hæmatic	hæmatic	JJ
46745	3353	49	medicines	medicine	NNS
46745	3353	50	,	,	,
46745	3353	51	it	-PRON-	PRP
46745	3353	52	is	be	VBZ
46745	3353	53	more	more	RBR
46745	3353	54	or	or	CC
46745	3353	55	less	less	RBR
46745	3353	56	permanently	permanently	RB
46745	3353	57	cured	cure	VBN
46745	3353	58	and	and	CC
46745	3353	59	put	put	VB
46745	3353	60	an	an	DT
46745	3353	61	end	end	NN
46745	3353	62	to	to	IN
46745	3353	63	.	.	.
46745	3354	1	In	in	IN
46745	3354	2	the	the	DT
46745	3354	3	above	above	JJ
46745	3354	4	Proposition	proposition	NN
46745	3354	5	I	-PRON-	PRP
46745	3354	6	have	have	VBP
46745	3354	7	endeavoured	endeavour	VBN
46745	3354	8	to	to	TO
46745	3354	9	state	state	VB
46745	3354	10	as	as	RB
46745	3354	11	much	much	RB
46745	3354	12	as	as	IN
46745	3354	13	we	-PRON-	PRP
46745	3354	14	know	know	VBP
46745	3354	15	with	with	IN
46745	3354	16	certainty	certainty	NN
46745	3354	17	of	of	IN
46745	3354	18	the	the	DT
46745	3354	19	action	action	NN
46745	3354	20	of	of	IN
46745	3354	21	Neurotics	Neurotics	NNP
46745	3354	22	.	.	.
46745	3355	1	To	to	IN
46745	3355	2	this	this	DT
46745	3355	3	certainty	certainty	NN
46745	3355	4	I	-PRON-	PRP
46745	3355	5	have	have	VBP
46745	3355	6	already	already	RB
46745	3355	7	ventured	venture	VBN
46745	3355	8	to	to	TO
46745	3355	9	add	add	VB
46745	3355	10	a	a	DT
46745	3355	11	surmise	surmise	NN
46745	3355	12	,	,	,
46745	3355	13	on	on	IN
46745	3355	14	which	which	WDT
46745	3355	15	no	no	DT
46745	3355	16	certain	certain	JJ
46745	3355	17	reliance	reliance	NN
46745	3355	18	can	can	MD
46745	3355	19	be	be	VB
46745	3355	20	placed	place	VBN
46745	3355	21	.	.	.
46745	3356	1	But	but	CC
46745	3356	2	even	even	RB
46745	3356	3	if	if	IN
46745	3356	4	the	the	DT
46745	3356	5	theory	theory	NN
46745	3356	6	of	of	IN
46745	3356	7	the	the	DT
46745	3356	8	action	action	NN
46745	3356	9	by	by	IN
46745	3356	10	atomic	atomic	JJ
46745	3356	11	shapes	shape	NNS
46745	3356	12	should	should	MD
46745	3356	13	be	be	VB
46745	3356	14	rejected	reject	VBN
46745	3356	15	as	as	IN
46745	3356	16	improbable	improbable	JJ
46745	3356	17	,	,	,
46745	3356	18	because	because	IN
46745	3356	19	affording	afford	VBG
46745	3356	20	too	too	RB
46745	3356	21	easy	easy	JJ
46745	3356	22	an	an	DT
46745	3356	23	explanation	explanation	NN
46745	3356	24	of	of	IN
46745	3356	25	a	a	DT
46745	3356	26	naturally	naturally	RB
46745	3356	27	inscrutable	inscrutable	JJ
46745	3356	28	operation	operation	NN
46745	3356	29	,	,	,
46745	3356	30	it	-PRON-	PRP
46745	3356	31	would	would	MD
46745	3356	32	still	still	RB
46745	3356	33	seem	seem	VB
46745	3356	34	likely	likely	JJ
46745	3356	35	that	that	IN
46745	3356	36	these	these	DT
46745	3356	37	medicines	medicine	NNS
46745	3356	38	may	may	MD
46745	3356	39	take	take	VB
46745	3356	40	effect	effect	NN
46745	3356	41	by	by	IN
46745	3356	42	exerting	exert	VBG
46745	3356	43	some	some	DT
46745	3356	44	minute	minute	NN
46745	3356	45	and	and	CC
46745	3356	46	imperceptible	imperceptible	JJ
46745	3356	47	influence	influence	NN
46745	3356	48	on	on	IN
46745	3356	49	nerve	nerve	NN
46745	3356	50	-	-	HYPH
46745	3356	51	fibre	fibre	NN
46745	3356	52	,	,	,
46745	3356	53	or	or	CC
46745	3356	54	producing	produce	VBG
46745	3356	55	in	in	IN
46745	3356	56	it	-PRON-	PRP
46745	3356	57	some	some	DT
46745	3356	58	inappreciable	inappreciable	JJ
46745	3356	59	disorganization	disorganization	NN
46745	3356	60	or	or	CC
46745	3356	61	change	change	NN
46745	3356	62	,	,	,
46745	3356	63	which	which	WDT
46745	3356	64	has	have	VBZ
46745	3356	65	the	the	DT
46745	3356	66	effect	effect	NN
46745	3356	67	of	of	IN
46745	3356	68	altering	alter	VBG
46745	3356	69	the	the	DT
46745	3356	70	natural	natural	JJ
46745	3356	71	performance	performance	NN
46745	3356	72	of	of	IN
46745	3356	73	its	-PRON-	PRP$
46745	3356	74	functions	function	NNS
46745	3356	75	.	.	.
46745	3357	1	The	the	DT
46745	3357	2	effect	effect	NN
46745	3357	3	of	of	IN
46745	3357	4	mechanical	mechanical	JJ
46745	3357	5	concussion	concussion	NN
46745	3357	6	or	or	CC
46745	3357	7	shock	shock	NN
46745	3357	8	,	,	,
46745	3357	9	which	which	WDT
46745	3357	10	may	may	MD
46745	3357	11	produce	produce	VB
46745	3357	12	death	death	NN
46745	3357	13	by	by	IN
46745	3357	14	minutely	minutely	RB
46745	3357	15	disarranging	disarrange	VBG
46745	3357	16	the	the	DT
46745	3357	17	particles	particle	NNS
46745	3357	18	of	of	IN
46745	3357	19	the	the	DT
46745	3357	20	nervous	nervous	JJ
46745	3357	21	centres	centre	NNS
46745	3357	22	,	,	,
46745	3357	23	presents	present	VBZ
46745	3357	24	an	an	DT
46745	3357	25	obvious	obvious	JJ
46745	3357	26	analogy	analogy	NN
46745	3357	27	to	to	IN
46745	3357	28	the	the	DT
46745	3357	29	sudden	sudden	JJ
46745	3357	30	and	and	CC
46745	3357	31	remarkable	remarkable	JJ
46745	3357	32	action	action	NN
46745	3357	33	of	of	IN
46745	3357	34	some	some	DT
46745	3357	35	nerve	nerve	NN
46745	3357	36	-	-	HYPH
46745	3357	37	poisons	poison	NNS
46745	3357	38	.	.	.
46745	3358	1	Having	have	VBG
46745	3358	2	offered	offer	VBN
46745	3358	3	these	these	DT
46745	3358	4	vague	vague	JJ
46745	3358	5	suggestions	suggestion	NNS
46745	3358	6	as	as	IN
46745	3358	7	to	to	IN
46745	3358	8	the	the	DT
46745	3358	9	ultimate	ultimate	JJ
46745	3358	10	_	_	NNP
46745	3358	11	modus	modus	NN
46745	3358	12	operandi	operandi	NNP
46745	3358	13	_	_	NNP
46745	3358	14	of	of	IN
46745	3358	15	Neurotics	Neurotics	NNP
46745	3358	16	,	,	,
46745	3358	17	I	-PRON-	PRP
46745	3358	18	will	will	MD
46745	3358	19	now	now	RB
46745	3358	20	proceed	proceed	VB
46745	3358	21	to	to	TO
46745	3358	22	divide	divide	VB
46745	3358	23	the	the	DT
46745	3358	24	Proposition	Proposition	NNP
46745	3358	25	in	in	IN
46745	3358	26	which	which	WDT
46745	3358	27	their	-PRON-	PRP$
46745	3358	28	more	more	RBR
46745	3358	29	obvious	obvious	JJ
46745	3358	30	action	action	NN
46745	3358	31	has	have	VBZ
46745	3358	32	been	be	VBN
46745	3358	33	stated	state	VBN
46745	3358	34	into	into	IN
46745	3358	35	a	a	DT
46745	3358	36	number	number	NN
46745	3358	37	of	of	IN
46745	3358	38	minor	minor	JJ
46745	3358	39	propositions	proposition	NNS
46745	3358	40	.	.	.
46745	3359	1	These	these	DT
46745	3359	2	apply	apply	VBP
46745	3359	3	to	to	IN
46745	3359	4	the	the	DT
46745	3359	5	whole	whole	JJ
46745	3359	6	class	class	NN
46745	3359	7	.	.	.
46745	3360	1	The	the	DT
46745	3360	2	three	three	CD
46745	3360	3	divisions	division	NNS
46745	3360	4	will	will	MD
46745	3360	5	be	be	VB
46745	3360	6	afterwards	afterwards	RB
46745	3360	7	shortly	shortly	RB
46745	3360	8	considered	consider	VBN
46745	3360	9	separately	separately	RB
46745	3360	10	.	.	.
46745	3361	1	_	_	NNP
46745	3361	2	m.	m.	NN
46745	3362	1	p.	p.	NN
46745	3362	2	1._--That	1._--that	CD
46745	3362	3	Neurotics	Neurotics	NNP
46745	3362	4	are	be	VBP
46745	3362	5	medicines	medicine	NNS
46745	3362	6	which	which	WDT
46745	3362	7	pass	pass	VBP
46745	3362	8	into	into	IN
46745	3362	9	the	the	DT
46745	3362	10	blood	blood	NN
46745	3362	11	.	.	.
46745	3363	1	_	_	NNP
46745	3363	2	m.	m.	NN
46745	3364	1	p.	p.	NN
46745	3364	2	2._--That	2._--that	CD
46745	3364	3	their	-PRON-	PRP$
46745	3364	4	action	action	NN
46745	3364	5	is	be	VBZ
46745	3364	6	evidenced	evidence	VBN
46745	3364	7	by	by	IN
46745	3364	8	a	a	DT
46745	3364	9	change	change	NN
46745	3364	10	in	in	IN
46745	3364	11	one	one	CD
46745	3364	12	or	or	CC
46745	3364	13	more	more	JJR
46745	3364	14	of	of	IN
46745	3364	15	those	those	DT
46745	3364	16	functions	function	NNS
46745	3364	17	which	which	WDT
46745	3364	18	are	be	VBP
46745	3364	19	attributed	attribute	VBN
46745	3364	20	to	to	IN
46745	3364	21	the	the	DT
46745	3364	22	nervous	nervous	JJ
46745	3364	23	system	system	NN
46745	3364	24	.	.	.
46745	3365	1	_	_	NNP
46745	3365	2	m.	m.	NN
46745	3366	1	p.	p.	NN
46745	3366	2	3._--That	3._--that	CD
46745	3366	3	it	-PRON-	PRP
46745	3366	4	is	be	VBZ
46745	3366	5	necessary	necessary	JJ
46745	3366	6	that	that	IN
46745	3366	7	they	-PRON-	PRP
46745	3366	8	should	should	MD
46745	3366	9	pass	pass	VB
46745	3366	10	from	from	IN
46745	3366	11	the	the	DT
46745	3366	12	blood	blood	NN
46745	3366	13	to	to	IN
46745	3366	14	that	that	DT
46745	3366	15	part	part	NN
46745	3366	16	of	of	IN
46745	3366	17	the	the	DT
46745	3366	18	nervous	nervous	JJ
46745	3366	19	system	system	NN
46745	3366	20	which	which	WDT
46745	3366	21	is	be	VBZ
46745	3366	22	influenced	influence	VBN
46745	3366	23	by	by	IN
46745	3366	24	them	-PRON-	PRP
46745	3366	25	.	.	.
46745	3367	1	_	_	NNP
46745	3367	2	m.	m.	NN
46745	3368	1	p.	p.	NN
46745	3368	2	4._--That	4._--that	CD
46745	3368	3	they	-PRON-	PRP
46745	3368	4	are	be	VBP
46745	3368	5	of	of	IN
46745	3368	6	use	use	NN
46745	3368	7	in	in	IN
46745	3368	8	an	an	DT
46745	3368	9	over	over	RB
46745	3368	10	-	-	HYPH
46745	3368	11	excited	excited	JJ
46745	3368	12	or	or	CC
46745	3368	13	depressed	depressed	JJ
46745	3368	14	state	state	NN
46745	3368	15	of	of	IN
46745	3368	16	the	the	DT
46745	3368	17	nervous	nervous	JJ
46745	3368	18	system	system	NN
46745	3368	19	.	.	.
46745	3369	1	_	_	NNP
46745	3369	2	m.	m.	NN
46745	3370	1	p.	p.	NN
46745	3370	2	5._--That	5._--that	CD
46745	3370	3	they	-PRON-	PRP
46745	3370	4	are	be	VBP
46745	3370	5	transitory	transitory	JJ
46745	3370	6	in	in	IN
46745	3370	7	action	action	NN
46745	3370	8	,	,	,
46745	3370	9	and	and	CC
46745	3370	10	can	can	MD
46745	3370	11	not	not	RB
46745	3370	12	remain	remain	VB
46745	3370	13	in	in	IN
46745	3370	14	the	the	DT
46745	3370	15	blood	blood	NN
46745	3370	16	.	.	.
46745	3371	1	Some	some	DT
46745	3371	2	space	space	NN
46745	3371	3	and	and	CC
46745	3371	4	labour	labour	NN
46745	3371	5	was	be	VBD
46745	3371	6	required	require	VBN
46745	3371	7	in	in	IN
46745	3371	8	the	the	DT
46745	3371	9	proof	proof	NN
46745	3371	10	of	of	IN
46745	3371	11	the	the	DT
46745	3371	12	minor	minor	JJ
46745	3371	13	propositions	proposition	NNS
46745	3371	14	relating	relate	VBG
46745	3371	15	to	to	IN
46745	3371	16	Hæmatics	Hæmatics	NNP
46745	3371	17	,	,	,
46745	3371	18	for	for	IN
46745	3371	19	among	among	IN
46745	3371	20	them	-PRON-	PRP
46745	3371	21	were	be	VBD
46745	3371	22	included	include	VBN
46745	3371	23	some	some	DT
46745	3371	24	things	thing	NNS
46745	3371	25	that	that	WDT
46745	3371	26	are	be	VBP
46745	3371	27	not	not	RB
46745	3371	28	universally	universally	RB
46745	3371	29	acknowledged	acknowledge	VBN
46745	3371	30	;	;	:
46745	3371	31	but	but	CC
46745	3371	32	the	the	DT
46745	3371	33	above	above	JJ
46745	3371	34	account	account	NN
46745	3371	35	of	of	IN
46745	3371	36	the	the	DT
46745	3371	37	action	action	NN
46745	3371	38	of	of	IN
46745	3371	39	Neurotics	Neurotics	NNP
46745	3371	40	concerns	concern	NNS
46745	3371	41	matters	matter	NNS
46745	3371	42	that	that	WDT
46745	3371	43	are	be	VBP
46745	3371	44	very	very	RB
46745	3371	45	generally	generally	RB
46745	3371	46	admitted	admit	VBN
46745	3371	47	,	,	,
46745	3371	48	and	and	CC
46745	3371	49	will	will	MD
46745	3371	50	not	not	RB
46745	3371	51	occupy	occupy	VB
46745	3371	52	us	-PRON-	PRP
46745	3371	53	nearly	nearly	RB
46745	3371	54	so	so	RB
46745	3371	55	long	long	RB
46745	3371	56	in	in	IN
46745	3371	57	its	-PRON-	PRP$
46745	3371	58	discussion	discussion	NN
46745	3371	59	.	.	.
46745	3372	1	In	in	IN
46745	3372	2	the	the	DT
46745	3372	3	first	first	JJ
46745	3372	4	place	place	NN
46745	3372	5	it	-PRON-	PRP
46745	3372	6	is	be	VBZ
46745	3372	7	affirmed	affirm	VBN
46745	3372	8	that	that	IN
46745	3372	9	Neurotic	neurotic	JJ
46745	3372	10	medicines	medicine	NNS
46745	3372	11	pass	pass	VB
46745	3372	12	into	into	IN
46745	3372	13	the	the	DT
46745	3372	14	blood	blood	NN
46745	3372	15	.	.	.
46745	3373	1	In	in	IN
46745	3373	2	the	the	DT
46745	3373	3	consideration	consideration	NN
46745	3373	4	of	of	IN
46745	3373	5	Prop	Prop	NNP
46745	3373	6	.	.	.
46745	3374	1	II	II	NNP
46745	3374	2	.	.	NNP
46745	3374	3	,	,	,
46745	3374	4	it	-PRON-	PRP
46745	3374	5	was	be	VBD
46745	3374	6	shown	show	VBN
46745	3374	7	that	that	IN
46745	3374	8	all	all	DT
46745	3374	9	of	of	IN
46745	3374	10	them,--whether	them,--whether	JJ
46745	3374	11	vegetable	vegetable	NN
46745	3374	12	alkaloids	alkaloid	NNS
46745	3374	13	,	,	,
46745	3374	14	volatile	volatile	JJ
46745	3374	15	oils	oil	NNS
46745	3374	16	,	,	,
46745	3374	17	resins	resin	NNS
46745	3374	18	,	,	,
46745	3374	19	or	or	CC
46745	3374	20	mineral	mineral	NN
46745	3374	21	substances,--were	substances,--were	ADD
46745	3374	22	more	more	RBR
46745	3374	23	or	or	CC
46745	3374	24	less	less	RBR
46745	3374	25	capable	capable	JJ
46745	3374	26	of	of	IN
46745	3374	27	being	be	VBG
46745	3374	28	absorbed	absorb	VBN
46745	3374	29	.	.	.
46745	3375	1	That	that	IN
46745	3375	2	they	-PRON-	PRP
46745	3375	3	do	do	VBP
46745	3375	4	pass	pass	VB
46745	3375	5	into	into	IN
46745	3375	6	the	the	DT
46745	3375	7	blood	blood	NN
46745	3375	8	is	be	VBZ
46745	3375	9	proved	prove	VBN
46745	3375	10	by	by	IN
46745	3375	11	the	the	DT
46745	3375	12	fact	fact	NN
46745	3375	13	that	that	IN
46745	3375	14	many	many	JJ
46745	3375	15	of	of	IN
46745	3375	16	them	-PRON-	PRP
46745	3375	17	have	have	VBP
46745	3375	18	been	be	VBN
46745	3375	19	detected	detect	VBN
46745	3375	20	there	there	RB
46745	3375	21	,	,	,
46745	3375	22	as	as	RB
46745	3375	23	well	well	RB
46745	3375	24	as	as	IN
46745	3375	25	found	find	VBN
46745	3375	26	in	in	IN
46745	3375	27	the	the	DT
46745	3375	28	secretions	secretion	NNS
46745	3375	29	into	into	IN
46745	3375	30	which	which	WDT
46745	3375	31	they	-PRON-	PRP
46745	3375	32	must	must	MD
46745	3375	33	have	have	VB
46745	3375	34	entered	enter	VBN
46745	3375	35	from	from	IN
46745	3375	36	the	the	DT
46745	3375	37	blood	blood	NN
46745	3375	38	.	.	.
46745	3376	1	Ammonia	Ammonia	NNP
46745	3376	2	,	,	,
46745	3376	3	Hydrocyanic	hydrocyanic	JJ
46745	3376	4	acid	acid	NN
46745	3376	5	,	,	,
46745	3376	6	Antimony	Antimony	NNP
46745	3376	7	,	,	,
46745	3376	8	Assaf[oe]tida	Assaf[oe]tida	NNP
46745	3376	9	,	,	,
46745	3376	10	Turpentine	Turpentine	NNP
46745	3376	11	,	,	,
46745	3376	12	Alcohol	Alcohol	NNP
46745	3376	13	,	,	,
46745	3376	14	and	and	CC
46745	3376	15	Camphor,--all	camphor,--all	NN
46745	3376	16	of	of	IN
46745	3376	17	which	which	WDT
46745	3376	18	are	be	VBP
46745	3376	19	Neurotic	neurotic	JJ
46745	3376	20	agents,--have	agents,--have	NNP
46745	3376	21	been	be	VBN
46745	3376	22	chemically	chemically	RB
46745	3376	23	detected	detect	VBN
46745	3376	24	in	in	IN
46745	3376	25	the	the	DT
46745	3376	26	blood	blood	NN
46745	3376	27	by	by	IN
46745	3376	28	Tiedemann	Tiedemann	NNP
46745	3376	29	and	and	CC
46745	3376	30	Gmelin	Gmelin	NNP
46745	3376	31	.	.	.
46745	3377	1	A	a	DT
46745	3377	2	still	still	RB
46745	3377	3	larger	large	JJR
46745	3377	4	number	number	NN
46745	3377	5	have	have	VBP
46745	3377	6	been	be	VBN
46745	3377	7	discovered	discover	VBN
46745	3377	8	in	in	IN
46745	3377	9	the	the	DT
46745	3377	10	urine	urine	NN
46745	3377	11	by	by	IN
46745	3377	12	Wöhler	Wöhler	NNP
46745	3377	13	,	,	,
46745	3377	14	particularly	particularly	RB
46745	3377	15	of	of	IN
46745	3377	16	volatile	volatile	JJ
46745	3377	17	oils	oil	NNS
46745	3377	18	and	and	CC
46745	3377	19	odorous	odorous	JJ
46745	3377	20	principles	principle	NNS
46745	3377	21	.	.	.
46745	3378	1	The	the	DT
46745	3378	2	active	active	JJ
46745	3378	3	principles	principle	NNS
46745	3378	4	of	of	IN
46745	3378	5	Opium	Opium	NNP
46745	3378	6	,	,	,
46745	3378	7	Belladonna	Belladonna	NNP
46745	3378	8	,	,	,
46745	3378	9	Stramonium	Stramonium	NNP
46745	3378	10	,	,	,
46745	3378	11	and	and	CC
46745	3378	12	Henbane	Henbane	NNP
46745	3378	13	,	,	,
46745	3378	14	have	have	VBP
46745	3378	15	been	be	VBN
46745	3378	16	detected	detect	VBN
46745	3378	17	in	in	IN
46745	3378	18	the	the	DT
46745	3378	19	same	same	JJ
46745	3378	20	secretion	secretion	NN
46745	3378	21	by	by	IN
46745	3378	22	others	other	NNS
46745	3378	23	.	.	.
46745	3379	1	Thus	thus	RB
46745	3379	2	Neurotics	neurotic	NNS
46745	3379	3	pass	pass	VBP
46745	3379	4	into	into	IN
46745	3379	5	the	the	DT
46745	3379	6	blood	blood	NN
46745	3379	7	.	.	.
46745	3380	1	That	that	IN
46745	3380	2	they	-PRON-	PRP
46745	3380	3	act	act	VBP
46745	3380	4	after	after	IN
46745	3380	5	this	this	DT
46745	3380	6	absorption	absorption	NN
46745	3380	7	,	,	,
46745	3380	8	and	and	CC
46745	3380	9	not	not	RB
46745	3380	10	by	by	IN
46745	3380	11	contact	contact	NN
46745	3380	12	with	with	IN
46745	3380	13	the	the	DT
46745	3380	14	mucous	mucous	JJ
46745	3380	15	surface	surface	NN
46745	3380	16	,	,	,
46745	3380	17	was	be	VBD
46745	3380	18	proved	prove	VBN
46745	3380	19	in	in	IN
46745	3380	20	the	the	DT
46745	3380	21	consideration	consideration	NN
46745	3380	22	of	of	IN
46745	3380	23	Prop	Prop	NNP
46745	3380	24	.	.	.
46745	3381	1	I.	I.	NNP
46745	3382	1	The	the	DT
46745	3382	2	second	second	JJ
46745	3382	3	minor	minor	JJ
46745	3382	4	proposition	proposition	NN
46745	3382	5	is	be	VBZ
46745	3382	6	borne	bear	VBN
46745	3382	7	out	out	RP
46745	3382	8	even	even	RB
46745	3382	9	by	by	IN
46745	3382	10	the	the	DT
46745	3382	11	names	name	NNS
46745	3382	12	by	by	IN
46745	3382	13	which	which	WDT
46745	3382	14	the	the	DT
46745	3382	15	recognised	recognise	VBN
46745	3382	16	action	action	NN
46745	3382	17	of	of	IN
46745	3382	18	these	these	DT
46745	3382	19	medicines	medicine	NNS
46745	3382	20	is	be	VBZ
46745	3382	21	distinguished	distinguish	VBN
46745	3382	22	.	.	.
46745	3383	1	Considered	consider	VBN
46745	3383	2	as	as	IN
46745	3383	3	a	a	DT
46745	3383	4	class	class	NN
46745	3383	5	,	,	,
46745	3383	6	they	-PRON-	PRP
46745	3383	7	have	have	VBP
46745	3383	8	no	no	DT
46745	3383	9	action	action	NN
46745	3383	10	on	on	IN
46745	3383	11	the	the	DT
46745	3383	12	blood	blood	NN
46745	3383	13	,	,	,
46745	3383	14	but	but	CC
46745	3383	15	their	-PRON-	PRP$
46745	3383	16	influence	influence	NN
46745	3383	17	is	be	VBZ
46745	3383	18	quickly	quickly	RB
46745	3383	19	and	and	CC
46745	3383	20	obviously	obviously	RB
46745	3383	21	exerted	exert	VBD
46745	3383	22	on	on	IN
46745	3383	23	the	the	DT
46745	3383	24	nervous	nervous	JJ
46745	3383	25	system	system	NN
46745	3383	26	,	,	,
46745	3383	27	or	or	CC
46745	3383	28	on	on	IN
46745	3383	29	the	the	DT
46745	3383	30	vital	vital	JJ
46745	3383	31	functions	function	NNS
46745	3383	32	which	which	WDT
46745	3383	33	are	be	VBP
46745	3383	34	universally	universally	RB
46745	3383	35	attributed	attribute	VBN
46745	3383	36	to	to	IN
46745	3383	37	that	that	DT
46745	3383	38	part	part	NN
46745	3383	39	of	of	IN
46745	3383	40	the	the	DT
46745	3383	41	animal	animal	NN
46745	3383	42	frame	frame	NN
46745	3383	43	.	.	.
46745	3384	1	Stimulants	stimulant	NNS
46745	3384	2	are	be	VBP
46745	3384	3	so	so	RB
46745	3384	4	called	call	VBN
46745	3384	5	because	because	IN
46745	3384	6	they	-PRON-	PRP
46745	3384	7	are	be	VBP
46745	3384	8	found	find	VBN
46745	3384	9	by	by	IN
46745	3384	10	experience	experience	NN
46745	3384	11	to	to	TO
46745	3384	12	exalt	exalt	VB
46745	3384	13	nervous	nervous	JJ
46745	3384	14	force	force	NN
46745	3384	15	;	;	:
46745	3384	16	Sedatives	sedative	NNS
46745	3384	17	,	,	,
46745	3384	18	because	because	IN
46745	3384	19	they	-PRON-	PRP
46745	3384	20	depress	depress	VBP
46745	3384	21	it	-PRON-	PRP
46745	3384	22	.	.	.
46745	3385	1	Thus	thus	RB
46745	3385	2	Ammonia	Ammonia	NNP
46745	3385	3	is	be	VBZ
46745	3385	4	given	give	VBN
46745	3385	5	to	to	TO
46745	3385	6	prevent	prevent	VB
46745	3385	7	Syncope	Syncope	NNP
46745	3385	8	,	,	,
46745	3385	9	caused	cause	VBN
46745	3385	10	by	by	IN
46745	3385	11	a	a	DT
46745	3385	12	weakness	weakness	NN
46745	3385	13	or	or	CC
46745	3385	14	failure	failure	NN
46745	3385	15	in	in	IN
46745	3385	16	power	power	NN
46745	3385	17	of	of	IN
46745	3385	18	the	the	DT
46745	3385	19	nerves	nerve	NNS
46745	3385	20	of	of	IN
46745	3385	21	the	the	DT
46745	3385	22	heart	heart	NN
46745	3385	23	;	;	:
46745	3385	24	and	and	CC
46745	3385	25	Aconite	Aconite	NNP
46745	3385	26	is	be	VBZ
46745	3385	27	prescribed	prescribe	VBN
46745	3385	28	to	to	TO
46745	3385	29	relieve	relieve	VB
46745	3385	30	pain	pain	NN
46745	3385	31	caused	cause	VBN
46745	3385	32	by	by	IN
46745	3385	33	an	an	DT
46745	3385	34	over	over	NN
46745	3385	35	-	-	HYPH
46745	3385	36	excitement	excitement	NN
46745	3385	37	of	of	IN
46745	3385	38	the	the	DT
46745	3385	39	sensory	sensory	JJ
46745	3385	40	nerves	nerve	NNS
46745	3385	41	.	.	.
46745	3386	1	Though	though	IN
46745	3386	2	in	in	IN
46745	3386	3	these	these	DT
46745	3386	4	examples	example	NNS
46745	3386	5	Ammonia	Ammonia	NNP
46745	3386	6	acts	act	VBZ
46745	3386	7	on	on	IN
46745	3386	8	the	the	DT
46745	3386	9	centre	centre	NN
46745	3386	10	,	,	,
46745	3386	11	and	and	CC
46745	3386	12	Aconite	Aconite	NNP
46745	3386	13	on	on	IN
46745	3386	14	the	the	DT
46745	3386	15	peripheral	peripheral	JJ
46745	3386	16	nerves	nerve	NNS
46745	3386	17	,	,	,
46745	3386	18	yet	yet	CC
46745	3386	19	they	-PRON-	PRP
46745	3386	20	are	be	VBP
46745	3386	21	both	both	RB
46745	3386	22	capable	capable	JJ
46745	3386	23	of	of	IN
46745	3386	24	exalting	exalt	VBG
46745	3386	25	or	or	CC
46745	3386	26	of	of	IN
46745	3386	27	depressing	depress	VBG
46745	3386	28	nervous	nervous	JJ
46745	3386	29	force	force	NN
46745	3386	30	in	in	IN
46745	3386	31	general	general	JJ
46745	3386	32	.	.	.
46745	3387	1	But	but	CC
46745	3387	2	neither	neither	CC
46745	3387	3	Stimulants	Stimulants	NNP
46745	3387	4	nor	nor	CC
46745	3387	5	Sedatives	Sedatives	NNPS
46745	3387	6	,	,	,
46745	3387	7	as	as	IN
46745	3387	8	defined	define	VBN
46745	3387	9	by	by	IN
46745	3387	10	me	-PRON-	PRP
46745	3387	11	,	,	,
46745	3387	12	exert	exert	VB
46745	3387	13	any	any	DT
46745	3387	14	marked	marked	JJ
46745	3387	15	influence	influence	NN
46745	3387	16	on	on	IN
46745	3387	17	the	the	DT
46745	3387	18	intellectual	intellectual	JJ
46745	3387	19	part	part	NN
46745	3387	20	of	of	IN
46745	3387	21	the	the	DT
46745	3387	22	brain	brain	NN
46745	3387	23	.	.	.
46745	3388	1	They	-PRON-	PRP
46745	3388	2	do	do	VBP
46745	3388	3	not	not	RB
46745	3388	4	affect	affect	VB
46745	3388	5	the	the	DT
46745	3388	6	phenomena	phenomenon	NNS
46745	3388	7	of	of	IN
46745	3388	8	mind	mind	NN
46745	3388	9	,	,	,
46745	3388	10	or	or	CC
46745	3388	11	of	of	IN
46745	3388	12	the	the	DT
46745	3388	13	four	four	CD
46745	3388	14	special	special	JJ
46745	3388	15	senses	sense	NNS
46745	3388	16	which	which	WDT
46745	3388	17	are	be	VBP
46745	3388	18	immediately	immediately	RB
46745	3388	19	associated	associate	VBN
46745	3388	20	with	with	IN
46745	3388	21	it	-PRON-	PRP
46745	3388	22	.	.	.
46745	3389	1	This	this	DT
46745	3389	2	influence	influence	NN
46745	3389	3	is	be	VBZ
46745	3389	4	confined	confine	VBN
46745	3389	5	to	to	IN
46745	3389	6	the	the	DT
46745	3389	7	intermediate	intermediate	JJ
46745	3389	8	division	division	NN
46745	3389	9	of	of	IN
46745	3389	10	Nerve	Nerve	NNP
46745	3389	11	-	-	HYPH
46745	3389	12	medicines	medicine	NNS
46745	3389	13	,	,	,
46745	3389	14	called	call	VBN
46745	3389	15	Narcotics	Narcotics	NNP
46745	3389	16	.	.	.
46745	3390	1	Their	-PRON-	PRP$
46745	3390	2	general	general	JJ
46745	3390	3	action	action	NN
46745	3390	4	is	be	VBZ
46745	3390	5	evidenced	evidence	VBN
46745	3390	6	by	by	IN
46745	3390	7	a	a	DT
46745	3390	8	short	short	JJ
46745	3390	9	or	or	CC
46745	3390	10	long	long	JJ
46745	3390	11	primary	primary	NN
46745	3390	12	stimulation,--and	stimulation,--and	IN
46745	3390	13	a	a	DT
46745	3390	14	subsequent	subsequent	JJ
46745	3390	15	depression	depression	NN
46745	3390	16	of	of	IN
46745	3390	17	nervous	nervous	JJ
46745	3390	18	force	force	NN
46745	3390	19	,	,	,
46745	3390	20	which	which	WDT
46745	3390	21	is	be	VBZ
46745	3390	22	also	also	RB
46745	3390	23	of	of	IN
46745	3390	24	variable	variable	JJ
46745	3390	25	intensity	intensity	NN
46745	3390	26	.	.	.
46745	3391	1	At	at	IN
46745	3391	2	the	the	DT
46745	3391	3	same	same	JJ
46745	3391	4	time	time	NN
46745	3391	5	they	-PRON-	PRP
46745	3391	6	affect	affect	VBP
46745	3391	7	the	the	DT
46745	3391	8	mind	mind	NN
46745	3391	9	in	in	IN
46745	3391	10	various	various	JJ
46745	3391	11	ways	way	NNS
46745	3391	12	;	;	,
46745	3391	13	exciting	excite	VBG
46745	3391	14	it	-PRON-	PRP
46745	3391	15	,	,	,
46745	3391	16	confusing	confuse	VBG
46745	3391	17	it	-PRON-	PRP
46745	3391	18	or	or	CC
46745	3391	19	lulling	lull	VBG
46745	3391	20	it	-PRON-	PRP
46745	3391	21	.	.	.
46745	3392	1	Opium	Opium	NNP
46745	3392	2	and	and	CC
46745	3392	3	Alcohol	Alcohol	NNP
46745	3392	4	are	be	VBP
46745	3392	5	examples	example	NNS
46745	3392	6	of	of	IN
46745	3392	7	Narcotics	Narcotics	NNP
46745	3392	8	.	.	.
46745	3393	1	These	these	DT
46745	3393	2	distinctions	distinction	NNS
46745	3393	3	are	be	VBP
46745	3393	4	in	in	IN
46745	3393	5	most	most	JJS
46745	3393	6	cases	case	NNS
46745	3393	7	obvious	obvious	JJ
46745	3393	8	and	and	CC
46745	3393	9	well	well	RB
46745	3393	10	defined	define	VBN
46745	3393	11	.	.	.
46745	3394	1	[	[	-LRB-
46745	3394	2	42	42	CD
46745	3394	3	]	]	-RRB-
46745	3394	4	The	the	DT
46745	3394	5	third	third	JJ
46745	3394	6	minor	minor	JJ
46745	3394	7	proposition	proposition	NN
46745	3394	8	repeats	repeat	VBZ
46745	3394	9	the	the	DT
46745	3394	10	rule	rule	NN
46745	3394	11	of	of	IN
46745	3394	12	local	local	JJ
46745	3394	13	access	access	NN
46745	3394	14	,	,	,
46745	3394	15	which	which	WDT
46745	3394	16	has	have	VBZ
46745	3394	17	already	already	RB
46745	3394	18	been	be	VBN
46745	3394	19	enforced	enforce	VBN
46745	3394	20	in	in	IN
46745	3394	21	treating	treating	NN
46745	3394	22	of	of	IN
46745	3394	23	the	the	DT
46745	3394	24	fifth	fifth	JJ
46745	3394	25	proposition	proposition	NN
46745	3394	26	.	.	.
46745	3395	1	It	-PRON-	PRP
46745	3395	2	was	be	VBD
46745	3395	3	not	not	RB
46745	3395	4	necessary	necessary	JJ
46745	3395	5	to	to	TO
46745	3395	6	maintain	maintain	VB
46745	3395	7	this	this	DT
46745	3395	8	in	in	IN
46745	3395	9	the	the	DT
46745	3395	10	case	case	NN
46745	3395	11	of	of	IN
46745	3395	12	medicines	medicine	NNS
46745	3395	13	acting	act	VBG
46745	3395	14	on	on	IN
46745	3395	15	the	the	DT
46745	3395	16	blood	blood	NN
46745	3395	17	;	;	:
46745	3395	18	but	but	CC
46745	3395	19	Neurotic	neurotic	JJ
46745	3395	20	agents	agent	NNS
46745	3395	21	must	must	MD
46745	3395	22	be	be	VB
46745	3395	23	shown	show	VBN
46745	3395	24	to	to	TO
46745	3395	25	operate	operate	VB
46745	3395	26	locally	locally	RB
46745	3395	27	on	on	IN
46745	3395	28	the	the	DT
46745	3395	29	various	various	JJ
46745	3395	30	nervous	nervous	JJ
46745	3395	31	organs	organ	NNS
46745	3395	32	.	.	.
46745	3396	1	I	-PRON-	PRP
46745	3396	2	have	have	VBP
46745	3396	3	only	only	RB
46745	3396	4	to	to	TO
46745	3396	5	repeat	repeat	VB
46745	3396	6	the	the	DT
46745	3396	7	arguments	argument	NNS
46745	3396	8	which	which	WDT
46745	3396	9	were	be	VBD
46745	3396	10	urged	urge	VBN
46745	3396	11	before	before	RB
46745	3396	12	.	.	.
46745	3397	1	It	-PRON-	PRP
46745	3397	2	is	be	VBZ
46745	3397	3	proved	prove	VBN
46745	3397	4	that	that	IN
46745	3397	5	the	the	DT
46745	3397	6	action	action	NN
46745	3397	7	of	of	IN
46745	3397	8	nerve	nerve	NN
46745	3397	9	-	-	HYPH
46745	3397	10	medicines	medicine	NNS
46745	3397	11	can	can	MD
46745	3397	12	not	not	RB
46745	3397	13	be	be	VB
46745	3397	14	propagated	propagate	VBN
46745	3397	15	by	by	IN
46745	3397	16	nervous	nervous	JJ
46745	3397	17	connexion	connexion	NN
46745	3397	18	,	,	,
46745	3397	19	but	but	CC
46745	3397	20	that	that	DT
46745	3397	21	passage	passage	NN
46745	3397	22	in	in	IN
46745	3397	23	the	the	DT
46745	3397	24	circulation	circulation	NN
46745	3397	25	is	be	VBZ
46745	3397	26	necessary	necessary	JJ
46745	3397	27	;	;	:
46745	3397	28	that	that	IN
46745	3397	29	the	the	DT
46745	3397	30	course	course	NN
46745	3397	31	of	of	IN
46745	3397	32	the	the	DT
46745	3397	33	latter	latter	JJ
46745	3397	34	is	be	VBZ
46745	3397	35	sufficiently	sufficiently	RB
46745	3397	36	rapid	rapid	JJ
46745	3397	37	to	to	TO
46745	3397	38	account	account	VB
46745	3397	39	even	even	RB
46745	3397	40	for	for	IN
46745	3397	41	the	the	DT
46745	3397	42	action	action	NN
46745	3397	43	of	of	IN
46745	3397	44	Hydrocyanic	hydrocyanic	JJ
46745	3397	45	acid	acid	NN
46745	3397	46	;	;	:
46745	3397	47	and	and	CC
46745	3397	48	that	that	IN
46745	3397	49	,	,	,
46745	3397	50	however	however	RB
46745	3397	51	near	near	IN
46745	3397	52	a	a	DT
46745	3397	53	medicine	medicine	NN
46745	3397	54	be	be	VB
46745	3397	55	introduced	introduce	VBN
46745	3397	56	to	to	IN
46745	3397	57	a	a	DT
46745	3397	58	nervous	nervous	JJ
46745	3397	59	organ	organ	NN
46745	3397	60	,	,	,
46745	3397	61	it	-PRON-	PRP
46745	3397	62	does	do	VBZ
46745	3397	63	not	not	RB
46745	3397	64	affect	affect	VB
46745	3397	65	it	-PRON-	PRP
46745	3397	66	unless	unless	IN
46745	3397	67	it	-PRON-	PRP
46745	3397	68	be	be	VB
46745	3397	69	allowed	allow	VBN
46745	3397	70	to	to	TO
46745	3397	71	reach	reach	VB
46745	3397	72	it	-PRON-	PRP
46745	3397	73	.	.	.
46745	3398	1	The	the	DT
46745	3398	2	nerves	nerve	NNS
46745	3398	3	are	be	VBP
46745	3398	4	not	not	RB
46745	3398	5	naturally	naturally	RB
46745	3398	6	constituted	constitute	VBN
46745	3398	7	for	for	IN
46745	3398	8	the	the	DT
46745	3398	9	conduction	conduction	NN
46745	3398	10	of	of	IN
46745	3398	11	medicinal	medicinal	JJ
46745	3398	12	impressions	impression	NNS
46745	3398	13	,	,	,
46745	3398	14	but	but	CC
46745	3398	15	only	only	RB
46745	3398	16	for	for	IN
46745	3398	17	the	the	DT
46745	3398	18	passage	passage	NN
46745	3398	19	of	of	IN
46745	3398	20	impulses	impulse	NNS
46745	3398	21	of	of	IN
46745	3398	22	volition	volition	NN
46745	3398	23	,	,	,
46745	3398	24	sensation	sensation	NN
46745	3398	25	,	,	,
46745	3398	26	or	or	CC
46745	3398	27	emotion	emotion	NN
46745	3398	28	.	.	.
46745	3399	1	And	and	CC
46745	3399	2	this	this	DT
46745	3399	3	evidently	evidently	RB
46745	3399	4	forms	form	VBZ
46745	3399	5	a	a	DT
46745	3399	6	powerful	powerful	JJ
46745	3399	7	safeguard	safeguard	NN
46745	3399	8	to	to	IN
46745	3399	9	the	the	DT
46745	3399	10	system	system	NN
46745	3399	11	against	against	IN
46745	3399	12	the	the	DT
46745	3399	13	effects	effect	NNS
46745	3399	14	of	of	IN
46745	3399	15	a	a	DT
46745	3399	16	poison	poison	NN
46745	3399	17	.	.	.
46745	3400	1	The	the	DT
46745	3400	2	assertion	assertion	NN
46745	3400	3	is	be	VBZ
46745	3400	4	further	further	RB
46745	3400	5	maintained	maintain	VBN
46745	3400	6	by	by	IN
46745	3400	7	the	the	DT
46745	3400	8	fact	fact	NN
46745	3400	9	that	that	IN
46745	3400	10	the	the	DT
46745	3400	11	action	action	NN
46745	3400	12	of	of	IN
46745	3400	13	a	a	DT
46745	3400	14	Neurotic	Neurotic	NNP
46745	3400	15	,	,	,
46745	3400	16	when	when	WRB
46745	3400	17	applied	apply	VBD
46745	3400	18	topically	topically	RB
46745	3400	19	to	to	IN
46745	3400	20	the	the	DT
46745	3400	21	part	part	NN
46745	3400	22	which	which	WDT
46745	3400	23	it	-PRON-	PRP
46745	3400	24	tends	tend	VBZ
46745	3400	25	to	to	TO
46745	3400	26	influence	influence	VB
46745	3400	27	,	,	,
46745	3400	28	is	be	VBZ
46745	3400	29	the	the	DT
46745	3400	30	same	same	JJ
46745	3400	31	as	as	IN
46745	3400	32	that	that	DT
46745	3400	33	which	which	WDT
46745	3400	34	is	be	VBZ
46745	3400	35	exerted	exert	VBN
46745	3400	36	by	by	IN
46745	3400	37	it	-PRON-	PRP
46745	3400	38	on	on	IN
46745	3400	39	the	the	DT
46745	3400	40	same	same	JJ
46745	3400	41	part	part	NN
46745	3400	42	after	after	IN
46745	3400	43	absorption	absorption	NN
46745	3400	44	.	.	.
46745	3401	1	And	and	CC
46745	3401	2	lastly	lastly	RB
46745	3401	3	,	,	,
46745	3401	4	some	some	DT
46745	3401	5	nerve	nerve	NN
46745	3401	6	-	-	HYPH
46745	3401	7	medicines	medicine	NNS
46745	3401	8	have	have	VBP
46745	3401	9	actually	actually	RB
46745	3401	10	been	be	VBN
46745	3401	11	found	find	VBN
46745	3401	12	after	after	IN
46745	3401	13	death	death	NN
46745	3401	14	in	in	IN
46745	3401	15	the	the	DT
46745	3401	16	substance	substance	NN
46745	3401	17	of	of	IN
46745	3401	18	those	those	DT
46745	3401	19	nerves	nerve	NNS
46745	3401	20	and	and	CC
46745	3401	21	centres	centre	NNS
46745	3401	22	which	which	WDT
46745	3401	23	had	have	VBD
46745	3401	24	been	be	VBN
46745	3401	25	affected	affect	VBN
46745	3401	26	by	by	IN
46745	3401	27	them	-PRON-	PRP
46745	3401	28	during	during	IN
46745	3401	29	life	life	NN
46745	3401	30	.	.	.
46745	3402	1	The	the	DT
46745	3402	2	use	use	NN
46745	3402	3	of	of	IN
46745	3402	4	these	these	DT
46745	3402	5	medicines	medicine	NNS
46745	3402	6	in	in	IN
46745	3402	7	the	the	DT
46745	3402	8	treatment	treatment	NN
46745	3402	9	of	of	IN
46745	3402	10	disease	disease	NN
46745	3402	11	is	be	VBZ
46745	3402	12	defined	define	VBN
46745	3402	13	in	in	IN
46745	3402	14	the	the	DT
46745	3402	15	fourth	fourth	JJ
46745	3402	16	minor	minor	JJ
46745	3402	17	proposition	proposition	NN
46745	3402	18	.	.	.
46745	3403	1	They	-PRON-	PRP
46745	3403	2	have	have	VBP
46745	3403	3	no	no	DT
46745	3403	4	influence	influence	NN
46745	3403	5	in	in	IN
46745	3403	6	the	the	DT
46745	3403	7	blood	blood	NN
46745	3403	8	.	.	.
46745	3404	1	They	-PRON-	PRP
46745	3404	2	are	be	VBP
46745	3404	3	not	not	RB
46745	3404	4	employed	employ	VBN
46745	3404	5	in	in	IN
46745	3404	6	slow	slow	JJ
46745	3404	7	or	or	CC
46745	3404	8	long	long	JJ
46745	3404	9	continuing	continue	VBG
46745	3404	10	diseases	disease	NNS
46745	3404	11	.	.	.
46745	3405	1	Their	-PRON-	PRP$
46745	3405	2	applications	application	NNS
46745	3405	3	depend	depend	VBP
46745	3405	4	on	on	IN
46745	3405	5	their	-PRON-	PRP$
46745	3405	6	known	know	VBN
46745	3405	7	physiological	physiological	JJ
46745	3405	8	tendencies	tendency	NNS
46745	3405	9	,	,	,
46745	3405	10	already	already	RB
46745	3405	11	stated	state	VBN
46745	3405	12	.	.	.
46745	3406	1	Abnormal	abnormal	JJ
46745	3406	2	deviations	deviation	NNS
46745	3406	3	from	from	IN
46745	3406	4	the	the	DT
46745	3406	5	proper	proper	JJ
46745	3406	6	functions	function	NNS
46745	3406	7	of	of	IN
46745	3406	8	the	the	DT
46745	3406	9	nervous	nervous	JJ
46745	3406	10	system	system	NN
46745	3406	11	are	be	VBP
46745	3406	12	rectified	rectify	VBN
46745	3406	13	by	by	IN
46745	3406	14	means	mean	NNS
46745	3406	15	of	of	IN
46745	3406	16	the	the	DT
46745	3406	17	influence	influence	NN
46745	3406	18	which	which	WDT
46745	3406	19	they	-PRON-	PRP
46745	3406	20	exert	exert	VBP
46745	3406	21	over	over	IN
46745	3406	22	the	the	DT
46745	3406	23	nervous	nervous	JJ
46745	3406	24	organs	organ	NNS
46745	3406	25	.	.	.
46745	3407	1	When	when	WRB
46745	3407	2	the	the	DT
46745	3407	3	powers	power	NNS
46745	3407	4	of	of	IN
46745	3407	5	life	life	NN
46745	3407	6	are	be	VBP
46745	3407	7	sinking	sink	VBG
46745	3407	8	,	,	,
46745	3407	9	the	the	DT
46745	3407	10	nervous	nervous	JJ
46745	3407	11	force	force	NN
46745	3407	12	on	on	IN
46745	3407	13	which	which	WDT
46745	3407	14	life	life	NN
46745	3407	15	depends	depend	VBZ
46745	3407	16	may	may	MD
46745	3407	17	perhaps	perhaps	RB
46745	3407	18	be	be	VB
46745	3407	19	roused	rouse	VBN
46745	3407	20	by	by	IN
46745	3407	21	a	a	DT
46745	3407	22	strong	strong	JJ
46745	3407	23	Stimulant	stimulant	NN
46745	3407	24	,	,	,
46745	3407	25	and	and	CC
46745	3407	26	maintained	maintain	VBN
46745	3407	27	by	by	IN
46745	3407	28	its	-PRON-	PRP$
46745	3407	29	repetition	repetition	NN
46745	3407	30	.	.	.
46745	3408	1	Sometimes	sometimes	RB
46745	3408	2	the	the	DT
46745	3408	3	emergency	emergency	NN
46745	3408	4	may	may	MD
46745	3408	5	be	be	VB
46745	3408	6	thus	thus	RB
46745	3408	7	postponed	postpone	VBN
46745	3408	8	,	,	,
46745	3408	9	and	and	CC
46745	3408	10	the	the	DT
46745	3408	11	danger	danger	NN
46745	3408	12	escaped	escape	VBD
46745	3408	13	.	.	.
46745	3409	1	In	in	IN
46745	3409	2	violent	violent	JJ
46745	3409	3	inflammations	inflammation	NNS
46745	3409	4	and	and	CC
46745	3409	5	fevers	fever	NNS
46745	3409	6	,	,	,
46745	3409	7	when	when	WRB
46745	3409	8	the	the	DT
46745	3409	9	action	action	NN
46745	3409	10	of	of	IN
46745	3409	11	the	the	DT
46745	3409	12	heart	heart	NN
46745	3409	13	is	be	VBZ
46745	3409	14	so	so	RB
46745	3409	15	violent	violent	JJ
46745	3409	16	,	,	,
46745	3409	17	and	and	CC
46745	3409	18	the	the	DT
46745	3409	19	nerves	nerve	NNS
46745	3409	20	that	that	WDT
46745	3409	21	control	control	VBP
46745	3409	22	it	-PRON-	PRP
46745	3409	23	so	so	RB
46745	3409	24	excited	excited	JJ
46745	3409	25	,	,	,
46745	3409	26	as	as	IN
46745	3409	27	to	to	TO
46745	3409	28	place	place	VB
46745	3409	29	life	life	NN
46745	3409	30	in	in	IN
46745	3409	31	peril	peril	NNP
46745	3409	32	,	,	,
46745	3409	33	we	-PRON-	PRP
46745	3409	34	may	may	MD
46745	3409	35	do	do	VB
46745	3409	36	good	good	NN
46745	3409	37	by	by	IN
46745	3409	38	the	the	DT
46745	3409	39	administration	administration	NN
46745	3409	40	of	of	IN
46745	3409	41	a	a	DT
46745	3409	42	Sedative	Sedative	NNP
46745	3409	43	,	,	,
46745	3409	44	such	such	JJ
46745	3409	45	as	as	IN
46745	3409	46	Antimony	Antimony	NNP
46745	3409	47	or	or	CC
46745	3409	48	Digitalis	Digitalis	NNP
46745	3409	49	,	,	,
46745	3409	50	by	by	IN
46745	3409	51	which	which	WDT
46745	3409	52	the	the	DT
46745	3409	53	nervous	nervous	JJ
46745	3409	54	force	force	NN
46745	3409	55	may	may	MD
46745	3409	56	be	be	VB
46745	3409	57	reduced	reduce	VBN
46745	3409	58	to	to	IN
46745	3409	59	its	-PRON-	PRP$
46745	3409	60	proper	proper	JJ
46745	3409	61	level	level	NN
46745	3409	62	.	.	.
46745	3410	1	Narcotics	narcotic	NNS
46745	3410	2	are	be	VBP
46745	3410	3	used	use	VBN
46745	3410	4	in	in	IN
46745	3410	5	various	various	JJ
46745	3410	6	cases	case	NNS
46745	3410	7	,	,	,
46745	3410	8	to	to	TO
46745	3410	9	cause	cause	VB
46745	3410	10	sleep	sleep	NN
46745	3410	11	,	,	,
46745	3410	12	or	or	CC
46745	3410	13	to	to	IN
46745	3410	14	quiet	quiet	JJ
46745	3410	15	mental	mental	JJ
46745	3410	16	irritability	irritability	NN
46745	3410	17	.	.	.
46745	3411	1	Both	both	CC
46745	3411	2	these	these	DT
46745	3411	3	and	and	CC
46745	3411	4	Sedatives	Sedatives	NNPS
46745	3411	5	are	be	VBP
46745	3411	6	employed	employ	VBN
46745	3411	7	to	to	TO
46745	3411	8	alleviate	alleviate	VB
46745	3411	9	the	the	DT
46745	3411	10	different	different	JJ
46745	3411	11	kinds	kind	NNS
46745	3411	12	of	of	IN
46745	3411	13	pain	pain	NN
46745	3411	14	.	.	.
46745	3412	1	Neurotics	neurotic	NNS
46745	3412	2	are	be	VBP
46745	3412	3	thus	thus	RB
46745	3412	4	applied	apply	VBN
46745	3412	5	to	to	IN
46745	3412	6	various	various	JJ
46745	3412	7	symptoms	symptom	NNS
46745	3412	8	,	,	,
46745	3412	9	and	and	CC
46745	3412	10	to	to	IN
46745	3412	11	many	many	JJ
46745	3412	12	disorders	disorder	NNS
46745	3412	13	.	.	.
46745	3413	1	Their	-PRON-	PRP$
46745	3413	2	different	different	JJ
46745	3413	3	modes	mode	NNS
46745	3413	4	of	of	IN
46745	3413	5	action	action	NN
46745	3413	6	will	will	MD
46745	3413	7	be	be	VB
46745	3413	8	detailed	detail	VBN
46745	3413	9	more	more	RBR
46745	3413	10	at	at	IN
46745	3413	11	length	length	NN
46745	3413	12	presently	presently	RB
46745	3413	13	.	.	.
46745	3414	1	It	-PRON-	PRP
46745	3414	2	must	must	MD
46745	3414	3	be	be	VB
46745	3414	4	remembered	remember	VBN
46745	3414	5	that	that	IN
46745	3414	6	all	all	PDT
46745	3414	7	these	these	DT
46745	3414	8	actions	action	NNS
46745	3414	9	,	,	,
46745	3414	10	powerful	powerful	JJ
46745	3414	11	though	though	IN
46745	3414	12	they	-PRON-	PRP
46745	3414	13	may	may	MD
46745	3414	14	be	be	VB
46745	3414	15	,	,	,
46745	3414	16	are	be	VBP
46745	3414	17	transitory	transitory	JJ
46745	3414	18	.	.	.
46745	3415	1	The	the	DT
46745	3415	2	effect	effect	NN
46745	3415	3	produced	produce	VBN
46745	3415	4	on	on	IN
46745	3415	5	the	the	DT
46745	3415	6	nerve	nerve	NN
46745	3415	7	is	be	VBZ
46745	3415	8	not	not	RB
46745	3415	9	a	a	DT
46745	3415	10	lasting	lasting	JJ
46745	3415	11	one	one	NN
46745	3415	12	,	,	,
46745	3415	13	and	and	CC
46745	3415	14	no	no	DT
46745	3415	15	essential	essential	JJ
46745	3415	16	change	change	NN
46745	3415	17	in	in	IN
46745	3415	18	the	the	DT
46745	3415	19	blood	blood	NN
46745	3415	20	is	be	VBZ
46745	3415	21	effected	effect	VBN
46745	3415	22	by	by	IN
46745	3415	23	true	true	JJ
46745	3415	24	Neurotics	neurotic	NNS
46745	3415	25	.	.	.
46745	3416	1	They	-PRON-	PRP
46745	3416	2	are	be	VBP
46745	3416	3	not	not	RB
46745	3416	4	natural	natural	JJ
46745	3416	5	elements	element	NNS
46745	3416	6	of	of	IN
46745	3416	7	this	this	DT
46745	3416	8	fluid	fluid	NN
46745	3416	9	,	,	,
46745	3416	10	but	but	CC
46745	3416	11	must	must	MD
46745	3416	12	quickly	quickly	RB
46745	3416	13	pass	pass	VB
46745	3416	14	out	out	IN
46745	3416	15	of	of	IN
46745	3416	16	it	-PRON-	PRP
46745	3416	17	;	;	:
46745	3416	18	and	and	CC
46745	3416	19	they	-PRON-	PRP
46745	3416	20	having	have	VBG
46745	3416	21	thus	thus	RB
46745	3416	22	left	leave	VBN
46745	3416	23	it	-PRON-	PRP
46745	3416	24	,	,	,
46745	3416	25	their	-PRON-	PRP$
46745	3416	26	action	action	NN
46745	3416	27	also	also	RB
46745	3416	28	is	be	VBZ
46745	3416	29	over	over	RB
46745	3416	30	.	.	.
46745	3417	1	Thus	thus	RB
46745	3417	2	the	the	DT
46745	3417	3	truth	truth	NN
46745	3417	4	of	of	IN
46745	3417	5	the	the	DT
46745	3417	6	fifth	fifth	JJ
46745	3417	7	minor	minor	JJ
46745	3417	8	proposition	proposition	NN
46745	3417	9	is	be	VBZ
46745	3417	10	plain	plain	JJ
46745	3417	11	.	.	.
46745	3418	1	I	-PRON-	PRP
46745	3418	2	will	will	MD
46745	3418	3	now	now	RB
46745	3418	4	attempt	attempt	VB
46745	3418	5	to	to	TO
46745	3418	6	give	give	VB
46745	3418	7	a	a	DT
46745	3418	8	brief	brief	JJ
46745	3418	9	but	but	CC
46745	3418	10	distinct	distinct	JJ
46745	3418	11	account	account	NN
46745	3418	12	of	of	IN
46745	3418	13	the	the	DT
46745	3418	14	three	three	CD
46745	3418	15	divisions	division	NNS
46745	3418	16	into	into	IN
46745	3418	17	which	which	WDT
46745	3418	18	I	-PRON-	PRP
46745	3418	19	have	have	VBP
46745	3418	20	divided	divide	VBN
46745	3418	21	this	this	DT
46745	3418	22	class	class	NN
46745	3418	23	of	of	IN
46745	3418	24	medicines	medicine	NNS
46745	3418	25	.	.	.
46745	3419	1	STIMULANTS	stimulant	NNS
46745	3419	2	.	.	.
46745	3420	1	Stimulants	stimulant	NNS
46745	3420	2	are	be	VBP
46745	3420	3	medicines	medicine	NNS
46745	3420	4	which	which	WDT
46745	3420	5	pass	pass	VBP
46745	3420	6	from	from	IN
46745	3420	7	the	the	DT
46745	3420	8	blood	blood	NN
46745	3420	9	to	to	IN
46745	3420	10	the	the	DT
46745	3420	11	nerves	nerve	NNS
46745	3420	12	or	or	CC
46745	3420	13	nerve	nerve	NN
46745	3420	14	-	-	HYPH
46745	3420	15	centres	centre	NNS
46745	3420	16	,	,	,
46745	3420	17	and	and	CC
46745	3420	18	act	act	VB
46745	3420	19	on	on	IN
46745	3420	20	them	-PRON-	PRP
46745	3420	21	so	so	IN
46745	3420	22	as	as	IN
46745	3420	23	to	to	TO
46745	3420	24	exalt	exalt	VB
46745	3420	25	nervous	nervous	JJ
46745	3420	26	force	force	NN
46745	3420	27	,	,	,
46745	3420	28	in	in	IN
46745	3420	29	general	general	JJ
46745	3420	30	or	or	CC
46745	3420	31	in	in	IN
46745	3420	32	particular	particular	JJ
46745	3420	33	.	.	.
46745	3421	1	That	that	RB
46745	3421	2	is	is	RB
46745	3421	3	,	,	,
46745	3421	4	they	-PRON-	PRP
46745	3421	5	may	may	MD
46745	3421	6	extend	extend	VB
46745	3421	7	their	-PRON-	PRP$
46745	3421	8	operation	operation	NN
46745	3421	9	more	more	RBR
46745	3421	10	or	or	CC
46745	3421	11	less	less	JJR
46745	3421	12	to	to	IN
46745	3421	13	the	the	DT
46745	3421	14	whole	whole	JJ
46745	3421	15	nervous	nervous	JJ
46745	3421	16	system	system	NN
46745	3421	17	,	,	,
46745	3421	18	having	have	VBG
46745	3421	19	a	a	DT
46745	3421	20	general	general	JJ
46745	3421	21	tendency	tendency	NN
46745	3421	22	to	to	TO
46745	3421	23	communicate	communicate	VB
46745	3421	24	nervous	nervous	JJ
46745	3421	25	energy	energy	NN
46745	3421	26	;	;	:
46745	3421	27	or	or	CC
46745	3421	28	they	-PRON-	PRP
46745	3421	29	may	may	MD
46745	3421	30	confine	confine	VB
46745	3421	31	their	-PRON-	PRP$
46745	3421	32	action	action	NN
46745	3421	33	to	to	IN
46745	3421	34	particular	particular	JJ
46745	3421	35	departments	department	NNS
46745	3421	36	of	of	IN
46745	3421	37	this	this	DT
46745	3421	38	system	system	NN
46745	3421	39	,	,	,
46745	3421	40	having	have	VBG
46745	3421	41	no	no	DT
46745	3421	42	manifest	manif	JJS
46745	3421	43	influence	influence	NN
46745	3421	44	on	on	IN
46745	3421	45	other	other	JJ
46745	3421	46	parts	part	NNS
46745	3421	47	.	.	.
46745	3422	1	On	on	IN
46745	3422	2	referring	refer	VBG
46745	3422	3	to	to	IN
46745	3422	4	the	the	DT
46745	3422	5	arrangement	arrangement	NN
46745	3422	6	at	at	IN
46745	3422	7	the	the	DT
46745	3422	8	commencement	commencement	NN
46745	3422	9	of	of	IN
46745	3422	10	the	the	DT
46745	3422	11	Essay	Essay	NNP
46745	3422	12	,	,	,
46745	3422	13	it	-PRON-	PRP
46745	3422	14	will	will	MD
46745	3422	15	be	be	VB
46745	3422	16	seen	see	VBN
46745	3422	17	that	that	IN
46745	3422	18	Stimulants	Stimulants	NNP
46745	3422	19	are	be	VBP
46745	3422	20	subdivided	subdivide	VBN
46745	3422	21	,	,	,
46745	3422	22	according	accord	VBG
46745	3422	23	to	to	IN
46745	3422	24	whether	whether	IN
46745	3422	25	their	-PRON-	PRP$
46745	3422	26	action	action	NN
46745	3422	27	is	be	VBZ
46745	3422	28	thus	thus	RB
46745	3422	29	extended	extend	VBN
46745	3422	30	or	or	CC
46745	3422	31	confined	confine	VBN
46745	3422	32	.	.	.
46745	3423	1	STIMULANTIA	STIMULANTIA	NNP
46745	3423	2	.	.	.
46745	3424	1	Ord	Ord	NNP
46745	3424	2	.	.	.
46745	3425	1	1	1	LS
46745	3425	2	.	.	.
46745	3426	1	Stimulantia	Stimulantia	NNP
46745	3426	2	generalia	generalia	NNP
46745	3426	3	.	.	.
46745	3427	1	Ord	Ord	NNP
46745	3427	2	.	.	.
46745	3428	1	2	2	LS
46745	3428	2	.	.	.
46745	3429	1	Stimulantia	Stimulantia	NNP
46745	3429	2	specifica	specifica	NNP
46745	3429	3	.	.	.
46745	3430	1	The	the	DT
46745	3430	2	first	first	JJ
46745	3430	3	order	order	NN
46745	3430	4	includes	include	VBZ
46745	3430	5	all	all	PDT
46745	3430	6	the	the	DT
46745	3430	7	medicines	medicine	NNS
46745	3430	8	that	that	WDT
46745	3430	9	are	be	VBP
46745	3430	10	commonly	commonly	RB
46745	3430	11	understood	understand	VBN
46745	3430	12	to	to	TO
46745	3430	13	be	be	VB
46745	3430	14	Stimulants	stimulant	NNS
46745	3430	15	.	.	.
46745	3431	1	But	but	CC
46745	3431	2	as	as	IN
46745	3431	3	the	the	DT
46745	3431	4	remedies	remedy	NNS
46745	3431	5	of	of	IN
46745	3431	6	the	the	DT
46745	3431	7	second	second	JJ
46745	3431	8	order	order	NN
46745	3431	9	obviously	obviously	RB
46745	3431	10	exalt	exalt	VB
46745	3431	11	nervous	nervous	JJ
46745	3431	12	force	force	NN
46745	3431	13	,	,	,
46745	3431	14	the	the	DT
46745	3431	15	term	term	NN
46745	3431	16	applied	apply	VBD
46745	3431	17	to	to	IN
46745	3431	18	the	the	DT
46745	3431	19	others	other	NNS
46745	3431	20	on	on	IN
46745	3431	21	that	that	DT
46745	3431	22	ground	ground	NN
46745	3431	23	could	could	MD
46745	3431	24	not	not	RB
46745	3431	25	consistently	consistently	RB
46745	3431	26	be	be	VB
46745	3431	27	withheld	withhold	VBN
46745	3431	28	from	from	IN
46745	3431	29	them	-PRON-	PRP
46745	3431	30	,	,	,
46745	3431	31	although	although	IN
46745	3431	32	their	-PRON-	PRP$
46745	3431	33	action	action	NN
46745	3431	34	is	be	VBZ
46745	3431	35	more	more	RBR
46745	3431	36	limited	limited	JJ
46745	3431	37	and	and	CC
46745	3431	38	local	local	JJ
46745	3431	39	in	in	IN
46745	3431	40	its	-PRON-	PRP$
46745	3431	41	nature	nature	NN
46745	3431	42	,	,	,
46745	3431	43	being	be	VBG
46745	3431	44	confined	confine	VBN
46745	3431	45	to	to	IN
46745	3431	46	a	a	DT
46745	3431	47	certain	certain	JJ
46745	3431	48	part	part	NN
46745	3431	49	of	of	IN
46745	3431	50	the	the	DT
46745	3431	51	body	body	NN
46745	3431	52	,	,	,
46745	3431	53	and	and	CC
46745	3431	54	to	to	IN
46745	3431	55	certain	certain	JJ
46745	3431	56	nerves	nerve	NNS
46745	3431	57	.	.	.
46745	3432	1	The	the	DT
46745	3432	2	same	same	JJ
46745	3432	3	remark	remark	NN
46745	3432	4	may	may	MD
46745	3432	5	be	be	VB
46745	3432	6	made	make	VBN
46745	3432	7	of	of	IN
46745	3432	8	the	the	DT
46745	3432	9	order	order	NN
46745	3432	10	of	of	IN
46745	3432	11	Special	Special	NNP
46745	3432	12	Sedatives	Sedatives	NNPS
46745	3432	13	,	,	,
46745	3432	14	which	which	WDT
46745	3432	15	will	will	MD
46745	3432	16	soon	soon	RB
46745	3432	17	have	have	VB
46745	3432	18	to	to	TO
46745	3432	19	be	be	VB
46745	3432	20	considered	consider	VBN
46745	3432	21	.	.	.
46745	3433	1	ORD	ORD	NNP
46745	3433	2	.	.	.
46745	3434	1	I.	I.	NNP
46745	3435	1	GENERAL	GENERAL	NNP
46745	3435	2	STIMULANTS	STIMULANTS	NNP
46745	3435	3	.	.	.
46745	3436	1	(	(	-LRB-
46745	3436	2	_	_	NNP
46745	3436	3	Mineral	Mineral	NNP
46745	3436	4	substances._--Ammonia	substances._--ammonia	NN
46745	3436	5	and	and	CC
46745	3436	6	its	-PRON-	PRP$
46745	3436	7	Carbonates	Carbonates	NNPS
46745	3436	8	.	.	.
46745	3437	1	Phosphorus	Phosphorus	NNP
46745	3437	2	.	.	.
46745	3438	1	_	_	NNP
46745	3438	2	Animal	Animal	NNP
46745	3438	3	substances._--Musk	substances._--Musk	:
46745	3438	4	,	,	,
46745	3438	5	and	and	CC
46745	3438	6	Castor	Castor	NNP
46745	3438	7	.	.	.
46745	3439	1	_	_	NNP
46745	3439	2	Vegetables	Vegetables	NNP
46745	3439	3	containing	contain	VBG
46745	3439	4	volatile	volatile	JJ
46745	3439	5	oils._--The	oils._--the	RB
46745	3439	6	aromatic	aromatic	JJ
46745	3439	7	Labiatæ	Labiatæ	NNP
46745	3439	8	,	,	,
46745	3439	9	Compositæ	Compositæ	NNP
46745	3439	10	,	,	,
46745	3439	11	and	and	CC
46745	3439	12	Umbelliferæ	Umbelliferæ	NNP
46745	3439	13	.	.	.
46745	3440	1	Cloves	clove	NNS
46745	3440	2	and	and	CC
46745	3440	3	Nutmeg	Nutmeg	NNP
46745	3440	4	.	.	.
46745	3441	1	Cinnamon	Cinnamon	NNP
46745	3441	2	,	,	,
46745	3441	3	Cassia	Cassia	NNP
46745	3441	4	,	,	,
46745	3441	5	Sassafras	Sassafras	NNP
46745	3441	6	.	.	.
46745	3442	1	Rue	Rue	NNP
46745	3442	2	,	,	,
46745	3442	3	Barosma	Barosma	NNP
46745	3442	4	.	.	.
46745	3443	1	The	the	DT
46745	3443	2	Aurantiaceæ	Aurantiaceæ	NNP
46745	3443	3	.	.	.
46745	3444	1	Canella	Canella	NNP
46745	3444	2	.	.	.
46745	3445	1	Valerian	valerian	JJ
46745	3445	2	.	.	.
46745	3446	1	Mustard	mustard	NN
46745	3446	2	.	.	.
46745	3447	1	Cajeput	Cajeput	NNP
46745	3447	2	and	and	CC
46745	3447	3	Pimenta	Pimenta	NNP
46745	3447	4	.	.	.
46745	3448	1	Hops	hop	NNS
46745	3448	2	.	.	.
46745	3449	1	Juniper	Juniper	NNP
46745	3449	2	,	,	,
46745	3449	3	Turpentine	Turpentine	NNP
46745	3449	4	.	.	.
46745	3450	1	Cardamom	Cardamom	NNS
46745	3450	2	.	.	.
46745	3451	1	Onion	onion	NN
46745	3451	2	.	.	.
46745	3452	1	_	_	NNP
46745	3452	2	Vegetables	Vegetables	NNP
46745	3452	3	containing	contain	VBG
46745	3452	4	acrid	acrid	JJ
46745	3452	5	principles._--Senega	principles._--senega	NN
46745	3452	6	.	.	.
46745	3453	1	Horseradish	Horseradish	NNP
46745	3453	2	.	.	.
46745	3454	1	Serpentary	Serpentary	NNP
46745	3454	2	.	.	.
46745	3455	1	Cascarilla	Cascarilla	NNP
46745	3455	2	.	.	.
46745	3456	1	Pepper	pepper	NN
46745	3456	2	.	.	.
46745	3457	1	Contrajerva	contrajerva	UH
46745	3457	2	.	.	.
46745	3458	1	Ginger	ginger	NN
46745	3458	2	.	.	.
46745	3459	1	Capsicum	Capsicum	NNP
46745	3459	2	.	.	.
46745	3460	1	Mezereon	Mezereon	NNP
46745	3460	2	.	.	.
46745	3461	1	_	_	NNP
46745	3461	2	Resinous	Resinous	NNP
46745	3461	3	substances._--Guaiacum	substances._--guaiacum	NN
46745	3461	4	.	.	.
46745	3462	1	Mastich	Mastich	NNP
46745	3462	2	,	,	,
46745	3462	3	Olibanum	Olibanum	NNP
46745	3462	4	,	,	,
46745	3462	5	Myrrh	Myrrh	NNP
46745	3462	6	,	,	,
46745	3462	7	Elemi	Elemi	NNP
46745	3462	8	.	.	.
46745	3463	1	Copaiba	Copaiba	NNP
46745	3463	2	.	.	.
46745	3464	1	Peru	Peru	NNP
46745	3464	2	,	,	,
46745	3464	3	Tolu	Tolu	NNP
46745	3464	4	.	.	.
46745	3465	1	Assaf[oe]tida	Assaf[oe]tida	NNP
46745	3465	2	,	,	,
46745	3465	3	Ammoniacum	Ammoniacum	NNP
46745	3465	4	,	,	,
46745	3465	5	Galbanum	Galbanum	NNP
46745	3465	6	.	.	.
46745	3466	1	Benzoin	Benzoin	NNP
46745	3466	2	,	,	,
46745	3466	3	Storax	Storax	NNP
46745	3466	4	.	.	.
46745	3467	1	Pine	pine	JJ
46745	3467	2	resin	resin	NN
46745	3467	3	.	.	.
46745	3467	4	)	)	-RRB-
46745	3468	1	This	this	DT
46745	3468	2	list	list	NN
46745	3468	3	of	of	IN
46745	3468	4	General	General	NNP
46745	3468	5	Stimulants	Stimulants	NNP
46745	3468	6	is	be	VBZ
46745	3468	7	long	long	JJ
46745	3468	8	,	,	,
46745	3468	9	but	but	CC
46745	3468	10	it	-PRON-	PRP
46745	3468	11	might	may	MD
46745	3468	12	even	even	RB
46745	3468	13	be	be	VB
46745	3468	14	further	further	RB
46745	3468	15	extended	extend	VBN
46745	3468	16	.	.	.
46745	3469	1	The	the	DT
46745	3469	2	majority	majority	NN
46745	3469	3	are	be	VBP
46745	3469	4	produced	produce	VBN
46745	3469	5	by	by	IN
46745	3469	6	the	the	DT
46745	3469	7	vegetable	vegetable	JJ
46745	3469	8	kingdom	kingdom	NN
46745	3469	9	.	.	.
46745	3470	1	The	the	DT
46745	3470	2	acrid	acrid	JJ
46745	3470	3	principles	principle	NNS
46745	3470	4	to	to	TO
46745	3470	5	which	which	WDT
46745	3470	6	some	some	DT
46745	3470	7	owe	owe	VBP
46745	3470	8	their	-PRON-	PRP$
46745	3470	9	power	power	NN
46745	3470	10	are	be	VBP
46745	3470	11	intermediate	intermediate	JJ
46745	3470	12	in	in	IN
46745	3470	13	nature	nature	NN
46745	3470	14	between	between	IN
46745	3470	15	volatile	volatile	JJ
46745	3470	16	oils	oil	NNS
46745	3470	17	and	and	CC
46745	3470	18	resins	resin	NNS
46745	3470	19	.	.	.
46745	3471	1	Some	some	DT
46745	3471	2	of	of	IN
46745	3471	3	them	-PRON-	PRP
46745	3471	4	are	be	VBP
46745	3471	5	volatile	volatile	JJ
46745	3471	6	,	,	,
46745	3471	7	like	like	IN
46745	3471	8	the	the	DT
46745	3471	9	former	former	JJ
46745	3471	10	;	;	:
46745	3471	11	others	other	NNS
46745	3471	12	fixed	fix	VBN
46745	3471	13	,	,	,
46745	3471	14	like	like	IN
46745	3471	15	the	the	DT
46745	3471	16	latter	latter	JJ
46745	3471	17	.	.	.
46745	3472	1	Some	some	DT
46745	3472	2	of	of	IN
46745	3472	3	the	the	DT
46745	3472	4	resinous	resinous	JJ
46745	3472	5	products	product	NNS
46745	3472	6	contain	contain	VBP
46745	3472	7	also	also	RB
46745	3472	8	a	a	DT
46745	3472	9	volatile	volatile	JJ
46745	3472	10	oil	oil	NN
46745	3472	11	.	.	.
46745	3473	1	The	the	DT
46745	3473	2	principles	principle	NNS
46745	3473	3	of	of	IN
46745	3473	4	Capsicum	Capsicum	NNP
46745	3473	5	and	and	CC
46745	3473	6	Mezereon	Mezereon	NNP
46745	3473	7	are	be	VBP
46745	3473	8	very	very	RB
46745	3473	9	similar	similar	JJ
46745	3473	10	in	in	IN
46745	3473	11	their	-PRON-	PRP$
46745	3473	12	chemical	chemical	NN
46745	3473	13	nature	nature	NN
46745	3473	14	to	to	IN
46745	3473	15	the	the	DT
46745	3473	16	true	true	JJ
46745	3473	17	resins	resin	NNS
46745	3473	18	.	.	.
46745	3474	1	(	(	-LRB-
46745	3474	2	_	_	NNP
46745	3474	3	Vide	Vide	NNP
46745	3474	4	_	_	NNP
46745	3474	5	page	page	NN
46745	3474	6	85	85	CD
46745	3474	7	.	.	.
46745	3474	8	)	)	-RRB-
46745	3475	1	These	these	DT
46745	3475	2	remedies	remedy	NNS
46745	3475	3	differ	differ	VBP
46745	3475	4	very	very	RB
46745	3475	5	much	much	RB
46745	3475	6	in	in	IN
46745	3475	7	power	power	NN
46745	3475	8	,	,	,
46745	3475	9	but	but	CC
46745	3475	10	their	-PRON-	PRP$
46745	3475	11	influence	influence	NN
46745	3475	12	is	be	VBZ
46745	3475	13	the	the	DT
46745	3475	14	same	same	JJ
46745	3475	15	in	in	IN
46745	3475	16	character	character	NN
46745	3475	17	.	.	.
46745	3476	1	They	-PRON-	PRP
46745	3476	2	exalt	exalt	VBP
46745	3476	3	nervous	nervous	JJ
46745	3476	4	force	force	NN
46745	3476	5	in	in	IN
46745	3476	6	general	general	JJ
46745	3476	7	.	.	.
46745	3477	1	They	-PRON-	PRP
46745	3477	2	seem	seem	VBP
46745	3477	3	to	to	TO
46745	3477	4	act	act	VB
46745	3477	5	on	on	IN
46745	3477	6	the	the	DT
46745	3477	7	whole	whole	JJ
46745	3477	8	nervous	nervous	JJ
46745	3477	9	system	system	NN
46745	3477	10	;	;	:
46745	3477	11	but	but	CC
46745	3477	12	their	-PRON-	PRP$
46745	3477	13	most	most	RBS
46745	3477	14	obvious	obvious	JJ
46745	3477	15	action	action	NN
46745	3477	16	is	be	VBZ
46745	3477	17	to	to	TO
46745	3477	18	increase	increase	VB
46745	3477	19	the	the	DT
46745	3477	20	force	force	NN
46745	3477	21	and	and	CC
46745	3477	22	frequency	frequency	NN
46745	3477	23	of	of	IN
46745	3477	24	the	the	DT
46745	3477	25	pulse	pulse	NN
46745	3477	26	,	,	,
46745	3477	27	and	and	CC
46745	3477	28	to	to	TO
46745	3477	29	invigorate	invigorate	VB
46745	3477	30	the	the	DT
46745	3477	31	circulation	circulation	NN
46745	3477	32	.	.	.
46745	3478	1	They	-PRON-	PRP
46745	3478	2	are	be	VBP
46745	3478	3	not	not	RB
46745	3478	4	,	,	,
46745	3478	5	for	for	IN
46745	3478	6	the	the	DT
46745	3478	7	most	most	JJS
46745	3478	8	part	part	NN
46745	3478	9	,	,	,
46745	3478	10	very	very	RB
46745	3478	11	powerful	powerful	JJ
46745	3478	12	medicines	medicine	NNS
46745	3478	13	;	;	:
46745	3478	14	and	and	CC
46745	3478	15	their	-PRON-	PRP$
46745	3478	16	action	action	NN
46745	3478	17	is	be	VBZ
46745	3478	18	seldom	seldom	RB
46745	3478	19	so	so	RB
46745	3478	20	violent	violent	JJ
46745	3478	21	as	as	IN
46745	3478	22	to	to	TO
46745	3478	23	be	be	VB
46745	3478	24	succeeded	succeed	VBN
46745	3478	25	by	by	IN
46745	3478	26	much	much	JJ
46745	3478	27	reaction	reaction	NN
46745	3478	28	.	.	.
46745	3479	1	They	-PRON-	PRP
46745	3479	2	improve	improve	VBP
46745	3479	3	digestion	digestion	NN
46745	3479	4	for	for	IN
46745	3479	5	a	a	DT
46745	3479	6	time	time	NN
46745	3479	7	,	,	,
46745	3479	8	by	by	IN
46745	3479	9	a	a	DT
46745	3479	10	stimulation	stimulation	NN
46745	3479	11	of	of	IN
46745	3479	12	the	the	DT
46745	3479	13	sympathetic	sympathetic	JJ
46745	3479	14	nerves	nerve	NNS
46745	3479	15	of	of	IN
46745	3479	16	the	the	DT
46745	3479	17	stomach	stomach	NN
46745	3479	18	and	and	CC
46745	3479	19	other	other	JJ
46745	3479	20	viscera	viscera	NNS
46745	3479	21	.	.	.
46745	3480	1	In	in	IN
46745	3480	2	large	large	JJ
46745	3480	3	doses	dose	NNS
46745	3480	4	they	-PRON-	PRP
46745	3480	5	are	be	VBP
46745	3480	6	irritants	irritant	NNS
46745	3480	7	,	,	,
46745	3480	8	and	and	CC
46745	3480	9	may	may	MD
46745	3480	10	impair	impair	VB
46745	3480	11	the	the	DT
46745	3480	12	digestive	digestive	JJ
46745	3480	13	powers	power	NNS
46745	3480	14	,	,	,
46745	3480	15	and	and	CC
46745	3480	16	cause	cause	NNP
46745	3480	17	headache	headache	NNP
46745	3480	18	.	.	.
46745	3481	1	Though	though	IN
46745	3481	2	possessing	possess	VBG
46745	3481	3	no	no	DT
46745	3481	4	marked	marked	JJ
46745	3481	5	stimulant	stimulant	JJ
46745	3481	6	power	power	NN
46745	3481	7	over	over	IN
46745	3481	8	the	the	DT
46745	3481	9	function	function	NN
46745	3481	10	of	of	IN
46745	3481	11	mind	mind	NN
46745	3481	12	,	,	,
46745	3481	13	like	like	IN
46745	3481	14	that	that	DT
46745	3481	15	of	of	IN
46745	3481	16	the	the	DT
46745	3481	17	Inebriant	Inebriant	NNP
46745	3481	18	Narcotics	Narcotics	NNP
46745	3481	19	,	,	,
46745	3481	20	yet	yet	RB
46745	3481	21	they	-PRON-	PRP
46745	3481	22	certainly	certainly	RB
46745	3481	23	exalt	exalt	VBP
46745	3481	24	the	the	DT
46745	3481	25	activity	activity	NN
46745	3481	26	of	of	IN
46745	3481	27	the	the	DT
46745	3481	28	brain	brain	NN
46745	3481	29	,	,	,
46745	3481	30	along	along	IN
46745	3481	31	with	with	IN
46745	3481	32	the	the	DT
46745	3481	33	other	other	JJ
46745	3481	34	nervous	nervous	JJ
46745	3481	35	forces	force	NNS
46745	3481	36	.	.	.
46745	3482	1	Dr.	Dr.	NNP
46745	3482	2	Pereira	Pereira	NNP
46745	3482	3	classes	class	VBZ
46745	3482	4	the	the	DT
46745	3482	5	majority	majority	NN
46745	3482	6	of	of	IN
46745	3482	7	Stimulants	Stimulants	NNPS
46745	3482	8	among	among	IN
46745	3482	9	_	_	NNP
46745	3482	10	Ganglionics	Ganglionics	NNP
46745	3482	11	_	_	NNP
46745	3482	12	,	,	,
46745	3482	13	considering	consider	VBG
46745	3482	14	that	that	IN
46745	3482	15	they	-PRON-	PRP
46745	3482	16	only	only	RB
46745	3482	17	act	act	VBP
46745	3482	18	on	on	IN
46745	3482	19	parts	part	NNS
46745	3482	20	supplied	supply	VBN
46745	3482	21	by	by	IN
46745	3482	22	the	the	DT
46745	3482	23	sympathetic	sympathetic	JJ
46745	3482	24	system	system	NN
46745	3482	25	of	of	IN
46745	3482	26	nerves	nerve	NNS
46745	3482	27	.	.	.
46745	3483	1	But	but	CC
46745	3483	2	this	this	DT
46745	3483	3	view	view	NN
46745	3483	4	of	of	IN
46745	3483	5	their	-PRON-	PRP$
46745	3483	6	operation	operation	NN
46745	3483	7	appears	appear	VBZ
46745	3483	8	to	to	IN
46745	3483	9	me	-PRON-	PRP
46745	3483	10	to	to	TO
46745	3483	11	be	be	VB
46745	3483	12	too	too	RB
46745	3483	13	limited	limited	JJ
46745	3483	14	;	;	:
46745	3483	15	for	for	IN
46745	3483	16	all	all	DT
46745	3483	17	of	of	IN
46745	3483	18	them	-PRON-	PRP
46745	3483	19	seem	seem	VBP
46745	3483	20	to	to	TO
46745	3483	21	have	have	VB
46745	3483	22	a	a	DT
46745	3483	23	certain	certain	JJ
46745	3483	24	action	action	NN
46745	3483	25	on	on	IN
46745	3483	26	the	the	DT
46745	3483	27	brain	brain	NN
46745	3483	28	.	.	.
46745	3484	1	Thus	thus	RB
46745	3484	2	Ammonia	Ammonia	NNP
46745	3484	3	is	be	VBZ
46745	3484	4	used	use	VBN
46745	3484	5	in	in	IN
46745	3484	6	Syncope	Syncope	NNP
46745	3484	7	,	,	,
46745	3484	8	a	a	DT
46745	3484	9	state	state	NN
46745	3484	10	which	which	WDT
46745	3484	11	no	no	RB
46745	3484	12	doubt	doubt	RB
46745	3484	13	depends	depend	VBZ
46745	3484	14	upon	upon	IN
46745	3484	15	a	a	DT
46745	3484	16	shock	shock	NN
46745	3484	17	received	receive	VBN
46745	3484	18	by	by	IN
46745	3484	19	the	the	DT
46745	3484	20	brain	brain	NN
46745	3484	21	.	.	.
46745	3485	1	And	and	CC
46745	3485	2	there	there	EX
46745	3485	3	are	be	VBP
46745	3485	4	several	several	JJ
46745	3485	5	things	thing	NNS
46745	3485	6	which	which	WDT
46745	3485	7	show	show	VBP
46745	3485	8	that	that	IN
46745	3485	9	it	-PRON-	PRP
46745	3485	10	relieves	relieve	VBZ
46745	3485	11	this	this	DT
46745	3485	12	state	state	NN
46745	3485	13	more	more	RBR
46745	3485	14	by	by	IN
46745	3485	15	stimulating	stimulate	VBG
46745	3485	16	the	the	DT
46745	3485	17	brain	brain	NN
46745	3485	18	than	than	IN
46745	3485	19	by	by	IN
46745	3485	20	merely	merely	RB
46745	3485	21	rousing	rouse	VBG
46745	3485	22	the	the	DT
46745	3485	23	heart	heart	NN
46745	3485	24	and	and	CC
46745	3485	25	vascular	vascular	JJ
46745	3485	26	system	system	NN
46745	3485	27	.	.	.
46745	3486	1	It	-PRON-	PRP
46745	3486	2	is	be	VBZ
46745	3486	3	found	find	VBN
46745	3486	4	to	to	TO
46745	3486	5	be	be	VB
46745	3486	6	most	most	RBS
46745	3486	7	effectual	effectual	JJ
46745	3486	8	when	when	WRB
46745	3486	9	inhaled	inhale	VBD
46745	3486	10	through	through	IN
46745	3486	11	the	the	DT
46745	3486	12	nose	nose	NN
46745	3486	13	;	;	:
46745	3486	14	by	by	IN
46745	3486	15	which	which	WDT
46745	3486	16	means	mean	VBZ
46745	3486	17	it	-PRON-	PRP
46745	3486	18	could	could	MD
46745	3486	19	easily	easily	RB
46745	3486	20	pass	pass	VB
46745	3486	21	at	at	RP
46745	3486	22	once	once	RB
46745	3486	23	into	into	IN
46745	3486	24	the	the	DT
46745	3486	25	cerebral	cerebral	JJ
46745	3486	26	circulation	circulation	NN
46745	3486	27	.	.	.
46745	3487	1	Dr.	Dr.	NNP
46745	3487	2	Pereira	Pereira	NNP
46745	3487	3	thinks	think	VBZ
46745	3487	4	that	that	IN
46745	3487	5	when	when	WRB
46745	3487	6	administered	administer	VBN
46745	3487	7	in	in	IN
46745	3487	8	the	the	DT
46745	3487	9	liquid	liquid	JJ
46745	3487	10	form	form	NN
46745	3487	11	it	-PRON-	PRP
46745	3487	12	can	can	MD
46745	3487	13	only	only	RB
46745	3487	14	pass	pass	VB
46745	3487	15	into	into	IN
46745	3487	16	the	the	DT
46745	3487	17	blood	blood	NN
46745	3487	18	as	as	IN
46745	3487	19	a	a	DT
46745	3487	20	salt	salt	NN
46745	3487	21	,	,	,
46745	3487	22	being	be	VBG
46745	3487	23	neutralized	neutralize	VBN
46745	3487	24	by	by	IN
46745	3487	25	the	the	DT
46745	3487	26	stomach	stomach	NN
46745	3487	27	-	-	HYPH
46745	3487	28	acid	acid	NN
46745	3487	29	.	.	.
46745	3488	1	In	in	IN
46745	3488	2	this	this	DT
46745	3488	3	case	case	NN
46745	3488	4	it	-PRON-	PRP
46745	3488	5	could	could	MD
46745	3488	6	only	only	RB
46745	3488	7	act	act	VB
46745	3488	8	before	before	IN
46745	3488	9	absorption	absorption	NN
46745	3488	10	.	.	.
46745	3489	1	But	but	CC
46745	3489	2	it	-PRON-	PRP
46745	3489	3	is	be	VBZ
46745	3489	4	probable	probable	JJ
46745	3489	5	that	that	IN
46745	3489	6	it	-PRON-	PRP
46745	3489	7	is	be	VBZ
46745	3489	8	too	too	RB
46745	3489	9	diffusible	diffusible	JJ
46745	3489	10	and	and	CC
46745	3489	11	too	too	RB
46745	3489	12	rapidly	rapidly	RB
46745	3489	13	absorbed	absorb	VBN
46745	3489	14	to	to	TO
46745	3489	15	be	be	VB
46745	3489	16	entirely	entirely	RB
46745	3489	17	so	so	RB
46745	3489	18	neutralized	neutralized	JJ
46745	3489	19	;	;	:
46745	3489	20	and	and	CC
46745	3489	21	besides	besides	RB
46745	3489	22	,	,	,
46745	3489	23	its	-PRON-	PRP$
46745	3489	24	operation	operation	NN
46745	3489	25	when	when	WRB
46745	3489	26	inhaled	inhale	VBD
46745	3489	27	is	be	VBZ
46745	3489	28	the	the	DT
46745	3489	29	same	same	JJ
46745	3489	30	as	as	IN
46745	3489	31	when	when	WRB
46745	3489	32	ingested	ingest	VBN
46745	3489	33	,	,	,
46745	3489	34	which	which	WDT
46745	3489	35	seems	seem	VBZ
46745	3489	36	to	to	TO
46745	3489	37	point	point	VB
46745	3489	38	to	to	IN
46745	3489	39	an	an	DT
46745	3489	40	agency	agency	NN
46745	3489	41	after	after	IN
46745	3489	42	absorption	absorption	NN
46745	3489	43	in	in	IN
46745	3489	44	the	the	DT
46745	3489	45	latter	latter	JJ
46745	3489	46	case	case	NN
46745	3489	47	.	.	.
46745	3490	1	For	for	IN
46745	3490	2	when	when	WRB
46745	3490	3	inhaled	inhale	VBN
46745	3490	4	,	,	,
46745	3490	5	it	-PRON-	PRP
46745	3490	6	must	must	MD
46745	3490	7	be	be	VB
46745	3490	8	absorbed	absorb	VBN
46745	3490	9	in	in	IN
46745	3490	10	the	the	DT
46745	3490	11	free	free	JJ
46745	3490	12	state	state	NN
46745	3490	13	.	.	.
46745	3491	1	And	and	CC
46745	3491	2	to	to	TO
46745	3491	3	suppose	suppose	VB
46745	3491	4	that	that	IN
46745	3491	5	it	-PRON-	PRP
46745	3491	6	acts	act	VBZ
46745	3491	7	by	by	IN
46745	3491	8	stimulating	stimulate	VBG
46745	3491	9	the	the	DT
46745	3491	10	nerves	nerve	NNS
46745	3491	11	of	of	IN
46745	3491	12	the	the	DT
46745	3491	13	stomach	stomach	NN
46745	3491	14	only	only	RB
46745	3491	15	,	,	,
46745	3491	16	is	be	VBZ
46745	3491	17	to	to	TO
46745	3491	18	receive	receive	VB
46745	3491	19	a	a	DT
46745	3491	20	thing	thing	NN
46745	3491	21	for	for	IN
46745	3491	22	which	which	WDT
46745	3491	23	we	-PRON-	PRP
46745	3491	24	find	find	VBP
46745	3491	25	no	no	DT
46745	3491	26	parallel	parallel	NN
46745	3491	27	in	in	IN
46745	3491	28	the	the	DT
46745	3491	29	action	action	NN
46745	3491	30	of	of	IN
46745	3491	31	medicines	medicine	NNS
46745	3491	32	.	.	.
46745	3492	1	(	(	-LRB-
46745	3492	2	_	_	NNP
46745	3492	3	Vide	Vide	NNP
46745	3492	4	Prop	Prop	NNP
46745	3492	5	.	.	.
46745	3493	1	I.	I.	NNP
46745	3493	2	_	_	NNP
46745	3493	3	)	)	-RRB-
46745	3493	4	Ammonia	Ammonia	NNP
46745	3493	5	has	have	VBZ
46745	3493	6	been	be	VBN
46745	3493	7	used	use	VBN
46745	3493	8	with	with	IN
46745	3493	9	advantage	advantage	NN
46745	3493	10	in	in	IN
46745	3493	11	the	the	DT
46745	3493	12	prevention	prevention	NN
46745	3493	13	of	of	IN
46745	3493	14	Epileptic	epileptic	JJ
46745	3493	15	fits	fit	NNS
46745	3493	16	,	,	,
46745	3493	17	being	be	VBG
46745	3493	18	given	give	VBN
46745	3493	19	just	just	RB
46745	3493	20	before	before	IN
46745	3493	21	their	-PRON-	PRP$
46745	3493	22	expected	expect	VBN
46745	3493	23	occurrence	occurrence	NN
46745	3493	24	.	.	.
46745	3494	1	It	-PRON-	PRP
46745	3494	2	could	could	MD
46745	3494	3	hardly	hardly	RB
46745	3494	4	be	be	VB
46745	3494	5	of	of	IN
46745	3494	6	use	use	NN
46745	3494	7	in	in	IN
46745	3494	8	this	this	DT
46745	3494	9	disorder	disorder	NN
46745	3494	10	unless	unless	IN
46745	3494	11	it	-PRON-	PRP
46745	3494	12	affected	affect	VBD
46745	3494	13	the	the	DT
46745	3494	14	brain	brain	NN
46745	3494	15	.	.	.
46745	3495	1	Other	Other	NNP
46745	3495	2	General	General	NNP
46745	3495	3	Stimulants	Stimulants	NNP
46745	3495	4	manifest	manifest	NN
46745	3495	5	this	this	DT
46745	3495	6	action	action	NN
46745	3495	7	on	on	IN
46745	3495	8	the	the	DT
46745	3495	9	brain	brain	NN
46745	3495	10	to	to	IN
46745	3495	11	a	a	DT
46745	3495	12	greater	great	JJR
46745	3495	13	or	or	CC
46745	3495	14	less	less	JJR
46745	3495	15	degree	degree	NN
46745	3495	16	.	.	.
46745	3496	1	Phosphorus	Phosphorus	NNP
46745	3496	2	is	be	VBZ
46745	3496	3	a	a	DT
46745	3496	4	Stimulant	stimulant	NN
46745	3496	5	.	.	.
46745	3497	1	In	in	IN
46745	3497	2	small	small	JJ
46745	3497	3	doses	dose	NNS
46745	3497	4	it	-PRON-	PRP
46745	3497	5	quickens	quicken	VBZ
46745	3497	6	the	the	DT
46745	3497	7	pulse	pulse	NN
46745	3497	8	.	.	.
46745	3498	1	It	-PRON-	PRP
46745	3498	2	somewhat	somewhat	RB
46745	3498	3	heightens	heighten	VBZ
46745	3498	4	the	the	DT
46745	3498	5	mental	mental	JJ
46745	3498	6	activity	activity	NN
46745	3498	7	.	.	.
46745	3499	1	It	-PRON-	PRP
46745	3499	2	is	be	VBZ
46745	3499	3	said	say	VBN
46745	3499	4	also	also	RB
46745	3499	5	to	to	TO
46745	3499	6	have	have	VB
46745	3499	7	an	an	DT
46745	3499	8	aphrodisiac	aphrodisiac	NN
46745	3499	9	operation	operation	NN
46745	3499	10	,	,	,
46745	3499	11	due	due	IN
46745	3499	12	to	to	IN
46745	3499	13	its	-PRON-	PRP$
46745	3499	14	powers	power	NNS
46745	3499	15	as	as	IN
46745	3499	16	a	a	DT
46745	3499	17	cerebral	cerebral	JJ
46745	3499	18	excitor	excitor	NN
46745	3499	19	.	.	.
46745	3500	1	Volatile	volatile	JJ
46745	3500	2	oils	oil	NNS
46745	3500	3	possess	possess	VBP
46745	3500	4	a	a	DT
46745	3500	5	certain	certain	JJ
46745	3500	6	influence	influence	NN
46745	3500	7	over	over	IN
46745	3500	8	the	the	DT
46745	3500	9	functions	function	NNS
46745	3500	10	of	of	IN
46745	3500	11	the	the	DT
46745	3500	12	brain	brain	NN
46745	3500	13	,	,	,
46745	3500	14	as	as	RB
46745	3500	15	well	well	RB
46745	3500	16	as	as	IN
46745	3500	17	those	those	DT
46745	3500	18	of	of	IN
46745	3500	19	the	the	DT
46745	3500	20	organic	organic	JJ
46745	3500	21	nerves	nerve	NNS
46745	3500	22	.	.	.
46745	3501	1	Cajeput	cajeput	NN
46745	3501	2	oil	oil	NN
46745	3501	3	has	have	VBZ
46745	3501	4	been	be	VBN
46745	3501	5	used	use	VBN
46745	3501	6	in	in	IN
46745	3501	7	Hysteria	Hysteria	NNP
46745	3501	8	;	;	,
46745	3501	9	employed	employ	VBN
46745	3501	10	to	to	TO
46745	3501	11	control	control	VB
46745	3501	12	various	various	JJ
46745	3501	13	spasmodic	spasmodic	JJ
46745	3501	14	movements	movement	NNS
46745	3501	15	;	;	,
46745	3501	16	and	and	CC
46745	3501	17	administered	administer	VBN
46745	3501	18	in	in	IN
46745	3501	19	Typhoid	Typhoid	NNP
46745	3501	20	fevers	fever	NNS
46745	3501	21	and	and	CC
46745	3501	22	Asiatic	Asiatic	NNP
46745	3501	23	Cholera	Cholera	NNP
46745	3501	24	,	,	,
46745	3501	25	to	to	TO
46745	3501	26	communicate	communicate	VB
46745	3501	27	nervous	nervous	JJ
46745	3501	28	power	power	NN
46745	3501	29	.	.	.
46745	3502	1	The	the	DT
46745	3502	2	fetid	fetid	JJ
46745	3502	3	gum	gum	NN
46745	3502	4	resins	resin	NNS
46745	3502	5	are	be	VBP
46745	3502	6	well	well	RB
46745	3502	7	known	know	VBN
46745	3502	8	as	as	IN
46745	3502	9	Antispasmodics	Antispasmodics	NNP
46745	3502	10	.	.	.
46745	3503	1	The	the	DT
46745	3503	2	spasms	spasm	NNS
46745	3503	3	which	which	WDT
46745	3503	4	these	these	DT
46745	3503	5	medicines	medicine	NNS
46745	3503	6	relieve	relieve	VBP
46745	3503	7	are	be	VBP
46745	3503	8	due	due	JJ
46745	3503	9	to	to	IN
46745	3503	10	a	a	DT
46745	3503	11	fault	fault	NN
46745	3503	12	in	in	IN
46745	3503	13	the	the	DT
46745	3503	14	nervous	nervous	JJ
46745	3503	15	polarity	polarity	NN
46745	3503	16	,	,	,
46745	3503	17	commencing	commence	VBG
46745	3503	18	generally	generally	RB
46745	3503	19	in	in	IN
46745	3503	20	the	the	DT
46745	3503	21	brain	brain	NN
46745	3503	22	or	or	CC
46745	3503	23	nerve	nerve	NN
46745	3503	24	-	-	HYPH
46745	3503	25	centres,--and	centres,--and	CD
46745	3503	26	are	be	VBP
46745	3503	27	more	more	RBR
46745	3503	28	or	or	CC
46745	3503	29	less	less	RBR
46745	3503	30	subdued	subdue	VBN
46745	3503	31	by	by	IN
46745	3503	32	general	general	JJ
46745	3503	33	stimulators	stimulator	NNS
46745	3503	34	of	of	IN
46745	3503	35	the	the	DT
46745	3503	36	nervous	nervous	JJ
46745	3503	37	functions	function	NNS
46745	3503	38	.	.	.
46745	3504	1	Copaiba	Copaiba	NNP
46745	3504	2	,	,	,
46745	3504	3	an	an	DT
46745	3504	4	oleo	oleo	NN
46745	3504	5	-	-	HYPH
46745	3504	6	resin	resin	NN
46745	3504	7	,	,	,
46745	3504	8	may	may	MD
46745	3504	9	cause	cause	VB
46745	3504	10	a	a	DT
46745	3504	11	general	general	JJ
46745	3504	12	febrile	febrile	NN
46745	3504	13	condition	condition	NN
46745	3504	14	,	,	,
46745	3504	15	accompanied	accompany	VBN
46745	3504	16	with	with	IN
46745	3504	17	headache,--when	headache,--when	.
46745	3504	18	given	give	VBN
46745	3504	19	in	in	IN
46745	3504	20	large	large	JJ
46745	3504	21	doses	dose	NNS
46745	3504	22	.	.	.
46745	3505	1	So	so	RB
46745	3505	2	obvious	obvious	JJ
46745	3505	3	is	be	VBZ
46745	3505	4	the	the	DT
46745	3505	5	cerebral	cerebral	JJ
46745	3505	6	power	power	NN
46745	3505	7	of	of	IN
46745	3505	8	some	some	DT
46745	3505	9	volatile	volatile	JJ
46745	3505	10	oils	oil	NNS
46745	3505	11	,	,	,
46745	3505	12	that	that	IN
46745	3505	13	Turpentine	Turpentine	NNP
46745	3505	14	,	,	,
46745	3505	15	in	in	IN
46745	3505	16	large	large	JJ
46745	3505	17	doses	dose	NNS
46745	3505	18	,	,	,
46745	3505	19	has	have	VBZ
46745	3505	20	been	be	VBN
46745	3505	21	known	know	VBN
46745	3505	22	to	to	TO
46745	3505	23	produce	produce	VB
46745	3505	24	inebriation	inebriation	NN
46745	3505	25	.	.	.
46745	3506	1	It	-PRON-	PRP
46745	3506	2	is	be	VBZ
46745	3506	3	not	not	RB
46745	3506	4	generally	generally	RB
46745	3506	5	used	use	VBN
46745	3506	6	for	for	IN
46745	3506	7	its	-PRON-	PRP$
46745	3506	8	Neurotic	neurotic	JJ
46745	3506	9	powers	power	NNS
46745	3506	10	,	,	,
46745	3506	11	but	but	CC
46745	3506	12	as	as	IN
46745	3506	13	a	a	DT
46745	3506	14	Purgative	Purgative	NNP
46745	3506	15	or	or	CC
46745	3506	16	a	a	DT
46745	3506	17	Diuretic	Diuretic	NNP
46745	3506	18	;	;	:
46745	3506	19	or	or	CC
46745	3506	20	else	else	RB
46745	3506	21	it	-PRON-	PRP
46745	3506	22	might	may	MD
46745	3506	23	have	have	VB
46745	3506	24	been	be	VBN
46745	3506	25	classed	class	VBN
46745	3506	26	among	among	IN
46745	3506	27	Inebriant	Inebriant	NNP
46745	3506	28	Narcotics	Narcotics	NNP
46745	3506	29	.	.	.
46745	3507	1	I	-PRON-	PRP
46745	3507	2	have	have	VBP
46745	3507	3	enumerated	enumerate	VBN
46745	3507	4	it	-PRON-	PRP
46745	3507	5	above	above	IN
46745	3507	6	among	among	IN
46745	3507	7	volatile	volatile	JJ
46745	3507	8	oils	oil	NNS
46745	3507	9	.	.	.
46745	3508	1	It	-PRON-	PRP
46745	3508	2	may	may	MD
46745	3508	3	be	be	VB
46745	3508	4	regarded	regard	VBN
46745	3508	5	as	as	IN
46745	3508	6	transitional	transitional	JJ
46745	3508	7	between	between	IN
46745	3508	8	true	true	JJ
46745	3508	9	Stimulants	Stimulants	NNP
46745	3508	10	and	and	CC
46745	3508	11	Narcotics	Narcotics	NNP
46745	3508	12	.	.	.
46745	3509	1	Ergot	Ergot	NNP
46745	3509	2	of	of	IN
46745	3509	3	Rye	Rye	NNP
46745	3509	4	is	be	VBZ
46745	3509	5	another	another	DT
46745	3509	6	medicine	medicine	NN
46745	3509	7	which	which	WDT
46745	3509	8	has	have	VBZ
46745	3509	9	a	a	DT
46745	3509	10	double	double	JJ
46745	3509	11	action	action	NN
46745	3509	12	.	.	.
46745	3510	1	It	-PRON-	PRP
46745	3510	2	is	be	VBZ
46745	3510	3	used	use	VBN
46745	3510	4	as	as	IN
46745	3510	5	a	a	DT
46745	3510	6	Special	Special	NNP
46745	3510	7	Stimulant	Stimulant	NNP
46745	3510	8	to	to	IN
46745	3510	9	the	the	DT
46745	3510	10	Uterus	Uterus	NNP
46745	3510	11	;	;	:
46745	3510	12	but	but	CC
46745	3510	13	it	-PRON-	PRP
46745	3510	14	is	be	VBZ
46745	3510	15	also	also	RB
46745	3510	16	a	a	DT
46745	3510	17	Narcotic	narcotic	NN
46745	3510	18	to	to	IN
46745	3510	19	the	the	DT
46745	3510	20	brain	brain	NN
46745	3510	21	.	.	.
46745	3511	1	Most	Most	JJS
46745	3511	2	General	General	NNP
46745	3511	3	Stimulants	Stimulants	NNPS
46745	3511	4	are	be	VBP
46745	3511	5	without	without	IN
46745	3511	6	any	any	DT
46745	3511	7	marked	marked	JJ
46745	3511	8	influence	influence	NN
46745	3511	9	on	on	IN
46745	3511	10	the	the	DT
46745	3511	11	mind	mind	NN
46745	3511	12	;	;	:
46745	3511	13	but	but	CC
46745	3511	14	stimulate	stimulate	VB
46745	3511	15	the	the	DT
46745	3511	16	organic	organic	JJ
46745	3511	17	and	and	CC
46745	3511	18	merely	merely	RB
46745	3511	19	animal	animal	NN
46745	3511	20	function	function	NN
46745	3511	21	of	of	IN
46745	3511	22	the	the	DT
46745	3511	23	brain	brain	NN
46745	3511	24	,	,	,
46745	3511	25	and	and	CC
46745	3511	26	of	of	IN
46745	3511	27	the	the	DT
46745	3511	28	Sympathetic	sympathetic	JJ
46745	3511	29	nerve	nerve	NN
46745	3511	30	throughout	throughout	IN
46745	3511	31	the	the	DT
46745	3511	32	system	system	NN
46745	3511	33	.	.	.
46745	3512	1	Concluding	conclude	VBG
46745	3512	2	that	that	IN
46745	3512	3	General	General	NNP
46745	3512	4	Stimulants	Stimulants	NNP
46745	3512	5	have	have	VBP
46745	3512	6	all	all	DT
46745	3512	7	more	more	RBR
46745	3512	8	or	or	CC
46745	3512	9	less	less	RBR
46745	3512	10	the	the	DT
46745	3512	11	power	power	NN
46745	3512	12	of	of	IN
46745	3512	13	exalting	exalt	VBG
46745	3512	14	nervous	nervous	JJ
46745	3512	15	force	force	NN
46745	3512	16	in	in	IN
46745	3512	17	general	general	JJ
46745	3512	18	,	,	,
46745	3512	19	we	-PRON-	PRP
46745	3512	20	have	have	VBP
46745	3512	21	still	still	RB
46745	3512	22	to	to	TO
46745	3512	23	consider	consider	VB
46745	3512	24	some	some	DT
46745	3512	25	other	other	JJ
46745	3512	26	questions	question	NNS
46745	3512	27	relating	relate	VBG
46745	3512	28	to	to	IN
46745	3512	29	their	-PRON-	PRP$
46745	3512	30	action	action	NN
46745	3512	31	.	.	.
46745	3513	1	It	-PRON-	PRP
46745	3513	2	is	be	VBZ
46745	3513	3	maintained	maintain	VBN
46745	3513	4	by	by	IN
46745	3513	5	some	some	DT
46745	3513	6	that	that	IN
46745	3513	7	Stimulants	Stimulants	NNP
46745	3513	8	have	have	VBP
46745	3513	9	simply	simply	RB
46745	3513	10	the	the	DT
46745	3513	11	power	power	NN
46745	3513	12	of	of	IN
46745	3513	13	calling	call	VBG
46745	3513	14	forth	forth	RP
46745	3513	15	the	the	DT
46745	3513	16	nervous	nervous	JJ
46745	3513	17	force	force	NN
46745	3513	18	which	which	WDT
46745	3513	19	already	already	RB
46745	3513	20	exists	exist	VBZ
46745	3513	21	in	in	IN
46745	3513	22	the	the	DT
46745	3513	23	system	system	NN
46745	3513	24	,	,	,
46745	3513	25	and	and	CC
46745	3513	26	that	that	IN
46745	3513	27	they	-PRON-	PRP
46745	3513	28	can	can	MD
46745	3513	29	not	not	RB
46745	3513	30	create	create	VB
46745	3513	31	any	any	DT
46745	3513	32	more	more	RBR
46745	3513	33	in	in	IN
46745	3513	34	addition	addition	NN
46745	3513	35	to	to	IN
46745	3513	36	this	this	DT
46745	3513	37	.	.	.
46745	3514	1	But	but	CC
46745	3514	2	if	if	IN
46745	3514	3	this	this	DT
46745	3514	4	were	be	VBD
46745	3514	5	the	the	DT
46745	3514	6	case	case	NN
46745	3514	7	,	,	,
46745	3514	8	then	then	RB
46745	3514	9	the	the	DT
46745	3514	10	reaction	reaction	NN
46745	3514	11	,	,	,
46745	3514	12	or	or	CC
46745	3514	13	subsequent	subsequent	JJ
46745	3514	14	failure	failure	NN
46745	3514	15	of	of	IN
46745	3514	16	nervous	nervous	JJ
46745	3514	17	power	power	NN
46745	3514	18	,	,	,
46745	3514	19	ought	ought	MD
46745	3514	20	to	to	TO
46745	3514	21	be	be	VB
46745	3514	22	exactly	exactly	RB
46745	3514	23	equivalent	equivalent	JJ
46745	3514	24	to	to	IN
46745	3514	25	the	the	DT
46745	3514	26	first	first	JJ
46745	3514	27	temporary	temporary	JJ
46745	3514	28	increase	increase	NN
46745	3514	29	of	of	IN
46745	3514	30	that	that	DT
46745	3514	31	power	power	NN
46745	3514	32	;	;	:
46745	3514	33	assuming	assume	VBG
46745	3514	34	this	this	DT
46745	3514	35	increase	increase	NN
46745	3514	36	to	to	TO
46745	3514	37	have	have	VB
46745	3514	38	been	be	VBN
46745	3514	39	simply	simply	RB
46745	3514	40	abstracted	abstract	VBN
46745	3514	41	from	from	IN
46745	3514	42	the	the	DT
46745	3514	43	natural	natural	JJ
46745	3514	44	resources	resource	NNS
46745	3514	45	.	.	.
46745	3515	1	But	but	CC
46745	3515	2	we	-PRON-	PRP
46745	3515	3	do	do	VBP
46745	3515	4	not	not	RB
46745	3515	5	find	find	VB
46745	3515	6	it	-PRON-	PRP
46745	3515	7	to	to	TO
46745	3515	8	be	be	VB
46745	3515	9	so	so	RB
46745	3515	10	.	.	.
46745	3516	1	The	the	DT
46745	3516	2	reaction	reaction	NN
46745	3516	3	from	from	IN
46745	3516	4	the	the	DT
46745	3516	5	effect	effect	NN
46745	3516	6	of	of	IN
46745	3516	7	a	a	DT
46745	3516	8	Stimulant	Stimulant	NNP
46745	3516	9	is	be	VBZ
46745	3516	10	always	always	RB
46745	3516	11	very	very	RB
46745	3516	12	slight	slight	JJ
46745	3516	13	,	,	,
46745	3516	14	and	and	CC
46745	3516	15	often	often	RB
46745	3516	16	quite	quite	RB
46745	3516	17	imperceptible	imperceptible	JJ
46745	3516	18	.	.	.
46745	3517	1	And	and	CC
46745	3517	2	there	there	EX
46745	3517	3	seems	seem	VBZ
46745	3517	4	to	to	TO
46745	3517	5	be	be	VB
46745	3517	6	no	no	DT
46745	3517	7	_	_	NNP
46745	3517	8	à	à	PRP
46745	3517	9	priori	priori	FW
46745	3517	10	_	_	NNP
46745	3517	11	reason	reason	NN
46745	3517	12	why	why	WRB
46745	3517	13	we	-PRON-	PRP
46745	3517	14	should	should	MD
46745	3517	15	not	not	RB
46745	3517	16	actually	actually	RB
46745	3517	17	cause	cause	VB
46745	3517	18	nervous	nervous	JJ
46745	3517	19	force	force	NN
46745	3517	20	to	to	TO
46745	3517	21	be	be	VB
46745	3517	22	generated	generate	VBN
46745	3517	23	.	.	.
46745	3518	1	We	-PRON-	PRP
46745	3518	2	know	know	VBP
46745	3518	3	that	that	IN
46745	3518	4	a	a	DT
46745	3518	5	galvanic	galvanic	JJ
46745	3518	6	current	current	NN
46745	3518	7	,	,	,
46745	3518	8	or	or	CC
46745	3518	9	even	even	RB
46745	3518	10	a	a	DT
46745	3518	11	mechanical	mechanical	JJ
46745	3518	12	cause	cause	NN
46745	3518	13	,	,	,
46745	3518	14	may	may	MD
46745	3518	15	induce	induce	VB
46745	3518	16	it	-PRON-	PRP
46745	3518	17	to	to	TO
46745	3518	18	be	be	VB
46745	3518	19	suddenly	suddenly	RB
46745	3518	20	and	and	CC
46745	3518	21	powerfully	powerfully	RB
46745	3518	22	manifested	manifest	VBN
46745	3518	23	.	.	.
46745	3519	1	I	-PRON-	PRP
46745	3519	2	believe	believe	VBP
46745	3519	3	that	that	IN
46745	3519	4	a	a	DT
46745	3519	5	Stimulant	stimulant	NN
46745	3519	6	is	be	VBZ
46745	3519	7	able	able	JJ
46745	3519	8	actually	actually	RB
46745	3519	9	to	to	TO
46745	3519	10	produce	produce	VB
46745	3519	11	nervous	nervous	JJ
46745	3519	12	action	action	NN
46745	3519	13	;	;	:
46745	3519	14	perhaps	perhaps	RB
46745	3519	15	by	by	IN
46745	3519	16	an	an	DT
46745	3519	17	irritative	irritative	JJ
46745	3519	18	operation	operation	NN
46745	3519	19	upon	upon	IN
46745	3519	20	nerve	nerve	NN
46745	3519	21	-	-	HYPH
46745	3519	22	fibre	fibre	NN
46745	3519	23	.	.	.
46745	3520	1	So	so	CC
46745	3520	2	by	by	IN
46745	3520	3	continually	continually	RB
46745	3520	4	repeating	repeat	VBG
46745	3520	5	the	the	DT
46745	3520	6	dose	dose	NN
46745	3520	7	of	of	IN
46745	3520	8	a	a	DT
46745	3520	9	Stimulant	Stimulant	NNP
46745	3520	10	,	,	,
46745	3520	11	as	as	IN
46745	3520	12	Ammonia	Ammonia	NNP
46745	3520	13	or	or	CC
46745	3520	14	Brandy	Brandy	NNP
46745	3520	15	,	,	,
46745	3520	16	it	-PRON-	PRP
46745	3520	17	is	be	VBZ
46745	3520	18	possible	possible	JJ
46745	3520	19	to	to	TO
46745	3520	20	maintain	maintain	VB
46745	3520	21	the	the	DT
46745	3520	22	circulation	circulation	NN
46745	3520	23	and	and	CC
46745	3520	24	nervous	nervous	JJ
46745	3520	25	energy	energy	NN
46745	3520	26	at	at	IN
46745	3520	27	a	a	DT
46745	3520	28	certain	certain	JJ
46745	3520	29	level	level	NN
46745	3520	30	,	,	,
46745	3520	31	without	without	IN
46745	3520	32	the	the	DT
46745	3520	33	occurrence	occurrence	NN
46745	3520	34	of	of	IN
46745	3520	35	any	any	DT
46745	3520	36	reaction	reaction	NN
46745	3520	37	for	for	IN
46745	3520	38	a	a	DT
46745	3520	39	considerable	considerable	JJ
46745	3520	40	period	period	NN
46745	3520	41	.	.	.
46745	3521	1	But	but	CC
46745	3521	2	we	-PRON-	PRP
46745	3521	3	must	must	MD
46745	3521	4	take	take	VB
46745	3521	5	care	care	NN
46745	3521	6	not	not	RB
46745	3521	7	to	to	TO
46745	3521	8	confound	confound	VB
46745	3521	9	_	_	NNP
46745	3521	10	nervous	nervous	JJ
46745	3521	11	force	force	NN
46745	3521	12	_	_	NNP
46745	3521	13	with	with	IN
46745	3521	14	_	_	NNP
46745	3521	15	vital	vital	JJ
46745	3521	16	force	force	NN
46745	3521	17	_	_	NNP
46745	3521	18	.	.	.
46745	3522	1	The	the	DT
46745	3522	2	former	former	JJ
46745	3522	3	may	may	MD
46745	3522	4	be	be	VB
46745	3522	5	very	very	RB
46745	3522	6	much	much	RB
46745	3522	7	increased	increase	VBN
46745	3522	8	,	,	,
46745	3522	9	as	as	IN
46745	3522	10	in	in	IN
46745	3522	11	high	high	JJ
46745	3522	12	inflammatory	inflammatory	JJ
46745	3522	13	fever	fever	NN
46745	3522	14	,	,	,
46745	3522	15	without	without	IN
46745	3522	16	a	a	DT
46745	3522	17	corresponding	corresponding	JJ
46745	3522	18	increase	increase	NN
46745	3522	19	of	of	IN
46745	3522	20	the	the	DT
46745	3522	21	latter	latter	JJ
46745	3522	22	.	.	.
46745	3523	1	The	the	DT
46745	3523	2	advantage	advantage	NN
46745	3523	3	of	of	IN
46745	3523	4	a	a	DT
46745	3523	5	stimulant	stimulant	NN
46745	3523	6	is	be	VBZ
46745	3523	7	regulated	regulate	VBN
46745	3523	8	by	by	IN
46745	3523	9	this	this	DT
46745	3523	10	rule	rule	NN
46745	3523	11	.	.	.
46745	3524	1	When	when	WRB
46745	3524	2	there	there	EX
46745	3524	3	is	be	VBZ
46745	3524	4	a	a	DT
46745	3524	5	failure	failure	NN
46745	3524	6	in	in	IN
46745	3524	7	vital	vital	JJ
46745	3524	8	energy	energy	NN
46745	3524	9	,	,	,
46745	3524	10	no	no	DT
46745	3524	11	Stimulant	Stimulant	NNP
46745	3524	12	will	will	MD
46745	3524	13	serve	serve	VB
46745	3524	14	to	to	TO
46745	3524	15	prolong	prolong	VB
46745	3524	16	life	life	NN
46745	3524	17	,	,	,
46745	3524	18	for	for	IN
46745	3524	19	it	-PRON-	PRP
46745	3524	20	can	can	MD
46745	3524	21	not	not	RB
46745	3524	22	communicate	communicate	VB
46745	3524	23	fresh	fresh	JJ
46745	3524	24	vital	vital	JJ
46745	3524	25	power	power	NN
46745	3524	26	.	.	.
46745	3525	1	But	but	CC
46745	3525	2	there	there	EX
46745	3525	3	may	may	MD
46745	3525	4	be	be	VB
46745	3525	5	no	no	DT
46745	3525	6	such	such	JJ
46745	3525	7	failure	failure	NN
46745	3525	8	of	of	IN
46745	3525	9	vital	vital	JJ
46745	3525	10	energy	energy	NN
46745	3525	11	,	,	,
46745	3525	12	and	and	CC
46745	3525	13	yet	yet	RB
46745	3525	14	a	a	DT
46745	3525	15	sudden	sudden	JJ
46745	3525	16	or	or	CC
46745	3525	17	accidental	accidental	JJ
46745	3525	18	deficiency	deficiency	NN
46745	3525	19	of	of	IN
46745	3525	20	nervous	nervous	JJ
46745	3525	21	force	force	NN
46745	3525	22	may	may	MD
46745	3525	23	serve	serve	VB
46745	3525	24	to	to	TO
46745	3525	25	peril	peril	VB
46745	3525	26	the	the	DT
46745	3525	27	continuance	continuance	NN
46745	3525	28	of	of	IN
46745	3525	29	health	health	NN
46745	3525	30	,	,	,
46745	3525	31	or	or	CC
46745	3525	32	even	even	RB
46745	3525	33	the	the	DT
46745	3525	34	tenure	tenure	NN
46745	3525	35	of	of	IN
46745	3525	36	life	life	NN
46745	3525	37	.	.	.
46745	3526	1	For	for	IN
46745	3526	2	a	a	DT
46745	3526	3	certain	certain	JJ
46745	3526	4	degree	degree	NN
46745	3526	5	of	of	IN
46745	3526	6	this	this	DT
46745	3526	7	nervous	nervous	JJ
46745	3526	8	force	force	NN
46745	3526	9	is	be	VBZ
46745	3526	10	necessary	necessary	JJ
46745	3526	11	both	both	DT
46745	3526	12	for	for	IN
46745	3526	13	life	life	NN
46745	3526	14	and	and	CC
46745	3526	15	health	health	NN
46745	3526	16	.	.	.
46745	3527	1	When	when	WRB
46745	3527	2	it	-PRON-	PRP
46745	3527	3	is	be	VBZ
46745	3527	4	diminished	diminish	VBN
46745	3527	5	,	,	,
46745	3527	6	all	all	PDT
46745	3527	7	the	the	DT
46745	3527	8	functions	function	NNS
46745	3527	9	must	must	MD
46745	3527	10	suffer	suffer	VB
46745	3527	11	;	;	:
46745	3527	12	when	when	WRB
46745	3527	13	it	-PRON-	PRP
46745	3527	14	fails	fail	VBZ
46745	3527	15	entirely	entirely	RB
46745	3527	16	,	,	,
46745	3527	17	the	the	DT
46745	3527	18	circulation	circulation	NN
46745	3527	19	must	must	MD
46745	3527	20	stop	stop	VB
46745	3527	21	,	,	,
46745	3527	22	and	and	CC
46745	3527	23	death	death	NN
46745	3527	24	ensues	ensue	NNS
46745	3527	25	.	.	.
46745	3528	1	It	-PRON-	PRP
46745	3528	2	is	be	VBZ
46745	3528	3	in	in	IN
46745	3528	4	these	these	DT
46745	3528	5	cases	case	NNS
46745	3528	6	that	that	WDT
46745	3528	7	a	a	DT
46745	3528	8	Stimulant	stimulant	JJ
46745	3528	9	medicine	medicine	NN
46745	3528	10	is	be	VBZ
46745	3528	11	appropriate	appropriate	JJ
46745	3528	12	.	.	.
46745	3529	1	It	-PRON-	PRP
46745	3529	2	does	do	VBZ
46745	3529	3	not	not	RB
46745	3529	4	do	do	VB
46745	3529	5	good	good	NN
46745	3529	6	by	by	IN
46745	3529	7	communicating	communicate	VBG
46745	3529	8	vital	vital	JJ
46745	3529	9	energy	energy	NN
46745	3529	10	,	,	,
46745	3529	11	but	but	CC
46745	3529	12	by	by	IN
46745	3529	13	remedying	remedy	VBG
46745	3529	14	the	the	DT
46745	3529	15	want	want	NN
46745	3529	16	of	of	IN
46745	3529	17	nervous	nervous	JJ
46745	3529	18	action	action	NN
46745	3529	19	,	,	,
46745	3529	20	by	by	IN
46745	3529	21	which	which	WDT
46745	3529	22	want	want	VBP
46745	3529	23	the	the	DT
46745	3529	24	manifestation	manifestation	NN
46745	3529	25	of	of	IN
46745	3529	26	the	the	DT
46745	3529	27	vital	vital	JJ
46745	3529	28	energy	energy	NN
46745	3529	29	is	be	VBZ
46745	3529	30	subdued	subdue	VBN
46745	3529	31	.	.	.
46745	3530	1	This	this	DT
46745	3530	2	must	must	MD
46745	3530	3	always	always	RB
46745	3530	4	be	be	VB
46745	3530	5	borne	bear	VBN
46745	3530	6	in	in	IN
46745	3530	7	mind	mind	NN
46745	3530	8	when	when	WRB
46745	3530	9	the	the	DT
46745	3530	10	applicability	applicability	NN
46745	3530	11	of	of	IN
46745	3530	12	Stimulants	Stimulants	NNP
46745	3530	13	is	be	VBZ
46745	3530	14	under	under	IN
46745	3530	15	consideration	consideration	NN
46745	3530	16	.	.	.
46745	3531	1	Some	some	DT
46745	3531	2	writers	writer	NNS
46745	3531	3	have	have	VBP
46745	3531	4	complicated	complicate	VBN
46745	3531	5	the	the	DT
46745	3531	6	subject	subject	NN
46745	3531	7	by	by	IN
46745	3531	8	classing	class	VBG
46745	3531	9	as	as	IN
46745	3531	10	Stimulants	Stimulants	NNP
46745	3531	11	all	all	DT
46745	3531	12	medicines	medicine	NNS
46745	3531	13	which	which	WDT
46745	3531	14	tend	tend	VBP
46745	3531	15	,	,	,
46745	3531	16	directly	directly	RB
46745	3531	17	or	or	CC
46745	3531	18	indirectly	indirectly	RB
46745	3531	19	,	,	,
46745	3531	20	to	to	TO
46745	3531	21	communicate	communicate	VB
46745	3531	22	vital	vital	JJ
46745	3531	23	strength	strength	NN
46745	3531	24	;	;	:
46745	3531	25	as	as	IN
46745	3531	26	Tonics	Tonics	NNP
46745	3531	27	,	,	,
46745	3531	28	and	and	CC
46745	3531	29	remedies	remedy	NNS
46745	3531	30	which	which	WDT
46745	3531	31	counteract	counteract	VBP
46745	3531	32	morbid	morbid	NN
46745	3531	33	depressing	depressing	NN
46745	3531	34	causes	cause	NNS
46745	3531	35	.	.	.
46745	3532	1	This	this	DT
46745	3532	2	is	be	VBZ
46745	3532	3	in	in	IN
46745	3532	4	direct	direct	JJ
46745	3532	5	contradiction	contradiction	NN
46745	3532	6	to	to	IN
46745	3532	7	the	the	DT
46745	3532	8	rule	rule	NN
46745	3532	9	given	give	VBN
46745	3532	10	above	above	RB
46745	3532	11	.	.	.
46745	3533	1	True	true	JJ
46745	3533	2	Stimulants	stimulant	NNS
46745	3533	3	are	be	VBP
46745	3533	4	only	only	RB
46745	3533	5	of	of	IN
46745	3533	6	use	use	NN
46745	3533	7	by	by	IN
46745	3533	8	counteracting	counteract	VBG
46745	3533	9	that	that	IN
46745	3533	10	failure	failure	NN
46745	3533	11	of	of	IN
46745	3533	12	nervous	nervous	JJ
46745	3533	13	force	force	NN
46745	3533	14	which	which	WDT
46745	3533	15	hinders	hinder	VBZ
46745	3533	16	the	the	DT
46745	3533	17	manifestation	manifestation	NN
46745	3533	18	of	of	IN
46745	3533	19	the	the	DT
46745	3533	20	vital	vital	JJ
46745	3533	21	strength	strength	NN
46745	3533	22	which	which	WDT
46745	3533	23	is	be	VBZ
46745	3533	24	stored	store	VBN
46745	3533	25	up	up	RP
46745	3533	26	somewhere	somewhere	RB
46745	3533	27	in	in	IN
46745	3533	28	the	the	DT
46745	3533	29	system	system	NN
46745	3533	30	.	.	.
46745	3534	1	For	for	IN
46745	3534	2	I	-PRON-	PRP
46745	3534	3	have	have	VBP
46745	3534	4	just	just	RB
46745	3534	5	observed	observe	VBN
46745	3534	6	,	,	,
46745	3534	7	that	that	DT
46745	3534	8	to	to	TO
46745	3534	9	exalt	exalt	VB
46745	3534	10	nervous	nervous	JJ
46745	3534	11	force	force	NN
46745	3534	12	is	be	VBZ
46745	3534	13	not	not	RB
46745	3534	14	necessarily	necessarily	RB
46745	3534	15	to	to	TO
46745	3534	16	exalt	exalt	VB
46745	3534	17	vital	vital	JJ
46745	3534	18	force	force	NN
46745	3534	19	,	,	,
46745	3534	20	but	but	CC
46745	3534	21	that	that	IN
46745	3534	22	any	any	DT
46745	3534	23	thing	thing	NN
46745	3534	24	which	which	WDT
46745	3534	25	tends	tend	VBZ
46745	3534	26	to	to	TO
46745	3534	27	destroy	destroy	VB
46745	3534	28	the	the	DT
46745	3534	29	former	former	JJ
46745	3534	30	must	must	NN
46745	3534	31	at	at	IN
46745	3534	32	length	length	NN
46745	3534	33	repress	repress	NN
46745	3534	34	and	and	CC
46745	3534	35	extinguish	extinguish	VB
46745	3534	36	the	the	DT
46745	3534	37	latter	latter	JJ
46745	3534	38	.	.	.
46745	3535	1	The	the	DT
46745	3535	2	above	above	JJ
46745	3535	3	considerations	consideration	NNS
46745	3535	4	apply	apply	VBP
46745	3535	5	to	to	IN
46745	3535	6	the	the	DT
46745	3535	7	action	action	NN
46745	3535	8	of	of	IN
46745	3535	9	these	these	DT
46745	3535	10	Stimulants	Stimulants	NNP
46745	3535	11	on	on	IN
46745	3535	12	the	the	DT
46745	3535	13	powers	power	NNS
46745	3535	14	of	of	IN
46745	3535	15	the	the	DT
46745	3535	16	system	system	NN
46745	3535	17	generally	generally	RB
46745	3535	18	.	.	.
46745	3536	1	But	but	CC
46745	3536	2	they	-PRON-	PRP
46745	3536	3	may	may	MD
46745	3536	4	act	act	VB
46745	3536	5	locally	locally	RB
46745	3536	6	.	.	.
46745	3537	1	Thus	thus	RB
46745	3537	2	in	in	IN
46745	3537	3	moderate	moderate	JJ
46745	3537	4	doses	dose	NNS
46745	3537	5	they	-PRON-	PRP
46745	3537	6	promote	promote	VBP
46745	3537	7	digestion	digestion	NN
46745	3537	8	,	,	,
46745	3537	9	by	by	IN
46745	3537	10	acting	act	VBG
46745	3537	11	on	on	IN
46745	3537	12	the	the	DT
46745	3537	13	nerves	nerve	NNS
46745	3537	14	of	of	IN
46745	3537	15	the	the	DT
46745	3537	16	stomach	stomach	NN
46745	3537	17	and	and	CC
46745	3537	18	intestinal	intestinal	JJ
46745	3537	19	canal	canal	NN
46745	3537	20	.	.	.
46745	3538	1	They	-PRON-	PRP
46745	3538	2	increase	increase	VBP
46745	3538	3	most	most	JJS
46745	3538	4	of	of	IN
46745	3538	5	the	the	DT
46745	3538	6	secretions	secretion	NNS
46745	3538	7	in	in	IN
46745	3538	8	passing	pass	VBG
46745	3538	9	through	through	IN
46745	3538	10	the	the	DT
46745	3538	11	glands	gland	NNS
46745	3538	12	in	in	IN
46745	3538	13	the	the	DT
46745	3538	14	blood	blood	NN
46745	3538	15	.	.	.
46745	3539	1	In	in	IN
46745	3539	2	both	both	DT
46745	3539	3	cases	case	NNS
46745	3539	4	they	-PRON-	PRP
46745	3539	5	exalt	exalt	VBP
46745	3539	6	nervous	nervous	JJ
46745	3539	7	force	force	NN
46745	3539	8	;	;	:
46745	3539	9	but	but	CC
46745	3539	10	in	in	IN
46745	3539	11	the	the	DT
46745	3539	12	latter	latter	JJ
46745	3539	13	case	case	NN
46745	3539	14	their	-PRON-	PRP$
46745	3539	15	action	action	NN
46745	3539	16	is	be	VBZ
46745	3539	17	of	of	IN
46745	3539	18	a	a	DT
46745	3539	19	particular	particular	JJ
46745	3539	20	nature	nature	NN
46745	3539	21	,	,	,
46745	3539	22	and	and	CC
46745	3539	23	will	will	MD
46745	3539	24	be	be	VB
46745	3539	25	treated	treat	VBN
46745	3539	26	of	of	IN
46745	3539	27	when	when	WRB
46745	3539	28	they	-PRON-	PRP
46745	3539	29	are	be	VBP
46745	3539	30	considered	consider	VBN
46745	3539	31	under	under	IN
46745	3539	32	the	the	DT
46745	3539	33	title	title	NN
46745	3539	34	of	of	IN
46745	3539	35	Eliminative	eliminative	JJ
46745	3539	36	medicines	medicine	NNS
46745	3539	37	.	.	.
46745	3540	1	To	to	TO
46745	3540	2	impress	impress	VB
46745	3540	3	the	the	DT
46745	3540	4	system	system	NN
46745	3540	5	generally	generally	RB
46745	3540	6	,	,	,
46745	3540	7	Stimulants	stimulant	NNS
46745	3540	8	are	be	VBP
46745	3540	9	used	use	VBN
46745	3540	10	when	when	WRB
46745	3540	11	there	there	EX
46745	3540	12	is	be	VBZ
46745	3540	13	a	a	DT
46745	3540	14	failure	failure	NN
46745	3540	15	of	of	IN
46745	3540	16	nervous	nervous	JJ
46745	3540	17	force	force	NN
46745	3540	18	on	on	IN
46745	3540	19	account	account	NN
46745	3540	20	of	of	IN
46745	3540	21	some	some	DT
46745	3540	22	sudden	sudden	JJ
46745	3540	23	and	and	CC
46745	3540	24	acute	acute	JJ
46745	3540	25	disorder	disorder	NN
46745	3540	26	,	,	,
46745	3540	27	without	without	IN
46745	3540	28	any	any	DT
46745	3540	29	material	material	JJ
46745	3540	30	undermining	undermining	NN
46745	3540	31	of	of	IN
46745	3540	32	the	the	DT
46745	3540	33	vital	vital	JJ
46745	3540	34	energies	energy	NNS
46745	3540	35	.	.	.
46745	3541	1	In	in	IN
46745	3541	2	long	long	JJ
46745	3541	3	chronic	chronic	JJ
46745	3541	4	cases	case	NNS
46745	3541	5	,	,	,
46745	3541	6	where	where	WRB
46745	3541	7	there	there	EX
46745	3541	8	is	be	VBZ
46745	3541	9	real	real	JJ
46745	3541	10	and	and	CC
46745	3541	11	manifest	manif	JJS
46745	3541	12	vital	vital	JJ
46745	3541	13	debility	debility	NN
46745	3541	14	,	,	,
46745	3541	15	Tonics	tonic	NNS
46745	3541	16	or	or	CC
46745	3541	17	blood	blood	NN
46745	3541	18	-	-	HYPH
46745	3541	19	medicines	medicine	NNS
46745	3541	20	are	be	VBP
46745	3541	21	required	require	VBN
46745	3541	22	.	.	.
46745	3542	1	But	but	CC
46745	3542	2	in	in	IN
46745	3542	3	such	such	PDT
46745	3542	4	a	a	DT
46745	3542	5	case	case	NN
46745	3542	6	as	as	IN
46745	3542	7	Syncope	Syncope	NNP
46745	3542	8	,	,	,
46745	3542	9	or	or	CC
46745	3542	10	stoppage	stoppage	NN
46745	3542	11	of	of	IN
46745	3542	12	the	the	DT
46745	3542	13	heart	heart	NN
46745	3542	14	on	on	IN
46745	3542	15	account	account	NN
46745	3542	16	of	of	IN
46745	3542	17	a	a	DT
46745	3542	18	sudden	sudden	JJ
46745	3542	19	nervous	nervous	JJ
46745	3542	20	shock	shock	NN
46745	3542	21	,	,	,
46745	3542	22	Stimulants	stimulant	NNS
46745	3542	23	are	be	VBP
46745	3542	24	particularly	particularly	RB
46745	3542	25	appropriate	appropriate	JJ
46745	3542	26	;	;	:
46745	3542	27	also	also	RB
46745	3542	28	in	in	IN
46745	3542	29	the	the	DT
46745	3542	30	latter	latter	JJ
46745	3542	31	stage	stage	NN
46745	3542	32	of	of	IN
46745	3542	33	Typhoid	Typhoid	NNP
46745	3542	34	fever	fever	NN
46745	3542	35	,	,	,
46745	3542	36	or	or	CC
46745	3542	37	of	of	IN
46745	3542	38	asthenic	asthenic	NNP
46745	3542	39	Pneumonia	Pneumonia	NNP
46745	3542	40	,	,	,
46745	3542	41	or	or	CC
46745	3542	42	of	of	IN
46745	3542	43	Cholera	Cholera	NNP
46745	3542	44	,	,	,
46745	3542	45	where	where	WRB
46745	3542	46	the	the	DT
46745	3542	47	existence	existence	NN
46745	3542	48	of	of	IN
46745	3542	49	life	life	NN
46745	3542	50	is	be	VBZ
46745	3542	51	endangered	endanger	VBN
46745	3542	52	by	by	IN
46745	3542	53	a	a	DT
46745	3542	54	great	great	JJ
46745	3542	55	loss	loss	NN
46745	3542	56	of	of	IN
46745	3542	57	nervous	nervous	JJ
46745	3542	58	power	power	NN
46745	3542	59	.	.	.
46745	3543	1	In	in	IN
46745	3543	2	spasmodic	spasmodic	JJ
46745	3543	3	diseases	disease	NNS
46745	3543	4	,	,	,
46745	3543	5	as	as	IN
46745	3543	6	Hysteria	Hysteria	NNP
46745	3543	7	,	,	,
46745	3543	8	where	where	WRB
46745	3543	9	the	the	DT
46745	3543	10	health	health	NN
46745	3543	11	is	be	VBZ
46745	3543	12	deteriorated	deteriorate	VBN
46745	3543	13	on	on	IN
46745	3543	14	account	account	NN
46745	3543	15	of	of	IN
46745	3543	16	a	a	DT
46745	3543	17	derangement	derangement	NN
46745	3543	18	of	of	IN
46745	3543	19	the	the	DT
46745	3543	20	nervous	nervous	JJ
46745	3543	21	functions	function	NNS
46745	3543	22	,	,	,
46745	3543	23	Stimulants	Stimulants	NNP
46745	3543	24	may	may	MD
46745	3543	25	be	be	VB
46745	3543	26	of	of	IN
46745	3543	27	use	use	NN
46745	3543	28	.	.	.
46745	3544	1	Such	such	JJ
46745	3544	2	then	then	RB
46745	3544	3	appears	appear	VBZ
46745	3544	4	to	to	TO
46745	3544	5	be	be	VB
46745	3544	6	the	the	DT
46745	3544	7	_	_	NNP
46745	3544	8	modus	modus	NN
46745	3544	9	operandi	operandi	NNP
46745	3544	10	_	_	NNP
46745	3544	11	,	,	,
46745	3544	12	and	and	CC
46745	3544	13	such	such	JJ
46745	3544	14	are	be	VBP
46745	3544	15	the	the	DT
46745	3544	16	chief	chief	JJ
46745	3544	17	applications	application	NNS
46745	3544	18	,	,	,
46745	3544	19	of	of	IN
46745	3544	20	the	the	DT
46745	3544	21	remedies	remedy	NNS
46745	3544	22	belonging	belong	VBG
46745	3544	23	to	to	IN
46745	3544	24	the	the	DT
46745	3544	25	order	order	NN
46745	3544	26	of	of	IN
46745	3544	27	General	General	NNP
46745	3544	28	Stimulants	Stimulants	NNP
46745	3544	29	.	.	.
46745	3545	1	Those	those	DT
46745	3545	2	of	of	IN
46745	3545	3	the	the	DT
46745	3545	4	next	next	JJ
46745	3545	5	order	order	NN
46745	3545	6	exert	exert	VBP
46745	3545	7	an	an	DT
46745	3545	8	action	action	NN
46745	3545	9	of	of	IN
46745	3545	10	the	the	DT
46745	3545	11	same	same	JJ
46745	3545	12	kind	kind	NN
46745	3545	13	,	,	,
46745	3545	14	but	but	CC
46745	3545	15	their	-PRON-	PRP$
46745	3545	16	field	field	NN
46745	3545	17	of	of	IN
46745	3545	18	operation	operation	NN
46745	3545	19	is	be	VBZ
46745	3545	20	on	on	IN
46745	3545	21	a	a	DT
46745	3545	22	more	more	RBR
46745	3545	23	confined	confined	JJ
46745	3545	24	scale	scale	NN
46745	3545	25	.	.	.
46745	3546	1	ORD	ORD	NNP
46745	3546	2	.	.	.
46745	3547	1	II	ii	CD
46745	3547	2	.	.	.
46745	3548	1	SPECIAL	SPECIAL	NNP
46745	3548	2	STIMULANTS	STIMULANTS	NNP
46745	3548	3	.	.	.
46745	3549	1	(	(	-LRB-
46745	3549	2	Strychnia	Strychnia	NNP
46745	3549	3	;	;	:
46745	3549	4	Brucia	Brucia	NNP
46745	3549	5	;	;	:
46745	3549	6	Toxicodendron	Toxicodendron	NNP
46745	3549	7	;	;	,
46745	3549	8	Ergot	Ergot	NNP
46745	3549	9	of	of	IN
46745	3549	10	Rye	Rye	NNP
46745	3549	11	;	;	:
46745	3549	12	Borax	Borax	NNP
46745	3549	13	;	;	:
46745	3549	14	Rue	Rue	NNP
46745	3549	15	.	.	.
46745	3549	16	)	)	-RRB-
46745	3550	1	These	these	DT
46745	3550	2	are	be	VBP
46745	3550	3	medicines	medicine	NNS
46745	3550	4	which	which	WDT
46745	3550	5	pass	pass	VBP
46745	3550	6	from	from	IN
46745	3550	7	the	the	DT
46745	3550	8	blood	blood	NN
46745	3550	9	to	to	IN
46745	3550	10	the	the	DT
46745	3550	11	nerves	nerve	NNS
46745	3550	12	or	or	CC
46745	3550	13	nerve	nerve	NN
46745	3550	14	-	-	HYPH
46745	3550	15	centres	centre	NNS
46745	3550	16	,	,	,
46745	3550	17	and	and	CC
46745	3550	18	act	act	VB
46745	3550	19	so	so	IN
46745	3550	20	as	as	IN
46745	3550	21	to	to	TO
46745	3550	22	exalt	exalt	VB
46745	3550	23	the	the	DT
46745	3550	24	energy	energy	NN
46745	3550	25	of	of	IN
46745	3550	26	particular	particular	JJ
46745	3550	27	nerves	nerve	NNS
46745	3550	28	or	or	CC
46745	3550	29	sets	set	NNS
46745	3550	30	of	of	IN
46745	3550	31	nerves	nerve	NNS
46745	3550	32	.	.	.
46745	3551	1	They	-PRON-	PRP
46745	3551	2	do	do	VBP
46745	3551	3	not	not	RB
46745	3551	4	affect	affect	VB
46745	3551	5	the	the	DT
46745	3551	6	whole	whole	JJ
46745	3551	7	nervous	nervous	JJ
46745	3551	8	system	system	NN
46745	3551	9	,	,	,
46745	3551	10	but	but	CC
46745	3551	11	they	-PRON-	PRP
46745	3551	12	operate	operate	VBP
46745	3551	13	on	on	IN
46745	3551	14	one	one	CD
46745	3551	15	set	set	NN
46745	3551	16	of	of	IN
46745	3551	17	nerves	nerve	NNS
46745	3551	18	in	in	IN
46745	3551	19	the	the	DT
46745	3551	20	same	same	JJ
46745	3551	21	way	way	NN
46745	3551	22	that	that	WDT
46745	3551	23	General	General	NNP
46745	3551	24	Stimulants	Stimulants	NNP
46745	3551	25	operate	operate	VBP
46745	3551	26	on	on	IN
46745	3551	27	all	all	DT
46745	3551	28	,	,	,
46745	3551	29	though	though	IN
46745	3551	30	usually	usually	RB
46745	3551	31	with	with	IN
46745	3551	32	greater	great	JJR
46745	3551	33	energy	energy	NN
46745	3551	34	.	.	.
46745	3552	1	The	the	DT
46745	3552	2	causes	cause	NNS
46745	3552	3	of	of	IN
46745	3552	4	such	such	PDT
46745	3552	5	a	a	DT
46745	3552	6	localized	localized	JJ
46745	3552	7	action	action	NN
46745	3552	8	are	be	VBP
46745	3552	9	hid	hide	VBN
46745	3552	10	in	in	IN
46745	3552	11	obscurity	obscurity	NN
46745	3552	12	;	;	:
46745	3552	13	but	but	CC
46745	3552	14	it	-PRON-	PRP
46745	3552	15	has	have	VBZ
46745	3552	16	already	already	RB
46745	3552	17	been	be	VBN
46745	3552	18	hinted	hint	VBN
46745	3552	19	that	that	IN
46745	3552	20	they	-PRON-	PRP
46745	3552	21	may	may	MD
46745	3552	22	perhaps	perhaps	RB
46745	3552	23	be	be	VB
46745	3552	24	partly	partly	RB
46745	3552	25	accounted	account	VBN
46745	3552	26	for	for	IN
46745	3552	27	by	by	IN
46745	3552	28	the	the	DT
46745	3552	29	differences	difference	NNS
46745	3552	30	in	in	IN
46745	3552	31	chemical	chemical	NN
46745	3552	32	or	or	CC
46745	3552	33	mechanical	mechanical	JJ
46745	3552	34	structure	structure	NN
46745	3552	35	existing	exist	VBG
46745	3552	36	between	between	IN
46745	3552	37	different	different	JJ
46745	3552	38	parts	part	NNS
46745	3552	39	of	of	IN
46745	3552	40	the	the	DT
46745	3552	41	nervous	nervous	JJ
46745	3552	42	system	system	NN
46745	3552	43	.	.	.
46745	3553	1	Strychnia	Strychnia	NNP
46745	3553	2	,	,	,
46745	3553	3	the	the	DT
46745	3553	4	alkaloid	alkaloid	NN
46745	3553	5	and	and	CC
46745	3553	6	chief	chief	JJ
46745	3553	7	active	active	JJ
46745	3553	8	principle	principle	NN
46745	3553	9	of	of	IN
46745	3553	10	Nux	Nux	NNP
46745	3553	11	Vomica	Vomica	NNP
46745	3553	12	,	,	,
46745	3553	13	acts	act	VBZ
46745	3553	14	as	as	IN
46745	3553	15	a	a	DT
46745	3553	16	Special	Special	NNP
46745	3553	17	Stimulant	Stimulant	NNP
46745	3553	18	,	,	,
46745	3553	19	chiefly	chiefly	RB
46745	3553	20	to	to	IN
46745	3553	21	the	the	DT
46745	3553	22	spinal	spinal	JJ
46745	3553	23	cord	cord	NN
46745	3553	24	and	and	CC
46745	3553	25	the	the	DT
46745	3553	26	nerves	nerve	NNS
46745	3553	27	that	that	WDT
46745	3553	28	proceed	proceed	VBP
46745	3553	29	from	from	IN
46745	3553	30	it	-PRON-	PRP
46745	3553	31	.	.	.
46745	3554	1	Its	-PRON-	PRP$
46745	3554	2	operation	operation	NN
46745	3554	3	is	be	VBZ
46745	3554	4	mainly	mainly	RB
46745	3554	5	exerted	exert	VBN
46745	3554	6	upon	upon	IN
46745	3554	7	the	the	DT
46745	3554	8	motor	motor	NN
46745	3554	9	branches	branch	NNS
46745	3554	10	.	.	.
46745	3555	1	Thus	thus	RB
46745	3555	2	in	in	IN
46745	3555	3	large	large	JJ
46745	3555	4	doses	dose	NNS
46745	3555	5	it	-PRON-	PRP
46745	3555	6	causes	cause	VBZ
46745	3555	7	a	a	DT
46745	3555	8	spasmodic	spasmodic	JJ
46745	3555	9	and	and	CC
46745	3555	10	powerful	powerful	JJ
46745	3555	11	contraction	contraction	NN
46745	3555	12	of	of	IN
46745	3555	13	the	the	DT
46745	3555	14	muscles	muscle	NNS
46745	3555	15	of	of	IN
46745	3555	16	the	the	DT
46745	3555	17	trunk	trunk	NN
46745	3555	18	,	,	,
46745	3555	19	and	and	CC
46745	3555	20	may	may	MD
46745	3555	21	even	even	RB
46745	3555	22	produce	produce	VB
46745	3555	23	death	death	NN
46745	3555	24	by	by	IN
46745	3555	25	rendering	render	VBG
46745	3555	26	respiration	respiration	NN
46745	3555	27	impossible	impossible	JJ
46745	3555	28	.	.	.
46745	3556	1	Its	-PRON-	PRP$
46745	3556	2	action	action	NN
46745	3556	3	is	be	VBZ
46745	3556	4	propagated	propagate	VBN
46745	3556	5	from	from	IN
46745	3556	6	a	a	DT
46745	3556	7	motor	motor	NN
46745	3556	8	nerve	nerve	NN
46745	3556	9	to	to	IN
46745	3556	10	a	a	DT
46745	3556	11	muscle	muscle	NN
46745	3556	12	,	,	,
46745	3556	13	and	and	CC
46745	3556	14	is	be	VBZ
46745	3556	15	kept	keep	VBN
46745	3556	16	up	up	RP
46745	3556	17	for	for	IN
46745	3556	18	some	some	DT
46745	3556	19	time	time	NN
46745	3556	20	.	.	.
46745	3557	1	In	in	IN
46745	3557	2	small	small	JJ
46745	3557	3	doses	dose	NNS
46745	3557	4	it	-PRON-	PRP
46745	3557	5	is	be	VBZ
46745	3557	6	useful	useful	JJ
46745	3557	7	in	in	IN
46745	3557	8	certain	certain	JJ
46745	3557	9	cases	case	NNS
46745	3557	10	of	of	IN
46745	3557	11	paralysis	paralysis	NN
46745	3557	12	.	.	.
46745	3558	1	Two	two	CD
46745	3558	2	things	thing	NNS
46745	3558	3	are	be	VBP
46745	3558	4	necessary	necessary	JJ
46745	3558	5	in	in	IN
46745	3558	6	order	order	NN
46745	3558	7	that	that	IN
46745	3558	8	it	-PRON-	PRP
46745	3558	9	may	may	MD
46745	3558	10	act	act	VB
46745	3558	11	efficiently	efficiently	RB
46745	3558	12	.	.	.
46745	3559	1	The	the	DT
46745	3559	2	muscles	muscle	NNS
46745	3559	3	of	of	IN
46745	3559	4	the	the	DT
46745	3559	5	part	part	NN
46745	3559	6	must	must	MD
46745	3559	7	be	be	VB
46745	3559	8	whole	whole	JJ
46745	3559	9	and	and	CC
46745	3559	10	sound	sound	JJ
46745	3559	11	;	;	:
46745	3559	12	for	for	IN
46745	3559	13	if	if	IN
46745	3559	14	destroyed	destroy	VBN
46745	3559	15	by	by	IN
46745	3559	16	excessive	excessive	JJ
46745	3559	17	atrophy	atrophy	NN
46745	3559	18	or	or	CC
46745	3559	19	fatty	fatty	NN
46745	3559	20	degeneration	degeneration	NN
46745	3559	21	,	,	,
46745	3559	22	they	-PRON-	PRP
46745	3559	23	can	can	MD
46745	3559	24	not	not	RB
46745	3559	25	be	be	VB
46745	3559	26	roused	rouse	VBN
46745	3559	27	by	by	IN
46745	3559	28	any	any	DT
46745	3559	29	stimulus	stimulus	NN
46745	3559	30	.	.	.
46745	3560	1	The	the	DT
46745	3560	2	nerve	nerve	NN
46745	3560	3	,	,	,
46745	3560	4	too	too	RB
46745	3560	5	,	,	,
46745	3560	6	and	and	CC
46745	3560	7	the	the	DT
46745	3560	8	centre	centre	NN
46745	3560	9	from	from	IN
46745	3560	10	which	which	WDT
46745	3560	11	it	-PRON-	PRP
46745	3560	12	originates	originate	VBZ
46745	3560	13	,	,	,
46745	3560	14	must	must	MD
46745	3560	15	be	be	VB
46745	3560	16	sound	sound	JJ
46745	3560	17	,	,	,
46745	3560	18	or	or	CC
46745	3560	19	else	else	RB
46745	3560	20	the	the	DT
46745	3560	21	medicinal	medicinal	JJ
46745	3560	22	impulse	impulse	NN
46745	3560	23	can	can	MD
46745	3560	24	not	not	RB
46745	3560	25	be	be	VB
46745	3560	26	conducted	conduct	VBN
46745	3560	27	along	along	IN
46745	3560	28	it	-PRON-	PRP
46745	3560	29	.	.	.
46745	3561	1	These	these	DT
46745	3561	2	two	two	CD
46745	3561	3	conditions	condition	NNS
46745	3561	4	can	can	MD
46745	3561	5	only	only	RB
46745	3561	6	concur	concur	VB
46745	3561	7	in	in	IN
46745	3561	8	paralysis	paralysis	NN
46745	3561	9	from	from	IN
46745	3561	10	disuse	disuse	NN
46745	3561	11	,	,	,
46745	3561	12	_	_	NNP
46745	3561	13	i.e.	i.e.	FW
46745	3561	14	_	_	NNP
46745	3561	15	when	when	WRB
46745	3561	16	the	the	DT
46745	3561	17	incapacity	incapacity	NN
46745	3561	18	to	to	TO
46745	3561	19	move	move	VB
46745	3561	20	a	a	DT
46745	3561	21	limb	limb	NN
46745	3561	22	depends	depend	VBZ
46745	3561	23	merely	merely	RB
46745	3561	24	upon	upon	IN
46745	3561	25	its	-PRON-	PRP$
46745	3561	26	having	have	VBG
46745	3561	27	long	long	RB
46745	3561	28	been	be	VBN
46745	3561	29	in	in	IN
46745	3561	30	a	a	DT
46745	3561	31	state	state	NN
46745	3561	32	of	of	IN
46745	3561	33	inactivity	inactivity	NN
46745	3561	34	,	,	,
46745	3561	35	but	but	CC
46745	3561	36	when	when	WRB
46745	3561	37	the	the	DT
46745	3561	38	lesion	lesion	NN
46745	3561	39	of	of	IN
46745	3561	40	the	the	DT
46745	3561	41	centre	centre	NN
46745	3561	42	which	which	WDT
46745	3561	43	caused	cause	VBD
46745	3561	44	the	the	DT
46745	3561	45	paralysis	paralysis	NN
46745	3561	46	has	have	VBZ
46745	3561	47	at	at	IN
46745	3561	48	length	length	NN
46745	3561	49	sufficiently	sufficiently	RB
46745	3561	50	healed	heal	VBN
46745	3561	51	,	,	,
46745	3561	52	and	and	CC
46745	3561	53	the	the	DT
46745	3561	54	nerve	nerve	NN
46745	3561	55	is	be	VBZ
46745	3561	56	now	now	RB
46745	3561	57	in	in	IN
46745	3561	58	a	a	DT
46745	3561	59	fit	fit	JJ
46745	3561	60	state	state	NN
46745	3561	61	to	to	TO
46745	3561	62	conduct	conduct	VB
46745	3561	63	a	a	DT
46745	3561	64	motor	motor	NN
46745	3561	65	impulse	impulse	NN
46745	3561	66	.	.	.
46745	3562	1	Strychnia	Strychnia	NNP
46745	3562	2	has	have	VBZ
46745	3562	3	no	no	DT
46745	3562	4	operation	operation	NN
46745	3562	5	on	on	IN
46745	3562	6	the	the	DT
46745	3562	7	intellectual	intellectual	JJ
46745	3562	8	functions	function	NNS
46745	3562	9	;	;	:
46745	3562	10	neither	neither	CC
46745	3562	11	does	do	VBZ
46745	3562	12	it	-PRON-	PRP
46745	3562	13	act	act	VB
46745	3562	14	upon	upon	IN
46745	3562	15	the	the	DT
46745	3562	16	sympathetic	sympathetic	JJ
46745	3562	17	nerves	nerve	NNS
46745	3562	18	of	of	IN
46745	3562	19	the	the	DT
46745	3562	20	heart	heart	NN
46745	3562	21	and	and	CC
46745	3562	22	arteries	artery	NNS
46745	3562	23	,	,	,
46745	3562	24	so	so	IN
46745	3562	25	as	as	IN
46745	3562	26	to	to	TO
46745	3562	27	quicken	quicken	VB
46745	3562	28	the	the	DT
46745	3562	29	pulse	pulse	NN
46745	3562	30	like	like	IN
46745	3562	31	ordinary	ordinary	JJ
46745	3562	32	stimulants	stimulant	NNS
46745	3562	33	.	.	.
46745	3563	1	It	-PRON-	PRP
46745	3563	2	exalts	exalt	VBZ
46745	3563	3	sensibility	sensibility	NN
46745	3563	4	as	as	RB
46745	3563	5	well	well	RB
46745	3563	6	as	as	IN
46745	3563	7	irritability	irritability	NN
46745	3563	8	,	,	,
46745	3563	9	but	but	CC
46745	3563	10	not	not	RB
46745	3563	11	so	so	RB
46745	3563	12	powerfully	powerfully	RB
46745	3563	13	.	.	.
46745	3564	1	It	-PRON-	PRP
46745	3564	2	is	be	VBZ
46745	3564	3	a	a	DT
46745	3564	4	special	special	JJ
46745	3564	5	Stimulant	stimulant	NN
46745	3564	6	to	to	IN
46745	3564	7	the	the	DT
46745	3564	8	motor	motor	NN
46745	3564	9	and	and	CC
46745	3564	10	sensory	sensory	JJ
46745	3564	11	nerves	nerve	NNS
46745	3564	12	throughout	throughout	IN
46745	3564	13	the	the	DT
46745	3564	14	body	body	NN
46745	3564	15	.	.	.
46745	3565	1	Acting	act	VBG
46745	3565	2	upon	upon	IN
46745	3565	3	the	the	DT
46745	3565	4	spinal	spinal	JJ
46745	3565	5	cord	cord	NN
46745	3565	6	,	,	,
46745	3565	7	it	-PRON-	PRP
46745	3565	8	tends	tend	VBZ
46745	3565	9	thus	thus	RB
46745	3565	10	to	to	TO
46745	3565	11	exalt	exalt	VB
46745	3565	12	reflex	reflex	JJ
46745	3565	13	action	action	NN
46745	3565	14	,	,	,
46745	3565	15	which	which	WDT
46745	3565	16	is	be	VBZ
46745	3565	17	derived	derive	VBN
46745	3565	18	from	from	IN
46745	3565	19	that	that	DT
46745	3565	20	centre	centre	NN
46745	3565	21	.	.	.
46745	3566	1	In	in	IN
46745	3566	2	small	small	JJ
46745	3566	3	doses	dose	NNS
46745	3566	4	it	-PRON-	PRP
46745	3566	5	appears	appear	VBZ
46745	3566	6	to	to	TO
46745	3566	7	promote	promote	VB
46745	3566	8	digestion	digestion	NN
46745	3566	9	,	,	,
46745	3566	10	and	and	CC
46745	3566	11	may	may	MD
46745	3566	12	perhaps	perhaps	RB
46745	3566	13	act	act	VB
46745	3566	14	upon	upon	IN
46745	3566	15	the	the	DT
46745	3566	16	ganglionic	ganglionic	JJ
46745	3566	17	nerves	nerve	NNS
46745	3566	18	supplied	supply	VBN
46745	3566	19	to	to	IN
46745	3566	20	the	the	DT
46745	3566	21	stomach	stomach	NN
46745	3566	22	.	.	.
46745	3567	1	Brucia	Brucia	NNP
46745	3567	2	,	,	,
46745	3567	3	which	which	WDT
46745	3567	4	is	be	VBZ
46745	3567	5	the	the	DT
46745	3567	6	other	other	JJ
46745	3567	7	alkaloid	alkaloid	NN
46745	3567	8	of	of	IN
46745	3567	9	Nux	Nux	NNP
46745	3567	10	Vomica,--and	Vomica,--and	NNP
46745	3567	11	the	the	DT
46745	3567	12	leaves	leave	NNS
46745	3567	13	of	of	IN
46745	3567	14	the	the	DT
46745	3567	15	Rhus	Rhus	NNP
46745	3567	16	Toxicodendron,--resemble	Toxicodendron,--resemble	NNP
46745	3567	17	Strychnia	Strychnia	NNP
46745	3567	18	in	in	IN
46745	3567	19	their	-PRON-	PRP$
46745	3567	20	action	action	NN
46745	3567	21	,	,	,
46745	3567	22	but	but	CC
46745	3567	23	are	be	VBP
46745	3567	24	less	less	RBR
46745	3567	25	powerful	powerful	JJ
46745	3567	26	.	.	.
46745	3568	1	Ergot	Ergot	NNP
46745	3568	2	of	of	IN
46745	3568	3	Rye	Rye	NNP
46745	3568	4	is	be	VBZ
46745	3568	5	a	a	DT
46745	3568	6	stimulant	stimulant	NN
46745	3568	7	to	to	IN
46745	3568	8	the	the	DT
46745	3568	9	muscular	muscular	JJ
46745	3568	10	nerves	nerve	NNS
46745	3568	11	of	of	IN
46745	3568	12	the	the	DT
46745	3568	13	Uterus	Uterus	NNP
46745	3568	14	of	of	IN
46745	3568	15	the	the	DT
46745	3568	16	female	female	NN
46745	3568	17	,	,	,
46745	3568	18	but	but	CC
46745	3568	19	to	to	IN
46745	3568	20	no	no	DT
46745	3568	21	other	other	JJ
46745	3568	22	nerves	nerve	NNS
46745	3568	23	in	in	IN
46745	3568	24	any	any	DT
46745	3568	25	marked	marked	JJ
46745	3568	26	degree	degree	NN
46745	3568	27	.	.	.
46745	3569	1	Borax	Borax	NNP
46745	3569	2	and	and	CC
46745	3569	3	Rue	Rue	NNP
46745	3569	4	possess	possess	VBP
46745	3569	5	a	a	DT
46745	3569	6	similar	similar	JJ
46745	3569	7	action	action	NN
46745	3569	8	,	,	,
46745	3569	9	but	but	CC
46745	3569	10	are	be	VBP
46745	3569	11	not	not	RB
46745	3569	12	so	so	RB
46745	3569	13	efficient	efficient	JJ
46745	3569	14	.	.	.
46745	3570	1	When	when	WRB
46745	3570	2	labour	labour	NN
46745	3570	3	is	be	VBZ
46745	3570	4	retarded	retard	VBN
46745	3570	5	on	on	IN
46745	3570	6	account	account	NN
46745	3570	7	of	of	IN
46745	3570	8	an	an	DT
46745	3570	9	atony	atony	NN
46745	3570	10	or	or	CC
46745	3570	11	debility	debility	NN
46745	3570	12	of	of	IN
46745	3570	13	the	the	DT
46745	3570	14	Uterine	uterine	JJ
46745	3570	15	muscle	muscle	NN
46745	3570	16	,	,	,
46745	3570	17	and	and	CC
46745	3570	18	when	when	WRB
46745	3570	19	also	also	RB
46745	3570	20	there	there	EX
46745	3570	21	is	be	VBZ
46745	3570	22	no	no	DT
46745	3570	23	obstruction	obstruction	NN
46745	3570	24	or	or	CC
46745	3570	25	danger	danger	NN
46745	3570	26	which	which	WDT
46745	3570	27	can	can	MD
46745	3570	28	result	result	VB
46745	3570	29	from	from	IN
46745	3570	30	bringing	bring	VBG
46745	3570	31	on	on	IN
46745	3570	32	contraction	contraction	NN
46745	3570	33	,	,	,
46745	3570	34	Ergot	Ergot	NNP
46745	3570	35	supplies	supply	VBZ
46745	3570	36	us	-PRON-	PRP
46745	3570	37	with	with	IN
46745	3570	38	a	a	DT
46745	3570	39	ready	ready	JJ
46745	3570	40	and	and	CC
46745	3570	41	effectual	effectual	JJ
46745	3570	42	means	mean	NNS
46745	3570	43	of	of	IN
46745	3570	44	doing	do	VBG
46745	3570	45	this	this	DT
46745	3570	46	.	.	.
46745	3571	1	It	-PRON-	PRP
46745	3571	2	is	be	VBZ
46745	3571	3	also	also	RB
46745	3571	4	efficacious	efficacious	JJ
46745	3571	5	in	in	IN
46745	3571	6	cases	case	NNS
46745	3571	7	of	of	IN
46745	3571	8	uterine	uterine	JJ
46745	3571	9	hæmorrhage	hæmorrhage	NN
46745	3571	10	,	,	,
46745	3571	11	because	because	IN
46745	3571	12	the	the	DT
46745	3571	13	open	open	JJ
46745	3571	14	mouths	mouth	NNS
46745	3571	15	of	of	IN
46745	3571	16	the	the	DT
46745	3571	17	bleeding	bleed	VBG
46745	3571	18	veins	vein	NNS
46745	3571	19	in	in	IN
46745	3571	20	the	the	DT
46745	3571	21	wall	wall	NN
46745	3571	22	of	of	IN
46745	3571	23	the	the	DT
46745	3571	24	uterus	uterus	NN
46745	3571	25	are	be	VBP
46745	3571	26	closed	close	VBN
46745	3571	27	by	by	IN
46745	3571	28	the	the	DT
46745	3571	29	contraction	contraction	NN
46745	3571	30	which	which	WDT
46745	3571	31	it	-PRON-	PRP
46745	3571	32	causes	cause	VBZ
46745	3571	33	.	.	.
46745	3572	1	When	when	WRB
46745	3572	2	given	give	VBN
46745	3572	3	in	in	IN
46745	3572	4	an	an	DT
46745	3572	5	over	over	NN
46745	3572	6	-	-	HYPH
46745	3572	7	dose	dose	NN
46745	3572	8	,	,	,
46745	3572	9	Ergot	Ergot	NNP
46745	3572	10	has	have	VBZ
46745	3572	11	a	a	DT
46745	3572	12	dangerous	dangerous	JJ
46745	3572	13	action	action	NN
46745	3572	14	on	on	IN
46745	3572	15	the	the	DT
46745	3572	16	brain	brain	NN
46745	3572	17	,	,	,
46745	3572	18	producing	produce	VBG
46745	3572	19	at	at	IN
46745	3572	20	some	some	DT
46745	3572	21	times	time	NNS
46745	3572	22	narcotism	narcotism	NN
46745	3572	23	,	,	,
46745	3572	24	at	at	IN
46745	3572	25	other	other	JJ
46745	3572	26	times	time	NNS
46745	3572	27	syncope	syncope	VBP
46745	3572	28	.	.	.
46745	3573	1	But	but	CC
46745	3573	2	this	this	DT
46745	3573	3	is	be	VBZ
46745	3573	4	not	not	RB
46745	3573	5	the	the	DT
46745	3573	6	effect	effect	NN
46745	3573	7	for	for	IN
46745	3573	8	which	which	WDT
46745	3573	9	it	-PRON-	PRP
46745	3573	10	is	be	VBZ
46745	3573	11	employed	employ	VBN
46745	3573	12	,	,	,
46745	3573	13	and	and	CC
46745	3573	14	is	be	VBZ
46745	3573	15	altogether	altogether	RB
46745	3573	16	distinct	distinct	JJ
46745	3573	17	from	from	IN
46745	3573	18	its	-PRON-	PRP$
46745	3573	19	operation	operation	NN
46745	3573	20	as	as	IN
46745	3573	21	a	a	DT
46745	3573	22	Special	Special	NNP
46745	3573	23	Stimulant	Stimulant	NNP
46745	3573	24	,	,	,
46745	3573	25	which	which	WDT
46745	3573	26	is	be	VBZ
46745	3573	27	exerted	exert	VBN
46745	3573	28	only	only	RB
46745	3573	29	upon	upon	IN
46745	3573	30	the	the	DT
46745	3573	31	ganglionic	ganglionic	JJ
46745	3573	32	nerves	nerve	NNS
46745	3573	33	of	of	IN
46745	3573	34	the	the	DT
46745	3573	35	muscular	muscular	JJ
46745	3573	36	uterus	uterus	NN
46745	3573	37	.	.	.
46745	3574	1	In	in	IN
46745	3574	2	small	small	JJ
46745	3574	3	doses	dose	NNS
46745	3574	4	it	-PRON-	PRP
46745	3574	5	produces	produce	VBZ
46745	3574	6	no	no	DT
46745	3574	7	other	other	JJ
46745	3574	8	effect	effect	NN
46745	3574	9	than	than	IN
46745	3574	10	this	this	DT
46745	3574	11	.	.	.
46745	3575	1	Like	like	IN
46745	3575	2	the	the	DT
46745	3575	3	other	other	JJ
46745	3575	4	medicines	medicine	NNS
46745	3575	5	of	of	IN
46745	3575	6	this	this	DT
46745	3575	7	order	order	NN
46745	3575	8	,	,	,
46745	3575	9	Ergot	Ergot	NNP
46745	3575	10	is	be	VBZ
46745	3575	11	not	not	RB
46745	3575	12	an	an	DT
46745	3575	13	excitor	excitor	NN
46745	3575	14	of	of	IN
46745	3575	15	the	the	DT
46745	3575	16	heart	heart	NN
46745	3575	17	and	and	CC
46745	3575	18	circulation	circulation	NN
46745	3575	19	.	.	.
46745	3576	1	Its	-PRON-	PRP$
46745	3576	2	stimulant	stimulant	NN
46745	3576	3	action	action	NN
46745	3576	4	is	be	VBZ
46745	3576	5	strictly	strictly	RB
46745	3576	6	local	local	JJ
46745	3576	7	in	in	IN
46745	3576	8	its	-PRON-	PRP$
46745	3576	9	nature	nature	NN
46745	3576	10	.	.	.
46745	3577	1	NARCOTICS	NARCOTICS	NNP
46745	3577	2	.	.	.
46745	3578	1	This	this	DT
46745	3578	2	,	,	,
46745	3578	3	the	the	DT
46745	3578	4	second	second	JJ
46745	3578	5	division	division	NN
46745	3578	6	of	of	IN
46745	3578	7	Neurotic	neurotic	JJ
46745	3578	8	medicines	medicine	NNS
46745	3578	9	,	,	,
46745	3578	10	is	be	VBZ
46745	3578	11	in	in	IN
46745	3578	12	one	one	CD
46745	3578	13	sense	sense	NN
46745	3578	14	intermediate	intermediate	JJ
46745	3578	15	between	between	IN
46745	3578	16	the	the	DT
46745	3578	17	other	other	JJ
46745	3578	18	two	two	CD
46745	3578	19	divisions	division	NNS
46745	3578	20	,	,	,
46745	3578	21	but	but	CC
46745	3578	22	in	in	IN
46745	3578	23	another	another	DT
46745	3578	24	sense	sense	NN
46745	3578	25	different	different	JJ
46745	3578	26	from	from	IN
46745	3578	27	both	both	DT
46745	3578	28	of	of	IN
46745	3578	29	them	-PRON-	PRP
46745	3578	30	.	.	.
46745	3579	1	Narcotics	narcotic	NNS
46745	3579	2	are	be	VBP
46745	3579	3	defined	define	VBN
46745	3579	4	to	to	TO
46745	3579	5	be	be	VB
46745	3579	6	medicines	medicine	NNS
46745	3579	7	which	which	WDT
46745	3579	8	pass	pass	VBP
46745	3579	9	from	from	IN
46745	3579	10	the	the	DT
46745	3579	11	blood	blood	NN
46745	3579	12	to	to	IN
46745	3579	13	the	the	DT
46745	3579	14	nerves	nerve	NNS
46745	3579	15	or	or	CC
46745	3579	16	nerve	nerve	NN
46745	3579	17	-	-	HYPH
46745	3579	18	centres	centre	NNS
46745	3579	19	;	;	:
46745	3579	20	which	which	WDT
46745	3579	21	act	act	VBP
46745	3579	22	so	so	RB
46745	3579	23	as	as	RB
46745	3579	24	first	first	JJ
46745	3579	25	to	to	TO
46745	3579	26	exalt	exalt	VB
46745	3579	27	nervous	nervous	JJ
46745	3579	28	force	force	NN
46745	3579	29	,	,	,
46745	3579	30	and	and	CC
46745	3579	31	then	then	RB
46745	3579	32	to	to	TO
46745	3579	33	depress	depress	VB
46745	3579	34	it	-PRON-	PRP
46745	3579	35	;	;	:
46745	3579	36	and	and	CC
46745	3579	37	have	have	VBP
46745	3579	38	also	also	RB
46745	3579	39	a	a	DT
46745	3579	40	special	special	JJ
46745	3579	41	action	action	NN
46745	3579	42	on	on	IN
46745	3579	43	the	the	DT
46745	3579	44	intellectual	intellectual	JJ
46745	3579	45	part	part	NN
46745	3579	46	of	of	IN
46745	3579	47	the	the	DT
46745	3579	48	brain	brain	NN
46745	3579	49	.	.	.
46745	3580	1	This	this	DT
46745	3580	2	primary	primary	JJ
46745	3580	3	exaltation	exaltation	NN
46745	3580	4	of	of	IN
46745	3580	5	nervous	nervous	JJ
46745	3580	6	force	force	NN
46745	3580	7	is	be	VBZ
46745	3580	8	produced	produce	VBN
46745	3580	9	by	by	IN
46745	3580	10	some	some	DT
46745	3580	11	to	to	IN
46745	3580	12	a	a	DT
46745	3580	13	very	very	RB
46745	3580	14	considerable	considerable	JJ
46745	3580	15	extent	extent	NN
46745	3580	16	,	,	,
46745	3580	17	but	but	CC
46745	3580	18	by	by	IN
46745	3580	19	others	other	NNS
46745	3580	20	very	very	RB
46745	3580	21	slightly	slightly	RB
46745	3580	22	.	.	.
46745	3581	1	Of	of	IN
46745	3581	2	the	the	DT
46745	3581	3	three	three	CD
46745	3581	4	orders	order	NNS
46745	3581	5	into	into	IN
46745	3581	6	which	which	WDT
46745	3581	7	I	-PRON-	PRP
46745	3581	8	have	have	VBP
46745	3581	9	divided	divide	VBN
46745	3581	10	Narcotics	Narcotics	NNP
46745	3581	11	,	,	,
46745	3581	12	which	which	WDT
46745	3581	13	are	be	VBP
46745	3581	14	named	name	VBN
46745	3581	15	from	from	IN
46745	3581	16	their	-PRON-	PRP$
46745	3581	17	respective	respective	JJ
46745	3581	18	actions	action	NNS
46745	3581	19	upon	upon	IN
46745	3581	20	the	the	DT
46745	3581	21	brain	brain	NN
46745	3581	22	,	,	,
46745	3581	23	Inebriants	inebriant	NNS
46745	3581	24	cause	cause	VBP
46745	3581	25	most	most	RBS
46745	3581	26	,	,	,
46745	3581	27	and	and	CC
46745	3581	28	Deliriants	deliriant	NNS
46745	3581	29	least	least	JJS
46745	3581	30	,	,	,
46745	3581	31	of	of	IN
46745	3581	32	this	this	DT
46745	3581	33	primary	primary	JJ
46745	3581	34	stimulation	stimulation	NN
46745	3581	35	.	.	.
46745	3582	1	In	in	IN
46745	3582	2	the	the	DT
46745	3582	3	second	second	JJ
46745	3582	4	place	place	NN
46745	3582	5	,	,	,
46745	3582	6	Narcotics	Narcotics	NNP
46745	3582	7	depress	depress	NN
46745	3582	8	nervous	nervous	JJ
46745	3582	9	influence	influence	NN
46745	3582	10	.	.	.
46745	3583	1	This	this	DT
46745	3583	2	depression	depression	NN
46745	3583	3	is	be	VBZ
46745	3583	4	not	not	RB
46745	3583	5	in	in	IN
46745	3583	6	a	a	DT
46745	3583	7	direct	direct	JJ
46745	3583	8	,	,	,
46745	3583	9	but	but	CC
46745	3583	10	in	in	IN
46745	3583	11	an	an	DT
46745	3583	12	inverse	inverse	NN
46745	3583	13	ratio	ratio	NN
46745	3583	14	to	to	IN
46745	3583	15	the	the	DT
46745	3583	16	primary	primary	JJ
46745	3583	17	stimulation	stimulation	NN
46745	3583	18	.	.	.
46745	3584	1	The	the	DT
46745	3584	2	less	less	RBR
46745	3584	3	the	the	DT
46745	3584	4	one	one	NN
46745	3584	5	,	,	,
46745	3584	6	the	the	DT
46745	3584	7	greater	great	JJR
46745	3584	8	the	the	DT
46745	3584	9	other	other	JJ
46745	3584	10	.	.	.
46745	3585	1	Thus	thus	RB
46745	3585	2	the	the	DT
46745	3585	3	depression	depression	NN
46745	3585	4	can	can	MD
46745	3585	5	not	not	RB
46745	3585	6	be	be	VB
46745	3585	7	considered	consider	VBN
46745	3585	8	as	as	IN
46745	3585	9	the	the	DT
46745	3585	10	mere	mere	JJ
46745	3585	11	re	re	NN
46745	3585	12	-	-	NN
46745	3585	13	action	action	NN
46745	3585	14	from	from	IN
46745	3585	15	the	the	DT
46745	3585	16	stimulation	stimulation	NN
46745	3585	17	,	,	,
46745	3585	18	as	as	IN
46745	3585	19	supposed	suppose	VBN
46745	3585	20	by	by	IN
46745	3585	21	Dr.	Dr.	NNP
46745	3585	22	Brown	Brown	NNP
46745	3585	23	,	,	,
46745	3585	24	for	for	IN
46745	3585	25	then	then	RB
46745	3585	26	there	there	EX
46745	3585	27	would	would	MD
46745	3585	28	be	be	VB
46745	3585	29	a	a	DT
46745	3585	30	direct	direct	JJ
46745	3585	31	relation	relation	NN
46745	3585	32	between	between	IN
46745	3585	33	the	the	DT
46745	3585	34	two	two	CD
46745	3585	35	effects	effect	NNS
46745	3585	36	.	.	.
46745	3586	1	But	but	CC
46745	3586	2	we	-PRON-	PRP
46745	3586	3	find	find	VBP
46745	3586	4	that	that	IN
46745	3586	5	the	the	DT
46745	3586	6	exhilarating	exhilarating	JJ
46745	3586	7	action	action	NN
46745	3586	8	of	of	IN
46745	3586	9	Alcohol	Alcohol	NNP
46745	3586	10	may	may	MD
46745	3586	11	often	often	RB
46745	3586	12	be	be	VB
46745	3586	13	followed	follow	VBN
46745	3586	14	by	by	IN
46745	3586	15	no	no	DT
46745	3586	16	manifest	manifest	NN
46745	3586	17	depression	depression	NN
46745	3586	18	;	;	:
46745	3586	19	and	and	CC
46745	3586	20	that	that	IN
46745	3586	21	Belladonna	Belladonna	NNP
46745	3586	22	,	,	,
46745	3586	23	which	which	WDT
46745	3586	24	scarcely	scarcely	RB
46745	3586	25	stimulates	stimulate	VBZ
46745	3586	26	at	at	RB
46745	3586	27	all	all	RB
46745	3586	28	,	,	,
46745	3586	29	exerts	exert	VBZ
46745	3586	30	a	a	DT
46745	3586	31	very	very	RB
46745	3586	32	sensible	sensible	JJ
46745	3586	33	depressing	depressing	JJ
46745	3586	34	influence	influence	NN
46745	3586	35	.	.	.
46745	3587	1	Regarded	regard	VBN
46745	3587	2	simply	simply	RB
46745	3587	3	in	in	IN
46745	3587	4	their	-PRON-	PRP$
46745	3587	5	action	action	NN
46745	3587	6	on	on	IN
46745	3587	7	nervous	nervous	JJ
46745	3587	8	force	force	NN
46745	3587	9	generally	generally	RB
46745	3587	10	,	,	,
46745	3587	11	the	the	DT
46745	3587	12	medicines	medicine	NNS
46745	3587	13	of	of	IN
46745	3587	14	the	the	DT
46745	3587	15	first	first	JJ
46745	3587	16	order	order	NN
46745	3587	17	of	of	IN
46745	3587	18	Narcotics	Narcotics	NNP
46745	3587	19	would	would	MD
46745	3587	20	approach	approach	VB
46745	3587	21	very	very	RB
46745	3587	22	nearly	nearly	RB
46745	3587	23	to	to	IN
46745	3587	24	Stimulants	Stimulants	NNP
46745	3587	25	,	,	,
46745	3587	26	and	and	CC
46745	3587	27	those	those	DT
46745	3587	28	of	of	IN
46745	3587	29	the	the	DT
46745	3587	30	third	third	JJ
46745	3587	31	order	order	NN
46745	3587	32	to	to	IN
46745	3587	33	Sedatives	sedative	NNS
46745	3587	34	.	.	.
46745	3588	1	But	but	CC
46745	3588	2	Narcotics	Narcotics	NNP
46745	3588	3	have	have	VBP
46745	3588	4	all	all	PDT
46745	3588	5	a	a	DT
46745	3588	6	power	power	NN
46745	3588	7	which	which	WDT
46745	3588	8	is	be	VBZ
46745	3588	9	possessed	possess	VBN
46745	3588	10	by	by	IN
46745	3588	11	neither	neither	DT
46745	3588	12	of	of	IN
46745	3588	13	the	the	DT
46745	3588	14	other	other	JJ
46745	3588	15	divisions	division	NNS
46745	3588	16	.	.	.
46745	3589	1	They	-PRON-	PRP
46745	3589	2	influence	influence	VBP
46745	3589	3	the	the	DT
46745	3589	4	intellectual	intellectual	JJ
46745	3589	5	functions	function	NNS
46745	3589	6	,	,	,
46745	3589	7	_	_	NNP
46745	3589	8	i.e.	i.e.	FW
46745	3589	9	_	_	NNP
46745	3589	10	the	the	DT
46745	3589	11	mind	mind	NN
46745	3589	12	,	,	,
46745	3589	13	and	and	CC
46745	3589	14	the	the	DT
46745	3589	15	physical	physical	JJ
46745	3589	16	ties	tie	NNS
46745	3589	17	by	by	IN
46745	3589	18	which	which	WDT
46745	3589	19	mind	mind	NN
46745	3589	20	is	be	VBZ
46745	3589	21	connected	connect	VBN
46745	3589	22	with	with	IN
46745	3589	23	matter	matter	NN
46745	3589	24	.	.	.
46745	3590	1	These	these	DT
46745	3590	2	physical	physical	JJ
46745	3590	3	ties	tie	NNS
46745	3590	4	are,--the	are,--the	VBP
46745	3590	5	functions	function	NNS
46745	3590	6	of	of	IN
46745	3590	7	volition	volition	NN
46745	3590	8	and	and	CC
46745	3590	9	sensation	sensation	NN
46745	3590	10	,	,	,
46745	3590	11	by	by	IN
46745	3590	12	which	which	WDT
46745	3590	13	the	the	DT
46745	3590	14	mind	mind	NN
46745	3590	15	is	be	VBZ
46745	3590	16	connected	connect	VBN
46745	3590	17	with	with	IN
46745	3590	18	the	the	DT
46745	3590	19	body	body	NN
46745	3590	20	,	,	,
46745	3590	21	moving	move	VBG
46745	3590	22	it	-PRON-	PRP
46745	3590	23	or	or	CC
46745	3590	24	feeling	feel	VBG
46745	3590	25	it	-PRON-	PRP
46745	3590	26	;	;	:
46745	3590	27	and	and	CC
46745	3590	28	the	the	DT
46745	3590	29	five	five	CD
46745	3590	30	senses	sense	NNS
46745	3590	31	,	,	,
46745	3590	32	by	by	IN
46745	3590	33	which	which	WDT
46745	3590	34	the	the	DT
46745	3590	35	mind	mind	NN
46745	3590	36	,	,	,
46745	3590	37	through	through	IN
46745	3590	38	the	the	DT
46745	3590	39	body	body	NN
46745	3590	40	,	,	,
46745	3590	41	is	be	VBZ
46745	3590	42	connected	connect	VBN
46745	3590	43	with	with	IN
46745	3590	44	external	external	JJ
46745	3590	45	things	thing	NNS
46745	3590	46	.	.	.
46745	3591	1	These	these	DT
46745	3591	2	intellectual	intellectual	JJ
46745	3591	3	properties	property	NNS
46745	3591	4	,	,	,
46745	3591	5	the	the	DT
46745	3591	6	centre	centre	NN
46745	3591	7	of	of	IN
46745	3591	8	which	which	WDT
46745	3591	9	is	be	VBZ
46745	3591	10	the	the	DT
46745	3591	11	brain	brain	NN
46745	3591	12	,	,	,
46745	3591	13	are	be	VBP
46745	3591	14	more	more	RBR
46745	3591	15	or	or	CC
46745	3591	16	less	less	RBR
46745	3591	17	affected	affected	JJ
46745	3591	18	by	by	IN
46745	3591	19	Narcotic	narcotic	JJ
46745	3591	20	medicines	medicine	NNS
46745	3591	21	.	.	.
46745	3592	1	The	the	DT
46745	3592	2	first	first	JJ
46745	3592	3	action	action	NN
46745	3592	4	of	of	IN
46745	3592	5	the	the	DT
46745	3592	6	latter	latter	JJ
46745	3592	7	is	be	VBZ
46745	3592	8	,	,	,
46745	3592	9	to	to	TO
46745	3592	10	exalt	exalt	VB
46745	3592	11	these	these	DT
46745	3592	12	functions	function	NNS
46745	3592	13	,	,	,
46745	3592	14	just	just	RB
46745	3592	15	as	as	IN
46745	3592	16	they	-PRON-	PRP
46745	3592	17	first	first	RB
46745	3592	18	exalt	exalt	VBP
46745	3592	19	nervous	nervous	JJ
46745	3592	20	force	force	NN
46745	3592	21	in	in	IN
46745	3592	22	general	general	JJ
46745	3592	23	.	.	.
46745	3593	1	The	the	DT
46745	3593	2	degree	degree	NN
46745	3593	3	of	of	IN
46745	3593	4	this	this	DT
46745	3593	5	exaltation	exaltation	NN
46745	3593	6	varies	vary	VBZ
46745	3593	7	,	,	,
46745	3593	8	as	as	IN
46745	3593	9	in	in	IN
46745	3593	10	the	the	DT
46745	3593	11	former	former	JJ
46745	3593	12	case	case	NN
46745	3593	13	.	.	.
46745	3594	1	Inebriants	inebriant	NNS
46745	3594	2	stimulate	stimulate	VBP
46745	3594	3	the	the	DT
46745	3594	4	mind	mind	NN
46745	3594	5	to	to	IN
46745	3594	6	a	a	DT
46745	3594	7	considerable	considerable	JJ
46745	3594	8	degree	degree	NN
46745	3594	9	;	;	:
46745	3594	10	Soporifics	Soporifics	NNP
46745	3594	11	less	less	RBR
46745	3594	12	;	;	:
46745	3594	13	and	and	CC
46745	3594	14	Deliriants	Deliriants	NNPS
46745	3594	15	possess	possess	VBP
46745	3594	16	least	least	JJS
46745	3594	17	of	of	IN
46745	3594	18	this	this	DT
46745	3594	19	primary	primary	JJ
46745	3594	20	exciting	exciting	JJ
46745	3594	21	power	power	NN
46745	3594	22	.	.	.
46745	3595	1	But	but	CC
46745	3595	2	it	-PRON-	PRP
46745	3595	3	is	be	VBZ
46745	3595	4	in	in	IN
46745	3595	5	their	-PRON-	PRP$
46745	3595	6	secondary	secondary	JJ
46745	3595	7	action	action	NN
46745	3595	8	on	on	IN
46745	3595	9	the	the	DT
46745	3595	10	mind	mind	NN
46745	3595	11	that	that	IN
46745	3595	12	we	-PRON-	PRP
46745	3595	13	find	find	VBP
46745	3595	14	the	the	DT
46745	3595	15	most	most	RBS
46745	3595	16	characteristic	characteristic	JJ
46745	3595	17	difference	difference	NN
46745	3595	18	between	between	IN
46745	3595	19	them	-PRON-	PRP
46745	3595	20	.	.	.
46745	3596	1	On	on	IN
46745	3596	2	referring	refer	VBG
46745	3596	3	to	to	IN
46745	3596	4	the	the	DT
46745	3596	5	arrangement	arrangement	NN
46745	3596	6	,	,	,
46745	3596	7	it	-PRON-	PRP
46745	3596	8	will	will	MD
46745	3596	9	be	be	VB
46745	3596	10	seen	see	VBN
46745	3596	11	that	that	IN
46745	3596	12	I	-PRON-	PRP
46745	3596	13	have	have	VBP
46745	3596	14	divided	divide	VBN
46745	3596	15	Narcotics	Narcotics	NNP
46745	3596	16	into	into	IN
46745	3596	17	the	the	DT
46745	3596	18	three	three	CD
46745	3596	19	orders	order	NNS
46745	3596	20	to	to	TO
46745	3596	21	which	which	WDT
46745	3596	22	I	-PRON-	PRP
46745	3596	23	have	have	VBP
46745	3596	24	already	already	RB
46745	3596	25	referred	refer	VBN
46745	3596	26	by	by	IN
46745	3596	27	name	name	NN
46745	3596	28	,	,	,
46745	3596	29	and	and	CC
46745	3596	30	which	which	WDT
46745	3596	31	are	be	VBP
46745	3596	32	thus	thus	RB
46745	3596	33	designated	designate	VBN
46745	3596	34	in	in	IN
46745	3596	35	Latin	Latin	NNP
46745	3596	36	:	:	:
46745	3596	37	NARCOTICA	NARCOTICA	NNP
46745	3596	38	.	.	.
46745	3597	1	Ord	Ord	NNP
46745	3597	2	.	.	.
46745	3598	1	1	1	LS
46745	3598	2	.	.	.
46745	3599	1	Inebriantia	Inebriantia	NNP
46745	3599	2	.	.	.
46745	3600	1	Ord	Ord	NNP
46745	3600	2	.	.	.
46745	3601	1	2	2	LS
46745	3601	2	.	.	.
46745	3602	1	Somnifera	Somnifera	NNP
46745	3602	2	.	.	.
46745	3603	1	Ord	Ord	NNP
46745	3603	2	.	.	.
46745	3604	1	3	3	LS
46745	3604	2	.	.	.
46745	3605	1	Deliriantia	deliriantia	NN
46745	3605	2	.	.	.
46745	3606	1	These	these	DT
46745	3606	2	Orders	order	NNS
46745	3606	3	are	be	VBP
46745	3606	4	named	name	VBN
46745	3606	5	from	from	IN
46745	3606	6	the	the	DT
46745	3606	7	secondary	secondary	JJ
46745	3606	8	action	action	NN
46745	3606	9	of	of	IN
46745	3606	10	these	these	DT
46745	3606	11	different	different	JJ
46745	3606	12	Narcotics	Narcotics	NNP
46745	3606	13	on	on	IN
46745	3606	14	the	the	DT
46745	3606	15	intellectual	intellectual	JJ
46745	3606	16	functions	function	NNS
46745	3606	17	.	.	.
46745	3607	1	In	in	IN
46745	3607	2	the	the	DT
46745	3607	3	production	production	NN
46745	3607	4	of	of	IN
46745	3607	5	inebriation	inebriation	NN
46745	3607	6	these	these	DT
46745	3607	7	functions	function	NNS
46745	3607	8	are	be	VBP
46745	3607	9	impaired	impair	VBN
46745	3607	10	and	and	CC
46745	3607	11	deranged	deranged	JJ
46745	3607	12	;	;	:
46745	3607	13	in	in	IN
46745	3607	14	sleep	sleep	NN
46745	3607	15	they	-PRON-	PRP
46745	3607	16	are	be	VBP
46745	3607	17	lulled	lull	VBN
46745	3607	18	or	or	CC
46745	3607	19	extinguished	extinguish	VBN
46745	3607	20	for	for	IN
46745	3607	21	a	a	DT
46745	3607	22	time	time	NN
46745	3607	23	;	;	:
46745	3607	24	and	and	CC
46745	3607	25	in	in	IN
46745	3607	26	delirium	delirium	NN
46745	3607	27	they	-PRON-	PRP
46745	3607	28	are	be	VBP
46745	3607	29	excited	excited	JJ
46745	3607	30	and	and	CC
46745	3607	31	led	lead	VBN
46745	3607	32	astray	astray	NNP
46745	3607	33	.	.	.
46745	3608	1	The	the	DT
46745	3608	2	several	several	JJ
46745	3608	3	actions	action	NNS
46745	3608	4	of	of	IN
46745	3608	5	these	these	DT
46745	3608	6	orders	order	NNS
46745	3608	7	will	will	MD
46745	3608	8	be	be	VB
46745	3608	9	more	more	RBR
46745	3608	10	minutely	minutely	RB
46745	3608	11	described	describe	VBN
46745	3608	12	presently	presently	RB
46745	3608	13	,	,	,
46745	3608	14	and	and	CC
46745	3608	15	the	the	DT
46745	3608	16	individual	individual	JJ
46745	3608	17	medicines	medicine	NNS
46745	3608	18	of	of	IN
46745	3608	19	which	which	WDT
46745	3608	20	they	-PRON-	PRP
46745	3608	21	are	be	VBP
46745	3608	22	composed	compose	VBN
46745	3608	23	will	will	MD
46745	3608	24	be	be	VB
46745	3608	25	shown	show	VBN
46745	3608	26	to	to	TO
46745	3608	27	agree	agree	VB
46745	3608	28	with	with	IN
46745	3608	29	the	the	DT
46745	3608	30	general	general	JJ
46745	3608	31	definition	definition	NN
46745	3608	32	of	of	IN
46745	3608	33	Narcotics	Narcotics	NNP
46745	3608	34	.	.	.
46745	3609	1	Dr.	Dr.	NNP
46745	3609	2	A.	A.	NNP
46745	3610	1	Billing	billing	NN
46745	3610	2	considers	consider	VBZ
46745	3610	3	that	that	IN
46745	3610	4	Stimulants	Stimulants	NNP
46745	3610	5	call	call	VBP
46745	3610	6	forth	forth	RP
46745	3610	7	nervous	nervous	JJ
46745	3610	8	force	force	NN
46745	3610	9	,	,	,
46745	3610	10	and	and	CC
46745	3610	11	Sedatives	Sedatives	NNPS
46745	3610	12	depress	depress	VBP
46745	3610	13	it	-PRON-	PRP
46745	3610	14	;	;	:
46745	3610	15	and	and	CC
46745	3610	16	that	that	IN
46745	3610	17	Narcotics	Narcotics	NNP
46745	3610	18	do	do	VBP
46745	3610	19	neither	neither	CC
46745	3610	20	the	the	DT
46745	3610	21	one	one	CD
46745	3610	22	nor	nor	CC
46745	3610	23	the	the	DT
46745	3610	24	other	other	JJ
46745	3610	25	,	,	,
46745	3610	26	but	but	CC
46745	3610	27	merely	merely	RB
46745	3610	28	impede	impede	VBZ
46745	3610	29	its	-PRON-	PRP$
46745	3610	30	communication	communication	NN
46745	3610	31	.	.	.
46745	3611	1	I	-PRON-	PRP
46745	3611	2	do	do	VBP
46745	3611	3	not	not	RB
46745	3611	4	consider	consider	VB
46745	3611	5	this	this	DT
46745	3611	6	distinction	distinction	NN
46745	3611	7	to	to	TO
46745	3611	8	be	be	VB
46745	3611	9	quite	quite	RB
46745	3611	10	correct	correct	JJ
46745	3611	11	.	.	.
46745	3612	1	Narcotics	narcotic	NNS
46745	3612	2	exert	exert	VBP
46745	3612	3	in	in	IN
46745	3612	4	the	the	DT
46745	3612	5	first	first	JJ
46745	3612	6	place	place	NN
46745	3612	7	a	a	DT
46745	3612	8	stimulant	stimulant	NN
46745	3612	9	,	,	,
46745	3612	10	and	and	CC
46745	3612	11	in	in	IN
46745	3612	12	the	the	DT
46745	3612	13	second	second	JJ
46745	3612	14	place	place	NN
46745	3612	15	a	a	DT
46745	3612	16	sedative	sedative	JJ
46745	3612	17	action	action	NN
46745	3612	18	;	;	:
46745	3612	19	but	but	CC
46745	3612	20	these	these	DT
46745	3612	21	actions	action	NNS
46745	3612	22	have	have	VBP
46745	3612	23	no	no	DT
46745	3612	24	relation	relation	NN
46745	3612	25	in	in	IN
46745	3612	26	degree	degree	NN
46745	3612	27	,	,	,
46745	3612	28	for	for	IN
46745	3612	29	one	one	CD
46745	3612	30	of	of	IN
46745	3612	31	them	-PRON-	PRP
46745	3612	32	always	always	RB
46745	3612	33	exceeds	exceed	VBZ
46745	3612	34	the	the	DT
46745	3612	35	other	other	JJ
46745	3612	36	,	,	,
46745	3612	37	as	as	IN
46745	3612	38	we	-PRON-	PRP
46745	3612	39	have	have	VBP
46745	3612	40	just	just	RB
46745	3612	41	seen	see	VBN
46745	3612	42	.	.	.
46745	3613	1	Thus	thus	RB
46745	3613	2	in	in	IN
46745	3613	3	the	the	DT
46745	3613	4	whole	whole	JJ
46745	3613	5	effect	effect	NN
46745	3613	6	,	,	,
46745	3613	7	either	either	CC
46745	3613	8	the	the	DT
46745	3613	9	stimulation	stimulation	NN
46745	3613	10	must	must	MD
46745	3613	11	exceed	exceed	VB
46745	3613	12	the	the	DT
46745	3613	13	depression	depression	NN
46745	3613	14	,	,	,
46745	3613	15	or	or	CC
46745	3613	16	the	the	DT
46745	3613	17	depression	depression	NN
46745	3613	18	must	must	MD
46745	3613	19	be	be	VB
46745	3613	20	greater	great	JJR
46745	3613	21	than	than	IN
46745	3613	22	the	the	DT
46745	3613	23	stimulation	stimulation	NN
46745	3613	24	.	.	.
46745	3614	1	So	so	IN
46745	3614	2	that	that	IN
46745	3614	3	in	in	IN
46745	3614	4	one	one	CD
46745	3614	5	way	way	NN
46745	3614	6	or	or	CC
46745	3614	7	the	the	DT
46745	3614	8	other	other	JJ
46745	3614	9	the	the	DT
46745	3614	10	quality	quality	NN
46745	3614	11	of	of	IN
46745	3614	12	nervous	nervous	JJ
46745	3614	13	influence	influence	NN
46745	3614	14	must	must	MD
46745	3614	15	be	be	VB
46745	3614	16	altered	alter	VBN
46745	3614	17	.	.	.
46745	3615	1	The	the	DT
46745	3615	2	medicines	medicine	NNS
46745	3615	3	of	of	IN
46745	3615	4	the	the	DT
46745	3615	5	first	first	JJ
46745	3615	6	order	order	NN
46745	3615	7	of	of	IN
46745	3615	8	Narcotics	Narcotics	NNP
46745	3615	9	resemble	resemble	JJ
46745	3615	10	Stimulants	Stimulants	NNP
46745	3615	11	so	so	RB
46745	3615	12	far	far	RB
46745	3615	13	as	as	IN
46745	3615	14	this	this	DT
46745	3615	15	,	,	,
46745	3615	16	that	that	IN
46745	3615	17	they	-PRON-	PRP
46745	3615	18	tend	tend	VBP
46745	3615	19	altogether	altogether	RB
46745	3615	20	to	to	TO
46745	3615	21	increase	increase	VB
46745	3615	22	the	the	DT
46745	3615	23	amount	amount	NN
46745	3615	24	of	of	IN
46745	3615	25	nervous	nervous	JJ
46745	3615	26	force	force	NN
46745	3615	27	.	.	.
46745	3616	1	Perhaps	perhaps	RB
46745	3616	2	Tobacco	Tobacco	NNP
46745	3616	3	and	and	CC
46745	3616	4	Lobelia	Lobelia	NNP
46745	3616	5	are	be	VBP
46745	3616	6	exceptions	exception	NNS
46745	3616	7	to	to	IN
46745	3616	8	this	this	DT
46745	3616	9	.	.	.
46745	3617	1	The	the	DT
46745	3617	2	medicines	medicine	NNS
46745	3617	3	of	of	IN
46745	3617	4	the	the	DT
46745	3617	5	third	third	JJ
46745	3617	6	order	order	NN
46745	3617	7	,	,	,
46745	3617	8	and	and	CC
46745	3617	9	some	some	DT
46745	3617	10	of	of	IN
46745	3617	11	those	those	DT
46745	3617	12	in	in	IN
46745	3617	13	the	the	DT
46745	3617	14	second	second	JJ
46745	3617	15	,	,	,
46745	3617	16	tend	tend	VB
46745	3617	17	on	on	IN
46745	3617	18	the	the	DT
46745	3617	19	whole	whole	NN
46745	3617	20	to	to	TO
46745	3617	21	diminish	diminish	VB
46745	3617	22	the	the	DT
46745	3617	23	quantity	quantity	NN
46745	3617	24	of	of	IN
46745	3617	25	nervous	nervous	JJ
46745	3617	26	force	force	NN
46745	3617	27	,	,	,
46745	3617	28	and	and	CC
46745	3617	29	are	be	VBP
46745	3617	30	thus	thus	RB
46745	3617	31	akin	akin	JJ
46745	3617	32	to	to	IN
46745	3617	33	Sedatives	Sedatives	NNPS
46745	3617	34	.	.	.
46745	3618	1	A	a	DT
46745	3618	2	correct	correct	JJ
46745	3618	3	understanding	understanding	NN
46745	3618	4	of	of	IN
46745	3618	5	the	the	DT
46745	3618	6	differences	difference	NNS
46745	3618	7	in	in	IN
46745	3618	8	action	action	NN
46745	3618	9	which	which	WDT
46745	3618	10	exist	exist	VBP
46745	3618	11	between	between	IN
46745	3618	12	the	the	DT
46745	3618	13	groups	group	NNS
46745	3618	14	of	of	IN
46745	3618	15	Neurotic	neurotic	JJ
46745	3618	16	medicines	medicine	NNS
46745	3618	17	is	be	VBZ
46745	3618	18	,	,	,
46745	3618	19	I	-PRON-	PRP
46745	3618	20	think	think	VBP
46745	3618	21	,	,	,
46745	3618	22	very	very	RB
46745	3618	23	essential	essential	JJ
46745	3618	24	to	to	IN
46745	3618	25	a	a	DT
46745	3618	26	right	right	JJ
46745	3618	27	application	application	NN
46745	3618	28	of	of	IN
46745	3618	29	these	these	DT
46745	3618	30	remedies	remedy	NNS
46745	3618	31	in	in	IN
46745	3618	32	the	the	DT
46745	3618	33	treatment	treatment	NN
46745	3618	34	of	of	IN
46745	3618	35	disease	disease	NN
46745	3618	36	.	.	.
46745	3619	1	ORD	ORD	NNP
46745	3619	2	.	.	.
46745	3620	1	I.	I.	NNP
46745	3620	2	INEBRIANTIA	INEBRIANTIA	NNP
46745	3620	3	.	.	.
46745	3621	1	(	(	-LRB-
46745	3621	2	Alcohol	alcohol	NN
46745	3621	3	;	;	:
46745	3621	4	Wine	wine	NN
46745	3621	5	;	;	:
46745	3621	6	Ethers	ether	NNS
46745	3621	7	;	;	:
46745	3621	8	Chloroform	chloroform	NN
46745	3621	9	;	;	:
46745	3621	10	Camphor	Camphor	NNP
46745	3621	11	;	;	:
46745	3621	12	Indian	Indian	NNP
46745	3621	13	Hemp	Hemp	NNP
46745	3621	14	;	;	:
46745	3621	15	Tobacco	Tobacco	NNP
46745	3621	16	;	;	:
46745	3621	17	Lobelia	Lobelia	NNP
46745	3621	18	.	.	.
46745	3621	19	)	)	-RRB-
46745	3622	1	The	the	DT
46745	3622	2	medicines	medicine	NNS
46745	3622	3	of	of	IN
46745	3622	4	this	this	DT
46745	3622	5	order	order	NN
46745	3622	6	,	,	,
46745	3622	7	taking	take	VBG
46745	3622	8	Alcohol	Alcohol	NNP
46745	3622	9	as	as	IN
46745	3622	10	the	the	DT
46745	3622	11	type	type	NN
46745	3622	12	,	,	,
46745	3622	13	approach	approach	VBP
46745	3622	14	more	more	RBR
46745	3622	15	nearly	nearly	RB
46745	3622	16	to	to	IN
46745	3622	17	Stimulants	Stimulants	NNP
46745	3622	18	than	than	IN
46745	3622	19	any	any	DT
46745	3622	20	other	other	JJ
46745	3622	21	Narcotics	Narcotics	NNP
46745	3622	22	.	.	.
46745	3623	1	When	when	WRB
46745	3623	2	given	give	VBN
46745	3623	3	in	in	IN
46745	3623	4	small	small	JJ
46745	3623	5	doses	dose	NNS
46745	3623	6	,	,	,
46745	3623	7	their	-PRON-	PRP$
46745	3623	8	narcotic	narcotic	JJ
46745	3623	9	operation	operation	NN
46745	3623	10	may	may	MD
46745	3623	11	hardly	hardly	RB
46745	3623	12	be	be	VB
46745	3623	13	perceived	perceive	VBN
46745	3623	14	.	.	.
46745	3624	1	They	-PRON-	PRP
46745	3624	2	are	be	VBP
46745	3624	3	then	then	RB
46745	3624	4	exhilarants	exhilarant	NNS
46745	3624	5	;	;	:
46745	3624	6	slightly	slightly	RB
46745	3624	7	quickening	quicken	VBG
46745	3624	8	the	the	DT
46745	3624	9	pulse	pulse	NN
46745	3624	10	,	,	,
46745	3624	11	and	and	CC
46745	3624	12	enlivening	enliven	VBG
46745	3624	13	the	the	DT
46745	3624	14	mental	mental	JJ
46745	3624	15	faculties	faculty	NNS
46745	3624	16	.	.	.
46745	3625	1	When	when	WRB
46745	3625	2	given	give	VBN
46745	3625	3	in	in	IN
46745	3625	4	large	large	JJ
46745	3625	5	doses	dose	NNS
46745	3625	6	,	,	,
46745	3625	7	this	this	DT
46745	3625	8	stimulating	stimulating	JJ
46745	3625	9	action	action	NN
46745	3625	10	on	on	IN
46745	3625	11	the	the	DT
46745	3625	12	heart	heart	NN
46745	3625	13	and	and	CC
46745	3625	14	mental	mental	JJ
46745	3625	15	powers	power	NNS
46745	3625	16	occurs	occur	VBZ
46745	3625	17	first	first	RB
46745	3625	18	,	,	,
46745	3625	19	and	and	CC
46745	3625	20	is	be	VBZ
46745	3625	21	now	now	RB
46745	3625	22	more	more	RBR
46745	3625	23	intense	intense	JJ
46745	3625	24	;	;	:
46745	3625	25	but	but	CC
46745	3625	26	it	-PRON-	PRP
46745	3625	27	is	be	VBZ
46745	3625	28	soon	soon	RB
46745	3625	29	succeeded	succeed	VBN
46745	3625	30	by	by	IN
46745	3625	31	disturbance	disturbance	NN
46745	3625	32	and	and	CC
46745	3625	33	impairment	impairment	NN
46745	3625	34	of	of	IN
46745	3625	35	the	the	DT
46745	3625	36	intellectual	intellectual	JJ
46745	3625	37	functions	function	NNS
46745	3625	38	.	.	.
46745	3626	1	The	the	DT
46745	3626	2	secondary	secondary	JJ
46745	3626	3	depression	depression	NN
46745	3626	4	of	of	IN
46745	3626	5	the	the	DT
46745	3626	6	heart	heart	NN
46745	3626	7	is	be	VBZ
46745	3626	8	comparatively	comparatively	RB
46745	3626	9	feeble	feeble	JJ
46745	3626	10	,	,	,
46745	3626	11	except	except	IN
46745	3626	12	in	in	IN
46745	3626	13	the	the	DT
46745	3626	14	case	case	NN
46745	3626	15	of	of	IN
46745	3626	16	Tobacco	Tobacco	NNP
46745	3626	17	and	and	CC
46745	3626	18	Lobelia	Lobelia	NNP
46745	3626	19	,	,	,
46745	3626	20	which	which	WDT
46745	3626	21	are	be	VBP
46745	3626	22	exceptional	exceptional	JJ
46745	3626	23	members	member	NNS
46745	3626	24	of	of	IN
46745	3626	25	this	this	DT
46745	3626	26	order	order	NN
46745	3626	27	.	.	.
46745	3627	1	The	the	DT
46745	3627	2	disturbance	disturbance	NN
46745	3627	3	of	of	IN
46745	3627	4	the	the	DT
46745	3627	5	mind	mind	NN
46745	3627	6	produced	produce	VBN
46745	3627	7	by	by	IN
46745	3627	8	these	these	DT
46745	3627	9	medicines	medicine	NNS
46745	3627	10	is	be	VBZ
46745	3627	11	not	not	RB
46745	3627	12	of	of	IN
46745	3627	13	a	a	DT
46745	3627	14	partial	partial	JJ
46745	3627	15	,	,	,
46745	3627	16	but	but	CC
46745	3627	17	of	of	IN
46745	3627	18	a	a	DT
46745	3627	19	general	general	JJ
46745	3627	20	character	character	NN
46745	3627	21	,	,	,
46745	3627	22	extending	extend	VBG
46745	3627	23	to	to	IN
46745	3627	24	all	all	PDT
46745	3627	25	the	the	DT
46745	3627	26	intellectual	intellectual	JJ
46745	3627	27	functions	function	NNS
46745	3627	28	.	.	.
46745	3628	1	It	-PRON-	PRP
46745	3628	2	is	be	VBZ
46745	3628	3	called	call	VBN
46745	3628	4	Inebriation	Inebriation	NNP
46745	3628	5	,	,	,
46745	3628	6	or	or	CC
46745	3628	7	drunkenness	drunkenness	NN
46745	3628	8	,	,	,
46745	3628	9	and	and	CC
46745	3628	10	may	may	MD
46745	3628	11	exist	exist	VB
46745	3628	12	in	in	IN
46745	3628	13	various	various	JJ
46745	3628	14	degrees	degree	NNS
46745	3628	15	.	.	.
46745	3629	1	The	the	DT
46745	3629	2	mind	mind	NN
46745	3629	3	itself	-PRON-	PRP
46745	3629	4	is	be	VBZ
46745	3629	5	confused	confused	JJ
46745	3629	6	and	and	CC
46745	3629	7	bewildered	bewildered	JJ
46745	3629	8	;	;	:
46745	3629	9	volition	volition	NN
46745	3629	10	is	be	VBZ
46745	3629	11	impaired	impair	VBN
46745	3629	12	,	,	,
46745	3629	13	so	so	IN
46745	3629	14	that	that	IN
46745	3629	15	the	the	DT
46745	3629	16	man	man	NN
46745	3629	17	staggers	stagger	VBZ
46745	3629	18	in	in	IN
46745	3629	19	his	-PRON-	PRP$
46745	3629	20	walk	walk	NN
46745	3629	21	;	;	,
46745	3629	22	and	and	CC
46745	3629	23	the	the	DT
46745	3629	24	powers	power	NNS
46745	3629	25	of	of	IN
46745	3629	26	the	the	DT
46745	3629	27	senses	sense	NNS
46745	3629	28	are	be	VBP
46745	3629	29	disordered	disorder	VBN
46745	3629	30	or	or	CC
46745	3629	31	lost	lose	VBN
46745	3629	32	.	.	.
46745	3630	1	This	this	DT
46745	3630	2	condition	condition	NN
46745	3630	3	,	,	,
46745	3630	4	when	when	WRB
46745	3630	5	carried	carry	VBN
46745	3630	6	to	to	IN
46745	3630	7	an	an	DT
46745	3630	8	excess	excess	NN
46745	3630	9	,	,	,
46745	3630	10	results	result	NNS
46745	3630	11	in	in	IN
46745	3630	12	stupefaction	stupefaction	NN
46745	3630	13	,	,	,
46745	3630	14	coma	coma	NN
46745	3630	15	,	,	,
46745	3630	16	and	and	CC
46745	3630	17	death	death	NN
46745	3630	18	.	.	.
46745	3631	1	These	these	DT
46745	3631	2	are	be	VBP
46745	3631	3	the	the	DT
46745	3631	4	several	several	JJ
46745	3631	5	degrees	degree	NNS
46745	3631	6	of	of	IN
46745	3631	7	the	the	DT
46745	3631	8	same	same	JJ
46745	3631	9	action	action	NN
46745	3631	10	,	,	,
46745	3631	11	which	which	WDT
46745	3631	12	is	be	VBZ
46745	3631	13	a	a	DT
46745	3631	14	general	general	JJ
46745	3631	15	impairment	impairment	NN
46745	3631	16	of	of	IN
46745	3631	17	all	all	PDT
46745	3631	18	the	the	DT
46745	3631	19	intellectual	intellectual	JJ
46745	3631	20	functions	function	NNS
46745	3631	21	.	.	.
46745	3632	1	Alcohol	Alcohol	NNP
46745	3632	2	and	and	CC
46745	3632	3	the	the	DT
46745	3632	4	Ethers	ether	NNS
46745	3632	5	produce	produce	VBP
46745	3632	6	the	the	DT
46745	3632	7	primary	primary	JJ
46745	3632	8	exhilaration	exhilaration	NN
46745	3632	9	in	in	IN
46745	3632	10	the	the	DT
46745	3632	11	greatest	great	JJS
46745	3632	12	degree	degree	NN
46745	3632	13	;	;	:
46745	3632	14	Tobacco	Tobacco	NNP
46745	3632	15	and	and	CC
46745	3632	16	Lobelia	Lobelia	NNP
46745	3632	17	,	,	,
46745	3632	18	in	in	IN
46745	3632	19	the	the	DT
46745	3632	20	least	least	JJS
46745	3632	21	.	.	.
46745	3633	1	Though	though	IN
46745	3633	2	varying	vary	VBG
46745	3633	3	in	in	RP
46745	3633	4	degree	degree	NN
46745	3633	5	,	,	,
46745	3633	6	yet	yet	CC
46745	3633	7	,	,	,
46745	3633	8	as	as	RB
46745	3633	9	far	far	RB
46745	3633	10	as	as	IN
46745	3633	11	the	the	DT
46745	3633	12	stage	stage	NN
46745	3633	13	of	of	IN
46745	3633	14	inebriation	inebriation	NN
46745	3633	15	,	,	,
46745	3633	16	the	the	DT
46745	3633	17	effects	effect	NNS
46745	3633	18	of	of	IN
46745	3633	19	these	these	DT
46745	3633	20	medicines	medicine	NNS
46745	3633	21	are	be	VBP
46745	3633	22	similar	similar	JJ
46745	3633	23	in	in	IN
46745	3633	24	kind	kind	NN
46745	3633	25	.	.	.
46745	3634	1	Stupefaction	Stupefaction	NNP
46745	3634	2	constitutes	constitute	VBZ
46745	3634	3	the	the	DT
46745	3634	4	next	next	JJ
46745	3634	5	stage	stage	NN
46745	3634	6	of	of	IN
46745	3634	7	the	the	DT
46745	3634	8	action	action	NN
46745	3634	9	of	of	IN
46745	3634	10	Alcohol	Alcohol	NNP
46745	3634	11	,	,	,
46745	3634	12	Camphor	Camphor	NNP
46745	3634	13	,	,	,
46745	3634	14	Indian	Indian	NNP
46745	3634	15	Hemp	Hemp	NNP
46745	3634	16	,	,	,
46745	3634	17	Ether	Ether	NNP
46745	3634	18	,	,	,
46745	3634	19	and	and	CC
46745	3634	20	Chloroform	chloroform	NN
46745	3634	21	.	.	.
46745	3635	1	Camphor	Camphor	NNP
46745	3635	2	and	and	CC
46745	3635	3	Indian	Indian	NNP
46745	3635	4	Hemp	Hemp	NNP
46745	3635	5	exert	exert	NN
46745	3635	6	at	at	IN
46745	3635	7	this	this	DT
46745	3635	8	period	period	NN
46745	3635	9	an	an	DT
46745	3635	10	anodyne	anodyne	NN
46745	3635	11	influence	influence	NN
46745	3635	12	;	;	:
46745	3635	13	to	to	TO
46745	3635	14	which	which	WDT
46745	3635	15	also	also	RB
46745	3635	16	,	,	,
46745	3635	17	in	in	IN
46745	3635	18	the	the	DT
46745	3635	19	case	case	NN
46745	3635	20	of	of	IN
46745	3635	21	Indian	Indian	NNP
46745	3635	22	Hemp	Hemp	NNP
46745	3635	23	,	,	,
46745	3635	24	may	may	MD
46745	3635	25	be	be	VB
46745	3635	26	added	add	VBN
46745	3635	27	a	a	DT
46745	3635	28	very	very	RB
46745	3635	29	curious	curious	JJ
46745	3635	30	imitation	imitation	NN
46745	3635	31	of	of	IN
46745	3635	32	Catalepsy	Catalepsy	NNP
46745	3635	33	.	.	.
46745	3636	1	Ether	Ether	NNP
46745	3636	2	and	and	CC
46745	3636	3	Chloroform	Chloroform	NNP
46745	3636	4	have	have	VBP
46745	3636	5	at	at	IN
46745	3636	6	this	this	DT
46745	3636	7	time	time	NN
46745	3636	8	a	a	DT
46745	3636	9	peculiar	peculiar	JJ
46745	3636	10	action	action	NN
46745	3636	11	in	in	IN
46745	3636	12	extinguishing	extinguish	VBG
46745	3636	13	the	the	DT
46745	3636	14	sense	sense	NN
46745	3636	15	of	of	IN
46745	3636	16	Feeling	feeling	NN
46745	3636	17	.	.	.
46745	3637	1	With	with	IN
46745	3637	2	this	this	DT
46745	3637	3	object	object	NN
46745	3637	4	they	-PRON-	PRP
46745	3637	5	are	be	VBP
46745	3637	6	commonly	commonly	RB
46745	3637	7	administered	administer	VBN
46745	3637	8	by	by	IN
46745	3637	9	inhalation	inhalation	NN
46745	3637	10	in	in	IN
46745	3637	11	painful	painful	JJ
46745	3637	12	surgical	surgical	JJ
46745	3637	13	operations	operation	NNS
46745	3637	14	.	.	.
46745	3638	1	The	the	DT
46745	3638	2	stupefaction	stupefaction	NN
46745	3638	3	produced	produce	VBN
46745	3638	4	by	by	IN
46745	3638	5	the	the	DT
46745	3638	6	above	above	JJ
46745	3638	7	medicines	medicine	NNS
46745	3638	8	is	be	VBZ
46745	3638	9	not	not	RB
46745	3638	10	at	at	RB
46745	3638	11	all	all	RB
46745	3638	12	prominent	prominent	JJ
46745	3638	13	in	in	IN
46745	3638	14	the	the	DT
46745	3638	15	case	case	NN
46745	3638	16	of	of	IN
46745	3638	17	Tobacco	Tobacco	NNP
46745	3638	18	and	and	CC
46745	3638	19	Lobelia	Lobelia	NNP
46745	3638	20	inflata	inflata	NN
46745	3638	21	.	.	.
46745	3639	1	Instead	instead	RB
46745	3639	2	of	of	IN
46745	3639	3	that	that	IN
46745	3639	4	they	-PRON-	PRP
46745	3639	5	both	both	DT
46745	3639	6	exert	exert	VBP
46745	3639	7	a	a	DT
46745	3639	8	particular	particular	JJ
46745	3639	9	sedative	sedative	JJ
46745	3639	10	action	action	NN
46745	3639	11	on	on	IN
46745	3639	12	the	the	DT
46745	3639	13	heart	heart	NN
46745	3639	14	and	and	CC
46745	3639	15	circulation	circulation	NN
46745	3639	16	.	.	.
46745	3640	1	This	this	DT
46745	3640	2	is	be	VBZ
46745	3640	3	accompanied	accompany	VBN
46745	3640	4	with	with	IN
46745	3640	5	nausea	nausea	NN
46745	3640	6	,	,	,
46745	3640	7	and	and	CC
46745	3640	8	with	with	IN
46745	3640	9	great	great	JJ
46745	3640	10	relaxation	relaxation	NN
46745	3640	11	of	of	IN
46745	3640	12	the	the	DT
46745	3640	13	muscular	muscular	JJ
46745	3640	14	system	system	NN
46745	3640	15	,	,	,
46745	3640	16	like	like	IN
46745	3640	17	that	that	DT
46745	3640	18	which	which	WDT
46745	3640	19	is	be	VBZ
46745	3640	20	produced	produce	VBN
46745	3640	21	by	by	IN
46745	3640	22	Antimony	Antimony	NNP
46745	3640	23	.	.	.
46745	3641	1	It	-PRON-	PRP
46745	3641	2	may	may	MD
46745	3641	3	lead	lead	VB
46745	3641	4	to	to	IN
46745	3641	5	syncope	syncope	VB
46745	3641	6	and	and	CC
46745	3641	7	death	death	NN
46745	3641	8	.	.	.
46745	3642	1	Syncope	Syncope	NNP
46745	3642	2	has	have	VBZ
46745	3642	3	been	be	VBN
46745	3642	4	known	know	VBN
46745	3642	5	to	to	TO
46745	3642	6	be	be	VB
46745	3642	7	suddenly	suddenly	RB
46745	3642	8	produced	produce	VBN
46745	3642	9	in	in	IN
46745	3642	10	some	some	DT
46745	3642	11	cases	case	NNS
46745	3642	12	of	of	IN
46745	3642	13	the	the	DT
46745	3642	14	inhalation	inhalation	NN
46745	3642	15	of	of	IN
46745	3642	16	Ether	Ether	NNP
46745	3642	17	and	and	CC
46745	3642	18	Chloroform	Chloroform	NNP
46745	3642	19	.	.	.
46745	3643	1	These	these	DT
46745	3643	2	two	two	CD
46745	3643	3	medicines	medicine	NNS
46745	3643	4	are	be	VBP
46745	3643	5	also	also	RB
46745	3643	6	muscular	muscular	JJ
46745	3643	7	relaxers	relaxer	NNS
46745	3643	8	,	,	,
46745	3643	9	like	like	IN
46745	3643	10	Tobacco	Tobacco	NNP
46745	3643	11	.	.	.
46745	3644	1	The	the	DT
46745	3644	2	cases	case	NNS
46745	3644	3	which	which	WDT
46745	3644	4	demand	demand	VBP
46745	3644	5	the	the	DT
46745	3644	6	employment	employment	NN
46745	3644	7	of	of	IN
46745	3644	8	these	these	DT
46745	3644	9	medicines	medicine	NNS
46745	3644	10	,	,	,
46745	3644	11	as	as	IN
46745	3644	12	also	also	RB
46745	3644	13	of	of	IN
46745	3644	14	the	the	DT
46745	3644	15	other	other	JJ
46745	3644	16	Narcotics	Narcotics	NNP
46745	3644	17	and	and	CC
46745	3644	18	Sedatives	Sedatives	NNPS
46745	3644	19	,	,	,
46745	3644	20	will	will	MD
46745	3644	21	be	be	VB
46745	3644	22	considered	consider	VBN
46745	3644	23	at	at	IN
46745	3644	24	the	the	DT
46745	3644	25	close	close	NN
46745	3644	26	of	of	IN
46745	3644	27	the	the	DT
46745	3644	28	section	section	NN
46745	3644	29	treating	treating	NN
46745	3644	30	of	of	IN
46745	3644	31	Neurotics	Neurotics	NNP
46745	3644	32	,	,	,
46745	3644	33	and	and	CC
46745	3644	34	again	again	RB
46745	3644	35	when	when	WRB
46745	3644	36	some	some	DT
46745	3644	37	of	of	IN
46745	3644	38	them	-PRON-	PRP
46745	3644	39	are	be	VBP
46745	3644	40	separately	separately	RB
46745	3644	41	described	describe	VBN
46745	3644	42	in	in	IN
46745	3644	43	the	the	DT
46745	3644	44	fourth	fourth	JJ
46745	3644	45	chapter	chapter	NN
46745	3644	46	.	.	.
46745	3645	1	ORD	ORD	NNP
46745	3645	2	.	.	.
46745	3646	1	II	ii	CD
46745	3646	2	.	.	.
46745	3647	1	SOPORIFICS	SOPORIFICS	NNP
46745	3647	2	.	.	.
46745	3648	1	(	(	-LRB-
46745	3648	2	Opium	opium	NN
46745	3648	3	.	.	.
46745	3649	1	Lactuca	Lactuca	NNP
46745	3649	2	.	.	.
46745	3650	1	Hops	hop	NNS
46745	3650	2	.	.	.
46745	3651	1	Nutmegs	Nutmegs	NNP
46745	3651	2	.	.	.
46745	3651	3	)	)	-RRB-
46745	3652	1	Opium	opium	NN
46745	3652	2	,	,	,
46745	3652	3	which	which	WDT
46745	3652	4	is	be	VBZ
46745	3652	5	the	the	DT
46745	3652	6	chief	chief	JJ
46745	3652	7	and	and	CC
46745	3652	8	only	only	JJ
46745	3652	9	important	important	JJ
46745	3652	10	medicine	medicine	NN
46745	3652	11	of	of	IN
46745	3652	12	this	this	DT
46745	3652	13	order	order	NN
46745	3652	14	,	,	,
46745	3652	15	may	may	MD
46745	3652	16	be	be	VB
46745	3652	17	considered	consider	VBN
46745	3652	18	as	as	IN
46745	3652	19	the	the	DT
46745	3652	20	type	type	NN
46745	3652	21	of	of	IN
46745	3652	22	Narcotics	Narcotics	NNP
46745	3652	23	.	.	.
46745	3653	1	It	-PRON-	PRP
46745	3653	2	causes	cause	VBZ
46745	3653	3	in	in	IN
46745	3653	4	the	the	DT
46745	3653	5	first	first	JJ
46745	3653	6	place	place	NN
46745	3653	7	a	a	DT
46745	3653	8	slight	slight	JJ
46745	3653	9	quickening	quickening	NN
46745	3653	10	of	of	IN
46745	3653	11	the	the	DT
46745	3653	12	pulse	pulse	NN
46745	3653	13	,	,	,
46745	3653	14	and	and	CC
46745	3653	15	some	some	DT
46745	3653	16	excitement	excitement	NN
46745	3653	17	of	of	IN
46745	3653	18	the	the	DT
46745	3653	19	mental	mental	JJ
46745	3653	20	faculties	faculty	NNS
46745	3653	21	.	.	.
46745	3654	1	It	-PRON-	PRP
46745	3654	2	is	be	VBZ
46745	3654	3	named	name	VBN
46745	3654	4	from	from	IN
46745	3654	5	its	-PRON-	PRP$
46745	3654	6	peculiar	peculiar	JJ
46745	3654	7	secondary	secondary	JJ
46745	3654	8	action	action	NN
46745	3654	9	on	on	IN
46745	3654	10	the	the	DT
46745	3654	11	latter	latter	NN
46745	3654	12	.	.	.
46745	3655	1	It	-PRON-	PRP
46745	3655	2	produces	produce	VBZ
46745	3655	3	drowsiness	drowsiness	NN
46745	3655	4	and	and	CC
46745	3655	5	sleep	sleep	NN
46745	3655	6	.	.	.
46745	3656	1	We	-PRON-	PRP
46745	3656	2	have	have	VBP
46745	3656	3	seen	see	VBN
46745	3656	4	that	that	IN
46745	3656	5	the	the	DT
46745	3656	6	term	term	NN
46745	3656	7	_	_	NNP
46745	3656	8	intellectual	intellectual	JJ
46745	3656	9	function	function	NN
46745	3656	10	_	_	NNP
46745	3656	11	must	must	MD
46745	3656	12	be	be	VB
46745	3656	13	understood	understand	VBN
46745	3656	14	to	to	TO
46745	3656	15	include	include	VB
46745	3656	16	not	not	RB
46745	3656	17	only	only	RB
46745	3656	18	the	the	DT
46745	3656	19	mind	mind	NN
46745	3656	20	itself	-PRON-	PRP
46745	3656	21	,	,	,
46745	3656	22	but	but	CC
46745	3656	23	also	also	RB
46745	3656	24	the	the	DT
46745	3656	25	powers	power	NNS
46745	3656	26	of	of	IN
46745	3656	27	volition	volition	NN
46745	3656	28	and	and	CC
46745	3656	29	sensation	sensation	NN
46745	3656	30	,	,	,
46745	3656	31	by	by	IN
46745	3656	32	which	which	WDT
46745	3656	33	the	the	DT
46745	3656	34	mind	mind	NN
46745	3656	35	is	be	VBZ
46745	3656	36	connected	connect	VBN
46745	3656	37	with	with	IN
46745	3656	38	the	the	DT
46745	3656	39	body,--and	body,--and	NN
46745	3656	40	the	the	DT
46745	3656	41	five	five	CD
46745	3656	42	senses	sense	NNS
46745	3656	43	,	,	,
46745	3656	44	by	by	IN
46745	3656	45	which	which	WDT
46745	3656	46	it	-PRON-	PRP
46745	3656	47	is	be	VBZ
46745	3656	48	enabled	enable	VBN
46745	3656	49	to	to	TO
46745	3656	50	appreciate	appreciate	VB
46745	3656	51	the	the	DT
46745	3656	52	external	external	JJ
46745	3656	53	world	world	NN
46745	3656	54	.	.	.
46745	3657	1	Inebriants	inebriant	NNS
46745	3657	2	affect	affect	VBP
46745	3657	3	these	these	DT
46745	3657	4	three	three	CD
46745	3657	5	in	in	IN
46745	3657	6	about	about	RB
46745	3657	7	the	the	DT
46745	3657	8	same	same	JJ
46745	3657	9	ratio	ratio	NN
46745	3657	10	.	.	.
46745	3658	1	Ordinarily	ordinarily	RB
46745	3658	2	they	-PRON-	PRP
46745	3658	3	impair	impair	VBP
46745	3658	4	the	the	DT
46745	3658	5	mind	mind	NN
46745	3658	6	,	,	,
46745	3658	7	and	and	CC
46745	3658	8	derange	derange	VB
46745	3658	9	the	the	DT
46745	3658	10	functions	function	NNS
46745	3658	11	with	with	IN
46745	3658	12	which	which	WDT
46745	3658	13	it	-PRON-	PRP
46745	3658	14	is	be	VBZ
46745	3658	15	connected	connect	VBN
46745	3658	16	;	;	:
46745	3658	17	but	but	CC
46745	3658	18	they	-PRON-	PRP
46745	3658	19	do	do	VBP
46745	3658	20	not	not	RB
46745	3658	21	quite	quite	RB
46745	3658	22	extinguish	extinguish	VB
46745	3658	23	either	either	DT
46745	3658	24	volition	volition	NN
46745	3658	25	,	,	,
46745	3658	26	sensation	sensation	NN
46745	3658	27	,	,	,
46745	3658	28	or	or	CC
46745	3658	29	the	the	DT
46745	3658	30	special	special	JJ
46745	3658	31	senses	sense	NNS
46745	3658	32	.	.	.
46745	3659	1	Soporifics	soporific	NNS
46745	3659	2	differ	differ	VBP
46745	3659	3	from	from	IN
46745	3659	4	this	this	DT
46745	3659	5	action	action	NN
46745	3659	6	in	in	IN
46745	3659	7	two	two	CD
46745	3659	8	ways	way	NNS
46745	3659	9	.	.	.
46745	3660	1	In	in	IN
46745	3660	2	sleep	sleep	NN
46745	3660	3	the	the	DT
46745	3660	4	mind	mind	NN
46745	3660	5	may	may	MD
46745	3660	6	remain	remain	VB
46745	3660	7	active	active	JJ
46745	3660	8	;	;	:
46745	3660	9	but	but	CC
46745	3660	10	it	-PRON-	PRP
46745	3660	11	is	be	VBZ
46745	3660	12	left	leave	VBN
46745	3660	13	alone	alone	RB
46745	3660	14	,	,	,
46745	3660	15	dreaming	dream	VBG
46745	3660	16	,	,	,
46745	3660	17	and	and	CC
46745	3660	18	uncontrolled	uncontrolle	VBN
46745	3660	19	by	by	IN
46745	3660	20	physical	physical	JJ
46745	3660	21	ties	tie	NNS
46745	3660	22	.	.	.
46745	3661	1	For	for	IN
46745	3661	2	the	the	DT
46745	3661	3	functions	function	NNS
46745	3661	4	of	of	IN
46745	3661	5	volition	volition	NN
46745	3661	6	and	and	CC
46745	3661	7	sensation	sensation	NN
46745	3661	8	,	,	,
46745	3661	9	and	and	CC
46745	3661	10	the	the	DT
46745	3661	11	special	special	JJ
46745	3661	12	senses	sense	NNS
46745	3661	13	of	of	IN
46745	3661	14	Sight	Sight	NNP
46745	3661	15	,	,	,
46745	3661	16	Hearing	Hearing	NNP
46745	3661	17	,	,	,
46745	3661	18	Smell	Smell	NNP
46745	3661	19	,	,	,
46745	3661	20	and	and	CC
46745	3661	21	Taste	Taste	NNP
46745	3661	22	,	,	,
46745	3661	23	are	be	VBP
46745	3661	24	entirely	entirely	RB
46745	3661	25	suspended	suspend	VBN
46745	3661	26	in	in	IN
46745	3661	27	perfect	perfect	JJ
46745	3661	28	sleep	sleep	NN
46745	3661	29	.	.	.
46745	3662	1	So	so	RB
46745	3662	2	that	that	IN
46745	3662	3	while	while	IN
46745	3662	4	Inebriants	inebriant	NNS
46745	3662	5	affect	affect	VBP
46745	3662	6	similarly	similarly	RB
46745	3662	7	both	both	CC
46745	3662	8	the	the	DT
46745	3662	9	mind	mind	NN
46745	3662	10	and	and	CC
46745	3662	11	the	the	DT
46745	3662	12	natural	natural	JJ
46745	3662	13	functions	function	NNS
46745	3662	14	with	with	IN
46745	3662	15	which	which	WDT
46745	3662	16	it	-PRON-	PRP
46745	3662	17	is	be	VBZ
46745	3662	18	connected	connect	VBN
46745	3662	19	,	,	,
46745	3662	20	Soporifics	Soporifics	NNPS
46745	3662	21	may	may	MD
46745	3662	22	leave	leave	VB
46745	3662	23	the	the	DT
46745	3662	24	first	first	JJ
46745	3662	25	untouched	untouched	JJ
46745	3662	26	,	,	,
46745	3662	27	but	but	CC
46745	3662	28	they	-PRON-	PRP
46745	3662	29	entirely	entirely	RB
46745	3662	30	subdue	subdue	VBP
46745	3662	31	the	the	DT
46745	3662	32	latter	latter	JJ
46745	3662	33	.	.	.
46745	3663	1	The	the	DT
46745	3663	2	condition	condition	NN
46745	3663	3	of	of	IN
46745	3663	4	sleep	sleep	NN
46745	3663	5	differs	differ	NNS
46745	3663	6	also	also	RB
46745	3663	7	in	in	IN
46745	3663	8	another	another	DT
46745	3663	9	important	important	JJ
46745	3663	10	particular	particular	JJ
46745	3663	11	from	from	IN
46745	3663	12	the	the	DT
46745	3663	13	state	state	NN
46745	3663	14	of	of	IN
46745	3663	15	inebriation,--as	inebriation,--as	NN
46745	3663	16	well	well	UH
46745	3663	17	as	as	IN
46745	3663	18	from	from	IN
46745	3663	19	delirium	delirium	NN
46745	3663	20	,	,	,
46745	3663	21	which	which	WDT
46745	3663	22	we	-PRON-	PRP
46745	3663	23	shall	shall	MD
46745	3663	24	have	have	VB
46745	3663	25	presently	presently	RB
46745	3663	26	to	to	TO
46745	3663	27	consider	consider	VB
46745	3663	28	.	.	.
46745	3664	1	Sleep	sleep	NN
46745	3664	2	is	be	VBZ
46745	3664	3	liable	liable	JJ
46745	3664	4	to	to	TO
46745	3664	5	be	be	VB
46745	3664	6	suddenly	suddenly	RB
46745	3664	7	interrupted	interrupt	VBN
46745	3664	8	or	or	CC
46745	3664	9	suspended	suspend	VBN
46745	3664	10	by	by	IN
46745	3664	11	comparatively	comparatively	RB
46745	3664	12	slight	slight	JJ
46745	3664	13	causes	cause	NNS
46745	3664	14	,	,	,
46745	3664	15	as	as	IN
46745	3664	16	a	a	DT
46745	3664	17	physical	physical	JJ
46745	3664	18	shock	shock	NN
46745	3664	19	,	,	,
46745	3664	20	or	or	CC
46745	3664	21	a	a	DT
46745	3664	22	forcible	forcible	JJ
46745	3664	23	impression	impression	NN
46745	3664	24	upon	upon	IN
46745	3664	25	one	one	CD
46745	3664	26	of	of	IN
46745	3664	27	the	the	DT
46745	3664	28	senses	sense	NNS
46745	3664	29	which	which	WDT
46745	3664	30	are	be	VBP
46745	3664	31	held	hold	VBN
46745	3664	32	in	in	IN
46745	3664	33	abeyance	abeyance	NN
46745	3664	34	and	and	CC
46745	3664	35	subjection	subjection	NN
46745	3664	36	.	.	.
46745	3665	1	Neither	neither	DT
46745	3665	2	inebriation	inebriation	NN
46745	3665	3	nor	nor	CC
46745	3665	4	delirium	delirium	NN
46745	3665	5	can	can	MD
46745	3665	6	be	be	VB
46745	3665	7	suddenly	suddenly	RB
46745	3665	8	put	put	VBN
46745	3665	9	an	an	DT
46745	3665	10	end	end	NN
46745	3665	11	to	to	IN
46745	3665	12	in	in	IN
46745	3665	13	this	this	DT
46745	3665	14	way	way	NN
46745	3665	15	.	.	.
46745	3666	1	Such	such	JJ
46745	3666	2	appears	appear	VBZ
46745	3666	3	to	to	TO
46745	3666	4	be	be	VB
46745	3666	5	the	the	DT
46745	3666	6	distinction	distinction	NN
46745	3666	7	between	between	IN
46745	3666	8	the	the	DT
46745	3666	9	operations	operation	NNS
46745	3666	10	of	of	IN
46745	3666	11	these	these	DT
46745	3666	12	two	two	CD
46745	3666	13	orders	order	NNS
46745	3666	14	of	of	IN
46745	3666	15	medicines	medicine	NNS
46745	3666	16	.	.	.
46745	3667	1	Pain	pain	NN
46745	3667	2	prevents	prevent	VBZ
46745	3667	3	sleep	sleep	VB
46745	3667	4	,	,	,
46745	3667	5	because	because	IN
46745	3667	6	it	-PRON-	PRP
46745	3667	7	enforces	enforce	VBZ
46745	3667	8	sensation	sensation	NN
46745	3667	9	.	.	.
46745	3668	1	Thus	thus	RB
46745	3668	2	a	a	DT
46745	3668	3	mere	mere	JJ
46745	3668	4	Soporific	Soporific	NNP
46745	3668	5	,	,	,
46745	3668	6	if	if	IN
46745	3668	7	effectual	effectual	JJ
46745	3668	8	,	,	,
46745	3668	9	would	would	MD
46745	3668	10	prove	prove	VB
46745	3668	11	anodyne	anodyne	NNP
46745	3668	12	,	,	,
46745	3668	13	and	and	CC
46745	3668	14	relieve	relieve	VB
46745	3668	15	pain	pain	NN
46745	3668	16	.	.	.
46745	3669	1	But	but	CC
46745	3669	2	Opium	Opium	NNP
46745	3669	3	has	have	VBZ
46745	3669	4	an	an	DT
46745	3669	5	important	important	JJ
46745	3669	6	anodyne	anodyne	NN
46745	3669	7	action	action	NN
46745	3669	8	,	,	,
46745	3669	9	which	which	WDT
46745	3669	10	is	be	VBZ
46745	3669	11	independent	independent	JJ
46745	3669	12	of	of	IN
46745	3669	13	its	-PRON-	PRP$
46745	3669	14	power	power	NN
46745	3669	15	of	of	IN
46745	3669	16	producing	produce	VBG
46745	3669	17	sleep	sleep	NN
46745	3669	18	,	,	,
46745	3669	19	for	for	IN
46745	3669	20	it	-PRON-	PRP
46745	3669	21	may	may	MD
46745	3669	22	occur	occur	VB
46745	3669	23	without	without	IN
46745	3669	24	the	the	DT
46745	3669	25	latter	latter	JJ
46745	3669	26	.	.	.
46745	3670	1	It	-PRON-	PRP
46745	3670	2	is	be	VBZ
46745	3670	3	by	by	IN
46745	3670	4	far	far	RB
46745	3670	5	the	the	DT
46745	3670	6	best	good	JJS
46745	3670	7	remedy	remedy	NN
46745	3670	8	for	for	IN
46745	3670	9	pain	pain	NN
46745	3670	10	in	in	IN
46745	3670	11	the	the	DT
46745	3670	12	whole	whole	JJ
46745	3670	13	catalogue	catalogue	NN
46745	3670	14	of	of	IN
46745	3670	15	medicines	medicine	NNS
46745	3670	16	.	.	.
46745	3671	1	It	-PRON-	PRP
46745	3671	2	also	also	RB
46745	3671	3	produces	produce	VBZ
46745	3671	4	relaxation	relaxation	NN
46745	3671	5	of	of	IN
46745	3671	6	the	the	DT
46745	3671	7	muscular	muscular	JJ
46745	3671	8	system	system	NN
46745	3671	9	,	,	,
46745	3671	10	and	and	CC
46745	3671	11	is	be	VBZ
46745	3671	12	thus	thus	RB
46745	3671	13	a	a	DT
46745	3671	14	powerful	powerful	JJ
46745	3671	15	antispasmodic	antispasmodic	NN
46745	3671	16	.	.	.
46745	3672	1	In	in	IN
46745	3672	2	excessive	excessive	JJ
46745	3672	3	dose	dose	VBD
46745	3672	4	it	-PRON-	PRP
46745	3672	5	produces	produce	VBZ
46745	3672	6	a	a	DT
46745	3672	7	marked	mark	VBN
46745	3672	8	sedative	sedative	JJ
46745	3672	9	effect	effect	NN
46745	3672	10	;	;	:
46745	3672	11	causing	cause	VBG
46745	3672	12	an	an	DT
46745	3672	13	imperceptible	imperceptible	JJ
46745	3672	14	or	or	CC
46745	3672	15	irregular	irregular	JJ
46745	3672	16	pulse	pulse	NN
46745	3672	17	,	,	,
46745	3672	18	and	and	CC
46745	3672	19	very	very	RB
46745	3672	20	slow	slow	JJ
46745	3672	21	breathing	breathing	NN
46745	3672	22	,	,	,
46745	3672	23	with	with	IN
46745	3672	24	contraction	contraction	NN
46745	3672	25	of	of	IN
46745	3672	26	the	the	DT
46745	3672	27	pupil	pupil	NN
46745	3672	28	of	of	IN
46745	3672	29	the	the	DT
46745	3672	30	eye	eye	NN
46745	3672	31	.	.	.
46745	3673	1	It	-PRON-	PRP
46745	3673	2	may	may	MD
46745	3673	3	kill	kill	VB
46745	3673	4	by	by	IN
46745	3673	5	apn[oe]a	apn[oe]a	NNP
46745	3673	6	;	;	:
46745	3673	7	_	_	NNP
46745	3673	8	i.e.	i.e.	FW
46745	3673	9	_	_	NNP
46745	3673	10	by	by	IN
46745	3673	11	stopping	stop	VBG
46745	3673	12	the	the	DT
46745	3673	13	respiration	respiration	NN
46745	3673	14	.	.	.
46745	3674	1	Tobacco	Tobacco	NNP
46745	3674	2	resembles	resemble	VBZ
46745	3674	3	Opium	Opium	NNP
46745	3674	4	in	in	IN
46745	3674	5	causing	cause	VBG
46745	3674	6	contraction	contraction	NN
46745	3674	7	of	of	IN
46745	3674	8	the	the	DT
46745	3674	9	pupil	pupil	NN
46745	3674	10	,	,	,
46745	3674	11	and	and	CC
46745	3674	12	relaxation	relaxation	NN
46745	3674	13	of	of	IN
46745	3674	14	muscular	muscular	JJ
46745	3674	15	fibre	fibre	NNP
46745	3674	16	.	.	.
46745	3675	1	But	but	CC
46745	3675	2	it	-PRON-	PRP
46745	3675	3	is	be	VBZ
46745	3675	4	inebriant	inebriant	JJ
46745	3675	5	,	,	,
46745	3675	6	and	and	CC
46745	3675	7	not	not	RB
46745	3675	8	soporific	soporific	JJ
46745	3675	9	;	;	:
46745	3675	10	and	and	CC
46745	3675	11	its	-PRON-	PRP$
46745	3675	12	secondary	secondary	JJ
46745	3675	13	sedative	sedative	JJ
46745	3675	14	action	action	NN
46745	3675	15	on	on	IN
46745	3675	16	the	the	DT
46745	3675	17	heart	heart	NN
46745	3675	18	is	be	VBZ
46745	3675	19	more	more	RBR
46745	3675	20	powerful	powerful	JJ
46745	3675	21	than	than	IN
46745	3675	22	that	that	DT
46745	3675	23	of	of	IN
46745	3675	24	Opium	Opium	NNP
46745	3675	25	.	.	.
46745	3676	1	The	the	DT
46745	3676	2	order	order	NN
46745	3676	3	of	of	IN
46745	3676	4	Deliriants	deliriant	NNS
46745	3676	5	dilate	dilate	VBP
46745	3676	6	the	the	DT
46745	3676	7	pupil	pupil	NN
46745	3676	8	.	.	.
46745	3677	1	Inebriants	Inebriants	NNPS
46745	3677	2	and	and	CC
46745	3677	3	Deliriants	Deliriants	NNPS
46745	3677	4	act	act	VBP
46745	3677	5	on	on	IN
46745	3677	6	the	the	DT
46745	3677	7	glands	gland	NNS
46745	3677	8	as	as	IN
46745	3677	9	Eliminatives	Eliminatives	NNP
46745	3677	10	,	,	,
46745	3677	11	being	be	VBG
46745	3677	12	mostly	mostly	RB
46745	3677	13	diuretic	diuretic	JJ
46745	3677	14	.	.	.
46745	3678	1	Opium	opium	NN
46745	3678	2	has	have	VBZ
46745	3678	3	a	a	DT
46745	3678	4	contrary	contrary	JJ
46745	3678	5	action	action	NN
46745	3678	6	;	;	:
46745	3678	7	it	-PRON-	PRP
46745	3678	8	diminishes	diminish	VBZ
46745	3678	9	all	all	PDT
46745	3678	10	the	the	DT
46745	3678	11	secretions	secretion	NNS
46745	3678	12	except	except	IN
46745	3678	13	that	that	DT
46745	3678	14	of	of	IN
46745	3678	15	the	the	DT
46745	3678	16	skin	skin	NN
46745	3678	17	,	,	,
46745	3678	18	which	which	WDT
46745	3678	19	it	-PRON-	PRP
46745	3678	20	increases	increase	VBZ
46745	3678	21	in	in	IN
46745	3678	22	amount	amount	NN
46745	3678	23	.	.	.
46745	3679	1	Most	most	RBS
46745	3679	2	particularly	particularly	RB
46745	3679	3	it	-PRON-	PRP
46745	3679	4	diminishes	diminish	VBZ
46745	3679	5	the	the	DT
46745	3679	6	secretion	secretion	NN
46745	3679	7	of	of	IN
46745	3679	8	the	the	DT
46745	3679	9	bowels	bowel	NNS
46745	3679	10	,	,	,
46745	3679	11	causing	cause	VBG
46745	3679	12	constipation	constipation	NN
46745	3679	13	.	.	.
46745	3680	1	At	at	IN
46745	3680	2	the	the	DT
46745	3680	3	same	same	JJ
46745	3680	4	time	time	NN
46745	3680	5	it	-PRON-	PRP
46745	3680	6	impairs	impair	VBZ
46745	3680	7	the	the	DT
46745	3680	8	appetite	appetite	NNP
46745	3680	9	and	and	CC
46745	3680	10	digestive	digestive	JJ
46745	3680	11	power	power	NN
46745	3680	12	,	,	,
46745	3680	13	producing	produce	VBG
46745	3680	14	often	often	RB
46745	3680	15	nausea	nausea	NN
46745	3680	16	,	,	,
46745	3680	17	and	and	CC
46745	3680	18	coating	coat	VBG
46745	3680	19	the	the	DT
46745	3680	20	tongue	tongue	NN
46745	3680	21	.	.	.
46745	3681	1	It	-PRON-	PRP
46745	3681	2	tends	tend	VBZ
46745	3681	3	also	also	RB
46745	3681	4	to	to	TO
46745	3681	5	produce	produce	VB
46745	3681	6	a	a	DT
46745	3681	7	determination	determination	NN
46745	3681	8	of	of	IN
46745	3681	9	blood	blood	NN
46745	3681	10	to	to	IN
46745	3681	11	the	the	DT
46745	3681	12	head	head	NN
46745	3681	13	.	.	.
46745	3682	1	Lettuce	lettuce	NN
46745	3682	2	,	,	,
46745	3682	3	from	from	IN
46745	3682	4	which	which	WDT
46745	3682	5	Lactucarium	Lactucarium	NNP
46745	3682	6	is	be	VBZ
46745	3682	7	prepared	prepare	VBN
46745	3682	8	,	,	,
46745	3682	9	resembles	resemble	VBZ
46745	3682	10	Opium	Opium	NNP
46745	3682	11	in	in	IN
46745	3682	12	its	-PRON-	PRP$
46745	3682	13	action	action	NN
46745	3682	14	,	,	,
46745	3682	15	but	but	CC
46745	3682	16	is	be	VBZ
46745	3682	17	neither	neither	DT
46745	3682	18	so	so	RB
46745	3682	19	powerful	powerful	JJ
46745	3682	20	nor	nor	CC
46745	3682	21	so	so	RB
46745	3682	22	efficient	efficient	JJ
46745	3682	23	.	.	.
46745	3683	1	Nutmeg	Nutmeg	NNP
46745	3683	2	and	and	CC
46745	3683	3	Hops	Hops	NNP
46745	3683	4	have	have	VBP
46745	3683	5	proved	prove	VBN
46745	3683	6	Soporifics	Soporifics	NNP
46745	3683	7	when	when	WRB
46745	3683	8	given	give	VBN
46745	3683	9	in	in	IN
46745	3683	10	large	large	JJ
46745	3683	11	doses	dose	NNS
46745	3683	12	.	.	.
46745	3684	1	The	the	DT
46745	3684	2	relief	relief	NN
46745	3684	3	of	of	IN
46745	3684	4	pain	pain	NN
46745	3684	5	,	,	,
46745	3684	6	and	and	CC
46745	3684	7	the	the	DT
46745	3684	8	production	production	NN
46745	3684	9	of	of	IN
46745	3684	10	sleep	sleep	NN
46745	3684	11	,	,	,
46745	3684	12	are	be	VBP
46745	3684	13	about	about	IN
46745	3684	14	the	the	DT
46745	3684	15	commonest	common	JJS
46745	3684	16	and	and	CC
46745	3684	17	the	the	DT
46745	3684	18	most	most	RBS
46745	3684	19	grateful	grateful	JJ
46745	3684	20	of	of	IN
46745	3684	21	the	the	DT
46745	3684	22	offices	office	NNS
46745	3684	23	which	which	WDT
46745	3684	24	fall	fall	VBP
46745	3684	25	to	to	IN
46745	3684	26	the	the	DT
46745	3684	27	lot	lot	NN
46745	3684	28	of	of	IN
46745	3684	29	the	the	DT
46745	3684	30	physician	physician	NN
46745	3684	31	;	;	:
46745	3684	32	and	and	CC
46745	3684	33	in	in	IN
46745	3684	34	either	either	DT
46745	3684	35	case	case	NN
46745	3684	36	Opium	Opium	NNP
46745	3684	37	,	,	,
46745	3684	38	or	or	CC
46745	3684	39	one	one	CD
46745	3684	40	of	of	IN
46745	3684	41	its	-PRON-	PRP$
46745	3684	42	preparations	preparation	NNS
46745	3684	43	,	,	,
46745	3684	44	may	may	MD
46745	3684	45	be	be	VB
46745	3684	46	said	say	VBN
46745	3684	47	to	to	TO
46745	3684	48	be	be	VB
46745	3684	49	indispensable	indispensable	JJ
46745	3684	50	.	.	.
46745	3685	1	But	but	CC
46745	3685	2	a	a	DT
46745	3685	3	certain	certain	JJ
46745	3685	4	caution	caution	NN
46745	3685	5	and	and	CC
46745	3685	6	care	care	NN
46745	3685	7	must	must	MD
46745	3685	8	be	be	VB
46745	3685	9	exercised	exercise	VBN
46745	3685	10	,	,	,
46745	3685	11	even	even	RB
46745	3685	12	in	in	IN
46745	3685	13	the	the	DT
46745	3685	14	administration	administration	NN
46745	3685	15	of	of	IN
46745	3685	16	this	this	DT
46745	3685	17	most	most	RBS
46745	3685	18	useful	useful	JJ
46745	3685	19	remedy	remedy	NN
46745	3685	20	.	.	.
46745	3686	1	(	(	-LRB-
46745	3686	2	_	_	NNP
46745	3686	3	Vide	Vide	NNP
46745	3686	4	Art	Art	NNP
46745	3686	5	.	.	.
46745	3687	1	Opium	Opium	NNP
46745	3687	2	_	_	NNP
46745	3687	3	,	,	,
46745	3687	4	Chap	Chap	NNP
46745	3687	5	.	.	.
46745	3688	1	IV	IV	NNP
46745	3688	2	.	.	.
46745	3688	3	)	)	-RRB-
46745	3689	1	ORD	ORD	NNP
46745	3689	2	.	.	.
46745	3690	1	III	iii	CD
46745	3690	2	.	.	.
46745	3691	1	DELIRIANTS	deliriant	NNS
46745	3691	2	.	.	.
46745	3692	1	(	(	-LRB-
46745	3692	2	Hyoscyamus	Hyoscyamus	NNP
46745	3692	3	;	;	:
46745	3692	4	Belladonna	Belladonna	NNP
46745	3692	5	;	;	:
46745	3692	6	Stramonium	Stramonium	NNP
46745	3692	7	.	.	.
46745	3692	8	)	)	-RRB-
46745	3693	1	These	these	DT
46745	3693	2	medicines	medicine	NNS
46745	3693	3	are	be	VBP
46745	3693	4	all	all	DT
46745	3693	5	produced	produce	VBN
46745	3693	6	by	by	IN
46745	3693	7	the	the	DT
46745	3693	8	natural	natural	JJ
46745	3693	9	order	order	NN
46745	3693	10	Solanaceæ	Solanaceæ	NNP
46745	3693	11	.	.	.
46745	3694	1	Of	of	IN
46745	3694	2	all	all	DT
46745	3694	3	Narcotics	narcotic	NNS
46745	3694	4	they	-PRON-	PRP
46745	3694	5	approach	approach	VBP
46745	3694	6	the	the	DT
46745	3694	7	nearest	near	JJS
46745	3694	8	to	to	IN
46745	3694	9	Sedatives	sedative	NNS
46745	3694	10	.	.	.
46745	3695	1	Their	-PRON-	PRP$
46745	3695	2	only	only	JJ
46745	3695	3	stimulating	stimulating	JJ
46745	3695	4	action	action	NN
46745	3695	5	is	be	VBZ
46745	3695	6	to	to	TO
46745	3695	7	produce	produce	VB
46745	3695	8	at	at	IN
46745	3695	9	the	the	DT
46745	3695	10	very	very	RB
46745	3695	11	first	first	JJ
46745	3695	12	a	a	DT
46745	3695	13	slight	slight	JJ
46745	3695	14	and	and	CC
46745	3695	15	evanescent	evanescent	NN
46745	3695	16	febrile	febrile	NN
46745	3695	17	condition,--a	condition,--a	NNP
46745	3695	18	quick	quick	JJ
46745	3695	19	pulse	pulse	NN
46745	3695	20	and	and	CC
46745	3695	21	heat	heat	NN
46745	3695	22	of	of	IN
46745	3695	23	skin,--which	skin,--which	NNP
46745	3695	24	never	never	RB
46745	3695	25	lasts	last	VBZ
46745	3695	26	long	long	RB
46745	3695	27	,	,	,
46745	3695	28	and	and	CC
46745	3695	29	is	be	VBZ
46745	3695	30	sometimes	sometimes	RB
46745	3695	31	overlooked	overlook	VBN
46745	3695	32	.	.	.
46745	3696	1	They	-PRON-	PRP
46745	3696	2	are	be	VBP
46745	3696	3	not	not	RB
46745	3696	4	Soporific	soporific	JJ
46745	3696	5	.	.	.
46745	3697	1	Their	-PRON-	PRP$
46745	3697	2	action	action	NN
46745	3697	3	is	be	VBZ
46745	3697	4	soon	soon	RB
46745	3697	5	manifested	manifest	VBN
46745	3697	6	by	by	IN
46745	3697	7	an	an	DT
46745	3697	8	anodyne	anodyne	NN
46745	3697	9	operation	operation	NN
46745	3697	10	,	,	,
46745	3697	11	and	and	CC
46745	3697	12	a	a	DT
46745	3697	13	sedative	sedative	JJ
46745	3697	14	influence	influence	NN
46745	3697	15	on	on	IN
46745	3697	16	the	the	DT
46745	3697	17	heart	heart	NN
46745	3697	18	and	and	CC
46745	3697	19	circulation	circulation	NN
46745	3697	20	.	.	.
46745	3698	1	For	for	IN
46745	3698	2	this	this	DT
46745	3698	3	double	double	JJ
46745	3698	4	action	action	NN
46745	3698	5	they	-PRON-	PRP
46745	3698	6	are	be	VBP
46745	3698	7	employed	employ	VBN
46745	3698	8	in	in	IN
46745	3698	9	medicine	medicine	NN
46745	3698	10	,	,	,
46745	3698	11	being	be	VBG
46745	3698	12	used	use	VBN
46745	3698	13	in	in	IN
46745	3698	14	painful	painful	JJ
46745	3698	15	disorders	disorder	NNS
46745	3698	16	,	,	,
46745	3698	17	fevers	fever	NNS
46745	3698	18	,	,	,
46745	3698	19	and	and	CC
46745	3698	20	inflammations	inflammation	NNS
46745	3698	21	.	.	.
46745	3699	1	As	as	IN
46745	3699	2	anodynes	anodyne	NNS
46745	3699	3	they	-PRON-	PRP
46745	3699	4	are	be	VBP
46745	3699	5	not	not	RB
46745	3699	6	so	so	RB
46745	3699	7	efficacious	efficacious	JJ
46745	3699	8	as	as	IN
46745	3699	9	Opium	Opium	NNP
46745	3699	10	,	,	,
46745	3699	11	but	but	CC
46745	3699	12	their	-PRON-	PRP$
46745	3699	13	action	action	NN
46745	3699	14	is	be	VBZ
46745	3699	15	not	not	RB
46745	3699	16	followed	follow	VBN
46745	3699	17	by	by	IN
46745	3699	18	constipation	constipation	NN
46745	3699	19	,	,	,
46745	3699	20	or	or	CC
46745	3699	21	by	by	IN
46745	3699	22	a	a	DT
46745	3699	23	diminution	diminution	NN
46745	3699	24	in	in	IN
46745	3699	25	any	any	DT
46745	3699	26	of	of	IN
46745	3699	27	the	the	DT
46745	3699	28	secretions	secretion	NNS
46745	3699	29	.	.	.
46745	3700	1	They	-PRON-	PRP
46745	3700	2	all	all	DT
46745	3700	3	dilate	dilate	VBP
46745	3700	4	the	the	DT
46745	3700	5	pupil	pupil	NN
46745	3700	6	of	of	IN
46745	3700	7	the	the	DT
46745	3700	8	eye	eye	NN
46745	3700	9	.	.	.
46745	3701	1	Belladonna	Belladonna	NNP
46745	3701	2	produces	produce	VBZ
46745	3701	3	a	a	DT
46745	3701	4	peculiar	peculiar	JJ
46745	3701	5	dryness	dryness	NN
46745	3701	6	of	of	IN
46745	3701	7	the	the	DT
46745	3701	8	throat	throat	NN
46745	3701	9	,	,	,
46745	3701	10	and	and	CC
46745	3701	11	has	have	VBZ
46745	3701	12	been	be	VBN
46745	3701	13	known	know	VBN
46745	3701	14	to	to	TO
46745	3701	15	cause	cause	VB
46745	3701	16	an	an	DT
46745	3701	17	erythematous	erythematous	JJ
46745	3701	18	eruption	eruption	NN
46745	3701	19	.	.	.
46745	3702	1	Stramonium	stramonium	NN
46745	3702	2	appears	appear	VBZ
46745	3702	3	especially	especially	RB
46745	3702	4	to	to	TO
46745	3702	5	control	control	VB
46745	3702	6	the	the	DT
46745	3702	7	respiratory	respiratory	JJ
46745	3702	8	nerves	nerve	NNS
46745	3702	9	,	,	,
46745	3702	10	and	and	CC
46745	3702	11	is	be	VBZ
46745	3702	12	thus	thus	RB
46745	3702	13	used	use	VBN
46745	3702	14	in	in	IN
46745	3702	15	Asthma	Asthma	NNP
46745	3702	16	,	,	,
46745	3702	17	where	where	WRB
46745	3702	18	there	there	EX
46745	3702	19	is	be	VBZ
46745	3702	20	a	a	DT
46745	3702	21	spasmodic	spasmodic	JJ
46745	3702	22	circular	circular	JJ
46745	3702	23	contraction	contraction	NN
46745	3702	24	of	of	IN
46745	3702	25	the	the	DT
46745	3702	26	smaller	small	JJR
46745	3702	27	bronchial	bronchial	JJ
46745	3702	28	tubes	tube	NNS
46745	3702	29	.	.	.
46745	3703	1	Lobelia	Lobelia	NNP
46745	3703	2	,	,	,
46745	3703	3	a	a	DT
46745	3703	4	medicine	medicine	NN
46745	3703	5	of	of	IN
46745	3703	6	the	the	DT
46745	3703	7	first	first	JJ
46745	3703	8	order	order	NN
46745	3703	9	,	,	,
46745	3703	10	possesses	possess	VBZ
46745	3703	11	a	a	DT
46745	3703	12	somewhat	somewhat	RB
46745	3703	13	similar	similar	JJ
46745	3703	14	power	power	NN
46745	3703	15	.	.	.
46745	3704	1	The	the	DT
46745	3704	2	action	action	NN
46745	3704	3	of	of	IN
46745	3704	4	the	the	DT
46745	3704	5	remedies	remedy	NNS
46745	3704	6	of	of	IN
46745	3704	7	this	this	DT
46745	3704	8	third	third	JJ
46745	3704	9	order	order	NN
46745	3704	10	of	of	IN
46745	3704	11	Narcotics	Narcotics	NNP
46745	3704	12	is	be	VBZ
46745	3704	13	distinguished	distinguish	VBN
46745	3704	14	by	by	IN
46745	3704	15	the	the	DT
46745	3704	16	production	production	NN
46745	3704	17	of	of	IN
46745	3704	18	delirium	delirium	NN
46745	3704	19	when	when	WRB
46745	3704	20	they	-PRON-	PRP
46745	3704	21	are	be	VBP
46745	3704	22	given	give	VBN
46745	3704	23	in	in	IN
46745	3704	24	large	large	JJ
46745	3704	25	doses	dose	NNS
46745	3704	26	.	.	.
46745	3705	1	Let	let	VB
46745	3705	2	us	-PRON-	PRP
46745	3705	3	again	again	RB
46745	3705	4	assume	assume	VB
46745	3705	5	the	the	DT
46745	3705	6	threefold	threefold	JJ
46745	3705	7	division	division	NN
46745	3705	8	of	of	IN
46745	3705	9	the	the	DT
46745	3705	10	mental	mental	JJ
46745	3705	11	functions	function	NNS
46745	3705	12	,	,	,
46745	3705	13	to	to	TO
46745	3705	14	which	which	WDT
46745	3705	15	allusion	allusion	NN
46745	3705	16	has	have	VBZ
46745	3705	17	already	already	RB
46745	3705	18	been	be	VBN
46745	3705	19	made	make	VBN
46745	3705	20	.	.	.
46745	3706	1	Inebriants	inebriant	NNS
46745	3706	2	impair	impair	VBP
46745	3706	3	equally	equally	RB
46745	3706	4	the	the	DT
46745	3706	5	mind	mind	NN
46745	3706	6	,	,	,
46745	3706	7	volition	volition	NN
46745	3706	8	,	,	,
46745	3706	9	and	and	CC
46745	3706	10	the	the	DT
46745	3706	11	five	five	CD
46745	3706	12	senses	sense	NNS
46745	3706	13	.	.	.
46745	3707	1	Soporifics	soporific	NNS
46745	3707	2	extinguish	extinguish	VBP
46745	3707	3	for	for	IN
46745	3707	4	awhile	awhile	JJ
46745	3707	5	both	both	CC
46745	3707	6	volition	volition	NN
46745	3707	7	and	and	CC
46745	3707	8	the	the	DT
46745	3707	9	senses	sense	NNS
46745	3707	10	,	,	,
46745	3707	11	but	but	CC
46745	3707	12	may	may	MD
46745	3707	13	leave	leave	VB
46745	3707	14	the	the	DT
46745	3707	15	mind	mind	NN
46745	3707	16	alone	alone	RB
46745	3707	17	.	.	.
46745	3708	1	In	in	IN
46745	3708	2	delirium	delirium	NN
46745	3708	3	these	these	DT
46745	3708	4	functions	function	NNS
46745	3708	5	are	be	VBP
46745	3708	6	not	not	RB
46745	3708	7	thus	thus	RB
46745	3708	8	impaired	impair	VBN
46745	3708	9	and	and	CC
46745	3708	10	held	hold	VBN
46745	3708	11	in	in	IN
46745	3708	12	subjection	subjection	NN
46745	3708	13	,	,	,
46745	3708	14	but	but	CC
46745	3708	15	they	-PRON-	PRP
46745	3708	16	are	be	VBP
46745	3708	17	excited	excited	JJ
46745	3708	18	and	and	CC
46745	3708	19	led	lead	VBN
46745	3708	20	astray	astray	NNP
46745	3708	21	.	.	.
46745	3709	1	The	the	DT
46745	3709	2	mind	mind	NN
46745	3709	3	is	be	VBZ
46745	3709	4	occupied	occupy	VBN
46745	3709	5	intently	intently	RB
46745	3709	6	upon	upon	IN
46745	3709	7	imaginary	imaginary	JJ
46745	3709	8	fancies	fancy	NNS
46745	3709	9	;	;	:
46745	3709	10	unreal	unreal	JJ
46745	3709	11	objects	object	NNS
46745	3709	12	and	and	CC
46745	3709	13	hallucinations	hallucination	NNS
46745	3709	14	are	be	VBP
46745	3709	15	presented	present	VBN
46745	3709	16	to	to	IN
46745	3709	17	the	the	DT
46745	3709	18	senses	sense	NNS
46745	3709	19	.	.	.
46745	3710	1	So	so	RB
46745	3710	2	that	that	IN
46745	3710	3	Deliriants	Deliriants	NNPS
46745	3710	4	,	,	,
46745	3710	5	in	in	IN
46745	3710	6	this	this	DT
46745	3710	7	peculiar	peculiar	JJ
46745	3710	8	phase	phase	NN
46745	3710	9	of	of	IN
46745	3710	10	their	-PRON-	PRP$
46745	3710	11	action	action	NN
46745	3710	12	,	,	,
46745	3710	13	tend	tend	VBP
46745	3710	14	to	to	TO
46745	3710	15	excite	excite	VB
46745	3710	16	the	the	DT
46745	3710	17	mind	mind	NN
46745	3710	18	and	and	CC
46745	3710	19	the	the	DT
46745	3710	20	volition	volition	NN
46745	3710	21	,	,	,
46745	3710	22	and	and	CC
46745	3710	23	to	to	TO
46745	3710	24	delude	delude	VB
46745	3710	25	or	or	CC
46745	3710	26	derange	derange	VB
46745	3710	27	the	the	DT
46745	3710	28	senses	sense	NNS
46745	3710	29	.	.	.
46745	3711	1	Speaking	speak	VBG
46745	3711	2	generally	generally	RB
46745	3711	3	and	and	CC
46745	3711	4	rather	rather	RB
46745	3711	5	inaccurately	inaccurately	RB
46745	3711	6	,	,	,
46745	3711	7	we	-PRON-	PRP
46745	3711	8	might	may	MD
46745	3711	9	say	say	VB
46745	3711	10	that	that	IN
46745	3711	11	the	the	DT
46745	3711	12	medicines	medicine	NNS
46745	3711	13	of	of	IN
46745	3711	14	the	the	DT
46745	3711	15	first	first	JJ
46745	3711	16	order	order	NN
46745	3711	17	of	of	IN
46745	3711	18	Narcotics	Narcotics	NNP
46745	3711	19	bewilder	bewilder	NN
46745	3711	20	and	and	CC
46745	3711	21	impair	impair	VB
46745	3711	22	the	the	DT
46745	3711	23	powers	power	NNS
46745	3711	24	of	of	IN
46745	3711	25	the	the	DT
46745	3711	26	mind	mind	NN
46745	3711	27	;	;	:
46745	3711	28	those	those	DT
46745	3711	29	of	of	IN
46745	3711	30	the	the	DT
46745	3711	31	second	second	JJ
46745	3711	32	order	order	NN
46745	3711	33	subdue	subdue	NN
46745	3711	34	and	and	CC
46745	3711	35	extinguish	extinguish	VB
46745	3711	36	them	-PRON-	PRP
46745	3711	37	for	for	IN
46745	3711	38	awhile	awhile	RB
46745	3711	39	;	;	:
46745	3711	40	and	and	CC
46745	3711	41	those	those	DT
46745	3711	42	of	of	IN
46745	3711	43	the	the	DT
46745	3711	44	third	third	JJ
46745	3711	45	kind	kind	NN
46745	3711	46	excite	excite	NN
46745	3711	47	and	and	CC
46745	3711	48	derange	derange	VB
46745	3711	49	them	-PRON-	PRP
46745	3711	50	.	.	.
46745	3712	1	Certain	certain	JJ
46745	3712	2	peculiar	peculiar	JJ
46745	3712	3	and	and	CC
46745	3712	4	exceptional	exceptional	JJ
46745	3712	5	effects	effect	NNS
46745	3712	6	are	be	VBP
46745	3712	7	produced	produce	VBN
46745	3712	8	by	by	IN
46745	3712	9	some	some	DT
46745	3712	10	Narcotics	Narcotics	NNP
46745	3712	11	when	when	WRB
46745	3712	12	they	-PRON-	PRP
46745	3712	13	are	be	VBP
46745	3712	14	administered	administer	VBN
46745	3712	15	in	in	IN
46745	3712	16	repeated	repeat	VBN
46745	3712	17	doses	dose	NNS
46745	3712	18	for	for	IN
46745	3712	19	a	a	DT
46745	3712	20	long	long	JJ
46745	3712	21	time	time	NN
46745	3712	22	together	together	RB
46745	3712	23	.	.	.
46745	3713	1	Taken	take	VBN
46745	3713	2	in	in	IN
46745	3713	3	this	this	DT
46745	3713	4	way	way	NN
46745	3713	5	,	,	,
46745	3713	6	Alcohol	Alcohol	NNP
46745	3713	7	produces	produce	VBZ
46745	3713	8	delirium	delirium	NN
46745	3713	9	tremens	tremen	NNS
46745	3713	10	,	,	,
46745	3713	11	and	and	CC
46745	3713	12	great	great	JJ
46745	3713	13	despondency	despondency	NN
46745	3713	14	of	of	IN
46745	3713	15	mind	mind	NN
46745	3713	16	;	;	:
46745	3713	17	as	as	RB
46745	3713	18	also	also	RB
46745	3713	19	often	often	RB
46745	3713	20	a	a	DT
46745	3713	21	chronic	chronic	JJ
46745	3713	22	inflammation	inflammation	NN
46745	3713	23	of	of	IN
46745	3713	24	the	the	DT
46745	3713	25	liver	liver	NN
46745	3713	26	.	.	.
46745	3714	1	The	the	DT
46745	3714	2	continued	continue	VBN
46745	3714	3	smoking	smoking	NN
46745	3714	4	of	of	IN
46745	3714	5	Tobacco	Tobacco	NNP
46745	3714	6	is	be	VBZ
46745	3714	7	found	find	VBN
46745	3714	8	to	to	TO
46745	3714	9	exert	exert	VB
46745	3714	10	a	a	DT
46745	3714	11	tranquilizing	tranquilizing	NN
46745	3714	12	influence	influence	NN
46745	3714	13	over	over	IN
46745	3714	14	the	the	DT
46745	3714	15	mind	mind	NN
46745	3714	16	.	.	.
46745	3715	1	And	and	CC
46745	3715	2	the	the	DT
46745	3715	3	continual	continual	JJ
46745	3715	4	use	use	NN
46745	3715	5	of	of	IN
46745	3715	6	Opium	Opium	NNP
46745	3715	7	or	or	CC
46745	3715	8	Indian	Indian	NNP
46745	3715	9	Hemp	Hemp	NNP
46745	3715	10	,	,	,
46745	3715	11	both	both	DT
46745	3715	12	of	of	IN
46745	3715	13	which	which	WDT
46745	3715	14	are	be	VBP
46745	3715	15	habitually	habitually	RB
46745	3715	16	consumed	consume	VBN
46745	3715	17	in	in	IN
46745	3715	18	large	large	JJ
46745	3715	19	quantities	quantity	NNS
46745	3715	20	in	in	IN
46745	3715	21	the	the	DT
46745	3715	22	East	East	NNP
46745	3715	23	,	,	,
46745	3715	24	produces	produce	VBZ
46745	3715	25	a	a	DT
46745	3715	26	curious	curious	JJ
46745	3715	27	and	and	CC
46745	3715	28	melancholy	melancholy	JJ
46745	3715	29	series	series	NN
46745	3715	30	of	of	IN
46745	3715	31	mental	mental	JJ
46745	3715	32	hallucinations	hallucination	NNS
46745	3715	33	and	and	CC
46745	3715	34	disorders	disorder	NNS
46745	3715	35	.	.	.
46745	3716	1	SEDATIVES	SEDATIVES	NNP
46745	3716	2	.	.	.
46745	3717	1	We	-PRON-	PRP
46745	3717	2	have	have	VBP
46745	3717	3	now	now	RB
46745	3717	4	to	to	TO
46745	3717	5	consider	consider	VB
46745	3717	6	the	the	DT
46745	3717	7	third	third	JJ
46745	3717	8	and	and	CC
46745	3717	9	last	last	JJ
46745	3717	10	division	division	NN
46745	3717	11	of	of	IN
46745	3717	12	Neurotic	neurotic	JJ
46745	3717	13	medicines	medicine	NNS
46745	3717	14	.	.	.
46745	3718	1	Sedatives	sedative	NNS
46745	3718	2	are	be	VBP
46745	3718	3	medicines	medicine	NNS
46745	3718	4	which	which	WDT
46745	3718	5	directly	directly	RB
46745	3718	6	depress	depress	VBP
46745	3718	7	nervous	nervous	JJ
46745	3718	8	force	force	NN
46745	3718	9	.	.	.
46745	3719	1	Some	some	DT
46745	3719	2	affect	affect	VBP
46745	3719	3	nervous	nervous	JJ
46745	3719	4	force	force	NN
46745	3719	5	in	in	IN
46745	3719	6	general	general	JJ
46745	3719	7	;	;	:
46745	3719	8	others	other	NNS
46745	3719	9	confine	confine	VBP
46745	3719	10	their	-PRON-	PRP$
46745	3719	11	action	action	NN
46745	3719	12	to	to	IN
46745	3719	13	particular	particular	JJ
46745	3719	14	nerves	nerve	NNS
46745	3719	15	.	.	.
46745	3720	1	They	-PRON-	PRP
46745	3720	2	are	be	VBP
46745	3720	3	mostly	mostly	RB
46745	3720	4	energetic	energetic	JJ
46745	3720	5	and	and	CC
46745	3720	6	dangerous	dangerous	JJ
46745	3720	7	agents	agent	NNS
46745	3720	8	.	.	.
46745	3721	1	For	for	IN
46745	3721	2	the	the	DT
46745	3721	3	time	time	NN
46745	3721	4	being	be	VBG
46745	3721	5	they	-PRON-	PRP
46745	3721	6	may	may	MD
46745	3721	7	destroy	destroy	VB
46745	3721	8	nervous	nervous	JJ
46745	3721	9	power	power	NN
46745	3721	10	,	,	,
46745	3721	11	and	and	CC
46745	3721	12	remove	remove	VB
46745	3721	13	nervous	nervous	JJ
46745	3721	14	control	control	NN
46745	3721	15	.	.	.
46745	3722	1	It	-PRON-	PRP
46745	3722	2	might	may	MD
46745	3722	3	already	already	RB
46745	3722	4	have	have	VB
46745	3722	5	been	be	VBN
46745	3722	6	concluded	conclude	VBN
46745	3722	7	,	,	,
46745	3722	8	from	from	IN
46745	3722	9	what	what	WP
46745	3722	10	has	have	VBZ
46745	3722	11	been	be	VBN
46745	3722	12	said	say	VBN
46745	3722	13	of	of	IN
46745	3722	14	the	the	DT
46745	3722	15	secondary	secondary	JJ
46745	3722	16	action	action	NN
46745	3722	17	of	of	IN
46745	3722	18	Narcotics	Narcotics	NNP
46745	3722	19	,	,	,
46745	3722	20	that	that	IN
46745	3722	21	there	there	EX
46745	3722	22	are	be	VBP
46745	3722	23	two	two	CD
46745	3722	24	ways	way	NNS
46745	3722	25	in	in	IN
46745	3722	26	which	which	WDT
46745	3722	27	a	a	DT
46745	3722	28	Sedative	sedative	JJ
46745	3722	29	action	action	NN
46745	3722	30	on	on	IN
46745	3722	31	nerve	nerve	NN
46745	3722	32	may	may	MD
46745	3722	33	be	be	VB
46745	3722	34	manifested	manifest	VBN
46745	3722	35	.	.	.
46745	3723	1	Sedatives	sedative	NNS
46745	3723	2	may	may	MD
46745	3723	3	destroy	destroy	VB
46745	3723	4	nervous	nervous	JJ
46745	3723	5	influence	influence	NN
46745	3723	6	;	;	:
46745	3723	7	or	or	CC
46745	3723	8	they	-PRON-	PRP
46745	3723	9	may	may	MD
46745	3723	10	simply	simply	RB
46745	3723	11	derange	derange	VB
46745	3723	12	it	-PRON-	PRP
46745	3723	13	.	.	.
46745	3724	1	Let	let	VB
46745	3724	2	us	-PRON-	PRP
46745	3724	3	suppose	suppose	VB
46745	3724	4	a	a	DT
46745	3724	5	special	special	JJ
46745	3724	6	Sedative	sedative	NN
46745	3724	7	to	to	TO
46745	3724	8	derange	derange	VB
46745	3724	9	the	the	DT
46745	3724	10	action	action	NN
46745	3724	11	of	of	IN
46745	3724	12	the	the	DT
46745	3724	13	Vagus	Vagus	NNP
46745	3724	14	nerve	nerve	NN
46745	3724	15	.	.	.
46745	3725	1	It	-PRON-	PRP
46745	3725	2	would	would	MD
46745	3725	3	probably	probably	RB
46745	3725	4	cause	cause	VB
46745	3725	5	the	the	DT
46745	3725	6	rhythmical	rhythmical	JJ
46745	3725	7	contraction	contraction	NN
46745	3725	8	of	of	IN
46745	3725	9	the	the	DT
46745	3725	10	heart	heart	NN
46745	3725	11	to	to	TO
46745	3725	12	be	be	VB
46745	3725	13	abnormally	abnormally	RB
46745	3725	14	slow	slow	JJ
46745	3725	15	or	or	CC
46745	3725	16	irregular	irregular	JJ
46745	3725	17	.	.	.
46745	3726	1	It	-PRON-	PRP
46745	3726	2	would	would	MD
46745	3726	3	be	be	VB
46745	3726	4	likely	likely	JJ
46745	3726	5	to	to	TO
46745	3726	6	diminish	diminish	VB
46745	3726	7	in	in	IN
46745	3726	8	the	the	DT
46745	3726	9	lungs	lung	NNS
46745	3726	10	the	the	DT
46745	3726	11	sensation	sensation	NN
46745	3726	12	of	of	IN
46745	3726	13	want	want	NN
46745	3726	14	of	of	IN
46745	3726	15	breath	breath	NN
46745	3726	16	,	,	,
46745	3726	17	and	and	CC
46745	3726	18	thus	thus	RB
46745	3726	19	decrease	decrease	VB
46745	3726	20	the	the	DT
46745	3726	21	number	number	NN
46745	3726	22	of	of	IN
46745	3726	23	the	the	DT
46745	3726	24	respirations	respiration	NNS
46745	3726	25	;	;	:
46745	3726	26	and	and	CC
46745	3726	27	at	at	IN
46745	3726	28	the	the	DT
46745	3726	29	same	same	JJ
46745	3726	30	time	time	NN
46745	3726	31	it	-PRON-	PRP
46745	3726	32	would	would	MD
46745	3726	33	repress	repress	VB
46745	3726	34	the	the	DT
46745	3726	35	irritability	irritability	NN
46745	3726	36	of	of	IN
46745	3726	37	the	the	DT
46745	3726	38	pulmonary	pulmonary	JJ
46745	3726	39	mucous	mucous	JJ
46745	3726	40	surface	surface	NN
46745	3726	41	.	.	.
46745	3727	1	Further	further	RB
46745	3727	2	,	,	,
46745	3727	3	it	-PRON-	PRP
46745	3727	4	would	would	MD
46745	3727	5	in	in	IN
46745	3727	6	some	some	DT
46745	3727	7	way	way	NN
46745	3727	8	derange	derange	NN
46745	3727	9	the	the	DT
46745	3727	10	normal	normal	JJ
46745	3727	11	function	function	NN
46745	3727	12	of	of	IN
46745	3727	13	the	the	DT
46745	3727	14	stomach	stomach	NN
46745	3727	15	.	.	.
46745	3728	1	All	all	PDT
46745	3728	2	these	these	DT
46745	3728	3	things	thing	NNS
46745	3728	4	a	a	DT
46745	3728	5	Sedative	Sedative	NNP
46745	3728	6	to	to	IN
46745	3728	7	the	the	DT
46745	3728	8	Vagus	Vagus	NNP
46745	3728	9	nerve	nerve	NN
46745	3728	10	does	do	VBZ
46745	3728	11	actually	actually	RB
46745	3728	12	effect	effect	VB
46745	3728	13	.	.	.
46745	3729	1	Given	give	VBN
46745	3729	2	in	in	IN
46745	3729	3	large	large	JJ
46745	3729	4	quantity	quantity	NN
46745	3729	5	,	,	,
46745	3729	6	it	-PRON-	PRP
46745	3729	7	may	may	MD
46745	3729	8	cause	cause	VB
46745	3729	9	death	death	NN
46745	3729	10	,	,	,
46745	3729	11	by	by	IN
46745	3729	12	destroying	destroy	VBG
46745	3729	13	those	those	DT
46745	3729	14	functions	function	NNS
46745	3729	15	which	which	WDT
46745	3729	16	in	in	IN
46745	3729	17	a	a	DT
46745	3729	18	small	small	JJ
46745	3729	19	dose	dose	VBD
46745	3729	20	it	-PRON-	PRP
46745	3729	21	deranges	derange	VBZ
46745	3729	22	.	.	.
46745	3730	1	All	all	PDT
46745	3730	2	the	the	DT
46745	3730	3	varieties	variety	NNS
46745	3730	4	in	in	IN
46745	3730	5	action	action	NN
46745	3730	6	of	of	IN
46745	3730	7	Sedative	sedative	JJ
46745	3730	8	medicines	medicine	NNS
46745	3730	9	may	may	MD
46745	3730	10	be	be	VB
46745	3730	11	accounted	account	VBN
46745	3730	12	for	for	IN
46745	3730	13	by	by	IN
46745	3730	14	considering	consider	VBG
46745	3730	15	that	that	IN
46745	3730	16	they	-PRON-	PRP
46745	3730	17	may	may	MD
46745	3730	18	either	either	CC
46745	3730	19	derange	derange	VB
46745	3730	20	or	or	CC
46745	3730	21	destroy	destroy	VB
46745	3730	22	the	the	DT
46745	3730	23	nervous	nervous	JJ
46745	3730	24	forces	force	NNS
46745	3730	25	.	.	.
46745	3731	1	In	in	IN
46745	3731	2	the	the	DT
46745	3731	3	case	case	NN
46745	3731	4	of	of	IN
46745	3731	5	each	each	DT
46745	3731	6	set	set	NN
46745	3731	7	of	of	IN
46745	3731	8	nerves	nerve	NNS
46745	3731	9	in	in	IN
46745	3731	10	the	the	DT
46745	3731	11	body	body	NN
46745	3731	12	we	-PRON-	PRP
46745	3731	13	may	may	MD
46745	3731	14	distinguish	distinguish	VB
46745	3731	15	an	an	DT
46745	3731	16	action	action	NN
46745	3731	17	of	of	IN
46745	3731	18	derangement	derangement	NN
46745	3731	19	,	,	,
46745	3731	20	and	and	CC
46745	3731	21	an	an	DT
46745	3731	22	action	action	NN
46745	3731	23	of	of	IN
46745	3731	24	destruction	destruction	NN
46745	3731	25	,	,	,
46745	3731	26	both	both	CC
46745	3731	27	producible	producible	JJ
46745	3731	28	by	by	IN
46745	3731	29	Sedative	sedative	JJ
46745	3731	30	medicines	medicine	NNS
46745	3731	31	.	.	.
46745	3732	1	Thus	thus	RB
46745	3732	2	by	by	IN
46745	3732	3	an	an	DT
46745	3732	4	action	action	NN
46745	3732	5	on	on	IN
46745	3732	6	the	the	DT
46745	3732	7	motor	motor	NN
46745	3732	8	nerves	nerve	NNS
46745	3732	9	of	of	IN
46745	3732	10	the	the	DT
46745	3732	11	cerebro	cerebro	JJ
46745	3732	12	-	-	HYPH
46745	3732	13	spinal	spinal	JJ
46745	3732	14	system	system	NN
46745	3732	15	,	,	,
46745	3732	16	convulsions	convulsion	NNS
46745	3732	17	or	or	CC
46745	3732	18	paralysis	paralysis	NN
46745	3732	19	may	may	MD
46745	3732	20	be	be	VB
46745	3732	21	produced	produce	VBN
46745	3732	22	.	.	.
46745	3733	1	By	by	IN
46745	3733	2	an	an	DT
46745	3733	3	influence	influence	NN
46745	3733	4	on	on	IN
46745	3733	5	the	the	DT
46745	3733	6	nerves	nerve	NNS
46745	3733	7	of	of	IN
46745	3733	8	sensation	sensation	NN
46745	3733	9	;	;	:
46745	3733	10	pain	pain	NN
46745	3733	11	,	,	,
46745	3733	12	or	or	CC
46745	3733	13	anæsthesia	anæsthesia	NNP
46745	3733	14	.	.	.
46745	3734	1	By	by	IN
46745	3734	2	an	an	DT
46745	3734	3	affection	affection	NN
46745	3734	4	of	of	IN
46745	3734	5	the	the	DT
46745	3734	6	organic	organic	JJ
46745	3734	7	nerves	nerve	NNS
46745	3734	8	of	of	IN
46745	3734	9	the	the	DT
46745	3734	10	heart	heart	NN
46745	3734	11	,	,	,
46745	3734	12	or	or	CC
46745	3734	13	of	of	IN
46745	3734	14	the	the	DT
46745	3734	15	brain	brain	NN
46745	3734	16	which	which	WDT
46745	3734	17	controls	control	VBZ
46745	3734	18	them	-PRON-	PRP
46745	3734	19	;	;	:
46745	3734	20	palpitation	palpitation	NN
46745	3734	21	,	,	,
46745	3734	22	or	or	CC
46745	3734	23	syncope	syncope	NN
46745	3734	24	.	.	.
46745	3735	1	By	by	IN
46745	3735	2	an	an	DT
46745	3735	3	action	action	NN
46745	3735	4	on	on	IN
46745	3735	5	the	the	DT
46745	3735	6	nerves	nerve	NNS
46745	3735	7	of	of	IN
46745	3735	8	the	the	DT
46745	3735	9	lungs	lung	NNS
46745	3735	10	;	;	,
46745	3735	11	cough	cough	NN
46745	3735	12	,	,	,
46745	3735	13	or	or	CC
46745	3735	14	apn[oe]a	apn[oe]a	NNP
46745	3735	15	.	.	.
46745	3736	1	By	by	IN
46745	3736	2	the	the	DT
46745	3736	3	exertion	exertion	NN
46745	3736	4	of	of	IN
46745	3736	5	a	a	DT
46745	3736	6	sedative	sedative	JJ
46745	3736	7	power	power	NN
46745	3736	8	over	over	IN
46745	3736	9	those	those	DT
46745	3736	10	of	of	IN
46745	3736	11	the	the	DT
46745	3736	12	stomach	stomach	NN
46745	3736	13	,	,	,
46745	3736	14	nausea	nausea	NN
46745	3736	15	may	may	MD
46745	3736	16	result	result	VB
46745	3736	17	,	,	,
46745	3736	18	or	or	CC
46745	3736	19	vomiting	vomiting	NN
46745	3736	20	.	.	.
46745	3737	1	These	these	DT
46745	3737	2	various	various	JJ
46745	3737	3	symptoms	symptom	NNS
46745	3737	4	are	be	VBP
46745	3737	5	all	all	DT
46745	3737	6	brought	bring	VBN
46745	3737	7	about	about	RP
46745	3737	8	by	by	IN
46745	3737	9	Sedative	sedative	JJ
46745	3737	10	medicines	medicine	NNS
46745	3737	11	,	,	,
46745	3737	12	but	but	CC
46745	3737	13	in	in	IN
46745	3737	14	each	each	DT
46745	3737	15	case	case	NN
46745	3737	16	the	the	DT
46745	3737	17	first	first	JJ
46745	3737	18	effect	effect	NN
46745	3737	19	is	be	VBZ
46745	3737	20	referrible	referrible	JJ
46745	3737	21	to	to	IN
46745	3737	22	a	a	DT
46745	3737	23	derangement	derangement	NN
46745	3737	24	,	,	,
46745	3737	25	the	the	DT
46745	3737	26	second	second	JJ
46745	3737	27	to	to	IN
46745	3737	28	a	a	DT
46745	3737	29	loss	loss	NN
46745	3737	30	of	of	IN
46745	3737	31	nervous	nervous	JJ
46745	3737	32	power	power	NN
46745	3737	33	.	.	.
46745	3738	1	In	in	IN
46745	3738	2	every	every	DT
46745	3738	3	instance	instance	NN
46745	3738	4	there	there	EX
46745	3738	5	is	be	VBZ
46745	3738	6	an	an	DT
46745	3738	7	impairment	impairment	NN
46745	3738	8	of	of	IN
46745	3738	9	natural	natural	JJ
46745	3738	10	nervous	nervous	JJ
46745	3738	11	force	force	NN
46745	3738	12	.	.	.
46745	3739	1	Narcotics	narcotic	NNS
46745	3739	2	act	act	VBP
46745	3739	3	on	on	IN
46745	3739	4	the	the	DT
46745	3739	5	mind	mind	NN
46745	3739	6	.	.	.
46745	3740	1	They	-PRON-	PRP
46745	3740	2	cause	cause	VBP
46745	3740	3	death	death	NN
46745	3740	4	,	,	,
46745	3740	5	with	with	IN
46745	3740	6	stupor	stupor	NN
46745	3740	7	or	or	CC
46745	3740	8	delirium	delirium	NN
46745	3740	9	.	.	.
46745	3741	1	Sedatives	sedative	NNS
46745	3741	2	act	act	VBP
46745	3741	3	on	on	IN
46745	3741	4	the	the	DT
46745	3741	5	organic	organic	JJ
46745	3741	6	function	function	NN
46745	3741	7	of	of	IN
46745	3741	8	the	the	DT
46745	3741	9	brain	brain	NN
46745	3741	10	,	,	,
46745	3741	11	which	which	WDT
46745	3741	12	is	be	VBZ
46745	3741	13	necessary	necessary	JJ
46745	3741	14	to	to	IN
46745	3741	15	life	life	NN
46745	3741	16	,	,	,
46745	3741	17	but	but	CC
46745	3741	18	they	-PRON-	PRP
46745	3741	19	do	do	VBP
46745	3741	20	not	not	RB
46745	3741	21	affect	affect	VB
46745	3741	22	the	the	DT
46745	3741	23	mind	mind	NN
46745	3741	24	.	.	.
46745	3742	1	In	in	IN
46745	3742	2	poisonous	poisonous	JJ
46745	3742	3	doses	dose	NNS
46745	3742	4	,	,	,
46745	3742	5	they	-PRON-	PRP
46745	3742	6	kill	kill	VBP
46745	3742	7	by	by	IN
46745	3742	8	producing	produce	VBG
46745	3742	9	syncope	syncope	NN
46745	3742	10	,	,	,
46745	3742	11	which	which	WDT
46745	3742	12	is	be	VBZ
46745	3742	13	a	a	DT
46745	3742	14	suspension	suspension	NN
46745	3742	15	of	of	IN
46745	3742	16	the	the	DT
46745	3742	17	action	action	NN
46745	3742	18	of	of	IN
46745	3742	19	the	the	DT
46745	3742	20	heart	heart	NN
46745	3742	21	.	.	.
46745	3743	1	Hydrocyanic	hydrocyanic	JJ
46745	3743	2	acid	acid	NN
46745	3743	3	causes	cause	NNS
46745	3743	4	at	at	IN
46745	3743	5	the	the	DT
46745	3743	6	same	same	JJ
46745	3743	7	time	time	NN
46745	3743	8	convulsions	convulsion	NNS
46745	3743	9	.	.	.
46745	3744	1	These	these	DT
46745	3744	2	convulsions	convulsion	NNS
46745	3744	3	appear	appear	VBP
46745	3744	4	to	to	TO
46745	3744	5	be	be	VB
46745	3744	6	caused	cause	VBN
46745	3744	7	by	by	IN
46745	3744	8	a	a	DT
46745	3744	9	derangement	derangement	NN
46745	3744	10	of	of	IN
46745	3744	11	the	the	DT
46745	3744	12	nervous	nervous	JJ
46745	3744	13	polarity	polarity	NN
46745	3744	14	of	of	IN
46745	3744	15	the	the	DT
46745	3744	16	spinal	spinal	JJ
46745	3744	17	cord	cord	NN
46745	3744	18	;	;	,
46745	3744	19	and	and	CC
46745	3744	20	not	not	RB
46745	3744	21	by	by	IN
46745	3744	22	a	a	DT
46745	3744	23	stimulation	stimulation	NN
46745	3744	24	of	of	IN
46745	3744	25	this	this	DT
46745	3744	26	centre	centre	NN
46745	3744	27	,	,	,
46745	3744	28	as	as	IN
46745	3744	29	the	the	DT
46745	3744	30	tonic	tonic	NN
46745	3744	31	spasm	spasm	NN
46745	3744	32	of	of	IN
46745	3744	33	Strychnia	Strychnia	NNP
46745	3744	34	.	.	.
46745	3745	1	(	(	-LRB-
46745	3745	2	_	_	NNP
46745	3745	3	Vide	Vide	NNP
46745	3745	4	_	_	NNP
46745	3745	5	page	page	NN
46745	3745	6	232	232	CD
46745	3745	7	.	.	.
46745	3745	8	)	)	-RRB-
46745	3746	1	Sedatives	sedative	NNS
46745	3746	2	are	be	VBP
46745	3746	3	divided	divide	VBN
46745	3746	4	into	into	IN
46745	3746	5	two	two	CD
46745	3746	6	orders	order	NNS
46745	3746	7	,	,	,
46745	3746	8	according	accord	VBG
46745	3746	9	to	to	IN
46745	3746	10	the	the	DT
46745	3746	11	extent	extent	NN
46745	3746	12	of	of	IN
46745	3746	13	their	-PRON-	PRP$
46745	3746	14	action	action	NN
46745	3746	15	;	;	:
46745	3746	16	in	in	IN
46745	3746	17	the	the	DT
46745	3746	18	same	same	JJ
46745	3746	19	way	way	NN
46745	3746	20	as	as	IN
46745	3746	21	Stimulants	stimulant	NNS
46745	3746	22	have	have	VBP
46745	3746	23	been	be	VBN
46745	3746	24	divided	divide	VBN
46745	3746	25	.	.	.
46745	3747	1	SEDANTIA	SEDANTIA	NNP
46745	3747	2	.	.	.
46745	3748	1	Ord	Ord	NNP
46745	3748	2	.	.	.
46745	3749	1	1	1	LS
46745	3749	2	.	.	.
46745	3750	1	Sedantia	Sedantia	NNP
46745	3750	2	Generalia	Generalia	NNP
46745	3750	3	.	.	.
46745	3751	1	Ord	Ord	NNP
46745	3751	2	.	.	.
46745	3752	1	2	2	LS
46745	3752	2	.	.	.
46745	3753	1	Sedantia	Sedantia	NNP
46745	3753	2	Specifica	Specifica	NNP
46745	3753	3	.	.	.
46745	3754	1	General	General	NNP
46745	3754	2	Sedatives	Sedatives	NNPS
46745	3754	3	have	have	VBP
46745	3754	4	a	a	DT
46745	3754	5	direct	direct	JJ
46745	3754	6	action	action	NN
46745	3754	7	upon	upon	IN
46745	3754	8	all	all	PDT
46745	3754	9	the	the	DT
46745	3754	10	nerves	nerve	NNS
46745	3754	11	and	and	CC
46745	3754	12	nerve	nerve	NN
46745	3754	13	-	-	HYPH
46745	3754	14	centres	centre	NNS
46745	3754	15	in	in	IN
46745	3754	16	the	the	DT
46745	3754	17	body	body	NN
46745	3754	18	,	,	,
46745	3754	19	the	the	DT
46745	3754	20	result	result	NN
46745	3754	21	of	of	IN
46745	3754	22	which	which	WDT
46745	3754	23	is	be	VBZ
46745	3754	24	a	a	DT
46745	3754	25	diminution	diminution	NN
46745	3754	26	of	of	IN
46745	3754	27	nervous	nervous	JJ
46745	3754	28	force	force	NN
46745	3754	29	.	.	.
46745	3755	1	Special	Special	NNP
46745	3755	2	Sedatives	Sedatives	NNPS
46745	3755	3	exert	exert	VBP
46745	3755	4	the	the	DT
46745	3755	5	same	same	JJ
46745	3755	6	depressing	depressing	JJ
46745	3755	7	action	action	NN
46745	3755	8	upon	upon	IN
46745	3755	9	particular	particular	JJ
46745	3755	10	nerves	nerve	NNS
46745	3755	11	only	only	RB
46745	3755	12	.	.	.
46745	3756	1	Like	like	IN
46745	3756	2	the	the	DT
46745	3756	3	order	order	NN
46745	3756	4	of	of	IN
46745	3756	5	Special	Special	NNP
46745	3756	6	Stimulants	Stimulants	NNPS
46745	3756	7	,	,	,
46745	3756	8	they	-PRON-	PRP
46745	3756	9	are	be	VBP
46745	3756	10	peculiar	peculiar	JJ
46745	3756	11	and	and	CC
46745	3756	12	exceptional	exceptional	JJ
46745	3756	13	agents	agent	NNS
46745	3756	14	.	.	.
46745	3757	1	All	all	PDT
46745	3757	2	those	those	DT
46745	3757	3	with	with	IN
46745	3757	4	which	which	WDT
46745	3757	5	we	-PRON-	PRP
46745	3757	6	are	be	VBP
46745	3757	7	acquainted	acquaint	VBN
46745	3757	8	appear	appear	VBP
46745	3757	9	to	to	TO
46745	3757	10	direct	direct	VB
46745	3757	11	their	-PRON-	PRP$
46745	3757	12	action	action	NN
46745	3757	13	to	to	IN
46745	3757	14	the	the	DT
46745	3757	15	branches	branch	NNS
46745	3757	16	of	of	IN
46745	3757	17	the	the	DT
46745	3757	18	Vagus	Vagus	NNP
46745	3757	19	nerve	nerve	NN
46745	3757	20	.	.	.
46745	3758	1	It	-PRON-	PRP
46745	3758	2	is	be	VBZ
46745	3758	3	among	among	IN
46745	3758	4	General	General	NNP
46745	3758	5	Sedatives	Sedatives	NNPS
46745	3758	6	that	that	IN
46745	3758	7	the	the	DT
46745	3758	8	types	type	NNS
46745	3758	9	or	or	CC
46745	3758	10	representatives	representative	NNS
46745	3758	11	of	of	IN
46745	3758	12	this	this	DT
46745	3758	13	division	division	NN
46745	3758	14	are	be	VBP
46745	3758	15	to	to	TO
46745	3758	16	be	be	VB
46745	3758	17	found	find	VBN
46745	3758	18	.	.	.
46745	3759	1	The	the	DT
46745	3759	2	definition	definition	NN
46745	3759	3	of	of	IN
46745	3759	4	this	this	DT
46745	3759	5	order	order	NN
46745	3759	6	does	do	VBZ
46745	3759	7	not	not	RB
46745	3759	8	admit	admit	VB
46745	3759	9	of	of	IN
46745	3759	10	so	so	RB
46745	3759	11	great	great	JJ
46745	3759	12	a	a	DT
46745	3759	13	variety	variety	NN
46745	3759	14	in	in	IN
46745	3759	15	action	action	NN
46745	3759	16	as	as	IN
46745	3759	17	must	must	MD
46745	3759	18	be	be	VB
46745	3759	19	allowed	allow	VBN
46745	3759	20	to	to	IN
46745	3759	21	Narcotics	Narcotics	NNP
46745	3759	22	.	.	.
46745	3760	1	A	a	DT
46745	3760	2	Stimulant	stimulant	JJ
46745	3760	3	medicine	medicine	NN
46745	3760	4	simply	simply	RB
46745	3760	5	exalts	exalt	VBZ
46745	3760	6	or	or	CC
46745	3760	7	increases	increase	VBZ
46745	3760	8	nervous	nervous	JJ
46745	3760	9	force	force	NN
46745	3760	10	;	;	:
46745	3760	11	and	and	CC
46745	3760	12	a	a	DT
46745	3760	13	Sedative	Sedative	NNP
46745	3760	14	simply	simply	RB
46745	3760	15	depresses	depress	VBZ
46745	3760	16	the	the	DT
46745	3760	17	same	same	JJ
46745	3760	18	.	.	.
46745	3761	1	But	but	CC
46745	3761	2	a	a	DT
46745	3761	3	Narcotic	narcotic	JJ
46745	3761	4	first	first	RB
46745	3761	5	does	do	VBZ
46745	3761	6	one	one	CD
46745	3761	7	thing	thing	NN
46745	3761	8	and	and	CC
46745	3761	9	then	then	RB
46745	3761	10	the	the	DT
46745	3761	11	other	other	JJ
46745	3761	12	;	;	:
46745	3761	13	and	and	CC
46745	3761	14	according	accord	VBG
46745	3761	15	to	to	IN
46745	3761	16	the	the	DT
46745	3761	17	degrees	degree	NNS
46745	3761	18	of	of	IN
46745	3761	19	these	these	DT
46745	3761	20	two	two	CD
46745	3761	21	actions	action	NNS
46745	3761	22	,	,	,
46745	3761	23	so	so	RB
46745	3761	24	do	do	VB
46745	3761	25	some	some	DT
46745	3761	26	Narcotics	Narcotics	NNP
46745	3761	27	resemble	resemble	JJ
46745	3761	28	Stimulants	Stimulants	NNP
46745	3761	29	,	,	,
46745	3761	30	and	and	CC
46745	3761	31	others	other	NNS
46745	3761	32	approach	approach	VBP
46745	3761	33	very	very	RB
46745	3761	34	nearly	nearly	RB
46745	3761	35	to	to	IN
46745	3761	36	Sedatives	sedative	NNS
46745	3761	37	.	.	.
46745	3762	1	But	but	CC
46745	3762	2	we	-PRON-	PRP
46745	3762	3	have	have	VBP
46745	3762	4	seen	see	VBN
46745	3762	5	that	that	IN
46745	3762	6	Narcotics	Narcotics	NNP
46745	3762	7	have	have	VBP
46745	3762	8	also	also	RB
46745	3762	9	a	a	DT
46745	3762	10	peculiar	peculiar	JJ
46745	3762	11	and	and	CC
46745	3762	12	mysterious	mysterious	JJ
46745	3762	13	action	action	NN
46745	3762	14	on	on	IN
46745	3762	15	the	the	DT
46745	3762	16	mind	mind	NN
46745	3762	17	,	,	,
46745	3762	18	which	which	WDT
46745	3762	19	action	action	NN
46745	3762	20	is	be	VBZ
46745	3762	21	of	of	IN
46745	3762	22	three	three	CD
46745	3762	23	separate	separate	JJ
46745	3762	24	kinds	kind	NNS
46745	3762	25	.	.	.
46745	3763	1	And	and	CC
46745	3763	2	the	the	DT
46745	3763	3	same	same	JJ
46745	3763	4	three	three	CD
46745	3763	5	orders	order	NNS
46745	3763	6	which	which	WDT
46745	3763	7	are	be	VBP
46745	3763	8	named	name	VBN
46745	3763	9	according	accord	VBG
46745	3763	10	to	to	IN
46745	3763	11	their	-PRON-	PRP$
46745	3763	12	respective	respective	JJ
46745	3763	13	actions	action	NNS
46745	3763	14	on	on	IN
46745	3763	15	the	the	DT
46745	3763	16	mind	mind	NN
46745	3763	17	,	,	,
46745	3763	18	are	be	VBP
46745	3763	19	found	find	VBN
46745	3763	20	to	to	TO
46745	3763	21	coincide	coincide	VB
46745	3763	22	with	with	IN
46745	3763	23	three	three	CD
46745	3763	24	stages	stage	NNS
46745	3763	25	of	of	IN
46745	3763	26	transition	transition	NN
46745	3763	27	from	from	IN
46745	3763	28	the	the	DT
46745	3763	29	action	action	NN
46745	3763	30	of	of	IN
46745	3763	31	a	a	DT
46745	3763	32	Stimulant	Stimulant	NNP
46745	3763	33	to	to	IN
46745	3763	34	that	that	DT
46745	3763	35	of	of	IN
46745	3763	36	a	a	DT
46745	3763	37	Sedative	sedative	JJ
46745	3763	38	medicine	medicine	NN
46745	3763	39	.	.	.
46745	3764	1	It	-PRON-	PRP
46745	3764	2	is	be	VBZ
46745	3764	3	impossible	impossible	JJ
46745	3764	4	to	to	TO
46745	3764	5	associate	associate	VB
46745	3764	6	in	in	IN
46745	3764	7	the	the	DT
46745	3764	8	same	same	JJ
46745	3764	9	prescription	prescription	NN
46745	3764	10	a	a	DT
46745	3764	11	Stimulant	Stimulant	NNP
46745	3764	12	and	and	CC
46745	3764	13	a	a	DT
46745	3764	14	Sedative	sedative	JJ
46745	3764	15	medicine	medicine	NN
46745	3764	16	;	;	:
46745	3764	17	for	for	IN
46745	3764	18	their	-PRON-	PRP$
46745	3764	19	actions	action	NNS
46745	3764	20	are	be	VBP
46745	3764	21	directly	directly	RB
46745	3764	22	contrary	contrary	JJ
46745	3764	23	,	,	,
46745	3764	24	and	and	CC
46745	3764	25	tend	tend	VBP
46745	3764	26	to	to	TO
46745	3764	27	counteract	counteract	VB
46745	3764	28	one	one	CD
46745	3764	29	another	another	DT
46745	3764	30	.	.	.
46745	3765	1	But	but	CC
46745	3765	2	it	-PRON-	PRP
46745	3765	3	is	be	VBZ
46745	3765	4	often	often	RB
46745	3765	5	desirable	desirable	JJ
46745	3765	6	to	to	TO
46745	3765	7	prescribe	prescribe	VB
46745	3765	8	an	an	DT
46745	3765	9	Inebriant	Inebriant	NNP
46745	3765	10	Narcotic	Narcotic	NNP
46745	3765	11	with	with	IN
46745	3765	12	a	a	DT
46745	3765	13	Stimulant	Stimulant	NNP
46745	3765	14	,	,	,
46745	3765	15	for	for	IN
46745	3765	16	their	-PRON-	PRP$
46745	3765	17	actions	action	NNS
46745	3765	18	resemble	resemble	VBP
46745	3765	19	each	each	DT
46745	3765	20	other	other	JJ
46745	3765	21	so	so	RB
46745	3765	22	much	much	RB
46745	3765	23	,	,	,
46745	3765	24	that	that	IN
46745	3765	25	they	-PRON-	PRP
46745	3765	26	are	be	VBP
46745	3765	27	able	able	JJ
46745	3765	28	to	to	TO
46745	3765	29	work	work	VB
46745	3765	30	together	together	RB
46745	3765	31	.	.	.
46745	3766	1	And	and	CC
46745	3766	2	Deliriants	deliriant	NNS
46745	3766	3	,	,	,
46745	3766	4	which	which	WDT
46745	3766	5	stand	stand	VBP
46745	3766	6	at	at	IN
46745	3766	7	the	the	DT
46745	3766	8	other	other	JJ
46745	3766	9	end	end	NN
46745	3766	10	of	of	IN
46745	3766	11	the	the	DT
46745	3766	12	Narcotic	narcotic	JJ
46745	3766	13	scale	scale	NN
46745	3766	14	,	,	,
46745	3766	15	may	may	MD
46745	3766	16	often	often	RB
46745	3766	17	advantageously	advantageously	RB
46745	3766	18	be	be	VB
46745	3766	19	given	give	VBN
46745	3766	20	with	with	IN
46745	3766	21	Sedatives	Sedatives	NNPS
46745	3766	22	,	,	,
46745	3766	23	which	which	WDT
46745	3766	24	they	-PRON-	PRP
46745	3766	25	very	very	RB
46745	3766	26	much	much	RB
46745	3766	27	resemble	resemble	VBP
46745	3766	28	in	in	IN
46745	3766	29	their	-PRON-	PRP$
46745	3766	30	nervous	nervous	JJ
46745	3766	31	operation	operation	NN
46745	3766	32	.	.	.
46745	3767	1	Thus	thus	RB
46745	3767	2	,	,	,
46745	3767	3	on	on	IN
46745	3767	4	the	the	DT
46745	3767	5	one	one	CD
46745	3767	6	head	head	NN
46745	3767	7	,	,	,
46745	3767	8	Brandy	Brandy	NNP
46745	3767	9	may	may	MD
46745	3767	10	be	be	VB
46745	3767	11	given	give	VBN
46745	3767	12	with	with	IN
46745	3767	13	Ammonia	Ammonia	NNP
46745	3767	14	;	;	:
46745	3767	15	on	on	IN
46745	3767	16	the	the	DT
46745	3767	17	other	other	JJ
46745	3767	18	hand	hand	NN
46745	3767	19	,	,	,
46745	3767	20	Hyoscyamus	Hyoscyamus	NNP
46745	3767	21	may	may	MD
46745	3767	22	be	be	VB
46745	3767	23	prescribed	prescribe	VBN
46745	3767	24	with	with	IN
46745	3767	25	Digitalis	Digitalis	NNP
46745	3767	26	or	or	CC
46745	3767	27	Hydrocyanic	hydrocyanic	JJ
46745	3767	28	acid	acid	NN
46745	3767	29	.	.	.
46745	3768	1	ORD	ORD	NNP
46745	3768	2	.	.	.
46745	3769	1	I.	I.	NNP
46745	3770	1	GENERAL	GENERAL	NNP
46745	3770	2	SEDATIVES	SEDATIVES	NNP
46745	3770	3	.	.	.
46745	3771	1	(	(	-LRB-
46745	3771	2	Hydrocyanic	hydrocyanic	JJ
46745	3771	3	acid	acid	NN
46745	3771	4	.	.	.
46745	3772	1	Creosote	creosote	NN
46745	3772	2	.	.	.
46745	3773	1	Aconite	aconite	JJ
46745	3773	2	.	.	.
46745	3774	1	Conium	conium	NN
46745	3774	2	.	.	.
46745	3775	1	Colchicum	Colchicum	NNP
46745	3775	2	.	.	.
46745	3776	1	Tea	tea	NN
46745	3776	2	and	and	CC
46745	3776	3	Coffee	Coffee	NNP
46745	3776	4	.	.	.
46745	3776	5	)	)	-RRB-
46745	3777	1	These	these	DT
46745	3777	2	are	be	VBP
46745	3777	3	medicines	medicine	NNS
46745	3777	4	which	which	WDT
46745	3777	5	pass	pass	VBP
46745	3777	6	into	into	IN
46745	3777	7	the	the	DT
46745	3777	8	stomach	stomach	NN
46745	3777	9	,	,	,
46745	3777	10	and	and	CC
46745	3777	11	are	be	VBP
46745	3777	12	capable	capable	JJ
46745	3777	13	of	of	IN
46745	3777	14	absorption	absorption	NN
46745	3777	15	;	;	:
46745	3777	16	which	which	WDT
46745	3777	17	are	be	VBP
46745	3777	18	absorbed	absorb	VBN
46745	3777	19	,	,	,
46745	3777	20	and	and	CC
46745	3777	21	are	be	VBP
46745	3777	22	proved	prove	VBN
46745	3777	23	to	to	TO
46745	3777	24	act	act	VB
46745	3777	25	after	after	IN
46745	3777	26	passage	passage	NN
46745	3777	27	into	into	IN
46745	3777	28	the	the	DT
46745	3777	29	blood	blood	NN
46745	3777	30	.	.	.
46745	3778	1	From	from	IN
46745	3778	2	the	the	DT
46745	3778	3	blood	blood	NN
46745	3778	4	they	-PRON-	PRP
46745	3778	5	pass	pass	VBP
46745	3778	6	to	to	IN
46745	3778	7	the	the	DT
46745	3778	8	nerves	nerve	NNS
46745	3778	9	and	and	CC
46745	3778	10	nerve	nerve	NN
46745	3778	11	-	-	HYPH
46745	3778	12	centres	centre	NNS
46745	3778	13	,	,	,
46745	3778	14	and	and	CC
46745	3778	15	on	on	IN
46745	3778	16	all	all	DT
46745	3778	17	of	of	IN
46745	3778	18	them	-PRON-	PRP
46745	3778	19	alike	alike	RB
46745	3778	20	exert	exert	VBP
46745	3778	21	a	a	DT
46745	3778	22	depressing	depressing	JJ
46745	3778	23	influence	influence	NN
46745	3778	24	.	.	.
46745	3779	1	Some	some	DT
46745	3779	2	of	of	IN
46745	3779	3	them	-PRON-	PRP
46745	3779	4	are	be	VBP
46745	3779	5	much	much	RB
46745	3779	6	more	more	RBR
46745	3779	7	powerful	powerful	JJ
46745	3779	8	than	than	IN
46745	3779	9	others	other	NNS
46745	3779	10	.	.	.
46745	3780	1	They	-PRON-	PRP
46745	3780	2	do	do	VBP
46745	3780	3	not	not	RB
46745	3780	4	exert	exert	VB
46745	3780	5	any	any	DT
46745	3780	6	primary	primary	JJ
46745	3780	7	stimulant	stimulant	NN
46745	3780	8	effect	effect	NN
46745	3780	9	,	,	,
46745	3780	10	or	or	CC
46745	3780	11	any	any	DT
46745	3780	12	action	action	NN
46745	3780	13	on	on	IN
46745	3780	14	the	the	DT
46745	3780	15	intellectual	intellectual	JJ
46745	3780	16	part	part	NN
46745	3780	17	of	of	IN
46745	3780	18	the	the	DT
46745	3780	19	brain	brain	NN
46745	3780	20	.	.	.
46745	3781	1	Most	Most	JJS
46745	3781	2	of	of	IN
46745	3781	3	them	-PRON-	PRP
46745	3781	4	have	have	VBP
46745	3781	5	special	special	JJ
46745	3781	6	actions	action	NNS
46745	3781	7	and	and	CC
46745	3781	8	tendencies	tendency	NNS
46745	3781	9	.	.	.
46745	3782	1	Hydrocyanic	hydrocyanic	JJ
46745	3782	2	acid	acid	NN
46745	3782	3	is	be	VBZ
46745	3782	4	a	a	DT
46745	3782	5	powerful	powerful	JJ
46745	3782	6	and	and	CC
46745	3782	7	dangerous	dangerous	JJ
46745	3782	8	medicine	medicine	NN
46745	3782	9	.	.	.
46745	3783	1	In	in	IN
46745	3783	2	large	large	JJ
46745	3783	3	doses	dose	NNS
46745	3783	4	it	-PRON-	PRP
46745	3783	5	very	very	RB
46745	3783	6	rapidly	rapidly	RB
46745	3783	7	takes	take	VBZ
46745	3783	8	effect	effect	NN
46745	3783	9	,	,	,
46745	3783	10	producing	produce	VBG
46745	3783	11	convulsions	convulsion	NNS
46745	3783	12	,	,	,
46745	3783	13	syncope	syncope	NN
46745	3783	14	,	,	,
46745	3783	15	and	and	CC
46745	3783	16	death	death	NN
46745	3783	17	.	.	.
46745	3784	1	In	in	IN
46745	3784	2	small	small	JJ
46745	3784	3	doses	dose	NNS
46745	3784	4	it	-PRON-	PRP
46745	3784	5	is	be	VBZ
46745	3784	6	anodyne	anodyne	NN
46745	3784	7	,	,	,
46745	3784	8	and	and	CC
46745	3784	9	antispasmodic	antispasmodic	JJ
46745	3784	10	.	.	.
46745	3785	1	It	-PRON-	PRP
46745	3785	2	is	be	VBZ
46745	3785	3	considered	consider	VBN
46745	3785	4	especially	especially	RB
46745	3785	5	to	to	TO
46745	3785	6	influence	influence	VB
46745	3785	7	the	the	DT
46745	3785	8	reflex	reflex	JJ
46745	3785	9	spinal	spinal	JJ
46745	3785	10	system	system	NN
46745	3785	11	,	,	,
46745	3785	12	and	and	CC
46745	3785	13	by	by	IN
46745	3785	14	this	this	DT
46745	3785	15	means	means	NN
46745	3785	16	may	may	MD
46745	3785	17	allay	allay	VB
46745	3785	18	convulsive	convulsive	NN
46745	3785	19	cough	cough	NN
46745	3785	20	,	,	,
46745	3785	21	and	and	CC
46745	3785	22	quiet	quiet	JJ
46745	3785	23	spasmodic	spasmodic	JJ
46745	3785	24	movement	movement	NN
46745	3785	25	.	.	.
46745	3786	1	It	-PRON-	PRP
46745	3786	2	is	be	VBZ
46745	3786	3	very	very	RB
46745	3786	4	useful	useful	JJ
46745	3786	5	in	in	IN
46745	3786	6	Gastrodynia	Gastrodynia	NNP
46745	3786	7	,	,	,
46745	3786	8	and	and	CC
46745	3786	9	appears	appear	VBZ
46745	3786	10	then	then	RB
46745	3786	11	to	to	TO
46745	3786	12	act	act	VB
46745	3786	13	locally	locally	RB
46745	3786	14	upon	upon	IN
46745	3786	15	the	the	DT
46745	3786	16	painful	painful	JJ
46745	3786	17	and	and	CC
46745	3786	18	irritable	irritable	JJ
46745	3786	19	nerves	nerve	NNS
46745	3786	20	of	of	IN
46745	3786	21	the	the	DT
46745	3786	22	stomach	stomach	NN
46745	3786	23	.	.	.
46745	3787	1	Creosote	creosote	NN
46745	3787	2	stands	stand	VBZ
46745	3787	3	,	,	,
46745	3787	4	as	as	IN
46745	3787	5	a	a	DT
46745	3787	6	medicine	medicine	NN
46745	3787	7	,	,	,
46745	3787	8	between	between	IN
46745	3787	9	Hydrocyanic	hydrocyanic	JJ
46745	3787	10	acid	acid	NN
46745	3787	11	and	and	CC
46745	3787	12	Turpentine	turpentine	NN
46745	3787	13	.	.	.
46745	3788	1	It	-PRON-	PRP
46745	3788	2	has	have	VBZ
46745	3788	3	a	a	DT
46745	3788	4	double	double	JJ
46745	3788	5	action	action	NN
46745	3788	6	;	;	:
46745	3788	7	being	be	VBG
46745	3788	8	anodyne	anodyne	NNP
46745	3788	9	,	,	,
46745	3788	10	like	like	IN
46745	3788	11	the	the	DT
46745	3788	12	former	former	JJ
46745	3788	13	;	;	:
46745	3788	14	and	and	CC
46745	3788	15	a	a	DT
46745	3788	16	mucous	mucous	JJ
46745	3788	17	stimulant	stimulant	NN
46745	3788	18	,	,	,
46745	3788	19	like	like	IN
46745	3788	20	the	the	DT
46745	3788	21	latter	latter	JJ
46745	3788	22	.	.	.
46745	3789	1	Moreover	moreover	RB
46745	3789	2	,	,	,
46745	3789	3	it	-PRON-	PRP
46745	3789	4	is	be	VBZ
46745	3789	5	a	a	DT
46745	3789	6	true	true	JJ
46745	3789	7	Astringent	Astringent	NNP
46745	3789	8	,	,	,
46745	3789	9	which	which	WDT
46745	3789	10	can	can	MD
46745	3789	11	not	not	RB
46745	3789	12	be	be	VB
46745	3789	13	said	say	VBN
46745	3789	14	of	of	IN
46745	3789	15	Turpentine	Turpentine	NNP
46745	3789	16	.	.	.
46745	3790	1	It	-PRON-	PRP
46745	3790	2	is	be	VBZ
46745	3790	3	not	not	RB
46745	3790	4	powerful	powerful	JJ
46745	3790	5	as	as	IN
46745	3790	6	a	a	DT
46745	3790	7	Sedative	Sedative	NNP
46745	3790	8	,	,	,
46745	3790	9	but	but	CC
46745	3790	10	its	-PRON-	PRP$
46745	3790	11	peculiarity	peculiarity	NN
46745	3790	12	of	of	IN
46745	3790	13	action	action	NN
46745	3790	14	often	often	RB
46745	3790	15	renders	render	VBZ
46745	3790	16	it	-PRON-	PRP
46745	3790	17	useful	useful	JJ
46745	3790	18	in	in	IN
46745	3790	19	Gastrodynia	Gastrodynia	NNP
46745	3790	20	.	.	.
46745	3791	1	It	-PRON-	PRP
46745	3791	2	is	be	VBZ
46745	3791	3	particularly	particularly	RB
46745	3791	4	applicable	applicable	JJ
46745	3791	5	when	when	WRB
46745	3791	6	pain	pain	NN
46745	3791	7	in	in	IN
46745	3791	8	the	the	DT
46745	3791	9	stomach	stomach	NN
46745	3791	10	is	be	VBZ
46745	3791	11	accompanied	accompany	VBN
46745	3791	12	with	with	IN
46745	3791	13	a	a	DT
46745	3791	14	tendency	tendency	NN
46745	3791	15	to	to	TO
46745	3791	16	hæmorrhage	hæmorrhage	VB
46745	3791	17	,	,	,
46745	3791	18	or	or	CC
46745	3791	19	with	with	IN
46745	3791	20	a	a	DT
46745	3791	21	probable	probable	JJ
46745	3791	22	relaxation	relaxation	NN
46745	3791	23	of	of	IN
46745	3791	24	the	the	DT
46745	3791	25	mucous	mucous	JJ
46745	3791	26	coat	coat	NN
46745	3791	27	.	.	.
46745	3792	1	Aconite	Aconite	NNP
46745	3792	2	is	be	VBZ
46745	3792	3	a	a	DT
46745	3792	4	powerful	powerful	JJ
46745	3792	5	anæsthetic	anæsthetic	NN
46745	3792	6	to	to	IN
46745	3792	7	the	the	DT
46745	3792	8	superficial	superficial	JJ
46745	3792	9	sensory	sensory	JJ
46745	3792	10	nerves	nerve	NNS
46745	3792	11	.	.	.
46745	3793	1	When	when	WRB
46745	3793	2	applied	apply	VBN
46745	3793	3	in	in	IN
46745	3793	4	solution	solution	NN
46745	3793	5	or	or	CC
46745	3793	6	ointment	ointment	NN
46745	3793	7	to	to	IN
46745	3793	8	the	the	DT
46745	3793	9	surface	surface	NN
46745	3793	10	of	of	IN
46745	3793	11	the	the	DT
46745	3793	12	skin	skin	NN
46745	3793	13	,	,	,
46745	3793	14	it	-PRON-	PRP
46745	3793	15	produces	produce	VBZ
46745	3793	16	first	first	RB
46745	3793	17	some	some	DT
46745	3793	18	heat	heat	NN
46745	3793	19	and	and	CC
46745	3793	20	tingling	tingling	NN
46745	3793	21	,	,	,
46745	3793	22	which	which	WDT
46745	3793	23	is	be	VBZ
46745	3793	24	attributable	attributable	JJ
46745	3793	25	to	to	IN
46745	3793	26	a	a	DT
46745	3793	27	derangement	derangement	NN
46745	3793	28	of	of	IN
46745	3793	29	the	the	DT
46745	3793	30	nervous	nervous	JJ
46745	3793	31	influence	influence	NN
46745	3793	32	;	;	,
46745	3793	33	and	and	CC
46745	3793	34	this	this	DT
46745	3793	35	is	be	VBZ
46745	3793	36	succeeded	succeed	VBN
46745	3793	37	by	by	IN
46745	3793	38	perfect	perfect	JJ
46745	3793	39	numbness	numbness	NN
46745	3793	40	.	.	.
46745	3794	1	It	-PRON-	PRP
46745	3794	2	is	be	VBZ
46745	3794	3	thus	thus	RB
46745	3794	4	a	a	DT
46745	3794	5	most	most	RBS
46745	3794	6	valuable	valuable	JJ
46745	3794	7	topical	topical	JJ
46745	3794	8	remedy	remedy	NN
46745	3794	9	in	in	IN
46745	3794	10	true	true	JJ
46745	3794	11	irritative	irritative	JJ
46745	3794	12	Neuralgia	Neuralgia	NNP
46745	3794	13	.	.	.
46745	3795	1	Other	other	JJ
46745	3795	2	Sedatives	Sedatives	NNPS
46745	3795	3	and	and	CC
46745	3795	4	Narcotics	Narcotics	NNP
46745	3795	5	have	have	VBP
46745	3795	6	the	the	DT
46745	3795	7	same	same	JJ
46745	3795	8	power	power	NN
46745	3795	9	as	as	IN
46745	3795	10	topical	topical	JJ
46745	3795	11	anodynes	anodyne	NNS
46745	3795	12	,	,	,
46745	3795	13	but	but	CC
46745	3795	14	not	not	RB
46745	3795	15	in	in	IN
46745	3795	16	so	so	RB
46745	3795	17	marked	mark	VBN
46745	3795	18	a	a	DT
46745	3795	19	degree	degree	NN
46745	3795	20	.	.	.
46745	3796	1	In	in	IN
46745	3796	2	large	large	JJ
46745	3796	3	doses	dose	NNS
46745	3796	4	Aconite	Aconite	NNP
46745	3796	5	is	be	VBZ
46745	3796	6	a	a	DT
46745	3796	7	General	General	NNP
46745	3796	8	Sedative	Sedative	NNP
46745	3796	9	;	;	,
46745	3796	10	producing	produce	VBG
46745	3796	11	tingling	tingling	NN
46745	3796	12	of	of	IN
46745	3796	13	the	the	DT
46745	3796	14	extremities	extremity	NNS
46745	3796	15	,	,	,
46745	3796	16	vomiting	vomiting	NN
46745	3796	17	,	,	,
46745	3796	18	and	and	CC
46745	3796	19	syncope	syncope	VB
46745	3796	20	;	;	:
46745	3796	21	and	and	CC
46745	3796	22	affecting	affect	VBG
46745	3796	23	the	the	DT
46745	3796	24	brain	brain	NN
46745	3796	25	in	in	IN
46745	3796	26	various	various	JJ
46745	3796	27	ways	way	NNS
46745	3796	28	,	,	,
46745	3796	29	as	as	IN
46745	3796	30	will	will	MD
46745	3796	31	be	be	VB
46745	3796	32	shown	show	VBN
46745	3796	33	by	by	IN
46745	3796	34	some	some	DT
46745	3796	35	experiments	experiment	NNS
46745	3796	36	which	which	WDT
46745	3796	37	I	-PRON-	PRP
46745	3796	38	have	have	VBP
46745	3796	39	made	make	VBN
46745	3796	40	upon	upon	IN
46745	3796	41	its	-PRON-	PRP$
46745	3796	42	action	action	NN
46745	3796	43	,	,	,
46745	3796	44	to	to	TO
46745	3796	45	be	be	VB
46745	3796	46	detailed	detail	VBN
46745	3796	47	in	in	IN
46745	3796	48	the	the	DT
46745	3796	49	fourth	fourth	JJ
46745	3796	50	chapter	chapter	NN
46745	3796	51	.	.	.
46745	3797	1	An	an	DT
46745	3797	2	alkaloid	alkaloid	NN
46745	3797	3	called	call	VBN
46745	3797	4	Aconitina	Aconitina	NNP
46745	3797	5	,	,	,
46745	3797	6	the	the	DT
46745	3797	7	most	most	RBS
46745	3797	8	powerful	powerful	JJ
46745	3797	9	of	of	IN
46745	3797	10	all	all	DT
46745	3797	11	known	know	VBN
46745	3797	12	medicines	medicine	NNS
46745	3797	13	,	,	,
46745	3797	14	is	be	VBZ
46745	3797	15	the	the	DT
46745	3797	16	active	active	JJ
46745	3797	17	principle	principle	NN
46745	3797	18	of	of	IN
46745	3797	19	this	this	DT
46745	3797	20	drug	drug	NN
46745	3797	21	.	.	.
46745	3798	1	Conium	Conium	NNP
46745	3798	2	(	(	-LRB-
46745	3798	3	Hemlock	Hemlock	NNP
46745	3798	4	)	)	-RRB-
46745	3798	5	also	also	RB
46745	3798	6	owes	owe	VBZ
46745	3798	7	its	-PRON-	PRP$
46745	3798	8	properties	property	NNS
46745	3798	9	to	to	IN
46745	3798	10	the	the	DT
46745	3798	11	alkaloid	alkaloid	NN
46745	3798	12	Conia	Conia	NNP
46745	3798	13	.	.	.
46745	3799	1	Dr.	Dr.	NNP
46745	3799	2	Christison	Christison	NNP
46745	3799	3	has	have	VBZ
46745	3799	4	made	make	VBN
46745	3799	5	some	some	DT
46745	3799	6	experiments	experiment	NNS
46745	3799	7	upon	upon	IN
46745	3799	8	the	the	DT
46745	3799	9	latter	latter	JJ
46745	3799	10	.	.	.
46745	3800	1	He	-PRON-	PRP
46745	3800	2	found	find	VBD
46745	3800	3	that	that	IN
46745	3800	4	it	-PRON-	PRP
46745	3800	5	produced	produce	VBD
46745	3800	6	swiftly	swiftly	RB
46745	3800	7	-	-	HYPH
46745	3800	8	spreading	spread	VBG
46745	3800	9	paralysis	paralysis	NN
46745	3800	10	of	of	IN
46745	3800	11	the	the	DT
46745	3800	12	motor	motor	NN
46745	3800	13	nerves	nerve	NNS
46745	3800	14	;	;	:
46745	3800	15	and	and	CC
46745	3800	16	he	-PRON-	PRP
46745	3800	17	considers	consider	VBZ
46745	3800	18	it	-PRON-	PRP
46745	3800	19	to	to	TO
46745	3800	20	act	act	VB
46745	3800	21	particularly	particularly	RB
46745	3800	22	as	as	IN
46745	3800	23	a	a	DT
46745	3800	24	Sedative	Sedative	NNP
46745	3800	25	to	to	IN
46745	3800	26	the	the	DT
46745	3800	27	reflex	reflex	JJ
46745	3800	28	spinal	spinal	JJ
46745	3800	29	functions	function	NNS
46745	3800	30	.	.	.
46745	3801	1	It	-PRON-	PRP
46745	3801	2	also	also	RB
46745	3801	3	paralyzes	paralyze	VBZ
46745	3801	4	the	the	DT
46745	3801	5	sensory	sensory	JJ
46745	3801	6	nerves	nerve	NNS
46745	3801	7	,	,	,
46745	3801	8	but	but	CC
46745	3801	9	in	in	IN
46745	3801	10	a	a	DT
46745	3801	11	less	less	JJR
46745	3801	12	degree	degree	NN
46745	3801	13	.	.	.
46745	3802	1	Conium	conium	NN
46745	3802	2	is	be	VBZ
46745	3802	3	certainly	certainly	RB
46745	3802	4	anodyne	anodyne	NN
46745	3802	5	;	;	:
46745	3802	6	and	and	CC
46745	3802	7	produces	produce	VBZ
46745	3802	8	often	often	RB
46745	3802	9	a	a	DT
46745	3802	10	sedative	sedative	JJ
46745	3802	11	action	action	NN
46745	3802	12	on	on	IN
46745	3802	13	the	the	DT
46745	3802	14	heart	heart	NN
46745	3802	15	.	.	.
46745	3803	1	It	-PRON-	PRP
46745	3803	2	would	would	MD
46745	3803	3	thus	thus	RB
46745	3803	4	appear	appear	VB
46745	3803	5	to	to	TO
46745	3803	6	be	be	VB
46745	3803	7	a	a	DT
46745	3803	8	General	General	NNP
46745	3803	9	Sedative	Sedative	NNP
46745	3803	10	.	.	.
46745	3804	1	But	but	CC
46745	3804	2	in	in	IN
46745	3804	3	some	some	DT
46745	3804	4	recorded	record	VBN
46745	3804	5	cases	case	NNS
46745	3804	6	of	of	IN
46745	3804	7	poisoning	poisoning	NN
46745	3804	8	by	by	IN
46745	3804	9	Hemlock	Hemlock	NNP
46745	3804	10	,	,	,
46745	3804	11	coma	coma	NN
46745	3804	12	has	have	VBZ
46745	3804	13	been	be	VBN
46745	3804	14	mentioned	mention	VBN
46745	3804	15	as	as	IN
46745	3804	16	a	a	DT
46745	3804	17	leading	leading	JJ
46745	3804	18	symptom	symptom	NN
46745	3804	19	.	.	.
46745	3805	1	Were	be	VBD
46745	3805	2	this	this	DT
46745	3805	3	to	to	TO
46745	3805	4	be	be	VB
46745	3805	5	authenticated	authenticate	VBN
46745	3805	6	,	,	,
46745	3805	7	and	and	CC
46745	3805	8	shown	show	VBN
46745	3805	9	to	to	TO
46745	3805	10	be	be	VB
46745	3805	11	the	the	DT
46745	3805	12	invariable	invariable	JJ
46745	3805	13	result	result	NN
46745	3805	14	of	of	IN
46745	3805	15	the	the	DT
46745	3805	16	action	action	NN
46745	3805	17	of	of	IN
46745	3805	18	this	this	DT
46745	3805	19	medicine	medicine	NN
46745	3805	20	in	in	IN
46745	3805	21	large	large	JJ
46745	3805	22	doses	dose	NNS
46745	3805	23	,	,	,
46745	3805	24	then	then	RB
46745	3805	25	it	-PRON-	PRP
46745	3805	26	ought	ought	MD
46745	3805	27	certainly	certainly	RB
46745	3805	28	to	to	TO
46745	3805	29	be	be	VB
46745	3805	30	classed	class	VBN
46745	3805	31	among	among	IN
46745	3805	32	Narcotics	Narcotics	NNP
46745	3805	33	.	.	.
46745	3806	1	Dr.	Dr.	NNP
46745	3806	2	Pereira	Pereira	NNP
46745	3806	3	considers	consider	VBZ
46745	3806	4	it	-PRON-	PRP
46745	3806	5	likely	likely	JJ
46745	3806	6	that	that	IN
46745	3806	7	the	the	DT
46745	3806	8	plant	plant	NN
46745	3806	9	contains	contain	VBZ
46745	3806	10	more	more	JJR
46745	3806	11	than	than	IN
46745	3806	12	one	one	CD
46745	3806	13	active	active	JJ
46745	3806	14	principle	principle	NN
46745	3806	15	.	.	.
46745	3807	1	Hemlock	Hemlock	NNP
46745	3807	2	has	have	VBZ
46745	3807	3	a	a	DT
46745	3807	4	paralyzing	paralyzing	NN
46745	3807	5	action	action	NN
46745	3807	6	on	on	IN
46745	3807	7	the	the	DT
46745	3807	8	nerves	nerve	NNS
46745	3807	9	of	of	IN
46745	3807	10	motion	motion	NN
46745	3807	11	,	,	,
46745	3807	12	which	which	WDT
46745	3807	13	is	be	VBZ
46745	3807	14	directly	directly	RB
46745	3807	15	the	the	DT
46745	3807	16	reverse	reverse	NN
46745	3807	17	of	of	IN
46745	3807	18	the	the	DT
46745	3807	19	stimulating	stimulating	JJ
46745	3807	20	action	action	NN
46745	3807	21	of	of	IN
46745	3807	22	Strychnia	Strychnia	NNP
46745	3807	23	;	;	:
46745	3807	24	and	and	CC
46745	3807	25	is	be	VBZ
46745	3807	26	thus	thus	RB
46745	3807	27	of	of	IN
46745	3807	28	use	use	NN
46745	3807	29	in	in	IN
46745	3807	30	cases	case	NNS
46745	3807	31	of	of	IN
46745	3807	32	convulsion	convulsion	NN
46745	3807	33	and	and	CC
46745	3807	34	spasm	spasm	NN
46745	3807	35	.	.	.
46745	3808	1	It	-PRON-	PRP
46745	3808	2	is	be	VBZ
46745	3808	3	also	also	RB
46745	3808	4	often	often	RB
46745	3808	5	prescribed	prescribe	VBN
46745	3808	6	as	as	IN
46745	3808	7	an	an	DT
46745	3808	8	anodyne	anodyne	NN
46745	3808	9	.	.	.
46745	3809	1	Conium	conium	NN
46745	3809	2	is	be	VBZ
46745	3809	3	further	further	RB
46745	3809	4	said	say	VBN
46745	3809	5	to	to	TO
46745	3809	6	have	have	VB
46745	3809	7	a	a	DT
46745	3809	8	curious	curious	JJ
46745	3809	9	resolvent	resolvent	NN
46745	3809	10	power	power	NN
46745	3809	11	over	over	IN
46745	3809	12	glandular	glandular	JJ
46745	3809	13	enlargements	enlargement	NNS
46745	3809	14	,	,	,
46745	3809	15	and	and	CC
46745	3809	16	to	to	TO
46745	3809	17	have	have	VB
46745	3809	18	thus	thus	RB
46745	3809	19	frequently	frequently	RB
46745	3809	20	caused	cause	VBN
46745	3809	21	their	-PRON-	PRP$
46745	3809	22	absorption	absorption	NN
46745	3809	23	and	and	CC
46745	3809	24	disappearance	disappearance	NN
46745	3809	25	.	.	.
46745	3810	1	This	this	DT
46745	3810	2	action	action	NN
46745	3810	3	was	be	VBD
46745	3810	4	first	first	RB
46745	3810	5	noticed	notice	VBN
46745	3810	6	and	and	CC
46745	3810	7	described	describe	VBN
46745	3810	8	by	by	IN
46745	3810	9	Dr.	Dr.	NNP
46745	3810	10	Fothergill	Fothergill	NNP
46745	3810	11	.	.	.
46745	3811	1	All	all	DT
46745	3811	2	true	true	JJ
46745	3811	3	resolvents	resolvent	NNS
46745	3811	4	operate	operate	VBP
46745	3811	5	by	by	IN
46745	3811	6	an	an	DT
46745	3811	7	action	action	NN
46745	3811	8	in	in	IN
46745	3811	9	the	the	DT
46745	3811	10	blood	blood	NN
46745	3811	11	,	,	,
46745	3811	12	but	but	CC
46745	3811	13	it	-PRON-	PRP
46745	3811	14	is	be	VBZ
46745	3811	15	difficult	difficult	JJ
46745	3811	16	to	to	TO
46745	3811	17	conceive	conceive	VB
46745	3811	18	how	how	WRB
46745	3811	19	such	such	PDT
46745	3811	20	an	an	DT
46745	3811	21	action	action	NN
46745	3811	22	can	can	MD
46745	3811	23	be	be	VB
46745	3811	24	exerted	exert	VBN
46745	3811	25	by	by	IN
46745	3811	26	a	a	DT
46745	3811	27	nerve	nerve	NN
46745	3811	28	-	-	HYPH
46745	3811	29	medicine	medicine	NN
46745	3811	30	.	.	.
46745	3812	1	It	-PRON-	PRP
46745	3812	2	may	may	MD
46745	3812	3	possibly	possibly	RB
46745	3812	4	act	act	VB
46745	3812	5	indirectly	indirectly	RB
46745	3812	6	by	by	IN
46745	3812	7	quieting	quiet	VBG
46745	3812	8	the	the	DT
46745	3812	9	action	action	NN
46745	3812	10	of	of	IN
46745	3812	11	the	the	DT
46745	3812	12	heart	heart	NN
46745	3812	13	,	,	,
46745	3812	14	and	and	CC
46745	3812	15	controlling	control	VBG
46745	3812	16	an	an	DT
46745	3812	17	irritable	irritable	JJ
46745	3812	18	state	state	NN
46745	3812	19	of	of	IN
46745	3812	20	the	the	DT
46745	3812	21	nervous	nervous	JJ
46745	3812	22	system	system	NN
46745	3812	23	.	.	.
46745	3813	1	In	in	IN
46745	3813	2	the	the	DT
46745	3813	3	same	same	JJ
46745	3813	4	way	way	NN
46745	3813	5	Opium	Opium	NNP
46745	3813	6	often	often	RB
46745	3813	7	appears	appear	VBZ
46745	3813	8	to	to	TO
46745	3813	9	act	act	VB
46745	3813	10	as	as	IN
46745	3813	11	a	a	DT
46745	3813	12	resolvent	resolvent	NN
46745	3813	13	.	.	.
46745	3814	1	And	and	CC
46745	3814	2	it	-PRON-	PRP
46745	3814	3	is	be	VBZ
46745	3814	4	certain	certain	JJ
46745	3814	5	that	that	IN
46745	3814	6	Hemlock	Hemlock	NNP
46745	3814	7	,	,	,
46745	3814	8	when	when	WRB
46745	3814	9	used	use	VBN
46745	3814	10	for	for	IN
46745	3814	11	this	this	DT
46745	3814	12	purpose	purpose	NN
46745	3814	13	,	,	,
46745	3814	14	very	very	RB
46745	3814	15	often	often	RB
46745	3814	16	fails	fail	VBZ
46745	3814	17	altogether	altogether	RB
46745	3814	18	.	.	.
46745	3815	1	It	-PRON-	PRP
46745	3815	2	has	have	VBZ
46745	3815	3	been	be	VBN
46745	3815	4	wrongfully	wrongfully	RB
46745	3815	5	extolled	extoll	VBN
46745	3815	6	as	as	IN
46745	3815	7	a	a	DT
46745	3815	8	panacea	panacea	NN
46745	3815	9	in	in	IN
46745	3815	10	Phthisis	Phthisis	NNP
46745	3815	11	;	;	:
46745	3815	12	but	but	CC
46745	3815	13	is	be	VBZ
46745	3815	14	in	in	IN
46745	3815	15	fact	fact	NN
46745	3815	16	of	of	IN
46745	3815	17	no	no	DT
46745	3815	18	greater	great	JJR
46745	3815	19	use	use	NN
46745	3815	20	in	in	IN
46745	3815	21	that	that	DT
46745	3815	22	disorder	disorder	NN
46745	3815	23	than	than	IN
46745	3815	24	Hyoscyamus	Hyoscyamus	NNP
46745	3815	25	,	,	,
46745	3815	26	Prussic	Prussic	NNP
46745	3815	27	acid	acid	NN
46745	3815	28	,	,	,
46745	3815	29	and	and	CC
46745	3815	30	other	other	JJ
46745	3815	31	medicines	medicine	NNS
46745	3815	32	which	which	WDT
46745	3815	33	reduce	reduce	VBP
46745	3815	34	the	the	DT
46745	3815	35	pulse	pulse	NN
46745	3815	36	.	.	.
46745	3816	1	For	for	IN
46745	3816	2	the	the	DT
46745	3816	3	patient	patient	NN
46745	3816	4	in	in	IN
46745	3816	5	this	this	DT
46745	3816	6	disease	disease	NN
46745	3816	7	is	be	VBZ
46745	3816	8	devoured	devour	VBN
46745	3816	9	by	by	IN
46745	3816	10	a	a	DT
46745	3816	11	continual	continual	JJ
46745	3816	12	slow	slow	JJ
46745	3816	13	fever	fever	NN
46745	3816	14	,	,	,
46745	3816	15	and	and	CC
46745	3816	16	any	any	DT
46745	3816	17	thing	thing	NN
46745	3816	18	which	which	WDT
46745	3816	19	tends	tend	VBZ
46745	3816	20	to	to	TO
46745	3816	21	lower	lower	VB
46745	3816	22	this	this	DT
46745	3816	23	fever	fever	NN
46745	3816	24	will	will	MD
46745	3816	25	serve	serve	VB
46745	3816	26	to	to	TO
46745	3816	27	prolong	prolong	VB
46745	3816	28	his	-PRON-	PRP$
46745	3816	29	existence	existence	NN
46745	3816	30	.	.	.
46745	3817	1	But	but	CC
46745	3817	2	altogether	altogether	RB
46745	3817	3	it	-PRON-	PRP
46745	3817	4	must	must	MD
46745	3817	5	be	be	VB
46745	3817	6	admitted	admit	VBN
46745	3817	7	that	that	IN
46745	3817	8	considerable	considerable	JJ
46745	3817	9	mystery	mystery	NN
46745	3817	10	attaches	attach	VBZ
46745	3817	11	to	to	IN
46745	3817	12	the	the	DT
46745	3817	13	operation	operation	NN
46745	3817	14	of	of	IN
46745	3817	15	this	this	DT
46745	3817	16	medicine	medicine	NN
46745	3817	17	.	.	.
46745	3818	1	Colchicum	Colchicum	NNP
46745	3818	2	has	have	VBZ
46745	3818	3	many	many	JJ
46745	3818	4	different	different	JJ
46745	3818	5	actions	action	NNS
46745	3818	6	.	.	.
46745	3819	1	It	-PRON-	PRP
46745	3819	2	has	have	VBZ
46745	3819	3	an	an	DT
46745	3819	4	agency	agency	NN
46745	3819	5	in	in	IN
46745	3819	6	the	the	DT
46745	3819	7	blood	blood	NN
46745	3819	8	,	,	,
46745	3819	9	being	be	VBG
46745	3819	10	Antiarthritic	antiarthritic	JJ
46745	3819	11	.	.	.
46745	3820	1	It	-PRON-	PRP
46745	3820	2	is	be	VBZ
46745	3820	3	an	an	DT
46745	3820	4	Eliminative	Eliminative	NNP
46745	3820	5	,	,	,
46745	3820	6	acting	act	VBG
46745	3820	7	on	on	IN
46745	3820	8	the	the	DT
46745	3820	9	liver	liver	NN
46745	3820	10	and	and	CC
46745	3820	11	bowels	bowel	NNS
46745	3820	12	.	.	.
46745	3821	1	And	and	CC
46745	3821	2	it	-PRON-	PRP
46745	3821	3	is	be	VBZ
46745	3821	4	also	also	RB
46745	3821	5	a	a	DT
46745	3821	6	General	General	NNP
46745	3821	7	Sedative	Sedative	NNP
46745	3821	8	.	.	.
46745	3822	1	To	to	IN
46745	3822	2	the	the	DT
46745	3822	3	combination	combination	NN
46745	3822	4	of	of	IN
46745	3822	5	an	an	DT
46745	3822	6	eliminative	eliminative	NN
46745	3822	7	with	with	IN
46745	3822	8	a	a	DT
46745	3822	9	sedative	sedative	JJ
46745	3822	10	or	or	CC
46745	3822	11	anodyne	anodyne	NN
46745	3822	12	action	action	NN
46745	3822	13	,	,	,
46745	3822	14	the	the	DT
46745	3822	15	use	use	NN
46745	3822	16	of	of	IN
46745	3822	17	Colchicum	Colchicum	NNP
46745	3822	18	in	in	IN
46745	3822	19	Gout	Gout	NNP
46745	3822	20	has	have	VBZ
46745	3822	21	been	be	VBN
46745	3822	22	,	,	,
46745	3822	23	I	-PRON-	PRP
46745	3822	24	think	think	VBP
46745	3822	25	,	,	,
46745	3822	26	erroneously	erroneously	RB
46745	3822	27	ascribed	ascribe	VBN
46745	3822	28	.	.	.
46745	3823	1	For	for	IN
46745	3823	2	in	in	IN
46745	3823	3	fact	fact	NN
46745	3823	4	it	-PRON-	PRP
46745	3823	5	seems	seem	VBZ
46745	3823	6	to	to	TO
46745	3823	7	act	act	VB
46745	3823	8	best	well	RBS
46745	3823	9	in	in	IN
46745	3823	10	this	this	DT
46745	3823	11	disorder	disorder	NN
46745	3823	12	when	when	WRB
46745	3823	13	it	-PRON-	PRP
46745	3823	14	causes	cause	VBZ
46745	3823	15	no	no	DT
46745	3823	16	purging	purging	NN
46745	3823	17	,	,	,
46745	3823	18	and	and	CC
46745	3823	19	scarcely	scarcely	RB
46745	3823	20	any	any	DT
46745	3823	21	action	action	NN
46745	3823	22	on	on	IN
46745	3823	23	the	the	DT
46745	3823	24	nerves	nerve	NNS
46745	3823	25	.	.	.
46745	3824	1	When	when	WRB
46745	3824	2	it	-PRON-	PRP
46745	3824	3	has	have	VBZ
46745	3824	4	been	be	VBN
46745	3824	5	long	long	RB
46745	3824	6	used	use	VBN
46745	3824	7	,	,	,
46745	3824	8	it	-PRON-	PRP
46745	3824	9	causes	cause	VBZ
46745	3824	10	a	a	DT
46745	3824	11	great	great	JJ
46745	3824	12	depression	depression	NN
46745	3824	13	of	of	IN
46745	3824	14	the	the	DT
46745	3824	15	spirits	spirit	NNS
46745	3824	16	,	,	,
46745	3824	17	like	like	IN
46745	3824	18	that	that	DT
46745	3824	19	which	which	WDT
46745	3824	20	may	may	MD
46745	3824	21	be	be	VB
46745	3824	22	caused	cause	VBN
46745	3824	23	by	by	IN
46745	3824	24	some	some	DT
46745	3824	25	undoubted	undoubted	JJ
46745	3824	26	blood	blood	NN
46745	3824	27	-	-	HYPH
46745	3824	28	medicines	medicine	NNS
46745	3824	29	,	,	,
46745	3824	30	as	as	IN
46745	3824	31	Mercury	Mercury	NNP
46745	3824	32	.	.	.
46745	3825	1	But	but	CC
46745	3825	2	it	-PRON-	PRP
46745	3825	3	does	do	VBZ
46745	3825	4	not	not	RB
46745	3825	5	affect	affect	VB
46745	3825	6	the	the	DT
46745	3825	7	understanding	understanding	NN
46745	3825	8	,	,	,
46745	3825	9	or	or	CC
46745	3825	10	the	the	DT
46745	3825	11	special	special	JJ
46745	3825	12	senses	sense	NNS
46745	3825	13	.	.	.
46745	3826	1	In	in	IN
46745	3826	2	poisonous	poisonous	JJ
46745	3826	3	doses	dose	NNS
46745	3826	4	it	-PRON-	PRP
46745	3826	5	depresses	depress	VBZ
46745	3826	6	the	the	DT
46745	3826	7	circulation	circulation	NN
46745	3826	8	and	and	CC
46745	3826	9	the	the	DT
46745	3826	10	nerves	nerve	NNS
46745	3826	11	generally	generally	RB
46745	3826	12	,	,	,
46745	3826	13	but	but	CC
46745	3826	14	it	-PRON-	PRP
46745	3826	15	causes	cause	VBZ
46745	3826	16	no	no	DT
46745	3826	17	stupor	stupor	NN
46745	3826	18	or	or	CC
46745	3826	19	insensibility	insensibility	NN
46745	3826	20	.	.	.
46745	3827	1	It	-PRON-	PRP
46745	3827	2	is	be	VBZ
46745	3827	3	therefore	therefore	RB
46745	3827	4	not	not	RB
46745	3827	5	a	a	DT
46745	3827	6	Narcotic	narcotic	NN
46745	3827	7	;	;	:
46745	3827	8	but	but	CC
46745	3827	9	,	,	,
46745	3827	10	like	like	IN
46745	3827	11	other	other	JJ
46745	3827	12	Sedatives	Sedatives	NNPS
46745	3827	13	,	,	,
46745	3827	14	it	-PRON-	PRP
46745	3827	15	kills	kill	VBZ
46745	3827	16	by	by	IN
46745	3827	17	syncope	syncope	NN
46745	3827	18	.	.	.
46745	3828	1	In	in	IN
46745	3828	2	the	the	DT
46745	3828	3	behaviour	behaviour	NN
46745	3828	4	of	of	IN
46745	3828	5	the	the	DT
46745	3828	6	system	system	NN
46745	3828	7	towards	towards	IN
46745	3828	8	Colchicum	Colchicum	NNP
46745	3828	9	,	,	,
46745	3828	10	Aconite	Aconite	NNP
46745	3828	11	,	,	,
46745	3828	12	Digitalis	Digitalis	NNP
46745	3828	13	,	,	,
46745	3828	14	and	and	CC
46745	3828	15	other	other	JJ
46745	3828	16	nerve	nerve	NN
46745	3828	17	-	-	HYPH
46745	3828	18	medicines	medicine	NNS
46745	3828	19	,	,	,
46745	3828	20	there	there	EX
46745	3828	21	are	be	VBP
46745	3828	22	two	two	CD
46745	3828	23	peculiarities	peculiarity	NNS
46745	3828	24	which	which	WDT
46745	3828	25	are	be	VBP
46745	3828	26	worthy	worthy	JJ
46745	3828	27	of	of	IN
46745	3828	28	remark	remark	NN
46745	3828	29	.	.	.
46745	3829	1	They	-PRON-	PRP
46745	3829	2	are	be	VBP
46745	3829	3	called	call	VBN
46745	3829	4	_	_	NNP
46745	3829	5	cumulation	cumulation	NN
46745	3829	6	_	_	NNP
46745	3829	7	and	and	CC
46745	3829	8	_	_	NNP
46745	3829	9	toleration	toleration	NN
46745	3829	10	_	_	NNP
46745	3829	11	.	.	.
46745	3830	1	Some	some	DT
46745	3830	2	quantity	quantity	NN
46745	3830	3	of	of	IN
46745	3830	4	the	the	DT
46745	3830	5	medicine	medicine	NN
46745	3830	6	may	may	MD
46745	3830	7	often	often	RB
46745	3830	8	be	be	VB
46745	3830	9	given	give	VBN
46745	3830	10	,	,	,
46745	3830	11	in	in	IN
46745	3830	12	repeated	repeat	VBN
46745	3830	13	doses	dose	NNS
46745	3830	14	for	for	IN
46745	3830	15	some	some	DT
46745	3830	16	time	time	NN
46745	3830	17	together	together	RB
46745	3830	18	,	,	,
46745	3830	19	without	without	IN
46745	3830	20	any	any	DT
46745	3830	21	apparent	apparent	JJ
46745	3830	22	result	result	NN
46745	3830	23	.	.	.
46745	3831	1	It	-PRON-	PRP
46745	3831	2	seems	seem	VBZ
46745	3831	3	to	to	TO
46745	3831	4	remain	remain	VB
46745	3831	5	in	in	IN
46745	3831	6	the	the	DT
46745	3831	7	blood	blood	NN
46745	3831	8	,	,	,
46745	3831	9	and	and	CC
46745	3831	10	to	to	TO
46745	3831	11	become	become	VB
46745	3831	12	accumulated	accumulated	JJ
46745	3831	13	or	or	CC
46745	3831	14	stored	store	VBN
46745	3831	15	up	up	RP
46745	3831	16	there	there	RB
46745	3831	17	.	.	.
46745	3832	1	But	but	CC
46745	3832	2	all	all	DT
46745	3832	3	on	on	RB
46745	3832	4	a	a	DT
46745	3832	5	sudden	sudden	JJ
46745	3832	6	it	-PRON-	PRP
46745	3832	7	breaks	break	VBZ
46745	3832	8	out	out	RP
46745	3832	9	,	,	,
46745	3832	10	appearing	appear	VBG
46745	3832	11	to	to	TO
46745	3832	12	be	be	VB
46745	3832	13	discharged	discharge	VBN
46745	3832	14	on	on	IN
46745	3832	15	the	the	DT
46745	3832	16	nerves	nerve	NNS
46745	3832	17	,	,	,
46745	3832	18	and	and	CC
46745	3832	19	may	may	MD
46745	3832	20	produce	produce	VB
46745	3832	21	very	very	RB
46745	3832	22	dangerous	dangerous	JJ
46745	3832	23	symptoms	symptom	NNS
46745	3832	24	.	.	.
46745	3833	1	This	this	DT
46745	3833	2	_	_	NNP
46745	3833	3	cumulative	cumulative	JJ
46745	3833	4	_	_	NNP
46745	3833	5	action	action	NN
46745	3833	6	is	be	VBZ
46745	3833	7	especially	especially	RB
46745	3833	8	observed	observe	VBN
46745	3833	9	of	of	IN
46745	3833	10	Digitalis	Digitalis	NNP
46745	3833	11	,	,	,
46745	3833	12	and	and	CC
46745	3833	13	therefore	therefore	RB
46745	3833	14	considerable	considerable	JJ
46745	3833	15	care	care	NN
46745	3833	16	is	be	VBZ
46745	3833	17	required	require	VBN
46745	3833	18	in	in	IN
46745	3833	19	the	the	DT
46745	3833	20	exhibition	exhibition	NN
46745	3833	21	of	of	IN
46745	3833	22	that	that	DT
46745	3833	23	medicine	medicine	NN
46745	3833	24	.	.	.
46745	3834	1	This	this	DT
46745	3834	2	medicine	medicine	NN
46745	3834	3	is	be	VBZ
46745	3834	4	a	a	DT
46745	3834	5	Special	Special	NNP
46745	3834	6	Sedative	Sedative	NNP
46745	3834	7	,	,	,
46745	3834	8	and	and	CC
46745	3834	9	will	will	MD
46745	3834	10	be	be	VB
46745	3834	11	presently	presently	RB
46745	3834	12	considered	consider	VBN
46745	3834	13	as	as	IN
46745	3834	14	such	such	JJ
46745	3834	15	.	.	.
46745	3835	1	In	in	IN
46745	3835	2	other	other	JJ
46745	3835	3	cases	case	NNS
46745	3835	4	we	-PRON-	PRP
46745	3835	5	find	find	VBP
46745	3835	6	that	that	IN
46745	3835	7	the	the	DT
46745	3835	8	nervous	nervous	JJ
46745	3835	9	system	system	NN
46745	3835	10	becomes	become	VBZ
46745	3835	11	by	by	IN
46745	3835	12	degrees	degree	NNS
46745	3835	13	inured	inure	VBN
46745	3835	14	to	to	IN
46745	3835	15	the	the	DT
46745	3835	16	effect	effect	NN
46745	3835	17	of	of	IN
46745	3835	18	a	a	DT
46745	3835	19	particular	particular	JJ
46745	3835	20	medicine	medicine	NN
46745	3835	21	,	,	,
46745	3835	22	and	and	CC
46745	3835	23	suffers	suffer	VBZ
46745	3835	24	less	less	RBR
46745	3835	25	by	by	IN
46745	3835	26	its	-PRON-	PRP$
46745	3835	27	presence	presence	NN
46745	3835	28	than	than	IN
46745	3835	29	it	-PRON-	PRP
46745	3835	30	did	do	VBD
46745	3835	31	at	at	IN
46745	3835	32	first	first	RB
46745	3835	33	.	.	.
46745	3836	1	This	this	DT
46745	3836	2	is	be	VBZ
46745	3836	3	called	call	VBN
46745	3836	4	_	_	NNP
46745	3836	5	toleration	toleration	NN
46745	3836	6	_	_	NNP
46745	3836	7	.	.	.
46745	3837	1	It	-PRON-	PRP
46745	3837	2	is	be	VBZ
46745	3837	3	particularly	particularly	RB
46745	3837	4	observed	observe	VBN
46745	3837	5	of	of	IN
46745	3837	6	Colchicum	Colchicum	NNP
46745	3837	7	and	and	CC
46745	3837	8	of	of	IN
46745	3837	9	Antimony	Antimony	NNP
46745	3837	10	,	,	,
46745	3837	11	and	and	CC
46745	3837	12	of	of	IN
46745	3837	13	all	all	DT
46745	3837	14	medicines	medicine	NNS
46745	3837	15	which	which	WDT
46745	3837	16	act	act	VBP
46745	3837	17	on	on	IN
46745	3837	18	the	the	DT
46745	3837	19	Vagus	Vagus	NNP
46745	3837	20	nerve	nerve	NN
46745	3837	21	so	so	IN
46745	3837	22	as	as	IN
46745	3837	23	to	to	TO
46745	3837	24	cause	cause	VB
46745	3837	25	vomiting	vomiting	NN
46745	3837	26	.	.	.
46745	3838	1	Tea	tea	NN
46745	3838	2	and	and	CC
46745	3838	3	Coffee	Coffee	NNP
46745	3838	4	,	,	,
46745	3838	5	common	common	JJ
46745	3838	6	articles	article	NNS
46745	3838	7	of	of	IN
46745	3838	8	diet	diet	NN
46745	3838	9	,	,	,
46745	3838	10	are	be	VBP
46745	3838	11	slightly	slightly	RB
46745	3838	12	sedative	sedative	JJ
46745	3838	13	to	to	IN
46745	3838	14	the	the	DT
46745	3838	15	nervous	nervous	JJ
46745	3838	16	system	system	NN
46745	3838	17	generally	generally	RB
46745	3838	18	.	.	.
46745	3839	1	They	-PRON-	PRP
46745	3839	2	lower	lower	VBP
46745	3839	3	the	the	DT
46745	3839	4	pulse	pulse	NN
46745	3839	5	,	,	,
46745	3839	6	and	and	CC
46745	3839	7	,	,	,
46745	3839	8	by	by	IN
46745	3839	9	diminishing	diminish	VBG
46745	3839	10	congestion	congestion	NN
46745	3839	11	of	of	IN
46745	3839	12	the	the	DT
46745	3839	13	brain	brain	NN
46745	3839	14	,	,	,
46745	3839	15	tend	tend	VBP
46745	3839	16	to	to	TO
46745	3839	17	clear	clear	VB
46745	3839	18	and	and	CC
46745	3839	19	tranquilize	tranquilize	VB
46745	3839	20	the	the	DT
46745	3839	21	action	action	NN
46745	3839	22	of	of	IN
46745	3839	23	the	the	DT
46745	3839	24	mind	mind	NN
46745	3839	25	.	.	.
46745	3840	1	This	this	DT
46745	3840	2	activity	activity	NN
46745	3840	3	of	of	IN
46745	3840	4	thought	thought	NN
46745	3840	5	is	be	VBZ
46745	3840	6	endangered	endanger	VBN
46745	3840	7	by	by	IN
46745	3840	8	the	the	DT
46745	3840	9	cerebral	cerebral	JJ
46745	3840	10	congestion	congestion	NN
46745	3840	11	which	which	WDT
46745	3840	12	exists	exist	VBZ
46745	3840	13	early	early	RB
46745	3840	14	in	in	IN
46745	3840	15	the	the	DT
46745	3840	16	morning	morning	NN
46745	3840	17	,	,	,
46745	3840	18	on	on	IN
46745	3840	19	account	account	NN
46745	3840	20	of	of	IN
46745	3840	21	recent	recent	JJ
46745	3840	22	sleep,--and	sleep,--and	NNP
46745	3840	23	again	again	RB
46745	3840	24	towards	towards	IN
46745	3840	25	the	the	DT
46745	3840	26	evening	evening	NN
46745	3840	27	,	,	,
46745	3840	28	from	from	IN
46745	3840	29	the	the	DT
46745	3840	30	full	full	JJ
46745	3840	31	meal	meal	NN
46745	3840	32	of	of	IN
46745	3840	33	the	the	DT
46745	3840	34	middle	middle	NN
46745	3840	35	of	of	IN
46745	3840	36	the	the	DT
46745	3840	37	day	day	NN
46745	3840	38	.	.	.
46745	3841	1	It	-PRON-	PRP
46745	3841	2	is	be	VBZ
46745	3841	3	thus	thus	RB
46745	3841	4	at	at	IN
46745	3841	5	these	these	DT
46745	3841	6	times	time	NNS
46745	3841	7	that	that	IN
46745	3841	8	they	-PRON-	PRP
46745	3841	9	are	be	VBP
46745	3841	10	found	find	VBN
46745	3841	11	so	so	RB
46745	3841	12	useful	useful	JJ
46745	3841	13	,	,	,
46745	3841	14	and	and	CC
46745	3841	15	are	be	VBP
46745	3841	16	so	so	RB
46745	3841	17	universally	universally	RB
46745	3841	18	adopted	adopt	VBN
46745	3841	19	.	.	.
46745	3842	1	They	-PRON-	PRP
46745	3842	2	are	be	VBP
46745	3842	3	,	,	,
46745	3842	4	in	in	IN
46745	3842	5	fact	fact	NN
46745	3842	6	,	,	,
46745	3842	7	almost	almost	RB
46745	3842	8	indispensable	indispensable	JJ
46745	3842	9	to	to	IN
46745	3842	10	the	the	DT
46745	3842	11	daily	daily	JJ
46745	3842	12	existence	existence	NN
46745	3842	13	of	of	IN
46745	3842	14	civilized	civilized	JJ
46745	3842	15	man	man	NN
46745	3842	16	,	,	,
46745	3842	17	with	with	IN
46745	3842	18	whom	whom	WP
46745	3842	19	a	a	DT
46745	3842	20	continual	continual	JJ
46745	3842	21	energy	energy	NN
46745	3842	22	of	of	IN
46745	3842	23	mind	mind	NN
46745	3842	24	is	be	VBZ
46745	3842	25	a	a	DT
46745	3842	26	necessary	necessary	JJ
46745	3842	27	of	of	IN
46745	3842	28	life	life	NN
46745	3842	29	.	.	.
46745	3843	1	Infusions	infusion	NNS
46745	3843	2	of	of	IN
46745	3843	3	these	these	DT
46745	3843	4	substances	substance	NNS
46745	3843	5	,	,	,
46745	3843	6	or	or	CC
46745	3843	7	of	of	IN
46745	3843	8	materials	material	NNS
46745	3843	9	similar	similar	JJ
46745	3843	10	to	to	IN
46745	3843	11	them	-PRON-	PRP
46745	3843	12	in	in	IN
46745	3843	13	medicinal	medicinal	JJ
46745	3843	14	nature	nature	NN
46745	3843	15	,	,	,
46745	3843	16	are	be	VBP
46745	3843	17	adopted	adopt	VBN
46745	3843	18	as	as	IN
46745	3843	19	a	a	DT
46745	3843	20	daily	daily	JJ
46745	3843	21	beverage	beverage	NN
46745	3843	22	by	by	IN
46745	3843	23	all	all	DT
46745	3843	24	civilized	civilized	JJ
46745	3843	25	nations	nation	NNS
46745	3843	26	.	.	.
46745	3844	1	By	by	IN
46745	3844	2	diminishing	diminish	VBG
46745	3844	3	congestion	congestion	NN
46745	3844	4	of	of	IN
46745	3844	5	the	the	DT
46745	3844	6	brain	brain	NN
46745	3844	7	,	,	,
46745	3844	8	Tea	Tea	NNP
46745	3844	9	and	and	CC
46745	3844	10	Coffee	Coffee	NNP
46745	3844	11	have	have	VBP
46745	3844	12	not	not	RB
46745	3844	13	only	only	RB
46745	3844	14	the	the	DT
46745	3844	15	effect	effect	NN
46745	3844	16	of	of	IN
46745	3844	17	clearing	clear	VBG
46745	3844	18	the	the	DT
46745	3844	19	mind	mind	NN
46745	3844	20	,	,	,
46745	3844	21	but	but	CC
46745	3844	22	in	in	IN
46745	3844	23	large	large	JJ
46745	3844	24	quantities	quantity	NNS
46745	3844	25	they	-PRON-	PRP
46745	3844	26	induce	induce	VBP
46745	3844	27	wakefulness	wakefulness	NN
46745	3844	28	.	.	.
46745	3845	1	This	this	DT
46745	3845	2	is	be	VBZ
46745	3845	3	particularly	particularly	RB
46745	3845	4	the	the	DT
46745	3845	5	case	case	NN
46745	3845	6	with	with	IN
46745	3845	7	Coffee	Coffee	NNP
46745	3845	8	.	.	.
46745	3846	1	It	-PRON-	PRP
46745	3846	2	is	be	VBZ
46745	3846	3	not	not	RB
46745	3846	4	clear	clear	JJ
46745	3846	5	that	that	IN
46745	3846	6	Tea	Tea	NNP
46745	3846	7	,	,	,
46745	3846	8	as	as	IN
46745	3846	9	commonly	commonly	RB
46745	3846	10	drunk	drunk	JJ
46745	3846	11	,	,	,
46745	3846	12	is	be	VBZ
46745	3846	13	ever	ever	RB
46745	3846	14	unwholesome	unwholesome	JJ
46745	3846	15	.	.	.
46745	3847	1	Green	Green	NNP
46745	3847	2	Tea	tea	NN
46745	3847	3	is	be	VBZ
46745	3847	4	a	a	DT
46745	3847	5	more	more	RBR
46745	3847	6	powerful	powerful	JJ
46745	3847	7	sedative	sedative	NN
46745	3847	8	,	,	,
46745	3847	9	and	and	CC
46745	3847	10	resembles	resemble	VBZ
46745	3847	11	Coffee	Coffee	NNP
46745	3847	12	.	.	.
46745	3848	1	Coffee	coffee	NN
46745	3848	2	has	have	VBZ
46745	3848	3	a	a	DT
46745	3848	4	more	more	RBR
46745	3848	5	potent	potent	JJ
46745	3848	6	influence	influence	NN
46745	3848	7	over	over	IN
46745	3848	8	the	the	DT
46745	3848	9	mind	mind	NN
46745	3848	10	and	and	CC
46745	3848	11	nervous	nervous	JJ
46745	3848	12	system	system	NN
46745	3848	13	than	than	IN
46745	3848	14	is	be	VBZ
46745	3848	15	possessed	possess	VBN
46745	3848	16	by	by	IN
46745	3848	17	Tea	Tea	NNP
46745	3848	18	,	,	,
46745	3848	19	and	and	CC
46745	3848	20	is	be	VBZ
46745	3848	21	apt	apt	JJ
46745	3848	22	to	to	TO
46745	3848	23	disagree	disagree	VB
46745	3848	24	with	with	IN
46745	3848	25	many	many	JJ
46745	3848	26	persons	person	NNS
46745	3848	27	.	.	.
46745	3849	1	Like	like	IN
46745	3849	2	Opium	Opium	NNP
46745	3849	3	,	,	,
46745	3849	4	but	but	CC
46745	3849	5	in	in	IN
46745	3849	6	a	a	DT
46745	3849	7	far	far	RB
46745	3849	8	less	less	JJR
46745	3849	9	degree	degree	NN
46745	3849	10	,	,	,
46745	3849	11	Coffee	Coffee	NNP
46745	3849	12	tends	tend	VBZ
46745	3849	13	to	to	TO
46745	3849	14	confine	confine	VB
46745	3849	15	the	the	DT
46745	3849	16	bowels	bowel	NNS
46745	3849	17	.	.	.
46745	3850	1	By	by	IN
46745	3850	2	diminishing	diminish	VBG
46745	3850	3	the	the	DT
46745	3850	4	congestion	congestion	NN
46745	3850	5	of	of	IN
46745	3850	6	the	the	DT
46745	3850	7	brain	brain	NN
46745	3850	8	which	which	WDT
46745	3850	9	is	be	VBZ
46745	3850	10	produced	produce	VBN
46745	3850	11	by	by	IN
46745	3850	12	Opium	Opium	NNP
46745	3850	13	,	,	,
46745	3850	14	strong	strong	JJ
46745	3850	15	Coffee	Coffee	NNP
46745	3850	16	is	be	VBZ
46745	3850	17	of	of	IN
46745	3850	18	use	use	NN
46745	3850	19	in	in	IN
46745	3850	20	cases	case	NNS
46745	3850	21	of	of	IN
46745	3850	22	poisoning	poisoning	NN
46745	3850	23	by	by	IN
46745	3850	24	the	the	DT
46745	3850	25	latter	latter	JJ
46745	3850	26	substance	substance	NN
46745	3850	27	.	.	.
46745	3851	1	Tea	tea	NN
46745	3851	2	and	and	CC
46745	3851	3	Coffee	Coffee	NNP
46745	3851	4	are	be	VBP
46745	3851	5	sometimes	sometimes	RB
46745	3851	6	said	say	VBN
46745	3851	7	to	to	TO
46745	3851	8	be	be	VB
46745	3851	9	mental	mental	JJ
46745	3851	10	exhilarants	exhilarant	NNS
46745	3851	11	;	;	:
46745	3851	12	but	but	CC
46745	3851	13	they	-PRON-	PRP
46745	3851	14	only	only	RB
46745	3851	15	become	become	VBP
46745	3851	16	so	so	RB
46745	3851	17	indirectly	indirectly	RB
46745	3851	18	,	,	,
46745	3851	19	by	by	IN
46745	3851	20	removing	remove	VBG
46745	3851	21	congestion	congestion	NN
46745	3851	22	,	,	,
46745	3851	23	which	which	WDT
46745	3851	24	is	be	VBZ
46745	3851	25	a	a	DT
46745	3851	26	cause	cause	NN
46745	3851	27	of	of	IN
46745	3851	28	stupidity	stupidity	NN
46745	3851	29	.	.	.
46745	3852	1	Both	both	DT
46745	3852	2	Tea	Tea	NNP
46745	3852	3	and	and	CC
46745	3852	4	Coffee	Coffee	NNP
46745	3852	5	contain	contain	VBP
46745	3852	6	the	the	DT
46745	3852	7	alkaloid	alkaloid	NN
46745	3852	8	Theine	Theine	NNP
46745	3852	9	;	;	:
46745	3852	10	but	but	CC
46745	3852	11	it	-PRON-	PRP
46745	3852	12	is	be	VBZ
46745	3852	13	probable	probable	JJ
46745	3852	14	that	that	IN
46745	3852	15	their	-PRON-	PRP$
46745	3852	16	Neurotic	neurotic	JJ
46745	3852	17	action	action	NN
46745	3852	18	is	be	VBZ
46745	3852	19	not	not	RB
46745	3852	20	so	so	RB
46745	3852	21	much	much	JJ
46745	3852	22	owing	owing	NN
46745	3852	23	to	to	IN
46745	3852	24	this	this	DT
46745	3852	25	,	,	,
46745	3852	26	as	as	IN
46745	3852	27	to	to	IN
46745	3852	28	a	a	DT
46745	3852	29	volatile	volatile	JJ
46745	3852	30	oil	oil	NN
46745	3852	31	,	,	,
46745	3852	32	which	which	WDT
46745	3852	33	exists	exist	VBZ
46745	3852	34	in	in	IN
46745	3852	35	both	both	DT
46745	3852	36	in	in	IN
46745	3852	37	some	some	DT
46745	3852	38	quantity	quantity	NN
46745	3852	39	.	.	.
46745	3853	1	ORD	ORD	NNP
46745	3853	2	.	.	.
46745	3854	1	II	ii	CD
46745	3854	2	.	.	.
46745	3855	1	SPECIAL	SPECIAL	NNP
46745	3855	2	SEDATIVES	SEDATIVES	NNP
46745	3855	3	.	.	.
46745	3856	1	(	(	-LRB-
46745	3856	2	Antimonials	antimonial	NNS
46745	3856	3	.	.	.
46745	3857	1	Ipecacuanha	Ipecacuanha	NNP
46745	3857	2	.	.	.
46745	3858	1	Digitalis	Digitalis	NNP
46745	3858	2	.	.	.
46745	3858	3	)	)	-RRB-
46745	3859	1	These	these	DT
46745	3859	2	are	be	VBP
46745	3859	3	medicines	medicine	NNS
46745	3859	4	which	which	WDT
46745	3859	5	,	,	,
46745	3859	6	like	like	IN
46745	3859	7	the	the	DT
46745	3859	8	last	last	JJ
46745	3859	9	,	,	,
46745	3859	10	depress	depress	JJ
46745	3859	11	nervous	nervous	JJ
46745	3859	12	force	force	NN
46745	3859	13	,	,	,
46745	3859	14	yet	yet	CC
46745	3859	15	they	-PRON-	PRP
46745	3859	16	do	do	VBP
46745	3859	17	not	not	RB
46745	3859	18	exert	exert	VB
46745	3859	19	their	-PRON-	PRP$
46745	3859	20	influence	influence	NN
46745	3859	21	on	on	IN
46745	3859	22	the	the	DT
46745	3859	23	nervous	nervous	JJ
46745	3859	24	system	system	NN
46745	3859	25	as	as	IN
46745	3859	26	a	a	DT
46745	3859	27	whole	whole	NN
46745	3859	28	,	,	,
46745	3859	29	but	but	CC
46745	3859	30	only	only	RB
46745	3859	31	on	on	IN
46745	3859	32	certain	certain	JJ
46745	3859	33	parts	part	NNS
46745	3859	34	of	of	IN
46745	3859	35	it	-PRON-	PRP
46745	3859	36	.	.	.
46745	3860	1	So	so	RB
46745	3860	2	far	far	RB
46745	3860	3	they	-PRON-	PRP
46745	3860	4	resemble	resemble	VBP
46745	3860	5	Special	Special	NNP
46745	3860	6	Stimulants	Stimulants	NNPS
46745	3860	7	;	;	:
46745	3860	8	but	but	CC
46745	3860	9	their	-PRON-	PRP$
46745	3860	10	effect	effect	NN
46745	3860	11	is	be	VBZ
46745	3860	12	of	of	IN
46745	3860	13	a	a	DT
46745	3860	14	directly	directly	RB
46745	3860	15	opposite	opposite	JJ
46745	3860	16	nature	nature	NN
46745	3860	17	.	.	.
46745	3861	1	They	-PRON-	PRP
46745	3861	2	have	have	VBP
46745	3861	3	also	also	RB
46745	3861	4	no	no	DT
46745	3861	5	direct	direct	JJ
46745	3861	6	influence	influence	NN
46745	3861	7	on	on	IN
46745	3861	8	any	any	DT
46745	3861	9	part	part	NN
46745	3861	10	of	of	IN
46745	3861	11	the	the	DT
46745	3861	12	brain	brain	NN
46745	3861	13	.	.	.
46745	3862	1	Antimony	Antimony	NNP
46745	3862	2	,	,	,
46745	3862	3	Ipecacuanha	Ipecacuanha	NNP
46745	3862	4	,	,	,
46745	3862	5	and	and	CC
46745	3862	6	Digitalis	Digitalis	NNP
46745	3862	7	,	,	,
46745	3862	8	have	have	VB
46745	3862	9	each	each	DT
46745	3862	10	of	of	IN
46745	3862	11	them	-PRON-	PRP
46745	3862	12	a	a	DT
46745	3862	13	number	number	NN
46745	3862	14	of	of	IN
46745	3862	15	different	different	JJ
46745	3862	16	actions	action	NNS
46745	3862	17	.	.	.
46745	3863	1	The	the	DT
46745	3863	2	first	first	JJ
46745	3863	3	has	have	VBZ
46745	3863	4	already	already	RB
46745	3863	5	been	be	VBN
46745	3863	6	included	include	VBN
46745	3863	7	among	among	IN
46745	3863	8	Catalytic	Catalytic	NNP
46745	3863	9	Hæmatics	Hæmatics	NNPS
46745	3863	10	,	,	,
46745	3863	11	as	as	IN
46745	3863	12	tending	tend	VBG
46745	3863	13	to	to	TO
46745	3863	14	counteract	counteract	VB
46745	3863	15	in	in	IN
46745	3863	16	the	the	DT
46745	3863	17	blood	blood	NN
46745	3863	18	the	the	DT
46745	3863	19	process	process	NN
46745	3863	20	of	of	IN
46745	3863	21	inflammation	inflammation	NN
46745	3863	22	.	.	.
46745	3864	1	But	but	CC
46745	3864	2	it	-PRON-	PRP
46745	3864	3	possesses	possess	VBZ
46745	3864	4	further	further	RB
46745	3864	5	a	a	DT
46745	3864	6	Neurotic	neurotic	JJ
46745	3864	7	power	power	NN
46745	3864	8	,	,	,
46745	3864	9	by	by	IN
46745	3864	10	which	which	WDT
46745	3864	11	it	-PRON-	PRP
46745	3864	12	is	be	VBZ
46745	3864	13	gifted	gift	VBN
46745	3864	14	indirectly	indirectly	RB
46745	3864	15	with	with	IN
46745	3864	16	a	a	DT
46745	3864	17	more	more	RBR
46745	3864	18	powerful	powerful	JJ
46745	3864	19	control	control	NN
46745	3864	20	over	over	IN
46745	3864	21	acute	acute	JJ
46745	3864	22	inflammations	inflammation	NNS
46745	3864	23	than	than	IN
46745	3864	24	could	could	MD
46745	3864	25	be	be	VB
46745	3864	26	exerted	exert	VBN
46745	3864	27	by	by	IN
46745	3864	28	any	any	DT
46745	3864	29	slow	slow	RB
46745	3864	30	-	-	HYPH
46745	3864	31	acting	act	VBG
46745	3864	32	blood	blood	NN
46745	3864	33	-	-	HYPH
46745	3864	34	medicine	medicine	NN
46745	3864	35	.	.	.
46745	3865	1	It	-PRON-	PRP
46745	3865	2	is	be	VBZ
46745	3865	3	also	also	RB
46745	3865	4	Eliminative	eliminative	JJ
46745	3865	5	.	.	.
46745	3866	1	Passing	pass	VBG
46745	3866	2	out	out	IN
46745	3866	3	of	of	IN
46745	3866	4	the	the	DT
46745	3866	5	body	body	NN
46745	3866	6	through	through	IN
46745	3866	7	the	the	DT
46745	3866	8	glands	gland	NNS
46745	3866	9	of	of	IN
46745	3866	10	the	the	DT
46745	3866	11	skin	skin	NN
46745	3866	12	,	,	,
46745	3866	13	it	-PRON-	PRP
46745	3866	14	becomes	become	VBZ
46745	3866	15	a	a	DT
46745	3866	16	Diaphoretic	Diaphoretic	NNP
46745	3866	17	.	.	.
46745	3867	1	This	this	DT
46745	3867	2	may	may	MD
46745	3867	3	be	be	VB
46745	3867	4	its	-PRON-	PRP$
46745	3867	5	only	only	JJ
46745	3867	6	action	action	NN
46745	3867	7	when	when	WRB
46745	3867	8	it	-PRON-	PRP
46745	3867	9	is	be	VBZ
46745	3867	10	given	give	VBN
46745	3867	11	in	in	IN
46745	3867	12	doses	dose	NNS
46745	3867	13	too	too	RB
46745	3867	14	small	small	JJ
46745	3867	15	to	to	TO
46745	3867	16	act	act	VB
46745	3867	17	upon	upon	IN
46745	3867	18	the	the	DT
46745	3867	19	nerves	nerve	NNS
46745	3867	20	.	.	.
46745	3868	1	It	-PRON-	PRP
46745	3868	2	must	must	MD
46745	3868	3	not	not	RB
46745	3868	4	be	be	VB
46745	3868	5	confounded	confound	VBN
46745	3868	6	with	with	IN
46745	3868	7	the	the	DT
46745	3868	8	diaphoresis	diaphoresis	NN
46745	3868	9	which	which	WDT
46745	3868	10	accompanies	accompany	VBZ
46745	3868	11	the	the	DT
46745	3868	12	condition	condition	NN
46745	3868	13	of	of	IN
46745	3868	14	nausea	nausea	NN
46745	3868	15	,	,	,
46745	3868	16	and	and	CC
46745	3868	17	which	which	WDT
46745	3868	18	is	be	VBZ
46745	3868	19	probably	probably	RB
46745	3868	20	produced	produce	VBN
46745	3868	21	in	in	IN
46745	3868	22	another	another	DT
46745	3868	23	way	way	NN
46745	3868	24	.	.	.
46745	3869	1	Ipecacuanha	Ipecacuanha	NNP
46745	3869	2	is	be	VBZ
46745	3869	3	in	in	IN
46745	3869	4	the	the	DT
46745	3869	5	first	first	JJ
46745	3869	6	place	place	NN
46745	3869	7	a	a	DT
46745	3869	8	Neurotic	neurotic	JJ
46745	3869	9	,	,	,
46745	3869	10	of	of	IN
46745	3869	11	less	less	JJR
46745	3869	12	power	power	NN
46745	3869	13	than	than	IN
46745	3869	14	Antimony	Antimony	NNP
46745	3869	15	;	;	:
46745	3869	16	in	in	IN
46745	3869	17	the	the	DT
46745	3869	18	second	second	JJ
46745	3869	19	place	place	NN
46745	3869	20	an	an	DT
46745	3869	21	Eliminative	Eliminative	NNP
46745	3869	22	,	,	,
46745	3869	23	increasing	increase	VBG
46745	3869	24	expectoration	expectoration	NN
46745	3869	25	,	,	,
46745	3869	26	as	as	RB
46745	3869	27	well	well	RB
46745	3869	28	as	as	IN
46745	3869	29	Diaphoresis	Diaphoresis	NNP
46745	3869	30	.	.	.
46745	3870	1	Digitalis	Digitalis	NNP
46745	3870	2	too	too	RB
46745	3870	3	acts	act	VBZ
46745	3870	4	first	first	RB
46745	3870	5	upon	upon	IN
46745	3870	6	the	the	DT
46745	3870	7	nervous	nervous	JJ
46745	3870	8	system	system	NN
46745	3870	9	;	;	:
46745	3870	10	then	then	RB
46745	3870	11	on	on	IN
46745	3870	12	the	the	DT
46745	3870	13	kidneys	kidney	NNS
46745	3870	14	,	,	,
46745	3870	15	being	be	VBG
46745	3870	16	a	a	DT
46745	3870	17	Diuretic	Diuretic	NNP
46745	3870	18	.	.	.
46745	3871	1	But	but	CC
46745	3871	2	we	-PRON-	PRP
46745	3871	3	are	be	VBP
46745	3871	4	now	now	RB
46745	3871	5	concerned	concerned	JJ
46745	3871	6	with	with	IN
46745	3871	7	the	the	DT
46745	3871	8	special	special	JJ
46745	3871	9	Neurotic	neurotic	JJ
46745	3871	10	actions	action	NNS
46745	3871	11	of	of	IN
46745	3871	12	this	this	DT
46745	3871	13	group	group	NN
46745	3871	14	of	of	IN
46745	3871	15	medicines	medicine	NNS
46745	3871	16	.	.	.
46745	3872	1	They	-PRON-	PRP
46745	3872	2	all	all	DT
46745	3872	3	exert	exert	VBP
46745	3872	4	an	an	DT
46745	3872	5	influence	influence	NN
46745	3872	6	over	over	IN
46745	3872	7	the	the	DT
46745	3872	8	three	three	CD
46745	3872	9	functions	function	NNS
46745	3872	10	of	of	IN
46745	3872	11	respiration	respiration	NN
46745	3872	12	,	,	,
46745	3872	13	circulation	circulation	NN
46745	3872	14	,	,	,
46745	3872	15	and	and	CC
46745	3872	16	digestion	digestion	NN
46745	3872	17	.	.	.
46745	3873	1	They	-PRON-	PRP
46745	3873	2	affect	affect	VBP
46745	3873	3	the	the	DT
46745	3873	4	heart	heart	NN
46745	3873	5	,	,	,
46745	3873	6	lungs	lung	NNS
46745	3873	7	,	,	,
46745	3873	8	and	and	CC
46745	3873	9	stomach	stomach	NN
46745	3873	10	,	,	,
46745	3873	11	parts	part	NNS
46745	3873	12	which	which	WDT
46745	3873	13	are	be	VBP
46745	3873	14	supplied	supply	VBN
46745	3873	15	by	by	IN
46745	3873	16	the	the	DT
46745	3873	17	branches	branch	NNS
46745	3873	18	of	of	IN
46745	3873	19	the	the	DT
46745	3873	20	Vagus	Vagus	NNP
46745	3873	21	nerve	nerve	NN
46745	3873	22	,	,	,
46745	3873	23	as	as	RB
46745	3873	24	well	well	RB
46745	3873	25	as	as	IN
46745	3873	26	by	by	IN
46745	3873	27	the	the	DT
46745	3873	28	Sympathetic	Sympathetic	NNP
46745	3873	29	.	.	.
46745	3874	1	Their	-PRON-	PRP$
46745	3874	2	action	action	NN
46745	3874	3	is	be	VBZ
46745	3874	4	not	not	RB
46745	3874	5	an	an	DT
46745	3874	6	external	external	JJ
46745	3874	7	action	action	NN
46745	3874	8	,	,	,
46745	3874	9	for	for	IN
46745	3874	10	it	-PRON-	PRP
46745	3874	11	is	be	VBZ
46745	3874	12	produced	produce	VBN
46745	3874	13	when	when	WRB
46745	3874	14	they	-PRON-	PRP
46745	3874	15	are	be	VBP
46745	3874	16	introduced	introduce	VBN
46745	3874	17	into	into	IN
46745	3874	18	the	the	DT
46745	3874	19	blood	blood	NN
46745	3874	20	at	at	IN
46745	3874	21	any	any	DT
46745	3874	22	part	part	NN
46745	3874	23	.	.	.
46745	3875	1	Thus	thus	RB
46745	3875	2	Tartar	Tartar	NNP
46745	3875	3	Emetic	Emetic	NNP
46745	3875	4	or	or	CC
46745	3875	5	Ipecacuanha	Ipecacuanha	NNP
46745	3875	6	,	,	,
46745	3875	7	when	when	WRB
46745	3875	8	injected	inject	VBN
46745	3875	9	in	in	IN
46745	3875	10	solution	solution	NN
46745	3875	11	into	into	IN
46745	3875	12	one	one	CD
46745	3875	13	of	of	IN
46745	3875	14	the	the	DT
46745	3875	15	veins	vein	NNS
46745	3875	16	,	,	,
46745	3875	17	will	will	MD
46745	3875	18	cause	cause	VB
46745	3875	19	vomiting	vomiting	NN
46745	3875	20	.	.	.
46745	3876	1	M.	M.	NNP
46745	3876	2	Magendie	Magendie	NNP
46745	3876	3	has	have	VBZ
46745	3876	4	found	find	VBN
46745	3876	5	that	that	IN
46745	3876	6	in	in	IN
46745	3876	7	the	the	DT
46745	3876	8	case	case	NN
46745	3876	9	of	of	IN
46745	3876	10	dogs	dog	NNS
46745	3876	11	they	-PRON-	PRP
46745	3876	12	also	also	RB
46745	3876	13	produce	produce	VBP
46745	3876	14	Pneumonia	Pneumonia	NNP
46745	3876	15	.	.	.
46745	3877	1	The	the	DT
46745	3877	2	mere	mere	JJ
46745	3877	3	inhalation	inhalation	NN
46745	3877	4	of	of	IN
46745	3877	5	the	the	DT
46745	3877	6	dust	dust	NN
46745	3877	7	of	of	IN
46745	3877	8	Ipecacuanha	Ipecacuanha	NNP
46745	3877	9	has	have	VBZ
46745	3877	10	been	be	VBN
46745	3877	11	found	find	VBN
46745	3877	12	to	to	TO
46745	3877	13	act	act	VB
46745	3877	14	upon	upon	IN
46745	3877	15	the	the	DT
46745	3877	16	lungs	lung	NNS
46745	3877	17	so	so	IN
46745	3877	18	as	as	IN
46745	3877	19	to	to	TO
46745	3877	20	cause	cause	VB
46745	3877	21	Bronchitis	Bronchitis	NNP
46745	3877	22	.	.	.
46745	3878	1	These	these	DT
46745	3878	2	actions	action	NNS
46745	3878	3	,	,	,
46745	3878	4	as	as	RB
46745	3878	5	well	well	RB
46745	3878	6	as	as	IN
46745	3878	7	the	the	DT
46745	3878	8	various	various	JJ
46745	3878	9	effects	effect	NNS
46745	3878	10	which	which	WDT
46745	3878	11	are	be	VBP
46745	3878	12	found	find	VBN
46745	3878	13	to	to	TO
46745	3878	14	follow	follow	VB
46745	3878	15	the	the	DT
46745	3878	16	introduction	introduction	NN
46745	3878	17	of	of	IN
46745	3878	18	these	these	DT
46745	3878	19	medicines	medicine	NNS
46745	3878	20	into	into	IN
46745	3878	21	the	the	DT
46745	3878	22	stomach	stomach	NN
46745	3878	23	,	,	,
46745	3878	24	can	can	MD
46745	3878	25	only	only	RB
46745	3878	26	be	be	VB
46745	3878	27	explained	explain	VBN
46745	3878	28	satisfactorily	satisfactorily	RB
46745	3878	29	by	by	IN
46745	3878	30	supposing	suppose	VBG
46745	3878	31	that	that	IN
46745	3878	32	they	-PRON-	PRP
46745	3878	33	act	act	VBP
46745	3878	34	as	as	IN
46745	3878	35	Sedatives	sedative	NNS
46745	3878	36	to	to	IN
46745	3878	37	the	the	DT
46745	3878	38	branches	branch	NNS
46745	3878	39	of	of	IN
46745	3878	40	the	the	DT
46745	3878	41	Vagus	Vagus	NNP
46745	3878	42	nerve	nerve	NN
46745	3878	43	,	,	,
46745	3878	44	thereby	thereby	RB
46745	3878	45	deranging	derange	VBG
46745	3878	46	or	or	CC
46745	3878	47	destroying	destroy	VBG
46745	3878	48	the	the	DT
46745	3878	49	natural	natural	JJ
46745	3878	50	influence	influence	NN
46745	3878	51	of	of	IN
46745	3878	52	that	that	DT
46745	3878	53	nerve	nerve	NN
46745	3878	54	in	in	IN
46745	3878	55	the	the	DT
46745	3878	56	direction	direction	NN
46745	3878	57	and	and	CC
46745	3878	58	regulation	regulation	NN
46745	3878	59	of	of	IN
46745	3878	60	the	the	DT
46745	3878	61	organs	organ	NNS
46745	3878	62	which	which	WDT
46745	3878	63	it	-PRON-	PRP
46745	3878	64	supplies	supply	VBZ
46745	3878	65	.	.	.
46745	3879	1	For	for	IN
46745	3879	2	we	-PRON-	PRP
46745	3879	3	have	have	VBP
46745	3879	4	already	already	RB
46745	3879	5	seen	see	VBN
46745	3879	6	that	that	IN
46745	3879	7	the	the	DT
46745	3879	8	action	action	NN
46745	3879	9	of	of	IN
46745	3879	10	a	a	DT
46745	3879	11	Sedative	sedative	JJ
46745	3879	12	medicine	medicine	NN
46745	3879	13	is	be	VBZ
46745	3879	14	of	of	IN
46745	3879	15	such	such	PDT
46745	3879	16	a	a	DT
46745	3879	17	nature	nature	NN
46745	3879	18	as	as	IN
46745	3879	19	to	to	TO
46745	3879	20	derange	derange	VB
46745	3879	21	nervous	nervous	JJ
46745	3879	22	force	force	NN
46745	3879	23	in	in	IN
46745	3879	24	some	some	DT
46745	3879	25	cases	case	NNS
46745	3879	26	,	,	,
46745	3879	27	and	and	CC
46745	3879	28	simply	simply	RB
46745	3879	29	subdue	subdue	VB
46745	3879	30	it	-PRON-	PRP
46745	3879	31	in	in	IN
46745	3879	32	others	other	NNS
46745	3879	33	.	.	.
46745	3880	1	These	these	DT
46745	3880	2	actions	action	NNS
46745	3880	3	are	be	VBP
46745	3880	4	obviously	obviously	RB
46745	3880	5	nervous	nervous	JJ
46745	3880	6	actions	action	NNS
46745	3880	7	;	;	:
46745	3880	8	for	for	CC
46745	3880	9	they	-PRON-	PRP
46745	3880	10	are	be	VBP
46745	3880	11	quick	quick	JJ
46745	3880	12	,	,	,
46745	3880	13	sudden	sudden	JJ
46745	3880	14	,	,	,
46745	3880	15	and	and	CC
46745	3880	16	transient	transient	NN
46745	3880	17	,	,	,
46745	3880	18	and	and	CC
46745	3880	19	confined	confine	VBN
46745	3880	20	to	to	IN
46745	3880	21	parts	part	NNS
46745	3880	22	supplied	supply	VBN
46745	3880	23	by	by	IN
46745	3880	24	a	a	DT
46745	3880	25	particular	particular	JJ
46745	3880	26	nerve	nerve	NN
46745	3880	27	.	.	.
46745	3881	1	They	-PRON-	PRP
46745	3881	2	are	be	VBP
46745	3881	3	exerted	exert	VBN
46745	3881	4	upon	upon	IN
46745	3881	5	nervous	nervous	JJ
46745	3881	6	forces	force	NNS
46745	3881	7	,	,	,
46745	3881	8	and	and	CC
46745	3881	9	not	not	RB
46745	3881	10	upon	upon	IN
46745	3881	11	the	the	DT
46745	3881	12	blood	blood	NN
46745	3881	13	.	.	.
46745	3882	1	If	if	IN
46745	3882	2	then	then	RB
46745	3882	3	they	-PRON-	PRP
46745	3882	4	are	be	VBP
46745	3882	5	nervous	nervous	JJ
46745	3882	6	operations	operation	NNS
46745	3882	7	,	,	,
46745	3882	8	they	-PRON-	PRP
46745	3882	9	must	must	MD
46745	3882	10	either	either	CC
46745	3882	11	be	be	VB
46745	3882	12	directed	direct	VBN
46745	3882	13	towards	towards	IN
46745	3882	14	the	the	DT
46745	3882	15	Vagus	Vagus	NNP
46745	3882	16	,	,	,
46745	3882	17	or	or	CC
46745	3882	18	to	to	IN
46745	3882	19	the	the	DT
46745	3882	20	Sympathetic	sympathetic	JJ
46745	3882	21	nerve	nerve	NN
46745	3882	22	,	,	,
46745	3882	23	for	for	IN
46745	3882	24	these	these	DT
46745	3882	25	are	be	VBP
46745	3882	26	the	the	DT
46745	3882	27	only	only	JJ
46745	3882	28	nerves	nerve	NNS
46745	3882	29	which	which	WDT
46745	3882	30	supply	supply	VBP
46745	3882	31	the	the	DT
46745	3882	32	parts	part	NNS
46745	3882	33	influenced	influence	VBN
46745	3882	34	by	by	IN
46745	3882	35	these	these	DT
46745	3882	36	medicines	medicine	NNS
46745	3882	37	.	.	.
46745	3883	1	They	-PRON-	PRP
46745	3883	2	can	can	MD
46745	3883	3	not	not	RB
46745	3883	4	act	act	VB
46745	3883	5	upon	upon	IN
46745	3883	6	the	the	DT
46745	3883	7	Sympathetic	Sympathetic	NNP
46745	3883	8	,	,	,
46745	3883	9	for	for	IN
46745	3883	10	two	two	CD
46745	3883	11	reasons	reason	NNS
46745	3883	12	.	.	.
46745	3884	1	If	if	IN
46745	3884	2	they	-PRON-	PRP
46745	3884	3	did	do	VBD
46745	3884	4	so	so	RB
46745	3884	5	,	,	,
46745	3884	6	we	-PRON-	PRP
46745	3884	7	might	may	MD
46745	3884	8	reasonably	reasonably	RB
46745	3884	9	expect	expect	VB
46745	3884	10	that	that	IN
46745	3884	11	the	the	DT
46745	3884	12	other	other	JJ
46745	3884	13	parts	part	NNS
46745	3884	14	of	of	IN
46745	3884	15	this	this	DT
46745	3884	16	nerve	nerve	NN
46745	3884	17	would	would	MD
46745	3884	18	be	be	VB
46745	3884	19	influenced	influence	VBN
46745	3884	20	at	at	IN
46745	3884	21	the	the	DT
46745	3884	22	same	same	JJ
46745	3884	23	time	time	NN
46745	3884	24	.	.	.
46745	3885	1	But	but	CC
46745	3885	2	this	this	DT
46745	3885	3	does	do	VBZ
46745	3885	4	not	not	RB
46745	3885	5	appear	appear	VB
46745	3885	6	to	to	TO
46745	3885	7	be	be	VB
46745	3885	8	the	the	DT
46745	3885	9	case	case	NN
46745	3885	10	.	.	.
46745	3886	1	And	and	CC
46745	3886	2	again	again	RB
46745	3886	3	,	,	,
46745	3886	4	an	an	DT
46745	3886	5	action	action	NN
46745	3886	6	upon	upon	IN
46745	3886	7	the	the	DT
46745	3886	8	Sympathetic	sympathetic	JJ
46745	3886	9	nerve	nerve	NN
46745	3886	10	could	could	MD
46745	3886	11	not	not	RB
46745	3886	12	be	be	VB
46745	3886	13	suddenly	suddenly	RB
46745	3886	14	and	and	CC
46745	3886	15	violently	violently	RB
46745	3886	16	evidenced	evidence	VBN
46745	3886	17	,	,	,
46745	3886	18	for	for	IN
46745	3886	19	the	the	DT
46745	3886	20	natural	natural	JJ
46745	3886	21	action	action	NN
46745	3886	22	of	of	IN
46745	3886	23	this	this	DT
46745	3886	24	nerve	nerve	NN
46745	3886	25	is	be	VBZ
46745	3886	26	slow	slow	JJ
46745	3886	27	,	,	,
46745	3886	28	chronic	chronic	JJ
46745	3886	29	,	,	,
46745	3886	30	and	and	CC
46745	3886	31	persistent	persistent	JJ
46745	3886	32	.	.	.
46745	3887	1	At	at	IN
46745	3887	2	all	all	DT
46745	3887	3	events	event	NNS
46745	3887	4	,	,	,
46745	3887	5	the	the	DT
46745	3887	6	effects	effect	NNS
46745	3887	7	for	for	IN
46745	3887	8	which	which	WDT
46745	3887	9	they	-PRON-	PRP
46745	3887	10	are	be	VBP
46745	3887	11	used	use	VBN
46745	3887	12	could	could	MD
46745	3887	13	not	not	RB
46745	3887	14	be	be	VB
46745	3887	15	produced	produce	VBN
46745	3887	16	by	by	IN
46745	3887	17	an	an	DT
46745	3887	18	affection	affection	NN
46745	3887	19	of	of	IN
46745	3887	20	this	this	DT
46745	3887	21	nerve	nerve	NN
46745	3887	22	.	.	.
46745	3888	1	We	-PRON-	PRP
46745	3888	2	may	may	MD
46745	3888	3	therefore	therefore	RB
46745	3888	4	conclude	conclude	VB
46745	3888	5	that	that	IN
46745	3888	6	the	the	DT
46745	3888	7	action	action	NN
46745	3888	8	of	of	IN
46745	3888	9	these	these	DT
46745	3888	10	medicines	medicine	NNS
46745	3888	11	is	be	VBZ
46745	3888	12	exerted	exert	VBN
46745	3888	13	upon	upon	IN
46745	3888	14	the	the	DT
46745	3888	15	Vagus	Vagus	NNP
46745	3888	16	nerve	nerve	NN
46745	3888	17	and	and	CC
46745	3888	18	its	-PRON-	PRP$
46745	3888	19	branches	branch	NNS
46745	3888	20	.	.	.
46745	3889	1	They	-PRON-	PRP
46745	3889	2	affect	affect	VBP
46745	3889	3	the	the	DT
46745	3889	4	different	different	JJ
46745	3889	5	parts	part	NNS
46745	3889	6	of	of	IN
46745	3889	7	the	the	DT
46745	3889	8	Vagus	Vagus	NNP
46745	3889	9	nerve	nerve	NN
46745	3889	10	in	in	IN
46745	3889	11	variable	variable	JJ
46745	3889	12	proportion	proportion	NN
46745	3889	13	.	.	.
46745	3890	1	Some	some	DT
46745	3890	2	apparent	apparent	JJ
46745	3890	3	anomalies	anomaly	NNS
46745	3890	4	in	in	IN
46745	3890	5	their	-PRON-	PRP$
46745	3890	6	physiological	physiological	JJ
46745	3890	7	influence	influence	NN
46745	3890	8	may	may	MD
46745	3890	9	be	be	VB
46745	3890	10	explained	explain	VBN
46745	3890	11	by	by	IN
46745	3890	12	considering	consider	VBG
46745	3890	13	the	the	DT
46745	3890	14	peculiarities	peculiarity	NNS
46745	3890	15	which	which	WDT
46745	3890	16	attach	attach	VBP
46745	3890	17	to	to	IN
46745	3890	18	all	all	DT
46745	3890	19	sedative	sedative	JJ
46745	3890	20	actions	action	NNS
46745	3890	21	.	.	.
46745	3891	1	Thus	thus	RB
46745	3891	2	we	-PRON-	PRP
46745	3891	3	have	have	VBP
46745	3891	4	seen	see	VBN
46745	3891	5	that	that	IN
46745	3891	6	when	when	WRB
46745	3891	7	given	give	VBN
46745	3891	8	in	in	IN
46745	3891	9	large	large	JJ
46745	3891	10	doses	dose	NNS
46745	3891	11	to	to	IN
46745	3891	12	healthy	healthy	JJ
46745	3891	13	persons	person	NNS
46745	3891	14	,	,	,
46745	3891	15	Hydrocyanic	hydrocyanic	JJ
46745	3891	16	acid	acid	NN
46745	3891	17	produces	produce	VBZ
46745	3891	18	convulsions	convulsion	NNS
46745	3891	19	by	by	IN
46745	3891	20	deranging	derange	VBG
46745	3891	21	the	the	DT
46745	3891	22	reflex	reflex	JJ
46745	3891	23	spinal	spinal	JJ
46745	3891	24	functions	function	NNS
46745	3891	25	;	;	,
46745	3891	26	and	and	CC
46745	3891	27	that	that	IN
46745	3891	28	in	in	IN
46745	3891	29	convulsive	convulsive	JJ
46745	3891	30	affections	affection	NNS
46745	3891	31	,	,	,
46745	3891	32	when	when	WRB
46745	3891	33	the	the	DT
46745	3891	34	same	same	JJ
46745	3891	35	functions	function	NNS
46745	3891	36	are	be	VBP
46745	3891	37	disordered	disorder	VBN
46745	3891	38	,	,	,
46745	3891	39	the	the	DT
46745	3891	40	same	same	JJ
46745	3891	41	remedy	remedy	NN
46745	3891	42	may	may	MD
46745	3891	43	do	do	VB
46745	3891	44	good	good	NN
46745	3891	45	by	by	IN
46745	3891	46	subduing	subdue	VBG
46745	3891	47	their	-PRON-	PRP$
46745	3891	48	excited	excited	JJ
46745	3891	49	condition	condition	NN
46745	3891	50	.	.	.
46745	3892	1	On	on	IN
46745	3892	2	similar	similar	JJ
46745	3892	3	grounds	ground	NNS
46745	3892	4	,	,	,
46745	3892	5	Tartar	Tartar	NNP
46745	3892	6	Emetic	Emetic	NNP
46745	3892	7	,	,	,
46745	3892	8	injected	inject	VBN
46745	3892	9	into	into	IN
46745	3892	10	the	the	DT
46745	3892	11	veins	vein	NNS
46745	3892	12	,	,	,
46745	3892	13	may	may	MD
46745	3892	14	produce	produce	VB
46745	3892	15	Pneumonia	Pneumonia	NNP
46745	3892	16	;	;	:
46745	3892	17	and	and	CC
46745	3892	18	Ipecacuanha	Ipecacuanha	NNP
46745	3892	19	,	,	,
46745	3892	20	introduced	introduce	VBN
46745	3892	21	as	as	IN
46745	3892	22	dust	dust	NN
46745	3892	23	into	into	IN
46745	3892	24	the	the	DT
46745	3892	25	lungs	lung	NNS
46745	3892	26	,	,	,
46745	3892	27	causes	cause	VBZ
46745	3892	28	Bronchitis	Bronchitis	NNP
46745	3892	29	or	or	CC
46745	3892	30	Asthma	Asthma	NNP
46745	3892	31	;	;	:
46745	3892	32	and	and	CC
46745	3892	33	yet	yet	RB
46745	3892	34	Tartar	Tartar	NNP
46745	3892	35	Emetic	Emetic	NNP
46745	3892	36	is	be	VBZ
46745	3892	37	advantageously	advantageously	RB
46745	3892	38	employed	employ	VBN
46745	3892	39	in	in	IN
46745	3892	40	the	the	DT
46745	3892	41	cure	cure	NN
46745	3892	42	of	of	IN
46745	3892	43	Pneumonia	Pneumonia	NNP
46745	3892	44	,	,	,
46745	3892	45	and	and	CC
46745	3892	46	Ipecacuanha	Ipecacuanha	NNP
46745	3892	47	is	be	VBZ
46745	3892	48	a	a	DT
46745	3892	49	remedy	remedy	NN
46745	3892	50	for	for	IN
46745	3892	51	Bronchitis	Bronchitis	NNP
46745	3892	52	.	.	.
46745	3893	1	When	when	WRB
46745	3893	2	the	the	DT
46745	3893	3	function	function	NN
46745	3893	4	of	of	IN
46745	3893	5	the	the	DT
46745	3893	6	healthy	healthy	JJ
46745	3893	7	nerve	nerve	NN
46745	3893	8	,	,	,
46745	3893	9	or	or	CC
46745	3893	10	that	that	DT
46745	3893	11	part	part	NN
46745	3893	12	supplied	supply	VBD
46745	3893	13	to	to	IN
46745	3893	14	the	the	DT
46745	3893	15	lungs	lung	NNS
46745	3893	16	,	,	,
46745	3893	17	is	be	VBZ
46745	3893	18	deranged	derange	VBN
46745	3893	19	to	to	IN
46745	3893	20	a	a	DT
46745	3893	21	certain	certain	JJ
46745	3893	22	degree	degree	NN
46745	3893	23	,	,	,
46745	3893	24	an	an	DT
46745	3893	25	inflammation	inflammation	NN
46745	3893	26	of	of	IN
46745	3893	27	the	the	DT
46745	3893	28	mucous	mucous	JJ
46745	3893	29	membrane	membrane	NN
46745	3893	30	or	or	CC
46745	3893	31	substance	substance	NN
46745	3893	32	of	of	IN
46745	3893	33	the	the	DT
46745	3893	34	lung	lung	NN
46745	3893	35	is	be	VBZ
46745	3893	36	a	a	DT
46745	3893	37	natural	natural	JJ
46745	3893	38	result	result	NN
46745	3893	39	.	.	.
46745	3894	1	But	but	CC
46745	3894	2	when	when	WRB
46745	3894	3	these	these	DT
46745	3894	4	tissues	tissue	NNS
46745	3894	5	are	be	VBP
46745	3894	6	already	already	RB
46745	3894	7	inflamed	inflame	VBN
46745	3894	8	,	,	,
46745	3894	9	a	a	DT
46745	3894	10	course	course	NN
46745	3894	11	of	of	IN
46745	3894	12	medicine	medicine	NN
46745	3894	13	,	,	,
46745	3894	14	which	which	WDT
46745	3894	15	at	at	IN
46745	3894	16	the	the	DT
46745	3894	17	same	same	JJ
46745	3894	18	time	time	NN
46745	3894	19	subdues	subdue	VBZ
46745	3894	20	the	the	DT
46745	3894	21	action	action	NN
46745	3894	22	of	of	IN
46745	3894	23	the	the	DT
46745	3894	24	heart	heart	NN
46745	3894	25	,	,	,
46745	3894	26	and	and	CC
46745	3894	27	represses	repress	VBZ
46745	3894	28	the	the	DT
46745	3894	29	irritability	irritability	NN
46745	3894	30	of	of	IN
46745	3894	31	the	the	DT
46745	3894	32	nerve	nerve	NN
46745	3894	33	supplied	supply	VBN
46745	3894	34	to	to	IN
46745	3894	35	the	the	DT
46745	3894	36	part	part	NN
46745	3894	37	will	will	MD
46745	3894	38	be	be	VB
46745	3894	39	likely	likely	JJ
46745	3894	40	to	to	TO
46745	3894	41	effect	effect	VB
46745	3894	42	a	a	DT
46745	3894	43	cure	cure	NN
46745	3894	44	.	.	.
46745	3895	1	They	-PRON-	PRP
46745	3895	2	are	be	VBP
46745	3895	3	both	both	DT
46745	3895	4	sedative	sedative	JJ
46745	3895	5	actions	action	NNS
46745	3895	6	;	;	:
46745	3895	7	but	but	CC
46745	3895	8	the	the	DT
46745	3895	9	first	first	JJ
46745	3895	10	is	be	VBZ
46745	3895	11	an	an	DT
46745	3895	12	action	action	NN
46745	3895	13	of	of	IN
46745	3895	14	derangement	derangement	NN
46745	3895	15	,	,	,
46745	3895	16	the	the	DT
46745	3895	17	second	second	JJ
46745	3895	18	one	one	CD
46745	3895	19	of	of	IN
46745	3895	20	depression	depression	NN
46745	3895	21	.	.	.
46745	3896	1	This	this	DT
46745	3896	2	seems	seem	VBZ
46745	3896	3	to	to	IN
46745	3896	4	me	-PRON-	PRP
46745	3896	5	to	to	TO
46745	3896	6	be	be	VB
46745	3896	7	the	the	DT
46745	3896	8	correct	correct	JJ
46745	3896	9	explanation	explanation	NN
46745	3896	10	of	of	IN
46745	3896	11	a	a	DT
46745	3896	12	difficult	difficult	JJ
46745	3896	13	matter	matter	NN
46745	3896	14	.	.	.
46745	3897	1	It	-PRON-	PRP
46745	3897	2	was	be	VBD
46745	3897	3	just	just	RB
46745	3897	4	now	now	RB
46745	3897	5	observed	observe	VBN
46745	3897	6	that	that	IN
46745	3897	7	these	these	DT
46745	3897	8	medicines	medicine	NNS
46745	3897	9	affect	affect	VBP
46745	3897	10	the	the	DT
46745	3897	11	functions	function	NNS
46745	3897	12	of	of	IN
46745	3897	13	the	the	DT
46745	3897	14	Vagus	Vagus	NNP
46745	3897	15	in	in	IN
46745	3897	16	different	different	JJ
46745	3897	17	proportions	proportion	NNS
46745	3897	18	.	.	.
46745	3898	1	The	the	DT
46745	3898	2	action	action	NN
46745	3898	3	of	of	IN
46745	3898	4	Ipecacuanha	Ipecacuanha	NNP
46745	3898	5	,	,	,
46745	3898	6	when	when	WRB
46745	3898	7	given	give	VBN
46745	3898	8	in	in	IN
46745	3898	9	repeated	repeat	VBN
46745	3898	10	small	small	JJ
46745	3898	11	doses	dose	NNS
46745	3898	12	,	,	,
46745	3898	13	is	be	VBZ
46745	3898	14	particularly	particularly	RB
46745	3898	15	directed	direct	VBN
46745	3898	16	to	to	IN
46745	3898	17	the	the	DT
46745	3898	18	pulmonary	pulmonary	JJ
46745	3898	19	organs	organ	NNS
46745	3898	20	.	.	.
46745	3899	1	It	-PRON-	PRP
46745	3899	2	allays	allay	VBZ
46745	3899	3	the	the	DT
46745	3899	4	sensation	sensation	NN
46745	3899	5	of	of	IN
46745	3899	6	want	want	NN
46745	3899	7	of	of	IN
46745	3899	8	breath	breath	NN
46745	3899	9	,	,	,
46745	3899	10	and	and	CC
46745	3899	11	diminishes	diminish	VBZ
46745	3899	12	the	the	DT
46745	3899	13	cough	cough	NN
46745	3899	14	,	,	,
46745	3899	15	of	of	IN
46745	3899	16	Bronchitis	Bronchitis	NNP
46745	3899	17	.	.	.
46745	3900	1	In	in	IN
46745	3900	2	larger	large	JJR
46745	3900	3	doses	dose	NNS
46745	3900	4	it	-PRON-	PRP
46745	3900	5	produces	produce	VBZ
46745	3900	6	first	first	JJ
46745	3900	7	nausea	nausea	NN
46745	3900	8	,	,	,
46745	3900	9	then	then	RB
46745	3900	10	vomiting	vomit	VBG
46745	3900	11	.	.	.
46745	3901	1	Still	still	RB
46745	3901	2	more	more	RBR
46745	3901	3	decided	decide	VBN
46745	3901	4	nausea	nausea	NN
46745	3901	5	is	be	VBZ
46745	3901	6	produced	produce	VBN
46745	3901	7	by	by	IN
46745	3901	8	Tartar	Tartar	NNP
46745	3901	9	Emetic	Emetic	NNP
46745	3901	10	.	.	.
46745	3902	1	It	-PRON-	PRP
46745	3902	2	is	be	VBZ
46745	3902	3	followed	follow	VBN
46745	3902	4	by	by	IN
46745	3902	5	vomiting	vomit	VBG
46745	3902	6	when	when	WRB
46745	3902	7	the	the	DT
46745	3902	8	dose	dose	NN
46745	3902	9	is	be	VBZ
46745	3902	10	sufficiently	sufficiently	RB
46745	3902	11	large	large	JJ
46745	3902	12	.	.	.
46745	3903	1	Nausea	nausea	NN
46745	3903	2	consists	consist	VBZ
46745	3903	3	in	in	IN
46745	3903	4	a	a	DT
46745	3903	5	sensation	sensation	NN
46745	3903	6	of	of	IN
46745	3903	7	discomfort	discomfort	NN
46745	3903	8	about	about	IN
46745	3903	9	the	the	DT
46745	3903	10	præcordial	præcordial	JJ
46745	3903	11	region	region	NN
46745	3903	12	,	,	,
46745	3903	13	which	which	WDT
46745	3903	14	is	be	VBZ
46745	3903	15	due	due	JJ
46745	3903	16	to	to	IN
46745	3903	17	a	a	DT
46745	3903	18	derangement	derangement	NN
46745	3903	19	of	of	IN
46745	3903	20	the	the	DT
46745	3903	21	stomach	stomach	NN
46745	3903	22	,	,	,
46745	3903	23	with	with	IN
46745	3903	24	a	a	DT
46745	3903	25	feeling	feeling	NN
46745	3903	26	of	of	IN
46745	3903	27	great	great	JJ
46745	3903	28	languor	languor	NN
46745	3903	29	,	,	,
46745	3903	30	a	a	DT
46745	3903	31	cold	cold	JJ
46745	3903	32	perspiration	perspiration	NN
46745	3903	33	and	and	CC
46745	3903	34	tremor	tremor	NN
46745	3903	35	,	,	,
46745	3903	36	and	and	CC
46745	3903	37	at	at	IN
46745	3903	38	the	the	DT
46745	3903	39	same	same	JJ
46745	3903	40	time	time	NN
46745	3903	41	a	a	DT
46745	3903	42	striking	strike	VBG
46745	3903	43	depression	depression	NN
46745	3903	44	of	of	IN
46745	3903	45	the	the	DT
46745	3903	46	action	action	NN
46745	3903	47	of	of	IN
46745	3903	48	the	the	DT
46745	3903	49	heart	heart	NN
46745	3903	50	.	.	.
46745	3904	1	This	this	DT
46745	3904	2	nausea	nausea	NN
46745	3904	3	may	may	MD
46745	3904	4	be	be	VB
46745	3904	5	caused	cause	VBN
46745	3904	6	without	without	IN
46745	3904	7	vomiting	vomiting	NN
46745	3904	8	,	,	,
46745	3904	9	by	by	IN
46745	3904	10	a	a	DT
46745	3904	11	regulation	regulation	NN
46745	3904	12	of	of	IN
46745	3904	13	the	the	DT
46745	3904	14	dose	dose	NN
46745	3904	15	.	.	.
46745	3905	1	On	on	IN
46745	3905	2	account	account	NN
46745	3905	3	of	of	IN
46745	3905	4	the	the	DT
46745	3905	5	depression	depression	NN
46745	3905	6	of	of	IN
46745	3905	7	the	the	DT
46745	3905	8	heart	heart	NN
46745	3905	9	's	's	POS
46745	3905	10	action	action	NN
46745	3905	11	,	,	,
46745	3905	12	which	which	WDT
46745	3905	13	is	be	VBZ
46745	3905	14	its	-PRON-	PRP$
46745	3905	15	chief	chief	JJ
46745	3905	16	symptom	symptom	NN
46745	3905	17	,	,	,
46745	3905	18	it	-PRON-	PRP
46745	3905	19	is	be	VBZ
46745	3905	20	often	often	RB
46745	3905	21	very	very	RB
46745	3905	22	desirable	desirable	JJ
46745	3905	23	to	to	TO
46745	3905	24	cause	cause	VB
46745	3905	25	nausea	nausea	NN
46745	3905	26	in	in	IN
46745	3905	27	acute	acute	JJ
46745	3905	28	inflammations	inflammation	NNS
46745	3905	29	and	and	CC
46745	3905	30	fevers	fever	NNS
46745	3905	31	.	.	.
46745	3906	1	It	-PRON-	PRP
46745	3906	2	is	be	VBZ
46745	3906	3	kept	keep	VBN
46745	3906	4	up	up	RP
46745	3906	5	by	by	IN
46745	3906	6	the	the	DT
46745	3906	7	careful	careful	JJ
46745	3906	8	administration	administration	NN
46745	3906	9	of	of	IN
46745	3906	10	Tartar	Tartar	NNP
46745	3906	11	Emetic	Emetic	NNP
46745	3906	12	.	.	.
46745	3907	1	It	-PRON-	PRP
46745	3907	2	may	may	MD
46745	3907	3	not	not	RB
46745	3907	4	be	be	VB
46745	3907	5	so	so	RB
46745	3907	6	desirable	desirable	JJ
46745	3907	7	to	to	TO
46745	3907	8	produce	produce	VB
46745	3907	9	vomiting	vomiting	NN
46745	3907	10	;	;	:
46745	3907	11	for	for	IN
46745	3907	12	this	this	DT
46745	3907	13	is	be	VBZ
46745	3907	14	accompanied	accompany	VBN
46745	3907	15	with	with	IN
46745	3907	16	great	great	JJ
46745	3907	17	vascular	vascular	JJ
46745	3907	18	excitement	excitement	NN
46745	3907	19	and	and	CC
46745	3907	20	active	active	JJ
46745	3907	21	congestion	congestion	NN
46745	3907	22	of	of	IN
46745	3907	23	the	the	DT
46745	3907	24	brain	brain	NN
46745	3907	25	.	.	.
46745	3908	1	And	and	CC
46745	3908	2	yet	yet	RB
46745	3908	3	it	-PRON-	PRP
46745	3908	4	is	be	VBZ
46745	3908	5	found	find	VBN
46745	3908	6	that	that	IN
46745	3908	7	the	the	DT
46745	3908	8	more	more	JJR
46745	3908	9	Antimony	Antimony	NNP
46745	3908	10	we	-PRON-	PRP
46745	3908	11	can	can	MD
46745	3908	12	get	get	VB
46745	3908	13	into	into	IN
46745	3908	14	the	the	DT
46745	3908	15	blood	blood	NN
46745	3908	16	,	,	,
46745	3908	17	the	the	DT
46745	3908	18	more	more	RBR
46745	3908	19	potent	potent	JJ
46745	3908	20	and	and	CC
46745	3908	21	durable	durable	JJ
46745	3908	22	will	will	MD
46745	3908	23	its	-PRON-	PRP$
46745	3908	24	antiphlogistic	antiphlogistic	JJ
46745	3908	25	influence	influence	NN
46745	3908	26	be	be	VB
46745	3908	27	.	.	.
46745	3909	1	For	for	IN
46745	3909	2	this	this	DT
46745	3909	3	medicine	medicine	NN
46745	3909	4	appears	appear	VBZ
46745	3909	5	to	to	TO
46745	3909	6	possess	possess	VB
46745	3909	7	a	a	DT
46745	3909	8	blood	blood	NN
46745	3909	9	-	-	HYPH
46745	3909	10	action	action	NN
46745	3909	11	as	as	RB
46745	3909	12	well	well	RB
46745	3909	13	as	as	IN
46745	3909	14	an	an	DT
46745	3909	15	action	action	NN
46745	3909	16	on	on	IN
46745	3909	17	nerve	nerve	NN
46745	3909	18	.	.	.
46745	3910	1	Experience	experience	NN
46745	3910	2	has	have	VBZ
46745	3910	3	shown	show	VBN
46745	3910	4	that	that	IN
46745	3910	5	if	if	IN
46745	3910	6	the	the	DT
46745	3910	7	dose	dose	NN
46745	3910	8	of	of	IN
46745	3910	9	Tartar	Tartar	NNP
46745	3910	10	Emetic	Emetic	NNP
46745	3910	11	be	be	VB
46745	3910	12	gradually	gradually	RB
46745	3910	13	increased	increase	VBN
46745	3910	14	on	on	IN
46745	3910	15	each	each	DT
46745	3910	16	repetition	repetition	NN
46745	3910	17	,	,	,
46745	3910	18	it	-PRON-	PRP
46745	3910	19	may	may	MD
46745	3910	20	often	often	RB
46745	3910	21	be	be	VB
46745	3910	22	tolerated	tolerate	VBN
46745	3910	23	by	by	IN
46745	3910	24	the	the	DT
46745	3910	25	system	system	NN
46745	3910	26	;	;	:
46745	3910	27	that	that	RB
46745	3910	28	is	is	RB
46745	3910	29	,	,	,
46745	3910	30	it	-PRON-	PRP
46745	3910	31	does	do	VBZ
46745	3910	32	not	not	RB
46745	3910	33	produce	produce	VB
46745	3910	34	vomiting	vomit	VBG
46745	3910	35	;	;	:
46745	3910	36	and	and	CC
46745	3910	37	then	then	RB
46745	3910	38	the	the	DT
46745	3910	39	remedy	remedy	NN
46745	3910	40	,	,	,
46745	3910	41	being	be	VBG
46745	3910	42	absorbed	absorb	VBN
46745	3910	43	,	,	,
46745	3910	44	is	be	VBZ
46745	3910	45	better	well	RBR
46745	3910	46	able	able	JJ
46745	3910	47	to	to	TO
46745	3910	48	continue	continue	VB
46745	3910	49	its	-PRON-	PRP$
46745	3910	50	antiphlogistic	antiphlogistic	JJ
46745	3910	51	and	and	CC
46745	3910	52	nauseating	nauseating	NN
46745	3910	53	action	action	NN
46745	3910	54	.	.	.
46745	3911	1	For	for	IN
46745	3911	2	the	the	DT
46745	3911	3	act	act	NN
46745	3911	4	of	of	IN
46745	3911	5	vomiting	vomiting	NN
46745	3911	6	,	,	,
46745	3911	7	besides	besides	IN
46745	3911	8	other	other	JJ
46745	3911	9	bad	bad	JJ
46745	3911	10	consequences	consequence	NNS
46745	3911	11	,	,	,
46745	3911	12	causes	cause	VBZ
46745	3911	13	the	the	DT
46745	3911	14	rejection	rejection	NN
46745	3911	15	of	of	IN
46745	3911	16	that	that	DT
46745	3911	17	part	part	NN
46745	3911	18	of	of	IN
46745	3911	19	the	the	DT
46745	3911	20	antimonial	antimonial	NN
46745	3911	21	which	which	WDT
46745	3911	22	has	have	VBZ
46745	3911	23	not	not	RB
46745	3911	24	been	be	VBN
46745	3911	25	absorbed	absorb	VBN
46745	3911	26	.	.	.
46745	3912	1	By	by	IN
46745	3912	2	the	the	DT
46745	3912	3	operation	operation	NN
46745	3912	4	of	of	IN
46745	3912	5	the	the	DT
46745	3912	6	Nauseant	Nauseant	NNP
46745	3912	7	the	the	DT
46745	3912	8	violent	violent	JJ
46745	3912	9	action	action	NN
46745	3912	10	of	of	IN
46745	3912	11	the	the	DT
46745	3912	12	heart	heart	NN
46745	3912	13	in	in	IN
46745	3912	14	high	high	JJ
46745	3912	15	fever	fever	NN
46745	3912	16	may	may	MD
46745	3912	17	be	be	VB
46745	3912	18	allayed	allay	VBN
46745	3912	19	.	.	.
46745	3913	1	It	-PRON-	PRP
46745	3913	2	is	be	VBZ
46745	3913	3	often	often	RB
46745	3913	4	of	of	IN
46745	3913	5	signal	signal	JJ
46745	3913	6	efficacy	efficacy	NN
46745	3913	7	,	,	,
46745	3913	8	most	most	RBS
46745	3913	9	especially	especially	RB
46745	3913	10	in	in	IN
46745	3913	11	Pneumonia	Pneumonia	NNP
46745	3913	12	.	.	.
46745	3914	1	Digitalis	Digitalis	NNP
46745	3914	2	given	give	VBN
46745	3914	3	in	in	IN
46745	3914	4	large	large	JJ
46745	3914	5	doses	dose	NNS
46745	3914	6	may	may	MD
46745	3914	7	also	also	RB
46745	3914	8	act	act	VB
46745	3914	9	on	on	IN
46745	3914	10	the	the	DT
46745	3914	11	stomach	stomach	NN
46745	3914	12	,	,	,
46745	3914	13	and	and	CC
46745	3914	14	cause	cause	VB
46745	3914	15	vomiting	vomiting	NN
46745	3914	16	.	.	.
46745	3915	1	This	this	DT
46745	3915	2	operation	operation	NN
46745	3915	3	has	have	VBZ
46745	3915	4	been	be	VBN
46745	3915	5	ascribed	ascribe	VBN
46745	3915	6	,	,	,
46745	3915	7	erroneously	erroneously	RB
46745	3915	8	,	,	,
46745	3915	9	as	as	IN
46745	3915	10	I	-PRON-	PRP
46745	3915	11	think	think	VBP
46745	3915	12	,	,	,
46745	3915	13	to	to	IN
46745	3915	14	an	an	DT
46745	3915	15	irritating	irritate	VBG
46745	3915	16	action	action	NN
46745	3915	17	possessed	possess	VBN
46745	3915	18	by	by	IN
46745	3915	19	this	this	DT
46745	3915	20	drug	drug	NN
46745	3915	21	.	.	.
46745	3916	1	But	but	CC
46745	3916	2	in	in	IN
46745	3916	3	smaller	small	JJR
46745	3916	4	doses	dose	NNS
46745	3916	5	it	-PRON-	PRP
46745	3916	6	affects	affect	VBZ
46745	3916	7	the	the	DT
46745	3916	8	heart	heart	NN
46745	3916	9	and	and	CC
46745	3916	10	circulation	circulation	NN
46745	3916	11	powerfully	powerfully	RB
46745	3916	12	,	,	,
46745	3916	13	without	without	IN
46745	3916	14	producing	produce	VBG
46745	3916	15	the	the	DT
46745	3916	16	other	other	JJ
46745	3916	17	symptoms	symptom	NNS
46745	3916	18	of	of	IN
46745	3916	19	nausea	nausea	NN
46745	3916	20	.	.	.
46745	3917	1	It	-PRON-	PRP
46745	3917	2	depresses	depress	VBZ
46745	3917	3	the	the	DT
46745	3917	4	action	action	NN
46745	3917	5	of	of	IN
46745	3917	6	the	the	DT
46745	3917	7	heart	heart	NN
46745	3917	8	.	.	.
46745	3918	1	Sometimes	sometimes	RB
46745	3918	2	the	the	DT
46745	3918	3	rapidity	rapidity	NN
46745	3918	4	of	of	IN
46745	3918	5	the	the	DT
46745	3918	6	beat	beat	NN
46745	3918	7	is	be	VBZ
46745	3918	8	slightly	slightly	RB
46745	3918	9	increased	increase	VBN
46745	3918	10	at	at	IN
46745	3918	11	the	the	DT
46745	3918	12	first	first	JJ
46745	3918	13	,	,	,
46745	3918	14	but	but	CC
46745	3918	15	the	the	DT
46745	3918	16	pulse	pulse	NN
46745	3918	17	at	at	IN
46745	3918	18	the	the	DT
46745	3918	19	same	same	JJ
46745	3918	20	time	time	NN
46745	3918	21	is	be	VBZ
46745	3918	22	weaker	weak	JJR
46745	3918	23	.	.	.
46745	3919	1	It	-PRON-	PRP
46745	3919	2	soon	soon	RB
46745	3919	3	becomes	become	VBZ
46745	3919	4	slower	slow	JJR
46745	3919	5	and	and	CC
46745	3919	6	sometimes	sometimes	RB
46745	3919	7	irregular	irregular	JJ
46745	3919	8	.	.	.
46745	3920	1	This	this	DT
46745	3920	2	action	action	NN
46745	3920	3	is	be	VBZ
46745	3920	4	characteristic	characteristic	JJ
46745	3920	5	of	of	IN
46745	3920	6	derangement	derangement	NN
46745	3920	7	of	of	IN
46745	3920	8	the	the	DT
46745	3920	9	Vagus	Vagus	NNP
46745	3920	10	nerve	nerve	NN
46745	3920	11	.	.	.
46745	3921	1	For	for	IN
46745	3921	2	it	-PRON-	PRP
46745	3921	3	was	be	VBD
46745	3921	4	found	find	VBN
46745	3921	5	,	,	,
46745	3921	6	in	in	IN
46745	3921	7	some	some	DT
46745	3921	8	experiments	experiment	NNS
46745	3921	9	on	on	IN
46745	3921	10	animals	animal	NNS
46745	3921	11	made	make	VBN
46745	3921	12	by	by	IN
46745	3921	13	M.	M.	NNP
46745	3921	14	Weber	Weber	NNP
46745	3921	15	,	,	,
46745	3921	16	that	that	IN
46745	3921	17	when	when	WRB
46745	3921	18	the	the	DT
46745	3921	19	function	function	NN
46745	3921	20	of	of	IN
46745	3921	21	this	this	DT
46745	3921	22	nerve	nerve	NN
46745	3921	23	was	be	VBD
46745	3921	24	disturbed	disturb	VBN
46745	3921	25	by	by	IN
46745	3921	26	mechanical	mechanical	JJ
46745	3921	27	irritation	irritation	NN
46745	3921	28	,	,	,
46745	3921	29	the	the	DT
46745	3921	30	rate	rate	NN
46745	3921	31	of	of	IN
46745	3921	32	the	the	DT
46745	3921	33	heart	heart	NN
46745	3921	34	was	be	VBD
46745	3921	35	first	first	RB
46745	3921	36	accelerated	accelerate	VBN
46745	3921	37	,	,	,
46745	3921	38	its	-PRON-	PRP$
46745	3921	39	action	action	NN
46745	3921	40	then	then	RB
46745	3921	41	became	become	VBD
46745	3921	42	slow	slow	JJ
46745	3921	43	and	and	CC
46745	3921	44	irregular,--and	irregular,--and	NNP
46745	3921	45	finally	finally	RB
46745	3921	46	it	-PRON-	PRP
46745	3921	47	stopped	stop	VBD
46745	3921	48	.	.	.
46745	3922	1	There	there	EX
46745	3922	2	can	can	MD
46745	3922	3	not	not	RB
46745	3922	4	be	be	VB
46745	3922	5	a	a	DT
46745	3922	6	greater	great	JJR
46745	3922	7	mistake	mistake	NN
46745	3922	8	than	than	IN
46745	3922	9	an	an	DT
46745	3922	10	attempt	attempt	NN
46745	3922	11	to	to	TO
46745	3922	12	explain	explain	VB
46745	3922	13	such	such	PDT
46745	3922	14	a	a	DT
46745	3922	15	derangement	derangement	NN
46745	3922	16	by	by	IN
46745	3922	17	supposing	suppose	VBG
46745	3922	18	this	this	DT
46745	3922	19	medicine	medicine	NN
46745	3922	20	to	to	TO
46745	3922	21	exert	exert	VB
46745	3922	22	a	a	DT
46745	3922	23	primary	primary	JJ
46745	3922	24	stimulant	stimulant	NN
46745	3922	25	action	action	NN
46745	3922	26	.	.	.
46745	3923	1	Coincident	coincident	NN
46745	3923	2	with	with	IN
46745	3923	3	the	the	DT
46745	3923	4	quickening	quickening	NN
46745	3923	5	of	of	IN
46745	3923	6	the	the	DT
46745	3923	7	pulse	pulse	NN
46745	3923	8	,	,	,
46745	3923	9	there	there	EX
46745	3923	10	is	be	VBZ
46745	3923	11	a	a	DT
46745	3923	12	manifest	manif	JJS
46745	3923	13	loss	loss	NN
46745	3923	14	of	of	IN
46745	3923	15	power	power	NN
46745	3923	16	.	.	.
46745	3924	1	Digitalis	Digitalis	NNP
46745	3924	2	is	be	VBZ
46745	3924	3	especially	especially	RB
46745	3924	4	useful	useful	JJ
46745	3924	5	in	in	IN
46745	3924	6	dropsies	dropsy	NNS
46745	3924	7	which	which	WDT
46745	3924	8	result	result	VBP
46745	3924	9	from	from	IN
46745	3924	10	an	an	DT
46745	3924	11	obstruction	obstruction	NN
46745	3924	12	to	to	IN
46745	3924	13	the	the	DT
46745	3924	14	cardiac	cardiac	JJ
46745	3924	15	circulation	circulation	NN
46745	3924	16	.	.	.
46745	3925	1	By	by	IN
46745	3925	2	subduing	subdue	VBG
46745	3925	3	the	the	DT
46745	3925	4	action	action	NN
46745	3925	5	of	of	IN
46745	3925	6	the	the	DT
46745	3925	7	heart	heart	NN
46745	3925	8	,	,	,
46745	3925	9	it	-PRON-	PRP
46745	3925	10	relieves	relieve	VBZ
46745	3925	11	that	that	IN
46745	3925	12	congestion	congestion	NN
46745	3925	13	of	of	IN
46745	3925	14	the	the	DT
46745	3925	15	vascular	vascular	JJ
46745	3925	16	system	system	NN
46745	3925	17	which	which	WDT
46745	3925	18	is	be	VBZ
46745	3925	19	the	the	DT
46745	3925	20	cause	cause	NN
46745	3925	21	of	of	IN
46745	3925	22	the	the	DT
46745	3925	23	effusion	effusion	NN
46745	3925	24	of	of	IN
46745	3925	25	serum	serum	NN
46745	3925	26	.	.	.
46745	3926	1	But	but	CC
46745	3926	2	it	-PRON-	PRP
46745	3926	3	is	be	VBZ
46745	3926	4	also	also	RB
46745	3926	5	a	a	DT
46745	3926	6	Diuretic	Diuretic	NNP
46745	3926	7	;	;	:
46745	3926	8	and	and	CC
46745	3926	9	may	may	MD
46745	3926	10	thus	thus	RB
46745	3926	11	too	too	RB
46745	3926	12	relieve	relieve	VB
46745	3926	13	the	the	DT
46745	3926	14	loaded	loaded	JJ
46745	3926	15	vessels	vessel	NNS
46745	3926	16	by	by	IN
46745	3926	17	carrying	carry	VBG
46745	3926	18	off	off	RP
46745	3926	19	in	in	IN
46745	3926	20	the	the	DT
46745	3926	21	urine	urine	NN
46745	3926	22	some	some	DT
46745	3926	23	of	of	IN
46745	3926	24	the	the	DT
46745	3926	25	water	water	NN
46745	3926	26	of	of	IN
46745	3926	27	the	the	DT
46745	3926	28	blood	blood	NN
46745	3926	29	.	.	.
46745	3927	1	Such	such	JJ
46745	3927	2	is	be	VBZ
46745	3927	3	an	an	DT
46745	3927	4	outline	outline	NN
46745	3927	5	of	of	IN
46745	3927	6	the	the	DT
46745	3927	7	action	action	NN
46745	3927	8	of	of	IN
46745	3927	9	Special	Special	NNP
46745	3927	10	Sedatives	Sedatives	NNPS
46745	3927	11	to	to	IN
46745	3927	12	the	the	DT
46745	3927	13	Vagus	Vagus	NNP
46745	3927	14	nerve	nerve	NN
46745	3927	15	.	.	.
46745	3928	1	It	-PRON-	PRP
46745	3928	2	is	be	VBZ
46745	3928	3	not	not	RB
46745	3928	4	clear	clear	JJ
46745	3928	5	whether	whether	IN
46745	3928	6	they	-PRON-	PRP
46745	3928	7	affect	affect	VBP
46745	3928	8	that	that	IN
46745	3928	9	nerve	nerve	NN
46745	3928	10	at	at	IN
46745	3928	11	its	-PRON-	PRP$
46745	3928	12	origin	origin	NN
46745	3928	13	in	in	IN
46745	3928	14	the	the	DT
46745	3928	15	brain	brain	NN
46745	3928	16	,	,	,
46745	3928	17	or	or	CC
46745	3928	18	whether	whether	IN
46745	3928	19	they	-PRON-	PRP
46745	3928	20	act	act	VBP
46745	3928	21	the	the	DT
46745	3928	22	extremities	extremity	NNS
46745	3928	23	of	of	IN
46745	3928	24	its	-PRON-	PRP$
46745	3928	25	filaments	filament	NNS
46745	3928	26	.	.	.
46745	3929	1	These	these	DT
46745	3929	2	Sedatives	sedative	NNS
46745	3929	3	do	do	VBP
46745	3929	4	not	not	RB
46745	3929	5	act	act	VB
46745	3929	6	directly	directly	RB
46745	3929	7	upon	upon	IN
46745	3929	8	the	the	DT
46745	3929	9	brain	brain	NN
46745	3929	10	itself	-PRON-	PRP
46745	3929	11	.	.	.
46745	3930	1	But	but	CC
46745	3930	2	indirectly	indirectly	RB
46745	3930	3	they	-PRON-	PRP
46745	3930	4	may	may	MD
46745	3930	5	affect	affect	VB
46745	3930	6	it	-PRON-	PRP
46745	3930	7	,	,	,
46745	3930	8	when	when	WRB
46745	3930	9	given	give	VBN
46745	3930	10	in	in	IN
46745	3930	11	large	large	JJ
46745	3930	12	doses	dose	NNS
46745	3930	13	.	.	.
46745	3931	1	For	for	IN
46745	3931	2	by	by	IN
46745	3931	3	depressing	depress	VBG
46745	3931	4	the	the	DT
46745	3931	5	action	action	NN
46745	3931	6	of	of	IN
46745	3931	7	the	the	DT
46745	3931	8	heart	heart	NN
46745	3931	9	they	-PRON-	PRP
46745	3931	10	cut	cut	VBD
46745	3931	11	off	off	RP
46745	3931	12	the	the	DT
46745	3931	13	natural	natural	JJ
46745	3931	14	supply	supply	NN
46745	3931	15	of	of	IN
46745	3931	16	blood	blood	NN
46745	3931	17	to	to	IN
46745	3931	18	the	the	DT
46745	3931	19	brain	brain	NN
46745	3931	20	,	,	,
46745	3931	21	and	and	CC
46745	3931	22	may	may	MD
46745	3931	23	,	,	,
46745	3931	24	by	by	IN
46745	3931	25	so	so	RB
46745	3931	26	doing	do	VBG
46745	3931	27	,	,	,
46745	3931	28	produce	produce	VB
46745	3931	29	delirium	delirium	NN
46745	3931	30	and	and	CC
46745	3931	31	convulsions	convulsion	NNS
46745	3931	32	.	.	.
46745	3932	1	They	-PRON-	PRP
46745	3932	2	tend	tend	VBP
46745	3932	3	obviously	obviously	RB
46745	3932	4	to	to	TO
46745	3932	5	kill	kill	VB
46745	3932	6	by	by	IN
46745	3932	7	syncope	syncope	NN
46745	3932	8	.	.	.
46745	3933	1	Some	some	DT
46745	3933	2	medicines	medicine	NNS
46745	3933	3	may	may	MD
46745	3933	4	cause	cause	VB
46745	3933	5	syncope	syncope	NN
46745	3933	6	by	by	IN
46745	3933	7	an	an	DT
46745	3933	8	action	action	NN
46745	3933	9	upon	upon	IN
46745	3933	10	the	the	DT
46745	3933	11	brain	brain	NN
46745	3933	12	.	.	.
46745	3934	1	General	General	NNP
46745	3934	2	Sedatives	Sedatives	NNPS
46745	3934	3	may	may	MD
46745	3934	4	do	do	VB
46745	3934	5	so	so	RB
46745	3934	6	;	;	:
46745	3934	7	but	but	CC
46745	3934	8	it	-PRON-	PRP
46745	3934	9	does	do	VBZ
46745	3934	10	not	not	RB
46745	3934	11	appear	appear	VB
46745	3934	12	that	that	IN
46745	3934	13	the	the	DT
46745	3934	14	medicines	medicine	NNS
46745	3934	15	of	of	IN
46745	3934	16	this	this	DT
46745	3934	17	order	order	NN
46745	3934	18	ever	ever	RB
46745	3934	19	act	act	VBP
46745	3934	20	in	in	IN
46745	3934	21	this	this	DT
46745	3934	22	way	way	NN
46745	3934	23	.	.	.
46745	3935	1	Some	some	DT
46745	3935	2	other	other	JJ
46745	3935	3	medicines	medicine	NNS
46745	3935	4	rest	rest	VBP
46745	3935	5	very	very	RB
46745	3935	6	closely	closely	RB
46745	3935	7	upon	upon	IN
46745	3935	8	the	the	DT
46745	3935	9	confines	confine	NNS
46745	3935	10	of	of	IN
46745	3935	11	this	this	DT
46745	3935	12	order	order	NN
46745	3935	13	.	.	.
46745	3936	1	Squill	squill	NN
46745	3936	2	is	be	VBZ
46745	3936	3	the	the	DT
46745	3936	4	chief	chief	NN
46745	3936	5	of	of	IN
46745	3936	6	these	these	DT
46745	3936	7	.	.	.
46745	3937	1	It	-PRON-	PRP
46745	3937	2	is	be	VBZ
46745	3937	3	not	not	RB
46745	3937	4	quite	quite	RB
46745	3937	5	clear	clear	JJ
46745	3937	6	whether	whether	IN
46745	3937	7	Squill	Squill	NNP
46745	3937	8	should	should	MD
46745	3937	9	be	be	VB
46745	3937	10	regarded	regard	VBN
46745	3937	11	as	as	IN
46745	3937	12	a	a	DT
46745	3937	13	Special	Special	NNP
46745	3937	14	Sedative	Sedative	NNP
46745	3937	15	,	,	,
46745	3937	16	or	or	CC
46745	3937	17	considered	consider	VBN
46745	3937	18	simply	simply	RB
46745	3937	19	as	as	IN
46745	3937	20	an	an	DT
46745	3937	21	irritant	irritant	JJ
46745	3937	22	Emetic	Emetic	NNP
46745	3937	23	and	and	CC
46745	3937	24	Eliminative	eliminative	JJ
46745	3937	25	.	.	.
46745	3938	1	It	-PRON-	PRP
46745	3938	2	is	be	VBZ
46745	3938	3	a	a	DT
46745	3938	4	valuable	valuable	JJ
46745	3938	5	Expectorant	expectorant	NN
46745	3938	6	.	.	.
46745	3939	1	It	-PRON-	PRP
46745	3939	2	is	be	VBZ
46745	3939	3	also	also	RB
46745	3939	4	a	a	DT
46745	3939	5	Diuretic	Diuretic	NNP
46745	3939	6	;	;	:
46745	3939	7	and	and	CC
46745	3939	8	from	from	IN
46745	3939	9	the	the	DT
46745	3939	10	analogy	analogy	NN
46745	3939	11	of	of	IN
46745	3939	12	its	-PRON-	PRP$
46745	3939	13	operation	operation	NN
46745	3939	14	to	to	IN
46745	3939	15	that	that	DT
46745	3939	16	of	of	IN
46745	3939	17	Digitalis	Digitalis	NNP
46745	3939	18	(	(	-LRB-
46745	3939	19	_	_	NNP
46745	3939	20	vide	vide	NN
46745	3939	21	supra	supra	NNP
46745	3939	22	_	_	NNP
46745	3939	23	,	,	,
46745	3939	24	)	)	-RRB-
46745	3939	25	and	and	CC
46745	3939	26	because	because	IN
46745	3939	27	it	-PRON-	PRP
46745	3939	28	appears	appear	VBZ
46745	3939	29	to	to	TO
46745	3939	30	be	be	VB
46745	3939	31	a	a	DT
46745	3939	32	specific	specific	JJ
46745	3939	33	Emetic	Emetic	NNP
46745	3939	34	,	,	,
46745	3939	35	it	-PRON-	PRP
46745	3939	36	is	be	VBZ
46745	3939	37	most	most	RBS
46745	3939	38	probably	probably	RB
46745	3939	39	a	a	DT
46745	3939	40	true	true	JJ
46745	3939	41	Neurotic	neurotic	JJ
46745	3939	42	.	.	.
46745	3940	1	But	but	CC
46745	3940	2	we	-PRON-	PRP
46745	3940	3	must	must	MD
46745	3940	4	not	not	RB
46745	3940	5	confound	confound	VB
46745	3940	6	with	with	IN
46745	3940	7	Neurotics	Neurotics	NNP
46745	3940	8	those	those	DT
46745	3940	9	medicines	medicine	NNS
46745	3940	10	which	which	WDT
46745	3940	11	exert	exert	VBP
46745	3940	12	a	a	DT
46745	3940	13	slow	slow	JJ
46745	3940	14	operation	operation	NN
46745	3940	15	in	in	IN
46745	3940	16	the	the	DT
46745	3940	17	blood	blood	NN
46745	3940	18	which	which	WDT
46745	3940	19	results	result	VBZ
46745	3940	20	at	at	IN
46745	3940	21	length	length	NN
46745	3940	22	in	in	IN
46745	3940	23	a	a	DT
46745	3940	24	nervous	nervous	JJ
46745	3940	25	affection	affection	NN
46745	3940	26	.	.	.
46745	3941	1	This	this	DT
46745	3941	2	may	may	MD
46745	3941	3	take	take	VB
46745	3941	4	place	place	NN
46745	3941	5	,	,	,
46745	3941	6	to	to	IN
46745	3941	7	a	a	DT
46745	3941	8	greater	great	JJR
46745	3941	9	or	or	CC
46745	3941	10	less	less	JJR
46745	3941	11	degree	degree	NN
46745	3941	12	,	,	,
46745	3941	13	with	with	IN
46745	3941	14	all	all	DT
46745	3941	15	Catalytic	catalytic	JJ
46745	3941	16	Hæmatics	Hæmatics	NNPS
46745	3941	17	.	.	.
46745	3942	1	Lead	Lead	NNP
46745	3942	2	,	,	,
46745	3942	3	which	which	WDT
46745	3942	4	is	be	VBZ
46745	3942	5	anti	anti	JJ
46745	3942	6	-	-	JJ
46745	3942	7	convulsive	convulsive	JJ
46745	3942	8	and	and	CC
46745	3942	9	astringent	astringent	NN
46745	3942	10	,	,	,
46745	3942	11	approaches	approach	VBZ
46745	3942	12	nearest	nearest	RB
46745	3942	13	of	of	IN
46745	3942	14	all	all	DT
46745	3942	15	to	to	IN
46745	3942	16	the	the	DT
46745	3942	17	recognised	recognise	VBN
46745	3942	18	nerve	nerve	NN
46745	3942	19	-	-	HYPH
46745	3942	20	medicines	medicine	NNS
46745	3942	21	.	.	.
46745	3943	1	After	after	IN
46745	3943	2	existing	exist	VBG
46745	3943	3	for	for	IN
46745	3943	4	some	some	DT
46745	3943	5	time	time	NN
46745	3943	6	in	in	IN
46745	3943	7	the	the	DT
46745	3943	8	blood	blood	NN
46745	3943	9	,	,	,
46745	3943	10	it	-PRON-	PRP
46745	3943	11	produces	produce	VBZ
46745	3943	12	local	local	JJ
46745	3943	13	palsy	palsy	NN
46745	3943	14	,	,	,
46745	3943	15	particularly	particularly	RB
46745	3943	16	of	of	IN
46745	3943	17	the	the	DT
46745	3943	18	muscles	muscle	NNS
46745	3943	19	about	about	IN
46745	3943	20	the	the	DT
46745	3943	21	wrist	wrist	NN
46745	3943	22	;	;	:
46745	3943	23	and	and	CC
46745	3943	24	it	-PRON-	PRP
46745	3943	25	sometimes	sometimes	RB
46745	3943	26	affects	affect	VBZ
46745	3943	27	the	the	DT
46745	3943	28	sensory	sensory	JJ
46745	3943	29	nerves	nerve	NNS
46745	3943	30	,	,	,
46745	3943	31	causing	cause	VBG
46745	3943	32	sharp	sharp	JJ
46745	3943	33	shooting	shooting	NN
46745	3943	34	pains	pain	NNS
46745	3943	35	in	in	IN
46745	3943	36	the	the	DT
46745	3943	37	limbs	limb	NNS
46745	3943	38	.	.	.
46745	3944	1	These	these	DT
46745	3944	2	nervous	nervous	JJ
46745	3944	3	symptoms	symptom	NNS
46745	3944	4	are	be	VBP
46745	3944	5	caused	cause	VBN
46745	3944	6	by	by	IN
46745	3944	7	the	the	DT
46745	3944	8	accumulation	accumulation	NN
46745	3944	9	in	in	IN
46745	3944	10	the	the	DT
46745	3944	11	system	system	NN
46745	3944	12	of	of	IN
46745	3944	13	the	the	DT
46745	3944	14	poison	poison	NN
46745	3944	15	of	of	IN
46745	3944	16	lead	lead	NN
46745	3944	17	,	,	,
46745	3944	18	and	and	CC
46745	3944	19	the	the	DT
46745	3944	20	deterioration	deterioration	NN
46745	3944	21	of	of	IN
46745	3944	22	the	the	DT
46745	3944	23	blood	blood	NN
46745	3944	24	which	which	WDT
46745	3944	25	is	be	VBZ
46745	3944	26	thereby	thereby	RB
46745	3944	27	produced	produce	VBN
46745	3944	28	.	.	.
46745	3945	1	In	in	IN
46745	3945	2	the	the	DT
46745	3945	3	case	case	NN
46745	3945	4	of	of	IN
46745	3945	5	the	the	DT
46745	3945	6	palsy	palsy	NN
46745	3945	7	,	,	,
46745	3945	8	we	-PRON-	PRP
46745	3945	9	can	can	MD
46745	3945	10	not	not	RB
46745	3945	11	certainly	certainly	RB
46745	3945	12	say	say	VB
46745	3945	13	whether	whether	IN
46745	3945	14	these	these	DT
46745	3945	15	causes	cause	NNS
46745	3945	16	operate	operate	VBP
46745	3945	17	first	first	RB
46745	3945	18	upon	upon	IN
46745	3945	19	the	the	DT
46745	3945	20	motor	motor	NN
46745	3945	21	nerves	nerve	NNS
46745	3945	22	,	,	,
46745	3945	23	or	or	CC
46745	3945	24	upon	upon	IN
46745	3945	25	the	the	DT
46745	3945	26	muscles	muscle	NNS
46745	3945	27	themselves	-PRON-	PRP
46745	3945	28	.	.	.
46745	3946	1	Lead	Lead	NNP
46745	3946	2	certainly	certainly	RB
46745	3946	3	has	have	VBZ
46745	3946	4	some	some	DT
46745	3946	5	tendency	tendency	NN
46745	3946	6	to	to	TO
46745	3946	7	affect	affect	VB
46745	3946	8	the	the	DT
46745	3946	9	brain	brain	NN
46745	3946	10	.	.	.
46745	3947	1	All	all	DT
46745	3947	2	kinds	kind	NNS
46745	3947	3	of	of	IN
46745	3947	4	brain	brain	NN
46745	3947	5	disorders	disorder	NNS
46745	3947	6	may	may	MD
46745	3947	7	occur	occur	VB
46745	3947	8	in	in	IN
46745	3947	9	cases	case	NNS
46745	3947	10	of	of	IN
46745	3947	11	chronic	chronic	JJ
46745	3947	12	lead	lead	NN
46745	3947	13	-	-	HYPH
46745	3947	14	poisoning	poisoning	NN
46745	3947	15	.	.	.
46745	3948	1	The	the	DT
46745	3948	2	metal	metal	NN
46745	3948	3	has	have	VBZ
46745	3948	4	been	be	VBN
46745	3948	5	found	find	VBN
46745	3948	6	in	in	IN
46745	3948	7	the	the	DT
46745	3948	8	brain	brain	NN
46745	3948	9	after	after	IN
46745	3948	10	death	death	NN
46745	3948	11	;	;	:
46745	3948	12	but	but	CC
46745	3948	13	it	-PRON-	PRP
46745	3948	14	also	also	RB
46745	3948	15	exists	exist	VBZ
46745	3948	16	at	at	IN
46745	3948	17	the	the	DT
46745	3948	18	same	same	JJ
46745	3948	19	time	time	NN
46745	3948	20	in	in	IN
46745	3948	21	other	other	JJ
46745	3948	22	parts	part	NNS
46745	3948	23	of	of	IN
46745	3948	24	the	the	DT
46745	3948	25	body	body	NN
46745	3948	26	.	.	.
46745	3949	1	In	in	IN
46745	3949	2	cases	case	NNS
46745	3949	3	of	of	IN
46745	3949	4	Lead	lead	NN
46745	3949	5	-	-	HYPH
46745	3949	6	colic	colic	NN
46745	3949	7	there	there	EX
46745	3949	8	is	be	VBZ
46745	3949	9	generally	generally	RB
46745	3949	10	a	a	DT
46745	3949	11	paralysis	paralysis	NN
46745	3949	12	of	of	IN
46745	3949	13	the	the	DT
46745	3949	14	muscular	muscular	JJ
46745	3949	15	fibre	fibre	NN
46745	3949	16	of	of	IN
46745	3949	17	a	a	DT
46745	3949	18	certain	certain	JJ
46745	3949	19	portion	portion	NN
46745	3949	20	of	of	IN
46745	3949	21	the	the	DT
46745	3949	22	intestine	intestine	NN
46745	3949	23	.	.	.
46745	3950	1	The	the	DT
46745	3950	2	pain	pain	NN
46745	3950	3	of	of	IN
46745	3950	4	the	the	DT
46745	3950	5	disorder	disorder	NN
46745	3950	6	is	be	VBZ
46745	3950	7	caused	cause	VBN
46745	3950	8	by	by	IN
46745	3950	9	an	an	DT
46745	3950	10	irritation	irritation	NN
46745	3950	11	of	of	IN
46745	3950	12	the	the	DT
46745	3950	13	nerves	nerve	NNS
46745	3950	14	of	of	IN
46745	3950	15	the	the	DT
46745	3950	16	part	part	NN
46745	3950	17	.	.	.
46745	3951	1	Neurotics	neurotic	NNS
46745	3951	2	are	be	VBP
46745	3951	3	medicines	medicine	NNS
46745	3951	4	which	which	WDT
46745	3951	5	tend	tend	VBP
46745	3951	6	,	,	,
46745	3951	7	immediately	immediately	RB
46745	3951	8	they	-PRON-	PRP
46745	3951	9	enter	enter	VBP
46745	3951	10	the	the	DT
46745	3951	11	blood	blood	NN
46745	3951	12	,	,	,
46745	3951	13	to	to	TO
46745	3951	14	be	be	VB
46745	3951	15	discharged	discharge	VBN
46745	3951	16	from	from	IN
46745	3951	17	it	-PRON-	PRP
46745	3951	18	upon	upon	IN
46745	3951	19	the	the	DT
46745	3951	20	nervous	nervous	JJ
46745	3951	21	system	system	NN
46745	3951	22	.	.	.
46745	3952	1	They	-PRON-	PRP
46745	3952	2	therefore	therefore	RB
46745	3952	3	immediately	immediately	RB
46745	3952	4	affect	affect	VBP
46745	3952	5	the	the	DT
46745	3952	6	latter	latter	JJ
46745	3952	7	.	.	.
46745	3953	1	Hæmatics	hæmatic	NNS
46745	3953	2	,	,	,
46745	3953	3	in	in	IN
46745	3953	4	small	small	JJ
46745	3953	5	doses	dose	NNS
46745	3953	6	,	,	,
46745	3953	7	pass	pass	VB
46745	3953	8	through	through	IN
46745	3953	9	the	the	DT
46745	3953	10	blood	blood	NN
46745	3953	11	without	without	IN
46745	3953	12	exerting	exert	VBG
46745	3953	13	any	any	DT
46745	3953	14	direct	direct	JJ
46745	3953	15	effect	effect	NN
46745	3953	16	upon	upon	IN
46745	3953	17	the	the	DT
46745	3953	18	nerves	nerve	NNS
46745	3953	19	.	.	.
46745	3954	1	They	-PRON-	PRP
46745	3954	2	are	be	VBP
46745	3954	3	never	never	RB
46745	3954	4	discharged	discharge	VBN
46745	3954	5	upon	upon	IN
46745	3954	6	the	the	DT
46745	3954	7	nervous	nervous	JJ
46745	3954	8	system	system	NN
46745	3954	9	except	except	IN
46745	3954	10	after	after	IN
46745	3954	11	they	-PRON-	PRP
46745	3954	12	have	have	VBP
46745	3954	13	for	for	IN
46745	3954	14	some	some	DT
46745	3954	15	time	time	NN
46745	3954	16	existed	exist	VBD
46745	3954	17	in	in	IN
46745	3954	18	the	the	DT
46745	3954	19	blood	blood	NN
46745	3954	20	in	in	IN
46745	3954	21	such	such	JJ
46745	3954	22	quantity	quantity	NN
46745	3954	23	as	as	IN
46745	3954	24	materially	materially	RB
46745	3954	25	to	to	TO
46745	3954	26	vitiate	vitiate	VB
46745	3954	27	its	-PRON-	PRP$
46745	3954	28	healthy	healthy	JJ
46745	3954	29	character	character	NN
46745	3954	30	.	.	.
46745	3955	1	Corrosive	corrosive	JJ
46745	3955	2	poisons	poison	NNS
46745	3955	3	affect	affect	VBP
46745	3955	4	the	the	DT
46745	3955	5	nerves	nerve	NNS
46745	3955	6	by	by	IN
46745	3955	7	a	a	DT
46745	3955	8	violent	violent	JJ
46745	3955	9	revulsive	revulsive	JJ
46745	3955	10	action	action	NN
46745	3955	11	;	;	,
46745	3955	12	and	and	CC
46745	3955	13	are	be	VBP
46745	3955	14	not	not	RB
46745	3955	15	to	to	TO
46745	3955	16	be	be	VB
46745	3955	17	considered	consider	VBN
46745	3955	18	in	in	IN
46745	3955	19	the	the	DT
46745	3955	20	same	same	JJ
46745	3955	21	category	category	NN
46745	3955	22	as	as	IN
46745	3955	23	medicines	medicine	NNS
46745	3955	24	.	.	.
46745	3956	1	Thus	thus	RB
46745	3956	2	Lead	Lead	NNP
46745	3956	3	is	be	VBZ
46745	3956	4	not	not	RB
46745	3956	5	a	a	DT
46745	3956	6	true	true	JJ
46745	3956	7	Neurotic	neurotic	JJ
46745	3956	8	,	,	,
46745	3956	9	but	but	CC
46745	3956	10	a	a	DT
46745	3956	11	blood	blood	NN
46745	3956	12	-	-	HYPH
46745	3956	13	medicine	medicine	NN
46745	3956	14	.	.	.
46745	3957	1	(	(	-LRB-
46745	3957	2	_	_	NNP
46745	3957	3	Vide	Vide	NNP
46745	3957	4	_	_	NNP
46745	3957	5	page	page	NN
46745	3957	6	175	175	CD
46745	3957	7	.	.	.
46745	3957	8	)	)	-RRB-
46745	3958	1	We	-PRON-	PRP
46745	3958	2	have	have	VBP
46745	3958	3	now	now	RB
46745	3958	4	concluded	conclude	VBN
46745	3958	5	our	-PRON-	PRP$
46745	3958	6	brief	brief	JJ
46745	3958	7	review	review	NN
46745	3958	8	of	of	IN
46745	3958	9	the	the	DT
46745	3958	10	action	action	NN
46745	3958	11	of	of	IN
46745	3958	12	Neurotic	neurotic	JJ
46745	3958	13	medicines	medicine	NNS
46745	3958	14	.	.	.
46745	3959	1	Some	some	DT
46745	3959	2	few	few	JJ
46745	3959	3	will	will	MD
46745	3959	4	be	be	VB
46745	3959	5	again	again	RB
46745	3959	6	treated	treat	VBN
46745	3959	7	of	of	IN
46745	3959	8	in	in	IN
46745	3959	9	the	the	DT
46745	3959	10	fourth	fourth	JJ
46745	3959	11	chapter	chapter	NN
46745	3959	12	.	.	.
46745	3960	1	The	the	DT
46745	3960	2	views	view	NNS
46745	3960	3	of	of	IN
46745	3960	4	their	-PRON-	PRP$
46745	3960	5	operation	operation	NN
46745	3960	6	which	which	WDT
46745	3960	7	I	-PRON-	PRP
46745	3960	8	have	have	VBP
46745	3960	9	wished	wish	VBN
46745	3960	10	to	to	TO
46745	3960	11	substantiate	substantiate	VB
46745	3960	12	are	be	VBP
46745	3960	13	in	in	IN
46745	3960	14	many	many	JJ
46745	3960	15	cases	case	NNS
46745	3960	16	the	the	DT
46745	3960	17	same	same	JJ
46745	3960	18	as	as	IN
46745	3960	19	those	those	DT
46745	3960	20	which	which	WDT
46745	3960	21	are	be	VBP
46745	3960	22	generally	generally	RB
46745	3960	23	adopted	adopt	VBN
46745	3960	24	,	,	,
46745	3960	25	in	in	IN
46745	3960	26	some	some	DT
46745	3960	27	cases	case	NNS
46745	3960	28	different	different	JJ
46745	3960	29	from	from	IN
46745	3960	30	them	-PRON-	PRP
46745	3960	31	.	.	.
46745	3961	1	In	in	IN
46745	3961	2	either	either	DT
46745	3961	3	instance	instance	NN
46745	3961	4	I	-PRON-	PRP
46745	3961	5	have	have	VBP
46745	3961	6	attempted	attempt	VBN
46745	3961	7	to	to	TO
46745	3961	8	base	base	VB
46745	3961	9	them	-PRON-	PRP
46745	3961	10	on	on	IN
46745	3961	11	observation	observation	NN
46745	3961	12	,	,	,
46745	3961	13	or	or	CC
46745	3961	14	on	on	IN
46745	3961	15	simple	simple	JJ
46745	3961	16	inductive	inductive	JJ
46745	3961	17	reasoning	reasoning	NN
46745	3961	18	.	.	.
46745	3962	1	It	-PRON-	PRP
46745	3962	2	has	have	VBZ
46745	3962	3	already	already	RB
46745	3962	4	been	be	VBN
46745	3962	5	observed	observe	VBN
46745	3962	6	that	that	IN
46745	3962	7	these	these	DT
46745	3962	8	nerve	nerve	NN
46745	3962	9	-	-	HYPH
46745	3962	10	medicines	medicine	NNS
46745	3962	11	are	be	VBP
46745	3962	12	more	more	RBR
46745	3962	13	rapid	rapid	JJ
46745	3962	14	and	and	CC
46745	3962	15	more	more	RBR
46745	3962	16	evanescent	evanescent	JJ
46745	3962	17	in	in	IN
46745	3962	18	their	-PRON-	PRP$
46745	3962	19	action	action	NN
46745	3962	20	than	than	IN
46745	3962	21	those	those	DT
46745	3962	22	which	which	WDT
46745	3962	23	preceded	precede	VBD
46745	3962	24	them	-PRON-	PRP
46745	3962	25	.	.	.
46745	3963	1	They	-PRON-	PRP
46745	3963	2	are	be	VBP
46745	3963	3	unable	unable	JJ
46745	3963	4	,	,	,
46745	3963	5	as	as	IN
46745	3963	6	a	a	DT
46745	3963	7	general	general	JJ
46745	3963	8	rule	rule	NN
46745	3963	9	,	,	,
46745	3963	10	to	to	TO
46745	3963	11	produce	produce	VB
46745	3963	12	a	a	DT
46745	3963	13	permanent	permanent	JJ
46745	3963	14	effect	effect	NN
46745	3963	15	.	.	.
46745	3964	1	When	when	WRB
46745	3964	2	such	such	PDT
46745	3964	3	a	a	DT
46745	3964	4	permanent	permanent	JJ
46745	3964	5	impression	impression	NN
46745	3964	6	is	be	VBZ
46745	3964	7	desired	desire	VBN
46745	3964	8	,	,	,
46745	3964	9	an	an	DT
46745	3964	10	approach	approach	NN
46745	3964	11	to	to	IN
46745	3964	12	it	-PRON-	PRP
46745	3964	13	can	can	MD
46745	3964	14	be	be	VB
46745	3964	15	made	make	VBN
46745	3964	16	by	by	IN
46745	3964	17	a	a	DT
46745	3964	18	continual	continual	JJ
46745	3964	19	repetition	repetition	NN
46745	3964	20	of	of	IN
46745	3964	21	the	the	DT
46745	3964	22	dose	dose	NN
46745	3964	23	,	,	,
46745	3964	24	by	by	IN
46745	3964	25	which	which	WDT
46745	3964	26	a	a	DT
46745	3964	27	transitory	transitory	JJ
46745	3964	28	action	action	NN
46745	3964	29	may	may	MD
46745	3964	30	be	be	VB
46745	3964	31	constantly	constantly	RB
46745	3964	32	renewed	renew	VBN
46745	3964	33	and	and	CC
46745	3964	34	kept	keep	VBD
46745	3964	35	up	up	RP
46745	3964	36	.	.	.
46745	3965	1	In	in	IN
46745	3965	2	other	other	JJ
46745	3965	3	cases	case	NNS
46745	3965	4	a	a	DT
46745	3965	5	mere	mere	JJ
46745	3965	6	transitory	transitory	JJ
46745	3965	7	action	action	NN
46745	3965	8	may	may	MD
46745	3965	9	produce	produce	VB
46745	3965	10	a	a	DT
46745	3965	11	cure	cure	NN
46745	3965	12	.	.	.
46745	3966	1	This	this	DT
46745	3966	2	may	may	MD
46745	3966	3	be	be	VB
46745	3966	4	the	the	DT
46745	3966	5	case	case	NN
46745	3966	6	in	in	IN
46745	3966	7	a	a	DT
46745	3966	8	sudden	sudden	JJ
46745	3966	9	and	and	CC
46745	3966	10	dangerous	dangerous	JJ
46745	3966	11	emergency	emergency	NN
46745	3966	12	,	,	,
46745	3966	13	which	which	WDT
46745	3966	14	will	will	MD
46745	3966	15	pass	pass	VB
46745	3966	16	over	over	RP
46745	3966	17	if	if	IN
46745	3966	18	the	the	DT
46745	3966	19	system	system	NN
46745	3966	20	can	can	MD
46745	3966	21	be	be	VB
46745	3966	22	supported	support	VBN
46745	3966	23	through	through	IN
46745	3966	24	it	-PRON-	PRP
46745	3966	25	,	,	,
46745	3966	26	but	but	CC
46745	3966	27	which	which	WDT
46745	3966	28	threatens	threaten	VBZ
46745	3966	29	life	life	NN
46745	3966	30	while	while	IN
46745	3966	31	it	-PRON-	PRP
46745	3966	32	lasts	last	VBZ
46745	3966	33	.	.	.
46745	3967	1	Or	or	CC
46745	3967	2	in	in	IN
46745	3967	3	Neuralgia	Neuralgia	NNP
46745	3967	4	,	,	,
46745	3967	5	if	if	IN
46745	3967	6	the	the	DT
46745	3967	7	irritability	irritability	NN
46745	3967	8	of	of	IN
46745	3967	9	the	the	DT
46745	3967	10	sensory	sensory	JJ
46745	3967	11	nerve	nerve	NN
46745	3967	12	be	be	VBP
46745	3967	13	continually	continually	RB
46745	3967	14	blunted	blunt	VBN
46745	3967	15	by	by	IN
46745	3967	16	the	the	DT
46745	3967	17	external	external	JJ
46745	3967	18	application	application	NN
46745	3967	19	of	of	IN
46745	3967	20	Aconite	Aconite	NNP
46745	3967	21	,	,	,
46745	3967	22	it	-PRON-	PRP
46745	3967	23	may	may	MD
46745	3967	24	at	at	IN
46745	3967	25	last	last	JJ
46745	3967	26	subside	subside	NN
46745	3967	27	altogether	altogether	RB
46745	3967	28	,	,	,
46745	3967	29	and	and	CC
46745	3967	30	a	a	DT
46745	3967	31	right	right	JJ
46745	3967	32	condition	condition	NN
46745	3967	33	of	of	IN
46745	3967	34	things	thing	NNS
46745	3967	35	be	be	VB
46745	3967	36	restored	restore	VBN
46745	3967	37	.	.	.
46745	3968	1	The	the	DT
46745	3968	2	same	same	JJ
46745	3968	3	may	may	MD
46745	3968	4	be	be	VB
46745	3968	5	said	say	VBN
46745	3968	6	of	of	IN
46745	3968	7	convulsive	convulsive	NN
46745	3968	8	disorders	disorder	NNS
46745	3968	9	,	,	,
46745	3968	10	and	and	CC
46745	3968	11	the	the	DT
46745	3968	12	stimulant	stimulant	NN
46745	3968	13	antispasmodics	antispasmodic	NNS
46745	3968	14	which	which	WDT
46745	3968	15	are	be	VBP
46745	3968	16	used	use	VBN
46745	3968	17	to	to	TO
46745	3968	18	control	control	VB
46745	3968	19	them	-PRON-	PRP
46745	3968	20	.	.	.
46745	3969	1	Neurotics	neurotic	NNS
46745	3969	2	are	be	VBP
46745	3969	3	mostly	mostly	RB
46745	3969	4	employed	employ	VBN
46745	3969	5	in	in	IN
46745	3969	6	temporary	temporary	JJ
46745	3969	7	emergencies	emergency	NNS
46745	3969	8	.	.	.
46745	3970	1	In	in	IN
46745	3970	2	such	such	JJ
46745	3970	3	cases	case	NNS
46745	3970	4	their	-PRON-	PRP$
46745	3970	5	action	action	NN
46745	3970	6	is	be	VBZ
46745	3970	7	often	often	RB
46745	3970	8	decisive	decisive	JJ
46745	3970	9	and	and	CC
46745	3970	10	gratifying	gratifying	JJ
46745	3970	11	.	.	.
46745	3971	1	Vital	vital	JJ
46745	3971	2	action	action	NN
46745	3971	3	may	may	MD
46745	3971	4	be	be	VB
46745	3971	5	restored	restore	VBN
46745	3971	6	and	and	CC
46745	3971	7	kept	keep	VBN
46745	3971	8	up	up	RP
46745	3971	9	;	;	:
46745	3971	10	or	or	CC
46745	3971	11	excess	excess	NN
46745	3971	12	of	of	IN
46745	3971	13	action	action	NN
46745	3971	14	allayed	allay	VBD
46745	3971	15	.	.	.
46745	3972	1	Pain	pain	NN
46745	3972	2	may	may	MD
46745	3972	3	be	be	VB
46745	3972	4	suddenly	suddenly	RB
46745	3972	5	and	and	CC
46745	3972	6	effectually	effectually	RB
46745	3972	7	removed	remove	VBN
46745	3972	8	;	;	:
46745	3972	9	delirium	delirium	NN
46745	3972	10	or	or	CC
46745	3972	11	convulsions	convulsion	NNS
46745	3972	12	subdued	subdue	VBD
46745	3972	13	.	.	.
46745	3973	1	Sleep	sleep	NN
46745	3973	2	may	may	MD
46745	3973	3	be	be	VB
46745	3973	4	substituted	substitute	VBN
46745	3973	5	for	for	IN
46745	3973	6	wakefulness	wakefulness	NN
46745	3973	7	,	,	,
46745	3973	8	or	or	CC
46745	3973	9	activity	activity	NN
46745	3973	10	for	for	IN
46745	3973	11	torpor	torpor	NN
46745	3973	12	.	.	.
46745	3974	1	By	by	IN
46745	3974	2	these	these	DT
46745	3974	3	powerful	powerful	JJ
46745	3974	4	remedies	remedy	NNS
46745	3974	5	we	-PRON-	PRP
46745	3974	6	are	be	VBP
46745	3974	7	enabled	enable	VBN
46745	3974	8	to	to	TO
46745	3974	9	exert	exert	VB
46745	3974	10	an	an	DT
46745	3974	11	immense	immense	JJ
46745	3974	12	control	control	NN
46745	3974	13	over	over	IN
46745	3974	14	the	the	DT
46745	3974	15	varied	varied	JJ
46745	3974	16	manifestations	manifestation	NNS
46745	3974	17	of	of	IN
46745	3974	18	nervous	nervous	JJ
46745	3974	19	force	force	NN
46745	3974	20	;	;	:
46745	3974	21	and	and	CC
46745	3974	22	may	may	MD
46745	3974	23	often	often	RB
46745	3974	24	,	,	,
46745	3974	25	when	when	WRB
46745	3974	26	we	-PRON-	PRP
46745	3974	27	wish	wish	VBP
46745	3974	28	it	-PRON-	PRP
46745	3974	29	,	,	,
46745	3974	30	substitute	substitute	VB
46745	3974	31	one	one	CD
46745	3974	32	condition	condition	NN
46745	3974	33	for	for	IN
46745	3974	34	another	another	DT
46745	3974	35	which	which	WDT
46745	3974	36	is	be	VBZ
46745	3974	37	the	the	DT
46745	3974	38	reverse	reverse	NN
46745	3974	39	of	of	IN
46745	3974	40	it	-PRON-	PRP
46745	3974	41	.	.	.
46745	3975	1	When	when	WRB
46745	3975	2	there	there	EX
46745	3975	3	is	be	VBZ
46745	3975	4	a	a	DT
46745	3975	5	deficiency	deficiency	NN
46745	3975	6	of	of	IN
46745	3975	7	nervous	nervous	JJ
46745	3975	8	force	force	NN
46745	3975	9	,	,	,
46745	3975	10	we	-PRON-	PRP
46745	3975	11	make	make	VBP
46745	3975	12	use	use	NN
46745	3975	13	of	of	IN
46745	3975	14	a	a	DT
46745	3975	15	Stimulant	Stimulant	NNP
46745	3975	16	,	,	,
46745	3975	17	or	or	CC
46745	3975	18	of	of	IN
46745	3975	19	one	one	CD
46745	3975	20	of	of	IN
46745	3975	21	the	the	DT
46745	3975	22	Inebriant	Inebriant	NNP
46745	3975	23	Narcotics	Narcotics	NNPS
46745	3975	24	;	;	:
46745	3975	25	when	when	WRB
46745	3975	26	there	there	EX
46745	3975	27	is	be	VBZ
46745	3975	28	an	an	DT
46745	3975	29	excess	excess	NN
46745	3975	30	of	of	IN
46745	3975	31	the	the	DT
46745	3975	32	same	same	JJ
46745	3975	33	,	,	,
46745	3975	34	we	-PRON-	PRP
46745	3975	35	employ	employ	VBP
46745	3975	36	a	a	DT
46745	3975	37	Sedative	Sedative	NNP
46745	3975	38	,	,	,
46745	3975	39	or	or	CC
46745	3975	40	one	one	CD
46745	3975	41	of	of	IN
46745	3975	42	the	the	DT
46745	3975	43	latter	latter	JJ
46745	3975	44	two	two	CD
46745	3975	45	Narcotic	narcotic	JJ
46745	3975	46	orders	order	NNS
46745	3975	47	.	.	.
46745	3976	1	But	but	CC
46745	3976	2	when	when	WRB
46745	3976	3	we	-PRON-	PRP
46745	3976	4	desire	desire	VBP
46745	3976	5	to	to	TO
46745	3976	6	quell	quell	VB
46745	3976	7	a	a	DT
46745	3976	8	long	long	RB
46745	3976	9	-	-	HYPH
46745	3976	10	standing	stand	VBG
46745	3976	11	and	and	CC
46745	3976	12	firmly	firmly	RB
46745	3976	13	-	-	HYPH
46745	3976	14	rooted	root	VBN
46745	3976	15	disorder	disorder	NN
46745	3976	16	,	,	,
46745	3976	17	which	which	WDT
46745	3976	18	is	be	VBZ
46745	3976	19	not	not	RB
46745	3976	20	displayed	display	VBN
46745	3976	21	by	by	IN
46745	3976	22	violent	violent	JJ
46745	3976	23	outward	outward	JJ
46745	3976	24	manifestations	manifestation	NNS
46745	3976	25	,	,	,
46745	3976	26	but	but	CC
46745	3976	27	is	be	VBZ
46745	3976	28	nevertheless	nevertheless	RB
46745	3976	29	working	work	VBG
46745	3976	30	fatally	fatally	RB
46745	3976	31	within	within	RB
46745	3976	32	,	,	,
46745	3976	33	we	-PRON-	PRP
46745	3976	34	must	must	MD
46745	3976	35	then	then	RB
46745	3976	36	call	call	VB
46745	3976	37	to	to	IN
46745	3976	38	our	-PRON-	PRP$
46745	3976	39	aid	aid	NN
46745	3976	40	some	some	DT
46745	3976	41	Hæmatic	hæmatic	JJ
46745	3976	42	medicine	medicine	NN
46745	3976	43	,	,	,
46745	3976	44	which	which	WDT
46745	3976	45	alone	alone	RB
46745	3976	46	can	can	MD
46745	3976	47	be	be	VB
46745	3976	48	of	of	IN
46745	3976	49	permanent	permanent	JJ
46745	3976	50	efficacy	efficacy	NN
46745	3976	51	in	in	IN
46745	3976	52	such	such	PDT
46745	3976	53	a	a	DT
46745	3976	54	case	case	NN
46745	3976	55	.	.	.
46745	3977	1	PROP	PROP	NNP
46745	3977	2	.	.	.
46745	3978	1	IX.--_That	ix.--_that	IN
46745	3978	2	a	a	DT
46745	3978	3	third	third	JJ
46745	3978	4	class	class	NN
46745	3978	5	of	of	IN
46745	3978	6	medicines	medicine	NNS
46745	3978	7	,	,	,
46745	3978	8	called	call	VBD
46745	3978	9	_	_	NNP
46745	3978	10	ASTRINGENTS	ASTRINGENTS	NNP
46745	3978	11	,	,	,
46745	3978	12	_	_	NNP
46745	3978	13	act	act	NN
46745	3978	14	by	by	IN
46745	3978	15	passing	pass	VBG
46745	3978	16	from	from	IN
46745	3978	17	the	the	DT
46745	3978	18	blood	blood	NN
46745	3978	19	to	to	IN
46745	3978	20	muscular	muscular	JJ
46745	3978	21	fibre	fibre	NNP
46745	3978	22	,	,	,
46745	3978	23	which	which	WDT
46745	3978	24	they	-PRON-	PRP
46745	3978	25	excite	excite	VBP
46745	3978	26	to	to	IN
46745	3978	27	contraction	contraction	NN
46745	3978	28	.	.	.
46745	3978	29	_	_	NNP
46745	3978	30	Although	although	IN
46745	3978	31	this	this	DT
46745	3978	32	class	class	NN
46745	3978	33	of	of	IN
46745	3978	34	Astringents	astringent	NNS
46745	3978	35	is	be	VBZ
46745	3978	36	a	a	DT
46745	3978	37	small	small	JJ
46745	3978	38	and	and	CC
46745	3978	39	comparatively	comparatively	RB
46745	3978	40	unimportant	unimportant	JJ
46745	3978	41	class	class	NN
46745	3978	42	,	,	,
46745	3978	43	yet	yet	CC
46745	3978	44	it	-PRON-	PRP
46745	3978	45	is	be	VBZ
46745	3978	46	necessary	necessary	JJ
46745	3978	47	to	to	TO
46745	3978	48	separate	separate	VB
46745	3978	49	it	-PRON-	PRP
46745	3978	50	from	from	IN
46745	3978	51	all	all	PDT
46745	3978	52	the	the	DT
46745	3978	53	others	other	NNS
46745	3978	54	,	,	,
46745	3978	55	because	because	IN
46745	3978	56	the	the	DT
46745	3978	57	medicines	medicine	NNS
46745	3978	58	which	which	WDT
46745	3978	59	compose	compose	VBP
46745	3978	60	it	-PRON-	PRP
46745	3978	61	are	be	VBP
46745	3978	62	completely	completely	RB
46745	3978	63	distinct	distinct	JJ
46745	3978	64	in	in	IN
46745	3978	65	their	-PRON-	PRP$
46745	3978	66	mode	mode	NN
46745	3978	67	of	of	IN
46745	3978	68	operation	operation	NN
46745	3978	69	.	.	.
46745	3979	1	They	-PRON-	PRP
46745	3979	2	do	do	VBP
46745	3979	3	not	not	RB
46745	3979	4	necessarily	necessarily	RB
46745	3979	5	act	act	VB
46745	3979	6	in	in	IN
46745	3979	7	the	the	DT
46745	3979	8	blood	blood	NN
46745	3979	9	,	,	,
46745	3979	10	although	although	IN
46745	3979	11	many	many	JJ
46745	3979	12	Hæmatics	Hæmatics	NNPS
46745	3979	13	are	be	VBP
46745	3979	14	also	also	RB
46745	3979	15	astringent	astringent	JJ
46745	3979	16	.	.	.
46745	3980	1	They	-PRON-	PRP
46745	3980	2	do	do	VBP
46745	3980	3	not	not	RB
46745	3980	4	pass	pass	VB
46745	3980	5	from	from	IN
46745	3980	6	the	the	DT
46745	3980	7	blood	blood	NN
46745	3980	8	to	to	IN
46745	3980	9	the	the	DT
46745	3980	10	nerves	nerve	NNS
46745	3980	11	.	.	.
46745	3981	1	They	-PRON-	PRP
46745	3981	2	do	do	VBP
46745	3981	3	not	not	RB
46745	3981	4	always	always	RB
46745	3981	5	act	act	VB
46745	3981	6	by	by	IN
46745	3981	7	passing	pass	VBG
46745	3981	8	out	out	IN
46745	3981	9	of	of	IN
46745	3981	10	the	the	DT
46745	3981	11	body	body	NN
46745	3981	12	through	through	IN
46745	3981	13	the	the	DT
46745	3981	14	glands	gland	NNS
46745	3981	15	.	.	.
46745	3982	1	Their	-PRON-	PRP$
46745	3982	2	operation	operation	NN
46745	3982	3	is	be	VBZ
46745	3982	4	peculiar	peculiar	JJ
46745	3982	5	,	,	,
46745	3982	6	but	but	CC
46745	3982	7	it	-PRON-	PRP
46745	3982	8	is	be	VBZ
46745	3982	9	simple	simple	JJ
46745	3982	10	.	.	.
46745	3983	1	As	as	IN
46745	3983	2	Neurotics	Neurotics	NNP
46745	3983	3	act	act	VBP
46745	3983	4	directly	directly	RB
46745	3983	5	on	on	IN
46745	3983	6	nerve	nerve	NN
46745	3983	7	,	,	,
46745	3983	8	so	so	IN
46745	3983	9	these	these	DT
46745	3983	10	act	act	VBP
46745	3983	11	directly	directly	RB
46745	3983	12	and	and	CC
46745	3983	13	especially	especially	RB
46745	3983	14	on	on	IN
46745	3983	15	muscular	muscular	JJ
46745	3983	16	fibre	fibre	NN
46745	3983	17	.	.	.
46745	3984	1	They	-PRON-	PRP
46745	3984	2	cause	cause	VBP
46745	3984	3	this	this	DT
46745	3984	4	to	to	TO
46745	3984	5	contract	contract	VB
46745	3984	6	,	,	,
46745	3984	7	whether	whether	IN
46745	3984	8	it	-PRON-	PRP
46745	3984	9	be	be	VB
46745	3984	10	striped	stripe	VBN
46745	3984	11	and	and	CC
46745	3984	12	voluntary	voluntary	JJ
46745	3984	13	,	,	,
46745	3984	14	or	or	CC
46745	3984	15	of	of	IN
46745	3984	16	the	the	DT
46745	3984	17	involuntary	involuntary	JJ
46745	3984	18	unstriped	unstriped	JJ
46745	3984	19	kind	kind	NN
46745	3984	20	.	.	.
46745	3985	1	Their	-PRON-	PRP$
46745	3985	2	action	action	NN
46745	3985	3	is	be	VBZ
46745	3985	4	more	more	RBR
46745	3985	5	readily	readily	RB
46745	3985	6	understood	understand	VBN
46745	3985	7	,	,	,
46745	3985	8	because	because	IN
46745	3985	9	it	-PRON-	PRP
46745	3985	10	can	can	MD
46745	3985	11	actually	actually	RB
46745	3985	12	be	be	VB
46745	3985	13	seen	see	VBN
46745	3985	14	.	.	.
46745	3986	1	It	-PRON-	PRP
46745	3986	2	takes	take	VBZ
46745	3986	3	place	place	NN
46745	3986	4	out	out	IN
46745	3986	5	of	of	IN
46745	3986	6	the	the	DT
46745	3986	7	body	body	NN
46745	3986	8	,	,	,
46745	3986	9	or	or	CC
46745	3986	10	in	in	IN
46745	3986	11	the	the	DT
46745	3986	12	body	body	NN
46745	3986	13	--	--	:
46745	3986	14	externally	externally	RB
46745	3986	15	,	,	,
46745	3986	16	or	or	CC
46745	3986	17	internally	internally	RB
46745	3986	18	.	.	.
46745	3987	1	Nearly	nearly	RB
46745	3987	2	all	all	DT
46745	3987	3	astringents	astringent	NNS
46745	3987	4	have	have	VBP
46745	3987	5	the	the	DT
46745	3987	6	power	power	NN
46745	3987	7	of	of	IN
46745	3987	8	coagulating	coagulate	VBG
46745	3987	9	or	or	CC
46745	3987	10	precipitating	precipitate	VBG
46745	3987	11	albumen	albuman	NNS
46745	3987	12	.	.	.
46745	3988	1	By	by	IN
46745	3988	2	virtue	virtue	NN
46745	3988	3	of	of	IN
46745	3988	4	this	this	DT
46745	3988	5	power	power	NN
46745	3988	6	they	-PRON-	PRP
46745	3988	7	are	be	VBP
46745	3988	8	enabled	enable	VBN
46745	3988	9	to	to	TO
46745	3988	10	constrict	constrict	VB
46745	3988	11	many	many	JJ
46745	3988	12	dead	dead	JJ
46745	3988	13	animal	animal	NN
46745	3988	14	matters	matter	NNS
46745	3988	15	.	.	.
46745	3989	1	They	-PRON-	PRP
46745	3989	2	affect	affect	VBP
46745	3989	3	fibrinous	fibrinous	JJ
46745	3989	4	tissues	tissue	NNS
46745	3989	5	in	in	IN
46745	3989	6	a	a	DT
46745	3989	7	similar	similar	JJ
46745	3989	8	chemical	chemical	NN
46745	3989	9	way	way	NN
46745	3989	10	.	.	.
46745	3990	1	But	but	CC
46745	3990	2	they	-PRON-	PRP
46745	3990	3	seem	seem	VBP
46745	3990	4	to	to	TO
46745	3990	5	possess	possess	VB
46745	3990	6	a	a	DT
46745	3990	7	further	further	JJ
46745	3990	8	dynamical	dynamical	JJ
46745	3990	9	influence	influence	NN
46745	3990	10	over	over	IN
46745	3990	11	living	living	NN
46745	3990	12	tissues	tissue	NNS
46745	3990	13	,	,	,
46745	3990	14	which	which	WDT
46745	3990	15	possibly	possibly	RB
46745	3990	16	depends	depend	VBZ
46745	3990	17	in	in	IN
46745	3990	18	some	some	DT
46745	3990	19	way	way	NN
46745	3990	20	on	on	IN
46745	3990	21	this	this	DT
46745	3990	22	chemical	chemical	JJ
46745	3990	23	property	property	NN
46745	3990	24	.	.	.
46745	3991	1	This	this	DT
46745	3991	2	dynamical	dynamical	JJ
46745	3991	3	influence	influence	NN
46745	3991	4	is	be	VBZ
46745	3991	5	,	,	,
46745	3991	6	as	as	IN
46745	3991	7	I	-PRON-	PRP
46745	3991	8	have	have	VBP
46745	3991	9	said	say	VBD
46745	3991	10	,	,	,
46745	3991	11	to	to	TO
46745	3991	12	cause	cause	VB
46745	3991	13	the	the	DT
46745	3991	14	contraction	contraction	NN
46745	3991	15	of	of	IN
46745	3991	16	muscular	muscular	JJ
46745	3991	17	fibre	fibre	NNP
46745	3991	18	.	.	.
46745	3992	1	By	by	IN
46745	3992	2	this	this	DT
46745	3992	3	all	all	PDT
46745	3992	4	their	-PRON-	PRP$
46745	3992	5	operations	operation	NNS
46745	3992	6	can	can	MD
46745	3992	7	be	be	VB
46745	3992	8	explained	explain	VBN
46745	3992	9	.	.	.
46745	3993	1	Taken	take	VBN
46745	3993	2	into	into	IN
46745	3993	3	the	the	DT
46745	3993	4	blood	blood	NN
46745	3993	5	in	in	IN
46745	3993	6	a	a	DT
46745	3993	7	state	state	NN
46745	3993	8	of	of	IN
46745	3993	9	solution	solution	NN
46745	3993	10	,	,	,
46745	3993	11	they	-PRON-	PRP
46745	3993	12	pass	pass	VBP
46745	3993	13	through	through	IN
46745	3993	14	the	the	DT
46745	3993	15	walls	wall	NNS
46745	3993	16	of	of	IN
46745	3993	17	the	the	DT
46745	3993	18	capillaries	capillary	NNS
46745	3993	19	to	to	IN
46745	3993	20	the	the	DT
46745	3993	21	muscular	muscular	JJ
46745	3993	22	tissue	tissue	NN
46745	3993	23	.	.	.
46745	3994	1	By	by	IN
46745	3994	2	inducing	induce	VBG
46745	3994	3	the	the	DT
46745	3994	4	fibre	fibre	NN
46745	3994	5	of	of	IN
46745	3994	6	the	the	DT
46745	3994	7	voluntary	voluntary	JJ
46745	3994	8	muscles	muscle	NNS
46745	3994	9	to	to	TO
46745	3994	10	contract	contract	VB
46745	3994	11	,	,	,
46745	3994	12	Astringents	Astringents	NNP
46745	3994	13	may	may	MD
46745	3994	14	brace	brace	VB
46745	3994	15	the	the	DT
46745	3994	16	system	system	NN
46745	3994	17	,	,	,
46745	3994	18	and	and	CC
46745	3994	19	simulate	simulate	VB
46745	3994	20	the	the	DT
46745	3994	21	action	action	NN
46745	3994	22	of	of	IN
46745	3994	23	Tonics	Tonics	NNP
46745	3994	24	.	.	.
46745	3995	1	But	but	CC
46745	3995	2	as	as	IN
46745	3995	3	the	the	DT
46745	3995	4	contraction	contraction	NN
46745	3995	5	of	of	IN
46745	3995	6	voluntary	voluntary	JJ
46745	3995	7	muscle	muscle	NN
46745	3995	8	is	be	VBZ
46745	3995	9	short	short	JJ
46745	3995	10	and	and	CC
46745	3995	11	brief	brief	JJ
46745	3995	12	,	,	,
46745	3995	13	it	-PRON-	PRP
46745	3995	14	requires	require	VBZ
46745	3995	15	for	for	IN
46745	3995	16	its	-PRON-	PRP$
46745	3995	17	maintenance	maintenance	NN
46745	3995	18	a	a	DT
46745	3995	19	continual	continual	JJ
46745	3995	20	excitation	excitation	NN
46745	3995	21	,	,	,
46745	3995	22	and	and	CC
46745	3995	23	unless	unless	IN
46745	3995	24	the	the	DT
46745	3995	25	medicine	medicine	NN
46745	3995	26	is	be	VBZ
46745	3995	27	thus	thus	RB
46745	3995	28	continually	continually	RB
46745	3995	29	repeated	repeat	VBN
46745	3995	30	,	,	,
46745	3995	31	the	the	DT
46745	3995	32	tonic	tonic	NN
46745	3995	33	effect	effect	NN
46745	3995	34	subsides	subside	NNS
46745	3995	35	.	.	.
46745	3996	1	But	but	CC
46745	3996	2	astringents	astringent	NNS
46745	3996	3	further	further	JJ
46745	3996	4	contract	contract	NN
46745	3996	5	involuntary	involuntary	JJ
46745	3996	6	muscle	muscle	NN
46745	3996	7	.	.	.
46745	3997	1	This	this	DT
46745	3997	2	contraction	contraction	NN
46745	3997	3	is	be	VBZ
46745	3997	4	slower	slow	JJR
46745	3997	5	,	,	,
46745	3997	6	and	and	CC
46745	3997	7	more	more	RBR
46745	3997	8	durable	durable	JJ
46745	3997	9	and	and	CC
46745	3997	10	important	important	JJ
46745	3997	11	in	in	IN
46745	3997	12	its	-PRON-	PRP$
46745	3997	13	results	result	NNS
46745	3997	14	.	.	.
46745	3998	1	Unstriped	unstriped	JJ
46745	3998	2	muscular	muscular	JJ
46745	3998	3	fibres	fibre	NNS
46745	3998	4	exist	exist	VBP
46745	3998	5	in	in	IN
46745	3998	6	the	the	DT
46745	3998	7	middle	middle	JJ
46745	3998	8	coat	coat	NN
46745	3998	9	of	of	IN
46745	3998	10	arteries	artery	NNS
46745	3998	11	,	,	,
46745	3998	12	in	in	IN
46745	3998	13	the	the	DT
46745	3998	14	walls	wall	NNS
46745	3998	15	of	of	IN
46745	3998	16	capillary	capillary	JJ
46745	3998	17	vessels	vessel	NNS
46745	3998	18	,	,	,
46745	3998	19	in	in	IN
46745	3998	20	the	the	DT
46745	3998	21	lining	lining	NN
46745	3998	22	of	of	IN
46745	3998	23	the	the	DT
46745	3998	24	ducts	duct	NNS
46745	3998	25	of	of	IN
46745	3998	26	glands	gland	NNS
46745	3998	27	generally	generally	RB
46745	3998	28	,	,	,
46745	3998	29	and	and	CC
46745	3998	30	in	in	IN
46745	3998	31	the	the	DT
46745	3998	32	substance	substance	NN
46745	3998	33	of	of	IN
46745	3998	34	the	the	DT
46745	3998	35	heart	heart	NN
46745	3998	36	and	and	CC
46745	3998	37	the	the	DT
46745	3998	38	coats	coat	NNS
46745	3998	39	of	of	IN
46745	3998	40	the	the	DT
46745	3998	41	stomach	stomach	NN
46745	3998	42	and	and	CC
46745	3998	43	intestines	intestine	NNS
46745	3998	44	.	.	.
46745	3999	1	Astringents	astringent	NNS
46745	3999	2	are	be	VBP
46745	3999	3	irritant	irritant	JJ
46745	3999	4	and	and	CC
46745	3999	5	poisonous	poisonous	JJ
46745	3999	6	in	in	IN
46745	3999	7	large	large	JJ
46745	3999	8	doses	dose	NNS
46745	3999	9	.	.	.
46745	4000	1	But	but	CC
46745	4000	2	in	in	IN
46745	4000	3	small	small	JJ
46745	4000	4	doses	dose	NNS
46745	4000	5	they	-PRON-	PRP
46745	4000	6	constrict	constrict	VBP
46745	4000	7	and	and	CC
46745	4000	8	stimulate	stimulate	VBP
46745	4000	9	to	to	IN
46745	4000	10	a	a	DT
46745	4000	11	healthy	healthy	JJ
46745	4000	12	condition	condition	NN
46745	4000	13	these	these	DT
46745	4000	14	tubes	tube	NNS
46745	4000	15	that	that	WDT
46745	4000	16	contain	contain	VBP
46745	4000	17	in	in	IN
46745	4000	18	their	-PRON-	PRP$
46745	4000	19	coats	coat	NNS
46745	4000	20	the	the	DT
46745	4000	21	unstriped	unstriped	JJ
46745	4000	22	fibre	fibre	NN
46745	4000	23	.	.	.
46745	4001	1	By	by	IN
46745	4001	2	diminishing	diminish	VBG
46745	4001	3	the	the	DT
46745	4001	4	caliber	caliber	NN
46745	4001	5	of	of	IN
46745	4001	6	the	the	DT
46745	4001	7	capillary	capillary	JJ
46745	4001	8	vessels	vessel	NNS
46745	4001	9	generally	generally	RB
46745	4001	10	,	,	,
46745	4001	11	they	-PRON-	PRP
46745	4001	12	promote	promote	VBP
46745	4001	13	health	health	NN
46745	4001	14	,	,	,
46745	4001	15	and	and	CC
46745	4001	16	counteract	counteract	VB
46745	4001	17	a	a	DT
46745	4001	18	lax	lax	NN
46745	4001	19	state	state	NN
46745	4001	20	of	of	IN
46745	4001	21	the	the	DT
46745	4001	22	system	system	NN
46745	4001	23	.	.	.
46745	4002	1	By	by	IN
46745	4002	2	the	the	DT
46745	4002	3	same	same	JJ
46745	4002	4	action	action	NN
46745	4002	5	on	on	IN
46745	4002	6	the	the	DT
46745	4002	7	extreme	extreme	JJ
46745	4002	8	vessels	vessel	NNS
46745	4002	9	,	,	,
46745	4002	10	they	-PRON-	PRP
46745	4002	11	prevent	prevent	VBP
46745	4002	12	hæmorrhages	hæmorrhage	NNS
46745	4002	13	.	.	.
46745	4003	1	By	by	IN
46745	4003	2	constricting	constrict	VBG
46745	4003	3	the	the	DT
46745	4003	4	ducts	duct	NNS
46745	4003	5	of	of	IN
46745	4003	6	the	the	DT
46745	4003	7	glands	gland	NNS
46745	4003	8	they	-PRON-	PRP
46745	4003	9	diminish	diminish	VBP
46745	4003	10	the	the	DT
46745	4003	11	secretion	secretion	NN
46745	4003	12	of	of	IN
46745	4003	13	those	those	DT
46745	4003	14	glands	gland	NNS
46745	4003	15	,	,	,
46745	4003	16	because	because	IN
46745	4003	17	denying	deny	VBG
46745	4003	18	it	-PRON-	PRP
46745	4003	19	an	an	DT
46745	4003	20	exit	exit	NN
46745	4003	21	.	.	.
46745	4004	1	By	by	IN
46745	4004	2	acting	act	VBG
46745	4004	3	on	on	IN
46745	4004	4	the	the	DT
46745	4004	5	stomach	stomach	NN
46745	4004	6	and	and	CC
46745	4004	7	intestines	intestine	NNS
46745	4004	8	,	,	,
46745	4004	9	they	-PRON-	PRP
46745	4004	10	are	be	VBP
46745	4004	11	able	able	JJ
46745	4004	12	to	to	TO
46745	4004	13	give	give	VB
46745	4004	14	them	-PRON-	PRP
46745	4004	15	tone	tone	NN
46745	4004	16	,	,	,
46745	4004	17	to	to	TO
46745	4004	18	diminish	diminish	VB
46745	4004	19	their	-PRON-	PRP$
46745	4004	20	secretions	secretion	NNS
46745	4004	21	when	when	WRB
46745	4004	22	excessive	excessive	JJ
46745	4004	23	,	,	,
46745	4004	24	and	and	CC
46745	4004	25	thus	thus	RB
46745	4004	26	to	to	TO
46745	4004	27	promote	promote	VB
46745	4004	28	digestion	digestion	NN
46745	4004	29	.	.	.
46745	4005	1	Having	have	VBG
46745	4005	2	premised	premise	VBN
46745	4005	3	this	this	DT
46745	4005	4	general	general	JJ
46745	4005	5	view	view	NN
46745	4005	6	of	of	IN
46745	4005	7	their	-PRON-	PRP$
46745	4005	8	action	action	NN
46745	4005	9	,	,	,
46745	4005	10	we	-PRON-	PRP
46745	4005	11	may	may	MD
46745	4005	12	now	now	RB
46745	4005	13	proceed	proceed	VB
46745	4005	14	to	to	TO
46745	4005	15	prove	prove	VB
46745	4005	16	the	the	DT
46745	4005	17	Proposition	Proposition	NNP
46745	4005	18	in	in	IN
46745	4005	19	which	which	WDT
46745	4005	20	it	-PRON-	PRP
46745	4005	21	is	be	VBZ
46745	4005	22	stated	state	VBN
46745	4005	23	,	,	,
46745	4005	24	dividing	divide	VBG
46745	4005	25	it	-PRON-	PRP
46745	4005	26	first	first	RB
46745	4005	27	into	into	IN
46745	4005	28	four	four	CD
46745	4005	29	minor	minor	JJ
46745	4005	30	propositions	proposition	NNS
46745	4005	31	.	.	.
46745	4006	1	_	_	NNP
46745	4006	2	m.	m.	NN
46745	4007	1	p.	p.	NN
46745	4007	2	1._--That	1._--that	CD
46745	4007	3	they	-PRON-	PRP
46745	4007	4	are	be	VBP
46745	4007	5	medicines	medicine	NNS
46745	4007	6	which	which	WDT
46745	4007	7	pass	pass	VBP
46745	4007	8	into	into	IN
46745	4007	9	the	the	DT
46745	4007	10	blood	blood	NN
46745	4007	11	.	.	.
46745	4008	1	_	_	NNP
46745	4008	2	m.	m.	NN
46745	4009	1	p.	p.	NN
46745	4009	2	2._--That	2._--that	CD
46745	4009	3	they	-PRON-	PRP
46745	4009	4	have	have	VBP
46745	4009	5	the	the	DT
46745	4009	6	power	power	NN
46745	4009	7	of	of	IN
46745	4009	8	causing	cause	VBG
46745	4009	9	the	the	DT
46745	4009	10	contraction	contraction	NN
46745	4009	11	of	of	IN
46745	4009	12	muscular	muscular	JJ
46745	4009	13	fibre	fibre	NNP
46745	4009	14	,	,	,
46745	4009	15	living	living	NN
46745	4009	16	or	or	CC
46745	4009	17	dead	dead	JJ
46745	4009	18	.	.	.
46745	4010	1	_	_	NNP
46745	4010	2	m.	m.	NN
46745	4011	1	p.	p.	NN
46745	4011	2	3._--That	3._--that	CD
46745	4011	3	their	-PRON-	PRP$
46745	4011	4	operation	operation	NN
46745	4011	5	is	be	VBZ
46745	4011	6	to	to	TO
46745	4011	7	diminish	diminish	VB
46745	4011	8	secretion	secretion	NN
46745	4011	9	,	,	,
46745	4011	10	to	to	TO
46745	4011	11	repress	repress	VB
46745	4011	12	hæmorrhage	hæmorrhage	NN
46745	4011	13	,	,	,
46745	4011	14	and	and	CC
46745	4011	15	to	to	TO
46745	4011	16	give	give	VB
46745	4011	17	tone	tone	NN
46745	4011	18	to	to	IN
46745	4011	19	the	the	DT
46745	4011	20	muscular	muscular	JJ
46745	4011	21	system	system	NN
46745	4011	22	.	.	.
46745	4012	1	_	_	NNP
46745	4012	2	m.	m.	NN
46745	4013	1	p.	p.	NN
46745	4013	2	4._--That	4._--that	CD
46745	4013	3	these	these	DT
46745	4013	4	results	result	NNS
46745	4013	5	are	be	VBP
46745	4013	6	to	to	TO
46745	4013	7	be	be	VB
46745	4013	8	accounted	account	VBN
46745	4013	9	for	for	IN
46745	4013	10	by	by	IN
46745	4013	11	their	-PRON-	PRP$
46745	4013	12	action	action	NN
46745	4013	13	on	on	IN
46745	4013	14	muscular	muscular	JJ
46745	4013	15	fibre	fibre	NN
46745	4013	16	,	,	,
46745	4013	17	to	to	TO
46745	4013	18	which	which	WDT
46745	4013	19	they	-PRON-	PRP
46745	4013	20	pass	pass	VBP
46745	4013	21	from	from	IN
46745	4013	22	the	the	DT
46745	4013	23	blood	blood	NN
46745	4013	24	.	.	.
46745	4014	1	These	these	DT
46745	4014	2	assertions	assertion	NNS
46745	4014	3	are	be	VBP
46745	4014	4	an	an	DT
46745	4014	5	extension	extension	NN
46745	4014	6	of	of	IN
46745	4014	7	the	the	DT
46745	4014	8	major	major	JJ
46745	4014	9	proposition	proposition	NN
46745	4014	10	,	,	,
46745	4014	11	but	but	CC
46745	4014	12	their	-PRON-	PRP$
46745	4014	13	establishment	establishment	NN
46745	4014	14	is	be	VBZ
46745	4014	15	necessary	necessary	JJ
46745	4014	16	to	to	IN
46745	4014	17	a	a	DT
46745	4014	18	correct	correct	JJ
46745	4014	19	understanding	understanding	NN
46745	4014	20	of	of	IN
46745	4014	21	the	the	DT
46745	4014	22	latter	latter	JJ
46745	4014	23	.	.	.
46745	4015	1	Their	-PRON-	PRP$
46745	4015	2	proof	proof	NN
46745	4015	3	is	be	VBZ
46745	4015	4	comparatively	comparatively	RB
46745	4015	5	easy	easy	JJ
46745	4015	6	and	and	CC
46745	4015	7	simple	simple	JJ
46745	4015	8	.	.	.
46745	4016	1	It	-PRON-	PRP
46745	4016	2	is	be	VBZ
46745	4016	3	not	not	RB
46745	4016	4	supposed	suppose	VBN
46745	4016	5	to	to	TO
46745	4016	6	be	be	VB
46745	4016	7	a	a	DT
46745	4016	8	certainty	certainty	NN
46745	4016	9	;	;	:
46745	4016	10	but	but	CC
46745	4016	11	simply	simply	RB
46745	4016	12	to	to	TO
46745	4016	13	amount	amount	VB
46745	4016	14	to	to	IN
46745	4016	15	a	a	DT
46745	4016	16	strong	strong	JJ
46745	4016	17	probability	probability	NN
46745	4016	18	,	,	,
46745	4016	19	which	which	WDT
46745	4016	20	is	be	VBZ
46745	4016	21	as	as	RB
46745	4016	22	much	much	JJ
46745	4016	23	as	as	IN
46745	4016	24	we	-PRON-	PRP
46745	4016	25	have	have	VBP
46745	4016	26	a	a	DT
46745	4016	27	right	right	NN
46745	4016	28	to	to	TO
46745	4016	29	expect	expect	VB
46745	4016	30	in	in	IN
46745	4016	31	such	such	JJ
46745	4016	32	cases	case	NNS
46745	4016	33	.	.	.
46745	4017	1	Astringents	astringent	NNS
46745	4017	2	constitute	constitute	VBP
46745	4017	3	the	the	DT
46745	4017	4	third	third	JJ
46745	4017	5	class	class	NN
46745	4017	6	of	of	IN
46745	4017	7	medicines	medicine	NNS
46745	4017	8	which	which	WDT
46745	4017	9	operate	operate	VBP
46745	4017	10	on	on	IN
46745	4017	11	the	the	DT
46745	4017	12	system	system	NN
46745	4017	13	after	after	IN
46745	4017	14	being	be	VBG
46745	4017	15	introduced	introduce	VBN
46745	4017	16	into	into	IN
46745	4017	17	the	the	DT
46745	4017	18	stomach	stomach	NN
46745	4017	19	.	.	.
46745	4018	1	Their	-PRON-	PRP$
46745	4018	2	action	action	NN
46745	4018	3	is	be	VBZ
46745	4018	4	,	,	,
46745	4018	5	however	however	RB
46745	4018	6	,	,	,
46745	4018	7	of	of	IN
46745	4018	8	so	so	RB
46745	4018	9	simple	simple	JJ
46745	4018	10	a	a	DT
46745	4018	11	kind	kind	NN
46745	4018	12	,	,	,
46745	4018	13	that	that	IN
46745	4018	14	it	-PRON-	PRP
46745	4018	15	may	may	MD
46745	4018	16	be	be	VB
46745	4018	17	exerted	exert	VBN
46745	4018	18	on	on	IN
46745	4018	19	the	the	DT
46745	4018	20	external	external	JJ
46745	4018	21	surface	surface	NN
46745	4018	22	in	in	IN
46745	4018	23	the	the	DT
46745	4018	24	same	same	JJ
46745	4018	25	way	way	NN
46745	4018	26	as	as	IN
46745	4018	27	in	in	IN
46745	4018	28	the	the	DT
46745	4018	29	interior	interior	NN
46745	4018	30	of	of	IN
46745	4018	31	the	the	DT
46745	4018	32	body	body	NN
46745	4018	33	.	.	.
46745	4019	1	It	-PRON-	PRP
46745	4019	2	will	will	MD
46745	4019	3	be	be	VB
46745	4019	4	seen	see	VBN
46745	4019	5	by	by	IN
46745	4019	6	a	a	DT
46745	4019	7	reference	reference	NN
46745	4019	8	to	to	IN
46745	4019	9	the	the	DT
46745	4019	10	table	table	NN
46745	4019	11	of	of	IN
46745	4019	12	medicines	medicine	NNS
46745	4019	13	,	,	,
46745	4019	14	that	that	IN
46745	4019	15	the	the	DT
46745	4019	16	class	class	NN
46745	4019	17	of	of	IN
46745	4019	18	Astringents	Astringents	NNPS
46745	4019	19	is	be	VBZ
46745	4019	20	there	there	RB
46745	4019	21	divided	divide	VBN
46745	4019	22	into	into	IN
46745	4019	23	two	two	CD
46745	4019	24	orders	order	NNS
46745	4019	25	.	.	.
46745	4020	1	ASTRINGENTIA	ASTRINGENTIA	NNP
46745	4020	2	.	.	.
46745	4021	1	Ord	Ord	NNP
46745	4021	2	.	.	.
46745	4022	1	1	1	LS
46745	4022	2	.	.	.
46745	4023	1	Astringentia	Astringentia	NNP
46745	4023	2	Mineralia	Mineralia	NNP
46745	4023	3	.	.	.
46745	4024	1	Ord	Ord	NNP
46745	4024	2	.	.	.
46745	4025	1	2	2	LS
46745	4025	2	.	.	.
46745	4026	1	Astringentia	Astringentia	NNP
46745	4026	2	Vegetabilia	Vegetabilia	NNP
46745	4026	3	.	.	.
46745	4027	1	The	the	DT
46745	4027	2	lists	list	NNS
46745	4027	3	of	of	IN
46745	4027	4	these	these	DT
46745	4027	5	orders	order	NNS
46745	4027	6	are	be	VBP
46745	4027	7	given	give	VBN
46745	4027	8	below	below	RB
46745	4027	9	.	.	.
46745	4028	1	With	with	IN
46745	4028	2	regard	regard	NN
46745	4028	3	to	to	IN
46745	4028	4	the	the	DT
46745	4028	5	first	first	JJ
46745	4028	6	minor	minor	JJ
46745	4028	7	proposition	proposition	NN
46745	4028	8	,	,	,
46745	4028	9	it	-PRON-	PRP
46745	4028	10	has	have	VBZ
46745	4028	11	already	already	RB
46745	4028	12	been	be	VBN
46745	4028	13	proved	prove	VBN
46745	4028	14	that	that	IN
46745	4028	15	most	most	JJS
46745	4028	16	of	of	IN
46745	4028	17	these	these	DT
46745	4028	18	medicines	medicine	NNS
46745	4028	19	pass	pass	VBP
46745	4028	20	into	into	IN
46745	4028	21	the	the	DT
46745	4028	22	blood	blood	NN
46745	4028	23	.	.	.
46745	4029	1	The	the	DT
46745	4029	2	minerals	mineral	NNS
46745	4029	3	included	include	VBN
46745	4029	4	in	in	IN
46745	4029	5	the	the	DT
46745	4029	6	first	first	JJ
46745	4029	7	order	order	NN
46745	4029	8	have	have	VBP
46745	4029	9	already	already	RB
46745	4029	10	been	be	VBN
46745	4029	11	noticed	notice	VBN
46745	4029	12	as	as	IN
46745	4029	13	Hæmatic	hæmatic	JJ
46745	4029	14	medicines	medicine	NNS
46745	4029	15	.	.	.
46745	4030	1	They	-PRON-	PRP
46745	4030	2	are	be	VBP
46745	4030	3	all	all	RB
46745	4030	4	soluble	soluble	JJ
46745	4030	5	in	in	IN
46745	4030	6	water	water	NN
46745	4030	7	.	.	.
46745	4031	1	They	-PRON-	PRP
46745	4031	2	are	be	VBP
46745	4031	3	absorbed	absorb	VBN
46745	4031	4	in	in	IN
46745	4031	5	the	the	DT
46745	4031	6	stomach	stomach	NN
46745	4031	7	and	and	CC
46745	4031	8	intestines	intestine	NNS
46745	4031	9	,	,	,
46745	4031	10	and	and	CC
46745	4031	11	pass	pass	VB
46745	4031	12	into	into	IN
46745	4031	13	the	the	DT
46745	4031	14	blood	blood	NN
46745	4031	15	.	.	.
46745	4032	1	Many	many	JJ
46745	4032	2	of	of	IN
46745	4032	3	them	-PRON-	PRP
46745	4032	4	pass	pass	VBP
46745	4032	5	on	on	RP
46745	4032	6	into	into	IN
46745	4032	7	the	the	DT
46745	4032	8	secretions	secretion	NNS
46745	4032	9	.	.	.
46745	4033	1	The	the	DT
46745	4033	2	astringent	astringent	JJ
46745	4033	3	parts	part	NNS
46745	4033	4	of	of	IN
46745	4033	5	the	the	DT
46745	4033	6	vegetables	vegetable	NNS
46745	4033	7	of	of	IN
46745	4033	8	the	the	DT
46745	4033	9	second	second	JJ
46745	4033	10	order	order	NN
46745	4033	11	are	be	VBP
46745	4033	12	also	also	RB
46745	4033	13	soluble	soluble	JJ
46745	4033	14	.	.	.
46745	4034	1	Tannic	tannic	JJ
46745	4034	2	acid	acid	NN
46745	4034	3	is	be	VBZ
46745	4034	4	the	the	DT
46745	4034	5	chief	chief	NN
46745	4034	6	of	of	IN
46745	4034	7	them	-PRON-	PRP
46745	4034	8	;	;	:
46745	4034	9	it	-PRON-	PRP
46745	4034	10	is	be	VBZ
46745	4034	11	simply	simply	RB
46745	4034	12	an	an	DT
46745	4034	13	Astringent	Astringent	NNP
46745	4034	14	;	;	:
46745	4034	15	it	-PRON-	PRP
46745	4034	16	has	have	VBZ
46745	4034	17	been	be	VBN
46745	4034	18	found	find	VBN
46745	4034	19	in	in	IN
46745	4034	20	the	the	DT
46745	4034	21	blood	blood	NN
46745	4034	22	,	,	,
46745	4034	23	where	where	WRB
46745	4034	24	it	-PRON-	PRP
46745	4034	25	changes	change	VBZ
46745	4034	26	into	into	IN
46745	4034	27	Gallic	Gallic	NNP
46745	4034	28	acid	acid	NN
46745	4034	29	,	,	,
46745	4034	30	and	and	CC
46745	4034	31	in	in	IN
46745	4034	32	that	that	DT
46745	4034	33	form	form	NN
46745	4034	34	it	-PRON-	PRP
46745	4034	35	passes	pass	VBZ
46745	4034	36	into	into	IN
46745	4034	37	the	the	DT
46745	4034	38	secretion	secretion	NN
46745	4034	39	of	of	IN
46745	4034	40	urine	urine	NN
46745	4034	41	.	.	.
46745	4035	1	What	what	WP
46745	4035	2	then	then	RB
46745	4035	3	are	be	VBP
46745	4035	4	the	the	DT
46745	4035	5	active	active	JJ
46745	4035	6	properties	property	NNS
46745	4035	7	of	of	IN
46745	4035	8	these	these	DT
46745	4035	9	medicines	medicine	NNS
46745	4035	10	?	?	.
46745	4036	1	They	-PRON-	PRP
46745	4036	2	have	have	VBP
46745	4036	3	all	all	PDT
46745	4036	4	a	a	DT
46745	4036	5	certain	certain	JJ
46745	4036	6	chemical	chemical	NN
46745	4036	7	power	power	NN
46745	4036	8	;	;	:
46745	4036	9	and	and	CC
46745	4036	10	a	a	DT
46745	4036	11	certain	certain	JJ
46745	4036	12	dynamical	dynamical	JJ
46745	4036	13	power	power	NN
46745	4036	14	.	.	.
46745	4037	1	All	all	PDT
46745	4037	2	the	the	DT
46745	4037	3	mineral	mineral	NN
46745	4037	4	Astringents	astringent	NNS
46745	4037	5	have	have	VBP
46745	4037	6	the	the	DT
46745	4037	7	power	power	NN
46745	4037	8	of	of	IN
46745	4037	9	precipitating	precipitate	VBG
46745	4037	10	an	an	DT
46745	4037	11	albuminous	albuminous	JJ
46745	4037	12	solution	solution	NN
46745	4037	13	.	.	.
46745	4038	1	So	so	RB
46745	4038	2	also	also	RB
46745	4038	3	do	do	VBP
46745	4038	4	Tannic	tannic	JJ
46745	4038	5	acid	acid	NN
46745	4038	6	,	,	,
46745	4038	7	Turpentine	turpentine	NN
46745	4038	8	,	,	,
46745	4038	9	and	and	CC
46745	4038	10	Creosote	Creosote	NNP
46745	4038	11	,	,	,
46745	4038	12	coagulate	coagulate	VBP
46745	4038	13	albumen	albuman	NNS
46745	4038	14	.	.	.
46745	4039	1	Tannic	tannic	JJ
46745	4039	2	acid	acid	NN
46745	4039	3	precipitates	precipitate	NNS
46745	4039	4	Gelatine	Gelatine	NNP
46745	4039	5	too	too	RB
46745	4039	6	.	.	.
46745	4040	1	The	the	DT
46745	4040	2	dynamical	dynamical	JJ
46745	4040	3	property	property	NN
46745	4040	4	,	,	,
46745	4040	5	which	which	WDT
46745	4040	6	is	be	VBZ
46745	4040	7	common	common	JJ
46745	4040	8	to	to	IN
46745	4040	9	all	all	DT
46745	4040	10	of	of	IN
46745	4040	11	these	these	DT
46745	4040	12	substances	substance	NNS
46745	4040	13	,	,	,
46745	4040	14	is	be	VBZ
46745	4040	15	a	a	DT
46745	4040	16	power	power	NN
46745	4040	17	of	of	IN
46745	4040	18	causing	cause	VBG
46745	4040	19	the	the	DT
46745	4040	20	contraction	contraction	NN
46745	4040	21	of	of	IN
46745	4040	22	muscular	muscular	JJ
46745	4040	23	fibre	fibre	NNP
46745	4040	24	.	.	.
46745	4041	1	It	-PRON-	PRP
46745	4041	2	seems	seem	VBZ
46745	4041	3	to	to	TO
46745	4041	4	depend	depend	VB
46745	4041	5	somehow	somehow	RB
46745	4041	6	on	on	IN
46745	4041	7	the	the	DT
46745	4041	8	chemical	chemical	JJ
46745	4041	9	power	power	NN
46745	4041	10	just	just	RB
46745	4041	11	mentioned	mention	VBD
46745	4041	12	;	;	:
46745	4041	13	for	for	IN
46745	4041	14	Astringents	astringent	NNS
46745	4041	15	appear	appear	VBP
46745	4041	16	to	to	TO
46745	4041	17	constringe	constringe	VB
46745	4041	18	fibrinous	fibrinous	JJ
46745	4041	19	as	as	RB
46745	4041	20	well	well	RB
46745	4041	21	as	as	IN
46745	4041	22	albuminous	albuminous	JJ
46745	4041	23	tissues	tissue	NNS
46745	4041	24	by	by	IN
46745	4041	25	a	a	DT
46745	4041	26	chemical	chemical	NN
46745	4041	27	action	action	NN
46745	4041	28	.	.	.
46745	4042	1	They	-PRON-	PRP
46745	4042	2	also	also	RB
46745	4042	3	coagulate	coagulate	VBP
46745	4042	4	fluids	fluid	NNS
46745	4042	5	and	and	CC
46745	4042	6	discharges	discharge	NNS
46745	4042	7	which	which	WDT
46745	4042	8	contain	contain	VBP
46745	4042	9	albumen	albuman	NNS
46745	4042	10	.	.	.
46745	4043	1	When	when	WRB
46745	4043	2	the	the	DT
46745	4043	3	solution	solution	NN
46745	4043	4	of	of	IN
46745	4043	5	any	any	DT
46745	4043	6	Astringent	Astringent	NNP
46745	4043	7	is	be	VBZ
46745	4043	8	applied	apply	VBN
46745	4043	9	to	to	IN
46745	4043	10	a	a	DT
46745	4043	11	fresh	fresh	JJ
46745	4043	12	fibre	fibre	NN
46745	4043	13	of	of	IN
46745	4043	14	dead	dead	JJ
46745	4043	15	muscle	muscle	NN
46745	4043	16	placed	place	VBN
46745	4043	17	under	under	IN
46745	4043	18	the	the	DT
46745	4043	19	microscope	microscope	NN
46745	4043	20	,	,	,
46745	4043	21	it	-PRON-	PRP
46745	4043	22	is	be	VBZ
46745	4043	23	seen	see	VBN
46745	4043	24	to	to	TO
46745	4043	25	contract	contract	VB
46745	4043	26	.	.	.
46745	4044	1	The	the	DT
46745	4044	2	power	power	NN
46745	4044	3	which	which	WDT
46745	4044	4	they	-PRON-	PRP
46745	4044	5	possess	possess	VBP
46745	4044	6	in	in	IN
46745	4044	7	causing	cause	VBG
46745	4044	8	the	the	DT
46745	4044	9	contraction	contraction	NN
46745	4044	10	of	of	IN
46745	4044	11	living	live	VBG
46745	4044	12	blood	blood	NN
46745	4044	13	-	-	HYPH
46745	4044	14	vessels	vessel	NNS
46745	4044	15	may	may	MD
46745	4044	16	be	be	VB
46745	4044	17	witnessed	witness	VBN
46745	4044	18	in	in	IN
46745	4044	19	a	a	DT
46745	4044	20	similar	similar	JJ
46745	4044	21	way	way	NN
46745	4044	22	.	.	.
46745	4045	1	The	the	DT
46745	4045	2	astringent	astringent	JJ
46745	4045	3	solution	solution	NN
46745	4045	4	may	may	MD
46745	4045	5	be	be	VB
46745	4045	6	applied	apply	VBN
46745	4045	7	to	to	IN
46745	4045	8	the	the	DT
46745	4045	9	web	web	NN
46745	4045	10	of	of	IN
46745	4045	11	a	a	DT
46745	4045	12	frog	frog	NN
46745	4045	13	's	's	POS
46745	4045	14	foot	foot	NN
46745	4045	15	,	,	,
46745	4045	16	confined	confine	VBN
46745	4045	17	in	in	IN
46745	4045	18	an	an	DT
46745	4045	19	extended	extended	JJ
46745	4045	20	position	position	NN
46745	4045	21	.	.	.
46745	4046	1	This	this	DT
46745	4046	2	web	web	NN
46745	4046	3	is	be	VBZ
46745	4046	4	traversed	traverse	VBN
46745	4046	5	in	in	IN
46745	4046	6	all	all	DT
46745	4046	7	directions	direction	NNS
46745	4046	8	by	by	IN
46745	4046	9	minute	minute	NN
46745	4046	10	ramifying	ramify	VBG
46745	4046	11	capillaries	capillary	NNS
46745	4046	12	;	;	:
46745	4046	13	and	and	CC
46745	4046	14	these	these	DT
46745	4046	15	are	be	VBP
46745	4046	16	found	find	VBN
46745	4046	17	gradually	gradually	RB
46745	4046	18	to	to	TO
46745	4046	19	diminish	diminish	VB
46745	4046	20	in	in	IN
46745	4046	21	caliber	caliber	NN
46745	4046	22	.	.	.
46745	4047	1	In	in	IN
46745	4047	2	the	the	DT
46745	4047	3	same	same	JJ
46745	4047	4	way	way	NN
46745	4047	5	as	as	IN
46745	4047	6	the	the	DT
46745	4047	7	mechanical	mechanical	JJ
46745	4047	8	irritation	irritation	NN
46745	4047	9	of	of	IN
46745	4047	10	a	a	DT
46745	4047	11	small	small	JJ
46745	4047	12	artery	artery	NN
46745	4047	13	will	will	MD
46745	4047	14	act	act	VB
46745	4047	15	upon	upon	IN
46745	4047	16	the	the	DT
46745	4047	17	unstriped	unstriped	JJ
46745	4047	18	muscular	muscular	NNP
46745	4047	19	fibre	fibre	NNP
46745	4047	20	contained	contain	VBN
46745	4047	21	in	in	IN
46745	4047	22	its	-PRON-	PRP$
46745	4047	23	coat	coat	NN
46745	4047	24	,	,	,
46745	4047	25	and	and	CC
46745	4047	26	thus	thus	RB
46745	4047	27	cause	cause	VB
46745	4047	28	the	the	DT
46745	4047	29	vessel	vessel	NN
46745	4047	30	to	to	TO
46745	4047	31	contract	contract	VB
46745	4047	32	at	at	IN
46745	4047	33	one	one	CD
46745	4047	34	point	point	NN
46745	4047	35	;	;	:
46745	4047	36	so	so	CC
46745	4047	37	it	-PRON-	PRP
46745	4047	38	seems	seem	VBZ
46745	4047	39	that	that	IN
46745	4047	40	an	an	DT
46745	4047	41	Astringent	Astringent	NNP
46745	4047	42	,	,	,
46745	4047	43	by	by	IN
46745	4047	44	a	a	DT
46745	4047	45	chemical	chemical	JJ
46745	4047	46	action	action	NN
46745	4047	47	on	on	IN
46745	4047	48	the	the	DT
46745	4047	49	same	same	JJ
46745	4047	50	muscular	muscular	JJ
46745	4047	51	tissue	tissue	NN
46745	4047	52	,	,	,
46745	4047	53	is	be	VBZ
46745	4047	54	able	able	JJ
46745	4047	55	to	to	TO
46745	4047	56	cause	cause	VB
46745	4047	57	the	the	DT
46745	4047	58	capillary	capillary	JJ
46745	4047	59	vessels	vessel	NNS
46745	4047	60	seen	see	VBN
46745	4047	61	under	under	IN
46745	4047	62	the	the	DT
46745	4047	63	microscope	microscope	NN
46745	4047	64	to	to	TO
46745	4047	65	contract	contract	VB
46745	4047	66	and	and	CC
46745	4047	67	diminish	diminish	VB
46745	4047	68	in	in	IN
46745	4047	69	size	size	NN
46745	4047	70	.	.	.
46745	4048	1	At	at	IN
46745	4048	2	all	all	DT
46745	4048	3	events	event	NNS
46745	4048	4	we	-PRON-	PRP
46745	4048	5	may	may	MD
46745	4048	6	conclude	conclude	VB
46745	4048	7	,	,	,
46745	4048	8	both	both	CC
46745	4048	9	from	from	IN
46745	4048	10	actual	actual	JJ
46745	4048	11	experiment	experiment	NN
46745	4048	12	and	and	CC
46745	4048	13	from	from	IN
46745	4048	14	a	a	DT
46745	4048	15	comparison	comparison	NN
46745	4048	16	of	of	IN
46745	4048	17	their	-PRON-	PRP$
46745	4048	18	several	several	JJ
46745	4048	19	operations	operation	NNS
46745	4048	20	,	,	,
46745	4048	21	that	that	IN
46745	4048	22	Astringents	astringent	NNS
46745	4048	23	are	be	VBP
46745	4048	24	able	able	JJ
46745	4048	25	to	to	TO
46745	4048	26	cause	cause	VB
46745	4048	27	the	the	DT
46745	4048	28	contraction	contraction	NN
46745	4048	29	of	of	IN
46745	4048	30	muscular	muscular	JJ
46745	4048	31	fibre	fibre	NNP
46745	4048	32	.	.	.
46745	4049	1	In	in	IN
46745	4049	2	the	the	DT
46745	4049	3	third	third	JJ
46745	4049	4	minor	minor	JJ
46745	4049	5	proposition	proposition	NN
46745	4049	6	the	the	DT
46745	4049	7	chief	chief	JJ
46745	4049	8	results	result	NNS
46745	4049	9	of	of	IN
46745	4049	10	their	-PRON-	PRP$
46745	4049	11	operation	operation	NN
46745	4049	12	are	be	VBP
46745	4049	13	stated	state	VBN
46745	4049	14	.	.	.
46745	4050	1	These	these	DT
46745	4050	2	have	have	VBP
46745	4050	3	already	already	RB
46745	4050	4	been	be	VBN
46745	4050	5	briefly	briefly	RB
46745	4050	6	described	describe	VBN
46745	4050	7	.	.	.
46745	4051	1	They	-PRON-	PRP
46745	4051	2	check	check	VBP
46745	4051	3	secretion	secretion	NN
46745	4051	4	.	.	.
46745	4052	1	They	-PRON-	PRP
46745	4052	2	are	be	VBP
46745	4052	3	thus	thus	RB
46745	4052	4	prescribed	prescribe	VBN
46745	4052	5	when	when	WRB
46745	4052	6	any	any	DT
46745	4052	7	secretion	secretion	NN
46745	4052	8	is	be	VBZ
46745	4052	9	excessive	excessive	JJ
46745	4052	10	.	.	.
46745	4053	1	The	the	DT
46745	4053	2	Tannic	tannic	JJ
46745	4053	3	vegetables	vegetable	NNS
46745	4053	4	are	be	VBP
46745	4053	5	given	give	VBN
46745	4053	6	in	in	IN
46745	4053	7	diarrh[oe]a	diarrh[oe]a	NNP
46745	4053	8	;	;	:
46745	4053	9	Nitrate	Nitrate	NNP
46745	4053	10	of	of	IN
46745	4053	11	Bismuth	Bismuth	NNP
46745	4053	12	is	be	VBZ
46745	4053	13	administered	administer	VBN
46745	4053	14	in	in	IN
46745	4053	15	Pyrosis	Pyrosis	NNP
46745	4053	16	;	;	:
46745	4053	17	Sulphuric	Sulphuric	NNP
46745	4053	18	acid	acid	NN
46745	4053	19	in	in	IN
46745	4053	20	profuse	profuse	NN
46745	4053	21	perspirations	perspiration	NNS
46745	4053	22	;	;	:
46745	4053	23	Uvæ	Uvæ	NNP
46745	4053	24	Ursi	Ursi	NNP
46745	4053	25	in	in	IN
46745	4053	26	mucous	mucous	JJ
46745	4053	27	flux	flux	NN
46745	4053	28	from	from	IN
46745	4053	29	the	the	DT
46745	4053	30	bladder	bladder	NN
46745	4053	31	.	.	.
46745	4054	1	They	-PRON-	PRP
46745	4054	2	repress	repress	VBP
46745	4054	3	hæmorrhage	hæmorrhage	NN
46745	4054	4	.	.	.
46745	4055	1	Thus	thus	RB
46745	4055	2	Acetate	Acetate	NNP
46745	4055	3	of	of	IN
46745	4055	4	lead	lead	NN
46745	4055	5	is	be	VBZ
46745	4055	6	employed	employ	VBN
46745	4055	7	in	in	IN
46745	4055	8	hæmoptysis	hæmoptysis	NN
46745	4055	9	;	;	:
46745	4055	10	Creosote	Creosote	NNP
46745	4055	11	and	and	CC
46745	4055	12	Uvæ	Uvæ	NNP
46745	4055	13	Ursi	Ursi	NNP
46745	4055	14	are	be	VBP
46745	4055	15	used	use	VBN
46745	4055	16	in	in	IN
46745	4055	17	hæmorrhage	hæmorrhage	NN
46745	4055	18	from	from	IN
46745	4055	19	the	the	DT
46745	4055	20	stomach	stomach	NN
46745	4055	21	or	or	CC
46745	4055	22	bladder	bladder	NN
46745	4055	23	;	;	:
46745	4055	24	and	and	CC
46745	4055	25	the	the	DT
46745	4055	26	vegetable	vegetable	NN
46745	4055	27	Astringents	astringent	NNS
46745	4055	28	are	be	VBP
46745	4055	29	prescribed	prescribe	VBN
46745	4055	30	in	in	IN
46745	4055	31	Dysentery	Dysentery	NNP
46745	4055	32	.	.	.
46745	4056	1	They	-PRON-	PRP
46745	4056	2	give	give	VBP
46745	4056	3	tone	tone	NN
46745	4056	4	to	to	IN
46745	4056	5	the	the	DT
46745	4056	6	system	system	NN
46745	4056	7	.	.	.
46745	4057	1	They	-PRON-	PRP
46745	4057	2	do	do	VBP
46745	4057	3	this	this	DT
46745	4057	4	when	when	WRB
46745	4057	5	there	there	EX
46745	4057	6	exists	exist	VBZ
46745	4057	7	an	an	DT
46745	4057	8	over	over	IN
46745	4057	9	-	-	HYPH
46745	4057	10	relaxation	relaxation	NN
46745	4057	11	of	of	IN
46745	4057	12	the	the	DT
46745	4057	13	solid	solid	JJ
46745	4057	14	fibres	fibre	NNS
46745	4057	15	on	on	IN
46745	4057	16	account	account	NN
46745	4057	17	of	of	IN
46745	4057	18	any	any	DT
46745	4057	19	depressing	depressing	JJ
46745	4057	20	cause	cause	NN
46745	4057	21	,	,	,
46745	4057	22	by	by	IN
46745	4057	23	exciting	excite	VBG
46745	4057	24	the	the	DT
46745	4057	25	muscles	muscle	NNS
46745	4057	26	to	to	IN
46745	4057	27	a	a	DT
46745	4057	28	more	more	RBR
46745	4057	29	or	or	CC
46745	4057	30	less	less	RBR
46745	4057	31	permanent	permanent	JJ
46745	4057	32	contraction	contraction	NN
46745	4057	33	,	,	,
46745	4057	34	and	and	CC
46745	4057	35	by	by	IN
46745	4057	36	constringing	constringe	VBG
46745	4057	37	the	the	DT
46745	4057	38	capillary	capillary	JJ
46745	4057	39	vessels	vessel	NNS
46745	4057	40	generally	generally	RB
46745	4057	41	.	.	.
46745	4058	1	In	in	IN
46745	4058	2	the	the	DT
46745	4058	3	fourth	fourth	JJ
46745	4058	4	place	place	NN
46745	4058	5	,	,	,
46745	4058	6	it	-PRON-	PRP
46745	4058	7	is	be	VBZ
46745	4058	8	maintained	maintain	VBN
46745	4058	9	that	that	IN
46745	4058	10	their	-PRON-	PRP$
46745	4058	11	action	action	NN
46745	4058	12	in	in	IN
46745	4058	13	all	all	PDT
46745	4058	14	these	these	DT
46745	4058	15	instances	instance	NNS
46745	4058	16	may	may	MD
46745	4058	17	be	be	VB
46745	4058	18	explained	explain	VBN
46745	4058	19	by	by	IN
46745	4058	20	a	a	DT
46745	4058	21	reference	reference	NN
46745	4058	22	to	to	IN
46745	4058	23	their	-PRON-	PRP$
46745	4058	24	power	power	NN
46745	4058	25	in	in	IN
46745	4058	26	causing	cause	VBG
46745	4058	27	the	the	DT
46745	4058	28	contraction	contraction	NN
46745	4058	29	of	of	IN
46745	4058	30	muscular	muscular	JJ
46745	4058	31	fibre	fibre	NNP
46745	4058	32	;	;	,
46745	4058	33	inasmuch	inasmuch	JJ
46745	4058	34	as	as	IN
46745	4058	35	they	-PRON-	PRP
46745	4058	36	are	be	VBP
46745	4058	37	found	find	VBN
46745	4058	38	to	to	TO
46745	4058	39	diminish	diminish	VB
46745	4058	40	the	the	DT
46745	4058	41	caliber	caliber	NN
46745	4058	42	of	of	IN
46745	4058	43	certain	certain	JJ
46745	4058	44	tubes	tube	NNS
46745	4058	45	and	and	CC
46745	4058	46	cavities	cavity	NNS
46745	4058	47	,	,	,
46745	4058	48	and	and	CC
46745	4058	49	these	these	DT
46745	4058	50	owe	owe	VBP
46745	4058	51	the	the	DT
46745	4058	52	contractility	contractility	NN
46745	4058	53	which	which	WDT
46745	4058	54	they	-PRON-	PRP
46745	4058	55	possess	possess	VBP
46745	4058	56	to	to	IN
46745	4058	57	the	the	DT
46745	4058	58	muscular	muscular	JJ
46745	4058	59	fibre	fibre	NN
46745	4058	60	which	which	WDT
46745	4058	61	is	be	VBZ
46745	4058	62	contained	contain	VBN
46745	4058	63	in	in	IN
46745	4058	64	their	-PRON-	PRP$
46745	4058	65	coats	coat	NNS
46745	4058	66	.	.	.
46745	4059	1	It	-PRON-	PRP
46745	4059	2	follows	follow	VBZ
46745	4059	3	then	then	RB
46745	4059	4	from	from	IN
46745	4059	5	the	the	DT
46745	4059	6	rule	rule	NN
46745	4059	7	of	of	IN
46745	4059	8	local	local	JJ
46745	4059	9	access	access	NN
46745	4059	10	,	,	,
46745	4059	11	that	that	IN
46745	4059	12	before	before	IN
46745	4059	13	they	-PRON-	PRP
46745	4059	14	can	can	MD
46745	4059	15	influence	influence	VB
46745	4059	16	these	these	DT
46745	4059	17	tissues	tissue	NNS
46745	4059	18	they	-PRON-	PRP
46745	4059	19	must	must	MD
46745	4059	20	pass	pass	VB
46745	4059	21	directly	directly	RB
46745	4059	22	to	to	IN
46745	4059	23	them	-PRON-	PRP
46745	4059	24	from	from	IN
46745	4059	25	the	the	DT
46745	4059	26	blood	blood	NN
46745	4059	27	.	.	.
46745	4060	1	Such	such	JJ
46745	4060	2	appears	appear	VBZ
46745	4060	3	to	to	TO
46745	4060	4	be	be	VB
46745	4060	5	the	the	DT
46745	4060	6	simplest	simple	JJS
46745	4060	7	and	and	CC
46745	4060	8	the	the	DT
46745	4060	9	most	most	RBS
46745	4060	10	rational	rational	JJ
46745	4060	11	explanation	explanation	NN
46745	4060	12	of	of	IN
46745	4060	13	the	the	DT
46745	4060	14	action	action	NN
46745	4060	15	of	of	IN
46745	4060	16	Astringent	astringent	JJ
46745	4060	17	medicines	medicine	NNS
46745	4060	18	.	.	.
46745	4061	1	ORD	ORD	NNP
46745	4061	2	.	.	.
46745	4062	1	I.	I.	NNP
46745	4063	1	MINERAL	MINERAL	NNP
46745	4063	2	ASTRINGENTS	astringent	NNS
46745	4063	3	.	.	.
46745	4064	1	(	(	-LRB-
46745	4064	2	Sulphuric	Sulphuric	NNP
46745	4064	3	,	,	,
46745	4064	4	Nitric	nitric	NN
46745	4064	5	,	,	,
46745	4064	6	and	and	CC
46745	4064	7	Hydrochloric	Hydrochloric	NNP
46745	4064	8	acids	acid	NNS
46745	4064	9	.	.	.
46745	4065	1	Acetate	Acetate	NNP
46745	4065	2	and	and	CC
46745	4065	3	Diacetate	Diacetate	NNP
46745	4065	4	of	of	IN
46745	4065	5	Lead	Lead	NNP
46745	4065	6	;	;	:
46745	4065	7	Sulphate	sulphate	NN
46745	4065	8	and	and	CC
46745	4065	9	Sesquichloride	Sesquichloride	NNP
46745	4065	10	of	of	IN
46745	4065	11	Iron	Iron	NNP
46745	4065	12	;	;	:
46745	4065	13	Alum	Alum	NNP
46745	4065	14	;	;	:
46745	4065	15	Sulphate	Sulphate	NNP
46745	4065	16	of	of	IN
46745	4065	17	Zinc	Zinc	NNP
46745	4065	18	;	;	:
46745	4065	19	Sulphate	Sulphate	NNP
46745	4065	20	of	of	IN
46745	4065	21	Copper	Copper	NNP
46745	4065	22	;	;	:
46745	4065	23	Bichloride	Bichloride	NNP
46745	4065	24	of	of	IN
46745	4065	25	Mercury	Mercury	NNP
46745	4065	26	;	;	:
46745	4065	27	Nitrate	Nitrate	NNP
46745	4065	28	of	of	IN
46745	4065	29	Silver	Silver	NNP
46745	4065	30	.	.	.
46745	4065	31	)	)	-RRB-
46745	4066	1	These	these	DT
46745	4066	2	medicines	medicine	NNS
46745	4066	3	have	have	VBP
46745	4066	4	already	already	RB
46745	4066	5	been	be	VBN
46745	4066	6	noticed	notice	VBN
46745	4066	7	among	among	IN
46745	4066	8	Restorative	Restorative	NNP
46745	4066	9	and	and	CC
46745	4066	10	Catalytic	Catalytic	NNP
46745	4066	11	Hæmatics	Hæmatics	NNPS
46745	4066	12	.	.	.
46745	4067	1	Their	-PRON-	PRP$
46745	4067	2	Astringent	astringent	JJ
46745	4067	3	action	action	NN
46745	4067	4	on	on	IN
46745	4067	5	muscle	muscle	NN
46745	4067	6	is	be	VBZ
46745	4067	7	of	of	IN
46745	4067	8	much	much	RB
46745	4067	9	less	less	JJR
46745	4067	10	moment	moment	NN
46745	4067	11	than	than	IN
46745	4067	12	their	-PRON-	PRP$
46745	4067	13	important	important	JJ
46745	4067	14	operations	operation	NNS
46745	4067	15	in	in	IN
46745	4067	16	the	the	DT
46745	4067	17	blood	blood	NN
46745	4067	18	.	.	.
46745	4068	1	Neither	neither	DT
46745	4068	2	is	be	VBZ
46745	4068	3	it	-PRON-	PRP
46745	4068	4	theoretically	theoretically	RB
46745	4068	5	a	a	DT
46745	4068	6	matter	matter	NN
46745	4068	7	of	of	IN
46745	4068	8	so	so	RB
46745	4068	9	much	much	JJ
46745	4068	10	difficulty	difficulty	NN
46745	4068	11	;	;	:
46745	4068	12	for	for	IN
46745	4068	13	it	-PRON-	PRP
46745	4068	14	appears	appear	VBZ
46745	4068	15	,	,	,
46745	4068	16	as	as	IN
46745	4068	17	we	-PRON-	PRP
46745	4068	18	have	have	VBP
46745	4068	19	seen	see	VBN
46745	4068	20	,	,	,
46745	4068	21	to	to	TO
46745	4068	22	admit	admit	VB
46745	4068	23	of	of	IN
46745	4068	24	a	a	DT
46745	4068	25	simple	simple	JJ
46745	4068	26	explanation	explanation	NN
46745	4068	27	.	.	.
46745	4069	1	By	by	IN
46745	4069	2	their	-PRON-	PRP$
46745	4069	3	chemical	chemical	NN
46745	4069	4	action	action	NN
46745	4069	5	on	on	IN
46745	4069	6	albumen	albuman	NNS
46745	4069	7	,	,	,
46745	4069	8	these	these	DT
46745	4069	9	substances	substance	NNS
46745	4069	10	coagulate	coagulate	VBP
46745	4069	11	blood	blood	NN
46745	4069	12	,	,	,
46745	4069	13	and	and	CC
46745	4069	14	thus	thus	RB
46745	4069	15	act	act	VBP
46745	4069	16	in	in	IN
46745	4069	17	a	a	DT
46745	4069	18	simple	simple	JJ
46745	4069	19	way	way	NN
46745	4069	20	as	as	IN
46745	4069	21	styptics	styptic	NNS
46745	4069	22	when	when	WRB
46745	4069	23	applied	apply	VBN
46745	4069	24	to	to	IN
46745	4069	25	bleeding	bleed	VBG
46745	4069	26	parts	part	NNS
46745	4069	27	externally	externally	RB
46745	4069	28	.	.	.
46745	4070	1	They	-PRON-	PRP
46745	4070	2	form	form	VBP
46745	4070	3	peculiar	peculiar	JJ
46745	4070	4	insoluble	insoluble	JJ
46745	4070	5	compounds	compound	NNS
46745	4070	6	both	both	DT
46745	4070	7	with	with	IN
46745	4070	8	albumen	albuman	NNS
46745	4070	9	and	and	CC
46745	4070	10	fibrine	fibrine	NN
46745	4070	11	,	,	,
46745	4070	12	and	and	CC
46745	4070	13	it	-PRON-	PRP
46745	4070	14	is	be	VBZ
46745	4070	15	probably	probably	RB
46745	4070	16	by	by	IN
46745	4070	17	virtue	virtue	NN
46745	4070	18	of	of	IN
46745	4070	19	their	-PRON-	PRP$
46745	4070	20	action	action	NN
46745	4070	21	on	on	IN
46745	4070	22	the	the	DT
46745	4070	23	latter	latter	JJ
46745	4070	24	that	that	IN
46745	4070	25	they	-PRON-	PRP
46745	4070	26	are	be	VBP
46745	4070	27	able	able	JJ
46745	4070	28	to	to	TO
46745	4070	29	cause	cause	VB
46745	4070	30	the	the	DT
46745	4070	31	contraction	contraction	NN
46745	4070	32	of	of	IN
46745	4070	33	muscular	muscular	NNP
46745	4070	34	fibre	fibre	NNP
46745	4070	35	,	,	,
46745	4070	36	which	which	WDT
46745	4070	37	is	be	VBZ
46745	4070	38	a	a	DT
46745	4070	39	fibrinous	fibrinous	JJ
46745	4070	40	tissue	tissue	NN
46745	4070	41	.	.	.
46745	4071	1	The	the	DT
46745	4071	2	constriction	constriction	NN
46745	4071	3	,	,	,
46745	4071	4	set	set	VBN
46745	4071	5	up	up	RP
46745	4071	6	chemically	chemically	RB
46745	4071	7	,	,	,
46745	4071	8	is	be	VBZ
46745	4071	9	apparently	apparently	RB
46745	4071	10	continued	continue	VBN
46745	4071	11	and	and	CC
46745	4071	12	propagated	propagate	VBN
46745	4071	13	by	by	IN
46745	4071	14	the	the	DT
46745	4071	15	vital	vital	JJ
46745	4071	16	force	force	NN
46745	4071	17	of	of	IN
46745	4071	18	the	the	DT
46745	4071	19	muscle	muscle	NN
46745	4071	20	.	.	.
46745	4072	1	The	the	DT
46745	4072	2	most	most	RBS
46745	4072	3	important	important	JJ
46745	4072	4	only	only	RB
46745	4072	5	of	of	IN
46745	4072	6	the	the	DT
46745	4072	7	mineral	mineral	NN
46745	4072	8	Astringents	astringent	NNS
46745	4072	9	are	be	VBP
46745	4072	10	mentioned	mention	VBN
46745	4072	11	above	above	RB
46745	4072	12	.	.	.
46745	4073	1	It	-PRON-	PRP
46745	4073	2	must	must	MD
46745	4073	3	not	not	RB
46745	4073	4	be	be	VB
46745	4073	5	supposed	suppose	VBN
46745	4073	6	,	,	,
46745	4073	7	when	when	WRB
46745	4073	8	their	-PRON-	PRP$
46745	4073	9	chemical	chemical	JJ
46745	4073	10	actions	action	NNS
46745	4073	11	are	be	VBP
46745	4073	12	mentioned	mention	VBN
46745	4073	13	,	,	,
46745	4073	14	that	that	IN
46745	4073	15	such	such	JJ
46745	4073	16	actions	action	NNS
46745	4073	17	are	be	VBP
46745	4073	18	always	always	RB
46745	4073	19	allowed	allow	VBN
46745	4073	20	free	free	JJ
46745	4073	21	play	play	NN
46745	4073	22	in	in	IN
46745	4073	23	the	the	DT
46745	4073	24	living	living	NN
46745	4073	25	and	and	CC
46745	4073	26	circulating	circulate	VBG
46745	4073	27	blood	blood	NN
46745	4073	28	.	.	.
46745	4074	1	They	-PRON-	PRP
46745	4074	2	are	be	VBP
46745	4074	3	no	no	RB
46745	4074	4	doubt	doubt	RB
46745	4074	5	constrained	constrain	VBN
46745	4074	6	by	by	IN
46745	4074	7	various	various	JJ
46745	4074	8	forces	force	NNS
46745	4074	9	from	from	IN
46745	4074	10	operating	operate	VBG
46745	4074	11	there	there	RB
46745	4074	12	,	,	,
46745	4074	13	or	or	CC
46745	4074	14	else	else	RB
46745	4074	15	the	the	DT
46745	4074	16	consequences	consequence	NNS
46745	4074	17	of	of	IN
46745	4074	18	such	such	PDT
46745	4074	19	a	a	DT
46745	4074	20	disturbance	disturbance	NN
46745	4074	21	of	of	IN
46745	4074	22	the	the	DT
46745	4074	23	condition	condition	NN
46745	4074	24	of	of	IN
46745	4074	25	the	the	DT
46745	4074	26	elements	element	NNS
46745	4074	27	of	of	IN
46745	4074	28	the	the	DT
46745	4074	29	blood	blood	NN
46745	4074	30	would	would	MD
46745	4074	31	be	be	VB
46745	4074	32	dangerous	dangerous	JJ
46745	4074	33	in	in	IN
46745	4074	34	the	the	DT
46745	4074	35	extreme	extreme	NN
46745	4074	36	.	.	.
46745	4075	1	(	(	-LRB-
46745	4075	2	_	_	NNP
46745	4075	3	Vide	Vide	NNP
46745	4075	4	_	_	NNP
46745	4075	5	page	page	NN
46745	4075	6	104	104	CD
46745	4075	7	.	.	.
46745	4075	8	)	)	-RRB-
46745	4076	1	They	-PRON-	PRP
46745	4076	2	act	act	VBP
46745	4076	3	,	,	,
46745	4076	4	before	before	IN
46745	4076	5	entry	entry	NN
46745	4076	6	into	into	IN
46745	4076	7	the	the	DT
46745	4076	8	blood	blood	NN
46745	4076	9	,	,	,
46745	4076	10	on	on	IN
46745	4076	11	mucous	mucous	JJ
46745	4076	12	membranes	membrane	NNS
46745	4076	13	and	and	CC
46745	4076	14	external	external	JJ
46745	4076	15	parts	part	NNS
46745	4076	16	;	;	:
46745	4076	17	and	and	CC
46745	4076	18	on	on	IN
46745	4076	19	coming	come	VBG
46745	4076	20	out	out	IN
46745	4076	21	of	of	IN
46745	4076	22	the	the	DT
46745	4076	23	blood	blood	NN
46745	4076	24	,	,	,
46745	4076	25	on	on	IN
46745	4076	26	the	the	DT
46745	4076	27	terminal	terminal	JJ
46745	4076	28	capillary	capillary	JJ
46745	4076	29	vessels	vessel	NNS
46745	4076	30	,	,	,
46745	4076	31	on	on	IN
46745	4076	32	the	the	DT
46745	4076	33	ducts	duct	NNS
46745	4076	34	of	of	IN
46745	4076	35	glands	gland	NNS
46745	4076	36	,	,	,
46745	4076	37	and	and	CC
46745	4076	38	on	on	IN
46745	4076	39	mucous	mucous	JJ
46745	4076	40	membranes	membrane	NNS
46745	4076	41	again	again	RB
46745	4076	42	.	.	.
46745	4077	1	Astringents	astringent	NNS
46745	4077	2	act	act	VBP
46745	4077	3	very	very	RB
46745	4077	4	much	much	RB
46745	4077	5	alike	alike	RB
46745	4077	6	on	on	IN
46745	4077	7	external	external	JJ
46745	4077	8	parts	part	NNS
46745	4077	9	;	;	,
46745	4077	10	only	only	RB
46745	4077	11	that	that	IN
46745	4077	12	some	some	DT
46745	4077	13	are	be	VBP
46745	4077	14	more	more	RBR
46745	4077	15	soluble	soluble	JJ
46745	4077	16	than	than	IN
46745	4077	17	others	other	NNS
46745	4077	18	,	,	,
46745	4077	19	and	and	CC
46745	4077	20	some	some	DT
46745	4077	21	excel	excel	VBP
46745	4077	22	the	the	DT
46745	4077	23	rest	rest	NN
46745	4077	24	in	in	IN
46745	4077	25	chemical	chemical	NN
46745	4077	26	activity	activity	NN
46745	4077	27	.	.	.
46745	4078	1	But	but	CC
46745	4078	2	they	-PRON-	PRP
46745	4078	3	differ	differ	VBP
46745	4078	4	considerably	considerably	RB
46745	4078	5	in	in	IN
46745	4078	6	their	-PRON-	PRP$
46745	4078	7	applicability	applicability	NN
46745	4078	8	for	for	IN
46745	4078	9	internal	internal	JJ
46745	4078	10	use	use	NN
46745	4078	11	.	.	.
46745	4079	1	They	-PRON-	PRP
46745	4079	2	must	must	MD
46745	4079	3	be	be	VB
46745	4079	4	given	give	VBN
46745	4079	5	in	in	IN
46745	4079	6	such	such	JJ
46745	4079	7	quantity	quantity	NN
46745	4079	8	that	that	WDT
46745	4079	9	,	,	,
46745	4079	10	after	after	IN
46745	4079	11	absorption	absorption	NN
46745	4079	12	and	and	CC
46745	4079	13	dilution	dilution	NN
46745	4079	14	by	by	IN
46745	4079	15	the	the	DT
46745	4079	16	whole	whole	JJ
46745	4079	17	mass	mass	NN
46745	4079	18	of	of	IN
46745	4079	19	the	the	DT
46745	4079	20	blood	blood	NN
46745	4079	21	,	,	,
46745	4079	22	they	-PRON-	PRP
46745	4079	23	may	may	MD
46745	4079	24	still	still	RB
46745	4079	25	be	be	VB
46745	4079	26	capable	capable	JJ
46745	4079	27	of	of	IN
46745	4079	28	exerting	exert	VBG
46745	4079	29	a	a	DT
46745	4079	30	perceptible	perceptible	JJ
46745	4079	31	action	action	NN
46745	4079	32	on	on	IN
46745	4079	33	distant	distant	JJ
46745	4079	34	parts	part	NNS
46745	4079	35	.	.	.
46745	4080	1	A	a	DT
46745	4080	2	small	small	JJ
46745	4080	3	portion	portion	NN
46745	4080	4	of	of	IN
46745	4080	5	one	one	CD
46745	4080	6	of	of	IN
46745	4080	7	them	-PRON-	PRP
46745	4080	8	will	will	MD
46745	4080	9	not	not	RB
46745	4080	10	suffice	suffice	VB
46745	4080	11	to	to	IN
46745	4080	12	repress	repress	NN
46745	4080	13	hæmorrhage	hæmorrhage	NN
46745	4080	14	,	,	,
46745	4080	15	or	or	CC
46745	4080	16	to	to	TO
46745	4080	17	diminish	diminish	VB
46745	4080	18	a	a	DT
46745	4080	19	super	super	JJ
46745	4080	20	-	-	JJ
46745	4080	21	abundant	abundant	JJ
46745	4080	22	secretion	secretion	NN
46745	4080	23	.	.	.
46745	4081	1	From	from	IN
46745	4081	2	this	this	DT
46745	4081	3	it	-PRON-	PRP
46745	4081	4	follows	follow	VBZ
46745	4081	5	that	that	IN
46745	4081	6	the	the	DT
46745	4081	7	mineral	mineral	NN
46745	4081	8	acids	acid	NNS
46745	4081	9	,	,	,
46745	4081	10	Alum	Alum	NNP
46745	4081	11	,	,	,
46745	4081	12	and	and	CC
46745	4081	13	the	the	DT
46745	4081	14	salts	salt	NNS
46745	4081	15	of	of	IN
46745	4081	16	Iron	Iron	NNP
46745	4081	17	,	,	,
46745	4081	18	are	be	VBP
46745	4081	19	the	the	DT
46745	4081	20	only	only	JJ
46745	4081	21	astringents	astringent	NNS
46745	4081	22	of	of	IN
46745	4081	23	this	this	DT
46745	4081	24	order	order	NN
46745	4081	25	which	which	WDT
46745	4081	26	can	can	MD
46745	4081	27	in	in	IN
46745	4081	28	all	all	DT
46745	4081	29	cases	case	NNS
46745	4081	30	be	be	VB
46745	4081	31	given	give	VBN
46745	4081	32	internally	internally	RB
46745	4081	33	with	with	IN
46745	4081	34	advantage	advantage	NN
46745	4081	35	.	.	.
46745	4082	1	For	for	IN
46745	4082	2	being	be	VBG
46745	4082	3	comparatively	comparatively	RB
46745	4082	4	innocuous	innocuous	JJ
46745	4082	5	,	,	,
46745	4082	6	they	-PRON-	PRP
46745	4082	7	can	can	MD
46745	4082	8	be	be	VB
46745	4082	9	safely	safely	RB
46745	4082	10	prescribed	prescribe	VBN
46745	4082	11	in	in	IN
46745	4082	12	the	the	DT
46745	4082	13	quantity	quantity	NN
46745	4082	14	required	require	VBN
46745	4082	15	;	;	:
46745	4082	16	whereas	whereas	IN
46745	4082	17	the	the	DT
46745	4082	18	other	other	JJ
46745	4082	19	mineral	mineral	NN
46745	4082	20	Astringents	astringent	NNS
46745	4082	21	are	be	VBP
46745	4082	22	poisonous	poisonous	JJ
46745	4082	23	substances	substance	NNS
46745	4082	24	,	,	,
46745	4082	25	which	which	WDT
46745	4082	26	can	can	MD
46745	4082	27	not	not	RB
46745	4082	28	be	be	VB
46745	4082	29	given	give	VBN
46745	4082	30	in	in	IN
46745	4082	31	large	large	JJ
46745	4082	32	doses	dose	NNS
46745	4082	33	without	without	IN
46745	4082	34	considerable	considerable	JJ
46745	4082	35	danger	danger	NN
46745	4082	36	.	.	.
46745	4083	1	Of	of	IN
46745	4083	2	the	the	DT
46745	4083	3	mineral	mineral	NN
46745	4083	4	acids	acid	NNS
46745	4083	5	,	,	,
46745	4083	6	Sulphuric	Sulphuric	NNP
46745	4083	7	acid	acid	NN
46745	4083	8	is	be	VBZ
46745	4083	9	the	the	DT
46745	4083	10	best	good	JJS
46745	4083	11	Astringent	Astringent	NNP
46745	4083	12	.	.	.
46745	4084	1	Phosphoric	phosphoric	NN
46745	4084	2	acid	acid	NN
46745	4084	3	is	be	VBZ
46745	4084	4	seldom	seldom	RB
46745	4084	5	or	or	CC
46745	4084	6	never	never	RB
46745	4084	7	used	use	VBN
46745	4084	8	as	as	IN
46745	4084	9	an	an	DT
46745	4084	10	Astringent	Astringent	NNP
46745	4084	11	.	.	.
46745	4085	1	We	-PRON-	PRP
46745	4085	2	might	may	MD
46745	4085	3	indeed	indeed	RB
46745	4085	4	have	have	VB
46745	4085	5	supposed	suppose	VBN
46745	4085	6	it	-PRON-	PRP
46745	4085	7	to	to	TO
46745	4085	8	be	be	VB
46745	4085	9	inapplicable	inapplicable	JJ
46745	4085	10	,	,	,
46745	4085	11	from	from	IN
46745	4085	12	the	the	DT
46745	4085	13	fact	fact	NN
46745	4085	14	that	that	IN
46745	4085	15	it	-PRON-	PRP
46745	4085	16	forms	form	VBZ
46745	4085	17	soluble	soluble	JJ
46745	4085	18	compounds	compound	NNS
46745	4085	19	with	with	IN
46745	4085	20	albumen	albuman	NNS
46745	4085	21	and	and	CC
46745	4085	22	fibrine,--instead	fibrine,--instead	NNP
46745	4085	23	of	of	IN
46745	4085	24	coagulating	coagulate	VBG
46745	4085	25	these	these	DT
46745	4085	26	substances	substance	NNS
46745	4085	27	,	,	,
46745	4085	28	like	like	IN
46745	4085	29	the	the	DT
46745	4085	30	other	other	JJ
46745	4085	31	mineral	mineral	NN
46745	4085	32	acids	acid	NNS
46745	4085	33	.	.	.
46745	4086	1	Sulphuric	sulphuric	JJ
46745	4086	2	acid	acid	NN
46745	4086	3	is	be	VBZ
46745	4086	4	a	a	DT
46745	4086	5	Restorative	Restorative	NNP
46745	4086	6	Hæmatic	Hæmatic	NNP
46745	4086	7	;	;	:
46745	4086	8	and	and	CC
46745	4086	9	,	,	,
46745	4086	10	when	when	WRB
46745	4086	11	given	give	VBN
46745	4086	12	in	in	IN
46745	4086	13	small	small	JJ
46745	4086	14	doses	dose	NNS
46745	4086	15	,	,	,
46745	4086	16	may	may	MD
46745	4086	17	remain	remain	VB
46745	4086	18	in	in	IN
46745	4086	19	the	the	DT
46745	4086	20	blood	blood	NN
46745	4086	21	,	,	,
46745	4086	22	and	and	CC
46745	4086	23	not	not	RB
46745	4086	24	pass	pass	VB
46745	4086	25	out	out	RP
46745	4086	26	through	through	IN
46745	4086	27	the	the	DT
46745	4086	28	glands	gland	NNS
46745	4086	29	.	.	.
46745	4087	1	It	-PRON-	PRP
46745	4087	2	acts	act	VBZ
46745	4087	3	first	first	RB
46745	4087	4	upon	upon	IN
46745	4087	5	the	the	DT
46745	4087	6	mucous	mucous	JJ
46745	4087	7	surface	surface	NN
46745	4087	8	of	of	IN
46745	4087	9	the	the	DT
46745	4087	10	stomach	stomach	NN
46745	4087	11	.	.	.
46745	4088	1	When	when	WRB
46745	4088	2	there	there	EX
46745	4088	3	is	be	VBZ
46745	4088	4	a	a	DT
46745	4088	5	relaxation	relaxation	NN
46745	4088	6	of	of	IN
46745	4088	7	this	this	DT
46745	4088	8	mucous	mucous	JJ
46745	4088	9	membrane	membrane	NN
46745	4088	10	,	,	,
46745	4088	11	as	as	IN
46745	4088	12	in	in	IN
46745	4088	13	many	many	JJ
46745	4088	14	cases	case	NNS
46745	4088	15	of	of	IN
46745	4088	16	atonic	atonic	JJ
46745	4088	17	dyspepsia	dyspepsia	NNP
46745	4088	18	,	,	,
46745	4088	19	with	with	IN
46745	4088	20	a	a	DT
46745	4088	21	large	large	JJ
46745	4088	22	formation	formation	NN
46745	4088	23	of	of	IN
46745	4088	24	flatus	flatus	NN
46745	4088	25	,	,	,
46745	4088	26	and	and	CC
46745	4088	27	an	an	DT
46745	4088	28	over	over	NN
46745	4088	29	-	-	HYPH
46745	4088	30	secretion	secretion	NN
46745	4088	31	of	of	IN
46745	4088	32	the	the	DT
46745	4088	33	gastric	gastric	JJ
46745	4088	34	fluid	fluid	NN
46745	4088	35	,	,	,
46745	4088	36	this	this	DT
46745	4088	37	acid	acid	NN
46745	4088	38	may	may	MD
46745	4088	39	be	be	VB
46745	4088	40	very	very	RB
46745	4088	41	serviceable	serviceable	JJ
46745	4088	42	.	.	.
46745	4089	1	It	-PRON-	PRP
46745	4089	2	tends	tend	VBZ
46745	4089	3	to	to	TO
46745	4089	4	correct	correct	VB
46745	4089	5	these	these	DT
46745	4089	6	evils	evil	NNS
46745	4089	7	by	by	IN
46745	4089	8	a	a	DT
46745	4089	9	topical	topical	JJ
46745	4089	10	action	action	NN
46745	4089	11	.	.	.
46745	4090	1	In	in	IN
46745	4090	2	cases	case	NNS
46745	4090	3	of	of	IN
46745	4090	4	Pyrosis	Pyrosis	NNP
46745	4090	5	,	,	,
46745	4090	6	where	where	WRB
46745	4090	7	there	there	EX
46745	4090	8	is	be	VBZ
46745	4090	9	an	an	DT
46745	4090	10	alkaline	alkaline	JJ
46745	4090	11	reaction	reaction	NN
46745	4090	12	in	in	IN
46745	4090	13	the	the	DT
46745	4090	14	vomited	vomit	VBN
46745	4090	15	fluid	fluid	NN
46745	4090	16	,	,	,
46745	4090	17	as	as	IN
46745	4090	18	sometimes	sometimes	RB
46745	4090	19	occurs	occur	VBZ
46745	4090	20	,	,	,
46745	4090	21	Sulphuric	sulphuric	JJ
46745	4090	22	acid	acid	NN
46745	4090	23	is	be	VBZ
46745	4090	24	still	still	RB
46745	4090	25	more	more	RBR
46745	4090	26	peculiarly	peculiarly	RB
46745	4090	27	applicable	applicable	JJ
46745	4090	28	,	,	,
46745	4090	29	because	because	IN
46745	4090	30	it	-PRON-	PRP
46745	4090	31	further	further	RB
46745	4090	32	acts	act	VBZ
46745	4090	33	chemically	chemically	RB
46745	4090	34	in	in	IN
46745	4090	35	neutralizing	neutralize	VBG
46745	4090	36	this	this	DT
46745	4090	37	alkali	alkali	NN
46745	4090	38	.	.	.
46745	4091	1	When	when	WRB
46745	4091	2	given	give	VBN
46745	4091	3	in	in	IN
46745	4091	4	large	large	JJ
46745	4091	5	doses	dose	NNS
46745	4091	6	,	,	,
46745	4091	7	the	the	DT
46745	4091	8	acid	acid	NN
46745	4091	9	can	can	MD
46745	4091	10	not	not	RB
46745	4091	11	remain	remain	VB
46745	4091	12	in	in	IN
46745	4091	13	the	the	DT
46745	4091	14	system	system	NN
46745	4091	15	,	,	,
46745	4091	16	but	but	CC
46745	4091	17	must	must	MD
46745	4091	18	be	be	VB
46745	4091	19	excreted	excrete	VBN
46745	4091	20	from	from	IN
46745	4091	21	it	-PRON-	PRP
46745	4091	22	by	by	IN
46745	4091	23	the	the	DT
46745	4091	24	glands	gland	NNS
46745	4091	25	.	.	.
46745	4092	1	In	in	IN
46745	4092	2	passing	pass	VBG
46745	4092	3	through	through	IN
46745	4092	4	them	-PRON-	PRP
46745	4092	5	it	-PRON-	PRP
46745	4092	6	tends	tend	VBZ
46745	4092	7	to	to	TO
46745	4092	8	act	act	VB
46745	4092	9	as	as	IN
46745	4092	10	an	an	DT
46745	4092	11	Astringent	Astringent	NNP
46745	4092	12	by	by	IN
46745	4092	13	corrugating	corrugate	VBG
46745	4092	14	and	and	CC
46745	4092	15	diminishing	diminish	VBG
46745	4092	16	in	in	IN
46745	4092	17	caliber	caliber	NN
46745	4092	18	their	-PRON-	PRP$
46745	4092	19	minute	minute	NN
46745	4092	20	ducts	duct	NNS
46745	4092	21	,	,	,
46745	4092	22	and	and	CC
46745	4092	23	thus	thus	RB
46745	4092	24	decreases	decrease	VBZ
46745	4092	25	the	the	DT
46745	4092	26	amount	amount	NN
46745	4092	27	of	of	IN
46745	4092	28	the	the	DT
46745	4092	29	secretion	secretion	NN
46745	4092	30	.	.	.
46745	4093	1	But	but	CC
46745	4093	2	it	-PRON-	PRP
46745	4093	3	does	do	VBZ
46745	4093	4	not	not	RB
46745	4093	5	act	act	VB
46745	4093	6	on	on	IN
46745	4093	7	all	all	DT
46745	4093	8	glands	gland	NNS
46745	4093	9	alike	alike	RB
46745	4093	10	.	.	.
46745	4094	1	Dr.	Dr.	NNP
46745	4094	2	Bence	Bence	NNP
46745	4094	3	Jones	Jones	NNP
46745	4094	4	has	have	VBZ
46745	4094	5	found	find	VBN
46745	4094	6	that	that	IN
46745	4094	7	it	-PRON-	PRP
46745	4094	8	seldom	seldom	RB
46745	4094	9	passes	pass	VBZ
46745	4094	10	out	out	RP
46745	4094	11	into	into	IN
46745	4094	12	the	the	DT
46745	4094	13	urine	urine	NN
46745	4094	14	.	.	.
46745	4095	1	It	-PRON-	PRP
46745	4095	2	therefore	therefore	RB
46745	4095	3	does	do	VBZ
46745	4095	4	not	not	RB
46745	4095	5	sensibly	sensibly	RB
46745	4095	6	diminish	diminish	VB
46745	4095	7	the	the	DT
46745	4095	8	secretion	secretion	NN
46745	4095	9	of	of	IN
46745	4095	10	urine	urine	NN
46745	4095	11	.	.	.
46745	4096	1	It	-PRON-	PRP
46745	4096	2	is	be	VBZ
46745	4096	3	probably	probably	RB
46745	4096	4	excreted	excrete	VBN
46745	4096	5	partly	partly	RB
46745	4096	6	by	by	IN
46745	4096	7	the	the	DT
46745	4096	8	skin	skin	NN
46745	4096	9	,	,	,
46745	4096	10	and	and	CC
46745	4096	11	partly	partly	RB
46745	4096	12	by	by	IN
46745	4096	13	the	the	DT
46745	4096	14	bowels	bowel	NNS
46745	4096	15	;	;	:
46745	4096	16	for	for	IN
46745	4096	17	it	-PRON-	PRP
46745	4096	18	diminishes	diminish	VBZ
46745	4096	19	the	the	DT
46745	4096	20	amount	amount	NN
46745	4096	21	of	of	IN
46745	4096	22	the	the	DT
46745	4096	23	sweat	sweat	NN
46745	4096	24	in	in	IN
46745	4096	25	profuse	profuse	NN
46745	4096	26	perspiration	perspiration	NN
46745	4096	27	,	,	,
46745	4096	28	and	and	CC
46745	4096	29	of	of	IN
46745	4096	30	the	the	DT
46745	4096	31	fæces	fæce	NNS
46745	4096	32	in	in	IN
46745	4096	33	diarrh[oe]a	diarrh[oe]a	NNP
46745	4096	34	.	.	.
46745	4096	35	Sulphuric	sulphuric	JJ
46745	4096	36	acid	acid	NN
46745	4096	37	is	be	VBZ
46745	4096	38	free	free	JJ
46745	4096	39	before	before	IN
46745	4096	40	entrance	entrance	NN
46745	4096	41	into	into	IN
46745	4096	42	the	the	DT
46745	4096	43	blood	blood	NN
46745	4096	44	,	,	,
46745	4096	45	and	and	CC
46745	4096	46	after	after	IN
46745	4096	47	expulsion	expulsion	NN
46745	4096	48	from	from	IN
46745	4096	49	it	-PRON-	PRP
46745	4096	50	into	into	IN
46745	4096	51	the	the	DT
46745	4096	52	secretions	secretion	NNS
46745	4096	53	.	.	.
46745	4097	1	Thus	thus	RB
46745	4097	2	at	at	IN
46745	4097	3	these	these	DT
46745	4097	4	periods	period	NNS
46745	4097	5	it	-PRON-	PRP
46745	4097	6	acts	act	VBZ
46745	4097	7	as	as	IN
46745	4097	8	an	an	DT
46745	4097	9	Astringent	Astringent	NNP
46745	4097	10	.	.	.
46745	4098	1	But	but	CC
46745	4098	2	while	while	IN
46745	4098	3	in	in	IN
46745	4098	4	the	the	DT
46745	4098	5	blood	blood	NN
46745	4098	6	it	-PRON-	PRP
46745	4098	7	combines	combine	VBZ
46745	4098	8	with	with	IN
46745	4098	9	the	the	DT
46745	4098	10	alkali	alkali	JJ
46745	4098	11	contained	contain	VBN
46745	4098	12	in	in	IN
46745	4098	13	that	that	DT
46745	4098	14	fluid	fluid	NN
46745	4098	15	,	,	,
46745	4098	16	and	and	CC
46745	4098	17	forms	form	VBZ
46745	4098	18	a	a	DT
46745	4098	19	salt	salt	NN
46745	4098	20	which	which	WDT
46745	4098	21	is	be	VBZ
46745	4098	22	not	not	RB
46745	4098	23	astringent	astringent	JJ
46745	4098	24	.	.	.
46745	4099	1	So	so	IN
46745	4099	2	that	that	IN
46745	4099	3	when	when	WRB
46745	4099	4	it	-PRON-	PRP
46745	4099	5	diminishes	diminish	VBZ
46745	4099	6	any	any	DT
46745	4099	7	secretion	secretion	NN
46745	4099	8	,	,	,
46745	4099	9	this	this	DT
46745	4099	10	is	be	VBZ
46745	4099	11	nearly	nearly	RB
46745	4099	12	tantamount	tantamount	JJ
46745	4099	13	to	to	IN
46745	4099	14	a	a	DT
46745	4099	15	proof	proof	NN
46745	4099	16	that	that	IN
46745	4099	17	it	-PRON-	PRP
46745	4099	18	is	be	VBZ
46745	4099	19	actually	actually	RB
46745	4099	20	excreted	excrete	VBN
46745	4099	21	by	by	IN
46745	4099	22	the	the	DT
46745	4099	23	gland	gland	NN
46745	4099	24	which	which	WDT
46745	4099	25	forms	form	VBZ
46745	4099	26	that	that	DT
46745	4099	27	secretion	secretion	NN
46745	4099	28	.	.	.
46745	4100	1	It	-PRON-	PRP
46745	4100	2	acts	act	VBZ
46745	4100	3	on	on	IN
46745	4100	4	mucous	mucous	JJ
46745	4100	5	membranes	membrane	NNS
46745	4100	6	generally	generally	RB
46745	4100	7	,	,	,
46745	4100	8	being	be	VBG
46745	4100	9	probably	probably	RB
46745	4100	10	excreted	excrete	VBN
46745	4100	11	in	in	IN
46745	4100	12	small	small	JJ
46745	4100	13	quantities	quantity	NNS
46745	4100	14	by	by	IN
46745	4100	15	those	those	DT
46745	4100	16	which	which	WDT
46745	4100	17	are	be	VBP
46745	4100	18	remote	remote	JJ
46745	4100	19	from	from	IN
46745	4100	20	the	the	DT
46745	4100	21	stomach	stomach	NN
46745	4100	22	.	.	.
46745	4101	1	It	-PRON-	PRP
46745	4101	2	is	be	VBZ
46745	4101	3	not	not	RB
46745	4101	4	of	of	IN
46745	4101	5	use	use	NN
46745	4101	6	in	in	IN
46745	4101	7	cases	case	NNS
46745	4101	8	of	of	IN
46745	4101	9	hæmorrhage	hæmorrhage	NN
46745	4101	10	,	,	,
46745	4101	11	except	except	IN
46745	4101	12	when	when	WRB
46745	4101	13	the	the	DT
46745	4101	14	bleeding	bleeding	NN
46745	4101	15	takes	take	VBZ
46745	4101	16	place	place	NN
46745	4101	17	from	from	IN
46745	4101	18	some	some	DT
46745	4101	19	mucous	mucous	JJ
46745	4101	20	membrane	membrane	NN
46745	4101	21	.	.	.
46745	4102	1	It	-PRON-	PRP
46745	4102	2	is	be	VBZ
46745	4102	3	thus	thus	RB
46745	4102	4	given	give	VBN
46745	4102	5	with	with	IN
46745	4102	6	more	more	JJR
46745	4102	7	or	or	CC
46745	4102	8	less	less	JJR
46745	4102	9	advantage	advantage	NN
46745	4102	10	in	in	IN
46745	4102	11	Hæmatemesis	Hæmatemesis	NNP
46745	4102	12	,	,	,
46745	4102	13	Hæmoptysis	Hæmoptysis	NNP
46745	4102	14	,	,	,
46745	4102	15	Melæna	Melæna	NNP
46745	4102	16	,	,	,
46745	4102	17	and	and	CC
46745	4102	18	chronic	chronic	JJ
46745	4102	19	Dysentery--_i.e	Dysentery--_i.e	NNP
46745	4102	20	.	.	.
46745	4102	21	_	_	NNP
46745	4102	22	in	in	IN
46745	4102	23	hæmorrhage	hæmorrhage	NN
46745	4102	24	from	from	IN
46745	4102	25	the	the	DT
46745	4102	26	mucous	mucous	JJ
46745	4102	27	surfaces	surface	NNS
46745	4102	28	of	of	IN
46745	4102	29	the	the	DT
46745	4102	30	lungs	lung	NNS
46745	4102	31	,	,	,
46745	4102	32	stomach	stomach	NN
46745	4102	33	,	,	,
46745	4102	34	and	and	CC
46745	4102	35	bowels	bowel	NNS
46745	4102	36	.	.	.
46745	4103	1	Alum	Alum	NNP
46745	4103	2	is	be	VBZ
46745	4103	3	a	a	DT
46745	4103	4	universal	universal	JJ
46745	4103	5	Astringent	Astringent	NNP
46745	4103	6	,	,	,
46745	4103	7	acting	act	VBG
46745	4103	8	more	more	RBR
46745	4103	9	or	or	CC
46745	4103	10	less	less	RBR
46745	4103	11	on	on	IN
46745	4103	12	all	all	DT
46745	4103	13	parts	part	NNS
46745	4103	14	of	of	IN
46745	4103	15	the	the	DT
46745	4103	16	body	body	NN
46745	4103	17	,	,	,
46745	4103	18	and	and	CC
46745	4103	19	diminishing	diminish	VBG
46745	4103	20	all	all	DT
46745	4103	21	secretions	secretion	NNS
46745	4103	22	.	.	.
46745	4104	1	It	-PRON-	PRP
46745	4104	2	is	be	VBZ
46745	4104	3	a	a	DT
46745	4104	4	very	very	RB
46745	4104	5	useful	useful	JJ
46745	4104	6	remedy	remedy	NN
46745	4104	7	in	in	IN
46745	4104	8	all	all	DT
46745	4104	9	cases	case	NNS
46745	4104	10	where	where	WRB
46745	4104	11	Astringents	astringent	NNS
46745	4104	12	are	be	VBP
46745	4104	13	required	require	VBN
46745	4104	14	.	.	.
46745	4105	1	It	-PRON-	PRP
46745	4105	2	does	do	VBZ
46745	4105	3	not	not	RB
46745	4105	4	seem	seem	VB
46745	4105	5	to	to	TO
46745	4105	6	be	be	VB
46745	4105	7	impaired	impair	VBN
46745	4105	8	in	in	IN
46745	4105	9	power	power	NN
46745	4105	10	while	while	IN
46745	4105	11	in	in	IN
46745	4105	12	the	the	DT
46745	4105	13	blood	blood	NN
46745	4105	14	,	,	,
46745	4105	15	as	as	IN
46745	4105	16	is	be	VBZ
46745	4105	17	the	the	DT
46745	4105	18	case	case	NN
46745	4105	19	with	with	IN
46745	4105	20	Sulphuric	Sulphuric	NNP
46745	4105	21	acid	acid	NN
46745	4105	22	;	;	:
46745	4105	23	and	and	CC
46745	4105	24	is	be	VBZ
46745	4105	25	therefore	therefore	RB
46745	4105	26	applicable	applicable	JJ
46745	4105	27	in	in	IN
46745	4105	28	all	all	DT
46745	4105	29	hæmorrhagic	hæmorrhagic	JJ
46745	4105	30	cases	case	NNS
46745	4105	31	.	.	.
46745	4106	1	It	-PRON-	PRP
46745	4106	2	has	have	VBZ
46745	4106	3	been	be	VBN
46745	4106	4	highly	highly	RB
46745	4106	5	recommended	recommend	VBN
46745	4106	6	in	in	IN
46745	4106	7	the	the	DT
46745	4106	8	case	case	NN
46745	4106	9	of	of	IN
46745	4106	10	lead	lead	JJ
46745	4106	11	colic	colic	NNP
46745	4106	12	,	,	,
46745	4106	13	and	and	CC
46745	4106	14	seems	seem	VBZ
46745	4106	15	to	to	TO
46745	4106	16	operate	operate	VB
46745	4106	17	in	in	IN
46745	4106	18	this	this	DT
46745	4106	19	instance	instance	NN
46745	4106	20	by	by	IN
46745	4106	21	stimulating	stimulate	VBG
46745	4106	22	to	to	IN
46745	4106	23	contraction	contraction	NN
46745	4106	24	the	the	DT
46745	4106	25	muscular	muscular	JJ
46745	4106	26	fibre	fibre	NN
46745	4106	27	of	of	IN
46745	4106	28	a	a	DT
46745	4106	29	paralyzed	paralyzed	JJ
46745	4106	30	portion	portion	NN
46745	4106	31	of	of	IN
46745	4106	32	the	the	DT
46745	4106	33	intestine	intestine	NN
46745	4106	34	.	.	.
46745	4107	1	The	the	DT
46745	4107	2	astringent	astringent	JJ
46745	4107	3	salts	salt	NNS
46745	4107	4	of	of	IN
46745	4107	5	Iron	Iron	NNP
46745	4107	6	are	be	VBP
46745	4107	7	less	less	RBR
46745	4107	8	active	active	JJ
46745	4107	9	in	in	IN
46745	4107	10	this	this	DT
46745	4107	11	kind	kind	NN
46745	4107	12	of	of	IN
46745	4107	13	influence	influence	NN
46745	4107	14	than	than	IN
46745	4107	15	the	the	DT
46745	4107	16	medicines	medicine	NNS
46745	4107	17	already	already	RB
46745	4107	18	referred	refer	VBD
46745	4107	19	to	to	IN
46745	4107	20	.	.	.
46745	4108	1	They	-PRON-	PRP
46745	4108	2	have	have	VBP
46745	4108	3	very	very	RB
46745	4108	4	little	little	JJ
46745	4108	5	action	action	NN
46745	4108	6	on	on	IN
46745	4108	7	the	the	DT
46745	4108	8	glands	gland	NNS
46745	4108	9	.	.	.
46745	4109	1	But	but	CC
46745	4109	2	in	in	IN
46745	4109	3	cases	case	NNS
46745	4109	4	of	of	IN
46745	4109	5	hæmorrhage	hæmorrhage	NN
46745	4109	6	they	-PRON-	PRP
46745	4109	7	are	be	VBP
46745	4109	8	particularly	particularly	RB
46745	4109	9	appropriate	appropriate	JJ
46745	4109	10	,	,	,
46745	4109	11	for	for	IN
46745	4109	12	in	in	IN
46745	4109	13	addition	addition	NN
46745	4109	14	to	to	IN
46745	4109	15	their	-PRON-	PRP$
46745	4109	16	astringent	astringent	JJ
46745	4109	17	action	action	NN
46745	4109	18	they	-PRON-	PRP
46745	4109	19	tend	tend	VBP
46745	4109	20	to	to	TO
46745	4109	21	restore	restore	VB
46745	4109	22	the	the	DT
46745	4109	23	deficient	deficient	JJ
46745	4109	24	red	red	JJ
46745	4109	25	colouring	colour	VBG
46745	4109	26	matter	matter	NN
46745	4109	27	of	of	IN
46745	4109	28	the	the	DT
46745	4109	29	blood	blood	NN
46745	4109	30	.	.	.
46745	4110	1	In	in	IN
46745	4110	2	many	many	JJ
46745	4110	3	such	such	JJ
46745	4110	4	instances	instance	NNS
46745	4110	5	the	the	DT
46745	4110	6	Sulphate	sulphate	NN
46745	4110	7	or	or	CC
46745	4110	8	the	the	DT
46745	4110	9	Sesquichloride	sesquichloride	JJ
46745	4110	10	of	of	IN
46745	4110	11	Iron	Iron	NNP
46745	4110	12	may	may	MD
46745	4110	13	be	be	VB
46745	4110	14	advantageously	advantageously	RB
46745	4110	15	prescribed	prescribe	VBN
46745	4110	16	along	along	IN
46745	4110	17	with	with	IN
46745	4110	18	Sulphuric	Sulphuric	NNP
46745	4110	19	acid	acid	NN
46745	4110	20	.	.	.
46745	4111	1	Acetate	Acetate	NNP
46745	4111	2	of	of	IN
46745	4111	3	Lead	Lead	NNP
46745	4111	4	is	be	VBZ
46745	4111	5	used	use	VBN
46745	4111	6	internally	internally	RB
46745	4111	7	as	as	IN
46745	4111	8	an	an	DT
46745	4111	9	Astringent	Astringent	NNP
46745	4111	10	,	,	,
46745	4111	11	but	but	CC
46745	4111	12	being	be	VBG
46745	4111	13	a	a	DT
46745	4111	14	more	more	RBR
46745	4111	15	dangerous	dangerous	JJ
46745	4111	16	remedy	remedy	NN
46745	4111	17	than	than	IN
46745	4111	18	the	the	DT
46745	4111	19	medicines	medicine	NNS
46745	4111	20	above	above	IN
46745	4111	21	mentioned	mention	VBD
46745	4111	22	,	,	,
46745	4111	23	it	-PRON-	PRP
46745	4111	24	requires	require	VBZ
46745	4111	25	greater	great	JJR
46745	4111	26	care	care	NN
46745	4111	27	in	in	IN
46745	4111	28	its	-PRON-	PRP$
46745	4111	29	application	application	NN
46745	4111	30	.	.	.
46745	4112	1	It	-PRON-	PRP
46745	4112	2	should	should	MD
46745	4112	3	not	not	RB
46745	4112	4	,	,	,
46745	4112	5	if	if	IN
46745	4112	6	possible	possible	JJ
46745	4112	7	,	,	,
46745	4112	8	be	be	VB
46745	4112	9	used	use	VBN
46745	4112	10	long	long	RB
46745	4112	11	at	at	IN
46745	4112	12	a	a	DT
46745	4112	13	time	time	NN
46745	4112	14	.	.	.
46745	4113	1	When	when	WRB
46745	4113	2	it	-PRON-	PRP
46745	4113	3	has	have	VBZ
46745	4113	4	been	be	VBN
46745	4113	5	for	for	IN
46745	4113	6	some	some	DT
46745	4113	7	time	time	NN
46745	4113	8	prescribed	prescribe	VBN
46745	4113	9	,	,	,
46745	4113	10	the	the	DT
46745	4113	11	blue	blue	JJ
46745	4113	12	line	line	NN
46745	4113	13	at	at	IN
46745	4113	14	the	the	DT
46745	4113	15	edge	edge	NN
46745	4113	16	of	of	IN
46745	4113	17	the	the	DT
46745	4113	18	gums	gum	NNS
46745	4113	19	,	,	,
46745	4113	20	which	which	WDT
46745	4113	21	is	be	VBZ
46745	4113	22	characteristic	characteristic	JJ
46745	4113	23	of	of	IN
46745	4113	24	a	a	DT
46745	4113	25	saturation	saturation	NN
46745	4113	26	of	of	IN
46745	4113	27	the	the	DT
46745	4113	28	system	system	NN
46745	4113	29	by	by	IN
46745	4113	30	the	the	DT
46745	4113	31	poison	poison	NN
46745	4113	32	of	of	IN
46745	4113	33	lead	lead	NN
46745	4113	34	,	,	,
46745	4113	35	will	will	MD
46745	4113	36	indicate	indicate	VB
46745	4113	37	that	that	IN
46745	4113	38	its	-PRON-	PRP$
46745	4113	39	further	further	JJ
46745	4113	40	administration	administration	NN
46745	4113	41	is	be	VBZ
46745	4113	42	unadvisable	unadvisable	JJ
46745	4113	43	.	.	.
46745	4114	1	The	the	DT
46745	4114	2	Acetate	Acetate	NNP
46745	4114	3	of	of	IN
46745	4114	4	Lead	lead	NN
46745	4114	5	is	be	VBZ
46745	4114	6	much	much	RB
46745	4114	7	esteemed	esteem	VBN
46745	4114	8	as	as	IN
46745	4114	9	an	an	DT
46745	4114	10	Astringent	Astringent	NNP
46745	4114	11	in	in	IN
46745	4114	12	the	the	DT
46745	4114	13	case	case	NN
46745	4114	14	of	of	IN
46745	4114	15	Hæmoptysis	Hæmoptysis	NNP
46745	4114	16	.	.	.
46745	4115	1	It	-PRON-	PRP
46745	4115	2	is	be	VBZ
46745	4115	3	frequently	frequently	RB
46745	4115	4	combined	combine	VBN
46745	4115	5	with	with	IN
46745	4115	6	Opium	Opium	NNP
46745	4115	7	,	,	,
46745	4115	8	in	in	IN
46745	4115	9	spite	spite	NN
46745	4115	10	of	of	IN
46745	4115	11	the	the	DT
46745	4115	12	chemical	chemical	NN
46745	4115	13	decomposition	decomposition	NN
46745	4115	14	which	which	WDT
46745	4115	15	follows	follow	VBZ
46745	4115	16	the	the	DT
46745	4115	17	admixture	admixture	NN
46745	4115	18	.	.	.
46745	4116	1	But	but	CC
46745	4116	2	it	-PRON-	PRP
46745	4116	3	must	must	MD
46745	4116	4	certainly	certainly	RB
46745	4116	5	not	not	RB
46745	4116	6	be	be	VB
46745	4116	7	prescribed	prescribe	VBN
46745	4116	8	with	with	IN
46745	4116	9	Alum	Alum	NNP
46745	4116	10	.	.	.
46745	4117	1	The	the	DT
46745	4117	2	soluble	soluble	JJ
46745	4117	3	salts	salt	NNS
46745	4117	4	of	of	IN
46745	4117	5	Silver	Silver	NNP
46745	4117	6	,	,	,
46745	4117	7	Zinc	Zinc	NNP
46745	4117	8	,	,	,
46745	4117	9	and	and	CC
46745	4117	10	Copper	Copper	NNP
46745	4117	11	,	,	,
46745	4117	12	and	and	CC
46745	4117	13	the	the	DT
46745	4117	14	Bichloride	Bichloride	NNP
46745	4117	15	of	of	IN
46745	4117	16	Mercury	Mercury	NNP
46745	4117	17	,	,	,
46745	4117	18	are	be	VBP
46745	4117	19	used	use	VBN
46745	4117	20	with	with	IN
46745	4117	21	advantage	advantage	NN
46745	4117	22	as	as	IN
46745	4117	23	external	external	JJ
46745	4117	24	Astringents	astringent	NNS
46745	4117	25	,	,	,
46745	4117	26	but	but	CC
46745	4117	27	can	can	MD
46745	4117	28	seldom	seldom	RB
46745	4117	29	be	be	VB
46745	4117	30	prescribed	prescribe	VBN
46745	4117	31	internally	internally	RB
46745	4117	32	so	so	IN
46745	4117	33	as	as	IN
46745	4117	34	to	to	TO
46745	4117	35	act	act	VB
46745	4117	36	in	in	IN
46745	4117	37	this	this	DT
46745	4117	38	way	way	NN
46745	4117	39	,	,	,
46745	4117	40	because	because	IN
46745	4117	41	they	-PRON-	PRP
46745	4117	42	are	be	VBP
46745	4117	43	poisonous	poisonous	JJ
46745	4117	44	when	when	WRB
46745	4117	45	given	give	VBN
46745	4117	46	in	in	IN
46745	4117	47	any	any	DT
46745	4117	48	quantity	quantity	NN
46745	4117	49	.	.	.
46745	4118	1	The	the	DT
46745	4118	2	Sulphates	Sulphates	NNP
46745	4118	3	of	of	IN
46745	4118	4	Zinc	Zinc	NNP
46745	4118	5	and	and	CC
46745	4118	6	Copper	Copper	NNP
46745	4118	7	have	have	VBP
46745	4118	8	,	,	,
46745	4118	9	however	however	RB
46745	4118	10	,	,	,
46745	4118	11	been	be	VBN
46745	4118	12	occasionally	occasionally	RB
46745	4118	13	used	use	VBN
46745	4118	14	in	in	IN
46745	4118	15	diarrh[oe]a	diarrh[oe]a	NNP
46745	4118	16	.	.	.
46745	4119	1	When	when	WRB
46745	4119	2	thus	thus	RB
46745	4119	3	applied	apply	VBN
46745	4119	4	as	as	IN
46745	4119	5	Astringents	astringent	NNS
46745	4119	6	externally	externally	RB
46745	4119	7	,	,	,
46745	4119	8	their	-PRON-	PRP$
46745	4119	9	solutions	solution	NNS
46745	4119	10	must	must	MD
46745	4119	11	be	be	VB
46745	4119	12	very	very	RB
46745	4119	13	dilute	dilute	JJ
46745	4119	14	,	,	,
46745	4119	15	for	for	IN
46745	4119	16	all	all	PDT
46745	4119	17	the	the	DT
46745	4119	18	mineral	mineral	NN
46745	4119	19	Astringents	astringent	NNS
46745	4119	20	are	be	VBP
46745	4119	21	caustic	caustic	JJ
46745	4119	22	and	and	CC
46745	4119	23	corrosive	corrosive	JJ
46745	4119	24	,	,	,
46745	4119	25	destroying	destroy	VBG
46745	4119	26	texture	texture	NN
46745	4119	27	,	,	,
46745	4119	28	when	when	WRB
46745	4119	29	in	in	IN
46745	4119	30	the	the	DT
46745	4119	31	solid	solid	JJ
46745	4119	32	state	state	NN
46745	4119	33	,	,	,
46745	4119	34	or	or	CC
46745	4119	35	in	in	IN
46745	4119	36	strong	strong	JJ
46745	4119	37	solutions	solution	NNS
46745	4119	38	.	.	.
46745	4120	1	These	these	DT
46745	4120	2	solutions	solution	NNS
46745	4120	3	may	may	MD
46745	4120	4	be	be	VB
46745	4120	5	applied	apply	VBN
46745	4120	6	to	to	IN
46745	4120	7	any	any	DT
46745	4120	8	part	part	NN
46745	4120	9	of	of	IN
46745	4120	10	the	the	DT
46745	4120	11	surface	surface	NN
46745	4120	12	of	of	IN
46745	4120	13	the	the	DT
46745	4120	14	skin	skin	NN
46745	4120	15	or	or	CC
46745	4120	16	mucous	mucous	JJ
46745	4120	17	membrane	membrane	NN
46745	4120	18	,	,	,
46745	4120	19	when	when	WRB
46745	4120	20	relaxed	relaxed	JJ
46745	4120	21	,	,	,
46745	4120	22	inflamed	inflamed	JJ
46745	4120	23	,	,	,
46745	4120	24	or	or	CC
46745	4120	25	ulcerated	ulcerated	JJ
46745	4120	26	.	.	.
46745	4121	1	Their	-PRON-	PRP$
46745	4121	2	operation	operation	NN
46745	4121	3	is	be	VBZ
46745	4121	4	simple	simple	JJ
46745	4121	5	and	and	CC
46745	4121	6	obvious	obvious	JJ
46745	4121	7	.	.	.
46745	4122	1	When	when	WRB
46745	4122	2	one	one	CD
46745	4122	3	of	of	IN
46745	4122	4	them	-PRON-	PRP
46745	4122	5	is	be	VBZ
46745	4122	6	applied	apply	VBN
46745	4122	7	to	to	IN
46745	4122	8	an	an	DT
46745	4122	9	inflamed	inflame	VBN
46745	4122	10	eye	eye	NN
46745	4122	11	,	,	,
46745	4122	12	or	or	CC
46745	4122	13	to	to	IN
46745	4122	14	a	a	DT
46745	4122	15	red	red	JJ
46745	4122	16	ulcerated	ulcerated	JJ
46745	4122	17	sore	sore	JJ
46745	4122	18	,	,	,
46745	4122	19	that	that	DT
46745	4122	20	is	be	VBZ
46745	4122	21	turgid	turgid	JJ
46745	4122	22	with	with	IN
46745	4122	23	blood	blood	NN
46745	4122	24	and	and	CC
46745	4122	25	discharges	discharge	VBZ
46745	4122	26	an	an	DT
46745	4122	27	unhealthy	unhealthy	JJ
46745	4122	28	matter	matter	NN
46745	4122	29	,	,	,
46745	4122	30	it	-PRON-	PRP
46745	4122	31	tends	tend	VBZ
46745	4122	32	to	to	TO
46745	4122	33	promote	promote	VB
46745	4122	34	the	the	DT
46745	4122	35	contraction	contraction	NN
46745	4122	36	of	of	IN
46745	4122	37	the	the	DT
46745	4122	38	dilated	dilate	VBN
46745	4122	39	vessels	vessel	NNS
46745	4122	40	,	,	,
46745	4122	41	and	and	CC
46745	4122	42	thus	thus	RB
46745	4122	43	dispels	dispel	VBZ
46745	4122	44	the	the	DT
46745	4122	45	congestion	congestion	NN
46745	4122	46	and	and	CC
46745	4122	47	diminishes	diminish	VBZ
46745	4122	48	the	the	DT
46745	4122	49	discharge	discharge	NN
46745	4122	50	.	.	.
46745	4123	1	Various	various	JJ
46745	4123	2	other	other	JJ
46745	4123	3	substances	substance	NNS
46745	4123	4	have	have	VBP
46745	4123	5	wrongly	wrongly	RB
46745	4123	6	obtained	obtain	VBN
46745	4123	7	the	the	DT
46745	4123	8	title	title	NN
46745	4123	9	of	of	IN
46745	4123	10	Astringents	Astringents	NNPS
46745	4123	11	,	,	,
46745	4123	12	regard	regard	NN
46745	4123	13	being	be	VBG
46745	4123	14	had	have	VBD
46745	4123	15	only	only	RB
46745	4123	16	to	to	IN
46745	4123	17	the	the	DT
46745	4123	18	result	result	NN
46745	4123	19	of	of	IN
46745	4123	20	their	-PRON-	PRP$
46745	4123	21	operation	operation	NN
46745	4123	22	,	,	,
46745	4123	23	and	and	CC
46745	4123	24	not	not	RB
46745	4123	25	to	to	IN
46745	4123	26	the	the	DT
46745	4123	27	mode	mode	NN
46745	4123	28	in	in	IN
46745	4123	29	which	which	WDT
46745	4123	30	it	-PRON-	PRP
46745	4123	31	is	be	VBZ
46745	4123	32	produced	produce	VBN
46745	4123	33	.	.	.
46745	4124	1	Thus	thus	RB
46745	4124	2	Chalk	Chalk	NNP
46745	4124	3	is	be	VBZ
46745	4124	4	often	often	RB
46745	4124	5	of	of	IN
46745	4124	6	benefit	benefit	NN
46745	4124	7	in	in	IN
46745	4124	8	diarrh[oe]a	diarrh[oe]a	NNP
46745	4124	9	.	.	.
46745	4125	1	It	-PRON-	PRP
46745	4125	2	acts	act	VBZ
46745	4125	3	both	both	DT
46745	4125	4	by	by	IN
46745	4125	5	mechanically	mechanically	RB
46745	4125	6	absorbing	absorb	VBG
46745	4125	7	irritating	irritating	JJ
46745	4125	8	fluids	fluid	NNS
46745	4125	9	,	,	,
46745	4125	10	and	and	CC
46745	4125	11	protecting	protect	VBG
46745	4125	12	the	the	DT
46745	4125	13	surface	surface	NN
46745	4125	14	of	of	IN
46745	4125	15	the	the	DT
46745	4125	16	bowel	bowel	NN
46745	4125	17	,	,	,
46745	4125	18	and	and	CC
46745	4125	19	by	by	IN
46745	4125	20	chemically	chemically	RB
46745	4125	21	neutralizing	neutralize	VBG
46745	4125	22	an	an	DT
46745	4125	23	acid	acid	JJ
46745	4125	24	matter	matter	NN
46745	4125	25	by	by	IN
46745	4125	26	which	which	WDT
46745	4125	27	the	the	DT
46745	4125	28	irritation	irritation	NN
46745	4125	29	is	be	VBZ
46745	4125	30	maintained	maintain	VBN
46745	4125	31	.	.	.
46745	4126	1	And	and	CC
46745	4126	2	when	when	WRB
46745	4126	3	applied	apply	VBN
46745	4126	4	to	to	IN
46745	4126	5	the	the	DT
46745	4126	6	surface	surface	NN
46745	4126	7	of	of	IN
46745	4126	8	inflamed	inflame	VBN
46745	4126	9	ulcerated	ulcerated	JJ
46745	4126	10	parts	part	NNS
46745	4126	11	,	,	,
46745	4126	12	it	-PRON-	PRP
46745	4126	13	does	do	VBZ
46745	4126	14	good	good	NN
46745	4126	15	by	by	IN
46745	4126	16	absorbing	absorb	VBG
46745	4126	17	the	the	DT
46745	4126	18	discharge	discharge	NN
46745	4126	19	,	,	,
46745	4126	20	and	and	CC
46745	4126	21	protecting	protect	VBG
46745	4126	22	from	from	IN
46745	4126	23	the	the	DT
46745	4126	24	contact	contact	NN
46745	4126	25	of	of	IN
46745	4126	26	air	air	NN
46745	4126	27	.	.	.
46745	4127	1	Thus	thus	RB
46745	4127	2	its	-PRON-	PRP$
46745	4127	3	action	action	NN
46745	4127	4	in	in	IN
46745	4127	5	both	both	DT
46745	4127	6	cases	case	NNS
46745	4127	7	is	be	VBZ
46745	4127	8	very	very	RB
46745	4127	9	different	different	JJ
46745	4127	10	from	from	IN
46745	4127	11	that	that	DT
46745	4127	12	of	of	IN
46745	4127	13	the	the	DT
46745	4127	14	true	true	JJ
46745	4127	15	Astringents	astringent	NNS
46745	4127	16	.	.	.
46745	4128	1	The	the	DT
46745	4128	2	action	action	NN
46745	4128	3	of	of	IN
46745	4128	4	some	some	DT
46745	4128	5	of	of	IN
46745	4128	6	the	the	DT
46745	4128	7	minerals	mineral	NNS
46745	4128	8	above	above	IN
46745	4128	9	named	name	VBN
46745	4128	10	,	,	,
46745	4128	11	when	when	WRB
46745	4128	12	applied	apply	VBN
46745	4128	13	externally	externally	RB
46745	4128	14	in	in	IN
46745	4128	15	the	the	DT
46745	4128	16	solid	solid	JJ
46745	4128	17	state	state	NN
46745	4128	18	,	,	,
46745	4128	19	as	as	IN
46745	4128	20	caustics	caustic	NNS
46745	4128	21	,	,	,
46745	4128	22	must	must	MD
46745	4128	23	not	not	RB
46745	4128	24	be	be	VB
46745	4128	25	confounded	confound	VBN
46745	4128	26	with	with	IN
46745	4128	27	their	-PRON-	PRP$
46745	4128	28	astringent	astringent	JJ
46745	4128	29	power	power	NN
46745	4128	30	.	.	.
46745	4129	1	Its	-PRON-	PRP$
46745	4129	2	efficacy	efficacy	NN
46745	4129	3	depends	depend	VBZ
46745	4129	4	upon	upon	IN
46745	4129	5	the	the	DT
46745	4129	6	revulsive	revulsive	JJ
46745	4129	7	effect	effect	NN
46745	4129	8	which	which	WDT
46745	4129	9	follows	follow	VBZ
46745	4129	10	a	a	DT
46745	4129	11	local	local	JJ
46745	4129	12	destruction	destruction	NN
46745	4129	13	of	of	IN
46745	4129	14	tissue	tissue	NN
46745	4129	15	.	.	.
46745	4130	1	ORD	ORD	NNP
46745	4130	2	.	.	.
46745	4131	1	II	ii	CD
46745	4131	2	.	.	.
46745	4132	1	VEGETABLE	VEGETABLE	NNP
46745	4132	2	ASTRINGENTS	ASTRINGENTS	NNPS
46745	4132	3	.	.	.
46745	4133	1	(	(	-LRB-
46745	4133	2	Tannic	tannic	JJ
46745	4133	3	Acid	acid	NN
46745	4133	4	.	.	.
46745	4134	1	Gallic	Gallic	NNP
46745	4134	2	Acid	Acid	NNP
46745	4134	3	.	.	.
46745	4135	1	Kino	Kino	NNP
46745	4135	2	;	;	:
46745	4135	3	Catechu	Catechu	NNP
46745	4135	4	;	;	:
46745	4135	5	Logwood	logwood	NN
46745	4135	6	;	;	:
46745	4135	7	Oak	Oak	NNP
46745	4135	8	-	-	HYPH
46745	4135	9	galls	gall	NNS
46745	4135	10	;	;	:
46745	4135	11	Rhatany	rhatany	NN
46745	4135	12	;	;	:
46745	4135	13	Bistort	Bistort	NNP
46745	4135	14	;	;	:
46745	4135	15	Pomegranate	pomegranate	NN
46745	4135	16	-	-	HYPH
46745	4135	17	rind	rind	NN
46745	4135	18	;	;	:
46745	4135	19	Rose	rose	NN
46745	4135	20	-	-	HYPH
46745	4135	21	leaves	leave	VBZ
46745	4135	22	;	;	:
46745	4135	23	Uvæ	Uvæ	NNP
46745	4135	24	Ursi	ursi	JJ
46745	4135	25	;	;	:
46745	4135	26	Tormentil	Tormentil	NNP
46745	4135	27	.	.	.
46745	4136	1	Creosote	creosote	NN
46745	4136	2	.	.	.
46745	4136	3	)	)	-RRB-
46745	4137	1	Tannic	Tannic	NNP
46745	4137	2	Acid	Acid	NNP
46745	4137	3	,	,	,
46745	4137	4	Gallic	Gallic	NNP
46745	4137	5	Acid	Acid	NNP
46745	4137	6	,	,	,
46745	4137	7	and	and	CC
46745	4137	8	Creosote	creosote	NN
46745	4137	9	are	be	VBP
46745	4137	10	the	the	DT
46745	4137	11	three	three	CD
46745	4137	12	chief	chief	JJ
46745	4137	13	Vegetable	Vegetable	NNP
46745	4137	14	Astringents	Astringents	NNP
46745	4137	15	.	.	.
46745	4138	1	To	to	IN
46745	4138	2	the	the	DT
46745	4138	3	first	first	JJ
46745	4138	4	two	two	CD
46745	4138	5	the	the	DT
46745	4138	6	vegetable	vegetable	NN
46745	4138	7	substances	substance	NNS
46745	4138	8	above	above	IN
46745	4138	9	enumerated	enumerate	VBN
46745	4138	10	appear	appear	VBP
46745	4138	11	to	to	TO
46745	4138	12	owe	owe	VB
46745	4138	13	their	-PRON-	PRP$
46745	4138	14	efficacy	efficacy	NN
46745	4138	15	.	.	.
46745	4139	1	All	all	DT
46745	4139	2	contain	contain	VBP
46745	4139	3	Tannic	Tannic	NNP
46745	4139	4	Acid	Acid	NNP
46745	4139	5	,	,	,
46745	4139	6	or	or	CC
46745	4139	7	some	some	DT
46745	4139	8	modification	modification	NN
46745	4139	9	of	of	IN
46745	4139	10	it	-PRON-	PRP
46745	4139	11	;	;	:
46745	4139	12	and	and	CC
46745	4139	13	Oak	Oak	NNP
46745	4139	14	-	-	HYPH
46745	4139	15	galls	gall	NNS
46745	4139	16	contain	contain	VBP
46745	4139	17	also	also	RB
46745	4139	18	Gallic	Gallic	NNP
46745	4139	19	Acid	Acid	NNP
46745	4139	20	.	.	.
46745	4140	1	The	the	DT
46745	4140	2	relative	relative	JJ
46745	4140	3	efficacy	efficacy	NN
46745	4140	4	of	of	IN
46745	4140	5	these	these	DT
46745	4140	6	active	active	JJ
46745	4140	7	principles	principle	NNS
46745	4140	8	may	may	MD
46745	4140	9	be	be	VB
46745	4140	10	summed	sum	VBN
46745	4140	11	up	up	RP
46745	4140	12	in	in	IN
46745	4140	13	a	a	DT
46745	4140	14	few	few	JJ
46745	4140	15	words	word	NNS
46745	4140	16	.	.	.
46745	4141	1	Tannic	tannic	JJ
46745	4141	2	and	and	CC
46745	4141	3	Gallic	Gallic	NNP
46745	4141	4	Acids	Acids	NNPS
46745	4141	5	may	may	MD
46745	4141	6	generally	generally	RB
46745	4141	7	be	be	VB
46745	4141	8	used	use	VBN
46745	4141	9	with	with	IN
46745	4141	10	great	great	JJ
46745	4141	11	advantage	advantage	NN
46745	4141	12	in	in	IN
46745	4141	13	all	all	DT
46745	4141	14	cases	case	NNS
46745	4141	15	in	in	IN
46745	4141	16	which	which	WDT
46745	4141	17	Astringents	astringent	NNS
46745	4141	18	are	be	VBP
46745	4141	19	required	require	VBN
46745	4141	20	.	.	.
46745	4142	1	When	when	WRB
46745	4142	2	applied	apply	VBN
46745	4142	3	externally	externally	RB
46745	4142	4	,	,	,
46745	4142	5	Tannic	Tannic	NNP
46745	4142	6	Acid	Acid	NNP
46745	4142	7	is	be	VBZ
46745	4142	8	the	the	DT
46745	4142	9	most	most	RBS
46745	4142	10	powerful	powerful	JJ
46745	4142	11	;	;	:
46745	4142	12	but	but	CC
46745	4142	13	for	for	IN
46745	4142	14	internal	internal	JJ
46745	4142	15	administration	administration	NN
46745	4142	16	Gallic	Gallic	NNP
46745	4142	17	Acid	Acid	NNP
46745	4142	18	is	be	VBZ
46745	4142	19	the	the	DT
46745	4142	20	best	good	JJS
46745	4142	21	.	.	.
46745	4143	1	The	the	DT
46745	4143	2	reason	reason	NN
46745	4143	3	of	of	IN
46745	4143	4	this	this	DT
46745	4143	5	will	will	MD
46745	4143	6	presently	presently	RB
46745	4143	7	appear	appear	VB
46745	4143	8	.	.	.
46745	4144	1	Creosote	creosote	NN
46745	4144	2	,	,	,
46745	4144	3	being	be	VBG
46745	4144	4	a	a	DT
46745	4144	5	powerful	powerful	JJ
46745	4144	6	Neurotic	Neurotic	NNP
46745	4144	7	,	,	,
46745	4144	8	can	can	MD
46745	4144	9	not	not	RB
46745	4144	10	be	be	VB
46745	4144	11	employed	employ	VBN
46745	4144	12	to	to	TO
46745	4144	13	act	act	VB
46745	4144	14	on	on	IN
46745	4144	15	distant	distant	JJ
46745	4144	16	parts	part	NNS
46745	4144	17	,	,	,
46745	4144	18	but	but	CC
46745	4144	19	is	be	VBZ
46745	4144	20	appropriate	appropriate	JJ
46745	4144	21	in	in	IN
46745	4144	22	cases	case	NNS
46745	4144	23	of	of	IN
46745	4144	24	hæmorrhage	hæmorrhage	NN
46745	4144	25	from	from	IN
46745	4144	26	the	the	DT
46745	4144	27	surface	surface	NN
46745	4144	28	of	of	IN
46745	4144	29	the	the	DT
46745	4144	30	stomach	stomach	NN
46745	4144	31	.	.	.
46745	4145	1	I	-PRON-	PRP
46745	4145	2	have	have	VBP
46745	4145	3	already	already	RB
46745	4145	4	said	say	VBN
46745	4145	5	that	that	IN
46745	4145	6	I	-PRON-	PRP
46745	4145	7	conceive	conceive	VBP
46745	4145	8	the	the	DT
46745	4145	9	astringent	astringent	JJ
46745	4145	10	powers	power	NNS
46745	4145	11	of	of	IN
46745	4145	12	these	these	DT
46745	4145	13	substances	substance	NNS
46745	4145	14	to	to	TO
46745	4145	15	depend	depend	VB
46745	4145	16	very	very	RB
46745	4145	17	much	much	RB
46745	4145	18	upon	upon	IN
46745	4145	19	their	-PRON-	PRP$
46745	4145	20	chemical	chemical	JJ
46745	4145	21	affinities	affinity	NNS
46745	4145	22	.	.	.
46745	4146	1	Tannic	tannic	JJ
46745	4146	2	Acid	Acid	NNP
46745	4146	3	precipitates	precipitate	VBZ
46745	4146	4	both	both	DT
46745	4146	5	Albumen	Albumen	NNP
46745	4146	6	and	and	CC
46745	4146	7	Gelatine	Gelatine	NNP
46745	4146	8	.	.	.
46745	4147	1	Creosote	creosote	NN
46745	4147	2	also	also	RB
46745	4147	3	coagulates	coagulate	VBZ
46745	4147	4	Albumen	Albumen	NNP
46745	4147	5	.	.	.
46745	4148	1	But	but	CC
46745	4148	2	Gallic	Gallic	NNP
46745	4148	3	Acid	Acid	NNP
46745	4148	4	does	do	VBZ
46745	4148	5	not	not	RB
46745	4148	6	affect	affect	VB
46745	4148	7	either	either	DT
46745	4148	8	of	of	IN
46745	4148	9	them	-PRON-	PRP
46745	4148	10	.	.	.
46745	4149	1	Tannic	tannic	JJ
46745	4149	2	Acid	Acid	NNP
46745	4149	3	does	do	VBZ
46745	4149	4	not	not	RB
46745	4149	5	seem	seem	VB
46745	4149	6	to	to	TO
46745	4149	7	be	be	VB
46745	4149	8	a	a	DT
46745	4149	9	simple	simple	JJ
46745	4149	10	substance	substance	NN
46745	4149	11	.	.	.
46745	4150	1	When	when	WRB
46745	4150	2	boiled	boil	VBN
46745	4150	3	with	with	IN
46745	4150	4	acids	acid	NNS
46745	4150	5	,	,	,
46745	4150	6	or	or	CC
46745	4150	7	with	with	IN
46745	4150	8	alkalies	alkali	NNS
46745	4150	9	,	,	,
46745	4150	10	it	-PRON-	PRP
46745	4150	11	yields	yield	VBZ
46745	4150	12	Gallic	Gallic	NNP
46745	4150	13	Acid	Acid	NNP
46745	4150	14	and	and	CC
46745	4150	15	a	a	DT
46745	4150	16	brown	brown	JJ
46745	4150	17	matter	matter	NN
46745	4150	18	.	.	.
46745	4151	1	Tannic	tannic	JJ
46745	4151	2	and	and	CC
46745	4151	3	Gallic	Gallic	NNP
46745	4151	4	Acids	Acids	NNPS
46745	4151	5	yield	yield	VBP
46745	4151	6	the	the	DT
46745	4151	7	same	same	JJ
46745	4151	8	set	set	NN
46745	4151	9	of	of	IN
46745	4151	10	products	product	NNS
46745	4151	11	when	when	WRB
46745	4151	12	submitted	submit	VBN
46745	4151	13	to	to	IN
46745	4151	14	destructive	destructive	JJ
46745	4151	15	distillation	distillation	NN
46745	4151	16	.	.	.
46745	4152	1	And	and	CC
46745	4152	2	it	-PRON-	PRP
46745	4152	3	appears	appear	VBZ
46745	4152	4	likely	likely	JJ
46745	4152	5	,	,	,
46745	4152	6	from	from	IN
46745	4152	7	the	the	DT
46745	4152	8	researches	research	NNS
46745	4152	9	of	of	IN
46745	4152	10	M.	M.	NNP
46745	4152	11	Braconnot	Braconnot	NNP
46745	4152	12	,	,	,
46745	4152	13	that	that	IN
46745	4152	14	Tannic	tannic	NN
46745	4152	15	is	be	VBZ
46745	4152	16	a	a	DT
46745	4152	17	compound	compound	NN
46745	4152	18	acid	acid	NN
46745	4152	19	consisting	consist	VBG
46745	4152	20	of	of	IN
46745	4152	21	Gallic	Gallic	NNP
46745	4152	22	Acid	Acid	NNP
46745	4152	23	in	in	IN
46745	4152	24	combination	combination	NN
46745	4152	25	with	with	IN
46745	4152	26	the	the	DT
46745	4152	27	elements	element	NNS
46745	4152	28	of	of	IN
46745	4152	29	grape	grape	NN
46745	4152	30	-	-	HYPH
46745	4152	31	sugar	sugar	NN
46745	4152	32	.	.	.
46745	4153	1	Three	three	CD
46745	4153	2	atoms	atom	NNS
46745	4153	3	of	of	IN
46745	4153	4	Tannic	tannic	JJ
46745	4153	5	Acid	Acid	NNP
46745	4153	6	are	be	VBP
46745	4153	7	together	together	RB
46745	4153	8	equivalent	equivalent	JJ
46745	4153	9	to	to	IN
46745	4153	10	six	six	CD
46745	4153	11	atoms	atom	NNS
46745	4153	12	of	of	IN
46745	4153	13	Gallic	Gallic	NNP
46745	4153	14	Acid	Acid	NNP
46745	4153	15	and	and	CC
46745	4153	16	one	one	CD
46745	4153	17	of	of	IN
46745	4153	18	grape	grape	NN
46745	4153	19	-	-	HYPH
46745	4153	20	sugar	sugar	NN
46745	4153	21	.	.	.
46745	4154	1	When	when	WRB
46745	4154	2	the	the	DT
46745	4154	3	solution	solution	NN
46745	4154	4	of	of	IN
46745	4154	5	the	the	DT
46745	4154	6	former	former	JJ
46745	4154	7	acid	acid	NN
46745	4154	8	is	be	VBZ
46745	4154	9	heated	heat	VBN
46745	4154	10	in	in	IN
46745	4154	11	the	the	DT
46745	4154	12	air	air	NN
46745	4154	13	,	,	,
46745	4154	14	or	or	CC
46745	4154	15	taken	take	VBN
46745	4154	16	into	into	IN
46745	4154	17	the	the	DT
46745	4154	18	human	human	JJ
46745	4154	19	system	system	NN
46745	4154	20	,	,	,
46745	4154	21	the	the	DT
46745	4154	22	elements	element	NNS
46745	4154	23	of	of	IN
46745	4154	24	grape	grape	NN
46745	4154	25	-	-	HYPH
46745	4154	26	sugar	sugar	NN
46745	4154	27	are	be	VBP
46745	4154	28	oxidized	oxidize	VBN
46745	4154	29	into	into	IN
46745	4154	30	Carbonic	Carbonic	NNP
46745	4154	31	Acid	Acid	NNP
46745	4154	32	and	and	CC
46745	4154	33	water	water	NN
46745	4154	34	,	,	,
46745	4154	35	and	and	CC
46745	4154	36	Gallic	Gallic	NNP
46745	4154	37	Acid	Acid	NNP
46745	4154	38	is	be	VBZ
46745	4154	39	set	set	VBN
46745	4154	40	free	free	JJ
46745	4154	41	.	.	.
46745	4155	1	(	(	-LRB-
46745	4155	2	_	_	NNP
46745	4155	3	Vide	Vide	NNP
46745	4155	4	_	_	NNP
46745	4155	5	Chap	Chap	NNP
46745	4155	6	.	.	.
46745	4156	1	IV	IV	NNP
46745	4156	2	.	.	.
46745	4157	1	_	_	NNP
46745	4157	2	Art	Art	NNP
46745	4157	3	.	.	.
46745	4158	1	Tannic	Tannic	NNP
46745	4158	2	Acid	Acid	NNP
46745	4158	3	_	_	NNP
46745	4158	4	.	.	.
46745	4158	5	)	)	-RRB-
46745	4159	1	It	-PRON-	PRP
46745	4159	2	is	be	VBZ
46745	4159	3	thus	thus	RB
46745	4159	4	Gallic	Gallic	NNP
46745	4159	5	Acid	Acid	NNP
46745	4159	6	which	which	WDT
46745	4159	7	passes	pass	VBZ
46745	4159	8	out	out	RP
46745	4159	9	into	into	IN
46745	4159	10	the	the	DT
46745	4159	11	secretions	secretion	NNS
46745	4159	12	,	,	,
46745	4159	13	and	and	CC
46745	4159	14	exerts	exert	VBZ
46745	4159	15	an	an	DT
46745	4159	16	astringent	astringent	JJ
46745	4159	17	action	action	NN
46745	4159	18	at	at	IN
46745	4159	19	distant	distant	JJ
46745	4159	20	parts	part	NNS
46745	4159	21	of	of	IN
46745	4159	22	the	the	DT
46745	4159	23	system	system	NN
46745	4159	24	.	.	.
46745	4160	1	And	and	CC
46745	4160	2	as	as	IN
46745	4160	3	the	the	DT
46745	4160	4	Tannic	tannic	JJ
46745	4160	5	Acid	Acid	NNP
46745	4160	6	loses	lose	VBZ
46745	4160	7	weight	weight	NN
46745	4160	8	by	by	IN
46745	4160	9	the	the	DT
46745	4160	10	decomposition	decomposition	NN
46745	4160	11	,	,	,
46745	4160	12	it	-PRON-	PRP
46745	4160	13	follows	follow	VBZ
46745	4160	14	that	that	IN
46745	4160	15	a	a	DT
46745	4160	16	dose	dose	NN
46745	4160	17	of	of	IN
46745	4160	18	Gallic	Gallic	NNP
46745	4160	19	Acid	Acid	NNP
46745	4160	20	produces	produce	VBZ
46745	4160	21	a	a	DT
46745	4160	22	greater	great	JJR
46745	4160	23	effect	effect	NN
46745	4160	24	as	as	IN
46745	4160	25	a	a	DT
46745	4160	26	medicine	medicine	NN
46745	4160	27	than	than	IN
46745	4160	28	an	an	DT
46745	4160	29	equal	equal	JJ
46745	4160	30	amount	amount	NN
46745	4160	31	of	of	IN
46745	4160	32	the	the	DT
46745	4160	33	other	other	JJ
46745	4160	34	.	.	.
46745	4161	1	Thus	thus	RB
46745	4161	2	one	one	CD
46745	4161	3	ascertained	ascertain	VBN
46745	4161	4	fact	fact	NN
46745	4161	5	is	be	VBZ
46745	4161	6	cleared	clear	VBN
46745	4161	7	up	up	RP
46745	4161	8	by	by	IN
46745	4161	9	these	these	DT
46745	4161	10	chemical	chemical	NN
46745	4161	11	considerations	consideration	NNS
46745	4161	12	,	,	,
46745	4161	13	but	but	CC
46745	4161	14	other	other	JJ
46745	4161	15	mysterious	mysterious	JJ
46745	4161	16	points	point	NNS
46745	4161	17	remain	remain	VBP
46745	4161	18	still	still	RB
46745	4161	19	to	to	TO
46745	4161	20	be	be	VB
46745	4161	21	explained	explain	VBN
46745	4161	22	.	.	.
46745	4162	1	Gallic	Gallic	NNP
46745	4162	2	Acid	Acid	NNP
46745	4162	3	does	do	VBZ
46745	4162	4	not	not	RB
46745	4162	5	precipitate	precipitate	VB
46745	4162	6	albumen	albuman	NNS
46745	4162	7	,	,	,
46745	4162	8	and	and	CC
46745	4162	9	is	be	VBZ
46745	4162	10	of	of	IN
46745	4162	11	little	little	JJ
46745	4162	12	use	use	NN
46745	4162	13	as	as	IN
46745	4162	14	an	an	DT
46745	4162	15	Astringent	Astringent	NNP
46745	4162	16	when	when	WRB
46745	4162	17	applied	apply	VBD
46745	4162	18	to	to	IN
46745	4162	19	external	external	JJ
46745	4162	20	parts	part	NNS
46745	4162	21	;	;	:
46745	4162	22	but	but	CC
46745	4162	23	it	-PRON-	PRP
46745	4162	24	is	be	VBZ
46745	4162	25	very	very	RB
46745	4162	26	efficacious	efficacious	JJ
46745	4162	27	when	when	WRB
46745	4162	28	given	give	VBN
46745	4162	29	internally	internally	RB
46745	4162	30	.	.	.
46745	4163	1	Tannic	Tannic	NNP
46745	4163	2	Acid	Acid	NNP
46745	4163	3	,	,	,
46745	4163	4	which	which	WDT
46745	4163	5	is	be	VBZ
46745	4163	6	equivalent	equivalent	JJ
46745	4163	7	in	in	IN
46745	4163	8	composition	composition	NN
46745	4163	9	to	to	IN
46745	4163	10	a	a	DT
46745	4163	11	combination	combination	NN
46745	4163	12	of	of	IN
46745	4163	13	Gallic	Gallic	NNP
46745	4163	14	Acid	Acid	NNP
46745	4163	15	with	with	IN
46745	4163	16	a	a	DT
46745	4163	17	saccharine	saccharine	NN
46745	4163	18	matter	matter	NN
46745	4163	19	,	,	,
46745	4163	20	is	be	VBZ
46745	4163	21	a	a	DT
46745	4163	22	valuable	valuable	JJ
46745	4163	23	external	external	JJ
46745	4163	24	Astringent	Astringent	NNP
46745	4163	25	.	.	.
46745	4164	1	A	a	DT
46745	4164	2	further	further	JJ
46745	4164	3	chemical	chemical	NN
46745	4164	4	discovery	discovery	NN
46745	4164	5	has	have	VBZ
46745	4164	6	been	be	VBN
46745	4164	7	made	make	VBN
46745	4164	8	,	,	,
46745	4164	9	which	which	WDT
46745	4164	10	appears	appear	VBZ
46745	4164	11	to	to	TO
46745	4164	12	bear	bear	VB
46745	4164	13	upon	upon	IN
46745	4164	14	these	these	DT
46745	4164	15	facts	fact	NNS
46745	4164	16	.	.	.
46745	4165	1	M.	M.	NNP
46745	4165	2	Pelletier	Pelletier	NNP
46745	4165	3	has	have	VBZ
46745	4165	4	found	find	VBN
46745	4165	5	that	that	IN
46745	4165	6	a	a	DT
46745	4165	7	mixture	mixture	NN
46745	4165	8	of	of	IN
46745	4165	9	a	a	DT
46745	4165	10	solution	solution	NN
46745	4165	11	of	of	IN
46745	4165	12	Gallic	Gallic	NNP
46745	4165	13	Acid	Acid	NNP
46745	4165	14	with	with	IN
46745	4165	15	one	one	CD
46745	4165	16	of	of	IN
46745	4165	17	Gum	Gum	NNP
46745	4165	18	will	will	MD
46745	4165	19	precipitate	precipitate	VB
46745	4165	20	albumen	albuman	NNS
46745	4165	21	,	,	,
46745	4165	22	although	although	IN
46745	4165	23	neither	neither	DT
46745	4165	24	of	of	IN
46745	4165	25	them	-PRON-	PRP
46745	4165	26	will	will	MD
46745	4165	27	affect	affect	VB
46745	4165	28	it	-PRON-	PRP
46745	4165	29	separately	separately	RB
46745	4165	30	.	.	.
46745	4166	1	[	[	-LRB-
46745	4166	2	43	43	CD
46745	4166	3	]	]	-RRB-
46745	4166	4	Gum	Gum	NNP
46745	4166	5	has	have	VBZ
46745	4166	6	the	the	DT
46745	4166	7	same	same	JJ
46745	4166	8	composition	composition	NN
46745	4166	9	as	as	IN
46745	4166	10	common	common	JJ
46745	4166	11	sugar	sugar	NN
46745	4166	12	;	;	:
46745	4166	13	and	and	CC
46745	4166	14	grape	grape	NN
46745	4166	15	-	-	HYPH
46745	4166	16	sugar	sugar	NN
46745	4166	17	,	,	,
46745	4166	18	or	or	CC
46745	4166	19	a	a	DT
46745	4166	20	material	material	NN
46745	4166	21	containing	contain	VBG
46745	4166	22	the	the	DT
46745	4166	23	same	same	JJ
46745	4166	24	elements	element	NNS
46745	4166	25	,	,	,
46745	4166	26	is	be	VBZ
46745	4166	27	known	know	VBN
46745	4166	28	to	to	TO
46745	4166	29	be	be	VB
46745	4166	30	continually	continually	RB
46745	4166	31	forming	form	VBG
46745	4166	32	in	in	IN
46745	4166	33	the	the	DT
46745	4166	34	blood	blood	NN
46745	4166	35	.	.	.
46745	4167	1	Thus	thus	RB
46745	4167	2	it	-PRON-	PRP
46745	4167	3	is	be	VBZ
46745	4167	4	likely	likely	JJ
46745	4167	5	that	that	IN
46745	4167	6	Gallic	Gallic	NNP
46745	4167	7	Acid	Acid	NNP
46745	4167	8	may	may	MD
46745	4167	9	act	act	VB
46745	4167	10	along	along	RP
46745	4167	11	with	with	IN
46745	4167	12	this	this	DT
46745	4167	13	saccharine	saccharine	JJ
46745	4167	14	matter	matter	NN
46745	4167	15	in	in	IN
46745	4167	16	the	the	DT
46745	4167	17	blood	blood	NN
46745	4167	18	,	,	,
46745	4167	19	and	and	CC
46745	4167	20	by	by	IN
46745	4167	21	this	this	DT
46745	4167	22	acquire	acquire	NN
46745	4167	23	chemically	chemically	RB
46745	4167	24	an	an	DT
46745	4167	25	astringent	astringent	JJ
46745	4167	26	power	power	NN
46745	4167	27	,	,	,
46745	4167	28	which	which	WDT
46745	4167	29	it	-PRON-	PRP
46745	4167	30	is	be	VBZ
46745	4167	31	not	not	RB
46745	4167	32	able	able	JJ
46745	4167	33	to	to	TO
46745	4167	34	exert	exert	VB
46745	4167	35	on	on	IN
46745	4167	36	external	external	JJ
46745	4167	37	parts	part	NNS
46745	4167	38	,	,	,
46745	4167	39	because	because	IN
46745	4167	40	then	then	RB
46745	4167	41	isolated	isolate	VBD
46745	4167	42	.	.	.
46745	4168	1	But	but	CC
46745	4168	2	the	the	DT
46745	4168	3	saccharine	saccharine	NN
46745	4168	4	matter	matter	NN
46745	4168	5	is	be	VBZ
46745	4168	6	required	require	VBN
46745	4168	7	in	in	IN
46745	4168	8	the	the	DT
46745	4168	9	system	system	NN
46745	4168	10	for	for	IN
46745	4168	11	special	special	JJ
46745	4168	12	purposes	purpose	NNS
46745	4168	13	,	,	,
46745	4168	14	and	and	CC
46745	4168	15	thus	thus	RB
46745	4168	16	Gallic	Gallic	NNP
46745	4168	17	Acid	Acid	NNP
46745	4168	18	passes	pass	VBZ
46745	4168	19	out	out	RP
46745	4168	20	into	into	IN
46745	4168	21	the	the	DT
46745	4168	22	secretions	secretion	NNS
46745	4168	23	alone	alone	RB
46745	4168	24	.	.	.
46745	4169	1	It	-PRON-	PRP
46745	4169	2	seems	seem	VBZ
46745	4169	3	probable	probable	JJ
46745	4169	4	,	,	,
46745	4169	5	when	when	WRB
46745	4169	6	Tannic	Tannic	NNP
46745	4169	7	Acid	Acid	NNP
46745	4169	8	is	be	VBZ
46745	4169	9	given	give	VBN
46745	4169	10	,	,	,
46745	4169	11	that	that	IN
46745	4169	12	it	-PRON-	PRP
46745	4169	13	is	be	VBZ
46745	4169	14	not	not	RB
46745	4169	15	decomposed	decompose	VBN
46745	4169	16	into	into	IN
46745	4169	17	its	-PRON-	PRP$
46745	4169	18	constituent	constituent	NN
46745	4169	19	parts	part	NNS
46745	4169	20	until	until	IN
46745	4169	21	it	-PRON-	PRP
46745	4169	22	has	have	VBZ
46745	4169	23	to	to	TO
46745	4169	24	be	be	VB
46745	4169	25	separated	separate	VBN
46745	4169	26	from	from	IN
46745	4169	27	the	the	DT
46745	4169	28	blood	blood	NN
46745	4169	29	by	by	IN
46745	4169	30	the	the	DT
46745	4169	31	glands	gland	NNS
46745	4169	32	.	.	.
46745	4170	1	These	these	DT
46745	4170	2	two	two	CD
46745	4170	3	compounds	compound	NNS
46745	4170	4	,	,	,
46745	4170	5	and	and	CC
46745	4170	6	the	the	DT
46745	4170	7	vegetable	vegetable	NN
46745	4170	8	substances	substance	NNS
46745	4170	9	that	that	WDT
46745	4170	10	contain	contain	VBP
46745	4170	11	them	-PRON-	PRP
46745	4170	12	,	,	,
46745	4170	13	are	be	VBP
46745	4170	14	used	use	VBN
46745	4170	15	in	in	IN
46745	4170	16	diarrh[oe]a	diarrh[oe]a	NNP
46745	4170	17	,	,	,
46745	4170	18	and	and	CC
46745	4170	19	in	in	IN
46745	4170	20	all	all	DT
46745	4170	21	hæmorrhagic	hæmorrhagic	JJ
46745	4170	22	cases	case	NNS
46745	4170	23	.	.	.
46745	4171	1	To	to	TO
46745	4171	2	diminish	diminish	VB
46745	4171	3	sweating	sweating	NN
46745	4171	4	,	,	,
46745	4171	5	Tannic	Tannic	NNP
46745	4171	6	is	be	VBZ
46745	4171	7	inferior	inferior	JJ
46745	4171	8	to	to	IN
46745	4171	9	Sulphuric	Sulphuric	NNP
46745	4171	10	Acid	Acid	NNP
46745	4171	11	;	;	:
46745	4171	12	but	but	CC
46745	4171	13	to	to	TO
46745	4171	14	act	act	VB
46745	4171	15	as	as	IN
46745	4171	16	a	a	DT
46745	4171	17	remote	remote	JJ
46745	4171	18	Styptic	styptic	NN
46745	4171	19	,	,	,
46745	4171	20	it	-PRON-	PRP
46745	4171	21	is	be	VBZ
46745	4171	22	preferable	preferable	JJ
46745	4171	23	to	to	IN
46745	4171	24	the	the	DT
46745	4171	25	other	other	JJ
46745	4171	26	.	.	.
46745	4172	1	Tannic	tannic	JJ
46745	4172	2	and	and	CC
46745	4172	3	Gallic	Gallic	NNP
46745	4172	4	Acids	Acids	NNP
46745	4172	5	diminish	diminish	VBP
46745	4172	6	secretions	secretion	NNS
46745	4172	7	generally	generally	RB
46745	4172	8	;	;	:
46745	4172	9	they	-PRON-	PRP
46745	4172	10	are	be	VBP
46745	4172	11	very	very	RB
46745	4172	12	useful	useful	JJ
46745	4172	13	in	in	IN
46745	4172	14	cases	case	NNS
46745	4172	15	of	of	IN
46745	4172	16	hæmaturia	hæmaturia	NN
46745	4172	17	,	,	,
46745	4172	18	where	where	WRB
46745	4172	19	Sulphuric	Sulphuric	NNP
46745	4172	20	Acid	Acid	NNP
46745	4172	21	is	be	VBZ
46745	4172	22	all	all	DT
46745	4172	23	but	but	IN
46745	4172	24	useless	useless	JJ
46745	4172	25	.	.	.
46745	4173	1	Creosote	creosote	NN
46745	4173	2	is	be	VBZ
46745	4173	3	a	a	DT
46745	4173	4	Sedative	Sedative	NNP
46745	4173	5	,	,	,
46745	4173	6	and	and	CC
46745	4173	7	can	can	MD
46745	4173	8	not	not	RB
46745	4173	9	be	be	VB
46745	4173	10	well	well	RB
46745	4173	11	given	give	VBN
46745	4173	12	in	in	IN
46745	4173	13	such	such	JJ
46745	4173	14	large	large	JJ
46745	4173	15	doses	dose	NNS
46745	4173	16	as	as	IN
46745	4173	17	to	to	TO
46745	4173	18	act	act	VB
46745	4173	19	upon	upon	IN
46745	4173	20	distant	distant	JJ
46745	4173	21	parts	part	NNS
46745	4173	22	.	.	.
46745	4174	1	In	in	IN
46745	4174	2	cases	case	NNS
46745	4174	3	of	of	IN
46745	4174	4	hæmatemesis	hæmatemesis	NN
46745	4174	5	it	-PRON-	PRP
46745	4174	6	acts	act	VBZ
46745	4174	7	topically	topically	RB
46745	4174	8	on	on	IN
46745	4174	9	the	the	DT
46745	4174	10	surface	surface	NN
46745	4174	11	of	of	IN
46745	4174	12	the	the	DT
46745	4174	13	stomach	stomach	NN
46745	4174	14	in	in	IN
46745	4174	15	a	a	DT
46745	4174	16	double	double	JJ
46745	4174	17	way	way	NN
46745	4174	18	,	,	,
46745	4174	19	diminishing	diminish	VBG
46745	4174	20	the	the	DT
46745	4174	21	hæmorrhage	hæmorrhage	NN
46745	4174	22	by	by	IN
46745	4174	23	its	-PRON-	PRP$
46745	4174	24	astringent	astringent	JJ
46745	4174	25	power	power	NN
46745	4174	26	over	over	IN
46745	4174	27	the	the	DT
46745	4174	28	vessels	vessel	NNS
46745	4174	29	,	,	,
46745	4174	30	and	and	CC
46745	4174	31	quieting	quiet	VBG
46745	4174	32	the	the	DT
46745	4174	33	nervous	nervous	JJ
46745	4174	34	irritation	irritation	NN
46745	4174	35	by	by	IN
46745	4174	36	which	which	WDT
46745	4174	37	the	the	DT
46745	4174	38	vascular	vascular	JJ
46745	4174	39	excitement	excitement	NN
46745	4174	40	is	be	VBZ
46745	4174	41	often	often	RB
46745	4174	42	maintained	maintain	VBN
46745	4174	43	.	.	.
46745	4175	1	In	in	IN
46745	4175	2	cancerous	cancerous	JJ
46745	4175	3	cases	case	NNS
46745	4175	4	the	the	DT
46745	4175	5	bleeding	bleeding	NN
46745	4175	6	can	can	MD
46745	4175	7	never	never	RB
46745	4175	8	be	be	VB
46745	4175	9	permanently	permanently	RB
46745	4175	10	stopped	stop	VBN
46745	4175	11	.	.	.
46745	4176	1	This	this	DT
46745	4176	2	concludes	conclude	VBZ
46745	4176	3	the	the	DT
46745	4176	4	list	list	NN
46745	4176	5	of	of	IN
46745	4176	6	Astringent	astringent	JJ
46745	4176	7	medicines	medicine	NNS
46745	4176	8	.	.	.
46745	4177	1	Certain	certain	JJ
46745	4177	2	stimulant	stimulant	NN
46745	4177	3	Eliminatives	eliminative	NNS
46745	4177	4	are	be	VBP
46745	4177	5	employed	employ	VBN
46745	4177	6	for	for	IN
46745	4177	7	the	the	DT
46745	4177	8	purpose	purpose	NN
46745	4177	9	of	of	IN
46745	4177	10	checking	check	VBG
46745	4177	11	mucous	mucous	JJ
46745	4177	12	fluxes	flux	NNS
46745	4177	13	,	,	,
46745	4177	14	and	and	CC
46745	4177	15	so	so	RB
46745	4177	16	far	far	RB
46745	4177	17	simulate	simulate	VBP
46745	4177	18	the	the	DT
46745	4177	19	action	action	NN
46745	4177	20	of	of	IN
46745	4177	21	true	true	JJ
46745	4177	22	Astringent	astringent	JJ
46745	4177	23	medicines	medicine	NNS
46745	4177	24	.	.	.
46745	4178	1	Thus	thus	RB
46745	4178	2	we	-PRON-	PRP
46745	4178	3	administer	administer	VBP
46745	4178	4	,	,	,
46745	4178	5	with	with	IN
46745	4178	6	more	more	JJR
46745	4178	7	or	or	CC
46745	4178	8	less	less	JJR
46745	4178	9	advantage	advantage	NN
46745	4178	10	,	,	,
46745	4178	11	Aromatics	Aromatics	NNP
46745	4178	12	in	in	IN
46745	4178	13	diarrh[oe]a	diarrh[oe]a	NNP
46745	4178	14	;	;	:
46745	4178	15	Cubebs	Cubebs	NNP
46745	4178	16	,	,	,
46745	4178	17	Copaiba	Copaiba	NNP
46745	4178	18	,	,	,
46745	4178	19	and	and	CC
46745	4178	20	Turpentine	Turpentine	NNP
46745	4178	21	,	,	,
46745	4178	22	in	in	IN
46745	4178	23	gonorrh[oe]a	gonorrh[oe]a	NNP
46745	4178	24	;	;	:
46745	4178	25	and	and	CC
46745	4178	26	Balsam	Balsam	NNP
46745	4178	27	of	of	IN
46745	4178	28	Peru	Peru	NNP
46745	4178	29	,	,	,
46745	4178	30	and	and	CC
46745	4178	31	other	other	JJ
46745	4178	32	oleo	oleo	NN
46745	4178	33	-	-	HYPH
46745	4178	34	resins	resin	NNS
46745	4178	35	,	,	,
46745	4178	36	in	in	IN
46745	4178	37	Catarrhal	Catarrhal	NNP
46745	4178	38	affections	affection	NNS
46745	4178	39	.	.	.
46745	4179	1	These	these	DT
46745	4179	2	medicines	medicine	NNS
46745	4179	3	all	all	DT
46745	4179	4	act	act	VBP
46745	4179	5	upon	upon	IN
46745	4179	6	and	and	CC
46745	4179	7	pass	pass	VB
46745	4179	8	through	through	IN
46745	4179	9	the	the	DT
46745	4179	10	glands	gland	NNS
46745	4179	11	of	of	IN
46745	4179	12	the	the	DT
46745	4179	13	several	several	JJ
46745	4179	14	mucous	mucous	JJ
46745	4179	15	surfaces	surface	NNS
46745	4179	16	which	which	WDT
46745	4179	17	they	-PRON-	PRP
46745	4179	18	affect	affect	VBP
46745	4179	19	:	:	:
46745	4179	20	while	while	IN
46745	4179	21	so	so	RB
46745	4179	22	doing	do	VBG
46745	4179	23	,	,	,
46745	4179	24	they	-PRON-	PRP
46745	4179	25	stimulate	stimulate	VBP
46745	4179	26	the	the	DT
46745	4179	27	healthy	healthy	JJ
46745	4179	28	function	function	NN
46745	4179	29	and	and	CC
46745	4179	30	secretion	secretion	NN
46745	4179	31	of	of	IN
46745	4179	32	the	the	DT
46745	4179	33	gland	gland	NN
46745	4179	34	,	,	,
46745	4179	35	and	and	CC
46745	4179	36	cause	cause	VB
46745	4179	37	it	-PRON-	PRP
46745	4179	38	to	to	TO
46745	4179	39	displace	displace	VB
46745	4179	40	the	the	DT
46745	4179	41	morbid	morbid	NN
46745	4179	42	one	one	NN
46745	4179	43	.	.	.
46745	4180	1	Dr.	Dr.	NNP
46745	4180	2	Williams	Williams	NNP
46745	4180	3	thinks	think	VBZ
46745	4180	4	that	that	IN
46745	4180	5	they	-PRON-	PRP
46745	4180	6	first	first	RB
46745	4180	7	cause	cause	VBP
46745	4180	8	dilatation	dilatation	NN
46745	4180	9	of	of	IN
46745	4180	10	the	the	DT
46745	4180	11	vessels	vessel	NNS
46745	4180	12	of	of	IN
46745	4180	13	a	a	DT
46745	4180	14	gland	gland	NN
46745	4180	15	,	,	,
46745	4180	16	and	and	CC
46745	4180	17	that	that	IN
46745	4180	18	this	this	DT
46745	4180	19	is	be	VBZ
46745	4180	20	followed	follow	VBN
46745	4180	21	by	by	IN
46745	4180	22	contraction	contraction	NN
46745	4180	23	.	.	.
46745	4181	1	There	there	EX
46745	4181	2	is	be	VBZ
46745	4181	3	no	no	DT
46745	4181	4	apparent	apparent	JJ
46745	4181	5	reason	reason	NN
46745	4181	6	why	why	WRB
46745	4181	7	the	the	DT
46745	4181	8	latter	latter	JJ
46745	4181	9	effect	effect	NN
46745	4181	10	should	should	MD
46745	4181	11	succeed	succeed	VB
46745	4181	12	the	the	DT
46745	4181	13	former	former	JJ
46745	4181	14	.	.	.
46745	4182	1	But	but	CC
46745	4182	2	supposing	suppose	VBG
46745	4182	3	contraction	contraction	NN
46745	4182	4	to	to	TO
46745	4182	5	take	take	VB
46745	4182	6	place	place	NN
46745	4182	7	in	in	IN
46745	4182	8	this	this	DT
46745	4182	9	way	way	NN
46745	4182	10	,	,	,
46745	4182	11	then	then	RB
46745	4182	12	these	these	DT
46745	4182	13	medicines	medicine	NNS
46745	4182	14	would	would	MD
46745	4182	15	be	be	VB
46745	4182	16	true	true	JJ
46745	4182	17	Astringents	astringent	NNS
46745	4182	18	.	.	.
46745	4183	1	But	but	CC
46745	4183	2	it	-PRON-	PRP
46745	4183	3	can	can	MD
46745	4183	4	not	not	RB
46745	4183	5	be	be	VB
46745	4183	6	so	so	RB
46745	4183	7	,	,	,
46745	4183	8	for	for	IN
46745	4183	9	they	-PRON-	PRP
46745	4183	10	do	do	VBP
46745	4183	11	not	not	RB
46745	4183	12	diminish	diminish	VB
46745	4183	13	any	any	DT
46745	4183	14	of	of	IN
46745	4183	15	the	the	DT
46745	4183	16	natural	natural	JJ
46745	4183	17	secretions	secretion	NNS
46745	4183	18	,	,	,
46745	4183	19	but	but	CC
46745	4183	20	,	,	,
46745	4183	21	on	on	IN
46745	4183	22	the	the	DT
46745	4183	23	contrary	contrary	NN
46745	4183	24	,	,	,
46745	4183	25	increase	increase	VB
46745	4183	26	them	-PRON-	PRP
46745	4183	27	.	.	.
46745	4184	1	Turpentine	turpentine	NN
46745	4184	2	,	,	,
46745	4184	3	Cubebs	Cubebs	NNP
46745	4184	4	,	,	,
46745	4184	5	and	and	CC
46745	4184	6	Copaiba	Copaiba	NNP
46745	4184	7	,	,	,
46745	4184	8	are	be	VBP
46745	4184	9	Diuretics	diuretic	NNS
46745	4184	10	,	,	,
46745	4184	11	and	and	CC
46745	4184	12	it	-PRON-	PRP
46745	4184	13	is	be	VBZ
46745	4184	14	possible	possible	JJ
46745	4184	15	that	that	IN
46745	4184	16	while	while	IN
46745	4184	17	passing	pass	VBG
46745	4184	18	out	out	RP
46745	4184	19	in	in	IN
46745	4184	20	the	the	DT
46745	4184	21	urine	urine	NN
46745	4184	22	they	-PRON-	PRP
46745	4184	23	may	may	MD
46745	4184	24	simply	simply	RB
46745	4184	25	stimulate	stimulate	VB
46745	4184	26	the	the	DT
46745	4184	27	mucous	mucous	JJ
46745	4184	28	surface	surface	NN
46745	4184	29	of	of	IN
46745	4184	30	the	the	DT
46745	4184	31	inflamed	inflamed	JJ
46745	4184	32	urethra	urethra	NNP
46745	4184	33	,	,	,
46745	4184	34	and	and	CC
46745	4184	35	excite	excite	VB
46745	4184	36	it	-PRON-	PRP
46745	4184	37	to	to	IN
46745	4184	38	a	a	DT
46745	4184	39	healthy	healthy	JJ
46745	4184	40	action	action	NN
46745	4184	41	.	.	.
46745	4185	1	These	these	DT
46745	4185	2	volatile	volatile	JJ
46745	4185	3	oils	oil	NNS
46745	4185	4	are	be	VBP
46745	4185	5	incapable	incapable	JJ
46745	4185	6	of	of	IN
46745	4185	7	exerting	exert	VBG
46745	4185	8	a	a	DT
46745	4185	9	true	true	JJ
46745	4185	10	astringent	astringent	JJ
46745	4185	11	action	action	NN
46745	4185	12	.	.	.
46745	4186	1	On	on	IN
46745	4186	2	the	the	DT
46745	4186	3	supposition	supposition	NN
46745	4186	4	that	that	IN
46745	4186	5	it	-PRON-	PRP
46745	4186	6	is	be	VBZ
46745	4186	7	really	really	RB
46745	4186	8	an	an	DT
46745	4186	9	Astringent	Astringent	NNP
46745	4186	10	,	,	,
46745	4186	11	Turpentine	Turpentine	NNP
46745	4186	12	has	have	VBZ
46745	4186	13	been	be	VBN
46745	4186	14	often	often	RB
46745	4186	15	prescribed	prescribe	VBN
46745	4186	16	as	as	IN
46745	4186	17	a	a	DT
46745	4186	18	remedy	remedy	NN
46745	4186	19	for	for	IN
46745	4186	20	hæmorrhages	hæmorrhage	NNS
46745	4186	21	in	in	IN
46745	4186	22	different	different	JJ
46745	4186	23	parts	part	NNS
46745	4186	24	of	of	IN
46745	4186	25	the	the	DT
46745	4186	26	body	body	NN
46745	4186	27	.	.	.
46745	4187	1	But	but	CC
46745	4187	2	it	-PRON-	PRP
46745	4187	3	has	have	VBZ
46745	4187	4	very	very	RB
46745	4187	5	much	much	RB
46745	4187	6	disappointed	disappoint	VBN
46745	4187	7	the	the	DT
46745	4187	8	expectations	expectation	NNS
46745	4187	9	that	that	WDT
46745	4187	10	were	be	VBD
46745	4187	11	entertained	entertain	VBN
46745	4187	12	of	of	IN
46745	4187	13	its	-PRON-	PRP$
46745	4187	14	efficacy	efficacy	NN
46745	4187	15	.	.	.
46745	4188	1	General	General	NNP
46745	4188	2	Stimulants	Stimulants	NNP
46745	4188	3	may	may	MD
46745	4188	4	act	act	VB
46745	4188	5	indirectly	indirectly	RB
46745	4188	6	as	as	IN
46745	4188	7	styptics	styptic	NNS
46745	4188	8	to	to	IN
46745	4188	9	a	a	DT
46745	4188	10	mucous	mucous	JJ
46745	4188	11	surface	surface	NN
46745	4188	12	,	,	,
46745	4188	13	when	when	WRB
46745	4188	14	relaxed	relaxed	JJ
46745	4188	15	and	and	CC
46745	4188	16	bleeding	bleed	VBG
46745	4188	17	on	on	IN
46745	4188	18	account	account	NN
46745	4188	19	of	of	IN
46745	4188	20	an	an	DT
46745	4188	21	atonic	atonic	JJ
46745	4188	22	condition	condition	NN
46745	4188	23	of	of	IN
46745	4188	24	the	the	DT
46745	4188	25	nerves	nerve	NNS
46745	4188	26	by	by	IN
46745	4188	27	which	which	WDT
46745	4188	28	the	the	DT
46745	4188	29	contraction	contraction	NN
46745	4188	30	of	of	IN
46745	4188	31	the	the	DT
46745	4188	32	minute	minute	NN
46745	4188	33	vessels	vessel	NNS
46745	4188	34	is	be	VBZ
46745	4188	35	maintained	maintain	VBN
46745	4188	36	.	.	.
46745	4189	1	Alcohol	Alcohol	NNP
46745	4189	2	,	,	,
46745	4189	3	in	in	IN
46745	4189	4	large	large	JJ
46745	4189	5	quantity	quantity	NN
46745	4189	6	,	,	,
46745	4189	7	coagulates	coagulate	VBZ
46745	4189	8	albumen	albuman	NNS
46745	4189	9	,	,	,
46745	4189	10	and	and	CC
46745	4189	11	it	-PRON-	PRP
46745	4189	12	may	may	MD
46745	4189	13	thus	thus	RB
46745	4189	14	act	act	VB
46745	4189	15	as	as	IN
46745	4189	16	a	a	DT
46745	4189	17	true	true	JJ
46745	4189	18	Astringent	Astringent	NNP
46745	4189	19	when	when	WRB
46745	4189	20	applied	apply	VBN
46745	4189	21	externally	externally	RB
46745	4189	22	.	.	.
46745	4190	1	Some	some	DT
46745	4190	2	Neurotic	neurotic	JJ
46745	4190	3	medicines	medicine	NNS
46745	4190	4	diminish	diminish	VBP
46745	4190	5	secretions	secretion	NNS
46745	4190	6	in	in	IN
46745	4190	7	a	a	DT
46745	4190	8	way	way	NN
46745	4190	9	which	which	WDT
46745	4190	10	is	be	VBZ
46745	4190	11	not	not	RB
46745	4190	12	well	well	RB
46745	4190	13	understood	understand	VBN
46745	4190	14	.	.	.
46745	4191	1	The	the	DT
46745	4191	2	chief	chief	NN
46745	4191	3	of	of	IN
46745	4191	4	these	these	DT
46745	4191	5	is	be	VBZ
46745	4191	6	Opium	Opium	NNP
46745	4191	7	,	,	,
46745	4191	8	which	which	WDT
46745	4191	9	particularly	particularly	RB
46745	4191	10	diminishes	diminish	VBZ
46745	4191	11	the	the	DT
46745	4191	12	secretion	secretion	NN
46745	4191	13	of	of	IN
46745	4191	14	the	the	DT
46745	4191	15	bowels	bowel	NNS
46745	4191	16	.	.	.
46745	4192	1	Attempts	attempt	NNS
46745	4192	2	have	have	VBP
46745	4192	3	been	be	VBN
46745	4192	4	made	make	VBN
46745	4192	5	to	to	TO
46745	4192	6	explain	explain	VB
46745	4192	7	this	this	DT
46745	4192	8	by	by	IN
46745	4192	9	an	an	DT
46745	4192	10	influence	influence	NN
46745	4192	11	possessed	possess	VBN
46745	4192	12	by	by	IN
46745	4192	13	Morphia	Morphia	NNP
46745	4192	14	on	on	IN
46745	4192	15	the	the	DT
46745	4192	16	process	process	NN
46745	4192	17	of	of	IN
46745	4192	18	Endosmosis	Endosmosis	NNP
46745	4192	19	,	,	,
46745	4192	20	but	but	CC
46745	4192	21	they	-PRON-	PRP
46745	4192	22	are	be	VBP
46745	4192	23	not	not	RB
46745	4192	24	satisfactory	satisfactory	JJ
46745	4192	25	.	.	.
46745	4193	1	Some	some	DT
46745	4193	2	little	little	JJ
46745	4193	3	light	light	NN
46745	4193	4	may	may	MD
46745	4193	5	perhaps	perhaps	RB
46745	4193	6	be	be	VB
46745	4193	7	thrown	throw	VBN
46745	4193	8	upon	upon	IN
46745	4193	9	the	the	DT
46745	4193	10	matter	matter	NN
46745	4193	11	by	by	IN
46745	4193	12	a	a	DT
46745	4193	13	consideration	consideration	NN
46745	4193	14	of	of	IN
46745	4193	15	the	the	DT
46745	4193	16	other	other	JJ
46745	4193	17	operations	operation	NNS
46745	4193	18	of	of	IN
46745	4193	19	Opium	Opium	NNP
46745	4193	20	;	;	:
46745	4193	21	but	but	CC
46745	4193	22	it	-PRON-	PRP
46745	4193	23	is	be	VBZ
46745	4193	24	difficult	difficult	JJ
46745	4193	25	to	to	TO
46745	4193	26	explain	explain	VB
46745	4193	27	it	-PRON-	PRP
46745	4193	28	decisively	decisively	RB
46745	4193	29	in	in	IN
46745	4193	30	any	any	DT
46745	4193	31	way	way	NN
46745	4193	32	.	.	.
46745	4194	1	PROP	PROP	NNP
46745	4194	2	.	.	.
46745	4195	1	X.--_That	x.--_that	IN
46745	4195	2	a	a	DT
46745	4195	3	fourth	fourth	JJ
46745	4195	4	class	class	NN
46745	4195	5	of	of	IN
46745	4195	6	medicines	medicine	NNS
46745	4195	7	,	,	,
46745	4195	8	called	call	VBD
46745	4195	9	_	_	NNP
46745	4195	10	ELIMINATIVES	ELIMINATIVES	NNP
46745	4195	11	,	,	,
46745	4195	12	_	_	NNP
46745	4195	13	act	act	NN
46745	4195	14	by	by	IN
46745	4195	15	passing	pass	VBG
46745	4195	16	out	out	IN
46745	4195	17	of	of	IN
46745	4195	18	the	the	DT
46745	4195	19	blood	blood	NN
46745	4195	20	through	through	IN
46745	4195	21	the	the	DT
46745	4195	22	glands	gland	NNS
46745	4195	23	,	,	,
46745	4195	24	which	which	WDT
46745	4195	25	they	-PRON-	PRP
46745	4195	26	excite	excite	VBP
46745	4195	27	to	to	IN
46745	4195	28	the	the	DT
46745	4195	29	performance	performance	NN
46745	4195	30	of	of	IN
46745	4195	31	their	-PRON-	PRP$
46745	4195	32	functions	function	NNS
46745	4195	33	_	_	NNP
46745	4195	34	.	.	.
46745	4196	1	In	in	IN
46745	4196	2	this	this	DT
46745	4196	3	Fourth	Fourth	NNP
46745	4196	4	Class	Class	NNP
46745	4196	5	are	be	VBP
46745	4196	6	included	include	VBN
46745	4196	7	all	all	PDT
46745	4196	8	the	the	DT
46745	4196	9	medicines	medicine	NNS
46745	4196	10	which	which	WDT
46745	4196	11	tend	tend	VBP
46745	4196	12	in	in	IN
46745	4196	13	a	a	DT
46745	4196	14	direct	direct	JJ
46745	4196	15	manner	manner	NN
46745	4196	16	to	to	TO
46745	4196	17	increase	increase	VB
46745	4196	18	secretion	secretion	NN
46745	4196	19	.	.	.
46745	4197	1	They	-PRON-	PRP
46745	4197	2	have	have	VBP
46745	4197	3	received	receive	VBN
46745	4197	4	various	various	JJ
46745	4197	5	appellations	appellation	NNS
46745	4197	6	:	:	:
46745	4197	7	some	some	DT
46745	4197	8	authors	author	NNS
46745	4197	9	have	have	VBP
46745	4197	10	called	call	VBN
46745	4197	11	them	-PRON-	PRP
46745	4197	12	special	special	JJ
46745	4197	13	Stimulants	stimulant	NNS
46745	4197	14	;	;	:
46745	4197	15	others	other	NNS
46745	4197	16	,	,	,
46745	4197	17	as	as	IN
46745	4197	18	Dr.	Dr.	NNP
46745	4197	19	Duncan	Duncan	NNP
46745	4197	20	,	,	,
46745	4197	21	have	have	VBP
46745	4197	22	named	name	VBN
46745	4197	23	them	-PRON-	PRP
46745	4197	24	Evacuants	evacuant	NNS
46745	4197	25	;	;	:
46745	4197	26	while	while	IN
46745	4197	27	Dr.	Dr.	NNP
46745	4197	28	Pereira	Pereira	NNP
46745	4197	29	entitles	entitle	VBZ
46745	4197	30	them	-PRON-	PRP
46745	4197	31	Eccritics	Eccritics	NNP
46745	4197	32	.	.	.
46745	4198	1	The	the	DT
46745	4198	2	mode	mode	NN
46745	4198	3	of	of	IN
46745	4198	4	operation	operation	NN
46745	4198	5	of	of	IN
46745	4198	6	Eliminative	eliminative	JJ
46745	4198	7	medicines	medicine	NNS
46745	4198	8	is	be	VBZ
46745	4198	9	a	a	DT
46745	4198	10	matter	matter	NN
46745	4198	11	of	of	IN
46745	4198	12	considerable	considerable	JJ
46745	4198	13	importance	importance	NN
46745	4198	14	,	,	,
46745	4198	15	and	and	CC
46745	4198	16	its	-PRON-	PRP$
46745	4198	17	consideration	consideration	NN
46745	4198	18	will	will	MD
46745	4198	19	require	require	VB
46745	4198	20	us	-PRON-	PRP
46745	4198	21	first	first	RB
46745	4198	22	to	to	TO
46745	4198	23	make	make	VB
46745	4198	24	some	some	DT
46745	4198	25	inquiry	inquiry	NN
46745	4198	26	into	into	IN
46745	4198	27	the	the	DT
46745	4198	28	character	character	NN
46745	4198	29	and	and	CC
46745	4198	30	functions	function	NNS
46745	4198	31	of	of	IN
46745	4198	32	those	those	DT
46745	4198	33	important	important	JJ
46745	4198	34	glandular	glandular	JJ
46745	4198	35	organs	organ	NNS
46745	4198	36	which	which	WDT
46745	4198	37	they	-PRON-	PRP
46745	4198	38	are	be	VBP
46745	4198	39	said	say	VBN
46745	4198	40	to	to	TO
46745	4198	41	excite	excite	VB
46745	4198	42	to	to	IN
46745	4198	43	action	action	NN
46745	4198	44	.	.	.
46745	4199	1	The	the	DT
46745	4199	2	rational	rational	JJ
46745	4199	3	explanation	explanation	NN
46745	4199	4	of	of	IN
46745	4199	5	the	the	DT
46745	4199	6	process	process	NN
46745	4199	7	of	of	IN
46745	4199	8	elimination	elimination	NN
46745	4199	9	or	or	CC
46745	4199	10	secretion	secretion	NN
46745	4199	11	has	have	VBZ
46745	4199	12	been	be	VBN
46745	4199	13	in	in	IN
46745	4199	14	all	all	DT
46745	4199	15	ages	age	NNS
46745	4199	16	of	of	IN
46745	4199	17	science	science	NN
46745	4199	18	a	a	DT
46745	4199	19	favourite	favourite	JJ
46745	4199	20	topic	topic	NN
46745	4199	21	for	for	IN
46745	4199	22	speculators	speculator	NNS
46745	4199	23	and	and	CC
46745	4199	24	theorists,--sound	theorists,--sound	NNP
46745	4199	25	or	or	CC
46745	4199	26	unsound	unsound	JJ
46745	4199	27	in	in	IN
46745	4199	28	their	-PRON-	PRP$
46745	4199	29	views	view	NNS
46745	4199	30	,	,	,
46745	4199	31	according	accord	VBG
46745	4199	32	to	to	IN
46745	4199	33	the	the	DT
46745	4199	34	light	light	NN
46745	4199	35	that	that	WDT
46745	4199	36	was	be	VBD
46745	4199	37	given	give	VBN
46745	4199	38	to	to	IN
46745	4199	39	them	-PRON-	PRP
46745	4199	40	.	.	.
46745	4200	1	With	with	IN
46745	4200	2	regard	regard	NN
46745	4200	3	to	to	IN
46745	4200	4	its	-PRON-	PRP$
46745	4200	5	essential	essential	JJ
46745	4200	6	nature	nature	NN
46745	4200	7	,	,	,
46745	4200	8	and	and	CC
46745	4200	9	its	-PRON-	PRP$
46745	4200	10	immediate	immediate	JJ
46745	4200	11	bearing	bearing	NN
46745	4200	12	on	on	IN
46745	4200	13	the	the	DT
46745	4200	14	cure	cure	NN
46745	4200	15	of	of	IN
46745	4200	16	disease	disease	NN
46745	4200	17	,	,	,
46745	4200	18	the	the	DT
46745	4200	19	subject	subject	NN
46745	4200	20	has	have	VBZ
46745	4200	21	been	be	VBN
46745	4200	22	generally	generally	RB
46745	4200	23	understood	understand	VBN
46745	4200	24	with	with	IN
46745	4200	25	tolerable	tolerable	JJ
46745	4200	26	clearness	clearness	NN
46745	4200	27	.	.	.
46745	4201	1	From	from	IN
46745	4201	2	the	the	DT
46745	4201	3	time	time	NN
46745	4201	4	of	of	IN
46745	4201	5	Hippocrates	Hippocrates	NNPS
46745	4201	6	downwards	downwards	RB
46745	4201	7	,	,	,
46745	4201	8	the	the	DT
46745	4201	9	use	use	NN
46745	4201	10	of	of	IN
46745	4201	11	Evacuants	Evacuants	NNPS
46745	4201	12	in	in	IN
46745	4201	13	the	the	DT
46745	4201	14	treatment	treatment	NN
46745	4201	15	of	of	IN
46745	4201	16	fevers	fever	NNS
46745	4201	17	and	and	CC
46745	4201	18	other	other	JJ
46745	4201	19	disorders	disorder	NNS
46745	4201	20	has	have	VBZ
46745	4201	21	been	be	VBN
46745	4201	22	recognised	recognise	VBN
46745	4201	23	,	,	,
46745	4201	24	and	and	CC
46745	4201	25	their	-PRON-	PRP$
46745	4201	26	efficacy	efficacy	NN
46745	4201	27	usually	usually	RB
46745	4201	28	explained	explain	VBN
46745	4201	29	by	by	IN
46745	4201	30	supposing	suppose	VBG
46745	4201	31	that	that	IN
46745	4201	32	they	-PRON-	PRP
46745	4201	33	caused	cause	VBD
46745	4201	34	the	the	DT
46745	4201	35	passage	passage	NN
46745	4201	36	out	out	IN
46745	4201	37	of	of	IN
46745	4201	38	the	the	DT
46745	4201	39	body	body	NN
46745	4201	40	through	through	IN
46745	4201	41	the	the	DT
46745	4201	42	glands	gland	NNS
46745	4201	43	of	of	IN
46745	4201	44	certain	certain	JJ
46745	4201	45	matters	matter	NNS
46745	4201	46	that	that	WDT
46745	4201	47	were	be	VBD
46745	4201	48	formed	form	VBN
46745	4201	49	in	in	IN
46745	4201	50	the	the	DT
46745	4201	51	blood	blood	NN
46745	4201	52	,	,	,
46745	4201	53	but	but	CC
46745	4201	54	ought	ought	MD
46745	4201	55	not	not	RB
46745	4201	56	to	to	TO
46745	4201	57	remain	remain	VB
46745	4201	58	in	in	IN
46745	4201	59	it	-PRON-	PRP
46745	4201	60	.	.	.
46745	4202	1	This	this	DT
46745	4202	2	view	view	NN
46745	4202	3	was	be	VBD
46745	4202	4	more	more	RBR
46745	4202	5	particularly	particularly	RB
46745	4202	6	insisted	insist	VBN
46745	4202	7	on	on	IN
46745	4202	8	towards	towards	IN
46745	4202	9	the	the	DT
46745	4202	10	close	close	NN
46745	4202	11	of	of	IN
46745	4202	12	the	the	DT
46745	4202	13	seventeenth	seventeenth	JJ
46745	4202	14	century	century	NN
46745	4202	15	by	by	IN
46745	4202	16	Dr.	Dr.	NNP
46745	4202	17	Thomas	Thomas	NNP
46745	4202	18	Sydenham	Sydenham	NNP
46745	4202	19	;	;	:
46745	4202	20	and	and	CC
46745	4202	21	again	again	RB
46745	4202	22	at	at	IN
46745	4202	23	the	the	DT
46745	4202	24	commencement	commencement	NN
46745	4202	25	of	of	IN
46745	4202	26	the	the	DT
46745	4202	27	eighteenth	eighteenth	NN
46745	4202	28	by	by	IN
46745	4202	29	Dr.	Dr.	NNP
46745	4202	30	A.	A.	NNP
46745	4202	31	Pitcairn	Pitcairn	NNP
46745	4202	32	,	,	,
46745	4202	33	in	in	IN
46745	4202	34	an	an	DT
46745	4202	35	Essay	Essay	NNP
46745	4202	36	on	on	IN
46745	4202	37	the	the	DT
46745	4202	38	use	use	NN
46745	4202	39	of	of	IN
46745	4202	40	Evacuants	Evacuants	NNPS
46745	4202	41	in	in	IN
46745	4202	42	Fevers	Fevers	NNP
46745	4202	43	.	.	.
46745	4203	1	These	these	DT
46745	4203	2	both	both	DT
46745	4203	3	had	have	VBD
46745	4203	4	observed	observe	VBN
46745	4203	5	that	that	IN
46745	4203	6	fevers	fever	NNS
46745	4203	7	and	and	CC
46745	4203	8	other	other	JJ
46745	4203	9	disorders	disorder	NNS
46745	4203	10	had	have	VBD
46745	4203	11	mostly	mostly	RB
46745	4203	12	a	a	DT
46745	4203	13	particular	particular	JJ
46745	4203	14	tendency	tendency	NN
46745	4203	15	to	to	TO
46745	4203	16	pass	pass	VB
46745	4203	17	off	off	RP
46745	4203	18	with	with	IN
46745	4203	19	an	an	DT
46745	4203	20	increase	increase	NN
46745	4203	21	in	in	IN
46745	4203	22	one	one	CD
46745	4203	23	or	or	CC
46745	4203	24	more	more	JJR
46745	4203	25	of	of	IN
46745	4203	26	the	the	DT
46745	4203	27	secretions	secretion	NNS
46745	4203	28	;	;	:
46745	4203	29	and	and	CC
46745	4203	30	they	-PRON-	PRP
46745	4203	31	drew	draw	VBD
46745	4203	32	from	from	IN
46745	4203	33	this	this	DT
46745	4203	34	,	,	,
46745	4203	35	and	and	CC
46745	4203	36	from	from	IN
46745	4203	37	the	the	DT
46745	4203	38	results	result	NNS
46745	4203	39	of	of	IN
46745	4203	40	their	-PRON-	PRP$
46745	4203	41	experience	experience	NN
46745	4203	42	,	,	,
46745	4203	43	that	that	IN
46745	4203	44	in	in	IN
46745	4203	45	stimulating	stimulate	VBG
46745	4203	46	and	and	CC
46745	4203	47	urging	urge	VBG
46745	4203	48	this	this	DT
46745	4203	49	secretion	secretion	NN
46745	4203	50	,	,	,
46745	4203	51	the	the	DT
46745	4203	52	physician	physician	NN
46745	4203	53	would	would	MD
46745	4203	54	be	be	VB
46745	4203	55	doing	do	VBG
46745	4203	56	his	-PRON-	PRP$
46745	4203	57	best	good	JJS
46745	4203	58	to	to	TO
46745	4203	59	promote	promote	VB
46745	4203	60	a	a	DT
46745	4203	61	cure	cure	NN
46745	4203	62	.	.	.
46745	4204	1	(	(	-LRB-
46745	4204	2	_	_	NNP
46745	4204	3	Vide	Vide	NNP
46745	4204	4	_	_	NNP
46745	4204	5	page	page	NN
46745	4204	6	55	55	CD
46745	4204	7	.	.	.
46745	4204	8	)	)	-RRB-
46745	4205	1	More	more	RBR
46745	4205	2	recently	recently	RB
46745	4205	3	the	the	DT
46745	4205	4	same	same	JJ
46745	4205	5	idea	idea	NN
46745	4205	6	has	have	VBZ
46745	4205	7	been	be	VBN
46745	4205	8	followed	follow	VBN
46745	4205	9	up	up	RP
46745	4205	10	by	by	IN
46745	4205	11	Cullen	Cullen	NNP
46745	4205	12	,	,	,
46745	4205	13	Hamilton	Hamilton	NNP
46745	4205	14	,	,	,
46745	4205	15	and	and	CC
46745	4205	16	others	other	NNS
46745	4205	17	.	.	.
46745	4206	1	This	this	DT
46745	4206	2	theory	theory	NN
46745	4206	3	is	be	VBZ
46745	4206	4	not	not	RB
46745	4206	5	in	in	IN
46745	4206	6	our	-PRON-	PRP$
46745	4206	7	immediate	immediate	JJ
46745	4206	8	province	province	NN
46745	4206	9	.	.	.
46745	4207	1	Though	though	IN
46745	4207	2	based	base	VBN
46745	4207	3	upon	upon	IN
46745	4207	4	reasonable	reasonable	JJ
46745	4207	5	grounds	ground	NNS
46745	4207	6	,	,	,
46745	4207	7	it	-PRON-	PRP
46745	4207	8	has	have	VBZ
46745	4207	9	perhaps	perhaps	RB
46745	4207	10	been	be	VBN
46745	4207	11	too	too	RB
46745	4207	12	universally	universally	RB
46745	4207	13	applied	apply	VBN
46745	4207	14	.	.	.
46745	4208	1	It	-PRON-	PRP
46745	4208	2	will	will	MD
46745	4208	3	suffice	suffice	VB
46745	4208	4	now	now	RB
46745	4208	5	if	if	IN
46745	4208	6	we	-PRON-	PRP
46745	4208	7	assume	assume	VBP
46745	4208	8	that	that	IN
46745	4208	9	remedies	remedy	NNS
46745	4208	10	whose	whose	WP$
46745	4208	11	action	action	NN
46745	4208	12	is	be	VBZ
46745	4208	13	to	to	TO
46745	4208	14	increase	increase	VB
46745	4208	15	the	the	DT
46745	4208	16	amount	amount	NN
46745	4208	17	of	of	IN
46745	4208	18	secretion	secretion	NN
46745	4208	19	have	have	VBP
46745	4208	20	often	often	RB
46745	4208	21	an	an	DT
46745	4208	22	important	important	JJ
46745	4208	23	bearing	bearing	NN
46745	4208	24	on	on	IN
46745	4208	25	the	the	DT
46745	4208	26	cure	cure	NN
46745	4208	27	of	of	IN
46745	4208	28	disease	disease	NN
46745	4208	29	.	.	.
46745	4209	1	We	-PRON-	PRP
46745	4209	2	have	have	VBP
46745	4209	3	only	only	RB
46745	4209	4	to	to	TO
46745	4209	5	inquire	inquire	VB
46745	4209	6	into	into	IN
46745	4209	7	their	-PRON-	PRP$
46745	4209	8	manner	manner	NN
46745	4209	9	of	of	IN
46745	4209	10	action	action	NN
46745	4209	11	.	.	.
46745	4210	1	As	as	IN
46745	4210	2	a	a	DT
46745	4210	3	preliminary	preliminary	JJ
46745	4210	4	step	step	NN
46745	4210	5	,	,	,
46745	4210	6	there	there	EX
46745	4210	7	is	be	VBZ
46745	4210	8	one	one	CD
46745	4210	9	general	general	JJ
46745	4210	10	law	law	NN
46745	4210	11	of	of	IN
46745	4210	12	secretion	secretion	NN
46745	4210	13	which	which	WDT
46745	4210	14	it	-PRON-	PRP
46745	4210	15	is	be	VBZ
46745	4210	16	of	of	IN
46745	4210	17	importance	importance	NN
46745	4210	18	that	that	IN
46745	4210	19	we	-PRON-	PRP
46745	4210	20	should	should	MD
46745	4210	21	clearly	clearly	RB
46745	4210	22	lay	lay	VB
46745	4210	23	down	down	RP
46745	4210	24	.	.	.
46745	4211	1	It	-PRON-	PRP
46745	4211	2	is	be	VBZ
46745	4211	3	this	this	DT
46745	4211	4	:	:	:
46745	4211	5	it	-PRON-	PRP
46745	4211	6	is	be	VBZ
46745	4211	7	the	the	DT
46745	4211	8	special	special	JJ
46745	4211	9	office	office	NN
46745	4211	10	of	of	IN
46745	4211	11	each	each	DT
46745	4211	12	gland	gland	NN
46745	4211	13	,	,	,
46745	4211	14	or	or	CC
46745	4211	15	set	set	NN
46745	4211	16	of	of	IN
46745	4211	17	glands	gland	NNS
46745	4211	18	,	,	,
46745	4211	19	to	to	TO
46745	4211	20	secrete	secrete	VB
46745	4211	21	from	from	IN
46745	4211	22	the	the	DT
46745	4211	23	blood	blood	NN
46745	4211	24	particular	particular	JJ
46745	4211	25	materials	material	NNS
46745	4211	26	,	,	,
46745	4211	27	and	and	CC
46745	4211	28	to	to	TO
46745	4211	29	pass	pass	VB
46745	4211	30	them	-PRON-	PRP
46745	4211	31	out	out	IN
46745	4211	32	of	of	IN
46745	4211	33	the	the	DT
46745	4211	34	body	body	NN
46745	4211	35	.	.	.
46745	4212	1	[	[	-LRB-
46745	4212	2	44	44	CD
46745	4212	3	]	]	-RRB-
46745	4212	4	It	-PRON-	PRP
46745	4212	5	follows	follow	VBZ
46745	4212	6	from	from	IN
46745	4212	7	this	this	DT
46745	4212	8	law	law	NN
46745	4212	9	of	of	IN
46745	4212	10	selective	selective	JJ
46745	4212	11	secretion	secretion	NN
46745	4212	12	,	,	,
46745	4212	13	that	that	IN
46745	4212	14	when	when	WRB
46745	4212	15	any	any	DT
46745	4212	16	morbid	morbid	NN
46745	4212	17	substance	substance	NN
46745	4212	18	or	or	CC
46745	4212	19	product,--or	product,--or	MD
46745	4212	20	any	any	DT
46745	4212	21	thing	thing	NN
46745	4212	22	which	which	WDT
46745	4212	23	is	be	VBZ
46745	4212	24	in	in	IN
46745	4212	25	the	the	DT
46745	4212	26	system	system	NN
46745	4212	27	,	,	,
46745	4212	28	but	but	CC
46745	4212	29	can	can	MD
46745	4212	30	not	not	RB
46745	4212	31	naturally	naturally	RB
46745	4212	32	remain	remain	VB
46745	4212	33	there,--has	there,--has	NNP
46745	4212	34	to	to	TO
46745	4212	35	pass	pass	VB
46745	4212	36	out	out	RP
46745	4212	37	,	,	,
46745	4212	38	it	-PRON-	PRP
46745	4212	39	prefers	prefer	VBZ
46745	4212	40	to	to	TO
46745	4212	41	pass	pass	VB
46745	4212	42	by	by	IN
46745	4212	43	some	some	DT
46745	4212	44	glands	gland	NNS
46745	4212	45	rather	rather	RB
46745	4212	46	than	than	IN
46745	4212	47	by	by	IN
46745	4212	48	others	other	NNS
46745	4212	49	.	.	.
46745	4213	1	It	-PRON-	PRP
46745	4213	2	must	must	MD
46745	4213	3	be	be	VB
46745	4213	4	remembered	remember	VBN
46745	4213	5	that	that	IN
46745	4213	6	the	the	DT
46745	4213	7	glands	gland	NNS
46745	4213	8	afford	afford	VBP
46745	4213	9	the	the	DT
46745	4213	10	only	only	JJ
46745	4213	11	means	mean	NNS
46745	4213	12	by	by	IN
46745	4213	13	which	which	WDT
46745	4213	14	a	a	DT
46745	4213	15	substance	substance	NN
46745	4213	16	can	can	MD
46745	4213	17	make	make	VB
46745	4213	18	its	-PRON-	PRP$
46745	4213	19	exit	exit	NN
46745	4213	20	from	from	IN
46745	4213	21	the	the	DT
46745	4213	22	blood	blood	NN
46745	4213	23	.	.	.
46745	4214	1	We	-PRON-	PRP
46745	4214	2	are	be	VBP
46745	4214	3	still	still	RB
46745	4214	4	much	much	RB
46745	4214	5	in	in	IN
46745	4214	6	the	the	DT
46745	4214	7	dark	dark	NN
46745	4214	8	as	as	IN
46745	4214	9	to	to	IN
46745	4214	10	the	the	DT
46745	4214	11	_	_	NNP
46745	4214	12	rationale	rationale	NN
46745	4214	13	_	_	NNP
46745	4214	14	of	of	IN
46745	4214	15	this	this	DT
46745	4214	16	force	force	NN
46745	4214	17	or	or	CC
46745	4214	18	attraction	attraction	NN
46745	4214	19	,	,	,
46745	4214	20	by	by	IN
46745	4214	21	which	which	WDT
46745	4214	22	particular	particular	JJ
46745	4214	23	matters	matter	NNS
46745	4214	24	are	be	VBP
46745	4214	25	drawn	draw	VBN
46745	4214	26	towards	towards	IN
46745	4214	27	each	each	DT
46745	4214	28	gland	gland	NN
46745	4214	29	.	.	.
46745	4215	1	Dr.	Dr.	NNP
46745	4215	2	Pitcairn	Pitcairn	NNP
46745	4215	3	,	,	,
46745	4215	4	a	a	DT
46745	4215	5	great	great	JJ
46745	4215	6	man	man	NN
46745	4215	7	for	for	IN
46745	4215	8	the	the	DT
46745	4215	9	age	age	NN
46745	4215	10	in	in	IN
46745	4215	11	which	which	WDT
46745	4215	12	he	-PRON-	PRP
46745	4215	13	lived,--a	lived,--a	NNP
46745	4215	14	man	man	NN
46745	4215	15	of	of	IN
46745	4215	16	original	original	JJ
46745	4215	17	thought	thought	NN
46745	4215	18	and	and	CC
46745	4215	19	natural	natural	JJ
46745	4215	20	genius,--gives	genius,--gives	.
46745	4215	21	us	-PRON-	PRP
46745	4215	22	,	,	,
46745	4215	23	in	in	IN
46745	4215	24	his	-PRON-	PRP$
46745	4215	25	Essay	Essay	NNP
46745	4215	26	on	on	IN
46745	4215	27	the	the	DT
46745	4215	28	Circulation	Circulation	NNP
46745	4215	29	of	of	IN
46745	4215	30	the	the	DT
46745	4215	31	Blood	Blood	NNP
46745	4215	32	,	,	,
46745	4215	33	a	a	DT
46745	4215	34	learned	learn	VBN
46745	4215	35	account	account	NN
46745	4215	36	of	of	IN
46745	4215	37	three	three	CD
46745	4215	38	theories	theory	NNS
46745	4215	39	on	on	IN
46745	4215	40	this	this	DT
46745	4215	41	matter	matter	NN
46745	4215	42	which	which	WDT
46745	4215	43	were	be	VBD
46745	4215	44	in	in	IN
46745	4215	45	vogue	vogue	NN
46745	4215	46	at	at	IN
46745	4215	47	his	-PRON-	PRP$
46745	4215	48	time	time	NN
46745	4215	49	.	.	.
46745	4216	1	They	-PRON-	PRP
46745	4216	2	are	be	VBP
46745	4216	3	of	of	IN
46745	4216	4	importance	importance	NN
46745	4216	5	,	,	,
46745	4216	6	as	as	IN
46745	4216	7	showing	show	VBG
46745	4216	8	that	that	IN
46745	4216	9	the	the	DT
46745	4216	10	fact	fact	NN
46745	4216	11	was	be	VBD
46745	4216	12	then	then	RB
46745	4216	13	very	very	RB
46745	4216	14	clearly	clearly	RB
46745	4216	15	recognised	recognise	VBN
46745	4216	16	,	,	,
46745	4216	17	however	however	RB
46745	4216	18	dubious	dubious	JJ
46745	4216	19	the	the	DT
46745	4216	20	explanation	explanation	NN
46745	4216	21	of	of	IN
46745	4216	22	it	-PRON-	PRP
46745	4216	23	might	may	MD
46745	4216	24	be	be	VB
46745	4216	25	.	.	.
46745	4217	1	One	one	CD
46745	4217	2	party	party	NN
46745	4217	3	supposed	suppose	VBD
46745	4217	4	that	that	IN
46745	4217	5	there	there	EX
46745	4217	6	was	be	VBD
46745	4217	7	in	in	IN
46745	4217	8	each	each	DT
46745	4217	9	gland	gland	NN
46745	4217	10	a	a	DT
46745	4217	11	certain	certain	JJ
46745	4217	12	material	material	NN
46745	4217	13	stored	store	VBN
46745	4217	14	up	up	RP
46745	4217	15	,	,	,
46745	4217	16	which	which	WDT
46745	4217	17	prevented	prevent	VBD
46745	4217	18	the	the	DT
46745	4217	19	passage	passage	NN
46745	4217	20	through	through	IN
46745	4217	21	to	to	IN
46745	4217	22	itself	-PRON-	PRP
46745	4217	23	of	of	IN
46745	4217	24	any	any	DT
46745	4217	25	substance	substance	NN
46745	4217	26	that	that	WDT
46745	4217	27	was	be	VBD
46745	4217	28	not	not	RB
46745	4217	29	like	like	IN
46745	4217	30	it	-PRON-	PRP
46745	4217	31	;	;	:
46745	4217	32	just	just	RB
46745	4217	33	as	as	IN
46745	4217	34	when	when	WRB
46745	4217	35	a	a	DT
46745	4217	36	sheet	sheet	NN
46745	4217	37	of	of	IN
46745	4217	38	paper	paper	NN
46745	4217	39	is	be	VBZ
46745	4217	40	steeped	steep	VBN
46745	4217	41	in	in	IN
46745	4217	42	oil	oil	NN
46745	4217	43	,	,	,
46745	4217	44	oil	oil	NN
46745	4217	45	only	only	RB
46745	4217	46	will	will	MD
46745	4217	47	pass	pass	VB
46745	4217	48	through	through	IN
46745	4217	49	it	-PRON-	PRP
46745	4217	50	,	,	,
46745	4217	51	and	and	CC
46745	4217	52	not	not	RB
46745	4217	53	water	water	NN
46745	4217	54	.	.	.
46745	4218	1	A	a	DT
46745	4218	2	second	second	JJ
46745	4218	3	party	party	NN
46745	4218	4	,	,	,
46745	4218	5	called	call	VBN
46745	4218	6	the	the	DT
46745	4218	7	Chymical	Chymical	NNP
46745	4218	8	party	party	NN
46745	4218	9	,	,	,
46745	4218	10	supposed	suppose	VBD
46745	4218	11	that	that	IN
46745	4218	12	there	there	EX
46745	4218	13	must	must	MD
46745	4218	14	be	be	VB
46745	4218	15	in	in	IN
46745	4218	16	the	the	DT
46745	4218	17	immediate	immediate	JJ
46745	4218	18	neighbourhood	neighbourhood	NN
46745	4218	19	of	of	IN
46745	4218	20	each	each	DT
46745	4218	21	gland	gland	NN
46745	4218	22	a	a	DT
46745	4218	23	subtle	subtle	JJ
46745	4218	24	fluid	fluid	NN
46745	4218	25	or	or	CC
46745	4218	26	ferment	ferment	NN
46745	4218	27	,	,	,
46745	4218	28	whose	whose	WP$
46745	4218	29	tendency	tendency	NN
46745	4218	30	and	and	CC
46745	4218	31	office	office	NN
46745	4218	32	it	-PRON-	PRP
46745	4218	33	was	be	VBD
46745	4218	34	to	to	TO
46745	4218	35	form	form	VB
46745	4218	36	and	and	CC
46745	4218	37	separate	separate	VB
46745	4218	38	from	from	IN
46745	4218	39	the	the	DT
46745	4218	40	blood	blood	NN
46745	4218	41	the	the	DT
46745	4218	42	materials	material	NNS
46745	4218	43	which	which	WDT
46745	4218	44	that	that	DT
46745	4218	45	gland	gland	NNP
46745	4218	46	had	have	VBD
46745	4218	47	to	to	TO
46745	4218	48	secrete	secrete	VB
46745	4218	49	.	.	.
46745	4219	1	A	a	DT
46745	4219	2	third	third	JJ
46745	4219	3	set	set	NN
46745	4219	4	of	of	IN
46745	4219	5	physicians	physician	NNS
46745	4219	6	armed	arm	VBN
46745	4219	7	themselves	-PRON-	PRP
46745	4219	8	with	with	IN
46745	4219	9	mathematics	mathematic	NNS
46745	4219	10	and	and	CC
46745	4219	11	with	with	IN
46745	4219	12	the	the	DT
46745	4219	13	newly	newly	RB
46745	4219	14	discovered	discover	VBN
46745	4219	15	principles	principle	NNS
46745	4219	16	of	of	IN
46745	4219	17	Newton	Newton	NNP
46745	4219	18	,	,	,
46745	4219	19	and	and	CC
46745	4219	20	actually	actually	RB
46745	4219	21	worked	work	VBD
46745	4219	22	out	out	RP
46745	4219	23	formulæ	formulæ	NN
46745	4219	24	and	and	CC
46745	4219	25	equations	equation	NNS
46745	4219	26	wherewith	wherewith	VBP
46745	4219	27	to	to	TO
46745	4219	28	support	support	VB
46745	4219	29	their	-PRON-	PRP$
46745	4219	30	arguments	argument	NNS
46745	4219	31	.	.	.
46745	4220	1	They	-PRON-	PRP
46745	4220	2	had	have	VBD
46745	4220	3	strong	strong	JJ
46745	4220	4	and	and	CC
46745	4220	5	perhaps	perhaps	RB
46745	4220	6	reasonable	reasonable	JJ
46745	4220	7	ideas	idea	NNS
46745	4220	8	as	as	IN
46745	4220	9	to	to	IN
46745	4220	10	the	the	DT
46745	4220	11	definite	definite	JJ
46745	4220	12	shapes	shape	NNS
46745	4220	13	of	of	IN
46745	4220	14	atoms	atom	NNS
46745	4220	15	.	.	.
46745	4221	1	They	-PRON-	PRP
46745	4221	2	averred	aver	VBD
46745	4221	3	that	that	IN
46745	4221	4	each	each	DT
46745	4221	5	gland	gland	NN
46745	4221	6	was	be	VBD
46745	4221	7	to	to	TO
46745	4221	8	be	be	VB
46745	4221	9	compared	compare	VBN
46745	4221	10	to	to	IN
46745	4221	11	a	a	DT
46745	4221	12	sieve	sieve	NN
46745	4221	13	or	or	CC
46745	4221	14	strainer	strainer	NN
46745	4221	15	,	,	,
46745	4221	16	having	have	VBG
46745	4221	17	in	in	IN
46745	4221	18	it	-PRON-	PRP
46745	4221	19	pores	pore	VBZ
46745	4221	20	of	of	IN
46745	4221	21	a	a	DT
46745	4221	22	particular	particular	JJ
46745	4221	23	size	size	NN
46745	4221	24	and	and	CC
46745	4221	25	certain	certain	JJ
46745	4221	26	geometrical	geometrical	JJ
46745	4221	27	shape	shape	NN
46745	4221	28	,	,	,
46745	4221	29	and	and	CC
46745	4221	30	that	that	IN
46745	4221	31	each	each	DT
46745	4221	32	secreted	secrete	VBN
46745	4221	33	atom	atom	NNS
46745	4221	34	could	could	MD
46745	4221	35	only	only	RB
46745	4221	36	pass	pass	VB
46745	4221	37	through	through	RP
46745	4221	38	a	a	DT
46745	4221	39	pore	pore	NN
46745	4221	40	that	that	WDT
46745	4221	41	would	would	MD
46745	4221	42	exactly	exactly	RB
46745	4221	43	coincide	coincide	VB
46745	4221	44	in	in	IN
46745	4221	45	size	size	NN
46745	4221	46	and	and	CC
46745	4221	47	figure	figure	NN
46745	4221	48	with	with	IN
46745	4221	49	itself	-PRON-	PRP
46745	4221	50	.	.	.
46745	4222	1	The	the	DT
46745	4222	2	first	first	JJ
46745	4222	3	two	two	CD
46745	4222	4	of	of	IN
46745	4222	5	these	these	DT
46745	4222	6	theories	theory	NNS
46745	4222	7	Dr.	Dr.	NNP
46745	4222	8	Pitcairn	Pitcairn	NNP
46745	4222	9	disputed	dispute	VBD
46745	4222	10	,	,	,
46745	4222	11	and	and	CC
46745	4222	12	treated	treat	VBN
46745	4222	13	with	with	IN
46745	4222	14	high	high	JJ
46745	4222	15	disdain	disdain	NN
46745	4222	16	.	.	.
46745	4223	1	The	the	DT
46745	4223	2	third	third	JJ
46745	4223	3	he	-PRON-	PRP
46745	4223	4	accepted	accept	VBD
46745	4223	5	in	in	IN
46745	4223	6	a	a	DT
46745	4223	7	modified	modify	VBN
46745	4223	8	form	form	NN
46745	4223	9	.	.	.
46745	4224	1	He	-PRON-	PRP
46745	4224	2	supposed	suppose	VBD
46745	4224	3	that	that	IN
46745	4224	4	the	the	DT
46745	4224	5	vessels	vessel	NNS
46745	4224	6	in	in	IN
46745	4224	7	the	the	DT
46745	4224	8	glands	gland	NNS
46745	4224	9	ended	end	VBN
46745	4224	10	in	in	IN
46745	4224	11	small	small	JJ
46745	4224	12	open	open	JJ
46745	4224	13	mouths	mouth	NNS
46745	4224	14	,	,	,
46745	4224	15	always	always	RB
46745	4224	16	circular	circular	JJ
46745	4224	17	,	,	,
46745	4224	18	but	but	CC
46745	4224	19	differing	differ	VBG
46745	4224	20	in	in	IN
46745	4224	21	diameter	diameter	NN
46745	4224	22	in	in	IN
46745	4224	23	different	different	JJ
46745	4224	24	glands	gland	NNS
46745	4224	25	,	,	,
46745	4224	26	so	so	IN
46745	4224	27	that	that	IN
46745	4224	28	each	each	DT
46745	4224	29	would	would	MD
46745	4224	30	only	only	RB
46745	4224	31	admit	admit	VB
46745	4224	32	the	the	DT
46745	4224	33	passage	passage	NN
46745	4224	34	of	of	IN
46745	4224	35	a	a	DT
46745	4224	36	particle	particle	NN
46745	4224	37	whose	whose	WP$
46745	4224	38	diameter	diameter	NN
46745	4224	39	approached	approach	VBD
46745	4224	40	a	a	DT
46745	4224	41	certain	certain	JJ
46745	4224	42	sum	sum	NN
46745	4224	43	.	.	.
46745	4225	1	Thus	thus	RB
46745	4225	2	he	-PRON-	PRP
46745	4225	3	supposed	suppose	VBD
46745	4225	4	that	that	IN
46745	4225	5	each	each	DT
46745	4225	6	secretion	secretion	NN
46745	4225	7	would	would	MD
46745	4225	8	consist	consist	VB
46745	4225	9	only	only	RB
46745	4225	10	of	of	IN
46745	4225	11	certain	certain	JJ
46745	4225	12	peculiar	peculiar	JJ
46745	4225	13	particles	particle	NNS
46745	4225	14	.	.	.
46745	4226	1	Possibly	possibly	RB
46745	4226	2	Dr.	Dr.	NNP
46745	4226	3	Pitcairn	Pitcairn	NNP
46745	4226	4	forgot	forget	VBD
46745	4226	5	that	that	IN
46745	4226	6	small	small	JJ
46745	4226	7	particles	particle	NNS
46745	4226	8	would	would	MD
46745	4226	9	seldom	seldom	RB
46745	4226	10	hesitate	hesitate	VB
46745	4226	11	to	to	TO
46745	4226	12	pass	pass	VB
46745	4226	13	through	through	IN
46745	4226	14	large	large	JJ
46745	4226	15	holes	hole	NNS
46745	4226	16	.	.	.
46745	4227	1	We	-PRON-	PRP
46745	4227	2	may	may	MD
46745	4227	3	perhaps	perhaps	RB
46745	4227	4	feel	feel	VB
46745	4227	5	inclined	inclined	JJ
46745	4227	6	to	to	TO
46745	4227	7	make	make	VB
46745	4227	8	light	light	NN
46745	4227	9	of	of	IN
46745	4227	10	these	these	DT
46745	4227	11	crude	crude	JJ
46745	4227	12	speculations	speculation	NNS
46745	4227	13	of	of	IN
46745	4227	14	the	the	DT
46745	4227	15	philosophers	philosopher	NNS
46745	4227	16	of	of	IN
46745	4227	17	the	the	DT
46745	4227	18	eighteenth	eighteenth	JJ
46745	4227	19	century	century	NN
46745	4227	20	;	;	:
46745	4227	21	we	-PRON-	PRP
46745	4227	22	may	may	MD
46745	4227	23	be	be	VB
46745	4227	24	disposed	dispose	VBN
46745	4227	25	to	to	TO
46745	4227	26	smile	smile	VB
46745	4227	27	at	at	IN
46745	4227	28	the	the	DT
46745	4227	29	idea	idea	NN
46745	4227	30	of	of	IN
46745	4227	31	vessels	vessel	NNS
46745	4227	32	with	with	IN
46745	4227	33	open	open	JJ
46745	4227	34	mouths	mouth	NNS
46745	4227	35	,	,	,
46745	4227	36	and	and	CC
46745	4227	37	of	of	IN
46745	4227	38	glands	gland	NNS
46745	4227	39	which	which	WDT
46745	4227	40	are	be	VBP
46745	4227	41	riddled	riddled	JJ
46745	4227	42	with	with	IN
46745	4227	43	holes	hole	NNS
46745	4227	44	like	like	IN
46745	4227	45	the	the	DT
46745	4227	46	buckets	bucket	NNS
46745	4227	47	of	of	IN
46745	4227	48	the	the	DT
46745	4227	49	Naiades	Naiades	NNP
46745	4227	50	;	;	:
46745	4227	51	but	but	CC
46745	4227	52	we	-PRON-	PRP
46745	4227	53	must	must	MD
46745	4227	54	after	after	RB
46745	4227	55	all	all	RB
46745	4227	56	confess	confess	VB
46745	4227	57	that	that	IN
46745	4227	58	if	if	IN
46745	4227	59	at	at	IN
46745	4227	60	the	the	DT
46745	4227	61	present	present	JJ
46745	4227	62	day	day	NN
46745	4227	63	we	-PRON-	PRP
46745	4227	64	have	have	VBP
46745	4227	65	swept	sweep	VBN
46745	4227	66	away	away	RB
46745	4227	67	these	these	DT
46745	4227	68	notions	notion	NNS
46745	4227	69	,	,	,
46745	4227	70	we	-PRON-	PRP
46745	4227	71	have	have	VBP
46745	4227	72	certainly	certainly	RB
46745	4227	73	added	add	VBN
46745	4227	74	nothing	nothing	NN
46745	4227	75	in	in	IN
46745	4227	76	their	-PRON-	PRP$
46745	4227	77	stead	stead	NN
46745	4227	78	,	,	,
46745	4227	79	nor	nor	CC
46745	4227	80	can	can	MD
46745	4227	81	we	-PRON-	PRP
46745	4227	82	explain	explain	VB
46745	4227	83	this	this	DT
46745	4227	84	matter	matter	NN
46745	4227	85	at	at	RB
46745	4227	86	all	all	RB
46745	4227	87	more	more	RBR
46745	4227	88	clearly	clearly	RB
46745	4227	89	than	than	IN
46745	4227	90	our	-PRON-	PRP$
46745	4227	91	predecessors	predecessor	NNS
46745	4227	92	a	a	DT
46745	4227	93	century	century	NN
46745	4227	94	and	and	CC
46745	4227	95	a	a	DT
46745	4227	96	half	half	NN
46745	4227	97	ago	ago	RB
46745	4227	98	.	.	.
46745	4228	1	The	the	DT
46745	4228	2	fact	fact	NN
46745	4228	3	,	,	,
46745	4228	4	however	however	RB
46745	4228	5	,	,	,
46745	4228	6	is	be	VBZ
46745	4228	7	plain	plain	JJ
46745	4228	8	,	,	,
46745	4228	9	however	however	RB
46745	4228	10	vainly	vainly	RB
46745	4228	11	we	-PRON-	PRP
46745	4228	12	may	may	MD
46745	4228	13	try	try	VB
46745	4228	14	to	to	TO
46745	4228	15	explain	explain	VB
46745	4228	16	it	-PRON-	PRP
46745	4228	17	.	.	.
46745	4229	1	It	-PRON-	PRP
46745	4229	2	is	be	VBZ
46745	4229	3	an	an	DT
46745	4229	4	established	establish	VBN
46745	4229	5	rule	rule	NN
46745	4229	6	,	,	,
46745	4229	7	to	to	TO
46745	4229	8	which	which	WDT
46745	4229	9	there	there	EX
46745	4229	10	are	be	VBP
46745	4229	11	few	few	JJ
46745	4229	12	exceptions	exception	NNS
46745	4229	13	,	,	,
46745	4229	14	that	that	IN
46745	4229	15	each	each	DT
46745	4229	16	substance	substance	NN
46745	4229	17	which	which	WDT
46745	4229	18	is	be	VBZ
46745	4229	19	formed	form	VBN
46745	4229	20	in	in	IN
46745	4229	21	the	the	DT
46745	4229	22	blood	blood	NN
46745	4229	23	and	and	CC
46745	4229	24	has	have	VBZ
46745	4229	25	to	to	TO
46745	4229	26	pass	pass	VB
46745	4229	27	out	out	IN
46745	4229	28	of	of	IN
46745	4229	29	the	the	DT
46745	4229	30	body	body	NN
46745	4229	31	,	,	,
46745	4229	32	tends	tend	VBZ
46745	4229	33	to	to	TO
46745	4229	34	pass	pass	VB
46745	4229	35	out	out	RP
46745	4229	36	through	through	IN
46745	4229	37	some	some	DT
46745	4229	38	particular	particular	JJ
46745	4229	39	glands	gland	NNS
46745	4229	40	;	;	:
46745	4229	41	that	that	IN
46745	4229	42	it	-PRON-	PRP
46745	4229	43	is	be	VBZ
46745	4229	44	the	the	DT
46745	4229	45	particular	particular	JJ
46745	4229	46	function	function	NN
46745	4229	47	of	of	IN
46745	4229	48	the	the	DT
46745	4229	49	kidneys	kidney	NNS
46745	4229	50	to	to	TO
46745	4229	51	excrete	excrete	VB
46745	4229	52	water	water	NN
46745	4229	53	,	,	,
46745	4229	54	urea	urea	NNP
46745	4229	55	,	,	,
46745	4229	56	uric	uric	JJ
46745	4229	57	acid	acid	NN
46745	4229	58	,	,	,
46745	4229	59	and	and	CC
46745	4229	60	certain	certain	JJ
46745	4229	61	salts	salt	NNS
46745	4229	62	;	;	:
46745	4229	63	that	that	IN
46745	4229	64	it	-PRON-	PRP
46745	4229	65	is	be	VBZ
46745	4229	66	the	the	DT
46745	4229	67	especial	especial	JJ
46745	4229	68	office	office	NN
46745	4229	69	of	of	IN
46745	4229	70	the	the	DT
46745	4229	71	bowels	bowel	NNS
46745	4229	72	to	to	TO
46745	4229	73	excrete	excrete	VB
46745	4229	74	certain	certain	JJ
46745	4229	75	effete	effete	JJ
46745	4229	76	matters	matter	NNS
46745	4229	77	and	and	CC
46745	4229	78	gases	gas	NNS
46745	4229	79	;	;	:
46745	4229	80	and	and	CC
46745	4229	81	that	that	IN
46745	4229	82	it	-PRON-	PRP
46745	4229	83	is	be	VBZ
46745	4229	84	the	the	DT
46745	4229	85	peculiar	peculiar	JJ
46745	4229	86	province	province	NN
46745	4229	87	of	of	IN
46745	4229	88	the	the	DT
46745	4229	89	liver	liver	NN
46745	4229	90	to	to	IN
46745	4229	91	excrete	excrete	VB
46745	4229	92	fatty	fatty	NN
46745	4229	93	matters	matter	NNS
46745	4229	94	,	,	,
46745	4229	95	taurine	taurine	NN
46745	4229	96	,	,	,
46745	4229	97	cholesterine	cholesterine	NN
46745	4229	98	,	,	,
46745	4229	99	and	and	CC
46745	4229	100	choleate	choleate	NN
46745	4229	101	of	of	IN
46745	4229	102	soda	soda	NN
46745	4229	103	.	.	.
46745	4230	1	Water	water	NN
46745	4230	2	,	,	,
46745	4230	3	being	be	VBG
46745	4230	4	the	the	DT
46745	4230	5	necessary	necessary	JJ
46745	4230	6	solvent	solvent	NN
46745	4230	7	of	of	IN
46745	4230	8	the	the	DT
46745	4230	9	solid	solid	JJ
46745	4230	10	matters	matter	NNS
46745	4230	11	in	in	IN
46745	4230	12	all	all	PDT
46745	4230	13	the	the	DT
46745	4230	14	fluid	fluid	JJ
46745	4230	15	secretions	secretion	NNS
46745	4230	16	,	,	,
46745	4230	17	is	be	VBZ
46745	4230	18	secreted	secrete	VBN
46745	4230	19	in	in	IN
46745	4230	20	greater	great	JJR
46745	4230	21	or	or	CC
46745	4230	22	less	less	JJR
46745	4230	23	quantity	quantity	NN
46745	4230	24	by	by	IN
46745	4230	25	all	all	PDT
46745	4230	26	the	the	DT
46745	4230	27	important	important	JJ
46745	4230	28	glands	gland	NNS
46745	4230	29	.	.	.
46745	4231	1	The	the	DT
46745	4231	2	kidneys	kidney	NNS
46745	4231	3	are	be	VBP
46745	4231	4	the	the	DT
46745	4231	5	chief	chief	JJ
46745	4231	6	emunctories	emunctorie	NNS
46745	4231	7	of	of	IN
46745	4231	8	water,--_i.e	water,--_i.e	CD
46745	4231	9	.	.	.
46745	4231	10	_	_	IN
46745	4231	11	they	-PRON-	PRP
46745	4231	12	have	have	VBP
46745	4231	13	to	to	TO
46745	4231	14	separate	separate	VB
46745	4231	15	it	-PRON-	PRP
46745	4231	16	from	from	IN
46745	4231	17	the	the	DT
46745	4231	18	blood	blood	NN
46745	4231	19	when	when	WRB
46745	4231	20	it	-PRON-	PRP
46745	4231	21	has	have	VBZ
46745	4231	22	entered	enter	VBN
46745	4231	23	in	in	IN
46745	4231	24	an	an	DT
46745	4231	25	unnatural	unnatural	JJ
46745	4231	26	amount	amount	NN
46745	4231	27	.	.	.
46745	4232	1	But	but	CC
46745	4232	2	in	in	IN
46745	4232	3	the	the	DT
46745	4232	4	excretion	excretion	NN
46745	4232	5	of	of	IN
46745	4232	6	water	water	NN
46745	4232	7	there	there	EX
46745	4232	8	exists	exist	VBZ
46745	4232	9	a	a	DT
46745	4232	10	compensating	compensating	NN
46745	4232	11	relation	relation	NN
46745	4232	12	between	between	IN
46745	4232	13	the	the	DT
46745	4232	14	skin	skin	NN
46745	4232	15	,	,	,
46745	4232	16	kidneys	kidney	NNS
46745	4232	17	,	,	,
46745	4232	18	and	and	CC
46745	4232	19	bowels,--particularly	bowels,--particularly	RB
46745	4232	20	between	between	IN
46745	4232	21	the	the	DT
46745	4232	22	two	two	CD
46745	4232	23	former	former	JJ
46745	4232	24	.	.	.
46745	4233	1	So	so	IN
46745	4233	2	that	that	DT
46745	4233	3	when	when	WRB
46745	4233	4	water	water	NN
46745	4233	5	is	be	VBZ
46745	4233	6	not	not	RB
46745	4233	7	properly	properly	RB
46745	4233	8	excreted	excrete	VBN
46745	4233	9	by	by	IN
46745	4233	10	the	the	DT
46745	4233	11	kidneys	kidney	NNS
46745	4233	12	,	,	,
46745	4233	13	it	-PRON-	PRP
46745	4233	14	may	may	MD
46745	4233	15	pass	pass	VB
46745	4233	16	out	out	RP
46745	4233	17	by	by	IN
46745	4233	18	the	the	DT
46745	4233	19	skin	skin	NN
46745	4233	20	,	,	,
46745	4233	21	and	and	CC
46745	4233	22	_	_	NNP
46745	4233	23	vice	vice	NNP
46745	4233	24	versâ	versâ	NNP
46745	4233	25	_	_	NNP
46745	4233	26	.	.	.
46745	4234	1	It	-PRON-	PRP
46745	4234	2	is	be	VBZ
46745	4234	3	well	well	RB
46745	4234	4	known	know	VBN
46745	4234	5	that	that	IN
46745	4234	6	this	this	DT
46745	4234	7	change	change	NN
46745	4234	8	may	may	MD
46745	4234	9	be	be	VB
46745	4234	10	determined	determine	VBN
46745	4234	11	by	by	IN
46745	4234	12	several	several	JJ
46745	4234	13	circumstances	circumstance	NNS
46745	4234	14	,	,	,
46745	4234	15	particularly	particularly	RB
46745	4234	16	by	by	IN
46745	4234	17	the	the	DT
46745	4234	18	conditions	condition	NNS
46745	4234	19	of	of	IN
46745	4234	20	heat	heat	NN
46745	4234	21	and	and	CC
46745	4234	22	cold	cold	JJ
46745	4234	23	,	,	,
46745	4234	24	or	or	CC
46745	4234	25	moisture	moisture	NN
46745	4234	26	and	and	CC
46745	4234	27	dryness	dryness	NN
46745	4234	28	.	.	.
46745	4235	1	The	the	DT
46745	4235	2	relation	relation	NN
46745	4235	3	between	between	IN
46745	4235	4	the	the	DT
46745	4235	5	function	function	NN
46745	4235	6	of	of	IN
46745	4235	7	the	the	DT
46745	4235	8	skin	skin	NN
46745	4235	9	and	and	CC
46745	4235	10	kidneys	kidney	NNS
46745	4235	11	applies	apply	VBZ
46745	4235	12	also	also	RB
46745	4235	13	to	to	IN
46745	4235	14	other	other	JJ
46745	4235	15	fluid	fluid	JJ
46745	4235	16	and	and	CC
46745	4235	17	solid	solid	JJ
46745	4235	18	substances	substance	NNS
46745	4235	19	,	,	,
46745	4235	20	as	as	IN
46745	4235	21	will	will	MD
46745	4235	22	be	be	VB
46745	4235	23	seen	see	VBN
46745	4235	24	when	when	WRB
46745	4235	25	we	-PRON-	PRP
46745	4235	26	consider	consider	VBP
46745	4235	27	the	the	DT
46745	4235	28	medicines	medicine	NNS
46745	4235	29	which	which	WDT
46745	4235	30	act	act	VBP
46745	4235	31	upon	upon	IN
46745	4235	32	these	these	DT
46745	4235	33	glands	gland	NNS
46745	4235	34	.	.	.
46745	4236	1	Now	now	RB
46745	4236	2	this	this	DT
46745	4236	3	law	law	NN
46745	4236	4	of	of	IN
46745	4236	5	selective	selective	JJ
46745	4236	6	secretion	secretion	NN
46745	4236	7	applies	apply	VBZ
46745	4236	8	not	not	RB
46745	4236	9	only	only	RB
46745	4236	10	,	,	,
46745	4236	11	as	as	IN
46745	4236	12	it	-PRON-	PRP
46745	4236	13	seems	seem	VBZ
46745	4236	14	to	to	IN
46745	4236	15	me	-PRON-	PRP
46745	4236	16	,	,	,
46745	4236	17	to	to	IN
46745	4236	18	substances	substance	NNS
46745	4236	19	which	which	WDT
46745	4236	20	in	in	IN
46745	4236	21	the	the	DT
46745	4236	22	course	course	NN
46745	4236	23	of	of	IN
46745	4236	24	nature	nature	NN
46745	4236	25	are	be	VBP
46745	4236	26	formed	form	VBN
46745	4236	27	in	in	IN
46745	4236	28	the	the	DT
46745	4236	29	blood	blood	NN
46745	4236	30	,	,	,
46745	4236	31	and	and	CC
46745	4236	32	have	have	VBP
46745	4236	33	to	to	TO
46745	4236	34	be	be	VB
46745	4236	35	excreted	excrete	VBN
46745	4236	36	from	from	IN
46745	4236	37	it	-PRON-	PRP
46745	4236	38	,	,	,
46745	4236	39	but	but	CC
46745	4236	40	also	also	RB
46745	4236	41	to	to	IN
46745	4236	42	other	other	JJ
46745	4236	43	matters	matter	NNS
46745	4236	44	which	which	WDT
46745	4236	45	have	have	VBP
46745	4236	46	been	be	VBN
46745	4236	47	,	,	,
46745	4236	48	as	as	IN
46745	4236	49	it	-PRON-	PRP
46745	4236	50	were	be	VBD
46745	4236	51	,	,	,
46745	4236	52	accidentally	accidentally	RB
46745	4236	53	introduced	introduce	VBN
46745	4236	54	from	from	IN
46745	4236	55	without	without	IN
46745	4236	56	,	,	,
46745	4236	57	and	and	CC
46745	4236	58	which	which	WDT
46745	4236	59	,	,	,
46745	4236	60	being	be	VBG
46745	4236	61	in	in	IN
46745	4236	62	the	the	DT
46745	4236	63	system	system	NN
46745	4236	64	,	,	,
46745	4236	65	can	can	MD
46745	4236	66	not	not	RB
46745	4236	67	properly	properly	RB
46745	4236	68	remain	remain	VB
46745	4236	69	there	there	RB
46745	4236	70	.	.	.
46745	4237	1	Thus	thus	RB
46745	4237	2	it	-PRON-	PRP
46745	4237	3	would	would	MD
46745	4237	4	apply	apply	VB
46745	4237	5	to	to	IN
46745	4237	6	all	all	DT
46745	4237	7	medicinal	medicinal	JJ
46745	4237	8	bodies	body	NNS
46745	4237	9	which	which	WDT
46745	4237	10	have	have	VBP
46745	4237	11	passed	pass	VBN
46745	4237	12	from	from	IN
46745	4237	13	the	the	DT
46745	4237	14	stomach	stomach	NN
46745	4237	15	into	into	IN
46745	4237	16	the	the	DT
46745	4237	17	blood	blood	NN
46745	4237	18	,	,	,
46745	4237	19	and	and	CC
46745	4237	20	which	which	WDT
46745	4237	21	,	,	,
46745	4237	22	not	not	RB
46745	4237	23	being	be	VBG
46745	4237	24	natural	natural	JJ
46745	4237	25	constituents	constituent	NNS
46745	4237	26	of	of	IN
46745	4237	27	that	that	DT
46745	4237	28	fluid	fluid	NN
46745	4237	29	,	,	,
46745	4237	30	must	must	MD
46745	4237	31	again	again	RB
46745	4237	32	pass	pass	VB
46745	4237	33	out	out	IN
46745	4237	34	of	of	IN
46745	4237	35	it	-PRON-	PRP
46745	4237	36	.	.	.
46745	4238	1	So	so	IN
46745	4238	2	that	that	IN
46745	4238	3	although	although	IN
46745	4238	4	it	-PRON-	PRP
46745	4238	5	is	be	VBZ
46745	4238	6	often	often	RB
46745	4238	7	laid	lay	VBN
46745	4238	8	down	down	RP
46745	4238	9	that	that	IN
46745	4238	10	medicines	medicine	NNS
46745	4238	11	acting	act	VBG
46745	4238	12	on	on	IN
46745	4238	13	the	the	DT
46745	4238	14	glands	gland	NNS
46745	4238	15	do	do	VBP
46745	4238	16	so	so	RB
46745	4238	17	simply	simply	RB
46745	4238	18	by	by	IN
46745	4238	19	passing	pass	VBG
46745	4238	20	along	along	RB
46745	4238	21	in	in	IN
46745	4238	22	the	the	DT
46745	4238	23	blood	blood	NN
46745	4238	24	,	,	,
46745	4238	25	and	and	CC
46745	4238	26	stimulating	stimulate	VBG
46745	4238	27	them	-PRON-	PRP
46745	4238	28	as	as	IN
46745	4238	29	they	-PRON-	PRP
46745	4238	30	go	go	VBP
46745	4238	31	by	by	RB
46745	4238	32	,	,	,
46745	4238	33	I	-PRON-	PRP
46745	4238	34	regard	regard	VBP
46745	4238	35	this	this	DT
46745	4238	36	as	as	IN
46745	4238	37	a	a	DT
46745	4238	38	needless	needless	JJ
46745	4238	39	complication	complication	NN
46745	4238	40	of	of	IN
46745	4238	41	the	the	DT
46745	4238	42	subject	subject	NN
46745	4238	43	,	,	,
46745	4238	44	and	and	CC
46745	4238	45	a	a	DT
46745	4238	46	thing	thing	NN
46745	4238	47	which	which	WDT
46745	4238	48	is	be	VBZ
46745	4238	49	wholly	wholly	RB
46745	4238	50	without	without	IN
46745	4238	51	proof	proof	NN
46745	4238	52	.	.	.
46745	4239	1	In	in	IN
46745	4239	2	fine	fine	JJ
46745	4239	3	,	,	,
46745	4239	4	I	-PRON-	PRP
46745	4239	5	am	be	VBP
46745	4239	6	brought	bring	VBN
46745	4239	7	to	to	IN
46745	4239	8	the	the	DT
46745	4239	9	opinion	opinion	NN
46745	4239	10	which	which	WDT
46745	4239	11	I	-PRON-	PRP
46745	4239	12	have	have	VBP
46745	4239	13	laid	lay	VBN
46745	4239	14	down	down	RP
46745	4239	15	in	in	IN
46745	4239	16	the	the	DT
46745	4239	17	Tenth	Tenth	NNP
46745	4239	18	Proposition	Proposition	NNP
46745	4239	19	,	,	,
46745	4239	20	and	and	CC
46745	4239	21	which	which	WDT
46745	4239	22	I	-PRON-	PRP
46745	4239	23	have	have	VBP
46745	4239	24	now	now	RB
46745	4239	25	to	to	TO
46745	4239	26	establish	establish	VB
46745	4239	27	as	as	RB
46745	4239	28	well	well	RB
46745	4239	29	as	as	IN
46745	4239	30	my	-PRON-	PRP$
46745	4239	31	space	space	NN
46745	4239	32	will	will	MD
46745	4239	33	permit	permit	VB
46745	4239	34	.	.	.
46745	4240	1	The	the	DT
46745	4240	2	affirmation	affirmation	NN
46745	4240	3	may	may	MD
46745	4240	4	be	be	VB
46745	4240	5	thus	thus	RB
46745	4240	6	divided	divide	VBN
46745	4240	7	into	into	IN
46745	4240	8	minor	minor	JJ
46745	4240	9	propositions:--	propositions:--	NN
46745	4240	10	_	_	NNP
46745	4240	11	m.	m.	NN
46745	4241	1	p.	p.	NN
46745	4241	2	_	_	NNP
46745	4241	3	1.--That	1.--That	NNP
46745	4241	4	Eliminatives	Eliminatives	NNPS
46745	4241	5	are	be	VBP
46745	4241	6	medicines	medicine	NNS
46745	4241	7	which	which	WDT
46745	4241	8	pass	pass	VBP
46745	4241	9	into	into	IN
46745	4241	10	the	the	DT
46745	4241	11	blood	blood	NN
46745	4241	12	.	.	.
46745	4242	1	_	_	NNP
46745	4242	2	m.	m.	NN
46745	4243	1	p.	p.	NN
46745	4243	2	_	_	NNP
46745	4243	3	2.--That	2.--that	CD
46745	4243	4	they	-PRON-	PRP
46745	4243	5	can	can	MD
46745	4243	6	not	not	RB
46745	4243	7	remain	remain	VB
46745	4243	8	there	there	RB
46745	4243	9	,	,	,
46745	4243	10	but	but	CC
46745	4243	11	must	must	MD
46745	4243	12	pass	pass	VB
46745	4243	13	out	out	IN
46745	4243	14	of	of	IN
46745	4243	15	the	the	DT
46745	4243	16	body	body	NN
46745	4243	17	.	.	.
46745	4244	1	_	_	NNP
46745	4244	2	m.	m.	NN
46745	4245	1	p.	p.	NN
46745	4245	2	_	_	NNP
46745	4245	3	3.--That	3.--that	CD
46745	4245	4	in	in	IN
46745	4245	5	so	so	RB
46745	4245	6	doing	do	VBG
46745	4245	7	,	,	,
46745	4245	8	they	-PRON-	PRP
46745	4245	9	tend	tend	VBP
46745	4245	10	to	to	TO
46745	4245	11	pass	pass	VB
46745	4245	12	out	out	RP
46745	4245	13	by	by	IN
46745	4245	14	some	some	DT
46745	4245	15	glands	gland	NNS
46745	4245	16	more	more	RBR
46745	4245	17	than	than	IN
46745	4245	18	by	by	IN
46745	4245	19	others	other	NNS
46745	4245	20	.	.	.
46745	4246	1	_	_	NNP
46745	4246	2	m.	m.	NN
46745	4247	1	p.	p.	NNP
46745	4247	2	_	_	NNP
46745	4247	3	4.--That	4.--that	CD
46745	4247	4	the	the	DT
46745	4247	5	result	result	NN
46745	4247	6	of	of	IN
46745	4247	7	their	-PRON-	PRP$
46745	4247	8	passage	passage	NN
46745	4247	9	through	through	IN
46745	4247	10	a	a	DT
46745	4247	11	gland	gland	NN
46745	4247	12	is	be	VBZ
46745	4247	13	to	to	TO
46745	4247	14	increase	increase	VB
46745	4247	15	its	-PRON-	PRP$
46745	4247	16	secretion	secretion	NN
46745	4247	17	.	.	.
46745	4248	1	_	_	NNP
46745	4248	2	m.	m.	NN
46745	4249	1	p.	p.	NN
46745	4249	2	_	_	NNP
46745	4249	3	5.--That	5.--That	NNP
46745	4249	4	they	-PRON-	PRP
46745	4249	5	are	be	VBP
46745	4249	6	of	of	IN
46745	4249	7	use	use	NN
46745	4249	8	when	when	WRB
46745	4249	9	the	the	DT
46745	4249	10	state	state	NN
46745	4249	11	of	of	IN
46745	4249	12	the	the	DT
46745	4249	13	system	system	NN
46745	4249	14	requires	require	VBZ
46745	4249	15	that	that	IN
46745	4249	16	the	the	DT
46745	4249	17	function	function	NN
46745	4249	18	of	of	IN
46745	4249	19	a	a	DT
46745	4249	20	gland	gland	NN
46745	4249	21	should	should	MD
46745	4249	22	be	be	VB
46745	4249	23	restored	restore	VBN
46745	4249	24	or	or	CC
46745	4249	25	promoted	promote	VBN
46745	4249	26	.	.	.
46745	4250	1	What	what	WP
46745	4250	2	I	-PRON-	PRP
46745	4250	3	wish	wish	VBP
46745	4250	4	to	to	TO
46745	4250	5	prove	prove	VB
46745	4250	6	is	be	VBZ
46745	4250	7	,	,	,
46745	4250	8	that	that	IN
46745	4250	9	a	a	DT
46745	4250	10	medicine	medicine	NN
46745	4250	11	increases	increase	VBZ
46745	4250	12	secretion	secretion	NN
46745	4250	13	simply	simply	RB
46745	4250	14	by	by	IN
46745	4250	15	being	be	VBG
46745	4250	16	itself	-PRON-	PRP
46745	4250	17	secreted	secrete	VBN
46745	4250	18	;	;	:
46745	4250	19	that	that	IN
46745	4250	20	while	while	IN
46745	4250	21	passing	pass	VBG
46745	4250	22	through	through	IN
46745	4250	23	a	a	DT
46745	4250	24	gland	gland	NN
46745	4250	25	it	-PRON-	PRP
46745	4250	26	stimulates	stimulate	VBZ
46745	4250	27	the	the	DT
46745	4250	28	secreting	secrete	VBG
46745	4250	29	cells	cell	NNS
46745	4250	30	,	,	,
46745	4250	31	and	and	CC
46745	4250	32	rouses	rouse	VBZ
46745	4250	33	them	-PRON-	PRP
46745	4250	34	to	to	IN
46745	4250	35	a	a	DT
46745	4250	36	proper	proper	JJ
46745	4250	37	performance	performance	NN
46745	4250	38	of	of	IN
46745	4250	39	their	-PRON-	PRP$
46745	4250	40	natural	natural	JJ
46745	4250	41	function	function	NN
46745	4250	42	;	;	:
46745	4250	43	that	that	IN
46745	4250	44	each	each	DT
46745	4250	45	eliminative	eliminative	JJ
46745	4250	46	medicine	medicine	NN
46745	4250	47	has	have	VBZ
46745	4250	48	a	a	DT
46745	4250	49	tendency	tendency	NN
46745	4250	50	towards	towards	IN
46745	4250	51	particular	particular	JJ
46745	4250	52	glands	gland	NNS
46745	4250	53	,	,	,
46745	4250	54	and	and	CC
46745	4250	55	increases	increase	VBZ
46745	4250	56	the	the	DT
46745	4250	57	secretion	secretion	NN
46745	4250	58	of	of	IN
46745	4250	59	those	those	DT
46745	4250	60	glands	gland	NNS
46745	4250	61	;	;	:
46745	4250	62	that	that	IN
46745	4250	63	thus	thus	RB
46745	4250	64	,	,	,
46745	4250	65	as	as	RB
46745	4250	66	far	far	RB
46745	4250	67	as	as	IN
46745	4250	68	our	-PRON-	PRP$
46745	4250	69	information	information	NN
46745	4250	70	on	on	IN
46745	4250	71	the	the	DT
46745	4250	72	subject	subject	NN
46745	4250	73	extends	extend	VBZ
46745	4250	74	,	,	,
46745	4250	75	we	-PRON-	PRP
46745	4250	76	find	find	VBP
46745	4250	77	that	that	IN
46745	4250	78	Cathartics	Cathartics	NNPS
46745	4250	79	are	be	VBP
46745	4250	80	excreted	excrete	VBN
46745	4250	81	from	from	IN
46745	4250	82	the	the	DT
46745	4250	83	blood	blood	NN
46745	4250	84	by	by	IN
46745	4250	85	the	the	DT
46745	4250	86	glands	gland	NNS
46745	4250	87	of	of	IN
46745	4250	88	the	the	DT
46745	4250	89	bowels	bowel	NNS
46745	4250	90	,	,	,
46745	4250	91	and	and	CC
46745	4250	92	pass	pass	VB
46745	4250	93	out	out	RP
46745	4250	94	with	with	IN
46745	4250	95	the	the	DT
46745	4250	96	fæces	fæce	NNS
46745	4250	97	;	;	:
46745	4250	98	that	that	IN
46745	4250	99	Diuretics	diuretic	NNS
46745	4250	100	are	be	VBP
46745	4250	101	to	to	TO
46745	4250	102	be	be	VB
46745	4250	103	discovered	discover	VBN
46745	4250	104	in	in	IN
46745	4250	105	the	the	DT
46745	4250	106	urine	urine	NN
46745	4250	107	,	,	,
46745	4250	108	Diaphoretics	diaphoretic	NNS
46745	4250	109	in	in	IN
46745	4250	110	the	the	DT
46745	4250	111	sweat	sweat	NN
46745	4250	112	,	,	,
46745	4250	113	and	and	CC
46745	4250	114	those	those	DT
46745	4250	115	Expectorants	expectorant	NNS
46745	4250	116	which	which	WDT
46745	4250	117	are	be	VBP
46745	4250	118	volatile	volatile	JJ
46745	4250	119	may	may	MD
46745	4250	120	be	be	VB
46745	4250	121	detected	detect	VBN
46745	4250	122	in	in	IN
46745	4250	123	the	the	DT
46745	4250	124	odour	odour	NN
46745	4250	125	of	of	IN
46745	4250	126	the	the	DT
46745	4250	127	breath	breath	NN
46745	4250	128	.	.	.
46745	4251	1	Any	any	DT
46745	4251	2	material	material	NN
46745	4251	3	which	which	WDT
46745	4251	4	is	be	VBZ
46745	4251	5	naturally	naturally	RB
46745	4251	6	eliminated	eliminate	VBN
46745	4251	7	would	would	MD
46745	4251	8	act	act	VB
46745	4251	9	as	as	IN
46745	4251	10	an	an	DT
46745	4251	11	eliminative	eliminative	JJ
46745	4251	12	medicine	medicine	NN
46745	4251	13	.	.	.
46745	4252	1	Thus	thus	RB
46745	4252	2	if	if	IN
46745	4252	3	a	a	DT
46745	4252	4	drachm	drachm	NN
46745	4252	5	of	of	IN
46745	4252	6	Urea	Urea	NNP
46745	4252	7	be	be	VB
46745	4252	8	dissolved	dissolve	VBN
46745	4252	9	in	in	IN
46745	4252	10	water	water	NN
46745	4252	11	,	,	,
46745	4252	12	and	and	CC
46745	4252	13	injected	inject	VBN
46745	4252	14	into	into	IN
46745	4252	15	the	the	DT
46745	4252	16	veins	vein	NNS
46745	4252	17	of	of	IN
46745	4252	18	a	a	DT
46745	4252	19	dog	dog	NN
46745	4252	20	,	,	,
46745	4252	21	it	-PRON-	PRP
46745	4252	22	causes	cause	VBZ
46745	4252	23	copious	copious	JJ
46745	4252	24	urination	urination	NN
46745	4252	25	,	,	,
46745	4252	26	which	which	WDT
46745	4252	27	continues	continue	VBZ
46745	4252	28	until	until	IN
46745	4252	29	the	the	DT
46745	4252	30	whole	whole	NN
46745	4252	31	is	be	VBZ
46745	4252	32	excreted	excrete	VBN
46745	4252	33	.	.	.
46745	4253	1	This	this	DT
46745	4253	2	well	well	RB
46745	4253	3	illustrates	illustrate	VBZ
46745	4253	4	the	the	DT
46745	4253	5	argument	argument	NN
46745	4253	6	.	.	.
46745	4254	1	Further	further	RB
46745	4254	2	,	,	,
46745	4254	3	we	-PRON-	PRP
46745	4254	4	find	find	VBP
46745	4254	5	that	that	IN
46745	4254	6	when	when	WRB
46745	4254	7	an	an	DT
46745	4254	8	eliminative	eliminative	JJ
46745	4254	9	medicine	medicine	NN
46745	4254	10	is	be	VBZ
46745	4254	11	diverted	divert	VBN
46745	4254	12	from	from	IN
46745	4254	13	the	the	DT
46745	4254	14	gland	gland	NN
46745	4254	15	by	by	IN
46745	4254	16	which	which	WDT
46745	4254	17	it	-PRON-	PRP
46745	4254	18	usually	usually	RB
46745	4254	19	passes	pass	VBZ
46745	4254	20	out	out	RP
46745	4254	21	,	,	,
46745	4254	22	it	-PRON-	PRP
46745	4254	23	no	no	RB
46745	4254	24	longer	long	RBR
46745	4254	25	augments	augment	VBZ
46745	4254	26	the	the	DT
46745	4254	27	secretion	secretion	NN
46745	4254	28	of	of	IN
46745	4254	29	that	that	DT
46745	4254	30	gland	gland	NN
46745	4254	31	.	.	.
46745	4255	1	Dr.	Dr.	NNP
46745	4255	2	Ward	Ward	NNP
46745	4255	3	gives	give	VBZ
46745	4255	4	an	an	DT
46745	4255	5	interesting	interesting	JJ
46745	4255	6	case	case	NN
46745	4255	7	of	of	IN
46745	4255	8	a	a	DT
46745	4255	9	woman	woman	NN
46745	4255	10	who	who	WP
46745	4255	11	was	be	VBD
46745	4255	12	never	never	RB
46745	4255	13	purged	purge	VBN
46745	4255	14	by	by	IN
46745	4255	15	Castor	castor	NN
46745	4255	16	-	-	HYPH
46745	4255	17	oil	oil	NN
46745	4255	18	,	,	,
46745	4255	19	but	but	CC
46745	4255	20	in	in	IN
46745	4255	21	whom	whom	WP
46745	4255	22	the	the	DT
46745	4255	23	oil	oil	NN
46745	4255	24	exuded	exude	VBD
46745	4255	25	from	from	IN
46745	4255	26	the	the	DT
46745	4255	27	skin	skin	NN
46745	4255	28	,	,	,
46745	4255	29	and	and	CC
46745	4255	30	acted	act	VBD
46745	4255	31	as	as	IN
46745	4255	32	a	a	DT
46745	4255	33	Diaphoretic	Diaphoretic	NNP
46745	4255	34	.	.	.
46745	4256	1	And	and	CC
46745	4256	2	it	-PRON-	PRP
46745	4256	3	is	be	VBZ
46745	4256	4	,	,	,
46745	4256	5	as	as	IN
46745	4256	6	I	-PRON-	PRP
46745	4256	7	have	have	VBP
46745	4256	8	said	say	VBD
46745	4256	9	,	,	,
46745	4256	10	well	well	RB
46745	4256	11	known	know	VBN
46745	4256	12	that	that	IN
46745	4256	13	the	the	DT
46745	4256	14	conditions	condition	NNS
46745	4256	15	of	of	IN
46745	4256	16	cold	cold	JJ
46745	4256	17	and	and	CC
46745	4256	18	exercise	exercise	NN
46745	4256	19	will	will	MD
46745	4256	20	cause	cause	VB
46745	4256	21	a	a	DT
46745	4256	22	Diaphoretic	Diaphoretic	NNP
46745	4256	23	,	,	,
46745	4256	24	in	in	IN
46745	4256	25	most	most	JJS
46745	4256	26	cases	case	NNS
46745	4256	27	,	,	,
46745	4256	28	to	to	TO
46745	4256	29	act	act	VB
46745	4256	30	on	on	IN
46745	4256	31	the	the	DT
46745	4256	32	kidneys	kidney	NNS
46745	4256	33	,	,	,
46745	4256	34	because	because	IN
46745	4256	35	it	-PRON-	PRP
46745	4256	36	is	be	VBZ
46745	4256	37	then	then	RB
46745	4256	38	excreted	excrete	VBN
46745	4256	39	by	by	IN
46745	4256	40	them	-PRON-	PRP
46745	4256	41	.	.	.
46745	4257	1	For	for	IN
46745	4257	2	the	the	DT
46745	4257	3	same	same	JJ
46745	4257	4	reason	reason	NN
46745	4257	5	,	,	,
46745	4257	6	warmth	warmth	NN
46745	4257	7	,	,	,
46745	4257	8	confinement	confinement	NN
46745	4257	9	,	,	,
46745	4257	10	and	and	CC
46745	4257	11	rest	rest	VB
46745	4257	12	,	,	,
46745	4257	13	will	will	MD
46745	4257	14	induce	induce	VB
46745	4257	15	a	a	DT
46745	4257	16	Diuretic	diuretic	JJ
46745	4257	17	medicine	medicine	NN
46745	4257	18	to	to	TO
46745	4257	19	act	act	VB
46745	4257	20	on	on	IN
46745	4257	21	the	the	DT
46745	4257	22	skin	skin	NN
46745	4257	23	.	.	.
46745	4258	1	Thus	thus	RB
46745	4258	2	if	if	IN
46745	4258	3	it	-PRON-	PRP
46745	4258	4	be	be	VB
46745	4258	5	shown	show	VBN
46745	4258	6	,	,	,
46745	4258	7	on	on	IN
46745	4258	8	the	the	DT
46745	4258	9	one	one	CD
46745	4258	10	hand	hand	NN
46745	4258	11	,	,	,
46745	4258	12	that	that	IN
46745	4258	13	Eliminative	eliminative	JJ
46745	4258	14	medicines	medicine	NNS
46745	4258	15	themselves	-PRON-	PRP
46745	4258	16	pass	pass	VBP
46745	4258	17	through	through	IN
46745	4258	18	the	the	DT
46745	4258	19	glands	gland	NNS
46745	4258	20	whose	whose	WP$
46745	4258	21	secretions	secretion	NNS
46745	4258	22	they	-PRON-	PRP
46745	4258	23	augment	augment	VBD
46745	4258	24	;	;	:
46745	4258	25	and	and	CC
46745	4258	26	,	,	,
46745	4258	27	on	on	IN
46745	4258	28	the	the	DT
46745	4258	29	other	other	JJ
46745	4258	30	hand	hand	NN
46745	4258	31	,	,	,
46745	4258	32	that	that	IN
46745	4258	33	when	when	WRB
46745	4258	34	they	-PRON-	PRP
46745	4258	35	do	do	VBP
46745	4258	36	not	not	RB
46745	4258	37	pass	pass	VB
46745	4258	38	through	through	IN
46745	4258	39	them	-PRON-	PRP
46745	4258	40	,	,	,
46745	4258	41	they	-PRON-	PRP
46745	4258	42	do	do	VBP
46745	4258	43	not	not	RB
46745	4258	44	,	,	,
46745	4258	45	as	as	IN
46745	4258	46	a	a	DT
46745	4258	47	general	general	JJ
46745	4258	48	rule	rule	NN
46745	4258	49	,	,	,
46745	4258	50	augment	augment	VBD
46745	4258	51	their	-PRON-	PRP$
46745	4258	52	secretion,--it	secretion,--it	NN
46745	4258	53	may	may	MD
46745	4258	54	then	then	RB
46745	4258	55	fairly	fairly	RB
46745	4258	56	be	be	VB
46745	4258	57	presumed	presume	VBN
46745	4258	58	that	that	IN
46745	4258	59	they	-PRON-	PRP
46745	4258	60	operate	operate	VBP
46745	4258	61	by	by	IN
46745	4258	62	so	so	RB
46745	4258	63	passing	pass	VBG
46745	4258	64	through	through	RB
46745	4258	65	.	.	.
46745	4259	1	I	-PRON-	PRP
46745	4259	2	assert	assert	VBP
46745	4259	3	,	,	,
46745	4259	4	then	then	RB
46745	4259	5	,	,	,
46745	4259	6	that	that	IN
46745	4259	7	medicines	medicine	NNS
46745	4259	8	which	which	WDT
46745	4259	9	stimulate	stimulate	VBP
46745	4259	10	secretions	secretion	NNS
46745	4259	11	are	be	VBP
46745	4259	12	themselves	-PRON-	PRP
46745	4259	13	secreted	secrete	VBN
46745	4259	14	.	.	.
46745	4260	1	But	but	CC
46745	4260	2	the	the	DT
46745	4260	3	converse	converse	NN
46745	4260	4	of	of	IN
46745	4260	5	this--_i.e	this--_i.e	NNP
46745	4260	6	.	.	.
46745	4260	7	_	_	IN
46745	4260	8	that	that	IN
46745	4260	9	all	all	DT
46745	4260	10	medicines	medicine	NNS
46745	4260	11	which	which	WDT
46745	4260	12	are	be	VBP
46745	4260	13	secreted	secrete	VBN
46745	4260	14	at	at	IN
46745	4260	15	the	the	DT
46745	4260	16	same	same	JJ
46745	4260	17	time	time	NN
46745	4260	18	increase	increase	NN
46745	4260	19	secretion,--though	secretion,--though	.
46745	4260	20	it	-PRON-	PRP
46745	4260	21	holds	hold	VBZ
46745	4260	22	good	good	JJ
46745	4260	23	in	in	IN
46745	4260	24	the	the	DT
46745	4260	25	main	main	JJ
46745	4260	26	,	,	,
46745	4260	27	is	be	VBZ
46745	4260	28	not	not	RB
46745	4260	29	invariably	invariably	RB
46745	4260	30	true	true	JJ
46745	4260	31	.	.	.
46745	4261	1	There	there	EX
46745	4261	2	are	be	VBP
46745	4261	3	two	two	CD
46745	4261	4	chief	chief	JJ
46745	4261	5	exceptions	exception	NNS
46745	4261	6	to	to	IN
46745	4261	7	it	-PRON-	PRP
46745	4261	8	.	.	.
46745	4262	1	These	these	DT
46745	4262	2	are	be	VBP
46745	4262	3	Astringents	Astringents	NNPS
46745	4262	4	and	and	CC
46745	4262	5	Hyperæmics	Hyperæmics	NNPS
46745	4262	6	.	.	.
46745	4263	1	When	when	WRB
46745	4263	2	an	an	DT
46745	4263	3	Astringent	Astringent	NNP
46745	4263	4	passes	pass	VBZ
46745	4263	5	through	through	IN
46745	4263	6	a	a	DT
46745	4263	7	gland	gland	NN
46745	4263	8	,	,	,
46745	4263	9	it	-PRON-	PRP
46745	4263	10	tends	tend	VBZ
46745	4263	11	,	,	,
46745	4263	12	by	by	IN
46745	4263	13	its	-PRON-	PRP$
46745	4263	14	natural	natural	JJ
46745	4263	15	force	force	NN
46745	4263	16	,	,	,
46745	4263	17	to	to	TO
46745	4263	18	decrease	decrease	VB
46745	4263	19	secretion	secretion	NN
46745	4263	20	,	,	,
46745	4263	21	and	and	CC
46745	4263	22	to	to	TO
46745	4263	23	cause	cause	VB
46745	4263	24	constriction	constriction	NN
46745	4263	25	of	of	IN
46745	4263	26	the	the	DT
46745	4263	27	ducts	duct	NNS
46745	4263	28	.	.	.
46745	4264	1	Thus	thus	RB
46745	4264	2	Uvæ	Uvæ	NNP
46745	4264	3	Ursi	Ursi	NNP
46745	4264	4	may	may	MD
46745	4264	5	decrease	decrease	VB
46745	4264	6	the	the	DT
46745	4264	7	amount	amount	NN
46745	4264	8	of	of	IN
46745	4264	9	the	the	DT
46745	4264	10	urine	urine	NN
46745	4264	11	,	,	,
46745	4264	12	although	although	IN
46745	4264	13	it	-PRON-	PRP
46745	4264	14	sometimes	sometimes	RB
46745	4264	15	does	do	VBZ
46745	4264	16	the	the	DT
46745	4264	17	opposite	opposite	NN
46745	4264	18	;	;	:
46745	4264	19	in	in	IN
46745	4264	20	which	which	WDT
46745	4264	21	case	case	NN
46745	4264	22	the	the	DT
46745	4264	23	eliminative	eliminative	NN
46745	4264	24	may	may	MD
46745	4264	25	be	be	VB
46745	4264	26	said	say	VBN
46745	4264	27	to	to	TO
46745	4264	28	surmount	surmount	VB
46745	4264	29	the	the	DT
46745	4264	30	astringent	astringent	JJ
46745	4264	31	tendency	tendency	NN
46745	4264	32	.	.	.
46745	4265	1	So	so	RB
46745	4265	2	also	also	RB
46745	4265	3	Catechu	Catechu	NNP
46745	4265	4	,	,	,
46745	4265	5	Kino	Kino	NNP
46745	4265	6	,	,	,
46745	4265	7	and	and	CC
46745	4265	8	Sulphuric	Sulphuric	NNP
46745	4265	9	Acid	Acid	NNP
46745	4265	10	,	,	,
46745	4265	11	decrease	decrease	VB
46745	4265	12	the	the	DT
46745	4265	13	secretion	secretion	NN
46745	4265	14	of	of	IN
46745	4265	15	the	the	DT
46745	4265	16	intestinal	intestinal	JJ
46745	4265	17	glands	gland	NNS
46745	4265	18	.	.	.
46745	4266	1	But	but	CC
46745	4266	2	general	general	JJ
46745	4266	3	Astringents	Astringents	NNPS
46745	4266	4	are	be	VBP
46745	4266	5	not	not	RB
46745	4266	6	always	always	RB
46745	4266	7	glandular	glandular	JJ
46745	4266	8	Astringents	astringent	NNS
46745	4266	9	.	.	.
46745	4267	1	Thus	thus	RB
46745	4267	2	the	the	DT
46745	4267	3	mineral	mineral	NN
46745	4267	4	acids	acid	NNS
46745	4267	5	act	act	VBP
46745	4267	6	as	as	IN
46745	4267	7	Diuretics	Diuretics	NNP
46745	4267	8	.	.	.
46745	4268	1	By	by	IN
46745	4268	2	Hyperæmics	Hyperæmics	NNPS
46745	4268	3	I	-PRON-	PRP
46745	4268	4	mean	mean	VBP
46745	4268	5	medicines	medicine	NNS
46745	4268	6	which	which	WDT
46745	4268	7	produce	produce	VBP
46745	4268	8	congestion	congestion	NN
46745	4268	9	.	.	.
46745	4269	1	Powerful	powerful	JJ
46745	4269	2	Eliminatives	Eliminatives	NNPS
46745	4269	3	do	do	VBP
46745	4269	4	this	this	DT
46745	4269	5	when	when	WRB
46745	4269	6	given	give	VBN
46745	4269	7	in	in	IN
46745	4269	8	excess	excess	NN
46745	4269	9	,	,	,
46745	4269	10	simply	simply	RB
46745	4269	11	by	by	IN
46745	4269	12	exciting	exciting	JJ
46745	4269	13	excessive	excessive	JJ
46745	4269	14	action	action	NN
46745	4269	15	.	.	.
46745	4270	1	Now	now	RB
46745	4270	2	it	-PRON-	PRP
46745	4270	3	is	be	VBZ
46745	4270	4	a	a	DT
46745	4270	5	general	general	JJ
46745	4270	6	rule	rule	NN
46745	4270	7	that	that	IN
46745	4270	8	congestion	congestion	NN
46745	4270	9	,	,	,
46745	4270	10	however	however	RB
46745	4270	11	caused	cause	VBN
46745	4270	12	,	,	,
46745	4270	13	diminishes	diminish	VBZ
46745	4270	14	the	the	DT
46745	4270	15	secretion	secretion	NN
46745	4270	16	of	of	IN
46745	4270	17	a	a	DT
46745	4270	18	gland	gland	NN
46745	4270	19	.	.	.
46745	4271	1	Thus	thus	RB
46745	4271	2	congestion	congestion	NN
46745	4271	3	of	of	IN
46745	4271	4	the	the	DT
46745	4271	5	liver	liver	NN
46745	4271	6	produces	produce	VBZ
46745	4271	7	jaundice	jaundice	NN
46745	4271	8	;	;	,
46745	4271	9	congestion	congestion	NN
46745	4271	10	of	of	IN
46745	4271	11	the	the	DT
46745	4271	12	kidney	kidney	NN
46745	4271	13	,	,	,
46745	4271	14	ischuria	ischuria	NNP
46745	4271	15	.	.	.
46745	4272	1	After	after	IN
46745	4272	2	scarlatina	scarlatina	NNP
46745	4272	3	,	,	,
46745	4272	4	when	when	WRB
46745	4272	5	the	the	DT
46745	4272	6	kidneys	kidney	NNS
46745	4272	7	are	be	VBP
46745	4272	8	suddenly	suddenly	RB
46745	4272	9	called	call	VBN
46745	4272	10	upon	upon	IN
46745	4272	11	to	to	TO
46745	4272	12	eliminate	eliminate	VB
46745	4272	13	a	a	DT
46745	4272	14	morbid	morbid	NN
46745	4272	15	material	material	NN
46745	4272	16	from	from	IN
46745	4272	17	the	the	DT
46745	4272	18	blood	blood	NN
46745	4272	19	,	,	,
46745	4272	20	congestion	congestion	NN
46745	4272	21	of	of	IN
46745	4272	22	the	the	DT
46745	4272	23	glands	gland	NNS
46745	4272	24	may	may	MD
46745	4272	25	be	be	VB
46745	4272	26	caused	cause	VBN
46745	4272	27	:	:	:
46745	4272	28	the	the	DT
46745	4272	29	urine	urine	NN
46745	4272	30	is	be	VBZ
46745	4272	31	diminished	diminish	VBN
46745	4272	32	,	,	,
46745	4272	33	and	and	CC
46745	4272	34	dropsy	dropsy	JJ
46745	4272	35	results	result	NNS
46745	4272	36	.	.	.
46745	4273	1	Cantharides	Cantharides	NNP
46745	4273	2	and	and	CC
46745	4273	3	Turpentine	Turpentine	NNP
46745	4273	4	are	be	VBP
46745	4273	5	Diuretics	Diuretics	NNP
46745	4273	6	.	.	.
46745	4274	1	They	-PRON-	PRP
46745	4274	2	increase	increase	VBP
46745	4274	3	the	the	DT
46745	4274	4	urine	urine	NN
46745	4274	5	when	when	WRB
46745	4274	6	taken	take	VBN
46745	4274	7	in	in	RP
46745	4274	8	moderate	moderate	JJ
46745	4274	9	doses	dose	NNS
46745	4274	10	;	;	:
46745	4274	11	but	but	CC
46745	4274	12	when	when	WRB
46745	4274	13	in	in	IN
46745	4274	14	an	an	DT
46745	4274	15	overdose	overdose	NN
46745	4274	16	,	,	,
46745	4274	17	they	-PRON-	PRP
46745	4274	18	diminish	diminish	VBP
46745	4274	19	it	-PRON-	PRP
46745	4274	20	,	,	,
46745	4274	21	and	and	CC
46745	4274	22	may	may	MD
46745	4274	23	cause	cause	VB
46745	4274	24	painful	painful	JJ
46745	4274	25	strangury	strangury	NN
46745	4274	26	,	,	,
46745	4274	27	with	with	IN
46745	4274	28	an	an	DT
46745	4274	29	almost	almost	RB
46745	4274	30	total	total	JJ
46745	4274	31	suppression	suppression	NN
46745	4274	32	of	of	IN
46745	4274	33	the	the	DT
46745	4274	34	secretion	secretion	NN
46745	4274	35	.	.	.
46745	4275	1	The	the	DT
46745	4275	2	explanation	explanation	NN
46745	4275	3	of	of	IN
46745	4275	4	such	such	PDT
46745	4275	5	an	an	DT
46745	4275	6	action	action	NN
46745	4275	7	is	be	VBZ
46745	4275	8	obvious	obvious	JJ
46745	4275	9	.	.	.
46745	4276	1	Congestion	congestion	NN
46745	4276	2	is	be	VBZ
46745	4276	3	caused	cause	VBN
46745	4276	4	by	by	IN
46745	4276	5	the	the	DT
46745	4276	6	excessive	excessive	JJ
46745	4276	7	action	action	NN
46745	4276	8	.	.	.
46745	4277	1	In	in	IN
46745	4277	2	the	the	DT
46745	4277	3	same	same	JJ
46745	4277	4	way	way	NN
46745	4277	5	we	-PRON-	PRP
46745	4277	6	find	find	VBP
46745	4277	7	that	that	IN
46745	4277	8	a	a	DT
46745	4277	9	large	large	JJ
46745	4277	10	dose	dose	NN
46745	4277	11	of	of	IN
46745	4277	12	Mercury	Mercury	NNP
46745	4277	13	,	,	,
46745	4277	14	naturally	naturally	RB
46745	4277	15	a	a	DT
46745	4277	16	Cholagogue	Cholagogue	NNP
46745	4277	17	,	,	,
46745	4277	18	may	may	MD
46745	4277	19	produce	produce	VB
46745	4277	20	jaundice	jaundice	NN
46745	4277	21	,	,	,
46745	4277	22	by	by	IN
46745	4277	23	causing	cause	VBG
46745	4277	24	congestion	congestion	NN
46745	4277	25	of	of	IN
46745	4277	26	the	the	DT
46745	4277	27	liver	liver	NN
46745	4277	28	.	.	.
46745	4278	1	This	this	DT
46745	4278	2	fact	fact	NN
46745	4278	3	has	have	VBZ
46745	4278	4	been	be	VBN
46745	4278	5	observed	observe	VBN
46745	4278	6	by	by	IN
46745	4278	7	Dr.	Dr.	NNP
46745	4278	8	Graves	Graves	NNP
46745	4278	9	,	,	,
46745	4278	10	of	of	IN
46745	4278	11	Dublin	Dublin	NNP
46745	4278	12	.	.	.
46745	4279	1	In	in	IN
46745	4279	2	all	all	DT
46745	4279	3	cases	case	NNS
46745	4279	4	,	,	,
46745	4279	5	then	then	RB
46745	4279	6	,	,	,
46745	4279	7	in	in	IN
46745	4279	8	which	which	WDT
46745	4279	9	observations	observation	NNS
46745	4279	10	have	have	VBP
46745	4279	11	been	be	VBN
46745	4279	12	made	make	VBN
46745	4279	13	,	,	,
46745	4279	14	we	-PRON-	PRP
46745	4279	15	find	find	VBP
46745	4279	16	that	that	IN
46745	4279	17	an	an	DT
46745	4279	18	Eliminative	eliminative	JJ
46745	4279	19	medicine	medicine	NN
46745	4279	20	is	be	VBZ
46745	4279	21	secreted	secrete	VBN
46745	4279	22	by	by	IN
46745	4279	23	the	the	DT
46745	4279	24	gland	gland	NN
46745	4279	25	which	which	WDT
46745	4279	26	is	be	VBZ
46745	4279	27	stimulated	stimulate	VBN
46745	4279	28	by	by	IN
46745	4279	29	it	-PRON-	PRP
46745	4279	30	,	,	,
46745	4279	31	and	and	CC
46745	4279	32	,	,	,
46745	4279	33	in	in	IN
46745	4279	34	most	most	JJS
46745	4279	35	cases	case	NNS
46745	4279	36	,	,	,
46745	4279	37	that	that	IN
46745	4279	38	a	a	DT
46745	4279	39	medicine	medicine	NN
46745	4279	40	which	which	WDT
46745	4279	41	is	be	VBZ
46745	4279	42	excreted	excrete	VBN
46745	4279	43	by	by	IN
46745	4279	44	a	a	DT
46745	4279	45	gland	gland	NN
46745	4279	46	tends	tend	VBZ
46745	4279	47	to	to	TO
46745	4279	48	increase	increase	VB
46745	4279	49	its	-PRON-	PRP$
46745	4279	50	particular	particular	JJ
46745	4279	51	secretion	secretion	NN
46745	4279	52	.	.	.
46745	4280	1	Having	have	VBG
46745	4280	2	made	make	VBN
46745	4280	3	this	this	DT
46745	4280	4	general	general	JJ
46745	4280	5	statement	statement	NN
46745	4280	6	of	of	IN
46745	4280	7	the	the	DT
46745	4280	8	case	case	NN
46745	4280	9	,	,	,
46745	4280	10	I	-PRON-	PRP
46745	4280	11	must	must	MD
46745	4280	12	attempt	attempt	VB
46745	4280	13	a	a	DT
46745	4280	14	more	more	RBR
46745	4280	15	particular	particular	JJ
46745	4280	16	and	and	CC
46745	4280	17	detailed	detailed	JJ
46745	4280	18	proof	proof	NN
46745	4280	19	.	.	.
46745	4281	1	I	-PRON-	PRP
46745	4281	2	will	will	MD
46745	4281	3	treat	treat	VB
46745	4281	4	in	in	IN
46745	4281	5	turn	turn	NN
46745	4281	6	of	of	IN
46745	4281	7	the	the	DT
46745	4281	8	above	above	IN
46745	4281	9	minor	minor	JJ
46745	4281	10	propositions	proposition	NNS
46745	4281	11	,	,	,
46745	4281	12	as	as	IN
46745	4281	13	applicable	applicable	JJ
46745	4281	14	to	to	IN
46745	4281	15	the	the	DT
46745	4281	16	following	follow	VBG
46745	4281	17	orders	order	NNS
46745	4281	18	of	of	IN
46745	4281	19	Eliminative	eliminative	JJ
46745	4281	20	medicines:--	medicines:--	NNP
46745	4281	21	CLASS	CLASS	NNP
46745	4281	22	IV	IV	NNP
46745	4281	23	.	.	.
46745	4282	1	ELIMINANTIA	ELIMINANTIA	NNP
46745	4282	2	.	.	.
46745	4283	1	Ord	Ord	NNP
46745	4283	2	.	.	.
46745	4284	1	1	1	LS
46745	4284	2	.	.	.
46745	4285	1	Sialagoga	sialagoga	NN
46745	4285	2	.	.	.
46745	4286	1	Ord	Ord	NNP
46745	4286	2	.	.	.
46745	4287	1	2	2	LS
46745	4287	2	.	.	.
46745	4288	1	Expectorantia	Expectorantia	NNP
46745	4288	2	.	.	.
46745	4289	1	Ord	Ord	NNP
46745	4289	2	.	.	.
46745	4290	1	3	3	LS
46745	4290	2	.	.	.
46745	4291	1	Cathartica	Cathartica	NNP
46745	4291	2	.	.	.
46745	4292	1	Ord	Ord	NNP
46745	4292	2	.	.	.
46745	4293	1	4	4	LS
46745	4293	2	.	.	.
46745	4294	1	Cholagoga	cholagoga	NN
46745	4294	2	.	.	.
46745	4295	1	Ord	Ord	NNP
46745	4295	2	.	.	.
46745	4296	1	5	5	CD
46745	4296	2	.	.	.
46745	4297	1	Diaphoretica	Diaphoretica	NNP
46745	4297	2	.	.	.
46745	4298	1	Ord	Ord	NNP
46745	4298	2	.	.	.
46745	4299	1	6	6	CD
46745	4299	2	.	.	.
46745	4300	1	Diuretica	Diuretica	NNP
46745	4300	2	.	.	.
46745	4301	1	They	-PRON-	PRP
46745	4301	2	are	be	VBP
46745	4301	3	enumerated	enumerate	VBN
46745	4301	4	nearly	nearly	RB
46745	4301	5	in	in	IN
46745	4301	6	the	the	DT
46745	4301	7	order	order	NN
46745	4301	8	of	of	IN
46745	4301	9	the	the	DT
46745	4301	10	glands	gland	NNS
46745	4301	11	,	,	,
46745	4301	12	from	from	IN
46745	4301	13	above	above	RB
46745	4301	14	downwards	downwards	RB
46745	4301	15	,	,	,
46745	4301	16	in	in	IN
46745	4301	17	the	the	DT
46745	4301	18	human	human	JJ
46745	4301	19	body	body	NN
46745	4301	20	.	.	.
46745	4302	1	I	-PRON-	PRP
46745	4302	2	have	have	VBP
46745	4302	3	not	not	RB
46745	4302	4	enumerated	enumerate	VBN
46745	4302	5	Errhines	Errhines	NNP
46745	4302	6	,	,	,
46745	4302	7	because	because	IN
46745	4302	8	the	the	DT
46745	4302	9	medicines	medicine	NNS
46745	4302	10	which	which	WDT
46745	4302	11	are	be	VBP
46745	4302	12	used	use	VBN
46745	4302	13	to	to	TO
46745	4302	14	increase	increase	VB
46745	4302	15	the	the	DT
46745	4302	16	nasal	nasal	NN
46745	4302	17	mucus	mucus	NN
46745	4302	18	are	be	VBP
46745	4302	19	merely	merely	RB
46745	4302	20	topical	topical	JJ
46745	4302	21	irritants	irritant	NNS
46745	4302	22	,	,	,
46745	4302	23	and	and	CC
46745	4302	24	not	not	RB
46745	4302	25	true	true	JJ
46745	4302	26	Eliminatives	Eliminatives	NNPS
46745	4302	27	.	.	.
46745	4303	1	Of	of	IN
46745	4303	2	Emetics	emetic	NNS
46745	4303	3	I	-PRON-	PRP
46745	4303	4	have	have	VBP
46745	4303	5	already	already	RB
46745	4303	6	spoken	speak	VBN
46745	4303	7	.	.	.
46745	4304	1	Some	some	DT
46745	4304	2	are	be	VBP
46745	4304	3	Neurotics	neurotic	NNS
46745	4304	4	,	,	,
46745	4304	5	acting	act	VBG
46745	4304	6	from	from	IN
46745	4304	7	the	the	DT
46745	4304	8	blood	blood	NN
46745	4304	9	on	on	IN
46745	4304	10	the	the	DT
46745	4304	11	nervous	nervous	JJ
46745	4304	12	system	system	NN
46745	4304	13	;	;	:
46745	4304	14	other	other	JJ
46745	4304	15	are	be	VBP
46745	4304	16	local	local	JJ
46745	4304	17	irritants	irritant	NNS
46745	4304	18	.	.	.
46745	4305	1	They	-PRON-	PRP
46745	4305	2	also	also	RB
46745	4305	3	are	be	VBP
46745	4305	4	not	not	RB
46745	4305	5	true	true	JJ
46745	4305	6	Eliminatives	Eliminatives	NNPS
46745	4305	7	.	.	.
46745	4306	1	Neither	neither	DT
46745	4306	2	are	be	VBP
46745	4306	3	Emmenagogues	Emmenagogues	NNPS
46745	4306	4	so	so	RB
46745	4306	5	;	;	:
46745	4306	6	for	for	IN
46745	4306	7	the	the	DT
46745	4306	8	uterus	uterus	NN
46745	4306	9	is	be	VBZ
46745	4306	10	not	not	RB
46745	4306	11	a	a	DT
46745	4306	12	gland	gland	NN
46745	4306	13	.	.	.
46745	4307	1	Some	some	DT
46745	4307	2	of	of	IN
46745	4307	3	these	these	DT
46745	4307	4	too	too	RB
46745	4307	5	are	be	VBP
46745	4307	6	Neurotics	Neurotics	NNP
46745	4307	7	.	.	.
46745	4308	1	Most	Most	JJS
46745	4308	2	of	of	IN
46745	4308	3	them	-PRON-	PRP
46745	4308	4	act	act	VBP
46745	4308	5	by	by	IN
46745	4308	6	causing	cause	VBG
46745	4308	7	a	a	DT
46745	4308	8	determination	determination	NN
46745	4308	9	of	of	IN
46745	4308	10	blood	blood	NN
46745	4308	11	towards	towards	IN
46745	4308	12	the	the	DT
46745	4308	13	organ	organ	NN
46745	4308	14	.	.	.
46745	4309	1	Cathartics	cathartic	NNS
46745	4309	2	do	do	VBP
46745	4309	3	this	this	DT
46745	4309	4	by	by	IN
46745	4309	5	their	-PRON-	PRP$
46745	4309	6	action	action	NN
46745	4309	7	on	on	IN
46745	4309	8	the	the	DT
46745	4309	9	contiguous	contiguous	JJ
46745	4309	10	mucous	mucous	JJ
46745	4309	11	membrane	membrane	NN
46745	4309	12	of	of	IN
46745	4309	13	the	the	DT
46745	4309	14	intestines	intestine	NNS
46745	4309	15	.	.	.
46745	4310	1	(	(	-LRB-
46745	4310	2	_	_	NNP
46745	4310	3	Vide	Vide	NNP
46745	4310	4	_	_	NNP
46745	4310	5	page	page	NN
46745	4310	6	102	102	CD
46745	4310	7	.	.	.
46745	4310	8	)	)	-RRB-
46745	4311	1	These	these	DT
46745	4311	2	then	then	RB
46745	4311	3	are	be	VBP
46745	4311	4	the	the	DT
46745	4311	5	six	six	CD
46745	4311	6	orders	order	NNS
46745	4311	7	of	of	IN
46745	4311	8	Eliminative	eliminative	JJ
46745	4311	9	medicines	medicine	NNS
46745	4311	10	.	.	.
46745	4312	1	In	in	IN
46745	4312	2	the	the	DT
46745	4312	3	first	first	JJ
46745	4312	4	minor	minor	JJ
46745	4312	5	proposition	proposition	NN
46745	4312	6	it	-PRON-	PRP
46745	4312	7	is	be	VBZ
46745	4312	8	stated	state	VBN
46745	4312	9	that	that	IN
46745	4312	10	they	-PRON-	PRP
46745	4312	11	pass	pass	VBP
46745	4312	12	into	into	IN
46745	4312	13	the	the	DT
46745	4312	14	blood	blood	NN
46745	4312	15	.	.	.
46745	4313	1	This	this	DT
46745	4313	2	has	have	VBZ
46745	4313	3	already	already	RB
46745	4313	4	been	be	VBN
46745	4313	5	in	in	IN
46745	4313	6	great	great	JJ
46745	4313	7	part	part	NN
46745	4313	8	proved	prove	VBN
46745	4313	9	;	;	:
46745	4313	10	for	for	IN
46745	4313	11	most	most	JJS
46745	4313	12	Eliminative	eliminative	JJ
46745	4313	13	medicines	medicine	NNS
46745	4313	14	belong	belong	VBP
46745	4313	15	also	also	RB
46745	4313	16	to	to	IN
46745	4313	17	one	one	CD
46745	4313	18	or	or	CC
46745	4313	19	more	more	JJR
46745	4313	20	of	of	IN
46745	4313	21	the	the	DT
46745	4313	22	preceding	precede	VBG
46745	4313	23	classes	class	NNS
46745	4313	24	,	,	,
46745	4313	25	of	of	IN
46745	4313	26	which	which	WDT
46745	4313	27	it	-PRON-	PRP
46745	4313	28	has	have	VBZ
46745	4313	29	been	be	VBN
46745	4313	30	shown	show	VBN
46745	4313	31	that	that	IN
46745	4313	32	they	-PRON-	PRP
46745	4313	33	pass	pass	VBP
46745	4313	34	into	into	IN
46745	4313	35	the	the	DT
46745	4313	36	blood	blood	NN
46745	4313	37	.	.	.
46745	4314	1	Thus	thus	RB
46745	4314	2	Antimony	Antimony	NNP
46745	4314	3	,	,	,
46745	4314	4	Mercury	Mercury	NNP
46745	4314	5	,	,	,
46745	4314	6	Acids	Acids	NNP
46745	4314	7	,	,	,
46745	4314	8	Alkalies	Alkalies	NNP
46745	4314	9	,	,	,
46745	4314	10	Sulphur	Sulphur	NNP
46745	4314	11	,	,	,
46745	4314	12	the	the	DT
46745	4314	13	Salts	Salts	NNP
46745	4314	14	,	,	,
46745	4314	15	etc	etc	FW
46745	4314	16	.	.	NN
46745	4314	17	,	,	,
46745	4314	18	are	be	VBP
46745	4314	19	Hæmatics	Hæmatics	NNPS
46745	4314	20	primarily	primarily	RB
46745	4314	21	.	.	.
46745	4315	1	The	the	DT
46745	4315	2	various	various	JJ
46745	4315	3	volatile	volatile	JJ
46745	4315	4	oils	oil	NNS
46745	4315	5	and	and	CC
46745	4315	6	resins	resin	NNS
46745	4315	7	are	be	VBP
46745	4315	8	more	more	RBR
46745	4315	9	or	or	CC
46745	4315	10	less	less	JJR
46745	4315	11	Stimulants	Stimulants	NNP
46745	4315	12	.	.	.
46745	4316	1	So	so	RB
46745	4316	2	also	also	RB
46745	4316	3	Alcohol	Alcohol	NNP
46745	4316	4	and	and	CC
46745	4316	5	Ether	Ether	NNP
46745	4316	6	,	,	,
46745	4316	7	as	as	RB
46745	4316	8	well	well	RB
46745	4316	9	as	as	IN
46745	4316	10	Camphor	Camphor	NNP
46745	4316	11	and	and	CC
46745	4316	12	others	other	NNS
46745	4316	13	,	,	,
46745	4316	14	are	be	VBP
46745	4316	15	found	find	VBN
46745	4316	16	among	among	IN
46745	4316	17	Narcotics	Narcotics	NNP
46745	4316	18	.	.	.
46745	4317	1	Colchicum	Colchicum	NNP
46745	4317	2	,	,	,
46745	4317	3	Digitalis	Digitalis	NNP
46745	4317	4	,	,	,
46745	4317	5	Creosote	Creosote	NNP
46745	4317	6	,	,	,
46745	4317	7	and	and	CC
46745	4317	8	Ipecacuanha	Ipecacuanha	NNP
46745	4317	9	,	,	,
46745	4317	10	are	be	VBP
46745	4317	11	Sedatives	sedative	NNS
46745	4317	12	.	.	.
46745	4318	1	Many	many	JJ
46745	4318	2	Eliminatives	Eliminatives	NNPS
46745	4318	3	are	be	VBP
46745	4318	4	certainly	certainly	RB
46745	4318	5	known	know	VBN
46745	4318	6	to	to	TO
46745	4318	7	pass	pass	VB
46745	4318	8	into	into	IN
46745	4318	9	the	the	DT
46745	4318	10	blood	blood	NN
46745	4318	11	,	,	,
46745	4318	12	because	because	IN
46745	4318	13	they	-PRON-	PRP
46745	4318	14	are	be	VBP
46745	4318	15	subsequently	subsequently	RB
46745	4318	16	found	find	VBN
46745	4318	17	in	in	IN
46745	4318	18	the	the	DT
46745	4318	19	secretions	secretion	NNS
46745	4318	20	,	,	,
46745	4318	21	as	as	IN
46745	4318	22	will	will	MD
46745	4318	23	be	be	VB
46745	4318	24	presently	presently	RB
46745	4318	25	seen	see	VBN
46745	4318	26	.	.	.
46745	4319	1	Secondly	secondly	RB
46745	4319	2	,	,	,
46745	4319	3	these	these	DT
46745	4319	4	medicines	medicine	NNS
46745	4319	5	can	can	MD
46745	4319	6	not	not	RB
46745	4319	7	remain	remain	VB
46745	4319	8	in	in	IN
46745	4319	9	the	the	DT
46745	4319	10	blood	blood	NN
46745	4319	11	,	,	,
46745	4319	12	but	but	CC
46745	4319	13	must	must	MD
46745	4319	14	sooner	sooner	RB
46745	4319	15	or	or	CC
46745	4319	16	later	later	RB
46745	4319	17	leave	leave	VB
46745	4319	18	it	-PRON-	PRP
46745	4319	19	.	.	.
46745	4320	1	If	if	IN
46745	4320	2	they	-PRON-	PRP
46745	4320	3	remained	remain	VBD
46745	4320	4	,	,	,
46745	4320	5	they	-PRON-	PRP
46745	4320	6	could	could	MD
46745	4320	7	not	not	RB
46745	4320	8	pass	pass	VB
46745	4320	9	through	through	IN
46745	4320	10	the	the	DT
46745	4320	11	glandular	glandular	JJ
46745	4320	12	cells	cell	NNS
46745	4320	13	.	.	.
46745	4321	1	But	but	CC
46745	4321	2	if	if	IN
46745	4321	3	they	-PRON-	PRP
46745	4321	4	pass	pass	VBP
46745	4321	5	out	out	RP
46745	4321	6	,	,	,
46745	4321	7	they	-PRON-	PRP
46745	4321	8	must	must	MD
46745	4321	9	inevitably	inevitably	RB
46745	4321	10	be	be	VB
46745	4321	11	excreted	excrete	VBN
46745	4321	12	by	by	IN
46745	4321	13	them	-PRON-	PRP
46745	4321	14	.	.	.
46745	4322	1	All	all	PDT
46745	4322	2	those	those	DT
46745	4322	3	medicines	medicine	NNS
46745	4322	4	must	must	MD
46745	4322	5	be	be	VB
46745	4322	6	secreted	secrete	VBN
46745	4322	7	which	which	WDT
46745	4322	8	have	have	VBP
46745	4322	9	nothing	nothing	NN
46745	4322	10	in	in	IN
46745	4322	11	the	the	DT
46745	4322	12	natural	natural	JJ
46745	4322	13	blood	blood	NN
46745	4322	14	corresponding	correspond	VBG
46745	4322	15	to	to	IN
46745	4322	16	them	-PRON-	PRP
46745	4322	17	.	.	.
46745	4323	1	This	this	DT
46745	4323	2	is	be	VBZ
46745	4323	3	the	the	DT
46745	4323	4	case	case	NN
46745	4323	5	with	with	IN
46745	4323	6	most	most	JJS
46745	4323	7	Eliminatives	Eliminatives	NNPS
46745	4323	8	,	,	,
46745	4323	9	and	and	CC
46745	4323	10	with	with	IN
46745	4323	11	all	all	DT
46745	4323	12	medicines	medicine	NNS
46745	4323	13	except	except	IN
46745	4323	14	the	the	DT
46745	4323	15	Restorative	Restorative	NNP
46745	4323	16	Hæmatics	Hæmatics	NNPS
46745	4323	17	.	.	.
46745	4324	1	And	and	CC
46745	4324	2	those	those	DT
46745	4324	3	Restoratives	restorative	NNS
46745	4324	4	which	which	WDT
46745	4324	5	act	act	VBP
46745	4324	6	as	as	IN
46745	4324	7	Eliminatives	Eliminatives	NNP
46745	4324	8	,	,	,
46745	4324	9	such	such	JJ
46745	4324	10	as	as	IN
46745	4324	11	Acids	Acids	NNPS
46745	4324	12	and	and	CC
46745	4324	13	Alkalies	Alkalies	NNPS
46745	4324	14	,	,	,
46745	4324	15	do	do	VB
46745	4324	16	so	so	RB
46745	4324	17	because	because	IN
46745	4324	18	they	-PRON-	PRP
46745	4324	19	are	be	VBP
46745	4324	20	introduced	introduce	VBN
46745	4324	21	in	in	IN
46745	4324	22	so	so	RB
46745	4324	23	large	large	JJ
46745	4324	24	a	a	DT
46745	4324	25	quantity	quantity	NN
46745	4324	26	that	that	WDT
46745	4324	27	they	-PRON-	PRP
46745	4324	28	can	can	MD
46745	4324	29	not	not	RB
46745	4324	30	possibly	possibly	RB
46745	4324	31	remain	remain	VB
46745	4324	32	in	in	IN
46745	4324	33	healthy	healthy	JJ
46745	4324	34	blood	blood	NN
46745	4324	35	.	.	.
46745	4325	1	Thus	thus	RB
46745	4325	2	all	all	PDT
46745	4325	3	these	these	DT
46745	4325	4	medicines	medicine	NNS
46745	4325	5	pass	pass	VBP
46745	4325	6	out	out	RP
46745	4325	7	through	through	IN
46745	4325	8	the	the	DT
46745	4325	9	glands	gland	NNS
46745	4325	10	.	.	.
46745	4326	1	Thirdly	thirdly	RB
46745	4326	2	,	,	,
46745	4326	3	we	-PRON-	PRP
46745	4326	4	find	find	VBP
46745	4326	5	that	that	IN
46745	4326	6	in	in	IN
46745	4326	7	so	so	RB
46745	4326	8	doing	do	VBG
46745	4326	9	they	-PRON-	PRP
46745	4326	10	tend	tend	VBP
46745	4326	11	to	to	TO
46745	4326	12	pass	pass	VB
46745	4326	13	out	out	RP
46745	4326	14	by	by	IN
46745	4326	15	some	some	DT
46745	4326	16	particular	particular	JJ
46745	4326	17	glands	gland	NNS
46745	4326	18	rather	rather	RB
46745	4326	19	than	than	IN
46745	4326	20	by	by	IN
46745	4326	21	others	other	NNS
46745	4326	22	.	.	.
46745	4327	1	In	in	IN
46745	4327	2	order	order	NN
46745	4327	3	to	to	TO
46745	4327	4	show	show	VB
46745	4327	5	this	this	DT
46745	4327	6	we	-PRON-	PRP
46745	4327	7	may	may	MD
46745	4327	8	consider	consider	VB
46745	4327	9	first	first	RB
46745	4327	10	the	the	DT
46745	4327	11	chief	chief	JJ
46745	4327	12	tendencies	tendency	NNS
46745	4327	13	of	of	IN
46745	4327	14	the	the	DT
46745	4327	15	great	great	JJ
46745	4327	16	groups	group	NNS
46745	4327	17	of	of	IN
46745	4327	18	Eliminative	eliminative	JJ
46745	4327	19	medicines	medicine	NNS
46745	4327	20	;	;	:
46745	4327	21	and	and	CC
46745	4327	22	secondly	secondly	RB
46745	4327	23	,	,	,
46745	4327	24	I	-PRON-	PRP
46745	4327	25	shall	shall	MD
46745	4327	26	endeavour	endeavour	VB
46745	4327	27	,	,	,
46745	4327	28	when	when	WRB
46745	4327	29	considering	consider	VBG
46745	4327	30	the	the	DT
46745	4327	31	six	six	CD
46745	4327	32	orders	order	NNS
46745	4327	33	,	,	,
46745	4327	34	to	to	TO
46745	4327	35	show	show	VB
46745	4327	36	that	that	IN
46745	4327	37	many	many	JJ
46745	4327	38	of	of	IN
46745	4327	39	the	the	DT
46745	4327	40	medicines	medicine	NNS
46745	4327	41	included	include	VBN
46745	4327	42	in	in	IN
46745	4327	43	them	-PRON-	PRP
46745	4327	44	have	have	VBP
46745	4327	45	actually	actually	RB
46745	4327	46	been	be	VBN
46745	4327	47	found	find	VBN
46745	4327	48	in	in	IN
46745	4327	49	the	the	DT
46745	4327	50	secretions	secretion	NNS
46745	4327	51	of	of	IN
46745	4327	52	the	the	DT
46745	4327	53	glands	gland	NNS
46745	4327	54	towards	towards	IN
46745	4327	55	which	which	WDT
46745	4327	56	they	-PRON-	PRP
46745	4327	57	tend	tend	VBP
46745	4327	58	.	.	.
46745	4328	1	The	the	DT
46745	4328	2	first	first	JJ
46745	4328	3	consideration	consideration	NN
46745	4328	4	will	will	MD
46745	4328	5	clear	clear	VB
46745	4328	6	the	the	DT
46745	4328	7	way	way	NN
46745	4328	8	for	for	IN
46745	4328	9	the	the	DT
46745	4328	10	second	second	JJ
46745	4328	11	.	.	.
46745	4329	1	What	what	WP
46745	4329	2	we	-PRON-	PRP
46745	4329	3	have	have	VBP
46745	4329	4	to	to	TO
46745	4329	5	ascertain	ascertain	VB
46745	4329	6	is	be	VBZ
46745	4329	7	,	,	,
46745	4329	8	that	that	IN
46745	4329	9	the	the	DT
46745	4329	10	principle	principle	NN
46745	4329	11	of	of	IN
46745	4329	12	selective	selective	JJ
46745	4329	13	secretion	secretion	NN
46745	4329	14	is	be	VBZ
46745	4329	15	generally	generally	RB
46745	4329	16	applicable	applicable	JJ
46745	4329	17	to	to	IN
46745	4329	18	Eliminative	eliminative	JJ
46745	4329	19	remedies	remedy	NNS
46745	4329	20	.	.	.
46745	4330	1	The	the	DT
46745	4330	2	most	most	RBS
46745	4330	3	important	important	JJ
46745	4330	4	of	of	IN
46745	4330	5	the	the	DT
46745	4330	6	substances	substance	NNS
46745	4330	7	which	which	WDT
46745	4330	8	are	be	VBP
46745	4330	9	used	use	VBN
46745	4330	10	to	to	TO
46745	4330	11	increase	increase	VB
46745	4330	12	secretion	secretion	NN
46745	4330	13	may	may	MD
46745	4330	14	be	be	VB
46745	4330	15	divided	divide	VBN
46745	4330	16	chemically	chemically	RB
46745	4330	17	under	under	IN
46745	4330	18	the	the	DT
46745	4330	19	following	following	JJ
46745	4330	20	six	six	CD
46745	4330	21	heads	head	NNS
46745	4330	22	,	,	,
46745	4330	23	of	of	IN
46745	4330	24	all	all	DT
46745	4330	25	of	of	IN
46745	4330	26	which	which	WDT
46745	4330	27	it	-PRON-	PRP
46745	4330	28	has	have	VBZ
46745	4330	29	been	be	VBN
46745	4330	30	proved	prove	VBN
46745	4330	31	that	that	IN
46745	4330	32	they	-PRON-	PRP
46745	4330	33	are	be	VBP
46745	4330	34	capable	capable	JJ
46745	4330	35	of	of	IN
46745	4330	36	absorption	absorption	NN
46745	4330	37	.	.	.
46745	4331	1	(	(	-LRB-
46745	4331	2	Prop	Prop	NNP
46745	4331	3	.	.	.
46745	4332	1	II	II	NNP
46745	4332	2	.	.	.
46745	4332	3	)	)	-RRB-
46745	4333	1	1	1	LS
46745	4333	2	.	.	.
46745	4334	1	Insoluble	insoluble	JJ
46745	4334	2	mineral	mineral	NN
46745	4334	3	substances	substance	NNS
46745	4334	4	.	.	.
46745	4335	1	2	2	LS
46745	4335	2	.	.	.
46745	4336	1	Soluble	soluble	JJ
46745	4336	2	minerals,--_i.e	minerals,--_i.e	CD
46745	4336	3	.	.	.
46745	4336	4	_	_	NNP
46745	4336	5	Acids	Acids	NNP
46745	4336	6	,	,	,
46745	4336	7	Alkalies	Alkalies	NNP
46745	4336	8	,	,	,
46745	4336	9	and	and	CC
46745	4336	10	Salts	Salts	NNP
46745	4336	11	.	.	.
46745	4337	1	3	3	LS
46745	4337	2	.	.	.
46745	4338	1	Ammonia	Ammonia	NNP
46745	4338	2	and	and	CC
46745	4338	3	volatile	volatile	JJ
46745	4338	4	oils	oil	NNS
46745	4338	5	.	.	.
46745	4339	1	4	4	LS
46745	4339	2	.	.	.
46745	4340	1	Fixed	fix	VBN
46745	4340	2	acrid	acrid	JJ
46745	4340	3	oils	oil	NNS
46745	4340	4	.	.	.
46745	4341	1	5	5	CD
46745	4341	2	.	.	.
46745	4342	1	Resins	resin	NNS
46745	4342	2	and	and	CC
46745	4342	3	neutral	neutral	JJ
46745	4342	4	acrid	acrid	JJ
46745	4342	5	principles	principle	NNS
46745	4342	6	.	.	.
46745	4343	1	6	6	CD
46745	4343	2	.	.	.
46745	4344	1	Soluble	soluble	JJ
46745	4344	2	vegetable	vegetable	NN
46745	4344	3	principles	principle	NNS
46745	4344	4	.	.	.
46745	4345	1	1	1	LS
46745	4345	2	.	.	.
46745	4346	1	_	_	NNP
46745	4346	2	Insoluble	insoluble	JJ
46745	4346	3	mineral	mineral	NN
46745	4346	4	substances._--The	substances._--The	:
46745	4346	5	chief	chief	NN
46745	4346	6	of	of	IN
46745	4346	7	these	these	DT
46745	4346	8	are	be	VBP
46745	4346	9	Mercurials	mercurial	NNS
46745	4346	10	(	(	-LRB-
46745	4346	11	Blue	Blue	NNP
46745	4346	12	Pill	Pill	NNP
46745	4346	13	and	and	CC
46745	4346	14	Calomel	Calomel	NNP
46745	4346	15	,	,	,
46745	4346	16	)	)	-RRB-
46745	4346	17	Iodine	Iodine	NNP
46745	4346	18	,	,	,
46745	4346	19	and	and	CC
46745	4346	20	Sulphur	Sulphur	NNP
46745	4346	21	.	.	.
46745	4347	1	They	-PRON-	PRP
46745	4347	2	are	be	VBP
46745	4347	3	all	all	RB
46745	4347	4	more	more	RBR
46745	4347	5	or	or	CC
46745	4347	6	less	less	RBR
46745	4347	7	changed	change	VBN
46745	4347	8	during	during	IN
46745	4347	9	the	the	DT
46745	4347	10	process	process	NN
46745	4347	11	of	of	IN
46745	4347	12	absorption	absorption	NN
46745	4347	13	,	,	,
46745	4347	14	as	as	IN
46745	4347	15	they	-PRON-	PRP
46745	4347	16	have	have	VBP
46745	4347	17	to	to	TO
46745	4347	18	be	be	VB
46745	4347	19	reduced	reduce	VBN
46745	4347	20	to	to	IN
46745	4347	21	a	a	DT
46745	4347	22	soluble	soluble	JJ
46745	4347	23	condition	condition	NN
46745	4347	24	.	.	.
46745	4348	1	They	-PRON-	PRP
46745	4348	2	stimulate	stimulate	VBP
46745	4348	3	secretion	secretion	NN
46745	4348	4	generally	generally	RB
46745	4348	5	;	;	:
46745	4348	6	but	but	CC
46745	4348	7	Mercury	Mercury	NNP
46745	4348	8	particularly	particularly	RB
46745	4348	9	tends	tend	VBZ
46745	4348	10	to	to	IN
46745	4348	11	the	the	DT
46745	4348	12	liver	liver	NN
46745	4348	13	,	,	,
46745	4348	14	bowels	bowel	NNS
46745	4348	15	,	,	,
46745	4348	16	salivary	salivary	JJ
46745	4348	17	glands	gland	NNS
46745	4348	18	,	,	,
46745	4348	19	and	and	CC
46745	4348	20	skin	skin	NN
46745	4348	21	;	;	:
46745	4348	22	Iodine	Iodine	NNP
46745	4348	23	,	,	,
46745	4348	24	to	to	IN
46745	4348	25	the	the	DT
46745	4348	26	kidneys	kidney	NNS
46745	4348	27	,	,	,
46745	4348	28	and	and	CC
46745	4348	29	to	to	IN
46745	4348	30	the	the	DT
46745	4348	31	salivary	salivary	JJ
46745	4348	32	and	and	CC
46745	4348	33	mucous	mucous	JJ
46745	4348	34	glands	gland	NNS
46745	4348	35	;	;	:
46745	4348	36	Sulphur	Sulphur	NNP
46745	4348	37	,	,	,
46745	4348	38	to	to	IN
46745	4348	39	the	the	DT
46745	4348	40	skin	skin	NN
46745	4348	41	.	.	.
46745	4349	1	2	2	LS
46745	4349	2	.	.	.
46745	4350	1	_	_	NNP
46745	4350	2	Soluble	soluble	JJ
46745	4350	3	mineral	mineral	NN
46745	4350	4	substances._--Acids	substances._--acid	NNS
46745	4350	5	,	,	,
46745	4350	6	Alkalies	Alkalies	NNP
46745	4350	7	,	,	,
46745	4350	8	and	and	CC
46745	4350	9	Salts	Salts	NNP
46745	4350	10	,	,	,
46745	4350	11	may	may	MD
46745	4350	12	pass	pass	VB
46745	4350	13	off	off	RP
46745	4350	14	by	by	IN
46745	4350	15	any	any	DT
46745	4350	16	of	of	IN
46745	4350	17	the	the	DT
46745	4350	18	fluid	fluid	JJ
46745	4350	19	secretions	secretion	NNS
46745	4350	20	.	.	.
46745	4351	1	The	the	DT
46745	4351	2	chief	chief	NN
46745	4351	3	of	of	IN
46745	4351	4	these	these	DT
46745	4351	5	secretions	secretion	NNS
46745	4351	6	are	be	VBP
46745	4351	7	the	the	DT
46745	4351	8	sweat	sweat	NN
46745	4351	9	,	,	,
46745	4351	10	the	the	DT
46745	4351	11	urine	urine	NN
46745	4351	12	,	,	,
46745	4351	13	and	and	CC
46745	4351	14	the	the	DT
46745	4351	15	secretion	secretion	NN
46745	4351	16	of	of	IN
46745	4351	17	the	the	DT
46745	4351	18	bowels	bowel	NNS
46745	4351	19	.	.	.
46745	4352	1	The	the	DT
46745	4352	2	sweat	sweat	NN
46745	4352	3	is	be	VBZ
46745	4352	4	only	only	RB
46745	4352	5	fluid	fluid	JJ
46745	4352	6	when	when	WRB
46745	4352	7	the	the	DT
46745	4352	8	skin	skin	NN
46745	4352	9	is	be	VBZ
46745	4352	10	kept	keep	VBN
46745	4352	11	covered	cover	VBN
46745	4352	12	and	and	CC
46745	4352	13	very	very	RB
46745	4352	14	warm	warm	JJ
46745	4352	15	.	.	.
46745	4353	1	In	in	IN
46745	4353	2	other	other	JJ
46745	4353	3	cases	case	NNS
46745	4353	4	the	the	DT
46745	4353	5	choice	choice	NN
46745	4353	6	lies	lie	VBZ
46745	4353	7	between	between	IN
46745	4353	8	the	the	DT
46745	4353	9	kidneys	kidney	NNS
46745	4353	10	and	and	CC
46745	4353	11	the	the	DT
46745	4353	12	bowels	bowel	NNS
46745	4353	13	.	.	.
46745	4354	1	The	the	DT
46745	4354	2	kidneys	kidney	NNS
46745	4354	3	are	be	VBP
46745	4354	4	the	the	DT
46745	4354	5	grand	grand	JJ
46745	4354	6	purifiers	purifier	NNS
46745	4354	7	of	of	IN
46745	4354	8	the	the	DT
46745	4354	9	blood	blood	NN
46745	4354	10	,	,	,
46745	4354	11	so	so	IN
46745	4354	12	that	that	IN
46745	4354	13	most	most	JJS
46745	4354	14	of	of	IN
46745	4354	15	the	the	DT
46745	4354	16	substances	substance	NNS
46745	4354	17	which	which	WDT
46745	4354	18	stimulate	stimulate	VBP
46745	4354	19	the	the	DT
46745	4354	20	other	other	JJ
46745	4354	21	glands	gland	NNS
46745	4354	22	may	may	MD
46745	4354	23	occasionally	occasionally	RB
46745	4354	24	pass	pass	VB
46745	4354	25	off	off	RP
46745	4354	26	in	in	IN
46745	4354	27	the	the	DT
46745	4354	28	urine	urine	NN
46745	4354	29	.	.	.
46745	4355	1	And	and	CC
46745	4355	2	soluble	soluble	JJ
46745	4355	3	minerals	mineral	NNS
46745	4355	4	,	,	,
46745	4355	5	which	which	WDT
46745	4355	6	require	require	VBP
46745	4355	7	some	some	DT
46745	4355	8	amount	amount	NN
46745	4355	9	of	of	IN
46745	4355	10	water	water	NN
46745	4355	11	for	for	IN
46745	4355	12	proper	proper	JJ
46745	4355	13	solution	solution	NN
46745	4355	14	,	,	,
46745	4355	15	would	would	MD
46745	4355	16	tend	tend	VB
46745	4355	17	for	for	IN
46745	4355	18	this	this	DT
46745	4355	19	reason	reason	NN
46745	4355	20	towards	towards	IN
46745	4355	21	the	the	DT
46745	4355	22	most	most	RBS
46745	4355	23	fluid	fluid	NN
46745	4355	24	of	of	IN
46745	4355	25	the	the	DT
46745	4355	26	secretions	secretion	NNS
46745	4355	27	.	.	.
46745	4356	1	But	but	CC
46745	4356	2	there	there	EX
46745	4356	3	are	be	VBP
46745	4356	4	some	some	DT
46745	4356	5	other	other	JJ
46745	4356	6	things	thing	NNS
46745	4356	7	which	which	WDT
46745	4356	8	counter	counter	VBP
46745	4356	9	-	-	NN
46745	4356	10	balance	balance	VBP
46745	4356	11	this	this	DT
46745	4356	12	tendency	tendency	NN
46745	4356	13	.	.	.
46745	4357	1	The	the	DT
46745	4357	2	constitution	constitution	NN
46745	4357	3	of	of	IN
46745	4357	4	the	the	DT
46745	4357	5	urine	urine	NN
46745	4357	6	is	be	VBZ
46745	4357	7	such	such	JJ
46745	4357	8	that	that	IN
46745	4357	9	it	-PRON-	PRP
46745	4357	10	can	can	MD
46745	4357	11	not	not	RB
46745	4357	12	safely	safely	RB
46745	4357	13	be	be	VB
46745	4357	14	disturbed	disturb	VBN
46745	4357	15	to	to	IN
46745	4357	16	a	a	DT
46745	4357	17	very	very	RB
46745	4357	18	great	great	JJ
46745	4357	19	extent	extent	NN
46745	4357	20	.	.	.
46745	4358	1	If	if	IN
46745	4358	2	there	there	EX
46745	4358	3	be	be	VB
46745	4358	4	much	much	RB
46745	4358	5	excess	excess	NN
46745	4358	6	in	in	IN
46745	4358	7	it	-PRON-	PRP
46745	4358	8	either	either	CC
46745	4358	9	of	of	IN
46745	4358	10	acid	acid	NN
46745	4358	11	or	or	CC
46745	4358	12	of	of	IN
46745	4358	13	alkali	alkali	JJ
46745	4358	14	,	,	,
46745	4358	15	a	a	DT
46745	4358	16	deposit	deposit	NN
46745	4358	17	is	be	VBZ
46745	4358	18	occasioned	occasion	VBN
46745	4358	19	.	.	.
46745	4359	1	Dr.	Dr.	NNP
46745	4359	2	Bence	Bence	NNP
46745	4359	3	Jones	Jones	NNP
46745	4359	4	found	find	VBD
46745	4359	5	that	that	IN
46745	4359	6	Sulphuric	Sulphuric	NNP
46745	4359	7	acid	acid	NN
46745	4359	8	never	never	RB
46745	4359	9	passed	pass	VBD
46745	4359	10	out	out	RP
46745	4359	11	in	in	IN
46745	4359	12	the	the	DT
46745	4359	13	urine	urine	NN
46745	4359	14	in	in	IN
46745	4359	15	any	any	DT
46745	4359	16	quantity	quantity	NN
46745	4359	17	.	.	.
46745	4360	1	We	-PRON-	PRP
46745	4360	2	find	find	VBP
46745	4360	3	too	too	RB
46745	4360	4	that	that	IN
46745	4360	5	when	when	WRB
46745	4360	6	a	a	DT
46745	4360	7	certain	certain	JJ
46745	4360	8	quantity	quantity	NN
46745	4360	9	of	of	IN
46745	4360	10	a	a	DT
46745	4360	11	saline	saline	NN
46745	4360	12	is	be	VBZ
46745	4360	13	administered	administer	VBN
46745	4360	14	,	,	,
46745	4360	15	too	too	RB
46745	4360	16	great	great	JJ
46745	4360	17	to	to	TO
46745	4360	18	pass	pass	VB
46745	4360	19	off	off	RP
46745	4360	20	readily	readily	RB
46745	4360	21	by	by	IN
46745	4360	22	the	the	DT
46745	4360	23	kidneys	kidney	NNS
46745	4360	24	,	,	,
46745	4360	25	it	-PRON-	PRP
46745	4360	26	prefers	prefer	VBZ
46745	4360	27	to	to	TO
46745	4360	28	act	act	VB
46745	4360	29	on	on	IN
46745	4360	30	the	the	DT
46745	4360	31	bowels	bowel	NNS
46745	4360	32	.	.	.
46745	4361	1	It	-PRON-	PRP
46745	4361	2	is	be	VBZ
46745	4361	3	more	more	RBR
46745	4361	4	likely	likely	JJ
46745	4361	5	to	to	TO
46745	4361	6	be	be	VB
46745	4361	7	diuretic	diuretic	JJ
46745	4361	8	if	if	IN
46745	4361	9	much	much	RB
46745	4361	10	diluted	dilute	VBN
46745	4361	11	with	with	IN
46745	4361	12	water	water	NN
46745	4361	13	;	;	:
46745	4361	14	but	but	CC
46745	4361	15	this	this	DT
46745	4361	16	is	be	VBZ
46745	4361	17	not	not	RB
46745	4361	18	the	the	DT
46745	4361	19	only	only	JJ
46745	4361	20	directing	direct	VBG
46745	4361	21	cause	cause	NN
46745	4361	22	,	,	,
46745	4361	23	for	for	IN
46745	4361	24	a	a	DT
46745	4361	25	very	very	RB
46745	4361	26	large	large	JJ
46745	4361	27	quantity	quantity	NN
46745	4361	28	of	of	IN
46745	4361	29	a	a	DT
46745	4361	30	saline	saline	NN
46745	4361	31	will	will	MD
46745	4361	32	prove	prove	VB
46745	4361	33	purgative	purgative	JJ
46745	4361	34	even	even	RB
46745	4361	35	when	when	WRB
46745	4361	36	largely	largely	RB
46745	4361	37	diluted	diluted	JJ
46745	4361	38	.	.	.
46745	4362	1	(	(	-LRB-
46745	4362	2	_	_	NNP
46745	4362	3	Vide	Vide	NNP
46745	4362	4	_	_	NNP
46745	4362	5	Prop	Prop	NNP
46745	4362	6	.	.	.
46745	4363	1	II	II	NNP
46745	4363	2	.	.	.
46745	4363	3	)	)	-RRB-
46745	4364	1	Thus	thus	RB
46745	4364	2	the	the	DT
46745	4364	3	general	general	JJ
46745	4364	4	rule	rule	NN
46745	4364	5	is	be	VBZ
46745	4364	6	this	this	DT
46745	4364	7	:	:	:
46745	4364	8	soluble	soluble	JJ
46745	4364	9	minerals	mineral	NNS
46745	4364	10	are	be	VBP
46745	4364	11	in	in	IN
46745	4364	12	small	small	JJ
46745	4364	13	doses	dose	NNS
46745	4364	14	Diuretic	Diuretic	NNP
46745	4364	15	,	,	,
46745	4364	16	in	in	IN
46745	4364	17	large	large	JJ
46745	4364	18	quantity	quantity	NN
46745	4364	19	Purgative	purgative	JJ
46745	4364	20	.	.	.
46745	4365	1	This	this	DT
46745	4365	2	applies	apply	VBZ
46745	4365	3	more	more	RBR
46745	4365	4	especially	especially	RB
46745	4365	5	to	to	IN
46745	4365	6	salts	salt	NNS
46745	4365	7	;	;	,
46745	4365	8	for	for	IN
46745	4365	9	mineral	mineral	NNP
46745	4365	10	acids	acids	NNPS
46745	4365	11	act	act	NNP
46745	4365	12	as	as	IN
46745	4365	13	astringents	astringent	NNS
46745	4365	14	on	on	IN
46745	4365	15	the	the	DT
46745	4365	16	bowels,--and	bowels,--and	NNP
46745	4365	17	mineral	mineral	NN
46745	4365	18	alkalies	alkali	NNS
46745	4365	19	,	,	,
46745	4365	20	being	be	VBG
46745	4365	21	corrosive	corrosive	JJ
46745	4365	22	,	,	,
46745	4365	23	can	can	MD
46745	4365	24	not	not	RB
46745	4365	25	be	be	VB
46745	4365	26	given	give	VBN
46745	4365	27	in	in	IN
46745	4365	28	large	large	JJ
46745	4365	29	doses	dose	NNS
46745	4365	30	.	.	.
46745	4366	1	3	3	LS
46745	4366	2	.	.	.
46745	4367	1	_	_	NNP
46745	4367	2	Ammonia	Ammonia	NNP
46745	4367	3	and	and	CC
46745	4367	4	volatile	volatile	JJ
46745	4367	5	oil._--The	oil._--the	CD
46745	4367	6	laws	law	NNS
46745	4367	7	of	of	IN
46745	4367	8	endosmosis	endosmosis	NN
46745	4367	9	favour	favour	VBP
46745	4367	10	the	the	DT
46745	4367	11	passage	passage	NN
46745	4367	12	of	of	IN
46745	4367	13	soluble	soluble	JJ
46745	4367	14	substances	substance	NNS
46745	4367	15	through	through	IN
46745	4367	16	to	to	IN
46745	4367	17	a	a	DT
46745	4367	18	liquid	liquid	JJ
46745	4367	19	secretion	secretion	NN
46745	4367	20	.	.	.
46745	4368	1	They	-PRON-	PRP
46745	4368	2	are	be	VBP
46745	4368	3	dissolved	dissolve	VBN
46745	4368	4	and	and	CC
46745	4368	5	carried	carry	VBN
46745	4368	6	away	away	RB
46745	4368	7	on	on	IN
46745	4368	8	the	the	DT
46745	4368	9	other	other	JJ
46745	4368	10	side	side	NN
46745	4368	11	of	of	IN
46745	4368	12	the	the	DT
46745	4368	13	membrane	membrane	NN
46745	4368	14	through	through	IN
46745	4368	15	which	which	WDT
46745	4368	16	they	-PRON-	PRP
46745	4368	17	pass	pass	VBP
46745	4368	18	.	.	.
46745	4369	1	In	in	IN
46745	4369	2	the	the	DT
46745	4369	3	same	same	JJ
46745	4369	4	way	way	NN
46745	4369	5	it	-PRON-	PRP
46745	4369	6	appears	appear	VBZ
46745	4369	7	that	that	IN
46745	4369	8	volatile	volatile	JJ
46745	4369	9	substances	substance	NNS
46745	4369	10	may	may	MD
46745	4369	11	dissolve	dissolve	VB
46745	4369	12	in	in	RB
46745	4369	13	,	,	,
46745	4369	14	and	and	CC
46745	4369	15	be	be	VB
46745	4369	16	carried	carry	VBN
46745	4369	17	away	away	RP
46745	4369	18	by	by	RB
46745	4369	19	,	,	,
46745	4369	20	air	air	NN
46745	4369	21	.	.	.
46745	4370	1	Thus	thus	RB
46745	4370	2	they	-PRON-	PRP
46745	4370	3	have	have	VBP
46745	4370	4	a	a	DT
46745	4370	5	tendency	tendency	NN
46745	4370	6	towards	towards	IN
46745	4370	7	the	the	DT
46745	4370	8	aeriform	aeriform	NN
46745	4370	9	secretions	secretion	NNS
46745	4370	10	.	.	.
46745	4371	1	These	these	DT
46745	4371	2	are,--the	are,--the	RB
46745	4371	3	expired	expire	VBD
46745	4371	4	air	air	NN
46745	4371	5	,	,	,
46745	4371	6	or	or	CC
46745	4371	7	the	the	DT
46745	4371	8	secretion	secretion	NN
46745	4371	9	of	of	IN
46745	4371	10	the	the	DT
46745	4371	11	air	air	NN
46745	4371	12	-	-	HYPH
46745	4371	13	cells	cell	NNS
46745	4371	14	of	of	IN
46745	4371	15	the	the	DT
46745	4371	16	lungs,--and	lungs,--and	NNP
46745	4371	17	the	the	DT
46745	4371	18	ordinary	ordinary	JJ
46745	4371	19	cutaneous	cutaneous	JJ
46745	4371	20	transpiration	transpiration	NN
46745	4371	21	.	.	.
46745	4372	1	While	while	IN
46745	4372	2	passing	pass	VBG
46745	4372	3	through	through	IN
46745	4372	4	the	the	DT
46745	4372	5	air	air	NN
46745	4372	6	-	-	HYPH
46745	4372	7	cells	cell	NNS
46745	4372	8	,	,	,
46745	4372	9	these	these	DT
46745	4372	10	matters	matter	NNS
46745	4372	11	stimulate	stimulate	VBP
46745	4372	12	the	the	DT
46745	4372	13	secretion	secretion	NN
46745	4372	14	of	of	IN
46745	4372	15	the	the	DT
46745	4372	16	lining	line	VBG
46745	4372	17	mucous	mucous	JJ
46745	4372	18	membrane	membrane	NN
46745	4372	19	.	.	.
46745	4373	1	They	-PRON-	PRP
46745	4373	2	cause	cause	VBP
46745	4373	3	a	a	DT
46745	4373	4	morbid	morbid	NN
46745	4373	5	secretion	secretion	NN
46745	4373	6	of	of	IN
46745	4373	7	this	this	DT
46745	4373	8	surface	surface	NN
46745	4373	9	to	to	TO
46745	4373	10	be	be	VB
46745	4373	11	replaced	replace	VBN
46745	4373	12	by	by	IN
46745	4373	13	a	a	DT
46745	4373	14	more	more	RBR
46745	4373	15	natural	natural	JJ
46745	4373	16	one	one	CD
46745	4373	17	.	.	.
46745	4374	1	Thus	thus	RB
46745	4374	2	Ammonia	Ammonia	NNP
46745	4374	3	and	and	CC
46745	4374	4	volatile	volatile	JJ
46745	4374	5	oils	oil	NNS
46745	4374	6	are	be	VBP
46745	4374	7	Expectorant	expectorant	JJ
46745	4374	8	and	and	CC
46745	4374	9	Diaphoretic	diaphoretic	JJ
46745	4374	10	.	.	.
46745	4375	1	They	-PRON-	PRP
46745	4375	2	may	may	MD
46745	4375	3	all	all	DT
46745	4375	4	pass	pass	VB
46745	4375	5	out	out	RP
46745	4375	6	in	in	IN
46745	4375	7	the	the	DT
46745	4375	8	urine	urine	NN
46745	4375	9	,	,	,
46745	4375	10	but	but	CC
46745	4375	11	do	do	VBP
46745	4375	12	not	not	RB
46745	4375	13	especially	especially	RB
46745	4375	14	tend	tend	VB
46745	4375	15	to	to	TO
46745	4375	16	do	do	VB
46745	4375	17	so	so	RB
46745	4375	18	,	,	,
46745	4375	19	with	with	IN
46745	4375	20	the	the	DT
46745	4375	21	exception	exception	NN
46745	4375	22	of	of	IN
46745	4375	23	some	some	DT
46745	4375	24	that	that	WDT
46745	4375	25	are	be	VBP
46745	4375	26	acrid	acrid	JJ
46745	4375	27	,	,	,
46745	4375	28	and	and	CC
46745	4375	29	approach	approach	VB
46745	4375	30	to	to	IN
46745	4375	31	the	the	DT
46745	4375	32	nature	nature	NN
46745	4375	33	of	of	IN
46745	4375	34	the	the	DT
46745	4375	35	resinous	resinous	JJ
46745	4375	36	group	group	NN
46745	4375	37	.	.	.
46745	4376	1	Turpentine	turpentine	NN
46745	4376	2	,	,	,
46745	4376	3	Juniper	Juniper	NNP
46745	4376	4	,	,	,
46745	4376	5	and	and	CC
46745	4376	6	Copaiba	Copaiba	NNP
46745	4376	7	,	,	,
46745	4376	8	are	be	VBP
46745	4376	9	Diuretic	diuretic	JJ
46745	4376	10	.	.	.
46745	4377	1	4	4	LS
46745	4377	2	.	.	.
46745	4378	1	_	_	NNP
46745	4378	2	Acrid	Acrid	NNP
46745	4378	3	fixed	fix	VBN
46745	4378	4	oils._--Such	oils._--Such	''
46745	4378	5	are	be	VBP
46745	4378	6	Castor	Castor	NNP
46745	4378	7	and	and	CC
46745	4378	8	Croton	Croton	NNP
46745	4378	9	Oils	Oils	NNPS
46745	4378	10	;	;	:
46745	4378	11	they	-PRON-	PRP
46745	4378	12	are	be	VBP
46745	4378	13	Purgatives	purgative	NNS
46745	4378	14	,	,	,
46745	4378	15	passing	pass	VBG
46745	4378	16	off	off	RP
46745	4378	17	by	by	IN
46745	4378	18	the	the	DT
46745	4378	19	bowels	bowel	NNS
46745	4378	20	.	.	.
46745	4379	1	5	5	CD
46745	4379	2	.	.	.
46745	4380	1	_	_	NNP
46745	4380	2	Resinous	Resinous	NNP
46745	4380	3	and	and	CC
46745	4380	4	neutral	neutral	JJ
46745	4380	5	acrid	acrid	NN
46745	4380	6	principles._--These	principles._--These	NNPS
46745	4380	7	are	be	VBP
46745	4380	8	soluble	soluble	JJ
46745	4380	9	in	in	IN
46745	4380	10	alkalies	alkali	NNS
46745	4380	11	,	,	,
46745	4380	12	and	and	CC
46745	4380	13	thus	thus	RB
46745	4380	14	partly	partly	RB
46745	4380	15	absorbed	absorb	VBN
46745	4380	16	in	in	IN
46745	4380	17	the	the	DT
46745	4380	18	intestinal	intestinal	JJ
46745	4380	19	canal	canal	NN
46745	4380	20	.	.	.
46745	4381	1	Most	Most	JJS
46745	4381	2	of	of	IN
46745	4381	3	them	-PRON-	PRP
46745	4381	4	are	be	VBP
46745	4381	5	Cathartic	cathartic	JJ
46745	4381	6	,	,	,
46745	4381	7	whether	whether	IN
46745	4381	8	introduced	introduce	VBN
46745	4381	9	into	into	IN
46745	4381	10	the	the	DT
46745	4381	11	stomach	stomach	NN
46745	4381	12	or	or	CC
46745	4381	13	injected	inject	VBN
46745	4381	14	into	into	IN
46745	4381	15	the	the	DT
46745	4381	16	veins	vein	NNS
46745	4381	17	.	.	.
46745	4382	1	Such	such	JJ
46745	4382	2	are	be	VBP
46745	4382	3	the	the	DT
46745	4382	4	resins	resin	NNS
46745	4382	5	of	of	IN
46745	4382	6	Scammony	Scammony	NNP
46745	4382	7	,	,	,
46745	4382	8	Jalap	Jalap	NNP
46745	4382	9	,	,	,
46745	4382	10	and	and	CC
46745	4382	11	Gamboge	Gamboge	NNP
46745	4382	12	,	,	,
46745	4382	13	and	and	CC
46745	4382	14	the	the	DT
46745	4382	15	principles	principle	NNS
46745	4382	16	of	of	IN
46745	4382	17	Colocynth	Colocynth	NNP
46745	4382	18	and	and	CC
46745	4382	19	Elaterium	Elaterium	NNP
46745	4382	20	.	.	.
46745	4383	1	Some	some	DT
46745	4383	2	few	few	JJ
46745	4383	3	of	of	IN
46745	4383	4	them	-PRON-	PRP
46745	4383	5	are	be	VBP
46745	4383	6	Diaphoretic	diaphoretic	JJ
46745	4383	7	,	,	,
46745	4383	8	as	as	IN
46745	4383	9	Guaiacum	Guaiacum	NNP
46745	4383	10	and	and	CC
46745	4383	11	Mezereon	Mezereon	NNP
46745	4383	12	.	.	.
46745	4384	1	Some	some	DT
46745	4384	2	again	again	RB
46745	4384	3	are	be	VBP
46745	4384	4	Diuretic	diuretic	JJ
46745	4384	5	,	,	,
46745	4384	6	especially	especially	RB
46745	4384	7	those	those	DT
46745	4384	8	which	which	WDT
46745	4384	9	are	be	VBP
46745	4384	10	liquid	liquid	JJ
46745	4384	11	or	or	CC
46745	4384	12	associated	associate	VBN
46745	4384	13	with	with	IN
46745	4384	14	a	a	DT
46745	4384	15	volatile	volatile	JJ
46745	4384	16	oil	oil	NN
46745	4384	17	,	,	,
46745	4384	18	which	which	WDT
46745	4384	19	is	be	VBZ
46745	4384	20	the	the	DT
46745	4384	21	case	case	NN
46745	4384	22	with	with	IN
46745	4384	23	Copaiba	Copaiba	NNP
46745	4384	24	,	,	,
46745	4384	25	Cubebs	Cubebs	NNP
46745	4384	26	,	,	,
46745	4384	27	Cantharides	Cantharides	NNPS
46745	4384	28	,	,	,
46745	4384	29	and	and	CC
46745	4384	30	others	other	NNS
46745	4384	31	.	.	.
46745	4385	1	6	6	CD
46745	4385	2	.	.	.
46745	4386	1	_	_	NNP
46745	4386	2	Vegetable	Vegetable	NNP
46745	4386	3	principles	principle	NNS
46745	4386	4	soluble	soluble	JJ
46745	4386	5	in	in	IN
46745	4386	6	water._--Most	water._--most	NN
46745	4386	7	of	of	IN
46745	4386	8	these	these	DT
46745	4386	9	are	be	VBP
46745	4386	10	Diuretic	diuretic	JJ
46745	4386	11	;	;	:
46745	4386	12	as	as	IN
46745	4386	13	are	be	VBP
46745	4386	14	the	the	DT
46745	4386	15	Vegetable	Vegetable	NNP
46745	4386	16	Acids	Acids	NNP
46745	4386	17	,	,	,
46745	4386	18	and	and	CC
46745	4386	19	the	the	DT
46745	4386	20	Alkaloids	alkaloid	NNS
46745	4386	21	of	of	IN
46745	4386	22	Digitalis	Digitalis	NNP
46745	4386	23	,	,	,
46745	4386	24	Tobacco	Tobacco	NNP
46745	4386	25	,	,	,
46745	4386	26	and	and	CC
46745	4386	27	Colchicum	Colchicum	NNP
46745	4386	28	.	.	.
46745	4387	1	So	so	RB
46745	4387	2	also	also	RB
46745	4387	3	are	be	VBP
46745	4387	4	the	the	DT
46745	4387	5	principles	principle	NNS
46745	4387	6	of	of	IN
46745	4387	7	Broom	Broom	NNP
46745	4387	8	and	and	CC
46745	4387	9	Sarsaparilla	Sarsaparilla	NNP
46745	4387	10	.	.	.
46745	4388	1	The	the	DT
46745	4388	2	Emetine	Emetine	NNP
46745	4388	3	in	in	IN
46745	4388	4	Ipecacuanha	Ipecacuanha	NNP
46745	4388	5	,	,	,
46745	4388	6	and	and	CC
46745	4388	7	the	the	DT
46745	4388	8	Morphia	Morphia	NNP
46745	4388	9	in	in	IN
46745	4388	10	Opium	Opium	NNP
46745	4388	11	,	,	,
46745	4388	12	act	act	VB
46745	4388	13	on	on	IN
46745	4388	14	the	the	DT
46745	4388	15	skin	skin	NN
46745	4388	16	.	.	.
46745	4389	1	Aloesin	Aloesin	NNP
46745	4389	2	,	,	,
46745	4389	3	the	the	DT
46745	4389	4	principle	principle	NN
46745	4389	5	of	of	IN
46745	4389	6	Aloes	Aloes	NNP
46745	4389	7	,	,	,
46745	4389	8	is	be	VBZ
46745	4389	9	purgative	purgative	JJ
46745	4389	10	.	.	.
46745	4390	1	So	so	RB
46745	4390	2	is	be	VBZ
46745	4390	3	Cathartin	Cathartin	NNP
46745	4390	4	,	,	,
46745	4390	5	the	the	DT
46745	4390	6	soluble	soluble	JJ
46745	4390	7	acrid	acrid	JJ
46745	4390	8	principle	principle	NN
46745	4390	9	of	of	IN
46745	4390	10	Senna	Senna	NNP
46745	4390	11	.	.	.
46745	4391	1	Having	have	VBG
46745	4391	2	thus	thus	RB
46745	4391	3	briefly	briefly	RB
46745	4391	4	sketched	sketch	VBN
46745	4391	5	out	out	RP
46745	4391	6	the	the	DT
46745	4391	7	particular	particular	JJ
46745	4391	8	tendencies	tendency	NNS
46745	4391	9	in	in	IN
46745	4391	10	the	the	DT
46745	4391	11	operation	operation	NN
46745	4391	12	of	of	IN
46745	4391	13	the	the	DT
46745	4391	14	groups	group	NNS
46745	4391	15	of	of	IN
46745	4391	16	medicines	medicine	NNS
46745	4391	17	which	which	WDT
46745	4391	18	act	act	VBP
46745	4391	19	on	on	IN
46745	4391	20	the	the	DT
46745	4391	21	glands	gland	NNS
46745	4391	22	,	,	,
46745	4391	23	it	-PRON-	PRP
46745	4391	24	remains	remain	VBZ
46745	4391	25	for	for	IN
46745	4391	26	me	-PRON-	PRP
46745	4391	27	to	to	TO
46745	4391	28	say	say	VB
46745	4391	29	that	that	IN
46745	4391	30	in	in	IN
46745	4391	31	very	very	RB
46745	4391	32	many	many	JJ
46745	4391	33	cases	case	NNS
46745	4391	34	these	these	DT
46745	4391	35	medicines	medicine	NNS
46745	4391	36	have	have	VBP
46745	4391	37	actually	actually	RB
46745	4391	38	been	be	VBN
46745	4391	39	proved	prove	VBN
46745	4391	40	to	to	TO
46745	4391	41	pass	pass	VB
46745	4391	42	out	out	IN
46745	4391	43	of	of	IN
46745	4391	44	the	the	DT
46745	4391	45	body	body	NN
46745	4391	46	by	by	IN
46745	4391	47	the	the	DT
46745	4391	48	glands	gland	NNS
46745	4391	49	whose	whose	WP$
46745	4391	50	secretions	secretion	NNS
46745	4391	51	they	-PRON-	PRP
46745	4391	52	tend	tend	VBP
46745	4391	53	to	to	TO
46745	4391	54	increase	increase	VB
46745	4391	55	.	.	.
46745	4392	1	Whenever	whenever	WRB
46745	4392	2	we	-PRON-	PRP
46745	4392	3	are	be	VBP
46745	4392	4	in	in	IN
46745	4392	5	a	a	DT
46745	4392	6	position	position	NN
46745	4392	7	to	to	TO
46745	4392	8	inquire	inquire	VB
46745	4392	9	into	into	IN
46745	4392	10	the	the	DT
46745	4392	11	facts	fact	NNS
46745	4392	12	by	by	IN
46745	4392	13	chemical	chemical	NN
46745	4392	14	or	or	CC
46745	4392	15	other	other	JJ
46745	4392	16	means	mean	NNS
46745	4392	17	,	,	,
46745	4392	18	we	-PRON-	PRP
46745	4392	19	find	find	VBP
46745	4392	20	that	that	IN
46745	4392	21	the	the	DT
46745	4392	22	Eliminative	eliminative	JJ
46745	4392	23	medicine	medicine	NN
46745	4392	24	is	be	VBZ
46745	4392	25	itself	-PRON-	PRP
46745	4392	26	contained	contain	VBN
46745	4392	27	in	in	IN
46745	4392	28	the	the	DT
46745	4392	29	secretion	secretion	NN
46745	4392	30	which	which	WDT
46745	4392	31	is	be	VBZ
46745	4392	32	augmented	augment	VBN
46745	4392	33	by	by	IN
46745	4392	34	its	-PRON-	PRP$
46745	4392	35	action	action	NN
46745	4392	36	,	,	,
46745	4392	37	and	and	CC
46745	4392	38	that	that	IN
46745	4392	39	when	when	WRB
46745	4392	40	the	the	DT
46745	4392	41	secretion	secretion	NN
46745	4392	42	upon	upon	IN
46745	4392	43	which	which	WDT
46745	4392	44	it	-PRON-	PRP
46745	4392	45	usually	usually	RB
46745	4392	46	acts	act	VBZ
46745	4392	47	is	be	VBZ
46745	4392	48	not	not	RB
46745	4392	49	augmented	augment	VBN
46745	4392	50	,	,	,
46745	4392	51	the	the	DT
46745	4392	52	medicine	medicine	NN
46745	4392	53	has	have	VBZ
46745	4392	54	passed	pass	VBN
46745	4392	55	off	off	RP
46745	4392	56	by	by	IN
46745	4392	57	some	some	DT
46745	4392	58	other	other	JJ
46745	4392	59	secretion	secretion	NN
46745	4392	60	instead	instead	RB
46745	4392	61	.	.	.
46745	4393	1	There	there	EX
46745	4393	2	are	be	VBP
46745	4393	3	doubtless	doubtless	RB
46745	4393	4	many	many	JJ
46745	4393	5	cases	case	NNS
46745	4393	6	in	in	IN
46745	4393	7	which	which	WDT
46745	4393	8	no	no	DT
46745	4393	9	inquiry	inquiry	NN
46745	4393	10	of	of	IN
46745	4393	11	the	the	DT
46745	4393	12	kind	kind	NN
46745	4393	13	has	have	VBZ
46745	4393	14	been	be	VBN
46745	4393	15	yet	yet	RB
46745	4393	16	made	make	VBN
46745	4393	17	;	;	:
46745	4393	18	but	but	CC
46745	4393	19	it	-PRON-	PRP
46745	4393	20	will	will	MD
46745	4393	21	be	be	VB
46745	4393	22	seen	see	VBN
46745	4393	23	when	when	WRB
46745	4393	24	we	-PRON-	PRP
46745	4393	25	consider	consider	VBP
46745	4393	26	separately	separately	RB
46745	4393	27	the	the	DT
46745	4393	28	Eliminative	eliminative	JJ
46745	4393	29	orders	order	NNS
46745	4393	30	,	,	,
46745	4393	31	that	that	IN
46745	4393	32	all	all	DT
46745	4393	33	that	that	WDT
46745	4393	34	is	be	VBZ
46745	4393	35	known	know	VBN
46745	4393	36	on	on	IN
46745	4393	37	the	the	DT
46745	4393	38	subject	subject	NN
46745	4393	39	is	be	VBZ
46745	4393	40	in	in	IN
46745	4393	41	favour	favour	NN
46745	4393	42	of	of	IN
46745	4393	43	the	the	DT
46745	4393	44	above	above	JJ
46745	4393	45	statement	statement	NN
46745	4393	46	.	.	.
46745	4394	1	Assuming	assume	VBG
46745	4394	2	,	,	,
46745	4394	3	then	then	RB
46745	4394	4	,	,	,
46745	4394	5	the	the	DT
46745	4394	6	third	third	JJ
46745	4394	7	and	and	CC
46745	4394	8	fourth	fourth	JJ
46745	4394	9	minor	minor	JJ
46745	4394	10	propositions	proposition	NNS
46745	4394	11	together	together	RB
46745	4394	12	,	,	,
46745	4394	13	we	-PRON-	PRP
46745	4394	14	conclude	conclude	VBP
46745	4394	15	that	that	IN
46745	4394	16	Eliminative	eliminative	JJ
46745	4394	17	medicines	medicine	NNS
46745	4394	18	,	,	,
46745	4394	19	which	which	WDT
46745	4394	20	must	must	MD
46745	4394	21	pass	pass	VB
46745	4394	22	out	out	IN
46745	4394	23	of	of	IN
46745	4394	24	the	the	DT
46745	4394	25	blood	blood	NN
46745	4394	26	,	,	,
46745	4394	27	tend	tend	VBP
46745	4394	28	to	to	TO
46745	4394	29	pass	pass	VB
46745	4394	30	out	out	RP
46745	4394	31	by	by	IN
46745	4394	32	some	some	DT
46745	4394	33	glands	gland	NNS
46745	4394	34	more	more	RBR
46745	4394	35	than	than	IN
46745	4394	36	by	by	IN
46745	4394	37	others	other	NNS
46745	4394	38	,	,	,
46745	4394	39	and	and	CC
46745	4394	40	that	that	IN
46745	4394	41	the	the	DT
46745	4394	42	result	result	NN
46745	4394	43	of	of	IN
46745	4394	44	their	-PRON-	PRP$
46745	4394	45	passage	passage	NN
46745	4394	46	through	through	IN
46745	4394	47	a	a	DT
46745	4394	48	gland	gland	NN
46745	4394	49	is	be	VBZ
46745	4394	50	to	to	TO
46745	4394	51	increase	increase	VB
46745	4394	52	its	-PRON-	PRP$
46745	4394	53	secretion	secretion	NN
46745	4394	54	.	.	.
46745	4395	1	They	-PRON-	PRP
46745	4395	2	do	do	VBP
46745	4395	3	not	not	RB
46745	4395	4	exert	exert	VB
46745	4395	5	a	a	DT
46745	4395	6	blood	blood	NN
46745	4395	7	-	-	HYPH
46745	4395	8	influence	influence	NN
46745	4395	9	,	,	,
46745	4395	10	nor	nor	CC
46745	4395	11	do	do	VBP
46745	4395	12	they	-PRON-	PRP
46745	4395	13	act	act	VB
46745	4395	14	on	on	IN
46745	4395	15	the	the	DT
46745	4395	16	nervous	nervous	JJ
46745	4395	17	functions	function	NNS
46745	4395	18	;	;	:
46745	4395	19	but	but	CC
46745	4395	20	they	-PRON-	PRP
46745	4395	21	operate	operate	VBP
46745	4395	22	on	on	IN
46745	4395	23	those	those	DT
46745	4395	24	obscure	obscure	JJ
46745	4395	25	vital	vital	JJ
46745	4395	26	forces	force	NNS
46745	4395	27	by	by	IN
46745	4395	28	which	which	WDT
46745	4395	29	secretion	secretion	NN
46745	4395	30	is	be	VBZ
46745	4395	31	directed	direct	VBN
46745	4395	32	and	and	CC
46745	4395	33	controlled	control	VBN
46745	4395	34	.	.	.
46745	4396	1	The	the	DT
46745	4396	2	fifth	fifth	JJ
46745	4396	3	minor	minor	JJ
46745	4396	4	proposition	proposition	NN
46745	4396	5	treats	treat	NNS
46745	4396	6	of	of	IN
46745	4396	7	the	the	DT
46745	4396	8	application	application	NN
46745	4396	9	of	of	IN
46745	4396	10	these	these	DT
46745	4396	11	agents	agent	NNS
46745	4396	12	in	in	IN
46745	4396	13	the	the	DT
46745	4396	14	treatment	treatment	NN
46745	4396	15	of	of	IN
46745	4396	16	disease	disease	NN
46745	4396	17	.	.	.
46745	4397	1	They	-PRON-	PRP
46745	4397	2	are	be	VBP
46745	4397	3	of	of	IN
46745	4397	4	use	use	NN
46745	4397	5	when	when	WRB
46745	4397	6	it	-PRON-	PRP
46745	4397	7	is	be	VBZ
46745	4397	8	requisite	requisite	JJ
46745	4397	9	that	that	IN
46745	4397	10	the	the	DT
46745	4397	11	function	function	NN
46745	4397	12	of	of	IN
46745	4397	13	a	a	DT
46745	4397	14	gland	gland	NN
46745	4397	15	should	should	MD
46745	4397	16	be	be	VB
46745	4397	17	restored	restore	VBN
46745	4397	18	or	or	CC
46745	4397	19	promoted	promote	VBN
46745	4397	20	.	.	.
46745	4398	1	There	there	EX
46745	4398	2	is	be	VBZ
46745	4398	3	scarcely	scarcely	RB
46745	4398	4	any	any	DT
46745	4398	5	disease	disease	NN
46745	4398	6	in	in	IN
46745	4398	7	which	which	WDT
46745	4398	8	some	some	DT
46745	4398	9	or	or	CC
46745	4398	10	other	other	JJ
46745	4398	11	of	of	IN
46745	4398	12	them	-PRON-	PRP
46745	4398	13	may	may	MD
46745	4398	14	not	not	RB
46745	4398	15	be	be	VB
46745	4398	16	of	of	IN
46745	4398	17	service	service	NN
46745	4398	18	.	.	.
46745	4399	1	Their	-PRON-	PRP$
46745	4399	2	remedial	remedial	JJ
46745	4399	3	applications	application	NNS
46745	4399	4	are	be	VBP
46745	4399	5	many	many	JJ
46745	4399	6	and	and	CC
46745	4399	7	important	important	JJ
46745	4399	8	.	.	.
46745	4400	1	Eliminatives	eliminative	NNS
46745	4400	2	are	be	VBP
46745	4400	3	used	use	VBN
46745	4400	4	to	to	TO
46745	4400	5	restore	restore	VB
46745	4400	6	the	the	DT
46745	4400	7	function	function	NN
46745	4400	8	of	of	IN
46745	4400	9	a	a	DT
46745	4400	10	gland	gland	NN
46745	4400	11	when	when	WRB
46745	4400	12	impaired	impair	VBN
46745	4400	13	.	.	.
46745	4401	1	With	with	IN
46745	4401	2	this	this	DT
46745	4401	3	view	view	NN
46745	4401	4	,	,	,
46745	4401	5	Cathartics	cathartic	NNS
46745	4401	6	are	be	VBP
46745	4401	7	employed	employ	VBN
46745	4401	8	in	in	IN
46745	4401	9	constipation	constipation	NN
46745	4401	10	,	,	,
46745	4401	11	Diaphoretics	diaphoretic	NNS
46745	4401	12	for	for	IN
46745	4401	13	dryness	dryness	NN
46745	4401	14	of	of	IN
46745	4401	15	skin	skin	NN
46745	4401	16	,	,	,
46745	4401	17	Cholagogues	Cholagogues	NNPS
46745	4401	18	in	in	IN
46745	4401	19	torpid	torpid	JJ
46745	4401	20	states	state	NNS
46745	4401	21	of	of	IN
46745	4401	22	the	the	DT
46745	4401	23	liver	liver	NN
46745	4401	24	.	.	.
46745	4402	1	They	-PRON-	PRP
46745	4402	2	may	may	MD
46745	4402	3	eliminate	eliminate	VB
46745	4402	4	a	a	DT
46745	4402	5	poison	poison	NN
46745	4402	6	or	or	CC
46745	4402	7	morbid	morbid	NN
46745	4402	8	material	material	NN
46745	4402	9	,	,	,
46745	4402	10	and	and	CC
46745	4402	11	thus	thus	RB
46745	4402	12	resolve	resolve	VB
46745	4402	13	a	a	DT
46745	4402	14	disease	disease	NN
46745	4402	15	.	.	.
46745	4403	1	This	this	DT
46745	4403	2	probably	probably	RB
46745	4403	3	is	be	VBZ
46745	4403	4	the	the	DT
46745	4403	5	rational	rational	JJ
46745	4403	6	explanation	explanation	NN
46745	4403	7	of	of	IN
46745	4403	8	the	the	DT
46745	4403	9	use	use	NN
46745	4403	10	of	of	IN
46745	4403	11	Diaphoretics	Diaphoretics	NNPS
46745	4403	12	and	and	CC
46745	4403	13	Diuretics	Diuretics	NNPS
46745	4403	14	in	in	IN
46745	4403	15	Fevers	Fevers	NNP
46745	4403	16	,	,	,
46745	4403	17	Gout	Gout	NNP
46745	4403	18	,	,	,
46745	4403	19	and	and	CC
46745	4403	20	Rheumatism	Rheumatism	NNP
46745	4403	21	,	,	,
46745	4403	22	and	and	CC
46745	4403	23	of	of	IN
46745	4403	24	purgative	purgative	JJ
46745	4403	25	medicines	medicine	NNS
46745	4403	26	in	in	IN
46745	4403	27	a	a	DT
46745	4403	28	great	great	JJ
46745	4403	29	number	number	NN
46745	4403	30	of	of	IN
46745	4403	31	disorders	disorder	NNS
46745	4403	32	.	.	.
46745	4404	1	We	-PRON-	PRP
46745	4404	2	may	may	MD
46745	4404	3	,	,	,
46745	4404	4	by	by	IN
46745	4404	5	an	an	DT
46745	4404	6	action	action	NN
46745	4404	7	on	on	IN
46745	4404	8	one	one	CD
46745	4404	9	gland	gland	NN
46745	4404	10	,	,	,
46745	4404	11	be	be	VB
46745	4404	12	enabled	enable	VBN
46745	4404	13	to	to	TO
46745	4404	14	replace	replace	VB
46745	4404	15	the	the	DT
46745	4404	16	function	function	NN
46745	4404	17	of	of	IN
46745	4404	18	another	another	DT
46745	4404	19	gland	gland	NN
46745	4404	20	.	.	.
46745	4405	1	The	the	DT
46745	4405	2	amount	amount	NN
46745	4405	3	of	of	IN
46745	4405	4	each	each	DT
46745	4405	5	secretion	secretion	NN
46745	4405	6	bears	bear	VBZ
46745	4405	7	more	more	RBR
46745	4405	8	or	or	CC
46745	4405	9	less	less	RBR
46745	4405	10	an	an	DT
46745	4405	11	inverse	inverse	JJ
46745	4405	12	proportion	proportion	NN
46745	4405	13	to	to	IN
46745	4405	14	that	that	DT
46745	4405	15	of	of	IN
46745	4405	16	other	other	JJ
46745	4405	17	secretions	secretion	NNS
46745	4405	18	.	.	.
46745	4406	1	Thus	thus	RB
46745	4406	2	when	when	WRB
46745	4406	3	one	one	CD
46745	4406	4	of	of	IN
46745	4406	5	them	-PRON-	PRP
46745	4406	6	is	be	VBZ
46745	4406	7	unduly	unduly	RB
46745	4406	8	copious	copious	JJ
46745	4406	9	,	,	,
46745	4406	10	we	-PRON-	PRP
46745	4406	11	may	may	MD
46745	4406	12	diminish	diminish	VB
46745	4406	13	it	-PRON-	PRP
46745	4406	14	by	by	IN
46745	4406	15	stimulating	stimulate	VBG
46745	4406	16	the	the	DT
46745	4406	17	formation	formation	NN
46745	4406	18	of	of	IN
46745	4406	19	another	another	DT
46745	4406	20	.	.	.
46745	4407	1	In	in	IN
46745	4407	2	other	other	JJ
46745	4407	3	cases	case	NNS
46745	4407	4	the	the	DT
46745	4407	5	reverse	reverse	JJ
46745	4407	6	condition	condition	NN
46745	4407	7	may	may	MD
46745	4407	8	occur	occur	VB
46745	4407	9	;	;	:
46745	4407	10	one	one	CD
46745	4407	11	of	of	IN
46745	4407	12	the	the	DT
46745	4407	13	secretions	secretion	NNS
46745	4407	14	may	may	MD
46745	4407	15	be	be	VB
46745	4407	16	diminished	diminish	VBN
46745	4407	17	or	or	CC
46745	4407	18	suppressed	suppress	VBN
46745	4407	19	by	by	IN
46745	4407	20	a	a	DT
46745	4407	21	cause	cause	NN
46745	4407	22	over	over	IN
46745	4407	23	which	which	WDT
46745	4407	24	we	-PRON-	PRP
46745	4407	25	have	have	VBP
46745	4407	26	no	no	DT
46745	4407	27	control	control	NN
46745	4407	28	,	,	,
46745	4407	29	and	and	CC
46745	4407	30	the	the	DT
46745	4407	31	matters	matter	NNS
46745	4407	32	which	which	WDT
46745	4407	33	should	should	MD
46745	4407	34	be	be	VB
46745	4407	35	contained	contain	VBN
46745	4407	36	in	in	IN
46745	4407	37	it	-PRON-	PRP
46745	4407	38	may	may	MD
46745	4407	39	be	be	VB
46745	4407	40	left	leave	VBN
46745	4407	41	in	in	IN
46745	4407	42	the	the	DT
46745	4407	43	blood	blood	NN
46745	4407	44	,	,	,
46745	4407	45	causing	cause	VBG
46745	4407	46	various	various	JJ
46745	4407	47	mischief	mischief	NN
46745	4407	48	there	there	RB
46745	4407	49	.	.	.
46745	4408	1	Here	here	RB
46745	4408	2	again	again	RB
46745	4408	3	,	,	,
46745	4408	4	by	by	IN
46745	4408	5	increasing	increase	VBG
46745	4408	6	one	one	CD
46745	4408	7	of	of	IN
46745	4408	8	the	the	DT
46745	4408	9	other	other	JJ
46745	4408	10	secretions	secretion	NNS
46745	4408	11	,	,	,
46745	4408	12	we	-PRON-	PRP
46745	4408	13	may	may	MD
46745	4408	14	replace	replace	VB
46745	4408	15	the	the	DT
46745	4408	16	function	function	NN
46745	4408	17	of	of	IN
46745	4408	18	the	the	DT
46745	4408	19	diseased	diseased	JJ
46745	4408	20	gland	gland	NN
46745	4408	21	,	,	,
46745	4408	22	and	and	CC
46745	4408	23	cause	cause	VB
46745	4408	24	the	the	DT
46745	4408	25	elimination	elimination	NN
46745	4408	26	of	of	IN
46745	4408	27	these	these	DT
46745	4408	28	products	product	NNS
46745	4408	29	from	from	IN
46745	4408	30	the	the	DT
46745	4408	31	body	body	NN
46745	4408	32	by	by	IN
46745	4408	33	another	another	DT
46745	4408	34	channel	channel	NN
46745	4408	35	.	.	.
46745	4409	1	Fourthly	fourthly	RB
46745	4409	2	,	,	,
46745	4409	3	Eliminative	eliminative	JJ
46745	4409	4	medicines	medicine	NNS
46745	4409	5	may	may	MD
46745	4409	6	be	be	VB
46745	4409	7	of	of	IN
46745	4409	8	service	service	NN
46745	4409	9	by	by	IN
46745	4409	10	draining	drain	VBG
46745	4409	11	away	away	RB
46745	4409	12	from	from	IN
46745	4409	13	the	the	DT
46745	4409	14	blood	blood	NN
46745	4409	15	fluid	fluid	NN
46745	4409	16	and	and	CC
46745	4409	17	solid	solid	JJ
46745	4409	18	matters	matter	NNS
46745	4409	19	.	.	.
46745	4410	1	The	the	DT
46745	4410	2	first	first	JJ
46745	4410	3	result	result	NN
46745	4410	4	of	of	IN
46745	4410	5	their	-PRON-	PRP$
46745	4410	6	action	action	NN
46745	4410	7	is	be	VBZ
46745	4410	8	to	to	TO
46745	4410	9	stimulate	stimulate	VB
46745	4410	10	the	the	DT
46745	4410	11	proper	proper	JJ
46745	4410	12	secretion	secretion	NN
46745	4410	13	of	of	IN
46745	4410	14	a	a	DT
46745	4410	15	gland	gland	NN
46745	4410	16	;	;	:
46745	4410	17	but	but	CC
46745	4410	18	when	when	WRB
46745	4410	19	it	-PRON-	PRP
46745	4410	20	is	be	VBZ
46745	4410	21	pushed	push	VBN
46745	4410	22	to	to	IN
46745	4410	23	a	a	DT
46745	4410	24	further	further	JJ
46745	4410	25	extent	extent	NN
46745	4410	26	,	,	,
46745	4410	27	they	-PRON-	PRP
46745	4410	28	may	may	MD
46745	4410	29	actually	actually	RB
46745	4410	30	case	case	VB
46745	4410	31	the	the	DT
46745	4410	32	excretion	excretion	NN
46745	4410	33	of	of	IN
46745	4410	34	some	some	DT
46745	4410	35	of	of	IN
46745	4410	36	the	the	DT
46745	4410	37	natural	natural	JJ
46745	4410	38	constituents	constituent	NNS
46745	4410	39	of	of	IN
46745	4410	40	the	the	DT
46745	4410	41	blood	blood	NN
46745	4410	42	.	.	.
46745	4411	1	Thus	thus	RB
46745	4411	2	by	by	IN
46745	4411	3	an	an	DT
46745	4411	4	action	action	NN
46745	4411	5	on	on	IN
46745	4411	6	the	the	DT
46745	4411	7	skin	skin	NN
46745	4411	8	or	or	CC
46745	4411	9	the	the	DT
46745	4411	10	kidneys	kidney	NNS
46745	4411	11	,	,	,
46745	4411	12	we	-PRON-	PRP
46745	4411	13	may	may	MD
46745	4411	14	cause	cause	VB
46745	4411	15	a	a	DT
46745	4411	16	copious	copious	JJ
46745	4411	17	evacuation	evacuation	NN
46745	4411	18	of	of	IN
46745	4411	19	water	water	NN
46745	4411	20	,	,	,
46745	4411	21	holding	hold	VBG
46745	4411	22	in	in	IN
46745	4411	23	solution	solution	NN
46745	4411	24	saline	saline	NN
46745	4411	25	matters	matter	NNS
46745	4411	26	.	.	.
46745	4412	1	By	by	IN
46745	4412	2	increasing	increase	VBG
46745	4412	3	the	the	DT
46745	4412	4	secretion	secretion	NN
46745	4412	5	of	of	IN
46745	4412	6	the	the	DT
46745	4412	7	intestinal	intestinal	JJ
46745	4412	8	glands	gland	NNS
46745	4412	9	,	,	,
46745	4412	10	we	-PRON-	PRP
46745	4412	11	may	may	MD
46745	4412	12	cause	cause	VB
46745	4412	13	the	the	DT
46745	4412	14	albuminous	albuminous	JJ
46745	4412	15	serum	serum	NN
46745	4412	16	of	of	IN
46745	4412	17	the	the	DT
46745	4412	18	blood	blood	NN
46745	4412	19	to	to	TO
46745	4412	20	be	be	VB
46745	4412	21	poured	pour	VBN
46745	4412	22	out	out	RP
46745	4412	23	into	into	IN
46745	4412	24	the	the	DT
46745	4412	25	cavity	cavity	NN
46745	4412	26	of	of	IN
46745	4412	27	the	the	DT
46745	4412	28	bowels	bowel	NNS
46745	4412	29	.	.	.
46745	4413	1	Thus	thus	RB
46745	4413	2	it	-PRON-	PRP
46745	4413	3	is	be	VBZ
46745	4413	4	that	that	IN
46745	4413	5	all	all	DT
46745	4413	6	Eliminatives	Eliminatives	NNPS
46745	4413	7	are	be	VBP
46745	4413	8	more	more	RBR
46745	4413	9	or	or	CC
46745	4413	10	less	less	RBR
46745	4413	11	antiphlogistic	antiphlogistic	JJ
46745	4413	12	.	.	.
46745	4414	1	Cathartics	cathartic	NNS
46745	4414	2	are	be	VBP
46745	4414	3	especially	especially	RB
46745	4414	4	so	so	RB
46745	4414	5	.	.	.
46745	4415	1	Their	-PRON-	PRP$
46745	4415	2	influence	influence	NN
46745	4415	3	,	,	,
46745	4415	4	when	when	WRB
46745	4415	5	carried	carry	VBN
46745	4415	6	to	to	IN
46745	4415	7	excess	excess	NN
46745	4415	8	,	,	,
46745	4415	9	is	be	VBZ
46745	4415	10	analogous	analogous	JJ
46745	4415	11	to	to	IN
46745	4415	12	that	that	DT
46745	4415	13	of	of	IN
46745	4415	14	blood	blood	NN
46745	4415	15	-	-	HYPH
46745	4415	16	letting	letting	NN
46745	4415	17	.	.	.
46745	4416	1	As	as	IN
46745	4416	2	evacuants	evacuant	NNS
46745	4416	3	,	,	,
46745	4416	4	Cathartics	cathartic	NNS
46745	4416	5	are	be	VBP
46745	4416	6	employed	employ	VBN
46745	4416	7	in	in	IN
46745	4416	8	diseases	disease	NNS
46745	4416	9	of	of	IN
46745	4416	10	the	the	DT
46745	4416	11	brain	brain	NN
46745	4416	12	especially	especially	RB
46745	4416	13	;	;	:
46745	4416	14	and	and	CC
46745	4416	15	Diuretics	diuretic	NNS
46745	4416	16	are	be	VBP
46745	4416	17	made	make	VBN
46745	4416	18	use	use	NN
46745	4416	19	of	of	IN
46745	4416	20	in	in	IN
46745	4416	21	dropsies	dropsy	NNS
46745	4416	22	to	to	TO
46745	4416	23	diminish	diminish	VB
46745	4416	24	the	the	DT
46745	4416	25	amount	amount	NN
46745	4416	26	of	of	IN
46745	4416	27	fluid	fluid	NN
46745	4416	28	in	in	IN
46745	4416	29	the	the	DT
46745	4416	30	blood	blood	NN
46745	4416	31	,	,	,
46745	4416	32	and	and	CC
46745	4416	33	in	in	IN
46745	4416	34	this	this	DT
46745	4416	35	way	way	NN
46745	4416	36	to	to	TO
46745	4416	37	promote	promote	VB
46745	4416	38	absorption	absorption	NN
46745	4416	39	.	.	.
46745	4417	1	So	so	RB
46745	4417	2	much	much	JJ
46745	4417	3	having	have	VBG
46745	4417	4	been	be	VBN
46745	4417	5	said	say	VBN
46745	4417	6	of	of	IN
46745	4417	7	the	the	DT
46745	4417	8	general	general	JJ
46745	4417	9	action	action	NN
46745	4417	10	of	of	IN
46745	4417	11	Eliminatives	Eliminatives	NNPS
46745	4417	12	,	,	,
46745	4417	13	we	-PRON-	PRP
46745	4417	14	proceed	proceed	VBP
46745	4417	15	to	to	TO
46745	4417	16	make	make	VB
46745	4417	17	a	a	DT
46745	4417	18	few	few	JJ
46745	4417	19	remarks	remark	NNS
46745	4417	20	on	on	IN
46745	4417	21	the	the	DT
46745	4417	22	individual	individual	JJ
46745	4417	23	orders	order	NNS
46745	4417	24	of	of	IN
46745	4417	25	medicines	medicine	NNS
46745	4417	26	which	which	WDT
46745	4417	27	are	be	VBP
46745	4417	28	included	include	VBN
46745	4417	29	in	in	IN
46745	4417	30	this	this	DT
46745	4417	31	division	division	NN
46745	4417	32	.	.	.
46745	4418	1	Those	those	DT
46745	4418	2	substances	substance	NNS
46745	4418	3	can	can	MD
46745	4418	4	alone	alone	RB
46745	4418	5	be	be	VB
46745	4418	6	properly	properly	RB
46745	4418	7	included	include	VBN
46745	4418	8	in	in	IN
46745	4418	9	these	these	DT
46745	4418	10	groups	group	NNS
46745	4418	11	which	which	WDT
46745	4418	12	really	really	RB
46745	4418	13	act	act	VBP
46745	4418	14	on	on	IN
46745	4418	15	the	the	DT
46745	4418	16	principle	principle	NN
46745	4418	17	of	of	IN
46745	4418	18	elimination	elimination	NN
46745	4418	19	,	,	,
46745	4418	20	as	as	IN
46745	4418	21	above	above	RB
46745	4418	22	defined	define	VBN
46745	4418	23	.	.	.
46745	4419	1	There	there	EX
46745	4419	2	are	be	VBP
46745	4419	3	in	in	IN
46745	4419	4	many	many	JJ
46745	4419	5	instances	instance	NNS
46745	4419	6	other	other	JJ
46745	4419	7	medicines	medicine	NNS
46745	4419	8	which	which	WDT
46745	4419	9	are	be	VBP
46745	4419	10	found	find	VBN
46745	4419	11	to	to	TO
46745	4419	12	increase	increase	VB
46745	4419	13	secretion	secretion	NN
46745	4419	14	in	in	IN
46745	4419	15	an	an	DT
46745	4419	16	indirect	indirect	JJ
46745	4419	17	way	way	NN
46745	4419	18	.	.	.
46745	4420	1	ORD	ORD	NNP
46745	4420	2	I.	I.	NNP
46745	4421	1	SIALAGOGUES	sialagogue	NNS
46745	4421	2	.	.	.
46745	4422	1	[	[	-LRB-
46745	4422	2	45	45	CD
46745	4422	3	]	]	-RRB-
46745	4422	4	This	this	DT
46745	4422	5	name	name	NN
46745	4422	6	is	be	VBZ
46745	4422	7	applied	apply	VBN
46745	4422	8	to	to	IN
46745	4422	9	medicines	medicine	NNS
46745	4422	10	which	which	WDT
46745	4422	11	in	in	IN
46745	4422	12	various	various	JJ
46745	4422	13	ways	way	NNS
46745	4422	14	increase	increase	VBP
46745	4422	15	the	the	DT
46745	4422	16	quantity	quantity	NN
46745	4422	17	or	or	CC
46745	4422	18	promote	promote	VB
46745	4422	19	the	the	DT
46745	4422	20	excretion	excretion	NN
46745	4422	21	of	of	IN
46745	4422	22	the	the	DT
46745	4422	23	saliva	saliva	NN
46745	4422	24	.	.	.
46745	4423	1	They	-PRON-	PRP
46745	4423	2	are	be	VBP
46745	4423	3	seldom	seldom	RB
46745	4423	4	employed	employ	VBN
46745	4423	5	as	as	IN
46745	4423	6	remedial	remedial	JJ
46745	4423	7	agents	agent	NNS
46745	4423	8	;	;	:
46745	4423	9	for	for	IN
46745	4423	10	the	the	DT
46745	4423	11	excretion	excretion	NN
46745	4423	12	of	of	IN
46745	4423	13	saliva	saliva	NNP
46745	4423	14	is	be	VBZ
46745	4423	15	constant	constant	JJ
46745	4423	16	and	and	CC
46745	4423	17	very	very	RB
46745	4423	18	rarely	rarely	RB
46745	4423	19	suppressed	suppress	VBN
46745	4423	20	,	,	,
46745	4423	21	and	and	CC
46745	4423	22	it	-PRON-	PRP
46745	4423	23	is	be	VBZ
46745	4423	24	so	so	RB
46745	4423	25	small	small	JJ
46745	4423	26	in	in	IN
46745	4423	27	quantity	quantity	NN
46745	4423	28	,	,	,
46745	4423	29	and	and	CC
46745	4423	30	so	so	RB
46745	4423	31	great	great	JJ
46745	4423	32	a	a	DT
46745	4423	33	source	source	NN
46745	4423	34	of	of	IN
46745	4423	35	inconvenience	inconvenience	NN
46745	4423	36	when	when	WRB
46745	4423	37	increased	increase	VBD
46745	4423	38	to	to	IN
46745	4423	39	any	any	DT
46745	4423	40	amount	amount	NN
46745	4423	41	,	,	,
46745	4423	42	that	that	IN
46745	4423	43	Sialagogues	Sialagogues	NNP
46745	4423	44	can	can	MD
46745	4423	45	never	never	RB
46745	4423	46	be	be	VB
46745	4423	47	employed	employ	VBN
46745	4423	48	as	as	IN
46745	4423	49	general	general	JJ
46745	4423	50	evacuants	evacuant	NNS
46745	4423	51	.	.	.
46745	4424	1	There	there	EX
46745	4424	2	are	be	VBP
46745	4424	3	two	two	CD
46745	4424	4	kinds	kind	NNS
46745	4424	5	of	of	IN
46745	4424	6	Sialagogues	sialagogue	NNS
46745	4424	7	.	.	.
46745	4425	1	Any	any	DT
46745	4425	2	solid	solid	JJ
46745	4425	3	substance	substance	NN
46745	4425	4	which	which	WDT
46745	4425	5	excites	excite	VBZ
46745	4425	6	the	the	DT
46745	4425	7	mucous	mucous	JJ
46745	4425	8	surface	surface	NN
46745	4425	9	of	of	IN
46745	4425	10	the	the	DT
46745	4425	11	mouth	mouth	NN
46745	4425	12	,	,	,
46745	4425	13	as	as	IN
46745	4425	14	the	the	DT
46745	4425	15	natural	natural	JJ
46745	4425	16	food,--or	food,--or	NNP
46745	4425	17	even	even	RB
46745	4425	18	the	the	DT
46745	4425	19	act	act	NN
46745	4425	20	of	of	IN
46745	4425	21	mastication	mastication	NN
46745	4425	22	alone,--will	alone,--will	NNP
46745	4425	23	suffice	suffice	NN
46745	4425	24	to	to	TO
46745	4425	25	bring	bring	VB
46745	4425	26	on	on	RP
46745	4425	27	the	the	DT
46745	4425	28	secretion	secretion	NN
46745	4425	29	of	of	IN
46745	4425	30	saliva	saliva	NNP
46745	4425	31	.	.	.
46745	4426	1	An	an	DT
46745	4426	2	irritant	irritant	JJ
46745	4426	3	substance	substance	NN
46745	4426	4	,	,	,
46745	4426	5	as	as	IN
46745	4426	6	Ginger	Ginger	NNP
46745	4426	7	,	,	,
46745	4426	8	or	or	CC
46745	4426	9	Pyrethrum	Pyrethrum	NNP
46745	4426	10	,	,	,
46745	4426	11	tends	tend	VBZ
46745	4426	12	especially	especially	RB
46745	4426	13	to	to	TO
46745	4426	14	cause	cause	VB
46745	4426	15	this	this	DT
46745	4426	16	secretion	secretion	NN
46745	4426	17	when	when	WRB
46745	4426	18	masticated	masticate	VBN
46745	4426	19	.	.	.
46745	4427	1	Catechu	Catechu	NNP
46745	4427	2	and	and	CC
46745	4427	3	Betelleaf	Betelleaf	NNP
46745	4427	4	are	be	VBP
46745	4427	5	chewed	chew	VBN
46745	4427	6	for	for	IN
46745	4427	7	this	this	DT
46745	4427	8	purpose	purpose	NN
46745	4427	9	by	by	IN
46745	4427	10	the	the	DT
46745	4427	11	natives	native	NNS
46745	4427	12	of	of	IN
46745	4427	13	the	the	DT
46745	4427	14	East	East	NNP
46745	4427	15	.	.	.
46745	4428	1	Such	such	PDT
46745	4428	2	a	a	DT
46745	4428	3	stimulation	stimulation	NN
46745	4428	4	of	of	IN
46745	4428	5	the	the	DT
46745	4428	6	salivary	salivary	JJ
46745	4428	7	glands	gland	NNS
46745	4428	8	may	may	MD
46745	4428	9	be	be	VB
46745	4428	10	advantageously	advantageously	RB
46745	4428	11	resorted	resort	VBN
46745	4428	12	to	to	IN
46745	4428	13	on	on	IN
46745	4428	14	the	the	DT
46745	4428	15	counter	counter	JJ
46745	4428	16	-	-	JJ
46745	4428	17	irritant	irritant	JJ
46745	4428	18	principle	principle	NN
46745	4428	19	in	in	IN
46745	4428	20	obstinate	obstinate	NN
46745	4428	21	cases	case	NNS
46745	4428	22	of	of	IN
46745	4428	23	head	head	NN
46745	4428	24	-	-	HYPH
46745	4428	25	ache	ache	NN
46745	4428	26	,	,	,
46745	4428	27	ear	ear	NN
46745	4428	28	-	-	HYPH
46745	4428	29	ache	ache	NN
46745	4428	30	,	,	,
46745	4428	31	or	or	CC
46745	4428	32	tooth	tooth	NN
46745	4428	33	-	-	HYPH
46745	4428	34	ache	ache	NN
46745	4428	35	,	,	,
46745	4428	36	or	or	CC
46745	4428	37	in	in	IN
46745	4428	38	neuralgic	neuralgic	JJ
46745	4428	39	or	or	CC
46745	4428	40	chronic	chronic	JJ
46745	4428	41	rheumatic	rheumatic	JJ
46745	4428	42	affections	affection	NNS
46745	4428	43	of	of	IN
46745	4428	44	the	the	DT
46745	4428	45	face	face	NN
46745	4428	46	.	.	.
46745	4429	1	When	when	WRB
46745	4429	2	the	the	DT
46745	4429	3	quantity	quantity	NN
46745	4429	4	of	of	IN
46745	4429	5	the	the	DT
46745	4429	6	saliva	saliva	NN
46745	4429	7	is	be	VBZ
46745	4429	8	thus	thus	RB
46745	4429	9	increased	increase	VBN
46745	4429	10	,	,	,
46745	4429	11	it	-PRON-	PRP
46745	4429	12	should	should	MD
46745	4429	13	not	not	RB
46745	4429	14	be	be	VB
46745	4429	15	rejected	reject	VBN
46745	4429	16	,	,	,
46745	4429	17	but	but	CC
46745	4429	18	always	always	RB
46745	4429	19	swallowed	swallow	VBD
46745	4429	20	when	when	WRB
46745	4429	21	possible	possible	JJ
46745	4429	22	;	;	:
46745	4429	23	for	for	IN
46745	4429	24	this	this	DT
46745	4429	25	secretion	secretion	NN
46745	4429	26	is	be	VBZ
46745	4429	27	apparently	apparently	RB
46745	4429	28	useful	useful	JJ
46745	4429	29	in	in	IN
46745	4429	30	the	the	DT
46745	4429	31	stomach	stomach	NN
46745	4429	32	,	,	,
46745	4429	33	and	and	CC
46745	4429	34	in	in	IN
46745	4429	35	some	some	DT
46745	4429	36	way	way	NN
46745	4429	37	essential	essential	JJ
46745	4429	38	to	to	IN
46745	4429	39	the	the	DT
46745	4429	40	proper	proper	JJ
46745	4429	41	carrying	carrying	NN
46745	4429	42	on	on	RP
46745	4429	43	of	of	IN
46745	4429	44	the	the	DT
46745	4429	45	digestive	digestive	JJ
46745	4429	46	process	process	NN
46745	4429	47	.	.	.
46745	4430	1	The	the	DT
46745	4430	2	chewing	chewing	NN
46745	4430	3	of	of	IN
46745	4430	4	Tobacco	Tobacco	NNP
46745	4430	5	,	,	,
46745	4430	6	Betel	Betel	NNP
46745	4430	7	,	,	,
46745	4430	8	and	and	CC
46745	4430	9	other	other	JJ
46745	4430	10	substances	substance	NNS
46745	4430	11	,	,	,
46745	4430	12	is	be	VBZ
46745	4430	13	frequently	frequently	RB
46745	4430	14	found	find	VBN
46745	4430	15	useful	useful	JJ
46745	4430	16	by	by	IN
46745	4430	17	sailors	sailor	NNS
46745	4430	18	on	on	IN
46745	4430	19	long	long	JJ
46745	4430	20	voyages	voyage	NNS
46745	4430	21	,	,	,
46745	4430	22	and	and	CC
46745	4430	23	is	be	VBZ
46745	4430	24	adopted	adopt	VBN
46745	4430	25	as	as	IN
46745	4430	26	a	a	DT
46745	4430	27	preservative	preservative	NN
46745	4430	28	against	against	IN
46745	4430	29	the	the	DT
46745	4430	30	dysentery	dysentery	NN
46745	4430	31	and	and	CC
46745	4430	32	diarrh[oe]a	diarrh[oe]a	NNP
46745	4430	33	with	with	IN
46745	4430	34	which	which	WDT
46745	4430	35	they	-PRON-	PRP
46745	4430	36	are	be	VBP
46745	4430	37	so	so	RB
46745	4430	38	often	often	RB
46745	4430	39	affected	affected	JJ
46745	4430	40	.	.	.
46745	4431	1	This	this	DT
46745	4431	2	advantage	advantage	NN
46745	4431	3	is	be	VBZ
46745	4431	4	to	to	TO
46745	4431	5	be	be	VB
46745	4431	6	attributed	attribute	VBN
46745	4431	7	to	to	IN
46745	4431	8	the	the	DT
46745	4431	9	increase	increase	NN
46745	4431	10	in	in	IN
46745	4431	11	the	the	DT
46745	4431	12	salivary	salivary	JJ
46745	4431	13	secretion	secretion	NN
46745	4431	14	.	.	.
46745	4432	1	On	on	IN
46745	4432	2	the	the	DT
46745	4432	3	other	other	JJ
46745	4432	4	hand	hand	NN
46745	4432	5	,	,	,
46745	4432	6	we	-PRON-	PRP
46745	4432	7	find	find	VBP
46745	4432	8	that	that	IN
46745	4432	9	the	the	DT
46745	4432	10	practice	practice	NN
46745	4432	11	of	of	IN
46745	4432	12	constant	constant	JJ
46745	4432	13	spitting	spitting	NN
46745	4432	14	is	be	VBZ
46745	4432	15	productive	productive	JJ
46745	4432	16	of	of	IN
46745	4432	17	very	very	RB
46745	4432	18	injurious	injurious	JJ
46745	4432	19	effects	effect	NNS
46745	4432	20	;	;	:
46745	4432	21	and	and	CC
46745	4432	22	it	-PRON-	PRP
46745	4432	23	is	be	VBZ
46745	4432	24	more	more	JJR
46745	4432	25	than	than	IN
46745	4432	26	possible	possible	JJ
46745	4432	27	that	that	IN
46745	4432	28	the	the	DT
46745	4432	29	pale	pale	JJ
46745	4432	30	faces	face	NNS
46745	4432	31	,	,	,
46745	4432	32	lank	lank	JJ
46745	4432	33	figures	figure	NNS
46745	4432	34	,	,	,
46745	4432	35	and	and	CC
46745	4432	36	dyspeptic	dyspeptic	JJ
46745	4432	37	maladies	malady	NNS
46745	4432	38	,	,	,
46745	4432	39	which	which	WDT
46745	4432	40	are	be	VBP
46745	4432	41	so	so	RB
46745	4432	42	common	common	JJ
46745	4432	43	among	among	IN
46745	4432	44	the	the	DT
46745	4432	45	American	american	JJ
46745	4432	46	people	people	NNS
46745	4432	47	,	,	,
46745	4432	48	may	may	MD
46745	4432	49	be	be	VB
46745	4432	50	due	due	JJ
46745	4432	51	in	in	IN
46745	4432	52	part	part	NN
46745	4432	53	to	to	IN
46745	4432	54	the	the	DT
46745	4432	55	prevalence	prevalence	NN
46745	4432	56	of	of	IN
46745	4432	57	this	this	DT
46745	4432	58	habit	habit	NN
46745	4432	59	among	among	IN
46745	4432	60	them	-PRON-	PRP
46745	4432	61	.	.	.
46745	4433	1	These	these	DT
46745	4433	2	topical	topical	JJ
46745	4433	3	irritants	irritant	NNS
46745	4433	4	and	and	CC
46745	4433	5	masticatories	masticatorie	NNS
46745	4433	6	are	be	VBP
46745	4433	7	not	not	RB
46745	4433	8	true	true	JJ
46745	4433	9	Eliminatives	Eliminatives	NNPS
46745	4433	10	.	.	.
46745	4434	1	There	there	EX
46745	4434	2	are	be	VBP
46745	4434	3	also	also	RB
46745	4434	4	some	some	DT
46745	4434	5	medicines	medicine	NNS
46745	4434	6	which	which	WDT
46745	4434	7	by	by	IN
46745	4434	8	another	another	DT
46745	4434	9	topical	topical	JJ
46745	4434	10	action	action	NN
46745	4434	11	may	may	MD
46745	4434	12	occasionally	occasionally	RB
46745	4434	13	produce	produce	VB
46745	4434	14	salivation	salivation	NN
46745	4434	15	.	.	.
46745	4435	1	These	these	DT
46745	4435	2	are	be	VBP
46745	4435	3	Sedatives	sedative	NNS
46745	4435	4	.	.	.
46745	4436	1	Hydrocyanic	hydrocyanic	JJ
46745	4436	2	acid	acid	NN
46745	4436	3	,	,	,
46745	4436	4	Digitalis	Digitalis	NNP
46745	4436	5	,	,	,
46745	4436	6	and	and	CC
46745	4436	7	nauseant	nauseant	JJ
46745	4436	8	medicines	medicine	NNS
46745	4436	9	,	,	,
46745	4436	10	may	may	MD
46745	4436	11	act	act	VB
46745	4436	12	locally	locally	RB
46745	4436	13	so	so	IN
46745	4436	14	as	as	IN
46745	4436	15	to	to	TO
46745	4436	16	paralyze	paralyze	VB
46745	4436	17	the	the	DT
46745	4436	18	muscular	muscular	JJ
46745	4436	19	fibres	fibre	NNS
46745	4436	20	by	by	IN
46745	4436	21	which	which	WDT
46745	4436	22	the	the	DT
46745	4436	23	constriction	constriction	NN
46745	4436	24	of	of	IN
46745	4436	25	the	the	DT
46745	4436	26	salivary	salivary	JJ
46745	4436	27	ducts	duct	NNS
46745	4436	28	is	be	VBZ
46745	4436	29	maintained	maintain	VBN
46745	4436	30	,	,	,
46745	4436	31	and	and	CC
46745	4436	32	thus	thus	RB
46745	4436	33	allow	allow	VB
46745	4436	34	the	the	DT
46745	4436	35	secretion	secretion	NN
46745	4436	36	to	to	TO
46745	4436	37	pour	pour	VB
46745	4436	38	out	out	RP
46745	4436	39	uncontrolled	uncontrolled	JJ
46745	4436	40	into	into	IN
46745	4436	41	the	the	DT
46745	4436	42	cavity	cavity	NN
46745	4436	43	of	of	IN
46745	4436	44	the	the	DT
46745	4436	45	mouth	mouth	NN
46745	4436	46	.	.	.
46745	4437	1	_	_	NNP
46745	4437	2	True	true	JJ
46745	4437	3	or	or	CC
46745	4437	4	Eliminant	Eliminant	NNP
46745	4437	5	Sialagogues._--These	Sialagogues._--These	NNS
46745	4437	6	are	be	VBP
46745	4437	7	medicines	medicine	NNS
46745	4437	8	which	which	WDT
46745	4437	9	are	be	VBP
46745	4437	10	actually	actually	RB
46745	4437	11	excreted	excrete	VBN
46745	4437	12	from	from	IN
46745	4437	13	the	the	DT
46745	4437	14	blood	blood	NN
46745	4437	15	by	by	IN
46745	4437	16	the	the	DT
46745	4437	17	salivary	salivary	JJ
46745	4437	18	glands	gland	NNS
46745	4437	19	,	,	,
46745	4437	20	and	and	CC
46745	4437	21	which	which	WDT
46745	4437	22	increase	increase	VBP
46745	4437	23	their	-PRON-	PRP$
46745	4437	24	natural	natural	JJ
46745	4437	25	secretion	secretion	NN
46745	4437	26	while	while	IN
46745	4437	27	passing	pass	VBG
46745	4437	28	through	through	IN
46745	4437	29	them	-PRON-	PRP
46745	4437	30	.	.	.
46745	4438	1	Mercury	Mercury	NNP
46745	4438	2	is	be	VBZ
46745	4438	3	the	the	DT
46745	4438	4	most	most	RBS
46745	4438	5	important	important	JJ
46745	4438	6	of	of	IN
46745	4438	7	these	these	DT
46745	4438	8	.	.	.
46745	4439	1	When	when	WRB
46745	4439	2	given	give	VBN
46745	4439	3	to	to	IN
46745	4439	4	a	a	DT
46745	4439	5	considerable	considerable	JJ
46745	4439	6	extent	extent	NN
46745	4439	7	,	,	,
46745	4439	8	it	-PRON-	PRP
46745	4439	9	causes	cause	VBZ
46745	4439	10	soreness	soreness	NN
46745	4439	11	and	and	CC
46745	4439	12	redness	redness	NN
46745	4439	13	of	of	IN
46745	4439	14	the	the	DT
46745	4439	15	gums	gum	NNS
46745	4439	16	,	,	,
46745	4439	17	and	and	CC
46745	4439	18	profuse	profuse	NN
46745	4439	19	salivation	salivation	NN
46745	4439	20	.	.	.
46745	4440	1	It	-PRON-	PRP
46745	4440	2	probably	probably	RB
46745	4440	3	increases	increase	VBZ
46745	4440	4	the	the	DT
46745	4440	5	amount	amount	NN
46745	4440	6	of	of	IN
46745	4440	7	saliva	saliva	NN
46745	4440	8	even	even	RB
46745	4440	9	before	before	IN
46745	4440	10	this	this	DT
46745	4440	11	soreness	soreness	NN
46745	4440	12	is	be	VBZ
46745	4440	13	produced	produce	VBN
46745	4440	14	.	.	.
46745	4441	1	It	-PRON-	PRP
46745	4441	2	is	be	VBZ
46745	4441	3	not	not	RB
46745	4441	4	given	give	VBN
46745	4441	5	for	for	IN
46745	4441	6	the	the	DT
46745	4441	7	purpose	purpose	NN
46745	4441	8	of	of	IN
46745	4441	9	producing	produce	VBG
46745	4441	10	salivation	salivation	NN
46745	4441	11	,	,	,
46745	4441	12	but	but	CC
46745	4441	13	in	in	IN
46745	4441	14	cases	case	NNS
46745	4441	15	where	where	WRB
46745	4441	16	the	the	DT
46745	4441	17	full	full	JJ
46745	4441	18	action	action	NN
46745	4441	19	of	of	IN
46745	4441	20	Mercury	Mercury	NNP
46745	4441	21	is	be	VBZ
46745	4441	22	desired	desire	VBN
46745	4441	23	this	this	DT
46745	4441	24	symptom	symptom	NN
46745	4441	25	is	be	VBZ
46745	4441	26	made	make	VBN
46745	4441	27	use	use	NN
46745	4441	28	of	of	IN
46745	4441	29	as	as	IN
46745	4441	30	a	a	DT
46745	4441	31	sign	sign	NN
46745	4441	32	that	that	IN
46745	4441	33	the	the	DT
46745	4441	34	medicine	medicine	NN
46745	4441	35	has	have	VBZ
46745	4441	36	taken	take	VBN
46745	4441	37	full	full	JJ
46745	4441	38	effect	effect	NN
46745	4441	39	upon	upon	IN
46745	4441	40	the	the	DT
46745	4441	41	system	system	NN
46745	4441	42	.	.	.
46745	4442	1	If	if	IN
46745	4442	2	we	-PRON-	PRP
46745	4442	3	permit	permit	VBP
46745	4442	4	it	-PRON-	PRP
46745	4442	5	to	to	TO
46745	4442	6	be	be	VB
46745	4442	7	carried	carry	VBN
46745	4442	8	to	to	IN
46745	4442	9	too	too	RB
46745	4442	10	great	great	JJ
46745	4442	11	an	an	DT
46745	4442	12	extent	extent	NN
46745	4442	13	,	,	,
46745	4442	14	sloughing	slough	VBG
46745	4442	15	of	of	IN
46745	4442	16	the	the	DT
46745	4442	17	gums	gum	NNS
46745	4442	18	and	and	CC
46745	4442	19	other	other	JJ
46745	4442	20	dangerous	dangerous	JJ
46745	4442	21	results	result	NNS
46745	4442	22	may	may	MD
46745	4442	23	be	be	VB
46745	4442	24	produced	produce	VBN
46745	4442	25	.	.	.
46745	4443	1	In	in	IN
46745	4443	2	some	some	DT
46745	4443	3	rare	rare	JJ
46745	4443	4	cases	case	NNS
46745	4443	5	salivation	salivation	NN
46745	4443	6	has	have	VBZ
46745	4443	7	followed	follow	VBN
46745	4443	8	the	the	DT
46745	4443	9	administration	administration	NN
46745	4443	10	of	of	IN
46745	4443	11	Iodine	Iodine	NNP
46745	4443	12	.	.	.
46745	4444	1	It	-PRON-	PRP
46745	4444	2	is	be	VBZ
46745	4444	3	also	also	RB
46745	4444	4	not	not	RB
46745	4444	5	an	an	DT
46745	4444	6	unfrequent	unfrequent	JJ
46745	4444	7	symptom	symptom	NN
46745	4444	8	of	of	IN
46745	4444	9	chronic	chronic	JJ
46745	4444	10	poisoning	poisoning	NN
46745	4444	11	by	by	IN
46745	4444	12	Lead	Lead	NNP
46745	4444	13	.	.	.
46745	4445	1	In	in	IN
46745	4445	2	cases	case	NNS
46745	4445	3	of	of	IN
46745	4445	4	salivation	salivation	NN
46745	4445	5	by	by	IN
46745	4445	6	these	these	DT
46745	4445	7	Eliminative	eliminative	JJ
46745	4445	8	medicines	medicine	NNS
46745	4445	9	,	,	,
46745	4445	10	the	the	DT
46745	4445	11	substance	substance	NN
46745	4445	12	which	which	WDT
46745	4445	13	has	have	VBZ
46745	4445	14	caused	cause	VBN
46745	4445	15	the	the	DT
46745	4445	16	increased	increase	VBN
46745	4445	17	secretion	secretion	NN
46745	4445	18	may	may	MD
46745	4445	19	be	be	VB
46745	4445	20	,	,	,
46745	4445	21	and	and	CC
46745	4445	22	has	have	VBZ
46745	4445	23	been	be	VBN
46745	4445	24	,	,	,
46745	4445	25	discovered	discover	VBN
46745	4445	26	in	in	IN
46745	4445	27	the	the	DT
46745	4445	28	saliva	saliva	NN
46745	4445	29	by	by	IN
46745	4445	30	chemical	chemical	NN
46745	4445	31	tests	test	NNS
46745	4445	32	.	.	.
46745	4446	1	They	-PRON-	PRP
46745	4446	2	are	be	VBP
46745	4446	3	therefore	therefore	RB
46745	4446	4	true	true	JJ
46745	4446	5	Sialagogues	sialagogue	NNS
46745	4446	6	.	.	.
46745	4447	1	ORD	ORD	NNP
46745	4447	2	.	.	.
46745	4448	1	II	ii	CD
46745	4448	2	.	.	.
46745	4449	1	EXPECTORANTS	expectorant	NNS
46745	4449	2	.	.	.
46745	4450	1	This	this	DT
46745	4450	2	term	term	NN
46745	4450	3	,	,	,
46745	4450	4	when	when	WRB
46745	4450	5	taken	take	VBN
46745	4450	6	in	in	IN
46745	4450	7	its	-PRON-	PRP$
46745	4450	8	widest	wide	JJS
46745	4450	9	sense	sense	NN
46745	4450	10	,	,	,
46745	4450	11	is	be	VBZ
46745	4450	12	applied	apply	VBN
46745	4450	13	to	to	IN
46745	4450	14	all	all	DT
46745	4450	15	medicines	medicine	NNS
46745	4450	16	that	that	WDT
46745	4450	17	cause	cause	VBP
46745	4450	18	the	the	DT
46745	4450	19	evacuation	evacuation	NN
46745	4450	20	of	of	IN
46745	4450	21	mucus	mucus	NN
46745	4450	22	from	from	IN
46745	4450	23	the	the	DT
46745	4450	24	secreting	secrete	VBG
46745	4450	25	surface	surface	NN
46745	4450	26	of	of	IN
46745	4450	27	the	the	DT
46745	4450	28	respiratory	respiratory	JJ
46745	4450	29	tubes	tube	NNS
46745	4450	30	and	and	CC
46745	4450	31	cavities	cavity	NNS
46745	4450	32	.	.	.
46745	4451	1	They	-PRON-	PRP
46745	4451	2	help	help	VBP
46745	4451	3	the	the	DT
46745	4451	4	natural	natural	JJ
46745	4451	5	process	process	NN
46745	4451	6	of	of	IN
46745	4451	7	Expectoration	Expectoration	NNP
46745	4451	8	.	.	.
46745	4452	1	Many	many	JJ
46745	4452	2	medicines	medicine	NNS
46745	4452	3	are	be	VBP
46745	4452	4	capable	capable	JJ
46745	4452	5	of	of	IN
46745	4452	6	acting	act	VBG
46745	4452	7	indirectly	indirectly	RB
46745	4452	8	as	as	IN
46745	4452	9	Expectorants	expectorant	NNS
46745	4452	10	.	.	.
46745	4453	1	Any	any	DT
46745	4453	2	thing	thing	NN
46745	4453	3	which	which	WDT
46745	4453	4	causes	cause	VBZ
46745	4453	5	cough	cough	NN
46745	4453	6	,	,	,
46745	4453	7	as	as	IN
46745	4453	8	an	an	DT
46745	4453	9	irritant	irritant	JJ
46745	4453	10	gas	gas	NN
46745	4453	11	,	,	,
46745	4453	12	will	will	MD
46745	4453	13	do	do	VB
46745	4453	14	it	-PRON-	PRP
46745	4453	15	.	.	.
46745	4454	1	So	so	CC
46745	4454	2	will	will	MD
46745	4454	3	any	any	DT
46745	4454	4	thing	thing	NN
46745	4454	5	that	that	WDT
46745	4454	6	thins	thin	VBZ
46745	4454	7	the	the	DT
46745	4454	8	mucus	mucus	NN
46745	4454	9	when	when	WRB
46745	4454	10	thick	thick	JJ
46745	4454	11	and	and	CC
46745	4454	12	viscid,--_e.g	viscid,--_e.g	UH
46745	4454	13	.	.	.
46745	4454	14	_	_	IN
46745	4454	15	the	the	DT
46745	4454	16	inspiration	inspiration	NN
46745	4454	17	of	of	IN
46745	4454	18	the	the	DT
46745	4454	19	vapour	vapour	NN
46745	4454	20	of	of	IN
46745	4454	21	hot	hot	JJ
46745	4454	22	water	water	NN
46745	4454	23	.	.	.
46745	4455	1	Special	Special	NNP
46745	4455	2	Sedatives	Sedatives	NNPS
46745	4455	3	,	,	,
46745	4455	4	which	which	WDT
46745	4455	5	control	control	VBP
46745	4455	6	the	the	DT
46745	4455	7	function	function	NN
46745	4455	8	of	of	IN
46745	4455	9	the	the	DT
46745	4455	10	Vagus	Vagus	NNP
46745	4455	11	nerve	nerve	NN
46745	4455	12	,	,	,
46745	4455	13	are	be	VBP
46745	4455	14	especially	especially	RB
46745	4455	15	notable	notable	JJ
46745	4455	16	as	as	IN
46745	4455	17	indirect	indirect	JJ
46745	4455	18	Expectorants	expectorant	NNS
46745	4455	19	.	.	.
46745	4456	1	Such	such	JJ
46745	4456	2	are	be	VBP
46745	4456	3	Antimony	Antimony	NNP
46745	4456	4	and	and	CC
46745	4456	5	Ipecacuanha	Ipecacuanha	NNP
46745	4456	6	.	.	.
46745	4457	1	By	by	IN
46745	4457	2	diminishing	diminish	VBG
46745	4457	3	the	the	DT
46745	4457	4	morbid	morbid	NN
46745	4457	5	irritability	irritability	NN
46745	4457	6	of	of	IN
46745	4457	7	the	the	DT
46745	4457	8	pulmonary	pulmonary	JJ
46745	4457	9	surface	surface	NN
46745	4457	10	,	,	,
46745	4457	11	they	-PRON-	PRP
46745	4457	12	prevent	prevent	VBP
46745	4457	13	the	the	DT
46745	4457	14	continued	continue	VBN
46745	4457	15	secretion	secretion	NN
46745	4457	16	of	of	IN
46745	4457	17	mucus	mucus	NN
46745	4457	18	.	.	.
46745	4458	1	By	by	IN
46745	4458	2	allaying	allay	VBG
46745	4458	3	a	a	DT
46745	4458	4	spasm	spasm	NN
46745	4458	5	of	of	IN
46745	4458	6	the	the	DT
46745	4458	7	small	small	JJ
46745	4458	8	bronchial	bronchial	JJ
46745	4458	9	tubes	tube	NNS
46745	4458	10	,	,	,
46745	4458	11	and	and	CC
46745	4458	12	controlling	control	VBG
46745	4458	13	the	the	DT
46745	4458	14	nervous	nervous	JJ
46745	4458	15	sensation	sensation	NN
46745	4458	16	of	of	IN
46745	4458	17	want	want	NN
46745	4458	18	of	of	IN
46745	4458	19	breath	breath	NN
46745	4458	20	,	,	,
46745	4458	21	they	-PRON-	PRP
46745	4458	22	may	may	MD
46745	4458	23	promote	promote	VB
46745	4458	24	the	the	DT
46745	4458	25	evacuation	evacuation	NN
46745	4458	26	of	of	IN
46745	4458	27	that	that	DT
46745	4458	28	which	which	WDT
46745	4458	29	is	be	VBZ
46745	4458	30	already	already	RB
46745	4458	31	secreted	secrete	VBN
46745	4458	32	.	.	.
46745	4459	1	Opium	Opium	NNP
46745	4459	2	and	and	CC
46745	4459	3	Stramonium	Stramonium	NNP
46745	4459	4	,	,	,
46745	4459	5	classed	class	VBN
46745	4459	6	among	among	IN
46745	4459	7	Narcotics	Narcotics	NNP
46745	4459	8	,	,	,
46745	4459	9	depress	depress	VB
46745	4459	10	the	the	DT
46745	4459	11	function	function	NN
46745	4459	12	of	of	IN
46745	4459	13	this	this	DT
46745	4459	14	nerve	nerve	NN
46745	4459	15	as	as	RB
46745	4459	16	well	well	RB
46745	4459	17	as	as	IN
46745	4459	18	the	the	DT
46745	4459	19	nervous	nervous	JJ
46745	4459	20	forces	force	NNS
46745	4459	21	generally	generally	RB
46745	4459	22	.	.	.
46745	4460	1	So	so	RB
46745	4460	2	do	do	VB
46745	4460	3	other	other	JJ
46745	4460	4	medicines	medicine	NNS
46745	4460	5	similar	similar	JJ
46745	4460	6	to	to	IN
46745	4460	7	them	-PRON-	PRP
46745	4460	8	.	.	.
46745	4461	1	Opium	opium	NN
46745	4461	2	in	in	IN
46745	4461	3	small	small	JJ
46745	4461	4	doses	dose	NNS
46745	4461	5	allays	allay	VBZ
46745	4461	6	irritability	irritability	NN
46745	4461	7	and	and	CC
46745	4461	8	diminishes	diminishe	NNS
46745	4461	9	spasm	spasm	NNP
46745	4461	10	,	,	,
46745	4461	11	and	and	CC
46745	4461	12	is	be	VBZ
46745	4461	13	then	then	RB
46745	4461	14	an	an	DT
46745	4461	15	indirect	indirect	JJ
46745	4461	16	Expectorant	expectorant	NN
46745	4461	17	;	;	:
46745	4461	18	but	but	CC
46745	4461	19	in	in	IN
46745	4461	20	large	large	JJ
46745	4461	21	doses	dose	NNS
46745	4461	22	it	-PRON-	PRP
46745	4461	23	acts	act	VBZ
46745	4461	24	so	so	RB
46745	4461	25	powerfully	powerfully	RB
46745	4461	26	as	as	IN
46745	4461	27	to	to	TO
46745	4461	28	render	render	VB
46745	4461	29	respiration	respiration	NN
46745	4461	30	difficult	difficult	JJ
46745	4461	31	and	and	CC
46745	4461	32	expectoration	expectoration	NN
46745	4461	33	impossible	impossible	JJ
46745	4461	34	.	.	.
46745	4462	1	Its	-PRON-	PRP$
46745	4462	2	use	use	NN
46745	4462	3	therefore	therefore	RB
46745	4462	4	demands	demand	VBZ
46745	4462	5	great	great	JJ
46745	4462	6	caution	caution	NN
46745	4462	7	.	.	.
46745	4463	1	_	_	NNP
46745	4463	2	True	true	JJ
46745	4463	3	Expectorants._--The	Expectorants._--The	NNP
46745	4463	4	action	action	NN
46745	4463	5	of	of	IN
46745	4463	6	Antimony	Antimony	NNP
46745	4463	7	and	and	CC
46745	4463	8	Ipecacuanha	Ipecacuanha	NNP
46745	4463	9	upon	upon	IN
46745	4463	10	the	the	DT
46745	4463	11	secretion	secretion	NN
46745	4463	12	of	of	IN
46745	4463	13	bronchial	bronchial	JJ
46745	4463	14	mucus	mucus	NN
46745	4463	15	is	be	VBZ
46745	4463	16	of	of	IN
46745	4463	17	so	so	RB
46745	4463	18	specific	specific	JJ
46745	4463	19	a	a	DT
46745	4463	20	character	character	NN
46745	4463	21	as	as	IN
46745	4463	22	to	to	TO
46745	4463	23	render	render	VB
46745	4463	24	it	-PRON-	PRP
46745	4463	25	highly	highly	RB
46745	4463	26	probable	probable	JJ
46745	4463	27	that	that	IN
46745	4463	28	these	these	DT
46745	4463	29	medicines	medicine	NNS
46745	4463	30	add	add	VBP
46745	4463	31	to	to	IN
46745	4463	32	their	-PRON-	PRP$
46745	4463	33	neurotic	neurotic	JJ
46745	4463	34	influence	influence	NN
46745	4463	35	a	a	DT
46745	4463	36	true	true	JJ
46745	4463	37	eliminative	eliminative	JJ
46745	4463	38	agency	agency	NN
46745	4463	39	.	.	.
46745	4464	1	We	-PRON-	PRP
46745	4464	2	are	be	VBP
46745	4464	3	as	as	RB
46745	4464	4	yet	yet	RB
46745	4464	5	unable	unable	JJ
46745	4464	6	to	to	TO
46745	4464	7	decide	decide	VB
46745	4464	8	whether	whether	IN
46745	4464	9	or	or	CC
46745	4464	10	not	not	RB
46745	4464	11	they	-PRON-	PRP
46745	4464	12	are	be	VBP
46745	4464	13	ever	ever	RB
46745	4464	14	secreted	secrete	VBN
46745	4464	15	by	by	IN
46745	4464	16	these	these	DT
46745	4464	17	mucous	mucous	JJ
46745	4464	18	glands	gland	NNS
46745	4464	19	,	,	,
46745	4464	20	because	because	IN
46745	4464	21	not	not	RB
46745	4464	22	only	only	RB
46745	4464	23	is	be	VBZ
46745	4464	24	the	the	DT
46745	4464	25	analysis	analysis	NN
46745	4464	26	of	of	IN
46745	4464	27	the	the	DT
46745	4464	28	mucus	mucus	NN
46745	4464	29	a	a	DT
46745	4464	30	matter	matter	NN
46745	4464	31	of	of	IN
46745	4464	32	difficulty	difficulty	NN
46745	4464	33	,	,	,
46745	4464	34	but	but	CC
46745	4464	35	hitherto	hitherto	UH
46745	4464	36	no	no	DT
46745	4464	37	investigation	investigation	NN
46745	4464	38	of	of	IN
46745	4464	39	the	the	DT
46745	4464	40	matter	matter	NN
46745	4464	41	has	have	VBZ
46745	4464	42	been	be	VBN
46745	4464	43	made	make	VBN
46745	4464	44	.	.	.
46745	4465	1	Squill	Squill	NNP
46745	4465	2	also	also	RB
46745	4465	3	is	be	VBZ
46745	4465	4	probably	probably	RB
46745	4465	5	an	an	DT
46745	4465	6	Eliminative	eliminative	JJ
46745	4465	7	Expectorant	expectorant	NN
46745	4465	8	.	.	.
46745	4466	1	Many	many	JJ
46745	4466	2	of	of	IN
46745	4466	3	the	the	DT
46745	4466	4	true	true	JJ
46745	4466	5	Expectorants	expectorant	NNS
46745	4466	6	are	be	VBP
46745	4466	7	volatile	volatile	JJ
46745	4466	8	and	and	CC
46745	4466	9	odorous	odorous	JJ
46745	4466	10	in	in	IN
46745	4466	11	nature	nature	NN
46745	4466	12	.	.	.
46745	4467	1	All	all	DT
46745	4467	2	excreted	excreted	JJ
46745	4467	3	substances	substance	NNS
46745	4467	4	have	have	VBP
46745	4467	5	to	to	TO
46745	4467	6	pass	pass	VB
46745	4467	7	by	by	RP
46745	4467	8	an	an	DT
46745	4467	9	endosmotic	endosmotic	JJ
46745	4467	10	process	process	NN
46745	4467	11	through	through	IN
46745	4467	12	a	a	DT
46745	4467	13	thin	thin	JJ
46745	4467	14	animal	animal	NN
46745	4467	15	membrane	membrane	NN
46745	4467	16	.	.	.
46745	4468	1	And	and	CC
46745	4468	2	it	-PRON-	PRP
46745	4468	3	is	be	VBZ
46745	4468	4	necessary	necessary	JJ
46745	4468	5	before	before	IN
46745	4468	6	they	-PRON-	PRP
46745	4468	7	can	can	MD
46745	4468	8	pass	pass	VB
46745	4468	9	,	,	,
46745	4468	10	that	that	IN
46745	4468	11	there	there	EX
46745	4468	12	should	should	MD
46745	4468	13	be	be	VB
46745	4468	14	on	on	IN
46745	4468	15	the	the	DT
46745	4468	16	other	other	JJ
46745	4468	17	side	side	NN
46745	4468	18	of	of	IN
46745	4468	19	this	this	DT
46745	4468	20	membrane	membrane	NN
46745	4468	21	something	something	NN
46745	4468	22	which	which	WDT
46745	4468	23	is	be	VBZ
46745	4468	24	capable	capable	JJ
46745	4468	25	of	of	IN
46745	4468	26	dissolving	dissolve	VBG
46745	4468	27	them	-PRON-	PRP
46745	4468	28	.	.	.
46745	4469	1	Diuretics	diuretic	NNS
46745	4469	2	are	be	VBP
46745	4469	3	soluble	soluble	JJ
46745	4469	4	in	in	IN
46745	4469	5	water	water	NN
46745	4469	6	,	,	,
46745	4469	7	and	and	CC
46745	4469	8	they	-PRON-	PRP
46745	4469	9	pass	pass	VBP
46745	4469	10	through	through	RP
46745	4469	11	into	into	IN
46745	4469	12	a	a	DT
46745	4469	13	watery	watery	JJ
46745	4469	14	fluid	fluid	NN
46745	4469	15	.	.	.
46745	4470	1	But	but	CC
46745	4470	2	these	these	DT
46745	4470	3	Expectorants	expectorant	NNS
46745	4470	4	,	,	,
46745	4470	5	whether	whether	IN
46745	4470	6	they	-PRON-	PRP
46745	4470	7	pass	pass	VBP
46745	4470	8	through	through	IN
46745	4470	9	the	the	DT
46745	4470	10	mucous	mucous	JJ
46745	4470	11	glands	gland	NNS
46745	4470	12	,	,	,
46745	4470	13	or	or	CC
46745	4470	14	immediately	immediately	RB
46745	4470	15	through	through	IN
46745	4470	16	the	the	DT
46745	4470	17	thin	thin	JJ
46745	4470	18	wall	wall	NN
46745	4470	19	of	of	IN
46745	4470	20	the	the	DT
46745	4470	21	lung	lung	NN
46745	4470	22	-	-	HYPH
46745	4470	23	cell	cell	NN
46745	4470	24	,	,	,
46745	4470	25	are	be	VBP
46745	4470	26	brought	bring	VBN
46745	4470	27	directly	directly	RB
46745	4470	28	into	into	IN
46745	4470	29	contact	contact	NN
46745	4470	30	with	with	IN
46745	4470	31	air	air	NN
46745	4470	32	.	.	.
46745	4471	1	And	and	CC
46745	4471	2	in	in	IN
46745	4471	3	this	this	DT
46745	4471	4	air	air	NN
46745	4471	5	these	these	DT
46745	4471	6	volatile	volatile	JJ
46745	4471	7	matters	matter	NNS
46745	4471	8	are	be	VBP
46745	4471	9	soluble	soluble	JJ
46745	4471	10	,	,	,
46745	4471	11	and	and	CC
46745	4471	12	are	be	VBP
46745	4471	13	carried	carry	VBN
46745	4471	14	away	away	RP
46745	4471	15	by	by	IN
46745	4471	16	it	-PRON-	PRP
46745	4471	17	.	.	.
46745	4472	1	This	this	DT
46745	4472	2	appears	appear	VBZ
46745	4472	3	to	to	TO
46745	4472	4	be	be	VB
46745	4472	5	the	the	DT
46745	4472	6	reason	reason	NN
46745	4472	7	why	why	WRB
46745	4472	8	the	the	DT
46745	4472	9	Eliminatives	Eliminatives	NNPS
46745	4472	10	which	which	WDT
46745	4472	11	are	be	VBP
46745	4472	12	volatile	volatile	JJ
46745	4472	13	in	in	IN
46745	4472	14	nature	nature	NN
46745	4472	15	tend	tend	VBP
46745	4472	16	particularly	particularly	RB
46745	4472	17	to	to	TO
46745	4472	18	act	act	VB
46745	4472	19	on	on	IN
46745	4472	20	the	the	DT
46745	4472	21	two	two	CD
46745	4472	22	aeriform	aeriform	NN
46745	4472	23	secretions,--_i.e	secretions,--_i.e	NNP
46745	4472	24	.	.	.
46745	4472	25	_	_	NNP
46745	4472	26	on	on	IN
46745	4472	27	that	that	DT
46745	4472	28	of	of	IN
46745	4472	29	the	the	DT
46745	4472	30	air	air	NN
46745	4472	31	-	-	HYPH
46745	4472	32	cells	cell	NNS
46745	4472	33	of	of	IN
46745	4472	34	the	the	DT
46745	4472	35	lungs	lung	NNS
46745	4472	36	,	,	,
46745	4472	37	and	and	CC
46745	4472	38	on	on	IN
46745	4472	39	the	the	DT
46745	4472	40	common	common	JJ
46745	4472	41	cutaneous	cutaneous	JJ
46745	4472	42	transpiration	transpiration	NN
46745	4472	43	.	.	.
46745	4473	1	For	for	IN
46745	4473	2	though	though	IN
46745	4473	3	the	the	DT
46745	4473	4	glands	gland	NNS
46745	4473	5	of	of	IN
46745	4473	6	the	the	DT
46745	4473	7	mucous	mucous	JJ
46745	4473	8	membrane	membrane	NN
46745	4473	9	of	of	IN
46745	4473	10	the	the	DT
46745	4473	11	lungs	lung	NNS
46745	4473	12	secrete	secrete	NNP
46745	4473	13	mucus	mucus	NN
46745	4473	14	,	,	,
46745	4473	15	yet	yet	CC
46745	4473	16	the	the	DT
46745	4473	17	chief	chief	JJ
46745	4473	18	object	object	NN
46745	4473	19	of	of	IN
46745	4473	20	the	the	DT
46745	4473	21	terminal	terminal	JJ
46745	4473	22	portion	portion	NN
46745	4473	23	of	of	IN
46745	4473	24	that	that	DT
46745	4473	25	membrane	membrane	NN
46745	4473	26	is	be	VBZ
46745	4473	27	to	to	TO
46745	4473	28	absorb	absorb	VB
46745	4473	29	and	and	CC
46745	4473	30	secrete	secrete	VB
46745	4473	31	the	the	DT
46745	4473	32	gaseous	gaseous	JJ
46745	4473	33	matters	matter	NNS
46745	4473	34	of	of	IN
46745	4473	35	the	the	DT
46745	4473	36	blood	blood	NN
46745	4473	37	.	.	.
46745	4474	1	The	the	DT
46745	4474	2	following	follow	VBG
46745	4474	3	are	be	VBP
46745	4474	4	the	the	DT
46745	4474	5	chief	chief	JJ
46745	4474	6	volatile	volatile	JJ
46745	4474	7	Expectorants	Expectorants	NNP
46745	4474	8	,	,	,
46745	4474	9	the	the	DT
46745	4474	10	odours	odour	NNS
46745	4474	11	of	of	IN
46745	4474	12	which	which	WDT
46745	4474	13	have	have	VBP
46745	4474	14	been	be	VBN
46745	4474	15	clearly	clearly	RB
46745	4474	16	detected	detect	VBN
46745	4474	17	in	in	IN
46745	4474	18	the	the	DT
46745	4474	19	breath	breath	NN
46745	4474	20	of	of	IN
46745	4474	21	persons	person	NNS
46745	4474	22	to	to	IN
46745	4474	23	whom	whom	WP
46745	4474	24	they	-PRON-	PRP
46745	4474	25	have	have	VBP
46745	4474	26	been	be	VBN
46745	4474	27	administered:--Turpentine	administered:--turpentine	NN
46745	4474	28	,	,	,
46745	4474	29	Camphor	Camphor	NNP
46745	4474	30	,	,	,
46745	4474	31	Alcohol	Alcohol	NNP
46745	4474	32	,	,	,
46745	4474	33	Ether	Ether	NNP
46745	4474	34	,	,	,
46745	4474	35	and	and	CC
46745	4474	36	the	the	DT
46745	4474	37	volatile	volatile	JJ
46745	4474	38	oils	oil	NNS
46745	4474	39	of	of	IN
46745	4474	40	Onions	Onions	NNPS
46745	4474	41	,	,	,
46745	4474	42	Fennel	Fennel	NNP
46745	4474	43	,	,	,
46745	4474	44	Asaf[oe]tida	Asaf[oe]tida	NNP
46745	4474	45	,	,	,
46745	4474	46	Carraway	Carraway	NNP
46745	4474	47	,	,	,
46745	4474	48	Cinnamon	Cinnamon	NNP
46745	4474	49	,	,	,
46745	4474	50	and	and	CC
46745	4474	51	Anise	Anise	NNP
46745	4474	52	.	.	.
46745	4475	1	These	these	DT
46745	4475	2	medicines	medicine	NNS
46745	4475	3	,	,	,
46745	4475	4	and	and	CC
46745	4475	5	others	other	NNS
46745	4475	6	like	like	IN
46745	4475	7	them	-PRON-	PRP
46745	4475	8	,	,	,
46745	4475	9	are	be	VBP
46745	4475	10	thus	thus	RB
46745	4475	11	excreted	excrete	VBN
46745	4475	12	by	by	IN
46745	4475	13	the	the	DT
46745	4475	14	air	air	NN
46745	4475	15	-	-	HYPH
46745	4475	16	cells	cell	NNS
46745	4475	17	or	or	CC
46745	4475	18	mucous	mucous	JJ
46745	4475	19	glands	gland	NNS
46745	4475	20	of	of	IN
46745	4475	21	the	the	DT
46745	4475	22	pulmonary	pulmonary	JJ
46745	4475	23	surface	surface	NN
46745	4475	24	,	,	,
46745	4475	25	and	and	CC
46745	4475	26	while	while	IN
46745	4475	27	thus	thus	RB
46745	4475	28	passing	pass	VBG
46745	4475	29	through	through	IN
46745	4475	30	they	-PRON-	PRP
46745	4475	31	stimulate	stimulate	VBP
46745	4475	32	the	the	DT
46745	4475	33	latter	latter	JJ
46745	4475	34	to	to	IN
46745	4475	35	a	a	DT
46745	4475	36	right	right	JJ
46745	4475	37	performance	performance	NN
46745	4475	38	of	of	IN
46745	4475	39	their	-PRON-	PRP$
46745	4475	40	function	function	NN
46745	4475	41	.	.	.
46745	4476	1	When	when	WRB
46745	4476	2	,	,	,
46745	4476	3	as	as	IN
46745	4476	4	in	in	IN
46745	4476	5	the	the	DT
46745	4476	6	case	case	NN
46745	4476	7	of	of	IN
46745	4476	8	Bronchitis	Bronchitis	NNP
46745	4476	9	,	,	,
46745	4476	10	the	the	DT
46745	4476	11	secretion	secretion	NN
46745	4476	12	of	of	IN
46745	4476	13	mucus	mucus	NNP
46745	4476	14	is	be	VBZ
46745	4476	15	increased	increase	VBN
46745	4476	16	in	in	IN
46745	4476	17	amount	amount	NN
46745	4476	18	,	,	,
46745	4476	19	or	or	CC
46745	4476	20	deteriorated	deteriorate	VBD
46745	4476	21	into	into	IN
46745	4476	22	a	a	DT
46745	4476	23	purulent	purulent	NN
46745	4476	24	matter	matter	NN
46745	4476	25	,	,	,
46745	4476	26	they	-PRON-	PRP
46745	4476	27	may	may	MD
46745	4476	28	be	be	VB
46745	4476	29	of	of	IN
46745	4476	30	service	service	NN
46745	4476	31	by	by	IN
46745	4476	32	causing	cause	VBG
46745	4476	33	the	the	DT
46745	4476	34	healthy	healthy	JJ
46745	4476	35	secretion	secretion	NN
46745	4476	36	to	to	TO
46745	4476	37	replace	replace	VB
46745	4476	38	the	the	DT
46745	4476	39	diseased	diseased	JJ
46745	4476	40	one	one	CD
46745	4476	41	.	.	.
46745	4477	1	Expectorants	expectorant	NNS
46745	4477	2	are	be	VBP
46745	4477	3	very	very	RB
46745	4477	4	uncertain	uncertain	JJ
46745	4477	5	agents	agent	NNS
46745	4477	6	.	.	.
46745	4478	1	The	the	DT
46745	4478	2	reason	reason	NN
46745	4478	3	of	of	IN
46745	4478	4	this	this	DT
46745	4478	5	is	be	VBZ
46745	4478	6	,	,	,
46745	4478	7	that	that	IN
46745	4478	8	the	the	DT
46745	4478	9	pulmonary	pulmonary	JJ
46745	4478	10	glands	gland	NNS
46745	4478	11	are	be	VBP
46745	4478	12	not	not	RB
46745	4478	13	naturally	naturally	RB
46745	4478	14	intended	intend	VBN
46745	4478	15	to	to	TO
46745	4478	16	act	act	VB
46745	4478	17	as	as	IN
46745	4478	18	emunctories	emunctorie	NNS
46745	4478	19	,	,	,
46745	4478	20	or	or	CC
46745	4478	21	dischargers	discharger	NNS
46745	4478	22	of	of	IN
46745	4478	23	morbid	morbid	NN
46745	4478	24	matters	matter	NNS
46745	4478	25	from	from	IN
46745	4478	26	the	the	DT
46745	4478	27	blood	blood	NN
46745	4478	28	,	,	,
46745	4478	29	and	and	CC
46745	4478	30	thus	thus	RB
46745	4478	31	are	be	VBP
46745	4478	32	less	less	RBR
46745	4478	33	prone	prone	JJ
46745	4478	34	to	to	TO
46745	4478	35	be	be	VB
46745	4478	36	excited	excite	VBN
46745	4478	37	by	by	IN
46745	4478	38	Eliminative	eliminative	JJ
46745	4478	39	medicines	medicine	NNS
46745	4478	40	than	than	IN
46745	4478	41	other	other	JJ
46745	4478	42	glands	gland	NNS
46745	4478	43	whose	whose	WP$
46745	4478	44	proper	proper	JJ
46745	4478	45	office	office	NN
46745	4478	46	is	be	VBZ
46745	4478	47	one	one	CD
46745	4478	48	of	of	IN
46745	4478	49	general	general	JJ
46745	4478	50	elimination	elimination	NN
46745	4478	51	.	.	.
46745	4479	1	And	and	CC
46745	4479	2	yet	yet	RB
46745	4479	3	we	-PRON-	PRP
46745	4479	4	find	find	VBP
46745	4479	5	that	that	IN
46745	4479	6	the	the	DT
46745	4479	7	effete	effete	JJ
46745	4479	8	gases	gas	NNS
46745	4479	9	which	which	WDT
46745	4479	10	should	should	MD
46745	4479	11	be	be	VB
46745	4479	12	excreted	excrete	VBN
46745	4479	13	by	by	IN
46745	4479	14	the	the	DT
46745	4479	15	bowels	bowel	NNS
46745	4479	16	are	be	VBP
46745	4479	17	sometimes	sometimes	RB
46745	4479	18	voided	void	VBN
46745	4479	19	by	by	IN
46745	4479	20	the	the	DT
46745	4479	21	lungs	lung	NNS
46745	4479	22	in	in	IN
46745	4479	23	case	case	NN
46745	4479	24	of	of	IN
46745	4479	25	aggravated	aggravate	VBN
46745	4479	26	dyspepsia	dyspepsia	NNP
46745	4479	27	,	,	,
46745	4479	28	causing	cause	VBG
46745	4479	29	tainted	tainted	JJ
46745	4479	30	breath	breath	NN
46745	4479	31	.	.	.
46745	4480	1	Just	just	RB
46745	4480	2	so	so	RB
46745	4480	3	may	may	MD
46745	4480	4	other	other	JJ
46745	4480	5	adventitious	adventitious	JJ
46745	4480	6	elements	element	NNS
46745	4480	7	of	of	IN
46745	4480	8	the	the	DT
46745	4480	9	blood	blood	NN
46745	4480	10	,	,	,
46745	4480	11	as	as	IN
46745	4480	12	these	these	DT
46745	4480	13	volatile	volatile	JJ
46745	4480	14	medicines	medicine	NNS
46745	4480	15	,	,	,
46745	4480	16	be	be	VB
46745	4480	17	sometimes	sometimes	RB
46745	4480	18	excreted	excrete	VBN
46745	4480	19	by	by	IN
46745	4480	20	the	the	DT
46745	4480	21	pulmonary	pulmonary	JJ
46745	4480	22	membrane	membrane	NN
46745	4480	23	.	.	.
46745	4481	1	But	but	CC
46745	4481	2	they	-PRON-	PRP
46745	4481	3	may	may	MD
46745	4481	4	often	often	RB
46745	4481	5	pass	pass	VB
46745	4481	6	off	off	RP
46745	4481	7	by	by	IN
46745	4481	8	the	the	DT
46745	4481	9	skin	skin	NN
46745	4481	10	or	or	CC
46745	4481	11	by	by	IN
46745	4481	12	the	the	DT
46745	4481	13	urine	urine	NN
46745	4481	14	,	,	,
46745	4481	15	and	and	CC
46745	4481	16	would	would	MD
46745	4481	17	not	not	RB
46745	4481	18	then	then	RB
46745	4481	19	act	act	VB
46745	4481	20	upon	upon	IN
46745	4481	21	the	the	DT
46745	4481	22	lungs	lung	NNS
46745	4481	23	at	at	RB
46745	4481	24	all	all	RB
46745	4481	25	.	.	.
46745	4482	1	For	for	IN
46745	4482	2	the	the	DT
46745	4482	3	same	same	JJ
46745	4482	4	reason	reason	NN
46745	4482	5	that	that	IN
46745	4482	6	the	the	DT
46745	4482	7	lungs	lung	NNS
46745	4482	8	are	be	VBP
46745	4482	9	not	not	RB
46745	4482	10	general	general	JJ
46745	4482	11	emunctories	emunctorie	NNS
46745	4482	12	,	,	,
46745	4482	13	and	and	CC
46745	4482	14	can	can	MD
46745	4482	15	not	not	RB
46745	4482	16	be	be	VB
46745	4482	17	made	make	VBN
46745	4482	18	use	use	NN
46745	4482	19	of	of	IN
46745	4482	20	to	to	TO
46745	4482	21	produce	produce	VB
46745	4482	22	a	a	DT
46745	4482	23	wholesale	wholesale	JJ
46745	4482	24	evacuation	evacuation	NN
46745	4482	25	from	from	IN
46745	4482	26	the	the	DT
46745	4482	27	blood	blood	NN
46745	4482	28	,	,	,
46745	4482	29	Expectorants	expectorant	NNS
46745	4482	30	are	be	VBP
46745	4482	31	of	of	IN
46745	4482	32	no	no	DT
46745	4482	33	use	use	NN
46745	4482	34	as	as	IN
46745	4482	35	general	general	JJ
46745	4482	36	Antiphlogistics	Antiphlogistics	NNP
46745	4482	37	.	.	.
46745	4483	1	In	in	IN
46745	4483	2	this	this	DT
46745	4483	3	they	-PRON-	PRP
46745	4483	4	differ	differ	VBP
46745	4483	5	from	from	IN
46745	4483	6	the	the	DT
46745	4483	7	four	four	CD
46745	4483	8	remaining	remain	VBG
46745	4483	9	groups	group	NNS
46745	4483	10	of	of	IN
46745	4483	11	Eliminatives	Eliminatives	NNPS
46745	4483	12	.	.	.
46745	4484	1	They	-PRON-	PRP
46745	4484	2	are	be	VBP
46745	4484	3	only	only	RB
46745	4484	4	employed	employ	VBN
46745	4484	5	in	in	IN
46745	4484	6	pulmonary	pulmonary	JJ
46745	4484	7	disorders	disorder	NNS
46745	4484	8	,	,	,
46745	4484	9	where	where	WRB
46745	4484	10	we	-PRON-	PRP
46745	4484	11	desire	desire	VBP
46745	4484	12	to	to	TO
46745	4484	13	influence	influence	VB
46745	4484	14	the	the	DT
46745	4484	15	amount	amount	NN
46745	4484	16	or	or	CC
46745	4484	17	character	character	NN
46745	4484	18	of	of	IN
46745	4484	19	the	the	DT
46745	4484	20	mucous	mucous	JJ
46745	4484	21	secretion	secretion	NN
46745	4484	22	,	,	,
46745	4484	23	when	when	WRB
46745	4484	24	the	the	DT
46745	4484	25	mucous	mucous	JJ
46745	4484	26	membrane	membrane	NN
46745	4484	27	is	be	VBZ
46745	4484	28	inflamed	inflame	VBN
46745	4484	29	or	or	CC
46745	4484	30	irritated	irritated	JJ
46745	4484	31	.	.	.
46745	4485	1	In	in	IN
46745	4485	2	old	old	JJ
46745	4485	3	and	and	CC
46745	4485	4	chronic	chronic	JJ
46745	4485	5	cases	case	NNS
46745	4485	6	of	of	IN
46745	4485	7	Bronchitis	Bronchitis	NNP
46745	4485	8	the	the	DT
46745	4485	9	stimulant	stimulant	NN
46745	4485	10	volatile	volatile	JJ
46745	4485	11	Expectorants	expectorant	NNS
46745	4485	12	are	be	VBP
46745	4485	13	the	the	DT
46745	4485	14	most	most	RBS
46745	4485	15	applicable	applicable	JJ
46745	4485	16	.	.	.
46745	4486	1	Tartar	Tartar	NNP
46745	4486	2	Emetic	Emetic	NNP
46745	4486	3	and	and	CC
46745	4486	4	Ipecacuanha	Ipecacuanha	NNP
46745	4486	5	are	be	VBP
46745	4486	6	appropriate	appropriate	JJ
46745	4486	7	in	in	IN
46745	4486	8	acute	acute	JJ
46745	4486	9	and	and	CC
46745	4486	10	inflammatory	inflammatory	JJ
46745	4486	11	cases	case	NNS
46745	4486	12	,	,	,
46745	4486	13	because	because	IN
46745	4486	14	they	-PRON-	PRP
46745	4486	15	exert	exert	VBP
46745	4486	16	a	a	DT
46745	4486	17	nauseating	nauseate	VBG
46745	4486	18	and	and	CC
46745	4486	19	depressing	depressing	JJ
46745	4486	20	action	action	NN
46745	4486	21	.	.	.
46745	4487	1	They	-PRON-	PRP
46745	4487	2	are	be	VBP
46745	4487	3	sometimes	sometimes	RB
46745	4487	4	given	give	VBN
46745	4487	5	in	in	IN
46745	4487	6	sufficient	sufficient	JJ
46745	4487	7	dose	dose	NN
46745	4487	8	to	to	TO
46745	4487	9	act	act	VB
46745	4487	10	as	as	IN
46745	4487	11	Emetics	emetic	NNS
46745	4487	12	;	;	:
46745	4487	13	for	for	IN
46745	4487	14	the	the	DT
46745	4487	15	act	act	NN
46745	4487	16	of	of	IN
46745	4487	17	vomiting	vomiting	NN
46745	4487	18	mechanically	mechanically	RB
46745	4487	19	assists	assist	VBZ
46745	4487	20	the	the	DT
46745	4487	21	expulsion	expulsion	NN
46745	4487	22	of	of	IN
46745	4487	23	mucus	mucus	NN
46745	4487	24	from	from	IN
46745	4487	25	the	the	DT
46745	4487	26	air	air	NN
46745	4487	27	-	-	HYPH
46745	4487	28	cells	cell	NNS
46745	4487	29	and	and	CC
46745	4487	30	passages	passage	NNS
46745	4487	31	by	by	IN
46745	4487	32	causing	cause	VBG
46745	4487	33	straining	straining	NN
46745	4487	34	and	and	CC
46745	4487	35	compression	compression	NN
46745	4487	36	of	of	IN
46745	4487	37	the	the	DT
46745	4487	38	lungs	lung	NNS
46745	4487	39	.	.	.
46745	4488	1	ORD	ORD	NNP
46745	4488	2	.	.	.
46745	4489	1	III	iii	CD
46745	4489	2	.	.	.
46745	4490	1	CATHARTICS	cathartics	UH
46745	4490	2	.	.	.
46745	4491	1	Cathartics	cathartic	NNS
46745	4491	2	are	be	VBP
46745	4491	3	medicines	medicine	NNS
46745	4491	4	which	which	WDT
46745	4491	5	tend	tend	VBP
46745	4491	6	to	to	TO
46745	4491	7	increase	increase	VB
46745	4491	8	the	the	DT
46745	4491	9	secretion	secretion	NN
46745	4491	10	from	from	IN
46745	4491	11	the	the	DT
46745	4491	12	inner	inner	JJ
46745	4491	13	surface	surface	NN
46745	4491	14	of	of	IN
46745	4491	15	the	the	DT
46745	4491	16	bowels	bowel	NNS
46745	4491	17	,	,	,
46745	4491	18	and	and	CC
46745	4491	19	promote	promote	VB
46745	4491	20	the	the	DT
46745	4491	21	natural	natural	JJ
46745	4491	22	expulsion	expulsion	NN
46745	4491	23	of	of	IN
46745	4491	24	the	the	DT
46745	4491	25	contents	content	NNS
46745	4491	26	of	of	IN
46745	4491	27	the	the	DT
46745	4491	28	intestinal	intestinal	JJ
46745	4491	29	tube	tube	NN
46745	4491	30	.	.	.
46745	4492	1	Of	of	IN
46745	4492	2	these	these	DT
46745	4492	3	two	two	CD
46745	4492	4	operations	operation	NNS
46745	4492	5	the	the	DT
46745	4492	6	first	first	JJ
46745	4492	7	only	only	RB
46745	4492	8	is	be	VBZ
46745	4492	9	an	an	DT
46745	4492	10	action	action	NN
46745	4492	11	of	of	IN
46745	4492	12	elimination	elimination	NN
46745	4492	13	,	,	,
46745	4492	14	and	and	CC
46745	4492	15	the	the	DT
46745	4492	16	second	second	JJ
46745	4492	17	is	be	VBZ
46745	4492	18	an	an	DT
46745	4492	19	accompaniment	accompaniment	NN
46745	4492	20	to	to	IN
46745	4492	21	it	-PRON-	PRP
46745	4492	22	.	.	.
46745	4493	1	The	the	DT
46745	4493	2	first	first	JJ
46745	4493	3	can	can	MD
46745	4493	4	hardly	hardly	RB
46745	4493	5	take	take	VB
46745	4493	6	place	place	NN
46745	4493	7	without	without	IN
46745	4493	8	being	be	VBG
46745	4493	9	followed	follow	VBN
46745	4493	10	by	by	IN
46745	4493	11	the	the	DT
46745	4493	12	second	second	JJ
46745	4493	13	;	;	:
46745	4493	14	but	but	CC
46745	4493	15	in	in	IN
46745	4493	16	some	some	DT
46745	4493	17	few	few	JJ
46745	4493	18	cases	case	NNS
46745	4493	19	the	the	DT
46745	4493	20	second	second	JJ
46745	4493	21	action	action	NN
46745	4493	22	alone	alone	RB
46745	4493	23	may	may	MD
46745	4493	24	be	be	VB
46745	4493	25	produced	produce	VBN
46745	4493	26	.	.	.
46745	4494	1	The	the	DT
46745	4494	2	subject	subject	NN
46745	4494	3	of	of	IN
46745	4494	4	the	the	DT
46745	4494	5	application	application	NN
46745	4494	6	of	of	IN
46745	4494	7	Purgative	purgative	JJ
46745	4494	8	medicines	medicine	NNS
46745	4494	9	is	be	VBZ
46745	4494	10	so	so	RB
46745	4494	11	extensive	extensive	JJ
46745	4494	12	,	,	,
46745	4494	13	that	that	IN
46745	4494	14	it	-PRON-	PRP
46745	4494	15	is	be	VBZ
46745	4494	16	impossible	impossible	JJ
46745	4494	17	for	for	IN
46745	4494	18	us	-PRON-	PRP
46745	4494	19	now	now	RB
46745	4494	20	to	to	TO
46745	4494	21	inquire	inquire	VB
46745	4494	22	into	into	IN
46745	4494	23	it	-PRON-	PRP
46745	4494	24	at	at	IN
46745	4494	25	any	any	DT
46745	4494	26	great	great	JJ
46745	4494	27	length	length	NN
46745	4494	28	.	.	.
46745	4495	1	It	-PRON-	PRP
46745	4495	2	should	should	MD
46745	4495	3	however	however	RB
46745	4495	4	be	be	VB
46745	4495	5	observed	observe	VBN
46745	4495	6	,	,	,
46745	4495	7	that	that	IN
46745	4495	8	they	-PRON-	PRP
46745	4495	9	are	be	VBP
46745	4495	10	the	the	DT
46745	4495	11	most	most	RBS
46745	4495	12	powerful	powerful	JJ
46745	4495	13	and	and	CC
46745	4495	14	the	the	DT
46745	4495	15	most	most	RBS
46745	4495	16	useful	useful	JJ
46745	4495	17	of	of	IN
46745	4495	18	all	all	DT
46745	4495	19	Eliminative	eliminative	JJ
46745	4495	20	medicines	medicine	NNS
46745	4495	21	.	.	.
46745	4496	1	The	the	DT
46745	4496	2	fæces	fæce	NNS
46745	4496	3	consist	consist	VBP
46745	4496	4	partly	partly	RB
46745	4496	5	of	of	IN
46745	4496	6	the	the	DT
46745	4496	7	undigested	undigested	JJ
46745	4496	8	matters	matter	NNS
46745	4496	9	of	of	IN
46745	4496	10	the	the	DT
46745	4496	11	food	food	NN
46745	4496	12	,	,	,
46745	4496	13	and	and	CC
46745	4496	14	partly	partly	RB
46745	4496	15	of	of	IN
46745	4496	16	a	a	DT
46745	4496	17	secretion	secretion	NN
46745	4496	18	which	which	WDT
46745	4496	19	is	be	VBZ
46745	4496	20	poured	pour	VBN
46745	4496	21	out	out	RP
46745	4496	22	by	by	IN
46745	4496	23	the	the	DT
46745	4496	24	inner	inner	JJ
46745	4496	25	surface	surface	NN
46745	4496	26	of	of	IN
46745	4496	27	the	the	DT
46745	4496	28	bowel	bowel	NN
46745	4496	29	.	.	.
46745	4497	1	(	(	-LRB-
46745	4497	2	_	_	NNP
46745	4497	3	Vide	Vide	NNP
46745	4497	4	infra	infra	NN
46745	4497	5	.	.	.
46745	4497	6	_	_	NNP
46745	4497	7	)	)	-RRB-
46745	4497	8	The	the	DT
46745	4497	9	majority	majority	NN
46745	4497	10	of	of	IN
46745	4497	11	Cathartics	Cathartics	NNPS
46745	4497	12	increase	increase	VBP
46745	4497	13	this	this	DT
46745	4497	14	secretion	secretion	NN
46745	4497	15	.	.	.
46745	4498	1	Whatever	whatever	WDT
46745	4498	2	notion	notion	NN
46745	4498	3	we	-PRON-	PRP
46745	4498	4	may	may	MD
46745	4498	5	adopt	adopt	VB
46745	4498	6	as	as	IN
46745	4498	7	to	to	IN
46745	4498	8	its	-PRON-	PRP$
46745	4498	9	physiological	physiological	JJ
46745	4498	10	purpose	purpose	NN
46745	4498	11	,	,	,
46745	4498	12	it	-PRON-	PRP
46745	4498	13	appears	appear	VBZ
46745	4498	14	that	that	IN
46745	4498	15	we	-PRON-	PRP
46745	4498	16	can	can	MD
46745	4498	17	act	act	VB
46745	4498	18	upon	upon	IN
46745	4498	19	this	this	DT
46745	4498	20	intestinal	intestinal	JJ
46745	4498	21	function	function	NN
46745	4498	22	with	with	IN
46745	4498	23	ease	ease	NN
46745	4498	24	and	and	CC
46745	4498	25	certainty	certainty	NN
46745	4498	26	in	in	IN
46745	4498	27	the	the	DT
46745	4498	28	great	great	JJ
46745	4498	29	majority	majority	NN
46745	4498	30	of	of	IN
46745	4498	31	cases	case	NNS
46745	4498	32	.	.	.
46745	4499	1	The	the	DT
46745	4499	2	surface	surface	NN
46745	4499	3	of	of	IN
46745	4499	4	the	the	DT
46745	4499	5	intestine	intestine	NN
46745	4499	6	,	,	,
46745	4499	7	covered	cover	VBN
46745	4499	8	as	as	IN
46745	4499	9	it	-PRON-	PRP
46745	4499	10	is	be	VBZ
46745	4499	11	with	with	IN
46745	4499	12	a	a	DT
46745	4499	13	closely	closely	RB
46745	4499	14	packed	pack	VBN
46745	4499	15	glandular	glandular	JJ
46745	4499	16	apparatus	apparatus	NN
46745	4499	17	,	,	,
46745	4499	18	forms	form	NNS
46745	4499	19	in	in	IN
46745	4499	20	the	the	DT
46745	4499	21	aggregate	aggregate	NN
46745	4499	22	the	the	DT
46745	4499	23	largest	large	JJS
46745	4499	24	secreting	secreting	JJ
46745	4499	25	organ	organ	NN
46745	4499	26	in	in	IN
46745	4499	27	the	the	DT
46745	4499	28	body	body	NN
46745	4499	29	.	.	.
46745	4500	1	From	from	IN
46745	4500	2	the	the	DT
46745	4500	3	measurements	measurement	NNS
46745	4500	4	made	make	VBN
46745	4500	5	by	by	IN
46745	4500	6	Meckel	Meckel	NNP
46745	4500	7	,	,	,
46745	4500	8	it	-PRON-	PRP
46745	4500	9	appears	appear	VBZ
46745	4500	10	that	that	IN
46745	4500	11	it	-PRON-	PRP
46745	4500	12	covers	cover	VBZ
46745	4500	13	a	a	DT
46745	4500	14	space	space	NN
46745	4500	15	of	of	IN
46745	4500	16	1400	1400	CD
46745	4500	17	square	square	JJ
46745	4500	18	inches	inch	NNS
46745	4500	19	.	.	.
46745	4501	1	By	by	IN
46745	4501	2	the	the	DT
46745	4501	3	administration	administration	NN
46745	4501	4	of	of	IN
46745	4501	5	a	a	DT
46745	4501	6	medicine	medicine	NN
46745	4501	7	of	of	IN
46745	4501	8	this	this	DT
46745	4501	9	sort	sort	NN
46745	4501	10	,	,	,
46745	4501	11	we	-PRON-	PRP
46745	4501	12	are	be	VBP
46745	4501	13	enabled	enable	VBN
46745	4501	14	to	to	TO
46745	4501	15	act	act	VB
46745	4501	16	upon	upon	IN
46745	4501	17	this	this	DT
46745	4501	18	surface	surface	NN
46745	4501	19	,	,	,
46745	4501	20	producing	produce	VBG
46745	4501	21	simply	simply	RB
46745	4501	22	an	an	DT
46745	4501	23	increase	increase	NN
46745	4501	24	of	of	IN
46745	4501	25	the	the	DT
46745	4501	26	fæcal	fæcal	JJ
46745	4501	27	secretion	secretion	NN
46745	4501	28	,	,	,
46745	4501	29	or	or	CC
46745	4501	30	causing	cause	VBG
46745	4501	31	,	,	,
46745	4501	32	when	when	WRB
46745	4501	33	the	the	DT
46745	4501	34	action	action	NN
46745	4501	35	is	be	VBZ
46745	4501	36	violent	violent	JJ
46745	4501	37	,	,	,
46745	4501	38	an	an	DT
46745	4501	39	outpouring	outpoure	VBG
46745	4501	40	even	even	RB
46745	4501	41	of	of	IN
46745	4501	42	the	the	DT
46745	4501	43	fluid	fluid	JJ
46745	4501	44	part	part	NN
46745	4501	45	of	of	IN
46745	4501	46	the	the	DT
46745	4501	47	blood	blood	NN
46745	4501	48	.	.	.
46745	4502	1	When	when	WRB
46745	4502	2	this	this	DT
46745	4502	3	secretion	secretion	NN
46745	4502	4	is	be	VBZ
46745	4502	5	stopped	stop	VBN
46745	4502	6	,	,	,
46745	4502	7	we	-PRON-	PRP
46745	4502	8	may	may	MD
46745	4502	9	cause	cause	VB
46745	4502	10	it	-PRON-	PRP
46745	4502	11	to	to	TO
46745	4502	12	reappear	reappear	VB
46745	4502	13	;	;	:
46745	4502	14	when	when	WRB
46745	4502	15	another	another	DT
46745	4502	16	secretion	secretion	NN
46745	4502	17	is	be	VBZ
46745	4502	18	repressed	repressed	JJ
46745	4502	19	,	,	,
46745	4502	20	we	-PRON-	PRP
46745	4502	21	may	may	MD
46745	4502	22	be	be	VB
46745	4502	23	enabled	enable	VBN
46745	4502	24	to	to	TO
46745	4502	25	replace	replace	VB
46745	4502	26	it	-PRON-	PRP
46745	4502	27	by	by	IN
46745	4502	28	this	this	DT
46745	4502	29	;	;	:
46745	4502	30	and	and	CC
46745	4502	31	in	in	IN
46745	4502	32	the	the	DT
46745	4502	33	treatment	treatment	NN
46745	4502	34	of	of	IN
46745	4502	35	plethoric	plethoric	NN
46745	4502	36	or	or	CC
46745	4502	37	inflammatory	inflammatory	JJ
46745	4502	38	disorders	disorder	NNS
46745	4502	39	,	,	,
46745	4502	40	we	-PRON-	PRP
46745	4502	41	find	find	VBP
46745	4502	42	among	among	IN
46745	4502	43	Cathartics	cathartic	NNS
46745	4502	44	the	the	DT
46745	4502	45	simplest	simple	JJS
46745	4502	46	and	and	CC
46745	4502	47	readiest	readiest	NN
46745	4502	48	of	of	IN
46745	4502	49	antiphlogistic	antiphlogistic	JJ
46745	4502	50	or	or	CC
46745	4502	51	evacuant	evacuant	JJ
46745	4502	52	medicines	medicine	NNS
46745	4502	53	.	.	.
46745	4503	1	For	for	IN
46745	4503	2	they	-PRON-	PRP
46745	4503	3	possess	possess	VBP
46745	4503	4	these	these	DT
46745	4503	5	great	great	JJ
46745	4503	6	advantages,--that	advantages,--that	.
46745	4503	7	they	-PRON-	PRP
46745	4503	8	act	act	VBP
46745	4503	9	with	with	IN
46745	4503	10	certainty	certainty	NN
46745	4503	11	,	,	,
46745	4503	12	and	and	CC
46745	4503	13	produce	produce	VB
46745	4503	14	a	a	DT
46745	4503	15	notable	notable	JJ
46745	4503	16	effect	effect	NN
46745	4503	17	.	.	.
46745	4504	1	All	all	DT
46745	4504	2	medicines	medicine	NNS
46745	4504	3	which	which	WDT
46745	4504	4	by	by	IN
46745	4504	5	a	a	DT
46745	4504	6	mere	mere	JJ
46745	4504	7	external	external	JJ
46745	4504	8	action	action	NN
46745	4504	9	augment	augment	VBD
46745	4504	10	the	the	DT
46745	4504	11	secretion	secretion	NN
46745	4504	12	of	of	IN
46745	4504	13	the	the	DT
46745	4504	14	bowels	bowel	NNS
46745	4504	15	,	,	,
46745	4504	16	or	or	CC
46745	4504	17	promote	promote	VB
46745	4504	18	its	-PRON-	PRP$
46745	4504	19	evacuation	evacuation	NN
46745	4504	20	,	,	,
46745	4504	21	must	must	MD
46745	4504	22	be	be	VB
46745	4504	23	regarded	regard	VBN
46745	4504	24	as	as	IN
46745	4504	25	_	_	NNP
46745	4504	26	indirect	indirect	NN
46745	4504	27	_	_	NNP
46745	4504	28	Cathartics	Cathartics	NNP
46745	4504	29	,	,	,
46745	4504	30	for	for	IN
46745	4504	31	they	-PRON-	PRP
46745	4504	32	do	do	VBP
46745	4504	33	not	not	RB
46745	4504	34	operate	operate	VB
46745	4504	35	on	on	IN
46745	4504	36	the	the	DT
46745	4504	37	eliminative	eliminative	JJ
46745	4504	38	principle	principle	NN
46745	4504	39	.	.	.
46745	4505	1	An	an	DT
46745	4505	2	outward	outward	JJ
46745	4505	3	irritation	irritation	NN
46745	4505	4	of	of	IN
46745	4505	5	the	the	DT
46745	4505	6	mucous	mucous	JJ
46745	4505	7	membrane	membrane	NN
46745	4505	8	is	be	VBZ
46745	4505	9	sufficient	sufficient	JJ
46745	4505	10	to	to	TO
46745	4505	11	excite	excite	VB
46745	4505	12	the	the	DT
46745	4505	13	peristaltic	peristaltic	JJ
46745	4505	14	contraction	contraction	NN
46745	4505	15	of	of	IN
46745	4505	16	the	the	DT
46745	4505	17	bowel	bowel	NN
46745	4505	18	,	,	,
46745	4505	19	and	and	CC
46745	4505	20	may	may	MD
46745	4505	21	even	even	RB
46745	4505	22	increase	increase	VB
46745	4505	23	the	the	DT
46745	4505	24	secretion	secretion	NN
46745	4505	25	of	of	IN
46745	4505	26	that	that	DT
46745	4505	27	mucous	mucous	JJ
46745	4505	28	surface	surface	NN
46745	4505	29	by	by	IN
46745	4505	30	a	a	DT
46745	4505	31	reflex	reflex	JJ
46745	4505	32	nervous	nervous	JJ
46745	4505	33	action	action	NN
46745	4505	34	,	,	,
46745	4505	35	in	in	IN
46745	4505	36	the	the	DT
46745	4505	37	same	same	JJ
46745	4505	38	way	way	NN
46745	4505	39	that	that	WDT
46745	4505	40	an	an	DT
46745	4505	41	irritation	irritation	NN
46745	4505	42	of	of	IN
46745	4505	43	the	the	DT
46745	4505	44	mucous	mucous	JJ
46745	4505	45	lining	lining	NN
46745	4505	46	of	of	IN
46745	4505	47	the	the	DT
46745	4505	48	mouth	mouth	NN
46745	4505	49	will	will	MD
46745	4505	50	cause	cause	VB
46745	4505	51	the	the	DT
46745	4505	52	secretion	secretion	NN
46745	4505	53	of	of	IN
46745	4505	54	the	the	DT
46745	4505	55	saliva	saliva	NN
46745	4505	56	.	.	.
46745	4506	1	All	all	DT
46745	4506	2	substances	substance	NNS
46745	4506	3	which	which	WDT
46745	4506	4	,	,	,
46745	4506	5	after	after	IN
46745	4506	6	being	be	VBG
46745	4506	7	taken	take	VBN
46745	4506	8	into	into	IN
46745	4506	9	the	the	DT
46745	4506	10	stomach	stomach	NN
46745	4506	11	,	,	,
46745	4506	12	are	be	VBP
46745	4506	13	not	not	RB
46745	4506	14	absorbed	absorb	VBN
46745	4506	15	,	,	,
46745	4506	16	which	which	WDT
46745	4506	17	are	be	VBP
46745	4506	18	thus	thus	RB
46745	4506	19	pushed	push	VBN
46745	4506	20	onwards	onwards	RB
46745	4506	21	along	along	IN
46745	4506	22	the	the	DT
46745	4506	23	inner	inner	JJ
46745	4506	24	coat	coat	NN
46745	4506	25	of	of	IN
46745	4506	26	the	the	DT
46745	4506	27	intestine	intestine	NN
46745	4506	28	,	,	,
46745	4506	29	and	and	CC
46745	4506	30	by	by	IN
46745	4506	31	their	-PRON-	PRP$
46745	4506	32	mere	mere	JJ
46745	4506	33	accumulation	accumulation	NN
46745	4506	34	excite	excite	NN
46745	4506	35	its	-PRON-	PRP$
46745	4506	36	muscular	muscular	JJ
46745	4506	37	contraction	contraction	NN
46745	4506	38	,	,	,
46745	4506	39	must	must	MD
46745	4506	40	operate	operate	VB
46745	4506	41	more	more	RBR
46745	4506	42	or	or	CC
46745	4506	43	less	less	RBR
46745	4506	44	as	as	IN
46745	4506	45	indirect	indirect	JJ
46745	4506	46	purgatives	purgative	NNS
46745	4506	47	.	.	.
46745	4507	1	Of	of	IN
46745	4507	2	such	such	PDT
46745	4507	3	a	a	DT
46745	4507	4	nature	nature	NN
46745	4507	5	are	be	VBP
46745	4507	6	the	the	DT
46745	4507	7	ligneous	ligneous	JJ
46745	4507	8	fibres	fibre	NNS
46745	4507	9	of	of	IN
46745	4507	10	vegetables,--the	vegetables,--the	DT
46745	4507	11	bulky	bulky	NN
46745	4507	12	pulp	pulp	NN
46745	4507	13	of	of	IN
46745	4507	14	fruits	fruit	NNS
46745	4507	15	,	,	,
46745	4507	16	as	as	IN
46745	4507	17	in	in	IN
46745	4507	18	Prunes	Prunes	NNP
46745	4507	19	,	,	,
46745	4507	20	Tamarinds	Tamarinds	NNP
46745	4507	21	,	,	,
46745	4507	22	and	and	CC
46745	4507	23	Cassia,--and	cassia,--and	VB
46745	4507	24	the	the	DT
46745	4507	25	husk	husk	NN
46745	4507	26	of	of	IN
46745	4507	27	wheat	wheat	NN
46745	4507	28	in	in	IN
46745	4507	29	brown	brown	JJ
46745	4507	30	bread,--all	bread,--all	NN
46745	4507	31	of	of	IN
46745	4507	32	which	which	WDT
46745	4507	33	are	be	VBP
46745	4507	34	known	know	VBN
46745	4507	35	to	to	TO
46745	4507	36	act	act	VB
46745	4507	37	as	as	IN
46745	4507	38	laxatives	laxative	NNS
46745	4507	39	.	.	.
46745	4508	1	Very	very	RB
46745	4508	2	different	different	JJ
46745	4508	3	from	from	IN
46745	4508	4	these	these	DT
46745	4508	5	in	in	IN
46745	4508	6	the	the	DT
46745	4508	7	intensity	intensity	NN
46745	4508	8	of	of	IN
46745	4508	9	their	-PRON-	PRP$
46745	4508	10	action	action	NN
46745	4508	11	are	be	VBP
46745	4508	12	the	the	DT
46745	4508	13	resinous	resinous	JJ
46745	4508	14	Cathartics	Cathartics	NNPS
46745	4508	15	,	,	,
46745	4508	16	as	as	IN
46745	4508	17	Scammony	Scammony	NNP
46745	4508	18	and	and	CC
46745	4508	19	Gamboge	Gamboge	NNP
46745	4508	20	,	,	,
46745	4508	21	which	which	WDT
46745	4508	22	,	,	,
46745	4508	23	though	though	IN
46745	4508	24	capable	capable	JJ
46745	4508	25	of	of	IN
46745	4508	26	absorption	absorption	NN
46745	4508	27	,	,	,
46745	4508	28	appear	appear	VBP
46745	4508	29	also	also	RB
46745	4508	30	to	to	TO
46745	4508	31	act	act	VB
46745	4508	32	in	in	IN
46745	4508	33	some	some	DT
46745	4508	34	cases	case	NNS
46745	4508	35	by	by	IN
46745	4508	36	an	an	DT
46745	4508	37	external	external	JJ
46745	4508	38	irritation	irritation	NN
46745	4508	39	of	of	IN
46745	4508	40	the	the	DT
46745	4508	41	intestinal	intestinal	JJ
46745	4508	42	surface	surface	NN
46745	4508	43	.	.	.
46745	4509	1	They	-PRON-	PRP
46745	4509	2	are	be	VBP
46745	4509	3	also	also	RB
46745	4509	4	true	true	JJ
46745	4509	5	Eliminatives	Eliminatives	NNPS
46745	4509	6	,	,	,
46745	4509	7	for	for	IN
46745	4509	8	they	-PRON-	PRP
46745	4509	9	are	be	VBP
46745	4509	10	known	know	VBN
46745	4509	11	to	to	TO
46745	4509	12	become	become	VB
46745	4509	13	absorbed	absorb	VBN
46745	4509	14	;	;	:
46745	4509	15	they	-PRON-	PRP
46745	4509	16	may	may	MD
46745	4509	17	thus	thus	RB
46745	4509	18	act	act	VB
46745	4509	19	in	in	IN
46745	4509	20	a	a	DT
46745	4509	21	double	double	JJ
46745	4509	22	way	way	NN
46745	4509	23	,	,	,
46745	4509	24	both	both	CC
46745	4509	25	directly	directly	RB
46745	4509	26	and	and	CC
46745	4509	27	indirectly	indirectly	RB
46745	4509	28	.	.	.
46745	4510	1	(	(	-LRB-
46745	4510	2	_	_	NNP
46745	4510	3	Vide	Vide	NNP
46745	4510	4	_	_	NNP
46745	4510	5	p.	p.	NN
46745	4511	1	96	96	CD
46745	4511	2	.	.	.
46745	4511	3	)	)	-RRB-
46745	4512	1	In	in	IN
46745	4512	2	small	small	JJ
46745	4512	3	doses	dose	NNS
46745	4512	4	it	-PRON-	PRP
46745	4512	5	is	be	VBZ
46745	4512	6	probable	probable	JJ
46745	4512	7	that	that	IN
46745	4512	8	they	-PRON-	PRP
46745	4512	9	are	be	VBP
46745	4512	10	simply	simply	RB
46745	4512	11	Eliminatives	Eliminatives	NNPS
46745	4512	12	,	,	,
46745	4512	13	but	but	CC
46745	4512	14	when	when	WRB
46745	4512	15	given	give	VBN
46745	4512	16	in	in	IN
46745	4512	17	large	large	JJ
46745	4512	18	doses	dose	NNS
46745	4512	19	they	-PRON-	PRP
46745	4512	20	may	may	MD
46745	4512	21	add	add	VB
46745	4512	22	to	to	IN
46745	4512	23	that	that	DT
46745	4512	24	an	an	DT
46745	4512	25	irritant	irritant	JJ
46745	4512	26	external	external	JJ
46745	4512	27	action	action	NN
46745	4512	28	,	,	,
46745	4512	29	and	and	CC
46745	4512	30	produce	produce	VB
46745	4512	31	a	a	DT
46745	4512	32	very	very	RB
46745	4512	33	powerful	powerful	JJ
46745	4512	34	or	or	CC
46745	4512	35	even	even	RB
46745	4512	36	dangerous	dangerous	JJ
46745	4512	37	effect	effect	NN
46745	4512	38	.	.	.
46745	4513	1	_	_	NNP
46745	4513	2	True	true	JJ
46745	4513	3	Cathartics._--These	Cathartics._--These	NNPS
46745	4513	4	are	be	VBP
46745	4513	5	very	very	RB
46745	4513	6	many	many	JJ
46745	4513	7	in	in	IN
46745	4513	8	number	number	NN
46745	4513	9	.	.	.
46745	4514	1	At	at	IN
46745	4514	2	whatever	whatever	WDT
46745	4514	3	part	part	NN
46745	4514	4	of	of	IN
46745	4514	5	the	the	DT
46745	4514	6	system	system	NN
46745	4514	7	they	-PRON-	PRP
46745	4514	8	are	be	VBP
46745	4514	9	introduced	introduce	VBN
46745	4514	10	,	,	,
46745	4514	11	their	-PRON-	PRP$
46745	4514	12	action	action	NN
46745	4514	13	is	be	VBZ
46745	4514	14	the	the	DT
46745	4514	15	same	same	JJ
46745	4514	16	.	.	.
46745	4515	1	If	if	IN
46745	4515	2	one	one	CD
46745	4515	3	of	of	IN
46745	4515	4	them	-PRON-	PRP
46745	4515	5	be	be	VB
46745	4515	6	injected	inject	VBN
46745	4515	7	in	in	IN
46745	4515	8	solution	solution	NN
46745	4515	9	into	into	IN
46745	4515	10	the	the	DT
46745	4515	11	veins	vein	NNS
46745	4515	12	,	,	,
46745	4515	13	or	or	CC
46745	4515	14	absorbed	absorb	VBN
46745	4515	15	from	from	IN
46745	4515	16	the	the	DT
46745	4515	17	surface	surface	NN
46745	4515	18	of	of	IN
46745	4515	19	the	the	DT
46745	4515	20	skin	skin	NN
46745	4515	21	,	,	,
46745	4515	22	it	-PRON-	PRP
46745	4515	23	passes	pass	VBZ
46745	4515	24	at	at	IN
46745	4515	25	length	length	NN
46745	4515	26	to	to	IN
46745	4515	27	the	the	DT
46745	4515	28	intestinal	intestinal	JJ
46745	4515	29	canal	canal	NN
46745	4515	30	,	,	,
46745	4515	31	is	be	VBZ
46745	4515	32	excreted	excrete	VBN
46745	4515	33	by	by	IN
46745	4515	34	the	the	DT
46745	4515	35	glands	gland	NNS
46745	4515	36	of	of	IN
46745	4515	37	the	the	DT
46745	4515	38	mucous	mucous	JJ
46745	4515	39	surface	surface	NN
46745	4515	40	,	,	,
46745	4515	41	and	and	CC
46745	4515	42	causes	cause	VBZ
46745	4515	43	purging	purging	NN
46745	4515	44	by	by	IN
46745	4515	45	augmenting	augment	VBG
46745	4515	46	their	-PRON-	PRP$
46745	4515	47	natural	natural	JJ
46745	4515	48	secretion	secretion	NN
46745	4515	49	.	.	.
46745	4516	1	When	when	WRB
46745	4516	2	given	give	VBN
46745	4516	3	as	as	IN
46745	4516	4	a	a	DT
46745	4516	5	medicine	medicine	NN
46745	4516	6	,	,	,
46745	4516	7	the	the	DT
46745	4516	8	Cathartic	cathartic	JJ
46745	4516	9	is	be	VBZ
46745	4516	10	first	first	RB
46745	4516	11	received	receive	VBN
46745	4516	12	into	into	IN
46745	4516	13	the	the	DT
46745	4516	14	stomach	stomach	NN
46745	4516	15	.	.	.
46745	4517	1	It	-PRON-	PRP
46745	4517	2	is	be	VBZ
46745	4517	3	capable	capable	JJ
46745	4517	4	of	of	IN
46745	4517	5	absorption,--whether	absorption,--whether	:
46745	4517	6	it	-PRON-	PRP
46745	4517	7	be	be	VB
46745	4517	8	soluble	soluble	JJ
46745	4517	9	in	in	IN
46745	4517	10	water	water	NN
46745	4517	11	,	,	,
46745	4517	12	or	or	CC
46745	4517	13	in	in	IN
46745	4517	14	acid	acid	NN
46745	4517	15	,	,	,
46745	4517	16	or	or	CC
46745	4517	17	be	be	VB
46745	4517	18	of	of	IN
46745	4517	19	an	an	DT
46745	4517	20	oily	oily	JJ
46745	4517	21	or	or	CC
46745	4517	22	resinous	resinous	JJ
46745	4517	23	nature,--as	nature,--as	NNP
46745	4517	24	was	be	VBD
46745	4517	25	ascertained	ascertain	VBN
46745	4517	26	in	in	IN
46745	4517	27	the	the	DT
46745	4517	28	consideration	consideration	NN
46745	4517	29	of	of	IN
46745	4517	30	Proposition	Proposition	NNP
46745	4517	31	II	II	NNP
46745	4517	32	.	.	.
46745	4518	1	It	-PRON-	PRP
46745	4518	2	is	be	VBZ
46745	4518	3	absorbed	absorb	VBN
46745	4518	4	;	;	:
46745	4518	5	and	and	CC
46745	4518	6	passes	pass	VBZ
46745	4518	7	along	along	RP
46745	4518	8	in	in	IN
46745	4518	9	the	the	DT
46745	4518	10	circulation	circulation	NN
46745	4518	11	.	.	.
46745	4519	1	But	but	CC
46745	4519	2	it	-PRON-	PRP
46745	4519	3	is	be	VBZ
46745	4519	4	unnatural	unnatural	JJ
46745	4519	5	to	to	IN
46745	4519	6	the	the	DT
46745	4519	7	blood	blood	NN
46745	4519	8	,	,	,
46745	4519	9	and	and	CC
46745	4519	10	can	can	MD
46745	4519	11	not	not	RB
46745	4519	12	remain	remain	VB
46745	4519	13	in	in	IN
46745	4519	14	it	-PRON-	PRP
46745	4519	15	;	;	:
46745	4519	16	so	so	IN
46745	4519	17	that	that	IN
46745	4519	18	it	-PRON-	PRP
46745	4519	19	is	be	VBZ
46745	4519	20	at	at	IN
46745	4519	21	length	length	NN
46745	4519	22	expelled	expel	VBN
46745	4519	23	by	by	IN
46745	4519	24	the	the	DT
46745	4519	25	eliminative	eliminative	JJ
46745	4519	26	force	force	NN
46745	4519	27	at	at	IN
46745	4519	28	the	the	DT
46745	4519	29	lower	low	JJR
46745	4519	30	part	part	NN
46745	4519	31	of	of	IN
46745	4519	32	the	the	DT
46745	4519	33	intestinal	intestinal	JJ
46745	4519	34	canal	canal	NN
46745	4519	35	,	,	,
46745	4519	36	at	at	IN
46745	4519	37	a	a	DT
46745	4519	38	part	part	NN
46745	4519	39	which	which	WDT
46745	4519	40	is	be	VBZ
46745	4519	41	more	more	RBR
46745	4519	42	active	active	JJ
46745	4519	43	in	in	IN
46745	4519	44	excretion	excretion	NN
46745	4519	45	than	than	IN
46745	4519	46	in	in	IN
46745	4519	47	absorption	absorption	NN
46745	4519	48	,	,	,
46745	4519	49	though	though	IN
46745	4519	50	not	not	RB
46745	4519	51	very	very	RB
46745	4519	52	remote	remote	JJ
46745	4519	53	from	from	IN
46745	4519	54	the	the	DT
46745	4519	55	absorbent	absorbent	JJ
46745	4519	56	surface	surface	NN
46745	4519	57	at	at	IN
46745	4519	58	which	which	WDT
46745	4519	59	the	the	DT
46745	4519	60	remedy	remedy	NN
46745	4519	61	first	first	RB
46745	4519	62	entered	enter	VBD
46745	4519	63	.	.	.
46745	4520	1	Cathartics	cathartic	NNS
46745	4520	2	may	may	MD
46745	4520	3	be	be	VB
46745	4520	4	advantageously	advantageously	RB
46745	4520	5	divided	divide	VBN
46745	4520	6	into	into	IN
46745	4520	7	three	three	CD
46745	4520	8	groups:--1	groups:--1	NNS
46745	4520	9	.	.	.
46745	4521	1	Mercurials	mercurial	NNS
46745	4521	2	,	,	,
46745	4521	3	which	which	WDT
46745	4521	4	tend	tend	VBP
46745	4521	5	to	to	TO
46745	4521	6	increase	increase	VB
46745	4521	7	all	all	DT
46745	4521	8	secretions	secretion	NNS
46745	4521	9	;	;	:
46745	4521	10	2	2	CD
46745	4521	11	.	.	.
46745	4522	1	Some	some	DT
46745	4522	2	resins	resin	NNS
46745	4522	3	,	,	,
46745	4522	4	oils	oil	NNS
46745	4522	5	,	,	,
46745	4522	6	and	and	CC
46745	4522	7	acrid	acrid	NNP
46745	4522	8	principles	principle	NNS
46745	4522	9	,	,	,
46745	4522	10	which	which	WDT
46745	4522	11	tend	tend	VBP
46745	4522	12	especially	especially	RB
46745	4522	13	to	to	IN
46745	4522	14	the	the	DT
46745	4522	15	bowels	bowel	NNS
46745	4522	16	;	;	:
46745	4522	17	and	and	CC
46745	4522	18	3	3	CD
46745	4522	19	.	.	.
46745	4523	1	Salines	saline	NNS
46745	4523	2	,	,	,
46745	4523	3	when	when	WRB
46745	4523	4	given	give	VBN
46745	4523	5	in	in	IN
46745	4523	6	such	such	JJ
46745	4523	7	amount	amount	NN
46745	4523	8	that	that	WDT
46745	4523	9	they	-PRON-	PRP
46745	4523	10	can	can	MD
46745	4523	11	not	not	RB
46745	4523	12	pass	pass	VB
46745	4523	13	off	off	RP
46745	4523	14	by	by	IN
46745	4523	15	the	the	DT
46745	4523	16	kidneys	kidney	NNS
46745	4523	17	.	.	.
46745	4524	1	Mercurials	mercurial	NNS
46745	4524	2	,	,	,
46745	4524	3	being	be	VBG
46745	4524	4	also	also	RB
46745	4524	5	Cholagogues	Cholagogues	NNPS
46745	4524	6	,	,	,
46745	4524	7	are	be	VBP
46745	4524	8	especially	especially	RB
46745	4524	9	useful	useful	JJ
46745	4524	10	in	in	IN
46745	4524	11	bilious	bilious	JJ
46745	4524	12	habits	habit	NNS
46745	4524	13	.	.	.
46745	4525	1	When	when	WRB
46745	4525	2	given	give	VBN
46745	4525	3	to	to	TO
46745	4525	4	act	act	VB
46745	4525	5	on	on	IN
46745	4525	6	the	the	DT
46745	4525	7	bowels	bowel	NNS
46745	4525	8	,	,	,
46745	4525	9	a	a	DT
46745	4525	10	Mercurial	mercurial	NN
46745	4525	11	is	be	VBZ
46745	4525	12	generally	generally	RB
46745	4525	13	conjoined	conjoin	VBN
46745	4525	14	with	with	IN
46745	4525	15	another	another	DT
46745	4525	16	purgative	purgative	NN
46745	4525	17	,	,	,
46745	4525	18	that	that	IN
46745	4525	19	it	-PRON-	PRP
46745	4525	20	may	may	MD
46745	4525	21	not	not	RB
46745	4525	22	do	do	VB
46745	4525	23	damage	damage	NN
46745	4525	24	in	in	IN
46745	4525	25	the	the	DT
46745	4525	26	system	system	NN
46745	4525	27	by	by	IN
46745	4525	28	remaining	remain	VBG
46745	4525	29	in	in	IN
46745	4525	30	the	the	DT
46745	4525	31	blood	blood	NN
46745	4525	32	.	.	.
46745	4526	1	In	in	IN
46745	4526	2	the	the	DT
46745	4526	3	second	second	JJ
46745	4526	4	group	group	NN
46745	4526	5	the	the	DT
46745	4526	6	great	great	JJ
46745	4526	7	majority	majority	NN
46745	4526	8	of	of	IN
46745	4526	9	Cathartics	Cathartics	NNPS
46745	4526	10	are	be	VBP
46745	4526	11	included	include	VBN
46745	4526	12	.	.	.
46745	4527	1	They	-PRON-	PRP
46745	4527	2	vary	vary	VBP
46745	4527	3	very	very	RB
46745	4527	4	much	much	RB
46745	4527	5	in	in	IN
46745	4527	6	the	the	DT
46745	4527	7	intensity	intensity	NN
46745	4527	8	of	of	IN
46745	4527	9	their	-PRON-	PRP$
46745	4527	10	action	action	NN
46745	4527	11	.	.	.
46745	4528	1	Some	some	DT
46745	4528	2	are	be	VBP
46745	4528	3	mild	mild	JJ
46745	4528	4	,	,	,
46745	4528	5	and	and	CC
46745	4528	6	may	may	MD
46745	4528	7	be	be	VB
46745	4528	8	administered	administer	VBN
46745	4528	9	in	in	IN
46745	4528	10	inflammations	inflammation	NNS
46745	4528	11	and	and	CC
46745	4528	12	fevers	fever	NNS
46745	4528	13	,	,	,
46745	4528	14	or	or	CC
46745	4528	15	even	even	RB
46745	4528	16	in	in	IN
46745	4528	17	pregnancy	pregnancy	NN
46745	4528	18	,	,	,
46745	4528	19	where	where	WRB
46745	4528	20	a	a	DT
46745	4528	21	gentle	gentle	JJ
46745	4528	22	action	action	NN
46745	4528	23	is	be	VBZ
46745	4528	24	required	require	VBN
46745	4528	25	;	;	:
46745	4528	26	others	other	NNS
46745	4528	27	are	be	VBP
46745	4528	28	powerful	powerful	JJ
46745	4528	29	and	and	CC
46745	4528	30	drastic	drastic	JJ
46745	4528	31	,	,	,
46745	4528	32	and	and	CC
46745	4528	33	may	may	MD
46745	4528	34	cause	cause	VB
46745	4528	35	serious	serious	JJ
46745	4528	36	congestion	congestion	NN
46745	4528	37	,	,	,
46745	4528	38	or	or	CC
46745	4528	39	even	even	RB
46745	4528	40	inflammation	inflammation	NN
46745	4528	41	of	of	IN
46745	4528	42	the	the	DT
46745	4528	43	bowel	bowel	NN
46745	4528	44	.	.	.
46745	4529	1	All	all	PDT
46745	4529	2	the	the	DT
46745	4529	3	resins	resin	NNS
46745	4529	4	and	and	CC
46745	4529	5	acrid	acrid	JJ
46745	4529	6	principles	principle	NNS
46745	4529	7	are	be	VBP
46745	4529	8	more	more	RBR
46745	4529	9	or	or	CC
46745	4529	10	less	less	JJR
46745	4529	11	heating	heating	NN
46745	4529	12	,	,	,
46745	4529	13	and	and	CC
46745	4529	14	should	should	MD
46745	4529	15	be	be	VB
46745	4529	16	administered	administer	VBN
46745	4529	17	very	very	RB
46745	4529	18	carefully	carefully	RB
46745	4529	19	in	in	IN
46745	4529	20	febrile	febrile	NN
46745	4529	21	states	state	NNS
46745	4529	22	of	of	IN
46745	4529	23	the	the	DT
46745	4529	24	system	system	NN
46745	4529	25	.	.	.
46745	4530	1	Of	of	IN
46745	4530	2	the	the	DT
46745	4530	3	resins	resin	NNS
46745	4530	4	,	,	,
46745	4530	5	Jalap	Jalap	NNP
46745	4530	6	is	be	VBZ
46745	4530	7	comparatively	comparatively	RB
46745	4530	8	mild	mild	JJ
46745	4530	9	,	,	,
46745	4530	10	and	and	CC
46745	4530	11	may	may	MD
46745	4530	12	be	be	VB
46745	4530	13	given	give	VBN
46745	4530	14	to	to	IN
46745	4530	15	children	child	NNS
46745	4530	16	without	without	IN
46745	4530	17	risk	risk	NN
46745	4530	18	;	;	:
46745	4530	19	while	while	IN
46745	4530	20	Scammony	Scammony	NNP
46745	4530	21	,	,	,
46745	4530	22	Colocynth	Colocynth	NNP
46745	4530	23	,	,	,
46745	4530	24	and	and	CC
46745	4530	25	Gamboge	Gamboge	NNP
46745	4530	26	are	be	VBP
46745	4530	27	more	more	RBR
46745	4530	28	drastic	drastic	JJ
46745	4530	29	.	.	.
46745	4531	1	Of	of	IN
46745	4531	2	the	the	DT
46745	4531	3	oils	oil	NNS
46745	4531	4	,	,	,
46745	4531	5	Olive	olive	NN
46745	4531	6	-	-	HYPH
46745	4531	7	oil	oil	NN
46745	4531	8	is	be	VBZ
46745	4531	9	merely	merely	RB
46745	4531	10	laxative	laxative	JJ
46745	4531	11	;	;	:
46745	4531	12	Castor	castor	NN
46745	4531	13	-	-	HYPH
46745	4531	14	oil	oil	NN
46745	4531	15	may	may	MD
46745	4531	16	be	be	VB
46745	4531	17	given	give	VBN
46745	4531	18	in	in	IN
46745	4531	19	all	all	DT
46745	4531	20	cases	case	NNS
46745	4531	21	without	without	IN
46745	4531	22	danger	danger	NN
46745	4531	23	;	;	:
46745	4531	24	but	but	CC
46745	4531	25	Croton	Croton	NNP
46745	4531	26	oil	oil	NN
46745	4531	27	is	be	VBZ
46745	4531	28	a	a	DT
46745	4531	29	dangerous	dangerous	JJ
46745	4531	30	hydragogue	hydragogue	NN
46745	4531	31	Cathartic	cathartic	JJ
46745	4531	32	.	.	.
46745	4532	1	Of	of	IN
46745	4532	2	the	the	DT
46745	4532	3	medicines	medicine	NNS
46745	4532	4	which	which	WDT
46745	4532	5	owe	owe	VBP
46745	4532	6	their	-PRON-	PRP$
46745	4532	7	efficacy	efficacy	NN
46745	4532	8	to	to	IN
46745	4532	9	acrid	acrid	NNP
46745	4532	10	principles	principle	NNS
46745	4532	11	,	,	,
46745	4532	12	there	there	EX
46745	4532	13	are	be	VBP
46745	4532	14	some	some	DT
46745	4532	15	which	which	WDT
46745	4532	16	are	be	VBP
46745	4532	17	mild	mild	JJ
46745	4532	18	in	in	IN
46745	4532	19	operation	operation	NN
46745	4532	20	,	,	,
46745	4532	21	and	and	CC
46745	4532	22	whose	whose	WP$
46745	4532	23	principles	principle	NNS
46745	4532	24	are	be	VBP
46745	4532	25	soluble	soluble	JJ
46745	4532	26	in	in	IN
46745	4532	27	Water	Water	NNP
46745	4532	28	.	.	.
46745	4533	1	Such	such	JJ
46745	4533	2	are	be	VBP
46745	4533	3	Rhubarb	Rhubarb	NNP
46745	4533	4	,	,	,
46745	4533	5	Aloes	Aloes	NNPS
46745	4533	6	,	,	,
46745	4533	7	and	and	CC
46745	4533	8	Senna	Senna	NNP
46745	4533	9	.	.	.
46745	4534	1	Senna	Senna	NNP
46745	4534	2	is	be	VBZ
46745	4534	3	somewhat	somewhat	RB
46745	4534	4	irritant	irritant	JJ
46745	4534	5	.	.	.
46745	4535	1	Aloes	Aloes	NNP
46745	4535	2	appears	appear	VBZ
46745	4535	3	to	to	TO
46745	4535	4	act	act	VB
46745	4535	5	on	on	IN
46745	4535	6	the	the	DT
46745	4535	7	lower	low	JJR
46745	4535	8	part	part	NN
46745	4535	9	of	of	IN
46745	4535	10	the	the	DT
46745	4535	11	intestine	intestine	NN
46745	4535	12	,	,	,
46745	4535	13	and	and	CC
46745	4535	14	is	be	VBZ
46745	4535	15	therefore	therefore	RB
46745	4535	16	objectionable	objectionable	JJ
46745	4535	17	in	in	IN
46745	4535	18	cases	case	NNS
46745	4535	19	of	of	IN
46745	4535	20	pregnancy	pregnancy	NN
46745	4535	21	or	or	CC
46745	4535	22	of	of	IN
46745	4535	23	uterine	uterine	JJ
46745	4535	24	disorder	disorder	NN
46745	4535	25	.	.	.
46745	4536	1	Hellebore	Hellebore	NNP
46745	4536	2	is	be	VBZ
46745	4536	3	a	a	DT
46745	4536	4	more	more	RBR
46745	4536	5	powerful	powerful	JJ
46745	4536	6	acrid	acrid	NN
46745	4536	7	,	,	,
46745	4536	8	but	but	CC
46745	4536	9	is	be	VBZ
46745	4536	10	now	now	RB
46745	4536	11	seldom	seldom	RB
46745	4536	12	used	use	VBN
46745	4536	13	.	.	.
46745	4537	1	Elaterium	elaterium	NN
46745	4537	2	is	be	VBZ
46745	4537	3	the	the	DT
46745	4537	4	most	most	RBS
46745	4537	5	potent	potent	JJ
46745	4537	6	purgative	purgative	JJ
46745	4537	7	known	know	VBN
46745	4537	8	.	.	.
46745	4538	1	In	in	IN
46745	4538	2	cases	case	NNS
46745	4538	3	of	of	IN
46745	4538	4	dropsy	dropsy	NNP
46745	4538	5	,	,	,
46745	4538	6	when	when	WRB
46745	4538	7	all	all	DT
46745	4538	8	other	other	JJ
46745	4538	9	medicines	medicine	NNS
46745	4538	10	have	have	VBP
46745	4538	11	failed	fail	VBN
46745	4538	12	,	,	,
46745	4538	13	one	one	CD
46745	4538	14	-	-	HYPH
46745	4538	15	twelfth	twelfth	NN
46745	4538	16	of	of	IN
46745	4538	17	a	a	DT
46745	4538	18	grain	grain	NN
46745	4538	19	of	of	IN
46745	4538	20	this	this	DT
46745	4538	21	substance	substance	NN
46745	4538	22	has	have	VBZ
46745	4538	23	been	be	VBN
46745	4538	24	known	know	VBN
46745	4538	25	to	to	TO
46745	4538	26	produce	produce	VB
46745	4538	27	a	a	DT
46745	4538	28	copious	copious	JJ
46745	4538	29	evacuation	evacuation	NN
46745	4538	30	.	.	.
46745	4539	1	Salines	saline	NNS
46745	4539	2	,	,	,
46745	4539	3	_	_	NNP
46745	4539	4	i.e.	i.e.	FW
46745	4539	5	_	_	NNP
46745	4539	6	salts	salt	NNS
46745	4539	7	of	of	IN
46745	4539	8	the	the	DT
46745	4539	9	alkaline	alkaline	NN
46745	4539	10	and	and	CC
46745	4539	11	earthy	earthy	JJ
46745	4539	12	metals	metal	NNS
46745	4539	13	,	,	,
46745	4539	14	are	be	VBP
46745	4539	15	all	all	DT
46745	4539	16	more	more	RBR
46745	4539	17	or	or	CC
46745	4539	18	less	less	RBR
46745	4539	19	purgative	purgative	JJ
46745	4539	20	when	when	WRB
46745	4539	21	given	give	VBN
46745	4539	22	under	under	IN
46745	4539	23	certain	certain	JJ
46745	4539	24	conditions	condition	NNS
46745	4539	25	.	.	.
46745	4540	1	Under	under	IN
46745	4540	2	other	other	JJ
46745	4540	3	circumstances	circumstance	NNS
46745	4540	4	they	-PRON-	PRP
46745	4540	5	may	may	MD
46745	4540	6	pass	pass	VB
46745	4540	7	off	off	RP
46745	4540	8	from	from	IN
46745	4540	9	the	the	DT
46745	4540	10	body	body	NN
46745	4540	11	by	by	IN
46745	4540	12	the	the	DT
46745	4540	13	kidneys	kidney	NNS
46745	4540	14	or	or	CC
46745	4540	15	the	the	DT
46745	4540	16	glands	gland	NNS
46745	4540	17	of	of	IN
46745	4540	18	the	the	DT
46745	4540	19	skin	skin	NN
46745	4540	20	.	.	.
46745	4541	1	The	the	DT
46745	4541	2	circumstances	circumstance	NNS
46745	4541	3	which	which	WDT
46745	4541	4	determine	determine	VBP
46745	4541	5	the	the	DT
46745	4541	6	excretion	excretion	NN
46745	4541	7	of	of	IN
46745	4541	8	saline	saline	NN
46745	4541	9	matters	matter	NNS
46745	4541	10	appear	appear	VBP
46745	4541	11	to	to	TO
46745	4541	12	be	be	VB
46745	4541	13	simple	simple	JJ
46745	4541	14	in	in	IN
46745	4541	15	nature	nature	NN
46745	4541	16	.	.	.
46745	4542	1	In	in	IN
46745	4542	2	the	the	DT
46745	4542	3	common	common	JJ
46745	4542	4	condition	condition	NN
46745	4542	5	of	of	IN
46745	4542	6	the	the	DT
46745	4542	7	body	body	NN
46745	4542	8	it	-PRON-	PRP
46745	4542	9	is	be	VBZ
46745	4542	10	not	not	RB
46745	4542	11	possible	possible	JJ
46745	4542	12	for	for	IN
46745	4542	13	the	the	DT
46745	4542	14	secretion	secretion	NN
46745	4542	15	of	of	IN
46745	4542	16	the	the	DT
46745	4542	17	skin	skin	NN
46745	4542	18	to	to	TO
46745	4542	19	be	be	VB
46745	4542	20	very	very	RB
46745	4542	21	largely	largely	RB
46745	4542	22	increased	increase	VBN
46745	4542	23	,	,	,
46745	4542	24	or	or	CC
46745	4542	25	rendered	render	VBN
46745	4542	26	fluid	fluid	NN
46745	4542	27	.	.	.
46745	4543	1	Suppose	suppose	VB
46745	4543	2	,	,	,
46745	4543	3	then	then	RB
46745	4543	4	,	,	,
46745	4543	5	a	a	DT
46745	4543	6	soluble	soluble	JJ
46745	4543	7	saline	saline	NN
46745	4543	8	,	,	,
46745	4543	9	as	as	IN
46745	4543	10	the	the	DT
46745	4543	11	Sulphate	Sulphate	NNP
46745	4543	12	of	of	IN
46745	4543	13	Soda	Soda	NNP
46745	4543	14	or	or	CC
46745	4543	15	Magnesia	Magnesia	NNP
46745	4543	16	,	,	,
46745	4543	17	or	or	CC
46745	4543	18	Tartarized	Tartarized	NNP
46745	4543	19	Soda	Soda	NNP
46745	4543	20	,	,	,
46745	4543	21	to	to	TO
46745	4543	22	have	have	VB
46745	4543	23	obtained	obtain	VBN
46745	4543	24	entry	entry	NN
46745	4543	25	into	into	IN
46745	4543	26	the	the	DT
46745	4543	27	blood	blood	NN
46745	4543	28	,	,	,
46745	4543	29	it	-PRON-	PRP
46745	4543	30	has	have	VBZ
46745	4543	31	the	the	DT
46745	4543	32	choice	choice	NN
46745	4543	33	of	of	IN
46745	4543	34	being	be	VBG
46745	4543	35	excreted	excrete	VBN
46745	4543	36	by	by	IN
46745	4543	37	the	the	DT
46745	4543	38	kidneys	kidney	NNS
46745	4543	39	or	or	CC
46745	4543	40	the	the	DT
46745	4543	41	bowels	bowel	NNS
46745	4543	42	.	.	.
46745	4544	1	The	the	DT
46745	4544	2	alternative	alternative	NN
46745	4544	3	appears	appear	VBZ
46745	4544	4	to	to	TO
46745	4544	5	depend	depend	VB
46745	4544	6	mainly	mainly	RB
46745	4544	7	upon	upon	IN
46745	4544	8	the	the	DT
46745	4544	9	amount	amount	NN
46745	4544	10	of	of	IN
46745	4544	11	the	the	DT
46745	4544	12	dose	dose	NN
46745	4544	13	.	.	.
46745	4545	1	A	a	DT
46745	4545	2	small	small	JJ
46745	4545	3	quantity	quantity	NN
46745	4545	4	may	may	MD
46745	4545	5	pass	pass	VB
46745	4545	6	in	in	RP
46745	4545	7	the	the	DT
46745	4545	8	urine	urine	NN
46745	4545	9	,	,	,
46745	4545	10	and	and	CC
46745	4545	11	will	will	MD
46745	4545	12	not	not	RB
46745	4545	13	produce	produce	VB
46745	4545	14	purging	purge	VBG
46745	4545	15	.	.	.
46745	4546	1	But	but	CC
46745	4546	2	a	a	DT
46745	4546	3	large	large	JJ
46745	4546	4	quantity	quantity	NN
46745	4546	5	can	can	MD
46745	4546	6	not	not	RB
46745	4546	7	so	so	RB
46745	4546	8	pass	pass	VB
46745	4546	9	;	;	:
46745	4546	10	it	-PRON-	PRP
46745	4546	11	is	be	VBZ
46745	4546	12	excreted	excrete	VBN
46745	4546	13	by	by	IN
46745	4546	14	the	the	DT
46745	4546	15	glands	gland	NNS
46745	4546	16	of	of	IN
46745	4546	17	the	the	DT
46745	4546	18	bowels	bowel	NNS
46745	4546	19	,	,	,
46745	4546	20	and	and	CC
46745	4546	21	acts	act	VBZ
46745	4546	22	as	as	IN
46745	4546	23	a	a	DT
46745	4546	24	Purgative	Purgative	NNP
46745	4546	25	.	.	.
46745	4547	1	It	-PRON-	PRP
46745	4547	2	has	have	VBZ
46745	4547	3	been	be	VBN
46745	4547	4	supposed	suppose	VBN
46745	4547	5	by	by	IN
46745	4547	6	some	some	DT
46745	4547	7	that	that	IN
46745	4547	8	a	a	DT
46745	4547	9	saline	saline	NN
46745	4547	10	solution	solution	NN
46745	4547	11	proves	prove	VBZ
46745	4547	12	Purgative	purgative	JJ
46745	4547	13	or	or	CC
46745	4547	14	Diuretic	Diuretic	NNP
46745	4547	15	according	accord	VBG
46745	4547	16	to	to	IN
46745	4547	17	the	the	DT
46745	4547	18	degree	degree	NN
46745	4547	19	of	of	IN
46745	4547	20	its	-PRON-	PRP$
46745	4547	21	dilution	dilution	NN
46745	4547	22	only	only	RB
46745	4547	23	.	.	.
46745	4548	1	This	this	DT
46745	4548	2	matter	matter	NN
46745	4548	3	we	-PRON-	PRP
46745	4548	4	have	have	VBP
46745	4548	5	already	already	RB
46745	4548	6	considered	consider	VBN
46745	4548	7	at	at	IN
46745	4548	8	some	some	DT
46745	4548	9	length	length	NN
46745	4548	10	;	;	:
46745	4548	11	and	and	CC
46745	4548	12	the	the	DT
46745	4548	13	reasons	reason	NNS
46745	4548	14	which	which	WDT
46745	4548	15	have	have	VBP
46745	4548	16	induced	induce	VBN
46745	4548	17	me	-PRON-	PRP
46745	4548	18	to	to	TO
46745	4548	19	arrive	arrive	VB
46745	4548	20	at	at	IN
46745	4548	21	a	a	DT
46745	4548	22	contrary	contrary	JJ
46745	4548	23	conclusion	conclusion	NN
46745	4548	24	have	have	VBP
46745	4548	25	been	be	VBN
46745	4548	26	detailed	detail	VBN
46745	4548	27	under	under	IN
46745	4548	28	the	the	DT
46745	4548	29	head	head	NN
46745	4548	30	of	of	IN
46745	4548	31	Proposition	Proposition	NNP
46745	4548	32	II	II	NNP
46745	4548	33	.	.	.
46745	4549	1	Salines	saline	NNS
46745	4549	2	are	be	VBP
46745	4549	3	hydragogue	hydragogue	NN
46745	4549	4	.	.	.
46745	4550	1	Requiring	require	VBG
46745	4550	2	water	water	NN
46745	4550	3	for	for	IN
46745	4550	4	their	-PRON-	PRP$
46745	4550	5	proper	proper	JJ
46745	4550	6	solution	solution	NN
46745	4550	7	,	,	,
46745	4550	8	and	and	CC
46745	4550	9	having	have	VBG
46745	4550	10	further	further	RB
46745	4550	11	a	a	DT
46745	4550	12	great	great	JJ
46745	4550	13	affinity	affinity	NN
46745	4550	14	for	for	IN
46745	4550	15	it	-PRON-	PRP
46745	4550	16	,	,	,
46745	4550	17	they	-PRON-	PRP
46745	4550	18	convey	convey	VBP
46745	4550	19	a	a	DT
46745	4550	20	large	large	JJ
46745	4550	21	quantity	quantity	NN
46745	4550	22	of	of	IN
46745	4550	23	the	the	DT
46745	4550	24	aqueous	aqueous	JJ
46745	4550	25	part	part	NN
46745	4550	26	of	of	IN
46745	4550	27	the	the	DT
46745	4550	28	blood	blood	NN
46745	4550	29	with	with	IN
46745	4550	30	them	-PRON-	PRP
46745	4550	31	through	through	IN
46745	4550	32	the	the	DT
46745	4550	33	glands	gland	NNS
46745	4550	34	of	of	IN
46745	4550	35	the	the	DT
46745	4550	36	bowels	bowel	NNS
46745	4550	37	.	.	.
46745	4551	1	When	when	WRB
46745	4551	2	their	-PRON-	PRP$
46745	4551	3	action	action	NN
46745	4551	4	is	be	VBZ
46745	4551	5	very	very	RB
46745	4551	6	powerful	powerful	JJ
46745	4551	7	,	,	,
46745	4551	8	some	some	DT
46745	4551	9	of	of	IN
46745	4551	10	the	the	DT
46745	4551	11	albumen	albuman	NNS
46745	4551	12	of	of	IN
46745	4551	13	the	the	DT
46745	4551	14	blood	blood	NN
46745	4551	15	may	may	MD
46745	4551	16	be	be	VB
46745	4551	17	purged	purge	VBN
46745	4551	18	away	away	RB
46745	4551	19	along	along	RB
46745	4551	20	with	with	IN
46745	4551	21	this	this	DT
46745	4551	22	.	.	.
46745	4552	1	This	this	DT
46745	4552	2	may	may	MD
46745	4552	3	also	also	RB
46745	4552	4	take	take	VB
46745	4552	5	place	place	NN
46745	4552	6	with	with	IN
46745	4552	7	the	the	DT
46745	4552	8	drastic	drastic	JJ
46745	4552	9	resinous	resinous	JJ
46745	4552	10	Cathartics	Cathartics	NNPS
46745	4552	11	.	.	.
46745	4553	1	But	but	CC
46745	4553	2	the	the	DT
46745	4553	3	latter	latter	JJ
46745	4553	4	are	be	VBP
46745	4553	5	much	much	RB
46745	4553	6	more	more	RBR
46745	4553	7	violent	violent	JJ
46745	4553	8	in	in	IN
46745	4553	9	their	-PRON-	PRP$
46745	4553	10	action	action	NN
46745	4553	11	,	,	,
46745	4553	12	producing	produce	VBG
46745	4553	13	a	a	DT
46745	4553	14	degree	degree	NN
46745	4553	15	of	of	IN
46745	4553	16	griping	griping	NN
46745	4553	17	and	and	CC
46745	4553	18	irritation	irritation	NN
46745	4553	19	which	which	WDT
46745	4553	20	is	be	VBZ
46745	4553	21	dangerous	dangerous	JJ
46745	4553	22	in	in	IN
46745	4553	23	febrile	febrile	NN
46745	4553	24	cases	case	NNS
46745	4553	25	.	.	.
46745	4554	1	Salines	saline	NNS
46745	4554	2	,	,	,
46745	4554	3	on	on	IN
46745	4554	4	the	the	DT
46745	4554	5	contrary	contrary	NN
46745	4554	6	,	,	,
46745	4554	7	are	be	VBP
46745	4554	8	cooling	cool	VBG
46745	4554	9	,	,	,
46745	4554	10	and	and	CC
46745	4554	11	mild	mild	JJ
46745	4554	12	in	in	IN
46745	4554	13	their	-PRON-	PRP$
46745	4554	14	operation	operation	NN
46745	4554	15	.	.	.
46745	4555	1	They	-PRON-	PRP
46745	4555	2	are	be	VBP
46745	4555	3	appropriate	appropriate	JJ
46745	4555	4	in	in	IN
46745	4555	5	inflammations	inflammation	NNS
46745	4555	6	,	,	,
46745	4555	7	not	not	RB
46745	4555	8	only	only	RB
46745	4555	9	for	for	IN
46745	4555	10	this	this	DT
46745	4555	11	reason	reason	NN
46745	4555	12	,	,	,
46745	4555	13	but	but	CC
46745	4555	14	because	because	IN
46745	4555	15	,	,	,
46745	4555	16	while	while	IN
46745	4555	17	passing	pass	VBG
46745	4555	18	through	through	IN
46745	4555	19	the	the	DT
46745	4555	20	blood	blood	NN
46745	4555	21	,	,	,
46745	4555	22	they	-PRON-	PRP
46745	4555	23	exert	exert	VBP
46745	4555	24	in	in	IN
46745	4555	25	it	-PRON-	PRP
46745	4555	26	,	,	,
46745	4555	27	as	as	IN
46745	4555	28	we	-PRON-	PRP
46745	4555	29	have	have	VBP
46745	4555	30	already	already	RB
46745	4555	31	seen	see	VBN
46745	4555	32	,	,	,
46745	4555	33	a	a	DT
46745	4555	34	mild	mild	JJ
46745	4555	35	action	action	NN
46745	4555	36	of	of	IN
46745	4555	37	an	an	DT
46745	4555	38	antiphlogistic	antiphlogistic	JJ
46745	4555	39	nature	nature	NN
46745	4555	40	.	.	.
46745	4556	1	(	(	-LRB-
46745	4556	2	_	_	NNP
46745	4556	3	Vide	Vide	NNP
46745	4556	4	_	_	NNP
46745	4556	5	page	page	NN
46745	4556	6	188	188	CD
46745	4556	7	.	.	.
46745	4556	8	)	)	-RRB-
46745	4557	1	When	when	WRB
46745	4557	2	the	the	DT
46745	4557	3	vegetable	vegetable	NN
46745	4557	4	salts	salt	NNS
46745	4557	5	of	of	IN
46745	4557	6	the	the	DT
46745	4557	7	alkalies	alkali	NNS
46745	4557	8	are	be	VBP
46745	4557	9	given	give	VBN
46745	4557	10	in	in	IN
46745	4557	11	diuretic	diuretic	JJ
46745	4557	12	doses	dose	NNS
46745	4557	13	they	-PRON-	PRP
46745	4557	14	are	be	VBP
46745	4557	15	decomposed	decompose	VBN
46745	4557	16	into	into	IN
46745	4557	17	carbonates	carbonate	NNS
46745	4557	18	while	while	IN
46745	4557	19	in	in	IN
46745	4557	20	the	the	DT
46745	4557	21	system	system	NN
46745	4557	22	.	.	.
46745	4558	1	This	this	DT
46745	4558	2	does	do	VBZ
46745	4558	3	not	not	RB
46745	4558	4	appear	appear	VB
46745	4558	5	to	to	TO
46745	4558	6	be	be	VB
46745	4558	7	the	the	DT
46745	4558	8	case	case	NN
46745	4558	9	when	when	WRB
46745	4558	10	they	-PRON-	PRP
46745	4558	11	are	be	VBP
46745	4558	12	given	give	VBN
46745	4558	13	in	in	IN
46745	4558	14	such	such	JJ
46745	4558	15	quantity	quantity	NN
46745	4558	16	as	as	IN
46745	4558	17	to	to	TO
46745	4558	18	pass	pass	VB
46745	4558	19	off	off	RP
46745	4558	20	quickly	quickly	RB
46745	4558	21	by	by	IN
46745	4558	22	the	the	DT
46745	4558	23	bowels	bowel	NNS
46745	4558	24	.	.	.
46745	4559	1	These	these	DT
46745	4559	2	various	various	JJ
46745	4559	3	Cathartic	cathartic	JJ
46745	4559	4	medicines	medicine	NNS
46745	4559	5	are	be	VBP
46745	4559	6	affirmed	affirm	VBN
46745	4559	7	to	to	TO
46745	4559	8	act	act	VB
46745	4559	9	on	on	IN
46745	4559	10	the	the	DT
46745	4559	11	eliminative	eliminative	JJ
46745	4559	12	principle	principle	NN
46745	4559	13	:	:	:
46745	4559	14	it	-PRON-	PRP
46745	4559	15	follows	follow	VBZ
46745	4559	16	then	then	RB
46745	4559	17	that	that	IN
46745	4559	18	they	-PRON-	PRP
46745	4559	19	must	must	MD
46745	4559	20	themselves	-PRON-	PRP
46745	4559	21	pass	pass	VB
46745	4559	22	out	out	IN
46745	4559	23	of	of	IN
46745	4559	24	the	the	DT
46745	4559	25	body	body	NN
46745	4559	26	along	along	IN
46745	4559	27	with	with	IN
46745	4559	28	the	the	DT
46745	4559	29	secretion	secretion	NN
46745	4559	30	which	which	WDT
46745	4559	31	is	be	VBZ
46745	4559	32	augmented	augment	VBN
46745	4559	33	by	by	IN
46745	4559	34	their	-PRON-	PRP$
46745	4559	35	action	action	NN
46745	4559	36	.	.	.
46745	4560	1	It	-PRON-	PRP
46745	4560	2	is	be	VBZ
46745	4560	3	natural	natural	JJ
46745	4560	4	that	that	IN
46745	4560	5	the	the	DT
46745	4560	6	fæces	fæce	NNS
46745	4560	7	should	should	MD
46745	4560	8	have	have	VB
46745	4560	9	been	be	VBN
46745	4560	10	less	less	RBR
46745	4560	11	examined	examine	VBN
46745	4560	12	than	than	IN
46745	4560	13	other	other	JJ
46745	4560	14	secretions	secretion	NNS
46745	4560	15	.	.	.
46745	4561	1	The	the	DT
46745	4561	2	resins	resin	NNS
46745	4561	3	of	of	IN
46745	4561	4	Jalap	Jalap	NNP
46745	4561	5	,	,	,
46745	4561	6	Scammony	Scammony	NNP
46745	4561	7	,	,	,
46745	4561	8	and	and	CC
46745	4561	9	other	other	JJ
46745	4561	10	such	such	JJ
46745	4561	11	substances	substance	NNS
46745	4561	12	,	,	,
46745	4561	13	are	be	VBP
46745	4561	14	affirmed	affirm	VBN
46745	4561	15	to	to	TO
46745	4561	16	pass	pass	VB
46745	4561	17	out	out	RP
46745	4561	18	along	along	IN
46745	4561	19	with	with	IN
46745	4561	20	them	-PRON-	PRP
46745	4561	21	.	.	.
46745	4562	1	Of	of	IN
46745	4562	2	the	the	DT
46745	4562	3	passage	passage	NN
46745	4562	4	of	of	IN
46745	4562	5	saline	saline	JJ
46745	4562	6	Purgatives	purgative	NNS
46745	4562	7	we	-PRON-	PRP
46745	4562	8	have	have	VBP
46745	4562	9	an	an	DT
46745	4562	10	indirect	indirect	JJ
46745	4562	11	proof	proof	NN
46745	4562	12	;	;	:
46745	4562	13	which	which	WDT
46745	4562	14	is	be	VBZ
46745	4562	15	,	,	,
46745	4562	16	that	that	IN
46745	4562	17	after	after	IN
46745	4562	18	their	-PRON-	PRP$
46745	4562	19	administration	administration	NN
46745	4562	20	the	the	DT
46745	4562	21	amount	amount	NN
46745	4562	22	of	of	IN
46745	4562	23	saline	saline	NN
46745	4562	24	matter	matter	NN
46745	4562	25	in	in	IN
46745	4562	26	the	the	DT
46745	4562	27	urine	urine	NN
46745	4562	28	is	be	VBZ
46745	4562	29	not	not	RB
46745	4562	30	materially	materially	RB
46745	4562	31	increased	increase	VBN
46745	4562	32	.	.	.
46745	4563	1	Castor	castor	NN
46745	4563	2	-	-	HYPH
46745	4563	3	oil	oil	NN
46745	4563	4	is	be	VBZ
46745	4563	5	seen	see	VBN
46745	4563	6	in	in	IN
46745	4563	7	the	the	DT
46745	4563	8	evacuations	evacuation	NNS
46745	4563	9	,	,	,
46745	4563	10	sometimes	sometimes	RB
46745	4563	11	little	little	JJ
46745	4563	12	altered	alter	VBN
46745	4563	13	,	,	,
46745	4563	14	at	at	IN
46745	4563	15	other	other	JJ
46745	4563	16	times	time	NNS
46745	4563	17	in	in	IN
46745	4563	18	the	the	DT
46745	4563	19	form	form	NN
46745	4563	20	of	of	IN
46745	4563	21	a	a	DT
46745	4563	22	solid	solid	JJ
46745	4563	23	fatty	fatty	NN
46745	4563	24	substance	substance	NN
46745	4563	25	.	.	.
46745	4564	1	M.	M.	NNP
46745	4564	2	Lehmann	Lehmann	NNP
46745	4564	3	has	have	VBZ
46745	4564	4	detected	detect	VBN
46745	4564	5	Mercury	Mercury	NNP
46745	4564	6	in	in	IN
46745	4564	7	the	the	DT
46745	4564	8	fæces	fæce	NNS
46745	4564	9	,	,	,
46745	4564	10	whenever	whenever	WRB
46745	4564	11	it	-PRON-	PRP
46745	4564	12	was	be	VBD
46745	4564	13	given	give	VBN
46745	4564	14	as	as	IN
46745	4564	15	a	a	DT
46745	4564	16	Purgative	Purgative	NNP
46745	4564	17	,	,	,
46745	4564	18	and	and	CC
46745	4564	19	whatever	whatever	WDT
46745	4564	20	the	the	DT
46745	4564	21	colour	colour	NN
46745	4564	22	of	of	IN
46745	4564	23	the	the	DT
46745	4564	24	evacuation	evacuation	NN
46745	4564	25	.	.	.
46745	4565	1	When	when	WRB
46745	4565	2	combined	combine	VBN
46745	4565	3	with	with	IN
46745	4565	4	a	a	DT
46745	4565	5	sufficient	sufficient	JJ
46745	4565	6	amount	amount	NN
46745	4565	7	of	of	IN
46745	4565	8	Opium	Opium	NNP
46745	4565	9	,	,	,
46745	4565	10	it	-PRON-	PRP
46745	4565	11	neither	neither	CC
46745	4565	12	acts	act	VBZ
46745	4565	13	as	as	IN
46745	4565	14	a	a	DT
46745	4565	15	Purgative	Purgative	NNP
46745	4565	16	,	,	,
46745	4565	17	nor	nor	CC
46745	4565	18	does	do	VBZ
46745	4565	19	it	-PRON-	PRP
46745	4565	20	pass	pass	VB
46745	4565	21	out	out	RP
46745	4565	22	by	by	IN
46745	4565	23	the	the	DT
46745	4565	24	bowels	bowel	NNS
46745	4565	25	;	;	:
46745	4565	26	and	and	CC
46745	4565	27	it	-PRON-	PRP
46745	4565	28	has	have	VBZ
46745	4565	29	therefore	therefore	RB
46745	4565	30	in	in	IN
46745	4565	31	that	that	DT
46745	4565	32	case	case	NN
46745	4565	33	a	a	DT
46745	4565	34	better	well	JJR
46745	4565	35	opportunity	opportunity	NN
46745	4565	36	of	of	IN
46745	4565	37	exerting	exert	VBG
46745	4565	38	its	-PRON-	PRP$
46745	4565	39	operation	operation	NN
46745	4565	40	in	in	IN
46745	4565	41	the	the	DT
46745	4565	42	blood	blood	NN
46745	4565	43	.	.	.
46745	4566	1	We	-PRON-	PRP
46745	4566	2	always	always	RB
46745	4566	3	find	find	VBP
46745	4566	4	that	that	IN
46745	4566	5	when	when	WRB
46745	4566	6	a	a	DT
46745	4566	7	Cathartic	cathartic	JJ
46745	4566	8	passes	pass	VBZ
46745	4566	9	off	off	RP
46745	4566	10	in	in	IN
46745	4566	11	some	some	DT
46745	4566	12	other	other	JJ
46745	4566	13	way	way	NN
46745	4566	14	than	than	IN
46745	4566	15	by	by	IN
46745	4566	16	the	the	DT
46745	4566	17	glands	gland	NNS
46745	4566	18	of	of	IN
46745	4566	19	the	the	DT
46745	4566	20	bowels	bowel	NNS
46745	4566	21	,	,	,
46745	4566	22	it	-PRON-	PRP
46745	4566	23	fails	fail	VBZ
46745	4566	24	to	to	TO
46745	4566	25	produce	produce	VB
46745	4566	26	purging	purge	VBG
46745	4566	27	.	.	.
46745	4567	1	Thus	thus	RB
46745	4567	2	a	a	DT
46745	4567	3	copious	copious	JJ
46745	4567	4	dilution	dilution	NN
46745	4567	5	with	with	IN
46745	4567	6	water	water	NN
46745	4567	7	may	may	MD
46745	4567	8	sometimes	sometimes	RB
46745	4567	9	cause	cause	VB
46745	4567	10	it	-PRON-	PRP
46745	4567	11	to	to	TO
46745	4567	12	be	be	VB
46745	4567	13	excreted	excrete	VBN
46745	4567	14	by	by	IN
46745	4567	15	the	the	DT
46745	4567	16	kidneys	kidney	NNS
46745	4567	17	,	,	,
46745	4567	18	which	which	WDT
46745	4567	19	are	be	VBP
46745	4567	20	the	the	DT
46745	4567	21	natural	natural	JJ
46745	4567	22	emunctories	emunctorie	NNS
46745	4567	23	of	of	IN
46745	4567	24	water	water	NN
46745	4567	25	.	.	.
46745	4568	1	In	in	IN
46745	4568	2	some	some	DT
46745	4568	3	persons	person	NNS
46745	4568	4	that	that	WDT
46745	4568	5	are	be	VBP
46745	4568	6	wo	will	MD
46745	4568	7	nt	not	RB
46745	4568	8	to	to	TO
46745	4568	9	perspire	perspire	VB
46745	4568	10	very	very	RB
46745	4568	11	freely	freely	RB
46745	4568	12	it	-PRON-	PRP
46745	4568	13	is	be	VBZ
46745	4568	14	difficult	difficult	JJ
46745	4568	15	to	to	TO
46745	4568	16	produce	produce	VB
46745	4568	17	purging	purge	VBG
46745	4568	18	.	.	.
46745	4569	1	The	the	DT
46745	4569	2	case	case	NN
46745	4569	3	related	relate	VBN
46745	4569	4	by	by	IN
46745	4569	5	Dr.	Dr.	NNP
46745	4569	6	Ward	Ward	NNP
46745	4569	7	of	of	IN
46745	4569	8	a	a	DT
46745	4569	9	woman	woman	NN
46745	4569	10	with	with	IN
46745	4569	11	whom	whom	WP
46745	4569	12	a	a	DT
46745	4569	13	dose	dose	NN
46745	4569	14	of	of	IN
46745	4569	15	Castor	castor	NN
46745	4569	16	-	-	HYPH
46745	4569	17	oil	oil	NN
46745	4569	18	was	be	VBD
46745	4569	19	seen	see	VBN
46745	4569	20	to	to	TO
46745	4569	21	pass	pass	VB
46745	4569	22	off	off	RP
46745	4569	23	by	by	IN
46745	4569	24	the	the	DT
46745	4569	25	skin	skin	NN
46745	4569	26	,	,	,
46745	4569	27	and	and	CC
46745	4569	28	invariably	invariably	RB
46745	4569	29	failed	fail	VBD
46745	4569	30	to	to	TO
46745	4569	31	act	act	VB
46745	4569	32	on	on	IN
46745	4569	33	the	the	DT
46745	4569	34	bowels	bowel	NNS
46745	4569	35	,	,	,
46745	4569	36	is	be	VBZ
46745	4569	37	an	an	DT
46745	4569	38	extreme	extreme	JJ
46745	4569	39	instance	instance	NN
46745	4569	40	of	of	IN
46745	4569	41	this	this	DT
46745	4569	42	kind	kind	NN
46745	4569	43	.	.	.
46745	4570	1	Of	of	IN
46745	4570	2	what	what	WP
46745	4570	3	use	use	NN
46745	4570	4	and	and	CC
46745	4570	5	intention	intention	NN
46745	4570	6	,	,	,
46745	4570	7	we	-PRON-	PRP
46745	4570	8	may	may	MD
46745	4570	9	now	now	RB
46745	4570	10	venture	venture	VB
46745	4570	11	to	to	TO
46745	4570	12	ask	ask	VB
46745	4570	13	,	,	,
46745	4570	14	is	be	VBZ
46745	4570	15	this	this	DT
46745	4570	16	intestinal	intestinal	JJ
46745	4570	17	function	function	NN
46745	4570	18	,	,	,
46745	4570	19	the	the	DT
46745	4570	20	continual	continual	JJ
46745	4570	21	maintenance	maintenance	NN
46745	4570	22	of	of	IN
46745	4570	23	which	which	WDT
46745	4570	24	in	in	IN
46745	4570	25	a	a	DT
46745	4570	26	healthy	healthy	JJ
46745	4570	27	condition	condition	NN
46745	4570	28	is	be	VBZ
46745	4570	29	found	find	VBN
46745	4570	30	to	to	TO
46745	4570	31	be	be	VB
46745	4570	32	so	so	RB
46745	4570	33	essential	essential	JJ
46745	4570	34	?	?	.
46745	4571	1	It	-PRON-	PRP
46745	4571	2	was	be	VBD
46745	4571	3	some	some	DT
46745	4571	4	time	time	NN
46745	4571	5	ago	ago	RB
46745	4571	6	supposed	suppose	VBD
46745	4571	7	that	that	IN
46745	4571	8	the	the	DT
46745	4571	9	fæces	fæce	NNS
46745	4571	10	consisted	consist	VBD
46745	4571	11	simply	simply	RB
46745	4571	12	of	of	IN
46745	4571	13	those	those	DT
46745	4571	14	parts	part	NNS
46745	4571	15	of	of	IN
46745	4571	16	the	the	DT
46745	4571	17	food	food	NN
46745	4571	18	which	which	WDT
46745	4571	19	remained	remain	VBD
46745	4571	20	unabsorbed	unabsorbed	JJ
46745	4571	21	,	,	,
46745	4571	22	and	and	CC
46745	4571	23	that	that	IN
46745	4571	24	all	all	DT
46745	4571	25	Purgative	purgative	JJ
46745	4571	26	medicines	medicine	NNS
46745	4571	27	alike	alike	RB
46745	4571	28	acted	act	VBN
46745	4571	29	by	by	IN
46745	4571	30	exciting	excite	VBG
46745	4571	31	the	the	DT
46745	4571	32	peristaltic	peristaltic	JJ
46745	4571	33	motion	motion	NN
46745	4571	34	of	of	IN
46745	4571	35	the	the	DT
46745	4571	36	bowels	bowel	NNS
46745	4571	37	,	,	,
46745	4571	38	and	and	CC
46745	4571	39	causing	cause	VBG
46745	4571	40	thus	thus	RB
46745	4571	41	the	the	DT
46745	4571	42	ejection	ejection	NN
46745	4571	43	of	of	IN
46745	4571	44	these	these	DT
46745	4571	45	undigested	undigested	JJ
46745	4571	46	matters	matter	NNS
46745	4571	47	.	.	.
46745	4572	1	Such	such	PDT
46745	4572	2	an	an	DT
46745	4572	3	opinion	opinion	NN
46745	4572	4	is	be	VBZ
46745	4572	5	now	now	RB
46745	4572	6	rarely	rarely	RB
46745	4572	7	maintained	maintain	VBN
46745	4572	8	.	.	.
46745	4573	1	Although	although	IN
46745	4573	2	very	very	RB
46745	4573	3	little	little	JJ
46745	4573	4	is	be	VBZ
46745	4573	5	known	know	VBN
46745	4573	6	of	of	IN
46745	4573	7	the	the	DT
46745	4573	8	separate	separate	JJ
46745	4573	9	functions	function	NNS
46745	4573	10	of	of	IN
46745	4573	11	the	the	DT
46745	4573	12	glands	gland	NNS
46745	4573	13	of	of	IN
46745	4573	14	the	the	DT
46745	4573	15	intestinal	intestinal	JJ
46745	4573	16	mucous	mucous	JJ
46745	4573	17	membrane	membrane	NN
46745	4573	18	,	,	,
46745	4573	19	yet	yet	CC
46745	4573	20	it	-PRON-	PRP
46745	4573	21	is	be	VBZ
46745	4573	22	generally	generally	RB
46745	4573	23	supposed	suppose	VBN
46745	4573	24	that	that	IN
46745	4573	25	the	the	DT
46745	4573	26	fæcal	fæcal	JJ
46745	4573	27	matters	matter	NNS
46745	4573	28	consist	consist	VBP
46745	4573	29	in	in	IN
46745	4573	30	great	great	JJ
46745	4573	31	part	part	NN
46745	4573	32	of	of	IN
46745	4573	33	excrementitious	excrementitious	JJ
46745	4573	34	substances	substance	NNS
46745	4573	35	which	which	WDT
46745	4573	36	are	be	VBP
46745	4573	37	separated	separate	VBN
46745	4573	38	by	by	IN
46745	4573	39	their	-PRON-	PRP$
46745	4573	40	means	mean	NNS
46745	4573	41	from	from	IN
46745	4573	42	the	the	DT
46745	4573	43	blood	blood	NN
46745	4573	44	.	.	.
46745	4574	1	The	the	DT
46745	4574	2	excretion	excretion	NN
46745	4574	3	of	of	IN
46745	4574	4	fæces	fæce	NNS
46745	4574	5	continues	continue	VBZ
46745	4574	6	when	when	WRB
46745	4574	7	no	no	DT
46745	4574	8	food	food	NN
46745	4574	9	is	be	VBZ
46745	4574	10	taken	take	VBN
46745	4574	11	.	.	.
46745	4575	1	It	-PRON-	PRP
46745	4575	2	is	be	VBZ
46745	4575	3	known	know	VBN
46745	4575	4	to	to	TO
46745	4575	5	go	go	VB
46745	4575	6	on	on	RP
46745	4575	7	with	with	IN
46745	4575	8	starving	starve	VBG
46745	4575	9	men	man	NNS
46745	4575	10	,	,	,
46745	4575	11	and	and	CC
46745	4575	12	with	with	IN
46745	4575	13	patients	patient	NNS
46745	4575	14	in	in	IN
46745	4575	15	fever	fever	NN
46745	4575	16	.	.	.
46745	4576	1	Liebig	Liebig	NNP
46745	4576	2	argues	argue	VBZ
46745	4576	3	for	for	IN
46745	4576	4	the	the	DT
46745	4576	5	secretion	secretion	NN
46745	4576	6	of	of	IN
46745	4576	7	the	the	DT
46745	4576	8	greater	great	JJR
46745	4576	9	part	part	NN
46745	4576	10	of	of	IN
46745	4576	11	the	the	DT
46745	4576	12	fæces	fæce	NNS
46745	4576	13	,	,	,
46745	4576	14	on	on	IN
46745	4576	15	the	the	DT
46745	4576	16	ground	ground	NN
46745	4576	17	that	that	IN
46745	4576	18	they	-PRON-	PRP
46745	4576	19	contain	contain	VBP
46745	4576	20	nitrogenous	nitrogenous	JJ
46745	4576	21	matters	matter	NNS
46745	4576	22	,	,	,
46745	4576	23	whereas	whereas	IN
46745	4576	24	all	all	PDT
46745	4576	25	the	the	DT
46745	4576	26	nitrogenous	nitrogenous	JJ
46745	4576	27	parts	part	NNS
46745	4576	28	of	of	IN
46745	4576	29	the	the	DT
46745	4576	30	food	food	NN
46745	4576	31	should	should	MD
46745	4576	32	be	be	VB
46745	4576	33	absorbed	absorb	VBN
46745	4576	34	for	for	IN
46745	4576	35	the	the	DT
46745	4576	36	purposes	purpose	NNS
46745	4576	37	of	of	IN
46745	4576	38	nutrition	nutrition	NN
46745	4576	39	.	.	.
46745	4577	1	Thus	thus	RB
46745	4577	2	these	these	DT
46745	4577	3	are	be	VBP
46745	4577	4	probably	probably	RB
46745	4577	5	the	the	DT
46745	4577	6	excreted	excreted	JJ
46745	4577	7	products	product	NNS
46745	4577	8	of	of	IN
46745	4577	9	changes	change	NNS
46745	4577	10	in	in	IN
46745	4577	11	the	the	DT
46745	4577	12	system	system	NN
46745	4577	13	,	,	,
46745	4577	14	which	which	WDT
46745	4577	15	it	-PRON-	PRP
46745	4577	16	is	be	VBZ
46745	4577	17	the	the	DT
46745	4577	18	province	province	NN
46745	4577	19	of	of	IN
46745	4577	20	the	the	DT
46745	4577	21	bowels	bowel	NNS
46745	4577	22	to	to	TO
46745	4577	23	separate	separate	VB
46745	4577	24	from	from	IN
46745	4577	25	the	the	DT
46745	4577	26	blood	blood	NN
46745	4577	27	.	.	.
46745	4578	1	(	(	-LRB-
46745	4578	2	_	_	NNP
46745	4578	3	Anim	Anim	NNP
46745	4578	4	.	.	.
46745	4579	1	Chem	Chem	NNP
46745	4579	2	.	.	.
46745	4579	3	_	_	NNP
46745	4579	4	p.	p.	NN
46745	4580	1	156	156	CD
46745	4580	2	.	.	.
46745	4580	3	)	)	-RRB-
46745	4581	1	The	the	DT
46745	4581	2	odour	odour	NN
46745	4581	3	of	of	IN
46745	4581	4	these	these	DT
46745	4581	5	matters	matter	NNS
46745	4581	6	is	be	VBZ
46745	4581	7	partly	partly	RB
46745	4581	8	owing	owe	VBG
46745	4581	9	to	to	IN
46745	4581	10	sulphuretted	sulphuret	VBN
46745	4581	11	hydrogen	hydrogen	NN
46745	4581	12	,	,	,
46745	4581	13	or	or	CC
46745	4581	14	hydrosulphate	hydrosulphate	NN
46745	4581	15	of	of	IN
46745	4581	16	ammonia	ammonia	NNP
46745	4581	17	,	,	,
46745	4581	18	both	both	DT
46745	4581	19	of	of	IN
46745	4581	20	which	which	WDT
46745	4581	21	are	be	VBP
46745	4581	22	the	the	DT
46745	4581	23	products	product	NNS
46745	4581	24	of	of	IN
46745	4581	25	animal	animal	NN
46745	4581	26	decomposition	decomposition	NN
46745	4581	27	.	.	.
46745	4582	1	On	on	IN
46745	4582	2	account	account	NN
46745	4582	3	of	of	IN
46745	4582	4	their	-PRON-	PRP$
46745	4582	5	presence	presence	NN
46745	4582	6	a	a	DT
46745	4582	7	black	black	JJ
46745	4582	8	colour	colour	NN
46745	4582	9	is	be	VBZ
46745	4582	10	communicated	communicate	VBN
46745	4582	11	to	to	IN
46745	4582	12	the	the	DT
46745	4582	13	fæces	fæce	NNS
46745	4582	14	by	by	IN
46745	4582	15	the	the	DT
46745	4582	16	internal	internal	NNP
46745	4582	17	administration	administration	NNP
46745	4582	18	of	of	IN
46745	4582	19	the	the	DT
46745	4582	20	salts	salt	NNS
46745	4582	21	of	of	IN
46745	4582	22	Iron	Iron	NNP
46745	4582	23	.	.	.
46745	4583	1	It	-PRON-	PRP
46745	4583	2	seems	seem	VBZ
46745	4583	3	to	to	IN
46745	4583	4	me	-PRON-	PRP
46745	4583	5	to	to	TO
46745	4583	6	be	be	VB
46745	4583	7	probable	probable	JJ
46745	4583	8	that	that	IN
46745	4583	9	the	the	DT
46745	4583	10	constituents	constituent	NNS
46745	4583	11	of	of	IN
46745	4583	12	the	the	DT
46745	4583	13	living	living	NN
46745	4583	14	as	as	RB
46745	4583	15	well	well	RB
46745	4583	16	as	as	IN
46745	4583	17	of	of	IN
46745	4583	18	the	the	DT
46745	4583	19	dead	dead	JJ
46745	4583	20	body	body	NN
46745	4583	21	are	be	VBP
46745	4583	22	constantly	constantly	RB
46745	4583	23	subjected	subject	VBN
46745	4583	24	to	to	IN
46745	4583	25	the	the	DT
46745	4583	26	control	control	NN
46745	4583	27	of	of	IN
46745	4583	28	chemical	chemical	JJ
46745	4583	29	laws	law	NNS
46745	4583	30	,	,	,
46745	4583	31	and	and	CC
46745	4583	32	undergoing	undergoing	JJ
46745	4583	33	destruction	destruction	NN
46745	4583	34	and	and	CC
46745	4583	35	change	change	NN
46745	4583	36	.	.	.
46745	4584	1	Some	some	DT
46745	4584	2	products	product	NNS
46745	4584	3	of	of	IN
46745	4584	4	these	these	DT
46745	4584	5	changes	change	NNS
46745	4584	6	in	in	IN
46745	4584	7	an	an	DT
46745	4584	8	early	early	JJ
46745	4584	9	stage	stage	NN
46745	4584	10	are	be	VBP
46745	4584	11	eliminated	eliminate	VBN
46745	4584	12	in	in	IN
46745	4584	13	the	the	DT
46745	4584	14	urine	urine	NN
46745	4584	15	;	;	:
46745	4584	16	but	but	CC
46745	4584	17	in	in	IN
46745	4584	18	great	great	JJ
46745	4584	19	part	part	NN
46745	4584	20	they	-PRON-	PRP
46745	4584	21	go	go	VBP
46745	4584	22	on	on	RP
46745	4584	23	to	to	IN
46745	4584	24	actual	actual	JJ
46745	4584	25	putrefaction	putrefaction	NN
46745	4584	26	.	.	.
46745	4585	1	The	the	DT
46745	4585	2	products	product	NNS
46745	4585	3	of	of	IN
46745	4585	4	this	this	DT
46745	4585	5	,	,	,
46745	4585	6	which	which	WDT
46745	4585	7	are	be	VBP
46745	4585	8	of	of	IN
46745	4585	9	an	an	DT
46745	4585	10	offensive	offensive	JJ
46745	4585	11	character	character	NN
46745	4585	12	,	,	,
46745	4585	13	are	be	VBP
46745	4585	14	apparently	apparently	RB
46745	4585	15	discharged	discharge	VBN
46745	4585	16	from	from	IN
46745	4585	17	the	the	DT
46745	4585	18	body	body	NN
46745	4585	19	through	through	IN
46745	4585	20	the	the	DT
46745	4585	21	follicles	follicle	NNS
46745	4585	22	and	and	CC
46745	4585	23	glands	gland	NNS
46745	4585	24	of	of	IN
46745	4585	25	the	the	DT
46745	4585	26	intestines	intestine	NNS
46745	4585	27	.	.	.
46745	4586	1	We	-PRON-	PRP
46745	4586	2	find	find	VBP
46745	4586	3	that	that	IN
46745	4586	4	this	this	DT
46745	4586	5	decomposition	decomposition	NN
46745	4586	6	is	be	VBZ
46745	4586	7	promoted	promote	VBN
46745	4586	8	and	and	CC
46745	4586	9	accelerated	accelerate	VBN
46745	4586	10	by	by	IN
46745	4586	11	heat	heat	NN
46745	4586	12	,	,	,
46745	4586	13	in	in	IN
46745	4586	14	the	the	DT
46745	4586	15	same	same	JJ
46745	4586	16	way	way	NN
46745	4586	17	as	as	IN
46745	4586	18	with	with	IN
46745	4586	19	dead	dead	JJ
46745	4586	20	animal	animal	NN
46745	4586	21	matter	matter	NN
46745	4586	22	.	.	.
46745	4587	1	For	for	IN
46745	4587	2	this	this	DT
46745	4587	3	reason	reason	NN
46745	4587	4	it	-PRON-	PRP
46745	4587	5	appears	appear	VBZ
46745	4587	6	that	that	IN
46745	4587	7	the	the	DT
46745	4587	8	natives	native	NNS
46745	4587	9	of	of	IN
46745	4587	10	warm	warm	JJ
46745	4587	11	climates	climate	NNS
46745	4587	12	excrete	excrete	VBP
46745	4587	13	a	a	DT
46745	4587	14	much	much	RB
46745	4587	15	larger	large	JJR
46745	4587	16	quantity	quantity	NN
46745	4587	17	of	of	IN
46745	4587	18	fæces	fæce	NNS
46745	4587	19	than	than	IN
46745	4587	20	the	the	DT
46745	4587	21	dwellers	dweller	NNS
46745	4587	22	in	in	IN
46745	4587	23	colder	cold	JJR
46745	4587	24	latitudes	latitude	NNS
46745	4587	25	;	;	:
46745	4587	26	and	and	CC
46745	4587	27	they	-PRON-	PRP
46745	4587	28	are	be	VBP
46745	4587	29	also	also	RB
46745	4587	30	more	more	RBR
46745	4587	31	subject	subject	JJ
46745	4587	32	to	to	IN
46745	4587	33	Dysentery	Dysentery	NNP
46745	4587	34	,	,	,
46745	4587	35	Diarrh[oe]a	diarrh[oe]a	CD
46745	4587	36	,	,	,
46745	4587	37	and	and	CC
46745	4587	38	Cholera	Cholera	NNP
46745	4587	39	,	,	,
46745	4587	40	on	on	IN
46745	4587	41	account	account	NN
46745	4587	42	of	of	IN
46745	4587	43	the	the	DT
46745	4587	44	extra	extra	JJ
46745	4587	45	work	work	NN
46745	4587	46	thrown	throw	VBN
46745	4587	47	upon	upon	IN
46745	4587	48	their	-PRON-	PRP$
46745	4587	49	intestines	intestine	NNS
46745	4587	50	.	.	.
46745	4588	1	A	a	DT
46745	4588	2	similar	similar	JJ
46745	4588	3	explanation	explanation	NN
46745	4588	4	may	may	MD
46745	4588	5	perhaps	perhaps	RB
46745	4588	6	be	be	VB
46745	4588	7	assigned	assign	VBN
46745	4588	8	to	to	IN
46745	4588	9	a	a	DT
46745	4588	10	curious	curious	JJ
46745	4588	11	fact	fact	NN
46745	4588	12	noticed	notice	VBD
46745	4588	13	some	some	DT
46745	4588	14	time	time	NN
46745	4588	15	ago	ago	RB
46745	4588	16	by	by	IN
46745	4588	17	Mr.	Mr.	NNP
46745	4589	1	Curling	curl	VBG
46745	4589	2	--	--	:
46745	4589	3	viz	viz	NN
46745	4589	4	.	.	.
46745	4589	5	,	,	,
46745	4589	6	that	that	DT
46745	4589	7	acute	acute	JJ
46745	4589	8	ulceration	ulceration	NN
46745	4589	9	of	of	IN
46745	4589	10	the	the	DT
46745	4589	11	duodenum	duodenum	NN
46745	4589	12	is	be	VBZ
46745	4589	13	a	a	DT
46745	4589	14	frequent	frequent	JJ
46745	4589	15	consequence	consequence	NN
46745	4589	16	of	of	IN
46745	4589	17	severe	severe	JJ
46745	4589	18	superficial	superficial	JJ
46745	4589	19	burns	burn	NNS
46745	4589	20	.	.	.
46745	4590	1	A	a	DT
46745	4590	2	quantity	quantity	NN
46745	4590	3	of	of	IN
46745	4590	4	gangrenous	gangrenous	JJ
46745	4590	5	or	or	CC
46745	4590	6	decomposing	decomposing	JJ
46745	4590	7	matter	matter	NN
46745	4590	8	may	may	MD
46745	4590	9	in	in	IN
46745	4590	10	such	such	PDT
46745	4590	11	a	a	DT
46745	4590	12	case	case	NN
46745	4590	13	be	be	VB
46745	4590	14	carried	carry	VBN
46745	4590	15	from	from	IN
46745	4590	16	the	the	DT
46745	4590	17	surface	surface	NN
46745	4590	18	into	into	IN
46745	4590	19	the	the	DT
46745	4590	20	circulation	circulation	NN
46745	4590	21	.	.	.
46745	4591	1	This	this	DT
46745	4591	2	blood	blood	NN
46745	4591	3	-	-	HYPH
46745	4591	4	decomposition	decomposition	NN
46745	4591	5	,	,	,
46745	4591	6	which	which	WDT
46745	4591	7	I	-PRON-	PRP
46745	4591	8	suppose	suppose	VBP
46745	4591	9	to	to	TO
46745	4591	10	be	be	VB
46745	4591	11	always	always	RB
46745	4591	12	going	go	VBG
46745	4591	13	on	on	RP
46745	4591	14	,	,	,
46745	4591	15	may	may	MD
46745	4591	16	be	be	VB
46745	4591	17	accelerated	accelerate	VBN
46745	4591	18	by	by	IN
46745	4591	19	the	the	DT
46745	4591	20	action	action	NN
46745	4591	21	of	of	IN
46745	4591	22	certain	certain	JJ
46745	4591	23	morbid	morbid	NN
46745	4591	24	poisons	poison	NNS
46745	4591	25	or	or	CC
46745	4591	26	processes	process	NNS
46745	4591	27	.	.	.
46745	4592	1	The	the	DT
46745	4592	2	secretion	secretion	NN
46745	4592	3	of	of	IN
46745	4592	4	the	the	DT
46745	4592	5	bowels	bowel	NNS
46745	4592	6	is	be	VBZ
46745	4592	7	then	then	RB
46745	4592	8	increased	increase	VBN
46745	4592	9	,	,	,
46745	4592	10	and	and	CC
46745	4592	11	by	by	IN
46745	4592	12	the	the	DT
46745	4592	13	excitement	excitement	NN
46745	4592	14	or	or	CC
46745	4592	15	over	over	IN
46745	4592	16	-	-	HYPH
46745	4592	17	work	work	VB
46745	4592	18	a	a	DT
46745	4592	19	diseased	disease	VBN
46745	4592	20	condition	condition	NN
46745	4592	21	of	of	IN
46745	4592	22	the	the	DT
46745	4592	23	intestinal	intestinal	JJ
46745	4592	24	surface	surface	NN
46745	4592	25	may	may	MD
46745	4592	26	be	be	VB
46745	4592	27	established	establish	VBN
46745	4592	28	.	.	.
46745	4593	1	In	in	IN
46745	4593	2	this	this	DT
46745	4593	3	way	way	NN
46745	4593	4	the	the	DT
46745	4593	5	diarrh[oe]a	diarrh[oe]a	NNP
46745	4593	6	and	and	CC
46745	4593	7	ulceration	ulceration	NN
46745	4593	8	of	of	IN
46745	4593	9	the	the	DT
46745	4593	10	glands	gland	NNS
46745	4593	11	in	in	IN
46745	4593	12	Typhoid	Typhoid	NNP
46745	4593	13	fever	fever	NN
46745	4593	14	may	may	MD
46745	4593	15	be	be	VB
46745	4593	16	accounted	account	VBN
46745	4593	17	for	for	IN
46745	4593	18	.	.	.
46745	4594	1	The	the	DT
46745	4594	2	air	air	NN
46745	4594	3	of	of	IN
46745	4594	4	a	a	DT
46745	4594	5	dissecting	dissecting	NN
46745	4594	6	-	-	HYPH
46745	4594	7	room	room	NN
46745	4594	8	,	,	,
46745	4594	9	or	or	CC
46745	4594	10	the	the	DT
46745	4594	11	neighbourhood	neighbourhood	NN
46745	4594	12	of	of	IN
46745	4594	13	a	a	DT
46745	4594	14	noxious	noxious	JJ
46745	4594	15	sewer	sewer	NN
46745	4594	16	,	,	,
46745	4594	17	is	be	VBZ
46745	4594	18	apt	apt	JJ
46745	4594	19	to	to	TO
46745	4594	20	bring	bring	VB
46745	4594	21	on	on	RP
46745	4594	22	diarrh[oe]a	diarrh[oe]a	NNP
46745	4594	23	by	by	IN
46745	4594	24	exciting	excite	VBG
46745	4594	25	a	a	DT
46745	4594	26	putrefaction	putrefaction	NN
46745	4594	27	of	of	IN
46745	4594	28	the	the	DT
46745	4594	29	blood	blood	NN
46745	4594	30	.	.	.
46745	4595	1	Severe	severe	JJ
46745	4595	2	bodily	bodily	RB
46745	4595	3	exercise	exercise	NN
46745	4595	4	,	,	,
46745	4595	5	as	as	IN
46745	4595	6	a	a	DT
46745	4595	7	long	long	JJ
46745	4595	8	walk	walk	NN
46745	4595	9	,	,	,
46745	4595	10	may	may	MD
46745	4595	11	cause	cause	VB
46745	4595	12	it	-PRON-	PRP
46745	4595	13	,	,	,
46745	4595	14	by	by	IN
46745	4595	15	increasing	increase	VBG
46745	4595	16	the	the	DT
46745	4595	17	waste	waste	NN
46745	4595	18	of	of	IN
46745	4595	19	tissue	tissue	NN
46745	4595	20	.	.	.
46745	4596	1	We	-PRON-	PRP
46745	4596	2	find	find	VBP
46745	4596	3	that	that	IN
46745	4596	4	constipation	constipation	NN
46745	4596	5	is	be	VBZ
46745	4596	6	commonest	common	JJS
46745	4596	7	in	in	IN
46745	4596	8	youth	youth	NN
46745	4596	9	,	,	,
46745	4596	10	when	when	WRB
46745	4596	11	nutrition	nutrition	NN
46745	4596	12	is	be	VBZ
46745	4596	13	most	most	RBS
46745	4596	14	active	active	JJ
46745	4596	15	;	;	:
46745	4596	16	and	and	CC
46745	4596	17	diarrh[oe]a	diarrh[oe]a	NNP
46745	4596	18	most	most	RBS
46745	4596	19	frequent	frequent	JJ
46745	4596	20	in	in	IN
46745	4596	21	old	old	JJ
46745	4596	22	age	age	NN
46745	4596	23	,	,	,
46745	4596	24	when	when	WRB
46745	4596	25	waste	waste	NN
46745	4596	26	and	and	CC
46745	4596	27	decay	decay	VB
46745	4596	28	go	go	VB
46745	4596	29	on	on	IN
46745	4596	30	the	the	DT
46745	4596	31	fastest	fast	JJS
46745	4596	32	.	.	.
46745	4597	1	When	when	WRB
46745	4597	2	these	these	DT
46745	4597	3	decomposed	decompose	VBN
46745	4597	4	matters	matter	NNS
46745	4597	5	which	which	WDT
46745	4597	6	should	should	MD
46745	4597	7	be	be	VB
46745	4597	8	excreted	excrete	VBN
46745	4597	9	,	,	,
46745	4597	10	are	be	VBP
46745	4597	11	retained	retain	VBN
46745	4597	12	in	in	IN
46745	4597	13	the	the	DT
46745	4597	14	blood	blood	NN
46745	4597	15	,	,	,
46745	4597	16	as	as	IN
46745	4597	17	is	be	VBZ
46745	4597	18	the	the	DT
46745	4597	19	case	case	NN
46745	4597	20	in	in	IN
46745	4597	21	constipation	constipation	NN
46745	4597	22	,	,	,
46745	4597	23	they	-PRON-	PRP
46745	4597	24	affect	affect	VBP
46745	4597	25	very	very	RB
46745	4597	26	injuriously	injuriously	RB
46745	4597	27	both	both	CC
46745	4597	28	the	the	DT
46745	4597	29	brain	brain	NN
46745	4597	30	and	and	CC
46745	4597	31	the	the	DT
46745	4597	32	system	system	NN
46745	4597	33	in	in	IN
46745	4597	34	general	general	JJ
46745	4597	35	,	,	,
46745	4597	36	causing	cause	VBG
46745	4597	37	torpidity	torpidity	NN
46745	4597	38	of	of	IN
46745	4597	39	the	the	DT
46745	4597	40	one	one	NN
46745	4597	41	,	,	,
46745	4597	42	and	and	CC
46745	4597	43	in	in	IN
46745	4597	44	the	the	DT
46745	4597	45	other	other	JJ
46745	4597	46	favouring	favour	VBG
46745	4597	47	the	the	DT
46745	4597	48	progress	progress	NN
46745	4597	49	and	and	CC
46745	4597	50	development	development	NN
46745	4597	51	of	of	IN
46745	4597	52	every	every	DT
46745	4597	53	description	description	NN
46745	4597	54	of	of	IN
46745	4597	55	morbid	morbid	NN
46745	4597	56	action	action	NN
46745	4597	57	.	.	.
46745	4598	1	It	-PRON-	PRP
46745	4598	2	is	be	VBZ
46745	4598	3	by	by	IN
46745	4598	4	cleaning	clean	VBG
46745	4598	5	such	such	JJ
46745	4598	6	matters	matter	NNS
46745	4598	7	out	out	IN
46745	4598	8	of	of	IN
46745	4598	9	the	the	DT
46745	4598	10	blood	blood	NN
46745	4598	11	,	,	,
46745	4598	12	as	as	RB
46745	4598	13	well	well	RB
46745	4598	14	as	as	IN
46745	4598	15	by	by	IN
46745	4598	16	their	-PRON-	PRP$
46745	4598	17	antiphlogistic	antiphlogistic	JJ
46745	4598	18	or	or	CC
46745	4598	19	evacuant	evacuant	JJ
46745	4598	20	action	action	NN
46745	4598	21	,	,	,
46745	4598	22	that	that	IN
46745	4598	23	Cathartics	Cathartics	NNPS
46745	4598	24	become	become	VBP
46745	4598	25	useful	useful	JJ
46745	4598	26	in	in	IN
46745	4598	27	so	so	RB
46745	4598	28	many	many	JJ
46745	4598	29	diseases	disease	NNS
46745	4598	30	,	,	,
46745	4598	31	and	and	CC
46745	4598	32	particularly	particularly	RB
46745	4598	33	in	in	IN
46745	4598	34	disorders	disorder	NNS
46745	4598	35	of	of	IN
46745	4598	36	the	the	DT
46745	4598	37	brain	brain	NN
46745	4598	38	.	.	.
46745	4599	1	It	-PRON-	PRP
46745	4599	2	would	would	MD
46745	4599	3	seem	seem	VB
46745	4599	4	that	that	IN
46745	4599	5	the	the	DT
46745	4599	6	substances	substance	NNS
46745	4599	7	which	which	WDT
46745	4599	8	would	would	MD
46745	4599	9	be	be	VB
46745	4599	10	eliminated	eliminate	VBN
46745	4599	11	by	by	IN
46745	4599	12	the	the	DT
46745	4599	13	bowels	bowel	NNS
46745	4599	14	have	have	VBP
46745	4599	15	,	,	,
46745	4599	16	when	when	WRB
46745	4599	17	retained	retain	VBN
46745	4599	18	in	in	IN
46745	4599	19	the	the	DT
46745	4599	20	blood	blood	NN
46745	4599	21	,	,	,
46745	4599	22	a	a	DT
46745	4599	23	peculiar	peculiar	JJ
46745	4599	24	action	action	NN
46745	4599	25	in	in	IN
46745	4599	26	the	the	DT
46745	4599	27	aggravation	aggravation	NN
46745	4599	28	of	of	IN
46745	4599	29	disorders	disorder	NNS
46745	4599	30	of	of	IN
46745	4599	31	this	this	DT
46745	4599	32	latter	latter	JJ
46745	4599	33	organ	organ	NN
46745	4599	34	.	.	.
46745	4600	1	Thus	thus	RB
46745	4600	2	from	from	IN
46745	4600	3	very	very	RB
46745	4600	4	early	early	JJ
46745	4600	5	times	time	NNS
46745	4600	6	the	the	DT
46745	4600	7	exhibition	exhibition	NN
46745	4600	8	of	of	IN
46745	4600	9	drastic	drastic	JJ
46745	4600	10	purgatives	purgative	NNS
46745	4600	11	,	,	,
46745	4600	12	particularly	particularly	RB
46745	4600	13	Hellebore	Hellebore	NNP
46745	4600	14	,	,	,
46745	4600	15	has	have	VBZ
46745	4600	16	been	be	VBN
46745	4600	17	strongly	strongly	RB
46745	4600	18	recommended	recommend	VBN
46745	4600	19	in	in	IN
46745	4600	20	cases	case	NNS
46745	4600	21	of	of	IN
46745	4600	22	mania	mania	NN
46745	4600	23	.	.	.
46745	4601	1	But	but	CC
46745	4601	2	there	there	EX
46745	4601	3	is	be	VBZ
46745	4601	4	scarcely	scarcely	RB
46745	4601	5	any	any	DT
46745	4601	6	disorder	disorder	NN
46745	4601	7	in	in	IN
46745	4601	8	which	which	WDT
46745	4601	9	there	there	EX
46745	4601	10	is	be	VBZ
46745	4601	11	not	not	RB
46745	4601	12	,	,	,
46745	4601	13	in	in	IN
46745	4601	14	some	some	DT
46745	4601	15	way	way	NN
46745	4601	16	or	or	CC
46745	4601	17	other	other	JJ
46745	4601	18	,	,	,
46745	4601	19	a	a	DT
46745	4601	20	deranged	derange	VBN
46745	4601	21	condition	condition	NN
46745	4601	22	of	of	IN
46745	4601	23	the	the	DT
46745	4601	24	intestinal	intestinal	JJ
46745	4601	25	function	function	NN
46745	4601	26	,	,	,
46745	4601	27	and	and	CC
46745	4601	28	in	in	IN
46745	4601	29	which	which	WDT
46745	4601	30	,	,	,
46745	4601	31	therefore	therefore	RB
46745	4601	32	,	,	,
46745	4601	33	the	the	DT
46745	4601	34	judicious	judicious	JJ
46745	4601	35	employment	employment	NN
46745	4601	36	of	of	IN
46745	4601	37	purgative	purgative	JJ
46745	4601	38	medicines	medicine	NNS
46745	4601	39	is	be	VBZ
46745	4601	40	not	not	RB
46745	4601	41	at	at	IN
46745	4601	42	some	some	DT
46745	4601	43	time	time	NN
46745	4601	44	necessary	necessary	JJ
46745	4601	45	.	.	.
46745	4602	1	Either	either	CC
46745	4602	2	there	there	EX
46745	4602	3	is	be	VBZ
46745	4602	4	constipation	constipation	NN
46745	4602	5	,	,	,
46745	4602	6	in	in	IN
46745	4602	7	which	which	WDT
46745	4602	8	case	case	NN
46745	4602	9	there	there	EX
46745	4602	10	is	be	VBZ
46745	4602	11	a	a	DT
46745	4602	12	danger	danger	NN
46745	4602	13	of	of	IN
46745	4602	14	the	the	DT
46745	4602	15	fæcal	fæcal	JJ
46745	4602	16	matters	matter	NNS
46745	4602	17	being	be	VBG
46745	4602	18	retained	retain	VBN
46745	4602	19	in	in	IN
46745	4602	20	the	the	DT
46745	4602	21	blood	blood	NN
46745	4602	22	;	;	:
46745	4602	23	or	or	CC
46745	4602	24	there	there	EX
46745	4602	25	is	be	VBZ
46745	4602	26	diarrh[oe]a	diarrh[oe]a	NNP
46745	4602	27	,	,	,
46745	4602	28	which	which	WDT
46745	4602	29	is	be	VBZ
46745	4602	30	probably	probably	RB
46745	4602	31	due	due	JJ
46745	4602	32	to	to	IN
46745	4602	33	an	an	DT
46745	4602	34	over	over	NN
46745	4602	35	-	-	HYPH
46745	4602	36	formation	formation	NN
46745	4602	37	of	of	IN
46745	4602	38	these	these	DT
46745	4602	39	materials	material	NNS
46745	4602	40	in	in	IN
46745	4602	41	the	the	DT
46745	4602	42	system	system	NN
46745	4602	43	,	,	,
46745	4602	44	and	and	CC
46745	4602	45	an	an	DT
46745	4602	46	attempt	attempt	NN
46745	4602	47	of	of	IN
46745	4602	48	nature	nature	NN
46745	4602	49	at	at	IN
46745	4602	50	their	-PRON-	PRP$
46745	4602	51	evacuation	evacuation	NN
46745	4602	52	.	.	.
46745	4603	1	In	in	IN
46745	4603	2	each	each	DT
46745	4603	3	of	of	IN
46745	4603	4	these	these	DT
46745	4603	5	cases	case	NNS
46745	4603	6	Cathartics	Cathartics	NNPS
46745	4603	7	may	may	MD
46745	4603	8	be	be	VB
46745	4603	9	necessary	necessary	JJ
46745	4603	10	.	.	.
46745	4604	1	The	the	DT
46745	4604	2	first	first	JJ
46745	4604	3	condition	condition	NN
46745	4604	4	is	be	VBZ
46745	4604	5	the	the	DT
46745	4604	6	more	more	JJR
46745	4604	7	obstinate	obstinate	NN
46745	4604	8	of	of	IN
46745	4604	9	the	the	DT
46745	4604	10	two	two	CD
46745	4604	11	;	;	:
46745	4604	12	the	the	DT
46745	4604	13	second	second	JJ
46745	4604	14	the	the	DT
46745	4604	15	more	more	RBR
46745	4604	16	immediately	immediately	RB
46745	4604	17	dangerous	dangerous	JJ
46745	4604	18	.	.	.
46745	4605	1	Some	some	DT
46745	4605	2	general	general	JJ
46745	4605	3	indications	indication	NNS
46745	4605	4	for	for	IN
46745	4605	5	their	-PRON-	PRP$
46745	4605	6	treatment	treatment	NN
46745	4605	7	may	may	MD
46745	4605	8	be	be	VB
46745	4605	9	alluded	allude	VBN
46745	4605	10	to	to	IN
46745	4605	11	.	.	.
46745	4606	1	In	in	IN
46745	4606	2	the	the	DT
46745	4606	3	treatment	treatment	NN
46745	4606	4	of	of	IN
46745	4606	5	constipated	constipate	VBN
46745	4606	6	habits	habit	NNS
46745	4606	7	it	-PRON-	PRP
46745	4606	8	is	be	VBZ
46745	4606	9	better	well	JJR
46745	4606	10	to	to	TO
46745	4606	11	keep	keep	VB
46745	4606	12	up	up	RP
46745	4606	13	a	a	DT
46745	4606	14	constant	constant	JJ
46745	4606	15	and	and	CC
46745	4606	16	gentle	gentle	JJ
46745	4606	17	action	action	NN
46745	4606	18	on	on	IN
46745	4606	19	the	the	DT
46745	4606	20	bowels	bowel	NNS
46745	4606	21	than	than	IN
46745	4606	22	to	to	TO
46745	4606	23	give	give	VB
46745	4606	24	violent	violent	JJ
46745	4606	25	doses	dose	NNS
46745	4606	26	occasionally	occasionally	RB
46745	4606	27	.	.	.
46745	4607	1	A	a	DT
46745	4607	2	condition	condition	NN
46745	4607	3	of	of	IN
46745	4607	4	this	this	DT
46745	4607	5	sort	sort	NN
46745	4607	6	may	may	MD
46745	4607	7	sometimes	sometimes	RB
46745	4607	8	co	co	VB
46745	4607	9	-	-	VB
46745	4607	10	exist	exist	VB
46745	4607	11	with	with	IN
46745	4607	12	comparative	comparative	JJ
46745	4607	13	health	health	NN
46745	4607	14	,	,	,
46745	4607	15	and	and	CC
46745	4607	16	may	may	MD
46745	4607	17	then	then	RB
46745	4607	18	often	often	RB
46745	4607	19	be	be	VB
46745	4607	20	remedied	remedie	VBN
46745	4607	21	by	by	IN
46745	4607	22	a	a	DT
46745	4607	23	slight	slight	JJ
46745	4607	24	alteration	alteration	NN
46745	4607	25	in	in	IN
46745	4607	26	diet	diet	NNP
46745	4607	27	,	,	,
46745	4607	28	and	and	CC
46745	4607	29	the	the	DT
46745	4607	30	prescription	prescription	NN
46745	4607	31	of	of	IN
46745	4607	32	such	such	JJ
46745	4607	33	kinds	kind	NNS
46745	4607	34	of	of	IN
46745	4607	35	food	food	NN
46745	4607	36	as	as	IN
46745	4607	37	are	be	VBP
46745	4607	38	more	more	RBR
46745	4607	39	relaxing	relaxing	JJ
46745	4607	40	in	in	IN
46745	4607	41	their	-PRON-	PRP$
46745	4607	42	nature	nature	NN
46745	4607	43	than	than	IN
46745	4607	44	those	those	DT
46745	4607	45	hitherto	hitherto	VBN
46745	4607	46	taken	take	VBN
46745	4607	47	.	.	.
46745	4608	1	Dr.	Dr.	NNP
46745	4608	2	Hamilton	Hamilton	NNP
46745	4608	3	,	,	,
46745	4608	4	in	in	IN
46745	4608	5	his	-PRON-	PRP$
46745	4608	6	work	work	NN
46745	4608	7	on	on	IN
46745	4608	8	Purgative	Purgative	NNP
46745	4608	9	Medicines	Medicines	NNP
46745	4608	10	,	,	,
46745	4608	11	states	state	VBZ
46745	4608	12	that	that	IN
46745	4608	13	when	when	WRB
46745	4608	14	they	-PRON-	PRP
46745	4608	15	are	be	VBP
46745	4608	16	given	give	VBN
46745	4608	17	in	in	IN
46745	4608	18	constipation	constipation	NN
46745	4608	19	he	-PRON-	PRP
46745	4608	20	has	have	VBZ
46745	4608	21	found	find	VBN
46745	4608	22	that	that	IN
46745	4608	23	they	-PRON-	PRP
46745	4608	24	become	become	VBP
46745	4608	25	more	more	RBR
46745	4608	26	and	and	CC
46745	4608	27	more	more	RBR
46745	4608	28	powerful	powerful	JJ
46745	4608	29	,	,	,
46745	4608	30	and	and	CC
46745	4608	31	may	may	MD
46745	4608	32	be	be	VB
46745	4608	33	taken	take	VBN
46745	4608	34	in	in	RP
46745	4608	35	smaller	small	JJR
46745	4608	36	and	and	CC
46745	4608	37	smaller	small	JJR
46745	4608	38	doses	dose	VBZ
46745	4608	39	the	the	DT
46745	4608	40	longer	long	JJR
46745	4608	41	they	-PRON-	PRP
46745	4608	42	are	be	VBP
46745	4608	43	continued	continue	VBN
46745	4608	44	.	.	.
46745	4609	1	This	this	DT
46745	4609	2	is	be	VBZ
46745	4609	3	probably	probably	RB
46745	4609	4	the	the	DT
46745	4609	5	case	case	NN
46745	4609	6	with	with	IN
46745	4609	7	such	such	JJ
46745	4609	8	as	as	IN
46745	4609	9	Castor	castor	NN
46745	4609	10	-	-	HYPH
46745	4609	11	oil	oil	NN
46745	4609	12	,	,	,
46745	4609	13	Scammony	Scammony	NNP
46745	4609	14	,	,	,
46745	4609	15	and	and	CC
46745	4609	16	Jalap	Jalap	NNP
46745	4609	17	,	,	,
46745	4609	18	which	which	WDT
46745	4609	19	are	be	VBP
46745	4609	20	simply	simply	RB
46745	4609	21	cathartic	cathartic	JJ
46745	4609	22	in	in	IN
46745	4609	23	their	-PRON-	PRP$
46745	4609	24	action	action	NN
46745	4609	25	.	.	.
46745	4610	1	But	but	CC
46745	4610	2	others	other	NNS
46745	4610	3	,	,	,
46745	4610	4	such	such	JJ
46745	4610	5	as	as	IN
46745	4610	6	Rhubarb	Rhubarb	NNP
46745	4610	7	and	and	CC
46745	4610	8	Aloes	Aloes	NNP
46745	4610	9	,	,	,
46745	4610	10	contain	contain	VB
46745	4610	11	a	a	DT
46745	4610	12	bitter	bitter	JJ
46745	4610	13	and	and	CC
46745	4610	14	astringent	astringent	JJ
46745	4610	15	matter	matter	NN
46745	4610	16	along	along	IN
46745	4610	17	with	with	IN
46745	4610	18	the	the	DT
46745	4610	19	purgative	purgative	JJ
46745	4610	20	principle	principle	NN
46745	4610	21	,	,	,
46745	4610	22	and	and	CC
46745	4610	23	though	though	IN
46745	4610	24	they	-PRON-	PRP
46745	4610	25	first	first	RB
46745	4610	26	act	act	VBP
46745	4610	27	upon	upon	IN
46745	4610	28	the	the	DT
46745	4610	29	bowels	bowel	NNS
46745	4610	30	tend	tend	VBP
46745	4610	31	for	for	IN
46745	4610	32	this	this	DT
46745	4610	33	reason	reason	NN
46745	4610	34	in	in	IN
46745	4610	35	the	the	DT
46745	4610	36	second	second	JJ
46745	4610	37	place	place	NN
46745	4610	38	to	to	TO
46745	4610	39	confine	confine	VB
46745	4610	40	them	-PRON-	PRP
46745	4610	41	.	.	.
46745	4611	1	Thus	thus	RB
46745	4611	2	while	while	IN
46745	4611	3	the	the	DT
46745	4611	4	former	former	JJ
46745	4611	5	are	be	VBP
46745	4611	6	best	good	JJS
46745	4611	7	in	in	IN
46745	4611	8	cases	case	NNS
46745	4611	9	of	of	IN
46745	4611	10	constipation	constipation	NN
46745	4611	11	,	,	,
46745	4611	12	the	the	DT
46745	4611	13	latter	latter	JJ
46745	4611	14	are	be	VBP
46745	4611	15	preferable	preferable	JJ
46745	4611	16	in	in	IN
46745	4611	17	diarrh[oe]a	diarrh[oe]a	NNP
46745	4611	18	,	,	,
46745	4611	19	as	as	IN
46745	4611	20	they	-PRON-	PRP
46745	4611	21	supply	supply	VBP
46745	4611	22	us	-PRON-	PRP
46745	4611	23	then	then	RB
46745	4611	24	with	with	IN
46745	4611	25	the	the	DT
46745	4611	26	very	very	JJ
46745	4611	27	action	action	NN
46745	4611	28	which	which	WDT
46745	4611	29	we	-PRON-	PRP
46745	4611	30	require	require	VBP
46745	4611	31	.	.	.
46745	4612	1	There	there	EX
46745	4612	2	are	be	VBP
46745	4612	3	two	two	CD
46745	4612	4	ways	way	NNS
46745	4612	5	,	,	,
46745	4612	6	apparently	apparently	RB
46745	4612	7	opposite	opposite	JJ
46745	4612	8	and	and	CC
46745	4612	9	inconsistent	inconsistent	JJ
46745	4612	10	,	,	,
46745	4612	11	of	of	IN
46745	4612	12	treating	treat	VBG
46745	4612	13	a	a	DT
46745	4612	14	flux	flux	NN
46745	4612	15	from	from	IN
46745	4612	16	the	the	DT
46745	4612	17	bowels	bowel	NNS
46745	4612	18	.	.	.
46745	4613	1	We	-PRON-	PRP
46745	4613	2	may	may	MD
46745	4613	3	try	try	VB
46745	4613	4	to	to	TO
46745	4613	5	encourage	encourage	VB
46745	4613	6	it	-PRON-	PRP
46745	4613	7	by	by	IN
46745	4613	8	Purgatives	purgative	NNS
46745	4613	9	;	;	:
46745	4613	10	or	or	CC
46745	4613	11	attempt	attempt	VB
46745	4613	12	to	to	TO
46745	4613	13	suppress	suppress	VB
46745	4613	14	it	-PRON-	PRP
46745	4613	15	by	by	IN
46745	4613	16	Astringents	astringent	NNS
46745	4613	17	.	.	.
46745	4614	1	Thus	thus	RB
46745	4614	2	we	-PRON-	PRP
46745	4614	3	may	may	MD
46745	4614	4	treat	treat	VB
46745	4614	5	a	a	DT
46745	4614	6	common	common	JJ
46745	4614	7	diarrh[oe]a	diarrh[oe]a	NNP
46745	4614	8	by	by	IN
46745	4614	9	Castor	castor	NN
46745	4614	10	-	-	HYPH
46745	4614	11	oil	oil	NN
46745	4614	12	,	,	,
46745	4614	13	or	or	CC
46745	4614	14	by	by	IN
46745	4614	15	Sulphuric	Sulphuric	NNP
46745	4614	16	Acid	Acid	NNP
46745	4614	17	.	.	.
46745	4615	1	In	in	IN
46745	4615	2	dysentery	dysentery	NN
46745	4615	3	we	-PRON-	PRP
46745	4615	4	may	may	MD
46745	4615	5	give	give	VB
46745	4615	6	Calomel	Calomel	NNP
46745	4615	7	,	,	,
46745	4615	8	or	or	CC
46745	4615	9	Catechu	Catechu	NNP
46745	4615	10	.	.	.
46745	4616	1	Even	even	RB
46745	4616	2	in	in	IN
46745	4616	3	Cholera	Cholera	NNP
46745	4616	4	some	some	DT
46745	4616	5	recommend	recommend	NN
46745	4616	6	Opium	Opium	NNP
46745	4616	7	,	,	,
46745	4616	8	while	while	IN
46745	4616	9	others	other	NNS
46745	4616	10	have	have	VBP
46745	4616	11	employed	employ	VBN
46745	4616	12	Croton	Croton	NNP
46745	4616	13	-	-	HYPH
46745	4616	14	oil	oil	NN
46745	4616	15	.	.	.
46745	4617	1	In	in	IN
46745	4617	2	the	the	DT
46745	4617	3	most	most	RBS
46745	4617	4	obvious	obvious	JJ
46745	4617	5	case	case	NN
46745	4617	6	,	,	,
46745	4617	7	_	_	NNP
46745	4617	8	i.e.	i.e.	FW
46745	4617	9	_	_	NNP
46745	4617	10	in	in	IN
46745	4617	11	simple	simple	NNP
46745	4617	12	diarrh[oe]a	diarrh[oe]a	NNP
46745	4617	13	,	,	,
46745	4617	14	it	-PRON-	PRP
46745	4617	15	is	be	VBZ
46745	4617	16	apparent	apparent	JJ
46745	4617	17	that	that	IN
46745	4617	18	both	both	DT
46745	4617	19	plans	plan	NNS
46745	4617	20	are	be	VBP
46745	4617	21	appropriate	appropriate	JJ
46745	4617	22	,	,	,
46745	4617	23	but	but	CC
46745	4617	24	at	at	IN
46745	4617	25	different	different	JJ
46745	4617	26	periods	period	NNS
46745	4617	27	of	of	IN
46745	4617	28	the	the	DT
46745	4617	29	disorder	disorder	NN
46745	4617	30	.	.	.
46745	4618	1	The	the	DT
46745	4618	2	symptom	symptom	NN
46745	4618	3	depends	depend	VBZ
46745	4618	4	upon	upon	IN
46745	4618	5	the	the	DT
46745	4618	6	fact	fact	NN
46745	4618	7	of	of	IN
46745	4618	8	something	something	NN
46745	4618	9	being	be	VBG
46745	4618	10	formed	form	VBN
46745	4618	11	in	in	IN
46745	4618	12	the	the	DT
46745	4618	13	blood	blood	NN
46745	4618	14	which	which	WDT
46745	4618	15	ought	ought	MD
46745	4618	16	to	to	TO
46745	4618	17	be	be	VB
46745	4618	18	excreted	excrete	VBN
46745	4618	19	from	from	IN
46745	4618	20	it	-PRON-	PRP
46745	4618	21	.	.	.
46745	4619	1	Probably	probably	RB
46745	4619	2	it	-PRON-	PRP
46745	4619	3	is	be	VBZ
46745	4619	4	an	an	DT
46745	4619	5	excess	excess	NN
46745	4619	6	of	of	IN
46745	4619	7	that	that	DT
46745	4619	8	material	material	NN
46745	4619	9	which	which	WDT
46745	4619	10	is	be	VBZ
46745	4619	11	ordinarily	ordinarily	RB
46745	4619	12	excreted	excrete	VBN
46745	4619	13	by	by	IN
46745	4619	14	the	the	DT
46745	4619	15	bowels	bowel	NNS
46745	4619	16	.	.	.
46745	4620	1	Its	-PRON-	PRP$
46745	4620	2	passage	passage	NN
46745	4620	3	out	out	RP
46745	4620	4	by	by	IN
46745	4620	5	a	a	DT
46745	4620	6	natural	natural	JJ
46745	4620	7	effort	effort	NN
46745	4620	8	causes	cause	NNS
46745	4620	9	at	at	IN
46745	4620	10	first	first	RB
46745	4620	11	a	a	DT
46745	4620	12	simple	simple	JJ
46745	4620	13	increase	increase	NN
46745	4620	14	of	of	IN
46745	4620	15	the	the	DT
46745	4620	16	usual	usual	JJ
46745	4620	17	evacuation	evacuation	NN
46745	4620	18	.	.	.
46745	4621	1	It	-PRON-	PRP
46745	4621	2	is	be	VBZ
46745	4621	3	at	at	IN
46745	4621	4	this	this	DT
46745	4621	5	time	time	NN
46745	4621	6	that	that	WDT
46745	4621	7	we	-PRON-	PRP
46745	4621	8	should	should	MD
46745	4621	9	give	give	VB
46745	4621	10	a	a	DT
46745	4621	11	Purgative	Purgative	NNP
46745	4621	12	,	,	,
46745	4621	13	to	to	TO
46745	4621	14	favour	favour	VB
46745	4621	15	the	the	DT
46745	4621	16	natural	natural	JJ
46745	4621	17	excretion	excretion	NN
46745	4621	18	,	,	,
46745	4621	19	and	and	CC
46745	4621	20	thus	thus	RB
46745	4621	21	,	,	,
46745	4621	22	if	if	IN
46745	4621	23	possible	possible	JJ
46745	4621	24	,	,	,
46745	4621	25	to	to	TO
46745	4621	26	put	put	VB
46745	4621	27	an	an	DT
46745	4621	28	end	end	NN
46745	4621	29	to	to	IN
46745	4621	30	the	the	DT
46745	4621	31	disturbance	disturbance	NN
46745	4621	32	.	.	.
46745	4622	1	But	but	CC
46745	4622	2	sometimes	sometimes	RB
46745	4622	3	it	-PRON-	PRP
46745	4622	4	fails	fail	VBZ
46745	4622	5	to	to	TO
46745	4622	6	do	do	VB
46745	4622	7	so	so	RB
46745	4622	8	.	.	.
46745	4623	1	The	the	DT
46745	4623	2	matters	matter	NNS
46745	4623	3	to	to	TO
46745	4623	4	be	be	VB
46745	4623	5	excreted	excrete	VBN
46745	4623	6	are	be	VBP
46745	4623	7	irritating	irritate	VBG
46745	4623	8	,	,	,
46745	4623	9	and	and	CC
46745	4623	10	such	such	PDT
46745	4623	11	an	an	DT
46745	4623	12	excitement	excitement	NN
46745	4623	13	may	may	MD
46745	4623	14	be	be	VB
46745	4623	15	caused	cause	VBN
46745	4623	16	in	in	IN
46745	4623	17	the	the	DT
46745	4623	18	glands	gland	NNS
46745	4623	19	by	by	IN
46745	4623	20	their	-PRON-	PRP$
46745	4623	21	passage	passage	NN
46745	4623	22	out	out	RP
46745	4623	23	,	,	,
46745	4623	24	that	that	IN
46745	4623	25	even	even	RB
46745	4623	26	after	after	IN
46745	4623	27	this	this	DT
46745	4623	28	necessary	necessary	JJ
46745	4623	29	secretion	secretion	NN
46745	4623	30	an	an	DT
46745	4623	31	inordinate	inordinate	JJ
46745	4623	32	and	and	CC
46745	4623	33	unnatural	unnatural	JJ
46745	4623	34	flux	flux	NN
46745	4623	35	may	may	MD
46745	4623	36	be	be	VB
46745	4623	37	maintained	maintain	VBN
46745	4623	38	.	.	.
46745	4624	1	When	when	WRB
46745	4624	2	the	the	DT
46745	4624	3	symptom	symptom	NN
46745	4624	4	is	be	VBZ
46745	4624	5	thus	thus	RB
46745	4624	6	inveterate	inveterate	JJ
46745	4624	7	,	,	,
46745	4624	8	and	and	CC
46745	4624	9	refuses	refuse	VBZ
46745	4624	10	to	to	TO
46745	4624	11	yield	yield	VB
46745	4624	12	to	to	IN
46745	4624	13	a	a	DT
46745	4624	14	brisk	brisk	JJ
46745	4624	15	Cathartic	cathartic	JJ
46745	4624	16	,	,	,
46745	4624	17	it	-PRON-	PRP
46745	4624	18	is	be	VBZ
46745	4624	19	advisable	advisable	JJ
46745	4624	20	to	to	TO
46745	4624	21	resort	resort	VB
46745	4624	22	to	to	IN
46745	4624	23	Astringents	Astringents	NNP
46745	4624	24	,	,	,
46745	4624	25	in	in	IN
46745	4624	26	order	order	NN
46745	4624	27	to	to	TO
46745	4624	28	put	put	VB
46745	4624	29	a	a	DT
46745	4624	30	speedy	speedy	JJ
46745	4624	31	stop	stop	NN
46745	4624	32	to	to	IN
46745	4624	33	the	the	DT
46745	4624	34	too	too	RB
46745	4624	35	copious	copious	JJ
46745	4624	36	secretion	secretion	NN
46745	4624	37	.	.	.
46745	4625	1	To	to	TO
46745	4625	2	do	do	VB
46745	4625	3	this	this	DT
46745	4625	4	in	in	IN
46745	4625	5	the	the	DT
46745	4625	6	first	first	JJ
46745	4625	7	instance	instance	NN
46745	4625	8	would	would	MD
46745	4625	9	have	have	VB
46745	4625	10	been	be	VBN
46745	4625	11	wrong	wrong	JJ
46745	4625	12	,	,	,
46745	4625	13	except	except	IN
46745	4625	14	in	in	IN
46745	4625	15	special	special	JJ
46745	4625	16	instances,--as	instances,--as	NNP
46745	4625	17	in	in	IN
46745	4625	18	the	the	DT
46745	4625	19	diarrh[oe]a	diarrh[oe]a	NNP
46745	4625	20	which	which	WDT
46745	4625	21	is	be	VBZ
46745	4625	22	the	the	DT
46745	4625	23	forerunner	forerunner	NN
46745	4625	24	of	of	IN
46745	4625	25	cholera	cholera	NNP
46745	4625	26	,	,	,
46745	4625	27	when	when	WRB
46745	4625	28	Astringents	Astringents	NNP
46745	4625	29	should	should	MD
46745	4625	30	be	be	VB
46745	4625	31	used	use	VBN
46745	4625	32	from	from	IN
46745	4625	33	the	the	DT
46745	4625	34	first	first	JJ
46745	4625	35	.	.	.
46745	4626	1	In	in	IN
46745	4626	2	some	some	DT
46745	4626	3	febrile	febrile	NN
46745	4626	4	and	and	CC
46745	4626	5	plethoric	plethoric	NN
46745	4626	6	cases	case	NNS
46745	4626	7	it	-PRON-	PRP
46745	4626	8	is	be	VBZ
46745	4626	9	difficult	difficult	JJ
46745	4626	10	to	to	TO
46745	4626	11	obtain	obtain	VB
46745	4626	12	the	the	DT
46745	4626	13	full	full	JJ
46745	4626	14	action	action	NN
46745	4626	15	of	of	IN
46745	4626	16	a	a	DT
46745	4626	17	Purgative	Purgative	NNP
46745	4626	18	.	.	.
46745	4627	1	This	this	DT
46745	4627	2	is	be	VBZ
46745	4627	3	because	because	IN
46745	4627	4	the	the	DT
46745	4627	5	absorption	absorption	NN
46745	4627	6	of	of	IN
46745	4627	7	the	the	DT
46745	4627	8	medicine	medicine	NN
46745	4627	9	is	be	VBZ
46745	4627	10	prevented	prevent	VBN
46745	4627	11	by	by	IN
46745	4627	12	the	the	DT
46745	4627	13	pressure	pressure	NN
46745	4627	14	on	on	IN
46745	4627	15	the	the	DT
46745	4627	16	vascular	vascular	JJ
46745	4627	17	system	system	NN
46745	4627	18	,	,	,
46745	4627	19	and	and	CC
46745	4627	20	without	without	IN
46745	4627	21	this	this	DT
46745	4627	22	absorption	absorption	NN
46745	4627	23	the	the	DT
46745	4627	24	proper	proper	JJ
46745	4627	25	action	action	NN
46745	4627	26	of	of	IN
46745	4627	27	the	the	DT
46745	4627	28	Purgative	Purgative	NNP
46745	4627	29	can	can	MD
46745	4627	30	not	not	RB
46745	4627	31	take	take	VB
46745	4627	32	place	place	NN
46745	4627	33	,	,	,
46745	4627	34	for	for	IN
46745	4627	35	it	-PRON-	PRP
46745	4627	36	has	have	VBZ
46745	4627	37	no	no	DT
46745	4627	38	opportunity	opportunity	NN
46745	4627	39	of	of	IN
46745	4627	40	passing	pass	VBG
46745	4627	41	out	out	IN
46745	4627	42	of	of	IN
46745	4627	43	the	the	DT
46745	4627	44	blood	blood	NN
46745	4627	45	through	through	IN
46745	4627	46	the	the	DT
46745	4627	47	glands	gland	NNS
46745	4627	48	of	of	IN
46745	4627	49	the	the	DT
46745	4627	50	bowels	bowel	NNS
46745	4627	51	.	.	.
46745	4628	1	In	in	IN
46745	4628	2	such	such	JJ
46745	4628	3	instances	instance	NNS
46745	4628	4	it	-PRON-	PRP
46745	4628	5	is	be	VBZ
46745	4628	6	well	well	JJ
46745	4628	7	to	to	TO
46745	4628	8	combine	combine	VB
46745	4628	9	the	the	DT
46745	4628	10	Cathartic	Cathartic	NNP
46745	4628	11	with	with	IN
46745	4628	12	a	a	DT
46745	4628	13	small	small	JJ
46745	4628	14	dose	dose	NN
46745	4628	15	of	of	IN
46745	4628	16	Tartar	Tartar	NNP
46745	4628	17	Emetic	Emetic	NNP
46745	4628	18	or	or	CC
46745	4628	19	Ipecacuanha	Ipecacuanha	NNP
46745	4628	20	,	,	,
46745	4628	21	which	which	WDT
46745	4628	22	by	by	IN
46745	4628	23	its	-PRON-	PRP$
46745	4628	24	nauseant	nauseant	JJ
46745	4628	25	operation	operation	NN
46745	4628	26	may	may	MD
46745	4628	27	diminish	diminish	VB
46745	4628	28	the	the	DT
46745	4628	29	vascular	vascular	JJ
46745	4628	30	pressure	pressure	NN
46745	4628	31	,	,	,
46745	4628	32	and	and	CC
46745	4628	33	thus	thus	RB
46745	4628	34	favour	favour	VBP
46745	4628	35	the	the	DT
46745	4628	36	necessary	necessary	JJ
46745	4628	37	absorption	absorption	NN
46745	4628	38	.	.	.
46745	4629	1	The	the	DT
46745	4629	2	action	action	NN
46745	4629	3	of	of	IN
46745	4629	4	a	a	DT
46745	4629	5	Cathartic	cathartic	JJ
46745	4629	6	itself	-PRON-	PRP
46745	4629	7	favours	favour	VBZ
46745	4629	8	absorption	absorption	NN
46745	4629	9	,	,	,
46745	4629	10	by	by	IN
46745	4629	11	draining	drain	VBG
46745	4629	12	away	away	RB
46745	4629	13	the	the	DT
46745	4629	14	fluid	fluid	JJ
46745	4629	15	part	part	NN
46745	4629	16	of	of	IN
46745	4629	17	the	the	DT
46745	4629	18	blood	blood	NN
46745	4629	19	,	,	,
46745	4629	20	and	and	CC
46745	4629	21	so	so	RB
46745	4629	22	diminishing	diminish	VBG
46745	4629	23	the	the	DT
46745	4629	24	tenseness	tenseness	NN
46745	4629	25	of	of	IN
46745	4629	26	the	the	DT
46745	4629	27	vessels	vessel	NNS
46745	4629	28	.	.	.
46745	4630	1	ORD	ORD	NNP
46745	4630	2	.	.	.
46745	4631	1	IV	IV	NNP
46745	4631	2	.	.	.
46745	4632	1	CHOLAGOQUES	CHOLAGOQUES	NNP
46745	4632	2	.	.	.
46745	4633	1	Medicines	medicine	NNS
46745	4633	2	which	which	WDT
46745	4633	3	are	be	VBP
46745	4633	4	thought	think	VBN
46745	4633	5	to	to	TO
46745	4633	6	stimulate	stimulate	VB
46745	4633	7	the	the	DT
46745	4633	8	action	action	NN
46745	4633	9	of	of	IN
46745	4633	10	the	the	DT
46745	4633	11	liver	liver	NN
46745	4633	12	,	,	,
46745	4633	13	and	and	CC
46745	4633	14	to	to	TO
46745	4633	15	promote	promote	VB
46745	4633	16	the	the	DT
46745	4633	17	excretion	excretion	NN
46745	4633	18	of	of	IN
46745	4633	19	bile	bile	NN
46745	4633	20	,	,	,
46745	4633	21	are	be	VBP
46745	4633	22	called	call	VBN
46745	4633	23	Cholagogues	Cholagogues	NNPS
46745	4633	24	.	.	.
46745	4634	1	There	there	EX
46745	4634	2	is	be	VBZ
46745	4634	3	no	no	DT
46745	4634	4	doubt	doubt	NN
46745	4634	5	that	that	IN
46745	4634	6	the	the	DT
46745	4634	7	function	function	NN
46745	4634	8	of	of	IN
46745	4634	9	the	the	DT
46745	4634	10	liver	liver	NN
46745	4634	11	,	,	,
46745	4634	12	regarded	regard	VBD
46745	4634	13	simply	simply	RB
46745	4634	14	as	as	IN
46745	4634	15	a	a	DT
46745	4634	16	gland	gland	NN
46745	4634	17	,	,	,
46745	4634	18	is	be	VBZ
46745	4634	19	of	of	IN
46745	4634	20	great	great	JJ
46745	4634	21	importance	importance	NN
46745	4634	22	in	in	IN
46745	4634	23	the	the	DT
46745	4634	24	animal	animal	NN
46745	4634	25	economy	economy	NN
46745	4634	26	.	.	.
46745	4635	1	We	-PRON-	PRP
46745	4635	2	know	know	VBP
46745	4635	3	that	that	IN
46745	4635	4	certain	certain	JJ
46745	4635	5	matters	matter	NNS
46745	4635	6	are	be	VBP
46745	4635	7	excreted	excrete	VBN
46745	4635	8	from	from	IN
46745	4635	9	the	the	DT
46745	4635	10	system	system	NN
46745	4635	11	by	by	IN
46745	4635	12	that	that	DT
46745	4635	13	organ	organ	NN
46745	4635	14	,	,	,
46745	4635	15	which	which	WDT
46745	4635	16	,	,	,
46745	4635	17	when	when	WRB
46745	4635	18	allowed	allow	VBN
46745	4635	19	to	to	TO
46745	4635	20	remain	remain	VB
46745	4635	21	in	in	IN
46745	4635	22	the	the	DT
46745	4635	23	blood	blood	NN
46745	4635	24	,	,	,
46745	4635	25	as	as	IN
46745	4635	26	in	in	IN
46745	4635	27	the	the	DT
46745	4635	28	case	case	NN
46745	4635	29	of	of	IN
46745	4635	30	jaundice	jaundice	NNP
46745	4635	31	,	,	,
46745	4635	32	are	be	VBP
46745	4635	33	found	find	VBN
46745	4635	34	to	to	TO
46745	4635	35	be	be	VB
46745	4635	36	hurtful	hurtful	JJ
46745	4635	37	.	.	.
46745	4636	1	Also	also	RB
46745	4636	2	it	-PRON-	PRP
46745	4636	3	appears	appear	VBZ
46745	4636	4	that	that	IN
46745	4636	5	certain	certain	JJ
46745	4636	6	other	other	JJ
46745	4636	7	parts	part	NNS
46745	4636	8	of	of	IN
46745	4636	9	the	the	DT
46745	4636	10	bile	bile	NN
46745	4636	11	are	be	VBP
46745	4636	12	secreted	secrete	VBN
46745	4636	13	or	or	CC
46745	4636	14	formed	form	VBN
46745	4636	15	by	by	IN
46745	4636	16	the	the	DT
46745	4636	17	same	same	JJ
46745	4636	18	gland	gland	NN
46745	4636	19	,	,	,
46745	4636	20	for	for	IN
46745	4636	21	the	the	DT
46745	4636	22	purpose	purpose	NN
46745	4636	23	of	of	IN
46745	4636	24	being	be	VBG
46745	4636	25	re	re	NN
46745	4636	26	-	-	VBN
46745	4636	27	absorbed	absorb	VBN
46745	4636	28	into	into	IN
46745	4636	29	the	the	DT
46745	4636	30	blood	blood	NN
46745	4636	31	from	from	IN
46745	4636	32	the	the	DT
46745	4636	33	intestine	intestine	NN
46745	4636	34	,	,	,
46745	4636	35	and	and	CC
46745	4636	36	that	that	IN
46745	4636	37	they	-PRON-	PRP
46745	4636	38	serve	serve	VBP
46745	4636	39	some	some	DT
46745	4636	40	useful	useful	JJ
46745	4636	41	purpose	purpose	NN
46745	4636	42	in	in	IN
46745	4636	43	the	the	DT
46745	4636	44	processes	process	NNS
46745	4636	45	which	which	WDT
46745	4636	46	go	go	VBP
46745	4636	47	on	on	RP
46745	4636	48	in	in	IN
46745	4636	49	the	the	DT
46745	4636	50	circulation	circulation	NN
46745	4636	51	.	.	.
46745	4637	1	(	(	-LRB-
46745	4637	2	_	_	NNP
46745	4637	3	Vide	Vide	NNP
46745	4637	4	_	_	NNP
46745	4637	5	p.	p.	NN
46745	4638	1	137	137	CD
46745	4638	2	.	.	.
46745	4638	3	)	)	-RRB-
46745	4639	1	A	a	DT
46745	4639	2	disorder	disorder	NN
46745	4639	3	of	of	IN
46745	4639	4	the	the	DT
46745	4639	5	liver	liver	NN
46745	4639	6	by	by	IN
46745	4639	7	itself	-PRON-	PRP
46745	4639	8	,	,	,
46745	4639	9	_	_	NNP
46745	4639	10	i.e.	i.e.	FW
46745	4639	11	_	_	NNP
46745	4639	12	unassociated	unassociate	VBD
46745	4639	13	with	with	IN
46745	4639	14	diseases	disease	NNS
46745	4639	15	of	of	IN
46745	4639	16	other	other	JJ
46745	4639	17	organs	organ	NNS
46745	4639	18	,	,	,
46745	4639	19	is	be	VBZ
46745	4639	20	comparatively	comparatively	RB
46745	4639	21	uncommon	uncommon	JJ
46745	4639	22	.	.	.
46745	4640	1	A	a	DT
46745	4640	2	failure	failure	NN
46745	4640	3	in	in	IN
46745	4640	4	the	the	DT
46745	4640	5	secretion	secretion	NN
46745	4640	6	of	of	IN
46745	4640	7	bile	bile	NN
46745	4640	8	is	be	VBZ
46745	4640	9	evidenced	evidence	VBN
46745	4640	10	more	more	RBR
46745	4640	11	or	or	CC
46745	4640	12	less	less	JJR
46745	4640	13	by	by	IN
46745	4640	14	the	the	DT
46745	4640	15	well	well	RB
46745	4640	16	known	know	VBN
46745	4640	17	icteric	icteric	JJ
46745	4640	18	symptoms	symptom	NNS
46745	4640	19	.	.	.
46745	4641	1	Jaundice	Jaundice	NNP
46745	4641	2	is	be	VBZ
46745	4641	3	often	often	RB
46745	4641	4	caused	cause	VBN
46745	4641	5	by	by	IN
46745	4641	6	an	an	DT
46745	4641	7	obstruction	obstruction	NN
46745	4641	8	in	in	IN
46745	4641	9	the	the	DT
46745	4641	10	hepatic	hepatic	JJ
46745	4641	11	ducts	duct	NNS
46745	4641	12	.	.	.
46745	4642	1	In	in	IN
46745	4642	2	such	such	JJ
46745	4642	3	cases	case	NNS
46745	4642	4	it	-PRON-	PRP
46745	4642	5	is	be	VBZ
46745	4642	6	worse	bad	JJR
46745	4642	7	than	than	IN
46745	4642	8	useless	useless	JJ
46745	4642	9	to	to	TO
46745	4642	10	urge	urge	VB
46745	4642	11	the	the	DT
46745	4642	12	liver	liver	NN
46745	4642	13	to	to	IN
46745	4642	14	an	an	DT
46745	4642	15	extra	extra	JJ
46745	4642	16	formation	formation	NN
46745	4642	17	of	of	IN
46745	4642	18	a	a	DT
46745	4642	19	secretion	secretion	NN
46745	4642	20	which	which	WDT
46745	4642	21	can	can	MD
46745	4642	22	find	find	VB
46745	4642	23	no	no	DT
46745	4642	24	outlet	outlet	NN
46745	4642	25	.	.	.
46745	4643	1	But	but	CC
46745	4643	2	other	other	JJ
46745	4643	3	cases	case	NNS
46745	4643	4	,	,	,
46745	4643	5	in	in	IN
46745	4643	6	which	which	WDT
46745	4643	7	the	the	DT
46745	4643	8	discoloration	discoloration	NN
46745	4643	9	of	of	IN
46745	4643	10	the	the	DT
46745	4643	11	skin	skin	NN
46745	4643	12	is	be	VBZ
46745	4643	13	in	in	IN
46745	4643	14	general	general	JJ
46745	4643	15	incomplete	incomplete	NN
46745	4643	16	,	,	,
46745	4643	17	may	may	MD
46745	4643	18	be	be	VB
46745	4643	19	due	due	IN
46745	4643	20	to	to	IN
46745	4643	21	torpidity	torpidity	NN
46745	4643	22	,	,	,
46745	4643	23	congestion	congestion	NN
46745	4643	24	,	,	,
46745	4643	25	or	or	CC
46745	4643	26	chronic	chronic	JJ
46745	4643	27	inflammation	inflammation	NN
46745	4643	28	of	of	IN
46745	4643	29	the	the	DT
46745	4643	30	organ	organ	NN
46745	4643	31	.	.	.
46745	4644	1	In	in	IN
46745	4644	2	such	such	JJ
46745	4644	3	instances	instance	NNS
46745	4644	4	Cholagogues	Cholagogues	NNPS
46745	4644	5	may	may	MD
46745	4644	6	be	be	VB
46745	4644	7	cautiously	cautiously	RB
46745	4644	8	used	use	VBN
46745	4644	9	;	;	:
46745	4644	10	but	but	CC
46745	4644	11	when	when	WRB
46745	4644	12	there	there	EX
46745	4644	13	is	be	VBZ
46745	4644	14	acute	acute	JJ
46745	4644	15	inflammation	inflammation	NN
46745	4644	16	they	-PRON-	PRP
46745	4644	17	may	may	MD
46745	4644	18	do	do	VB
46745	4644	19	harm	harm	NN
46745	4644	20	;	;	:
46745	4644	21	and	and	CC
46745	4644	22	when	when	WRB
46745	4644	23	there	there	EX
46745	4644	24	is	be	VBZ
46745	4644	25	a	a	DT
46745	4644	26	probability	probability	NN
46745	4644	27	of	of	IN
46745	4644	28	structural	structural	JJ
46745	4644	29	change	change	NN
46745	4644	30	in	in	IN
46745	4644	31	the	the	DT
46745	4644	32	liver	liver	NN
46745	4644	33	,	,	,
46745	4644	34	they	-PRON-	PRP
46745	4644	35	may	may	MD
46745	4644	36	be	be	VB
46745	4644	37	useless	useless	JJ
46745	4644	38	.	.	.
46745	4645	1	The	the	DT
46745	4645	2	great	great	JJ
46745	4645	3	majority	majority	NN
46745	4645	4	of	of	IN
46745	4645	5	intestinal	intestinal	JJ
46745	4645	6	diseases	disease	NNS
46745	4645	7	,	,	,
46745	4645	8	as	as	IN
46745	4645	9	also	also	RB
46745	4645	10	of	of	IN
46745	4645	11	chronic	chronic	JJ
46745	4645	12	blood	blood	NN
46745	4645	13	-	-	HYPH
46745	4645	14	disorders	disorder	NNS
46745	4645	15	,	,	,
46745	4645	16	are	be	VBP
46745	4645	17	associated	associate	VBN
46745	4645	18	with	with	IN
46745	4645	19	a	a	DT
46745	4645	20	torpidity	torpidity	NN
46745	4645	21	or	or	CC
46745	4645	22	derangement	derangement	NN
46745	4645	23	of	of	IN
46745	4645	24	the	the	DT
46745	4645	25	function	function	NN
46745	4645	26	of	of	IN
46745	4645	27	the	the	DT
46745	4645	28	liver	liver	NN
46745	4645	29	.	.	.
46745	4646	1	We	-PRON-	PRP
46745	4646	2	find	find	VBP
46745	4646	3	this	this	DT
46745	4646	4	to	to	TO
46745	4646	5	be	be	VB
46745	4646	6	the	the	DT
46745	4646	7	case	case	NN
46745	4646	8	with	with	IN
46745	4646	9	diarrh[oe]a	diarrh[oe]a	NNP
46745	4646	10	and	and	CC
46745	4646	11	constipation	constipation	NN
46745	4646	12	,	,	,
46745	4646	13	with	with	IN
46745	4646	14	dysentery	dysentery	NN
46745	4646	15	and	and	CC
46745	4646	16	cholera	cholera	NN
46745	4646	17	;	;	:
46745	4646	18	as	as	RB
46745	4646	19	well	well	RB
46745	4646	20	as	as	IN
46745	4646	21	with	with	IN
46745	4646	22	ague	ague	NN
46745	4646	23	and	and	CC
46745	4646	24	remittents,--gout	remittents,--gout	NNP
46745	4646	25	,	,	,
46745	4646	26	and	and	CC
46745	4646	27	rheumatism,--Phthisis	rheumatism,--phthisis	NN
46745	4646	28	,	,	,
46745	4646	29	and	and	CC
46745	4646	30	scrofula	scrofula	NN
46745	4646	31	.	.	.
46745	4647	1	In	in	IN
46745	4647	2	all	all	DT
46745	4647	3	of	of	IN
46745	4647	4	these	these	DT
46745	4647	5	diseases	disease	NNS
46745	4647	6	it	-PRON-	PRP
46745	4647	7	is	be	VBZ
46745	4647	8	of	of	IN
46745	4647	9	great	great	JJ
46745	4647	10	importance	importance	NN
46745	4647	11	to	to	TO
46745	4647	12	attend	attend	VB
46745	4647	13	to	to	IN
46745	4647	14	the	the	DT
46745	4647	15	state	state	NN
46745	4647	16	of	of	IN
46745	4647	17	the	the	DT
46745	4647	18	liver	liver	NN
46745	4647	19	.	.	.
46745	4648	1	I	-PRON-	PRP
46745	4648	2	have	have	VBP
46745	4648	3	already	already	RB
46745	4648	4	stated	state	VBN
46745	4648	5	that	that	IN
46745	4648	6	Quina	Quina	NNP
46745	4648	7	and	and	CC
46745	4648	8	other	other	JJ
46745	4648	9	Tonics	Tonics	NNPS
46745	4648	10	are	be	VBP
46745	4648	11	of	of	IN
46745	4648	12	very	very	RB
46745	4648	13	particular	particular	JJ
46745	4648	14	use	use	NN
46745	4648	15	in	in	IN
46745	4648	16	such	such	JJ
46745	4648	17	cases	case	NNS
46745	4648	18	of	of	IN
46745	4648	19	disorder	disorder	NN
46745	4648	20	of	of	IN
46745	4648	21	the	the	DT
46745	4648	22	hepatic	hepatic	JJ
46745	4648	23	functions	function	NNS
46745	4648	24	,	,	,
46745	4648	25	and	and	CC
46745	4648	26	have	have	VBP
46745	4648	27	attempted	attempt	VBN
46745	4648	28	to	to	TO
46745	4648	29	discover	discover	VB
46745	4648	30	an	an	DT
46745	4648	31	explanation	explanation	NN
46745	4648	32	of	of	IN
46745	4648	33	this	this	DT
46745	4648	34	fact	fact	NN
46745	4648	35	(	(	-LRB-
46745	4648	36	p.	p.	NN
46745	4649	1	142	142	CD
46745	4649	2	.	.	.
46745	4649	3	)	)	-RRB-
46745	4650	1	But	but	CC
46745	4650	2	we	-PRON-	PRP
46745	4650	3	are	be	VBP
46745	4650	4	at	at	IN
46745	4650	5	present	present	JJ
46745	4650	6	concerned	concern	VBN
46745	4650	7	with	with	IN
46745	4650	8	medicines	medicine	NNS
46745	4650	9	which	which	WDT
46745	4650	10	tend	tend	VBP
46745	4650	11	immediately	immediately	RB
46745	4650	12	to	to	TO
46745	4650	13	increase	increase	VB
46745	4650	14	the	the	DT
46745	4650	15	secretion	secretion	NN
46745	4650	16	of	of	IN
46745	4650	17	bile	bile	NN
46745	4650	18	.	.	.
46745	4651	1	They	-PRON-	PRP
46745	4651	2	are	be	VBP
46745	4651	3	more	more	RBR
46745	4651	4	or	or	CC
46745	4651	5	less	less	RBR
46745	4651	6	applicable	applicable	JJ
46745	4651	7	in	in	IN
46745	4651	8	all	all	PDT
46745	4651	9	the	the	DT
46745	4651	10	disorders	disorder	NNS
46745	4651	11	which	which	WDT
46745	4651	12	have	have	VBP
46745	4651	13	just	just	RB
46745	4651	14	been	be	VBN
46745	4651	15	enumerated	enumerate	VBN
46745	4651	16	.	.	.
46745	4652	1	All	all	DT
46745	4652	2	Cathartic	cathartic	JJ
46745	4652	3	medicines	medicine	NNS
46745	4652	4	act	act	VBP
46745	4652	5	as	as	IN
46745	4652	6	indirect	indirect	JJ
46745	4652	7	Cholagogues	Cholagogues	NNPS
46745	4652	8	.	.	.
46745	4653	1	This	this	DT
46745	4653	2	is	be	VBZ
46745	4653	3	particularly	particularly	RB
46745	4653	4	the	the	DT
46745	4653	5	case	case	NN
46745	4653	6	with	with	IN
46745	4653	7	the	the	DT
46745	4653	8	drastic	drastic	JJ
46745	4653	9	purgatives	purgative	NNS
46745	4653	10	.	.	.
46745	4654	1	There	there	EX
46745	4654	2	appears	appear	VBZ
46745	4654	3	to	to	TO
46745	4654	4	be	be	VB
46745	4654	5	a	a	DT
46745	4654	6	vital	vital	JJ
46745	4654	7	connexion	connexion	NN
46745	4654	8	between	between	IN
46745	4654	9	the	the	DT
46745	4654	10	action	action	NN
46745	4654	11	of	of	IN
46745	4654	12	the	the	DT
46745	4654	13	intestinal	intestinal	JJ
46745	4654	14	canal	canal	NN
46745	4654	15	and	and	CC
46745	4654	16	that	that	DT
46745	4654	17	of	of	IN
46745	4654	18	the	the	DT
46745	4654	19	liver	liver	NN
46745	4654	20	,	,	,
46745	4654	21	so	so	IN
46745	4654	22	that	that	IN
46745	4654	23	any	any	DT
46745	4654	24	process	process	NN
46745	4654	25	going	go	VBG
46745	4654	26	on	on	RP
46745	4654	27	in	in	IN
46745	4654	28	the	the	DT
46745	4654	29	one	one	NN
46745	4654	30	will	will	MD
46745	4654	31	excite	excite	VB
46745	4654	32	the	the	DT
46745	4654	33	function	function	NN
46745	4654	34	of	of	IN
46745	4654	35	the	the	DT
46745	4654	36	other	other	JJ
46745	4654	37	.	.	.
46745	4655	1	Thus	thus	RB
46745	4655	2	the	the	DT
46745	4655	3	bile	bile	NN
46745	4655	4	is	be	VBZ
46745	4655	5	poured	pour	VBN
46745	4655	6	out	out	RP
46745	4655	7	during	during	IN
46745	4655	8	the	the	DT
46745	4655	9	process	process	NN
46745	4655	10	of	of	IN
46745	4655	11	digestion	digestion	NN
46745	4655	12	;	;	,
46745	4655	13	and	and	CC
46745	4655	14	the	the	DT
46745	4655	15	peristaltic	peristaltic	JJ
46745	4655	16	motion	motion	NN
46745	4655	17	and	and	CC
46745	4655	18	extra	extra	JJ
46745	4655	19	-	-	HYPH
46745	4655	20	secretion	secretion	NN
46745	4655	21	,	,	,
46745	4655	22	produced	produce	VBN
46745	4655	23	in	in	IN
46745	4655	24	the	the	DT
46745	4655	25	bowel	bowel	NN
46745	4655	26	by	by	IN
46745	4655	27	the	the	DT
46745	4655	28	action	action	NN
46745	4655	29	of	of	IN
46745	4655	30	a	a	DT
46745	4655	31	purge	purge	NN
46745	4655	32	,	,	,
46745	4655	33	causes	cause	VBZ
46745	4655	34	likewise	likewise	RB
46745	4655	35	a	a	DT
46745	4655	36	sympathetic	sympathetic	JJ
46745	4655	37	formation	formation	NN
46745	4655	38	and	and	CC
46745	4655	39	excretion	excretion	NN
46745	4655	40	of	of	IN
46745	4655	41	bile	bile	NN
46745	4655	42	.	.	.
46745	4656	1	It	-PRON-	PRP
46745	4656	2	is	be	VBZ
46745	4656	3	supposed	suppose	VBN
46745	4656	4	by	by	IN
46745	4656	5	some	some	DT
46745	4656	6	that	that	IN
46745	4656	7	this	this	DT
46745	4656	8	result	result	NN
46745	4656	9	is	be	VBZ
46745	4656	10	due	due	JJ
46745	4656	11	to	to	IN
46745	4656	12	an	an	DT
46745	4656	13	irritation	irritation	NN
46745	4656	14	of	of	IN
46745	4656	15	the	the	DT
46745	4656	16	orifice	orifice	NN
46745	4656	17	of	of	IN
46745	4656	18	the	the	DT
46745	4656	19	hepatic	hepatic	JJ
46745	4656	20	duct	duct	NN
46745	4656	21	in	in	IN
46745	4656	22	the	the	DT
46745	4656	23	duodenum	duodenum	NN
46745	4656	24	,	,	,
46745	4656	25	produced	produce	VBN
46745	4656	26	by	by	IN
46745	4656	27	the	the	DT
46745	4656	28	purgative	purgative	JJ
46745	4656	29	medicine	medicine	NN
46745	4656	30	.	.	.
46745	4657	1	We	-PRON-	PRP
46745	4657	2	must	must	MD
46745	4657	3	either	either	CC
46745	4657	4	suppose	suppose	VB
46745	4657	5	the	the	DT
46745	4657	6	stimulus	stimulus	NN
46745	4657	7	of	of	IN
46745	4657	8	the	the	DT
46745	4657	9	food	food	NN
46745	4657	10	,	,	,
46745	4657	11	which	which	WDT
46745	4657	12	produces	produce	VBZ
46745	4657	13	the	the	DT
46745	4657	14	same	same	JJ
46745	4657	15	effect	effect	NN
46745	4657	16	,	,	,
46745	4657	17	to	to	TO
46745	4657	18	operate	operate	VB
46745	4657	19	in	in	IN
46745	4657	20	the	the	DT
46745	4657	21	same	same	JJ
46745	4657	22	way,--or	way,--or	NNP
46745	4657	23	reject	reject	VBP
46745	4657	24	such	such	PDT
46745	4657	25	an	an	DT
46745	4657	26	explanation	explanation	NN
46745	4657	27	as	as	IN
46745	4657	28	superfluous	superfluous	JJ
46745	4657	29	,	,	,
46745	4657	30	which	which	WDT
46745	4657	31	appears	appear	VBZ
46745	4657	32	to	to	IN
46745	4657	33	me	-PRON-	PRP
46745	4657	34	the	the	DT
46745	4657	35	better	well	JJR
46745	4657	36	alternative	alternative	NN
46745	4657	37	.	.	.
46745	4658	1	For	for	IN
46745	4658	2	it	-PRON-	PRP
46745	4658	3	is	be	VBZ
46745	4658	4	probable	probable	JJ
46745	4658	5	that	that	IN
46745	4658	6	the	the	DT
46745	4658	7	action	action	NN
46745	4658	8	of	of	IN
46745	4658	9	a	a	DT
46745	4658	10	Purgative	Purgative	NNP
46745	4658	11	is	be	VBZ
46745	4658	12	not	not	RB
46745	4658	13	at	at	RB
46745	4658	14	all	all	RB
46745	4658	15	exerted	exert	VBN
46745	4658	16	in	in	IN
46745	4658	17	the	the	DT
46745	4658	18	duodenum	duodenum	NN
46745	4658	19	,	,	,
46745	4658	20	but	but	CC
46745	4658	21	that	that	IN
46745	4658	22	it	-PRON-	PRP
46745	4658	23	is	be	VBZ
46745	4658	24	actually	actually	RB
46745	4658	25	absorbed	absorb	VBN
46745	4658	26	there	there	RB
46745	4658	27	,	,	,
46745	4658	28	and	and	CC
46745	4658	29	works	work	VBZ
46745	4658	30	out	out	RP
46745	4658	31	its	-PRON-	PRP$
46745	4658	32	operation	operation	NN
46745	4658	33	in	in	IN
46745	4658	34	the	the	DT
46745	4658	35	lower	low	JJR
46745	4658	36	part	part	NN
46745	4658	37	of	of	IN
46745	4658	38	the	the	DT
46745	4658	39	small	small	JJ
46745	4658	40	and	and	CC
46745	4658	41	in	in	IN
46745	4658	42	the	the	DT
46745	4658	43	large	large	JJ
46745	4658	44	intestine	intestine	NN
46745	4658	45	.	.	.
46745	4659	1	_	_	NNP
46745	4659	2	True	true	JJ
46745	4659	3	Cholagogues._--We	cholagogues._--we	NN
46745	4659	4	are	be	VBP
46745	4659	5	not	not	RB
46745	4659	6	well	well	RB
46745	4659	7	informed	inform	VBN
46745	4659	8	as	as	IN
46745	4659	9	to	to	IN
46745	4659	10	the	the	DT
46745	4659	11	exact	exact	JJ
46745	4659	12	number	number	NN
46745	4659	13	of	of	IN
46745	4659	14	medicines	medicine	NNS
46745	4659	15	which	which	WDT
46745	4659	16	pass	pass	VBP
46745	4659	17	out	out	RP
46745	4659	18	into	into	IN
46745	4659	19	the	the	DT
46745	4659	20	secretion	secretion	NN
46745	4659	21	of	of	IN
46745	4659	22	bile	bile	NN
46745	4659	23	,	,	,
46745	4659	24	and	and	CC
46745	4659	25	act	act	VB
46745	4659	26	thus	thus	RB
46745	4659	27	on	on	IN
46745	4659	28	the	the	DT
46745	4659	29	true	true	JJ
46745	4659	30	eliminative	eliminative	JJ
46745	4659	31	plan	plan	NN
46745	4659	32	.	.	.
46745	4660	1	But	but	CC
46745	4660	2	there	there	EX
46745	4660	3	is	be	VBZ
46745	4660	4	no	no	DT
46745	4660	5	medicine	medicine	NN
46745	4660	6	which	which	WDT
46745	4660	7	is	be	VBZ
46745	4660	8	of	of	IN
46745	4660	9	such	such	JJ
46745	4660	10	great	great	JJ
46745	4660	11	and	and	CC
46745	4660	12	universal	universal	JJ
46745	4660	13	utility	utility	NN
46745	4660	14	in	in	IN
46745	4660	15	all	all	DT
46745	4660	16	liver	liver	NN
46745	4660	17	diseases	disease	NNS
46745	4660	18	as	as	IN
46745	4660	19	Mercury,--in	mercury,--in	JJ
46745	4660	20	its	-PRON-	PRP$
46745	4660	21	various	various	JJ
46745	4660	22	forms	form	NNS
46745	4660	23	.	.	.
46745	4661	1	Mercurials	mercurial	NNS
46745	4661	2	increase	increase	VBP
46745	4661	3	more	more	RBR
46745	4661	4	or	or	CC
46745	4661	5	less	less	RBR
46745	4661	6	all	all	DT
46745	4661	7	secretions	secretion	NNS
46745	4661	8	;	;	:
46745	4661	9	and	and	CC
46745	4661	10	even	even	RB
46745	4661	11	if	if	IN
46745	4661	12	we	-PRON-	PRP
46745	4661	13	had	have	VBD
46745	4661	14	no	no	DT
46745	4661	15	direct	direct	JJ
46745	4661	16	proof	proof	NN
46745	4661	17	of	of	IN
46745	4661	18	their	-PRON-	PRP$
46745	4661	19	action	action	NN
46745	4661	20	on	on	IN
46745	4661	21	the	the	DT
46745	4661	22	liver	liver	NN
46745	4661	23	,	,	,
46745	4661	24	we	-PRON-	PRP
46745	4661	25	might	may	MD
46745	4661	26	almost	almost	RB
46745	4661	27	have	have	VB
46745	4661	28	affirmed	affirm	VBN
46745	4661	29	that	that	IN
46745	4661	30	they	-PRON-	PRP
46745	4661	31	especially	especially	RB
46745	4661	32	increased	increase	VBD
46745	4661	33	the	the	DT
46745	4661	34	secretion	secretion	NN
46745	4661	35	of	of	IN
46745	4661	36	bile	bile	NN
46745	4661	37	,	,	,
46745	4661	38	from	from	IN
46745	4661	39	the	the	DT
46745	4661	40	obvious	obvious	JJ
46745	4661	41	way	way	NN
46745	4661	42	in	in	IN
46745	4661	43	which	which	WDT
46745	4661	44	bilious	bilious	JJ
46745	4661	45	symptoms	symptom	NNS
46745	4661	46	yield	yield	VBP
46745	4661	47	to	to	IN
46745	4661	48	their	-PRON-	PRP$
46745	4661	49	action	action	NN
46745	4661	50	.	.	.
46745	4662	1	But	but	CC
46745	4662	2	we	-PRON-	PRP
46745	4662	3	have	have	VBP
46745	4662	4	a	a	DT
46745	4662	5	direct	direct	JJ
46745	4662	6	proof	proof	NN
46745	4662	7	of	of	IN
46745	4662	8	this	this	DT
46745	4662	9	.	.	.
46745	4663	1	M.	M.	NNP
46745	4663	2	Buchheim	Buchheim	NNP
46745	4663	3	has	have	VBZ
46745	4663	4	made	make	VBN
46745	4663	5	some	some	DT
46745	4663	6	careful	careful	JJ
46745	4663	7	experiments	experiment	NNS
46745	4663	8	on	on	IN
46745	4663	9	a	a	DT
46745	4663	10	dog	dog	NN
46745	4663	11	.	.	.
46745	4664	1	Having	have	VBG
46745	4664	2	given	give	VBN
46745	4664	3	it	-PRON-	PRP
46745	4664	4	Mercury	Mercury	NNP
46745	4664	5	,	,	,
46745	4664	6	he	-PRON-	PRP
46745	4664	7	cut	cut	VBD
46745	4664	8	down	down	RP
46745	4664	9	upon	upon	IN
46745	4664	10	the	the	DT
46745	4664	11	hepatic	hepatic	JJ
46745	4664	12	duct	duct	NN
46745	4664	13	,	,	,
46745	4664	14	observed	observe	VBN
46745	4664	15	and	and	CC
46745	4664	16	collected	collect	VBD
46745	4664	17	the	the	DT
46745	4664	18	secretion	secretion	NN
46745	4664	19	,	,	,
46745	4664	20	and	and	CC
46745	4664	21	subsequently	subsequently	RB
46745	4664	22	analyzed	analyze	VBD
46745	4664	23	it	-PRON-	PRP
46745	4664	24	.	.	.
46745	4665	1	He	-PRON-	PRP
46745	4665	2	found	find	VBD
46745	4665	3	that	that	IN
46745	4665	4	the	the	DT
46745	4665	5	bile	bile	NN
46745	4665	6	was	be	VBD
46745	4665	7	increased	increase	VBN
46745	4665	8	,	,	,
46745	4665	9	and	and	CC
46745	4665	10	that	that	IN
46745	4665	11	Mercury	Mercury	NNP
46745	4665	12	was	be	VBD
46745	4665	13	contained	contain	VBN
46745	4665	14	in	in	IN
46745	4665	15	it	-PRON-	PRP
46745	4665	16	.	.	.
46745	4666	1	(	(	-LRB-
46745	4666	2	_	_	NNP
46745	4666	3	Vide	Vide	NNP
46745	4666	4	_	_	NNP
46745	4666	5	p.	p.	NN
46745	4667	1	275	275	CD
46745	4667	2	.	.	.
46745	4667	3	)	)	-RRB-
46745	4668	1	Certain	certain	JJ
46745	4668	2	other	other	JJ
46745	4668	3	purgative	purgative	JJ
46745	4668	4	medicines	medicine	NNS
46745	4668	5	are	be	VBP
46745	4668	6	popularly	popularly	RB
46745	4668	7	,	,	,
46745	4668	8	and	and	CC
46745	4668	9	perhaps	perhaps	RB
46745	4668	10	correctly	correctly	RB
46745	4668	11	,	,	,
46745	4668	12	esteemed	esteem	VBN
46745	4668	13	as	as	IN
46745	4668	14	specific	specific	JJ
46745	4668	15	Cholagogues	Cholagogues	NNPS
46745	4668	16	.	.	.
46745	4669	1	These	these	DT
46745	4669	2	are	be	VBP
46745	4669	3	Rhubarb	Rhubarb	NNP
46745	4669	4	and	and	CC
46745	4669	5	Aloes	Aloes	NNPS
46745	4669	6	.	.	.
46745	4670	1	Taraxacum	Taraxacum	NNP
46745	4670	2	is	be	VBZ
46745	4670	3	also	also	RB
46745	4670	4	thought	think	VBN
46745	4670	5	to	to	TO
46745	4670	6	act	act	VB
46745	4670	7	upon	upon	IN
46745	4670	8	the	the	DT
46745	4670	9	liver	liver	NN
46745	4670	10	.	.	.
46745	4671	1	But	but	CC
46745	4671	2	of	of	IN
46745	4671	3	the	the	DT
46745	4671	4	true	true	JJ
46745	4671	5	eliminative	eliminative	JJ
46745	4671	6	action	action	NN
46745	4671	7	of	of	IN
46745	4671	8	these	these	DT
46745	4671	9	medicines	medicine	NNS
46745	4671	10	we	-PRON-	PRP
46745	4671	11	have	have	VBP
46745	4671	12	no	no	DT
46745	4671	13	proof	proof	NN
46745	4671	14	.	.	.
46745	4672	1	It	-PRON-	PRP
46745	4672	2	is	be	VBZ
46745	4672	3	probable	probable	JJ
46745	4672	4	that	that	IN
46745	4672	5	alkalies	alkali	NNS
46745	4672	6	and	and	CC
46745	4672	7	fatty	fatty	NN
46745	4672	8	matters	matter	NNS
46745	4672	9	may	may	MD
46745	4672	10	act	act	VB
46745	4672	11	in	in	IN
46745	4672	12	certain	certain	JJ
46745	4672	13	cases	case	NNS
46745	4672	14	as	as	IN
46745	4672	15	true	true	JJ
46745	4672	16	Cholagogues	Cholagogues	NNPS
46745	4672	17	,	,	,
46745	4672	18	for	for	IN
46745	4672	19	they	-PRON-	PRP
46745	4672	20	are	be	VBP
46745	4672	21	both	both	DT
46745	4672	22	contained	contain	VBN
46745	4672	23	in	in	IN
46745	4672	24	the	the	DT
46745	4672	25	natural	natural	JJ
46745	4672	26	secretion	secretion	NN
46745	4672	27	of	of	IN
46745	4672	28	bile	bile	NN
46745	4672	29	,	,	,
46745	4672	30	and	and	CC
46745	4672	31	therefore	therefore	RB
46745	4672	32	likely	likely	JJ
46745	4672	33	to	to	TO
46745	4672	34	pass	pass	VB
46745	4672	35	into	into	IN
46745	4672	36	it	-PRON-	PRP
46745	4672	37	.	.	.
46745	4673	1	In	in	IN
46745	4673	2	many	many	JJ
46745	4673	3	cases	case	NNS
46745	4673	4	of	of	IN
46745	4673	5	debility	debility	NN
46745	4673	6	,	,	,
46745	4673	7	and	and	CC
46745	4673	8	even	even	RB
46745	4673	9	of	of	IN
46745	4673	10	Scrofula	Scrofula	NNP
46745	4673	11	,	,	,
46745	4673	12	small	small	JJ
46745	4673	13	doses	dose	NNS
46745	4673	14	of	of	IN
46745	4673	15	Mercury	Mercury	NNP
46745	4673	16	may	may	MD
46745	4673	17	act	act	VB
46745	4673	18	efficiently	efficiently	RB
46745	4673	19	as	as	IN
46745	4673	20	tonics	tonic	NNS
46745	4673	21	,	,	,
46745	4673	22	by	by	IN
46745	4673	23	stimulating	stimulate	VBG
46745	4673	24	the	the	DT
46745	4673	25	function	function	NN
46745	4673	26	of	of	IN
46745	4673	27	the	the	DT
46745	4673	28	liver	liver	NN
46745	4673	29	,	,	,
46745	4673	30	which	which	WDT
46745	4673	31	in	in	IN
46745	4673	32	such	such	JJ
46745	4673	33	instances	instance	NNS
46745	4673	34	is	be	VBZ
46745	4673	35	generally	generally	RB
46745	4673	36	deranged	derange	VBN
46745	4673	37	.	.	.
46745	4674	1	ORD	ORD	NNP
46745	4674	2	.	.	.
46745	4675	1	V.	V.	NNP
46745	4675	2	DIAPHORETICS	DIAPHORETICS	NNP
46745	4675	3	.	.	.
46745	4676	1	These	these	DT
46745	4676	2	are	be	VBP
46745	4676	3	medicines	medicine	NNS
46745	4676	4	which	which	WDT
46745	4676	5	tend	tend	VBP
46745	4676	6	to	to	TO
46745	4676	7	promote	promote	VB
46745	4676	8	the	the	DT
46745	4676	9	secretion	secretion	NN
46745	4676	10	and	and	CC
46745	4676	11	exhalation	exhalation	NN
46745	4676	12	from	from	IN
46745	4676	13	the	the	DT
46745	4676	14	surface	surface	NN
46745	4676	15	of	of	IN
46745	4676	16	the	the	DT
46745	4676	17	skin	skin	NN
46745	4676	18	.	.	.
46745	4677	1	Of	of	IN
46745	4677	2	the	the	DT
46745	4677	3	matters	matter	NNS
46745	4677	4	which	which	WDT
46745	4677	5	are	be	VBP
46745	4677	6	given	give	VBN
46745	4677	7	off	off	RP
46745	4677	8	from	from	IN
46745	4677	9	the	the	DT
46745	4677	10	surface	surface	NN
46745	4677	11	of	of	IN
46745	4677	12	the	the	DT
46745	4677	13	body	body	NN
46745	4677	14	there	there	EX
46745	4677	15	are	be	VBP
46745	4677	16	three	three	CD
46745	4677	17	kinds	kind	NNS
46745	4677	18	.	.	.
46745	4678	1	Water	water	NN
46745	4678	2	in	in	IN
46745	4678	3	the	the	DT
46745	4678	4	state	state	NN
46745	4678	5	of	of	IN
46745	4678	6	insensible	insensible	JJ
46745	4678	7	vapour	vapour	NN
46745	4678	8	,	,	,
46745	4678	9	and	and	CC
46745	4678	10	volatile	volatile	JJ
46745	4678	11	matters	matter	NNS
46745	4678	12	,	,	,
46745	4678	13	are	be	VBP
46745	4678	14	continually	continually	RB
46745	4678	15	exhaling	exhale	VBG
46745	4678	16	from	from	IN
46745	4678	17	the	the	DT
46745	4678	18	skin	skin	NN
46745	4678	19	at	at	IN
46745	4678	20	all	all	DT
46745	4678	21	points	point	NNS
46745	4678	22	,	,	,
46745	4678	23	and	and	CC
46745	4678	24	pass	pass	VB
46745	4678	25	unnoticed	unnoticed	JJ
46745	4678	26	into	into	IN
46745	4678	27	the	the	DT
46745	4678	28	atmosphere	atmosphere	NN
46745	4678	29	around	around	RB
46745	4678	30	.	.	.
46745	4679	1	The	the	DT
46745	4679	2	liquid	liquid	JJ
46745	4679	3	sweat	sweat	NN
46745	4679	4	,	,	,
46745	4679	5	which	which	WDT
46745	4679	6	in	in	IN
46745	4679	7	the	the	DT
46745	4679	8	ordinary	ordinary	JJ
46745	4679	9	state	state	NN
46745	4679	10	of	of	IN
46745	4679	11	the	the	DT
46745	4679	12	body	body	NN
46745	4679	13	is	be	VBZ
46745	4679	14	only	only	RB
46745	4679	15	given	give	VBN
46745	4679	16	off	off	RP
46745	4679	17	in	in	IN
46745	4679	18	sufficient	sufficient	JJ
46745	4679	19	amount	amount	NN
46745	4679	20	to	to	TO
46745	4679	21	prevent	prevent	VB
46745	4679	22	the	the	DT
46745	4679	23	skin	skin	NN
46745	4679	24	from	from	IN
46745	4679	25	becoming	become	VBG
46745	4679	26	over	over	RB
46745	4679	27	-	-	HYPH
46745	4679	28	dry	dry	NN
46745	4679	29	,	,	,
46745	4679	30	is	be	VBZ
46745	4679	31	secreted	secrete	VBN
46745	4679	32	by	by	IN
46745	4679	33	the	the	DT
46745	4679	34	sudoriferous	sudoriferous	JJ
46745	4679	35	glands	gland	NNS
46745	4679	36	,	,	,
46745	4679	37	whose	whose	WP$
46745	4679	38	ducts	duct	NNS
46745	4679	39	terminate	terminate	VBP
46745	4679	40	in	in	IN
46745	4679	41	large	large	JJ
46745	4679	42	numbers	number	NNS
46745	4679	43	on	on	IN
46745	4679	44	the	the	DT
46745	4679	45	surface	surface	NN
46745	4679	46	at	at	IN
46745	4679	47	every	every	DT
46745	4679	48	part	part	NN
46745	4679	49	.	.	.
46745	4680	1	There	there	EX
46745	4680	2	is	be	VBZ
46745	4680	3	in	in	IN
46745	4680	4	the	the	DT
46745	4680	5	third	third	JJ
46745	4680	6	place	place	NN
46745	4680	7	an	an	DT
46745	4680	8	oily	oily	JJ
46745	4680	9	material	material	NN
46745	4680	10	,	,	,
46745	4680	11	formed	form	VBN
46745	4680	12	for	for	IN
46745	4680	13	a	a	DT
46745	4680	14	similar	similar	JJ
46745	4680	15	purpose	purpose	NN
46745	4680	16	by	by	IN
46745	4680	17	the	the	DT
46745	4680	18	sebaceous	sebaceous	JJ
46745	4680	19	glands	gland	NNS
46745	4680	20	,	,	,
46745	4680	21	which	which	WDT
46745	4680	22	are	be	VBP
46745	4680	23	widely	widely	RB
46745	4680	24	distributed	distribute	VBN
46745	4680	25	,	,	,
46745	4680	26	but	but	CC
46745	4680	27	fewer	few	JJR
46745	4680	28	in	in	IN
46745	4680	29	number	number	NN
46745	4680	30	than	than	IN
46745	4680	31	the	the	DT
46745	4680	32	last	last	JJ
46745	4680	33	.	.	.
46745	4681	1	Diaphoretics	diaphoretic	NNS
46745	4681	2	seem	seem	VBP
46745	4681	3	to	to	TO
46745	4681	4	increase	increase	VB
46745	4681	5	only	only	RB
46745	4681	6	the	the	DT
46745	4681	7	first	first	JJ
46745	4681	8	two	two	CD
46745	4681	9	kinds	kind	NNS
46745	4681	10	,	,	,
46745	4681	11	viz	viz	NNP
46745	4681	12	.	.	NNP
46745	4681	13	,	,	,
46745	4681	14	the	the	DT
46745	4681	15	aeriform	aeriform	NN
46745	4681	16	transpiration	transpiration	NN
46745	4681	17	,	,	,
46745	4681	18	and	and	CC
46745	4681	19	the	the	DT
46745	4681	20	liquid	liquid	JJ
46745	4681	21	sweat	sweat	NN
46745	4681	22	;	;	:
46745	4681	23	and	and	CC
46745	4681	24	they	-PRON-	PRP
46745	4681	25	act	act	VBP
46745	4681	26	upon	upon	IN
46745	4681	27	these	these	DT
46745	4681	28	in	in	IN
46745	4681	29	a	a	DT
46745	4681	30	varying	varying	JJ
46745	4681	31	proportion	proportion	NN
46745	4681	32	.	.	.
46745	4682	1	In	in	IN
46745	4682	2	the	the	DT
46745	4682	3	consideration	consideration	NN
46745	4682	4	of	of	IN
46745	4682	5	this	this	DT
46745	4682	6	order	order	NN
46745	4682	7	we	-PRON-	PRP
46745	4682	8	have	have	VBP
46745	4682	9	not	not	RB
46745	4682	10	only	only	RB
46745	4682	11	to	to	TO
46745	4682	12	bear	bear	VB
46745	4682	13	in	in	IN
46745	4682	14	mind	mind	NN
46745	4682	15	the	the	DT
46745	4682	16	distinction	distinction	NN
46745	4682	17	between	between	IN
46745	4682	18	these	these	DT
46745	4682	19	two	two	CD
46745	4682	20	kinds	kind	NNS
46745	4682	21	of	of	IN
46745	4682	22	diaphoresis	diaphoresis	NN
46745	4682	23	,	,	,
46745	4682	24	but	but	CC
46745	4682	25	to	to	TO
46745	4682	26	note	note	VB
46745	4682	27	further	further	RB
46745	4682	28	the	the	DT
46745	4682	29	important	important	JJ
46745	4682	30	relations	relation	NNS
46745	4682	31	existing	exist	VBG
46745	4682	32	between	between	IN
46745	4682	33	the	the	DT
46745	4682	34	action	action	NN
46745	4682	35	of	of	IN
46745	4682	36	these	these	DT
46745	4682	37	medicines	medicine	NNS
46745	4682	38	and	and	CC
46745	4682	39	the	the	DT
46745	4682	40	state	state	NN
46745	4682	41	of	of	IN
46745	4682	42	the	the	DT
46745	4682	43	atmosphere	atmosphere	NN
46745	4682	44	,	,	,
46745	4682	45	the	the	DT
46745	4682	46	condition	condition	NN
46745	4682	47	of	of	IN
46745	4682	48	the	the	DT
46745	4682	49	body	body	NN
46745	4682	50	,	,	,
46745	4682	51	and	and	CC
46745	4682	52	amount	amount	NN
46745	4682	53	of	of	IN
46745	4682	54	other	other	JJ
46745	4682	55	secretions	secretion	NNS
46745	4682	56	.	.	.
46745	4683	1	In	in	IN
46745	4683	2	all	all	DT
46745	4683	3	relaxed	relaxed	JJ
46745	4683	4	conditions	condition	NNS
46745	4683	5	of	of	IN
46745	4683	6	the	the	DT
46745	4683	7	general	general	JJ
46745	4683	8	system	system	NN
46745	4683	9	,	,	,
46745	4683	10	the	the	DT
46745	4683	11	amount	amount	NN
46745	4683	12	of	of	IN
46745	4683	13	the	the	DT
46745	4683	14	perspiration	perspiration	NN
46745	4683	15	is	be	VBZ
46745	4683	16	apt	apt	JJ
46745	4683	17	to	to	TO
46745	4683	18	be	be	VB
46745	4683	19	increased	increase	VBN
46745	4683	20	.	.	.
46745	4684	1	This	this	DT
46745	4684	2	is	be	VBZ
46745	4684	3	especially	especially	RB
46745	4684	4	evident	evident	JJ
46745	4684	5	in	in	IN
46745	4684	6	the	the	DT
46745	4684	7	weakness	weakness	NN
46745	4684	8	which	which	WDT
46745	4684	9	follows	follow	VBZ
46745	4684	10	a	a	DT
46745	4684	11	paroxysm	paroxysm	NNS
46745	4684	12	of	of	IN
46745	4684	13	simple	simple	JJ
46745	4684	14	fever	fever	NN
46745	4684	15	.	.	.
46745	4685	1	The	the	DT
46745	4685	2	force	force	NN
46745	4685	3	of	of	IN
46745	4685	4	the	the	DT
46745	4685	5	heart	heart	NN
46745	4685	6	is	be	VBZ
46745	4685	7	weakened	weaken	VBN
46745	4685	8	,	,	,
46745	4685	9	the	the	DT
46745	4685	10	tone	tone	NN
46745	4685	11	of	of	IN
46745	4685	12	the	the	DT
46745	4685	13	capillaries	capillary	NNS
46745	4685	14	impaired,--and	impaired,--and	XX
46745	4685	15	by	by	IN
46745	4685	16	these	these	DT
46745	4685	17	conditions	condition	NNS
46745	4685	18	absorption	absorption	NN
46745	4685	19	is	be	VBZ
46745	4685	20	favoured	favour	VBN
46745	4685	21	,	,	,
46745	4685	22	and	and	CC
46745	4685	23	the	the	DT
46745	4685	24	amount	amount	NN
46745	4685	25	of	of	IN
46745	4685	26	fluid	fluid	NN
46745	4685	27	in	in	IN
46745	4685	28	the	the	DT
46745	4685	29	blood	blood	NN
46745	4685	30	increased	increase	VBD
46745	4685	31	.	.	.
46745	4686	1	At	at	IN
46745	4686	2	the	the	DT
46745	4686	3	same	same	JJ
46745	4686	4	time	time	NN
46745	4686	5	the	the	DT
46745	4686	6	muscular	muscular	JJ
46745	4686	7	system	system	NN
46745	4686	8	is	be	VBZ
46745	4686	9	relaxed	relaxed	JJ
46745	4686	10	,	,	,
46745	4686	11	and	and	CC
46745	4686	12	the	the	DT
46745	4686	13	sudoriferous	sudoriferous	JJ
46745	4686	14	ducts	duct	NNS
46745	4686	15	being	be	VBG
46745	4686	16	thrown	throw	VBN
46745	4686	17	open	open	JJ
46745	4686	18	by	by	IN
46745	4686	19	the	the	DT
46745	4686	20	diminished	diminished	JJ
46745	4686	21	contraction	contraction	NN
46745	4686	22	of	of	IN
46745	4686	23	the	the	DT
46745	4686	24	involuntary	involuntary	JJ
46745	4686	25	fibre	fibre	NN
46745	4686	26	that	that	DT
46745	4686	27	surrounds	surround	VBZ
46745	4686	28	them	-PRON-	PRP
46745	4686	29	,	,	,
46745	4686	30	the	the	DT
46745	4686	31	excretion	excretion	NN
46745	4686	32	of	of	IN
46745	4686	33	the	the	DT
46745	4686	34	sweat	sweat	NN
46745	4686	35	is	be	VBZ
46745	4686	36	favoured	favour	VBN
46745	4686	37	,	,	,
46745	4686	38	and	and	CC
46745	4686	39	the	the	DT
46745	4686	40	watery	watery	JJ
46745	4686	41	parts	part	NNS
46745	4686	42	of	of	IN
46745	4686	43	the	the	DT
46745	4686	44	blood	blood	NN
46745	4686	45	are	be	VBP
46745	4686	46	poured	pour	VBN
46745	4686	47	out	out	RP
46745	4686	48	through	through	IN
46745	4686	49	the	the	DT
46745	4686	50	skin	skin	NN
46745	4686	51	.	.	.
46745	4687	1	This	this	DT
46745	4687	2	general	general	JJ
46745	4687	3	relaxation	relaxation	NN
46745	4687	4	precedes	precede	NNS
46745	4687	5	and	and	CC
46745	4687	6	follows	follow	VBZ
46745	4687	7	the	the	DT
46745	4687	8	act	act	NN
46745	4687	9	of	of	IN
46745	4687	10	vomiting	vomiting	NN
46745	4687	11	,	,	,
46745	4687	12	as	as	IN
46745	4687	13	induced	induce	VBN
46745	4687	14	by	by	IN
46745	4687	15	a	a	DT
46745	4687	16	dose	dose	NN
46745	4687	17	of	of	IN
46745	4687	18	Tartar	Tartar	NNP
46745	4687	19	Emetic	Emetic	NNP
46745	4687	20	or	or	CC
46745	4687	21	Ipecacuanha	Ipecacuanha	NNP
46745	4687	22	.	.	.
46745	4688	1	Thus	thus	RB
46745	4688	2	these	these	DT
46745	4688	3	medicines	medicine	NNS
46745	4688	4	act	act	VBP
46745	4688	5	indirectly	indirectly	RB
46745	4688	6	as	as	IN
46745	4688	7	Diaphoretics	Diaphoretics	NNP
46745	4688	8	,	,	,
46745	4688	9	when	when	WRB
46745	4688	10	given	give	VBN
46745	4688	11	in	in	IN
46745	4688	12	emetic	emetic	JJ
46745	4688	13	doses	dose	NNS
46745	4688	14	.	.	.
46745	4689	1	_	_	NNP
46745	4689	2	True	True	NNP
46745	4689	3	Diaphoretics._--The	Diaphoretics._--The	NNP
46745	4689	4	following	follow	VBG
46745	4689	5	groups	group	NNS
46745	4689	6	of	of	IN
46745	4689	7	medicines	medicine	NNS
46745	4689	8	may	may	MD
46745	4689	9	be	be	VB
46745	4689	10	briefly	briefly	RB
46745	4689	11	noticed	notice	VBN
46745	4689	12	as	as	IN
46745	4689	13	tending	tend	VBG
46745	4689	14	to	to	TO
46745	4689	15	act	act	VB
46745	4689	16	as	as	IN
46745	4689	17	Eliminatives	Eliminatives	NNPS
46745	4689	18	on	on	IN
46745	4689	19	the	the	DT
46745	4689	20	glands	gland	NNS
46745	4689	21	of	of	IN
46745	4689	22	the	the	DT
46745	4689	23	skin	skin	NN
46745	4689	24	.	.	.
46745	4690	1	Five	five	CD
46745	4690	2	divisions	division	NNS
46745	4690	3	may	may	MD
46745	4690	4	be	be	VB
46745	4690	5	made:--1	made:--1	NNP
46745	4690	6	.	.	.
46745	4691	1	Salines	saline	NNS
46745	4691	2	and	and	CC
46745	4691	3	diluents	diluent	NNS
46745	4691	4	,	,	,
46745	4691	5	under	under	IN
46745	4691	6	certain	certain	JJ
46745	4691	7	conditions	condition	NNS
46745	4691	8	;	;	:
46745	4691	9	2	2	CD
46745	4691	10	.	.	.
46745	4692	1	Volatile	volatile	JJ
46745	4692	2	substances	substance	NNS
46745	4692	3	which	which	WDT
46745	4692	4	are	be	VBP
46745	4692	5	soluble	soluble	JJ
46745	4692	6	in	in	IN
46745	4692	7	air	air	NN
46745	4692	8	,	,	,
46745	4692	9	as	as	IN
46745	4692	10	Ammonia	Ammonia	NNP
46745	4692	11	,	,	,
46745	4692	12	volatile	volatile	JJ
46745	4692	13	oils	oil	NNS
46745	4692	14	,	,	,
46745	4692	15	and	and	CC
46745	4692	16	Alcohol	Alcohol	NNP
46745	4692	17	;	;	:
46745	4692	18	3	3	CD
46745	4692	19	.	.	.
46745	4693	1	Certain	certain	JJ
46745	4693	2	acrid	acrid	JJ
46745	4693	3	matters	matter	VBZ
46745	4693	4	,	,	,
46745	4693	5	as	as	IN
46745	4693	6	Guaiacum	Guaiacum	NNP
46745	4693	7	;	;	:
46745	4693	8	4	4	CD
46745	4693	9	.	.	.
46745	4694	1	Certain	Certain	NNP
46745	4694	2	Narcotics	Narcotics	NNP
46745	4694	3	,	,	,
46745	4694	4	as	as	IN
46745	4694	5	Opium	Opium	NNP
46745	4694	6	and	and	CC
46745	4694	7	Camphor	Camphor	NNP
46745	4694	8	;	;	:
46745	4694	9	5	5	CD
46745	4694	10	.	.	.
46745	4695	1	Antimony	Antimony	NNP
46745	4695	2	,	,	,
46745	4695	3	Mercury	Mercury	NNP
46745	4695	4	,	,	,
46745	4695	5	and	and	CC
46745	4695	6	Sulphur	Sulphur	NNP
46745	4695	7	.	.	.
46745	4696	1	These	these	DT
46745	4696	2	Diaphoretics	diaphoretic	NNS
46745	4696	3	are	be	VBP
46745	4696	4	all	all	RB
46745	4696	5	more	more	RBR
46745	4696	6	or	or	CC
46745	4696	7	less	less	RBR
46745	4696	8	uncertain	uncertain	JJ
46745	4696	9	in	in	IN
46745	4696	10	their	-PRON-	PRP$
46745	4696	11	action	action	NN
46745	4696	12	,	,	,
46745	4696	13	as	as	IN
46745	4696	14	we	-PRON-	PRP
46745	4696	15	have	have	VBP
46745	4696	16	seen	see	VBN
46745	4696	17	to	to	TO
46745	4696	18	be	be	VB
46745	4696	19	the	the	DT
46745	4696	20	case	case	NN
46745	4696	21	with	with	IN
46745	4696	22	Expectorants	expectorant	NNS
46745	4696	23	.	.	.
46745	4697	1	There	there	EX
46745	4697	2	are	be	VBP
46745	4697	3	two	two	CD
46745	4697	4	causes	cause	NNS
46745	4697	5	of	of	IN
46745	4697	6	this	this	DT
46745	4697	7	uncertainty	uncertainty	NN
46745	4697	8	.	.	.
46745	4698	1	In	in	IN
46745	4698	2	the	the	DT
46745	4698	3	first	first	JJ
46745	4698	4	place	place	NN
46745	4698	5	,	,	,
46745	4698	6	the	the	DT
46745	4698	7	secretion	secretion	NN
46745	4698	8	of	of	IN
46745	4698	9	sweat	sweat	NN
46745	4698	10	,	,	,
46745	4698	11	like	like	IN
46745	4698	12	that	that	DT
46745	4698	13	of	of	IN
46745	4698	14	the	the	DT
46745	4698	15	lungs	lung	NNS
46745	4698	16	,	,	,
46745	4698	17	can	can	MD
46745	4698	18	not	not	RB
46745	4698	19	be	be	VB
46745	4698	20	considered	consider	VBN
46745	4698	21	as	as	IN
46745	4698	22	a	a	DT
46745	4698	23	common	common	JJ
46745	4698	24	emunctory	emunctory	NN
46745	4698	25	.	.	.
46745	4699	1	There	there	EX
46745	4699	2	are	be	VBP
46745	4699	3	hardly	hardly	RB
46745	4699	4	any	any	DT
46745	4699	5	solid	solid	JJ
46745	4699	6	matters	matter	NNS
46745	4699	7	in	in	IN
46745	4699	8	it	-PRON-	PRP
46745	4699	9	which	which	WDT
46745	4699	10	are	be	VBP
46745	4699	11	not	not	RB
46745	4699	12	also	also	RB
46745	4699	13	contained	contain	VBN
46745	4699	14	in	in	IN
46745	4699	15	the	the	DT
46745	4699	16	urine	urine	NN
46745	4699	17	,	,	,
46745	4699	18	and	and	CC
46745	4699	19	commonly	commonly	RB
46745	4699	20	excreted	excrete	VBN
46745	4699	21	by	by	IN
46745	4699	22	the	the	DT
46745	4699	23	kidneys	kidney	NNS
46745	4699	24	.	.	.
46745	4700	1	It	-PRON-	PRP
46745	4700	2	is	be	VBZ
46745	4700	3	only	only	RB
46745	4700	4	in	in	IN
46745	4700	5	special	special	JJ
46745	4700	6	cases	case	NNS
46745	4700	7	,	,	,
46745	4700	8	or	or	CC
46745	4700	9	when	when	WRB
46745	4700	10	there	there	EX
46745	4700	11	is	be	VBZ
46745	4700	12	a	a	DT
46745	4700	13	fault	fault	NN
46745	4700	14	in	in	IN
46745	4700	15	the	the	DT
46745	4700	16	normal	normal	JJ
46745	4700	17	formation	formation	NN
46745	4700	18	of	of	IN
46745	4700	19	urine	urine	NN
46745	4700	20	,	,	,
46745	4700	21	that	that	IN
46745	4700	22	the	the	DT
46745	4700	23	skin	skin	NN
46745	4700	24	is	be	VBZ
46745	4700	25	called	call	VBN
46745	4700	26	upon	upon	IN
46745	4700	27	to	to	TO
46745	4700	28	eliminate	eliminate	VB
46745	4700	29	materials	material	NNS
46745	4700	30	from	from	IN
46745	4700	31	the	the	DT
46745	4700	32	blood	blood	NN
46745	4700	33	.	.	.
46745	4701	1	In	in	IN
46745	4701	2	the	the	DT
46745	4701	3	second	second	JJ
46745	4701	4	place	place	NN
46745	4701	5	,	,	,
46745	4701	6	there	there	EX
46745	4701	7	are	be	VBP
46745	4701	8	certain	certain	JJ
46745	4701	9	atmospheric	atmospheric	JJ
46745	4701	10	and	and	CC
46745	4701	11	other	other	JJ
46745	4701	12	conditions	condition	NNS
46745	4701	13	which	which	WDT
46745	4701	14	promote	promote	VBP
46745	4701	15	the	the	DT
46745	4701	16	secretion	secretion	NN
46745	4701	17	of	of	IN
46745	4701	18	sweat	sweat	NN
46745	4701	19	,	,	,
46745	4701	20	and	and	CC
46745	4701	21	certain	certain	JJ
46745	4701	22	others	other	NNS
46745	4701	23	of	of	IN
46745	4701	24	an	an	DT
46745	4701	25	opposite	opposite	JJ
46745	4701	26	nature	nature	NN
46745	4701	27	which	which	WDT
46745	4701	28	tend	tend	VBP
46745	4701	29	to	to	TO
46745	4701	30	retard	retard	VB
46745	4701	31	it	-PRON-	PRP
46745	4701	32	,	,	,
46745	4701	33	and	and	CC
46745	4701	34	to	to	TO
46745	4701	35	divert	divert	VB
46745	4701	36	into	into	IN
46745	4701	37	another	another	DT
46745	4701	38	channel	channel	NN
46745	4701	39	the	the	DT
46745	4701	40	aqueous	aqueous	JJ
46745	4701	41	materials	material	NNS
46745	4701	42	which	which	WDT
46745	4701	43	should	should	MD
46745	4701	44	pass	pass	VB
46745	4701	45	into	into	IN
46745	4701	46	it	-PRON-	PRP
46745	4701	47	.	.	.
46745	4702	1	With	with	IN
46745	4702	2	regard	regard	NN
46745	4702	3	to	to	IN
46745	4702	4	the	the	DT
46745	4702	5	state	state	NN
46745	4702	6	of	of	IN
46745	4702	7	the	the	DT
46745	4702	8	atmosphere	atmosphere	NN
46745	4702	9	,	,	,
46745	4702	10	warmth	warmth	NNP
46745	4702	11	favours	favour	VBZ
46745	4702	12	diaphoresis	diaphoresis	NN
46745	4702	13	,	,	,
46745	4702	14	cold	cold	JJ
46745	4702	15	repels	repel	NNS
46745	4702	16	it	-PRON-	PRP
46745	4702	17	.	.	.
46745	4703	1	Warm	warm	JJ
46745	4703	2	dry	dry	JJ
46745	4703	3	air	air	NN
46745	4703	4	,	,	,
46745	4703	5	especially	especially	RB
46745	4703	6	when	when	WRB
46745	4703	7	in	in	IN
46745	4703	8	motion	motion	NN
46745	4703	9	,	,	,
46745	4703	10	promotes	promote	VBZ
46745	4703	11	the	the	DT
46745	4703	12	aeriform	aeriform	NN
46745	4703	13	transpiration	transpiration	NN
46745	4703	14	,	,	,
46745	4703	15	by	by	IN
46745	4703	16	favouring	favour	VBG
46745	4703	17	evaporation	evaporation	NN
46745	4703	18	.	.	.
46745	4704	1	Moist	moist	JJ
46745	4704	2	air	air	NN
46745	4704	3	,	,	,
46745	4704	4	which	which	WDT
46745	4704	5	hinders	hinder	VBZ
46745	4704	6	evaporation	evaporation	NN
46745	4704	7	,	,	,
46745	4704	8	promotes	promote	VBZ
46745	4704	9	liquid	liquid	JJ
46745	4704	10	sweating	sweating	NN
46745	4704	11	.	.	.
46745	4705	1	Very	very	RB
46745	4705	2	active	active	JJ
46745	4705	3	exercise	exercise	NN
46745	4705	4	,	,	,
46745	4705	5	with	with	IN
46745	4705	6	the	the	DT
46745	4705	7	surface	surface	NN
46745	4705	8	warmly	warmly	RB
46745	4705	9	clad	clothe	VBN
46745	4705	10	,	,	,
46745	4705	11	produces	produce	VBZ
46745	4705	12	liquid	liquid	JJ
46745	4705	13	perspiration	perspiration	NN
46745	4705	14	.	.	.
46745	4706	1	Moderate	moderate	JJ
46745	4706	2	exercise	exercise	NN
46745	4706	3	,	,	,
46745	4706	4	with	with	IN
46745	4706	5	a	a	DT
46745	4706	6	cool	cool	JJ
46745	4706	7	surface	surface	NN
46745	4706	8	,	,	,
46745	4706	9	favours	favour	VBZ
46745	4706	10	diuresis	diuresis	NN
46745	4706	11	.	.	.
46745	4707	1	The	the	DT
46745	4707	2	recumbent	recumbent	JJ
46745	4707	3	posture	posture	NN
46745	4707	4	,	,	,
46745	4707	5	and	and	CC
46745	4707	6	sleep	sleep	NN
46745	4707	7	,	,	,
46745	4707	8	promote	promote	VB
46745	4707	9	diaphoresis	diaphoresis	NN
46745	4707	10	;	;	:
46745	4707	11	the	the	DT
46745	4707	12	erect	erect	NN
46745	4707	13	posture	posture	NN
46745	4707	14	and	and	CC
46745	4707	15	wakefulness	wakefulness	NN
46745	4707	16	,	,	,
46745	4707	17	diuresis	diuresis	NN
46745	4707	18	.	.	.
46745	4708	1	Thus	thus	RB
46745	4708	2	when	when	WRB
46745	4708	3	it	-PRON-	PRP
46745	4708	4	is	be	VBZ
46745	4708	5	required	require	VBN
46745	4708	6	to	to	TO
46745	4708	7	produce	produce	VB
46745	4708	8	sweating	sweating	NN
46745	4708	9	,	,	,
46745	4708	10	the	the	DT
46745	4708	11	patient	patient	NN
46745	4708	12	is	be	VBZ
46745	4708	13	ordered	order	VBN
46745	4708	14	to	to	TO
46745	4708	15	lie	lie	VB
46745	4708	16	in	in	IN
46745	4708	17	bed	bed	NN
46745	4708	18	,	,	,
46745	4708	19	to	to	TO
46745	4708	20	be	be	VB
46745	4708	21	covered	cover	VBN
46745	4708	22	warmly	warmly	RB
46745	4708	23	,	,	,
46745	4708	24	and	and	CC
46745	4708	25	to	to	TO
46745	4708	26	compose	compose	VB
46745	4708	27	himself	-PRON-	PRP
46745	4708	28	to	to	TO
46745	4708	29	sleep	sleep	VB
46745	4708	30	.	.	.
46745	4709	1	Any	any	DT
46745	4709	2	thing	thing	NN
46745	4709	3	which	which	WDT
46745	4709	4	keeps	keep	VBZ
46745	4709	5	the	the	DT
46745	4709	6	surface	surface	NN
46745	4709	7	of	of	IN
46745	4709	8	the	the	DT
46745	4709	9	skin	skin	NN
46745	4709	10	unnaturally	unnaturally	RB
46745	4709	11	warm	warm	JJ
46745	4709	12	,	,	,
46745	4709	13	as	as	IN
46745	4709	14	a	a	DT
46745	4709	15	hot	hot	JJ
46745	4709	16	-	-	HYPH
46745	4709	17	air	air	NN
46745	4709	18	or	or	CC
46745	4709	19	hot	hot	JJ
46745	4709	20	-	-	HYPH
46745	4709	21	vapour	vapour	NN
46745	4709	22	bath,--or	bath,--or	NNP
46745	4709	23	thick	thick	JJ
46745	4709	24	flannel	flannel	NN
46745	4709	25	clothing	clothing	NN
46745	4709	26	,	,	,
46745	4709	27	which	which	WDT
46745	4709	28	is	be	VBZ
46745	4709	29	a	a	DT
46745	4709	30	non	non	JJ
46745	4709	31	-	-	JJ
46745	4709	32	conductor	conductor	NN
46745	4709	33	of	of	IN
46745	4709	34	heat,--tends	heat,--tends	NNPS
46745	4709	35	powerfully	powerfully	RB
46745	4709	36	to	to	TO
46745	4709	37	cause	cause	VB
46745	4709	38	diaphoresis	diaphoresis	NN
46745	4709	39	.	.	.
46745	4710	1	So	so	RB
46745	4710	2	does	do	VBZ
46745	4710	3	friction	friction	NN
46745	4710	4	,	,	,
46745	4710	5	which	which	WDT
46745	4710	6	stimulates	stimulate	VBZ
46745	4710	7	and	and	CC
46745	4710	8	dilates	dilate	VBZ
46745	4710	9	the	the	DT
46745	4710	10	external	external	JJ
46745	4710	11	capillaries	capillary	NNS
46745	4710	12	.	.	.
46745	4711	1	So	so	RB
46745	4711	2	far	far	RB
46745	4711	3	the	the	DT
46745	4711	4	conditions	condition	NNS
46745	4711	5	of	of	IN
46745	4711	6	sweating	sweating	NN
46745	4711	7	and	and	CC
46745	4711	8	of	of	IN
46745	4711	9	diuresis	diuresis	NN
46745	4711	10	are	be	VBP
46745	4711	11	nearly	nearly	RB
46745	4711	12	opposite	opposite	JJ
46745	4711	13	.	.	.
46745	4712	1	But	but	CC
46745	4712	2	this	this	DT
46745	4712	3	is	be	VBZ
46745	4712	4	not	not	RB
46745	4712	5	the	the	DT
46745	4712	6	case	case	NN
46745	4712	7	with	with	IN
46745	4712	8	the	the	DT
46745	4712	9	medicines	medicine	NNS
46745	4712	10	which	which	WDT
46745	4712	11	are	be	VBP
46745	4712	12	used	use	VBN
46745	4712	13	to	to	TO
46745	4712	14	cause	cause	VB
46745	4712	15	them	-PRON-	PRP
46745	4712	16	.	.	.
46745	4713	1	Diluents	diluent	NNS
46745	4713	2	,	,	,
46745	4713	3	and	and	CC
46745	4713	4	salines	saline	NNS
46745	4713	5	soluble	soluble	JJ
46745	4713	6	in	in	IN
46745	4713	7	water	water	NN
46745	4713	8	,	,	,
46745	4713	9	form	form	VB
46745	4713	10	the	the	DT
46745	4713	11	first	first	JJ
46745	4713	12	group	group	NN
46745	4713	13	of	of	IN
46745	4713	14	true	true	JJ
46745	4713	15	Diaphoretics	diaphoretic	NNS
46745	4713	16	.	.	.
46745	4714	1	Water	water	NN
46745	4714	2	promotes	promote	VBZ
46745	4714	3	alike	alike	RB
46745	4714	4	the	the	DT
46745	4714	5	function	function	NN
46745	4714	6	of	of	IN
46745	4714	7	the	the	DT
46745	4714	8	skin	skin	NN
46745	4714	9	and	and	CC
46745	4714	10	of	of	IN
46745	4714	11	the	the	DT
46745	4714	12	kidneys	kidney	NNS
46745	4714	13	;	;	:
46745	4714	14	and	and	CC
46745	4714	15	it	-PRON-	PRP
46745	4714	16	is	be	VBZ
46745	4714	17	only	only	RB
46745	4714	18	by	by	IN
46745	4714	19	a	a	DT
46745	4714	20	regulation	regulation	NN
46745	4714	21	of	of	IN
46745	4714	22	the	the	DT
46745	4714	23	circumstances	circumstance	NNS
46745	4714	24	mentioned	mention	VBN
46745	4714	25	above	above	RB
46745	4714	26	that	that	IN
46745	4714	27	it	-PRON-	PRP
46745	4714	28	can	can	MD
46745	4714	29	be	be	VB
46745	4714	30	diverted	divert	VBN
46745	4714	31	from	from	IN
46745	4714	32	the	the	DT
46745	4714	33	latter	latter	JJ
46745	4714	34	towards	towards	IN
46745	4714	35	the	the	DT
46745	4714	36	former	former	JJ
46745	4714	37	.	.	.
46745	4715	1	Diluent	diluent	JJ
46745	4715	2	drinks	drink	NNS
46745	4715	3	are	be	VBP
46745	4715	4	indispensable	indispensable	JJ
46745	4715	5	adjuncts	adjunct	NNS
46745	4715	6	to	to	IN
46745	4715	7	a	a	DT
46745	4715	8	Diaphoretic	diaphoretic	JJ
46745	4715	9	regimen	regimen	NN
46745	4715	10	.	.	.
46745	4716	1	Salines	saline	NNS
46745	4716	2	also	also	RB
46745	4716	3	tend	tend	VBP
46745	4716	4	naturally	naturally	RB
46745	4716	5	to	to	TO
46745	4716	6	pass	pass	VB
46745	4716	7	off	off	RP
46745	4716	8	in	in	IN
46745	4716	9	the	the	DT
46745	4716	10	urine	urine	NN
46745	4716	11	,	,	,
46745	4716	12	when	when	WRB
46745	4716	13	in	in	IN
46745	4716	14	small	small	JJ
46745	4716	15	doses	dose	NNS
46745	4716	16	;	;	:
46745	4716	17	but	but	CC
46745	4716	18	when	when	WRB
46745	4716	19	in	in	IN
46745	4716	20	large	large	JJ
46745	4716	21	amount	amount	NN
46745	4716	22	,	,	,
46745	4716	23	by	by	IN
46745	4716	24	the	the	DT
46745	4716	25	bowels	bowel	NNS
46745	4716	26	.	.	.
46745	4717	1	A	a	DT
46745	4717	2	saline	saline	NN
46745	4717	3	,	,	,
46745	4717	4	being	be	VBG
46745	4717	5	soluble	soluble	JJ
46745	4717	6	in	in	IN
46745	4717	7	water	water	NN
46745	4717	8	,	,	,
46745	4717	9	can	can	MD
46745	4717	10	not	not	RB
46745	4717	11	pass	pass	VB
46745	4717	12	out	out	RP
46745	4717	13	except	except	IN
46745	4717	14	into	into	IN
46745	4717	15	a	a	DT
46745	4717	16	fluid	fluid	JJ
46745	4717	17	secretion	secretion	NN
46745	4717	18	;	;	:
46745	4717	19	so	so	IN
46745	4717	20	that	that	IN
46745	4717	21	a	a	DT
46745	4717	22	saline	saline	NN
46745	4717	23	diaphoretic	diaphoretic	JJ
46745	4717	24	should	should	MD
46745	4717	25	be	be	VB
46745	4717	26	given	give	VBN
46745	4717	27	in	in	IN
46745	4717	28	a	a	DT
46745	4717	29	moderate	moderate	JJ
46745	4717	30	dose	dose	NN
46745	4717	31	,	,	,
46745	4717	32	and	and	CC
46745	4717	33	to	to	TO
46745	4717	34	secure	secure	VB
46745	4717	35	its	-PRON-	PRP$
46745	4717	36	action	action	NN
46745	4717	37	the	the	DT
46745	4717	38	skin	skin	NN
46745	4717	39	should	should	MD
46745	4717	40	be	be	VB
46745	4717	41	kept	keep	VBN
46745	4717	42	covered	cover	VBN
46745	4717	43	and	and	CC
46745	4717	44	warm	warm	JJ
46745	4717	45	,	,	,
46745	4717	46	and	and	CC
46745	4717	47	the	the	DT
46745	4717	48	patient	patient	NN
46745	4717	49	in	in	IN
46745	4717	50	a	a	DT
46745	4717	51	recumbent	recumbent	JJ
46745	4717	52	posture	posture	NN
46745	4717	53	.	.	.
46745	4718	1	The	the	DT
46745	4718	2	medicine	medicine	NN
46745	4718	3	will	will	MD
46745	4718	4	then	then	RB
46745	4718	5	pass	pass	VB
46745	4718	6	off	off	RP
46745	4718	7	into	into	IN
46745	4718	8	the	the	DT
46745	4718	9	liquid	liquid	JJ
46745	4718	10	sweat	sweat	NN
46745	4718	11	,	,	,
46745	4718	12	as	as	IN
46745	4718	13	it	-PRON-	PRP
46745	4718	14	otherwise	otherwise	RB
46745	4718	15	would	would	MD
46745	4718	16	have	have	VB
46745	4718	17	passed	pass	VBN
46745	4718	18	into	into	IN
46745	4718	19	the	the	DT
46745	4718	20	urine	urine	NN
46745	4718	21	.	.	.
46745	4719	1	Volatile	Volatile	NNP
46745	4719	2	Diaphoretics	Diaphoretics	NNP
46745	4719	3	may	may	MD
46745	4719	4	increase	increase	VB
46745	4719	5	the	the	DT
46745	4719	6	cutaneous	cutaneous	JJ
46745	4719	7	transpiration	transpiration	NN
46745	4719	8	,	,	,
46745	4719	9	and	and	CC
46745	4719	10	pass	pass	VB
46745	4719	11	off	off	RP
46745	4719	12	by	by	IN
46745	4719	13	the	the	DT
46745	4719	14	skin	skin	NN
46745	4719	15	,	,	,
46745	4719	16	without	without	IN
46745	4719	17	the	the	DT
46745	4719	18	production	production	NN
46745	4719	19	of	of	IN
46745	4719	20	sensible	sensible	JJ
46745	4719	21	liquid	liquid	JJ
46745	4719	22	sweating	sweating	NN
46745	4719	23	.	.	.
46745	4720	1	For	for	IN
46745	4720	2	being	be	VBG
46745	4720	3	soluble	soluble	JJ
46745	4720	4	in	in	IN
46745	4720	5	air	air	NN
46745	4720	6	,	,	,
46745	4720	7	and	and	CC
46745	4720	8	capable	capable	JJ
46745	4720	9	of	of	IN
46745	4720	10	being	be	VBG
46745	4720	11	carried	carry	VBN
46745	4720	12	away	away	RB
46745	4720	13	by	by	IN
46745	4720	14	it	-PRON-	PRP
46745	4720	15	,	,	,
46745	4720	16	they	-PRON-	PRP
46745	4720	17	therefore	therefore	RB
46745	4720	18	tend	tend	VBP
46745	4720	19	especially	especially	RB
46745	4720	20	to	to	IN
46745	4720	21	the	the	DT
46745	4720	22	two	two	CD
46745	4720	23	aeriform	aeriform	NN
46745	4720	24	secretions	secretion	NNS
46745	4720	25	,	,	,
46745	4720	26	_	_	NNP
46745	4720	27	i.e.	i.e.	FW
46745	4720	28	_	_	NNP
46745	4720	29	those	those	DT
46745	4720	30	of	of	IN
46745	4720	31	the	the	DT
46745	4720	32	lungs	lung	NNS
46745	4720	33	and	and	CC
46745	4720	34	of	of	IN
46745	4720	35	the	the	DT
46745	4720	36	cutaneous	cutaneous	JJ
46745	4720	37	surface	surface	NN
46745	4720	38	.	.	.
46745	4721	1	(	(	-LRB-
46745	4721	2	_	_	NNP
46745	4721	3	Vide	Vide	NNP
46745	4721	4	_	_	NNP
46745	4721	5	pp	pp	NNP
46745	4721	6	.	.	.
46745	4722	1	278	278	CD
46745	4722	2	,	,	,
46745	4722	3	285	285	CD
46745	4722	4	.	.	.
46745	4722	5	)	)	-RRB-
46745	4723	1	Ammonia	Ammonia	NNP
46745	4723	2	and	and	CC
46745	4723	3	its	-PRON-	PRP$
46745	4723	4	various	various	JJ
46745	4723	5	salts	salt	NNS
46745	4723	6	are	be	VBP
46745	4723	7	very	very	RB
46745	4723	8	useful	useful	JJ
46745	4723	9	as	as	IN
46745	4723	10	Diaphoretics	Diaphoretics	NNP
46745	4723	11	.	.	.
46745	4724	1	Volatile	volatile	JJ
46745	4724	2	oils	oil	NNS
46745	4724	3	are	be	VBP
46745	4724	4	less	less	RBR
46745	4724	5	energetic	energetic	JJ
46745	4724	6	,	,	,
46745	4724	7	for	for	IN
46745	4724	8	they	-PRON-	PRP
46745	4724	9	often	often	RB
46745	4724	10	pass	pass	VBP
46745	4724	11	off	off	RP
46745	4724	12	with	with	IN
46745	4724	13	such	such	JJ
46745	4724	14	ease	ease	NN
46745	4724	15	as	as	IN
46745	4724	16	not	not	RB
46745	4724	17	sensibly	sensibly	RB
46745	4724	18	to	to	TO
46745	4724	19	increase	increase	VB
46745	4724	20	the	the	DT
46745	4724	21	secretion	secretion	NN
46745	4724	22	of	of	IN
46745	4724	23	the	the	DT
46745	4724	24	skin	skin	NN
46745	4724	25	.	.	.
46745	4725	1	Some	some	DT
46745	4725	2	acrid	acrid	JJ
46745	4725	3	matters	matter	VBZ
46745	4725	4	,	,	,
46745	4725	5	as	as	IN
46745	4725	6	Guaiacum	Guaiacum	NNP
46745	4725	7	,	,	,
46745	4725	8	Mezereon	Mezereon	NNP
46745	4725	9	,	,	,
46745	4725	10	and	and	CC
46745	4725	11	Senega	Senega	NNP
46745	4725	12	,	,	,
46745	4725	13	appear	appear	VBP
46745	4725	14	to	to	TO
46745	4725	15	act	act	VB
46745	4725	16	specifically	specifically	RB
46745	4725	17	on	on	IN
46745	4725	18	the	the	DT
46745	4725	19	function	function	NN
46745	4725	20	of	of	IN
46745	4725	21	the	the	DT
46745	4725	22	skin	skin	NN
46745	4725	23	.	.	.
46745	4726	1	So	so	RB
46745	4726	2	also	also	RB
46745	4726	3	do	do	VBP
46745	4726	4	certain	certain	JJ
46745	4726	5	Narcotics	Narcotics	NNP
46745	4726	6	,	,	,
46745	4726	7	among	among	IN
46745	4726	8	which	which	WDT
46745	4726	9	Opium	Opium	NNP
46745	4726	10	is	be	VBZ
46745	4726	11	conspicuous	conspicuous	JJ
46745	4726	12	as	as	IN
46745	4726	13	the	the	DT
46745	4726	14	most	most	RBS
46745	4726	15	certain	certain	JJ
46745	4726	16	Diaphoretic	diaphoretic	JJ
46745	4726	17	that	that	IN
46745	4726	18	we	-PRON-	PRP
46745	4726	19	possess	possess	VBP
46745	4726	20	,	,	,
46745	4726	21	though	though	IN
46745	4726	22	its	-PRON-	PRP$
46745	4726	23	other	other	JJ
46745	4726	24	operations	operation	NNS
46745	4726	25	prevent	prevent	VBP
46745	4726	26	it	-PRON-	PRP
46745	4726	27	from	from	IN
46745	4726	28	being	be	VBG
46745	4726	29	applicable	applicable	JJ
46745	4726	30	in	in	IN
46745	4726	31	all	all	DT
46745	4726	32	cases	case	NNS
46745	4726	33	.	.	.
46745	4727	1	Antimony	Antimony	NNP
46745	4727	2	,	,	,
46745	4727	3	Mercury	Mercury	NNP
46745	4727	4	,	,	,
46745	4727	5	and	and	CC
46745	4727	6	Sulphur	Sulphur	NNP
46745	4727	7	,	,	,
46745	4727	8	are	be	VBP
46745	4727	9	medicines	medicine	NNS
46745	4727	10	which	which	WDT
46745	4727	11	appear	appear	VBP
46745	4727	12	to	to	IN
46745	4727	13	a	a	DT
46745	4727	14	greater	great	JJR
46745	4727	15	or	or	CC
46745	4727	16	less	less	JJR
46745	4727	17	degree	degree	NN
46745	4727	18	to	to	TO
46745	4727	19	increase	increase	VB
46745	4727	20	all	all	PDT
46745	4727	21	the	the	DT
46745	4727	22	secretions	secretion	NNS
46745	4727	23	in	in	IN
46745	4727	24	the	the	DT
46745	4727	25	body	body	NN
46745	4727	26	.	.	.
46745	4728	1	When	when	WRB
46745	4728	2	given	give	VBN
46745	4728	3	in	in	IN
46745	4728	4	the	the	DT
46745	4728	5	insoluble	insoluble	JJ
46745	4728	6	form	form	NN
46745	4728	7	,	,	,
46745	4728	8	they	-PRON-	PRP
46745	4728	9	are	be	VBP
46745	4728	10	reduced	reduce	VBN
46745	4728	11	by	by	IN
46745	4728	12	the	the	DT
46745	4728	13	system	system	NN
46745	4728	14	to	to	IN
46745	4728	15	a	a	DT
46745	4728	16	soluble	soluble	JJ
46745	4728	17	state	state	NN
46745	4728	18	.	.	.
46745	4729	1	When	when	WRB
46745	4729	2	Tartar	Tartar	NNP
46745	4729	3	Emetic	Emetic	NNP
46745	4729	4	is	be	VBZ
46745	4729	5	given	give	VBN
46745	4729	6	in	in	IN
46745	4729	7	small	small	JJ
46745	4729	8	doses	dose	NNS
46745	4729	9	,	,	,
46745	4729	10	its	-PRON-	PRP$
46745	4729	11	only	only	JJ
46745	4729	12	apparent	apparent	JJ
46745	4729	13	action	action	NN
46745	4729	14	is	be	VBZ
46745	4729	15	slightly	slightly	RB
46745	4729	16	to	to	TO
46745	4729	17	increase	increase	VB
46745	4729	18	the	the	DT
46745	4729	19	perspiration	perspiration	NN
46745	4729	20	.	.	.
46745	4730	1	It	-PRON-	PRP
46745	4730	2	is	be	VBZ
46745	4730	3	probable	probable	JJ
46745	4730	4	that	that	IN
46745	4730	5	it	-PRON-	PRP
46745	4730	6	then	then	RB
46745	4730	7	passes	pass	VBZ
46745	4730	8	out	out	RP
46745	4730	9	through	through	IN
46745	4730	10	the	the	DT
46745	4730	11	glands	gland	NNS
46745	4730	12	of	of	IN
46745	4730	13	the	the	DT
46745	4730	14	skin	skin	NN
46745	4730	15	.	.	.
46745	4731	1	When	when	WRB
46745	4731	2	given	give	VBN
46745	4731	3	in	in	IN
46745	4731	4	emetic	emetic	JJ
46745	4731	5	doses	dose	NNS
46745	4731	6	,	,	,
46745	4731	7	it	-PRON-	PRP
46745	4731	8	may	may	MD
46745	4731	9	produce	produce	VB
46745	4731	10	sweating	sweat	VBG
46745	4731	11	indirectly	indirectly	RB
46745	4731	12	,	,	,
46745	4731	13	as	as	IN
46745	4731	14	mentioned	mention	VBN
46745	4731	15	above	above	RB
46745	4731	16	.	.	.
46745	4732	1	Iodine	Iodine	NNP
46745	4732	2	,	,	,
46745	4732	3	which	which	WDT
46745	4732	4	also	also	RB
46745	4732	5	increases	increase	VBZ
46745	4732	6	secretion	secretion	NN
46745	4732	7	generally	generally	RB
46745	4732	8	,	,	,
46745	4732	9	acts	act	VBZ
46745	4732	10	sometimes	sometimes	RB
46745	4732	11	as	as	IN
46745	4732	12	a	a	DT
46745	4732	13	Diaphoretic	Diaphoretic	NNP
46745	4732	14	.	.	.
46745	4733	1	Many	many	JJ
46745	4733	2	volatile	volatile	JJ
46745	4733	3	oils	oil	NNS
46745	4733	4	have	have	VBP
46745	4733	5	been	be	VBN
46745	4733	6	detected	detect	VBN
46745	4733	7	by	by	IN
46745	4733	8	their	-PRON-	PRP$
46745	4733	9	odour	odour	NN
46745	4733	10	in	in	IN
46745	4733	11	the	the	DT
46745	4733	12	perspiration	perspiration	NN
46745	4733	13	,	,	,
46745	4733	14	as	as	IN
46745	4733	15	those	those	DT
46745	4733	16	of	of	IN
46745	4733	17	Garlic	Garlic	NNP
46745	4733	18	,	,	,
46745	4733	19	Onion	Onion	NNP
46745	4733	20	,	,	,
46745	4733	21	Asaf[oe]tida	Asaf[oe]tida	NNP
46745	4733	22	,	,	,
46745	4733	23	Musk	Musk	NNP
46745	4733	24	,	,	,
46745	4733	25	and	and	CC
46745	4733	26	Copaiba	Copaiba	NNP
46745	4733	27	.	.	.
46745	4734	1	Mercury	Mercury	NNP
46745	4734	2	,	,	,
46745	4734	3	Sulphur	Sulphur	NNP
46745	4734	4	,	,	,
46745	4734	5	and	and	CC
46745	4734	6	Iodine	Iodine	NNP
46745	4734	7	,	,	,
46745	4734	8	have	have	VBP
46745	4734	9	been	be	VBN
46745	4734	10	detected	detect	VBN
46745	4734	11	chemically	chemically	RB
46745	4734	12	in	in	IN
46745	4734	13	it	-PRON-	PRP
46745	4734	14	.	.	.
46745	4735	1	It	-PRON-	PRP
46745	4735	2	has	have	VBZ
46745	4735	3	happened	happen	VBN
46745	4735	4	,	,	,
46745	4735	5	when	when	WRB
46745	4735	6	a	a	DT
46745	4735	7	course	course	NN
46745	4735	8	of	of	IN
46745	4735	9	Mercury	Mercury	NNP
46745	4735	10	has	have	VBZ
46745	4735	11	followed	follow	VBN
46745	4735	12	the	the	DT
46745	4735	13	administration	administration	NN
46745	4735	14	of	of	IN
46745	4735	15	Sulphur	Sulphur	NNP
46745	4735	16	,	,	,
46745	4735	17	that	that	IN
46745	4735	18	parts	part	NNS
46745	4735	19	of	of	IN
46745	4735	20	the	the	DT
46745	4735	21	skin	skin	NN
46745	4735	22	have	have	VBP
46745	4735	23	turned	turn	VBN
46745	4735	24	black	black	JJ
46745	4735	25	,	,	,
46745	4735	26	from	from	IN
46745	4735	27	the	the	DT
46745	4735	28	formation	formation	NN
46745	4735	29	of	of	IN
46745	4735	30	Sulphuret	Sulphuret	NNP
46745	4735	31	of	of	IN
46745	4735	32	Mercury	Mercury	NNP
46745	4735	33	.	.	.
46745	4736	1	So	so	CC
46745	4736	2	it	-PRON-	PRP
46745	4736	3	is	be	VBZ
46745	4736	4	proved	prove	VBN
46745	4736	5	of	of	IN
46745	4736	6	many	many	JJ
46745	4736	7	of	of	IN
46745	4736	8	these	these	DT
46745	4736	9	Diaphoretics	diaphoretic	NNS
46745	4736	10	,	,	,
46745	4736	11	and	and	CC
46745	4736	12	thus	thus	RB
46745	4736	13	rendered	render	VBN
46745	4736	14	highly	highly	RB
46745	4736	15	probable	probable	JJ
46745	4736	16	of	of	IN
46745	4736	17	the	the	DT
46745	4736	18	rest	rest	NN
46745	4736	19	,	,	,
46745	4736	20	that	that	IN
46745	4736	21	they	-PRON-	PRP
46745	4736	22	are	be	VBP
46745	4736	23	true	true	JJ
46745	4736	24	Eliminatives	Eliminatives	NNPS
46745	4736	25	,	,	,
46745	4736	26	being	be	VBG
46745	4736	27	themselves	-PRON-	PRP
46745	4736	28	excreted	excrete	VBN
46745	4736	29	by	by	IN
46745	4736	30	the	the	DT
46745	4736	31	glands	gland	NNS
46745	4736	32	which	which	WDT
46745	4736	33	they	-PRON-	PRP
46745	4736	34	excite	excite	VBP
46745	4736	35	to	to	IN
46745	4736	36	action	action	NN
46745	4736	37	.	.	.
46745	4737	1	When	when	WRB
46745	4737	2	copious	copious	JJ
46745	4737	3	diaphoresis	diaphoresis	NN
46745	4737	4	has	have	VBZ
46745	4737	5	been	be	VBN
46745	4737	6	excited	excite	VBN
46745	4737	7	,	,	,
46745	4737	8	care	care	NN
46745	4737	9	should	should	MD
46745	4737	10	be	be	VB
46745	4737	11	taken	take	VBN
46745	4737	12	that	that	IN
46745	4737	13	it	-PRON-	PRP
46745	4737	14	be	be	VB
46745	4737	15	allowed	allow	VBN
46745	4737	16	to	to	TO
46745	4737	17	subside	subside	VB
46745	4737	18	gradually	gradually	RB
46745	4737	19	,	,	,
46745	4737	20	or	or	CC
46745	4737	21	the	the	DT
46745	4737	22	consequences	consequence	NNS
46745	4737	23	may	may	MD
46745	4737	24	be	be	VB
46745	4737	25	hurtful	hurtful	JJ
46745	4737	26	.	.	.
46745	4738	1	It	-PRON-	PRP
46745	4738	2	may	may	MD
46745	4738	3	be	be	VB
46745	4738	4	remarked	remark	VBN
46745	4738	5	that	that	IN
46745	4738	6	cleanliness	cleanliness	NN
46745	4738	7	of	of	IN
46745	4738	8	the	the	DT
46745	4738	9	surface	surface	NN
46745	4738	10	,	,	,
46745	4738	11	by	by	IN
46745	4738	12	which	which	WDT
46745	4738	13	the	the	DT
46745	4738	14	sudoriferous	sudoriferous	JJ
46745	4738	15	ducts	duct	NNS
46745	4738	16	are	be	VBP
46745	4738	17	kept	keep	VBN
46745	4738	18	open	open	JJ
46745	4738	19	and	and	CC
46745	4738	20	healthy	healthy	JJ
46745	4738	21	,	,	,
46745	4738	22	is	be	VBZ
46745	4738	23	highly	highly	RB
46745	4738	24	important	important	JJ
46745	4738	25	to	to	IN
46745	4738	26	the	the	DT
46745	4738	27	proper	proper	JJ
46745	4738	28	function	function	NN
46745	4738	29	of	of	IN
46745	4738	30	the	the	DT
46745	4738	31	skin	skin	NN
46745	4738	32	.	.	.
46745	4739	1	Diaphoretics	diaphoretic	NNS
46745	4739	2	are	be	VBP
46745	4739	3	useful	useful	JJ
46745	4739	4	in	in	IN
46745	4739	5	various	various	JJ
46745	4739	6	disorders	disorder	NNS
46745	4739	7	.	.	.
46745	4740	1	In	in	IN
46745	4740	2	what	what	WP
46745	4740	3	is	be	VBZ
46745	4740	4	called	call	VBN
46745	4740	5	_	_	NNP
46745	4740	6	a	a	DT
46745	4740	7	cold	cold	JJ
46745	4740	8	_	_	NNP
46745	4740	9	,	,	,
46745	4740	10	when	when	WRB
46745	4740	11	the	the	DT
46745	4740	12	function	function	NN
46745	4740	13	of	of	IN
46745	4740	14	the	the	DT
46745	4740	15	skin	skin	NN
46745	4740	16	has	have	VBZ
46745	4740	17	been	be	VBN
46745	4740	18	suddenly	suddenly	RB
46745	4740	19	interfered	interfere	VBN
46745	4740	20	with	with	IN
46745	4740	21	,	,	,
46745	4740	22	and	and	CC
46745	4740	23	the	the	DT
46745	4740	24	vaporous	vaporous	JJ
46745	4740	25	transpiration	transpiration	NN
46745	4740	26	is	be	VBZ
46745	4740	27	all	all	DT
46745	4740	28	thrown	throw	VBN
46745	4740	29	upon	upon	IN
46745	4740	30	the	the	DT
46745	4740	31	lungs	lung	NNS
46745	4740	32	,	,	,
46745	4740	33	producing	produce	VBG
46745	4740	34	irritation	irritation	NN
46745	4740	35	or	or	CC
46745	4740	36	inflammation	inflammation	NN
46745	4740	37	of	of	IN
46745	4740	38	the	the	DT
46745	4740	39	respiratory	respiratory	JJ
46745	4740	40	mucous	mucous	JJ
46745	4740	41	surface	surface	NN
46745	4740	42	,	,	,
46745	4740	43	Diaphoretics	diaphoretic	NNS
46745	4740	44	are	be	VBP
46745	4740	45	generally	generally	RB
46745	4740	46	required	require	VBN
46745	4740	47	.	.	.
46745	4741	1	In	in	IN
46745	4741	2	Fevers	fever	NNS
46745	4741	3	,	,	,
46745	4741	4	and	and	CC
46745	4741	5	some	some	DT
46745	4741	6	other	other	JJ
46745	4741	7	disorders	disorder	NNS
46745	4741	8	,	,	,
46745	4741	9	as	as	IN
46745	4741	10	Gout	Gout	NNP
46745	4741	11	and	and	CC
46745	4741	12	Rheumatism	Rheumatism	NNP
46745	4741	13	,	,	,
46745	4741	14	which	which	WDT
46745	4741	15	are	be	VBP
46745	4741	16	apt	apt	JJ
46745	4741	17	to	to	TO
46745	4741	18	improve	improve	VB
46745	4741	19	or	or	CC
46745	4741	20	to	to	TO
46745	4741	21	pass	pass	VB
46745	4741	22	off	off	RP
46745	4741	23	with	with	IN
46745	4741	24	an	an	DT
46745	4741	25	increase	increase	NN
46745	4741	26	of	of	IN
46745	4741	27	perspiration	perspiration	NN
46745	4741	28	,	,	,
46745	4741	29	and	and	CC
46745	4741	30	in	in	IN
46745	4741	31	which	which	WDT
46745	4741	32	it	-PRON-	PRP
46745	4741	33	often	often	RB
46745	4741	34	seems	seem	VBZ
46745	4741	35	likely	likely	JJ
46745	4741	36	that	that	IN
46745	4741	37	some	some	DT
46745	4741	38	morbid	morbid	NN
46745	4741	39	material	material	NN
46745	4741	40	may	may	MD
46745	4741	41	be	be	VB
46745	4741	42	eliminated	eliminate	VBN
46745	4741	43	by	by	IN
46745	4741	44	this	this	DT
46745	4741	45	channel	channel	NN
46745	4741	46	,	,	,
46745	4741	47	the	the	DT
46745	4741	48	same	same	JJ
46745	4741	49	medicines	medicine	NNS
46745	4741	50	are	be	VBP
46745	4741	51	constantly	constantly	RB
46745	4741	52	necessary	necessary	JJ
46745	4741	53	.	.	.
46745	4742	1	When	when	WRB
46745	4742	2	another	another	DT
46745	4742	3	secretion	secretion	NN
46745	4742	4	is	be	VBZ
46745	4742	5	unduly	unduly	RB
46745	4742	6	copious	copious	JJ
46745	4742	7	,	,	,
46745	4742	8	an	an	DT
46745	4742	9	increase	increase	NN
46745	4742	10	in	in	IN
46745	4742	11	the	the	DT
46745	4742	12	sweat	sweat	NN
46745	4742	13	may	may	MD
46745	4742	14	cause	cause	VB
46745	4742	15	it	-PRON-	PRP
46745	4742	16	to	to	TO
46745	4742	17	diminish	diminish	VB
46745	4742	18	.	.	.
46745	4743	1	Thus	thus	RB
46745	4743	2	in	in	IN
46745	4743	3	some	some	DT
46745	4743	4	cases	case	NNS
46745	4743	5	of	of	IN
46745	4743	6	diarrh[oe]a	diarrh[oe]a	NNP
46745	4743	7	,	,	,
46745	4743	8	and	and	CC
46745	4743	9	still	still	RB
46745	4743	10	more	more	JJR
46745	4743	11	in	in	IN
46745	4743	12	diabetes	diabetes	NN
46745	4743	13	,	,	,
46745	4743	14	Diaphoretics	diaphoretic	NNS
46745	4743	15	are	be	VBP
46745	4743	16	appropriate	appropriate	JJ
46745	4743	17	.	.	.
46745	4744	1	In	in	IN
46745	4744	2	contrary	contrary	JJ
46745	4744	3	conditions	condition	NNS
46745	4744	4	,	,	,
46745	4744	5	as	as	IN
46745	4744	6	when	when	WRB
46745	4744	7	the	the	DT
46745	4744	8	formation	formation	NN
46745	4744	9	of	of	IN
46745	4744	10	urine	urine	NN
46745	4744	11	is	be	VBZ
46745	4744	12	unnaturally	unnaturally	RB
46745	4744	13	small	small	JJ
46745	4744	14	,	,	,
46745	4744	15	on	on	IN
46745	4744	16	account	account	NN
46745	4744	17	of	of	IN
46745	4744	18	granular	granular	JJ
46745	4744	19	degeneration	degeneration	NN
46745	4744	20	of	of	IN
46745	4744	21	the	the	DT
46745	4744	22	kidney	kidney	NN
46745	4744	23	,	,	,
46745	4744	24	it	-PRON-	PRP
46745	4744	25	is	be	VBZ
46745	4744	26	again	again	RB
46745	4744	27	important	important	JJ
46745	4744	28	to	to	TO
46745	4744	29	stimulate	stimulate	VB
46745	4744	30	the	the	DT
46745	4744	31	secretion	secretion	NN
46745	4744	32	of	of	IN
46745	4744	33	the	the	DT
46745	4744	34	skin	skin	NN
46745	4744	35	,	,	,
46745	4744	36	that	that	IN
46745	4744	37	it	-PRON-	PRP
46745	4744	38	may	may	MD
46745	4744	39	,	,	,
46745	4744	40	if	if	IN
46745	4744	41	possible	possible	JJ
46745	4744	42	,	,	,
46745	4744	43	be	be	VB
46745	4744	44	able	able	JJ
46745	4744	45	to	to	TO
46745	4744	46	replace	replace	VB
46745	4744	47	the	the	DT
46745	4744	48	other	other	JJ
46745	4744	49	.	.	.
46745	4745	1	(	(	-LRB-
46745	4745	2	_	_	NNP
46745	4745	3	Vide	Vide	NNP
46745	4745	4	_	_	NNP
46745	4745	5	p.	p.	NN
46745	4746	1	280	280	CD
46745	4746	2	.	.	.
46745	4746	3	)	)	-RRB-
46745	4747	1	ORD	ORD	NNP
46745	4747	2	.	.	.
46745	4748	1	VI	VI	NNP
46745	4748	2	.	.	.
46745	4749	1	DIURETICS	diuretics	UH
46745	4749	2	.	.	.
46745	4750	1	These	these	DT
46745	4750	2	are	be	VBP
46745	4750	3	medicines	medicine	NNS
46745	4750	4	which	which	WDT
46745	4750	5	tend	tend	VBP
46745	4750	6	to	to	TO
46745	4750	7	increase	increase	VB
46745	4750	8	the	the	DT
46745	4750	9	secretion	secretion	NN
46745	4750	10	of	of	IN
46745	4750	11	urine	urine	NN
46745	4750	12	.	.	.
46745	4751	1	By	by	IN
46745	4751	2	means	mean	NNS
46745	4751	3	of	of	IN
46745	4751	4	the	the	DT
46745	4751	5	kidneys	kidney	NNS
46745	4751	6	a	a	DT
46745	4751	7	large	large	JJ
46745	4751	8	amount	amount	NN
46745	4751	9	of	of	IN
46745	4751	10	aqueous	aqueous	JJ
46745	4751	11	material	material	NN
46745	4751	12	is	be	VBZ
46745	4751	13	every	every	DT
46745	4751	14	day	day	NN
46745	4751	15	separated	separate	VBN
46745	4751	16	from	from	IN
46745	4751	17	the	the	DT
46745	4751	18	blood	blood	NN
46745	4751	19	,	,	,
46745	4751	20	and	and	CC
46745	4751	21	excreted	excrete	VBD
46745	4751	22	.	.	.
46745	4752	1	This	this	DT
46745	4752	2	water	water	NN
46745	4752	3	is	be	VBZ
46745	4752	4	in	in	IN
46745	4752	5	the	the	DT
46745	4752	6	first	first	JJ
46745	4752	7	instance	instance	NN
46745	4752	8	absorbed	absorb	VBN
46745	4752	9	by	by	IN
46745	4752	10	the	the	DT
46745	4752	11	surface	surface	NN
46745	4752	12	of	of	IN
46745	4752	13	the	the	DT
46745	4752	14	stomach	stomach	NN
46745	4752	15	and	and	CC
46745	4752	16	intestine	intestine	NN
46745	4752	17	.	.	.
46745	4753	1	The	the	DT
46745	4753	2	causes	cause	NNS
46745	4753	3	which	which	WDT
46745	4753	4	demand	demand	VBP
46745	4753	5	its	-PRON-	PRP$
46745	4753	6	excretion	excretion	NN
46745	4753	7	are	be	VBP
46745	4753	8	twofold	twofold	JJ
46745	4753	9	.	.	.
46745	4754	1	In	in	IN
46745	4754	2	the	the	DT
46745	4754	3	first	first	JJ
46745	4754	4	place	place	NN
46745	4754	5	,	,	,
46745	4754	6	it	-PRON-	PRP
46745	4754	7	is	be	VBZ
46745	4754	8	necessary	necessary	JJ
46745	4754	9	that	that	IN
46745	4754	10	the	the	DT
46745	4754	11	blood	blood	NN
46745	4754	12	should	should	MD
46745	4754	13	be	be	VB
46745	4754	14	kept	keep	VBN
46745	4754	15	down	down	RP
46745	4754	16	to	to	IN
46745	4754	17	its	-PRON-	PRP$
46745	4754	18	normal	normal	JJ
46745	4754	19	standard	standard	NN
46745	4754	20	as	as	IN
46745	4754	21	regards	regard	VBZ
46745	4754	22	water	water	NN
46745	4754	23	,	,	,
46745	4754	24	and	and	CC
46745	4754	25	that	that	IN
46745	4754	26	the	the	DT
46745	4754	27	surplus	surplus	NN
46745	4754	28	fluid	fluid	NN
46745	4754	29	which	which	WDT
46745	4754	30	is	be	VBZ
46745	4754	31	daily	daily	RB
46745	4754	32	added	add	VBN
46745	4754	33	to	to	IN
46745	4754	34	it	-PRON-	PRP
46745	4754	35	should	should	MD
46745	4754	36	be	be	VB
46745	4754	37	removed	remove	VBN
46745	4754	38	.	.	.
46745	4755	1	Secondly	secondly	RB
46745	4755	2	,	,	,
46745	4755	3	this	this	DT
46745	4755	4	water	water	NN
46745	4755	5	is	be	VBZ
46745	4755	6	required	require	VBN
46745	4755	7	in	in	IN
46745	4755	8	the	the	DT
46745	4755	9	urine	urine	NN
46745	4755	10	as	as	IN
46745	4755	11	a	a	DT
46745	4755	12	vehicle	vehicle	NN
46745	4755	13	,	,	,
46745	4755	14	to	to	TO
46745	4755	15	hold	hold	VB
46745	4755	16	in	in	RP
46745	4755	17	solution	solution	NN
46745	4755	18	there	there	RB
46745	4755	19	certain	certain	JJ
46745	4755	20	soluble	soluble	JJ
46745	4755	21	matters	matter	NNS
46745	4755	22	which	which	WDT
46745	4755	23	are	be	VBP
46745	4755	24	continually	continually	RB
46745	4755	25	forming	form	VBG
46745	4755	26	in	in	IN
46745	4755	27	the	the	DT
46745	4755	28	blood	blood	NN
46745	4755	29	,	,	,
46745	4755	30	or	or	CC
46745	4755	31	being	be	VBG
46745	4755	32	received	receive	VBN
46745	4755	33	into	into	IN
46745	4755	34	it	-PRON-	PRP
46745	4755	35	,	,	,
46745	4755	36	but	but	CC
46745	4755	37	which	which	WDT
46745	4755	38	have	have	VBP
46745	4755	39	to	to	TO
46745	4755	40	be	be	VB
46745	4755	41	excreted	excrete	VBN
46745	4755	42	from	from	IN
46745	4755	43	it	-PRON-	PRP
46745	4755	44	by	by	IN
46745	4755	45	means	mean	NNS
46745	4755	46	of	of	IN
46745	4755	47	the	the	DT
46745	4755	48	kidneys	kidney	NNS
46745	4755	49	.	.	.
46745	4756	1	These	these	DT
46745	4756	2	matters	matter	NNS
46745	4756	3	comprehend	comprehend	VBP
46745	4756	4	a	a	DT
46745	4756	5	variety	variety	NN
46745	4756	6	of	of	IN
46745	4756	7	salts,--and	salts,--and	NN
46745	4756	8	a	a	DT
46745	4756	9	number	number	NN
46745	4756	10	of	of	IN
46745	4756	11	nitrogenous	nitrogenous	JJ
46745	4756	12	substances	substance	NNS
46745	4756	13	,	,	,
46745	4756	14	of	of	IN
46745	4756	15	which	which	WDT
46745	4756	16	the	the	DT
46745	4756	17	best	well	RBS
46745	4756	18	-	-	HYPH
46745	4756	19	known	know	VBN
46745	4756	20	are	be	VBP
46745	4756	21	urea	urea	NNP
46745	4756	22	and	and	CC
46745	4756	23	uric	uric	JJ
46745	4756	24	acid	acid	NN
46745	4756	25	.	.	.
46745	4757	1	These	these	DT
46745	4757	2	last	last	JJ
46745	4757	3	are	be	VBP
46745	4757	4	formed	form	VBN
46745	4757	5	in	in	IN
46745	4757	6	the	the	DT
46745	4757	7	blood	blood	NN
46745	4757	8	by	by	IN
46745	4757	9	the	the	DT
46745	4757	10	gradual	gradual	JJ
46745	4757	11	decomposition	decomposition	NN
46745	4757	12	or	or	CC
46745	4757	13	change	change	NN
46745	4757	14	of	of	IN
46745	4757	15	the	the	DT
46745	4757	16	animal	animal	NN
46745	4757	17	tissues	tissue	NNS
46745	4757	18	through	through	IN
46745	4757	19	which	which	WDT
46745	4757	20	it	-PRON-	PRP
46745	4757	21	flows	flow	VBZ
46745	4757	22	.	.	.
46745	4758	1	When	when	WRB
46745	4758	2	retained	retain	VBN
46745	4758	3	in	in	IN
46745	4758	4	the	the	DT
46745	4758	5	circulation	circulation	NN
46745	4758	6	,	,	,
46745	4758	7	on	on	IN
46745	4758	8	account	account	NN
46745	4758	9	of	of	IN
46745	4758	10	a	a	DT
46745	4758	11	failure	failure	NN
46745	4758	12	of	of	IN
46745	4758	13	the	the	DT
46745	4758	14	function	function	NN
46745	4758	15	of	of	IN
46745	4758	16	the	the	DT
46745	4758	17	kidneys	kidney	NNS
46745	4758	18	,	,	,
46745	4758	19	they	-PRON-	PRP
46745	4758	20	act	act	VBP
46745	4758	21	as	as	IN
46745	4758	22	poisons	poison	NNS
46745	4758	23	.	.	.
46745	4759	1	The	the	DT
46745	4759	2	kidneys	kidney	NNS
46745	4759	3	are	be	VBP
46745	4759	4	the	the	DT
46745	4759	5	chief	chief	JJ
46745	4759	6	emunctories	emunctorie	NNS
46745	4759	7	of	of	IN
46745	4759	8	water	water	NN
46745	4759	9	;	;	:
46745	4759	10	and	and	CC
46745	4759	11	mineral	mineral	NN
46745	4759	12	substances	substance	NNS
46745	4759	13	which	which	WDT
46745	4759	14	are	be	VBP
46745	4759	15	soluble	soluble	JJ
46745	4759	16	in	in	IN
46745	4759	17	water	water	NN
46745	4759	18	tend	tend	VB
46745	4759	19	for	for	IN
46745	4759	20	this	this	DT
46745	4759	21	reason	reason	NN
46745	4759	22	to	to	TO
46745	4759	23	pass	pass	VB
46745	4759	24	out	out	RP
46745	4759	25	into	into	IN
46745	4759	26	the	the	DT
46745	4759	27	urine	urine	NN
46745	4759	28	.	.	.
46745	4760	1	Many	many	JJ
46745	4760	2	of	of	IN
46745	4760	3	these	these	DT
46745	4760	4	,	,	,
46745	4760	5	as	as	IN
46745	4760	6	the	the	DT
46745	4760	7	salts	salt	NNS
46745	4760	8	of	of	IN
46745	4760	9	Iron	Iron	NNP
46745	4760	10	,	,	,
46745	4760	11	Silver	Silver	NNP
46745	4760	12	,	,	,
46745	4760	13	Lead	Lead	NNP
46745	4760	14	,	,	,
46745	4760	15	and	and	CC
46745	4760	16	Copper	Copper	NNP
46745	4760	17	,	,	,
46745	4760	18	are	be	VBP
46745	4760	19	Astringents	astringent	NNS
46745	4760	20	,	,	,
46745	4760	21	and	and	CC
46745	4760	22	tend	tend	VB
46745	4760	23	to	to	TO
46745	4760	24	diminish	diminish	VB
46745	4760	25	rather	rather	RB
46745	4760	26	than	than	IN
46745	4760	27	to	to	TO
46745	4760	28	increase	increase	VB
46745	4760	29	the	the	DT
46745	4760	30	amount	amount	NN
46745	4760	31	of	of	IN
46745	4760	32	urine	urine	NN
46745	4760	33	.	.	.
46745	4761	1	But	but	CC
46745	4761	2	the	the	DT
46745	4761	3	urine	urine	NN
46745	4761	4	is	be	VBZ
46745	4761	5	so	so	RB
46745	4761	6	necessary	necessary	JJ
46745	4761	7	and	and	CC
46745	4761	8	so	so	RB
46745	4761	9	constant	constant	JJ
46745	4761	10	a	a	DT
46745	4761	11	secretion	secretion	NN
46745	4761	12	,	,	,
46745	4761	13	that	that	IN
46745	4761	14	it	-PRON-	PRP
46745	4761	15	is	be	VBZ
46745	4761	16	very	very	RB
46745	4761	17	difficult	difficult	JJ
46745	4761	18	to	to	TO
46745	4761	19	diminish	diminish	VB
46745	4761	20	it	-PRON-	PRP
46745	4761	21	in	in	IN
46745	4761	22	quantity	quantity	NN
46745	4761	23	.	.	.
46745	4762	1	Saline	saline	JJ
46745	4762	2	medicines	medicine	NNS
46745	4762	3	act	act	VBP
46745	4762	4	as	as	IN
46745	4762	5	Diuretics	diuretic	NNS
46745	4762	6	under	under	IN
46745	4762	7	certain	certain	JJ
46745	4762	8	conditions	condition	NNS
46745	4762	9	.	.	.
46745	4763	1	So	so	RB
46745	4763	2	also	also	RB
46745	4763	3	do	do	VB
46745	4763	4	acids	acid	NNS
46745	4763	5	and	and	CC
46745	4763	6	alkalies	alkali	NNS
46745	4763	7	,	,	,
46745	4763	8	and	and	CC
46745	4763	9	many	many	JJ
46745	4763	10	vegetable	vegetable	JJ
46745	4763	11	substances	substance	NNS
46745	4763	12	,	,	,
46745	4763	13	which	which	WDT
46745	4763	14	will	will	MD
46745	4763	15	be	be	VB
46745	4763	16	presently	presently	RB
46745	4763	17	spoken	speak	VBN
46745	4763	18	of	of	IN
46745	4763	19	.	.	.
46745	4764	1	The	the	DT
46745	4764	2	soluble	soluble	JJ
46745	4764	3	substances	substance	NNS
46745	4764	4	which	which	WDT
46745	4764	5	thus	thus	RB
46745	4764	6	pass	pass	VBP
46745	4764	7	off	off	RP
46745	4764	8	in	in	IN
46745	4764	9	the	the	DT
46745	4764	10	urine	urine	NN
46745	4764	11	,	,	,
46745	4764	12	and	and	CC
46745	4764	13	act	act	VB
46745	4764	14	as	as	IN
46745	4764	15	Diuretics	Diuretics	NNP
46745	4764	16	,	,	,
46745	4764	17	are	be	VBP
46745	4764	18	many	many	JJ
46745	4764	19	in	in	IN
46745	4764	20	number	number	NN
46745	4764	21	,	,	,
46745	4764	22	but	but	CC
46745	4764	23	they	-PRON-	PRP
46745	4764	24	are	be	VBP
46745	4764	25	all	all	RB
46745	4764	26	uncertain	uncertain	JJ
46745	4764	27	in	in	IN
46745	4764	28	action	action	NN
46745	4764	29	,	,	,
46745	4764	30	for	for	IN
46745	4764	31	several	several	JJ
46745	4764	32	reasons	reason	NNS
46745	4764	33	.	.	.
46745	4765	1	The	the	DT
46745	4765	2	amount	amount	NN
46745	4765	3	of	of	IN
46745	4765	4	the	the	DT
46745	4765	5	urine	urine	NN
46745	4765	6	depends	depend	VBZ
46745	4765	7	very	very	RB
46745	4765	8	much	much	RB
46745	4765	9	on	on	IN
46745	4765	10	the	the	DT
46745	4765	11	quantity	quantity	NN
46745	4765	12	of	of	IN
46745	4765	13	water	water	NN
46745	4765	14	taken	take	VBN
46745	4765	15	into	into	IN
46745	4765	16	the	the	DT
46745	4765	17	stomach	stomach	NN
46745	4765	18	,	,	,
46745	4765	19	or	or	CC
46745	4765	20	absorbed	absorb	VBN
46745	4765	21	from	from	IN
46745	4765	22	the	the	DT
46745	4765	23	atmosphere	atmosphere	NN
46745	4765	24	through	through	IN
46745	4765	25	the	the	DT
46745	4765	26	skin	skin	NN
46745	4765	27	;	;	:
46745	4765	28	so	so	IN
46745	4765	29	that	that	IN
46745	4765	30	when	when	WRB
46745	4765	31	there	there	EX
46745	4765	32	is	be	VBZ
46745	4765	33	not	not	RB
46745	4765	34	a	a	DT
46745	4765	35	sufficient	sufficient	JJ
46745	4765	36	quantity	quantity	NN
46745	4765	37	of	of	IN
46745	4765	38	water	water	NN
46745	4765	39	in	in	IN
46745	4765	40	the	the	DT
46745	4765	41	system	system	NN
46745	4765	42	,	,	,
46745	4765	43	it	-PRON-	PRP
46745	4765	44	is	be	VBZ
46745	4765	45	impossible	impossible	JJ
46745	4765	46	for	for	IN
46745	4765	47	more	more	JJR
46745	4765	48	urine	urine	NN
46745	4765	49	to	to	TO
46745	4765	50	be	be	VB
46745	4765	51	formed	form	VBN
46745	4765	52	.	.	.
46745	4766	1	This	this	DT
46745	4766	2	necessary	necessary	JJ
46745	4766	3	absorption	absorption	NN
46745	4766	4	of	of	IN
46745	4766	5	water	water	NN
46745	4766	6	depends	depend	VBZ
46745	4766	7	again	again	RB
46745	4766	8	upon	upon	IN
46745	4766	9	the	the	DT
46745	4766	10	pressure	pressure	NN
46745	4766	11	of	of	IN
46745	4766	12	the	the	DT
46745	4766	13	circulation	circulation	NN
46745	4766	14	;	;	:
46745	4766	15	when	when	WRB
46745	4766	16	this	this	DT
46745	4766	17	is	be	VBZ
46745	4766	18	too	too	RB
46745	4766	19	great	great	JJ
46745	4766	20	,	,	,
46745	4766	21	it	-PRON-	PRP
46745	4766	22	can	can	MD
46745	4766	23	not	not	RB
46745	4766	24	go	go	VB
46745	4766	25	on	on	RP
46745	4766	26	,	,	,
46745	4766	27	and	and	CC
46745	4766	28	the	the	DT
46745	4766	29	urine	urine	NN
46745	4766	30	is	be	VBZ
46745	4766	31	diminished	diminish	VBN
46745	4766	32	.	.	.
46745	4767	1	A	a	DT
46745	4767	2	large	large	JJ
46745	4767	3	increase	increase	NN
46745	4767	4	in	in	IN
46745	4767	5	any	any	DT
46745	4767	6	other	other	JJ
46745	4767	7	of	of	IN
46745	4767	8	the	the	DT
46745	4767	9	secretions	secretion	NNS
46745	4767	10	,	,	,
46745	4767	11	as	as	IN
46745	4767	12	that	that	DT
46745	4767	13	of	of	IN
46745	4767	14	the	the	DT
46745	4767	15	bowels,--but	bowels,--but	NNP
46745	4767	16	particularly	particularly	RB
46745	4767	17	of	of	IN
46745	4767	18	the	the	DT
46745	4767	19	skin	skin	NN
46745	4767	20	,	,	,
46745	4767	21	as	as	IN
46745	4767	22	in	in	IN
46745	4767	23	warm	warm	JJ
46745	4767	24	dry	dry	JJ
46745	4767	25	weather,--hinders	weather,--hinder	NNS
46745	4767	26	diuresis	diuresis	NN
46745	4767	27	.	.	.
46745	4768	1	The	the	DT
46745	4768	2	secretion	secretion	NN
46745	4768	3	of	of	IN
46745	4768	4	the	the	DT
46745	4768	5	urine	urine	NN
46745	4768	6	is	be	VBZ
46745	4768	7	favoured	favour	VBN
46745	4768	8	by	by	IN
46745	4768	9	those	those	DT
46745	4768	10	conditions	condition	NNS
46745	4768	11	which	which	WDT
46745	4768	12	repress	repress	VBP
46745	4768	13	the	the	DT
46745	4768	14	perspiration	perspiration	NN
46745	4768	15	;	;	:
46745	4768	16	as	as	IN
46745	4768	17	by	by	IN
46745	4768	18	coldness	coldness	NN
46745	4768	19	of	of	IN
46745	4768	20	the	the	DT
46745	4768	21	surface	surface	NN
46745	4768	22	,	,	,
46745	4768	23	light	light	JJ
46745	4768	24	clothing	clothing	NN
46745	4768	25	,	,	,
46745	4768	26	a	a	DT
46745	4768	27	cold	cold	JJ
46745	4768	28	and	and	CC
46745	4768	29	damp	damp	JJ
46745	4768	30	condition	condition	NN
46745	4768	31	of	of	IN
46745	4768	32	the	the	DT
46745	4768	33	atmosphere	atmosphere	NN
46745	4768	34	,	,	,
46745	4768	35	and	and	CC
46745	4768	36	the	the	DT
46745	4768	37	erect	erect	NN
46745	4768	38	posture	posture	NN
46745	4768	39	.	.	.
46745	4769	1	In	in	IN
46745	4769	2	the	the	DT
46745	4769	3	fourth	fourth	JJ
46745	4769	4	place	place	NN
46745	4769	5	,	,	,
46745	4769	6	the	the	DT
46745	4769	7	urine	urine	NN
46745	4769	8	is	be	VBZ
46745	4769	9	diminished	diminish	VBN
46745	4769	10	by	by	IN
46745	4769	11	causes	cause	NNS
46745	4769	12	which	which	WDT
46745	4769	13	impede	impede	VBZ
46745	4769	14	the	the	DT
46745	4769	15	circulation	circulation	NN
46745	4769	16	,	,	,
46745	4769	17	as	as	IN
46745	4769	18	by	by	IN
46745	4769	19	congestion	congestion	NN
46745	4769	20	of	of	IN
46745	4769	21	the	the	DT
46745	4769	22	kidney	kidney	NN
46745	4769	23	or	or	CC
46745	4769	24	liver,--or	liver,--or	NN
46745	4769	25	of	of	IN
46745	4769	26	the	the	DT
46745	4769	27	whole	whole	JJ
46745	4769	28	venous	venous	JJ
46745	4769	29	system	system	NN
46745	4769	30	,	,	,
46745	4769	31	on	on	IN
46745	4769	32	account	account	NN
46745	4769	33	of	of	IN
46745	4769	34	obstruction	obstruction	NN
46745	4769	35	in	in	IN
46745	4769	36	the	the	DT
46745	4769	37	heart,--conditions	heart,--conditions	NNPS
46745	4769	38	which	which	WDT
46745	4769	39	produce	produce	VBP
46745	4769	40	dropsy	dropsy	JJ
46745	4769	41	.	.	.
46745	4770	1	Those	those	DT
46745	4770	2	medicines	medicine	NNS
46745	4770	3	act	act	VBP
46745	4770	4	as	as	IN
46745	4770	5	indirect	indirect	JJ
46745	4770	6	Diuretics	Diuretics	NNP
46745	4770	7	,	,	,
46745	4770	8	which	which	WDT
46745	4770	9	,	,	,
46745	4770	10	by	by	IN
46745	4770	11	favouring	favour	VBG
46745	4770	12	the	the	DT
46745	4770	13	removal	removal	NN
46745	4770	14	of	of	IN
46745	4770	15	one	one	CD
46745	4770	16	of	of	IN
46745	4770	17	these	these	DT
46745	4770	18	hindering	hinder	VBG
46745	4770	19	causes	cause	NNS
46745	4770	20	,	,	,
46745	4770	21	tend	tend	VBP
46745	4770	22	to	to	TO
46745	4770	23	allow	allow	VB
46745	4770	24	the	the	DT
46745	4770	25	secretion	secretion	NN
46745	4770	26	of	of	IN
46745	4770	27	urine	urine	NN
46745	4770	28	to	to	TO
46745	4770	29	go	go	VB
46745	4770	30	on	on	RP
46745	4770	31	as	as	IN
46745	4770	32	in	in	IN
46745	4770	33	health	health	NN
46745	4770	34	.	.	.
46745	4771	1	The	the	DT
46745	4771	2	powerful	powerful	JJ
46745	4771	3	action	action	NN
46745	4771	4	of	of	IN
46745	4771	5	the	the	DT
46745	4771	6	heart	heart	NN
46745	4771	7	in	in	IN
46745	4771	8	fevers	fever	NNS
46745	4771	9	and	and	CC
46745	4771	10	inflammations	inflammation	NNS
46745	4771	11	causes	cause	VBZ
46745	4771	12	such	such	PDT
46745	4771	13	a	a	DT
46745	4771	14	pressure	pressure	NN
46745	4771	15	on	on	IN
46745	4771	16	the	the	DT
46745	4771	17	vessels	vessel	NNS
46745	4771	18	as	as	IN
46745	4771	19	to	to	TO
46745	4771	20	retard	retard	VB
46745	4771	21	absorption	absorption	NN
46745	4771	22	,	,	,
46745	4771	23	and	and	CC
46745	4771	24	thus	thus	RB
46745	4771	25	hinders	hinder	VBZ
46745	4771	26	diuresis	diuresis	NN
46745	4771	27	.	.	.
46745	4772	1	A	a	DT
46745	4772	2	hard	hard	JJ
46745	4772	3	bounding	bounding	NN
46745	4772	4	pulse	pulse	NN
46745	4772	5	and	and	CC
46745	4772	6	hot	hot	JJ
46745	4772	7	skin	skin	NN
46745	4772	8	favour	favour	NN
46745	4772	9	sweating	sweat	VBG
46745	4772	10	more	more	JJR
46745	4772	11	than	than	IN
46745	4772	12	diuresis	diuresis	NN
46745	4772	13	,	,	,
46745	4772	14	though	though	IN
46745	4772	15	they	-PRON-	PRP
46745	4772	16	often	often	RB
46745	4772	17	diminish	diminish	VBP
46745	4772	18	both	both	DT
46745	4772	19	of	of	IN
46745	4772	20	these	these	DT
46745	4772	21	secretions	secretion	NNS
46745	4772	22	.	.	.
46745	4773	1	Both	both	DT
46745	4773	2	are	be	VBP
46745	4773	3	assisted	assist	VBN
46745	4773	4	by	by	IN
46745	4773	5	a	a	DT
46745	4773	6	relaxed	relaxed	JJ
46745	4773	7	state	state	NN
46745	4773	8	of	of	IN
46745	4773	9	the	the	DT
46745	4773	10	circulation	circulation	NN
46745	4773	11	,	,	,
46745	4773	12	which	which	WDT
46745	4773	13	favours	favour	VBZ
46745	4773	14	the	the	DT
46745	4773	15	absorption	absorption	NN
46745	4773	16	of	of	IN
46745	4773	17	fluids	fluid	NNS
46745	4773	18	.	.	.
46745	4774	1	Thus	thus	RB
46745	4774	2	venesection	venesection	NN
46745	4774	3	,	,	,
46745	4774	4	purging	purging	NN
46745	4774	5	,	,	,
46745	4774	6	Antimony	Antimony	NNP
46745	4774	7	,	,	,
46745	4774	8	or	or	CC
46745	4774	9	any	any	DT
46745	4774	10	thing	thing	NN
46745	4774	11	that	that	WDT
46745	4774	12	diminishes	diminish	VBZ
46745	4774	13	a	a	DT
46745	4774	14	febrile	febrile	NN
46745	4774	15	reaction	reaction	NN
46745	4774	16	,	,	,
46745	4774	17	will	will	MD
46745	4774	18	help	help	VB
46745	4774	19	diuresis	diuresis	NN
46745	4774	20	in	in	IN
46745	4774	21	such	such	JJ
46745	4774	22	cases	case	NNS
46745	4774	23	.	.	.
46745	4775	1	In	in	IN
46745	4775	2	cases	case	NNS
46745	4775	3	of	of	IN
46745	4775	4	congestion	congestion	NN
46745	4775	5	on	on	IN
46745	4775	6	account	account	NN
46745	4775	7	of	of	IN
46745	4775	8	cardiac	cardiac	JJ
46745	4775	9	disease	disease	NN
46745	4775	10	,	,	,
46745	4775	11	Digitalis	Digitalis	NNP
46745	4775	12	,	,	,
46745	4775	13	which	which	WDT
46745	4775	14	,	,	,
46745	4775	15	by	by	IN
46745	4775	16	powerfully	powerfully	RB
46745	4775	17	weakening	weaken	VBG
46745	4775	18	the	the	DT
46745	4775	19	force	force	NN
46745	4775	20	of	of	IN
46745	4775	21	the	the	DT
46745	4775	22	heart	heart	NN
46745	4775	23	,	,	,
46745	4775	24	both	both	DT
46745	4775	25	diminishes	diminish	VBZ
46745	4775	26	congestion	congestion	NN
46745	4775	27	and	and	CC
46745	4775	28	favours	favour	VBZ
46745	4775	29	absorption	absorption	NN
46745	4775	30	,	,	,
46745	4775	31	is	be	VBZ
46745	4775	32	a	a	DT
46745	4775	33	most	most	RBS
46745	4775	34	efficient	efficient	JJ
46745	4775	35	promoter	promoter	NN
46745	4775	36	of	of	IN
46745	4775	37	the	the	DT
46745	4775	38	natural	natural	JJ
46745	4775	39	function	function	NN
46745	4775	40	of	of	IN
46745	4775	41	the	the	DT
46745	4775	42	kidneys	kidney	NNS
46745	4775	43	.	.	.
46745	4776	1	When	when	WRB
46745	4776	2	the	the	DT
46745	4776	3	portal	portal	JJ
46745	4776	4	circulation	circulation	NN
46745	4776	5	is	be	VBZ
46745	4776	6	the	the	DT
46745	4776	7	seat	seat	NN
46745	4776	8	of	of	IN
46745	4776	9	the	the	DT
46745	4776	10	obstruction	obstruction	NN
46745	4776	11	,	,	,
46745	4776	12	a	a	DT
46745	4776	13	mercurial	mercurial	JJ
46745	4776	14	,	,	,
46745	4776	15	such	such	JJ
46745	4776	16	as	as	IN
46745	4776	17	blue	blue	JJ
46745	4776	18	pill	pill	NN
46745	4776	19	,	,	,
46745	4776	20	which	which	WDT
46745	4776	21	especially	especially	RB
46745	4776	22	acts	act	VBZ
46745	4776	23	on	on	IN
46745	4776	24	the	the	DT
46745	4776	25	liver	liver	NN
46745	4776	26	,	,	,
46745	4776	27	will	will	MD
46745	4776	28	be	be	VB
46745	4776	29	a	a	DT
46745	4776	30	most	most	RBS
46745	4776	31	desirable	desirable	JJ
46745	4776	32	adjunct	adjunct	JJ
46745	4776	33	to	to	IN
46745	4776	34	the	the	DT
46745	4776	35	other	other	JJ
46745	4776	36	remedies	remedy	NNS
46745	4776	37	employed	employ	VBN
46745	4776	38	.	.	.
46745	4777	1	Tobacco	Tobacco	NNP
46745	4777	2	and	and	CC
46745	4777	3	Lobelia	Lobelia	NNP
46745	4777	4	,	,	,
46745	4777	5	like	like	IN
46745	4777	6	Digitalis	Digitalis	NNP
46745	4777	7	,	,	,
46745	4777	8	promote	promote	VB
46745	4777	9	diuresis	diuresis	NN
46745	4777	10	by	by	IN
46745	4777	11	diminishing	diminish	VBG
46745	4777	12	the	the	DT
46745	4777	13	force	force	NN
46745	4777	14	of	of	IN
46745	4777	15	the	the	DT
46745	4777	16	heart	heart	NN
46745	4777	17	.	.	.
46745	4778	1	_	_	NNP
46745	4778	2	True	True	NNP
46745	4778	3	Diuretics._--Though	diuretics._--though	IN
46745	4778	4	all	all	DT
46745	4778	5	true	true	JJ
46745	4778	6	Diuretics	diuretic	NNS
46745	4778	7	pass	pass	VB
46745	4778	8	into	into	IN
46745	4778	9	the	the	DT
46745	4778	10	urine	urine	NN
46745	4778	11	,	,	,
46745	4778	12	the	the	DT
46745	4778	13	converse	converse	NN
46745	4778	14	of	of	IN
46745	4778	15	this	this	DT
46745	4778	16	,	,	,
46745	4778	17	_	_	NNP
46745	4778	18	i.e.	i.e.	FW
46745	4778	19	_	_	NNP
46745	4778	20	that	that	IN
46745	4778	21	all	all	DT
46745	4778	22	matters	matter	NNS
46745	4778	23	which	which	WDT
46745	4778	24	pass	pass	VBP
46745	4778	25	into	into	IN
46745	4778	26	the	the	DT
46745	4778	27	urine	urine	NN
46745	4778	28	are	be	VBP
46745	4778	29	Diuretic	diuretic	JJ
46745	4778	30	,	,	,
46745	4778	31	is	be	VBZ
46745	4778	32	not	not	RB
46745	4778	33	always	always	RB
46745	4778	34	true	true	JJ
46745	4778	35	.	.	.
46745	4779	1	Thus	thus	RB
46745	4779	2	the	the	DT
46745	4779	3	astringent	astringent	JJ
46745	4779	4	mineral	mineral	NN
46745	4779	5	salts	salt	NNS
46745	4779	6	pass	pass	VBP
46745	4779	7	frequently	frequently	RB
46745	4779	8	out	out	IN
46745	4779	9	of	of	IN
46745	4779	10	the	the	DT
46745	4779	11	system	system	NN
46745	4779	12	in	in	IN
46745	4779	13	the	the	DT
46745	4779	14	urine	urine	NN
46745	4779	15	,	,	,
46745	4779	16	but	but	CC
46745	4779	17	seldom	seldom	RB
46745	4779	18	affect	affect	VB
46745	4779	19	its	-PRON-	PRP$
46745	4779	20	amount	amount	NN
46745	4779	21	in	in	IN
46745	4779	22	either	either	DT
46745	4779	23	way	way	NN
46745	4779	24	.	.	.
46745	4780	1	And	and	CC
46745	4780	2	for	for	IN
46745	4780	3	the	the	DT
46745	4780	4	reasons	reason	NNS
46745	4780	5	already	already	RB
46745	4780	6	enumerated	enumerate	VBN
46745	4780	7	,	,	,
46745	4780	8	it	-PRON-	PRP
46745	4780	9	is	be	VBZ
46745	4780	10	often	often	RB
46745	4780	11	impossible	impossible	JJ
46745	4780	12	,	,	,
46745	4780	13	even	even	RB
46745	4780	14	by	by	IN
46745	4780	15	the	the	DT
46745	4780	16	most	most	RBS
46745	4780	17	powerful	powerful	JJ
46745	4780	18	medicines	medicine	NNS
46745	4780	19	of	of	IN
46745	4780	20	this	this	DT
46745	4780	21	order	order	NN
46745	4780	22	,	,	,
46745	4780	23	to	to	TO
46745	4780	24	increase	increase	VB
46745	4780	25	the	the	DT
46745	4780	26	urine	urine	NN
46745	4780	27	beyond	beyond	IN
46745	4780	28	a	a	DT
46745	4780	29	certain	certain	JJ
46745	4780	30	amount	amount	NN
46745	4780	31	.	.	.
46745	4781	1	Diuretics	diuretic	NNS
46745	4781	2	may	may	MD
46745	4781	3	be	be	VB
46745	4781	4	somewhat	somewhat	RB
46745	4781	5	loosely	loosely	RB
46745	4781	6	arranged	arrange	VBN
46745	4781	7	in	in	IN
46745	4781	8	four	four	CD
46745	4781	9	groups:--1	groups:--1	NNP
46745	4781	10	.	.	.
46745	4782	1	Water	water	NN
46745	4782	2	,	,	,
46745	4782	3	and	and	CC
46745	4782	4	soluble	soluble	JJ
46745	4782	5	mineral	mineral	NN
46745	4782	6	substances	substance	NNS
46745	4782	7	,	,	,
46745	4782	8	_	_	NNP
46745	4782	9	i.e.	i.e.	FW
46745	4782	10	_	_	NNP
46745	4782	11	acids	acid	NNS
46745	4782	12	,	,	,
46745	4782	13	alkalies	alkali	NNS
46745	4782	14	,	,	,
46745	4782	15	and	and	CC
46745	4782	16	salines	saline	NNS
46745	4782	17	under	under	IN
46745	4782	18	certain	certain	JJ
46745	4782	19	conditions	condition	NNS
46745	4782	20	;	;	:
46745	4782	21	2	2	CD
46745	4782	22	.	.	.
46745	4783	1	Acrid	Acrid	NNP
46745	4783	2	matters	matter	NNS
46745	4783	3	of	of	IN
46745	4783	4	various	various	JJ
46745	4783	5	kinds	kind	NNS
46745	4783	6	;	;	:
46745	4783	7	3	3	CD
46745	4783	8	.	.	.
46745	4784	1	Alcoholic	alcoholic	JJ
46745	4784	2	and	and	CC
46745	4784	3	ethereal	ethereal	JJ
46745	4784	4	liquids	liquid	NNS
46745	4784	5	;	;	:
46745	4784	6	4	4	CD
46745	4784	7	.	.	.
46745	4785	1	The	the	DT
46745	4785	2	minerals	mineral	NNS
46745	4785	3	which	which	WDT
46745	4785	4	increase	increase	VBP
46745	4785	5	all	all	DT
46745	4785	6	secretions	secretion	NNS
46745	4785	7	.	.	.
46745	4786	1	Diluents	diluent	NNS
46745	4786	2	promote	promote	VBP
46745	4786	3	the	the	DT
46745	4786	4	secretions	secretion	NNS
46745	4786	5	of	of	IN
46745	4786	6	the	the	DT
46745	4786	7	skin	skin	NN
46745	4786	8	and	and	CC
46745	4786	9	kidneys	kidney	NNS
46745	4786	10	.	.	.
46745	4787	1	A	a	DT
46745	4787	2	certain	certain	JJ
46745	4787	3	quantity	quantity	NN
46745	4787	4	of	of	IN
46745	4787	5	water	water	NN
46745	4787	6	must	must	MD
46745	4787	7	be	be	VB
46745	4787	8	given	give	VBN
46745	4787	9	with	with	IN
46745	4787	10	every	every	DT
46745	4787	11	diuretic	diuretic	JJ
46745	4787	12	dose	dose	NN
46745	4787	13	,	,	,
46745	4787	14	and	and	CC
46745	4787	15	the	the	DT
46745	4787	16	larger	large	JJR
46745	4787	17	the	the	DT
46745	4787	18	quantity	quantity	NN
46745	4787	19	the	the	DT
46745	4787	20	greater	great	JJR
46745	4787	21	will	will	MD
46745	4787	22	be	be	VB
46745	4787	23	the	the	DT
46745	4787	24	effect	effect	NN
46745	4787	25	produced	produce	VBN
46745	4787	26	.	.	.
46745	4788	1	In	in	IN
46745	4788	2	the	the	DT
46745	4788	3	case	case	NN
46745	4788	4	of	of	IN
46745	4788	5	a	a	DT
46745	4788	6	Diaphoretic	Diaphoretic	NNP
46745	4788	7	,	,	,
46745	4788	8	this	this	DT
46745	4788	9	is	be	VBZ
46745	4788	10	all	all	DT
46745	4788	11	that	that	WDT
46745	4788	12	is	be	VBZ
46745	4788	13	required	require	VBN
46745	4788	14	.	.	.
46745	4789	1	But	but	CC
46745	4789	2	as	as	IN
46745	4789	3	Diuretics	diuretic	NNS
46745	4789	4	are	be	VBP
46745	4789	5	generally	generally	RB
46745	4789	6	given	give	VBN
46745	4789	7	,	,	,
46745	4789	8	as	as	IN
46745	4789	9	in	in	IN
46745	4789	10	dropsies	dropsy	NNS
46745	4789	11	,	,	,
46745	4789	12	for	for	IN
46745	4789	13	the	the	DT
46745	4789	14	purpose	purpose	NN
46745	4789	15	of	of	IN
46745	4789	16	eliminating	eliminate	VBG
46745	4789	17	fluid	fluid	NN
46745	4789	18	out	out	IN
46745	4789	19	of	of	IN
46745	4789	20	the	the	DT
46745	4789	21	system	system	NN
46745	4789	22	,	,	,
46745	4789	23	this	this	DT
46745	4789	24	object	object	NN
46745	4789	25	would	would	MD
46745	4789	26	be	be	VB
46745	4789	27	clearly	clearly	RB
46745	4789	28	defeated	defeat	VBN
46745	4789	29	by	by	IN
46745	4789	30	the	the	DT
46745	4789	31	introduction	introduction	NN
46745	4789	32	of	of	IN
46745	4789	33	a	a	DT
46745	4789	34	large	large	JJ
46745	4789	35	quantity	quantity	NN
46745	4789	36	of	of	IN
46745	4789	37	water	water	NN
46745	4789	38	into	into	IN
46745	4789	39	the	the	DT
46745	4789	40	system	system	NN
46745	4789	41	.	.	.
46745	4790	1	This	this	DT
46745	4790	2	,	,	,
46745	4790	3	therefore	therefore	RB
46745	4790	4	,	,	,
46745	4790	5	should	should	MD
46745	4790	6	be	be	VB
46745	4790	7	avoided	avoid	VBN
46745	4790	8	.	.	.
46745	4791	1	The	the	DT
46745	4791	2	free	free	JJ
46745	4791	3	acids	acid	NNS
46745	4791	4	,	,	,
46745	4791	5	both	both	DT
46745	4791	6	mineral	mineral	NN
46745	4791	7	and	and	CC
46745	4791	8	vegetable	vegetable	NN
46745	4791	9	,	,	,
46745	4791	10	with	with	IN
46745	4791	11	the	the	DT
46745	4791	12	exception	exception	NN
46745	4791	13	of	of	IN
46745	4791	14	Sulphuric	Sulphuric	NNP
46745	4791	15	acid	acid	NN
46745	4791	16	(	(	-LRB-
46745	4791	17	_	_	NNP
46745	4791	18	vide	vide	NN
46745	4791	19	_	_	NNP
46745	4791	20	p.	p.	NN
46745	4791	21	262	262	CD
46745	4791	22	,	,	,
46745	4791	23	)	)	-RRB-
46745	4791	24	pass	pass	VB
46745	4791	25	into	into	IN
46745	4791	26	the	the	DT
46745	4791	27	urine	urine	NN
46745	4791	28	,	,	,
46745	4791	29	and	and	CC
46745	4791	30	act	act	VB
46745	4791	31	as	as	IN
46745	4791	32	Diuretics	Diuretics	NNP
46745	4791	33	.	.	.
46745	4792	1	So	so	RB
46745	4792	2	also	also	RB
46745	4792	3	do	do	VB
46745	4792	4	the	the	DT
46745	4792	5	mineral	mineral	NN
46745	4792	6	alkalies	alkali	NNS
46745	4792	7	.	.	.
46745	4793	1	But	but	CC
46745	4793	2	as	as	IN
46745	4793	3	these	these	DT
46745	4793	4	medicines	medicine	NNS
46745	4793	5	have	have	VBP
46745	4793	6	important	important	JJ
46745	4793	7	agencies	agency	NNS
46745	4793	8	in	in	IN
46745	4793	9	the	the	DT
46745	4793	10	blood	blood	NN
46745	4793	11	,	,	,
46745	4793	12	and	and	CC
46745	4793	13	tend	tend	VB
46745	4793	14	further	far	RBR
46745	4793	15	,	,	,
46745	4793	16	by	by	IN
46745	4793	17	altering	alter	VBG
46745	4793	18	the	the	DT
46745	4793	19	reaction	reaction	NN
46745	4793	20	of	of	IN
46745	4793	21	the	the	DT
46745	4793	22	urine	urine	NN
46745	4793	23	,	,	,
46745	4793	24	to	to	TO
46745	4793	25	produce	produce	VB
46745	4793	26	in	in	IN
46745	4793	27	it	-PRON-	PRP
46745	4793	28	deposits	deposit	NNS
46745	4793	29	of	of	IN
46745	4793	30	different	different	JJ
46745	4793	31	kinds	kind	NNS
46745	4793	32	(	(	-LRB-
46745	4793	33	_	_	NNP
46745	4793	34	vide	vide	NN
46745	4793	35	_	_	NNP
46745	4793	36	p.	p.	NN
46745	4793	37	151	151	CD
46745	4793	38	,	,	,
46745	4793	39	)	)	-RRB-
46745	4793	40	they	-PRON-	PRP
46745	4793	41	can	can	MD
46745	4793	42	seldom	seldom	RB
46745	4793	43	be	be	VB
46745	4793	44	safely	safely	RB
46745	4793	45	employed	employ	VBN
46745	4793	46	for	for	IN
46745	4793	47	this	this	DT
46745	4793	48	purpose	purpose	NN
46745	4793	49	.	.	.
46745	4794	1	Salines	saline	NNS
46745	4794	2	are	be	VBP
46745	4794	3	more	more	RBR
46745	4794	4	appropriate	appropriate	JJ
46745	4794	5	.	.	.
46745	4795	1	They	-PRON-	PRP
46745	4795	2	should	should	MD
46745	4795	3	not	not	RB
46745	4795	4	be	be	VB
46745	4795	5	given	give	VBN
46745	4795	6	in	in	IN
46745	4795	7	large	large	JJ
46745	4795	8	doses	dose	NNS
46745	4795	9	,	,	,
46745	4795	10	for	for	IN
46745	4795	11	they	-PRON-	PRP
46745	4795	12	will	will	MD
46745	4795	13	then	then	RB
46745	4795	14	act	act	VB
46745	4795	15	upon	upon	IN
46745	4795	16	the	the	DT
46745	4795	17	bowels	bowel	NNS
46745	4795	18	.	.	.
46745	4796	1	The	the	DT
46745	4796	2	dose	dose	NN
46745	4796	3	should	should	MD
46745	4796	4	be	be	VB
46745	4796	5	small	small	JJ
46745	4796	6	,	,	,
46745	4796	7	and	and	CC
46745	4796	8	moderately	moderately	RB
46745	4796	9	diluted	dilute	VBN
46745	4796	10	with	with	IN
46745	4796	11	water	water	NN
46745	4796	12	.	.	.
46745	4797	1	To	to	TO
46745	4797	2	prevent	prevent	VB
46745	4797	3	it	-PRON-	PRP
46745	4797	4	from	from	IN
46745	4797	5	acting	act	VBG
46745	4797	6	upon	upon	IN
46745	4797	7	the	the	DT
46745	4797	8	skin	skin	NN
46745	4797	9	,	,	,
46745	4797	10	the	the	DT
46745	4797	11	conditions	condition	NNS
46745	4797	12	which	which	WDT
46745	4797	13	favour	favour	VBP
46745	4797	14	diaphoresis	diaphoresis	NN
46745	4797	15	should	should	MD
46745	4797	16	be	be	VB
46745	4797	17	,	,	,
46745	4797	18	if	if	IN
46745	4797	19	possible	possible	JJ
46745	4797	20	,	,	,
46745	4797	21	avoided	avoid	VBN
46745	4797	22	.	.	.
46745	4798	1	The	the	DT
46745	4798	2	subject	subject	NN
46745	4798	3	of	of	IN
46745	4798	4	the	the	DT
46745	4798	5	action	action	NN
46745	4798	6	of	of	IN
46745	4798	7	saline	saline	JJ
46745	4798	8	medicines	medicine	NNS
46745	4798	9	,	,	,
46745	4798	10	and	and	CC
46745	4798	11	the	the	DT
46745	4798	12	effect	effect	NN
46745	4798	13	of	of	IN
46745	4798	14	dilution	dilution	NN
46745	4798	15	upon	upon	IN
46745	4798	16	this	this	DT
46745	4798	17	action	action	NN
46745	4798	18	,	,	,
46745	4798	19	has	have	VBZ
46745	4798	20	been	be	VBN
46745	4798	21	already	already	RB
46745	4798	22	considered	consider	VBN
46745	4798	23	.	.	.
46745	4799	1	(	(	-LRB-
46745	4799	2	p.	p.	NN
46745	4800	1	74	74	CD
46745	4800	2	.	.	.
46745	4800	3	)	)	-RRB-
46745	4801	1	The	the	DT
46745	4801	2	acrid	acrid	JJ
46745	4801	3	Diuretics	Diuretics	NNPS
46745	4801	4	are	be	VBP
46745	4801	5	perhaps	perhaps	RB
46745	4801	6	the	the	DT
46745	4801	7	most	most	RBS
46745	4801	8	powerful	powerful	JJ
46745	4801	9	medicines	medicine	NNS
46745	4801	10	in	in	IN
46745	4801	11	the	the	DT
46745	4801	12	order	order	NN
46745	4801	13	.	.	.
46745	4802	1	One	one	CD
46745	4802	2	of	of	IN
46745	4802	3	them	-PRON-	PRP
46745	4802	4	,	,	,
46745	4802	5	Cantharides	Cantharides	NNP
46745	4802	6	,	,	,
46745	4802	7	is	be	VBZ
46745	4802	8	an	an	DT
46745	4802	9	animal	animal	NN
46745	4802	10	product	product	NN
46745	4802	11	.	.	.
46745	4803	1	Some	some	DT
46745	4803	2	contain	contain	VBP
46745	4803	3	or	or	CC
46745	4803	4	consist	consist	VBP
46745	4803	5	of	of	IN
46745	4803	6	volatile	volatile	JJ
46745	4803	7	oils	oil	NNS
46745	4803	8	:	:	:
46745	4803	9	as	as	IN
46745	4803	10	Juniper	Juniper	NNP
46745	4803	11	,	,	,
46745	4803	12	Turpentine	Turpentine	NNP
46745	4803	13	,	,	,
46745	4803	14	Cajeput	Cajeput	NNP
46745	4803	15	,	,	,
46745	4803	16	Copaiba	Copaiba	NNP
46745	4803	17	,	,	,
46745	4803	18	Horseradish	Horseradish	NNP
46745	4803	19	.	.	.
46745	4804	1	These	these	DT
46745	4804	2	volatile	volatile	JJ
46745	4804	3	oils	oil	NNS
46745	4804	4	may	may	MD
46745	4804	5	act	act	VB
46745	4804	6	upon	upon	IN
46745	4804	7	the	the	DT
46745	4804	8	skin	skin	NN
46745	4804	9	instead	instead	RB
46745	4804	10	of	of	IN
46745	4804	11	the	the	DT
46745	4804	12	kidneys	kidney	NNS
46745	4804	13	,	,	,
46745	4804	14	under	under	IN
46745	4804	15	the	the	DT
46745	4804	16	conditions	condition	NNS
46745	4804	17	which	which	WDT
46745	4804	18	are	be	VBP
46745	4804	19	mentioned	mention	VBN
46745	4804	20	above	above	RB
46745	4804	21	as	as	IN
46745	4804	22	favouring	favour	VBG
46745	4804	23	diaphoresis	diaphoresis	NN
46745	4804	24	.	.	.
46745	4805	1	Others	other	NNS
46745	4805	2	of	of	IN
46745	4805	3	this	this	DT
46745	4805	4	group	group	NN
46745	4805	5	contain	contain	VBP
46745	4805	6	peculiar	peculiar	JJ
46745	4805	7	vegetable	vegetable	NN
46745	4805	8	principles	principle	NNS
46745	4805	9	;	;	:
46745	4805	10	as	as	IN
46745	4805	11	Broom	Broom	NNP
46745	4805	12	,	,	,
46745	4805	13	Chimaphila	Chimaphila	NNP
46745	4805	14	,	,	,
46745	4805	15	Taraxacum	Taraxacum	NNP
46745	4805	16	,	,	,
46745	4805	17	Colchicum	Colchicum	NNP
46745	4805	18	,	,	,
46745	4805	19	and	and	CC
46745	4805	20	Squill	Squill	NNP
46745	4805	21	.	.	.
46745	4806	1	Alcohol	Alcohol	NNP
46745	4806	2	,	,	,
46745	4806	3	Ether	Ether	NNP
46745	4806	4	,	,	,
46745	4806	5	and	and	CC
46745	4806	6	Nitric	nitric	JJ
46745	4806	7	ether	ether	NN
46745	4806	8	,	,	,
46745	4806	9	act	act	VBP
46745	4806	10	powerfully	powerfully	RB
46745	4806	11	both	both	CC
46745	4806	12	on	on	IN
46745	4806	13	the	the	DT
46745	4806	14	kidneys	kidney	NNS
46745	4806	15	and	and	CC
46745	4806	16	on	on	IN
46745	4806	17	the	the	DT
46745	4806	18	skin	skin	NN
46745	4806	19	.	.	.
46745	4807	1	Wine	Wine	NNP
46745	4807	2	,	,	,
46745	4807	3	which	which	WDT
46745	4807	4	further	further	RB
46745	4807	5	contains	contain	VBZ
46745	4807	6	certain	certain	JJ
46745	4807	7	volatile	volatile	JJ
46745	4807	8	oils	oil	NNS
46745	4807	9	,	,	,
46745	4807	10	and	and	CC
46745	4807	11	sometimes	sometimes	RB
46745	4807	12	a	a	DT
46745	4807	13	vegetable	vegetable	NN
46745	4807	14	acid	acid	NN
46745	4807	15	,	,	,
46745	4807	16	acts	act	VBZ
46745	4807	17	on	on	IN
46745	4807	18	the	the	DT
46745	4807	19	kidneys	kidney	NNS
46745	4807	20	when	when	WRB
46745	4807	21	drunk	drunk	JJ
46745	4807	22	in	in	IN
46745	4807	23	any	any	DT
46745	4807	24	quantity	quantity	NN
46745	4807	25	.	.	.
46745	4808	1	The	the	DT
46745	4808	2	diuretic	diuretic	JJ
46745	4808	3	effect	effect	NN
46745	4808	4	of	of	IN
46745	4808	5	these	these	DT
46745	4808	6	liquids	liquid	NNS
46745	4808	7	is	be	VBZ
46745	4808	8	,	,	,
46745	4808	9	as	as	IN
46745	4808	10	in	in	IN
46745	4808	11	the	the	DT
46745	4808	12	case	case	NN
46745	4808	13	of	of	IN
46745	4808	14	salines	saline	NNS
46745	4808	15	,	,	,
46745	4808	16	greater	great	JJR
46745	4808	17	when	when	WRB
46745	4808	18	the	the	DT
46745	4808	19	surface	surface	NN
46745	4808	20	is	be	VBZ
46745	4808	21	cold	cold	JJ
46745	4808	22	,	,	,
46745	4808	23	and	and	CC
46745	4808	24	less	less	JJR
46745	4808	25	when	when	WRB
46745	4808	26	it	-PRON-	PRP
46745	4808	27	is	be	VBZ
46745	4808	28	warm	warm	JJ
46745	4808	29	and	and	CC
46745	4808	30	covered	covered	JJ
46745	4808	31	.	.	.
46745	4809	1	Mercury	Mercury	NNP
46745	4809	2	,	,	,
46745	4809	3	Antimony	Antimony	NNP
46745	4809	4	,	,	,
46745	4809	5	and	and	CC
46745	4809	6	Iodine	Iodine	NNP
46745	4809	7	,	,	,
46745	4809	8	which	which	WDT
46745	4809	9	increase	increase	VBP
46745	4809	10	more	more	RBR
46745	4809	11	or	or	CC
46745	4809	12	less	less	RBR
46745	4809	13	all	all	PDT
46745	4809	14	the	the	DT
46745	4809	15	animal	animal	NN
46745	4809	16	secretions	secretion	NNS
46745	4809	17	,	,	,
46745	4809	18	act	act	NNP
46745	4809	19	,	,	,
46745	4809	20	among	among	IN
46745	4809	21	others	other	NNS
46745	4809	22	,	,	,
46745	4809	23	upon	upon	IN
46745	4809	24	the	the	DT
46745	4809	25	secretion	secretion	NN
46745	4809	26	of	of	IN
46745	4809	27	urine	urine	NN
46745	4809	28	.	.	.
46745	4810	1	Iodine	Iodine	NNP
46745	4810	2	particularly	particularly	RB
46745	4810	3	is	be	VBZ
46745	4810	4	said	say	VBN
46745	4810	5	to	to	TO
46745	4810	6	be	be	VB
46745	4810	7	diuretic	diuretic	JJ
46745	4810	8	.	.	.
46745	4811	1	Mercury	Mercury	NNP
46745	4811	2	and	and	CC
46745	4811	3	Antimony	Antimony	NNP
46745	4811	4	are	be	VBP
46745	4811	5	most	most	RBS
46745	4811	6	efficacious	efficacious	JJ
46745	4811	7	as	as	IN
46745	4811	8	indirect	indirect	JJ
46745	4811	9	agents	agent	NNS
46745	4811	10	;	;	:
46745	4811	11	the	the	DT
46745	4811	12	former	former	JJ
46745	4811	13	by	by	IN
46745	4811	14	stimulating	stimulate	VBG
46745	4811	15	the	the	DT
46745	4811	16	function	function	NN
46745	4811	17	of	of	IN
46745	4811	18	the	the	DT
46745	4811	19	liver	liver	NN
46745	4811	20	when	when	WRB
46745	4811	21	impaired	impair	VBN
46745	4811	22	,	,	,
46745	4811	23	the	the	DT
46745	4811	24	other	other	JJ
46745	4811	25	by	by	IN
46745	4811	26	diminishing	diminish	VBG
46745	4811	27	the	the	DT
46745	4811	28	pressure	pressure	NN
46745	4811	29	on	on	IN
46745	4811	30	the	the	DT
46745	4811	31	vessels	vessel	NNS
46745	4811	32	in	in	IN
46745	4811	33	febrile	febrile	NN
46745	4811	34	cases	case	NNS
46745	4811	35	.	.	.
46745	4812	1	A	a	DT
46745	4812	2	large	large	JJ
46745	4812	3	number	number	NN
46745	4812	4	of	of	IN
46745	4812	5	Diuretics	diuretic	NNS
46745	4812	6	are	be	VBP
46745	4812	7	themselves	-PRON-	PRP
46745	4812	8	secreted	secrete	VBN
46745	4812	9	by	by	IN
46745	4812	10	the	the	DT
46745	4812	11	kidneys	kidney	NNS
46745	4812	12	,	,	,
46745	4812	13	and	and	CC
46745	4812	14	have	have	VBP
46745	4812	15	been	be	VBN
46745	4812	16	proved	prove	VBN
46745	4812	17	to	to	TO
46745	4812	18	pass	pass	VB
46745	4812	19	out	out	RP
46745	4812	20	into	into	IN
46745	4812	21	the	the	DT
46745	4812	22	urine	urine	NN
46745	4812	23	.	.	.
46745	4813	1	A	a	DT
46745	4813	2	great	great	JJ
46745	4813	3	many	many	JJ
46745	4813	4	have	have	VBP
46745	4813	5	been	be	VBN
46745	4813	6	detected	detect	VBN
46745	4813	7	in	in	IN
46745	4813	8	the	the	DT
46745	4813	9	urine	urine	NN
46745	4813	10	by	by	IN
46745	4813	11	different	different	JJ
46745	4813	12	chemists	chemist	NNS
46745	4813	13	,	,	,
46745	4813	14	especially	especially	RB
46745	4813	15	by	by	IN
46745	4813	16	M.	M.	NNP
46745	4813	17	Wöhler	Wöhler	NNP
46745	4813	18	.	.	.
46745	4814	1	The	the	DT
46745	4814	2	Carbonate	Carbonate	NNP
46745	4814	3	,	,	,
46745	4814	4	Nitrate	Nitrate	NNP
46745	4814	5	,	,	,
46745	4814	6	and	and	CC
46745	4814	7	Chlorate	Chlorate	NNP
46745	4814	8	of	of	IN
46745	4814	9	Potash	Potash	NNP
46745	4814	10	,	,	,
46745	4814	11	and	and	CC
46745	4814	12	the	the	DT
46745	4814	13	Iodide	Iodide	NNP
46745	4814	14	of	of	IN
46745	4814	15	Potassium	Potassium	NNP
46745	4814	16	,	,	,
46745	4814	17	have	have	VBP
46745	4814	18	been	be	VBN
46745	4814	19	found	find	VBN
46745	4814	20	there	there	RB
46745	4814	21	.	.	.
46745	4815	1	So	so	RB
46745	4815	2	also	also	RB
46745	4815	3	have	have	VB
46745	4815	4	the	the	DT
46745	4815	5	mineral	mineral	NN
46745	4815	6	acids	acid	NNS
46745	4815	7	--	--	:
46745	4815	8	the	the	DT
46745	4815	9	vegetable	vegetable	NN
46745	4815	10	acids	acid	NNS
46745	4815	11	--	--	:
46745	4815	12	Magnesia	Magnesia	NNP
46745	4815	13	--	--	:
46745	4815	14	Mercury,[46	Mercury,[46	NNP
46745	4815	15	]	]	-RRB-
46745	4815	16	in	in	IN
46745	4815	17	combination	combination	NN
46745	4815	18	--	--	:
46745	4815	19	and	and	CC
46745	4815	20	Iodine	Iodine	NNP
46745	4815	21	,	,	,
46745	4815	22	in	in	IN
46745	4815	23	the	the	DT
46745	4815	24	form	form	NN
46745	4815	25	of	of	IN
46745	4815	26	Hydriotic	hydriotic	JJ
46745	4815	27	acid	acid	NN
46745	4815	28	.	.	.
46745	4816	1	Among	among	IN
46745	4816	2	vegetables	vegetable	NNS
46745	4816	3	,	,	,
46745	4816	4	the	the	DT
46745	4816	5	principles	principle	NNS
46745	4816	6	of	of	IN
46745	4816	7	Chimaphila	Chimaphila	NNP
46745	4816	8	and	and	CC
46745	4816	9	Uvæ	Uvæ	NNP
46745	4816	10	Ursi	Ursi	NNP
46745	4816	11	--	--	:
46745	4816	12	the	the	DT
46745	4816	13	oils	oil	NNS
46745	4816	14	of	of	IN
46745	4816	15	Turpentine	Turpentine	NNP
46745	4816	16	and	and	CC
46745	4816	17	Juniper	Juniper	NNP
46745	4816	18	,	,	,
46745	4816	19	somewhat	somewhat	RB
46745	4816	20	altered	alter	VBN
46745	4816	21	in	in	IN
46745	4816	22	nature	nature	NN
46745	4816	23	--	--	:
46745	4816	24	the	the	DT
46745	4816	25	oil	oil	NN
46745	4816	26	and	and	CC
46745	4816	27	resin	resin	NN
46745	4816	28	of	of	IN
46745	4816	29	Copaiba	Copaiba	NNP
46745	4816	30	--	--	:
46745	4816	31	and	and	CC
46745	4816	32	the	the	DT
46745	4816	33	acrid	acrid	JJ
46745	4816	34	principle	principle	NN
46745	4816	35	of	of	IN
46745	4816	36	Cubebs	Cubebs	NNP
46745	4816	37	,	,	,
46745	4816	38	all	all	DT
46745	4816	39	pass	pass	VBP
46745	4816	40	into	into	IN
46745	4816	41	it	-PRON-	PRP
46745	4816	42	.	.	.
46745	4817	1	Other	other	JJ
46745	4817	2	substances	substance	NNS
46745	4817	3	,	,	,
46745	4817	4	which	which	WDT
46745	4817	5	are	be	VBP
46745	4817	6	not	not	RB
46745	4817	7	diuretic	diuretic	JJ
46745	4817	8	,	,	,
46745	4817	9	but	but	CC
46745	4817	10	astringent	astringent	NN
46745	4817	11	,	,	,
46745	4817	12	have	have	VBP
46745	4817	13	been	be	VBN
46745	4817	14	found	find	VBN
46745	4817	15	in	in	IN
46745	4817	16	the	the	DT
46745	4817	17	urine	urine	NN
46745	4817	18	;	;	:
46745	4817	19	as	as	IN
46745	4817	20	Alum	Alum	NNP
46745	4817	21	,	,	,
46745	4817	22	Lead	Lead	NNP
46745	4817	23	,	,	,
46745	4817	24	and	and	CC
46745	4817	25	the	the	DT
46745	4817	26	Morphia	Morphia	NNP
46745	4817	27	and	and	CC
46745	4817	28	Meconic	Meconic	NNP
46745	4817	29	acid	acid	NN
46745	4817	30	of	of	IN
46745	4817	31	Opium	Opium	NNP
46745	4817	32	.	.	.
46745	4818	1	When	when	WRB
46745	4818	2	a	a	DT
46745	4818	3	powerful	powerful	JJ
46745	4818	4	Diuretic	Diuretic	NNP
46745	4818	5	is	be	VBZ
46745	4818	6	given	give	VBN
46745	4818	7	in	in	IN
46745	4818	8	too	too	RB
46745	4818	9	large	large	JJ
46745	4818	10	a	a	DT
46745	4818	11	dose	dose	NN
46745	4818	12	,	,	,
46745	4818	13	it	-PRON-	PRP
46745	4818	14	may	may	MD
46745	4818	15	cause	cause	VB
46745	4818	16	a	a	DT
46745	4818	17	degree	degree	NN
46745	4818	18	of	of	IN
46745	4818	19	action	action	NN
46745	4818	20	sufficient	sufficient	JJ
46745	4818	21	to	to	TO
46745	4818	22	produce	produce	VB
46745	4818	23	congestion	congestion	NN
46745	4818	24	of	of	IN
46745	4818	25	the	the	DT
46745	4818	26	kidney	kidney	NN
46745	4818	27	,	,	,
46745	4818	28	and	and	CC
46745	4818	29	so	so	RB
46745	4818	30	defeat	defeat	VB
46745	4818	31	the	the	DT
46745	4818	32	object	object	NN
46745	4818	33	for	for	IN
46745	4818	34	which	which	WDT
46745	4818	35	it	-PRON-	PRP
46745	4818	36	was	be	VBD
46745	4818	37	intended	intend	VBN
46745	4818	38	.	.	.
46745	4819	1	For	for	IN
46745	4819	2	congestion	congestion	NN
46745	4819	3	of	of	IN
46745	4819	4	a	a	DT
46745	4819	5	gland	gland	NN
46745	4819	6	is	be	VBZ
46745	4819	7	invariably	invariably	RB
46745	4819	8	followed	follow	VBN
46745	4819	9	by	by	IN
46745	4819	10	a	a	DT
46745	4819	11	diminution	diminution	NN
46745	4819	12	or	or	CC
46745	4819	13	stoppage	stoppage	NN
46745	4819	14	of	of	IN
46745	4819	15	its	-PRON-	PRP$
46745	4819	16	secretion	secretion	NN
46745	4819	17	.	.	.
46745	4820	1	So	so	RB
46745	4820	2	a	a	DT
46745	4820	3	large	large	JJ
46745	4820	4	dose	dose	NN
46745	4820	5	of	of	IN
46745	4820	6	Turpentine	Turpentine	NNP
46745	4820	7	or	or	CC
46745	4820	8	Cantharides	Cantharides	NNP
46745	4820	9	may	may	MD
46745	4820	10	cause	cause	VB
46745	4820	11	a	a	DT
46745	4820	12	dangerous	dangerous	JJ
46745	4820	13	attack	attack	NN
46745	4820	14	of	of	IN
46745	4820	15	strangury	strangury	NN
46745	4820	16	,	,	,
46745	4820	17	or	or	CC
46745	4820	18	even	even	RB
46745	4820	19	a	a	DT
46745	4820	20	total	total	JJ
46745	4820	21	suppression	suppression	NN
46745	4820	22	of	of	IN
46745	4820	23	the	the	DT
46745	4820	24	urine	urine	NN
46745	4820	25	for	for	IN
46745	4820	26	a	a	DT
46745	4820	27	time	time	NN
46745	4820	28	.	.	.
46745	4821	1	(	(	-LRB-
46745	4821	2	_	_	NNP
46745	4821	3	Vide	Vide	NNP
46745	4821	4	_	_	NNP
46745	4821	5	p.	p.	NN
46745	4822	1	274	274	CD
46745	4822	2	.	.	.
46745	4822	3	)	)	-RRB-
46745	4823	1	It	-PRON-	PRP
46745	4823	2	can	can	MD
46745	4823	3	hardly	hardly	RB
46745	4823	4	be	be	VB
46745	4823	5	said	say	VBN
46745	4823	6	that	that	IN
46745	4823	7	Diuretics	diuretic	NNS
46745	4823	8	are	be	VBP
46745	4823	9	of	of	IN
46745	4823	10	very	very	RB
46745	4823	11	extensive	extensive	JJ
46745	4823	12	application	application	NN
46745	4823	13	in	in	IN
46745	4823	14	the	the	DT
46745	4823	15	treatment	treatment	NN
46745	4823	16	of	of	IN
46745	4823	17	disease	disease	NN
46745	4823	18	,	,	,
46745	4823	19	or	or	CC
46745	4823	20	that	that	IN
46745	4823	21	they	-PRON-	PRP
46745	4823	22	are	be	VBP
46745	4823	23	medicines	medicine	NNS
46745	4823	24	which	which	WDT
46745	4823	25	can	can	MD
46745	4823	26	ever	ever	RB
46745	4823	27	be	be	VB
46745	4823	28	much	much	RB
46745	4823	29	relied	rely	VBN
46745	4823	30	upon	upon	IN
46745	4823	31	.	.	.
46745	4824	1	For	for	IN
46745	4824	2	not	not	RB
46745	4824	3	only	only	RB
46745	4824	4	are	be	VBP
46745	4824	5	the	the	DT
46745	4824	6	remedies	remedy	NNS
46745	4824	7	themselves	-PRON-	PRP
46745	4824	8	uncertain	uncertain	JJ
46745	4824	9	in	in	IN
46745	4824	10	action	action	NN
46745	4824	11	,	,	,
46745	4824	12	but	but	CC
46745	4824	13	it	-PRON-	PRP
46745	4824	14	happens	happen	VBZ
46745	4824	15	also	also	RB
46745	4824	16	that	that	IN
46745	4824	17	the	the	DT
46745	4824	18	disorders	disorder	NNS
46745	4824	19	in	in	IN
46745	4824	20	which	which	WDT
46745	4824	21	they	-PRON-	PRP
46745	4824	22	are	be	VBP
46745	4824	23	most	most	RBS
46745	4824	24	required	require	VBN
46745	4824	25	are	be	VBP
46745	4824	26	of	of	IN
46745	4824	27	a	a	DT
46745	4824	28	peculiarly	peculiarly	JJ
46745	4824	29	obstinate	obstinate	NN
46745	4824	30	nature	nature	NN
46745	4824	31	.	.	.
46745	4825	1	There	there	EX
46745	4825	2	are	be	VBP
46745	4825	3	two	two	CD
46745	4825	4	chief	chief	JJ
46745	4825	5	actions	action	NNS
46745	4825	6	for	for	IN
46745	4825	7	which	which	WDT
46745	4825	8	Diuretics	Diuretics	NNPS
46745	4825	9	may	may	MD
46745	4825	10	be	be	VB
46745	4825	11	required	require	VBN
46745	4825	12	.	.	.
46745	4826	1	They	-PRON-	PRP
46745	4826	2	may	may	MD
46745	4826	3	be	be	VB
46745	4826	4	used	use	VBN
46745	4826	5	:	:	:
46745	4826	6	(	(	-LRB-
46745	4826	7	1	1	CD
46745	4826	8	.	.	.
46745	4826	9	)	)	-RRB-
46745	4827	1	to	to	TO
46745	4827	2	eliminate	eliminate	VB
46745	4827	3	solid	solid	JJ
46745	4827	4	materials	material	NNS
46745	4827	5	from	from	IN
46745	4827	6	the	the	DT
46745	4827	7	blood	blood	NN
46745	4827	8	;	;	,
46745	4827	9	(	(	-LRB-
46745	4827	10	2	2	CD
46745	4827	11	.	.	.
46745	4827	12	)	)	-RRB-
46745	4828	1	to	to	TO
46745	4828	2	promote	promote	VB
46745	4828	3	absorption	absorption	NN
46745	4828	4	,	,	,
46745	4828	5	by	by	IN
46745	4828	6	diminishing	diminish	VBG
46745	4828	7	the	the	DT
46745	4828	8	amount	amount	NN
46745	4828	9	of	of	IN
46745	4828	10	fluid	fluid	NN
46745	4828	11	in	in	IN
46745	4828	12	the	the	DT
46745	4828	13	blood	blood	NN
46745	4828	14	.	.	.
46745	4829	1	It	-PRON-	PRP
46745	4829	2	is	be	VBZ
46745	4829	3	easier	easy	JJR
46745	4829	4	to	to	TO
46745	4829	5	employ	employ	VB
46745	4829	6	the	the	DT
46745	4829	7	first	first	JJ
46745	4829	8	than	than	IN
46745	4829	9	to	to	TO
46745	4829	10	exert	exert	VB
46745	4829	11	the	the	DT
46745	4829	12	second	second	JJ
46745	4829	13	of	of	IN
46745	4829	14	these	these	DT
46745	4829	15	operations	operation	NNS
46745	4829	16	.	.	.
46745	4830	1	When	when	WRB
46745	4830	2	there	there	EX
46745	4830	3	is	be	VBZ
46745	4830	4	habitually	habitually	RB
46745	4830	5	a	a	DT
46745	4830	6	deposit	deposit	NN
46745	4830	7	in	in	IN
46745	4830	8	the	the	DT
46745	4830	9	urine	urine	NN
46745	4830	10	,	,	,
46745	4830	11	of	of	IN
46745	4830	12	lithates	lithate	NNS
46745	4830	13	,	,	,
46745	4830	14	or	or	CC
46745	4830	15	phosphates	phosphate	NNS
46745	4830	16	,	,	,
46745	4830	17	or	or	CC
46745	4830	18	other	other	JJ
46745	4830	19	solid	solid	JJ
46745	4830	20	matters	matter	NNS
46745	4830	21	,	,	,
46745	4830	22	the	the	DT
46745	4830	23	simplest	simple	JJS
46745	4830	24	mode	mode	NN
46745	4830	25	of	of	IN
46745	4830	26	obtaining	obtain	VBG
46745	4830	27	a	a	DT
46745	4830	28	solution	solution	NN
46745	4830	29	of	of	IN
46745	4830	30	this	this	DT
46745	4830	31	deposit	deposit	NN
46745	4830	32	,	,	,
46745	4830	33	and	and	CC
46745	4830	34	thus	thus	RB
46745	4830	35	preventing	prevent	VBG
46745	4830	36	dangerous	dangerous	JJ
46745	4830	37	consequences	consequence	NNS
46745	4830	38	,	,	,
46745	4830	39	is	be	VBZ
46745	4830	40	to	to	TO
46745	4830	41	increase	increase	VB
46745	4830	42	the	the	DT
46745	4830	43	amount	amount	NN
46745	4830	44	of	of	IN
46745	4830	45	the	the	DT
46745	4830	46	fluid	fluid	JJ
46745	4830	47	part	part	NN
46745	4830	48	of	of	IN
46745	4830	49	the	the	DT
46745	4830	50	secretion	secretion	NN
46745	4830	51	.	.	.
46745	4831	1	Water	water	NN
46745	4831	2	is	be	VBZ
46745	4831	3	the	the	DT
46745	4831	4	best	good	JJS
46745	4831	5	medicine	medicine	NN
46745	4831	6	for	for	IN
46745	4831	7	this	this	DT
46745	4831	8	purpose	purpose	NN
46745	4831	9	,	,	,
46745	4831	10	and	and	CC
46745	4831	11	all	all	DT
46745	4831	12	Diuretics	Diuretics	NNPS
46745	4831	13	that	that	WDT
46745	4831	14	are	be	VBP
46745	4831	15	given	give	VBN
46745	4831	16	with	with	IN
46745	4831	17	such	such	PDT
46745	4831	18	an	an	DT
46745	4831	19	object	object	NN
46745	4831	20	should	should	MD
46745	4831	21	be	be	VB
46745	4831	22	freely	freely	RB
46745	4831	23	diluted	dilute	VBN
46745	4831	24	with	with	IN
46745	4831	25	water	water	NN
46745	4831	26	.	.	.
46745	4832	1	In	in	IN
46745	4832	2	Gout	Gout	NNP
46745	4832	3	and	and	CC
46745	4832	4	Rheumatism	Rheumatism	NNP
46745	4832	5	,	,	,
46745	4832	6	remedies	remedy	NNS
46745	4832	7	of	of	IN
46745	4832	8	this	this	DT
46745	4832	9	order	order	NN
46745	4832	10	may	may	MD
46745	4832	11	be	be	VB
46745	4832	12	of	of	IN
46745	4832	13	service	service	NN
46745	4832	14	by	by	IN
46745	4832	15	promoting	promote	VBG
46745	4832	16	the	the	DT
46745	4832	17	excretion	excretion	NN
46745	4832	18	from	from	IN
46745	4832	19	the	the	DT
46745	4832	20	blood	blood	NN
46745	4832	21	of	of	IN
46745	4832	22	the	the	DT
46745	4832	23	uric	uric	JJ
46745	4832	24	or	or	CC
46745	4832	25	lactic	lactic	JJ
46745	4832	26	acid	acid	NN
46745	4832	27	formed	form	VBN
46745	4832	28	there	there	RB
46745	4832	29	.	.	.
46745	4833	1	They	-PRON-	PRP
46745	4833	2	may	may	MD
46745	4833	3	also	also	RB
46745	4833	4	be	be	VB
46745	4833	5	used	use	VBN
46745	4833	6	as	as	IN
46745	4833	7	Eliminatives	Eliminatives	NNPS
46745	4833	8	in	in	IN
46745	4833	9	fevers	fever	NNS
46745	4833	10	and	and	CC
46745	4833	11	other	other	JJ
46745	4833	12	disorders	disorder	NNS
46745	4833	13	.	.	.
46745	4834	1	In	in	IN
46745	4834	2	the	the	DT
46745	4834	3	strangury	strangury	NN
46745	4834	4	which	which	WDT
46745	4834	5	may	may	MD
46745	4834	6	sometimes	sometimes	RB
46745	4834	7	follow	follow	VB
46745	4834	8	the	the	DT
46745	4834	9	application	application	NN
46745	4834	10	of	of	IN
46745	4834	11	a	a	DT
46745	4834	12	blister	blister	NN
46745	4834	13	to	to	IN
46745	4834	14	the	the	DT
46745	4834	15	skin	skin	NN
46745	4834	16	,	,	,
46745	4834	17	copious	copious	JJ
46745	4834	18	draughts	draught	NNS
46745	4834	19	of	of	IN
46745	4834	20	water	water	NN
46745	4834	21	are	be	VBP
46745	4834	22	often	often	RB
46745	4834	23	prescribed	prescribe	VBN
46745	4834	24	with	with	IN
46745	4834	25	advantage	advantage	NN
46745	4834	26	,	,	,
46745	4834	27	for	for	IN
46745	4834	28	they	-PRON-	PRP
46745	4834	29	serve	serve	VBP
46745	4834	30	to	to	TO
46745	4834	31	wash	wash	VB
46745	4834	32	out	out	IN
46745	4834	33	of	of	IN
46745	4834	34	the	the	DT
46745	4834	35	blood	blood	NN
46745	4834	36	the	the	DT
46745	4834	37	acrid	acrid	JJ
46745	4834	38	matter	matter	NN
46745	4834	39	which	which	WDT
46745	4834	40	has	have	VBZ
46745	4834	41	been	be	VBN
46745	4834	42	absorbed	absorb	VBN
46745	4834	43	from	from	IN
46745	4834	44	the	the	DT
46745	4834	45	surface	surface	NN
46745	4834	46	.	.	.
46745	4835	1	It	-PRON-	PRP
46745	4835	2	is	be	VBZ
46745	4835	3	for	for	IN
46745	4835	4	the	the	DT
46745	4835	5	second	second	JJ
46745	4835	6	purpose	purpose	NN
46745	4835	7	,	,	,
46745	4835	8	in	in	IN
46745	4835	9	cases	case	NNS
46745	4835	10	of	of	IN
46745	4835	11	dropsy	dropsy	NNP
46745	4835	12	,	,	,
46745	4835	13	produced	produce	VBN
46745	4835	14	by	by	IN
46745	4835	15	congestion	congestion	NN
46745	4835	16	of	of	IN
46745	4835	17	the	the	DT
46745	4835	18	liver	liver	NN
46745	4835	19	,	,	,
46745	4835	20	kidneys	kidney	NNS
46745	4835	21	,	,	,
46745	4835	22	or	or	CC
46745	4835	23	general	general	JJ
46745	4835	24	circulation	circulation	NN
46745	4835	25	,	,	,
46745	4835	26	that	that	IN
46745	4835	27	Diuretics	diuretic	NNS
46745	4835	28	are	be	VBP
46745	4835	29	most	most	RBS
46745	4835	30	urgently	urgently	RB
46745	4835	31	required	require	VBN
46745	4835	32	,	,	,
46745	4835	33	but	but	CC
46745	4835	34	are	be	VBP
46745	4835	35	least	least	JJS
46745	4835	36	efficacious	efficacious	JJ
46745	4835	37	.	.	.
46745	4836	1	This	this	DT
46745	4836	2	congestion	congestion	NN
46745	4836	3	or	or	CC
46745	4836	4	pressure	pressure	NN
46745	4836	5	on	on	IN
46745	4836	6	the	the	DT
46745	4836	7	veins	vein	NNS
46745	4836	8	diminishes	diminish	VBZ
46745	4836	9	the	the	DT
46745	4836	10	amount	amount	NN
46745	4836	11	of	of	IN
46745	4836	12	the	the	DT
46745	4836	13	secretion	secretion	NN
46745	4836	14	of	of	IN
46745	4836	15	urine	urine	NN
46745	4836	16	,	,	,
46745	4836	17	and	and	CC
46745	4836	18	by	by	IN
46745	4836	19	so	so	RB
46745	4836	20	doing	do	VBG
46745	4836	21	increases	increase	NNS
46745	4836	22	itself	-PRON-	PRP
46745	4836	23	,	,	,
46745	4836	24	and	and	CC
46745	4836	25	aggravates	aggravate	VBZ
46745	4836	26	the	the	DT
46745	4836	27	effusion	effusion	NN
46745	4836	28	and	and	CC
46745	4836	29	disorder	disorder	NN
46745	4836	30	.	.	.
46745	4837	1	The	the	DT
46745	4837	2	same	same	JJ
46745	4837	3	cause	cause	NN
46745	4837	4	most	most	RBS
46745	4837	5	effectually	effectually	RB
46745	4837	6	hinders	hinder	VBZ
46745	4837	7	the	the	DT
46745	4837	8	action	action	NN
46745	4837	9	of	of	IN
46745	4837	10	a	a	DT
46745	4837	11	Diuretic	Diuretic	NNP
46745	4837	12	.	.	.
46745	4838	1	If	if	IN
46745	4838	2	only	only	RB
46745	4838	3	we	-PRON-	PRP
46745	4838	4	could	could	MD
46745	4838	5	largely	largely	RB
46745	4838	6	increase	increase	VB
46745	4838	7	the	the	DT
46745	4838	8	secretion	secretion	NN
46745	4838	9	of	of	IN
46745	4838	10	urine	urine	NN
46745	4838	11	,	,	,
46745	4838	12	the	the	DT
46745	4838	13	pressure	pressure	NN
46745	4838	14	on	on	IN
46745	4838	15	the	the	DT
46745	4838	16	venous	venous	JJ
46745	4838	17	system	system	NN
46745	4838	18	would	would	MD
46745	4838	19	be	be	VB
46745	4838	20	diminished	diminish	VBN
46745	4838	21	,	,	,
46745	4838	22	and	and	CC
46745	4838	23	absorption	absorption	NN
46745	4838	24	of	of	IN
46745	4838	25	the	the	DT
46745	4838	26	effused	effuse	VBN
46745	4838	27	fluids	fluid	NNS
46745	4838	28	might	may	MD
46745	4838	29	take	take	VB
46745	4838	30	place	place	NN
46745	4838	31	.	.	.
46745	4839	1	In	in	IN
46745	4839	2	some	some	DT
46745	4839	3	cases	case	NNS
46745	4839	4	of	of	IN
46745	4839	5	dropsy	dropsy	JJ
46745	4839	6	caused	cause	VBN
46745	4839	7	by	by	IN
46745	4839	8	renal	renal	JJ
46745	4839	9	congestion	congestion	NN
46745	4839	10	,	,	,
46745	4839	11	the	the	DT
46745	4839	12	attempt	attempt	NN
46745	4839	13	is	be	VBZ
46745	4839	14	so	so	RB
46745	4839	15	hopeless	hopeless	JJ
46745	4839	16	that	that	IN
46745	4839	17	it	-PRON-	PRP
46745	4839	18	is	be	VBZ
46745	4839	19	better	well	JJR
46745	4839	20	to	to	TO
46745	4839	21	resort	resort	VB
46745	4839	22	to	to	IN
46745	4839	23	Diaphoretics	Diaphoretics	NNP
46745	4839	24	.	.	.
46745	4840	1	In	in	IN
46745	4840	2	obstruction	obstruction	NN
46745	4840	3	on	on	IN
46745	4840	4	account	account	NN
46745	4840	5	of	of	IN
46745	4840	6	heart	heart	NN
46745	4840	7	disease	disease	NN
46745	4840	8	,	,	,
46745	4840	9	or	or	CC
46745	4840	10	congestion	congestion	NN
46745	4840	11	of	of	IN
46745	4840	12	the	the	DT
46745	4840	13	liver	liver	NN
46745	4840	14	,	,	,
46745	4840	15	we	-PRON-	PRP
46745	4840	16	may	may	MD
46745	4840	17	sometimes	sometimes	RB
46745	4840	18	gain	gain	VB
46745	4840	19	our	-PRON-	PRP$
46745	4840	20	point	point	NN
46745	4840	21	by	by	IN
46745	4840	22	combining	combine	VBG
46745	4840	23	other	other	JJ
46745	4840	24	Diuretics	Diuretics	NNPS
46745	4840	25	with	with	IN
46745	4840	26	Digitalis	Digitalis	NNP
46745	4840	27	or	or	CC
46745	4840	28	Blue	Blue	NNP
46745	4840	29	-	-	HYPH
46745	4840	30	pill	pill	NN
46745	4840	31	,	,	,
46745	4840	32	remedies	remedy	NNS
46745	4840	33	which	which	WDT
46745	4840	34	tend	tend	VBP
46745	4840	35	to	to	TO
46745	4840	36	remove	remove	VB
46745	4840	37	the	the	DT
46745	4840	38	causes	cause	NNS
46745	4840	39	by	by	IN
46745	4840	40	which	which	WDT
46745	4840	41	the	the	DT
46745	4840	42	diuretic	diuretic	JJ
46745	4840	43	action	action	NN
46745	4840	44	is	be	VBZ
46745	4840	45	hindered	hinder	VBN
46745	4840	46	.	.	.
46745	4841	1	(	(	-LRB-
46745	4841	2	_	_	NNP
46745	4841	3	Vide	Vide	NNP
46745	4841	4	_	_	NNP
46745	4841	5	p.	p.	NN
46745	4842	1	304	304	CD
46745	4842	2	.	.	.
46745	4842	3	)	)	-RRB-
46745	4843	1	Even	even	RB
46745	4843	2	then	then	RB
46745	4843	3	we	-PRON-	PRP
46745	4843	4	can	can	MD
46745	4843	5	often	often	RB
46745	4843	6	produce	produce	VB
46745	4843	7	a	a	DT
46745	4843	8	much	much	RB
46745	4843	9	more	more	RBR
46745	4843	10	copious	copious	JJ
46745	4843	11	and	and	CC
46745	4843	12	effectual	effectual	JJ
46745	4843	13	drain	drain	NN
46745	4843	14	of	of	IN
46745	4843	15	fluid	fluid	NN
46745	4843	16	from	from	IN
46745	4843	17	the	the	DT
46745	4843	18	blood	blood	NN
46745	4843	19	by	by	IN
46745	4843	20	an	an	DT
46745	4843	21	action	action	NN
46745	4843	22	on	on	IN
46745	4843	23	the	the	DT
46745	4843	24	bowels	bowel	NNS
46745	4843	25	,	,	,
46745	4843	26	as	as	IN
46745	4843	27	by	by	IN
46745	4843	28	a	a	DT
46745	4843	29	dose	dose	NN
46745	4843	30	of	of	IN
46745	4843	31	Jalap	Jalap	NNP
46745	4843	32	or	or	CC
46745	4843	33	Elaterium	Elaterium	NNP
46745	4843	34	.	.	.
46745	4844	1	When	when	WRB
46745	4844	2	a	a	DT
46745	4844	3	Diuretic	Diuretic	NNP
46745	4844	4	is	be	VBZ
46745	4844	5	required	require	VBN
46745	4844	6	to	to	TO
46745	4844	7	eliminate	eliminate	VB
46745	4844	8	fluid	fluid	NN
46745	4844	9	from	from	IN
46745	4844	10	the	the	DT
46745	4844	11	system	system	NN
46745	4844	12	,	,	,
46745	4844	13	the	the	DT
46745	4844	14	dose	dose	NN
46745	4844	15	should	should	MD
46745	4844	16	not	not	RB
46745	4844	17	be	be	VB
46745	4844	18	much	much	RB
46745	4844	19	diluted	dilute	VBN
46745	4844	20	with	with	IN
46745	4844	21	water	water	NN
46745	4844	22	;	;	:
46745	4844	23	this	this	DT
46745	4844	24	should	should	MD
46745	4844	25	only	only	RB
46745	4844	26	be	be	VB
46745	4844	27	done	do	VBN
46745	4844	28	when	when	WRB
46745	4844	29	we	-PRON-	PRP
46745	4844	30	desire	desire	VBP
46745	4844	31	to	to	TO
46745	4844	32	eliminate	eliminate	VB
46745	4844	33	solids	solid	NNS
46745	4844	34	from	from	IN
46745	4844	35	the	the	DT
46745	4844	36	blood	blood	NN
46745	4844	37	.	.	.
46745	4845	1	It	-PRON-	PRP
46745	4845	2	is	be	VBZ
46745	4845	3	often	often	RB
46745	4845	4	advisable	advisable	JJ
46745	4845	5	to	to	TO
46745	4845	6	combine	combine	VB
46745	4845	7	together	together	RB
46745	4845	8	a	a	DT
46745	4845	9	number	number	NN
46745	4845	10	of	of	IN
46745	4845	11	different	different	JJ
46745	4845	12	Diuretics	diuretic	NNS
46745	4845	13	,	,	,
46745	4845	14	in	in	IN
46745	4845	15	the	the	DT
46745	4845	16	same	same	JJ
46745	4845	17	prescription	prescription	NN
46745	4845	18	,	,	,
46745	4845	19	so	so	IN
46745	4845	20	that	that	IN
46745	4845	21	by	by	IN
46745	4845	22	their	-PRON-	PRP$
46745	4845	23	joint	joint	JJ
46745	4845	24	but	but	CC
46745	4845	25	various	various	JJ
46745	4845	26	agencies	agency	NNS
46745	4845	27	the	the	DT
46745	4845	28	causes	cause	NNS
46745	4845	29	which	which	WDT
46745	4845	30	hinder	hinder	VBP
46745	4845	31	their	-PRON-	PRP$
46745	4845	32	action	action	NN
46745	4845	33	may	may	MD
46745	4845	34	be	be	VB
46745	4845	35	overcome	overcome	VBN
46745	4845	36	.	.	.
46745	4846	1	The	the	DT
46745	4846	2	operation	operation	NN
46745	4846	3	of	of	IN
46745	4846	4	Diaphoretics	Diaphoretics	NNP
46745	4846	5	is	be	VBZ
46745	4846	6	opposed	oppose	VBN
46745	4846	7	to	to	IN
46745	4846	8	that	that	DT
46745	4846	9	of	of	IN
46745	4846	10	Diuretics	Diuretics	NNP
46745	4846	11	,	,	,
46745	4846	12	but	but	CC
46745	4846	13	it	-PRON-	PRP
46745	4846	14	is	be	VBZ
46745	4846	15	not	not	RB
46745	4846	16	always	always	RB
46745	4846	17	so	so	RB
46745	4846	18	with	with	IN
46745	4846	19	purgative	purgative	JJ
46745	4846	20	medicines	medicine	NNS
46745	4846	21	.	.	.
46745	4847	1	The	the	DT
46745	4847	2	urine	urine	NN
46745	4847	3	is	be	VBZ
46745	4847	4	often	often	RB
46745	4847	5	increased	increase	VBN
46745	4847	6	by	by	IN
46745	4847	7	the	the	DT
46745	4847	8	action	action	NN
46745	4847	9	of	of	IN
46745	4847	10	a	a	DT
46745	4847	11	hydragogue	hydragogue	NN
46745	4847	12	Cathartic	cathartic	JJ
46745	4847	13	;	;	:
46745	4847	14	and	and	CC
46745	4847	15	a	a	DT
46745	4847	16	combination	combination	NN
46745	4847	17	of	of	IN
46745	4847	18	Blue	Blue	NNP
46745	4847	19	-	-	HYPH
46745	4847	20	pill	pill	NN
46745	4847	21	and	and	CC
46745	4847	22	Squill	Squill	NNP
46745	4847	23	supplies	supply	VBZ
46745	4847	24	us	-PRON-	PRP
46745	4847	25	with	with	IN
46745	4847	26	one	one	CD
46745	4847	27	of	of	IN
46745	4847	28	the	the	DT
46745	4847	29	best	good	JJS
46745	4847	30	of	of	IN
46745	4847	31	known	know	VBN
46745	4847	32	Diuretics	diuretic	NNS
46745	4847	33	.	.	.
46745	4848	1	It	-PRON-	PRP
46745	4848	2	is	be	VBZ
46745	4848	3	applicable	applicable	JJ
46745	4848	4	in	in	IN
46745	4848	5	cardiac	cardiac	JJ
46745	4848	6	dropsy	dropsy	NNP
46745	4848	7	as	as	RB
46745	4848	8	well	well	RB
46745	4848	9	as	as	IN
46745	4848	10	in	in	IN
46745	4848	11	hepatic	hepatic	JJ
46745	4848	12	cases	case	NNS
46745	4848	13	.	.	.
46745	4849	1	Thus	thus	RB
46745	4849	2	is	be	VBZ
46745	4849	3	concluded	conclude	VBN
46745	4849	4	a	a	DT
46745	4849	5	brief	brief	JJ
46745	4849	6	outline	outline	NN
46745	4849	7	of	of	IN
46745	4849	8	the	the	DT
46745	4849	9	actions	action	NNS
46745	4849	10	and	and	CC
46745	4849	11	uses	use	NNS
46745	4849	12	of	of	IN
46745	4849	13	the	the	DT
46745	4849	14	six	six	CD
46745	4849	15	orders	order	NNS
46745	4849	16	of	of	IN
46745	4849	17	Eliminative	eliminative	JJ
46745	4849	18	medicines	medicine	NNS
46745	4849	19	.	.	.
46745	4850	1	CHAPTER	CHAPTER	NNP
46745	4850	2	IV	IV	NNP
46745	4850	3	.	.	.
46745	4851	1	ON	on	IN
46745	4851	2	THE	the	DT
46745	4851	3	ACTION	action	NN
46745	4851	4	OF	of	IN
46745	4851	5	SOME	some	NN
46745	4851	6	OF	of	IN
46745	4851	7	THE	the	DT
46745	4851	8	MORE	more	RBR
46745	4851	9	IMPORTANT	important	JJ
46745	4851	10	MEDICINES	medicine	NNS
46745	4851	11	IN	in	IN
46745	4851	12	PARTICULAR	PARTICULAR	NNP
46745	4851	13	.	.	.
46745	4852	1	The	the	DT
46745	4852	2	chief	chief	JJ
46745	4852	3	objects	object	NNS
46745	4852	4	for	for	IN
46745	4852	5	which	which	WDT
46745	4852	6	I	-PRON-	PRP
46745	4852	7	have	have	VBP
46745	4852	8	designed	design	VBN
46745	4852	9	this	this	DT
46745	4852	10	Fourth	Fourth	NNP
46745	4852	11	Chapter	chapter	NN
46745	4852	12	are	be	VBP
46745	4852	13	that	that	IN
46745	4852	14	I	-PRON-	PRP
46745	4852	15	may	may	MD
46745	4852	16	be	be	VB
46745	4852	17	enabled	enable	VBN
46745	4852	18	to	to	TO
46745	4852	19	illustrate	illustrate	VB
46745	4852	20	some	some	DT
46745	4852	21	general	general	JJ
46745	4852	22	principles	principle	NNS
46745	4852	23	of	of	IN
46745	4852	24	the	the	DT
46745	4852	25	action	action	NN
46745	4852	26	of	of	IN
46745	4852	27	medicines	medicine	NNS
46745	4852	28	which	which	WDT
46745	4852	29	have	have	VBP
46745	4852	30	been	be	VBN
46745	4852	31	laid	lay	VBN
46745	4852	32	down	down	RP
46745	4852	33	in	in	IN
46745	4852	34	the	the	DT
46745	4852	35	Propositions	Propositions	NNPS
46745	4852	36	,	,	,
46745	4852	37	and	and	CC
46745	4852	38	show	show	VB
46745	4852	39	in	in	IN
46745	4852	40	what	what	WDT
46745	4852	41	manner	manner	NN
46745	4852	42	they	-PRON-	PRP
46745	4852	43	are	be	VBP
46745	4852	44	applicable	applicable	JJ
46745	4852	45	to	to	IN
46745	4852	46	special	special	JJ
46745	4852	47	cases,--and	cases,--and	NNP
46745	4852	48	to	to	TO
46745	4852	49	enter	enter	VB
46745	4852	50	into	into	IN
46745	4852	51	certain	certain	JJ
46745	4852	52	details	detail	NNS
46745	4852	53	respecting	respect	VBG
46745	4852	54	the	the	DT
46745	4852	55	more	more	RBR
46745	4852	56	important	important	JJ
46745	4852	57	remedies	remedy	NNS
46745	4852	58	,	,	,
46745	4852	59	which	which	WDT
46745	4852	60	have	have	VBP
46745	4852	61	not	not	RB
46745	4852	62	been	be	VBN
46745	4852	63	attempted	attempt	VBN
46745	4852	64	as	as	RB
46745	4852	65	yet	yet	RB
46745	4852	66	.	.	.
46745	4853	1	Of	of	IN
46745	4853	2	many	many	JJ
46745	4853	3	of	of	IN
46745	4853	4	these	these	DT
46745	4853	5	medicines	medicine	NNS
46745	4853	6	a	a	DT
46745	4853	7	tolerably	tolerably	RB
46745	4853	8	full	full	JJ
46745	4853	9	account	account	NN
46745	4853	10	has	have	VBZ
46745	4853	11	already	already	RB
46745	4853	12	been	be	VBN
46745	4853	13	given	give	VBN
46745	4853	14	;	;	:
46745	4853	15	but	but	CC
46745	4853	16	they	-PRON-	PRP
46745	4853	17	may	may	MD
46745	4853	18	again	again	RB
46745	4853	19	be	be	VB
46745	4853	20	mentioned	mention	VBN
46745	4853	21	here	here	RB
46745	4853	22	for	for	IN
46745	4853	23	the	the	DT
46745	4853	24	purpose	purpose	NN
46745	4853	25	of	of	IN
46745	4853	26	shortly	shortly	RB
46745	4853	27	summing	sum	VBG
46745	4853	28	up	up	RP
46745	4853	29	their	-PRON-	PRP$
46745	4853	30	several	several	JJ
46745	4853	31	actions	action	NNS
46745	4853	32	,	,	,
46745	4853	33	and	and	CC
46745	4853	34	comparing	compare	VBG
46745	4853	35	them	-PRON-	PRP
46745	4853	36	one	one	CD
46745	4853	37	with	with	IN
46745	4853	38	another	another	DT
46745	4853	39	.	.	.
46745	4854	1	It	-PRON-	PRP
46745	4854	2	often	often	RB
46745	4854	3	happens	happen	VBZ
46745	4854	4	that	that	IN
46745	4854	5	there	there	EX
46745	4854	6	is	be	VBZ
46745	4854	7	more	more	JJR
46745	4854	8	than	than	IN
46745	4854	9	one	one	CD
46745	4854	10	point	point	NN
46745	4854	11	of	of	IN
46745	4854	12	view	view	NN
46745	4854	13	from	from	IN
46745	4854	14	which	which	WDT
46745	4854	15	the	the	DT
46745	4854	16	action	action	NN
46745	4854	17	of	of	IN
46745	4854	18	a	a	DT
46745	4854	19	medicine	medicine	NN
46745	4854	20	may	may	MD
46745	4854	21	be	be	VB
46745	4854	22	regarded	regard	VBN
46745	4854	23	.	.	.
46745	4855	1	For	for	IN
46745	4855	2	many	many	JJ
46745	4855	3	medicines	medicine	NNS
46745	4855	4	are	be	VBP
46745	4855	5	numbered	number	VBN
46745	4855	6	under	under	IN
46745	4855	7	several	several	JJ
46745	4855	8	distinct	distinct	JJ
46745	4855	9	heads	head	NNS
46745	4855	10	,	,	,
46745	4855	11	being	be	VBG
46745	4855	12	included	include	VBN
46745	4855	13	in	in	IN
46745	4855	14	different	different	JJ
46745	4855	15	groups	group	NNS
46745	4855	16	on	on	IN
46745	4855	17	account	account	NN
46745	4855	18	of	of	IN
46745	4855	19	the	the	DT
46745	4855	20	several	several	JJ
46745	4855	21	phases	phase	NNS
46745	4855	22	of	of	IN
46745	4855	23	their	-PRON-	PRP$
46745	4855	24	operation	operation	NN
46745	4855	25	.	.	.
46745	4856	1	There	there	EX
46745	4856	2	are	be	VBP
46745	4856	3	three	three	CD
46745	4856	4	stages	stage	NNS
46745	4856	5	in	in	IN
46745	4856	6	the	the	DT
46745	4856	7	progress	progress	NN
46745	4856	8	of	of	IN
46745	4856	9	the	the	DT
46745	4856	10	remedy	remedy	NN
46745	4856	11	through	through	IN
46745	4856	12	the	the	DT
46745	4856	13	system	system	NN
46745	4856	14	,	,	,
46745	4856	15	at	at	IN
46745	4856	16	each	each	DT
46745	4856	17	of	of	IN
46745	4856	18	which	which	WDT
46745	4856	19	it	-PRON-	PRP
46745	4856	20	may	may	MD
46745	4856	21	exert	exert	VB
46745	4856	22	a	a	DT
46745	4856	23	special	special	JJ
46745	4856	24	action	action	NN
46745	4856	25	.	.	.
46745	4857	1	There	there	EX
46745	4857	2	is	be	VBZ
46745	4857	3	a	a	DT
46745	4857	4	contact	contact	NN
46745	4857	5	with	with	IN
46745	4857	6	the	the	DT
46745	4857	7	surface	surface	NN
46745	4857	8	;	;	:
46745	4857	9	a	a	DT
46745	4857	10	continuance	continuance	NN
46745	4857	11	in	in	IN
46745	4857	12	the	the	DT
46745	4857	13	system	system	NN
46745	4857	14	;	;	:
46745	4857	15	and	and	CC
46745	4857	16	a	a	DT
46745	4857	17	passage	passage	NN
46745	4857	18	out	out	IN
46745	4857	19	of	of	IN
46745	4857	20	the	the	DT
46745	4857	21	system	system	NN
46745	4857	22	.	.	.
46745	4858	1	In	in	IN
46745	4858	2	the	the	DT
46745	4858	3	first	first	JJ
46745	4858	4	place	place	NN
46745	4858	5	a	a	DT
46745	4858	6	medicine	medicine	NN
46745	4858	7	touches	touch	VBZ
46745	4858	8	the	the	DT
46745	4858	9	mucous	mucous	JJ
46745	4858	10	surface	surface	NN
46745	4858	11	of	of	IN
46745	4858	12	the	the	DT
46745	4858	13	alimentary	alimentary	JJ
46745	4858	14	canal	canal	NN
46745	4858	15	;	;	:
46745	4858	16	here	here	RB
46745	4858	17	some	some	DT
46745	4858	18	few	few	JJ
46745	4858	19	evidence	evidence	NN
46745	4858	20	their	-PRON-	PRP$
46745	4858	21	action	action	NN
46745	4858	22	.	.	.
46745	4859	1	From	from	IN
46745	4859	2	this	this	DT
46745	4859	3	,	,	,
46745	4859	4	if	if	IN
46745	4859	5	in	in	IN
46745	4859	6	any	any	DT
46745	4859	7	way	way	NN
46745	4859	8	soluble	soluble	JJ
46745	4859	9	,	,	,
46745	4859	10	it	-PRON-	PRP
46745	4859	11	passes	pass	VBZ
46745	4859	12	into	into	IN
46745	4859	13	the	the	DT
46745	4859	14	blood	blood	NN
46745	4859	15	.	.	.
46745	4860	1	Here	here	RB
46745	4860	2	it	-PRON-	PRP
46745	4860	3	may	may	MD
46745	4860	4	act	act	VB
46745	4860	5	on	on	IN
46745	4860	6	the	the	DT
46745	4860	7	blood	blood	NN
46745	4860	8	,	,	,
46745	4860	9	being	be	VBG
46745	4860	10	Hæmatic	hæmatic	JJ
46745	4860	11	.	.	.
46745	4861	1	Or	or	CC
46745	4861	2	it	-PRON-	PRP
46745	4861	3	may	may	MD
46745	4861	4	employ	employ	VB
46745	4861	5	the	the	DT
46745	4861	6	blood	blood	NN
46745	4861	7	merely	merely	RB
46745	4861	8	as	as	IN
46745	4861	9	a	a	DT
46745	4861	10	means	means	NN
46745	4861	11	of	of	IN
46745	4861	12	transit	transit	NN
46745	4861	13	,	,	,
46745	4861	14	and	and	CC
46745	4861	15	direct	direct	VB
46745	4861	16	itself	-PRON-	PRP
46745	4861	17	towards	towards	IN
46745	4861	18	nerve	nerve	NN
46745	4861	19	or	or	CC
46745	4861	20	muscular	muscular	JJ
46745	4861	21	fibre	fibre	NN
46745	4861	22	,	,	,
46745	4861	23	being	be	VBG
46745	4861	24	Neurotic	neurotic	JJ
46745	4861	25	or	or	CC
46745	4861	26	Astringent	astringent	JJ
46745	4861	27	.	.	.
46745	4862	1	But	but	CC
46745	4862	2	we	-PRON-	PRP
46745	4862	3	have	have	VBP
46745	4862	4	seen	see	VBN
46745	4862	5	that	that	IN
46745	4862	6	none	none	NN
46745	4862	7	of	of	IN
46745	4862	8	these	these	DT
46745	4862	9	medicines	medicine	NNS
46745	4862	10	,	,	,
46745	4862	11	with	with	IN
46745	4862	12	the	the	DT
46745	4862	13	only	only	JJ
46745	4862	14	exception	exception	NN
46745	4862	15	of	of	IN
46745	4862	16	Restorative	Restorative	NNP
46745	4862	17	Hæmatics	Hæmatics	NNPS
46745	4862	18	,	,	,
46745	4862	19	can	can	MD
46745	4862	20	remain	remain	VB
46745	4862	21	long	long	JJ
46745	4862	22	in	in	IN
46745	4862	23	the	the	DT
46745	4862	24	system	system	NN
46745	4862	25	.	.	.
46745	4863	1	They	-PRON-	PRP
46745	4863	2	must	must	MD
46745	4863	3	pass	pass	VB
46745	4863	4	out	out	RP
46745	4863	5	,	,	,
46745	4863	6	and	and	CC
46745	4863	7	the	the	DT
46745	4863	8	mode	mode	NN
46745	4863	9	of	of	IN
46745	4863	10	passage	passage	NN
46745	4863	11	is	be	VBZ
46745	4863	12	through	through	IN
46745	4863	13	the	the	DT
46745	4863	14	glands	gland	NNS
46745	4863	15	.	.	.
46745	4864	1	Here	here	RB
46745	4864	2	is	be	VBZ
46745	4864	3	a	a	DT
46745	4864	4	third	third	JJ
46745	4864	5	opportunity	opportunity	NN
46745	4864	6	of	of	IN
46745	4864	7	operation	operation	NN
46745	4864	8	.	.	.
46745	4865	1	The	the	DT
46745	4865	2	medicine	medicine	NN
46745	4865	3	may	may	MD
46745	4865	4	act	act	VB
46745	4865	5	now	now	RB
46745	4865	6	as	as	IN
46745	4865	7	an	an	DT
46745	4865	8	Eliminative	Eliminative	NNP
46745	4865	9	,	,	,
46745	4865	10	increasing	increase	VBG
46745	4865	11	the	the	DT
46745	4865	12	secretion	secretion	NN
46745	4865	13	of	of	IN
46745	4865	14	the	the	DT
46745	4865	15	gland	gland	NN
46745	4865	16	;	;	:
46745	4865	17	or	or	CC
46745	4865	18	,	,	,
46745	4865	19	more	more	RBR
46745	4865	20	rarely	rarely	RB
46745	4865	21	,	,	,
46745	4865	22	as	as	IN
46745	4865	23	a	a	DT
46745	4865	24	glandular	glandular	JJ
46745	4865	25	Astringent	Astringent	NNP
46745	4865	26	,	,	,
46745	4865	27	because	because	IN
46745	4865	28	tending	tend	VBG
46745	4865	29	to	to	TO
46745	4865	30	diminish	diminish	VB
46745	4865	31	it	-PRON-	PRP
46745	4865	32	.	.	.
46745	4866	1	As	as	IN
46745	4866	2	a	a	DT
46745	4866	3	general	general	JJ
46745	4866	4	rule	rule	NN
46745	4866	5	,	,	,
46745	4866	6	though	though	IN
46745	4866	7	not	not	RB
46745	4866	8	in	in	IN
46745	4866	9	all	all	DT
46745	4866	10	cases	case	NNS
46745	4866	11	,	,	,
46745	4866	12	the	the	DT
46745	4866	13	most	most	RBS
46745	4866	14	important	important	JJ
46745	4866	15	action	action	NN
46745	4866	16	of	of	IN
46745	4866	17	a	a	DT
46745	4866	18	medicine	medicine	NN
46745	4866	19	is	be	VBZ
46745	4866	20	that	that	IN
46745	4866	21	which	which	WDT
46745	4866	22	it	-PRON-	PRP
46745	4866	23	first	first	JJ
46745	4866	24	evidences	evidence	VBZ
46745	4866	25	,	,	,
46745	4866	26	the	the	DT
46745	4866	27	subsequent	subsequent	JJ
46745	4866	28	operations	operation	NNS
46745	4866	29	being	be	VBG
46745	4866	30	secondary	secondary	JJ
46745	4866	31	,	,	,
46745	4866	32	and	and	CC
46745	4866	33	of	of	IN
46745	4866	34	less	less	JJR
46745	4866	35	moment	moment	NN
46745	4866	36	.	.	.
46745	4867	1	Thus	thus	RB
46745	4867	2	Mercury	Mercury	NNP
46745	4867	3	is	be	VBZ
46745	4867	4	,	,	,
46745	4867	5	in	in	IN
46745	4867	6	the	the	DT
46745	4867	7	first	first	JJ
46745	4867	8	place	place	NN
46745	4867	9	,	,	,
46745	4867	10	a	a	DT
46745	4867	11	Catalytic	Catalytic	NNP
46745	4867	12	Hæmatic	Hæmatic	NNP
46745	4867	13	;	;	:
46745	4867	14	in	in	IN
46745	4867	15	the	the	DT
46745	4867	16	second	second	JJ
46745	4867	17	place	place	NN
46745	4867	18	,	,	,
46745	4867	19	an	an	DT
46745	4867	20	Eliminative	Eliminative	NNP
46745	4867	21	.	.	.
46745	4868	1	Creosote	creosote	NN
46745	4868	2	is	be	VBZ
46745	4868	3	firstly	firstly	RB
46745	4868	4	a	a	DT
46745	4868	5	general	general	JJ
46745	4868	6	Sedative	Sedative	NNP
46745	4868	7	,	,	,
46745	4868	8	secondly	secondly	RB
46745	4868	9	an	an	DT
46745	4868	10	Astringent	Astringent	NNP
46745	4868	11	.	.	.
46745	4869	1	Antimony	Antimony	NNP
46745	4869	2	probably	probably	RB
46745	4869	3	belongs	belong	VBZ
46745	4869	4	to	to	IN
46745	4869	5	three	three	CD
46745	4869	6	out	out	IN
46745	4869	7	of	of	IN
46745	4869	8	the	the	DT
46745	4869	9	four	four	CD
46745	4869	10	classes	class	NNS
46745	4869	11	,	,	,
46745	4869	12	and	and	CC
46745	4869	13	its	-PRON-	PRP$
46745	4869	14	second	second	JJ
46745	4869	15	operation	operation	NN
46745	4869	16	is	be	VBZ
46745	4869	17	perhaps	perhaps	RB
46745	4869	18	the	the	DT
46745	4869	19	most	most	RBS
46745	4869	20	important	important	JJ
46745	4869	21	.	.	.
46745	4870	1	It	-PRON-	PRP
46745	4870	2	is	be	VBZ
46745	4870	3	a	a	DT
46745	4870	4	Catalytic	catalytic	JJ
46745	4870	5	,	,	,
46745	4870	6	a	a	DT
46745	4870	7	special	special	JJ
46745	4870	8	Sedative	Sedative	NNP
46745	4870	9	,	,	,
46745	4870	10	and	and	CC
46745	4870	11	also	also	RB
46745	4870	12	an	an	DT
46745	4870	13	Eliminative	eliminative	NN
46745	4870	14	.	.	.
46745	4871	1	COD	COD	NNP
46745	4871	2	-	-	HYPH
46745	4871	3	LIVER	LIVER	NNP
46745	4871	4	OIL	OIL	NNP
46745	4871	5	.	.	.
46745	4872	1	Class	class	NN
46745	4872	2	I.	I.	NNP
46745	4872	3	Div	Div	NNP
46745	4872	4	.	.	.
46745	4873	1	I.	I.	NNP
46745	4873	2	Ord	Ord	NNP
46745	4873	3	.	.	.
46745	4874	1	I.	I.	NNP
46745	4874	2	ALIMENTA	ALIMENTA	NNP
46745	4874	3	.	.	.
46745	4875	1	This	this	DT
46745	4875	2	oil	oil	NN
46745	4875	3	has	have	VBZ
46745	4875	4	been	be	VBN
46745	4875	5	proved	prove	VBN
46745	4875	6	by	by	IN
46745	4875	7	the	the	DT
46745	4875	8	experience	experience	NN
46745	4875	9	of	of	IN
46745	4875	10	many	many	JJ
46745	4875	11	physicians	physician	NNS
46745	4875	12	to	to	TO
46745	4875	13	be	be	VB
46745	4875	14	a	a	DT
46745	4875	15	medicine	medicine	NN
46745	4875	16	of	of	IN
46745	4875	17	great	great	JJ
46745	4875	18	utility	utility	NN
46745	4875	19	in	in	IN
46745	4875	20	most	most	JJS
46745	4875	21	cases	case	NNS
46745	4875	22	in	in	IN
46745	4875	23	which	which	WDT
46745	4875	24	there	there	EX
46745	4875	25	is	be	VBZ
46745	4875	26	a	a	DT
46745	4875	27	general	general	JJ
46745	4875	28	deficiency	deficiency	NN
46745	4875	29	of	of	IN
46745	4875	30	fat	fat	NN
46745	4875	31	in	in	IN
46745	4875	32	the	the	DT
46745	4875	33	system	system	NN
46745	4875	34	.	.	.
46745	4876	1	It	-PRON-	PRP
46745	4876	2	is	be	VBZ
46745	4876	3	thought	think	VBN
46745	4876	4	also	also	RB
46745	4876	5	to	to	TO
46745	4876	6	exert	exert	VB
46745	4876	7	a	a	DT
46745	4876	8	specific	specific	JJ
46745	4876	9	action	action	NN
46745	4876	10	in	in	IN
46745	4876	11	the	the	DT
46745	4876	12	cure	cure	NN
46745	4876	13	of	of	IN
46745	4876	14	pulmonary	pulmonary	JJ
46745	4876	15	Phthisis	Phthisis	NNP
46745	4876	16	,	,	,
46745	4876	17	and	and	CC
46745	4876	18	it	-PRON-	PRP
46745	4876	19	certainly	certainly	RB
46745	4876	20	appears	appear	VBZ
46745	4876	21	to	to	TO
46745	4876	22	be	be	VB
46745	4876	23	the	the	DT
46745	4876	24	only	only	JJ
46745	4876	25	medicine	medicine	NN
46745	4876	26	that	that	WDT
46745	4876	27	possesses	possess	VBZ
46745	4876	28	any	any	DT
46745	4876	29	marked	marked	JJ
46745	4876	30	or	or	CC
46745	4876	31	peculiar	peculiar	JJ
46745	4876	32	power	power	NN
46745	4876	33	over	over	IN
46745	4876	34	the	the	DT
46745	4876	35	progress	progress	NN
46745	4876	36	of	of	IN
46745	4876	37	this	this	DT
46745	4876	38	disorder	disorder	NN
46745	4876	39	.	.	.
46745	4877	1	When	when	WRB
46745	4877	2	administered	administer	VBN
46745	4877	3	in	in	IN
46745	4877	4	favourable	favourable	JJ
46745	4877	5	cases	case	NNS
46745	4877	6	it	-PRON-	PRP
46745	4877	7	seems	seem	VBZ
46745	4877	8	not	not	RB
46745	4877	9	only	only	JJ
46745	4877	10	to	to	TO
46745	4877	11	have	have	VB
46745	4877	12	the	the	DT
46745	4877	13	power	power	NN
46745	4877	14	of	of	IN
46745	4877	15	fattening	fatten	VBG
46745	4877	16	the	the	DT
46745	4877	17	patient	patient	NN
46745	4877	18	,	,	,
46745	4877	19	but	but	CC
46745	4877	20	to	to	TO
46745	4877	21	be	be	VB
46745	4877	22	able	able	JJ
46745	4877	23	also	also	RB
46745	4877	24	to	to	TO
46745	4877	25	combat	combat	VB
46745	4877	26	and	and	CC
46745	4877	27	cure	cure	VB
46745	4877	28	the	the	DT
46745	4877	29	disease	disease	NN
46745	4877	30	itself	-PRON-	PRP
46745	4877	31	,	,	,
46745	4877	32	arresting	arrest	VBG
46745	4877	33	or	or	CC
46745	4877	34	retarding	retard	VBG
46745	4877	35	the	the	DT
46745	4877	36	tubercular	tubercular	JJ
46745	4877	37	deposit	deposit	NN
46745	4877	38	.	.	.
46745	4878	1	Sometimes	sometimes	RB
46745	4878	2	it	-PRON-	PRP
46745	4878	3	is	be	VBZ
46745	4878	4	unable	unable	JJ
46745	4878	5	to	to	TO
46745	4878	6	do	do	VB
46745	4878	7	this	this	DT
46745	4878	8	;	;	:
46745	4878	9	but	but	CC
46745	4878	10	in	in	IN
46745	4878	11	all	all	DT
46745	4878	12	cases	case	NNS
46745	4878	13	of	of	IN
46745	4878	14	consumption	consumption	NN
46745	4878	15	a	a	DT
46745	4878	16	trial	trial	NN
46745	4878	17	should	should	MD
46745	4878	18	at	at	IN
46745	4878	19	least	least	JJS
46745	4878	20	be	be	VB
46745	4878	21	given	give	VBN
46745	4878	22	to	to	IN
46745	4878	23	it	-PRON-	PRP
46745	4878	24	.	.	.
46745	4879	1	It	-PRON-	PRP
46745	4879	2	is	be	VBZ
46745	4879	3	of	of	IN
46745	4879	4	most	most	JJS
46745	4879	5	service	service	NN
46745	4879	6	when	when	WRB
46745	4879	7	the	the	DT
46745	4879	8	disease	disease	NN
46745	4879	9	is	be	VBZ
46745	4879	10	only	only	RB
46745	4879	11	incipient	incipient	JJ
46745	4879	12	,	,	,
46745	4879	13	and	and	CC
46745	4879	14	,	,	,
46745	4879	15	if	if	IN
46745	4879	16	given	give	VBN
46745	4879	17	in	in	IN
46745	4879	18	the	the	DT
46745	4879	19	first	first	JJ
46745	4879	20	stage	stage	NN
46745	4879	21	,	,	,
46745	4879	22	may	may	MD
46745	4879	23	often	often	RB
46745	4879	24	prevent	prevent	VB
46745	4879	25	its	-PRON-	PRP$
46745	4879	26	further	further	JJ
46745	4879	27	progress	progress	NN
46745	4879	28	;	;	:
46745	4879	29	but	but	CC
46745	4879	30	it	-PRON-	PRP
46745	4879	31	may	may	MD
46745	4879	32	even	even	RB
46745	4879	33	cure	cure	VB
46745	4879	34	patients	patient	NNS
46745	4879	35	in	in	IN
46745	4879	36	whom	whom	WP
46745	4879	37	the	the	DT
46745	4879	38	deposit	deposit	NN
46745	4879	39	has	have	VBZ
46745	4879	40	passed	pass	VBN
46745	4879	41	the	the	DT
46745	4879	42	stage	stage	NN
46745	4879	43	of	of	IN
46745	4879	44	softening	soften	VBG
46745	4879	45	,	,	,
46745	4879	46	as	as	IN
46745	4879	47	appears	appear	VBZ
46745	4879	48	from	from	IN
46745	4879	49	the	the	DT
46745	4879	50	reports	report	NNS
46745	4879	51	of	of	IN
46745	4879	52	the	the	DT
46745	4879	53	Brompton	Brompton	NNP
46745	4879	54	Hospital	Hospital	NNP
46745	4879	55	.	.	.
46745	4880	1	It	-PRON-	PRP
46745	4880	2	is	be	VBZ
46745	4880	3	also	also	RB
46745	4880	4	of	of	IN
46745	4880	5	use	use	NN
46745	4880	6	in	in	IN
46745	4880	7	Scrofula	Scrofula	NNP
46745	4880	8	,	,	,
46745	4880	9	in	in	IN
46745	4880	10	chronic	chronic	JJ
46745	4880	11	Rheumatism	rheumatism	NN
46745	4880	12	,	,	,
46745	4880	13	and	and	CC
46745	4880	14	in	in	IN
46745	4880	15	cases	case	NNS
46745	4880	16	of	of	IN
46745	4880	17	emaciation	emaciation	NN
46745	4880	18	generally	generally	RB
46745	4880	19	.	.	.
46745	4881	1	It	-PRON-	PRP
46745	4881	2	may	may	MD
46745	4881	3	prove	prove	VB
46745	4881	4	nutritive	nutritive	JJ
46745	4881	5	in	in	IN
46745	4881	6	Diabetes	diabetes	NN
46745	4881	7	mellitus	mellitus	NN
46745	4881	8	,	,	,
46745	4881	9	because	because	IN
46745	4881	10	it	-PRON-	PRP
46745	4881	11	is	be	VBZ
46745	4881	12	not	not	RB
46745	4881	13	likely	likely	JJ
46745	4881	14	to	to	TO
46745	4881	15	be	be	VB
46745	4881	16	converted	convert	VBN
46745	4881	17	into	into	IN
46745	4881	18	sugar	sugar	NN
46745	4881	19	in	in	IN
46745	4881	20	the	the	DT
46745	4881	21	system	system	NN
46745	4881	22	,	,	,
46745	4881	23	whereas	whereas	IN
46745	4881	24	in	in	IN
46745	4881	25	that	that	DT
46745	4881	26	disorder	disorder	NN
46745	4881	27	all	all	DT
46745	4881	28	kinds	kind	NNS
46745	4881	29	of	of	IN
46745	4881	30	food	food	NN
46745	4881	31	,	,	,
46745	4881	32	excepting	except	VBG
46745	4881	33	fats	fat	NNS
46745	4881	34	and	and	CC
46745	4881	35	oils	oil	NNS
46745	4881	36	,	,	,
46745	4881	37	are	be	VBP
46745	4881	38	liable	liable	JJ
46745	4881	39	to	to	IN
46745	4881	40	this	this	DT
46745	4881	41	change	change	NN
46745	4881	42	.	.	.
46745	4882	1	Cod	cod	VB
46745	4882	2	-	-	HYPH
46745	4882	3	liver	liver	NN
46745	4882	4	oil	oil	NN
46745	4882	5	is	be	VBZ
46745	4882	6	assimilated	assimilate	VBN
46745	4882	7	to	to	IN
46745	4882	8	the	the	DT
46745	4882	9	tissues	tissue	NNS
46745	4882	10	,	,	,
46745	4882	11	and	and	CC
46745	4882	12	there	there	EX
46745	4882	13	seems	seem	VBZ
46745	4882	14	to	to	TO
46745	4882	15	be	be	VB
46745	4882	16	something	something	NN
46745	4882	17	in	in	IN
46745	4882	18	it	-PRON-	PRP
46745	4882	19	which	which	WDT
46745	4882	20	not	not	RB
46745	4882	21	only	only	RB
46745	4882	22	renders	render	VBZ
46745	4882	23	it	-PRON-	PRP
46745	4882	24	more	more	RBR
46745	4882	25	easy	easy	JJ
46745	4882	26	to	to	TO
46745	4882	27	assimilate	assimilate	VB
46745	4882	28	than	than	IN
46745	4882	29	other	other	JJ
46745	4882	30	oils	oil	NNS
46745	4882	31	,	,	,
46745	4882	32	but	but	CC
46745	4882	33	which	which	WDT
46745	4882	34	further	further	RB
46745	4882	35	endows	endow	VBZ
46745	4882	36	it	-PRON-	PRP
46745	4882	37	with	with	IN
46745	4882	38	a	a	DT
46745	4882	39	special	special	JJ
46745	4882	40	influence	influence	NN
46745	4882	41	over	over	IN
46745	4882	42	tuberculous	tuberculous	JJ
46745	4882	43	diseases	disease	NNS
46745	4882	44	.	.	.
46745	4883	1	It	-PRON-	PRP
46745	4883	2	does	do	VBZ
46745	4883	3	not	not	RB
46745	4883	4	appear	appear	VB
46745	4883	5	that	that	IN
46745	4883	6	any	any	DT
46745	4883	7	other	other	JJ
46745	4883	8	oils	oil	NNS
46745	4883	9	are	be	VBP
46745	4883	10	equally	equally	RB
46745	4883	11	effective	effective	JJ
46745	4883	12	.	.	.
46745	4884	1	Though	though	IN
46745	4884	2	Dr.	Dr.	NNP
46745	4884	3	Duncan	Duncan	NNP
46745	4884	4	and	and	CC
46745	4884	5	Mr.	Mr.	NNP
46745	4884	6	Nunn	Nunn	NNP
46745	4884	7	have	have	VBP
46745	4884	8	recommended	recommend	VBN
46745	4884	9	Almond	Almond	NNP
46745	4884	10	-	-	HYPH
46745	4884	11	oil	oil	NN
46745	4884	12	instead	instead	RB
46745	4884	13	of	of	IN
46745	4884	14	Cod	cod	NN
46745	4884	15	-	-	HYPH
46745	4884	16	liver	liver	NN
46745	4884	17	oil	oil	NN
46745	4884	18	,	,	,
46745	4884	19	yet	yet	CC
46745	4884	20	the	the	DT
46745	4884	21	general	general	JJ
46745	4884	22	experience	experience	NN
46745	4884	23	of	of	IN
46745	4884	24	others	other	NNS
46745	4884	25	is	be	VBZ
46745	4884	26	decidedly	decidedly	RB
46745	4884	27	against	against	IN
46745	4884	28	such	such	PDT
46745	4884	29	a	a	DT
46745	4884	30	substitution	substitution	NN
46745	4884	31	.	.	.
46745	4885	1	It	-PRON-	PRP
46745	4885	2	has	have	VBZ
46745	4885	3	not	not	RB
46745	4885	4	yet	yet	RB
46745	4885	5	been	be	VBN
46745	4885	6	clearly	clearly	RB
46745	4885	7	ascertained	ascertain	VBN
46745	4885	8	to	to	IN
46745	4885	9	which	which	WDT
46745	4885	10	of	of	IN
46745	4885	11	the	the	DT
46745	4885	12	constituents	constituent	NNS
46745	4885	13	of	of	IN
46745	4885	14	this	this	DT
46745	4885	15	oil	oil	NN
46745	4885	16	its	-PRON-	PRP$
46745	4885	17	valuable	valuable	JJ
46745	4885	18	properties	property	NNS
46745	4885	19	are	be	VBP
46745	4885	20	owing	owe	VBG
46745	4885	21	.	.	.
46745	4886	1	Being	be	VBG
46745	4886	2	itself	-PRON-	PRP
46745	4886	3	an	an	DT
46745	4886	4	animal	animal	NN
46745	4886	5	product	product	NN
46745	4886	6	,	,	,
46745	4886	7	it	-PRON-	PRP
46745	4886	8	is	be	VBZ
46745	4886	9	for	for	IN
46745	4886	10	that	that	DT
46745	4886	11	reason	reason	NN
46745	4886	12	more	more	RBR
46745	4886	13	easy	easy	JJ
46745	4886	14	of	of	IN
46745	4886	15	assimilation	assimilation	NN
46745	4886	16	than	than	IN
46745	4886	17	a	a	DT
46745	4886	18	vegetable	vegetable	JJ
46745	4886	19	oil	oil	NN
46745	4886	20	.	.	.
46745	4887	1	Many	many	JJ
46745	4887	2	have	have	VBP
46745	4887	3	attributed	attribute	VBN
46745	4887	4	its	-PRON-	PRP$
46745	4887	5	virtues	virtue	NNS
46745	4887	6	to	to	IN
46745	4887	7	Iodine	Iodine	NNP
46745	4887	8	,	,	,
46745	4887	9	of	of	IN
46745	4887	10	which	which	WDT
46745	4887	11	,	,	,
46745	4887	12	according	accord	VBG
46745	4887	13	to	to	IN
46745	4887	14	De	De	NNP
46745	4887	15	Jongh	Jongh	NNP
46745	4887	16	,	,	,
46745	4887	17	it	-PRON-	PRP
46745	4887	18	contains	contain	VBZ
46745	4887	19	29	29	CD
46745	4887	20	parts	part	NNS
46745	4887	21	in	in	IN
46745	4887	22	100,000	100,000	CD
46745	4887	23	.	.	.
46745	4888	1	Dr.	Dr.	NNP
46745	4888	2	Theophilus	Theophilus	NNP
46745	4888	3	Thompson	Thompson	NNP
46745	4888	4	has	have	VBZ
46745	4888	5	tried	try	VBN
46745	4888	6	both	both	DT
46745	4888	7	Olive	Olive	NNP
46745	4888	8	and	and	CC
46745	4888	9	Almond	Almond	NNP
46745	4888	10	oils	oil	NNS
46745	4888	11	in	in	IN
46745	4888	12	consumptive	consumptive	JJ
46745	4888	13	cases	case	NNS
46745	4888	14	,	,	,
46745	4888	15	but	but	CC
46745	4888	16	has	have	VBZ
46745	4888	17	not	not	RB
46745	4888	18	found	find	VBN
46745	4888	19	that	that	IN
46745	4888	20	any	any	DT
46745	4888	21	material	material	NN
46745	4888	22	benefit	benefit	NN
46745	4888	23	is	be	VBZ
46745	4888	24	derived	derive	VBN
46745	4888	25	from	from	IN
46745	4888	26	their	-PRON-	PRP$
46745	4888	27	use	use	NN
46745	4888	28	.	.	.
46745	4889	1	He	-PRON-	PRP
46745	4889	2	considers	consider	VBZ
46745	4889	3	that	that	IN
46745	4889	4	Cod	cod	NN
46745	4889	5	-	-	HYPH
46745	4889	6	oil	oil	NN
46745	4889	7	produces	produce	VBZ
46745	4889	8	its	-PRON-	PRP$
46745	4889	9	best	good	JJS
46745	4889	10	effects	effect	NNS
46745	4889	11	in	in	IN
46745	4889	12	cases	case	NNS
46745	4889	13	where	where	WRB
46745	4889	14	Iodine	Iodine	NNP
46745	4889	15	would	would	MD
46745	4889	16	be	be	VB
46745	4889	17	inadmissible	inadmissible	JJ
46745	4889	18	.	.	.
46745	4890	1	Neither	neither	CC
46745	4890	2	does	do	VBZ
46745	4890	3	he	-PRON-	PRP
46745	4890	4	think	think	VB
46745	4890	5	its	-PRON-	PRP$
46745	4890	6	virtue	virtue	NN
46745	4890	7	to	to	TO
46745	4890	8	be	be	VB
46745	4890	9	due	due	IN
46745	4890	10	to	to	IN
46745	4890	11	the	the	DT
46745	4890	12	biliary	biliary	JJ
46745	4890	13	matters	matter	NNS
46745	4890	14	which	which	WDT
46745	4890	15	it	-PRON-	PRP
46745	4890	16	contains	contain	VBZ
46745	4890	17	,	,	,
46745	4890	18	for	for	IN
46745	4890	19	a	a	DT
46745	4890	20	mixture	mixture	NN
46745	4890	21	of	of	IN
46745	4890	22	ox	ox	JJ
46745	4890	23	-	-	NN
46745	4890	24	gall	gall	NN
46745	4890	25	with	with	IN
46745	4890	26	Almond	Almond	NNP
46745	4890	27	-	-	HYPH
46745	4890	28	oil	oil	NN
46745	4890	29	does	do	VBZ
46745	4890	30	not	not	RB
46745	4890	31	supply	supply	VB
46745	4890	32	its	-PRON-	PRP$
46745	4890	33	place	place	NN
46745	4890	34	.	.	.
46745	4891	1	Cod	cod	NN
46745	4891	2	-	-	HYPH
46745	4891	3	oil	oil	NN
46745	4891	4	contains	contain	VBZ
46745	4891	5	7	7	CD
46745	4891	6	-	-	SYM
46745	4891	7	1/2	1/2	CD
46745	4891	8	parts	part	NNS
46745	4891	9	in	in	IN
46745	4891	10	100,000	100,000	CD
46745	4891	11	of	of	IN
46745	4891	12	Phosphorus	Phosphorus	NNP
46745	4891	13	.	.	.
46745	4892	1	Dr.	Dr.	NNP
46745	4892	2	Thompson	Thompson	NNP
46745	4892	3	supposes	suppose	VBZ
46745	4892	4	that	that	IN
46745	4892	5	its	-PRON-	PRP$
46745	4892	6	efficacy	efficacy	NN
46745	4892	7	may	may	MD
46745	4892	8	be	be	VB
46745	4892	9	partly	partly	RB
46745	4892	10	owing	owe	VBG
46745	4892	11	to	to	IN
46745	4892	12	this	this	DT
46745	4892	13	.	.	.
46745	4893	1	He	-PRON-	PRP
46745	4893	2	has	have	VBZ
46745	4893	3	made	make	VBN
46745	4893	4	trial	trial	NN
46745	4893	5	of	of	IN
46745	4893	6	Phosphuretted	Phosphuretted	NNP
46745	4893	7	Almond	Almond	NNP
46745	4893	8	-	-	HYPH
46745	4893	9	oil	oil	NN
46745	4893	10	,	,	,
46745	4893	11	containing	contain	VBG
46745	4893	12	one	one	CD
46745	4893	13	grain	grain	NN
46745	4893	14	of	of	IN
46745	4893	15	Phosphorus	Phosphorus	NNP
46745	4893	16	to	to	IN
46745	4893	17	the	the	DT
46745	4893	18	pint	pint	NN
46745	4893	19	.	.	.
46745	4894	1	He	-PRON-	PRP
46745	4894	2	suggests	suggest	VBZ
46745	4894	3	that	that	IN
46745	4894	4	this	this	DT
46745	4894	5	Phosphorus	Phosphorus	NNP
46745	4894	6	may	may	MD
46745	4894	7	be	be	VB
46745	4894	8	of	of	IN
46745	4894	9	use	use	NN
46745	4894	10	in	in	IN
46745	4894	11	diverting	divert	VBG
46745	4894	12	some	some	DT
46745	4894	13	of	of	IN
46745	4894	14	the	the	DT
46745	4894	15	Oxygen	oxygen	NN
46745	4894	16	from	from	IN
46745	4894	17	the	the	DT
46745	4894	18	tissues	tissue	NNS
46745	4894	19	.	.	.
46745	4895	1	This	this	DT
46745	4895	2	is	be	VBZ
46745	4895	3	to	to	TO
46745	4895	4	adopt	adopt	VB
46745	4895	5	Liebig	Liebig	NNP
46745	4895	6	's	's	POS
46745	4895	7	theory	theory	NN
46745	4895	8	of	of	IN
46745	4895	9	the	the	DT
46745	4895	10	excess	excess	NN
46745	4895	11	of	of	IN
46745	4895	12	Oxygen	Oxygen	NNP
46745	4895	13	in	in	IN
46745	4895	14	Phthisis	Phthisis	NNP
46745	4895	15	;	;	:
46745	4895	16	an	an	DT
46745	4895	17	idea	idea	NN
46745	4895	18	which	which	WDT
46745	4895	19	is	be	VBZ
46745	4895	20	not	not	RB
46745	4895	21	very	very	RB
46745	4895	22	consistent	consistent	JJ
46745	4895	23	with	with	IN
46745	4895	24	the	the	DT
46745	4895	25	experiments	experiment	NNS
46745	4895	26	of	of	IN
46745	4895	27	Dr.	Dr.	NNP
46745	4895	28	Hutchinson	Hutchinson	NNP
46745	4895	29	on	on	IN
46745	4895	30	his	-PRON-	PRP$
46745	4895	31	Spirometer	Spirometer	NNP
46745	4895	32	,	,	,
46745	4895	33	from	from	IN
46745	4895	34	which	which	WDT
46745	4895	35	it	-PRON-	PRP
46745	4895	36	appears	appear	VBZ
46745	4895	37	that	that	IN
46745	4895	38	the	the	DT
46745	4895	39	quantity	quantity	NN
46745	4895	40	of	of	IN
46745	4895	41	air	air	NN
46745	4895	42	inhaled	inhale	VBN
46745	4895	43	at	at	IN
46745	4895	44	each	each	DT
46745	4895	45	breath	breath	NN
46745	4895	46	by	by	IN
46745	4895	47	a	a	DT
46745	4895	48	consumptive	consumptive	JJ
46745	4895	49	patient	patient	NN
46745	4895	50	is	be	VBZ
46745	4895	51	considerably	considerably	RB
46745	4895	52	less	less	JJR
46745	4895	53	than	than	IN
46745	4895	54	in	in	IN
46745	4895	55	health	health	NN
46745	4895	56	,	,	,
46745	4895	57	on	on	IN
46745	4895	58	account	account	NN
46745	4895	59	of	of	IN
46745	4895	60	a	a	DT
46745	4895	61	diminished	diminished	JJ
46745	4895	62	capacity	capacity	NN
46745	4895	63	of	of	IN
46745	4895	64	the	the	DT
46745	4895	65	lungs	lung	NNS
46745	4895	66	.	.	.
46745	4896	1	But	but	CC
46745	4896	2	when	when	WRB
46745	4896	3	a	a	DT
46745	4896	4	continual	continual	JJ
46745	4896	5	fever	fever	NN
46745	4896	6	has	have	VBZ
46745	4896	7	set	set	VBN
46745	4896	8	in	in	RP
46745	4896	9	,	,	,
46745	4896	10	an	an	DT
46745	4896	11	oxidation	oxidation	NN
46745	4896	12	and	and	CC
46745	4896	13	waste	waste	NN
46745	4896	14	of	of	IN
46745	4896	15	the	the	DT
46745	4896	16	tissues	tissue	NNS
46745	4896	17	must	must	MD
46745	4896	18	certainly	certainly	RB
46745	4896	19	take	take	VB
46745	4896	20	place	place	NN
46745	4896	21	.	.	.
46745	4897	1	(	(	-LRB-
46745	4897	2	_	_	NNP
46745	4897	3	Lancet	Lancet	NNP
46745	4897	4	_	_	NNP
46745	4897	5	,	,	,
46745	4897	6	October	October	NNP
46745	4897	7	,	,	,
46745	4897	8	1851	1851	CD
46745	4897	9	.	.	.
46745	4897	10	)	)	-RRB-
46745	4898	1	The	the	DT
46745	4898	2	Phosphorus	Phosphorus	NNPS
46745	4898	3	in	in	IN
46745	4898	4	Cod	cod	NN
46745	4898	5	-	-	HYPH
46745	4898	6	liver	liver	NN
46745	4898	7	oil	oil	NN
46745	4898	8	would	would	MD
46745	4898	9	soon	soon	RB
46745	4898	10	be	be	VB
46745	4898	11	oxidized	oxidize	VBN
46745	4898	12	,	,	,
46745	4898	13	and	and	CC
46745	4898	14	it	-PRON-	PRP
46745	4898	15	would	would	MD
46745	4898	16	seem	seem	VB
46745	4898	17	to	to	TO
46745	4898	18	be	be	VB
46745	4898	19	too	too	RB
46745	4898	20	small	small	JJ
46745	4898	21	in	in	IN
46745	4898	22	amount	amount	NN
46745	4898	23	to	to	TO
46745	4898	24	be	be	VB
46745	4898	25	of	of	IN
46745	4898	26	service	service	NN
46745	4898	27	in	in	IN
46745	4898	28	this	this	DT
46745	4898	29	way	way	NN
46745	4898	30	.	.	.
46745	4899	1	If	if	IN
46745	4899	2	any	any	DT
46745	4899	3	thing	thing	NN
46745	4899	4	were	be	VBD
46745	4899	5	thus	thus	RB
46745	4899	6	needed	need	VBN
46745	4899	7	as	as	IN
46745	4899	8	a	a	DT
46745	4899	9	pabulum	pabulum	NN
46745	4899	10	for	for	IN
46745	4899	11	Oxygen	Oxygen	NNP
46745	4899	12	,	,	,
46745	4899	13	we	-PRON-	PRP
46745	4899	14	might	may	MD
46745	4899	15	suppose	suppose	VB
46745	4899	16	it	-PRON-	PRP
46745	4899	17	to	to	TO
46745	4899	18	be	be	VB
46745	4899	19	the	the	DT
46745	4899	20	oil	oil	NN
46745	4899	21	itself	-PRON-	PRP
46745	4899	22	that	that	WDT
46745	4899	23	was	be	VBD
46745	4899	24	thus	thus	RB
46745	4899	25	burnt	burn	VBN
46745	4899	26	.	.	.
46745	4900	1	Possibly	possibly	RB
46745	4900	2	the	the	DT
46745	4900	3	utility	utility	NN
46745	4900	4	of	of	IN
46745	4900	5	this	this	DT
46745	4900	6	medicine	medicine	NN
46745	4900	7	may	may	MD
46745	4900	8	depend	depend	VB
46745	4900	9	upon	upon	IN
46745	4900	10	a	a	DT
46745	4900	11	combination	combination	NN
46745	4900	12	of	of	IN
46745	4900	13	several	several	JJ
46745	4900	14	constituents	constituent	NNS
46745	4900	15	and	and	CC
46745	4900	16	various	various	JJ
46745	4900	17	properties	property	NNS
46745	4900	18	.	.	.
46745	4901	1	It	-PRON-	PRP
46745	4901	2	is	be	VBZ
46745	4901	3	an	an	DT
46745	4901	4	oil	oil	NN
46745	4901	5	;	;	:
46745	4901	6	and	and	CC
46745	4901	7	thus	thus	RB
46745	4901	8	of	of	IN
46745	4901	9	use	use	NN
46745	4901	10	as	as	IN
46745	4901	11	an	an	DT
46745	4901	12	Aliment	Aliment	NNP
46745	4901	13	,	,	,
46745	4901	14	and	and	CC
46745	4901	15	as	as	IN
46745	4901	16	a	a	DT
46745	4901	17	supporter	supporter	NN
46745	4901	18	of	of	IN
46745	4901	19	the	the	DT
46745	4901	20	respiratory	respiratory	JJ
46745	4901	21	function	function	NN
46745	4901	22	.	.	.
46745	4902	1	It	-PRON-	PRP
46745	4902	2	is	be	VBZ
46745	4902	3	an	an	DT
46745	4902	4	animal	animal	NN
46745	4902	5	oil	oil	NN
46745	4902	6	;	;	:
46745	4902	7	and	and	CC
46745	4902	8	thus	thus	RB
46745	4902	9	peculiarly	peculiarly	RB
46745	4902	10	adapted	adapt	VBN
46745	4902	11	for	for	IN
46745	4902	12	being	be	VBG
46745	4902	13	digested	digest	VBN
46745	4902	14	,	,	,
46745	4902	15	absorbed	absorb	VBN
46745	4902	16	and	and	CC
46745	4902	17	assimilated	assimilate	VBN
46745	4902	18	to	to	IN
46745	4902	19	the	the	DT
46745	4902	20	adipose	adipose	JJ
46745	4902	21	tissues	tissue	NNS
46745	4902	22	of	of	IN
46745	4902	23	the	the	DT
46745	4902	24	human	human	JJ
46745	4902	25	body	body	NN
46745	4902	26	.	.	.
46745	4903	1	It	-PRON-	PRP
46745	4903	2	contains	contain	VBZ
46745	4903	3	Iodine	Iodine	NNP
46745	4903	4	and	and	CC
46745	4903	5	Bromine	Bromine	NNP
46745	4903	6	,	,	,
46745	4903	7	which	which	WDT
46745	4903	8	are	be	VBP
46745	4903	9	useful	useful	JJ
46745	4903	10	as	as	IN
46745	4903	11	Alteratives	alterative	NNS
46745	4903	12	or	or	CC
46745	4903	13	blood	blood	NN
46745	4903	14	medicines	medicine	NNS
46745	4903	15	,	,	,
46745	4903	16	both	both	CC
46745	4903	17	in	in	IN
46745	4903	18	Phthisis	Phthisis	NNP
46745	4903	19	and	and	CC
46745	4903	20	Scrofula	Scrofula	NNP
46745	4903	21	.	.	.
46745	4904	1	Their	-PRON-	PRP$
46745	4904	2	proportion	proportion	NN
46745	4904	3	will	will	MD
46745	4904	4	not	not	RB
46745	4904	5	seem	seem	VB
46745	4904	6	so	so	RB
46745	4904	7	small	small	JJ
46745	4904	8	when	when	WRB
46745	4904	9	the	the	DT
46745	4904	10	large	large	JJ
46745	4904	11	dose	dose	NN
46745	4904	12	of	of	IN
46745	4904	13	the	the	DT
46745	4904	14	oil	oil	NN
46745	4904	15	and	and	CC
46745	4904	16	its	-PRON-	PRP$
46745	4904	17	frequent	frequent	JJ
46745	4904	18	repetition	repetition	NN
46745	4904	19	are	be	VBP
46745	4904	20	taken	take	VBN
46745	4904	21	into	into	IN
46745	4904	22	account	account	NN
46745	4904	23	.	.	.
46745	4905	1	But	but	CC
46745	4905	2	their	-PRON-	PRP$
46745	4905	3	presence	presence	NN
46745	4905	4	alone	alone	RB
46745	4905	5	would	would	MD
46745	4905	6	not	not	RB
46745	4905	7	be	be	VB
46745	4905	8	sufficient	sufficient	JJ
46745	4905	9	to	to	TO
46745	4905	10	explain	explain	VB
46745	4905	11	the	the	DT
46745	4905	12	utility	utility	NN
46745	4905	13	of	of	IN
46745	4905	14	the	the	DT
46745	4905	15	oil	oil	NN
46745	4905	16	.	.	.
46745	4906	1	It	-PRON-	PRP
46745	4906	2	contains	contain	VBZ
46745	4906	3	also	also	RB
46745	4906	4	Phosphorus	Phosphorus	NNP
46745	4906	5	,	,	,
46745	4906	6	a	a	DT
46745	4906	7	general	general	JJ
46745	4906	8	Stimulant	Stimulant	NNP
46745	4906	9	,	,	,
46745	4906	10	which	which	WDT
46745	4906	11	may	may	MD
46745	4906	12	prove	prove	VB
46745	4906	13	of	of	IN
46745	4906	14	use	use	NN
46745	4906	15	when	when	WRB
46745	4906	16	there	there	EX
46745	4906	17	is	be	VBZ
46745	4906	18	a	a	DT
46745	4906	19	failure	failure	NN
46745	4906	20	of	of	IN
46745	4906	21	the	the	DT
46745	4906	22	nervous	nervous	JJ
46745	4906	23	forces	force	NNS
46745	4906	24	.	.	.
46745	4907	1	Sometimes	sometimes	RB
46745	4907	2	the	the	DT
46745	4907	3	dose	dose	NN
46745	4907	4	of	of	IN
46745	4907	5	the	the	DT
46745	4907	6	oil	oil	NN
46745	4907	7	excites	excite	VBZ
46745	4907	8	a	a	DT
46745	4907	9	most	most	RBS
46745	4907	10	distressing	distressing	JJ
46745	4907	11	nausea	nausea	NN
46745	4907	12	.	.	.
46745	4908	1	This	this	DT
46745	4908	2	may	may	MD
46745	4908	3	perhaps	perhaps	RB
46745	4908	4	be	be	VB
46745	4908	5	prevented	prevent	VBN
46745	4908	6	by	by	IN
46745	4908	7	a	a	DT
46745	4908	8	judicious	judicious	JJ
46745	4908	9	modification	modification	NN
46745	4908	10	of	of	IN
46745	4908	11	the	the	DT
46745	4908	12	vehicle	vehicle	NN
46745	4908	13	.	.	.
46745	4909	1	It	-PRON-	PRP
46745	4909	2	may	may	MD
46745	4909	3	be	be	VB
46745	4909	4	floated	float	VBN
46745	4909	5	on	on	IN
46745	4909	6	an	an	DT
46745	4909	7	aromatic	aromatic	JJ
46745	4909	8	water	water	NN
46745	4909	9	,	,	,
46745	4909	10	on	on	IN
46745	4909	11	a	a	DT
46745	4909	12	bitter	bitter	JJ
46745	4909	13	infusion	infusion	NN
46745	4909	14	,	,	,
46745	4909	15	on	on	IN
46745	4909	16	milk	milk	NN
46745	4909	17	,	,	,
46745	4909	18	on	on	IN
46745	4909	19	wine	wine	NN
46745	4909	20	,	,	,
46745	4909	21	or	or	CC
46745	4909	22	on	on	IN
46745	4909	23	cold	cold	JJ
46745	4909	24	tea	tea	NN
46745	4909	25	,	,	,
46745	4909	26	to	to	TO
46745	4909	27	suit	suit	VB
46745	4909	28	various	various	JJ
46745	4909	29	tastes	taste	NNS
46745	4909	30	.	.	.
46745	4910	1	In	in	IN
46745	4910	2	other	other	JJ
46745	4910	3	instances	instance	NNS
46745	4910	4	the	the	DT
46745	4910	5	dose	dose	NN
46745	4910	6	is	be	VBZ
46745	4910	7	swallowed	swallow	VBN
46745	4910	8	without	without	IN
46745	4910	9	inconvenience	inconvenience	NN
46745	4910	10	,	,	,
46745	4910	11	but	but	CC
46745	4910	12	the	the	DT
46745	4910	13	patient	patient	NN
46745	4910	14	is	be	VBZ
46745	4910	15	not	not	RB
46745	4910	16	fattened	fatten	VBN
46745	4910	17	,	,	,
46745	4910	18	nor	nor	CC
46745	4910	19	is	be	VBZ
46745	4910	20	his	-PRON-	PRP$
46745	4910	21	condition	condition	NN
46745	4910	22	in	in	IN
46745	4910	23	the	the	DT
46745	4910	24	least	least	JJS
46745	4910	25	improved	improve	VBN
46745	4910	26	by	by	IN
46745	4910	27	it	-PRON-	PRP
46745	4910	28	.	.	.
46745	4911	1	In	in	IN
46745	4911	2	such	such	JJ
46745	4911	3	incurable	incurable	JJ
46745	4911	4	conditions	condition	NNS
46745	4911	5	it	-PRON-	PRP
46745	4911	6	is	be	VBZ
46745	4911	7	probable	probable	JJ
46745	4911	8	that	that	IN
46745	4911	9	there	there	EX
46745	4911	10	is	be	VBZ
46745	4911	11	often	often	RB
46745	4911	12	an	an	DT
46745	4911	13	organic	organic	JJ
46745	4911	14	disease	disease	NN
46745	4911	15	of	of	IN
46745	4911	16	the	the	DT
46745	4911	17	Pancreas	Pancreas	NNP
46745	4911	18	,	,	,
46745	4911	19	or	or	CC
46745	4911	20	a	a	DT
46745	4911	21	failure	failure	NN
46745	4911	22	in	in	IN
46745	4911	23	the	the	DT
46745	4911	24	function	function	NN
46745	4911	25	of	of	IN
46745	4911	26	that	that	DT
46745	4911	27	gland	gland	NN
46745	4911	28	.	.	.
46745	4912	1	For	for	IN
46745	4912	2	it	-PRON-	PRP
46745	4912	3	appears	appear	VBZ
46745	4912	4	that	that	IN
46745	4912	5	the	the	DT
46745	4912	6	absorption	absorption	NN
46745	4912	7	of	of	IN
46745	4912	8	fats	fat	NNS
46745	4912	9	is	be	VBZ
46745	4912	10	effected	effect	VBN
46745	4912	11	by	by	IN
46745	4912	12	means	mean	NNS
46745	4912	13	of	of	IN
46745	4912	14	an	an	DT
46745	4912	15	alkali	alkali	JJ
46745	4912	16	contained	contain	VBN
46745	4912	17	in	in	IN
46745	4912	18	the	the	DT
46745	4912	19	Pancreatic	pancreatic	JJ
46745	4912	20	fluid	fluid	NN
46745	4912	21	.	.	.
46745	4913	1	When	when	WRB
46745	4913	2	there	there	EX
46745	4913	3	is	be	VBZ
46745	4913	4	reason	reason	NN
46745	4913	5	to	to	TO
46745	4913	6	suspect	suspect	VB
46745	4913	7	this	this	DT
46745	4913	8	cause	cause	NN
46745	4913	9	of	of	IN
46745	4913	10	the	the	DT
46745	4913	11	emaciation	emaciation	NN
46745	4913	12	,	,	,
46745	4913	13	it	-PRON-	PRP
46745	4913	14	is	be	VBZ
46745	4913	15	advisable	advisable	JJ
46745	4913	16	to	to	TO
46745	4913	17	saponify	saponify	VB
46745	4913	18	the	the	DT
46745	4913	19	oil	oil	NN
46745	4913	20	by	by	IN
46745	4913	21	shaking	shake	VBG
46745	4913	22	it	-PRON-	PRP
46745	4913	23	with	with	IN
46745	4913	24	a	a	DT
46745	4913	25	sufficient	sufficient	JJ
46745	4913	26	quantity	quantity	NN
46745	4913	27	of	of	IN
46745	4913	28	solution	solution	NN
46745	4913	29	of	of	IN
46745	4913	30	Potash	Potash	NNP
46745	4913	31	or	or	CC
46745	4913	32	of	of	IN
46745	4913	33	Carbonate	Carbonate	NNP
46745	4913	34	of	of	IN
46745	4913	35	Soda	Soda	NNP
46745	4913	36	.	.	.
46745	4914	1	The	the	DT
46745	4914	2	dose	dose	NN
46745	4914	3	will	will	MD
46745	4914	4	then	then	RB
46745	4914	5	be	be	VB
46745	4914	6	in	in	IN
46745	4914	7	a	a	DT
46745	4914	8	state	state	NN
46745	4914	9	of	of	IN
46745	4914	10	solution	solution	NN
46745	4914	11	,	,	,
46745	4914	12	and	and	CC
46745	4914	13	ready	ready	JJ
46745	4914	14	for	for	IN
46745	4914	15	absorption	absorption	NN
46745	4914	16	.	.	.
46745	4915	1	Cod	cod	VB
46745	4915	2	-	-	HYPH
46745	4915	3	liver	liver	NN
46745	4915	4	oil	oil	NN
46745	4915	5	may	may	MD
46745	4915	6	be	be	VB
46745	4915	7	used	use	VBN
46745	4915	8	with	with	IN
46745	4915	9	advantage	advantage	NN
46745	4915	10	as	as	IN
46745	4915	11	a	a	DT
46745	4915	12	vehicle	vehicle	NN
46745	4915	13	for	for	IN
46745	4915	14	Iodide	Iodide	NNP
46745	4915	15	of	of	IN
46745	4915	16	Iron	Iron	NNP
46745	4915	17	,	,	,
46745	4915	18	in	in	IN
46745	4915	19	scrofulous	scrofulous	JJ
46745	4915	20	cases	case	NNS
46745	4915	21	.	.	.
46745	4916	1	Two	two	CD
46745	4916	2	grains	grain	NNS
46745	4916	3	of	of	IN
46745	4916	4	this	this	DT
46745	4916	5	may	may	MD
46745	4916	6	be	be	VB
46745	4916	7	dissolved	dissolve	VBN
46745	4916	8	in	in	IN
46745	4916	9	each	each	DT
46745	4916	10	ounce	ounce	NN
46745	4916	11	of	of	IN
46745	4916	12	the	the	DT
46745	4916	13	oil	oil	NN
46745	4916	14	.	.	.
46745	4917	1	(	(	-LRB-
46745	4917	2	_	_	NNP
46745	4917	3	Vide	Vide	NNP
46745	4917	4	_	_	NNP
46745	4917	5	pp	pp	NNP
46745	4917	6	.	.	.
46745	4918	1	119	119	CD
46745	4918	2	,	,	,
46745	4918	3	191	191	CD
46745	4918	4	,	,	,
46745	4918	5	229	229	CD
46745	4918	6	.	.	.
46745	4919	1	[	[	-LRB-
46745	4919	2	47	47	CD
46745	4919	3	]	]	-RRB-
46745	4919	4	)	)	-RRB-
46745	4919	5	SULPHURIC	SULPHURIC	NNP
46745	4919	6	ACID	ACID	NNP
46745	4919	7	.	.	.
46745	4920	1	Class	class	NN
46745	4920	2	I.	I.	NNP
46745	4920	3	Div	Div	NNP
46745	4920	4	.	.	.
46745	4921	1	I.	I.	NNP
46745	4921	2	Ord	Ord	NNP
46745	4921	3	.	.	.
46745	4922	1	II	ii	CD
46745	4922	2	.	.	.
46745	4923	1	ACIDA	ACIDA	NNP
46745	4923	2	.	.	.
46745	4924	1	Class	class	NN
46745	4924	2	III	iii	CD
46745	4924	3	.	.	.
46745	4925	1	Ord	Ord	NNP
46745	4925	2	.	.	.
46745	4926	1	I.	I.	NNP
46745	4926	2	ASTRINGENTIA	ASTRINGENTIA	NNP
46745	4926	3	MINERALIA	MINERALIA	NNP
46745	4926	4	.	.	.
46745	4927	1	This	this	DT
46745	4927	2	medicine	medicine	NN
46745	4927	3	acts	act	VBZ
46745	4927	4	chemically	chemically	RB
46745	4927	5	as	as	IN
46745	4927	6	an	an	DT
46745	4927	7	acid	acid	NN
46745	4927	8	in	in	IN
46745	4927	9	the	the	DT
46745	4927	10	blood	blood	NN
46745	4927	11	and	and	CC
46745	4927	12	in	in	IN
46745	4927	13	the	the	DT
46745	4927	14	secretions	secretion	NNS
46745	4927	15	.	.	.
46745	4928	1	When	when	WRB
46745	4928	2	diluted	dilute	VBN
46745	4928	3	it	-PRON-	PRP
46745	4928	4	is	be	VBZ
46745	4928	5	easily	easily	RB
46745	4928	6	absorbed	absorb	VBN
46745	4928	7	,	,	,
46745	4928	8	and	and	CC
46745	4928	9	meeting	meeting	NN
46745	4928	10	in	in	IN
46745	4928	11	the	the	DT
46745	4928	12	stomach	stomach	NN
46745	4928	13	with	with	IN
46745	4928	14	an	an	DT
46745	4928	15	acid	acid	JJ
46745	4928	16	secretion	secretion	NN
46745	4928	17	,	,	,
46745	4928	18	it	-PRON-	PRP
46745	4928	19	passes	pass	VBZ
46745	4928	20	into	into	IN
46745	4928	21	the	the	DT
46745	4928	22	circulation	circulation	NN
46745	4928	23	without	without	IN
46745	4928	24	being	be	VBG
46745	4928	25	first	first	RB
46745	4928	26	neutralized	neutralize	VBN
46745	4928	27	.	.	.
46745	4929	1	If	if	IN
46745	4929	2	in	in	IN
46745	4929	3	small	small	JJ
46745	4929	4	quantity	quantity	NN
46745	4929	5	,	,	,
46745	4929	6	it	-PRON-	PRP
46745	4929	7	is	be	VBZ
46745	4929	8	neutralized	neutralize	VBN
46745	4929	9	by	by	IN
46745	4929	10	the	the	DT
46745	4929	11	slight	slight	JJ
46745	4929	12	excess	excess	NN
46745	4929	13	of	of	IN
46745	4929	14	alkali	alkali	JJ
46745	4929	15	in	in	IN
46745	4929	16	the	the	DT
46745	4929	17	blood	blood	NN
46745	4929	18	;	;	:
46745	4929	19	if	if	IN
46745	4929	20	in	in	IN
46745	4929	21	larger	large	JJR
46745	4929	22	amount	amount	NN
46745	4929	23	,	,	,
46745	4929	24	it	-PRON-	PRP
46745	4929	25	may	may	MD
46745	4929	26	exceed	exceed	VB
46745	4929	27	this	this	DT
46745	4929	28	alkali	alkali	JJ
46745	4929	29	,	,	,
46745	4929	30	and	and	CC
46745	4929	31	displace	displace	VB
46745	4929	32	and	and	CC
46745	4929	33	set	set	VB
46745	4929	34	free	free	JJ
46745	4929	35	other	other	JJ
46745	4929	36	acids	acid	NNS
46745	4929	37	in	in	IN
46745	4929	38	the	the	DT
46745	4929	39	blood	blood	NN
46745	4929	40	,	,	,
46745	4929	41	combining	combine	VBG
46745	4929	42	with	with	IN
46745	4929	43	their	-PRON-	PRP$
46745	4929	44	bases	basis	NNS
46745	4929	45	on	on	IN
46745	4929	46	account	account	NN
46745	4929	47	of	of	IN
46745	4929	48	its	-PRON-	PRP$
46745	4929	49	strong	strong	JJ
46745	4929	50	affinities	affinity	NNS
46745	4929	51	.	.	.
46745	4930	1	In	in	IN
46745	4930	2	all	all	DT
46745	4930	3	cases	case	NNS
46745	4930	4	it	-PRON-	PRP
46745	4930	5	increases	increase	VBZ
46745	4930	6	the	the	DT
46745	4930	7	quantity	quantity	NN
46745	4930	8	of	of	IN
46745	4930	9	free	free	JJ
46745	4930	10	acid	acid	NN
46745	4930	11	in	in	IN
46745	4930	12	the	the	DT
46745	4930	13	system	system	NN
46745	4930	14	,	,	,
46745	4930	15	and	and	CC
46745	4930	16	tends	tend	VBZ
46745	4930	17	to	to	TO
46745	4930	18	render	render	VB
46745	4930	19	the	the	DT
46745	4930	20	secretions	secretion	NNS
46745	4930	21	,	,	,
46745	4930	22	as	as	IN
46745	4930	23	the	the	DT
46745	4930	24	urine	urine	NN
46745	4930	25	,	,	,
46745	4930	26	more	more	RBR
46745	4930	27	acid	acid	JJ
46745	4930	28	than	than	IN
46745	4930	29	they	-PRON-	PRP
46745	4930	30	were	be	VBD
46745	4930	31	before	before	RB
46745	4930	32	.	.	.
46745	4931	1	(	(	-LRB-
46745	4931	2	_	_	NNP
46745	4931	3	Vide	Vide	NNP
46745	4931	4	_	_	NNP
46745	4931	5	Dr.	Dr.	NNP
46745	4931	6	Bence	Bence	NNP
46745	4931	7	Jones	Jones	NNP
46745	4931	8	's	's	POS
46745	4931	9	_	_	NNP
46745	4931	10	Animal	Animal	NNP
46745	4931	11	Chemistry	Chemistry	NNP
46745	4931	12	_	_	NNP
46745	4931	13	,	,	,
46745	4931	14	p.	p.	NN
46745	4932	1	49	49	CD
46745	4932	2	.	.	.
46745	4932	3	)	)	-RRB-
46745	4933	1	By	by	IN
46745	4933	2	this	this	DT
46745	4933	3	chemical	chemical	NN
46745	4933	4	action	action	NN
46745	4933	5	Sulphuric	Sulphuric	NNP
46745	4933	6	Acid	Acid	NNP
46745	4933	7	is	be	VBZ
46745	4933	8	rendered	render	VBN
46745	4933	9	useful	useful	JJ
46745	4933	10	in	in	IN
46745	4933	11	alkalinity	alkalinity	NN
46745	4933	12	of	of	IN
46745	4933	13	the	the	DT
46745	4933	14	blood	blood	NN
46745	4933	15	,	,	,
46745	4933	16	which	which	WDT
46745	4933	17	may	may	MD
46745	4933	18	occur	occur	VB
46745	4933	19	in	in	IN
46745	4933	20	fevers	fever	NNS
46745	4933	21	;	;	:
46745	4933	22	or	or	CC
46745	4933	23	of	of	IN
46745	4933	24	the	the	DT
46745	4933	25	urine	urine	NN
46745	4933	26	,	,	,
46745	4933	27	as	as	IN
46745	4933	28	in	in	IN
46745	4933	29	Phosphaturia	Phosphaturia	NNP
46745	4933	30	.	.	.
46745	4934	1	It	-PRON-	PRP
46745	4934	2	thus	thus	RB
46745	4934	3	acts	act	VBZ
46745	4934	4	as	as	IN
46745	4934	5	a	a	DT
46745	4934	6	Restorative	Restorative	NNP
46745	4934	7	Hæmatic	Hæmatic	NNP
46745	4934	8	.	.	.
46745	4935	1	But	but	CC
46745	4935	2	it	-PRON-	PRP
46745	4935	3	is	be	VBZ
46745	4935	4	not	not	RB
46745	4935	5	right	right	JJ
46745	4935	6	that	that	IN
46745	4935	7	there	there	EX
46745	4935	8	should	should	MD
46745	4935	9	be	be	VB
46745	4935	10	more	more	JJR
46745	4935	11	than	than	IN
46745	4935	12	a	a	DT
46745	4935	13	certain	certain	JJ
46745	4935	14	quantity	quantity	NN
46745	4935	15	of	of	IN
46745	4935	16	this	this	DT
46745	4935	17	acid	acid	NN
46745	4935	18	in	in	IN
46745	4935	19	the	the	DT
46745	4935	20	system	system	NN
46745	4935	21	.	.	.
46745	4936	1	So	so	IN
46745	4936	2	that	that	DT
46745	4936	3	when	when	WRB
46745	4936	4	introduced	introduce	VBN
46745	4936	5	in	in	IN
46745	4936	6	large	large	JJ
46745	4936	7	quantity	quantity	NN
46745	4936	8	it	-PRON-	PRP
46745	4936	9	must	must	MD
46745	4936	10	be	be	VB
46745	4936	11	excreted	excrete	VBN
46745	4936	12	.	.	.
46745	4937	1	It	-PRON-	PRP
46745	4937	2	does	do	VBZ
46745	4937	3	not	not	RB
46745	4937	4	appear	appear	VB
46745	4937	5	that	that	IN
46745	4937	6	it	-PRON-	PRP
46745	4937	7	is	be	VBZ
46745	4937	8	itself	-PRON-	PRP
46745	4937	9	excreted	excrete	VBN
46745	4937	10	in	in	IN
46745	4937	11	the	the	DT
46745	4937	12	urine	urine	NN
46745	4937	13	,	,	,
46745	4937	14	though	though	IN
46745	4937	15	it	-PRON-	PRP
46745	4937	16	may	may	MD
46745	4937	17	cause	cause	VB
46745	4937	18	an	an	DT
46745	4937	19	excess	excess	NN
46745	4937	20	of	of	IN
46745	4937	21	other	other	JJ
46745	4937	22	acids	acid	NNS
46745	4937	23	in	in	IN
46745	4937	24	that	that	DT
46745	4937	25	secretion	secretion	NN
46745	4937	26	.	.	.
46745	4938	1	On	on	IN
46745	4938	2	this	this	DT
46745	4938	3	point	point	NN
46745	4938	4	Dr.	Dr.	NNP
46745	4938	5	Bence	Bence	NNP
46745	4938	6	Jones	Jones	NNP
46745	4938	7	has	have	VBZ
46745	4938	8	made	make	VBN
46745	4938	9	some	some	DT
46745	4938	10	careful	careful	JJ
46745	4938	11	experiments	experiment	NNS
46745	4938	12	.	.	.
46745	4939	1	(	(	-LRB-
46745	4939	2	_	_	NNP
46745	4939	3	Anim	Anim	NNP
46745	4939	4	.	.	.
46745	4940	1	Chem	Chem	NNP
46745	4940	2	.	.	.
46745	4940	3	_	_	NNP
46745	4940	4	,	,	,
46745	4940	5	p.	p.	NN
46745	4941	1	75	75	CD
46745	4941	2	.	.	.
46745	4941	3	)	)	-RRB-
46745	4942	1	He	-PRON-	PRP
46745	4942	2	finds	find	VBZ
46745	4942	3	that	that	IN
46745	4942	4	Sulphuric	Sulphuric	NNP
46745	4942	5	Acid	Acid	NNP
46745	4942	6	does	do	VBZ
46745	4942	7	not	not	RB
46745	4942	8	pass	pass	VB
46745	4942	9	off	off	RP
46745	4942	10	in	in	IN
46745	4942	11	the	the	DT
46745	4942	12	urine	urine	NN
46745	4942	13	,	,	,
46745	4942	14	either	either	CC
46745	4942	15	free	free	JJ
46745	4942	16	or	or	CC
46745	4942	17	in	in	IN
46745	4942	18	combination	combination	NN
46745	4942	19	,	,	,
46745	4942	20	except	except	IN
46745	4942	21	when	when	WRB
46745	4942	22	given	give	VBN
46745	4942	23	in	in	IN
46745	4942	24	great	great	JJ
46745	4942	25	quantity	quantity	NN
46745	4942	26	.	.	.
46745	4943	1	Now	now	RB
46745	4943	2	it	-PRON-	PRP
46745	4943	3	is	be	VBZ
46745	4943	4	found	find	VBN
46745	4943	5	that	that	IN
46745	4943	6	Sulphuric	Sulphuric	NNP
46745	4943	7	Acid	Acid	NNP
46745	4943	8	is	be	VBZ
46745	4943	9	of	of	IN
46745	4943	10	great	great	JJ
46745	4943	11	use	use	NN
46745	4943	12	as	as	IN
46745	4943	13	an	an	DT
46745	4943	14	Astringent	Astringent	NNP
46745	4943	15	in	in	IN
46745	4943	16	diarrh[oe]a	diarrh[oe]a	NNP
46745	4943	17	.	.	.
46745	4944	1	Placing	place	VBG
46745	4944	2	these	these	DT
46745	4944	3	two	two	CD
46745	4944	4	facts	fact	NNS
46745	4944	5	in	in	IN
46745	4944	6	juxtaposition	juxtaposition	NN
46745	4944	7	,	,	,
46745	4944	8	it	-PRON-	PRP
46745	4944	9	would	would	MD
46745	4944	10	seem	seem	VB
46745	4944	11	that	that	IN
46745	4944	12	the	the	DT
46745	4944	13	acid	acid	NN
46745	4944	14	,	,	,
46745	4944	15	which	which	WDT
46745	4944	16	is	be	VBZ
46745	4944	17	doubtless	doubtless	RB
46745	4944	18	absorbed	absorb	VBN
46745	4944	19	in	in	IN
46745	4944	20	the	the	DT
46745	4944	21	first	first	JJ
46745	4944	22	place	place	NN
46745	4944	23	,	,	,
46745	4944	24	must	must	MD
46745	4944	25	afterwards	afterwards	RB
46745	4944	26	be	be	VB
46745	4944	27	eliminated	eliminate	VBN
46745	4944	28	from	from	IN
46745	4944	29	the	the	DT
46745	4944	30	system	system	NN
46745	4944	31	by	by	IN
46745	4944	32	the	the	DT
46745	4944	33	surface	surface	NN
46745	4944	34	of	of	IN
46745	4944	35	the	the	DT
46745	4944	36	bowels	bowel	NNS
46745	4944	37	.	.	.
46745	4945	1	This	this	DT
46745	4945	2	is	be	VBZ
46745	4945	3	perhaps	perhaps	RB
46745	4945	4	because	because	IN
46745	4945	5	the	the	DT
46745	4945	6	secretion	secretion	NN
46745	4945	7	of	of	IN
46745	4945	8	this	this	DT
46745	4945	9	mucous	mucous	JJ
46745	4945	10	membrane	membrane	NN
46745	4945	11	is	be	VBZ
46745	4945	12	the	the	DT
46745	4945	13	one	one	CD
46745	4945	14	which	which	WDT
46745	4945	15	is	be	VBZ
46745	4945	16	least	least	RBS
46745	4945	17	likely	likely	JJ
46745	4945	18	to	to	TO
46745	4945	19	be	be	VB
46745	4945	20	deranged	derange	VBN
46745	4945	21	by	by	IN
46745	4945	22	the	the	DT
46745	4945	23	presence	presence	NN
46745	4945	24	of	of	IN
46745	4945	25	the	the	DT
46745	4945	26	acid	acid	NN
46745	4945	27	.	.	.
46745	4946	1	The	the	DT
46745	4946	2	free	free	JJ
46745	4946	3	acid	acid	NN
46745	4946	4	is	be	VBZ
46745	4946	5	an	an	DT
46745	4946	6	Astringent	Astringent	NNP
46745	4946	7	,	,	,
46745	4946	8	and	and	CC
46745	4946	9	has	have	VBZ
46745	4946	10	the	the	DT
46745	4946	11	power	power	NN
46745	4946	12	of	of	IN
46745	4946	13	coagulating	coagulate	VBG
46745	4946	14	albumen	albuman	NNS
46745	4946	15	,	,	,
46745	4946	16	and	and	CC
46745	4946	17	causing	cause	VBG
46745	4946	18	the	the	DT
46745	4946	19	contraction	contraction	NN
46745	4946	20	of	of	IN
46745	4946	21	muscular	muscular	JJ
46745	4946	22	fibre	fibre	NNP
46745	4946	23	.	.	.
46745	4947	1	(	(	-LRB-
46745	4947	2	p.	p.	NN
46745	4948	1	256	256	CD
46745	4948	2	.	.	.
46745	4948	3	)	)	-RRB-
46745	4949	1	Though	though	IN
46745	4949	2	probably	probably	RB
46745	4949	3	neutralized	neutralize	VBN
46745	4949	4	and	and	CC
46745	4949	5	combined	combine	VBN
46745	4949	6	while	while	IN
46745	4949	7	in	in	IN
46745	4949	8	the	the	DT
46745	4949	9	blood	blood	NN
46745	4949	10	,	,	,
46745	4949	11	it	-PRON-	PRP
46745	4949	12	is	be	VBZ
46745	4949	13	free	free	JJ
46745	4949	14	before	before	IN
46745	4949	15	absorption	absorption	NN
46745	4949	16	,	,	,
46745	4949	17	and	and	CC
46745	4949	18	after	after	IN
46745	4949	19	excretion	excretion	NN
46745	4949	20	.	.	.
46745	4950	1	Before	before	IN
46745	4950	2	absorption	absorption	NN
46745	4950	3	it	-PRON-	PRP
46745	4950	4	is	be	VBZ
46745	4950	5	an	an	DT
46745	4950	6	Astringent	Astringent	NNP
46745	4950	7	to	to	IN
46745	4950	8	the	the	DT
46745	4950	9	surface	surface	NN
46745	4950	10	of	of	IN
46745	4950	11	the	the	DT
46745	4950	12	stomach	stomach	NN
46745	4950	13	;	;	:
46745	4950	14	after	after	IN
46745	4950	15	and	and	CC
46745	4950	16	during	during	IN
46745	4950	17	excretion	excretion	NN
46745	4950	18	,	,	,
46745	4950	19	to	to	IN
46745	4950	20	the	the	DT
46745	4950	21	surface	surface	NN
46745	4950	22	of	of	IN
46745	4950	23	the	the	DT
46745	4950	24	bowels	bowel	NNS
46745	4950	25	.	.	.
46745	4951	1	It	-PRON-	PRP
46745	4951	2	is	be	VBZ
46745	4951	3	useful	useful	JJ
46745	4951	4	chemically	chemically	RB
46745	4951	5	in	in	IN
46745	4951	6	alkaline	alkaline	NN
46745	4951	7	Pyrosis	Pyrosis	NNP
46745	4951	8	.	.	.
46745	4952	1	Its	-PRON-	PRP$
46745	4952	2	astringent	astringent	JJ
46745	4952	3	property	property	NN
46745	4952	4	explains	explain	VBZ
46745	4952	5	its	-PRON-	PRP$
46745	4952	6	utility	utility	NN
46745	4952	7	in	in	IN
46745	4952	8	_	_	NNP
46745	4952	9	acid	acid	NN
46745	4952	10	_	_	NNP
46745	4952	11	dyspepsia	dyspepsia	NNP
46745	4952	12	,	,	,
46745	4952	13	which	which	WDT
46745	4952	14	appears	appear	VBZ
46745	4952	15	at	at	IN
46745	4952	16	first	first	JJ
46745	4952	17	sight	sight	NN
46745	4952	18	incomprehensible	incomprehensible	JJ
46745	4952	19	.	.	.
46745	4953	1	Lactic	lactic	JJ
46745	4953	2	acid	acid	NN
46745	4953	3	,	,	,
46745	4953	4	or	or	CC
46745	4953	5	some	some	DT
46745	4953	6	similar	similar	JJ
46745	4953	7	acid	acid	NN
46745	4953	8	,	,	,
46745	4953	9	is	be	VBZ
46745	4953	10	poured	pour	VBN
46745	4953	11	out	out	RP
46745	4953	12	in	in	IN
46745	4953	13	excess	excess	NN
46745	4953	14	by	by	IN
46745	4953	15	the	the	DT
46745	4953	16	glands	gland	NNS
46745	4953	17	of	of	IN
46745	4953	18	the	the	DT
46745	4953	19	stomach	stomach	NN
46745	4953	20	.	.	.
46745	4954	1	Sulphuric	sulphuric	JJ
46745	4954	2	acid	acid	NN
46745	4954	3	topically	topically	RB
46745	4954	4	constringes	constringe	VBZ
46745	4954	5	the	the	DT
46745	4954	6	muscular	muscular	JJ
46745	4954	7	fibre	fibre	NN
46745	4954	8	of	of	IN
46745	4954	9	the	the	DT
46745	4954	10	ducts	duct	NNS
46745	4954	11	of	of	IN
46745	4954	12	these	these	DT
46745	4954	13	glands	gland	NNS
46745	4954	14	,	,	,
46745	4954	15	and	and	CC
46745	4954	16	in	in	IN
46745	4954	17	this	this	DT
46745	4954	18	way	way	NN
46745	4954	19	diminishes	diminish	VBZ
46745	4954	20	their	-PRON-	PRP$
46745	4954	21	secretion	secretion	NN
46745	4954	22	.	.	.
46745	4955	1	The	the	DT
46745	4955	2	acid	acid	NN
46745	4955	3	,	,	,
46745	4955	4	if	if	IN
46745	4955	5	in	in	IN
46745	4955	6	excess	excess	NN
46745	4955	7	in	in	IN
46745	4955	8	the	the	DT
46745	4955	9	blood	blood	NN
46745	4955	10	,	,	,
46745	4955	11	may	may	MD
46745	4955	12	tend	tend	VB
46745	4955	13	to	to	TO
46745	4955	14	brace	brace	VB
46745	4955	15	the	the	DT
46745	4955	16	system	system	NN
46745	4955	17	by	by	IN
46745	4955	18	causing	cause	VBG
46745	4955	19	a	a	DT
46745	4955	20	general	general	JJ
46745	4955	21	contraction	contraction	NN
46745	4955	22	of	of	IN
46745	4955	23	the	the	DT
46745	4955	24	fibres	fibre	NNS
46745	4955	25	of	of	IN
46745	4955	26	the	the	DT
46745	4955	27	voluntary	voluntary	JJ
46745	4955	28	muscles	muscle	NNS
46745	4955	29	.	.	.
46745	4956	1	But	but	CC
46745	4956	2	it	-PRON-	PRP
46745	4956	3	is	be	VBZ
46745	4956	4	chiefly	chiefly	RB
46745	4956	5	on	on	IN
46745	4956	6	account	account	NN
46745	4956	7	of	of	IN
46745	4956	8	its	-PRON-	PRP$
46745	4956	9	anti	anti	JJ
46745	4956	10	-	-	JJ
46745	4956	11	dyspeptic	dyspeptic	JJ
46745	4956	12	agency	agency	NN
46745	4956	13	,	,	,
46745	4956	14	and	and	CC
46745	4956	15	its	-PRON-	PRP$
46745	4956	16	astringent	astringent	JJ
46745	4956	17	action	action	NN
46745	4956	18	on	on	IN
46745	4956	19	the	the	DT
46745	4956	20	secretions	secretion	NNS
46745	4956	21	,	,	,
46745	4956	22	that	that	IN
46745	4956	23	the	the	DT
46745	4956	24	title	title	NN
46745	4956	25	of	of	IN
46745	4956	26	Tonic	Tonic	NNP
46745	4956	27	has	have	VBZ
46745	4956	28	been	be	VBN
46745	4956	29	so	so	RB
46745	4956	30	often	often	RB
46745	4956	31	applied	apply	VBN
46745	4956	32	to	to	IN
46745	4956	33	it	-PRON-	PRP
46745	4956	34	.	.	.
46745	4957	1	Next	next	RB
46745	4957	2	to	to	IN
46745	4957	3	that	that	DT
46745	4957	4	of	of	IN
46745	4957	5	the	the	DT
46745	4957	6	bowels	bowel	NNS
46745	4957	7	,	,	,
46745	4957	8	the	the	DT
46745	4957	9	acid	acid	NN
46745	4957	10	appears	appear	VBZ
46745	4957	11	to	to	TO
46745	4957	12	act	act	VB
46745	4957	13	most	most	JJS
46745	4957	14	on	on	IN
46745	4957	15	the	the	DT
46745	4957	16	secretion	secretion	NN
46745	4957	17	of	of	IN
46745	4957	18	the	the	DT
46745	4957	19	skin	skin	NN
46745	4957	20	.	.	.
46745	4958	1	Probably	probably	RB
46745	4958	2	there	there	EX
46745	4958	3	also	also	RB
46745	4958	4	eliminated	eliminate	VBD
46745	4958	5	in	in	IN
46745	4958	6	a	a	DT
46745	4958	7	free	free	JJ
46745	4958	8	state	state	NN
46745	4958	9	,	,	,
46745	4958	10	it	-PRON-	PRP
46745	4958	11	is	be	VBZ
46745	4958	12	thus	thus	RB
46745	4958	13	able	able	JJ
46745	4958	14	to	to	TO
46745	4958	15	diminish	diminish	VB
46745	4958	16	excessive	excessive	JJ
46745	4958	17	diaphoresis	diaphoresis	NN
46745	4958	18	.	.	.
46745	4959	1	It	-PRON-	PRP
46745	4959	2	is	be	VBZ
46745	4959	3	applicable	applicable	JJ
46745	4959	4	in	in	IN
46745	4959	5	cases	case	NNS
46745	4959	6	of	of	IN
46745	4959	7	Hæmorrhage	Hæmorrhage	NNP
46745	4959	8	,	,	,
46745	4959	9	when	when	WRB
46745	4959	10	this	this	DT
46745	4959	11	takes	take	VBZ
46745	4959	12	place	place	NN
46745	4959	13	from	from	IN
46745	4959	14	a	a	DT
46745	4959	15	mucous	mucous	JJ
46745	4959	16	membrane	membrane	NN
46745	4959	17	,	,	,
46745	4959	18	for	for	IN
46745	4959	19	it	-PRON-	PRP
46745	4959	20	probably	probably	RB
46745	4959	21	passes	pass	VBZ
46745	4959	22	off	off	RP
46745	4959	23	in	in	IN
46745	4959	24	small	small	JJ
46745	4959	25	quantities	quantity	NNS
46745	4959	26	from	from	IN
46745	4959	27	all	all	PDT
46745	4959	28	the	the	DT
46745	4959	29	mucous	mucous	JJ
46745	4959	30	surfaces	surface	NNS
46745	4959	31	.	.	.
46745	4960	1	It	-PRON-	PRP
46745	4960	2	is	be	VBZ
46745	4960	3	very	very	RB
46745	4960	4	useful	useful	JJ
46745	4960	5	in	in	IN
46745	4960	6	diarrh[oe]a	diarrh[oe]a	NNP
46745	4960	7	.	.	.
46745	4961	1	(	(	-LRB-
46745	4961	2	_	_	NNP
46745	4961	3	Vide	Vide	NNP
46745	4961	4	_	_	NNP
46745	4961	5	p.	p.	NN
46745	4962	1	294	294	CD
46745	4962	2	.	.	.
46745	4962	3	)	)	-RRB-
46745	4963	1	Being	be	VBG
46745	4963	2	a	a	DT
46745	4963	3	special	special	JJ
46745	4963	4	Astringent	Astringent	NNP
46745	4963	5	to	to	IN
46745	4963	6	the	the	DT
46745	4963	7	intestinal	intestinal	JJ
46745	4963	8	mucous	mucous	JJ
46745	4963	9	surface	surface	NN
46745	4963	10	,	,	,
46745	4963	11	it	-PRON-	PRP
46745	4963	12	may	may	MD
46745	4963	13	possibly	possibly	RB
46745	4963	14	be	be	VB
46745	4963	15	useful	useful	JJ
46745	4963	16	even	even	RB
46745	4963	17	in	in	IN
46745	4963	18	malignant	malignant	JJ
46745	4963	19	cholera	cholera	NNS
46745	4963	20	,	,	,
46745	4963	21	especially	especially	RB
46745	4963	22	if	if	IN
46745	4963	23	given	give	VBN
46745	4963	24	in	in	IN
46745	4963	25	the	the	DT
46745	4963	26	early	early	JJ
46745	4963	27	stage	stage	NN
46745	4963	28	of	of	IN
46745	4963	29	that	that	DT
46745	4963	30	disorder	disorder	NN
46745	4963	31	.	.	.
46745	4964	1	(	(	-LRB-
46745	4964	2	_	_	NNP
46745	4964	3	Vide	Vide	NNP
46745	4964	4	_	_	NNP
46745	4964	5	pp	pp	NNP
46745	4964	6	.	.	.
46745	4965	1	120	120	CD
46745	4965	2	,	,	,
46745	4965	3	154	154	CD
46745	4965	4	,	,	,
46745	4965	5	262	262	CD
46745	4965	6	.	.	.
46745	4965	7	)	)	-RRB-
46745	4966	1	POTASH	POTASH	NNP
46745	4966	2	.	.	.
46745	4967	1	Class	class	NN
46745	4967	2	I.	I.	NNP
46745	4967	3	Div	Div	NNP
46745	4967	4	.	.	.
46745	4968	1	I.	I.	NNP
46745	4968	2	Ord	Ord	NNP
46745	4968	3	.	.	.
46745	4969	1	III	iii	CD
46745	4969	2	.	.	.
46745	4970	1	ALKALIA	ALKALIA	NNP
46745	4970	2	.	.	.
46745	4971	1	Class	class	NN
46745	4971	2	I.	I.	NNP
46745	4971	3	Div	Div	NNP
46745	4971	4	.	.	.
46745	4972	1	II	ii	CD
46745	4972	2	.	.	.
46745	4973	1	Ord	Ord	NNP
46745	4973	2	.	.	.
46745	4974	1	I.	I.	NNP
46745	4974	2	ANTIPHLOGISTICA	ANTIPHLOGISTICA	NNP
46745	4974	3	.	.	.
46745	4975	1	Class	class	NN
46745	4975	2	I.	I.	NNP
46745	4975	3	Div	Div	NNP
46745	4975	4	.	.	.
46745	4976	1	II	ii	CD
46745	4976	2	.	.	.
46745	4977	1	Ord	Ord	NNP
46745	4977	2	.	.	.
46745	4978	1	III	iii	CD
46745	4978	2	.	.	.
46745	4979	1	ANTISCROFULOSA	ANTISCROFULOSA	NNP
46745	4979	2	.	.	.
46745	4980	1	Class	Class	NNP
46745	4980	2	IV	IV	NNP
46745	4980	3	.	.	.
46745	4981	1	Ord	Ord	NNP
46745	4981	2	.	.	.
46745	4982	1	VI	VI	NNP
46745	4982	2	.	.	.
46745	4983	1	DIURETICA	DIURETICA	NNP
46745	4983	2	.	.	.
46745	4984	1	Potash	Potash	NNP
46745	4984	2	is	be	VBZ
46745	4984	3	one	one	CD
46745	4984	4	of	of	IN
46745	4984	5	those	those	DT
46745	4984	6	medicines	medicine	NNS
46745	4984	7	which	which	WDT
46745	4984	8	have	have	VBP
46745	4984	9	several	several	JJ
46745	4984	10	distinct	distinct	JJ
46745	4984	11	actions	action	NNS
46745	4984	12	;	;	:
46745	4984	13	but	but	CC
46745	4984	14	its	-PRON-	PRP$
46745	4984	15	various	various	JJ
46745	4984	16	operations	operation	NNS
46745	4984	17	are	be	VBP
46745	4984	18	comparatively	comparatively	RB
46745	4984	19	simple	simple	JJ
46745	4984	20	in	in	IN
46745	4984	21	nature	nature	NN
46745	4984	22	,	,	,
46745	4984	23	and	and	CC
46745	4984	24	easy	easy	JJ
46745	4984	25	to	to	TO
46745	4984	26	comprehend	comprehend	VB
46745	4984	27	.	.	.
46745	4985	1	In	in	IN
46745	4985	2	the	the	DT
46745	4985	3	solid	solid	JJ
46745	4985	4	state	state	NN
46745	4985	5	it	-PRON-	PRP
46745	4985	6	is	be	VBZ
46745	4985	7	powerfully	powerfully	RB
46745	4985	8	caustic	caustic	JJ
46745	4985	9	and	and	CC
46745	4985	10	corrosive	corrosive	JJ
46745	4985	11	,	,	,
46745	4985	12	having	have	VBG
46745	4985	13	a	a	DT
46745	4985	14	great	great	JJ
46745	4985	15	affinity	affinity	NN
46745	4985	16	for	for	IN
46745	4985	17	water	water	NN
46745	4985	18	,	,	,
46745	4985	19	and	and	CC
46745	4985	20	abstracting	abstract	VBG
46745	4985	21	it	-PRON-	PRP
46745	4985	22	from	from	IN
46745	4985	23	the	the	DT
46745	4985	24	animal	animal	NN
46745	4985	25	tissues	tissue	NNS
46745	4985	26	with	with	IN
46745	4985	27	which	which	WDT
46745	4985	28	it	-PRON-	PRP
46745	4985	29	is	be	VBZ
46745	4985	30	brought	bring	VBN
46745	4985	31	in	in	IN
46745	4985	32	contact	contact	NN
46745	4985	33	.	.	.
46745	4986	1	When	when	WRB
46745	4986	2	a	a	DT
46745	4986	3	dose	dose	NN
46745	4986	4	of	of	IN
46745	4986	5	the	the	DT
46745	4986	6	solution	solution	NN
46745	4986	7	,	,	,
46745	4986	8	properly	properly	RB
46745	4986	9	diluted	dilute	VBN
46745	4986	10	with	with	IN
46745	4986	11	water	water	NN
46745	4986	12	,	,	,
46745	4986	13	is	be	VBZ
46745	4986	14	administered	administer	VBN
46745	4986	15	internally	internally	RB
46745	4986	16	,	,	,
46745	4986	17	it	-PRON-	PRP
46745	4986	18	passes	pass	VBZ
46745	4986	19	first	first	RB
46745	4986	20	into	into	IN
46745	4986	21	the	the	DT
46745	4986	22	stomach	stomach	NN
46745	4986	23	,	,	,
46745	4986	24	and	and	CC
46745	4986	25	either	either	DT
46745	4986	26	combines	combine	VBZ
46745	4986	27	with	with	IN
46745	4986	28	the	the	DT
46745	4986	29	acid	acid	NN
46745	4986	30	of	of	IN
46745	4986	31	the	the	DT
46745	4986	32	gastric	gastric	JJ
46745	4986	33	juice	juice	NN
46745	4986	34	,	,	,
46745	4986	35	or	or	CC
46745	4986	36	,	,	,
46745	4986	37	what	what	WP
46745	4986	38	is	be	VBZ
46745	4986	39	more	more	RBR
46745	4986	40	probable	probable	JJ
46745	4986	41	,	,	,
46745	4986	42	it	-PRON-	PRP
46745	4986	43	becomes	become	VBZ
46745	4986	44	absorbed	absorb	VBN
46745	4986	45	too	too	RB
46745	4986	46	rapidly	rapidly	RB
46745	4986	47	to	to	TO
46745	4986	48	be	be	VB
46745	4986	49	neutralized	neutralize	VBN
46745	4986	50	by	by	IN
46745	4986	51	it	-PRON-	PRP
46745	4986	52	.	.	.
46745	4987	1	It	-PRON-	PRP
46745	4987	2	passes	pass	VBZ
46745	4987	3	then	then	RB
46745	4987	4	into	into	IN
46745	4987	5	the	the	DT
46745	4987	6	blood	blood	NN
46745	4987	7	,	,	,
46745	4987	8	and	and	CC
46745	4987	9	probably	probably	RB
46745	4987	10	exists	exist	VBZ
46745	4987	11	in	in	IN
46745	4987	12	that	that	DT
46745	4987	13	liquid	liquid	NN
46745	4987	14	in	in	IN
46745	4987	15	a	a	DT
46745	4987	16	free	free	JJ
46745	4987	17	state	state	NN
46745	4987	18	,	,	,
46745	4987	19	for	for	IN
46745	4987	20	the	the	DT
46745	4987	21	blood	blood	NN
46745	4987	22	already	already	RB
46745	4987	23	contains	contain	VBZ
46745	4987	24	a	a	DT
46745	4987	25	slight	slight	JJ
46745	4987	26	excess	excess	NN
46745	4987	27	of	of	IN
46745	4987	28	alkali	alkali	JJ
46745	4987	29	.	.	.
46745	4988	1	However	however	RB
46745	4988	2	this	this	DT
46745	4988	3	may	may	MD
46745	4988	4	be	be	VB
46745	4988	5	,	,	,
46745	4988	6	it	-PRON-	PRP
46745	4988	7	certainly	certainly	RB
46745	4988	8	increases	increase	VBZ
46745	4988	9	the	the	DT
46745	4988	10	amount	amount	NN
46745	4988	11	of	of	IN
46745	4988	12	alkali	alkali	JJ
46745	4988	13	in	in	IN
46745	4988	14	the	the	DT
46745	4988	15	system	system	NN
46745	4988	16	.	.	.
46745	4989	1	Its	-PRON-	PRP$
46745	4989	2	hæmatic	hæmatic	JJ
46745	4989	3	action	action	NN
46745	4989	4	depends	depend	VBZ
46745	4989	5	in	in	IN
46745	4989	6	great	great	JJ
46745	4989	7	part	part	NN
46745	4989	8	on	on	IN
46745	4989	9	its	-PRON-	PRP$
46745	4989	10	power	power	NN
46745	4989	11	of	of	IN
46745	4989	12	neutralizing	neutralize	VBG
46745	4989	13	acidity	acidity	NN
46745	4989	14	.	.	.
46745	4990	1	It	-PRON-	PRP
46745	4990	2	is	be	VBZ
46745	4990	3	thus	thus	RB
46745	4990	4	useful	useful	JJ
46745	4990	5	in	in	IN
46745	4990	6	cases	case	NNS
46745	4990	7	of	of	IN
46745	4990	8	acid	acid	JJ
46745	4990	9	dyspepsia	dyspepsia	NNP
46745	4990	10	,	,	,
46745	4990	11	heartburn	heartburn	NN
46745	4990	12	,	,	,
46745	4990	13	or	or	CC
46745	4990	14	gastrodynia	gastrodynia	NNP
46745	4990	15	,	,	,
46745	4990	16	when	when	WRB
46745	4990	17	it	-PRON-	PRP
46745	4990	18	combines	combine	VBZ
46745	4990	19	with	with	IN
46745	4990	20	the	the	DT
46745	4990	21	excess	excess	NN
46745	4990	22	of	of	IN
46745	4990	23	acid	acid	NN
46745	4990	24	which	which	WDT
46745	4990	25	exists	exist	VBZ
46745	4990	26	in	in	IN
46745	4990	27	the	the	DT
46745	4990	28	gastric	gastric	JJ
46745	4990	29	secretion	secretion	NN
46745	4990	30	,	,	,
46745	4990	31	and	and	CC
46745	4990	32	probably	probably	RB
46745	4990	33	also	also	RB
46745	4990	34	in	in	IN
46745	4990	35	the	the	DT
46745	4990	36	blood	blood	NN
46745	4990	37	.	.	.
46745	4991	1	For	for	IN
46745	4991	2	the	the	DT
46745	4991	3	same	same	JJ
46745	4991	4	reason	reason	NN
46745	4991	5	it	-PRON-	PRP
46745	4991	6	is	be	VBZ
46745	4991	7	useful	useful	JJ
46745	4991	8	in	in	IN
46745	4991	9	some	some	DT
46745	4991	10	cutaneous	cutaneous	JJ
46745	4991	11	diseases	disease	NNS
46745	4991	12	that	that	WDT
46745	4991	13	are	be	VBP
46745	4991	14	connected	connect	VBN
46745	4991	15	with	with	IN
46745	4991	16	disordered	disorder	VBN
46745	4991	17	digestion	digestion	NN
46745	4991	18	.	.	.
46745	4992	1	It	-PRON-	PRP
46745	4992	2	is	be	VBZ
46745	4992	3	employed	employ	VBN
46745	4992	4	in	in	IN
46745	4992	5	Gout	Gout	NNP
46745	4992	6	and	and	CC
46745	4992	7	Rheumatism	Rheumatism	NNP
46745	4992	8	,	,	,
46745	4992	9	where	where	WRB
46745	4992	10	there	there	EX
46745	4992	11	is	be	VBZ
46745	4992	12	obviously	obviously	RB
46745	4992	13	an	an	DT
46745	4992	14	excess	excess	NN
46745	4992	15	of	of	IN
46745	4992	16	acid	acid	NN
46745	4992	17	both	both	DT
46745	4992	18	in	in	IN
46745	4992	19	the	the	DT
46745	4992	20	blood	blood	NN
46745	4992	21	and	and	CC
46745	4992	22	in	in	IN
46745	4992	23	the	the	DT
46745	4992	24	secretions	secretion	NNS
46745	4992	25	.	.	.
46745	4993	1	(	(	-LRB-
46745	4993	2	p.	p.	NN
46745	4994	1	202	202	CD
46745	4994	2	.	.	.
46745	4994	3	)	)	-RRB-
46745	4995	1	When	when	WRB
46745	4995	2	Potash	Potash	NNP
46745	4995	3	,	,	,
46745	4995	4	is	be	VBZ
46745	4995	5	administered	administer	VBN
46745	4995	6	in	in	IN
46745	4995	7	any	any	DT
46745	4995	8	quantity	quantity	NN
46745	4995	9	,	,	,
46745	4995	10	it	-PRON-	PRP
46745	4995	11	must	must	MD
46745	4995	12	be	be	VB
46745	4995	13	excreted	excrete	VBN
46745	4995	14	from	from	IN
46745	4995	15	the	the	DT
46745	4995	16	blood	blood	NN
46745	4995	17	.	.	.
46745	4996	1	The	the	DT
46745	4996	2	secretion	secretion	NN
46745	4996	3	of	of	IN
46745	4996	4	alkalies	alkali	NNS
46745	4996	5	is	be	VBZ
46745	4996	6	mainly	mainly	RB
46745	4996	7	performed	perform	VBN
46745	4996	8	by	by	IN
46745	4996	9	the	the	DT
46745	4996	10	kidneys	kidney	NNS
46745	4996	11	,	,	,
46745	4996	12	and	and	CC
46745	4996	13	by	by	IN
46745	4996	14	their	-PRON-	PRP$
46745	4996	15	agency	agency	NN
46745	4996	16	we	-PRON-	PRP
46745	4996	17	may	may	MD
46745	4996	18	render	render	VB
46745	4996	19	the	the	DT
46745	4996	20	urine	urine	NN
46745	4996	21	neutral	neutral	JJ
46745	4996	22	or	or	CC
46745	4996	23	alkaline	alkaline	NN
46745	4996	24	,	,	,
46745	4996	25	and	and	CC
46745	4996	26	thus	thus	RB
46745	4996	27	counteract	counteract	VB
46745	4996	28	a	a	DT
46745	4996	29	tendency	tendency	NN
46745	4996	30	to	to	IN
46745	4996	31	lithic	lithic	JJ
46745	4996	32	deposits	deposit	NNS
46745	4996	33	.	.	.
46745	4997	1	(	(	-LRB-
46745	4997	2	_	_	NNP
46745	4997	3	Vide	Vide	NNP
46745	4997	4	_	_	NNP
46745	4997	5	Solvents	Solvents	NNPS
46745	4997	6	.	.	.
46745	4997	7	)	)	-RRB-
46745	4998	1	For	for	IN
46745	4998	2	this	this	DT
46745	4998	3	purpose	purpose	NN
46745	4998	4	Potash	Potash	NNP
46745	4998	5	is	be	VBZ
46745	4998	6	preferable	preferable	JJ
46745	4998	7	to	to	TO
46745	4998	8	free	free	JJ
46745	4998	9	Soda	Soda	NNP
46745	4998	10	,	,	,
46745	4998	11	for	for	IN
46745	4998	12	the	the	DT
46745	4998	13	lithate	lithate	NN
46745	4998	14	of	of	IN
46745	4998	15	Soda	Soda	NNP
46745	4998	16	is	be	VBZ
46745	4998	17	comparatively	comparatively	RB
46745	4998	18	an	an	DT
46745	4998	19	insoluble	insoluble	JJ
46745	4998	20	salt	salt	NN
46745	4998	21	.	.	.
46745	4999	1	The	the	DT
46745	4999	2	salts	salt	NNS
46745	4999	3	of	of	IN
46745	4999	4	Potash	Potash	NNP
46745	4999	5	with	with	IN
46745	4999	6	vegetable	vegetable	JJ
46745	4999	7	acids	acid	NNS
46745	4999	8	change	change	VBP
46745	4999	9	into	into	IN
46745	4999	10	carbonates	carbonate	NNS
46745	4999	11	while	while	IN
46745	4999	12	in	in	IN
46745	4999	13	the	the	DT
46745	4999	14	blood	blood	NN
46745	4999	15	,	,	,
46745	4999	16	and	and	CC
46745	4999	17	will	will	MD
46745	4999	18	render	render	VB
46745	4999	19	the	the	DT
46745	4999	20	urine	urine	NN
46745	4999	21	alkaline	alkaline	NN
46745	4999	22	.	.	.
46745	5000	1	M.	M.	NNP
46745	5000	2	Wöhler	Wöhler	NNP
46745	5000	3	,	,	,
46745	5000	4	who	who	WP
46745	5000	5	has	have	VBZ
46745	5000	6	discovered	discover	VBN
46745	5000	7	this	this	DT
46745	5000	8	fact	fact	NN
46745	5000	9	,	,	,
46745	5000	10	finds	find	VBZ
46745	5000	11	that	that	IN
46745	5000	12	it	-PRON-	PRP
46745	5000	13	does	do	VBZ
46745	5000	14	not	not	RB
46745	5000	15	occur	occur	VB
46745	5000	16	with	with	IN
46745	5000	17	the	the	DT
46745	5000	18	super	super	JJ
46745	5000	19	-	-	NNS
46745	5000	20	salts	salts	JJ
46745	5000	21	.	.	.
46745	5001	1	Even	even	RB
46745	5001	2	the	the	DT
46745	5001	3	neutral	neutral	JJ
46745	5001	4	salts	salt	NNS
46745	5001	5	escape	escape	VBP
46745	5001	6	the	the	DT
46745	5001	7	oxidation	oxidation	NN
46745	5001	8	when	when	WRB
46745	5001	9	they	-PRON-	PRP
46745	5001	10	are	be	VBP
46745	5001	11	given	give	VBN
46745	5001	12	in	in	IN
46745	5001	13	such	such	JJ
46745	5001	14	large	large	JJ
46745	5001	15	doses	dose	NNS
46745	5001	16	as	as	IN
46745	5001	17	to	to	TO
46745	5001	18	act	act	VB
46745	5001	19	on	on	IN
46745	5001	20	the	the	DT
46745	5001	21	bowels	bowel	NNS
46745	5001	22	.	.	.
46745	5002	1	Potash	Potash	NNP
46745	5002	2	is	be	VBZ
46745	5002	3	thus	thus	RB
46745	5002	4	a	a	DT
46745	5002	5	Restorative	Restorative	NNP
46745	5002	6	Hæmatic	Hæmatic	NNP
46745	5002	7	,	,	,
46745	5002	8	and	and	CC
46745	5002	9	where	where	WRB
46745	5002	10	,	,	,
46745	5002	11	from	from	IN
46745	5002	12	any	any	DT
46745	5002	13	reason	reason	NN
46745	5002	14	,	,	,
46745	5002	15	alkaline	alkaline	NN
46745	5002	16	matter	matter	NN
46745	5002	17	is	be	VBZ
46745	5002	18	needed	need	VBN
46745	5002	19	in	in	IN
46745	5002	20	the	the	DT
46745	5002	21	system	system	NN
46745	5002	22	,	,	,
46745	5002	23	it	-PRON-	PRP
46745	5002	24	directly	directly	RB
46745	5002	25	supplies	supply	VBZ
46745	5002	26	the	the	DT
46745	5002	27	want	want	NN
46745	5002	28	.	.	.
46745	5003	1	But	but	CC
46745	5003	2	it	-PRON-	PRP
46745	5003	3	has	have	VBZ
46745	5003	4	also	also	RB
46745	5003	5	other	other	JJ
46745	5003	6	actions	action	NNS
46745	5003	7	which	which	WDT
46745	5003	8	render	render	VBP
46745	5003	9	it	-PRON-	PRP
46745	5003	10	Catalytic	catalytic	JJ
46745	5003	11	,	,	,
46745	5003	12	and	and	CC
46745	5003	13	which	which	WDT
46745	5003	14	are	be	VBP
46745	5003	15	evidenced	evidence	VBN
46745	5003	16	in	in	IN
46745	5003	17	disorders	disorder	NNS
46745	5003	18	in	in	IN
46745	5003	19	which	which	WDT
46745	5003	20	there	there	EX
46745	5003	21	is	be	VBZ
46745	5003	22	no	no	DT
46745	5003	23	such	such	JJ
46745	5003	24	deficiency	deficiency	NN
46745	5003	25	of	of	IN
46745	5003	26	alkali	alkali	JJ
46745	5003	27	.	.	.
46745	5004	1	By	by	IN
46745	5004	2	dissolving	dissolve	VBG
46745	5004	3	Fibrine	Fibrine	NNP
46745	5004	4	,	,	,
46745	5004	5	it	-PRON-	PRP
46745	5004	6	tends	tend	VBZ
46745	5004	7	to	to	TO
46745	5004	8	prevent	prevent	VB
46745	5004	9	its	-PRON-	PRP$
46745	5004	10	deposition	deposition	NN
46745	5004	11	from	from	IN
46745	5004	12	the	the	DT
46745	5004	13	blood	blood	NN
46745	5004	14	.	.	.
46745	5005	1	It	-PRON-	PRP
46745	5005	2	thus	thus	RB
46745	5005	3	interferes	interfere	VBZ
46745	5005	4	with	with	IN
46745	5005	5	the	the	DT
46745	5005	6	inflammatory	inflammatory	JJ
46745	5005	7	process	process	NN
46745	5005	8	,	,	,
46745	5005	9	and	and	CC
46745	5005	10	acts	act	VBZ
46745	5005	11	as	as	IN
46745	5005	12	a	a	DT
46745	5005	13	general	general	JJ
46745	5005	14	Antiphlogistic	Antiphlogistic	NNP
46745	5005	15	.	.	.
46745	5006	1	It	-PRON-	PRP
46745	5006	2	is	be	VBZ
46745	5006	3	possibly	possibly	RB
46745	5006	4	by	by	IN
46745	5006	5	a	a	DT
46745	5006	6	similar	similar	JJ
46745	5006	7	action	action	NN
46745	5006	8	that	that	IN
46745	5006	9	it	-PRON-	PRP
46745	5006	10	seems	seem	VBZ
46745	5006	11	able	able	JJ
46745	5006	12	to	to	TO
46745	5006	13	counteract	counteract	VB
46745	5006	14	the	the	DT
46745	5006	15	deposit	deposit	NN
46745	5006	16	of	of	IN
46745	5006	17	crude	crude	JJ
46745	5006	18	tubercle	tubercle	NN
46745	5006	19	,	,	,
46745	5006	20	and	and	CC
46745	5006	21	exerts	exert	VBZ
46745	5006	22	a	a	DT
46745	5006	23	special	special	JJ
46745	5006	24	action	action	NN
46745	5006	25	in	in	IN
46745	5006	26	the	the	DT
46745	5006	27	prevention	prevention	NN
46745	5006	28	and	and	CC
46745	5006	29	cure	cure	NN
46745	5006	30	of	of	IN
46745	5006	31	strumous	strumous	JJ
46745	5006	32	disorders	disorder	NNS
46745	5006	33	.	.	.
46745	5007	1	It	-PRON-	PRP
46745	5007	2	is	be	VBZ
46745	5007	3	very	very	RB
46745	5007	4	useful	useful	JJ
46745	5007	5	in	in	IN
46745	5007	6	the	the	DT
46745	5007	7	early	early	JJ
46745	5007	8	stage	stage	NN
46745	5007	9	of	of	IN
46745	5007	10	Phthisis	Phthisis	NNP
46745	5007	11	,	,	,
46745	5007	12	and	and	CC
46745	5007	13	in	in	IN
46745	5007	14	all	all	DT
46745	5007	15	stages	stage	NNS
46745	5007	16	of	of	IN
46745	5007	17	Scrofula	Scrofula	NNP
46745	5007	18	.	.	.
46745	5008	1	In	in	IN
46745	5008	2	Syphilis	Syphilis	NNP
46745	5008	3	,	,	,
46745	5008	4	when	when	WRB
46745	5008	5	occurring	occur	VBG
46745	5008	6	in	in	IN
46745	5008	7	scrofulous	scrofulous	JJ
46745	5008	8	subjects	subject	NNS
46745	5008	9	,	,	,
46745	5008	10	Potash	Potash	NNP
46745	5008	11	has	have	VBZ
46745	5008	12	sometimes	sometimes	RB
46745	5008	13	been	be	VBN
46745	5008	14	used	use	VBN
46745	5008	15	with	with	IN
46745	5008	16	greater	great	JJR
46745	5008	17	advantage	advantage	NN
46745	5008	18	than	than	IN
46745	5008	19	Mercury	Mercury	NNP
46745	5008	20	.	.	.
46745	5009	1	Potash	Potash	NNP
46745	5009	2	and	and	CC
46745	5009	3	its	-PRON-	PRP$
46745	5009	4	salts	salt	NNS
46745	5009	5	have	have	VBP
46745	5009	6	been	be	VBN
46745	5009	7	used	use	VBN
46745	5009	8	in	in	IN
46745	5009	9	Scurvy	Scurvy	NNP
46745	5009	10	by	by	IN
46745	5009	11	Dr.	Dr.	NNP
46745	5009	12	Garrod	Garrod	NNP
46745	5009	13	,	,	,
46745	5009	14	on	on	IN
46745	5009	15	the	the	DT
46745	5009	16	supposition	supposition	NN
46745	5009	17	that	that	IN
46745	5009	18	there	there	EX
46745	5009	19	is	be	VBZ
46745	5009	20	in	in	IN
46745	5009	21	that	that	DT
46745	5009	22	disorder	disorder	NN
46745	5009	23	a	a	DT
46745	5009	24	particular	particular	JJ
46745	5009	25	deficiency	deficiency	NN
46745	5009	26	of	of	IN
46745	5009	27	Potash	Potash	NNP
46745	5009	28	in	in	IN
46745	5009	29	the	the	DT
46745	5009	30	system	system	NN
46745	5009	31	.	.	.
46745	5010	1	But	but	CC
46745	5010	2	the	the	DT
46745	5010	3	fact	fact	NN
46745	5010	4	that	that	IN
46745	5010	5	Citric	Citric	NNP
46745	5010	6	acid	acid	NN
46745	5010	7	is	be	VBZ
46745	5010	8	at	at	IN
46745	5010	9	least	least	JJS
46745	5010	10	of	of	IN
46745	5010	11	equal	equal	JJ
46745	5010	12	utility	utility	NN
46745	5010	13	in	in	IN
46745	5010	14	the	the	DT
46745	5010	15	treatment	treatment	NN
46745	5010	16	of	of	IN
46745	5010	17	scorbutic	scorbutic	JJ
46745	5010	18	diseases	disease	NNS
46745	5010	19	,	,	,
46745	5010	20	would	would	MD
46745	5010	21	seem	seem	VB
46745	5010	22	to	to	TO
46745	5010	23	be	be	VB
46745	5010	24	opposed	oppose	VBN
46745	5010	25	to	to	IN
46745	5010	26	such	such	PDT
46745	5010	27	an	an	DT
46745	5010	28	idea	idea	NN
46745	5010	29	.	.	.
46745	5011	1	When	when	WRB
46745	5011	2	given	give	VBN
46745	5011	3	in	in	IN
46745	5011	4	moderate	moderate	JJ
46745	5011	5	doses	dose	NNS
46745	5011	6	,	,	,
46745	5011	7	and	and	CC
46745	5011	8	not	not	RB
46745	5011	9	retained	retain	VBN
46745	5011	10	in	in	IN
46745	5011	11	the	the	DT
46745	5011	12	system	system	NN
46745	5011	13	,	,	,
46745	5011	14	Potash	Potash	NNP
46745	5011	15	and	and	CC
46745	5011	16	its	-PRON-	PRP$
46745	5011	17	salts	salt	NNS
46745	5011	18	pass	pass	VBP
46745	5011	19	out	out	RP
46745	5011	20	into	into	IN
46745	5011	21	the	the	DT
46745	5011	22	urine	urine	NN
46745	5011	23	,	,	,
46745	5011	24	and	and	CC
46745	5011	25	act	act	VB
46745	5011	26	as	as	IN
46745	5011	27	Diuretics	Diuretics	NNP
46745	5011	28	.	.	.
46745	5012	1	(	(	-LRB-
46745	5012	2	_	_	NNP
46745	5012	3	Vide	Vide	NNP
46745	5012	4	_	_	NNP
46745	5012	5	pp	pp	NNP
46745	5012	6	.	.	.
46745	5013	1	126	126	CD
46745	5013	2	,	,	,
46745	5013	3	187	187	CD
46745	5013	4	,	,	,
46745	5013	5	193	193	CD
46745	5013	6	,	,	,
46745	5013	7	202	202	CD
46745	5013	8	,	,	,
46745	5013	9	206	206	CD
46745	5013	10	.	.	.
46745	5013	11	)	)	-RRB-
46745	5014	1	QUININE	QUININE	NNP
46745	5014	2	.	.	.
46745	5015	1	Class	class	NN
46745	5015	2	I.	I.	NNP
46745	5015	3	Div	Div	NNP
46745	5015	4	.	.	.
46745	5016	1	I.	I.	NNP
46745	5016	2	Ord	Ord	NNP
46745	5016	3	.	.	.
46745	5017	1	IV	IV	NNP
46745	5017	2	.	.	.
46745	5018	1	TONICA	TONICA	NNP
46745	5018	2	.	.	.
46745	5019	1	Though	though	IN
46745	5019	2	the	the	DT
46745	5019	3	utility	utility	NN
46745	5019	4	of	of	IN
46745	5019	5	this	this	DT
46745	5019	6	important	important	JJ
46745	5019	7	remedy	remedy	NN
46745	5019	8	is	be	VBZ
46745	5019	9	often	often	RB
46745	5019	10	of	of	IN
46745	5019	11	a	a	DT
46745	5019	12	sufficiently	sufficiently	RB
46745	5019	13	direct	direct	JJ
46745	5019	14	and	and	CC
46745	5019	15	obvious	obvious	JJ
46745	5019	16	character	character	NN
46745	5019	17	,	,	,
46745	5019	18	its	-PRON-	PRP$
46745	5019	19	precise	precise	JJ
46745	5019	20	mode	mode	NN
46745	5019	21	of	of	IN
46745	5019	22	action	action	NN
46745	5019	23	is	be	VBZ
46745	5019	24	enveloped	envelop	VBN
46745	5019	25	in	in	IN
46745	5019	26	no	no	DT
46745	5019	27	small	small	JJ
46745	5019	28	degree	degree	NN
46745	5019	29	of	of	IN
46745	5019	30	doubt	doubt	NN
46745	5019	31	and	and	CC
46745	5019	32	obscurity	obscurity	NN
46745	5019	33	.	.	.
46745	5020	1	This	this	DT
46745	5020	2	subject	subject	NN
46745	5020	3	has	have	VBZ
46745	5020	4	been	be	VBN
46745	5020	5	discussed	discuss	VBN
46745	5020	6	at	at	IN
46745	5020	7	some	some	DT
46745	5020	8	length	length	NN
46745	5020	9	in	in	IN
46745	5020	10	the	the	DT
46745	5020	11	article	article	NN
46745	5020	12	on	on	IN
46745	5020	13	Tonics	Tonics	NNP
46745	5020	14	.	.	.
46745	5021	1	It	-PRON-	PRP
46745	5021	2	appears	appear	VBZ
46745	5021	3	,	,	,
46745	5021	4	from	from	IN
46745	5021	5	the	the	DT
46745	5021	6	character	character	NN
46745	5021	7	and	and	CC
46745	5021	8	results	result	NNS
46745	5021	9	of	of	IN
46745	5021	10	its	-PRON-	PRP$
46745	5021	11	medicinal	medicinal	JJ
46745	5021	12	influence	influence	NN
46745	5021	13	,	,	,
46745	5021	14	that	that	IN
46745	5021	15	it	-PRON-	PRP
46745	5021	16	is	be	VBZ
46745	5021	17	exerted	exert	VBN
46745	5021	18	primarily	primarily	RB
46745	5021	19	in	in	IN
46745	5021	20	the	the	DT
46745	5021	21	blood	blood	NN
46745	5021	22	,	,	,
46745	5021	23	and	and	CC
46745	5021	24	not	not	RB
46745	5021	25	on	on	IN
46745	5021	26	the	the	DT
46745	5021	27	nerves	nerve	NNS
46745	5021	28	.	.	.
46745	5022	1	It	-PRON-	PRP
46745	5022	2	is	be	VBZ
46745	5022	3	included	include	VBN
46745	5022	4	in	in	IN
46745	5022	5	the	the	DT
46745	5022	6	Restorative	Restorative	NNP
46745	5022	7	group	group	NN
46745	5022	8	of	of	IN
46745	5022	9	Hæmatics	Hæmatics	NNP
46745	5022	10	,	,	,
46745	5022	11	and	and	CC
46745	5022	12	the	the	DT
46745	5022	13	general	general	JJ
46745	5022	14	results	result	NNS
46745	5022	15	of	of	IN
46745	5022	16	its	-PRON-	PRP$
46745	5022	17	action	action	NN
46745	5022	18	differ	differ	VBP
46745	5022	19	widely	widely	RB
46745	5022	20	from	from	IN
46745	5022	21	those	those	DT
46745	5022	22	of	of	IN
46745	5022	23	a	a	DT
46745	5022	24	Catalytic	Catalytic	NNP
46745	5022	25	Hæmatic	Hæmatic	NNP
46745	5022	26	.	.	.
46745	5023	1	It	-PRON-	PRP
46745	5023	2	produces	produce	VBZ
46745	5023	3	no	no	DT
46745	5023	4	marked	marked	JJ
46745	5023	5	effect	effect	NN
46745	5023	6	upon	upon	IN
46745	5023	7	the	the	DT
46745	5023	8	system	system	NN
46745	5023	9	in	in	IN
46745	5023	10	health	health	NN
46745	5023	11	.	.	.
46745	5024	1	Its	-PRON-	PRP$
46745	5024	2	operation	operation	NN
46745	5024	3	consists	consist	VBZ
46745	5024	4	in	in	IN
46745	5024	5	the	the	DT
46745	5024	6	cure	cure	NN
46745	5024	7	of	of	IN
46745	5024	8	general	general	JJ
46745	5024	9	debility	debility	NN
46745	5024	10	,	,	,
46745	5024	11	however	however	RB
46745	5024	12	produced	produce	VBN
46745	5024	13	,	,	,
46745	5024	14	and	and	CC
46745	5024	15	in	in	IN
46745	5024	16	the	the	DT
46745	5024	17	prevention	prevention	NN
46745	5024	18	of	of	IN
46745	5024	19	periodic	periodic	JJ
46745	5024	20	disorders	disorder	NNS
46745	5024	21	in	in	IN
46745	5024	22	the	the	DT
46745	5024	23	blood	blood	NN
46745	5024	24	.	.	.
46745	5025	1	Debility	debility	NN
46745	5025	2	depends	depend	VBZ
46745	5025	3	on	on	IN
46745	5025	4	a	a	DT
46745	5025	5	want	want	NN
46745	5025	6	in	in	IN
46745	5025	7	the	the	DT
46745	5025	8	blood	blood	NN
46745	5025	9	,	,	,
46745	5025	10	and	and	CC
46745	5025	11	not	not	RB
46745	5025	12	on	on	IN
46745	5025	13	any	any	DT
46745	5025	14	active	active	JJ
46745	5025	15	morbid	morbid	NN
46745	5025	16	process	process	NN
46745	5025	17	;	;	:
46745	5025	18	and	and	CC
46745	5025	19	there	there	EX
46745	5025	20	are	be	VBP
46745	5025	21	circumstances	circumstance	NNS
46745	5025	22	which	which	WDT
46745	5025	23	render	render	VBP
46745	5025	24	it	-PRON-	PRP
46745	5025	25	likely	likely	JJ
46745	5025	26	that	that	IN
46745	5025	27	Ague	Ague	NNP
46745	5025	28	may	may	MD
46745	5025	29	be	be	VB
46745	5025	30	curable	curable	JJ
46745	5025	31	by	by	IN
46745	5025	32	the	the	DT
46745	5025	33	supply	supply	NN
46745	5025	34	of	of	IN
46745	5025	35	a	a	DT
46745	5025	36	similar	similar	JJ
46745	5025	37	want	want	NN
46745	5025	38	.	.	.
46745	5026	1	Quinine	Quinine	NNP
46745	5026	2	is	be	VBZ
46745	5026	3	also	also	RB
46745	5026	4	serviceable	serviceable	JJ
46745	5026	5	in	in	IN
46745	5026	6	Gout	Gout	NNP
46745	5026	7	,	,	,
46745	5026	8	Scrofula	Scrofula	NNP
46745	5026	9	,	,	,
46745	5026	10	Dyspepsia	Dyspepsia	NNP
46745	5026	11	,	,	,
46745	5026	12	and	and	CC
46745	5026	13	other	other	JJ
46745	5026	14	disorders	disorder	NNS
46745	5026	15	;	;	:
46745	5026	16	in	in	IN
46745	5026	17	all	all	DT
46745	5026	18	of	of	IN
46745	5026	19	which	which	WDT
46745	5026	20	other	other	JJ
46745	5026	21	medicines	medicine	NNS
46745	5026	22	,	,	,
46745	5026	23	which	which	WDT
46745	5026	24	stimulate	stimulate	VBP
46745	5026	25	the	the	DT
46745	5026	26	secretion	secretion	NN
46745	5026	27	of	of	IN
46745	5026	28	the	the	DT
46745	5026	29	bile	bile	NN
46745	5026	30	,	,	,
46745	5026	31	are	be	VBP
46745	5026	32	more	more	RBR
46745	5026	33	or	or	CC
46745	5026	34	less	less	RBR
46745	5026	35	applicable	applicable	JJ
46745	5026	36	.	.	.
46745	5027	1	Torpidity	torpidity	NN
46745	5027	2	of	of	IN
46745	5027	3	the	the	DT
46745	5027	4	liver	liver	NN
46745	5027	5	is	be	VBZ
46745	5027	6	likewise	likewise	RB
46745	5027	7	a	a	DT
46745	5027	8	usual	usual	JJ
46745	5027	9	accompaniment	accompaniment	NN
46745	5027	10	of	of	IN
46745	5027	11	the	the	DT
46745	5027	12	various	various	JJ
46745	5027	13	forms	form	NNS
46745	5027	14	of	of	IN
46745	5027	15	debility	debility	NN
46745	5027	16	,	,	,
46745	5027	17	and	and	CC
46745	5027	18	occurs	occur	VBZ
46745	5027	19	in	in	IN
46745	5027	20	intermittent	intermittent	NN
46745	5027	21	,	,	,
46745	5027	22	remittent	remittent	NN
46745	5027	23	,	,	,
46745	5027	24	typhoid	typhoid	NN
46745	5027	25	,	,	,
46745	5027	26	and	and	CC
46745	5027	27	yellow	yellow	JJ
46745	5027	28	fevers	fever	NNS
46745	5027	29	;	;	:
46745	5027	30	in	in	IN
46745	5027	31	each	each	DT
46745	5027	32	of	of	IN
46745	5027	33	which	which	WDT
46745	5027	34	this	this	DT
46745	5027	35	medicine	medicine	NN
46745	5027	36	has	have	VBZ
46745	5027	37	been	be	VBN
46745	5027	38	recommended	recommend	VBN
46745	5027	39	,	,	,
46745	5027	40	and	and	CC
46745	5027	41	used	use	VBN
46745	5027	42	with	with	IN
46745	5027	43	advantage	advantage	NN
46745	5027	44	.	.	.
46745	5028	1	In	in	IN
46745	5028	2	fact	fact	NN
46745	5028	3	it	-PRON-	PRP
46745	5028	4	may	may	MD
46745	5028	5	be	be	VB
46745	5028	6	said	say	VBN
46745	5028	7	,	,	,
46745	5028	8	that	that	IN
46745	5028	9	in	in	IN
46745	5028	10	all	all	DT
46745	5028	11	diseases	disease	NNS
46745	5028	12	in	in	IN
46745	5028	13	which	which	WDT
46745	5028	14	Quinine	Quinine	NNP
46745	5028	15	is	be	VBZ
46745	5028	16	used	use	VBN
46745	5028	17	there	there	EX
46745	5028	18	is	be	VBZ
46745	5028	19	a	a	DT
46745	5028	20	failure	failure	NN
46745	5028	21	in	in	IN
46745	5028	22	the	the	DT
46745	5028	23	secretion	secretion	NN
46745	5028	24	of	of	IN
46745	5028	25	bile	bile	NN
46745	5028	26	;	;	:
46745	5028	27	and	and	CC
46745	5028	28	in	in	IN
46745	5028	29	all	all	DT
46745	5028	30	diseases	disease	NNS
46745	5028	31	in	in	IN
46745	5028	32	which	which	WDT
46745	5028	33	there	there	EX
46745	5028	34	is	be	VBZ
46745	5028	35	a	a	DT
46745	5028	36	failure	failure	NN
46745	5028	37	in	in	IN
46745	5028	38	the	the	DT
46745	5028	39	secretion	secretion	NN
46745	5028	40	of	of	IN
46745	5028	41	bile	bile	NN
46745	5028	42	,	,	,
46745	5028	43	Quinine	Quinine	NNP
46745	5028	44	is	be	VBZ
46745	5028	45	serviceable	serviceable	JJ
46745	5028	46	.	.	.
46745	5029	1	There	there	EX
46745	5029	2	appears	appear	VBZ
46745	5029	3	then	then	RB
46745	5029	4	to	to	TO
46745	5029	5	be	be	VB
46745	5029	6	some	some	DT
46745	5029	7	connexion	connexion	NN
46745	5029	8	between	between	IN
46745	5029	9	these	these	DT
46745	5029	10	two	two	CD
46745	5029	11	things	thing	NNS
46745	5029	12	.	.	.
46745	5030	1	Certain	certain	JJ
46745	5030	2	of	of	IN
46745	5030	3	the	the	DT
46745	5030	4	constituents	constituent	NNS
46745	5030	5	of	of	IN
46745	5030	6	the	the	DT
46745	5030	7	bile	bile	NN
46745	5030	8	are	be	VBP
46745	5030	9	formed	form	VBN
46745	5030	10	by	by	IN
46745	5030	11	the	the	DT
46745	5030	12	liver	liver	NN
46745	5030	13	out	out	IN
46745	5030	14	of	of	IN
46745	5030	15	the	the	DT
46745	5030	16	blood	blood	NN
46745	5030	17	,	,	,
46745	5030	18	for	for	IN
46745	5030	19	the	the	DT
46745	5030	20	purpose	purpose	NN
46745	5030	21	,	,	,
46745	5030	22	apparently	apparently	RB
46745	5030	23	,	,	,
46745	5030	24	of	of	IN
46745	5030	25	being	be	VBG
46745	5030	26	again	again	RB
46745	5030	27	absorbed	absorb	VBN
46745	5030	28	at	at	IN
46745	5030	29	some	some	DT
46745	5030	30	part	part	NN
46745	5030	31	of	of	IN
46745	5030	32	the	the	DT
46745	5030	33	surface	surface	NN
46745	5030	34	of	of	IN
46745	5030	35	the	the	DT
46745	5030	36	intestinal	intestinal	JJ
46745	5030	37	canal	canal	NN
46745	5030	38	.	.	.
46745	5031	1	One	one	CD
46745	5031	2	of	of	IN
46745	5031	3	these	these	DT
46745	5031	4	,	,	,
46745	5031	5	Taurine	Taurine	NNP
46745	5031	6	,	,	,
46745	5031	7	has	have	VBZ
46745	5031	8	been	be	VBN
46745	5031	9	shown	show	VBN
46745	5031	10	to	to	TO
46745	5031	11	be	be	VB
46745	5031	12	chemically	chemically	RB
46745	5031	13	analogous	analogous	JJ
46745	5031	14	to	to	IN
46745	5031	15	Quinine	Quinine	NNP
46745	5031	16	.	.	.
46745	5032	1	Thus	thus	RB
46745	5032	2	it	-PRON-	PRP
46745	5032	3	seems	seem	VBZ
46745	5032	4	to	to	IN
46745	5032	5	me	-PRON-	PRP
46745	5032	6	to	to	TO
46745	5032	7	be	be	VB
46745	5032	8	not	not	RB
46745	5032	9	improbable	improbable	JJ
46745	5032	10	that	that	IN
46745	5032	11	this	this	DT
46745	5032	12	alkaloid	alkaloid	NN
46745	5032	13	may	may	MD
46745	5032	14	be	be	VB
46745	5032	15	of	of	IN
46745	5032	16	service	service	NN
46745	5032	17	in	in	IN
46745	5032	18	these	these	DT
46745	5032	19	disorders	disorder	NNS
46745	5032	20	by	by	IN
46745	5032	21	supplying	supply	VBG
46745	5032	22	the	the	DT
46745	5032	23	place	place	NN
46745	5032	24	in	in	IN
46745	5032	25	the	the	DT
46745	5032	26	blood	blood	NN
46745	5032	27	of	of	IN
46745	5032	28	this	this	DT
46745	5032	29	biliary	biliary	JJ
46745	5032	30	matter	matter	NN
46745	5032	31	,	,	,
46745	5032	32	which	which	WDT
46745	5032	33	for	for	IN
46745	5032	34	some	some	DT
46745	5032	35	reason	reason	NN
46745	5032	36	may	may	MD
46745	5032	37	be	be	VB
46745	5032	38	needful	needful	JJ
46745	5032	39	in	in	IN
46745	5032	40	the	the	DT
46745	5032	41	animal	animal	NN
46745	5032	42	economy	economy	NN
46745	5032	43	,	,	,
46745	5032	44	or	or	CC
46745	5032	45	that	that	IN
46745	5032	46	it	-PRON-	PRP
46745	5032	47	may	may	MD
46745	5032	48	actually	actually	RB
46745	5032	49	become	become	VB
46745	5032	50	changed	change	VBN
46745	5032	51	into	into	IN
46745	5032	52	the	the	DT
46745	5032	53	latter	latter	JJ
46745	5032	54	while	while	IN
46745	5032	55	in	in	IN
46745	5032	56	the	the	DT
46745	5032	57	system	system	NN
46745	5032	58	.	.	.
46745	5033	1	Were	be	VBD
46745	5033	2	this	this	DT
46745	5033	3	proved	prove	VBN
46745	5033	4	,	,	,
46745	5033	5	its	-PRON-	PRP$
46745	5033	6	restorative	restorative	JJ
46745	5033	7	action	action	NN
46745	5033	8	would	would	MD
46745	5033	9	be	be	VB
46745	5033	10	effectually	effectually	RB
46745	5033	11	cleared	clear	VBN
46745	5033	12	up	up	RP
46745	5033	13	.	.	.
46745	5034	1	The	the	DT
46745	5034	2	Disulphate	Disulphate	NNP
46745	5034	3	of	of	IN
46745	5034	4	Quinine	Quinine	NNP
46745	5034	5	(	(	-LRB-
46745	5034	6	or	or	CC
46745	5034	7	Quina	Quina	NNP
46745	5034	8	)	)	-RRB-
46745	5034	9	is	be	VBZ
46745	5034	10	the	the	DT
46745	5034	11	preparation	preparation	NN
46745	5034	12	of	of	IN
46745	5034	13	the	the	DT
46745	5034	14	alkaloid	alkaloid	NN
46745	5034	15	which	which	WDT
46745	5034	16	is	be	VBZ
46745	5034	17	most	most	RBS
46745	5034	18	commonly	commonly	RB
46745	5034	19	used	use	VBN
46745	5034	20	.	.	.
46745	5035	1	Arsenic	Arsenic	NNP
46745	5035	2	is	be	VBZ
46745	5035	3	used	use	VBN
46745	5035	4	in	in	IN
46745	5035	5	Ague	Ague	NNP
46745	5035	6	and	and	CC
46745	5035	7	intermittent	intermittent	JJ
46745	5035	8	disorders	disorder	NNS
46745	5035	9	,	,	,
46745	5035	10	and	and	CC
46745	5035	11	acts	act	NNS
46745	5035	12	on	on	IN
46745	5035	13	the	the	DT
46745	5035	14	Catalytic	catalytic	JJ
46745	5035	15	principle	principle	NN
46745	5035	16	,	,	,
46745	5035	17	but	but	CC
46745	5035	18	it	-PRON-	PRP
46745	5035	19	is	be	VBZ
46745	5035	20	not	not	RB
46745	5035	21	serviceable	serviceable	JJ
46745	5035	22	in	in	IN
46745	5035	23	the	the	DT
46745	5035	24	other	other	JJ
46745	5035	25	cases	case	NNS
46745	5035	26	in	in	IN
46745	5035	27	which	which	WDT
46745	5035	28	Quinine	Quinine	NNP
46745	5035	29	is	be	VBZ
46745	5035	30	used	use	VBN
46745	5035	31	.	.	.
46745	5036	1	It	-PRON-	PRP
46745	5036	2	is	be	VBZ
46745	5036	3	not	not	RB
46745	5036	4	a	a	DT
46745	5036	5	Tonic	Tonic	NNP
46745	5036	6	,	,	,
46745	5036	7	nor	nor	CC
46745	5036	8	does	do	VBZ
46745	5036	9	it	-PRON-	PRP
46745	5036	10	seem	seem	VB
46745	5036	11	to	to	TO
46745	5036	12	have	have	VB
46745	5036	13	any	any	DT
46745	5036	14	relation	relation	NN
46745	5036	15	to	to	IN
46745	5036	16	the	the	DT
46745	5036	17	function	function	NN
46745	5036	18	of	of	IN
46745	5036	19	the	the	DT
46745	5036	20	liver	liver	NN
46745	5036	21	.	.	.
46745	5037	1	I	-PRON-	PRP
46745	5037	2	have	have	VBP
46745	5037	3	thought	think	VBN
46745	5037	4	it	-PRON-	PRP
46745	5037	5	advisable	advisable	JJ
46745	5037	6	to	to	TO
46745	5037	7	restrict	restrict	VB
46745	5037	8	the	the	DT
46745	5037	9	term	term	NN
46745	5037	10	_	_	NNP
46745	5037	11	Antiperiodic	Antiperiodic	NNP
46745	5037	12	_	_	NNP
46745	5037	13	to	to	IN
46745	5037	14	the	the	DT
46745	5037	15	_	_	NNP
46745	5037	16	Catalytics	Catalytics	NNP
46745	5037	17	_	_	NNP
46745	5037	18	which	which	WDT
46745	5037	19	are	be	VBP
46745	5037	20	used	use	VBN
46745	5037	21	in	in	IN
46745	5037	22	Ague	Ague	NNP
46745	5037	23	.	.	.
46745	5038	1	(	(	-LRB-
46745	5038	2	_	_	NNP
46745	5038	3	Vide	Vide	NNP
46745	5038	4	_	_	NNP
46745	5038	5	p.	p.	NN
46745	5039	1	141	141	CD
46745	5039	2	.	.	.
46745	5039	3	)	)	-RRB-
46745	5040	1	Quinine	quinine	JJ
46745	5040	2	and	and	CC
46745	5040	3	Arsenic	Arsenic	NNP
46745	5040	4	may	may	MD
46745	5040	5	both	both	DT
46745	5040	6	be	be	VB
46745	5040	7	employed	employ	VBN
46745	5040	8	in	in	IN
46745	5040	9	all	all	DT
46745	5040	10	disorders	disorder	NNS
46745	5040	11	which	which	WDT
46745	5040	12	put	put	VBD
46745	5040	13	on	on	RP
46745	5040	14	an	an	DT
46745	5040	15	intermittent	intermittent	JJ
46745	5040	16	or	or	CC
46745	5040	17	periodic	periodic	JJ
46745	5040	18	type	type	NN
46745	5040	19	.	.	.
46745	5041	1	The	the	DT
46745	5041	2	chief	chief	NN
46745	5041	3	of	of	IN
46745	5041	4	these	these	DT
46745	5041	5	is	be	VBZ
46745	5041	6	Ague	Ague	NNP
46745	5041	7	,	,	,
46745	5041	8	or	or	CC
46745	5041	9	Intermittent	Intermittent	NNP
46745	5041	10	Fever	Fever	NNP
46745	5041	11	.	.	.
46745	5042	1	It	-PRON-	PRP
46745	5042	2	is	be	VBZ
46745	5042	3	perhaps	perhaps	RB
46745	5042	4	easier	easy	JJR
46745	5042	5	to	to	TO
46745	5042	6	arrest	arrest	VB
46745	5042	7	the	the	DT
46745	5042	8	disorder	disorder	NN
46745	5042	9	by	by	IN
46745	5042	10	Quinine	Quinine	NNP
46745	5042	11	than	than	IN
46745	5042	12	by	by	IN
46745	5042	13	Arsenic	Arsenic	NNP
46745	5042	14	;	;	:
46745	5042	15	for	for	IN
46745	5042	16	Quinine	Quinine	NNP
46745	5042	17	may	may	MD
46745	5042	18	be	be	VB
46745	5042	19	given	give	VBN
46745	5042	20	in	in	IN
46745	5042	21	large	large	JJ
46745	5042	22	doses	dose	NNS
46745	5042	23	,	,	,
46745	5042	24	which	which	WDT
46745	5042	25	can	can	MD
46745	5042	26	not	not	RB
46745	5042	27	be	be	VB
46745	5042	28	done	do	VBN
46745	5042	29	with	with	IN
46745	5042	30	Arsenic	Arsenic	NNP
46745	5042	31	.	.	.
46745	5043	1	But	but	CC
46745	5043	2	the	the	DT
46745	5043	3	administration	administration	NN
46745	5043	4	of	of	IN
46745	5043	5	the	the	DT
46745	5043	6	latter	latter	JJ
46745	5043	7	may	may	MD
46745	5043	8	be	be	VB
46745	5043	9	continued	continue	VBN
46745	5043	10	during	during	IN
46745	5043	11	the	the	DT
46745	5043	12	paroxysm	paroxysm	NNS
46745	5043	13	,	,	,
46745	5043	14	when	when	WRB
46745	5043	15	the	the	DT
46745	5043	16	great	great	JJ
46745	5043	17	febrile	febrile	NN
46745	5043	18	reaction	reaction	NN
46745	5043	19	forbids	forbid	VBZ
46745	5043	20	the	the	DT
46745	5043	21	use	use	NN
46745	5043	22	of	of	IN
46745	5043	23	the	the	DT
46745	5043	24	other	other	JJ
46745	5043	25	.	.	.
46745	5044	1	The	the	DT
46745	5044	2	dose	dose	NN
46745	5044	3	of	of	IN
46745	5044	4	Quinine	Quinine	NNP
46745	5044	5	is	be	VBZ
46745	5044	6	apt	apt	JJ
46745	5044	7	to	to	TO
46745	5044	8	disagree	disagree	VB
46745	5044	9	with	with	IN
46745	5044	10	an	an	DT
46745	5044	11	irritable	irritable	JJ
46745	5044	12	stomach	stomach	NN
46745	5044	13	,	,	,
46745	5044	14	and	and	CC
46745	5044	15	to	to	TO
46745	5044	16	increase	increase	VB
46745	5044	17	the	the	DT
46745	5044	18	fever	fever	NN
46745	5044	19	.	.	.
46745	5045	1	It	-PRON-	PRP
46745	5045	2	is	be	VBZ
46745	5045	3	generally	generally	RB
46745	5045	4	laid	lay	VBN
46745	5045	5	down	down	RP
46745	5045	6	that	that	IN
46745	5045	7	this	this	DT
46745	5045	8	remedy	remedy	NN
46745	5045	9	should	should	MD
46745	5045	10	not	not	RB
46745	5045	11	be	be	VB
46745	5045	12	administered	administer	VBN
46745	5045	13	when	when	WRB
46745	5045	14	there	there	EX
46745	5045	15	is	be	VBZ
46745	5045	16	a	a	DT
46745	5045	17	quick	quick	JJ
46745	5045	18	hard	hard	JJ
46745	5045	19	pulse	pulse	NN
46745	5045	20	,	,	,
46745	5045	21	or	or	CC
46745	5045	22	heat	heat	NN
46745	5045	23	and	and	CC
46745	5045	24	dryness	dryness	NN
46745	5045	25	of	of	IN
46745	5045	26	the	the	DT
46745	5045	27	skin	skin	NN
46745	5045	28	.	.	.
46745	5046	1	Some	some	DT
46745	5046	2	,	,	,
46745	5046	3	however	however	RB
46745	5046	4	,	,	,
46745	5046	5	have	have	VBP
46745	5046	6	lately	lately	RB
46745	5046	7	ventured	venture	VBN
46745	5046	8	to	to	TO
46745	5046	9	prescribe	prescribe	VB
46745	5046	10	it	-PRON-	PRP
46745	5046	11	to	to	IN
46745	5046	12	patients	patient	NNS
46745	5046	13	in	in	IN
46745	5046	14	high	high	JJ
46745	5046	15	fever	fever	NN
46745	5046	16	.	.	.
46745	5047	1	It	-PRON-	PRP
46745	5047	2	appears	appear	VBZ
46745	5047	3	that	that	IN
46745	5047	4	there	there	EX
46745	5047	5	is	be	VBZ
46745	5047	6	a	a	DT
46745	5047	7	particular	particular	JJ
46745	5047	8	class	class	NN
46745	5047	9	of	of	IN
46745	5047	10	patients	patient	NNS
46745	5047	11	which	which	WDT
46745	5047	12	in	in	IN
46745	5047	13	such	such	JJ
46745	5047	14	cases	case	NNS
46745	5047	15	will	will	MD
46745	5047	16	bear	bear	VB
46745	5047	17	the	the	DT
46745	5047	18	administration	administration	NN
46745	5047	19	of	of	IN
46745	5047	20	Quinine	Quinine	NNP
46745	5047	21	with	with	IN
46745	5047	22	impunity	impunity	NN
46745	5047	23	;	;	:
46745	5047	24	while	while	IN
46745	5047	25	others	other	NNS
46745	5047	26	are	be	VBP
46745	5047	27	unfavourably	unfavourably	RB
46745	5047	28	affected	affect	VBN
46745	5047	29	by	by	IN
46745	5047	30	the	the	DT
46745	5047	31	smallest	small	JJS
46745	5047	32	dose	dose	NN
46745	5047	33	.	.	.
46745	5048	1	It	-PRON-	PRP
46745	5048	2	is	be	VBZ
46745	5048	3	perhaps	perhaps	RB
46745	5048	4	at	at	RB
46745	5048	5	all	all	DT
46745	5048	6	times	time	NNS
46745	5048	7	advisable	advisable	JJ
46745	5048	8	to	to	TO
46745	5048	9	arrange	arrange	VB
46745	5048	10	so	so	IN
46745	5048	11	that	that	IN
46745	5048	12	the	the	DT
46745	5048	13	medicine	medicine	NN
46745	5048	14	shall	shall	MD
46745	5048	15	,	,	,
46745	5048	16	if	if	IN
46745	5048	17	possible	possible	JJ
46745	5048	18	,	,	,
46745	5048	19	be	be	VB
46745	5048	20	taken	take	VBN
46745	5048	21	after	after	IN
46745	5048	22	meals	meal	NNS
46745	5048	23	,	,	,
46745	5048	24	for	for	IN
46745	5048	25	it	-PRON-	PRP
46745	5048	26	is	be	VBZ
46745	5048	27	less	less	RBR
46745	5048	28	likely	likely	JJ
46745	5048	29	to	to	TO
46745	5048	30	irritate	irritate	VB
46745	5048	31	a	a	DT
46745	5048	32	full	full	JJ
46745	5048	33	stomach	stomach	NN
46745	5048	34	.	.	.
46745	5049	1	And	and	CC
46745	5049	2	when	when	WRB
46745	5049	3	it	-PRON-	PRP
46745	5049	4	is	be	VBZ
46745	5049	5	thought	think	VBN
46745	5049	6	proper	proper	JJ
46745	5049	7	to	to	TO
46745	5049	8	give	give	VB
46745	5049	9	it	-PRON-	PRP
46745	5049	10	to	to	IN
46745	5049	11	a	a	DT
46745	5049	12	patient	patient	NN
46745	5049	13	in	in	IN
46745	5049	14	fever	fever	NN
46745	5049	15	,	,	,
46745	5049	16	a	a	DT
46745	5049	17	small	small	JJ
46745	5049	18	dose	dose	NN
46745	5049	19	of	of	IN
46745	5049	20	Tartar	Tartar	NNP
46745	5049	21	Emetic	Emetic	NNP
46745	5049	22	or	or	CC
46745	5049	23	Ipecacuanha	Ipecacuanha	NNP
46745	5049	24	should	should	MD
46745	5049	25	be	be	VB
46745	5049	26	conjoined	conjoin	VBN
46745	5049	27	with	with	IN
46745	5049	28	it	-PRON-	PRP
46745	5049	29	--	--	:
46745	5049	30	not	not	RB
46745	5049	31	,	,	,
46745	5049	32	of	of	IN
46745	5049	33	course	course	NN
46745	5049	34	,	,	,
46745	5049	35	sufficient	sufficient	JJ
46745	5049	36	to	to	TO
46745	5049	37	produce	produce	VB
46745	5049	38	vomiting	vomiting	NN
46745	5049	39	,	,	,
46745	5049	40	but	but	CC
46745	5049	41	so	so	RB
46745	5049	42	that	that	IN
46745	5049	43	an	an	DT
46745	5049	44	increase	increase	NN
46745	5049	45	of	of	IN
46745	5049	46	the	the	DT
46745	5049	47	febrile	febrile	NN
46745	5049	48	excitement	excitement	NN
46745	5049	49	may	may	MD
46745	5049	50	be	be	VB
46745	5049	51	prevented	prevent	VBN
46745	5049	52	.	.	.
46745	5050	1	Quinine	Quinine	NNP
46745	5050	2	is	be	VBZ
46745	5050	3	in	in	IN
46745	5050	4	all	all	DT
46745	5050	5	cases	case	NNS
46745	5050	6	better	well	RBR
46745	5050	7	tolerated	tolerate	VBN
46745	5050	8	by	by	IN
46745	5050	9	the	the	DT
46745	5050	10	stomach	stomach	NN
46745	5050	11	when	when	WRB
46745	5050	12	the	the	DT
46745	5050	13	dose	dose	NN
46745	5050	14	is	be	VBZ
46745	5050	15	considerably	considerably	RB
46745	5050	16	diluted	dilute	VBN
46745	5050	17	with	with	IN
46745	5050	18	water	water	NN
46745	5050	19	.	.	.
46745	5051	1	A	a	DT
46745	5051	2	combination	combination	NN
46745	5051	3	of	of	IN
46745	5051	4	Quinine	Quinine	NNP
46745	5051	5	and	and	CC
46745	5051	6	Iron	Iron	NNP
46745	5051	7	is	be	VBZ
46745	5051	8	often	often	RB
46745	5051	9	of	of	IN
46745	5051	10	great	great	JJ
46745	5051	11	service	service	NN
46745	5051	12	in	in	IN
46745	5051	13	feeble	feeble	JJ
46745	5051	14	and	and	CC
46745	5051	15	relaxed	relaxed	JJ
46745	5051	16	conditions	condition	NNS
46745	5051	17	,	,	,
46745	5051	18	where	where	WRB
46745	5051	19	there	there	EX
46745	5051	20	is	be	VBZ
46745	5051	21	co	co	JJ
46745	5051	22	-	-	JJ
46745	5051	23	existent	existent	JJ
46745	5051	24	Anæmia	anæmia	NN
46745	5051	25	.	.	.
46745	5052	1	(	(	-LRB-
46745	5052	2	_	_	NNP
46745	5052	3	Vide	Vide	NNP
46745	5052	4	_	_	NNP
46745	5052	5	p.	p.	NN
46745	5053	1	129	129	CD
46745	5053	2	.	.	.
46745	5053	3	)	)	-RRB-
46745	5054	1	IRON	IRON	NNP
46745	5054	2	.	.	.
46745	5055	1	Class	class	NN
46745	5055	2	I.	I.	NNP
46745	5055	3	Div	Div	NNP
46745	5055	4	.	.	.
46745	5056	1	I.	I.	NNP
46745	5056	2	Ord	Ord	NNP
46745	5056	3	.	.	.
46745	5057	1	V.	V.	NNP
46745	5057	2	CHALYBEATA	CHALYBEATA	NNP
46745	5057	3	.	.	.
46745	5058	1	It	-PRON-	PRP
46745	5058	2	has	have	VBZ
46745	5058	3	been	be	VBN
46745	5058	4	shown	show	VBN
46745	5058	5	,	,	,
46745	5058	6	in	in	IN
46745	5058	7	the	the	DT
46745	5058	8	article	article	NN
46745	5058	9	on	on	IN
46745	5058	10	Chalybeates	Chalybeates	NNPS
46745	5058	11	,	,	,
46745	5058	12	that	that	IN
46745	5058	13	the	the	DT
46745	5058	14	action	action	NN
46745	5058	15	of	of	IN
46745	5058	16	Iron	Iron	NNP
46745	5058	17	is	be	VBZ
46745	5058	18	of	of	IN
46745	5058	19	a	a	DT
46745	5058	20	distinctly	distinctly	RB
46745	5058	21	Restorative	restorative	JJ
46745	5058	22	nature	nature	NN
46745	5058	23	.	.	.
46745	5059	1	There	there	EX
46745	5059	2	is	be	VBZ
46745	5059	3	in	in	IN
46745	5059	4	the	the	DT
46745	5059	5	blood	blood	NN
46745	5059	6	a	a	DT
46745	5059	7	red	red	JJ
46745	5059	8	colouring	colouring	NN
46745	5059	9	matter	matter	NN
46745	5059	10	,	,	,
46745	5059	11	called	call	VBN
46745	5059	12	Hæmatosin	Hæmatosin	NNP
46745	5059	13	.	.	.
46745	5060	1	It	-PRON-	PRP
46745	5060	2	is	be	VBZ
46745	5060	3	found	find	VBN
46745	5060	4	by	by	IN
46745	5060	5	chemical	chemical	JJ
46745	5060	6	analysis	analysis	NN
46745	5060	7	that	that	WDT
46745	5060	8	Iron	Iron	NNP
46745	5060	9	is	be	VBZ
46745	5060	10	an	an	DT
46745	5060	11	essential	essential	JJ
46745	5060	12	part	part	NN
46745	5060	13	of	of	IN
46745	5060	14	this	this	DT
46745	5060	15	substance	substance	NN
46745	5060	16	.	.	.
46745	5061	1	The	the	DT
46745	5061	2	existence	existence	NN
46745	5061	3	of	of	IN
46745	5061	4	the	the	DT
46745	5061	5	right	right	JJ
46745	5061	6	amount	amount	NN
46745	5061	7	of	of	IN
46745	5061	8	Hæmatosin	Hæmatosin	NNP
46745	5061	9	in	in	IN
46745	5061	10	the	the	DT
46745	5061	11	blood	blood	NN
46745	5061	12	is	be	VBZ
46745	5061	13	of	of	IN
46745	5061	14	vital	vital	JJ
46745	5061	15	importance	importance	NN
46745	5061	16	.	.	.
46745	5062	1	It	-PRON-	PRP
46745	5062	2	is	be	VBZ
46745	5062	3	contained	contain	VBN
46745	5062	4	in	in	IN
46745	5062	5	the	the	DT
46745	5062	6	red	red	JJ
46745	5062	7	globules	globule	NNS
46745	5062	8	of	of	IN
46745	5062	9	the	the	DT
46745	5062	10	blood	blood	NN
46745	5062	11	.	.	.
46745	5063	1	When	when	WRB
46745	5063	2	it	-PRON-	PRP
46745	5063	3	is	be	VBZ
46745	5063	4	diminished	diminish	VBN
46745	5063	5	in	in	IN
46745	5063	6	quantity	quantity	NN
46745	5063	7	,	,	,
46745	5063	8	the	the	DT
46745	5063	9	number	number	NN
46745	5063	10	of	of	IN
46745	5063	11	these	these	DT
46745	5063	12	red	red	JJ
46745	5063	13	globules	globule	NNS
46745	5063	14	is	be	VBZ
46745	5063	15	lessened	lessen	VBN
46745	5063	16	in	in	IN
46745	5063	17	the	the	DT
46745	5063	18	same	same	JJ
46745	5063	19	proportion	proportion	NN
46745	5063	20	.	.	.
46745	5064	1	This	this	DT
46745	5064	2	produces	produce	VBZ
46745	5064	3	a	a	DT
46745	5064	4	paleness	paleness	NN
46745	5064	5	of	of	IN
46745	5064	6	all	all	PDT
46745	5064	7	the	the	DT
46745	5064	8	tissues	tissue	NNS
46745	5064	9	,	,	,
46745	5064	10	an	an	DT
46745	5064	11	inactivity	inactivity	NN
46745	5064	12	of	of	IN
46745	5064	13	the	the	DT
46745	5064	14	muscular	muscular	JJ
46745	5064	15	fibre	fibre	NN
46745	5064	16	,	,	,
46745	5064	17	an	an	DT
46745	5064	18	impairment	impairment	NN
46745	5064	19	of	of	IN
46745	5064	20	all	all	PDT
46745	5064	21	the	the	DT
46745	5064	22	animal	animal	NN
46745	5064	23	functions	function	NNS
46745	5064	24	,	,	,
46745	5064	25	and	and	CC
46745	5064	26	a	a	DT
46745	5064	27	general	general	JJ
46745	5064	28	languor	languor	NN
46745	5064	29	and	and	CC
46745	5064	30	debility	debility	NN
46745	5064	31	of	of	IN
46745	5064	32	the	the	DT
46745	5064	33	whole	whole	JJ
46745	5064	34	frame	frame	NN
46745	5064	35	.	.	.
46745	5065	1	This	this	DT
46745	5065	2	is	be	VBZ
46745	5065	3	Anæmia	Anæmia	NNP
46745	5065	4	.	.	.
46745	5066	1	In	in	IN
46745	5066	2	all	all	DT
46745	5066	3	cases	case	NNS
46745	5066	4	in	in	IN
46745	5066	5	which	which	WDT
46745	5066	6	Iron	Iron	NNP
46745	5066	7	is	be	VBZ
46745	5066	8	used	use	VBN
46745	5066	9	there	there	EX
46745	5066	10	is	be	VBZ
46745	5066	11	a	a	DT
46745	5066	12	deficiency	deficiency	NN
46745	5066	13	of	of	IN
46745	5066	14	this	this	DT
46745	5066	15	red	red	JJ
46745	5066	16	colouring	colouring	NN
46745	5066	17	matter	matter	NN
46745	5066	18	;	;	,
46745	5066	19	and	and	CC
46745	5066	20	in	in	IN
46745	5066	21	all	all	DT
46745	5066	22	instances	instance	NNS
46745	5066	23	of	of	IN
46745	5066	24	Anæmia	Anæmia	NNP
46745	5066	25	Iron	Iron	NNP
46745	5066	26	is	be	VBZ
46745	5066	27	appropriate	appropriate	JJ
46745	5066	28	as	as	IN
46745	5066	29	a	a	DT
46745	5066	30	remedy	remedy	NN
46745	5066	31	.	.	.
46745	5067	1	The	the	DT
46745	5067	2	blood	blood	NN
46745	5067	3	has	have	VBZ
46745	5067	4	been	be	VBN
46745	5067	5	analyzed	analyze	VBN
46745	5067	6	before	before	IN
46745	5067	7	its	-PRON-	PRP$
46745	5067	8	use	use	NN
46745	5067	9	,	,	,
46745	5067	10	and	and	CC
46745	5067	11	found	find	VBD
46745	5067	12	to	to	TO
46745	5067	13	contain	contain	VB
46745	5067	14	a	a	DT
46745	5067	15	smaller	small	JJR
46745	5067	16	quantity	quantity	NN
46745	5067	17	of	of	IN
46745	5067	18	Hæmatosin	Hæmatosin	NNP
46745	5067	19	and	and	CC
46745	5067	20	fewer	few	JJR
46745	5067	21	red	red	JJ
46745	5067	22	globules	globule	NNS
46745	5067	23	than	than	IN
46745	5067	24	in	in	IN
46745	5067	25	health	health	NN
46745	5067	26	.	.	.
46745	5068	1	After	after	IN
46745	5068	2	its	-PRON-	PRP$
46745	5068	3	employment	employment	NN
46745	5068	4	the	the	DT
46745	5068	5	blood	blood	NN
46745	5068	6	has	have	VBZ
46745	5068	7	been	be	VBN
46745	5068	8	analyzed	analyze	VBN
46745	5068	9	again	again	RB
46745	5068	10	,	,	,
46745	5068	11	and	and	CC
46745	5068	12	it	-PRON-	PRP
46745	5068	13	is	be	VBZ
46745	5068	14	found	find	VBN
46745	5068	15	that	that	IN
46745	5068	16	the	the	DT
46745	5068	17	amount	amount	NN
46745	5068	18	of	of	IN
46745	5068	19	Hæmatosin	Hæmatosin	NNP
46745	5068	20	and	and	CC
46745	5068	21	of	of	IN
46745	5068	22	red	red	JJ
46745	5068	23	globules	globule	NNS
46745	5068	24	is	be	VBZ
46745	5068	25	increased	increase	VBN
46745	5068	26	.	.	.
46745	5069	1	Iron	iron	NN
46745	5069	2	,	,	,
46745	5069	3	then	then	RB
46745	5069	4	,	,	,
46745	5069	5	is	be	VBZ
46745	5069	6	given	give	VBN
46745	5069	7	in	in	IN
46745	5069	8	Anæmia	Anæmia	NNP
46745	5069	9	.	.	.
46745	5070	1	It	-PRON-	PRP
46745	5070	2	is	be	VBZ
46745	5070	3	also	also	RB
46745	5070	4	given	give	VBN
46745	5070	5	in	in	IN
46745	5070	6	cases	case	NNS
46745	5070	7	of	of	IN
46745	5070	8	Scrofula	Scrofula	NNP
46745	5070	9	,	,	,
46745	5070	10	Cancer	Cancer	NNP
46745	5070	11	,	,	,
46745	5070	12	Chorea	Chorea	NNP
46745	5070	13	,	,	,
46745	5070	14	Hysteria	Hysteria	NNP
46745	5070	15	,	,	,
46745	5070	16	and	and	CC
46745	5070	17	other	other	JJ
46745	5070	18	disorders	disorder	NNS
46745	5070	19	,	,	,
46745	5070	20	when	when	WRB
46745	5070	21	these	these	DT
46745	5070	22	are	be	VBP
46745	5070	23	attended	attend	VBN
46745	5070	24	with	with	IN
46745	5070	25	Anæmia	Anæmia	NNP
46745	5070	26	.	.	.
46745	5071	1	When	when	WRB
46745	5071	2	this	this	DT
46745	5071	3	last	last	JJ
46745	5071	4	condition	condition	NN
46745	5071	5	is	be	VBZ
46745	5071	6	wanting	want	VBG
46745	5071	7	,	,	,
46745	5071	8	it	-PRON-	PRP
46745	5071	9	seldom	seldom	RB
46745	5071	10	proves	prove	VBZ
46745	5071	11	efficacious	efficacious	JJ
46745	5071	12	.	.	.
46745	5072	1	Iron	iron	NN
46745	5072	2	,	,	,
46745	5072	3	when	when	WRB
46745	5072	4	given	give	VBN
46745	5072	5	in	in	IN
46745	5072	6	moderate	moderate	JJ
46745	5072	7	doses	dose	NNS
46745	5072	8	,	,	,
46745	5072	9	remains	remain	VBZ
46745	5072	10	in	in	IN
46745	5072	11	the	the	DT
46745	5072	12	system	system	NN
46745	5072	13	,	,	,
46745	5072	14	and	and	CC
46745	5072	15	enters	enter	VBZ
46745	5072	16	into	into	IN
46745	5072	17	the	the	DT
46745	5072	18	composition	composition	NN
46745	5072	19	of	of	IN
46745	5072	20	the	the	DT
46745	5072	21	blood	blood	NN
46745	5072	22	.	.	.
46745	5073	1	It	-PRON-	PRP
46745	5073	2	is	be	VBZ
46745	5073	3	then	then	RB
46745	5073	4	a	a	DT
46745	5073	5	Restorative	Restorative	NNP
46745	5073	6	Hæmatic	Hæmatic	NNP
46745	5073	7	.	.	.
46745	5074	1	Some	some	DT
46745	5074	2	of	of	IN
46745	5074	3	the	the	DT
46745	5074	4	salts	salt	NNS
46745	5074	5	of	of	IN
46745	5074	6	Iron	Iron	NNP
46745	5074	7	are	be	VBP
46745	5074	8	also	also	RB
46745	5074	9	Astringent	Astringent	NNP
46745	5074	10	.	.	.
46745	5075	1	Thus	thus	RB
46745	5075	2	the	the	DT
46745	5075	3	Sulphate	Sulphate	NNP
46745	5075	4	and	and	CC
46745	5075	5	Sesquichloride	Sesquichloride	NNP
46745	5075	6	may	may	MD
46745	5075	7	,	,	,
46745	5075	8	by	by	IN
46745	5075	9	their	-PRON-	PRP$
46745	5075	10	topical	topical	JJ
46745	5075	11	action	action	NN
46745	5075	12	on	on	IN
46745	5075	13	the	the	DT
46745	5075	14	stomach	stomach	NN
46745	5075	15	,	,	,
46745	5075	16	be	be	VB
46745	5075	17	of	of	IN
46745	5075	18	service	service	NN
46745	5075	19	in	in	IN
46745	5075	20	cases	case	NNS
46745	5075	21	of	of	IN
46745	5075	22	atonic	atonic	JJ
46745	5075	23	Dyspepsia	Dyspepsia	NNP
46745	5075	24	.	.	.
46745	5076	1	In	in	IN
46745	5076	2	Anæmia	Anæmia	NNP
46745	5076	3	produced	produce	VBN
46745	5076	4	by	by	IN
46745	5076	5	special	special	JJ
46745	5076	6	causes	cause	NNS
46745	5076	7	,	,	,
46745	5076	8	as	as	IN
46745	5076	9	by	by	IN
46745	5076	10	scrofulous	scrofulous	JJ
46745	5076	11	or	or	CC
46745	5076	12	nervous	nervous	JJ
46745	5076	13	disorder	disorder	NN
46745	5076	14	,	,	,
46745	5076	15	we	-PRON-	PRP
46745	5076	16	may	may	MD
46745	5076	17	often	often	RB
46745	5076	18	do	do	VB
46745	5076	19	most	most	RBS
46745	5076	20	good	good	JJ
46745	5076	21	by	by	IN
46745	5076	22	striking	strike	VBG
46745	5076	23	at	at	IN
46745	5076	24	the	the	DT
46745	5076	25	root	root	NN
46745	5076	26	of	of	IN
46745	5076	27	the	the	DT
46745	5076	28	evil,--employing	evil,--employe	VBG
46745	5076	29	a	a	DT
46745	5076	30	Catalytic	catalytic	JJ
46745	5076	31	medicine	medicine	NN
46745	5076	32	which	which	WDT
46745	5076	33	shall	shall	MD
46745	5076	34	be	be	VB
46745	5076	35	able	able	JJ
46745	5076	36	to	to	TO
46745	5076	37	do	do	VB
46745	5076	38	this	this	DT
46745	5076	39	.	.	.
46745	5077	1	In	in	IN
46745	5077	2	simple	simple	JJ
46745	5077	3	Anæmia	Anæmia	NNP
46745	5077	4	,	,	,
46745	5077	5	Iron	Iron	NNP
46745	5077	6	is	be	VBZ
46745	5077	7	of	of	IN
46745	5077	8	more	more	JJR
46745	5077	9	use	use	NN
46745	5077	10	than	than	IN
46745	5077	11	any	any	DT
46745	5077	12	other	other	JJ
46745	5077	13	medicine	medicine	NN
46745	5077	14	.	.	.
46745	5078	1	It	-PRON-	PRP
46745	5078	2	should	should	MD
46745	5078	3	be	be	VB
46745	5078	4	combined	combine	VBN
46745	5078	5	with	with	IN
46745	5078	6	exercise	exercise	NN
46745	5078	7	,	,	,
46745	5078	8	air	air	NN
46745	5078	9	,	,	,
46745	5078	10	light	light	NN
46745	5078	11	,	,	,
46745	5078	12	and	and	CC
46745	5078	13	good	good	JJ
46745	5078	14	living	living	NN
46745	5078	15	.	.	.
46745	5079	1	In	in	IN
46745	5079	2	other	other	JJ
46745	5079	3	disorders	disorder	NNS
46745	5079	4	a	a	DT
46745	5079	5	combination	combination	NN
46745	5079	6	of	of	IN
46745	5079	7	drugs	drug	NNS
46745	5079	8	is	be	VBZ
46745	5079	9	frequently	frequently	RB
46745	5079	10	of	of	IN
46745	5079	11	use	use	NN
46745	5079	12	.	.	.
46745	5080	1	In	in	IN
46745	5080	2	chronic	chronic	JJ
46745	5080	3	Ague	Ague	NNP
46745	5080	4	,	,	,
46745	5080	5	and	and	CC
46745	5080	6	in	in	IN
46745	5080	7	many	many	JJ
46745	5080	8	cases	case	NNS
46745	5080	9	of	of	IN
46745	5080	10	debility	debility	NN
46745	5080	11	,	,	,
46745	5080	12	Iron	Iron	NNP
46745	5080	13	and	and	CC
46745	5080	14	Bark	Bark	NNP
46745	5080	15	may	may	MD
46745	5080	16	be	be	VB
46745	5080	17	given	give	VBN
46745	5080	18	together	together	RB
46745	5080	19	.	.	.
46745	5081	1	Iron	iron	NN
46745	5081	2	and	and	CC
46745	5081	3	Aloetic	aloetic	JJ
46745	5081	4	purges	purge	NNS
46745	5081	5	may	may	MD
46745	5081	6	be	be	VB
46745	5081	7	prescribed	prescribe	VBN
46745	5081	8	in	in	IN
46745	5081	9	Chlorosis	Chlorosis	NNP
46745	5081	10	and	and	CC
46745	5081	11	Amenorrh[oe]a	amenorrh[oe]a	CD
46745	5081	12	.	.	.
46745	5082	1	A	a	DT
46745	5082	2	mild	mild	JJ
46745	5082	3	purgative	purgative	NN
46745	5082	4	should	should	MD
46745	5082	5	be	be	VB
46745	5082	6	occasionally	occasionally	RB
46745	5082	7	given	give	VBN
46745	5082	8	in	in	IN
46745	5082	9	all	all	DT
46745	5082	10	cases	case	NNS
46745	5082	11	in	in	IN
46745	5082	12	which	which	WDT
46745	5082	13	Iron	Iron	NNP
46745	5082	14	is	be	VBZ
46745	5082	15	used	use	VBN
46745	5082	16	.	.	.
46745	5083	1	The	the	DT
46745	5083	2	Ammonio	Ammonio	NNP
46745	5083	3	-	-	HYPH
46745	5083	4	citrate	citrate	NN
46745	5083	5	of	of	IN
46745	5083	6	Iron,--the	iron,--the	PRP$
46745	5083	7	compound	compound	NN
46745	5083	8	Iron	Iron	NNP
46745	5083	9	mixture	mixture	NN
46745	5083	10	,	,	,
46745	5083	11	which	which	WDT
46745	5083	12	contains	contain	VBZ
46745	5083	13	the	the	DT
46745	5083	14	Carbonate,--and	Carbonate,--and	NNP
46745	5083	15	the	the	DT
46745	5083	16	Tincture	Tincture	NNP
46745	5083	17	of	of	IN
46745	5083	18	the	the	DT
46745	5083	19	Sesquichloride,--are	sesquichloride,--are	NN
46745	5083	20	perhaps	perhaps	RB
46745	5083	21	the	the	DT
46745	5083	22	best	good	JJS
46745	5083	23	of	of	IN
46745	5083	24	the	the	DT
46745	5083	25	officinal	officinal	JJ
46745	5083	26	Chalybeate	Chalybeate	NNP
46745	5083	27	preparations	preparation	NNS
46745	5083	28	.	.	.
46745	5084	1	The	the	DT
46745	5084	2	first	first	JJ
46745	5084	3	of	of	IN
46745	5084	4	these	these	DT
46745	5084	5	is	be	VBZ
46745	5084	6	the	the	DT
46745	5084	7	mildest	mild	JJS
46745	5084	8	,	,	,
46745	5084	9	and	and	CC
46745	5084	10	the	the	DT
46745	5084	11	last	last	JJ
46745	5084	12	the	the	DT
46745	5084	13	most	most	RBS
46745	5084	14	irritant	irritant	NN
46745	5084	15	of	of	IN
46745	5084	16	the	the	DT
46745	5084	17	three	three	CD
46745	5084	18	.	.	.
46745	5085	1	(	(	-LRB-
46745	5085	2	_	_	NNP
46745	5085	3	Vide	Vide	NNP
46745	5085	4	_	_	NNP
46745	5085	5	pp	pp	NNP
46745	5085	6	.	.	.
46745	5086	1	145	145	CD
46745	5086	2	,	,	,
46745	5086	3	263	263	CD
46745	5086	4	.	.	.
46745	5086	5	)	)	-RRB-
46745	5087	1	ANTIMONY	ANTIMONY	NNP
46745	5087	2	.	.	.
46745	5088	1	Class	class	NN
46745	5088	2	I.	I.	NNP
46745	5088	3	Div	Div	NNP
46745	5088	4	.	.	.
46745	5089	1	II	ii	CD
46745	5089	2	.	.	.
46745	5090	1	Ord	Ord	NNP
46745	5090	2	.	.	.
46745	5091	1	I.	I.	NNP
46745	5091	2	ANTIPHLOGISTICA	ANTIPHLOGISTICA	NNP
46745	5091	3	.	.	.
46745	5092	1	Class	class	NN
46745	5092	2	II	II	NNP
46745	5092	3	.	.	.
46745	5093	1	Div	Div	NNP
46745	5093	2	.	.	.
46745	5094	1	III	iii	CD
46745	5094	2	.	.	.
46745	5095	1	Ord	Ord	NNP
46745	5095	2	.	.	.
46745	5096	1	II	ii	CD
46745	5096	2	.	.	.
46745	5097	1	SEDANTIA	SEDANTIA	NNP
46745	5097	2	SPECIFICA	SPECIFICA	NNP
46745	5097	3	.	.	.
46745	5098	1	Class	Class	NNP
46745	5098	2	IV	IV	NNP
46745	5098	3	.	.	.
46745	5099	1	Ord	Ord	NNP
46745	5099	2	.	.	.
46745	5100	1	II	ii	CD
46745	5100	2	.	.	.
46745	5101	1	EXPECTORANTIA	EXPECTORANTIA	NNP
46745	5101	2	.	.	.
46745	5102	1	Class	Class	NNP
46745	5102	2	IV	IV	NNP
46745	5102	3	.	.	.
46745	5103	1	Ord	Ord	NNP
46745	5103	2	.	.	.
46745	5104	1	V.	V.	NNP
46745	5104	2	DIAPHORETICA	DIAPHORETICA	NNP
46745	5104	3	.	.	.
46745	5105	1	The	the	DT
46745	5105	2	best	good	JJS
46745	5105	3	Antimonial	Antimonial	NNP
46745	5105	4	for	for	IN
46745	5105	5	general	general	JJ
46745	5105	6	purposes	purpose	NNS
46745	5105	7	,	,	,
46745	5105	8	and	and	CC
46745	5105	9	the	the	DT
46745	5105	10	most	most	RBS
46745	5105	11	characteristic	characteristic	JJ
46745	5105	12	in	in	IN
46745	5105	13	its	-PRON-	PRP$
46745	5105	14	mode	mode	NN
46745	5105	15	of	of	IN
46745	5105	16	operation	operation	NN
46745	5105	17	,	,	,
46745	5105	18	is	be	VBZ
46745	5105	19	Tartar	Tartar	NNP
46745	5105	20	Emetic	Emetic	NNP
46745	5105	21	.	.	.
46745	5106	1	In	in	IN
46745	5106	2	this	this	DT
46745	5106	3	medicine	medicine	NN
46745	5106	4	are	be	VBP
46745	5106	5	exhibited	exhibit	VBN
46745	5106	6	three	three	CD
46745	5106	7	distinct	distinct	JJ
46745	5106	8	varieties	variety	NNS
46745	5106	9	of	of	IN
46745	5106	10	action	action	NN
46745	5106	11	.	.	.
46745	5107	1	The	the	DT
46745	5107	2	first	first	JJ
46745	5107	3	of	of	IN
46745	5107	4	the	the	DT
46745	5107	5	terms	term	NNS
46745	5107	6	which	which	WDT
46745	5107	7	are	be	VBP
46745	5107	8	applied	apply	VBN
46745	5107	9	to	to	IN
46745	5107	10	it	-PRON-	PRP
46745	5107	11	above	above	RB
46745	5107	12	implies	imply	VBZ
46745	5107	13	that	that	IN
46745	5107	14	it	-PRON-	PRP
46745	5107	15	has	have	VBZ
46745	5107	16	a	a	DT
46745	5107	17	Catalytic	catalytic	JJ
46745	5107	18	action	action	NN
46745	5107	19	in	in	IN
46745	5107	20	the	the	DT
46745	5107	21	blood	blood	NN
46745	5107	22	.	.	.
46745	5108	1	As	as	IN
46745	5108	2	a	a	DT
46745	5108	3	Special	Special	NNP
46745	5108	4	Sedative	Sedative	NNP
46745	5108	5	,	,	,
46745	5108	6	it	-PRON-	PRP
46745	5108	7	is	be	VBZ
46745	5108	8	able	able	JJ
46745	5108	9	to	to	TO
46745	5108	10	cause	cause	VB
46745	5108	11	nausea	nausea	NN
46745	5108	12	and	and	CC
46745	5108	13	vomiting	vomiting	NN
46745	5108	14	.	.	.
46745	5109	1	And	and	CC
46745	5109	2	it	-PRON-	PRP
46745	5109	3	acts	act	VBZ
46745	5109	4	upon	upon	IN
46745	5109	5	the	the	DT
46745	5109	6	glands	gland	NNS
46745	5109	7	as	as	IN
46745	5109	8	an	an	DT
46745	5109	9	Eliminative	Eliminative	NNP
46745	5109	10	;	;	:
46745	5109	11	being	be	VBG
46745	5109	12	a	a	DT
46745	5109	13	Diaphoretic	diaphoretic	JJ
46745	5109	14	and	and	CC
46745	5109	15	an	an	DT
46745	5109	16	Expectorant	expectorant	NN
46745	5109	17	.	.	.
46745	5110	1	I	-PRON-	PRP
46745	5110	2	have	have	VBP
46745	5110	3	found	find	VBN
46745	5110	4	it	-PRON-	PRP
46745	5110	5	convenient	convenient	JJ
46745	5110	6	to	to	TO
46745	5110	7	restrict	restrict	VB
46745	5110	8	the	the	DT
46745	5110	9	term	term	NN
46745	5110	10	_	_	NNP
46745	5110	11	Antiphlogistic	Antiphlogistic	NNP
46745	5110	12	_	_	NNP
46745	5110	13	to	to	IN
46745	5110	14	those	those	DT
46745	5110	15	medicines	medicine	NNS
46745	5110	16	which	which	WDT
46745	5110	17	counteract	counteract	VBD
46745	5110	18	the	the	DT
46745	5110	19	inflammatory	inflammatory	JJ
46745	5110	20	process	process	NN
46745	5110	21	by	by	IN
46745	5110	22	an	an	DT
46745	5110	23	action	action	NN
46745	5110	24	in	in	IN
46745	5110	25	the	the	DT
46745	5110	26	blood	blood	NN
46745	5110	27	.	.	.
46745	5111	1	In	in	IN
46745	5111	2	this	this	DT
46745	5111	3	sense	sense	NN
46745	5111	4	it	-PRON-	PRP
46745	5111	5	is	be	VBZ
46745	5111	6	applicable	applicable	JJ
46745	5111	7	to	to	IN
46745	5111	8	Antimony	Antimony	NNP
46745	5111	9	;	;	:
46745	5111	10	although	although	IN
46745	5111	11	this	this	DT
46745	5111	12	medicine	medicine	NN
46745	5111	13	is	be	VBZ
46745	5111	14	still	still	RB
46745	5111	15	better	well	RBR
46745	5111	16	able	able	JJ
46745	5111	17	to	to	TO
46745	5111	18	subdue	subdue	VB
46745	5111	19	inflammation	inflammation	NN
46745	5111	20	by	by	IN
46745	5111	21	its	-PRON-	PRP$
46745	5111	22	powerful	powerful	JJ
46745	5111	23	neurotic	neurotic	JJ
46745	5111	24	action	action	NN
46745	5111	25	.	.	.
46745	5112	1	The	the	DT
46745	5112	2	operation	operation	NN
46745	5112	3	in	in	IN
46745	5112	4	the	the	DT
46745	5112	5	blood	blood	NN
46745	5112	6	is	be	VBZ
46745	5112	7	naturally	naturally	RB
46745	5112	8	slower	slow	JJR
46745	5112	9	than	than	IN
46745	5112	10	the	the	DT
46745	5112	11	action	action	NN
46745	5112	12	on	on	IN
46745	5112	13	nerve	nerve	NN
46745	5112	14	,	,	,
46745	5112	15	and	and	CC
46745	5112	16	is	be	VBZ
46745	5112	17	therefore	therefore	RB
46745	5112	18	less	less	RBR
46745	5112	19	marked	marked	JJ
46745	5112	20	,	,	,
46745	5112	21	and	and	CC
46745	5112	22	less	less	RBR
46745	5112	23	immediately	immediately	RB
46745	5112	24	applicable	applicable	JJ
46745	5112	25	.	.	.
46745	5113	1	Antimony	Antimony	NNP
46745	5113	2	deteriorates	deteriorate	VBZ
46745	5113	3	and	and	CC
46745	5113	4	impoverishes	impoverish	VBZ
46745	5113	5	the	the	DT
46745	5113	6	blood	blood	NN
46745	5113	7	in	in	IN
46745	5113	8	very	very	RB
46745	5113	9	much	much	RB
46745	5113	10	the	the	DT
46745	5113	11	same	same	JJ
46745	5113	12	way	way	NN
46745	5113	13	as	as	IN
46745	5113	14	Mercury	Mercury	NNP
46745	5113	15	,	,	,
46745	5113	16	and	and	CC
46745	5113	17	,	,	,
46745	5113	18	if	if	IN
46745	5113	19	given	give	VBN
46745	5113	20	in	in	IN
46745	5113	21	small	small	JJ
46745	5113	22	and	and	CC
46745	5113	23	carefully	carefully	RB
46745	5113	24	regulated	regulated	JJ
46745	5113	25	doses	dose	NNS
46745	5113	26	,	,	,
46745	5113	27	is	be	VBZ
46745	5113	28	simply	simply	RB
46745	5113	29	a	a	DT
46745	5113	30	mild	mild	JJ
46745	5113	31	Antiphlogistic	Antiphlogistic	NNP
46745	5113	32	and	and	CC
46745	5113	33	Eliminative	eliminative	JJ
46745	5113	34	.	.	.
46745	5114	1	It	-PRON-	PRP
46745	5114	2	tends	tend	VBZ
46745	5114	3	to	to	TO
46745	5114	4	increase	increase	VB
46745	5114	5	all	all	DT
46745	5114	6	secretions	secretion	NNS
46745	5114	7	,	,	,
46745	5114	8	but	but	CC
46745	5114	9	particularly	particularly	RB
46745	5114	10	the	the	DT
46745	5114	11	exhalation	exhalation	NN
46745	5114	12	from	from	IN
46745	5114	13	the	the	DT
46745	5114	14	skin	skin	NN
46745	5114	15	and	and	CC
46745	5114	16	lungs	lung	NNS
46745	5114	17	,	,	,
46745	5114	18	independently	independently	RB
46745	5114	19	of	of	IN
46745	5114	20	the	the	DT
46745	5114	21	production	production	NN
46745	5114	22	of	of	IN
46745	5114	23	nausea	nausea	NN
46745	5114	24	(	(	-LRB-
46745	5114	25	p.	p.	NN
46745	5114	26	324	324	CD
46745	5114	27	,	,	,
46745	5114	28	)	)	-RRB-
46745	5114	29	a	a	DT
46745	5114	30	symptom	symptom	NN
46745	5114	31	which	which	WDT
46745	5114	32	is	be	VBZ
46745	5114	33	not	not	RB
46745	5114	34	brought	bring	VBN
46745	5114	35	on	on	RP
46745	5114	36	by	by	IN
46745	5114	37	a	a	DT
46745	5114	38	small	small	JJ
46745	5114	39	dose	dose	NN
46745	5114	40	.	.	.
46745	5115	1	It	-PRON-	PRP
46745	5115	2	is	be	VBZ
46745	5115	3	probable	probable	JJ
46745	5115	4	that	that	IN
46745	5115	5	a	a	DT
46745	5115	6	diaphoretic	diaphoretic	JJ
46745	5115	7	dose	dose	NN
46745	5115	8	of	of	IN
46745	5115	9	Tartar	Tartar	NNP
46745	5115	10	Emetic	Emetic	NNP
46745	5115	11	is	be	VBZ
46745	5115	12	actually	actually	RB
46745	5115	13	eliminated	eliminate	VBN
46745	5115	14	from	from	IN
46745	5115	15	the	the	DT
46745	5115	16	skin	skin	NN
46745	5115	17	and	and	CC
46745	5115	18	mucous	mucous	JJ
46745	5115	19	membranes	membrane	NNS
46745	5115	20	.	.	.
46745	5116	1	Antimony	Antimony	NNP
46745	5116	2	is	be	VBZ
46745	5116	3	appropriate	appropriate	JJ
46745	5116	4	as	as	IN
46745	5116	5	a	a	DT
46745	5116	6	Diaphoretic	Diaphoretic	NNP
46745	5116	7	in	in	IN
46745	5116	8	high	high	JJ
46745	5116	9	fevers	fever	NNS
46745	5116	10	,	,	,
46745	5116	11	and	and	CC
46745	5116	12	in	in	IN
46745	5116	13	cases	case	NNS
46745	5116	14	where	where	WRB
46745	5116	15	Opium	Opium	NNP
46745	5116	16	could	could	MD
46745	5116	17	hardly	hardly	RB
46745	5116	18	be	be	VB
46745	5116	19	used	use	VBN
46745	5116	20	.	.	.
46745	5117	1	But	but	CC
46745	5117	2	Opium	Opium	NNP
46745	5117	3	is	be	VBZ
46745	5117	4	preferable	preferable	JJ
46745	5117	5	in	in	IN
46745	5117	6	cases	case	NNS
46745	5117	7	where	where	WRB
46745	5117	8	there	there	EX
46745	5117	9	is	be	VBZ
46745	5117	10	gastric	gastric	JJ
46745	5117	11	irritation	irritation	NN
46745	5117	12	,	,	,
46745	5117	13	and	and	CC
46745	5117	14	a	a	DT
46745	5117	15	weak	weak	JJ
46745	5117	16	compressible	compressible	JJ
46745	5117	17	pulse	pulse	NN
46745	5117	18	.	.	.
46745	5118	1	The	the	DT
46745	5118	2	action	action	NN
46745	5118	3	by	by	IN
46745	5118	4	virtue	virtue	NN
46745	5118	5	of	of	IN
46745	5118	6	which	which	WDT
46745	5118	7	Antimony	Antimony	NNP
46745	5118	8	has	have	VBZ
46745	5118	9	gained	gain	VBN
46745	5118	10	its	-PRON-	PRP$
46745	5118	11	high	high	JJ
46745	5118	12	reputation	reputation	NN
46745	5118	13	as	as	IN
46745	5118	14	a	a	DT
46745	5118	15	medicine	medicine	NN
46745	5118	16	is	be	VBZ
46745	5118	17	of	of	IN
46745	5118	18	a	a	DT
46745	5118	19	different	different	JJ
46745	5118	20	kind	kind	NN
46745	5118	21	.	.	.
46745	5119	1	By	by	IN
46745	5119	2	an	an	DT
46745	5119	3	influence	influence	NN
46745	5119	4	on	on	IN
46745	5119	5	a	a	DT
46745	5119	6	part	part	NN
46745	5119	7	of	of	IN
46745	5119	8	the	the	DT
46745	5119	9	nervous	nervous	JJ
46745	5119	10	system	system	NN
46745	5119	11	,	,	,
46745	5119	12	apparently	apparently	RB
46745	5119	13	the	the	DT
46745	5119	14	Vagus	Vagus	NNP
46745	5119	15	nerve	nerve	NN
46745	5119	16	,	,	,
46745	5119	17	it	-PRON-	PRP
46745	5119	18	produces	produce	VBZ
46745	5119	19	first	first	RB
46745	5119	20	the	the	DT
46745	5119	21	state	state	NN
46745	5119	22	called	call	VBN
46745	5119	23	nausea	nausea	NN
46745	5119	24	,	,	,
46745	5119	25	and	and	CC
46745	5119	26	afterwards	afterwards	RB
46745	5119	27	vomiting	vomit	VBG
46745	5119	28	.	.	.
46745	5120	1	The	the	DT
46745	5120	2	most	most	RBS
46745	5120	3	important	important	JJ
46745	5120	4	symptom	symptom	NN
46745	5120	5	in	in	IN
46745	5120	6	this	this	DT
46745	5120	7	nausea	nausea	NN
46745	5120	8	,	,	,
46745	5120	9	and	and	CC
46745	5120	10	in	in	IN
46745	5120	11	the	the	DT
46745	5120	12	state	state	NN
46745	5120	13	of	of	IN
46745	5120	14	system	system	NN
46745	5120	15	which	which	WDT
46745	5120	16	succeeds	succeed	VBZ
46745	5120	17	the	the	DT
46745	5120	18	vomiting	vomiting	NN
46745	5120	19	,	,	,
46745	5120	20	and	and	CC
46745	5120	21	continues	continue	VBZ
46745	5120	22	for	for	IN
46745	5120	23	some	some	DT
46745	5120	24	time	time	NN
46745	5120	25	after	after	IN
46745	5120	26	it	-PRON-	PRP
46745	5120	27	,	,	,
46745	5120	28	is	be	VBZ
46745	5120	29	a	a	DT
46745	5120	30	depression	depression	NN
46745	5120	31	of	of	IN
46745	5120	32	the	the	DT
46745	5120	33	action	action	NN
46745	5120	34	of	of	IN
46745	5120	35	the	the	DT
46745	5120	36	heart	heart	NN
46745	5120	37	.	.	.
46745	5121	1	At	at	IN
46745	5121	2	the	the	DT
46745	5121	3	same	same	JJ
46745	5121	4	time	time	NN
46745	5121	5	the	the	DT
46745	5121	6	muscular	muscular	JJ
46745	5121	7	system	system	NN
46745	5121	8	is	be	VBZ
46745	5121	9	relaxed	relaxed	JJ
46745	5121	10	,	,	,
46745	5121	11	and	and	CC
46745	5121	12	the	the	DT
46745	5121	13	breathing	breathing	NN
46745	5121	14	is	be	VBZ
46745	5121	15	rendered	render	VBN
46745	5121	16	slower	slow	JJR
46745	5121	17	.	.	.
46745	5122	1	This	this	DT
46745	5122	2	nausea	nausea	NN
46745	5122	3	is	be	VBZ
46745	5122	4	not	not	RB
46745	5122	5	produced	produce	VBN
46745	5122	6	to	to	IN
46745	5122	7	any	any	DT
46745	5122	8	extent	extent	NN
46745	5122	9	by	by	IN
46745	5122	10	a	a	DT
46745	5122	11	mere	mere	JJ
46745	5122	12	irritant	irritant	NN
46745	5122	13	Emetic	Emetic	NNP
46745	5122	14	,	,	,
46745	5122	15	such	such	JJ
46745	5122	16	as	as	IN
46745	5122	17	Sulphate	Sulphate	NNP
46745	5122	18	of	of	IN
46745	5122	19	Zinc	Zinc	NNP
46745	5122	20	,	,	,
46745	5122	21	which	which	WDT
46745	5122	22	acts	act	VBZ
46745	5122	23	externally	externally	RB
46745	5122	24	and	and	CC
46745	5122	25	takes	take	VBZ
46745	5122	26	effect	effect	NN
46745	5122	27	immediately	immediately	RB
46745	5122	28	.	.	.
46745	5123	1	The	the	DT
46745	5123	2	Antimonial	Antimonial	NNP
46745	5123	3	can	can	MD
46745	5123	4	not	not	RB
46745	5123	5	act	act	VB
46745	5123	6	so	so	RB
46745	5123	7	quickly	quickly	RB
46745	5123	8	;	;	:
46745	5123	9	part	part	NN
46745	5123	10	of	of	IN
46745	5123	11	it	-PRON-	PRP
46745	5123	12	must	must	MD
46745	5123	13	first	first	RB
46745	5123	14	be	be	VB
46745	5123	15	absorbed	absorb	VBN
46745	5123	16	,	,	,
46745	5123	17	so	so	IN
46745	5123	18	that	that	IN
46745	5123	19	it	-PRON-	PRP
46745	5123	20	may	may	MD
46745	5123	21	reach	reach	VB
46745	5123	22	the	the	DT
46745	5123	23	nerve	nerve	NN
46745	5123	24	.	.	.
46745	5124	1	We	-PRON-	PRP
46745	5124	2	know	know	VBP
46745	5124	3	that	that	IN
46745	5124	4	it	-PRON-	PRP
46745	5124	5	does	do	VBZ
46745	5124	6	not	not	RB
46745	5124	7	act	act	VB
46745	5124	8	by	by	IN
46745	5124	9	outward	outward	JJ
46745	5124	10	irritation	irritation	NN
46745	5124	11	,	,	,
46745	5124	12	from	from	IN
46745	5124	13	the	the	DT
46745	5124	14	fact	fact	NN
46745	5124	15	that	that	IN
46745	5124	16	if	if	IN
46745	5124	17	the	the	DT
46745	5124	18	solution	solution	NN
46745	5124	19	be	be	VB
46745	5124	20	injected	inject	VBN
46745	5124	21	into	into	IN
46745	5124	22	the	the	DT
46745	5124	23	veins	vein	NNS
46745	5124	24	at	at	IN
46745	5124	25	any	any	DT
46745	5124	26	part	part	NN
46745	5124	27	of	of	IN
46745	5124	28	the	the	DT
46745	5124	29	body	body	NN
46745	5124	30	,	,	,
46745	5124	31	it	-PRON-	PRP
46745	5124	32	will	will	MD
46745	5124	33	equally	equally	RB
46745	5124	34	produce	produce	VB
46745	5124	35	nausea	nausea	NN
46745	5124	36	and	and	CC
46745	5124	37	vomiting	vomiting	NN
46745	5124	38	.	.	.
46745	5125	1	Antimony	Antimony	NNP
46745	5125	2	has	have	VBZ
46745	5125	3	no	no	DT
46745	5125	4	direct	direct	JJ
46745	5125	5	action	action	NN
46745	5125	6	upon	upon	IN
46745	5125	7	the	the	DT
46745	5125	8	brain	brain	NN
46745	5125	9	;	;	:
46745	5125	10	it	-PRON-	PRP
46745	5125	11	affects	affect	VBZ
46745	5125	12	only	only	RB
46745	5125	13	a	a	DT
46745	5125	14	part	part	NN
46745	5125	15	of	of	IN
46745	5125	16	the	the	DT
46745	5125	17	nervous	nervous	JJ
46745	5125	18	system	system	NN
46745	5125	19	.	.	.
46745	5126	1	In	in	IN
46745	5126	2	the	the	DT
46745	5126	3	nausea	nausea	NN
46745	5126	4	we	-PRON-	PRP
46745	5126	5	recognise	recognise	VBP
46745	5126	6	a	a	DT
46745	5126	7	sedative	sedative	JJ
46745	5126	8	action	action	NN
46745	5126	9	upon	upon	IN
46745	5126	10	the	the	DT
46745	5126	11	nerves	nerve	NNS
46745	5126	12	of	of	IN
46745	5126	13	the	the	DT
46745	5126	14	heart	heart	NN
46745	5126	15	;	;	:
46745	5126	16	and	and	CC
46745	5126	17	in	in	IN
46745	5126	18	the	the	DT
46745	5126	19	slow	slow	JJ
46745	5126	20	breathing	breathing	NN
46745	5126	21	a	a	DT
46745	5126	22	similar	similar	JJ
46745	5126	23	action	action	NN
46745	5126	24	upon	upon	IN
46745	5126	25	the	the	DT
46745	5126	26	nerves	nerve	NNS
46745	5126	27	of	of	IN
46745	5126	28	the	the	DT
46745	5126	29	lungs	lung	NNS
46745	5126	30	.	.	.
46745	5127	1	But	but	CC
46745	5127	2	it	-PRON-	PRP
46745	5127	3	may	may	MD
46745	5127	4	be	be	VB
46745	5127	5	objected	object	VBN
46745	5127	6	that	that	IN
46745	5127	7	the	the	DT
46745	5127	8	production	production	NN
46745	5127	9	of	of	IN
46745	5127	10	vomiting	vomiting	NN
46745	5127	11	is	be	VBZ
46745	5127	12	not	not	RB
46745	5127	13	a	a	DT
46745	5127	14	sedative	sedative	JJ
46745	5127	15	action	action	NN
46745	5127	16	,	,	,
46745	5127	17	for	for	IN
46745	5127	18	we	-PRON-	PRP
46745	5127	19	know	know	VBP
46745	5127	20	that	that	IN
46745	5127	21	the	the	DT
46745	5127	22	same	same	JJ
46745	5127	23	symptom	symptom	NN
46745	5127	24	may	may	MD
46745	5127	25	be	be	VB
46745	5127	26	caused	cause	VBN
46745	5127	27	by	by	IN
46745	5127	28	a	a	DT
46745	5127	29	mere	mere	JJ
46745	5127	30	external	external	JJ
46745	5127	31	stimulant	stimulant	NN
46745	5127	32	.	.	.
46745	5128	1	And	and	CC
46745	5128	2	yet	yet	RB
46745	5128	3	there	there	EX
46745	5128	4	are	be	VBP
46745	5128	5	several	several	JJ
46745	5128	6	reasons	reason	NNS
46745	5128	7	which	which	WDT
46745	5128	8	have	have	VBP
46745	5128	9	induced	induce	VBN
46745	5128	10	me	-PRON-	PRP
46745	5128	11	to	to	TO
46745	5128	12	conclude	conclude	VB
46745	5128	13	that	that	IN
46745	5128	14	this	this	DT
46745	5128	15	also	also	RB
46745	5128	16	is	be	VBZ
46745	5128	17	a	a	DT
46745	5128	18	sedative	sedative	JJ
46745	5128	19	action	action	NN
46745	5128	20	.	.	.
46745	5129	1	It	-PRON-	PRP
46745	5129	2	would	would	MD
46745	5129	3	be	be	VB
46745	5129	4	inconsistent	inconsistent	JJ
46745	5129	5	to	to	TO
46745	5129	6	suppose	suppose	VB
46745	5129	7	that	that	IN
46745	5129	8	Antimony	Antimony	NNP
46745	5129	9	could	could	MD
46745	5129	10	be	be	VB
46745	5129	11	a	a	DT
46745	5129	12	Sedative	Sedative	NNP
46745	5129	13	in	in	IN
46745	5129	14	producing	produce	VBG
46745	5129	15	nausea	nausea	NN
46745	5129	16	,	,	,
46745	5129	17	and	and	CC
46745	5129	18	a	a	DT
46745	5129	19	Stimulant	Stimulant	NNP
46745	5129	20	in	in	IN
46745	5129	21	causing	cause	VBG
46745	5129	22	vomiting	vomiting	NN
46745	5129	23	.	.	.
46745	5130	1	We	-PRON-	PRP
46745	5130	2	have	have	VBP
46745	5130	3	already	already	RB
46745	5130	4	noticed	notice	VBN
46745	5130	5	that	that	IN
46745	5130	6	a	a	DT
46745	5130	7	Sedative	sedative	JJ
46745	5130	8	medicine	medicine	NN
46745	5130	9	may	may	MD
46745	5130	10	affect	affect	VB
46745	5130	11	nervous	nervous	JJ
46745	5130	12	force	force	NN
46745	5130	13	in	in	IN
46745	5130	14	either	either	DT
46745	5130	15	of	of	IN
46745	5130	16	two	two	CD
46745	5130	17	ways	way	NNS
46745	5130	18	;	;	:
46745	5130	19	it	-PRON-	PRP
46745	5130	20	may	may	MD
46745	5130	21	derange	derange	VB
46745	5130	22	it	-PRON-	PRP
46745	5130	23	,	,	,
46745	5130	24	or	or	CC
46745	5130	25	it	-PRON-	PRP
46745	5130	26	may	may	MD
46745	5130	27	depress	depress	VB
46745	5130	28	it	-PRON-	PRP
46745	5130	29	.	.	.
46745	5131	1	(	(	-LRB-
46745	5131	2	p.	p.	NN
46745	5132	1	243	243	CD
46745	5132	2	.	.	.
46745	5132	3	)	)	-RRB-
46745	5133	1	That	that	DT
46745	5133	2	influence	influence	NN
46745	5133	3	which	which	WDT
46745	5133	4	causes	cause	VBZ
46745	5133	5	the	the	DT
46745	5133	6	contraction	contraction	NN
46745	5133	7	of	of	IN
46745	5133	8	the	the	DT
46745	5133	9	stomach	stomach	NN
46745	5133	10	to	to	TO
46745	5133	11	commence	commence	VB
46745	5133	12	at	at	IN
46745	5133	13	the	the	DT
46745	5133	14	pylorus	pylorus	NNP
46745	5133	15	,	,	,
46745	5133	16	and	and	CC
46745	5133	17	to	to	TO
46745	5133	18	result	result	VB
46745	5133	19	in	in	IN
46745	5133	20	the	the	DT
46745	5133	21	expulsion	expulsion	NN
46745	5133	22	of	of	IN
46745	5133	23	its	-PRON-	PRP$
46745	5133	24	contents	content	NNS
46745	5133	25	upwards	upwards	RB
46745	5133	26	along	along	IN
46745	5133	27	the	the	DT
46745	5133	28	[	[	-LRB-
46745	5133	29	oe]sophagus	oe]sophagus	NNP
46745	5133	30	,	,	,
46745	5133	31	is	be	VBZ
46745	5133	32	obviously	obviously	RB
46745	5133	33	explained	explain	VBN
46745	5133	34	by	by	IN
46745	5133	35	an	an	DT
46745	5133	36	action	action	NN
46745	5133	37	of	of	IN
46745	5133	38	derangement	derangement	NN
46745	5133	39	,	,	,
46745	5133	40	for	for	IN
46745	5133	41	it	-PRON-	PRP
46745	5133	42	is	be	VBZ
46745	5133	43	an	an	DT
46745	5133	44	exact	exact	JJ
46745	5133	45	reversal	reversal	NN
46745	5133	46	of	of	IN
46745	5133	47	the	the	DT
46745	5133	48	natural	natural	JJ
46745	5133	49	state	state	NN
46745	5133	50	of	of	IN
46745	5133	51	things	thing	NNS
46745	5133	52	.	.	.
46745	5134	1	(	(	-LRB-
46745	5134	2	p.	p.	NN
46745	5135	1	92	92	CD
46745	5135	2	.	.	.
46745	5135	3	)	)	-RRB-
46745	5136	1	But	but	CC
46745	5136	2	the	the	DT
46745	5136	3	effects	effect	NNS
46745	5136	4	of	of	IN
46745	5136	5	derangement	derangement	NN
46745	5136	6	are	be	VBP
46745	5136	7	often	often	RB
46745	5136	8	very	very	RB
46745	5136	9	similar	similar	JJ
46745	5136	10	to	to	IN
46745	5136	11	those	those	DT
46745	5136	12	of	of	IN
46745	5136	13	excitation	excitation	NN
46745	5136	14	.	.	.
46745	5137	1	Thus	thus	RB
46745	5137	2	convulsions	convulsion	NNS
46745	5137	3	of	of	IN
46745	5137	4	the	the	DT
46745	5137	5	muscular	muscular	JJ
46745	5137	6	system	system	NN
46745	5137	7	are	be	VBP
46745	5137	8	caused	cause	VBN
46745	5137	9	by	by	IN
46745	5137	10	Hydrocyanic	hydrocyanic	JJ
46745	5137	11	acid	acid	NN
46745	5137	12	,	,	,
46745	5137	13	a	a	DT
46745	5137	14	Sedative,--and	Sedative,--and	NNP
46745	5137	15	by	by	IN
46745	5137	16	Strychnia	Strychnia	NNP
46745	5137	17	,	,	,
46745	5137	18	a	a	DT
46745	5137	19	Stimulant	stimulant	NN
46745	5137	20	;	;	:
46745	5137	21	and	and	CC
46745	5137	22	vomiting	vomiting	NN
46745	5137	23	is	be	VBZ
46745	5137	24	producible	producible	JJ
46745	5137	25	by	by	IN
46745	5137	26	Tartar	Tartar	NNP
46745	5137	27	Emetic	Emetic	NNP
46745	5137	28	,	,	,
46745	5137	29	a	a	DT
46745	5137	30	Sedative,--or	sedative,--or	NN
46745	5137	31	by	by	IN
46745	5137	32	an	an	DT
46745	5137	33	external	external	JJ
46745	5137	34	irritant	irritant	NN
46745	5137	35	of	of	IN
46745	5137	36	the	the	DT
46745	5137	37	mucous	mucous	JJ
46745	5137	38	membrane	membrane	NN
46745	5137	39	.	.	.
46745	5138	1	It	-PRON-	PRP
46745	5138	2	is	be	VBZ
46745	5138	3	by	by	IN
46745	5138	4	the	the	DT
46745	5138	5	production	production	NN
46745	5138	6	of	of	IN
46745	5138	7	nausea	nausea	NN
46745	5138	8	that	that	WDT
46745	5138	9	Antimony	Antimony	NNP
46745	5138	10	becomes	become	VBZ
46745	5138	11	so	so	RB
46745	5138	12	valuable	valuable	JJ
46745	5138	13	an	an	DT
46745	5138	14	agent	agent	NN
46745	5138	15	in	in	IN
46745	5138	16	the	the	DT
46745	5138	17	control	control	NN
46745	5138	18	of	of	IN
46745	5138	19	high	high	JJ
46745	5138	20	fevers	fever	NNS
46745	5138	21	and	and	CC
46745	5138	22	acute	acute	JJ
46745	5138	23	inflammations	inflammation	NNS
46745	5138	24	.	.	.
46745	5139	1	The	the	DT
46745	5139	2	force	force	NN
46745	5139	3	of	of	IN
46745	5139	4	the	the	DT
46745	5139	5	heart	heart	NN
46745	5139	6	being	be	VBG
46745	5139	7	diminished	diminish	VBN
46745	5139	8	,	,	,
46745	5139	9	the	the	DT
46745	5139	10	fever	fever	NN
46745	5139	11	is	be	VBZ
46745	5139	12	allayed	allay	VBN
46745	5139	13	;	;	:
46745	5139	14	and	and	CC
46745	5139	15	the	the	DT
46745	5139	16	active	active	JJ
46745	5139	17	congestion	congestion	NN
46745	5139	18	of	of	IN
46745	5139	19	the	the	DT
46745	5139	20	vascular	vascular	JJ
46745	5139	21	system	system	NN
46745	5139	22	,	,	,
46745	5139	23	whether	whether	IN
46745	5139	24	local	local	JJ
46745	5139	25	or	or	CC
46745	5139	26	general	general	JJ
46745	5139	27	,	,	,
46745	5139	28	which	which	WDT
46745	5139	29	was	be	VBD
46745	5139	30	produced	produce	VBN
46745	5139	31	by	by	IN
46745	5139	32	the	the	DT
46745	5139	33	inflammation	inflammation	NN
46745	5139	34	,	,	,
46745	5139	35	and	and	CC
46745	5139	36	maintained	maintain	VBN
46745	5139	37	by	by	IN
46745	5139	38	the	the	DT
46745	5139	39	violent	violent	JJ
46745	5139	40	action	action	NN
46745	5139	41	of	of	IN
46745	5139	42	the	the	DT
46745	5139	43	heart	heart	NN
46745	5139	44	,	,	,
46745	5139	45	is	be	VBZ
46745	5139	46	effectually	effectually	RB
46745	5139	47	subdued	subdue	VBN
46745	5139	48	.	.	.
46745	5140	1	At	at	IN
46745	5140	2	the	the	DT
46745	5140	3	same	same	JJ
46745	5140	4	time	time	NN
46745	5140	5	absorption	absorption	NN
46745	5140	6	is	be	VBZ
46745	5140	7	favoured	favour	VBN
46745	5140	8	by	by	IN
46745	5140	9	the	the	DT
46745	5140	10	removal	removal	NN
46745	5140	11	of	of	IN
46745	5140	12	the	the	DT
46745	5140	13	pressure	pressure	NN
46745	5140	14	from	from	IN
46745	5140	15	the	the	DT
46745	5140	16	capillary	capillary	JJ
46745	5140	17	circulation	circulation	NN
46745	5140	18	.	.	.
46745	5141	1	For	for	IN
46745	5141	2	its	-PRON-	PRP$
46745	5141	3	power	power	NN
46745	5141	4	therefore	therefore	RB
46745	5141	5	as	as	IN
46745	5141	6	a	a	DT
46745	5141	7	Special	Special	NNP
46745	5141	8	Sedative	Sedative	NNP
46745	5141	9	,	,	,
46745	5141	10	by	by	IN
46745	5141	11	which	which	WDT
46745	5141	12	it	-PRON-	PRP
46745	5141	13	produces	produce	VBZ
46745	5141	14	nausea	nausea	NN
46745	5141	15	,	,	,
46745	5141	16	Antimony	Antimony	NNP
46745	5141	17	is	be	VBZ
46745	5141	18	used	use	VBN
46745	5141	19	in	in	IN
46745	5141	20	sthenic	sthenic	JJ
46745	5141	21	inflammations	inflammation	NNS
46745	5141	22	generally	generally	RB
46745	5141	23	,	,	,
46745	5141	24	especially	especially	RB
46745	5141	25	in	in	IN
46745	5141	26	those	those	DT
46745	5141	27	that	that	WDT
46745	5141	28	are	be	VBP
46745	5141	29	rapid	rapid	JJ
46745	5141	30	,	,	,
46745	5141	31	and	and	CC
46745	5141	32	in	in	IN
46745	5141	33	which	which	WDT
46745	5141	34	we	-PRON-	PRP
46745	5141	35	desire	desire	VBP
46745	5141	36	a	a	DT
46745	5141	37	sudden	sudden	JJ
46745	5141	38	and	and	CC
46745	5141	39	powerful	powerful	JJ
46745	5141	40	action	action	NN
46745	5141	41	.	.	.
46745	5142	1	In	in	IN
46745	5142	2	such	such	JJ
46745	5142	3	cases	case	NNS
46745	5142	4	it	-PRON-	PRP
46745	5142	5	is	be	VBZ
46745	5142	6	preferable	preferable	JJ
46745	5142	7	to	to	IN
46745	5142	8	Mercury,--which	Mercury,--which	NNP
46745	5142	9	is	be	VBZ
46745	5142	10	a	a	DT
46745	5142	11	simple	simple	JJ
46745	5142	12	Antiphlogistic	Antiphlogistic	NNP
46745	5142	13	,	,	,
46745	5142	14	acting	act	VBG
46745	5142	15	in	in	IN
46745	5142	16	the	the	DT
46745	5142	17	blood	blood	NN
46745	5142	18	,	,	,
46745	5142	19	and	and	CC
46745	5142	20	having	have	VBG
46745	5142	21	no	no	DT
46745	5142	22	operation	operation	NN
46745	5142	23	on	on	IN
46745	5142	24	nerve	nerve	NN
46745	5142	25	.	.	.
46745	5143	1	It	-PRON-	PRP
46745	5143	2	is	be	VBZ
46745	5143	3	thus	thus	RB
46745	5143	4	indispensable	indispensable	JJ
46745	5143	5	in	in	IN
46745	5143	6	Croup	Croup	NNP
46745	5143	7	.	.	.
46745	5144	1	It	-PRON-	PRP
46745	5144	2	is	be	VBZ
46745	5144	3	very	very	RB
46745	5144	4	efficacious	efficacious	JJ
46745	5144	5	in	in	IN
46745	5144	6	sthenic	sthenic	JJ
46745	5144	7	Pneumonia	Pneumonia	NNP
46745	5144	8	.	.	.
46745	5145	1	Laennec	Laennec	NNP
46745	5145	2	speaks	speak	VBZ
46745	5145	3	highly	highly	RB
46745	5145	4	of	of	IN
46745	5145	5	its	-PRON-	PRP$
46745	5145	6	use	use	NN
46745	5145	7	in	in	IN
46745	5145	8	acute	acute	JJ
46745	5145	9	Bronchitis	Bronchitis	NNP
46745	5145	10	.	.	.
46745	5146	1	In	in	IN
46745	5146	2	Fevers	fever	NNS
46745	5146	3	,	,	,
46745	5146	4	Dr.	Dr.	NNP
46745	5146	5	Graves	Graves	NNP
46745	5146	6	recommends	recommend	VBZ
46745	5146	7	that	that	IN
46745	5146	8	it	-PRON-	PRP
46745	5146	9	should	should	MD
46745	5146	10	be	be	VB
46745	5146	11	combined	combine	VBN
46745	5146	12	with	with	IN
46745	5146	13	Opium	Opium	NNP
46745	5146	14	.	.	.
46745	5147	1	In	in	IN
46745	5147	2	inflammations	inflammation	NNS
46745	5147	3	of	of	IN
46745	5147	4	the	the	DT
46745	5147	5	lungs	lung	NNS
46745	5147	6	it	-PRON-	PRP
46745	5147	7	is	be	VBZ
46745	5147	8	particularly	particularly	RB
46745	5147	9	applicable	applicable	JJ
46745	5147	10	,	,	,
46745	5147	11	for	for	IN
46745	5147	12	it	-PRON-	PRP
46745	5147	13	exerts	exert	VBZ
46745	5147	14	a	a	DT
46745	5147	15	sedative	sedative	JJ
46745	5147	16	influence	influence	NN
46745	5147	17	over	over	IN
46745	5147	18	the	the	DT
46745	5147	19	nerves	nerve	NNS
46745	5147	20	of	of	IN
46745	5147	21	those	those	DT
46745	5147	22	organs	organ	NNS
46745	5147	23	.	.	.
46745	5148	1	If	if	IN
46745	5148	2	a	a	DT
46745	5148	3	small	small	JJ
46745	5148	4	dose	dose	NN
46745	5148	5	be	be	VB
46745	5148	6	constantly	constantly	RB
46745	5148	7	repeated	repeat	VBN
46745	5148	8	,	,	,
46745	5148	9	and	and	CC
46745	5148	10	gradually	gradually	RB
46745	5148	11	increased	increase	VBD
46745	5148	12	to	to	IN
46745	5148	13	a	a	DT
46745	5148	14	large	large	JJ
46745	5148	15	one	one	NN
46745	5148	16	,	,	,
46745	5148	17	the	the	DT
46745	5148	18	system	system	NN
46745	5148	19	will	will	MD
46745	5148	20	at	at	IN
46745	5148	21	length	length	NN
46745	5148	22	be	be	VB
46745	5148	23	induced	induce	VBN
46745	5148	24	to	to	TO
46745	5148	25	tolerate	tolerate	VB
46745	5148	26	the	the	DT
46745	5148	27	medicine	medicine	NN
46745	5148	28	,	,	,
46745	5148	29	and	and	CC
46745	5148	30	it	-PRON-	PRP
46745	5148	31	will	will	MD
46745	5148	32	not	not	RB
46745	5148	33	produce	produce	VB
46745	5148	34	vomiting	vomit	VBG
46745	5148	35	.	.	.
46745	5149	1	Laennec	Laennec	NNP
46745	5149	2	recommended	recommend	VBD
46745	5149	3	that	that	IN
46745	5149	4	it	-PRON-	PRP
46745	5149	5	should	should	MD
46745	5149	6	be	be	VB
46745	5149	7	given	give	VBN
46745	5149	8	in	in	IN
46745	5149	9	this	this	DT
46745	5149	10	way	way	NN
46745	5149	11	in	in	IN
46745	5149	12	inflammations	inflammation	NNS
46745	5149	13	.	.	.
46745	5150	1	He	-PRON-	PRP
46745	5150	2	considered	consider	VBD
46745	5150	3	the	the	DT
46745	5150	4	production	production	NN
46745	5150	5	of	of	IN
46745	5150	6	vomiting	vomit	VBG
46745	5150	7	unadvisable	unadvisable	JJ
46745	5150	8	;	;	:
46745	5150	9	for	for	IN
46745	5150	10	by	by	IN
46745	5150	11	that	that	DT
46745	5150	12	act	act	NN
46745	5150	13	the	the	DT
46745	5150	14	system	system	NN
46745	5150	15	is	be	VBZ
46745	5150	16	temporarily	temporarily	RB
46745	5150	17	excited	excited	JJ
46745	5150	18	,	,	,
46745	5150	19	and	and	CC
46745	5150	20	a	a	DT
46745	5150	21	large	large	JJ
46745	5150	22	quantity	quantity	NN
46745	5150	23	of	of	IN
46745	5150	24	the	the	DT
46745	5150	25	medicine	medicine	NN
46745	5150	26	rejected	reject	VBD
46745	5150	27	,	,	,
46745	5150	28	which	which	WDT
46745	5150	29	should	should	MD
46745	5150	30	have	have	VB
46745	5150	31	been	be	VBN
46745	5150	32	absorbed	absorb	VBN
46745	5150	33	into	into	IN
46745	5150	34	the	the	DT
46745	5150	35	blood	blood	NN
46745	5150	36	to	to	TO
46745	5150	37	work	work	VB
46745	5150	38	out	out	RP
46745	5150	39	its	-PRON-	PRP$
46745	5150	40	action	action	NN
46745	5150	41	there	there	RB
46745	5150	42	.	.	.
46745	5151	1	The	the	DT
46745	5151	2	soundness	soundness	NN
46745	5151	3	of	of	IN
46745	5151	4	his	-PRON-	PRP$
46745	5151	5	views	view	NNS
46745	5151	6	on	on	IN
46745	5151	7	this	this	DT
46745	5151	8	point	point	NN
46745	5151	9	has	have	VBZ
46745	5151	10	been	be	VBN
46745	5151	11	generally	generally	RB
46745	5151	12	admitted	admit	VBN
46745	5151	13	by	by	IN
46745	5151	14	those	those	DT
46745	5151	15	who	who	WP
46745	5151	16	have	have	VBP
46745	5151	17	succeeded	succeed	VBN
46745	5151	18	him	-PRON-	PRP
46745	5151	19	.	.	.
46745	5152	1	Given	give	VBN
46745	5152	2	simply	simply	RB
46745	5152	3	as	as	IN
46745	5152	4	an	an	DT
46745	5152	5	Emetic	Emetic	NNP
46745	5152	6	,	,	,
46745	5152	7	this	this	DT
46745	5152	8	medicine	medicine	NN
46745	5152	9	has	have	VBZ
46745	5152	10	been	be	VBN
46745	5152	11	used	use	VBN
46745	5152	12	in	in	IN
46745	5152	13	the	the	DT
46745	5152	14	early	early	JJ
46745	5152	15	stage	stage	NN
46745	5152	16	of	of	IN
46745	5152	17	acute	acute	JJ
46745	5152	18	local	local	JJ
46745	5152	19	inflammations	inflammation	NNS
46745	5152	20	,	,	,
46745	5152	21	as	as	IN
46745	5152	22	Ophthalmia	Ophthalmia	NNP
46745	5152	23	and	and	CC
46745	5152	24	Gonorrh[oe]a	Gonorrh[oe]a	NNP
46745	5152	25	.	.	.
46745	5153	1	It	-PRON-	PRP
46745	5153	2	may	may	MD
46745	5153	3	cut	cut	VB
46745	5153	4	these	these	DT
46745	5153	5	short	short	JJ
46745	5153	6	at	at	IN
46745	5153	7	their	-PRON-	PRP$
46745	5153	8	outset	outset	NN
46745	5153	9	,	,	,
46745	5153	10	by	by	IN
46745	5153	11	hindering	hinder	VBG
46745	5153	12	the	the	DT
46745	5153	13	tendency	tendency	NN
46745	5153	14	of	of	IN
46745	5153	15	the	the	DT
46745	5153	16	local	local	JJ
46745	5153	17	irritation	irritation	NN
46745	5153	18	to	to	TO
46745	5153	19	excite	excite	VB
46745	5153	20	the	the	DT
46745	5153	21	force	force	NN
46745	5153	22	of	of	IN
46745	5153	23	the	the	DT
46745	5153	24	heart	heart	NN
46745	5153	25	.	.	.
46745	5154	1	When	when	WRB
46745	5154	2	we	-PRON-	PRP
46745	5154	3	wish	wish	VBP
46745	5154	4	simply	simply	RB
46745	5154	5	to	to	TO
46745	5154	6	evacuate	evacuate	VB
46745	5154	7	the	the	DT
46745	5154	8	stomach	stomach	NN
46745	5154	9	,	,	,
46745	5154	10	as	as	IN
46745	5154	11	in	in	IN
46745	5154	12	a	a	DT
46745	5154	13	case	case	NN
46745	5154	14	of	of	IN
46745	5154	15	poisoning	poisoning	NN
46745	5154	16	,	,	,
46745	5154	17	an	an	DT
46745	5154	18	irritant	irritant	JJ
46745	5154	19	emetic	emetic	NN
46745	5154	20	,	,	,
46745	5154	21	as	as	IN
46745	5154	22	Mustard	Mustard	NNP
46745	5154	23	or	or	CC
46745	5154	24	Sulphate	Sulphate	NNP
46745	5154	25	of	of	IN
46745	5154	26	Zinc	Zinc	NNP
46745	5154	27	,	,	,
46745	5154	28	which	which	WDT
46745	5154	29	acts	act	VBZ
46745	5154	30	at	at	IN
46745	5154	31	once	once	RB
46745	5154	32	without	without	IN
46745	5154	33	producing	produce	VBG
46745	5154	34	nausea	nausea	NN
46745	5154	35	,	,	,
46745	5154	36	should	should	MD
46745	5154	37	be	be	VB
46745	5154	38	preferred	prefer	VBN
46745	5154	39	,	,	,
46745	5154	40	for	for	IN
46745	5154	41	three	three	CD
46745	5154	42	reasons	reason	NNS
46745	5154	43	.	.	.
46745	5155	1	Its	-PRON-	PRP$
46745	5155	2	operation	operation	NN
46745	5155	3	is	be	VBZ
46745	5155	4	more	more	RBR
46745	5155	5	rapid	rapid	JJ
46745	5155	6	.	.	.
46745	5156	1	The	the	DT
46745	5156	2	distressing	distress	VBG
46745	5156	3	condition	condition	NN
46745	5156	4	of	of	IN
46745	5156	5	nausea	nausea	NN
46745	5156	6	would	would	MD
46745	5156	7	be	be	VB
46745	5156	8	an	an	DT
46745	5156	9	aggravation	aggravation	NN
46745	5156	10	of	of	IN
46745	5156	11	the	the	DT
46745	5156	12	existing	exist	VBG
46745	5156	13	mischief	mischief	NN
46745	5156	14	.	.	.
46745	5157	1	And	and	CC
46745	5157	2	the	the	DT
46745	5157	3	production	production	NN
46745	5157	4	of	of	IN
46745	5157	5	nausea	nausea	NN
46745	5157	6	,	,	,
46745	5157	7	by	by	IN
46745	5157	8	taking	take	VBG
46745	5157	9	off	off	RP
46745	5157	10	the	the	DT
46745	5157	11	pressure	pressure	NN
46745	5157	12	from	from	IN
46745	5157	13	the	the	DT
46745	5157	14	vascular	vascular	JJ
46745	5157	15	system	system	NN
46745	5157	16	,	,	,
46745	5157	17	favours	favour	VBZ
46745	5157	18	absorption	absorption	NN
46745	5157	19	,	,	,
46745	5157	20	which	which	WDT
46745	5157	21	is	be	VBZ
46745	5157	22	the	the	DT
46745	5157	23	very	very	JJ
46745	5157	24	thing	thing	NN
46745	5157	25	that	that	WDT
46745	5157	26	we	-PRON-	PRP
46745	5157	27	wish	wish	VBP
46745	5157	28	to	to	TO
46745	5157	29	avoid	avoid	VB
46745	5157	30	.	.	.
46745	5158	1	The	the	DT
46745	5158	2	object	object	NN
46745	5158	3	of	of	IN
46745	5158	4	an	an	DT
46745	5158	5	antimonial	antimonial	JJ
46745	5158	6	Emetic	Emetic	NNP
46745	5158	7	is	be	VBZ
46745	5158	8	not	not	RB
46745	5158	9	so	so	RB
46745	5158	10	much	much	JJ
46745	5158	11	to	to	TO
46745	5158	12	empty	empty	VB
46745	5158	13	the	the	DT
46745	5158	14	stomach	stomach	NN
46745	5158	15	as	as	IN
46745	5158	16	to	to	TO
46745	5158	17	make	make	VB
46745	5158	18	a	a	DT
46745	5158	19	powerful	powerful	JJ
46745	5158	20	impression	impression	NN
46745	5158	21	on	on	IN
46745	5158	22	the	the	DT
46745	5158	23	system	system	NN
46745	5158	24	.	.	.
46745	5159	1	The	the	DT
46745	5159	2	influence	influence	NN
46745	5159	3	of	of	IN
46745	5159	4	Antimony	Antimony	NNP
46745	5159	5	on	on	IN
46745	5159	6	the	the	DT
46745	5159	7	glandular	glandular	JJ
46745	5159	8	organs	organ	NNS
46745	5159	9	is	be	VBZ
46745	5159	10	indirectly	indirectly	RB
46745	5159	11	but	but	CC
46745	5159	12	powerfully	powerfully	RB
46745	5159	13	intensified	intensify	VBN
46745	5159	14	by	by	IN
46745	5159	15	its	-PRON-	PRP$
46745	5159	16	nauseant	nauseant	JJ
46745	5159	17	action	action	NN
46745	5159	18	.	.	.
46745	5160	1	In	in	IN
46745	5160	2	small	small	JJ
46745	5160	3	doses	dose	NNS
46745	5160	4	it	-PRON-	PRP
46745	5160	5	is	be	VBZ
46745	5160	6	a	a	DT
46745	5160	7	simple	simple	JJ
46745	5160	8	Expectorant	expectorant	NN
46745	5160	9	;	;	:
46745	5160	10	in	in	IN
46745	5160	11	nauseant	nauseant	JJ
46745	5160	12	doses	dose	NNS
46745	5160	13	,	,	,
46745	5160	14	it	-PRON-	PRP
46745	5160	15	assists	assist	VBZ
46745	5160	16	expectoration	expectoration	NN
46745	5160	17	by	by	IN
46745	5160	18	relaxing	relax	VBG
46745	5160	19	the	the	DT
46745	5160	20	bronchial	bronchial	JJ
46745	5160	21	tubes	tube	NNS
46745	5160	22	,	,	,
46745	5160	23	and	and	CC
46745	5160	24	diminishing	diminish	VBG
46745	5160	25	the	the	DT
46745	5160	26	number	number	NN
46745	5160	27	of	of	IN
46745	5160	28	the	the	DT
46745	5160	29	respirations	respiration	NNS
46745	5160	30	.	.	.
46745	5161	1	In	in	IN
46745	5161	2	a	a	DT
46745	5161	3	small	small	JJ
46745	5161	4	dose	dose	NN
46745	5161	5	it	-PRON-	PRP
46745	5161	6	is	be	VBZ
46745	5161	7	Diaphoretic	diaphoretic	JJ
46745	5161	8	;	;	:
46745	5161	9	but	but	CC
46745	5161	10	in	in	IN
46745	5161	11	large	large	JJ
46745	5161	12	doses	dose	NNS
46745	5161	13	it	-PRON-	PRP
46745	5161	14	may	may	MD
46745	5161	15	cause	cause	VB
46745	5161	16	copious	copious	JJ
46745	5161	17	sweating	sweating	NN
46745	5161	18	,	,	,
46745	5161	19	by	by	IN
46745	5161	20	favouring	favour	VBG
46745	5161	21	the	the	DT
46745	5161	22	absorption	absorption	NN
46745	5161	23	of	of	IN
46745	5161	24	fluid	fluid	NN
46745	5161	25	into	into	IN
46745	5161	26	the	the	DT
46745	5161	27	blood	blood	NN
46745	5161	28	,	,	,
46745	5161	29	and	and	CC
46745	5161	30	dilating	dilate	VBG
46745	5161	31	the	the	DT
46745	5161	32	capillaries	capillary	NNS
46745	5161	33	and	and	CC
46745	5161	34	pores	pore	NNS
46745	5161	35	of	of	IN
46745	5161	36	the	the	DT
46745	5161	37	sudorific	sudorific	JJ
46745	5161	38	glands	gland	NNS
46745	5161	39	.	.	.
46745	5162	1	In	in	IN
46745	5162	2	inflammatory	inflammatory	JJ
46745	5162	3	habits	habit	NNS
46745	5162	4	a	a	DT
46745	5162	5	small	small	JJ
46745	5162	6	addition	addition	NN
46745	5162	7	of	of	IN
46745	5162	8	Tartar	Tartar	NNP
46745	5162	9	Emetic	Emetic	NNP
46745	5162	10	forms	form	NNS
46745	5162	11	a	a	DT
46745	5162	12	powerful	powerful	JJ
46745	5162	13	adjunct	adjunct	NN
46745	5162	14	to	to	IN
46745	5162	15	a	a	DT
46745	5162	16	purgative	purgative	JJ
46745	5162	17	dose	dose	NN
46745	5162	18	;	;	:
46745	5162	19	for	for	CC
46745	5162	20	by	by	IN
46745	5162	21	it	-PRON-	PRP
46745	5162	22	the	the	DT
46745	5162	23	absorption	absorption	NN
46745	5162	24	of	of	IN
46745	5162	25	the	the	DT
46745	5162	26	other	other	JJ
46745	5162	27	medicine	medicine	NN
46745	5162	28	is	be	VBZ
46745	5162	29	assisted	assist	VBN
46745	5162	30	,	,	,
46745	5162	31	and	and	CC
46745	5162	32	at	at	IN
46745	5162	33	the	the	DT
46745	5162	34	same	same	JJ
46745	5162	35	time	time	NN
46745	5162	36	an	an	DT
46745	5162	37	over	over	IN
46745	5162	38	-	-	HYPH
46745	5162	39	tonicity	tonicity	NN
46745	5162	40	of	of	IN
46745	5162	41	the	the	DT
46745	5162	42	muscular	muscular	JJ
46745	5162	43	fibre	fibre	NN
46745	5162	44	of	of	IN
46745	5162	45	the	the	DT
46745	5162	46	intestine	intestine	NN
46745	5162	47	may	may	MD
46745	5162	48	be	be	VB
46745	5162	49	diminished	diminish	VBN
46745	5162	50	.	.	.
46745	5163	1	But	but	CC
46745	5163	2	in	in	IN
46745	5163	3	relaxed	relaxed	JJ
46745	5163	4	conditions	condition	NNS
46745	5163	5	of	of	IN
46745	5163	6	the	the	DT
46745	5163	7	system	system	NN
46745	5163	8	,	,	,
46745	5163	9	where	where	WRB
46745	5163	10	the	the	DT
46745	5163	11	intestine	intestine	NN
46745	5163	12	is	be	VBZ
46745	5163	13	apt	apt	JJ
46745	5163	14	to	to	TO
46745	5163	15	be	be	VB
46745	5163	16	over	over	RB
46745	5163	17	-	-	HYPH
46745	5163	18	dilated	dilate	VBN
46745	5163	19	,	,	,
46745	5163	20	and	and	CC
46745	5163	21	Catharsis	Catharsis	NNP
46745	5163	22	is	be	VBZ
46745	5163	23	favoured	favour	VBN
46745	5163	24	by	by	IN
46745	5163	25	Tonic	Tonic	NNP
46745	5163	26	medicines,--Tartar	medicines,--Tartar	NNP
46745	5163	27	Emetic	Emetic	NNP
46745	5163	28	would	would	MD
46745	5163	29	hinder	hinder	VB
46745	5163	30	it	-PRON-	PRP
46745	5163	31	.	.	.
46745	5164	1	Ipecacuanha	Ipecacuanha	NNP
46745	5164	2	,	,	,
46745	5164	3	a	a	DT
46745	5164	4	vegetable	vegetable	NN
46745	5164	5	substance	substance	NN
46745	5164	6	,	,	,
46745	5164	7	resembles	resemble	VBZ
46745	5164	8	Antimony	Antimony	NNP
46745	5164	9	in	in	IN
46745	5164	10	all	all	DT
46745	5164	11	its	-PRON-	PRP$
46745	5164	12	operations	operation	NNS
46745	5164	13	,	,	,
46745	5164	14	excepting	except	VBG
46745	5164	15	its	-PRON-	PRP$
46745	5164	16	blood	blood	NN
46745	5164	17	-	-	HYPH
46745	5164	18	action	action	NN
46745	5164	19	.	.	.
46745	5165	1	It	-PRON-	PRP
46745	5165	2	is	be	VBZ
46745	5165	3	less	less	RBR
46745	5165	4	potent	potent	JJ
46745	5165	5	as	as	IN
46745	5165	6	a	a	DT
46745	5165	7	Neurotic	neurotic	JJ
46745	5165	8	;	;	:
46745	5165	9	less	less	RBR
46745	5165	10	efficacious	efficacious	JJ
46745	5165	11	as	as	IN
46745	5165	12	a	a	DT
46745	5165	13	Diaphoretic	diaphoretic	JJ
46745	5165	14	;	;	:
46745	5165	15	but	but	CC
46745	5165	16	excels	excel	VBZ
46745	5165	17	it	-PRON-	PRP
46745	5165	18	as	as	IN
46745	5165	19	an	an	DT
46745	5165	20	Expectorant	expectorant	NN
46745	5165	21	.	.	.
46745	5166	1	(	(	-LRB-
46745	5166	2	_	_	NNP
46745	5166	3	Vide	Vide	NNP
46745	5166	4	_	_	NNP
46745	5166	5	pp	pp	NNP
46745	5166	6	.	.	.
46745	5167	1	93	93	CD
46745	5167	2	,	,	,
46745	5167	3	168	168	CD
46745	5167	4	,	,	,
46745	5167	5	185	185	CD
46745	5167	6	,	,	,
46745	5167	7	249	249	CD
46745	5167	8	,	,	,
46745	5167	9	283	283	CD
46745	5167	10	,	,	,
46745	5167	11	298	298	CD
46745	5167	12	.	.	.
46745	5167	13	)	)	-RRB-
46745	5168	1	MERCURY	MERCURY	NNP
46745	5168	2	.	.	.
46745	5169	1	Class	class	NN
46745	5169	2	I.	I.	NNP
46745	5169	3	Div	Div	NNP
46745	5169	4	.	.	.
46745	5170	1	II	ii	CD
46745	5170	2	.	.	.
46745	5171	1	Ord	Ord	NNP
46745	5171	2	.	.	.
46745	5172	1	I.	I.	NNP
46745	5172	2	ANTIPHLOGISTICA	ANTIPHLOGISTICA	NNP
46745	5172	3	.	.	.
46745	5173	1	Class	class	NN
46745	5173	2	I.	I.	NNP
46745	5173	3	Div	Div	NNP
46745	5173	4	.	.	.
46745	5174	1	II	ii	CD
46745	5174	2	.	.	.
46745	5175	1	Ord	Ord	NNP
46745	5175	2	.	.	.
46745	5176	1	II	ii	CD
46745	5176	2	.	.	.
46745	5177	1	ANTISYPHILITICA	ANTISYPHILITICA	NNP
46745	5177	2	.	.	.
46745	5178	1	Class	Class	NNP
46745	5178	2	IV	IV	NNP
46745	5178	3	.	.	.
46745	5179	1	Ord	Ord	NNP
46745	5179	2	.	.	.
46745	5180	1	III	iii	CD
46745	5180	2	.	.	.
46745	5181	1	CATHARTICA	CATHARTICA	NNP
46745	5181	2	.	.	.
46745	5182	1	Class	Class	NNP
46745	5182	2	IV	IV	NNP
46745	5182	3	.	.	.
46745	5183	1	Ord	Ord	NNP
46745	5183	2	.	.	.
46745	5184	1	IV	IV	NNP
46745	5184	2	.	.	.
46745	5185	1	CHOLAGOGA	CHOLAGOGA	NNP
46745	5185	2	.	.	.
46745	5186	1	There	there	EX
46745	5186	2	are	be	VBP
46745	5186	3	three	three	CD
46745	5186	4	principal	principal	JJ
46745	5186	5	forms	form	NNS
46745	5186	6	in	in	IN
46745	5186	7	which	which	WDT
46745	5186	8	this	this	DT
46745	5186	9	medicine	medicine	NN
46745	5186	10	may	may	MD
46745	5186	11	be	be	VB
46745	5186	12	exhibited	exhibit	VBN
46745	5186	13	.	.	.
46745	5187	1	Blue	blue	JJ
46745	5187	2	pill	pill	NN
46745	5187	3	contains	contain	VBZ
46745	5187	4	the	the	DT
46745	5187	5	metal	metal	NN
46745	5187	6	itself	-PRON-	PRP
46745	5187	7	in	in	IN
46745	5187	8	a	a	DT
46745	5187	9	finely	finely	RB
46745	5187	10	divided	divide	VBN
46745	5187	11	state	state	NN
46745	5187	12	,	,	,
46745	5187	13	as	as	RB
46745	5187	14	well	well	RB
46745	5187	15	as	as	IN
46745	5187	16	a	a	DT
46745	5187	17	small	small	JJ
46745	5187	18	quantity	quantity	NN
46745	5187	19	of	of	IN
46745	5187	20	the	the	DT
46745	5187	21	oxide	oxide	NN
46745	5187	22	.	.	.
46745	5188	1	Calomel	Calomel	NNP
46745	5188	2	is	be	VBZ
46745	5188	3	an	an	DT
46745	5188	4	insoluble	insoluble	JJ
46745	5188	5	Chloride	Chloride	NNP
46745	5188	6	of	of	IN
46745	5188	7	Mercury	Mercury	NNP
46745	5188	8	.	.	.
46745	5189	1	From	from	IN
46745	5189	2	the	the	DT
46745	5189	3	great	great	JJ
46745	5189	4	similarity	similarity	NN
46745	5189	5	that	that	WDT
46745	5189	6	exists	exist	VBZ
46745	5189	7	between	between	IN
46745	5189	8	the	the	DT
46745	5189	9	action	action	NN
46745	5189	10	of	of	IN
46745	5189	11	these	these	DT
46745	5189	12	two	two	CD
46745	5189	13	it	-PRON-	PRP
46745	5189	14	seems	seem	VBZ
46745	5189	15	likely	likely	JJ
46745	5189	16	that	that	IN
46745	5189	17	they	-PRON-	PRP
46745	5189	18	are	be	VBP
46745	5189	19	reduced	reduce	VBN
46745	5189	20	by	by	IN
46745	5189	21	the	the	DT
46745	5189	22	gastric	gastric	JJ
46745	5189	23	fluid	fluid	NN
46745	5189	24	to	to	IN
46745	5189	25	the	the	DT
46745	5189	26	same	same	JJ
46745	5189	27	condition	condition	NN
46745	5189	28	.	.	.
46745	5190	1	Both	both	DT
46745	5190	2	must	must	MD
46745	5190	3	be	be	VB
46745	5190	4	rendered	render	VBN
46745	5190	5	soluble	soluble	JJ
46745	5190	6	(	(	-LRB-
46745	5190	7	p.	p.	NN
46745	5190	8	88	88	CD
46745	5190	9	)	)	-RRB-
46745	5190	10	before	before	IN
46745	5190	11	they	-PRON-	PRP
46745	5190	12	can	can	MD
46745	5190	13	be	be	VB
46745	5190	14	absorbed	absorb	VBN
46745	5190	15	.	.	.
46745	5191	1	Probably	probably	RB
46745	5191	2	they	-PRON-	PRP
46745	5191	3	are	be	VBP
46745	5191	4	both	both	DT
46745	5191	5	absorbed	absorb	VBN
46745	5191	6	in	in	IN
46745	5191	7	combination	combination	NN
46745	5191	8	with	with	IN
46745	5191	9	the	the	DT
46745	5191	10	acid	acid	NN
46745	5191	11	of	of	IN
46745	5191	12	the	the	DT
46745	5191	13	stomach	stomach	NN
46745	5191	14	.	.	.
46745	5192	1	Bichloride	Bichloride	NNP
46745	5192	2	of	of	IN
46745	5192	3	Mercury	Mercury	NNP
46745	5192	4	is	be	VBZ
46745	5192	5	soluble	soluble	JJ
46745	5192	6	in	in	IN
46745	5192	7	water	water	NN
46745	5192	8	,	,	,
46745	5192	9	and	and	CC
46745	5192	10	probably	probably	RB
46745	5192	11	absorbed	absorb	VBD
46745	5192	12	unchanged	unchanged	JJ
46745	5192	13	.	.	.
46745	5193	1	It	-PRON-	PRP
46745	5193	2	differs	differ	VBZ
46745	5193	3	from	from	IN
46745	5193	4	the	the	DT
46745	5193	5	other	other	JJ
46745	5193	6	two	two	CD
46745	5193	7	as	as	IN
46745	5193	8	a	a	DT
46745	5193	9	medicine	medicine	NN
46745	5193	10	,	,	,
46745	5193	11	partly	partly	RB
46745	5193	12	,	,	,
46745	5193	13	but	but	CC
46745	5193	14	not	not	RB
46745	5193	15	entirely	entirely	RB
46745	5193	16	,	,	,
46745	5193	17	on	on	IN
46745	5193	18	account	account	NN
46745	5193	19	of	of	IN
46745	5193	20	its	-PRON-	PRP$
46745	5193	21	solubility	solubility	NN
46745	5193	22	.	.	.
46745	5194	1	The	the	DT
46745	5194	2	dose	dose	NN
46745	5194	3	required	require	VBN
46745	5194	4	is	be	VBZ
46745	5194	5	smaller	small	JJR
46745	5194	6	,	,	,
46745	5194	7	for	for	IN
46745	5194	8	it	-PRON-	PRP
46745	5194	9	is	be	VBZ
46745	5194	10	much	much	RB
46745	5194	11	more	more	RBR
46745	5194	12	powerful	powerful	JJ
46745	5194	13	.	.	.
46745	5195	1	It	-PRON-	PRP
46745	5195	2	is	be	VBZ
46745	5195	3	also	also	RB
46745	5195	4	much	much	RB
46745	5195	5	more	more	RBR
46745	5195	6	irritant	irritant	JJ
46745	5195	7	,	,	,
46745	5195	8	being	be	VBG
46745	5195	9	in	in	IN
46745	5195	10	large	large	JJ
46745	5195	11	doses	dose	NNS
46745	5195	12	a	a	DT
46745	5195	13	corrosive	corrosive	JJ
46745	5195	14	poison	poison	NN
46745	5195	15	,	,	,
46745	5195	16	and	and	CC
46745	5195	17	often	often	RB
46745	5195	18	producing	produce	VBG
46745	5195	19	soreness	soreness	NN
46745	5195	20	of	of	IN
46745	5195	21	the	the	DT
46745	5195	22	throat	throat	NN
46745	5195	23	and	and	CC
46745	5195	24	of	of	IN
46745	5195	25	the	the	DT
46745	5195	26	urinary	urinary	JJ
46745	5195	27	passages	passage	NNS
46745	5195	28	.	.	.
46745	5196	1	Thirdly	thirdly	RB
46745	5196	2	,	,	,
46745	5196	3	it	-PRON-	PRP
46745	5196	4	is	be	VBZ
46745	5196	5	less	less	RBR
46745	5196	6	likely	likely	JJ
46745	5196	7	to	to	TO
46745	5196	8	produce	produce	VB
46745	5196	9	salivation	salivation	NN
46745	5196	10	.	.	.
46745	5197	1	It	-PRON-	PRP
46745	5197	2	is	be	VBZ
46745	5197	3	more	more	RBR
46745	5197	4	adapted	adapt	VBN
46745	5197	5	for	for	IN
46745	5197	6	chronic	chronic	JJ
46745	5197	7	than	than	IN
46745	5197	8	for	for	IN
46745	5197	9	acute	acute	JJ
46745	5197	10	diseases	disease	NNS
46745	5197	11	.	.	.
46745	5198	1	As	as	IN
46745	5198	2	Hæmatic	hæmatic	JJ
46745	5198	3	medicines	medicine	NNS
46745	5198	4	,	,	,
46745	5198	5	Mercurials	mercurial	NNS
46745	5198	6	have	have	VBP
46745	5198	7	a	a	DT
46745	5198	8	double	double	JJ
46745	5198	9	action	action	NN
46745	5198	10	.	.	.
46745	5199	1	They	-PRON-	PRP
46745	5199	2	counteract	counteract	VBP
46745	5199	3	inflammation	inflammation	NN
46745	5199	4	in	in	IN
46745	5199	5	general	general	JJ
46745	5199	6	,	,	,
46745	5199	7	and	and	CC
46745	5199	8	the	the	DT
46745	5199	9	poisons	poison	NNS
46745	5199	10	of	of	IN
46745	5199	11	Syphilis	Syphilis	NNP
46745	5199	12	in	in	IN
46745	5199	13	particular	particular	JJ
46745	5199	14	.	.	.
46745	5200	1	They	-PRON-	PRP
46745	5200	2	thus	thus	RB
46745	5200	3	belong	belong	VBP
46745	5200	4	to	to	IN
46745	5200	5	the	the	DT
46745	5200	6	first	first	JJ
46745	5200	7	and	and	CC
46745	5200	8	second	second	JJ
46745	5200	9	orders	order	NNS
46745	5200	10	of	of	IN
46745	5200	11	Catalytics	Catalytics	NNP
46745	5200	12	.	.	.
46745	5201	1	Mercury	Mercury	NNP
46745	5201	2	deteriorates	deteriorate	VBZ
46745	5201	3	the	the	DT
46745	5201	4	blood	blood	NN
46745	5201	5	,	,	,
46745	5201	6	diminishing	diminish	VBG
46745	5201	7	in	in	IN
46745	5201	8	it	-PRON-	PRP
46745	5201	9	the	the	DT
46745	5201	10	amount	amount	NN
46745	5201	11	of	of	IN
46745	5201	12	fibrine	fibrine	NN
46745	5201	13	and	and	CC
46745	5201	14	corpuscles	corpuscle	NNS
46745	5201	15	.	.	.
46745	5202	1	As	as	IN
46745	5202	2	an	an	DT
46745	5202	3	anti	anti	JJ
46745	5202	4	-	-	JJ
46745	5202	5	inflammatory	inflammatory	JJ
46745	5202	6	agent	agent	NN
46745	5202	7	,	,	,
46745	5202	8	it	-PRON-	PRP
46745	5202	9	may	may	MD
46745	5202	10	be	be	VB
46745	5202	11	thus	thus	RB
46745	5202	12	compared	compare	VBN
46745	5202	13	with	with	IN
46745	5202	14	Antimony	Antimony	NNP
46745	5202	15	and	and	CC
46745	5202	16	Blood	blood	NN
46745	5202	17	-	-	HYPH
46745	5202	18	letting	letting	NN
46745	5202	19	.	.	.
46745	5203	1	The	the	DT
46745	5203	2	immediate	immediate	JJ
46745	5203	3	effect	effect	NN
46745	5203	4	of	of	IN
46745	5203	5	Blood	blood	NN
46745	5203	6	-	-	HYPH
46745	5203	7	letting	letting	NN
46745	5203	8	is	be	VBZ
46745	5203	9	mechanical	mechanical	JJ
46745	5203	10	;	;	:
46745	5203	11	that	that	DT
46745	5203	12	of	of	IN
46745	5203	13	Antimony	Antimony	NNP
46745	5203	14	,	,	,
46745	5203	15	nervous	nervous	JJ
46745	5203	16	;	;	:
46745	5203	17	that	that	DT
46745	5203	18	of	of	IN
46745	5203	19	Mercury	Mercury	NNP
46745	5203	20	,	,	,
46745	5203	21	hæmatic	hæmatic	JJ
46745	5203	22	.	.	.
46745	5204	1	Blood	blood	NN
46745	5204	2	-	-	HYPH
46745	5204	3	letting	let	VBG
46745	5204	4	weakens	weaken	VBZ
46745	5204	5	the	the	DT
46745	5204	6	force	force	NN
46745	5204	7	of	of	IN
46745	5204	8	the	the	DT
46745	5204	9	heart	heart	NN
46745	5204	10	by	by	IN
46745	5204	11	diminishing	diminish	VBG
46745	5204	12	the	the	DT
46745	5204	13	pressure	pressure	NN
46745	5204	14	on	on	IN
46745	5204	15	the	the	DT
46745	5204	16	vessels	vessel	NNS
46745	5204	17	;	;	:
46745	5204	18	Antimony	Antimony	NNP
46745	5204	19	diminishes	diminish	VBZ
46745	5204	20	the	the	DT
46745	5204	21	pressure	pressure	NN
46745	5204	22	on	on	IN
46745	5204	23	the	the	DT
46745	5204	24	vessels	vessel	NNS
46745	5204	25	by	by	IN
46745	5204	26	weakening	weaken	VBG
46745	5204	27	the	the	DT
46745	5204	28	force	force	NN
46745	5204	29	of	of	IN
46745	5204	30	the	the	DT
46745	5204	31	heart	heart	NN
46745	5204	32	;	;	:
46745	5204	33	and	and	CC
46745	5204	34	Mercury	Mercury	NNP
46745	5204	35	does	do	VBZ
46745	5204	36	both	both	DT
46745	5204	37	of	of	IN
46745	5204	38	these	these	DT
46745	5204	39	things	thing	NNS
46745	5204	40	,	,	,
46745	5204	41	by	by	IN
46745	5204	42	impoverishing	impoverish	VBG
46745	5204	43	the	the	DT
46745	5204	44	blood	blood	NN
46745	5204	45	.	.	.
46745	5205	1	Thus	thus	RB
46745	5205	2	all	all	DT
46745	5205	3	of	of	IN
46745	5205	4	them	-PRON-	PRP
46745	5205	5	favour	favour	VBP
46745	5205	6	absorption	absorption	NN
46745	5205	7	,	,	,
46745	5205	8	and	and	CC
46745	5205	9	counteract	counteract	JJ
46745	5205	10	effusion	effusion	NN
46745	5205	11	;	;	:
46745	5205	12	but	but	CC
46745	5205	13	,	,	,
46745	5205	14	from	from	IN
46745	5205	15	its	-PRON-	PRP$
46745	5205	16	nature	nature	NN
46745	5205	17	,	,	,
46745	5205	18	the	the	DT
46745	5205	19	action	action	NN
46745	5205	20	of	of	IN
46745	5205	21	Mercury	Mercury	NNP
46745	5205	22	is	be	VBZ
46745	5205	23	slower	slow	JJR
46745	5205	24	than	than	IN
46745	5205	25	that	that	DT
46745	5205	26	of	of	IN
46745	5205	27	the	the	DT
46745	5205	28	others	other	NNS
46745	5205	29	,	,	,
46745	5205	30	and	and	CC
46745	5205	31	for	for	IN
46745	5205	32	the	the	DT
46745	5205	33	same	same	JJ
46745	5205	34	reason	reason	NN
46745	5205	35	more	more	RBR
46745	5205	36	lasting	lasting	JJ
46745	5205	37	.	.	.
46745	5206	1	To	to	TO
46745	5206	2	produce	produce	VB
46745	5206	3	this	this	DT
46745	5206	4	action	action	NN
46745	5206	5	on	on	IN
46745	5206	6	the	the	DT
46745	5206	7	blood	blood	NN
46745	5206	8	,	,	,
46745	5206	9	the	the	DT
46745	5206	10	Mercurial	mercurial	NN
46745	5206	11	should	should	MD
46745	5206	12	be	be	VB
46745	5206	13	continued	continue	VBN
46745	5206	14	until	until	IN
46745	5206	15	some	some	DT
46745	5206	16	effect	effect	NN
46745	5206	17	on	on	IN
46745	5206	18	the	the	DT
46745	5206	19	mouth	mouth	NN
46745	5206	20	is	be	VBZ
46745	5206	21	perceived	perceive	VBN
46745	5206	22	,	,	,
46745	5206	23	but	but	CC
46745	5206	24	not	not	RB
46745	5206	25	so	so	IN
46745	5206	26	as	as	IN
46745	5206	27	to	to	TO
46745	5206	28	cause	cause	VB
46745	5206	29	copious	copious	JJ
46745	5206	30	salivation	salivation	NN
46745	5206	31	.	.	.
46745	5207	1	This	this	DT
46745	5207	2	symptom	symptom	NN
46745	5207	3	is	be	VBZ
46745	5207	4	a	a	DT
46745	5207	5	sign	sign	NN
46745	5207	6	that	that	IN
46745	5207	7	the	the	DT
46745	5207	8	blood	blood	NN
46745	5207	9	is	be	VBZ
46745	5207	10	sufficiently	sufficiently	RB
46745	5207	11	saturated	saturate	VBN
46745	5207	12	with	with	IN
46745	5207	13	the	the	DT
46745	5207	14	medicine	medicine	NN
46745	5207	15	.	.	.
46745	5208	1	This	this	DT
46745	5208	2	point	point	NN
46745	5208	3	will	will	MD
46745	5208	4	be	be	VB
46745	5208	5	sooner	soon	RBR
46745	5208	6	reached	reach	VBN
46745	5208	7	if	if	IN
46745	5208	8	the	the	DT
46745	5208	9	Mercury	Mercury	NNP
46745	5208	10	be	be	VB
46745	5208	11	conjoined	conjoin	VBN
46745	5208	12	with	with	IN
46745	5208	13	Opium	Opium	NNP
46745	5208	14	,	,	,
46745	5208	15	so	so	IN
46745	5208	16	as	as	IN
46745	5208	17	to	to	TO
46745	5208	18	prevent	prevent	VB
46745	5208	19	it	-PRON-	PRP
46745	5208	20	from	from	IN
46745	5208	21	passing	pass	VBG
46745	5208	22	out	out	RP
46745	5208	23	directly	directly	RB
46745	5208	24	by	by	IN
46745	5208	25	the	the	DT
46745	5208	26	bowels	bowel	NNS
46745	5208	27	.	.	.
46745	5209	1	Any	any	DT
46745	5209	2	ill	ill	JJ
46745	5209	3	result	result	NN
46745	5209	4	is	be	VBZ
46745	5209	5	less	less	RBR
46745	5209	6	likely	likely	JJ
46745	5209	7	to	to	TO
46745	5209	8	occur	occur	VB
46745	5209	9	if	if	IN
46745	5209	10	the	the	DT
46745	5209	11	patient	patient	NN
46745	5209	12	be	be	VB
46745	5209	13	kept	keep	VBN
46745	5209	14	warm	warm	JJ
46745	5209	15	and	and	CC
46745	5209	16	quiet	quiet	JJ
46745	5209	17	while	while	IN
46745	5209	18	under	under	IN
46745	5209	19	the	the	DT
46745	5209	20	influence	influence	NN
46745	5209	21	of	of	IN
46745	5209	22	the	the	DT
46745	5209	23	medicine	medicine	NN
46745	5209	24	.	.	.
46745	5210	1	On	on	IN
46745	5210	2	account	account	NN
46745	5210	3	of	of	IN
46745	5210	4	the	the	DT
46745	5210	5	durable	durable	JJ
46745	5210	6	and	and	CC
46745	5210	7	effectual	effectual	JJ
46745	5210	8	nature	nature	NN
46745	5210	9	of	of	IN
46745	5210	10	its	-PRON-	PRP$
46745	5210	11	action	action	NN
46745	5210	12	,	,	,
46745	5210	13	Mercury	Mercury	NNP
46745	5210	14	is	be	VBZ
46745	5210	15	of	of	IN
46745	5210	16	great	great	JJ
46745	5210	17	use	use	NN
46745	5210	18	in	in	IN
46745	5210	19	preventing	prevent	VBG
46745	5210	20	the	the	DT
46745	5210	21	process	process	NN
46745	5210	22	of	of	IN
46745	5210	23	effusion	effusion	NN
46745	5210	24	,	,	,
46745	5210	25	and	and	CC
46745	5210	26	in	in	IN
46745	5210	27	causing	cause	VBG
46745	5210	28	the	the	DT
46745	5210	29	absorption	absorption	NN
46745	5210	30	of	of	IN
46745	5210	31	effused	effuse	VBN
46745	5210	32	products	product	NNS
46745	5210	33	.	.	.
46745	5211	1	It	-PRON-	PRP
46745	5211	2	is	be	VBZ
46745	5211	3	thus	thus	RB
46745	5211	4	employed	employ	VBN
46745	5211	5	with	with	IN
46745	5211	6	advantage	advantage	NN
46745	5211	7	in	in	IN
46745	5211	8	Pleurisy	Pleurisy	NNP
46745	5211	9	,	,	,
46745	5211	10	and	and	CC
46745	5211	11	in	in	IN
46745	5211	12	other	other	JJ
46745	5211	13	membranous	membranous	JJ
46745	5211	14	inflammations	inflammation	NNS
46745	5211	15	.	.	.
46745	5212	1	Next	next	RB
46745	5212	2	to	to	IN
46745	5212	3	these	these	DT
46745	5212	4	,	,	,
46745	5212	5	it	-PRON-	PRP
46745	5212	6	is	be	VBZ
46745	5212	7	most	most	RBS
46745	5212	8	useful	useful	JJ
46745	5212	9	in	in	IN
46745	5212	10	inflammations	inflammation	NNS
46745	5212	11	of	of	IN
46745	5212	12	the	the	DT
46745	5212	13	liver	liver	NN
46745	5212	14	and	and	CC
46745	5212	15	brain	brain	NN
46745	5212	16	.	.	.
46745	5213	1	It	-PRON-	PRP
46745	5213	2	is	be	VBZ
46745	5213	3	inferior	inferior	JJ
46745	5213	4	to	to	IN
46745	5213	5	Antimony	Antimony	NNP
46745	5213	6	in	in	IN
46745	5213	7	fevers	fever	NNS
46745	5213	8	and	and	CC
46745	5213	9	rapid	rapid	JJ
46745	5213	10	inflammations	inflammation	NNS
46745	5213	11	,	,	,
46745	5213	12	because	because	IN
46745	5213	13	slower	slow	JJR
46745	5213	14	in	in	IN
46745	5213	15	operation	operation	NN
46745	5213	16	,	,	,
46745	5213	17	and	and	CC
46745	5213	18	without	without	IN
46745	5213	19	any	any	DT
46745	5213	20	direct	direct	JJ
46745	5213	21	action	action	NN
46745	5213	22	on	on	IN
46745	5213	23	the	the	DT
46745	5213	24	nervous	nervous	JJ
46745	5213	25	system	system	NN
46745	5213	26	.	.	.
46745	5214	1	In	in	IN
46745	5214	2	cases	case	NNS
46745	5214	3	of	of	IN
46745	5214	4	primary	primary	JJ
46745	5214	5	Syphilis	Syphilis	NNP
46745	5214	6	,	,	,
46745	5214	7	Mercury	Mercury	NNP
46745	5214	8	is	be	VBZ
46745	5214	9	by	by	IN
46745	5214	10	far	far	RB
46745	5214	11	the	the	DT
46745	5214	12	best	good	JJS
46745	5214	13	medicine	medicine	NN
46745	5214	14	with	with	IN
46745	5214	15	which	which	WDT
46745	5214	16	we	-PRON-	PRP
46745	5214	17	are	be	VBP
46745	5214	18	acquainted	acquaint	VBN
46745	5214	19	.	.	.
46745	5215	1	It	-PRON-	PRP
46745	5215	2	should	should	MD
46745	5215	3	be	be	VB
46745	5215	4	used	use	VBN
46745	5215	5	in	in	IN
46745	5215	6	all	all	DT
46745	5215	7	cases	case	NNS
46745	5215	8	except	except	IN
46745	5215	9	where	where	WRB
46745	5215	10	there	there	EX
46745	5215	11	is	be	VBZ
46745	5215	12	deep	deep	RB
46745	5215	13	-	-	HYPH
46745	5215	14	rooted	rooted	JJ
46745	5215	15	scrofula	scrofula	NN
46745	5215	16	,	,	,
46745	5215	17	or	or	CC
46745	5215	18	marked	marked	JJ
46745	5215	19	debility	debility	NN
46745	5215	20	,	,	,
46745	5215	21	or	or	CC
46745	5215	22	a	a	DT
46745	5215	23	sloughing	sloughing	JJ
46745	5215	24	and	and	CC
46745	5215	25	irregular	irregular	JJ
46745	5215	26	condition	condition	NN
46745	5215	27	of	of	IN
46745	5215	28	the	the	DT
46745	5215	29	primary	primary	JJ
46745	5215	30	sore	sore	NN
46745	5215	31	.	.	.
46745	5216	1	(	(	-LRB-
46745	5216	2	Dr.	Dr.	NNP
46745	5217	1	Pereira	Pereira	NNP
46745	5217	2	.	.	.
46745	5217	3	)	)	-RRB-
46745	5218	1	It	-PRON-	PRP
46745	5218	2	should	should	MD
46745	5218	3	always	always	RB
46745	5218	4	be	be	VB
46745	5218	5	given	give	VBN
46745	5218	6	in	in	IN
46745	5218	7	Iritis	Iritis	NNP
46745	5218	8	.	.	.
46745	5219	1	In	in	IN
46745	5219	2	Periostitis	Periostitis	NNP
46745	5219	3	,	,	,
46745	5219	4	and	and	CC
46745	5219	5	secondary	secondary	JJ
46745	5219	6	eruptions	eruption	NNS
46745	5219	7	,	,	,
46745	5219	8	Iodide	Iodide	NNP
46745	5219	9	of	of	IN
46745	5219	10	Potassium	Potassium	NNP
46745	5219	11	is	be	VBZ
46745	5219	12	generally	generally	RB
46745	5219	13	preferable	preferable	JJ
46745	5219	14	.	.	.
46745	5220	1	Mercury	Mercury	NNP
46745	5220	2	,	,	,
46745	5220	3	being	be	VBG
46745	5220	4	unnatural	unnatural	JJ
46745	5220	5	to	to	IN
46745	5220	6	the	the	DT
46745	5220	7	blood	blood	NN
46745	5220	8	,	,	,
46745	5220	9	passes	pass	VBZ
46745	5220	10	at	at	IN
46745	5220	11	length	length	NN
46745	5220	12	out	out	IN
46745	5220	13	of	of	IN
46745	5220	14	the	the	DT
46745	5220	15	system	system	NN
46745	5220	16	through	through	IN
46745	5220	17	the	the	DT
46745	5220	18	glands	gland	NNS
46745	5220	19	,	,	,
46745	5220	20	and	and	CC
46745	5220	21	acts	act	VBZ
46745	5220	22	as	as	IN
46745	5220	23	an	an	DT
46745	5220	24	Eliminative	Eliminative	NNP
46745	5220	25	.	.	.
46745	5221	1	Like	like	IN
46745	5221	2	Antimony	Antimony	NNP
46745	5221	3	it	-PRON-	PRP
46745	5221	4	tends	tend	VBZ
46745	5221	5	to	to	TO
46745	5221	6	increase	increase	VB
46745	5221	7	all	all	PDT
46745	5221	8	the	the	DT
46745	5221	9	secretions	secretion	NNS
46745	5221	10	in	in	IN
46745	5221	11	the	the	DT
46745	5221	12	body	body	NN
46745	5221	13	.	.	.
46745	5222	1	But	but	CC
46745	5222	2	whereas	whereas	IN
46745	5222	3	Antimony	Antimony	NNP
46745	5222	4	acts	act	VBZ
46745	5222	5	especially	especially	RB
46745	5222	6	on	on	IN
46745	5222	7	the	the	DT
46745	5222	8	secretions	secretion	NNS
46745	5222	9	of	of	IN
46745	5222	10	the	the	DT
46745	5222	11	skin	skin	NN
46745	5222	12	and	and	CC
46745	5222	13	pulmonary	pulmonary	NN
46745	5222	14	membrane	membrane	NN
46745	5222	15	,	,	,
46745	5222	16	Mercury	Mercury	NNP
46745	5222	17	tends	tend	VBZ
46745	5222	18	particularly	particularly	RB
46745	5222	19	to	to	TO
46745	5222	20	excite	excite	VB
46745	5222	21	the	the	DT
46745	5222	22	functions	function	NNS
46745	5222	23	of	of	IN
46745	5222	24	the	the	DT
46745	5222	25	liver	liver	NN
46745	5222	26	and	and	CC
46745	5222	27	bowels	bowel	NNS
46745	5222	28	,	,	,
46745	5222	29	being	be	VBG
46745	5222	30	Cathartic	cathartic	JJ
46745	5222	31	and	and	CC
46745	5222	32	Cholagogue	Cholagogue	NNP
46745	5222	33	.	.	.
46745	5223	1	Of	of	IN
46745	5223	2	its	-PRON-	PRP$
46745	5223	3	true	true	JJ
46745	5223	4	eliminative	eliminative	JJ
46745	5223	5	action	action	NN
46745	5223	6	we	-PRON-	PRP
46745	5223	7	have	have	VBP
46745	5223	8	better	well	JJR
46745	5223	9	proof	proof	NN
46745	5223	10	than	than	IN
46745	5223	11	has	have	VBZ
46745	5223	12	yet	yet	RB
46745	5223	13	been	be	VBN
46745	5223	14	obtained	obtain	VBN
46745	5223	15	in	in	IN
46745	5223	16	the	the	DT
46745	5223	17	case	case	NN
46745	5223	18	of	of	IN
46745	5223	19	Antimony	Antimony	NNP
46745	5223	20	;	;	:
46745	5223	21	for	for	IN
46745	5223	22	Mercury	Mercury	NNP
46745	5223	23	has	have	VBZ
46745	5223	24	been	be	VBN
46745	5223	25	found	find	VBN
46745	5223	26	to	to	TO
46745	5223	27	pass	pass	VB
46745	5223	28	into	into	IN
46745	5223	29	the	the	DT
46745	5223	30	alvine	alvine	NN
46745	5223	31	excretions	excretion	NNS
46745	5223	32	,	,	,
46745	5223	33	by	by	IN
46745	5223	34	M.	M.	NNP
46745	5223	35	Lehmann	Lehmann	NNP
46745	5223	36	;	;	:
46745	5223	37	and	and	CC
46745	5223	38	discovered	discover	VBN
46745	5223	39	in	in	IN
46745	5223	40	the	the	DT
46745	5223	41	bile	bile	NN
46745	5223	42	of	of	IN
46745	5223	43	dogs	dog	NNS
46745	5223	44	to	to	IN
46745	5223	45	whom	whom	WP
46745	5223	46	it	-PRON-	PRP
46745	5223	47	had	have	VBD
46745	5223	48	been	be	VBN
46745	5223	49	administered	administer	VBN
46745	5223	50	,	,	,
46745	5223	51	by	by	IN
46745	5223	52	M.	M.	NNP
46745	5223	53	Buchheim	Buchheim	NNP
46745	5223	54	.	.	.
46745	5224	1	For	for	IN
46745	5224	2	the	the	DT
46745	5224	3	purpose	purpose	NN
46745	5224	4	of	of	IN
46745	5224	5	acting	act	VBG
46745	5224	6	upon	upon	IN
46745	5224	7	the	the	DT
46745	5224	8	liver	liver	NN
46745	5224	9	and	and	CC
46745	5224	10	bowels	bowel	NNS
46745	5224	11	,	,	,
46745	5224	12	Mercurials	mercurial	NNS
46745	5224	13	are	be	VBP
46745	5224	14	frequently	frequently	RB
46745	5224	15	used	use	VBN
46745	5224	16	in	in	IN
46745	5224	17	disordered	disorder	VBN
46745	5224	18	digestion	digestion	NN
46745	5224	19	and	and	CC
46745	5224	20	cases	case	NNS
46745	5224	21	of	of	IN
46745	5224	22	hepatic	hepatic	JJ
46745	5224	23	derangement	derangement	NN
46745	5224	24	.	.	.
46745	5225	1	In	in	IN
46745	5225	2	Intermittent	intermittent	JJ
46745	5225	3	disorders	disorder	NNS
46745	5225	4	,	,	,
46745	5225	5	debility	debility	NN
46745	5225	6	,	,	,
46745	5225	7	Gout	Gout	NNP
46745	5225	8	,	,	,
46745	5225	9	Rheumatism	Rheumatism	NNP
46745	5225	10	,	,	,
46745	5225	11	and	and	CC
46745	5225	12	Scrofula	Scrofula	NNP
46745	5225	13	,	,	,
46745	5225	14	small	small	JJ
46745	5225	15	doses	dose	NNS
46745	5225	16	of	of	IN
46745	5225	17	Mercury	Mercury	NNP
46745	5225	18	are	be	VBP
46745	5225	19	often	often	RB
46745	5225	20	of	of	IN
46745	5225	21	service	service	NN
46745	5225	22	.	.	.
46745	5226	1	I	-PRON-	PRP
46745	5226	2	have	have	VBP
46745	5226	3	endeavoured	endeavour	VBN
46745	5226	4	to	to	TO
46745	5226	5	show	show	VB
46745	5226	6	(	(	-LRB-
46745	5226	7	p.	p.	NN
46745	5226	8	143	143	CD
46745	5226	9	)	)	-RRB-
46745	5226	10	that	that	IN
46745	5226	11	in	in	IN
46745	5226	12	these	these	DT
46745	5226	13	cases	case	NNS
46745	5226	14	they	-PRON-	PRP
46745	5226	15	may	may	MD
46745	5226	16	prove	prove	VB
46745	5226	17	indirectly	indirectly	RB
46745	5226	18	tonic	tonic	NN
46745	5226	19	,	,	,
46745	5226	20	by	by	IN
46745	5226	21	restoring	restore	VBG
46745	5226	22	to	to	IN
46745	5226	23	the	the	DT
46745	5226	24	system	system	NN
46745	5226	25	some	some	DT
46745	5226	26	of	of	IN
46745	5226	27	the	the	DT
46745	5226	28	wanting	want	VBG
46745	5226	29	elements	element	NNS
46745	5226	30	of	of	IN
46745	5226	31	bile	bile	NN
46745	5226	32	,	,	,
46745	5226	33	which	which	WDT
46745	5226	34	are	be	VBP
46745	5226	35	normally	normally	RB
46745	5226	36	secreted	secrete	VBN
46745	5226	37	by	by	IN
46745	5226	38	the	the	DT
46745	5226	39	liver	liver	NN
46745	5226	40	for	for	IN
46745	5226	41	the	the	DT
46745	5226	42	purpose	purpose	NN
46745	5226	43	of	of	IN
46745	5226	44	being	be	VBG
46745	5226	45	reabsorbed	reabsorb	VBN
46745	5226	46	into	into	IN
46745	5226	47	the	the	DT
46745	5226	48	system	system	NN
46745	5226	49	.	.	.
46745	5227	1	In	in	IN
46745	5227	2	incipient	incipient	JJ
46745	5227	3	and	and	CC
46745	5227	4	chronic	chronic	JJ
46745	5227	5	cases	case	NNS
46745	5227	6	of	of	IN
46745	5227	7	Scrofula	Scrofula	NNP
46745	5227	8	,	,	,
46745	5227	9	consumption	consumption	NN
46745	5227	10	,	,	,
46745	5227	11	and	and	CC
46745	5227	12	mesenteric	mesenteric	JJ
46745	5227	13	disease	disease	NN
46745	5227	14	,	,	,
46745	5227	15	it	-PRON-	PRP
46745	5227	16	is	be	VBZ
46745	5227	17	possible	possible	JJ
46745	5227	18	that	that	IN
46745	5227	19	Mercurials	Mercurials	NNP
46745	5227	20	may	may	MD
46745	5227	21	act	act	VB
46745	5227	22	yet	yet	RB
46745	5227	23	in	in	IN
46745	5227	24	another	another	DT
46745	5227	25	way	way	NN
46745	5227	26	.	.	.
46745	5228	1	They	-PRON-	PRP
46745	5228	2	no	no	RB
46745	5228	3	doubt	doubt	RB
46745	5228	4	stimulate	stimulate	VBP
46745	5228	5	the	the	DT
46745	5228	6	formation	formation	NN
46745	5228	7	of	of	IN
46745	5228	8	the	the	DT
46745	5228	9	Pancreatic	pancreatic	JJ
46745	5228	10	secretion	secretion	NN
46745	5228	11	,	,	,
46745	5228	12	which	which	WDT
46745	5228	13	is	be	VBZ
46745	5228	14	similar	similar	JJ
46745	5228	15	in	in	IN
46745	5228	16	nature	nature	NN
46745	5228	17	to	to	IN
46745	5228	18	the	the	DT
46745	5228	19	saliva	saliva	NN
46745	5228	20	.	.	.
46745	5229	1	By	by	IN
46745	5229	2	doing	do	VBG
46745	5229	3	so	so	RB
46745	5229	4	they	-PRON-	PRP
46745	5229	5	may	may	MD
46745	5229	6	assist	assist	VB
46745	5229	7	the	the	DT
46745	5229	8	absorption	absorption	NN
46745	5229	9	of	of	IN
46745	5229	10	the	the	DT
46745	5229	11	fatty	fatty	NN
46745	5229	12	matters	matter	NNS
46745	5229	13	of	of	IN
46745	5229	14	the	the	DT
46745	5229	15	food	food	NN
46745	5229	16	in	in	IN
46745	5229	17	the	the	DT
46745	5229	18	case	case	NN
46745	5229	19	of	of	IN
46745	5229	20	thin	thin	JJ
46745	5229	21	and	and	CC
46745	5229	22	emaciated	emaciated	JJ
46745	5229	23	subjects	subject	NNS
46745	5229	24	,	,	,
46745	5229	25	in	in	IN
46745	5229	26	whom	whom	WP
46745	5229	27	it	-PRON-	PRP
46745	5229	28	is	be	VBZ
46745	5229	29	probable	probable	JJ
46745	5229	30	that	that	IN
46745	5229	31	the	the	DT
46745	5229	32	function	function	NN
46745	5229	33	of	of	IN
46745	5229	34	this	this	DT
46745	5229	35	gland	gland	NN
46745	5229	36	is	be	VBZ
46745	5229	37	frequently	frequently	RB
46745	5229	38	impaired	impair	VBN
46745	5229	39	.	.	.
46745	5230	1	(	(	-LRB-
46745	5230	2	_	_	NNP
46745	5230	3	Vide	Vide	NNP
46745	5230	4	_	_	NNP
46745	5230	5	p.	p.	NN
46745	5231	1	313	313	CD
46745	5231	2	.	.	.
46745	5231	3	)	)	-RRB-
46745	5232	1	Mercury	Mercury	NNP
46745	5232	2	assists	assist	VBZ
46745	5232	3	the	the	DT
46745	5232	4	operation	operation	NN
46745	5232	5	of	of	IN
46745	5232	6	all	all	DT
46745	5232	7	other	other	JJ
46745	5232	8	medicines	medicine	NNS
46745	5232	9	which	which	WDT
46745	5232	10	act	act	VBP
46745	5232	11	upon	upon	IN
46745	5232	12	the	the	DT
46745	5232	13	secretions	secretion	NNS
46745	5232	14	.	.	.
46745	5233	1	In	in	IN
46745	5233	2	cases	case	NNS
46745	5233	3	of	of	IN
46745	5233	4	hepatic	hepatic	JJ
46745	5233	5	dropsy	dropsy	NN
46745	5233	6	it	-PRON-	PRP
46745	5233	7	helps	help	VBZ
46745	5233	8	the	the	DT
46745	5233	9	action	action	NN
46745	5233	10	of	of	IN
46745	5233	11	Diuretics	Diuretics	NNP
46745	5233	12	,	,	,
46745	5233	13	and	and	CC
46745	5233	14	tends	tend	VBZ
46745	5233	15	to	to	TO
46745	5233	16	remove	remove	VB
46745	5233	17	the	the	DT
46745	5233	18	cause	cause	NN
46745	5233	19	of	of	IN
46745	5233	20	the	the	DT
46745	5233	21	congestion	congestion	NN
46745	5233	22	,	,	,
46745	5233	23	by	by	IN
46745	5233	24	stimulating	stimulate	VBG
46745	5233	25	the	the	DT
46745	5233	26	function	function	NN
46745	5233	27	of	of	IN
46745	5233	28	the	the	DT
46745	5233	29	liver	liver	NN
46745	5233	30	.	.	.
46745	5234	1	The	the	DT
46745	5234	2	blood	blood	NN
46745	5234	3	-	-	HYPH
46745	5234	4	operation	operation	NN
46745	5234	5	of	of	IN
46745	5234	6	Mercury	Mercury	NNP
46745	5234	7	,	,	,
46745	5234	8	by	by	IN
46745	5234	9	which	which	WDT
46745	5234	10	it	-PRON-	PRP
46745	5234	11	is	be	VBZ
46745	5234	12	enabled	enable	VBN
46745	5234	13	to	to	TO
46745	5234	14	counteract	counteract	VB
46745	5234	15	morbid	morbid	NN
46745	5234	16	processes	process	NNS
46745	5234	17	,	,	,
46745	5234	18	is	be	VBZ
46745	5234	19	involved	involve	VBN
46745	5234	20	in	in	IN
46745	5234	21	considerable	considerable	JJ
46745	5234	22	obscurity	obscurity	NN
46745	5234	23	.	.	.
46745	5235	1	The	the	DT
46745	5235	2	same	same	JJ
46745	5235	3	must	must	MD
46745	5235	4	be	be	VB
46745	5235	5	said	say	VBN
46745	5235	6	of	of	IN
46745	5235	7	all	all	DT
46745	5235	8	Catalytic	catalytic	JJ
46745	5235	9	medicines	medicine	NNS
46745	5235	10	(	(	-LRB-
46745	5235	11	_	_	NNP
46745	5235	12	Vide	Vide	NNP
46745	5235	13	_	_	NNP
46745	5235	14	p.	p.	NN
46745	5236	1	179	179	CD
46745	5236	2	.	.	.
46745	5236	3	)	)	-RRB-
46745	5237	1	Dr.	Dr.	NNP
46745	5238	1	Billing	Billing	NNP
46745	5238	2	(	(	-LRB-
46745	5238	3	_	_	NNP
46745	5238	4	Principles	Principles	NNPS
46745	5238	5	of	of	IN
46745	5238	6	Medicine	Medicine	NNP
46745	5238	7	_	_	NNP
46745	5238	8	,	,	,
46745	5238	9	p.	p.	NN
46745	5238	10	73	73	CD
46745	5238	11	)	)	-RRB-
46745	5238	12	is	be	VBZ
46745	5238	13	of	of	IN
46745	5238	14	opinion	opinion	NN
46745	5238	15	that	that	IN
46745	5238	16	Mercury	Mercury	NNP
46745	5238	17	acts	act	VBZ
46745	5238	18	by	by	IN
46745	5238	19	contracting	contract	VBG
46745	5238	20	the	the	DT
46745	5238	21	capillary	capillary	JJ
46745	5238	22	vessels	vessel	NNS
46745	5238	23	.	.	.
46745	5239	1	I	-PRON-	PRP
46745	5239	2	have	have	VBP
46745	5239	3	already	already	RB
46745	5239	4	stated	state	VBN
46745	5239	5	my	-PRON-	PRP$
46745	5239	6	reasons	reason	NNS
46745	5239	7	for	for	IN
46745	5239	8	dissenting	dissent	VBG
46745	5239	9	from	from	IN
46745	5239	10	this	this	DT
46745	5239	11	notion	notion	NN
46745	5239	12	.	.	.
46745	5240	1	(	(	-LRB-
46745	5240	2	p.	p.	NN
46745	5241	1	163	163	CD
46745	5241	2	.	.	.
46745	5241	3	)	)	-RRB-
46745	5242	1	The	the	DT
46745	5242	2	same	same	JJ
46745	5242	3	author	author	NN
46745	5242	4	denies	deny	VBZ
46745	5242	5	the	the	DT
46745	5242	6	specific	specific	JJ
46745	5242	7	action	action	NN
46745	5242	8	of	of	IN
46745	5242	9	Mercury	Mercury	NNP
46745	5242	10	in	in	IN
46745	5242	11	Syphilis	Syphilis	NNP
46745	5242	12	.	.	.
46745	5243	1	But	but	CC
46745	5243	2	if	if	IN
46745	5243	3	we	-PRON-	PRP
46745	5243	4	only	only	RB
46745	5243	5	admit	admit	VBP
46745	5243	6	that	that	IN
46745	5243	7	there	there	EX
46745	5243	8	is	be	VBZ
46745	5243	9	no	no	DT
46745	5243	10	other	other	JJ
46745	5243	11	medicine	medicine	NN
46745	5243	12	that	that	WDT
46745	5243	13	will	will	MD
46745	5243	14	cure	cure	VB
46745	5243	15	primary	primary	JJ
46745	5243	16	Syphilis	Syphilis	NNP
46745	5243	17	so	so	RB
46745	5243	18	well	well	RB
46745	5243	19	as	as	IN
46745	5243	20	Mercury	Mercury	NNP
46745	5243	21	,	,	,
46745	5243	22	we	-PRON-	PRP
46745	5243	23	can	can	MD
46745	5243	24	not	not	RB
46745	5243	25	then	then	RB
46745	5243	26	surely	surely	RB
46745	5243	27	deny	deny	VB
46745	5243	28	that	that	IN
46745	5243	29	its	-PRON-	PRP$
46745	5243	30	action	action	NN
46745	5243	31	in	in	IN
46745	5243	32	that	that	DT
46745	5243	33	disorder	disorder	NN
46745	5243	34	is	be	VBZ
46745	5243	35	of	of	IN
46745	5243	36	a	a	DT
46745	5243	37	special	special	JJ
46745	5243	38	nature	nature	NN
46745	5243	39	.	.	.
46745	5244	1	He	-PRON-	PRP
46745	5244	2	considers	consider	VBZ
46745	5244	3	it	-PRON-	PRP
46745	5244	4	to	to	TO
46745	5244	5	be	be	VB
46745	5244	6	neither	neither	CC
46745	5244	7	stimulant	stimulant	NN
46745	5244	8	nor	nor	CC
46745	5244	9	sedative,--but	sedative,--but	JJ
46745	5244	10	tonic	tonic	NN
46745	5244	11	.	.	.
46745	5245	1	(	(	-LRB-
46745	5245	2	_	_	NNP
46745	5245	3	Op	Op	NNP
46745	5245	4	.	.	.
46745	5246	1	cit	cit	NNP
46745	5246	2	.	.	.
46745	5246	3	_	_	NNP
46745	5246	4	p.	p.	NN
46745	5247	1	101	101	CD
46745	5247	2	.	.	.
46745	5247	3	)	)	-RRB-
46745	5248	1	No	no	DT
46745	5248	2	one	one	NN
46745	5248	3	of	of	IN
46745	5248	4	these	these	DT
46745	5248	5	terms	term	NNS
46745	5248	6	appears	appear	VBZ
46745	5248	7	to	to	IN
46745	5248	8	me	-PRON-	PRP
46745	5248	9	to	to	TO
46745	5248	10	be	be	VB
46745	5248	11	strictly	strictly	RB
46745	5248	12	applicable	applicable	JJ
46745	5248	13	,	,	,
46745	5248	14	but	but	CC
46745	5248	15	perhaps	perhaps	RB
46745	5248	16	the	the	DT
46745	5248	17	last	last	JJ
46745	5248	18	is	be	VBZ
46745	5248	19	the	the	DT
46745	5248	20	best	good	JJS
46745	5248	21	of	of	IN
46745	5248	22	the	the	DT
46745	5248	23	three	three	CD
46745	5248	24	.	.	.
46745	5249	1	Some	some	DT
46745	5249	2	have	have	VBP
46745	5249	3	,	,	,
46745	5249	4	without	without	IN
46745	5249	5	sufficient	sufficient	JJ
46745	5249	6	reason	reason	NN
46745	5249	7	,	,	,
46745	5249	8	assumed	assume	VBD
46745	5249	9	Calomel	Calomel	NNP
46745	5249	10	to	to	TO
46745	5249	11	be	be	VB
46745	5249	12	a	a	DT
46745	5249	13	Sedative	sedative	NN
46745	5249	14	when	when	WRB
46745	5249	15	given	give	VBN
46745	5249	16	in	in	IN
46745	5249	17	large	large	JJ
46745	5249	18	doses	dose	NNS
46745	5249	19	.	.	.
46745	5250	1	To	to	TO
46745	5250	2	act	act	VB
46745	5250	3	in	in	IN
46745	5250	4	this	this	DT
46745	5250	5	way	way	NN
46745	5250	6	,	,	,
46745	5250	7	very	very	RB
46745	5250	8	large	large	JJ
46745	5250	9	doses	dose	NNS
46745	5250	10	have	have	VBP
46745	5250	11	been	be	VBN
46745	5250	12	recommended	recommend	VBN
46745	5250	13	and	and	CC
46745	5250	14	given	give	VBN
46745	5250	15	in	in	IN
46745	5250	16	fever	fever	NN
46745	5250	17	and	and	CC
46745	5250	18	malignant	malignant	JJ
46745	5250	19	cholera	cholera	NNS
46745	5250	20	.	.	.
46745	5251	1	Calomel	Calomel	NNP
46745	5251	2	is	be	VBZ
46745	5251	3	naturally	naturally	RB
46745	5251	4	an	an	DT
46745	5251	5	insoluble	insoluble	JJ
46745	5251	6	substance	substance	NN
46745	5251	7	;	;	:
46745	5251	8	and	and	CC
46745	5251	9	in	in	IN
46745	5251	10	these	these	DT
46745	5251	11	cases	case	NNS
46745	5251	12	the	the	DT
46745	5251	13	function	function	NN
46745	5251	14	of	of	IN
46745	5251	15	absorption	absorption	NN
46745	5251	16	is	be	VBZ
46745	5251	17	at	at	IN
46745	5251	18	the	the	DT
46745	5251	19	very	very	RB
46745	5251	20	lowest	low	JJS
46745	5251	21	ebb	ebb	NN
46745	5251	22	;	;	:
46745	5251	23	so	so	IN
46745	5251	24	that	that	IN
46745	5251	25	it	-PRON-	PRP
46745	5251	26	is	be	VBZ
46745	5251	27	probable	probable	JJ
46745	5251	28	that	that	IN
46745	5251	29	the	the	DT
46745	5251	30	large	large	JJ
46745	5251	31	doses	dose	NNS
46745	5251	32	are	be	VBP
46745	5251	33	often	often	RB
46745	5251	34	left	leave	VBN
46745	5251	35	unabsorbed	unabsorbed	JJ
46745	5251	36	,	,	,
46745	5251	37	and	and	CC
46745	5251	38	pass	pass	VB
46745	5251	39	out	out	IN
46745	5251	40	of	of	IN
46745	5251	41	the	the	DT
46745	5251	42	bowels	bowel	NNS
46745	5251	43	very	very	RB
46745	5251	44	much	much	RB
46745	5251	45	as	as	IN
46745	5251	46	they	-PRON-	PRP
46745	5251	47	entered	enter	VBD
46745	5251	48	,	,	,
46745	5251	49	producing	produce	VBG
46745	5251	50	scarcely	scarcely	RB
46745	5251	51	any	any	DT
46745	5251	52	more	more	JJR
46745	5251	53	effect	effect	NN
46745	5251	54	than	than	IN
46745	5251	55	so	so	RB
46745	5251	56	much	much	JJ
46745	5251	57	chalk	chalk	JJ
46745	5251	58	mixture	mixture	NN
46745	5251	59	.	.	.
46745	5252	1	(	(	-LRB-
46745	5252	2	_	_	NNP
46745	5252	3	Vide	Vide	NNP
46745	5252	4	_	_	NNP
46745	5252	5	pp	pp	NNP
46745	5252	6	.	.	.
46745	5253	1	88	88	CD
46745	5253	2	,	,	,
46745	5253	3	143	143	CD
46745	5253	4	,	,	,
46745	5253	5	163	163	CD
46745	5253	6	,	,	,
46745	5253	7	168	168	CD
46745	5253	8	,	,	,
46745	5253	9	185	185	CD
46745	5253	10	,	,	,
46745	5253	11	188	188	CD
46745	5253	12	,	,	,
46745	5253	13	203	203	CD
46745	5253	14	,	,	,
46745	5253	15	286	286	CD
46745	5253	16	,	,	,
46745	5253	17	295	295	CD
46745	5253	18	,	,	,
46745	5253	19	308	308	CD
46745	5253	20	.	.	.
46745	5253	21	)	)	-RRB-
46745	5254	1	IODINE	IODINE	NNP
46745	5254	2	.	.	.
46745	5255	1	Class	class	NN
46745	5255	2	I.	I.	NNP
46745	5255	3	Div	Div	NNP
46745	5255	4	.	.	.
46745	5256	1	II	ii	CD
46745	5256	2	.	.	.
46745	5257	1	Ord	Ord	NNP
46745	5257	2	.	.	.
46745	5258	1	II	ii	CD
46745	5258	2	.	.	.
46745	5259	1	ANTISYPHILITICA	ANTISYPHILITICA	NNP
46745	5259	2	.	.	.
46745	5260	1	Class	class	NN
46745	5260	2	I.	I.	NNP
46745	5260	3	Div	Div	NNP
46745	5260	4	.	.	.
46745	5261	1	II	ii	CD
46745	5261	2	.	.	.
46745	5262	1	Ord	Ord	NNP
46745	5262	2	.	.	.
46745	5263	1	III	iii	CD
46745	5263	2	.	.	.
46745	5264	1	ANTISCROFULOSA	ANTISCROFULOSA	NNP
46745	5264	2	.	.	.
46745	5265	1	The	the	DT
46745	5265	2	readiest	readiest	NN
46745	5265	3	and	and	CC
46745	5265	4	best	good	JJS
46745	5265	5	way	way	NN
46745	5265	6	of	of	IN
46745	5265	7	obtaining	obtain	VBG
46745	5265	8	the	the	DT
46745	5265	9	beneficial	beneficial	JJ
46745	5265	10	effects	effect	NNS
46745	5265	11	of	of	IN
46745	5265	12	Iodine	Iodine	NNP
46745	5265	13	is	be	VBZ
46745	5265	14	by	by	IN
46745	5265	15	the	the	DT
46745	5265	16	use	use	NN
46745	5265	17	of	of	IN
46745	5265	18	Iodide	Iodide	NNP
46745	5265	19	of	of	IN
46745	5265	20	Potassium	Potassium	NNP
46745	5265	21	.	.	.
46745	5266	1	This	this	DT
46745	5266	2	is	be	VBZ
46745	5266	3	a	a	DT
46745	5266	4	very	very	RB
46745	5266	5	soluble	soluble	JJ
46745	5266	6	salt	salt	NN
46745	5266	7	.	.	.
46745	5267	1	The	the	DT
46745	5267	2	peculiar	peculiar	JJ
46745	5267	3	virtues	virtue	NNS
46745	5267	4	of	of	IN
46745	5267	5	Iodine	Iodine	NNP
46745	5267	6	are	be	VBP
46745	5267	7	not	not	RB
46745	5267	8	impaired	impair	VBN
46745	5267	9	,	,	,
46745	5267	10	but	but	CC
46745	5267	11	rather	rather	RB
46745	5267	12	improved	improve	VBN
46745	5267	13	,	,	,
46745	5267	14	by	by	IN
46745	5267	15	its	-PRON-	PRP$
46745	5267	16	chemical	chemical	NN
46745	5267	17	combination	combination	NN
46745	5267	18	with	with	IN
46745	5267	19	the	the	DT
46745	5267	20	alkali	alkali	JJ
46745	5267	21	.	.	.
46745	5268	1	And	and	CC
46745	5268	2	when	when	WRB
46745	5268	3	we	-PRON-	PRP
46745	5268	4	administer	administer	VBP
46745	5268	5	the	the	DT
46745	5268	6	Iodine	Iodine	NNP
46745	5268	7	itself	-PRON-	PRP
46745	5268	8	,	,	,
46745	5268	9	as	as	IN
46745	5268	10	in	in	IN
46745	5268	11	the	the	DT
46745	5268	12	tincture	tincture	NN
46745	5268	13	,	,	,
46745	5268	14	there	there	EX
46745	5268	15	is	be	VBZ
46745	5268	16	no	no	DT
46745	5268	17	doubt	doubt	NN
46745	5268	18	that	that	IN
46745	5268	19	after	after	IN
46745	5268	20	entry	entry	NN
46745	5268	21	into	into	IN
46745	5268	22	the	the	DT
46745	5268	23	blood	blood	NN
46745	5268	24	it	-PRON-	PRP
46745	5268	25	combines	combine	VBZ
46745	5268	26	with	with	IN
46745	5268	27	some	some	DT
46745	5268	28	alkaline	alkaline	NN
46745	5268	29	base	base	NN
46745	5268	30	.	.	.
46745	5269	1	If	if	IN
46745	5269	2	the	the	DT
46745	5269	3	use	use	NN
46745	5269	4	of	of	IN
46745	5269	5	Iodine	Iodine	NNP
46745	5269	6	be	be	VB
46745	5269	7	continued	continue	VBN
46745	5269	8	for	for	IN
46745	5269	9	some	some	DT
46745	5269	10	time	time	NN
46745	5269	11	it	-PRON-	PRP
46745	5269	12	has	have	VBZ
46745	5269	13	the	the	DT
46745	5269	14	effect	effect	NN
46745	5269	15	of	of	IN
46745	5269	16	impoverishing	impoverish	VBG
46745	5269	17	the	the	DT
46745	5269	18	blood	blood	NN
46745	5269	19	.	.	.
46745	5270	1	It	-PRON-	PRP
46745	5270	2	sometimes	sometimes	RB
46745	5270	3	produces	produce	VBZ
46745	5270	4	a	a	DT
46745	5270	5	vesicular	vesicular	JJ
46745	5270	6	eruption	eruption	NN
46745	5270	7	on	on	IN
46745	5270	8	the	the	DT
46745	5270	9	skin	skin	NN
46745	5270	10	,	,	,
46745	5270	11	and	and	CC
46745	5270	12	causes	cause	VBZ
46745	5270	13	a	a	DT
46745	5270	14	considerable	considerable	JJ
46745	5270	15	degree	degree	NN
46745	5270	16	of	of	IN
46745	5270	17	irritation	irritation	NN
46745	5270	18	of	of	IN
46745	5270	19	the	the	DT
46745	5270	20	mucous	mucous	JJ
46745	5270	21	membrane	membrane	NN
46745	5270	22	of	of	IN
46745	5270	23	the	the	DT
46745	5270	24	nose	nose	NN
46745	5270	25	and	and	CC
46745	5270	26	eyes	eye	NNS
46745	5270	27	.	.	.
46745	5271	1	The	the	DT
46745	5271	2	preparations	preparation	NNS
46745	5271	3	of	of	IN
46745	5271	4	Iodine	Iodine	NNP
46745	5271	5	exert	exert	NN
46745	5271	6	in	in	IN
46745	5271	7	the	the	DT
46745	5271	8	blood	blood	NN
46745	5271	9	some	some	DT
46745	5271	10	special	special	JJ
46745	5271	11	actions	action	NNS
46745	5271	12	of	of	IN
46745	5271	13	a	a	DT
46745	5271	14	Catalytic	catalytic	JJ
46745	5271	15	kind	kind	NN
46745	5271	16	,	,	,
46745	5271	17	by	by	IN
46745	5271	18	virtue	virtue	NN
46745	5271	19	of	of	IN
46745	5271	20	which	which	WDT
46745	5271	21	they	-PRON-	PRP
46745	5271	22	are	be	VBP
46745	5271	23	enabled	enable	VBN
46745	5271	24	to	to	TO
46745	5271	25	counteract	counteract	VB
46745	5271	26	the	the	DT
46745	5271	27	morbid	morbid	NN
46745	5271	28	actions	action	NNS
46745	5271	29	of	of	IN
46745	5271	30	secondary	secondary	JJ
46745	5271	31	Syphilis	Syphilis	NNP
46745	5271	32	and	and	CC
46745	5271	33	of	of	IN
46745	5271	34	Scrofula	Scrofula	NNP
46745	5271	35	.	.	.
46745	5272	1	Iodine	Iodine	NNP
46745	5272	2	is	be	VBZ
46745	5272	3	not	not	RB
46745	5272	4	,	,	,
46745	5272	5	like	like	IN
46745	5272	6	Mercury	Mercury	NNP
46745	5272	7	,	,	,
46745	5272	8	a	a	DT
46745	5272	9	general	general	JJ
46745	5272	10	Antiphlogistic	Antiphlogistic	NNP
46745	5272	11	;	;	:
46745	5272	12	but	but	CC
46745	5272	13	it	-PRON-	PRP
46745	5272	14	is	be	VBZ
46745	5272	15	a	a	DT
46745	5272	16	stimulator	stimulator	NN
46745	5272	17	of	of	IN
46745	5272	18	the	the	DT
46745	5272	19	function	function	NN
46745	5272	20	of	of	IN
46745	5272	21	absorption	absorption	NN
46745	5272	22	,	,	,
46745	5272	23	as	as	IN
46745	5272	24	are	be	VBP
46745	5272	25	all	all	PDT
46745	5272	26	the	the	DT
46745	5272	27	medicines	medicine	NNS
46745	5272	28	that	that	WDT
46745	5272	29	tend	tend	VBP
46745	5272	30	to	to	TO
46745	5272	31	impoverish	impoverish	VB
46745	5272	32	the	the	DT
46745	5272	33	blood	blood	NN
46745	5272	34	.	.	.
46745	5273	1	This	this	DT
46745	5273	2	action	action	NN
46745	5273	3	in	in	IN
46745	5273	4	causing	cause	VBG
46745	5273	5	absorption	absorption	NN
46745	5273	6	can	can	MD
46745	5273	7	be	be	VB
46745	5273	8	no	no	DT
46745	5273	9	explanation	explanation	NN
46745	5273	10	of	of	IN
46745	5273	11	the	the	DT
46745	5273	12	blood	blood	NN
46745	5273	13	-	-	HYPH
46745	5273	14	operations	operation	NNS
46745	5273	15	for	for	IN
46745	5273	16	which	which	WDT
46745	5273	17	it	-PRON-	PRP
46745	5273	18	is	be	VBZ
46745	5273	19	employed	employ	VBN
46745	5273	20	;	;	:
46745	5273	21	for	for	IN
46745	5273	22	these	these	DT
46745	5273	23	are	be	VBP
46745	5273	24	peculiar	peculiar	JJ
46745	5273	25	to	to	IN
46745	5273	26	it	-PRON-	PRP
46745	5273	27	alone	alone	RB
46745	5273	28	,	,	,
46745	5273	29	whereas	whereas	IN
46745	5273	30	the	the	DT
46745	5273	31	other	other	JJ
46745	5273	32	property	property	NN
46745	5273	33	is	be	VBZ
46745	5273	34	shared	share	VBN
46745	5273	35	by	by	IN
46745	5273	36	other	other	JJ
46745	5273	37	remedies	remedy	NNS
46745	5273	38	.	.	.
46745	5274	1	(	(	-LRB-
46745	5274	2	p.	p.	NN
46745	5275	1	192	192	CD
46745	5275	2	.	.	.
46745	5275	3	)	)	-RRB-
46745	5276	1	Iodine	Iodine	NNP
46745	5276	2	is	be	VBZ
46745	5276	3	an	an	DT
46745	5276	4	Antisyphilitic	Antisyphilitic	NNP
46745	5276	5	.	.	.
46745	5277	1	But	but	CC
46745	5277	2	this	this	DT
46745	5277	3	term	term	NN
46745	5277	4	is	be	VBZ
46745	5277	5	not	not	RB
46745	5277	6	applicable	applicable	JJ
46745	5277	7	to	to	IN
46745	5277	8	it	-PRON-	PRP
46745	5277	9	in	in	IN
46745	5277	10	exactly	exactly	RB
46745	5277	11	the	the	DT
46745	5277	12	same	same	JJ
46745	5277	13	sense	sense	NN
46745	5277	14	as	as	IN
46745	5277	15	to	to	IN
46745	5277	16	Mercury	Mercury	NNP
46745	5277	17	.	.	.
46745	5278	1	Its	-PRON-	PRP$
46745	5278	2	use	use	NN
46745	5278	3	is	be	VBZ
46745	5278	4	confined	confine	VBN
46745	5278	5	to	to	IN
46745	5278	6	the	the	DT
46745	5278	7	later	later	JJ
46745	5278	8	symptoms,--to	symptoms,--to	NNP
46745	5278	9	Periostitis	Periostitis	NNP
46745	5278	10	,	,	,
46745	5278	11	and	and	CC
46745	5278	12	the	the	DT
46745	5278	13	late	late	JJ
46745	5278	14	eruptions	eruption	NNS
46745	5278	15	,	,	,
46745	5278	16	as	as	IN
46745	5278	17	Rupia	Rupia	NNP
46745	5278	18	.	.	.
46745	5279	1	Sometimes	sometimes	RB
46745	5279	2	it	-PRON-	PRP
46745	5279	3	even	even	RB
46745	5279	4	fails	fail	VBZ
46745	5279	5	in	in	IN
46745	5279	6	these	these	DT
46745	5279	7	.	.	.
46745	5280	1	This	this	DT
46745	5280	2	is	be	VBZ
46745	5280	3	generally	generally	RB
46745	5280	4	when	when	WRB
46745	5280	5	the	the	DT
46745	5280	6	primary	primary	JJ
46745	5280	7	disorder	disorder	NN
46745	5280	8	has	have	VBZ
46745	5280	9	not	not	RB
46745	5280	10	been	be	VBN
46745	5280	11	met	meet	VBN
46745	5280	12	by	by	IN
46745	5280	13	Mercury	Mercury	NNP
46745	5280	14	.	.	.
46745	5281	1	Some	some	DT
46745	5281	2	preparation	preparation	NN
46745	5281	3	of	of	IN
46745	5281	4	Mercury	Mercury	NNP
46745	5281	5	should	should	MD
46745	5281	6	then	then	RB
46745	5281	7	be	be	VB
46745	5281	8	administered	administer	VBN
46745	5281	9	for	for	IN
46745	5281	10	awhile	awhile	RB
46745	5281	11	;	;	:
46745	5281	12	and	and	CC
46745	5281	13	the	the	DT
46745	5281	14	Iodide	Iodide	NNP
46745	5281	15	of	of	IN
46745	5281	16	Potassium	Potassium	NNP
46745	5281	17	may	may	MD
46745	5281	18	be	be	VB
46745	5281	19	given	give	VBN
46745	5281	20	afterwards	afterwards	RB
46745	5281	21	.	.	.
46745	5282	1	Thus	thus	RB
46745	5282	2	the	the	DT
46745	5282	3	disorder	disorder	NN
46745	5282	4	which	which	WDT
46745	5282	5	is	be	VBZ
46745	5282	6	controlled	control	VBN
46745	5282	7	by	by	IN
46745	5282	8	the	the	DT
46745	5282	9	latter	latter	JJ
46745	5282	10	medicine	medicine	NN
46745	5282	11	is	be	VBZ
46745	5282	12	so	so	RB
46745	5282	13	modified	modified	JJ
46745	5282	14	as	as	IN
46745	5282	15	to	to	TO
46745	5282	16	be	be	VB
46745	5282	17	something	something	NN
46745	5282	18	quite	quite	RB
46745	5282	19	distinct	distinct	JJ
46745	5282	20	from	from	IN
46745	5282	21	the	the	DT
46745	5282	22	primary	primary	JJ
46745	5282	23	Syphilis	Syphilis	NNP
46745	5282	24	.	.	.
46745	5283	1	The	the	DT
46745	5283	2	same	same	JJ
46745	5283	3	medicine	medicine	NN
46745	5283	4	is	be	VBZ
46745	5283	5	an	an	DT
46745	5283	6	Antiscrofulic	Antiscrofulic	NNP
46745	5283	7	.	.	.
46745	5284	1	It	-PRON-	PRP
46745	5284	2	is	be	VBZ
46745	5284	3	applicable	applicable	JJ
46745	5284	4	in	in	IN
46745	5284	5	all	all	PDT
46745	5284	6	the	the	DT
46745	5284	7	forms	form	NNS
46745	5284	8	of	of	IN
46745	5284	9	Scrofula	Scrofula	NNP
46745	5284	10	,	,	,
46745	5284	11	and	and	CC
46745	5284	12	in	in	IN
46745	5284	13	Goitre	Goitre	NNP
46745	5284	14	.	.	.
46745	5285	1	Possibly	possibly	RB
46745	5285	2	it	-PRON-	PRP
46745	5285	3	acts	act	VBZ
46745	5285	4	differently	differently	RB
46745	5285	5	in	in	IN
46745	5285	6	such	such	JJ
46745	5285	7	cases	case	NNS
46745	5285	8	;	;	:
46745	5285	9	but	but	CC
46745	5285	10	it	-PRON-	PRP
46745	5285	11	is	be	VBZ
46745	5285	12	certain	certain	JJ
46745	5285	13	that	that	IN
46745	5285	14	there	there	EX
46745	5285	15	is	be	VBZ
46745	5285	16	often	often	RB
46745	5285	17	,	,	,
46745	5285	18	in	in	IN
46745	5285	19	cases	case	NNS
46745	5285	20	of	of	IN
46745	5285	21	confirmed	confirm	VBN
46745	5285	22	Syphilis	Syphilis	NNP
46745	5285	23	,	,	,
46745	5285	24	a	a	DT
46745	5285	25	cachexy	cachexy	NN
46745	5285	26	similar	similar	JJ
46745	5285	27	to	to	IN
46745	5285	28	that	that	DT
46745	5285	29	produced	produce	VBN
46745	5285	30	by	by	IN
46745	5285	31	Scrofula	Scrofula	NNP
46745	5285	32	.	.	.
46745	5286	1	In	in	IN
46745	5286	2	either	either	DT
46745	5286	3	disorder	disorder	NN
46745	5286	4	,	,	,
46745	5286	5	when	when	WRB
46745	5286	6	this	this	DT
46745	5286	7	cachexy	cachexy	NN
46745	5286	8	is	be	VBZ
46745	5286	9	confirmed	confirm	VBN
46745	5286	10	,	,	,
46745	5286	11	Mercury	Mercury	NNP
46745	5286	12	is	be	VBZ
46745	5286	13	most	most	RBS
46745	5286	14	objectionable	objectionable	JJ
46745	5286	15	.	.	.
46745	5287	1	On	on	IN
46745	5287	2	the	the	DT
46745	5287	3	contrary	contrary	NN
46745	5287	4	,	,	,
46745	5287	5	in	in	IN
46745	5287	6	primary	primary	JJ
46745	5287	7	Syphilis	Syphilis	NNP
46745	5287	8	,	,	,
46745	5287	9	and	and	CC
46745	5287	10	even	even	RB
46745	5287	11	in	in	IN
46745	5287	12	incipient	incipient	JJ
46745	5287	13	Scrofula	Scrofula	NNP
46745	5287	14	,	,	,
46745	5287	15	Mercury	Mercury	NNP
46745	5287	16	may	may	MD
46745	5287	17	be	be	VB
46745	5287	18	used	use	VBN
46745	5287	19	.	.	.
46745	5288	1	Like	like	IN
46745	5288	2	all	all	DT
46745	5288	3	potent	potent	JJ
46745	5288	4	remedies	remedy	NNS
46745	5288	5	,	,	,
46745	5288	6	Iodine	Iodine	NNP
46745	5288	7	requires	require	VBZ
46745	5288	8	to	to	TO
46745	5288	9	be	be	VB
46745	5288	10	carefully	carefully	RB
46745	5288	11	used	use	VBN
46745	5288	12	.	.	.
46745	5289	1	It	-PRON-	PRP
46745	5289	2	is	be	VBZ
46745	5289	3	sufficient	sufficient	JJ
46745	5289	4	to	to	TO
46745	5289	5	give	give	VB
46745	5289	6	it	-PRON-	PRP
46745	5289	7	in	in	IN
46745	5289	8	small	small	JJ
46745	5289	9	doses	dose	NNS
46745	5289	10	.	.	.
46745	5290	1	If	if	IN
46745	5290	2	given	give	VBN
46745	5290	3	in	in	IN
46745	5290	4	large	large	JJ
46745	5290	5	doses	dose	NNS
46745	5290	6	,	,	,
46745	5290	7	and	and	CC
46745	5290	8	too	too	RB
46745	5290	9	long	long	RB
46745	5290	10	continued	continued	JJ
46745	5290	11	,	,	,
46745	5290	12	it	-PRON-	PRP
46745	5290	13	causes	cause	VBZ
46745	5290	14	a	a	DT
46745	5290	15	deterioration	deterioration	NN
46745	5290	16	of	of	IN
46745	5290	17	the	the	DT
46745	5290	18	blood	blood	NN
46745	5290	19	,	,	,
46745	5290	20	followed	follow	VBN
46745	5290	21	by	by	IN
46745	5290	22	an	an	DT
46745	5290	23	emaciation	emaciation	NN
46745	5290	24	of	of	IN
46745	5290	25	the	the	DT
46745	5290	26	whole	whole	JJ
46745	5290	27	frame	frame	NN
46745	5290	28	.	.	.
46745	5291	1	So	so	RB
46745	5291	2	vigorously	vigorously	RB
46745	5291	3	was	be	VBD
46745	5291	4	this	this	DT
46745	5291	5	medicine	medicine	NN
46745	5291	6	used	use	VBN
46745	5291	7	by	by	IN
46745	5291	8	the	the	DT
46745	5291	9	Swiss	swiss	JJ
46745	5291	10	practitioners	practitioner	NNS
46745	5291	11	after	after	IN
46745	5291	12	its	-PRON-	PRP$
46745	5291	13	first	first	JJ
46745	5291	14	discovery	discovery	NN
46745	5291	15	,	,	,
46745	5291	16	that	that	IN
46745	5291	17	serious	serious	JJ
46745	5291	18	consequences	consequence	NNS
46745	5291	19	,	,	,
46745	5291	20	as	as	IN
46745	5291	21	the	the	DT
46745	5291	22	absorption	absorption	NN
46745	5291	23	of	of	IN
46745	5291	24	the	the	DT
46745	5291	25	mammæ	mammæ	NN
46745	5291	26	or	or	CC
46745	5291	27	the	the	DT
46745	5291	28	testes	testis	NNS
46745	5291	29	of	of	IN
46745	5291	30	healthy	healthy	JJ
46745	5291	31	individuals	individual	NNS
46745	5291	32	,	,	,
46745	5291	33	are	be	VBP
46745	5291	34	said	say	VBN
46745	5291	35	to	to	TO
46745	5291	36	have	have	VB
46745	5291	37	ensued	ensue	VBN
46745	5291	38	in	in	IN
46745	5291	39	several	several	JJ
46745	5291	40	cases	case	NNS
46745	5291	41	.	.	.
46745	5292	1	By	by	IN
46745	5292	2	these	these	DT
46745	5292	3	mishaps	mishap	NNS
46745	5292	4	their	-PRON-	PRP$
46745	5292	5	faith	faith	NN
46745	5292	6	in	in	IN
46745	5292	7	its	-PRON-	PRP$
46745	5292	8	utility	utility	NN
46745	5292	9	was	be	VBD
46745	5292	10	much	much	RB
46745	5292	11	shaken	shake	VBN
46745	5292	12	.	.	.
46745	5293	1	But	but	CC
46745	5293	2	M.	M.	NNP
46745	5293	3	Magendie	Magendie	NNP
46745	5293	4	states	state	VBZ
46745	5293	5	that	that	IN
46745	5293	6	he	-PRON-	PRP
46745	5293	7	has	have	VBZ
46745	5293	8	never	never	RB
46745	5293	9	known	know	VBN
46745	5293	10	such	such	PDT
46745	5293	11	a	a	DT
46745	5293	12	thing	thing	NN
46745	5293	13	to	to	TO
46745	5293	14	occur	occur	VB
46745	5293	15	;	;	:
46745	5293	16	and	and	CC
46745	5293	17	M.	M.	NNP
46745	5293	18	Lugol	Lugol	NNP
46745	5293	19	,	,	,
46745	5293	20	the	the	DT
46745	5293	21	most	most	RBS
46745	5293	22	devoted	devoted	JJ
46745	5293	23	and	and	CC
46745	5293	24	enthusiastic	enthusiastic	JJ
46745	5293	25	of	of	IN
46745	5293	26	all	all	PDT
46745	5293	27	the	the	DT
46745	5293	28	advocates	advocate	NNS
46745	5293	29	of	of	IN
46745	5293	30	Iodine	Iodine	NNP
46745	5293	31	,	,	,
46745	5293	32	has	have	VBZ
46745	5293	33	observed	observe	VBN
46745	5293	34	that	that	IN
46745	5293	35	scrofulous	scrofulous	JJ
46745	5293	36	patients	patient	NNS
46745	5293	37	frequently	frequently	RB
46745	5293	38	become	become	VBP
46745	5293	39	fattened	fatten	VBN
46745	5293	40	during	during	IN
46745	5293	41	its	-PRON-	PRP$
46745	5293	42	employment	employment	NN
46745	5293	43	.	.	.
46745	5294	1	The	the	DT
46745	5294	2	therapeutic	therapeutic	JJ
46745	5294	3	actions	action	NNS
46745	5294	4	of	of	IN
46745	5294	5	Iodine	Iodine	NNP
46745	5294	6	have	have	VBP
46745	5294	7	been	be	VBN
46745	5294	8	ascribed	ascribe	VBN
46745	5294	9	by	by	IN
46745	5294	10	Dr.	Dr.	NNP
46745	5295	1	Billing	bill	VBG
46745	5295	2	to	to	IN
46745	5295	3	a	a	DT
46745	5295	4	contraction	contraction	NN
46745	5295	5	of	of	IN
46745	5295	6	the	the	DT
46745	5295	7	capillary	capillary	JJ
46745	5295	8	vessels	vessel	NNS
46745	5295	9	;	;	:
46745	5295	10	by	by	IN
46745	5295	11	Dr.	Dr.	NNP
46745	5295	12	Pereira	Pereira	NNP
46745	5295	13	,	,	,
46745	5295	14	to	to	IN
46745	5295	15	a	a	DT
46745	5295	16	liquefaction	liquefaction	NN
46745	5295	17	of	of	IN
46745	5295	18	the	the	DT
46745	5295	19	blood	blood	NN
46745	5295	20	;	;	:
46745	5295	21	by	by	IN
46745	5295	22	others	other	NNS
46745	5295	23	,	,	,
46745	5295	24	to	to	IN
46745	5295	25	a	a	DT
46745	5295	26	direct	direct	JJ
46745	5295	27	stimulation	stimulation	NN
46745	5295	28	of	of	IN
46745	5295	29	the	the	DT
46745	5295	30	absorbent	absorbent	JJ
46745	5295	31	system	system	NN
46745	5295	32	.	.	.
46745	5296	1	It	-PRON-	PRP
46745	5296	2	probably	probably	RB
46745	5296	3	counteracts	counteract	VBZ
46745	5296	4	morbid	morbid	VBP
46745	5296	5	operations	operation	NNS
46745	5296	6	in	in	IN
46745	5296	7	some	some	DT
46745	5296	8	way	way	NN
46745	5296	9	that	that	WDT
46745	5296	10	we	-PRON-	PRP
46745	5296	11	do	do	VBP
46745	5296	12	not	not	RB
46745	5296	13	understand	understand	VB
46745	5296	14	.	.	.
46745	5297	1	It	-PRON-	PRP
46745	5297	2	is	be	VBZ
46745	5297	3	one	one	CD
46745	5297	4	of	of	IN
46745	5297	5	those	those	DT
46745	5297	6	medicines	medicine	NNS
46745	5297	7	which	which	WDT
46745	5297	8	tend	tend	VBP
46745	5297	9	to	to	TO
46745	5297	10	increase	increase	VB
46745	5297	11	secretion	secretion	NN
46745	5297	12	in	in	IN
46745	5297	13	general	general	JJ
46745	5297	14	.	.	.
46745	5298	1	It	-PRON-	PRP
46745	5298	2	appears	appear	VBZ
46745	5298	3	to	to	TO
46745	5298	4	act	act	VB
46745	5298	5	most	most	JJS
46745	5298	6	upon	upon	IN
46745	5298	7	the	the	DT
46745	5298	8	urine	urine	NN
46745	5298	9	,	,	,
46745	5298	10	but	but	CC
46745	5298	11	is	be	VBZ
46745	5298	12	not	not	RB
46745	5298	13	a	a	DT
46745	5298	14	powerful	powerful	JJ
46745	5298	15	Eliminative	eliminative	NN
46745	5298	16	.	.	.
46745	5299	1	It	-PRON-	PRP
46745	5299	2	has	have	VBZ
46745	5299	3	been	be	VBN
46745	5299	4	chemically	chemically	RB
46745	5299	5	discovered	discover	VBN
46745	5299	6	in	in	IN
46745	5299	7	the	the	DT
46745	5299	8	blood	blood	NN
46745	5299	9	,	,	,
46745	5299	10	urine	urine	NN
46745	5299	11	,	,	,
46745	5299	12	and	and	CC
46745	5299	13	sweat	sweat	NN
46745	5299	14	;	;	:
46745	5299	15	as	as	RB
46745	5299	16	also	also	RB
46745	5299	17	in	in	IN
46745	5299	18	the	the	DT
46745	5299	19	saliva	saliva	NN
46745	5299	20	,	,	,
46745	5299	21	tears	tear	NNS
46745	5299	22	,	,	,
46745	5299	23	and	and	CC
46745	5299	24	nasal	nasal	NNP
46745	5299	25	mucus	mucus	NNP
46745	5299	26	,	,	,
46745	5299	27	which	which	WDT
46745	5299	28	secretions	secretion	NNS
46745	5299	29	are	be	VBP
46745	5299	30	apt	apt	JJ
46745	5299	31	to	to	TO
46745	5299	32	be	be	VB
46745	5299	33	increased	increase	VBN
46745	5299	34	in	in	IN
46745	5299	35	quantity	quantity	NN
46745	5299	36	during	during	IN
46745	5299	37	its	-PRON-	PRP$
46745	5299	38	action	action	NN
46745	5299	39	.	.	.
46745	5300	1	The	the	DT
46745	5300	2	Iodide	Iodide	NNP
46745	5300	3	of	of	IN
46745	5300	4	Potassium	Potassium	NNP
46745	5300	5	should	should	MD
46745	5300	6	be	be	VB
46745	5300	7	cautiously	cautiously	RB
46745	5300	8	administered	administer	VBN
46745	5300	9	to	to	IN
46745	5300	10	excitable	excitable	JJ
46745	5300	11	patients	patient	NNS
46745	5300	12	,	,	,
46745	5300	13	as	as	IN
46745	5300	14	it	-PRON-	PRP
46745	5300	15	sometimes	sometimes	RB
46745	5300	16	acts	act	VBZ
46745	5300	17	as	as	IN
46745	5300	18	an	an	DT
46745	5300	19	irritant	irritant	NN
46745	5300	20	.	.	.
46745	5301	1	When	when	WRB
46745	5301	2	the	the	DT
46745	5301	3	stomach	stomach	NN
46745	5301	4	is	be	VBZ
46745	5301	5	irritable	irritable	JJ
46745	5301	6	,	,	,
46745	5301	7	it	-PRON-	PRP
46745	5301	8	should	should	MD
46745	5301	9	be	be	VB
46745	5301	10	given	give	VBN
46745	5301	11	after	after	IN
46745	5301	12	meals	meal	NNS
46745	5301	13	,	,	,
46745	5301	14	and	and	CC
46745	5301	15	the	the	DT
46745	5301	16	dose	dose	NN
46745	5301	17	considerably	considerably	RB
46745	5301	18	diluted	dilute	VBN
46745	5301	19	with	with	IN
46745	5301	20	water	water	NN
46745	5301	21	.	.	.
46745	5302	1	A	a	DT
46745	5302	2	bronchocele	bronchocele	NNP
46745	5302	3	,	,	,
46745	5302	4	to	to	TO
46745	5302	5	be	be	VB
46745	5302	6	benefited	benefit	VBN
46745	5302	7	by	by	IN
46745	5302	8	Iodine	Iodine	NNP
46745	5302	9	,	,	,
46745	5302	10	should	should	MD
46745	5302	11	consist	consist	VB
46745	5302	12	of	of	IN
46745	5302	13	a	a	DT
46745	5302	14	simple	simple	JJ
46745	5302	15	enlargement	enlargement	NN
46745	5302	16	of	of	IN
46745	5302	17	the	the	DT
46745	5302	18	gland	gland	NN
46745	5302	19	,	,	,
46745	5302	20	not	not	RB
46745	5302	21	of	of	IN
46745	5302	22	very	very	RB
46745	5302	23	long	long	JJ
46745	5302	24	standing	standing	NN
46745	5302	25	,	,	,
46745	5302	26	nor	nor	CC
46745	5302	27	painful	painful	JJ
46745	5302	28	to	to	IN
46745	5302	29	the	the	DT
46745	5302	30	touch	touch	NN
46745	5302	31	.	.	.
46745	5303	1	All	all	DT
46745	5303	2	scrofulous	scrofulous	JJ
46745	5303	3	affections	affection	NNS
46745	5303	4	,	,	,
46745	5303	5	whether	whether	IN
46745	5303	6	of	of	IN
46745	5303	7	the	the	DT
46745	5303	8	glands	gland	NNS
46745	5303	9	,	,	,
46745	5303	10	joints	joint	NNS
46745	5303	11	,	,	,
46745	5303	12	liver	liver	NN
46745	5303	13	,	,	,
46745	5303	14	or	or	CC
46745	5303	15	other	other	JJ
46745	5303	16	parts	part	NNS
46745	5303	17	,	,	,
46745	5303	18	are	be	VBP
46745	5303	19	more	more	RBR
46745	5303	20	or	or	CC
46745	5303	21	less	less	RBR
46745	5303	22	benefited	benefit	VBN
46745	5303	23	by	by	IN
46745	5303	24	the	the	DT
46745	5303	25	use	use	NN
46745	5303	26	of	of	IN
46745	5303	27	Iodine	Iodine	NNP
46745	5303	28	.	.	.
46745	5304	1	Iodine	Iodine	NNP
46745	5304	2	has	have	VBZ
46745	5304	3	been	be	VBN
46745	5304	4	used	use	VBN
46745	5304	5	in	in	IN
46745	5304	6	simple	simple	JJ
46745	5304	7	enlargement	enlargement	NN
46745	5304	8	and	and	CC
46745	5304	9	induration	induration	NN
46745	5304	10	of	of	IN
46745	5304	11	various	various	JJ
46745	5304	12	organs	organ	NNS
46745	5304	13	,	,	,
46745	5304	14	particularly	particularly	RB
46745	5304	15	the	the	DT
46745	5304	16	uterus	uterus	NN
46745	5304	17	.	.	.
46745	5305	1	Dr.	Dr.	NNP
46745	5305	2	A.	A.	NNP
46745	5305	3	T.	T.	NNP
46745	5305	4	Thomson	Thomson	NNP
46745	5305	5	speaks	speak	VBZ
46745	5305	6	highly	highly	RB
46745	5305	7	of	of	IN
46745	5305	8	its	-PRON-	PRP$
46745	5305	9	efficacy	efficacy	NN
46745	5305	10	in	in	IN
46745	5305	11	ovarian	ovarian	NNP
46745	5305	12	dropsy	dropsy	NNP
46745	5305	13	.	.	.
46745	5306	1	It	-PRON-	PRP
46745	5306	2	is	be	VBZ
46745	5306	3	probable	probable	JJ
46745	5306	4	that	that	IN
46745	5306	5	Chlorine	Chlorine	NNP
46745	5306	6	,	,	,
46745	5306	7	Bromine	Bromine	NNP
46745	5306	8	,	,	,
46745	5306	9	and	and	CC
46745	5306	10	their	-PRON-	PRP$
46745	5306	11	compounds	compound	NNS
46745	5306	12	,	,	,
46745	5306	13	closely	closely	RB
46745	5306	14	resemble	resemble	VB
46745	5306	15	the	the	DT
46745	5306	16	preparations	preparation	NNS
46745	5306	17	of	of	IN
46745	5306	18	Iodine	Iodine	NNP
46745	5306	19	in	in	IN
46745	5306	20	their	-PRON-	PRP$
46745	5306	21	therapeutic	therapeutic	JJ
46745	5306	22	operations	operation	NNS
46745	5306	23	.	.	.
46745	5307	1	(	(	-LRB-
46745	5307	2	_	_	NNP
46745	5307	3	Vide	Vide	NNP
46745	5307	4	_	_	NNP
46745	5307	5	pp	pp	NNP
46745	5307	6	.	.	.
46745	5308	1	169	169	CD
46745	5308	2	,	,	,
46745	5308	3	188	188	CD
46745	5308	4	,	,	,
46745	5308	5	191	191	CD
46745	5308	6	,	,	,
46745	5308	7	306	306	CD
46745	5308	8	.	.	.
46745	5308	9	)	)	-RRB-
46745	5309	1	COLCHICUM	COLCHICUM	NNP
46745	5309	2	.	.	.
46745	5310	1	Class	class	NN
46745	5310	2	I.	I.	NNP
46745	5310	3	Div	Div	NNP
46745	5310	4	.	.	.
46745	5311	1	II	ii	CD
46745	5311	2	.	.	.
46745	5312	1	Ord	Ord	NNP
46745	5312	2	IV	IV	NNP
46745	5312	3	.	.	.
46745	5313	1	ANTIARTHRITICA	ANTIARTHRITICA	NNP
46745	5313	2	.	.	.
46745	5314	1	Class	class	NN
46745	5314	2	II	II	NNP
46745	5314	3	.	.	.
46745	5315	1	Div	Div	NNP
46745	5315	2	.	.	.
46745	5316	1	III	iii	CD
46745	5316	2	.	.	.
46745	5317	1	Ord	Ord	NNP
46745	5317	2	.	.	.
46745	5318	1	I.	I.	NNP
46745	5318	2	SEDANTIA	SEDANTIA	NNP
46745	5318	3	GENERALIA	GENERALIA	NNP
46745	5318	4	.	.	.
46745	5319	1	Class	Class	NNP
46745	5319	2	IV	IV	NNP
46745	5319	3	.	.	.
46745	5320	1	Ord	Ord	NNP
46745	5320	2	.	.	.
46745	5321	1	III	iii	CD
46745	5321	2	.	.	.
46745	5322	1	CATHARTICA	CATHARTICA	NNP
46745	5322	2	.	.	.
46745	5323	1	The	the	DT
46745	5323	2	majority	majority	NN
46745	5323	3	of	of	IN
46745	5323	4	medicines	medicine	NNS
46745	5323	5	that	that	WDT
46745	5323	6	affect	affect	VBP
46745	5323	7	the	the	DT
46745	5323	8	blood	blood	NN
46745	5323	9	permanently	permanently	RB
46745	5323	10	belong	belong	VBP
46745	5323	11	to	to	IN
46745	5323	12	the	the	DT
46745	5323	13	mineral	mineral	NN
46745	5323	14	kingdom	kingdom	NN
46745	5323	15	,	,	,
46745	5323	16	while	while	IN
46745	5323	17	most	most	JJS
46745	5323	18	of	of	IN
46745	5323	19	those	those	DT
46745	5323	20	that	that	WDT
46745	5323	21	powerfully	powerfully	RB
46745	5323	22	impress	impress	VBP
46745	5323	23	the	the	DT
46745	5323	24	nerves	nerve	NNS
46745	5323	25	are	be	VBP
46745	5323	26	derived	derive	VBN
46745	5323	27	from	from	IN
46745	5323	28	vegetables	vegetable	NNS
46745	5323	29	.	.	.
46745	5324	1	But	but	CC
46745	5324	2	to	to	IN
46745	5324	3	the	the	DT
46745	5324	4	rule	rule	NN
46745	5324	5	that	that	IN
46745	5324	6	Hæmatic	hæmatic	JJ
46745	5324	7	medicines	medicine	NNS
46745	5324	8	are	be	VBP
46745	5324	9	of	of	IN
46745	5324	10	mineral	mineral	NN
46745	5324	11	origin	origin	NN
46745	5324	12	,	,	,
46745	5324	13	we	-PRON-	PRP
46745	5324	14	have	have	VBP
46745	5324	15	already	already	RB
46745	5324	16	found	find	VBN
46745	5324	17	one	one	CD
46745	5324	18	important	important	JJ
46745	5324	19	exception	exception	NN
46745	5324	20	in	in	IN
46745	5324	21	the	the	DT
46745	5324	22	case	case	NN
46745	5324	23	of	of	IN
46745	5324	24	Quinine	Quinine	NNP
46745	5324	25	and	and	CC
46745	5324	26	Tonics	Tonics	NNP
46745	5324	27	.	.	.
46745	5325	1	Colchicum	Colchicum	NNP
46745	5325	2	appears	appear	VBZ
46745	5325	3	to	to	TO
46745	5325	4	be	be	VB
46745	5325	5	another	another	DT
46745	5325	6	instance	instance	NN
46745	5325	7	of	of	IN
46745	5325	8	the	the	DT
46745	5325	9	kind	kind	NN
46745	5325	10	.	.	.
46745	5326	1	The	the	DT
46745	5326	2	great	great	JJ
46745	5326	3	and	and	CC
46745	5326	4	obvious	obvious	JJ
46745	5326	5	use	use	NN
46745	5326	6	of	of	IN
46745	5326	7	this	this	DT
46745	5326	8	remedy	remedy	NN
46745	5326	9	is	be	VBZ
46745	5326	10	that	that	IN
46745	5326	11	action	action	NN
46745	5326	12	in	in	IN
46745	5326	13	the	the	DT
46745	5326	14	blood	blood	NN
46745	5326	15	which	which	WDT
46745	5326	16	above	above	RB
46745	5326	17	is	be	VBZ
46745	5326	18	classed	class	VBN
46745	5326	19	first	first	RB
46745	5326	20	,	,	,
46745	5326	21	i.e.	i.e.	FW
46745	5327	1	its	-PRON-	PRP$
46745	5327	2	influence	influence	NN
46745	5327	3	in	in	IN
46745	5327	4	the	the	DT
46745	5327	5	counteraction	counteraction	NN
46745	5327	6	of	of	IN
46745	5327	7	gouty	gouty	JJ
46745	5327	8	disorders	disorder	NNS
46745	5327	9	.	.	.
46745	5328	1	We	-PRON-	PRP
46745	5328	2	have	have	VBP
46745	5328	3	already	already	RB
46745	5328	4	considered	consider	VBN
46745	5328	5	at	at	IN
46745	5328	6	some	some	DT
46745	5328	7	length	length	NN
46745	5328	8	(	(	-LRB-
46745	5328	9	p.	p.	NN
46745	5328	10	200	200	CD
46745	5328	11	)	)	-RRB-
46745	5328	12	a	a	DT
46745	5328	13	number	number	NN
46745	5328	14	of	of	IN
46745	5328	15	Antiarthritic	antiarthritic	JJ
46745	5328	16	medicines	medicine	NNS
46745	5328	17	that	that	WDT
46745	5328	18	seem	seem	VBP
46745	5328	19	to	to	TO
46745	5328	20	act	act	VB
46745	5328	21	in	in	IN
46745	5328	22	a	a	DT
46745	5328	23	chemical	chemical	NN
46745	5328	24	manner	manner	NN
46745	5328	25	.	.	.
46745	5329	1	Colchicum	Colchicum	NNP
46745	5329	2	is	be	VBZ
46745	5329	3	not	not	RB
46745	5329	4	one	one	CD
46745	5329	5	of	of	IN
46745	5329	6	these	these	DT
46745	5329	7	.	.	.
46745	5330	1	It	-PRON-	PRP
46745	5330	2	is	be	VBZ
46745	5330	3	a	a	DT
46745	5330	4	General	General	NNP
46745	5330	5	Sedative	Sedative	NNP
46745	5330	6	,	,	,
46745	5330	7	and	and	CC
46745	5330	8	a	a	DT
46745	5330	9	Cathartic	cathartic	JJ
46745	5330	10	;	;	:
46745	5330	11	in	in	IN
46745	5330	12	large	large	JJ
46745	5330	13	doses	dose	NNS
46745	5330	14	,	,	,
46745	5330	15	an	an	DT
46745	5330	16	irritant	irritant	JJ
46745	5330	17	poison	poison	NN
46745	5330	18	.	.	.
46745	5331	1	It	-PRON-	PRP
46745	5331	2	seems	seem	VBZ
46745	5331	3	also	also	RB
46745	5331	4	to	to	TO
46745	5331	5	increase	increase	VB
46745	5331	6	the	the	DT
46745	5331	7	amount	amount	NN
46745	5331	8	of	of	IN
46745	5331	9	other	other	JJ
46745	5331	10	secretions	secretion	NNS
46745	5331	11	,	,	,
46745	5331	12	particularly	particularly	RB
46745	5331	13	the	the	DT
46745	5331	14	urine	urine	NN
46745	5331	15	and	and	CC
46745	5331	16	the	the	DT
46745	5331	17	bile	bile	NN
46745	5331	18	.	.	.
46745	5332	1	But	but	CC
46745	5332	2	it	-PRON-	PRP
46745	5332	3	is	be	VBZ
46745	5332	4	used	use	VBN
46745	5332	5	beneficially	beneficially	RB
46745	5332	6	in	in	IN
46745	5332	7	Gout	Gout	NNP
46745	5332	8	;	;	:
46745	5332	9	and	and	CC
46745	5332	10	it	-PRON-	PRP
46745	5332	11	is	be	VBZ
46745	5332	12	assumed	assume	VBN
46745	5332	13	that	that	IN
46745	5332	14	in	in	IN
46745	5332	15	the	the	DT
46745	5332	16	cure	cure	NN
46745	5332	17	of	of	IN
46745	5332	18	this	this	DT
46745	5332	19	disorder	disorder	NN
46745	5332	20	it	-PRON-	PRP
46745	5332	21	exerts	exert	VBZ
46745	5332	22	an	an	DT
46745	5332	23	action	action	NN
46745	5332	24	in	in	IN
46745	5332	25	the	the	DT
46745	5332	26	blood	blood	NN
46745	5332	27	,	,	,
46745	5332	28	inasmuch	inasmuch	JJ
46745	5332	29	as	as	IN
46745	5332	30	its	-PRON-	PRP$
46745	5332	31	remedial	remedial	JJ
46745	5332	32	operation	operation	NN
46745	5332	33	appears	appear	VBZ
46745	5332	34	to	to	TO
46745	5332	35	be	be	VB
46745	5332	36	independent	independent	JJ
46745	5332	37	of	of	IN
46745	5332	38	its	-PRON-	PRP$
46745	5332	39	nervous	nervous	JJ
46745	5332	40	and	and	CC
46745	5332	41	glandular	glandular	JJ
46745	5332	42	actions	action	NNS
46745	5332	43	.	.	.
46745	5333	1	This	this	DT
46745	5333	2	hæmatic	hæmatic	JJ
46745	5333	3	action	action	NN
46745	5333	4	must	must	MD
46745	5333	5	be	be	VB
46745	5333	6	of	of	IN
46745	5333	7	the	the	DT
46745	5333	8	Catalytic	catalytic	JJ
46745	5333	9	kind	kind	NN
46745	5333	10	,	,	,
46745	5333	11	and	and	CC
46745	5333	12	may	may	MD
46745	5333	13	probably	probably	RB
46745	5333	14	consist	consist	VB
46745	5333	15	in	in	IN
46745	5333	16	the	the	DT
46745	5333	17	exertion	exertion	NN
46745	5333	18	of	of	IN
46745	5333	19	a	a	DT
46745	5333	20	special	special	JJ
46745	5333	21	influence	influence	NN
46745	5333	22	over	over	IN
46745	5333	23	the	the	DT
46745	5333	24	erring	err	VBG
46745	5333	25	assimilative	assimilative	NN
46745	5333	26	processes	process	NNS
46745	5333	27	,	,	,
46745	5333	28	which	which	WDT
46745	5333	29	tends	tend	VBZ
46745	5333	30	to	to	TO
46745	5333	31	resolve	resolve	VB
46745	5333	32	them	-PRON-	PRP
46745	5333	33	into	into	IN
46745	5333	34	a	a	DT
46745	5333	35	right	right	JJ
46745	5333	36	direction	direction	NN
46745	5333	37	.	.	.
46745	5334	1	But	but	CC
46745	5334	2	it	-PRON-	PRP
46745	5334	3	should	should	MD
46745	5334	4	be	be	VB
46745	5334	5	observed	observe	VBN
46745	5334	6	that	that	IN
46745	5334	7	at	at	RB
46745	5334	8	least	least	RBS
46745	5334	9	three	three	CD
46745	5334	10	other	other	JJ
46745	5334	11	explanations	explanation	NNS
46745	5334	12	of	of	IN
46745	5334	13	the	the	DT
46745	5334	14	action	action	NN
46745	5334	15	of	of	IN
46745	5334	16	this	this	DT
46745	5334	17	remedy	remedy	NN
46745	5334	18	have	have	VBP
46745	5334	19	been	be	VBN
46745	5334	20	proposed	propose	VBN
46745	5334	21	,	,	,
46745	5334	22	each	each	DT
46745	5334	23	of	of	IN
46745	5334	24	which	which	WDT
46745	5334	25	is	be	VBZ
46745	5334	26	possessed	possess	VBN
46745	5334	27	of	of	IN
46745	5334	28	a	a	DT
46745	5334	29	degree	degree	NN
46745	5334	30	of	of	IN
46745	5334	31	plausibility	plausibility	NN
46745	5334	32	.	.	.
46745	5335	1	Some	some	DT
46745	5335	2	have	have	VBP
46745	5335	3	ascribed	ascribe	VBN
46745	5335	4	its	-PRON-	PRP$
46745	5335	5	efficacy	efficacy	NN
46745	5335	6	to	to	IN
46745	5335	7	the	the	DT
46745	5335	8	union	union	NN
46745	5335	9	of	of	IN
46745	5335	10	a	a	DT
46745	5335	11	cathartic	cathartic	NN
46745	5335	12	with	with	IN
46745	5335	13	a	a	DT
46745	5335	14	sedative	sedative	JJ
46745	5335	15	effect	effect	NN
46745	5335	16	,	,	,
46745	5335	17	and	and	CC
46745	5335	18	have	have	VBP
46745	5335	19	even	even	RB
46745	5335	20	substituted	substitute	VBN
46745	5335	21	for	for	IN
46745	5335	22	it	-PRON-	PRP
46745	5335	23	a	a	DT
46745	5335	24	combination	combination	NN
46745	5335	25	of	of	IN
46745	5335	26	Opium	Opium	NNP
46745	5335	27	with	with	IN
46745	5335	28	a	a	DT
46745	5335	29	drastic	drastic	JJ
46745	5335	30	purgative	purgative	NN
46745	5335	31	.	.	.
46745	5336	1	Those	those	DT
46745	5336	2	who	who	WP
46745	5336	3	adopt	adopt	VBP
46745	5336	4	this	this	DT
46745	5336	5	view	view	NN
46745	5336	6	of	of	IN
46745	5336	7	its	-PRON-	PRP$
46745	5336	8	action	action	NN
46745	5336	9	aver	aver	VBD
46745	5336	10	that	that	IN
46745	5336	11	Colchicum	Colchicum	NNP
46745	5336	12	acts	act	VBZ
46745	5336	13	best	best	RB
46745	5336	14	when	when	WRB
46745	5336	15	it	-PRON-	PRP
46745	5336	16	purges	purge	VBZ
46745	5336	17	freely	freely	RB
46745	5336	18	.	.	.
46745	5337	1	But	but	CC
46745	5337	2	though	though	IN
46745	5337	3	Purgatives	purgative	NNS
46745	5337	4	are	be	VBP
46745	5337	5	often	often	RB
46745	5337	6	of	of	IN
46745	5337	7	use	use	NN
46745	5337	8	in	in	IN
46745	5337	9	gouty	gouty	JJ
46745	5337	10	disorders	disorder	NNS
46745	5337	11	,	,	,
46745	5337	12	it	-PRON-	PRP
46745	5337	13	is	be	VBZ
46745	5337	14	generally	generally	RB
46745	5337	15	found	find	VBN
46745	5337	16	that	that	IN
46745	5337	17	Colchicum	Colchicum	NNP
46745	5337	18	operates	operate	VBZ
46745	5337	19	most	most	RBS
46745	5337	20	favourably	favourably	RB
46745	5337	21	when	when	WRB
46745	5337	22	given	give	VBN
46745	5337	23	in	in	RB
46745	5337	24	too	too	RB
46745	5337	25	small	small	JJ
46745	5337	26	a	a	DT
46745	5337	27	dose	dose	NN
46745	5337	28	to	to	TO
46745	5337	29	produce	produce	VB
46745	5337	30	any	any	DT
46745	5337	31	purging	purging	NN
46745	5337	32	.	.	.
46745	5338	1	Colchicum	Colchicum	NNP
46745	5338	2	stimulates	stimulate	VBZ
46745	5338	3	the	the	DT
46745	5338	4	function	function	NN
46745	5338	5	of	of	IN
46745	5338	6	the	the	DT
46745	5338	7	liver	liver	NN
46745	5338	8	,	,	,
46745	5338	9	which	which	WDT
46745	5338	10	is	be	VBZ
46745	5338	11	generally	generally	RB
46745	5338	12	deranged	derange	VBN
46745	5338	13	in	in	IN
46745	5338	14	gouty	gouty	JJ
46745	5338	15	disorders	disorder	NNS
46745	5338	16	.	.	.
46745	5339	1	Mercury	Mercury	NNP
46745	5339	2	,	,	,
46745	5339	3	which	which	WDT
46745	5339	4	also	also	RB
46745	5339	5	promotes	promote	VBZ
46745	5339	6	the	the	DT
46745	5339	7	secretion	secretion	NN
46745	5339	8	of	of	IN
46745	5339	9	bile	bile	NN
46745	5339	10	,	,	,
46745	5339	11	is	be	VBZ
46745	5339	12	in	in	IN
46745	5339	13	this	this	DT
46745	5339	14	way	way	NN
46745	5339	15	useful	useful	JJ
46745	5339	16	in	in	IN
46745	5339	17	Gout	Gout	NNP
46745	5339	18	.	.	.
46745	5340	1	It	-PRON-	PRP
46745	5340	2	seems	seem	VBZ
46745	5340	3	that	that	IN
46745	5340	4	the	the	DT
46745	5340	5	formation	formation	NN
46745	5340	6	of	of	IN
46745	5340	7	this	this	DT
46745	5340	8	secretion	secretion	NN
46745	5340	9	is	be	VBZ
46745	5340	10	in	in	IN
46745	5340	11	some	some	DT
46745	5340	12	manner	manner	NN
46745	5340	13	essential	essential	JJ
46745	5340	14	to	to	IN
46745	5340	15	the	the	DT
46745	5340	16	integrity	integrity	NN
46745	5340	17	of	of	IN
46745	5340	18	those	those	DT
46745	5340	19	blood	blood	NN
46745	5340	20	-	-	HYPH
46745	5340	21	processes	process	NNS
46745	5340	22	which	which	WDT
46745	5340	23	are	be	VBP
46745	5340	24	disturbed	disturb	VBN
46745	5340	25	in	in	IN
46745	5340	26	arthritic	arthritic	JJ
46745	5340	27	diseases	disease	NNS
46745	5340	28	.	.	.
46745	5341	1	It	-PRON-	PRP
46745	5341	2	might	may	MD
46745	5341	3	therefore	therefore	RB
46745	5341	4	be	be	VB
46745	5341	5	supposed	suppose	VBN
46745	5341	6	that	that	IN
46745	5341	7	Colchicum	Colchicum	NNP
46745	5341	8	too	too	RB
46745	5341	9	acted	act	VBD
46745	5341	10	as	as	IN
46745	5341	11	a	a	DT
46745	5341	12	Cholagogue	Cholagogue	NNP
46745	5341	13	.	.	.
46745	5342	1	But	but	CC
46745	5342	2	it	-PRON-	PRP
46745	5342	3	is	be	VBZ
46745	5342	4	not	not	RB
46745	5342	5	clear	clear	JJ
46745	5342	6	that	that	IN
46745	5342	7	it	-PRON-	PRP
46745	5342	8	increases	increase	VBZ
46745	5342	9	the	the	DT
46745	5342	10	secretion	secretion	NN
46745	5342	11	of	of	IN
46745	5342	12	the	the	DT
46745	5342	13	bile	bile	NN
46745	5342	14	in	in	IN
46745	5342	15	any	any	DT
46745	5342	16	very	very	RB
46745	5342	17	marked	mark	VBN
46745	5342	18	degree	degree	NN
46745	5342	19	.	.	.
46745	5343	1	Thirdly	thirdly	RB
46745	5343	2	,	,	,
46745	5343	3	it	-PRON-	PRP
46745	5343	4	is	be	VBZ
46745	5343	5	affirmed	affirm	VBN
46745	5343	6	by	by	IN
46745	5343	7	some	some	DT
46745	5343	8	that	that	IN
46745	5343	9	this	this	DT
46745	5343	10	medicine	medicine	NN
46745	5343	11	is	be	VBZ
46745	5343	12	of	of	IN
46745	5343	13	use	use	NN
46745	5343	14	in	in	IN
46745	5343	15	eliminating	eliminate	VBG
46745	5343	16	uric	uric	JJ
46745	5343	17	acid	acid	NN
46745	5343	18	from	from	IN
46745	5343	19	the	the	DT
46745	5343	20	blood	blood	NN
46745	5343	21	,	,	,
46745	5343	22	this	this	DT
46745	5343	23	product	product	NN
46745	5343	24	being	be	VBG
46745	5343	25	supposed	suppose	VBN
46745	5343	26	to	to	TO
46745	5343	27	accumulate	accumulate	VB
46745	5343	28	in	in	IN
46745	5343	29	the	the	DT
46745	5343	30	system	system	NN
46745	5343	31	before	before	IN
46745	5343	32	the	the	DT
46745	5343	33	paroxysm	paroxysm	NNS
46745	5343	34	of	of	IN
46745	5343	35	Gout	Gout	NNP
46745	5343	36	.	.	.
46745	5344	1	It	-PRON-	PRP
46745	5344	2	is	be	VBZ
46745	5344	3	said	say	VBN
46745	5344	4	that	that	IN
46745	5344	5	under	under	IN
46745	5344	6	the	the	DT
46745	5344	7	action	action	NN
46745	5344	8	of	of	IN
46745	5344	9	Colchicum	Colchicum	NNP
46745	5344	10	the	the	DT
46745	5344	11	natural	natural	JJ
46745	5344	12	amount	amount	NN
46745	5344	13	of	of	IN
46745	5344	14	this	this	DT
46745	5344	15	substance	substance	NN
46745	5344	16	in	in	IN
46745	5344	17	the	the	DT
46745	5344	18	urine	urine	NN
46745	5344	19	is	be	VBZ
46745	5344	20	much	much	RB
46745	5344	21	increased	increase	VBN
46745	5344	22	.	.	.
46745	5345	1	This	this	DT
46745	5345	2	would	would	MD
46745	5345	3	be	be	VB
46745	5345	4	an	an	DT
46745	5345	5	important	important	JJ
46745	5345	6	fact	fact	NN
46745	5345	7	if	if	IN
46745	5345	8	it	-PRON-	PRP
46745	5345	9	were	be	VBD
46745	5345	10	certainly	certainly	RB
46745	5345	11	proved	prove	VBN
46745	5345	12	.	.	.
46745	5346	1	But	but	CC
46745	5346	2	it	-PRON-	PRP
46745	5346	3	does	do	VBZ
46745	5346	4	not	not	RB
46745	5346	5	seem	seem	VB
46745	5346	6	to	to	TO
46745	5346	7	be	be	VB
46745	5346	8	so	so	RB
46745	5346	9	;	;	:
46745	5346	10	nor	nor	CC
46745	5346	11	is	be	VBZ
46745	5346	12	it	-PRON-	PRP
46745	5346	13	clearly	clearly	RB
46745	5346	14	shown	show	VBN
46745	5346	15	that	that	IN
46745	5346	16	the	the	DT
46745	5346	17	observed	observed	JJ
46745	5346	18	increase	increase	NN
46745	5346	19	in	in	IN
46745	5346	20	uric	uric	JJ
46745	5346	21	acid	acid	NN
46745	5346	22	is	be	VBZ
46745	5346	23	not	not	RB
46745	5346	24	a	a	DT
46745	5346	25	symptom	symptom	NN
46745	5346	26	of	of	IN
46745	5346	27	the	the	DT
46745	5346	28	disorder	disorder	NN
46745	5346	29	,	,	,
46745	5346	30	rather	rather	RB
46745	5346	31	than	than	IN
46745	5346	32	of	of	IN
46745	5346	33	the	the	DT
46745	5346	34	treatment	treatment	NN
46745	5346	35	.	.	.
46745	5347	1	Colchicum	Colchicum	NNP
46745	5347	2	is	be	VBZ
46745	5347	3	more	more	RBR
46745	5347	4	or	or	CC
46745	5347	5	less	less	RBR
46745	5347	6	applicable	applicable	JJ
46745	5347	7	in	in	IN
46745	5347	8	the	the	DT
46745	5347	9	gouty	gouty	JJ
46745	5347	10	forms	form	NNS
46745	5347	11	of	of	IN
46745	5347	12	Rheumatism	Rheumatism	NNP
46745	5347	13	,	,	,
46745	5347	14	in	in	IN
46745	5347	15	Lithiasis	Lithiasis	NNP
46745	5347	16	,	,	,
46745	5347	17	and	and	CC
46745	5347	18	in	in	IN
46745	5347	19	acid	acid	JJ
46745	5347	20	dyspepsia	dyspepsia	NNP
46745	5347	21	,	,	,
46745	5347	22	but	but	CC
46745	5347	23	it	-PRON-	PRP
46745	5347	24	is	be	VBZ
46745	5347	25	most	most	RBS
46745	5347	26	efficient	efficient	JJ
46745	5347	27	in	in	IN
46745	5347	28	the	the	DT
46745	5347	29	simple	simple	JJ
46745	5347	30	gouty	gouty	JJ
46745	5347	31	paroxysm	paroxysm	NNS
46745	5347	32	.	.	.
46745	5348	1	There	there	EX
46745	5348	2	are	be	VBP
46745	5348	3	several	several	JJ
46745	5348	4	objections	objection	NNS
46745	5348	5	to	to	IN
46745	5348	6	the	the	DT
46745	5348	7	indiscriminate	indiscriminate	JJ
46745	5348	8	use	use	NN
46745	5348	9	of	of	IN
46745	5348	10	this	this	DT
46745	5348	11	remedy	remedy	NN
46745	5348	12	.	.	.
46745	5349	1	Some	some	DT
46745	5349	2	have	have	VBP
46745	5349	3	observed	observe	VBN
46745	5349	4	that	that	DT
46745	5349	5	though	though	IN
46745	5349	6	it	-PRON-	PRP
46745	5349	7	cures	cure	VBZ
46745	5349	8	for	for	IN
46745	5349	9	a	a	DT
46745	5349	10	time	time	NN
46745	5349	11	the	the	DT
46745	5349	12	gouty	gouty	JJ
46745	5349	13	attack	attack	NN
46745	5349	14	,	,	,
46745	5349	15	it	-PRON-	PRP
46745	5349	16	causes	cause	VBZ
46745	5349	17	the	the	DT
46745	5349	18	next	next	JJ
46745	5349	19	assault	assault	NN
46745	5349	20	of	of	IN
46745	5349	21	the	the	DT
46745	5349	22	disease	disease	NN
46745	5349	23	to	to	TO
46745	5349	24	recur	recur	VB
46745	5349	25	more	more	RBR
46745	5349	26	quickly	quickly	RB
46745	5349	27	than	than	IN
46745	5349	28	it	-PRON-	PRP
46745	5349	29	would	would	MD
46745	5349	30	otherwise	otherwise	RB
46745	5349	31	have	have	VB
46745	5349	32	done	do	VBN
46745	5349	33	.	.	.
46745	5350	1	The	the	DT
46745	5350	2	dose	dose	NN
46745	5350	3	also	also	RB
46745	5350	4	certainly	certainly	RB
46745	5350	5	requires	require	VBZ
46745	5350	6	to	to	TO
46745	5350	7	be	be	VB
46745	5350	8	considerably	considerably	RB
46745	5350	9	increased	increase	VBN
46745	5350	10	on	on	IN
46745	5350	11	each	each	DT
46745	5350	12	successive	successive	JJ
46745	5350	13	occasion	occasion	NN
46745	5350	14	.	.	.
46745	5351	1	Sometimes	sometimes	RB
46745	5351	2	this	this	DT
46745	5351	3	medicine	medicine	NN
46745	5351	4	produces	produce	VBZ
46745	5351	5	a	a	DT
46745	5351	6	great	great	JJ
46745	5351	7	depression	depression	NN
46745	5351	8	of	of	IN
46745	5351	9	the	the	DT
46745	5351	10	spirits	spirit	NNS
46745	5351	11	.	.	.
46745	5352	1	Dr.	Dr.	NNP
46745	5352	2	Todd	Todd	NNP
46745	5352	3	believes	believe	VBZ
46745	5352	4	that	that	IN
46745	5352	5	Colchicum	Colchicum	NNP
46745	5352	6	has	have	VBZ
46745	5352	7	often	often	RB
46745	5352	8	a	a	DT
46745	5352	9	tendency	tendency	NN
46745	5352	10	to	to	TO
46745	5352	11	change	change	VB
46745	5352	12	the	the	DT
46745	5352	13	common	common	JJ
46745	5352	14	acute	acute	JJ
46745	5352	15	form	form	NN
46745	5352	16	of	of	IN
46745	5352	17	Gout	Gout	NNP
46745	5352	18	into	into	IN
46745	5352	19	an	an	DT
46745	5352	20	asthenic	asthenic	JJ
46745	5352	21	form	form	NN
46745	5352	22	which	which	WDT
46745	5352	23	is	be	VBZ
46745	5352	24	less	less	RBR
46745	5352	25	amenable	amenable	JJ
46745	5352	26	to	to	IN
46745	5352	27	treatment	treatment	NN
46745	5352	28	.	.	.
46745	5353	1	So	so	RB
46745	5353	2	that	that	IN
46745	5353	3	,	,	,
46745	5353	4	altogether	altogether	RB
46745	5353	5	,	,	,
46745	5353	6	it	-PRON-	PRP
46745	5353	7	is	be	VBZ
46745	5353	8	perhaps	perhaps	RB
46745	5353	9	a	a	DT
46745	5353	10	good	good	JJ
46745	5353	11	rule	rule	NN
46745	5353	12	to	to	TO
46745	5353	13	treat	treat	VB
46745	5353	14	the	the	DT
46745	5353	15	patient	patient	NN
46745	5353	16	without	without	IN
46745	5353	17	Colchicum	Colchicum	NNP
46745	5353	18	as	as	RB
46745	5353	19	long	long	RB
46745	5353	20	as	as	IN
46745	5353	21	it	-PRON-	PRP
46745	5353	22	can	can	MD
46745	5353	23	be	be	VB
46745	5353	24	done	do	VBN
46745	5353	25	with	with	IN
46745	5353	26	safety	safety	NN
46745	5353	27	,	,	,
46745	5353	28	adopting	adopt	VBG
46745	5353	29	this	this	DT
46745	5353	30	medicine	medicine	NN
46745	5353	31	only	only	RB
46745	5353	32	as	as	IN
46745	5353	33	a	a	DT
46745	5353	34	last	last	JJ
46745	5353	35	resource	resource	NN
46745	5353	36	,	,	,
46745	5353	37	when	when	WRB
46745	5353	38	other	other	JJ
46745	5353	39	remedies	remedy	NNS
46745	5353	40	have	have	VBP
46745	5353	41	been	be	VBN
46745	5353	42	tried	try	VBN
46745	5353	43	and	and	CC
46745	5353	44	failed	fail	VBN
46745	5353	45	.	.	.
46745	5354	1	It	-PRON-	PRP
46745	5354	2	ought	ought	MD
46745	5354	3	rarely	rarely	RB
46745	5354	4	to	to	TO
46745	5354	5	be	be	VB
46745	5354	6	used	use	VBN
46745	5354	7	in	in	IN
46745	5354	8	Rheumatism	Rheumatism	NNP
46745	5354	9	.	.	.
46745	5355	1	In	in	IN
46745	5355	2	the	the	DT
46745	5355	3	asthenic	asthenic	JJ
46745	5355	4	form	form	NN
46745	5355	5	of	of	IN
46745	5355	6	Gout	Gout	NNP
46745	5355	7	,	,	,
46745	5355	8	or	or	CC
46745	5355	9	in	in	IN
46745	5355	10	old	old	JJ
46745	5355	11	chronic	chronic	JJ
46745	5355	12	cases	case	NNS
46745	5355	13	,	,	,
46745	5355	14	when	when	WRB
46745	5355	15	there	there	EX
46745	5355	16	are	be	VBP
46745	5355	17	chalk	chalk	JJ
46745	5355	18	-	-	HYPH
46745	5355	19	stones	stone	NNS
46745	5355	20	on	on	IN
46745	5355	21	the	the	DT
46745	5355	22	knuckles	knuckle	NNS
46745	5355	23	,	,	,
46745	5355	24	Quinine	Quinine	NNP
46745	5355	25	,	,	,
46745	5355	26	Stimulants	Stimulants	NNP
46745	5355	27	,	,	,
46745	5355	28	and	and	CC
46745	5355	29	Purgatives	Purgatives	NNP
46745	5355	30	,	,	,
46745	5355	31	constitute	constitute	VBP
46745	5355	32	the	the	DT
46745	5355	33	best	good	JJS
46745	5355	34	treatment	treatment	NN
46745	5355	35	.	.	.
46745	5356	1	Alkalies	alkali	NNS
46745	5356	2	and	and	CC
46745	5356	3	Mercurials	Mercurials	NNPS
46745	5356	4	may	may	MD
46745	5356	5	prove	prove	VB
46745	5356	6	serviceable	serviceable	JJ
46745	5356	7	in	in	IN
46745	5356	8	acute	acute	JJ
46745	5356	9	cases	case	NNS
46745	5356	10	.	.	.
46745	5357	1	But	but	CC
46745	5357	2	it	-PRON-	PRP
46745	5357	3	is	be	VBZ
46745	5357	4	certain	certain	JJ
46745	5357	5	that	that	IN
46745	5357	6	in	in	IN
46745	5357	7	many	many	JJ
46745	5357	8	cases	case	NNS
46745	5357	9	of	of	IN
46745	5357	10	this	this	DT
46745	5357	11	painful	painful	JJ
46745	5357	12	disorder	disorder	NN
46745	5357	13	Colchicum	Colchicum	NNP
46745	5357	14	gives	give	VBZ
46745	5357	15	immense	immense	JJ
46745	5357	16	relief	relief	NN
46745	5357	17	;	;	:
46745	5357	18	and	and	CC
46745	5357	19	it	-PRON-	PRP
46745	5357	20	often	often	RB
46745	5357	21	seems	seem	VBZ
46745	5357	22	to	to	TO
46745	5357	23	be	be	VB
46745	5357	24	the	the	DT
46745	5357	25	only	only	JJ
46745	5357	26	medicine	medicine	NN
46745	5357	27	that	that	WDT
46745	5357	28	is	be	VBZ
46745	5357	29	capable	capable	JJ
46745	5357	30	of	of	IN
46745	5357	31	doing	do	VBG
46745	5357	32	so	so	RB
46745	5357	33	.	.	.
46745	5358	1	(	(	-LRB-
46745	5358	2	_	_	NNP
46745	5358	3	Vide	Vide	NNP
46745	5358	4	_	_	NNP
46745	5358	5	pp	pp	NNP
46745	5358	6	.	.	.
46745	5359	1	194	194	CD
46745	5359	2	,	,	,
46745	5359	3	247	247	CD
46745	5359	4	.	.	.
46745	5359	5	)	)	-RRB-
46745	5360	1	ARSENIC	ARSENIC	NNP
46745	5360	2	.	.	.
46745	5361	1	Class	class	NN
46745	5361	2	I.	I.	NNP
46745	5361	3	Div	Div	NNP
46745	5361	4	.	.	.
46745	5362	1	II	ii	CD
46745	5362	2	.	.	.
46745	5363	1	Ord	Ord	NNP
46745	5363	2	.	.	.
46745	5364	1	VI	VI	NNP
46745	5364	2	.	.	.
46745	5365	1	ANTIPHRIODICA	ANTIPHRIODICA	NNP
46745	5365	2	.	.	.
46745	5366	1	Class	class	NN
46745	5366	2	I.	I.	NNP
46745	5366	3	Div	Div	NNP
46745	5366	4	.	.	.
46745	5367	1	II	ii	CD
46745	5367	2	.	.	.
46745	5368	1	Ord	Ord	NNP
46745	5368	2	.	.	.
46745	5369	1	VII	VII	NNP
46745	5369	2	.	.	.
46745	5370	1	ANTICONVULSIVA	ANTICONVULSIVA	NNP
46745	5370	2	.	.	.
46745	5371	1	Class	class	NN
46745	5371	2	I.	I.	NNP
46745	5371	3	Div	Div	NNP
46745	5371	4	.	.	.
46745	5372	1	II	ii	CD
46745	5372	2	.	.	.
46745	5373	1	Ord	Ord	NNP
46745	5373	2	.	.	.
46745	5374	1	VIII	VIII	NNP
46745	5374	2	.	.	.
46745	5375	1	ANTISQUAMOSA	ANTISQUAMOSA	NNP
46745	5375	2	.	.	.
46745	5376	1	This	this	DT
46745	5376	2	medicine	medicine	NN
46745	5376	3	has	have	VBZ
46745	5376	4	already	already	RB
46745	5376	5	been	be	VBN
46745	5376	6	noticed	notice	VBN
46745	5376	7	at	at	IN
46745	5376	8	considerable	considerable	JJ
46745	5376	9	length	length	NN
46745	5376	10	in	in	IN
46745	5376	11	the	the	DT
46745	5376	12	account	account	NN
46745	5376	13	of	of	IN
46745	5376	14	the	the	DT
46745	5376	15	last	last	JJ
46745	5376	16	three	three	CD
46745	5376	17	orders	order	NNS
46745	5376	18	of	of	IN
46745	5376	19	Catalytic	catalytic	JJ
46745	5376	20	medicines	medicine	NNS
46745	5376	21	.	.	.
46745	5377	1	It	-PRON-	PRP
46745	5377	2	is	be	VBZ
46745	5377	3	again	again	RB
46745	5377	4	noticed	notice	VBN
46745	5377	5	here	here	RB
46745	5377	6	as	as	IN
46745	5377	7	one	one	CD
46745	5377	8	of	of	IN
46745	5377	9	the	the	DT
46745	5377	10	most	most	RBS
46745	5377	11	remarkable	remarkable	JJ
46745	5377	12	of	of	IN
46745	5377	13	those	those	DT
46745	5377	14	mineral	mineral	NN
46745	5377	15	substances	substance	NNS
46745	5377	16	that	that	WDT
46745	5377	17	are	be	VBP
46745	5377	18	used	use	VBN
46745	5377	19	to	to	TO
46745	5377	20	counteract	counteract	VB
46745	5377	21	blood	blood	NN
46745	5377	22	-	-	HYPH
46745	5377	23	disorders	disorder	NNS
46745	5377	24	.	.	.
46745	5378	1	It	-PRON-	PRP
46745	5378	2	appears	appear	VBZ
46745	5378	3	to	to	TO
46745	5378	4	be	be	VB
46745	5378	5	capable	capable	JJ
46745	5378	6	of	of	IN
46745	5378	7	exerting	exert	VBG
46745	5378	8	no	no	DT
46745	5378	9	less	less	JJR
46745	5378	10	than	than	IN
46745	5378	11	three	three	CD
46745	5378	12	kinds	kind	NNS
46745	5378	13	of	of	IN
46745	5378	14	action	action	NN
46745	5378	15	in	in	IN
46745	5378	16	the	the	DT
46745	5378	17	blood	blood	NN
46745	5378	18	,	,	,
46745	5378	19	which	which	WDT
46745	5378	20	operations	operation	NNS
46745	5378	21	result	result	VBP
46745	5378	22	in	in	IN
46745	5378	23	the	the	DT
46745	5378	24	counteraction	counteraction	NN
46745	5378	25	of	of	IN
46745	5378	26	Periodic	periodic	JJ
46745	5378	27	disorders	disorder	NNS
46745	5378	28	,	,	,
46745	5378	29	Convulsive	Convulsive	NNP
46745	5378	30	diseases	disease	NNS
46745	5378	31	,	,	,
46745	5378	32	and	and	CC
46745	5378	33	certain	certain	JJ
46745	5378	34	Cutaneous	cutaneous	JJ
46745	5378	35	eruptions	eruption	NNS
46745	5378	36	.	.	.
46745	5379	1	That	that	DT
46745	5379	2	must	must	MD
46745	5379	3	of	of	IN
46745	5379	4	necessity	necessity	NN
46745	5379	5	be	be	VB
46745	5379	6	a	a	DT
46745	5379	7	various	various	JJ
46745	5379	8	and	and	CC
46745	5379	9	obscure	obscure	JJ
46745	5379	10	agency	agency	NN
46745	5379	11	,	,	,
46745	5379	12	which	which	WDT
46745	5379	13	is	be	VBZ
46745	5379	14	gifted	gift	VBN
46745	5379	15	with	with	IN
46745	5379	16	the	the	DT
46745	5379	17	power	power	NN
46745	5379	18	of	of	IN
46745	5379	19	arresting	arrest	VBG
46745	5379	20	and	and	CC
46745	5379	21	controlling	control	VBG
46745	5379	22	so	so	RB
46745	5379	23	great	great	JJ
46745	5379	24	a	a	DT
46745	5379	25	variety	variety	NN
46745	5379	26	of	of	IN
46745	5379	27	morbid	morbid	NN
46745	5379	28	actions	action	NNS
46745	5379	29	.	.	.
46745	5380	1	It	-PRON-	PRP
46745	5380	2	would	would	MD
46745	5380	3	seem	seem	VB
46745	5380	4	that	that	IN
46745	5380	5	Ague	Ague	NNP
46745	5380	6	and	and	CC
46745	5380	7	its	-PRON-	PRP$
46745	5380	8	kindred	kindred	JJ
46745	5380	9	disorders	disorder	NNS
46745	5380	10	are	be	VBP
46745	5380	11	capable	capable	JJ
46745	5380	12	of	of	IN
46745	5380	13	being	be	VBG
46745	5380	14	combated	combat	VBN
46745	5380	15	and	and	CC
46745	5380	16	cured	cure	VBN
46745	5380	17	in	in	IN
46745	5380	18	two	two	CD
46745	5380	19	different	different	JJ
46745	5380	20	ways	way	NNS
46745	5380	21	;	;	:
46745	5380	22	by	by	IN
46745	5380	23	Restoratives	restorative	NNS
46745	5380	24	,	,	,
46745	5380	25	such	such	JJ
46745	5380	26	as	as	IN
46745	5380	27	Quina	Quina	NNP
46745	5380	28	,	,	,
46745	5380	29	which	which	WDT
46745	5380	30	appear	appear	VBP
46745	5380	31	to	to	TO
46745	5380	32	supply	supply	VB
46745	5380	33	the	the	DT
46745	5380	34	blood	blood	NN
46745	5380	35	with	with	IN
46745	5380	36	a	a	DT
46745	5380	37	certain	certain	JJ
46745	5380	38	needful	needful	JJ
46745	5380	39	material	material	NN
46745	5380	40	;	;	:
46745	5380	41	or	or	CC
46745	5380	42	by	by	IN
46745	5380	43	Catalytics	Catalytics	NNP
46745	5380	44	,	,	,
46745	5380	45	as	as	IN
46745	5380	46	Arsenious	arsenious	JJ
46745	5380	47	acid	acid	NN
46745	5380	48	,	,	,
46745	5380	49	which	which	WDT
46745	5380	50	operate	operate	VBP
46745	5380	51	by	by	IN
46745	5380	52	antagonizing	antagonize	VBG
46745	5380	53	a	a	DT
46745	5380	54	morbid	morbid	NN
46745	5380	55	action	action	NN
46745	5380	56	,	,	,
46745	5380	57	which	which	WDT
46745	5380	58	is	be	VBZ
46745	5380	59	either	either	CC
46745	5380	60	the	the	DT
46745	5380	61	cause	cause	NN
46745	5380	62	or	or	CC
46745	5380	63	the	the	DT
46745	5380	64	result	result	NN
46745	5380	65	of	of	IN
46745	5380	66	the	the	DT
46745	5380	67	blood	blood	NN
46745	5380	68	-	-	HYPH
46745	5380	69	disease	disease	NN
46745	5380	70	.	.	.
46745	5381	1	I	-PRON-	PRP
46745	5381	2	have	have	VBP
46745	5381	3	given	give	VBN
46745	5381	4	my	-PRON-	PRP$
46745	5381	5	reasons	reason	NNS
46745	5381	6	for	for	IN
46745	5381	7	ranking	rank	VBG
46745	5381	8	Quina	Quina	NNP
46745	5381	9	and	and	CC
46745	5381	10	Tonics	Tonics	NNP
46745	5381	11	among	among	IN
46745	5381	12	Restorative	Restorative	NNP
46745	5381	13	medicines	medicine	NNS
46745	5381	14	.	.	.
46745	5382	1	The	the	DT
46745	5382	2	following	follow	VBG
46745	5382	3	are	be	VBP
46745	5382	4	the	the	DT
46745	5382	5	principal	principal	JJ
46745	5382	6	grounds	ground	NNS
46745	5382	7	for	for	IN
46745	5382	8	which	which	WDT
46745	5382	9	Arsenic	Arsenic	NNP
46745	5382	10	is	be	VBZ
46745	5382	11	included	include	VBN
46745	5382	12	among	among	IN
46745	5382	13	Catalytics	Catalytics	NNP
46745	5382	14	.	.	.
46745	5383	1	It	-PRON-	PRP
46745	5383	2	is	be	VBZ
46745	5383	3	unnatural	unnatural	JJ
46745	5383	4	to	to	IN
46745	5383	5	the	the	DT
46745	5383	6	blood	blood	NN
46745	5383	7	,	,	,
46745	5383	8	and	and	CC
46745	5383	9	is	be	VBZ
46745	5383	10	at	at	IN
46745	5383	11	length	length	NN
46745	5383	12	excreted	excrete	VBN
46745	5383	13	from	from	IN
46745	5383	14	the	the	DT
46745	5383	15	system	system	NN
46745	5383	16	.	.	.
46745	5384	1	It	-PRON-	PRP
46745	5384	2	acts	act	VBZ
46745	5384	3	as	as	IN
46745	5384	4	a	a	DT
46745	5384	5	poison	poison	NN
46745	5384	6	;	;	,
46745	5384	7	and	and	CC
46745	5384	8	is	be	VBZ
46745	5384	9	able	able	JJ
46745	5384	10	to	to	TO
46745	5384	11	work	work	VB
46745	5384	12	out	out	RP
46745	5384	13	in	in	IN
46745	5384	14	the	the	DT
46745	5384	15	blood	blood	NN
46745	5384	16	a	a	DT
46745	5384	17	certain	certain	JJ
46745	5384	18	process	process	NN
46745	5384	19	of	of	IN
46745	5384	20	its	-PRON-	PRP$
46745	5384	21	own	own	JJ
46745	5384	22	.	.	.
46745	5385	1	It	-PRON-	PRP
46745	5385	2	has	have	VBZ
46745	5385	3	no	no	DT
46745	5385	4	sudden	sudden	JJ
46745	5385	5	action	action	NN
46745	5385	6	on	on	IN
46745	5385	7	the	the	DT
46745	5385	8	nervous	nervous	JJ
46745	5385	9	system	system	NN
46745	5385	10	,	,	,
46745	5385	11	like	like	IN
46745	5385	12	that	that	DT
46745	5385	13	which	which	WDT
46745	5385	14	is	be	VBZ
46745	5385	15	possessed	possess	VBN
46745	5385	16	by	by	IN
46745	5385	17	Neurotic	neurotic	JJ
46745	5385	18	medicines	medicine	NNS
46745	5385	19	.	.	.
46745	5386	1	And	and	CC
46745	5386	2	it	-PRON-	PRP
46745	5386	3	is	be	VBZ
46745	5386	4	able	able	JJ
46745	5386	5	to	to	TO
46745	5386	6	counteract	counteract	VB
46745	5386	7	a	a	DT
46745	5386	8	number	number	NN
46745	5386	9	of	of	IN
46745	5386	10	disorders	disorder	NNS
46745	5386	11	,	,	,
46745	5386	12	as	as	IN
46745	5386	13	Lepra	Lepra	NNP
46745	5386	14	and	and	CC
46745	5386	15	Impetigo	Impetigo	NNP
46745	5386	16	,	,	,
46745	5386	17	which	which	WDT
46745	5386	18	are	be	VBP
46745	5386	19	assumed	assume	VBN
46745	5386	20	to	to	TO
46745	5386	21	depend	depend	VB
46745	5386	22	upon	upon	IN
46745	5386	23	morbid	morbid	NN
46745	5386	24	actions	action	NNS
46745	5386	25	in	in	IN
46745	5386	26	the	the	DT
46745	5386	27	blood	blood	NN
46745	5386	28	.	.	.
46745	5387	1	Arsenic	Arsenic	NNP
46745	5387	2	has	have	VBZ
46745	5387	3	been	be	VBN
46745	5387	4	recommended	recommend	VBN
46745	5387	5	in	in	IN
46745	5387	6	Syphilis	Syphilis	NNP
46745	5387	7	,	,	,
46745	5387	8	but	but	CC
46745	5387	9	it	-PRON-	PRP
46745	5387	10	exerts	exert	VBZ
46745	5387	11	no	no	DT
46745	5387	12	marked	marked	JJ
46745	5387	13	power	power	NN
46745	5387	14	over	over	IN
46745	5387	15	that	that	DT
46745	5387	16	disorder	disorder	NN
46745	5387	17	.	.	.
46745	5388	1	In	in	IN
46745	5388	2	ague	ague	NN
46745	5388	3	it	-PRON-	PRP
46745	5388	4	possesses	possess	VBZ
46745	5388	5	this	this	DT
46745	5388	6	advantage	advantage	NN
46745	5388	7	over	over	IN
46745	5388	8	Quina	Quina	NNP
46745	5388	9	,	,	,
46745	5388	10	that	that	IN
46745	5388	11	it	-PRON-	PRP
46745	5388	12	may	may	MD
46745	5388	13	be	be	VB
46745	5388	14	administered	administer	VBN
46745	5388	15	with	with	IN
46745	5388	16	safety	safety	NN
46745	5388	17	during	during	IN
46745	5388	18	the	the	DT
46745	5388	19	paroxysm	paroxysm	NNS
46745	5388	20	.	.	.
46745	5389	1	The	the	DT
46745	5389	2	ordinary	ordinary	JJ
46745	5389	3	precautions	precaution	NNS
46745	5389	4	in	in	IN
46745	5389	5	the	the	DT
46745	5389	6	administration	administration	NN
46745	5389	7	of	of	IN
46745	5389	8	the	the	DT
46745	5389	9	Arsenical	arsenical	JJ
46745	5389	10	solution	solution	NN
46745	5389	11	(	(	-LRB-
46745	5389	12	Liquor	Liquor	NNP
46745	5389	13	Potassæ	Potassæ	NNP
46745	5389	14	Arsenitis	Arsenitis	NNP
46745	5389	15	)	)	-RRB-
46745	5389	16	have	have	VBP
46745	5389	17	been	be	VBN
46745	5389	18	already	already	RB
46745	5389	19	enumerated	enumerate	VBN
46745	5389	20	,	,	,
46745	5389	21	viz	viz	NNP
46745	5389	22	.	.	NNP
46745	5389	23	,	,	,
46745	5389	24	that	that	IN
46745	5389	25	the	the	DT
46745	5389	26	dose	dose	NN
46745	5389	27	should	should	MD
46745	5389	28	be	be	VB
46745	5389	29	small	small	JJ
46745	5389	30	at	at	IN
46745	5389	31	first	first	RB
46745	5389	32	,	,	,
46745	5389	33	and	and	CC
46745	5389	34	afterwards	afterwards	RB
46745	5389	35	gradually	gradually	RB
46745	5389	36	increased	increase	VBD
46745	5389	37	;	;	:
46745	5389	38	that	that	IN
46745	5389	39	as	as	RB
46745	5389	40	soon	soon	RB
46745	5389	41	as	as	IN
46745	5389	42	it	-PRON-	PRP
46745	5389	43	produces	produce	VBZ
46745	5389	44	swelling	swell	VBG
46745	5389	45	of	of	IN
46745	5389	46	the	the	DT
46745	5389	47	face	face	NN
46745	5389	48	and	and	CC
46745	5389	49	eyelids	eyelid	NNS
46745	5389	50	,	,	,
46745	5389	51	or	or	CC
46745	5389	52	irritation	irritation	NN
46745	5389	53	of	of	IN
46745	5389	54	the	the	DT
46745	5389	55	stomach	stomach	NN
46745	5389	56	,	,	,
46745	5389	57	it	-PRON-	PRP
46745	5389	58	should	should	MD
46745	5389	59	be	be	VB
46745	5389	60	discontinued	discontinue	VBN
46745	5389	61	,	,	,
46745	5389	62	or	or	CC
46745	5389	63	the	the	DT
46745	5389	64	dose	dose	VBN
46745	5389	65	reduced	reduce	VBN
46745	5389	66	;	;	:
46745	5389	67	and	and	CC
46745	5389	68	that	that	IN
46745	5389	69	it	-PRON-	PRP
46745	5389	70	should	should	MD
46745	5389	71	generally	generally	RB
46745	5389	72	be	be	VB
46745	5389	73	given	give	VBN
46745	5389	74	on	on	IN
46745	5389	75	a	a	DT
46745	5389	76	full	full	JJ
46745	5389	77	stomach	stomach	NN
46745	5389	78	,	,	,
46745	5389	79	as	as	IN
46745	5389	80	it	-PRON-	PRP
46745	5389	81	is	be	VBZ
46745	5389	82	then	then	RB
46745	5389	83	less	less	RBR
46745	5389	84	likely	likely	JJ
46745	5389	85	to	to	TO
46745	5389	86	irritate	irritate	VB
46745	5389	87	.	.	.
46745	5390	1	(	(	-LRB-
46745	5390	2	_	_	NNP
46745	5390	3	Vide	Vide	NNP
46745	5390	4	_	_	NNP
46745	5390	5	pp	pp	NNP
46745	5390	6	.	.	.
46745	5391	1	140	140	CD
46745	5391	2	,	,	,
46745	5391	3	165	165	CD
46745	5391	4	,	,	,
46745	5391	5	170	170	CD
46745	5391	6	,	,	,
46745	5391	7	176	176	CD
46745	5391	8	,	,	,
46745	5391	9	207	207	CD
46745	5391	10	,	,	,
46745	5391	11	211	211	CD
46745	5391	12	,	,	,
46745	5391	13	213	213	CD
46745	5391	14	.	.	.
46745	5391	15	)	)	-RRB-
46745	5392	1	AMMONIA	AMMONIA	NNP
46745	5392	2	.	.	.
46745	5393	1	Class	class	NN
46745	5393	2	I.	I.	NNP
46745	5393	3	Div	Div	NNP
46745	5393	4	.	.	.
46745	5394	1	I.	I.	NNP
46745	5394	2	Ord	Ord	NNP
46745	5394	3	.	.	.
46745	5395	1	III	iii	CD
46745	5395	2	.	.	.
46745	5396	1	ALKALIA	ALKALIA	NNP
46745	5396	2	.	.	.
46745	5397	1	Class	class	NN
46745	5397	2	II	II	NNP
46745	5397	3	.	.	.
46745	5398	1	Div	Div	NNP
46745	5398	2	.	.	.
46745	5399	1	I.	I.	NNP
46745	5399	2	Ord	Ord	NNP
46745	5399	3	.	.	.
46745	5400	1	I.	I.	NNP
46745	5400	2	STIMULANTIA	STIMULANTIA	NNP
46745	5400	3	GENERALIA	GENERALIA	NNP
46745	5400	4	.	.	.
46745	5401	1	Class	Class	NNP
46745	5401	2	IV	IV	NNP
46745	5401	3	.	.	.
46745	5402	1	Ord	Ord	NNP
46745	5402	2	.	.	.
46745	5403	1	II	ii	CD
46745	5403	2	.	.	.
46745	5404	1	EXPECTORANTIA	EXPECTORANTIA	NNP
46745	5404	2	.	.	.
46745	5405	1	Class	Class	NNP
46745	5405	2	IV	IV	NNP
46745	5405	3	.	.	.
46745	5406	1	Ord	Ord	NNP
46745	5406	2	.	.	.
46745	5407	1	V.	V.	NNP
46745	5407	2	DIAPHORETICA	DIAPHORETICA	NNP
46745	5407	3	.	.	.
46745	5408	1	This	this	DT
46745	5408	2	medicine	medicine	NN
46745	5408	3	may	may	MD
46745	5408	4	be	be	VB
46745	5408	5	taken	take	VBN
46745	5408	6	as	as	IN
46745	5408	7	the	the	DT
46745	5408	8	type	type	NN
46745	5408	9	of	of	IN
46745	5408	10	simple	simple	JJ
46745	5408	11	General	General	NNP
46745	5408	12	Stimulants	Stimulants	NNP
46745	5408	13	.	.	.
46745	5409	1	It	-PRON-	PRP
46745	5409	2	tends	tend	VBZ
46745	5409	3	to	to	TO
46745	5409	4	excite	excite	VB
46745	5409	5	the	the	DT
46745	5409	6	nervous	nervous	JJ
46745	5409	7	forces	force	NNS
46745	5409	8	generally	generally	RB
46745	5409	9	.	.	.
46745	5410	1	The	the	DT
46745	5410	2	remedies	remedy	NNS
46745	5410	3	of	of	IN
46745	5410	4	this	this	DT
46745	5410	5	group	group	NN
46745	5410	6	are	be	VBP
46745	5410	7	not	not	RB
46745	5410	8	very	very	RB
46745	5410	9	potent	potent	JJ
46745	5410	10	in	in	IN
46745	5410	11	their	-PRON-	PRP$
46745	5410	12	action	action	NN
46745	5410	13	,	,	,
46745	5410	14	Ammonia	Ammonia	NNP
46745	5410	15	being	be	VBG
46745	5410	16	perhaps	perhaps	RB
46745	5410	17	as	as	RB
46745	5410	18	powerful	powerful	JJ
46745	5410	19	as	as	IN
46745	5410	20	any	any	DT
46745	5410	21	of	of	IN
46745	5410	22	them	-PRON-	PRP
46745	5410	23	.	.	.
46745	5411	1	Alcohol	Alcohol	NNP
46745	5411	2	,	,	,
46745	5411	3	an	an	DT
46745	5411	4	Inebriant	Inebriant	NNP
46745	5411	5	Narcotic	Narcotic	NNP
46745	5411	6	,	,	,
46745	5411	7	produces	produce	VBZ
46745	5411	8	at	at	IN
46745	5411	9	first	first	RB
46745	5411	10	a	a	DT
46745	5411	11	greater	great	JJR
46745	5411	12	stimulant	stimulant	NN
46745	5411	13	effect	effect	NN
46745	5411	14	,	,	,
46745	5411	15	but	but	CC
46745	5411	16	its	-PRON-	PRP$
46745	5411	17	action	action	NN
46745	5411	18	is	be	VBZ
46745	5411	19	followed	follow	VBN
46745	5411	20	up	up	RP
46745	5411	21	by	by	IN
46745	5411	22	a	a	DT
46745	5411	23	depression	depression	NN
46745	5411	24	of	of	IN
46745	5411	25	the	the	DT
46745	5411	26	nervous	nervous	JJ
46745	5411	27	forces	force	NNS
46745	5411	28	,	,	,
46745	5411	29	and	and	CC
46745	5411	30	an	an	DT
46745	5411	31	affection	affection	NN
46745	5411	32	of	of	IN
46745	5411	33	the	the	DT
46745	5411	34	powers	power	NNS
46745	5411	35	of	of	IN
46745	5411	36	the	the	DT
46745	5411	37	mind	mind	NN
46745	5411	38	.	.	.
46745	5412	1	This	this	DT
46745	5412	2	influence	influence	NN
46745	5412	3	over	over	IN
46745	5412	4	the	the	DT
46745	5412	5	intellectual	intellectual	JJ
46745	5412	6	functions	function	NNS
46745	5412	7	is	be	VBZ
46745	5412	8	confined	confine	VBN
46745	5412	9	to	to	IN
46745	5412	10	the	the	DT
46745	5412	11	Narcotic	narcotic	JJ
46745	5412	12	division	division	NN
46745	5412	13	of	of	IN
46745	5412	14	nerve	nerve	NN
46745	5412	15	-	-	HYPH
46745	5412	16	medicines	medicine	NNS
46745	5412	17	,	,	,
46745	5412	18	and	and	CC
46745	5412	19	is	be	VBZ
46745	5412	20	not	not	RB
46745	5412	21	possessed	possess	VBN
46745	5412	22	by	by	IN
46745	5412	23	Ammonia	Ammonia	NNP
46745	5412	24	.	.	.
46745	5413	1	Ammonia	Ammonia	NNP
46745	5413	2	is	be	VBZ
46745	5413	3	capable	capable	JJ
46745	5413	4	of	of	IN
46745	5413	5	acting	act	VBG
46745	5413	6	chemically	chemically	RB
46745	5413	7	as	as	IN
46745	5413	8	an	an	DT
46745	5413	9	alkali	alkali	NN
46745	5413	10	in	in	IN
46745	5413	11	the	the	DT
46745	5413	12	system	system	NN
46745	5413	13	,	,	,
46745	5413	14	and	and	CC
46745	5413	15	may	may	MD
46745	5413	16	be	be	VB
46745	5413	17	used	use	VBN
46745	5413	18	in	in	IN
46745	5413	19	the	the	DT
46745	5413	20	various	various	JJ
46745	5413	21	cases	case	NNS
46745	5413	22	in	in	IN
46745	5413	23	which	which	WDT
46745	5413	24	alkalies	alkali	NNS
46745	5413	25	are	be	VBP
46745	5413	26	wo	will	MD
46745	5413	27	nt	not	RB
46745	5413	28	to	to	TO
46745	5413	29	be	be	VB
46745	5413	30	employed	employ	VBN
46745	5413	31	;	;	:
46745	5413	32	but	but	CC
46745	5413	33	it	-PRON-	PRP
46745	5413	34	is	be	VBZ
46745	5413	35	inferior	inferior	JJ
46745	5413	36	to	to	IN
46745	5413	37	Potash	Potash	NNP
46745	5413	38	in	in	IN
46745	5413	39	such	such	JJ
46745	5413	40	disorders	disorder	NNS
46745	5413	41	,	,	,
46745	5413	42	because	because	IN
46745	5413	43	its	-PRON-	PRP$
46745	5413	44	affinities	affinity	NNS
46745	5413	45	are	be	VBP
46745	5413	46	far	far	RB
46745	5413	47	less	less	RBR
46745	5413	48	powerful	powerful	JJ
46745	5413	49	than	than	IN
46745	5413	50	those	those	DT
46745	5413	51	of	of	IN
46745	5413	52	that	that	DT
46745	5413	53	alkali	alkali	JJ
46745	5413	54	.	.	.
46745	5414	1	It	-PRON-	PRP
46745	5414	2	is	be	VBZ
46745	5414	3	also	also	RB
46745	5414	4	caustic	caustic	JJ
46745	5414	5	and	and	CC
46745	5414	6	irritant	irritant	JJ
46745	5414	7	when	when	WRB
46745	5414	8	applied	apply	VBN
46745	5414	9	externally	externally	RB
46745	5414	10	in	in	IN
46745	5414	11	any	any	DT
46745	5414	12	form	form	NN
46745	5414	13	.	.	.
46745	5415	1	Administered	administer	VBN
46745	5415	2	internally	internally	RB
46745	5415	3	in	in	IN
46745	5415	4	solution	solution	NN
46745	5415	5	,	,	,
46745	5415	6	it	-PRON-	PRP
46745	5415	7	has	have	VBZ
46745	5415	8	a	a	DT
46745	5415	9	power	power	NN
46745	5415	10	of	of	IN
46745	5415	11	quickening	quicken	VBG
46745	5415	12	the	the	DT
46745	5415	13	action	action	NN
46745	5415	14	of	of	IN
46745	5415	15	the	the	DT
46745	5415	16	heart	heart	NN
46745	5415	17	,	,	,
46745	5415	18	and	and	CC
46745	5415	19	exciting	excite	VBG
46745	5415	20	the	the	DT
46745	5415	21	circulation	circulation	NN
46745	5415	22	generally	generally	RB
46745	5415	23	.	.	.
46745	5416	1	It	-PRON-	PRP
46745	5416	2	is	be	VBZ
46745	5416	3	therefore	therefore	RB
46745	5416	4	particularly	particularly	RB
46745	5416	5	useful	useful	JJ
46745	5416	6	in	in	IN
46745	5416	7	the	the	DT
46745	5416	8	common	common	JJ
46745	5416	9	case	case	NN
46745	5416	10	of	of	IN
46745	5416	11	fainting	fainting	NN
46745	5416	12	,	,	,
46745	5416	13	or	or	CC
46745	5416	14	threatened	threaten	VBN
46745	5416	15	syncope	syncope	NN
46745	5416	16	.	.	.
46745	5417	1	This	this	DT
46745	5417	2	stimulant	stimulant	NN
46745	5417	3	power	power	NN
46745	5417	4	is	be	VBZ
46745	5417	5	possessed	possess	VBN
46745	5417	6	only	only	RB
46745	5417	7	by	by	IN
46745	5417	8	the	the	DT
46745	5417	9	free	free	JJ
46745	5417	10	alkali	alkali	NNP
46745	5417	11	and	and	CC
46745	5417	12	its	-PRON-	PRP$
46745	5417	13	carbonates	carbonate	NNS
46745	5417	14	.	.	.
46745	5418	1	And	and	CC
46745	5418	2	as	as	IN
46745	5418	3	the	the	DT
46745	5418	4	secretion	secretion	NN
46745	5418	5	of	of	IN
46745	5418	6	the	the	DT
46745	5418	7	stomach	stomach	NN
46745	5418	8	is	be	VBZ
46745	5418	9	acid	acid	NN
46745	5418	10	,	,	,
46745	5418	11	Dr.	Dr.	NNP
46745	5418	12	Pereira	Pereira	NNP
46745	5418	13	supposes	suppose	VBZ
46745	5418	14	that	that	IN
46745	5418	15	the	the	DT
46745	5418	16	free	free	JJ
46745	5418	17	or	or	CC
46745	5418	18	carbonated	carbonate	VBN
46745	5418	19	Ammonia	Ammonia	NNP
46745	5418	20	becomes	become	VBZ
46745	5418	21	neutralized	neutralize	VBN
46745	5418	22	before	before	IN
46745	5418	23	absorption	absorption	NN
46745	5418	24	;	;	:
46745	5418	25	that	that	IN
46745	5418	26	it	-PRON-	PRP
46745	5418	27	is	be	VBZ
46745	5418	28	therefore	therefore	RB
46745	5418	29	unable	unable	JJ
46745	5418	30	to	to	TO
46745	5418	31	act	act	VB
46745	5418	32	in	in	IN
46745	5418	33	the	the	DT
46745	5418	34	blood	blood	NN
46745	5418	35	except	except	IN
46745	5418	36	as	as	IN
46745	5418	37	a	a	DT
46745	5418	38	salt	salt	NN
46745	5418	39	,	,	,
46745	5418	40	and	and	CC
46745	5418	41	can	can	MD
46745	5418	42	only	only	RB
46745	5418	43	operate	operate	VB
46745	5418	44	as	as	IN
46745	5418	45	a	a	DT
46745	5418	46	Stimulant	Stimulant	NNP
46745	5418	47	while	while	IN
46745	5418	48	in	in	IN
46745	5418	49	contact	contact	NN
46745	5418	50	with	with	IN
46745	5418	51	the	the	DT
46745	5418	52	coat	coat	NN
46745	5418	53	of	of	IN
46745	5418	54	the	the	DT
46745	5418	55	stomach	stomach	NN
46745	5418	56	.	.	.
46745	5419	1	Its	-PRON-	PRP$
46745	5419	2	influence	influence	NN
46745	5419	3	must	must	MD
46745	5419	4	then	then	RB
46745	5419	5	be	be	VB
46745	5419	6	conducted	conduct	VBN
46745	5419	7	by	by	IN
46745	5419	8	the	the	DT
46745	5419	9	nerves	nerve	NNS
46745	5419	10	from	from	IN
46745	5419	11	the	the	DT
46745	5419	12	surface	surface	NN
46745	5419	13	of	of	IN
46745	5419	14	the	the	DT
46745	5419	15	stomach	stomach	NN
46745	5419	16	to	to	IN
46745	5419	17	the	the	DT
46745	5419	18	heart	heart	NN
46745	5419	19	.	.	.
46745	5420	1	But	but	CC
46745	5420	2	though	though	IN
46745	5420	3	the	the	DT
46745	5420	4	nerves	nerve	NNS
46745	5420	5	are	be	VBP
46745	5420	6	the	the	DT
46745	5420	7	natural	natural	JJ
46745	5420	8	channels	channel	NNS
46745	5420	9	of	of	IN
46745	5420	10	various	various	JJ
46745	5420	11	motor	motor	NN
46745	5420	12	and	and	CC
46745	5420	13	sensory	sensory	JJ
46745	5420	14	impressions	impression	NNS
46745	5420	15	,	,	,
46745	5420	16	it	-PRON-	PRP
46745	5420	17	is	be	VBZ
46745	5420	18	to	to	TO
46745	5420	19	assume	assume	VB
46745	5420	20	an	an	DT
46745	5420	21	unprecedented	unprecedented	JJ
46745	5420	22	thing	thing	NN
46745	5420	23	to	to	TO
46745	5420	24	suppose	suppose	VB
46745	5420	25	that	that	IN
46745	5420	26	a	a	DT
46745	5420	27	medicinal	medicinal	JJ
46745	5420	28	action	action	NN
46745	5420	29	can	can	MD
46745	5420	30	be	be	VB
46745	5420	31	transmitted	transmit	VBN
46745	5420	32	by	by	IN
46745	5420	33	their	-PRON-	PRP$
46745	5420	34	means	mean	NNS
46745	5420	35	to	to	IN
46745	5420	36	a	a	DT
46745	5420	37	distant	distant	JJ
46745	5420	38	part	part	NN
46745	5420	39	.	.	.
46745	5421	1	For	for	IN
46745	5421	2	this	this	DT
46745	5421	3	and	and	CC
46745	5421	4	for	for	IN
46745	5421	5	other	other	JJ
46745	5421	6	reasons	reason	NNS
46745	5421	7	it	-PRON-	PRP
46745	5421	8	seems	seem	VBZ
46745	5421	9	to	to	IN
46745	5421	10	me	-PRON-	PRP
46745	5421	11	to	to	TO
46745	5421	12	be	be	VB
46745	5421	13	most	most	RBS
46745	5421	14	likely	likely	JJ
46745	5421	15	that	that	IN
46745	5421	16	the	the	DT
46745	5421	17	solution	solution	NN
46745	5421	18	of	of	IN
46745	5421	19	Ammonia	Ammonia	NNP
46745	5421	20	is	be	VBZ
46745	5421	21	absorbed	absorb	VBN
46745	5421	22	too	too	RB
46745	5421	23	fast	fast	RB
46745	5421	24	in	in	IN
46745	5421	25	the	the	DT
46745	5421	26	stomach	stomach	NN
46745	5421	27	to	to	TO
46745	5421	28	be	be	VB
46745	5421	29	neutralized	neutralize	VBN
46745	5421	30	by	by	IN
46745	5421	31	the	the	DT
46745	5421	32	gastric	gastric	JJ
46745	5421	33	juice	juice	NN
46745	5421	34	.	.	.
46745	5422	1	Or	or	CC
46745	5422	2	even	even	RB
46745	5422	3	if	if	IN
46745	5422	4	it	-PRON-	PRP
46745	5422	5	were	be	VBD
46745	5422	6	neutralized	neutralize	VBN
46745	5422	7	before	before	IN
46745	5422	8	absorption	absorption	NN
46745	5422	9	,	,	,
46745	5422	10	it	-PRON-	PRP
46745	5422	11	would	would	MD
46745	5422	12	probably	probably	RB
46745	5422	13	be	be	VB
46745	5422	14	again	again	RB
46745	5422	15	set	set	VBN
46745	5422	16	free	free	JJ
46745	5422	17	on	on	IN
46745	5422	18	entrance	entrance	NN
46745	5422	19	into	into	IN
46745	5422	20	the	the	DT
46745	5422	21	blood	blood	NN
46745	5422	22	,	,	,
46745	5422	23	in	in	IN
46745	5422	24	which	which	WDT
46745	5422	25	there	there	EX
46745	5422	26	is	be	VBZ
46745	5422	27	a	a	DT
46745	5422	28	slight	slight	JJ
46745	5422	29	excess	excess	NN
46745	5422	30	of	of	IN
46745	5422	31	alkaline	alkaline	NN
46745	5422	32	matter	matter	NN
46745	5422	33	.	.	.
46745	5423	1	Thus	thus	RB
46745	5423	2	Ammonia	Ammonia	NNP
46745	5423	3	would	would	MD
46745	5423	4	exist	exist	VB
46745	5423	5	in	in	IN
46745	5423	6	the	the	DT
46745	5423	7	blood	blood	NN
46745	5423	8	in	in	IN
46745	5423	9	a	a	DT
46745	5423	10	free	free	JJ
46745	5423	11	state	state	NN
46745	5423	12	,	,	,
46745	5423	13	except	except	IN
46745	5423	14	in	in	IN
46745	5423	15	those	those	DT
46745	5423	16	morbid	morbid	NN
46745	5423	17	conditions	condition	NNS
46745	5423	18	in	in	IN
46745	5423	19	which	which	WDT
46745	5423	20	there	there	EX
46745	5423	21	is	be	VBZ
46745	5423	22	a	a	DT
46745	5423	23	general	general	JJ
46745	5423	24	excess	excess	NN
46745	5423	25	of	of	IN
46745	5423	26	acid	acid	NN
46745	5423	27	in	in	IN
46745	5423	28	the	the	DT
46745	5423	29	system	system	NN
46745	5423	30	.	.	.
46745	5424	1	I	-PRON-	PRP
46745	5424	2	suppose	suppose	VBP
46745	5424	3	the	the	DT
46745	5424	4	same	same	JJ
46745	5424	5	to	to	TO
46745	5424	6	be	be	VB
46745	5424	7	the	the	DT
46745	5424	8	case	case	NN
46745	5424	9	with	with	IN
46745	5424	10	Potash	Potash	NNP
46745	5424	11	,	,	,
46745	5424	12	when	when	WRB
46745	5424	13	it	-PRON-	PRP
46745	5424	14	is	be	VBZ
46745	5424	15	given	give	VBN
46745	5424	16	in	in	IN
46745	5424	17	any	any	DT
46745	5424	18	quantity	quantity	NN
46745	5424	19	.	.	.
46745	5425	1	The	the	DT
46745	5425	2	great	great	JJ
46745	5425	3	diffusibility	diffusibility	NN
46745	5425	4	of	of	IN
46745	5425	5	the	the	DT
46745	5425	6	free	free	JJ
46745	5425	7	Ammonia	Ammonia	NNP
46745	5425	8	would	would	MD
46745	5425	9	be	be	VB
46745	5425	10	an	an	DT
46745	5425	11	additional	additional	JJ
46745	5425	12	reason	reason	NN
46745	5425	13	for	for	IN
46745	5425	14	its	-PRON-	PRP$
46745	5425	15	rapid	rapid	JJ
46745	5425	16	absorption	absorption	NN
46745	5425	17	.	.	.
46745	5426	1	When	when	WRB
46745	5426	2	the	the	DT
46745	5426	3	gas	gas	NN
46745	5426	4	is	be	VBZ
46745	5426	5	inhaled	inhale	VBN
46745	5426	6	,	,	,
46745	5426	7	as	as	IN
46745	5426	8	in	in	IN
46745	5426	9	the	the	DT
46745	5426	10	use	use	NN
46745	5426	11	of	of	IN
46745	5426	12	smelling	smelling	NN
46745	5426	13	-	-	HYPH
46745	5426	14	salts	salt	NNS
46745	5426	15	,	,	,
46745	5426	16	and	and	CC
46745	5426	17	applied	apply	VBD
46745	5426	18	thus	thus	RB
46745	5426	19	to	to	IN
46745	5426	20	the	the	DT
46745	5426	21	nasal	nasal	NN
46745	5426	22	and	and	CC
46745	5426	23	pulmonary	pulmonary	JJ
46745	5426	24	mucous	mucous	JJ
46745	5426	25	membranes	membrane	NNS
46745	5426	26	,	,	,
46745	5426	27	it	-PRON-	PRP
46745	5426	28	must	must	MD
46745	5426	29	pass	pass	VB
46745	5426	30	through	through	RP
46745	5426	31	to	to	IN
46745	5426	32	the	the	DT
46745	5426	33	blood	blood	NN
46745	5426	34	in	in	IN
46745	5426	35	a	a	DT
46745	5426	36	free	free	JJ
46745	5426	37	state	state	NN
46745	5426	38	,	,	,
46745	5426	39	for	for	IN
46745	5426	40	these	these	DT
46745	5426	41	surfaces	surface	NNS
46745	5426	42	do	do	VBP
46745	5426	43	not	not	RB
46745	5426	44	secrete	secrete	VB
46745	5426	45	an	an	DT
46745	5426	46	acid	acid	NN
46745	5426	47	.	.	.
46745	5427	1	And	and	CC
46745	5427	2	yet	yet	RB
46745	5427	3	its	-PRON-	PRP$
46745	5427	4	effects	effect	NNS
46745	5427	5	in	in	IN
46745	5427	6	this	this	DT
46745	5427	7	case	case	NN
46745	5427	8	are	be	VBP
46745	5427	9	the	the	DT
46745	5427	10	same	same	JJ
46745	5427	11	as	as	IN
46745	5427	12	when	when	WRB
46745	5427	13	it	-PRON-	PRP
46745	5427	14	is	be	VBZ
46745	5427	15	taken	take	VBN
46745	5427	16	into	into	IN
46745	5427	17	the	the	DT
46745	5427	18	stomach	stomach	NN
46745	5427	19	,	,	,
46745	5427	20	which	which	WDT
46745	5427	21	further	further	RB
46745	5427	22	renders	render	VBZ
46745	5427	23	it	-PRON-	PRP
46745	5427	24	probable	probable	JJ
46745	5427	25	that	that	IN
46745	5427	26	in	in	IN
46745	5427	27	the	the	DT
46745	5427	28	latter	latter	JJ
46745	5427	29	instance	instance	NN
46745	5427	30	it	-PRON-	PRP
46745	5427	31	is	be	VBZ
46745	5427	32	absorbed	absorb	VBN
46745	5427	33	free	free	JJ
46745	5427	34	.	.	.
46745	5428	1	When	when	WRB
46745	5428	2	there	there	EX
46745	5428	3	is	be	VBZ
46745	5428	4	an	an	DT
46745	5428	5	excess	excess	NN
46745	5428	6	of	of	IN
46745	5428	7	acid	acid	NN
46745	5428	8	in	in	IN
46745	5428	9	the	the	DT
46745	5428	10	system	system	NN
46745	5428	11	,	,	,
46745	5428	12	Ammonia	Ammonia	NNP
46745	5428	13	may	may	MD
46745	5428	14	be	be	VB
46745	5428	15	used	use	VBN
46745	5428	16	as	as	IN
46745	5428	17	a	a	DT
46745	5428	18	Restorative	Restorative	NNP
46745	5428	19	.	.	.
46745	5429	1	It	-PRON-	PRP
46745	5429	2	diminishes	diminish	VBZ
46745	5429	3	the	the	DT
46745	5429	4	acid	acid	JJ
46745	5429	5	reaction	reaction	NN
46745	5429	6	of	of	IN
46745	5429	7	the	the	DT
46745	5429	8	secretions	secretion	NNS
46745	5429	9	by	by	IN
46745	5429	10	combining	combine	VBG
46745	5429	11	with	with	IN
46745	5429	12	the	the	DT
46745	5429	13	acid	acid	NN
46745	5429	14	to	to	TO
46745	5429	15	form	form	VB
46745	5429	16	a	a	DT
46745	5429	17	salt	salt	NN
46745	5429	18	.	.	.
46745	5430	1	In	in	IN
46745	5430	2	ordinary	ordinary	JJ
46745	5430	3	conditions	condition	NNS
46745	5430	4	(	(	-LRB-
46745	5430	5	_	_	NNP
46745	5430	6	i.e.	i.e.	FW
46745	5430	7	_	_	NNP
46745	5430	8	when	when	WRB
46745	5430	9	not	not	RB
46745	5430	10	required	require	VBN
46745	5430	11	in	in	IN
46745	5430	12	the	the	DT
46745	5430	13	system	system	NN
46745	5430	14	)	)	-RRB-
46745	5430	15	it	-PRON-	PRP
46745	5430	16	has	have	VBZ
46745	5430	17	to	to	TO
46745	5430	18	be	be	VB
46745	5430	19	excreted	excrete	VBN
46745	5430	20	from	from	IN
46745	5430	21	the	the	DT
46745	5430	22	blood	blood	NN
46745	5430	23	.	.	.
46745	5431	1	Both	both	DT
46745	5431	2	Ammonia	Ammonia	NNP
46745	5431	3	and	and	CC
46745	5431	4	its	-PRON-	PRP$
46745	5431	5	salts	salt	NNS
46745	5431	6	act	act	NN
46745	5431	7	as	as	IN
46745	5431	8	Expectorants	Expectorants	NNP
46745	5431	9	and	and	CC
46745	5431	10	Diaphoretics	Diaphoretics	NNP
46745	5431	11	,	,	,
46745	5431	12	being	be	VBG
46745	5431	13	excreted	excrete	VBN
46745	5431	14	on	on	IN
46745	5431	15	the	the	DT
46745	5431	16	mucous	mucous	JJ
46745	5431	17	surface	surface	NN
46745	5431	18	of	of	IN
46745	5431	19	the	the	DT
46745	5431	20	lungs	lung	NNS
46745	5431	21	,	,	,
46745	5431	22	and	and	CC
46745	5431	23	on	on	IN
46745	5431	24	the	the	DT
46745	5431	25	skin	skin	NN
46745	5431	26	.	.	.
46745	5432	1	Free	Free	NNP
46745	5432	2	Ammonia	Ammonia	NNP
46745	5432	3	is	be	VBZ
46745	5432	4	a	a	DT
46745	5432	5	better	well	JJR
46745	5432	6	Expectorant	expectorant	NN
46745	5432	7	than	than	IN
46745	5432	8	any	any	DT
46745	5432	9	of	of	IN
46745	5432	10	its	-PRON-	PRP$
46745	5432	11	neutral	neutral	JJ
46745	5432	12	salts	salt	NNS
46745	5432	13	.	.	.
46745	5433	1	The	the	DT
46745	5433	2	secretion	secretion	NN
46745	5433	3	of	of	IN
46745	5433	4	sweat	sweat	NN
46745	5433	5	contains	contain	VBZ
46745	5433	6	an	an	DT
46745	5433	7	acid	acid	NN
46745	5433	8	.	.	.
46745	5434	1	The	the	DT
46745	5434	2	Ammonia	Ammonia	NNP
46745	5434	3	which	which	WDT
46745	5434	4	passes	pass	VBZ
46745	5434	5	out	out	RP
46745	5434	6	on	on	IN
46745	5434	7	the	the	DT
46745	5434	8	skin	skin	NN
46745	5434	9	combines	combine	VBZ
46745	5434	10	with	with	IN
46745	5434	11	this	this	DT
46745	5434	12	acid	acid	NN
46745	5434	13	.	.	.
46745	5435	1	But	but	CC
46745	5435	2	on	on	IN
46745	5435	3	the	the	DT
46745	5435	4	pulmonary	pulmonary	JJ
46745	5435	5	surface	surface	NN
46745	5435	6	it	-PRON-	PRP
46745	5435	7	is	be	VBZ
46745	5435	8	probably	probably	RB
46745	5435	9	excreted	excrete	VBN
46745	5435	10	free	free	JJ
46745	5435	11	.	.	.
46745	5436	1	For	for	IN
46745	5436	2	it	-PRON-	PRP
46745	5436	3	is	be	VBZ
46745	5436	4	found	find	VBN
46745	5436	5	that	that	IN
46745	5436	6	the	the	DT
46745	5436	7	careful	careful	JJ
46745	5436	8	inhalation	inhalation	NN
46745	5436	9	of	of	IN
46745	5436	10	Ammoniacal	ammoniacal	JJ
46745	5436	11	gas	gas	NN
46745	5436	12	has	have	VBZ
46745	5436	13	the	the	DT
46745	5436	14	same	same	JJ
46745	5436	15	effect	effect	NN
46745	5436	16	in	in	IN
46745	5436	17	augmenting	augment	VBG
46745	5436	18	the	the	DT
46745	5436	19	mucous	mucous	JJ
46745	5436	20	secretion	secretion	NN
46745	5436	21	as	as	IN
46745	5436	22	the	the	DT
46745	5436	23	internal	internal	JJ
46745	5436	24	use	use	NN
46745	5436	25	of	of	IN
46745	5436	26	Ammonia	Ammonia	NNP
46745	5436	27	.	.	.
46745	5437	1	Ammonia	Ammonia	NNP
46745	5437	2	is	be	VBZ
46745	5437	3	volatile	volatile	JJ
46745	5437	4	,	,	,
46745	5437	5	and	and	CC
46745	5437	6	soluble	soluble	JJ
46745	5437	7	in	in	IN
46745	5437	8	air	air	NN
46745	5437	9	;	;	,
46745	5437	10	and	and	CC
46745	5437	11	tends	tend	VBZ
46745	5437	12	for	for	IN
46745	5437	13	that	that	DT
46745	5437	14	reason	reason	NN
46745	5437	15	to	to	TO
46745	5437	16	pass	pass	VB
46745	5437	17	off	off	RP
46745	5437	18	freely	freely	RB
46745	5437	19	from	from	IN
46745	5437	20	those	those	DT
46745	5437	21	secreting	secreting	JJ
46745	5437	22	surfaces	surface	NNS
46745	5437	23	which	which	WDT
46745	5437	24	are	be	VBP
46745	5437	25	immediately	immediately	RB
46745	5437	26	in	in	IN
46745	5437	27	contact	contact	NN
46745	5437	28	with	with	IN
46745	5437	29	the	the	DT
46745	5437	30	atmosphere	atmosphere	NN
46745	5437	31	.	.	.
46745	5438	1	(	(	-LRB-
46745	5438	2	p.	p.	NN
46745	5439	1	278	278	CD
46745	5439	2	.	.	.
46745	5439	3	)	)	-RRB-
46745	5440	1	It	-PRON-	PRP
46745	5440	2	is	be	VBZ
46745	5440	3	supposed	suppose	VBN
46745	5440	4	by	by	IN
46745	5440	5	some	some	DT
46745	5440	6	that	that	IN
46745	5440	7	diffusible	diffusible	JJ
46745	5440	8	Stimulants	Stimulants	NNP
46745	5440	9	act	act	VBP
46745	5440	10	simply	simply	RB
46745	5440	11	on	on	IN
46745	5440	12	the	the	DT
46745	5440	13	ganglionic	ganglionic	NN
46745	5440	14	system	system	NN
46745	5440	15	of	of	IN
46745	5440	16	nerves	nerve	NNS
46745	5440	17	,	,	,
46745	5440	18	being	be	VBG
46745	5440	19	able	able	JJ
46745	5440	20	through	through	IN
46745	5440	21	them	-PRON-	PRP
46745	5440	22	to	to	TO
46745	5440	23	excite	excite	VB
46745	5440	24	the	the	DT
46745	5440	25	functions	function	NNS
46745	5440	26	of	of	IN
46745	5440	27	the	the	DT
46745	5440	28	heart	heart	NN
46745	5440	29	,	,	,
46745	5440	30	vessels	vessel	NNS
46745	5440	31	,	,	,
46745	5440	32	and	and	CC
46745	5440	33	glands	gland	NNS
46745	5440	34	.	.	.
46745	5441	1	But	but	CC
46745	5441	2	Ammonia	Ammonia	NNP
46745	5441	3	is	be	VBZ
46745	5441	4	used	use	VBN
46745	5441	5	with	with	IN
46745	5441	6	advantage	advantage	NN
46745	5441	7	in	in	IN
46745	5441	8	some	some	DT
46745	5441	9	cases	case	NNS
46745	5441	10	in	in	IN
46745	5441	11	which	which	WDT
46745	5441	12	the	the	DT
46745	5441	13	whole	whole	JJ
46745	5441	14	nervous	nervous	JJ
46745	5441	15	system	system	NN
46745	5441	16	is	be	VBZ
46745	5441	17	implicated	implicate	VBN
46745	5441	18	in	in	IN
46745	5441	19	the	the	DT
46745	5441	20	disorder	disorder	NN
46745	5441	21	.	.	.
46745	5442	1	It	-PRON-	PRP
46745	5442	2	has	have	VBZ
46745	5442	3	been	be	VBN
46745	5442	4	employed	employ	VBN
46745	5442	5	in	in	IN
46745	5442	6	cases	case	NNS
46745	5442	7	of	of	IN
46745	5442	8	Typhus	Typhus	NNP
46745	5442	9	,	,	,
46745	5442	10	of	of	IN
46745	5442	11	simple	simple	JJ
46745	5442	12	febrile	febrile	NN
46745	5442	13	exhaustion	exhaustion	NN
46745	5442	14	,	,	,
46745	5442	15	of	of	IN
46745	5442	16	Hysteria	Hysteria	NNP
46745	5442	17	,	,	,
46745	5442	18	Epilepsy	Epilepsy	NNP
46745	5442	19	.	.	.
46745	5443	1	In	in	IN
46745	5443	2	such	such	JJ
46745	5443	3	affections	affection	NNS
46745	5443	4	the	the	DT
46745	5443	5	brain	brain	NN
46745	5443	6	is	be	VBZ
46745	5443	7	at	at	IN
46745	5443	8	least	least	RBS
46745	5443	9	involved	involve	VBN
46745	5443	10	,	,	,
46745	5443	11	if	if	IN
46745	5443	12	not	not	RB
46745	5443	13	often	often	RB
46745	5443	14	the	the	DT
46745	5443	15	chief	chief	JJ
46745	5443	16	seat	seat	NN
46745	5443	17	of	of	IN
46745	5443	18	the	the	DT
46745	5443	19	disorder	disorder	NN
46745	5443	20	.	.	.
46745	5444	1	Spasms	spasm	NNS
46745	5444	2	and	and	CC
46745	5444	3	convulsions	convulsion	NNS
46745	5444	4	are	be	VBP
46745	5444	5	due	due	JJ
46745	5444	6	to	to	IN
46745	5444	7	a	a	DT
46745	5444	8	general	general	JJ
46745	5444	9	derangement	derangement	NN
46745	5444	10	of	of	IN
46745	5444	11	the	the	DT
46745	5444	12	nervous	nervous	JJ
46745	5444	13	forces	force	NNS
46745	5444	14	,	,	,
46745	5444	15	and	and	CC
46745	5444	16	particularly	particularly	RB
46745	5444	17	of	of	IN
46745	5444	18	the	the	DT
46745	5444	19	brain	brain	NN
46745	5444	20	,	,	,
46745	5444	21	in	in	IN
46745	5444	22	which	which	WDT
46745	5444	23	these	these	DT
46745	5444	24	centre	centre	NN
46745	5444	25	and	and	CC
46745	5444	26	originate	originate	NN
46745	5444	27	.	.	.
46745	5445	1	Stimulants	stimulant	NNS
46745	5445	2	,	,	,
46745	5445	3	by	by	IN
46745	5445	4	exalting	exalt	VBG
46745	5445	5	the	the	DT
46745	5445	6	natural	natural	JJ
46745	5445	7	functions	function	NNS
46745	5445	8	,	,	,
46745	5445	9	counteract	counteract	NN
46745	5445	10	and	and	CC
46745	5445	11	control	control	VB
46745	5445	12	this	this	DT
46745	5445	13	derangement	derangement	NN
46745	5445	14	.	.	.
46745	5446	1	It	-PRON-	PRP
46745	5446	2	is	be	VBZ
46745	5446	3	thus	thus	RB
46745	5446	4	that	that	IN
46745	5446	5	Ammonia	Ammonia	NNP
46745	5446	6	and	and	CC
46745	5446	7	volatile	volatile	JJ
46745	5446	8	oils	oil	NNS
46745	5446	9	are	be	VBP
46745	5446	10	of	of	IN
46745	5446	11	use	use	NN
46745	5446	12	in	in	IN
46745	5446	13	convulsive	convulsive	JJ
46745	5446	14	disorders	disorder	NNS
46745	5446	15	;	;	:
46745	5446	16	but	but	CC
46745	5446	17	they	-PRON-	PRP
46745	5446	18	are	be	VBP
46745	5446	19	seldom	seldom	RB
46745	5446	20	of	of	IN
46745	5446	21	any	any	DT
46745	5446	22	permanent	permanent	JJ
46745	5446	23	efficacy	efficacy	NN
46745	5446	24	,	,	,
46745	5446	25	as	as	IN
46745	5446	26	in	in	IN
46745	5446	27	most	most	JJS
46745	5446	28	cases	case	NNS
46745	5446	29	of	of	IN
46745	5446	30	Hysteria	Hysteria	NNP
46745	5446	31	and	and	CC
46745	5446	32	Epilepsy	Epilepsy	NNP
46745	5446	33	there	there	EX
46745	5446	34	is	be	VBZ
46745	5446	35	at	at	IN
46745	5446	36	the	the	DT
46745	5446	37	bottom	bottom	NN
46745	5446	38	a	a	DT
46745	5446	39	blood	blood	NN
46745	5446	40	-	-	HYPH
46745	5446	41	disease	disease	NN
46745	5446	42	,	,	,
46745	5446	43	of	of	IN
46745	5446	44	which	which	WDT
46745	5446	45	the	the	DT
46745	5446	46	spasmodic	spasmodic	JJ
46745	5446	47	fits	fit	NNS
46745	5446	48	are	be	VBP
46745	5446	49	only	only	RB
46745	5446	50	the	the	DT
46745	5446	51	symptom	symptom	NN
46745	5446	52	and	and	CC
46745	5446	53	outbreak	outbreak	NN
46745	5446	54	.	.	.
46745	5447	1	(	(	-LRB-
46745	5447	2	_	_	NNP
46745	5447	3	Vide	Vide	NNP
46745	5447	4	_	_	NNP
46745	5447	5	p.	p.	NN
46745	5448	1	176	176	CD
46745	5448	2	.	.	.
46745	5448	3	)	)	-RRB-
46745	5449	1	So	so	RB
46745	5449	2	also	also	RB
46745	5449	3	is	be	VBZ
46745	5449	4	there	there	EX
46745	5449	5	a	a	DT
46745	5449	6	limit	limit	NN
46745	5449	7	to	to	IN
46745	5449	8	the	the	DT
46745	5449	9	efficiency	efficiency	NN
46745	5449	10	of	of	IN
46745	5449	11	Stimulants	Stimulants	NNPS
46745	5449	12	in	in	IN
46745	5449	13	such	such	JJ
46745	5449	14	cases	case	NNS
46745	5449	15	as	as	IN
46745	5449	16	Typhus	Typhus	NNP
46745	5449	17	fever	fever	NN
46745	5449	18	;	;	:
46745	5449	19	there	there	EX
46745	5449	20	is	be	VBZ
46745	5449	21	a	a	DT
46745	5449	22	certain	certain	JJ
46745	5449	23	point	point	NN
46745	5449	24	of	of	IN
46745	5449	25	exhaustion	exhaustion	NN
46745	5449	26	beyond	beyond	IN
46745	5449	27	which	which	WDT
46745	5449	28	they	-PRON-	PRP
46745	5449	29	are	be	VBP
46745	5449	30	of	of	IN
46745	5449	31	no	no	DT
46745	5449	32	avail	avail	NN
46745	5449	33	.	.	.
46745	5450	1	For	for	IN
46745	5450	2	I	-PRON-	PRP
46745	5450	3	have	have	VBP
46745	5450	4	attempted	attempt	VBN
46745	5450	5	to	to	TO
46745	5450	6	show	show	VB
46745	5450	7	that	that	IN
46745	5450	8	though	though	IN
46745	5450	9	Stimulants	stimulant	NNS
46745	5450	10	are	be	VBP
46745	5450	11	competent	competent	JJ
46745	5450	12	to	to	TO
46745	5450	13	exalt	exalt	VB
46745	5450	14	nervous	nervous	JJ
46745	5450	15	force	force	NN
46745	5450	16	,	,	,
46745	5450	17	they	-PRON-	PRP
46745	5450	18	are	be	VBP
46745	5450	19	unable	unable	JJ
46745	5450	20	to	to	TO
46745	5450	21	supply	supply	VB
46745	5450	22	vital	vital	JJ
46745	5450	23	force	force	NN
46745	5450	24	.	.	.
46745	5451	1	A	a	DT
46745	5451	2	degree	degree	NN
46745	5451	3	of	of	IN
46745	5451	4	nervous	nervous	JJ
46745	5451	5	force	force	NN
46745	5451	6	is	be	VBZ
46745	5451	7	necessary	necessary	JJ
46745	5451	8	to	to	IN
46745	5451	9	the	the	DT
46745	5451	10	continuance	continuance	NN
46745	5451	11	of	of	IN
46745	5451	12	life	life	NN
46745	5451	13	;	;	:
46745	5451	14	but	but	CC
46745	5451	15	when	when	WRB
46745	5451	16	the	the	DT
46745	5451	17	powers	power	NNS
46745	5451	18	of	of	IN
46745	5451	19	life	life	NN
46745	5451	20	themselves	-PRON-	PRP
46745	5451	21	are	be	VBP
46745	5451	22	ebbing	ebb	VBG
46745	5451	23	away	away	RB
46745	5451	24	,	,	,
46745	5451	25	it	-PRON-	PRP
46745	5451	26	is	be	VBZ
46745	5451	27	impossible	impossible	JJ
46745	5451	28	then	then	RB
46745	5451	29	to	to	TO
46745	5451	30	prolong	prolong	VB
46745	5451	31	any	any	DT
46745	5451	32	further	further	RB
46745	5451	33	the	the	DT
46745	5451	34	thread	thread	NN
46745	5451	35	of	of	IN
46745	5451	36	existence	existence	NN
46745	5451	37	by	by	IN
46745	5451	38	the	the	DT
46745	5451	39	exhibition	exhibition	NN
46745	5451	40	of	of	IN
46745	5451	41	stimulant	stimulant	NN
46745	5451	42	medicines	medicine	NNS
46745	5451	43	.	.	.
46745	5452	1	The	the	DT
46745	5452	2	action	action	NN
46745	5452	3	of	of	IN
46745	5452	4	Ammonia	Ammonia	NNP
46745	5452	5	is	be	VBZ
46745	5452	6	directly	directly	RB
46745	5452	7	the	the	DT
46745	5452	8	reverse	reverse	NN
46745	5452	9	of	of	IN
46745	5452	10	that	that	DT
46745	5452	11	of	of	IN
46745	5452	12	Prussic	prussic	JJ
46745	5452	13	acid	acid	NN
46745	5452	14	,	,	,
46745	5452	15	which	which	WDT
46745	5452	16	is	be	VBZ
46745	5452	17	a	a	DT
46745	5452	18	General	General	NNP
46745	5452	19	Sedative	Sedative	NNP
46745	5452	20	,	,	,
46745	5452	21	producing	produce	VBG
46745	5452	22	Convulsions	Convulsions	NNPS
46745	5452	23	and	and	CC
46745	5452	24	Syncope	Syncope	NNP
46745	5452	25	.	.	.
46745	5453	1	Ammonia	Ammonia	NNP
46745	5453	2	is	be	VBZ
46745	5453	3	thus	thus	RB
46745	5453	4	used	use	VBN
46745	5453	5	in	in	IN
46745	5453	6	cases	case	NNS
46745	5453	7	of	of	IN
46745	5453	8	poisoning	poisoning	NN
46745	5453	9	by	by	IN
46745	5453	10	that	that	DT
46745	5453	11	liquid	liquid	NN
46745	5453	12	.	.	.
46745	5454	1	(	(	-LRB-
46745	5454	2	_	_	NNP
46745	5454	3	Vide	Vide	NNP
46745	5454	4	_	_	NNP
46745	5454	5	pp	pp	NNP
46745	5454	6	.	.	.
46745	5455	1	126	126	CD
46745	5455	2	,	,	,
46745	5455	3	227	227	CD
46745	5455	4	,	,	,
46745	5455	5	278	278	CD
46745	5455	6	,	,	,
46745	5455	7	283	283	CD
46745	5455	8	,	,	,
46745	5455	9	301	301	CD
46745	5455	10	.	.	.
46745	5455	11	)	)	-RRB-
46745	5455	12	.	.	.
46745	5456	1	STRYCHNIA	STRYCHNIA	NNP
46745	5456	2	.	.	.
46745	5457	1	Class	class	NN
46745	5457	2	II	II	NNP
46745	5457	3	.	.	.
46745	5458	1	Div	Div	NNP
46745	5458	2	.	.	.
46745	5459	1	I.	I.	NNP
46745	5459	2	Ord	Ord	NNP
46745	5459	3	.	.	.
46745	5460	1	II	ii	CD
46745	5460	2	.	.	.
46745	5461	1	STIMULANTIA	STIMULANTIA	NNP
46745	5461	2	SPECIFICA	SPECIFICA	NNP
46745	5461	3	.	.	.
46745	5462	1	Strychnia	Strychnia	NNP
46745	5462	2	is	be	VBZ
46745	5462	3	the	the	DT
46745	5462	4	chief	chief	JJ
46745	5462	5	alkaloid	alkaloid	NN
46745	5462	6	and	and	CC
46745	5462	7	active	active	JJ
46745	5462	8	principle	principle	NN
46745	5462	9	of	of	IN
46745	5462	10	Nux	Nux	NNP
46745	5462	11	Vomica	Vomica	NNP
46745	5462	12	.	.	.
46745	5463	1	This	this	DT
46745	5463	2	medicine	medicine	NN
46745	5463	3	is	be	VBZ
46745	5463	4	comparatively	comparatively	RB
46745	5463	5	simple	simple	JJ
46745	5463	6	in	in	IN
46745	5463	7	its	-PRON-	PRP$
46745	5463	8	action	action	NN
46745	5463	9	.	.	.
46745	5464	1	It	-PRON-	PRP
46745	5464	2	has	have	VBZ
46745	5464	3	no	no	DT
46745	5464	4	claim	claim	NN
46745	5464	5	to	to	IN
46745	5464	6	the	the	DT
46745	5464	7	title	title	NN
46745	5464	8	of	of	IN
46745	5464	9	Sedative	Sedative	NNP
46745	5464	10	,	,	,
46745	5464	11	which	which	WDT
46745	5464	12	is	be	VBZ
46745	5464	13	sometimes	sometimes	RB
46745	5464	14	applied	apply	VBN
46745	5464	15	to	to	IN
46745	5464	16	it	-PRON-	PRP
46745	5464	17	.	.	.
46745	5465	1	It	-PRON-	PRP
46745	5465	2	does	do	VBZ
46745	5465	3	not	not	RB
46745	5465	4	affect	affect	VB
46745	5465	5	the	the	DT
46745	5465	6	nerves	nerve	NNS
46745	5465	7	generally	generally	RB
46745	5465	8	.	.	.
46745	5466	1	It	-PRON-	PRP
46745	5466	2	has	have	VBZ
46745	5466	3	no	no	DT
46745	5466	4	direct	direct	JJ
46745	5466	5	action	action	NN
46745	5466	6	on	on	IN
46745	5466	7	the	the	DT
46745	5466	8	brain	brain	NN
46745	5466	9	,	,	,
46745	5466	10	but	but	CC
46745	5466	11	stimulates	stimulate	VBZ
46745	5466	12	chiefly	chiefly	RB
46745	5466	13	the	the	DT
46745	5466	14	function	function	NN
46745	5466	15	of	of	IN
46745	5466	16	the	the	DT
46745	5466	17	spinal	spinal	JJ
46745	5466	18	cord	cord	NN
46745	5466	19	,	,	,
46745	5466	20	and	and	CC
46745	5466	21	its	-PRON-	PRP$
46745	5466	22	system	system	NN
46745	5466	23	of	of	IN
46745	5466	24	nerves	nerve	NNS
46745	5466	25	.	.	.
46745	5467	1	Of	of	IN
46745	5467	2	these	these	DT
46745	5467	3	nerves	nerve	NNS
46745	5467	4	it	-PRON-	PRP
46745	5467	5	affects	affect	VBZ
46745	5467	6	the	the	DT
46745	5467	7	motor	motor	NN
46745	5467	8	considerably	considerably	RB
46745	5467	9	more	more	JJR
46745	5467	10	than	than	IN
46745	5467	11	the	the	DT
46745	5467	12	sensory	sensory	JJ
46745	5467	13	branches	branch	NNS
46745	5467	14	.	.	.
46745	5468	1	Along	along	IN
46745	5468	2	with	with	IN
46745	5468	3	the	the	DT
46745	5468	4	spinal	spinal	JJ
46745	5468	5	cord	cord	NN
46745	5468	6	,	,	,
46745	5468	7	it	-PRON-	PRP
46745	5468	8	doubtless	doubtless	RB
46745	5468	9	also	also	RB
46745	5468	10	acts	act	VBZ
46745	5468	11	upon	upon	IN
46745	5468	12	that	that	DT
46745	5468	13	part	part	NN
46745	5468	14	of	of	IN
46745	5468	15	the	the	DT
46745	5468	16	brain	brain	NN
46745	5468	17	which	which	WDT
46745	5468	18	is	be	VBZ
46745	5468	19	immediately	immediately	RB
46745	5468	20	associated	associate	VBN
46745	5468	21	with	with	IN
46745	5468	22	the	the	DT
46745	5468	23	spinal	spinal	JJ
46745	5468	24	system	system	NN
46745	5468	25	of	of	IN
46745	5468	26	nerves	nerve	NNS
46745	5468	27	.	.	.
46745	5469	1	But	but	CC
46745	5469	2	the	the	DT
46745	5469	3	function	function	NN
46745	5469	4	of	of	IN
46745	5469	5	reflex	reflex	NNP
46745	5469	6	motion	motion	NN
46745	5469	7	,	,	,
46745	5469	8	which	which	WDT
46745	5469	9	is	be	VBZ
46745	5469	10	thought	think	VBN
46745	5469	11	to	to	TO
46745	5469	12	reside	reside	VB
46745	5469	13	in	in	IN
46745	5469	14	the	the	DT
46745	5469	15	spinal	spinal	JJ
46745	5469	16	cord	cord	NN
46745	5469	17	,	,	,
46745	5469	18	is	be	VBZ
46745	5469	19	particularly	particularly	RB
46745	5469	20	stimulated	stimulate	VBN
46745	5469	21	.	.	.
46745	5470	1	Strychnia	Strychnia	NNP
46745	5470	2	is	be	VBZ
46745	5470	3	thus	thus	RB
46745	5470	4	an	an	DT
46745	5470	5	exciter	exciter	NN
46745	5470	6	of	of	IN
46745	5470	7	muscular	muscular	JJ
46745	5470	8	contraction	contraction	NN
46745	5470	9	and	and	CC
46745	5470	10	of	of	IN
46745	5470	11	motion	motion	NN
46745	5470	12	;	;	:
46745	5470	13	exalting	exalt	VBG
46745	5470	14	sensation	sensation	NN
46745	5470	15	in	in	IN
46745	5470	16	a	a	DT
46745	5470	17	less	less	JJR
46745	5470	18	degree	degree	NN
46745	5470	19	.	.	.
46745	5471	1	It	-PRON-	PRP
46745	5471	2	has	have	VBZ
46745	5471	3	also	also	RB
46745	5471	4	apparently	apparently	RB
46745	5471	5	some	some	DT
46745	5471	6	action	action	NN
46745	5471	7	on	on	IN
46745	5471	8	part	part	NN
46745	5471	9	of	of	IN
46745	5471	10	the	the	DT
46745	5471	11	ganglionic	ganglionic	NN
46745	5471	12	system	system	NN
46745	5471	13	of	of	IN
46745	5471	14	nerves	nerve	NNS
46745	5471	15	,	,	,
46745	5471	16	by	by	IN
46745	5471	17	which	which	WDT
46745	5471	18	it	-PRON-	PRP
46745	5471	19	is	be	VBZ
46745	5471	20	enabled	enable	VBN
46745	5471	21	to	to	TO
46745	5471	22	promote	promote	VB
46745	5471	23	the	the	DT
46745	5471	24	function	function	NN
46745	5471	25	of	of	IN
46745	5471	26	the	the	DT
46745	5471	27	stomach	stomach	NN
46745	5471	28	,	,	,
46745	5471	29	and	and	CC
46745	5471	30	becomes	become	VBZ
46745	5471	31	temporarily	temporarily	RB
46745	5471	32	a	a	DT
46745	5471	33	tonic	tonic	NN
46745	5471	34	when	when	WRB
46745	5471	35	given	give	VBN
46745	5471	36	in	in	IN
46745	5471	37	relaxed	relaxed	JJ
46745	5471	38	conditions	condition	NNS
46745	5471	39	of	of	IN
46745	5471	40	that	that	DT
46745	5471	41	organ	organ	NN
46745	5471	42	.	.	.
46745	5472	1	But	but	CC
46745	5472	2	it	-PRON-	PRP
46745	5472	3	does	do	VBZ
46745	5472	4	not	not	RB
46745	5472	5	excite	excite	VB
46745	5472	6	the	the	DT
46745	5472	7	action	action	NN
46745	5472	8	of	of	IN
46745	5472	9	the	the	DT
46745	5472	10	heart	heart	NN
46745	5472	11	.	.	.
46745	5473	1	In	in	IN
46745	5473	2	cases	case	NNS
46745	5473	3	of	of	IN
46745	5473	4	poisoning	poisoning	NN
46745	5473	5	by	by	IN
46745	5473	6	Nux	Nux	NNP
46745	5473	7	Vomica	Vomica	NNP
46745	5473	8	,	,	,
46745	5473	9	the	the	DT
46745	5473	10	brain	brain	NN
46745	5473	11	and	and	CC
46745	5473	12	the	the	DT
46745	5473	13	heart	heart	NN
46745	5473	14	are	be	VBP
46745	5473	15	unaffected	unaffected	JJ
46745	5473	16	.	.	.
46745	5474	1	Tetanic	tetanic	JJ
46745	5474	2	and	and	CC
46745	5474	3	general	general	JJ
46745	5474	4	convulsions	convulsion	NNS
46745	5474	5	are	be	VBP
46745	5474	6	produced	produce	VBN
46745	5474	7	;	;	:
46745	5474	8	and	and	CC
46745	5474	9	the	the	DT
46745	5474	10	immediate	immediate	JJ
46745	5474	11	cause	cause	NN
46745	5474	12	of	of	IN
46745	5474	13	death	death	NN
46745	5474	14	is	be	VBZ
46745	5474	15	a	a	DT
46745	5474	16	spasm	spasm	NN
46745	5474	17	of	of	IN
46745	5474	18	the	the	DT
46745	5474	19	muscles	muscle	NNS
46745	5474	20	of	of	IN
46745	5474	21	respiration	respiration	NN
46745	5474	22	.	.	.
46745	5475	1	Strychnia	Strychnia	NNP
46745	5475	2	causes	cause	VBZ
46745	5475	3	a	a	DT
46745	5475	4	contraction	contraction	NN
46745	5475	5	of	of	IN
46745	5475	6	the	the	DT
46745	5475	7	muscles	muscle	NNS
46745	5475	8	by	by	IN
46745	5475	9	stimulating	stimulate	VBG
46745	5475	10	the	the	DT
46745	5475	11	motor	motor	NN
46745	5475	12	centres	centre	NNS
46745	5475	13	,	,	,
46745	5475	14	and	and	CC
46745	5475	15	originating	originate	VBG
46745	5475	16	in	in	IN
46745	5475	17	them	-PRON-	PRP
46745	5475	18	an	an	DT
46745	5475	19	impulse	impulse	NN
46745	5475	20	which	which	WDT
46745	5475	21	is	be	VBZ
46745	5475	22	propagated	propagate	VBN
46745	5475	23	along	along	IN
46745	5475	24	the	the	DT
46745	5475	25	motor	motor	NN
46745	5475	26	nerves	nerve	NNS
46745	5475	27	.	.	.
46745	5476	1	So	so	IN
46745	5476	2	that	that	IN
46745	5476	3	when	when	WRB
46745	5476	4	these	these	DT
46745	5476	5	centres	centre	NNS
46745	5476	6	are	be	VBP
46745	5476	7	diseased	disease	VBN
46745	5476	8	,	,	,
46745	5476	9	or	or	CC
46745	5476	10	the	the	DT
46745	5476	11	continuity	continuity	NN
46745	5476	12	of	of	IN
46745	5476	13	their	-PRON-	PRP$
46745	5476	14	fibres	fibre	NNS
46745	5476	15	destroyed	destroy	VBN
46745	5476	16	,	,	,
46745	5476	17	it	-PRON-	PRP
46745	5476	18	is	be	VBZ
46745	5476	19	unable	unable	JJ
46745	5476	20	to	to	TO
46745	5476	21	exert	exert	VB
46745	5476	22	its	-PRON-	PRP$
46745	5476	23	power	power	NN
46745	5476	24	.	.	.
46745	5477	1	It	-PRON-	PRP
46745	5477	2	is	be	VBZ
46745	5477	3	used	use	VBN
46745	5477	4	as	as	IN
46745	5477	5	a	a	DT
46745	5477	6	medicine	medicine	NN
46745	5477	7	in	in	IN
46745	5477	8	cases	case	NNS
46745	5477	9	of	of	IN
46745	5477	10	Paralysis	Paralysis	NNP
46745	5477	11	.	.	.
46745	5478	1	But	but	CC
46745	5478	2	when	when	WRB
46745	5478	3	the	the	DT
46745	5478	4	lesion	lesion	NN
46745	5478	5	of	of	IN
46745	5478	6	the	the	DT
46745	5478	7	nervous	nervous	JJ
46745	5478	8	centre	centre	NN
46745	5478	9	is	be	VBZ
46745	5478	10	of	of	IN
46745	5478	11	recent	recent	JJ
46745	5478	12	occurrence	occurrence	NN
46745	5478	13	,	,	,
46745	5478	14	or	or	CC
46745	5478	15	when	when	WRB
46745	5478	16	it	-PRON-	PRP
46745	5478	17	has	have	VBZ
46745	5478	18	been	be	VBN
46745	5478	19	of	of	IN
46745	5478	20	so	so	RB
46745	5478	21	serious	serious	JJ
46745	5478	22	or	or	CC
46745	5478	23	extensive	extensive	JJ
46745	5478	24	a	a	DT
46745	5478	25	nature	nature	NN
46745	5478	26	as	as	IN
46745	5478	27	to	to	TO
46745	5478	28	admit	admit	VB
46745	5478	29	of	of	IN
46745	5478	30	no	no	DT
46745	5478	31	repair	repair	NN
46745	5478	32	in	in	IN
46745	5478	33	the	the	DT
46745	5478	34	course	course	NN
46745	5478	35	of	of	IN
46745	5478	36	time	time	NN
46745	5478	37	,	,	,
46745	5478	38	the	the	DT
46745	5478	39	remedy	remedy	NN
46745	5478	40	will	will	MD
46745	5478	41	be	be	VB
46745	5478	42	ineffectual	ineffectual	JJ
46745	5478	43	.	.	.
46745	5479	1	It	-PRON-	PRP
46745	5479	2	is	be	VBZ
46745	5479	3	only	only	RB
46745	5479	4	successful	successful	JJ
46745	5479	5	in	in	IN
46745	5479	6	cases	case	NNS
46745	5479	7	where	where	WRB
46745	5479	8	the	the	DT
46745	5479	9	injury	injury	NN
46745	5479	10	to	to	IN
46745	5479	11	the	the	DT
46745	5479	12	nervous	nervous	JJ
46745	5479	13	centre	centre	NN
46745	5479	14	has	have	VBZ
46745	5479	15	healed	heal	VBN
46745	5479	16	up	up	RP
46745	5479	17	,	,	,
46745	5479	18	and	and	CC
46745	5479	19	where	where	WRB
46745	5479	20	the	the	DT
46745	5479	21	limb	limb	NN
46745	5479	22	continues	continue	VBZ
46745	5479	23	paralyzed	paralyzed	JJ
46745	5479	24	merely	merely	RB
46745	5479	25	because	because	IN
46745	5479	26	the	the	DT
46745	5479	27	motor	motor	NN
46745	5479	28	nerves	nerve	NNS
46745	5479	29	have	have	VBP
46745	5479	30	lost	lose	VBN
46745	5479	31	the	the	DT
46745	5479	32	power	power	NN
46745	5479	33	to	to	TO
46745	5479	34	transmit	transmit	VB
46745	5479	35	the	the	DT
46745	5479	36	necessary	necessary	JJ
46745	5479	37	impulse	impulse	NN
46745	5479	38	,	,	,
46745	5479	39	from	from	IN
46745	5479	40	having	have	VBG
46745	5479	41	been	be	VBN
46745	5479	42	so	so	RB
46745	5479	43	long	long	RB
46745	5479	44	unaccustomed	unaccustomed	JJ
46745	5479	45	to	to	IN
46745	5479	46	the	the	DT
46745	5479	47	discharge	discharge	NN
46745	5479	48	of	of	IN
46745	5479	49	this	this	DT
46745	5479	50	office	office	NN
46745	5479	51	.	.	.
46745	5480	1	As	as	IN
46745	5480	2	it	-PRON-	PRP
46745	5480	3	is	be	VBZ
46745	5480	4	able	able	JJ
46745	5480	5	to	to	TO
46745	5480	6	act	act	VB
46745	5480	7	on	on	IN
46745	5480	8	the	the	DT
46745	5480	9	nerve	nerve	NN
46745	5480	10	itself	-PRON-	PRP
46745	5480	11	,	,	,
46745	5480	12	it	-PRON-	PRP
46745	5480	13	is	be	VBZ
46745	5480	14	sometimes	sometimes	RB
46745	5480	15	thought	think	VBN
46745	5480	16	best	well	RBS
46745	5480	17	to	to	TO
46745	5480	18	apply	apply	VB
46745	5480	19	it	-PRON-	PRP
46745	5480	20	to	to	IN
46745	5480	21	the	the	DT
46745	5480	22	affected	affected	JJ
46745	5480	23	part	part	NN
46745	5480	24	on	on	IN
46745	5480	25	a	a	DT
46745	5480	26	raw	raw	JJ
46745	5480	27	surface	surface	NN
46745	5480	28	produced	produce	VBN
46745	5480	29	by	by	IN
46745	5480	30	a	a	DT
46745	5480	31	blister	blister	NN
46745	5480	32	.	.	.
46745	5481	1	The	the	DT
46745	5481	2	advantage	advantage	NN
46745	5481	3	of	of	IN
46745	5481	4	this	this	DT
46745	5481	5	plan	plan	NN
46745	5481	6	is	be	VBZ
46745	5481	7	most	most	RBS
46745	5481	8	obvious	obvious	JJ
46745	5481	9	in	in	IN
46745	5481	10	the	the	DT
46745	5481	11	case	case	NN
46745	5481	12	of	of	IN
46745	5481	13	Lead	lead	NN
46745	5481	14	-	-	HYPH
46745	5481	15	palsy	palsy	NN
46745	5481	16	,	,	,
46745	5481	17	where	where	WRB
46745	5481	18	the	the	DT
46745	5481	19	cause	cause	NN
46745	5481	20	of	of	IN
46745	5481	21	the	the	DT
46745	5481	22	paralysis	paralysis	NN
46745	5481	23	is	be	VBZ
46745	5481	24	local	local	JJ
46745	5481	25	,	,	,
46745	5481	26	residing	reside	VBG
46745	5481	27	in	in	IN
46745	5481	28	the	the	DT
46745	5481	29	nerve	nerve	NN
46745	5481	30	,	,	,
46745	5481	31	and	and	CC
46745	5481	32	not	not	RB
46745	5481	33	in	in	IN
46745	5481	34	the	the	DT
46745	5481	35	centre	centre	NN
46745	5481	36	.	.	.
46745	5482	1	But	but	CC
46745	5482	2	in	in	IN
46745	5482	3	this	this	DT
46745	5482	4	case	case	NN
46745	5482	5	also	also	RB
46745	5482	6	it	-PRON-	PRP
46745	5482	7	is	be	VBZ
46745	5482	8	necessary	necessary	JJ
46745	5482	9	that	that	IN
46745	5482	10	the	the	DT
46745	5482	11	nerve	nerve	NN
46745	5482	12	-	-	HYPH
46745	5482	13	centre	centre	NN
46745	5482	14	be	be	VB
46745	5482	15	sound	sound	JJ
46745	5482	16	.	.	.
46745	5483	1	Dr.	Dr.	NNP
46745	5483	2	Neligan	Neligan	NNP
46745	5483	3	recommends	recommend	VBZ
46745	5483	4	Strychnia	Strychnia	NNP
46745	5483	5	in	in	IN
46745	5483	6	Lead	lead	NN
46745	5483	7	-	-	HYPH
46745	5483	8	colic	colic	NN
46745	5483	9	,	,	,
46745	5483	10	in	in	IN
46745	5483	11	which	which	WDT
46745	5483	12	disorder	disorder	NN
46745	5483	13	constipation	constipation	NN
46745	5483	14	and	and	CC
46745	5483	15	distention	distention	NN
46745	5483	16	of	of	IN
46745	5483	17	the	the	DT
46745	5483	18	bowel	bowel	NN
46745	5483	19	are	be	VBP
46745	5483	20	produced	produce	VBN
46745	5483	21	by	by	IN
46745	5483	22	a	a	DT
46745	5483	23	paralysis	paralysis	NN
46745	5483	24	of	of	IN
46745	5483	25	a	a	DT
46745	5483	26	portion	portion	NN
46745	5483	27	of	of	IN
46745	5483	28	the	the	DT
46745	5483	29	large	large	JJ
46745	5483	30	intestine	intestine	NN
46745	5483	31	.	.	.
46745	5484	1	Strychnia	Strychnia	NNP
46745	5484	2	has	have	VBZ
46745	5484	3	been	be	VBN
46745	5484	4	used	use	VBN
46745	5484	5	with	with	IN
46745	5484	6	benefit	benefit	NN
46745	5484	7	by	by	IN
46745	5484	8	Dr.	Dr.	NNP
46745	5484	9	Golding	Golding	NNP
46745	5484	10	Bird	Bird	NNP
46745	5484	11	in	in	IN
46745	5484	12	cases	case	NNS
46745	5484	13	of	of	IN
46745	5484	14	Phosphaturia	phosphaturia	NN
46745	5484	15	connected	connect	VBN
46745	5484	16	with	with	IN
46745	5484	17	a	a	DT
46745	5484	18	functional	functional	JJ
46745	5484	19	derangement	derangement	NN
46745	5484	20	of	of	IN
46745	5484	21	the	the	DT
46745	5484	22	spinal	spinal	JJ
46745	5484	23	cord	cord	NN
46745	5484	24	.	.	.
46745	5485	1	(	(	-LRB-
46745	5485	2	_	_	NNP
46745	5485	3	Vide	Vide	NNP
46745	5485	4	_	_	NNP
46745	5485	5	p.	p.	NN
46745	5486	1	232	232	CD
46745	5486	2	.	.	.
46745	5486	3	)	)	-RRB-
46745	5487	1	ALCOHOL	ALCOHOL	NNP
46745	5487	2	Class	Class	NNP
46745	5487	3	II	II	NNP
46745	5487	4	.	.	.
46745	5488	1	Div	Div	NNP
46745	5488	2	.	.	.
46745	5489	1	II	ii	CD
46745	5489	2	.	.	.
46745	5490	1	Ord	Ord	NNP
46745	5490	2	.	.	.
46745	5491	1	I.	I.	NNP
46745	5491	2	NARCOTICA	NARCOTICA	NNP
46745	5491	3	INEBRIANTIA	INEBRIANTIA	NNP
46745	5491	4	.	.	.
46745	5492	1	Class	Class	NNP
46745	5492	2	IV	IV	NNP
46745	5492	3	.	.	.
46745	5493	1	Ord	Ord	NNP
46745	5493	2	.	.	.
46745	5494	1	V.	V.	NNP
46745	5494	2	DIAPHORETICA	DIAPHORETICA	NNP
46745	5494	3	.	.	.
46745	5495	1	Class	Class	NNP
46745	5495	2	IV	IV	NNP
46745	5495	3	.	.	.
46745	5496	1	Ord	Ord	NNP
46745	5496	2	.	.	.
46745	5497	1	VI	VI	NNP
46745	5497	2	.	.	.
46745	5498	1	DIURETICA	DIURETICA	NNP
46745	5498	2	.	.	.
46745	5499	1	We	-PRON-	PRP
46745	5499	2	have	have	VBP
46745	5499	3	already	already	RB
46745	5499	4	considered	consider	VBN
46745	5499	5	in	in	IN
46745	5499	6	order	order	NN
46745	5499	7	the	the	DT
46745	5499	8	peculiarities	peculiarity	NNS
46745	5499	9	in	in	IN
46745	5499	10	action	action	NN
46745	5499	11	that	that	WDT
46745	5499	12	distinguish	distinguish	VBP
46745	5499	13	Narcotics	Narcotics	NNP
46745	5499	14	alike	alike	RB
46745	5499	15	from	from	IN
46745	5499	16	Stimulant	Stimulant	NNP
46745	5499	17	and	and	CC
46745	5499	18	Sedative	Sedative	NNP
46745	5499	19	medicines	medicine	NNS
46745	5499	20	;	;	:
46745	5499	21	how	how	WRB
46745	5499	22	they	-PRON-	PRP
46745	5499	23	tend	tend	VBP
46745	5499	24	first	first	RB
46745	5499	25	to	to	TO
46745	5499	26	exalt	exalt	VB
46745	5499	27	the	the	DT
46745	5499	28	nervous	nervous	JJ
46745	5499	29	forces	force	NNS
46745	5499	30	,	,	,
46745	5499	31	and	and	CC
46745	5499	32	then	then	RB
46745	5499	33	to	to	TO
46745	5499	34	depress	depress	VB
46745	5499	35	them	-PRON-	PRP
46745	5499	36	,	,	,
46745	5499	37	and	and	CC
46745	5499	38	have	have	VBP
46745	5499	39	further	further	JJ
46745	5499	40	a	a	DT
46745	5499	41	particular	particular	JJ
46745	5499	42	action	action	NN
46745	5499	43	on	on	IN
46745	5499	44	the	the	DT
46745	5499	45	intellectual	intellectual	JJ
46745	5499	46	part	part	NN
46745	5499	47	of	of	IN
46745	5499	48	the	the	DT
46745	5499	49	brain	brain	NN
46745	5499	50	.	.	.
46745	5500	1	We	-PRON-	PRP
46745	5500	2	have	have	VBP
46745	5500	3	observed	observe	VBN
46745	5500	4	that	that	IN
46745	5500	5	these	these	DT
46745	5500	6	remedies	remedy	NNS
46745	5500	7	may	may	MD
46745	5500	8	be	be	VB
46745	5500	9	divided	divide	VBN
46745	5500	10	into	into	IN
46745	5500	11	three	three	CD
46745	5500	12	minor	minor	JJ
46745	5500	13	groups	group	NNS
46745	5500	14	,	,	,
46745	5500	15	which	which	WDT
46745	5500	16	differ	differ	VBP
46745	5500	17	considerably	considerably	RB
46745	5500	18	,	,	,
46745	5500	19	if	if	IN
46745	5500	20	only	only	RB
46745	5500	21	regarded	regard	VBD
46745	5500	22	in	in	IN
46745	5500	23	their	-PRON-	PRP$
46745	5500	24	action	action	NN
46745	5500	25	on	on	IN
46745	5500	26	the	the	DT
46745	5500	27	nervous	nervous	JJ
46745	5500	28	forces	force	NNS
46745	5500	29	generally	generally	RB
46745	5500	30	.	.	.
46745	5501	1	For	for	IN
46745	5501	2	that	that	DT
46745	5501	3	Inebriants	inebriant	NNS
46745	5501	4	approach	approach	VBP
46745	5501	5	very	very	RB
46745	5501	6	nearly	nearly	RB
46745	5501	7	to	to	IN
46745	5501	8	Stimulants	Stimulants	NNP
46745	5501	9	,	,	,
46745	5501	10	and	and	CC
46745	5501	11	Deliriants	deliriant	NNS
46745	5501	12	to	to	IN
46745	5501	13	Sedatives	sedative	NNS
46745	5501	14	,	,	,
46745	5501	15	while	while	IN
46745	5501	16	Soporifics	soporific	NNS
46745	5501	17	occupy	occupy	VBP
46745	5501	18	an	an	DT
46745	5501	19	intermediate	intermediate	JJ
46745	5501	20	place	place	NN
46745	5501	21	.	.	.
46745	5502	1	We	-PRON-	PRP
46745	5502	2	have	have	VBP
46745	5502	3	seen	see	VBN
46745	5502	4	also	also	RB
46745	5502	5	that	that	DT
46745	5502	6	though	though	RB
46745	5502	7	,	,	,
46745	5502	8	during	during	IN
46745	5502	9	the	the	DT
46745	5502	10	stage	stage	NN
46745	5502	11	of	of	IN
46745	5502	12	stimulation	stimulation	NN
46745	5502	13	,	,	,
46745	5502	14	these	these	DT
46745	5502	15	three	three	CD
46745	5502	16	orders	order	NNS
46745	5502	17	tend	tend	VBP
46745	5502	18	all	all	DT
46745	5502	19	more	more	RBR
46745	5502	20	or	or	CC
46745	5502	21	less	less	JJR
46745	5502	22	to	to	TO
46745	5502	23	excite	excite	VB
46745	5502	24	the	the	DT
46745	5502	25	powers	power	NNS
46745	5502	26	of	of	IN
46745	5502	27	the	the	DT
46745	5502	28	mind	mind	NN
46745	5502	29	,	,	,
46745	5502	30	they	-PRON-	PRP
46745	5502	31	differ	differ	VBP
46745	5502	32	characteristically	characteristically	RB
46745	5502	33	in	in	IN
46745	5502	34	their	-PRON-	PRP$
46745	5502	35	secondary	secondary	JJ
46745	5502	36	or	or	CC
46745	5502	37	depressing	depressing	JJ
46745	5502	38	effect	effect	NN
46745	5502	39	upon	upon	IN
46745	5502	40	the	the	DT
46745	5502	41	same	same	JJ
46745	5502	42	.	.	.
46745	5503	1	That	that	IN
46745	5503	2	,	,	,
46745	5503	3	with	with	IN
46745	5503	4	respect	respect	NN
46745	5503	5	to	to	IN
46745	5503	6	our	-PRON-	PRP$
46745	5503	7	present	present	JJ
46745	5503	8	purpose	purpose	NN
46745	5503	9	,	,	,
46745	5503	10	the	the	DT
46745	5503	11	intellectual	intellectual	JJ
46745	5503	12	functions	function	NNS
46745	5503	13	may	may	MD
46745	5503	14	be	be	VB
46745	5503	15	divided	divide	VBN
46745	5503	16	into	into	IN
46745	5503	17	three	three	CD
46745	5503	18	parts	part	NNS
46745	5503	19	:	:	:
46745	5503	20	the	the	DT
46745	5503	21	mind	mind	NN
46745	5503	22	itself	-PRON-	PRP
46745	5503	23	;	;	:
46745	5503	24	volition	volition	NN
46745	5503	25	and	and	CC
46745	5503	26	sensation	sensation	NN
46745	5503	27	,	,	,
46745	5503	28	by	by	IN
46745	5503	29	which	which	WDT
46745	5503	30	it	-PRON-	PRP
46745	5503	31	is	be	VBZ
46745	5503	32	united	united	JJ
46745	5503	33	to	to	IN
46745	5503	34	the	the	DT
46745	5503	35	body	body	NN
46745	5503	36	;	;	:
46745	5503	37	and	and	CC
46745	5503	38	the	the	DT
46745	5503	39	special	special	JJ
46745	5503	40	senses	sense	NNS
46745	5503	41	,	,	,
46745	5503	42	by	by	IN
46745	5503	43	means	mean	NNS
46745	5503	44	of	of	IN
46745	5503	45	which	which	WDT
46745	5503	46	it	-PRON-	PRP
46745	5503	47	is	be	VBZ
46745	5503	48	connected	connect	VBN
46745	5503	49	with	with	IN
46745	5503	50	external	external	JJ
46745	5503	51	things	thing	NNS
46745	5503	52	.	.	.
46745	5504	1	And	and	CC
46745	5504	2	that	that	IN
46745	5504	3	the	the	DT
46745	5504	4	secondary	secondary	JJ
46745	5504	5	or	or	CC
46745	5504	6	depressing	depressing	JJ
46745	5504	7	action	action	NN
46745	5504	8	of	of	IN
46745	5504	9	Inebriants	inebriant	NNS
46745	5504	10	is	be	VBZ
46745	5504	11	such	such	JJ
46745	5504	12	as	as	IN
46745	5504	13	to	to	IN
46745	5504	14	_	_	NNP
46745	5504	15	impair	impair	NN
46745	5504	16	_	_	NNP
46745	5504	17	these	these	DT
46745	5504	18	three	three	CD
46745	5504	19	in	in	IN
46745	5504	20	a	a	DT
46745	5504	21	tolerably	tolerably	RB
46745	5504	22	equal	equal	JJ
46745	5504	23	degree	degree	NN
46745	5504	24	;	;	:
46745	5504	25	that	that	DT
46745	5504	26	of	of	IN
46745	5504	27	Soporifics	Soporifics	NNPS
46745	5504	28	_	_	NNP
46745	5504	29	extinguishes	extinguish	VBZ
46745	5504	30	_	_	NNP
46745	5504	31	for	for	IN
46745	5504	32	a	a	DT
46745	5504	33	time	time	NN
46745	5504	34	sensation	sensation	NN
46745	5504	35	,	,	,
46745	5504	36	volition	volition	NN
46745	5504	37	,	,	,
46745	5504	38	and	and	CC
46745	5504	39	the	the	DT
46745	5504	40	five	five	CD
46745	5504	41	senses	sense	NNS
46745	5504	42	,	,	,
46745	5504	43	while	while	IN
46745	5504	44	it	-PRON-	PRP
46745	5504	45	may	may	MD
46745	5504	46	leave	leave	VB
46745	5504	47	the	the	DT
46745	5504	48	mind	mind	NN
46745	5504	49	unaffected	unaffected	JJ
46745	5504	50	;	;	:
46745	5504	51	but	but	CC
46745	5504	52	that	that	DT
46745	5504	53	of	of	IN
46745	5504	54	Deliriants	Deliriants	NNPS
46745	5504	55	_	_	NNP
46745	5504	56	excites	excites	NNPS
46745	5504	57	_	_	NNP
46745	5504	58	and	and	CC
46745	5504	59	_	_	NNP
46745	5504	60	deranges	derange	VBZ
46745	5504	61	_	_	NNP
46745	5504	62	all	all	PDT
46745	5504	63	the	the	DT
46745	5504	64	intellectual	intellectual	JJ
46745	5504	65	functions	function	NNS
46745	5504	66	.	.	.
46745	5505	1	If	if	IN
46745	5505	2	these	these	DT
46745	5505	3	things	thing	NNS
46745	5505	4	are	be	VBP
46745	5505	5	borne	bear	VBN
46745	5505	6	in	in	IN
46745	5505	7	mind	mind	NN
46745	5505	8	,	,	,
46745	5505	9	the	the	DT
46745	5505	10	physiological	physiological	JJ
46745	5505	11	action	action	NN
46745	5505	12	of	of	IN
46745	5505	13	Alcohol	Alcohol	NNP
46745	5505	14	will	will	MD
46745	5505	15	be	be	VB
46745	5505	16	tolerably	tolerably	RB
46745	5505	17	understood	understand	VBN
46745	5505	18	when	when	WRB
46745	5505	19	it	-PRON-	PRP
46745	5505	20	is	be	VBZ
46745	5505	21	said	say	VBN
46745	5505	22	to	to	TO
46745	5505	23	be	be	VB
46745	5505	24	an	an	DT
46745	5505	25	Inebriant	inebriant	JJ
46745	5505	26	Narcotic	narcotic	NN
46745	5505	27	.	.	.
46745	5506	1	But	but	CC
46745	5506	2	it	-PRON-	PRP
46745	5506	3	must	must	MD
46745	5506	4	be	be	VB
46745	5506	5	observed	observe	VBN
46745	5506	6	that	that	IN
46745	5506	7	when	when	WRB
46745	5506	8	given	give	VBN
46745	5506	9	in	in	IN
46745	5506	10	small	small	JJ
46745	5506	11	quantities	quantity	NNS
46745	5506	12	its	-PRON-	PRP$
46745	5506	13	stimulant	stimulant	JJ
46745	5506	14	effect	effect	NN
46745	5506	15	may	may	MD
46745	5506	16	be	be	VB
46745	5506	17	the	the	DT
46745	5506	18	chief	chief	JJ
46745	5506	19	action	action	NN
46745	5506	20	manifested	manifest	VBN
46745	5506	21	,	,	,
46745	5506	22	its	-PRON-	PRP$
46745	5506	23	secondary	secondary	JJ
46745	5506	24	sedative	sedative	JJ
46745	5506	25	effect	effect	NN
46745	5506	26	may	may	MD
46745	5506	27	hardly	hardly	RB
46745	5506	28	take	take	VB
46745	5506	29	place	place	NN
46745	5506	30	,	,	,
46745	5506	31	and	and	CC
46745	5506	32	the	the	DT
46745	5506	33	production	production	NN
46745	5506	34	of	of	IN
46745	5506	35	Inebriation	inebriation	NN
46745	5506	36	,	,	,
46745	5506	37	or	or	CC
46745	5506	38	drunkenness	drunkenness	NN
46745	5506	39	,	,	,
46745	5506	40	may	may	MD
46745	5506	41	be	be	VB
46745	5506	42	altogether	altogether	RB
46745	5506	43	avoided	avoid	VBN
46745	5506	44	.	.	.
46745	5507	1	So	so	RB
46745	5507	2	much	much	JJ
46745	5507	3	is	be	VBZ
46745	5507	4	this	this	DT
46745	5507	5	the	the	DT
46745	5507	6	case	case	NN
46745	5507	7	that	that	IN
46745	5507	8	Alcohol	Alcohol	NNP
46745	5507	9	is	be	VBZ
46745	5507	10	by	by	IN
46745	5507	11	some	some	DT
46745	5507	12	regarded	regard	VBN
46745	5507	13	as	as	IN
46745	5507	14	a	a	DT
46745	5507	15	Stimulant	Stimulant	NNP
46745	5507	16	.	.	.
46745	5508	1	But	but	CC
46745	5508	2	the	the	DT
46745	5508	3	same	same	JJ
46745	5508	4	thing	thing	NN
46745	5508	5	is	be	VBZ
46745	5508	6	remarked	remark	VBN
46745	5508	7	of	of	IN
46745	5508	8	Opium	Opium	NNP
46745	5508	9	,	,	,
46745	5508	10	though	though	IN
46745	5508	11	in	in	IN
46745	5508	12	a	a	DT
46745	5508	13	less	less	JJR
46745	5508	14	degree	degree	NN
46745	5508	15	.	.	.
46745	5509	1	And	and	CC
46745	5509	2	the	the	DT
46745	5509	3	effects	effect	NNS
46745	5509	4	of	of	IN
46745	5509	5	a	a	DT
46745	5509	6	large	large	JJ
46745	5509	7	dose	dose	NN
46745	5509	8	of	of	IN
46745	5509	9	Alcohol	Alcohol	NNP
46745	5509	10	are	be	VBP
46745	5509	11	sufficiently	sufficiently	RB
46745	5509	12	obvious	obvious	JJ
46745	5509	13	to	to	TO
46745	5509	14	indicate	indicate	VB
46745	5509	15	its	-PRON-	PRP$
46745	5509	16	place	place	NN
46745	5509	17	amongst	amongst	IN
46745	5509	18	Narcotics	Narcotics	NNP
46745	5509	19	.	.	.
46745	5510	1	For	for	IN
46745	5510	2	the	the	DT
46745	5510	3	state	state	NN
46745	5510	4	of	of	IN
46745	5510	5	Inebriation	Inebriation	NNP
46745	5510	6	may	may	MD
46745	5510	7	even	even	RB
46745	5510	8	pass	pass	VB
46745	5510	9	on	on	RP
46745	5510	10	into	into	IN
46745	5510	11	coma	coma	NN
46745	5510	12	,	,	,
46745	5510	13	and	and	CC
46745	5510	14	death	death	NN
46745	5510	15	.	.	.
46745	5511	1	In	in	IN
46745	5511	2	small	small	JJ
46745	5511	3	quantities	quantity	NNS
46745	5511	4	,	,	,
46745	5511	5	for	for	IN
46745	5511	6	the	the	DT
46745	5511	7	purpose	purpose	NN
46745	5511	8	of	of	IN
46745	5511	9	producing	produce	VBG
46745	5511	10	exhilaration	exhilaration	NN
46745	5511	11	,	,	,
46745	5511	12	and	and	CC
46745	5511	13	of	of	IN
46745	5511	14	overcoming	overcome	VBG
46745	5511	15	various	various	JJ
46745	5511	16	depressing	depressing	JJ
46745	5511	17	causes	cause	NNS
46745	5511	18	which	which	WDT
46745	5511	19	are	be	VBP
46745	5511	20	of	of	IN
46745	5511	21	daily	daily	JJ
46745	5511	22	occurrence	occurrence	NN
46745	5511	23	,	,	,
46745	5511	24	alcoholic	alcoholic	JJ
46745	5511	25	liquors	liquor	NNS
46745	5511	26	of	of	IN
46745	5511	27	various	various	JJ
46745	5511	28	kinds	kind	NNS
46745	5511	29	,	,	,
46745	5511	30	Beer	beer	NN
46745	5511	31	,	,	,
46745	5511	32	Wine	Wine	NNP
46745	5511	33	,	,	,
46745	5511	34	and	and	CC
46745	5511	35	Spirits	Spirits	NNPS
46745	5511	36	,	,	,
46745	5511	37	are	be	VBP
46745	5511	38	habitually	habitually	RB
46745	5511	39	employed	employ	VBN
46745	5511	40	by	by	IN
46745	5511	41	a	a	DT
46745	5511	42	large	large	JJ
46745	5511	43	portion	portion	NN
46745	5511	44	of	of	IN
46745	5511	45	mankind	mankind	NN
46745	5511	46	.	.	.
46745	5512	1	On	on	IN
46745	5512	2	the	the	DT
46745	5512	3	broad	broad	JJ
46745	5512	4	and	and	CC
46745	5512	5	important	important	JJ
46745	5512	6	question	question	NN
46745	5512	7	of	of	IN
46745	5512	8	their	-PRON-	PRP$
46745	5512	9	use	use	NN
46745	5512	10	and	and	CC
46745	5512	11	abuse	abuse	NN
46745	5512	12	as	as	IN
46745	5512	13	articles	article	NNS
46745	5512	14	of	of	IN
46745	5512	15	diet	diet	NN
46745	5512	16	this	this	DT
46745	5512	17	is	be	VBZ
46745	5512	18	not	not	RB
46745	5512	19	the	the	DT
46745	5512	20	opportunity	opportunity	NN
46745	5512	21	to	to	TO
46745	5512	22	enter	enter	VB
46745	5512	23	.	.	.
46745	5513	1	In	in	IN
46745	5513	2	the	the	DT
46745	5513	3	form	form	NN
46745	5513	4	of	of	IN
46745	5513	5	Brandy	Brandy	NNP
46745	5513	6	(	(	-LRB-
46745	5513	7	which	which	WDT
46745	5513	8	is	be	VBZ
46745	5513	9	more	more	RBR
46745	5513	10	agreeable	agreeable	JJ
46745	5513	11	to	to	IN
46745	5513	12	the	the	DT
46745	5513	13	palate	palate	NN
46745	5513	14	,	,	,
46745	5513	15	)	)	-RRB-
46745	5513	16	Alcohol	alcohol	NN
46745	5513	17	is	be	VBZ
46745	5513	18	applicable	applicable	JJ
46745	5513	19	as	as	IN
46745	5513	20	a	a	DT
46745	5513	21	medicine	medicine	NN
46745	5513	22	in	in	IN
46745	5513	23	low	low	JJ
46745	5513	24	Fevers	fever	NNS
46745	5513	25	,	,	,
46745	5513	26	in	in	IN
46745	5513	27	asthenic	asthenic	JJ
46745	5513	28	Erysipelas	Erysipelas	NNP
46745	5513	29	,	,	,
46745	5513	30	in	in	IN
46745	5513	31	Typhoid	typhoid	JJ
46745	5513	32	forms	form	NNS
46745	5513	33	of	of	IN
46745	5513	34	Pneumonia	Pneumonia	NNP
46745	5513	35	,	,	,
46745	5513	36	and	and	CC
46745	5513	37	in	in	IN
46745	5513	38	Collapse	Collapse	NNP
46745	5513	39	or	or	CC
46745	5513	40	Syncope	Syncope	NNP
46745	5513	41	produced	produce	VBN
46745	5513	42	by	by	IN
46745	5513	43	surgical	surgical	JJ
46745	5513	44	injuries	injury	NNS
46745	5513	45	or	or	CC
46745	5513	46	other	other	JJ
46745	5513	47	causes	cause	NNS
46745	5513	48	.	.	.
46745	5514	1	It	-PRON-	PRP
46745	5514	2	restores	restore	VBZ
46745	5514	3	the	the	DT
46745	5514	4	action	action	NN
46745	5514	5	of	of	IN
46745	5514	6	the	the	DT
46745	5514	7	heart	heart	NN
46745	5514	8	,	,	,
46745	5514	9	and	and	CC
46745	5514	10	enables	enable	VBZ
46745	5514	11	the	the	DT
46745	5514	12	system	system	NN
46745	5514	13	to	to	TO
46745	5514	14	bear	bear	VB
46745	5514	15	up	up	RP
46745	5514	16	against	against	IN
46745	5514	17	the	the	DT
46745	5514	18	disorder	disorder	NN
46745	5514	19	.	.	.
46745	5515	1	The	the	DT
46745	5515	2	stimulant	stimulant	NN
46745	5515	3	action	action	NN
46745	5515	4	may	may	MD
46745	5515	5	be	be	VB
46745	5515	6	maintained	maintain	VBN
46745	5515	7	,	,	,
46745	5515	8	and	and	CC
46745	5515	9	the	the	DT
46745	5515	10	secondary	secondary	JJ
46745	5515	11	sedative	sedative	JJ
46745	5515	12	effect	effect	NN
46745	5515	13	prevented	prevent	VBN
46745	5515	14	,	,	,
46745	5515	15	by	by	IN
46745	5515	16	a	a	DT
46745	5515	17	continual	continual	JJ
46745	5515	18	repetition	repetition	NN
46745	5515	19	of	of	IN
46745	5515	20	the	the	DT
46745	5515	21	dose	dose	NN
46745	5515	22	.	.	.
46745	5516	1	Thus	thus	RB
46745	5516	2	when	when	WRB
46745	5516	3	once	once	IN
46745	5516	4	the	the	DT
46745	5516	5	employment	employment	NN
46745	5516	6	of	of	IN
46745	5516	7	this	this	DT
46745	5516	8	stimulant	stimulant	NN
46745	5516	9	has	have	VBZ
46745	5516	10	been	be	VBN
46745	5516	11	determined	determine	VBN
46745	5516	12	upon	upon	IN
46745	5516	13	,	,	,
46745	5516	14	it	-PRON-	PRP
46745	5516	15	should	should	MD
46745	5516	16	be	be	VB
46745	5516	17	steadily	steadily	RB
46745	5516	18	and	and	CC
46745	5516	19	unremittingly	unremittingly	RB
46745	5516	20	persevered	persevere	VBD
46745	5516	21	in	in	RB
46745	5516	22	until	until	IN
46745	5516	23	decided	decide	VBN
46745	5516	24	symptoms	symptom	NNS
46745	5516	25	of	of	IN
46745	5516	26	improvement	improvement	NN
46745	5516	27	have	have	VBP
46745	5516	28	shown	show	VBN
46745	5516	29	themselves	-PRON-	PRP
46745	5516	30	in	in	IN
46745	5516	31	the	the	DT
46745	5516	32	patient	patient	NN
46745	5516	33	.	.	.
46745	5517	1	The	the	DT
46745	5517	2	tendency	tendency	NN
46745	5517	3	of	of	IN
46745	5517	4	the	the	DT
46745	5517	5	practice	practice	NN
46745	5517	6	of	of	IN
46745	5517	7	the	the	DT
46745	5517	8	present	present	JJ
46745	5517	9	day	day	NN
46745	5517	10	is	be	VBZ
46745	5517	11	towards	towards	IN
46745	5517	12	a	a	DT
46745	5517	13	freer	free	JJR
46745	5517	14	use	use	NN
46745	5517	15	of	of	IN
46745	5517	16	Stimulants	Stimulants	NNP
46745	5517	17	,	,	,
46745	5517	18	and	and	CC
46745	5517	19	a	a	DT
46745	5517	20	more	more	RBR
46745	5517	21	sparing	sparing	NN
46745	5517	22	employment	employment	NN
46745	5517	23	of	of	IN
46745	5517	24	blood	blood	NN
46745	5517	25	-	-	HYPH
46745	5517	26	letting	letting	NN
46745	5517	27	and	and	CC
46745	5517	28	antiphlogistic	antiphlogistic	JJ
46745	5517	29	agents	agent	NNS
46745	5517	30	,	,	,
46745	5517	31	than	than	IN
46745	5517	32	was	be	VBD
46745	5517	33	some	some	DT
46745	5517	34	time	time	NN
46745	5517	35	ago	ago	RB
46745	5517	36	prescribed	prescribe	VBN
46745	5517	37	.	.	.
46745	5518	1	And	and	CC
46745	5518	2	this	this	DT
46745	5518	3	is	be	VBZ
46745	5518	4	probably	probably	RB
46745	5518	5	an	an	DT
46745	5518	6	advance	advance	NN
46745	5518	7	in	in	IN
46745	5518	8	the	the	DT
46745	5518	9	right	right	JJ
46745	5518	10	direction	direction	NN
46745	5518	11	;	;	:
46745	5518	12	for	for	IN
46745	5518	13	in	in	IN
46745	5518	14	morbid	morbid	JJ
46745	5518	15	actions	action	NNS
46745	5518	16	there	there	EX
46745	5518	17	is	be	VBZ
46745	5518	18	altogether	altogether	RB
46745	5518	19	very	very	RB
46745	5518	20	little	little	JJ
46745	5518	21	that	that	WDT
46745	5518	22	is	be	VBZ
46745	5518	23	really	really	RB
46745	5518	24	sthenic	sthenic	JJ
46745	5518	25	;	;	:
46745	5518	26	and	and	CC
46745	5518	27	it	-PRON-	PRP
46745	5518	28	is	be	VBZ
46745	5518	29	,	,	,
46745	5518	30	as	as	IN
46745	5518	31	a	a	DT
46745	5518	32	general	general	JJ
46745	5518	33	rule	rule	NN
46745	5518	34	,	,	,
46745	5518	35	a	a	DT
46745	5518	36	wiser	wise	JJR
46745	5518	37	thing	thing	NN
46745	5518	38	to	to	TO
46745	5518	39	support	support	VB
46745	5518	40	the	the	DT
46745	5518	41	system	system	NN
46745	5518	42	against	against	IN
46745	5518	43	the	the	DT
46745	5518	44	wearing	wear	VBG
46745	5518	45	action	action	NN
46745	5518	46	of	of	IN
46745	5518	47	a	a	DT
46745	5518	48	disorder	disorder	NN
46745	5518	49	,	,	,
46745	5518	50	than	than	IN
46745	5518	51	to	to	TO
46745	5518	52	add	add	VB
46745	5518	53	to	to	IN
46745	5518	54	the	the	DT
46745	5518	55	heap	heap	NN
46745	5518	56	of	of	IN
46745	5518	57	its	-PRON-	PRP$
46745	5518	58	various	various	JJ
46745	5518	59	troubles	trouble	NNS
46745	5518	60	another	another	DT
46745	5518	61	depressing	depressing	JJ
46745	5518	62	cause	cause	NN
46745	5518	63	.	.	.
46745	5519	1	But	but	CC
46745	5519	2	Alcohol	Alcohol	NNP
46745	5519	3	is	be	VBZ
46745	5519	4	a	a	DT
46745	5519	5	potent	potent	JJ
46745	5519	6	agent	agent	NN
46745	5519	7	for	for	IN
46745	5519	8	evil	evil	NN
46745	5519	9	as	as	RB
46745	5519	10	well	well	RB
46745	5519	11	as	as	IN
46745	5519	12	for	for	IN
46745	5519	13	good	good	NN
46745	5519	14	.	.	.
46745	5520	1	When	when	WRB
46745	5520	2	large	large	JJ
46745	5520	3	quantities	quantity	NNS
46745	5520	4	are	be	VBP
46745	5520	5	taken	take	VBN
46745	5520	6	continually	continually	RB
46745	5520	7	for	for	IN
46745	5520	8	a	a	DT
46745	5520	9	considerable	considerable	JJ
46745	5520	10	length	length	NN
46745	5520	11	of	of	IN
46745	5520	12	time	time	NN
46745	5520	13	,	,	,
46745	5520	14	it	-PRON-	PRP
46745	5520	15	is	be	VBZ
46745	5520	16	capable	capable	JJ
46745	5520	17	of	of	IN
46745	5520	18	producing	produce	VBG
46745	5520	19	a	a	DT
46745	5520	20	chronic	chronic	JJ
46745	5520	21	injury	injury	NN
46745	5520	22	of	of	IN
46745	5520	23	the	the	DT
46745	5520	24	brain	brain	NN
46745	5520	25	and	and	CC
46745	5520	26	mind	mind	NN
46745	5520	27	.	.	.
46745	5521	1	By	by	IN
46745	5521	2	impairing	impair	VBG
46745	5521	3	the	the	DT
46745	5521	4	function	function	NN
46745	5521	5	of	of	IN
46745	5521	6	the	the	DT
46745	5521	7	former	former	JJ
46745	5521	8	,	,	,
46745	5521	9	it	-PRON-	PRP
46745	5521	10	brings	bring	VBZ
46745	5521	11	on	on	IN
46745	5521	12	the	the	DT
46745	5521	13	shaking	shake	VBG
46745	5521	14	paralysis	paralysis	NN
46745	5521	15	of	of	IN
46745	5521	16	Delirium	Delirium	NNP
46745	5521	17	tremens	tremen	NNS
46745	5521	18	.	.	.
46745	5522	1	By	by	IN
46745	5522	2	an	an	DT
46745	5522	3	action	action	NN
46745	5522	4	on	on	IN
46745	5522	5	the	the	DT
46745	5522	6	mind	mind	NN
46745	5522	7	,	,	,
46745	5522	8	it	-PRON-	PRP
46745	5522	9	causes	cause	VBZ
46745	5522	10	the	the	DT
46745	5522	11	strange	strange	JJ
46745	5522	12	hallucinations	hallucination	NNS
46745	5522	13	and	and	CC
46745	5522	14	the	the	DT
46745	5522	15	habitual	habitual	JJ
46745	5522	16	despondency	despondency	NN
46745	5522	17	which	which	WDT
46745	5522	18	characterize	characterize	VBP
46745	5522	19	that	that	IN
46745	5522	20	disorder	disorder	NN
46745	5522	21	.	.	.
46745	5523	1	Habitual	habitual	JJ
46745	5523	2	drinking	drinking	NN
46745	5523	3	may	may	MD
46745	5523	4	likewise	likewise	RB
46745	5523	5	cause	cause	VB
46745	5523	6	a	a	DT
46745	5523	7	chronic	chronic	JJ
46745	5523	8	inflammation	inflammation	NN
46745	5523	9	of	of	IN
46745	5523	10	the	the	DT
46745	5523	11	liver	liver	NN
46745	5523	12	,	,	,
46745	5523	13	called	call	VBN
46745	5523	14	Cirrhosis	Cirrhosis	NNP
46745	5523	15	,	,	,
46745	5523	16	which	which	WDT
46745	5523	17	is	be	VBZ
46745	5523	18	succeeded	succeed	VBN
46745	5523	19	by	by	IN
46745	5523	20	Dropsy	Dropsy	NNP
46745	5523	21	.	.	.
46745	5524	1	Alcohol	Alcohol	NNP
46745	5524	2	is	be	VBZ
46745	5524	3	absorbed	absorb	VBN
46745	5524	4	by	by	IN
46745	5524	5	the	the	DT
46745	5524	6	stomach	stomach	NN
46745	5524	7	;	;	:
46745	5524	8	and	and	CC
46745	5524	9	,	,	,
46745	5524	10	on	on	IN
46745	5524	11	passing	pass	VBG
46745	5524	12	through	through	IN
46745	5524	13	the	the	DT
46745	5524	14	Portal	Portal	NNP
46745	5524	15	vein	vein	NN
46745	5524	16	to	to	IN
46745	5524	17	the	the	DT
46745	5524	18	liver	liver	NN
46745	5524	19	,	,	,
46745	5524	20	may	may	MD
46745	5524	21	there	there	EX
46745	5524	22	produce	produce	VB
46745	5524	23	this	this	DT
46745	5524	24	condition	condition	NN
46745	5524	25	of	of	IN
46745	5524	26	the	the	DT
46745	5524	27	organ	organ	NN
46745	5524	28	by	by	IN
46745	5524	29	the	the	DT
46745	5524	30	continual	continual	JJ
46745	5524	31	irritation	irritation	NN
46745	5524	32	which	which	WDT
46745	5524	33	it	-PRON-	PRP
46745	5524	34	excites	excite	VBZ
46745	5524	35	.	.	.
46745	5525	1	When	when	WRB
46745	5525	2	taken	take	VBN
46745	5525	3	in	in	IN
46745	5525	4	considerable	considerable	JJ
46745	5525	5	quantity	quantity	NN
46745	5525	6	Alcohol	Alcohol	NNP
46745	5525	7	passes	pass	VBZ
46745	5525	8	out	out	IN
46745	5525	9	of	of	IN
46745	5525	10	the	the	DT
46745	5525	11	system	system	NN
46745	5525	12	by	by	IN
46745	5525	13	the	the	DT
46745	5525	14	skin	skin	NN
46745	5525	15	and	and	CC
46745	5525	16	kidneys	kidney	NNS
46745	5525	17	,	,	,
46745	5525	18	and	and	CC
46745	5525	19	thus	thus	RB
46745	5525	20	acts	act	VBZ
46745	5525	21	as	as	IN
46745	5525	22	a	a	DT
46745	5525	23	Diaphoretic	diaphoretic	JJ
46745	5525	24	and	and	CC
46745	5525	25	Diuretic	diuretic	JJ
46745	5525	26	.	.	.
46745	5526	1	But	but	CC
46745	5526	2	Liebig	Liebig	NNP
46745	5526	3	states	state	VBZ
46745	5526	4	that	that	IN
46745	5526	5	when	when	WRB
46745	5526	6	taken	take	VBN
46745	5526	7	in	in	IN
46745	5526	8	small	small	JJ
46745	5526	9	quantities	quantity	NNS
46745	5526	10	it	-PRON-	PRP
46745	5526	11	does	do	VBZ
46745	5526	12	not	not	RB
46745	5526	13	pass	pass	VB
46745	5526	14	off	off	RP
46745	5526	15	in	in	IN
46745	5526	16	the	the	DT
46745	5526	17	secretions	secretion	NNS
46745	5526	18	,	,	,
46745	5526	19	but	but	CC
46745	5526	20	is	be	VBZ
46745	5526	21	consumed	consume	VBN
46745	5526	22	or	or	CC
46745	5526	23	burnt	burn	VBN
46745	5526	24	in	in	IN
46745	5526	25	the	the	DT
46745	5526	26	system	system	NN
46745	5526	27	into	into	IN
46745	5526	28	Carbonic	Carbonic	NNP
46745	5526	29	Acid	Acid	NNP
46745	5526	30	and	and	CC
46745	5526	31	water	water	NN
46745	5526	32	.	.	.
46745	5527	1	He	-PRON-	PRP
46745	5527	2	has	have	VBZ
46745	5527	3	found	find	VBN
46745	5527	4	that	that	IN
46745	5527	5	persons	person	NNS
46745	5527	6	who	who	WP
46745	5527	7	are	be	VBP
46745	5527	8	accustomed	accustomed	JJ
46745	5527	9	to	to	TO
46745	5527	10	take	take	VB
46745	5527	11	Beer	beer	NN
46745	5527	12	in	in	IN
46745	5527	13	moderation	moderation	NN
46745	5527	14	require	require	VBP
46745	5527	15	less	less	JJR
46745	5527	16	bread	bread	NN
46745	5527	17	in	in	IN
46745	5527	18	their	-PRON-	PRP$
46745	5527	19	food	food	NN
46745	5527	20	.	.	.
46745	5528	1	(	(	-LRB-
46745	5528	2	_	_	NNP
46745	5528	3	Animal	Animal	NNP
46745	5528	4	Chemistry	Chemistry	NNP
46745	5528	5	_	_	NNP
46745	5528	6	,	,	,
46745	5528	7	Part	Part	NNP
46745	5528	8	I.	I.	NNP
46745	5528	9	,	,	,
46745	5528	10	p.	p.	NN
46745	5529	1	96	96	CD
46745	5529	2	.	.	.
46745	5529	3	)	)	-RRB-
46745	5530	1	And	and	CC
46745	5530	2	as	as	IN
46745	5530	3	it	-PRON-	PRP
46745	5530	4	contains	contain	VBZ
46745	5530	5	more	more	JJR
46745	5530	6	Hydrogen	hydrogen	NN
46745	5530	7	than	than	IN
46745	5530	8	starchy	starchy	JJ
46745	5530	9	food	food	NN
46745	5530	10	,	,	,
46745	5530	11	and	and	CC
46745	5530	12	by	by	IN
46745	5530	13	the	the	DT
46745	5530	14	combustion	combustion	NN
46745	5530	15	of	of	IN
46745	5530	16	this	this	DT
46745	5530	17	Hydrogen	Hydrogen	NNP
46745	5530	18	the	the	DT
46745	5530	19	animal	animal	NN
46745	5530	20	heat	heat	NN
46745	5530	21	is	be	VBZ
46745	5530	22	partly	partly	RB
46745	5530	23	maintained	maintain	VBN
46745	5530	24	,	,	,
46745	5530	25	Vierordt	Vierordt	NNP
46745	5530	26	has	have	VBZ
46745	5530	27	shown	show	VBN
46745	5530	28	that	that	IN
46745	5530	29	during	during	IN
46745	5530	30	the	the	DT
46745	5530	31	use	use	NN
46745	5530	32	of	of	IN
46745	5530	33	alcoholic	alcoholic	JJ
46745	5530	34	liquors	liquor	NNS
46745	5530	35	the	the	DT
46745	5530	36	amount	amount	NN
46745	5530	37	of	of	IN
46745	5530	38	Carbonic	carbonic	JJ
46745	5530	39	Acid	Acid	NNP
46745	5530	40	exhaled	exhale	VBN
46745	5530	41	by	by	IN
46745	5530	42	the	the	DT
46745	5530	43	lungs	lung	NNS
46745	5530	44	is	be	VBZ
46745	5530	45	diminished	diminish	VBN
46745	5530	46	.	.	.
46745	5531	1	Thus	thus	RB
46745	5531	2	Alcohol	Alcohol	NNP
46745	5531	3	may	may	MD
46745	5531	4	be	be	VB
46745	5531	5	regarded	regard	VBN
46745	5531	6	as	as	IN
46745	5531	7	one	one	CD
46745	5531	8	of	of	IN
46745	5531	9	the	the	DT
46745	5531	10	calorifacient	calorifacient	NN
46745	5531	11	articles	article	NNS
46745	5531	12	of	of	IN
46745	5531	13	food	food	NN
46745	5531	14	.	.	.
46745	5532	1	(	(	-LRB-
46745	5532	2	_	_	NNP
46745	5532	3	Vide	Vide	NNP
46745	5532	4	_	_	NNP
46745	5532	5	pp	pp	NNP
46745	5532	6	.	.	.
46745	5533	1	234	234	CD
46745	5533	2	,	,	,
46745	5533	3	237	237	CD
46745	5533	4	,	,	,
46745	5533	5	241	241	CD
46745	5533	6	,	,	,
46745	5533	7	255	255	CD
46745	5533	8	.	.	.
46745	5533	9	)	)	-RRB-
46745	5534	1	CHLOROFORM	CHLOROFORM	NNP
46745	5534	2	.	.	.
46745	5535	1	Class	class	NN
46745	5535	2	II	II	NNP
46745	5535	3	.	.	.
46745	5536	1	Div	Div	NNP
46745	5536	2	.	.	.
46745	5537	1	II	ii	CD
46745	5537	2	.	.	.
46745	5538	1	Ord	Ord	NNP
46745	5538	2	.	.	.
46745	5539	1	I.	I.	NNP
46745	5539	2	NARCOTICA	NARCOTICA	NNP
46745	5539	3	INEBRIANTIA	INEBRIANTIA	NNP
46745	5539	4	.	.	.
46745	5540	1	Class	Class	NNP
46745	5540	2	IV	IV	NNP
46745	5540	3	.	.	.
46745	5541	1	Ord	Ord	NNP
46745	5541	2	.	.	.
46745	5542	1	V.	V.	NNP
46745	5542	2	DIAPHORETICA	DIAPHORETICA	NNP
46745	5542	3	.	.	.
46745	5543	1	Class	Class	NNP
46745	5543	2	IV	IV	NNP
46745	5543	3	.	.	.
46745	5544	1	Ord	Ord	NNP
46745	5544	2	.	.	.
46745	5545	1	VI	VI	NNP
46745	5545	2	.	.	.
46745	5546	1	DIURETICA	DIURETICA	NNP
46745	5546	2	.	.	.
46745	5547	1	Chloroform	chloroform	NN
46745	5547	2	,	,	,
46745	5547	3	or	or	CC
46745	5547	4	Terchloride	Terchloride	NNP
46745	5547	5	of	of	IN
46745	5547	6	Formyle	Formyle	NNP
46745	5547	7	,	,	,
46745	5547	8	is	be	VBZ
46745	5547	9	a	a	DT
46745	5547	10	volatile	volatile	JJ
46745	5547	11	liquid	liquid	NN
46745	5547	12	which	which	WDT
46745	5547	13	is	be	VBZ
46745	5547	14	analogous	analogous	JJ
46745	5547	15	to	to	IN
46745	5547	16	Ether	Ether	NNP
46745	5547	17	and	and	CC
46745	5547	18	Alcohol	Alcohol	NNP
46745	5547	19	both	both	CC
46745	5547	20	in	in	IN
46745	5547	21	nature	nature	NN
46745	5547	22	and	and	CC
46745	5547	23	medicinal	medicinal	JJ
46745	5547	24	action	action	NN
46745	5547	25	,	,	,
46745	5547	26	but	but	CC
46745	5547	27	very	very	RB
46745	5547	28	different	different	JJ
46745	5547	29	in	in	IN
46745	5547	30	chemical	chemical	JJ
46745	5547	31	construction	construction	NN
46745	5547	32	.	.	.
46745	5548	1	Ether	ether	NN
46745	5548	2	=	=	SYM
46745	5548	3	C_{4}H_{5	C_{4}H_{5	NNP
46745	5548	4	}	}	-RRB-
46745	5548	5	,	,	,
46745	5548	6	O.	O.	NNP
46745	5549	1	Alcohol	Alcohol	NNP
46745	5549	2	=	=	SYM
46745	5549	3	C_{4}H_{5	C_{4}H_{5	NNP
46745	5549	4	}	}	-RRB-
46745	5549	5	,	,	,
46745	5549	6	O+HO	O+HO	NNP
46745	5549	7	.	.	.
46745	5550	1	Chloroform	chloroform	NN
46745	5550	2	=	=	SYM
46745	5550	3	C_{2}H	c_{2}h	NN
46745	5550	4	,	,	,
46745	5550	5	Cl_{3	cl_{3	NN
46745	5550	6	}	}	-RRB-
46745	5550	7	.	.	.
46745	5551	1	A	a	DT
46745	5551	2	solution	solution	NN
46745	5551	3	of	of	IN
46745	5551	4	Chloroform	Chloroform	NNP
46745	5551	5	in	in	IN
46745	5551	6	spirit	spirit	NN
46745	5551	7	,	,	,
46745	5551	8	sold	sell	VBN
46745	5551	9	under	under	IN
46745	5551	10	the	the	DT
46745	5551	11	names	name	NNS
46745	5551	12	_	_	NNP
46745	5551	13	Terchloride	Terchloride	NNP
46745	5551	14	of	of	IN
46745	5551	15	Carbon	Carbon	NNP
46745	5551	16	_	_	NNP
46745	5551	17	and	and	CC
46745	5551	18	_	_	NNP
46745	5551	19	Chloric	Chloric	NNP
46745	5551	20	ether	ether	NN
46745	5551	21	_	_	NNP
46745	5551	22	,	,	,
46745	5551	23	is	be	VBZ
46745	5551	24	in	in	IN
46745	5551	25	very	very	RB
46745	5551	26	general	general	JJ
46745	5551	27	use	use	NN
46745	5551	28	,	,	,
46745	5551	29	and	and	CC
46745	5551	30	is	be	VBZ
46745	5551	31	employed	employ	VBN
46745	5551	32	in	in	IN
46745	5551	33	very	very	RB
46745	5551	34	much	much	RB
46745	5551	35	the	the	DT
46745	5551	36	same	same	JJ
46745	5551	37	cases	case	NNS
46745	5551	38	as	as	IN
46745	5551	39	Nitric	nitric	JJ
46745	5551	40	ether	ether	NN
46745	5551	41	,	,	,
46745	5551	42	being	be	VBG
46745	5551	43	in	in	IN
46745	5551	44	the	the	DT
46745	5551	45	first	first	JJ
46745	5551	46	place	place	NN
46745	5551	47	stimulant	stimulant	NN
46745	5551	48	,	,	,
46745	5551	49	and	and	CC
46745	5551	50	subsequently	subsequently	RB
46745	5551	51	anodyne	anodyne	NNP
46745	5551	52	,	,	,
46745	5551	53	soporific	soporific	JJ
46745	5551	54	,	,	,
46745	5551	55	and	and	CC
46745	5551	56	diaphoretic	diaphoretic	JJ
46745	5551	57	.	.	.
46745	5552	1	Chloroform	chloroform	NN
46745	5552	2	is	be	VBZ
46745	5552	3	physiologically	physiologically	RB
46745	5552	4	an	an	DT
46745	5552	5	Inebriant	Inebriant	NNP
46745	5552	6	.	.	.
46745	5553	1	But	but	CC
46745	5553	2	it	-PRON-	PRP
46745	5553	3	is	be	VBZ
46745	5553	4	for	for	IN
46745	5553	5	certain	certain	JJ
46745	5553	6	peculiar	peculiar	JJ
46745	5553	7	actions	action	NNS
46745	5553	8	that	that	WDT
46745	5553	9	are	be	VBP
46745	5553	10	coincident	coincident	JJ
46745	5553	11	with	with	IN
46745	5553	12	,	,	,
46745	5553	13	or	or	CC
46745	5553	14	immediately	immediately	RB
46745	5553	15	follow	follow	VB
46745	5553	16	,	,	,
46745	5553	17	this	this	DT
46745	5553	18	production	production	NN
46745	5553	19	of	of	IN
46745	5553	20	inebriation	inebriation	NN
46745	5553	21	,	,	,
46745	5553	22	that	that	IN
46745	5553	23	it	-PRON-	PRP
46745	5553	24	has	have	VBZ
46745	5553	25	been	be	VBN
46745	5553	26	so	so	RB
46745	5553	27	widely	widely	RB
46745	5553	28	and	and	CC
46745	5553	29	so	so	RB
46745	5553	30	successfully	successfully	RB
46745	5553	31	employed	employ	VBN
46745	5553	32	in	in	IN
46745	5553	33	medicine	medicine	NN
46745	5553	34	since	since	IN
46745	5553	35	its	-PRON-	PRP$
46745	5553	36	recent	recent	JJ
46745	5553	37	discovery	discovery	NN
46745	5553	38	.	.	.
46745	5554	1	Its	-PRON-	PRP$
46745	5554	2	two	two	CD
46745	5554	3	important	important	JJ
46745	5554	4	operations	operation	NNS
46745	5554	5	are	be	VBP
46745	5554	6	its	-PRON-	PRP$
46745	5554	7	anæsthetic	anæsthetic	JJ
46745	5554	8	effect	effect	NN
46745	5554	9	on	on	IN
46745	5554	10	sensory	sensory	JJ
46745	5554	11	nerves	nerve	NNS
46745	5554	12	,	,	,
46745	5554	13	and	and	CC
46745	5554	14	its	-PRON-	PRP$
46745	5554	15	paralyzing	paralyzing	NN
46745	5554	16	influence	influence	NN
46745	5554	17	on	on	IN
46745	5554	18	muscle	muscle	NN
46745	5554	19	.	.	.
46745	5555	1	With	with	IN
46745	5555	2	regard	regard	NN
46745	5555	3	first	first	RB
46745	5555	4	to	to	IN
46745	5555	5	the	the	DT
46745	5555	6	general	general	JJ
46745	5555	7	selection	selection	NN
46745	5555	8	of	of	IN
46745	5555	9	anæsthetic	anæsthetic	JJ
46745	5555	10	or	or	CC
46745	5555	11	anodyne	anodyne	NN
46745	5555	12	remedies	remedy	NNS
46745	5555	13	,	,	,
46745	5555	14	it	-PRON-	PRP
46745	5555	15	is	be	VBZ
46745	5555	16	to	to	TO
46745	5555	17	be	be	VB
46745	5555	18	observed	observe	VBN
46745	5555	19	that	that	IN
46745	5555	20	there	there	EX
46745	5555	21	are	be	VBP
46745	5555	22	four	four	CD
46745	5555	23	distinct	distinct	JJ
46745	5555	24	kinds	kind	NNS
46745	5555	25	of	of	IN
46745	5555	26	Pain	Pain	NNP
46745	5555	27	,	,	,
46745	5555	28	which	which	WDT
46745	5555	29	differ	differ	VBP
46745	5555	30	very	very	RB
46745	5555	31	much	much	RB
46745	5555	32	in	in	IN
46745	5555	33	the	the	DT
46745	5555	34	treatment	treatment	NN
46745	5555	35	required	require	VBN
46745	5555	36	.	.	.
46745	5556	1	(	(	-LRB-
46745	5556	2	1	1	CD
46745	5556	3	.	.	.
46745	5556	4	)	)	-RRB-
46745	5557	1	Firstly	firstly	RB
46745	5557	2	,	,	,
46745	5557	3	there	there	EX
46745	5557	4	is	be	VBZ
46745	5557	5	_	_	NNP
46745	5557	6	inflammatory	inflammatory	JJ
46745	5557	7	_	_	NNP
46745	5557	8	pain	pain	NN
46745	5557	9	,	,	,
46745	5557	10	caused	cause	VBN
46745	5557	11	by	by	IN
46745	5557	12	an	an	DT
46745	5557	13	active	active	JJ
46745	5557	14	disease	disease	NN
46745	5557	15	.	.	.
46745	5558	1	It	-PRON-	PRP
46745	5558	2	is	be	VBZ
46745	5558	3	aggravated	aggravate	VBN
46745	5558	4	by	by	IN
46745	5558	5	pressure	pressure	NN
46745	5558	6	;	;	:
46745	5558	7	and	and	CC
46745	5558	8	it	-PRON-	PRP
46745	5558	9	has	have	VBZ
46745	5558	10	a	a	DT
46745	5558	11	local	local	JJ
46745	5558	12	cause	cause	NN
46745	5558	13	.	.	.
46745	5559	1	For	for	IN
46745	5559	2	this	this	DT
46745	5559	3	Opium	Opium	NNP
46745	5559	4	is	be	VBZ
46745	5559	5	the	the	DT
46745	5559	6	best	good	JJS
46745	5559	7	Neurotic	neurotic	JJ
46745	5559	8	remedy	remedy	NN
46745	5559	9	,	,	,
46745	5559	10	but	but	CC
46745	5559	11	it	-PRON-	PRP
46745	5559	12	should	should	MD
46745	5559	13	not	not	RB
46745	5559	14	be	be	VB
46745	5559	15	used	use	VBN
46745	5559	16	without	without	IN
46745	5559	17	an	an	DT
46745	5559	18	attempt	attempt	NN
46745	5559	19	being	be	VBG
46745	5559	20	previously	previously	RB
46745	5559	21	or	or	CC
46745	5559	22	at	at	IN
46745	5559	23	the	the	DT
46745	5559	24	same	same	JJ
46745	5559	25	time	time	NN
46745	5559	26	made	make	VBN
46745	5559	27	to	to	TO
46745	5559	28	subdue	subdue	VB
46745	5559	29	the	the	DT
46745	5559	30	active	active	JJ
46745	5559	31	inflammation	inflammation	NN
46745	5559	32	.	.	.
46745	5560	1	(	(	-LRB-
46745	5560	2	2	2	CD
46745	5560	3	.	.	.
46745	5560	4	)	)	-RRB-
46745	5561	1	_	_	NNP
46745	5561	2	Irritative	Irritative	NNP
46745	5561	3	_	_	NNP
46745	5561	4	pain	pain	NN
46745	5561	5	is	be	VBZ
46745	5561	6	different	different	JJ
46745	5561	7	.	.	.
46745	5562	1	It	-PRON-	PRP
46745	5562	2	depends	depend	VBZ
46745	5562	3	merely	merely	RB
46745	5562	4	on	on	IN
46745	5562	5	nervous	nervous	JJ
46745	5562	6	irritation	irritation	NN
46745	5562	7	.	.	.
46745	5563	1	It	-PRON-	PRP
46745	5563	2	also	also	RB
46745	5563	3	has	have	VBZ
46745	5563	4	a	a	DT
46745	5563	5	local	local	JJ
46745	5563	6	origin	origin	NN
46745	5563	7	;	;	:
46745	5563	8	but	but	CC
46745	5563	9	it	-PRON-	PRP
46745	5563	10	is	be	VBZ
46745	5563	11	relieved	relieve	VBN
46745	5563	12	,	,	,
46745	5563	13	instead	instead	RB
46745	5563	14	of	of	IN
46745	5563	15	being	be	VBG
46745	5563	16	aggravated	aggravate	VBN
46745	5563	17	,	,	,
46745	5563	18	by	by	IN
46745	5563	19	a	a	DT
46745	5563	20	pressure	pressure	NN
46745	5563	21	or	or	CC
46745	5563	22	friction	friction	NN
46745	5563	23	.	.	.
46745	5564	1	Such	such	JJ
46745	5564	2	is	be	VBZ
46745	5564	3	the	the	DT
46745	5564	4	pain	pain	NN
46745	5564	5	produced	produce	VBN
46745	5564	6	by	by	IN
46745	5564	7	lead	lead	NN
46745	5564	8	-	-	HYPH
46745	5564	9	colic	colic	NN
46745	5564	10	,	,	,
46745	5564	11	or	or	CC
46745	5564	12	by	by	IN
46745	5564	13	the	the	DT
46745	5564	14	passage	passage	NN
46745	5564	15	of	of	IN
46745	5564	16	a	a	DT
46745	5564	17	gallstone	gallstone	NN
46745	5564	18	or	or	CC
46745	5564	19	renal	renal	JJ
46745	5564	20	calculus	calculus	NN
46745	5564	21	.	.	.
46745	5565	1	The	the	DT
46745	5565	2	pain	pain	NN
46745	5565	3	of	of	IN
46745	5565	4	Neuralgia	Neuralgia	NNP
46745	5565	5	is	be	VBZ
46745	5565	6	generally	generally	RB
46745	5565	7	of	of	IN
46745	5565	8	the	the	DT
46745	5565	9	irritative	irritative	JJ
46745	5565	10	kind	kind	NN
46745	5565	11	.	.	.
46745	5566	1	So	so	RB
46745	5566	2	is	be	VBZ
46745	5566	3	that	that	DT
46745	5566	4	of	of	IN
46745	5566	5	Gastrodynia	Gastrodynia	NNP
46745	5566	6	.	.	.
46745	5567	1	So	so	RB
46745	5567	2	also	also	RB
46745	5567	3	the	the	DT
46745	5567	4	pain	pain	NN
46745	5567	5	artificially	artificially	RB
46745	5567	6	inflicted	inflict	VBN
46745	5567	7	by	by	IN
46745	5567	8	the	the	DT
46745	5567	9	knife	knife	NN
46745	5567	10	in	in	IN
46745	5567	11	surgical	surgical	JJ
46745	5567	12	operations	operation	NNS
46745	5567	13	.	.	.
46745	5568	1	For	for	IN
46745	5568	2	irritative	irritative	JJ
46745	5568	3	pain	pain	NN
46745	5568	4	on	on	IN
46745	5568	5	the	the	DT
46745	5568	6	surface	surface	NN
46745	5568	7	Aconite	Aconite	NNP
46745	5568	8	is	be	VBZ
46745	5568	9	most	most	RBS
46745	5568	10	efficacious	efficacious	JJ
46745	5568	11	.	.	.
46745	5569	1	Belladonna	Belladonna	NNP
46745	5569	2	comes	come	VBZ
46745	5569	3	next	next	RB
46745	5569	4	to	to	IN
46745	5569	5	it	-PRON-	PRP
46745	5569	6	.	.	.
46745	5570	1	In	in	IN
46745	5570	2	Gastrodynia	Gastrodynia	NNP
46745	5570	3	Hydrocyanic	Hydrocyanic	NNP
46745	5570	4	Acid	Acid	NNP
46745	5570	5	is	be	VBZ
46745	5570	6	to	to	TO
46745	5570	7	be	be	VB
46745	5570	8	preferred	prefer	VBN
46745	5570	9	.	.	.
46745	5571	1	But	but	CC
46745	5571	2	to	to	TO
46745	5571	3	counteract	counteract	VB
46745	5571	4	the	the	DT
46745	5571	5	pain	pain	NN
46745	5571	6	of	of	IN
46745	5571	7	a	a	DT
46745	5571	8	surgical	surgical	JJ
46745	5571	9	operation	operation	NN
46745	5571	10	we	-PRON-	PRP
46745	5571	11	require	require	VBP
46745	5571	12	a	a	DT
46745	5571	13	medicine	medicine	NN
46745	5571	14	which	which	WDT
46745	5571	15	shall	shall	MD
46745	5571	16	be	be	VB
46745	5571	17	capable	capable	JJ
46745	5571	18	of	of	IN
46745	5571	19	producing	produce	VBG
46745	5571	20	a	a	DT
46745	5571	21	powerful	powerful	JJ
46745	5571	22	effect	effect	NN
46745	5571	23	on	on	IN
46745	5571	24	the	the	DT
46745	5571	25	whole	whole	JJ
46745	5571	26	system	system	NN
46745	5571	27	at	at	IN
46745	5571	28	once	once	RB
46745	5571	29	.	.	.
46745	5572	1	Such	such	JJ
46745	5572	2	medicines	medicine	NNS
46745	5572	3	are	be	VBP
46745	5572	4	Ether	Ether	NNP
46745	5572	5	and	and	CC
46745	5572	6	Chloroform	Chloroform	NNP
46745	5572	7	.	.	.
46745	5573	1	It	-PRON-	PRP
46745	5573	2	is	be	VBZ
46745	5573	3	found	find	VBN
46745	5573	4	most	most	RBS
46745	5573	5	convenient	convenient	JJ
46745	5573	6	to	to	TO
46745	5573	7	bring	bring	VB
46745	5573	8	the	the	DT
46745	5573	9	patient	patient	NN
46745	5573	10	under	under	IN
46745	5573	11	their	-PRON-	PRP$
46745	5573	12	influence	influence	NN
46745	5573	13	by	by	IN
46745	5573	14	causing	cause	VBG
46745	5573	15	him	-PRON-	PRP
46745	5573	16	to	to	TO
46745	5573	17	inhale	inhale	VB
46745	5573	18	the	the	DT
46745	5573	19	vapour	vapour	NN
46745	5573	20	into	into	IN
46745	5573	21	his	-PRON-	PRP$
46745	5573	22	lungs	lung	NNS
46745	5573	23	.	.	.
46745	5574	1	Being	be	VBG
46745	5574	2	absorbed	absorb	VBN
46745	5574	3	by	by	IN
46745	5574	4	the	the	DT
46745	5574	5	pulmonary	pulmonary	JJ
46745	5574	6	mucous	mucous	JJ
46745	5574	7	surface	surface	NN
46745	5574	8	,	,	,
46745	5574	9	and	and	CC
46745	5574	10	passing	pass	VBG
46745	5574	11	directly	directly	RB
46745	5574	12	into	into	IN
46745	5574	13	the	the	DT
46745	5574	14	circulation	circulation	NN
46745	5574	15	,	,	,
46745	5574	16	the	the	DT
46745	5574	17	medicine	medicine	NN
46745	5574	18	thus	thus	RB
46745	5574	19	takes	take	VBZ
46745	5574	20	effect	effect	NN
46745	5574	21	rapidly	rapidly	RB
46745	5574	22	.	.	.
46745	5575	1	There	there	EX
46745	5575	2	is	be	VBZ
46745	5575	3	no	no	DT
46745	5575	4	time	time	NN
46745	5575	5	for	for	IN
46745	5575	6	the	the	DT
46745	5575	7	volatile	volatile	JJ
46745	5575	8	liquid	liquid	NN
46745	5575	9	to	to	TO
46745	5575	10	be	be	VB
46745	5575	11	excreted	excrete	VBN
46745	5575	12	from	from	IN
46745	5575	13	the	the	DT
46745	5575	14	blood	blood	NN
46745	5575	15	,	,	,
46745	5575	16	so	so	IN
46745	5575	17	that	that	IN
46745	5575	18	the	the	DT
46745	5575	19	ulterior	ulterior	JJ
46745	5575	20	effect	effect	NN
46745	5575	21	of	of	IN
46745	5575	22	the	the	DT
46745	5575	23	anæsthetic	anæsthetic	NN
46745	5575	24	can	can	MD
46745	5575	25	not	not	RB
46745	5575	26	be	be	VB
46745	5575	27	escaped	escape	VBN
46745	5575	28	.	.	.
46745	5576	1	The	the	DT
46745	5576	2	third	third	JJ
46745	5576	3	and	and	CC
46745	5576	4	most	most	RBS
46745	5576	5	important	important	JJ
46745	5576	6	advantage	advantage	NN
46745	5576	7	of	of	IN
46745	5576	8	this	this	DT
46745	5576	9	mode	mode	NN
46745	5576	10	of	of	IN
46745	5576	11	administering	administer	VBG
46745	5576	12	Chloroform	Chloroform	NNP
46745	5576	13	is	be	VBZ
46745	5576	14	that	that	IN
46745	5576	15	by	by	IN
46745	5576	16	it	-PRON-	PRP
46745	5576	17	we	-PRON-	PRP
46745	5576	18	are	be	VBP
46745	5576	19	enabled	enable	VBN
46745	5576	20	to	to	TO
46745	5576	21	regulate	regulate	VB
46745	5576	22	with	with	IN
46745	5576	23	exactness	exactness	NN
46745	5576	24	the	the	DT
46745	5576	25	degree	degree	NN
46745	5576	26	of	of	IN
46745	5576	27	its	-PRON-	PRP$
46745	5576	28	action	action	NN
46745	5576	29	,	,	,
46745	5576	30	which	which	WDT
46745	5576	31	is	be	VBZ
46745	5576	32	a	a	DT
46745	5576	33	dangerous	dangerous	JJ
46745	5576	34	one	one	NN
46745	5576	35	,	,	,
46745	5576	36	and	and	CC
46745	5576	37	to	to	TO
46745	5576	38	stop	stop	VB
46745	5576	39	it	-PRON-	PRP
46745	5576	40	when	when	WRB
46745	5576	41	it	-PRON-	PRP
46745	5576	42	has	have	VBZ
46745	5576	43	gone	go	VBN
46745	5576	44	far	far	RB
46745	5576	45	enough	enough	RB
46745	5576	46	.	.	.
46745	5577	1	When	when	WRB
46745	5577	2	introduced	introduce	VBN
46745	5577	3	by	by	IN
46745	5577	4	inhalation	inhalation	NN
46745	5577	5	into	into	IN
46745	5577	6	the	the	DT
46745	5577	7	general	general	JJ
46745	5577	8	circulation	circulation	NN
46745	5577	9	,	,	,
46745	5577	10	Chloroform	Chloroform	NNP
46745	5577	11	acts	act	VBZ
46745	5577	12	upon	upon	IN
46745	5577	13	the	the	DT
46745	5577	14	brain	brain	NN
46745	5577	15	and	and	CC
46745	5577	16	sensory	sensory	JJ
46745	5577	17	nerves	nerve	NNS
46745	5577	18	throughout	throughout	IN
46745	5577	19	the	the	DT
46745	5577	20	body	body	NN
46745	5577	21	,	,	,
46745	5577	22	so	so	IN
46745	5577	23	as	as	IN
46745	5577	24	completely	completely	RB
46745	5577	25	to	to	TO
46745	5577	26	extinguish	extinguish	VB
46745	5577	27	their	-PRON-	PRP$
46745	5577	28	natural	natural	JJ
46745	5577	29	sensibility	sensibility	NN
46745	5577	30	.	.	.
46745	5578	1	It	-PRON-	PRP
46745	5578	2	is	be	VBZ
46745	5578	3	thus	thus	RB
46745	5578	4	an	an	DT
46745	5578	5	agent	agent	NN
46745	5578	6	of	of	IN
46745	5578	7	immense	immense	JJ
46745	5578	8	value	value	NN
46745	5578	9	where	where	WRB
46745	5578	10	we	-PRON-	PRP
46745	5578	11	wish	wish	VBP
46745	5578	12	to	to	TO
46745	5578	13	save	save	VB
46745	5578	14	the	the	DT
46745	5578	15	patient	patient	NN
46745	5578	16	from	from	IN
46745	5578	17	an	an	DT
46745	5578	18	extreme	extreme	JJ
46745	5578	19	and	and	CC
46745	5578	20	agonizing	agonizing	JJ
46745	5578	21	degree	degree	NN
46745	5578	22	of	of	IN
46745	5578	23	irritative	irritative	JJ
46745	5578	24	pain	pain	NN
46745	5578	25	,	,	,
46745	5578	26	whether	whether	IN
46745	5578	27	to	to	TO
46745	5578	28	be	be	VB
46745	5578	29	caused	cause	VBN
46745	5578	30	by	by	IN
46745	5578	31	the	the	DT
46745	5578	32	edge	edge	NN
46745	5578	33	of	of	IN
46745	5578	34	a	a	DT
46745	5578	35	cutting	cut	VBG
46745	5578	36	instrument	instrument	NN
46745	5578	37	,	,	,
46745	5578	38	or	or	CC
46745	5578	39	by	by	IN
46745	5578	40	the	the	DT
46745	5578	41	throes	throe	NNS
46745	5578	42	of	of	IN
46745	5578	43	parturition	parturition	NN
46745	5578	44	.	.	.
46745	5579	1	But	but	CC
46745	5579	2	it	-PRON-	PRP
46745	5579	3	also	also	RB
46745	5579	4	acts	act	VBZ
46745	5579	5	as	as	IN
46745	5579	6	an	an	DT
46745	5579	7	anæsthetic	anæsthetic	NN
46745	5579	8	when	when	WRB
46745	5579	9	applied	apply	VBN
46745	5579	10	locally	locally	RB
46745	5579	11	,	,	,
46745	5579	12	as	as	IN
46745	5579	13	to	to	IN
46745	5579	14	a	a	DT
46745	5579	15	painful	painful	JJ
46745	5579	16	ulcer	ulcer	NN
46745	5579	17	,	,	,
46745	5579	18	or	or	CC
46745	5579	19	a	a	DT
46745	5579	20	hollow	hollow	JJ
46745	5579	21	tooth	tooth	NN
46745	5579	22	-	-	HYPH
46745	5579	23	stump	stump	NN
46745	5579	24	.	.	.
46745	5580	1	(	(	-LRB-
46745	5580	2	3	3	CD
46745	5580	3	.	.	.
46745	5580	4	)	)	-RRB-
46745	5581	1	The	the	DT
46745	5581	2	third	third	JJ
46745	5581	3	kind	kind	NN
46745	5581	4	of	of	IN
46745	5581	5	pain	pain	NN
46745	5581	6	is	be	VBZ
46745	5581	7	_	_	NNP
46745	5581	8	reflex	reflex	NNP
46745	5581	9	_	_	NNP
46745	5581	10	in	in	IN
46745	5581	11	its	-PRON-	PRP$
46745	5581	12	origin	origin	NN
46745	5581	13	;	;	:
46745	5581	14	as	as	IN
46745	5581	15	the	the	DT
46745	5581	16	pain	pain	NN
46745	5581	17	in	in	IN
46745	5581	18	the	the	DT
46745	5581	19	knee	knee	NN
46745	5581	20	in	in	IN
46745	5581	21	Hip	hip	NN
46745	5581	22	-	-	HYPH
46745	5581	23	joint	joint	JJ
46745	5581	24	disease	disease	NN
46745	5581	25	.	.	.
46745	5582	1	We	-PRON-	PRP
46745	5582	2	should	should	MD
46745	5582	3	do	do	VB
46745	5582	4	no	no	DT
46745	5582	5	good	good	NN
46745	5582	6	if	if	IN
46745	5582	7	we	-PRON-	PRP
46745	5582	8	troubled	trouble	VBD
46745	5582	9	ourselves	-PRON-	PRP
46745	5582	10	to	to	TO
46745	5582	11	combat	combat	VB
46745	5582	12	the	the	DT
46745	5582	13	local	local	JJ
46745	5582	14	symptom	symptom	NN
46745	5582	15	in	in	IN
46745	5582	16	such	such	PDT
46745	5582	17	a	a	DT
46745	5582	18	case	case	NN
46745	5582	19	;	;	:
46745	5582	20	we	-PRON-	PRP
46745	5582	21	should	should	MD
46745	5582	22	rather	rather	RB
46745	5582	23	direct	direct	VB
46745	5582	24	our	-PRON-	PRP$
46745	5582	25	attention	attention	NN
46745	5582	26	to	to	IN
46745	5582	27	that	that	DT
46745	5582	28	condition	condition	NN
46745	5582	29	which	which	WDT
46745	5582	30	is	be	VBZ
46745	5582	31	the	the	DT
46745	5582	32	distant	distant	JJ
46745	5582	33	cause	cause	NN
46745	5582	34	of	of	IN
46745	5582	35	the	the	DT
46745	5582	36	pain	pain	NN
46745	5582	37	.	.	.
46745	5583	1	(	(	-LRB-
46745	5583	2	4	4	CD
46745	5583	3	.	.	.
46745	5583	4	)	)	-RRB-
46745	5584	1	A	a	DT
46745	5584	2	fourth	fourth	JJ
46745	5584	3	kind	kind	NN
46745	5584	4	of	of	IN
46745	5584	5	pain	pain	NN
46745	5584	6	may	may	MD
46745	5584	7	be	be	VB
46745	5584	8	called	call	VBN
46745	5584	9	_	_	NNP
46745	5584	10	eccentric	eccentric	JJ
46745	5584	11	_	_	NNP
46745	5584	12	.	.	.
46745	5585	1	Like	like	IN
46745	5585	2	the	the	DT
46745	5585	3	last	last	JJ
46745	5585	4	,	,	,
46745	5585	5	it	-PRON-	PRP
46745	5585	6	does	do	VBZ
46745	5585	7	not	not	RB
46745	5585	8	originate	originate	VB
46745	5585	9	in	in	IN
46745	5585	10	the	the	DT
46745	5585	11	painful	painful	JJ
46745	5585	12	part	part	NN
46745	5585	13	.	.	.
46745	5586	1	It	-PRON-	PRP
46745	5586	2	has	have	VBZ
46745	5586	3	its	-PRON-	PRP$
46745	5586	4	origin	origin	NN
46745	5586	5	in	in	IN
46745	5586	6	the	the	DT
46745	5586	7	brain	brain	NN
46745	5586	8	or	or	CC
46745	5586	9	nervous	nervous	JJ
46745	5586	10	centres	centre	NNS
46745	5586	11	.	.	.
46745	5587	1	Of	of	IN
46745	5587	2	such	such	PDT
46745	5587	3	a	a	DT
46745	5587	4	kind	kind	NN
46745	5587	5	are	be	VBP
46745	5587	6	the	the	DT
46745	5587	7	various	various	JJ
46745	5587	8	pains	pain	NNS
46745	5587	9	of	of	IN
46745	5587	10	Hysteria	Hysteria	NNP
46745	5587	11	.	.	.
46745	5588	1	Local	local	JJ
46745	5588	2	anæsthetics	anæsthetic	NNS
46745	5588	3	are	be	VBP
46745	5588	4	here	here	RB
46745	5588	5	worse	bad	JJR
46745	5588	6	than	than	IN
46745	5588	7	useless	useless	JJ
46745	5588	8	.	.	.
46745	5589	1	The	the	DT
46745	5589	2	brain	brain	NN
46745	5589	3	disorder	disorder	NN
46745	5589	4	must	must	MD
46745	5589	5	,	,	,
46745	5589	6	if	if	IN
46745	5589	7	possible	possible	JJ
46745	5589	8	,	,	,
46745	5589	9	be	be	VB
46745	5589	10	remedied	remedie	VBN
46745	5589	11	.	.	.
46745	5590	1	Chloroform	chloroform	NN
46745	5590	2	is	be	VBZ
46745	5590	3	better	well	RBR
46745	5590	4	adapted	adapt	VBN
46745	5590	5	for	for	IN
46745	5590	6	inhalation	inhalation	NN
46745	5590	7	than	than	IN
46745	5590	8	Ether	Ether	NNP
46745	5590	9	,	,	,
46745	5590	10	because	because	IN
46745	5590	11	it	-PRON-	PRP
46745	5590	12	is	be	VBZ
46745	5590	13	considerably	considerably	RB
46745	5590	14	less	less	RBR
46745	5590	15	irritating	irritating	JJ
46745	5590	16	.	.	.
46745	5591	1	It	-PRON-	PRP
46745	5591	2	is	be	VBZ
46745	5591	3	,	,	,
46745	5591	4	on	on	IN
46745	5591	5	the	the	DT
46745	5591	6	whole	whole	JJ
46745	5591	7	,	,	,
46745	5591	8	very	very	RB
46745	5591	9	safe	safe	JJ
46745	5591	10	,	,	,
46745	5591	11	when	when	WRB
46745	5591	12	proper	proper	JJ
46745	5591	13	care	care	NN
46745	5591	14	is	be	VBZ
46745	5591	15	taken	take	VBN
46745	5591	16	.	.	.
46745	5592	1	And	and	CC
46745	5592	2	yet	yet	RB
46745	5592	3	it	-PRON-	PRP
46745	5592	4	can	can	MD
46745	5592	5	not	not	RB
46745	5592	6	be	be	VB
46745	5592	7	denied	deny	VBN
46745	5592	8	that	that	IN
46745	5592	9	sudden	sudden	JJ
46745	5592	10	deaths	death	NNS
46745	5592	11	_	_	NNP
46745	5592	12	have	have	VBP
46745	5592	13	_	_	NNP
46745	5592	14	occurred	occur	VBD
46745	5592	15	from	from	IN
46745	5592	16	the	the	DT
46745	5592	17	use	use	NN
46745	5592	18	of	of	IN
46745	5592	19	Chloroform	Chloroform	NNP
46745	5592	20	,	,	,
46745	5592	21	which	which	WDT
46745	5592	22	could	could	MD
46745	5592	23	not	not	RB
46745	5592	24	have	have	VB
46745	5592	25	been	be	VBN
46745	5592	26	avoided	avoid	VBN
46745	5592	27	by	by	IN
46745	5592	28	any	any	DT
46745	5592	29	known	known	JJ
46745	5592	30	precautions	precaution	NNS
46745	5592	31	.	.	.
46745	5593	1	Such	such	PDT
46745	5593	2	an	an	DT
46745	5593	3	admission	admission	NN
46745	5593	4	tells	tell	VBZ
46745	5593	5	little	little	JJ
46745	5593	6	against	against	IN
46745	5593	7	the	the	DT
46745	5593	8	remedy	remedy	NN
46745	5593	9	;	;	:
46745	5593	10	for	for	IN
46745	5593	11	supposing	suppose	VBG
46745	5593	12	the	the	DT
46745	5593	13	proportion	proportion	NN
46745	5593	14	of	of	IN
46745	5593	15	deaths	death	NNS
46745	5593	16	from	from	IN
46745	5593	17	inhalation	inhalation	NN
46745	5593	18	to	to	TO
46745	5593	19	be	be	VB
46745	5593	20	about	about	IN
46745	5593	21	1	1	CD
46745	5593	22	in	in	IN
46745	5593	23	10,000	10,000	CD
46745	5593	24	,	,	,
46745	5593	25	it	-PRON-	PRP
46745	5593	26	must	must	MD
46745	5593	27	be	be	VB
46745	5593	28	confessed	confess	VBN
46745	5593	29	that	that	IN
46745	5593	30	it	-PRON-	PRP
46745	5593	31	is	be	VBZ
46745	5593	32	better	well	JJR
46745	5593	33	that	that	DT
46745	5593	34	one	one	CD
46745	5593	35	out	out	IN
46745	5593	36	of	of	IN
46745	5593	37	that	that	DT
46745	5593	38	number	number	NN
46745	5593	39	should	should	MD
46745	5593	40	die	die	VB
46745	5593	41	of	of	IN
46745	5593	42	the	the	DT
46745	5593	43	Chloroform	Chloroform	NNP
46745	5593	44	than	than	IN
46745	5593	45	that	that	DT
46745	5593	46	100	100	CD
46745	5593	47	should	should	MD
46745	5593	48	die	die	VB
46745	5593	49	of	of	IN
46745	5593	50	fright	fright	NN
46745	5593	51	.	.	.
46745	5594	1	Out	out	IN
46745	5594	2	of	of	IN
46745	5594	3	9000	9000	CD
46745	5594	4	cases	case	NNS
46745	5594	5	of	of	IN
46745	5594	6	its	-PRON-	PRP$
46745	5594	7	inhalation	inhalation	NN
46745	5594	8	at	at	IN
46745	5594	9	St.	St.	NNP
46745	5594	10	Bartholomew	Bartholomew	NNP
46745	5594	11	's	's	POS
46745	5594	12	Hospital	Hospital	NNP
46745	5594	13	it	-PRON-	PRP
46745	5594	14	is	be	VBZ
46745	5594	15	reported	report	VBN
46745	5594	16	that	that	IN
46745	5594	17	not	not	RB
46745	5594	18	one	one	CD
46745	5594	19	died	die	VBD
46745	5594	20	of	of	IN
46745	5594	21	the	the	DT
46745	5594	22	anæsthetic	anæsthetic	NN
46745	5594	23	.	.	.
46745	5595	1	The	the	DT
46745	5595	2	stages	stage	NNS
46745	5595	3	of	of	IN
46745	5595	4	the	the	DT
46745	5595	5	action	action	NN
46745	5595	6	of	of	IN
46745	5595	7	Chloroform	Chloroform	NNP
46745	5595	8	when	when	WRB
46745	5595	9	inhaled	inhale	VBN
46745	5595	10	may	may	MD
46745	5595	11	be	be	VB
46745	5595	12	briefly	briefly	RB
46745	5595	13	stated	state	VBN
46745	5595	14	as	as	IN
46745	5595	15	follows	follow	VBZ
46745	5595	16	:	:	:
46745	5595	17	_	_	NNP
46745	5595	18	1st	1st	JJ
46745	5595	19	stage	stage	NN
46745	5595	20	_	_	NNP
46745	5595	21	:	:	:
46745	5595	22	some	some	DT
46745	5595	23	alteration	alteration	NN
46745	5595	24	in	in	IN
46745	5595	25	the	the	DT
46745	5595	26	feelings	feeling	NNS
46745	5595	27	of	of	IN
46745	5595	28	the	the	DT
46745	5595	29	patient	patient	NN
46745	5595	30	;	;	:
46745	5595	31	_	_	NNP
46745	5595	32	2d	2d	CD
46745	5595	33	stage	stage	NN
46745	5595	34	_	_	NNP
46745	5595	35	:	:	:
46745	5595	36	inebriation	inebriation	NN
46745	5595	37	;	;	:
46745	5595	38	the	the	DT
46745	5595	39	mind	mind	NN
46745	5595	40	and	and	CC
46745	5595	41	volition	volition	NN
46745	5595	42	are	be	VBP
46745	5595	43	impaired	impaired	JJ
46745	5595	44	;	;	:
46745	5595	45	consciousness	consciousness	NN
46745	5595	46	remains	remain	VBZ
46745	5595	47	;	;	:
46745	5595	48	_	_	NNP
46745	5595	49	3d	3d	CD
46745	5595	50	stage	stage	NN
46745	5595	51	_	_	NNP
46745	5595	52	:	:	:
46745	5595	53	unconsciousness	unconsciousness	NN
46745	5595	54	;	;	:
46745	5595	55	anæsthesia	anæsthesia	NNP
46745	5595	56	.	.	.
46745	5596	1	[	[	-LRB-
46745	5596	2	48	48	CD
46745	5596	3	]	]	-RRB-
46745	5596	4	The	the	DT
46745	5596	5	loss	loss	NN
46745	5596	6	of	of	IN
46745	5596	7	sensibility	sensibility	NN
46745	5596	8	may	may	MD
46745	5596	9	even	even	RB
46745	5596	10	occur	occur	VB
46745	5596	11	in	in	IN
46745	5596	12	the	the	DT
46745	5596	13	second	second	JJ
46745	5596	14	stage	stage	NN
46745	5596	15	,	,	,
46745	5596	16	the	the	DT
46745	5596	17	patient	patient	NN
46745	5596	18	remaining	remain	VBG
46745	5596	19	conscious	conscious	NN
46745	5596	20	.	.	.
46745	5597	1	The	the	DT
46745	5597	2	inhalation	inhalation	NN
46745	5597	3	should	should	MD
46745	5597	4	not	not	RB
46745	5597	5	be	be	VB
46745	5597	6	prolonged	prolong	VBN
46745	5597	7	beyond	beyond	IN
46745	5597	8	the	the	DT
46745	5597	9	occurrence	occurrence	NN
46745	5597	10	of	of	IN
46745	5597	11	the	the	DT
46745	5597	12	third	third	JJ
46745	5597	13	stage	stage	NN
46745	5597	14	.	.	.
46745	5598	1	The	the	DT
46745	5598	2	pulse	pulse	NN
46745	5598	3	is	be	VBZ
46745	5598	4	still	still	RB
46745	5598	5	full	full	JJ
46745	5598	6	.	.	.
46745	5599	1	There	there	EX
46745	5599	2	may	may	MD
46745	5599	3	be	be	VB
46745	5599	4	muscular	muscular	JJ
46745	5599	5	movements	movement	NNS
46745	5599	6	,	,	,
46745	5599	7	or	or	CC
46745	5599	8	even	even	RB
46745	5599	9	cries	cry	NNS
46745	5599	10	.	.	.
46745	5600	1	In	in	IN
46745	5600	2	the	the	DT
46745	5600	3	next	next	JJ
46745	5600	4	stage	stage	NN
46745	5600	5	there	there	EX
46745	5600	6	is	be	VBZ
46745	5600	7	stertorous	stertorous	JJ
46745	5600	8	breathing	breathing	NN
46745	5600	9	;	;	:
46745	5600	10	the	the	DT
46745	5600	11	eyelids	eyelid	NNS
46745	5600	12	no	no	RB
46745	5600	13	longer	long	RBR
46745	5600	14	contract	contract	NN
46745	5600	15	when	when	WRB
46745	5600	16	touched	touch	VBN
46745	5600	17	with	with	IN
46745	5600	18	the	the	DT
46745	5600	19	finger	finger	NN
46745	5600	20	;	;	:
46745	5600	21	the	the	DT
46745	5600	22	pulse	pulse	NN
46745	5600	23	is	be	VBZ
46745	5600	24	felt	feel	VBN
46745	5600	25	to	to	TO
46745	5600	26	falter	falter	VB
46745	5600	27	.	.	.
46745	5601	1	This	this	DT
46745	5601	2	is	be	VBZ
46745	5601	3	dangerous	dangerous	JJ
46745	5601	4	.	.	.
46745	5602	1	To	to	IN
46745	5602	2	this	this	DT
46745	5602	3	succeed	succeed	VB
46745	5602	4	stoppage	stoppage	NN
46745	5602	5	of	of	IN
46745	5602	6	the	the	DT
46745	5602	7	heart	heart	NN
46745	5602	8	and	and	CC
46745	5602	9	respiration;--death	respiration;--death	NN
46745	5602	10	.	.	.
46745	5603	1	There	there	EX
46745	5603	2	are	be	VBP
46745	5603	3	four	four	CD
46745	5603	4	rules	rule	NNS
46745	5603	5	which	which	WDT
46745	5603	6	it	-PRON-	PRP
46745	5603	7	is	be	VBZ
46745	5603	8	safe	safe	JJ
46745	5603	9	to	to	TO
46745	5603	10	follow	follow	VB
46745	5603	11	in	in	IN
46745	5603	12	the	the	DT
46745	5603	13	administration	administration	NN
46745	5603	14	of	of	IN
46745	5603	15	Chloroform	Chloroform	NNP
46745	5603	16	;	;	:
46745	5603	17	not	not	RB
46745	5603	18	to	to	TO
46745	5603	19	go	go	VB
46745	5603	20	on	on	RP
46745	5603	21	when	when	WRB
46745	5603	22	there	there	EX
46745	5603	23	is	be	VBZ
46745	5603	24	stertorous	stertorous	JJ
46745	5603	25	breathing	breathing	NN
46745	5603	26	;	;	:
46745	5603	27	not	not	RB
46745	5603	28	to	to	TO
46745	5603	29	administer	administer	VB
46745	5603	30	it	-PRON-	PRP
46745	5603	31	when	when	WRB
46745	5603	32	there	there	EX
46745	5603	33	exists	exist	VBZ
46745	5603	34	any	any	DT
46745	5603	35	serious	serious	JJ
46745	5603	36	disease	disease	NN
46745	5603	37	of	of	IN
46745	5603	38	the	the	DT
46745	5603	39	heart	heart	NN
46745	5603	40	or	or	CC
46745	5603	41	lungs	lung	NNS
46745	5603	42	;	;	,
46745	5603	43	not	not	RB
46745	5603	44	to	to	TO
46745	5603	45	undertake	undertake	VB
46745	5603	46	under	under	IN
46745	5603	47	its	-PRON-	PRP$
46745	5603	48	influence	influence	NN
46745	5603	49	an	an	DT
46745	5603	50	extensive	extensive	JJ
46745	5603	51	operation	operation	NN
46745	5603	52	on	on	IN
46745	5603	53	the	the	DT
46745	5603	54	mouth	mouth	NN
46745	5603	55	or	or	CC
46745	5603	56	jaws	jaw	NNS
46745	5603	57	;	;	:
46745	5603	58	and	and	CC
46745	5603	59	so	so	RB
46745	5603	60	to	to	TO
46745	5603	61	arrange	arrange	VB
46745	5603	62	the	the	DT
46745	5603	63	process	process	NN
46745	5603	64	as	as	IN
46745	5603	65	that	that	IN
46745	5603	66	the	the	DT
46745	5603	67	vapour	vapour	NN
46745	5603	68	shall	shall	MD
46745	5603	69	be	be	VB
46745	5603	70	freely	freely	RB
46745	5603	71	diluted	dilute	VBN
46745	5603	72	with	with	IN
46745	5603	73	air	air	NN
46745	5603	74	.	.	.
46745	5604	1	If	if	IN
46745	5604	2	the	the	DT
46745	5604	3	third	third	JJ
46745	5604	4	rule	rule	NN
46745	5604	5	be	be	VB
46745	5604	6	neglected	neglect	VBN
46745	5604	7	,	,	,
46745	5604	8	the	the	DT
46745	5604	9	blood	blood	NN
46745	5604	10	may	may	MD
46745	5604	11	flow	flow	VB
46745	5604	12	into	into	IN
46745	5604	13	the	the	DT
46745	5604	14	windpipe	windpipe	NN
46745	5604	15	and	and	CC
46745	5604	16	cause	cause	NN
46745	5604	17	suffocation	suffocation	NN
46745	5604	18	,	,	,
46745	5604	19	for	for	IN
46745	5604	20	the	the	DT
46745	5604	21	patient	patient	NN
46745	5604	22	is	be	VBZ
46745	5604	23	deprived	deprive	VBN
46745	5604	24	of	of	IN
46745	5604	25	the	the	DT
46745	5604	26	power	power	NN
46745	5604	27	of	of	IN
46745	5604	28	swallowing	swallow	VBG
46745	5604	29	.	.	.
46745	5605	1	The	the	DT
46745	5605	2	dilution	dilution	NN
46745	5605	3	with	with	IN
46745	5605	4	air	air	NN
46745	5605	5	is	be	VBZ
46745	5605	6	necessary	necessary	JJ
46745	5605	7	,	,	,
46745	5605	8	not	not	RB
46745	5605	9	only	only	RB
46745	5605	10	to	to	TO
46745	5605	11	moderate	moderate	VB
46745	5605	12	the	the	DT
46745	5605	13	action	action	NN
46745	5605	14	of	of	IN
46745	5605	15	the	the	DT
46745	5605	16	remedy	remedy	NN
46745	5605	17	,	,	,
46745	5605	18	but	but	CC
46745	5605	19	that	that	IN
46745	5605	20	the	the	DT
46745	5605	21	necessary	necessary	JJ
46745	5605	22	vital	vital	JJ
46745	5605	23	function	function	NN
46745	5605	24	of	of	IN
46745	5605	25	respiration	respiration	NN
46745	5605	26	may	may	MD
46745	5605	27	not	not	RB
46745	5605	28	be	be	VB
46745	5605	29	interfered	interfere	VBN
46745	5605	30	with	with	IN
46745	5605	31	.	.	.
46745	5606	1	It	-PRON-	PRP
46745	5606	2	is	be	VBZ
46745	5606	3	also	also	RB
46745	5606	4	well	well	RB
46745	5606	5	known	know	VBN
46745	5606	6	that	that	IN
46745	5606	7	it	-PRON-	PRP
46745	5606	8	is	be	VBZ
46745	5606	9	convenient	convenient	JJ
46745	5606	10	to	to	TO
46745	5606	11	administer	administer	VB
46745	5606	12	Chloroform	chloroform	NN
46745	5606	13	on	on	IN
46745	5606	14	an	an	DT
46745	5606	15	empty	empty	JJ
46745	5606	16	stomach	stomach	NN
46745	5606	17	,	,	,
46745	5606	18	or	or	CC
46745	5606	19	it	-PRON-	PRP
46745	5606	20	will	will	MD
46745	5606	21	be	be	VB
46745	5606	22	likely	likely	JJ
46745	5606	23	to	to	TO
46745	5606	24	produce	produce	VB
46745	5606	25	vomiting	vomit	VBG
46745	5606	26	.	.	.
46745	5607	1	Though	though	IN
46745	5607	2	Chloroform	Chloroform	NNP
46745	5607	3	rarely	rarely	RB
46745	5607	4	fails	fail	VBZ
46745	5607	5	to	to	TO
46745	5607	6	annihilate	annihilate	VB
46745	5607	7	pain	pain	NN
46745	5607	8	,	,	,
46745	5607	9	and	and	CC
46745	5607	10	thus	thus	RB
46745	5607	11	greatly	greatly	RB
46745	5607	12	to	to	TO
46745	5607	13	diminish	diminish	VB
46745	5607	14	the	the	DT
46745	5607	15	terror	terror	NN
46745	5607	16	of	of	IN
46745	5607	17	the	the	DT
46745	5607	18	patient	patient	NN
46745	5607	19	,	,	,
46745	5607	20	it	-PRON-	PRP
46745	5607	21	will	will	MD
46745	5607	22	not	not	RB
46745	5607	23	prevent	prevent	VB
46745	5607	24	him	-PRON-	PRP
46745	5607	25	from	from	IN
46745	5607	26	sometimes	sometimes	RB
46745	5607	27	dying	die	VBG
46745	5607	28	of	of	IN
46745	5607	29	the	the	DT
46745	5607	30	shock	shock	NN
46745	5607	31	of	of	IN
46745	5607	32	a	a	DT
46745	5607	33	serious	serious	JJ
46745	5607	34	operation	operation	NN
46745	5607	35	.	.	.
46745	5608	1	An	an	DT
46745	5608	2	extensive	extensive	JJ
46745	5608	3	injury	injury	NN
46745	5608	4	to	to	IN
46745	5608	5	the	the	DT
46745	5608	6	body	body	NN
46745	5608	7	will	will	MD
46745	5608	8	suffice	suffice	VB
46745	5608	9	to	to	TO
46745	5608	10	produce	produce	VB
46745	5608	11	a	a	DT
46745	5608	12	prejudicial	prejudicial	JJ
46745	5608	13	effect	effect	NN
46745	5608	14	upon	upon	IN
46745	5608	15	the	the	DT
46745	5608	16	heart	heart	NN
46745	5608	17	and	and	CC
46745	5608	18	nervous	nervous	JJ
46745	5608	19	system	system	NN
46745	5608	20	,	,	,
46745	5608	21	which	which	WDT
46745	5608	22	is	be	VBZ
46745	5608	23	independent	independent	JJ
46745	5608	24	of	of	IN
46745	5608	25	the	the	DT
46745	5608	26	feeling	feeling	NN
46745	5608	27	of	of	IN
46745	5608	28	pain	pain	NN
46745	5608	29	,	,	,
46745	5608	30	and	and	CC
46745	5608	31	may	may	MD
46745	5608	32	occur	occur	VB
46745	5608	33	without	without	IN
46745	5608	34	moral	moral	JJ
46745	5608	35	suffering	suffering	NN
46745	5608	36	.	.	.
46745	5609	1	Chloroform	chloroform	NN
46745	5609	2	is	be	VBZ
46745	5609	3	employed	employ	VBN
46745	5609	4	by	by	IN
46745	5609	5	some	some	DT
46745	5609	6	to	to	TO
46745	5609	7	relieve	relieve	VB
46745	5609	8	the	the	DT
46745	5609	9	pain	pain	NN
46745	5609	10	of	of	IN
46745	5609	11	parturition	parturition	NN
46745	5609	12	.	.	.
46745	5610	1	It	-PRON-	PRP
46745	5610	2	is	be	VBZ
46745	5610	3	not	not	RB
46745	5610	4	found	find	VBN
46745	5610	5	to	to	TO
46745	5610	6	interrupt	interrupt	VB
46745	5610	7	the	the	DT
46745	5610	8	action	action	NN
46745	5610	9	of	of	IN
46745	5610	10	the	the	DT
46745	5610	11	uterus	uterus	NN
46745	5610	12	.	.	.
46745	5611	1	But	but	CC
46745	5611	2	,	,	,
46745	5611	3	with	with	IN
46745	5611	4	this	this	DT
46745	5611	5	exception	exception	NN
46745	5611	6	,	,	,
46745	5611	7	it	-PRON-	PRP
46745	5611	8	is	be	VBZ
46745	5611	9	a	a	DT
46745	5611	10	general	general	JJ
46745	5611	11	muscular	muscular	JJ
46745	5611	12	relaxer	relaxer	NN
46745	5611	13	and	and	CC
46745	5611	14	paralyzer	paralyzer	NNP
46745	5611	15	,	,	,
46745	5611	16	and	and	CC
46745	5611	17	may	may	MD
46745	5611	18	thus	thus	RB
46745	5611	19	be	be	VB
46745	5611	20	inhaled	inhale	VBN
46745	5611	21	before	before	IN
46745	5611	22	an	an	DT
46745	5611	23	attempt	attempt	NN
46745	5611	24	to	to	TO
46745	5611	25	reduce	reduce	VB
46745	5611	26	an	an	DT
46745	5611	27	old	old	JJ
46745	5611	28	dislocation	dislocation	NN
46745	5611	29	,	,	,
46745	5611	30	or	or	CC
46745	5611	31	to	to	TO
46745	5611	32	restore	restore	VB
46745	5611	33	a	a	DT
46745	5611	34	hernia	hernia	NN
46745	5611	35	of	of	IN
46745	5611	36	long	long	JJ
46745	5611	37	standing	standing	NN
46745	5611	38	.	.	.
46745	5612	1	It	-PRON-	PRP
46745	5612	2	is	be	VBZ
46745	5612	3	more	more	RBR
46745	5612	4	efficient	efficient	JJ
46745	5612	5	in	in	IN
46745	5612	6	such	such	JJ
46745	5612	7	cases	case	NNS
46745	5612	8	than	than	IN
46745	5612	9	either	either	DT
46745	5612	10	Opium	Opium	NNP
46745	5612	11	or	or	CC
46745	5612	12	Tartar	Tartar	NNP
46745	5612	13	Emetic	Emetic	NNP
46745	5612	14	,	,	,
46745	5612	15	and	and	CC
46745	5612	16	produces	produce	VBZ
46745	5612	17	less	less	JJR
46745	5612	18	distress	distress	NN
46745	5612	19	than	than	IN
46745	5612	20	the	the	DT
46745	5612	21	latter	latter	JJ
46745	5612	22	.	.	.
46745	5613	1	For	for	IN
46745	5613	2	the	the	DT
46745	5613	3	same	same	JJ
46745	5613	4	operation	operation	NN
46745	5613	5	it	-PRON-	PRP
46745	5613	6	is	be	VBZ
46745	5613	7	sometimes	sometimes	RB
46745	5613	8	employed	employ	VBN
46745	5613	9	in	in	IN
46745	5613	10	spasmodic	spasmodic	JJ
46745	5613	11	disorders	disorder	NNS
46745	5613	12	.	.	.
46745	5614	1	It	-PRON-	PRP
46745	5614	2	has	have	VBZ
46745	5614	3	even	even	RB
46745	5614	4	been	be	VBN
46745	5614	5	known	know	VBN
46745	5614	6	to	to	TO
46745	5614	7	arrest	arrest	VB
46745	5614	8	the	the	DT
46745	5614	9	paroxysm	paroxysm	NNS
46745	5614	10	of	of	IN
46745	5614	11	that	that	DT
46745	5614	12	most	most	RBS
46745	5614	13	incurable	incurable	JJ
46745	5614	14	of	of	IN
46745	5614	15	all	all	DT
46745	5614	16	disorders	disorder	NNS
46745	5614	17	,	,	,
46745	5614	18	Tetanus	Tetanus	NNP
46745	5614	19	.	.	.
46745	5615	1	I	-PRON-	PRP
46745	5615	2	have	have	VBP
46745	5615	3	known	know	VBN
46745	5615	4	it	-PRON-	PRP
46745	5615	5	to	to	TO
46745	5615	6	do	do	VB
46745	5615	7	great	great	JJ
46745	5615	8	service	service	NN
46745	5615	9	both	both	DT
46745	5615	10	in	in	IN
46745	5615	11	Epilepsy	Epilepsy	NNP
46745	5615	12	and	and	CC
46745	5615	13	in	in	IN
46745	5615	14	Hysteria	Hysteria	NNP
46745	5615	15	,	,	,
46745	5615	16	when	when	WRB
46745	5615	17	ordered	order	VBN
46745	5615	18	to	to	TO
46745	5615	19	be	be	VB
46745	5615	20	inhaled	inhale	VBN
46745	5615	21	regularly	regularly	RB
46745	5615	22	twice	twice	PDT
46745	5615	23	a	a	DT
46745	5615	24	day	day	NN
46745	5615	25	.	.	.
46745	5616	1	It	-PRON-	PRP
46745	5616	2	has	have	VBZ
46745	5616	3	been	be	VBN
46745	5616	4	highly	highly	RB
46745	5616	5	recommended	recommend	VBN
46745	5616	6	by	by	IN
46745	5616	7	some	some	DT
46745	5616	8	who	who	WP
46745	5616	9	have	have	VBP
46745	5616	10	tried	try	VBN
46745	5616	11	it	-PRON-	PRP
46745	5616	12	in	in	IN
46745	5616	13	Delirium	Delirium	NNP
46745	5616	14	tremens	tremen	NNS
46745	5616	15	.	.	.
46745	5617	1	(	(	-LRB-
46745	5617	2	_	_	NNP
46745	5617	3	Vide	Vide	NNP
46745	5617	4	_	_	NNP
46745	5617	5	p.	p.	NN
46745	5618	1	237	237	CD
46745	5618	2	.	.	.
46745	5618	3	)	)	-RRB-
46745	5619	1	OPIUM	OPIUM	NNP
46745	5619	2	.	.	.
46745	5620	1	Class	class	NN
46745	5620	2	II	II	NNP
46745	5620	3	.	.	.
46745	5621	1	Div	Div	NNP
46745	5621	2	.	.	.
46745	5622	1	II	ii	CD
46745	5622	2	.	.	.
46745	5623	1	Ord	Ord	NNP
46745	5623	2	.	.	.
46745	5624	1	II	ii	CD
46745	5624	2	.	.	.
46745	5625	1	NARCOTICA	NARCOTICA	NNP
46745	5625	2	SOMNIFERA	SOMNIFERA	NNP
46745	5625	3	.	.	.
46745	5626	1	Class	Class	NNP
46745	5626	2	IV	IV	NNP
46745	5626	3	.	.	.
46745	5627	1	Ord	Ord	NNP
46745	5627	2	.	.	.
46745	5628	1	V.	V.	NNP
46745	5628	2	DIAPHORETICA	DIAPHORETICA	NNP
46745	5628	3	.	.	.
46745	5629	1	Opium	opium	NN
46745	5629	2	is	be	VBZ
46745	5629	3	the	the	DT
46745	5629	4	chief	chief	JJ
46745	5629	5	member	member	NN
46745	5629	6	of	of	IN
46745	5629	7	the	the	DT
46745	5629	8	second	second	JJ
46745	5629	9	division	division	NN
46745	5629	10	of	of	IN
46745	5629	11	Narcotics	Narcotics	NNP
46745	5629	12	,	,	,
46745	5629	13	which	which	WDT
46745	5629	14	consist	consist	VBP
46745	5629	15	of	of	IN
46745	5629	16	medicines	medicine	NNS
46745	5629	17	that	that	WDT
46745	5629	18	,	,	,
46745	5629	19	in	in	IN
46745	5629	20	their	-PRON-	PRP$
46745	5629	21	action	action	NN
46745	5629	22	on	on	IN
46745	5629	23	the	the	DT
46745	5629	24	heart	heart	NN
46745	5629	25	,	,	,
46745	5629	26	are	be	VBP
46745	5629	27	about	about	RB
46745	5629	28	intermediate	intermediate	JJ
46745	5629	29	between	between	IN
46745	5629	30	Stimulants	Stimulants	NNP
46745	5629	31	and	and	CC
46745	5629	32	Sedatives	Sedatives	NNPS
46745	5629	33	,	,	,
46745	5629	34	and	and	CC
46745	5629	35	in	in	IN
46745	5629	36	their	-PRON-	PRP$
46745	5629	37	secondary	secondary	JJ
46745	5629	38	action	action	NN
46745	5629	39	,	,	,
46745	5629	40	on	on	IN
46745	5629	41	the	the	DT
46745	5629	42	intellectual	intellectual	JJ
46745	5629	43	functions	function	NNS
46745	5629	44	produce	produce	VBP
46745	5629	45	in	in	IN
46745	5629	46	them	-PRON-	PRP
46745	5629	47	,	,	,
46745	5629	48	the	the	DT
46745	5629	49	condition	condition	NN
46745	5629	50	of	of	IN
46745	5629	51	sleep	sleep	NN
46745	5629	52	(	(	-LRB-
46745	5629	53	p.	p.	NN
46745	5630	1	239	239	CD
46745	5630	2	.	.	.
46745	5630	3	)	)	-RRB-
46745	5631	1	Opium	opium	NN
46745	5631	2	produces	produce	VBZ
46745	5631	3	at	at	IN
46745	5631	4	first	first	RB
46745	5631	5	some	some	DT
46745	5631	6	stimulation	stimulation	NN
46745	5631	7	,	,	,
46745	5631	8	and	and	CC
46745	5631	9	exhilaration	exhilaration	NN
46745	5631	10	of	of	IN
46745	5631	11	the	the	DT
46745	5631	12	mind	mind	NN
46745	5631	13	,	,	,
46745	5631	14	with	with	IN
46745	5631	15	a	a	DT
46745	5631	16	full	full	JJ
46745	5631	17	pulse	pulse	NN
46745	5631	18	,	,	,
46745	5631	19	and	and	CC
46745	5631	20	general	general	JJ
46745	5631	21	febrile	febrile	NN
46745	5631	22	excitement	excitement	NN
46745	5631	23	.	.	.
46745	5632	1	This	this	DT
46745	5632	2	soon	soon	RB
46745	5632	3	subsides	subside	NNS
46745	5632	4	,	,	,
46745	5632	5	and	and	CC
46745	5632	6	is	be	VBZ
46745	5632	7	succeeded	succeed	VBN
46745	5632	8	by	by	IN
46745	5632	9	drowsiness	drowsiness	NN
46745	5632	10	and	and	CC
46745	5632	11	sleep	sleep	VB
46745	5632	12	.	.	.
46745	5633	1	Large	large	JJ
46745	5633	2	doses	dose	NNS
46745	5633	3	cause	cause	VBP
46745	5633	4	slowness	slowness	NN
46745	5633	5	of	of	IN
46745	5633	6	the	the	DT
46745	5633	7	pulse	pulse	NN
46745	5633	8	,	,	,
46745	5633	9	slow	slow	JJ
46745	5633	10	and	and	CC
46745	5633	11	difficult	difficult	JJ
46745	5633	12	breathing	breathing	NN
46745	5633	13	,	,	,
46745	5633	14	and	and	CC
46745	5633	15	coma	coma	NN
46745	5633	16	.	.	.
46745	5634	1	If	if	IN
46745	5634	2	a	a	DT
46745	5634	3	small	small	JJ
46745	5634	4	dose	dose	NN
46745	5634	5	of	of	IN
46745	5634	6	Opium	opium	NN
46745	5634	7	be	be	VB
46745	5634	8	continually	continually	RB
46745	5634	9	repeated	repeat	VBN
46745	5634	10	,	,	,
46745	5634	11	the	the	DT
46745	5634	12	stimulant	stimulant	NN
46745	5634	13	action	action	NN
46745	5634	14	may	may	MD
46745	5634	15	be	be	VB
46745	5634	16	maintained	maintain	VBN
46745	5634	17	for	for	IN
46745	5634	18	a	a	DT
46745	5634	19	time	time	NN
46745	5634	20	,	,	,
46745	5634	21	and	and	CC
46745	5634	22	the	the	DT
46745	5634	23	Narcotic	narcotic	JJ
46745	5634	24	effect	effect	NN
46745	5634	25	prevented	prevent	VBN
46745	5634	26	.	.	.
46745	5635	1	But	but	CC
46745	5635	2	whenever	whenever	WRB
46745	5635	3	it	-PRON-	PRP
46745	5635	4	is	be	VBZ
46745	5635	5	taken	take	VBN
46745	5635	6	habitually	habitually	RB
46745	5635	7	,	,	,
46745	5635	8	the	the	DT
46745	5635	9	dose	dose	NN
46745	5635	10	will	will	MD
46745	5635	11	require	require	VB
46745	5635	12	to	to	TO
46745	5635	13	be	be	VB
46745	5635	14	gradually	gradually	RB
46745	5635	15	increased	increase	VBN
46745	5635	16	,	,	,
46745	5635	17	or	or	CC
46745	5635	18	the	the	DT
46745	5635	19	desired	desire	VBN
46745	5635	20	effect	effect	NN
46745	5635	21	will	will	MD
46745	5635	22	not	not	RB
46745	5635	23	be	be	VB
46745	5635	24	produced	produce	VBN
46745	5635	25	,	,	,
46745	5635	26	for	for	IN
46745	5635	27	the	the	DT
46745	5635	28	system	system	NN
46745	5635	29	is	be	VBZ
46745	5635	30	induced	induce	VBN
46745	5635	31	by	by	IN
46745	5635	32	degrees	degree	NNS
46745	5635	33	to	to	TO
46745	5635	34	tolerate	tolerate	VB
46745	5635	35	the	the	DT
46745	5635	36	remedy	remedy	NN
46745	5635	37	in	in	IN
46745	5635	38	larger	large	JJR
46745	5635	39	and	and	CC
46745	5635	40	larger	large	JJR
46745	5635	41	quantities	quantity	NNS
46745	5635	42	.	.	.
46745	5636	1	Given	give	VBN
46745	5636	2	in	in	IN
46745	5636	3	moderate	moderate	JJ
46745	5636	4	doses	dose	NNS
46745	5636	5	,	,	,
46745	5636	6	it	-PRON-	PRP
46745	5636	7	powerfully	powerfully	RB
46745	5636	8	relieves	relieve	VBZ
46745	5636	9	pain	pain	NN
46745	5636	10	,	,	,
46745	5636	11	and	and	CC
46745	5636	12	controls	control	VBZ
46745	5636	13	nervous	nervous	JJ
46745	5636	14	irritability	irritability	NN
46745	5636	15	.	.	.
46745	5637	1	Though	though	IN
46745	5637	2	it	-PRON-	PRP
46745	5637	3	always	always	RB
46745	5637	4	tends	tend	VBZ
46745	5637	5	to	to	TO
46745	5637	6	produce	produce	VB
46745	5637	7	sleep	sleep	NN
46745	5637	8	,	,	,
46745	5637	9	its	-PRON-	PRP$
46745	5637	10	anodyne	anodyne	NN
46745	5637	11	effect	effect	NN
46745	5637	12	may	may	MD
46745	5637	13	take	take	VB
46745	5637	14	place	place	NN
46745	5637	15	without	without	IN
46745	5637	16	its	-PRON-	PRP$
46745	5637	17	soporific	soporific	JJ
46745	5637	18	action	action	NN
46745	5637	19	.	.	.
46745	5638	1	It	-PRON-	PRP
46745	5638	2	is	be	VBZ
46745	5638	3	useful	useful	JJ
46745	5638	4	in	in	IN
46745	5638	5	the	the	DT
46745	5638	6	painful	painful	JJ
46745	5638	7	inflammations	inflammation	NNS
46745	5638	8	of	of	IN
46745	5638	9	the	the	DT
46745	5638	10	serous	serous	JJ
46745	5638	11	and	and	CC
46745	5638	12	mucous	mucous	JJ
46745	5638	13	membranes	membrane	NNS
46745	5638	14	.	.	.
46745	5639	1	But	but	CC
46745	5639	2	it	-PRON-	PRP
46745	5639	3	tends	tend	VBZ
46745	5639	4	to	to	TO
46745	5639	5	cause	cause	VB
46745	5639	6	congestion	congestion	NN
46745	5639	7	of	of	IN
46745	5639	8	the	the	DT
46745	5639	9	brain	brain	NN
46745	5639	10	.	.	.
46745	5640	1	It	-PRON-	PRP
46745	5640	2	should	should	MD
46745	5640	3	thus	thus	RB
46745	5640	4	be	be	VB
46745	5640	5	generally	generally	RB
46745	5640	6	avoided	avoid	VBN
46745	5640	7	in	in	IN
46745	5640	8	brain	brain	NN
46745	5640	9	-	-	HYPH
46745	5640	10	disorders	disorder	NNS
46745	5640	11	;	;	:
46745	5640	12	and	and	CC
46745	5640	13	,	,	,
46745	5640	14	on	on	IN
46745	5640	15	account	account	NN
46745	5640	16	of	of	IN
46745	5640	17	its	-PRON-	PRP$
46745	5640	18	primary	primary	JJ
46745	5640	19	stimulant	stimulant	NN
46745	5640	20	action	action	NN
46745	5640	21	,	,	,
46745	5640	22	it	-PRON-	PRP
46745	5640	23	should	should	MD
46745	5640	24	only	only	RB
46745	5640	25	be	be	VB
46745	5640	26	very	very	RB
46745	5640	27	cautiously	cautiously	RB
46745	5640	28	used	use	VBN
46745	5640	29	,	,	,
46745	5640	30	or	or	CC
46745	5640	31	altogether	altogether	RB
46745	5640	32	avoided	avoid	VBN
46745	5640	33	in	in	IN
46745	5640	34	cases	case	NNS
46745	5640	35	of	of	IN
46745	5640	36	high	high	JJ
46745	5640	37	fever	fever	NN
46745	5640	38	,	,	,
46745	5640	39	where	where	WRB
46745	5640	40	there	there	EX
46745	5640	41	is	be	VBZ
46745	5640	42	a	a	DT
46745	5640	43	hot	hot	JJ
46745	5640	44	dry	dry	JJ
46745	5640	45	skin	skin	NN
46745	5640	46	,	,	,
46745	5640	47	or	or	CC
46745	5640	48	a	a	DT
46745	5640	49	full	full	JJ
46745	5640	50	and	and	CC
46745	5640	51	hard	hard	JJ
46745	5640	52	pulse	pulse	NN
46745	5640	53	.	.	.
46745	5641	1	The	the	DT
46745	5641	2	system	system	NN
46745	5641	3	may	may	MD
46745	5641	4	sometimes	sometimes	RB
46745	5641	5	be	be	VB
46745	5641	6	prepared	prepare	VBN
46745	5641	7	for	for	IN
46745	5641	8	it	-PRON-	PRP
46745	5641	9	by	by	IN
46745	5641	10	antiphlogistic	antiphlogistic	JJ
46745	5641	11	treatment	treatment	NN
46745	5641	12	;	;	:
46745	5641	13	or	or	CC
46745	5641	14	Tartar	Tartar	NNP
46745	5641	15	Emetic	Emetic	NNP
46745	5641	16	or	or	CC
46745	5641	17	Ipecacuanha	Ipecacuanha	NNP
46745	5641	18	may	may	MD
46745	5641	19	be	be	VB
46745	5641	20	conjoined	conjoin	VBN
46745	5641	21	with	with	IN
46745	5641	22	the	the	DT
46745	5641	23	dose	dose	NN
46745	5641	24	of	of	IN
46745	5641	25	Opium	Opium	NNP
46745	5641	26	.	.	.
46745	5642	1	Ipecacuanha	Ipecacuanha	NNP
46745	5642	2	and	and	CC
46745	5642	3	Opium	Opium	NNP
46745	5642	4	are	be	VBP
46745	5642	5	combined	combine	VBN
46745	5642	6	in	in	IN
46745	5642	7	Dover	Dover	NNP
46745	5642	8	's	's	POS
46745	5642	9	powder	powder	NN
46745	5642	10	.	.	.
46745	5643	1	Opium	opium	NN
46745	5643	2	is	be	VBZ
46745	5643	3	a	a	DT
46745	5643	4	Diaphoretic	diaphoretic	JJ
46745	5643	5	;	;	:
46745	5643	6	but	but	CC
46745	5643	7	it	-PRON-	PRP
46745	5643	8	diminishes	diminish	VBZ
46745	5643	9	all	all	PDT
46745	5643	10	the	the	DT
46745	5643	11	other	other	JJ
46745	5643	12	secretions	secretion	NNS
46745	5643	13	,	,	,
46745	5643	14	and	and	CC
46745	5643	15	most	most	RBS
46745	5643	16	especially	especially	RB
46745	5643	17	that	that	DT
46745	5643	18	of	of	IN
46745	5643	19	the	the	DT
46745	5643	20	bowels	bowel	NNS
46745	5643	21	.	.	.
46745	5644	1	In	in	IN
46745	5644	2	the	the	DT
46745	5644	3	treatment	treatment	NN
46745	5644	4	of	of	IN
46745	5644	5	fevers	fever	NNS
46745	5644	6	and	and	CC
46745	5644	7	inflammations	inflammation	NNS
46745	5644	8	it	-PRON-	PRP
46745	5644	9	is	be	VBZ
46745	5644	10	often	often	RB
46745	5644	11	combined	combine	VBN
46745	5644	12	with	with	IN
46745	5644	13	Calomel	Calomel	NNP
46745	5644	14	,	,	,
46745	5644	15	for	for	IN
46745	5644	16	the	the	DT
46745	5644	17	purpose	purpose	NN
46745	5644	18	of	of	IN
46745	5644	19	preventing	prevent	VBG
46745	5644	20	the	the	DT
46745	5644	21	latter	latter	JJ
46745	5644	22	from	from	IN
46745	5644	23	passing	pass	VBG
46745	5644	24	out	out	RP
46745	5644	25	by	by	IN
46745	5644	26	the	the	DT
46745	5644	27	bowels	bowel	NNS
46745	5644	28	,	,	,
46745	5644	29	and	and	CC
46745	5644	30	of	of	IN
46745	5644	31	allaying	allay	VBG
46745	5644	32	at	at	IN
46745	5644	33	the	the	DT
46745	5644	34	same	same	JJ
46745	5644	35	time	time	NN
46745	5644	36	the	the	DT
46745	5644	37	nervous	nervous	JJ
46745	5644	38	excitement	excitement	NN
46745	5644	39	and	and	CC
46745	5644	40	pain	pain	NN
46745	5644	41	.	.	.
46745	5645	1	Whether	whether	IN
46745	5645	2	any	any	DT
46745	5645	3	precise	precise	JJ
46745	5645	4	connexion	connexion	NN
46745	5645	5	may	may	MD
46745	5645	6	exist	exist	VB
46745	5645	7	between	between	IN
46745	5645	8	these	these	DT
46745	5645	9	various	various	JJ
46745	5645	10	actions	action	NNS
46745	5645	11	of	of	IN
46745	5645	12	Opium	Opium	NNP
46745	5645	13	,	,	,
46745	5645	14	is	be	VBZ
46745	5645	15	a	a	DT
46745	5645	16	difficult	difficult	JJ
46745	5645	17	thing	thing	NN
46745	5645	18	to	to	TO
46745	5645	19	determine	determine	VB
46745	5645	20	.	.	.
46745	5646	1	It	-PRON-	PRP
46745	5646	2	is	be	VBZ
46745	5646	3	certain	certain	JJ
46745	5646	4	that	that	IN
46745	5646	5	there	there	EX
46745	5646	6	are	be	VBP
46745	5646	7	other	other	JJ
46745	5646	8	Narcotics	Narcotics	NNPS
46745	5646	9	and	and	CC
46745	5646	10	Sedatives	Sedatives	NNPS
46745	5646	11	which	which	WDT
46745	5646	12	are	be	VBP
46745	5646	13	able	able	JJ
46745	5646	14	to	to	TO
46745	5646	15	relieve	relieve	VB
46745	5646	16	pain	pain	NN
46745	5646	17	,	,	,
46745	5646	18	but	but	CC
46745	5646	19	which	which	WDT
46745	5646	20	neither	neither	CC
46745	5646	21	cause	cause	VBP
46745	5646	22	constipation	constipation	NN
46745	5646	23	,	,	,
46745	5646	24	nor	nor	CC
46745	5646	25	produce	produce	VB
46745	5646	26	cerebral	cerebral	JJ
46745	5646	27	congestion	congestion	NN
46745	5646	28	.	.	.
46745	5647	1	Purgative	purgative	JJ
46745	5647	2	medicines	medicine	NNS
46745	5647	3	,	,	,
46745	5647	4	which	which	WDT
46745	5647	5	open	open	VBP
46745	5647	6	the	the	DT
46745	5647	7	bowels	bowel	NNS
46745	5647	8	and	and	CC
46745	5647	9	diminish	diminish	JJ
46745	5647	10	cerebral	cerebral	JJ
46745	5647	11	congestion	congestion	NN
46745	5647	12	,	,	,
46745	5647	13	are	be	VBP
46745	5647	14	so	so	RB
46745	5647	15	far	far	RB
46745	5647	16	opposed	opposed	JJ
46745	5647	17	to	to	IN
46745	5647	18	Opium	Opium	NNP
46745	5647	19	.	.	.
46745	5648	1	Those	those	DT
46745	5648	2	effete	effete	JJ
46745	5648	3	matters	matter	NNS
46745	5648	4	which	which	WDT
46745	5648	5	it	-PRON-	PRP
46745	5648	6	is	be	VBZ
46745	5648	7	the	the	DT
46745	5648	8	function	function	NN
46745	5648	9	of	of	IN
46745	5648	10	the	the	DT
46745	5648	11	bowels	bowel	NNS
46745	5648	12	to	to	TO
46745	5648	13	excrete	excrete	VB
46745	5648	14	from	from	IN
46745	5648	15	the	the	DT
46745	5648	16	blood	blood	NN
46745	5648	17	,	,	,
46745	5648	18	and	and	CC
46745	5648	19	whose	whose	WP$
46745	5648	20	excretion	excretion	NN
46745	5648	21	is	be	VBZ
46745	5648	22	promoted	promote	VBN
46745	5648	23	by	by	IN
46745	5648	24	purgative	purgative	JJ
46745	5648	25	medicines	medicine	NNS
46745	5648	26	,	,	,
46745	5648	27	have	have	VBP
46745	5648	28	an	an	DT
46745	5648	29	action	action	NN
46745	5648	30	on	on	IN
46745	5648	31	the	the	DT
46745	5648	32	brain	brain	NN
46745	5648	33	which	which	WDT
46745	5648	34	in	in	IN
46745	5648	35	some	some	DT
46745	5648	36	degree	degree	NN
46745	5648	37	resembles	resemble	VBZ
46745	5648	38	that	that	IN
46745	5648	39	of	of	IN
46745	5648	40	Opium	Opium	NNP
46745	5648	41	.	.	.
46745	5649	1	Constipation	constipation	NN
46745	5649	2	produces	produce	VBZ
46745	5649	3	drowsiness	drowsiness	NN
46745	5649	4	,	,	,
46745	5649	5	and	and	CC
46745	5649	6	torpor	torpor	NN
46745	5649	7	of	of	IN
46745	5649	8	the	the	DT
46745	5649	9	mental	mental	JJ
46745	5649	10	faculties	faculty	NNS
46745	5649	11	.	.	.
46745	5650	1	And	and	CC
46745	5650	2	it	-PRON-	PRP
46745	5650	3	is	be	VBZ
46745	5650	4	worthy	worthy	JJ
46745	5650	5	of	of	IN
46745	5650	6	remark	remark	NN
46745	5650	7	that	that	IN
46745	5650	8	Opium	Opium	NNP
46745	5650	9	does	do	VBZ
46745	5650	10	not	not	RB
46745	5650	11	seem	seem	VB
46745	5650	12	to	to	TO
46745	5650	13	produce	produce	VB
46745	5650	14	quite	quite	PDT
46745	5650	15	its	-PRON-	PRP$
46745	5650	16	proper	proper	JJ
46745	5650	17	effect	effect	NN
46745	5650	18	when	when	WRB
46745	5650	19	combined	combine	VBN
46745	5650	20	with	with	IN
46745	5650	21	a	a	DT
46745	5650	22	medicine	medicine	NN
46745	5650	23	which	which	WDT
46745	5650	24	causes	cause	VBZ
46745	5650	25	purging	purging	NN
46745	5650	26	.	.	.
46745	5651	1	Thus	thus	RB
46745	5651	2	it	-PRON-	PRP
46745	5651	3	is	be	VBZ
46745	5651	4	barely	barely	RB
46745	5651	5	possible	possible	JJ
46745	5651	6	that	that	IN
46745	5651	7	the	the	DT
46745	5651	8	action	action	NN
46745	5651	9	of	of	IN
46745	5651	10	Opium	Opium	NNP
46745	5651	11	in	in	IN
46745	5651	12	causing	cause	VBG
46745	5651	13	congestion	congestion	NN
46745	5651	14	of	of	IN
46745	5651	15	the	the	DT
46745	5651	16	brain	brain	NN
46745	5651	17	may	may	MD
46745	5651	18	be	be	VB
46745	5651	19	in	in	IN
46745	5651	20	part	part	NN
46745	5651	21	referrible	referrible	JJ
46745	5651	22	to	to	IN
46745	5651	23	the	the	DT
46745	5651	24	influence	influence	NN
46745	5651	25	of	of	IN
46745	5651	26	those	those	DT
46745	5651	27	excrementitious	excrementitious	JJ
46745	5651	28	matters	matter	NNS
46745	5651	29	which	which	WDT
46745	5651	30	it	-PRON-	PRP
46745	5651	31	hinders	hinder	VBZ
46745	5651	32	from	from	IN
46745	5651	33	passing	pass	VBG
46745	5651	34	out	out	RP
46745	5651	35	through	through	IN
46745	5651	36	the	the	DT
46745	5651	37	intestinal	intestinal	JJ
46745	5651	38	glands	gland	NNS
46745	5651	39	(	(	-LRB-
46745	5651	40	p.	p.	NN
46745	5652	1	291	291	CD
46745	5652	2	.	.	.
46745	5652	3	)	)	-RRB-
46745	5653	1	But	but	CC
46745	5653	2	nothing	nothing	NN
46745	5653	3	conclusive	conclusive	JJ
46745	5653	4	is	be	VBZ
46745	5653	5	known	know	VBN
46745	5653	6	on	on	IN
46745	5653	7	the	the	DT
46745	5653	8	subject	subject	NN
46745	5653	9	.	.	.
46745	5654	1	How	how	WRB
46745	5654	2	,	,	,
46745	5654	3	we	-PRON-	PRP
46745	5654	4	may	may	MD
46745	5654	5	ask	ask	VB
46745	5654	6	in	in	IN
46745	5654	7	the	the	DT
46745	5654	8	next	next	JJ
46745	5654	9	place	place	NN
46745	5654	10	,	,	,
46745	5654	11	does	do	VBZ
46745	5654	12	Opium	opium	NN
46745	5654	13	produce	produce	VB
46745	5654	14	constipation	constipation	NN
46745	5654	15	?	?	.
46745	5655	1	It	-PRON-	PRP
46745	5655	2	has	have	VBZ
46745	5655	3	none	none	NN
46745	5655	4	of	of	IN
46745	5655	5	the	the	DT
46745	5655	6	characters	character	NNS
46745	5655	7	of	of	IN
46745	5655	8	a	a	DT
46745	5655	9	general	general	JJ
46745	5655	10	Astringent	Astringent	NNP
46745	5655	11	,	,	,
46745	5655	12	and	and	CC
46745	5655	13	yet	yet	RB
46745	5655	14	there	there	EX
46745	5655	15	is	be	VBZ
46745	5655	16	no	no	DT
46745	5655	17	Astringent	Astringent	NNP
46745	5655	18	like	like	IN
46745	5655	19	it	-PRON-	PRP
46745	5655	20	in	in	IN
46745	5655	21	its	-PRON-	PRP$
46745	5655	22	action	action	NN
46745	5655	23	on	on	IN
46745	5655	24	the	the	DT
46745	5655	25	bowels	bowel	NNS
46745	5655	26	.	.	.
46745	5656	1	An	an	DT
46745	5656	2	attempt	attempt	NN
46745	5656	3	has	have	VBZ
46745	5656	4	been	be	VBN
46745	5656	5	made	make	VBN
46745	5656	6	to	to	TO
46745	5656	7	explain	explain	VB
46745	5656	8	it	-PRON-	PRP
46745	5656	9	on	on	IN
46745	5656	10	mechanical	mechanical	JJ
46745	5656	11	grounds	ground	NNS
46745	5656	12	.	.	.
46745	5657	1	Poisseuille	Poisseuille	NNP
46745	5657	2	some	some	DT
46745	5657	3	time	time	NN
46745	5657	4	ago	ago	RB
46745	5657	5	asserted	assert	VBD
46745	5657	6	that	that	IN
46745	5657	7	a	a	DT
46745	5657	8	solution	solution	NN
46745	5657	9	of	of	IN
46745	5657	10	Morphia	Morphia	NNP
46745	5657	11	prevented	prevent	VBD
46745	5657	12	the	the	DT
46745	5657	13	process	process	NN
46745	5657	14	of	of	IN
46745	5657	15	endosmosis	endosmosis	NN
46745	5657	16	through	through	IN
46745	5657	17	a	a	DT
46745	5657	18	dead	dead	JJ
46745	5657	19	animal	animal	NN
46745	5657	20	membrane	membrane	NN
46745	5657	21	.	.	.
46745	5658	1	Matteucci	Matteucci	NNS
46745	5658	2	and	and	CC
46745	5658	3	others	other	NNS
46745	5658	4	account	account	VBP
46745	5658	5	for	for	IN
46745	5658	6	the	the	DT
46745	5658	7	operation	operation	NN
46745	5658	8	of	of	IN
46745	5658	9	Opium	Opium	NNP
46745	5658	10	on	on	IN
46745	5658	11	this	this	DT
46745	5658	12	principle	principle	NN
46745	5658	13	,	,	,
46745	5658	14	supposing	suppose	VBG
46745	5658	15	that	that	IN
46745	5658	16	by	by	IN
46745	5658	17	exerting	exert	VBG
46745	5658	18	this	this	DT
46745	5658	19	action	action	NN
46745	5658	20	on	on	IN
46745	5658	21	the	the	DT
46745	5658	22	living	live	VBG
46745	5658	23	mucous	mucous	JJ
46745	5658	24	membrane	membrane	NN
46745	5658	25	,	,	,
46745	5658	26	it	-PRON-	PRP
46745	5658	27	is	be	VBZ
46745	5658	28	able	able	JJ
46745	5658	29	to	to	TO
46745	5658	30	prevent	prevent	VB
46745	5658	31	the	the	DT
46745	5658	32	transudation	transudation	NN
46745	5658	33	of	of	IN
46745	5658	34	fluids	fluid	NNS
46745	5658	35	from	from	IN
46745	5658	36	the	the	DT
46745	5658	37	blood	blood	NN
46745	5658	38	into	into	IN
46745	5658	39	the	the	DT
46745	5658	40	cavity	cavity	NN
46745	5658	41	of	of	IN
46745	5658	42	the	the	DT
46745	5658	43	bowel	bowel	NN
46745	5658	44	.	.	.
46745	5659	1	But	but	CC
46745	5659	2	this	this	DT
46745	5659	3	view	view	NN
46745	5659	4	seems	seem	VBZ
46745	5659	5	even	even	RB
46745	5659	6	at	at	IN
46745	5659	7	first	first	JJ
46745	5659	8	sight	sight	NN
46745	5659	9	unsatisfactory	unsatisfactory	JJ
46745	5659	10	.	.	.
46745	5660	1	If	if	IN
46745	5660	2	such	such	PDT
46745	5660	3	a	a	DT
46745	5660	4	force	force	NN
46745	5660	5	is	be	VBZ
46745	5660	6	really	really	RB
46745	5660	7	exerted	exert	VBN
46745	5660	8	,	,	,
46745	5660	9	and	and	CC
46745	5660	10	the	the	DT
46745	5660	11	passage	passage	NN
46745	5660	12	of	of	IN
46745	5660	13	fluids	fluid	NNS
46745	5660	14	through	through	IN
46745	5660	15	a	a	DT
46745	5660	16	membrane	membrane	NN
46745	5660	17	prevented	prevent	VBN
46745	5660	18	by	by	IN
46745	5660	19	the	the	DT
46745	5660	20	action	action	NN
46745	5660	21	of	of	IN
46745	5660	22	Opium	Opium	NNP
46745	5660	23	,	,	,
46745	5660	24	must	must	MD
46745	5660	25	it	-PRON-	PRP
46745	5660	26	not	not	RB
46745	5660	27	apply	apply	VB
46745	5660	28	to	to	IN
46745	5660	29	the	the	DT
46745	5660	30	stomach	stomach	NN
46745	5660	31	as	as	RB
46745	5660	32	well	well	RB
46745	5660	33	as	as	IN
46745	5660	34	to	to	IN
46745	5660	35	the	the	DT
46745	5660	36	bowel	bowel	NN
46745	5660	37	?	?	.
46745	5661	1	Why	why	WRB
46745	5661	2	is	be	VBZ
46745	5661	3	Morphia	Morphia	NNP
46745	5661	4	absorbed	absorb	VBN
46745	5661	5	at	at	RB
46745	5661	6	all	all	RB
46745	5661	7	?	?	.
46745	5662	1	It	-PRON-	PRP
46745	5662	2	should	should	MD
46745	5662	3	stop	stop	VB
46745	5662	4	the	the	DT
46745	5662	5	digestive	digestive	JJ
46745	5662	6	process	process	NN
46745	5662	7	altogether	altogether	RB
46745	5662	8	.	.	.
46745	5663	1	And	and	CC
46745	5663	2	why	why	WRB
46745	5663	3	is	be	VBZ
46745	5663	4	the	the	DT
46745	5663	5	secretion	secretion	NN
46745	5663	6	of	of	IN
46745	5663	7	the	the	DT
46745	5663	8	skin	skin	NN
46745	5663	9	increased	increase	VBD
46745	5663	10	by	by	IN
46745	5663	11	Opium	Opium	NNP
46745	5663	12	,	,	,
46745	5663	13	while	while	IN
46745	5663	14	that	that	DT
46745	5663	15	of	of	IN
46745	5663	16	the	the	DT
46745	5663	17	bowels	bowel	NNS
46745	5663	18	is	be	VBZ
46745	5663	19	suppressed	suppress	VBN
46745	5663	20	?	?	.
46745	5664	1	(	(	-LRB-
46745	5664	2	_	_	NNP
46745	5664	3	Vide	Vide	NNP
46745	5664	4	_	_	NNP
46745	5664	5	Matteucci	Matteucci	NNP
46745	5664	6	's	's	POS
46745	5664	7	_	_	NNP
46745	5664	8	Lectures	Lectures	NNP
46745	5664	9	_	_	NNP
46745	5664	10	,	,	,
46745	5664	11	p.	p.	NN
46745	5665	1	74	74	CD
46745	5665	2	.	.	.
46745	5665	3	)	)	-RRB-
46745	5666	1	But	but	CC
46745	5666	2	there	there	EX
46745	5666	3	is	be	VBZ
46745	5666	4	reason	reason	NN
46745	5666	5	to	to	TO
46745	5666	6	suppose	suppose	VB
46745	5666	7	that	that	IN
46745	5666	8	a	a	DT
46745	5666	9	serious	serious	JJ
46745	5666	10	error	error	NN
46745	5666	11	of	of	IN
46745	5666	12	observation	observation	NN
46745	5666	13	has	have	VBZ
46745	5666	14	been	be	VBN
46745	5666	15	made	make	VBN
46745	5666	16	by	by	IN
46745	5666	17	those	those	DT
46745	5666	18	who	who	WP
46745	5666	19	first	first	RB
46745	5666	20	asserted	assert	VBD
46745	5666	21	that	that	IN
46745	5666	22	a	a	DT
46745	5666	23	solution	solution	NN
46745	5666	24	of	of	IN
46745	5666	25	Morphia	Morphia	NNP
46745	5666	26	tended	tend	VBD
46745	5666	27	to	to	TO
46745	5666	28	arrest	arrest	VB
46745	5666	29	the	the	DT
46745	5666	30	process	process	NN
46745	5666	31	of	of	IN
46745	5666	32	endosmosis	endosmosis	NN
46745	5666	33	.	.	.
46745	5667	1	Dr.	Dr.	NNP
46745	5667	2	Cogswell	Cogswell	NNP
46745	5667	3	has	have	VBZ
46745	5667	4	lately	lately	RB
46745	5667	5	made	make	VBN
46745	5667	6	some	some	DT
46745	5667	7	careful	careful	JJ
46745	5667	8	experiments	experiment	NNS
46745	5667	9	on	on	IN
46745	5667	10	the	the	DT
46745	5667	11	subject	subject	NN
46745	5667	12	,	,	,
46745	5667	13	and	and	CC
46745	5667	14	he	-PRON-	PRP
46745	5667	15	finds	find	VBZ
46745	5667	16	that	that	IN
46745	5667	17	a	a	DT
46745	5667	18	solution	solution	NN
46745	5667	19	of	of	IN
46745	5667	20	Muriate	Muriate	NNP
46745	5667	21	of	of	IN
46745	5667	22	Morphia	Morphia	NNP
46745	5667	23	passes	pass	VBZ
46745	5667	24	readily	readily	RB
46745	5667	25	through	through	IN
46745	5667	26	the	the	DT
46745	5667	27	bladder	bladder	NN
46745	5667	28	of	of	IN
46745	5667	29	an	an	DT
46745	5667	30	endosmometer	endosmometer	NN
46745	5667	31	to	to	TO
46745	5667	32	serum	serum	NN
46745	5667	33	or	or	CC
46745	5667	34	a	a	DT
46745	5667	35	heavy	heavy	JJ
46745	5667	36	saline	saline	NN
46745	5667	37	solution	solution	NN
46745	5667	38	.	.	.
46745	5668	1	And	and	CC
46745	5668	2	when	when	WRB
46745	5668	3	experiments	experiment	NNS
46745	5668	4	are	be	VBP
46745	5668	5	made	make	VBN
46745	5668	6	on	on	IN
46745	5668	7	two	two	CD
46745	5668	8	other	other	JJ
46745	5668	9	liquids	liquid	NNS
46745	5668	10	of	of	IN
46745	5668	11	different	different	JJ
46745	5668	12	density	density	NN
46745	5668	13	,	,	,
46745	5668	14	the	the	DT
46745	5668	15	addition	addition	NN
46745	5668	16	of	of	IN
46745	5668	17	Morphia	Morphia	NNP
46745	5668	18	to	to	IN
46745	5668	19	one	one	CD
46745	5668	20	or	or	CC
46745	5668	21	other	other	JJ
46745	5668	22	of	of	IN
46745	5668	23	them	-PRON-	PRP
46745	5668	24	is	be	VBZ
46745	5668	25	found	find	VBN
46745	5668	26	to	to	TO
46745	5668	27	effect	effect	VB
46745	5668	28	no	no	DT
46745	5668	29	alteration	alteration	NN
46745	5668	30	in	in	IN
46745	5668	31	the	the	DT
46745	5668	32	direction	direction	NN
46745	5668	33	or	or	CC
46745	5668	34	rapidity	rapidity	NN
46745	5668	35	of	of	IN
46745	5668	36	the	the	DT
46745	5668	37	current	current	NN
46745	5668	38	.	.	.
46745	5669	1	Opium	opium	NN
46745	5669	2	is	be	VBZ
46745	5669	3	a	a	DT
46745	5669	4	general	general	JJ
46745	5669	5	paralyzer	paralyzer	NN
46745	5669	6	to	to	IN
46745	5669	7	muscular	muscular	NNP
46745	5669	8	fibre	fibre	NNP
46745	5669	9	,	,	,
46745	5669	10	both	both	DT
46745	5669	11	of	of	IN
46745	5669	12	the	the	DT
46745	5669	13	voluntary	voluntary	JJ
46745	5669	14	and	and	CC
46745	5669	15	involuntary	involuntary	JJ
46745	5669	16	kind	kind	NN
46745	5669	17	,	,	,
46745	5669	18	but	but	CC
46745	5669	19	particularly	particularly	RB
46745	5669	20	of	of	IN
46745	5669	21	the	the	DT
46745	5669	22	latter	latter	JJ
46745	5669	23	.	.	.
46745	5670	1	And	and	CC
46745	5670	2	the	the	DT
46745	5670	3	only	only	JJ
46745	5670	4	reasonable	reasonable	JJ
46745	5670	5	attempt	attempt	NN
46745	5670	6	that	that	WDT
46745	5670	7	can	can	MD
46745	5670	8	be	be	VB
46745	5670	9	made	make	VBN
46745	5670	10	to	to	TO
46745	5670	11	explain	explain	VB
46745	5670	12	the	the	DT
46745	5670	13	action	action	NN
46745	5670	14	of	of	IN
46745	5670	15	Opium	Opium	NNP
46745	5670	16	in	in	IN
46745	5670	17	producing	produce	VBG
46745	5670	18	constipation	constipation	NN
46745	5670	19	,	,	,
46745	5670	20	is	be	VBZ
46745	5670	21	by	by	IN
46745	5670	22	a	a	DT
46745	5670	23	reference	reference	NN
46745	5670	24	to	to	IN
46745	5670	25	this	this	DT
46745	5670	26	its	-PRON-	PRP$
46745	5670	27	paralyzing	paralyzing	NN
46745	5670	28	influence	influence	NN
46745	5670	29	on	on	IN
46745	5670	30	the	the	DT
46745	5670	31	coat	coat	NN
46745	5670	32	of	of	IN
46745	5670	33	the	the	DT
46745	5670	34	bowel	bowel	NN
46745	5670	35	,	,	,
46745	5670	36	taken	take	VBN
46745	5670	37	in	in	IN
46745	5670	38	conjunction	conjunction	NN
46745	5670	39	with	with	IN
46745	5670	40	the	the	DT
46745	5670	41	torpid	torpid	JJ
46745	5670	42	condition	condition	NN
46745	5670	43	of	of	IN
46745	5670	44	the	the	DT
46745	5670	45	general	general	JJ
46745	5670	46	system	system	NN
46745	5670	47	,	,	,
46745	5670	48	and	and	CC
46745	5670	49	suspension	suspension	NN
46745	5670	50	of	of	IN
46745	5670	51	the	the	DT
46745	5670	52	animal	animal	NN
46745	5670	53	functions	function	NNS
46745	5670	54	,	,	,
46745	5670	55	produced	produce	VBN
46745	5670	56	by	by	IN
46745	5670	57	the	the	DT
46745	5670	58	secondary	secondary	JJ
46745	5670	59	action	action	NN
46745	5670	60	of	of	IN
46745	5670	61	this	this	DT
46745	5670	62	Narcotic	Narcotic	NNP
46745	5670	63	on	on	IN
46745	5670	64	the	the	DT
46745	5670	65	nervous	nervous	JJ
46745	5670	66	forces	force	NNS
46745	5670	67	.	.	.
46745	5671	1	A	a	DT
46745	5671	2	considerable	considerable	JJ
46745	5671	3	dose	dose	NN
46745	5671	4	of	of	IN
46745	5671	5	Opium	opium	NN
46745	5671	6	produces	produce	VBZ
46745	5671	7	contraction	contraction	NN
46745	5671	8	of	of	IN
46745	5671	9	the	the	DT
46745	5671	10	pupil	pupil	NN
46745	5671	11	of	of	IN
46745	5671	12	the	the	DT
46745	5671	13	eye	eye	NN
46745	5671	14	.	.	.
46745	5672	1	A	a	DT
46745	5672	2	larger	large	JJR
46745	5672	3	dose	dose	NN
46745	5672	4	causes	cause	VBZ
46745	5672	5	coma	coma	NN
46745	5672	6	.	.	.
46745	5673	1	The	the	DT
46745	5673	2	Deliriant	Deliriant	NNP
46745	5673	3	Narcotics	Narcotics	NNP
46745	5673	4	,	,	,
46745	5673	5	_	_	NNP
46745	5673	6	i.e.	i.e.	FW
46745	5673	7	_	_	NNP
46745	5673	8	Hyoscyamus	Hyoscyamus	NNP
46745	5673	9	,	,	,
46745	5673	10	Belladonna	Belladonna	NNP
46745	5673	11	,	,	,
46745	5673	12	and	and	CC
46745	5673	13	Stramonium	Stramonium	NNP
46745	5673	14	,	,	,
46745	5673	15	dilate	dilate	VBP
46745	5673	16	the	the	DT
46745	5673	17	pupil	pupil	NN
46745	5673	18	,	,	,
46745	5673	19	and	and	CC
46745	5673	20	in	in	IN
46745	5673	21	large	large	JJ
46745	5673	22	doses	dose	NNS
46745	5673	23	cause	cause	IN
46745	5673	24	delirium	delirium	NN
46745	5673	25	.	.	.
46745	5674	1	Their	-PRON-	PRP$
46745	5674	2	action	action	NN
46745	5674	3	is	be	VBZ
46745	5674	4	thus	thus	RB
46745	5674	5	readily	readily	RB
46745	5674	6	distinguished	distinguish	VBN
46745	5674	7	in	in	IN
46745	5674	8	cases	case	NNS
46745	5674	9	of	of	IN
46745	5674	10	poisoning	poisoning	NN
46745	5674	11	.	.	.
46745	5675	1	Opium	opium	NN
46745	5675	2	is	be	VBZ
46745	5675	3	the	the	DT
46745	5675	4	best	good	JJS
46745	5675	5	internal	internal	JJ
46745	5675	6	remedy	remedy	NN
46745	5675	7	in	in	IN
46745	5675	8	all	all	DT
46745	5675	9	cases	case	NNS
46745	5675	10	of	of	IN
46745	5675	11	pain	pain	NN
46745	5675	12	and	and	CC
46745	5675	13	nervous	nervous	JJ
46745	5675	14	irritation	irritation	NN
46745	5675	15	,	,	,
46745	5675	16	except	except	IN
46745	5675	17	where	where	WRB
46745	5675	18	contraindicated	contraindicate	VBN
46745	5675	19	by	by	IN
46745	5675	20	great	great	JJ
46745	5675	21	febrile	febrile	NN
46745	5675	22	excitement	excitement	NN
46745	5675	23	,	,	,
46745	5675	24	by	by	IN
46745	5675	25	stomach	stomach	NN
46745	5675	26	irritation	irritation	NN
46745	5675	27	,	,	,
46745	5675	28	or	or	CC
46745	5675	29	by	by	IN
46745	5675	30	cerebral	cerebral	JJ
46745	5675	31	congestion	congestion	NN
46745	5675	32	.	.	.
46745	5676	1	It	-PRON-	PRP
46745	5676	2	acts	act	VBZ
46745	5676	3	powerfully	powerfully	RB
46745	5676	4	on	on	IN
46745	5676	5	children	child	NNS
46745	5676	6	,	,	,
46745	5676	7	and	and	CC
46745	5676	8	should	should	MD
46745	5676	9	be	be	VB
46745	5676	10	administered	administer	VBN
46745	5676	11	to	to	IN
46745	5676	12	them	-PRON-	PRP
46745	5676	13	very	very	RB
46745	5676	14	cautiously	cautiously	RB
46745	5676	15	,	,	,
46745	5676	16	or	or	CC
46745	5676	17	not	not	RB
46745	5676	18	at	at	RB
46745	5676	19	all	all	RB
46745	5676	20	.	.	.
46745	5677	1	It	-PRON-	PRP
46745	5677	2	is	be	VBZ
46745	5677	3	given	give	VBN
46745	5677	4	to	to	TO
46745	5677	5	lessen	lessen	VB
46745	5677	6	the	the	DT
46745	5677	7	secretion	secretion	NN
46745	5677	8	in	in	IN
46745	5677	9	some	some	DT
46745	5677	10	cases	case	NNS
46745	5677	11	of	of	IN
46745	5677	12	diarrh[oe]a	diarrh[oe]a	NNP
46745	5677	13	.	.	.
46745	5678	1	It	-PRON-	PRP
46745	5678	2	is	be	VBZ
46745	5678	3	generally	generally	RB
46745	5678	4	unadvisable	unadvisable	JJ
46745	5678	5	to	to	TO
46745	5678	6	give	give	VB
46745	5678	7	it	-PRON-	PRP
46745	5678	8	when	when	WRB
46745	5678	9	there	there	EX
46745	5678	10	is	be	VBZ
46745	5678	11	constipation	constipation	NN
46745	5678	12	or	or	CC
46745	5678	13	hepatic	hepatic	JJ
46745	5678	14	congestion	congestion	NN
46745	5678	15	.	.	.
46745	5679	1	In	in	IN
46745	5679	2	wakefulness	wakefulness	NN
46745	5679	3	,	,	,
46745	5679	4	mania	mania	NN
46745	5679	5	,	,	,
46745	5679	6	and	and	CC
46745	5679	7	delirium	delirium	NN
46745	5679	8	,	,	,
46745	5679	9	when	when	WRB
46745	5679	10	unattended	unattende	VBN
46745	5679	11	with	with	IN
46745	5679	12	congestion	congestion	NN
46745	5679	13	of	of	IN
46745	5679	14	the	the	DT
46745	5679	15	brain	brain	NN
46745	5679	16	or	or	CC
46745	5679	17	fever	fever	NN
46745	5679	18	,	,	,
46745	5679	19	it	-PRON-	PRP
46745	5679	20	is	be	VBZ
46745	5679	21	highly	highly	RB
46745	5679	22	serviceable	serviceable	JJ
46745	5679	23	.	.	.
46745	5680	1	In	in	IN
46745	5680	2	spasmodic	spasmodic	JJ
46745	5680	3	disorders	disorder	NNS
46745	5680	4	,	,	,
46745	5680	5	convulsions	convulsion	NNS
46745	5680	6	,	,	,
46745	5680	7	and	and	CC
46745	5680	8	cough	cough	NN
46745	5680	9	,	,	,
46745	5680	10	it	-PRON-	PRP
46745	5680	11	is	be	VBZ
46745	5680	12	more	more	RBR
46745	5680	13	or	or	CC
46745	5680	14	less	less	RBR
46745	5680	15	applicable	applicable	JJ
46745	5680	16	.	.	.
46745	5681	1	That	that	IN
46745	5681	2	the	the	DT
46745	5681	3	active	active	JJ
46745	5681	4	principles	principle	NNS
46745	5681	5	of	of	IN
46745	5681	6	Opium	Opium	NNP
46745	5681	7	are	be	VBP
46745	5681	8	absorbed	absorb	VBN
46745	5681	9	,	,	,
46745	5681	10	and	and	CC
46745	5681	11	pass	pass	VB
46745	5681	12	into	into	IN
46745	5681	13	the	the	DT
46745	5681	14	blood	blood	NN
46745	5681	15	,	,	,
46745	5681	16	has	have	VBZ
46745	5681	17	been	be	VBN
46745	5681	18	proved	prove	VBN
46745	5681	19	by	by	IN
46745	5681	20	their	-PRON-	PRP$
46745	5681	21	detection	detection	NN
46745	5681	22	in	in	IN
46745	5681	23	the	the	DT
46745	5681	24	urine	urine	NN
46745	5681	25	.	.	.
46745	5682	1	(	(	-LRB-
46745	5682	2	p.	p.	NN
46745	5683	1	223	223	CD
46745	5683	2	.	.	.
46745	5683	3	)	)	-RRB-
46745	5684	1	It	-PRON-	PRP
46745	5684	2	does	do	VBZ
46745	5684	3	not	not	RB
46745	5684	4	act	act	VB
46745	5684	5	on	on	IN
46745	5684	6	the	the	DT
46745	5684	7	system	system	NN
46745	5684	8	before	before	IN
46745	5684	9	time	time	NN
46745	5684	10	has	have	VBZ
46745	5684	11	been	be	VBN
46745	5684	12	allowed	allow	VBN
46745	5684	13	for	for	IN
46745	5684	14	this	this	DT
46745	5684	15	absorption	absorption	NN
46745	5684	16	.	.	.
46745	5685	1	If	if	IN
46745	5685	2	taken	take	VBN
46745	5685	3	by	by	IN
46745	5685	4	a	a	DT
46745	5685	5	mother	mother	NN
46745	5685	6	during	during	IN
46745	5685	7	suckling	suckle	VBG
46745	5685	8	,	,	,
46745	5685	9	it	-PRON-	PRP
46745	5685	10	may	may	MD
46745	5685	11	act	act	VB
46745	5685	12	upon	upon	IN
46745	5685	13	the	the	DT
46745	5685	14	infant	infant	NN
46745	5685	15	by	by	IN
46745	5685	16	passing	pass	VBG
46745	5685	17	into	into	IN
46745	5685	18	the	the	DT
46745	5685	19	secretion	secretion	NN
46745	5685	20	of	of	IN
46745	5685	21	milk	milk	NN
46745	5685	22	.	.	.
46745	5686	1	It	-PRON-	PRP
46745	5686	2	acts	act	VBZ
46745	5686	3	upon	upon	IN
46745	5686	4	the	the	DT
46745	5686	5	nervous	nervous	JJ
46745	5686	6	system	system	NN
46745	5686	7	,	,	,
46745	5686	8	and	and	CC
46745	5686	9	probably	probably	RB
46745	5686	10	on	on	IN
46745	5686	11	the	the	DT
46745	5686	12	muscles	muscle	NNS
46745	5686	13	also	also	RB
46745	5686	14	(	(	-LRB-
46745	5686	15	_	_	NNP
46745	5686	16	see	see	NNP
46745	5686	17	note	note	NN
46745	5686	18	_	_	NNP
46745	5686	19	,	,	,
46745	5686	20	p.	p.	NN
46745	5686	21	224	224	CD
46745	5686	22	,	,	,
46745	5686	23	)	)	-RRB-
46745	5686	24	through	through	IN
46745	5686	25	the	the	DT
46745	5686	26	medium	medium	NN
46745	5686	27	of	of	IN
46745	5686	28	the	the	DT
46745	5686	29	blood	blood	NN
46745	5686	30	.	.	.
46745	5687	1	As	as	IN
46745	5687	2	a	a	DT
46745	5687	3	Diaphoretic	Diaphoretic	NNP
46745	5687	4	in	in	IN
46745	5687	5	fevers	fever	NNS
46745	5687	6	and	and	CC
46745	5687	7	inflammations	inflammation	NNS
46745	5687	8	,	,	,
46745	5687	9	Opium	Opium	NNP
46745	5687	10	is	be	VBZ
46745	5687	11	to	to	TO
46745	5687	12	be	be	VB
46745	5687	13	preferred	prefer	VBN
46745	5687	14	in	in	IN
46745	5687	15	cases	case	NNS
46745	5687	16	where	where	WRB
46745	5687	17	the	the	DT
46745	5687	18	skin	skin	NN
46745	5687	19	is	be	VBZ
46745	5687	20	already	already	RB
46745	5687	21	moist	moist	JJ
46745	5687	22	and	and	CC
46745	5687	23	cool	cool	JJ
46745	5687	24	,	,	,
46745	5687	25	where	where	WRB
46745	5687	26	the	the	DT
46745	5687	27	pulse	pulse	NN
46745	5687	28	is	be	VBZ
46745	5687	29	soft	soft	JJ
46745	5687	30	,	,	,
46745	5687	31	and	and	CC
46745	5687	32	the	the	DT
46745	5687	33	tongue	tongue	NN
46745	5687	34	not	not	RB
46745	5687	35	coated	coat	VBN
46745	5687	36	.	.	.
46745	5688	1	But	but	CC
46745	5688	2	where	where	WRB
46745	5688	3	there	there	EX
46745	5688	4	is	be	VBZ
46745	5688	5	febrile	febrile	NN
46745	5688	6	excitement	excitement	NN
46745	5688	7	,	,	,
46745	5688	8	Antimony	Antimony	NNP
46745	5688	9	,	,	,
46745	5688	10	or	or	CC
46745	5688	11	Ipecacuanha	Ipecacuanha	NNP
46745	5688	12	,	,	,
46745	5688	13	is	be	VBZ
46745	5688	14	rather	rather	RB
46745	5688	15	indicated	indicate	VBN
46745	5688	16	.	.	.
46745	5689	1	Opium	opium	NN
46745	5689	2	may	may	MD
46745	5689	3	act	act	VB
46745	5689	4	on	on	IN
46745	5689	5	the	the	DT
46745	5689	6	glands	gland	NNS
46745	5689	7	of	of	IN
46745	5689	8	the	the	DT
46745	5689	9	skin	skin	NN
46745	5689	10	as	as	IN
46745	5689	11	a	a	DT
46745	5689	12	true	true	JJ
46745	5689	13	Eliminative	eliminative	NN
46745	5689	14	;	;	:
46745	5689	15	or	or	CC
46745	5689	16	it	-PRON-	PRP
46745	5689	17	may	may	MD
46745	5689	18	possibly	possibly	RB
46745	5689	19	operate	operate	VB
46745	5689	20	in	in	IN
46745	5689	21	the	the	DT
46745	5689	22	same	same	JJ
46745	5689	23	indirect	indirect	JJ
46745	5689	24	way	way	NN
46745	5689	25	as	as	IN
46745	5689	26	a	a	DT
46745	5689	27	nauseant	nauseant	JJ
46745	5689	28	dose	dose	NN
46745	5689	29	of	of	IN
46745	5689	30	Tartar	Tartar	NNP
46745	5689	31	Emetic	Emetic	NNP
46745	5689	32	,	,	,
46745	5689	33	relaxing	relax	VBG
46745	5689	34	the	the	DT
46745	5689	35	ducts	duct	NNS
46745	5689	36	of	of	IN
46745	5689	37	the	the	DT
46745	5689	38	sudorific	sudorific	JJ
46745	5689	39	glands	gland	NNS
46745	5689	40	by	by	IN
46745	5689	41	its	-PRON-	PRP$
46745	5689	42	paralyzing	paralyzing	NN
46745	5689	43	influence	influence	NN
46745	5689	44	on	on	IN
46745	5689	45	their	-PRON-	PRP$
46745	5689	46	muscular	muscular	JJ
46745	5689	47	fibre	fibre	NN
46745	5689	48	.	.	.
46745	5690	1	The	the	DT
46745	5690	2	chemical	chemical	NN
46745	5690	3	construction	construction	NN
46745	5690	4	of	of	IN
46745	5690	5	Opium	Opium	NNP
46745	5690	6	is	be	VBZ
46745	5690	7	a	a	DT
46745	5690	8	matter	matter	NN
46745	5690	9	of	of	IN
46745	5690	10	considerable	considerable	JJ
46745	5690	11	interest	interest	NN
46745	5690	12	.	.	.
46745	5691	1	Morphia	Morphia	NNP
46745	5691	2	,	,	,
46745	5691	3	the	the	DT
46745	5691	4	chief	chief	JJ
46745	5691	5	active	active	JJ
46745	5691	6	principle	principle	NN
46745	5691	7	,	,	,
46745	5691	8	is	be	VBZ
46745	5691	9	an	an	DT
46745	5691	10	alkaloid	alkaloid	NN
46745	5691	11	which	which	WDT
46745	5691	12	is	be	VBZ
46745	5691	13	almost	almost	RB
46745	5691	14	identical	identical	JJ
46745	5691	15	with	with	IN
46745	5691	16	Opium	Opium	NNP
46745	5691	17	in	in	IN
46745	5691	18	its	-PRON-	PRP$
46745	5691	19	narcotic	narcotic	JJ
46745	5691	20	actions	action	NNS
46745	5691	21	but	but	CC
46745	5691	22	slightly	slightly	RB
46745	5691	23	more	more	RBR
46745	5691	24	sedative	sedative	JJ
46745	5691	25	.	.	.
46745	5692	1	Unencumbered	unencumbered	JJ
46745	5692	2	by	by	IN
46745	5692	3	inert	inert	JJ
46745	5692	4	matters	matter	NNS
46745	5692	5	,	,	,
46745	5692	6	it	-PRON-	PRP
46745	5692	7	presents	present	VBZ
46745	5692	8	us	-PRON-	PRP
46745	5692	9	with	with	IN
46745	5692	10	an	an	DT
46745	5692	11	anodyne	anodyne	NN
46745	5692	12	in	in	IN
46745	5692	13	a	a	DT
46745	5692	14	more	more	RBR
46745	5692	15	concentrated	concentrated	JJ
46745	5692	16	form	form	NN
46745	5692	17	.	.	.
46745	5693	1	But	but	CC
46745	5693	2	the	the	DT
46745	5693	3	combination	combination	NN
46745	5693	4	of	of	IN
46745	5693	5	the	the	DT
46745	5693	6	Morphia	Morphia	NNP
46745	5693	7	with	with	IN
46745	5693	8	other	other	JJ
46745	5693	9	principles	principle	NNS
46745	5693	10	in	in	IN
46745	5693	11	the	the	DT
46745	5693	12	crude	crude	JJ
46745	5693	13	Opium	Opium	NNP
46745	5693	14	is	be	VBZ
46745	5693	15	worthy	worthy	JJ
46745	5693	16	of	of	IN
46745	5693	17	remark	remark	NN
46745	5693	18	.	.	.
46745	5694	1	Both	both	DT
46745	5694	2	Morphia	Morphia	NNP
46745	5694	3	and	and	CC
46745	5694	4	Opium	Opium	NNP
46745	5694	5	are	be	VBP
46745	5694	6	liable	liable	JJ
46745	5694	7	occasionally	occasionally	RB
46745	5694	8	to	to	TO
46745	5694	9	produce	produce	VB
46745	5694	10	nausea	nausea	NN
46745	5694	11	,	,	,
46745	5694	12	headache	headache	NNP
46745	5694	13	,	,	,
46745	5694	14	loss	loss	NN
46745	5694	15	of	of	IN
46745	5694	16	appetite	appetite	NN
46745	5694	17	,	,	,
46745	5694	18	and	and	CC
46745	5694	19	depression	depression	NN
46745	5694	20	of	of	IN
46745	5694	21	the	the	DT
46745	5694	22	spirits	spirit	NNS
46745	5694	23	.	.	.
46745	5695	1	There	there	EX
46745	5695	2	are	be	VBP
46745	5695	3	various	various	JJ
46745	5695	4	ways	way	NNS
46745	5695	5	in	in	IN
46745	5695	6	which	which	WDT
46745	5695	7	we	-PRON-	PRP
46745	5695	8	may	may	MD
46745	5695	9	try	try	VB
46745	5695	10	to	to	TO
46745	5695	11	obviate	obviate	VB
46745	5695	12	these	these	DT
46745	5695	13	unpleasant	unpleasant	JJ
46745	5695	14	symptoms	symptom	NNS
46745	5695	15	.	.	.
46745	5696	1	To	to	TO
46745	5696	2	prevent	prevent	VB
46745	5696	3	nausea	nausea	NN
46745	5696	4	,	,	,
46745	5696	5	we	-PRON-	PRP
46745	5696	6	may	may	MD
46745	5696	7	combine	combine	VB
46745	5696	8	the	the	DT
46745	5696	9	dose	dose	NN
46745	5696	10	with	with	IN
46745	5696	11	an	an	DT
46745	5696	12	aromatic	aromatic	NN
46745	5696	13	.	.	.
46745	5697	1	Dr.	Dr.	NNP
46745	5697	2	Copland	Copland	NNP
46745	5697	3	has	have	VBZ
46745	5697	4	successfully	successfully	RB
46745	5697	5	combined	combine	VBN
46745	5697	6	Morphia	Morphia	NNP
46745	5697	7	with	with	IN
46745	5697	8	an	an	DT
46745	5697	9	aromatic	aromatic	JJ
46745	5697	10	spirit	spirit	NN
46745	5697	11	,	,	,
46745	5697	12	in	in	IN
46745	5697	13	cases	case	NNS
46745	5697	14	where	where	WRB
46745	5697	15	alone	alone	JJ
46745	5697	16	it	-PRON-	PRP
46745	5697	17	was	be	VBD
46745	5697	18	apt	apt	JJ
46745	5697	19	to	to	TO
46745	5697	20	bring	bring	VB
46745	5697	21	on	on	RP
46745	5697	22	hypochondriasis	hypochondriasis	NN
46745	5697	23	.	.	.
46745	5698	1	And	and	CC
46745	5698	2	to	to	TO
46745	5698	3	prevent	prevent	VB
46745	5698	4	the	the	DT
46745	5698	5	loss	loss	NN
46745	5698	6	of	of	IN
46745	5698	7	appetite	appetite	NN
46745	5698	8	in	in	IN
46745	5698	9	Delirium	Delirium	NNP
46745	5698	10	tremens	tremen	NNS
46745	5698	11	,	,	,
46745	5698	12	Dr.	Dr.	NNP
46745	5698	13	Todd	Todd	NNP
46745	5698	14	recommends	recommend	VBZ
46745	5698	15	to	to	TO
46745	5698	16	combine	combine	VB
46745	5698	17	Morphia	Morphia	NNP
46745	5698	18	or	or	CC
46745	5698	19	Opium	Opium	NNP
46745	5698	20	with	with	IN
46745	5698	21	Quinine	Quinine	NNP
46745	5698	22	or	or	CC
46745	5698	23	some	some	DT
46745	5698	24	other	other	JJ
46745	5698	25	Tonic	Tonic	NNP
46745	5698	26	.	.	.
46745	5699	1	But	but	CC
46745	5699	2	it	-PRON-	PRP
46745	5699	3	is	be	VBZ
46745	5699	4	very	very	RB
46745	5699	5	curious	curious	JJ
46745	5699	6	that	that	IN
46745	5699	7	in	in	IN
46745	5699	8	the	the	DT
46745	5699	9	construction	construction	NN
46745	5699	10	of	of	IN
46745	5699	11	Opium	Opium	NNP
46745	5699	12	an	an	DT
46745	5699	13	attempt	attempt	NN
46745	5699	14	is	be	VBZ
46745	5699	15	made	make	VBN
46745	5699	16	by	by	IN
46745	5699	17	nature	nature	NN
46745	5699	18	at	at	IN
46745	5699	19	the	the	DT
46745	5699	20	very	very	JJ
46745	5699	21	things	thing	NNS
46745	5699	22	that	that	WDT
46745	5699	23	we	-PRON-	PRP
46745	5699	24	so	so	RB
46745	5699	25	much	much	JJ
46745	5699	26	desire	desire	NN
46745	5699	27	in	in	IN
46745	5699	28	practice	practice	NN
46745	5699	29	.	.	.
46745	5700	1	For	for	IN
46745	5700	2	the	the	DT
46745	5700	3	drug	drug	NN
46745	5700	4	contains	contain	VBZ
46745	5700	5	,	,	,
46745	5700	6	in	in	IN
46745	5700	7	addition	addition	NN
46745	5700	8	to	to	IN
46745	5700	9	Morphia	Morphia	NNP
46745	5700	10	,	,	,
46745	5700	11	an	an	DT
46745	5700	12	aromatic	aromatic	JJ
46745	5700	13	volatile	volatile	JJ
46745	5700	14	oil	oil	NN
46745	5700	15	,	,	,
46745	5700	16	and	and	CC
46745	5700	17	a	a	DT
46745	5700	18	neutral	neutral	JJ
46745	5700	19	principle	principle	NN
46745	5700	20	,	,	,
46745	5700	21	wrongly	wrongly	RB
46745	5700	22	called	call	VBN
46745	5700	23	Narcotine	Narcotine	NNP
46745	5700	24	,	,	,
46745	5700	25	which	which	WDT
46745	5700	26	has	have	VBZ
46745	5700	27	been	be	VBN
46745	5700	28	proved	prove	VBN
46745	5700	29	by	by	IN
46745	5700	30	some	some	DT
46745	5700	31	experiments	experiment	NNS
46745	5700	32	made	make	VBN
46745	5700	33	in	in	IN
46745	5700	34	India	India	NNP
46745	5700	35	to	to	TO
46745	5700	36	be	be	VB
46745	5700	37	a	a	DT
46745	5700	38	simple	simple	JJ
46745	5700	39	Tonic	Tonic	NNP
46745	5700	40	,	,	,
46745	5700	41	like	like	IN
46745	5700	42	Quinine	Quinine	NNP
46745	5700	43	.	.	.
46745	5701	1	So	so	RB
46745	5701	2	that	that	IN
46745	5701	3	if	if	IN
46745	5701	4	we	-PRON-	PRP
46745	5701	5	could	could	MD
46745	5701	6	only	only	RB
46745	5701	7	separate	separate	VB
46745	5701	8	from	from	IN
46745	5701	9	the	the	DT
46745	5701	10	other	other	JJ
46745	5701	11	parts	part	NNS
46745	5701	12	of	of	IN
46745	5701	13	the	the	DT
46745	5701	14	drug	drug	NN
46745	5701	15	the	the	DT
46745	5701	16	Morphia	Morphia	NNP
46745	5701	17	,	,	,
46745	5701	18	volatile	volatile	JJ
46745	5701	19	oil	oil	NN
46745	5701	20	,	,	,
46745	5701	21	and	and	CC
46745	5701	22	Tonic	Tonic	NNP
46745	5701	23	principle	principle	NN
46745	5701	24	,	,	,
46745	5701	25	we	-PRON-	PRP
46745	5701	26	should	should	MD
46745	5701	27	obtain	obtain	VB
46745	5701	28	an	an	DT
46745	5701	29	admirable	admirable	JJ
46745	5701	30	combination	combination	NN
46745	5701	31	made	make	VBD
46745	5701	32	ready	ready	JJ
46745	5701	33	to	to	IN
46745	5701	34	our	-PRON-	PRP$
46745	5701	35	hand	hand	NN
46745	5701	36	.	.	.
46745	5702	1	But	but	CC
46745	5702	2	Opium	Opium	NNP
46745	5702	3	contains	contain	VBZ
46745	5702	4	also	also	RB
46745	5702	5	other	other	JJ
46745	5702	6	matters	matter	NNS
46745	5702	7	which	which	WDT
46745	5702	8	are	be	VBP
46745	5702	9	mere	mere	JJ
46745	5702	10	incumbrances	incumbrance	NNS
46745	5702	11	,	,	,
46745	5702	12	but	but	CC
46745	5702	13	which	which	WDT
46745	5702	14	are	be	VBP
46745	5702	15	more	more	RBR
46745	5702	16	or	or	CC
46745	5702	17	less	less	RBR
46745	5702	18	taken	take	VBN
46745	5702	19	up	up	RP
46745	5702	20	by	by	IN
46745	5702	21	the	the	DT
46745	5702	22	various	various	JJ
46745	5702	23	liquid	liquid	NN
46745	5702	24	menstrua	menstrua	NN
46745	5702	25	that	that	WDT
46745	5702	26	we	-PRON-	PRP
46745	5702	27	employ	employ	VBP
46745	5702	28	;	;	:
46745	5702	29	as	as	IN
46745	5702	30	,	,	,
46745	5702	31	an	an	DT
46745	5702	32	irritant	irritant	JJ
46745	5702	33	resin	resin	NN
46745	5702	34	;	;	:
46745	5702	35	other	other	JJ
46745	5702	36	neutral	neutral	JJ
46745	5702	37	principles	principle	NNS
46745	5702	38	,	,	,
46745	5702	39	as	as	IN
46745	5702	40	narceine	narceine	NN
46745	5702	41	,	,	,
46745	5702	42	Meconine	Meconine	NNP
46745	5702	43	,	,	,
46745	5702	44	and	and	CC
46745	5702	45	Papaverine,--and	Papaverine,--and	NNP
46745	5702	46	Meconic	Meconic	NNP
46745	5702	47	acid,--all	acid,--all	NNP
46745	5702	48	of	of	IN
46745	5702	49	which	which	WDT
46745	5702	50	are	be	VBP
46745	5702	51	probably	probably	RB
46745	5702	52	inert	inert	JJ
46745	5702	53	;	;	:
46745	5702	54	and	and	CC
46745	5702	55	,	,	,
46745	5702	56	what	what	WP
46745	5702	57	is	be	VBZ
46745	5702	58	worst	bad	JJS
46745	5702	59	of	of	IN
46745	5702	60	all	all	DT
46745	5702	61	,	,	,
46745	5702	62	a	a	DT
46745	5702	63	small	small	JJ
46745	5702	64	quantity	quantity	NN
46745	5702	65	of	of	IN
46745	5702	66	an	an	DT
46745	5702	67	alkaloid	alkaloid	NN
46745	5702	68	called	call	VBN
46745	5702	69	Thebaia	Thebaia	NNP
46745	5702	70	,	,	,
46745	5702	71	said	say	VBD
46745	5702	72	by	by	IN
46745	5702	73	Magendie	Magendie	NNP
46745	5702	74	to	to	TO
46745	5702	75	have	have	VB
46745	5702	76	an	an	DT
46745	5702	77	action	action	NN
46745	5702	78	identical	identical	JJ
46745	5702	79	with	with	IN
46745	5702	80	that	that	DT
46745	5702	81	of	of	IN
46745	5702	82	Strychnia	Strychnia	NNP
46745	5702	83	.	.	.
46745	5703	1	Though	Though	NNP
46745	5703	2	Morphia	Morphia	NNP
46745	5703	3	constitutes	constitute	VBZ
46745	5703	4	only	only	RB
46745	5703	5	about	about	RB
46745	5703	6	twelve	twelve	CD
46745	5703	7	per	per	IN
46745	5703	8	cent	cent	NN
46745	5703	9	.	.	.
46745	5704	1	of	of	IN
46745	5704	2	the	the	DT
46745	5704	3	best	good	JJS
46745	5704	4	Opium	Opium	NNP
46745	5704	5	,	,	,
46745	5704	6	the	the	DT
46745	5704	7	dose	dose	NN
46745	5704	8	of	of	IN
46745	5704	9	it	-PRON-	PRP
46745	5704	10	required	require	VBN
46745	5704	11	is	be	VBZ
46745	5704	12	at	at	RB
46745	5704	13	least	least	RBS
46745	5704	14	one	one	CD
46745	5704	15	fourth	fourth	NN
46745	5704	16	of	of	IN
46745	5704	17	that	that	DT
46745	5704	18	of	of	IN
46745	5704	19	the	the	DT
46745	5704	20	latter	latter	JJ
46745	5704	21	.	.	.
46745	5705	1	It	-PRON-	PRP
46745	5705	2	seems	seem	VBZ
46745	5705	3	therefore	therefore	RB
46745	5705	4	that	that	IN
46745	5705	5	Opium	Opium	NNP
46745	5705	6	must	must	MD
46745	5705	7	contain	contain	VB
46745	5705	8	some	some	DT
46745	5705	9	other	other	JJ
46745	5705	10	narcotic	narcotic	JJ
46745	5705	11	principle	principle	NN
46745	5705	12	.	.	.
46745	5706	1	Codeia	codeia	NN
46745	5706	2	is	be	VBZ
46745	5706	3	a	a	DT
46745	5706	4	Narcotic	narcotic	JJ
46745	5706	5	,	,	,
46745	5706	6	of	of	IN
46745	5706	7	less	less	JJR
46745	5706	8	power	power	NN
46745	5706	9	than	than	IN
46745	5706	10	Morphia	Morphia	NNP
46745	5706	11	,	,	,
46745	5706	12	and	and	CC
46745	5706	13	though	though	IN
46745	5706	14	it	-PRON-	PRP
46745	5706	15	is	be	VBZ
46745	5706	16	contained	contain	VBN
46745	5706	17	in	in	IN
46745	5706	18	Opium	Opium	NNP
46745	5706	19	,	,	,
46745	5706	20	it	-PRON-	PRP
46745	5706	21	is	be	VBZ
46745	5706	22	scarcely	scarcely	RB
46745	5706	23	in	in	IN
46745	5706	24	sufficient	sufficient	JJ
46745	5706	25	quantity	quantity	NN
46745	5706	26	to	to	TO
46745	5706	27	explain	explain	VB
46745	5706	28	the	the	DT
46745	5706	29	strength	strength	NN
46745	5706	30	of	of	IN
46745	5706	31	the	the	DT
46745	5706	32	drug	drug	NN
46745	5706	33	.	.	.
46745	5707	1	It	-PRON-	PRP
46745	5707	2	is	be	VBZ
46745	5707	3	likely	likely	JJ
46745	5707	4	that	that	IN
46745	5707	5	Opium	Opium	NNP
46745	5707	6	contains	contain	VBZ
46745	5707	7	more	more	JJR
46745	5707	8	than	than	IN
46745	5707	9	one	one	CD
46745	5707	10	volatile	volatile	JJ
46745	5707	11	oil	oil	NN
46745	5707	12	,	,	,
46745	5707	13	and	and	CC
46745	5707	14	that	that	IN
46745	5707	15	the	the	DT
46745	5707	16	odorous	odorous	JJ
46745	5707	17	principle	principle	NN
46745	5707	18	to	to	TO
46745	5707	19	which	which	WDT
46745	5707	20	its	-PRON-	PRP$
46745	5707	21	peculiar	peculiar	JJ
46745	5707	22	smell	smell	NN
46745	5707	23	is	be	VBZ
46745	5707	24	owing	owing	JJ
46745	5707	25	is	be	VBZ
46745	5707	26	itself	-PRON-	PRP
46745	5707	27	narcotic	narcotic	JJ
46745	5707	28	in	in	IN
46745	5707	29	its	-PRON-	PRP$
46745	5707	30	action	action	NN
46745	5707	31	.	.	.
46745	5708	1	A	a	DT
46745	5708	2	parallel	parallel	JJ
46745	5708	3	case	case	NN
46745	5708	4	to	to	IN
46745	5708	5	this	this	DT
46745	5708	6	is	be	VBZ
46745	5708	7	verified	verify	VBN
46745	5708	8	in	in	IN
46745	5708	9	the	the	DT
46745	5708	10	instance	instance	NN
46745	5708	11	of	of	IN
46745	5708	12	bitter	bitter	JJ
46745	5708	13	almonds	almond	NNS
46745	5708	14	,	,	,
46745	5708	15	which	which	WDT
46745	5708	16	not	not	RB
46745	5708	17	only	only	RB
46745	5708	18	yield	yield	VBP
46745	5708	19	Hydrocyanic	hydrocyanic	JJ
46745	5708	20	acid	acid	NN
46745	5708	21	,	,	,
46745	5708	22	the	the	DT
46745	5708	23	most	most	RBS
46745	5708	24	powerful	powerful	JJ
46745	5708	25	Sedative	Sedative	NNP
46745	5708	26	known	know	VBN
46745	5708	27	,	,	,
46745	5708	28	but	but	CC
46745	5708	29	contain	contain	VB
46745	5708	30	a	a	DT
46745	5708	31	large	large	JJ
46745	5708	32	quantity	quantity	NN
46745	5708	33	of	of	IN
46745	5708	34	a	a	DT
46745	5708	35	volatile	volatile	JJ
46745	5708	36	oil	oil	NN
46745	5708	37	,	,	,
46745	5708	38	which	which	WDT
46745	5708	39	remarkably	remarkably	RB
46745	5708	40	resembles	resemble	VBZ
46745	5708	41	the	the	DT
46745	5708	42	acid	acid	NN
46745	5708	43	in	in	IN
46745	5708	44	its	-PRON-	PRP$
46745	5708	45	poisonous	poisonous	JJ
46745	5708	46	action	action	NN
46745	5708	47	.	.	.
46745	5709	1	(	(	-LRB-
46745	5709	2	_	_	NNP
46745	5709	3	Vide	Vide	NNP
46745	5709	4	_	_	NNP
46745	5709	5	pp	pp	NNP
46745	5709	6	.	.	.
46745	5710	1	238	238	CD
46745	5710	2	,	,	,
46745	5710	3	268	268	CD
46745	5710	4	.	.	.
46745	5710	5	)	)	-RRB-
46745	5711	1	HYDROCYANIC	HYDROCYANIC	NNP
46745	5711	2	ACID	ACID	NNP
46745	5711	3	.	.	.
46745	5712	1	Class	class	NN
46745	5712	2	II	II	NNP
46745	5712	3	.	.	.
46745	5713	1	Div	Div	NNP
46745	5713	2	.	.	.
46745	5714	1	III	iii	CD
46745	5714	2	.	.	.
46745	5715	1	ORD	ORD	NNP
46745	5715	2	.	.	.
46745	5716	1	I.	I.	NNP
46745	5716	2	SEDANTIA	SEDANTIA	NNP
46745	5716	3	GENERALIA	GENERALIA	NNP
46745	5716	4	.	.	.
46745	5717	1	Hydrocyanic	hydrocyanic	JJ
46745	5717	2	or	or	CC
46745	5717	3	prussic	prussic	JJ
46745	5717	4	acid	acid	NN
46745	5717	5	(	(	-LRB-
46745	5717	6	C_{2	C_{2	NNP
46745	5717	7	}	}	-RRB-
46745	5717	8	N	N	NNP
46745	5717	9	,	,	,
46745	5717	10	H	h	NN
46745	5717	11	,	,	,
46745	5717	12	)	)	-RRB-
46745	5717	13	a	a	DT
46745	5717	14	very	very	RB
46745	5717	15	volatile	volatile	JJ
46745	5717	16	liquid	liquid	NN
46745	5717	17	,	,	,
46745	5717	18	soluble	soluble	JJ
46745	5717	19	in	in	IN
46745	5717	20	water	water	NN
46745	5717	21	,	,	,
46745	5717	22	is	be	VBZ
46745	5717	23	one	one	CD
46745	5717	24	of	of	IN
46745	5717	25	those	those	DT
46745	5717	26	mysterious	mysterious	JJ
46745	5717	27	vegetable	vegetable	NN
46745	5717	28	compounds	compound	NNS
46745	5717	29	which	which	WDT
46745	5717	30	,	,	,
46745	5717	31	containing	contain	VBG
46745	5717	32	no	no	DT
46745	5717	33	chemical	chemical	NN
46745	5717	34	element	element	NN
46745	5717	35	that	that	WDT
46745	5717	36	is	be	VBZ
46745	5717	37	not	not	RB
46745	5717	38	also	also	RB
46745	5717	39	contained	contain	VBN
46745	5717	40	in	in	IN
46745	5717	41	animal	animal	NN
46745	5717	42	structure	structure	NN
46745	5717	43	,	,	,
46745	5717	44	are	be	VBP
46745	5717	45	yet	yet	RB
46745	5717	46	gifted	gift	VBN
46745	5717	47	with	with	IN
46745	5717	48	a	a	DT
46745	5717	49	wonderful	wonderful	JJ
46745	5717	50	power	power	NN
46745	5717	51	over	over	IN
46745	5717	52	the	the	DT
46745	5717	53	vital	vital	JJ
46745	5717	54	forces	force	NNS
46745	5717	55	.	.	.
46745	5718	1	One	one	CD
46745	5718	2	drop	drop	NN
46745	5718	3	of	of	IN
46745	5718	4	the	the	DT
46745	5718	5	pure	pure	JJ
46745	5718	6	acid	acid	NN
46745	5718	7	is	be	VBZ
46745	5718	8	sufficient	sufficient	JJ
46745	5718	9	to	to	TO
46745	5718	10	cause	cause	VB
46745	5718	11	death	death	NN
46745	5718	12	.	.	.
46745	5719	1	But	but	CC
46745	5719	2	the	the	DT
46745	5719	3	officinal	officinal	JJ
46745	5719	4	acid	acid	NN
46745	5719	5	is	be	VBZ
46745	5719	6	an	an	DT
46745	5719	7	aqueous	aqueous	JJ
46745	5719	8	solution	solution	NN
46745	5719	9	,	,	,
46745	5719	10	containing	contain	VBG
46745	5719	11	only	only	RB
46745	5719	12	2	2	CD
46745	5719	13	per	per	NN
46745	5719	14	cent	cent	NN
46745	5719	15	.	.	.
46745	5720	1	of	of	IN
46745	5720	2	the	the	DT
46745	5720	3	other	other	JJ
46745	5720	4	.	.	.
46745	5721	1	It	-PRON-	PRP
46745	5721	2	is	be	VBZ
46745	5721	3	a	a	DT
46745	5721	4	powerful	powerful	JJ
46745	5721	5	Sedative	sedative	NN
46745	5721	6	to	to	IN
46745	5721	7	the	the	DT
46745	5721	8	nerves	nerve	NNS
46745	5721	9	generally	generally	RB
46745	5721	10	.	.	.
46745	5722	1	Its	-PRON-	PRP$
46745	5722	2	action	action	NN
46745	5722	3	is	be	VBZ
46745	5722	4	direct	direct	JJ
46745	5722	5	,	,	,
46745	5722	6	and	and	CC
46745	5722	7	is	be	VBZ
46745	5722	8	not	not	RB
46745	5722	9	preceded	precede	VBN
46745	5722	10	by	by	IN
46745	5722	11	any	any	DT
46745	5722	12	primary	primary	JJ
46745	5722	13	stimulation	stimulation	NN
46745	5722	14	.	.	.
46745	5723	1	Diminishing	diminish	VBG
46745	5723	2	sensibility	sensibility	NN
46745	5723	3	,	,	,
46745	5723	4	it	-PRON-	PRP
46745	5723	5	is	be	VBZ
46745	5723	6	therefore	therefore	RB
46745	5723	7	used	use	VBN
46745	5723	8	as	as	IN
46745	5723	9	an	an	DT
46745	5723	10	anodyne	anodyne	NN
46745	5723	11	.	.	.
46745	5724	1	Controlling	control	VBG
46745	5724	2	muscular	muscular	JJ
46745	5724	3	action	action	NN
46745	5724	4	,	,	,
46745	5724	5	it	-PRON-	PRP
46745	5724	6	is	be	VBZ
46745	5724	7	employed	employ	VBN
46745	5724	8	as	as	IN
46745	5724	9	an	an	DT
46745	5724	10	anti	anti	JJ
46745	5724	11	-	-	JJ
46745	5724	12	spasmodic	spasmodic	JJ
46745	5724	13	.	.	.
46745	5725	1	But	but	CC
46745	5725	2	it	-PRON-	PRP
46745	5725	3	appears	appear	VBZ
46745	5725	4	especially	especially	RB
46745	5725	5	to	to	TO
46745	5725	6	influence	influence	VB
46745	5725	7	the	the	DT
46745	5725	8	reflex	reflex	JJ
46745	5725	9	nervous	nervous	JJ
46745	5725	10	actions	action	NNS
46745	5725	11	.	.	.
46745	5726	1	It	-PRON-	PRP
46745	5726	2	is	be	VBZ
46745	5726	3	therefore	therefore	RB
46745	5726	4	of	of	IN
46745	5726	5	especial	especial	JJ
46745	5726	6	use	use	NN
46745	5726	7	in	in	IN
46745	5726	8	the	the	DT
46745	5726	9	paroxysmal	paroxysmal	JJ
46745	5726	10	coughs	cough	NNS
46745	5726	11	of	of	IN
46745	5726	12	Hooping	hooping	NN
46745	5726	13	-	-	HYPH
46745	5726	14	cough	cough	NNP
46745	5726	15	and	and	CC
46745	5726	16	of	of	IN
46745	5726	17	Phthisis	Phthisis	NNP
46745	5726	18	,	,	,
46745	5726	19	which	which	WDT
46745	5726	20	have	have	VBP
46745	5726	21	a	a	DT
46745	5726	22	reflex	reflex	JJ
46745	5726	23	origin	origin	NN
46745	5726	24	in	in	IN
46745	5726	25	the	the	DT
46745	5726	26	irritation	irritation	NN
46745	5726	27	of	of	IN
46745	5726	28	the	the	DT
46745	5726	29	mucous	mucous	JJ
46745	5726	30	membrane	membrane	NN
46745	5726	31	.	.	.
46745	5727	1	It	-PRON-	PRP
46745	5727	2	acts	act	VBZ
46745	5727	3	on	on	IN
46745	5727	4	nerves	nerve	NNS
46745	5727	5	as	as	RB
46745	5727	6	well	well	RB
46745	5727	7	as	as	IN
46745	5727	8	on	on	IN
46745	5727	9	nerve	nerve	NN
46745	5727	10	-	-	HYPH
46745	5727	11	centres	centre	NNS
46745	5727	12	.	.	.
46745	5728	1	Thus	thus	RB
46745	5728	2	it	-PRON-	PRP
46745	5728	3	is	be	VBZ
46745	5728	4	particularly	particularly	RB
46745	5728	5	useful	useful	JJ
46745	5728	6	in	in	IN
46745	5728	7	neuralgic	neuralgic	JJ
46745	5728	8	forms	form	NNS
46745	5728	9	of	of	IN
46745	5728	10	Gastrodynia	Gastrodynia	NNP
46745	5728	11	;	;	:
46745	5728	12	and	and	CC
46745	5728	13	it	-PRON-	PRP
46745	5728	14	seems	seem	VBZ
46745	5728	15	to	to	TO
46745	5728	16	allay	allay	VB
46745	5728	17	the	the	DT
46745	5728	18	pain	pain	NN
46745	5728	19	in	in	IN
46745	5728	20	the	the	DT
46745	5728	21	stomach	stomach	NN
46745	5728	22	by	by	IN
46745	5728	23	diffusing	diffuse	VBG
46745	5728	24	itself	-PRON-	PRP
46745	5728	25	directly	directly	RB
46745	5728	26	it	-PRON-	PRP
46745	5728	27	reaches	reach	VBZ
46745	5728	28	it	-PRON-	PRP
46745	5728	29	,	,	,
46745	5728	30	so	so	RB
46745	5728	31	passing	pass	VBG
46745	5728	32	through	through	IN
46745	5728	33	the	the	DT
46745	5728	34	mucous	mucous	JJ
46745	5728	35	membrane	membrane	NN
46745	5728	36	at	at	IN
46745	5728	37	all	all	DT
46745	5728	38	points	point	NNS
46745	5728	39	,	,	,
46745	5728	40	and	and	CC
46745	5728	41	coming	come	VBG
46745	5728	42	in	in	IN
46745	5728	43	contact	contact	NN
46745	5728	44	every	every	DT
46745	5728	45	where	where	WRB
46745	5728	46	with	with	IN
46745	5728	47	the	the	DT
46745	5728	48	irritated	irritated	JJ
46745	5728	49	sensory	sensory	JJ
46745	5728	50	nerves	nerve	NNS
46745	5728	51	.	.	.
46745	5729	1	It	-PRON-	PRP
46745	5729	2	is	be	VBZ
46745	5729	3	sometimes	sometimes	RB
46745	5729	4	useful	useful	JJ
46745	5729	5	in	in	IN
46745	5729	6	cases	case	NNS
46745	5729	7	of	of	IN
46745	5729	8	vomiting	vomiting	NN
46745	5729	9	,	,	,
46745	5729	10	or	or	CC
46745	5729	11	pyrosis	pyrosis	NN
46745	5729	12	.	.	.
46745	5730	1	If	if	IN
46745	5730	2	applied	apply	VBN
46745	5730	3	to	to	IN
46745	5730	4	the	the	DT
46745	5730	5	surface	surface	NN
46745	5730	6	of	of	IN
46745	5730	7	the	the	DT
46745	5730	8	skin	skin	NN
46745	5730	9	,	,	,
46745	5730	10	it	-PRON-	PRP
46745	5730	11	numbs	numb	VBZ
46745	5730	12	the	the	DT
46745	5730	13	superficial	superficial	JJ
46745	5730	14	nerves	nerve	NNS
46745	5730	15	;	;	:
46745	5730	16	but	but	CC
46745	5730	17	on	on	IN
46745	5730	18	account	account	NN
46745	5730	19	of	of	IN
46745	5730	20	its	-PRON-	PRP$
46745	5730	21	rapid	rapid	JJ
46745	5730	22	volatility	volatility	NN
46745	5730	23	,	,	,
46745	5730	24	and	and	CC
46745	5730	25	the	the	DT
46745	5730	26	dangerous	dangerous	JJ
46745	5730	27	results	result	NNS
46745	5730	28	that	that	WDT
46745	5730	29	would	would	MD
46745	5730	30	follow	follow	VB
46745	5730	31	the	the	DT
46745	5730	32	inhalation	inhalation	NN
46745	5730	33	of	of	IN
46745	5730	34	its	-PRON-	PRP$
46745	5730	35	vapour	vapour	NN
46745	5730	36	,	,	,
46745	5730	37	it	-PRON-	PRP
46745	5730	38	is	be	VBZ
46745	5730	39	not	not	RB
46745	5730	40	appropriate	appropriate	JJ
46745	5730	41	as	as	IN
46745	5730	42	an	an	DT
46745	5730	43	external	external	JJ
46745	5730	44	anaesthetic	anaesthetic	NN
46745	5730	45	.	.	.
46745	5731	1	A	a	DT
46745	5731	2	poisonous	poisonous	JJ
46745	5731	3	dose	dose	NN
46745	5731	4	produces	produce	VBZ
46745	5731	5	first	first	JJ
46745	5731	6	convulsions	convulsion	NNS
46745	5731	7	of	of	IN
46745	5731	8	the	the	DT
46745	5731	9	whole	whole	JJ
46745	5731	10	frame	frame	NN
46745	5731	11	,	,	,
46745	5731	12	then	then	RB
46745	5731	13	syncope	syncope	VB
46745	5731	14	,	,	,
46745	5731	15	and	and	CC
46745	5731	16	death	death	NN
46745	5731	17	.	.	.
46745	5732	1	Strychnia	Strychnia	NNP
46745	5732	2	produces	produce	VBZ
46745	5732	3	convulsions	convulsion	NNS
46745	5732	4	,	,	,
46745	5732	5	but	but	CC
46745	5732	6	they	-PRON-	PRP
46745	5732	7	are	be	VBP
46745	5732	8	not	not	RB
46745	5732	9	caused	cause	VBN
46745	5732	10	in	in	IN
46745	5732	11	the	the	DT
46745	5732	12	same	same	JJ
46745	5732	13	way	way	NN
46745	5732	14	as	as	IN
46745	5732	15	those	those	DT
46745	5732	16	of	of	IN
46745	5732	17	Hydrocyanic	hydrocyanic	JJ
46745	5732	18	acid	acid	NN
46745	5732	19	.	.	.
46745	5733	1	For	for	IN
46745	5733	2	the	the	DT
46745	5733	3	two	two	CD
46745	5733	4	medicines	medicine	NNS
46745	5733	5	are	be	VBP
46745	5733	6	obviously	obviously	RB
46745	5733	7	opposed	opposed	JJ
46745	5733	8	in	in	IN
46745	5733	9	their	-PRON-	PRP$
46745	5733	10	action	action	NN
46745	5733	11	,	,	,
46745	5733	12	Strychnia	Strychnia	NNP
46745	5733	13	being	be	VBG
46745	5733	14	an	an	DT
46745	5733	15	exalter	exalter	NN
46745	5733	16	of	of	IN
46745	5733	17	sensation	sensation	NN
46745	5733	18	and	and	CC
46745	5733	19	of	of	IN
46745	5733	20	reflex	reflex	JJ
46745	5733	21	action	action	NN
46745	5733	22	,	,	,
46745	5733	23	and	and	CC
46745	5733	24	Hydrocyanic	hydrocyanic	JJ
46745	5733	25	acid	acid	VBP
46745	5733	26	a	a	DT
46745	5733	27	depresser	depresser	NN
46745	5733	28	of	of	IN
46745	5733	29	the	the	DT
46745	5733	30	same	same	JJ
46745	5733	31	.	.	.
46745	5734	1	The	the	DT
46745	5734	2	convulsion	convulsion	NN
46745	5734	3	caused	cause	VBN
46745	5734	4	by	by	IN
46745	5734	5	Strychnia	Strychnia	NNP
46745	5734	6	is	be	VBZ
46745	5734	7	tonic	tonic	NN
46745	5734	8	;	;	:
46745	5734	9	that	that	IN
46745	5734	10	by	by	IN
46745	5734	11	Hydrocyanic	hydrocyanic	JJ
46745	5734	12	acid	acid	NN
46745	5734	13	,	,	,
46745	5734	14	asthenic	asthenic	NNP
46745	5734	15	.	.	.
46745	5735	1	The	the	DT
46745	5735	2	one	one	CD
46745	5735	3	,	,	,
46745	5735	4	being	be	VBG
46745	5735	5	a	a	DT
46745	5735	6	special	special	JJ
46745	5735	7	Stimulant	Stimulant	NNP
46745	5735	8	,	,	,
46745	5735	9	causes	cause	VBZ
46745	5735	10	convulsions	convulsion	NNS
46745	5735	11	by	by	IN
46745	5735	12	an	an	DT
46745	5735	13	excitement	excitement	NN
46745	5735	14	of	of	IN
46745	5735	15	the	the	DT
46745	5735	16	spinal	spinal	JJ
46745	5735	17	cord	cord	NN
46745	5735	18	;	;	:
46745	5735	19	the	the	DT
46745	5735	20	other	other	JJ
46745	5735	21	,	,	,
46745	5735	22	being	be	VBG
46745	5735	23	a	a	DT
46745	5735	24	Sedative	Sedative	NNP
46745	5735	25	,	,	,
46745	5735	26	does	do	VBZ
46745	5735	27	it	-PRON-	PRP
46745	5735	28	by	by	IN
46745	5735	29	deranging	derange	VBG
46745	5735	30	the	the	DT
46745	5735	31	function	function	NN
46745	5735	32	of	of	IN
46745	5735	33	that	that	DT
46745	5735	34	centre	centre	NN
46745	5735	35	.	.	.
46745	5736	1	(	(	-LRB-
46745	5736	2	_	_	NNP
46745	5736	3	Vide	Vide	NNP
46745	5736	4	_	_	NNP
46745	5736	5	pp	pp	NNP
46745	5736	6	.	.	.
46745	5737	1	245	245	CD
46745	5737	2	,	,	,
46745	5737	3	243	243	CD
46745	5737	4	.	.	.
46745	5737	5	)	)	-RRB-
46745	5738	1	ACONITE	ACONITE	NNP
46745	5738	2	.	.	.
46745	5739	1	Class	class	NN
46745	5739	2	II	II	NNP
46745	5739	3	.	.	.
46745	5740	1	Div	Div	NNP
46745	5740	2	.	.	.
46745	5741	1	III	iii	CD
46745	5741	2	.	.	.
46745	5742	1	Ord	Ord	NNP
46745	5742	2	.	.	.
46745	5743	1	I.	I.	NNP
46745	5743	2	SEDANTIA	SEDANTIA	NNP
46745	5743	3	GENERALIA	GENERALIA	NNP
46745	5743	4	.	.	.
46745	5744	1	This	this	DT
46745	5744	2	medicine	medicine	NN
46745	5744	3	,	,	,
46745	5744	4	like	like	IN
46745	5744	5	the	the	DT
46745	5744	6	last	last	JJ
46745	5744	7	,	,	,
46745	5744	8	is	be	VBZ
46745	5744	9	a	a	DT
46745	5744	10	powerful	powerful	JJ
46745	5744	11	General	General	NNP
46745	5744	12	Sedative	Sedative	NNP
46745	5744	13	,	,	,
46745	5744	14	and	and	CC
46745	5744	15	a	a	DT
46745	5744	16	dangerous	dangerous	JJ
46745	5744	17	poison	poison	NN
46745	5744	18	.	.	.
46745	5745	1	It	-PRON-	PRP
46745	5745	2	depresses	depress	VBZ
46745	5745	3	the	the	DT
46745	5745	4	influence	influence	NN
46745	5745	5	of	of	IN
46745	5745	6	the	the	DT
46745	5745	7	brain	brain	NN
46745	5745	8	,	,	,
46745	5745	9	and	and	CC
46745	5745	10	paralyzes	paralyze	VBZ
46745	5745	11	all	all	PDT
46745	5745	12	the	the	DT
46745	5745	13	nervous	nervous	JJ
46745	5745	14	functions	function	NNS
46745	5745	15	.	.	.
46745	5746	1	It	-PRON-	PRP
46745	5746	2	tends	tend	VBZ
46745	5746	3	at	at	IN
46745	5746	4	length	length	NN
46745	5746	5	to	to	TO
46745	5746	6	kill	kill	VB
46745	5746	7	by	by	IN
46745	5746	8	producing	produce	VBG
46745	5746	9	syncope	syncope	NN
46745	5746	10	.	.	.
46745	5747	1	It	-PRON-	PRP
46745	5747	2	acts	act	VBZ
46745	5747	3	especially	especially	RB
46745	5747	4	on	on	IN
46745	5747	5	the	the	DT
46745	5747	6	superficial	superficial	JJ
46745	5747	7	sensory	sensory	JJ
46745	5747	8	nerves	nerve	NNS
46745	5747	9	,	,	,
46745	5747	10	and	and	CC
46745	5747	11	tends	tend	VBZ
46745	5747	12	to	to	TO
46745	5747	13	extinguish	extinguish	VB
46745	5747	14	feeling	feeling	NN
46745	5747	15	and	and	CC
46745	5747	16	pain	pain	NN
46745	5747	17	.	.	.
46745	5748	1	It	-PRON-	PRP
46745	5748	2	is	be	VBZ
46745	5748	3	the	the	DT
46745	5748	4	best	good	JJS
46745	5748	5	external	external	JJ
46745	5748	6	anæsthetic	anæsthetic	NN
46745	5748	7	with	with	IN
46745	5748	8	which	which	WDT
46745	5748	9	we	-PRON-	PRP
46745	5748	10	are	be	VBP
46745	5748	11	acquainted	acquaint	VBN
46745	5748	12	.	.	.
46745	5749	1	It	-PRON-	PRP
46745	5749	2	is	be	VBZ
46745	5749	3	thus	thus	RB
46745	5749	4	eminently	eminently	RB
46745	5749	5	useful	useful	JJ
46745	5749	6	in	in	IN
46745	5749	7	the	the	DT
46745	5749	8	treatment	treatment	NN
46745	5749	9	of	of	IN
46745	5749	10	that	that	DT
46745	5749	11	most	most	RBS
46745	5749	12	painful	painful	JJ
46745	5749	13	of	of	IN
46745	5749	14	all	all	DT
46745	5749	15	disorders	disorder	NNS
46745	5749	16	,	,	,
46745	5749	17	Tic	Tic	NNP
46745	5749	18	douloureux	douloureux	JJ
46745	5749	19	,	,	,
46745	5749	20	or	or	CC
46745	5749	21	irritative	irritative	JJ
46745	5749	22	Neuralgia	Neuralgia	NNP
46745	5749	23	of	of	IN
46745	5749	24	the	the	DT
46745	5749	25	face	face	NN
46745	5749	26	.	.	.
46745	5750	1	When	when	WRB
46745	5750	2	Quinine	Quinine	NNP
46745	5750	3	and	and	CC
46745	5750	4	all	all	DT
46745	5750	5	internal	internal	JJ
46745	5750	6	remedies	remedy	NNS
46745	5750	7	have	have	VBP
46745	5750	8	failed	fail	VBN
46745	5750	9	,	,	,
46745	5750	10	the	the	DT
46745	5750	11	tincture	tincture	NN
46745	5750	12	of	of	IN
46745	5750	13	Aconite	Aconite	NNP
46745	5750	14	,	,	,
46745	5750	15	or	or	CC
46745	5750	16	an	an	DT
46745	5750	17	ointment	ointment	NN
46745	5750	18	containing	contain	VBG
46745	5750	19	the	the	DT
46745	5750	20	alkaloid	alkaloid	NN
46745	5750	21	,	,	,
46745	5750	22	will	will	MD
46745	5750	23	in	in	IN
46745	5750	24	most	most	JJS
46745	5750	25	cases	case	NNS
46745	5750	26	,	,	,
46745	5750	27	if	if	IN
46745	5750	28	applied	apply	VBN
46745	5750	29	to	to	IN
46745	5750	30	the	the	DT
46745	5750	31	part	part	NN
46745	5750	32	,	,	,
46745	5750	33	effectually	effectually	RB
46745	5750	34	relieve	relieve	VBP
46745	5750	35	the	the	DT
46745	5750	36	pain	pain	NN
46745	5750	37	.	.	.
46745	5751	1	It	-PRON-	PRP
46745	5751	2	is	be	VBZ
46745	5751	3	applicable	applicable	JJ
46745	5751	4	in	in	IN
46745	5751	5	local	local	JJ
46745	5751	6	irritative	irritative	JJ
46745	5751	7	pain	pain	NN
46745	5751	8	at	at	IN
46745	5751	9	any	any	DT
46745	5751	10	part	part	NN
46745	5751	11	of	of	IN
46745	5751	12	the	the	DT
46745	5751	13	surface	surface	NN
46745	5751	14	,	,	,
46745	5751	15	as	as	IN
46745	5751	16	in	in	IN
46745	5751	17	Sciatica	Sciatica	NNP
46745	5751	18	,	,	,
46745	5751	19	Lumbago	Lumbago	NNP
46745	5751	20	,	,	,
46745	5751	21	or	or	CC
46745	5751	22	a	a	DT
46745	5751	23	Scirrhus	Scirrhus	NNP
46745	5751	24	of	of	IN
46745	5751	25	the	the	DT
46745	5751	26	breast	breast	NN
46745	5751	27	that	that	WDT
46745	5751	28	has	have	VBZ
46745	5751	29	not	not	RB
46745	5751	30	opened	open	VBN
46745	5751	31	.	.	.
46745	5752	1	But	but	CC
46745	5752	2	,	,	,
46745	5752	3	like	like	IN
46745	5752	4	the	the	DT
46745	5752	5	other	other	JJ
46745	5752	6	local	local	JJ
46745	5752	7	anæsthetics	anæsthetic	NNS
46745	5752	8	,	,	,
46745	5752	9	it	-PRON-	PRP
46745	5752	10	is	be	VBZ
46745	5752	11	of	of	IN
46745	5752	12	little	little	JJ
46745	5752	13	service	service	NN
46745	5752	14	in	in	IN
46745	5752	15	cases	case	NNS
46745	5752	16	of	of	IN
46745	5752	17	inflammatory	inflammatory	JJ
46745	5752	18	pain	pain	NN
46745	5752	19	,	,	,
46745	5752	20	for	for	IN
46745	5752	21	this	this	DT
46745	5752	22	,	,	,
46745	5752	23	when	when	WRB
46745	5752	24	local	local	JJ
46745	5752	25	,	,	,
46745	5752	26	depends	depend	VBZ
46745	5752	27	upon	upon	IN
46745	5752	28	an	an	DT
46745	5752	29	active	active	JJ
46745	5752	30	cause	cause	NN
46745	5752	31	,	,	,
46745	5752	32	and	and	CC
46745	5752	33	would	would	MD
46745	5752	34	be	be	VB
46745	5752	35	liable	liable	JJ
46745	5752	36	to	to	TO
46745	5752	37	be	be	VB
46745	5752	38	increased	increase	VBN
46745	5752	39	by	by	IN
46745	5752	40	the	the	DT
46745	5752	41	rubbing	rubbing	NN
46745	5752	42	required	require	VBN
46745	5752	43	in	in	IN
46745	5752	44	the	the	DT
46745	5752	45	application	application	NN
46745	5752	46	of	of	IN
46745	5752	47	the	the	DT
46745	5752	48	Aconite	Aconite	NNP
46745	5752	49	.	.	.
46745	5753	1	When	when	WRB
46745	5753	2	the	the	DT
46745	5753	3	remedy	remedy	NN
46745	5753	4	takes	take	VBZ
46745	5753	5	effect	effect	NN
46745	5753	6	,	,	,
46745	5753	7	some	some	DT
46745	5753	8	heat	heat	NN
46745	5753	9	is	be	VBZ
46745	5753	10	first	first	RB
46745	5753	11	experienced	experience	VBN
46745	5753	12	at	at	IN
46745	5753	13	the	the	DT
46745	5753	14	part	part	NN
46745	5753	15	;	;	:
46745	5753	16	there	there	EX
46745	5753	17	is	be	VBZ
46745	5753	18	then	then	RB
46745	5753	19	tingling	tingle	VBG
46745	5753	20	;	;	:
46745	5753	21	and	and	CC
46745	5753	22	lastly	lastly	RB
46745	5753	23	,	,	,
46745	5753	24	complete	complete	JJ
46745	5753	25	numbness	numbness	NN
46745	5753	26	,	,	,
46745	5753	27	and	and	CC
46745	5753	28	a	a	DT
46745	5753	29	sensation	sensation	NN
46745	5753	30	of	of	IN
46745	5753	31	cold	cold	NN
46745	5753	32	,	,	,
46745	5753	33	which	which	WDT
46745	5753	34	endure	endure	VBP
46745	5753	35	for	for	IN
46745	5753	36	some	some	DT
46745	5753	37	time	time	NN
46745	5753	38	.	.	.
46745	5754	1	No	no	DT
46745	5754	2	visible	visible	JJ
46745	5754	3	change	change	NN
46745	5754	4	is	be	VBZ
46745	5754	5	effected	effect	VBN
46745	5754	6	.	.	.
46745	5755	1	Aconite	aconite	JJ
46745	5755	2	subdues	subdue	NNS
46745	5755	3	the	the	DT
46745	5755	4	action	action	NN
46745	5755	5	of	of	IN
46745	5755	6	the	the	DT
46745	5755	7	heart	heart	NN
46745	5755	8	.	.	.
46745	5756	1	Dr.	Dr.	NNP
46745	5756	2	Fleming	Fleming	NNP
46745	5756	3	has	have	VBZ
46745	5756	4	therefore	therefore	RB
46745	5756	5	recommended	recommend	VBN
46745	5756	6	small	small	JJ
46745	5756	7	doses	dose	NNS
46745	5756	8	internally	internally	RB
46745	5756	9	in	in	IN
46745	5756	10	cases	case	NNS
46745	5756	11	of	of	IN
46745	5756	12	acute	acute	JJ
46745	5756	13	rheumatism	rheumatism	NN
46745	5756	14	.	.	.
46745	5757	1	But	but	CC
46745	5757	2	considerable	considerable	JJ
46745	5757	3	care	care	NN
46745	5757	4	is	be	VBZ
46745	5757	5	required	require	VBN
46745	5757	6	in	in	IN
46745	5757	7	the	the	DT
46745	5757	8	internal	internal	JJ
46745	5757	9	employment	employment	NN
46745	5757	10	of	of	IN
46745	5757	11	the	the	DT
46745	5757	12	drug	drug	NN
46745	5757	13	,	,	,
46745	5757	14	on	on	IN
46745	5757	15	account	account	NN
46745	5757	16	not	not	RB
46745	5757	17	only	only	RB
46745	5757	18	of	of	IN
46745	5757	19	its	-PRON-	PRP$
46745	5757	20	dangerous	dangerous	JJ
46745	5757	21	properties	property	NNS
46745	5757	22	,	,	,
46745	5757	23	but	but	CC
46745	5757	24	of	of	IN
46745	5757	25	the	the	DT
46745	5757	26	great	great	JJ
46745	5757	27	variety	variety	NN
46745	5757	28	in	in	IN
46745	5757	29	strength	strength	NN
46745	5757	30	which	which	WDT
46745	5757	31	exists	exist	VBZ
46745	5757	32	among	among	IN
46745	5757	33	the	the	DT
46745	5757	34	preparations	preparation	NNS
46745	5757	35	that	that	WDT
46745	5757	36	are	be	VBP
46745	5757	37	usually	usually	RB
46745	5757	38	employed	employ	VBN
46745	5757	39	.	.	.
46745	5758	1	The	the	DT
46745	5758	2	difficulty	difficulty	NN
46745	5758	3	experienced	experience	VBD
46745	5758	4	in	in	IN
46745	5758	5	the	the	DT
46745	5758	6	preparation	preparation	NN
46745	5758	7	of	of	IN
46745	5758	8	the	the	DT
46745	5758	9	alkaloid	alkaloid	NN
46745	5758	10	Aconitina	Aconitina	NNP
46745	5758	11	,	,	,
46745	5758	12	which	which	WDT
46745	5758	13	is	be	VBZ
46745	5758	14	the	the	DT
46745	5758	15	active	active	JJ
46745	5758	16	principle	principle	NN
46745	5758	17	of	of	IN
46745	5758	18	the	the	DT
46745	5758	19	plant	plant	NN
46745	5758	20	,	,	,
46745	5758	21	and	and	CC
46745	5758	22	the	the	DT
46745	5758	23	very	very	RB
46745	5758	24	high	high	JJ
46745	5758	25	price	price	NN
46745	5758	26	at	at	IN
46745	5758	27	which	which	WDT
46745	5758	28	that	that	DT
46745	5758	29	substance	substance	NN
46745	5758	30	is	be	VBZ
46745	5758	31	usually	usually	RB
46745	5758	32	sold	sell	VBN
46745	5758	33	,	,	,
46745	5758	34	have	have	VBP
46745	5758	35	prevented	prevent	VBN
46745	5758	36	it	-PRON-	PRP
46745	5758	37	from	from	IN
46745	5758	38	being	be	VBG
46745	5758	39	so	so	RB
46745	5758	40	extensively	extensively	RB
46745	5758	41	employed	employ	VBN
46745	5758	42	in	in	IN
46745	5758	43	practice	practice	NN
46745	5758	44	as	as	IN
46745	5758	45	its	-PRON-	PRP$
46745	5758	46	medicinal	medicinal	JJ
46745	5758	47	properties	property	NNS
46745	5758	48	would	would	MD
46745	5758	49	appear	appear	VB
46745	5758	50	to	to	TO
46745	5758	51	deserve	deserve	VB
46745	5758	52	for	for	IN
46745	5758	53	it	-PRON-	PRP
46745	5758	54	.	.	.
46745	5759	1	On	on	IN
46745	5759	2	account	account	NN
46745	5759	3	of	of	IN
46745	5759	4	its	-PRON-	PRP$
46745	5759	5	cleanliness	cleanliness	NN
46745	5759	6	as	as	IN
46745	5759	7	an	an	DT
46745	5759	8	outward	outward	JJ
46745	5759	9	application	application	NN
46745	5759	10	,	,	,
46745	5759	11	and	and	CC
46745	5759	12	the	the	DT
46745	5759	13	certainty	certainty	NN
46745	5759	14	and	and	CC
46745	5759	15	uniformity	uniformity	NN
46745	5759	16	of	of	IN
46745	5759	17	its	-PRON-	PRP$
46745	5759	18	sedative	sedative	JJ
46745	5759	19	and	and	CC
46745	5759	20	anæsthetic	anæsthetic	JJ
46745	5759	21	actions	action	NNS
46745	5759	22	,	,	,
46745	5759	23	the	the	DT
46745	5759	24	pure	pure	JJ
46745	5759	25	alkaloid	alkaloid	NN
46745	5759	26	is	be	VBZ
46745	5759	27	far	far	RB
46745	5759	28	preferable	preferable	JJ
46745	5759	29	as	as	IN
46745	5759	30	a	a	DT
46745	5759	31	medicine	medicine	NN
46745	5759	32	to	to	TO
46745	5759	33	Aconite	aconite	VB
46745	5759	34	itself	-PRON-	PRP
46745	5759	35	,	,	,
46745	5759	36	and	and	CC
46745	5759	37	is	be	VBZ
46745	5759	38	adapted	adapt	VBN
46745	5759	39	for	for	IN
46745	5759	40	all	all	PDT
46745	5759	41	the	the	DT
46745	5759	42	cases	case	NNS
46745	5759	43	in	in	IN
46745	5759	44	which	which	WDT
46745	5759	45	the	the	DT
46745	5759	46	latter	latter	NN
46745	5759	47	has	have	VBZ
46745	5759	48	been	be	VBN
46745	5759	49	employed	employ	VBN
46745	5759	50	.	.	.
46745	5760	1	Having	have	VBG
46745	5760	2	some	some	DT
46745	5760	3	time	time	NN
46745	5760	4	ago	ago	RB
46745	5760	5	been	be	VBN
46745	5760	6	successful	successful	JJ
46745	5760	7	in	in	IN
46745	5760	8	an	an	DT
46745	5760	9	attempt	attempt	NN
46745	5760	10	to	to	TO
46745	5760	11	discover	discover	VB
46745	5760	12	a	a	DT
46745	5760	13	mode	mode	NN
46745	5760	14	of	of	IN
46745	5760	15	preparing	prepare	VBG
46745	5760	16	Aconitina,[49	Aconitina,[49	NNP
46745	5760	17	]	]	-RRB-
46745	5760	18	I	-PRON-	PRP
46745	5760	19	have	have	VBP
46745	5760	20	made	make	VBN
46745	5760	21	some	some	DT
46745	5760	22	experiments	experiment	NNS
46745	5760	23	with	with	IN
46745	5760	24	it	-PRON-	PRP
46745	5760	25	on	on	IN
46745	5760	26	various	various	JJ
46745	5760	27	small	small	JJ
46745	5760	28	animals	animal	NNS
46745	5760	29	,	,	,
46745	5760	30	for	for	IN
46745	5760	31	the	the	DT
46745	5760	32	purpose	purpose	NN
46745	5760	33	of	of	IN
46745	5760	34	ascertaining	ascertain	VBG
46745	5760	35	its	-PRON-	PRP$
46745	5760	36	power	power	NN
46745	5760	37	,	,	,
46745	5760	38	and	and	CC
46745	5760	39	the	the	DT
46745	5760	40	symptoms	symptom	NNS
46745	5760	41	of	of	IN
46745	5760	42	its	-PRON-	PRP$
46745	5760	43	action	action	NN
46745	5760	44	.	.	.
46745	5761	1	It	-PRON-	PRP
46745	5761	2	is	be	VBZ
46745	5761	3	a	a	DT
46745	5761	4	very	very	RB
46745	5761	5	active	active	JJ
46745	5761	6	poison	poison	NN
46745	5761	7	.	.	.
46745	5762	1	Proceeding	proceed	VBG
46745	5762	2	upwards	upwards	RB
46745	5762	3	in	in	IN
46745	5762	4	the	the	DT
46745	5762	5	animal	animal	NN
46745	5762	6	scale	scale	NN
46745	5762	7	,	,	,
46745	5762	8	I	-PRON-	PRP
46745	5762	9	find	find	VBP
46745	5762	10	that	that	IN
46745	5762	11	1/300th	1/300th	NNS
46745	5762	12	of	of	IN
46745	5762	13	a	a	DT
46745	5762	14	grain	grain	NN
46745	5762	15	,	,	,
46745	5762	16	in	in	IN
46745	5762	17	solution	solution	NN
46745	5762	18	in	in	IN
46745	5762	19	water	water	NN
46745	5762	20	,	,	,
46745	5762	21	suffices	suffice	VBZ
46745	5762	22	to	to	TO
46745	5762	23	kill	kill	VB
46745	5762	24	a	a	DT
46745	5762	25	mouse	mouse	NN
46745	5762	26	.	.	.
46745	5763	1	1/100th	1/100th	NNP
46745	5763	2	kills	kill	VBZ
46745	5763	3	a	a	DT
46745	5763	4	small	small	JJ
46745	5763	5	bird	bird	NN
46745	5763	6	after	after	IN
46745	5763	7	a	a	DT
46745	5763	8	few	few	JJ
46745	5763	9	minutes	minute	NNS
46745	5763	10	;	;	:
46745	5763	11	1/50th	1/50th	CD
46745	5763	12	almost	almost	RB
46745	5763	13	instantaneously	instantaneously	RB
46745	5763	14	.	.	.
46745	5764	1	1/20th	1/20th	CD
46745	5764	2	of	of	IN
46745	5764	3	a	a	DT
46745	5764	4	grain	grain	NN
46745	5764	5	has	have	VBZ
46745	5764	6	killed	kill	VBN
46745	5764	7	a	a	DT
46745	5764	8	cat	cat	NN
46745	5764	9	.	.	.
46745	5765	1	1/10th	1/10th	CD
46745	5765	2	invariably	invariably	RB
46745	5765	3	proves	prove	VBZ
46745	5765	4	fatal	fatal	JJ
46745	5765	5	to	to	IN
46745	5765	6	the	the	DT
46745	5765	7	unfortunate	unfortunate	JJ
46745	5765	8	feline	feline	NN
46745	5765	9	in	in	IN
46745	5765	10	the	the	DT
46745	5765	11	course	course	NN
46745	5765	12	of	of	IN
46745	5765	13	twenty	twenty	CD
46745	5765	14	minutes	minute	NNS
46745	5765	15	or	or	CC
46745	5765	16	half	half	PDT
46745	5765	17	an	an	DT
46745	5765	18	hour	hour	NN
46745	5765	19	.	.	.
46745	5766	1	Calculating	calculate	VBG
46745	5766	2	as	as	RB
46745	5766	3	well	well	RB
46745	5766	4	as	as	IN
46745	5766	5	I	-PRON-	PRP
46745	5766	6	can	can	MD
46745	5766	7	from	from	IN
46745	5766	8	these	these	DT
46745	5766	9	data	datum	NNS
46745	5766	10	,	,	,
46745	5766	11	I	-PRON-	PRP
46745	5766	12	consider	consider	VBP
46745	5766	13	that	that	IN
46745	5766	14	1/10th	1/10th	CD
46745	5766	15	of	of	IN
46745	5766	16	a	a	DT
46745	5766	17	grain	grain	NN
46745	5766	18	of	of	IN
46745	5766	19	this	this	DT
46745	5766	20	alkaloid	alkaloid	NN
46745	5766	21	would	would	MD
46745	5766	22	be	be	VB
46745	5766	23	sufficient	sufficient	JJ
46745	5766	24	to	to	TO
46745	5766	25	cause	cause	VB
46745	5766	26	the	the	DT
46745	5766	27	death	death	NN
46745	5766	28	of	of	IN
46745	5766	29	an	an	DT
46745	5766	30	adult	adult	NN
46745	5766	31	man	man	NN
46745	5766	32	.	.	.
46745	5767	1	During	during	IN
46745	5767	2	the	the	DT
46745	5767	3	action	action	NN
46745	5767	4	of	of	IN
46745	5767	5	the	the	DT
46745	5767	6	poison	poison	NN
46745	5767	7	on	on	IN
46745	5767	8	cats	cat	NNS
46745	5767	9	the	the	DT
46745	5767	10	following	follow	VBG
46745	5767	11	succession	succession	NN
46745	5767	12	of	of	IN
46745	5767	13	symptoms	symptom	NNS
46745	5767	14	is	be	VBZ
46745	5767	15	generally	generally	RB
46745	5767	16	observed	observe	VBN
46745	5767	17	.	.	.
46745	5768	1	They	-PRON-	PRP
46745	5768	2	will	will	MD
46745	5768	3	illustrate	illustrate	VB
46745	5768	4	in	in	IN
46745	5768	5	most	most	JJS
46745	5768	6	of	of	IN
46745	5768	7	its	-PRON-	PRP$
46745	5768	8	phases	phase	NNS
46745	5768	9	the	the	DT
46745	5768	10	action	action	NN
46745	5768	11	of	of	IN
46745	5768	12	a	a	DT
46745	5768	13	Sedative	sedative	JJ
46745	5768	14	medicine	medicine	NN
46745	5768	15	.	.	.
46745	5769	1	1	1	LS
46745	5769	2	.	.	.
46745	5770	1	An	an	DT
46745	5770	2	increased	increase	VBN
46745	5770	3	flow	flow	NN
46745	5770	4	of	of	IN
46745	5770	5	the	the	DT
46745	5770	6	salivary	salivary	JJ
46745	5770	7	secretion	secretion	NN
46745	5770	8	.	.	.
46745	5771	1	(	(	-LRB-
46745	5771	2	_	_	NNP
46745	5771	3	Vide	Vide	NNP
46745	5771	4	_	_	NNP
46745	5771	5	p.	p.	NN
46745	5772	1	282	282	CD
46745	5772	2	.	.	.
46745	5772	3	)	)	-RRB-
46745	5773	1	2	2	LS
46745	5773	2	.	.	.
46745	5774	1	Vomiting	vomiting	NN
46745	5774	2	.	.	.
46745	5775	1	3	3	LS
46745	5775	2	.	.	.
46745	5776	1	Delirium	delirium	NN
46745	5776	2	,	,	,
46745	5776	3	with	with	IN
46745	5776	4	hallucinations	hallucination	NNS
46745	5776	5	.	.	.
46745	5777	1	Impairment	impairment	NN
46745	5777	2	of	of	IN
46745	5777	3	volition	volition	NN
46745	5777	4	;	;	:
46745	5777	5	apparent	apparent	JJ
46745	5777	6	loss	loss	NN
46745	5777	7	of	of	IN
46745	5777	8	sensation	sensation	NN
46745	5777	9	.	.	.
46745	5778	1	4	4	LS
46745	5778	2	.	.	.
46745	5779	1	Convulsions	convulsion	NNS
46745	5779	2	;	;	:
46745	5779	3	paralysis	paralysis	NN
46745	5779	4	.	.	.
46745	5780	1	5	5	CD
46745	5780	2	.	.	.
46745	5781	1	Breathing	breathe	VBG
46745	5781	2	difficult	difficult	JJ
46745	5781	3	and	and	CC
46745	5781	4	gasping,--gradually	gasping,--gradually	JJ
46745	5781	5	ceasing	cease	VBG
46745	5781	6	.	.	.
46745	5782	1	6	6	CD
46745	5782	2	.	.	.
46745	5783	1	Death	death	NN
46745	5783	2	;	;	:
46745	5783	3	pupils	pupil	NNS
46745	5783	4	of	of	IN
46745	5783	5	the	the	DT
46745	5783	6	eye	eye	NN
46745	5783	7	are	be	VBP
46745	5783	8	seen	see	VBN
46745	5783	9	to	to	TO
46745	5783	10	be	be	VB
46745	5783	11	dilated	dilate	VBN
46745	5783	12	.	.	.
46745	5784	1	Aconitina	Aconitina	NNP
46745	5784	2	has	have	VBZ
46745	5784	3	thus	thus	RB
46745	5784	4	a	a	DT
46745	5784	5	powerful	powerful	JJ
46745	5784	6	action	action	NN
46745	5784	7	on	on	IN
46745	5784	8	the	the	DT
46745	5784	9	brain	brain	NN
46745	5784	10	,	,	,
46745	5784	11	and	and	CC
46745	5784	12	on	on	IN
46745	5784	13	the	the	DT
46745	5784	14	nerves	nerve	NNS
46745	5784	15	generally	generally	RB
46745	5784	16	.	.	.
46745	5785	1	The	the	DT
46745	5785	2	flow	flow	NN
46745	5785	3	of	of	IN
46745	5785	4	saliva	saliva	NN
46745	5785	5	seems	seem	VBZ
46745	5785	6	partly	partly	RB
46745	5785	7	to	to	TO
46745	5785	8	arise	arise	VB
46745	5785	9	from	from	IN
46745	5785	10	a	a	DT
46745	5785	11	paralysis	paralysis	NN
46745	5785	12	of	of	IN
46745	5785	13	the	the	DT
46745	5785	14	fauces	fauce	NNS
46745	5785	15	.	.	.
46745	5786	1	The	the	DT
46745	5786	2	animal	animal	NN
46745	5786	3	makes	make	VBZ
46745	5786	4	ineffectual	ineffectual	JJ
46745	5786	5	attempts	attempt	NNS
46745	5786	6	to	to	TO
46745	5786	7	swallow	swallow	VB
46745	5786	8	,	,	,
46745	5786	9	and	and	CC
46745	5786	10	breathes	breathe	VBZ
46745	5786	11	spasmodically	spasmodically	RB
46745	5786	12	.	.	.
46745	5787	1	By	by	IN
46745	5787	2	a	a	DT
46745	5787	3	small	small	JJ
46745	5787	4	dose	dose	VBD
46745	5787	5	the	the	DT
46745	5787	6	anæsthesia	anæsthesia	NN
46745	5787	7	would	would	MD
46745	5787	8	probably	probably	RB
46745	5787	9	be	be	VB
46745	5787	10	produced	produce	VBN
46745	5787	11	,	,	,
46745	5787	12	without	without	IN
46745	5787	13	the	the	DT
46745	5787	14	other	other	JJ
46745	5787	15	effects	effect	NNS
46745	5787	16	.	.	.
46745	5788	1	On	on	IN
46745	5788	2	examination	examination	NN
46745	5788	3	of	of	IN
46745	5788	4	the	the	DT
46745	5788	5	body	body	NN
46745	5788	6	after	after	IN
46745	5788	7	death	death	NN
46745	5788	8	the	the	DT
46745	5788	9	lungs	lung	NNS
46745	5788	10	are	be	VBP
46745	5788	11	found	find	VBN
46745	5788	12	to	to	TO
46745	5788	13	be	be	VB
46745	5788	14	healthy	healthy	JJ
46745	5788	15	,	,	,
46745	5788	16	but	but	CC
46745	5788	17	shrunken	shrunken	NN
46745	5788	18	and	and	CC
46745	5788	19	bloodless	bloodless	NN
46745	5788	20	;	;	:
46745	5788	21	the	the	DT
46745	5788	22	trachea	trachea	NN
46745	5788	23	contains	contain	VBZ
46745	5788	24	much	much	JJ
46745	5788	25	frothy	frothy	JJ
46745	5788	26	mucus	mucus	NN
46745	5788	27	,	,	,
46745	5788	28	which	which	WDT
46745	5788	29	may	may	MD
46745	5788	30	possibly	possibly	RB
46745	5788	31	have	have	VB
46745	5788	32	flowed	flow	VBN
46745	5788	33	into	into	IN
46745	5788	34	it	-PRON-	PRP
46745	5788	35	on	on	IN
46745	5788	36	account	account	NN
46745	5788	37	of	of	IN
46745	5788	38	the	the	DT
46745	5788	39	palsy	palsy	NN
46745	5788	40	of	of	IN
46745	5788	41	the	the	DT
46745	5788	42	glottis	glottis	NN
46745	5788	43	;	;	:
46745	5788	44	the	the	DT
46745	5788	45	cavities	cavity	NNS
46745	5788	46	of	of	IN
46745	5788	47	the	the	DT
46745	5788	48	heart	heart	NN
46745	5788	49	are	be	VBP
46745	5788	50	full	full	JJ
46745	5788	51	;	;	:
46745	5788	52	the	the	DT
46745	5788	53	mucous	mucous	JJ
46745	5788	54	membrane	membrane	NN
46745	5788	55	of	of	IN
46745	5788	56	the	the	DT
46745	5788	57	stomach	stomach	NN
46745	5788	58	pale	pale	JJ
46745	5788	59	.	.	.
46745	5789	1	It	-PRON-	PRP
46745	5789	2	seems	seem	VBZ
46745	5789	3	then	then	RB
46745	5789	4	that	that	IN
46745	5789	5	the	the	DT
46745	5789	6	immediate	immediate	JJ
46745	5789	7	cause	cause	NN
46745	5789	8	of	of	IN
46745	5789	9	death	death	NN
46745	5789	10	is	be	VBZ
46745	5789	11	paralytic	paralytic	JJ
46745	5789	12	syncope,--a	syncope,--a	NNP
46745	5789	13	loss	loss	NN
46745	5789	14	of	of	IN
46745	5789	15	power	power	NN
46745	5789	16	in	in	IN
46745	5789	17	the	the	DT
46745	5789	18	heart	heart	NN
46745	5789	19	.	.	.
46745	5790	1	As	as	IN
46745	5790	2	the	the	DT
46745	5790	3	mucous	mucous	JJ
46745	5790	4	coat	coat	NN
46745	5790	5	of	of	IN
46745	5790	6	the	the	DT
46745	5790	7	stomach	stomach	NN
46745	5790	8	evinces	evince	NNS
46745	5790	9	no	no	DT
46745	5790	10	trace	trace	NN
46745	5790	11	of	of	IN
46745	5790	12	congestion	congestion	NN
46745	5790	13	,	,	,
46745	5790	14	it	-PRON-	PRP
46745	5790	15	is	be	VBZ
46745	5790	16	probable	probable	JJ
46745	5790	17	that	that	IN
46745	5790	18	the	the	DT
46745	5790	19	vomiting	vomiting	NN
46745	5790	20	is	be	VBZ
46745	5790	21	not	not	RB
46745	5790	22	caused	cause	VBN
46745	5790	23	by	by	IN
46745	5790	24	irritation	irritation	NN
46745	5790	25	,	,	,
46745	5790	26	but	but	CC
46745	5790	27	by	by	IN
46745	5790	28	a	a	DT
46745	5790	29	sedative	sedative	JJ
46745	5790	30	or	or	CC
46745	5790	31	deranging	derange	VBG
46745	5790	32	action	action	NN
46745	5790	33	on	on	IN
46745	5790	34	the	the	DT
46745	5790	35	function	function	NN
46745	5790	36	of	of	IN
46745	5790	37	the	the	DT
46745	5790	38	Vagus	Vagus	NNP
46745	5790	39	nerve	nerve	NN
46745	5790	40	.	.	.
46745	5791	1	(	(	-LRB-
46745	5791	2	_	_	NNP
46745	5791	3	Vide	Vide	NNP
46745	5791	4	_	_	NNP
46745	5791	5	pp	pp	NNP
46745	5791	6	.	.	.
46745	5792	1	242	242	CD
46745	5792	2	,	,	,
46745	5792	3	245	245	CD
46745	5792	4	.	.	.
46745	5792	5	)	)	-RRB-
46745	5793	1	DIGITALIS	DIGITALIS	NNP
46745	5793	2	.	.	.
46745	5794	1	Class	class	NN
46745	5794	2	II	II	NNP
46745	5794	3	.	.	.
46745	5795	1	Div	Div	NNP
46745	5795	2	.	.	.
46745	5796	1	III	iii	CD
46745	5796	2	.	.	.
46745	5797	1	Ord	Ord	NNP
46745	5797	2	.	.	.
46745	5798	1	II	ii	CD
46745	5798	2	.	.	.
46745	5799	1	SEDANTIA	SEDANTIA	NNP
46745	5799	2	SPECIFICA	SPECIFICA	NNP
46745	5799	3	.	.	.
46745	5800	1	Class	Class	NNP
46745	5800	2	IV	IV	NNP
46745	5800	3	.	.	.
46745	5801	1	Ord	Ord	NNP
46745	5801	2	.	.	.
46745	5802	1	VI	VI	NNP
46745	5802	2	.	.	.
46745	5803	1	DIURETICA	DIURETICA	NNP
46745	5803	2	.	.	.
46745	5804	1	This	this	DT
46745	5804	2	important	important	JJ
46745	5804	3	medicine	medicine	NN
46745	5804	4	has	have	VBZ
46745	5804	5	already	already	RB
46745	5804	6	been	be	VBN
46745	5804	7	prominently	prominently	RB
46745	5804	8	noticed	notice	VBN
46745	5804	9	as	as	IN
46745	5804	10	one	one	CD
46745	5804	11	of	of	IN
46745	5804	12	the	the	DT
46745	5804	13	agents	agent	NNS
46745	5804	14	that	that	WDT
46745	5804	15	exert	exert	VBP
46745	5804	16	a	a	DT
46745	5804	17	special	special	JJ
46745	5804	18	sedative	sedative	NN
46745	5804	19	and	and	CC
46745	5804	20	deranging	derange	VBG
46745	5804	21	power	power	NN
46745	5804	22	over	over	IN
46745	5804	23	the	the	DT
46745	5804	24	functions	function	NNS
46745	5804	25	of	of	IN
46745	5804	26	the	the	DT
46745	5804	27	Vagus	Vagus	NNP
46745	5804	28	nerve	nerve	NN
46745	5804	29	.	.	.
46745	5805	1	It	-PRON-	PRP
46745	5805	2	will	will	MD
46745	5805	3	only	only	RB
46745	5805	4	be	be	VB
46745	5805	5	necessary	necessary	JJ
46745	5805	6	now	now	RB
46745	5805	7	to	to	TO
46745	5805	8	sum	sum	VB
46745	5805	9	up	up	RP
46745	5805	10	shortly	shortly	RB
46745	5805	11	the	the	DT
46745	5805	12	details	detail	NNS
46745	5805	13	of	of	IN
46745	5805	14	its	-PRON-	PRP$
46745	5805	15	action	action	NN
46745	5805	16	.	.	.
46745	5806	1	It	-PRON-	PRP
46745	5806	2	does	do	VBZ
46745	5806	3	not	not	RB
46745	5806	4	depress	depress	VB
46745	5806	5	nervous	nervous	JJ
46745	5806	6	force	force	NN
46745	5806	7	generally	generally	RB
46745	5806	8	.	.	.
46745	5807	1	It	-PRON-	PRP
46745	5807	2	has	have	VBZ
46745	5807	3	no	no	DT
46745	5807	4	action	action	NN
46745	5807	5	on	on	IN
46745	5807	6	the	the	DT
46745	5807	7	brain	brain	NN
46745	5807	8	,	,	,
46745	5807	9	except	except	IN
46745	5807	10	as	as	IN
46745	5807	11	connected	connect	VBN
46745	5807	12	with	with	IN
46745	5807	13	the	the	DT
46745	5807	14	Vagus	Vagus	NNP
46745	5807	15	nerve	nerve	NN
46745	5807	16	.	.	.
46745	5808	1	Neither	neither	CC
46745	5808	2	does	do	VBZ
46745	5808	3	it	-PRON-	PRP
46745	5808	4	affect	affect	VB
46745	5808	5	the	the	DT
46745	5808	6	spinal	spinal	JJ
46745	5808	7	cord	cord	NN
46745	5808	8	,	,	,
46745	5808	9	or	or	CC
46745	5808	10	the	the	DT
46745	5808	11	nerves	nerve	NNS
46745	5808	12	of	of	IN
46745	5808	13	sensation	sensation	NN
46745	5808	14	or	or	CC
46745	5808	15	motion	motion	NN
46745	5808	16	.	.	.
46745	5809	1	Its	-PRON-	PRP$
46745	5809	2	most	most	RBS
46745	5809	3	obvious	obvious	JJ
46745	5809	4	action	action	NN
46745	5809	5	in	in	IN
46745	5809	6	small	small	JJ
46745	5809	7	doses	dose	NNS
46745	5809	8	is	be	VBZ
46745	5809	9	to	to	TO
46745	5809	10	depress	depress	VB
46745	5809	11	the	the	DT
46745	5809	12	force	force	NN
46745	5809	13	of	of	IN
46745	5809	14	the	the	DT
46745	5809	15	heart	heart	NN
46745	5809	16	.	.	.
46745	5810	1	It	-PRON-	PRP
46745	5810	2	sometimes	sometimes	RB
46745	5810	3	quickens	quicken	VBZ
46745	5810	4	the	the	DT
46745	5810	5	pulse	pulse	NN
46745	5810	6	,	,	,
46745	5810	7	but	but	CC
46745	5810	8	always	always	RB
46745	5810	9	weakens	weaken	VBZ
46745	5810	10	it	-PRON-	PRP
46745	5810	11	,	,	,
46745	5810	12	and	and	CC
46745	5810	13	reduces	reduce	VBZ
46745	5810	14	its	-PRON-	PRP$
46745	5810	15	rate	rate	NN
46745	5810	16	in	in	IN
46745	5810	17	the	the	DT
46745	5810	18	end	end	NN
46745	5810	19	.	.	.
46745	5811	1	It	-PRON-	PRP
46745	5811	2	therefore	therefore	RB
46745	5811	3	supplies	supply	VBZ
46745	5811	4	us	-PRON-	PRP
46745	5811	5	with	with	IN
46745	5811	6	a	a	DT
46745	5811	7	ready	ready	JJ
46745	5811	8	means	mean	NNS
46745	5811	9	of	of	IN
46745	5811	10	weakening	weaken	VBG
46745	5811	11	the	the	DT
46745	5811	12	heart	heart	NN
46745	5811	13	,	,	,
46745	5811	14	whenever	whenever	WRB
46745	5811	15	we	-PRON-	PRP
46745	5811	16	desire	desire	VBP
46745	5811	17	to	to	TO
46745	5811	18	do	do	VB
46745	5811	19	this	this	DT
46745	5811	20	.	.	.
46745	5812	1	In	in	IN
46745	5812	2	cases	case	NNS
46745	5812	3	of	of	IN
46745	5812	4	hypertrophy	hypertrophy	NN
46745	5812	5	,	,	,
46745	5812	6	where	where	WRB
46745	5812	7	the	the	DT
46745	5812	8	heart	heart	NN
46745	5812	9	is	be	VBZ
46745	5812	10	too	too	RB
46745	5812	11	strong,--or	strong,--or	NNP
46745	5812	12	in	in	IN
46745	5812	13	aortic	aortic	JJ
46745	5812	14	aneurism	aneurism	NN
46745	5812	15	,	,	,
46745	5812	16	or	or	CC
46745	5812	17	active	active	JJ
46745	5812	18	hemorrhage	hemorrhage	NN
46745	5812	19	,	,	,
46745	5812	20	where	where	WRB
46745	5812	21	a	a	DT
46745	5812	22	forcible	forcible	JJ
46745	5812	23	beat	beat	NN
46745	5812	24	would	would	MD
46745	5812	25	be	be	VB
46745	5812	26	dangerous,--Digitalis	dangerous,--Digitalis	NNP
46745	5812	27	may	may	MD
46745	5812	28	be	be	VB
46745	5812	29	used	use	VBN
46745	5812	30	for	for	IN
46745	5812	31	this	this	DT
46745	5812	32	purpose	purpose	NN
46745	5812	33	.	.	.
46745	5813	1	But	but	CC
46745	5813	2	it	-PRON-	PRP
46745	5813	3	is	be	VBZ
46745	5813	4	especially	especially	RB
46745	5813	5	useful	useful	JJ
46745	5813	6	in	in	IN
46745	5813	7	dropsies	dropsy	NNS
46745	5813	8	;	;	,
46745	5813	9	for	for	IN
46745	5813	10	by	by	IN
46745	5813	11	its	-PRON-	PRP$
46745	5813	12	action	action	NN
46745	5813	13	on	on	IN
46745	5813	14	the	the	DT
46745	5813	15	heart	heart	NN
46745	5813	16	,	,	,
46745	5813	17	it	-PRON-	PRP
46745	5813	18	diminishes	diminish	VBZ
46745	5813	19	congestion	congestion	NN
46745	5813	20	of	of	IN
46745	5813	21	the	the	DT
46745	5813	22	venous	venous	JJ
46745	5813	23	system	system	NN
46745	5813	24	,	,	,
46745	5813	25	and	and	CC
46745	5813	26	by	by	IN
46745	5813	27	thus	thus	RB
46745	5813	28	removing	remove	VBG
46745	5813	29	the	the	DT
46745	5813	30	pressure	pressure	NN
46745	5813	31	from	from	IN
46745	5813	32	the	the	DT
46745	5813	33	veins	vein	NNS
46745	5813	34	,	,	,
46745	5813	35	it	-PRON-	PRP
46745	5813	36	favours	favour	VBZ
46745	5813	37	the	the	DT
46745	5813	38	absorption	absorption	NN
46745	5813	39	of	of	IN
46745	5813	40	the	the	DT
46745	5813	41	fluids	fluid	NNS
46745	5813	42	effused	effuse	VBD
46745	5813	43	.	.	.
46745	5814	1	It	-PRON-	PRP
46745	5814	2	should	should	MD
46745	5814	3	,	,	,
46745	5814	4	however	however	RB
46745	5814	5	,	,	,
46745	5814	6	be	be	VB
46745	5814	7	avoided	avoid	VBN
46745	5814	8	in	in	IN
46745	5814	9	cases	case	NNS
46745	5814	10	where	where	WRB
46745	5814	11	there	there	EX
46745	5814	12	is	be	VBZ
46745	5814	13	very	very	RB
46745	5814	14	serious	serious	JJ
46745	5814	15	cardiac	cardiac	JJ
46745	5814	16	obstruction	obstruction	NN
46745	5814	17	,	,	,
46745	5814	18	or	or	CC
46745	5814	19	where	where	WRB
46745	5814	20	the	the	DT
46745	5814	21	heart	heart	NN
46745	5814	22	is	be	VBZ
46745	5814	23	habitually	habitually	RB
46745	5814	24	weak	weak	JJ
46745	5814	25	,	,	,
46745	5814	26	and	and	CC
46745	5814	27	there	there	EX
46745	5814	28	is	be	VBZ
46745	5814	29	a	a	DT
46745	5814	30	natural	natural	JJ
46745	5814	31	liability	liability	NN
46745	5814	32	to	to	TO
46745	5814	33	syncope	syncope	VB
46745	5814	34	.	.	.
46745	5815	1	For	for	IN
46745	5815	2	the	the	DT
46745	5815	3	tendency	tendency	NN
46745	5815	4	of	of	IN
46745	5815	5	the	the	DT
46745	5815	6	medicine	medicine	NN
46745	5815	7	is	be	VBZ
46745	5815	8	to	to	TO
46745	5815	9	cause	cause	VB
46745	5815	10	death	death	NN
46745	5815	11	by	by	IN
46745	5815	12	producing	produce	VBG
46745	5815	13	syncope	syncope	NN
46745	5815	14	.	.	.
46745	5816	1	Certain	certain	JJ
46745	5816	2	precautions	precaution	NNS
46745	5816	3	are	be	VBP
46745	5816	4	necessary	necessary	JJ
46745	5816	5	in	in	IN
46745	5816	6	its	-PRON-	PRP$
46745	5816	7	administration	administration	NN
46745	5816	8	.	.	.
46745	5817	1	The	the	DT
46745	5817	2	patient	patient	NN
46745	5817	3	should	should	MD
46745	5817	4	be	be	VB
46745	5817	5	generally	generally	RB
46745	5817	6	confined	confine	VBN
46745	5817	7	to	to	IN
46745	5817	8	the	the	DT
46745	5817	9	recumbent	recumbent	JJ
46745	5817	10	posture	posture	NN
46745	5817	11	;	;	:
46745	5817	12	for	for	IN
46745	5817	13	if	if	IN
46745	5817	14	,	,	,
46745	5817	15	while	while	IN
46745	5817	16	under	under	IN
46745	5817	17	the	the	DT
46745	5817	18	influence	influence	NN
46745	5817	19	of	of	IN
46745	5817	20	Digitalis	Digitalis	NNP
46745	5817	21	,	,	,
46745	5817	22	he	-PRON-	PRP
46745	5817	23	should	should	MD
46745	5817	24	suddenly	suddenly	RB
46745	5817	25	rise	rise	VB
46745	5817	26	,	,	,
46745	5817	27	and	and	CC
46745	5817	28	the	the	DT
46745	5817	29	heart	heart	NN
46745	5817	30	,	,	,
46745	5817	31	already	already	RB
46745	5817	32	weakened	weaken	VBN
46745	5817	33	,	,	,
46745	5817	34	have	have	VBP
46745	5817	35	further	further	RB
46745	5817	36	to	to	TO
46745	5817	37	contend	contend	VB
46745	5817	38	with	with	IN
46745	5817	39	the	the	DT
46745	5817	40	force	force	NN
46745	5817	41	of	of	IN
46745	5817	42	gravity	gravity	NN
46745	5817	43	in	in	IN
46745	5817	44	the	the	DT
46745	5817	45	propulsion	propulsion	NN
46745	5817	46	of	of	IN
46745	5817	47	the	the	DT
46745	5817	48	blood	blood	NN
46745	5817	49	upwards	upwards	RB
46745	5817	50	,	,	,
46745	5817	51	it	-PRON-	PRP
46745	5817	52	may	may	MD
46745	5817	53	actually	actually	RB
46745	5817	54	stop	stop	VB
46745	5817	55	.	.	.
46745	5818	1	The	the	DT
46745	5818	2	dose	dose	NN
46745	5818	3	also	also	RB
46745	5818	4	should	should	MD
46745	5818	5	be	be	VB
46745	5818	6	cautiously	cautiously	RB
46745	5818	7	regulated	regulate	VBN
46745	5818	8	,	,	,
46745	5818	9	and	and	CC
46745	5818	10	,	,	,
46745	5818	11	if	if	IN
46745	5818	12	it	-PRON-	PRP
46745	5818	13	do	do	VBP
46745	5818	14	not	not	RB
46745	5818	15	operate	operate	VB
46745	5818	16	at	at	IN
46745	5818	17	once	once	RB
46745	5818	18	,	,	,
46745	5818	19	it	-PRON-	PRP
46745	5818	20	must	must	MD
46745	5818	21	not	not	RB
46745	5818	22	be	be	VB
46745	5818	23	increased	increase	VBN
46745	5818	24	,	,	,
46745	5818	25	or	or	CC
46745	5818	26	too	too	RB
46745	5818	27	soon	soon	RB
46745	5818	28	repeated	repeat	VBN
46745	5818	29	;	;	:
46745	5818	30	for	for	IN
46745	5818	31	this	this	DT
46745	5818	32	medicine	medicine	NN
46745	5818	33	is	be	VBZ
46745	5818	34	apt	apt	JJ
46745	5818	35	sometimes	sometimes	RB
46745	5818	36	to	to	TO
46745	5818	37	accumulate	accumulate	VB
46745	5818	38	in	in	IN
46745	5818	39	the	the	DT
46745	5818	40	blood	blood	NN
46745	5818	41	,	,	,
46745	5818	42	and	and	CC
46745	5818	43	though	though	IN
46745	5818	44	several	several	JJ
46745	5818	45	doses	dose	NNS
46745	5818	46	may	may	MD
46745	5818	47	perhaps	perhaps	RB
46745	5818	48	be	be	VB
46745	5818	49	given	give	VBN
46745	5818	50	without	without	IN
46745	5818	51	effect	effect	NN
46745	5818	52	,	,	,
46745	5818	53	they	-PRON-	PRP
46745	5818	54	are	be	VBP
46745	5818	55	afterwards	afterwards	RB
46745	5818	56	liable	liable	JJ
46745	5818	57	at	at	IN
46745	5818	58	any	any	DT
46745	5818	59	time	time	NN
46745	5818	60	to	to	TO
46745	5818	61	be	be	VB
46745	5818	62	suddenly	suddenly	RB
46745	5818	63	discharged	discharge	VBN
46745	5818	64	upon	upon	IN
46745	5818	65	the	the	DT
46745	5818	66	nervous	nervous	JJ
46745	5818	67	system	system	NN
46745	5818	68	,	,	,
46745	5818	69	and	and	CC
46745	5818	70	may	may	MD
46745	5818	71	then	then	RB
46745	5818	72	produce	produce	VB
46745	5818	73	by	by	IN
46745	5818	74	their	-PRON-	PRP$
46745	5818	75	united	unite	VBN
46745	5818	76	action	action	NN
46745	5818	77	a	a	DT
46745	5818	78	dangerous	dangerous	JJ
46745	5818	79	result	result	NN
46745	5818	80	.	.	.
46745	5819	1	A	a	DT
46745	5819	2	considerable	considerable	JJ
46745	5819	3	dose	dose	NN
46745	5819	4	of	of	IN
46745	5819	5	Digitalis	Digitalis	NNP
46745	5819	6	,	,	,
46745	5819	7	as	as	IN
46745	5819	8	of	of	IN
46745	5819	9	Tartar	Tartar	NNP
46745	5819	10	Emetic	Emetic	NNP
46745	5819	11	,	,	,
46745	5819	12	deranges	derange	VBZ
46745	5819	13	the	the	DT
46745	5819	14	control	control	NN
46745	5819	15	of	of	IN
46745	5819	16	the	the	DT
46745	5819	17	Vagus	Vagus	NNP
46745	5819	18	nerve	nerve	NN
46745	5819	19	over	over	IN
46745	5819	20	the	the	DT
46745	5819	21	function	function	NN
46745	5819	22	of	of	IN
46745	5819	23	the	the	DT
46745	5819	24	stomach	stomach	NN
46745	5819	25	,	,	,
46745	5819	26	and	and	CC
46745	5819	27	may	may	MD
46745	5819	28	in	in	IN
46745	5819	29	this	this	DT
46745	5819	30	way	way	NN
46745	5819	31	produce	produce	VBP
46745	5819	32	nausea	nausea	NN
46745	5819	33	and	and	CC
46745	5819	34	vomiting	vomiting	NN
46745	5819	35	.	.	.
46745	5820	1	There	there	EX
46745	5820	2	is	be	VBZ
46745	5820	3	no	no	DT
46745	5820	4	reason	reason	NN
46745	5820	5	for	for	IN
46745	5820	6	supposing	suppose	VBG
46745	5820	7	that	that	IN
46745	5820	8	it	-PRON-	PRP
46745	5820	9	irritates	irritate	VBZ
46745	5820	10	the	the	DT
46745	5820	11	coat	coat	NN
46745	5820	12	of	of	IN
46745	5820	13	the	the	DT
46745	5820	14	stomach	stomach	NN
46745	5820	15	.	.	.
46745	5821	1	(	(	-LRB-
46745	5821	2	_	_	NNP
46745	5821	3	Vide	Vide	NNP
46745	5821	4	_	_	NNP
46745	5821	5	p.	p.	NN
46745	5822	1	93	93	CD
46745	5822	2	.	.	.
46745	5822	3	)	)	-RRB-
46745	5823	1	The	the	DT
46745	5823	2	active	active	JJ
46745	5823	3	principle	principle	NN
46745	5823	4	of	of	IN
46745	5823	5	Digitalis	Digitalis	NNP
46745	5823	6	is	be	VBZ
46745	5823	7	secreted	secrete	VBN
46745	5823	8	from	from	IN
46745	5823	9	the	the	DT
46745	5823	10	system	system	NN
46745	5823	11	in	in	IN
46745	5823	12	the	the	DT
46745	5823	13	urine	urine	NN
46745	5823	14	,	,	,
46745	5823	15	and	and	CC
46745	5823	16	probably	probably	RB
46745	5823	17	acts	act	VBZ
46745	5823	18	as	as	IN
46745	5823	19	a	a	DT
46745	5823	20	true	true	JJ
46745	5823	21	Eliminative	Eliminative	NNP
46745	5823	22	Diuretic	Diuretic	NNP
46745	5823	23	.	.	.
46745	5824	1	But	but	CC
46745	5824	2	it	-PRON-	PRP
46745	5824	3	tends	tend	VBZ
46745	5824	4	more	more	RBR
46745	5824	5	powerfully	powerfully	RB
46745	5824	6	to	to	TO
46745	5824	7	promote	promote	VB
46745	5824	8	diuresis	diuresis	NN
46745	5824	9	in	in	IN
46745	5824	10	another	another	DT
46745	5824	11	indirect	indirect	JJ
46745	5824	12	way	way	NN
46745	5824	13	.	.	.
46745	5825	1	Any	any	DT
46745	5825	2	thing	thing	NN
46745	5825	3	which	which	WDT
46745	5825	4	diminishes	diminish	VBZ
46745	5825	5	the	the	DT
46745	5825	6	pressure	pressure	NN
46745	5825	7	on	on	IN
46745	5825	8	the	the	DT
46745	5825	9	vascular	vascular	JJ
46745	5825	10	system	system	NN
46745	5825	11	,	,	,
46745	5825	12	as	as	IN
46745	5825	13	Digitalis	Digitalis	NNP
46745	5825	14	,	,	,
46745	5825	15	by	by	IN
46745	5825	16	weakening	weaken	VBG
46745	5825	17	the	the	DT
46745	5825	18	force	force	NN
46745	5825	19	of	of	IN
46745	5825	20	the	the	DT
46745	5825	21	heart	heart	NN
46745	5825	22	,	,	,
46745	5825	23	tends	tend	VBZ
46745	5825	24	thereby	thereby	RB
46745	5825	25	to	to	TO
46745	5825	26	promote	promote	VB
46745	5825	27	absorption	absorption	NN
46745	5825	28	,	,	,
46745	5825	29	and	and	CC
46745	5825	30	to	to	TO
46745	5825	31	increase	increase	VB
46745	5825	32	the	the	DT
46745	5825	33	secretion	secretion	NN
46745	5825	34	of	of	IN
46745	5825	35	urine	urine	NN
46745	5825	36	.	.	.
46745	5826	1	So	so	RB
46745	5826	2	that	that	IN
46745	5826	3	the	the	DT
46745	5826	4	employment	employment	NN
46745	5826	5	of	of	IN
46745	5826	6	Digitalis	Digitalis	NNP
46745	5826	7	in	in	IN
46745	5826	8	Dropsy	Dropsy	NNP
46745	5826	9	is	be	VBZ
46745	5826	10	attended	attend	VBN
46745	5826	11	with	with	IN
46745	5826	12	a	a	DT
46745	5826	13	twofold	twofold	JJ
46745	5826	14	advantage	advantage	NN
46745	5826	15	;	;	:
46745	5826	16	by	by	IN
46745	5826	17	its	-PRON-	PRP$
46745	5826	18	cardiac	cardiac	JJ
46745	5826	19	action	action	NN
46745	5826	20	,	,	,
46745	5826	21	it	-PRON-	PRP
46745	5826	22	prevents	prevent	VBZ
46745	5826	23	a	a	DT
46745	5826	24	renewal	renewal	NN
46745	5826	25	of	of	IN
46745	5826	26	the	the	DT
46745	5826	27	dropsical	dropsical	JJ
46745	5826	28	effusion	effusion	NN
46745	5826	29	;	;	:
46745	5826	30	by	by	IN
46745	5826	31	its	-PRON-	PRP$
46745	5826	32	diuretic	diuretic	JJ
46745	5826	33	power	power	NN
46745	5826	34	,	,	,
46745	5826	35	it	-PRON-	PRP
46745	5826	36	causes	cause	VBZ
46745	5826	37	a	a	DT
46745	5826	38	quantity	quantity	NN
46745	5826	39	of	of	IN
46745	5826	40	fluid	fluid	NN
46745	5826	41	to	to	TO
46745	5826	42	be	be	VB
46745	5826	43	drained	drain	VBN
46745	5826	44	out	out	IN
46745	5826	45	of	of	IN
46745	5826	46	the	the	DT
46745	5826	47	system	system	NN
46745	5826	48	through	through	IN
46745	5826	49	the	the	DT
46745	5826	50	kidneys	kidney	NNS
46745	5826	51	.	.	.
46745	5827	1	That	that	IN
46745	5827	2	it	-PRON-	PRP
46745	5827	3	may	may	MD
46745	5827	4	do	do	VB
46745	5827	5	this	this	DT
46745	5827	6	the	the	DT
46745	5827	7	more	more	RBR
46745	5827	8	effectually	effectually	RB
46745	5827	9	,	,	,
46745	5827	10	it	-PRON-	PRP
46745	5827	11	is	be	VBZ
46745	5827	12	generally	generally	RB
46745	5827	13	considered	consider	VBN
46745	5827	14	advisable	advisable	JJ
46745	5827	15	to	to	TO
46745	5827	16	combine	combine	VB
46745	5827	17	it	-PRON-	PRP
46745	5827	18	with	with	IN
46745	5827	19	other	other	JJ
46745	5827	20	diuretics	diuretic	NNS
46745	5827	21	.	.	.
46745	5828	1	(	(	-LRB-
46745	5828	2	_	_	NNP
46745	5828	3	Vide	Vide	NNP
46745	5828	4	_	_	NNP
46745	5828	5	pp	pp	NNP
46745	5828	6	.	.	.
46745	5829	1	251	251	CD
46745	5829	2	,	,	,
46745	5829	3	304	304	CD
46745	5829	4	,	,	,
46745	5829	5	308	308	CD
46745	5829	6	.	.	.
46745	5829	7	)	)	-RRB-
46745	5830	1	TANNIC	TANNIC	NNP
46745	5830	2	ACID	ACID	NNP
46745	5830	3	.	.	.
46745	5831	1	Class	class	NN
46745	5831	2	III	iii	CD
46745	5831	3	.	.	.
46745	5832	1	Ord	Ord	NNP
46745	5832	2	.	.	.
46745	5833	1	II	ii	CD
46745	5833	2	.	.	.
46745	5834	1	ASTRINGENTIA	ASTRINGENTIA	NNP
46745	5834	2	VEGETABILIA	VEGETABILIA	NNP
46745	5834	3	.	.	.
46745	5835	1	This	this	DT
46745	5835	2	is	be	VBZ
46745	5835	3	the	the	DT
46745	5835	4	chief	chief	JJ
46745	5835	5	astringent	astringent	JJ
46745	5835	6	principle	principle	NN
46745	5835	7	of	of	IN
46745	5835	8	vegetables	vegetable	NNS
46745	5835	9	.	.	.
46745	5836	1	It	-PRON-	PRP
46745	5836	2	is	be	VBZ
46745	5836	3	very	very	RB
46745	5836	4	soluble	soluble	JJ
46745	5836	5	in	in	IN
46745	5836	6	water	water	NN
46745	5836	7	,	,	,
46745	5836	8	crystallizable	crystallizable	JJ
46745	5836	9	,	,	,
46745	5836	10	and	and	CC
46745	5836	11	has	have	VBZ
46745	5836	12	a	a	DT
46745	5836	13	strong	strong	JJ
46745	5836	14	astringent	astringent	JJ
46745	5836	15	taste	taste	NN
46745	5836	16	.	.	.
46745	5837	1	It	-PRON-	PRP
46745	5837	2	is	be	VBZ
46745	5837	3	not	not	RB
46745	5837	4	possessed	possess	VBN
46745	5837	5	of	of	IN
46745	5837	6	those	those	DT
46745	5837	7	marked	mark	VBN
46745	5837	8	properties	property	NNS
46745	5837	9	that	that	WDT
46745	5837	10	are	be	VBP
46745	5837	11	vulgarly	vulgarly	RB
46745	5837	12	attributed	attribute	VBN
46745	5837	13	to	to	IN
46745	5837	14	acids	acid	NNS
46745	5837	15	;	;	:
46745	5837	16	but	but	CC
46745	5837	17	its	-PRON-	PRP$
46745	5837	18	solution	solution	NN
46745	5837	19	reddens	redden	VBZ
46745	5837	20	litmus	litmus	NN
46745	5837	21	-	-	HYPH
46745	5837	22	paper	paper	NN
46745	5837	23	,	,	,
46745	5837	24	and	and	CC
46745	5837	25	it	-PRON-	PRP
46745	5837	26	combines	combine	VBZ
46745	5837	27	with	with	IN
46745	5837	28	bases	basis	NNS
46745	5837	29	to	to	TO
46745	5837	30	form	form	VB
46745	5837	31	salts	salt	NNS
46745	5837	32	.	.	.
46745	5838	1	When	when	WRB
46745	5838	2	received	receive	VBN
46745	5838	3	into	into	IN
46745	5838	4	the	the	DT
46745	5838	5	stomach	stomach	NN
46745	5838	6	,	,	,
46745	5838	7	it	-PRON-	PRP
46745	5838	8	is	be	VBZ
46745	5838	9	absorbed	absorb	VBN
46745	5838	10	,	,	,
46745	5838	11	and	and	CC
46745	5838	12	passes	pass	VBZ
46745	5838	13	in	in	IN
46745	5838	14	the	the	DT
46745	5838	15	circulation	circulation	NN
46745	5838	16	to	to	TO
46745	5838	17	distant	distant	VB
46745	5838	18	parts	part	NNS
46745	5838	19	.	.	.
46745	5839	1	Its	-PRON-	PRP$
46745	5839	2	action	action	NN
46745	5839	3	consists	consist	VBZ
46745	5839	4	in	in	IN
46745	5839	5	a	a	DT
46745	5839	6	power	power	NN
46745	5839	7	of	of	IN
46745	5839	8	causing	cause	VBG
46745	5839	9	the	the	DT
46745	5839	10	contraction	contraction	NN
46745	5839	11	of	of	IN
46745	5839	12	muscular	muscular	JJ
46745	5839	13	fibre	fibre	NNP
46745	5839	14	when	when	WRB
46745	5839	15	in	in	IN
46745	5839	16	contact	contact	NN
46745	5839	17	with	with	IN
46745	5839	18	it	-PRON-	PRP
46745	5839	19	;	;	:
46745	5839	20	and	and	CC
46745	5839	21	this	this	DT
46745	5839	22	power	power	NN
46745	5839	23	appears	appear	VBZ
46745	5839	24	to	to	TO
46745	5839	25	depend	depend	VB
46745	5839	26	mainly	mainly	RB
46745	5839	27	upon	upon	IN
46745	5839	28	a	a	DT
46745	5839	29	chemical	chemical	JJ
46745	5839	30	property	property	NN
46745	5839	31	that	that	WDT
46745	5839	32	it	-PRON-	PRP
46745	5839	33	possesses	possess	VBZ
46745	5839	34	of	of	IN
46745	5839	35	coagulating	coagulate	VBG
46745	5839	36	albumen	albuman	NNS
46745	5839	37	and	and	CC
46745	5839	38	analogous	analogous	JJ
46745	5839	39	compounds	compound	NNS
46745	5839	40	.	.	.
46745	5840	1	Capillary	capillary	JJ
46745	5840	2	vessels	vessel	NNS
46745	5840	3	,	,	,
46745	5840	4	and	and	CC
46745	5840	5	the	the	DT
46745	5840	6	small	small	JJ
46745	5840	7	ducts	duct	NNS
46745	5840	8	of	of	IN
46745	5840	9	glands	gland	NNS
46745	5840	10	,	,	,
46745	5840	11	contain	contain	VBP
46745	5840	12	in	in	IN
46745	5840	13	their	-PRON-	PRP$
46745	5840	14	walls	wall	NNS
46745	5840	15	certain	certain	JJ
46745	5840	16	fibres	fibre	NNS
46745	5840	17	of	of	IN
46745	5840	18	unstriped	unstriped	JJ
46745	5840	19	muscle	muscle	NN
46745	5840	20	;	;	:
46745	5840	21	and	and	CC
46745	5840	22	Tannic	Tannic	NNP
46745	5840	23	Acid	Acid	NNP
46745	5840	24	,	,	,
46745	5840	25	by	by	IN
46745	5840	26	causing	cause	VBG
46745	5840	27	this	this	DT
46745	5840	28	muscle	muscle	NN
46745	5840	29	to	to	TO
46745	5840	30	contract	contract	VB
46745	5840	31	,	,	,
46745	5840	32	is	be	VBZ
46745	5840	33	able	able	JJ
46745	5840	34	to	to	TO
46745	5840	35	diminish	diminish	VB
46745	5840	36	the	the	DT
46745	5840	37	caliber	caliber	NN
46745	5840	38	of	of	IN
46745	5840	39	these	these	DT
46745	5840	40	tubes	tube	NNS
46745	5840	41	,	,	,
46745	5840	42	and	and	CC
46745	5840	43	thus	thus	RB
46745	5840	44	to	to	TO
46745	5840	45	moderate	moderate	VB
46745	5840	46	or	or	CC
46745	5840	47	arrest	arrest	VB
46745	5840	48	the	the	DT
46745	5840	49	flow	flow	NN
46745	5840	50	of	of	IN
46745	5840	51	blood	blood	NN
46745	5840	52	in	in	IN
46745	5840	53	the	the	DT
46745	5840	54	vessel	vessel	NN
46745	5840	55	,	,	,
46745	5840	56	or	or	CC
46745	5840	57	to	to	TO
46745	5840	58	lessen	lessen	VB
46745	5840	59	the	the	DT
46745	5840	60	amount	amount	NN
46745	5840	61	of	of	IN
46745	5840	62	the	the	DT
46745	5840	63	excretion	excretion	NN
46745	5840	64	of	of	IN
46745	5840	65	the	the	DT
46745	5840	66	gland	gland	NN
46745	5840	67	.	.	.
46745	5841	1	Thus	thus	RB
46745	5841	2	,	,	,
46745	5841	3	in	in	IN
46745	5841	4	all	all	DT
46745	5841	5	cases	case	NNS
46745	5841	6	of	of	IN
46745	5841	7	hæmorrhage	hæmorrhage	NN
46745	5841	8	from	from	IN
46745	5841	9	the	the	DT
46745	5841	10	small	small	JJ
46745	5841	11	vessels	vessel	NNS
46745	5841	12	,	,	,
46745	5841	13	or	or	CC
46745	5841	14	of	of	IN
46745	5841	15	inordinate	inordinate	JJ
46745	5841	16	secretion	secretion	NN
46745	5841	17	from	from	IN
46745	5841	18	any	any	DT
46745	5841	19	glandular	glandular	JJ
46745	5841	20	organ	organ	NN
46745	5841	21	,	,	,
46745	5841	22	Tannic	tannic	JJ
46745	5841	23	acid	acid	NN
46745	5841	24	is	be	VBZ
46745	5841	25	appropriate	appropriate	JJ
46745	5841	26	.	.	.
46745	5842	1	It	-PRON-	PRP
46745	5842	2	is	be	VBZ
46745	5842	3	the	the	DT
46745	5842	4	best	good	JJS
46745	5842	5	and	and	CC
46745	5842	6	safest	safe	JJS
46745	5842	7	of	of	IN
46745	5842	8	all	all	DT
46745	5842	9	Astringents	astringent	NNS
46745	5842	10	for	for	IN
46745	5842	11	internal	internal	JJ
46745	5842	12	use	use	NN
46745	5842	13	,	,	,
46745	5842	14	excepting	except	VBG
46745	5842	15	only	only	JJ
46745	5842	16	Gallic	gallic	JJ
46745	5842	17	acid	acid	NN
46745	5842	18	.	.	.
46745	5843	1	I	-PRON-	PRP
46745	5843	2	have	have	VBP
46745	5843	3	already	already	RB
46745	5843	4	stated	state	VBN
46745	5843	5	as	as	IN
46745	5843	6	worthy	worthy	JJ
46745	5843	7	of	of	IN
46745	5843	8	remark	remark	NN
46745	5843	9	the	the	DT
46745	5843	10	fact	fact	NN
46745	5843	11	that	that	IN
46745	5843	12	Gallic	gallic	JJ
46745	5843	13	acid	acid	NN
46745	5843	14	is	be	VBZ
46745	5843	15	of	of	IN
46745	5843	16	little	little	JJ
46745	5843	17	or	or	CC
46745	5843	18	no	no	DT
46745	5843	19	use	use	NN
46745	5843	20	as	as	IN
46745	5843	21	an	an	DT
46745	5843	22	Astringent	Astringent	NNP
46745	5843	23	when	when	WRB
46745	5843	24	applied	apply	VBD
46745	5843	25	to	to	IN
46745	5843	26	external	external	JJ
46745	5843	27	parts	part	NNS
46745	5843	28	.	.	.
46745	5844	1	Given	give	VBN
46745	5844	2	internally	internally	RB
46745	5844	3	,	,	,
46745	5844	4	it	-PRON-	PRP
46745	5844	5	is	be	VBZ
46745	5844	6	very	very	RB
46745	5844	7	efficacious	efficacious	JJ
46745	5844	8	.	.	.
46745	5845	1	From	from	IN
46745	5845	2	this	this	DT
46745	5845	3	alone	alone	JJ
46745	5845	4	it	-PRON-	PRP
46745	5845	5	would	would	MD
46745	5845	6	seem	seem	VB
46745	5845	7	that	that	IN
46745	5845	8	there	there	EX
46745	5845	9	must	must	MD
46745	5845	10	be	be	VB
46745	5845	11	something	something	NN
46745	5845	12	in	in	IN
46745	5845	13	the	the	DT
46745	5845	14	blood	blood	NN
46745	5845	15	which	which	WDT
46745	5845	16	enables	enable	VBZ
46745	5845	17	it	-PRON-	PRP
46745	5845	18	to	to	TO
46745	5845	19	take	take	VB
46745	5845	20	effect	effect	NN
46745	5845	21	.	.	.
46745	5846	1	Reasons	reason	NNS
46745	5846	2	have	have	VBP
46745	5846	3	also	also	RB
46745	5846	4	been	be	VBN
46745	5846	5	alleged	allege	VBN
46745	5846	6	for	for	IN
46745	5846	7	supposing	suppose	VBG
46745	5846	8	that	that	DT
46745	5846	9	Tannic	tannic	JJ
46745	5846	10	acid	acid	NN
46745	5846	11	is	be	VBZ
46745	5846	12	not	not	RB
46745	5846	13	a	a	DT
46745	5846	14	simple	simple	JJ
46745	5846	15	substance	substance	NN
46745	5846	16	.	.	.
46745	5847	1	When	when	WRB
46745	5847	2	it	-PRON-	PRP
46745	5847	3	is	be	VBZ
46745	5847	4	taken	take	VBN
46745	5847	5	into	into	IN
46745	5847	6	the	the	DT
46745	5847	7	system	system	NN
46745	5847	8	,	,	,
46745	5847	9	Gallic	gallic	JJ
46745	5847	10	acid	acid	NN
46745	5847	11	is	be	VBZ
46745	5847	12	secreted	secrete	VBN
46745	5847	13	in	in	IN
46745	5847	14	the	the	DT
46745	5847	15	urine	urine	NN
46745	5847	16	;	;	:
46745	5847	17	and	and	CC
46745	5847	18	it	-PRON-	PRP
46745	5847	19	appears	appear	VBZ
46745	5847	20	that	that	IN
46745	5847	21	Tannic	Tannic	NNP
46745	5847	22	must	must	MD
46745	5847	23	actually	actually	RB
46745	5847	24	consist	consist	VB
46745	5847	25	of	of	IN
46745	5847	26	Gallic	gallic	JJ
46745	5847	27	acid	acid	NN
46745	5847	28	combined	combine	VBN
46745	5847	29	with	with	IN
46745	5847	30	certain	certain	JJ
46745	5847	31	other	other	JJ
46745	5847	32	elements	element	NNS
46745	5847	33	,	,	,
46745	5847	34	or	or	CC
46745	5847	35	with	with	IN
46745	5847	36	some	some	DT
46745	5847	37	other	other	JJ
46745	5847	38	definite	definite	JJ
46745	5847	39	substance	substance	NN
46745	5847	40	;	;	:
46745	5847	41	and	and	CC
46745	5847	42	that	that	IN
46745	5847	43	the	the	DT
46745	5847	44	astringent	astringent	JJ
46745	5847	45	property	property	NN
46745	5847	46	which	which	WDT
46745	5847	47	is	be	VBZ
46745	5847	48	so	so	RB
46745	5847	49	valuable	valuable	JJ
46745	5847	50	is	be	VBZ
46745	5847	51	confined	confine	VBN
46745	5847	52	to	to	IN
46745	5847	53	the	the	DT
46745	5847	54	compound	compound	NN
46745	5847	55	body	body	NN
46745	5847	56	thus	thus	RB
46745	5847	57	produced	produce	VBD
46745	5847	58	.	.	.
46745	5848	1	Gallic	gallic	JJ
46745	5848	2	acid	acid	NN
46745	5848	3	alone	alone	RB
46745	5848	4	has	have	VBZ
46745	5848	5	not	not	RB
46745	5848	6	the	the	DT
46745	5848	7	power	power	NN
46745	5848	8	of	of	IN
46745	5848	9	precipitating	precipitate	VBG
46745	5848	10	albumen	albuman	NNS
46745	5848	11	.	.	.
46745	5849	1	What	what	WP
46745	5849	2	then	then	RB
46745	5849	3	is	be	VBZ
46745	5849	4	this	this	DT
46745	5849	5	other	other	JJ
46745	5849	6	substance	substance	NN
46745	5849	7	?	?	.
46745	5850	1	It	-PRON-	PRP
46745	5850	2	must	must	MD
46745	5850	3	be	be	VB
46745	5850	4	something	something	NN
46745	5850	5	which	which	WDT
46745	5850	6	is	be	VBZ
46745	5850	7	contained	contain	VBN
46745	5850	8	in	in	IN
46745	5850	9	or	or	CC
46745	5850	10	formed	form	VBN
46745	5850	11	in	in	IN
46745	5850	12	the	the	DT
46745	5850	13	blood	blood	NN
46745	5850	14	,	,	,
46745	5850	15	which	which	WDT
46745	5850	16	added	add	VBD
46745	5850	17	to	to	IN
46745	5850	18	Gallic	Gallic	NNP
46745	5850	19	,	,	,
46745	5850	20	will	will	MD
46745	5850	21	be	be	VB
46745	5850	22	capable	capable	JJ
46745	5850	23	of	of	IN
46745	5850	24	forming	form	VBG
46745	5850	25	Tannic	tannic	JJ
46745	5850	26	acid	acid	NN
46745	5850	27	;	;	:
46745	5850	28	and	and	CC
46745	5850	29	which	which	WDT
46745	5850	30	,	,	,
46745	5850	31	when	when	WRB
46745	5850	32	united	united	JJ
46745	5850	33	to	to	IN
46745	5850	34	it	-PRON-	PRP
46745	5850	35	,	,	,
46745	5850	36	will	will	MD
46745	5850	37	enable	enable	VB
46745	5850	38	Gallic	Gallic	NNP
46745	5850	39	acid	acid	NN
46745	5850	40	to	to	TO
46745	5850	41	precipitate	precipitate	VB
46745	5850	42	Albumen	Albumen	NNP
46745	5850	43	.	.	.
46745	5851	1	These	these	DT
46745	5851	2	various	various	JJ
46745	5851	3	requirements	requirement	NNS
46745	5851	4	are	be	VBP
46745	5851	5	fulfilled	fulfil	VBN
46745	5851	6	by	by	IN
46745	5851	7	the	the	DT
46745	5851	8	group	group	NN
46745	5851	9	of	of	IN
46745	5851	10	elements	element	NNS
46745	5851	11	that	that	WDT
46745	5851	12	constitutes	constitute	VBZ
46745	5851	13	grape	grape	NN
46745	5851	14	-	-	HYPH
46745	5851	15	sugar	sugar	NN
46745	5851	16	(	(	-LRB-
46745	5851	17	C_{12}H_{12}O_{12	C_{12}H_{12}O_{12	NNP
46745	5851	18	}	}	-RRB-
46745	5851	19	.	.	.
46745	5851	20	)	)	-RRB-
46745	5852	1	This	this	DT
46745	5852	2	compound	compound	NN
46745	5852	3	is	be	VBZ
46745	5852	4	continually	continually	RB
46745	5852	5	forming	form	VBG
46745	5852	6	in	in	IN
46745	5852	7	the	the	DT
46745	5852	8	blood	blood	NN
46745	5852	9	during	during	IN
46745	5852	10	the	the	DT
46745	5852	11	blood	blood	NN
46745	5852	12	-	-	HYPH
46745	5852	13	processes	process	NNS
46745	5852	14	that	that	WDT
46745	5852	15	are	be	VBP
46745	5852	16	connected	connect	VBN
46745	5852	17	with	with	IN
46745	5852	18	respiration	respiration	NN
46745	5852	19	.	.	.
46745	5853	1	It	-PRON-	PRP
46745	5853	2	has	have	VBZ
46745	5853	3	been	be	VBN
46745	5853	4	observed	observe	VBN
46745	5853	5	that	that	IN
46745	5853	6	a	a	DT
46745	5853	7	solution	solution	NN
46745	5853	8	of	of	IN
46745	5853	9	gum	gum	NN
46745	5853	10	(	(	-LRB-
46745	5853	11	C_{12}H_{11}O_{11	C_{12}H_{11}O_{11	NNP
46745	5853	12	}	}	-RRB-
46745	5853	13	,	,	,
46745	5853	14	)	)	-RRB-
46745	5853	15	added	add	VBD
46745	5853	16	to	to	IN
46745	5853	17	one	one	CD
46745	5853	18	of	of	IN
46745	5853	19	Gallic	Gallic	NNP
46745	5853	20	acid	acid	NN
46745	5853	21	,	,	,
46745	5853	22	will	will	MD
46745	5853	23	enable	enable	VB
46745	5853	24	the	the	DT
46745	5853	25	latter	latter	JJ
46745	5853	26	to	to	TO
46745	5853	27	coagulate	coagulate	VB
46745	5853	28	Albumen	Albumen	NNP
46745	5853	29	.	.	.
46745	5854	1	And	and	CC
46745	5854	2	the	the	DT
46745	5854	3	elements	element	NNS
46745	5854	4	of	of	IN
46745	5854	5	Tannic	tannic	JJ
46745	5854	6	acid	acid	NN
46745	5854	7	may	may	MD
46745	5854	8	be	be	VB
46745	5854	9	constructed	construct	VBN
46745	5854	10	out	out	IN
46745	5854	11	of	of	IN
46745	5854	12	those	those	DT
46745	5854	13	of	of	IN
46745	5854	14	Gallic	Gallic	NNP
46745	5854	15	acid	acid	NN
46745	5854	16	and	and	CC
46745	5854	17	grape	grape	NN
46745	5854	18	-	-	HYPH
46745	5854	19	sugar	sugar	NN
46745	5854	20	.	.	.
46745	5855	1	Tannic	tannic	JJ
46745	5855	2	acid	acid	NN
46745	5855	3	=	=	SYM
46745	5855	4	C_{18}H_{6}O_{10	c_{18}h_{6}o_{10	NN
46745	5855	5	}	}	-RRB-
46745	5855	6	+	+	CC
46745	5855	7	2	2	CD
46745	5855	8	aq	aq	NNP
46745	5855	9	.	.	.
46745	5856	1	Gallic	gallic	JJ
46745	5856	2	acid	acid	NN
46745	5856	3	=	=	SYM
46745	5856	4	C_{7}HO_{3	c_{7}ho_{3	NN
46745	5856	5	}	}	-RRB-
46745	5856	6	+	+	CC
46745	5856	7	2	2	CD
46745	5856	8	aq	aq	NNP
46745	5856	9	.	.	.
46745	5857	1	Three	three	CD
46745	5857	2	equivalents	equivalent	NNS
46745	5857	3	of	of	IN
46745	5857	4	anhydrous	anhydrous	JJ
46745	5857	5	Tannic	tannic	JJ
46745	5857	6	acid	acid	NN
46745	5857	7	amount	amount	NN
46745	5857	8	to	to	IN
46745	5857	9	six	six	CD
46745	5857	10	of	of	IN
46745	5857	11	Gallic	gallic	JJ
46745	5857	12	acid	acid	NN
46745	5857	13	and	and	CC
46745	5857	14	one	one	CD
46745	5857	15	of	of	IN
46745	5857	16	grape	grape	NN
46745	5857	17	-	-	HYPH
46745	5857	18	sugar	sugar	NN
46745	5857	19	.	.	.
46745	5858	1	3(C_{18}H_{6}O_{10	3(C_{18}H_{6}O_{10	NNP
46745	5858	2	}	}	-RRB-
46745	5858	3	)	)	-RRB-
46745	5858	4	=	=	NFP
46745	5858	5	6(C_{7}HO_{3	6(c_{7}ho_{3	NN
46745	5858	6	}	}	-RRB-
46745	5858	7	)	)	-RRB-
46745	5858	8	+	+	NFP
46745	5858	9	C_{12}H_{12}O_{12	C_{12}H_{12}O_{12	NNP
46745	5858	10	}	}	-RRB-
46745	5858	11	.	.	.
46745	5859	1	So	so	RB
46745	5859	2	that	that	IN
46745	5859	3	it	-PRON-	PRP
46745	5859	4	is	be	VBZ
46745	5859	5	very	very	RB
46745	5859	6	probable	probable	JJ
46745	5859	7	that	that	IN
46745	5859	8	when	when	WRB
46745	5859	9	Gallic	gallic	JJ
46745	5859	10	acid	acid	NN
46745	5859	11	is	be	VBZ
46745	5859	12	taken	take	VBN
46745	5859	13	into	into	IN
46745	5859	14	the	the	DT
46745	5859	15	blood	blood	NN
46745	5859	16	,	,	,
46745	5859	17	it	-PRON-	PRP
46745	5859	18	acts	act	VBZ
46745	5859	19	as	as	IN
46745	5859	20	an	an	DT
46745	5859	21	Astringent	Astringent	NNP
46745	5859	22	by	by	IN
46745	5859	23	co	co	NN
46745	5859	24	-	-	NN
46745	5859	25	operating	operate	VBG
46745	5859	26	or	or	CC
46745	5859	27	uniting	unite	VBG
46745	5859	28	with	with	IN
46745	5859	29	the	the	DT
46745	5859	30	elements	element	NNS
46745	5859	31	of	of	IN
46745	5859	32	grape	grape	NN
46745	5859	33	-	-	HYPH
46745	5859	34	sugar	sugar	NN
46745	5859	35	in	in	IN
46745	5859	36	that	that	DT
46745	5859	37	fluid	fluid	NN
46745	5859	38	.	.	.
46745	5860	1	But	but	CC
46745	5860	2	when	when	WRB
46745	5860	3	Tannic	tannic	JJ
46745	5860	4	acid	acid	NN
46745	5860	5	is	be	VBZ
46745	5860	6	received	receive	VBN
46745	5860	7	into	into	IN
46745	5860	8	the	the	DT
46745	5860	9	organism	organism	NN
46745	5860	10	,	,	,
46745	5860	11	and	and	CC
46745	5860	12	has	have	VBZ
46745	5860	13	done	do	VBN
46745	5860	14	its	-PRON-	PRP$
46745	5860	15	work	work	NN
46745	5860	16	there	there	RB
46745	5860	17	,	,	,
46745	5860	18	it	-PRON-	PRP
46745	5860	19	is	be	VBZ
46745	5860	20	finally	finally	RB
46745	5860	21	decomposed	decompose	VBN
46745	5860	22	,	,	,
46745	5860	23	Gallic	Gallic	NNP
46745	5860	24	acid	acid	NN
46745	5860	25	passing	pass	VBG
46745	5860	26	out	out	RP
46745	5860	27	into	into	IN
46745	5860	28	the	the	DT
46745	5860	29	secretions	secretion	NNS
46745	5860	30	,	,	,
46745	5860	31	and	and	CC
46745	5860	32	the	the	DT
46745	5860	33	sugar	sugar	NN
46745	5860	34	being	be	VBG
46745	5860	35	retained	retain	VBN
46745	5860	36	in	in	IN
46745	5860	37	the	the	DT
46745	5860	38	body	body	NN
46745	5860	39	for	for	IN
46745	5860	40	combustion	combustion	NN
46745	5860	41	into	into	IN
46745	5860	42	carbonic	carbonic	JJ
46745	5860	43	acid	acid	NN
46745	5860	44	and	and	CC
46745	5860	45	water	water	NN
46745	5860	46	.	.	.
46745	5861	1	(	(	-LRB-
46745	5861	2	p.	p.	NN
46745	5862	1	116	116	CD
46745	5862	2	.	.	.
46745	5862	3	)	)	-RRB-
46745	5863	1	The	the	DT
46745	5863	2	principal	principal	JJ
46745	5863	3	vegetable	vegetable	NN
46745	5863	4	substances	substance	NNS
46745	5863	5	that	that	WDT
46745	5863	6	are	be	VBP
46745	5863	7	employed	employ	VBN
46745	5863	8	as	as	IN
46745	5863	9	Astringents	astringent	NNS
46745	5863	10	are	be	VBP
46745	5863	11	said	say	VBN
46745	5863	12	to	to	TO
46745	5863	13	contain	contain	VB
46745	5863	14	Tannic	tannic	JJ
46745	5863	15	acid	acid	NN
46745	5863	16	in	in	IN
46745	5863	17	the	the	DT
46745	5863	18	following	follow	VBG
46745	5863	19	proportions:--	proportions:--	NNP
46745	5863	20	Kino	Kino	NNP
46745	5863	21	70	70	CD
46745	5863	22	per	per	IN
46745	5863	23	cent	cent	NN
46745	5863	24	.	.	.
46745	5864	1	Krameria	Krameria	NNP
46745	5864	2	43	43	CD
46745	5864	3	"	"	``
46745	5864	4	Catechu	Catechu	NNP
46745	5864	5	40	40	CD
46745	5864	6	"	"	``
46745	5864	7	Uvæ	Uvæ	NNP
46745	5864	8	Ursi	Ursi	NNP
46745	5864	9	36	36	CD
46745	5864	10	"	"	``
46745	5864	11	Oak	Oak	NNP
46745	5864	12	-	-	HYPH
46745	5864	13	galls	gall	VBZ
46745	5864	14	26	26	CD
46745	5864	15	"	"	``
46745	5864	16	Pomegranate	Pomegranate	NNP
46745	5864	17	-	-	HYPH
46745	5864	18	bark	bark	NN
46745	5864	19	19	19	CD
46745	5864	20	"	"	``
46745	5864	21	Tormentil	Tormentil	NNP
46745	5864	22	18	18	CD
46745	5864	23	"	"	``
46745	5864	24	Oak	Oak	NNP
46745	5864	25	-	-	HYPH
46745	5864	26	bark	bark	NNP
46745	5864	27	16	16	CD
46745	5864	28	"	"	``
46745	5864	29	These	these	DT
46745	5864	30	numbers	number	NNS
46745	5864	31	are	be	VBP
46745	5864	32	a	a	DT
46745	5864	33	tolerably	tolerably	RB
46745	5864	34	fair	fair	JJ
46745	5864	35	measure	measure	NN
46745	5864	36	of	of	IN
46745	5864	37	the	the	DT
46745	5864	38	astringent	astringent	JJ
46745	5864	39	power	power	NN
46745	5864	40	of	of	IN
46745	5864	41	the	the	DT
46745	5864	42	substances	substance	NNS
46745	5864	43	named	name	VBN
46745	5864	44	.	.	.
46745	5865	1	But	but	CC
46745	5865	2	it	-PRON-	PRP
46745	5865	3	must	must	MD
46745	5865	4	not	not	RB
46745	5865	5	be	be	VB
46745	5865	6	supposed	suppose	VBN
46745	5865	7	that	that	IN
46745	5865	8	the	the	DT
46745	5865	9	astringent	astringent	JJ
46745	5865	10	principle	principle	NN
46745	5865	11	is	be	VBZ
46745	5865	12	in	in	IN
46745	5865	13	all	all	DT
46745	5865	14	cases	case	NNS
46745	5865	15	strictly	strictly	RB
46745	5865	16	identical	identical	JJ
46745	5865	17	with	with	IN
46745	5865	18	Tannic	tannic	JJ
46745	5865	19	acid	acid	NN
46745	5865	20	,	,	,
46745	5865	21	properly	properly	RB
46745	5865	22	so	so	RB
46745	5865	23	called	call	VBN
46745	5865	24	;	;	:
46745	5865	25	for	for	CC
46745	5865	26	there	there	EX
46745	5865	27	appear	appear	VB
46745	5865	28	to	to	TO
46745	5865	29	be	be	VB
46745	5865	30	various	various	JJ
46745	5865	31	modifications	modification	NNS
46745	5865	32	of	of	IN
46745	5865	33	this	this	DT
46745	5865	34	substance	substance	NN
46745	5865	35	contained	contain	VBN
46745	5865	36	in	in	IN
46745	5865	37	the	the	DT
46745	5865	38	different	different	JJ
46745	5865	39	plants	plant	NNS
46745	5865	40	,	,	,
46745	5865	41	many	many	JJ
46745	5865	42	of	of	IN
46745	5865	43	which	which	WDT
46745	5865	44	have	have	VBP
46745	5865	45	peculiar	peculiar	JJ
46745	5865	46	chemical	chemical	JJ
46745	5865	47	characters	character	NNS
46745	5865	48	of	of	IN
46745	5865	49	their	-PRON-	PRP$
46745	5865	50	own	own	JJ
46745	5865	51	,	,	,
46745	5865	52	but	but	CC
46745	5865	53	all	all	DT
46745	5865	54	of	of	IN
46745	5865	55	which	which	WDT
46745	5865	56	agree	agree	VBP
46745	5865	57	in	in	IN
46745	5865	58	possessing	possess	VBG
46745	5865	59	the	the	DT
46745	5865	60	power	power	NN
46745	5865	61	of	of	IN
46745	5865	62	tanning	tanning	NN
46745	5865	63	,	,	,
46745	5865	64	or	or	CC
46745	5865	65	combining	combine	VBG
46745	5865	66	with	with	IN
46745	5865	67	animal	animal	NN
46745	5865	68	gelatine	gelatine	NN
46745	5865	69	,	,	,
46745	5865	70	and	and	CC
46745	5865	71	in	in	IN
46745	5865	72	the	the	DT
46745	5865	73	medicinal	medicinal	JJ
46745	5865	74	property	property	NN
46745	5865	75	of	of	IN
46745	5865	76	astringency	astringency	NN
46745	5865	77	.	.	.
46745	5866	1	GENERAL	GENERAL	NNP
46745	5866	2	INDEX	INDEX	NNP
46745	5866	3	.	.	.
46745	5867	1	Absorption	absorption	NN
46745	5867	2	,	,	,
46745	5867	3	action	action	NN
46745	5867	4	of	of	IN
46745	5867	5	medicines	medicine	NNS
46745	5867	6	by	by	IN
46745	5867	7	,	,	,
46745	5867	8	61	61	CD
46745	5867	9	,	,	,
46745	5867	10	68	68	CD
46745	5867	11	,	,	,
46745	5867	12	87	87	CD
46745	5867	13	.	.	.
46745	5868	1	Acids	acid	NNS
46745	5868	2	,	,	,
46745	5868	3	120	120	CD
46745	5868	4	.	.	.
46745	5869	1	Aconite	Aconite	NNP
46745	5869	2	,	,	,
46745	5869	3	352	352	CD
46745	5869	4	.	.	.
46745	5870	1	Aconitina	Aconitina	NNP
46745	5870	2	,	,	,
46745	5870	3	symptoms	symptom	NNS
46745	5870	4	of	of	IN
46745	5870	5	action	action	NN
46745	5870	6	of	of	IN
46745	5870	7	,	,	,
46745	5870	8	353	353	CD
46745	5870	9	.	.	.
46745	5871	1	Ague	Ague	NNP
46745	5871	2	,	,	,
46745	5871	3	remedies	remedy	NNS
46745	5871	4	used	use	VBN
46745	5871	5	for	for	IN
46745	5871	6	,	,	,
46745	5871	7	129	129	CD
46745	5871	8	,	,	,
46745	5871	9	207	207	CD
46745	5871	10	.	.	.
46745	5872	1	Alcohol	Alcohol	NNP
46745	5872	2	,	,	,
46745	5872	3	339	339	CD
46745	5872	4	.	.	.
46745	5873	1	Aliments	aliment	NNS
46745	5873	2	,	,	,
46745	5873	3	115	115	CD
46745	5873	4	.	.	.
46745	5874	1	Alkalies	alkali	NNS
46745	5874	2	,	,	,
46745	5874	3	126	126	CD
46745	5874	4	.	.	.
46745	5875	1	Aloes	aloe	NNS
46745	5875	2	,	,	,
46745	5875	3	absorption	absorption	NN
46745	5875	4	and	and	CC
46745	5875	5	action	action	NN
46745	5875	6	of	of	IN
46745	5875	7	,	,	,
46745	5875	8	80	80	CD
46745	5875	9	,	,	,
46745	5875	10	96	96	CD
46745	5875	11	,	,	,
46745	5875	12	289	289	CD
46745	5875	13	.	.	.
46745	5876	1	Alteratives	alterative	NNS
46745	5876	2	,	,	,
46745	5876	3	35	35	CD
46745	5876	4	,	,	,
46745	5876	5	157	157	CD
46745	5876	6	,	,	,
46745	5876	7	165	165	CD
46745	5876	8	.	.	.
46745	5877	1	Alum	Alum	NNP
46745	5877	2	,	,	,
46745	5877	3	as	as	IN
46745	5877	4	an	an	DT
46745	5877	5	Astringent	Astringent	NNP
46745	5877	6	,	,	,
46745	5877	7	263	263	CD
46745	5877	8	.	.	.
46745	5878	1	Ammonia	Ammonia	NNP
46745	5878	2	,	,	,
46745	5878	3	334	334	CD
46745	5878	4	.	.	.
46745	5879	1	Anæmia	anæmia	NN
46745	5879	2	,	,	,
46745	5879	3	treatment	treatment	NN
46745	5879	4	of	of	IN
46745	5879	5	,	,	,
46745	5879	6	148	148	CD
46745	5879	7	,	,	,
46745	5879	8	320	320	CD
46745	5879	9	.	.	.
46745	5880	1	Anthelmintics	anthelmintic	NNS
46745	5880	2	,	,	,
46745	5880	3	97	97	CD
46745	5880	4	.	.	.
46745	5881	1	Antidotes	antidote	NNS
46745	5881	2	,	,	,
46745	5881	3	action	action	NN
46745	5881	4	of	of	IN
46745	5881	5	,	,	,
46745	5881	6	92	92	CD
46745	5881	7	.	.	.
46745	5882	1	Antimony	Antimony	NNP
46745	5882	2	,	,	,
46745	5882	3	321	321	CD
46745	5882	4	.	.	.
46745	5883	1	Arsenic	Arsenic	NNP
46745	5883	2	,	,	,
46745	5883	3	333	333	CD
46745	5883	4	.	.	.
46745	5884	1	Astringents	astringent	NNS
46745	5884	2	,	,	,
46745	5884	3	256	256	CD
46745	5884	4	,	,	,
46745	5884	5	358	358	CD
46745	5884	6	.	.	.
46745	5885	1	Belladonna	Belladonna	NNP
46745	5885	2	,	,	,
46745	5885	3	240	240	CD
46745	5885	4	.	.	.
46745	5886	1	Benzoic	benzoic	JJ
46745	5886	2	acid	acid	NN
46745	5886	3	in	in	IN
46745	5886	4	lithic	lithic	JJ
46745	5886	5	deposits	deposit	NNS
46745	5886	6	,	,	,
46745	5886	7	156	156	CD
46745	5886	8	.	.	.
46745	5887	1	Bile	bile	NN
46745	5887	2	,	,	,
46745	5887	3	relation	relation	NN
46745	5887	4	of	of	IN
46745	5887	5	remedies	remedy	NNS
46745	5887	6	to	to	IN
46745	5887	7	the	the	DT
46745	5887	8	,	,	,
46745	5887	9	137	137	CD
46745	5887	10	.	.	.
46745	5888	1	Billing	Billing	NNP
46745	5888	2	,	,	,
46745	5888	3	Dr.	Dr.	NNP
46745	5888	4	,	,	,
46745	5888	5	on	on	IN
46745	5888	6	action	action	NN
46745	5888	7	of	of	IN
46745	5888	8	medicines	medicine	NNS
46745	5888	9	,	,	,
46745	5888	10	132	132	CD
46745	5888	11	,	,	,
46745	5888	12	163	163	CD
46745	5888	13	,	,	,
46745	5888	14	216	216	CD
46745	5888	15	.	.	.
46745	5889	1	Bismuth	Bismuth	NNP
46745	5889	2	,	,	,
46745	5889	3	nitrate	nitrate	JJ
46745	5889	4	of	of	IN
46745	5889	5	,	,	,
46745	5889	6	87	87	CD
46745	5889	7	,	,	,
46745	5889	8	94	94	CD
46745	5889	9	,	,	,
46745	5889	10	97	97	CD
46745	5889	11	.	.	.
46745	5890	1	Blood	blood	NN
46745	5890	2	,	,	,
46745	5890	3	medicinal	medicinal	JJ
46745	5890	4	actions	action	NNS
46745	5890	5	in	in	IN
46745	5890	6	the	the	DT
46745	5890	7	,	,	,
46745	5890	8	103	103	CD
46745	5890	9	,	,	,
46745	5890	10	106	106	CD
46745	5890	11	,	,	,
46745	5890	12	167	167	CD
46745	5890	13	.	.	.
46745	5891	1	Borax	Borax	NNS
46745	5891	2	,	,	,
46745	5891	3	actions	action	NNS
46745	5891	4	of	of	IN
46745	5891	5	,	,	,
46745	5891	6	155	155	CD
46745	5891	7	,	,	,
46745	5891	8	232	232	CD
46745	5891	9	.	.	.
46745	5892	1	Brodie	Brodie	NNP
46745	5892	2	,	,	,
46745	5892	3	Sir	Sir	NNP
46745	5892	4	B.	B.	NNP
46745	5892	5	,	,	,
46745	5892	6	his	-PRON-	PRP$
46745	5892	7	experiments	experiment	NNS
46745	5892	8	,	,	,
46745	5892	9	63	63	CD
46745	5892	10	.	.	.
46745	5893	1	Calomel	Calomel	NNP
46745	5893	2	,	,	,
46745	5893	3	not	not	RB
46745	5893	4	a	a	DT
46745	5893	5	sedative	sedative	NN
46745	5893	6	,	,	,
46745	5893	7	328	328	CD
46745	5893	8	.	.	.
46745	5894	1	Cantharides	cantharide	NNS
46745	5894	2	,	,	,
46745	5894	3	its	-PRON-	PRP$
46745	5894	4	uses	use	NNS
46745	5894	5	,	,	,
46745	5894	6	67	67	CD
46745	5894	7	,	,	,
46745	5894	8	214	214	CD
46745	5894	9	,	,	,
46745	5894	10	307	307	CD
46745	5894	11	.	.	.
46745	5895	1	Castor	castor	NN
46745	5895	2	oil	oil	NN
46745	5895	3	,	,	,
46745	5895	4	291	291	CD
46745	5895	5	.	.	.
46745	5896	1	Catechu	Catechu	NNP
46745	5896	2	,	,	,
46745	5896	3	358	358	CD
46745	5896	4	.	.	.
46745	5897	1	Cathartics	Cathartics	NNP
46745	5897	2	,	,	,
46745	5897	3	95	95	CD
46745	5897	4	,	,	,
46745	5897	5	286	286	CD
46745	5897	6	.	.	.
46745	5898	1	Chalk	chalk	VB
46745	5898	2	,	,	,
46745	5898	3	not	not	RB
46745	5898	4	astringent	astringent	JJ
46745	5898	5	,	,	,
46745	5898	6	264	264	CD
46745	5898	7	.	.	.
46745	5899	1	Charcoal	Charcoal	NNP
46745	5899	2	,	,	,
46745	5899	3	said	say	VBD
46745	5899	4	to	to	TO
46745	5899	5	become	become	VB
46745	5899	6	absorbed	absorb	VBN
46745	5899	7	,	,	,
46745	5899	8	88	88	CD
46745	5899	9	.	.	.
46745	5900	1	Chemical	chemical	JJ
46745	5900	2	theories	theory	NNS
46745	5900	3	of	of	IN
46745	5900	4	medicinal	medicinal	JJ
46745	5900	5	actions	action	NNS
46745	5900	6	,	,	,
46745	5900	7	47	47	CD
46745	5900	8	.	.	.
46745	5901	1	Chlorine	Chlorine	NNP
46745	5901	2	,	,	,
46745	5901	3	an	an	DT
46745	5901	4	Antiscrofulic	Antiscrofulic	NNP
46745	5901	5	,	,	,
46745	5901	6	193	193	CD
46745	5901	7	.	.	.
46745	5902	1	Chloroform	chloroform	NN
46745	5902	2	,	,	,
46745	5902	3	342	342	CD
46745	5902	4	.	.	.
46745	5903	1	Cholagogues	cholagogue	NNS
46745	5903	2	,	,	,
46745	5903	3	295	295	CD
46745	5903	4	.	.	.
46745	5904	1	Cinchona	Cinchona	NNP
46745	5904	2	,	,	,
46745	5904	3	129	129	CD
46745	5904	4	.	.	.
46745	5905	1	Citric	citric	JJ
46745	5905	2	acid	acid	NN
46745	5905	3	,	,	,
46745	5905	4	its	-PRON-	PRP$
46745	5905	5	actions	action	NNS
46745	5905	6	,	,	,
46745	5905	7	123	123	CD
46745	5905	8	,	,	,
46745	5905	9	202	202	CD
46745	5905	10	,	,	,
46745	5905	11	205	205	CD
46745	5905	12	.	.	.
46745	5906	1	Cod	cod	VB
46745	5906	2	-	-	HYPH
46745	5906	3	liver	liver	NN
46745	5906	4	oil	oil	NN
46745	5906	5	,	,	,
46745	5906	6	310	310	CD
46745	5906	7	.	.	.
46745	5907	1	Colchicum	Colchicum	NNP
46745	5907	2	,	,	,
46745	5907	3	331	331	CD
46745	5907	4	.	.	.
46745	5908	1	Conium	conium	NN
46745	5908	2	,	,	,
46745	5908	3	its	-PRON-	PRP$
46745	5908	4	actions	action	NNS
46745	5908	5	,	,	,
46745	5908	6	246	246	CD
46745	5908	7	.	.	.
46745	5909	1	Copaiba	Copaiba	NNP
46745	5909	2	,	,	,
46745	5909	3	action	action	NN
46745	5909	4	of	of	IN
46745	5909	5	,	,	,
46745	5909	6	267	267	CD
46745	5909	7	.	.	.
46745	5910	1	Copper	copper	NN
46745	5910	2	,	,	,
46745	5910	3	Sulphate	Sulphate	NNP
46745	5910	4	of	of	IN
46745	5910	5	,	,	,
46745	5910	6	93	93	CD
46745	5910	7	,	,	,
46745	5910	8	211	211	CD
46745	5910	9	,	,	,
46745	5910	10	264	264	CD
46745	5910	11	.	.	.
46745	5911	1	Counter	counter	NN
46745	5911	2	-	-	HYPH
46745	5911	3	irritants	irritant	NNS
46745	5911	4	,	,	,
46745	5911	5	action	action	NN
46745	5911	6	of	of	IN
46745	5911	7	,	,	,
46745	5911	8	67	67	CD
46745	5911	9	,	,	,
46745	5911	10	91	91	CD
46745	5911	11	.	.	.
46745	5912	1	Creosote	creosote	NN
46745	5912	2	,	,	,
46745	5912	3	actions	action	NNS
46745	5912	4	of	of	IN
46745	5912	5	,	,	,
46745	5912	6	94	94	CD
46745	5912	7	,	,	,
46745	5912	8	245	245	CD
46745	5912	9	,	,	,
46745	5912	10	265	265	CD
46745	5912	11	.	.	.
46745	5913	1	Diabetes	diabetes	NN
46745	5913	2	,	,	,
46745	5913	3	treatment	treatment	NN
46745	5913	4	of	of	IN
46745	5913	5	,	,	,
46745	5913	6	119	119	CD
46745	5913	7	,	,	,
46745	5913	8	194	194	CD
46745	5913	9	.	.	.
46745	5914	1	Diaphoretics	diaphoretic	NNS
46745	5914	2	,	,	,
46745	5914	3	298	298	CD
46745	5914	4	.	.	.
46745	5915	1	Diarrh[oe]a	Diarrh[oe]a	NNP
46745	5915	2	,	,	,
46745	5915	3	treatment	treatment	NN
46745	5915	4	of	of	IN
46745	5915	5	,	,	,
46745	5915	6	294	294	CD
46745	5915	7	.	.	.
46745	5916	1	Diet	Diet	NNP
46745	5916	2	,	,	,
46745	5916	3	rules	rule	NNS
46745	5916	4	of	of	IN
46745	5916	5	,	,	,
46745	5916	6	118	118	CD
46745	5916	7	.	.	.
46745	5917	1	Digestion	digestion	NN
46745	5917	2	of	of	IN
46745	5917	3	medicines	medicine	NNS
46745	5917	4	,	,	,
46745	5917	5	68	68	CD
46745	5917	6	-	-	SYM
46745	5917	7	86	86	CD
46745	5917	8	,	,	,
46745	5917	9	104	104	CD
46745	5917	10	.	.	.
46745	5918	1	Digitalis	Digitalis	NNP
46745	5918	2	,	,	,
46745	5918	3	364	364	CD
46745	5918	4	.	.	.
46745	5919	1	Diuretics	Diuretics	NNP
46745	5919	2	,	,	,
46745	5919	3	302	302	CD
46745	5919	4	.	.	.
46745	5920	1	Duncan	Duncan	NNP
46745	5920	2	,	,	,
46745	5920	3	Dr.	Dr.	NNP
46745	5920	4	,	,	,
46745	5920	5	his	-PRON-	PRP$
46745	5920	6	classification	classification	NN
46745	5920	7	,	,	,
46745	5920	8	34	34	CD
46745	5920	9	.	.	.
46745	5921	1	Dropsy	Dropsy	NNP
46745	5921	2	,	,	,
46745	5921	3	treatment	treatment	NN
46745	5921	4	of	of	IN
46745	5921	5	,	,	,
46745	5921	6	307	307	CD
46745	5921	7	,	,	,
46745	5921	8	355	355	CD
46745	5921	9	.	.	.
46745	5922	1	Eberle	Eberle	NNP
46745	5922	2	,	,	,
46745	5922	3	his	-PRON-	PRP$
46745	5922	4	arrangement	arrangement	NN
46745	5922	5	of	of	IN
46745	5922	6	medicines	medicine	NNS
46745	5922	7	,	,	,
46745	5922	8	39	39	CD
46745	5922	9	.	.	.
46745	5923	1	Elaterium	elaterium	NN
46745	5923	2	,	,	,
46745	5923	3	its	-PRON-	PRP$
46745	5923	4	modes	mode	NNS
46745	5923	5	of	of	IN
46745	5923	6	action	action	NN
46745	5923	7	,	,	,
46745	5923	8	85	85	CD
46745	5923	9	,	,	,
46745	5923	10	289	289	CD
46745	5923	11	.	.	.
46745	5924	1	Eliminatives	Eliminatives	NNP
46745	5924	2	,	,	,
46745	5924	3	268	268	CD
46745	5924	4	.	.	.
46745	5925	1	Emetics	emetic	NNS
46745	5925	2	,	,	,
46745	5925	3	92	92	CD
46745	5925	4	,	,	,
46745	5925	5	324	324	CD
46745	5925	6	.	.	.
46745	5926	1	Emmenagogues	emmenagogue	NNS
46745	5926	2	,	,	,
46745	5926	3	102	102	CD
46745	5926	4	,	,	,
46745	5926	5	275	275	CD
46745	5926	6	.	.	.
46745	5927	1	Endosmosis	endosmosis	NN
46745	5927	2	,	,	,
46745	5927	3	passage	passage	NN
46745	5927	4	of	of	IN
46745	5927	5	medicines	medicine	NNS
46745	5927	6	by	by	IN
46745	5927	7	,	,	,
46745	5927	8	71	71	CD
46745	5927	9	.	.	.
46745	5928	1	Epilepsy	Epilepsy	NNP
46745	5928	2	,	,	,
46745	5928	3	remedies	remedy	NNS
46745	5928	4	used	use	VBN
46745	5928	5	in	in	IN
46745	5928	6	,	,	,
46745	5928	7	211	211	CD
46745	5928	8	,	,	,
46745	5928	9	229	229	CD
46745	5928	10	,	,	,
46745	5928	11	337	337	CD
46745	5928	12	,	,	,
46745	5928	13	345	345	CD
46745	5928	14	.	.	.
46745	5929	1	Ergot	Ergot	NNP
46745	5929	2	of	of	IN
46745	5929	3	Rye	Rye	NNP
46745	5929	4	,	,	,
46745	5929	5	233	233	CD
46745	5929	6	.	.	.
46745	5930	1	Ether	ether	NN
46745	5930	2	,	,	,
46745	5930	3	343	343	CD
46745	5930	4	.	.	.
46745	5931	1	Evacuants	evacuant	NNS
46745	5931	2	,	,	,
46745	5931	3	action	action	NN
46745	5931	4	of	of	IN
46745	5931	5	,	,	,
46745	5931	6	55	55	CD
46745	5931	7	,	,	,
46745	5931	8	269	269	CD
46745	5931	9	,	,	,
46745	5931	10	280	280	CD
46745	5931	11	.	.	.
46745	5932	1	Expectorants	expectorant	NNS
46745	5932	2	,	,	,
46745	5932	3	283	283	CD
46745	5932	4	.	.	.
46745	5933	1	Fermentations	fermentation	NNS
46745	5933	2	in	in	IN
46745	5933	3	the	the	DT
46745	5933	4	blood	blood	NN
46745	5933	5	,	,	,
46745	5933	6	180	180	CD
46745	5933	7	.	.	.
46745	5934	1	Fevers	fever	NNS
46745	5934	2	,	,	,
46745	5934	3	treatment	treatment	NN
46745	5934	4	of	of	IN
46745	5934	5	,	,	,
46745	5934	6	124	124	CD
46745	5934	7	,	,	,
46745	5934	8	185	185	CD
46745	5934	9	,	,	,
46745	5934	10	188	188	CD
46745	5934	11	,	,	,
46745	5934	12	302	302	CD
46745	5934	13	.	.	.
46745	5935	1	Gallic	gallic	JJ
46745	5935	2	acid	acid	NN
46745	5935	3	,	,	,
46745	5935	4	265	265	CD
46745	5935	5	,	,	,
46745	5935	6	357	357	CD
46745	5935	7	.	.	.
46745	5936	1	Gold	gold	NN
46745	5936	2	,	,	,
46745	5936	3	its	-PRON-	PRP$
46745	5936	4	use	use	NN
46745	5936	5	in	in	IN
46745	5936	6	Syphilis	Syphilis	NNP
46745	5936	7	,	,	,
46745	5936	8	189	189	CD
46745	5936	9	.	.	.
46745	5937	1	Gout	gout	NN
46745	5937	2	,	,	,
46745	5937	3	treatment	treatment	NN
46745	5937	4	of	of	IN
46745	5937	5	,	,	,
46745	5937	6	194	194	CD
46745	5937	7	,	,	,
46745	5937	8	331	331	CD
46745	5937	9	.	.	.
46745	5938	1	Grape	grape	NN
46745	5938	2	-	-	HYPH
46745	5938	3	sugar	sugar	NN
46745	5938	4	in	in	IN
46745	5938	5	the	the	DT
46745	5938	6	blood	blood	NN
46745	5938	7	,	,	,
46745	5938	8	116	116	CD
46745	5938	9	,	,	,
46745	5938	10	198	198	CD
46745	5938	11	.	.	.
46745	5939	1	Hæmatosin	hæmatosin	NN
46745	5939	2	,	,	,
46745	5939	3	relation	relation	NN
46745	5939	4	of	of	IN
46745	5939	5	to	to	IN
46745	5939	6	Iron	Iron	NNP
46745	5939	7	,	,	,
46745	5939	8	145	145	CD
46745	5939	9	.	.	.
46745	5940	1	Hæmorrhage	hæmorrhage	NN
46745	5940	2	,	,	,
46745	5940	3	treatment	treatment	NN
46745	5940	4	of	of	IN
46745	5940	5	,	,	,
46745	5940	6	263	263	CD
46745	5940	7	.	.	.
46745	5941	1	Hom[oe]opathy	Hom[oe]opathy	NNP
46745	5941	2	,	,	,
46745	5941	3	fallacies	fallacy	NNS
46745	5941	4	of	of	IN
46745	5941	5	,	,	,
46745	5941	6	53	53	CD
46745	5941	7	,	,	,
46745	5941	8	184	184	CD
46745	5941	9	.	.	.
46745	5942	1	Hydrocyanic	hydrocyanic	JJ
46745	5942	2	acid	acid	NN
46745	5942	3	,	,	,
46745	5942	4	351	351	CD
46745	5942	5	.	.	.
46745	5943	1	Hyoscyamus	Hyoscyamus	NNP
46745	5943	2	,	,	,
46745	5943	3	240	240	CD
46745	5943	4	.	.	.
46745	5944	1	Hysteria	Hysteria	NNP
46745	5944	2	,	,	,
46745	5944	3	remedies	remedy	NNS
46745	5944	4	used	use	VBN
46745	5944	5	in	in	IN
46745	5944	6	,	,	,
46745	5944	7	211	211	CD
46745	5944	8	,	,	,
46745	5944	9	232	232	CD
46745	5944	10	,	,	,
46745	5944	11	337	337	CD
46745	5944	12	.	.	.
46745	5945	1	Inflammations	inflammation	NNS
46745	5945	2	,	,	,
46745	5945	3	treatment	treatment	NN
46745	5945	4	of	of	IN
46745	5945	5	,	,	,
46745	5945	6	185	185	CD
46745	5945	7	,	,	,
46745	5945	8	323	323	CD
46745	5945	9	,	,	,
46745	5945	10	325	325	CD
46745	5945	11	.	.	.
46745	5946	1	Iodide	iodide	NN
46745	5946	2	of	of	IN
46745	5946	3	Potassium	Potassium	NNP
46745	5946	4	,	,	,
46745	5946	5	188	188	CD
46745	5946	6	,	,	,
46745	5946	7	191	191	CD
46745	5946	8	,	,	,
46745	5946	9	328	328	CD
46745	5946	10	.	.	.
46745	5947	1	Iodine	Iodine	NNP
46745	5947	2	,	,	,
46745	5947	3	328	328	CD
46745	5947	4	.	.	.
46745	5948	1	Ipecacuanha	Ipecacuanha	NNP
46745	5948	2	,	,	,
46745	5948	3	actions	action	NNS
46745	5948	4	of	of	IN
46745	5948	5	,	,	,
46745	5948	6	249	249	CD
46745	5948	7	,	,	,
46745	5948	8	283	283	CD
46745	5948	9	,	,	,
46745	5948	10	295	295	CD
46745	5948	11	,	,	,
46745	5948	12	298	298	CD
46745	5948	13	.	.	.
46745	5949	1	Iron	iron	NN
46745	5949	2	,	,	,
46745	5949	3	145	145	CD
46745	5949	4	,	,	,
46745	5949	5	319	319	CD
46745	5949	6	.	.	.
46745	5950	1	Jalap	Jalap	NNP
46745	5950	2	,	,	,
46745	5950	3	absorption	absorption	NN
46745	5950	4	and	and	CC
46745	5950	5	action	action	NN
46745	5950	6	of	of	IN
46745	5950	7	,	,	,
46745	5950	8	85	85	CD
46745	5950	9	,	,	,
46745	5950	10	96	96	CD
46745	5950	11	,	,	,
46745	5950	12	289	289	CD
46745	5950	13	.	.	.
46745	5951	1	Lactic	lactic	JJ
46745	5951	2	acid	acid	NN
46745	5951	3	in	in	IN
46745	5951	4	the	the	DT
46745	5951	5	system	system	NN
46745	5951	6	,	,	,
46745	5951	7	69	69	CD
46745	5951	8	,	,	,
46745	5951	9	116	116	CD
46745	5951	10	,	,	,
46745	5951	11	198	198	CD
46745	5951	12	.	.	.
46745	5952	1	Laxatives	Laxatives	NNP
46745	5952	2	,	,	,
46745	5952	3	287	287	CD
46745	5952	4	.	.	.
46745	5953	1	Lead	lead	NN
46745	5953	2	,	,	,
46745	5953	3	actions	action	NNS
46745	5953	4	of	of	IN
46745	5953	5	,	,	,
46745	5953	6	211	211	CD
46745	5953	7	,	,	,
46745	5953	8	254	254	CD
46745	5953	9	,	,	,
46745	5953	10	263	263	CD
46745	5953	11	.	.	.
46745	5954	1	Lemon	lemon	NN
46745	5954	2	-	-	HYPH
46745	5954	3	juice	juice	NN
46745	5954	4	,	,	,
46745	5954	5	uses	use	VBZ
46745	5954	6	of	of	IN
46745	5954	7	,	,	,
46745	5954	8	202	202	CD
46745	5954	9	,	,	,
46745	5954	10	205	205	CD
46745	5954	11	.	.	.
46745	5955	1	Local	local	JJ
46745	5955	2	access	access	NN
46745	5955	3	,	,	,
46745	5955	4	rule	rule	NN
46745	5955	5	of	of	IN
46745	5955	6	,	,	,
46745	5955	7	98	98	CD
46745	5955	8	.	.	.
46745	5956	1	Magendie	Magendie	NNP
46745	5956	2	,	,	,
46745	5956	3	M.	M.	NNP
46745	5956	4	,	,	,
46745	5956	5	his	-PRON-	PRP$
46745	5956	6	experiments	experiment	NNS
46745	5956	7	,	,	,
46745	5956	8	63	63	CD
46745	5956	9	.	.	.
46745	5957	1	Masticatories	masticatorie	NNS
46745	5957	2	,	,	,
46745	5957	3	281	281	CD
46745	5957	4	.	.	.
46745	5958	1	Mechanical	mechanical	JJ
46745	5958	2	theories	theory	NNS
46745	5958	3	of	of	IN
46745	5958	4	medicinal	medicinal	JJ
46745	5958	5	actions	action	NNS
46745	5958	6	,	,	,
46745	5958	7	43	43	CD
46745	5958	8	,	,	,
46745	5958	9	219	219	CD
46745	5958	10	.	.	.
46745	5959	1	Mercury	Mercury	NNP
46745	5959	2	,	,	,
46745	5959	3	325	325	CD
46745	5959	4	.	.	.
46745	5960	1	Morphia	Morphia	NNP
46745	5960	2	,	,	,
46745	5960	3	modus	modus	NN
46745	5960	4	operandi	operandi	NNP
46745	5960	5	of	of	IN
46745	5960	6	,	,	,
46745	5960	7	220	220	CD
46745	5960	8	,	,	,
46745	5960	9	347	347	CD
46745	5960	10	.	.	.
46745	5961	1	Murray	Murray	NNP
46745	5961	2	,	,	,
46745	5961	3	Dr.	Dr.	NNP
46745	5961	4	,	,	,
46745	5961	5	his	-PRON-	PRP$
46745	5961	6	classification	classification	NN
46745	5961	7	,	,	,
46745	5961	8	36	36	CD
46745	5961	9	.	.	.
46745	5962	1	Narcotics	Narcotics	NNP
46745	5962	2	,	,	,
46745	5962	3	234	234	CD
46745	5962	4	.	.	.
46745	5963	1	Nitric	nitric	JJ
46745	5963	2	acid	acid	NN
46745	5963	3	,	,	,
46745	5963	4	its	-PRON-	PRP$
46745	5963	5	uses	use	NNS
46745	5963	6	,	,	,
46745	5963	7	120	120	CD
46745	5963	8	,	,	,
46745	5963	9	196	196	CD
46745	5963	10	.	.	.
46745	5964	1	Nitrohydrochloric	Nitrohydrochloric	NNP
46745	5964	2	acid	acid	NN
46745	5964	3	in	in	IN
46745	5964	4	Oxaluria	Oxaluria	NNP
46745	5964	5	,	,	,
46745	5964	6	196	196	CD
46745	5964	7	.	.	.
46745	5965	1	Nux	nux	NN
46745	5965	2	vomica	vomica	NNP
46745	5965	3	,	,	,
46745	5965	4	337	337	CD
46745	5965	5	.	.	.
46745	5966	1	[	[	-LRB-
46745	5966	2	OE]sterlen	OE]sterlen	NNP
46745	5966	3	,	,	,
46745	5966	4	Prof.	Prof.	NNP
46745	5966	5	,	,	,
46745	5966	6	on	on	IN
46745	5966	7	absorption	absorption	NN
46745	5966	8	of	of	IN
46745	5966	9	medicines	medicine	NNS
46745	5966	10	,	,	,
46745	5966	11	88	88	CD
46745	5966	12	.	.	.
46745	5967	1	Oils	oil	NNS
46745	5967	2	,	,	,
46745	5967	3	fixed	fix	VBN
46745	5967	4	,	,	,
46745	5967	5	absorption	absorption	NN
46745	5967	6	and	and	CC
46745	5967	7	action	action	NN
46745	5967	8	of	of	IN
46745	5967	9	,	,	,
46745	5967	10	84	84	CD
46745	5967	11	,	,	,
46745	5967	12	278	278	CD
46745	5967	13	,	,	,
46745	5967	14	288	288	CD
46745	5967	15	.	.	.
46745	5968	1	Oils	oil	NNS
46745	5968	2	,	,	,
46745	5968	3	volatile	volatile	JJ
46745	5968	4	,	,	,
46745	5968	5	their	-PRON-	PRP$
46745	5968	6	actions	action	NNS
46745	5968	7	,	,	,
46745	5968	8	227	227	CD
46745	5968	9	,	,	,
46745	5968	10	267	267	CD
46745	5968	11	,	,	,
46745	5968	12	278	278	CD
46745	5968	13	.	.	.
46745	5969	1	Opium	opium	NN
46745	5969	2	,	,	,
46745	5969	3	346	346	CD
46745	5969	4	.	.	.
46745	5970	1	Pain	pain	NN
46745	5970	2	,	,	,
46745	5970	3	treatment	treatment	NN
46745	5970	4	of	of	IN
46745	5970	5	,	,	,
46745	5970	6	342	342	CD
46745	5970	7	.	.	.
46745	5971	1	Pereira	Pereira	NNP
46745	5971	2	,	,	,
46745	5971	3	Dr.	Dr.	NNP
46745	5971	4	,	,	,
46745	5971	5	on	on	IN
46745	5971	6	action	action	NN
46745	5971	7	of	of	IN
46745	5971	8	medicines	medicine	NNS
46745	5971	9	,	,	,
46745	5971	10	40	40	CD
46745	5971	11	,	,	,
46745	5971	12	131	131	CD
46745	5971	13	,	,	,
46745	5971	14	162	162	CD
46745	5971	15	,	,	,
46745	5971	16	228	228	CD
46745	5971	17	.	.	.
46745	5972	1	Phosphoric	phosphoric	NN
46745	5972	2	acid	acid	NN
46745	5972	3	,	,	,
46745	5972	4	not	not	RB
46745	5972	5	astringent	astringent	JJ
46745	5972	6	,	,	,
46745	5972	7	262	262	CD
46745	5972	8	.	.	.
46745	5973	1	Phosphorus	Phosphorus	NNP
46745	5973	2	,	,	,
46745	5973	3	its	-PRON-	PRP$
46745	5973	4	actions	action	NNS
46745	5973	5	,	,	,
46745	5973	6	229	229	CD
46745	5973	7	,	,	,
46745	5973	8	311	311	CD
46745	5973	9	.	.	.
46745	5974	1	Pitch	Pitch	NNP
46745	5974	2	,	,	,
46745	5974	3	used	use	VBN
46745	5974	4	in	in	IN
46745	5974	5	Lepra	Lepra	NNP
46745	5974	6	,	,	,
46745	5974	7	214	214	CD
46745	5974	8	.	.	.
46745	5975	1	Potash	Potash	NNP
46745	5975	2	,	,	,
46745	5975	3	315	315	CD
46745	5975	4	.	.	.
46745	5976	1	Purgatives	purgative	NNS
46745	5976	2	,	,	,
46745	5976	3	286	286	CD
46745	5976	4	.	.	.
46745	5977	1	Quinine	Quinine	NNP
46745	5977	2	,	,	,
46745	5977	3	317	317	CD
46745	5977	4	.	.	.
46745	5978	1	Refrigerants	refrigerant	NNS
46745	5978	2	,	,	,
46745	5978	3	chemical	chemical	NN
46745	5978	4	theory	theory	NN
46745	5978	5	of	of	IN
46745	5978	6	,	,	,
46745	5978	7	123	123	CD
46745	5978	8	.	.	.
46745	5979	1	Resins	resin	NNS
46745	5979	2	,	,	,
46745	5979	3	absorption	absorption	NN
46745	5979	4	and	and	CC
46745	5979	5	action	action	NN
46745	5979	6	of	of	IN
46745	5979	7	,	,	,
46745	5979	8	83	83	CD
46745	5979	9	,	,	,
46745	5979	10	279	279	CD
46745	5979	11	,	,	,
46745	5979	12	288	288	CD
46745	5979	13	.	.	.
46745	5980	1	Rheumatism	rheumatism	NN
46745	5980	2	,	,	,
46745	5980	3	remedies	remedy	NNS
46745	5980	4	used	use	VBN
46745	5980	5	in	in	IN
46745	5980	6	,	,	,
46745	5980	7	194	194	CD
46745	5980	8	.	.	.
46745	5981	1	Rhubarb	rhubarb	NN
46745	5981	2	,	,	,
46745	5981	3	action	action	NN
46745	5981	4	of	of	IN
46745	5981	5	,	,	,
46745	5981	6	294	294	CD
46745	5981	7	.	.	.
46745	5982	1	Salines	saline	NNS
46745	5982	2	,	,	,
46745	5982	3	absorption	absorption	NN
46745	5982	4	and	and	CC
46745	5982	5	mode	mode	NN
46745	5982	6	of	of	IN
46745	5982	7	action	action	NN
46745	5982	8	of	of	IN
46745	5982	9	,	,	,
46745	5982	10	74	74	CD
46745	5982	11	,	,	,
46745	5982	12	188	188	CD
46745	5982	13	,	,	,
46745	5982	14	289	289	CD
46745	5982	15	,	,	,
46745	5982	16	300	300	CD
46745	5982	17	.	.	.
46745	5983	1	Salt	salt	NN
46745	5983	2	,	,	,
46745	5983	3	common	common	JJ
46745	5983	4	,	,	,
46745	5983	5	its	-PRON-	PRP$
46745	5983	6	actions	action	NNS
46745	5983	7	,	,	,
46745	5983	8	93	93	CD
46745	5983	9	,	,	,
46745	5983	10	193	193	CD
46745	5983	11	,	,	,
46745	5983	12	210	210	CD
46745	5983	13	.	.	.
46745	5984	1	Sarsaparilla	sarsaparilla	NN
46745	5984	2	in	in	IN
46745	5984	3	Syphilis	Syphilis	NNP
46745	5984	4	,	,	,
46745	5984	5	190	190	CD
46745	5984	6	.	.	.
46745	5985	1	Scammony	Scammony	NNP
46745	5985	2	,	,	,
46745	5985	3	absorption	absorption	NN
46745	5985	4	and	and	CC
46745	5985	5	action	action	NN
46745	5985	6	of	of	IN
46745	5985	7	,	,	,
46745	5985	8	85	85	CD
46745	5985	9	,	,	,
46745	5985	10	96	96	CD
46745	5985	11	,	,	,
46745	5985	12	289	289	CD
46745	5985	13	.	.	.
46745	5986	1	Schultz	Schultz	NNP
46745	5986	2	,	,	,
46745	5986	3	classification	classification	NN
46745	5986	4	of	of	IN
46745	5986	5	,	,	,
46745	5986	6	57	57	CD
46745	5986	7	.	.	.
46745	5987	1	Scrofula	Scrofula	NNP
46745	5987	2	,	,	,
46745	5987	3	treatment	treatment	NN
46745	5987	4	of	of	IN
46745	5987	5	,	,	,
46745	5987	6	191	191	CD
46745	5987	7	.	.	.
46745	5988	1	Scurvy	Scurvy	NNP
46745	5988	2	,	,	,
46745	5988	3	remedies	remedy	NNS
46745	5988	4	used	use	VBN
46745	5988	5	in	in	IN
46745	5988	6	,	,	,
46745	5988	7	205	205	CD
46745	5988	8	.	.	.
46745	5989	1	Sedatives	sedative	NNS
46745	5989	2	,	,	,
46745	5989	3	242	242	CD
46745	5989	4	.	.	.
46745	5990	1	Senna	senna	NN
46745	5990	2	,	,	,
46745	5990	3	chemical	chemical	NN
46745	5990	4	nature	nature	NN
46745	5990	5	and	and	CC
46745	5990	6	action	action	NN
46745	5990	7	,	,	,
46745	5990	8	279	279	CD
46745	5990	9	,	,	,
46745	5990	10	289	289	CD
46745	5990	11	.	.	.
46745	5991	1	Sialagogues	sialagogue	NNS
46745	5991	2	,	,	,
46745	5991	3	281	281	CD
46745	5991	4	.	.	.
46745	5992	1	Silver	silver	NN
46745	5992	2	,	,	,
46745	5992	3	nitrate	nitrate	JJ
46745	5992	4	of	of	IN
46745	5992	5	,	,	,
46745	5992	6	its	-PRON-	PRP$
46745	5992	7	actions	action	NNS
46745	5992	8	,	,	,
46745	5992	9	211	211	CD
46745	5992	10	,	,	,
46745	5992	11	264	264	CD
46745	5992	12	.	.	.
46745	5993	1	Skin	skin	NN
46745	5993	2	diseases	disease	NNS
46745	5993	3	,	,	,
46745	5993	4	treatment	treatment	NN
46745	5993	5	of	of	IN
46745	5993	6	,	,	,
46745	5993	7	213	213	CD
46745	5993	8	.	.	.
46745	5994	1	Special	Special	NNP
46745	5994	2	Sedatives	Sedatives	NNPS
46745	5994	3	,	,	,
46745	5994	4	249	249	CD
46745	5994	5	.	.	.
46745	5995	1	Special	Special	NNP
46745	5995	2	Stimulants	Stimulants	NNP
46745	5995	3	,	,	,
46745	5995	4	233	233	CD
46745	5995	5	.	.	.
46745	5996	1	Squill	squill	NN
46745	5996	2	,	,	,
46745	5996	3	its	-PRON-	PRP$
46745	5996	4	doubtful	doubtful	JJ
46745	5996	5	action	action	NN
46745	5996	6	,	,	,
46745	5996	7	253	253	CD
46745	5996	8	.	.	.
46745	5997	1	Starch	starch	NN
46745	5997	2	,	,	,
46745	5997	3	digestion	digestion	NN
46745	5997	4	of	of	IN
46745	5997	5	,	,	,
46745	5997	6	82	82	CD
46745	5997	7	,	,	,
46745	5997	8	116	116	CD
46745	5997	9	,	,	,
46745	5997	10	197	197	CD
46745	5997	11	.	.	.
46745	5998	1	Stimulants	Stimulants	NNP
46745	5998	2	,	,	,
46745	5998	3	226	226	CD
46745	5998	4	.	.	.
46745	5999	1	Stramonium	Stramonium	NNP
46745	5999	2	,	,	,
46745	5999	3	240	240	CD
46745	5999	4	.	.	.
46745	6000	1	Strychnia	Strychnia	NNP
46745	6000	2	,	,	,
46745	6000	3	337	337	CD
46745	6000	4	.	.	.
46745	6001	1	Sulphur	Sulphur	NNP
46745	6001	2	,	,	,
46745	6001	3	in	in	IN
46745	6001	4	skin	skin	NN
46745	6001	5	diseases	disease	NNS
46745	6001	6	,	,	,
46745	6001	7	215	215	CD
46745	6001	8	,	,	,
46745	6001	9	301	301	CD
46745	6001	10	.	.	.
46745	6002	1	Sulphuric	sulphuric	JJ
46745	6002	2	acid	acid	NN
46745	6002	3	,	,	,
46745	6002	4	313	313	CD
46745	6002	5	.	.	.
46745	6003	1	Syphilis	Syphilis	NNP
46745	6003	2	,	,	,
46745	6003	3	treatment	treatment	NN
46745	6003	4	of	of	IN
46745	6003	5	,	,	,
46745	6003	6	188	188	CD
46745	6003	7	.	.	.
46745	6004	1	Tannic	tannic	JJ
46745	6004	2	acid	acid	NN
46745	6004	3	,	,	,
46745	6004	4	356	356	CD
46745	6004	5	.	.	.
46745	6005	1	Tartar	Tartar	NNP
46745	6005	2	emetic	emetic	NNP
46745	6005	3	,	,	,
46745	6005	4	321	321	CD
46745	6005	5	.	.	.
46745	6006	1	Tea	tea	NN
46745	6006	2	,	,	,
46745	6006	3	a	a	DT
46745	6006	4	Sedative	Sedative	NNP
46745	6006	5	,	,	,
46745	6006	6	248	248	CD
46745	6006	7	.	.	.
46745	6007	1	Thomson	Thomson	NNP
46745	6007	2	,	,	,
46745	6007	3	Dr.	Dr.	NNP
46745	6007	4	A.	A.	NNP
46745	6007	5	T.	T.	NNP
46745	6007	6	,	,	,
46745	6007	7	on	on	IN
46745	6007	8	action	action	NN
46745	6007	9	of	of	IN
46745	6007	10	medicines	medicine	NNS
46745	6007	11	,	,	,
46745	6007	12	39	39	CD
46745	6007	13	.	.	.
46745	6008	1	Tonics	tonic	NNS
46745	6008	2	,	,	,
46745	6008	3	129	129	CD
46745	6008	4	.	.	.
46745	6009	1	Turpentine	turpentine	NN
46745	6009	2	,	,	,
46745	6009	3	its	-PRON-	PRP$
46745	6009	4	modes	mode	NNS
46745	6009	5	of	of	IN
46745	6009	6	action	action	NN
46745	6009	7	,	,	,
46745	6009	8	229	229	CD
46745	6009	9	,	,	,
46745	6009	10	267	267	CD
46745	6009	11	,	,	,
46745	6009	12	305	305	CD
46745	6009	13	.	.	.
46745	6010	1	Urinary	urinary	JJ
46745	6010	2	deposits	deposit	NNS
46745	6010	3	,	,	,
46745	6010	4	treatment	treatment	NN
46745	6010	5	of	of	IN
46745	6010	6	,	,	,
46745	6010	7	149	149	CD
46745	6010	8	,	,	,
46745	6010	9	307	307	CD
46745	6010	10	.	.	.
46745	6011	1	Water	water	NN
46745	6011	2	,	,	,
46745	6011	3	its	-PRON-	PRP$
46745	6011	4	elimination	elimination	NN
46745	6011	5	,	,	,
46745	6011	6	154	154	CD
46745	6011	7	,	,	,
46745	6011	8	300	300	CD
46745	6011	9	,	,	,
46745	6011	10	307	307	CD
46745	6011	11	.	.	.
46745	6012	1	Young	Young	NNP
46745	6012	2	,	,	,
46745	6012	3	Dr.	Dr.	NNP
46745	6012	4	,	,	,
46745	6012	5	his	-PRON-	PRP$
46745	6012	6	classification	classification	NN
46745	6012	7	,	,	,
46745	6012	8	32	32	CD
46745	6012	9	.	.	.
46745	6013	1	Zinc	zinc	NN
46745	6013	2	,	,	,
46745	6013	3	sulphate	sulphate	NN
46745	6013	4	of	of	IN
46745	6013	5	,	,	,
46745	6013	6	its	-PRON-	PRP$
46745	6013	7	actions	action	NNS
46745	6013	8	,	,	,
46745	6013	9	93	93	CD
46745	6013	10	,	,	,
46745	6013	11	211	211	CD
46745	6013	12	,	,	,
46745	6013	13	264	264	CD
46745	6013	14	.	.	.
46745	6014	1	FOOTNOTES	footnote	NNS
46745	6014	2	:	:	:
46745	6014	3	[	[	-LRB-
46745	6014	4	1	1	CD
46745	6014	5	]	]	-RRB-
46745	6014	6	"	"	``
46745	6014	7	In	in	IN
46745	6014	8	reasoning	reasoning	NN
46745	6014	9	as	as	IN
46745	6014	10	to	to	IN
46745	6014	11	the	the	DT
46745	6014	12	probable	probable	JJ
46745	6014	13	effects	effect	NNS
46745	6014	14	of	of	IN
46745	6014	15	particular	particular	JJ
46745	6014	16	remedies	remedy	NNS
46745	6014	17	on	on	IN
46745	6014	18	the	the	DT
46745	6014	19	human	human	JJ
46745	6014	20	body	body	NN
46745	6014	21	,	,	,
46745	6014	22	the	the	DT
46745	6014	23	conditions	condition	NNS
46745	6014	24	and	and	CC
46745	6014	25	circumstances	circumstance	NNS
46745	6014	26	of	of	IN
46745	6014	27	the	the	DT
46745	6014	28	latter	latter	JJ
46745	6014	29	are	be	VBP
46745	6014	30	so	so	RB
46745	6014	31	various	various	JJ
46745	6014	32	in	in	IN
46745	6014	33	different	different	JJ
46745	6014	34	cases	case	NNS
46745	6014	35	,	,	,
46745	6014	36	and	and	CC
46745	6014	37	the	the	DT
46745	6014	38	number	number	NN
46745	6014	39	of	of	IN
46745	6014	40	concomitants	concomitant	NNS
46745	6014	41	which	which	WDT
46745	6014	42	have	have	VBP
46745	6014	43	to	to	TO
46745	6014	44	be	be	VB
46745	6014	45	considered	consider	VBN
46745	6014	46	in	in	IN
46745	6014	47	addition	addition	NN
46745	6014	48	to	to	IN
46745	6014	49	the	the	DT
46745	6014	50	more	more	RBR
46745	6014	51	obvious	obvious	JJ
46745	6014	52	facts	fact	NNS
46745	6014	53	and	and	CC
46745	6014	54	symptoms	symptom	NNS
46745	6014	55	,	,	,
46745	6014	56	is	be	VBZ
46745	6014	57	so	so	RB
46745	6014	58	great	great	JJ
46745	6014	59	that	that	IN
46745	6014	60	the	the	DT
46745	6014	61	utmost	utmost	JJ
46745	6014	62	exertion	exertion	NN
46745	6014	63	of	of	IN
46745	6014	64	human	human	JJ
46745	6014	65	sagacity	sagacity	NN
46745	6014	66	,	,	,
46745	6014	67	founded	found	VBN
46745	6014	68	upon	upon	IN
46745	6014	69	the	the	DT
46745	6014	70	largest	large	JJS
46745	6014	71	induction	induction	NN
46745	6014	72	of	of	IN
46745	6014	73	particulars	particular	NNS
46745	6014	74	which	which	WDT
46745	6014	75	any	any	DT
46745	6014	76	one	one	CD
46745	6014	77	mind	mind	NN
46745	6014	78	is	be	VBZ
46745	6014	79	capable	capable	JJ
46745	6014	80	of	of	IN
46745	6014	81	embracing	embrace	VBG
46745	6014	82	and	and	CC
46745	6014	83	retaining	retain	VBG
46745	6014	84	,	,	,
46745	6014	85	can	can	MD
46745	6014	86	do	do	VB
46745	6014	87	no	no	DT
46745	6014	88	more	more	JJR
46745	6014	89	than	than	IN
46745	6014	90	approximate	approximate	JJ
46745	6014	91	to	to	IN
46745	6014	92	that	that	DT
46745	6014	93	real	real	JJ
46745	6014	94	evidence	evidence	NN
46745	6014	95	of	of	IN
46745	6014	96	which	which	WDT
46745	6014	97	the	the	DT
46745	6014	98	case	case	NN
46745	6014	99	seems	seem	VBZ
46745	6014	100	by	by	IN
46745	6014	101	its	-PRON-	PRP$
46745	6014	102	proper	proper	JJ
46745	6014	103	nature	nature	NN
46745	6014	104	to	to	TO
46745	6014	105	be	be	VB
46745	6014	106	susceptible	susceptible	JJ
46745	6014	107	.	.	.
46745	6014	108	"	"	''
46745	6015	1	--_Glassford	--_Glassford	:
46745	6015	2	's	's	POS
46745	6015	3	Principles	Principles	NNPS
46745	6015	4	of	of	IN
46745	6015	5	Evidence	Evidence	NNP
46745	6015	6	.	.	.
46745	6015	7	_	_	NNP
46745	6015	8	[	[	-LRB-
46745	6015	9	2	2	CD
46745	6015	10	]	]	-RRB-
46745	6015	11	Dr.	Dr.	NNP
46745	6015	12	A.	A.	NNP
46745	6015	13	Pitcairn	Pitcairn	NNP
46745	6015	14	,	,	,
46745	6015	15	in	in	IN
46745	6015	16	1704	1704	CD
46745	6015	17	,	,	,
46745	6015	18	concluded	conclude	VBD
46745	6015	19	one	one	CD
46745	6015	20	of	of	IN
46745	6015	21	his	-PRON-	PRP$
46745	6015	22	works	work	NNS
46745	6015	23	by	by	IN
46745	6015	24	saying	say	VBG
46745	6015	25	,	,	,
46745	6015	26	"	"	``
46745	6015	27	Thus	thus	RB
46745	6015	28	have	have	VBP
46745	6015	29	I	-PRON-	PRP
46745	6015	30	succeeded	succeed	VBN
46745	6015	31	in	in	IN
46745	6015	32	solving	solve	VBG
46745	6015	33	the	the	DT
46745	6015	34	noble	noble	JJ
46745	6015	35	problem	problem	NN
46745	6015	36	,	,	,
46745	6015	37	viz	viz	NNP
46745	6015	38	.	.	NNP
46745	6015	39	,	,	,
46745	6015	40	to	to	TO
46745	6015	41	find	find	VB
46745	6015	42	a	a	DT
46745	6015	43	remedy	remedy	NN
46745	6015	44	for	for	IN
46745	6015	45	a	a	DT
46745	6015	46	given	give	VBN
46745	6015	47	disease	disease	NN
46745	6015	48	.	.	.
46745	6016	1	_	_	NNP
46745	6016	2	Jamque	Jamque	NNP
46745	6016	3	opus	opus	NN
46745	6016	4	exegi	exegi	NN
46745	6016	5	.	.	.
46745	6016	6	_	_	NNP
46745	6016	7	"	"	``
46745	6016	8	[	[	-LRB-
46745	6016	9	3	3	CD
46745	6016	10	]	]	-RRB-
46745	6016	11	"	"	``
46745	6016	12	In	in	IN
46745	6016	13	the	the	DT
46745	6016	14	mean	mean	JJ
46745	6016	15	time	time	NN
46745	6016	16	it	-PRON-	PRP
46745	6016	17	may	may	MD
46745	6016	18	suffice	suffice	VB
46745	6016	19	for	for	IN
46745	6016	20	the	the	DT
46745	6016	21	physician	physician	NN
46745	6016	22	to	to	TO
46745	6016	23	know	know	VB
46745	6016	24	the	the	DT
46745	6016	25	effects	effect	NNS
46745	6016	26	of	of	IN
46745	6016	27	a	a	DT
46745	6016	28	medicine	medicine	NN
46745	6016	29	when	when	WRB
46745	6016	30	applied	apply	VBN
46745	6016	31	to	to	IN
46745	6016	32	the	the	DT
46745	6016	33	body	body	NN
46745	6016	34	,	,	,
46745	6016	35	though	though	IN
46745	6016	36	he	-PRON-	PRP
46745	6016	37	knows	know	VBZ
46745	6016	38	not	not	RB
46745	6016	39	the	the	DT
46745	6016	40	particular	particular	JJ
46745	6016	41	manner	manner	NN
46745	6016	42	whereby	whereby	WRB
46745	6016	43	it	-PRON-	PRP
46745	6016	44	acts	act	VBZ
46745	6016	45	.	.	.
46745	6016	46	"	"	''
46745	6017	1	--_Van	--_Van	NFP
46745	6017	2	Sweiten	Sweiten	NNP
46745	6017	3	's	's	POS
46745	6017	4	Commentaries	Commentaries	NNPS
46745	6017	5	on	on	IN
46745	6017	6	Boerhaave	Boerhaave	NNP
46745	6017	7	_	_	NNP
46745	6017	8	,	,	,
46745	6017	9	vol	vol	NNP
46745	6017	10	.	.	.
46745	6018	1	i.	i.	NNP
46745	6018	2	p.	p.	NNP
46745	6018	3	394	394	CD
46745	6018	4	.	.	.
46745	6019	1	[	[	-LRB-
46745	6019	2	4	4	CD
46745	6019	3	]	]	-RRB-
46745	6019	4	"	"	``
46745	6019	5	Every	every	DT
46745	6019	6	branch	branch	NN
46745	6019	7	of	of	IN
46745	6019	8	study	study	NN
46745	6019	9	which	which	WDT
46745	6019	10	can	can	MD
46745	6019	11	at	at	RB
46745	6019	12	all	all	RB
46745	6019	13	claim	claim	VB
46745	6019	14	the	the	DT
46745	6019	15	character	character	NN
46745	6019	16	of	of	IN
46745	6019	17	a	a	DT
46745	6019	18	science	science	NN
46745	6019	19	requires	require	VBZ
46745	6019	20	two	two	CD
46745	6019	21	things	thing	NNS
46745	6019	22	:	:	:
46745	6019	23	1	1	CD
46745	6019	24	.	.	.
46745	6020	1	A	a	DT
46745	6020	2	correct	correct	JJ
46745	6020	3	ascertainment	ascertainment	NN
46745	6020	4	of	of	IN
46745	6020	5	the	the	DT
46745	6020	6	data	datum	NNS
46745	6020	7	from	from	IN
46745	6020	8	which	which	WDT
46745	6020	9	we	-PRON-	PRP
46745	6020	10	are	be	VBP
46745	6020	11	to	to	TO
46745	6020	12	reason	reason	NN
46745	6020	13	;	;	:
46745	6020	14	and	and	CC
46745	6020	15	2	2	CD
46745	6020	16	.	.	.
46745	6021	1	Correctness	correctness	NN
46745	6021	2	in	in	IN
46745	6021	3	the	the	DT
46745	6021	4	process	process	NN
46745	6021	5	of	of	IN
46745	6021	6	deducing	deduce	VBG
46745	6021	7	conclusions	conclusion	NNS
46745	6021	8	from	from	IN
46745	6021	9	them	-PRON-	PRP
46745	6021	10	.	.	.
46745	6021	11	"	"	''
46745	6022	1	--_Whateley	--_Whateley	NNP
46745	6022	2	's	's	POS
46745	6022	3	Elements	Elements	NNPS
46745	6022	4	of	of	IN
46745	6022	5	Logic	Logic	NNP
46745	6022	6	.	.	.
46745	6022	7	_	_	NNP
46745	6022	8	[	[	-LRB-
46745	6022	9	5	5	CD
46745	6022	10	]	]	-RRB-
46745	6022	11	There	there	EX
46745	6022	12	is	be	VBZ
46745	6022	13	no	no	DT
46745	6022	14	doubt	doubt	NN
46745	6022	15	that	that	IN
46745	6022	16	the	the	DT
46745	6022	17	small	small	JJ
46745	6022	18	veins	vein	NNS
46745	6022	19	which	which	WDT
46745	6022	20	ramify	ramify	VBP
46745	6022	21	outside	outside	IN
46745	6022	22	the	the	DT
46745	6022	23	coats	coat	NNS
46745	6022	24	of	of	IN
46745	6022	25	the	the	DT
46745	6022	26	stomach	stomach	NN
46745	6022	27	and	and	CC
46745	6022	28	intestines	intestine	NNS
46745	6022	29	are	be	VBP
46745	6022	30	capable	capable	JJ
46745	6022	31	of	of	IN
46745	6022	32	taking	take	VBG
46745	6022	33	up	up	RP
46745	6022	34	any	any	DT
46745	6022	35	matters	matter	NNS
46745	6022	36	in	in	IN
46745	6022	37	a	a	DT
46745	6022	38	state	state	NN
46745	6022	39	of	of	IN
46745	6022	40	proper	proper	JJ
46745	6022	41	solution	solution	NN
46745	6022	42	,	,	,
46745	6022	43	even	even	RB
46745	6022	44	fats	fat	VBZ
46745	6022	45	when	when	WRB
46745	6022	46	dissolved	dissolve	VBN
46745	6022	47	in	in	IN
46745	6022	48	alkali	alkali	JJ
46745	6022	49	.	.	.
46745	6023	1	But	but	CC
46745	6023	2	are	be	VBP
46745	6023	3	medicines	medicine	NNS
46745	6023	4	ever	ever	RB
46745	6023	5	taken	take	VBN
46745	6023	6	up	up	RP
46745	6023	7	by	by	IN
46745	6023	8	the	the	DT
46745	6023	9	lacteal	lacteal	NN
46745	6023	10	absorbents	absorbent	NNS
46745	6023	11	?	?	.
46745	6024	1	Probably	probably	RB
46745	6024	2	seldom	seldom	RB
46745	6024	3	or	or	CC
46745	6024	4	never	never	RB
46745	6024	5	;	;	:
46745	6024	6	for	for	IN
46745	6024	7	it	-PRON-	PRP
46745	6024	8	seems	seem	VBZ
46745	6024	9	that	that	IN
46745	6024	10	these	these	DT
46745	6024	11	vessels	vessel	NNS
46745	6024	12	are	be	VBP
46745	6024	13	only	only	RB
46745	6024	14	engaged	engage	VBN
46745	6024	15	after	after	IN
46745	6024	16	a	a	DT
46745	6024	17	full	full	JJ
46745	6024	18	meal	meal	NN
46745	6024	19	,	,	,
46745	6024	20	and	and	CC
46745	6024	21	subsequent	subsequent	JJ
46745	6024	22	to	to	IN
46745	6024	23	the	the	DT
46745	6024	24	regular	regular	JJ
46745	6024	25	formation	formation	NN
46745	6024	26	of	of	IN
46745	6024	27	chyle	chyle	NN
46745	6024	28	.	.	.
46745	6025	1	They	-PRON-	PRP
46745	6025	2	do	do	VBP
46745	6025	3	not	not	RB
46745	6025	4	exist	exist	VB
46745	6025	5	in	in	IN
46745	6025	6	the	the	DT
46745	6025	7	coat	coat	NN
46745	6025	8	of	of	IN
46745	6025	9	the	the	DT
46745	6025	10	stomach	stomach	NN
46745	6025	11	,	,	,
46745	6025	12	but	but	CC
46745	6025	13	commence	commence	NN
46745	6025	14	in	in	IN
46745	6025	15	the	the	DT
46745	6025	16	small	small	JJ
46745	6025	17	intestine	intestine	NN
46745	6025	18	at	at	IN
46745	6025	19	some	some	DT
46745	6025	20	distance	distance	NN
46745	6025	21	from	from	IN
46745	6025	22	the	the	DT
46745	6025	23	pylorus	pylorus	NNP
46745	6025	24	.	.	.
46745	6026	1	[	[	-LRB-
46745	6026	2	6	6	CD
46745	6026	3	]	]	-RRB-
46745	6026	4	It	-PRON-	PRP
46745	6026	5	may	may	MD
46745	6026	6	be	be	VB
46745	6026	7	of	of	IN
46745	6026	8	some	some	DT
46745	6026	9	use	use	NN
46745	6026	10	if	if	IN
46745	6026	11	I	-PRON-	PRP
46745	6026	12	adduce	adduce	VBP
46745	6026	13	here	here	RB
46745	6026	14	a	a	DT
46745	6026	15	characteristic	characteristic	JJ
46745	6026	16	example	example	NN
46745	6026	17	of	of	IN
46745	6026	18	each	each	DT
46745	6026	19	of	of	IN
46745	6026	20	the	the	DT
46745	6026	21	great	great	JJ
46745	6026	22	groups	group	NNS
46745	6026	23	of	of	IN
46745	6026	24	medicines	medicine	NNS
46745	6026	25	to	to	TO
46745	6026	26	which	which	WDT
46745	6026	27	I	-PRON-	PRP
46745	6026	28	have	have	VBP
46745	6026	29	alluded	allude	VBN
46745	6026	30	above	above	RB
46745	6026	31	:	:	:
46745	6026	32	CLASS	CLASS	NNP
46745	6026	33	I.	i.	NN
46745	6027	1	_	_	NNP
46745	6027	2	Hæmatics	Hæmatics	NNP
46745	6027	3	.	.	.
46745	6027	4	_	_	NNP
46745	6027	5	Div	Div	NNP
46745	6027	6	.	.	.
46745	6028	1	1	1	LS
46745	6028	2	.	.	.
46745	6029	1	Restoratives	restorative	NNS
46745	6029	2	.	.	.
46745	6030	1	Iron	iron	NN
46745	6030	2	,	,	,
46745	6030	3	in	in	IN
46745	6030	4	Anæmia	Anæmia	NNP
46745	6030	5	.	.	.
46745	6031	1	Div	Div	NNP
46745	6031	2	.	.	.
46745	6032	1	2	2	LS
46745	6032	2	.	.	.
46745	6033	1	Catalytics	catalytic	NNS
46745	6033	2	.	.	.
46745	6034	1	Mercury	Mercury	NNP
46745	6034	2	,	,	,
46745	6034	3	in	in	IN
46745	6034	4	Syphilis	Syphilis	NNP
46745	6034	5	.	.	.
46745	6035	1	CLASS	CLASS	NNP
46745	6035	2	II	II	NNP
46745	6035	3	.	.	.
46745	6036	1	_	_	NNP
46745	6036	2	Neurotics	Neurotics	NNP
46745	6036	3	.	.	.
46745	6036	4	_	_	NNP
46745	6036	5	Div	Div	NNP
46745	6036	6	.	.	.
46745	6037	1	1	1	LS
46745	6037	2	.	.	.
46745	6038	1	Stimulants	stimulant	NNS
46745	6038	2	.	.	.
46745	6039	1	Ammonia	Ammonia	NNP
46745	6039	2	.	.	.
46745	6040	1	Div	Div	NNP
46745	6040	2	.	.	.
46745	6041	1	2	2	LS
46745	6041	2	.	.	.
46745	6042	1	Narcotics	narcotic	NNS
46745	6042	2	.	.	.
46745	6043	1	Opium	opium	NN
46745	6043	2	.	.	.
46745	6044	1	Div	Div	NNP
46745	6044	2	.	.	.
46745	6045	1	3	3	LS
46745	6045	2	.	.	.
46745	6046	1	Sedatives	sedative	NNS
46745	6046	2	.	.	.
46745	6047	1	Hydrocyanic	hydrocyanic	JJ
46745	6047	2	Acid	Acid	NNP
46745	6047	3	.	.	.
46745	6048	1	CLASS	CLASS	NNP
46745	6048	2	III	iii	CD
46745	6048	3	.	.	.
46745	6049	1	_	_	NNP
46745	6049	2	Astringents	Astringents	NNP
46745	6049	3	.	.	.
46745	6049	4	_	_	NNP
46745	6049	5	Tannic	Tannic	NNP
46745	6049	6	Acid	Acid	NNP
46745	6049	7	.	.	.
46745	6050	1	CLASS	CLASS	NNP
46745	6050	2	IV	IV	NNP
46745	6050	3	.	.	.
46745	6051	1	_	_	NNP
46745	6051	2	Eliminatives	Eliminatives	NNP
46745	6051	3	.	.	.
46745	6051	4	_	_	NNP
46745	6051	5	Cantharides	Cantharides	NNP
46745	6051	6	,	,	,
46745	6051	7	and	and	CC
46745	6051	8	Croton	Croton	NNP
46745	6051	9	Oil	Oil	NNP
46745	6051	10	.	.	.
46745	6052	1	[	[	-LRB-
46745	6052	2	7	7	LS
46745	6052	3	]	]	-RRB-
46745	6052	4	The	the	DT
46745	6052	5	whimsical	whimsical	JJ
46745	6052	6	"	"	``
46745	6052	7	_	_	NNP
46745	6052	8	doctrine	doctrine	NN
46745	6052	9	of	of	IN
46745	6052	10	signatures	signature	NNS
46745	6052	11	_	_	NNP
46745	6052	12	"	"	''
46745	6052	13	which	which	WDT
46745	6052	14	prevailed	prevail	VBD
46745	6052	15	in	in	IN
46745	6052	16	the	the	DT
46745	6052	17	middle	middle	JJ
46745	6052	18	ages	age	NNS
46745	6052	19	,	,	,
46745	6052	20	and	and	CC
46745	6052	21	had	have	VBD
46745	6052	22	its	-PRON-	PRP$
46745	6052	23	origin	origin	NN
46745	6052	24	from	from	IN
46745	6052	25	very	very	RB
46745	6052	26	remote	remote	JJ
46745	6052	27	times	time	NNS
46745	6052	28	,	,	,
46745	6052	29	serves	serve	VBZ
46745	6052	30	at	at	IN
46745	6052	31	least	least	RBS
46745	6052	32	to	to	TO
46745	6052	33	show	show	VB
46745	6052	34	that	that	IN
46745	6052	35	the	the	DT
46745	6052	36	local	local	JJ
46745	6052	37	tendencies	tendency	NNS
46745	6052	38	of	of	IN
46745	6052	39	medicines	medicine	NNS
46745	6052	40	have	have	VBP
46745	6052	41	always	always	RB
46745	6052	42	been	be	VBN
46745	6052	43	more	more	RBR
46745	6052	44	or	or	CC
46745	6052	45	less	less	RBR
46745	6052	46	recognised	recognised	JJ
46745	6052	47	.	.	.
46745	6053	1	So	so	RB
46745	6053	2	slight	slight	JJ
46745	6053	3	an	an	DT
46745	6053	4	experience	experience	NN
46745	6053	5	is	be	VBZ
46745	6053	6	sufficient	sufficient	JJ
46745	6053	7	to	to	TO
46745	6053	8	demonstrate	demonstrate	VB
46745	6053	9	their	-PRON-	PRP$
46745	6053	10	existence	existence	NN
46745	6053	11	,	,	,
46745	6053	12	that	that	IN
46745	6053	13	it	-PRON-	PRP
46745	6053	14	could	could	MD
46745	6053	15	indeed	indeed	RB
46745	6053	16	hardly	hardly	RB
46745	6053	17	be	be	VB
46745	6053	18	otherwise	otherwise	RB
46745	6053	19	.	.	.
46745	6054	1	It	-PRON-	PRP
46745	6054	2	was	be	VBD
46745	6054	3	oddly	oddly	RB
46745	6054	4	supposed	suppose	VBN
46745	6054	5	that	that	IN
46745	6054	6	every	every	DT
46745	6054	7	natural	natural	JJ
46745	6054	8	substance	substance	NN
46745	6054	9	bore	bear	VBD
46745	6054	10	evidence	evidence	NN
46745	6054	11	in	in	IN
46745	6054	12	its	-PRON-	PRP$
46745	6054	13	outward	outward	JJ
46745	6054	14	form	form	NN
46745	6054	15	or	or	CC
46745	6054	16	physical	physical	JJ
46745	6054	17	peculiarities	peculiarity	NNS
46745	6054	18	of	of	IN
46745	6054	19	the	the	DT
46745	6054	20	part	part	NN
46745	6054	21	of	of	IN
46745	6054	22	the	the	DT
46745	6054	23	system	system	NN
46745	6054	24	over	over	IN
46745	6054	25	which	which	WDT
46745	6054	26	it	-PRON-	PRP
46745	6054	27	exerted	exert	VBD
46745	6054	28	a	a	DT
46745	6054	29	curative	curative	JJ
46745	6054	30	power	power	NN
46745	6054	31	.	.	.
46745	6055	1	[	[	-LRB-
46745	6055	2	8	8	CD
46745	6055	3	]	]	-RRB-
46745	6055	4	"	"	``
46745	6055	5	He	-PRON-	PRP
46745	6055	6	was	be	VBD
46745	6055	7	one	one	CD
46745	6055	8	of	of	IN
46745	6055	9	the	the	DT
46745	6055	10	first	first	JJ
46745	6055	11	who	who	WP
46745	6055	12	,	,	,
46745	6055	13	leaving	leave	VBG
46745	6055	14	the	the	DT
46745	6055	15	old	old	JJ
46745	6055	16	conjectural	conjectural	JJ
46745	6055	17	method	method	NN
46745	6055	18	of	of	IN
46745	6055	19	physical	physical	JJ
46745	6055	20	writers	writer	NNS
46745	6055	21	,	,	,
46745	6055	22	struck	strike	VBD
46745	6055	23	into	into	IN
46745	6055	24	a	a	DT
46745	6055	25	new	new	JJ
46745	6055	26	and	and	CC
46745	6055	27	more	more	RBR
46745	6055	28	solid	solid	JJ
46745	6055	29	way	way	NN
46745	6055	30	of	of	IN
46745	6055	31	reasoning	reasoning	NN
46745	6055	32	,	,	,
46745	6055	33	grounded	ground	VBN
46745	6055	34	upon	upon	IN
46745	6055	35	observations	observation	NNS
46745	6055	36	and	and	CC
46745	6055	37	mathematical	mathematical	JJ
46745	6055	38	principles	principle	NNS
46745	6055	39	.	.	.
46745	6055	40	"	"	''
46745	6056	1	--	--	:
46745	6056	2	_	_	NNP
46745	6056	3	Preface	Preface	NNP
46745	6056	4	to	to	IN
46745	6056	5	Dr.	Dr.	NNP
46745	6056	6	Pitcairn	Pitcairn	NNP
46745	6056	7	's	's	POS
46745	6056	8	Works	work	NNS
46745	6056	9	:	:	:
46745	6056	10	1715	1715	CD
46745	6056	11	_	_	XX
46745	6056	12	.	.	.
46745	6057	1	[	[	-LRB-
46745	6057	2	9	9	CD
46745	6057	3	]	]	-RRB-
46745	6057	4	"	"	``
46745	6057	5	A	a	DT
46745	6057	6	Treatise	Treatise	NNP
46745	6057	7	of	of	IN
46745	6057	8	Diseases	Diseases	NNPS
46745	6057	9	in	in	IN
46745	6057	10	General	General	NNP
46745	6057	11	,	,	,
46745	6057	12	wherein	wherein	WRB
46745	6057	13	the	the	DT
46745	6057	14	true	true	JJ
46745	6057	15	causes	cause	NNS
46745	6057	16	,	,	,
46745	6057	17	natures	nature	NNS
46745	6057	18	,	,	,
46745	6057	19	and	and	CC
46745	6057	20	essences	essence	NNS
46745	6057	21	of	of	IN
46745	6057	22	all	all	PDT
46745	6057	23	the	the	DT
46745	6057	24	principal	principal	JJ
46745	6057	25	diseases	disease	NNS
46745	6057	26	incident	incident	NN
46745	6057	27	to	to	IN
46745	6057	28	the	the	DT
46745	6057	29	human	human	JJ
46745	6057	30	body	body	NN
46745	6057	31	,	,	,
46745	6057	32	are	be	VBP
46745	6057	33	mechanically	mechanically	RB
46745	6057	34	accounted	account	VBN
46745	6057	35	for	for	IN
46745	6057	36	and	and	CC
46745	6057	37	explained	explain	VBD
46745	6057	38	,	,	,
46745	6057	39	and	and	CC
46745	6057	40	their	-PRON-	PRP$
46745	6057	41	respective	respective	JJ
46745	6057	42	intentions	intention	NNS
46745	6057	43	of	of	IN
46745	6057	44	cure	cure	NN
46745	6057	45	assigned	assign	VBN
46745	6057	46	upon	upon	IN
46745	6057	47	the	the	DT
46745	6057	48	same	same	JJ
46745	6057	49	principles	principle	NNS
46745	6057	50	,	,	,
46745	6057	51	"	"	''
46745	6057	52	vol	vol	NNP
46745	6057	53	.	.	.
46745	6058	1	ii	ii	LS
46745	6058	2	.	.	.
46745	6059	1	p.	p.	NN
46745	6059	2	813	813	CD
46745	6059	3	,	,	,
46745	6059	4	820	820	CD
46745	6059	5	.	.	.
46745	6060	1	[	[	-LRB-
46745	6060	2	10	10	CD
46745	6060	3	]	]	-RRB-
46745	6060	4	"	"	``
46745	6060	5	Medical	Medical	NNP
46745	6060	6	Precepts	Precepts	NNPS
46745	6060	7	and	and	CC
46745	6060	8	Cautions	Cautions	NNPS
46745	6060	9	,	,	,
46745	6060	10	"	"	''
46745	6060	11	page	page	NN
46745	6060	12	294	294	CD
46745	6060	13	.	.	.
46745	6061	1	[	[	-LRB-
46745	6061	2	11	11	CD
46745	6061	3	]	]	-RRB-
46745	6061	4	"	"	``
46745	6061	5	If	if	IN
46745	6061	6	there	there	EX
46745	6061	7	be	be	VBP
46745	6061	8	any	any	DT
46745	6061	9	bodies	body	NNS
46745	6061	10	--	--	:
46745	6061	11	suppose	suppose	VB
46745	6061	12	gold	gold	NN
46745	6061	13	and	and	CC
46745	6061	14	silver	silver	NN
46745	6061	15	--	--	:
46745	6061	16	out	out	IN
46745	6061	17	of	of	IN
46745	6061	18	which	which	WDT
46745	6061	19	all	all	PDT
46745	6061	20	these	these	DT
46745	6061	21	principles	principle	NNS
46745	6061	22	can	can	MD
46745	6061	23	not	not	RB
46745	6061	24	be	be	VB
46745	6061	25	drawn	draw	VBN
46745	6061	26	,	,	,
46745	6061	27	let	let	VB
46745	6061	28	not	not	RB
46745	6061	29	the	the	DT
46745	6061	30	artist	artist	NN
46745	6061	31	think	think	VB
46745	6061	32	that	that	IN
46745	6061	33	it	-PRON-	PRP
46745	6061	34	is	be	VBZ
46745	6061	35	because	because	IN
46745	6061	36	they	-PRON-	PRP
46745	6061	37	are	be	VBP
46745	6061	38	not	not	RB
46745	6061	39	therein	therein	RB
46745	6061	40	contained	contain	VBN
46745	6061	41	.	.	.
46745	6062	1	No	no	UH
46745	6062	2	!	!	.
46745	6063	1	it	-PRON-	PRP
46745	6063	2	is	be	VBZ
46745	6063	3	because	because	IN
46745	6063	4	that	that	IN
46745	6063	5	God	God	NNP
46745	6063	6	has	have	VBZ
46745	6063	7	so	so	RB
46745	6063	8	firmly	firmly	RB
46745	6063	9	united	unite	VBN
46745	6063	10	them	-PRON-	PRP
46745	6063	11	against	against	IN
46745	6063	12	the	the	DT
46745	6063	13	possibility	possibility	NN
46745	6063	14	of	of	IN
46745	6063	15	our	-PRON-	PRP$
46745	6063	16	separation	separation	NN
46745	6063	17	.	.	.
46745	6063	18	"--P.	"--P.	''
46745	6064	1	809	809	CD
46745	6064	2	.	.	.
46745	6065	1	[	[	-LRB-
46745	6065	2	12	12	CD
46745	6065	3	]	]	-RRB-
46745	6065	4	Dr.	Dr.	NNP
46745	6065	5	Pitcairn	Pitcairn	NNP
46745	6065	6	's	's	POS
46745	6065	7	Works	work	NNS
46745	6065	8	,	,	,
46745	6065	9	1715	1715	CD
46745	6065	10	,	,	,
46745	6065	11	p.	p.	NN
46745	6065	12	219	219	CD
46745	6065	13	.	.	.
46745	6066	1	[	[	-LRB-
46745	6066	2	13	13	CD
46745	6066	3	]	]	-RRB-
46745	6066	4	I	-PRON-	PRP
46745	6066	5	have	have	VBP
46745	6066	6	omitted	omit	VBN
46745	6066	7	here	here	RB
46745	6066	8	to	to	TO
46745	6066	9	make	make	VB
46745	6066	10	mention	mention	NN
46745	6066	11	of	of	IN
46745	6066	12	the	the	DT
46745	6066	13	doctrine	doctrine	NN
46745	6066	14	of	of	IN
46745	6066	15	infinitesimal	infinitesimal	JJ
46745	6066	16	doses	dose	NNS
46745	6066	17	,	,	,
46745	6066	18	not	not	RB
46745	6066	19	only	only	RB
46745	6066	20	because	because	IN
46745	6066	21	it	-PRON-	PRP
46745	6066	22	is	be	VBZ
46745	6066	23	out	out	IN
46745	6066	24	of	of	IN
46745	6066	25	my	-PRON-	PRP$
46745	6066	26	province	province	NN
46745	6066	27	,	,	,
46745	6066	28	but	but	CC
46745	6066	29	because	because	IN
46745	6066	30	it	-PRON-	PRP
46745	6066	31	is	be	VBZ
46745	6066	32	really	really	RB
46745	6066	33	too	too	RB
46745	6066	34	unreasonable	unreasonable	JJ
46745	6066	35	to	to	TO
46745	6066	36	be	be	VB
46745	6066	37	even	even	RB
46745	6066	38	discussed	discuss	VBN
46745	6066	39	.	.	.
46745	6067	1	When	when	WRB
46745	6067	2	it	-PRON-	PRP
46745	6067	3	is	be	VBZ
46745	6067	4	said	say	VBN
46745	6067	5	that	that	IN
46745	6067	6	the	the	DT
46745	6067	7	decillionth	decillionth	NN
46745	6067	8	of	of	IN
46745	6067	9	a	a	DT
46745	6067	10	grain	grain	NN
46745	6067	11	--	--	:
46745	6067	12	the	the	DT
46745	6067	13	ordinary	ordinary	JJ
46745	6067	14	dose	dose	NN
46745	6067	15	among	among	IN
46745	6067	16	these	these	DT
46745	6067	17	practitioners	practitioner	NNS
46745	6067	18	--	--	:
46745	6067	19	is	be	VBZ
46745	6067	20	expressed	express	VBN
46745	6067	21	by	by	IN
46745	6067	22	a	a	DT
46745	6067	23	fraction	fraction	NN
46745	6067	24	,	,	,
46745	6067	25	the	the	DT
46745	6067	26	denominator	denominator	NN
46745	6067	27	of	of	IN
46745	6067	28	which	which	WDT
46745	6067	29	is	be	VBZ
46745	6067	30	a	a	DT
46745	6067	31	unit	unit	NN
46745	6067	32	followed	follow	VBN
46745	6067	33	by	by	IN
46745	6067	34	sixty	sixty	CD
46745	6067	35	ciphers	cipher	NNS
46745	6067	36	,	,	,
46745	6067	37	this	this	DT
46745	6067	38	statement	statement	NN
46745	6067	39	will	will	MD
46745	6067	40	be	be	VB
46745	6067	41	surely	surely	RB
46745	6067	42	enough	enough	RB
46745	6067	43	for	for	IN
46745	6067	44	any	any	DT
46745	6067	45	man	man	NN
46745	6067	46	who	who	WP
46745	6067	47	is	be	VBZ
46745	6067	48	at	at	RB
46745	6067	49	all	all	RB
46745	6067	50	acquainted	acquaint	VBN
46745	6067	51	with	with	IN
46745	6067	52	figures	figure	NNS
46745	6067	53	.	.	.
46745	6068	1	I	-PRON-	PRP
46745	6068	2	do	do	VBP
46745	6068	3	not	not	RB
46745	6068	4	conceive	conceive	VB
46745	6068	5	it	-PRON-	PRP
46745	6068	6	possible	possible	JJ
46745	6068	7	that	that	IN
46745	6068	8	matter	matter	NN
46745	6068	9	is	be	VBZ
46745	6068	10	_	_	NNP
46745	6068	11	divisible	divisible	JJ
46745	6068	12	_	_	NNP
46745	6068	13	to	to	IN
46745	6068	14	any	any	DT
46745	6068	15	thing	thing	NN
46745	6068	16	like	like	IN
46745	6068	17	this	this	DT
46745	6068	18	extent	extent	NN
46745	6068	19	.	.	.
46745	6069	1	[	[	-LRB-
46745	6069	2	14	14	CD
46745	6069	3	]	]	-RRB-
46745	6069	4	Sydenham	Sydenham	NNP
46745	6069	5	's	's	POS
46745	6069	6	Works	work	NNS
46745	6069	7	,	,	,
46745	6069	8	translated	translate	VBN
46745	6069	9	from	from	IN
46745	6069	10	the	the	DT
46745	6069	11	Latin	Latin	NNP
46745	6069	12	by	by	IN
46745	6069	13	Dr.	Dr.	NNP
46745	6069	14	Swan	Swan	NNP
46745	6069	15	.	.	.
46745	6070	1	5th	5th	JJ
46745	6070	2	edition	edition	NNP
46745	6070	3	,	,	,
46745	6070	4	1769	1769	CD
46745	6070	5	,	,	,
46745	6070	6	p.	p.	NN
46745	6070	7	1	1	CD
46745	6070	8	.	.	.
46745	6071	1	[	[	-LRB-
46745	6071	2	15	15	CD
46745	6071	3	]	]	-RRB-
46745	6071	4	Preface	preface	NN
46745	6071	5	to	to	IN
46745	6071	6	the	the	DT
46745	6071	7	same	same	JJ
46745	6071	8	,	,	,
46745	6071	9	p.	p.	NN
46745	6071	10	22	22	CD
46745	6071	11	.	.	.
46745	6072	1	[	[	-LRB-
46745	6072	2	16	16	CD
46745	6072	3	]	]	-RRB-
46745	6072	4	"	"	``
46745	6072	5	First	first	JJ
46745	6072	6	Lines	line	NNS
46745	6072	7	of	of	IN
46745	6072	8	the	the	DT
46745	6072	9	Practice	Practice	NNP
46745	6072	10	of	of	IN
46745	6072	11	Physic	Physic	NNP
46745	6072	12	.	.	.
46745	6072	13	"	"	''
46745	6073	1	Fourth	fourth	JJ
46745	6073	2	edition	edition	NN
46745	6073	3	,	,	,
46745	6073	4	1784	1784	CD
46745	6073	5	.	.	.
46745	6074	1	Vol	Vol	NNP
46745	6074	2	.	.	.
46745	6075	1	i.	i.	NNP
46745	6075	2	p.	p.	NN
46745	6075	3	126	126	CD
46745	6075	4	et	et	NN
46745	6075	5	seq	seq	NN
46745	6075	6	.	.	.
46745	6076	1	[	[	-LRB-
46745	6076	2	17	17	CD
46745	6076	3	]	]	-RRB-
46745	6076	4	An	an	DT
46745	6076	5	exception	exception	NN
46745	6076	6	should	should	MD
46745	6076	7	be	be	VB
46745	6076	8	made	make	VBN
46745	6076	9	here	here	RB
46745	6076	10	of	of	IN
46745	6076	11	certain	certain	JJ
46745	6076	12	animal	animal	NN
46745	6076	13	poisons	poison	NNS
46745	6076	14	,	,	,
46745	6076	15	such	such	JJ
46745	6076	16	as	as	IN
46745	6076	17	the	the	DT
46745	6076	18	venom	venom	NN
46745	6076	19	of	of	IN
46745	6076	20	serpents	serpent	NNS
46745	6076	21	,	,	,
46745	6076	22	which	which	WDT
46745	6076	23	,	,	,
46745	6076	24	though	though	IN
46745	6076	25	they	-PRON-	PRP
46745	6076	26	act	act	VBP
46745	6076	27	on	on	IN
46745	6076	28	the	the	DT
46745	6076	29	system	system	NN
46745	6076	30	when	when	WRB
46745	6076	31	introduced	introduce	VBN
46745	6076	32	directly	directly	RB
46745	6076	33	into	into	IN
46745	6076	34	the	the	DT
46745	6076	35	blood	blood	NN
46745	6076	36	,	,	,
46745	6076	37	seems	seem	VBZ
46745	6076	38	to	to	TO
46745	6076	39	be	be	VB
46745	6076	40	rendered	render	VBN
46745	6076	41	innocuous	innocuous	JJ
46745	6076	42	by	by	IN
46745	6076	43	the	the	DT
46745	6076	44	action	action	NN
46745	6076	45	of	of	IN
46745	6076	46	the	the	DT
46745	6076	47	stomach	stomach	NN
46745	6076	48	,	,	,
46745	6076	49	which	which	WDT
46745	6076	50	probably	probably	RB
46745	6076	51	decomposes	decompose	VBZ
46745	6076	52	them	-PRON-	PRP
46745	6076	53	.	.	.
46745	6077	1	[	[	-LRB-
46745	6077	2	18	18	CD
46745	6077	3	]	]	-RRB-
46745	6077	4	Physiological	Physiological	NNP
46745	6077	5	Researches	Researches	NNP
46745	6077	6	,	,	,
46745	6077	7	p.	p.	NN
46745	6077	8	63	63	CD
46745	6077	9	-	-	SYM
46745	6077	10	67	67	CD
46745	6077	11	.	.	.
46745	6078	1	[	[	-LRB-
46745	6078	2	19	19	CD
46745	6078	3	]	]	-RRB-
46745	6078	4	It	-PRON-	PRP
46745	6078	5	should	should	MD
46745	6078	6	be	be	VB
46745	6078	7	mentioned	mention	VBN
46745	6078	8	that	that	IN
46745	6078	9	Sir	Sir	NNP
46745	6078	10	Benjamin	Benjamin	NNP
46745	6078	11	Brodie	Brodie	NNP
46745	6078	12	,	,	,
46745	6078	13	though	though	IN
46745	6078	14	admitting	admit	VBG
46745	6078	15	the	the	DT
46745	6078	16	force	force	NN
46745	6078	17	of	of	IN
46745	6078	18	the	the	DT
46745	6078	19	above	above	JJ
46745	6078	20	experiments	experiment	NNS
46745	6078	21	,	,	,
46745	6078	22	and	and	CC
46745	6078	23	deriving	derive	VBG
46745	6078	24	from	from	IN
46745	6078	25	them	-PRON-	PRP
46745	6078	26	very	very	RB
46745	6078	27	similar	similar	JJ
46745	6078	28	inferences	inference	NNS
46745	6078	29	,	,	,
46745	6078	30	yet	yet	CC
46745	6078	31	considers	consider	VBZ
46745	6078	32	it	-PRON-	PRP
46745	6078	33	likely	likely	JJ
46745	6078	34	that	that	IN
46745	6078	35	the	the	DT
46745	6078	36	action	action	NN
46745	6078	37	of	of	IN
46745	6078	38	a	a	DT
46745	6078	39	medicine	medicine	NN
46745	6078	40	or	or	CC
46745	6078	41	poison	poison	NN
46745	6078	42	may	may	MD
46745	6078	43	be	be	VB
46745	6078	44	_	_	NNP
46745	6078	45	partly	partly	RB
46745	6078	46	_	_	NNP
46745	6078	47	propagated	propagate	VBN
46745	6078	48	by	by	IN
46745	6078	49	means	mean	NNS
46745	6078	50	of	of	IN
46745	6078	51	the	the	DT
46745	6078	52	nervous	nervous	JJ
46745	6078	53	system	system	NN
46745	6078	54	.	.	.
46745	6079	1	_	_	NNP
46745	6079	2	Op	Op	NNP
46745	6079	3	.	.	.
46745	6080	1	cit	cit	NNP
46745	6080	2	.	.	.
46745	6080	3	_	_	NNP
46745	6080	4	p.	p.	NN
46745	6080	5	127	127	CD
46745	6080	6	.	.	.
46745	6081	1	[	[	-LRB-
46745	6081	2	20	20	CD
46745	6081	3	]	]	-RRB-
46745	6081	4	_	_	NNP
46745	6081	5	Vide	Vide	NNP
46745	6081	6	_	_	NNP
46745	6081	7	Paper	Paper	NNP
46745	6081	8	in	in	IN
46745	6081	9	Medical	Medical	NNP
46745	6081	10	Gazette	Gazette	NNP
46745	6081	11	,	,	,
46745	6081	12	June	June	NNP
46745	6081	13	18th	18th	NN
46745	6081	14	,	,	,
46745	6081	15	1841	1841	CD
46745	6081	16	.	.	.
46745	6082	1	[	[	-LRB-
46745	6082	2	21	21	LS
46745	6082	3	]	]	-RRB-
46745	6082	4	Todd	Todd	NNP
46745	6082	5	and	and	CC
46745	6082	6	Bowman	Bowman	NNP
46745	6082	7	's	's	POS
46745	6082	8	Physiology	Physiology	NNP
46745	6082	9	,	,	,
46745	6082	10	vol	vol	NNP
46745	6082	11	.	.	.
46745	6083	1	ii	ii	LS
46745	6083	2	.	.	.
46745	6084	1	p.	p.	NN
46745	6084	2	280	280	CD
46745	6084	3	.	.	.
46745	6085	1	[	[	-LRB-
46745	6085	2	22	22	CD
46745	6085	3	]	]	-RRB-
46745	6085	4	_	_	NNP
46745	6085	5	Vide	Vide	NNP
46745	6085	6	_	_	NNP
46745	6085	7	Pereira	Pereira	NNP
46745	6085	8	's	's	POS
46745	6085	9	Materia	Materia	NNP
46745	6085	10	Medica	Medica	NNP
46745	6085	11	,	,	,
46745	6085	12	vol	vol	NNP
46745	6085	13	.	.	.
46745	6086	1	i.	i.	NNP
46745	6086	2	pp	pp	NNP
46745	6086	3	.	.	.
46745	6087	1	101	101	CD
46745	6087	2	,	,	,
46745	6087	3	106	106	CD
46745	6087	4	.	.	.
46745	6088	1	[	[	-LRB-
46745	6088	2	23	23	CD
46745	6088	3	]	]	-RRB-
46745	6088	4	Such	such	JJ
46745	6088	5	is	be	VBZ
46745	6088	6	the	the	DT
46745	6088	7	case	case	NN
46745	6088	8	in	in	IN
46745	6088	9	health	health	NN
46745	6088	10	,	,	,
46745	6088	11	when	when	WRB
46745	6088	12	the	the	DT
46745	6088	13	muscular	muscular	JJ
46745	6088	14	pressure	pressure	NN
46745	6088	15	of	of	IN
46745	6088	16	the	the	DT
46745	6088	17	intestine	intestine	NN
46745	6088	18	must	must	MD
46745	6088	19	exceed	exceed	VB
46745	6088	20	the	the	DT
46745	6088	21	pressure	pressure	NN
46745	6088	22	on	on	IN
46745	6088	23	the	the	DT
46745	6088	24	vascular	vascular	JJ
46745	6088	25	system	system	NN
46745	6088	26	on	on	IN
46745	6088	27	the	the	DT
46745	6088	28	other	other	JJ
46745	6088	29	side	side	NN
46745	6088	30	.	.	.
46745	6089	1	This	this	DT
46745	6089	2	latter	latter	JJ
46745	6089	3	pressure	pressure	NN
46745	6089	4	,	,	,
46745	6089	5	when	when	WRB
46745	6089	6	increased	increase	VBN
46745	6089	7	,	,	,
46745	6089	8	tends	tend	VBZ
46745	6089	9	to	to	TO
46745	6089	10	stop	stop	VB
46745	6089	11	or	or	CC
46745	6089	12	to	to	TO
46745	6089	13	reverse	reverse	VB
46745	6089	14	the	the	DT
46745	6089	15	inward	inward	JJ
46745	6089	16	current	current	NN
46745	6089	17	.	.	.
46745	6090	1	Thus	thus	RB
46745	6090	2	plethora	plethora	NNP
46745	6090	3	and	and	CC
46745	6090	4	fever	fever	NN
46745	6090	5	,	,	,
46745	6090	6	diseased	diseased	JJ
46745	6090	7	conditions	condition	NNS
46745	6090	8	,	,	,
46745	6090	9	counteract	counteract	VBN
46745	6090	10	absorption	absorption	NN
46745	6090	11	by	by	IN
46745	6090	12	causing	cause	VBG
46745	6090	13	pressure	pressure	NN
46745	6090	14	on	on	IN
46745	6090	15	the	the	DT
46745	6090	16	coats	coat	NNS
46745	6090	17	of	of	IN
46745	6090	18	these	these	DT
46745	6090	19	capillary	capillary	JJ
46745	6090	20	vessels	vessel	NNS
46745	6090	21	.	.	.
46745	6091	1	Bleeding,--a	bleeding,--a	JJ
46745	6091	2	drain	drain	NNP
46745	6091	3	of	of	IN
46745	6091	4	fluid	fluid	NN
46745	6091	5	caused	cause	VBN
46745	6091	6	by	by	IN
46745	6091	7	an	an	DT
46745	6091	8	increased	increase	VBN
46745	6091	9	secretion,--or	secretion,--or	NN
46745	6091	10	such	such	JJ
46745	6091	11	agents	agent	NNS
46745	6091	12	as	as	IN
46745	6091	13	Tartar	Tartar	NNP
46745	6091	14	Emetic	Emetic	NNP
46745	6091	15	and	and	CC
46745	6091	16	Ipecacuanha,--diminish	ipecacuanha,--diminish	VB
46745	6091	17	this	this	DT
46745	6091	18	pressure	pressure	NN
46745	6091	19	by	by	IN
46745	6091	20	weakening	weaken	VBG
46745	6091	21	the	the	DT
46745	6091	22	force	force	NN
46745	6091	23	of	of	IN
46745	6091	24	the	the	DT
46745	6091	25	heart	heart	NN
46745	6091	26	,	,	,
46745	6091	27	and	and	CC
46745	6091	28	thus	thus	RB
46745	6091	29	favour	favour	VBP
46745	6091	30	natural	natural	JJ
46745	6091	31	absorption	absorption	NN
46745	6091	32	.	.	.
46745	6092	1	[	[	-LRB-
46745	6092	2	24	24	CD
46745	6092	3	]	]	-RRB-
46745	6092	4	It	-PRON-	PRP
46745	6092	5	is	be	VBZ
46745	6092	6	stated	state	VBN
46745	6092	7	by	by	IN
46745	6092	8	Dr.	Dr.	NNP
46745	6092	9	Carpenter	Carpenter	NNP
46745	6092	10	,	,	,
46745	6092	11	that	that	IN
46745	6092	12	if	if	IN
46745	6092	13	a	a	DT
46745	6092	14	ligature	ligature	NN
46745	6092	15	be	be	VB
46745	6092	16	applied	apply	VBN
46745	6092	17	below	below	IN
46745	6092	18	the	the	DT
46745	6092	19	pylorus	pylorus	NN
46745	6092	20	of	of	IN
46745	6092	21	an	an	DT
46745	6092	22	animal	animal	NN
46745	6092	23	,	,	,
46745	6092	24	and	and	CC
46745	6092	25	Sulphate	Sulphate	NNP
46745	6092	26	of	of	IN
46745	6092	27	Magnesia	Magnesia	NNP
46745	6092	28	then	then	RB
46745	6092	29	introduced	introduce	VBD
46745	6092	30	into	into	IN
46745	6092	31	the	the	DT
46745	6092	32	stomach	stomach	NN
46745	6092	33	,	,	,
46745	6092	34	purging	purging	NN
46745	6092	35	is	be	VBZ
46745	6092	36	produced	produce	VBN
46745	6092	37	.	.	.
46745	6093	1	This	this	DT
46745	6093	2	could	could	MD
46745	6093	3	only	only	RB
46745	6093	4	be	be	VB
46745	6093	5	by	by	IN
46745	6093	6	the	the	DT
46745	6093	7	absorption	absorption	NN
46745	6093	8	of	of	IN
46745	6093	9	the	the	DT
46745	6093	10	salt	salt	NN
46745	6093	11	,	,	,
46745	6093	12	and	and	CC
46745	6093	13	its	-PRON-	PRP$
46745	6093	14	subsequent	subsequent	JJ
46745	6093	15	action	action	NN
46745	6093	16	from	from	IN
46745	6093	17	within	within	IN
46745	6093	18	on	on	IN
46745	6093	19	the	the	DT
46745	6093	20	mucous	mucous	JJ
46745	6093	21	membrane	membrane	NN
46745	6093	22	of	of	IN
46745	6093	23	the	the	DT
46745	6093	24	bowel	bowel	NN
46745	6093	25	below	below	IN
46745	6093	26	the	the	DT
46745	6093	27	ligature	ligature	NN
46745	6093	28	.	.	.
46745	6094	1	This	this	DT
46745	6094	2	experiment	experiment	NN
46745	6094	3	is	be	VBZ
46745	6094	4	unauthenticated	unauthenticated	JJ
46745	6094	5	,	,	,
46745	6094	6	but	but	CC
46745	6094	7	if	if	IN
46745	6094	8	verified	verify	VBN
46745	6094	9	would	would	MD
46745	6094	10	certainly	certainly	RB
46745	6094	11	be	be	VB
46745	6094	12	most	most	RBS
46745	6094	13	conclusive	conclusive	JJ
46745	6094	14	in	in	IN
46745	6094	15	favour	favour	NN
46745	6094	16	of	of	IN
46745	6094	17	the	the	DT
46745	6094	18	view	view	NN
46745	6094	19	adopted	adopt	VBN
46745	6094	20	above	above	RB
46745	6094	21	.	.	.
46745	6095	1	[	[	-LRB-
46745	6095	2	25	25	CD
46745	6095	3	]	]	-RRB-
46745	6095	4	Hydrochloric	Hydrochloric	NNP
46745	6095	5	acid	acid	NN
46745	6095	6	would	would	MD
46745	6095	7	probably	probably	RB
46745	6095	8	precipitate	precipitate	VB
46745	6095	9	medicinal	medicinal	JJ
46745	6095	10	solutions	solution	NNS
46745	6095	11	containing	contain	VBG
46745	6095	12	silver	silver	NN
46745	6095	13	,	,	,
46745	6095	14	and	and	CC
46745	6095	15	thus	thus	RB
46745	6095	16	render	render	VB
46745	6095	17	this	this	DT
46745	6095	18	substance	substance	NN
46745	6095	19	inert	inert	RB
46745	6095	20	when	when	WRB
46745	6095	21	given	give	VBN
46745	6095	22	internally	internally	RB
46745	6095	23	.	.	.
46745	6096	1	Another	another	DT
46745	6096	2	therapeutic	therapeutic	JJ
46745	6096	3	argument	argument	NN
46745	6096	4	against	against	IN
46745	6096	5	this	this	DT
46745	6096	6	,	,	,
46745	6096	7	as	as	IN
46745	6096	8	the	the	DT
46745	6096	9	acid	acid	NN
46745	6096	10	of	of	IN
46745	6096	11	the	the	DT
46745	6096	12	gastric	gastric	JJ
46745	6096	13	secretion	secretion	NN
46745	6096	14	,	,	,
46745	6096	15	may	may	MD
46745	6096	16	be	be	VB
46745	6096	17	drawn	draw	VBN
46745	6096	18	from	from	IN
46745	6096	19	the	the	DT
46745	6096	20	fact	fact	NN
46745	6096	21	that	that	IN
46745	6096	22	the	the	DT
46745	6096	23	action	action	NN
46745	6096	24	of	of	IN
46745	6096	25	calomel	calomel	NN
46745	6096	26	is	be	VBZ
46745	6096	27	very	very	RB
46745	6096	28	different	different	JJ
46745	6096	29	from	from	IN
46745	6096	30	that	that	DT
46745	6096	31	of	of	IN
46745	6096	32	bichloride	bichloride	NN
46745	6096	33	of	of	IN
46745	6096	34	mercury,--whereas	mercury,--whereas	NNP
46745	6096	35	this	this	DT
46745	6096	36	acid	acid	NN
46745	6096	37	would	would	MD
46745	6096	38	convert	convert	VB
46745	6096	39	the	the	DT
46745	6096	40	former	former	JJ
46745	6096	41	into	into	IN
46745	6096	42	the	the	DT
46745	6096	43	latter	latter	JJ
46745	6096	44	.	.	.
46745	6097	1	[	[	-LRB-
46745	6097	2	26	26	CD
46745	6097	3	]	]	-RRB-
46745	6097	4	Liebig	Liebig	NNP
46745	6097	5	(	(	-LRB-
46745	6097	6	_	_	NNP
46745	6097	7	Animal	Animal	NNP
46745	6097	8	Chemistry	Chemistry	NNP
46745	6097	9	_	_	NNP
46745	6097	10	,	,	,
46745	6097	11	Part	Part	NNP
46745	6097	12	I.	I.	NNP
46745	6097	13	p.	p.	NN
46745	6097	14	76	76	CD
46745	6097	15	)	)	-RRB-
46745	6097	16	states	state	VBZ
46745	6097	17	that	that	IN
46745	6097	18	the	the	DT
46745	6097	19	Bile	Bile	NNP
46745	6097	20	contains	contain	VBZ
46745	6097	21	Carbonate	carbonate	NN
46745	6097	22	of	of	IN
46745	6097	23	Soda	Soda	NNP
46745	6097	24	.	.	.
46745	6098	1	The	the	DT
46745	6098	2	assertion	assertion	NN
46745	6098	3	that	that	IN
46745	6098	4	the	the	DT
46745	6098	5	Pancreatic	pancreatic	JJ
46745	6098	6	juice	juice	NN
46745	6098	7	is	be	VBZ
46745	6098	8	alkaline	alkaline	NN
46745	6098	9	must	must	MD
46745	6098	10	be	be	VB
46745	6098	11	rested	rest	VBN
46745	6098	12	mainly	mainly	RB
46745	6098	13	on	on	IN
46745	6098	14	the	the	DT
46745	6098	15	authority	authority	NN
46745	6098	16	of	of	IN
46745	6098	17	M.	M.	NNP
46745	6098	18	Bernard	Bernard	NNP
46745	6098	19	.	.	.
46745	6099	1	[	[	-LRB-
46745	6099	2	27	27	CD
46745	6099	3	]	]	-RRB-
46745	6099	4	Occasionally	occasionally	RB
46745	6099	5	,	,	,
46745	6099	6	as	as	IN
46745	6099	7	in	in	IN
46745	6099	8	certain	certain	JJ
46745	6099	9	cases	case	NNS
46745	6099	10	of	of	IN
46745	6099	11	Pyrosis	Pyrosis	NNP
46745	6099	12	,	,	,
46745	6099	13	slight	slight	JJ
46745	6099	14	vomiting	vomiting	NN
46745	6099	15	may	may	MD
46745	6099	16	take	take	VB
46745	6099	17	place	place	NN
46745	6099	18	without	without	IN
46745	6099	19	any	any	DT
46745	6099	20	straining	strain	VBG
46745	6099	21	effort	effort	NN
46745	6099	22	of	of	IN
46745	6099	23	this	this	DT
46745	6099	24	kind	kind	NN
46745	6099	25	,	,	,
46745	6099	26	but	but	CC
46745	6099	27	apparently	apparently	RB
46745	6099	28	from	from	IN
46745	6099	29	the	the	DT
46745	6099	30	contraction	contraction	NN
46745	6099	31	of	of	IN
46745	6099	32	the	the	DT
46745	6099	33	stomach	stomach	NN
46745	6099	34	alone	alone	RB
46745	6099	35	.	.	.
46745	6100	1	[	[	-LRB-
46745	6100	2	28	28	CD
46745	6100	3	]	]	-RRB-
46745	6100	4	Pereira	Pereira	NNP
46745	6100	5	's	's	POS
46745	6100	6	Materia	Materia	NNP
46745	6100	7	Medica	Medica	NNP
46745	6100	8	,	,	,
46745	6100	9	2d	2d	CD
46745	6100	10	edit	edit	NN
46745	6100	11	.	.	.
46745	6100	12	,	,	,
46745	6100	13	vol	vol	NNP
46745	6100	14	.	.	.
46745	6101	1	ii	ii	LS
46745	6101	2	.	.	.
46745	6102	1	pp	pp	NNP
46745	6102	2	.	.	.
46745	6103	1	1496	1496	CD
46745	6103	2	,	,	,
46745	6103	3	1507	1507	CD
46745	6103	4	,	,	,
46745	6103	5	and	and	CC
46745	6103	6	elsewhere	elsewhere	RB
46745	6103	7	.	.	.
46745	6104	1	[	[	-LRB-
46745	6104	2	29	29	CD
46745	6104	3	]	]	-RRB-
46745	6104	4	Irritant	Irritant	NNP
46745	6104	5	Cathartics	Cathartics	NNPS
46745	6104	6	,	,	,
46745	6104	7	like	like	IN
46745	6104	8	irritant	irritant	JJ
46745	6104	9	emetics	emetic	NNS
46745	6104	10	,	,	,
46745	6104	11	may	may	MD
46745	6104	12	sometimes	sometimes	RB
46745	6104	13	affect	affect	VB
46745	6104	14	remote	remote	JJ
46745	6104	15	parts	part	NNS
46745	6104	16	on	on	IN
46745	6104	17	the	the	DT
46745	6104	18	principle	principle	NN
46745	6104	19	of	of	IN
46745	6104	20	counter	counter	NN
46745	6104	21	-	-	NN
46745	6104	22	irritation	irritation	NN
46745	6104	23	.	.	.
46745	6105	1	Some	some	DT
46745	6105	2	explain	explain	VBP
46745	6105	3	in	in	IN
46745	6105	4	this	this	DT
46745	6105	5	way	way	NN
46745	6105	6	the	the	DT
46745	6105	7	use	use	NN
46745	6105	8	of	of	IN
46745	6105	9	purgatives	purgative	NNS
46745	6105	10	in	in	IN
46745	6105	11	disorders	disorder	NNS
46745	6105	12	of	of	IN
46745	6105	13	the	the	DT
46745	6105	14	brain	brain	NN
46745	6105	15	,	,	,
46745	6105	16	but	but	CC
46745	6105	17	there	there	EX
46745	6105	18	are	be	VBP
46745	6105	19	other	other	JJ
46745	6105	20	reasons	reason	NNS
46745	6105	21	which	which	WDT
46745	6105	22	serve	serve	VBP
46745	6105	23	to	to	TO
46745	6105	24	account	account	VB
46745	6105	25	for	for	IN
46745	6105	26	this	this	DT
46745	6105	27	still	still	RB
46745	6105	28	more	more	RBR
46745	6105	29	satisfactorily	satisfactorily	RB
46745	6105	30	.	.	.
46745	6106	1	(	(	-LRB-
46745	6106	2	_	_	NNP
46745	6106	3	Vide	Vide	NNP
46745	6106	4	Chap	Chap	NNP
46745	6106	5	.	.	.
46745	6107	1	IV	IV	NNP
46745	6107	2	.	.	NNP
46745	6107	3	,	,	,
46745	6107	4	Art	art	NN
46745	6107	5	.	.	.
46745	6108	1	Purgatives	purgative	NNS
46745	6108	2	.	.	.
46745	6108	3	_	_	NNP
46745	6108	4	)	)	-RRB-
46745	6108	5	[	[	-LRB-
46745	6108	6	30	30	CD
46745	6108	7	]	]	-RRB-
46745	6108	8	The	the	DT
46745	6108	9	process	process	NN
46745	6108	10	of	of	IN
46745	6108	11	cure	cure	NN
46745	6108	12	by	by	IN
46745	6108	13	_	_	NNP
46745	6108	14	counter	counter	NN
46745	6108	15	-	-	NN
46745	6108	16	irritation	irritation	NN
46745	6108	17	_	_	NNP
46745	6108	18	may	may	MD
46745	6108	19	be	be	VB
46745	6108	20	ascribed	ascribe	VBN
46745	6108	21	to	to	IN
46745	6108	22	the	the	DT
46745	6108	23	_	_	NNP
46745	6108	24	secondary	secondary	JJ
46745	6108	25	_	_	NNP
46745	6108	26	action	action	NN
46745	6108	27	of	of	IN
46745	6108	28	some	some	DT
46745	6108	29	medicines	medicine	NNS
46745	6108	30	.	.	.
46745	6109	1	Such	such	PDT
46745	6109	2	an	an	DT
46745	6109	3	operation	operation	NN
46745	6109	4	may	may	MD
46745	6109	5	take	take	VB
46745	6109	6	place	place	NN
46745	6109	7	at	at	IN
46745	6109	8	a	a	DT
46745	6109	9	distance	distance	NN
46745	6109	10	from	from	IN
46745	6109	11	the	the	DT
46745	6109	12	part	part	NN
46745	6109	13	affected	affect	VBN
46745	6109	14	;	;	:
46745	6109	15	but	but	CC
46745	6109	16	it	-PRON-	PRP
46745	6109	17	is	be	VBZ
46745	6109	18	attributable	attributable	JJ
46745	6109	19	to	to	IN
46745	6109	20	a	a	DT
46745	6109	21	peculiar	peculiar	JJ
46745	6109	22	affection	affection	NN
46745	6109	23	of	of	IN
46745	6109	24	the	the	DT
46745	6109	25	nervous	nervous	JJ
46745	6109	26	system	system	NN
46745	6109	27	,	,	,
46745	6109	28	and	and	CC
46745	6109	29	has	have	VBZ
46745	6109	30	no	no	DT
46745	6109	31	necessary	necessary	JJ
46745	6109	32	connexion	connexion	NN
46745	6109	33	with	with	IN
46745	6109	34	the	the	DT
46745	6109	35	primary	primary	JJ
46745	6109	36	or	or	CC
46745	6109	37	proper	proper	JJ
46745	6109	38	action	action	NN
46745	6109	39	of	of	IN
46745	6109	40	a	a	DT
46745	6109	41	medicine	medicine	NN
46745	6109	42	.	.	.
46745	6110	1	_	_	NNP
46745	6110	2	Vide	Vide	NNP
46745	6110	3	_	_	NNP
46745	6110	4	p.	p.	NN
46745	6110	5	67	67	CD
46745	6110	6	.	.	.
46745	6111	1	[	[	-LRB-
46745	6111	2	31	31	CD
46745	6111	3	]	]	-RRB-
46745	6111	4	The	the	DT
46745	6111	5	details	detail	NNS
46745	6111	6	of	of	IN
46745	6111	7	this	this	DT
46745	6111	8	arrangement	arrangement	NN
46745	6111	9	are	be	VBP
46745	6111	10	founded	found	VBN
46745	6111	11	solely	solely	RB
46745	6111	12	upon	upon	IN
46745	6111	13	the	the	DT
46745	6111	14	_	_	NNP
46745	6111	15	therapeutic	therapeutic	JJ
46745	6111	16	operation	operation	NN
46745	6111	17	_	_	NNP
46745	6111	18	of	of	IN
46745	6111	19	medicines	medicine	NNS
46745	6111	20	,	,	,
46745	6111	21	as	as	IN
46745	6111	22	used	use	VBN
46745	6111	23	to	to	TO
46745	6111	24	cure	cure	VB
46745	6111	25	diseases	disease	NNS
46745	6111	26	,	,	,
46745	6111	27	and	and	CC
46745	6111	28	not	not	RB
46745	6111	29	in	in	IN
46745	6111	30	any	any	DT
46745	6111	31	way	way	NN
46745	6111	32	upon	upon	IN
46745	6111	33	their	-PRON-	PRP$
46745	6111	34	_	_	NNP
46745	6111	35	physiological	physiological	JJ
46745	6111	36	action	action	NN
46745	6111	37	_	_	NNP
46745	6111	38	upon	upon	IN
46745	6111	39	a	a	DT
46745	6111	40	healthy	healthy	JJ
46745	6111	41	man	man	NN
46745	6111	42	.	.	.
46745	6112	1	Much	much	JJ
46745	6112	2	unnecessary	unnecessary	JJ
46745	6112	3	confusion	confusion	NN
46745	6112	4	,	,	,
46745	6112	5	in	in	IN
46745	6112	6	works	work	NNS
46745	6112	7	on	on	IN
46745	6112	8	Materia	Materia	NNP
46745	6112	9	Medica	Medica	NNP
46745	6112	10	,	,	,
46745	6112	11	has	have	VBZ
46745	6112	12	arisen	arise	VBN
46745	6112	13	from	from	IN
46745	6112	14	these	these	DT
46745	6112	15	two	two	CD
46745	6112	16	different	different	JJ
46745	6112	17	matters	matter	NNS
46745	6112	18	being	be	VBG
46745	6112	19	taken	take	VBN
46745	6112	20	into	into	IN
46745	6112	21	account	account	NN
46745	6112	22	at	at	IN
46745	6112	23	the	the	DT
46745	6112	24	same	same	JJ
46745	6112	25	time	time	NN
46745	6112	26	.	.	.
46745	6113	1	Food	food	NN
46745	6113	2	is	be	VBZ
46745	6113	3	the	the	DT
46745	6113	4	only	only	JJ
46745	6113	5	restoration	restoration	NN
46745	6113	6	of	of	IN
46745	6113	7	wanting	want	VBG
46745	6113	8	material	material	NN
46745	6113	9	needful	needful	JJ
46745	6113	10	to	to	IN
46745	6113	11	a	a	DT
46745	6113	12	healthy	healthy	JJ
46745	6113	13	man	man	NN
46745	6113	14	;	;	:
46745	6113	15	neither	neither	CC
46745	6113	16	is	be	VBZ
46745	6113	17	there	there	RB
46745	6113	18	in	in	IN
46745	6113	19	such	such	PDT
46745	6113	20	a	a	DT
46745	6113	21	case	case	NN
46745	6113	22	any	any	DT
46745	6113	23	need	need	NN
46745	6113	24	or	or	CC
46745	6113	25	opportunity	opportunity	NN
46745	6113	26	for	for	IN
46745	6113	27	the	the	DT
46745	6113	28	counteraction	counteraction	NN
46745	6113	29	of	of	IN
46745	6113	30	morbid	morbid	NN
46745	6113	31	agencies	agency	NNS
46745	6113	32	.	.	.
46745	6114	1	[	[	-LRB-
46745	6114	2	32	32	CD
46745	6114	3	]	]	-RRB-
46745	6114	4	Animal	Animal	NNP
46745	6114	5	Chemistry	Chemistry	NNP
46745	6114	6	,	,	,
46745	6114	7	p.	p.	NN
46745	6114	8	20	20	CD
46745	6114	9	.	.	.
46745	6115	1	[	[	-LRB-
46745	6115	2	33	33	CD
46745	6115	3	]	]	-RRB-
46745	6115	4	Possibly	possibly	RB
46745	6115	5	some	some	DT
46745	6115	6	parts	part	NNS
46745	6115	7	of	of	IN
46745	6115	8	the	the	DT
46745	6115	9	bile	bile	NN
46745	6115	10	,	,	,
46745	6115	11	besides	besides	IN
46745	6115	12	the	the	DT
46745	6115	13	colouring	colour	VBG
46745	6115	14	matter	matter	NN
46745	6115	15	,	,	,
46745	6115	16	are	be	VBP
46745	6115	17	truly	truly	RB
46745	6115	18	excrementitious	excrementitious	JJ
46745	6115	19	.	.	.
46745	6116	1	But	but	CC
46745	6116	2	part	part	NN
46745	6116	3	of	of	IN
46745	6116	4	it	-PRON-	PRP
46745	6116	5	is	be	VBZ
46745	6116	6	needful	needful	JJ
46745	6116	7	in	in	IN
46745	6116	8	the	the	DT
46745	6116	9	animal	animal	NN
46745	6116	10	economy	economy	NN
46745	6116	11	,	,	,
46745	6116	12	as	as	IN
46745	6116	13	has	have	VBZ
46745	6116	14	been	be	VBN
46745	6116	15	proved	prove	VBN
46745	6116	16	by	by	IN
46745	6116	17	experiment	experiment	NN
46745	6116	18	.	.	.
46745	6117	1	M.	M.	NNP
46745	6117	2	Schwann	Schwann	NNP
46745	6117	3	found	find	VBD
46745	6117	4	that	that	IN
46745	6117	5	when	when	WRB
46745	6117	6	the	the	DT
46745	6117	7	contents	content	NNS
46745	6117	8	of	of	IN
46745	6117	9	the	the	DT
46745	6117	10	bile	bile	NN
46745	6117	11	-	-	HYPH
46745	6117	12	duct	duct	NN
46745	6117	13	in	in	IN
46745	6117	14	dogs	dog	NNS
46745	6117	15	were	be	VBD
46745	6117	16	caused	cause	VBN
46745	6117	17	to	to	TO
46745	6117	18	discharge	discharge	VB
46745	6117	19	themselves	-PRON-	PRP
46745	6117	20	externally	externally	RB
46745	6117	21	through	through	IN
46745	6117	22	a	a	DT
46745	6117	23	fistulous	fistulous	JJ
46745	6117	24	opening	opening	NN
46745	6117	25	in	in	IN
46745	6117	26	the	the	DT
46745	6117	27	wall	wall	NN
46745	6117	28	of	of	IN
46745	6117	29	the	the	DT
46745	6117	30	abdomen	abdomen	NNP
46745	6117	31	,	,	,
46745	6117	32	the	the	DT
46745	6117	33	animals	animal	NNS
46745	6117	34	quickly	quickly	RB
46745	6117	35	wasted	waste	VBD
46745	6117	36	away	away	RB
46745	6117	37	and	and	CC
46745	6117	38	died	die	VBD
46745	6117	39	.	.	.
46745	6118	1	In	in	IN
46745	6118	2	some	some	DT
46745	6118	3	cases	case	NNS
46745	6118	4	of	of	IN
46745	6118	5	jaundice	jaundice	NN
46745	6118	6	,	,	,
46745	6118	7	the	the	DT
46745	6118	8	constituents	constituent	NNS
46745	6118	9	of	of	IN
46745	6118	10	the	the	DT
46745	6118	11	bile	bile	NN
46745	6118	12	appear	appear	VBP
46745	6118	13	to	to	TO
46745	6118	14	be	be	VB
46745	6118	15	vicariously	vicariously	RB
46745	6118	16	excreted	excrete	VBN
46745	6118	17	by	by	IN
46745	6118	18	the	the	DT
46745	6118	19	kidneys	kidney	NNS
46745	6118	20	;	;	:
46745	6118	21	and	and	CC
46745	6118	22	perhaps	perhaps	RB
46745	6118	23	the	the	DT
46745	6118	24	great	great	JJ
46745	6118	25	depression	depression	NN
46745	6118	26	produced	produce	VBN
46745	6118	27	by	by	IN
46745	6118	28	that	that	DT
46745	6118	29	disorder	disorder	NN
46745	6118	30	maybe	maybe	RB
46745	6118	31	partly	partly	RB
46745	6118	32	accounted	account	VBN
46745	6118	33	for	for	IN
46745	6118	34	by	by	IN
46745	6118	35	the	the	DT
46745	6118	36	impossibility	impossibility	NN
46745	6118	37	of	of	IN
46745	6118	38	the	the	DT
46745	6118	39	re	re	NN
46745	6118	40	-	-	NN
46745	6118	41	absorption	absorption	NN
46745	6118	42	into	into	IN
46745	6118	43	the	the	DT
46745	6118	44	blood	blood	NN
46745	6118	45	of	of	IN
46745	6118	46	these	these	DT
46745	6118	47	substances	substance	NNS
46745	6118	48	,	,	,
46745	6118	49	naturally	naturally	RB
46745	6118	50	formed	form	VBN
46745	6118	51	by	by	IN
46745	6118	52	the	the	DT
46745	6118	53	liver	liver	NN
46745	6118	54	.	.	.
46745	6119	1	Having	have	VBG
46745	6119	2	passed	pass	VBN
46745	6119	3	into	into	IN
46745	6119	4	the	the	DT
46745	6119	5	urine	urine	NN
46745	6119	6	,	,	,
46745	6119	7	there	there	EX
46745	6119	8	is	be	VBZ
46745	6119	9	no	no	DT
46745	6119	10	provision	provision	NN
46745	6119	11	to	to	TO
46745	6119	12	enable	enable	VB
46745	6119	13	them	-PRON-	PRP
46745	6119	14	to	to	TO
46745	6119	15	return	return	VB
46745	6119	16	.	.	.
46745	6120	1	[	[	-LRB-
46745	6120	2	34	34	CD
46745	6120	3	]	]	-RRB-
46745	6120	4	He	-PRON-	PRP
46745	6120	5	states	state	VBZ
46745	6120	6	that	that	IN
46745	6120	7	one	one	CD
46745	6120	8	equivalent	equivalent	NN
46745	6120	9	of	of	IN
46745	6120	10	binoxalate	binoxalate	NN
46745	6120	11	of	of	IN
46745	6120	12	ammonia	ammonia	NN
46745	6120	13	and	and	CC
46745	6120	14	four	four	CD
46745	6120	15	of	of	IN
46745	6120	16	water	water	NN
46745	6120	17	contain	contain	VB
46745	6120	18	together	together	RB
46745	6120	19	the	the	DT
46745	6120	20	same	same	JJ
46745	6120	21	elements	element	NNS
46745	6120	22	as	as	IN
46745	6120	23	an	an	DT
46745	6120	24	atom	atom	NN
46745	6120	25	of	of	IN
46745	6120	26	Taurine	Taurine	NNP
46745	6120	27	.	.	.
46745	6121	1	(	(	-LRB-
46745	6121	2	_	_	NNP
46745	6121	3	Vide	Vide	NNP
46745	6121	4	Simon	Simon	NNP
46745	6121	5	's	's	POS
46745	6121	6	Animal	Animal	NNP
46745	6121	7	Chemistry	Chemistry	NNP
46745	6121	8	_	_	NNP
46745	6121	9	,	,	,
46745	6121	10	vol	vol	NNP
46745	6121	11	.	.	.
46745	6122	1	i.	i.	NNP
46745	6122	2	p.	p.	NN
46745	6122	3	47	47	CD
46745	6122	4	.	.	.
46745	6123	1	_	_	NNP
46745	6123	2	Syd	Syd	NNP
46745	6123	3	.	.	.
46745	6124	1	Society	society	NN
46745	6124	2	.	.	.
46745	6124	3	_	_	NNP
46745	6124	4	)	)	-RRB-
46745	6124	5	[	[	-LRB-
46745	6124	6	35	35	CD
46745	6124	7	]	]	-RRB-
46745	6124	8	A	a	DT
46745	6124	9	deposit	deposit	NN
46745	6124	10	of	of	IN
46745	6124	11	Oxalate	Oxalate	NNP
46745	6124	12	of	of	IN
46745	6124	13	Lime	Lime	NNP
46745	6124	14	occurs	occur	VBZ
46745	6124	15	sometimes	sometimes	RB
46745	6124	16	.	.	.
46745	6125	1	It	-PRON-	PRP
46745	6125	2	is	be	VBZ
46745	6125	3	seen	see	VBN
46745	6125	4	in	in	IN
46745	6125	5	minute	minute	NN
46745	6125	6	octahedra	octahedron	NNS
46745	6125	7	;	;	:
46745	6125	8	but	but	CC
46745	6125	9	is	be	VBZ
46745	6125	10	rarely	rarely	RB
46745	6125	11	in	in	IN
46745	6125	12	sufficient	sufficient	JJ
46745	6125	13	quantity	quantity	NN
46745	6125	14	to	to	TO
46745	6125	15	be	be	VB
46745	6125	16	distinguished	distinguish	VBN
46745	6125	17	by	by	IN
46745	6125	18	chemical	chemical	NN
46745	6125	19	tests	test	NNS
46745	6125	20	.	.	.
46745	6126	1	It	-PRON-	PRP
46745	6126	2	does	do	VBZ
46745	6126	3	not	not	RB
46745	6126	4	come	come	VB
46745	6126	5	within	within	IN
46745	6126	6	the	the	DT
46745	6126	7	influence	influence	NN
46745	6126	8	of	of	IN
46745	6126	9	Solvent	Solvent	NNP
46745	6126	10	medicines	medicine	NNS
46745	6126	11	.	.	.
46745	6127	1	[	[	-LRB-
46745	6127	2	36	36	CD
46745	6127	3	]	]	-RRB-
46745	6127	4	Some	some	DT
46745	6127	5	suppose	suppose	VBP
46745	6127	6	that	that	IN
46745	6127	7	this	this	DT
46745	6127	8	acid	acid	NN
46745	6127	9	occurs	occur	VBZ
46745	6127	10	in	in	IN
46745	6127	11	healthy	healthy	JJ
46745	6127	12	urine	urine	NN
46745	6127	13	is	be	VBZ
46745	6127	14	a	a	DT
46745	6127	15	free	free	JJ
46745	6127	16	state	state	NN
46745	6127	17	.	.	.
46745	6128	1	It	-PRON-	PRP
46745	6128	2	is	be	VBZ
46745	6128	3	more	more	RBR
46745	6128	4	commonly	commonly	RB
46745	6128	5	thought	think	VBN
46745	6128	6	to	to	TO
46745	6128	7	exist	exist	VB
46745	6128	8	as	as	IN
46745	6128	9	Urate	Urate	NNP
46745	6128	10	of	of	IN
46745	6128	11	Ammonia	Ammonia	NNP
46745	6128	12	.	.	.
46745	6129	1	Lehmann	Lehmann	NNP
46745	6129	2	states	state	VBZ
46745	6129	3	that	that	IN
46745	6129	4	it	-PRON-	PRP
46745	6129	5	is	be	VBZ
46745	6129	6	found	find	VBN
46745	6129	7	as	as	IN
46745	6129	8	Urate	Urate	NNP
46745	6129	9	of	of	IN
46745	6129	10	Soda	Soda	NNP
46745	6129	11	.	.	.
46745	6130	1	Others	other	NNS
46745	6130	2	imagine	imagine	VBP
46745	6130	3	that	that	IN
46745	6130	4	it	-PRON-	PRP
46745	6130	5	is	be	VBZ
46745	6130	6	held	hold	VBN
46745	6130	7	in	in	IN
46745	6130	8	solution	solution	NN
46745	6130	9	by	by	IN
46745	6130	10	means	mean	NNS
46745	6130	11	of	of	IN
46745	6130	12	Phosphate	Phosphate	NNP
46745	6130	13	of	of	IN
46745	6130	14	Soda	Soda	NNP
46745	6130	15	.	.	.
46745	6131	1	[	[	-LRB-
46745	6131	2	37	37	CD
46745	6131	3	]	]	-RRB-
46745	6131	4	This	this	DT
46745	6131	5	acid	acid	NN
46745	6131	6	is	be	VBZ
46745	6131	7	ascribed	ascribe	VBN
46745	6131	8	by	by	IN
46745	6131	9	some	some	DT
46745	6131	10	to	to	IN
46745	6131	11	Urate	Urate	NNP
46745	6131	12	of	of	IN
46745	6131	13	Ammonia	Ammonia	NNP
46745	6131	14	,	,	,
46745	6131	15	which	which	WDT
46745	6131	16	is	be	VBZ
46745	6131	17	to	to	IN
46745	6131	18	a	a	DT
46745	6131	19	small	small	JJ
46745	6131	20	extent	extent	NN
46745	6131	21	soluble	soluble	JJ
46745	6131	22	in	in	IN
46745	6131	23	water	water	NN
46745	6131	24	.	.	.
46745	6132	1	Others	other	NNS
46745	6132	2	consider	consider	VBP
46745	6132	3	that	that	IN
46745	6132	4	it	-PRON-	PRP
46745	6132	5	is	be	VBZ
46745	6132	6	due	due	JJ
46745	6132	7	both	both	DT
46745	6132	8	to	to	IN
46745	6132	9	this	this	DT
46745	6132	10	and	and	CC
46745	6132	11	to	to	IN
46745	6132	12	Phosphoric	Phosphoric	NNP
46745	6132	13	acid	acid	NN
46745	6132	14	,	,	,
46745	6132	15	which	which	WDT
46745	6132	16	is	be	VBZ
46745	6132	17	the	the	DT
46745	6132	18	opinion	opinion	NN
46745	6132	19	of	of	IN
46745	6132	20	Dr.	Dr.	NNP
46745	6132	21	Prout	Prout	NNP
46745	6132	22	and	and	CC
46745	6132	23	Dr.	Dr.	NNP
46745	6132	24	G.	G.	NNP
46745	6132	25	Bird	Bird	NNP
46745	6132	26	.	.	.
46745	6133	1	Others	other	NNS
46745	6133	2	attribute	attribute	VBP
46745	6133	3	it	-PRON-	PRP
46745	6133	4	to	to	IN
46745	6133	5	Lactic	lactic	JJ
46745	6133	6	acid	acid	NN
46745	6133	7	,	,	,
46745	6133	8	which	which	WDT
46745	6133	9	is	be	VBZ
46745	6133	10	stated	state	VBN
46745	6133	11	by	by	IN
46745	6133	12	Berzelius	Berzelius	NNP
46745	6133	13	,	,	,
46745	6133	14	Lehmann	Lehmann	NNP
46745	6133	15	,	,	,
46745	6133	16	and	and	CC
46745	6133	17	Simon	Simon	NNP
46745	6133	18	,	,	,
46745	6133	19	to	to	TO
46745	6133	20	exist	exist	VB
46745	6133	21	in	in	IN
46745	6133	22	healthy	healthy	JJ
46745	6133	23	urine	urine	NN
46745	6133	24	.	.	.
46745	6134	1	Some	some	DT
46745	6134	2	consider	consider	VBP
46745	6134	3	the	the	DT
46745	6134	4	acid	acid	NN
46745	6134	5	to	to	TO
46745	6134	6	consist	consist	VB
46745	6134	7	in	in	IN
46745	6134	8	a	a	DT
46745	6134	9	Super	super	JJ
46745	6134	10	-	-	NN
46745	6134	11	phosphate	phosphate	NN
46745	6134	12	of	of	IN
46745	6134	13	Soda	Soda	NNP
46745	6134	14	.	.	.
46745	6135	1	Liebig	Liebig	NNP
46745	6135	2	supposes	suppose	VBZ
46745	6135	3	that	that	IN
46745	6135	4	it	-PRON-	PRP
46745	6135	5	is	be	VBZ
46745	6135	6	due	due	JJ
46745	6135	7	to	to	IN
46745	6135	8	Uric	Uric	NNP
46745	6135	9	acid	acid	NN
46745	6135	10	,	,	,
46745	6135	11	held	hold	VBN
46745	6135	12	in	in	IN
46745	6135	13	solution	solution	NN
46745	6135	14	by	by	IN
46745	6135	15	the	the	DT
46745	6135	16	common	common	JJ
46745	6135	17	Phosphate	Phosphate	NNP
46745	6135	18	of	of	IN
46745	6135	19	Soda	Soda	NNP
46745	6135	20	.	.	.
46745	6136	1	He	-PRON-	PRP
46745	6136	2	also	also	RB
46745	6136	3	considers	consider	VBZ
46745	6136	4	Hippuric	Hippuric	NNP
46745	6136	5	acid	acid	NN
46745	6136	6	to	to	TO
46745	6136	7	be	be	VB
46745	6136	8	an	an	DT
46745	6136	9	invariable	invariable	JJ
46745	6136	10	ingredient	ingredient	NN
46745	6136	11	in	in	IN
46745	6136	12	healthy	healthy	JJ
46745	6136	13	human	human	JJ
46745	6136	14	urine	urine	NN
46745	6136	15	.	.	.
46745	6137	1	[	[	-LRB-
46745	6137	2	38	38	CD
46745	6137	3	]	]	-RRB-
46745	6137	4	According	accord	VBG
46745	6137	5	to	to	IN
46745	6137	6	Simon	Simon	NNP
46745	6137	7	it	-PRON-	PRP
46745	6137	8	is	be	VBZ
46745	6137	9	1.0125	1.0125	CD
46745	6137	10	;	;	:
46745	6137	11	Becquerel	Becquerel	NNP
46745	6137	12	makes	make	VBZ
46745	6137	13	it	-PRON-	PRP
46745	6137	14	1.017	1.017	CD
46745	6137	15	;	;	:
46745	6137	16	Dr.	Dr.	NNP
46745	6137	17	Prout	Prout	NNP
46745	6137	18	and	and	CC
46745	6137	19	Dr.	Dr.	NNP
46745	6137	20	Golding	Golding	NNP
46745	6137	21	Bird	Bird	NNP
46745	6137	22	,	,	,
46745	6137	23	1.020	1.020	CD
46745	6137	24	;	;	:
46745	6137	25	Berzelius	Berzelius	NNP
46745	6137	26	rates	rate	VBZ
46745	6137	27	it	-PRON-	PRP
46745	6137	28	still	still	RB
46745	6137	29	higher	high	JJR
46745	6137	30	.	.	.
46745	6138	1	[	[	-LRB-
46745	6138	2	39	39	CD
46745	6138	3	]	]	-RRB-
46745	6138	4	"	"	``
46745	6138	5	The	the	DT
46745	6138	6	state	state	NN
46745	6138	7	or	or	CC
46745	6138	8	condition	condition	NN
46745	6138	9	of	of	IN
46745	6138	10	formation	formation	NN
46745	6138	11	or	or	CC
46745	6138	12	decomposition	decomposition	NN
46745	6138	13	of	of	IN
46745	6138	14	a	a	DT
46745	6138	15	body	body	NN
46745	6138	16	,	,	,
46745	6138	17	the	the	DT
46745	6138	18	state	state	NN
46745	6138	19	of	of	IN
46745	6138	20	change	change	NN
46745	6138	21	of	of	IN
46745	6138	22	place	place	NN
46745	6138	23	or	or	CC
46745	6138	24	motion	motion	NN
46745	6138	25	in	in	IN
46745	6138	26	which	which	WDT
46745	6138	27	its	-PRON-	PRP$
46745	6138	28	particles	particle	NNS
46745	6138	29	are	be	VBP
46745	6138	30	,	,	,
46745	6138	31	exerts	exert	VBZ
46745	6138	32	an	an	DT
46745	6138	33	influence	influence	NN
46745	6138	34	on	on	IN
46745	6138	35	the	the	DT
46745	6138	36	particles	particle	NNS
46745	6138	37	of	of	IN
46745	6138	38	many	many	JJ
46745	6138	39	other	other	JJ
46745	6138	40	compounds	compound	NNS
46745	6138	41	,	,	,
46745	6138	42	if	if	IN
46745	6138	43	in	in	IN
46745	6138	44	contact	contact	NN
46745	6138	45	with	with	IN
46745	6138	46	them	-PRON-	PRP
46745	6138	47	.	.	.
46745	6139	1	The	the	DT
46745	6139	2	latter	latter	JJ
46745	6139	3	are	be	VBP
46745	6139	4	brought	bring	VBN
46745	6139	5	into	into	IN
46745	6139	6	the	the	DT
46745	6139	7	same	same	JJ
46745	6139	8	state	state	NN
46745	6139	9	;	;	:
46745	6139	10	their	-PRON-	PRP$
46745	6139	11	elements	element	NNS
46745	6139	12	are	be	VBP
46745	6139	13	separated	separate	VBN
46745	6139	14	and	and	CC
46745	6139	15	newly	newly	RB
46745	6139	16	arranged	arrange	VBN
46745	6139	17	in	in	IN
46745	6139	18	a	a	DT
46745	6139	19	similar	similar	JJ
46745	6139	20	way	way	NN
46745	6139	21	,	,	,
46745	6139	22	and	and	CC
46745	6139	23	acquire	acquire	VB
46745	6139	24	the	the	DT
46745	6139	25	power	power	NN
46745	6139	26	of	of	IN
46745	6139	27	entering	enter	VBG
46745	6139	28	into	into	IN
46745	6139	29	combination	combination	NN
46745	6139	30	,	,	,
46745	6139	31	a	a	DT
46745	6139	32	power	power	NN
46745	6139	33	which	which	WDT
46745	6139	34	they	-PRON-	PRP
46745	6139	35	did	do	VBD
46745	6139	36	not	not	RB
46745	6139	37	,	,	,
46745	6139	38	under	under	IN
46745	6139	39	similar	similar	JJ
46745	6139	40	circumstances	circumstance	NNS
46745	6139	41	,	,	,
46745	6139	42	previously	previously	RB
46745	6139	43	possess	possess	VBP
46745	6139	44	.	.	.
46745	6139	45	"	"	''
46745	6140	1	--_Liebig	--_Liebig	NNP
46745	6140	2	's	's	POS
46745	6140	3	Animal	Animal	NNP
46745	6140	4	Chemistry	Chemistry	NNP
46745	6140	5	_	_	NNP
46745	6140	6	,	,	,
46745	6140	7	vol	vol	NNP
46745	6140	8	.	.	.
46745	6141	1	i.	i.	NNP
46745	6141	2	p.	p.	NN
46745	6141	3	194	194	CD
46745	6141	4	.	.	.
46745	6142	1	[	[	-LRB-
46745	6142	2	40	40	CD
46745	6142	3	]	]	-RRB-
46745	6142	4	Dr.	Dr.	NNP
46745	6142	5	Mead	Mead	NNP
46745	6142	6	,	,	,
46745	6142	7	in	in	IN
46745	6142	8	1751	1751	CD
46745	6142	9	,	,	,
46745	6142	10	recommended	recommend	VBD
46745	6142	11	the	the	DT
46745	6142	12	employment	employment	NN
46745	6142	13	in	in	IN
46745	6142	14	Scrofula	Scrofula	NNP
46745	6142	15	of	of	IN
46745	6142	16	burnt	burn	VBN
46745	6142	17	sponge	sponge	NN
46745	6142	18	,	,	,
46745	6142	19	and	and	CC
46745	6142	20	a	a	DT
46745	6142	21	pill	pill	NN
46745	6142	22	containing	contain	VBG
46745	6142	23	"	"	``
46745	6142	24	sublimed	sublime	VBD
46745	6142	25	Mercury	Mercury	NNP
46745	6142	26	"	"	''
46745	6142	27	and	and	CC
46745	6142	28	precipitated	precipitate	VBD
46745	6142	29	Sulphuret	Sulphuret	NNP
46745	6142	30	of	of	IN
46745	6142	31	Antimony	Antimony	NNP
46745	6142	32	.	.	.
46745	6143	1	Plummer	Plummer	NNP
46745	6143	2	's	's	POS
46745	6143	3	pill	pill	NN
46745	6143	4	is	be	VBZ
46745	6143	5	often	often	RB
46745	6143	6	prescribed	prescribe	VBN
46745	6143	7	in	in	IN
46745	6143	8	these	these	DT
46745	6143	9	cases	case	NNS
46745	6143	10	at	at	IN
46745	6143	11	the	the	DT
46745	6143	12	present	present	JJ
46745	6143	13	day	day	NN
46745	6143	14	.	.	.
46745	6144	1	[	[	-LRB-
46745	6144	2	41	41	CD
46745	6144	3	]	]	-RRB-
46745	6144	4	Among	among	IN
46745	6144	5	these	these	DT
46745	6144	6	,	,	,
46745	6144	7	Dock	Dock	NNP
46745	6144	8	,	,	,
46745	6144	9	Sorrel	Sorrel	NNP
46745	6144	10	,	,	,
46745	6144	11	Wood	wood	NN
46745	6144	12	-	-	HYPH
46745	6144	13	sorrel	sorrel	NNP
46745	6144	14	,	,	,
46745	6144	15	and	and	CC
46745	6144	16	Stonecrop	Stonecrop	NNP
46745	6144	17	,	,	,
46745	6144	18	may	may	MD
46745	6144	19	be	be	VB
46745	6144	20	mentioned	mention	VBN
46745	6144	21	.	.	.
46745	6145	1	Such	such	JJ
46745	6145	2	herbs	herb	NNS
46745	6145	3	have	have	VBP
46745	6145	4	been	be	VBN
46745	6145	5	long	long	RB
46745	6145	6	employed	employ	VBN
46745	6145	7	,	,	,
46745	6145	8	and	and	CC
46745	6145	9	recommended	recommend	VBN
46745	6145	10	by	by	IN
46745	6145	11	authority	authority	NN
46745	6145	12	.	.	.
46745	6146	1	Dr.	Dr.	NNP
46745	6146	2	Mead	Mead	NNP
46745	6146	3	,	,	,
46745	6146	4	in	in	IN
46745	6146	5	1751	1751	CD
46745	6146	6	,	,	,
46745	6146	7	recommended	recommend	VBD
46745	6146	8	Scurvy	Scurvy	NNP
46745	6146	9	-	-	HYPH
46745	6146	10	grass	grass	NN
46745	6146	11	,	,	,
46745	6146	12	Lettuce	lettuce	NN
46745	6146	13	,	,	,
46745	6146	14	and	and	CC
46745	6146	15	Brooklime	Brooklime	NNP
46745	6146	16	.	.	.
46745	6147	1	He	-PRON-	PRP
46745	6147	2	also	also	RB
46745	6147	3	made	make	VBD
46745	6147	4	particular	particular	JJ
46745	6147	5	mention	mention	NN
46745	6147	6	of	of	IN
46745	6147	7	the	the	DT
46745	6147	8	_	_	NNP
46745	6147	9	Herba	Herba	NNP
46745	6147	10	Britannica	Britannica	NNP
46745	6147	11	_	_	NNP
46745	6147	12	,	,	,
46745	6147	13	which	which	WDT
46745	6147	14	seems	seem	VBZ
46745	6147	15	to	to	TO
46745	6147	16	have	have	VB
46745	6147	17	been	be	VBN
46745	6147	18	the	the	DT
46745	6147	19	great	great	JJ
46745	6147	20	Dock	Dock	NNP
46745	6147	21	,	,	,
46745	6147	22	Rumex	Rumex	NNP
46745	6147	23	hydrolapathum	hydrolapathum	NNP
46745	6147	24	.	.	.
46745	6148	1	The	the	DT
46745	6148	2	same	same	JJ
46745	6148	3	physician	physician	NN
46745	6148	4	appears	appear	VBZ
46745	6148	5	to	to	TO
46745	6148	6	have	have	VB
46745	6148	7	anticipated	anticipate	VBN
46745	6148	8	some	some	DT
46745	6148	9	of	of	IN
46745	6148	10	the	the	DT
46745	6148	11	modern	modern	JJ
46745	6148	12	applications	application	NNS
46745	6148	13	of	of	IN
46745	6148	14	Lemon	Lemon	NNP
46745	6148	15	juice	juice	NN
46745	6148	16	.	.	.
46745	6149	1	He	-PRON-	PRP
46745	6149	2	employed	employ	VBD
46745	6149	3	it	-PRON-	PRP
46745	6149	4	in	in	IN
46745	6149	5	liver	liver	NN
46745	6149	6	-	-	HYPH
46745	6149	7	diseases	disease	NNS
46745	6149	8	generally	generally	RB
46745	6149	9	,	,	,
46745	6149	10	among	among	IN
46745	6149	11	which	which	WDT
46745	6149	12	he	-PRON-	PRP
46745	6149	13	included	include	VBD
46745	6149	14	a	a	DT
46745	6149	15	number	number	NN
46745	6149	16	of	of	IN
46745	6149	17	dyspeptic	dyspeptic	JJ
46745	6149	18	and	and	CC
46745	6149	19	gouty	gouty	JJ
46745	6149	20	disorders	disorder	NNS
46745	6149	21	.	.	.
46745	6150	1	He	-PRON-	PRP
46745	6150	2	gave	give	VBD
46745	6150	3	it	-PRON-	PRP
46745	6150	4	in	in	IN
46745	6150	5	six	six	CD
46745	6150	6	-	-	HYPH
46745	6150	7	drachm	drachm	NN
46745	6150	8	doses	dose	NNS
46745	6150	9	;	;	:
46745	6150	10	and	and	CC
46745	6150	11	says	say	VBZ
46745	6150	12	that	that	IN
46745	6150	13	he	-PRON-	PRP
46745	6150	14	employed	employ	VBD
46745	6150	15	also	also	RB
46745	6150	16	in	in	IN
46745	6150	17	similar	similar	JJ
46745	6150	18	cases	case	NNS
46745	6150	19	_	_	IN
46745	6150	20	saponaceous	saponaceous	JJ
46745	6150	21	_	_	NNP
46745	6150	22	medicines	medicine	NNS
46745	6150	23	,	,	,
46745	6150	24	and	and	CC
46745	6150	25	rhubarb	rhubarb	JJ
46745	6150	26	.	.	.
46745	6151	1	These	these	DT
46745	6151	2	remedies	remedy	NNS
46745	6151	3	,	,	,
46745	6151	4	apparently	apparently	RB
46745	6151	5	heterogeneous	heterogeneous	JJ
46745	6151	6	,	,	,
46745	6151	7	were	be	VBD
46745	6151	8	recognised	recognise	VBN
46745	6151	9	then	then	RB
46745	6151	10	,	,	,
46745	6151	11	as	as	IN
46745	6151	12	now	now	RB
46745	6151	13	,	,	,
46745	6151	14	to	to	TO
46745	6151	15	be	be	VB
46745	6151	16	useful	useful	JJ
46745	6151	17	in	in	IN
46745	6151	18	the	the	DT
46745	6151	19	same	same	JJ
46745	6151	20	cases	case	NNS
46745	6151	21	.	.	.
46745	6152	1	For	for	IN
46745	6152	2	we	-PRON-	PRP
46745	6152	3	have	have	VBP
46745	6152	4	just	just	RB
46745	6152	5	seen	see	VBN
46745	6152	6	that	that	IN
46745	6152	7	Lemon	Lemon	NNP
46745	6152	8	-	-	HYPH
46745	6152	9	juice	juice	NN
46745	6152	10	,	,	,
46745	6152	11	Alkalies	Alkalies	NNP
46745	6152	12	,	,	,
46745	6152	13	Cholagogues	Cholagogues	NNPS
46745	6152	14	,	,	,
46745	6152	15	and	and	CC
46745	6152	16	Tonics	Tonics	NNP
46745	6152	17	,	,	,
46745	6152	18	are	be	VBP
46745	6152	19	all	all	RB
46745	6152	20	more	more	RBR
46745	6152	21	or	or	CC
46745	6152	22	less	less	RBR
46745	6152	23	applicable	applicable	JJ
46745	6152	24	in	in	IN
46745	6152	25	diseases	disease	NNS
46745	6152	26	of	of	IN
46745	6152	27	the	the	DT
46745	6152	28	Arthritic	arthritic	JJ
46745	6152	29	group	group	NN
46745	6152	30	.	.	.
46745	6153	1	[	[	-LRB-
46745	6153	2	42	42	CD
46745	6153	3	]	]	-RRB-
46745	6153	4	I	-PRON-	PRP
46745	6153	5	have	have	VBP
46745	6153	6	just	just	RB
46745	6153	7	said	say	VBN
46745	6153	8	that	that	IN
46745	6153	9	Neurotic	neurotic	JJ
46745	6153	10	medicines	medicine	NNS
46745	6153	11	influence	influence	VBP
46745	6153	12	those	those	DT
46745	6153	13	functions	function	NNS
46745	6153	14	which	which	WDT
46745	6153	15	are	be	VBP
46745	6153	16	attributed	attribute	VBN
46745	6153	17	to	to	IN
46745	6153	18	the	the	DT
46745	6153	19	nervous	nervous	JJ
46745	6153	20	system	system	NN
46745	6153	21	.	.	.
46745	6154	1	Now	now	RB
46745	6154	2	there	there	EX
46745	6154	3	can	can	MD
46745	6154	4	be	be	VB
46745	6154	5	no	no	DT
46745	6154	6	reasonable	reasonable	JJ
46745	6154	7	doubt	doubt	NN
46745	6154	8	that	that	IN
46745	6154	9	they	-PRON-	PRP
46745	6154	10	actually	actually	RB
46745	6154	11	influence	influence	VBP
46745	6154	12	the	the	DT
46745	6154	13	nerves	nerve	NNS
46745	6154	14	.	.	.
46745	6155	1	But	but	CC
46745	6155	2	it	-PRON-	PRP
46745	6155	3	is	be	VBZ
46745	6155	4	worth	worth	JJ
46745	6155	5	while	while	IN
46745	6155	6	to	to	TO
46745	6155	7	notice	notice	VB
46745	6155	8	here	here	RB
46745	6155	9	the	the	DT
46745	6155	10	curious	curious	JJ
46745	6155	11	fact	fact	NN
46745	6155	12	that	that	IN
46745	6155	13	the	the	DT
46745	6155	14	same	same	JJ
46745	6155	15	agents	agent	NNS
46745	6155	16	have	have	VBP
46745	6155	17	been	be	VBN
46745	6155	18	found	find	VBN
46745	6155	19	to	to	TO
46745	6155	20	paralyze	paralyze	VB
46745	6155	21	the	the	DT
46745	6155	22	irritable	irritable	JJ
46745	6155	23	or	or	CC
46745	6155	24	contractile	contractile	JJ
46745	6155	25	tissues	tissue	NNS
46745	6155	26	of	of	IN
46745	6155	27	certain	certain	JJ
46745	6155	28	vegetables	vegetable	NNS
46745	6155	29	.	.	.
46745	6156	1	Professor	Professor	NNP
46745	6156	2	Marcet	Marcet	NNP
46745	6156	3	of	of	IN
46745	6156	4	Geneva	Geneva	NNP
46745	6156	5	first	first	RB
46745	6156	6	noticed	notice	VBD
46745	6156	7	that	that	IN
46745	6156	8	the	the	DT
46745	6156	9	vapours	vapour	NNS
46745	6156	10	of	of	IN
46745	6156	11	Chloroform	Chloroform	NNP
46745	6156	12	and	and	CC
46745	6156	13	Ether	Ether	NNP
46745	6156	14	affected	affect	VBD
46745	6156	15	the	the	DT
46745	6156	16	leaf	leaf	NN
46745	6156	17	of	of	IN
46745	6156	18	the	the	DT
46745	6156	19	sensitive	sensitive	JJ
46745	6156	20	plant	plant	NN
46745	6156	21	so	so	IN
46745	6156	22	as	as	IN
46745	6156	23	to	to	TO
46745	6156	24	prevent	prevent	VB
46745	6156	25	it	-PRON-	PRP
46745	6156	26	from	from	IN
46745	6156	27	contracting	contract	VBG
46745	6156	28	at	at	IN
46745	6156	29	the	the	DT
46745	6156	30	touch	touch	NN
46745	6156	31	,	,	,
46745	6156	32	but	but	CC
46745	6156	33	without	without	IN
46745	6156	34	at	at	IN
46745	6156	35	the	the	DT
46745	6156	36	same	same	JJ
46745	6156	37	time	time	NN
46745	6156	38	perceptibly	perceptibly	RB
46745	6156	39	injuring	injure	VBG
46745	6156	40	its	-PRON-	PRP$
46745	6156	41	structure	structure	NN
46745	6156	42	.	.	.
46745	6157	1	I	-PRON-	PRP
46745	6157	2	have	have	VBP
46745	6157	3	produced	produce	VBN
46745	6157	4	the	the	DT
46745	6157	5	same	same	JJ
46745	6157	6	effect	effect	NN
46745	6157	7	on	on	IN
46745	6157	8	a	a	DT
46745	6157	9	species	species	NN
46745	6157	10	of	of	IN
46745	6157	11	Acacia	Acacia	NNP
46745	6157	12	,	,	,
46745	6157	13	which	which	WDT
46745	6157	14	naturally	naturally	RB
46745	6157	15	closes	close	VBZ
46745	6157	16	its	-PRON-	PRP$
46745	6157	17	leaves	leave	NNS
46745	6157	18	at	at	IN
46745	6157	19	the	the	DT
46745	6157	20	approach	approach	NN
46745	6157	21	of	of	IN
46745	6157	22	night	night	NN
46745	6157	23	.	.	.
46745	6158	1	The	the	DT
46745	6158	2	leaf	leaf	NN
46745	6158	3	experimented	experiment	VBN
46745	6158	4	on	on	IN
46745	6158	5	remained	remain	VBN
46745	6158	6	open	open	JJ
46745	6158	7	,	,	,
46745	6158	8	while	while	IN
46745	6158	9	the	the	DT
46745	6158	10	others	other	NNS
46745	6158	11	closed	close	VBD
46745	6158	12	.	.	.
46745	6159	1	After	after	IN
46745	6159	2	a	a	DT
46745	6159	3	certain	certain	JJ
46745	6159	4	time	time	NN
46745	6159	5	it	-PRON-	PRP
46745	6159	6	recovered	recover	VBD
46745	6159	7	.	.	.
46745	6160	1	Solutions	solution	NNS
46745	6160	2	of	of	IN
46745	6160	3	Morphia	Morphia	NNP
46745	6160	4	,	,	,
46745	6160	5	Conia	Conia	NNP
46745	6160	6	,	,	,
46745	6160	7	and	and	CC
46745	6160	8	other	other	JJ
46745	6160	9	sedatives	sedative	NNS
46745	6160	10	,	,	,
46745	6160	11	have	have	VBP
46745	6160	12	been	be	VBN
46745	6160	13	found	find	VBN
46745	6160	14	to	to	TO
46745	6160	15	produce	produce	VB
46745	6160	16	the	the	DT
46745	6160	17	same	same	JJ
46745	6160	18	result	result	NN
46745	6160	19	.	.	.
46745	6161	1	Now	now	RB
46745	6161	2	the	the	DT
46745	6161	3	existence	existence	NN
46745	6161	4	in	in	IN
46745	6161	5	plants	plant	NNS
46745	6161	6	of	of	IN
46745	6161	7	nervous	nervous	JJ
46745	6161	8	tissues	tissue	NNS
46745	6161	9	is	be	VBZ
46745	6161	10	not	not	RB
46745	6161	11	usually	usually	RB
46745	6161	12	admitted	admit	VBN
46745	6161	13	.	.	.
46745	6162	1	How	how	WRB
46745	6162	2	then	then	RB
46745	6162	3	are	be	VBP
46745	6162	4	we	-PRON-	PRP
46745	6162	5	to	to	TO
46745	6162	6	explain	explain	VB
46745	6162	7	the	the	DT
46745	6162	8	analogous	analogous	JJ
46745	6162	9	action	action	NN
46745	6162	10	of	of	IN
46745	6162	11	these	these	DT
46745	6162	12	paralyzing	paralyze	VBG
46745	6162	13	Neurotics	neurotic	NNS
46745	6162	14	on	on	IN
46745	6162	15	animals	animal	NNS
46745	6162	16	and	and	CC
46745	6162	17	vegetables	vegetable	NNS
46745	6162	18	?	?	.
46745	6163	1	Possibly	possibly	RB
46745	6163	2	they	-PRON-	PRP
46745	6163	3	may	may	MD
46745	6163	4	be	be	VB
46745	6163	5	capable	capable	JJ
46745	6163	6	of	of	IN
46745	6163	7	acting	act	VBG
46745	6163	8	directly	directly	RB
46745	6163	9	on	on	IN
46745	6163	10	contractile	contractile	NN
46745	6163	11	or	or	CC
46745	6163	12	irritable	irritable	JJ
46745	6163	13	tissues	tissue	NNS
46745	6163	14	in	in	IN
46745	6163	15	both	both	DT
46745	6163	16	cases	case	NNS
46745	6163	17	,	,	,
46745	6163	18	without	without	IN
46745	6163	19	necessarily	necessarily	RB
46745	6163	20	influencing	influence	VBG
46745	6163	21	the	the	DT
46745	6163	22	nerves	nerve	NNS
46745	6163	23	in	in	IN
46745	6163	24	order	order	NN
46745	6163	25	to	to	TO
46745	6163	26	produce	produce	VB
46745	6163	27	paralysis	paralysis	NN
46745	6163	28	.	.	.
46745	6164	1	[	[	-LRB-
46745	6164	2	43	43	CD
46745	6164	3	]	]	-RRB-
46745	6164	4	Turner	Turner	NNP
46745	6164	5	's	's	POS
46745	6164	6	Chemistry	Chemistry	NNP
46745	6164	7	,	,	,
46745	6164	8	7th	7th	JJ
46745	6164	9	edit	edit	NN
46745	6164	10	.	.	.
46745	6164	11	,	,	,
46745	6164	12	p.	p.	NN
46745	6164	13	995	995	CD
46745	6164	14	.	.	.
46745	6165	1	[	[	-LRB-
46745	6165	2	44	44	CD
46745	6165	3	]	]	-RRB-
46745	6165	4	I	-PRON-	PRP
46745	6165	5	do	do	VBP
46745	6165	6	not	not	RB
46745	6165	7	here	here	RB
46745	6165	8	mean	mean	VB
46745	6165	9	to	to	TO
46745	6165	10	imply	imply	VB
46745	6165	11	that	that	IN
46745	6165	12	the	the	DT
46745	6165	13	products	product	NNS
46745	6165	14	of	of	IN
46745	6165	15	the	the	DT
46745	6165	16	actions	action	NNS
46745	6165	17	of	of	IN
46745	6165	18	all	all	DT
46745	6165	19	glands	gland	NNS
46745	6165	20	are	be	VBP
46745	6165	21	destined	destine	VBN
46745	6165	22	for	for	IN
46745	6165	23	excretion	excretion	NN
46745	6165	24	.	.	.
46745	6166	1	It	-PRON-	PRP
46745	6166	2	is	be	VBZ
46745	6166	3	probable	probable	JJ
46745	6166	4	that	that	IN
46745	6166	5	the	the	DT
46745	6166	6	bile	bile	NN
46745	6166	7	and	and	CC
46745	6166	8	some	some	DT
46745	6166	9	other	other	JJ
46745	6166	10	secretions	secretion	NNS
46745	6166	11	are	be	VBP
46745	6166	12	partly	partly	RB
46745	6166	13	re	re	VBN
46745	6166	14	-	-	VBN
46745	6166	15	absorbed	absorb	VBN
46745	6166	16	into	into	IN
46745	6166	17	the	the	DT
46745	6166	18	blood	blood	NN
46745	6166	19	.	.	.
46745	6167	1	But	but	CC
46745	6167	2	we	-PRON-	PRP
46745	6167	3	are	be	VBP
46745	6167	4	now	now	RB
46745	6167	5	concerned	concerned	JJ
46745	6167	6	only	only	RB
46745	6167	7	with	with	IN
46745	6167	8	the	the	DT
46745	6167	9	function	function	NN
46745	6167	10	of	of	IN
46745	6167	11	glands	gland	NNS
46745	6167	12	as	as	IN
46745	6167	13	emunctories	emunctorie	NNS
46745	6167	14	.	.	.
46745	6168	1	[	[	-LRB-
46745	6168	2	45	45	CD
46745	6168	3	]	]	-RRB-
46745	6168	4	No	no	DT
46745	6168	5	lists	list	NNS
46745	6168	6	of	of	IN
46745	6168	7	the	the	DT
46745	6168	8	Eliminative	eliminative	JJ
46745	6168	9	orders	order	NNS
46745	6168	10	will	will	MD
46745	6168	11	be	be	VB
46745	6168	12	given	give	VBN
46745	6168	13	;	;	:
46745	6168	14	for	for	IN
46745	6168	15	as	as	IN
46745	6168	16	only	only	RB
46745	6168	17	a	a	DT
46745	6168	18	general	general	JJ
46745	6168	19	outline	outline	NN
46745	6168	20	of	of	IN
46745	6168	21	the	the	DT
46745	6168	22	mode	mode	NN
46745	6168	23	of	of	IN
46745	6168	24	action	action	NN
46745	6168	25	of	of	IN
46745	6168	26	these	these	DT
46745	6168	27	medicines	medicine	NNS
46745	6168	28	is	be	VBZ
46745	6168	29	intended	intend	VBN
46745	6168	30	,	,	,
46745	6168	31	a	a	DT
46745	6168	32	detailed	detailed	JJ
46745	6168	33	enumeration	enumeration	NN
46745	6168	34	of	of	IN
46745	6168	35	the	the	DT
46745	6168	36	remedies	remedy	NNS
46745	6168	37	comprised	comprise	VBN
46745	6168	38	in	in	IN
46745	6168	39	each	each	DT
46745	6168	40	order	order	NN
46745	6168	41	would	would	MD
46745	6168	42	be	be	VB
46745	6168	43	a	a	DT
46745	6168	44	needless	needless	JJ
46745	6168	45	appropriation	appropriation	NN
46745	6168	46	of	of	IN
46745	6168	47	space	space	NN
46745	6168	48	.	.	.
46745	6169	1	[	[	-LRB-
46745	6169	2	46	46	CD
46745	6169	3	]	]	-RRB-
46745	6169	4	It	-PRON-	PRP
46745	6169	5	has	have	VBZ
46745	6169	6	been	be	VBN
46745	6169	7	asserted	assert	VBN
46745	6169	8	by	by	IN
46745	6169	9	Dr.	Dr.	NNP
46745	6169	10	Murray	Murray	NNP
46745	6169	11	that	that	IN
46745	6169	12	it	-PRON-	PRP
46745	6169	13	is	be	VBZ
46745	6169	14	impossible	impossible	JJ
46745	6169	15	for	for	IN
46745	6169	16	Mercury	Mercury	NNP
46745	6169	17	to	to	TO
46745	6169	18	pass	pass	VB
46745	6169	19	off	off	RP
46745	6169	20	in	in	IN
46745	6169	21	the	the	DT
46745	6169	22	urine	urine	NN
46745	6169	23	,	,	,
46745	6169	24	on	on	IN
46745	6169	25	account	account	NN
46745	6169	26	of	of	IN
46745	6169	27	the	the	DT
46745	6169	28	Phosphoric	Phosphoric	NNP
46745	6169	29	acid	acid	NN
46745	6169	30	contained	contain	VBN
46745	6169	31	in	in	IN
46745	6169	32	that	that	DT
46745	6169	33	secretion	secretion	NN
46745	6169	34	,	,	,
46745	6169	35	which	which	WDT
46745	6169	36	would	would	MD
46745	6169	37	precipitate	precipitate	VB
46745	6169	38	the	the	DT
46745	6169	39	metal	metal	NN
46745	6169	40	.	.	.
46745	6170	1	But	but	CC
46745	6170	2	Phosphoric	Phosphoric	NNP
46745	6170	3	acid	acid	NN
46745	6170	4	is	be	VBZ
46745	6170	5	also	also	RB
46745	6170	6	contained	contain	VBN
46745	6170	7	in	in	IN
46745	6170	8	the	the	DT
46745	6170	9	blood	blood	NN
46745	6170	10	;	;	:
46745	6170	11	and	and	CC
46745	6170	12	Mercury	Mercury	NNP
46745	6170	13	has	have	VBZ
46745	6170	14	been	be	VBN
46745	6170	15	discovered	discover	VBN
46745	6170	16	in	in	IN
46745	6170	17	the	the	DT
46745	6170	18	urine	urine	NN
46745	6170	19	.	.	.
46745	6171	1	[	[	-LRB-
46745	6171	2	47	47	CD
46745	6171	3	]	]	-RRB-
46745	6171	4	Reference	reference	NN
46745	6171	5	is	be	VBZ
46745	6171	6	made	make	VBN
46745	6171	7	at	at	IN
46745	6171	8	the	the	DT
46745	6171	9	end	end	NN
46745	6171	10	of	of	IN
46745	6171	11	each	each	DT
46745	6171	12	article	article	NN
46745	6171	13	to	to	IN
46745	6171	14	those	those	DT
46745	6171	15	parts	part	NNS
46745	6171	16	of	of	IN
46745	6171	17	the	the	DT
46745	6171	18	Essay	Essay	NNP
46745	6171	19	in	in	IN
46745	6171	20	which	which	WDT
46745	6171	21	the	the	DT
46745	6171	22	remedy	remedy	NN
46745	6171	23	has	have	VBZ
46745	6171	24	been	be	VBN
46745	6171	25	mentioned	mention	VBN
46745	6171	26	before	before	RB
46745	6171	27	.	.	.
46745	6172	1	[	[	-LRB-
46745	6172	2	48	48	CD
46745	6172	3	]	]	-RRB-
46745	6172	4	See	See	NNP
46745	6172	5	Pereira	Pereira	NNP
46745	6172	6	's	's	POS
46745	6172	7	"	"	``
46745	6172	8	Materia	Materia	NNP
46745	6172	9	Medica	Medica	NNP
46745	6172	10	,	,	,
46745	6172	11	"	"	''
46745	6172	12	vol	vol	NNP
46745	6172	13	.	.	.
46745	6173	1	i.	i.	NNP
46745	6173	2	p.	p.	NNP
46745	6173	3	204	204	CD
46745	6173	4	.	.	.
46745	6174	1	[	[	-LRB-
46745	6174	2	49	49	CD
46745	6174	3	]	]	-RRB-
46745	6174	4	See	see	VB
46745	6174	5	account	account	NN
46745	6174	6	of	of	IN
46745	6174	7	the	the	DT
46745	6174	8	mode	mode	NN
46745	6174	9	of	of	IN
46745	6174	10	preparation	preparation	NN
46745	6174	11	,	,	,
46745	6174	12	by	by	IN
46745	6174	13	the	the	DT
46745	6174	14	Author	author	NN
46745	6174	15	,	,	,
46745	6174	16	in	in	IN
46745	6174	17	the	the	DT
46745	6174	18	second	second	JJ
46745	6174	19	edition	edition	NN
46745	6174	20	of	of	IN
46745	6174	21	Dr.	Dr.	NNP
46745	6174	22	Royle	Royle	NNP
46745	6174	23	's	's	POS
46745	6174	24	"	"	``
46745	6174	25	Manual	Manual	NNP
46745	6174	26	of	of	IN
46745	6174	27	Materia	Materia	NNP
46745	6174	28	Medica	Medica	NNP
46745	6174	29	.	.	.
46745	6174	30	"	"	''
46745	6175	1	Transcriber	Transcriber	NNP
46745	6175	2	's	's	POS
46745	6175	3	Note	note	NN
46745	6175	4	The	the	DT
46745	6175	5	oe	oe	JJ
46745	6175	6	ligature	ligature	NN
46745	6175	7	is	be	VBZ
46745	6175	8	represented	represent	VBN
46745	6175	9	by	by	IN
46745	6175	10	[	[	-LRB-
46745	6175	11	oe	oe	IN
46745	6175	12	]	]	-RRB-
46745	6175	13	Subscripts	subscript	NNS
46745	6175	14	are	be	VBP
46745	6175	15	introduced	introduce	VBN
46745	6175	16	by	by	IN
46745	6175	17	an	an	DT
46745	6175	18	underscore	underscore	NN
46745	6175	19	,	,	,
46745	6175	20	e.g.	e.g.	RB
46745	6176	1	CO_{2	CO_{2	NNP
46745	6176	2	}	}	-RRB-
46745	6176	3	Greek	greek	JJ
46745	6176	4	words	word	NNS
46745	6176	5	have	have	VBP
46745	6176	6	been	be	VBN
46745	6176	7	transliterated	transliterate	VBN
46745	6176	8	,	,	,
46745	6176	9	e.g.	e.g.	RB
46745	6177	1	[	[	-LRB-
46745	6177	2	Greek	Greek	NNP
46745	6177	3	:	:	:
46745	6177	4	kineô	kineô	NN
46745	6177	5	]	]	-RRB-
46745	6177	6	The	the	DT
46745	6177	7	apothecaries	apothecary	NNS
46745	6177	8	'	'	POS
46745	6177	9	symbol	symbol	NN
46745	6177	10	for	for	IN
46745	6177	11	the	the	DT
46745	6177	12	dram	dram	NNP
46745	6177	13	is	be	VBZ
46745	6177	14	represented	represent	VBN
46745	6177	15	by	by	IN
46745	6177	16	[	[	-LRB-
46745	6177	17	dram	dram	NNP
46745	6177	18	]	]	-RRB-
46745	6177	19	.	.	.
46745	6178	1	When	when	WRB
46745	6178	2	followed	follow	VBN
46745	6178	3	by	by	IN
46745	6178	4	"	"	``
46745	6178	5	j	j	NNP
46745	6178	6	"	"	``
46745	6178	7	the	the	DT
46745	6178	8	quantity	quantity	NN
46745	6178	9	is	be	VBZ
46745	6178	10	1	1	CD
46745	6178	11	dram	dram	NNP
46745	6178	12	;	;	:
46745	6178	13	when	when	WRB
46745	6178	14	followed	follow	VBN
46745	6178	15	by	by	IN
46745	6178	16	"	"	``
46745	6178	17	ss	ss	FW
46745	6178	18	"	"	''
46745	6178	19	the	the	DT
46745	6178	20	quantity	quantity	NN
46745	6178	21	is	be	VBZ
46745	6178	22	1/2	1/2	CD
46745	6178	23	dram	dram	RB
46745	6178	24	.	.	.
46745	6179	1	The	the	DT
46745	6179	2	apothecaries	apothecary	NNS
46745	6179	3	'	'	POS
46745	6179	4	dram	dram	NNP
46745	6179	5	is	be	VBZ
46745	6179	6	3.8879346	3.8879346	CD
46745	6179	7	grams	gram	NNS
46745	6179	8	.	.	.